FN Clarivate Analytics Web of Science
VR 1.0
PT C
AU Obembe, F
   Obembe, D
AF Obembe, Funmi
   Obembe, Demola
BE GarciaPerez, A
   Simkin, L
TI The Impact of Digital Transformation on Knowledge Management During
   COVID-19
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE Digital transformation; COVID-19; Intelligent knowledge management;
   Adaptive knowledge management; Innovative technologies; Knowledge
   management systems
ID TECHNOLOGY ACCEPTANCE MODEL; INFORMATION-TECHNOLOGY; ADOPTION
AB Technology and digital transformations are increasingly important in today's world. The COVID-19 pandemic that the entire world has been grappling with for the last year has made this even more so. The speed at which different organisations across various sectors have had to embrace digital transformations has been unprecedented. In some sectors this has been driven by the need to simply survive during this pandemic. However, beyond just responding to crisis, digital transformation, and the use of data to drive it has over the years brought about disruptions which have led to great innovations and progress. In many instances these innovations have not only been driven by digital transformations but by a merging of digital transformations and intelligent/adaptive knowledge management systems that have arisen from it. Even before the emergence of the pandemic, digital transformations, AI, machine learning techniques and various innovative technologies had started to be used to design intelligent and adaptive knowledge management systems. COVID-19 has greatly accelerated the uptake of these technologies across a wide range of sectors. Organisations that would successfully navigate these times and be ready for the future need their knowledge management systems to be intelligent and highly adaptive. Digital transformations and innovative technologies are increasingly making this possible. In this work in progress paper, we start to explore the impact of digital transformation and innovative technologies on organisations' knowledge management systems and the changes in the factors that contribute to whether organisations adopt these innovative technologies/digital transformations in times of crisis such as during the COVID-19 pandemic. Knowledge management systems that can respond to inevitable changes that arise in crisis situations such as COVID-19 are invaluable. These systems are positioned to naturally produce actionable intelligence resulting in competitive advantage.
C1 [Obembe, Funmi; Obembe, Demola] De Montfort Univ, Leicester, Leics, England.
RP Obembe, F (corresponding author), De Montfort Univ, Leicester, Leics, England.
EM funmi.obembe@dmu.ac.uk; dobembe@dmu.ac.uk
OI Obembe, Funmi/0000-0003-3375-9147
CR ADAMS DA, 1992, MIS QUART, V16, P227, DOI 10.2307/249577
   Ammirato S, 2021, KNOWL MAN RES PRACT, V19, P415, DOI 10.1080/14778238.2020.1801364
   Budd J, 2020, NAT MED, V26, P1183, DOI 10.1038/s41591-020-1011-4
   Chuttur M.Y, 2009, WORK PAP INF SYST, V9, P9, DOI DOI 10.1021/jf001443p
   Conger S, 2020, INFORM SYST MANAGE, V37, P327, DOI 10.1080/10580530.2020.1820636
   Consultancy.uk, 2020, COV 19 HAS ACC DIG T
   Davenport Thomas, 2019, Future Healthc J, V6, P94, DOI 10.7861/futurehosp.6-2-94
   Davis F. D., 1985, TECHNOLOGY ACCEPTANC
   Di Vaio A, 2021, J BUS RES, V123, P220, DOI 10.1016/j.jbusres.2020.09.042
   Golinelli D, 2020, J MED INTERNET RES, V22, DOI 10.2196/22280
   Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002
   Hutchings R., 2020, IMPACT COVID 19 USE
   Kudyba S, 2020, INFORM SYST MANAGE, V37, P284, DOI 10.1080/10580530.2020.1818903
   Kuhle L, 2021, RELIGIONS, V12, DOI 10.3390/rel12070496
   Levanon G, 2020, FORBES
   Liu IF, 2010, COMPUT EDUC, V54, P600, DOI 10.1016/j.compedu.2009.09.009
   Ross, 2015, J ONLINE LEARNING TE, V11, DOI DOI 10.12720/JOAMS.4.2.92-97
   Scherer R, 2019, COMPUT EDUC, V128, P13, DOI 10.1016/j.compedu.2018.09.009
   Soto-Acosta P, 2020, INFORM SYST MANAGE, V37, P260, DOI 10.1080/10580530.2020.1814461
   Taherdoost H, 2018, PROCEDIA MANUF, V22, P960, DOI 10.1016/j.promfg.2018.03.137
   United Nations Educational Scientific and Cultural Organization (UNESCO), 2020, COVID 19 ED DISR RES
   Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Venkatesh V, 2008, DECISION SCI, V39, P273, DOI 10.1111/j.1540-5915.2008.00192.x
NR 24
TC 0
Z9 0
U1 2
U2 2
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 992
EP 997
DI 10.34190/EKM.21.169
PG 6
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900116
DA 2022-04-20
ER

PT C
AU Morawiec, P
   Soltysik-Piorunkiewicz, A
AF Morawiec, Patryk
   Soltysik-Piorunkiewicz, Anna
BE Themistocleous, M
   Papadaki, M
TI Knowledge Management Significance in Agile Organization in Lights of
   COVID-19 Pandemic Changes
SO INFORMATION SYSTEMS (EMCIS 2021)
SE Lecture Notes in Business Information Processing
LA English
DT Proceedings Paper
CT 18th European, Mediterranean, and Middle Eastern Conference on
   Information Systems (EMCIS)
CY DEC 08-09, 2021
CL ELECTR NETWORK
SP Unov Nicosia, British Univ Dubai, Dubai Block Chain Ctr
DE Organizational agility; Knowledge management; Knowledge processes;
   COVID-19
AB The paper discuss how organizational agility can affect the knowledge management processes in organization, especially in case of ongoing COVID-19 pandemics changes. The research problems are to show a link between knowledge management and agility in organization and to examine a COVID-19 pandemics impact on both knowledge management in organization and organizational agility. We carefully examined a literature from knowledge management-related, recognized scientific journals. We searched journal articles from 1994-2021 and divided the results into 3 time periods to show the historic view on knowledge management in agility, the current view in 2015-2019 and latest time period (2020-2021) to show the impact of COVID-19 pandemics on knowledge management and organizational agility. The study shows the relation of knowledge management and organizational agility with some diversity of research scopes related with COVID-19 pandemics. The insights of our research may be useful for organizations in transforming their knowledge management processes in dynamically changing environment.
C1 [Morawiec, Patryk; Soltysik-Piorunkiewicz, Anna] Univ Econ Katowice, 1 Maja 50, PL-40287 Katowice, Poland.
RP Morawiec, P (corresponding author), Univ Econ Katowice, 1 Maja 50, PL-40287 Katowice, Poland.
EM patryk.morawiec@edu.uekat.pl; anna.soltysik-piorunkiewicz@uekat.pl
OI Morawiec, Patryk/0000-0002-4130-2705
CR Aburub F., 2018, J INF SYST TELECOMMU, V6, P149, DOI [10.7508/jist.2018.03.004, DOI 10.7508/JIST.2018.03.004]
   Aburub F, 2015, INFORM TECHNOL PEOPL, V28, P570, DOI 10.1108/ITP-06-2014-0124
   Akella D, 2021, LEARN ORGAN, V28, P71, DOI 10.1108/TLO-06-2020-0117
   Ammirato S, 2021, KNOWL MAN RES PRACT, V19, P415, DOI 10.1080/14778238.2020.1801364
   Ashok M, 2021, J KNOWL MANAG, V25, P2245, DOI 10.1108/JKM-09-2020-0700
   Becerra-Fernandez I., 2015, KNOWLEDGE MANAGEMENT
   Carillo K, 2021, EUR J INFORM SYST, V30, P69, DOI 10.1080/0960085X.2020.1829512
   Cegarra-Navarro JG, 2016, J BUS RES, V69, P1544, DOI 10.1016/j.jbusres.2015.10.014
   Chatwani N., 2019, ORG AGILITY EXPLORIN, DOI [10.1007/978-3-030-17249-7, DOI 10.1007/978-3-030-17249-7]
   Chin T, 2021, J KNOWL MANAG, V25, P1, DOI 10.1108/JKM-04-2020-0244
   Dalkir K., 2005, KNOWLEDGE MANAGEMENT
   Davenport T.H., 2000, UBIQUITY, DOI [10.1145/347634.348775, DOI 10.1145/347634.348775]
   Dingsoyr T, 2009, SOFTWARE ARCHITECTURE KNOWLEDGE MANAGEMENT: THEORY AND PRACTICE, P59, DOI 10.1007/978-3-642-02374-3_4
   Flaszewska S., 2017, PROJEKTOWANIE ORGANI
   Gadner J., 2004, ORG KNOWLEDGE, DOI [10. 1057/9780230523111, DOI 10.1057/9780230523111]
   Girard J.P., 2009, LEADERS GUIDE KNOWLE, DOI [10. 4128/9781606490198, DOI 10.4128/9781606490198]
   Grundstein M., 2019, CURRENT ISSUES KNOWL, DOI [10.5772/intechopen. 86757, DOI 10.5772/INTECHOPEN.86757]
   Haider SA, 2021, J KNOWL MANAG, V25, P298, DOI 10.1108/JKM-01-2020-0026
   Handzic M., 2004, KNOWLEDGE MANAGEMENT
   Haneberg DH, 2021, LEARN ORGAN, V28, P137, DOI 10.1108/TLO-05-2020-0101
   Harraf A., 2015, JABR, V31, P675, DOI [10.19030/ jabr.v31i2.9160, DOI 10.19030/JABR.V31I2.9160]
   Henningsson S, 2021, EUR J INFORM SYST, V30, P137, DOI 10.1080/0960085X.2020.1860656
   Holbeche L., 2018, AGILE ORG BUILD ENGA
   Iacuzzi S, 2021, KNOWL MAN RES PRACT, V19, P433, DOI 10.1080/14778238.2020.1838963
   Jasimuddin S.M., 2011, KNOWLEDGE MANAGEMENT, P1
   Lent B., 2013, CYBERNETIC APPROACH, DOI [10.1007/978-3-642-32504-5, DOI 10.1007/978-3-642-32504-5]
   Maczuga P., ZARZADZANIEWIEDZA 20
   Mandviwalla M, 2021, EUR J INFORM SYST, V30, P359, DOI 10.1080/0960085X.2021.1891004
   Newell Sue, 2005, JISTEM J.Inf.Syst. Technol. Manag., V2, P275
   Nonaka I., 1998, EC IMPACT KNOWLEDGE, P175, DOI [10.1016/B978-0-7506-7009-8.50016-1, DOI 10.1016/B978-0-7506-7009-8.50016-1]
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Paterek P., 2017, MARLETING RYNEK, V4, P294
   Paul J, 2020, INT BUS REV, V29, DOI 10.1016/j.ibusrev.2020.101717
   Pee LG, 2021, EUR J INFORM SYST, V30, P157, DOI 10.1080/0960085X.2020.1863751
   Raudeliuniene J, 2021, J KNOWL MANAG, V25, P871, DOI 10.1108/JKM-03-2020-0168
   Rollett H., 2003, KNOWLEDGE MANAGEMENT, DOI [10. 1007/978-1-4615-0345-3, DOI 10.1007/978-1-4615-0345-3]
   Rowe F, 2020, EUR J INFORM SYST, V29, P545, DOI 10.1080/0960085X.2020.1803155
   Sadeghi JK, 2021, J KNOWL MANAG, V25, P714, DOI 10.1108/JKM-06-2020-0404
   Senge P. M., 1994, 5 DISCIPLINE ART PRA
   Serenko A, 2017, J KNOWL MANAG, V21, P675, DOI 10.1108/JKM-11-2016-0490
   Soltysik-Piorunkiewicz A., 2018, MODELE OCENY UZYTECZ
   Soluk J, 2021, EUR J INFORM SYST, V30, P676, DOI 10.1080/0960085X.2020.1857666
   STEIN EW, 1995, INT J INFORM MANAGE, V15, P17, DOI 10.1016/0268-4012(94)00003-C
   Trzcielinski S, 2015, PROCEDIA MANUF, V3, P6615, DOI 10.1016/j.promfg.2015.11.001
   Van Looy A, 2021, KNOWL PROCESS MANAG, V28, P107, DOI 10.1002/kpm.1659
   Welsh R, 2021, LEARN ORGAN, V28, P367, DOI 10.1108/TLO-05-2020-0093
   Young R., 2020, KNOWLEDGE MANAGEMENT
   Zytniewski M., 2020, ZORIENTOWANE PROCESY
NR 48
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1865-1348
EI 1865-1356
BN 978-3-030-95947-0; 978-3-030-95946-3
J9 LECT NOTES BUS INF P
PY 2022
VL 437
BP 705
EP 722
DI 10.1007/978-3-030-95947-0_50
PG 18
WC Computer Science, Information Systems
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS8EJ
UT WOS:000771721100050
DA 2022-04-20
ER

PT J
AU Xu, DD
   Yan, S
   Zhang, YH
   Zhang, S
   Nakamori, Y
   Chen, LL
AF Xu, Dandan
   Yan, Shuo
   Zhang, Yuhan
   Zhang, Si
   Nakamori, Yoshiteru
   Chen, Lili
TI Knowledge management for extreme public health events COVID-19: based on
   Tiktok data
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article; Early Access
DE Knowledge management; Knowledge sharing behavior; COVID-19; Douyin
   (Tiktok); Governance suggestion
ID INFORMATION-TECHNOLOGY; SOCIAL MEDIA; TRUST; DETERMINANTS; COMMUNITIES;
   NETWORKS; BARRIERS
AB Purpose Taking the COVID-19 as the background, this study aims to investigate the direct influencing factors regarding knowledge sharing behavior (KSB) on new media platforms and discuss how the characteristics of the users could enhance the KSB through moderation effect, and provide empirical evidences. Design/methodology/approach Based on the social exchange theory and after the text analysis of the data collected from the Tiktok platform in 2020, this paper uses the quantitative method to evaluate the factors influence KSB on short video social platform during the COVID-19 outbreak. Findings KSB on new media platform could be enhanced by richer knowledge content of the video posted and the attribute of the platform users directly. Platform users could affect the trustworthiness of the knowledge shared, thus influence the knowledge sharing. On the early stage of the COVID-19, the richer content of the knowledge released by users could effectively enhance the KSB. On the early stage of the emergency events, the official users could play a significant role on KS. During the mitigation stage of COVID-19, the KSB of the knowledge shared by unofficial users with richer content could be enhanced and the moderation effect is relatively stronger. Originality/value The research extends the social exchange theory to a disaster management context. The authors provide an effective reference for future governments to effectively cope with the epidemic and spread public knowledge in an emergency response context. By analyzing the influence of knowledge content and influencer characteristics, it could help the social media platform to improve content management and optimize resource allocation.
C1 [Xu, Dandan; Yan, Shuo; Zhang, Yuhan; Chen, Lili] Beijing Technol & Business Univ, Beijing, Peoples R China.
   [Zhang, Si] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Nakamori, Yoshiteru] Adv Inst Sci & Technol, Nomi, Japan.
RP Chen, LL (corresponding author), Beijing Technol & Business Univ, Beijing, Peoples R China.
EM chenlili918@126.com
CR Aguirre BE, 1998, SOCIOL FORUM, V13, P301, DOI 10.1023/A:1022145900928
   Akhavan P, 2015, ASLIB J INFORM MANAG, V67, P562, DOI 10.1108/AJIM-02-2015-0018
   Al-Alawi A.I., 2007, J KNOWL MANAG, V11, P22, DOI [10.1108/13673270710738898, DOI 10.1108/13673270710738898]
   Amayah AT, 2013, J KNOWL MANAG, V17, P454, DOI 10.1108/JKM-11-2012-0369
   Ardichvili A., 2003, HUMAN RESOURCE DEV I, V6, P5, DOI DOI 10.1080/13678860110063596
   Barua A, 1997, J INFORM SCI, V23, P239, DOI 10.1177/0165551974231786
   Bircham-Connolly H., 2005, ELECT J KNOWLEDGE MA, V32, P1
   Blau P., 1964, EXCHANGE POWER SOCIA
   Bock GW, 2005, MIS QUART, V29, P87, DOI 10.2307/25148669
   Brown JS, 1991, ORGAN SCI, V2, P40, DOI 10.1287/orsc.2.1.40
   Butler JK, 1999, GROUP ORGAN MANAGE, V24, P217, DOI 10.1177/1059601199242005
   Chin TC, 2022, J KNOWL MANAG, V26, P88, DOI 10.1108/JKM-10-2020-0787
   Chin TC, 2021, ASIA PAC BUS REV, V27, P331, DOI 10.1080/13602381.2021.1911402
   Chin T, 2021, ASIA PAC BUS REV, V27, P342, DOI 10.1080/13602381.2020.1795481
   Chin T, 2021, J KNOWL MANAG, V25, P1, DOI 10.1108/JKM-04-2020-0244
   Connelly C.E., 2003, LEADERSHIP ORG DEV J, V24, P294
   Damodaran L, 2000, BEHAV INFORM TECHNOL, V19, P405, DOI 10.1080/014492900750052660
   Davenport T., 1998, WORKING KNOWLEDGE OR
   De Long DW, 2000, ACAD MANAGE EXEC, V14, P113, DOI 10.5465/AME.2000.3979820
   Depaula N., 2008, 1 MONDAY, V23
   Dong RS, 2018, IEEE T COMPUT SOC SY, V5, P265, DOI 10.1109/TCSS.2017.2786545
   Elrehail H., 2017, TELEMAT INFORM, V35
   Foss N., 2002, J INT MANAG, V8, P49, DOI DOI 10.1016/S1075-4253(01)00054-0
   Gagne M, 2009, HUM RESOUR MANAGE-US, V48, P571, DOI 10.1002/hrm.20298
   Gee Woo Bock, 2002, Information Resources Management Journal, V15, P14, DOI 10.4018/irmj.2002040102
   Harrigan P, 2021, INT J INFORM MANAGE, V56, DOI 10.1016/j.ijinfomgt.2020.102246
   Hinds PJ, 2001, J APPL PSYCHOL, V86, P1232, DOI 10.1037/0021-9010.86.6.1232
   Hislop D., 2013, KNOWLEDGE MANAGEMENT
   Huang CM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-57
   Huang MQ, 2018, EXPERT SYST APPL, V102, P70, DOI 10.1016/j.eswa.2018.02.021
   Jackson SE, 2006, RES PERS H, V25, P27, DOI 10.1016/S0742-7301(06)25002-3
   Jarrah HY, 2020, INT J INSTR, V13, P1, DOI 10.29333/iji.2020.1331a
   Jones GR, 1998, ACAD MANAGE REV, V23, P531, DOI 10.2307/259293
   Kankanhalli A, 2005, MIS QUART, V29, P113, DOI 10.2307/25148670
   Kim J, 2018, INT J INFORM MANAGE, V40, P153, DOI 10.1016/j.ijinfomgt.2018.02.003
   Kim J, 2018, INT J INFORM MANAGE, V38, P86, DOI 10.1016/j.ijinfomgt.2017.08.003
   Kim S, 2006, PUBLIC ADMIN REV, V66, P370, DOI 10.1111/j.1540-6210.2006.00595.x
   Laurence D, 2019, J BUS RES, V104, P183, DOI 10.1016/j.jbusres.2019.06.045
   Levy M, 2009, J KNOWL MANAG, V13, P120, DOI 10.1108/13673270910931215
   Lin CP, 2007, J BUS ETHICS, V70, P411, DOI 10.1007/s10551-006-9119-0
   Lin HF, 2007, J INF SCI, V33, P135, DOI 10.1177/0165551506068174
   Luarn P, 2014, COMPUT HUM BEHAV, V37, P1, DOI 10.1016/j.chb.2014.04.019
   Martin Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181701
   Mayer RC, 2005, ACAD MANAGE J, V48, P874
   Mcafee AP, 2006, MIT SLOAN MANAGE REV, V47, P21
   McDermott R, 1999, CALIF MANAGE REV, V41, P103, DOI 10.2307/41166012
   Murray-Tuite P, 2013, TRANSPORT RES C-EMER, V27, P25, DOI 10.1016/j.trc.2012.11.005
   Ngai EWT, 2015, INT J INFORM MANAGE, V35, P33, DOI 10.1016/j.ijinfomgt.2014.09.004
   Palen L, 2009, SOC SCI COMPUT REV, V27, P467, DOI 10.1177/0894439309332302
   Paroutis S, 2009, J KNOWL MANAG, V13, P52, DOI 10.1108/13673270910971824
   Paton Douglas, 2008, International Journal of Global Environmental Issues, V8, P2, DOI 10.1504/IJGENVI.2008.017256
   Quercia D., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P307, DOI 10.1109/PASSAT/SocialCom.2011.27
   Roy KC, 2020, INT J INFORM MANAGE, V52, DOI 10.1016/j.ijinfomgt.2019.102060
   Sadri A.M., 2020, TRANSPORTATION RES I, V6, DOI DOI 10.1016/J.TRIP.2020.100143
   Shiau WL, 2018, INT J INFORM MANAGE, V43, P52, DOI 10.1016/j.ijinfomgt.2018.06.006
   Szulanski G, 2004, ORGAN SCI, V15, P600, DOI 10.1287/orsc.1040.0096
   Walczak S, 2005, LEARN ORGAN, V12, P330, DOI 10.1108/09696470510599118
   Wasko MM, 2000, J STRATEGIC INF SYST, V9, P155
   WHO, 2020, NOV COR 2019 NCOV SI
   Wiig K. M., 2002, Journal of Knowledge Management, V6, P224, DOI 10.1108/13673270210434331
   World Bank, 2021, GLOB EC OUTL COVID 1
   Yang Y, 2019, INT J DISAST RISK RE, V38, DOI 10.1016/j.ijdrr.2019.101204
   Yates D, 2011, INT J INFORM MANAGE, V31, P6, DOI 10.1016/j.ijinfomgt.2010.10.001
   Zheng YM, 2021, INT J DIGIT EARTH, V14, P1624, DOI 10.1080/17538947.2021.1962995
NR 64
TC 0
Z9 0
U1 49
U2 49
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
DI 10.1108/JKM-06-2021-0450
EA NOV 2021
PG 16
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XD9OX
UT WOS:000723030200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Wang, WT
   Wu, SY
AF Wang, Wei-Tsong
   Wu, Su-Ying
TI Knowledge management based on information technology in response to
   COVID-19 crisis
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE COVID-19; crisis management; knowledge management; information
   technology; healthcare organisation
AB COVID-19's rapid spread has caused a global pandemic. Consequently, it is imperative that healthcare organisations conduct crisis management (CM) to cope with this calamity. This study presents a set of operational guidelines for healthcare organisations to launch effective countermeasures against such crises by means of effective knowledge management (KM) practices. Additionally, information-technology (IT) applications can significantly improve organisations' CM and KM capabilities by enhancing organisational responsiveness and flexibility. This study thus aims to articulate how the use of innovative IT-enabled mechanisms (e.g., non-contact monitoring devices, intelligent robots, and telemedicine) can reduce the risk of exposure and leverage an artificial intelligence-based epidemic intelligence dashboard to support appropriate decision-making by taking the operation of healthcare organisations in Taiwan during COVID-19 crisis as an example. The research results demonstrate the effectiveness of the employment of IT-enabled KM practices in CM settings in terms of preventing or minimising undesirable crisis consequences.
C1 [Wang, Wei-Tsong] Natl Cheng Kung Univ, Dept Ind & Informat Management, Tainan, Taiwan.
   [Wu, Su-Ying] Natl Cheng Kung Univ, Inst Informat Management, Tainan, Taiwan.
   [Wu, Su-Ying] Kaohsiung Med Univ, Dept Med Informat, Kaohsiung, Taiwan.
RP Wang, WT (corresponding author), Natl Cheng Kung Univ, Dept Ind & Informat Management, Tainan, Taiwan.
EM wtwang@mail.ncku.edu.tw
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST 107-2410-H-006-047-MY2]
FX This work was supported by the Ministry of Science and Technology,
   Taiwan [MOST 107-2410-H-006-047-MY2].
CR Arabi YM, 2020, INTENS CARE MED, V46, P833, DOI 10.1007/s00134-020-05955-1
   de Souza DSDA, 2020, KNOWL MAN RES PRACT, V18, P462, DOI 10.1080/14778238.2020.1730716
   Aydiner AS, 2019, INT J INFORM MANAGE, V47, P168, DOI 10.1016/j.ijinfomgt.2018.12.015
   Bakos L, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11236676
   Burkle FM, 2019, TOHOKU J EXP MED, V249, P33, DOI 10.1620/tjem.249.33
   Durst S, 2019, J BUS RES, V105, P1, DOI 10.1016/j.jbusres.2019.08.002
   Fisher D, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01533-w
   Giraldo SM, 2019, J KNOWL MANAG, V23, P1355, DOI 10.1108/JKM-08-2018-0479
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Meyer V, 2021, DISASTER PREV MANAG, V30, P209, DOI 10.1108/DPM-08-2019-0245
   Miller C, 2013, LIVER TRANSPLANT, V19, P656, DOI 10.1002/lt.23637
   MITROFF I, 1994, CALIF MANAGE REV, V36
   Palos-Sanchez PR, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11101253
   Rong XM, 2020, MATH BIOSCI ENG, V17, P2725, DOI 10.3934/mbe.2020149
   Wang WT, 2011, SYST RES BEHAV SCI, V28, P105, DOI 10.1002/sres.1063
   Wang WT, 2009, IND MANAGE DATA SYST, V109, P445, DOI 10.1108/02635570910948605
NR 16
TC 3
Z9 3
U1 10
U2 34
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 468
EP 474
DI 10.1080/14778238.2020.1860665
EA DEC 2020
PG 7
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000600762300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Velasquez, RMA
   Lara, JVM
AF Velasquez, Ricardo Manuel Arias
   Lara, Jennifer Vanessa Mejia
TI Knowledge management in two universities before and during the COVID-19
   effect in Peru
SO TECHNOLOGY IN SOCIETY
LA English
DT Article
DE Knowledge management; University; COVID-19; Per?
AB Knowledge management evaluation is an important and complex problem in Peruvian universities. An efficient policy in knowledge management is a critical success factor and will also advance teaching and research. Likewise, innovation is a key resource for the well-being of national economies and international competitive advantage, especially with COVID-19 9 restrictions. This research article has demonstrated that an assessment of knowledge management (KM) capability in two private universities could be used for an efficient policy, in order to obtain the best result in knowledge management maturity. Having discussed how to construct a model for KM, the final section of this paper addresses ways of the incorporation of this technology in the society. The case study has been developed in Lima, associated to two universities with 271 teachers and 5928 students; with this model could be used for KM assessment in all university in Peru. This study uses the ?Intellectus Model, Mejia model organizational knowledge capability areas and Knowledge Management Capability Assessment (KMCA) model for the assessment, before and during COVID-19. Our findings have demonstrated the university performance and challenges associated to knowledge management during COVID-19, the new policy for virtual instructions and digital transformation of the educational process have improved the cost efficiencies. However, this system also has a number of serious drawbacks and challenges in innovation, researching, connections with industry and academy; this 2021 requires a new perspective in innovation with a knowledge management scheme in Peruvian universities.
C1 [Velasquez, Ricardo Manuel Arias; Lara, Jennifer Vanessa Mejia] Pontificia Univ Catolica Peru, Lima, Peru.
   [Velasquez, Ricardo Manuel Arias] Univ Nacl San Agustin, Arequipa, Peru.
RP Velasquez, RMA (corresponding author), Univ Nacl San Agustin, Arequipa, Peru.; Lara, JVM (corresponding author), Pontificia Univ Catolica Peru, Escuela Posgrad, Doctorado Ingn, Lima, Peru.
EM ricardoariasvelasquez@hotmail.com; jejemejial@gmail.com
RI Velásquez, Ricardo Manuel Arias/R-6348-2019
OI Velásquez, Ricardo Manuel Arias/0000-0002-1067-9753; Mejia Lara,
   Jennifer Vanessa/0000-0002-6901-7113
CR Acar D., 2005, J OVERVIEW ACCOUNTIN, V14, P23
   Al-Emran M, 2020, TECHNOL SOC, V61, DOI 10.1016/j.techsoc.2020.101247
   Al-Sharafi, 2020, TELEMAT INFORM, P1
   Velasquez RMA, 2020, ENG FAIL ANAL, V118, DOI 10.1016/j.engfailanal.2020.104856
   Velasquez RMA, 2020, URBAN CLIM, V33, DOI 10.1016/j.uclim.2020.100664
   Bonk C. J., 2004, HDB BLENDED LEARNING, V1st
   Bozbura FT, 2007, EXPERT SYST APPL, V32, P1100, DOI 10.1016/j.eswa.2006.02.006
   Bueno E., 2011, MODELO INTELLECTUS M
   CONNOR R, 2020, J SURG EDUC, V77, P729, DOI DOI 10.1016/j.jsurg.2020.03.018
   Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
   Demchig B, 2015, PROCD SOC BEHV, V174, P3633, DOI 10.1016/j.sbspro.2015.01.1082
   Dias SB, 2015, EXPERT SYST APPL, V42, P7399, DOI 10.1016/j.eswa.2015.05.048
   Edvinsson L., 1999, CAPITAL INTELECTUAL
   Freeze R, 2005, INT C SYST SCI, p251A
   Fullan, 2001, LEADING CULTURE CHAN
   Galbraith J. K., 1969, AFFLUENT SOC
   Glass RI, 2018, LANCET GLOB HEALTH, V6, pE728, DOI 10.1016/S2214-109X(18)30234-1
   Holgersson M, 2019, TECHNOL SOC, V59, DOI 10.1016/j.techsoc.2019.04.008
   Iyo, BRAIN BEHAV IMMUN HL, V6
   Kulkarni U, 2004, 25 INT C INF SYST
   Malhotra Rajesh, 2020, J Clin Orthop Trauma, V11, pS448, DOI 10.1016/j.jcot.2020.07.002
   MALONE DW, 1975, P IEEE, V63, P397, DOI 10.1109/PROC.1975.9765
   Mejia J., 2020, CHAOS SOLITON FRACT, V136
   Melgar A, 2019, PROCEDIA COMPUT SCI, V146, P220, DOI 10.1016/j.procs.2019.01.096
   MEYSAM A, 2016, P IEEE, P21, DOI DOI 10.1016/j.eswa.2015.12.044
   Neumeyer X, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105058
   Nonaka I, 2000, LONG RANGE PLANN, V33, P5, DOI 10.1016/S0024-6301(99)00115-6
   Rowley J., 2000, INT J EDUC DEV, V14, P325, DOI DOI 10.1108/09513540010378978
   Sanchez A. J., 2007, INVESTIGACIONES EURO, V13, P97
   Valadez G. Velazquez, 2004, ORG CAPITAL HUMANO
   van der Walt, 2020, SOCIAL SCI HUMANITIE, V2
   Velasquez RMA, 2017, INTERCON, P1
   WENMIN L, 2012, EXPERT SYST APPL, V29, P1081, DOI DOI 10.1016/j.econmod.2012.03.021
   WINMIU L, 2014, KNOWL BASE SYST, V71, P201, DOI DOI 10.1016/j.knosys.2014.08.001
   Yeo Y, 2020, TECHNOL SOC, V62, DOI 10.1016/j.techsoc.2020.101295
   Yldz, 2010, INTELLECTUAL CAPITAL, P1
NR 36
TC 12
Z9 13
U1 5
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0160-791X
EI 1879-3274
J9 TECHNOL SOC
JI Technol. Soc.
PD FEB
PY 2021
VL 64
AR 101479
DI 10.1016/j.techsoc.2020.101479
PG 7
WC Social Issues; Social Sciences, Interdisciplinary
WE Social Science Citation Index (SSCI)
SC Social Issues; Social Sciences - Other Topics
GA QW6NO
UT WOS:000628764100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Kirchner, K
   Ipsen, C
   Hansen, JP
AF Kirchner, Kathrin
   Ipsen, Christine
   Hansen, John Paulin
TI COVID-19 leadership challenges in knowledge work
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Managers; knowledge work; working from home; distance management;
   well-being; COVID-19; challenges
AB Considerable attention has been paid to employees' experiences when working from home (WFH) during the COVID-19 pandemic, including their well-being and performance. However, less attention has been paid to how managers experience WFH and how this may challenge them in their new role as distance managers. This study investigates how managers of knowledge work experienced distance management during COVID-19. An international survey was distributed in the first weeks of the Danish national lockdown and collected data in spring 2020. Based on Danish responses from 1053 employees and 290 managers of knowledge work, who had limited prior experience in distance management, our analysis revealed 12 items where managers found their work during lockdown to be more challenging than employees did. The implications are that research and practice should consider the well-being and performance consequences of WFH not only for employees but also for managers, as their experiences differ, and the managers express challenges in their leadership.
C1 [Kirchner, Kathrin; Ipsen, Christine; Hansen, John Paulin] Tech Univ Denmark, DTU Management, Akad Vej 358, DK-2800 Lyngby, Denmark.
RP Kirchner, K (corresponding author), Tech Univ Denmark, DTU Management, Akad Vej 358, DK-2800 Lyngby, Denmark.
EM kakir@dtu.dk
RI Ipsen, Christine/A-8583-2017; Kirchner, Kathrin/C-4984-2016
OI Ipsen, Christine/0000-0002-2394-5571; Kirchner,
   Kathrin/0000-0002-4638-0403; Hansen, John Paulin/0000-0001-5594-3645
CR Adenle C., 2020, WORKING HOME CORONAV
   Alvesson M., 2004, KNOWLEDGE WORK KNOWL
   Anderson AJ, 2015, EUR J WORK ORGAN PSY, V24, P882, DOI 10.1080/1359432X.2014.966086
   [Anonymous], 2020, ECONOMIST
   [Anonymous], 2020, GARTNER
   ARGYRIS C, 1977, HARVARD BUS REV, V55, P115
   Argyris C., 1996, ORG LEARNING 2 THEOR
   Bailey DE, 2002, J ORGAN BEHAV, V23, P383, DOI 10.1002/job.144
   Bolisani E, 2020, MANAG MARK, V15, P458, DOI 10.2478/mmcks-2020-0027
   Bosch-Sijtsema PM, 2009, J KNOWL MANAG, V13, P533, DOI 10.1108/13673270910997178
   Boughzala I, 2012, J ASSOC INF SYST, V13, P714
   Bryman A., 2004, SOCIAL RES METHODS, V2
   Cropper S, 2008, OXFORD HDB INTERORGA
   DeFilippis E., NATL BUREAU EC RES W, DOI [10.3386 /w27612, DOI 10.3386/W27612, 10.2139/ssrn.3654470, DOI 10.2139/SSRN.3654470]
   Denscombe M, 2010, GOOD RES GUIDE SMALL, V4th
   Galbraith J. R., 2002, DESIGNING ORG EXECUT
   Giurge L.M., 2020, HARVARD BUS REV
   Gurstein P., 2001, WIRED WORLD CHAINED
   Hertel G., 2005, Human Resources Management Review, V15, P69, DOI 10.1016/j.hrmr.2005.01.002
   Hesketh I., 2019, WELLBEING WORK DESIG
   Ipsen C., 2020, INT S HUM, P321
   Jackson P.J., 2001, VIRTUAL WORKING SOCI
   Jones G., 2012, 50 TOP TOOLS COACHIN
   Kurland NB, 1999, ORGAN DYN, V28, P53
   Lee M.K., 2011, P SICGHI C HUM FACT, P33
   Nardelli G., 2019, PROS 2019 PROF DEV W
   National Health Service-UK, 2020, MENTAL WELLBEING STA
   Newell S., 2009, MANAGING KNOWLEDGE W
   Pearlman DM, 2010, J CONV EVENT TOUR, V11, P247, DOI 10.1080/15470148.2010.530535
   Poulsen S, 2017, SAFETY SCI, V100, P37, DOI 10.1016/j.ssci.2017.05.002
   Razmerita L, 2014, J ORG COMP ELECT COM, V24, P74, DOI 10.1080/10919392.2014.866504
   Sarka P, 2017, KNOWL MAN RES PRACT, V15, P594, DOI 10.1057/s41275-017-0075-5
   Sofo F., 2011, COMMUNICATIONS COMPU, V278, P271
   Sofo F., 2013, ORG CULTURES INT J, V12, P71, DOI [10.18848/2327-8013/CGP/v12i01/50893, DOI 10.18848/2327-8013/CGP/V12I01/50893]
   Statsministeriet, 2020, PRESS BRIEFING
   Stich JF, 2020, INTELL BUILD INT, V12, P208, DOI 10.1080/17508975.2020.1759023
   The European Commission's Science and Knowledge Centre, 2020, TELEWORK EU COVID 19
   Tsui KM, 2011, ACMIEEE INT CONF HUM, P11, DOI 10.1145/1957656.1957664
   van der Lippe T, 2020, NEW TECH WORK EMPLOY, V35, P60, DOI 10.1111/ntwe.12153
   Vargas O.L., 2020, COVID 19 UNLEASHED P
   Verburg RM, 2013, INT J PROJ MANAG, V31, P68, DOI 10.1016/j.ijproman.2012.04.005
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   World Health Organisation, 2020, HEALTHYATHOME MENTAL
NR 43
TC 18
Z9 18
U1 37
U2 70
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 493
EP 500
DI 10.1080/14778238.2021.1877579
EA FEB 2021
PG 8
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000613789000001
OA Green Submitted
DA 2022-04-20
ER

PT J
AU Saide, S
   Sheng, ML
AF Saide, Saide
   Sheng, Margaret L.
TI Knowledge exploration-exploitation and information technology: crisis
   management of teaching-learning scenario in the COVID-19 outbreak
SO TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT
LA English
DT Article
DE Knowledge management; information systems (online learning); knowledge
   exploration&#8211; exploitation; crisis times (e; g; COVID-19)
AB Education institution closure is considered as an effective way to prevent coronavirus (COVID-19) pandemic. However, there are several challenges concerning teaching and learning activities (knowledge transfer) in crisis times such a COVID-19. This study aims to provide a holistic view of knowledge transfer and information technology scenario in the education sector during COVID-19 or another uncertain environment. A systematic literature review was conducted by several search techniques such as study selection, synthesis of papers, and reporting the results. A total of 290 peer-reviewed research studies were carried out. These articles were filtered, and 51 relevant articles were selected. The study mainly contributes by illustrating the schema or scenario of effective knowledge transfer of the teaching-learning process in the context of coronavirus crisis through maximising the information technology (IT) tools and knowledge management (KM) approach. Several factors namely IT tools of remote and online learning, knowledge exploration-exploitation, education's knowledge types (tacit-explicit knowledge), and internal-external knowledge in education were identified. The study further provides the new paradigm for future study. Additionally, several concepts and theories were merged, namely SECI theory and ambidexterity view (knowledge exploration and knowledge exploitation). Future studies may extend the research area to different types of organisations and extend this model into empirical tests.
C1 [Saide, Saide; Sheng, Margaret L.] Natl Taiwan Univ Sci & Technol, Dept Informat Management, Taipei, Taiwan.
   [Sheng, Margaret L.] Natl Taiwan Univ Sci & Technol, Dept Business Adm, Taipei, Taiwan.
RP Saide, S (corresponding author), Natl Taiwan Univ Sci & Technol, Dept Informat Management, Taipei, Taiwan.
EM saide@uin-suska.ac.id
RI Saide, Saide/H-2399-2018
OI Saide, Saide/0000-0002-1866-5305
FU National Taiwan University of Science and Technology (Department of
   Information Management)
FX This research was supported and cooperated with the National Taiwan
   University of Science and Technology (Department of Information
   Management).
CR Agarwal S, 2020, INDIAN J PEDIATR, V87, P554, DOI 10.1007/s12098-020-03327-7
   Almarashdeh I, 2016, COMPUT HUM BEHAV, V63, P249, DOI 10.1016/j.chb.2016.05.013
   Almarzooq ZI, 2020, J AM COLL CARDIOL, V75, P2635, DOI 10.1016/j.jacc.2020.04.015
   Arntzen AAB, 2009, J KNOWL MANAG, V13, P127, DOI 10.1108/13673270910942745
   Asma K, 2016, J INF KNOWL MANAG, V15, DOI 10.1142/S0219649216500416
   Balka E, 2012, INFORM SYST FRONT, V14, P19, DOI 10.1007/s10796-011-9302-4
   Bamel UK, 2018, J KNOWL MANAG, V22, P1555, DOI 10.1108/JKM-10-2017-0460
   Bao W, 2020, HUM BEHAV EMERG TECH, V2, P113, DOI 10.1002/hbe2.191
   Bennett S, 2017, ETR&D-EDUC TECH RES, V65, P125, DOI 10.1007/s11423-016-9469-y
   Cabeza-Pulles D, 2020, EUR MANAG J, V38, P450, DOI 10.1016/j.emj.2019.12.008
   Centobelli P, 2019, TECHNOL FORECAST SOC, V141, P172, DOI 10.1016/j.techfore.2018.10.014
   Conroy ML, 2020, AM J GERIAT PSYCHIAT, V28, P1004, DOI 10.1016/j.jagp.2020.06.003
   Darroch J., 2005, Journal of Knowledge Management, V9, P101, DOI 10.1108/13673270510602809
   Davenport T.H., 1998, IEEE ENG MANAGEMENT, V31, P301, DOI [10.1109/EMR.2003.1267012, DOI 10.1109/EMR.2003.1267012]
   Durak G, 2017, INT REV RES OPEN DIS, V18, P84
   Else FC, 2015, J HIGH EDUC POLICY M, V37, P363, DOI 10.1080/1360080X.2015.1056599
   Feder T, 2020, PHYS TODAY, V73, P22, DOI 10.1063/PT.3.4492
   Ferreira J, 2018, J KNOWL MANAG, V24, P121, DOI 10.1108/JKM-07-2018-0461
   GARVIN DA, 1993, HARVARD BUS REV, V71, P78
   George Marcus L., 2020, Journal of Educational Technology Systems, V49, P23, DOI 10.1177/0047239520934017
   Gresty KA, 2012, BRIT J EDUC TECHNOL, V43, P153, DOI 10.1111/j.1467-8535.2010.01156.x
   Guzman G, 2011, HIGH EDUC, V62, P451, DOI 10.1007/s10734-010-9398-3
   Hafiza, 2017, 2 INT C KNOWL ENG AP, P162, DOI DOI 10.1109/ICKEA.2017.8169922
   Halberstadt J, 2019, J KNOWL MANAG, V23, P1925, DOI 10.1108/JKM-12-2018-0744
   Hartono R, 2016, TECHNOL ANAL STRATEG, V28, P335, DOI 10.1080/09537325.2015.1095289
   Higgins J.P.T., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Hollenweger J, 2013, DISABIL REHABIL, V35, P1087, DOI 10.3109/09638288.2012.740135
   Huang R., 2020, HDB FACILITATING FLE
   Hurley D., 2017, J TEACHING LEARNING, V6, P65, DOI [10.14434/jotlt.v6.n1.19528, DOI 10.14434/JOTLT.V6.N1.19528]
   Jaeger MM, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100524
   Jiang ZY, 2020, TECHNOL ANAL STRATEG, V32, P785, DOI 10.1080/09537325.2020.1714025
   Karnani F, 2013, J TECHNOL TRANSFER, V38, P235, DOI 10.1007/s10961-012-9251-1
   Kayode BK, 2018, INT REV RES OPEN DIS, V19, P17
   Kim L, 1998, ORGAN SCI, V9, P506, DOI 10.1287/orsc.9.4.506
   Kitchenham B, 2010, INFORM SOFTWARE TECH, V52, P792, DOI 10.1016/j.infsof.2010.03.006
   Kraaijenbrink J, 2008, KNOWL MAN RES PRACT, V6, P274, DOI 10.1057/kmrp.2008.26
   Lee SM, 2002, IND MANAGE DATA SYST, V102, P17, DOI 10.1108/02635570210414622
   Liu FH, 2020, J KNOWL MANAG, V24, P1005, DOI 10.1108/JKM-09-2019-0497
   Liu PL, 2004, TECHNOVATION, V24, P971, DOI 10.1016/S0166-4972(03)00061-0
   Sein-Echaluce ML, 2015, LECT NOTES COMPUT SC, V9192, P510, DOI 10.1007/978-3-319-20609-7_48
   Lyu HB, 2017, ENTERP INF SYST-UK, V11, P1416, DOI 10.1080/17517575.2016.1273393
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Margaret LS, 2019, J INT MANAG, V25, DOI 10.1016/j.intman.2019.100705
   Martins N, 2015, PROCD SOC BEHV, V171, P929, DOI 10.1016/j.sbspro.2015.01.211
   Mulenga E. M., 2020, CONT ED TECHNOLOGY, V12, P1, DOI [10.30935/cedtech/7949, DOI 10.30935/CEDTECH/7949]
   Mumford E, 2006, INFORM SYST J, V16, P317, DOI 10.1111/j.1365-2575.2006.00221.x
   Murphy MPA, 2020, CONTEMP SECUR POL, V41, P492, DOI 10.1080/13523260.2020.1761749
   Musingafi M. C. C., 2015, J ED PRACTICE, V6, P59
   Muthuveloo R, 2017, ASIA PAC MANAG REV, V22, P192, DOI 10.1016/j.apmrv.2017.07.010
   Muwardi D, 2020, INT J INNOV MANAG, V24, DOI 10.1142/S1363919621500092
   Nawaz M.M., 2014, J QUALITY TECHNOLOGY, VX, P59
   Ng PL, 2017, MALAYS J LIBR INF SC, V22, P28, DOI 10.22452/mjlis.vol22no1.3
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Nonaka I, 1997, KNOWLEDGE CREATING C
   O'Reilly CA, 2013, ACAD MANAGE PERSPECT, V27, P324, DOI 10.5465/amp.2013.0025
   Olk P, 2020, J MANAGE INQUIRY, V29, P134, DOI 10.1177/1056492619864639
   Peng JY, 2013, PROCEDIA COMPUT SCI, V22, P95, DOI 10.1016/j.procs.2013.09.085
   Polanyi M, 1962, PERSONAL KNOWLEDGE P
   Popovic N, 2018, ADV PHYSIOL EDUC, V42, P111, DOI 10.1152/advan.00155.2017
   Quezada RL, 2020, J EDUC TEACHING, V46, P472, DOI 10.1080/02607476.2020.1801330
   Qureshi MI, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11164294
   Rajhans V, 2020, J OPTOM, V13, P216, DOI 10.1016/j.optom.2020.06.002
   Ramjeawon PV, 2017, LEARN ORGAN, V24, P366, DOI 10.1108/TLO-03-2017-0030
   Randy B., 2019, BIG DATA AI EXECUTIV
   ROUXDUFORT C, 2000, REV BUS, V21, P25
   Saide, 2017, INT J BUS SOC, V18, P353
   Saide, 2015, PROCEDIA COMPUT SCI, V72, P613, DOI 10.1016/j.procs.2015.12.170
   Saide S, 2020, BIG DATA-US, V8, P464, DOI 10.1089/big.2020.0140
   Saide S, 2019, J SCI TECHNOL POLICY, V10, P1047, DOI 10.1108/JSTPM-06-2018-0056
   Saide S, 2019, J SCI TECHNOL POLICY, V10, P551, DOI 10.1108/JSTPM-06-2018-0067
   Sandars J., 2020, MEDEDPUBLISH, V9, P49, DOI [10.15694/mep.2020.000049.1, DOI 10.15694/MEP.2020.000049.1]
   Schmidt S. W., 2016, ONLINE J DISTANCE LE, V19, P1
   Segarra-Cipres M, 2014, KNOWL MAN RES PRACT, V12, P203, DOI 10.1057/kmrp.2012.55
   Sengupta A, 2017, RES POLICY, V46, P881, DOI 10.1016/j.respol.2017.03.008
   Shaw D, 2007, J ORGAN CHANGE MANAG, V20, P559, DOI 10.1108/09534810710760081
   Simon L., 2000, REV BUSINESS, V21, P6
   Singhal MK, 2020, J CHEM EDUC, V97, P2711, DOI 10.1021/acs.jchemed.0c00675
   SOBAIH AEE, 2020, SUSTAINABILITY SWITZ, V12, DOI DOI 10.3390/su12166520
   Stewart W., 2006, CASE STUDY OPEN ED R
   Sudhindra S, 2020, KNOWL MAN RES PRACT, V18, P310, DOI 10.1080/14778238.2019.1654417
   Toquero C. M, 2020, PEDAGOGICAL RES, V5
   UNESCO, 2020, COVID 19 IMP ED
   Urgal B, 2013, TECHNOL ANAL STRATEG, V25, P543, DOI 10.1080/09537325.2013.785514
   Wang CH, 2020, J KNOWL MANAG, V24, P301, DOI 10.1108/JKM-04-2019-0198
   WHO, 2020, 99 WHO 99 WHO
   Wu P, 2015, J PROF ISS ENG ED PR, V141, DOI 10.1061/(ASCE)EI.1943-5541.0000245
NR 86
TC 6
Z9 6
U1 8
U2 25
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0953-7325
EI 1465-3990
J9 TECHNOL ANAL STRATEG
JI Technol. Anal. Strateg. Manage.
PD AUG 3
PY 2021
VL 33
IS 8
BP 927
EP 942
DI 10.1080/09537325.2020.1854714
EA DEC 2020
PG 16
WC Management; Multidisciplinary Sciences
WE Social Science Citation Index (SSCI)
SC Business & Economics; Science & Technology - Other Topics
GA TP8SS
UT WOS:000596646400001
OA Bronze
DA 2022-04-20
ER

PT C
AU Jallow, H
   Renukappa, S
   Suresh, S
   Algahtani, K
AF Jallow, Haddy
   Renukappa, Suresh
   Suresh, Subashini
   Algahtani, Khaled
BE GarciaPerez, A
   Simkin, L
TI Managing COVID-19 Related Knowledge in the UK Infrastructure Sector
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE COVID-19; Industry 4.0; Knowledge Management; Big Data; Construction;
   Artificial Intelligence
AB COVID-19 has caused the most serious economic and health crisis globally that we have witnessed in decades. Millions of people across the world have lost jobs, while the healthcare systems are struggling to cope with the rapid increase in cases. Many sectors have been affected with this pandemic including the construction infrastructure sector which benefits from engineers and different staff members travelling to site and interacting/collaborating with peers. Infrastructure construction organisations have responded well during the pandemic in order to carry on works while minimising risks to their employees and their families, however management styles have had to be updated and the transferring/ storage and collection of knowledge has seen new processes and methods being adopted. The relationship between Knowledge and its management within the infrastructure sector during the COVID-19 Pandemic is a topic that has not been regularly researched. This paper aims to review both the impact that COVID-19 has had within the infrastructure sector and Knowledge Management during these times attempting to gain an output of how knowledge has been managed throughout the pandemic within the sector. Methodology: Given the lack of research on this topic, this study adopted and implemented a case study methodology approach. Ten semi-structured interviews were conducted as well as observations with the organisations that took part on the research. A total of five organisations took part on this research and the patterns and connections were analysed during the data analysis stage to draw a conclusion from the study. Findings: COVID-19 has turned our worlds upside down with everything coming to a halt and everyone's lives changing constantly. All sectors have had to change and adapt to this new way of life which also means working management styles are to accommodate for these new ways of working. Innovative technologies are at a rise and construction companies are aware of these advancements. However, the industry has been one of the slowest industries in adopting these advances in relation to Knowledge Management. Knowledge is a big influencer within the infrastructure sector, there is a lot of resistance in terms of adopting innovative techniques to boost KM practices positively as most companies are not fully aware of beneficial adoption practices and tend to overlook the potential benefits and instead investigate the challenges it may raise during adoption. During these difficult times, organisations within the infrastructure sector have had to become a lot more digital. Data storage environments are being heavily used as people are not travelling to work offices which gave employees the ability to use resources and data from the office itself whether it be through face-to-face communication or paper drawings and information. Some companies though have implemented some form of innovative KM processes, one which was highlighted as a trend was Big Data. The industry should enhance their awareness of these technological advances and explore more processes that could benefit the industry to explore the benefits that they can gain. Value: This study provides contribution of the digitisation of knowledge within the construction sector.
   The paper highlights the challenges that the infrastructure sector has faced during COVID-19 and key innovative technologies that can provide benefits to the construction industry and enhance knowledge management processes within the construction sector. It has been concluded that awareness and training of these technologies can boost coordination within companies and enables organisations to have better practices achieving goals despite these current circumstances.
C1 [Jallow, Haddy] Costain Plc, London, England.
   [Renukappa, Suresh; Suresh, Subashini] Univ Wolverhampton, Wolverhampton, England.
   [Algahtani, Khaled] Minist Justice, Riyadh, Saudi Arabia.
RP Jallow, H (corresponding author), Costain Plc, London, England.
EM haddy.jallow@costain.com; Suresh.Renukappa@wlv.ac.uk;
   S.Subashini@wlv.ac.uk; khmghtani@moj.gov.sa
CR DeFranzo S. E, 2020, WHATS DIFFERENCE QUA
   Fennelly KP, 2020, LANCET RESP MED, V8, P914, DOI 10.1016/S2213-2600(20)30323-4
   Flick U., 2009, INTRO QUALITATIVE RE, V4
   Gov.uk, 2021, COR COVID 19
   HM Government, 2020, WORK SAF COVID 19 CO
   HM Treasury and Cabinet Office, 2016, NAT INFR DEL PLAN 20
   HSE, 2019, CONSTR STAT GREAT BR
   HSE, 2021, MAK YOUR WORKPL COVI
   Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036
   McLeod S, 2020, J CLIN PSYCHOL, V76, P59, DOI 10.1002/jclp.22868
   Penaloza GA, 2020, APPL ERGON, V82, DOI 10.1016/j.apergo.2019.102978
   Ritchie H., 2021, CORONAVIRUS COVID 19
   Rogerson M, 2020, COVID 19 NEW NORMALI
   Suman R, 2020, J CLIN EXP HEPATOL, V10, P386, DOI 10.1016/j.jceh.2020.04.020
   Woolley M, 2020, SAFETY SCI, V132, DOI 10.1016/j.ssci.2020.104984
   Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270
NR 16
TC 0
Z9 0
U1 1
U2 1
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 371
EP 380
DI 10.34190/EKM.21.027
PG 10
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900044
DA 2022-04-20
ER

PT J
AU Abdalla, W
   Renukappa, S
   Suresh, S
AF Abdalla, Wala
   Renukappa, Suresh
   Suresh, Subashini
TI An evaluation of critical knowledge areas for managing the COVID-19
   pandemic
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article; Early Access
DE Knowledge mapping; COVID-19; Coronavirus; Concept map; Knowledge areas
ID ABSORPTIVE-CAPACITY; BIG DATA; INFECTION PREVENTION; MANAGEMENT;
   DIRECTIONS; INNOVATION; SYSTEMS; INTELLIGENCE; METHODOLOGY; TECHNOLOGY
AB Purpose The ability to manage the COVID-19 pandemic is contingent upon the ability to effectively manage its heterogeneous knowledge resources. Knowledge mapping represents a great opportunity to create value by bringing stakeholders together, facilitating comprehensive collaboration and facilitating broader in-depth knowledge sharing and transfer. However, identifying and analysing critical knowledge areas is one of the most important steps when creating a knowledge map. Therefore, the purpose of this paper is to appraise the critical knowledge areas for managing COVID-19, and thereby enhance decision-making in tackling the consequences of the pandemic. Design/methodology/approach The methodological approach for this study is a critical literature review, covering publications on knowledge management, knowledge mapping and COVID-19. EBSCOhost, PubMed, Scopus, Science Direct, TRID, Web of Science and Wiley Online Library were searched for full text, peer-reviewed articles written in English that investigated on critical knowledge areas for managing the spread of COVID-19. After full screening, 21 articles met the criteria for inclusion and were analysed and reported. Findings The study revealed seven critical knowledge areas for managing the COVID-19 pandemic. These are cleaning and disinfection; training, education and communication; reporting guidance and updates; testing; infection control measures, personal protective equipment; and potential COVID-19 transmission in health and other care settings. The study developed a concept knowledge map illustrating areas of critical knowledge which decision-makers need to be aware of. Practical implications Providing decision-makers with access to key knowledge during the COVID-19 pandemic seems to be crucial for effective decision-making. This study has provided insights for the professionals and decision-makers identifying the critical knowledge areas for managing the COVID-19 pandemic. Social implications The study advances the literature on knowledge management and builds a theoretical link with the management of public health emergencies. Additionally, the findings support the theoretical position that knowledge maps facilitate decision-making and help users to identify critical knowledge areas easily and effectively. Originality/value This study fills gaps in the existing literature by providing an explicit representation of know-how for managing the COVID-19 pandemic. This paper uses an objective and qualitative approach by reviewing related publications, reports and guidelines in the analysis. The concept map illustrates the critical knowledge areas for managing the COVID-19 pandemic.
C1 [Abdalla, Wala; Renukappa, Suresh; Suresh, Subashini] Univ Wolverhampton, Fac Sci & Engn, Wolverhampton, England.
RP Renukappa, S (corresponding author), Univ Wolverhampton, Fac Sci & Engn, Wolverhampton, England.
EM suresh.renukappa@wlv.ac.uk
CR Abdalla W, 2020, J ENTREP MANAG INNOV, V16, P47, DOI 10.7341/20201642
   Agbehadji IE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155330
   Al Hakim S, 2021, VINE J INF KNOWL MAN, V51, P773, DOI 10.1108/VJIKMS-11-2019-0170
   Al-Hity S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.14029
   Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961
   Allam Z, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010046
   Ambavi H, 2020, CIKM '20: PROCEEDINGS OF THE 29TH ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT, P3365, DOI 10.1145/3340531.3417428
   American Productivity & Quality Center (APQC), 2018, APQC 4 STEP GUID KNO
   American Productivity & Quality Center (APQC), 2018, GETT START KNOWL MAP
   Amidon D., 1997, J KNOWL MANAGE, V1, P27
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Anttiroiko AV, 2021, INT J E-PLAN RES, V10, P1, DOI 10.4018/IJEPR.20210401.oa1
   Arshad MI, 2021, TROP ANIM HEALTH PRO, V53, DOI 10.1007/s11250-020-02479-0
   Balaid A.S.S., 2013, J INFORM SYSTEMS RES, V3, P61
   Balaid A, 2016, INT J INFORM MANAGE, V36, P451, DOI 10.1016/j.ijinfomgt.2016.02.005
   Bamel N, 2021, J KNOWL MANAG, V25, P1782, DOI 10.1108/JKM-06-2020-0443
   Bamel UK, 2018, J KNOWL MANAG, V22, P1555, DOI 10.1108/JKM-10-2017-0460
   Becerra-Fernandez I., 2006, ENCY KNOWLEDGE MANAG, P230
   Bhamra Navdeep, 2021, Br J Nurs, V30, P16, DOI 10.12968/bjon.2021.30.1.16
   Brahami M, 2013, J INF PROCESS SYST, V9, P1, DOI 10.3745/JIPS.2013.9.1.001
   Buheji M., 2020, HUMAN RESOURCE MANAG, V2020, P27, DOI 10.5923/j.hrmr.20201002.01
   Burnett S., 2004, KNOWL PROCESS MANAG, V11, P25, DOI DOI 10.1002/KPM.194
   Caputo F, 2019, J KNOWL MANAG, V23, P1314, DOI 10.1108/JKM-10-2018-0645
   Carayannis EG, 2017, J KNOWL MANAG, V21, P35, DOI 10.1108/JKM-10-2015-0366
   Cargnel M, 2021, TRANSBOUND EMERG DIS, V68, P1175, DOI 10.1111/tbed.13768
   Casella F, 2021, IEEE CONTR SYST LETT, V5, P1079, DOI 10.1109/LCSYS.2020.3009912
   Castellanos OF, 2010, PICMET 2010: TECHNOLOGY MANAGEMENT FOR GLOBAL ECONOMIC GROWTH
   Centers for Medicare and Medicaid services (CMS), 2020, TOOLK STAT ACT MIT C
   Chaudhuri R, 2021, J KNOWL MANAG, V25, P1550, DOI 10.1108/JKM-07-2020-0571
   Chellamuthu G, 2020, INT ORTHOP, V44, P1481, DOI 10.1007/s00264-020-04622-w
   Chen HC, 2012, MIS QUART, V36, P1165
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   Dana J, 2020, J KNOWL ECON, V11, P405, DOI 10.1007/s13132-018-0553-x
   Das TK, 2007, MANAGE DECIS, V45, P684, DOI 10.1108/00251740710745980
   Davenport T., 1998, WORKING KNOWLEDGE OR
   Del Giudice M, 2014, J KNOWL MANAG, V18, P841, DOI 10.1108/JKM-06-2014-0264
   Department of Health and Social Care (DHSC, 2020, COVID 19 GUID INF PR
   Despres C., 2000, KNOWLEDGE HORIZONS P
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Drucker P., 1993, POSTCAPITALIST SOC
   DRUCKER PF, 1988, HARVARD BUS REV, V66, P45
   Elavarasan RM, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138858
   European Union (EU), 2020, JOINT EUR ROADM LIFT
   Ferreira J, 2018, J KNOWL MANAG, V24, P121, DOI 10.1108/JKM-07-2018-0461
   Ferreira JJM, 2016, SCIENTOMETRICS, V109, P1, DOI 10.1007/s11192-016-2008-0
   Filius R., 2000, J WORKPLACE LEARNING, V12, P286, DOI DOI 10.1108/13665620010353360
   Frankson R, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00192
   Gombos K, 2021, POPUL HEALTH MANAG, V24, P35, DOI 10.1089/pop.2020.0159
   Goniewicz K, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093838
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Gupta B, 2000, IND MANAGE DATA SYST, V100, P17, DOI 10.1108/02635570010273018
   Hart OE, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138875
   Heisig P, 2016, J KNOWL MANAG, V20, P1169, DOI 10.1108/JKM-12-2015-0521
   Heldal F, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4222-y
   Nguyen HL, 2020, INFORM FUSION, V61, P56, DOI 10.1016/j.inffus.2020.03.014
   Holmgren AJ, 2020, J AM MED INFORM ASSN, V27, P1306, DOI 10.1093/jamia/ocaa112
   Hossain MM, 2020, CURRENT STATUS GLOBA, V9, P374, DOI DOI 10.2139/SSRN.3547824
   Iandolo F, 2021, J KNOWL ECON, V12, P1982, DOI 10.1007/s13132-020-00703-8
   Ibn-Mohammed T, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105169
   Castaneda DI, 2018, J KNOWL MANAG, V22, P299, DOI 10.1108/JKM-01-2017-0041
   Islam MS, 2020, INFECT CONT HOSP EP, V41, P1196, DOI 10.1017/ice.2020.237
   Jallow H, 2021, SMART SUSTAIN BUILT, V10, P581, DOI 10.1108/SASBE-05-2020-0068
   Jennex Murray E, 2009, VINE, V39, P174, DOI 10.1108/03055720910988878
   Kebede G, 2010, INT J INFORM MANAGE, V30, P416, DOI 10.1016/j.ijinfomgt.2010.02.004
   Khowaja S.A., 2021, ARXIV PREPRINT ARXIV
   Kruesi L, 2020, J KNOWL MANAG, V24, P2553, DOI 10.1108/JKM-05-2020-0370
   Kummitha RKR, 2020, GOV INFORM Q, V37, DOI 10.1016/j.giq.2020.101481
   La Marca A, 2020, REPROD BIOMED ONLINE, V41, P483, DOI 10.1016/j.rbmo.2020.06.001
   Lane PJ, 1998, STRATEGIC MANAGE J, V19, P461, DOI 10.1002/(SICI)1097-0266(199805)19:5<461::AID-SMJ953>3.0.CO;2-L
   Lee Y, 2021, J KNOWL MANAG, V25, P1526, DOI 10.1108/JKM-06-2020-0483
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liang CC, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118800199
   Liebowitz J., 2000, KNOWL PROCESS MANAG, V7, P3, DOI DOI 10.1002/(SICI)1099-1441(200001/03)7:1<3::AID-KPM72>3.0.CO;2-0
   Lin YC, 2006, AUTOMAT CONSTR, V15, P693, DOI 10.1016/j.autcon.2005.09.006
   Malhotra Y., 2005, Journal of Knowledge Management, V9, P7, DOI 10.1108/13673270510582938
   Malik A, 2020, J BUS RES, V109, P524, DOI 10.1016/j.jbusres.2019.01.029
   Manesh MF, 2021, IEEE T ENG MANAGE, V68, P289, DOI 10.1109/TEM.2019.2963489
   McAfee A, 2012, HARVARD BUS REV, V90, P60
   Mehreen H, 2021, INT MARKET REV, DOI 10.1108/IMR-11-2020-0264
   Michailova S., 2006, Journal of Knowledge Management, V10, P44, DOI 10.1108/13673270610650094
   Mital M, 2018, TECHNOL FORECAST SOC, V131, P159, DOI 10.1016/j.techfore.2017.05.036
   Monteiro LF, 2008, ORGAN SCI, V19, P90, DOI 10.1287/orsc.1070.0264
   Moradi R, 2017, J INF KNOWL MANAG, V16, DOI 10.1142/S0219649217500083
   Moreira MWL, 2019, IEEE SYST J, V13, P3536, DOI 10.1109/JSYST.2018.2890121
   Mortazavi A., 2021, RADIATION, V1, P18
   Natalicchio A, 2017, J KNOWL MANAG, V21, P1362, DOI 10.1108/JKM-11-2016-0516
   Nathavitharana RR, 2020, J HOSP MED, V15, P299, DOI 10.12788/jhm.3439
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Obeso M, 2020, J KNOWL MANAG, V24, P1859, DOI 10.1108/JKM-10-2019-0553
   Papa A, 2020, TECHNOL FORECAST SOC, V153, DOI 10.1016/j.techfore.2018.02.018
   Parra CM, 2021, INT J INFORM MANAGE, V57, DOI 10.1016/j.ijinfomgt.2020.102271
   Polanyi M., 1967, TACIT DIMENSION
   Public Health England (PHE), 2021, COVID 19 GUID MAINT
   Renukappa S., 2007, INFORM KNOWLEDGE MAN, P335
   Rialti R, 2020, MANAGE DECIS, V58, P1585, DOI 10.1108/MD-09-2019-1237
   Rowan NJ, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138532
   Santoro G, 2020, TECHNOVATION, V92-93, DOI 10.1016/j.technovation.2018.06.003
   Schwerdtle PN, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2898
   Scuotto V, 2017, J TECHNOL TRANSFER, V42, P409, DOI 10.1007/s10961-016-9517-0
   Sensuse DI, 2019, J INF KNOWL MANAG, V18, DOI 10.1142/S0219649219500217
   Seufert A., 1999, J KNOWLEDGE MANAGEME, V3, P180, DOI DOI 10.1108/13673279910288608
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Singh S.K., 2020, IEEE T ENG MANAGE, DOI DOI 10.1109/TEM.2020.3038867
   Snyder H, 2019, J BUS RES, V104, P333, DOI 10.1016/j.jbusres.2019.07.039
   Speel P.H., 1999, MODELLING MANAGEMENT
   Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627
   Stirling AC, 2009, ECOL SOC, V14
   Storey J., 2000, J KNOWLEDGE MANAGEME, V4, P145, DOI DOI 10.1108/13673270010372279
   Sturm A, 2017, J KNOWL MANAG, V21, P454, DOI 10.1108/JKM-04-2016-0173
   Suresh S., 2008, CIB W102 INFORM KNOW, P48
   Suyeon Kim, 2003, Journal of Knowledge Management, V7, P34, DOI 10.1108/13673270310477270
   Swanson D, 2021, LOGISTICS-BASEL, V5, DOI 10.3390/logistics5010007
   Todericiu R, 2019, STUD BUS ECON-ROM, V14, P231, DOI 10.2478/sbe-2019-0056
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Vaishya R, 2020, DIABETES METAB SYND, V14, P337, DOI 10.1016/j.dsx.2020.04.012
   Vasudeva G, 2013, ORGAN SCI, V24, P319, DOI 10.1287/orsc.1120.0743
   Vimal R, 2020, CONSERV BIOL, V34, P1433, DOI 10.1111/cobi.13563
   Wamba SF, 2017, J BUS RES, V70, P356, DOI 10.1016/j.jbusres.2016.08.009
   Wang FY, 2012, IEEE INTELL SYST, V27, P2
   Wang WS, 2021, KAOHSIUNG J MED SCI, V37, P215, DOI 10.1002/kjm2.12322
   Watthananon J, 2012, PROCEDIA ENGINEER, V32, P1169, DOI 10.1016/j.proeng.2012.02.073
   Weintraub RL, 2021, HEALTH AFFAIR, V40, P33, DOI 10.1377/hlthaff.2020.01523
   Wexler, 2001, J KNOWLEDGE MANAGEME, V5, P249, DOI DOI 10.1108/EUM0000000005868
   Wiig KM, 1997, LONG RANGE PLANN, V30, P399, DOI 10.1016/S0024-6301(97)90256-9
   World Health Organization, 2020, WHO COR DIS COVID 19
   Wu SJ, 2020, AM J INFECT CONTROL, V48, P910, DOI 10.1016/j.ajic.2020.05.003
   Xinyi Zhou, 2020, CIKM '20: Proceedings of the 29th International Conference on Information & Knowledge Management, P3205, DOI 10.1145/3340531.3412880
   Yang R, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114410
   Yasin F., 2011, 27 ANN ARCOM C, P603
   Younan M, 2020, MEASUREMENT, V151, DOI 10.1016/j.measurement.2019.107198
   Zack MH, 1999, CALIF MANAGE REV, V41, P125, DOI 10.2307/41166000
   Zammuto RF, 2007, ORGAN SCI, V18, P749, DOI 10.1287/orsc.1070.0307
   Zhou CH, 2020, GEOGR SUSTAIN, V1, P77, DOI 10.1016/j.geosus.2020.03.005
   Zhou J, 2021, CLIN INFECT DIS, V73, pE1870, DOI 10.1093/cid/ciaa905
NR 134
TC 1
Z9 1
U1 14
U2 14
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
DI 10.1108/JKM-01-2021-0083
EA JAN 2022
PG 34
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA YD9WR
UT WOS:000740784300001
OA Green Accepted, Bronze
DA 2022-04-20
ER

PT J
AU Ng, DWL
   Alonso, AD
   Bressan, A
   Vu, OTK
AF Ng, David Wai Lun
   Alonso, Abel Duarte
   Bressan, Alessandro
   Oanh Thi Kim Vu
TI Impacts, lessons learnt and envisioning the future of firms under
   COVID-19-implications for knowledge management
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article; Early Access
DE Knowledge management; Knowledge-based view of the firm; COVID-19; Firm
   owners; managers
ID CRISIS; EXPLORATION; SATURATION; RESOURCE; TACIT; VIEW
AB Purpose The purpose of this study is to examine the significance of knowledge management as a tool for firms to adapt to an ongoing unprecedented crisis. Moreover, in considering the knowledge-based view of the firm, the study will ascertain the impacts, lessons learnt and how firms envisage their future under the current unpredictable regime from the viewpoints of firm owners/managers. Design/methodology/approach A qualitative data collection approach was selected, with face-to-face and online interviews undertaken with owners/managers of 33 firms operating in Singapore. Findings The data analysis reveals as many as eight dimensions pertaining to impacts, lessons learnt and the envisioned future of the firms. The relevance of knowledge management emerged, for instance, in supporting firms and staff to overcome initial challenges after the crisis became apparent. Knowledge management was also an exemplar of lessons learnt, through new knowledge development, strengthening links with consumers, through operational skilfulness and awareness, as well as in explaining how firms envision their future. These findings also underscore key tenets of the knowledge-based view of the firm. Originality/value Conceptually, the proposed dimensions stemming from the three examined research questions, together with the propositions and theoretical framework, contribute to a deeper understanding of the links between knowledge management and how firms confront a severe crisis. Empirically, the findings' highlighted associations with knowledge management elements to illuminate how firms address the impacts of the COVID-19 crisis, as well as the lessons learnt and the envisioned future of firms operating under severe crisis conditions.
C1 [Ng, David Wai Lun] Curtin Univ Singapore, Singapore, Singapore.
   [Alonso, Abel Duarte; Oanh Thi Kim Vu] RMIT Univ Vietnam, Sch Business & Management, Hanoi, Vietnam.
   [Bressan, Alessandro] Univ Notre Dame Australia, Sch Business, Sydney Campus Broadway, Broadway, Australia.
RP Alonso, AD (corresponding author), RMIT Univ Vietnam, Sch Business & Management, Hanoi, Vietnam.
EM aronso5@hotmail.com
CR ACRA, 2021, 2021 STAT HIGHL MONT
   Aldianto L, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13063132
   Ammirato S, 2021, KNOWL MAN RES PRACT, V19, P415, DOI 10.1080/14778238.2020.1801364
   Anderson C, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408141
   Beninger S., 2021, BUS HORIZONS
   Bezzina F., 2021, FRONTIERS SUSTAINABI, V2, P1
   Birchall J., 2009, RESILIENCE COOPERATI
   Brewer P, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102777
   Caballero-Morales SO, 2021, RES INT BUS FINANC, V57, DOI 10.1016/j.ribaf.2021.101396
   Campanella F, 2019, J KNOWL MANAG, V23, P263, DOI 10.1108/JKM-11-2017-0506
   Carayannis EG, 2014, J KNOWL MANAG, V18, P1020, DOI 10.1108/JKM-06-2014-0249
   Cardinal LB., 2001, J KNOWL MANAG, V5, P195, DOI [DOI 10.1108/13673270110393266, 10.1108/13673270110393266]
   Carvalho A, 2016, HUM RESOUR MANAGE-US, V55, P479, DOI 10.1002/hrm.21676
   Chen J, 2021, J KNOWL MANAG, V25, P23, DOI 10.1108/JKM-02-2020-0159
   Creswell JW, 2018, DESIGNING CONDUCTING, V3rd
   Dalkin S, 2021, INT J SOC RES METHOD, V24, P123, DOI 10.1080/13645579.2020.1803528
   Dalkir K., 2005, KNOWLEDGE MANAGEMENT
   Eger L, 2021, J RETAIL CONSUM SERV, V61, DOI 10.1016/j.jretconser.2021.102542
   Ergazakis K., 2008, J KNOWLEDGE MANAGEME, V12, P137, DOI [10.1108/13673270810902993, DOI 10.1108/13673270810902993]
   Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151
   Gioia D, 2021, J APPL BEHAV SCI, V57, P20, DOI 10.1177/0021886320982715
   Grant RM, 2004, J MANAGE STUD, V41, P61, DOI 10.1111/j.1467-6486.2004.00421.x
   GRANT RM, 1995, BEST PAP PROC, P17
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   Guo H, 2020, FRONT BUS RES CHINA, V14, DOI 10.1186/s11782-020-00087-1
   Hoekstra JC., 2020, ITALIAN J MARKETING, V4, P249, DOI [10.1007/s43039-020-00016-3, DOI 10.1007/S43039-020-00016-3]
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Iacuzzi S, 2021, KNOWL MAN RES PRACT, V19, P433, DOI 10.1080/14778238.2020.1838963
   Iqbal A, 2021, J KNOWL MANAG, V25, P2334, DOI 10.1108/JKM-07-2020-0546
   Jebreen I., 2012, INT J COMPUT INF SCI, V01, P162
   Kottika E, 2020, IND MARKET MANAG, V88, P352, DOI 10.1016/j.indmarman.2020.05.021
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Lecuona JR, 2014, STRATEGIC MANAGE J, V35, P954, DOI 10.1002/smj.2143
   Maalaoui A, 2020, J KNOWL MANAG, V24, P1513, DOI 10.1108/JKM-11-2019-0603
   Manolova TS, 2020, INT SMALL BUS J, V38, P481, DOI 10.1177/0266242620949136
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Martelo-Landroguez S, 2016, KNOWL MAN RES PRACT, V14, P423, DOI 10.1057/kmrp.2015.26
   Merat A, 2013, J KNOWL MANAG, V17, P3, DOI 10.1108/13673271311300697
   Meutia M., 2018, INT J CIVIL ENG TECH, V9, P424
   Nonaka I., 2001, CREATIVE MANAGEMENT, P64
   O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106
   Patton MQ, 2002, QUALITATIVE EVALUATI, V3
   Pedauga L, 2022, SMALL BUS ECON, V58, P665, DOI 10.1007/s11187-021-00476-7
   Pereira V, 2021, J BUS RES, V132, P557, DOI 10.1016/j.jbusres.2021.04.021
   POLANYI M, 1966, PHILOSOPHY, V41, P1, DOI 10.1017/S0031819100066110
   Ponis ST, 2012, KNOWL PROCESS MANAG, V19, P148, DOI 10.1002/kpm.1390
   Rapaccini M, 2020, IND MARKET MANAG, V88, P225, DOI 10.1016/j.indmarman.2020.05.017
   Schiuma G., 2008, J KNOWLEDGE MANAGEME, V5, P121, DOI [10.1108/13673270810902984, DOI 10.1108/13673270810902984]
   Shaw D, 2007, J ORGAN CHANGE MANAG, V20, P559, DOI 10.1108/09534810710760081
   Southon G., 2001, AUSTR LIB J, V50, P259
   Spender J. C., 1992, INT EXECUTIVE, V34, P389, DOI DOI 10.1002/TIE.5060340503
   Stanton, 2020, NATL BUREAU EC RES W, DOI [10.3386/w26989, DOI 10.3386/W26989]
   Tan JB, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010252
   Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748
   Tortorella G, 2021, KNOWL MAN RES PRACT, V19, P551, DOI 10.1080/14778238.2021.1909430
   Tovstiga N, 2021, KNOWL MAN RES PRACT, V19, P427, DOI 10.1080/14778238.2020.1806749
   van den Berg HA, 2013, J KNOWL MANAG, V17, P159, DOI 10.1108/13673271311315141
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   Wang WT, 2021, KNOWL MAN RES PRACT, V19, P468, DOI 10.1080/14778238.2020.1860665
   Wang WT, 2009, J INF SCI, V35, P635, DOI 10.1177/0165551509104234
   Wang WT, 2009, IND MANAGE DATA SYST, V109, P445, DOI 10.1108/02635570910948605
   Westgate CJ, 2021, SOUND STUD, V7, P273, DOI 10.1080/20551940.2021.1944060
   Woods M, 2016, INT J SOC RES METHOD, V19, P385, DOI 10.1080/13645579.2015.1023964
   Zheng SL, 2011, J KNOWL MANAG, V15, P1035, DOI 10.1108/13673271111179352
NR 65
TC 0
Z9 0
U1 9
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
DI 10.1108/JKM-07-2021-0584
EA FEB 2022
PG 21
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA YT5SX
UT WOS:000751420500001
DA 2022-04-20
ER

PT C
AU Tome, E
   Gromova, E
   Hatch, A
AF Tome, Eduardo
   Gromova, Elizaveta
   Hatch, Andrew
BE GarciaPerez, A
   Simkin, L
TI The Portuguese Case of Covid-19 as a case of Knowledge Management
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE Covid-19; Coronavirus; Portugal
ID DYNAMIC CAPABILITIES; TRUST
AB There are many ways in which it is possible to look at the impact of Covid-19 in societies. For us it is essentially a crisis of knowledge. First, we lacked a vaccine; second, we lacked the ability to manage our societies to minimize the costs of not having vaccines; third, even when the vaccine was developed, problems arose on how and when to implement it. In another paper we discussed the situation on Portugal in the third semester of 2020 (Tome, Gromova, Hatch, 2020). Here we extend and update the analysis. We use a model based on technology, people and processes (Edwards 2011). We assume that there are several generic questions related to KM that explain the crisis, namely the following: 1) lack of basic scientific medical knowledge, 2) lack of social knowledge, 3) lack of information and difficulties in informing policies; 4) lack of trust; 5) relation between technology, people and processes; 6) competence and incompetency and finally 7) management of knowledge and information by politicians. We also assume there are several questions that need to be considered specifically about Portugal namely the following: 1) how big is the crisis? 2) how is the crisis explained?; 3) what kind of crisis is it ?; 4) what is the economic explanation to the "new normal"?; 5) what policies should be developed ?; 6) what will happen in politics? 7) what change will happen ? We point out that in Portugal, the massive crisis about Covid-19 happened in January and February 2021 (Worldmeter, 2021). If the cause of the descent in February is easy to find - lockdown imposed since January 16, the causes of the massive surge in January remain to be found and it is around the quest for those causes, and within the TPP framework, that we write this paper.
C1 [Tome, Eduardo] Univ Lusofona Humanidades & Tecnol, Lisbon, Portugal.
   [Tome, Eduardo] GOVCOPP, Aveiro, Portugal.
   [Gromova, Elizaveta] Peter Great St Petersburg Polytech Univ, St Petersburg, Russia.
   [Hatch, Andrew] Univ Aveiro, GOVCOPP, Aveiro, Portugal.
RP Tome, E (corresponding author), Univ Lusofona Humanidades & Tecnol, Lisbon, Portugal.; Tome, E (corresponding author), GOVCOPP, Aveiro, Portugal.
EM eduardo.tome@gmail.com; lizaveta-90@yandex.ru
CR Al Ahbabi SA, 2019, J KNOWL MANAG, V23, P351, DOI 10.1108/JKM-08-2017-0348
   Andreeva T, 2012, J KNOWL MANAG, V16, P617, DOI 10.1108/13673271211246185
   Anibal S., 2020, PORTUGAL PERANTE DES
   [Anonymous], 2020, MONDE
   [Anonymous], 2020, BBC
   [Anonymous], 2020, BBC NEWS
   [Anonymous], 2020, THE CNN
   Baldwin R., 2020, EC TIME COVID 19, P59
   Blomqvist K., 1997, SCAND J MANAG, V13, P271, DOI DOI 10.1016/S0956-5221(97)84644-1
   Bounfour A., 2005, INTELLECTUAL CAPITAL, V1st ed.
   Chams-Anturi O, 2020, PERS REV, V49, P956, DOI 10.1108/PR-07-2018-0239
   Chatti MA, 2012, J KNOWL MANAG, V16, P829, DOI 10.1108/13673271211262835
   Edwards John, 2011, Electronic Journal of Knowledge Management, V9, P297
   Galha L., 2020, HIST QUEM NAO CONSEG
   Gallagher J., 2020, CORONAVIRUS VACCINE
   Germain Marie-Line, 2018, NARCISSISM WORK PERS, VFirst, DOI [10.1007/978-3-319-60330-8, DOI 10.1007/978-3-319-60330-8]
   Goldman S.L., 1995, AGILE COMPETITORS VI
   Granados ML, 2017, J KNOWL MANAG, V21, P376, DOI 10.1108/JKM-01-2016-0026
   Larman C., 2004, AGILE ITERATIVE DEV
   Lusa, 2020, DUAS FAS DESC PAR CO
   Manifesto, 2020, MANIFESTO AGILE SOFT
   Nonaka I, 1998, CALIF MANAGE REV, V40, P40, DOI 10.2307/41165942
   Nonaka I, 1995, KNOWLEDGE CREATING C
   North K, 2003, KNOWLEDGE
   Penela R., 2020, ESTADO CALAMIDADE NA
   Podesva RJ, 2015, LANG VAR CHANGE, V27, P59, DOI 10.1017/S0954394514000192
   Pordata, 2020, IND PORT EC
   Reiersen J, 2017, J BUS ECON MANAG, V18, P585, DOI 10.3846/16111699.2017.1334228
   Sankowska A., 2016, J EC MANAGEMENT, V23, P33
   Sousa J, 2020, PORTUGAL SWEDEN 5 EU
   Sutherland J., 2014, SCRUM ART DOING TWIC
   Sveiby KE, 2012, ECIC
   Teece D, 2016, CALIF MANAGE REV, V58, P13, DOI 10.1525/cmr.2016.58.4.13
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Tome E, 2020, MANAG MARK, V15, P477, DOI 10.2478/mmcks-2020-0028
   White MP, 2006, RISK ANAL, V26, P1187, DOI 10.1111/j.1539-6924.2006.00807.x
   World Travel Awards, 2020, TUR PORT ASS AUG 11
   Worldmeter, 2021, PORT COV 19
NR 38
TC 0
Z9 0
U1 0
U2 0
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 768
EP 776
DI 10.34190/EKM.21.167
PG 9
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900089
DA 2022-04-20
ER

PT C
AU Albrychiewicz-Slocinska, A
AF Albrychiewicz-Slocinska, Anna
BE GarciaPerez, A
   Simkin, L
TI Knowledge and Medical Worker Health Security Management During a
   Pandemic COVID-19
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE knowledge; health security; pandemic COVID-19; medical worker
ID SAFETY; DESIGN
AB Successive waves of the pandemic observed in Europe and around the world demonstrate the dramatic working conditions of medical staff. Constant exposure to dangerous SARS-Cov-2 virus undoubtedly affects the medical community's sense of security in terms of functioning in the workplace. The year 2020 demonstrated the unstable condition of information-related conditions that we live in. In an age of near-instant communication in the form of the Internet and other types of communicators, citizens received various, most often contradictory and untrue information concerning the virus, the pandemic conditions, and the principles of safe functioning in them. It seems, however, that medical specialists, due to their education and occupations, are among the best prepared in terms of knowledge, out of all professions. In addition to knowledge concerning the virus itself, these specialists also understand where to look for reliable information concerning the latest scientific reports on the pandemic. The article aims to present the views of medical workers regarding their sense of health security in relation to access to knowledge and information about the COVID-19 pandemic and their functioning in the work environment. The results of the research reveal positive dependencies between the access of knowledge and information and healthcare professionals sense of health security.
C1 [Albrychiewicz-Slocinska, Anna] Czestochowa Tech Univ, Czestochowa, Poland.
RP Albrychiewicz-Slocinska, A (corresponding author), Czestochowa Tech Univ, Czestochowa, Poland.
EM a.albrychiewicz-slocinska@pcz.pl
CR [Anonymous], 2018, GLOWN URZ STAT GUS
   Babbie E, 2004, BADANIA SPOLECZNE PR
   Bartkowiak G, 2021, J CLEAN PROD, V280, DOI 10.1016/j.jclepro.2020.124366
   Beccari MN, 2021, REV TECNOL SOC, V17, P22, DOI 10.3895/rts.v17n46.10973
   Bienkowski J, 2017, PRZEDSIEBIORCZOSC ZA, V18, P11
   Bleijenbergh I, 2021, HUM RESOUR MANAGE R, V31, DOI 10.1016/j.hrmr.2020.100764
   Bostan S, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8228
   Botma Y, 2020, AFR J HEALTH PROF ED, V12, P175, DOI 10.7196/AJHPE.2020.v12i4.1350
   Brankston G, 2021, CAN J PUBLIC HEALTH, V112, P363, DOI 10.17269/s41997-021-00501-y
   Breu R, 2004, INFORM COMM TECH KNO, V1, P646
   Campbell J, 2013, 3 GLOB FOR HUM RES H
   Churchill G.A., 2002, BADANIA MARKETINGOWE
   Cobianchi L, 2020, ANN SURG, V272, pE296, DOI 10.1097/SLA.0000000000004489
   Dal Mas F., 2021, HUMAN CENTERED ORG C, P139
   Domagala A., 2013, ZESZYTY NAUKOWE OCHR, V11, P148
   European Union, 2012, EU LEV COLL FOR HLTH
   Gherardi S, 2000, J MANAGE INQUIRY, V9, P7, DOI 10.1177/105649260091002
   Glendon AI, 2000, SAFETY SCI, V34, P193, DOI 10.1016/S0925-7535(00)00013-8
   Guldenmund FW, 2000, SAFETY SCI, V34, P215, DOI 10.1016/S0925-7535(00)00014-X
   Gustafsson K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026491
   Kohler H, 2021, J PRIM CARE COMMUNIT, V12, DOI 10.1177/2150132721996898
   Koziej S, 2011, BEZPIECZENSTWO NAROD, V4
   Krueger JI, 2018, COLLABRA-PSYCHOL, V4, DOI 10.1525/collabra.108
   Le Morvan P, 2016, PHILOSOPHY, V91, P411, DOI 10.1017/S0031819116000176
   Leonard S, 2018, PRACT RADIAT ONCOL, V8, pE17, DOI 10.1016/j.prro.2017.08.005
   Liu HF, 2021, TECHNOL FORECAST SOC, V166, DOI 10.1016/j.techfore.2021.120600
   Lutostanski M, 2017, BEZPIECZENSTWO ZAR 3, V18
   Monterrosa-Castro A, 2020, J INVEST MED, V68, P1228, DOI 10.1136/jim-2020-001456
   Nachar N, 2008, TUTOR QUANT METHODS, V4, P13, DOI 10.20982/tqmp.04.1.p013
   Naczelna Izba Pielegniarek i Poloznych, 2021, STRUKT SREDN WIEK PI
   Najwyzsza Izba Kontroli (Supreme Audit Office),, 2016, KSZTALC PRZYG ZAW KA
   NONAKA I, 1991, HARVARD BUS REV, V69, P96
   Nonaka I, 2009, ORGAN SCI, V20, P635, DOI 10.1287/orsc.1080.0412
   Rind E, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043908
   Robiony M, 2021, J CRANIO MAXILL SURG, V49, P323, DOI 10.1016/j.jcms.2021.01.027
   Rypicz L, 2021, J NURS MANAGE, V29, P468, DOI 10.1111/jonm.13192
   Sas M, 2021, SECUR J, V34, P340, DOI 10.1057/s41284-020-00228-4
   Sauro K, 2020, BMJ QUAL SAF, V29, P341, DOI 10.1136/bmjqs-2019-009824
   Stanisz A, 2006, PRZYSTEPNY KURS STAT, V1
   Sulkowski L., 2016, KULTURA AKAD KONIEC
   Szweda E., 2017, BEZPIECZENSTWO ZAR 3, V18, P11
   Van Hecke T, 2012, J STAT MANAG SYST, V15, P241, DOI 10.1080/09720510.2012.10701623
   von Krogh G, 2012, J MANAGE STUD, V49, P240, DOI 10.1111/j.1467-6486.2010.00978.x
   Williams CM, 2021, J FOOT ANKLE RES, V14, DOI 10.1186/s13047-021-00449-9
   World Health Organization, 2019, COR DIS COVID 19 PAN
   Wu WZ, 2020, J MED VIROL, V92, P1962, DOI 10.1002/jmv.25914
   Zanesco C, 2020, REV PESQUI-CUID FUND, V12, P148, DOI 10.9789/2175-5361.rpcfo.v12.7171
   Zhuravlev AL, 2020, PSIKHOL ZH, V41, P5, DOI 10.31857/S020595920010383-7
NR 48
TC 0
Z9 0
U1 0
U2 0
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 20
EP 28
DI 10.34190/EKM.21.072
PG 9
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900003
DA 2022-04-20
ER

PT C
AU Zieba, K
AF Zieba, Krzysztof
BE GarciaPerez, A
   Simkin, L
TI Knowledge Sharing in the COVID-19 Era of Remote Teaching: What Can
   Academia Learn from Business?
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE knowledge sharing; COVID-19 crisis; change management
ID MANAGEMENT; EDUCATION; FUTURE
AB Purpose: The COVID-19 pandemic outbreak resulted at the university level in a massive transition from traditional ways of teaching to remote forms. This sudden conversion has led to changes in the patterns of knowledge sharing (from teachers to students and among students). The aim of this paper is to investigate how universities may benefit from experiences of businesses that were also forced to use remote forms of business operations. Large companies, operating in the international context may be a valuable source of information on how to improve knowledge sharing processes among university students and between students and teachers. Methodology: The paper uses a qualitative research method (in-depth interviews) to explore the possibilities of knowledge sharing improvements at the university-level teaching, based on the experiences elicited in the business sector. The theoretical sampling was used to find informants familiar with both transition to remote teaching and shift to online business operations forced by the COVID-19 pandemic. Findings: Interviews were conducted with experienced managers participating in an MBA programme. During the outburst of the COVID-19 pandemic the programme has been switched to a remote mode. At the same time, the interviewed managers had to cope with the transition to remote mode at work. Their work-related ordeals were contrasted and compared with their university-related experiences regarding knowledge sharing. Conclusions and recommendations have been formulated on the basis of evidence gathered during the interviews. Research limitations: This paper is of an exploratory character. The triangulation of findings presented here is limited. The sample consists of participants of one MBA programme only, hence the conclusions cannot be generalised. At this stage the paper may serve as a basis for further development. Practical implications: The paper presents possible improvements to be introduced by academia in the remote mode teaching. Business sector and especially large businesses may offer experience-based solutions that allow to boost knowledge sharing processes among students and increase the efficiency of knowledge sharing between teachers and students. Originality/value: The topic of the paper is very up-to-date and of considerable significance. Knowledge sharing processes at the university-level teaching have been significantly distorted by the COVID-19 pandemic outburst. Using experiences from the business sector can be very helpful in this regard.
C1 [Zieba, Krzysztof] Gdansk Univ Technol, Gdansk, Poland.
RP Zieba, K (corresponding author), Gdansk Univ Technol, Gdansk, Poland.
EM kzieba@zie.pg.gda.pl
CR Ahmad F, 2019, J WORKPLACE LEARN, V31, P207, DOI 10.1108/JWL-07-2018-0096
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Al-Kurdi O, 2018, J ENTERP INF MANAG, V31, P226, DOI 10.1108/JEIM-09-2017-0129
   Argote L, 2000, ORGAN BEHAV HUM DEC, V82, P150, DOI 10.1006/obhd.2000.2893
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117
   Bendavid E, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13484
   Boroujerdi SS, 2020, KYBERNETES, V49, P442, DOI 10.1108/K-09-2018-0492
   Bratianu C, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042313
   Bratianu C, 2021, KNOWL PROCESS MANAG, V28, P11, DOI 10.1002/kpm.1656
   Bratianu C, 2020, MANAG MARK, V15, P410, DOI 10.2478/mmcks-2020-0024
   Burki TK, 2020, LANCET ONCOL, V21, P758, DOI 10.1016/S1470-2045(20)30287-4
   Christensen P. H., 2007, Journal of Knowledge Management, V11, P36, DOI 10.1108/13673270710728222
   Crawford J., 2020, J APPL LEARN TEACH, V3, P1, DOI DOI 10.37074/JALT.2020.3.1.7
   Cummings JN, 2004, MANAGE SCI, V50, P352, DOI 10.1287/mnsc.1030.0134
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Farooq R, 2018, INT J INOV SCI, V10, P238, DOI 10.1108/IJIS-09-2017-0087
   Fuller D, 2019, STUD HIGH EDUC, V44, P86, DOI 10.1080/03075079.2017.1339029
   Fullwood R, 2017, J KNOWL MANAG, V21, P1254, DOI 10.1108/JKM-07-2016-0274
   Fullwood R, 2013, J KNOWL MANAG, V17, P123, DOI 10.1108/13673271311300831
   Govender LN, 2018, S AFR J INFORM MANAG, V20, DOI 10.4102/sajim.v20i1.966
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Ipe M., 2003, HUM RESOUR DEV REV, V2, P337, DOI DOI 10.1177/1534484303257985
   Krishnamurthy S, 2020, J BUS RES, V117, P1, DOI 10.1016/j.jbusres.2020.05.034
   Leedy P.D., 2010, PRACTICAL RES PLANNI, V9th ed.
   Marinoni G., 2020, IMPACT COVID 19 HIGH
   Matzler K, 2005, STRATEG CHANG, V14, P1, DOI 10.1002/jsc.700
   Quarchioni S, 2020, KNOWL MAN RES PRACT, DOI 10.1080/14778238.2020.1730717
   Renzl B, 2008, OMEGA-INT J MANAGE S, V36, P206, DOI 10.1016/j.omega.2006.06.005
   Rowley J., 2000, INT J EDUC DEV, V14, P325, DOI DOI 10.1108/09513540010378978
   Smith E.A., 2001, J KNOWL MANAG, V5, P311
   Sohail M Sadiq, 2009, VINE, V39, P125, DOI 10.1108/03055720910988841
   Suter W. N, 2011, INTRO ED RES CRITICA
   Tuyet-Mai Nguyen, 2019, VINE Journal of Information and Knowledge Management Systems, V49, P76, DOI 10.1108/VJIKMS-10-2018-0086
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Veer-Ramjeawon P, 2020, STUD HIGH EDUC, V45, P2324, DOI 10.1080/03075079.2019.1608431
   Witherspoon CL, 2013, J KNOWL MANAG, V17, P250, DOI 10.1108/13673271311315204
   Yang HL, 2008, TECHNOL FORECAST SOC, V75, P1128, DOI 10.1016/j.techfore.2007.11.008
   Yin R.K., 2009, ESSENTIAL GUIDE QUAL, Vfourth, DOI [10.1097/FCH.0b013-31822dda9e, DOI 10.1097/FCH.0B013-31822DDA9E]
   ZIMMERMAN J, 2020, CHRON HIGHER ED
NR 40
TC 0
Z9 0
U1 0
U2 0
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 856
EP 863
DI 10.34190/EKM.21.116
PG 8
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900099
DA 2022-04-20
ER

PT J
AU Nguyen, AN
   Le, XTT
   Ta, NTK
   Wong, D
   Nguyen, NTT
   Le, HT
   Nguyen, TT
   Pham, QT
   Nguyen, QT
   Duong, QV
   Luong, AM
   Koh, D
   Hoang, MT
   Pham, HQ
   Vu, TMT
   Vu, GT
   Latkin, CA
   Ho, CSH
   Ho, RCM
AF Anh Ngoc Nguyen
   Xuan Thi Thanh Le
   Nhung Thi Kim Ta
   Danny Wong
   Nguyen Thao Thi Nguyen
   Huong Thi Le
   Thao Thanh Nguyen
   Quan Thi Pham
   Quynh Thi Nguyen
   Quan Van Duong
   Anh Mai Luong
   Koh, David
   Men Thi Hoang
   Hai Quang Pham
   Thuc Minh Thi Vu
   Giang Thu Vu
   Latkin, Carl A.
   Ho, Cyrus S. H.
   Ho, Roger C. M.
TI Knowledge and Self-Protective Practices Against COVID-19 Among
   Healthcare Workers in Vietnam
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE COVID-19; knowledge; practice; national lockdown; Vietnam
ID ATTITUDES
AB Background: In middle-income countries such as Vietnam, where healthcare resources are already constrained, protecting healthcare workers (HCWs) is essential for ensuring the sustainability of COVID-19 response in Vietnam. This study was conducted to assess the knowledge and practices regarding the prevention of the COVID-19 among the HCWs in Vietnam to identify the ways of disseminating information to maximize the safety of these essential workers.
   Methods: An online cross-sectional study, using respondent-driven sampling, was conducted in Vietnam with 742 participants within 2 weeks. The validity of the questionnaire was examined by exploratory factor analysis. Descriptive statistics were used to identify the level of knowledge and practices among the HCWs to prevent the COVID-19. Inferential statistics and regression modeling were used to identify the associated factors with results.
   Results: Vietnamese HCWs had a high level of knowledge with more than 75% of the participants demonstrating awareness of all the modes of transmission aside from air. The mean knowledge score was 3.7 +/- 0.8 (range 1-5). Nearly all the participants relied on the Ministry of Health (98.3%) and the internet (95.5%) for information regarding the COVID-19. The participants endorsed a moderately high level of self-protective practices with mean scores of 4.2 and 3.6 (band score 1-5) for the precautionary and psychological measures, respectively. Nurses were more likely to practice the precautionary measures than doctors and the HCWs at the central level were more likely to practice the psychological measures than those at the district level.
   Conclusion: Future education initiatives should consolidate the latest literature in an accessible format, focusing initially on the gaps of knowledge regarding aerosol transmission. These initiatives should primarily focus on the doctors, especially those in emergency and intensive care departments.
C1 [Anh Ngoc Nguyen; Xuan Thi Thanh Le; Nhung Thi Kim Ta; Huong Thi Le; Thao Thanh Nguyen; Quan Thi Pham; Quynh Thi Nguyen; Quan Van Duong] Hanoi Med Univ, Sch Prevent Med & Publ Hlth, Hanoi, Vietnam.
   [Danny Wong] Univ San Francisco, Sch Nursing & Hlth Profess, San Francisco, CA USA.
   [Nguyen Thao Thi Nguyen] Duke Univ, Duke Sch Med, Durham, NC USA.
   [Anh Mai Luong] Vietnam Hlth Environm Management Agcy, Minist Hlth, Hanoi, Vietnam.
   [Koh, David] Univ Brunei Darussalam, Inst Hlth Sci, Pengiran Anak Puteri Rashidah Saadatul Bolkiah PA, Gadong, Brunei.
   [Koh, David] Natl Univ Singapore, SSH Sch Publ Hlth, Singapore, Singapore.
   [Men Thi Hoang; Hai Quang Pham] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam.
   [Men Thi Hoang; Hai Quang Pham] Duy Tan Univ, Fac Med, Da Nang, Vietnam.
   [Thuc Minh Thi Vu] Inst Hlth Econ & Technol, Hanoi, Vietnam.
   [Giang Thu Vu] Nguyen Tat Thanh Univ, Ctr Excellence Evidence Based Med, Ho Chi Minh City, Vietnam.
   [Latkin, Carl A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Ho, Cyrus S. H.; Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore.
   [Ho, Cyrus S. H.] Natl Univ Hlth Syst, Dept Psychol Med, Singapore, Singapore.
   [Ho, Roger C. M.] Natl Univ Singapore, Inst Hlth Innovat & Technol iHealthtech, Singapore, Singapore.
RP Pham, HQ (corresponding author), Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam.; Pham, HQ (corresponding author), Duy Tan Univ, Fac Med, Da Nang, Vietnam.
EM phamquanghai@duyttan.edu.vn
FU Vingroup Joint Stock Company (Vingroup JSC); Vingroup Innovation
   Foundation (VINIF) [VINIF. 2020.COVID-19.DA03];  [2020.COVID-19]; 
   [DA03]
FX This study was funded by the Vingroup Joint Stock Company (Vingroup JSC)
   and supported by the Vingroup Innovation Foundation (VINIF) under the
   project code VINIF. 2020.COVID-19.DA03.
CR Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Bardhan R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183243
   CDC, 2020, COVID 19 IPC OV
   CDC, 2020, SOC DIST TRIB COMM L
   Centers for Disease Control and prevention, 2020, INT INF PREV CONTR R
   Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049
   Durand AC, 2019, WORK, V63, P57, DOI 10.3233/WOR-192908
   Elder E, 2020, INT EMERG NURS, V52, DOI 10.1016/j.ienj.2020.100841
   Holakouie-Naieni K, 2015, IRAN J PUBLIC HEALTH, V44, P1670
   Huaxia, 2020, VIETN REC NO NEW COV
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027
   Ma JX, 2021, CLIN INFECT DIS, V72, pE652, DOI 10.1093/cid/ciaa1283
   Moro Matteo, 2020, Acta Biomed, V91, P29, DOI 10.23750/abm.v91i3-S.9419
   Nava S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01445-2020
   Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848
   Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X
   de la Cruz SP, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041007
   Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Neto MLR, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112972
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Tuan V., 2020, GETS TOUGH SOCIAL DI
   Vaidya A., 2020, MORE 62000 US HEALTH
   Vietnamese Ministry of Health, 2020, VIETN MIN HLTH SHOWS
   Weigl M, 2021, MED KLIN-INTENSIVMED, V116, P229, DOI 10.1007/s00063-020-00657-4
   WHO, 2020, WHO DIR GEN REM G20
   WHO, 2020, B WORLD HEALTH ORGAN, V2019, P2633
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   World Health Organization: Representative Office for Viet Nam, 2020, VIET NAM COVID 19 SI
   Worldometer, 2021, CORONAVIRUS
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 35
TC 1
Z9 1
U1 4
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD OCT 28
PY 2021
VL 9
AR 658107
DI 10.3389/fpubh.2021.658107
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA WW1NC
UT WOS:000717691200001
PM 34778159
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Pavelic, K
   Pavelic, SK
   Brix, B
   Goswami, N
AF Pavelic, Kresimir
   Kraljevic Pavelic, Sandra
   Brix, Bianca
   Goswami, Nandu
TI A Perspective on COVID-19 Management
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE SARS-CoV-2; endothelium; COVID-19 management
ID ACUTE RESPIRATORY SYNDROME; CONVALESCENT PLASMA; INTERFERON BETA-1B;
   POSITION PAPER; CLEAVAGE SITE; CORONAVIRUS; SARS-COV-2; CHLOROQUINE;
   PROTEIN; SPIKE
AB A novel coronavirus-Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)-outbreak correlated with the global coronavirus disease 2019 (COVID-19) pandemic was declared by the WHO in March 2020, resulting in numerous counted cases attributed to SARS-CoV-2 worldwide. Herein, we discuss current knowledge on the available therapy options for patients diagnosed with COVID-19. Based on available scientific data, we present an overview of solutions in COVID-19 management by use of drugs, vaccines and antibodies. Many questions with non-conclusive answers on the measures for the management of the COVID-19 pandemic and its impact on health still exist-i.e., the actual infection percentage of the population, updated precise mortality data, variability in response to infection by the population, the nature of immunity and its duration, vaccine development issues, a fear that science might end up with excessive promises in response to COVID-19-and were raised among scientists. Indeed, science may or may not deliver results in real time. In the presented paper we discuss some consequences of disease, its detection and serological tests, some solutions to disease prevention and management, pitfalls and obstacles, including vaccination. The presented ideas and data herein are meant to contribute to the ongoing debate on COVID-19 without pre-selection of available information.
C1 [Pavelic, Kresimir] Juraj Dobrila Univ Pula, Fac Med, Zagrebacka 30, Pula 52100, Croatia.
   [Kraljevic Pavelic, Sandra] Univ Rijeka, Fac Hlth Studies, Viktora Cara Emina 5, Rijeka 51000, Croatia.
   [Brix, Bianca; Goswami, Nandu] Med Univ Graz, Div Physiol, Otto Loewi Res Ctr Vasc Biol Immunol & Inflammat, Neue Stiftingtalstr 6-D-05, A-8010 Graz, Austria.
RP Goswami, N (corresponding author), Med Univ Graz, Div Physiol, Otto Loewi Res Ctr Vasc Biol Immunol & Inflammat, Neue Stiftingtalstr 6-D-05, A-8010 Graz, Austria.
EM pavelic@unipu.hr; sandrakp@biotech.uniri.hr; bianca.brix@medunigraz.at;
   nandu.goswami@medunigraz.at
RI Kraljevic Pavelic, Sandra/J-3864-2012; Pavelic, Kresimir/T-2002-2018
OI Kraljevic Pavelic, Sandra/0000-0003-0491-673X; Brix,
   Bianca/0000-0002-7308-5450; Pavelic, Kresimir/0000-0001-7706-6858;
   Goswami, Nandu/0000-0002-6704-0723
CR Accorsi P, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102817
   ACIP, 2020, COVID 19 VACCINE WOR
   Adams Emily R, 2020, Wellcome Open Res, V5, P139, DOI 10.12688/wellcomeopenres.15927.1
   Ahmed Mukhtar H, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00610-8
   Ahmed S, 2021, INT J INFECT DIS, V103, P214, DOI 10.1016/j.ijid.2020.11.191
   Andreakos E, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012465
   Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020
   Azoulay P, 2020, SCIENCE, V368, P553, DOI 10.1126/science.abc5792
   Bae M, 2020, MOLECULES, V25, DOI 10.3390/molecules25225346
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bilezikian JP, 2020, EUR J ENDOCRINOL, V183, pR133, DOI 10.1530/EJE-20-0665
   Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Cantini F, 2020, J INFECTION, V81, P318, DOI 10.1016/j.jinf.2020.04.017
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849
   Cheng MP, 2020, ANN INTERN MED, V173, P450, DOI 10.7326/M20-2854
   Chhabra N, 2009, INTERNET J MED UPDAT, V4, P33
   Cohen J, 2020, SCIENCE, V368, P564, DOI 10.1126/science.368.6491.564
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742
   Davoudi-Monfared E, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01061-20
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Dondorp AM, 2020, AM J TROP MED HYG, V102, P1191, DOI 10.4269/ajtmh.20-0283
   Entrenas Castillo Marta, 2020, J Steroid Biochem Mol Biol, V203, P105751, DOI 10.1016/j.jsbmb.2020.105751
   Fauchere F, 2020, PRESENCE SARS COV 2, DOI [10.1101/2020.04.17.20061440, DOI 10.1101/2020.04.17.20061440]
   FLCCC Alliance, 2020, FLCCC ALLIANCE CALLS
   Food and Drug Administration US Department of Health and Human Services, 2020, PFIZER BIONTECH COVI
   Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498
   Gattinoni L, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02195-2020
   Ge XY, 2016, VIROL SIN, V31, P31, DOI 10.1007/s12250-016-3713-9
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Golchin A, 2020, STEM CELL REV REP, V16, P427, DOI 10.1007/s12015-020-09973-w
   Gonzalez-Gonzalez E, 2017, CRIT REV BIOTECHNOL, V37, P53, DOI 10.3109/07388551.2015.1114465
   Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
   Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2
   Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Juurlink DN, 2020, CAN MED ASSOC J, V192, pE450, DOI 10.1503/cmaj.200528
   Kanji JN, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01489-0
   Katusic ZS, 2007, CIRC RES, V101, P640, DOI 10.1161/CIRCRESAHA.107.162701
   Klotz LC, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00116
   Kohmer N, 2020, J MED VIROL, V92, P2243, DOI 10.1002/jmv.26145
   Krammer F, 2020, SCIENCE, V368, P1060, DOI 10.1126/science.abc1227
   Kupferschmidt K, 2020, SCIENCE, V367, P1412, DOI 10.1126/science.367.6485.1412
   Lagier JC, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101791
   Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5
   Lauring AS, 2021, JAMA-J AM MED ASSOC, V325, P529, DOI 10.1001/jama.2020.27124
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Letko Michael, 2020, bioRxiv, DOI 10.1101/2020.01.22.915660
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Lin X., 2020, PREPRINTS, V579, P270
   Liu Haolin, 2021, bioRxiv, DOI 10.1101/2021.02.02.428884
   Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4362
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   MARLETTA M, 2010, NAT IMMUNOL, V11, P455
   Martinelli I, 2021, INTERN EMERG MED, V16, P1223, DOI 10.1007/s11739-020-02585-9
   Mathuria JP, 2020, J INFECT PUBLIC HEAL, V13, P901, DOI 10.1016/j.jiph.2020.06.005
   Mawer C, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1542
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Meo SA, 2020, EUR REV MED PHARMACO, V24, P4539, DOI 10.26355/eurrev_202004_21038
   Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863
   Nicol T, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104511
   Noy-Porat T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18159-4
   Paderno A, 2020, INT FORUM ALLERGY RH, V10, P955, DOI 10.1002/alr.22610
   Pandey S, 2020, DIABETES METAB SYND, V14, P1921, DOI 10.1016/j.dsx.2020.09.027
   Pandey SC, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117956
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y
   Piplani S., 2020, ARXIV200506199
   Prokunina-Olsson L, 2020, J EXP MED, V217, DOI 10.1084/jem.20200653
   Rabec C, 2020, RESPIR MED RES-FRANC, V78, DOI 10.1016/j.resmer.2020.100768
   Rajarshi Keshav, 2020, Biotechnology Reports, V26, pe00467, DOI 10.1016/j.btre.2020.e00467
   Rajter JC, 2021, CHEST, V159, P85, DOI 10.1016/j.chest.2020.10.009
   Segreto R., 2020, IS CONSIDERING GENET, DOI [10.13140/RG.2.2.31358.13129/1, DOI 10.13140/RG.2.2.31358.13129/1]
   Shalhoub S, 2020, LANCET, V395, P1670, DOI 10.1016/S0140-6736(20)31101-6
   Stockmann H, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04501-0
   Strijdom H, 2012, CARDIOVASC J AFR, V23
   Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111
   Sullivan HC, 2020, TRANSFUS MED REV, V34, P145, DOI 10.1016/j.tmrv.2020.04.001
   Surkova E, 2020, LANCET RESP MED, V8, P1167, DOI 10.1016/S2213-2600(20)30453-7
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Theoharides TC, 2020, J BIOL REG HOMEOS AG, V34, P1241, DOI 10.23812/20-EDITORIAL_1-5
   TOMASHEFSKI JF, 1983, AM J PATHOL, V112, P112
   Toovey OTR, 2021, J INFECTION, V82, pE23, DOI 10.1016/j.jinf.2021.01.025
   Touret F, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104762
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   VERMA N, 2020, PHYS ENG SCI MED, V22, P1, DOI DOI 10.1007/S10544-020-00534-Z
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16256-y
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang HH, 2020, EUR J CLIN MICROBIOL, V39, P1629, DOI 10.1007/s10096-020-03899-4
   Wang Q, 2020, VIROL SIN, V35, P337, DOI 10.1007/s12250-020-00212-7
   Wang Y, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0158-2
   Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002
   WHO, 2020, Q A COVID 19 HIV ANT
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Wood EM, 2021, BLOOD, V137, P1573, DOI 10.1182/blood.2020008903
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xie Yuanliang, 2020, Radiol Cardiothorac Imaging, V2, pe200067, DOI 10.1148/ryct.2020200067
   Xydakis MS, 2020, LANCET INFECT DIS, V20, P1015, DOI 10.1016/S1473-3099(20)30293-0
   Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346
   Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100
   Zeng LP, 2016, J VIROL, V90, P6573, DOI 10.1128/JVI.03079-15
   Zhang LB, 2020, AGING-US, V12, P6536, DOI 10.18632/aging.103102
   Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou H, 2020, CURR BIOL, V30, P2196, DOI 10.1016/j.cub.2020.05.023
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou Q, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01061
   Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3
NR 120
TC 1
Z9 1
U1 5
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD APR
PY 2021
VL 10
IS 8
AR 1586
DI 10.3390/jcm10081586
PG 15
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA RT5BO
UT WOS:000644474900001
PM 33918624
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Edghiem, F
   Abualqumboz, M
   Mouzughi, Y
AF Edghiem, Farag
   Abualqumboz, Moheeb
   Mouzughi, Yusra
TI Covid-19 transition, could Twitter support UK Universities?
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Knowledge management; knowledge sharing; crisis knowledge; UK
   Universities; Covid-19; Twitter
ID SOCIAL MEDIA; KNOWLEDGE MANAGEMENT; TECHNOLOGY
AB This paper seeks to conceptually explore the use of social media platforms such as Twitter as a microblog to share Covid-19 prescribed knowledge through developing a conceptual framework of university ecosystem knowledge regime. The framework outlines three ecosystem artefacts; teaching, assessment, and student experience and what knowledge-sharing strategies that may help representing these artefacts to the wider community of the ecosystem. The paper provides valuable practical insight to UK Universities' practitioners, students, and concerned stakeholders on the use of Twitter microblogs to share or retrieve knowledge required to cope with the current Covid-19 transition. The paper sheds light on the unique characteristics of knowledge sharing by UK Universities through Twitter in relation to the current Covid-19 pandemic. The paper also highlights the unconventional use of Twitter by UK Universities to share Covid-19 prescribed knowledge with its stakeholders.
C1 [Edghiem, Farag] Inst Management Greater Manchester, Bolton, England.
   [Abualqumboz, Moheeb] Salford Business Sch, Manchester, Lancs, England.
   [Mouzughi, Yusra] Univ Muscat, Muscat, Oman.
RP Edghiem, F (corresponding author), Inst Management Greater Manchester, Mkt Management, Bolton, England.
EM faragibb@gmail.com
RI Abualqumboz, Moheeb/AAJ-1048-2021
OI Abualqumboz, Moheeb/0000-0002-1681-2930; Edghiem,
   Farag/0000-0001-9755-7435
CR Ammirato S, 2019, KNOWL MAN RES PRACT, V17, P52, DOI 10.1080/14778238.2018.1541779
   Ashcraft KL, 2009, ACAD MANAG ANN, V3, P1, DOI 10.1080/19416520903047186
   Barad K., 2007, M UNIVERSE HALFWAY Q
   Birkholz J. M., 2015, DRIVERS HIGHER ED I
   Carpenter J, 2020, PROF DEV EDUC, DOI 10.1080/19415257.2020.1752287
   Chiu CM, 2006, DECIS SUPPORT SYST, V42, P1872, DOI 10.1016/j.dss.2006.04.001
   Chuang CH, 2016, J MANAGE, V42, P524, DOI 10.1177/0149206313478189
   Demetis DS, 2016, INFORM ORGAN-UK, V26, P116, DOI 10.1016/j.infoandorg.2016.09.002
   Devinney T., 2020, TIMES HIGHER ED
   Dragicevic N, 2020, KNOWL MAN RES PRACT, V18, P199, DOI 10.1080/14778238.2019.1633893
   Durst S, 2019, KNOWL MAN RES PRACT, V17, P1, DOI 10.1080/14778238.2018.1538603
   Grace TPL, 2009, J KNOWL MANAG, V13, P64, DOI 10.1108/13673270910971833
   Heavey C, 2020, STRATEGIC MANAGE J, V41, P1490, DOI 10.1002/smj.3156
   Hodges Charles., 2020, EDUCAUSE REV, V502
   Larsson R, 1998, ORGAN SCI, V9, P285, DOI 10.1287/orsc.9.3.285
   Magnier-Watanabe R, 2010, J KNOWL MANAG, V14, P910, DOI 10.1108/13673271011084934
   Nansubuga F, 2020, J KNOWL MANAG, V24, P105, DOI 10.1108/JKM-09-2018-0603
   Nova N. A., 2016, INT JOINT C KNOWL DI
   Orlikowski WJ, 2007, ORGAN STUD, V28, P1435, DOI 10.1177/0170840607081138
   Paananen S, 2020, MANAGE LEARN, V51, P257, DOI 10.1177/1350507619896079
   Qi C, 2018, J ORG COMP ELECT COM, V28, P31, DOI 10.1080/10919392.2018.1407081
   Rutter R, 2016, J BUS RES, V69, P3096, DOI 10.1016/j.jbusres.2016.01.025
   Sarka P, 2017, KNOWL MAN RES PRACT, V15, P594, DOI 10.1057/s41275-017-0075-5
   Schlagwein D, 2017, J INF TECHNOL-UK, V32, P194, DOI 10.1057/jit.2016.7
   Shotter J., 2013, MATTER MATTEROBJEC, P32
   Shujahat M, 2019, J BUS RES, V94, P442, DOI 10.1016/j.jbusres.2017.11.001
   Sigala M, 2012, INT J CONTEMP HOSP M, V24, P966, DOI 10.1108/09596111211258874
   Squire M, 2015, 2015 IEEE/ACM 37TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, VOL 2, P219, DOI 10.1109/ICSE.2015.150
   Sundaresan S, 2020, ENTERP INF SYST-UK, V14, P661, DOI 10.1080/17517575.2020.1737884
   Treem JW, 2020, J COMPUT-MEDIAT COMM, V25, P44, DOI 10.1093/jcmc/zmz024
   Zighan S, 2021, INT J PRODUCT PERFOR, V70, P675, DOI 10.1108/IJPPM-05-2019-0215
NR 31
TC 2
Z9 2
U1 4
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 439
EP 444
DI 10.1080/14778238.2020.1848364
EA DEC 2020
PG 6
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000598957000001
OA Green Submitted, Bronze
DA 2022-04-20
ER

PT J
AU Rowland, P
   Tavares, W
   Lowe, M
   Tripp, T
   Richardson, J
   Anderson, M
   Oja, LA
   Paton, M
   Wiljer, D
   Woods, N
   Ng, S
AF Rowland, Paula
   Tavares, Walter
   Lowe, Mandy
   Tripp, Tim
   Richardson, Juanita
   Anderson, Melanie
   Oja, Lori Anne
   Paton, Morag
   Wiljer, David
   Woods, Nicole
   Ng, Stella
TI Rapid Knowledge Mobilization and Continuing Professional Development:
   Educational Responses to COVID-19
SO JOURNAL OF CONTINUING EDUCATION IN THE HEALTH PROFESSIONS
LA English
DT Article
DE continuing professional development; knowledge mobilization; case study
   methodology; COVID-19
ID TRANSLATION; CPD
AB Introduction: The field of Continuing Professional Development (CPD) has a role to play in supporting health care professionals as they respond to the COVID-19 pandemic. However, the evolving science of COVID-19, the need for quick action, and the disruption of conventional knowledge networks pose challenges to existing CPD practices. To meet these emergent and rapidly evolving needs, what is required is an approach to CPD that draws insights from the domain of knowledge mobilization (KMb). Methods: This short report describes a research protocol for exploring rapid KMb responses to COVID-19 at one Canadian academic teaching hospital. The proposed research will proceed as a case study using a mixed methods design collecting quantitative (surveys and Web site use metrics) and qualitative data (interviews) from individuals involved in developing, using, and supporting the KMb resources. Analysis will proceed in two phases: descriptive analysis of data to share insights and integrative analysis of data to build theory. Results: Results from this study will inform the immediate KMb and CPD contribution to the COVID-19 response. Discussion: Findings from this study will also make a broader contribution to the field of CPD, theoretically informing intersections between KMb and CPD and therefore contributing to an integrated science of CPD.
C1 [Rowland, Paula; Tavares, Walter; Woods, Nicole; Ng, Stella] Univ Hlth Network, Wilson Ctr, 200 Elizabeth Ave,1ES 565, Toronto, ON M5G 2C4, Canada.
   [Rowland, Paula; Tavares, Walter] Univ Hlth Network, PostMD Educ, Toronto, ON, Canada.
   [Rowland, Paula; Tavares, Walter; Woods, Nicole; Ng, Stella] Univ Toronto, Toronto, ON, Canada.
   [Rowland, Paula; Lowe, Mandy] Univ Toronto, Temetry Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada.
   [Tavares, Walter] Univ Toronto, Temetry Fac Med, Dept Med, Toronto, ON, Canada.
   [Tavares, Walter] Reg Municipal York, Community & Hlth Serv Dept, York Reg Paramed & Senior Serv, Newmarket, Suffolk, England.
   [Lowe, Mandy] Univ Hlth Network, Clin Educ, Toronto, ON, Canada.
   [Tripp, Tim; Anderson, Melanie] Univ Hlth Network, Lib & Informat Serv, Toronto, ON, Canada.
   [Richardson, Juanita] UHN, Michener Inst Educ, Learning Resource Ctr, Toronto, ON, Canada.
   [Oja, Lori Anne] Hlth Sci Informat Consortium, Toronto, ON, Canada.
   [Paton, Morag] Univ Toronto, Temetry Fac Med, Continuing Profess Dev, Toronto, ON, Canada.
   [Paton, Morag] Univ Toronto, Ontario Inst Studies Educ, Toronto, ON, Canada.
   [Wiljer, David] Univ Hlth Network, UHN Digital, Educ Technol & Innovat, Toronto, ON, Canada.
   [Wiljer, David] Univ Toronto, Temetry Fac Med, Dept Psychiat, Toronto, ON, Canada.
   [Wiljer, David] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Wiljer, David] Univ Toronto, CPD Res & Scholarship, Off Continuing Profess Dev, Toronto, ON, Canada.
   [Woods, Nicole] Univ Hlth Network, Inst Educ Res TIER, Toronto, ON, Canada.
   [Woods, Nicole] Univ Toronto, Temetry Fac Med, Dept Family & Community Med, Toronto, ON, Canada.
   [Ng, Stella] Univ Toronto, Ctr Fac Dev, Res, Toronto, ON, Canada.
   [Ng, Stella] Univ Toronto, Temetry Fac Med, Dept Speech Language Pathol, Toronto, ON, Canada.
   [Ng, Stella] Univ Hlth Network, Ctr Interprofess Educ, Toronto, ON, Canada.
RP Rowland, P (corresponding author), Univ Hlth Network, Wilson Ctr, 200 Elizabeth Ave,1ES 565, Toronto, ON M5G 2C4, Canada.
EM paula.rowland@utoronto.ca
RI Anderson, Melanie A/J-1145-2016
OI Anderson, Melanie A/0000-0001-9786-1656; Oja, Lori
   Anne/0000-0002-1207-8425
FU University of Toronto, Faculty of Medicine Office of Continuing
   Professional Development through the COVID-19 Response Fund
FX This project has received funding from University of Toronto, Faculty of
   Medicine Office of Continuing Professional Development through the
   COVID-19 Response Fund.
CR Brown JS., 2017, SOCIAL LIFE INFORM
   Clarke AE, 2003, SYMB INTERACT, V26, P553, DOI 10.1525/si.2003.26.4.553
   Creswell J.W, 2014, RES DESIGN QUALITATI, V4th
   Greenhalgh T, 2011, J ROY SOC MED, V104, P501, DOI 10.1258/jrsm.2011.110285
   Guetterman TC, 2018, AM BEHAV SCI, V62, P900, DOI 10.1177/0002764218772641
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Kitto S., 2019, UNDERSTANDING MED ED, V3rd, P263
   Kitto S, 2019, J CONTIN EDUC HEALTH, V39, P159, DOI 10.1097/CEH.0000000000000265
   Kitto SC, 2013, J CONTIN EDUC HEALTH, V33, P81, DOI 10.1002/chp.21169
   Kitto SC, 2012, ADV HEALTH SCI EDUC, V17, P289, DOI 10.1007/s10459-011-9303-6
   Lave J., 1991, SITUATED LEARNING LE, DOI DOI 10.1017/CBO9780511815355
   Merriam S.B., 1998, QUALITATIVE RES CASE
   Sargeant J, 2017, J CONTIN EDUC HEALTH, V37, P268, DOI 10.1097/CEH.0000000000000179
   Sfard A., 1998, ED RES, V27, P4, DOI [10.3102/0013189X027002004, DOI 10.3102/0013189X027002004]
   Swan J., 2016, MOBILIZING KNOWLEDGE, P1
   Tavory Iddo, 2014, ABDUCTIVE ANAL THEOR
   Thomas DC, 2017, AM J MED QUAL, V32, P438, DOI 10.1177/1062860616662523
NR 17
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0894-1912
EI 1554-558X
J9 J CONTIN EDUC HEALTH
JI J. Contin. Educ. Health Prof.
PY 2022
VL 42
IS 1
BP 66
EP 69
DI 10.1097/CEH.0000000000000348
PG 4
WC Education, Scientific Disciplines; Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Education & Educational Research; Health Care Sciences & Services
GA ZW3EF
UT WOS:000771098300021
PM 34009838
DA 2022-04-20
ER

PT J
AU Qhal, EMA
AF Qhal, Eissa Mohammed Ali
TI Vitalizing Knowledge Management for Assessing Organizational Behavior
   during Covid-19
SO INTERNATIONAL TRANSACTION JOURNAL OF ENGINEERING MANAGEMENT & APPLIED
   SCIENCES & TECHNOLOGIES
LA English
DT Article
DE Knowledge; Organizational Behavior Virtualization; Cloud Computing;
   Video Conferencing; Covid-19 MS Teams; Anatomy knowledge
ID PERFORMANCE
AB Coronavirus has produced a requirement for innovations that empower correspondence, joint effort, training and logical talk while keeping actual separation and physical distance. Organization terminations because of COVID-19 and physical separating measures disturb scholarly exercises that happened eye to eye and to assess the organizational behavior. This study incorporates the information on friendly and social sciences, looking through its application in administrative practice. Hierarchical conduct consequently addresses interdisciplinary methodology towards HR's the executives in the work process. It examines human assets on the boar and utilizes the consequences of investigation for the executives' improvement limitations set on organizations because COVID-19 has blocked most traditional types of enterprises, trade, business and allied talks including managing knowledge and behavioral activities. Anatomists presently require legitimate, strong and simple to-utilize specialized instruments to work with remote instructing, learning, exchange an information exploration. Late advances in correspondence, video conferencing, online meetings and computerized innovations might work with the progression of a company and exploration exercises. Models incorporate exceptionally intelligent video conferencing innovation, collective apparatuses, web-based media and systems administration stages using virtualization. In this account survey, we inspect the utility of these innovations in supporting compelling correspondence and expert exercises of knowledge anatomists during COVID-19 and later pandemic effects by the usage of cloud computing and virtualization techniques. (C) 2021 INT TRANS J ENG MANAG SCI TECH.
C1 [Qhal, Eissa Mohammed Ali] Jazan Univ, Appl Coll, Adm Dept, Jazan, Saudi Arabia.
RP Qhal, EMA (corresponding author), Jazan Univ, Appl Coll, Adm Dept, Jazan, Saudi Arabia.
EM Egohal@jazanu.edu.sa
CR AAMODT A, 1995, DATA KNOWL ENG, V16, P191, DOI 10.1016/0169-023X(95)00017-M
   Al-Qdah M.S., 2018, INTERDISCIPLINARY J, V13, P311, DOI [10.28945/4107, DOI 10.28945/4107]
   Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961
   Alvesson M, 2001, HUM RELAT, V54, P863, DOI 10.1177/0018726701547004
   Alvesson M, 2001, J MANAGE STUD, V38, P995, DOI 10.1111/1467-6486.00269
   Ashrafi R., 2008, ELECT J INFORM SYSTE, V11, P125, DOI DOI 10.1177/014920639101700108
   Barclay R. O., 1997, KNOWLEDGE PRAXIS WHA
   Bley K., 2016, 22 AM C INF SYST AMC
   Cascio WF, 2000, ACAD MANAGE EXEC, V14, P81, DOI 10.5465/AME.2000.4468068
   Chong CW, 2009, KNOWL MAN RES PRACT, V7, P142, DOI 10.1057/kmrp.2009.5
   Cirrincione L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093603
   Cox L. V., 2016, THESIS BRANDMAN U BR
   Heaidari M., 2011, BRIT J SCI, V1, P54
   Kumar S., 2015, INT J IND SYSTEMS EN, V21, P180
   Lee H, 2003, J MANAGE INFORM SYST, V20, P179
   Magnier-Watanabe R, 2017, KNOWL MAN RES PRACT, V15, P325, DOI 10.1057/s41275-017-0058-6
   Sarkis J., 2020, RESOUR CONSERV RECY
   Trees L., 2015, AQPC BLOG
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Wiewiora A, 2013, INT J PROJ MANAG, V31, P1163, DOI 10.1016/j.ijproman.2012.12.014
NR 20
TC 0
Z9 0
U1 0
U2 0
PU TUENGR GROUP
PI PATHUMTAN
PA 88-244 MOO 3 KLONG NO 2 KLONG-LUANG, PATHUMTAN, 12120, THAILAND
SN 2228-9860
EI 1906-9642
J9 INT TRANS J ENG MANA
JI Int. Trans. J. Eng. Manag. Appl. Sci. Technol.
PY 2021
VL 12
IS 13
AR 12A13U
DI 10.14456/ITJEMAST.2021.273
PG 21
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA ZI0TO
UT WOS:000761339600011
DA 2022-04-20
ER

PT J
AU Tovstiga, N
   Tovstiga, G
AF Tovstiga, Nicole
   Tovstiga, George
TI COVID-19: a knowledge and learning perspective
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE COVID-19; knowledge; learning trajectory; sense-making;
   conscious-competence model
AB The COVID-19 pandemic presents a unique knowledge dilemma. What do we know? What don't we know? What do we not even know we don't know? While we are in the midst of the global COVID-19 crisis, this article attempts to make sense of the pandemic from a knowledge perspective. An analysis based on the classic four-quadrant 'conscious-competence' framework examines the current state of the COVID-19 crisis. It draws on qualitative current media reporting limited to international, fact-checked coverage of the pandemic. The focus of the analysis is on the first quadrimester of 2020, during which the pandemic made its first appearance. The analysis highlights key junctures along the evolving knowledge trajectory. The article posits that while progress is evident on many fronts, we are as yet primarily in the 'conscious - ignorance' learning stage in which a knowledge base-line is in the process of being established.
C1 [Tovstiga, Nicole] Publicis Sapient, London, England.
   [Tovstiga, George] EDHEC Business Sch, Paris, France.
RP Tovstiga, G (corresponding author), 16-18 Rue 4 Septembre, F-75002 Paris, France.
EM george.tovstiga@edhec.edu
CR Curtiss P. R., 1973, TRAINING RES DEV LIF
   Dewey J, 1938, EXPERIENCE ED
   Durst S, 2019, KNOWL MAN RES PRACT, V17, P1, DOI 10.1080/14778238.2018.1538603
   Gibbons M., 2000, NEW PRODUCTION KNOWL
   Hussey, 2009, BUSINESS RES
   Kransdorff A., 1998, CORPORATE AMNESIA
   Leonard-Barton D., 1995, WELLSPRINGS KNOWLEDG
   March JG, 1994, PRIMER DECISION MAKI
   Nicholson JD, 2018, IND MARKET MANAG, V73, P206, DOI 10.1016/j.indmarman.2018.02.014
   Nonaka I., 2003, Knowledge Management Research & Practice, V1, P2, DOI 10.1057/palgrave.kmrp.8500001
   Nonaka  & Takeuchi, 1995, KNOWLEDGE CREATING C
   O'Dell C, 1998, ONLY WE KNEW WHAT WE
   O'Malley P, 2009, B WORLD HEALTH ORGAN, V87, P614, DOI 10.2471/BLT.08.056689
   Tobin D. R., 1996, TRANSFORMATIONAL LEA
   Weick K. E., 1997, KNOWLEDGE MANAGEMENT
   Yi JL, 2009, KNOWL MAN RES PRACT, V7, P65, DOI 10.1057/kmrp.2008.36
   Yin R.K., 2014, CASE STUDY RES APPL, V5th ed.
NR 17
TC 6
Z9 6
U1 4
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 427
EP 432
DI 10.1080/14778238.2020.1806749
EA AUG 2020
PG 6
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000562601900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Sah, MK
   Singh, A
   Sangroula, RK
AF Sah, Mukesh Kumar
   Singh, Abanish
   Sangroula, Raj Kumar
TI Knowledge of novel coronavirus disease (COVID-19) among dental surgeons
   of Nepal: a nationwide study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Case management; COVID-19; Dental surgeons; Knowledge
AB BackgroundCOVID-19 is an emerging respiratory disease caused by a novel coronavirus. There is not much evidence assessing the knowledge of dental surgeons regarding COVID-19. This study was conducted to assess the knowledge of COVID-19 among dental surgeons of Nepal.MethodsA web-based cross-sectional study was conducted among registered dental surgeons of Nepal. Ethical approval was obtained. Consent was taken, and knowledge on COVID-19 was assessed via a pre-tested structured questionnaire using Google form. The form was emailed to the participants. Descriptive analysis was performed using frequency, percentage, median and inter-quartile range. Man-Whitney test and Kruskal-Wallis tests were carried out to see the difference in knowledge score. P-value <0.05 was considered statistically significant.ResultsTotal 227 dental surgeons responded to the questionnaire (male: 46.4%; female: 53.7%). Almost two-third ( 65.2% ) of the respondents were B.D.S. (Bachelor of Dental Surgery) graduates. Only 29.1% worked in the government hospitals. 17.6% were currently involved in COVID-19 management. Of the participants, 87.7% knew about the condition of the requirement of Personal Protective Equipment (PPE) but only 29.1% could correctly answer the framed question for PPE. The median knowledge score calculated was 14.0 (8.0-18.0). The bivariate analysis showed a statistically significant difference in knowledge score among the age group <greater than or equal to>30years and<30years (p=0.013); M.D.S. (Master of Dental Surgery) graduate and B.D.S. graduate (0.041); dental surgeons of government healthcare facilities and other healthcare facilities (p< 0.001); dental surgeons of COVID-19 centers and non-COVID-19 centers (0.002).ConclusionThe dental surgeons of Nepal have a good knowledge of COVID-19, and they can be utilized for assisting in the management of COVID-19 cases in Nepal.
C1 [Sah, Mukesh Kumar] Patan Acad Hlth Sci, Dept Emergency Med & Gen Practice, Lalitpur, Bagmati Provinc, Nepal.
   [Singh, Abanish] Narayani Hosp, Birgunj 2, Province, Nepal.
   [Sangroula, Raj Kumar] Nepal Publ Hlth Res & Dev Ctr, Kathmandu, Bagmati Provinc, Nepal.
RP Sah, MK (corresponding author), Patan Acad Hlth Sci, Dept Emergency Med & Gen Practice, Lalitpur, Bagmati Provinc, Nepal.
EM sahmukeshkumar88@gmail.com
OI Singh, Abanish/0000-0001-5659-9807; Sah, Mukesh
   Kumar/0000-0002-4363-9678; Sangroula, Raj Kumar/0000-0002-3841-7819
CR Adhikari B, 2016, LANCET, V388, P2739, DOI 10.1016/S0140-6736(16)32423-0
   Aggarwal R, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-37
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   Bhagavathula AS, 2020, NOVEL CORONAVIRUS HE
   Cagetti MG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113835
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Masic Izet, 2008, Acta Inform Med, V16, P219, DOI 10.5455/aim.2008.16.219-225
   Memarpour Mahtab, 2015, Asia Pac Fam Med, V14, P1, DOI 10.1186/s12930-015-0019-2
   Ministry of Health and population, LAT UPD COVID 19
   Olowookere SA, 2015, J TROP MED-US, V2015, DOI 10.1155/2015/431317
   Quadri MFA, 2020, J INFECT PUBLIC HEAL, V13, P856, DOI 10.1016/j.jiph.2020.05.010
   Richmond H, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1047-4
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Shrestha Rabindra Man, 2017, J Nepal Health Res Counc, V15, P187
   Singh A, 2019, KATHMANDU U MED J, V66, P82
   WHO, NOV COR COVID 19 SIT
NR 18
TC 2
Z9 2
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 23
PY 2020
VL 20
IS 1
AR 871
DI 10.1186/s12879-020-05620-4
PG 7
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA PA7DK
UT WOS:000595791200003
PM 33225910
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kara, E
   Ozdemir, N
   Dizman, GT
   Demirkan, K
   Unal, S
AF Kara, Emre
   Ozdemir, Nesligul
   Dizman, Gulcin Telli
   Demirkan, Kutay
   Unal, Serhat
TI Knowledge and attitudes of pharmacy students about COVID-19
SO JOURNAL OF RESEARCH IN PHARMACY
LA English
DT Article
DE COVID-19; pharmacy students; knowledge; attitude; coronavirus
ID UNIVERSITY-STUDENTS
AB The level of knowledge about COVID-19 varies among students in the field of healthcare. In this study, it was aimed to compare pharmacy students' level of knowledge about COVID-19 before and after an educational seminar. This study was conducted in the first wave of COVID-19 and just at the beginning of the pandemic. A seminar on COVID-19 and protection ways was presented by an infectious disease physician to the pharmacy students in a faculty of pharmacy from Ankara. Before and after the seminar, a questionnaire about COVID-19 consisting of 17 multiple-choice or open-ended questions was applied to the students. A total of 114 pharmacy students (46.5% female) attended the seminar and all of them participated in the study. The most common information resources in terms of COVID-19 that were used by the participants was internet (non-scientific resources) (n=90, 78.9%), classical media (TV, newspaper) (n=79, 69.3%) and social media (n=77, 67.5%). The rates of knowing that the coronavirus is a zoonotic virus (p<0.001) and awareness of cough and dyspnea, which are symptoms of COVID-19, showed a statistically significant increase after the seminar (p=0.039 and p<0.001, respectively). The students' knowledge of protection from the disease such as covering the nose and mouth with tissue paper, using eyeglasses, and wearing protective clothing was significantly improved after the seminar (p=0.043, p<0.001, p<0.004, respectively). Although the knowledge of pharmacy students about the new pandemic was not insufficient, it had also increased significantly after the seminar. It is thought that determining and improving their knowledge about the pandemic will contribute to pandemic management.
C1 [Kara, Emre; Demirkan, Kutay] Hacettepe Univ, Fac Pharm, Dept Clin Pharm, TR-06100 Ankara, Turkey.
   [Ozdemir, Nesligul; Dizman, Gulcin Telli; Unal, Serhat] Hacettepe Univ, Fac Med, Dept Infect Dis & Clin Microbiol, TR-06100 Ankara, Turkey.
RP Kara, E (corresponding author), Hacettepe Univ, Fac Pharm, Dept Clin Pharm, TR-06100 Ankara, Turkey.
EM emrekara@hacettepe.edu.tr
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254
   Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008
   Hamza MS, 2021, J COMMUN HEALTH, V46, P139, DOI 10.1007/s10900-020-00859-z
   Huang JQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.588508
   Iwanowicz SL, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj700357
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243024
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Li HO, 2020, ANTIMICROB AGENTS CH, V64, DOI [10.1128/AAC.00483-20, 10.1128/AAC.00483-20.]
   Mustafa Ruba M, 2020, Eur J Dent, V14, pS50, DOI 10.1055/s-0040-1719212
   Noreen K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243696
   Nugraha RV, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/2560645
   Olaimat AN, 2020, AM J TROP MED HYG, V103, P1177, DOI 10.4269/ajtmh.20-0418
   Organization WH, COR DIS COVID 2019 S
   Pascarella G, 2020, J INTERN MED, V288, P192, DOI 10.1111/joim.13091
   Rovetta A, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/19374
   Cuan-Baltazar JY, 2020, JMIR PUBLIC HLTH SUR, V6, P176, DOI 10.2196/18444
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 20
TC 0
Z9 0
U1 0
U2 0
PU MARMARA UNIV
PI ISTANBUL
PA GOZTEPE CAMPUS, KADIKOY, ISTANBUL, 34722, TURKEY
SN 2630-6344
J9 J RES PHARM
JI J. Res. Pharm.
PY 2021
VL 25
IS 6
BP 898
EP 904
DI 10.29228/jrp.86
PG 7
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA XG9JX
UT WOS:000725063300018
OA gold
DA 2022-04-20
ER

PT J
AU Mennini, FS
   Magni, D
   Daniele, LM
   Favato, G
AF Mennini, Francesco Saverio
   Magni, Domitilla
   Daniele, Lucia Michela
   Favato, Giampiero
TI Knowledge management in turbulent times: time-based scenario analysis of
   vaccinations against COVID-19
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article
DE COVID-19; Scenario-based analysis; GDP; Vaccination
ID VIEW
AB Purpose This paper aims to estimate the delay or timely effects of the national vaccination strategy for COVID-19 on Italian gross domestic product (GDP). By adopting a knowledge management lens, the study highlights the importance of "time" for Italian recovery. Indeed, recovering an adequate growth rate is crucial for the future of employment, well-being and management of Italian public debt. Design/methodology/approach This study applies an epidemiological model of a universal access vaccination programme against COVID-19. The economic model is based on the time-shift of available quarterly projections deriving from the expected delay or acceleration of the national vaccination plan against COVID-19. Findings The basic concept underlying the scenario analysis is that the sustainability of the expected recovery of the Italian economy due to the COVID-19 shock, and consequently the growth of the GDP, is time-dependent on the rollout of the national vaccination plan. Research limitations/implications A delay in the vaccination campaign could have a twofold negative impact on the growth of the Italian gross product: it reduces the quarterly growth over the previous year in the short term and it delays the quarterly upwards trend over the next two years. Policymakers and practitioners are called to promptly face new dynamic scenarios due to public and economic policies to fight the COVID-19 crisis. Originality/value To the best of the authors' knowledge, this is the first attempt of research that focuses attention on the synchrony between the economic time necessary for recovery and the real-time necessary to achieve vaccination coverage for the restart of production activities.
C1 [Mennini, Francesco Saverio] Univ Roma Tor Vergata, Dept Econ & Finance, Rome, Italy.
   [Mennini, Francesco Saverio] Kingston Univ, Inst Leadership & Management Hlth, London, England.
   [Magni, Domitilla] RomaTre Univ, Dept Business Studies, Rome, Italy.
   [Daniele, Lucia Michela] Univ Campania Luigi Vanvitelli, Dept Econ, Capua, Italy.
   [Favato, Giampiero] Kingston Univ, Fac Business & Social Sci, Inst Leadership & Management Hlth, London, England.
RP Magni, D (corresponding author), RomaTre Univ, Dept Business Studies, Rome, Italy.
EM domitilla.magni@uniroma3.it
RI Magni, Domitilla/AAE-8279-2019; Daniele, Lucia Michela/AAP-4141-2021
OI Daniele, Lucia Michela/0000-0002-7394-8391
CR Ashok M, 2021, J KNOWL MANAG, V25, P2245, DOI 10.1108/JKM-09-2020-0700
   Bank of Italy, 2020, IMP COV 19 PAND IT E
   Bank of Italy, 2021, MACR PROJ IT EC EUR
   BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949
   Caputo F., 2017, INT J KNOWL MANAG ST, V8, P177, DOI DOI 10.1504/IJKMS.2017.087065
   Caputo F, 2021, J BUS RES, V135, P19, DOI 10.1016/j.jbusres.2021.06.012
   Caputo F, 2019, J KNOWL MANAG, V23, P1314, DOI 10.1108/JKM-10-2018-0645
   Christensen P, 2018, P NATL ACAD SCI USA, V115, P5409, DOI 10.1073/pnas.1713628115
   Dana J, 2020, J KNOWL ECON, V11, P405, DOI 10.1007/s13132-018-0553-x
   Di Mascio F, 2020, AM REV PUBLIC ADM, V50, P621, DOI 10.1177/0275074020941735
   Duan YL, 2021, J KNOWL MANAG, DOI 10.1108/JKM-11-2020-0854
   European Medicines Agency, 2021, ASTRAZENECAS COVID 1
   Ferreira J, 2018, J KNOWL MANAG, V24, P121, DOI 10.1108/JKM-07-2018-0461
   Foroni C, 2022, INT J FORECASTING, V38, P596, DOI 10.1016/j.ijforecast.2020.12.005
   Giraldo SM, 2019, J KNOWL MANAG, V23, P1355, DOI 10.1108/JKM-08-2018-0479
   Iandolo F, 2021, J KNOWL ECON, V12, P1982, DOI 10.1007/s13132-020-00703-8
   IMF Data Mapper, 2021, IT GDP CURR PRIC BIL
   International Monetary Fund, 2020, WORLD EC OUTL GREAT
   Italian National Institute of Statistics, 2021, STIM PREL PIL 4 TRIM
   Italian Office of National Statistics, 2020, PROSP EC IT NEL 2020
   Lee Y, 2021, J KNOWL MANAG, V25, P1526, DOI 10.1108/JKM-06-2020-0483
   Ltifi M, 2022, J KNOWL MANAG, V26, P165, DOI 10.1108/JKM-06-2020-0471
   Mennini F.S., 2021, IMPACT COVID 19 VACC, DOI [10.1101/2021.06.08.21258561, DOI 10.1101/2021.06.08.21258561]
   OECD, 2021, NEED SPEED FAST VACC
   Orlando B, 2021, J INTELLECT CAP, V22, P384, DOI 10.1108/JIC-03-2020-0076
   Papa A, 2020, TECHNOL FORECAST SOC, V153, DOI 10.1016/j.techfore.2018.02.018
   Postolov K., 2020, INT J KNOWLEDGE, V42, P1
   Scuotto V, 2017, J KNOWL MANAG, V21, P640, DOI 10.1108/JKM-10-2016-0465
   Spence M., 2021, RIPRESA EC NEL 2022
   Aurilio MT, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050500
   World Health Organization, 2021, LOOK BACK YEAR CHANG
NR 31
TC 0
Z9 0
U1 10
U2 10
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
PD DEC 19
PY 2022
VL 26
IS 11
BP 71
EP 88
DI 10.1108/JKM-09-2021-0710
EA NOV 2021
PG 18
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA 0G7SQ
UT WOS:000723031900001
OA Green Submitted, hybrid
DA 2022-04-20
ER

PT J
AU Ioannou, P
   Karakonstantis, S
   Mathioudaki, A
   Sourris, A
   Papakosta, V
   Panagopoulos, P
   Petrakis, V
   Papazoglou, D
   Arvaniti, K
   Trakatelli, CM
   Christodoulou, E
   Poulakou, G
   Syrigos, KN
   Rapti, V
   Leontis, K
   Karapiperis, D
   Kofteridis, DP
AF Ioannou, Petros
   Karakonstantis, Stamatis
   Mathioudaki, Anna
   Sourris, Angelos
   Papakosta, Vasiliki
   Panagopoulos, Periklis
   Petrakis, Vasilis
   Papazoglou, Dimitrios
   Arvaniti, Kostoula
   Trakatelli, Christina Maria
   Christodoulou, Evgenia
   Poulakou, Garyfallia
   Syrigos, Konstantinos N.
   Rapti, Vasiliki
   Leontis, Konstantinos
   Karapiperis, Dimitrios
   Kofteridis, Diamantis P.
TI Knowledge and Perceptions about COVID-19 among Health Care Workers:
   Evidence from COVID-19 Hospitals during the Second Pandemic Wave
SO TROPICAL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE COVID-19; SARS-CoV-2; healthcare workers; attitudes; perceptions;
   knowledge
ID HAND HYGIENE; ADHERENCE; BEHAVIORS
AB Health care workers (HCWs) face a higher risk of infection, since they work at the front line of COVID-19 patients' management. Misinterpretations of current scientific evidence among HCWs may impact the delivery of appropriate care to COVID-19 patients and increase the risk of SARS-CoV-2 transmission in the hospital setting. Moreover, knowledge may affect HCWs perceptions depending on their broad beliefs and past experiences. The aim of this study was to explore the knowledge and perceptions of HCWs regarding COVID-19 issues during the second wave of the pandemic. A cross-sectional survey, involving a printed questionnaire, was conducted from 21 October 2020 to 31 January 2021 in four tertiary care hospitals located at four distant geographical regions in Greece. In total, 294 HCWs participated in this study. The majority of HCWs provided precise responses regarding general knowledge, perceptions, and practices concerning the COVID-19 pandemic. However, responses on hand hygiene and antimicrobial use in HCWs with COVID-19 were mistaken. This study reveals a certain degree of misconceptions and knowledge gaps in HCWs everyday practice, especially regarding hand hygiene and antimicrobial use in COVID-19 patients.
C1 [Ioannou, Petros; Karakonstantis, Stamatis; Mathioudaki, Anna; Sourris, Angelos; Papakosta, Vasiliki; Kofteridis, Diamantis P.] Univ Hosp Heraklion, Dept Internal Med & Infect Dis, Iraklion 71110, Greece.
   [Panagopoulos, Periklis; Petrakis, Vasilis; Papazoglou, Dimitrios] Univ Hosp Alexandroupoli, Dept Infect Dis, Dept Internal Med 2, Alexandroupolis 68100, Greece.
   [Arvaniti, Kostoula; Trakatelli, Christina Maria; Christodoulou, Evgenia] Gen Hosp Papageorgiou, Infect Control Unit, COVID 19 Coordinating Team, Thessaloniki 56403, Greece.
   [Poulakou, Garyfallia; Syrigos, Konstantinos N.; Rapti, Vasiliki; Leontis, Konstantinos] Thorac Dis Gen Hosp Sotiria, Dept Med 3, Athens 11527, Greece.
   [Karapiperis, Dimitrios] 424 Gen Mil Teaching Hosp, Dept Infect Dis, Thessaloniki 56429, Greece.
RP Kofteridis, DP (corresponding author), Univ Hosp Heraklion, Dept Internal Med & Infect Dis, Iraklion 71110, Greece.
EM p.ioannou@med.uoc.gr; stamkar2003@gmail.com; mathiouanna94@gmail.com;
   angelosourris@gmail.com; vasopapacosta@gmail.com; ppanago@med.duth.gr;
   vasilispetrakis1994@gmail.com; dpapazog@med.duth.gr;
   arvanitik@hotmail.com; cmtrakatelli@gmail.com; eugenia1381@yahoo.gr;
   gpoulakou@gmail.com; ksyrigos@med.uoa.gr; vassiarapti@gmail.com;
   kostas.leontis@hotmail.com; dimkarapip@yahoo.gr; kofteridisd@hotmail.com
RI Rapti, Vasiliki/AGY-3601-2022; Karakonstantis, Stamatis/ABH-7532-2020
OI Rapti, Vasiliki/0000-0002-8322-635X; Karakonstantis,
   Stamatis/0000-0002-2643-3184; Petrakis, Vasilis/0000-0002-9065-4811;
   Trakatelli, Christina/0000-0001-8110-938X; Ioannou,
   Petros/0000-0003-1082-5674
CR AL-Shammary AA, 2021, HEALTH PROMOT PERSPE, V11, P69, DOI 10.34172/hpp.2021.10
   Anand S, 2021, TRENDS ANAESTH CRIT, V36, P17, DOI 10.1016/j.tacc.2020.09.008
   Apisarnthanarak A, 2020, INFECT CONT HOSP EP, V41, P1093, DOI 10.1017/ice.2020.280
   Arslanca T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250017
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1485, DOI 10.15585/mmwr.mm6941a3
   Gagneux-Brunon A, 2021, J HOSP INFECT, V108, P168, DOI [10.1016/j.jhin.2020.11.0200195-6701, 10.1016/j.jhin.2020.11.020]
   Guzek D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165770
   Iversen K, 2020, LANCET INFECT DIS, V20, P1401, DOI 10.1016/S1473-3099(20)30589-2
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Kim JS, 2016, J CLIN NURS, V25, P2542, DOI 10.1111/jocn.13295
   Krammer S, 2020, PSYCHOTHER PSYCH MED, V70, P272, DOI 10.1055/a-1192-6608
   Lang R, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10790-0
   Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016
   Lansbury L, 2020, J INFECTION, V81, P266, DOI 10.1016/j.jinf.2020.05.046
   Marasco G, 2020, DIGEST LIVER DIS, V52, P1396, DOI 10.1016/j.dld.2020.05.023
   Marcoux JT, 2020, J FOOT ANKLE SURG, V59, DOI 10.1053/j.jfas.2020.06.009
   McKee M, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00441-5
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Norgaard SK, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.1.2002023
   Oppenheim B, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020311
   Perozziello A, 2019, J ANTIMICROB CHEMOTH, V74, P2451, DOI 10.1093/jac/dkz179
   Post L, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/25695
   Sax H, 2007, INFECT CONT HOSP EP, V28, P1267, DOI 10.1086/521663
   Siettos C, 2021, PATHOG GLOB HEALTH, V115, P133, DOI 10.1080/20477724.2021.1881372
   Spernovasilis N, 2021, TROP MED INFECT DIS, V6, DOI 10.3390/tropicalmed6010020
   Turcu-Stiolica A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040864
   Ungureanu BS, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.579177
   Verger P, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.3.2002047
   Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5
   Wake AD, 2021, RISK MANAG HEALTHC P, V14, P2609, DOI 10.2147/RMHP.S311074
   World Health Organization 2020, PREV ID MAN HLTH WOR
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 34
TC 1
Z9 1
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2414-6366
J9 TROP MED INFECT DIS
JI Trop. Med. Infect. Dis.
PD SEP
PY 2021
VL 6
IS 3
AR 136
DI 10.3390/tropicalmed6030136
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Parasitology; Tropical Medicine
GA UX9IH
UT WOS:000701149200001
PM 34287390
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Yu, Q
   Wang, Q
   Zhang, YF
   Chen, CY
   Ryu, H
   Park, N
   Baek, JE
   Li, KY
   Wu, YF
   Li, DF
   Xu, J
   Liu, MJ
   Yang, JJ
   Zhang, CW
   Lu, C
   Zhang, P
   Li, X
   Chen, BT
   Ebeid, IA
   Fensel, J
   Min, C
   Zhai, YJ
   Song, M
   Ding, Y
   Bu, Y
AF Yu, Qi
   Wang, Qi
   Zhang, Yafei
   Chen, Chongyan
   Ryu, Hyeyoung
   Park, Namu
   Baek, Jae-Eun
   Li, Keyuan
   Wu, Yifei
   Li, Daifeng
   Xu, Jian
   Liu, Meijun
   Yang, Jeremy J.
   Zhang, Chenwei
   Lu, Chao
   Zhang, Peng
   Li, Xin
   Chen, Baitong
   Ebeid, Islam Akef
   Fensel, Julia
   Min, Chao
   Zhai, Yujia
   Song, Min
   Ding, Ying
   Bu, Yi
TI Analyzing knowledge entities about COVID-19 using entitymetrics
SO SCIENTOMETRICS
LA English
DT Article
DE COVID-19; Knowledge graph; Entity; Entitymetrics; Scientific
   publications; Bibliometrics
AB COVID-19 cases have surpassed the 109 + million markers, with deaths tallying up to 2.4 million. Tens of thousands of papers regarding COVID-19 have been published along with countless bibliometric analyses done on COVID-19 literature. Despite this, none of the analyses have focused on domain entities occurring in scientific publications. However, analysis of these bio-entities and the relations among them, a strategy called entity metrics, could offer more insights into knowledge usage and diffusion in specific cases. Thus, this paper presents an entitymetric analysis on COVID-19 literature. We construct an entity-entity co-occurrence network and employ network indicators to analyze the extracted entities. We find that ACE-2 and C-reactive protein are two very important genes and that lopinavir and ritonavir are two very important chemicals, regardless of the results from either ranking.
C1 [Yu, Qi; Wang, Qi; Zhang, Yafei] Shanxi Med Univ, Inst Med Data Sci, Taiyuan, Peoples R China.
   [Yu, Qi] Shanxi Med Univ, Sch Management, Taiyuan, Peoples R China.
   [Wang, Qi] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan, Peoples R China.
   [Chen, Chongyan; Ebeid, Islam Akef; Ding, Ying] Univ Texas Austin, Sch Informat, Austin, TX 78712 USA.
   [Ryu, Hyeyoung] Univ Washington, Informat Sch, Seattle, WA 98195 USA.
   [Park, Namu] Yonsei Univ, Dept Digital Analyt, Seoul, South Korea.
   [Baek, Jae-Eun] Dae Gu Univ, Dept Lib & Informat Sci, Gyongsan, South Korea.
   [Li, Keyuan] Indiana Univ, Coll Arts & Sci, Dept Stat, Bloomington, IN USA.
   [Wu, Yifei; Zhang, Peng] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China.
   [Li, Daifeng; Xu, Jian] Sun Yat Sen Univ, Sch Informat Management, Guangzhou, Guangdong, Peoples R China.
   [Liu, Meijun] Fudan Univ, Inst Global Publ Policy, Shanghai, Peoples R China.
   [Liu, Meijun] Fudan Univ, LSE Fudan Res Ctr Global Publ Policy, Shanghai, Peoples R China.
   [Zhang, Chenwei] Univ Hong Kong, Fac Educ, Hong Kong, Peoples R China.
   [Yang, Jeremy J.] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA.
   [Lu, Chao] Hohai Univ, Business Sch, Nanjing, Jiangsu, Peoples R China.
   [Li, Xin; Zhai, Yujia] Wuhan Univ, Sch Informat Management, Wuhan, Hubei, Peoples R China.
   [Chen, Baitong] Shanghai Univ, Dept Lib Informat & Arch, Shanghai, Peoples R China.
   [Fensel, Julia] Westlake High Sch, Austin, TX USA.
   [Min, Chao] Nanjing Univ, Sch Informat Management, Nanjing, Jiangsu, Peoples R China.
   [Zhai, Yujia] Tianjin Normal Univ, Dept Informat Resource Management, Tianjin, Peoples R China.
   [Song, Min] Yonsei Univ, Dept Lib & Informat Sci, Seoul, South Korea.
   [Ding, Ying] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA.
   [Bu, Yi] Peking Univ, Dept Informat Management, Beijing, Peoples R China.
RP Song, M (corresponding author), Yonsei Univ, Dept Lib & Informat Sci, Seoul, South Korea.; Bu, Y (corresponding author), Peking Univ, Dept Informat Management, Beijing, Peoples R China.
EM min.song@yonsei.ac.kr; buyi@pku.edu.cn
RI Li, Xin/ABD-7192-2020; Min, Chao/N-9175-2015
OI Li, Xin/0000-0002-8169-6059; Min, Chao/0000-0002-0627-995X; Ryu,
   Hyeyoung/0000-0003-2589-834X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71573162]; Shanxi Scholarship Council of
   China [HGKY2019057]; Ministry of Education of the Republic of Korea;
   National Research Foundation of KoreaNational Research Foundation of
   Korea [2020S1A5B1104865]; NSF RAPIDNational Science Foundation (NSF)
   [2028717]; Ministry of Education of China Project of Humanities and
   Social Sciences [18YJC870002]
FX The authors are grateful to Allen Institute of AI for publicly sharing
   the COVID-19 open research dataset and Drs. Zhiyong Lu and Chih-Hsuan
   Wei for their kind help on PubTator usage. The authors thank the
   anonymous reviewer to offer many suggestions to improve the quality of
   this paper. Qi Yu acknowledges financial supports from National Natural
   Science Foundation of China (Grant Number: 71573162) and the Shanxi
   Scholarship Council of China (Grant Number: HGKY2019057). This work was
   supported by Min Song acknowledges financial supports from the Ministry
   of Education of the Republic of Korea and the National Research
   Foundation of Korea (Grant Number: 2020S1A5B1104865). Ying Ding
   acknowledges financial support from the NSF RAPID (Grant Number:
   2028717). Baitong Chen acknowledges financial support from the Ministry
   of Education of China Project of Humanities and Social Sciences (Grant
   Number: 18YJC870002).
CR Alhazzani W., 2020, Intensive Care Med., V46, P854, DOI [10.1007/s00134-020-06022-5, DOI 10.1007/S00134-020-06022-5]
   Amano-Patino N., 2020, WHO IS DOING NEW RES
   [Anonymous], 2020, COVID 19 OP RES DAT
   Bell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021474
   Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X
   Chahrour M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7357
   Choy KT, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104786
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Dehghanbanadaki Hojat, 2020, Med J Islam Repub Iran, V34, P51, DOI 10.34171/mjiri.34.51
   Ding Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071416
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Farooq R, 2021, J FAM COMMUNITY MED, V28, P1, DOI 10.4103/jfcm.JFCM_332_20
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Gysi DM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025581118
   Hamidah I., 2020, INDONESIAN J SCI TEC, V5, P209, DOI [10.17509/ijost.v5i2.24522, DOI 10.17509/IJOST.V5I2.24522]
   Hossain MM, 2020, CURRENT STATUS GLOBA, V9, P374, DOI DOI 10.2139/SSRN.3547824
   Kousha K, 2020, QUANT SCI STUD, V1, P1068, DOI 10.1162/qss_a_00066
   Lee K, 2017, J ASSOC INF SCI TECH, V68, P1295, DOI 10.1002/asi.23752
   Li CX, 2019, BMC IMMUNOL, V20, DOI 10.1186/s12865-019-0311-2
   Li X, 2020, JMIR MED INF, V8, DOI 10.2196/16739
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Myers KR, 2020, NAT HUM BEHAV, V4, P880, DOI 10.1038/s41562-020-0921-y
   Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
   Rafiei Nasab F., 2020, HLTH INFORMATICS, DOI [10.1101/2020.03.19.20038752, DOI 10.1101/2020.03.19.20038752]
   Ren LH, 2011, ASIAN J CONTROL, V13, P726, DOI 10.1002/asjc.395
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Salehi S, 2020, AM J ROENTGENOL, V215, P87, DOI [10.2214/AJR.20.23034, 10.2214/AJR.20.23034S.]
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Song, 2016, P 5 INT WORKSH COMP, P1
   박진균, 2017, [Journal of the Korean Biblia Society for Library and Information Science, 한국비블리아학회지], V28, P191, DOI 10.14699/kbiblia.2017.28.1.191
   Song M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084639
   South AM, 2020, AM J PHYSIOL-HEART C, V318, pH1084, DOI 10.1152/ajpheart.00217.2020
   Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324
   Vincent-Lamarre P, 2020, NATURE INDEX    0519
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Wagner CS, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3595455, DOI 10.2139/SSRN.3595455]
   Wang L, 2020, MED MALADIES INFECT, V50, P332, DOI 10.1016/j.medmal.2020.03.007
   Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441
   Xu J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0543-2
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Zhai F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113766
   Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405
NR 44
TC 6
Z9 6
U1 18
U2 37
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0138-9130
EI 1588-2861
J9 SCIENTOMETRICS
JI Scientometrics
PD MAY
PY 2021
VL 126
IS 5
BP 4491
EP 4509
DI 10.1007/s11192-021-03933-y
EA MAR 2021
PG 19
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science; Information Science & Library Science
GA RU1KG
UT WOS:000628128900008
PM 33746309
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Fan, ZY
   Mou, YL
   Cheng, R
   Zhao, Y
   Zhang, F
AF Fan, Zhaoya
   Mou, Yuanlin
   Cheng, Rui
   Zhao, Yong
   Zhang, Fan
TI Investigation of Knowledge, Attitude and Practice of Personal Protection
   Among Different Types of Workers Returning to Work Under COVID-19
   Epidemic
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE COVID-19; knowledge; attitudes; practices; personal protection
ID MENTAL-HEALTH; TRANSMISSION; CHINA
AB Background: Since the outbreak of the coronavirus disease 2019 (COVID-19) world pandemic, it has had a significant negative impact on the economy and employment. The orderly resumption of work and production is an important factor in reducing the impact of the COVID-19 and an important guarantee of social and economic stability. The study aimed to investigate the knowledge, attitudes, and practice (KAP) of people returning to work about personal protection under the COVID-19 world pandemic.
   Methods: During March 2020, based on WeChat, QQ and other internet platforms, online questionnaire survey was conducted by the convenience sampling method. SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA) was used for statistics analysis. Descriptive statistics and multiple linear regression analyses were conducted to analyze the data.
   Results: A total of 302 valid questionnaires was collected, and the valid response rate was 86.7%. About knowledge, people who return to work had the highest awareness rate of safe communication distance and the lowest awareness rate of exposure risk levels in different workplaces. The average scores of respondents in different occupations were higher than 95 in terms of personal protective attitude. In terms of practice, the average scores of respondents in different occupations were higher than 90 points. Multiple linear regression results showed that education and place of residence were the influencing factors of knowledge, while gender was the influencing factor of practice.
   Conclusion: The awareness of prevention and control among the 302 participants was good. There were differences in personal protection knowledge among different occupational groups, but there were no differences in attitude and practice. Our findings were of great significance to improve the pertinence of COVID-19 prevention programs.
C1 [Fan, Zhaoya; Mou, Yuanlin; Cheng, Rui; Zhao, Yong; Zhang, Fan] Chongqing Med Univ, Sch Publ Hlth & Management, Res Ctr Med & Social Dev, Collaborat Innovat Ctr Social Risks Governance Hl, Chongqing, Peoples R China.
RP Zhao, Y; Zhang, F (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Res Ctr Med & Social Dev, Collaborat Innovat Ctr Social Risks Governance Hl, Chongqing, Peoples R China.
EM epicqmu@163.com; zhaoyong@cqmu.edu.cn
RI Zhao, Yong/Z-3231-2019
OI Zhao, Yong/0000-0001-9290-109X
FU Chongqing Medical University School of Public Health and Management,
   Research Center for Medicine and Social Development, COVID-19
   Prevention, and Control Emergency Research (Management) Project
FX This research was funded by Chongqing Medical University School of
   Public Health and Management, Research Center for Medicine and Social
   Development, COVID-19 Prevention, and Control Emergency Research
   (Management) Project.
CR Ahmed F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5446-1
   [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   Chen B., 2012, INJURY MED ELECT EDI, V1, P58, DOI [10.3868/j.issn.2095-1566.2012.04.012, DOI 10.3868/J.ISSN.2095-1566.2012.04.012]
   Chen Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/23729
   Chinese Center for Disease Control and Prevention (CDC), 2020, KNOWL WORLD
   Dousari AS, 2020, INFECT DRUG RESIST, V13, P2819, DOI 10.2147/IDR.S259279
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995
   Gao HM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09961-2
   Nhu HV, 2020, J COMMUN HEALTH, V45, P1263, DOI 10.1007/s10900-020-00919-4
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang JT., 2000, HEALTH EDUC
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   Lee K, 2009, GLOB INST, P1
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liang YM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186550
   Moghadam MT, 2021, IRAN J PSYCHIATRY BE, V15, DOI 10.5812/ijpbs.106041
   Moghadam MT, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.570235
   National Health Commission of the People's Republic China (NHC), 2020, KNOWL PREV CONTR COV
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Qu JY, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab014
   Saadatjoo S, 2021, PUBLIC HEALTH, V194, P185, DOI 10.1016/j.puhe.2021.03.005
   Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055
   The State Council, 2020, NOT PREV CONTR MEAS
   Worldmeter, 2020, COVID 19 UPD LIV
   Xinhua, 2020, STAT COUNC TIPS WORK
   Yang KH, 2021, J ADV NURS, V77, P1839, DOI 10.1111/jan.14718
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 28
TC 1
Z9 1
U1 10
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD MAY 17
PY 2021
VL 9
AR 679699
DI 10.3389/fpubh.2021.679699
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA SK2LT
UT WOS:000656052100001
PM 34079789
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Sengupta, M
   Dutta, S
   Roy, A
   Chakrabarti, S
   Mukhopadhyay, I
AF Sengupta, Mitali
   Dutta, Smita
   Roy, Arijit
   Chakrabarti, Satyajit
   Mukhopadhyay, Indraneel
TI Knowledge, attitude and practice survey towards COVID-19 vaccination: A
   mediation analysis
SO INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT
LA English
DT Article; Early Access
DE attitude; COVID-19; India; knowledge; practice; vaccination
AB Background and Aim The COVID-19 pandemic has significantly impacted human lives across the world. In a country like India, with the second highest population in the world, impact of COVID-19 has been diverse and multidimensional. Under such circumstances, vaccination against COVID-19 infection is claimed to be one of the major solutions to contain the pandemic. Understanding of Knowledge, Attitude and Practice (KAP) measures are essential prerequisites to design suitable intervention programs. This paper examines the different KAP factors in Indians towards their decision of vaccine uptake. Method An online questionnaire was administered to Indian respondents. (Pilot study: n = 100, Main study: n = 221) to assess their existing knowledge on COVID-19 infections and vaccination, attitude and intentions towards COVID-19 vaccines and their decision towards COVID-19 vaccine uptake. Result The findings highlighted that existing knowledge on COVID-19 infections and vaccination directly impacted their attitude and intention towards vaccination. The attitude and intention towards COVID-19 vaccines directly impacted their practice of undergoing COVID-19 vaccination. Further, there was a statistically significant and considerably large indirect effect of existing knowledge on COVID-19 infections and vaccination on the practice of undergoing COVID-19 vaccination through attitude and intention towards the vaccine. There was no direct effect of Knowledge (existing knowledge on COVID-19 infections and vaccination) on Practice (decision to undergo COVID-19 vaccination). Therefore, Attitude and intention towards COVID-19 vaccine is the primary mediator between Knowledge (existing knowledge on COVID-19 infections and vaccination) and Practice (decision to undergo COVID-19 vaccination). Conclusion Participants decision towards COVID-19 vaccination decisions are strongly related to their attitude and intentions that confirms the strong role of attitude towards success of COVID-19 vaccination programme. Therefore, 'person-centric' attitude based positive intervention strategies that links their prior knowledge on COVID-19 infections and vaccination must be designed for greater vaccine acceptance amongst Indians.
C1 [Sengupta, Mitali; Dutta, Smita; Chakrabarti, Satyajit] Univ Engn & Management, Plot 3,B-5,New Town Rd,Act Area 3, Kolkata 700160, W Bengal, India.
   [Roy, Arijit] Chikitsa Medicare Ctr Pvt Ltd, Cradle Fertil Ctr, Kolkata, India.
   [Mukhopadhyay, Indraneel] Inst Engn & Management, Kolkata, India.
RP Sengupta, M (corresponding author), Univ Engn & Management, Plot 3,B-5,New Town Rd,Act Area 3, Kolkata 700160, W Bengal, India.
EM mitali.sengupta@uem.edu.in
OI Sengupta, Mitali/0000-0002-2865-4394
CR Afzal MS, 2021, J COMMUN HEALTH, V46, P476, DOI 10.1007/s10900-020-00875-z
   Ajzen I, 2020, HUM BEHAV EMERG TECH, V2, P314, DOI 10.1002/hbe2.195
   Al-Marshoudi S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060602
   Al-Qerem WA, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.632914
   Alwi SARS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11071-6
   Andrews MA, 2020, INDIAN J MED RES, V151, P490, DOI 10.4103/ijmr.IJMR_2131_20
   [Anonymous], 2021, BEST TIM PREV NEXT P
   Brown TA, 2015, CONFIRMATORY FACTOR, V2
   Buchari I., 2015, PROCEDIA EC FINANCE, V30, P68, DOI DOI 10.1016/S2212-5671(15)01256-3
   Charumilind S., 2021, WILL COVID 19 PANDEM
   Chu HR, 2021, PATIENT EDUC COUNS, V104, P1878, DOI 10.1016/j.pec.2021.02.031
   Cicchetti DV., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]
   Cohen J., 1988, STAT POWER ANAL BEHA, V2, DOI [10.1111/1467-9507.00183, DOI 10.4324/9780203771587]
   Cordina M, 2021, PHARM PRACT-GRANADA, V19, DOI [10.18549/PharmPract.2021.1.2317, 10.18549/pharmpract.2021.1.2317]
   Dharmalingam A., 2017, INT J CONT PEDIAT, V4, P783, DOI [10.18203/2349-3291.ijcp20171488, DOI 10.18203/2349-3291.IJCP20171488]
   Dodd RH, 2021, LANCET INFECT DIS, V21, P161, DOI 10.1016/S1473-3099(20)30926-9
   El-Elimat T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250555
   Elhadi M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10987-3
   FlesS, 1986, DESIGN ANAL CLIN EXP, P1
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x
   Giubilini A, 2019, PALGRAVE ST ETHICS P, P1, DOI 10.1007/978-3-030-02068-2
   Goodman JL, 2020, JAMA-J AM MED ASSOC, V324, P2027, DOI 10.1001/jama.2020.20590
   Goralnick E, 2021, NEW ENGL J MED, V384, pE67, DOI 10.1056/NEJMp2102535
   Gupta M., 2021, INT J COMMUNITY MED, V8, P4776, DOI [10.18203/2394-6040.ijcmph20213664, DOI 10.18203/2394-6040.IJCMPH20213664]
   Hair JF., 2009, MULTIVARIATE DATA AN
   Hord SM., 1999, SW ED DEV LAB, V7, pn1
   Islam MS, 2021, J PUBLIC HEALTH-UK, V43, P13, DOI 10.1093/pubmed/fdaa182
   Kar SK, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100915
   Karlsson LC, 2021, PERS INDIV DIFFER, V172, DOI 10.1016/j.paid.2020.110590
   Kline R.B., 2015, PRINCIPLES PRACTICE, V4th ed., P300
   Knol DL, 2011, MEASUREMENT MED PRAC, VDL, P96
   Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012
   Kumar D, 2016, ISR J HEALTH POLICY, V5, DOI 10.1186/s13584-016-0062-y
   Kumari A, 2021, DIABETES METAB SYND, V15, P919, DOI 10.1016/j.dsx.2021.04.004
   Kwok KO, 2021, INT J NURS STUD, V114, DOI 10.1016/j.ijnurstu.2020.103854
   Lameris Marlee, 2013, J Can Chiropr Assoc, V57, P214
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   Lee M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10285-y
   Mallapaty Smriti, 2021, Nature, DOI 10.1038/d41586-021-00450-z
   Nunnally J., 1994, PSYCHOMETRIC THEORY, V3rd ed, P11
   Pal M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7423
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Paul E, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100012
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338
   Segars AH, 1997, OMEGA-INT J MANAGE S, V25, P107, DOI 10.1016/S0305-0483(96)00051-5
   Sengupta M, 2021, J HEALTH MANAG, V23, P339, DOI 10.1177/09720634211011695
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   Sonawane K, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100016
   Srivastava S, 2021, J BIOSCIENCES, V46, DOI 10.1007/s12038-021-00145-7
   Thiagarajan K, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n196
   Watson R, 2001, J ADV NURS, V36, P478, DOI 10.1046/j.1365-2648.2001.2027c.x
   Worldometer, 2020, COVID 19 CORONAVIRUS
   Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018
   Zhang YT, 2021, HUM VACC IMMUNOTHER, V17, P1622, DOI 10.1080/21645515.2020.1847585
NR 57
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0749-6753
EI 1099-1751
J9 INT J HEALTH PLAN M
JI Int. J. Health Plan. Manag.
DI 10.1002/hpm.3449
EA FEB 2022
PG 18
WC Health Policy & Services; Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA ZJ1RS
UT WOS:000762090000001
PM 35229357
OA hybrid
DA 2022-04-20
ER

PT J
AU Jia, YH
   Ma, SL
   Bai, LJ
   Xiao, Q
   Wu, Y
   Gao, Y
   Han, YF
   Xie, ZP
   Tang, XW
   Ge, J
AF Jia, Yuehui
   Ma, Shuli
   Bai, Lianjie
   Xiao, Qiong
   Wu, Yu
   Gao, Ying
   Han, Yunfeng
   Xie, Zhiping
   Tang, Xiaowei
   Ge, Jie
TI Health Literacy and Disparities in Knowledge, Attitude and Practice
   Regarding COVID-19 Among College Students During the COVID-19 Outbreak
   in China: A Cross-Sectional Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; knowledge; attitude; practice; college students
ID CORONAVIRUS DISEASE COVID-19; WUHAN
AB Purpose: This study aimed to assess the knowledge, attitude and practice (KAP) towards COVID-19 of Chinese college students during the COVID-19 outbreak and identify the determinants considerably associated with KAP. Methods: An online cross-sectional questionnaire survey was conducted in February 2020 in China to recruit participants on the Wen-Juan-Xing online platform. A self-made questionnaire was used to assess the KAP towards COVID-19. Results: The average scores of COVID-19-related KAP among college students were 32.16 +/- 4.09, 16.84 +/- 3.18 and 15.36 +/- 1.83, respectively. The average correct response rate of COVID-19-related knowledge was 84.62%. 94.59% of the respondents believed China could control and conquer the pandemic; 98.92% of the respondents wore a mask when they went out. The multiple linear regression showed that the female students had higher scores of COVID-19-related knowledge than male students (beta = 0.79, P = 0.01), and the students from 985 or 211 universities (beta = -2.22, P < 0.01) were significantly associated with higher knowledge scores. Furthermore, a significantly positive correlation was found between the scores of COVID-19-related KAP among students. Conclusion: The college students had a good KAP towards the COVID-19 pandemic. The present study was able to access the COVID-19-related KAP among college students during the pandemic and identify their weaknesses in pandemic prevention. Consequently, the results of this study provide theoretical basis for implementing precision health education among college students and reference for campuses to conduct scientific prevention and control during a pandemic. Results also provide beneficial experience to curb similar major public health emergencies in the future.
C1 [Jia, Yuehui; Ma, Shuli; Han, Yunfeng; Xie, Zhiping; Ge, Jie] Qiqihar Med Univ, Sch Publ Hlth, 333 Bukui St, Qiqihar 161000, Heilongjiang, Peoples R China.
   [Bai, Lianjie] Qiqihar Med Univ, Affiliated Hosp 2, Qiqihar, Heilongjiang, Peoples R China.
   [Xiao, Qiong; Wu, Yu] Qiqihar Med Univ, Sch Nursing, Qiqihar, Heilongjiang, Peoples R China.
   [Gao, Ying] Qiqihar Med Univ, Sch Mental Hlth, Qiqihar, Heilongjiang, Peoples R China.
   [Tang, Xiaowei] Qiqihar Med Univ, Sanit Anal Ctr, Sci Res Off, Qiqihar, Heilongjiang, Peoples R China.
RP Ge, J (corresponding author), Qiqihar Med Univ, Sch Publ Hlth, 333 Bukui St, Qiqihar 161000, Heilongjiang, Peoples R China.
EM gejieqiao@126.com
FU Heilongjiang Department of Education [2020-KYYWF-0054, 2016-KYYWF-0885];
   Science and Technology Bureau of Qiqihar [LHYD-2021045]
FX This study was supported by the Heilongjiang Department of Education
   [grant number: 2020-KYYWF-0054 and 2016-KYYWF-0885], and the Science and
   Technology Bureau of Qiqihar [grant number: LHYD-2021045].
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Al Ahdab S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10353-3
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Almomani EY, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.595874
   Alrasheedy AA, 2021, RISK MANAG HEALTHC P, V14, P729, DOI 10.2147/RMHP.S292354
   Awadasseid A, 2020, INT J BIOL SCI, V16, P1846, DOI 10.7150/ijbs.45018
   Chen PJ, 2020, J SPORT HEALTH SCI, V9, P103, DOI 10.1016/j.jshs.2020.02.001
   Chen Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/23729
   Chinese Center for Disease Control and Prevention, 2020, NOV COR PNEUM DASHB
   Domiati S, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00542
   Fan JC, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101741
   Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008
   Gudi SK, 2020, DRUGS THER PERSPECT, V36, P413, DOI 10.1007/s40267-020-00752-8
   Habib MA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245176
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Kanu S, 2021, J MULTIDISCIP HEALTH, V14, P67, DOI 10.2147/JMDH.S287156
   Kasemy ZA, 2020, J EPIDEMIOL GLOB HEA, V10, P378, DOI 10.2991/jegh.k.200909.001
   Lake EA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247204
   Lin KG, 2020, AM J PSYCHIAT, V177, P635, DOI 10.1176/appi.ajp.2020.20040374
   McCaffery KJ, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp30342012
   Nakhostin-Ansari Amin, 2020, J Prev Med Hyg, V61, pE501, DOI 10.15167/2421-4248/jpmh2020.61.4.1576
   National Health Commission of the People's Republic of China, 2020, PREVENTION CONTROL N
   Niu ZM, 2021, HEALTH COMMUN, DOI 10.1080/10410236.2021.1880684
   Sayedahmed AMS, 2020, SCI AFR, V10, DOI 10.1016/j.sciaf.2020.e00652
   Tamang N, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10025-8
   Tesfaye ZT, 2020, INTEGR PHARM RES PRA, V9, P105, DOI 10.2147/IPRP.S261275
   The Central People's Government of the People's Republic of China, 2020, DIS PREV CONTR BUR D
   Thomas R, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043421
   Tsai FJ, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025210
   Tu HL, 2020, J INFECTION, V81, P1, DOI 10.1016/j.jinf.2020.04.011
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   World Health Organization, 2021, WHO COR DIS COVID 19
   Yang JZ, 2020, BRAIN BEHAV IMMUN, V87, P113, DOI 10.1016/j.bbi.2020.04.075
   Yang KH, 2021, J ADV NURS, V77, P1839, DOI 10.1111/jan.14718
   Yazew BG, 2021, PATIENT PREFER ADHER, V15, P337, DOI 10.2147/PPA.S288186
   Yimenu DK, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120973498
   Yousaf MA, 2020, SOC WORK PUBLIC HLTH, V35, P569, DOI 10.1080/19371918.2020.1806983
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhu Z, 2020, J PSYCHIATR RES, V129, P1, DOI 10.1016/j.jpsychires.2020.05.026
NR 39
TC 0
Z9 0
U1 13
U2 13
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 4477
EP 4488
DI 10.2147/RMHP.S319331
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA WU7GZ
UT WOS:000716711000003
PM 34754254
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Aljondi, R
   Alghamdi, SS
   Abdelaziz, I
   Bushara, L
   Alghamdi, S
   Aljehani, A
   Zailae, A
   Alghamdi, JS
   Feteih, I
   Mahmoud, MZ
   Tajaldeen, A
AF Aljondi, Rowa
   Alghamdi, Salem Saeed
   Abdelaziz, Ikhlas
   Bushara, Lubna
   Alghamdi, Somayah
   Aljehani, Abdullah
   Zailae, Ali
   Alghamdi, Jamaan S.
   Feteih, Iyad
   Mahmoud, Mustafa Z.
   Tajaldeen, Abdulrahman
TI Knowledge of COVID-19 infection control among healthcare workers in
   radiology departments in Saudi Arabia
SO JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES
LA English
DT Article
DE Knowledge; infection control; radiology department; COVID-19
ID HOSPITALIZED-PATIENTS; MERS; PREPAREDNESS; PNEUMONIA; WUHAN
AB Radiological examinations have played a crucial role in the identification and management of COVID-19 patients. Therefore, knowledge and awareness of infection control among healthcare workers in radiology departments are important to prevent disease transmission. This study aimed to assess the knowledge and practice of infection control for COVID-19 among healthcare workers in radiology departments in Saudi Arabia. A cross-sectional, online questionnaire was administered among healthcare workers in radiology departments in Saudi Arabia in May 2020. The questionnaire consisted of demographic characteristics, profession, knowledge of infection control for COVID-19, and good practice of infection control measures for COVID-19 in radiology departments. A descriptive statistical analysis and chi-square test were performed using SPSS software. A total of 234 (91%) of healthcare workers replied that they have good knowledge about the precautions needed during the examination of positive COVID-19 cases in radiology departments, and 216 (84%) replied that they knew the necessary precautions when using portable X-ray machine. Moreover, 191 (>74%) of those surveyed agreed that wearing personal protective equipment and following the CDC sequence. There was significant association between profession and good clinical practices in radiology departments regarding COVID-19. Such knowledge could limit the spread of COVID-19 among the healthcare workers in radiology departments.
C1 [Aljondi, Rowa; Alghamdi, Salem Saeed; Abdelaziz, Ikhlas; Bushara, Lubna] Univ Jeddah, Dept Appl Radiol Technol, Coll Appl Med Sci, Jeddah 23218, Saudi Arabia.
   [Alghamdi, Somayah] King Abdulaziz Univ Hosp, Radiol Dept, Jeddah, Saudi Arabia.
   [Aljehani, Abdullah] King Abdulaziz Hosp, Radiol Dept, Jeddah, Saudi Arabia.
   [Zailae, Ali] King Saud Med City, Radiol Dept, Riyadh, Saudi Arabia.
   [Alghamdi, Jamaan S.] King Abdulaziz Univ, Coll Appl Med Sci, Diagnost Radiol Technol Dept, Jeddah, Saudi Arabia.
   [Feteih, Iyad] Univ Jeddah, Coll Med, Jeddah, Saudi Arabia.
   [Mahmoud, Mustafa Z.] Prince Sattam Bin Abdulaziz Univ, Coll Appl Med Sci, Radiol & Med Imaging Dept, Al Kharj, Saudi Arabia.
   [Tajaldeen, Abdulrahman] Imam Abdulrahman Bin Faisal Univ, Coll Appl Med Sci, Radiol Sci Dept, Dammam, Saudi Arabia.
RP Aljondi, R (corresponding author), Univ Jeddah, Dept Appl Radiol Technol, Coll Appl Med Sci, Jeddah 23218, Saudi Arabia.
EM rmaljondi@uj.edu.sa
RI Mahmoud, Mustafa Z./AAD-4833-2022; Tajaldeen, Abdulrahman/AAE-5640-2020
OI Tajaldeen, Abdulrahman/0000-0002-2505-1352
FU University of Jeddah; Vice-President for Graduate Studies; College of
   Applied Medical Sciences
FX The authors thank Dr. Adnan Al-Homaidan, President of the University of
   Jeddah, and the Vice-President for Graduate Studies and Scientific
   Research, Dr. Obaid Al-Modaf, for their support and encouragement of
   research related to COVID-19. In addition, the authors would like to
   thank the College of Applied Medical Sciences and the Department of
   Medical Imaging and Radiation Sciences in the University of Jeddah for
   their full support. We thank all those who participated in the survey
   for providing essential information.
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Algaissi AA, 2020, J INFECT PUBLIC HEAL, V13, P834, DOI 10.1016/j.jiph.2020.04.016
   Alraddadi BM, 2016, EMERG INFECT DIS, V22, P1915, DOI 10.3201/eid2211.160920
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   Alshammari TM, 2020, SAUDI PHARM J, V28, P898, DOI 10.1016/j.jsps.2020.05.005
   Ayinde O., 2020, ADV INFECT DIS, V10, P6, DOI [10.4236/aid.2020.103002, DOI 10.4236/AID.2020.103002]
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Barry M., 2020, J NAT SCI MED, V3, P155, DOI [10.4103/JNSM.JNSM_29_20, DOI 10.4103/JNSM.JNSM_29_20]
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chu JJ, 2020, J MED VIROL, V92, P807, DOI 10.1002/jmv.25793
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Gan WH, 2020, SAF HEALTH WORK-KR, V11, P241, DOI 10.1016/j.shaw.2020.03.001
   He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Kooraki S, 2020, J AM COLL RADIOL, V17, P447, DOI 10.1016/j.jacr.2020.02.008
   Li YF, 2020, J MED VIROL, V92, P903, DOI 10.1002/jmv.25786
   Long CQ, 2020, EUR J RADIOL, V126, DOI 10.1016/j.ejrad.2020.108961
   Michelen M., PATIENTS COVID19 WHA
   Mossa-Basha M, 2020, RADIOLOGY, V296, pE106, DOI 10.1148/radiol.2020200988
   Nasir MU, 2020, CAN ASSOC RADIOL J, V71, P293, DOI 10.1177/0846537120916419
   Nour MO., 2015, INT RES J MED MED SC, V3, P103
   Omrani AS, 2015, J HOSP INFECT, V91, P188, DOI 10.1016/j.jhin.2015.08.002
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P548, DOI 10.1016/j.jiph.2016.11.008
   Rubin GD, 2020, RADIOLOGY, V296, P172, DOI 10.1148/radiol.2020201365
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Shahzeb M, 2020, J PURE APPL MICROBIO, V14, P911, DOI 10.22207/JPAM.14.SPL1.28
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Wan YL, 2020, J THORAC IMAG, V35, P239, DOI 10.1097/RTI.0000000000000529
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WHO, 2020, INFECT PREVENTION CO
   World Health Organization, 2020, RAT US PERS PROT EQ
   Xiao J, 2020, J INFECT PUBLIC HEAL, V13, P843, DOI 10.1016/j.jiph.2020.05.019
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Yu J, 2020, ACAD RADIOL, V27, P614, DOI 10.1016/j.acra.2020.03.025
   Zhang, 2020, LAB DIAGNOSIS MONITO
   Zhang GM, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01338-8
   Zhang HW, 2020, ACAD RADIOL, V27, P463, DOI 10.1016/j.acra.2020.02.003
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490
NR 44
TC 2
Z9 2
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1687-8507
J9 J RADIAT RES APPL SC
JI J. Radiat. Res. Appl. Sci.
PD JAN 1
PY 2021
VL 14
IS 1
BP 51
EP 60
DI 10.1080/16878507.2020.1856587
EA DEC 2020
PG 10
WC Multidisciplinary Sciences; Radiology, Nuclear Medicine & Medical
   Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics; Radiology, Nuclear Medicine &
   Medical Imaging
GA QP4JC
UT WOS:000600149300001
DA 2022-04-20
ER

PT J
AU Hussain, A
   Bhowmik, B
   Moreira, NCD
AF Hussain, Akhtar
   Bhowmik, Bishwajit
   do Vale Moreira, Nayla Cristina
TI COVID-19 and diabetes: Knowledge in progress
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Review
DE COVID-19; SARS-CoV-2; Diabetes; Pathogenesis; Clinical management
ID SARS CORONAVIRUS; PLASMA-GLUCOSE; MELLITUS; MORTALITY; PNEUMONIA;
   HYDROXYCHLOROQUINE; ASSOCIATION; MANAGEMENT; INFECTION; RECEPTOR
AB Aims: We aimed to briefly review the general characteristics of the novel coronavirus (SARS-CoV-2) and provide a better understanding of the coronavirus disease (COVID-19) in people with diabetes, and its management.
   Methods: We searched for articles in PubMed and Google Scholar databases till 02 April 2020, with the following keywords: "SARS-CoV-2", "COVID-19", "infection", "pathogenesis", "incubation period", "transmission", "clinical features", "diagnosis", "treatment", "diabetes", with interposition of the Boolean operator "AND".
   Results: The clinical spectrum of COVID-19 is heterogeneous, ranging from mild flu-like symptoms to acute respiratory distress syndrome, multiple organ failure and death. Older age, diabetes and other comorbidities are reported as significant predictors of morbidity and mortality. Chronic inflammation, increased coagulation activity, immune response impairment, and potential direct pancreatic damage by SARS-CoV-2 might be among the underlying mechanisms of the association between diabetes and COVID-19. No conclusive evidence exists to support the discontinuation of angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers or thiazolidinediones because of COVID-19 in people with diabetes. Caution should be taken to potential hypoglycemic events with the use of chloroquine in these subjects. Patient tailored therapeutic strategies, rigorous glucose monitoring and careful consideration of drug interactions might reduce adverse outcomes.
   Conclusions: Suggestions are made on the possible pathophysiological mechanisms of the relationship between diabetes and COVID-19, and its management. No definite conclusions can be made based on current limited evidence. Further research regarding this relationship and its clinical management is warranted. (C) 2020 The Author(s). Published by Elsevier B.V.
C1 [Hussain, Akhtar] Nord Univ, Fac Hlth Sci, N-8049 Bodo, Norway.
   [Hussain, Akhtar; do Vale Moreira, Nayla Cristina] Fed Univ Ceara FAMED UFC, Fac Med, Fortaleza, Ceara, Brazil.
   [Hussain, Akhtar] Int Diabet Federat IDF, 166 Chaussee Hulpe, B-1170 Brussels, Belgium.
   [Hussain, Akhtar] Diabet Asian Study Grp DASG, Ahmadabad 380015, Gujarat, India.
   [Hussain, Akhtar; Bhowmik, Bishwajit] Diabet Assoc Bangladesh, Ctr Global Hlth Res, Dhaka 1000, Bangladesh.
   [Bhowmik, Bishwajit; do Vale Moreira, Nayla Cristina] Univ Oslo UiO, Inst Hlth & Soc, Dept Community Med & Global Hlth, N-0318 Oslo, Norway.
RP Hussain, A (corresponding author), Post Box 1490, N-8049 Bodo, Norway.
EM hussain.akhtar@nord.no
RI Bhowmik, Bishwajit/AAD-5108-2021
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC
   Arabi YM, 2017, NEW ENGL J MED, V376, P584, DOI 10.1056/NEJMsr1408795
   Banik GR, 2016, VIROL SIN, V31, P81, DOI 10.1007/s12250-015-3679-z
   Ceccarelli M, 2020, EUR REV MED PHARMACO, V24, P2781, DOI 10.26355/eurrev_202003_20551
   Centers for Diasease Control and Prevention, SYMPT COR 2020
   Centers for Disease Control and Prevention, 2020, UPD GUID EV TEST PER
   Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016
   Clore JN, 2009, ENDOCR PRACT, V15, P469, DOI 10.4158/EP08331.RAR
   Dunn EJ, 2005, CURR MOL MED, V5, P323, DOI 10.2174/1566524053766059
   Emami J, 1998, LIFE SCI, V64, P325, DOI 10.1016/S0024-3205(98)00568-2
   Fadini GP, 2020, J ENDOCRINOL INVEST, V43, P867, DOI 10.1007/s40618-020-01236-2
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X
   Gentile S, 2020, DIABETES RES CLIN PR, V161, DOI 10.1016/j.diabres.2020.108047
   Gerstein HC, 2002, DIABETES RES CLIN PR, V55, P209, DOI 10.1016/S0168-8227(01)00325-4
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gullestad L, 1999, J AM COLL CARDIOL, V34, P2061, DOI 10.1016/S0735-1097(99)00495-7
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Gurwitz D, 2020, DRUG DEVELOP RES, V81, P537, DOI 10.1002/ddr.21656
   Henry Christopher, 2018, Proc (Bayl Univ Med Cent), V31, P419, DOI 10.1080/08998280.2018.1499293
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ilyas R, 2011, IMMUNOBIOLOGY, V216, P126, DOI 10.1016/j.imbio.2010.06.002
   Iqbal A, 2019, J CLIN ENDOCR METAB, V104, P1187, DOI 10.1210/jc.2018-01168
   Jalava K, 2020, INT J HYG ENVIR HEAL, V226, DOI 10.1016/j.ijheh.2020.113490
   Knapp S, 2013, GERONTOLOGY, V59, P99, DOI 10.1159/000345107
   Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kumar, 2018, INT J BASIC CLIN PHA, V7, P1959, DOI [DOI 10.18203/2319-2003.IJBCP20183930, 10.18203/2319-2003.ijbcp20183930]
   LANGE P, 1989, EUR RESPIR J, V2, P14
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Letko Michael, 2020, bioRxiv, DOI 10.1101/2020.01.22.915660
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li HO, 2020, ANTIMICROB AGENTS CH, V64, DOI [10.1128/AAC.00483-20, 10.1128/AAC.00483-20.]
   Li S, 2019, DIABETES METAB J, V43, P319, DOI 10.4093/dmj.2018.0060
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1131, DOI [10.1515/cclm-2020-1761, 10.1515/cclm-2020-0198]
   Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2
   Longato E, 2020, NUTR METAB CARDIOVAS, V30, P84, DOI 10.1016/j.numecd.2019.08.017
   McDonald HI, 2014, DIABETIC MED, V31, P606, DOI 10.1111/dme.12384
   Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006
   MOUTSCHEN MP, 1992, DIABETES METAB, V18, P187
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Pearson-Stuttard J, 2016, LANCET DIABETES ENDO, V4, P148, DOI 10.1016/S2213-8587(15)00379-4
   Peng Y D, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P450, DOI 10.3760/cma.j.cn112148-20200220-00105
   Petrie JR, 2018, CAN J CARDIOL, V34, P575, DOI 10.1016/j.cjca.2017.12.005
   Popov D, 1997, EUR RESPIR J, V10, P1850, DOI 10.1183/09031936.97.10081850
   Qiao WL, 2015, CARDIOLOGY, V131, P97, DOI 10.1159/000375362
   Rekedal LR, 2010, ARTHRITIS RHEUM-US, V62, P3569, DOI 10.1002/art.27703
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Schoen K, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4592-0
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang AH, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108118
   Wang D, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.1585, DOI 10.1001/JAMA.2020.1585]
   Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   WHO, COR DIS COVID 19 TEC
   (WHO) WHO, ROLL UPD COR DIS COV
   Williams R, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108072
   World Health Organization, OV TYP CLASS CAND TH
   World Health Organization, COR DIS COVID 19 PAN
   World Health Organization, NAM COR DIS COVID 19
   World Health Organization (WHO), MOD TRANSM VIR CAUS
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang Wenfu, 2013, J VIBRATION SHOCK, V10, P12, DOI [10.13465/j.cnki.jvs.2013.10.026, DOI 10.13465/J.CNKI.JVS.2013.10.026]
   Zheng Y.C., 2020, ADV CIV ENG, V2020, P3, DOI [10.1155/2020/3479475, DOI 10.1155/2020/3479475]
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou J, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154216
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 80
TC 320
Z9 334
U1 11
U2 28
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD APR
PY 2020
VL 162
AR 108142
DI 10.1016/j.diabres.2020.108142
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA LV3UL
UT WOS:000538364500004
PM 32278764
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Kef, K
AF Kef, Kemal
TI COVID- 19: The Level of Knowledge, Anxiety and Symptom Presentation
SO PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT
LA English
DT Article
DE COVID-19; anxiety; knowledge level; symptoms
ID MENTAL-HEALTH; DEPRESSION; OUTBREAK
AB Objective: This study aims to establish whether there is a relationship between the level of knowledge about COVID-19, anxiety scores, and pseudo increases in the symptoms of the patients or not.
   Methods: The Beck Anxiety Inventory (BAI) and Republic of Turkey Ministry of Health General Directorate's COVID-19 (SARS-CoV-2 infection) General Information, Epidemiology, and Diagnosis Guide were reviewed to generate the questionnaire's content. The data were obtained through a face-to-face interview method. To test their level of knowledge about COVID-19, they were asked multiple-choice questions that have one or more possible right answers. The Statistical Package for Social Sciences was used for statistical analysis. The results were presented as mean and standard deviations for numerical variables and as frequency and percentage for categorical data.
   Results: A total of 402 patients were included in this questionnaire-based study. The average age of the patients was 44.67 +/- 4.95 years, and 204 (50.7%) of them were female. The average anxiety score according to the BAI was 7.98 +/- 1.29 which classifies as mild anxiety. The overall responses for the knowledge level on COVID-19 section are presented in Table 2. The average score was 9.2 +/- 2.7 points out of a possible 14.
   Conclusion: The study population showed a moderate level of knowledge, and on average, the patients were not very anxious about the outbreak. The psychosomatic effects of the anxiety caused by the pandemic should be kept in mind by the clinicians since the patients might require a psychiatric consultation in the treatment process.
C1 [Kef, Kemal] Private Kesan Hosp, Dept ENT, Edirne, Turkey.
RP Kef, K (corresponding author), Private Kesan Hosp, Dept ENT, Edirne, Turkey.
EM dr.kemalkef@gmail.com
RI Kef, Kemal/AAO-5596-2021
OI Kef, Kemal/0000-0001-7217-8228
CR Aki OE, 2020, TURK J GERIATR, V23, P291, DOI 10.31086/tjgeri.2020.165
   Amin F, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02864-x
   Cavanagh D., 2009, PRINCIPLES PRACTICE, P379, DOI [10.1002/0470020970.ch10, DOI 10.1002/0470020970.CH10]
   Chacko Mason, 2020, SN Compr Clin Med, V2, P2391, DOI 10.1007/s42399-020-00530-7
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Ferrando SJ, 2020, PSYCHOSOMATICS, V61, P551, DOI 10.1016/j.psym.2020.05.012
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Hasoksuz M, 2020, TURK J MED SCI, V50, P549, DOI 10.3906/sag-2004-127
   Holt-Lunstad J., 2017, PUBLIC POLICY AGING, V27, P127, DOI [10.1093/ppar/prx030, DOI 10.1093/PPAR/PRX030]
   Le HT, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.589359
   Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048
   Kaya Y, 2020, J INT HLTH SCI MANAG, V6, P8, DOI [10.48121/jihsam.772710, DOI 10.48121/JIHSAM.772710]
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Luo Y, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.565098
   Mahony JB, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1414
   Ministry of Health, 2020, SAGL BAK COVID 19 BI
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Park JS, 2018, ARCH PSYCHIAT NURS, V32, P2, DOI 10.1016/j.apnu.2017.09.006
   Petzold MB, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1745
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Sahu K, 2020, J FAM MED PRIM CARE, V9, P2149, DOI 10.4103/jfmpc.jfmpc_728_20
   Sancak B, 2020, DUSUNEN ADAM, V33, P366, DOI 10.14744/DAJPNS.2020.00105
   Saravanan C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.582189
   Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201
   Tee M, 2021, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.568929
   The Republic of Turkey Ministry of Health, 2020, 19 GEN INFORM EPIDEM
   Ulusoy M., 1998, J COGN PSYCOTHER INT, V12, P163
   Unal S, 2020, KLIN PSIKIYATR DERG, V23, P67, DOI 10.5505/kpd.2020.30932
   Uyaroglu OA, 2020, INTERN MED J, V50, P1350, DOI 10.1111/imj.14981
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459
   WHO, 2020, WHO MERS GLOB SUMM A
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   Wu KK, 2005, J TRAUMA STRESS, V18, P39, DOI 10.1002/jts.20004
   Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 36
TC 2
Z9 2
U1 6
U2 10
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-1578
J9 PSYCHOL RES BEHAV MA
JI Psychol. Res. Behav. Manag.
PY 2021
VL 14
BP 541
EP 548
DI 10.2147/PRBM.S307050
PG 8
WC Psychology, Clinical; Psychiatry; Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology; Psychiatry
GA RZ2IP
UT WOS:000648420400001
PM 33986616
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Vallejo, OG
   Vargas, MF
   Gil, IG
   Gomez, NV
   Carbonell, AP
   Morant, JP
AF Garcia Vallejo, O.
   Frias Vargas, M.
   Gil Gil, I
   Vazquez Gomez, N.
   Piera Carbonell, A.
   Peiro Morant, J.
CA EMERGEN
TI Knowledge of thromboprophylaxis-COVID-19 in healthcare professionals in
   Spain
SO MEDICINA DE FAMILIA-SEMERGEN
LA Spanish
DT Article
DE Knowledge; Thromboprofylaxis; COVID-19; Physicians; Spain
AB Introductions: Patients suffering from coronavirus infection have an increased risk of venous thromboembolic disease (VTE) associated with COVID-19, which confers a higher risk of mortality. For this reason, it is necessary to analyze the knowledge and the different actions in the management of thromboprophylaxis in work environments.
   Material and methods: Observational, descriptive and cross-sectional study with data collection through a Google (R) form with 19 questions for professionals involved in the care of COVID-19. 414 surveys were received. The quantitative variables were represented with means and standard deviation and the qualitative variables with percentages and confidence intervals.
   Results: 414 surveys analyzed. 58.2% were women. The most participatory age group was 5665 years. 95.2% stated that COVID-19 patients had a higher risk of VTE and peripheral arterial microthrombosis. 93.6% considered that outpatient COVID-19 patients should receive thromboprophylaxis. 60.5% of the physicians did not know any protocol for the evaluation of thrombotic risk in these patients. Low molecular weight heparin was considered the main treatment for thromboprophylaxis.
   Conclusions: The majority of doctors consider that COVID-19 patients have a higher risk of suffering VTE and peripheral arterial microthrombosis than the general population, however more than a third do not assess the thrombotic risk and a significant percentage claim not to know protocols to evaluate said risk. The survey highlights the training needs of our professionals in thromboprophylaxis so that our patients receive healthcare with the highest possible quality. (C) 2021 Sociedad Espanola de Medicos de Atencion Primaria (SEMERGEN). Published by ElsevierEspana, S.L.U. All rights reserved.
C1 [Garcia Vallejo, O.; Frias Vargas, M.] Ctr Salud Comillas, Madrid, Spain.
   [Gil Gil, I] Ctr Salud Vielha, Vielha, Lleida, Spain.
   [Vazquez Gomez, N.] Ctr Salud Auxiliar Moncofar, Moncofar, Castellon, Spain.
   [Piera Carbonell, A.] Ctr Salud Luanco Gozon, Luanco, Asturias, Spain.
   [Peiro Morant, J.] Ctr Salud Ponent, Mallorca, Islles Balears, Spain.
RP Vallejo, OG (corresponding author), Ctr Salud Comillas, Madrid, Spain.
EM olgagvallejo61@gmail.com
OI PIERA CARBONELL, ANA/0000-0003-3948-0833; Frias Vargas,
   Manuel/0000-0003-2692-5063
CR Barbar S, 2010, J THROMB HAEMOST, V8, P2450, DOI 10.1111/j.1538-7836.2010.04044.x
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Cabrera Ferriols MA, 2020, SEMERGEN, V46, P93, DOI [10.1016/j.semerg.2020.06.002.368, DOI 10.1016/J.SEMERG.2020.06.002.368]
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   SERRANOCUMPLIDO A, 2020, SEMERGEN, V46, pS55
   Suarez L, 2019, ACTUAL MED, V104, P24
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yin SY, 2021, J THROMB THROMBOLYS, V51, P1107, DOI 10.1007/s11239-020-02105-8
NR 13
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1138-3593
EI 1578-8865
J9 MED FAM-SEMERGEN
JI Med. Fam.-SEMERGEN
PD SEP
PY 2021
VL 47
IS 6
BP 361
EP 368
DI 10.1016/j.semerg.2021.01.002
EA SEP 2021
PG 8
WC Primary Health Care
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA WB0ZV
UT WOS:000703310400002
PM 33810943
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Zieba, M
   Bongiovanni, I
AF Zieba, Malgorzata
   Bongiovanni, Ivano
TI Knowledge management and knowledge security-Building an integrated
   framework in the light of COVID-19
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article; Early Access
ID INNOVATION; SYSTEMS
AB This paper presents a framework of knowledge risk management in the face of the COVID-19 crisis, derived from the literature on knowledge management, knowledge security, and COVID-19. So far, both researchers and practitioners have focused on knowledge as an asset and their efforts have been aimed at the implementation of knowledge management in various organizational contexts. However, with increasing threats related to cyberattacks or hazards associated with knowledge loss (as magnified by the COVID-19 crisis), there is a growing need to account for knowledge-related risks. In this conceptual paper, we integrate the contributions from the knowledge management and knowledge security fields, together with research on COVID-19 to help organizations protect the knowledge they create, store and share. Based on a structured literature review, our investigation provides researchers and managers with a framework for securely handling organizational knowledge in a critical situation. Our framework revolves around two foci: one the one hand, building appropriate knowledge risk measures and controls; on the other hand, holistically tackling knowledge risks as part of knowledge management activities.
C1 [Zieba, Malgorzata] Gdansk Univ Technol, Fac Management & Econ, Dept Management, Gdansk, Poland.
   [Bongiovanni, Ivano] Univ Queensland, Sch Business, Brisbane, Qld, Australia.
RP Zieba, M (corresponding author), Gdansk Univ Technol, Fac Management & Econ, Dept Management, Gdansk, Poland.
EM mz@zie.pg.gda.pl
FU National Science Centre (Poland)National Science Centre, Poland
   [2019/33/B/HS4/02250]
FX Study supported with the research grant received by Malgorzata Zieba
   from the National Science Centre (Poland) in the context of a research
   project "Knowledge risks in modern organizations" (No.
   2019/33/B/HS4/02250).
CR Aday S, 2020, FOOD QUAL SAF-OXFORD, V4, P167, DOI 10.1093/fqsafe/fyaa024
   Ahmad A, 2014, COMPUT SECUR, V42, P27, DOI 10.1016/j.cose.2014.01.001
   Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961
   Andreeva T, 2012, J KNOWL MANAG, V16, P617, DOI 10.1108/13673271211246185
   Arntz Melanie, 2020, Inter Econ, V55, P381, DOI 10.1007/s10272-020-0938-5
   Associated Press,, ASSOCIATED PRESS
   Australian Government, 2020, AUSTR GOV
   Baldwin R., 2020, MITIGATING COVID EC
   Bekkers E., 2020, TRADE COVID 19 WTOS
   Blustein DL, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103436
   Bolisani E, 2021, KNOWL MAN RES PRACT, V19, P517, DOI 10.1080/14778238.2021.1911606
   Bongiovanni I, 2020, J INTELLECT CAP, V21, P481, DOI 10.1108/JIC-08-2019-0197
   Bose R, 2003, EXPERT SYST APPL, V24, P59, DOI 10.1016/S0957-4174(02)00083-0
   Bratianu C., 2018, MANAGEMENT DYNAMICS, V6, P593, DOI [10.25019/MDKE/6.4.06, DOI 10.25019/MDKE/6.4.06]
   Bratianu C, 2021, KNOWL PROCESS MANAG, V28, P11, DOI 10.1002/kpm.1656
   Bratianu C, 2020, MANAG MARK, V15, P410, DOI 10.2478/mmcks-2020-0024
   Bukowitz W.R., 2000, KNOWLEDGE MANAGEMENT
   Bunker D, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102201
   Cegarra-Navarro JG, 2021, J KNOWL MANAG, DOI 10.1108/JKM-05-2021-0395
   Cegarra-Navarro JG, 2021, J BUS RES, V137, P58, DOI 10.1016/j.jbusres.2021.08.021
   Cegarra-Navarro JG, 2021, KNOWL PROCESS MANAG, V28, P134, DOI 10.1002/kpm.1662
   Chan I, 2008, COMMUN ACM, V51, P83, DOI 10.1145/1330311.1330328
   Dalkir K., 2011, KNOWLEDGE MANAGEMENT
   Darroch J., 2005, Journal of Knowledge Management, V9, P101, DOI 10.1108/13673270510602809
   Darroch J., 2003, EUR J MARKETING, V37, P572, DOI [10.1108/03090560310459096, DOI 10.1108/03090560310459096]
   Desouza K.C., 2006, J INFORM SCI TECHNOL, V3, P1
   du Plessis Marina, 2007, Journal of Knowledge Management, V11, P20, DOI 10.1108/13673270710762684
   Durst S, 2019, KNOWL MAN RES PRACT, V17, P1, DOI 10.1080/14778238.2018.1538603
   Durst S, 2016, INT J KNOWL SYST SCI, V7, P19, DOI 10.4018/IJKSS.2016070102
   Edvardsson IR, 2013, PROCD SOC BEHV, V81, P351, DOI 10.1016/j.sbspro.2013.06.441
   Gallant J., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3702514, DOI 10.2139/SSRN.3702514]
   Gomez-Pineda J.G., 2020, COVID EC, V40, P196
   Ilvonen I., 2013, THESIS TAMPERE U
   Interpol,, 2020, CYB AR CONST EV ORD
   Ivanov Dmitry, 2020, International Journal of Integrated Supply Management, V13, P90
   Jennex ME, 2007, INFORM SYST FRONT, V9, P493, DOI 10.1007/s10796-007-9053-4
   Junges FM, 2015, INT J INNOV LEARN, V18, P198, DOI 10.1504/IJIL.2015.070867
   Khurshid A, 2020, JMIR MED INF, V8, DOI 10.2196/20477
   Kramer A, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103442
   Lee MR, 2011, EXPERT SYST APPL, V38, P729, DOI 10.1016/j.eswa.2010.07.025
   Lovari A, 2020, MEDIA COMMUN-LISBON, V8, P458, DOI 10.17645/mac.v8i2.3219
   Manhart M, 2015, J KNOWL MANAG, V19, P190, DOI 10.1108/JKM-05-2014-0198
   Mollenkopf DA, 2021, J SERV MANAGE, V32, P190, DOI 10.1108/JOSM-05-2020-0143
   Obitade PO, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0229-9
   Pennycook G., 2020, FIGHTING COVID 19 MI
   Probst G., 2000, MANAGING KNOWLEDGE B, P35
   Renaud K, 2019, J INTELLECT CAP, V20, P621, DOI 10.1108/JIC-04-2019-0079
   Renkel S., 2020, NEW YORK TIMES
   Ross C.M.V., 2005, CREATING DISCIPLINE, P157
   Singapore Government, 2020, SING GOV
   Vaccaro A, 2010, TECHNOL FORECAST SOC, V77, P1076, DOI 10.1016/j.techfore.2010.02.006
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   Webster J, 2002, MIS QUART, V26, pXIII
   Wei YH, 2011, IND MARKET MANAG, V40, P267, DOI 10.1016/j.indmarman.2010.06.039
   World Economic Forum,, 2020, THIS IS EFF COVID 19
   Zieba M., 2018, KNOWLEDGE MANAGEMENT, P253, DOI [10.1007/978-3-319-66,890-1_13, DOI 10.1007/978-3-319-66,890-1_13]
NR 57
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
DI 10.1002/kpm.1707
EA MAR 2022
PG 11
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA 0A5NE
UT WOS:000774000400001
DA 2022-04-20
ER

PT J
AU Gumbo, M
   Gaotlhobogwe, M
AF Gumbo, Mishack
   Gaotlhobogwe, Michael
TI African Indigenous Knowledge and Practices to Combat COVID-19 Pandemic
SO JOURNAL OF MANAGEMENT SPIRITUALITY & RELIGION
LA English
DT Article
DE African; indigenous people; indigenous knowledge; practices; COVID-19
ID SOUTH-AFRICA; UBUNTU; ETHICS
AB Indigenous knowledge and practices suffer marginalisation when it comes to seeking solutions to social problems. The world misses out on the richness of this knowledge and practices and role that they can play. This qualitative existential phenomenological study explored experiences of African indigenous knowledge holders and practitioners on their views regarding solutions towards COVID-19 pandemic. Interviews were conducted through WhatsApp and face-to-face with ten participants and data were analysed thematically. The findings show African knowledge and practices that could combat COVID-19 in terms of restrictions, heat related remedies and plant related remedies, and how these knowledge and practices can be applied through ancestral, environmental, metaphysical and generational modes. Africa and the world could benefit from how indigenous people respond to diseases such as COVID-19 and adopt/adapt some of these knowledge and practices; indigenous knowledge and practices have a role to play by contributing solutions to the world's problems.
C1 [Gumbo, Mishack] Univ South Africa, Dept Sci & Technol Educ, Pretoria, South Africa.
   [Gaotlhobogwe, Michael] Univ Botswana, Educ Fdn, Gaborone, Botswana.
RP Gumbo, M (corresponding author), Univ South Africa, Dept Sci & Technol Educ, Pretoria, South Africa.
EM gumbomt@unisa.ac.za
CR Adekson M. O, 2017, JSM HLTH ED PRIM HLT, V2, P1
   Adu-Gyamfi S., 2019, PHILOS SOCIAL HUMAN, V1, P69
   Begay J., 2020, DECOLONIZING COMMUNI
   Bryman A., 2016, SOCIAL RES METHODS
   Cardinal C., 2011, RELIG STUD THEOL, V127, P128, DOI [10.1558/rsth.v30i2.127, DOI 10.1558/RSTH.V30I2.127]
   Chibvongodze Danford T., 2016, Journal of Human Ecology, V53, P157
   Chilisa B., 2012, INDIGENOUS RES METHO
   Creswell J. W., 2007, QUALITATIVE INQUIRY, V2, P53, DOI DOI 10.1177/1524839915580941
   DREWAL HJ, 1988, TDR-DRAMA REV-J PERF, V32, P160, DOI 10.2307/1145857
   Du Toit C, 2012, HURIA J, V13, P252
   Du Toit-Brits C., 2012, PROGRESSIO, V34, P3
   Ewuoso C, 2019, S AFR J BIOETH LAW, V12, P93, DOI 10.7196/SAJBL.2019.v12i2.679
   EzeanyaEsiobu C, 2019, FRONT AFR BUS RES, P1, DOI 10.1007/978-981-13-6635-2
   Fehderau R. D., 2018, CONVERSATION
   Gee S, 2018, QUAL HEALTH RES, V28, P1499, DOI 10.1177/1049732318759936
   Gorman D., 2006, ABORIGINAL ISLANDER, V30, P28
   HARLEY DA, 2006, INT J DISABIL DEV ED, V53, P433, DOI DOI 10.1080/10349120601008605
   Holroyd C., 2001, INDO-PAC J PHENOMEN, V1, DOI 10.1080/20797222.2001.11433859
   Hoppers Catherine A. Odora, 2017, CULTURE INDIGENOUS K
   Kaufmann K, 2020, MOB MEDIA COMMUN, V8, P229, DOI 10.1177/2050157919852392
   Kauka E. O, 2018, INT J NOVEL RES ED L, V5, P43
   Lavallee LF, 2009, INT J QUALITATIVE RE, V8, P21, DOI [10.1177/160940690900800103, DOI 10.1177/160940690900800103]
   Mahomoodally MF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/617459
   McMillan J.H., 2010, RES ED EVIDENCE BASE, V7th ed.
   Midgley J., 1983, PROFESSIONAL IMPERIA
   Mpofu V, 2014, CULT STUD SCI EDUCAT, V9, P221, DOI 10.1007/s11422-013-9508-5
   Mucina D. D., 2011, THESIS U TORONTO
   Mugumbate J., 2013, AFRICAN J SOCIAL WOR, V3, P82
   Muwanga-Zake JWF, 2009, DISCOURSE-ABINGDON, V30, P413, DOI 10.1080/01596300903237198
   Nattrass N, 2005, SOC DYNAMICS, V31, P161, DOI 10.1080/02533950508628712
   Nicolas G., 2018, CONVERSATION
   Nkondo GM, 2007, INT J AFR RENAISS ST, V2, P88, DOI 10.1080/18186870701384202
   Osman A., 2009, INDIGENOUS KNOWLEDGE
   Owusu-Ansah FE, 2013, AFR J DISABIL, V2, DOI 10.4102/ajod.v2i1.30
   Ozioma EOJ, 2019, HERBAL MED AFRICAN T
   Palys Ted., 2008, SAGE ENCY QUALITATIV, V2, P697
   Perls T., 2020, WORLD EC FORUM
   Ross E, 2010, S AFR J BIOETH LAW, V3, P44
   Semenya SS, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/2183705
   Shawanda A., 2017, THESIS LAURENTIAN U
   Sodi T, 2011, INT J HEALTH PROMOT, V49, P101, DOI 10.1080/14635240.2011.10708216
   Solomon A., 2005, INTEGRATING HEALERS, P52
   Vally Z., 2020, RES BOOTCAMP
   Walker PO, 2015, PEACE PSYCHOL BOOK S, V26, P159, DOI 10.1007/978-3-319-18395-4_8
   Winters A., USING TALKING CIRCLE
NR 45
TC 0
Z9 0
U1 4
U2 4
PU IMASR-INT ASSOC MANAGEMENT SPIRITUALITY & RELIGION
PI LONDON
PA 262 SHAKESPEARE TOWER, LONDON, ENGLAND
SN 1476-6086
EI 1942-258X
J9 J MANAG SPIRITUAL RE
JI J. Manag. Spiritual. Relig.
PD OCT
PY 2021
VL 18
IS 5
SI SI
BP 462
EP 481
DI 10.51327/EDTA1013
PG 20
WC Religion
WE Emerging Sources Citation Index (ESCI)
SC Religion
GA XR9IQ
UT WOS:000732534400007
DA 2022-04-20
ER

PT C
AU Liu, FF
   Di, L
AF Liu Fangfang
   Di, Liu
GP IEEE
TI Visualization Mapping Analysis of Emergency Management Scientific
   Research Big Data during COVID-19
SO 2020 5TH INTERNATIONAL CONFERENCE ON MECHANICAL, CONTROL AND COMPUTER
   ENGINEERING (ICMCCE 2020)
LA English
DT Proceedings Paper
CT 5th International Conference on Mechanical, Control and Computer
   Engineering (ICMCCE)
CY DEC 25-27, 2020
CL Harbin, PEOPLES R CHINA
SP Xijing Univ, Acad Exchange Informat Ctr
DE component; COVID-19; Big data of Scientific research; Emergency
   Management; CiteSpace
AB [Objective] To better understand the research status of emergency management during the outbreak of COVID-19 in China, and further improve the level of China's emergency management, [method] In this paper, the big data of emergency management research during COVID-19 was visualized and analyzed, and the visual knowledge map was drawn to study the big data of China's emergency management literature. [Conclusion] This paper reveals the current situation and characteristics of China's emergency management during COVID-19 by using the visual knowledge map, summarizes the research trend in the future, and points out the new ways to improve China's emergency management ability in the period after the COVID-19.
C1 [Liu Fangfang] Yunnan Vocat Coll Land & Resources, Yinchuan, Ningxia, Peoples R China.
   [Di, Liu] Yunnan Vocat Coll Land & Resources, Shenyang, Liaoning, Peoples R China.
RP Di, L (corresponding author), Yunnan Vocat Coll Land & Resources, Shenyang, Liaoning, Peoples R China.
EM 40133232@qq.com; 247180969@qq.com
FU scientific Research Fund project of Yunnan Provincial Department of
   Education [2021J0961]
FX The successful completion of this article is thanks to the support of
   the scientific Research Fund project of Yunnan Provincial Department of
   Education on the Improvement of Public Safety emergency Response
   Capacity by large numbers of technologies -- A Case Study of COVID-19
   Epidemic "(Project No. 2021J0961).
CR [Anonymous], Author affiliations: first author: Fang Fang Liu 1 (1984 student), female, Ningxia
   Bai Junsong, INGENUITY, V2020, P231
   Chen Chaomei, 2009, J INTELL-BASEL, P401
   Jiang B, 2019, J KUNMING ACAD, V41, P106
   Liu D, 2020, MODERN VOCATIONAL ED, P32
   Liu Di., 2019, YUNNAN HYDRAULIC POW, V35, P22
   Zhang Ling., 2020, SAFETY PRODUCTION CH, V15, P40
NR 7
TC 1
Z9 1
U1 13
U2 25
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-6654-2314-4
PY 2020
BP 2340
EP 2345
DI 10.1109/ICMCCE51767.2020.00506
PG 6
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Engineering, Mechanical
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Automation & Control Systems; Engineering
GA BR9HD
UT WOS:000675598100498
DA 2022-04-20
ER

PT J
AU Ali, S
   Talha, N
AF Ali, Shahzad
   Talha, Nighat
TI During COVID-19, impact of subjective and objective financial knowledge
   and economic insecurity on financial management behavior: Mediating role
   of financial wellbeing
SO JOURNAL OF PUBLIC AFFAIRS
LA English
DT Article; Early Access
DE COVID-19; economic insecurity; financial management behavior; financial
   well-being; Islamic financial knowledge; objective and subjective
   financial knowledge
ID JOB INSECURITY; MODERATING ROLE; PLS-SEM
AB The purpose of this research is to look into financial management behavior during the COVID-19. Without a doubt, financial knowledge is an important, but in the COVID-19, the majority of people are experiencing economic insecurity, which is regarded as unique contribution when testing financial management behavior. Furthermore, Pakistan is an Islamic country, so, financial knowledge, is further subdivided into objective, subjective, and Islamic financial knowledge, with financial wellbeing serving as mediating variable. Pakistan has a diverse population of respondents, this model was tested on university students in Pakistan between the ages of 20 and 40, with the majority of respondents experiencing job and food insecurity as a result of COVID-19. The research employs a two-stage method, PLS-SEM, for reliability checking via composite reliability and average variance extract, and discriminant validity checking via HTMT ratio. According to the findings, Islamic financial knowledge as positive, and other financial knowledge as negative, and economic insecurity (food and job insecurity) also has negative and significant impact on students' financial management behavior. Financial well-being significantly acts as a bridge between independents and dependent variables. The findings imply that financial knowledge has a significant impact on financial management behavior. Policymakers and administrators should improve information disclosure while promoting financial education in order to foster trust and responsible financial conduct among people.
C1 [Ali, Shahzad] Super Univ, Fac Management Sci, Lahore, Pakistan.
   [Ali, Shahzad; Talha, Nighat] Univ Utara Malaysia, Kedah, Malaysia.
RP Ali, S (corresponding author), Super Univ, Fac Management Sci, Lahore, Pakistan.
EM shahzadalird@gmail.com
RI Ali, Shahzad/AAE-2752-2020
OI Ali, Shahzad/0000-0003-2294-3758
CR Ab Hamid MR, 2017, J PHYS CONF SER, V890, DOI 10.1088/1742-6596/890/1/012163
   Ailawadi K.L., 2003, PERCEPTUAL OBJECTIVE
   Anderson CJ, 2007, EUR J POLIT RES, V46, P211, DOI 10.1111/j.1475-6765.2007.00692.x
   [Anonymous], 2012, INT J BUSINESS SOCIA
   Antara PM, 2017, PERTANIKA J SOC SCI, V25, P251
   Archuleta KL, 2020, CONTEMP FAM THER, V42, P68, DOI 10.1007/s10591-019-09501-0
   Aziz N, 2020, LAND USE POLICY, V94, DOI 10.1016/j.landusepol.2020.104529
   Ballard T.J., 2013, FOOD AGR STAT
   Bapat D, 2020, INT J BANK MARK, V38, P1177, DOI 10.1108/IJBM-10-2019-0356
   Becker JM, 2012, LONG RANGE PLANN, V45, P359, DOI 10.1016/j.lrp.2012.10.001
   Borden LM, 2008, J FAM ECON ISS, V29, P23, DOI 10.1007/s10834-007-9087-2
   Carlson JP, 2009, J CONSUM RES, V35, P864, DOI 10.1086/593688
   CFBP Consumer Financial Protection Bureau, 2017, FIN WELL BEING AM OF
   Choi SL, 2020, INT J CONSUM STUD, V44, P353, DOI 10.1111/ijcs.12571
   De Witte H, 1999, EUR WORK ORG PSYCHOL, V8, P155, DOI DOI 10.1080/135943299398302
   Dew J., 2011, J FINANCIAL COUNSELI, V22, P43
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Ferrie JE, 2001, J ROY SOC MED, V94, P71, DOI 10.1177/014107680109400206
   Gambetti E, 2012, J ECON PSYCHOL, V33, P1059, DOI 10.1016/j.joep.2012.07.001
   Gaunt R, 2007, COMMIMITY WORK FAM, V10, P341, DOI 10.1080/13668800701456336
   Gebreyesus SH, 2015, BMC NUTR, V1, P2
   Grable J., 2015, J FINANCIAL THERAPY, V5, P2, DOI [10.4148/1944-9771.1083, DOI 10.4148/1944-9771.1083]
   Grable JE., 2006, COLL STUDENT J, V40, P400
   Grable JE, 2020, CONTEMP FAM THER, V42, P15, DOI 10.1007/s10591-019-09520-x
   Hair JF., 2017, PARTIAL LEAST SQUARE
   Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128
   Hayhoe CR, 2012, FAM CONSUM SCI RES J, V41, P69, DOI 10.1111/j.1552-3934.2012.02129.x
   Headey D, 2013, FOOD SECUR, V5, P327, DOI 10.1007/s12571-013-0253-0
   Hellgren J, 2010, EUROPEAN J WORK ORG, V8, P179, DOI DOI 10.1080/135943299398311
   Hilgert M., 2003, FED RESERVE BULL, V89, P309, DOI DOI 10.1093/RFS/HHV072
   Huston SJ, 2010, J CONSUM AFF, V44, P296, DOI 10.1111/j.1745-6606.2010.01170.x
   KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308
   Lim HanN.A., 2014, J FINANC COUNS PLAN, V25, P148
   Lind T, 2020, J FAM ECON ISS, V41, P626, DOI 10.1007/s10834-020-09678-9
   Lyons AC, 2004, J CONSUM AFF, V38, P56, DOI 10.1111/j.1745-6606.2004.tb00465.x
   Mandell L., 2009, J FINANC COUNS PLAN, V20, P15
   Mountain TP, 2021, J FAM ECON ISS, V42, P113, DOI 10.1007/s10834-020-09689-6
   Mukhibad, 2020, ACCOUNTING, V6, P961, DOI DOI 10.5267/J.AC.2020.7.024
   Nielsen A., 2008, ANZ 2005 ANZ SURVEY
   O'Neill B., 2006, J FINANC COUNS PLAN, V17, P46
   Pereira MC, 2020, J FAM ECON ISS, V41, P615, DOI 10.1007/s10834-020-09662-3
   Robb C.A., 2011, J FINANC COUNS PLAN, V22, P60, DOI DOI 10.4148/JFT.V3I1.1453
   Robb C.A., 2009, J FINANC COUNS PLAN, V20, P25
   Sarstedt M., 2016, PRIMER PARTIAL LEAST
   Shapiro GK, 2012, J NEUROSCI PSYCHOL E, V5, P92, DOI 10.1037/a0027647
   Shim S, 2015, J APPL DEV PSYCHOL, V38, P29, DOI 10.1016/j.appdev.2015.01.002
   Tang N, 2016, J ECON PSYCHOL, V54, P164, DOI 10.1016/j.joep.2016.04.005
   Tibshirani R.J., 1993, INTRO BOOTSTRAP
   Topa G, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02419
   TURNER JB, 1991, AM J COMMUN PSYCHOL, V19, P521, DOI 10.1007/BF00937990
   Turner JC., 1991, SOC INFLUENCE
   von Eije H, 2008, J FINANC ECON, V89, P347, DOI 10.1016/j.jfineco.2007.11.002
   VOYDANOFF P, 1990, J MARRIAGE FAM, V52, P1099, DOI 10.2307/353321
NR 53
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1472-3891
EI 1479-1854
J9 J PUBLIC AFF
JI J. Public Aff.
AR e2789
DI 10.1002/pa.2789
EA NOV 2021
PG 8
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA WS5DE
UT WOS:000715200700001
PM 34899065
OA Green Published
DA 2022-04-20
ER

PT J
AU Shafiq, M
   Elharake, JA
   Malik, AA
   McFadden, SM
   Aguolu, OG
   Omer, SB
AF Shafiq, Mehr
   Elharake, Jad A.
   Malik, Amyn A.
   McFadden, SarahAnn M.
   Aguolu, Obianuju Genevieve
   Omer, Saad B.
TI COVID-19 Sources of Information, Knowledge, and Preventive Behaviors
   Among the US Adult Population
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE behavior; COVID-19; disparities; information; knowledge
AB Context:
   The COVID-19 pandemic has resulted in more than 20 million cases and 350 000 deaths in the United States. With the ongoing media coverage and spread of misinformation, public health authorities need to identify effective strategies and create culturally appropriate and evidence-based messaging that best encourage preventive health behaviors to control the spread of COVID-19.
   Objective:
   The purpose of this study was to understand the relationship between COVID-19 sources of information and knowledge, and how US adults' knowledge may be associated with preventive health behaviors to help mitigate COVID-19 cases and deaths.
   Design and Setting:
   For this cross-sectional study, survey data pertaining to COVID-19 were collected via online platform, Qualtrics, in February and May 2020.
   Participants:
   Data responses included 718 US adults from the February survey and 672 US adults from the May survey-both representative of the US adult population.
   Main Outcome Measures:
   Sociodemographic characteristics, COVID-19 knowledge score, COVID-19 reliable sources of information, and adherence to COVID-19 preventive health behaviors.
   Results and Conclusions:
   The main findings showed that disseminating COVID-19 information across various sources, particularly television, health care providers, and health officials, to increase people's COVID-19 knowledge contributes to greater adherence to infection prevention behaviors. Across February and May 2020 survey data, participants 55 years and older and those with higher educational background reported a higher average COVID-19 knowledge score. In addition, among the racial and ethnic categories, Black/African American and Native American/Alaska Native participants reported a lower average COVID-19 knowledge score than white participants-signaling the need to establish COVID-19 communication that is culturally-tailored and community-based. Overall, health care authorities must deliver clear and concise messaging about the importance of adhering to preventive health behaviors, even as COVID-19 vaccines become widely available to the general public. Health officials must also focus on increasing COVID-19 knowledge and dispelling misinformation.
C1 [Shafiq, Mehr; Elharake, Jad A.; Malik, Amyn A.; McFadden, SarahAnn M.; Aguolu, Obianuju Genevieve; Omer, Saad B.] Yale Inst Global Hlth, New Haven, CT USA.
   [Shafiq, Mehr] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.
   [Elharake, Jad A.; Omer, Saad B.] Yale Sch Publ Hlth, New Haven, CT USA.
   [Malik, Amyn A.; McFadden, SarahAnn M.; Aguolu, Obianuju Genevieve; Omer, Saad B.] Yale Sch Med, Church St,Ste 340, New Haven, CT 06510 USA.
   [Omer, Saad B.] Yale Sch Nursing, Orange, CT USA.
RP McFadden, SM (corresponding author), Yale Sch Med, Church St,Ste 340, New Haven, CT 06510 USA.
EM mehrshafiq14@gmail.com; jad.elharake@yale.edu; amyn.malik@yale.edu;
   sarahann.mcfadden@yale.edu; obianuju.aguolu@yale.edu; saad.omer@yale.edu
RI Malik, Amyn A./AAF-4883-2021
OI Malik, Amyn A./0000-0003-4875-9916
FU Yale Institute for Global Health
FX The study was funded by the Yale Institute for Global Health.
CR [Anonymous], 2020, LANCET INFECT DIS, V20, P875, DOI 10.1016/S1473-3099(20)30565-X
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Balog-Way DHP, 2020, J RISK RES, V23, P838, DOI 10.1080/13669877.2020.1758192
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Brainard J, 2020, SIMUL-T SOC MOD SIM, V96, P365, DOI 10.1177/0037549719885021
   Centers for Disease Control and Prevention, 2020, IMPORTANCE COVID 19
   Centers for Disease Control and Prevention, 2020, CDC COVID DATA TRACK
   Centers for Disease Control and Prevention, 2020, HLTH EQUITY CONSIDER
   Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003
   Finset A, 2020, PATIENT EDUC COUNS, V103, P873, DOI 10.1016/j.pec.2020.03.027
   Food and Drug Administration, 2020, COVID 19 VACCINES
   GRILICHES Z, 1972, J POLIT ECON, V80, pS74, DOI 10.1086/259988
   Johns Hopkins University of Medicine, 2020, COVID 19 US CASES
   Kaiser Family Foundation, 2020, RACIAL DISPARITIES C
   Khazanchi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19933
   Larson HJ, 2020, NAT REV IMMUNOL, V20, P449, DOI 10.1038/s41577-020-0380-8
   Litman L, 2017, BEHAV RES METHODS, V49, P433, DOI 10.3758/s13428-016-0727-z
   Malik A.A., 2020, ECLINICALMEDICINE, V26, P100495, DOI [10.1016/j.eclinm.2020.100495, DOI 10.1016/J.ECLINM.2020.100495]
   McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808
   National Academies of Sciences Engineering and Medicine, 2020, ENCOURAGING ADOPTION
   National Academies of Sciences Engineering Medicine, 2020, FRAMEWORK EQUITABLE
   Purdum T., 2020, BEWARE DANGER VACCIN
   Quinn SC, 2011, AM J PUBLIC HEALTH, V101, P285, DOI 10.2105/AJPH.2009.188029
   Tasnim Samia, 2020, J Prev Med Public Health, V53, P171, DOI 10.3961/jpmph.20.094
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Vraga EK, 2020, WORLD MED HEALTH POL, V12, P233, DOI 10.1002/wmh3.359
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 27
TC 9
Z9 9
U1 18
U2 46
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD MAY-JUN
PY 2021
VL 27
IS 3
SI SI
BP 278
EP 284
DI 10.1097/PHH.0000000000001348
PG 7
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA RH9OU
UT WOS:000636540000015
PM 33762543
DA 2022-04-20
ER

PT J
AU Abd Samat, AH
   Isa, MH
   Sabardin, DM
   Jamal, SM
   Jaafar, MJ
   Hamzah, FA
   Mahmud, A
   Sanip, A
   Ali, SMS
   Saiboon, IM
AF Abd Samat, Azlan Helmy
   Isa, Mohd Hisham
   Sabardin, Dazlin Masdiana
   Jamal, Shamsuriani Md
   Jaafar, Mohd Johar
   Hamzah, Faizal Amri
   Mahmud, Alias
   Sanip, Amirudin
   Ali, Syed Mohammad Syed
   Saiboon, Ismail Mohd
TI Knowledge and Confidence Level Among Emergency Healthcare Workers in
   Airway Management and Resuscitation of Suspected COVID-19 Patients: A
   Cross Sectional Study in Malaysia
SO ANNALS ACADEMY OF MEDICINE SINGAPORE
LA English
DT Article
DE Airway; Confidence; COVID-19; Knowledge; Resuscitation (CPR)
ID DISEASE 2019 COVID-19; IMPACT
AB Introduction: This study aims to evaluate the knowledge and confidence of emergency healthcare workers (EHCW) in facing the COVID-19 pandemic. Materials and Methods: A cross-sectional online study using a validated questionnaire was distributed to doctors (MD), assistant medical officers (AMO), and staff nurses (SN) at an urban tertiary Emergency Department. It comprised of 40 knowledge and 10 confidence-level questions related to resuscitation and airway management steps. Results: A total of 135 from 167 eligible EHCW were enrolled. 68.9% (n = 93) had high knowledge while 53.3% (n = 72) possessed high confidence level. Overall knowledge mean score was 32.96/40 (SD = 3.63) between MD (33.88 +/- 3.09), AMO (32.28 +/- 4.03), and SN (32.00 +/- 13.60), P = 0.025. EHCWs with a length of service (LOS) between 4-10 years had the highest knowledge compared to those with LOS <4-year (33.71 +/- 3.39 versus 31.21 +/- 3.19 P = 0.002). Airway-related knowledge was significantly different between the designations and LOS (P = 0.002 and P = 0.003, respectively). Overall, EHCW confidence level against LOS showed significant difference [F (2, 132) = 5.46, P = 0.0051 with longer LOS showing better confidence. MD showed the highest confidence compared to AMO and SN (3.67 +/- 0.69, 3.53 +/- 10.68, 3.26 +/- 0.64) P = 0.049. The majority EHCW were confident in performing high-quality chest-compression, and handling of Personal Protective Equipment but less than half were confident in resuscitating, leading the resuscitation, managing the airway or being successful in first intubation attempt. Conclusions: EHCW possessed good knowledge in airway and resuscitation of COVID-19 patients, but differed between designations and LOS. A longer LOS was associated with better confidence, but there were some aspects in airway management and resuscitation that needed improvement.
C1 [Abd Samat, Azlan Helmy; Isa, Mohd Hisham; Sabardin, Dazlin Masdiana; Jamal, Shamsuriani Md; Jaafar, Mohd Johar; Hamzah, Faizal Amri; Mahmud, Alias; Sanip, Amirudin; Ali, Syed Mohammad Syed; Saiboon, Ismail Mohd] Univ Kebangsaan Malaysia, Fac Med, Dept Emergency Med, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
RP Saiboon, IM (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Emergency Med, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
EM ismail@ppukm.ukm.edu.my
RI Mahmud, Alias/AAC-8813-2021; BIN ISA, MOHD HISHAM/AAS-1361-2020; Hamzah,
   Faizal Amri/AAM-8817-2020
OI BIN ISA, MOHD HISHAM/0000-0003-0821-9640; Hamzah, Faizal
   Amri/0000-0001-6309-6394; Mahmud, Alias/0000-0001-9077-9174
CR Abdullah Noor Hisham, 2020, KENYATAAN AKHBAR KET
   Academy of Emergency Sciences Manila, AHA COVID 19 PALS AL
   Awad Z, 2007, J LARYNGOL OTOL, V121, P57, DOI 10.1017/S0022215106002738
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Bashirian S, 2020, J HOSP INFECT, V105, P430, DOI 10.1016/j.jhin.2020.04.035
   Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X
   Brewster DJ, 2020, MED J AUSTRALIA, V212, P472, DOI 10.5694/mja2.50598
   Chew F Z A W M N K S, 2011, Med J Malaysia, V66, P56
   Chowell G., 2020, ESTIMATING RISK 2019, DOI [10.1101/2020.02.19.20025163, DOI 10.1101/2020.02.19.20025163]
   Edelson DP, 2020, CIRCULATION, V141, pE933, DOI 10.1161/CIRCULATIONAHA.120.047463
   Goh KJ, 2020, ANN ACAD MED SINGAP, V49, P108
   Hashimoto, 2020, BRAIN BEHAV IMMUN HL, V4, DOI DOI 10.1016/J.BBIH.2020.100064
   Hisham IM, 2020, MED HEALTH-KUALA LUM, V15, P250, DOI 10.17576/MH.2020.1501.23
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   Houghton C, 2020, COCHRANE DB SYST REV, V4
   Hsu LY, 2020, ANN ACAD MED SINGAP, V49, P105
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kim C, 2013, EMERG MED J, V30, P888, DOI 10.1136/emermed-2012-201708
   Mark ME, 2020, OTOLARYNG HEAD NECK, V163, P271, DOI 10.1177/0194599820933168
   Ministry of health Malaysia, 2020, LAT UPD COVID 19 MAL
   Mohammed Z, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00277-x
   Mouli TC, 2020, INDIAN J ANAESTH, V64, pS136, DOI 10.4103/ija.IJA_452_20
   Nolan JP, 2020, RESUSCITATION, V153, P45, DOI 10.1016/j.resuscitation.2020.06.001
   Raboud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010717
   Ritchie Hannah, 2020, STAT RES CORONAVIRUS
   Saiboon IM, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018201
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Shah AUM, 2020, INT J INFECT DIS, V97, P108, DOI 10.1016/j.ijid.2020.05.093
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   Wong TY, 2008, ANN ACAD MED SINGAP, V37, P96
   Worldometers, 2021, COVID 19 COR PAND
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 32
TC 4
Z9 4
U1 1
U2 2
PU ACAD MEDICINE SINGAPORE
PI REPUBLIC SINGAPORE
PA 142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE
SN 0304-4602
J9 ANN ACAD MED SINGAP
JI Ann. Acad. Med. Singap.
PD SEP
PY 2020
VL 49
IS 9
BP 643
EP 651
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA OH7AM
UT WOS:000582746800003
PM 33241252
DA 2022-04-20
ER

PT C
AU Li, XD
   Cheng, R
   Najafi, M
   Chang, K
   Han, XL
   Cao, HT
AF Li, Xiaodong
   Cheng, Reynold
   Najafi, Matin
   Chang, Kevin
   Han, Xiaolin
   Cao, Hongtai
GP ASSOC COMP MACHINERY
TI M-Cypher: A GQL Framework Supporting Motifs Demonstrated by Covid-19
   Knowledge Graph Analysis
SO CIKM '20: PROCEEDINGS OF THE 29TH ACM INTERNATIONAL CONFERENCE ON
   INFORMATION & KNOWLEDGE MANAGEMENT
LA English
DT Proceedings Paper
CT 29th ACM International Conference on Information and Knowledge
   Management (CIKM)
CY OCT 19-23, 2020
CL ELECTR NETWORK
SP Assoc Comp Machinery, ACM SIGIR, ACM SIGWEB
DE motif; GQL; Covid-19 knowledge graph
AB Graph databases witness the rise of Graph Query Language (GQL) in recent years, which enables non-programmers to express a graph query. However, the current solution does not support motif-related queries on knowledge graphs, which are proven important in many real-world scenarios. In this paper, we propose a GQL framework for mining knowledge graphs, named M-Cypher. It supports motif-related graph queries in an effective, efficient and user-friendly manner. We demonstrate the usage of the system by the emerging Covid-19 knowledge graph analytic tasks.
C1 [Li, Xiaodong; Cheng, Reynold; Najafi, Matin; Han, Xiaolin] Univ Hong Kong, Hong Kong, Peoples R China.
   [Chang, Kevin; Cao, Hongtai] Univ Illinois, Urbana, IL USA.
RP Li, XD (corresponding author), Univ Hong Kong, Hong Kong, Peoples R China.
EM xdli@cs.hku.hk; kcchang@illinois.edu; mnajafi@cs.hku.hk;
   ckcheng@cs.hku.hk; xlhan@cs.hku.hk; hongtai2@illinois.edu
FU HK RGCHong Kong Research Grants Council [17229116, 106150091, 17205115];
   HKUUniversity of Hong Kong [104004572, 102009508, 104004129]; HKITF
   [MRP/029/18]; National Science FoundationNational Science Foundation
   (NSF) [IIS 16-19302, IIS 16-33755]; ZJU Research [083650]; Futurewei
   Technologies [HF2017060011, 094013]; UIUC OVCR CCIL Planning Grant
   [434S34]; UIUC CSBS Small Grant [434C8U]; Advanced Digital Sciences
   Center Faculty Grant
FX R. Cheng, X. Li and X. Han were supported by HK RGC (17229116,
   106150091, and 17205115), HKU (104004572, 102009508, and 104004129), and
   HKITF (MRP/029/18). K. Chang and H. Cao were supported by National
   Science Foundation IIS 16-19302 and IIS 16-33755, ZJU Research 083650,
   Futurewei Technologies HF2017060011 and 094013, UIUC OVCR CCIL Planning
   Grant 434S34, UIUC CSBS Small Grant 434C8U, and Advanced Digital
   Sciences Center Faculty Grant.
CR AbuOda G., 2019, JOINT EUR C MACH LEA, P412
   [Anonymous], 2019, HKU TECHNIQUE REPORT
   Benson AR, 2016, SCIENCE, V353, P163, DOI 10.1126/science.aad9029
   Fang YX, 2019, IEEE T KNOWL DATA EN, V31, P783, DOI 10.1109/TKDE.2018.2845414
   Fang YX, 2017, PROC VLDB ENDOW, V10, P709, DOI 10.14778/3055330.3055337
   FRANCIS N, 2018, ACM SIGMOD, P1433, DOI DOI 10.1145/3183713.3190657
   Han XL, 2020, PROC INT CONF DATA, P1866, DOI 10.1109/ICDE48307.2020.00190
   Kuchaiev O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-24
   Leskovec J, 2016, ACM T INTEL SYST TEC, V8, DOI 10.1145/2898361
   Li BX, 2020, PROC INT CONF DATA, P1722, DOI 10.1109/ICDE48307.2020.00154
   Li X., 2018, EDBT
   Li XD, 2019, IEEE INT CONF MOB DA, P377, DOI 10.1109/MDM.2019.00-23
   Li Y., 2018, MLG WORKSH KDD
   Ma CH, 2019, PROC VLDB ENDOW, V13, P155, DOI 10.14778/3364324.3364330
   Pareja-Tobes P., 2015, BIORXIV
   Van Parys T, 2017, BIOINFORMATICS, V33, P461, DOI 10.1093/bioinformatics/btw626
   Zhao H, 2018, THIRTY-SECOND AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTIETH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / EIGHTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P232
   Zhou Y., 2020, CELL DISCOV, V6, P1
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY, UNITED STATES
BN 978-1-4503-6859-9
PY 2020
BP 3433
EP 3436
DI 10.1145/3340531.3417440
PG 4
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS6LW
UT WOS:000749561303080
DA 2022-04-20
ER

PT C
AU Suryati, E
   Umar, E
   Hamdiah, D
AF Suryati, Eti
   Umar, Erna
   Hamdiah, Dedeh
GP KNOWLEDGE E
TI Stress Management for Family and Community During the COVID-19 Pandemic
SO 4TH INTERNATIONAL VIRTUAL CONFERENCE ON NURSING
SE KnE Life Sciences
LA English
DT Proceedings Paper
CT 4th International Virtual Conference on Nursing (IVCN)
CY AUG 30, 2020
CL STIKep PPNI Jawa, Bandung, INDIA
SP National Cheng Kung
HO STIKep PPNI Jawa
DE stress management; COVID-19
AB Although mental health issues are not considered as a disorder that causes immediate death, this disorder can lead to an individual's inability to work. Stress is experienced by everyone. Mental pressure if not managed properly can lead to mental disorders and despair (suicide). For this reason, management of stress is an important thing in human life. A total of 30 community members agreed to participate in this program. Most (80%) were women with a mean age of 32.54 (SD = 2.76). The most frequently used sources of information were mostly (86.7%) via the internet. Based on the results of the paired t-test, it was found that this program was effective in increasing knowledge, attitudes, and behavior about COVID-19 and stress (p value < 0.001), with a difference value of 7.13 for knowledge, 5.02 for attitudes, and 4.24. for behavior, 3.45 for stress. This program is an approach based on the empowerment of health workers by utilizing existing applications for communication, namely social media and reminder systems. A subsequent program needs to be developed to increase the sustainability of this iniative, such as through integrated development and using technology as a medium of delivery and promotion.
C1 [Suryati, Eti; Umar, Erna; Hamdiah, Dedeh] Univ Sultan Ageng Tirtayasa, Program Studi Keperawatan D 3, Serang, Banten, Indonesia.
RP Suryati, E (corresponding author), Univ Sultan Ageng Tirtayasa, Program Studi Keperawatan D 3, Serang, Banten, Indonesia.
EM etisuryati671@gmail.com
CR Kementerian Kesehatan RePulik Indonesia, 2020, AP YANG HAR DIL MAS
   Razi F., 2020, BUNGAN RAMPAI COVID
   World Health Organization, CORONAVIRUS
NR 3
TC 0
Z9 0
U1 2
U2 3
PU KNOWLEDGE E
PI DUBAI
PA OFFICE 4402, X2 TOWER, JLT, PO BOX 488239, DUBAI, 00000, U ARAB EMIRATES
SN 2413-0877
J9 KNE LIFE SCI
PY 2021
BP 812
EP 817
DI 10.18502/kls.v6i1.8758
PG 6
WC Nursing
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Nursing
GA BR6NL
UT WOS:000662211700077
OA gold
DA 2022-04-20
ER

PT J
AU Adikaram, AS
   Naotunna, NPGSI
   Priyankara, HPR
AF Adikaram, Arosha S.
   Naotunna, N. P. G. S., I
   Priyankara, H. P. R.
TI Battling COVID-19 with human resource management bundling
SO EMPLOYEE RELATIONS
LA English
DT Article
DE COVID-19; Crisis management; HRM bundling; Human resource management;
   Soft HRM approach
AB Purpose This paper aims to present an empirically driven crisis management framework of complementary human resource management (HRM) bundles that can be utilized in simultaneously managing the health crisis, financial crisis and disruptions to business operations through lockdown and other government restrictions propelled by the COVID-19 pandemic. Design/methodology/approach The framework is developed employing qualitative methodology, drawing from the successful HRM practices adopted by 26 Sri Lankan companies in battling the many crises of COVID-19 and using the soft HRM approach as the theoretical basis. Findings The findings report a framework that consists of three key HRM bundles (health and safety bundle, cost-saving bundle and employee motivation and engagement bundle) entailing an array of inter-related, internally consistent, complementary and mutually reinforcing HRM practices and HRM activities. These HRM bundles and the HRM practices as well as the HRM activities therein, indicate how a softer approach to managing employees can be used during a crisis. Practical implications The framework will inform the HRPs of the HRM bundles, HRM practices and HRM activities that can be used to manage the multiple crises created by COVID-19 and other similar pandemics. Originality/value The study contributes to and expands the knowledge of HRM in crisis management generally and HRM in a global pandemic more specifically.
C1 [Adikaram, Arosha S.] Univ Colombo, Dept Human Resources Management, Colombo, Sri Lanka.
   [Naotunna, N. P. G. S., I; Priyankara, H. P. R.] Sabaragamuwa Univ Sri Lanka, Dept Business Management, Belihuloya, Sri Lanka.
RP Naotunna, NPGSI (corresponding author), Sabaragamuwa Univ Sri Lanka, Dept Business Management, Belihuloya, Sri Lanka.
EM shashi@mgt.sab.ac.lk
OI Adikaram, Arosha/0000-0002-2248-6035
CR Bailey K, 2021, INT J MANAG REV, V23, P3, DOI 10.1111/ijmr.12237
   Bello-Pintado A, 2015, HUM RESOUR MANAG J, V25, P311, DOI 10.1111/1748-8583.12067
   Beltran-Martin I, 2018, BRQ-BUS RES Q, V21, P99, DOI 10.1016/j.brq.2018.02.001
   Boselie P, 2001, INT J HUM RESOUR MAN, V12, P1107, DOI 10.1080/09585190110068331
   Bromfield P., 2009, STRATEGY LEADERSHIP, V37, P9
   Caligiuri P, 2020, J INT BUS STUD, V51, P697, DOI 10.1057/s41267-020-00335-9
   CAMERON KS, 1994, HUM RESOURCE MANAGE, V33, P189, DOI 10.1002/hrm.3930330204
   Carnevale JB, 2020, J BUS RES, V116, P183, DOI 10.1016/j.jbusres.2020.05.037
   Cook H, 2016, HUM RESOUR MANAG J, V26, P557, DOI 10.1111/1748-8583.12122
   De Leon V., 2020, THESIS CALIFORNIA ST
   Delery JE, 1996, ACAD MANAGE J, V39, P802, DOI 10.2307/256713
   Giancola, 2009, COMPENS BENEFITS REV, V41, P27
   Gooderham P, 2008, INT J HUM RESOUR MAN, V19, P2041, DOI 10.1080/09585190802404296
   Gunnigle P, 2013, INT J MANPOWER, V34, P214, DOI 10.1108/IJM-04-2013-0078
   Ichniowski C, 1997, AM ECON REV, V87, P291
   Kazancoglu Y., 2020, SUSTAINABLE OPERATIO, V1, P1, DOI [10.1016/j.susoc.2020.06.001, DOI 10.1016/J.SUSOC.2020.06.001]
   Kim WB, 2003, J CONTEMP ASIA, V33, P449, DOI 10.1080/00472330380000281
   Kniffin KM, 2021, AM PSYCHOL, V76, P63, DOI 10.1037/amp0000716
   Kooij DTAM, 2014, INT J HUM RESOUR MAN, V25, P2192, DOI 10.1080/09585192.2013.872169
   Kramer A, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103442
   MACDUFFIE JP, 1995, IND LABOR RELAT REV, V48, P197, DOI 10.2307/2524483
   Monks K, 2006, INT J HUM RESOUR MAN, V17, P1926, DOI 10.1080/09585190601000121
   Perry-Smith JE, 2000, ACAD MANAGE J, V43, P1107, DOI 10.2307/1556339
   PricewaterhouseCoopers, 2020, COVID  19 OUTBR IMP
   Rico M., 2019, BRQ-BUS RES Q, DOI [10.1016/j.brq.2019.06.002, DOI 10.1016/J.BRQ.2019.06.002]
   Roan A., 2001, J IND RELAT, V43, P387
   Roche WK, 2012, HUM RELAT, V65, P1333, DOI 10.1177/0018726712451282
   Rudolph CW, 2021, J BUS PSYCHOL, V36, P945, DOI 10.1007/s10869-020-09715-2
   Santana M, 2017, BRQ-BUS RES Q, V20, P206, DOI 10.1016/j.brq.2017.01.003
   Shen HY, 2020, EMERG MARK FINANC TR, V56, P2213, DOI 10.1080/1540496X.2020.1785863
   Subramony M, 2009, HUM RESOUR MANAGE-US, V48, P745, DOI 10.1002/hrm.20315
   Teague P, 2014, HUM RESOUR MANAG J, V24, P176, DOI 10.1111/1748-8583.12019
   Truss C, 1997, J MANAGE STUD, V34, P53, DOI 10.1111/1467-6486.00042
   Viljanen M., 2009, IIRA HRM STUDY GROUP, V24
   Wright P.M., 1991, HUMAN RESOURCE MANAG, V1, P203, DOI DOI 10.1016/1053-4822(91)90015-5
NR 35
TC 1
Z9 1
U1 18
U2 44
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0142-5455
EI 1758-7069
J9 EMPL RELAT
JI Empl. Relat.
PD OCT 1
PY 2021
VL 43
IS 6
BP 1269
EP 1289
DI 10.1108/ER-08-2020-0390
EA APR 2021
PG 21
WC Industrial Relations & Labor; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA WB6NL
UT WOS:000637870000001
OA Bronze
DA 2022-04-20
ER

PT J
AU Chatterjee, S
   Chaudhuri, R
   Vrontis, D
   Mahto, RV
   Kraus, S
AF Chatterjee, Sheshadri
   Chaudhuri, Ranjan
   Vrontis, Demetris
   Mahto, Raj, V
   Kraus, Sascha
TI Global talent management by multinational enterprises post-COVID-19: The
   role of enterprise social networking and senior leadership
SO THUNDERBIRD INTERNATIONAL BUSINESS REVIEW
LA English
DT Article; Early Access
DE COVID-19; enterprise social network; global talent management; knowledge
   management; senior leadership team
ID KNOWLEDGE MANAGEMENT; COMPETITIVE ADVANTAGE; FIRM PERFORMANCE; MEDIATING
   ROLE; GOVERNMENT; INNOVATION; SUBSIDIARIES; PERSPECTIVE; CREATION;
   SUPPORT
AB Multinational enterprises' (MNEs') workforce is made up of people from diverse backgrounds and different locations around the globe. The cross-border transfer of knowledge, skills, and best practices among MNE employees is important to maintain global standards and competitiveness. In the post-COVID-19 period, there is a greater need to exchange knowledge in the changing business environment. The purpose of this study is to examine the issues related to MN Es' global talent management, post-COVID-19. The study investigates the use of enterprise social networking applications for better knowledge exchange and tries to understand the moderating role of senior leadership team support in facilitating the usage of enterprise social networks for cross-border collaboration and talent management. After reviewing the literature and relevant theories, we developed a conceptual model, which is then validated using the SEM technique with 347 respondents from 12 MNEs. The study reveals the importance of using enterprise social networks for cross-border knowledge exchange in the post-COVID-19 period.
C1 [Chatterjee, Sheshadri] Indian Inst Technol Kharagpu, Dept Comp Sci & Engn, Kharagpur, W Bengal, India.
   [Chaudhuri, Ranjan] Natl Inst Ind Engn, Dept Mkt, Mumbai, Maharashtra, India.
   [Vrontis, Demetris] Univ Nicosia, Sch Business, Nicosia, Cyprus.
   [Mahto, Raj, V] Univ New Mexico, Anderson Sch Management, Albuquerque, NM 87131 USA.
   [Kraus, Sascha] Free Univ Bozen Bolzano, Fac Econ & Management, Piazza Univ 1, I-39100 Bolzano, Italy.
   [Kraus, Sascha] Univ Johannesburg, Dept Business Management, Johannesburg, South Africa.
RP Kraus, S (corresponding author), Free Univ Bozen Bolzano, Fac Econ & Management, Piazza Univ 1, I-39100 Bolzano, Italy.
EM sheshadri.academic@gmail.com; ranjan@nitie.ac.in; vrontis.d@unic.ac.cy;
   rmahto@unm.edu; sascha.kraus@zfke.de
OI Chaudhuri, Ranjan/0000-0001-7148-0329; Kraus,
   Sascha/0000-0003-4886-7482; Chatterjee, Sheshadri/0000-0003-1075-5549
CR Al Ariss A, 2014, J WORLD BUS, V49, P173, DOI 10.1016/j.jwb.2013.11.001
   Alraouf AA, 2021, ARCHNET-IJAR, V15, P167, DOI 10.1108/ARCH-10-2020-0249
   [Anonymous], 2020, UN NEWS
   Arfaoui N, 2020, EUROMED J BUS, V15, P102, DOI 10.1108/EMJB-03-2018-0024
   BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108
   Belyaeva Z, 2020, EUROMED J BUS, V15, P269, DOI 10.1108/EMJB-06-2019-0085
   Bontis N, 1998, MANAGE DECIS, V36, P63, DOI 10.1108/00251749810204142
   Bontis N., 2002, J INTELLECT CAP, V3, P223, DOI DOI 10.1108/14691930210435589
   Boonstra A, 2013, INT J PROJ MANAG, V31, P498, DOI 10.1016/j.ijproman.2012.09.013
   Butter MC, 2015, COMPUT HUM BEHAV, V51, P1191, DOI 10.1016/j.chb.2015.01.030
   Carpenter S, 2018, COMMUN METHODS MEAS, V12, P25, DOI 10.1080/19312458.2017.1396583
   Chatterjee S., 2020, J RELATIONSHIP MARKE, V19, P75, DOI [10.1080/15332667.2019.1664870, DOI 10.1080/15332667.2019.1664870]
   Chatterjee S, 2021, J STRATEGY MANAG, DOI 10.1108/JSMA-02-2021-0049
   Chatterjee S, 2021, INT MARKET REV, DOI 10.1108/IMR-11-2020-0261
   Chatterjee S, 2021, J COMPUT INFORM SYST, DOI 10.1080/08874417.2021.1873080
   Chatterjee S, 2021, BOTTOM LINE, V34, P101, DOI 10.1108/BL-11-2020-0070
   Chatterjee S, 2020, BOTTOM LINE, V33, P359, DOI 10.1108/BL-08-2020-0057
   Chatterjee S, 2020, J KNOWL MANAG, V24, P2531, DOI 10.1108/JKM-04-2020-0252
   Chatterjee S, 2021, INF COMPUT SECUR, V29, P1, DOI 10.1108/ICS-02-2019-0029
   Chatterjee S, 2021, INT J ORGAN ANAL, V29, P35, DOI 10.1108/IJOA-11-2019-1933
   Chatterjee S, 2020, BUS PROCESS MANAG J, V26, P1261, DOI 10.1108/BPMJ-05-2019-0183
   Chatterjee S, 2020, EDUC INF TECHNOL, V25, P3443, DOI 10.1007/s10639-020-10159-7
   Chatterjee S, 2019, INT J ELECTRON GOV R, V15, P21, DOI 10.4018/IJEGR.2019070102
   Chatterjee S, 2020, EDUC INF TECHNOL, V25, P4057, DOI 10.1007/s10639-020-10168-6
   Chatterjee S, 2019, INT J ELECTRON GOV R, V15, P19, DOI 10.4018/IJEGR.2019040102
   Chatterjee S, 2020, BEHAV INFORM TECHNOL, V39, P133, DOI 10.1080/0144929X.2019.1587001
   Chatterjee S, 2020, INT J INTELL UNMANNE, V8, P97, DOI 10.1108/IJIUS-09-2019-0051
   Chatterjee S, 2021, ENTERP INF SYST-UK, V15, P585, DOI 10.1080/17517575.2019.1654617
   Chatterjee S, 2020, STUD HIGH EDUC, V45, P1566, DOI 10.1080/03075079.2019.1599847
   Chatterjee S, 2018, GOV INFORM Q, V35, P349, DOI 10.1016/j.giq.2018.05.002
   Chaudhuri R., 2013, GLOBAL J MANAGEMENT, V13, P42
   Chaudhuri R., 2013, GLOBAL J E BUSINESS, V5, P8
   Christofi M, 2019, TECHNOL FORECAST SOC, V146, P148, DOI 10.1016/j.techfore.2019.05.026
   Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003
   Dabic M, 2019, J KNOWL MANAG, V23, P1477, DOI 10.1108/JKM-03-2019-0129
   Damsgaard J, 2001, INFORM SOC, V17, P195, DOI 10.1080/01972240152493056
   DelGiudice M, 2012, INNOV TECH KNOWL MAN, P1, DOI 10.1007/978-1-4614-2089-7
   Denicolai S, 2015, TECHNOL ANAL STRATEG, V27, P219, DOI 10.1080/09537325.2014.959484
   Dess G.D., 2000, PRODUCTIVITY LEADING
   Dimitropoulos P, 2020, EUROMED J BUS, V15, P333, DOI 10.1108/EMJB-08-2019-0104
   Edvinsson L., 1997, INTELLECTUAL CAPITAL
   Felin T, 2007, ACAD MANAGE REV, V32, P195, DOI 10.5465/amr.2007.23464020
   Ferraris A, 2017, EUR J INT MANAG, V11, P452, DOI 10.1504/EJIM.2017.10006514
   Ferraris A, 2017, J KNOWL MANAG, V21, P540, DOI 10.1108/JKM-09-2016-0411
   Ferreira A, 2020, EUROMED J BUS, V15, P65, DOI 10.1108/EMJB-04-2019-0052
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gonzalez-Loureiro M, 2015, INT J INTERCULT REL, V49, P239, DOI 10.1016/j.ijintrel.2015.05.003
   Guo Y, 2020, J KNOWL MANAG, V24, P553, DOI 10.1108/JKM-09-2017-0399
   Gupta S, 2020, IND MARKET MANAG, V90, P581, DOI 10.1016/j.indmarman.2019.11.009
   Haak-Saheem W, 2020, ASIAN BUS MANAG, V19, P298, DOI 10.1057/s41291-020-00120-4
   Haas MR, 2005, STRATEGIC MANAGE J, V26, P1, DOI 10.1002/smj.429
   Hair J.F., 2018, ADV ISSUES PARTIAL L
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Han SH, 2016, J WORKPLACE LEARN, V28, P130, DOI 10.1108/JWL-09-2015-0066
   Ho CT, 2009, IND MANAGE DATA SYST, V109, P98, DOI 10.1108/02635570910926618
   Horak S, 2019, THUNDERBIRD INT BUS, V61, P471, DOI 10.1002/tie.21959
   Hsu YH, 2009, TECHNOL FORECAST SOC, V76, P664, DOI 10.1016/j.techfore.2008.03.012
   [Ilyin D.S. Ilyin D.S.], 2014, [Корпоративные финансы, Korporativnye finansy], P46
   Donate MJ, 2011, J KNOWL MANAG, V15, P890, DOI 10.1108/13673271111179271
   John J, 2021, EUR J MARKETING, V55, P1679, DOI 10.1108/EJM-08-2020-0607
   Kallmuenzer A, 2021, TOUR MANAG PERSPECT, V38, DOI 10.1016/j.tmp.2021.100801
   Kang SC, 2009, J MANAGE STUD, V46, P65, DOI 10.1111/j.1467-6486.2008.00776.x
   Kar A. K., 2018, GLOB J FLEX SYST MAN, V19, P95, DOI DOI 10.1007/S40171-017-0173-5
   Khilji SE, 2015, HUM RESOUR MANAGE R, V25, P236, DOI 10.1016/j.hrmr.2015.04.001
   Kong E, 2008, INT J NONPROFIT VOLU, V13, P119, DOI 10.1002/nvsm.315
   Levy O, 2015, J INT BUS STUD, V46, P285, DOI 10.1057/jibs.2014.53
   Makkonen H, 2015, TECHNOL ANAL STRATEG, V27, P1212, DOI 10.1080/09537325.2015.1061120
   McDowell WC, 2018, J BUS RES, V88, P321, DOI 10.1016/j.jbusres.2018.01.025
   Mehralian G, 2018, J KNOWL MANAG, V22, P802, DOI 10.1108/JKM-10-2016-0457
   Minbaeva D, 2013, INT J HUM RESOUR MAN, V24, P1762, DOI 10.1080/09585192.2013.777539
   Morgan T. L, 2012, THESIS CAPELLA U
   Newell S., 2009, MANAGING KNOWLEDGE W
   O'Sullivan Kevin J, 2007, International Journal of Learning and Intellectual Capital, V4, P453, DOI 10.1504/IJLIC.2007.016338
   Oliver C, 1997, STRATEGIC MANAGE J, V18, P697, DOI 10.1002/(SICI)1097-0266(199710)18:9<697::AID-SMJ909>3.0.CO;2-C
   Penco L, 2019, EUROMED J BUS, V14, P189, DOI 10.1108/EMJB-11-2018-0076
   Phusavat K, 2011, IND MANAGE DATA SYST, V111, P810, DOI 10.1108/02635571111144928
   PRAHALAD CK, 1990, HARVARD BUS REV, V68, P79
   Raab KJ, 2014, J WORLD BUS, V49, P32, DOI 10.1016/j.jwb.2013.02.005
   Roos G, 1997, LONG RANGE PLANN, V30, P413, DOI 10.1016/S0024-6301(97)90260-0
   Rupcic N, 2019, LEARN ORGAN, V26, P219, DOI 10.1108/TLO-02-2019-221
   Scott W.R., 2008, I ORG IDEAS INTEREST
   Scupola A., 2003, Journal of Global Information Technology Management (JGITM), V6, P52
   Secundo G, 2018, J INTELLECT CAP, V19, P2, DOI 10.1108/JIC-10-2017-0140
   Seleim A, 2013, KNOWL PROCESS MANAG, V20, P131, DOI 10.1002/kpm.1412
   Shao JJ, 2020, INT BUS REV, V29, DOI 10.1016/j.ibusrev.2019.101634
   St-Pierre J, 2011, J INTELLECT CAP, V12, P202, DOI 10.1108/14691931111123395
   STEWART TA, 1991, FORTUNE, V123, P44
   Sumedrea S, 2013, PROC ECON FINANC, V6, P137, DOI 10.1016/S2212-5671(13)00125-1
   Tarique I, 2010, J WORLD BUS, V45, P122, DOI 10.1016/j.jwb.2009.09.019
   Thakur R, 2016, J BUS RES, V69, P2764, DOI 10.1016/j.jbusres.2015.11.012
   Thrassou A, 2020, J KNOWL MANAG, V24, P861, DOI 10.1108/JKM-06-2019-0291
   Venkitachalam K, 2012, J KNOWL MANAG, V16, P356, DOI 10.1108/13673271211218915
   Vrontis D, 2021, J INTELLECT CAP, V22, P95, DOI 10.1108/JIC-11-2019-0258
   Whittington R, 2012, STRATEG ORGAN, V10, P263, DOI 10.1177/1476127012452828
   Wiesneth K, 2016, P 24 EUR C INF SYST
   Winata AP, 2021, DIGIT LIBR PERSPECT, V37, P77, DOI 10.1108/DLP-07-2020-0059
   Zhu YQ, 2016, GOV INFORM Q, V33, P629, DOI 10.1016/j.giq.2016.08.002
NR 97
TC 0
Z9 0
U1 9
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1096-4762
EI 1520-6874
J9 THUNDERBIRD INT BUS
JI Thunderbird Int. Bus. Rev.
DI 10.1002/tie.22248
EA JAN 2022
PG 12
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA XZ3TR
UT WOS:000737578400001
OA Bronze
DA 2022-04-20
ER

PT J
AU Li, HL
   Hu, QQ
   Zhao, GZ
   Li, B
AF Li, Honglei
   Hu, Qianqian
   Zhao, Guangzhi
   Li, Bin
TI Viewpoint: The co-evolution of knowledge management and business model
   transformation in the post-COVID-19 era: insights based on Chinese
   e-commerce companies
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article; Early Access
DE Knowledge management; Business model; Post-COVID-19 era; Business
   co-evolution; Business ecosystem; Dynamic co-evolution
ID INNOVATION; DIRECTIONS; STRATEGY; VIEW
AB Purpose This study aims to answer the question of how business models (BMs) maintain stability while coping with environmental uncertainties. This study proposes a dynamic co-evolution of knowledge management and business model transformation based on a comparative analysis of the focal firms' BMs and their main partners in two e-commerce ecosystems in China. Design/methodology/approach The open data of listed companies regarding the introduction of emerging topics on the transformation tendency of BMs in the post-COVID-19 business world is qualitatively analysed. The theoretical foundation is based on a critical review of the literature. Findings Three aspects of the co-evolution between knowledge management and business model transformation are introduced. These three aspects are as follows: knowledge integration helps with multi-system business integration and decision-making collaborations; knowledge sharing helps to enhance cognitive ability and network value based on businesses; and the creation of new knowledge helps enrich the knowledge base and promote the transformation of BMs. Research limitations/implications Solely attributing a firm's ability to cope with environmental uncertainties to its business model weakens the importance of its knowledge management. This study argues that the co-evolution between knowledge management and business model transformation also plays a key role in a firm's response to issues post-COVID-19. Originality/value This study calls for the development of a normative theory of co-evolution between knowledge management and business model transformation, implying uncharted territories of knowledge management based on interaction with business model designs in e-business ecosystems.
C1 [Li, Honglei] Beijing Informat Sci & Technol Univ, Sch Econ & Management, Beijing, Peoples R China.
   [Hu, Qianqian] Zhejiang Univ Technol, Sch Management, Hangzhou, Peoples R China.
   [Zhao, Guangzhi] Norwegian Sch Econ, Bergen, Norway.
   [Li, Bin] Southeast Univ, Sch Econ & Management, Nanjing, Peoples R China.
RP Li, HL (corresponding author), Beijing Informat Sci & Technol Univ, Sch Econ & Management, Beijing, Peoples R China.
EM lee_hl@126.com; ruthhqq@163.com; bergenfisk@126.com; lee0812@126.com
FU National Social Science Fund of China [20BGL094]
FX This research was supported by The National Social Science Fund of China
   Grant No. 20BGL094.
CR Aspara J, 2013, LONG RANGE PLANN, V46, P459, DOI 10.1016/j.lrp.2011.06.001
   Bouncken RB, 2021, REV MANAG SCI, V15, P1, DOI 10.1007/s11846-019-00366-z
   Caputo F, 2019, J KNOWL MANAG, V23, P1314, DOI 10.1108/JKM-10-2018-0645
   Chin T, 2021, J CAREER DEV, DOI 10.1177/0894845321993234
   Chin T, 2021, ASIA PAC BUS REV, V27, P342, DOI 10.1080/13602381.2020.1795481
   Chin T, 2021, J KNOWL MANAG, V25, P1, DOI 10.1108/JKM-04-2020-0244
   Cillo V, 2019, CORP SOC RESP ENV MA, V26, P1012, DOI 10.1002/csr.1783
   Del Giudice M., 2020, J PROD INNOVAT MANAG, V38
   Del Giudice M, 2021, INT J LOGIST MANAG, V32, P337, DOI 10.1108/IJLM-03-2020-0119
   Del Giudice M, 2017, J ORGAN BEHAV, V38, P1396, DOI 10.1002/job.2237
   Del Giudice M, 2017, INT MARKET REV, V34, P652, DOI 10.1108/IMR-05-2016-0098
   Del Giudice M, 2016, J KNOWL MANAG, V20, P484, DOI 10.1108/JKM-07-2015-0257
   Del Giudice M, 2014, J KNOWL MANAG, V18, P841, DOI 10.1108/JKM-06-2014-0264
   Denyer D., 2017, ORG RESILIENCE SUMMA, P8
   DesJardine M, 2019, J MANAGE, V45, P1434, DOI 10.1177/0149206317708854
   Ferreira J, 2018, J KNOWL MANAG, V24, P121, DOI 10.1108/JKM-07-2018-0461
   Ferreira JJM, 2016, SCIENTOMETRICS, V109, P1, DOI 10.1007/s11192-016-2008-0
   Gaviria-Marin M, 2018, J KNOWL MANAG, V22, P1655, DOI 10.1108/JKM-10-2017-0497
   Kotabe M., 2018, ADV GLOBAL MARKETING, P365
   Lin HF, 2013, INTERNET RES, V23, P439, DOI 10.1108/IntR-11-2012-0233
   Loebbecke C, 2015, J STRATEGIC INF SYST, V24, P149, DOI 10.1016/j.jsis.2015.08.002
   Matricano D, 2019, J KNOWL MANAG, V23, P786, DOI 10.1108/JKM-10-2018-0625
   McInerney C, 2002, J AM SOC INF SCI TEC, V53, P1009, DOI 10.1002/asi.10109
   Nonaka I, 2007, HARVARD BUS REV, V85, P162
   Papa A, 2020, J KNOWL MANAG, V24, P589, DOI 10.1108/JKM-09-2017-0391
   Priyono A., 2020, J OPEN INNOV TECHNOL, V6, P1
   Rachinger M., 2019, J MANUFACTURING TECH, V30
   Sallos MP, 2019, J INTELLECT CAP, V20, P581, DOI 10.1108/JIC-03-2019-0041
   Santoro G, 2021, SMALL BUS ECON, V57, P455, DOI 10.1007/s11187-020-00319-x
   Scuotto V, 2017, CREAT INNOV MANAG, V26, P247, DOI 10.1111/caim.12221
   Scuotto V, 2017, J KNOWL MANAG, V21, P640, DOI 10.1108/JKM-10-2016-0465
   Sein MK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102164
   Soto-Acosta P, 2018, J KNOWL MANAG, V22, P824, DOI 10.1108/JKM-10-2017-0448
   Umar M., 2021, J KNOWL MANAG, V25
   Wang S., 2020, J KNOWL MANAG, V26
   Wang WS, 2021, KAOHSIUNG J MED SCI, V37, P215, DOI 10.1002/kjm2.12322
   Weick K.E., 2001, MANAGING UNEXPECTED, V9
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Zott C., 2015, OXFORD HDB CREATIVIT, P395
   Zott C, 2008, STRATEGIC MANAGE J, V29, P1, DOI 10.1002/smj.642
NR 40
TC 2
Z9 2
U1 33
U2 41
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
DI 10.1108/JKM-03-2021-0177
EA JUL 2021
PG 11
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA TQ9LG
UT WOS:000678596700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Chawe, A
   Mfune, RL
   Syapiila, PM
   Zimba, SD
   Vlahakis, PA
   Mwale, S
   Mwape, K
   Chirambo-Kalolekesha, M
   Chileshe, M
   Mutale, J
   Mudend, T
   Manda, G
   Daka, V
AF Chawe, Adon
   Mfune, Ruth L.
   Syapiila, Paul M.
   Zimba, Sharon D.
   Vlahakis, Pipina A.
   Mwale, Samson
   Mwape, Kapambwe
   Chirambo-Kalolekesha, Memory
   Chileshe, Misheck
   Mutale, Joseph
   Mudend, Tobela
   Manda, Grace
   Daka, Victor
TI Knowledge, attitude and practices of COVID-19 among medical laboratory
   professionals in Zambia
SO AFRICAN JOURNAL OF LABORATORY MEDICINE
LA English
DT Article
DE COVID-19; medical laboratory professional; knowledge; attitude;
   practices
ID PREVENTION
AB Background: Coronavirus disease 2019 (COVID-19) is a novel disease that has spread to nearly every country worldwide. Medical laboratory professionals are key in the fight against COVID-19 as they provide confirmatory diagnosis for subsequent management and mitigation of the disease.
   Objective: This study investigated the knowledge, attitude and practices of COVID-19 and their predictors among medical laboratory personnel in Zambia.
   Methods: We conducted a cross-sectional study among medical laboratory professionals in Zambia from 10 to 29 June 2020. Data were collected using Google Forms and exported to Statistical Package for Social Sciences version 23 for statistical analysis. Independent predictors of COVID-19 knowledge and practices were determined. Adjusted odds ratios (AOR) and their 95% confidence intervals (CI) are reported.
   Results: A total of 208 medical laboratory professionals, 58.2% male, participated in the study. The majority of respondents had good knowledge (84.1%) and practice (75.0%) regarding COVID-19. Predictors of good knowledge included having a bachelor's degree (AOR: 5.0, CI: 1.13-22.19) and having prior COVID-19 related training (AOR: 8.83, CI: 2.03-38.44). Predictors of good practice included having a master's or Doctor of Philosophy (PhD) qualification (AOR: 5.23, CI: 1.15-23.87) and having prior COVID-19 related training (AOR: 14.01, CI: 6.47-30.36).
   Conclusion: Our findings revealed that medical laboratory professionals in Zambia have good knowledge regarding COVID-19. There is need for continuous professional development to ensure that medical laboratory professionals are well informed and aware of best practices to aid in curbing the pandemic.
C1 [Chawe, Adon] St Francis Mission Hosp, Lab Dept, Katete, Zambia.
   [Mfune, Ruth L.; Syapiila, Paul M.; Mwape, Kapambwe; Chirambo-Kalolekesha, Memory; Daka, Victor] Copperbelt Univ, Fac Med, Michael Chilufya Sch Med, Dept Clin Sci, Ndola, Zambia.
   [Zimba, Sharon D.] Chikankata Coll Biomed Sci, Fac Med, Dept Clin Sci, Chikankata, Zambia.
   [Vlahakis, Pipina A.] Copperbelt Univ, Fac Med, Michael Chilufya Sch Med, Dept Basic Sci, Ndola, Zambia.
   [Mwale, Samson] Trop Dis Res Ctr, Dept Biomed Sci, Ndola, Zambia.
   [Chileshe, Misheck] Mary Begg Hlth Serv, Lab Dept, Ndola, Zambia.
   [Mutale, Joseph] Kabompo Dist Hosp, Lab Dept, Kabompo, Zambia.
   [Mudend, Tobela] Ndola Teaching Hosp, Dept Pathol, Ndola, Zambia.
   [Manda, Grace] Kalomo Dist Hosp, Lab Dept, Kalomo, Zambia.
RP Mfune, RL (corresponding author), Copperbelt Univ, Fac Med, Michael Chilufya Sch Med, Dept Clin Sci, Ndola, Zambia.
EM lindizyani@gmail.com
OI Mwale, Samson/0000-0001-7439-6907; Chileshe,
   Misheck/0000-0001-7282-9166; Zimba, Sharon Duba/0000-0002-9275-180X;
   Mutale, Joseph/0000-0003-4569-1397; Mfune, Ruth
   Lindizyani/0000-0001-9707-2673; Vlahakis, Pipina/0000-0002-3987-1167
CR Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P477
   Chileshe M, 2020, PAN AFR MED J PAN AFR MED J, P37
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Geberemariyam BS, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0314-0
   Guner R, 2020, TURK J MED SCI, V50, P571, DOI 10.3906/sag-2004-146
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Jean SS, 2020, J MICROBIOL IMMUNOL, V53, P436, DOI 10.1016/j.jmii.2020.03.034
   Li L, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00661-z
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   MOH, 2020, ZAMB COVID 19 GEN D ZAMB COVID 19 GEN D
   Nakhleh RE, 2016, ARCH PATHOL LAB MED, V140, P29, DOI 10.5858/arpa.2014-0511-SA
   Nepal R., 2020, KNOWLEDGE ATTITUDE P, DOI [10.21203/rs.3.rs-26774/v1, DOI 10.21203/RS.3.RS-26774/V1]
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14
   Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2
   Tait FN, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.65.12578
   Wang H, 2020, NURS ETHICS, V27, P1490, DOI 10.1177/0969733020934146
   WHO, 2020, 82 WHO
   WHO, 2020, 10 000 HLTH WORK AFR
   World Health Organization, 2020, COR DIS COVID 19 SIT
   Wu Renyi, 2020, Curr Pharmacol Rep, V6, P56, DOI 10.1007/s40495-020-00216-7
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 28
TC 1
Z9 1
U1 0
U2 0
PU AOSIS
PI CAPE TOWN
PA POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH
   AFRICA
SN 2225-2002
EI 2225-2010
J9 AFR J LAB MED
JI Afr. J. Lab. Med.
PD MAR 4
PY 2021
VL 10
IS 1
AR a1403
DI 10.4102/ajlm.v10i1.1403
PG 7
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA TK8AC
UT WOS:000674375000001
PM 33821204
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Yazdizadeh, B
   Ehsani-Chimeh, E
   Zendehdel, K
   Mobinizadeh, M
   Mesgarpour, B
   Fakoorfard, Z
AF Yazdizadeh, Bahareh
   Ehsani-Chimeh, Elham
   Zendehdel, Kazem
   Mobinizadeh, Mohammadreza
   Mesgarpour, Bita
   Fakoorfard, Zeinab
TI Knowledge gaps and national research priorities for COVID-19 in Iran
SO HEALTH RESEARCH POLICY AND SYSTEMS
LA English
DT Article
DE COVID-19; Knowledge need; Research priority-setting; Challenges;
   Research priority; Health systems research
AB Background In the present COVID-19 crisis, one of the greatest challenges for research funding at both the international and national level is selecting the best research topic to achieve efficiency and equity in health research and to address the knowledge gap urgently raised due to the event. Despite international recommendations, countries should consider their context-specific situation and define local research priorities. We aimed to exercise a priority-setting activity to identify the knowledge gaps and suggest research priorities in response to the COVID-19 epidemic in Iran. Methods First, we tried to identify the contextual knowledge gaps based on an online survey, performing key informant interviews (i.e. health professionals, policy-makers and managers) and media analysis. We also performed a literature review and considered international research priorities for COVID-19. Subsequently, we prepared a list of research questions and challenges to respond to the COVID-19 crisis in Iran using a systems approach. Then we mapped approved COVID-19 research projects in the country to research questions. Finally, we compared the identified research questions (not challenges) with the prioritized research from international organizations and then prioritized them for Iran. Results We found risk factors and epidemiological dissemination patterns of the virus and its consequences in an epidemiology domain, implementation of clinical and hygiene in a clinical management domain, genetic studies for targeting prevention and treatment in a candidate treatment and vaccine research and development (R&D) knowledge domain, examination of the manifestations of ethics in society instead of ethics in research in an ethics domain, "care, access and health system" and "public health and participation in response to public health and clinical research" as two sub-domains of a social sciences domain, and finally, no new questions in either the virology, transmission, diagnosis or animal and environmental domain. Conclusions In the event of global health crises like COVID-19, prioritization of research questions can be done globally, but some of the research priorities are context-specific and may vary by regional needs. To better manage research resources, researchers must respond to the challenges faced in each country based on its political, economic, social and cultural characteristics, and to make evidence-informed decisions, global knowledge gaps must be customized in each country.
C1 [Yazdizadeh, Bahareh] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Epidemiol, Tehran, Iran.
   [Ehsani-Chimeh, Elham; Mobinizadeh, Mohammadreza] Univ Tehran Med Sci, Natl Inst Hlth Res, Hlth Serv Management, Tehran, Iran.
   [Zendehdel, Kazem] Univ Tehran Med Sci, Canc Res Ctr, Canc Res Inst, Epidemiol, Tehran, Iran.
   [Mesgarpour, Bita] Natl Inst Med Res Dev NIMAD, Pharmacoepidemiol, Tehran, Iran.
   [Fakoorfard, Zeinab] Univ Tehran Med Sci, Natl Inst Hlth Res, Hlth Econ, Tehran, Iran.
RP Ehsani-Chimeh, E (corresponding author), Univ Tehran Med Sci, Natl Inst Hlth Res, Hlth Serv Management, Tehran, Iran.
EM ehsanielham@yahoo.com
OI Zendehdel, Kazem/0000-0002-0269-4945
FU Minisry of Health and Medical Education of Iran; Tehran University of
   Medical SciencesTehran University of Medical Sciences [48033]
FX This study has been funded by Minisry of Health and Medical Education of
   Iran and Tehran University of Medical Sciences, code 48033.
CR Badakhshan A, 2018, E MEDITERR HEALTH J, V24, P753, DOI 10.26719/2018.24.8.753
   Bengtsson M., 2016, NURSINGPLUS OPEN, V2, P8, DOI [DOI 10.1016/J.NPLS.2016.01.001, 10.1016/j.npls.2016.01.001]
   Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1
   Gilson L, 2020, HEALTH POLICY PLANN, V35, P1231, DOI 10.1093/heapol/czaa112
   Hinrichs-Krapels S, 2016, PALGR COMMUN, V2, DOI 10.1057/palcomms.2016.90
   Norton Alice, 2020, BMJ Glob Health, V5, DOI 10.1136/bmjgh-2020-003306
   Organization WH. COVID 19 public health emergency of international concern (PHEIC), 2020, COVID 19 PUBL HLTH E
   Organizational ethics framework, ORG ETH FRAM ACC REA
   Yazdizadeh B, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00667-w
   Zhang HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103370
NR 10
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-4505
J9 HEALTH RES POLICY SY
JI Health Res. Policy Syst.
PD MAR 2
PY 2022
VL 20
IS 1
AR 25
DI 10.1186/s12961-021-00805-y
PG 14
WC Health Policy & Services
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZL0TA
UT WOS:000763391800001
PM 35236369
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Singh, JP
   Sewda, A
   Gupta, SD
AF Singh, Jagajeet Prasad
   Sewda, Anshuman
   Gupta, Shiv Dutt
TI Assessing the Knowledge, Attitude and Practices of Students Regarding
   the COVID-19 Pandemic
SO JOURNAL OF HEALTH MANAGEMENT
LA English
DT Article
DE COVID-19; knowledge; attitude; practice; coronavirus
AB Introduction:The coronavirus disease (COVID-19) pandemic has impacted everyone, including students. Accurate information about the disease, its spread, preventive measures and government-issued advisories is critical for containing an outbreak. We evaluated the knowledge, attitudes and practices, and the key behavioural determinants of clinical outcomes, among university students.Materials and methods:We conducted a cross-sectional study among IIHMR University students (31 March to 10 April 2020), soon after the nationwide lockdown in India. Through purposive sampling, we enrolled 529 students, who completed a semi-structured questionnaire (44% completion rate). Knowledge level of the participants was assessed using a scoring system, and chi-squared test andt-test were performed to detect significant (p< 0.05) differences among various groups.Results:More than 70 per cent of students had good knowledge of COVID-19 symptoms, mode of transmission and preventive measures, and 66 per cent knew about treatment approaches. Social media (83%) and TV (77%) were their primary sources of information. Most students showed a willingness to follow social distancing and lockdown guidelines; however, only 27 per cent perceived the risk of infection. Nearly all students reported compliance with government health advisories.Conclusions:We evaluated COVID-19 awareness and impacts of various information sources on effective outbreak containment. Improved community engagement activities and effective communication are needed during widespread disease outbreaks.
C1 [Singh, Jagajeet Prasad; Sewda, Anshuman; Gupta, Shiv Dutt] IIHMR Univ, Jaipur, Rajasthan, India.
RP Singh, JP (corresponding author), IIHMR Univ, Inst Hlth Management Res, 1 Prabhu Dayal Marg, Jaipur 302029, Rajasthan, India.
EM jpsingh@iihmr.edu.in
RI Sewda, Anshuman/ABH-6847-2020; SINGH, JAGAJEET PRASAD/AAZ-7173-2021;
   GUPTA, SHIV DUTT/AAX-8923-2021
OI Sewda, Anshuman/0000-0002-2272-5382; SINGH, JAGAJEET
   PRASAD/0000-0003-0648-490X; GUPTA, SHIV DUTT/0000-0002-8641-3724
CR Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5
   CDC, 2020, SYMPT COR
   CDC, 2020, COR COVID 19 COVID 1
   Center for Disease Control and Prevention, 2020, INT CLIN GUID MAN PA
   Center for Disease Control and Prevention. [CDC], 2020, PROT YOURS OTH
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Diwanji S., 2020, DIGITAL POPULATION I
   Diwanji S., 2020, DISTRIBUTION INTERNE
   Elsevier, 2020, NOV COR VIR INF CTR
   Peng Y., 2020, BMC PUBLIC HEALTH, V127, P1
   WHO, 2021, STAT 2 M INT HLTH RE
   WHO, 2020, Q COR COVID 19
   WHO, 2020, INF PREV CONTR HLTH
   World Health Organization, 2020, ROLL UPD COR DIS COV
   World Health Organization, 2019, NONPH PUBL HLTH MEAS
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 16
TC 12
Z9 13
U1 0
U2 5
PU SAGE PUBLICATIONS INDIA  PVT LTD
PI NEW DELHI
PA B-1-I-1 MOHAN CO-OPERATIVE INDUSTRIAL AREA, MATHURA RD, POST BAG NO 7,
   NEW DELHI 110 044, INDIA
SN 0972-0634
EI 0973-0729
J9 J HEALTH MANAG
JI J. Health Manag.
PD JUN
PY 2020
VL 22
IS 2
BP 281
EP 290
DI 10.1177/0972063420935669
PG 10
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA MY9HX
UT WOS:000558731500017
OA hybrid
DA 2022-04-20
ER

PT J
AU Wu, JJ
AF Wu, Jiajing
TI Construct a Knowledge Graph for China Coronavirus (COVID-19) Patient
   Information Tracking
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; knowledge graph; Neo4j; CRF; tracking
ID INFECTIOUS-DISEASE SURVEILLANCE; BIG-DATA; SYSTEMS
AB Since first outbreak of respiratory disease in China, the Coronavirus epidemic (COVID-19) spread on a large scale, causing huge losses to individuals, families, communities and society in the country. The conventional research on the transmission process is basically to study the law or trend of the transmission of infectious diseases from a macro perspective. For in-depth study of the critical data of the newly confirmed patients, one effective way to improve the social isolation measures requires the formation of an organized tracking knowledge system for the confirmed patients and the personnel who have been removed, and the deep data mining and application. Knowledge graph (KG) is one of the irreplaceable techniques to quickly gather patient contact information and outbreak event, which reflecting the relationship between knowledge evolution and structure of novel Coronavirus. Therefore, this paper proposes a method for the analysis of COVID-19 epidemic situation using knowledge graph combined with interactive visual analysis. Firstly, based on the key factors of novel Coronavirus disease, the entity model of the patient, the relationship type of the patient and the expression of knowledge modeling were proposed, and the knowledge graph of the action track of the COVID-19 patient was deeply explored and comparative summarized. Secondly, in the process of constructing knowledge graph, conditional random field (CRF) algorithm is used to extract entity and knowledge. Meanwhile, to better analyze the disease relationship between patients, the semantic relationship of knowledge graph was combined with the visualization of knowledge graph, and the semantic model was verified by deep learning calculation and node attribute similarity. To discover the community detection of patients in the patient knowledge graph, this paper uses PageRank combined with Label propagation algorithms to discover community propagation in the network. Finally, COVID-19 epidemic situation was analyzed from confirmed patient data and multi-view collaborative interactions, such as map distribution visualization, knowledge graph visualization, and track visualization. The results show that the construction of a knowledge graph of COVID-19 patient activity is feasible for the transmission process, analysis of key nodes and tracing of activity tracks.
C1 [Wu, Jiajing] Ocean Univ China, Sch Informat Sci & Engn, Qingdao 265100, Peoples R China.
   [Wu, Jiajing] Chifeng Univ, Sch Math & Comp Sci, Chifeng City 024000, Inner Mongolia, Peoples R China.
RP Wu, JJ (corresponding author), Ocean Univ China, Sch Informat Sci & Engn, Qingdao 265100, Peoples R China.; Wu, JJ (corresponding author), Chifeng Univ, Sch Math & Comp Sci, Chifeng City 024000, Inner Mongolia, Peoples R China.
EM wujiajing@stu.ouc.edu.cn
CR Abidi Syed Sibte Raza, 2019, Healthc Manage Forum, V32, P178, DOI 10.1177/0840470419846134
   Bansal S, 2016, J INFECT DIS, V214, pS375, DOI 10.1093/infdis/jiw400
   [蔡强 Cai Qiang], 2018, [中文信息学报, Journal of Chinese Information Processing], V32, P96
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen J, 2017, CCKS 2017 KNOWLEDGE, P165
   Chen X, 2020, J WUHAN U, V45, P816
   Davies Clare, 2013, Spatial Information Theory. 11th International Conference, COSIT 2013. Proceedings: LNCS 8116, P320, DOI 10.1007/978-3-319-01790-7_18
   Dong X, 2017, J PUBLIC HEALTH-UK, V39, P274, DOI 10.1093/pubmed/fdw022
   [段红伟 Duang Hongwei], 2014, [测绘学报, Acta Geodetica et Cartographica Sinica], V43, P193
   Feng J, 2018, 32 AAAI C ART INT NE
   Gur N, 2018, SEMANT WEB, V9, P557, DOI 10.3233/SW-170281
   Houlihan CF, 2019, CLIN MED, V19, P140, DOI 10.7861/clinmedicine.19-2-140
   Jiang X, 2016, P COLING 2016 26 INT
   Jun C, 2019, GEOMAT INF SCI WUHAN, V44, P38
   Kong DJ, 2020, SCIENTOMETRICS, V125, P1983, DOI 10.1007/s11192-020-03696-y
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   [陆锋 Lu Feng], 2017, [地球信息科学学报, Journal of Geo-Information Science], V19, P723
   Ming Z, 2016, J AGR MACHIN, V47, P278
   Pujara J, 2013, LECT NOTES COMPUT SC, V8218, P542, DOI 10.1007/978-3-642-41335-3_34
   Salathe M, 2016, J INFECT DIS, V214, pS399, DOI 10.1093/infdis/jiw281
   Simonsen L, 2016, J INFECT DIS, V214, pS380, DOI 10.1093/infdis/jiw376
   Sun Z, 2018, 12TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS), P297, DOI 10.1145/3240323.3240361
   Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248
   Vo NTK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020093
   Wan JF, 2018, IEEE T IND INFORM, V14, P4548, DOI 10.1109/TII.2018.2818932
   Wang S, 2019, ISPRS INT J GEO-INF, V8, DOI 10.3390/ijgi8040184
   Wang X, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P950, DOI 10.1145/3292500.3330989
   World Health Organization, 2 M INT HLTH REG EM
   Wozniak M, 2014, INFORM FUSION, V16, P3, DOI 10.1016/j.inffus.2013.04.006
   [余丽 Yu Li], 2016, [测绘学报, Acta Geodetica et Cartographica Sinica], V45, P616
   Zeng D, 2014, RELATION CLASSIFICAT
   Zeng DJ., 2015, P 2015 C EMP METH NA, P1753, DOI DOI 10.18653/V1/D15-1203
   Zhou P, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2016), VOL 2, P207, DOI 10.18653/v1/p16-2034
NR 33
TC 1
Z9 1
U1 4
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 4321
EP 4337
DI 10.2147/RMHP.S309732
PG 17
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZT4YK
UT WOS:000769163100001
PM 34707418
DA 2022-04-20
ER

PT C
AU Rezaei, E
   Ghoreyshi, K
   Sadique, KM
AF Rezaei, Elham
   Ghoreyshi, Kajal
   Sadique, Kazi Masum
BE Abraham, A
   Madureira, AM
   Kaklauskas, A
   Gandhi, N
   Bajaj, A
   Muda, AK
   Kriksciuniene, D
   Ferreira, JC
TI Data Science for COVID-19 Vaccination Management
SO INNOVATIONS IN BIO-INSPIRED COMPUTING AND APPLICATIONS, IBICA 2021
SE Lecture Notes in Networks and Systems
LA English
DT Proceedings Paper
CT 12th International Conference on Innovations in Bio-Inspired Computing
   and Applications (IBICA) / 11th World Congress on Information and
   Communication Technologies (WICT)
CY DEC 16-18, 2021
CL ELECTR NETWORK
DE Data science; COVID-19; Supply chain management; Vaccination; Patient
   data
AB Medicine and health are essential sectors in industrial societies. Extracting knowledge from the vast amount of data related to disease records and medical records of individuals using the data mining process can identify the laws governing the creation, growth, and spread of disease and provide valuable information to identify the causes of disease. To diagnose, predict and treat diseases according to the prevailing environmental factors to provide health professionals and practitioners. The result of this issue is to increase life expectancy and create peace for the people of the society. With the spread of the COVID-19 virus in recent months worldwide, various organizations are working to find ways to combat the virus. By using data mining technology, intelligent systems can be developed that can automatically understand and interpret the medical characteristics of individuals and extract useful information that can play an effective role in the process of vaccine supply chain management. In this article, we have proposed a solution for the efficient COVID-19 vaccination management.
C1 [Rezaei, Elham; Ghoreyshi, Kajal] Linnaeus Univ, Fac Technol, Dept Informat, Kalmar, Sweden.
   [Sadique, Kazi Masum] Stockholm Univ SU, Dept Comp & Syst Sci DSV, Stockholm, Sweden.
RP Sadique, KM (corresponding author), Stockholm Univ SU, Dept Comp & Syst Sci DSV, Stockholm, Sweden.
EM er222rv@student.lnu.se; kg222jf@student.lnu.se; sadique@dsv.su.se
OI Sadique, Kazi Masum/0000-0002-9423-6270
CR Chapman P, 2000, CRISP DM 1 0 STEP BY, V9, P13
   Ladu M, 2020, J URBAN PLAN DEV, V146, DOI 10.1061/(ASCE)UP.1943-5444.0000622
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Piret J, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.631736
   Shankar S., CHALLENGES EQUITABLE
   Sharda R., 2014, BUSINESS INTELLIGENC
   Wallentin G, 2020, INT J HEALTH POLICY, V9, P508, DOI 10.34172/ijhpm.2020.130
   Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2367-3370
EI 2367-3389
BN 978-3-030-96299-9; 978-3-030-96298-2
J9 LECT NOTE NETW SYST
PY 2022
VL 419
BP 852
EP 861
DI 10.1007/978-3-030-96299-9_80
PG 10
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS8NX
UT WOS:000773951800080
DA 2022-04-20
ER

PT J
AU Pongsakornrungsilp, S
   Pongsakornrungsilp, P
   Kumar, V
   Maswongssa, B
AF Pongsakornrungsilp, Siwarit
   Pongsakornrungsilp, Pimlapas
   Kumar, Vikas
   Maswongssa, Bhuritt
TI The Art of Survival: Tourism Businesses in Thailand Recovering from
   COVID-19 through Brand Management
SO SUSTAINABILITY
LA English
DT Article
DE crisis management; COVID-19; brand management; Thailand; tourism
   business; recovery
ID CRISIS MANAGEMENT; CORPORATE BRAND; CORONAVIRUS; FRAMEWORK; INDUSTRY;
   TRAVEL; MODEL; TIMES; PERCEPTION; KNOWLEDGE
AB The purpose of this study is to employ the existing theory on crisis management and corporate branding in a service context to explore how tourism businesses in Thailand can recover from the crisis caused by the impact of COVID-19. To manage the impact of COVID-19, the concepts of crisis management from different scholars are integrated, and crisis management is divided into three phases: the Pre-Crisis, Crisis, and Post-Crisis phases. This exploratory research employs stakeholder interviews to discover the impacts of COVID-19 on tourism businesses and attempts to develop guidelines for recovering tourism businesses within the service context. Our findings indicate that a strong brand and its proper management can help firms to survive during the crisis period. Moreover, our findings highlight the importance of communication for engaging with all staff during the recovery period. This paper sheds light on how a brand is employed as a proactive strategy to mitigate the impacts of the crisis. Most brands have been affected by the COVID-19 pandemic, and only strong brands are able to survive. Our study also adds to the limited empirical evidence on tourism business recovery during COVID-19 in the context of a developing country. From practitioners' perspectives, trust, solid relationships, and honest communication with their business partners play an important role in survival after the crisis. Additionally, in this paper, corporate branding is conceived as a strategic tool that affects how staff and stakeholders can collaborate and unite in response to the crisis.
C1 [Pongsakornrungsilp, Siwarit] Walailak Univ, Sch Management, Dept Business Adm, Nakhon Si Thammarat 80160, Thailand.
   [Pongsakornrungsilp, Pimlapas] Walailak Univ, Dept Tourism & Hospitality Ind, Sch Management, Nakhon Si Thammarat 80160, Thailand.
   [Kumar, Vikas] Univ West England, Bristol Business Sch, Bristol BS16 1QY, Avon, England.
   [Maswongssa, Bhuritt] Patong Resort, Phuket 83150, Thailand.
RP Pongsakornrungsilp, P (corresponding author), Walailak Univ, Dept Tourism & Hospitality Ind, Sch Management, Nakhon Si Thammarat 80160, Thailand.
EM psiwarit@wu.ac.th; kpimlapa@wu.ac.th; vikas.kumar@uwe.ac.uk;
   bhuritt@patongresorthotel.com
RI Kumar, Vikas/E-3272-2018
OI Kumar, Vikas/0000-0002-8062-7123
FU Center of Excellence for Tourism Business Management and Creative
   Economy
FX This research was partially funded by the Center of Excellence for
   Tourism Business Management and Creative Economy.
CR Alonso AD, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102654
   Amujo OC, 2012, TOURIST STUD, V12, P87, DOI 10.1177/1468797612444196
   Attride-Sterling J., 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307
   Balakrishnan MS, 2011, MANAG RES REV, V34, P1309, DOI 10.1108/01409171111186423
   Balmer JMT, 2016, J BRAND MANAG, V23, P8, DOI 10.1057/bm.2015.45
   Balmer JMT, 2013, J BRAND MANAG, V20, P723, DOI 10.1057/bm.2013.15
   Chemli S, 2022, CURR ISSUES TOUR, V25, P179, DOI 10.1080/13683500.2020.1846502
   Chen C.W, 2017, J TOUR HOSP, V6, P1
   Darling J.R., 1994, LEADERSHIP ORG DEV J, V15, P3, DOI DOI 10.1108/01437739410073047
   David G., 2011, J MEDIA RES, V2, P72
   Department of Tourism, THAIL TOUR STAT
   Evans N., 2005, International Journal of Tourism Research, V7, P135, DOI 10.1002/jtr.527
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Fink S, 1986, CRISIS MANAGEMENT
   Fournier S, 1998, J CONSUM RES, V24, P343, DOI 10.1086/209515
   Gaur SS, 2019, J SERV THEOR PRACT, V29, P592, DOI 10.1108/JSTP-12-2018-0295
   Han H, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208639
   Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636
   Hatch M.J., 2003, EUR J MARKETING, V37, P1041, DOI DOI 10.1108/03090560310477654
   Hegner SM, 2014, J BRAND MANAG, V21, P429, DOI 10.1057/bm.2014.12
   Heide, 2015, INT J STRATEGIC COMM, V9, P134, DOI [DOI 10.1080/1553118X.2015.1008636, 10.1080/1553118X.2015.1008636]
   Henderson J. C., 2003, Journal of Vacation Marketing, V10, P67, DOI 10.1177/135676670301000107
   Hiemstra S., 2002, Journal of Travel & Tourism Marketing, V13, P43
   Holt DB, 2004, BRANDS BECOME ICONS
   Huang L, 2006, TOURISM MANAGE, V27, P1308, DOI 10.1016/j.tourman.2005.06.005
   Huang L, 2013, CURR ISSUES TOUR, V16, P313, DOI 10.1080/13683500.2012.690370
   Iglesias O, 2020, IND MARKET MANAG, V85, P32, DOI 10.1016/j.indmarman.2019.09.008
   Jamal T, 2020, J TOUR FUTURES, V6, P181, DOI 10.1108/JTF-02-2020-0014
   Kapferer J- N, 2008, NEW STRATEGIC BRAND
   Kim D.H, 2017, J PROMT MANAG, V24, P1, DOI [10.1080/10496491.2017.1408526, DOI 10.1080/10496491.2017.1408526]
   Kim SeongSeop [Kim S. S. S.], 2005, Asia Pacific Journal of Tourism Research, V10, P369, DOI 10.1080/10941660500363694
   Koporcic N, 2018, IMP J, V12, P392, DOI 10.1108/IMP-05-2017-0026
   Kotler P., 2016, MARK MANAG
   Kulatunga, 2016, P 32 ANN ARCOM C ARC
   Lawrence B, 2019, IND MARKET MANAG, V83, P148, DOI 10.1016/j.indmarman.2018.09.003
   Laws E., 2005, Journal of Travel & Tourism Marketing, V19, P1, DOI 10.1300/J073v19n02_01
   Lee KH, 2016, J TRAVEL TOUR MARK, V33, P613, DOI 10.1080/10548408.2016.1167349
   Liu BJ, 2016, TOURISM MANAGE, V55, P310, DOI 10.1016/j.tourman.2016.02.021
   Mao CK, 2010, TOURISM MANAGE, V31, P855, DOI 10.1016/j.tourman.2009.09.003
   Mazzei A., 2012, INT J STRATEGIC COMM, V6, P31
   Meller M., 2008, P 4 INT C ENT OD TOU, P815
   Mulder N, 2020, LCTS2020147 EC COMM
   Olive JL, 2014, FORUM QUALITATIVE SO, V15
   Pedeliento G, 2017, J SERV THEOR PRACT, V27, P1081, DOI 10.1108/JSTP-10-2016-0185
   Pforr C., 2007, Journal of Travel & Tourism Marketing, V23, P249
   Pine R., 2004, International Journal of Contemporary Hospitality Management, V16, P139, DOI 10.1108/09596110410520034
   Radic A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176968
   Riley C., AIRLINES FACE 113 BI
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Rittichainuwat BN, 2013, TOURISM MANAGE, V34, P112, DOI 10.1016/j.tourman.2012.03.018
   Roberts V., 1994, DISASTER PREVENTION, V3, P44, DOI [10.1108/09653569410053932, DOI 10.1108/09653569410053932]
   Rodriguez-Anton JM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208599
   Rogerson J. M., 2021, GeoJournal of Tourism and Geosites, V35, P338, DOI 10.30892/gtg.35211-657
   Schroeder JE, 2009, MARKETING THEOR, V9, P123, DOI 10.1177/1470593108100067
   Sharma A, 2020, ANN TOURISM RES, V83, DOI 10.1016/j.annals.2020.102990
   Shen L, 2019, J BUS RES, V95, P103, DOI 10.1016/j.jbusres.2018.10.007
   Smith C., 2004, RES PRACTICE HUMAN R, V12, P90
   Soemodinoto A, 2001, ANN TOURISM RES, V28, P1056, DOI 10.1016/S0160-7383(01)00011-1
   Sreejesh S, 2018, J SERV THEOR PRACT, V28, P130, DOI 10.1108/JSTP-11-2016-0207
   Stafford G., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P27, DOI 10.1016/S0010-8804(02)80054-4
   Tan A. Y. F., 2002, Journal of Travel & Tourism Marketing, V13, P63
   Thompson CJ, 1997, J MARKETING RES, V34, P438, DOI 10.2307/3151963
   Toanoglou M, 2022, J ORGAN CHANGE MANAG, V35, P293, DOI 10.1108/JOCM-12-2020-0369
   Tse Alan C B, 2006, Int J Hosp Manag, V25, P3, DOI 10.1016/j.ijhm.2004.12.001
   Tuzunkan D., 2018, GeoJournal of Tourism and Geosites, V22, P329, DOI 10.30892/gtg.22204-291
   Urde M., 2003, EUR J MARKETING, V7/8, P1017, DOI DOI 10.1108/03090560310477645
   Wang F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135454
   Wang WT, 2009, IND MANAGE DATA SYST, V109, P445, DOI 10.1108/02635570910948605
   Wei H., 2015, AM J IND BUSINESMA, V6, P89, DOI [10.4236/ajibm.2016.62008, DOI 10.4236/AJIBM.2016.62008]
   Young E, ATLANTIC
   Yu M, 2020, CURR ISSUES TOUR, DOI 10.1080/13683500.2020.1733497
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
NR 72
TC 4
Z9 4
U1 24
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JUN
PY 2021
VL 13
IS 12
AR 6690
DI 10.3390/su13126690
PG 17
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA TA0AD
UT WOS:000666917300001
OA gold
DA 2022-04-20
ER

PT J
AU Semerci, R
   Kudubes, AA
   Esref, FC
AF Semerci, Remziye
   Kudubes, Asli Akdeniz
   Esref, Ferhan Cetin
TI Assessment of Turkish oncology nurses' knowledge regarding COVID-19
   during the current outbreak in Turkey
SO SUPPORTIVE CARE IN CANCER
LA English
DT Article
DE Oncology nursing; Cancer; COVID-19; Coronavirus; Knowledge
ID CANCER
AB Purpose To assess Turkish oncology nurses' knowledge regarding novel coronavirus (COVID-19) during the current outbreak in Turkey. Methods This descriptive study was carried out with the 185 oncology nurses between April and May 2020 in Turkey. Research data were collected through online survey using "Nurse Information Form" and "Nurse Information Scale for COVID-19." Multilinear regression analysis was used in determining the factors affecting oncology nurses' information regarding COVID-19. Results According to the data delivered from 185 oncology nurses, 57.7% of the participants had an undergraduate degree, 74.1% were working in adult oncology units, and 52.4% of them were working as clinical nurses, 48.1% of the nurses received education for COVID-19 (51.9% did not receive) and 70.3% followed and read the COVID-19 Guidelines published by the Ministry of Health (29.7% did not follow guidelines). Using multiple regression analysis, a model based on the relationship between the variables was created. In the model, the descriptive characteristics of the oncology nurses and their experiences of COVID-19 were found to explain 29.1% of their knowledge level for COVID-19. Nurses' education level, the presence of a relative diagnosed with COVID-19, and following the COVID-19 guidelines were found to statistically significantly affect the knowledge levels of COVID-19. Conclusion These findings suggest that hospital management and the Ministry of Health should provide more information for the oncology nurses to better control of cancer patients from the infectious disease.
C1 [Semerci, Remziye] Trakya Univ, Fac Hlth Sci, Dept Nursing, TR-22030 Edirne, Turkey.
   [Kudubes, Asli Akdeniz] Dokuz Eylul Univ, Fac Nursing, TR-35340 Izmir, Turkey.
   [Esref, Ferhan Cetin] Hacettepe Univ, Oncol Hosp, Ankara, Turkey.
RP Semerci, R (corresponding author), Trakya Univ, Fac Hlth Sci, Dept Nursing, TR-22030 Edirne, Turkey.
EM remziyesemerci@gmail.com; asliakdeniz@hotmail.com;
   ferhan.cetin@hacettepe.edu.tr
RI Ertan, Asli/AAE-6201-2021; KUDUBEŞ, ASLI AKDENİZ/P-8119-2019
OI KUDUBEŞ, ASLI AKDENİZ/0000-0002-0911-8182
CR Al-Mohaissen M, 2017, E MEDITERR HEALTH J, V23, P351, DOI 10.26719/2017.23.5.351
   Cannizzaro R, 2020, DIGEST LIVER DIS, V52, P595, DOI 10.1016/j.dld.2020.03.030
   Capik C, 2018, FLORENCE NIGHTINGALE, V26, P199, DOI 10.26650/FNJN397481
   Chen SC, 2020, J NURS RES, V28, DOI 10.1097/NRJ.0000000000000389
   Chen XJ, 2020, LANCET INFECT DIS, V20, P397, DOI 10.1016/S1473-3099(20)30110-9
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072
   Esin MN, 2015, HEMIRELIKTE ARATRMA, P193
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Huh S, 2020, J EDUC EVAL HEALTH P, V17, DOI 10.3352/jeehp.2020.17.10
   Jackson D, 2020, J CLIN NURS, V29, P2041, DOI 10.1111/jocn.15257
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Mei H, 2020, LANCET ONCOL, V21, P634, DOI 10.1016/S1470-2045(20)30238-2
   Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Paterson C, 2020, SEMIN ONCOL NURS, V36, DOI 10.1016/j.soncn.2020.151028
   Pramesh CS, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2011595
   Saglik T.C., 2020, COVID 19 SARS COV 2
   Tingbo L., 2020, HDB COVID 19 PREVENT
   Turkey Ministry of Health, 2020, COR DIS 2019
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   World Health Organisation, 2020, HLTH WORKF
   World Health Organisation, 2020, COR DIS COVID 19 OUT
   World Health Organisation, 2020, 88 WHO
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xie JF, 2020, INTENS CARE MED, V46, P837, DOI 10.1007/s00134-020-05979-7
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 26
TC 1
Z9 1
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0941-4355
EI 1433-7339
J9 SUPPORT CARE CANCER
JI Support. Care Cancer
PD APR
PY 2021
VL 29
IS 4
BP 1999
EP 2006
DI 10.1007/s00520-020-05700-w
EA AUG 2020
PG 8
WC Oncology; Health Care Sciences & Services; Rehabilitation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Health Care Sciences & Services; Rehabilitation
GA QJ1HC
UT WOS:000561718900001
PM 32829464
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Thomson, M
   Martin, A
   Long, E
   Logue, J
   Simpson, SA
AF Thomson, Meigan
   Martin, Anne
   Long, Emily
   Logue, Jennifer
   Simpson, Sharon A.
TI A qualitative exploration of weight management during COVID-19
SO CLINICAL OBESITY
LA English
DT Article; Early Access
DE barriers; behaviour change; COVID-19; facilitators; weight loss; weight
   management
ID PROTECTION MOTIVATION; METAANALYSIS; INTERVIEWS; TELEPHONE; SUPPORT;
   IMPACT
AB COVID-19 has been associated with worse outcomes in people living with obesity and has altered how people can engage with weight management. However, the impact of risk perceptions and changes to daily life on weight loss has not been explored. This study aimed to examine how COVID-19 and perception of risk interacted with weight loss attempts in adults participating in a behavioural weight management programme. Forty-eight participants completed a semi-structured interview exploring the impact of COVID-19 on their weight management experience. Interviews were completed via telephone and analysed using a thematic approach. Reaction to perceived risk varied, but most participants reported the knowledge of increased risk promoted anxiety and avoidance behaviours. Despite this, many reported it as a motivating factor for weight loss. Restrictions both helped (e.g., reduced temptation) and hindered their weight loss (e.g., less support). However, there was consensus that the changes to everyday life meant participants had more time to engage with and take control of their weight loss. To the authors' knowledge, this is the first study to explore the impact of COVID-19 on participation in a weight management programme started during the pandemic in the United Kingdom. Restrictions had varying impacts on participant's weight loss. How risk is perceived and reported to participants is an important factor influencing engagement with weight management. The framing of health information needs to be considered carefully to encourage engagement with weight management to mitigate risk. Additionally, the impact of restrictions and personal well-being are key considerations for weight management programmes.
C1 [Thomson, Meigan; Martin, Anne; Long, Emily] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Berkeley Sq,99 Berkeley St, Glasgow G3 7HR, Lanark, Scotland.
   [Logue, Jennifer; Simpson, Sharon A.] Univ Lancaster, Lancaster Med Sch, Lancaster, Scotland.
RP Thomson, M (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Berkeley Sq,99 Berkeley St, Glasgow G3 7HR, Lanark, Scotland.
EM m.thomson.3@research.gla.ac.uk
OI Thomson, Meigan/0000-0002-2171-9159; Logue, Jennifer/0000-0001-9549-2738
FU MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC)
   [MC_ST_U18004]; UK Medical Research Council and Scottish Chief Scientist
   Office core funding as part of the MRC/CSO Social and Public Health
   Sciences Unit 'Complexity in Health Improvement' programme
   [MC_UU_12017/14, MC_UU_00022/1, SPHSU14, SPHSU16]; MRC Skills
   Development Fellowship Award [MR/S015078/1]
FX This research is funded as part of an MRC PhD studentship
   (MC_ST_U18004). AM and SS were supported by UK Medical Research Council
   and Scottish Chief Scientist Office core funding as part of the MRC/CSO
   Social and Public Health Sciences Unit `Complexity in Health
   Improvement' programme (MC_UU_12017/14, MC_UU_00022/1 and SPHSU14,
   SPHSU16). EL was supported by MRC Skills Development Fellowship Award
   (MR/S015078/1).
CR [Anonymous], GUARDIAN
   Avery A, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11143-7
   Baker C., 2019, HOUSE COMMONS LIB OB
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Bristow C, 2020, HEALTH PROMOT INT, V35, P1551, DOI 10.1093/heapro/daaa018
   Brown A, 2021, ECLINICALMEDICINE, V34, DOI 10.1016/j.eclinm.2021.100796
   Butland B, 2007, FORESIGHT TACKLING O
   Cecchetto C, 2021, APPETITE, V160, DOI 10.1016/j.appet.2021.105122
   Cheval B, 2021, J SPORT SCI, V39, P699, DOI 10.1080/02640414.2020.1841396
   Dombrowski SU, 2012, HEALTH PSYCHOL REV, V6, P7, DOI 10.1080/17437199.2010.513298
   Estlin AFL, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14646
   Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x
   Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017
   Gill TP, 2012, CURR OBES REP, V1, DOI 10.1007/s13679-011-0003-6
   Grannell A, 2020, CLIN OBES, V10, DOI 10.1111/cob.12406
   Hamer M, 2020, P NATL ACAD SCI USA, V117, P21011, DOI 10.1073/pnas.2011086117
   Hayes JF, 2021, ANN BEHAV MED, V55, P14, DOI 10.1093/abm/kaaa021
   Holt A, 2010, QUAL RES, V10, P113, DOI 10.1177/1468794109348686
   Johnson DR, 2021, SOC SCI COMPUT REV, V39, P1142, DOI 10.1177/0894439319893612
   Karfopoulou E, 2016, J BEHAV MED, V39, P511, DOI 10.1007/s10865-016-9717-y
   Knittle K, 2020, NAT HUM BEHAV, V4, P215, DOI 10.1038/s41562-019-0798-9
   Kumanyika SK, 2009, ARCH INTERN MED, V169, P1795, DOI 10.1001/archinternmed.2009.337
   Lewis S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-309
   MADDUX JE, 1983, J EXP SOC PSYCHOL, V19, P469, DOI 10.1016/0022-1031(83)90023-9
   Mehanna O, 2021, DIABET METAB SYND OB, V14, P409, DOI 10.2147/DMSO.S287779
   Pezalla AE, 2012, QUAL RES, V12, P165, DOI 10.1177/1468794111422107
   Public Health England, 2020, SUPP WEIGHT MAN SERV
   Public Health England, 2020, EXC WEIGHT COVID 19
   QSR International Pty Ltd, 2018, NVIVO VERS 12
   Robinson E, 2021, APPETITE, V156, DOI 10.1016/j.appet.2020.104853
   Scottish Government, 2020, OB FOOD INS, V1
   Sebire SJ, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5114-5
   Senthilingam M, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n411
   Stead M., 2019, PUBLIC HLTH RES, DOI [10.3310/phr07080, DOI 10.3310/PHR07080, 10.34133/2019/7109535]
   Tan M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2237
   Taylor JK, 2021, OPEN HEART, V8, DOI 10.1136/openhrt-2021-001600
   Thomson M, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01427-1
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   Ward K, 2015, J ADV NURS, V71, P2775, DOI 10.1111/jan.12748
   Yang J, 2021, J MED VIROL, V93, P257, DOI 10.1002/jmv.26237
   Youngs W, 2016, PRACT DIABETES, V33, P171, DOI 10.1002/pdi.2030
   Zhang X., 2021, ENVIRON CHEM LETT, V1, P1
NR 42
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1758-8103
EI 1758-8111
J9 CLIN OBES
JI Clin. Obes.
AR e12512
DI 10.1111/cob.12512
EA FEB 2022
PG 10
WC Endocrinology & Metabolism
WE Emerging Sources Citation Index (ESCI)
SC Endocrinology & Metabolism
GA ZF1QA
UT WOS:000759347300001
PM 35194943
OA hybrid, Green Accepted
DA 2022-04-20
ER

PT J
AU Emara, HE
   Alhindi, AA
   Orebi, HA
   Kabbash, IA
   Elghazally, NM
AF Emara, Hesham Elsayed
   Alhindi, Abdallah Ahmoud
   Orebi, Hisham Ahmed
   Kabbash, Ibrahim Ali
   Elghazally, Noha M.
TI COVID-19 Pandemic: Knowledge, Attitude, and Perception of Medical
   Students Toward the Novel Coronavirus Disease
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article; Early Access
DE COVID-19; knowledge; medical students; attitude; prevention
ID EPIDEMIC
AB Background: Medical students are vulnerable to infection by the coronavirus. Their awareness of the disease is crucial for their safety and for the management of the epidemic by spreading supportive information in their communities. The aim of this study was to assess coronavirus disease 2019 (COVID-19)-related knowledge, attitude, and preventive practices among Egyptian medical students. Methods: We conducted a cross-sectional study from the beginning of April to June 2020; a total of 439 undergraduate medical students (1st to 6th academic years) were assessed using an online questionnaire. The questionnaire consisted of 33 questions, including 5 items regarding socio-demographic features, 23 items concerning COVID-19 related knowledge, 2 items regarding attitude, and 3 items related to preventive measures. Results: We observed an acceptable level of knowledge (74.3%) among the sample studied. Preclinical and female students were significantly more optimistic as 69.1% expected successful control of COVID-19, and 48.9% predicted that Egypt will win the fight against COVID-19. The majority of participants reported wearing a facemask in public places as a preventive measure (56.7%). Conclusions: Egyptian medical students had an acceptable level of knowledge, positive attitude, and good practices of preventive measures regarding the COVID-19 virus. There is no significant difference in almost all items of knowledge, attitude, and practices in relation to gender or academic grade.
C1 [Emara, Hesham Elsayed; Alhindi, Abdallah Ahmoud; Orebi, Hisham Ahmed] Univ Tanta, Fac Med, Tanta, Egypt.
   [Kabbash, Ibrahim Ali; Elghazally, Noha M.] Univ Tanta, Fac Med, Publ Hlth & Community Med, Tanta, Egypt.
RP Elghazally, NM (corresponding author), Univ Tanta, Fac Med, Publ Hlth & Community Med, Tanta, Egypt.
EM nohaelghazally1@gmail.com
CR Abbas AM., AJBSR MS ID 001408, DOI [10.34297/AJBSR.2020.09.001408, DOI 10.34297/AJBSR.2020.09.001408]
   Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   [Anonymous], EGYPT TODAY
   Caliskan F, 2020, POSTGRAD MED, V132, P764, DOI 10.1080/00325481.2020.1795486
   Egyptian Ministry of Health Population, EG HLTH DAIL STAT RE
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Gao ZY, 2020, J INFECT PUBLIC HEAL, V13, P1419, DOI 10.1016/j.jiph.2020.06.031
   Hymowitz MB, 2006, ARCH DERMATOL, V142, P523, DOI 10.1001/archderm.142.4.523
   Jairoun A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6878-y
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Lemeshow S, 1990, WHO ADEQUACY SAMPLE
   Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281
   Plaster AN, 2018, J COMMUN HEALTH, V43, P647, DOI 10.1007/s10900-017-0463-z
   Prilutskaya M. V., 2020, Ekologiya Cheloveka / Human Ecology, P4, DOI 10.33396/1728-0869-2020-6-4-12
   Reliefweb: Johns Hopki University, COR COVID 19 GLOB CA
   Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988
   Starr I, 2006, ANN INTERN MED, V145, P138, DOI 10.7326/0003-4819-145-2-200607180-00132
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   The World Health Organization, 2020, 2019 NCOV OUTBR IS E
   West JB, 2005, J APPL PHYSIOL, V99, P424, DOI 10.1152/japplphysiol.00184.2005
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 21
TC 0
Z9 0
U1 2
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
AR PII S1935789321001695
DI 10.1017/dmp.2021.169
EA JUN 2021
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZB8JL
UT WOS:000757081800001
PM 34096491
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Datoussaid, A
   Hamadi, A
   Ezzine, A
AF Datoussaid, Aimad
   Hamadi, Abdelkader
   Ezzine, Abdelmadjid
TI Indigenous Tacit Knowledge of Traditional Medicine Against COVID-19 in
   Algeria
SO JOURNAL OF MANAGEMENT SPIRITUALITY & RELIGION
LA English
DT Article
DE COVID-19; Islam; traditional medicine; indigenous tacit knowledge;
   survival analysis
ID CORONAVIRUS DISEASE 2019; NORTH JEOLLA PROVINCE; CHINESE MEDICINE;
   ETHNOBOTANICAL SURVEY; SPIRITUAL DIMENSION; HERBAL MEDICINE; PLANTS;
   DISCOVERY; HEALERS; EXPERIENCE
AB This research aims mainly to emphasize the contribution of indigenous tacit Knowledge of traditional medicine to treat COVID-19 symptoms in a traditional and Islamic context in Algeria. In order to do so, we proceed as follows. First of all, to find out whether traditional treatment delays the death of people affected by COVID-19, a survival analysis was carried out among a sample of 74 hospitalized patients at the University Hospital Center in a region located to the west of Algeria. Subsequently, interviews with 185 traditional healers from the same region were held to identify the plants on which these patients relied. Three main results emerge from our study: first, the use of traditional treatment helped prolong the survival of people with COVID-19. Second, we were able to identify 11 medicinal plants. Third, Healers over 80 who had acquired tacit knowledge knew more medicinal plants compared to other age groups.
C1 [Datoussaid, Aimad] Univ Djillali Lyabes, Lab Innovat Management & Mkt, Dept Business Sci, Maghtech Network, Sidi Bel Abbes, Algeria.
   [Hamadi, Abdelkader] Univ Lille, Lab ILIS, Lille, France.
   [Ezzine, Abdelmadjid] Univ Djillali Lyabes, Dept Business Sci, Sidi Bel Abbes, Algeria.
RP Datoussaid, A (corresponding author), Univ Djillali Lyabes, Lab Innovat Management & Mkt, Dept Business Sci, Maghtech Network, Sidi Bel Abbes, Algeria.
EM datou_imad@yahoo.fr
CR Abdelli I, 2021, J BIOMOL STRUCT DYN, V39, P3263, DOI 10.1080/07391102.2020.1763199
   Al-Essa MA, 1998, ANN SAUDI MED, V18, P79, DOI 10.5144/0256-4947.1998.79
   Al-Meshal I.-A., 1987, MED PLANTS SAUDI ARA
   Alqethami A, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0193-4
   Anand AV, 2021, MOLECULES, V26, DOI 10.3390/molecules26061775
   Ancelle T., 2002, STATISTIQUE EPIDEMIO
   ARROW KJ, 1962, REV ECON STUD, V29, P155, DOI 10.2307/2295952
   Cakilcioglu U, 2011, J ETHNOPHARMACOL, V137, P469, DOI 10.1016/j.jep.2011.05.046
   Carlos WG, 2020, AM J RESP CRIT CARE, V201, pP7, DOI 10.1164/rccm.2014P7
   Cavusgil ST, 2003, J BUS IND MARK, V18, P6, DOI 10.1108/08858620310458615
   Cloatre E, 2019, CRIT PUBLIC HEALTH, V29, P424, DOI 10.1080/09581596.2019.1594696
   Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008
   Cui HT, 2020, TRADIT MED RES, V5, P65, DOI [10.12032/TMR20200222165, 10.53388/TMR20200222165]
   Datoussaid A, 2019, INT J KNOWLEDGE MANA, V7, P7
   Dayuan, 2011, 4 INT C INT NETW INT
   Denaro M, 2020, PHYTOTHER RES, V34, P742, DOI 10.1002/ptr.6575
   Desquilbet L, 2021, INTRO ANAL SURVIE
   Deuraseh N., 2006, JISHIM, V5, P2
   Dike IP, 2012, J ETHNOPHARMACOL, V144, P618, DOI 10.1016/j.jep.2012.10.002
   Dusser Lauge, 2017, THESIS U 3 PAUL SABA
   Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005
   Ferdj Y, 2017, CAHIERS CREAD, V33, P104
   FORAY D, 2009, EC CONNAISSANCE
   Gathirwa JW, 2011, J ETHNOPHARMACOL, V134, P434, DOI 10.1016/j.jep.2010.12.043
   Gessler MC, 1995, J ETHNOPHARMACOL, V48, P131, DOI 10.1016/0378-8741(95)01293-M
   Golmard, 2012, AN STATISTIQUE DONNE
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gupta Ranjan, 2005, Curr Drug Discov Technol, V2, P203, DOI 10.2174/157016305775202937
   Hamadi Abdelkader, 2019, [مجلة الباحث, El-Bahith Review, Magallaẗ al-baḥiṯ (Ouargla)], P541, DOI 10.35156/0505-000-019-036
   Hesketh T, 1997, BRIT MED J, V315, P115, DOI 10.1136/bmj.315.7100.115
   Hsiao WLW, 2010, PLANTA MED, V76, P1118, DOI 10.1055/s-0030-1250186
   Jamila F, 2014, J ETHNOPHARMACOL, V154, P76, DOI 10.1016/j.jep.2014.03.016
   Kasote DM, 2017, J ETHNOPHARMACOL, V203, P55, DOI 10.1016/j.jep.2017.03.038
   Katuura E, 2007, AFR J ECOL, V45, P48, DOI 10.1111/j.1365-2028.2007.00737.x
   Khanal Pukar, 2022, J Ayurveda Integr Med, V13, P100374, DOI 10.1016/j.jaim.2020.11.004
   Kim H, 2014, J ETHNOPHARMACOL, V153, P85, DOI 10.1016/j.jep.2013.10.047
   Kim H, 2012, J ALTERN COMPLEM MED, V18, P287, DOI 10.1089/acm.2010.0848
   Kim H, 2011, J MED PLANTS RES, V5, P5730
   Kim S, 2016, J ETHNOPHARMACOL, V178, P82, DOI 10.1016/j.jep.2015.11.045
   Kleinbaum DG, 2010, SURVIVAL ANAL SELF L
   Laestadius S, 1995, REV EUROPEENNE, V6
   Lau TF, 2005, AM J CHINESE MED, V33, P345, DOI 10.1142/S0192415X05002965
   Lemonnier N., 2017, PROG PREV MED, V2, pe0011, DOI [10.1097/pp9.0000000000000011, DOI 10.1097/PP9.0000000000000011]
   Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0
   Li LQ, 2020, J MED VIROL, V92, P1433, DOI 10.1002/jmv.25924
   Li X, 2007, J WORLD INTELLECT PR, V10, P125, DOI 10.1111/j.1747-1796.2007.00317.x
   Liu CX, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7150391
   Lukman S, 2007, COMPUT METH PROG BIO, V88, P283, DOI 10.1016/j.cmpb.2007.09.008
   Maluleka J.-R., 2017, THESIS U S AFRICA
   Ngulube P, 2011, INDILINGA AFRICAN J, V10, P129
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Pan T, 2020, SCAND J GASTROENTERO, V55, P123, DOI 10.1080/00365521.2019.1707275
   Polanyi M., 1967, TACIT DIMENSION
   Poorna RL, 2014, CURR SCI INDIA, V107, P1240
   Pushpanathan K, 2021, ARTIF INTELL REV, V54, P305, DOI 10.1007/s10462-020-09847-0
   Rakoto, 2004, THESIS I NAT POLYT T
   Rassool GH, 2000, J ADV NURS, V32, P1476, DOI 10.1046/j.1365-2648.2000.01614.x
   RATHBONE J, 2005, COCHRANE DB SYST REV
   Ren JL, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104743
   Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722
   ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Semenya SS, 2012, J ETHNOPHARMACOL, V144, P395, DOI 10.1016/j.jep.2012.09.027
   Semenya SS, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-4
   Smith E.A., 2001, J KNOWL MANAG, V5, P311
   Sun Y, 2003, EVOL DEV, V5, P532, DOI 10.1046/j.1525-142X.2003.03058.x
   Tang JL, 2008, LANCET, V372, P1938, DOI 10.1016/S0140-6736(08)61354-9
   Traore MS, 2013, J ETHNOPHARMACOL, V150, P1145, DOI 10.1016/j.jep.2013.10.048
   Trendafilova A, 2021, FOODS, V10, DOI 10.3390/foods10010065
   United Nations organisations, 2020, IMP COVID 19 ELD
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang ZY, 2016, AM J CHINESE MED, V44, P1525, DOI 10.1142/S0192415X16500853
   Weir D., 2004, J MANAGEMENT PHILOS, V1, P224, DOI DOI 10.1080/14766080409518557
   Weir D, 2012, J MANAG SPIRITUAL RE, V9, P67, DOI 10.1080/14766086.2012.641098
   Winter S., 1982, EVOL THEOR, DOI [10.2307/2232409, DOI 10.2307/2232409]
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Yang Y, 2020, INT J BIOL SCI, V16, P1708, DOI 10.7150/ijbs.45538
   Yuan HD, 2016, MOLECULES, V21, DOI 10.3390/molecules21050559
   Zhang, 2020, CHINESE MED CULTURE, V3, P15, DOI [10.4103/CMAC.CMAC_2_20, DOI 10.4103/CMAC.CMAC_2_20]
   Zhang JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102506
   Zhou L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085008
   Zhou XZ, 2010, J BIOMED INFORM, V43, P650, DOI 10.1016/j.jbi.2010.01.002
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 84
TC 0
Z9 0
U1 0
U2 0
PU IMASR-INT ASSOC MANAGEMENT SPIRITUALITY & RELIGION
PI LONDON
PA 262 SHAKESPEARE TOWER, LONDON, ENGLAND
SN 1476-6086
EI 1942-258X
J9 J MANAG SPIRITUAL RE
JI J. Manag. Spiritual. Relig.
PD OCT
PY 2021
VL 18
IS 5
SI SI
BP 444
EP 461
DI 10.51327/WDBD2443
PG 18
WC Religion
WE Emerging Sources Citation Index (ESCI)
SC Religion
GA XR9IQ
UT WOS:000732534400006
DA 2022-04-20
ER

PT J
AU Schleper, MC
   Gold, S
   Trautrims, A
   Baldock, D
AF Schleper, Martin C.
   Gold, Stefan
   Trautrims, Alexander
   Baldock, Duncan
TI Pandemic-induced knowledge gaps in operations and supply chain
   management: COVID-19's impacts on retailing
SO INTERNATIONAL JOURNAL OF OPERATIONS & PRODUCTION MANAGEMENT
LA English
DT Article
DE COVID-19 pandemic; Operations management; Research agenda;
   Research-practice gap; Retailing; Supply chain management
ID DECISION
AB Purpose This Impact Pathways paper aims to provide a timely and structured discussion of real-world problems at Marks and Spencer and in retail in general, evoked through the current COVID-19 pandemic. Design/methodology/approach The article presents collaborative research based on more than five hours of interviews and several iterative paper writing steps between management scholars and Marks & Spencer's Head of Procurement - Logistics and Supply Chain. Continuous discussions for more than ten months among the research team assure the timeliness and relevance of the findings. The exceptional position of the executive and his career biography allowed the integration of a variety of intra-organisational and inter-organisational stakeholders. Findings This paper highlights the impacts of the current COVID-19 pandemic on operations and supply chain management (OSCM) in the retail industry, structured in upstream, internal and operational, and downstream and customer perspectives. The paper concludes with a practice-infused research agenda, which aims to trigger relevant research about the current and potential future crises. Research limitations/implications Although the research agenda is directly related to the COVID-19 pandemic and the retail industry, the future research pathways are expected to inform business responses to potential future external shocks other than pandemics and in different industries as well. Originality/value Despite a plethora of studies already published on COVID-19 and OSCM, little is known on how the outbreak affects specific firms and industries. This paper offers an overview of COVID-19 related change as it happens at the retailer and in the retailing industry in general. This article is among the first to provide a practice-infused call for research on urgent issues being faced by business leaders directly relevant to our domain.
C1 [Schleper, Martin C.] Univ Sussex, Sch Business, Brighton, E Sussex, England.
   [Gold, Stefan] Univ Kassel, Fac Econ & Management, Kassel, Germany.
   [Trautrims, Alexander] Nottingham Univ Business Sch, Operat Management & Informat Syst, Nottingham, England.
   [Baldock, Duncan] Marks & Spencer, London, England.
RP Trautrims, A (corresponding author), Nottingham Univ Business Sch, Operat Management & Informat Syst, Nottingham, England.
EM m.c.schleper@sussex.ac.uk; gold@uni-kassel.de;
   alexander.trautrims@nottingham.ac.uk;
   Duncan.Baldock@marks-and-spencer.com
RI ; Trautrims, Alexander/B-6896-2013
OI Gold, Stefan/0000-0001-9945-742X; Schleper, Martin
   C./0000-0003-0532-3397; Trautrims, Alexander/0000-0001-8428-3682
FU Economic and Social Research CouncilUK Research & Innovation
   (UKRI)Economic & Social Research Council (ESRC) [ES/T501992/1]
FX This work was supported by the Economic and Social Research Council
   [grant number ES/T501992/1].
CR Arora N., 2020, MCKINSEY CO
   Aslam H, 2018, INT J OPER PROD MAN, V38, P2266, DOI 10.1108/IJOPM-09-2017-0555
   Avishai, 2020, NEW YORKER
   Blackall M., 2020, THE GUARDIAN
   Campo K, 2000, J RETAILING, V76, P219, DOI 10.1016/S0022-4359(00)00026-9
   Cao M, 2011, J OPER MANAG, V29, P163, DOI 10.1016/j.jom.2010.12.008
   Chen IJ, 2004, J OPER MANAG, V22, P119, DOI 10.1016/j.jom.2003.12.007
   Corley KG, 2011, ACAD MANAGE REV, V36, P12, DOI 10.5465/amr.2009.0486
   Durbach IN, 2012, EUR J OPER RES, V223, P1, DOI 10.1016/j.ejor.2012.04.038
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Ellinger AE, 2014, EUR J TRAIN DEV, V38, P118, DOI 10.1108/EJTD-09-2013-0093
   Gerbl M, 2016, INT J OPER PROD MAN, V36, P1037, DOI 10.1108/IJOPM-04-2014-0192
   Geylani T, 2007, MARKET SCI, V26, P164, DOI 10.1287/mksc.1060.0239
   Ghadge A, 2021, INT J PROD RES, V59, P7090, DOI 10.1080/00207543.2020.1834638
   Gunessee S, 2020, INT J OPER PROD MAN, V40, P1201, DOI 10.1108/IJOPM-07-2019-0530
   Handfield RB, 2020, INT J OPER PROD MAN, V40, P1649, DOI 10.1108/IJOPM-03-2020-0171
   Hedwall M., 2020, ONGOING IMPACT COVID
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Lee HL, 1997, MANAGE SCI, V43, P546, DOI 10.1287/mnsc.43.4.546
   Lee HL, 2002, CALIF MANAGE REV, V44, P105, DOI 10.2307/41166135
   Li F, 2020, INT J OPER PROD MAN, V40, P809, DOI 10.1108/IJOPM-04-2020-0202
   Luo YD, 2011, J ACAD MARKET SCI, V39, P307, DOI 10.1007/s11747-010-0198-1
   Martinez-de-Albeniz V, 2019, PROD OPER MANAG, V28, P2087, DOI 10.1111/poms.13026
   Pagell M, 2010, J SUPPLY CHAIN MANAG, V46, P57, DOI 10.1111/j.1745-493X.2009.03186.x
   Petter O, 2020, INDEPENDENT
   Polyviou M, 2019, INT J OPER PROD MAN, V40, P68, DOI 10.1108/IJOPM-09-2017-0530
   Reiner G, 2013, PROD OPER MANAG, V22, P924, DOI 10.1111/poms.12003
   Roggeveen AL, 2020, J RETAILING, V96, P169, DOI 10.1016/j.jretai.2020.04.002
   Rouquet A, 2017, INT J OPER PROD MAN, V37, P321, DOI 10.1108/IJOPM-01-2015-0049
   Rynes SL, 2001, ACAD MANAGE J, V44, P340, DOI 10.2307/3069460
   Sayegh L., 2004, HUM RESOUR MANAG REV, V14, P179, DOI [https://doi.org/10.1016/j.hrmr.2004.05.002, DOI 10.1016/J.HRMR.2004.05.002]
   Schleper MC, 2017, J BUS ETHICS, V140, P97, DOI 10.1007/s10551-015-2681-6
   Schwab L, 2019, INT J PROD ECON, V212, P8, DOI 10.1016/j.ijpe.2018.12.023
   Shapiro DL, 2007, ACAD MANAGE J, V50, P249, DOI 10.2307/20159853
   Sharif AM, 2012, INT J PROD ECON, V140, P57, DOI 10.1016/j.ijpe.2012.01.041
   Taleb N., 2008, BLACK SWAN IMPACT HI
   THART P, 1993, ADMIN SOC, V25, P12, DOI 10.1177/009539979302500102
   Trautrims A, 2020, J RISK RES, V23, P1067, DOI 10.1080/13669877.2020.1772347
   Um KH, 2020, INT J OPER PROD MAN, V40, P415, DOI 10.1108/IJOPM-07-2019-0507
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Visser M, 2007, ACAD MANAGE REV, V32, P659
   Vrechopoulos AP, 2004, J RETAILING, V80, P13, DOI 10.1016/j.jretai.2004.01.006
   Wollenburg J, 2018, INT J PHYS DISTR LOG, V48, P415, DOI 10.1108/IJPDLM-10-2016-0290
NR 43
TC 5
Z9 5
U1 14
U2 30
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0144-3577
EI 1758-6593
J9 INT J OPER PROD MAN
JI Int. J. Oper. Prod. Manage.
PD MAY 6
PY 2021
VL 41
IS 3
BP 193
EP 205
DI 10.1108/IJOPM-12-2020-0837
EA APR 2021
PG 13
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA RZ4YI
UT WOS:000645630300001
OA hybrid, Green Accepted
DA 2022-04-20
ER

PT J
AU Mariano, S
AF Mariano, Stefania
TI Let me help you! Navigating through the COVID-19 crisis with prosocial
   expert knowledge behaviour
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Expert knowledge; organisational knowledge; knowledge management;
   prosocial expert knowledge behaviour; communities; COVID-19
AB Collecting examples from the current COVID-19 crisis, this paper discusses the role of prosocial expert knowledge behaviour that is proposed to produce resourceful heuristic methods such as experimentations, extensions, combinations, and reconversions, under causal and intervening conditions. In turn, these resourceful heuristic methods are proposed to have a positive influence on organisational coping strategies, organisational crisis readiness, and organisational survival. Implications for theory and practice in the context of organisational knowledge literature are discussed, and directions to future research offered.
C1 [Mariano, Stefania] Amer Univ Sharjah, Sch Business Adm, Sharjah, U Arab Emirates.
RP Mariano, S (corresponding author), Amer Univ Sharjah, Sch Business Adm, Sharjah, U Arab Emirates.
EM smariano@aus.edu
RI Mariano, Stefania/AAD-4763-2021
OI Mariano, Stefania/0000-0003-2138-0172
CR Alvesson M, 2001, HUM RELAT, V54, P863, DOI 10.1177/0018726701547004
   Amara N, 2009, SERV IND J, V29, P407, DOI 10.1080/02642060802307847
   Atapattu M, 2018, KNOWL MAN RES PRACT, V16, P356, DOI 10.1080/14778238.2018.1493365
   Blackler F, 1995, ORGAN STUD, V16, P1021, DOI 10.1177/017084069501600605
   Bradley JH, 2006, INFORM MANAGE-AMSTER, V43, P77, DOI 10.1016/j.im.2004.11.009
   Caprara GV, 2012, J PERS SOC PSYCHOL, V102, P1289, DOI 10.1037/a0025626
   Carlo G, 2005, PERS INDIV DIFFER, V38, P1293, DOI 10.1016/j.paid.2004.08.012
   Chong CW, 2009, KNOWL MAN RES PRACT, V7, P142, DOI 10.1057/kmrp.2009.5
   CORBIN JM, 1990, QUAL SOCIOL, V13
   Dul J, 2011, HUM RESOUR MANAGE-US, V50, P715, DOI 10.1002/hrm.20454
   Empson L, 2001, HUM RELAT, V54, P839, DOI 10.1177/0018726701547003
   Fosstenlokken SM, 2003, ORGAN STUD, V24, P859, DOI 10.1177/0170840603024006003
   Garcia A., 2015, IND ORG PSYCHOL, V53, P24
   GEORGE JM, 1992, PSYCHOL BULL, V1122
   Giles D., 2009, MANAGING CRISES
   GWI, 2019, GLOB WEB IND REP
   HE ZL, 2009, INNOVATION, V11
   Heizmann H, 2011, MANAGE LEARN, V42, P379, DOI 10.1177/1350507610394409
   Lund AK, 2019, SCAND J MANAG, V35, DOI 10.1016/j.scaman.2019.101060
   Makani J, 2010, KNOWL MAN RES PRACT, V8, P265, DOI 10.1057/kmrp.2010.13
   Mariano S., 2020, EUR AC MAN C 2020 VI
   Mariano S, 2020, LEARN ORGAN, V27, P185, DOI 10.1108/TLO-12-2019-0182
   Mariano S, 2018, MANAG RES REV, V41, P278, DOI 10.1108/MRR-02-2017-0028
   Martin-Raugh MP, 2016, PERS INDIV DIFFER, V90, P41, DOI 10.1016/j.paid.2015.10.024
   Motowidlo SJ, 2013, J APPL SOC PSYCHOL, V43, P1851, DOI 10.1111/jasp.12137
   Nielsen R.K., 2020, REUTERS I STUDY JOUR
   Paechter C., 1999, LEARNING KNOWLEDGE, P88
   Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141
   Robertson M, 2003, J MANAGE STUD, V40, P831, DOI 10.1111/1467-6486.00362
   Senivongse C, 2020, KNOWL MAN RES PRACT, DOI 10.1080/14778238.2020.1784050
   STARBUCK WH, 1993, J MANAGE STUD, V30, P885, DOI 10.1111/j.1467-6486.1993.tb00471.x
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   von Nordenflycht A, 2010, ACAD MANAGE REV, V35, P155, DOI 10.5465/AMR.2010.45577926
   Webster J, 2002, MIS QUART, V26, pXIII
   Wipawayangkool K, 2019, KNOWL MAN RES PRACT, V17, P70, DOI 10.1080/14778238.2018.1557798
NR 35
TC 2
Z9 2
U1 2
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 484
EP 492
DI 10.1080/14778238.2020.1866445
EA JAN 2021
PG 9
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000605711700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Kim, MY
   Brennan, DC
   Shah, P
AF Kim, Min Young
   Brennan, Daniel C.
   Shah, Pali
TI General Approach to the Clinical Care of Solid Organ Transplant
   Recipients with COVID-19 Infection Management for Transplant Recipients
SO CURRENT TRANSPLANTATION REPORTS
LA English
DT Article
DE COVID-19; Transplant recipient; Prevention; Management
ID DISEASE 2019 COVID-19; CYTOMEGALOVIRUS-INFECTION; IMMUNOSUPPRESSION;
   IMPACT; REPLICATION; PNEUMONIA; VIRUS; WUHAN
AB Purpose of Review Insufficient knowledge about COVID-19 and the potential risks of COVID-19 are limiting organ transplantation in wait-listed candidates and deferring essential health care in solid organ transplant recipients. In this review, we expand the understanding and present an overview of the optimized management of COVID-19 in solid organ transplant recipients. Recent Findings Transplant recipients are at an increased risk of severe COVID-19. The unique characteristics of transplant recipients can make it more difficult to identify COVID-19. Based on the COVID-19 data to date and our experience, we present testing, management, and prevention methods for COVID-19. Comprehensive diagnostic tests should be performed to determine disease severity, phase of illness, and identify other comorbidities in transplant recipients diagnosed with COVID-19. Outpatients should receive education for preventative measures and optimal health care delivery minimizing potential infectious exposures. Multidisciplinary interventions should be provided to hospitalized transplant recipients for COVID-19 because of the complexity of caring for transplant recipients. Transplant recipients should strictly adhere to infection prevention measures. Understanding of the transplant specific pathophysiology and development of effective treatment strategies for COVID-19 should be prioritized.
C1 [Kim, Min Young; Brennan, Daniel C.; Shah, Pali] Johns Hopkins Sch Med, Dept Internal Med, Baltimore, MD 21205 USA.
   [Shah, Pali] Johns Hopkins Univ, Div Pulm & Crit Care, Sch Med, Baltimore, MD 21205 USA.
RP Shah, P (corresponding author), Johns Hopkins Sch Med, Dept Internal Med, Baltimore, MD 21205 USA.; Shah, P (corresponding author), Johns Hopkins Univ, Div Pulm & Crit Care, Sch Med, Baltimore, MD 21205 USA.
EM pdedhiy2@jhmi.edu
CR Abbasi-Oshaghi E, 2020, INT J SURG, V79, P143, DOI 10.1016/j.ijsu.2020.05.018
   Ahn C, 2020, TRANSPLANTATION, V104, P1974, DOI 10.1097/TP.0000000000003258
   Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117
   Alberici F, 2020, KIDNEY INT, V97, P1083, DOI 10.1016/j.kint.2020.04.002
   Amalou A, 2020, ACAD RADIOL, V27, P1119, DOI 10.1016/j.acra.2020.05.017
   Amrein K, 2018, ENDOCR CONNECT, V7, pR304, DOI 10.1530/EC-18-0184
   Martinez-Rojas MA, 2020, AM J PHYSIOL-RENAL, V318, pF1454, DOI 10.1152/ajprenal.00160.2020
   AST, 2019 NCOV COR REC GU
   Astor BC, 2019, TRANSPLANTATION, V103, P1683, DOI 10.1097/TP.0000000000002672
   Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419
   Bloom RD, 2017, J AM SOC NEPHROL, V28, P2221, DOI 10.1681/ASN.2016091034
   Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100113
   Boyarsky BJ, 2020, AM J TRANSPLANT, V20, P1809, DOI 10.1111/ajt.15915
   Brennan DC, 2013, REV MED VIROL, V23, P97, DOI 10.1002/rmv.1733
   Bromberg J, 2020, TRANSPLANTATION, V104, P2252, DOI 10.1097/TP.0000000000003362
   Cai QX, 2020, J HEPATOL, V73, P566, DOI 10.1016/j.jhep.2020.04.006
   Carbajo-Lozoya J, 2012, VIRUS RES, V165, P112, DOI 10.1016/j.virusres.2012.02.002
   CDC, COR COVID 19
   Chaudhry ZS, 2020, AM J TRANSPLANT, V20, P3051, DOI 10.1111/ajt.16188
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Daggubati LC, 2020, WORLD NEUROSURG, V139, pE859, DOI 10.1016/j.wneu.2020.05.140
   De Pasquale C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00106
   Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985
   European Society of Cardiology (ESC), ESC GUID DIAGN MAN C
   Eyal O, 2013, ISR MED ASSOC J, V15, P628
   Fernandez-Ruiz M, 2020, AM J TRANSPLANT, V20, P1849, DOI 10.1111/ajt.15929
   Fishman JA, 2017, AM J TRANSPLANT, V17, P856, DOI 10.1111/ajt.14208
   Fix OK, 2020, HEPATOLOGY, V72, P287, DOI 10.1002/hep.31281
   Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301
   Galloway JB, 2020, J INFECTION, V81, P282, DOI 10.1016/j.jinf.2020.05.064
   Ginde AA, 2019, NEW ENGL J MED, V381, P2529, DOI 10.1056/NEJMoa1911124
   Giwa Al, 2020, Emerg Med Pract, V22, P1
   Gleeson SE, 2020, CLIN J AM SOC NEPHRO, V15, P892, DOI 10.2215/CJN.04510420
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gunasekaran M, 2020, J HEART LUNG TRANSPL, V39, P379, DOI 10.1016/j.healun.2019.12.009
   Pham H, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173020
   Han JE, 2016, J CLIN TRANSL ENDOCR, V4, P59, DOI 10.1016/j.jcte.2016.04.004
   Hardinger KL, 2010, AM J TRANSPLANT, V10, P407, DOI 10.1111/j.1600-6143.2009.02952.x
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414
   Kalluri HV, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12955
   Kates Olivia S, 2021, Clin Infect Dis, V73, pe4090, DOI 10.1093/cid/ciaa1097
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Konig MF, 2020, J CLIN INVEST, V130, P3345, DOI 10.1172/JCI139642
   Kronbichler A, 2020, NAT REV NEPHROL, V16, P365, DOI 10.1038/s41581-020-0305-6
   Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P505, DOI 10.1016/j.jmii.2020.05.013
   Lal Hitesh, 2020, J Clin Orthop Trauma, V11, P700, DOI 10.1016/j.jcot.2020.05.009
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9
   Lippi G, 2020, CLIN CHIM ACTA, V505, P190, DOI 10.1016/j.cca.2020.03.004
   Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370
   Manuel O, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13511
   Massie AB, 2020, AM J TRANSPLANT, V20, P2997, DOI 10.1111/ajt.16117
   Mayo PH, 2019, INTENS CARE MED, V45, P1200, DOI 10.1007/s00134-019-05725-8
   Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725
   Mohan S, 2020, J AM SOC NEPHROL, V31, P1150, DOI 10.1681/ASN.2020030375
   Mwintshi K, 2007, EXPERT REV ANTI-INFE, V5, P295, DOI 10.1586/14787210.5.2.295
   Pascarella G, 2020, J INTERN MED, V288, P192, DOI 10.1111/joim.13091
   Peghin M, 2019, CLIN INFECT DIS, V69, P1192, DOI 10.1093/cid/ciy1047
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Pereira MR, 2020, AM J TRANSPLANT, V20, P1800, DOI 10.1111/ajt.15941
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Rabb H, 2020, J CLIN INVEST, V130, P2749, DOI 10.1172/JCI138871
   Reiter RJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00226
   Riegler LL, 2019, THER CLIN RISK MANAG, V15, P323, DOI 10.2147/TCRM.S150524
   Roberts MB, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13407
   Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Sanchis-Gomar F, 2020, MAYO CLIN PROC, V95, P1222, DOI 10.1016/j.mayocp.2020.03.026
   Sarno G, 2017, REV ENDOCR METAB DIS, V18, P323, DOI 10.1007/s11154-017-9418-z
   Sawyer RG, 1999, CLIN TRANSPLANT, V13, P260, DOI 10.1034/j.1399-0012.1999.130307.x
   Seifert ME, 2017, J AM SOC NEPHROL, V28, P1314, DOI 10.1681/ASN.2016030285
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Shneider A, 2020, INT REV IMMUNOL, V39, P153, DOI 10.1080/08830185.2020.1756284
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   South AM, 2020, NAT REV NEPHROL, V16, P305, DOI 10.1038/s41581-020-0279-4
   Spinner ML, 2010, TRANSPLANTATION, V90, P412, DOI 10.1097/TP.0b013e3181e81afc
   Staedtke V, 2018, NATURE, V564, P273, DOI 10.1038/s41586-018-0774-y
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Tanaka Y, 2013, VIRUSES-BASEL, V5, P1250, DOI 10.3390/v5051250
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Timsit JF, 2019, INTENS CARE MED, V45, P573, DOI 10.1007/s00134-019-05597-y
   Tschopp J, 2020, AM J TRANSPLANT, V20, P2876, DOI 10.1111/ajt.16062
   Vogelstein Joshua T, 2020, ArXiv
   Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272
   Willicombe M, 2020, J AM SOC NEPHROL, V31, P1145, DOI 10.1681/ASN.2020030348
   Yi SG, 2020, TRANSPLANTATION, V104, P2208, DOI 10.1097/TP.0000000000003339
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhang R, 2020, LIFE SCI, V250, DOI 10.1016/j.lfs.2020.117583
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu L, 2020, EUR UROL, V77, P748, DOI 10.1016/j.eururo.2020.03.039
   Zhu XJ, 2020, VIRUS RES, V285, DOI 10.1016/j.virusres.2020.198005
NR 94
TC 1
Z9 1
U1 1
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2196-3029
J9 CURR TRANSPLANT REP
JI Curr. Transplant. Rep.
PD DEC
PY 2020
VL 7
IS 4
BP 366
EP 378
DI 10.1007/s40472-020-00305-y
PG 13
WC Surgery; Transplantation
WE Emerging Sources Citation Index (ESCI)
SC Surgery; Transplantation
GA WE0LZ
UT WOS:000705322800018
PM 33145146
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Aladul, MI
   Al-Qazaz, HK
   Allela, OQB
AF Aladul, Mohammed I.
   Kh. Al-Qazaz, Harith
   Allela, Omer Q. B.
TI Healthcare professionals' knowledge, perception and practice towards
   COVID-19: A cross-sectional web-survey
SO JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH
LA English
DT Article
DE corona virus; COVID-19; healthcare professionals; knowledge; perception
ID SOCIAL MEDIA
AB Objective COVID-19 is a highly contagious disease. Healthcare professionals (HCPs) are increasingly facing suspected and confirmed cases of COVID-19. To evaluate Iraqi HCPs (physicians, dentists and pharmacists) knowledge, perception and practice towards COVID-19.
   Methods This was a cross-sectional, anonymised web-survey, using an electronic application (Surveyheart (R)). The web-survey link was posted via the closed groups of physicians, dentists and pharmacists in Iraq on Facebook and Twitter. The questionnaire was self-administered and data was collected between, 10th-25th of March 2020.
   Key findings Three hundred seventy two HCPs participated in the study. The majority of Iraqi HCPs have a good knowledge about the origin, incubation period, the mode of transmission, the common signs and symptoms and the groups of patients who were at higher risk of COVID-19. HCPs identified internet, social media as the main source of information about the disease. The lowest rate of correct answers was found in items related to the virus which is responsible for the development of COVID-19 disease (44.6%) and the types of face mask that protect against COVID-19 (40.6%). Physicians were found to have higher score of knowledge compared to dentists and pharmacists. Iraqi HCPs requested more strict preventive measure to be applied to prevent the spread of the disease. Iraqi HCPs expressed their inclination to use the international guidelines to treat confirmed cases.
   Conclusions Iraqi HCPs have an overall good knowledge towards COVID-19. More information should be published from reputable and authentic sources to HCPs. The Ministry of Health in Iraq could take its responsibility to inform the health providers with updated and confirmed information about COVID-19 prevention and management.
C1 [Aladul, Mohammed I.; Kh. Al-Qazaz, Harith] Univ Mosul, Coll Pharm, Nineveh 41002, Iraq.
   [Allela, Omer Q. B.] Al Noor Coll Univ, Pharm Dept, Nineveh, Iraq.
RP Aladul, MI (corresponding author), Univ Mosul, Coll Pharm, Nineveh 41002, Iraq.
EM m.i.m.aladul@uomosul.edu.iq
RI Aladul, Mohammed/T-1441-2019; Allela, Omer Qutaiba B./U-6055-2019;
   Aladul, Mohammed/AAL-7622-2021
OI Aladul, Mohammed/0000-0002-7368-3469; Allela, Omer Qutaiba
   B./0000-0001-6803-9794; 
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   American College of Cardiology, 2020, VENTR ARRH RISK DUE
   [Anonymous], 2020, AL MONITOR
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072
   Di Napoli R, 2020, FEATURES EVALUATION
   European Centre for Disease Prevention and Control (ECDC), 2020, OUTBR NOV COR DIS CO
   European Centre for Disease Prevention and Control (ECDC), 2020, NOV COR DIS 2019 COV
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Government of Iraq, COV 19 GUID UPD IR G
   Grindrod K, 2014, RES SOC ADMIN PHARM, V10, P256, DOI 10.1016/j.sapharm.2013.05.004
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui M, 2020, QUARTZ
   Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Middle East Monitor, 2020, IR IMP WEEK LONG CUR
   Mikhael Ehab Mudher, 2020, Public Health Pract (Oxf), V1, P100004, DOI 10.1016/j.puhip.2020.100004
   Ministero Della Salute, 2020, COV 19 SIT MOND
   NINA, 2020, WHO REAS IR THER IS
   Reuters, 2020, MED CRIS THATS AGGR
   U.S. Embassy & Consulate in Iraq, 2020, COVID 19 INF
   Ventola C Lee, 2014, P T, V39, P491
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WHO, 2020, NAM COR DIS COVID 19
   World Health Organization, 2020, WHO STAT REG CLUST P
   Worldometers, 2021, COVID 19 COR PAND
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
NR 34
TC 4
Z9 4
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-8885
EI 1759-8893
J9 J PHARM HEALTH SERV
JI J. Pharm. Health Serv. Res.
PD NOV
PY 2020
VL 11
IS 4
BP 355
EP 363
DI 10.1111/jphs.12385
EA SEP 2020
PG 9
WC Health Care Sciences & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA OO6HQ
UT WOS:000569317000001
PM 34191949
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Ammirato, S
   Linzalone, R
   Felicetti, AM
AF Ammirato, Salvatore
   Linzalone, Roberto
   Felicetti, Alberto M.
TI Knowledge management in pandemics. A critical literature review
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Knowledge management; disaster management; pandemic; COVID-19;
   literature review
ID DECISION-SUPPORT; PUBLIC-HEALTH; INFLUENZA; MEDIA; PREPAREDNESS;
   SIMULATION; DISASTERS; OUTBREAKS; CAPACITY; SYSTEMS
AB The ongoing pandemic COVID-19 is soliciting the question: what do we know about the knowledge management in a pandemic? Knowledge is a strategic resource to drive decisionmakers in the management of a pandemic, to mitigate health and socio-economic effects. Unlike other natural disasters, pandemics have a long lead time, and during this time can be actively managed. Decisions taken in such a complex process can change the course and the effects of a pandemic. Despite the critical role of knowledge management in pandemics, that inform and enable decision-makers, the literature on this specific issue is poor, fragmented, mainly addressed by "health" journals and marginally addressed by the "knowledge management" scholars. This paper aims to provide the ground for filling this gap, by detecting the state-of-art, that is the topics and the past studies, about Knowledge Management in pandemics.
C1 [Ammirato, Salvatore; Linzalone, Roberto; Felicetti, Alberto M.] Univ Calabria, Dept Mech Energy & Management Engn, Arcavacata Di Rende, Italy.
RP Linzalone, R (corresponding author), Univ Calabria, Dept Mech Energy & Management Engn, I-87036 Arcavacata Di Rende, Italy.
EM roberto.linzalone@unical.it
RI Ammirato, Salvatore/AAI-9056-2020
OI Ammirato, Salvatore/0000-0001-6617-3789; Felicetti, Alberto
   Michele/0000-0002-3692-2643; Linzalone, Roberto/0000-0003-4695-3803
CR Araz OM, 2012, J MED SYST, V36, P1475, DOI 10.1007/s10916-010-9608-7
   Bdeir F, 2013, KNOWL MAN RES PRACT, V11, P241, DOI 10.1057/kmrp.2012.1
   Chung JB, 2013, DISASTER PREV MANAG, V22, P148, DOI 10.1108/09653561311325299
   Clark R. A., 2016, BUSINESS COMTINUITY
   Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570
   Das TK, 2008, IIE TRANS, V40, P893, DOI 10.1080/07408170802165856
   Denyer D., 2009, SAGE HDB ORG RES MET
   Devadoss PR, 2005, IEEE T INF TECHNOL B, V9, P266, DOI 10.1109/TITB.2005.847160
   Dorasamy M, 2013, TECHNOL FORECAST SOC, V80, P1834, DOI 10.1016/j.techfore.2012.12.008
   Eastwood K, 2009, B WORLD HEALTH ORGAN, V87, P588, DOI 10.2471/BLT.08.060772
   Eriksson Henrik, 2009, AMIA Annu Symp Proc, V2009, P173
   Ferrante G, 2011, EUR J EPIDEMIOL, V26, P211, DOI 10.1007/s10654-011-9576-3
   Fogli D, 2013, DECIS SUPPORT SYST, V55, P336, DOI 10.1016/j.dss.2013.01.022
   Genereux M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040587
   Ho SS, 2012, MASS COMMUN SOC, V15, P695, DOI 10.1080/15205436.2011.616275
   Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059
   Ibarra-Vega D, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138917
   Jehn M, 2011, J PUBLIC HEALTH MAN, V17, P431, DOI 10.1097/PHH.0b013e3182113921
   Korstanje M.E., 2011, INT J DISASTER RESIL, V2, P59
   Lai AY, 2012, ASIA-PAC J PUBLIC HE, V24, P7, DOI 10.1177/1010539511429592
   Leiba A, 2010, ISR MED ASSOC J, V12, P460
   Lloyd-Jones T., 2009, BUILT ENV PROFESSION
   Luoma-aho V, 2013, J COMMUN MANAG, V17, P239, DOI 10.1108/JCOM-11-2010-0069
   Marshall H, 2009, AM J PUBLIC HEALTH, V99, pS365, DOI 10.2105/AJPH.2008.153056
   Moe TunLin, 2007, Disaster Prevention & Management, V16, P785, DOI 10.1108/09653560710837073
   Moghadas SM, 2009, INFLUENZA OTHER RESP, V3, P75, DOI 10.1111/j.1750-2659.2009.00081.x
   Rim H, 2014, J COMMUN MANAG, V18, P101, DOI 10.1108/JCOM-05-2012-0044
   Rivera-Izquierdo M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235107
   Scanlon J, 2011, DISASTER PREV MANAG, V20, P172, DOI 10.1108/09653561111126102
   Seneviratne K., 2010, CIB WORLD C SALF UK, P138
   Snyder H, 2019, J BUS RES, V104, P333, DOI 10.1016/j.jbusres.2019.07.039
   Sofo F., 2010, INT J DIGITAL CONTEN, V4, P38, DOI [10.4156/jdcta.vol4.issue7.4, DOI 10.4156/JDCTA.VOL4.ISSUE7.4]
   Southby K., 2006, STRATEGIC DIRECTION, V22, P62, DOI [10.1108/sd.2006.05622hab.002, DOI 10.1108/SD.2006.05622HAB.002]
   Su JF, 2018, J INTELL FUZZY SYST, V34, P2087, DOI 10.3233/JIFS-162116
   Therrien MC, 2017, J HEALTH ORGAN MANAG, V31, P96, DOI 10.1108/JHOM-04-2016-0067
   Torraco R. J., 2005, HUMAN RESOURCE DEV R, V4, P3, DOI DOI 10.1177/1534484305278283
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Vybornova O, 2016, J HUMANIT LOGIST SUP, V6, P264, DOI 10.1108/JHLSCM-06-2016-0025
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   Woodward N. H., 2006, HUMAN RESOURCE MANAG, V14, P46, DOI [10.1108/hrmid.2006.04414gad.001, DOI 10.1108/HRMID.2006.04414GAD.001]
   World Health Organization W, 2010, WHAT IS PAND EM PREP
   Yu HJ, 2009, INFLUENZA OTHER RESP, V3, P223, DOI 10.1111/j.1750-2659.2009.00093.x
NR 42
TC 14
Z9 14
U1 13
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 415
EP 426
DI 10.1080/14778238.2020.1801364
EA AUG 2020
PG 12
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000558486000001
OA hybrid
DA 2022-04-20
ER

PT J
AU Min, S
   Xiang, C
   Zhang, XH
AF Min Shi
   Xiang Cheng
   Zhang Xiao-heng
TI Impacts of the COVID-19 pandemic on consumers' food safety knowledge and
   behavior in China
SO JOURNAL OF INTEGRATIVE AGRICULTURE
LA English
DT Article
DE food safety; knowledge; behavior; COVID-19
AB This study assesses the impacts of the COVID-19 pandemic on Chinese residents' food safety knowledge and behavior, and explores the possible influence mechanism, namely, focus on media information. The study is based on internet survey data of 1 373 residents in China. A series of econometric models are developed to estimate food safety knowledge and behavior of residents. Both the descriptive and econometric results indicate that the existence of COVID-19 cases in a community has a significantly positive effect on residents' food safety knowledge and behavior. Residents focusing on food safety-related information tend to have higher food safety knowledge and practice food safety behavior. When controlling the variable focused on food safety-related information, the marginal effects of the existence of COVID-19 cases in a community on residents' food safety knowledge and behavior significantly decrease. However, the decrease in consumers' food safety knowledge is quite minor. Hence, the COVID-19 pandemic indeed improves Chinese residents' food safety knowledge and behavior, while focus on food safety-related information is an important mechanism for improving food safety behavior. Moreover, the estimation results of the simultaneous equations model reveal that consumers' food safety knowledge has a significant and positive effect on their food safety behavior. Heterogeneous impacts of the COVID-19 pandemic on residents' food safety knowledge and behavior among different regions and income groups are observed. The findings of this study provide evidence that public health events could enhance residents' safety awareness and behavior, while residents' focus on relevant information plays an important role in improving knowledge and impacting behavior.
C1 [Min Shi; Zhang Xiao-heng] Huazhong Agr Univ, Coll Econ & Management, Wuhan 430070, Peoples R China.
   [Xiang Cheng] Chinese Acad Agr Sci, Inst Agr Econ & Dev, Beijing 100081, Peoples R China.
RP Xiang, C (corresponding author), Chinese Acad Agr Sci, Inst Agr Econ & Dev, Beijing 100081, Peoples R China.
EM min@mail.hzau.edu.cn; xiangcheng@caas.cn
FU Huazhong Agricultural University Scientific & Technological
   Self-innovation Foundation China; Philosophy and Social Sciences Project
   of Ministry of Education of China [19YJC630191]; Fundamental Research
   Funds for the Central University, China [2662020JGPYG15]; National
   Science and Technology Major Project, China [2018ZX08015001]
FX We acknowledge the funding support from the Huazhong Agricultural
   University Scientific & Technological Self-innovation Foundation China,
   the Philosophy and Social Sciences Project of Ministry of Education of
   China (19YJC630191), the Fundamental Research Funds for the Central
   University, China (2662020JGPYG15), and the National Science and
   Technology Major Project, China (2018ZX08015001).
CR Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]
   Baker S., 2020, 26949 NBER
   Baldwin R., 2020, MITIGATING COVID EC
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Byrd-Bredbenner C, 2007, BRIT FOOD J, V109, P519, DOI 10.1108/00070700710761518
   Eichenbaum M.S., 2020, 26882 NBER
   Fang H M, 2020, 20011 PIER
   FAO (Food and Agriculture Organization of the United Nations) WHO (World Health Organization), 2020, COVID 19 FOOD SAF GU
   Gong BL, 2020, J CHIN GOV, V5, P249, DOI 10.1080/23812346.2020.1741940
   Guerrieri V., 2020, 26918 NBER
   Jin HJ, 2014, FOOD POLICY, V44, P95, DOI 10.1016/j.foodpol.2013.10.007
   Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058
   Liu P, 2016, FOOD POLICY, V63, P102, DOI 10.1016/j.foodpol.2016.07.005
   Losasso C, 2012, FOOD CONTROL, V26, P252, DOI 10.1016/j.foodcont.2012.01.038
   McLeod ER, 2011, J AM DIET ASSOC, V111, P696, DOI 10.1016/j.jada.2011.02.011
   Min S, 2021, FOOD POLICY, V98, DOI 10.1016/j.foodpol.2020.101896
   Qiao GH, 2012, FOOD CONTROL, V26, P378, DOI 10.1016/j.foodcont.2012.01.045
   Qing P., 2020, FARMERS DAILY, V4
   Ren YJ, 2019, SOC SCI MED, V232, P58, DOI 10.1016/j.socscimed.2019.04.016
   Shimokawa S, 2013, FOOD POLICY, V38, P35, DOI 10.1016/j.foodpol.2012.09.001
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   Wang YB, 2020, CHINA AGR ECON REV, V12, P427, DOI 10.1108/CAER-04-2020-0053
   Weng, 2020, 26866 NBER
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Xiao KP, 2020, NATURE, V583, P286, DOI 10.1038/s41586-020-2313-x
   Xinhua News Agency, 2020, CHIN HAS BANN TRAD I
   Yi X, 2020, CHINA DAILY
   Zhao QR, 2020, J DEV STUD, V56, P578, DOI 10.1080/00220388.2019.1573315
NR 28
TC 18
Z9 18
U1 8
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2095-3119
J9 J INTEGR AGR
JI J. Integr. Agric.
PD DEC
PY 2020
VL 19
IS 12
BP 2926
EP 2936
DI 10.1016/S2095-3119(20)63388-3
PG 11
WC Agriculture, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Agriculture
GA OY8PB
UT WOS:000594501900008
OA gold
DA 2022-04-20
ER

PT J
AU Zheng, LZ
   Chen, K
   Ma, L
AF Zheng, Linzi
   Chen, Ke
   Ma, Ling
TI Knowledge, Attitudes, and Practices Toward COVID-19 Among Construction
   Industry Practitioners in China
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE COVID-19; knowledge; attitude; practice; construction industry
   practitioner
ID PRACTICES KAP
AB The COVID-19 pandemic has put labor-intensive industries at risk, among which the construction industry is a typical one. Practitioners in the construction industry are facing high probabilities of COVID-19 transmission, while their knowledge, attitudes, and practices (KAP) are critical to the prevention of virus spread. This study seeks to investigate the KAP of construction industry practitioners in China through an online questionnaire survey conducted from 15 to 30 June 2020. A total of 702 effective responses were received and analyzed. The results revealed that: (1) although an overwhelming percentage of respondents had the correct knowledge about COVID-19, there were significant respondents (15% of all) who were unsure or wrong about the human-to-human transmission of the virus; (2) practitioners generally showed an optimistic attitude about winning the battle against the COVID-19 pandemic and were satisfied with the governments' contingency measures; (3) practitioners tended to actively take preventive measures, although checking body temperature, wearing face masks, and keeping safe social distance still needs to be reinforced. This research is among the first to identify the KAP of construction industry practitioners toward the COVID-19 pandemic in China. Results presented here have implications for enhancing strategies to reduce and prevent COVID-19 spread in the construction industry.
C1 [Zheng, Linzi] Huazhong Univ Sci & Technol, Coll Publ Adm, Wuhan, Peoples R China.
   [Chen, Ke] Huazhong Univ Sci & Technol, Sch Civil & Hydraul Engn, Dept Construct Management, Wuhan, Peoples R China.
   [Ma, Ling] UCL, Bartlett Sch Construct & Project Management, London, England.
RP Chen, K (corresponding author), Huazhong Univ Sci & Technol, Sch Civil & Hydraul Engn, Dept Construct Management, Wuhan, Peoples R China.
EM chenkecm@hust.edu.cn
RI Ma, Ling/F-6641-2010; CHEN, KE/A-4018-2015
OI Ma, Ling/0000-0002-9187-471X; CHEN, KE/0000-0003-3918-3820
FU Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [2019kfyXJJS185]
FX This research was funded by the Fundamental Research Funds for the
   Central Universities, Grant Number 2019kfyXJJS185.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Centers for Disease Control and Prevention (CDCP), 2020, WHAT CONSTR WORK NEE
   Chen SM, 2020, LANCET, V395, P1305, DOI 10.1016/S0140-6736(20)30744-3
   Fan YH, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3122-9
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Hayat K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103347
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   Li ZH, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008584
   Luo HB, 2020, AUTOMAT CONSTR, V119, DOI 10.1016/j.autcon.2020.103345
   McKinsey and Company, 2020, NEXT NORM CONSTR
   Mian A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01556-3
   Ministry of Housing and Urban-Rural Development of the People's Republic of China (MOHURD), 2020, NOT GEN OFF MIN HOUS
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   The Johns Hopkins Coronavirus Resource Center, 2020, COVID 19 DASHB
   Yousaf MA, 2020, SOC WORK PUBLIC HLTH, V35, P569, DOI 10.1080/19371918.2020.1806983
   Yuan ZM, 2020, B WORLD HEALTH ORGAN, V98, P484, DOI 10.2471/BLT.20.254045
   Yue ST, 2021, J COMMUN HEALTH, V46, P286, DOI 10.1007/s10900-020-00877-x
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 24
TC 7
Z9 7
U1 13
U2 24
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD JAN 8
PY 2021
VL 8
AR 599769
DI 10.3389/fpubh.2020.599769
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA PU6LZ
UT WOS:000609414600001
PM 33490020
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Zheng, WB
   Yan, L
   Gou, C
   Zhang, ZC
   Zhang, JJ
   Hu, M
   Wang, FY
AF Zheng, Wenbo
   Yan, Lan
   Gou, Chao
   Zhang, Zhi-Cheng
   Zhang, Jun Jason
   Hu, Ming
   Wang, Fei-Yue
TI Pay attention to doctor-patient dialogues: Multi-modal knowledge graph
   attention image-text embedding for COVID-19 diagnosis
SO INFORMATION FUSION
LA English
DT Article
DE COVID-19 diagnose; Knowledge attention mechanism; Knowledge-based
   representation learning; Knowledge embedding
ID PREDICTING COVID-19; FUSION; CLASSIFICATION; LOCALIZATION; FRAMEWORK;
   ACCURATE; NETWORK; SYSTEM; CANCER
AB The sudden increase in coronavirus disease 2019 (COVID-19) cases puts high pressure on healthcare services worldwide. At this stage, fast, accurate, and early clinical assessment of the disease severity is vital. In general, there are two issues to overcome: (1) Current deep learning-based works suffer from multimodal data adequacy issues; (2) In this scenario, multimodal (e.g., text, image) information should be taken into account together to make accurate inferences. To address these challenges, we propose a multi-modal knowledge graph attention embedding for COVID-19 diagnosis. Our method not only learns the relational embedding from nodes in a constituted knowledge graph but also has access to medical knowledge, aiming at improving the performance of the classifier through the mechanism of medical knowledge attention. The experimental results show that our approach significantly improves classification performance compared to other state-of-the-art techniques and possesses robustness for each modality from multi-modal data. Moreover, we construct a new COVID-19 multi-modal dataset based on text mining, consisting of 1393 doctor-patient dialogues and their 3706 images (347 X-ray + 2598 CT + 761 ultrasound) about COVID-19 patients and 607 non-COVID-19 patient dialogues and their 10754 images (9658 X-ray + 494 CT + 761 ultrasound), and the fine-grained labels of all. We hope this work can provide insights to the researchers working in this area to shift the attention from only medical images to the doctor-patient dialogue and its corresponding medical images.
C1 [Zheng, Wenbo] Xi An Jiao Tong Univ, Sch Software Engn, Xian 710049, Peoples R China.
   [Zheng, Wenbo; Yan, Lan; Wang, Fei-Yue] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China.
   [Yan, Lan] Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing 100190, Peoples R China.
   [Gou, Chao] Sun Yat Sen Univ, Sch Intelligent Syst Engn, Guangzhou 510275, Peoples R China.
   [Zhang, Zhi-Cheng] Gen Hosp Peoples Liberat Army, Med Ctr 7, Beijing 100700, Peoples R China.
   [Zhang, Jun Jason] Wuhan Univ, Sch Elect Engn & Automat, Wuhan 430072, Peoples R China.
   [Hu, Ming] Wuhan Pulm Hosp, Intens Care Unit, Wuhan 430030, Peoples R China.
RP Wang, FY (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China.
EM zwb2017@stu.xjtu.edu.cn; Yanlan2017@ia.ac.cn; gouchao@mail.sysu.edu.cn;
   dr_zhangzhicheng@126.com; jun.zhang.ee@whu.edu.cn; huming74@163.com;
   feiyue.wang@ia.ac.cn
OI Gou, Chao/0000-0002-4128-886X; Yan, Lan/0000-0001-6452-9649
FU National Key RAMP;D Program of China [2020YFB1600400]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   (NSFC) [61806198, 61533019, U1811463]; Key Technologies Research and
   Development Program of Guangzhou, China [202007050002]; National Key
   Research and Development Program of China [2018AAA0101502]
FX We would like to thank the General Hospital of the People's Liberation
   Army and Wuhan Pulmonary Hospital for medical data and helpful advice on
   this research. This work is supported in part by the National Key R&D
   Program of China (2020YFB1600400), in part by the National Natural
   Science Foundation of China (61806198, 61533019, U1811463), in part by
   the Key Technologies Research and Development Program of Guangzhou,
   China (202007050002), and in part by the National Key Research and
   Development Program of China (No. 2018AAA0101502).
CR Abdel-Basset M, 2020, INFORM FUSION, V61, P84, DOI 10.1016/j.inffus.2020.03.010
   Afshar P, 2020, PATTERN RECOGN LETT, V138, P638, DOI 10.1016/j.patrec.2020.09.010
   Angelou M, 2019, PATTERN RECOGN, V95, P296, DOI 10.1016/j.patcog.2019.06.013
   Armbrust M, 2018, INT CONF MANAGE DATA, P601, DOI 10.1145/3183713.3190664
   Bai S., 2019, P INT C LEARN REPR
   Bi WL, 2019, CA-CANCER J CLIN, V69, P127, DOI 10.3322/caac.21552
   BUTOW PN, 1995, BRIT J CANCER, V71, P1115, DOI 10.1038/bjc.1995.216
   Cai HY, 2018, IEEE T KNOWL DATA EN, V30, P1616, DOI 10.1109/TKDE.2018.2807452
   Cen YK, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1358, DOI 10.1145/3292500.3330964
   Chatterjee Shailja, 2014, J Oral Maxillofac Pathol, V18, pS111, DOI 10.4103/0973-029X.141346
   Chen TS, 2019, PROC CVPR IEEE, P6156, DOI 10.1109/CVPR.2019.00632
   Chen TS, 2018, PROCEEDINGS OF THE 2018 ACM MULTIMEDIA CONFERENCE (MM'18), P2023, DOI 10.1145/3240508.3240523
   Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4
   Colby K.M, 1973, P 3 INT JOINT C ART, P278
   Cong, 2020, ARXIV PREPRINT ARXIV
   Dai R, 2019, 2019 16TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE (AVSS)
   Dao, 2020, ARXIV200311597
   Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848
   Devlin J, 2019, BERT PRETRAINING DEE, DOI DOI 10.18653/V1/N19-1423
   Dhamodharavadhani S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00441
   Ding W., IEEE T FUZZY SYSTEMS, DOI [10.1109/TFUZZ.2021.3052461, DOI 10.1109/TFUZZ.2021.3052461]
   Dong YX, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P135, DOI 10.1145/3097983.3098036
   Dotolo S, 2021, BRIEF BIOINFORM, V22, P726, DOI 10.1093/bib/bbaa288
   Drach LL, 2020, J PERINATOL, V40, P1412, DOI 10.1038/s41372-020-0673-6
   Farooq M., 2020, ARXIV PREPRINT ARXIV
   Fu XY, 2020, WEB CONFERENCE 2020: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2020), P2331, DOI 10.1145/3366423.3380297
   Furfaro F, 2020, NAT REV GASTRO HEPAT, V17, P507, DOI 10.1038/s41575-020-0319-3
   Garcia-Duran A., 2018, EMNLP
   Gong C, 2016, IEEE T IMAGE PROCESS, V25, P3249, DOI 10.1109/TIP.2016.2563981
   Gui T, 2019, THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P110
   Guo JX, 2018, THIRTY-SECOND AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTIETH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / EIGHTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P5141
   Han ZY, 2020, IEEE T MED IMAGING, V39, P2584, DOI 10.1109/TMI.2020.2996256
   Hao H., 2020, TEMPORAL CONVOLUTION
   He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90
   Heymann DL, 2020, LANCET, V395, P469, DOI 10.1016/S0140-6736(20)30184-7
   Nguyen HL, 2020, INFORM FUSION, V61, P56, DOI 10.1016/j.inffus.2020.03.014
   Hu ZN, 2020, WEB CONFERENCE 2020: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2020), P2704, DOI 10.1145/3366423.3380027
   Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243
   Huang X, 2017, LECT NOTES COMPUT SC, V10666, P477, DOI 10.1007/978-3-319-71607-7_42
   Ikizler TA, 2020, NAT REV NEPHROL, V16, P311, DOI 10.1038/s41581-020-0280-y
   Illendula A, 2019, COMPANION OF THE WORLD WIDE WEB CONFERENCE (WWW 2019 ), P439, DOI 10.1145/3308560.3316549
   Jin C, 2020, DEV EVALUATION AI SY, DOI [10.1101/2020.03.20.20039834, DOI 10.1101/2020.03.20.20039834]
   Kang HY, 2020, IEEE T MED IMAGING, V39, P2606, DOI 10.1109/TMI.2020.2992546
   Kim GU, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.04.040
   King DB, 2015, ACS SYM SER, V1214, P1
   Kipf T.N., 2017, J BANK FINANC, DOI DOI 10.1016/j.jbankfin.2010.06.001
   Kolter J.Z., 2018, arXiv
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Lee JB, 2019, ACM T KNOWL DISCOV D, V13, DOI 10.1145/3363574
   Li L, 2020, RADIOLOGY, V296, pE65, DOI 10.1148/radiol.2020200905
   Li YR, 2019, THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P1004
   Li ZK, 2021, MED IMAGE ANAL, V69, DOI 10.1016/j.media.2021.101978
   Liang WH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17280-8
   Lin GF, 2017, PATTERN RECOGN, V68, P14, DOI 10.1016/j.patcog.2017.03.014
   Lin X, 2020, PROC CVPR IEEE, P3743, DOI 10.1109/CVPR42600.2020.00380
   Liu Q, 2020, DATA, V5, DOI 10.3390/data5030068
   Liu ZL, 2021, IEEE T SYST MAN CY-S, V51, P209, DOI 10.1109/TSMC.2020.3043147
   Lopez-Sastre, 2017, ARXIV170902314
   Luo Y, 2016, IEEE T IMAGE PROCESS, V25, P414, DOI 10.1109/TIP.2015.2495116
   Luwei Yang, 2020, Advances in Information Retrieval. 42nd European Conference on IR Research, ECIR 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12036), P425, DOI 10.1007/978-3-030-45442-5_53
   Maguolo G, 2021, INFORM FUSION, V76, P1, DOI 10.1016/j.inffus.2021.04.008
   Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010
   Mei XY, 2020, NAT MED, V26, P1224, DOI 10.1038/s41591-020-0931-3
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Oh Y, 2020, IEEE T MED IMAGING, V39, P2688, DOI 10.1109/TMI.2020.2993291
   Okereafor K., 2020, JMIR BIOMED ENG, V5, DOI [10.2196/19623, DOI 10.2196/19623]
   Ouyang X, 2020, IEEE T MED IMAGING, V39, P2595, DOI 10.1109/TMI.2020.2995508
   Pang GS, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P353, DOI 10.1145/3292500.3330871
   Peng YX, 2017, FRONT INFORM TECH EL, V18, P44, DOI 10.1631/FITEE.1601787
   Perozzi B, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P701, DOI 10.1145/2623330.2623732
   Quiroz JC, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0190-1
   Robilotti EV, 2020, NAT MED, V26, P1218, DOI 10.1038/s41591-020-0979-0
   Roy S., 2020, IEEE T MED IMAGING, V39, P2676, DOI DOI 10.1109/TMI.2020.2994459
   Schett G, 2020, NAT REV RHEUMATOL, V16, P465, DOI 10.1038/s41584-020-0451-z
   Schlichtkrull Michael, 2018, The Semantic Web. 15th International Conference, ESWC 2018. Proceedings: LNCS 10843, P593, DOI 10.1007/978-3-319-93417-4_38
   Shang J, 2016, ARXIV PREPRINT ARXIV
   Shi C, 2019, IEEE T KNOWL DATA EN, V31, P357, DOI 10.1109/TKDE.2018.2833443
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Shi W., 2020, DEEP LEARNING BASED, DOI [10.2139/ssrn.3546089, DOI 10.2139/SSRN.3546089]
   Simonyan K., 2014, ARXIV14091556
   Singh, 2018, P 2018 C EMP METH NA, P3208
   Sun Z, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.609974
   Tabik S, 2020, IEEE J BIOMED HEALTH, V24, P3595, DOI 10.1109/JBHI.2020.3037127
   Trivedi R, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P252, DOI 10.18653/v1/P18-1024
   van de Haar J, 2020, NAT MED, V26, P665, DOI [10.1038/s41591-020-0874-8, 10.1038/s41591-020-0948-7]
   Van Den Oord Aaron, 2016, SSW, P125, DOI DOI 10.21437/SSW.2016
   Vaswani A, 2017, ADV NEUR IN, V30
   Velikovic P., 2018, INT C LEARN REPR ICL
   Wang LJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61138-4
   Wang X, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P2022, DOI 10.1145/3308558.3313562
   Wang XG, 2020, IEEE T MED IMAGING, V39, P2615, DOI 10.1109/TMI.2020.2995965
   Wang YB, 2017, PROC CVPR IEEE, P2097, DOI 10.1109/CVPR.2017.226
   Wei YW, 2019, PROCEEDINGS OF THE 27TH ACM INTERNATIONAL CONFERENCE ON MULTIMEDIA (MM'19), P1437, DOI 10.1145/3343031.3351034
   Wenbo Zheng, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P12442, DOI 10.1109/CVPR42600.2020.01246
   Wiedemann N, 2020, POCOVID NET AUTOMATI, V39, P2676, DOI [10.1109/TMI.2020.2994459, DOI 10.1109/TMI.2020.2994459]
   Wilk AJ., 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, DOI 10.1038/s41591-020-0944-y]
   Wu ZH, 2021, IEEE T NEUR NET LEAR, V32, P4, DOI 10.1109/TNNLS.2020.2978386
   Xie, 2020, ARXIV200313865
   Xie RB, 2016, THIRTIETH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2659
   Xu XW, 2020, ENGINEERING-PRC, V6, P1122, DOI 10.1016/j.eng.2020.04.010
   Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7
   Yang RR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10182
   Yu Z., 2020, ARXIV200505442
   Zhang CX, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P793, DOI 10.1145/3292500.3330961
   Zhang J., 2020, IEEE JSAC, P1385
   Zhang T, 2022, IEEE T AFFECT COMPUT, V13, P379, DOI 10.1109/TAFFC.2019.2937768
   Zhang WS, 2021, IEEE INTERNET THINGS, V8, P15884, DOI 10.1109/JIOT.2021.3056185
   Zhang Y., 2020, ARXIV200501577
   Zhang ZW, 2022, IEEE T KNOWL DATA EN, V34, P249, DOI 10.1109/TKDE.2020.2981333
   Zheng NN, 2020, IEEE T CYBERNETICS, V50, P2891, DOI 10.1109/TCYB.2020.2990162
   Zheng WB, 2021, INT J INTELL SYST, V36, P4033, DOI 10.1002/int.22449
   Zheng WB, 2020, IEEE INT CON MULTI
   Zheng WB, 2021, INFORM FUSION, V67, P14, DOI 10.1016/j.inffus.2020.10.007
   Zhou LX, 2020, IEEE T MED IMAGING, V39, P2638, DOI 10.1109/TMI.2020.3001810
NR 114
TC 4
Z9 4
U1 30
U2 73
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1566-2535
EI 1872-6305
J9 INFORM FUSION
JI Inf. Fusion
PD NOV
PY 2021
VL 75
BP 168
EP 185
DI 10.1016/j.inffus.2021.05.015
EA JUN 2021
PG 18
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA TF9EV
UT WOS:000671018300014
PM 34093095
OA Bronze, Green Published
DA 2022-04-20
ER

PT C
AU Cegarra-Navarro, JG
   Vatamanescu, EM
   Martinez-Martinez, A
AF Cegarra-Navarro, Juan-Gabriel
   Vatamanescu, Elena-Madalina
   Martinez-Martinez, Aurora
GP IEEE
TI A knowledge hiding approach to cope with COVID-19: A Comparison between
   Spain and China
SO 2020 IEEE INTERNATIONAL CONFERENCE ON TECHNOLOGY MANAGEMENT, OPERATIONS
   AND DECISIONS (ICTMOD)
SE IEEE International Technology Management Conference
LA English
DT Proceedings Paper
CT IEEE International Conference on Technology Management, Operations and
   Decisions (ICTMOD)
CY NOV 24-27, 2020
CL Marrakech, MOROCCO
SP IEEE
DE Hiding knowledge; COVID-19; Citizen Engagement; Realized Absorptive
   Capacity
ID MODERATING ROLE; PLS; BIAS
AB Although it is not clear what positive and negative effects knowledge hiding may have on citizens, some Governments have tried to address the crisis caused by COVID-19 through hiding or distorting information available to citizens. This study suggests that the presence of realized absorptive capacity (RACAP) allows citizens to stop the spreading of fake news about COVID 19. The paper focuses on RACAP as a method to counteract the potential negative effects of knowledge hiding and thus increase citizen engagement. To do so, this study analyses data collected from 251 citizens of two countries: Spain and China. Results provides evidence that while Spaniards have the feeling that a lot of information has been hidden from them, Chinese citizens are ultimately much more committed to taking appropriate COVID 19 measures. Despite these differences, in both samples RACAP help to ensure compliance with new legislation and COVID-19-related restrictions.
C1 [Cegarra-Navarro, Juan-Gabriel; Martinez-Martinez, Aurora] Univ Politecn Cartagena, Fac Business Sci, Cartagena, Spain.
   [Vatamanescu, Elena-Madalina] SNSPA, Fac Management, Bucharest, Romania.
RP Cegarra-Navarro, JG (corresponding author), Univ Politecn Cartagena, Fac Business Sci, Cartagena, Spain.
EM juan.cegarra@upct.es; madalina.vatamanescu@facultateademanagement.ro;
   aurora.martinez@upct.es
RI Martínez-Martínez, Aurora/Y-1510-2018
OI Martínez-Martínez, Aurora/0000-0001-5579-8142
FU Ministerio de Economia, Industria y Competitividad of the Spanish
   Government [ECO2017-88987-R]; European Union FEDER fundsEuropean
   Commission
FX The authors gratefully acknowledge the Ministerio de Economia, Industria
   y Competitividad of the Spanish Government for financing the research
   project ECO2017-88987-R (MINECO/FEDER;UE), cofinanced from the European
   Union FEDER funds.
CR Alexandru VA, 2020, KYBERNETES, V49, P73, DOI 10.1108/K-03-2019-0211
   Allcott H, 2019, RES POLITICS, V6, DOI 10.1177/2053168019848554
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Cegarra-Navarro JG, 2014, EUR MANAG J, V32, P165, DOI 10.1016/j.emj.2013.05.005
   Cerne M, 2014, ACAD MANAGE J, V57, P172, DOI 10.5465/amj.2012.0122
   Connelly CE, 2015, EUR J WORK ORGAN PSY, V24, P479, DOI 10.1080/1359432X.2014.931325
   Connelly CE, 2012, J ORGAN BEHAV, V33, P64, DOI 10.1002/job.737
   Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280
   Dee T., 2010, INT ENCY ED, V2, P235
   Dijkstra TK, 2015, COMPUT STAT DATA AN, V81, P10, DOI 10.1016/j.csda.2014.07.008
   Dorsey J. M., 2019, CHINA WORLD, DOI [10.1142/s259172931950024x, DOI 10.1142/S259172931950024X]
   Edmondson A. C, 2020, HARVARD BUS REV, P2
   Edwards B, 2001, CONTEMP SOCIOL, V30, P227, DOI 10.2307/3089235
   Escribano A, 2009, RES POLICY, V38, P96, DOI 10.1016/j.respol.2008.10.022
   Cegarra-Navarro JG, 2017, J TECHNOL TRANSFER, V42, P302, DOI 10.1007/s10961-016-9506-3
   Cegarra-Navarro JG, 2011, SPAN J PSYCHOL, V14, P808, DOI 10.5209/rev_SJOP.2011.v14.n2.28
   Haynes K, 2019, INT INTERACT, V45, P421, DOI 10.1080/03050629.2019.1554572
   Hays RA, 2007, J URBAN AFF, V29, P401, DOI 10.1111/j.1467-9906.2007.00353.x
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Henseler J, 2014, ORGAN RES METHODS, V17, P182, DOI 10.1177/1094428114526928
   Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014
   Hofmeister M., 2020, CORONAVIRUS ERSCHUTT
   Hofstede G., 2011, ONLINE READ PSYCHOL, V2, P1, DOI [10.9707/2307-0919.1014, DOI 10.9707/2307-0919.1014]
   Jiang Z, 2019, J ORGAN BEHAV, V40, P800, DOI 10.1002/job.2358
   Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1
   Martin S, 2015, ACAD MANAG P, V2015, P11966
   McGoey L, 2012, ECON SOC, V41, P1, DOI 10.1080/03085147.2011.637330
   National Advisory Council on State and Local Budgeting, 1998, REC BUDG PRACT FRAM
   Nebus J, 2006, ACAD MANAGE REV, V31, P615, DOI 10.5465/AMR.2006.21318921
   Noonan W.R., 2007, DISCUSSING UNDISCUSS
   Peng GZ, 2018, IEEE T SERV COMPUT, V11, P306, DOI 10.1109/TSC.2016.2518161
   Richter NF, 2016, EUR MANAG J, V34, P589, DOI 10.1016/j.emj.2016.08.001
   Sarstedt M, 2016, J BUS RES, V69, P3998, DOI 10.1016/j.jbusres.2016.06.007
   Sevillano, 2020, COVID 19 SPAIN UNREL
   Taylor SN, 2011, J APPL BEHAV SCI, V47, P432, DOI 10.1177/0021886311408724
   Tiefenhuler A., 2020, NEW YORK TIMES
   van Oudenhoven JP, 2012, SWISS J PSYCHOL, V71, P29, DOI 10.1024/1421-0185/a000068
   Vatamanescu EM, 2018, INFORM TECHNOL PEOPL, V31, P84, DOI 10.1108/ITP-06-2016-0135
   Warren AM, 2014, GOV INFORM Q, V31, P291, DOI 10.1016/j.giq.2013.11.007
   Wijnhoven F, 2015, GOV INFORM Q, V32, P30, DOI 10.1016/j.giq.2014.10.002
   Yuan J, 2020, INT J INFECT DIS, V95, P311, DOI 10.1016/j.ijid.2020.03.050
   Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351
NR 43
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2372-7268
BN 978-1-7281-5950-8
J9 IEEE INT TECHNOL MAN
PY 2020
DI 10.1109/ICTMOD49425.2020.9380601
PG 6
WC Engineering, Electrical & Electronic
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Engineering
GA BR6QR
UT WOS:000662940500023
OA Bronze
DA 2022-04-20
ER

PT J
AU Spagnuolo, R
   Larussa, T
   Iannelli, C
   Cosco, C
   Nistico, E
   Manduci, E
   Bruno, A
   Boccuto, L
   Abenavoli, L
   Luzza, F
   Doldo, P
AF Spagnuolo, Rocco
   Larussa, Tiziana
   Iannelli, Chiara
   Cosco, Cristina
   Nistico, Eleonora
   Manduci, Elena
   Bruno, Amalia
   Boccuto, Luigi
   Abenavoli, Ludovico
   Luzza, Francesco
   Doldo, Patrizia
TI COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and
   Perceptions in a Single Center Survey
SO MEDICINA-LITHUANIA
LA English
DT Article
DE COVID-19; inflammatory bowel disease; knowledge; anxiety; pandemic;
   health care; prevention measures
ID EUROPEAN CROHNS; TRAIT ANXIETY; DEPRESSION; MANAGEMENT; OUTBREAK; STATE
AB Background and objectives: Spreading of SARS-CoV-2 infection from China to countries with a higher prevalence of inflammatory bowel disease (IBD) has generated concern among gastroenterologists and patients. The aim of this survey is to evaluate knowledge about clinical importance of COVID-19, disease management, prevention measures, and anxiety level during pandemic among patients with IBD.Material and methods: From 15th March to 15th April 2020, a questionnaire survey was administered to 200 patients with IBD by email or phone application. The questionnaire consisted of five sections: (1) anthropometric, demographic and clinical characteristics, (2) knowledge about clinical importance of COVID-19, (3) IBD management, (4) prevention measures, (5) anxiety level during pandemic.Results: One hundred forty two questionnaires were completed. Ninety-seven patients (68.3%) were males with a mean age of 46 years (SD 13; range 17-76).Fifty-four individuals (38%) were affected by Crohn disease and 88 (62%) by Ulcerative Colitis. Most patients reported high knowledge about clinical importance of COVID-19 (80%), IBD management (72%), and prevention measures (97%). Sixty-two percent of them showed moderate-high level of anxiety. High education level was independently associated with high knowledge about clinical importance of COVID-19 (odds ratio [OR] 5, 95% confidence interval [CI] 1.49-16.6,p= 0.009) and older age (OR 1, 95%, CI 1.01-1.1,p= 0.01), while the receipt of e-format educational material with low knowledge about clinical importance of COVID-19 (OR 3, 95%, CI 1.08-9.3,p= 0.03). Displaying an active disease appeared to be independently associated with low knowledge of IBD management (OR 5.8, 95% CI 1.4-22.8,p= 0.01) and no variables other than an older age was independently associated with higher level of anxiety (OR 1.04, 95% CI 1.009-1.09,p= 0.01).Conclusions: High educational level and aging promote knowledge about clinical importance of COVID-19, while e-format educational material does not. Taken together with findings that an active disease status compromises knowledge of IBD management and the high level of anxiety related to increasing age, these data suggest the need of further supporting patient-oriented strategies in IBD during Covid-19 pandemic.
C1 [Spagnuolo, Rocco; Cosco, Cristina; Nistico, Eleonora; Manduci, Elena; Bruno, Amalia; Doldo, Patrizia] Magna Graecia Univ Catanzaro, Clin & Expt Med Dept, Viale Europa, I-88100 Catanzaro, Italy.
   [Larussa, Tiziana; Iannelli, Chiara; Abenavoli, Ludovico; Luzza, Francesco] Magna Graecia Univ Catanzaro, Hlth Sci Dept, Viale Europa, I-88100 Catanzaro, Italy.
   [Boccuto, Luigi] Clemson Univ, Greenwood Genet Ctr, Clemson, SC 29631 USA.
RP Spagnuolo, R (corresponding author), Magna Graecia Univ Catanzaro, Clin & Expt Med Dept, Viale Europa, I-88100 Catanzaro, Italy.
EM spagnuolo@unicz.it; tiziana.larussa@gmail.com; iannelly@yahoo.it;
   cosco.cristina@libero.it; eleonoranis7@gmail.com;
   manducielena93@gmail.com; amalia.bru93@yahoo.it; lboccuto@ggc.org;
   l.abenavoli@unicz.it; luzza@unicz.it; doldo@unicz.it
RI spagnuolo, rocco/K-7979-2018
OI spagnuolo, rocco/0000-0002-0871-4644; Luzza,
   Francesco/0000-0001-5120-1046; Larussa, Tiziana/0000-0001-6998-8502;
   MONTEBIANCO ABENAVOLI, Ludovico/0000-0002-5922-1524; Boccuto,
   Luigi/0000-0003-2017-4270
CR Abenavoli L, 2020, REV RECENT CLIN TRIA, V15, P87, DOI 10.2174/1574887115999200407143449
   Addolorato G, 2008, INT J CLIN PRACT, V62, P1063, DOI 10.1111/j.1742-1241.2008.01763.x
   Al-Ani AH, 2020, ALIMENT PHARM THER, V52, P54, DOI 10.1111/apt.15779
   Allocca M, 2020, CLIN GASTROENTEROL H, V18, P1882, DOI 10.1016/j.cgh.2020.04.028
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   Bezzio C, 2020, GUT, V69, P1213, DOI 10.1136/gutjnl-2020-321411
   Boyapati RK, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012540.pub2
   Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372
   D'Amico F, 2020, GASTROENTEROLOGY, V159, P14, DOI 10.1053/j.gastro.2020.04.059
   D'Amico F, 2020, LANCET GASTROENTEROL, V5, P631, DOI 10.1016/S2468-1253(20)30151-5
   Danese S, 2020, NAT REV GASTRO HEPAT, V17, P253, DOI 10.1038/s41575-020-0294-8
   Doherty G, 2018, J CROHNS COLITIS, V12, P17, DOI 10.1093/ecco-jcc/jjx101
   Fiorino G, 2020, J CROHNS COLITIS, V14, P1330, DOI 10.1093/ecco-jcc/jjaa058
   Grunert PC, 2020, J CROHNS COLITIS, V14, P1702, DOI 10.1093/ecco-jcc/jjaa126
   HARVEY RF, 1980, LANCET, V1, P514
   IOIBD, UPD COVID19 PAT CHRO
   Kurina LM, 2001, J EPIDEMIOL COMMUN H, V55, P716, DOI 10.1136/jech.55.10.716
   Lewis K, 2019, INFLAMM BOWEL DIS, V25, P1674, DOI 10.1093/ibd/izz045
   Magro F, 2017, J CROHNS COLITIS, V11, P649, DOI 10.1093/ecco-jcc/jjx008
   Mancina RM, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56010045
   Monteleone G, 2020, J CROHNS COLITIS, V14, P1334, DOI 10.1093/ecco-jcc/jjaa061
   Mosli M, 2020, J GASTROENTEROL, DOI [10.4103/sjg.SJG_220_20, DOI 10.4103/SJG.SJG_220_20]
   Norsa L, 2020, GASTROENTEROLOGY, V159, P371, DOI [10.1053/j.gastro.2020.03.062, 10.1053/j.gastro.2020.03.06]
   Rahier JF, 2014, J CROHNS COLITIS, V8, P443, DOI 10.1016/j.crohns.2013.12.013
   Ren H, 2020, PROTECTION 318 INFLA
   Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516
   Spagnuolo R, PEERJ
   Tluczek A, 2009, J NURS MEAS, V17, P19, DOI 10.1891/1061-3749.17.1.19
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 30
TC 9
Z9 9
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1010-660X
EI 1648-9144
J9 MEDICINA-LITHUANIA
JI Med. Lith.
PD AUG
PY 2020
VL 56
IS 8
AR 407
DI 10.3390/medicina56080407
PG 11
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA NG7DF
UT WOS:000564140000001
PM 32823727
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Tome, E
   Gromova, E
   Hatch, A
AF Tome, Eduardo
   Gromova, Elizaveta
   Hatch, Andrew
TI Knowledge management and COVID-19: Technology, people and processes
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article
ID DYNAMIC CAPABILITIES; TRUST; PERCEPTION
AB In this paper, we analyse the impact of the Covid-19 crisis in organizations from the point of view of knowledge management. Specifically, we address the question of technology, people and processes. We conclude, first, that KM should be put at the centre stage in 2021 because, above all, first and foremost, the Covid-19 crisis is a crisis about knowledge, and that a massive knowledge failure has been at its core namely, the absence of a vaccine and the cure for Covid-19. We furthermore conclude that in organizations, there was a complete lack of "social knowledge" linked with "organizational behaviour" which led to an organizational crisis; quite crucially, we believe that the mentioned crisis was even fostered by the immense technology available, but continued because, despite all the value of people, there was not knowledge about processes; in fact, suddenly, the drastic change in setting caused previously competent people to become incompetent. All this leads to the third conclusion, namely, the solution of the crisis will be achieved using technology and making people competent again and teaching them the right processes. Finally, for the time being, Humanity is still searching for answers, and we believe that all the partial measures (such as use of masks, social distance, washing hands, home/remote working, etc.) will mean an advance and increase in organizational agility.
C1 [Tome, Eduardo] Univ Lusofona Humanidades & Tecnol Lisboa, Sch Econ & Org, Aveiro, Portugal.
   [Tome, Eduardo] Univ Aveiro, GOVCOPP, Aveiro, Portugal.
   [Gromova, Elizaveta] Peter Great St Petersburg Polytech Univ, Dept Econ Management & Mkt, St Petersburg, Russia.
   [Hatch, Andrew] Univ Aveiro, GOVCOPP, Publ Policy Sect, Aveiro, Portugal.
RP Tome, E (corresponding author), Univ Lusofona Humanidades & Tecnol Lisboa, Sch Econ & Org, Aveiro, Portugal.; Tome, E (corresponding author), Univ Aveiro, GOVCOPP, Aveiro, Portugal.
EM eduardo.tome@gmail.com
CR Al Ahbabi SA, 2019, J KNOWL MANAG, V23, P351, DOI 10.1108/JKM-08-2017-0348
   Andreeva T, 2012, J KNOWL MANAG, V16, P617, DOI 10.1108/13673271211246185
   [Anonymous], 2020, BBC
   [Anonymous], 2020, THE GUARDIAN
   Biospace, 2021, CAN COVID 19 BE ER N
   Blackwell, 2002, KNOWLEDGE MANAGEMENT, P43
   Blomqvist K., 1997, SCAND J MANAG, V13, P271, DOI DOI 10.1016/S0956-5221(97)84644-1
   Booth R., 1996, Engineering Management Journal, V6, P105, DOI 10.1049/em:19960206
   BrainyQuote, 2021, HERACLITE
   Bratianu C, 2021, KNOWL PROCESS MANAG, V28, P11, DOI 10.1002/kpm.1656
   Bratianu C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041348
   Brooks D.., 2020, PANDEMIC FEAR AGONY
   Butcher, 2020, CORONAVIRUS DEATHS B
   Chams-Anturi O, 2020, PERS REV, V49, P956, DOI 10.1108/PR-07-2018-0239
   Chatti MA, 2012, J KNOWL MANAG, V16, P829, DOI 10.1108/13673271211262835
   Drahokoupil, 2020, POLITICAL BUSINESS C
   Dumay, 2016, ECKM 2016
   Edvinsson, 2005, INTELLECTUAL CAPITAL, P368
   Edwards John, 2011, Electronic Journal of Knowledge Management, V9, P297
   European Commission, 2008, EUR QUAL FRAM LIF LE
   European Commission, 2021, REC PLAN EUR
   Fifield A.., 2020, NZ EDGES BACK NORMAL
   Figueiredo P.., 2015, KNOWLEDGE MANAGEMENT, V3, P193
   Gallagher J., 2020, CORONAVIRUS VACCINE
   Goldman S.L., 1995, AGILE COMPETITORS VI
   Gopinath G., 2020, GREAT LOCKDOWN WORST
   Granados ML, 2017, J KNOWL MANAG, V21, P376, DOI 10.1108/JKM-01-2016-0026
   Gunasekaran A, 1998, INT J PROD RES, V36, P1223, DOI 10.1080/002075498193291
   Gunasekaran A, 2008, OMEGA-INT J MANAGE S, V36, P549, DOI 10.1016/j.omega.2006.12.002
   Harper, 2020, CORONAVIRUS FLEXIBLE
   Hazel, 2020, DATA IS CHEAP INFORM
   Highsmith J, 2004, AGILE PROJECT MANAGE
   Jornal I.., 2021, GOUVEIA MELO SAYS HE
   Kidd P.T., 1994, AGILE MANUFACTURING
   Kim T.H.., 2020, WHY SWEDEN IS UNLIKE
   Le Deist FD, 2005, HUM RESOUR DEV INT, V8, P27, DOI 10.1080/1367886042000338227
   Mc Guire, 2014, HUMAN RESOURCE DEV
   Nonaka I, 1998, CALIF MANAGE REV, V40, P40, DOI 10.2307/41165942
   Nonaka I, 1995, KNOWLEDGE CREATING C
   North K, 2003, J UNIVERS COMPUT SCI, V9, P463
   Phillips N, 2021, NATURE, V590, P382, DOI 10.1038/d41586-021-00396-2
   Pistaferri, 2020, COVID 19 RECESSION I
   Podesva RJ, 2015, LANG VAR CHANGE, V27, P59, DOI 10.1017/S0954394514000192
   Reiersen J, 2017, J BUS ECON MANAG, V18, P585, DOI 10.3846/16111699.2017.1334228
   Remenyi, 2020, KM POSTCOVID 19 NEW, P133
   Roos P., 2021, ADAPTING UNEXPECTED, V139
   Roser M., 2020, CORONAVIRUS COVID 19
   Rowley J, 2007, J INF SCI, V33, P163, DOI 10.1177/0165551506070706
   Sankowska A., 2016, J EC MANAGEMENT, V23, P33
   Sapienza P, 2012, INT REV FINANC, V12, P123, DOI 10.1111/j.1468-2443.2012.01152.x
   Sargent G.., 2020, TRUMP IS BADLY BOTCH
   Shubhangi, 2019, INT J BUSINESS INSIG, V12, P32
   Sveiby K.-E., 2012, CHALLENGING INNOVATI
   Tankersley J.., 2021, BIDEN DETAILS 2 TRIL
   Teece D, 2016, CALIF MANAGE REV, V58, P13, DOI 10.1525/cmr.2016.58.4.13
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Tome E, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13084518
   Weider di Mauro B.., 2020, EC TIME COVID 19 EDI
   White MP, 2006, RISK ANAL, V26, P1187, DOI 10.1111/j.1539-6924.2006.00807.x
   WHO, 2021, STAT 2 M INT HLTH RE
   Winfiel N.., 2020, NEW NORMALCOUNTRIES
   Worldmeters, 2021, COVID 19
NR 62
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
PD JAN
PY 2022
VL 29
IS 1
BP 70
EP 78
DI 10.1002/kpm.1699
EA JAN 2022
PG 9
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZD1GF
UT WOS:000739900300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Turki, H
   Taieb, MAH
   Shafee, T
   Lubiana, T
   Jemielniak, D
   Ben Aouicha, M
   Gayo, JEL
   Youngstrom, EA
   Banat, M
   Das, D
   Mietchen, D
AF Turki, Houcemeddine
   Taieb, Mohamed Ali Hadj
   Shafee, Thomas
   Lubiana, Tiago
   Jemielniak, Dariusz
   Ben Aouicha, Mohamed
   Gayo, Jose Emilio Labra
   Youngstrom, Eric A.
   Banat, Mus'ab
   Das, Diptanshu
   Mietchen, Daniel
CA WikiProject COVID-19
TI Representing COVID-19 information in collaborative knowledge graphs: The
   case of Wikidata
SO SEMANTIC WEB
LA English
DT Article
DE Public health surveillance; Wikidata; knowledge graph; COVID-19; SPARQL;
   community curation; FAIR data; linked open data
ID LINKED DATA; EVOLUTION; IMPACT
AB Information related to the COVID-19 pandemic ranges from biological to bibliographic, from geographical to genetic and beyond. The structure of the raw data is highly complex, so converting it to meaningful insight requires data curation, integration, extraction and visualization, the global crowdsourcing of which provides both additional challenges and opportunities. Wikidata is an interdisciplinary, multilingual, open collaborative knowledge base of more than 90 million entities connected by well over a billion relationships. It acts as a web-scale platform for broader computer-supported cooperative work and linked open data, since it can be written to and queried in multiple ways in near real time by specialists, automated tools and the public. The main query language, SPARQL, is a semantic language used to retrieve and process information from databases saved in Resource Description Framework (RDF) format.
   Here, we introduce four aspects of Wikidata that enable it to serve as a knowledge base for general information on the COVID-19 pandemic: its flexible data model, its multilingual features, its alignment to multiple external databases, and its multidisciplinary organization. The rich knowledge graph created for COVID-19 in Wikidata can be visualized, explored, and analyzed for purposes like decision support as well as educational and scholarly research.
C1 [Turki, Houcemeddine] Univ Sfax, Fac Med Sfax, Sfax, Tunisia.
   [Turki, Houcemeddine; Taieb, Mohamed Ali Hadj; Ben Aouicha, Mohamed] Univ Sfax, Fac Sci Sfax, Data Engn & Semant Res Unit, Sfax, Tunisia.
   [Shafee, Thomas] La Trobe Univ, Melbourne, Vic, Australia.
   [Lubiana, Tiago] Univ Sao Paulo, Computat Syst Biol Lab, Sao Paulo, SP, Brazil.
   [Jemielniak, Dariusz] Kozminski Univ, Dept Management Networked & Digital Soc, Warsaw, Poland.
   [Gayo, Jose Emilio Labra] Univ Oviedo, Web Semant Oviedo WESO Res Grp, Oviedo, Spain.
   [Youngstrom, Eric A.] Univ N Carolina, Dept Psychol & Neurosci, CB 3270,Davie Hall, Chapel Hill, NC 27599 USA.
   [Banat, Mus'ab] Hashemite Univ, Fac Med, Zarqa, Jordan.
   [Das, Diptanshu] Inst Child Hlth ICH, Kolkata, India.
   [Das, Diptanshu] Med Superspecialty Hosp, Kolkata, India.
   [Mietchen, Daniel] Univ Virginia, Sch Data Sci, Charlottesville, VA 22904 USA.
   [Mietchen, Daniel] Fraunhofer Inst Biomed Engn, Biomed Data & Bioeth, Wurzburg, Germany.
RP Mietchen, D (corresponding author), Univ Virginia, Sch Data Sci, Charlottesville, VA 22904 USA.; Mietchen, D (corresponding author), Fraunhofer Inst Biomed Engn, Biomed Data & Bioeth, Wurzburg, Germany.
EM daniel.mietchen@ibmt.fraunhofer.de
RI Jemielniak, Dariusz/M-9949-2019; Youngstrom, Eric A./ABE-3258-2020;
   Labra-Gayo, Jose Emilio/L-9181-2014; Mietchen, Daniel/A-7748-2009;
   Turki, Houcemeddine/J-8929-2013
OI Jemielniak, Dariusz/0000-0002-3745-7931; Youngstrom, Eric
   A./0000-0003-2251-6860; Hadj Taieb, Mohamed Ali/0000-0002-2786-8913;
   Labra-Gayo, Jose Emilio/0000-0001-8907-5348; Mietchen,
   Daniel/0000-0001-9488-1870; Shafee, Thomas/0000-0002-2298-7593; Das,
   Diptanshu/0000-0002-7221-5022; Ben Aouicha, Mohamed/0000-0002-2277-5814;
   Lubiana Alves, Tiago/0000-0003-2473-2313; Turki,
   Houcemeddine/0000-0003-3492-2014
FU Ministry of Higher Education and Scientific Research in Tunisia (MoHESR)
   [PRFCOV19-D1-P1]; Spanish Ministry of Economy and CompetitivenessSpanish
   Government [TIN2017-88877-R]; Alfred P. Sloan FoundationAlfred P. Sloan
   Foundation [G-2019-11458]; Polish National Science Center
   [2019/35/B/HS6/01056]
FX The work done by Houcemeddine Turki, Mohamed Ali Hadj Taieb and Mohamed
   Ben Aouicha was supported by the Ministry of Higher Education and
   Scientific Research in Tunisia (MoHESR) in the framework of Federated
   Research Project PRFCOV19-D1-P1. The work done by Jose Emilio Labra Gayo
   was partially funded by the Spanish Ministry of Economy and
   Competitiveness (Society challenges: TIN2017-88877-R). The work done by
   Daniel Mietchen was supported in part by the Alfred P. Sloan Foundation
   under grant number G-2019-11458. The work done by Dariusz Jemielniak was
   funded by Polish National Science Center grant no 2019/35/B/HS6/01056.
   We thank the Wikidata community, Egon Willighagen (Maastricht
   University, Netherlands), Toby Hudson (University of Sydney, Australia),
   Adam Shorland (Wikimedia Deutschland, Germany), and Mahir Morshed
   (University of Illinois at Urbana-Champaign, United States of America)
   for useful comments and discussions about the topic of this research
   paper.
CR Abian D, 2018, LECT NOTES COMPUT SC, V10546, P142, DOI 10.1007/978-3-319-74497-1_14
   Addshore D., 2020, Zenodo, DOI 10.5281/ zenodo.3977414
   Allison-Cassin S., 2018, CODE4LIB J, V40
   Alocci D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144578
   Angles R., 2019, P 13 A MEND INT WORK
   Aturban M, 2018, ACM-IEEE J CONF DIG, P321, DOI 10.1145/3197026.3203880
   Balaraman V, 2018, COMPANION PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE 2018 (WWW 2018), P1787, DOI 10.1145/3184558.3191641
   Bellomarini L., 2020, ARXIV PREPRINT ARXIV
   Benjakob O., 2021, METARESEARCH CITATIO, DOI [10.1101/2021.03.01.433379, DOI 10.1101/2021.03.01.433379]
   Boccone A., 2019, BIBLIOTHECAE, V8, P227, DOI [10.6092/issn.2283-9364/9503, DOI 10.6092/ISSN.2283-9364/9503]
   Burgstaller-Muehlbacher S, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw015
   Chaari L, 2020, EPMA J, V11, P133, DOI 10.1007/s13167-020-00207-0
   Chrzanowski J, 2021, J MED INTERNET RES, V23, DOI 10.2196/26331
   Ciechanowski L, 2020, J BUS RES, V117, P322, DOI 10.1016/j.jbusres.2020.06.012
   Cohen J., 1988, STAT POWER ANAL BEHA, V2, DOI [10.1111/1467-9507.00183, DOI 10.4324/9780203771587]
   Dadzie AS, 2011, SEMANT WEB, V2, P89, DOI 10.3233/SW-2011-0037
   Darari F, 2021, JURNAL ILMU KOMPUTER, V14, P39, DOI [10.21609/jiki.v14i1. 941, DOI 10.21609/JIKI.V14I1.941]
   Darari F, 2016, LECT NOTES COMPUT SC, V9671, P170, DOI 10.1007/978-3-319-38791-8_10
   de Freitas F., 2009, ELECT J COMMUNICATIO, P7
   De Giacomo G., 2018, COMPREHENSIVE GUIDE, P187, DOI DOI 10.1007/978-3-319-61893-7_11
   De Melo G., 2010, PRINCIPLES CONSTRUCT, P149
   Debattista J, 2018, SEMANT WEB, V9, P859, DOI 10.3233/SW-180306
   Desvars-Larrive A, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00609-9
   Dimitrov D., 2020, ARXIV PREPRINT ARXIV
   Domingo-Fernndez D, 2020, COVID 19 KNOWLEDGE G, DOI [10.1101/2020.04.14.040667, DOI 10.1101/2020.04.14.040667]
   Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035
   Eberhand DM, 2020, ETHNOLOGUE LANGUAGES
   Ehrlinger L., 2016, SEMANTICS
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Erxleben F, 2014, LECT NOTES COMPUT SC, V8796, P50, DOI 10.1007/978-3-319-11964-9_4
   Farber M, 2018, SEMANT WEB, V9
   Farda-Sarbas M, 2019, PROCEEDINGS OF THE 15TH INTERNATIONAL SYMPOSIUM ON OPEN COLLABORATION (OPENSYM), DOI 10.1145/3306446.3340833
   Finn RD, 2012, NUCLEIC ACIDS RES, V40, pD9, DOI 10.1093/nar/gkr1195
   Fontelo P, 2007, STUD HEALTH TECHNOL, V129, P817
   Guidotti E., 2020, J OPEN SOURCE SOFTW, V5, P2376, DOI [10.21105/joss.02376, DOI 10.21105/JOSS.02376]
   Hagedorn G, 2011, ZOOKEYS, P127, DOI 10.3897/zookeys.150.2189
   He YQ, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0523-6
   Heilman JM, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4069
   Henriksson A., 2013, P 2013 WORKSH BIOM N, P36
   Hernndez D., 2015, P SCAL SEM WEB SYST, P32, DOI DOI 10.1145/2566486.2567973
   Hitzler P, 2013, SEMANT WEB, V4, P233, DOI 10.3233/SW-130117
   Hu XJ, 2011, J INFORMETR, V5, P27, DOI 10.1016/j.joi.2010.07.004
   Huss JW, 2008, PLOS BIOL, V6, P1398, DOI 10.1371/journal.pbio.0060175
   Iglesias E., 2020, ARXIV200807176
   Ismayilov A, 2018, SEMANT WEB, V9, P493, DOI 10.3233/SW-170277
   Jaradeh MY, 2019, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON KNOWLEDGE CAPTURE (K-CAP '19), P243, DOI 10.1145/3360901.3364435
   Jemielniak D., 2014, COMMON KNOWLEDGE ETH
   Jemielniak D, 2019, J MED INTERNET RES, V21, DOI 10.2196/11429
   Jette N, 2010, MED CARE, V48, P1105, DOI 10.1097/MLR.0b013e3181ef9d3e
   Juul S, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01371-0
   Kaffee LA, 2018, PROCEEDINGS OF THE 14TH INTERNATIONAL SYMPOSIUM ON OPEN COLLABORATION (OPENSYM'18), DOI 10.1145/3233391.3233965
   Kaffee Lucie-Aimee, 2017, P 13 INT S, P1, DOI [10.1145/3125433.3125465, DOI 10.1145/3125433.3125465]
   Kagan D, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa085
   Keegan B.C., 2020, ARXIV PREPRINT ARXIV
   Keegan B, 2013, AM BEHAV SCI, V57, P595, DOI 10.1177/0002764212469367
   Keegan BC, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P533, DOI 10.1145/2675133.2675238
   Kirk, 2016, DATA VISUALISATION H
   Klein M., 2013, CODE4LIB J, P22
   Konieczny P, 2010, J INF TECHNOL POLITI, V7, P263, DOI 10.1080/19331681.2010.489408
   Lehmann J, 2015, SEMANT WEB, V6, P167, DOI 10.3233/SW-140134
   Liu, 2020, ONTOLOGICAL BIOINFOR, DOI [10.20944/PREPRINTS202003.0413.V1, DOI 10.20944/PREPRINTS202003.0413.V1]
   Liu Fang, 2006, AMIA Annu Symp Proc, P1012
   Lu Wang L., 2020, CORD 19 COVID 19 OPE
   Lublin DM, 2000, TRANSFUSION, V40, P1285, DOI 10.1046/j.1537-2995.2000.40111285.x
   Majumder MS, 2020, LANCET GLOB HEALTH, V8, pE627, DOI 10.1016/S2214-109X(20)30113-3
   Malyshev S, 2018, LECT NOTES COMPUT SC, V11137, P376, DOI 10.1007/978-3-030-00668-6_23
   Manske Magnus, 2019, Wellcome Open Res, V4, P114, DOI 10.12688/wellcomeopenres.15355.1
   Mietchen D., 2015, RES IDEAS OUTCOMES, V1, pe7573, DOI [10.3897/rio.1.e7573, DOI 10.3897/RI0.1.E7573]
   Mietchen D., 2020, WORKSH OP CIT OP SCH, DOI [10.5281/zenodo. 4019954, DOI 10.5281/ZENODO.4019954]
   Mortensen JM, 2015, J AM MED INFORM ASSN, V22, P640, DOI 10.1136/amiajnl-2014-002901
   Motta E., 2014, P INT C CONS LINK DA, V1264, P73, DOI DOI 10.5555/2877789.2877796
   Nielsen FA, 2017, IN SY AP IN WE HC, V10577, P237, DOI 10.1007/978-3-319-70407-4_36
   Nunn J., 2019, STANDARDISED DATA IN, DOI [10.31219/osf.io/5q47h, DOI 10.31219/OSF.IO/5Q47H]
   Ordun C., 2020, ARXIV200503082
   Ostaszewski M, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0477-8
   Page R., 2016, RES IDEAS OUTCOMES, V2, P8767, DOI [10.3897/rio.2.e8767, DOI 10.3897/RIO.2.E8767]
   Paulheim H, 2017, SEMANT WEB, V8, P489, DOI 10.3233/SW-160218
   Penev L, 2017, RES IDEAS OUTCOMES, V3, DOI DOI 10.3897/RIO.3.E12431
   Prudhommeaux E., 2014, P 10 INT C SEM SYST, P32, DOI DOI 10.1145/2660517.2660523
   Putman TE, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax025
   Queralt-Rosinach N, 2020, DATABASE-OXFORD, V2020, DOI 10.1093/database/baaa015
   Rahimi A., 2020, ARXIV PREPRINT ARXIV
   RDA COVID-19 Working Group, 2020, REC GUID DAT SHAR, DOI [10.15497/rda00052, DOI 10.15497/RDA00052]
   Rico M, 2018, 33RD ANNUAL ACM SYMPOSIUM ON APPLIED COMPUTING, P323, DOI 10.1145/3167132.3167164
   Ringler D, 2017, LECT NOTES ARTIF INT, V10505, P366, DOI 10.1007/978-3-319-67190-1_33
   Ristoski P, 2016, LECT NOTES COMPUT SC, V9982, P186, DOI 10.1007/978-3-319-46547-0_20
   Rodgers RPC, 2004, STUD HEALTH TECHNOL, V107, P425
   Rotmensch M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05778-z
   Samuel J., 2018, COMPANION WEB C 2018, P23
   Schriml LM, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0524-5
   Sebei H, 2018, SOC NETW ANAL MIN, V8, DOI 10.1007/s13278-018-0507-0
   Shafee T, 2017, J EPIDEMIOL COMMUN H, V71, P1122, DOI 10.1136/jech-2016-208601
   Tanon TP, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P1419, DOI 10.1145/2872427.2874809
   Taraborelli D., 2017, WIKICITE 2017 REPORT, DOI [10.6084/m9. figshare.5648233, DOI 10.6084/M9.FIGSHARE.5648233]
   Terryn AR, 2020, LANG RESOUR EVAL, V54, P385, DOI 10.1007/s10579-019-09453-9
   Turki H., 2020, Csisc/WikidataCOVID19SPARQL: Data about Wikidata coverage of Covid-19, DOI 10.5281/zenodo.4022591
   Turki H., 2020, ZENODO, DOI [10.5281/zenodo.4008358, DOI 10.5281/ZENODO.4008358]
   Turki H, 2019, J BIOMED INFORM, V99, DOI 10.1016/j.jbi.2019.103292
   Turki H, 2018, J BIOMED INFORM, V83, P217, DOI 10.1016/j.jbi.2018.05.011
   United Nations Development Programme, 2020, HUM DEV REP 2020 NEX, P343
   Vincent N, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3174140
   Vossen P, 2016, KNOWL-BASED SYST, V110, P60, DOI 10.1016/j.knosys.2016.07.013
   Vrandecic D, 2014, COMMUN ACM, V57, P78, DOI 10.1145/2629489
   Waagmeester A., 2019, BIODIVERSITY INFORM, V3, DOI [10.3897/biss.3.35206, DOI 10.3897/BISS.3.35206]
   Waagmeester A, 2021, BMC BIOL, V19, DOI 10.1186/s12915-020-00940-y
   Waagmeester A, 2020, ELIFE, V9, DOI 10.7554/eLife.52614
   Wyatt L., 2020, WIKICITE ANN REPORT, DOI [10.5281/zenodo.3869809, DOI 10.5281/ZENODO.3869809]
   Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5
   Zaveri A, 2016, SEMANT WEB, V7, P63, DOI 10.3233/SW-150175
   Zhang YJ, 2018, J BIOMED INFORM, V81, P83, DOI 10.1016/j.jbi.2018.03.011
   Zhang ZQ, 2020, J INFECTION, V81, P170, DOI 10.1016/j.jinf.2020.03.018
NR 111
TC 0
Z9 0
U1 3
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1570-0844
EI 2210-4968
J9 SEMANT WEB
JI Semant. Web
PY 2022
VL 13
IS 2
BP 233
EP 264
DI 10.3233/SW-210444
PG 32
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA YV6TV
UT WOS:000752861100006
OA Green Submitted, hybrid
DA 2022-04-20
ER

PT J
AU Gonzalez-Aguna, A
   Jimenez-Rodriguez, ML
   Fernandez-Batalla, M
   Herrero-Jaen, S
   Monsalvo-San Macario, E
   Real-Martinez, V
   Santamaria-Garcia, JM
AF Gonzalez-Aguna, Alexandra
   Lourdes Jimenez-Rodriguez, Maria
   Fernandez-Batalla, Marta
   Herrero-Jaen, Sara
   Monsalvo-San Macario, Enrique
   Real-Martinez, Veronica
   Maria Santamaria-Garcia, Jose
TI Nursing Diagnoses for Coronavirus Disease, COVID-19: Identification by
   Taxonomic Triangulation
SO INTERNATIONAL JOURNAL OF NURSING KNOWLEDGE
LA English
DT Article
DE coronavirus; diagnosis; knowledge management; nursing methodology
   research; standardized nursing terminology
AB PURPOSE To identify the nursing care problems related to the clinical process of disease by COVID-19. METHOD The study applied the taxonomic triangulation technique on a clinical management guide to coronavirus disease, COVID-19, from the World Health Organization. The technique is divided into the phases: extraction of knowledge in natural language about assessment, planning and intervention, translation into standard language NOC and NIC, linking to NANDA-I diagnoses, triangulation looking for diagnostic matches in the three sets, and, finally, validation by a panel of experts from a hospital and a university. FINDINGS The extraction identified 159 terms in natural language that were translated into 173 variables: 34 NOC for assessment, 19 NOC for planning, and 120 NIC for intervention. The relationships to NANDA-I diagnoses recorded 2,182 links and the triangulation returned 109 diagnoses, 54 of them for a critical situation. The panel of experts unanimously validated the 29 diagnoses with the highest number of links. CONCLUSION Coronavirus disease, COVID-19, involves a complex situation with multiple associated care problems that can be identified using the taxonomic triangulation technique. IMPLICATIONS FOR NURSING PRACTICE The links between taxonomies and the taxonomic triangulation technique are an important tool for generating knowledge. The results of this study may guide the diagnosis and treatment of coronavirus disease, COVID-19, as well as similar processes that occur with acute respiratory distress syndrome.
C1 [Gonzalez-Aguna, Alexandra] Univ Alcala De Henares, Res Grp MISKC, Henares Univ Hosp, Community Madrid Hlth Serv SERMAS, Madrid, Spain.
   [Lourdes Jimenez-Rodriguez, Maria] Univ Alcala De Henares, Comp Sci Dept, Res Grp MISKC UAH, Madrid, Spain.
   [Fernandez-Batalla, Marta] Univ Alcala De Henares, Community Madrid Hlth Serv SERMAS, Res Grp MISKC, Torres Alameda Hlth Ctr, Madrid, Spain.
   [Herrero-Jaen, Sara] Univ Alcala De Henares, Res Grp MISKC, Severo Ochoa Univ Hosp, Community Madrid Hlth Serv SERMAS, Madrid, Spain.
   [Monsalvo-San Macario, Enrique] Univ Alcala De Henares, Res Grp MISKC, La Garena Hlth Ctr, Community Madrid Hlth Serv SERMAS, Madrid, Spain.
   [Real-Martinez, Veronica] COVID 19 IFEMA Hosp, Community Madrid Hlth Serv SERMAS, Madrid Emergency Med Serv SUMMA 112, Madrid, Spain.
   [Maria Santamaria-Garcia, Jose] Univ Alcala De Henares, COVID 19 IFEMA Hosp, Meco Hlth Ctr, Res Grp MISKC,Community Madrid Hlth Serv SERMAS, Madrid, Spain.
RP Gonzalez-Aguna, A (corresponding author), Univ Alcala De Henares, Res Grp MISKC, Henares Univ Hosp, Community Madrid Hlth Serv SERMAS, Madrid, Spain.
EM alexandra.gonzalez@uah.es
RI Rodrí­guez, María Lourdes Jiménez/Y-9763-2018; Lin, Chen/AFV-2163-2022
OI Rodrí­guez, María Lourdes Jiménez/0000-0003-4398-5404; HERRERO JAEN,
   SARA/0000-0001-8830-2983; Monsalvo San Macario,
   Enrique/0000-0001-6662-1633; Gonzalez Aguna,
   Alexandra/0000-0001-9991-6980
FU Madrid Scientific Care Society; Nursing Management team of the COVID-19
   IFEMA Hospital; Research Group MISKC of the University of Alcala
FX The authors would like to thank the support of Madrid Scientific Care
   Society, Nursing Management team of the COVID-19 IFEMA Hospital and the
   Research Group MISKC of the University of Alcala. Furthermore, the
   authors wish to acknowledge Academia Sorge for its support in modeling
   care through languages.
CR All-Party Parliamentary Group on Global Health (APPG), 2016, TRIPL IMP DEV NURS W
   Alligood M. R., 2018, NURSING THEORISTS TH
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2016, INVESTIGACION METODO
   Berger AM, 2004, CIN-COMPUT INFORM NU, V22, P123, DOI 10.1097/00024665-200405000-00006
   Brucker Mary C, 2020, Nurs Womens Health, V24, P155, DOI 10.1016/j.nwh.2020.04.004
   Bulechek G. M., 2013, NURSING INTERVENTION
   Chen LYA, 2016, CIN-COMPUT INFORM NU, V34, P448, DOI 10.1097/CIN.0000000000000282
   D'Agostino F, 2020, INT J NURS KNOWL, V31, P4, DOI 10.1111/2047-3095.12200
   Lopes MVD, 2017, INT J NURS KNOWL, V28, P53, DOI 10.1111/2047-3095.12104
   Dehnavieh R, 2020, INFECT CONT HOSP EP, V41, P878, DOI 10.1017/ice.2020.108
   Gilliam S, 2019, NURSE PRACT, V44, P51, DOI 10.1097/01.NPR.0000554675.55073.5a
   González Aguña Alexandra, 2018, Ene., V12, P1233
   Herdman TH., 2017, NANDA INT NURSING DI, V11th edition
   Huang LS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2841-7
   IFEMA Feria de Madrid, 2020, HOSP IFEMA EST VIR P
   International Organization for Standardization, 2014, 181042014 ISO
   Perez-Rivas FJ, 2020, INT J NURS KNOWL, V31, P124, DOI 10.1111/2047-3095.12253
   Kamitsuru S, 2014, NANDA INT NURSING DI
   Legido-Quigley H, 2020, LANCET PUBLIC HEALTH, V5, pE251, DOI 10.1016/S2468-2667(20)30060-8
   Lloyd-Sherlock PG, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1164
   Mantovani VM, 2020, INT J NURS KNOWL, V31, P246, DOI 10.1111/2047-3095.12279
   Marion J., 2011, NOC NIC LINKAGES NAN
   Moorhead S., 2018, NURSING OUTCOMES CLA, V6
   Moorhead S, 2021, INT J NURS KNOWL, V32, P59, DOI 10.1111/2047-3095.12291
   Nelson R, 2018, ACHIEVING SUSTAINABLE CULTIVATION OF SOYBEANS, VOL 1: BREEDING AND CULTIVATION TECHNIQUES, P23, DOI 10.19103/AS.2017.0034.02
   Newby JC, 2020, J NEUROSCI NURS, V52, pE13, DOI 10.1097/JNN.0000000000000525
   Nunes SRT, 2014, CIN-COMPUT INFORM NU, V32, P322, DOI 10.1097/CIN.0000000000000060
   Othman EH, 2020, INT J NURS KNOWL, V31, P19, DOI 10.1111/2047-3095.12265
   Raurell-Torreda M, 2020, ENFERM INTENSIV, V31, P90, DOI 10.1016/j.enfi.2020.03.002
   Sociedad Cientifica Madrilena del Cuidado, 2020, MUND SOC CIENT MADR
   Swanson, 2013, NURSING OUTCOMES CLA
   University of Alcala, 2020, RES GROUPS MAN INF S
   Vega-Escano J, 2020, INT J NURS KNOWL, V31, P275, DOI 10.1111/2047-3095.12281
   Wagner C.M., 2018, NURSING INTERVENTION
   Wang SS, 2020, CURR MED SCI, V40, P285, DOI 10.1007/s11596-020-2174-4
   WHO, 2021, STAT 2 M INT HLTH RE
   WHO, 2020, Q A COR COVID 19
   WHO, 2020, NOVEL CORONAVIRUS CH
   WHO International Council of Nurses & Nursing Now, 2020, STAT WORLDS NURS 202
   World Health Organization, 2020, WHO PARTN CALL URG I
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1
   Zhang YX, 2020, J ADV NURS, V76, P1483, DOI 10.1111/jan.14364
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 45
TC 6
Z9 6
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-3087
EI 2047-3095
J9 INT J NURS KNOWL
JI Int. J. Nurs. Knowl.
PD APR
PY 2021
VL 32
IS 2
BP 108
EP 116
DI 10.1111/2047-3095.12301
EA AUG 2020
PG 9
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA RI2TW
UT WOS:000559670000001
PM 32798300
OA Bronze
DA 2022-04-20
ER

PT J
AU Li, HB
   Cheng, LL
   Tao, J
   Chen, DY
   Zeng, CC
AF Li, Huoba
   Cheng, Lulu
   Tao, Juan
   Chen, Deyu
   Zeng, Chenchen
TI Knowledge and willingness to receive a COVID-19 vaccine: a survey from
   Anhui Province, China
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE COVID-19 vaccine; geriatric care facility; knowledge; willingness;
   survey
ID POPULATION; LEVEL
AB Objectives Vaccinations can prevent COVID-19 and control its spread quickly and efficiently. This study aimed to investigate knowledge and willingness of geriatric care facility staff to receive a COVID-19 vaccine, and to provide a basis for the government to promote the COVID-19 vaccine and guide people to get vaccinated. Study design A cross-sectional study. Methods Data on characteristics of the participants, knowledge about the COVID-19 vaccine, and willingness to get vaccinated for COVID-19 were collected through an online survey from May 19 to June 18, 2021. Statistical analyses were conducted with ANOVA, chi-square, logistic regression. Results The survey illustrated that the highest score of COVID-19 vaccine knowledge was 50, the lowest 20, and the average 44.22. It also demonstrated that 91.3% of the participants had a good knowledge of COVID-19 vaccine, and that 97.3% participants were willing to receive the COVID-19 vaccine. The results showed that geriatric care facility staff had varied level of the COVID-19 vaccine knowledge depending upon their age, educational background, and other factors, and correspondingly, their willingness to receive COVID-19 vaccine was affected by their knowledge level of COVID-19 vaccine. Conclusions In general, the participants, the staff of geriatric care facilities in Anhui Province, had good mastery of the COVID-19 vaccine, and they were willing to get vaccinated. However, there still existed a few participants with poor knowledge, who were unwilling to get vaccinated against COVID-19. Government can guide people to accept vaccination by enhancing publicity about the effects and adverse reactions of COVID-19 vaccines.
C1 [Li, Huoba; Tao, Juan] Anhui Vocat Coll City Management, Dept Hlth & Elderly Care, Hefei, Anhui, Peoples R China.
   [Cheng, Lulu] Shenzhen Longgang Dist Peoples Hosp, Dept Ophthalmol, Shengzhen, Guangdong, Peoples R China.
   [Chen, Deyu] Fuyang Normal Univ, Med Coll, 100 Qinghe Rd, Fuyang 236037, Anhui, Peoples R China.
   [Zeng, Chenchen] FuYang Inst Technol, Fuyang Hlth Sch, Fuyang, Anhui, Peoples R China.
RP Chen, DY (corresponding author), Fuyang Normal Univ, Med Coll, 100 Qinghe Rd, Fuyang 236037, Anhui, Peoples R China.
EM chendeyu7104@aliyun.com
FU National Natural Science FundNational Natural Science Foundation of
   China (NSFC) [81771567]
FX This study was sponsored by National Natural Science Fund [81771567].
CR Adane D, 2021, RISK MANAG HEALTHC P, V14, P1509, DOI 10.2147/RMHP.S302974
   Ali SN, 2021, LANCET, V397, P1443, DOI 10.1016/S0140-6736(21)00779-0
   AlKetbi LM., 2021, IJID REGIONS, V1, P20, DOI [10.1016/j.ijregi.2021.08.003, DOI 10.1016/J.IJREGI.2021.08.003]
   Aniyeloye AO., 2021, J ADV MED MED RES, V33, P13, DOI [DOI 10.9734/JAMMR/2021/V33I830881, 10.9734/jammr/2021/v33i830881]
   Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Belsti Y, 2021, J MULTIDISCIP HEALTH, V14, P1233, DOI 10.2147/JMDH.S312637
   Bilal A, 2020, INT J GERIATR PSYCH, V35, P1442, DOI 10.1002/gps.5386
   Caban-Martinez AJ, 2021, J OCCUP ENVIRON MED, V63, P369, DOI 10.1097/JOM.0000000000002152
   Chen MS, 2021, HUM VACC IMMUNOTHER, V17, P2279, DOI 10.1080/21645515.2020.1853449
   Danchin M, 2021, INTERN MED J, V51, P1987, DOI 10.1111/imj.15599
   Dib F, 2022, HUM VACC IMMUNOTHER, V18, DOI 10.1080/21645515.2021.1874218
   Ditekemena JD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020153
   Gakuba C, 2021, ANAESTH CRIT CARE PA, V40, DOI 10.1016/j.accpm.2021.100860
   Halim M., 2020, J HLTH CARE RES J HL, V3, P172, DOI [10.36502/2020/hcr.6176, DOI 10.36502/2020/HCR.6176]
   Harris RJ, 2021, NEW ENGL J MED, V385, P759, DOI 10.1056/NEJMc2107717
   Jacob J, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.15271
   Jaramillo-Monge J, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060678
   Kabir R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050416
   Khan MSR, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182111702
   Kourlaba G, 2021, GLOB HEALTH RES POL, V6, DOI 10.1186/s41256-021-00188-1
   Kreps SE, 2021, VACCINE, V39, P3250, DOI 10.1016/j.vaccine.2021.04.044
   Kumari A, 2021, DIABETES METAB SYND, V15, P987, DOI 10.1016/j.dsx.2021.04.015
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Liu CH, 2021, J CHIN MED ASSOC, V84, P9, DOI 10.1097/JCMA.0000000000000461
   Liu RG, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030292
   Mahmud S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257096
   Marquez RR, 2021, J AM DENT ASSOC, V152, P730, DOI 10.1016/j.adaj.2021.03.004
   Mohamed NA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256110
   Nguyen Long H, 2021, medRxiv, DOI 10.1101/2021.02.25.21252402
   Okubo R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060662
   Okubo R, 2021, J AFFECT DISORDERS, V287, P89, DOI 10.1016/j.jad.2021.03.028
   Rodriguez-Blanco N, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105272
   Serrazina F, 2021, MULT SCLER RELAT DIS, V51, DOI 10.1016/j.msard.2021.102880
   Shrestha S, 2021, DRUGS THER PERSPECT, V37, P376, DOI 10.1007/s40267-021-00852-z
   Singh DR, 2020, J COMMUN HEALTH, V45, P1116, DOI 10.1007/s10900-020-00839-3
   Sun SF, 2021, PREV MED REP, V22, DOI 10.1016/j.pmedr.2021.101350
   Thaker J, 2021, J HEALTH COMMUN, V26, P104, DOI 10.1080/10810730.2021.1899346
   Unroe KT, 2021, J AM GERIATR SOC, V69, P593, DOI 10.1111/jgs.17022
   Waite NM, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040346
   Wang JH, 2021, VACCINE, V39, P1968, DOI 10.1016/j.vaccine.2021.02.060
   Wang Q, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040342
   Wang Y., 2021, WILLINGNESS COVID 19, DOI [10.21203/rs.3.rs-275435/v1, DOI 10.21203/RS.3.RS-275435/V1]
   Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279
   Zhang YT, 2021, HUM VACC IMMUNOTHER, V17, P1622, DOI 10.1080/21645515.2020.1847585
   Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3
   Zhu Fengcai, 2021, Clin Infect Dis, DOI 10.1093/cid/ciab845
   Zhu YF, 2021, ASIAN J PHARM SCI, V16, P4, DOI 10.1016/j.ajps.2020.06.001
   Zivkovic SA, 2021, MUSCLE NERVE, V63, P294, DOI 10.1002/mus.27179
NR 48
TC 0
Z9 0
U1 7
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD DEC 31
PY 2022
VL 18
IS 1
DI 10.1080/21645515.2021.2024064
EA FEB 2022
PG 8
WC Biotechnology & Applied Microbiology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biotechnology & Applied Microbiology; Immunology
GA 0H5KQ
UT WOS:000752250100001
PM 35130110
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU AlRasheed, MM
   Alshahrani, AH
   AlMuhaini, SA
   AlKofide, HA
   Alhawassi, TM
   Aldemerdash, A
   Alhaj, OA
   Bragazzi, NL
   Jahrami, HA
AF AlRasheed, Maha M.
   Alshahrani, Amani H.
   AlMuhaini, Sara A.
   AlKofide, Hadeel A.
   Alhawassi, Tariq M.
   Aldemerdash, Ahmed
   Alhaj, Omar A.
   Bragazzi, Nicola L.
   Jahrami, Haitham A.
TI Knowledge, Attitude, and Practice Towards COVID-19 Among Pharmacists: A
   Cross-Sectional Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; pandemic; pharmacists; knowledge; attitudes; practices
ID HEALTH-CARE WORKERS; RESIDENTS
AB Purpose: The COVID-19 outbreak has caused governments to put pandemic-related guidelines requiring compliance and understanding by healthcare professionals to mitigate its spread uncontrollably. We studied pharmacists' knowledge, attitude, and practice towards the COVD-19 outbreak compared with other healthcare workers during the pandemic in Saudi Arabia. Methods: We surveyed pharmacists' socio-demographics (n=50) compared with other healthcare professionals (n=378) during lockdown starting in June 2020. We measured respondents' level of knowledge (n=10 questions, maximum score of 10), attitude (n=17 questions, maximum score of 80), and their practices (n=16 questions, maximum score of 80) towards COVID-19 infection. Results: Median knowledge score was 8 (25th-75th percentiles: 7-9), attitude score 76 (70- 80) and practice score 74 (68-78). Good knowledge predictors were >20 years working experience [OR: 2.05 (95% CI: 1.03-4.06); P=0.04] and >50% working in clinical practice [OR: 1.72 (95% CI: 1.12-2.66); P=0.01], in inverse relationship with paramedical profes-sions [OR: 0.45 (95% CI: 0.45 (0.28-0.72)); P=0.001] and working in a university hospital [OR: 0.51 (95% CI: 0.33. 0.81); P=0.004]. Availability of pharmaceutical information and treatment options was associated with good attitude [OR: 2.19 (95% CI: 1.04-4.59); P=0.039] and acquaintance as primary information sources negatively associated with good attitude [OR: 0.34 (95% CI: 0.15-0.8); P=0.013]. Good practice predictors were female gender [OR: 3.84 (95% CI: 2.37-6.24); P<0.001], military hospital employment [OR: 2.32 (95% CI: 1.25-4.31); P=0.008], USA [OR: 3.41 (95% CI: 1.03-11.22); P=0.044] or UK [OR: 8.86 (95% CI: 1.91-41.07); P=0.005] qualifications, and information on supportive measures [OR: 2.2 (95% CI: 1.36-3.56); P=0.001]. Conclusion: Health workers displayed good knowledge about COVID-19, while profession and working experience predicted adequate knowledge, positive attitude, or practice towards disease management.
C1 [AlRasheed, Maha M.; Alshahrani, Amani H.; AlMuhaini, Sara A.; AlKofide, Hadeel A.; Alhawassi, Tariq M.; Aldemerdash, Ahmed] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.
   [Alhawassi, Tariq M.] King Saud Univ, Coll Pharm, Medicat Safety Res Chair, Riyadh, Saudi Arabia.
   [Alhaj, Omar A.] Univ Petra, Fac Pharm & Med Sci, Dept Nutr, Amman, Jordan.
   [Bragazzi, Nicola L.] York Univ, Dept & Stat, Lab Ind & Appl Math, Toronto, ON, Canada.
   [Jahrami, Haitham A.] Minist Hlth, Manama, Bahrain.
   [Jahrami, Haitham A.] Arabian Gulf Univ, Coll Med & Med Sci, Manama, Bahrain.
RP AlRasheed, MM (corresponding author), King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.
EM mahalrasheed@ksu.edu.sa
RI Alhaj, Omar A./AAM-6772-2021
OI Alhaj, Omar A./0000-0003-0082-3843; AlRasheed, Maha/0000-0001-6668-2874;
   Alkofide, Hadeel/0000-0002-5032-1895; Aldemerdash,
   Ahmed/0000-0002-8655-7410
FU "Research Center of the Female Scientific and Medical Colleges",
   Deanship of Scientific Research, King Saud UniversityKing Saud
   University
FX This research project was supported by a grant from the "Research Center
   of the Female Scientific and Medical Colleges", Deanship of Scientific
   Research, King Saud University.
CR Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015
   Alobuia WM, 2020, J PUBLIC HEALTH-UK, V42, P470, DOI 10.1093/pubmed/fdaa069
   AlRasheed MM, 2021, NAT SCI SLEEP, V13, P1037, DOI 10.2147/NSS.S313373
   AlRasheed MM, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.631717
   Alyami MH, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00506
   [Anonymous], 2004, RAOSOFT SAMPLE SIZE
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Baig M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243526
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Chakraborty C, 2020, EUR REV MED PHARMACO, V24, P4016, DOI 10.26355/eurrev_202004_20871
   Contini C, 2020, J INFECT DEV COUNTR, V14, P254, DOI 10.3855/jidc.12671
   Dkhar SA, 2020, INDIAN J PUBLIC HLTH, V64, P205, DOI 10.4103/ijph.IJPH_469_20
   Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912
   Ghimire Prabina, 2020, J Nepal Health Res Counc, V18, P293, DOI 10.33314/jnhrc.v18i2.2658
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Habib MA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245176
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Kasemy ZA, 2020, J EPIDEMIOL GLOB HEA, V10, P378, DOI 10.2991/jegh.k.200909.001
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Koster ES, 2021, RES SOC ADMIN PHARM, V17, P2002, DOI 10.1016/j.sapharm.2020.07.001
   Li Chunyan, 2020, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V45, P665, DOI 10.11817/j.issn.1672-7347.2020.200277
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Moore WJ, 2021, AM J HEALTH-SYST PH, V78, P1104, DOI 10.1093/ajhp/zxab114
   Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832
   Moreau C, 2021, J AM BOARD FAM MED, V34, pS21, DOI 10.3122/jabfm.2021.S1.200180
   Naser AY, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094699
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Parajuli Janaki, 2020, J Nepal Health Res Counc, V18, P466, DOI 10.33314/jnhrc.v18i3.2816
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Perez M, 2022, EUR J HOSP PHARM, V29, pE30, DOI 10.1136/ejhpharm-2020-002542
   Qadah T, 2020, J INFECT DEV COUNTR, V14, P1090, DOI 10.3855/jidc.13083
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Siddiqui AA, 2020, WORK, V66, P767, DOI 10.3233/WOR-203223
   Ssebuufu R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.618731
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Tamang N, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10025-8
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 49
TC 2
Z9 2
U1 2
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 3079
EP 3090
DI 10.2147/RMHP.S317779
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA TP5UT
UT WOS:000677665200002
PM 34326673
OA Green Published
DA 2022-04-20
ER

PT J
AU Nizami, M
   Grieco, C
   Hogan, J
   Aresu, G
AF Nizami, Maria
   Grieco, Charlotte
   Hogan, John
   Aresu, Giuseppe
TI Surgical management of a COVID-19-associated necrotic pneumonia
SO BMJ CASE REPORTS
LA English
DT Article
DE COVID-19; empyema; cardiothoracic surgery
AB At the outset of the pandemic, SARS-CoV-2 was thought to present simply as persistent cough and fever. However, with time, the medical community noted a myriad of associated symptoms well-described in the literature. Medical complications were particularly common in elderly populations and many early publications described pneumonia, organ failure, acute respiratory distress syndrome, hypercoagulability/microthrombosis and superimposed bacterial/viral infections. There is, however, a lack of literature describing surgical complications of COVID-19 and as such little knowledge regarding safe surgical interventions. This case describes the presentation/management of a patient who developed COVID-19-associated necrotising pneumonia. Video-assisted thoracoscopy lobectomy was performed following CT demonstration of necrotising pneumonia. Pathological evaluation of the surgical resection specimen demonstrated the microarchitecture of a severely diseased COVID-19 lung-fibrosis. This case demonstrates the safe management of a necrotic lung using a minimal access approach in the context of COVID-19 infection.
C1 [Nizami, Maria; Grieco, Charlotte; Hogan, John; Aresu, Giuseppe] Royal Papworth Hosp NHS Fdn Trust, Cardiothorac Surg, Cambridge, England.
RP Nizami, M (corresponding author), Royal Papworth Hosp NHS Fdn Trust, Cardiothorac Surg, Cambridge, England.
EM mnizami21@gmail.com
CR Bharat A, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abe4282
   Copin MC, 2020, INTENS CARE MED, V46, P1124, DOI 10.1007/s00134-020-06057-8
   Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263
   Goursaud S, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00182-2020
   HAMMOND JMJ, 1993, CHEST, V104, P1610, DOI 10.1378/chest.104.5.1610
   Lang C, 2020, LANCET RESP MED, V8, P1057, DOI 10.1016/S2213-2600(20)30361-1
   Maiese A, 2021, FORENSIC SCI MED PAT, V17, P279, DOI 10.1007/s12024-020-00310-8
   Peeters K, 2021, ANN THORAC SURG, V111, pE241, DOI 10.1016/j.athoracsur.2020.10.038
   Reimel Beth Ann, 2006, Can Respir J, V13, P369
   Renaud-Picard B, 2020, RESPIR MED RES-FRANC, V78, DOI 10.1016/j.resmer.2020.100776
   Sessa F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072026
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
NR 12
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 1757-790X
J9 BMJ CASE REP
JI BMJ Case Rep.
PD JUN
PY 2021
VL 14
IS 6
AR e240766
DI 10.1136/bcr-2020-240766
PG 3
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA ZM2GE
UT WOS:000764180800006
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Adane, M
   Ademas, A
   Kloos, H
AF Adane, Metadel
   Ademas, Ayechew
   Kloos, Helmut
TI Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to
   receive COVID-19 vaccine among healthcare workers in northeastern
   Ethiopia
SO BMC PUBLIC HEALTH
LA English
DT Article
DE attitudes; COVID-19 vaccine; healthcare workers; knowledge; perceptions;
   vaccine refusal; Ethiopia
ID ACCEPTANCE
AB Background Major efforts are being made to control the spread and impacts of the coronavirus pandemic using vaccines. Ethiopia began on March 13, 2021, to vaccinate healthcare workers (HCWs) for COVID-19 with the AstraZeneca vaccine. However, willingness to be vaccinated depends to a large extent on factors beyond the availability of vaccines. This study aimed to determine the rate of intention to refuse COVID-19 vaccination and associated factors among HCWs in northeastern Ethiopia. northeastern, Ethiopia. Method An institution-based cross-sectional study was employed among 404 HCWs in Dessie City, northeastern Ethiopia in May, 2021. Data were collected, checked, coded, entered into EpiData Version 4.6 and exported to Statistical Package of Social Sciences (SPSS) Version 25.0 for cleaning and analysis. The dependent variable was refuse to receive COVID-19 vaccination and the independent variables included socio-demographic factors, knowledge, attitudes and perceptions. A Binary logistic regression model was used to determine the association between vaccine refusal and the independent variables. From bivariate analysis, variables with p-values < 0.25 were retained for multivariable analysis. From multivariable analysis, variables with adjusted odds ratio (AOR), p-values <0.05 at 95% confidence interval (CI) were declared as factors significantly associated with refusal to be vaccinated among HCWs in Dessie City, northeastern Ethiopia. Results The proportion of HCWs with overall good knowledge, good perception, and positive attitudes about COVID-19 vaccination were 62.5%, 60.5%, and 52.3%, respectively; 64.0% of the HCWs wanted to be vaccinated while 36.0% said that they would refuse to do so. Multivariable analysis identified negative attitudes (AOR: 3.057; 95%CI [1.860 - 5.026]) and poor perceptions (AOR: 4.73; 95%CI [2.911 - 7.684]) about COVID-19 vaccines were significantly associated with refusal to be vaccinated for COVID-19. Nearly half (46.9%) of the HCWs stated that vaccines could worsen any pre-existing medical conditions and 39.5% of them thought that vaccines could cause COVID-19 infections. Conclusion The willingness of HCWs to get vaccinated against COVID-19 was relatively high among HCWs. Negative attitudes and poor perceptions towards the anticipated COVID-19 vaccination were significant factors to refuse to be vaccinated. Our findings may provide information for the management authorities and stakeholders to promote and improve attitudes, knowledge and perceptions towards COVID-19 vaccination uptake among HCWs.
C1 [Adane, Metadel; Ademas, Ayechew] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.
   [Kloos, Helmut] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA.
RP Ademas, A (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.
EM aayechew19@gmail.com
RI Ademas, Ayechew/AAG-5984-2021
OI Ademas, Ayechew/0000-0003-2602-162X; Adane (PhD),
   Metadel/0000-0002-7039-4768
CR Agyekum MW, 2021, ADV PUBLIC HLTH, V2021, DOI 10.1155/2021/9998176
   Al-Metwali BZ, 2021, J EVAL CLIN PRACT, V27, P1112, DOI 10.1111/jep.13581
   Alle Yewlsew Fentie, 2021, VirusDisease, V32, DOI 10.1007/s13337-021-00708-0
   [Anonymous], BBC, P2021
   [Anonymous], 2021, AFRICANEWS
   [Anonymous], 2021, REUTERS
   [Anonymous], 2021, AFR VACC ACQ TRUST D
   Biswas N, 2021, J COMMUN HEALTH, V46, P1244, DOI 10.1007/s10900-021-00984-3
   Chew NWS, 2021, INT J INFECT DIS, V106, P52, DOI 10.1016/j.ijid.2021.03.069
   Ciardi F, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050516
   Elhadi M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10987-3
   Fares Samar, 2021, J Prim Care Community Health, V12, p21501327211013303, DOI 10.1177/21501327211013303
   FDRE (Federal Democratic Repuplic of Ethiopia), 2020, COVID 19 STAT EM
   Gadoth A, 2021, ANN INTERN MED, V174, P882, DOI 10.7326/M20-7580
   Huynh G, 2021, ASIAN PAC J TROP MED, V14, P159, DOI 10.4103/1995-7645.312513
   Josh Holder, 2021, NEW YORK TIMES
   Khadka D, 2021, J ETHNOBIOL ETHNOMED, V17, DOI 10.1186/s13002-021-00449-w
   Materu B, 2021, TANZANIANS URGED USE
   Mesele M, 2021, INFECT DRUG RESIST, V14, P2361, DOI 10.2147/IDR.S320771
   Muhumuza R, 2021, VACCINE HESITANCY AD
   Nzaji MK, 2020, PRAGMAT OBS RES, V11, P103, DOI 10.2147/POR.S271096
   Paudel S, 2021, RISK MANAG HEALTHC P, V14, P2253, DOI 10.2147/RMHP.S310289
   Paul E, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100012
   Qattan AMN, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.644300
   Shekhar R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020119
   Singhania N, 2021, CLIN MICROBIOL INFEC, V27, P1064, DOI 10.1016/j.cmi.2021.03.008
   Sun YF, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.664905
   Tobin EA., 2021, J MED RES, V5, P1, DOI DOI 10.11648/J.CAJPH.20210702.12
   WHO, 2020, WHO ISS ITS 1 EM US
   WHO, 2021, ETH INTR COVID 19 VA
   Worku A.M, 2019, PLANT PATHOLOGY MICR, V10, P484
   Worldometer, 2021, COR CAS DEATHS REC
   Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8
NR 33
TC 1
Z9 1
U1 4
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 18
PY 2022
VL 22
IS 1
AR 128
DI 10.1186/s12889-021-12362-8
PG 14
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA YI5ZR
UT WOS:000743926600006
PM 35042476
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kundu, S
   Al Banna, MH
   Sayeed, A
   Begum, MR
   Brazendale, K
   Hasan, MT
   Habiba, SJ
   Abid, MT
   Khan, MA
   Chowdhury, S
   Kormoker, T
   Proshad, R
   Khan, MSI
AF Kundu, Satyajit
   Al Banna, Md Hasan
   Sayeed, Abu
   Begum, Musammet Rasheda
   Brazendale, Keith
   Hasan, M. Tasdik
   Habiba, Sanjida Jahan
   Abid, Mohammad Tazrian
   Khan, Md Asaduzzaman
   Chowdhury, Sukanta
   Kormoker, Tapos
   Proshad, Ram
   Khan, Md Shafiqul Islam
TI Knowledge, attitudes, and preventive practices toward the COVID-19
   pandemic: an online survey among Bangladeshi residents
SO JOURNAL OF PUBLIC HEALTH-HEIDELBERG
LA English
DT Article; Early Access
DE COVID-19; Knowledge; Attitude; Practice; Bangladesh
ID STUDENTS KNOWLEDGE; RISK-TAKING; OUTBREAK; EBOLA
AB Aim The novel coronavirus (SARS-CoV-2) has rapidly infected people worldwide, leading to a massive public reaction. Peoples' knowledge, attitudes, and practices (KAP) toward COVID-19 are the most important for the control and prevention of the infectious disease pandemic. This study aimed to assess the knowledge, attitude, and preventive practices (KAP) toward the COVID-19 among Bangladeshi residents during the lockdown situation. Subjects and methods An online-based cross-sectional survey was conducted among 1765 Bangladeshi adults through the social media networks of the authors. Results The respondents were older than 18 years, with an average age of 24.88 years (SD 6.30). Approximately 15% of our participants received online training. The mean knowledge score was 14.49 (SD 1.8, range 0-17), and the overall correct response rate on this knowledge test was 85%. Approximately 67.2% scored well (above the mean 4.5, range 1-5) regarding the practices. To avoid the infection, 96.6% wore masks outside the home, and 98.7% washed their hands with soap when they came back. COVID-19 knowledge score was significantly associated with a lower odds of (OR 0.87, 95% CI 0.79-0.92) negative attitudes. Again, the awareness score was associated with a lower likelihood of (OR 0.94, 95% CI 0.87-0.98) poor practices. Conclusion Online health education programs focusing on young people, housewives, and people with less education may potentially improve the attitudes and practices to control the COVID-19 pandemic in the long term in such a low-resource setting.
C1 [Kundu, Satyajit] Patuakhali Sci & Technol Univ, Dept Biochem & Food Anal, Patuakhali 8602, Bangladesh.
   [Al Banna, Md Hasan; Khan, Md Shafiqul Islam] Patuakhali Sci & Technol Univ, Dept Food Microbiol, Patuakhali 8602, Bangladesh.
   [Sayeed, Abu] Patuakhali Sci & Technol Univ, Dept Postharvest Technol & Mkt, Patuakhali 8602, Bangladesh.
   [Begum, Musammet Rasheda] Chattogram Vet & Anim Sci Univ, Dept Agr Econ & Social Sci, Chattogram, Bangladesh.
   [Brazendale, Keith] Univ Cent Florida, Dept Hlth Sci, Orlando, FL 32816 USA.
   [Hasan, M. Tasdik] Univ Liverpool, Dept Primary Care & Mental Hlth, Liverpool, Merseyside, England.
   [Habiba, Sanjida Jahan; Abid, Mohammad Tazrian] Patuakhali Sci & Technol Univ, Fac Nutr & Food Sci, Patuakhali 8602, Bangladesh.
   [Khan, Md Asaduzzaman] Southwest Med Univ, Res Ctr Preclin Med, Luzhou, Sichuan, Peoples R China.
   [Chowdhury, Sukanta] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, IInfect Dis Div, Dhaka 1212, Bangladesh.
   [Kormoker, Tapos] Patuakhali Sci & Technol Univ, Dept Emergency Management, Patuakhali 8602, Bangladesh.
   [Proshad, Ram] Chinese Acad Sci, Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu 610041, Sichuan, Peoples R China.
   [Proshad, Ram] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Sayeed, A (corresponding author), Patuakhali Sci & Technol Univ, Dept Postharvest Technol & Mkt, Patuakhali 8602, Bangladesh.
EM shuvo.nfs.pstu@gmail.com
RI Kundu, Satyajit/ABA-2436-2020; Brazendale, Keith/ABB-1965-2021; Sayeed,
   Abu/ABH-5919-2020; Khan, Asaduzzaman/F-5392-2011
OI Kundu, Satyajit/0000-0001-9610-1479; Sayeed, Abu/0000-0003-0745-1755;
   Khan, Asaduzzaman/0000-0001-7851-0500; Abid, Mohammad
   Tazrian/0000-0003-1515-4689
CR Abu Sayeed, 2020, PSYCHIAT DANUB, V32, P491, DOI 10.24869/psyd.2020.491
   Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969
   Anadolu Agency, 2020, BANGL CONF 1 CAS COR BANGL CONF 1 CAS COR
   Anwar S, 2020, FRONT PUBLIC HEAL, V8
   Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.571689
   Asaduzzaman M., 2015, J WOMENS ENTREP ED, V3-4, P54
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Banna MH Al, 2020, INT J ENVIRON HEAL R, V113, P613, DOI [10.1093/qjmed/hcaa207, DOI 10.1093/QJMED/HCAA207]
   Begum Musammet Rasheda, 2021, J Affect Disord Rep, V4, P100103, DOI 10.1016/j.jadr.2021.100103
   Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729
   Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   CDC, 2020, COR DIS 2019 COVID 1
   Clements JM, 2020, KNOWLEDGE BEHAV COVI, DOI [10.1101/2020.03.31.20048967, DOI 10.1101/2020.03.31.20048967]
   Cobey KD, 2013, EVOL PSYCHOL-US, V11, P350, DOI 10.1177/147470491301100206
   de la Vega R, 2020, GLOB PUBLIC HEALTH, V15, P1278, DOI 10.1080/17441692.2020.1791212
   Dorfan NM, 2011, J SOC CLIN PSYCHOL, V30, P105, DOI 10.1521/jscp.2011.30.2.105
   Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y
   Erfani A, 2020, B WORLD HEALTH ORGAN, V76, P648, DOI DOI 10.2471/BLT.20.256651
   Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.5.200131e
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766
   Hussain ZA, 2012, AM J INFECT CONTROL, V40, pE11, DOI 10.1016/j.ajic.2011.12.004
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Institute of Epidemiology Disease Control and Research (IEDCR)., 2020, COV 19 STAT BANGL
   Islam MR., 2020, KNOWLEDGE ATTITUDE P
   Jiao J., 2005, CHINA TROP MED, V4
   Kundu S, 2021, PUBLIC HEALTH NUTR, V24, P1079, DOI 10.1017/S1368980020005042
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Pawlowski B, 2008, EVOL PSYCHOL-US, V6, P29, DOI 10.1177/147470490800600104
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Sauer LM., 2020, WHAT IS CORONAVIRUS
   Sayeed A, 2020, CHILD YOUTH SERV REV, V119, DOI 10.1016/j.childyouth.2020.105658
   Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0
   Srichan P, 2020, KNOWLEDGE ATTITUDE P, DOI DOI 10.2139/SSRN.3546046
   Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2
   Tachfouti N, 2012, PAN AFR MED J, V12
   Vartti AM, 2009, INT J BEHAV MED, V16, P41, DOI 10.1007/s12529-008-9004-6
   WHO, 2020, 7 WHO
   WHO (2020b) World health organization, 2020, WHO EM RESP VIR INCL WHO EM RESP VIR INCL
   WHO OIE FAO, 2020, WHO
   World Health Organisation W, 2020, COR DIS COVID 19 ADV
   World Health Organization, 2020, 4 WHO
   World Health Organization, 2020, COMMUNICATION 0311
   World Health Organization, 2020, 85 WHO
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Yang JZ, 2018, J RISK RES, V21, P834, DOI 10.1080/13669877.2016.1247378
   최정실, 2010, [Korean Journal of Adult Nursing, 성인간호학회지], V22, P250
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 49
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2198-1833
EI 1613-2238
J9 J PUBLIC HEALTH-HEID
JI J. Public Health-Heidelberg
DI 10.1007/s10389-021-01636-5
EA AUG 2021
PG 15
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA TZ9MM
UT WOS:000684791900001
PM 34414065
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Neupane, HC
   Shrestha, N
   Adhikari, S
   Angadi, S
   Shrestha, BK
   Gauli, B
AF Neupane, Harish Chandra
   Shrestha, Niki
   Adhikari, Shital
   Angadi, Siddeshwar
   Shrestha, Bishow Kumar
   Gauli, Basanta
TI Knowledge of Health Care Professionals and Medical Students Regarding
   Covid-19 in a Tertiary Care Hospital in Nepal
SO JOURNAL OF NEPAL MEDICAL ASSOCIATION
LA English
DT Article
DE COVID-19; health care professionals; knowledge
AB Introduction: The lack of knowledge among health care professionals leads to diagnostic delays, further spread of disease, and poor infection control practices. Health care professionals must be updated knowledge regarding COVID-19. This study aims to assess the knowledge of health care professionals regarding COVID-19 in a medical college in Chitwan.
   Methods: A Knowledge, Attitude and Practice Study was carried out in a tertiary care hospital in Chitwan, Nepal from April 22, 2020, to April 28, 2020. The institutional review committee of Chitwan Medical College provided ethical approval for the research. Data were collected with an online questionnaire using Google forms. The questionnaire was sent out to 724 potential responders who included health care professionals from medical, dental, nursing, and allied health sciences in Chitwan Medical College. A convenient sampling method was used for data collection. Data were analyzed using Statistical Package of Social Sciences.
   Results: A total of 181 respondents completed the web survey. Overall, a total of 35 (19.3%) respondents were found to have "Good" knowledge; 105 (58%) respondents had "Fair" knowledge and 41 (22.7%) respondents had "Poor" knowledge regarding various aspects of COVID-19. There was no significant difference among the various health professional groups in their knowledge scores under the four knowledge domains.
   Conclusions: The study of knowledge of health care professionals could act as a reference for the prevention and better management of COVID-19. This study shows that there is a need to implement periodic educational interventions and training programs on infection control practices for COVID-19 across all healthcare professions.
C1 [Neupane, Harish Chandra] Chitwan Med Coll, Dept Surg, Bharatpur, Chitwan, Nepal.
   [Shrestha, Niki] Chitwan Med Coll, Dept Community Med, Bharatpur, Chitwan, Nepal.
   [Adhikari, Shital; Shrestha, Bishow Kumar] Chitwan Med Coll, Dept Med, Bharatpur, Chitwan, Nepal.
   [Angadi, Siddeshwar] Chitwan Med Coll, Sch Nursing, Bharatpur, Chitwan, Nepal.
   [Gauli, Basanta] Chitwan Med Coll, Dept Anaesthesiol & Crit Care Med, Bharatpur, Nepal.
RP Shrestha, N (corresponding author), Chitwan Med Coll, Dept Community Med, Bharatpur, Chitwan, Nepal.
EM drnikis1@gmail.com
CR Abolfotouh MA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2096-8
   [Anonymous], ALG SUSP COVID 19 IN
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Centers for Disease Control and Prevention (CDC), INT INF PREV CONTR R
   Centers for Disease Control and Prevention (CDC), PROT YOURS OTH
   Hillier Mark Dexter, 2020, Nurs Stand, V35, P45, DOI 10.7748/ns.2020.e11552
   Hoe GW, 2020, SAF HLTH WORK
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   Nemati M, 2020, ARCH CLIN INFECT DIS
   Omrani AS, 2015, J HOSP INFECT, V91, P188, DOI 10.1016/j.jhin.2015.08.002
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   WHO, COUNTR TECHN GUID CO
   Wilder-Smith A, 2020, J TRAVEL MED, V13, P27
   World Health Organization, Q A COVID 19 BREASTF
   World Health Organization, COVID 19 STRAT UPD
   World Health Organization, BREASTFEEDING
   World Health Organization (WHO), COR DIS COVID 19 ADV
   Zhou M, 2020, J HOSP INFECT
NR 20
TC 2
Z9 2
U1 0
U2 4
PU NEPAL MEDICAL ASSOC
PI KATHMANDU
PA NMA BUILDING, SIDDIHI SADAN, PO BOX 189, EXHIBITION RD, KATHMANDU,
   00000, NEPAL
SN 0028-2715
EI 1815-672X
J9 J NEPAL MED ASSOC
JI J. Nepal Med. Assoc.
PD JUL
PY 2020
VL 58
IS 227
BP 480
EP 486
DI 10.31729/jnma.4995
PG 7
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA MZ4QA
UT WOS:000559107200007
PM 32827009
OA Green Published
DA 2022-04-20
ER

PT J
AU Bicer, I
   Cakmak, C
   Orgev, C
   Demir, H
AF Bicer, Ismail
   Cakmak, Cuma
   Orgev, Cemil
   Demir, Halil
TI Knowledge, attitude and practices (KAP) regarding COVID-19 and
   Coronavirus anxiety levels in the Turkish population
SO ANNALS OF CLINICAL AND ANALYTICAL MEDICINE
LA English
DT Article
DE COVID-19; Knowledge; Attitude; Anxiety; Turkey
AB Aim: The knowledge, attitude and practice level of the people about the disease can provide data on behavioral change for the health authorities. This study aims to measure the knowledge, attitude, and practice levels of people living in Turkey towards COVID-19 and determine their anxiety levels.
   Material and Methods: Eight hundred sixty people were reached through online surveys between May 20-30, 2020. Along with questions measuring demographic features, Knowledge, Attitude, and Practices (KAP) Towards COVID-19 and Coronavirus Anxiety Scale (CAS) were used in the research. Descriptive statistical analysis, chi-square tests, t-tests, one-way analysis of variance (ANOVA), multiple linear regression analyses, and logistic regression analysis were used in the study.
   Results: The overall mean of the KAP scale was 10.65 +/- 1.26. This shows that Turkish people have a high level of knowledge about COVID-19. Moreover, the overall mean of the anxiety scale was 1.96 +/- 3.30, and the general anxiety levels of the participants were determined to be very low. Most of the participants showed positive attitudes towards the successful control of COVID-19 (65.9%) and Turkey's ability to defeat the disease (82.1%).
   Discussion: It can be stated that this study is important because it is the first study evaluating the KAP and CAS levels for COVID-19 in Turkey. As a result, health education programs and awareness-raising activities targeting individuals with less knowledge about COVID-19 can be important in controlling the outbreak.
C1 [Bicer, Ismail] Istanbul Arel Univ, Med Documentat & Secretarial Program, Halkali St 101, TR-34100 Istanbul, Turkey.
   [Cakmak, Cuma] Hacettepe Univ, Dept Healthcare Management, Ankara, Turkey.
   [Orgev, Cemil] Sakarya Upplied Sci Univ, Environm Protect Technol, Sakarya, Turkey.
   [Demir, Halil] Istanbul Rumeli Univ, Med Documentat & Secretarial Program, Istanbul, Turkey.
RP Bicer, I (corresponding author), Istanbul Arel Univ, Med Documentat & Secretarial Program, Halkali St 101, TR-34100 Istanbul, Turkey.
EM ismailbiceer@gmail.com
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Anju KJ., 2020, JAC J COMPOSITION TH, V13, P241
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Byanaku A., 2020, KNOWLEDGE ATTITUDES, DOI 10.1101/2020.04.26.20080820v2
   Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161
   Deng CX, 2020, INT J BIOL SCI, V16, P1676, DOI 10.7150/ijbs.45587
   Hayat K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103347
   Hussain Shalam Mohamed, 2020, Glob Pediatr Health, V7, p2333794X20931613, DOI 10.1177/2333794X20931613
   Kurt, 2020, ANADOLU KLINIGI TIP, V25, P216, DOI [10.21673/anadoluklin.731092, DOI 10.21673/ANADOLUKLIN.731092]
   Lee SA, 2020, DEATH STUD, DOI [10.1080/07481187.2020.1748481, 10.1080/07481187.2020.1853885]
   Moorthy V, 2020, B WORLD HEALTH ORGAN, V98, P150, DOI 10.2471/BLT.20.251561
   Naser A. Y., 2020, KNOWLEDGE PRACTICES, DOI [10.1101/2020.04.13.20063560, DOI 10.1101/2020.04.13.20063560]
   Nathiya D, 2020, INDIAN COMMUNITYS KN
   Okoro J, 2020, EMERALD OPEN RES, V2, P26, DOI DOI 10.35241/EMERALDOPENRES.13684.2
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Rios-González Carlos Miguel, 2020, Rev. salud publica Parag., V10, P17, DOI 10.18004/rspp.2020.diciembre.17
   Tamornpark R., 2020, J HLTH SCI ALTERNATI, V2, P25
   Wadood M, 2020, RES SQ, DOI [10.21203/rs.3.rs-29364/v1, DOI 10.21203/RS.3.RS-29364/V1]
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 20
TC 1
Z9 1
U1 0
U2 0
PU BAYRAKOL MEDICAL PUBLISHER
PI ANKARA
PA EMRAH MAHALLESI, GULGUN CADDESI, NO 62-58, KECIOREN, ANKARA, 06010,
   TURKEY
EI 2667-663X
J9 ANN CLIN ANAL MED
JI Ann. Clin. Anal. Med.
PD AUG
PY 2021
VL 12
IS 8
BP 880
EP 887
DI 10.4328/ACAM.20482
PG 8
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA YD9SY
UT WOS:000740774500010
OA gold
DA 2022-04-20
ER

PT J
AU Wu, ZS
   Xue, R
   Shao, MY
AF Wu, Zongsheng
   Xue, Ru
   Shao, Meiyun
TI Knowledge graph analysis and visualization of AI technology applied in
   COVID-19
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE COVID-19; Coronavirus disease; Knowledge graph; AI; Data visualization;
   Visual analysis
AB With the global outbreak of coronavirus disease (COVID-19) all over the world, artificial intelligence (AI) technology is widely used in COVID-19 and has become a hot topic. In recent 2 years, the application of AI technology in COVID-19 has developed rapidly, and more than 100 relevant papers are published every month. In this paper, we combined with the bibliometric and visual knowledge map analysis, used the WOS database as the sample data source, and applied VOSviewer and CiteSpace analysis tools to carry out multi-dimensional statistical analysis and visual analysis about 1903 pieces of literature of recent 2 years (by the end of July this year). The data is analyzed by several terms with the main annual article and citation count, major publication sources, institutions and countries, their contribution and collaboration, etc. Since last year, the research on the COVID-19 has sharply increased; especially the corresponding research fields combined with the AI technology are expanding, such as medicine, management, economics, and informatics. The China and USA are the most prolific countries in AI applied in COVID-19, which have made a significant contribution to AI applied in COVID-19, as the high-level international collaboration of countries and institutions is increasing and more impactful. Moreover, we widely studied the issues: detection, surveillance, risk prediction, therapeutic research, virus modeling, and analysis of COVID-19. Finally, we put forward perspective challenges and limits to the application of AI in the COVID-19 for researchers and practitioners to facilitate future research on AI applied in COVID-19.
C1 [Wu, Zongsheng] Xianyang Normal Univ, Sch Comp Sci, Xianyang 712000, Shaanxi, Peoples R China.
   [Xue, Ru; Shao, Meiyun] Xizang Minzu Univ, Sch Informat Engn, Xianyang 712082, Shaanxi, Peoples R China.
RP Wu, ZS (corresponding author), Xianyang Normal Univ, Sch Comp Sci, Xianyang 712000, Shaanxi, Peoples R China.
EM wuzs2005@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [62,073,218]; Natural Science Foundation of
   Tibet Autonomous Region [XZ202001ZR0048G]; Scientific Research Project
   of Xianyang Science and Technology Bureau [2020K02-14]; Scientific
   Research Fund Project of Xianyang Normal University [XSYK20025]
FX This work is supported in part by four foundations:; National Natural
   Science Foundation of China (Grant: 62,073,218); Natural Science
   Foundation of Tibet Autonomous Region (Grant: XZ202001ZR0048G);
   Scientific Research Project of Xianyang Science and Technology Bureau
   (Grant: 2020K02-14); Scientific Research Fund Project of Xianyang Normal
   University (Grant: XSYK20025)
CR Aa B, 2020, INFORM MED UNLOCKED, V19
   Alam F, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13073797
   Benyass A, 2021, EUR J PREV CARDIOL
   Bindak R, 2018, ENTIA HORTICULTURAE, V246, P418
   Chen S., 2020, ARTIF INTELL
   Det Ers A R, 2021, BIOCYBERN BIOMED ENG
   Effendi, 2021, INDONESIAN J ELECT E, V22, P1334, DOI [10.11591/ijeecs.v22.i3.pp1334-1344, DOI 10.11591/IJEECS.V22.I3.PP1334-1344]
   Fazzini D, 2020, AIFORCOVID PREDICTIN
   Ganatra A, 2020, APPL ARTIF INTELL
   Glenisson P, 2005, INFORM PROCESS MANAG, V41, P1548, DOI 10.1016/j.ipm.2005.03.021
   Guizani N., 2020, IEEE NETWORK, P1, DOI DOI 10.1101/2020.04.08.20058164
   Gunasekeran DV, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00412-9
   Hasan AM, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22050517
   Imran Ali, 2020, Inform Med Unlocked, V20, P100378, DOI 10.1016/j.imu.2020.100378
   Lee K, 2009, GLOB INST, P1
   Majumder S., 2021, J PHYS C SERIES, V1797
   Mascolo C., 2021, EXPLORING AUTOMATIC
   Nobanee H, AI ENABLED COVID 19
   Ozyurt, CHEM INTELL LAB SYST, V203
   Paul M, 2020, COMPUTER VISION COVI
   Pinter G, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8060890
   Refat C, 2020, COVID 19 DATASETS MA
   Reingold A.L, 2021, FEASIBILITY EFFECTIV
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Shimon C, 2021, J ACOUST SOC AM, V149, P1120, DOI 10.1121/10.0003434
   Shuja J, 2021, APPL INTELL, V51, P1296, DOI 10.1007/s10489-020-01862-6
   Soghaier MA, 2015, AIMS PUBLIC HEALTH, V2, P218, DOI 10.3934/publichealth.2015.2.218
   Steinhubl S.R, 2020, PASSIVE MONITORING P
   Volkamer M., 2020, HLTH SURVEILLANCE DE
   Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64
   Zhukov V, 2021, PROJECT ACHOO PRACTI
   Zia S, 2020, MACHINE DEEP LEARNIN
NR 32
TC 0
Z9 0
U1 29
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2022
VL 29
IS 18
BP 26396
EP 26408
DI 10.1007/s11356-021-17800-z
EA DEC 2021
PG 13
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA 0I5GL
UT WOS:000725470500006
PM 34859342
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Abdulrahman, S
   Aboalshamat, K
   Dewedar, A
   Gazzaz, N
   Almabdi, A
AF Abdulrahman, Somaya
   Aboalshamat, Khalid
   Dewedar, Arwa
   Gazzaz, Nada
   Almabdi, Alaa
TI Dental Professionals Management of Avulsed Teeth and Implementation of
   COVID-19 Related Safety Precautions
SO JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE
LA English
DT Article
DE Management; Avulsed teeth; Dentists; Saudi Arabia and COVID-19
ID EMERGENCY MANAGEMENT; TOOTH AVULSION; KNOWLEDGE; DENTISTS; RIYADH;
   GUIDELINES; TRAUMA
AB Aim: One of the most common dental problems is oral trauma, which is a great threat to the dental health of children and adolescents. This study aims to improve Saudi dentists' knowledge of the management of avulsed teeth and the safety precautions necessitated by the coronavirus disease 2019 (COVID-19) pandemic.
   Materials and methods: A cross-sectional study was conducted. The 403 participants, who were from Saudi Arabia, were recruited through social media. The data were collected by a questionnaire that assessed their knowledge about managing avulsed teeth. Significance was set at p=0.05.
   Results: The mean score for the correct answers to 22 questions to assess clinical knowledge about avulsed teeth was 15.26 (SD=3.48). According to the responses, 93.3% knew that an avulsed permanent tooth can be replanted, 72.2% indicated that an avulsed primary tooth can be replanted, 63.8% were aware of the best splinting materials, and 58.3% knew the optimal splinting duration. Only 29.8% indicated knowledge about the most recent (2020) International Association for Dental Traumatology guidelines for avulsed permanent teeth. The mean score for the correct answers to the four questions about the management of avulsed teeth during the COVID-19 pandemic was 3.27 (SD=1.02).
   Conclusion: Saudi dental professionals were found to have moderate levels of knowledge about the management of tooth avulsion. The answers to the COVID-19-related questions revealed good knowledge about managing avulsed teeth during the pandemic. Health campaigns or online lectures would be helpful in improving dentists' knowledge about managing avulsed teeth.
C1 [Abdulrahman, Somaya; Aboalshamat, Khalid; Dewedar, Arwa; Gazzaz, Nada; Almabdi, Alaa] Umm Al Qura Univ, Fac Dent, Dept Dent, Mecca, Saudi Arabia.
RP Abdulrahman, S (corresponding author), Umm Al Qura Univ, Fac Dent, Dept Dent, Mecca, Saudi Arabia.
EM Somaya.a@outlook.com
CR Abdullah Dalia, 2016, Singapore Dent J, V37, P21, DOI 10.1016/j.sdj.2016.01.001
   Al-Majed I, 2001, DENT TRAUMATOL, V17, P153, DOI 10.1034/j.1600-9657.2001.170403.x
   Al-Shamiri Hashem Motahir, 2015, Eur J Dent, V9, P518, DOI 10.4103/1305-7456.172636
   Alaslami Redhwan Abdullah, 2018, Open Access Maced J Med Sci, V6, P1712, DOI 10.3889/oamjms.2018.299
   AlGhamdi NMS, 2016, J DENT RES REV, V3, P85
   Alharbi R, 2020, OPEN DENT J, V14, P396, DOI 10.2174/1874210602014010396
   Ali SNA, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/6059346
   AlJazairy YH, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0126-3
   Alzahrani MS, 2019, SAUDI ENDOD J, V9, P82
   Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Azmi MA, 2016, J DENT RES REV, V3, P140
   Baginska J, 2013, EUR J DENT EDUC, V17, pe88, DOI 10.1111/j.1600-0579.2012.00765.x
   Bourguignon C, 2020, DENT TRAUMATOL, V36, P314, DOI 10.1111/edt.12578
   Cosme-Silva L, 2017, J PUBLIC HEALTH-HEID, V25, P167, DOI 10.1007/s10389-016-0776-x
   Day P, 2020, DENT TRAUMATOL, V36, P314
   Westphalen VPD, 2007, DENT TRAUMATOL, V23, P6, DOI [10.1111/j.1600-9657.2005.00392.x, 10.1111/j.1600-9657.2005.00392]
   Duruk G, 2020, DENT TRAUMATOL, V36, P371, DOI 10.1111/edt.12543
   Flores MT, 2001, DENT TRAUMATOL, V17, P193, DOI 10.1034/j.1600-9657.2001.170501.x
   Fouad AF, 2020, DENT TRAUMATOL, V36, P331, DOI 10.1111/edt.12573
   Fujita Y, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-34
   Guo HQ, 2020, J DENT SCI, V15, P564, DOI 10.1016/j.jds.2020.02.002
   Halawany HS, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-46
   Holan G, 2003, Int J Paediatr Dent, V13, P13, DOI 10.1046/j.1365-263X.2003.00414.x
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jain N, 2018, INT J ADOLESC MED HL, V32, P1
   Lee JY, 2009, PEDIATR DENT, V31, P96
   Levin L, 2020, DENT TRAUMATOL, V36, P309, DOI 10.1111/edt.12574
   Nikam Atul Pralhad, 2014, J Int Oral Health, V6, P1
   Ningthoujam Sharna, 2019, Natl J Maxillofac Surg, V10, P33, DOI 10.4103/njms.NJMS_64_17
   Robertson A, 2001, DENT TRAUMATOL, V17, P5, DOI 10.1034/j.1600-9657.2001.170102.x
   Soares AD, 2008, DENT TRAUMATOL, V24, P183, DOI 10.1111/j.1600-9657.2007.00528.x
   Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090
NR 33
TC 0
Z9 0
U1 2
U2 3
PU AMBER PUBLICATION
PI GUJARAT
PA 402, PARIJAT APT, WALKESHWARI NAGAR, JAMNAGAR, GUJARAT, 361 008, INDIA
SN 2347-2545
EI 2347-2367
J9 J RES MED DENT SCI
JI J. Res. Med. Dent. Sci.
PY 2021
VL 9
IS 2
BP 1
EP 7
PG 7
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA QQ2MR
UT WOS:000624360000001
DA 2022-04-20
ER

PT J
AU Zaki, MK
   Sobh, ZK
AF Zaki, Mamdouh Kamal
   Sobh, Zahraa Khalifa
TI Knowledge, attitude, and practice of forensic practitioners during
   COVID-19 pandemic in Arab countries
SO LEGAL MEDICINE
LA English
DT Article
DE Forensic practitioners; Knowledge; Attitude; Arab countries; COVID-19
   pandemic
ID ISLAMIC LAW; MEDICINE; SCIENCE; AUTOPSY
AB COVID-19 pandemic burdens forensic practice worldwide. The experience of crisis management is a lesson learned that guides future preparedness for similar casualties. Thus, the present study takes an in-depth look at the knowledge, attitude, and practice of forensic practitioners during the COVID-19 pandemic in the Arab world. A comprehensive questionnaire was adopted in compliance with optimum international standards for the management of deaths during the pandemic. The survey was electronically distributed in 13 Arab countries. The responses were received from 29 forensic practitioners from 11 countries. Total median knowledge, attitude, and practice scores of respondents constituted 37.9%, 74%, and 36.8% of optimum scores respectively. Regarding knowledge, better scores are related to risk assessment and routes of exposure to Coronavirus, whereas, least scores were related to ventilation and negative pressure system. Most of the participants had a positive attitude, 85.2% were concerned about proper management of COVID-19 deaths, and 77.8% trusted the decisions of their teams. Considering practice, better scores are related to forensic staff competence, whereas, least scores were related to the implementation of ideal safety measures. Participants described the management process as useful (52%), reliable (35%), high quality (21%), and cost-effective (17%), however, they expressed challenges as staff infection, limited resources, and infrastructure issues. This survey guides readjusting of procedures and future preparedness for similar disasters in the Arab world. This research adopted a questionnaire that could be used in initial and periodic assessments in any medicolegal institute worldwide. Also, it could support infrastructure projects and disaster management plans.
C1 [Zaki, Mamdouh Kamal] Minist Hlth, Forens Med Ctr, Jeddah, Saudi Arabia.
   [Sobh, Zahraa Khalifa] Alexandria Univ, Fac Med, Forens Med & Clin Toxicol Dept, Alexandria, Egypt.
RP Sobh, ZK (corresponding author), Alexandria Univ, Fac Med, Forens Med & Clin Toxicol Dept, Alexandria, Egypt.
EM mklz@hotmail.com; zahraa.sobh@alexmed.edu.eg
RI Sobh, Zahraa Khalifa/U-6862-2019
OI Sobh, Zahraa Khalifa/0000-0002-7836-9639; Zaki,
   Mamdouh/0000-0002-1396-4373
CR Al Madani OM, 2012, AM J FOREN MED PATH, V33, P147, DOI 10.1097/PAF.0b013e318221b895
   Al-Dawoody A, 2017, INT REV RED CROSS, V99, P759, DOI 10.1017/S1816383118000486
   Al-Waheeb S, 2015, J FORENSIC LEG MED, V32, P4, DOI 10.1016/j.jflm.2015.02.003
   Algaissi AA, 2020, J INFECT PUBLIC HEAL, V13, P834, DOI 10.1016/j.jiph.2020.04.016
   Alkahtani T, 2015, J FORENSIC LEG MED, V34, P179, DOI 10.1016/j.jflm.2015.04.017
   Alyami A., 2020, EJEPH, V5, P1
   Bamousa MS, 2016, AM J FOREN MED PATH, V37, P127, DOI 10.1097/PAF.0000000000000234
   Calmon M., 2020, CONSIDERATIONS CORON, V2, DOI DOI 10.1016/J.FSIR.2020.100110
   Cattaneo C, 2020, FORENSIC SCI INT, V312, DOI 10.1016/j.forsciint.2020.110308
   CDC, 2020, COLL SUBM POSTM SPEC
   College of American Pathologists, 2020, AM COVID 19 AUT GUID
   European Centre for Disease Prevention and Control (ECDC), 2020, CONS REL SAF HANDL B
   Finegan Oran, 2020, Forensic Sci Int Synerg, V2, P129, DOI 10.1016/j.fsisyn.2020.03.007
   Green SB, 2016, PSYCHON B REV, V23, P750, DOI 10.3758/s13423-015-0968-3
   Han B, 2020, ARCH PATHOL LAB MED, V144, P1295, DOI 10.5858/arpa.2020-0341-LE
   Kharoshah MAA, 2011, J FORENSIC LEG MED, V18, P10, DOI 10.1016/j.jflm.2010.11.009
   Khoo LS, 2020, FORENSIC SCI MED PAT, V16, P463, DOI 10.1007/s12024-020-00269-6
   Lam K, 2020, JAMA INTERN MED, V180, P1389, DOI 10.1001/jamainternmed.2020.2671
   Mansour R, 2020, BMC MED ETHICS, V21, DOI 10.1186/s12910-020-00513-2
   Mao DM, 2020, FOREN SCI RES, V5, P1, DOI 10.1080/20961790.2020.1744400
   Page P, 2014, INT J SPORTS PHYS TH, V9, P726
   Puschel K, 2020, INT J LEGAL MED, V134, P1267, DOI 10.1007/s00414-020-02332-x
   Roux C, 2020, FORENSIC SCI INT, V316, DOI 10.1016/j.forsciint.2020.110503
   Sajid MI, 2016, AM J FOREN MED PATH, V37, P29, DOI 10.1097/PAF.0000000000000207
   Sapino A, 2020, VIRCHOWS ARCH, V476, P821, DOI 10.1007/s00428-020-02828-2
   Shokry DA, 2015, FORENSIC SCI FOC, P73
   Sobh Z., 2021, ZJFM, V19, P1
   Sperhake JP, 2020, LEGAL MED-TOKYO, V47, DOI 10.1016/j.legalmed.2020.101769
   Teresinski Grzegorz, 2019, Arch Med Sadowej Kryminol, V69, P147, DOI 10.5114/amsik.2019.95714
   World Health Organization, INF PREV CONTR SAF M
   Xue Ye, 2020, Forensic Sci Int Synerg, V2, P126, DOI 10.1016/j.fsisyn.2020.04.001
   Yan T, 2012, J OFF STAT, V28, P503
   Yang Xingyi, 2020, Forensic Sci Int Synerg, V2, P210, DOI 10.1016/j.fsisyn.2020.06.002
   Zhao J., 2020, J FORENSIC SCI MED, V6, P62
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1344-6223
J9 LEGAL MED-TOKYO
JI Leg. Med.
PD SEP
PY 2021
VL 52
AR 101903
DI 10.1016/j.legalmed.2021.101903
EA MAY 2021
PG 10
WC Medicine, Legal; Social Sciences, Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Legal Medicine; Biomedical Social Sciences
GA TH1VI
UT WOS:000671882900006
PM 33990044
OA Bronze
DA 2022-04-20
ER

PT J
AU Shcherbak, V
   Gryshchenko, I
   Ganushchak-Yefimenko, L
   Nifatova, O
   Bobrovnyk, V
   Verhun, M
AF Shcherbak, V
   Gryshchenko, I
   Ganushchak-Yefimenko, L.
   Nifatova, O.
   Bobrovnyk, V
   Verhun, M.
TI Energy-innovation knowledge common connection point management in
   preventing outbreak of the Covid-19 pandemicin a University
SO GLOBAL JOURNAL OF ENVIRONMENTAL SCIENCE AND MANAGEMENT-GJESM
LA English
DT Article
DE Audit; Certification; Covid-19 pandemic; Efficiency; Potential; Solar
ID EFFICIENCY
AB BACKGROUND AND OBJECTIVES: The new wave of the Covid-19 pandemic has complicated the working conditions of higher education institutions in Ukraine. In this regard, saving energy resources of the university offers an opportunity to get out of the crisis. The purpose of the study is to develop a management system for energy complexes with non-conventional renewable energy sources in the context of preventing a new outbreak of Covid-19 pandemic.
   METHODS: The method of Deutsche Gesellschaft fur Nachhaltiges Bauen was used to conduct energy audits, construct energy profiles of university offices. The cluster analysis was used to perform energy certification of university offices according to the indicators of integral energy efficiency potential and the level of annual specific energy consumption. Fuzzy methods made it possible to classify all the buildings into 3 categories (A, B, C) to prioritize their use in the light of Covid-19 pandemic. The system for monitoring the attained level of energy efficiency is based on the use of discriminant analysis.
   FINDINGS: Implementation of the weighted strategy has proved that the classes will be given online, 23% of all offices. Category A (administrative, technical, service buildings; laboratories with unique equipment with 24-hour service) will be used in a pessimistic scenario (continuation of Covid-19 pandemic). In the optimistic scenario (end of Covid-19 pandemic), by means of the suggested energy efficiency monitoring system, the probability of using category A officesmakes100%, B offices- 50% and C offices- 13%.
   CONCLUSION: Implementation of the developed energy efficiency action plan will offer the opportunity for the University to use reasonably the common connection point of knowledge management of energy complexes with non-conventional renewable energy sources in the context of preventing a new outbreak of the Covid-19 pandemic. The profitability of implementing a weighted energy efficiency strategy is 15%, with a payback period of 6.7 years for the purchase and installation of non-conventional renewable energy equipment. In the future, it would be advisable to convert gradually all of the remaining 14 university buildings to the autonomous use of non-conventional renewable energy sources, using a common connection point for the knowledge management of the energy complexes. (C) 2022 GJESM. All rights reserved.
C1 [Shcherbak, V; Nifatova, O.] Kyiv Natl Univ Technol & Design, Dept Entrepreneurship & Business, Kiev, Ukraine.
   [Gryshchenko, I; Bobrovnyk, V] Kyiv Natl Univ Technol & Design, Kiev, Ukraine.
   [Ganushchak-Yefimenko, L.] Kyiv Natl Univ Technol & Design, Res & Innovat, Kiev, Ukraine.
   [Verhun, M.] Kyiv Natl Univ Technol & Design, Financial Econ & Social Work, Kiev, Ukraine.
RP Shcherbak, V (corresponding author), Kyiv Natl Univ Technol & Design, Dept Entrepreneurship & Business, Kiev, Ukraine.
EM valery_shcherbak@i.ua; hrischenko@gmail.com; glm5@ukr.net;
   Helen_Bykhova@live.ru; Bobrovnik.v@knutd.edu.ua; verhun.m@knutd.edu.ua
CR Abu-Rayash A, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101682
   Amirreza N., 2021, CLEAN TECHNOL ENVIR, V23, P183
   Balode L, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13063370
   Chen CF, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101688
   Di Stefano J, 2000, ENERGY, V25, P823, DOI 10.1016/S0360-5442(00)00015-3
   Edomah Norbert, 2020, Glob Transit, V2, P127, DOI 10.1016/j.glt.2020.07.002
   Ganushchak-Efimenko L, 2018, OECON COPERNIC, V9, P715, DOI 10.24136/oc.2018.035
   Garcia S, 2021, APPL ENERG, V287, DOI 10.1016/j.apenergy.2021.116547
   Gryshchenko I., 2017, E EUR J ENTERPTECHNO, V6, P65
   Halbrugge S, 2021, APPL ENERG, V285, DOI 10.1016/j.apenergy.2020.116370
   Hansen CH, 2019, ENERGY, V177, P77, DOI 10.1016/j.energy.2019.04.046
   Huang LQ, 2021, APPL ENERG, V283, DOI 10.1016/j.apenergy.2020.116339
   Jiang P, 2021, APPL ENERG, V285, DOI 10.1016/j.apenergy.2021.116441
   Kanda W, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101666
   Kaplun V., 2016, ACTUAL PROBL ECON, V12, P349
   Khan I., 2021, AIP ADV, V11, P1
   Klemes JJ, 2021, INT J ENERG RES, V45, P3457, DOI 10.1002/er.6007
   Krarti M., 2021, RENEWABLE SUSTAINABL, V143, P1
   Kuzemko C, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101685
   Liu JZ, 2019, ENERGY, V172, P555, DOI 10.1016/j.energy.2019.01.071
   Mastropietro P, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101678
   Michaud L, 2021, J MOTOR BEHAV, DOI 10.1080/00222895.2021.1896468
   Navon A, 2021, ENERGIES, V14, DOI 10.3390/en14041056
   Nayak J, 2022, EXPERT SYST, V39, DOI 10.1111/exsy.12677
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Papageorgiou C, 2017, REV ECON STAT, V99, P281, DOI 10.1162/REST_a_00592
   Ruan GC, 2021, APPL ENERG, V286, DOI 10.1016/j.apenergy.2020.116354
   Shaposhnikova K., 2016, SCI SOC, V3-2, P63
   Shcherbak V, 2019, GLOB J ENVIRON SCI M, V5, P501, DOI 10.22034/gjesm.2019.04.09
   Skiba M, 2017, APPL ENERG, V188, P356, DOI 10.1016/j.apenergy.2016.12.006
   Soava G, 2021, ENERGIES, V14, DOI 10.3390/en14092394
   Sovacool BK, 2020, RENEW SUST ENERG REV, V120, DOI 10.1016/j.rser.2019.109663
   Steffen B, 2020, JOULE, V4, P1137, DOI 10.1016/j.joule.2020.04.011
   Van Fan Y, 2020, ENERGIES, V13, DOI 10.3390/en13164062
   Vieira E., 2020, IND ENG OPERATIONS M, V337, P463
   Wang Q, 2021, J CLEAN PROD, V295, DOI 10.1016/j.jclepro.2021.126265
   Werth A, 2021, APPL ENERG, V281, DOI 10.1016/j.apenergy.2020.116045
   Xing XK, 2019, J CLEAN PROD, V218, P782, DOI 10.1016/j.jclepro.2019.02.052
   Zhang XX, 2020, APPL ENERG, V280, DOI 10.1016/j.apenergy.2020.115954
   Zhong HW, 2020, CSEE J POWER ENERGY, V6, P489, DOI 10.17775/CSEEJPES.2020.02500
NR 40
TC 0
Z9 0
U1 5
U2 8
PU IRAN SOLID WASTE ASSOC
PI TEHRAN
PA UNIV TEHRAN, PO BOX 1417853111, TEHRAN, 19166, IRAN
SN 2383-3572
J9 GLOB J ENVIRON SCI M
JI Glob. J. Environ. Sci. Manag.
PY 2022
VL 8
IS 1
BP 45
EP 58
DI 10.22034/gjesm.2022.01.04
PG 14
WC Environmental Sciences
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology
GA UG3ZY
UT WOS:000689196000004
DA 2022-04-20
ER

PT J
AU Dalui, A
   Banerjee, S
   Roy, R
AF Dalui, Anirban
   Banerjee, Sitikantha
   Roy, Ramaprasad
TI Assessment of knowledge, Attitude, and Practice about Biomedical Waste
   Management among Healthcare Workers during COVID-19 Pandemic in a Health
   District of West Bengal
SO INDIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Attitude; biomedical waste; COVID-19; healthcare workers; knowledge
ID PROFESSIONALS
AB Background: Efforts to combat Coronavirus disease (COVID-19) pandemic have significantly increased the quantity of bio-medical waste (BMW) generation. Objectives: A cross-sectional study was performed to assess the knowledge, practice, and attitude and factors affecting knowledge on BMW management among Health Care Workers (HCWs) when taking care of patients with COVID-19. Methods: This cross-sectional study was conducted among 384 HCWs, actively involved in caring of COVID-19 patients in Healthcare settings of North 24 Parganas Health District, West Bengal. Data were collected using a structured self-administered questionnaire (through Google Fonns) and an observational checklist after selection criteria and having consent. The Questionnaire included four sections like the sociodemographic information, knowledge related to BMW management, observational questionnaire assessing the practice of HCWs on BMW management and rating scale related to attitudes towards BMW management. Results: 166 HCWs (43.2%) had an excellent knowledge with overall mean score 13.5 +/- 3.6. A high mean score (14.4 +/- 3.2) was obtained by doctors followed by nurses (13.6 +/- 3.8). Regarding practice, the majority of HCWs (52.8%) followed the color-coding of BMW and 49.5% followed policies in separating the wastes according to hazard. Doctors (91%) and nurses (81%) had more favorable attitude than others. There was a statistically significant association found among knowledge level and educational qualification (P = 0.0001), gender (P = 0.001), and work experience (P = 0.05) and work area (P = 0.05). Conclusion: Emphasis should be given to aware and train all HCWs regarding proper BMW management during this pandemic to prevent infection transmission.
C1 [Dalui, Anirban] RG Kar Med Coll & Hosp, Dept Community Med, Kolkata, India.
   [Roy, Ramaprasad] Arambagh Govt Med Coll, Dept Community Med, Arambagh, W Bengal, India.
   [Banerjee, Sitikantha] AIIMS, Dept Community Med, Nagpur, Maharashtra, India.
RP Dalui, A (corresponding author), 20 C Sri Gopal Mullick Lane,Flat 3,1st Floor, Kolkala 700012, W Bengal, India.
EM dr.daluianirban@gmail.com
CR Albalushi AY, 2018, GLOB J HLTH SCI, V10, P70
   Alshahrani NZ, 2021, INT J PHARM RES, V13, P1875
   Bokhoree C., 2014, APCBEE Procedia, V9, P36, DOI 10.1016/j.apcbee.2014.01.007
   Deress T, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/7672981
   Dona D, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030311
   Gazette of India, 2016, GSR 343 E DATED 28 M, P1
   Goswami M, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06313
   Jalal SM, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9060747
   Khoironi A, 2020, MAR POLLUT BULL, V151, DOI 10.1016/j.marpolbul.2019.110868
   Kumar Ramesh, 2013, J Ayub Med Coll Abbottabad, V25, P109
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Letho Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243817
   Mardani A, 2019, SCI TOTAL ENVIRON, V649, P31, DOI 10.1016/j.scitotenv.2018.08.229
   Mugabi B, 2018, NIGER J CLIN PRACT, V21, P1627, DOI 10.4103/njcp.njcp_270_17
   National Centre for Disease Control Ministry of Health and Family Welfare Government of India, 2020, GUID QUAR FAC COVID
   Pandey A, 2016, J CLIN DIAGN RES, V10, pDC1, DOI 10.7860/JCDR/2016/22595.8822
   Parida A, 2019, J LAB PHYS, V11, P292, DOI 10.4103/JLP.JLP_88_19
   Rao D., 2018, BIOMED PHARMACOL J, V11, P1737, DOI DOI 10.13005/bpj/1543
   Sachan R, 2012, INT J SCI RES PUBLIC, V2, P1
   Shaheen T, 2020, CUREUS, V12, DOI 10.7759/cureus.12196
   Shammi M, 2021, ENVIRON SCI TECHNOL, V55, P4087, DOI 10.1021/acs.est.0c05117
   Singh T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1742326
   Sunmeet GA, 2017, INT J INNOV RES SCI, V3, P307
   World Health Organization, 2017, REP HEALTHC WAST MAN
   Yousefi M, 2021, ENVIRON SCI POLLUT R, V28, P32200, DOI 10.1007/s11356-021-14214-9
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 26
TC 0
Z9 0
U1 1
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0019-557X
EI 2229-7693
J9 INDIAN J PUBLIC HLTH
JI Indian J. Public Health
PD OCT-DEC
PY 2021
VL 65
IS 4
BP 345
EP 351
AR PMID 34975076
DI 10.4103/ijph.ijph_2103_21
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZB5UV
UT WOS:000756907800004
PM 34975076
OA gold
DA 2022-04-20
ER

PT J
AU Jung, S
   Lee, J
AF Jung, Sookhwa
   Lee, Jaewoo
TI Current and future influences of COVID-19 on the knowledge management
   function of conventions and exhibitions
SO SERVICE BUSINESS
LA English
DT Article; Early Access
DE Conventions and exhibitions; COVID-19; Meeting technology; Tacit
   knowledge; Temporary cluster
ID INTERNATIONAL-TRADE FAIRS; TO-FACE CONTACT; TACIT KNOWLEDGE; DYNAMIC
   THEORY; BUZZ; INFORMATION; CLUSTERS; ATTENDANCE; PIPELINES; VISITOR
AB This study presents a new perspective on conventions and exhibitions (termed "C&E") as places of knowledge exchange and conversion in which participants acquire, create, and disseminate tacit and explicit knowledge. C&E is defined as a temporary cluster promoting tacit knowledge exchange, which cannot be conveyed without meeting in person. However, C&E has been forced to convert to online/virtual events owing to the COVID-19 pandemic and is now changing to a hybrid mode of on-site and virtual events. This phenomenon is expected to continue post-pandemic, as long as socialization for tacit knowing is still the primary concern for people attending events.
C1 [Jung, Sookhwa; Lee, Jaewoo] Pusan Natl Univ, Grad Sch Int Studies, San 30, Busan 46241, South Korea.
RP Lee, J (corresponding author), Pusan Natl Univ, Grad Sch Int Studies, San 30, Busan 46241, South Korea.
EM sukajung@gmail.com; aggieljw@naver.com
FU Pusan National UniversityPusan National University
FX This work was supported by a 2-year Research Grant of Pusan National
   University.
CR Bae SY, 2021, CURR ISSUES TOUR, V24, P1017, DOI 10.1080/13683500.2020.1798895
   Bathelt H, 2004, PROG HUM GEOG, V28, P31, DOI 10.1191/0309132504ph469oa
   Bathelt H, 2011, GEOFORUM, V42, P520, DOI 10.1016/j.geoforum.2011.04.007
   Bathelt H, 2010, EUR PLAN STUD, V18, P1957, DOI 10.1080/09654313.2010.515815
   Blackler F, 1995, ORGAN STUD, V16, P1021, DOI 10.1177/017084069501600605
   Blythe J, 2002, IND MARKET MANAG, V31, P627, DOI 10.1016/S0019-8501(02)00183-9
   Blythe J., 1999, MARK INTELL PLAN, V17, P100, DOI [10.1108/02634509910260959, DOI 10.1108/02634509910260959]
   Center for Exhibition industry Research (CEIR), 1992, POW TRAD SHOWS SIMM
   Chinowsky PS, 2003, J MANAGE ENG, V19, P98, DOI 10.1061/(ASCE)0742-597X(2003)19:3(98)
   Choi JC, 2020, CORONA SAPIENS INFLU
   Davenport T.H., 1998, WORKING KNOWLEDGE OR, P1
   Drucker PF, 1999, CALIF MANAGE REV, V41, P79, DOI 10.2307/41165987
   Falconer L, 2006, LEARN ORGAN, V13, P140, DOI 10.1108/09696470610645476
   Fryatt J, 2012, HYBR M EV MPI FDN M
   Gebarowski M, 2014, CONT TRADE SHOWS PLA, P335
   GERTLER MS, 1995, ECON GEOGR, V71, P1, DOI 10.2307/144433
   Gertler MS, 2003, J ECON GEOGR, V3, P75, DOI 10.1093/jeg/3.1.75
   Getz D., 2020, EVENT STUDIES THEORY, V4th
   Hameed BZ, 2021, UROLOGY
   Hansen K., 1996, INT MARKET REV, DOI [10.1108/02651339610115764, DOI 10.1108/02651339610115764]
   Henn S, 2015, GEOFORUM, V58, P104, DOI 10.1016/j.geoforum.2014.10.015
   Hobson JP., 1993, INT J HOSP MANAG, V12, P115, DOI [10.1016/0278-4319(93)90002-Q, DOI 10.1016/0278-4319(93)90002-Q]
   Jasimuddin SM., 2012, KNOWLEDGE MANAGEMENT, DOI [10.1142/7246, DOI 10.1142/7246]
   Jeong Joon, 2016, [The Korean Journal of Economics, 한국경제학보(구 연세경제연구)], V23, P3
   Johannessen JA, 2001, INT J INFORM MANAGE, V21, P3, DOI 10.1016/S0268-4012(00)00047-5
   Jung Mihae, 2008, [International Journal of Tourism Management and Sciences, 관광연구], V23, P305
   Jung SH., 2019, TOUR MANAG RES ORG, V23, P395
   JUNG Sook-Hwa, 2020, [Journal of Tourism Management Research, 관광경영연구], V24, P863
   JUNG Sook-Hwa, 2018, [Journal of Korea Service Management Society, 서비스경영학회지], V19, P47, DOI 10.15706/jksms.2018.19.1.003
   JUNG Sook-Hwa, 2016, [JOURNAL OF MICE & TOURISM RESEARCH, MICE관광연구], V16, P43
   JUNG Sook-Hwa, 2020, [Journal of Tourism Management Research, 관광경영연구], V24, P641
   KERIN RA, 1987, J MARKETING, V51, P87, DOI 10.2307/1251649
   Kim H, 2006, TOURISM MANAGE, V27, P957, DOI 10.1016/j.tourman.2005.09.007
   Kim KJ, 2021, PIVOTING ONE ONE BOO
   Kukminilbo, 2020, COR GO UNT DEEPT
   Lee SM, 2020, SERV BUS, V14, P1, DOI 10.1007/s11628-019-00408-2
   Malmberg A., 1997, EUROPEAN PLANNING ST, V5, P25, DOI DOI 10.1080/09654319708720382
   Maskell P, 2006, EUR PLAN STUD, V14, P997, DOI 10.1080/09654310600852332
   Mattila Anna S., 2002, J SERVICES RES, V4, P268, DOI DOI 10.1177/1094670502004004004
   McDermott R, 1999, CALIF MANAGE REV, V41, P103, DOI 10.2307/41166012
   Meetingsnet, HYBR M WHATS NEW WHA
   Meetingspotlight, 2021, BUYER Q A HYBR EV RE
   Meetingspotlight (2020b), STATS 95 EV ORG LIK
   Mitchell VW, 2016, IND MARKET MANAG, V52, P100, DOI 10.1016/j.indmarman.2015.05.014
   Morell K, 2010, MEET TODAY
   Morrow SL, 1997, ART SHOW INTRO STUDY
   Munter M., 1998, BUS COMMUN Q, V61, P82, DOI [10.1177/108056999806100210, DOI 10.1177/108056999806100210]
   Munuera JL, 1999, J BUS RES, V44, P17, DOI 10.1016/S0148-2963(97)00174-4
   Nadler R., 2020, COMPUTERS COMPOSITIO, V58, P102613, DOI [10.1016/j.compcom.2020.102613, DOI 10.1016/J.COMPCOM.2020.102613]
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Nonaka I, 2000, LONG RANGE PLANN, V33, P5, DOI 10.1016/S0024-6301(99)00115-6
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Oppermann M, 1997, ANN TOURISM RES, V24, P178, DOI 10.1016/S0160-7383(96)00049-7
   Panahi S, 2013, J KNOWL MANAG, V17, P379, DOI 10.1108/JKM-11-2012-0364
   Parker J, 2009, RUNNING VIRTUAL HYBR
   PCMA UMB Studios and Virtual Edge Institute, 2011, BUS MOT SOC BEH IN P
   Polanyi M., 1967, TACIT DIMENSION
   Porter ME, 1998, HARVARD BUS REV, V76, P77
   Prentice C, 2021, SERV IND J, V41, P1, DOI 10.1080/02642069.2021.1883262
   Reinach WC, 2021, VIRTUAL PLATFORMS AR
   Rice JL., 2005, INT J ORG BEHAV, V9, P671
   Rinallo D, 2011, ECON GEOGR, V87, P453, DOI 10.1111/j.1944-8287.2011.01127.x
   Rittichainuwat B, 2012, TOURISM MANAGE, V33, P1236, DOI 10.1016/j.tourman.2011.11.002
   Rogers T., 2013, C CONVENTIONS GLOBAL, DOI [10.4324/9780203119402, DOI 10.4324/9780203119402]
   ROMER PM, 1986, J POLIT ECON, V94, P1002, DOI 10.1086/261420
   ROSSON PJ, 1995, J BUS RES, V32, P81, DOI 10.1016/0148-2963(94)00012-4
   Sarmento M, 2015, IND MARKET MANAG, V44, P131, DOI 10.1016/j.indmarman.2014.10.010
   Schuldt N, 2011, EUR PLAN STUD, V19, P1, DOI 10.1080/09654313.2011.530390
   Seong-Ok Lyu，, 2015, [Korean Journal of Hospitality and Tourism(KJHT), 호텔경영학연구], V24, P1
   Sharland A, 1996, IND MARKET MANAG, V25, P59, DOI 10.1016/0019-8501(95)00065-8
   Shipley D., 1993, J MARK MANAG, V9, P55, DOI [10.1080/0267257X.1993.9964217, DOI 10.1080/0267257X.1993.9964217]
   Skare M, 2021, SERV BUS, DOI 10.1007/s11628-021-00471-8
   Smith TM, 2003, J BUS IND MARK, V18, P403, DOI 10.1108/08858620310480296
   Spender JC, 1996, STRATEGIC MANAGE J, V17, P45, DOI 10.1002/smj.4250171106
   Storper M, 2004, J ECON GEOGR, V4, P351, DOI 10.1093/jnlecg/lbh027
   Tanner JF., 2001, J CONV EXHIBIT MANAG, V3, P3, DOI [10.1300/J143v03n03_02, DOI 10.1300/J143V03N03_02]
   Khoa DT, 2021, SERV IND J, V41, P32, DOI 10.1080/02642069.2020.1831477
   Tradeshow Logic, 2020, VIRT EV EXP, V1
   UFI, 2020, UFI GLOB EXH BAR
   UIA, 2021, INT M STAT REP, V62nd
   UIA, 2020, INT M STAT REP
   UNWTO, 2020, WORLD TOUR BAR MAY 2
   Wiederhold BK, 2020, CYBERPSYCH BEH SOC N, V23, P437, DOI 10.1089/cyber.2020.29188.bkw
   Yang K, 2021, SERV IND J, V41, P84, DOI 10.1080/02642069.2020.1863373
   Zwanka RJ, 2021, J INT CONSUM MARK, V33, P58, DOI 10.1080/08961530.2020.1771646
NR 85
TC 1
Z9 1
U1 4
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1862-8516
EI 1862-8508
J9 SERV BUS
JI Serv. Bus.
DI 10.1007/s11628-022-00488-7
EA MAR 2022
PG 21
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA ZS7HX
UT WOS:000768634200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Aleanizy, FS
   Alqahtani, FY
AF Aleanizy, Fadilah Sfouq
   Alqahtani, Fulwah Yahya
TI Awareness and knowledge of COVID-19 infection control precautions and
   waste management among healthcare workers Saudi cross-sectional study
SO MEDICINE
LA English
DT Article
DE COVID-19 infection; healthcare workers; infection control; infection
   supplies; waste management
ID RESPIRATORY SYNDROME; MERS-COV; CORONAVIRUS; STUDENTS; ARABIA
AB Healthcare workers (HWs) perform a critical role not only in the clinical management of patients but also in providing adequate infection control and prevention measures and waste management procedures to be implemented in healthcare facilities. The aim of this study was to evaluate the awareness and knowledge of COVID-19 infection control precautions and waste management procedures among HWs in Saudi Arabian hospitals. This was a descriptive, cross-sectional study. Information on knowledge, awareness, and practice of infection control and waste management procedures were obtained from the HWs using a structured questionnaire. A thematic analysis was used to analyze the data. Our findings indicated that most of the study participants were knowledgeable, with a mean score of 78.3%. In total, 92.5%, 90.3%, and 91.7% of the participants were aware of the infection control precautions, COVID-19 waste management procedures, the availability of infection control supplies, respectively. HWs' Knowledge regarding waste management and infection control procedures correlated significantly with sex (P <= .001 and <.001), education (P = .024 and .043), and working experience (P = .029 and .009), respectively. Most participants appreciated the importance of their role in infection control, surveillance, and monitoring of the ongoing safety practices in their patients as well as their facilities and communities.
C1 [Aleanizy, Fadilah Sfouq; Alqahtani, Fulwah Yahya] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia.
RP Aleanizy, FS (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia.
EM faleanizy@ksu.edu.sa
RI Aleanizy, Fadilah Sfouq/AAL-6436-2020
OI Aleanizy, Fadilah Sfouq/0000-0002-6161-3121; Alqahtani,
   fulwah/0000-0002-9320-0516
FU "Research Center of the Female Scientific and Medical Colleges,"
   Deanship of Scientific Research, King Saud UniversityKing Saud
   University
FX This research project was supported by a grant from the "Research Center
   of the Female Scientific and Medical Colleges," Deanship of Scientific
   Research, King Saud University.
CR Al-Hanawi MK, 2019, PUBLIC HEALTH REV, V40, DOI 10.1186/s40985-019-0112-4
   Al-Hazmi A, 2018, SAUDI J BIOL SCI, V25, P572, DOI 10.1016/j.sjbs.2016.01.032
   Al-Rabiaah A, 2020, J INFECT PUBLIC HEAL, V13, P687, DOI 10.1016/j.jiph.2020.01.005
   Alagoz AZ, 2008, WASTE MANAGE, V28, P1461, DOI 10.1016/j.wasman.2007.08.024
   Aleanizy FS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2137-3
   Alqahtani FY, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002923
   Babu S, 2010, TANZANIA DENT J, V16, P39, DOI DOI 10.4314/TDJ.V16I2.69867
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Da Silva CE, 2005, WASTE MANAGE, V25, P600, DOI 10.1016/j.wasman.2004.03.002
   Fakhri, 1998, GUIDE HLTH WASTE MAN
   Garg R., 2014, J ATMOS POL, V2, P17, DOI DOI 10.12691/JAP-2-1-4
   Hassan MM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-36
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Memish ZA, 2004, J TRAVEL MED, V11, P127, DOI 10.2310/7060.2004.16954
   Ministry of Health-Singapore. General Directorarte of Health Affairs (Eastern Province Saudi Arabia), 1998, GUIDE MANAGEMENT MED
   Ministry of Health-Singapore. Ministry of Health, 2020, SAUDI ARBIA 2020 NOV
   Ministry of Health-Singapore. Ministry of Health, 2020, SAUDI ARBIA 2020 COV
   Mohamed Rania Ali El Hadi, 2020, Pak J Biol Sci, V23, P119, DOI 10.3923/pjbs.2020.119.125
   Parmet WE, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2004211
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Shalini Sharma, 2010, International Journal of Environmental Science and Development, V1, P251
   Shi FPL, 2020, EIEF WORKING PAPERS
   Slyne H., 2012, Journal of Infection Prevention, V13, P92, DOI 10.1177/1757177412446855
   Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]
   World Health Organization, 2020, COVID 19 DASHBOARD S
   World Health Organization, 2020, COVID 19 DASHBOARD
   World Health Organization, 2014, HOSP PREPAREDNESS EP
   World Health Organization. World Health Organization, 2020, MIDDLE E RESP SYNDRO
NR 32
TC 2
Z9 2
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD MAY 28
PY 2021
VL 100
IS 21
AR e26102
DI 10.1097/MD.0000000000026102
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA SO8CZ
UT WOS:000659204000060
PM 34032750
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Ciftciler, R
   Haznedaroglu, IC
   Tufan, A
   Ozturk, MA
AF Ciftciler, Rafiye
   Haznedaroglu, Ibrahim C.
   Tufan, Abdurrahman
   Ozturk, Mehmet Akif
TI Covid-19 scientific publications from Turkey
SO TURKISH JOURNAL OF MEDICAL SCIENCES
LA English
DT Review
DE Covid-19; Turkish COVID 19 publications; literature; pathobiology;
   diagnosis; treatment
ID CORONAVIRUS DISEASE COVID-19; SARS-COV-2; SURGERY; HEALTH
AB Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak poses a major global threat to the public health worldwide. The infectious disease caused by the virus that affected the entire world was named as the Coronavirus disease-2019 (COVID-19). The knowledge regarding the wide clinico-biological aspects of the COVID-19 continues to evolve very rapidly, given the growing data from all over the world. During this complicated process, healthcare professionals have benefited from each other's experiences in combatting against the COVID-19 syndrome. COVID-19 related studies have been performed by a wide variety of research groups in Turkey as well as the rest of the world. The aim of this paper is to outline Turkish COVID-19 research indexed in the LitCovid system. LitCovid is a curated literature hub for tracking up-to-date scientific data about the SARS-CoV-2. COVID-19's first case was detected in Turkey, on March 11th, 2020. Six months after the first case was observed, the total number of COVID-19 patients was reported to be as 286,455, and the total number of deaths due to SARS-CoV-2 was 6895. The genetic sequence of the novel coronavirus showed significant identity to SARS-CoV and MERS-CoV. Numerous drugs including lopinavir/ritonavir, favipiravir, neuraminidase inhibitors, remdesivir, umifenovir, azithromycin, and chloroquine have been suggested for the management of COVID-19 although the exact treatment is yet to be determined.
C1 [Ciftciler, Rafiye] Aksaray Univ Training & Res Hosp, Fac Med, Dept Hematol, Aksaray, Turkey.
   [Haznedaroglu, Ibrahim C.] Hacettepe Univ, Fac Med, Dept Hematol, Ankara, Turkey.
   [Tufan, Abdurrahman; Ozturk, Mehmet Akif] Gazi Univ, Fac Med, Dept Rheumatol, Ankara, Turkey.
RP Ciftciler, R (corresponding author), Aksaray Univ Training & Res Hosp, Fac Med, Dept Hematol, Aksaray, Turkey.
EM rafiyesarigul@gmail.com
OI OZTURK, MEHMET AKIF/0000-0003-1096-7306
CR Acikgoz O, 2020, TURK J MED SCI, V50, P520, DOI 10.3906/sag-2004-6
   Adebali O, 2020, TURK J BIOL, V44, P146, DOI 10.3906/biy-2005-35
   Agalar C, 2020, TURK J MED SCI, V50, P578, DOI 10.3906/sag-2004-132
   Akin L., 2020, TURK J MED SCI, DOI [10.3906/sag-2005-478, DOI 10.3906/SAG-2005-478]
   Aksu K, 2020, CLIN EXP IMMUNOL, V202, P220, DOI 10.1111/cei.13507
   Aktas B, 2020, TURK J BIOL, V44, P265, DOI 10.3906/biy-2005-102
   Akyil FT, 2020, TURK THORAC J, V21, P185, DOI 10.5152/TurkThoracJ.2020.20052
   Alpaydin AO, 2021, J MED VIROL, V93, P1119, DOI 10.1002/jmv.26410
   Altun E, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13972
   Aydin OA, 2020, J MED VIROL, V92, P2288, DOI 10.1002/jmv.25955
   Ankarali H, 2020, ASIA-PAC J PUBLIC HE, V32, P157, DOI 10.1177/1010539520928180
   Arslan H, 2020, EXP CLIN TRANSPLANT, V18, P275, DOI 10.6002/ect.2020.0194
   Aslan S, 2021, DIAGN INTERV RADIOL, V27, P181, DOI 10.5152/dir.2020.20350
   Ayaz Caglayan Merve, 2020, Infez Med, V28, P351
   Aykac N, 2020, TURK THORAC J, V21, P291, DOI 10.5152/TurkThoracJ.2020.20085
   Azkur AK, 2020, ALLERGY, V75, P1564, DOI 10.1111/all.14364
   Batu ED, 2020, RHEUMATOL INT, V40, P1193, DOI 10.1007/s00296-020-04612-6
   Bolay H, 2020, HEADACHE, V60, P1415, DOI 10.1111/head.13856
   Bulut C, 2020, TURK J MED SCI, V50, P563, DOI 10.3906/sag-2004-172
   Calik Basaran N, 2021, TURK J MED SCI, V51, P411, DOI 10.3906/sag-2006-173
   Chen QY, 2020, NATURE, V579, P193, DOI 10.1038/d41586-020-00694-1
   Ciftciler R, 2020, UHOD-ULUSLAR HEMATOL, V30, P113, DOI 10.4999/uhod.204171
   Ciftciler R, 2020, TURK J HEMATOL, V37, P207, DOI 10.4274/tjh.galenos.2020.2020.0174
   Cinkooglu A, 2020, DIAGN INTERV RADIOL, V26, P308, DOI 10.5152/dir.2020.20307
   Coskun H, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141663
   Demir AB, 2020, TURK J BIOL, V44, P178, DOI 10.3906/biy-2005-69
   Demir E, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13371
   Demirbilek Y, 2020, TURK J MED SCI, V50, P489, DOI 10.3906/sag-2004-187
   Dertlioglu SB, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13932
   Djilali S, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109971
   Esme M, 2021, J GERONTOL A-BIOL, V76, pE68, DOI 10.1093/gerona/glaa219
   Gok AFK, 2020, ULUS TRAVMA ACIL CER, V26, P335, DOI 10.14744/tjtes.2020.79954
   Goker H, 2020, TURK J MED SCI, V50, P679, DOI 10.3906/sag-2005-395
   Gorkem SB, 2020, DIAGN INTERV RADIOL, V26, P608, DOI 10.5152/dir.2020.20361
   Gul S, 2020, J INFECT DEV COUNTR, V14, P713, DOI 10.3855/jidc.12844
   Gul U, 2020, TURK J MED SCI, V50, P1751, DOI 10.3906/sag-2005-182
   Guner R, 2020, TURK J MED SCI, V50, P1801, DOI 10.3906/sag-2006-164
   Guner R, 2020, TURK J MED SCI, V50, P571, DOI 10.3906/sag-2004-146
   Haberal M, 2020, EXP CLIN TRANSPLANT, V18, P139, DOI 10.6002/ect.2020.000e
   Hacibekiroglu T, 2021, TURK J MED SCI, V51, P45, DOI 10.3906/sag-2007-59
   Halacli B, 2020, TURK J MED SCI, V50, P585, DOI 10.3906/sag-2004-122
   Hasoksuz M, 2020, TURK J MED SCI, V50, P549, DOI 10.3906/sag-2004-127
   Kalafat E, 2020, ULTRASOUND OBST GYN, V55, P835, DOI 10.1002/uog.22034
   Kanburoglu MK, 2020, PEDIATR INFECT DIS J, V39, pE297, DOI 10.1097/INF.0000000000002862
   Karacan I, 2020, NORTH CLIN ISTANB, V7, P203, DOI 10.14744/nci.2020.90532
   Batur LK, 2021, J MED VIROL, V93, P1409, DOI 10.1002/jmv.26409
   Kirbas I, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.110015
   Korkmaz MF, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e236
   Kuman Tuncel O, 2020, TURK J MED SCI, V50, P1792, DOI 10.3906/sag-2006-140
   Kutlu O, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14096
   Marim F, 2020, EURASIAN J MED, V52, P202, DOI 10.5152/eurasianjmed.2020.20118
   Medetalibeyoglu A, 2020, TURK J MED SCI, V50, P1436, DOI 10.3906/sag-2004-98
   Solak EO, 2021, J EUR ACAD DERMATOL, V35, pE105, DOI 10.1111/jdv.16904
   Oncel MY, 2021, EUR J PEDIATR, V180, P733, DOI 10.1007/s00431-020-03767-5
   Ozdag Acarli AN, 2020, NOROPSIKIYATRI ARS, V57, P154, DOI 10.29399/npa.26148
   Ozger HS, 2020, TURK J MED SCI, V50, P1810, DOI 10.3906/sag-2005-385
   Ozturk CN, 2020, ANN PLAS SURG, V85, pS155, DOI 10.1097/SAP.0000000000002443
   Ozturk G, 2020, TURK J MED SCI, V50, P1504, DOI 10.3906/sag-2005-356
   Ozturk R, 2020, TURK J MED SCI, V50, P638, DOI 10.3906/sag-2005-287
   Pavel STI, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238614
   Sahin D, 2020, INT J GYNECOL OBSTET, V151, P74, DOI 10.1002/ijgo.13318
   Sahin TT, 2020, WORLD J GASTROENTERO, V26, P2987, DOI 10.3748/wjg.v26.i22.2987
   Sargin SA, 2021, J ETHNOPHARMACOL, V265, DOI 10.1016/j.jep.2020.113319
   Sarialioglu F, 2021, TURK J MED SCI, V51, P382, DOI 10.3906/sag-2007-133
   Sarinoglu RC, 2020, J INFECT DEV COUNTR, V14, P721, DOI 10.3855/jidc.13152
   Sarioglu N, 2020, TUBERK TORAK, V68, P141, DOI 10.5578/tt.69775
   Satici B, 2021, INT J MENT HEALTH AD, V19, P1980, DOI 10.1007/s11469-020-00294-0
   Satici C, 2020, INT J INFECT DIS, V98, P84, DOI 10.1016/j.ijid.2020.06.038
   Sayin I, 2020, OTOLARYNG HEAD NECK, V163, P473, DOI 10.1177/0194599820931820
   Sayinalp B, 2021, TURK J MED SCI, V51, P1, DOI 10.3906/sag-2005-410
   Simsek Yavuz S, 2020, TURK J MED SCI, V50, P611, DOI 10.3906/sag-2004-145
   Sipahi S, 2021, TURK J MED SCI, V51, P421, DOI 10.3906/sag-2006-54
   Sonkaya AR, 2021, TURK J MED SCI, V51, P435, DOI 10.3906/sag-2006-203
   Soy M, 2020, CLIN RHEUMATOL, V39, P2085, DOI 10.1007/s10067-020-05190-5
   Surmelioglu N, 2021, POSTGRAD MED, V133, P237, DOI 10.1080/00325481.2020.1807809
   Tanacan A, 2020, EUR J OBSTET GYN R B, V253, P31, DOI 10.1016/j.ejogrb.2020.07.051
   Tastan C, 2020, TURK J BIOL, V44, P192, DOI 10.3906/biy-2004-113
   Tezer H, 2020, TURK J MED SCI, V50, P592, DOI 10.3906/sag-2004-174
   Tufan A, 2020, TURK J MED SCI, V50, P620, DOI 10.3906/sag-2004-168
   Tunc A, 2020, J CLIN NEUROSCI, V77, P227, DOI 10.1016/j.jocn.2020.05.018
   Tuncer T, 2020, CARDIOL YOUNG, V30, P1482, DOI 10.1017/S1047951120002425
   Yakar MN, 2020, TURK J ANAESTHESIOL, V48, P244, DOI 10.5152/TJAR.2020.607
   Yassa M, 2020, J MATERN-FETAL NEO M, V33, P3820, DOI 10.1080/14767058.2020.1798398
   Yayla BCC, 2020, BALK MED J, V37, P341, DOI 10.4274/balkanmedj.galenos.2020.2020.7.52
   Yigenoglu TN, 2021, J MED VIROL, V93, P1099, DOI 10.1002/jmv.26404
   Yigenoglu TN, 2020, J CLIN APHERESIS, V35, P367, DOI 10.1002/jca.21806
   Yormaz B, 2021, TURK J MED SCI, V51, P28, DOI 10.3906/sag-2006-184
NR 87
TC 3
Z9 3
U1 43
U2 68
PU TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY
PI ANKARA
PA ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY
SN 1300-0144
EI 1303-6165
J9 TURK J MED SCI
JI Turk. J. Med. Sci.
PY 2021
VL 51
IS 3
BP 877
EP 889
DI 10.3906/sag-2010-261
PG 13
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA TB9DN
UT WOS:000668244900001
PM 33306333
OA Bronze
DA 2022-04-20
ER

PT J
AU Iandolo, F
   Loia, F
   Fulco, I
   Nespoli, C
   Caputo, F
AF Iandolo, Francesca
   Loia, Francesca
   Fulco, Irene
   Nespoli, Chiara
   Caputo, Francesco
TI Combining Big Data and Artificial Intelligence for Managing Collective
   Knowledge in Unpredictable Environment-Insights from the Chinese Case in
   Facing COVID-19
SO JOURNAL OF THE KNOWLEDGE ECONOMY
LA English
DT Article
DE Knowledge management; Collective knowledge; Big data; Artificial
   intelligence; Viable systems approach; COVID-19
ID MANAGEMENT; INFORMATION; INNOVATION; ANALYTICS; SYSTEMS; WEB;
   CONFIGURATION; TECHNOLOGIES; CAPABILITY; ADVANTAGE
AB The increasing fluidity of social and business configurations made possible by the opportunities provided by the World Wide Web and the new technologies is questioning the validity of consolidated business models and managerial approaches. New rules are emerging and multiple changes are required to both individuals and organizations engaged in dynamic and unpredictable paths. In such a scenario, the paper aims at describing the potential role of big data and artificial intelligence in the path toward a collective approach to knowledge management. Thanks to the interpretative lens provided by systems thinking, a framework able to explain human-machine interaction is depicted and its contribution to the definition of a collective approach to knowledge management in unpredictable environment is traced. Reflections herein are briefly discussed with reference to the Chinese governmental approach for managing COVID-19 spread to emphasise the support that a technology-based collective approach to knowledge management can provide to decision-making processes in unpredictable environments.
C1 [Iandolo, Francesca] Univ Roma La Sapienza, Fac Econ, Dept Management, Via Castro Laurenziano 9, I-00161 Rome, Italy.
   [Loia, Francesca; Caputo, Francesco] Univ Naples Federico II, Dept Econ Management & Inst DEMI, Via Cintia 21, I-80126 Naples, Italy.
   [Fulco, Irene] Univ Tuscia Viterbo, Dept Econ & Management DEIM, Via Paradiso 47, I-01100 Viterbo, Italy.
   [Nespoli, Chiara] Univ Campania L Vanvitelli, Via Roma 29, I-81031 Aversa, CE, Italy.
RP Caputo, F (corresponding author), Univ Naples Federico II, Dept Econ Management & Inst DEMI, Via Cintia 21, I-80126 Naples, Italy.
EM francesca.iandolo@uniroma1.it; francesca.loia@unina.it;
   irenefulco@unitus.it; chiaranespoli1@gmail.com;
   francesco.caputo2@unina.it
RI Iandolo, Francesca/AAF-7345-2022; Iandolo, Francesca/AFK-0311-2022
OI Iandolo, Francesca/0000-0002-2366-4892; Iandolo,
   Francesca/0000-0002-2366-4892; FULCO, IRENE/0000-0003-0907-6450; Caputo,
   Francesco/0000-0001-9583-7222
FU Universita degli Studi di Napoli Federico II within the CRUI-CARE
   Agreement
FX Open access funding provided by Universita degli Studi di Napoli
   Federico II within the CRUI-CARE Agreement.
CR Allam Z, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010046
   Allred CR, 2011, DECISION SCI, V42, P129, DOI 10.1111/j.1540-5915.2010.00304.x
   Amendola C, 2018, J RETAIL CONSUM SERV, V43, P251, DOI 10.1016/j.jretconser.2018.04.005
   Arrigo E, 2018, J KNOWL ECON, V9, P150, DOI 10.1007/s13132-015-0327-7
   Ashby W.R., 1968, SYSTEMS RES BEHAV SC
   Ashton K., 2009, RFID J, V22, P97, DOI DOI 10.1145/2967977
   Asrar-ul-Haq M, 2016, COGENT BUS MANAG, V3, DOI 10.1080/23311975.2015.1127744
   Ball K., 2011, SURVIVING BABY BOOME
   Barile S, 2013, CONTRIBUTIONS THEORE
   Barile S., 2010, SERV SCI, V2, P21, DOI [10.1287/serv.2.1_2.21, DOI 10.1287/SERV.2.1_2.21]
   Barile S., 2012, J BUS MARK MANAG, V2, P54
   Barile S., 2009, MANAGEMENT SISTEMICO
   Beer S., 1984, J OPERATIONAL RES SO, V35, P7, DOI DOI 10.1057/jors.1984.2
   Bose R, 2009, IND MANAGE DATA SYST, V109, P155, DOI 10.1108/02635570910930073
   Bourdieu P, 2019, SOCIAL THEORY CHANGI
   Bresciani S, 2018, TECHNOL FORECAST SOC, V136, P331, DOI 10.1016/j.techfore.2017.03.002
   Brynjolfsson E., 2002, UNDERSTANDING DIGITA
   Capra F., 1997, WEB LIFE NEW SCI UND, VAnchor
   Caputo F, 2018, ANNALS BUS RES, P25
   Caputo F, 2017, EUROMED ACAD BUS CON, P287
   Caputo F, 2017, SYSTEMS, V5, DOI 10.3390/systems5010001
   Caputo F, 2016, INNOVATION, ENTREPRENEURSHIP AND DIGITAL ECOSYSTEMS, P455
   Carrubbo L, 2017, J SERV THEOR PRACT, V27, P1006, DOI 10.1108/JSTP-09-2015-0202
   Checkland P., 1981, SYSTEMS THINKING SYS
   Chen CLP, 2014, INFORM SCIENCES, V275, P314, DOI 10.1016/j.ins.2014.01.015
   Chinnaswamy A, 2019, MANAGE DECIS, V57, P1937, DOI 10.1108/MD-07-2018-0835
   Choudhary AK, 2013, INT J PROD RES, V51, P1953, DOI 10.1080/00207543.2012.758508
   Christensen CM, 2001, MIT SLOAN MANAGE REV, V42, P105
   Constantiou I, 2017, MIS Q EXEC, V16, P231
   Coyle K, 2006, J ACAD LIBR, V32, P641, DOI 10.1016/j.acalib.2006.08.002
   Dana J, 2020, J KNOWL ECON, V11, P405, DOI 10.1007/s13132-018-0553-x
   Davies J., 2003, SEMANTIC WEB ONTOLOG, V1st
   Del Giudice M, 2017, INT MARKET REV, V34, P652, DOI 10.1108/IMR-05-2016-0098
   Del Giudice M, 2016, J DECIS SYST, V25, P214, DOI 10.1080/12460125.2016.1187546
   Erickson S., 2015, LEADING ISSUES KNOWL, VTwo, P204
   Fan W., 2013, ACM SIGKDD EXPLORATI, V14, P1, DOI DOI 10.1145/2481244.2481246
   Feblowitz J., 2013, P SPE DIGITAL ENERGY
   Gaeta M., 2019, INT J BUSINESS MANAG, V1, P17
   Goldman D.P., 2020, CHINA SUPPRESSED COV
   Golinelli G. M., 2010, GOVERNING BUSINESS D
   Gruber T, 2008, J WEB SEMANT, V6, P4, DOI 10.1016/j.websem.2007.11.011
   Hair JF, 2007, EUR BUS REV, V19, P303, DOI 10.1108/09555340710760134
   HANDSCHUH S, 2003, ANNOTATION SEMANTIC
   Hecker A, 2012, ORGAN STUD, V33, P423, DOI 10.1177/0170840611433995
   Hennig-Thurau T., 2013, RELATIONSHIP MARKETI
   Hepp M, 2005, INT CONF E BUS ENG, P535, DOI 10.1109/ICEBE.2005.110
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Holtshouse D., 2013, INFORM TECHNOLOGY KN
   Hopkins MS, 2010, MIT SLOAN MANAGE REV, V52, P22
   Hu TS, 2005, TECHNOVATION, V25, P367, DOI 10.1016/j.technovation.2003.09.002
   Hu Z., 2020, ARXIV200207112, DOI DOI 10.18562/IJEE.054
   Kanter, 2003, CHALLENGE ORG CHANGE
   Ketchen DJ, 2007, STRATEG ENTREP J, V1, P371, DOI 10.1002/sej.20
   Khan Z, 2017, J KNOWL MANAG, V21, P18, DOI 10.1108/JKM-06-2015-0238
   Khanbhai M, 2014, ISRN Hematol, V2014, P547914, DOI 10.1155/2014/547914
   Kirton MJ, 2004, ADAPTION INNOVATION
   Lamont J., 2012, KM WORLD, V21, P8
   Laney, 2012, IMPORTANCE BIG DATA
   Lastowka G., 2007, VAND J ENT TECH L, V10, P893
   Laszlo E, 1996, SYSTEMS VIEW WORLD H
   Lavalle S, 2011, MIT SLOAN MANAGE REV, V52, P21
   Leeflang PSH, 2014, EUR MANAG J, V32, P1, DOI 10.1016/j.emj.2013.12.001
   Levy P., 1997, COLLECTIVE INTELLIGE
   Liedtka J.M., 1996, ACAD MANAGEMENT EXEC, V10, P20, DOI DOI 10.5465/AME.1996.9606161550
   McAfee A, 2012, HARVARD BUS REV, V90, P60
   Meadows D., 2008, THINKING SYSTEMS PRI
   Morgan RM, 1999, J BUS RES, V46, P281, DOI 10.1016/S0148-2963(98)00035-6
   Nilsson N.J, 2014, PRINCIPLES ARTIFICIA
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Papa A, 2020, TECHNOL FORECAST SOC, V153, DOI 10.1016/j.techfore.2018.02.018
   Paroutis S, 2009, J KNOWL MANAG, V13, P52, DOI 10.1108/13673270910971824
   Pauleen DJ, 2017, J KNOWL MANAG, V21, P1, DOI 10.1108/JKM-08-2016-0339
   Qiu JF, 2016, EURASIP J ADV SIG PR, DOI 10.1186/s13634-016-0355-x
   Ratten V, 2016, J KNOWL ECON, V7, P935, DOI 10.1007/s13132-015-0319-7
   Sandberg S, 2014, INT BUS REV, V23, P20, DOI 10.1016/j.ibusrev.2013.08.001
   Santoro G, 2018, TECHNOL FORECAST SOC, V136, P347, DOI 10.1016/j.techfore.2017.02.034
   Saviano M., 2013, CONTRIBUTIONS THEORE, P219
   Saviano M., 2018, CYBERNET SYST, P261
   Saviano M, 2018, SINERGIE ITAL J MANA, V105, P63
   Saviano M, 2017, J SERV THEOR PRACT, V27, P951, DOI 10.1108/JSTP-10-2015-0228
   Soto-Acosta P, 2018, BALT J MANAG, V13, P298, DOI 10.1108/BJM-07-2018-398
   Sumbal MS, 2017, J KNOWL MANAG, V21, P180, DOI 10.1108/JKM-07-2016-0262
   Sundararajan A, 2016, SHARING ECONOMY: THE END OF EMPLOYMENT AND THE RISE OF CROWD-BASED CAPITALISM, P1
   Sweet P, 2001, INT J SERV IND MANAG, V12, P70, DOI 10.1108/09564230110382781
   Taleb N.N., 2007, BLACK SWAN IMPACT HI
   Tanriverdi H, 2005, MIS QUART, V29, P311
   Tapscott D., 1996, DIGITAL EC PROMISE P
   Turban E, 2006, INFORM TECHNOLOGY MA
   van Oosterhout M, 2006, EUR J INFORM SYST, V15, P132, DOI 10.1057/palgrave.ejis.3000601
   Vivacqua A.S., 2010, P 14 INT C COMP SUPP, P623
   Vivacqua AS, 2012, J NETW COMPUT APPL, V35, P189, DOI 10.1016/j.jnca.2011.03.002
   von Bertalanffy L., 1968, GEN SYSTEM THEORY FD
   WEINBERG GM, 1975, INTRO GEN SYSTEMS TH
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yu DK, 2018, J KNOWL ECON, V9, P782, DOI 10.1007/s13132-016-0375-7
   Zainon N, 2011, WORLD ACAD SCI ENG T, V5, P990
   Zancul ED, 2016, BUS PROCESS MANAG J, V22, P305, DOI 10.1108/BPMJ-05-2015-0078
   Zaslavsky A., 2013, ARXIV13010159, V1301, P159
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou LN, 2017, NEUROCOMPUTING, V237, P350, DOI 10.1016/j.neucom.2017.01.026
   Zikopoulos P, 2011, UNDERSTANDING BIG DA
NR 101
TC 7
Z9 7
U1 4
U2 14
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1868-7865
EI 1868-7873
J9 J KNOWL ECON
JI J. Knowl. Econ.
PD DEC
PY 2021
VL 12
IS 4
BP 1982
EP 1996
DI 10.1007/s13132-020-00703-8
EA NOV 2020
PG 15
WC Economics
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA WX0DO
UT WOS:000589446900001
OA hybrid
DA 2022-04-20
ER

PT J
AU Ahmed, N
   Abbasi, MS
   Bin-Shuwaish, MS
   Al-Aali, KA
   Al-Hamdan, RS
   Abduljabbar, T
   Vohra, F
AF Ahmed, N.
   Abbasi, M. S.
   Bin-Shuwaish, M. S.
   Al-Aali, K. A.
   Al-Hamdan, R. S.
   Abduljabbar, T.
   Vohra, F.
TI Knowledge attitude and practice of safety measures for corona virus
   disease-19 (COVID-19) among general population
SO NIGERIAN JOURNAL OF CLINICAL PRACTICE
LA English
DT Article
DE Awareness; COVID-19; general population; knowledge; safety measures
ID OUTBREAK
AB Objective: To evaluate the knowledge, attitude, and practice of general population for Corona virus disease 19 (COVID-19). Methods: A total of 950 participants submitted an online self-administered questionnaire, which was developed through literature search and validated. The online survey link was distributed through various social media platforms (WhatsApp, Instagram, Facebook, LinkedIn, Twitter, Snapchat, Pinterest, and Tumblr). And 861 forms were included in the study after checking for completion of relevant response from participants, whereas 89 forms were excluded. The data were analyzed through Statistical Package for Social Sciences. Descriptive statistics were performed for percentage and frequency determination of quantitative and qualitative variables. Spearman's correlation and Chi square test were performed to control confounders and association of knowledge, attitude, and practices with gender and education level. The P value <0.05 was considered as statistically significant. Results: More than two third of the population was aware of COVID-19 and three fourth had had bachelor's degrees, whereas 18% had master level education. 85% have not attended any courses, awareness campaigns, and lectures to inculcate recent and updated knowledge. 83% believed that COVID-19 is a serious threat to the community; hence, prevention strategies should be adopted. There was no significant relationship (p = 0.23) between knowledge, attitude, and practice levels with gender, whereas a significant relationship (p = 0.01) was noted with education of participant. Similarly, a significant relationship (p = 0.00) was seen between knowledge and practices of participants toward COVID-19. Conclusion: The studied population displayed adequate knowledge, attitude, and practice to combat COVID-19. However, we also find a knowledge gap between information source and perception of COVID-19 among our study participants. Therefore, there is a critical need for effective education and widespread public campaigns aiming to enhance relevant and contemporary information related to prevention and management of COVID-19.
C1 [Ahmed, N.; Abbasi, M. S.] Altamash Inst Dent Med, Dept Prosthodont, Karachi, Pakistan.
   [Bin-Shuwaish, M. S.; Al-Hamdan, R. S.] King Saud Univ, Coll Dent, Dept Restorat Dent Sci, Riyadh, Saudi Arabia.
   [Abduljabbar, T.; Vohra, F.] King Saud Univ, Coll Dent, Dept Prosthet Dent Sci, Riyadh 11545, Saudi Arabia.
   [Al-Aali, K. A.] Princess Nourah Bint Abdulrahman Univ, Coll Dent, Dept Clin Dent Sci, Riyadh, Saudi Arabia.
RP Vohra, F (corresponding author), King Saud Univ, Coll Dent, Dept Prosthet Dent Sci, Riyadh 11545, Saudi Arabia.
EM fvohra@ksu.edu.sa
RI Ahmed, Naseer/C-8119-2019
OI Ahmed, Naseer/0000-0002-0960-1123
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Ahmed N, 2020, PAK J MED SCI, V36, pS49, DOI 10.12669/pjms.36.COVID19-S4.2704
   Ahmed N, 2020, PAK J MED SCI, V36, pS104, DOI 10.12669/pjms.36.COVID19-S4.2739
   Al-Awadhi AM, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100326
   Al-Hazmi A, 2018, SAUDI J BIOL SCI, V25, P572, DOI 10.1016/j.sjbs.2016.01.032
   Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082
   Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42
   Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X
   Byanaku A., 2020, KNOWLEDGE ATTITUDES, DOI 10.1101/2020.04.26.20080820v2
   Di Napoli R., 2020, FEATURES EVALUATION
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Islam MR., 2020, RES SQUARE, DOI [10.21203/rs3.rs-24562/v1, DOI 10.21203/RS3.RS-24562/V1]
   Johnson DF, 2009, CLIN INFECT DIS, V49, P275, DOI 10.1086/600041
   Leon MPD, 2020, J PEDIAT INF DIS SOC, V9, P407, DOI 10.1093/jpids/piaa061
   Mirza TM., 2020, PAFMJ, V70, P338
   Olapegba PO, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105685
   Shen KL, 2020, WORLD J PEDIATR, V16, P223, DOI 10.1007/s12519-020-00343-7
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   WHO (World Health Organization), 2020, COR DIS COVID 19 OUT
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134
   Yuen KS, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00404-4
   Zhao HY, 2020, J AFFECT DISORDERS, V276, P446, DOI 10.1016/j.jad.2020.07.085
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 28
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 1119-3077
J9 NIGER J CLIN PRACT
JI Niger. J. Clin. Pract.
PD JUL
PY 2021
VL 24
IS 7
BP 1037
EP 1043
DI 10.4103/njcp.njcp_394_20
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA TR0AQ
UT WOS:000678636700011
PM 34290180
DA 2022-04-20
ER

PT J
AU Jalil, A
   Kanwal, R
   Idrees, Z
   Khan, KM
   Naseem, M
   Kamal, MS
AF Jalil, Amir
   Kanwal, Rahila
   Idrees, Zeeshan
   Khan, Kashif Mehmood
   Naseem, Muhammad
   Kamal, Muhammad Safi
TI Knowledge, Attitude & Practices of Surgeons in the time of COVID-19
SO ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE
LA English
DT Article
DE Surgeons; COVID-19; infection; incubation; transmission
ID HEALTH; WORKERS
AB Objective: The objective of the study was to determine the knowledge, attitude and practices of surgical interns, residents and surgeons in the time of COVID-19.
   Methods: A cross-sectional study was conducted on surgical interns, trainees, registrar and consult-ants working in public and private sector tertiary care hospitals of Karachi. Non-Convenience sampling technique is used. A total of 184 patients were included. The study was performed on assessing patients' demographics, basic knowledge and awareness of COVID 19 and individuals' practices toward COVID 19 in their professional routines. Data were stored and analyzed using IBM-SPSS version 23.0. Pearson Chi Square test was used to test the association outcomes, awareness and attitude items on COVID-19 between private and public sector hospitals. P-values less than 0.05 were considered statistically significant
   Results: The study comprised a total of 184 participants. Mostly from public 115(63%) rest 69(37%) belonged private sector hospitals. Most respondents 122(66.3%) were aware of COVID 19 incubation, symptoms and the detection of patients at risk and modalities of transmission in operating rooms.Results showed among public vs Private sector hospitals (81.7% / 68.1%) were treating co-rona virus, there were (35.7% / 46.3%) screening and admitted the cases, (56.5% / 62.4) tentative numbers of COVID-19 cases reported range from 0-25, (40.9%/ 11.6%) surgeons were assigned ad-ditional duties for COVID-19 by hospital management found statistically significant with "p<0.01".
   Conclusion: It is concluded after this study that the surgeons in Pakistan are well aware of the situation, have adequate knowledge of the risk factors and symptoms of COVID-19. But statistically, probably because of limited resources and work load, there is a substantial gap in practices between public and private sector surgeons. There is also a dire need to develop local guidelines related to preventive measures in our health care systems according to our demands and supply.
C1 [Jalil, Amir; Kanwal, Rahila; Idrees, Zeeshan; Khan, Kashif Mehmood; Naseem, Muhammad; Kamal, Muhammad Safi] Abbasi Shaheed Hosp, Dept Orthoped, Karachi, Pakistan.
   [Jalil, Amir; Kanwal, Rahila; Idrees, Zeeshan; Khan, Kashif Mehmood; Naseem, Muhammad; Kamal, Muhammad Safi] Karachi Med & Dent Coll, Karachi, Pakistan.
RP Jalil, A (corresponding author), Abbasi Shaheed Hosp, Dept Orthoped, Karachi, Pakistan.; Jalil, A (corresponding author), Karachi Med & Dent Coll, Karachi, Pakistan.
EM dramrijalil@yahoo.com
CR Al-Muharraqi MA, 2020, BRIT J ORAL MAX SURG, V58, P503, DOI 10.1016/j.bjoms.2020.04.014
   [Anonymous], BBC NEWS
   [Anonymous], 2020, WHO CORONAVIRUS DIS
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Brat Gabriel A, 2020, Ann Surg, DOI 10.1097/SLA.0000000000003926
   Brindle ME, 2020, ANN SURG, V272, pE1, DOI 10.1097/SLA.0000000000003923
   Centers for Disease Control and Prevention , 2020, PERSONAL PROTECTIVE
   Centre for Disease Control USA, INT INF PREV CONTR R
   Guo XD, 2020, J BONE JOINT SURG AM, V102, P847, DOI 10.2106/JBJS.20.00417
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Lei SQ, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100331
   Liu Z, 2020, INDIAN J SURG, V82, P124, DOI 10.1007/s12262-020-02173-3
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Naspro R, 2020, NAT REV UROL, V17, P251, DOI 10.1038/s41585-020-0312-1
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Pryor A, SAGES EAES RECOMMEND
   Rana W, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102080
   Tao K X, 2020, Zhonghua Wai Ke Za Zhi, V58, pE001, DOI 10.3760/cma.j.issn.0529-5815.2020.0001
   Ti LK, 2020, CAN J ANESTH, V67, P756, DOI 10.1007/s12630-020-01617-4
   W.H.O.Europe, COR DIS COVID 19 OUT
   Waris A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100681
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLL
PI KARACHI
PA BLOCK M, N NAZIMABAD, KARACHI, 74700, PAKISTAN
SN 1563-3241
J9 ANN ABBASI SHAHEED H
JI Ann. Abbasi Shaheed Hosp. Karachi Med. Dent. Coll.
PD MAR
PY 2021
VL 26
IS 1
BP 286
EP 295
PG 10
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA YN7VD
UT WOS:000747461100001
DA 2022-04-20
ER

PT J
AU Shahabi, N
   Takhti, HK
   Azad, MH
   Rad, RE
   Ghaffari, HR
   Mohseni, S
   Aghamolaei, T
   Norozian, F
AF Shahabi, Nahid
   Kamalzadeh Takhti, Hesamaddin
   Hassani Azad, Mehdi
   Ezati Rad, Roghayeh
   Ghaffari, Hamid Reza
   Mohseni, Shokrollah
   Aghamolaei, Teamur
   Norozian, Fatemeh
TI Knowledge, attitude, and preventive behaviors of Hormozgan residents
   toward COVID-19, one month after the epidemic in Iran
SO JOURNAL OF PUBLIC HEALTH-HEIDELBERG
LA English
DT Article; Early Access
DE Knowledge; Attitude; Preventive behavior; COVID-19
ID HEALTH-CARE WORKERS; STUDENTS; PERIOD
AB Aim COVID-19 has become prevalent in the world since December 2019. The further prevalence of the disease can be prevented by correct management of society and increasing knowledge, practices, and attitudes of the people. The present research aimed to evaluate the knowledge, attitudes, and preventive behaviors of people in Hormozgan in the south of Iran toward COVID-19.
   Subject and methods The present cross-sectional research was conducted over 2 months (March 2020-April 2020). The online questionnaire comprised four sections: demographic information, knowledge, attitude, and behavior toward COVID-19. Knowledge included 36 items, attitude eight items, and behavior ten items. The collected data were analyzed statistically using SPSS ver. 22. The split-half method was used to test the reliability of knowledge and the estimated value was 0.84. That of attitude and behavior was estimated via Cronbach's alpha and was found to be 0.81 and 0.75, respectively.
   Results A total number of 2024 participants with an average age of 33.94 years took part in this research. Of all participants, 64.4% were female. According to the results, 65.8% enjoyed a good level of knowledge and 34.2% enjoyed an average level. In addition, 63.2% demonstrated a good attitude and 36.8% an average level. A large percentage of participants (90.6%) had good practices and only 9.4% had an average level of practices.
   Conclusion The present findings show that participants had a relatively good level of knowledge, positive attitude, and good behavior concerning COVID-19.
C1 [Shahabi, Nahid; Ezati Rad, Roghayeh] Hormozgan Univ Med Sci, Fac Hlth, Student Res Comm, Bandar Abbas, Iran.
   [Kamalzadeh Takhti, Hesamaddin] Hormozgan Univ Med Sci, Sch Med, Dept Community Med, Bandar Abbas, Iran.
   [Hassani Azad, Mehdi] Hormozgan Univ Med Sci, Hormozgan Hlth Inst, Infect & Trop Dis Res Ctr, Bandar Abbas, Iran.
   [Ghaffari, Hamid Reza; Mohseni, Shokrollah; Norozian, Fatemeh] Hormozgan Univ Med Sci, Hormozgan Hlth Inst, Social Determinants Hlth Promot Res Ctr, Bandar Abbas, Iran.
   [Aghamolaei, Teamur] Hormozgan Univ Med Sci, Cardiovasc Res Ctr, Bandar Abbas, Iran.
RP Aghamolaei, T (corresponding author), Hormozgan Univ Med Sci, Cardiovasc Res Ctr, Bandar Abbas, Iran.
EM teaghamolaei@gmail.com
OI Aghamolaei, Teamur/0000-0002-2504-8014
FU Deputy of Research and Technology of Hormozgan University of Medical
   Sciences
FX This research was funded by the Deputy of Research and Technology of
   Hormozgan University of Medical Sciences.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Adab Z., 2016, RAHAVARD SALAMAT J, V2, P10
   Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969
   Al-Hazmi A, 2018, SAUDI J BIOL SCI, V25, P572, DOI 10.1016/j.sjbs.2016.01.032
   Alfahan A, 2016, J COMMUNITY HOSP INT, V6, DOI 10.3402/jchimp.v6.32151
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Baseer Mohammad-Abdul, 2016, J Clin Exp Dent, V8, pe379
   Bener A, 2004, J R SOC PROMO HEALTH, V124, P167, DOI 10.1177/146642400412400408
   Bradley C, 2006, ANN INTERN MED, V144, P784, DOI [10.7326/0003-4819-144-10-200605160-00022, DOI 10.7326/0003-4819-144-10-200605160-00022]
   Chan EYY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2245-9
   Chen Y, 2020, Zhonghua Yu Fang Yi Xue Za Zhi, V54, pE004, DOI 10.3760/cma.j.issn.0253-9624.2020.0004
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Choi JS, 2016, NURS EDUC TODAY, V40, P168, DOI 10.1016/j.nedt.2016.03.006
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Gu H, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3394
   Jiang LL, 2018, J HOSP INFECT, V98, P404, DOI 10.1016/j.jhin.2017.10.020
   Kakemam E, 2020, KNOWLEDGE ATTITUDES, DOI [10.1101/2020.06.10.20127258, DOI 10.1101/2020.06.10.20127258]
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027
   Keykhaie Zohreh, 2014, Acta Inform Med, V22, P379, DOI 10.5455/aim.2014.22.379-384
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   KIM MIJA, 2017, [Journal of the Korea Convergence Society, 한국융합학회논문지], V8, P149, DOI 10.15207/JKCS.2017.8.4.149
   Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron
   Langarizadeh Mostafa, 2018, Electron Physician, V10, P6333, DOI 10.19082/6333
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Nour MO., 2015, INT RES J MED MED SC, V3, P103
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Saadatjoo S., 2020, SYSTEMATIC REV KNOWL, DOI [10.1101/2020.10.04.20206094, DOI 10.1101/2020.10.04.20206094]
   Salehi M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.17256
   Shahzad F, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139115
   Sharifi S, 2014, J N KHORASAN U MED S, V5, P943, DOI [10.29252/jnkums.5.5.S5.943, DOI 10.29252/JNKUMS.5.5.S5.943]
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Tao J, 2020, BRIT J DERMATOL, V182, P1477, DOI 10.1111/bjd.19011
   Tosepu R, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138436
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Wu F, 2020, COMPLETE GENOME CHAR, DOI [10.1101/2020.01.24.919183, DOI 10.1101/2020.01.24.919183]
   Xiao ZP, 2020, J INFECT DEV COUNTR, V14, P323, DOI 10.3855/jidc.12718
   Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 47
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2198-1833
EI 1613-2238
J9 J PUBLIC HEALTH-HEID
JI J. Public Health-Heidelberg
DI 10.1007/s10389-020-01454-1
EA JAN 2021
PG 12
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA PP6AE
UT WOS:000605942500003
PM 33432291
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Afzal, M
   Hussain, M
   Hussain, J
   Bang, J
   Lee, S
AF Afzal, Muhammad
   Hussain, Maqbool
   Hussain, Jamil
   Bang, Jaehun
   Lee, Sungyoung
TI COVID-19 Knowledge Resource Categorization and Tracking: Conceptual
   Framework Study
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE information organization; resource management; knowledge graphs;
   interactive dashboard; dependency tracking; COVID-19; pandemic;
   information technology; tracing information; dashboards; digital health
AB Background: Since the declaration of COVID-19 as a global pandemic by the World Health Organization, the disease has gained momentum with every passing day. Various private and government sectors of different countries allocated funding for research in multiple capacities. A significant portion of efforts has been devoted to information technology and service infrastructure development, including research on developing intelligent models and techniques for alerts, monitoring, early diagnosis, prevention, and other relevant services. As a result, many information resources have been created globally and are available for use. However, a defined structure to organize these resources into categories based on the nature and origin of the data are lacking.
   Objective: This study aims to organize COVID-19 information resources into a well-defined structure to facilitate the easy identification of a resource, tracking information workflows, and to provide a guide for a contextual dashboard design and development.
   Methods: A sequence of action research was performed that involved a review of COVID-19 efforts and initiatives on a global scale during the year 2020. Data were collected according to the defined structure of primary, secondary, and tertiary categories. Various techniques for descriptive statistical analysis were employed to gain insights into the data to help develop a conceptual framework to organize resources and track interactions between different resources.
   Results: Investigating diverse information at the primary, secondary, and tertiary levels enabled us to develop a conceptual framework for COVID-19-related efforts and initiatives. The framework of resource categorization provides a gateway to access global initiatives with enriched metadata, and assists users in tracking the workflow of tertiary, secondary, and primary resources with relationships between various fragments of information. The results demonstrated mapping initiatives at the tertiary level to secondary level and then to the primary level to reach firsthand data, research, and trials.
   Conclusions: Adopting the proposed three-level structure allows for a consistent organization and management of existing COVID-19 knowledge resources and provides a roadmap for classifying future resources. This study is one of the earliest studies to introduce an infrastructure for locating and placing the right information at the right place. By implementing the proposed framework according to the stated guidelines, this study allows for the development of applications such as interactive dashboards to facilitate the contextual identification and tracking of interdependent COVID-19 knowledge resources.
C1 [Afzal, Muhammad; Hussain, Maqbool] Sejong Univ, Dept Software, 209 Neungdong Ro,Innovat Ctr Off 422, Seoul 05006, South Korea.
   [Hussain, Jamil] Sejong Univ, Dept Data Sci, Seoul, South Korea.
   [Bang, Jaehun; Lee, Sungyoung] Kyung Hee Univ, Dept Comp Sci & Engn, Yongin, South Korea.
RP Afzal, M (corresponding author), Sejong Univ, Dept Software, 209 Neungdong Ro,Innovat Ctr Off 422, Seoul 05006, South Korea.
EM mafzal@sejong.ac.kr
RI Afzal, Muhammad/D-3741-2019
OI Afzal, Muhammad/0000-0002-7851-2327; HUSSAIN,
   MAQBOOL/0000-0002-1663-1718
FU Ministry of Science and ICT (MSIT), South Korea, through the Information
   Technology Research Center (ITRC) Support Program
   [IITP-2021-2017-0-01629]; Institute for Information & Communications
   Technology Promotion (IITP), through the Korea Government (MSIT)
   [2017-0-00655, IITP-2021-2020-0-01489, NRF-2019R1A2C2090504]
FX This work was supported in part by the Ministry of Science and ICT
   (MSIT), South Korea, through the Information Technology Research Center
   (ITRC) Support Program (IITP-2021-2017-0-01629), and in part by the
   Institute for Information & Communications Technology Promotion (IITP),
   through the Korea Government (MSIT) (2017-0-00655,
   IITP-2021-2020-0-01489, and NRF-2019R1A2C2090504).
CR Afzal M, M AFZAL COVID 19 RES
   Alderman J., 2012, PRIMARY SECONDARY TE
   Alper BS, 2021, J BIOMED INFORM, V115, DOI 10.1016/j.jbi.2021.103685
   Alper BS, 2020, J AM MED INFORM ASSN, V27, P1338, DOI 10.1093/jamia/ocaa114
   [Anonymous], 2020, DYNAMED
   [Anonymous], CONFLUENCE
   [Anonymous], MeSH Browser
   [Anonymous], 2020, CORONAVIRUS LIVE UPD
   [Anonymous], 2020, TECHNICAL GUIDANCE P
   [Anonymous], CORONAVIRUS DIS 2019
   [Anonymous], 2020, COVID 19 ELECTIVE CA
   [Anonymous], SEARCH COVID 19 LIST
   [Anonymous], 2020, STANDARDS ALLIANCE P
   [Anonymous], REUSTLE
   [Anonymous], PUBTATOR CENTRAL
   [Anonymous], COVID 19 EVIDENCE AL
   [Anonymous], COVID 19 ADV LIT CLA
   [Anonymous], COVID-19 Dashboard by the Centre for Systems Science and Engineering at John Hopkins University
   [Anonymous], SARS COV 2 COVID 19
   [Anonymous], 2020, LITCOVID
   [Anonymous], COVID 19 TERMS
   [Anonymous], 2020, ICD 10 900 OFFICIAL
   [Anonymous], 2020, COVID 19 PUBLIC DATA
   [Anonymous], IEEE DATAPORT
   [Anonymous], 2020, COVID 19 OPEN DATASE
   [Anonymous], 2020, CORONAVIRUS COVID 19
   [Anonymous], HEALTHCARE WORKERS I
   [Anonymous], COVID 19 CORONAVIRUS
   [Anonymous], UNDERSTANDING CORONA
   [Anonymous], 2020, SEARCH COVID 19
   [Anonymous], SNOMED CT COVID 19
   [Anonymous], ICD 10 900
   [Anonymous], SNOMED CT COVID 19 R
   [Anonymous], ACTS COVID-19 Guidance-to-Action Collaborative.
   [Anonymous], COVID 19 KNOWLEDGE A
   [Anonymous], 2020, COVID 19 RESPONSE FR
   [Anonymous], CORONAVIRUS COVID 19
   [Anonymous], COVID 19 GLOBAL PAND
   [Anonymous], 2020, COVID 19 DASHBOARD, DOI DOI 10.1002/CPBI.3
   [Anonymous], 2020, THERE ARE 54 COVID 1
   [Anonymous], EBSCO COVID 19 CLIN
   [Anonymous], 2020, NLM TECHNICAL B
   [Anonymous], 2020, COVID 19 NATL RESOUR
   Bazzoli F., 2020, SANER PROJECT USING
   Bernardo T, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/25935
   Budd J, 2020, NAT MED, V26, P1183, DOI 10.1038/s41591-020-1011-4
   Chen QY, 2021, NUCLEIC ACIDS RES, V49, pD1534, DOI 10.1093/nar/gkaa952
   Chen QY, 2020, NATURE, V579, P193, DOI 10.1038/d41586-020-00694-1
   Chinese Clinical Trial Registry (ChiCTR), 2018, CHICTR ORG
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Elayyan M., 2020, BOOKS BYTES NAVIGATI, DOI [10.7916/d8-t2wa-he85, DOI 10.7916/D8-T2WA-HE85]
   Huser V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068409
   ISRCTN-Search results, ISRCTN REGISTRY
   Kalhori SRN, 2021, J MED INTERNET RES, V23, DOI 10.2196/19473
   Li R, 2020, J MED INTERNET RES, V22, DOI 10.2196/20645
   Lu Wang L, ARXIV
   McKiernan G., 2000, INT J GREY LIT, V1, P127, DOI [10.1108/14666180010345564, DOI 10.1108/14666180010345564]
   Search, KAGGLE
   Sever R, 2019, PREPRINT SERVER BIOL, DOI DOI 10.1101/833400
   SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529
   Singh J, 2004, INDIAN J PHARMACOL, V84, P1035, DOI [10.1097/01.phm.0000189841.18419.16, DOI 10.1097/01.PHM.0000189841.18419.16]
   Sultan S, 2020, GASTROENTEROLOGY, V159, P320, DOI 10.1053/j.gastro.2020.05.001
   Tangcharoensathien V, 2020, J MED INTERNET RES, V22, DOI 10.2196/19659
NR 64
TC 0
Z9 0
U1 3
U2 7
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD JUN 1
PY 2021
VL 23
IS 6
AR e29730
DI 10.2196/29730
PG 22
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Medical Informatics
GA SL5NR
UT WOS:000656965400003
PM 33999833
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Teng, YM
   Wu, KS
   Wang, WC
   Xu, D
AF Teng, Yi-Man
   Wu, Kun-Shan
   Wang, Wen-Cheng
   Xu, Dan
TI Assessing the Knowledge, Attitudes and Practices of COVID-19 among
   Quarantine Hotel Workers in China
SO HEALTHCARE
LA English
DT Article
DE COVID-19; quarantine hotel workers; knowledge; attitudes; practices
ID PREVENTIVE BEHAVIORS; HEALTH; OUTBREAK; STUDENTS; IMPACT
AB During the pandemic, quarantine hotel workers face a higher risk of infection while they host quarantine guests from overseas. This study's aim is to gain an understanding of the knowledge, attitudes, and practices (KAP) of quarantine hotel workers in China. A total of 170 participants took part in a cross-sectional survey to assess the KAP of quarantine hotel workers in China, during the COVID-19 pandemic. The chi-square test, independent t-test, one-way analysis of variance (ANOVA), descriptive analysis, and binary logistic regression were used to examine the sociodemographic factors associated with KAP levels during the COVID-19 pandemic. The results show that 62.41% have good knowledge, 94.7% have a positive attitude towards COVID-19, but only 78.2% have good practices. Most quarantine hotel workers (95.3%) are confident that COVID-19 will be successfully controlled and that China is handling the COVID-19 crisis well (98.8%). Most quarantine hotel workers are also taking personal precautions, such as avoiding crowds (80.6%) and wearing facemasks (97.6%). The results evidence that quarantine hotel workers in China have acquired the necessary knowledge, positive attitudes and proactive practices in response to the COVID-19 pandemic. The results of this study can provide a reference for quarantine hotel workers and their targeted education and intervention.
C1 [Teng, Yi-Man; Xu, Dan] Yango Univ, Coll Modern Management, Fuzhou 350015, Peoples R China.
   [Wu, Kun-Shan] Tamkang Univ, Dept Business Adm, Taipei 251301, Taiwan.
   [Wang, Wen-Cheng] Yango Univ, Coll Innovat & Entrepreneurship Educ, Fuzhou 350015, Peoples R China.
RP Wu, KS (corresponding author), Tamkang Univ, Dept Business Adm, Taipei 251301, Taiwan.
EM yimanteng@gmail.com; kunshan@mail.tku.edu.tw; wcwang@go.hwh.edu.tw;
   dxu@ygu.edu.cn
OI /0000-0003-1194-2522; Wu, Kun-Shan/0000-0001-9550-8840
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Abuya T., 2020, COVID 19 RELATED KNO
   Addis SG, 2021, DIABETES METAB SYND, V15, P847, DOI 10.1016/j.dsx.2021.03.033
   Afzal MS, 2021, J COMMUN HEALTH, V46, P476, DOI 10.1007/s10900-020-00875-z
   Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Ali M, 2020, KNOWLEDGE ATTITUDE P, DOI [10.1101/2020.05.26.20113233, DOI 10.1101/2020.05.26.20113233]
   Alrubaiee GG, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09644-y
   Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Austrian K, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3576785, DOI 10.2139/SSRN.3576785]
   Awan MI, 2021, J ISLAMIC MARK, V12, P543, DOI 10.1108/JIMA-08-2020-0229
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Banik R., 2020, RES SQ, DOI [10.21203/rs.3.rs-37946/v1, DOI 10.21203/RS.3.RS-37946/V1]
   Byanaku A., 2020, KNOWLEDGE ATTITUDES, DOI 10.1101/2020.04.26.20080820v2
   Caviglia-Harris J, 2012, FIELD METHOD, V24, P74, DOI 10.1177/1525822X11399704
   de Lima BF, 2021, ACTA DIABETOL, V58, P19, DOI 10.1007/s00592-020-01580-y
   Deng JF, 2006, PUBLIC HEALTH, V120, P15, DOI 10.1016/j.puhe.2005.10.001
   Dilucca M, 2020, BIORXIV, V9, P1, DOI [10.1101/2020.05.08.084236, DOI 10.1101/2020.05.08.084236]
   Duong MC, 2021, J COMMUN HEALTH, V46, P975, DOI 10.1007/s10900-021-00981-6
   Erfani A, 2020, B WORLD HEALTH ORGAN, V76, P648, DOI DOI 10.2471/BLT.20.256651
   Feng E., 2020, QUARANTINED WUHAN HO
   Galle F, 2021, BEHAV SCI-BASEL, V11, DOI 10.3390/bs11040045
   Gebretsadik D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246154
   Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912
   Gupta PK, 2021, J PUBLIC AFF, V21, DOI 10.1002/pa.2555
   Hoke AM, 2018, HEALTH EDUC J, V77, P249, DOI 10.1177/0017896917734017
   HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941
   Hossain MA, 2021, J MULTIDISCIP HEALTH, V14, P229, DOI 10.2147/JMDH.S293717
   Hossain MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239646
   Islam MS, 2021, J PUBLIC HEALTH-UK, V43, P13, DOI 10.1093/pubmed/fdaa182
   Jia YH, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045034
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Kaliyaperumal K., 2004, COMMUNITY OPHTHALMOL, V4, P7
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   Lee M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10285-y
   Lin C-Y, 2020, SOCIAL HLTH BEHAV, V3, P1, DOI [10.4103/SHB.SHB_11_20, DOI 10.4103/SHB.SHB_11_20]
   Mahmoudi N., 2020, COST EFFECTIVENESS A
   Masoud AT, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043971
   McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808
   Nathiya D, 2020, INDIAN COMMUNITYS KN
   Nuskiya M.H.F., 2020, J TOUR EC APPL RES, V4, DOI [10.2139/ssrn.3587170, DOI 10.2139/SSRN.3587170]
   Paduano S, 2021, ANN IG MED PREV COMU, V33, P527, DOI 10.7416/ai.2021.2437
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Qutob N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244925
   Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223
   Rosemberg MAS, 2020, OCCUP MED-OXFORD, V70, P382, DOI 10.1093/occmed/kqaa053
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Sarria-Guzman Y, 2021, J INFECT DEV COUNTR, V15, P9, DOI 10.3855/jidc.14388
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Tachfouti N, 2012, PAN AFR MED J, V12
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Tang KHD, 2022, J PUBLIC HEALTH-HEID, V30, P583, DOI 10.1007/s10389-020-01316-w
   Tariq Saba, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.408
   Teng XD, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.620930
   Teng YM, 2020, RISK MANAG HEALTHC P, V13, P2743, DOI 10.2147/RMHP.S286171
   Wen F., 2020, KNOWLEDGE ATTITUDES, DOI [10.1101/2020.06.29.20138628, DOI 10.1101/2020.06.29.20138628]
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Wong IA, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102655
   World Health Organization, 2020, MENT HLTH PSYCH CONS
   Wu XL, 2021, INFECT DRUG RESIST, V14, P507, DOI 10.2147/IDR.S291199
   Yue ST, 2021, J COMMUN HEALTH, V46, P286, DOI 10.1007/s10900-020-00877-x
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 67
TC 4
Z9 4
U1 9
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9032
J9 HEALTHCARE-BASEL
JI Healthcare
PD JUN
PY 2021
VL 9
IS 6
AR 772
DI 10.3390/healthcare9060772
PG 13
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA TA7PC
UT WOS:000667437100001
PM 34205519
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Yilmaz, ZK
   Sencan, N
AF Yilmaz, Zekiye Kubra
   Sencan, Nazli
TI An Examination of the Factors Affecting Community Pharmacists'
   Knowledge, Attitudes, and Impressions About the COVID-19 Pandemic
SO TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE COVID-19; pandemic; community pharmacists; knowledge; attitude
ID CORONAVIRUS
AB Objectives: Coronavirus disease-2019 (COVID-19)-related cases and deaths are ongoing throughout the world, but there is still no effective drug in its treatment, and the vaccine supply is not adequate for the global population. It is important that pharmacists have sufficient knowledge and awareness to prevent and control the disease. COVID-19 has been widely covered in the media, which has been a source widely used by healthcare professionals. This study aimed to assess the knowledge, attitudes, and impressions of community pharmacists about COVID-19 and the factors affecting them.
   Materials and Methods: The questions in this survey were formed using the guideline created by the World Health Organization, a guide composed by the Turkish COVID-19 Scholarly Commission, and data disclosed to the public on the website of the Ministry of Health. The questionnaire was designed with Google forms and then applied to community pharmacists all over Turkey by sharing the survey link.
   Results: Analyses of 393 questionnaires showed that Ministry of Health/government statements, the internet (scientific sources), and the media were the preferred sources of information (96.7%, 89.6%, and 84%, respectively). "Ways to avoid COVID-19" was the most searched title (96.9%). It was determined that the names of the two drugs most frequently mentioned by the participants to be used in the treatment of COVID-19 in Turkey were hydroxychloroquine and azithromycin (57.5%; 50.1%, respectively). Participants who received information from the media gave less education to patients/customers on personal protection measures against COVID-19 (83.3%) and symptoms of COVID-19 (78.8%); however, their behavior regarding the training of pharmacy personnel was found to be the opposite. It has been determined that about half of the participants (46.6%) mostly trust the Ministry of Health regarding the COVID-19 pandemic.
   Conclusion: Media and other sources influence the knowledge, behavior and impressions of pharmacists'. Having a high level of knowledge positively affects people's behavior. It is important for pharmacists to have accurate information about COVID-19 and to transfer their knowledge to the community to provide patient education and to prevent/control the spread of COVID-19.
C1 [Yilmaz, Zekiye Kubra] Acibadem Mehmet Ali Aydinlar Univ, Dept Clin Pharm, Fac Pharm, Istanbul, Turkey.
   [Sencan, Nazli] Acibadem Mehmet Ali Aydinlar Univ, Dept Pharm Management, Fac Pharm, Istanbul, Turkey.
RP Yilmaz, ZK (corresponding author), Acibadem Mehmet Ali Aydinlar Univ, Dept Clin Pharm, Fac Pharm, Istanbul, Turkey.
EM zekiye.yilmaz@acibadem.edu.tr
OI YILMAZ, ZEKIYE/0000-0002-0041-6140
CR Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254
   Al-Qahtani AA, 2020, SAUDI J BIOL SCI, V27, P2531, DOI 10.1016/j.sjbs.2020.04.033
   [Anonymous], 2020, SURV TOOL GUID BEH I
   Balla Mamtha, 2020, J Clin Med Res, V12, P215, DOI 10.14740/jocmr4142
   Chin TWF, 2004, PHARMACOTHERAPY, V24, P705, DOI 10.1592/phco.24.8.705.36063
   Elbeddini A, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00241-3
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Han QM, 2020, J INFECTION, V80, P373, DOI 10.1016/j.jinf.2020.02.010
   Ippolito G, 2020, LANCET RESP MED, V8, P230, DOI 10.1016/S2213-2600(20)30070-9
   Kara E, 2020, TURK J PHARM SCI, V17, P242, DOI 10.4274/tjps.galenos.2020.72325
   Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027
   Li HO, 2020, ANTIMICROB AGENTS CH, V64, DOI [10.1128/AAC.00483-20, 10.1128/AAC.00483-20.]
   Liu S, 2020, INT J CLIN PHARM-NET, V42, P299, DOI 10.1007/s11096-020-01017-0
   Miller S, 2012, J AM PHARM ASSOC, V52, P763, DOI 10.1331/JAPhA.2012.11003
   Mukattash TL, 2020, PHARM PRACT-GRANADA, V18, DOI [10.18549/PharmPract.2020.3.1900, 10.18549/pharmpract.2020.3.1900]
   Sarma P, 2020, INDIAN J PHARMACOL, V52, P1, DOI 10.4103/ijp.IJP_119_20
   WHO, 2020, INF PREV CONTR HLTH
NR 17
TC 0
Z9 0
U1 0
U2 0
PU GALENOS PUBL HOUSE
PI ISTANBUL
PA  MOLLA GURANI MAHALLESI KACAMAK SOKAK NO 21-1, ISTANBUL, TURKEY
SN 1304-530X
EI 2148-6247
J9 TURK J PHARM SCI
JI Turk. J. Pharm. Sci.
PD OCT
PY 2021
VL 18
IS 5
BP 530
EP 540
DI 10.4274/tjps.galenos.2020.01212
PG 11
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA ZA7VM
UT WOS:000756366800002
PM 34708643
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Li, L
   Wang, J
   Leng, AL
   Nicholas, S
   Maitland, E
   Liu, RG
AF Li, Lu
   Wang, Jian
   Leng, Anli
   Nicholas, Stephen
   Maitland, Elizabeth
   Liu, Rugang
TI Will COVID-19 Vaccinations End Discrimination against COVID-19 Patients
   in China? New Evidence on Recovered COVID-19 Patients
SO VACCINES
LA English
DT Article
DE COVID-19; discrimination; vaccination; determinant
ID STIGMA; WORKERS
AB (1) Background: By April 2021, over 160 million Chinese have been vaccinated against coronavirus disease 2019 (COVID-19). This study analyzed the impact of vaccination on discrimination against recovered COVID-19 patients and the determinants of discrimination among intended vaccinated people. (2) Methods: A self-designed questionnaire was used to collect data on COVID-19 associated discrimination from nine provinces in China. Pearson chi-square tests and a multivariate ordered logistic regression analyzed the determinants of COVID-19-related discrimination. (3) Results: People who intended to be COVID-19 vaccinated displayed a high level of discrimination against recovered COVID-19 patients, with only 37.74% of the intended vaccinated without any prejudice and 34.11% displaying severe discrimination. However, vaccinations reduced COVID-19-related discrimination against recovered COVID-19 patients from 79.76% to 62.26%. Sex, age, education level, occupation, geographical region, respondents' awareness of vaccine effectiveness and infection risk, and COVID-19 knowledge score had a significant influence on the COVID-19 related discrimination (p < 0.05). (4) Conclusions: Vaccination significantly reduced COVID-19 associated discrimination, but discrimination rates remained high. Among the intended vaccinated respondents, females, the older aged, people with high school and above education level, retirees, migrant workers, and residents in central China were identified as key targets for information campaigns to reduce COVID-19 related discrimination.
C1 [Li, Lu] Jiangsu Vocat Inst Commerce, Sch Business Adm, Nanjing 211168, Peoples R China.
   [Wang, Jian] Wuhan Univ, Dong Fureng Econ & Social Dev Sch, Beijing 100010, Peoples R China.
   [Wang, Jian] Wuhan Univ, Ctr Hlth Econ & Management, Sch Econ & Management, Wuhan 430072, Peoples R China.
   [Leng, Anli] Shandong Univ, Inst Governance, Sch Polit Sci & Publ Adm, Qingdao 266237, Peoples R China.
   [Nicholas, Stephen] Australian Natl Inst Management & Commerce, Sydney, NSW 2015, Australia.
   [Nicholas, Stephen] Guangdong Univ Foreign Studies, Res Inst Int Strategies, Guangzhou 510420, Peoples R China.
   [Nicholas, Stephen] Tianjin Normal Univ, Sch Econ, Tianjin 300074, Peoples R China.
   [Nicholas, Stephen] Tianjin Normal Univ, Sch Management, Tianjin 300074, Peoples R China.
   [Nicholas, Stephen] Univ Newcastle, Newcastle Business Sch, Newcastle, NSW 2308, Australia.
   [Maitland, Elizabeth] Univ Liverpool, Sch Management, Chatham Bldg,Chatham St, Liverpool L69 7ZH, Merseyside, England.
   [Liu, Rugang] Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing 211166, Peoples R China.
   [Liu, Rugang] Nanjing Med Univ, Ctr Global Hlth, Nanjing 211166, Peoples R China.
RP Liu, RG (corresponding author), Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing 211166, Peoples R China.; Liu, RG (corresponding author), Nanjing Med Univ, Ctr Global Hlth, Nanjing 211166, Peoples R China.
EM 200015@jvic.edu.cn; wangjian993@whu.edu.cn; lenganli@sdu.edu.cn;
   stephen.nicholas@newcastle.edu.au; e.maitland@liverpool.ac.uk;
   rugangliu@njmu.edu.cn
RI Maitland, Elizabeth T/O-7703-2018; NICHOLAS, STEPHEN/ABE-4726-2021;
   Leng, Anli/ABG-3086-2021
OI Maitland, Elizabeth T/0000-0003-1551-4787; leng,
   anli/0000-0002-6775-2085; Liu, Rugang/0000-0002-4270-9507; Nicholas,
   Stephen/0000-0001-6770-7105; WANG, JIAN/0000-0001-8769-7928
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71904089]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2019M662392]; Qingdao
   Postdoctoral Foundation; Excellent Innovation Team of Philosophy and
   Social Sciences in the Universities and Colleges of Jiangsu Province
   "the Public Health Policy and Management Innovation Research Team"
FX This research was funded by National Natural Science Foundation of
   China, grant number 71904089; the China Postdoctoral Science Foundation,
   grant number 2019M662392; the Qingdao Postdoctoral Foundation; and the
   Excellent Innovation Team of Philosophy and Social Sciences in the
   Universities and Colleges of Jiangsu Province "the Public Health Policy
   and Management Innovation Research Team".
CR Abdelhafiz AS, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00429
   [Anonymous], COVID 19 VACCINATION
   [Anonymous], CHINA MAKE RULES PRO
   [Anonymous], REAL TIME BIG DATA R
   [Anonymous], SOCIAL STIGMA ASS CO
   [Anonymous], CORONAVIRUS COVID 19
   [Anonymous], DISCRIMINATION HEPAT
   Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Bartoszek A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207417
   Bhanot D, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.577018
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Cavalcanti T, 2016, ECON J, V126, P109, DOI 10.1111/ecoj.12303
   Chopra K K, 2020, Indian J Tuberc, V67, P284, DOI 10.1016/j.ijtb.2020.07.012
   Eguchi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076921
   Grover S, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102381
   Gunnell D, 2020, LANCET PSYCHIAT, V7, P468, DOI 10.1016/S2215-0366(20)30171-1
   Huang JX, 2016, LIVER INT, V36, P1595, DOI 10.1111/liv.13168
   Kyriakou G, 2021, CLIN EXP DERMATOL, V46, P762, DOI 10.1111/ced.14619
   Lee H, 2019, PAC ECON REV, V24, P659, DOI 10.1111/1468-0106.12285
   Leng AL, 2016, HUM VACC IMMUNOTHER, V12, P1164, DOI 10.1080/21645515.2015.1131883
   Li L, 2007, INT J EPIDEMIOL, V36, P178, DOI 10.1093/ije/dyl256
   Liu RG, 2022, HUM VACC IMMUNOTHER, V18, DOI 10.1080/21645515.2021.1913966
   Liu RG, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030292
   Logie CH, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25504
   Logie CH, 2020, AIDS BEHAV, V24, P2003, DOI 10.1007/s10461-020-02856-8
   Peprah P, 2020, ARCH GERONTOL GERIAT, V90, DOI 10.1016/j.archger.2020.104149
   Prah J, 2020, J PUBLIC HEALTH AFR, V11, P8, DOI 10.4081/jphia.2020.1020
   Singh R, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102222
   Szmyd B, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030218
   Szmyd B, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020128
   Tehrani H, 2020, GERIATR GERONTOL INT, V20, P796, DOI 10.1111/ggi.13985
   van Daalen KR, 2021, J EPIDEMIOL COMMUN H, V75, P313, DOI 10.1136/jech-2020-214436
   Whiteside-Mansell L, 2020, J NATL MED ASSOC, V112, P668, DOI 10.1016/j.jnma.2020.06.012
   World Health Organization, DIRECTOR GEN STATEME
   Yadav, 2017, COMMUNITY ACQUIRED I, V4, P6, DOI [10.4103/2225-6482.203265, DOI 10.4103/2225-6482.203265]
   Yang T, 2011, LANCET, V378, P1059, DOI 10.1016/S0140-6736(11)61460-8
   Yu LJ, 2016, HUM VACC IMMUNOTHER, V12, P70, DOI 10.1080/21645515.2015.1069932
NR 38
TC 2
Z9 2
U1 23
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD MAY
PY 2021
VL 9
IS 5
AR 490
DI 10.3390/vaccines9050490
PG 13
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Immunology; Research & Experimental Medicine
GA SI1ZF
UT WOS:000654623400001
PM 34064737
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mahdi, OR
   Nassar, IA
AF Mahdi, Omar Rabeea
   Nassar, Islam A.
TI The Business Model of Sustainable Competitive Advantage through
   Strategic Leadership Capabilities and Knowledge Management Processes to
   Overcome COVID-19 Pandemic
SO SUSTAINABILITY
LA English
DT Article
DE sustainable competitive advantage; strategic leadership capabilities;
   knowledge management processes; theoretical framework; COVID-19; human
   capital; social capital; resource-based view; knowledge-based view;
   knowledge creation theory
ID RESOURCE-BASED VIEW; CORE COMPETENCE; ORGANIZATIONAL CAPABILITIES; FIRM
   RESOURCES; PERFORMANCE; SYSTEM; ENVIRONMENTS; FRAMEWORK; ENABLERS;
   SUCCESS
AB In recent decades, particularly during the outbreak of COVID-19, businesses organizations have focused on knowledge management processes in order to attain a sustainable competitive advantage by creating human and social capital as strategic leadership capabilities. This paper aims to develop an integrated conceptual and theoretical framework that connects strategic leadership capabilities, knowledge management processes, and sustainable competitive advantage for the public and private organizations within the service industry. The model approach has been used to build a theoretical framework that predicts the relationships between the variables. To support the link between them, a systematic literature review of traditional and contemporary theoretical and empirical research studies is conducted. Through the combination of the related literature, propositions are established. This conceptual research is primarily comprised of a model and assertions concerning strategic leadership capabilities, knowledge management processes, and sustainable competitive advantage. The outcomes of this study reflect that strategic leadership capabilities can accomplish sustainable competitive advantage. They also have the greatest potential to impact sustainable competitive advantage via engaging the knowledge management processes. Particularly, there are significant implications of this study. Regarding the theoretical implication, it contributes to the resource-based view, knowledge-based view, and knowledge creation theory in supporting strategic leadership capabilities, knowledge management processes, and sustainable competitive advantage. To the practical implication, the study linked the concepts of research variables for public and private enterprises within the service industry. It can also enable strategic leaders and businesses owners to participate in real-time opportunities and determine threats for achieving a sustainable competitive advantage in light of the COVID-19 pandemic. This is a preliminary study of the sustainable competitive advantage literature that includes the concept of strategic leadership as a knowledge management processes enabler for achieving a sustainable competitive advantage. Until now, there has not been any work like it in the literature, save in the qualitative style.
C1 [Mahdi, Omar Rabeea; Nassar, Islam A.] Appl Sci Univ, Coll Adm Sci, Dept Business Adm, East Al Ekir 623, Bahrain.
RP Mahdi, OR (corresponding author), Appl Sci Univ, Coll Adm Sci, Dept Business Adm, East Al Ekir 623, Bahrain.
EM omar.almafrachi@asu.edu.bh; islam.nassar@asu.edu.bh
CR Adams G. L., 2003, Journal of Knowledge Management, V7, P142, DOI 10.1108/13673270310477342
   Adler PS, 2002, ACAD MANAGE REV, V27, P17, DOI 10.2307/4134367
   Al-Alawi A.I., 2007, J KNOWL MANAG, V11, P22, DOI [10.1108/13673270710738898, DOI 10.1108/13673270710738898]
   Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961
   Albers J.A., 2003, J KNOWLEDGE MANAGEME, V4, P1
   Alfirevic N, 2004, J UNIVERS COMPUT SCI, V10, P712
   Alvarenga A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145824
   AMIT R, 1993, STRATEGIC MANAGE J, V14, P33, DOI 10.1002/smj.4250140105
   Au Alan Kai Ming, 2008, Journal of European Industrial Training, V32, P19, DOI 10.1108/03090590810846548
   Balkundi P, 2005, LEADERSHIP QUART, V16, P941, DOI 10.1016/j.leaqua.2005.09.004
   Ballout H.I., 2007, J MANAGERIAL PSYCHOL, V22, P741, DOI DOI 10.1108/02683940710837705
   BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108
   Barney J., 2007, GAINING SUSTAINING C
   Barney J., 2009, STRATEG MANAG, V3rd
   Barney J., 1995, ACAD MANAGE EXEC, V9, P49, DOI [DOI 10.5465/ame.1995.9512032192, DOI 10.5465/AME.1995.9512032192]
   Barney J. B., 1986, Management Science, V32, P1231, DOI 10.1287/mnsc.32.10.1231
   BART CK, 2001, J INTELLECT CAP, V2, P320, DOI DOI 10.1108/14691930110400146
   Bartol K.M., 2002, J LEADERSHIP ORG STU, V9, P64, DOI DOI 10.1177/107179190200900105
   Birasnav M, 2011, LEADERSHIP ORG DEV J, V32, P106, DOI 10.1108/01437731111112962
   Boal K.B., 2004, ENCY LEADERSHIP, P1497
   Boal KB, 2007, LEADERSHIP QUART, V18, P411, DOI 10.1016/j.leaqua.2007.04.008
   Bolisani E, 2017, J KNOWL MANAG, V21, P233, DOI 10.1108/JKM-02-2016-0071
   Bollinger A.S., 2001, J KNOWL MANAG, V5, P8, DOI [http://doi.org/10.1108/13673270110384365, DOI 10.1108/13673270110384365]
   Bontis N, 1998, MANAGE DECIS, V36, P63, DOI 10.1108/00251749810204142
   Bontis N, 2009, J INTELLECT CAP, V10, P53, DOI 10.1108/14691930910922897
   Bou-Llusar J. C., 2006, Journal of Knowledge Management, V10, P100, DOI 10.1108/13673270610679390
   Bryant S.E., 2003, J LEADERSH ORG STUD, V9, P32, DOI [DOI 10.1177/107179190300900403, 10.1177/107179190300900403]
   Burt R.S., 2010, NEIGHBOR NETWORKS CO
   Calabro A, 2021, INT ENTREP MANAG J, V17, P261, DOI 10.1007/s11365-020-00657-y
   Carmeli A., 2001, PUBLIC ADM MANAG INT, V6, P122
   Chen L, 2010, Construction Innovation, V10, P138, DOI 10.1108/14714171011037165
   Chu KW, 2016, J KNOWL MANAG, V20, P1104, DOI 10.1108/JKM-10-2015-0390
   Chua A, 2004, INT J INFORM MANAGE, V24, P87, DOI 10.1016/j.ijinfomgt.2003.10.003
   Chuang SH, 2004, EXPERT SYST APPL, V27, P459, DOI 10.1016/j.eswa.2004.05.008
   Clark D.N., 2007, RESOURCE BASED THEOR
   Coakes E., 2003, KNOWLEDGE MANAGEMENT
   Cockburn IM, 2000, STRATEGIC MANAGE J, V21, P1123, DOI 10.1002/1097-0266(200010/11)21:10/11<1123::AID-SMJ130>3.0.CO;2-R
   Cooper C.L., 1999, BLACKWELL ENCY MANAG
   Crossan M, 2008, LEADERSHIP QUART, V19, P569, DOI 10.1016/j.leaqua.2008.07.008
   Czinkota MR, 2000, IND MARKET MANAG, V29, P483, DOI 10.1016/S0019-8501(00)00123-1
   Daud S, 2010, ASIAN ACAD MANAG J, V15, P135
   Davenport T., 1998, WORKING KNOWLEDGE OR
   Davenport TH, 1998, SLOAN MANAGE REV, V39, P43
   Day David V., 2007, Human Resource Management Review, V17, P360, DOI 10.1016/j.hrmr.2007.08.007
   Dizgah M.R., 2011, AUST J BASIC APPL SC, V5, P803
   DRUCKER P, 1993, POSTCAPITALIST SOC
   Eden C, 2000, J OPER RES SOC, V51, P12, DOI 10.2307/253943
   Edmonstone J, 2011, LEADERSH HEALTH SERV, V24, P8, DOI 10.1108/17511871111102490
   Edwards John, 2011, Electronic Journal of Knowledge Management, V9, P297
   Eisenhardt K., 2000, HDB STRATEGY MANAGEM, P544
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   El Shafeey T, 2014, EUR BUS REV, V26, P122, DOI 10.1108/EBR-07-2013-0096
   Ellinger AE, 2011, J BUS RES, V64, P572, DOI 10.1016/j.jbusres.2010.06.008
   Fernandes I.B., 2004, KNOWLEDGE MANAGEMENT, V1st
   Galbreath J, 2005, TECHNOVATION, V25, P979, DOI 10.1016/j.technovation.2004.02.008
   Gamo-Sanchez AL, 2015, J KNOWL MANAG, V19, P593, DOI 10.1108/JKM-02-2015-0052
   Gandhi S, 2004, J ACAD LIBR, V30, P368, DOI 10.1016/j.acalib.2004.06.003
   Ghemawat P., 2001, STRATEGY BUSINESS LA
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   GRANT RM, 1991, CALIF MANAGE REV, V33, P114, DOI 10.2307/41166664
   Grant RM, 1996, ORGAN SCI, V7, P375, DOI 10.1287/orsc.7.4.375
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Haanes K., 2000, EUROPEAN MANAGEMENT, V18, P52, DOI DOI 10.1016/S0263-2373(99)00068-7
   Hafeez K, 2002, IEEE T ENG MANAGE, V49, P28, DOI 10.1109/17.985745
   HAGEN A, 1998, MANAGEMENT, V63, P39
   Hamadamin HH, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11205782
   Hao G., 2006, P 2 INT C INF MAN BU, P542
   Harley B, 1999, WORK EMPLOY SOC, V13, P41, DOI 10.1017/S0950017099000045
   Hartley J., 2008, LEADERSHIP HEALTHCAR
   Heisig P., 2001, KNOWLEDGE MANAGEMENT, P97
   Helfat CE, 2003, STRATEGIC MANAGE J, V24, P997, DOI 10.1002/smj.332
   HENDERSON R, 1994, STRATEGIC MANAGE J, V15, P63, DOI 10.1002/smj.4250150906
   Hirschi G., 2009, MIBES T, V3, P1, DOI 10.1504/IJPMB.2008.021790
   Hirschi G., 2008, MIBES T, P60
   Hitt I., 1995, STRATEG MANAG, V1st
   Hitt M.A., 2010, STRATEG MANAG, V8th
   Hitt M.A., 2002, J LEADERSH ORG STUD, V9, P3, DOI 10.1177/107179190200900101
   Hitt MA, 2000, ACAD MANAGE J, V43, P449, DOI 10.2307/1556404
   Hitt MA, 2003, ADV GLOB LEADERSHIP, V3, P9
   Hitt MA, 2010, BUS HORIZONS, V53, P437, DOI 10.1016/j.bushor.2010.05.004
   Holsapple CW, 2001, EXPERT SYST APPL, V20, P77, DOI 10.1016/S0957-4174(00)00050-6
   Holste JS, 2010, J KNOWL MANAG, V14, P128, DOI 10.1108/13673271011015615
   Hong HK, 2008, IND MANAGE DATA SYST, V108, P385, DOI 10.1108/02635570810858787
   Hsieh HC, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208755
   HUSEMAN RC, 1999, LEADING KNOWLEDGE NA
   Ireland RD, 2005, ACAD MANAGE EXEC, V19, P63, DOI 10.5465/AME.2005.19417908
   Jaakkola E., 2020, AMS REV, V10, P18, DOI [10.1007/s13162-020-00161-0, DOI 10.1007/S13162-020-00161-0]
   Javidan M, 1998, LONG RANGE PLANN, V31, P60, DOI 10.1016/S0024-6301(97)00091-5
   Donate MJ, 2011, J KNOWL MANAG, V15, P890, DOI 10.1108/13673271111179271
   Jiajia W., 2007, THESIS NW POLYTECHNI
   Joia LA, 2010, J KNOWL MANAG, V14, P410, DOI 10.1108/13673271011050139
   Jones G. R., 2007, ORG THEORY DESIGN CH
   Kassaneh TC, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13052956
   KOGUT B, 1992, ORGAN SCI, V3, P383, DOI 10.1287/orsc.3.3.383
   Kraaijenbrink J, 2010, J MANAGE, V36, P349, DOI 10.1177/0149206309350775
   Kwon K, 2016, J KNOWL MANAG, V20, P1025, DOI 10.1108/JKM-10-2015-0413
   Lakshman C, 2007, Leadership & Organization Development Journal, V28, P51, DOI 10.1108/01437730710718245
   Lakshman Chandrashekhar, 2009, Leadership & Organization Development Journal, V30, P338, DOI 10.1108/01437730910961676
   Landau L, 2009, J INT SOC RES, V2, P60
   Lee CL, 2010, TURK ONLINE J EDUC T, V9, P10
   Lee H, 2003, J MANAGE INFORM SYST, V20, P179
   Lee YC, 2007, HUM FACTORS ERGONOM, V17, P21, DOI 10.1002/hfm.20065
   Leitch B. J. M., 2001, MANCHESTER REV, V6, P9
   Liu PL, 2004, TECHNOVATION, V24, P971, DOI 10.1016/S0166-4972(03)00061-0
   Ljungquist U, 2008, EUR BUS REV, V20, P73, DOI 10.1108/09555340810843708
   Lucas LM, 2006, LEARN ORGAN, V13, P7, DOI 10.1108/09696470610639103
   MacInnis DJ, 2011, J MARKETING, V75, P136, DOI 10.1509/jmkg.75.4.136
   Mahdi OR, 2011, AFR J BUS MANAGE, V5, P9912
   Mahdi OR, 2014, PROCD SOC BEHV, V129, P289, DOI 10.1016/j.sbspro.2014.03.679
   MAHONEY JT, 1992, STRATEGIC MANAGE J, V13, P363, DOI 10.1002/smj.4250130505
   Mandi OR, 2019, J BUS RES, V94, P320, DOI 10.1016/j.jbusres.2018.02.013
   Martin JS, 2005, LEARN ORGAN, V12, P140, DOI 10.1108/09696470510583520
   McCallum Shelly, 2009, Leadership & Organization Development Journal, V30, P152, DOI 10.1108/01437730910935756
   McFarlane D.A., 2008, J KNOWL MANAG PRACT, V9, P3
   Meredith J., 1993, International Journal of Operations & Production Management, V13, P3, DOI 10.1108/01443579310028120
   MERTINS K, 2001, KNOWLEDGE MANAGEMENT
   Millar CCJM, 2016, J KNOWL MANAG, V20, P845, DOI 10.1108/JKM-07-2016-0296
   Motley A., 2007, BUSINESS OFFICER MAG
   Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373
   Nemanick R, 2007, LEADERSH EFF
   Nesheim T, 2011, J KNOWL MANAG, V15, P836, DOI 10.1108/13673271111174357
   Newbert SL, 2008, STRATEGIC MANAGE J, V29, P745, DOI 10.1002/smj.686
   Tuan NP, 2010, ASIAN ACAD MANAG J, V15, P1
   Njuguna J, 2009, KCA J BUS MANAG, V2, P32, DOI [10.4314/kjbm.v2i1.44409, DOI 10.4314/KJBM.V2I1.44409]
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Nonaka I, 2000, LONG RANGE PLANN, V33, P5, DOI 10.1016/S0024-6301(99)00115-6
   Nonaka I., 2003, Knowledge Management Research & Practice, V1, P2, DOI 10.1057/palgrave.kmrp.8500001
   Nonaka I., 1995, KNOWLEDGE CREATING C
   Okunoye A., 2008, CURRENT ISSUES KNOWL, P12
   Pearce J. A., 1995, FORMULATION IMPLEMEN
   PETERAF MA, 1993, STRATEGIC MANAGE J, V14, P179, DOI 10.1002/smj.4250140303
   Polanyi M., 1967, TACIT DIMENSION
   Porter M.E., 1985, COMPETITIVE ADVANTAG
   Porter ME, 2006, HARVARD BUS REV, V84, P78
   PRAHALAD CK, 1990, HARVARD BUS REV, V68, P79
   Prusak L, 2001, HARVARD BUS REV, V79, P86
   Raelin JA, 2006, J MANAG EDUC, V30, P670, DOI 10.1177/1052562905285912
   Robbins S.P., 2013, ORG BEHAV, V15th
   Rothaermel F., 2013, STRATEG MANAG, V1st
   Rumelt R., 2003, RESOURCES FIRMS STRA, P556
   Sanchez R, 2004, J BUS RES, V57, P518, DOI 10.1016/S0148-2963(02)00318-1
   Sanchez R., 1997, EUROPEAN MANAGEMENT, V15, P303, DOI DOI 10.1016/S0263-2373(97)00010-8
   Sandhawalia BS, 2011, J KNOWL MANAG, V15, P313, DOI 10.1108/13673271111119718
   Savory C., 2006, Management Decision, V44, P1052, DOI 10.1108/00251740610690612
   Sayyadi M., 2019, BUSINESS INFORM REV, V36, P30, DOI DOI 10.1177/0266382119829643
   Schiuma G., 2012, VINE, V42, P4, DOI [10.1108/03055721211207815, DOI 10.1108/03055721211207815]
   Seemann P., 2002, KNOWLEDGE MANAGEMENT, P1
   Sekaran U., 2003, RES METHODS BUSINESS, V4th edn.
   Sekaran U, 2010, RES METHODS BUSINESS
   Sharkie R., 2003, Journal of Knowledge Management, V7, P20, DOI 10.1108/13673270310463590
   Shin M, 2004, INFORM MANAGE-AMSTER, V42, P179, DOI 10.1016/j.im.2003.06.006
   Sinclair M., 2007, EVIDENCE BASED MIDWI, V5, P39
   Singh Sanjay Kumar, 2008, Journal of Knowledge Management, V12, P3, DOI 10.1108/13673270810884219
   Sirmon DG, 2007, ACAD MANAGE REV, V32, P273, DOI 10.5465/AMR.2007.23466005
   Small C.T., 2006, KNOWL MANAG, V5, P153
   Spencer JW, 2003, STRATEGIC MANAGE J, V24, P217, DOI 10.1002/smj.290
   Stewart T.A., 1997, INTELLECTUAL CAPITAL
   Studies T., 2020, TURKISH STUD SCI, V15, P1946, DOI [10.29228/TurkishStudies.43445R, DOI 10.29228/TURKISHSTUDIES.43445R]
   Supyuenyong V, 2009, J ENTERP INF MANAG, V22, P63, DOI 10.1108/17410390910922831
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Tome Eduardo, 2011, Journal of European Industrial Training, V35, P524, DOI 10.1108/03090591111150077
   Tome E, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13084518
   Tyler K., 2007, THESIS SCH MECH ENG
   Ulrich D., 1999, RESULTS BASED LEADER
   Vandaie R, 2008, KNOWL-BASED SYST, V21, P920, DOI 10.1016/j.knosys.2008.04.001
   Villasalero M, 2014, J KNOWL MANAG, V18, P1165, DOI 10.1108/JKM-03-2014-0104
   von Krogh G, 1998, CALIF MANAGE REV, V40, P133, DOI 10.2307/41165947
   Vorbeck J., 2001, KNOWLEDGE MANAGEMENT, P37
   Walczak S, 2005, LEARN ORGAN, V12, P330, DOI 10.1108/09696470510599118
   Wayne SJ, 1999, J ORGAN BEHAV, V20, P577, DOI 10.1002/(SICI)1099-1379(199909)20:5<577::AID-JOB958>3.0.CO;2-0
   Webster, 1961, WEBST NEW 20 CENT DI, V1st
   WERNERFELT B, 1984, STRATEGIC MANAGE J, V5, P171, DOI 10.1002/smj.4250050207
   Xue YJ, 2011, J KNOWL MANAG, V15, P299, DOI 10.1108/13673271111119709
   Yahya S., 2002, Journal of Knowledge Management, V6, P457, DOI 10.1108/13673270210450414
   Yeh YJ, 2006, IND MANAGE DATA SYST, V106, P793, DOI 10.1108/02635570610671489
   Yu CP, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9122280
   Zhao YX, 2013, J KNOWL MANAG, V17, P902, DOI 10.1108/JKM-06-2013-0242
   Zuckerman A, 1998, QUAL PROG, V31, P81
NR 178
TC 3
Z9 3
U1 21
U2 28
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD SEP
PY 2021
VL 13
IS 17
AR 9891
DI 10.3390/su13179891
PG 27
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA UO1ZJ
UT WOS:000694499700001
OA gold
DA 2022-04-20
ER

PT J
AU Jalil, A
   Kanwal, R
   Idrees, Z
   Khan, KM
   Naseem, M
   Kamal, MS
AF Jalil, Amir
   Kanwal, Rahila
   Idrees, Zeeshan
   Khan, Kashif Mehmood
   Naseem, Muhammad
   Kamal, Muhammad Safi
TI Knowledge, Attitude & Practices of Surgeons in the time of COVID-19
SO ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE
LA English
DT Article
DE Surgeons; COVID-19; infection; incubation; transmission
ID HEALTH; WORKERS
AB Objective: The objective of the study was to determine the knowledge, attitude and practices of surgical interns, residents and surgeons in the time of COVID-19.
   Methods: A cross-sectional study was conducted on surgical interns, trainees, registrar and consult-ants working in public and private sector tertiary care hospitals of Karachi. Non-Convenience sampling technique is used. A total of 184 patients were included. The study was performed on assessing patients' demographics, basic knowledge and awareness of COVID 19 and individuals' practices toward COVID 19 in their professional routines. Data were stored and analyzed using IBM-SPSS version 23.0. Pearson Chi Square test was used to test the association outcomes, awareness and attitude items on COVID-19 between private and public sector hospitals. P-values less than 0.05 were considered statistically significant Results: The study comprised a total of 184 participants. Mostly from public 115(63%) rest 69(37%) belonged private sector hospitals. Most respondents 122(66.3%) were aware of COVID 19 incubation, symptoms and the detection of patients at risk and modalities of transmission in operating rooms.
   Results showed among public vs Private sector hospitals (81.7% / 68.1%) were treating corona virus, there were (35.7% / 46.3%) screening and admitted the cases, (56.5% / 62.4) tentative numbers of COVID-19 cases reported range from 0-25, (40.9%/11.6%) surgeons were assigned additional duties for COVID-19 by hospital management found statistically significant with "p<0.01".
   Conclusion: It is concluded after this study that the surgeons in Pakistan are well aware of the situation, have adequate knowledge of the risk factors and symptoms of COVID-19. But statistically, probably because of limited resources and work load, there is a substantial gap in practices between public and private sector surgeons. There is also a dire need to develop local guidelines related to preventive measures in our health care systems according to our demands and supply.
C1 [Jalil, Amir; Kanwal, Rahila; Idrees, Zeeshan; Khan, Kashif Mehmood; Naseem, Muhammad; Kamal, Muhammad Safi] Abbasi Shaheed Hosp & Karachi Med & Dent Coll, Dept Orthoped, Karachi, Pakistan.
RP Jalil, A (corresponding author), Abbasi Shaheed Hosp & Karachi Med & Dent Coll, Dept Orthoped, Karachi, Pakistan.
EM dramrijalil@yahoo.com
CR Ahmed A., GULF NEWS
   Al-Muharraqi MA, 2020, BRIT J ORAL MAX SURG, V58, P503, DOI 10.1016/j.bjoms.2020.04.014
   [Anonymous], BBC NEWS
   [Anonymous], 2020, WHO CORONAVIRUS DIS
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Brat Gabriel A, 2020, Ann Surg, DOI 10.1097/SLA.0000000000003926
   Brindle ME, 2020, ANN SURG, V272, pE1, DOI 10.1097/SLA.0000000000003923
   Centers for Disease Control and Prevention , 2020, PERSONAL PROTECTIVE
   Centre for Disease Control USA, INT INF PREV CONTR R
   Guo XD, 2020, J BONE JOINT SURG AM, V102, P847, DOI 10.2106/JBJS.20.00417
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Lei SQ, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100331
   Liu Z, 2020, INDIAN J SURG, V82, P124, DOI 10.1007/s12262-020-02173-3
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Naspro R, 2020, NAT REV UROL, V17, P251, DOI 10.1038/s41585-020-0312-1
   Pryor A, SAGES EAES RECOMMEND
   Rana W, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102080
   Shehzad R, THE EXPRESS TRIBUNE
   Tao K X, 2020, Zhonghua Wai Ke Za Zhi, V58, pE001, DOI 10.3760/cma.j.issn.0529-5815.2020.0001
   Ti LK, 2020, CAN J ANESTH, V67, P756, DOI 10.1007/s12630-020-01617-4
   W.H.O.Europe, COR DIS COVID 19 OUT
   Waris A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100681
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLL
PI KARACHI
PA BLOCK M, N NAZIMABAD, KARACHI, 74700, PAKISTAN
SN 1563-3241
J9 ANN ABBASI SHAHEED H
JI Ann. Abbasi Shaheed Hosp. Karachi Med. Dent. Coll.
PD MAR
PY 2021
VL 26
IS 1
BP 286
EP 295
PG 10
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA XQ3RQ
UT WOS:000731465700008
DA 2022-04-20
ER

PT J
AU Valdes-Bango, M
   Meler, E
   Cobo, T
   Hernandez, S
   Caballero, A
   Garcia, F
   Ribera, L
   Guirado, L
   Ferrer, P
   Salvia, D
   Figueras, F
   Palacio, M
   Gonce, A
   Lopez, M
AF Valdes-Bango, M.
   Meler, E.
   Cobo, T.
   Hernandez, S.
   Caballero, A.
   Garcia, F.
   Ribera, L.
   Guirado, L.
   Ferrer, P.
   Salvia, D.
   Figueras, F.
   Palacio, M.
   Gonce, A.
   Lopez, M.
TI A clinical management protocol for COVID-19 infection in pregnant women
SO CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA
LA Spanish
DT Review
DE COVID-19; SARS-CoV-2; Coronavirus; Pregnancy; Management; Delivery
AB The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has caused a large global outbreak and has had a major impact on health systems and societies worldwide. The generation of knowledge about the disease has occurred almost as fast as its global expansion. Very few studies have reported on the effects of the infection on maternal health, since its onset. The mother and foetus do not seem to be at particularly high risk. Nevertheless, obstetrics and maternal-foetal medicine practice have made profound changes in order to adapt to the pandemic. In addition, there are aspects specific to COVID-19 and gestation that should be known by specialists. In this review an evidenced-based protocol is presented for the management of COVID-19 in pregnancy. (C) 2020 Elsevier Espana, S.L.U. All rights reserved.
C1 [Valdes-Bango, M.; Meler, E.; Cobo, T.; Hernandez, S.; Ribera, L.; Guirado, L.; Ferrer, P.; Figueras, F.; Palacio, M.; Gonce, A.; Lopez, M.] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Hosp Clin, Ctr Med Maternofetal & Neonatal Barcelona,Serv Me, Barcelona, Spain.
   [Valdes-Bango, M.; Meler, E.; Cobo, T.; Hernandez, S.; Ribera, L.; Guirado, L.; Ferrer, P.; Figueras, F.; Palacio, M.; Gonce, A.; Lopez, M.] Univ Barcelona, Hosp St Joan Deu, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Barcelona, Spain.
   [Caballero, A.] Univ Barcelona, Hosp Clin, Serv Anestesiol, Barcelona, Spain.
   [Garcia, F.] Univ Barcelona, Hosp Clin, Serv Enfermedades Infecciosas, Barcelona, Spain.
   [Salvia, D.] Univ Barcelona, Hosp Clin, Serv Neonatol, Barcelona, Spain.
RP Lopez, M (corresponding author), Univ Barcelona, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Hosp Clin, Ctr Med Maternofetal & Neonatal Barcelona,Serv Me, Barcelona, Spain.; Lopez, M (corresponding author), Univ Barcelona, Hosp St Joan Deu, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Barcelona, Spain.
EM lopezro@clinic.cat
CR [Anonymous], COR DIS COVID 19 BRE
   Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100118
   Centers for Disease Control and Prevention (CDC), CONS INP OBST HEALTH
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen YH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.023
   Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   European Medicines Agency, 2020, EMA GIV ADV US NONST
   Ferrazzi EM, 2020, INT J GYNECOL OBSTET, V149, P377, DOI 10.1002/ijgo.13162
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   ISCIII, 2020, INF 22 SIT COVID 19
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012
   Lamouroux A, 2020, AM J OBSTET GYNECOL, V223, P91, DOI 10.1016/j.ajog.2020.04.039
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lopez M, 2020, FETAL DIAGN THER, V47, P519, DOI 10.1159/000508487
   Martinez-Portilla RJ, 2020, LANCET INFECT DIS, V20, P655, DOI 10.1016/S1473-3099(20)30285-1
   Poon LC, 2020, ULTRASOUND OBST GYN, V55, P700, DOI 10.1002/uog.22013
   Qian GQ, 2020, INFECT DIS-NOR, V52, P511, DOI 10.1080/23744235.2020.1748705
   Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P799, DOI 10.5858/arpa.2020-0901-SA
   Society for Obstetric and Anesthesia and Perinatology, 2020, INT CONS OBST AN CAR
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tang PP, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2070-0
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wong HYF, 2019, RADIOLOGY, DOI [10.1148/radiot.7020201160, DOI 10.1148/RADIOT.7020201160]
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yan J, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.014
   Zamaniyan M, 2020, PRENATAL DIAG, V40, P1759, DOI 10.1002/pd.5713
   Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838
   Zeng LK, 2020, JAMA PEDIATR, V174, P722, DOI 10.1001/jamapediatrics.2020.0878
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 33
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER ESPANA
PI MADRID
PA CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN
SN 0210-573X
EI 1578-9349
J9 CLIN INVESTIG GINECO
JI Clin. Investig. Ginecol. Obstet.
PD JUL-SEP
PY 2020
VL 47
IS 3
BP 118
EP 127
DI 10.1016/j.gine.2020.06.014
PG 10
WC Obstetrics & Gynecology
WE Emerging Sources Citation Index (ESCI)
SC Obstetrics & Gynecology
GA MS0GT
UT WOS:000553966200006
PM 32834309
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Chhabra, HS
   Bagaraia, V
   Keny, S
   Kalidindi, KKV
   Mallepally, A
   Dhillon, MS
   Malhotra, R
   Rajasekharan, S
AF Chhabra, Harvinder Singh
   Bagaraia, Vaibhav
   Keny, Swapnil
   Kalidindi, Kalyan Kumar Varma
   Mallepally, Abhinandan
   Dhillon, Mandeep Singh
   Malhotra, Rajesh
   Rajasekharan, Shanmuganathan
TI COVID-19: Current Knowledge and Best Practices for Orthopaedic Surgeons
SO INDIAN JOURNAL OF ORTHOPAEDICS
LA English
DT Review
DE COVID-19; SARS-CoV-2; Orthopaedics; Outpatient; Surgical procedures;
   Operative; Guideline
ID OUTBREAK
AB Background A mysterious cluster outbreak of pneumonia in Wuhan, China in December 2019 was traced to Severe Acute Respiratory Syndrome Coronavirus 2 and declared a Pandemic by WHO on 11th March 2020. The pandemic has spread rapidly causing widespread devastation globally. Purpose This review provides a brief understanding of pathophysiology, clinical features, diagnosis and management of COVID-19 and highlights the current knowledge as well as best practices for orthopaedic surgeons. These are likely to change as knowledge and evidence is gained. Results Orthopaedic surgeons, like other front-line workers, carry the risk of getting infected during their practice, which as such is already substantially affected. Implementation of infection prevention and control as well as other safety measures for health care workers assumes great importance. All patients/visitors and staff visiting the hospital should be screened. Conservative treatment should be the first line of treatment except for those requiring urgent/emergent care. During lockdown all elective surgeries are to be withheld. All attempts should be made to reduce hospital visits and telemedicine is to be encouraged. Inpatient management of COVID-19 patients requires approval from concerned authorities. All patients being admitted to the hospital in and around containment zones should be tested for COVID-19. There are special considerations for anaesthesia with preference for regional anaesthesia. A separate Operation room with specific workflow should be dedicated for COVID-19 positive cases. Conclusions Despite the magnitude of challenge, the pandemic offers significant lessons for the orthopaedic surgeon who should seek the opportunity within the adversity and use this time wisely to achieve his/her Ikigai.
C1 [Chhabra, Harvinder Singh] Indian Spinal Injuries Ctr, Dept Spine Serv, New Delhi 110070, India.
   [Chhabra, Harvinder Singh] Indian Spinal Injuries Ctr, New Delhi 110070, India.
   [Bagaraia, Vaibhav] Sir HN Reliance Fdn Hosp, Dept Orthopaed, Mumbai 431202, Maharashtra, India.
   [Keny, Swapnil] Grant Med Coll, Mumbai 400008, Maharashtra, India.
   [Keny, Swapnil] Sir JJ Hosp, Mumbai 400008, Maharashtra, India.
   [Keny, Swapnil] Sir HN Reliance Hosp, Mumbai 431202, Maharashtra, India.
   [Kalidindi, Kalyan Kumar Varma; Mallepally, Abhinandan] Indian Spinal Injuries Ctr, Dept Spine Serv, New Delhi 110070, India.
   [Dhillon, Mandeep Singh] PGIMER, Phys Med Dept, Chandigarh 160012, India.
   [Malhotra, Rajesh] All India Inst Med Sci, JPN Apex Trauma Ctr, New Delhi 110029, India.
   [Malhotra, Rajesh] All India Inst Med Sci, COVID 19 Facil, Dept Orthopaed, New Delhi 110029, India.
   [Rajasekharan, Shanmuganathan] Ganga Hosp, Dept Orthopaed & Spine Surg, Coimbatore 641043, Tamil Nadu, India.
RP Chhabra, HS (corresponding author), Indian Spinal Injuries Ctr, Dept Spine Serv, New Delhi 110070, India.; Chhabra, HS (corresponding author), Indian Spinal Injuries Ctr, New Delhi 110070, India.
EM issicon@isiconline.org; drbagaria@gmail.com; swapnilkeny@hotmail.com;
   kalyanvarmambbs@gmail.com; mabhi28@gmail.com; drdhillon@gmail.com;
   rmalhotra62@gmail.com; rajasekaran.orth@gmail.com
RI Chhabra, Harvinder/AAR-8376-2021; Rajasekaran,
   Shanmuganathan/ABG-7570-2020; kalidindi, kalyan kumar varma kumar
   varma/AAW-8267-2021
OI kalidindi, kalyan kumar varma kumar varma/0000-0002-4408-7035; Dhillon,
   Mandeep/0000-0002-2592-1362
CR Abel KAPN, 2017, JBJS J ORTHOPAEDICS, V5, P26
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Al-Muharraqi MA, 2020, BRIT J ORAL MAX SURG, V58, P503, DOI 10.1016/j.bjoms.2020.04.014
   [Anonymous], 2020, CLIN MANAGEMENT SEVE
   [Anonymous], 2020, GUID CLIN MAN COVID
   [Anonymous], 2020, LANCET, V395, P10228
   [Anonymous], 2020, LANCET
   Auricchio F, 2016, EFORT OPEN REV, V1, P121, DOI 10.1302/2058-5241.1.000012
   Ayebare RR, 2020, LANCET RESP MED, V8, pE22, DOI 10.1016/S2213-2600(20)30114-4
   Azhari A, 2020, ARCH BONE JT SURG-AB, V8, P317, DOI 10.22038/abjs.2020.47777.2350
   Board of Governors, SUP MED COUNC IND TE
   Bracchi-Ricard V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0574-y
   Brindle ME, 2020, ANN SURG, V272, pE1, DOI 10.1097/SLA.0000000000003923
   British Orthopaedic Association, 2020, MAN PAT URG ORTH CON
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Center for Disease Control and Prevention, 2018, EB GUID PERS PROT EQ
   Center for Disease Control and Prevention, 2020, COR VIR DIS 2019 COV
   Centers for Disease Control and Prevention. , COR DIS 2019
   Chen AF, 2018, J BONE JOINT SURG AM, V100, P1984, DOI 10.2106/JBJS.17.01397
   COVID-19 Surveillance Group, 2020, CHAR COVID 19 PAT DY
   da Silva AG, 2020, BRAZ J PSYCHIAT, V42, P229, DOI 10.1590/1516-4446-2020-0009
   Daruwalla ZJ, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3303
   Editorial Board of the Wall Street Journal, 2020, WALL STREET J
   Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Game FL, 2012, DIABETES-METAB RES, V28, P232, DOI 10.1002/dmrr.2250
   Gan WH, 2020, SAF HEALTH WORK-KR, V11, P241, DOI 10.1016/j.shaw.2020.03.001
   Government of India. Ministry of health & family Welfare Services DG of HD (EMR), 2020, REV GUID CLIN MAN CO
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo XD, 2020, J BONE JOINT SURG AM, V102, P847, DOI 10.2106/JBJS.20.00417
   Guy Daniel K., AAOS GUID EL SURG CO
   Hindson J, 2020, NAT REV GASTRO HEPAT, V17, P259, DOI 10.1038/s41575-020-0295-7
   Holgate J, 2017, ANN ROY COLL SURG, V99, P51, DOI 10.1308/rcsann.2016.0255
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Indian Council of Medical Research, 2020, STRAT COVID 19 TEST
   Kasibhatla SM, 2020, J MED VIROL, V92, P1932, DOI 10.1002/jmv.25909
   Keith P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2836-4
   Kogan E, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-019-1010-x
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Li H, 2020, J CELL MOL MED, V24, P6558, DOI 10.1111/jcmm.15364
   Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]
   Liang LJ, 2020, INT J GEOMECH, V20, DOI 10.1061/(ASCE)GM.1943-5622.0001643
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Ministry of Health and Family Welfare, 2020, CONT PLAN LARG OUTBR
   Ministry of Health & Family Welfare Directorate General of Health Services EMR Division, GUID DOC APPR MAN SU
   Ministry of Health & Family Welfare Government of India, 2020, REV GUID CLIN MAN CO
   Nazinitsky A, 2010, INFECT DIS CLIN PRAC, V18, P188, DOI DOI 10.1097/IPC.0B013E3181D2EE41
   Ng K, 2020, ANN INTERN MED, V172, P766, DOI 10.7326/L20-0175
   Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775
   Royal College of Surgeons, 2020, GOOD PRACT SURG SURG
   SANTARPIA JL, 2020, TRANSMISSION POTENTI, DOI [10.1101/2020.03.23.20039446, DOI 10.1038/S41598-020-69286-3]
   Savage KE, 2016, GLOB SPINE J, V6, P607, DOI 10.1055/s-0035-1570751
   Shuchang Z, 2020, AM J ROENTGENOL, V20, P1
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Small SR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033832
   Smith JA, 2020, HEALTH PROMOT J AUST, V31, P158, DOI 10.1002/hpja.333
   The Centers for Disease Control and Prevention (CDC), 2019, REC GUID EXT US LTD
   The Royal College of Surgeons of England, 2020, GUID SURG WORK COVID
   U.S Food and Drug administration, IMP INF US SER TESTS
   Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624
   Udwadia Zarir F, 2020, Med J Armed Forces India, V76, P128, DOI 10.1016/j.mjafi.2020.03.009
   Van Doremalen N, 2020, NEW ENGL J MED, V20, P17
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang W., 2020, DEFINITION RISKS CYT, DOI [10.1101/2020.02.26.20026989, DOI 10.1101/2020.02.26.20026989]
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   WHO, 2020, WHO INFECT PREVENTIO
   World confederation for physical therapy, COVID 19 INF HUB
   World Health Organization, COR DIS COVID 19 PAN
   World Health Organization, ALG COVID 19 TRIAG R
   World Health Organization, NAM COR DIS COVID 19
   World Health Organization, 2020, RAT US PERS PROT EQ
   World Health Organization, 2020, COR DIS COVID 19 TRA
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou J, 2020, ASIAN SPINE J, V14, P258, DOI [10.31616/asj.2020.0122, 10.31615/asj.2020.0122]
NR 78
TC 15
Z9 16
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0019-5413
EI 1998-3727
J9 INDIAN J ORTHOP
JI Indian J. Orthop.
PD JUL
PY 2020
VL 54
IS 4
BP 411
EP 425
DI 10.1007/s43465-020-00135-1
EA MAY 2020
PG 15
WC Orthopedics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Orthopedics
GA LU4MG
UT WOS:000533846600001
PM 32425237
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Lee-Geiller, S
   Lee, TJ
AF Lee-Geiller, Seulki
   (David) Lee, Taejun
TI How Does Digital Governance Contribute to Effective Crisis Management? A
   Case Study of Korea's Response to COVID-19
SO PUBLIC PERFORMANCE & MANAGEMENT REVIEW
LA English
DT Article; Early Access
DE Digital governance; crisis management; COVID-19; collaborative
   governance; collaborative crisis management
ID E-GOVERNMENT; COLLABORATIVE GOVERNANCE; DOCUMENT ANALYSIS; PERFORMANCE;
   CHALLENGES; EVOLUTION; PROGRESS; GUIDE; STATE
AB The COVID-19 global pandemic has challenged governance practices around the world and led to calls for reform to better fit newly emerged expectations. Studies have identified multiple types of governance practices and important qualities in governance for coping with crises, but they have tended to focus on one or a few aspects. In addition, while the pandemic has shown us how the digital readiness of a country plays a pivotal role in adjusting to and mitigating the societal impact of a crisis, there is limited knowledge of how digital tools and strategies within digital governance can best be utilized in the context of crisis management. This study synthesizes the literature on governance and crisis management to draw a comprehensive analytical framework, aiming to examine the specific roles of digital governance in supporting crisis management. We utilize an interpretive case study of Korea's response to COVID-19, given the country's highly regarded digital governance performance and COVID-19 response. This study offers specific evidence and examples of how Korea's digital governance has operated in response to the pandemic and provides implications for existing theory by linking the digital governance literature to the context of pandemics as well as more effective crisis management practices.
C1 [Lee-Geiller, Seulki] Rutgers Univ Newark, Newark, NJ USA.
   [(David) Lee, Taejun] KDI Sch Publ Policy & Management, Yeongi Gun, South Korea.
RP Lee-Geiller, S (corresponding author), 175 Univ Ave Room,Conklin Hall Room 220A, Newark, NJ 07102 USA.
EM seulki.lee@rutgers.edu
FU Korea Development Institute School of Public Policy and Management
FX This work was supported by the Korea Development Institute School of
   Public Policy and Management.
CR Ahn NY, 2020, IEEE ACCESS, V8, P171325, DOI 10.1109/ACCESS.2020.3025971
   Akhgar B., 2021, TECHNOLOGY DEV SECUR
   Altheide D. L., 2013, QUALITATIVE MEDIA AN, P23, DOI DOI 10.4135/9781452270043
   Andersen KV, 2006, GOV INFORM Q, V23, P236, DOI 10.1016/j.giq.2005.11.008
   Ansell C, 2012, OXFORD HDB GOVERNANC, P1
   Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Antonacopoulou EP, 2014, J MANAGE INQUIRY, V23, P5, DOI 10.1177/1056492612472730
   Anttiroiko Ari-Veikko, 2012, International Journal of Information Communication Technologies and Human Development, V4, P1, DOI 10.4018/jicthd.2012070101
   Anttiroiko A.-V., 2004, ETRANSFORMATION GOVE, P22
   Azralon M, 2020, SCIENCEDAILY
   Azzopardi-Muscat N, 2021, J AM MED INFORM ASSN, V28, P638, DOI 10.1093/jamia/ocaa308
   Bae Y, 2016, HABITAT INT, V52, P50, DOI 10.1016/j.habitatint.2015.08.027
   Baker DL, 2009, GOV INFORM Q, V26, P82, DOI 10.1016/j.giq.2008.01.004
   Bannister F., 2012, E SERVICE J, V8, P3
   Barben D, 2007, HANDBOOK OF SCIENCE AND TECHNOLOGY STUDIES, THIRD EDITION, P979
   Bennett NJ, 2018, ENVIRON MANAGE, V61, P597, DOI 10.1007/s00267-017-0993-2
   Blanchet K, 2017, INT J HEALTH POLICY, V6, P431, DOI 10.15171/ijhpm.2017.36
   Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027
   Bronen R, 2013, P NATL ACAD SCI USA, V110, P9320, DOI 10.1073/pnas.1210508110
   Brudney J.L., 2009, PUBLIC PERFORMANCE M, V32, P372
   Chi K.S., 2008, 4 STRATEGIES TRANSFO
   Choi J, 2021, J SUSTAIN TOUR, V29, P540, DOI 10.1080/09669582.2020.1777143
   Choi YJ, 2020, WORLD MED HEALTH POL, V12, P430, DOI 10.1002/wmh3.376
   Chriscaden K., 2020, JOINT STATEMENT ILO
   Cole S, 2001, J AM PLANN ASSOC, V67, P372, DOI 10.1080/01944360108976246
   Collins A, 2020, J RISK RES, V23, P1073, DOI 10.1080/13669877.2020.1760332
   Cooper TL, 2006, PUBLIC ADMIN REV, V66, P76, DOI 10.1111/j.1540-6210.2006.00668.x
   Dawes SS, 2008, PUBLIC ADMIN REV, V68, pS86, DOI 10.1111/j.1540-6210.2008.00981.x
   Dawes SS, 2009, GOV INFORM Q, V26, P257, DOI 10.1016/j.giq.2008.12.003
   Deep Knowledge Group, 2021, COVID 19 REG SAF ASS
   Dervin B., 1998, Journal of Knowledge Management, V2, P36, DOI 10.1108/13673279810249369
   Egbejule E, 2020, OZY
   Emerson K, 2015, PUBLIC PERFORM MANAG, V38, P717, DOI 10.1080/15309576.2015.1031016
   Emerson K, 2012, J PUBL ADM RES THEOR, V22, P1, DOI 10.1093/jopart/mur011
   Fisher E., 2012, OXFORD HDB GOVERNANC
   George B, 2020, PUBLIC ADMIN REV, V80, P696, DOI 10.1111/puar.13255
   Hermansson HML, 2016, PUBLIC ADMIN, V94, P333, DOI 10.1111/padm.12203
   Huang IYF, 2020, PUBLIC ADMIN REV, V80, P665, DOI 10.1111/puar.13239
   Huffam C. J, 2011, P 32 INT IND TRAIN S
   Huh Y., 2020, COVID 19 REPORT 1 88
   Ignatjeva O.A., 2019, COMMUNICATIVE STRATE, P1, DOI [10.1145/3373722.3373784, DOI 10.1145/3373722.3373784]
   Jaeger C.C., 2001, RISK UNCERTAINTY RAT, P159
   Janowski T, 2015, GOV INFORM Q, V32, P221, DOI 10.1016/j.giq.2015.07.001
   Janssen M, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102180
   Janssen M, 2016, GOV INFORM Q, V33, P1, DOI 10.1016/j.giq.2016.02.003
   Kaarbo J, 1999, POLIT PSYCHOL, V20, P369, DOI 10.1111/0162-895X.00149
   Kapucu N, 2011, PUBLIC PERFORM MANAG, V34, P549, DOI 10.2753/PMR1530-9576340406
   Khan M, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105213
   Kim J, 2020, YONHAPNEWS 0316
   Kim Y, 2020, AM REV PUBLIC ADM, V50, P736, DOI 10.1177/0275074020942414
   Kim Y, 2011, PUBLIC PERFORM MANAG, V34, P580, DOI 10.2753/PMR1530-9576340407
   Kooiman J., 2003, GOVERNRING GOVERNANC
   Koraeus M, 2013, STRATEGIC INTELLIGENCE MANAGEMENT: NATIONAL SECURITY IMPERATIVES AND INFORMATION AND COMMUNICATIONS TECHNOLOGIES, P134
   Korea Research Institute for Local Administration, 2020, KRILA POL BRIEF
   Kostetska I, 2014, MANAG THEORY STUD RU, V36, P569
   Kye B, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100523
   Larsson OL, 2017, RISK HAZARDS CRISIS, V8, P312, DOI 10.1002/rhc3.12120
   Layne K, 2001, GOV INFORM Q, V18, P122, DOI 10.1016/S0740-624X(01)00066-1
   Lee David, 2020, Transp Res Interdiscip Perspect, V5, P100111, DOI 10.1016/j.trip.2020.100111
   Lee E, 2020, SYSTEMS-BASEL, V8, DOI 10.3390/systems8020018
   Lee J, 2010, GOV INFORM Q, V27, P220, DOI 10.1016/j.giq.2009.12.009
   Lee S, 2020, POLICY SOC, V39, P363, DOI 10.1080/14494035.2020.1785195
   Lee T, 2020, GOV INFORM Q, V37, DOI 10.1016/j.giq.2020.101482
   Lee-Geiller S, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105110
   Lee-Geiller S, 2019, INT J ELECTRON GOV R, V15, P19, DOI 10.4018/IJEGR.2019100102
   Lee-Geiller S, 2019, GOV INFORM Q, V36, P208, DOI 10.1016/j.giq.2019.01.003
   Liu BF, 2011, PUBLIC RELAT REV, V37, P233, DOI 10.1016/j.pubrev.2011.03.005
   Luna-Reyes LF, 2021, GOV INFORM Q, V38, DOI 10.1016/j.giq.2021.101570
   Lynn L.E, 2012, OXFORD HDB GOVERNANC
   Malone T., 2004, FUTURE WORK
   Maor M, 2020, POLICY DES PRACT, V3, P228, DOI 10.1080/25741292.2020.1824379
   March J.G., 2010, DEMOCRATIC GOVERNANC
   Marche S, 2003, CAN J ADM SCI, V20, P74
   Marmor T.R., 2012, POLITICS HLTH HEALTH, V6988, P297
   Martin E, 2016, DISASTERS, V40, P621, DOI 10.1111/disa.12173
   McCormick S, 2016, DISASTERS, V40, P207, DOI 10.1111/disa.12141
   MINTZBERG H, 1985, ADMIN SCI QUART, V30, P160, DOI 10.2307/2393104
   Mintzberg H., 1979, STRUCTURING ORG SYNT
   Nohrstedt D, 2016, ADMIN SOC, V48, P135, DOI 10.1177/0095399712473983
   O'Leary R, 2006, PUBLIC ADMIN REV, V66, P6, DOI 10.1111/j.1540-6210.2006.00661.x
   OECD, 2016, GOV GLANC KOR COMPAR
   OECD, DIG GOV
   OECD, 2019, DIG GOV IND
   OECD Data, 2019, HOSP BEDS
   Overby E, 2006, EUR J INFORM SYST, V15, P120, DOI 10.1057/palgrave.ejis.3000600
   Owen G.T., 2014, QUAL REP, V19, P1, DOI https://doi.org/10.46743/2160-3715/2014.1211
   Park CH, 2020, PUBLIC PERFORM MANAG, V43, P587, DOI 10.1080/15309576.2019.1677253
   Park J, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105198
   Pathan A.S.K., 2020, INT J COMPUTERS APPL, V42, P531
   Peters B.G., 2012, OXFORD HDB GOVERNANC
   Pynes J., 2007, PUBLIC PERFORMANCE M, V31, P101, DOI [10.2753/PMR1530-9576310105, DOI 10.2753/PMR1530-9576310105]
   Quay R, 2010, J AM PLANN ASSOC, V76, P496, DOI 10.1080/01944363.2010.508428
   Rahman M, 2021, HERE ARE COUNTRIES U
   Rethemeyer R.K., 2009, PUBLIC PERFORMANCE M, V32, P565, DOI [https://doi.org/10.2753/PMR1530-9576320405, DOI 10.2753/PMR1530-9576320405]
   Riemer K, 2020, EUR J INFORM SYST, V29, P731, DOI 10.1080/0960085X.2020.1819898
   Robers P., 2020, AM POLITICAL SCI ASS
   SAVOLAINEN R, 1993, INFORM PROCESS MANAG, V29, P13, DOI 10.1016/0306-4573(93)90020-E
   Scharpf FritzW., 1999, GOVERNING EUROPE EFF
   Seawright J, 2008, POLIT RES QUART, V61, P294, DOI 10.1177/1065912907313077
   Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090
   Smith D, 2007, MANAGE LEARN, V38, P519, DOI 10.1177/1350507607083205
   Sridhar D, 2021, THE GUARDIAN 1117
   Stern E., 1997, J CONTING CRISIS MAN, V5, P69, DOI DOI 10.1111/1468-5973.00039
   Stifrung B, 2021, RESILIENCE GOVERNANC
   Susha I, 2015, SOC SCI COMPUT REV, V33, P613, DOI 10.1177/0894439314560852
   Terry LD, 1998, PUBLIC ADMIN REV, V58, P194, DOI 10.2307/976559
   Tierney K, 2012, ANNU REV ENV RESOUR, V37, P341, DOI 10.1146/annurev-environ-020911-095618
   Toney J.H., 2020, AM SCI, V108, P344, DOI [https://doi.org/10.1511/2020.108.6.344, DOI 10.1511/2020.108.6.344]
   Torfing J., 2012, OXFORD HDB GOVERNANC
   Torres N., 2018, 3 EMERGING TECHNOLOG
   United Nations, 2008, UN E GOV SURV 2008 E
   United Nations, 2002, BENCHM E GOV GLOB PE
   United Nations Department of Economic and Social Affairs, 2016, UN E GOV SURV 2016 E
   van den Oord S, 2020, PUBLIC ADMIN REV, V80, P880, DOI 10.1111/puar.13256
   Veljkovic N, 2014, GOV INFORM Q, V31, P278, DOI 10.1016/j.giq.2013.10.011
   Vogt M., P S ANN HAW INT C SY, P1
   Williamson B, 2015, LEARN MEDIA TECHNOL, V40, P83, DOI 10.1080/17439884.2014.924527
   Wood LM, 2020, QUAL REP, V25, P456
   Xiong W, 2019, PUBLIC PERFORM MANAG, V42, P1279, DOI 10.1080/15309576.2019.1574592
   Yang K., 2007, PUBLIC PERFORMANCE M, V31, P131, DOI [https://doi.org/10.2753/PMR1530-9576310200, DOI 10.2753/PMR1530-9576310200]
   Yen WT, 2020, ASIAN POLIT POLICY, V12, P455, DOI 10.1111/aspp.12541
   Zumbansen P., 2012, OXFORD HDB GOVERNANC, P1
NR 122
TC 0
Z9 0
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1530-9576
EI 1557-9271
J9 PUBLIC PERFORM MANAG
JI Public Perform. Manag. Rev.
DI 10.1080/15309576.2022.2054434
EA APR 2022
PG 34
WC Public Administration
WE Social Science Citation Index (SSCI)
SC Public Administration
GA 0G3OS
UT WOS:000777958200001
DA 2022-04-20
ER

PT J
AU El-Jardali, F
   Bou-Karroum, L
   Fadlallah, R
AF El-Jardali, Fadi
   Bou-Karroum, Lama
   Fadlallah, Racha
TI Amplifying the role of knowledge translation platforms in the COVID-19
   pandemic response
SO HEALTH RESEARCH POLICY AND SYSTEMS
LA English
DT Article
DE COVID-19 pandemic; knowledge translation; evidence-informed
   policy-making; evidence; research; data
ID PUBLIC-HEALTH RESPONSE; MONEY
AB The COVID-19 pandemic presents the worst public health crisis in recent history. The response to the COVID-19 pandemic has been challenged by many factors, including scientific uncertainties, scarcity of relevant research, proliferation of misinformation and fake news, poor access to actionable evidence, time constraints, and weak collaborations among relevant stakeholders. Knowledge translation (KT) platforms, composed of organisations, initiatives and networks supporting evidence-informed policy-making, can play an important role in providing relevant and timely evidence to inform pandemic responses and bridge the gap between science, policy, practice and politics. In this Commentary, we highlight the emerging roles of KT platforms in light of the COVID-19 pandemic. We also reflect on the lessons learned from the efforts of a KT platform in a middle-income country to inform decision-making and practice during the COVID-19 pandemic. The lessons learned can be integrated into strengthening the role, structures and mandates of KT platforms as hubs for trustworthy evidence that can inform policies and practice during public health crises and in promoting their integration and institutionalisation within the policy-making processes.
C1 [El-Jardali, Fadi; Bou-Karroum, Lama; Fadlallah, Racha] Amer Univ Beirut, Dept Hlth Management & Policy, Fac Hlth Sci, Beirut, Lebanon.
   [El-Jardali, Fadi; Bou-Karroum, Lama; Fadlallah, Racha] Amer Univ Beirut, Knowledge Policy K2P Ctr, Fac Hlth Sci, Beirut, Lebanon.
   [El-Jardali, Fadi] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.
RP El-Jardali, F (corresponding author), Amer Univ Beirut, Dept Hlth Management & Policy, Fac Hlth Sci, Beirut, Lebanon.; El-Jardali, F (corresponding author), Amer Univ Beirut, Knowledge Policy K2P Ctr, Fac Hlth Sci, Beirut, Lebanon.
EM fe08@aub.edu.lb
CR Abbasi K, 2020, J ROY SOC MED, V113, P131, DOI 10.1177/0141076820918796
   Akhlaq A, 2016, HEALTH POLICY PLANN, V31, P1310, DOI 10.1093/heapol/czw056
   Alwan NA, 2020, LANCET, V395, P1036, DOI 10.1016/S0140-6736(20)30667-X
   Bennett S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001081
   Blanchet K., 2018, USING RES EVIDENCE H
   Carbone EG, 2018, AM J PUBLIC HEALTH, V108, pS383, DOI [10.2105/ajph.2018.304702, 10.2105/AJPH.2018.304702]
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   El-Jardali F, 2018, E MEDITERR HEALTH J, V24, P672, DOI 10.26719/2018.24.7.672
   El-Jardali F, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-15
   European Centre for Disease Prevention and Control (ECDC), 2019, US EV DEC MAK DUR PU
   Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]
   Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297
   Kasonde JM, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-31
   Khalid AF, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-0530-2
   Lavis JN, 2006, B WORLD HEALTH ORGAN, V84, P620, DOI 10.2471/BLT.06.030312
   Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI 10.1186/1478-4505-7-S1-S3
   Mahapatra Prasanta, 2014, J Evid Based Med, V7, P238, DOI 10.1111/jebm.12129
   Mateus ALP, 2014, B WORLD HEALTH ORGAN, V92, P868, DOI 10.2471/BLT.14.135590
   Moat KA, 2014, B WORLD HEALTH ORGAN, V92, P20, DOI 10.2471/BLT.12.116806
   Ongolo-Zogo P, 2018, HEALTH POLICY PLANN, V33, P539, DOI 10.1093/heapol/czx194
   Orso D, 2020, EUR J EMERG MED, V27, P327, DOI 10.1097/MEJ.0000000000000713
   Pasquini-Descomps H, 2017, VALUE HEALTH, V20, P819, DOI 10.1016/j.jval.2016.05.005
   Patel A, 2020, MMWR-MORBID MORTAL W, V69, P140, DOI 10.15585/mmwr.mm6905e1
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Salajan A, 2020, EVID POLICY, V16, P453, DOI 10.1332/174426420X15808913064302
   Tambo E, 2018, EVIDENCE DECISION MA, DOI 10.20944/preprints201804.0045.v1
   Wang BY, 2012, IRAN J PUBLIC HEALTH, V41, P34
   WORLD HEALTH ORGANIZATION, 2020, COR DIS 2019 COVID 2
   World Health Organization, 2012, KEY CHANG PAND PLANS
NR 29
TC 16
Z9 16
U1 3
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-4505
J9 HEALTH RES POLICY SY
JI Health Res. Policy Syst.
PD JUN 3
PY 2020
VL 18
IS 1
DI 10.1186/s12961-020-00576-y
PG 7
WC Health Policy & Services
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA LX7ZP
UT WOS:000540046700005
PM 32493339
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Mohammadi, A
   Balan, I
   Yadav, S
   Matos, WF
   Kharawala, A
   Gaddam, M
   Sarabia, N
   Koneru, SC
   Suddapalli, SK
   Marzban, S
AF Mohammadi, Asma
   Balan, Irina
   Yadav, Shikha
   Matos, Wanessa F.
   Kharawala, Amrin
   Gaddam, Mrunanjali
   Sarabia, Noemi
   Koneru, Sri Charitha
   Suddapalli, Siva K.
   Marzban, Sima
TI Post-COVID-19 Pulmonary Fibrosis
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Review
DE covid-19; ards; lung fibrosis; sars cov and pulmonary fibrosis; covid-19
   and pulmonary fibrosis
ID BLOOD BIOMARKERS; CORONAVIRUS; COVID-19
AB Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions worldwide with a high mortality rate due to a lack of definitive treatment. Despite having a wide range of clinical features, acute respiratory distress syndrome (ARDS) has emerged as the primary cause of mortality in these patients. Risk factors and comorbidities like advanced age with limited lung function, pre-existing diabetes, hypertension, cardiovascular diseases, and obesity have increased the risk for severe COVID-19 infection. Rise in inflammatory markers like transforming growth factor beta (TGF-beta), interleukin-6 (IL-6), and expression of matrix metalloproteinase 1 and 7 (MMP-1, MMP-7), along with collagen deposition at the site of lung injury, results in extensive lung scarring and fibrosis. Anti-fibrotic drugs, such as Pirfenidone and Nintedanib, have emerged as potential treatment options for post-COVID-19 pulmonary fibrosis. A lung transplant might be the only life-saving treatment. Despite the current advances in the management of COVID-19, there is still a considerable knowledge gap in the management of long-term sequelae in such patients, especially concerning pulmonary fibrosis. Follow up on the current clinical trials and research to test the efficacy of various anti-inflammatory drugs is needed to prevent long-term sequelae early mortality in these patients.
C1 [Mohammadi, Asma] Univ Nebraska Med Ctr, Publ Hlth, Omaha, NE 68198 USA.
   [Mohammadi, Asma; Yadav, Shikha; Matos, Wanessa F.; Sarabia, Noemi; Koneru, Sri Charitha; Suddapalli, Siva K.; Marzban, Sima] Larkin Community Hosp, Res & Acad Affairs, Miami, FL 33143 USA.
   [Balan, Irina] State Med & Pharmaceut Univ N Testemitate, Internal Med, Fayetteville, NC USA.
   [Yadav, Shikha] Kathmandu Univ, Internal Med, Kathmandu, Nepal.
   [Matos, Wanessa F.] Inst Syst Biol ISB, Res, Hadlock Lab, Seattle, WA USA.
   [Kharawala, Amrin] Med Coll Baroda, Med, Vadodara, India.
   [Kharawala, Amrin] Albert Einstein Coll Med, Jacobi Med Ctr, Internal Med, New York, NY USA.
   [Gaddam, Mrunanjali] Andhra Med Coll, Internal Med, Visakhapatnam, Andhra Pradesh, India.
   [Gaddam, Mrunanjali] Mayo Clin, Internal Med, Rochester, MN USA.
RP Mohammadi, A (corresponding author), Univ Nebraska Med Ctr, Publ Hlth, Omaha, NE 68198 USA.; Mohammadi, A (corresponding author), Larkin Community Hosp, Res & Acad Affairs, Miami, FL 33143 USA.
EM doctorasma1931@gmail.com
CR Abdel-Hamid Hoda M, 2021, Indian J Tuberc, V68, P450, DOI 10.1016/j.ijtb.2021.01.006
   [Anonymous], 2021, STUDY USE NINTEDANIB
   [Anonymous], 2020, FAST LIT UPDATES MAS
   [Anonymous], PIRFENIDONE VS NINTE
   [Anonymous], 2021, COLCHICINE POST COVI
   [Anonymous], 2021, MINERALOCORTICOID RE
   Awano N, 2020, RESPIR INVESTIG, V58, P440, DOI 10.1016/j.resinv.2020.07.004
   Barison A, 2020, EUR J PREV CARDIOL, V27, P1017, DOI 10.1177/2047487320924501
   Bharat A, 2021, LANCET RESP MED, V9, P487, DOI 10.1016/S2213-2600(21)00077-1
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   d'Alessandro M, 2021, INTERN EMERG MED, V16, P1541, DOI 10.1007/s11739-020-02614-7
   Dadhwal R, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.12501
   De Lara LV, 2000, AM J PHYSIOL-LUNG C, V279, pL950, DOI 10.1152/ajplung.2000.279.5.L950
   Gao ZR, 2021, J MICROBIOL IMMUNOL, V54, P12, DOI 10.1016/j.jmii.2020.05.001
   Gentile F, 2020, EUR J PREV CARDIOL, V27, P1442, DOI 10.1177/2047487320932695
   George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3
   Goodwin VA, 2021, PHYSIOTHERAPY, V111, P4, DOI 10.1016/j.physio.2021.01.007
   Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI 10.1056/NEJMoa2100433
   Grifoni E, 2020, J INFECTION, V81, P466, DOI 10.1016/j.jinf.2020.06.008
   Grzesk G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010282
   Guan WJ, 2020, NEW ENGL J MED, V382, P1708
   Guiot J, 2017, LUNG, V195, P273, DOI 10.1007/s00408-017-9993-5
   Hamai K, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/4759040
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hosseini ES, 2020, VIROLOGY, V551, P1, DOI 10.1016/j.virol.2020.08.011
   Ikeda K, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01582-y
   Inoue Y, 2020, CHEST, V158, P646, DOI 10.1016/j.chest.2020.03.037
   Isidori AM, 2021, ANDROLOGY-US, V9, P33, DOI 10.1111/andr.12837
   Ko UW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244114
   Kobayashi T, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0261-z
   Lee JS, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1835-9
   Lee K, 2009, GLOB INST, P1
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Leng L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00355-9
   Lew TWK, 2003, JAMA-J AM MED ASSOC, V290, P374, DOI 10.1001/jama.290.3.374
   Maher TM, 2021, ARTHRITIS RHEUMATOL, DOI 10.1002/art.41895
   Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020
   McDonald LT, 2021, AM J PHYSIOL-LUNG C, V320, pL257, DOI 10.1152/ajplung.00238.2020
   Mossel EC, 2008, VIROLOGY, V372, P127, DOI 10.1016/j.virol.2007.09.045
   Ni WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03120-0
   Ojha V, 2020, EUR RADIOL, V30, P6129, DOI 10.1007/s00330-020-06975-7
   Ojo AS, 2020, PULM MED, V2020, DOI 10.1155/2020/6175964
   Peng DH, 2021, CLIN CHIM ACTA, V517, P48, DOI 10.1016/j.cca.2021.02.012
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Polak SB, 2020, MODERN PATHOL, V33, P2128, DOI 10.1038/s41379-020-0603-3
   Reina-Gutierrez S, 2021, ARCH PHYS MED REHAB, V102, P1989, DOI 10.1016/j.apmr.2021.03.035
   Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584
   Seifirad S, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110005
   Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015
   Tzouvelekis A, 2017, RESPIROLOGY, V22, P486, DOI 10.1111/resp.12920
   Vasarmidi E, 2020, EXP THER MED, V20, P2557, DOI 10.3892/etm.2020.8980
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Vij R, 2012, TRANSL RES, V159, P218, DOI 10.1016/j.trsl.2012.01.012
   Vitiello Antonio, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00487-7
   Weinheimer VK, 2012, J INFECT DIS, V206, P1685, DOI 10.1093/infdis/jis455
   Wigen Jenny, 2020, Respir Med X, V2, P100023, DOI 10.1016/j.yrmex.2020.100023
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu J, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12944
   Yoon HY, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0907-8
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou JN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248957
NR 62
TC 0
Z9 0
U1 0
U2 0
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD MAR 2
PY 2022
VL 14
IS 3
AR e22770
DI 10.7759/cureus.22770
PG 7
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA ZU7VB
UT WOS:000770046900011
PM 35371880
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Akyurt, N
AF Akyurt, Nuran
TI Knowledge, practice and emotional status related to COVID-19 pandemic
   among radiology technicians working at pandemic hospitals
SO EUROPEAN JOURNAL OF RADIOLOGY
LA English
DT Article
DE COVID-19 pandemic; Radiology technicians; Knowledge; Attitude; Practice;
   Emotional state
ID HEALTH-CARE WORKERS; PSYCHOLOGICAL IMPACT; RADIATION SAFETY; OUTBREAK;
   AWARENESS; ANXIETY
AB Purpose: This study aimed to evaluate knowledge, attitude, practice and emotional and psychological concerns related to COVID-19 pandemic among radiology technicians working at pandemic hospitals across Turkey
   Methods: A total of 228 radiology technicians working at pandemic hospitals across Turkey were included on a voluntary basis in this questionnaire-based online survey The questionnaire form elicited items on socio-demographic and occupational characteristics and personal opinions and experience on COVID-19 outbreak and related protective strategies, along with survey scales including Knowledge on COVID-19 Outbreak Scale (KCS), Knowledge on Protective Strategies for COVID-19 Scale (KPSCS), General Preventive Practices for COVID-19 Scale (GPPCS), Emotional State Scale (ESS) and Fear of COVID-19 Scale (FCS).
   Results: Males had lower ESS (p = 0.004) scores and higher FCS (p = 0.026) scores than females. Having a COVID-19 training (63.4 %) was associated with higher KCS (p = 0.006) and PSCS (p < 0.001) scores, while higher KCS was also related with higher PSCS (p < 0.001) and GPPCS (p < 0.0001) and lower ESS (p = 0.004) scores. Those who had knowledge on the facility safety (56.6 %) and risk management (59.2 %) plans had higher scores on KCS, PSCS, GPPCS and FCS, while had lower scores on ESS (p < 0.05 for each).
   Conclusions: Our findings revealed association of female gender, co-morbid psychiatric disease, lack of training unawareness of safety and risk management plans, lack of experience in COVID-19 imaging and high workload with higher risk of poor emotional state and/or intense fear of the disease among radiology technicians during pandemic.
C1 [Akyurt, Nuran] Marmara Univ, Dept Med Imaging Tech, Vocat Sch Hlth Serv, Ozcan Sabanci Binasi,Kartal Yerleskesi, TR-34865 Istanbul, Turkey.
RP Akyurt, N (corresponding author), Marmara Univ, Dept Med Imaging Tech, Vocat Sch Hlth Serv, Ozcan Sabanci Binasi,Kartal Yerleskesi, TR-34865 Istanbul, Turkey.
EM nakyurt@marmara.edu.tr
CR Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   An P, 2020, DIAGN INTERV RADIOL, V26, P200, DOI 10.5152/dir.2020.20167
   [Anonymous], 2020, ISRRT RESPONSE DOCUM
   [Anonymous], 2020, CORONAVIRUS DIS COVI
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004
   Bernier MO, 2018, OCCUP ENVIRON MED, V75, P553, DOI 10.1136/oemed-2017-104559
   Bostan S, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7944
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chandy PE, 2020, DIAGN INTERV RADIOL, V26, P236, DOI 10.5152/dir.2020.20166
   Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049
   Demirbilek Y, 2020, TURK J MED SCI, V50, P489, DOI 10.3906/sag-2004-187
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703
   Hidiroglu S, 2010, VACCINE, V28, P8120, DOI 10.1016/j.vaccine.2010.09.104
   Huang L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925669
   Inui Shohei, 2020, Radiol Cardiothorac Imaging, V2, pe200110, DOI 10.1148/ryct.2020200110
   Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
   Kooraki S, 2020, J AM COLL RADIOL, V17, P447, DOI 10.1016/j.jacr.2020.02.008
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Mojiri M., 2011, J PARAMED SCI, V2, P2
   Mossa-Basha M, 2020, RADIOLOGY, V296, pE106, DOI 10.1148/radiol.2020200988
   Ozkan S, 2016, J ACAD RES MED, V6, P162, DOI 10.5152/jarem.2016.1056
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Petersen E, 2020, TURK J MED SCI, V50, P509, DOI 10.3906/sag-2003-260
   Rubin GJ, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m313
   Shah K, 2020, CUREUS, V12, DOI 10.7759/cureus.7538
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Stergachis A, 2011, DISASTER MED PUBLIC, V5, P300, DOI 10.1001/dmp.2011.77
   Szarmacha A, 2015, POL J RADIOL, V80, P57, DOI 10.12659/PJR.892758
   Tao M., 1994, CHIN J NERV MENT DIS, V5, P301
   Team TNCPERE, 2020, EP CHAR OUTBR 2019 N
   Turkish Society of Radiology, 2012, MRI CT ASS STAND
   Turkish Society of Radiology, 2007, THOR CT ASS
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459
   WHO, 2020, WHO CHARACTERIZES CO
   WHO, 2010, WHAT IS PAND
   Wong TW, 2005, EUR J EMERG MED, V12, P13, DOI 10.1097/00063110-200502000-00005
   Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504
   Yoon SH, 2020, KOREAN J RADIOL, V21, P494, DOI 10.3348/kjr.2020.0132
   Zhang SX, 2020, BRAIN BEHAV IMMUN, V87, P144, DOI 10.1016/j.bbi.2020.05.010
   Zhu J, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00206
   ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371
NR 45
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0720-048X
EI 1872-7727
J9 EUR J RADIOL
JI Eur. J. Radiol.
PD JAN
PY 2021
VL 134
AR 109431
DI 10.1016/j.ejrad.2020.109431
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA PR8TJ
UT WOS:000607504800012
PM 33259991
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Leoni, G
   Lai, A
   Stacchezzini, R
   Steccolini, I
   Brammer, S
   Linnenluecke, M
   Demirag, I
AF Leoni, Giulia
   Lai, Alessandro
   Stacchezzini, Riccardo
   Steccolini, Ileana
   Brammer, Stephen
   Linnenluecke, Martina
   Demirag, Istemi
TI Accounting, management and accountability in times of crisis: lessons
   from the COVID-19 pandemic
SO ACCOUNTING AUDITING & ACCOUNTABILITY JOURNAL
LA English
DT Article
DE COVID-19; Emergency; Crisis; Accounting; Accountability; Management
ID GENDER; AUSTERITY; SYSTEMS
AB Purpose The purpose of this paper is to discuss the themes emerging from the first studies exploring accounting, accountability and management practices during the COVID-19 pandemic and coming from a diversity of experiences, across countries, organizations and individuals. In so doing, the paper gives an overview of the most recent findings about the role of accounting and accountability in times of crisis that are hosted in this special issue of Accounting, Auditing and Accountability Journal (AAAJ). Design/methodology/approach The paper draws together and identifies emerging themes related to the current COVID-19 pandemic and its impacts on accounting, accountability and management practices and considers how the studies in this issue extend one's knowledge of accounting and contribute to accounting research. Findings Three emerging themes are drawn and their contribution to accounting scholarship is discussed. The first theme deals with the role of accounting and numbers in supporting governmental responses to COVID-19. The second theme considers accounting practices used to make exceptional decisions at the organizational level in times of crisis. The third theme addresses a relevant frontier of research into accounting and inequalities. Practical implications In considering the diverse contributions of this special issue, the paper points out how uncertainty and change can impact the design, use and understanding of accounting, management and accountability practices and can be accepted by scholars and practitioners as part of such practices. Originality/value This paper provides a timely and comprehensive picture of the first reflections and research findings on the impacts of the COVID-19 pandemic on one's interpretation of accounting, accountability and management practices.
C1 [Leoni, Giulia] Univ Genoa, Dept Econ & Management Studies, Genoa, Italy.
   [Lai, Alessandro; Stacchezzini, Riccardo] Univ Verona, Dept Business Adm, Verona, Italy.
   [Steccolini, Ileana] Univ Essex, Essex Business Sch, Colchester, Essex, England.
   [Brammer, Stephen] Univ Bath, Sch Management, Bath, Avon, England.
   [Linnenluecke, Martina] Macquarie Univ, Ctr Corp Sustainabil & Environm Finance, Sydney, NSW, Australia.
   [Demirag, Istemi] Tallinn Univ Technol, Dept Business Adm, Tallinn, Estonia.
RP Leoni, G (corresponding author), Univ Genoa, Dept Econ & Management Studies, Genoa, Italy.
EM giulia.leoni@unige.it; alessandro.lai@univr.it;
   riccardo.stacchezzini@univr.it; ileana.steccolini@essex.ac.uk;
   mnssjab@bath.ac.uk; martina.linnenluecke@mq.edu.au;
   istemi.demirag@taltech.ee
RI Demirag, Istemi/AAG-8021-2019; Brammer, Stephen/ABE-2187-2021; Leoni,
   Giulia/J-4601-2017; Linnenluecke, Martina/J-7237-2013
OI Demirag, Istemi/0000-0003-0116-1829; Brammer,
   Stephen/0000-0003-1424-0008; Leoni, Giulia/0000-0002-1132-0523;
   Stacchezzini, Riccardo/0000-0002-2938-4656; Linnenluecke,
   Martina/0000-0001-7984-9717; LAI, Alessandro/0000-0002-8070-5953;
   Steccolini, Ileana/0000-0003-4346-2742
CR Adhikari, 2019, CRIT PERSPECT ACCOUN, V72, P1
   Ahmad S, 2021, ACCOUNT AUDIT ACCOUN, V34, P1362, DOI 10.1108/AAAJ-08-2020-4863
   Ahn PD, 2021, ACCOUNT AUDIT ACCOUN, V34, P1320, DOI 10.1108/AAAJ-08-2020-4829
   Al Mahameed M, 2021, ACCOUNT AUDIT ACCOUN, V34, P1080, DOI 10.1108/AAAJ-08-2019-4129
   Andrew J, 2021, ACCOUNT AUDIT ACCOUN, V34, P1471, DOI 10.1108/AAAJ-07-2020-4688
   Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401
   Barbera C, 2020, ACCOUNT AUDIT ACCOUN, V33, P529, DOI 10.1108/AAAJ-11-2018-3739
   Barbera C, 2017, PUBLIC ADMIN, V95, P670, DOI 10.1111/padm.12350
   Bebbington J, 2018, ACCOUNT AUDIT ACCOUN, V31, P2, DOI 10.1108/AAAJ-05-2017-2929
   Bebbington J, 2017, CRIT PERSPECT ACCOUN, V48, P21, DOI 10.1016/j.cpa.2017.06.002
   Blundell R, 2020, FISC STUD, V41, P291, DOI 10.1111/1475-5890.12232
   Board GPM., 2019, WORLD RISK ANN REPOR
   Boin A., 2016, POLITICS CRISIS MANA
   Bracci E, 2015, ACCOUNT AUDIT ACCOUN, V28, P878, DOI 10.1108/AAAJ-06-2015-2090
   Brammer S, 2020, ACAD MANAGE PERSPECT, V34, P493, DOI 10.5465/amp.2019.0053
   Brammer S, 2019, AUST J MANAGE, V44, P517, DOI 10.1177/0312896219871337
   Bryer AR, 2014, CRIT PERSPECT ACCOUN, V25, P93, DOI 10.1016/j.cpa.2011.09.001
   Burchell G., 1991, DISCIPLINE PUNISH BI
   Capelo M, 2019, COMPUTIS, V16, P42, DOI 10.26784/issn.1886-1881.v16i2.354
   Catchpowle L, 2016, ACCOUNT FORUM, V40, P220, DOI 10.1016/j.accfor.2016.05.001
   Chabrak N, 2015, CRIT PERSPECT ACCOUN, V30, P1, DOI 10.1016/j.cpa.2015.01.002
   Chenhall RH, 2003, ACCOUNT ORG SOC, V28, P127, DOI 10.1016/S0361-3682(01)00027-7
   Christ KL, 2021, ACCOUNT AUDIT ACCOUN, V34, P1484, DOI 10.1108/AAAJ-08-2020-4726
   Chung J, 2018, ACCOUNT PERSPECT, V17, P207, DOI 10.1111/1911-3838.12171
   Cortese C, 2021, ACCOUNTING AUDITING, V34
   Court CD, 2021, INT REV APPL ECON, V35, P813, DOI 10.1080/02692171.2021.1912716
   Delfino GF, 2021, ACCOUNT AUDIT ACCOUN, V34, P1376, DOI 10.1108/AAAJ-06-2020-4657
   Dumay J, 2020, CRIT PERSPECT ACCOUN, V70, DOI 10.1016/j.cpa.2020.102185
   Ferry L, 2021, ACCOUNTING AUDITING, V34
   Fisher AN, 2021, GROUP PROCESS INTERG, V24, P237, DOI 10.1177/1368430220984248
   Gallhofer S, 1997, CRIT PERSPECT, V8, P71, DOI DOI 10.1006/CPAC.1996.0087
   Gendron Y, 2018, CRIT PERSPECT ACCOUN, V50, P1, DOI 10.1016/j.cpa.2017.11.001
   Head BW, 2019, POLICY SOC, V38, P180, DOI 10.1080/14494035.2018.1488797
   Hodges R, 2016, FINANC ACCOUNT MANAG, V32, P265, DOI 10.1111/faam.12096
   Huber C, 2021, ACCOUNT AUDIT ACCOUN, V34, P1445, DOI 10.1108/AAAJ-08-2020-4882
   Jacobs K, 2014, ACCOUNT AUDIT ACCOUN, V27, P1250, DOI 10.1108/AAAJ-06-2014-1732
   Johns Hopkins University & Medicine, 2020, COR RES CTR
   Lai A, 2021, MEDITARI ACCOUNT RES, V29, P405, DOI 10.1108/MEDAR-02-2021-1199
   Lai A, 2014, CRIT PERSPECT ACCOUN, V25, P579, DOI 10.1016/j.cpa.2014.04.002
   Lehman C, 2012, ACCOUNT AUDIT ACCOUN, V25, P256, DOI 10.1108/09513571211198764
   Leider JP, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2017.303882
   Linnenluecke MK, 2017, INT J MANAG REV, V19, P4, DOI 10.1111/ijmr.12076
   Marx U, 2019, GENDER WORK ORGAN, V26, P1176, DOI 10.1111/gwao.12307
   Merchant K.A., 2012, MANAGEMENT CONTROL S
   Michael Ryan J., 2020, COVID 19 GLOBAL PAND, V1st, P109
   Mitchell F, 2021, ACCOUNT AUDIT ACCOUN, V34, P1345, DOI 10.1108/AAAJ-08-2020-4778
   Molinari M, 2021, ACCOUNT AUDIT ACCOUN, V34
   Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4
   Newberry S, 2020, FINANC ACCOUNT MANAG, V36, P189, DOI 10.1111/faam.12232
   Passetti E, 2021, ACCOUNT AUDIT ACCOUN, V34, P1430, DOI 10.1108/AAAJ-08-2020-4839
   Perkiss S, 2020, CRIT PERSPECT ACCOUN, V67-68, DOI 10.1016/j.cpa.2017.11.002
   Rouleau L, 2021, J MANAGE STUD, V58, P243, DOI 10.1111/joms.12649
   Sargiacomo M, 2021, ACCOUNT AUDIT ACCOUN, V34, P1457, DOI 10.1108/AAAJ-09-2020-4926
   Sargiacomo M, 2015, ACCOUNT ORG SOC, V42, P67, DOI 10.1016/j.aos.2015.02.001
   Sargiacomo M, 2014, CRIT PERSPECT ACCOUN, V25, P652, DOI 10.1016/j.cpa.2014.03.011
   Sargiacomo M, 2014, CRIT PERSPECT ACCOUN, V25, P576, DOI 10.1016/j.cpa.2014.09.009
   Sciulli N, 2018, FINANC ACCOUNT MANAG, V34, P30, DOI 10.1111/faam.12134
   Steccolini I, 2019, ACCOUNT AUDIT ACCOUN, V32, P255, DOI 10.1108/AAAJ-03-2018-3423
   Tekin E., 2021, J BUDGETING ACCOUNTI, V32, P889
   Thamber P, 2021, ACCOUNT AUDIT ACCOUN, V34
   Thomasson A, 2020, FINANC ACCOUNT MANAG, V36, P113, DOI 10.1111/faam.12246
   Tweedie D, 2019, ACCOUNT AUDIT ACCOUN, V32, P1982, DOI 10.1108/AAAJ-09-2018-3649
   Velayutham A, 2021, ACCOUNT AUDIT ACCOUN, V34, P1404, DOI 10.1108/AAAJ-08-2020-4800
   Walker SP, 2014, CRIT PERSPECT ACCOUN, V25, P604, DOI 10.1016/j.cpa.2013.06.005
   Wilson DC, 2010, ACCOUNT AUDIT ACCOUN, V23, P699, DOI 10.1108/09513571011054945
NR 65
TC 7
Z9 7
U1 9
U2 17
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0951-3574
EI 1758-4205
J9 ACCOUNT AUDIT ACCOUN
JI Account . Audit Account.
PD JUL 23
PY 2021
VL 34
IS 6
SI SI
BP 1305
EP 1319
DI 10.1108/AAAJ-05-2021-5279
EA JUL 2021
PG 15
WC Business, Finance
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA TP4DD
UT WOS:000674303300001
OA Green Submitted, Green Accepted, hybrid
DA 2022-04-20
ER

PT J
AU Zarkesh, K
   Entezar-Almahdi, E
   Ghasemiyeh, P
   Akbarian, M
   Bahmani, M
   Roudaki, S
   Fazlinejad, R
   Mohammadi-Samani, S
   Firouzabadi, N
   Hosseini, M
   Farjadian, F
AF Zarkesh, Khatereh
   Entezar-Almahdi, Elaheh
   Ghasemiyeh, Parisa
   Akbarian, Mohsen
   Bahmani, Marzieh
   Roudaki, Shahrzad
   Fazlinejad, Rahil
   Mohammadi-Samani, Soliman
   Firouzabadi, Negar
   Hosseini, Majid
   Farjadian, Fatemeh
TI Drug-based therapeutic strategies for COVID-19-infected patients and
   their challenges
SO FUTURE MICROBIOLOGY
LA English
DT Review
DE antibiotics; antimalarial; antiparasitic; corticosteroids; COVID-19;
   immunomodulatory drugs; immunosuppressants; therapeutic drugs
ID RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; INDUCED PULMONARY
   INJURY; CORONAVIRUS DISEASE 2019; CHRONIC HEPATITIS-B; STEM-CELL
   THERAPY; COVID-19 PNEUMONIA; THROMBUS FORMATION; ANTIVIRAL ACTIVITY;
   N-ACETYLCYSTEINE
AB Emerging epidemic-prone diseases have introduced numerous health and economic challenges in recent years. Given current knowledge of COVID-19, herd immunity through vaccines alone is unlikely. In addition, vaccination of the global population is an ongoing challenge. Besides, the questions regarding the prevalence and the timing of immunization are still under investigation. Therefore, medical treatment remains essential in the management of COVID-19. Herein, recent advances from beginning observations of COVID-19 outbreak to an understanding of the essential factors contributing to the spread and transmission of COVID-19 and its treatment are reviewed. Furthermore, an in-depth discussion on the epidemiological aspects, clinical symptoms and most efficient medical treatment strategies to mitigate the mortality and spread rates of COVID-19 is presented.
C1 [Zarkesh, Khatereh; Entezar-Almahdi, Elaheh; Ghasemiyeh, Parisa; Akbarian, Mohsen; Bahmani, Marzieh; Roudaki, Shahrzad; Mohammadi-Samani, Soliman; Farjadian, Fatemeh] Shiraz Univ Med Sci, Pharmaceut Sci Res Ctr, Shiraz, Iran.
   [Zarkesh, Khatereh; Entezar-Almahdi, Elaheh; Mohammadi-Samani, Soliman] Shiraz Univ Med Sci, Sch Pharm, Dept Pharmaceut, Shiraz, Iran.
   [Ghasemiyeh, Parisa] Shiraz Univ Med Sci, Sch Pharm, Dept Clin Pharm, Shiraz, Iran.
   [Fazlinejad, Rahil; Firouzabadi, Negar] Shiraz Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Shiraz, Iran.
   [Hosseini, Majid] Univ Texas Rio Grande Valley, Dept Mfg & Ind Engn, Edinburg, TX 78539 USA.
RP Mohammadi-Samani, S; Farjadian, F (corresponding author), Shiraz Univ Med Sci, Pharmaceut Sci Res Ctr, Shiraz, Iran.; Mohammadi-Samani, S (corresponding author), Shiraz Univ Med Sci, Sch Pharm, Dept Pharmaceut, Shiraz, Iran.; Firouzabadi, N (corresponding author), Shiraz Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Shiraz, Iran.; Hosseini, M (corresponding author), Univ Texas Rio Grande Valley, Dept Mfg & Ind Engn, Edinburg, TX 78539 USA.
EM smsamani@sums.ac.ir; Firouzabadi@sums.ac.ir; majid.hosseini01@utrgv.edu;
   farjadian_f@sums.ac.ir
OI Akbarian, Mohsen/0000-0002-2684-1727; Hosseini,
   Majid/0000-0002-7563-6092
FU Research Council of Shiraz University under COVID-19 special projects
   [98-01-10622079]
FX This work was supported by the Research Council of Shiraz University
   under COVID-19 special projects, grant no. 98-01-10622079. The authors
   have no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Abdolahi N, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04499-5
   Abobaker A, 2020, EUR J CLIN PHARMACOL, V76, P1619, DOI 10.1007/s00228-020-02942-9
   Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Ahmadi S, 2020, NANO TODAY, V34, DOI 10.1016/j.nantod.2020.100914
   Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117
   Akbarian M, 2020, CHEM COMMUN, V56, P11354, DOI 10.1039/d0cc05171c
   Ali, 2020, THROMB HAEMOST RES, V4, P1042
   Almeida MQ, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2022
   Alzghari SK, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104380
   Amirshahrokhi K, 2013, INT IMMUNOPHARMACOL, V17, P210, DOI 10.1016/j.intimp.2013.06.005
   Anderson VR, 2007, DRUGS, V67, P1947, DOI 10.2165/00003495-200767130-00015
   Andreani J, 2020, MICROB PATHOGENESIS, V145, DOI 10.1016/j.micpath.2020.104228
   Aouba A, 2020, ANN RHEUM DIS, V79, P1381, DOI 10.1136/annrheumdis-2020-217706
   Arrieta O, 2006, CANCER-AM CANCER SOC, V107, P1852, DOI 10.1002/cncr.22198
   Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099
   Aslamkhan AG, 2003, MOL PHARMACOL, V63, P590, DOI 10.1124/mol.63.3.590
   Bagheri A, 2021, INT IMMUNOPHARMACOL, V91, DOI 10.1016/j.intimp.2020.107245
   Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bavinger JC, 2020, CURR OPIN OPHTHALMOL, V31, P416, DOI 10.1097/ICU.0000000000000683
   Becatti M, 2016, CIRCULATION, V133, P302, DOI 10.1161/CIRCULATIONAHA.115.017738
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Berk M, 2013, TRENDS PHARMACOL SCI, V34, P167, DOI 10.1016/j.tips.2013.01.001
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Billah MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242128
   Bonaventura A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01625
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   BOSEM ME, 1990, INVEST OPHTH VIS SCI, V31, P1683
   Boulis NM, 2003, NEUROSURGERY, V52, P381, DOI 10.1227/01.NEU.0000044459.24519.3E
   Bramante CT, 2021, LANCET HEALTH LONGEV, V2, pE34, DOI 10.1016/S2666-7568(20)30033-7
   BROGAN TD, 1974, BRIT J DIS CHEST, V68, P28, DOI 10.1016/S0007-0971(74)80032-X
   Brotons C, 2015, AM J CARDIOVASC DRUG, V15, P113, DOI 10.1007/s40256-014-0100-5
   BUNN PA, 1986, CANCER, V57, P1689, DOI 10.1002/1097-0142(19860415)57:8+<1689::AID-CNCR2820571311>3.0.CO;2-M
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa102
   Capuano A., 2020, PHARM ADV, V02, DOI [10.36118/pharmadvances.01.2020.03, DOI 10.36118/PHARMADVANCES.01.2020.03]
   Carr AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02851-4
   Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097
   Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2
   Chen SJ, 2021, J THROMB THROMBOLYS, V51, P33, DOI 10.1007/s11239-020-02181-w
   Chen X, 2020, J INFECTION, V81, P652, DOI 10.1016/j.jinf.2020.05.020
   Cheng Richard Z, 2020, Med Drug Discov, V5, P100028, DOI 10.1016/j.medidd.2020.100028
   CHRISTEN.F, 1970, BRIT MED J, V4, P117, DOI 10.1136/bmj.4.5727.117-a
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Colafrancesco S, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102573
   Biancatelli RMLC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01451
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Corbett AH, 2002, ANN PHARMACOTHER, V36, P1193
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   COVID-19 Treatment Guidelines Panel, 2021, COR DIS 2019 COVID 1
   Crisafulli S, 2020, BIODRUGS, V34, P415, DOI 10.1007/s40259-020-00430-1
   Crotti C, 2019, DRUGS, V79, P1741, DOI 10.1007/s40265-019-01192-z
   Cure MC, 2020, CLIN RHEUMATOL, V39, P2101, DOI 10.1007/s10067-020-05144-x
   Cvetkovic RS, 2003, DRUGS, V63, P769, DOI 10.2165/00003495-200363080-00004
   Dalamaga M, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154260
   Damle B, 2020, CLIN PHARMACOL THER, V108, P201, DOI 10.1002/cpt.1857
   Dastan F, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106688
   Dastan F, 2020, IRAN J PHARM RES, V19, P1, DOI [10.22037/IJPR.2020.113369.14259, 10.22037/ijpr.2020.113369.14259]
   Davies Jonathan T, 2016, Lipid Insights, V9, P13
   De Flora S, 2020, FASEB J, V34, P13185, DOI 10.1096/fj.202001807
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Della-Torre E, 2020, ANN RHEUM DIS, V79, P1277, DOI [10.1136/annrheumdis-2020-218122, 10.1136/annrheumdis-2020-218724, 10.1136/annrheumdis-2020-218759]
   Demelo-Rodriguez P, 2020, THROMB RES, V192, P23, DOI 10.1016/j.thromres.2020.05.018
   Deretic V, 2019, EXPERT OPIN DRUG MET, V15, P213, DOI 10.1080/17425255.2019.1578748
   Di Tano Giuseppe, 2020, Eur J Case Rep Intern Med, V7, P001790, DOI 10.12890/2020_001790
   Diaz-Guimaraens B, 2020, JAMA DERMATOL, V156, P820, DOI 10.1001/jamadermatol.2020.1741
   Dilly S, 2018, J MED CHEM, V61, P7202, DOI 10.1021/acs.jmedchem.8b00557
   Dong XY, 2017, INFLAMMATION, V40, P1836, DOI 10.1007/s10753-017-0625-2
   Drewe J, 1999, BIOCHEM PHARMACOL, V57, P1147, DOI 10.1016/S0006-2952(99)00026-X
   Du YX, 2020, CLIN PHARMACOL THER, V108, P242, DOI 10.1002/cpt.1844
   Eisenhut M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00872
   EL-Arabey AA, 2020, J MED VIROL, V92, P2293, DOI 10.1002/jmv.25958
   Ellis LM, 2006, SEMIN ONCOL, V33, pS1, DOI 10.1053/j.seminoncol.2006.08.002
   Entezar-Almahdi E, 2020, INT J NANOMED, V15, P5445, DOI 10.2147/IJN.S257700
   Erlich JM, 2011, CHEST, V139, P289, DOI 10.1378/chest.10-0891
   Esam Z, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108282
   Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Farjadian F, 2019, CHEM ENG J, V359, P684, DOI 10.1016/j.cej.2018.11.156
   Farjadian F, 2019, NANOMEDICINE-UK, V14, P93, DOI 10.2217/nnm-2018-0120
   Farjadian F, 2018, BIOTECHNOL ADV, V36, P968, DOI 10.1016/j.biotechadv.2018.02.016
   Filatov A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7352
   Floreani A, 1998, ALIMENT PHARM THERAP, V12, P653
   Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777
   Fu BQ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02339-3
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   GALLAGHER CH, 1960, BIOCHEM J, V74, P38, DOI 10.1042/bj0740038
   Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gavriilaki E, 2020, BRIT J HAEMATOL, V189, pE227, DOI 10.1111/bjh.16783
   Gharbharan A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23469-2
   Ghasemiyeh Parisa, 2021, Acta Biomed, V92, pe2021250, DOI 10.23750/abm.v92i3.11683
   Ghasemiyeh P, 2020, HEART LUNG, V49, P763, DOI 10.1016/j.hrtlng.2020.08.025
   Ghasemiyeh P, 2020, THER CLIN RISK MANAG, V16, P595, DOI 10.2147/TCRM.S259152
   Giles AJ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0371-5
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Gorham J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244628
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Gulati K, 2016, NUTRACEUTICALS, P75, DOI DOI 10.1016/B978-0-12-802147-7.00006-1
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002401382731
   Halpin DMG, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01009-2020
   Health NIO, 1995, GLOB IN ASTHM GLOB S
   Hegerova L, 2020, BLOOD, V136, P759, DOI 10.1182/blood.2020006964
   Herman SEM, 2017, CLIN CANCER RES, V23, P2831, DOI 10.1158/1078-0432.CCR-16-0463
   Hirsh J, 2001, ARTERIOSCL THROM VAS, V21, P1094, DOI 10.1161/hq0701.093686
   Ho CM, 2004, ANESTH ANALG, V99, P734, DOI 10.1213/01.ANE.0000130003.68288.C7
   Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hosseinzadeh M, 2018, IEEE T SMART GRID, V9, P2809, DOI 10.1109/TSG.2016.2620803
   Hu S, 2013, J BIOL CHEM, V288, P27059, DOI 10.1074/jbc.M113.491530
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Husain A., 2016, ADV BIOMED PHARM, V3, P227, DOI DOI 10.19046/ABP.V03I04.07
   Iba T, 2019, J THROMB HAEMOST, V17, P283, DOI 10.1111/jth.14371
   Iba T, 2018, J THROMB HAEMOST, V16, P231, DOI 10.1111/jth.13911
   Iba Toshiaki, 2015, Intensive Care Med Exp, V3, P36, DOI 10.1186/s40635-015-0072-z
   Ingwersen J, 2012, CLIN IMMUNOL, V142, P15, DOI [10.1016/j.clim.2011.05.005, 10.1016/j.clim.2011.10.008]
   Ip A, 2020, HYPERTENSION RENIN A
   Iqbal Nida, 2014, Chemother Res Pract, V2014, P357027, DOI 10.1155/2014/357027
   Isaac K, 2020, CANCER MANAG RES, V12, P2079, DOI 10.2147/CMAR.S219570
   Isidori AM, 2020, J ENDOCRINOL INVEST, V43, P1141, DOI 10.1007/s40618-020-01266-w
   Iwasaki A, 2021, LANCET INFECT DIS, V21, P3, DOI 10.1016/S1473-3099(20)30783-0
   Jain Siddharth, 2020, Ann Rheum Dis, DOI 10.1136/annrheumdis-2020-218519
   Jakimovski D, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a032003
   Java A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140711
   Ji P, 2020, J CLIN PHARMACOL, V60, P1275, DOI 10.1002/jcph.1729
   Jiang XL, 2015, CLIN PHARMACOKINET, V54, P147, DOI 10.1007/s40262-014-0230-6
   Jodele S, 2021, BRIT J PHARMACOL, V178, P2832, DOI 10.1111/bph.15187
   Johnson RM, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2648
   Kalita P, 2020, MICROB PATHOGENESIS, V145, DOI 10.1016/j.micpath.2020.104236
   Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09
   Kaptein SJF, 2020, P NATL ACAD SCI USA, V117, P26955, DOI 10.1073/pnas.2014441117
   Kaye RJ, 2020, PAIN PHYSICIAN, V23, pS421
   Kelleni MT, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104874
   Khiali S, 2020, J CLIN PHARMACOL, V60, P1131, DOI 10.1002/jcph.1693
   Khorshidi M, 2020, HEART LUNG, V49, P745, DOI 10.1016/j.hrtlng.2020.08.007
   King A, 2020, LANCET RHEUMATOL, V2, pE379, DOI 10.1016/S2665-9913(20)30160-0
   Kor DJ, 2011, CRIT CARE MED, V39, P2393, DOI 10.1097/CCM.0b013e318225757f
   Kordzadeh-Kermani E, 2020, FUTURE MICROBIOL, V15, P1287, DOI 10.2217/fmb-2020-0110
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kuster GM, 2020, EUR HEART J, V41, P1801, DOI 10.1093/eurheartj/ehaa235
   Lang FM, 2020, NAT REV IMMUNOL, V20, P507, DOI 10.1038/s41577-020-0357-7
   Lee JW, 2019, BLOOD, V133, P530, DOI 10.1182/blood-2018-09-876136
   Lee N, 2017, ANTIVIR RES, V144, P48, DOI 10.1016/j.antiviral.2017.05.008
   Lejal N, 2018, BBA-GEN SUBJECTS, V1862, P1263, DOI 10.1016/j.bbagen.2018.03.004
   Lejal N, 2013, ANTIMICROB AGENTS CH, V57, P2231, DOI 10.1128/AAC.02335-12
   Lepist EI, 2012, ANTIMICROB AGENTS CH, V56, P5409, DOI 10.1128/AAC.01089-12
   Leung YY, 2015, SEMIN ARTHRITIS RHEU, V45, P341, DOI 10.1016/j.semarthrit.2015.06.013
   Lian N, 2020, CLIN MICROBIOL INFEC, V26, P917, DOI 10.1016/j.cmi.2020.04.026
   Lim J, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e79
   Lin FC, 2014, CYTOKINE GROWTH F R, V25, P369, DOI 10.1016/j.cytogfr.2014.07.015
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1131, DOI [10.1515/cclm-2020-1761, 10.1515/cclm-2020-0198]
   Lipworth B, 2020, AM J RESP CRIT CARE, V202, P899, DOI 10.1164/rccm.202005-2000LE
   Liu F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039519
   Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0
   Liu J, 2020, RES PRACT THROMB HAE, V4, P518, DOI 10.1002/rth2.12353
   Lundstrom K, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020317
   Luo P, 2020, AM J TROP MED HYG, V103, P69, DOI 10.4269/ajtmh.20-0375
   Maggio R, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104837
   Mahmoud Dina B., 2020, Journal of Genetic Engineering and Biotechnology, V18, P35, DOI 10.1186/s43141-020-00055-5
   Malhotra A, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101425
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Marone EM, 2020, J VASC SURG-VENOUS L, V8, P694, DOI 10.1016/j.jvsv.2020.04.004
   McGee MC, 2021, J LEUKOCYTE BIOL, V109, P49, DOI 10.1002/JLB.5COVR0620-306R
   McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1
   Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mekaj YH, 2015, THER CLIN RISK MANAG, V11, DOI [10.2147/TCRM.S92222, 10.2147/TCRM.S84210]
   Menez C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001883
   Meng FP, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00286-5
   Meo SA, 2020, J KING SAUD UNIV SCI, V32, P2495, DOI 10.1016/j.jksus.2020.04.004
   Metcalfe, 2020, MED DRUG DISCOV, V5, P100019, DOI DOI 10.1016/J.MEDIDD.2020.100019
   Mohamed-Hussein AAR, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109975
   Mohammadi-Samani, 2020, TRENDS PHARMACOL SCI, V6, P65, DOI DOI 10.30476/TIPS.2020.86274.1047
   Moore N, 2020, DRUG SAFETY, V43, P611, DOI 10.1007/s40264-020-00953-0
   Morales-Ortega A, 2020, CLIN IMMUNOL, V218, DOI 10.1016/j.clim.2020.108518
   Mubarak A, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/6491738
   Mullally A, 2020, BLOOD ADV, V4, P1792, DOI 10.1182/bloodadvances.2019000954
   Nasi A, 2020, TOXICOL REP, V7, P768, DOI 10.1016/j.toxrep.2020.06.003
   Nouchi A, 2018, ACTA DERM-VENEREOL, V98, P134, DOI 10.2340/00015555-2761
   O'Neal HR, 2011, CRIT CARE MED, V39, P1343, DOI 10.1097/CCM.0b013e3182120992
   Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014
   Olszewska-Parasiewicz J, 2021, LIFE-BASEL, V11, DOI 10.3390/life11060565
   Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005
   Owji H, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106924
   Padhi AK, 2021, BIOCHEM BIOPH RES CO, V555, P147, DOI 10.1016/j.bbrc.2021.03.118
   Padhi AK, 2021, EUR J PHARMACOL, V894, DOI 10.1016/j.ejphar.2020.173836
   Padhi AK, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101992
   Padhi AK, 2020, ACS PHARMACOL TRANSL, V3, P1023, DOI 10.1021/acsptsci.0c00113
   Padmanabhan S, 2020, TRIALS, V21, P1
   Pannucci CJ, 2018, ANN THORAC SURG, V106, P404, DOI 10.1016/j.athoracsur.2018.02.085
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardo Joe, 2020, Drugs Context, V9, DOI 10.7573/dic.2020-4-14
   Patri A, 2020, J AM ACAD DERMATOL, V82, pE221, DOI 10.1016/j.jaad.2020.04.017
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Peng HB, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01802-8
   Perez-Olmeda M, 2003, AIDS, V17, P1023, DOI 10.1097/00002030-200305020-00011
   Perlis RH., 2020, IDENTIFYING COMMON P
   Perricone C, 2020, IMMUNOL RES, V68, P213, DOI 10.1007/s12026-020-09145-5
   Piantoni S, 2020, CLIN RHEUMATOL, V39, P2489, DOI 10.1007/s10067-020-05232-y
   Plosker GL, 2007, DRUGS, V67, P613, DOI 10.2165/00003495-200767040-00013
   Polonikov A, 2020, ACS INFECT DIS, V6, P1558, DOI 10.1021/acsinfecdis.0c00288
   Pospisilova M, 2001, J PHARMACEUT BIOMED, V24, P421, DOI 10.1016/S0731-7085(00)00448-9
   Prete A, 2020, J CLIN ENDOCR METAB, V105, P2262, DOI 10.1210/clinem/dgaa133
   Proskurnina EV, 2020, MOLECULES, V25, DOI 10.3390/molecules25071577
   Pudrith C, 2010, INT J PEDIATR OTORHI, V74, P1273, DOI 10.1016/j.ijporl.2010.08.003
   QUESADA JR, 1984, NEW ENGL J MED, V310, P15, DOI 10.1056/NEJM198401053100104
   Radford Ian R, 2002, Curr Opin Investig Drugs, V3, P492
   Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854
   Rassy D, 2020, J NEUROPATH EXP NEUR, V79, P226, DOI 10.1093/jnen/nlz128
   Reynolds NA, 2004, DRUGS, V64, P431, DOI 10.2165/00003495-200464040-00006
   Rizk JG, 2020, DRUGS, V80, P1267, DOI 10.1007/s40265-020-01367-z
   Rizzo AN, 2015, AM J PHYSIOL-LUNG C, V309, pL1294, DOI 10.1152/ajplung.00031.2015
   Roback JD, 2020, JAMA-J AM MED ASSOC, V323, P1561, DOI 10.1001/jama.2020.4940
   Rochwerg B, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2924
   Rodrigues-Diez RR, 2020, BRIT J PHARMACOL, V177, P4873, DOI 10.1111/bph.15166
   Rojas M, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102554
   Roschewski M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd0110
   Rossingol JF, 2016, J INFECT PUBLIC HEAL, V9, P227, DOI 10.1016/j.jiph.2016.04.001
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Roychoudhury S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249411
   Sallard E, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104791
   Samaee H, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107018
   Samama MM, 2011, THROMB RES, V127, P497, DOI 10.1016/j.thromres.2010.09.008
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Sayad B, 2020, ARCH MED RES, V51, P577, DOI 10.1016/j.arcmed.2020.04.018
   Scavone C, 2020, BRIT J PHARMACOL, V177, P4813, DOI 10.1111/bph.15072
   Scheen AJ, 2020, DIABETES METAB, V46, P423, DOI 10.1016/j.diabet.2020.07.006
   Scott LJ, 2017, DRUGS, V77, P705, DOI 10.1007/s40265-017-0724-2
   Sebba A, 2008, AM J HEALTH-SYST PH, V65, P1413, DOI 10.2146/ajhp070449
   Shao ZY, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1192
   Sharma S, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108183
   Shetty AK, 2020, AGING DIS, V11, P462, DOI 10.14336/AD.2020.0301
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Simsek Yavuz S, 2020, TURK J MED SCI, V50, P611, DOI 10.3906/sag-2004-145
   Singh AK, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108268
   Smith K, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04548-z
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Sokal EM, 1998, GASTROENTEROLOGY, V114, P988, DOI 10.1016/S0016-5085(98)70318-X
   Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665
   Subramaniam S, 2017, BLOOD, V129, P2291, DOI 10.1182/blood-2016-11-749879
   Sultana J, 2020, DRUG SAFETY, V43, P691, DOI 10.1007/s40264-020-00976-7
   Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402
   Talpaz M, 2021, LEUKEMIA, V35, P1, DOI 10.1038/s41375-020-0954-2
   Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090
   Tardif JC, 2019, NEW ENGL J MED, V381, P2497, DOI 10.1056/NEJMoa1912388
   Tarus B, 2015, J BIOMOL STRUCT DYN, V33, P1899, DOI 10.1080/07391102.2014.979230
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Temesgen Z, 2020, MAYO CLIN PROC, V95, P2382, DOI 10.1016/j.mayocp.2020.08.038
   Terrier O, BROAD SPECTRUM ANTIV, DOI [10.1101/2020.04.30.069922, DOI 10.1101/2020.04.30.069922]
   Thachil J, 2020, J THROMB HAEMOST, V18, P1020, DOI 10.1111/jth.14821
   The World Health Organization, 2021, COVID 19 VACC
   Theoharides TC, 2020, J BIOL REG HOMEOS AG, V34, P1241, DOI 10.23812/20-EDITORIAL_1-5
   Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7
   Toniati P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102568
   Trifiro G, 2020, DRUG SAFETY, V43, P507, DOI 10.1007/s40264-020-00935-2
   Tripathi, 2013, ESSENTIALS MED PHARM
   Tripathi T., 2021, STRUCTURAL PROTEOMIC, DOI [10.1002/1873-3468.14182, DOI 10.1002/1873-3468.14182]
   Tu YF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072657
   Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2
   Tursi A, 2020, GUT, V69, P1364, DOI 10.1136/gutjnl-2020-321240
   Ursini F, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108167
   Vankadari N, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105998
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Viecca M, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104950
   Villalain J, 2010, J PHYS CHEM B, V114, P8544, DOI 10.1021/jp102619w
   Rosa SGV, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.40
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang DD, 2020, INT J PHARMACEUT, V585, DOI 10.1016/j.ijpharm.2020.119456
   [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wheatley K, 2007, J CLIN ONCOL, V25, P4693, DOI 10.1200/JCO.2007.13.3389
   Wu M, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106873
   Wu P, 2020, JAMA OPHTHALMOL, V138, P575, DOI 10.1001/jamaophthalmol.2020.1291
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Xiao K, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01804-6
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yang MJ, 2019, INFECTION, V47, P377, DOI 10.1007/s15010-018-1229-y
   Yang SNY, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104760
   Yang Y, 2013, PROTEIN CELL, V4, P951, DOI 10.1007/s13238-013-3096-8
   Yu HR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013010
   Zha L, 2020, MED J AUSTRALIA, V212, P416, DOI 10.5694/mja2.50577
   Zhang SY, 2020, CLIN DRUG INVEST, V40, P511, DOI 10.1007/s40261-020-00917-3
   Zhu HY, 2014, INFLAMMATION, V37, P2091, DOI 10.1007/s10753-014-9943-9
   Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060
   Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490
NR 299
TC 1
Z9 1
U1 5
U2 5
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD DEC
PY 2021
VL 16
IS 18
BP 1415
EP 1451
DI 10.2217/fmb-2021-0116
EA NOV 2021
PG 37
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA XD4BE
UT WOS:000721364100001
PM 34812049
OA Green Submitted, Green Published
DA 2022-04-20
ER

PT J
AU Santo, PMD
   Cardoso, PMA
   Marques, AMA
AF do Espirito Santo, Pedro Manuel
   Azinheira Cardoso, Patricia Milene
   Ascensao Marques, Alzira Maria
TI Effects of E-Business Adoption on Organizational Agility in the COVID-19
   Context
SO INTERNATIONAL JOURNAL OF MARKETING COMMUNICATION AND NEW MEDIA
LA Portuguese
DT Article
DE E-business; Organizational Agility; Knowledge Management; COVID-19
ID KNOWLEDGE; FIRMS
AB The COVID-19 pandemic caused a confinement in world society that had no memory of such an event. This event caused the associations to accelerate the online transaction processes, so the continuity of the companies depended on the adoption of e-business systems, which resulted in greater flexibility and agility in the business. Digital transformation and organizational agility are two concepts present in the current COVID-19 context and the adoption of e-business systems depends on the human knowledge existing in the associations. In this context, we developed a study that aimed to study the effects of adopting e-business systems on business agility. For this, we identified that knowledge management is a basis for companies to implement e-business systems. Thus, we carried out an investigation that, through PLS estimation, found that business agility depends on the adoption of e-business systems in a pandemic context such as the case of COVID-19. In this sense, we present theoretical and practical statements of this study.
C1 [do Espirito Santo, Pedro Manuel] Inst Politecn Coimbra, ESTGOH, Coimbra, Portugal.
   [Azinheira Cardoso, Patricia Milene] Inst Politecn Coimbra, ESEC, Coimbra, Portugal.
   [Ascensao Marques, Alzira Maria] Inst Politecn Leiria, CARME, Escola Super Tecnol & Gestao, Leiria, Portugal.
RP Santo, PMD (corresponding author), Inst Politecn Coimbra, ESTGOH, Coimbra, Portugal.
EM pedro.santo@estgoh.ipc.pt; patricia.milene.cardoso@gmail.com;
   alzira.marques@ipleiria.pt
CR Al-Omoush KS, 2020, J INNOV KNOWL, V5, P279, DOI 10.1016/j.jik.2020.10.002
   Augusto L., 2020, REV IBERICA SISTEMAS, P557
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Cabrera A, 2002, ORGAN STUD, V23, P687, DOI 10.1177/0170840602235001
   Carneiro A., 2000, J KNOWLEDGE MANAGEME, V4, P87, DOI [10.1108/13673270010372242, DOI 10.1108/13673270010372242]
   Cegarra-Navarro JG, 2007, INT J MANPOWER, V28, P298, DOI 10.1108/01437720710755263
   Chaffey D., 2019, DIGITAL BUSINESS E C
   Chin WW, 1998, QUANT METH SER, P295
   Santo PMD, 2019, PROC EUR CONF KNOWL, P312, DOI 10.34190/KM.19.142
   Ferreira V., 2015, MEDIATOR ROLE LEADER
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Grimsdottir E, 2018, SAGE OPEN, V8, DOI 10.1177/2158244018807320
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014
   Hsiu-Fen Lin, 2005, Management Decision, V43, P171, DOI 10.1108/00251740510581902
   Kim TT, 2013, INT J HOSP MANAG, V34, P324, DOI 10.1016/j.ijhm.2013.04.009
   Lee Y, 2021, J KNOWL MANAG, V25, P1526, DOI 10.1108/JKM-06-2020-0483
   Lucia-Palacios L, 2014, INTERNET RES, V24, P223, DOI 10.1108/IntR-09-2012-0195
   Luo C, 2021, INFORM PROCESS MANAG, V58, DOI 10.1016/j.ipm.2021.102667
   Nissen V., 2017, MEASURING AGILITY IT
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Pastiu CA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12229780
   Pittino D, 2018, J BUS RES, V84, P312, DOI 10.1016/j.jbusres.2017.08.014
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Ravichandran T, 2018, J STRATEGIC INF SYST, V27, P22, DOI 10.1016/j.jsis.2017.07.002
   Rese A, 2020, J KNOWL MANAG, V24, P2327, DOI 10.1108/JKM-04-2020-0243
   Ringle C.M., 2015, SMART PLS 3
   Roberts N, 2012, J MANAGE INFORM SYST, V28, P231, DOI 10.2753/MIS0742-1222280409
   Santo P. E., 2021, EMPLOYER BRANDING MA
   Santo PE, 2022, BALT J MANAG, V17, P56, DOI 10.1108/BJM-04-2021-0140
   Seethamraju R, 2013, IIMB MANAG REV, V25, P137, DOI 10.1016/j.iimb.2013.05.001
   Singh S, 2021, INT J PROD RES, V59, P1993, DOI 10.1080/00207543.2020.1792000
   Wynn M, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13137356
NR 34
TC 0
Z9 0
U1 0
U2 0
PU INST SUPERIOR ENTRE DOURO & VOUGA
PI SANTA MARIA DA FEIRA
PA RUA ANT CASTRO CORTE REAL, SANTA MARIA DA FEIRA, AVEIRO 4520-909,
   PORTUGAL
SN 2182-9306
J9 INT J MARKET COMMUN
JI Int. J. Market. Commun. New Media
PD JAN
PY 2022
IS 11
SI SI
BP 45
EP 61
DI 10.54663/2182-9306.sn11.45-61
PG 17
WC Communication
WE Emerging Sources Citation Index (ESCI)
SC Communication
GA ZO0UP
UT WOS:000765444300003
DA 2022-04-20
ER

PT J
AU Alwazzan, RA
   Baseer, MA
   ALMugeiren, OM
   Ingle, NA
AF Alwazzan, Rayyan Abdallah
   Baseer, Mohammad A.
   ALMugeiren, Osamah Mohammed
   Ingle, Navin Anand
TI Dental Professional's Knowledge, Preventive Awareness and Attitude
   Towards COVID-19 in Saudi Arabia: A Cross-Sectional Survey
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE attitude; awareness; COVID-19; dental professional; knowledge
ID TRANSMISSION; DENTISTS; AIRBORNE
AB Background: Given the COVID-19 pandemic, it is necessary to assess the dentist's knowledge, preventive awareness, and attitude towards COVID-19 in Saudi Arabia. This study aimed to assess dental professionals' knowledge, preventive awareness, and attitude towards dental care during the COVID-19 pandemic in Saudi Arabia.
   Study Subjects and Methods: The study participants consisted of dental professionals working in government, private and academic sectors in Saudi Arabia. An online questionnaire (Whatsapp and Twitter) was sent to dental professionals in July 2020. The questionnaire consisted of questions on dental professional's demographic variables, their knowledge of the incubation period, the symptoms, mode of transmission, preventive awareness of COVID-19, and their attitude toward treating patients with COVID-19. Mann-Whitney U and Kruskal-Wallis tests were applied to compare mean ranks and a p<0.05 is considered statistically significant.
   Results: This study included a total of 356 dental professionals (dentists and dental students) aged 22-60 years (mean +/- SD, 32.14 +/- 7.48 years). Majority of the participants were graduates/ general practitioners (GP) 145 (40.7%), followed by post graduate (PG) student 108 (30.3%), undergraduate students 23 (6.5%) and specialist 80 (22.5%). Dental professionals showed a high level (>90% correct responses) of knowledge of COVID-19 except for the infection among comorbid patients 283 (79.5%) and incubation period of COVID-19, 164 (46.1%). An overall high knowledge of COVID-19 (87.26%), preventive awareness (88.64%) and a positive attitude (65.26%) towards dental care were observed among the study participants. The mean knowledge ranks differed significantly in different genders (p=0.029) and marital status (p=0.023), whereas preventive awareness differed significantly across various qualifications (p=0.004). The mean attitude rank was significantly higher among Saudi (182.29) compared to non-Saudi (141.36) study participants (p=0.025).
   Conclusion: The dental professionals participated in this study demonstrated adequate knowledge of symptoms, preventive awareness, and a positive attitude towards dental care of the COVID-19 infected patients.
C1 [Alwazzan, Rayyan Abdallah; Baseer, Mohammad A.; ALMugeiren, Osamah Mohammed; Ingle, Navin Anand] Riyadh Elm Univ, Coll Dent, Dept Prevent Dent, Namuthajiya Campus,POB 84891, Riyadh 11681, Saudi Arabia.
RP Baseer, MA (corresponding author), Riyadh Elm Univ, Coll Dent, Dept Prevent Dent, Namuthajiya Campus,POB 84891, Riyadh 11681, Saudi Arabia.
EM ma_baseer@riyadh.edu.sa
RI Abdul, MOhammad/AAL-3769-2021
CR Abolfotouh MA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2096-8
   Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Al Jasser R, 2020, J MULTIDISCIP HEALTH, V13, P1317, DOI [10.2147/JMDH.S267956, 10.2147/JMADH.S267956]
   AlBaker AA, 2017, SAUDI PHARM J, V25, P1208, DOI 10.1016/j.jsps.2017.09.005
   ALBatanouni M., 2020, KNOWLEDGE ATTITUDES
   American Dental Association-ADA. American Dental Association-ADA, 2020, ADA REC DENT POSTP E
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Bahabri RH, 2021, J TAIBAH UNIV MED SC, V16, P456, DOI 10.1016/j.jtumed.2020.12.017
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Beggs C.B., 2020, IS THERE AIRBORNE CO
   Estrich CG, 2020, J AM DENT ASSOC, V151, P815, DOI 10.1016/j.adaj.2020.09.005
   Gaffar BO, 2019, SAUDI MED J, V40, P714, DOI 10.15537/smj.2019.7.24304
   Grayson SA, 2017, PEDIATR PULM, V52, P684, DOI 10.1002/ppul.23630
   Hinds C., 1999, AEROSOL TECHNOLOGY P
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Judson SD, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100940
   Kahwaji, 2020, UNIVERSAL PRECAUTION
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   MOH, 2020, DENT EM PROT COVID 1
   Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x
   Mustafa RM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239016
   Nawabi S, 2020, DENT FACULTYS KNOWLE
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Raoult D, 2020, CELL STRESS, V4, P66, DOI 10.15698/cst2020.04.216
   Sarfaraz S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030232
   Shiu EYC, 2019, CURR OPIN INFECT DIS, V32, P372, DOI 10.1097/QCO.0000000000000563
   Srivastava KC, 2020, J INT MED RES, V48, DOI 10.1177/0300060520977593
   Tarakji B, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010330
NR 31
TC 2
Z9 2
U1 1
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 2277
EP 2288
DI 10.2147/RMHP.S303858
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA SZ4XP
UT WOS:000666570100001
PM 34104018
OA Green Published
DA 2022-04-20
ER

PT J
AU Krithiga, P
   Sudharsana, V
   Sribalaji, R
   Snega, C
AF Krithiga, P.
   Sudharsana, V
   Sribalaji, R.
   Snega, C.
TI COVID 19 PANDEMIC: ASSESSMENT OF KNOWLEDGE AND ATTITUDES IN BIOMEDICAL
   WASTE MANAGEMENT AMONG HEALTH CARE PROFESSIONALS IN TAMIL NADU
SO ASIA PACIFIC JOURNAL OF HEALTH MANAGEMENT
LA English
DT Article
DE Biomedical; Waste Management; awareness; health hazards; COVID 19;
   Pandemic management
AB Coronavirus, which was started provincially at Wuhan of China, has become a worldwide pandemic by affecting individuals of almost all the world. The developing pandemic of COVID-19 disease requires social distancing and individual cleanliness measures to secure general wellbeing. The aim of the present study is to evaluate the knowledge, attitude, practice and awareness of biomedical waste management in this pandemic situation among healthcare workers and medical students across Tamil Nadu.
   A cross sectional questionnaire survey was prepared to evaluate the knowledge regarding waste management and waste handling techniques. The survey found that most of the hospitals (50%) are using plastic containers for waste collection. Almost 79.7% of the respondents said they follow colour coding while disposing waste. When asked about exact category only few gave correct answers. Nearly 72.8% answered that they collect the Covid patient's wastes separately. As coronavirus is a contagious disease, each healthcare worker should be trained in safe handling of wastes. From this survey, it is clear that training about safe handling of waste is needed among workers. This survey will help government and healthcare providers to handle this Covid pandemic successfully and more effectively.
C1 [Krithiga, P.; Sudharsana, V; Sribalaji, R.; Snega, C.] Kongu Engn Coll, SBMS, Dept Civil Engn, Perundurai, Erode, India.
RP Krithiga, P (corresponding author), Kongu Engn Coll, SBMS, Dept Civil Engn, Perundurai, Erode, India.
EM krithipalanisamy@gmail.com
CR Abrol A., 2019, INDIAN J MICROBIOLOG, V6, P92
   Ahuja Aastha, YEARENDER 2020 STEPP
   [Anonymous], EMERGING RESP VIRUSE
   Anurag V., 2013, INT J CURRENT ENG TE, V3, P2030
   Asante B., 2014, INT J SCI TECHNOLOGY, V3
   Bazrafshan E, 2011, WASTE MANAGE RES, V29, P442, DOI 10.1177/0734242X10374901
   Central pollution control board, 2018, ANN REP 2017 2018, P1
   Central pollution control board, 2019, A PERMANENT NATL NEC, P1
   Chand S, 2021, CLIN EPIDEMIOL GLOB, V11, DOI 10.1016/j.cegh.2021.100715
   Chartier Y, 2014, SAFE MANAGEMENT WAST
   Deo D, 2006, J INDIAN SOC HOSP WA, V5, P12
   Deress T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4174-7
   Francis L, 2018, ASIAN J NURSING ED R, V8, P335
   Golandaj J.A., 2000, J HUMANITIES APPL SO
   Golandaj J.A., 2020, J HUMANITIES APPL SO
   Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652
   Ismail I. M., 2013, Al Ameen Journal of Medical Sciences, V6, P376
   Kumar M, 2016, INT J COMMUNITY MED, V6, P3354
   LI CS, 1993, INFECT CONT HOSP EP, V14, P145
   Mahmood, 2011, J PHARM SCI RES, V3, P1412
   Manupati VK, 2021, J CLEAN PROD, V281, DOI 10.1016/j.jclepro.2020.125175
   MOEF& FF: Central Pollution Control Board, REVISION 4 GUIDELINE
   Mohamed LF, 2009, WASTE MANAGE, V29, P2404, DOI 10.1016/j.wasman.2009.02.015
   Nzediegwu C, 2020, RESOUR CONSERV RECY, V161, DOI 10.1016/j.resconrec.2020.104947
   Padmaja K, 2017, SCH J APPL MED SCI, V5, P526
   Qasmi S.A., 2019, J BIOSAFETY BIOSECUR, V1, P100
   Raju M.L., APPL WATER SCI, V7, P1497
   Ramteke S., 2020, CASE STUD CHEM ENV E, P100029, DOI [DOI 10.1016/J.CSCEE.2020.100029, 10.1016/j.cscee.2020.100029]
   Sangkham S., 2020, CASE STUD CHEM ENV E, V2, DOI DOI 10.1016/J.CSCEE.2020.100052
   Scudellari M, 2020, NATURE, V584, P22, DOI 10.1038/d41586-020-02278-5
   Sharma SK, 2017, CLIN EPIDEMIOL GLOB, V5, P169, DOI 10.1016/j.cegh.2017.07.002
   Sood Ashima Garg, 2011, Indian J Dent Res, V22, P371, DOI 10.4103/0970-9290.87055
   Sudhir KM, 2006, J INDIAN ASS PUBLIC, V8, P44
   Verma LK, 2008, WASTE MANAGE, V28, P2723, DOI 10.1016/j.wasman.2007.12.013
   Worldometer.info, COR CAS
   Yadavannavar Mc, 2010, Indian J Community Med, V35, P170, DOI 10.4103/0970-0218.62591
NR 36
TC 1
Z9 1
U1 1
U2 1
PU AUSTRALIAN COLL HEALTH SERVICE MANAGEMENT
PI NORTH RYDE
PA PO BOX 341, NORTH RYDE, NSW 1670, AUSTRALIA
SN 1833-3818
J9 ASIA-PAC J HEALTH MA
JI Asia Pac. J. Health Manag.
PY 2021
VL 16
IS 3
SI SI
BP 154
EP 164
PG 11
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA WF7KK
UT WOS:000706480700023
DA 2022-04-20
ER

PT J
AU Kabir, M
   Mehboob, R
   Gilani, SA
   Ahmad, FJ
AF Kabir, Mahvish
   Mehboob, Riffat
   Gilani, Syed Amir
   Ahmad, Fridoon Jawad
TI Diagnosis and Treatment of Cytokine Storming as a Management of COVID-19
   Infection
SO ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN
LA English
DT Review
DE Cytokine storming; COVID-19; diagnosis; management
AB Background: COVID-19 is a global pandemic with 12% mortality rate. This pandemic has shattered health care sector of many developed countries across the globe. According to World Health Organization (WHO) India and Pakistan will be badly hit by the pandemic till end of June 2020. Both countries are densely populated and the fragile health sector of these countries is incapable to facilitate of large number of critically ill patients. Data analysis from different studies revealed that Cytokine Storming (CS) is main cause of COVID-19 related respiratory, renal, cardiac and neural complications in critically ill patients.
   Objectives: The aim of this review is to highlight the significance of CS in management of COVID-19 infection,
   Methods: Literature from previous studies was collected to suggest the possible diagnostic testing as well as strategies to manage these patients. Mesh terms such as Corona, COVID-19, Cytokine storming, Wuhan, Pandemic were applied on PUBMED as well as google to search for the latest published articles. Reports and newpapers were also considered as this is an ongoing pandemic and there is scarcity of knowledge and information in this regard.
   Results: IL6 and TNF alpha blockers are helpful in regulating the uncontrolled immune response due to CS. Levels of different substances like ferritin, Cytokine Reactive Proteins and D-dimer can be helpful in early detection of these complications.
   Conclusions: The early dctcction of CS can be used for selection of appropriate treatment, reduction in burden on Intensive Care Units (ICU) and ultimately saving many lives.
C1 [Kabir, Mahvish] Univ Management & Technol, Lahore, Pakistan.
   [Mehboob, Riffat; Gilani, Syed Amir] Univ Lahore, Fac Allied Hlth Sci, Lahore, Pakistan.
   [Ahmad, Fridoon Jawad] Univ Hlth Sci, Dept Physiol, Lahore, Pakistan.
RP Mehboob, R (corresponding author), Univ Lahore, Fac Allied Hlth Sci, Lahore, Pakistan.
EM mehboob.riffat@gmail.com
CR [Anonymous], POP S AS
   Brudno JN, 2019, BLOOD REV, V34, P45, DOI 10.1016/j.blre.2018.11.002
   Brune K, 2015, AM J PHYSIOL-LUNG C, V308, pL731, DOI 10.1152/ajplung.00309.2014
   Cunningham AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2818-6
   Golden EB, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.12.FOCUS14748
   Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153
   Janeway C.A., 2001, INFECT AGENTS THEY C, V5th
   Kishimoto T, 2015, INNOVATIVE MED BASIC, P131, DOI [10.1007/978-4-431., DOI 10.1007/978-4-431-55651-0_11]
   Laborada G, 2003, AM J PERINAT, V20, P491, DOI 10.1055/s-2003-45382
   Li PF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1080-x
   Liu Q, 2020, Fa Yi Xue Za Zhi, V36, P21, DOI 10.12116/j.issn.1004-5619.2020.01.005
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Montoya JG, 2017, P NATL ACAD SCI USA, V114, pE7150, DOI 10.1073/pnas.1710519114
   MORIKAWA K, 1995, LEUKEMIA LYMPHOMA, V18, P429, DOI 10.3109/10428199509059641
   Richter K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01604
   Silk AW, 2019, HEMATOL ONCOL CLIN N, V33, P261, DOI 10.1016/j.hoc.2018.12.004
   Teijaro JR, 2017, SEMIN IMMUNOPATHOL, V39, P501, DOI 10.1007/s00281-017-0640-2
   Vaninov Natalie, 2020, Nat Rev Immunol, V20, P277, DOI 10.1038/s41577-020-0305-6
   World Health Organization, 73 WHO
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Zhai Pan, 2020, Int J Antimicrob Agents, V55, P105955, DOI 10.1016/j.ijantimicag.2020.105955
   Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859
NR 23
TC 0
Z9 0
U1 0
U2 0
PU RESEARCH & MEDICAL EDUCATION CENTRE
PI LAHORE
PA KING EDWARD MEDICAL COLLEGE, NILA GUMBAD, LAHORE, 00000, PAKISTAN
SN 2079-7192
EI 2079-0694
J9 ANN KING EDWARD MED
JI Ann. King Edward Med. Univ. Lahore Pak.
PY 2020
VL 26
SI SI
BP 214
EP 217
PG 4
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA OI7HU
UT WOS:000583445800023
DA 2022-04-20
ER

PT J
AU Huynh, G
   Nguyen, MQ
   Tran, TT
   Nguyen, VT
   Nguyen, TV
   Do, THT
   Nguyen, PHN
   Phan, THY
   Vu, TT
   Nguyen, TNH
AF Giao Huynh
   Minh Quan Nguyen
   Thien Thuan Tran
   Van Tap Nguyen
   Truong Vien Nguyen
   Thi Hoai Thuong Do
   Phi Hong Ngan Nguyen
   Thi Hoai Yen Phan
   Thanh Thuy Vu
   Thi Ngoc Han Nguyen
TI Knowledge, Attitude, and Practices Regarding COVID-19 Among Chronic
   Illness Patients at Outpatient Departments in Ho Chi Minh City, Vietnam
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE knowledge; attitude; practice; COVID-19; chronic disease
AB Background: The novel coronavirus disease (COVID-19) has become a major threat to human life around the world. This study aims to assess the knowledge, attitude, and practices regarding COVID-19 among people with chronic diseases at the outpatient departments in Ho Chi Minh City.
   Methods: A cross-sectional study was carried out between February and March 2020 using a convenience sampling strategy in three hospitals in Ho Chi Minh City (HCMC) via the use of a structured self-administered questionnaire. Factors relating to practices, prevalence ratio (PR), and 95% confidence interval were estimated by using the Poisson regression with robust options. P-value <0.05 was considered as statistically different.
   Results: A total of 522 participants had a mean age of 51.5 +/- 10.6 years. Most of them reported seeing information regarding the COVID-19 pandemic (93.7%) via television and social media (72.8% and 62.1%, respectively). Just over two-thirds of the participants (68.4%) answered with sufficient knowledge of COVID-19. Most respondents had a positive attitude toward COVID-19 (90.8%), although some misconceptions existed. Almost over three-fourths of them (77.2%) maintained good practices for prevention. The rate of good practices in those who had sufficient knowledge was 1.24 times greater than that among those who had insufficient knowledge (PR 1.24, 95% CI: 1.10-1.41, P<0.05). Also, the rate of good practices in males was lower than that of females (PR: 0.91, 95% CI: 0.83-0.99, P<0.05).
   Conclusion: There still exists an amount of insufficient knowledge and negative attitude regarding COVID-19, which may be barriers to good prevention practices among chronic illness patients. Education programs need to continue via television and social media and emphasize that people with chronic diseases are more likely to experience severe symptoms, including death from COVID-19. Additionally, management authorities should prolong specific policies to protect the more vulnerable in our community.
C1 [Giao Huynh; Thien Thuan Tran; Van Tap Nguyen; Truong Vien Nguyen; Thi Hoai Thuong Do; Thi Hoai Yen Phan] Univ Med & Pharm Ho Chi Minh City, Fac Publ Hlth, Ho Chi Minh City, Vietnam.
   [Minh Quan Nguyen] Thu Duc Dist Hosp, Dept Sci Res, Ho Chi Minh City, Vietnam.
   [Phi Hong Ngan Nguyen; Thanh Thuy Vu] Dist 2 Hosp, Dept Sci Res, Ho Chi Minh City, Vietnam.
   [Thi Ngoc Han Nguyen] Univ Med Ctr Ho Chi Minh City, Infect Control Dept, Ho Chi Minh City, Vietnam.
RP Nguyen, MQ (corresponding author), Thu Duc Dist Hosp, Ho Chi Minh City, Vietnam.; Huynh, G (corresponding author), Univ Med & Pharm Ho Chi Minh City, 217 Hong Bang St,Dist 5, Ho Chi Minh City, Vietnam.
EM hgiaoytcc@ump.edu.vn; minhquanbvtd@gmail.com
OI Do, Thuong Thi hoai/0000-0003-0587-0067; HUYNH,
   GIAO/0000-0002-6882-1097; , Han Thi Ngoc Nguyen/0000-0002-1986-0647;
   Nguyen, Minh Quan/0000-0002-4900-6249
CR Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Albarrak AI, 2019, J INFECT PUBLIC HEAL, DOI [10.1016/j.jiph.2019.06.02914., DOI 10.1016/J.JIPH.2019.06.02914]
   [Anonymous], 2019, WHO MERS GLOB SUMM A
   Asaad AM, 2019, E MEDITERR HLTH J, V25
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bener A, 2004, J R SOC PROMO HEALTH, V124, P167, DOI 10.1177/146642400412400408
   Ha BTT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093125
   CDC (Centers for Disease Control and Prevention, 2020, PROT YOURS
   Centers for Diseases Control and Prevention, 2020, INT INF PREV CONTR R
   Falahi S, 2021, J MED VIROL, V93, P151, DOI 10.1002/jmv.26243
   Huynh G, 2020, ASIAN PAC J TROP MED, V13, P295, DOI 10.4103/1995-7645.285828
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Ministry of Health in Vietnam, 2020, SIT REP COVID 19
   Sun PF, 2020, J MED VIROL, V92, P612, DOI 10.1002/jmv.25735
   Tung LT, 2020, J GERONTOL SOC WORK, V63, P682, DOI 10.1080/01634372.2020.1773596
   WHO, 2004, SUMM PROB SARS CAS O
   WHO, 2020, WATER SANITATION HYG
   WHO, 2020, Q A COR COVID 19
   World Health Organisation W, 2020, COR DIS COVID 19 ADV
   World Health Organization, 2020, COVID 19 NCDS
   World Health Organization, 2020, CLIN MANAGEMENT COVI
   World Health Organization, 2020, GETT YOUR WORKPL REA
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 24
TC 18
Z9 18
U1 0
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 1571
EP 1578
DI 10.2147/RMHP.S268876
PG 8
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA NN9WG
UT WOS:000569139000001
PM 32982515
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Sah, GS
   Shrestha, G
   Dhakal, A
   Mulmi, R
   Sapkota, A
   Poudel, S
AF Sah, Guru Sharan
   Shrestha, Gambhir
   Dhakal, Aayush
   Mulmi, Rashmi
   Sapkota, Ashok
   Poudel, Shivaji
TI Knowledge, Attitudes, and Practices of Cancer Patients Towards COVID-19:
   A Cross-Sectional Study in Central Nepal
SO CANCER MANAGEMENT AND RESEARCH
LA English
DT Article
DE COVID-19; neoplasms; knowledge; attitudes and practice; Nepal
AB Introduction: Cancer patients are at higher risk of COVID-19 infection as they are highly immunocompromised. The patients adherence to control measures is affected by their knowledge, attitudes, and practices (KAP) towards COVID-19. This study assesses the KAP towards COVID-19 among the admitted cancer patients in Nepal and is first of its kind.
   Patients and Methods: A cross-sectional study was conducted among the 224 admitted cancer patients in B.P. Koirala Memorial Cancer Hospital, Chitwan, Nepal, between April 20 and May 20, 2020, which was the early phase of the lockdown due to COVID-19. The study was conducted via face-to-face interviews taking optimum precautions. The research used a semi-structured questionnaire consisting of demographic characteristics, cancer-related information, 14 knowledge items, 4 attitude items, and 10 practice items. Independent sample t-tests and one-way analysis of variance were used to assess the association of knowledge with demographic characteristics.
   Results: The overall correct response rate of the knowledge component of the questionnaire was 79.4%. Most of the participants (89.7%) had a positive attitude towards accepting isolation if they had the COVID-19 infection. Only 4.5% reported that they had visited the crowded places recently. More than 98% of the patients were found to be compliant with the recommended preventive behaviors such as using the face mask, avoiding touching the eyes, nose, and mouth, washing the hands more than usual, and avoiding close contact with other patients or the caretakers not using the face masks. A total of 21.9% of respondents were using the same face mask for more than 3 days. Male gender, younger age group, and higher education were the positive predictors of knowledge regarding COVID-19.
   Conclusion: The overwhelming majority of the cancer patients had a good knowledge of COVID-19 and maintained positive attitudes and practice towards it. When tailored health education programs are planned, age, gender, and educational status should be taken into a consideration.
C1 [Sah, Guru Sharan; Sapkota, Ashok] BP Koirala Mem Canc Hosp, Dept Med Oncol, Bharatpur, Chitwan, Nepal.
   [Shrestha, Gambhir] Tribhuvan Univ, Inst Med, Dept Community Med, Maharajgunj Med Campus, Kathmandu, Nepal.
   [Dhakal, Aayush] Bharatpur Cent Hosp, Bharatpur, Chitwan, Nepal.
   [Mulmi, Rashmi] BP Koirala Mem Canc Hosp, Dept Canc Prevent Control & Res, Bharatpur, Chitwan, Nepal.
   [Poudel, Shivaji] BP Koirala Mem Canc Hosp, Dept Radiat Oncol, Bharatpur, Chitwan, Nepal.
RP Shrestha, G (corresponding author), Tribhuvan Univ, Inst Med, Dept Community Med, Maharajgunj Med Campus, Kathmandu, Nepal.
EM gamvir.stha@gmail.com
OI Sapkota, Ashok/0000-0003-2548-1843
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Centers for Disease Control and Prevention, 2020, CENT DIS CONTROL PRE
   Centers for Disease Control and Prevention, 2020, REC REG US CLOTH FAC
   GLOBOCAN, 2018, GLOB CANC OBS NEP FA
   Haque T, 2020, RES SQ, DOI [10.21203/rs.3.rs- 24562/v121., DOI 10.21203/RS.3.RS-24562/V121]
   Koirala B.P., 2018, ANN REPORT
   Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9
   Liang W, 2020, JAMA INTERN MED, DOI 10.1001/jamainternmed.2020.2033.10.
   Ministry of Health and Population (MoHP), 2020, MOHP NEP COVID 19 SI
   Ministry of Health and Population (MoHP), 2020, MOHP NEP COVID 19 UP
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Singh DR, 2020, J COMMUN HEALTH, V45, P1116, DOI 10.1007/s10900-020-00839-3
   Vaidya B, 2020, OPEN ACCESS RHEUMATO, V12, P167, DOI 10.2147/OARRR.S265816
   World Health Organization (WHO), 2020, COR DIS 2019 COVID 1, P145
   World Health Organization (WHO), 2020, REP WHO CHIN JOINT M
   World Health Organization (WHO), 2019, COR DIS 2019 COR DIS
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 21
TC 5
Z9 5
U1 0
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-1322
J9 CANCER MANAG RES
JI Cancer Manag. Res.
PY 2020
VL 12
BP 10173
EP 10180
DI 10.2147/CMAR.S271910
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA NZ9CC
UT WOS:000577396400025
PM 33116872
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Hagan, JE
   Quansah, F
   Anin, SK
   Sorkpor, RS
   Abieraba, RSK
   Frimpong, JB
   Srem-Sai, M
   Schack, T
AF Hagan, John Elvis, Jr.
   Quansah, Frank
   Anin, Stephen Kofi
   Sorkpor, Richmond Stephen
   Abieraba, Richard Samuel Kwadwo
   Frimpong, James Boadu
   Srem-Sai, Medina
   Schack, Thomas
TI COVID-19-Related Knowledge and Anxiety Response among Physical Education
   Teachers during Practical In-Person Lessons: Effects of Potential
   Moderators
SO BEHAVIORAL SCIENCES
LA English
DT Article
DE COVID-19; COVID-19-related anxiety; educational qualifications;
   knowledge; PE teachers; workplace safety perception
ID DEPRESSION; OUTBREAK; STUDENTS; SYMPTOM; LEVEL
AB The COVID-19 pandemic has resulted in heightened anxiety levels among teachers, especially regarding PE teachers who are required to engage students in practical in-person or contact teaching lessons. Previous research showed that these levels of anxiety among PE teachers appeared to be explained by the interplay between COVID-19 knowledge, workplace safety perception, and educational qualification. This study assessed the relationship between COVID-19-related knowledge and anxiety response among PE teachers during such practical lessons while moderating the effects of workplace safety perception and educational qualification within the relationship. The study conveniently recruited 160 PE teachers to solicit responses through both online and printed questionnaires. Using correlation and linear regression analyses, the study revealed a significant negative relationship between COVID-19-related knowledge and anxiety response among PE teachers. The educational qualification of PE teachers did not significantly moderate the association between COVID-19-related knowledge and anxiety response. Workplace safety perception significantly moderated the association between COVID-19-related knowledge and anxiety response among PE teachers. The findings remind educational authorities about the essence of creating a positive and safe working environment conducive to academic work. Achieving this goal requires the provision of adequate COVID-19 management logistics (e.g., personal protective equipment, hand sanitizers) by educational authorities for PE teachers to maintain safety practices and optimal learning conditions.
C1 [Hagan, John Elvis, Jr.; Frimpong, James Boadu] Univ Cape Coast, Dept Hlth Phys Educ & Recreat, PMB TF0494, Cape Coast, Ghana.
   [Hagan, John Elvis, Jr.; Schack, Thomas] Bielefeld Univ, Fac Psychol & Sports Sci, Neurocognit & Act Biomech Res Grp, Postfach 10 01 31, D-33501 Bielefeld, Germany.
   [Quansah, Frank] Univ Educ, Dept Educ Fdn, POB 25, Winneba, Ghana.
   [Anin, Stephen Kofi] Takoradi Tech Univ, Fac Appl Sci, Dept Ind & Hlth Sci, POB 256,WS 200-1123, Takoradi, Ghana.
   [Anin, Stephen Kofi] Bielefeld Univ, Sch Publ Hlth, POB 100131, D-33501 Bielefeld, Germany.
   [Sorkpor, Richmond Stephen; Abieraba, Richard Samuel Kwadwo; Srem-Sai, Medina] Univ Educ, Dept Hlth Phys Educ Recreat & Sports, POB 25, Winneba, Ghana.
RP Hagan, JE (corresponding author), Univ Cape Coast, Dept Hlth Phys Educ & Recreat, PMB TF0494, Cape Coast, Ghana.; Hagan, JE (corresponding author), Bielefeld Univ, Fac Psychol & Sports Sci, Neurocognit & Act Biomech Res Grp, Postfach 10 01 31, D-33501 Bielefeld, Germany.
EM elvis.hagan@ucc.edu.gh; fquansah@uew.edu.gh; stephen.anin@ttu.edu.gh;
   rssorkpor@uew.edu.gh; rskabieraba@uew.edu.gh;
   james.frimpong@stu.ucc.edu.gh; mssai@uew.edu.gh;
   thomas.schack@uni-bielefeld.de
OI Boadu Frimpong, James/0000-0002-9416-1176; Hagan Jnr., Dr. John
   Elvis/0000-0003-3530-6133; Quansah, Frank/0000-0002-4580-0939
FU Bielefeld University, Germany
FX The authors sincerely thank Bielefeld University, Germany, for providing
   financial support through the "Special Funding Line, Corona 2021" for
   the data collection and article processing charge for the manuscript
   through the Open Access Publication Fund.
CR Agormedah EdmondKwesi., 2020, J ED TECHNOL ONLINE, V3, P183, DOI DOI 10.31681/JETOL.726441
   Arenliu A, 2021, HEALTH PSYCHOL BEHAV, V9, P239, DOI 10.1080/21642850.2021.1903327
   Armour K.M., 1998, PHYS ED TEACHERS LIV
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055
   Bailey R, 2009, RES PAP EDUC, V24, P1, DOI 10.1080/02671520701809817
   Barkoukis V, 2021, RES Q EXERCISE SPORT, V92, P477, DOI 10.1080/02701367.2020.1751029
   BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
   Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019
   British Medical Association, 2020, STRESS BURN WARN COV
   Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   Centers for Disease Control and Prevention (CDC), 2020, HEALTHC PERS 1 RESP
   Centre for Evidence-Based Medicine, 2020, COVID 19 WHAT PROP A
   Chen HB, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.706830
   Crawford J., 2020, J APPL LEARN TEACH, V3, P1, DOI DOI 10.37074/JALT.2020.3.1.7
   Creswell J. W, 2012, ED RES PLANNING COND
   Crocker L., 2008, INTRO CLASSICAL MODE
   Cronbach L. J., 1990, ESSENTIALS PSYCHOL T
   DeVellis RF., 2017, SCALE DEV THEORY APP
   Doraiswamy S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18126439
   Du J, 2020, GEN HOSP PSYCHIAT, V67, P144, DOI 10.1016/j.genhosppsych.2020.03.011
   Dubik SD, 2021, EDUC RES INT, V2021, DOI 10.1155/2021/8893057
   Escriva-Boulley G, 2018, SPORT EXERC PERFORM, V7, P218, DOI 10.1037/spy0000119
   Falco A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257197
   Germani A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567505
   Giorgi G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217857
   Gobbi E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249431
   Gong K, 2020, J MED INTERNET RES, V22, DOI 10.2196/18908
   Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211
   Guan YJ, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103438
   Hagger M.S., 2010, INT REV SPORT EXER P, V3, P62, DOI [10.1080/17509840903322815, DOI 10.1080/17509840903322815]
   Hagger MS, 2016, REV EDUC RES, V86, P360, DOI 10.3102/0034654315585005
   Hoffart A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.589127
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Hoque Md Najmol, 2021, J Affect Disord Rep, V6, P100241, DOI 10.1016/j.jadr.2021.100241
   Iddi S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253800
   Kamath MS, 2021, HUM REPROD OPEN, V2021, DOI 10.1093/hropen/hoab039
   Kef K, 2021, PSYCHOL RES BEHAV MA, V14, P541, DOI 10.2147/PRBM.S307050
   Khoshaim HB, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.579750
   Kluger J, 2020, CORONAVIRUS PANDEMIC
   Lee J, 2021, INNOV HIGH EDUC, V46, P519, DOI 10.1007/s10755-021-09552-y
   Levkovich I, 2021, INT HEALTH, V13, P555, DOI 10.1093/inthealth/ihaa101
   Li XB, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.563741
   Li ZH, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008584
   Lin YL, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00236
   Mayorga-Vega D, 2018, J SPORT SCI, V36, P1913, DOI 10.1080/02640414.2018.1425967
   Miller M.D., 2009, MEASUREMENT ASSESSME, V10th ed.
   Nugba R.M., 2021, ASIAN J ED SOC STUD, V15, P42, DOI [10.9734/ajess/2021/v15i330383, DOI 10.9734/AJESS/2021/V15I330383]
   O'Connor DB, 2020, BRIT J PSYCHOL, V111, P603, DOI 10.1111/bjop.12468
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Pallant J., 2013, SPSS SURVIVAL MANUAL
   Patrick SW, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-016824
   Pokhrel S., 2021, HIGH ED FUTURE, V8, P133, DOI DOI 10.1177/2347631120983481
   Poon E., 2004, Hong Kong Medical Journal, V10, P325
   Pragholapati A., 2020, COVID 19 IMPACT STUD
   Quansah Frank, 2022, Front Psychol, V13, P820288, DOI 10.3389/fpsyg.2022.820288
   Quansah F, 2022, EUR J INVEST HEALTH, V12, P28, DOI 10.3390/ejihpe12010003
   Quansah Frank., 2017, AFRICA J TEACHER ED, V6, P56, DOI [10.21083/ajote.v6i1.3970, DOI 10.21083/AJOTE.V6I1.3970]
   Ren ZY, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.641806
   Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372
   Santi G, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.601743
   Saravanan C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.582189
   Sogut S, 2021, PERSPECT PSYCHIATR C, V57, P246, DOI 10.1111/ppc.12555
   Srol J, 2021, APPL COGNITIVE PSYCH, V35, P720, DOI 10.1002/acp.3798
   Steimer Thierry, 2002, Dialogues Clin Neurosci, V4, P231
   UNESCO, 2021, U TACKL IMP COVID 19
   UNICEF, 2020, UNICEF MICR LAUNCH G
   United Nations Educational Scientific and Cultural Organization [UNESCO], ED QUAL DEF BAS INT
   United Nations Educational Scientific and Cultural Organization (UNESCO), 2020, COVID 19 ED DISR RES
   Varea V, 2021, SPORT EDUC SOC, V26, P831, DOI 10.1080/13573322.2020.1791814
   Vulic-Prtoric A., 2020, PSYARXIV, V1, P1
   Wang YB, 2020, RES Q EXERCISE SPORT, V91, P197, DOI [10.1080/02701367.2019.1656325, 10.1080/02701367.2019.1603775]
   Wang ZH, 2020, J AFFECT DISORDERS, V275, P188, DOI 10.1016/j.jad.2020.06.034
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   World Health Organisation Coronavirus Disease (COVID-19), 2020, 121 WHO
   World Health Organization Regional Office for Europe, 2018, PROMOTING PHYS ACTIV
   Yildirim M, 2021, DEATH STUD, DOI 10.1080/07481187.2021.1882617
   Zhai YS, 2020, BRAIN BEHAV IMMUN, V87, P80, DOI 10.1016/j.bbi.2020.04.053
   Zhao J, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.715929
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 80
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-328X
J9 BEHAV SCI-BASEL
JI Behav. Sci.
PD MAR
PY 2022
VL 12
IS 3
AR 83
DI 10.3390/bs12030083
PG 15
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA 0D5SX
UT WOS:000776056200001
PM 35323402
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ozdemir, PG
   Celik, V
AF Gokmirza Ozdemir, Pinar
   Celik, Velat
TI Current Recommendations on the Management of Pediatric Asthma and
   Allergic Rhinitis during the COVID-19 Pandemic versus Real-Life Practice
SO INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
LA English
DT Article; Early Access
DE Asthma; Allergic rhinitis; Children; Management; COVID-19; Pandemic;
   Knowledge
AB Introduction: Several statements and position papers on the management of childhood asthma and allergies during the COVID-19 pandemic have been published of late. The aim of this study was to evaluate the knowledge and awareness of pediatricians and family physicians regarding the management of asthma and allergic rhinitis during the pandemic according to recently published updated guidelines. Method: We conducted an online survey among pediatricians and family physicians in Turkey, using a questionnaire designed to evaluate 4 items: (1) the relationship between COVID-19 infection risk and pediatric asthma/allergic rhinitis and medications used in treatment; (2) the follow-up and management of asthma/allergic rhinitis according to published updated recommendations; (3) pediatricians' and family physicians' observations and perceptions of treatment compliance and the attitudes of their pediatric asthma patients; and (4) pediatricians and family physicians' attitudes to using telehealth in the follow-up and management of pediatric asthma patients during the pandemic. Results: A total of 346 participants responded to the survey. The relationship between the risk of COVID-19 and asthma was known by less than 25% of the participants. More than 33% of family physicians and 20% of pediatricians were unaware that asthma medication does not lead to a susceptibility to COVID-19 infection; 55% of family physicians and 48% of pediatricians thought that patients showed better compliance with asthma controller medication; over 33% of pediatricians and approximately 50% of family physicians stated that they could not distinguish between an asthma attack and lung involvement in COVID-19 infection; of the respondents, over 75% stated that they prefer face-to-face visits with patients, even in situations that do not require a physical examination. Conclusion: The overall knowledge and awareness of pediatricians and, especially, family physicians regarding the management of pediatric asthma/allergic rhinitis during the pandemic is not at a satisfactory level. There is an urgent need to inform them about updated recommendations appearing in recent guidelines published by allergy organizations.
C1 [Gokmirza Ozdemir, Pinar] Trakya Univ, Sch Med, Dept Pediat Allergy & Immunol, Edirne, Turkey.
   [Celik, Velat] Necip Fazil City Hosp, Dept Pediat Allergy & Immunol, Kahramanmaras, Turkey.
RP Ozdemir, PG (corresponding author), Trakya Univ, Sch Med, Dept Pediat Allergy & Immunol, Edirne, Turkey.
EM drpinar1975@hotmail.com
OI celik, velat/0000-0002-8893-9420
CR [Anonymous], 2020, COVID 19 GINA ANSW F
   British Thoracic Society, ADV HEALTHC PROF TRE
   Brough HA, 2020, PEDIAT ALLERG IMM-UK, V31, P442, DOI 10.1111/pai.13262
   Dong X, 2020, ALLERGY, V75, P1699, DOI 10.1111/all.14289
   Gupta A, 2020, LANCET RESP MED, V8, P1070, DOI 10.1016/S2213-2600(20)30278-2
   Kenyon CC, 2020, J ALLER CL IMM-PRACT, V8, P2774, DOI 10.1016/j.jaip.2020.05.045
   Klimek Ludger, 2020, Allergol Select, V4, P53, DOI 10.5414/ALX02166E
   Krivec U, 2020, ARCH DIS CHILD, V105, P809, DOI 10.1136/archdischild-2020-319522
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Occupational Safety and Health Administration (OSHA), COVID 19 CONTR PREV
   Oreskovic NM, 2020, J ALLER CL IMM-PRACT, V8, P2489, DOI 10.1016/j.jaip.2020.05.027
   Pfaar O, 2021, ALLERGY, V76, P648, DOI 10.1111/all.14453
   Portnoy J, 2020, J ALLER CL IMM-PRACT, V8, P1489, DOI 10.1016/j.jaip.2020.03.008
   Riggioni C, 2020, ALLERGY, V75, P2503, DOI 10.1111/all.14449
   Vultaggio A, 2020, ALLERGY, V75, P2764, DOI 10.1111/all.14407
   World Health Organization, INF PREV CONTR HLTH
NR 16
TC 0
Z9 0
U1 2
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1018-2438
EI 1423-0097
J9 INT ARCH ALLERGY IMM
JI Int. Arch. Allergy Immunol.
DI 10.1159/000521117
EA DEC 2021
PG 8
WC Allergy; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Allergy; Immunology
GA YB1RT
UT WOS:000738799000001
PM 34963116
DA 2022-04-20
ER

PT J
AU Genovese, G
   Moltrasio, C
   Berti, E
   Marzano, AV
AF Genovese, Giovanni
   Moltrasio, Chiara
   Berti, Emilio
   Marzano, Angelo Valerio
TI Skin Manifestations Associated with COVID-19: Current Knowledge and
   Future Perspectives
SO DERMATOLOGY
LA English
DT Review
DE COVID-19; Cutaneous manifestations; SARS-CoV-2
ID VARICELLA-LIKE EXANTHEM; VIRUS HERPES-SIMPLEX; LESIONS; FEATURES; ZOSTER
AB Background: Coronavirus disease-19 (COVID-19) is an ongoing global pandemic caused by the "severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2), which was isolated for the first time in Wuhan (China) in December 2019. Common symptoms include fever, cough, fatigue, dyspnea and hypogeusia/hyposmia. Among extrapulmonary signs associated with COVID-19, dermatological manifestations have been increasingly reported in the last few months. Summary: The polymorphic nature of COVID-19-associated cutaneous manifestations led our group to propose a classification, which distinguishes the following six main clinical patterns: (i) urticarial rash, (ii) confluent erythematous/maculopapular/morbilliform rash, (iii) papulovesicular exanthem, (iv) chilblain-like acral pattern, (v) livedo reticularis/racemosa-like pattern, (vi) purpuric "vasculitic" pattern. This review summarizes the current knowledge on COVID-19-associated cutaneous manifestations, focusing on clinical features and therapeutic management of each category and attempting to give an overview of the hypothesized pathophysiological mechanisms of these conditions.
C1 [Genovese, Giovanni; Moltrasio, Chiara; Berti, Emilio; Marzano, Angelo Valerio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy.
   [Genovese, Giovanni; Berti, Emilio; Marzano, Angelo Valerio] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Moltrasio, Chiara] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
RP Marzano, AV (corresponding author), Univ Milan, Dermatol Unit, Via Pace 9, IT-20122 Milan, Italy.
EM angelo.marzano@unimi.it
RI Moltrasio, Chiara/AAX-8849-2021
OI Berti, Emilio/0000-0001-6753-4910; Moltrasio, Chiara/0000-0003-0060-5870
CR Almutairi A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9446
   Alramthan A, 2020, CLIN EXP DERMATOL, V45, P746, DOI 10.1111/ced.14243
   Amatore F, 2020, J EUR ACAD DERMATOL, V34, pE304, DOI 10.1111/jdv.16528
   Askin O, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13896
   Bosch-Amate X, 2020, J EUR ACAD DERMATOL, V34, pE548, DOI 10.1111/jdv.16689
   Bouaziz JD, 2020, J EUR ACAD DERMATOL, V34, pE451, DOI 10.1111/jdv.16544
   Caputo V, 2020, J EUR ACAD DERMATOL, V34, pE579, DOI 10.1111/jdv.16737
   Caselli D, 2020, BRIT J DERMATOL, V183, P784, DOI 10.1111/bjd.19349
   Catala A, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14170
   Cepeda-Valdes R, 2020, CLIN EXP DERMATOL, V45, P895, DOI 10.1111/ced.14290
   Chibane S, 2021, J THROMB THROMBOLYS, V51, P25, DOI 10.1007/s11239-020-02173-w
   Colmenero I, 2020, BRIT J DERMATOL, V183, P729, DOI 10.1111/bjd.19327
   Colonna C, 2020, J AM ACAD DERMATOL, V83, P965, DOI 10.1016/j.jaad.2020.06.019
   Cordoro KM, 2020, PEDIATR DERMATOL, V37, P419, DOI 10.1111/pde.14227
   Criado PR, 2020, INFLAMM RES, V69, P745, DOI 10.1007/s00011-020-01370-w
   Cugno M, 2020, J ALLERGY CLIN IMMUN, V146, P215, DOI 10.1016/j.jaci.2020.05.006
   De Giorgi V, 2020, J AM ACAD DERMATOL, V83, P674, DOI 10.1016/j.jaad.2020.05.073
   de Masson A, 2020, J AM ACAD DERMATOL, V83, P667, DOI 10.1016/j.jaad.2020.04.161
   de Perosanz-Lobo D, 2020, J EUR ACAD DERMATOL, V34, pE566, DOI 10.1111/jdv.16713
   Del Giudice P, 2020, J EUR ACAD DERMATOL, V34, pE679, DOI 10.1111/jdv.16763
   Delaleu J, 2020, J ALLER CL IMM-PRACT, V8, P2777, DOI 10.1016/j.jaip.2020.05.046
   Denina M, 2020, J AM ACAD DERMATOL, V83, P1751, DOI 10.1016/j.jaad.2020.08.021
   Docampo-Simon A, 2020, J EUR ACAD DERMATOL, V34, pE445, DOI 10.1111/jdv.16665
   Droesch C, 2020, JAMA DERMATOL, V156, P1022, DOI 10.1001/jamadermatol.2020.2800
   Ehsani AH, 2020, J EUR ACAD DERMATOL, V34, pE436, DOI 10.1111/jdv.16579
   Elsaie ML, 2022, J DERMATOL TREAT, V33, P1123, DOI 10.1080/09546634.2020.1782823
   Fernandez-Nieto D, 2020, CLIN EXP DERMATOL, V45, P872, DOI 10.1111/ced.14277
   Fernandez-Nieto D, 2020, J AM ACAD DERMATOL, V83, pE257, DOI 10.1016/j.jaad.2020.06.063
   Fernandez-Nieto D, 2020, J AM ACAD DERMATOL, V83, pE61, DOI 10.1016/j.jaad.2020.04.093
   Freeman EE, 2020, J AM ACAD DERMATOL, V83, P486, DOI 10.1016/j.jaad.2020.05.109
   Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163
   Garcia-Gil MF, 2020, INT J DERMATOL, V59, P1151, DOI 10.1111/ijd.15041
   Genovese G, 2020, PEDIATR DERMATOL, V37, P435, DOI 10.1111/pde.14201
   Gianotti R, 2020, ACTA DERM-VENEREOL, V100, DOI 10.2340/00015555-3490
   Gisondi P, 2020, J EUR ACAD DERMATOL, V34, P2499, DOI 10.1111/jdv.16774
   Griffiths C, 2016, ROOKS TXB DERMATOLOG, DOI [10.1002/9781118441213, DOI 10.1002/9781118441213]
   Gupta AK, 2022, J DERMATOL TREAT, V33, P62, DOI [10.1080/09546634.2020.1749547, 10.1093/tropej/fmaa060]
   Hassan K, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-236981
   Herman A, 2020, J EUR ACAD DERMATOL, V34, pE768, DOI 10.1111/jdv.16838
   Herman A, 2020, JAMA DERMATOL, V156, P998, DOI 10.1001/jamadermatol.2020.2368
   Herrero-Moyano M, 2020, J EUR ACAD DERMATOL, V34, pE460, DOI 10.1111/jdv.16631
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Imbalzano E, 2016, ALLERGY ASTHMA PROC, V37, P18, DOI 10.2500/aap.2016.37.3915
   Jimenez-Cauhe J, 2020, CLIN EXP DERMATOL, V45, P892, DOI 10.1111/ced.14281
   Jimenez-Cauhe J, 2020, J AM ACAD DERMATOL, V83, pE141, DOI 10.1016/j.jaad.2020.04.016
   Joob B, 2020, J AM ACAD DERMATOL, V82, pE177, DOI 10.1016/j.jaad.2020.03.036
   Kanitakis J, 2020, J AM ACAD DERMATOL, V83, P870, DOI 10.1016/j.jaad.2020.05.145
   Karaca Z, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13798
   Kaya G, 2020, DERMATOPATHOL-BASEL, V7, P3, DOI 10.3390/dermatopathology7010002
   Khalil Shadi, 2020, JAAD Case Rep, V6, P871, DOI 10.1016/j.jdcr.2020.07.014
   Ko CEJ, 2020, J CUTAN PATHOL, V47, P997, DOI 10.1111/cup.13830
   Ladha MA, 2020, J CUTAN MED SURG, V24, P504, DOI 10.1177/1203475420937978
   Larrondo J, 2020, J EUR ACAD DERMATOL, V34, pE570, DOI 10.1111/jdv.16732
   Le Cleach L, 2020, BRIT J DERMATOL, V183, P866, DOI 10.1111/bjd.19377
   Lesort C, 2020, J EUR ACAD DERMATOL, V34, pE757, DOI 10.1111/jdv.16779
   Lim SYD, 2020, BRIT J DERMATOL, V183, P790, DOI 10.1111/bjd.19347
   Llamas-Velasco M, 2020, CLIN EXP DERMATOL, V45, P896, DOI 10.1111/ced.14305
   Llamas-Velasco M, 2020, J AM ACAD DERMATOL, V83, pE253, DOI 10.1016/j.jaad.2020.04.180
   Locatelli AG, 2020, J EUR ACAD DERMATOL, V34, pE365, DOI 10.1111/jdv.16617
   Magro CM, 2021, BRIT J DERMATOL, V184, P141, DOI 10.1111/bjd.19415
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mahe A, 2020, J EUR ACAD DERMATOL, V34, pE559, DOI 10.1111/jdv.16706
   Manalo IF, 2020, J AM ACAD DERMATOL, V83, P700, DOI 10.1016/j.jaad.2020.04.018
   Marzano AV, 2020, BRIT J DERMATOL, V183, P431, DOI 10.1111/bjd.19264
   Marzano AV, 2020, J AM ACAD DERMATOL, V83, pE255, DOI 10.1016/j.jaad.2020.05.072
   Marzano AV, 2020, J AM ACAD DERMATOL, V83, P280, DOI 10.1016/j.jaad.2020.04.044
   Matar S, 2020, J EUR ACAD DERMATOL, V34, pE686, DOI 10.1111/jdv.16775
   Mazzotta F, 2020, EUR J PEDIAT DERMATO, V30, P71, DOI DOI 10.26326/2281-9649.30.2.2102
   Najafzadeh M, 2020, J EUR ACAD DERMATOL, V34, pE568, DOI 10.1111/jdv.16721
   Najarian David James, 2020, JAAD Case Rep, V6, P493, DOI 10.1016/j.jdcr.2020.04.015
   Navarro L, 2020, J EUR ACAD DERMATOL, V34, pE762, DOI 10.1111/jdv.16800
   Negrini S, 2020, J EUR ACAD DERMATOL, V34, pE675, DOI 10.1111/jdv.16760
   Novak N, 2021, ALLERGY, V76, P698, DOI 10.1111/all.14498
   Piccolo V, 2020, J EUR ACAD DERMATOL, V34, pE291, DOI 10.1111/jdv.16526
   Potekaev NN, 2020, INT J DERMATOL, V59, P1000, DOI 10.1111/ijd.15030
   Proietti I, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14089
   Quintana-Castanedo Lucia, 2020, JAAD Case Rep, V6, P498, DOI 10.1016/j.jdcr.2020.04.026
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387
   Reymundo A, 2020, J EUR ACAD DERMATOL, V34, pE755, DOI 10.1111/jdv.16707
   Rivera-Oyola Ryan, 2020, JAAD Case Rep, V6, P537, DOI 10.1016/j.jdcr.2020.04.027
   Roca-Gines J, 2020, JAMA DERMATOL, V156, P992, DOI 10.1001/jamadermatol.2020.2340
   Rodriguez-Jimenez P, 2020, J EUR ACAD DERMATOL, V34, pE459, DOI 10.1111/jdv.16618
   Seirafianpour F, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13986
   Shanshal M, 2022, J DERMATOL TREAT, V33, P1114, DOI 10.1080/09546634.2020.1792400
   Tammaro A, 2020, J EUR ACAD DERMATOL, V34, pE306, DOI 10.1111/jdv.16530
   Trellu LT, 2020, JAMA DERMATOL, V156, P922, DOI 10.1001/jamadermatol.2020.1966
   van Damme C, 2020, J EUR ACAD DERMATOL, V34, pE300, DOI 10.1111/jdv.16523
   Verheyden M, 2020, J EUR ACAD DERMATOL, V34, pE684, DOI 10.1111/jdv.16773
   Wang YZ, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13713
   Yim E, 2021, INT J DERMATOL, V60, pE100, DOI 10.1111/ijd.15201
   Yong SB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226759
   Zhao Q, 2020, J EUR ACAD DERMATOL, V34, P2505, DOI 10.1111/jdv.16778
   Zhou Z., 2020, SSRN ELECT J
NR 93
TC 53
Z9 55
U1 1
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1018-8665
EI 1421-9832
J9 DERMATOLOGY
JI Dermatology
PD JAN
PY 2021
VL 237
IS 1
BP 1
EP 12
DI 10.1159/000512932
EA NOV 2020
PG 12
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA PU7ED
UT WOS:000592538000001
PM 33232965
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Peterson, MB
   Gurnaney, HG
   Disma, N
   Matava, C
   Jagannathan, N
   Stein, ML
   Liu, H
   Kovatsis, PG
   Von Ungern-Sternberg, BS
   Fiadjoe, JE
AF Peterson, M. Brooks
   Gurnaney, H. G.
   Disma, N.
   Matava, C.
   Jagannathan, N.
   Stein, M. L.
   Liu, H.
   Kovatsis, P. G.
   Von Ungern-Sternberg, B. S.
   Fiadjoe, J. E.
CA PAWS-COVID-19 Grp
TI Complications associated with paediatric airway management during the
   COVID-19 pandemic: an international, multicentre, observational study
SO ANAESTHESIA
LA English
DT Article; Early Access
DE airway; airway adverse events; COVID-19; paediatrics; tracheal
   intubation
AB Respiratory adverse events in adults with COVID-19 undergoing general anaesthesia can be life-threatening. However, there remains a knowledge gap about respiratory adverse events in children with COVID-19. We created an international observational registry to collect airway management outcomes in children with COVID-19 who were having a general anaesthetic. We hypothesised that children with confirmed or suspected COVID-19 would experience more hypoxaemia and complications than those without. Between 3 April 2020 and 1 November 2020, 78 international centres participated. In phase 1, centres collected outcomes on all children (age <= 18 y) having a general anaesthetic for 2 consecutive weeks. In phase 2, centres recorded outcomes for children with test-confirmed or suspected COVID-19 (based on symptoms) having a general anaesthetic. We did not study children whose tracheas were already intubated. The primary outcome was the incidence of hypoxaemia during airway management. Secondary outcomes included: incidence of other complications; and first-pass success rate for tracheal intubation. In total, 7896 children were analysed (7567 COVID-19 negative and 329 confirmed or presumed COVID-19 positive). The incidence of hypoxaemia during airway management was greater in children who were COVID-19 positive (24 out of 329 (7%) vs. 214 out of 7567 (3%); OR 2.70 (95%CI 1.70-4.10)). Children who had symptoms of COVID-19 had a higher incidence of hypoxaemia compared with those who were asymptomatic (9 out of 51 (19%) vs. 14 out of 258 (5%), respectively; OR 3.7 (95%CI 1.5-9.1)). Children with confirmed or presumed COVID-19 have an increased risk of hypoxaemia during airway management in conjunction with general anaesthesia.
C1 [Peterson, M. Brooks] Univ Colorado, Dept Anesthesiol, Childrens Hosp Colorado, Sch Med, Aurora, CO USA.
   [Gurnaney, H. G.; Fiadjoe, J. E.] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA.
   [Gurnaney, H. G.; Fiadjoe, J. E.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Disma, N.] Ist Giannina Gaslini, Unit Res & Innovat, Dept Pediat Anesthesia, Genoa, Italy.
   [Matava, C.] Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON, Canada.
   [Jagannathan, N.] Northwestern Univ, Ann & Robert Lurie Childrens Hosp Chicago, Chicago, IL USA.
   [Stein, M. L.; Kovatsis, P. G.; Fiadjoe, J. E.] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA.
   [Liu, H.] Childrens Hosp Philadelphia, Dept Biomed & Hlth, Data Sci & Biostat Unit, Philadelphia, PA USA.
   [Von Ungern-Sternberg, B. S.] Univ Western Australia, Perth Childrens Hosp, Telethon Kids Inst, Dept Anesthesia & Pain Med, Perth, WA, Australia.
RP Fiadjoe, JE (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA.; Fiadjoe, JE (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Fiadjoe, JE (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA.
EM john.fiadjoe@childrens.harvard.edu
OI von Ungern-Sternberg, Britta/0000-0002-8043-8541; Jagannathan,
   Narasimhan/0000-0002-1657-0353
FU Children's Hospital of Philadelphia Department of Anesthesiology and
   Critical Care Medicine; Anesthesia Patient Safety Foundation
FX This study was supported by the Children's Hospital of Philadelphia
   Department of Anesthesiology and Critical Care Medicine. The study was
   registered at (NCT04449042). PK is a medical advisor to Verathon, Inc.
   JF discloses grant funding from the Anesthesia Patient Safety Foundation
   unrelated to this work. No other external funding or competing interests
   declared.
CR Gomez-Rios MA, 2020, ANAESTH INTENSIVE TH, V52, P344, DOI 10.5114/ait.2020.99504
   Baker PA, 2020, PEDIATR ANESTH, V30, P734, DOI 10.1111/pan.13932
   Brooks Peterson Melissa L, 2020, Anesth Analg, V131, pe45, DOI 10.1213/ANE.0000000000004901
   Brown J, 2021, ANAESTHESIA, V76, P174, DOI 10.1111/anae.15292
   Brown S, 2020, ANESTH ANALG, V131, pE34, DOI 10.1213/ANE.0000000000004876
   COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X
   Gai N, 2021, J ANESTH, V35, P345, DOI 10.1007/s00540-020-02837-0
   Garcia-Marcinkiewicz AG, 2020, LANCET, V396, P1905, DOI 10.1016/S0140-6736(20)32532-0
   Hall D, 2020, ANAESTHESIA, V75, P822, DOI 10.1111/anae.15047
   Lin EE, 2020, JAMA SURG, V155, P775, DOI 10.1001/jamasurg.2020.2588
   Matava C, 2020, BRIT J ANAESTH, V125, pE363, DOI 10.1016/j.bja.2020.07.014
   Park RS, 2021, ANESTH ANALG, V132, P367, DOI 10.1213/ANE.0000000000004344
   Peyton J, 2020, PEDIATR ANESTH, V30, P732, DOI 10.1111/pan.13908
   Saynhalath R, 2021, ANESTH ANALG, V133, P483, DOI 10.1213/ANE.0000000000005606
   Shrimpton AJ, 2021, ANAESTHESIA, V76, P1577, DOI [10.1111/anae.15542, 10.1111/anae.15572]
   Shrimpton AJ, 2022, ANAESTHESIA, V77, P22, DOI 10.1111/anae.15599
   Sorbello M, 2020, BRIT J ANAESTH, V125, P880, DOI 10.1016/j.bja.2020.08.038
   Tighe NTG, 2021, PEDIATR ANESTH, V31, P461, DOI 10.1111/pan.14091
   Wolter NE, 2020, J AM COLL SURGEONS, V231, P304, DOI 10.1016/j.jamcollsurg.2020.04.034
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang YL, 2020, ANESTH ANALG, V131, pE97, DOI 10.1213/ANE.0000000000004923
NR 21
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-2409
EI 1365-2044
J9 ANAESTHESIA
JI Anaesthesia
DI 10.1111/anae.15716
EA MAR 2022
PG 10
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA ZX5RW
UT WOS:000771954800001
PM 35319088
DA 2022-04-20
ER

PT J
AU Twinamasiko, N
   Olum, R
   Gwokyalya, AM
   Nakityo, I
   Wasswa, E
   Sserunjogi, E
AF Twinamasiko, Nelson
   Olum, Ronald
   Gwokyalya, Anna Maria
   Nakityo, Innocent
   Wasswa, Enock
   Sserunjogi, Emmanuel
TI Assessing Knowledge, Attitudes and Practices Towards COVID-19 Public
   Health Preventive Measures Among Patients at Mulago National Referral
   Hospital
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; knowledge; attitudes; practices; patients; Uganda
ID OUTBREAK
AB Background: COVID-19 has become a major global health challenge, with Uganda reporting over 20,000 cases. There is, however, a scarcity of data on the perception of patients in Uganda towards the highly infectious disease. We aimed to assess the awareness, knowledge, attitudes, and practices towards COVID-19 preventive measures among patients at Mulago National Referral Hospital (MNRH), Uganda.
   Methods: A cross-sectional quantitative survey was conducted in August, 2020, among patients in surgical and medical wards at MNRH. An interviewer-administered, pre-validated questionnaire was used to collect data that was entered into Google Forms and analyzed using Microsoft Excel and STATA 16. Descriptive statistics was used to present data from univariate analysis. Patients whose knowledge and practice scores were greater or equal to the average score were regarded to have good knowledge and practices respectively. Chi-square, Fisher's Exact tests and binary logistic regression were used to assess factors associated with COVID-19 knowledge and practices. A P<0.05 was statistically significant.
   Results: Overall, 114 patients were approached and 102 consented to participate. Most were females (53.8%), aged above 45 years (31.4%) with 40.2% reporting primary level as the highest level of education. About 55.9% (n=57) had adequate knowledge for COVID-19 and its related practices, and 52% (n=53) had good COVID-19 related practices. Knowledge significantly differed by marital status at bivariate analysis (P=0.020), however this lost significance at logistic regression. Female patients were thrice more likely to have good COVID-19 prevention practices compared to males (COR: 2.59, 95% CI: 1.2 to 5.8, P=0.020). Some 47 (46.1%) participants perceived that COVID-19 preventive measures were not difficult at all to observe.
   Conclusion: About half of the patients at Mulago National Referral Hospital lack adequate knowledge and practice on COVID-19 prevention. Continued patient education is required to increase knowledge which will in turn improve adherence to COVID-19 preventive practices.
C1 [Twinamasiko, Nelson; Olum, Ronald; Gwokyalya, Anna Maria; Nakityo, Innocent; Wasswa, Enock; Sserunjogi, Emmanuel] Makerere Univ, Coll Hlth Sci, Sch Med, POB 7062, Kampala, Uganda.
RP Twinamasiko, N (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Med, POB 7062, Kampala, Uganda.
EM drtwinamasikonelson@gmail.com
RI Olum, Ronald/AAR-4279-2020
OI Olum, Ronald/0000-0003-1289-0111; Nelson,
   Twinamasiko/0000-0003-3716-1468
CR Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Atalan A, 2020, ANN MED SURG, V56, P38, DOI 10.1016/j.amsu.2020.06.010
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Besigye IK, 2020, AFR J PRIM HEALTH CA, V12, DOI 10.4102/phcfm.v12i1.2443
   Echoru I, 2020, RELIG INFLUENCES COM
   FISHER WA, 1995, HEALTH PSYCHOL, V14, P255, DOI 10.1037/0278-6133.14.3.255
   Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912
   Huynh G, 2020, J TROPICAL MED, V13, P260, DOI DOI 10.4103/1995-7645.280396
   Li ZH, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008584
   Muruganandam P, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113265
   Olum R, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/19847
   Olum R, 2020, INT J INFECT DIS, V96, P517, DOI 10.1016/j.ijid.2020.05.073
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Riou J., 2020, PATTERN EARLY HUMAN, DOI [10.1101/2020.01.23.917351, DOI 10.1101/2020.01.23.917351]
   Sahin AR, 2020, EURASIAN J MED ONCOL, V4, P1, DOI 10.14744/ejmo.2020.12220
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Ssebuufu R, 2020, AWARENESS KNOWLEDGE, V8, P1
   The Independent, INDEPENDENT NEWSPAPE
   Usman IM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00340
   Woldometer, 2020, COVID 19 COR PAND
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Zhang J, 2020, CLIN MICROBIOL INFEC, V26, P767, DOI 10.1016/j.cmi.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 26
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 221
EP 230
DI 10.2147/RMHP.S287379
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA QC0VE
UT WOS:000614551400001
PM 33505175
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Aboalela, A
   AlShafei, A
   Almousa, MA
   Alharbi, GK
   Alqahtani, AS
   Bin Shraim, NM
AF Aboalela, Ali
   AlShafei, Ahmad
   Almousa, Mandlin Abdulaziz
   Alharbi, Ghadah Khalid
   Alqahtani, Amerah Saeed
   Bin Shraim, Nassir Mohammed
TI Knowledge and Awareness of COVID-19 among Dental Students, Interns,
   Clinicians and Academics
SO INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES
LA English
DT Article
DE Knowledge of COVID-19; Dental practitioners; Cross sectional study;
   Dental precautions; Disease transmission; Infection control
AB Introduction: COVID-19 is a highly infectious disease caused by an RNA virus belonging to a large family of coronaviruses. WHO declared COVID-19 as a public health emergency and classified it as a pandemic. Aim: The study aims to evaluate and assess knowledge with regards to COVID-19 among dental students, interns, clinicians and academics in Riyadh, Saudi Arabia. Methodology: A cross-sectional study was conducted among 366 dental students, interns, joint academic appointee, and full-time faculty. Data was collected using an electronic based questionnaire distributed through E-mails. Data was entered and analyzed using SPSS Version 23 with a significance value of p<0.05. Chi-square test was used to compare categorical variables. Results: Almost all participants acquire adequate level of knowledge regarding the mode of transmission, incubation period and symptoms of COVID-19. Approximately half of the participants 205 (56%) thought that standard precautions in the dental clinics were insufficient in the management of suspected cases of COVID-19. Nearly all participants thought that elective dental treatment should be deferred, and only emergency treatment can be provided. However, there was a poor response regarding the correct survival duration of COVID-19 on plastic or stainless-steel surfaces and the use of pre-operational hydrogen peroxide mouth rinse as a method of preventing transmission. Conclusion: This study identified areas where participants lacked the knowledge in managing COVID-19 with the best methods available especially at an undergraduate level. In order to have a more efficient and appropriate response for future pandemics, dental curriculums and educational activities should pro-actively provide training opportunities.
C1 [Aboalela, Ali; AlShafei, Ahmad; Almousa, Mandlin Abdulaziz; Alharbi, Ghadah Khalid; Alqahtani, Amerah Saeed; Bin Shraim, Nassir Mohammed] King Saud bin Abdulaziz Univ Hlth Sci, Coll Dent, Riyadh, Saudi Arabia.
   [Aboalela, Ali; AlShafei, Ahmad; Bin Shraim, Nassir Mohammed] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.
   [Aboalela, Ali; AlShafei, Ahmad; Bin Shraim, Nassir Mohammed] Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
RP Aboalela, A (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Coll Dent, Riyadh, Saudi Arabia.; Aboalela, A (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.; Aboalela, A (corresponding author), Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
EM aboalelae@ngha.med.sa
RI Aboalela, Ali/AAV-3307-2020
OI Aboalela, Ali/0000-0003-0963-5574
CR [Anonymous], 2020, CORONAVIRUS DIS 19 C
   [Anonymous], 2020, ADA CORONAVIRUS CTR
   Centers for Disease Control and Prevention, 2020, **NON-TRADITIONAL**
   He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766
   Javed M. Q, 2020, RES SQUARE, P1
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Sabino-Silva R, 2020, CLIN ORAL INVEST, V24, P1619, DOI 10.1007/s00784-020-03248-x
   Saudi Ministry of Health, 2020, CORONAVIRUS DIS 19 C
   Spagnuolo G, 2020, INT J ENV RES PUB HE, V17, P1
   World Health Organization, 2014, INFECT PREVENTION CO
NR 12
TC 4
Z9 4
U1 0
U2 4
PU SUAMTHI PUBLICATIONS
PI AHMEDNAGAR
PA SUAMTHI PUBLICATIONS, AHMEDNAGAR, 00000, INDIA
SN 2319-5886
J9 INT J MED RES HEALTH
JI Int. J. Med. Res. Health Sci.
PY 2020
VL 9
IS 7
BP 25
EP 31
PG 7
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA NY9MM
UT WOS:000576709000004
DA 2022-04-20
ER

PT J
AU Gokdemir, O
   Pak, H
   Bakola, M
   Bhattacharya, S
   Hoedebecke, K
   Jelastopulu, E
AF Gokdemir, Ozden
   Pak, Halil
   Bakola, Maria
   Bhattacharya, Sudip
   Hoedebecke, Kyle
   Jelastopulu, Eleni
TI Family Physicians' Knowledge about and Attitudes towards COVID-19 - A
   Cross-sectional Multicentric Study
SO INFECTION AND CHEMOTHERAPY
LA English
DT Article
DE Anxiety; Fear of death; COVID-19; Family physician; Knowledge; Attitude
ID LIFE SCALE; RESPONSE RATES; SATISFACTION; ANXIETY; DEATH; VALIDATION;
   CONSTRUCTION
AB Background: The coronavirus disease 2019 (COVID-19) pandemic has affected every country on earth, and family physicians (FPs) have helped patients at every stage. The first objective of our study was to study the FPs' knowledge about COVID-19 and second objective was to assess their attitudes, stress and death anxiety surrounding the current pandemic.
   Materials and Methods: An online questionnaire was prepared to collect responses from FPs between March-April 2020. A descriptive and correlational design was utilized.
   Results: 240 FPs from eight countries were evaluated. The majority reported that they received most information from medical journals (77%). Most of the respondents also noted that the most common symptoms were acute respiratory syndrome and fever - with the most effective treatment in most cases consisting of symptomatic treatment (41%). Although FPs generally had a positive attitude, most of them (68%) were concerned about contacting COVID-19 from patients and as a result, they experienced increased stress (64%).
   Conclusion: The research was conducted during the COVID-19 outbreak while the FPs were working on the frontline of the pandemic. This research revealed that most of the FPs had good knowledge of, and a positive attitude towards COVID-19 treatment. It was observed that participants who tended towards conscientiousness, emotional stability, and openness to experience, and who had higher life satisfaction, and lower levels of death anxiety also reported more positive attitudes towards COVID-19. While the main target population of COVID-19 disease were the older age groups, FPs' attitudes and fear levels were not associated with age, gender, or years of experience.
C1 [Gokdemir, Ozden] Izmir Univ Econ, Fac Med, Izmir, Turkey.
   [Pak, Halil] Izmir Univ Econ, Vocat Sch, Izmir, Turkey.
   [Bakola, Maria] Univ Patras, Postgrad Program Publ Hlth, Patras, Greece.
   [Bhattacharya, Sudip] Himalayan Inst Med Sci, Dehra Dun, Uttarakhand, India.
   [Hoedebecke, Kyle] Oscar Hlth, Utilizat Management, Dallas, TX USA.
   [Jelastopulu, Eleni] Univ Patras, Sch Med, Dept Publ Hlth, Patras, Greece.
RP Gokdemir, O (corresponding author), Izmir Univ Econ, Fac Med, Physiol, Izmir, Turkey.
EM gokdemirozden@gmail.com
RI Bakola, Maria/AAM-4675-2021; Gokdemir, Ozden/W-1663-2017
OI Bakola, Maria/0000-0002-9016-9322; Gokdemir, Ozden/0000-0002-0542-5767;
   Jelastopulu, Eleni/0000-0001-7499-4034; Hoedebecke,
   Kyle/0000-0002-3303-2258; Bhattacharya, Sudip/0000-0001-7935-9013
CR Aasland OG, 2013, GEN HOSP PSYCHIAT, V35, P1, DOI 10.1016/j.genhosppsych.2012.09.005
   Abdel-Khalek AM, 2002, OMEGA-J DEATH DYING, V45, P277, DOI 10.2190/CNP8-BN0U-HB5X-13TG
   Al-Omari A, 2019, DIAGN MICR INFEC DIS, V93, P265, DOI 10.1016/j.diagmicrobio.2018.10.011
   American College of Emergency Physicians (ACEP), ACEP MOURNS LOSS NY
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Balaratnasingam S, 2006, CURR OPIN PSYCHIATR, V19, P171, DOI 10.1097/01.yco.0000214343.59872.7a
   Bujang MA, 2017, EPIDEMIOLBIOSTATIST, V14
   CDC, INF CONTR GUID HEALT
   Cook T, 2020, HLTH SERV J, V2020, P22
   Cooke Fiona J., 2003, International Journal of Infectious Diseases, V7, P80, DOI 10.1016/S1201-9712(03)90001-4
   Cull WL, 2005, HEALTH SERV RES, V40, P213, DOI 10.1111/j.1475-6773.2005.00350.x
   Decieux JP, 2015, PSIHOLOGIJA, V48, P311, DOI 10.2298/PSI1504311D
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Dunlop Catherine, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101041
   Ehrhart MG, 2009, PERS INDIV DIFFER, V47, P900, DOI 10.1016/j.paid.2009.07.012
   Flesia L, STABLE PSYCHOL TRAIT
   Flores G, 2000, J PEDIATR-US, V136, P14, DOI 10.1016/S0022-3476(00)90043-X
   Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1
   Gray K, 2020, MEASURING 2 DISTINCT
   Hardy V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012503
   Hofstede G, 2010, CULTURES ORG, V3rd
   Hofstede G., 2011, ONLINE READ PSYCHOL, V2, P1, DOI [10.9707/2307-0919.1014, DOI 10.9707/2307-0919.1014]
   KASTENBAUM R, 1977, ANNU REV PSYCHOL, V28, P225, DOI 10.1146/annurev.ps.28.020177.001301
   Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   Nunes A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00461
   Orucu MC, 2009, STRESS HEALTH, V25, P103, DOI 10.1002/smi.1218
   PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17
   Romero E, 2012, PERS INDIV DIFFER, V53, P289, DOI 10.1016/j.paid.2012.03.035
   Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988
   Singelis TM, 2006, HISPANIC J BEHAV SCI, V28, P231, DOI 10.1177/0739986306286682
   TEMPLER DI, 1970, J GEN PSYCHOL, V82, P165, DOI 10.1080/00221309.1970.9920634
   Templer DI, 2006, OMEGA-J DEATH DYING, V53, P209, DOI 10.2190/BQFP-9ULN-NULY-4JDR
   THORSON JA, 1992, DEATH STUD, V16, P507, DOI 10.1080/07481189208252595
   Vassar M, 2008, SOC INDIC RES, V86, P47, DOI 10.1007/s11205-007-9113-7
   Weichenthal L, 2017, STIGMA SURROUNDING P
   WHO, COUNTR TECHN GUID CO
   World Health Organization, COR DIS COVID 19 OUT
   Xiong Y, 2020, LANCET GLOB HEALTH, V8, pE740, DOI 10.1016/S2214-109X(20)30214-X
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 40
TC 5
Z9 5
U1 2
U2 3
PU KOREAN SOC ANTIMICROBIAL THERAPY
PI SEOUL
PA 806, SEOCHO TOWN TRAPALACE, 23 SEOCHO-DAERO 74-GIL, SEOCHO-GU, SEOUL,
   06621, SOUTH KOREA
SN 2093-2340
EI 2092-6448
J9 INFECT CHEMOTHER
JI Infect. Chemother.
PD DEC
PY 2020
VL 52
IS 4
BP 539
EP 549
DI 10.3947/ic.2020.52.4.539
PG 11
WC Infectious Diseases
WE Emerging Sources Citation Index (ESCI)
SC Infectious Diseases
GA PN2MP
UT WOS:000604319100007
PM 33124215
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Sotomayor-Castillo, C
   Li, C
   Kaufman-Francis, K
   Nahidi, S
   Walsh, LJ
   Liberali, SA
   Irving, E
   Holden, AC
   Shaban, RZ
AF Sotomayor-Castillo, Cristina
   Li, Cecilia
   Kaufman-Francis, Keren
   Nahidi, Shizar
   Walsh, Laurence J.
   Liberali, Sharon Ac
   Irving, Eithne
   Holden, Alexander Cl
   Shaban, Ramon Z.
TI Australian dentists' knowledge, preparedness, and experiences during the
   COVID-19 pandemic
SO INFECTION DISEASE & HEALTH
LA English
DT Article
DE COVID-19; Dentists; Infection control; Dental health services; Outbreaks
ID PHYSICIANS; INFECTION
AB Background: COVID-19 is a global health crisis. Close contact with the mucous membranes and respiratory secretions of patients and aerosol-generating procedures renders dentists and other oral health professionals at high risk of exposure to SARS-CoV-2. We exam-ined dentists' knowledge, preparedness, and experiences of managing COVID-19 in Australia.
   Methods: A cross-sectional online survey of dentists with a current membership with The Australian Dental Association (ADA) was conducted between March and April 2021.
   Results: Of the 368 survey responses, most dentists (72.3%) reported having a good level of knowledge about COVID-19, with most visiting the ADA Federal COVID-19 (74.7%) and state/territory department of health websites (62.8%), respectively to source up-to-date informa-tion. Most dentists (87.6%) felt prepared to manage COVID-19 into the future, although 66% re-ported not receiving training or certification in the use of PPE. Over half (58.7%) reported not being concerned about contracting SARS-CoV-2 at work, with some (28.9%, n = 98/339) feeling more stressed than usual and having heavier workloads.
   Conclusion: COVID-19 had significant impact in oral healthcare in Australia. Dentistry has adapted to the varied challenges raised by the pandemic. Comprehensive training and detailed guidelines were fundamental for successful patient management during the COVID-19 outbreak. (C) 2021 Australasian College for Infection Prevention and Control. Published by Elsevier B.V. All rights reserved.
C1 [Sotomayor-Castillo, Cristina; Li, Cecilia; Kaufman-Francis, Keren; Nahidi, Shizar; Shaban, Ramon Z.] Univ Sydney, Fac Med & Hlth, Susan Wakil Sch Nursing & Midwifery, Camperdown, NSW, Australia.
   [Sotomayor-Castillo, Cristina; Li, Cecilia; Nahidi, Shizar; Shaban, Ramon Z.] Univ Sydney, Sydney Inst Infect Dis, Camperdown, NSW, Australia.
   [Walsh, Laurence J.] Univ Queensland, Sch Dent, Herston, Qld, Australia.
   [Liberali, Sharon Ac] Univ Adelaide, Adelaide Dent Sch, Adelaide, SA, Australia.
   [Liberali, Sharon Ac] Adelaide Dent Hosp, Special Needs Unit, SA Dent, Adelaide, SA, Australia.
   [Irving, Eithne] Australian Dent Assoc, St Leonards, NSW, Australia.
   [Holden, Alexander Cl] Univ Sydney, Sch Dent, Fac Med & Hlth, Surry Hills, NSW, Australia.
   [Holden, Alexander Cl] Sydney Dent Hosp, Sydney Local Hlth Dist, Surry Hills, NSW, Australia.
   [Shaban, Ramon Z.] Westmead Hosp, Div Infect Dis & Sexual Hlth, Dept Infect Prevent & Control, Westmead, NSW, Australia.
   [Shaban, Ramon Z.] Western Sydney Local Hlth Dist, Westmead, NSW, Australia.
   [Shaban, Ramon Z.] Western Sydney Local Hlth Dist & New South Wales, New South Wales Biocontainment Ctr, North Parramatta, NSW, Australia.
RP Shaban, RZ (corresponding author), Univ Sydney, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia.; Shaban, RZ (corresponding author), Western Sydney Local Hlth Dist, Westmead Hosp, Res & Educ Network, Off 2033,176 Hawkesbury Rd, Westmead, NSW 2145, Australia.
EM cristina.sotomayor@sydney.edu.au; cecilia.z.li@sydney.edu.au;
   kfra3613@uni.sydney.edu.au; l.walsh@uq.edu.au;
   sharon.liberali@sa.gov.au; eithne.irving@ada.org.au;
   alexander.holden@sydney.edu.au; ramon.shaban@sydney.edu.au
RI Li, Cecilia/AAL-7437-2021
OI Li, Cecilia/0000-0002-4100-4580
CR Abbag HF, 2018, J INFECT PUBLIC HEAL, V11, P720, DOI 10.1016/j.jiph.2018.02.001
   Abou-Abbas L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09585-6
   Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Al-Amri S, 2019, J FAM MED PRIM CARE, V8, P455, DOI 10.4103/jfmpc.jfmpc_336_18
   Al-Khalifa KS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237630
   Aldhuwayhi S, 2021, RISK MANAG HEALTHC P, V14, P2851, DOI 10.2147/RMHP.S306880
   Almas K, 2020, EUR J DERMATOL, V14, P563
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   Atukorallaya DS, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.656926
   Australian Dental Association, 2021, RES DENT PROF
   Australian Dental Association, 2020, ADA COVID 19 RISK MA
   Australian Dental Association, 2015, ADAS GUID INF CONTR, V3rd
   Australian Health Protection Principal Committee (AHPPC), 2020, ADV NAT CAB 25 MARCH
   Australian Institute of Health and Welfare, 2021, ORAL HLTH DENT CARE
   Bakaeen LG, 2021, J AM DENT ASSOC, V152, P16, DOI 10.1016/j.adaj.2020.09.022
   Bastani P, 2021, SYST REV-LONDON, V10, DOI 10.1186/s13643-020-01574-5
   Bellini P, 2021, MINERBA DENT ORAL SC, V70, P32, DOI [10.23736/S0026-4970.20.04430-1, 10.23736/S2724-6329.20.04430-1]
   Bhumireddy J, 2021, ENVIRON SCI POLLUT R, V28, P1275, DOI 10.1007/s11356-020-10983-x
   Cagetti MG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113835
   Casillas Santana MA, INT J ENV RES PUBL H, V18
   Collin V, 2021, BRIT DENT J, DOI 10.1038/s41415-020-2592-5
   Consolo U, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103459
   COVID-19 National Incident Room Surveillance Team, 2021, COVID 19 AUSTR EP RE, V45
   De Stefani A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113867
   Deng JF, 2006, PUBLIC HEALTH, V120, P15, DOI 10.1016/j.puhe.2005.10.001
   Dental Practitioner Support, 2021, DENT PRACTITIONER SU
   Estrich CG, 2020, J AM DENT ASSOC, V151, P815, DOI 10.1016/j.adaj.2020.09.005
   Hopcraft M, 2021, COMMUNITY DENT ORAL, V49, P369, DOI 10.1111/cdoe.12611
   Induri SNR, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9060679
   Jungo S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246586
   Kadoya Y, 2021, J CARDIOL, V77, P239, DOI 10.1016/j.jjcc.2020.07.029
   Kamran R, 2021, BMC ORAL HEALTH, V21, DOI 10.1186/s12903-021-01413-6
   Kelly B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2441-7
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Lam SKK, 2018, J CLIN NURS, V27, pE1244, DOI 10.1111/jocn.14210
   Li C, 2021, AUSTRALAS EMERG CARE, V24, P186, DOI 10.1016/j.auec.2021.03.008
   Lo Giudice R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093067
   Lord H, 2021, INTENS CRIT CARE NUR, V62, DOI 10.1016/j.iccn.2020.102946
   Mahdee AF, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.595028
   Mehta S, 2021, LANCET RESP MED, V9, P226, DOI 10.1016/S2213-2600(21)00068-0
   Mekhemar M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10051008
   Mishra S, 2020, J INT SOC PREV COMMU, V10, P794, DOI 10.4103/jispcd.JISPCD_340_20
   Nahidi SS-CC, ANTIVIR CHEM CHEMOTH, V2021, DOI [10.1016/- j.aucc.2021.04.008, DOI 10.1016/-J.AUCC.2021.04.008]
   Nashwan AJ, 2021, NURS OPEN, V8, P695, DOI 10.1002/nop2.674
   Nasser Z, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01273-6
   Nibali L, 2020, J DENT, V102, DOI 10.1016/j.jdent.2020.103481
   Ozarslan M, 2021, CURR PSYCHOL, V40, P3113, DOI 10.1007/s12144-021-01764-x
   Pitigoi D, 2018, PUBLIC HEALTH, V164, P7, DOI 10.1016/j.puhe.2018.07.002
   Sarfaraz S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030232
   Shaukat N, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00299-5
   Sotomayor-Castillo CNS, 2021, INFECTION CONTROL PR
   Stangvaltaite-Mouhat L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165843
   Uhlen MM, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06443-y
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
NR 54
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2468-0451
J9 INFECT DIS HEALTH
JI Infect. Dis. Health
PD FEB
PY 2022
VL 27
IS 1
BP 49
EP 57
DI 10.1016/j.idh.2021.10.001
PG 9
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA YI8XE
UT WOS:000744124900008
PM 34750088
OA Bronze, Green Published
DA 2022-04-20
ER

PT C
AU Ambavi, H
   Vaishnaw, K
   Vyas, U
   Tiwari, A
   Singh, M
AF Ambavi, Heer
   Vaishnaw, Kavita
   Vyas, Udit
   Tiwari, Abhisht
   Singh, Mayank
GP ASSOC COMP MACHINERY
TI COVIDEXPLORER: A Multi-faceted AI-based Search and Visualization Engine
   for COVID-19 Information
SO CIKM '20: PROCEEDINGS OF THE 29TH ACM INTERNATIONAL CONFERENCE ON
   INFORMATION & KNOWLEDGE MANAGEMENT
LA English
DT Proceedings Paper
CT 29th ACM International Conference on Information and Knowledge
   Management (CIKM)
CY OCT 19-23, 2020
CL ELECTR NETWORK
SP Assoc Comp Machinery, ACM SIGIR, ACM SIGWEB
DE COVID-19; Coronaviruses; Search; Visualization; Social Media
AB The entire world is engulfed in the fight against the COVID-19 pandemic, leading to a significant surge in research experiments, government policies, and social media discussions. A multi-modal information access and data visualization platform can play a critical role in supporting research aimed at understanding and developing preventive measures for the pandemic. In this paper, we present a multi-faceted AI-based search and visualization engine, COVIDEXPLORER. Our system aims to help researchers understand current state-of-the-art COVID-19 research, identify research articles relevant to their domain, and visualize real-time trends and statistics of COVID-19 cases. In contrast to other existing systems, CovidExplorer also brings in India-specific topical discussions on social media to study different aspects of COVID-19. The system, demo video, and the datasets are available at http://covidexplorer.in.
C1 [Ambavi, Heer; Vaishnaw, Kavita; Vyas, Udit; Tiwari, Abhisht; Singh, Mayank] Indian Inst Technol, Gandhinagar, Gujarat, India.
RP Singh, M (corresponding author), Indian Inst Technol, Gandhinagar, Gujarat, India.
EM singh.mayank@iitgn.ac.in
FU Google Cloud COVID-19 credits program
FX This work was partially supported by Google Cloud COVID-19 credits
   program.
CR Beltagy I., 2019, P 2019 C EMP METH NA, P3615, DOI DOI 10.18653/V1/D19-1371
   Chen Emily, 2020, ARXIV200307372CSSI
   Dogan RI, 2014, J BIOMED INFORM, V47, P1, DOI 10.1016/j.jbi.2013.12.006
   Hosseini Pedram, 2020, ARXIV200508400
   Huang Ming-Siang, 2019, ABS190110219 CORR
   Muller M., 2020, ARXIV200507503
   Wang Lucy Lu, 2020, ABS200410706 ARXIV
NR 7
TC 2
Z9 2
U1 2
U2 2
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY, UNITED STATES
BN 978-1-4503-6859-9
PY 2020
BP 3365
EP 3368
DI 10.1145/3340531.3417428
PG 4
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS6LW
UT WOS:000749561303063
OA Green Submitted
DA 2022-04-20
ER

PT J
AU Abdalla, W
   Renukappa, S
   Suresh, S
AF Abdalla, Wala
   Renukappa, Suresh
   Suresh, Subashini
TI Managing COVID-19-related knowledge: A smart cities perspective
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article; Early Access
ID BIG-DATA; TACIT KNOWLEDGE; MANAGEMENT; INNOVATION; LESSONS; CITY;
   PERFORMANCE; COMMUNITY; OUTBREAK; CRITIQUE
AB Effective management of coronavirus disease 2019 (COVID-19) and the urgent need to improve epidemic prevention require rapid response and immediate solutions, deploying appropriate knowledge management procedures and facilitating effective decision-making and managerial efforts. The increased adoption of smart cities (SC) technologies offers various technologies that can support knowledge capturing, acquisition, sharing, and transferring. However, knowledge management practitioners and decision-makers face various challenges to manage huge data generated from the various SC platforms. Managing COVID-19-related knowledge necessitates filtering, cleaning, keeping, and sharing only useful data. Therefore, the aim of this paper is to investigate managing knowledge related to COVID-19 from a SC perspective. The methodological approach for this study is a systematic literature review. The findings indicate that SC technologies, through the advanced deployment of information communications technology (ICT) applications, have a crucial role in knowledge capturing and sharing. Smart cities strategies enable knowledge extraction through facilitating data collection and analysis over various disparate databases, as well as facilitating quick and accurate handling and analysis of huge and unpredicted amount of data. Managing knowledge related to COVID-19 pandemic has the potential to improve the planning, treatment and controlling the pandemic, enhance decision-making, and enable disaster management. However, the managing of a huge amount of complex, unstructured data and information remains a big challenge for COVID-19 knowledge management (KM) initiatives. The paper proposes a conceptual model and illustrates the various components and links between SC strategies, KM and COVID-19, and how this can inform, facilitate, and enhance decision-making to take steps for the path of recovery.
C1 [Abdalla, Wala; Renukappa, Suresh; Suresh, Subashini] Univ Wolverhampton, Fac Sci & Engn, Wolverhampton, W Midlands, England.
RP Renukappa, S (corresponding author), Univ Wolverhampton, Fac Sci & Engn, Wolverhampton, W Midlands, England.
EM suresh.renukappa@wlv.ac.uk
CR Abdalla W, 2020, J ENTREP MANAG INNOV, V16, P47, DOI 10.7341/20201642
   Abdulmajeed K, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105683
   ADLER PS, 1990, SLOAN MANAGE REV, V32, P25
   Ahvenniemi H, 2017, CITIES, V60, P234, DOI 10.1016/j.cities.2016.09.009
   Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961
   Allam Z, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010046
   Alomari E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010282
   AMABILE TM, 1988, RES ORGAN BEHAV, V10, P123
   Andres H.P., 2002, TEAM PERFORM MANAG, V8, P39
   Anttiroiko AV, 2021, INT J E-PLAN RES, V10, P1, DOI 10.4018/IJEPR.20210401.oa1
   Batty M, 2012, EUR PHYS J-SPEC TOP, V214, P481, DOI 10.1140/epjst/e2012-01703-3
   Berens J., 2016, MAPPING COMPARING RE
   Bessick J, 2013, S AFR J INFORM MANAG, V15, DOI 10.4102/sajim.v15i2.556
   Bettencourt LMA, 2014, BIG DATA-US, V2, P12, DOI 10.1089/big.2013.0042
   Bolisani E, 2021, KNOWL MAN RES PRACT, V19, P517, DOI 10.1080/14778238.2021.1911606
   Bolisani E, 2020, MANAG MARK, V15, P458, DOI 10.2478/mmcks-2020-0027
   Boulton A., 2011, INT HDB GLOBALIZATIO, P198
   Bragazzi NL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093176
   Bragazzi Nicola Luigi, 2019, Mediterr J Rheumatol, V30, P3, DOI 10.31138/mjr.30.1.3
   Bratianu C., 2015, ORG KNOWLEDGE DYNAMI
   Bratianu C, 2020, MANAGEMENT DYNAMICS, V8, P345
   Bratianu C, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042313
   Bratianu C, 2021, KNOWL PROCESS MANAG, V28, P11, DOI 10.1002/kpm.1656
   Bratianu C, 2021, MANAGE DECIS, V59, P306, DOI 10.1108/MD-05-2019-0559
   Bricout J, 2021, INT J E-PLAN RES, V10, P94, DOI 10.4018/IJEPR.20210401.oa8
   BritainThinks, 2015, LIFE OFFLINE WHAT LI
   Bump J.B., 2021, BMJ-BRIT MED J, V372, P1
   Cai Qinyi, 2020, J Shanghai Jiaotong Univ Sci, V25, P137, DOI 10.1007/s12204-020-2166-3
   Carrillo A.M.P., 2020, INT J MED STUDENTS, V8, P58
   Casado-Aranda LA, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110416
   Cegarra-Navarro JG, 2021, J KNOWL MANAG, DOI 10.1108/JKM-05-2021-0395
   Cegarra-Navarro JG, 2021, J BUS RES, V137, P58, DOI 10.1016/j.jbusres.2021.08.021
   Chakraborty I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138882
   Chan AKM, 2020, ANAESTHESIA, V75, P1579, DOI 10.1111/anae.15057
   Chen HC, 2005, INT SER I S, V8, P3
   Chick RC, 2020, J SURG EDUC, V77, P729, DOI 10.1016/j.jsurg.2020.03.018
   Choi J, 2021, J SUSTAIN TOUR, V29, P540, DOI 10.1080/09669582.2020.1777143
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   Connolly C, 2020, DIALOGUES HUM GEOGR, V10, P213, DOI 10.1177/2043820620934209
   Costa Daniel G., 2020, IET Smart Cities, V2, P64, DOI 10.1049/iet-smc.2020.0044
   Bezerra MCD, 2020, J CLEAN PROD, V247, DOI 10.1016/j.jclepro.2019.119114
   Dalkir K., 2008, BUILDING KNOWLEDGE S, P89
   Dameri RP, 2015, J INTELLECT CAP, V16, P860, DOI 10.1108/JIC-02-2015-0018
   Davenport T., 1998, WORKING KNOWLEDGE OR
   De Las Heras A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12229320
   Deloitte, 2015, SMART CITIES RAPID A
   DESA U, 2018, 68 WORLD POP PROJ LI
   Ehrenberg JP, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-020-00790-4
   Elavarasan RM, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138858
   Farnese ML, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02730
   Ferraris A, 2019, MANAGE DECIS, V57, P1923, DOI 10.1108/MD-07-2018-0825
   Forman R, 2020, HEALTH POLICY, V124, P577, DOI 10.1016/j.healthpol.2020.05.008
   Garavaglia C, 2021, EURASIAN GEOGR ECON, V62, P76, DOI 10.1080/15387216.2020.1845222
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   Goniewicz K, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093838
   Hantrais L., 2021, CONTEMP SOC SCI, V16, P1
   Hart OE, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138875
   Iandolo F, 2021, J KNOWL ECON, V12, P1982, DOI 10.1007/s13132-020-00703-8
   Ivona O., 2009, ANN U ORADEA, V2, P414
   James P, 2020, DIALOGUES HUM GEOGR, V10, P255, DOI 10.1177/2043820620934211
   Kakderi C, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13063158
   Kang W, 2012, 2012 IEEE 23RD INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P2449, DOI 10.1109/PIMRC.2012.6362768
   Katapally TR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19357
   Kazi S, 2020, THROMB RES, V192, P37, DOI 10.1016/j.thromres.2020.05.023
   Khan SU, 2011, J SYST SOFTWARE, V84, P686, DOI 10.1016/j.jss.2010.12.010
   Khowaja S.A., 2021, ARXIV PREPRINT ARXIV
   Kim J, 2011, INT J INFORM MANAGE, V31, P111, DOI 10.1016/j.ijinfomgt.2010.05.011
   Kirchner K, 2021, KNOWL MAN RES PRACT, V19, P493, DOI 10.1080/14778238.2021.1877579
   Kitchenham B., 2004, PROCEDURES PERFORMIN, V33, P1
   Klitmoller A, 2013, J WORLD BUS, V48, P398, DOI 10.1016/j.jwb.2012.07.023
   Kourtit K., 2018, SCI REGIONALI, DOI 10.14650/88819
   Kourtit K, 2012, INNOVATION-ABINGDON, V25, P93, DOI 10.1080/13511610.2012.660331
   Kummitha RKR, 2020, GOV INFORM Q, V37, DOI 10.1016/j.giq.2020.101481
   Laurini R., 2020, LAND USE POLICY, V111, P104832, DOI DOI 10.1016/j.lusepol.2020.104832
   Lee David, 2020, Transp Res Interdiscip Perspect, V5, P100111, DOI 10.1016/j.trip.2020.100111
   Lee K, 2009, GLOB INST, P1
   Liao QY, 2020, J MED INTERNET RES, V22, DOI 10.2196/18796
   Liu M, 2020, PUBLIC HEALTH, V183, P76, DOI 10.1016/j.puhe.2020.05.001
   Liu XH, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041756
   Mariano S, 2021, KNOWL MAN RES PRACT, V19, P484, DOI 10.1080/14778238.2020.1866445
   McAdam R, 2000, NEW TECH WORK EMPLOY, V15, P155, DOI 10.1111/1468-005X.00071
   McAfee A, 2012, HARVARD BUS REV, V90, P60
   Megahed NA, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102350
   Modjarrad K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001935
   Montani F., 2021, R D MANAGEMENT, V52, P193
   Moon MJ, 2020, PUBLIC ADMIN REV, V80, P651, DOI 10.1111/puar.13214
   Mortazavi A., 2021, RADIATION, V1, P18
   Natalicchio A, 2017, J KNOWL MANAG, V21, P1362, DOI 10.1108/JKM-11-2016-0516
   Nathavitharana RR, 2020, J HOSP MED, V15, P299, DOI 10.12788/jhm.3439
   Nguyen H.L., 2020, KNOWLEDGE GRAPH FUSI
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Nonaka I, 1995, KNOWLEDGE CREATING C
   O'Connor C, 2017, J KNOWL MANAG, V21, P156, DOI 10.1108/JKM-08-2016-0357
   Olaimat AN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00254
   Petrovic N.N., 2021, 7 WEB CITY WEB INT R
   Plasek JM, 2020, J AM MED INFORM ASSN, V27, P1139, DOI 10.1093/jamia/ocaa063
   Polanyi M., 1967, TACIT DIMENSION
   Pramanik MI, 2020, EXPERT SYST APPL, V152, DOI 10.1016/j.eswa.2020.113388
   Ren XF, 2020, EURASIAN GEOGR ECON, V61, P423, DOI 10.1080/15387216.2020.1762103
   Rialti R, 2020, MANAGE DECIS, V58, P1585, DOI 10.1108/MD-09-2019-1237
   Roblek Vasja, 2020, dg.o '20: The 21st Annual International Conference on Digital Government Research, P52, DOI 10.1145/3396956.3398263
   Scuotto V, 2016, BUS PROCESS MANAG J, V22, P357, DOI 10.1108/BPMJ-05-2015-0074
   Shah SS, 2020, J HOSP MED, V15, P261, DOI 10.12788/jhm.3441
   Shamsie J, 2013, ORGAN SCI, V24, P513, DOI 10.1287/orsc.1120.0741
   Sharifi A, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.142391
   Sheng J, 2021, BRIT J MANAGE, V32, P1164, DOI 10.1111/1467-8551.12441
   Snow CC, 2016, CALIF MANAGE REV, V59, P92, DOI 10.1177/0008125616683954
   Soda G, 2019, J MANAGE, V45, P1739, DOI 10.1177/0149206317724509
   Sonn J.W., 2020, CONVERSATION
   Sonn JW, 2020, EURASIAN GEOGR ECON, V61, P482, DOI 10.1080/15387216.2020.1768423
   Spraggon M, 2017, MANAGE DECIS, V55, P119, DOI 10.1108/MD-05-2015-0173
   Rao ASRS, 2020, INFECT CONT HOSP EP, V41, P826, DOI 10.1017/ice.2020.61
   Sun Y, 2020, TELEMAT INFORM, V51, DOI 10.1016/j.tele.2020.101402
   Todericiu R, 2019, STUD BUS ECON-ROM, V14, P231, DOI 10.2478/sbe-2019-0056
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Vaishya R, 2020, DIABETES METAB SYND, V14, P337, DOI 10.1016/j.dsx.2020.04.012
   Vera-Baquero A, 2016, TELEMAT INFORM, V33, P793, DOI 10.1016/j.tele.2015.12.005
   Wamba SF, 2017, J BUS RES, V70, P356, DOI 10.1016/j.jbusres.2016.08.009
   Wang SH, 2020, J KNOWL MANAG, V24, P881, DOI 10.1108/JKM-02-2020-0081
   Wang WT, 2021, KNOWL MAN RES PRACT, V19, P468, DOI 10.1080/14778238.2020.1860665
   Wang YC, 2018, TECHNOL FORECAST SOC, V126, P3, DOI 10.1016/j.techfore.2015.12.019
   Weintraub RL, 2021, HEALTH AFFAIR, V40, P33, DOI 10.1377/hlthaff.2020.01523
   Wu T, 2021, AMBIO, V50, P822, DOI 10.1007/s13280-020-01497-4
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia H., 2020, SOCIO EC PLANNING SC, V10
   Xiong, 2020, ARXIV PREPRINT ARXIV
   Yan AH, 2020, J AM MED INFORM ASSN, V27, P991, DOI 10.1093/jamia/ocaa064
   Yigitcanlar T, 2020, ENERGIES, V13, DOI 10.3390/en13061473
   Younan M, 2020, MEASUREMENT, V151, DOI 10.1016/j.measurement.2019.107198
   Zhang J, 2010, CHINA MEDIA RES, V6, P80
   Zhang JY, 2021, TRANSPORT POLICY, V103, P68, DOI 10.1016/j.tranpol.2021.01.011
   Zhou CH, 2020, GEOGR SUSTAIN, V1, P77, DOI 10.1016/j.geosus.2020.03.005
NR 132
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
DI 10.1002/kpm.1706
EA MAR 2022
PG 23
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZS6JP
UT WOS:000768570600001
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Andrabi, S
AF Andrabi, Shazana
TI Decolonising knowledge production in disaster management: a feminist
   perspective
SO DISASTER PREVENTION AND MANAGEMENT
LA English
DT Article; Early Access
DE Feminism; Disaster management; COVID-19; Decolonising knowledge
ID GENDER EQUALITY; COVID-19; IMPACTS
AB Purpose This paper focuses on how feminist research seeks to integrate the inclusion of women in society for them to be active participants in disaster management, and goes on to prove how crucial it is for disaster research to collaborate with feminist research to arrive at a cohesive, interwoven, interdisciplinary field and methodology, while at the same time giving the agency in the hands of local agents for them to bring about change through traditional methods interwoven with broader methodologies. To hand over the process to local agents would result in decolonisation of knowledge production and implementation. Design/methodology/approach The paper was written using secondary sources, mainly in the form of books, journal articles and news articles. Reports by international organisations were used to augment data and other theoretical frameworks and references in the paper. The secondary sources were selected keeping in view one of the primary objectives of the paper, namely "decolonising knowledge production". Analysis by postcolonial authors from the global South has been included. Research and literature based in local contexts form an important part of the sources consulted throughout this paper. The ongoing COVID-19 pandemic has been used as a case study to highlight how disasters are still "gendered"; it opens up space for further research on the topic. Findings Even though women are increasingly recognised as agents of positive change in prevention, mitigation and post-disaster efforts, very little is done at the policy and implementation levels to include their experiences and benefit from them. There is an urgent need for systemic, gender-aware changes at socio-economic and political levels so that hazards may be prevented from turning into disasters by reducing the vulnerability of populations. Originality/value The importance of this research lies in its interdisciplinary approach and the integration of three fields of study disaster management, feminist/gender studies and decolonising knowledge production. The attempt is to analyse the interdependence of these fields of study to understand the lacunae in planning and implementation of disaster management policies, and to pave the way for further research by way of this integration.
C1 [Andrabi, Shazana] Islamic Univ Sci & Technol, Awantipora, India.
RP Andrabi, S (corresponding author), Islamic Univ Sci & Technol, Awantipora, India.
EM shazana20@yahoo.com
OI Andrabi, Shazana/0000-0001-8333-4003
CR Adjei P. B., 2007, CANADIAN J ED, V30, P1046, DOI DOI 10.2307/20466678
   Aguilar L., ACKNOWLEDGING LINKAG
   Anderson M. B., 1994, Focus on Gender, V2, P7
   [Anonymous], 2021, UN NEWS
   Austin KF, 2016, SOC FORCES, V95, P355, DOI 10.1093/sf/sow056
   Banford A., 2015, JIWS, V16, P170
   Basher R, 2008, SOC RES, V75, P937
   Dehingia N, 2021, LANCET GLOB HEALTH, V9, pE14, DOI 10.1016/S2214-109X(20)30464-2
   DeVault, 1999, LIBERATING METHOD FE
   Devisch R., 2005, AFRICA DEV AFRIQUE D, V30, P1
   Enarson E., 1998, GENDERED TERRAIN DIS, P1
   Fothergill, 1996, INT J MASS EMERGENCI, V14, P33
   Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X
   JAIN S, 1984, ECON POLIT WEEKLY, V19, P1788
   Kaul N, 2021, J IMP COMMONW HIST, V49, P629, DOI 10.1080/03086534.2021.1883245
   Kelman I, 2012, GEOGRAPHY, V97, P12
   Law WW, 1997, COMP EDUC, V33, P187, DOI 10.1080/03050069728523
   Madgavkar A., 2020, COVID 19 GENDER EQUA
   Molden D, 2014, MT RES DEV, V34, P297, DOI 10.1659/MRD-JOURNAL-D-14-00064
   Neumayer E, 2007, ANN ASSOC AM GEOGR, V97, P551, DOI 10.1111/j.1467-8306.2007.00563.x
   O'Mathuna D.P., 2018, DISASTERS CORE CONCE, DOI [10.1007/978-3-319-92722-0, DOI 10.1007/978-3-319-92722-0]
   OKEEFE P, 1976, NATURE, V260, P566, DOI 10.1038/260566a0
   OliverSmith A, 1996, ANNU REV ANTHROPOL, V25, P303, DOI 10.1146/annurev.anthro.25.1.303
   Quilo Q., 2015, SPECIAL ISSUE SOCIOL, V63, P105
   Ramani S, 2011, ECON POLIT WEEKLY, VXLVI, P17
   Revet S., 2020, COVID 19 NATURAL DIS
   Rumbach A, 2014, ECOL SOC, V19, DOI 10.5751/ES-06189-190119
   Sahapedia, 2020, A DEVI 362 BISHN SAC
   Said E, 2001, ORIENTALISM
   Sen A, 2001, J PUBLIC HEALTH POL, V22, P169, DOI 10.2307/3343457
   Spivak G.C., 1988, MARXISM INTERPRETATI, P271, DOI 10.5840/philosophin200314275
   Thorat M, 2008, ECON POLIT WEEKLY, V43, P73
   Tyagi A., 2010, INDIAN J POLITICAL S, V71, P9
   UN Women, 2020, SURV SHOW COVID 19 G
   UNDP, 2010, GEND DIS
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   World Health Organization, 2002, GEND HLTH DIS
   Yadav P, 2021, INT J DISAST RISK RE, V54, DOI 10.1016/j.ijdrr.2020.102026
NR 38
TC 0
Z9 0
U1 2
U2 2
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0965-3562
EI 1758-6100
J9 DISASTER PREV MANAG
JI Disaster Prev. Manag.
DI 10.1108/DPM-04-2021-0154
EA NOV 2021
PG 13
WC Environmental Studies; Public, Environmental & Occupational Health;
   Management
WE Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Business & Economics
GA WU0KC
UT WOS:000716242600001
DA 2022-04-20
ER

PT J
AU Zhou, Y
   Fang, JJ
   Wang, SS
AF Zhou, Yun
   Fang, Jing-Jing
   Wang, Shan-Shan
TI Discussion on the Management Method of COVID-19 Infection Prevention in
   Medical Residents
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Medical resident; Homogenization management; COVID-19; China
AB Background: To explore the homogenized management method of infection prevention and control in medical resident under COVID-19 epidemic situation.
   Methods: Overall, 268 members in Ningbo Medical Group which was participating in the management of novel coronavirus pneumonia in Wuhan, China were managed homogeneously in terms of personal cleaning and disinfection of articles, prevention and control of infection in life, training and assessment of relevant infection knowledge in hospitals.
   Results: In the epidemic situation, the homogenization management of infection prevention and control in the resident of medical team is an important measure to block the transmission link.
   Conclusion: 1. Conduct homogenization management on the training of hospital infection knowledge for medical staff. 2. Conduct homogeneous management of effective assessment of training knowledge. 3. Conduct homogenization management from personal cleaning and disinfection, as well as infection prevention and control in daily life.
C1 [Zhou, Yun] Med Sch, Affiliated Hosp, Dept Emergency, Ningbo 315020, Zhejiang, Peoples R China.
   [Fang, Jing-Jing; Wang, Shan-Shan] Med Sch, Affiliated Hosp, Dept Intens Care Unit, Ningbo 315020, Zhejiang, Peoples R China.
RP Wang, SS (corresponding author), Med Sch, Affiliated Hosp, Dept Intens Care Unit, Ningbo 315020, Zhejiang, Peoples R China.
EM fywangshanshan@nbu.edu.cn
CR Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   WHO, 2020, ADV US MASKS COMM HO
   WHO, 2020, INF PREV CONTR HLTH
NR 3
TC 0
Z9 0
U1 5
U2 5
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PY 2020
VL 49
SU 1
BP 87
EP 91
PG 5
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA LL8AA
UT WOS:000531776100012
PM 34268210
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Tripathi, YB
   Joshi, N
   Dubey, SK
   Byadgi, PS
   Bhat, S
   Prasad, R
   Dwivedi, BK
   Pandey, KK
   Tripathi, JS
   Pandey, CS
   Murthy, KHHVSSN
   Suman, S
   Pandey, AK
   Srivastava, V
   Jaisawal, V
   Dwivedi, KN
AF Tripathi, Y. B.
   Joshi, N.
   Dubey, S. K.
   Byadgi, P. S.
   Bhat, S.
   Prasad, R.
   Dwivedi, B. K.
   Pandey, K. K.
   Tripathi, J. S.
   Pandey, C. S.
   Murthy, K. H. H. V. S. S. N.
   Suman, S.
   Pandey, A. K.
   Srivastava, V
   Jaisawal, V
   Dwivedi, K. N.
TI Management of COVID-19: Ayurvedic perspective
SO INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE
LA English
DT Article
DE Astang Ayurveda; Ayurvedic-guideline; Bhootvidya; COVID-19; Treatment-
   protocol
ID MINDFULNESS; KIDNEY
AB Ayurveda a branch of AYUSH system of health care in India is considered as alternative/complementary of medicine (CAM) in WHO. Here, its products are covered under.drug and cosmetics. act but in abroad they are supplements or functional foods. The aim of Ayurveda is to maintain the wellness of a healthy person and to treat a patient. For treatment, Ayurveda adopts 3 approaches i.e., (1) Daivavyapasharya chikitsa) (ypareht enivid2( Yuktivyapashraya chikitsa (Rational therapy) 3 Satvavajaya chikitsa (Psychotherapy) and focuses to enhance the Vyadhikshmatwa (capacity to fight against spread of pathogenesis by strengthening all 7 dhatus (rasa, rakta, meda, mansa, asthi, majja and shukra). The disease COVID-19 falls under.Bhootvidya (GrahaVidya)., which is one of the 8 branches of.Astanga Ayurveda.. It is an.Agantuja. disease, where the disease symptoms appear in 1st stage followed by its spread in the body. Thus, progress of disease (Samprapti) has been considered under concept of shatkriyakala (6 stages of disease development), which has been given high importance for deciding the stage of disease progress and its treatment protocol. Here, we have described the introduction to Astang Ayurveda, concept of disease pathogenesis and holistic approach of treatment in respect to management of COVID-19. It specifically covers symptom based stage of disease progress and its targeted treatment guideline by including all 3 approaches of treatment, described above. Here, the current line of diagnosis, treatment and research related to COVID-19 management has been included, which are reported by basic scientists and physicians of allopathic system. These are indexed in Pubmed and web of science and also described in classical text books of Ayurveda. The same has been reviewed and summarized here, with an objective of possible correlation between the 2 languages of science of health care.
C1 [Tripathi, Y. B.; Joshi, N.; Dubey, S. K.; Byadgi, P. S.; Bhat, S.; Prasad, R.; Dwivedi, B. K.; Pandey, K. K.; Tripathi, J. S.; Pandey, C. S.; Murthy, K. H. H. V. S. S. N.; Suman, S.; Pandey, A. K.; Srivastava, V; Jaisawal, V; Dwivedi, K. N.] Banaras Hindu Univ, Fac Ayurveda, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.
RP Tripathi, YB (corresponding author), Banaras Hindu Univ, Fac Ayurveda, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.
EM yamini@bhu.ac.in; kndbhu@gmail.com
RI Tripathi, Yamini Bhusan/Q-6160-2019
OI Tripathi, Yamini Bhusan/0000-0002-8093-1109; joshi,
   namrata/0000-0001-8023-8390
CR Anantkumar V, 2013, INT J ADV AYURVEDA Y, V2, P143
   [Anonymous], 2005, SHARANGADHAR SAMHITA
   [Anonymous], 1971, RASA TARANGINI
   [Anonymous], 2007, SUSHRUT SAMHITA NIBA
   [Anonymous], 1998, SUSHRUT SAMHITA SUTR
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 1998, CHARAKA SAMHITA CHIK
   [Anonymous], 2007, SUSHRUT SAMHITA NIBA
   [Anonymous], 1992, CHARAKA SAMHITA NIDA
   [Anonymous], 1998, CHARAKA SAMHITA CHIK
   [Anonymous], 2000, ASTANGA HRDAYAM SARV
   [Anonymous], **DROPPED REF**
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 1984, SIDDHA YOGA SANGRAHA
   [Anonymous], 2017, J COMPLEMENT INTEGR, DOI DOI 10.1007/S11128-017-1661-4
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 1998, CHARAKA SAMHITA CHIK
   [Anonymous], 1998, CHARAKA SAMHITA CHIK
   [Anonymous], 1997, BHAISHAJYA RATNAVALI
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 1992, CHARAKA SAMHITA SUST
   [Anonymous], 1992, CHARAKA SAMHITA VIMA
   [Anonymous], 1988, SUSHRUT SAMHITA NIDA
   [Anonymous], 1998, CHARAKA SAMHITA CHIK
   [Anonymous], 1971, RASA TARANGINI
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 2009, SUSHRUT SAMHITA NIBA
   [Anonymous], 1998, CHARAKA SAMHITA CHIK
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 2007, SUSHRUTA SAMHITA KAL
   [Anonymous], 1992, CHARAKA SAMHITA SUTR
   [Anonymous], 2000, ASHTANGA HRDAYAM SAR
   Bhatwalkar SB, 2019, J AYURVEDA INTEGR ME, V10, P203, DOI 10.1016/j.jaim.2019.05.002
   Birla H, 2019, BEHAV BRAIN FUNCT, V15, DOI 10.1186/s12993-019-0160-4
   BURNET M, 1954, BRIT MED J, V2, P189, DOI 10.1136/bmj.2.4881.189
   Cacho NT, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00584
   Carneiro E M, 2018, J COMPLEMENT INTEGR, V15
   Casula C, 2018, ANN PALLIAT MED, V7, P32, DOI 10.21037/apm.2017.07.07
   Chang SY, 2018, NEURAL REGEN RES, V13, P1711, DOI 10.4103/1673-5374.238605
   Chu XT, 2014, ASIAN PAC J CANCER P, V15, P4809, DOI 10.7314/APJCP.2014.15.12.4809
   Colson P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105932
   Cortes-Rojas Diego Francisco, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P90, DOI 10.1016/S2221-1691(14)60215-X
   Davidson RJ, 2015, AM PSYCHOL, V70, P581, DOI 10.1037/a0039512
   Durrant DM, 2016, ACS CHEM NEUROSCI, V7, P464, DOI 10.1021/acschemneuro.6b00043
   Ghoke SS, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2238-1
   Gonzalez-Quilen C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050979
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Gupta B. B. P., 2005, Indian Journal of Experimental Biology, V43, P115
   Hai AH, 2019, DRUG ALCOHOL DEPEN, V202, P134, DOI 10.1016/j.drugalcdep.2019.04.045
   Haque MI, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2129-5
   Hinton DE, 2017, CULT MED PSYCHIAT, V41, P3, DOI 10.1007/s11013-016-9493-8
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Jadhav P, 2012, N AM J MED SCI, V4, P641, DOI 10.4103/1947-2714.104316
   Kumar G, 2014, INDIAN J MED RES, V139, P610
   Lane MR, 2008, CANCER NURS, V31, pE24, DOI 10.1097/01.NCC.0000305719.90894.e9
   Lichtenstein AH, 2017, ANN PALLIAT MED, V6, P248, DOI 10.21037/apm.2017.06.16
   Lodi S, 2011, INDIAN J PHARMACOL, V43, P441, DOI 10.4103/0253-7613.83118
   Lv JJ, 2015, PHYTOCHEMISTRY, V117, P123, DOI 10.1016/j.phytochem.2015.06.001
   Nene YL, 2014, ASIAN AGRIHISTORY, V18, P23
   Pal M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7423
   Pandey AK, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02161
   Paul Willi, 2011, Int J Ayurveda Res, V2, P14, DOI 10.4103/0974-7788.83183
   Puchalski CM, 2018, HEMATOL ONCOL CLIN N, V32, P505, DOI 10.1016/j.hoc.2018.01.011
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Roy S, 2015, PHARMACOGN RES, V7, P263, DOI 10.4103/0974-8490.157977
   Ruiz L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00696
   Sharma U, 2012, J ETHNOPHARMACOL, V141, P918, DOI 10.1016/j.jep.2012.03.027
   Shree P, 2022, J BIOMOL STRUCT DYN, V40, P190, DOI 10.1080/07391102.2020.1810778
   Teut M, 2019, COMPLEMENT MED RES, V26, P265, DOI 10.1159/000496736
   Trammell SAJ, 2016, J NUTR, V146, P957, DOI 10.3945/jn.116.230078
   van der Hoek L, 2007, ANTIVIR THER, V12, P651
   Wallin J E Wallace, 1914, Psychol Clin, V8, P170
   Wani N. S., 2013, International Journal of PharmTech Research, V5, P40
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yao L, 2014, IMMUNOL LETT, V161, P76, DOI 10.1016/j.imlet.2014.05.001
   Yoon YC, 2012, BIOFACTORS, V38, P360, DOI 10.1002/biof.1025
   Yoshii K, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00048
NR 79
TC 1
Z9 1
U1 1
U2 2
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0972-5938
EI 0975-1068
J9 INDIAN J TRADIT KNOW
JI Indian J. Tradit. Knowl.
PD DEC
PY 2020
VL 19
IS 4
SI SI
BP S69
EP S80
PG 12
WC Plant Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences
GA QJ6AA
UT WOS:000619769800009
DA 2022-04-20
ER

PT J
AU Haneberg, DH
AF Haneberg, Dag Hakon
TI Interorganizational learning between knowledge-based entrepreneurial
   ventures responding to COVID-19
SO LEARNING ORGANIZATION
LA English
DT Article
DE Interorganizational learning; COVID-19; Coronavirus; Startups;
   Quantitative
ID ABSORPTIVE-CAPACITY; COMPETITIVE ADVANTAGE; SOCIAL NETWORKS; BUSINESS;
   INNOVATION; PERSPECTIVES; CAPABILITIES; ORIENTATION; PERFORMANCE; MODEL
AB Purpose
   The COVID-19 crisis has significantly affected entrepreneurial ventures, where knowledge resources are limited and contextual uncertainty is heightened. This paper aims to identify if and how interorganizational learning (IOL) may assist entrepreneurial ventures adapt, survive and grow in a crisis.
   Design/methodology/approach
   The following research question is asked: How may responding to the adversity induced by the COVID-19 pandemic affect IOL between entrepreneurial ventures? Four hypotheses were developed to carry out a quantitative study of 228 knowledge-based entrepreneurial ventures in Norway.
   Findings
   The results illustrate how different combinations of adversity from COVID-19 and the active responses conducted by entrepreneurial ventures influence IOL. Four clusters representing different behaviors are developed accordingly as follows: "collaborators", "supporters", "responders" and "victims." The findings provide empirical support for the importance of engaging in interactive and collaborative activities for IOL.
   Research limitations/implications
   The findings can help in understanding how COVID-19 influences IOL between entrepreneurial ventures. Policymakers may use these findings to promote organizational continuity in entrepreneurial ventures by creating and nurturing support systems that promote IOL during a crisis.
   Originality/value
   Studying a contemporary and critical situation - the COVID-19 pandemic - the present paper provides an empirical study of the antecedents to IOL, adding to the currently scarce body of research on IOL in and between entrepreneurial ventures.
C1 [Haneberg, Dag Hakon] Norwegian Univ Sci & Technol, Dept Ind Econ & Technol Management, Trondheim, Norway.
RP Haneberg, DH (corresponding author), Norwegian Univ Sci & Technol, Dept Ind Econ & Technol Management, Trondheim, Norway.
EM dag.haneberg@ntnu.no
RI Haneberg, Dag Håkon/AAH-3890-2021
CR acs Z.J., 2015, GLOBAL ENTREPRENEURS
   Anand A, 2021, LEARN ORGAN, V28, P111, DOI 10.1108/TLO-02-2020-0023
   Brix J, 2019, LEARN ORGAN, V26, P337, DOI 10.1108/TLO-02-2019-0034
   Brockman B. K., 2013, J SMALL BUSINESS ENT, V26, P261, DOI DOI 10.1080/08276331.2013.803673
   Bruneel J, 2010, STRATEG ENTREP J, V4, P164, DOI 10.1002/sej.89
   Cao FY, 2009, COMPUT MATH APPL, V58, P474, DOI 10.1016/j.camwa.2009.04.017
   Choi K, 2019, INT MARKET REV, V36, P1042, DOI 10.1108/IMR-07-2017-0130
   Chou SY, 2019, LEARN ORGAN, V26, P132, DOI 10.1108/TLO-10-2018-0168
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   Cope J, 2005, ENTREP THEORY PRACT, V29, P373, DOI 10.1111/j.1540-6520.2005.00090.x
   Cope J, 2003, MANAGE LEARN, V34, P429, DOI 10.1177/1350507603039067
   Corey CM, 2011, J CONTING CRISIS MAN, V19, P169, DOI 10.1111/j.1468-5973.2011.00642.x
   Davidsson P, 2003, J BUS VENTURING, V18, P301, DOI 10.1016/S0883-9026(02)00097-6
   Deakins D., 1998, LEARN ORGAN, V5, P144, DOI [10.1108/09696479810223428, DOI 10.1108/09696479810223428]
   Doern R, 2019, ENTREP REGION DEV, V31, P400, DOI 10.1080/08985626.2018.1541590
   Doern R, 2016, ENTREP REGION DEV, V28, P471, DOI 10.1080/08985626.2016.1198091
   Doern R, 2016, INT SMALL BUS J, V34, P276, DOI 10.1177/0266242614553863
   Dutta DK, 2005, ENTREP THEORY PRACT, V29, P425, DOI 10.1111/j.1540-6520.2005.00092.x
   Easterby-Smith M, 2008, J MANAGE STUD, V45, P677, DOI 10.1111/j.1467-6486.2008.00773.x
   Eiriz V, 2017, EUR J INNOV MANAG, V20, P230, DOI 10.1108/EJIM-11-2015-0117
   El-Awad Z, 2017, INT J ENTREP BEHAV R, V23, P381, DOI 10.1108/IJEBR-06-2016-0177
   Eltibi M.F., 2011, INT J COMPUTER APPL, V29, P51
   Fang SC, 2010, INT SMALL BUS J, V28, P90, DOI 10.1177/0266242609350853
   Franco M, 2009, J SMALL BUS ENTERP D, V16, P628, DOI 10.1108/14626000911000965
   Fredrich V, 2019, J BUS RES, V101, P862, DOI 10.1016/j.jbusres.2018.11.038
   GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311
   Greve A, 2003, ENTREP THEORY PRACT, V28, P1, DOI 10.1111/1540-8520.00029
   Haneberg DH, 2019, LEARN ORGAN, V26, P631, DOI 10.1108/TLO-04-2018-0064
   Hayter CS, 2013, SMALL BUS ECON, V41, P899, DOI 10.1007/s11187-013-9512-x
   Herbane B, 2010, INT SMALL BUS J, V28, P43, DOI 10.1177/0266242609350804
   Holmqvist M, 2003, ORGAN STUD, V24, P95, DOI 10.1177/0170840603024001684
   Huber GP, 1991, ORGAN SCI, V2, P88, DOI 10.1287/orsc.2.1.88
   Irvine W., 2004, INT J ENTREP BEHAV R, V10, P229, DOI [10.1108/13552550410544204, DOI 10.1108/13552550410544204]
   Janowicz-Panjaitan M, 2008, RES POLICY, V37, P1337, DOI 10.1016/j.respol.2008.04.025
   Jones O, 2006, LONG RANGE PLANN, V39, P155, DOI 10.1016/j.lrp.2005.02.012
   Karatas-Ozkan M, 2011, ENTREP REGION DEV, V23, P877, DOI 10.1080/08985626.2011.577817
   KRACKHARDT D, 1992, NETWORKS AND ORGANIZATIONS : STRUCTURE, FORM, AND ACTION, P216
   Kruckenberg LJ, 2015, ENERGY SUSTAIN DEV, V29, P91, DOI 10.1016/j.esd.2015.10.003
   Kuckertz A., 2020, J BUS VENTURING INSI, DOI 10.1016/j.jbvi.2020.e00169
   Kwong CCY, 2019, ENTREP REGION DEV, V31, P435, DOI 10.1080/08985626.2018.1541592
   Lane PJ, 1998, STRATEGIC MANAGE J, V19, P461, DOI 10.1002/(SICI)1097-0266(199805)19:5<461::AID-SMJ953>3.0.CO;2-L
   Larsson R, 1998, ORGAN SCI, V9, P285, DOI 10.1287/orsc.9.3.285
   Laskovaia A, 2019, ENTREP REGION DEV, V31, P456, DOI 10.1080/08985626.2018.1541593
   Lefebvre V, 2015, ENTREP REGION DEV, V27, P500, DOI 10.1080/08985626.2015.1070539
   Leung A, 2019, MANAG RES REV, V42, P122, DOI 10.1108/MRR-02-2018-0057
   Levesque M, 2009, ENTREP THEORY PRACT, V33, P547, DOI 10.1111/j.1540-6520.2009.00303.x
   Makles A, 2012, STATA J, V12, P347, DOI 10.1177/1536867X1201200213
   Mansoori Y, 2017, INT J ENTREP BEHAV R, V23, P812, DOI 10.1108/IJEBR-06-2016-0195
   Manuj I, 2013, TRANSPORT J, V52, P463
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Mariotti F, 2012, KNOWL PROCESS MANAG, V19, P215, DOI 10.1002/kpm.1395
   Martinelli E, 2018, INT J ENTREP BEHAV R, V24, P1222, DOI 10.1108/IJEBR-11-2016-0386
   Miao C., 2017, J BUSINESS VENTURING, V8, P93, DOI DOI 10.1016/J.JBVI.2017.07.003
   Miller JI, 2012, STRATEG ENTREP J, V6, P59, DOI 10.1002/sej.1128
   Munoz P, 2019, ENTREP REGION DEV, V31, P413, DOI 10.1080/08985626.2018.1541591
   Nogueira TF, 2019, LEARN ORGAN, V26, P560, DOI 10.1108/TLO-04-2018-0067
   Olsson A, 2010, ACTION LEARN, V7, P167, DOI 10.1080/14767333.2010.488328
   Ortenblad A, 2018, LEARN ORGAN, V25, P150, DOI 10.1108/TLO-02-2018-0016
   Peltier JW, 2012, J SMALL BUS ENTERP D, V19, P56, DOI 10.1108/14626001211196406
   Peronard JP, 2019, LEARN ORGAN, V26, P276, DOI 10.1108/TLO-08-2018-0137
   Pina-Stranger A, 2011, SOCIOL QUART, V52, P268, DOI 10.1111/j.1533-8525.2011.01204.x
   Pratono AH, 2019, BOTTOM LINE, V32, P2, DOI 10.1108/BL-10-2018-0045
   Rajala A, 2018, J BUS IND MARK, V33, P574, DOI 10.1108/JBIM-08-2017-0205
   Rejeb-Khachlouf N, 2011, J SMALL BUS ENTERP D, V18, P278, DOI 10.1108/14626001111127070
   Saunders MNK, 2014, EUR J TRAIN DEV, V38, P136, DOI 10.1108/EJTD-07-2013-0073
   Scarmozzino E, 2017, INT J ENTREP BEHAV R, V23, P406, DOI 10.1108/IJEBR-12-2015-0302
   Seet PS, 2018, ASIA PAC BUS REV, V24, P233, DOI 10.1080/13602381.2018.1431250
   Seo R, 2020, J KNOWL MANAG, V24, P395, DOI 10.1108/JKM-06-2019-0265
   Smallbone D, 2012, INT SMALL BUS J, V30, P754, DOI 10.1177/0266242612448077
   Soetanto D, 2017, INT J ENTREP BEHAV R, V23, P547, DOI 10.1108/IJEBR-11-2015-0230
   Storey DJ, 1998, RES POLICY, V26, P933, DOI 10.1016/S0048-7333(97)00052-8
   Taylor D.W., 2004, J SMALL BUS ENTERP D, V11, P203
   Williams N, 2014, ENTREP REGION DEV, V26, P257, DOI 10.1080/08985626.2014.894129
   Wooldridge J.M, 2016, INTRO ECONOMETRICS M
   Wu WQ, 2021, J TECHNOL TRANSFER, V46, P1707, DOI 10.1007/s10961-020-09790-w
   Yang TT, 2017, SOC SCI RES, V63, P36, DOI 10.1016/j.ssresearch.2016.09.006
NR 76
TC 3
Z9 3
U1 4
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0969-6474
EI 1758-7905
J9 LEARN ORGAN
JI Learn. Organ.
PD MAY 13
PY 2021
VL 28
IS 2
SI SI
BP 137
EP 152
DI 10.1108/TLO-05-2020-0101
EA OCT 2020
PG 16
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA SF2OE
UT WOS:000590738800001
OA Green Submitted, Bronze
DA 2022-04-20
ER

PT J
AU Gavriilaki, E
   Eftychidis, I
   Papassotiriou, I
AF Gavriilaki, Eleni
   Eftychidis, Ioannis
   Papassotiriou, Ioannis
TI Update on endothelial dysfunction in COVID-19: severe disease, long
   COVID-19 and pediatric characteristics
SO JOURNAL OF LABORATORY MEDICINE
LA English
DT Review
DE COVID-19; endothelial dysfunction; long COVID-19; pediatric; SARS-COV-2;
   thrombosis
ID ACUTE RESPIRATORY SYNDROME; VON-WILLEBRAND-FACTOR; VENOUS THROMBOEMBOLIC
   EVENTS; ACUTE LIMB ISCHEMIA; P-SELECTIN; SYNDROME CORONAVIRUS;
   VIRAL-INFECTIONS; SYNDROME SARS; MECHANISMS; PATHOLOGY
AB Objectives: To review current literature on the role of endothelial dysfunction in coronavirus disease-2019 (COVID-19) infection in terms of pathophysiology, laboratory features and markers, clinical phenotype in adults and children, as well as long COVID-19. Content: We conducted a thorough assessment of the literature and critically analyzed current data, mostly utilizing the PubMed and Medline search engines to find original studies published in the previous decade. Summary and Outlook: Accumulating evidence suggests that endothelial dysfunction may be a common denominator of severe COVID-19 in adults and children, as well as long COVID-19, implicating mutual pathophysiological pathways. This narrative review summarizes the up-to-date knowledge of endothelial dysfunction caused by COVID-19, including novel aspects of long COVID-19 and pediatric disease. This knowledge is important in order not only to understand the multisystemic attack of COVID-19, but also to improve patient management and prognosis.
C1 [Papassotiriou, Ioannis] Aghia Sophia Childrens Hosp Athens, Dept Clin Biochem, Athens, Greece.
   [Papassotiriou, Ioannis] Emerging Technol Pediat Lab Med C ETPLM, IFCC Emerging Technol Div, Milan, Italy.
   [Gavriilaki, Eleni; Eftychidis, Ioannis] G Papanikolaou Hosp, BMT Unit, Hematol Dept, Thessaloniki, Greece.
RP Papassotiriou, I (corresponding author), Aghia Sophia Childrens Hosp Athens, Dept Clin Biochem, Athens, Greece.; Papassotiriou, I (corresponding author), Emerging Technol Pediat Lab Med C ETPLM, IFCC Emerging Technol Div, Milan, Italy.
EM biochem@paidon-agiasofia.gr
FU AMERICAN SOCIETY OF HEMATOLOGY (ASH) Global Research Award
FX Given the broad scope of this review, the authors often refer to
   specialized review articles rather than primary literature, and they
   have been able to include only selected examples of original work in the
   field. Therefore, the authors thank colleagues who are not specifically
   cited for their contribution and their understanding. E.G. is supported
   by the AMERICAN SOCIETY OF HEMATOLOGY (ASH) Global Research Award 2020.
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   [Anonymous], 2020, LANCET, V396, P1861, DOI 10.1016/S0140-6736(20)32662-3
   Avula A, 2020, BRAIN BEHAV IMMUN, V87, P115, DOI 10.1016/j.bbi.2020.04.077
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Bellosta R, 2020, J VASC SURG, V72, P1864, DOI 10.1016/j.jvs.2020.04.483
   Benussi A, 2020, NEUROLOGY, V95, pE910, DOI 10.1212/WNL.0000000000009848
   Bevers LM, 2006, HYPERTENSION, V47, P87, DOI 10.1161/01.HYP.0000196735.85398.0e
   Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021
   Boonyawat K, 2020, THROMB J, V18, DOI 10.1186/s12959-020-00248-5
   Bryckaert M, 2015, CELL MOL LIFE SCI, V72, P307, DOI 10.1007/s00018-014-1743-8
   Buchtele N, 2018, THROMB HAEMOSTASIS, V118, P959, DOI 10.1055/s-0038-1648251
   Bularga A, 2021, CLIN CHEM, V67, P1044, DOI 10.1093/clinchem/hvab111
   Busch MH, 2020, CIRCULATION, V142, P1787, DOI 10.1161/CIRCULATIONAHA.120.050656
   Cambien B, 2004, TRENDS MOL MED, V10, P179, DOI 10.1016/j.molmed.2004.02.007
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Cheung EW, 2020, JAMA-J AM MED ASSOC, V324, P294, DOI 10.1001/jama.2020.10374
   Chi G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082489
   Chua TH, 2020, BRAIN INJURY, V34, P1549, DOI 10.1080/02699052.2020.1831606
   Ciceri F, 2020, CRIT CARE RESUSC, V22, P95
   Collantes MEV, 2021, CAN J NEUROL SCI, V48, P66, DOI [10.1017/cjn.2020.146, 10.1145/3334480.3382865]
   Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8
   De Michieli L, 2021, CLIN CHEM, V67, P1080, DOI 10.1093/clinchem/hvab062
   Di Minno A, 2020, SEMIN THROMB HEMOST, V46, P763, DOI 10.1055/s-0040-1715456
   Ding YQ, 2003, J PATHOL, V200, P282, DOI 10.1002/path.1440
   Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875
   Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
   Ergul E, 2022, INT J CARDIOVAS IMAG, V38, P25, DOI 10.1007/s10554-021-02356-3
   Favas TT, 2020, NEUROL SCI, V41, P3437, DOI 10.1007/s10072-020-04801-y
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Fu LH, 2021, CLIN CARDIOL, V44, P276, DOI 10.1002/clc.23540
   Gavriilaki E, 2021, CLIN IMMUNOL, V226, DOI 10.1016/j.clim.2021.108726
   Gavriilaki E, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-01078-6
   Gavriilaki E, 2020, BRIT J HAEMATOL, V189, pE227, DOI 10.1111/bjh.16783
   Gavriilaki E, 2020, J CLIN INVEST, V130, P2152, DOI 10.1172/JCI136094
   Gavriilaki E, 2019, THROMB HAEMOSTASIS, V119, P1433, DOI 10.1055/s-0039-1692721
   Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362
   Gkaliagkousi E, 2019, AM J HYPERTENS, V32, P1199, DOI 10.1093/ajh/hpz116
   Gkaliagkousi E, 2018, J CLIN HYPERTENS, V20, P680, DOI 10.1111/jch.13237
   Gkaliagkousi E, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0596-3
   Godo S, 2017, ARTERIOSCL THROM VAS, V37, pE108, DOI 10.1161/ATVBAHA.117.309813
   Goeijenbier M, 2012, J MED VIROL, V84, P1680, DOI 10.1002/jmv.23354
   Gragnano F, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5620314
   Gralinski LE, 2015, J PATHOL, V235, P185, DOI 10.1002/path.4454
   Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13
   Guo Y, 2008, VIRUS RES, V133, P4, DOI 10.1016/j.virusres.2007.01.022
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Han MF, 2008, J BIOCHEM, V144, P51, DOI 10.1093/jb/mvn042
   Hasan SS, 2020, J THROMB THROMBOLYS, V50, P814, DOI 10.1007/s11239-020-02235-z
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Heyman I, 2021, ARCH DIS CHILD, V106, P420, DOI 10.1136/archdischild-2021-321748
   Holter JC, 2020, P NATL ACAD SCI USA, V117, P25018, DOI 10.1073/pnas.2010540117
   Hu M, 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962
   Hwang DM, 2005, MODERN PATHOL, V18, P1, DOI 10.1038/modpathol.3800247
   Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005
   Kabanova A, 2020, HEMASPHERE, V4, DOI 10.1097/HS9.0000000000000499
   Kalagara T, 2018, BLOOD ADV, V2, P2347, DOI 10.1182/bloodadvances.2017013995
   Kamal M, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13746
   Koeppen M, 2021, CLIN MED INSIGHTS-CI, V15, DOI 10.1177/1179548421992327
   Kollias A, 2021, VASC MED, V26, P415, DOI 10.1177/1358863X21995566
   Kowalewski M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02925-3
   Kresch E, 2021, WORLD J MENS HEALTH, V39, P466, DOI 10.5534/wjmh.210055
   Kyrle PA, 2007, THROMB HAEMOSTASIS, V97, P880, DOI 10.1160/TH07-02-0115
   Lazo-Langner A, 2021, TH OPEN, V5, P286
   Lazzari MA, 2012, HEMATOLOGY, V17, pS150, DOI 10.1179/102453312X13336169156618
   Lee CCE, 2021, DISEASES-BASEL, V9, DOI 10.3390/diseases9030047
   Lee KW, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.579070
   List BM, 1997, BIOCHEM J, V323, P159, DOI 10.1042/bj3230159
   Lowenstein CJ, 2020, CIRCULATION, V142, P1609, DOI 10.1161/CIRCULATIONAHA.120.050354
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Lu YF, 2020, INT J INFECT DIS, V100, P34, DOI 10.1016/j.ijid.2020.08.023
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mai V, 2021, VASC PHARMACOL, V139, DOI 10.1016/j.vph.2021.106882
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450
   Mastellos DC, 2020, CLIN IMMUNOL, V220, DOI 10.1016/j.clim.2020.108598
   Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333
   Mohamed MFH, 2021, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.598846
   Neishaboori AM, 2020, ARCH ACAD EMERG MED, V8
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Newburger JW, 2016, J AM COLL CARDIOL, V67, P1738, DOI 10.1016/j.jacc.2015.12.073
   Ng LF, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-34
   Nopp S, 2020, RES PRACT THROMB HAE, V4, P1178, DOI 10.1002/rth2.12439
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Panicker SR, 2017, BLOOD, V130, P181, DOI 10.1182/blood-2017-02-770479
   Paniz-Mondolfi A, 2020, J MED VIROL, V92, P699, DOI 10.1002/jmv.25915
   Pappas G, 2006, CLIN MICROBIOL INFEC, V12, P823, DOI 10.1111/j.1469-0691.2006.01442.x
   Parsay S, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105552
   Steven P, 2021, NEW ENGL J MED, V385, P577, DOI 10.1056/NEJMp2109285
   Porfidia A, 2020, THROMB RES, V196, P67, DOI 10.1016/j.thromres.2020.08.020
   Pranata R, 2020, J RENIN-ANGIO-ALDO S, V21, DOI 10.1177/1470320320926899
   Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502
   Ramapanicker R, 2013, BIOCONJUGATE CHEM, V24, P17, DOI 10.1021/bc300186z
   Rambaldi A, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.152001
   Ramlall Vijendra, 2020, medRxiv, DOI 10.1101/2020.05.05.20092452
   Raveendran AV, 2021, DIABETES METAB SYND, V15, P145, DOI 10.1016/j.dsx.2020.12.025
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Risitano AM, 2020, NAT REV IMMUNOL, V20, P343, DOI 10.1038/s41577-020-0320-7
   Romero-Sanchez CM, 2020, NEUROLOGY, V95, pE1060, DOI 10.1212/WNL.0000000000009937
   Romiti GF, 2021, J CLIN MED, V10, DOI 10.3390/jcm10112490
   Rowley AH, 2008, NAT REV MICROBIOL, V6, P394, DOI 10.1038/nrmicro1853
   Sabatino J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237131
   Sahranavard M, 2021, ARCH IRAN MED, V24, P152, DOI 10.34172/aim.2021.24
   Sanchez JB, 2021, ANN VASC SURG, V72, P196, DOI 10.1016/j.avsg.2020.12.005
   Santoso A, 2021, AM J EMERG MED, V44, P352, DOI 10.1016/j.ajem.2020.04.052
   Sarfraz A, 2021, CLIN APPL THROMB-HEM, V27, DOI 10.1177/1076029621993573
   Sharifi-Razavi A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100669
   Siepmann T, 2021, EUR J NEUROL, V28, P238, DOI 10.1111/ene.14535
   Siow I, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105549
   Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Steinberg BE, 2012, ANTIVIR RES, V93, P2, DOI 10.1016/j.antiviral.2011.10.019
   Stephenson T, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-052838
   Tang BSF, 2005, J VIROL, V79, P6180, DOI 10.1128/JVI.79.10.6180-6193.2005
   Tetro JA, 2020, MICROBES INFECT, V22, P72, DOI 10.1016/j.micinf.2020.02.006
   Topcu AC, 2021, ANN VASC SURG, V74, P88, DOI [10.1016/j.avsg.2021.03.003, 10.1016/j.avsg.2021.03.0032021]
   Toraih EA, 2020, J MED VIROL, V92, P2473, DOI 10.1002/jmv.26166
   Townsend L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247280
   Vakhshoori M, 2020, ARCH IRAN MED, V23, P801, DOI 10.34172/aim.2020.107
   Vakili K, 2021, EUR NEUROL, V84, P307, DOI 10.1159/000516258
   Valenti L, 2021, J AUTOIMMUN, V117, DOI 10.1016/j.jaut.2021.102595
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Venkatesan P, 2021, LANCET RESP MED, V9, P129, DOI 10.1016/S2213-2600(21)00031-X
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Wada H, 2008, SEMIN THROMB HEMOST, V34, P33, DOI 10.1055/s-2008-1066021
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang C, 2020, EUR REV MED PHARMACO, V24, P10279, DOI 10.26355/eurrev_202010_23252
   Wang ZF, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023327
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   Whitworth H, 2021, BLOOD, V138, P190, DOI 10.1182/blood.2020010218
   Wu T, 2021, AGE AGEING, V50, P284, DOI 10.1093/ageing/afaa259
   Wu YP, 2006, THROMB HAEMOSTASIS, V96, P100, DOI 10.1160/TH05-12-0827
   Wu ZH, 2021, ACTA DIABETOL, V58, P139, DOI 10.1007/s00592-020-01546-0
   Yang J, 2021, J MED VIROL, V93, P2662, DOI 10.1002/jmv.26677
   Yang M, 2008, THROMB RES, V122, P473, DOI 10.1016/j.thromres.2007.12.021
   Yang YH, 2005, J MED VIROL, V77, P1, DOI 10.1002/jmv.20407
   Yassin A, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02161-4
   Yi XH, 2010, AM J RESP CRIT CARE, V182, P436, DOI 10.1164/ajrccm.182.3.436
   Yu Jia, 2021, Haematologica, DOI 10.3324/haematol.2021.279155
   Yu J, 2020, BLOOD, V136, P2080, DOI 10.1182/blood.2020008248
   Zhai ZG, 2020, THROMB HAEMOSTASIS, V120, P937, DOI 10.1055/s-0040-1710019
   Zhang C, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00151
   Zhang J, 2020, AGING-US, V12, P23450, DOI 10.18632/aging.104086
   Zhang R, 2021, J VASC SURG-VENOUS L, V9, P289, DOI 10.1016/j.jvsv.2020.11.023
   Zhao YH, 2021, REV CARDIOVASC MED, V22, P159, DOI 10.31083/j.rcm.2021.01.238
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 148
TC 2
Z9 1
U1 1
U2 1
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2567-9430
EI 2567-9449
J9 J LAB MED
JI J. Lab. Med.
PD DEC
PY 2021
VL 45
IS 6
BP 293
EP 302
DI 10.1515/labmed-2021-0134
PG 10
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA XK3MS
UT WOS:000727374600006
OA gold
DA 2022-04-20
ER

PT J
AU Hegazy, AA
   Seddik, SA
AF Hegazy, Amira Aly
   Seddik, Salma AbdelRehim
TI Knowledge, attitude and response preparedness to COVID-19: An Egyptian
   tertiary public hospital client perspective
SO INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19; outpatient clients; knowledge; In-depth interview; attitudes
AB Introduction: On 14 February 2020, Egypt announced its first COVID-19 confirmed case. Accordingly, the country's response included evacuation of Egyptian citizens from heavily infected countries, closure of educational facilities, and banning of all public meetings and gatherings. With rapid emerging of the pandemic, how individuals respond to advice on transmission prevention is as important as government actions, if not more important to protect themselves.
   Aim: To assess knowledge and attitudes about COVID-19 among a sample of the general public attending Kasr Alainy hospital in Cairo, Egypt.
   Methodology: A cross sectional study that was conducted in a tertiary care hospital in Cairo, Egypt over a period of 2 months in early 2020. Two hundred outpatient clients agreed to fill out the study questionnaire. Twenty-four of the total participants approved to be included in in-depth interviews regarding the current COVID-19 pandemic.
   Results: The median knowledge score was significantly higher among highly educated clients than their counterparts were (23 Vs 19, P = 0.002) and was higher among urban residents than their counterparts (21 Vs 18, P = 0.004).
   Conclusion: Egyptians participating in this study had good knowledge and attitude about COVID-19, and using protective measures. This knowledge is mainly acquired through social media platforms and television. However, further focus is needed in certain aspects, including the delivery of messages regarding health-seeking behavior of people infected with SARS-COV-2.
C1 [Hegazy, Amira Aly; Seddik, Salma AbdelRehim] Cairo Univ, Dept Publ Hlth & Community Med, Cairo, Egypt.
RP Hegazy, AA (corresponding author), Cairo Univ, Kasr Alainy Med Sch, Dept Publ Hlth & Community Med, Cairo 11562, Egypt.
EM amirahegazy@kasralainy.edu.eg
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Ali O, 2020, B PHARM SCI ASSIUT, V43, P177
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   [Anonymous], 2020, EGYPT SHUTS SCH U 2
   [Anonymous], 2020, EGYPTIAN GOVT ANTIVI
   Baseer Mohammad-Abdul, 2016, J Clin Exp Dent, V8, pe379
   Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   CDC, 2021, SCI BRIEF SARS COV 2
   CDC, 2021, SYMPT COVID 19
   CDC, 2021, WHAT YOU NEED KNOW V
   Coccia M, 2022, ENVIRON RES, V203, DOI 10.1016/j.envres.2021.111678
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Fusch PI, 2015, QUAL REP, V20, P1408
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5
   Imperial College London MRC Centre for Global Infectious Disease Analysis, 2020, NEWS COVID 19 REP 3
   Islam MM, 2020, INT J HEALTHCARE MAN, V13, P263, DOI 10.1080/20479700.2020.1765120
   Jaber RM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250461
   Kabbash IA, 2018, ENVIRON SCI POLLUT R, V25, P30755, DOI 10.1007/s11356-016-7848-x
   Saied AA, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.696082
   Sakr S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10575-5
   Singh R, 2020, INT J HEALTHCARE MAN, V13, P257, DOI 10.1080/20479700.2020.1782661
   Thompson A., 2001, ETHICS MEDICAL RES M
   World Health Organization, 2021, TRACK SARS COV 2 VAR
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2047-9700
EI 2047-9719
J9 INT J HEALTHCARE MAN
JI Int. J. Healthcare Manag.
DI 10.1080/20479700.2022.2035574
EA FEB 2022
PG 11
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA YX0AE
UT WOS:000753770600001
DA 2022-04-20
ER

PT J
AU Santos, MRC
   Laureano, RMS
AF Santos, Marcia R. C.
   Laureano, Raul M. S.
TI COVID-19-Related Studies of Nonprofit Management: A Critical Review and
   Research Agenda
SO VOLUNTAS
LA English
DT Review; Early Access
DE COVID-19; Nonprofit; Management; Crisis; Literature analysis; Critical
   review
ID ORGANIZATIONS; BUSINESS; FACEBOOK
AB During crises such as the present coronavirus disease-19 (COVID-19) pandemic, nonprofits play a key role in ensuring support to improve the most vulnerable individuals' health, social, and economic conditions. One year into the COVID-19 pandemic, an extensive automated literature analysis was conducted of 154 academic articles on nonprofit management during the pandemic-all of which were published in 2020. This study sought to identify and systematize academics' contributions to knowledge about the crisis's impact on the nonprofit sector and to ascertain the most urgent directions for future research. The results provide policymakers, nonprofit practitioners, and scholars an overview of the themes addressed and highlight the important assistance academic researchers provide to nonprofits dealing with the COVID-19 pandemic.
C1 [Santos, Marcia R. C.] Inst Politecn Setubal, ESCE, Setubal, Portugal.
   [Santos, Marcia R. C.; Laureano, Raul M. S.] Inst Univ Lisboa ISCTE IUL, Informat Sci & Technol & Architecture Res Ctr IST, Lisbon, Portugal.
   [Laureano, Raul M. S.] Inst Univ Lisboa ISCTE IUL, Business Res Unit BRU IUL, Lisbon, Portugal.
RP Santos, MRC (corresponding author), Inst Politecn Setubal, ESCE, Setubal, Portugal.; Santos, MRC (corresponding author), Inst Univ Lisboa ISCTE IUL, Informat Sci & Technol & Architecture Res Ctr IST, Lisbon, Portugal.
EM marcia.cadete.santos@gmail.com; raul.laureano@isete-iul.pt
OI R. C. Santos, Marcia/0000-0001-8741-0122
FU Fundaca o para a Ciencia e TecnologiaPortuguese Foundation for Science
   and TechnologyEuropean Commission [FCT UIDB/04466/2020, UIDP/04466/2020,
   UID/GES/00315/2020]; Instituto Politecnico de Setubal
FX This publication/researh was partially supported by Fundaca o para a
   Ciencia e Tecnologia throught project grant FCT UIDB/04466/2020,
   UIDP/04466/2020 and UID/GES/00315/2020, and also by Instituto
   Politecnico de Setubal [RAADRI program].
CR Akpan I.J., 2020, J SMALL BUS ENTERPRE, P1
   Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12219132
   Baxter-Tomkins T., 2009, AUSTR J VOLUNTEER, V14, P1
   Bell K, 2015, NURS EDUC TODAY, V35, P530, DOI 10.1016/j.nedt.2014.12.013
   Bennett NJ, 2020, COAST MANAGE, V48, P336, DOI 10.1080/08920753.2020.1766937
   Berry B, 2020, PHI DELTA KAPPAN, V102, P14, DOI 10.1177/0031721720956840
   Bin-Nashwan SA, 2022, INT J SOCIOL SOC POL, V42, P232, DOI 10.1108/IJSSP-05-2020-0173
   Bradshaw P, 2009, NONPROFIT MANAG LEAD, V20, P60, DOI 10.1002/nml.241
   Brainard LA, 2004, NONPROF VOLUNT SEC Q, V33, P435, DOI 10.1177/0899764004266021
   Branas-Garza P., 2020, EXPOSURE COVID 19 PA
   Bryson JR, 2020, J GEOGR HIGHER EDUC, V44, P608, DOI 10.1080/03098265.2020.1807478
   Calheiros AC, 2017, J HOSP MARKET MANAG, V26, P675, DOI 10.1080/19368623.2017.1310075
   Campos-Mercade P., 2020, PROSOCIALITY PREDICT, DOI [10.5167/uzh-187672, DOI 10.5167/UZH-187672]
   Castka P, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114740
   Chege SM, 2020, INFORM TECHNOL DEV, V26, P316, DOI 10.1080/02681102.2019.1573717
   Corburn J, 2020, J URBAN HEALTH, V97, P348, DOI 10.1007/s11524-020-00438-6
   Curtis L, 2010, PUBLIC RELAT REV, V36, P90, DOI 10.1016/j.pubrev.2009.10.003
   Dainelli F, 2013, VOLUNTAS, V24, P649, DOI 10.1007/s11266-012-9278-9
   DEBROECK W, 2018, INT J SUSTAIN ENERGY, V15, P3, DOI DOI 10.5278/IJSEPM.2018.15.2
   Deitrick L., 2020, NONPROFIT SECTOR RES
   Fernandes E, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102830
   Finchum-Mason E, 2020, NONPROF VOLUNT SEC Q, V49, P1129, DOI 10.1177/0899764020966047
   Galiatsatos P, 2020, J RELIG HEALTH, V59, P2256, DOI 10.1007/s10943-020-01057-w
   Wilke NG, 2020, CHILD ABUSE NEGLECT, V110, DOI 10.1016/j.chiabu.2020.104712
   Guerreiro J, 2016, J BUS ETHICS, V139, P111, DOI 10.1007/s10551-015-2622-4
   Hassan SU, 2019, BEHAV INFORM TECHNOL, V38, P924, DOI 10.1080/0144929X.2019.1583282
   Ihm J, 2021, VOLUNTAS, V32, P678, DOI 10.1007/s11266-021-00335-9
   Lee TE, 2001, J COMPUT INFORM SYST, V41, P26
   Lucic L, 2020, J CHILD SERV, V15, P229, DOI 10.1108/JCS-07-2020-0041
   Maher CS, 2020, PUBLIC ADMIN REV, V80, P644, DOI 10.1111/puar.13238
   Martinez CV, 2003, J BUS ETHICS, V47, P209, DOI 10.1023/A:1026212902564
   Mas-Tur A., 2019, QUAL QUANT, V53, P981, DOI [10.1007/s11135-018-0799-1, DOI 10.1007/S11135-018-0799-1]
   Maserat E, 2020, HEALTH TECHNOL-GER, V10, P1421, DOI 10.1007/s12553-020-00470-1
   Medel K, 2020, J HUMANIT LOGIST SUP, V10, P509, DOI 10.1108/JHLSCM-09-2019-0066
   Modak NM, 2020, COMPUT CHEM ENG, V141, DOI 10.1016/j.compchemeng.2020.106978
   Nisanci A, 2020, INT SOC WORK, V63, P685, DOI 10.1177/0020872820940032
   Ortigosa A, 2014, COMPUT HUM BEHAV, V31, P527, DOI 10.1016/j.chb.2013.05.024
   Park E, 2020, CURR ISSUES TOUR, V23, P605, DOI 10.1080/13683500.2018.1549025
   Pitts J, 2020, J CHILD SERV, V15, P209, DOI 10.1108/JCS-06-2020-0024
   Raffo D.M., 2016, ACAD STRATEGIC MANAG, V15
   Riccucci F, 2020, ADM THEORY PRAXIS, V42, P588, DOI [10.1080/10841806.2020.1798694, DOI 10.1080/10841806.2020.1798694]
   Rossitto S., 2020, ASIA PASIFIC J JAPAN, V18, P1
   Ruelle O, 2017, CHIN J COMMUN, V10, P12, DOI 10.1080/17544750.2016.1217899
   Salamon LM, 2016, VOLUNTAS, V27, P1515, DOI 10.1007/s11266-016-9726-z
   Salamon LM, 2011, ANN PUBLIC COOP ECON, V82, P217, DOI 10.1111/j.1467-8292.2011.00437.x
   Santos MRC, 2021, PUBLIC MANAG REV, DOI 10.1080/14719037.2021.1972685
   Santos MRC, 2020, VOLUNTAS, V31, P56, DOI 10.1007/s11266-018-00055-7
   Saxton GD, 2014, NONPROF VOLUNT SEC Q, V43, P850, DOI 10.1177/0899764013485159
   Saxton GD, 2014, J PUBLIC RELAT RES, V26, P280, DOI 10.1080/1062726X.2014.908721
   Selamet J., 2020, INT J DESIGNED OBJEC, V14, P1, DOI [10.18848/2325-1379/CGP/V14I02/1-17, DOI 10.18848/2325-1379/CGP/V14I02/1-17]
   Shah SHH, 2020, KYBERNETES, V49, P1020, DOI 10.1108/K-12-2018-0696
   Shaw S, 2009, NONPROFIT MANAG LEAD, V20, P83, DOI 10.1002/nml.242
   Simo G, 2007, PUBLIC ADMIN REV, V67, P125, DOI 10.1111/j.1540-6210.2007.00821.x
   Singh S, 2020, TECHNOL SOC, V62, DOI 10.1016/j.techsoc.2020.101305
   Smith DH., 2006, NONPROFIT TERMS CONC
   Strand R, 2015, J BUS ETHICS, V127, P65, DOI 10.1007/s10551-013-1792-1
   Tafesse W, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102303
   Tierney A, 2020, WORLD DEV, V136, DOI 10.1016/j.worlddev.2020.105113
   Trautmann Kristy, 2007, Leadership & Organization Development Journal, V28, P269, DOI 10.1108/01437730710739675
   Tran T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12104195
   Tzifakis N, 2017, VOLUNTAS, V28, P2176, DOI 10.1007/s11266-017-9851-3
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Eck NJ, 2009, J AM SOC INF SCI TEC, V60, P1635, DOI 10.1002/asi.21075
   Venkatesh V., 2015, WILEY ENCY MANAGEMEN, P1, DOI DOI 10.1002/9781118785317.WEOM070047
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Wang S, 2021, PROC INT CONF SOFTW, P1548, DOI 10.1109/ICSE43902.2021.00138
   WHO, 2020, COR DIS COVID 19 PAN
   Wilke NG, 2020, CHILD ABUSE NEGLECT, V110, DOI 10.1016/j.chiabu.2020.104642
   Williams D, 2021, J RURAL HEALTH, V37, P133, DOI 10.1111/jrh.12524
   Wilson CE, 2013, NONPROF VOLUNT SEC Q, V42, P963, DOI 10.1177/0899764012461400
   Yu YT, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-4235
   Zhang HW, 2020, J FAM VIOLENCE, DOI 10.1007/s10896-020-00196-8
   Zhang L, 2020, SCIENTOMETRICS, V124, P747, DOI 10.1007/s11192-020-03531-4
   Zhao T, 2020, AM REV PUBLIC ADM, V50, P777, DOI 10.1177/0275074020942455
   Zhou HQ, 2021, VOLUNTAS, V32, P498, DOI 10.1007/s11266-019-00112-9
NR 75
TC 0
Z9 0
U1 8
U2 8
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0957-8765
EI 1573-7888
J9 VOLUNTAS
JI Voluntas
DI 10.1007/s11266-021-00432-9
EA NOV 2021
PG 16
WC Social Issues
WE Social Science Citation Index (SSCI)
SC Social Issues
GA XE7QL
UT WOS:000723577800001
PM 34866809
OA Green Published, Bronze, Green Accepted
DA 2022-04-20
ER

PT J
AU Al Ahdab, S
AF Al Ahdab, Sanaa
TI A cross-sectional survey of knowledge, attitude and practice (KAP)
   towards COVID-19 pandemic among the Syrian residents
SO BMC PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Knowledge; Attitude and practice; Syria; Pandemic
AB BackgroundEffective COVID-19 pandemic management requires adequate understanding of factors that influence behavioral changes. This study aims to assess knowledge, attitudes and practices towards COVID-19 among Syrians in a post-conflict context.MethodA cross sectional web-based survey was conducted on the Syrian residents of 16years and above. It contains questions on knowledge, attitudes and practices (KAP) with respect to COVID-19. Participants' demographic characteristics are recorded and analyzed. The study is conducted during the global outbreak of COVID-19.ResultsA total of 706 participants (female, 444; male, 262) were enrolled. This study included 405 participants aged between 16 and 29, 204 aged between 30 and 49, and 97 aged above 60years. There were 642 who have a university degree and 61 who have high school degree. Among the participants 253 were students, 316 were employed, 75 work as freelancers, and 62 were unemployed. Results showed that overall knowledge score towards the disease was about 60% (mean score 3.541.20; range 0-6). Knowledge scores significantly differed across age groups (P<0.05), education levels (P=0.001), and occupations (P<0.05). Attitude and practice scores were 2.45 +/- 0.81 (range 0-4), 5.90 +/- 1.52 (range 0-8), respectively. Attitude scores were significantly different between males and females (P<0.05), whereas practice scores varied significantly across gender (P<0.05), age groups (P=0.01), education levels (P=0.015), occupations (P<0.05), and according to knowledge score (P=0.000). Results from multiple linear regression indicated that lower knowledge scores were significantly associated with lower education level (P<0.05), whereas poor preventive practices were common among male, young and unemployed participants with significance levels of P<0.01, P=.000, P<0.01, respectively.Conclusion The findings of this study suggest that the Syrian residents demonstrate modest knowledge, attitudes and practices towards COVID-19 at the time of its global outbreak. Efforts should be directed towards raising the awareness of the disease to improve their practices in the current COVID-19 pandemic, as well as for future epidemics.
C1 [Al Ahdab, Sanaa] Al Rasheed Int Univ Sci & Technol, Fac Pharm, Dept Pharmacol & Toxicol, Ghabagheb, Daraa, Syria.
   [Al Ahdab, Sanaa] Al Baath Univ, Fac Pharm, Dept Pharmacol & Toxicol, Homs, Syria.
RP Al Ahdab, S (corresponding author), Al Rasheed Int Univ Sci & Technol, Fac Pharm, Dept Pharmacol & Toxicol, Ghabagheb, Daraa, Syria.; Al Ahdab, S (corresponding author), Al Baath Univ, Fac Pharm, Dept Pharmacol & Toxicol, Homs, Syria.
EM salahdab@albaath-univ.edu.sy
OI Al Ahdab, Sanaa/0000-0002-7571-8776
CR Al Faisal W, 2012, LANCET, V379, P2241, DOI 10.1016/S0140-6736(12)60871-X
   [Anonymous], 2020, SYRIAN ARAB NEWS AGE
   [Anonymous], 2020, HLTH MINISTER 1 CASE
   Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729
   Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y
   Erfani A, 2020, B WORLD HEALTH ORGAN, V30, DOI [10.2471/BLT.20.251561, DOI 10.2471/BLT.20.251561]
   Gharibah M, POLICY MEMO CONFLICT
   Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166
   Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18
   Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864
   Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923
   Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340
   Lin YL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-128
   Michie S., 2014, HLTH SERV DELIV RES, V2, P1, DOI [10.3310/hsdr02410, DOI 10.3310/HSDR02410]
   Moran KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164541
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Shaza, 2020, SYRIAN ARAB NEW 0520
   Srichan P, 2020, KNOWLEDGE ATTITUDE P, DOI DOI 10.2139/SSRN.3546046
   Stangl T, COVID 19 SITUATION S
   Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887
   Tooher R, 2013, INFLUENZA OTHER RESP, V7, P1316, DOI 10.1111/irv.12103
   United Nations Educational Scientific and Cultural Organization, COVID 19 ED DISR RES
   Ward T.S., 2019, HDB HLTH SOCIAL WORK, P143, DOI DOI 10.1002/9781119420743.CH7
   Yap J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-442
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 25
TC 17
Z9 17
U1 2
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 5
PY 2021
VL 21
IS 1
AR 296
DI 10.1186/s12889-021-10353-3
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA QG2AR
UT WOS:000617392700002
PM 33546652
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Asdaq, SMB
   Alshrari, AS
   Imran, M
   Sreeharsha, N
   Sultana, R
AF Asdaq, Syed Mohammed Basheeruddin
   Alshrari, A. S.
   Imran, Mohd.
   Sreeharsha, Nagaraja
   Sultana, Rokeya
TI Knowledge, attitude and practices of healthcare professionals of Riyadh,
   Saudi Arabia towards covid-19: A cross-sectional study
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE Healthcare professionals; COVID-19; Knowledge; Attitude; Practices;
   Riyadh; Saudi Arabia; KAP
ID WORKERS
AB Background & objectives: COVID-19 is an emerging pandemic that necessitates the implementation of effective infection prevention and control steps. The knowledge, attitudes, and practices (KAP) of health-care professionals toward COVID-19 affect their compliance to prevention and control initiatives. During the evolving pandemic, we examined the KAP among healthcare professionals against COVID-19 in this research. Materials and methods: This was a cross-sectional study conducted among Riyadh region health care pro-fessionals from the beginning of December 2020 to the end of February 2021 using a validated self-administered questionnaire. The knowledge questionnaire contained questions about COVID-19 clinical characteristics, prevention, and management. The evaluation of attitudes and practices included ques-tions regarding actions and adjustments in COVID-19 response activities. Knowledge scores were mea-sured and compared using demographic characteristics, as well as attitudes and practices toward COVID-19. Using SPSS-IBM 25, bivariate statistics were done to analyze the data. Results: 146 healthcare professionals completed the survey. Physicians were the most prominent party in the survey, accounting for 74 (51 percent), followed by nurses 44 (30 percent) and pharmacists 28 (19 percent). The participants' average age was 39.69 +/- 8.48 years. The participant's mean knowledge, atti-tude, and practice scores were 11.43 +/- 1.34, 3.89 +/- 0.93, and 3.85 +/- 0.81, respectively. With a positive atti-tude, the mean knowledge score was 11.52, and with proper practice, it was 11.32. With an improvement in knowledge, the attitude score increased significantly (r = 0.172, P = 0.001). Besides, there was a greater association between attitudes and practices (r = 0.170, P = 0.029). A significant enhancement in the prac-tice score of the professionals was noted with an increase in knowledge score (r = 0.095, P = 0.010), an indicator for a positive correlation between practice and knowledge scores. Interpretation & conclusion: Healthcare practitioners have a good understanding of COVID-19. Improved knowledge and a positive attitude toward COVID-19 infection are linked to appropriate practice. There is a need for more manpower, better COVID-19 management training, and strategies to reduce anxiety among healthcare professionals. (c) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Asdaq, Syed Mohammed Basheeruddin] AlMaarefa Univ, Dept Pharm Practice, Coll Pharm, Riyadh 13713, Saudi Arabia.
   [Alshrari, A. S.] Northern Border Univ, Dept Biol Sci, Fac Sci, Ar Ar, Saudi Arabia.
   [Imran, Mohd.] Northern Border Univ, Dept Pharmaceut Chem, Fac Pharm, Rafha, Saudi Arabia.
   [Sreeharsha, Nagaraja] King Faisal Univ, Coll Clin Pharm, Dept Pharmaceut Sci, Al Hasa 31982, Saudi Arabia.
   [Sultana, Rokeya] Yenepoya Deemed Univ, Yenepoya Pharm Coll & Res Ctr, Dept Pharmacognosy, Mangalore, India.
RP Asdaq, SMB (corresponding author), AlMaarefa Univ, Dept Pharm Practice, Coll Pharm, Riyadh 13713, Saudi Arabia.
EM sasdag@mcst.edu.sa
RI Sultana, Rokeya/ABN-9961-2022; asdaq, Syed Mohammed
   Basheeruddin/AAH-8283-2019; Imran, Mohd/AAV-4144-2021
OI Sultana, Rokeya/0000-0002-1720-3547; asdaq, Syed Mohammed
   Basheeruddin/0000-0003-1533-9667; Ansari, Mohd.
   Imran/0000-0002-6064-1040; alshrari, ahmed/0000-0002-3666-3848
FU AlMaarefa University
FX The authors are thankful to AlMaarefa University for providing support
   to do this research.
CR Albott CS, 2020, ANESTH ANALG, V131, P43, DOI 10.1213/ANE.0000000000004912
   Alenazi TH, 2020, J INFECT PUBLIC HEAL, V13, P1645, DOI 10.1016/j.jiph.2020.09.001
   Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656
   Alshrari AS, 2020, J PHARM RES INT, V32, P23, DOI 10.9734/JPRI/2020/v32i2230768
   Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bandyopadhyay S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003097
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Jiang LL, 2018, J HOSP INFECT, V98, P404, DOI 10.1016/j.jhin.2017.10.020
   Kassie BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238415
   Kumar J, 2020, CUREUS, V12, DOI 10.7759/cureus.7737
   Legido-Quigley H, 2020, LANCET PUBLIC HEALTH, V5, pE251, DOI 10.1016/S2468-2667(20)30060-8
   Limbu DK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242126
   Liu BM, 2019, J VIROL METHODS, V272, DOI 10.1016/j.jviromet.2019.113690
   Martin SD, 2011, J NURS MANAGE, V19, P98, DOI 10.1111/j.1365-2834.2010.01190.x
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mokhtari R, 2020, INT J MENT HEALTH NU, V29, P1275, DOI 10.1111/inm.12800
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Raudenska J, 2020, BEST PRAC RES-CL ANA, V34, P553, DOI 10.1016/j.bpa.2020.07.008
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sahin MK, 2020, J COMMUN HEALTH, V45, P1168, DOI 10.1007/s10900-020-00921-w
   Salman M, 2020, DRUGS THER PERSPECT, V36, P319, DOI 10.1007/s40267-020-00737-7
   Sari DK, 2021, J COMMUN HEALTH, V46, P182, DOI 10.1007/s10900-020-00866-0
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Temsah MH, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001958
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   Valdez C., 2013, J MANAG POLICY PRACT, V14, P43
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 33
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
EI 2213-7106
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD SEP
PY 2021
VL 28
IS 9
BP 5275
EP 5282
DI 10.1016/j.sjbs.2021.05.036
EA AUG 2021
PG 8
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA UD0JJ
UT WOS:000686903300004
PM 34054326
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Alzghoul, SE
   Smadi, OA
   Almomani, TD
   Alzghoul, MB
   Albataineh, OM
AF Alzghoul, S. E.
   Smadi, O. A.
   Almomani, T. D.
   Alzghoul, M. B.
   Albataineh, O. M.
TI Solid medical waste management practices and awareness in COVID-19
   screening stations
SO GLOBAL JOURNAL OF ENVIRONMENTAL SCIENCE AND MANAGEMENT-GJESM
LA English
DT Article
DE Administrative protocols; COVID-19 (Coronavirus disease 2019); Medical
   waste management; Solid medical wastes
ID HEALTH-CARE WORKERS; KNOWLEDGE
AB BACKGROUND AND OBJECTIVES: During the Coronavirus disease 2019 pandemic, an effective and efficient medical waste management plan is required to prevent disease transmission from the Coronavirus disease 2019 viral solid wastes. Screening stations are critical locations where solid Coronavirus disease 2019 wastes are created. Solid trash collection and management strategies for screening stations must be studied as they are the first point of origin for solid Coronavirus disease 2019 wastes. The goal of this study is to evaluate the level of healthcare workers' knowledge in the medical waste management field in Jordanian Coronavirus disease 2019 screening stations, with an emphasis on understanding and implementing Jordanian medical waste management protocols, by examining the awareness, perspective, and practice ahni it the many aspects of Coronavirus disease 2019 wastes.
   METHODS: A study sample (n = 78) involving technicians, nurses, and physicians working at various screening stations in Jordan's public and private sectors was evaluated. From April 2021 to September 2021, a cross-sectional survey involving questionnaires was carried out. The survey included questions on medical waste management knowledge and awareness among healthcare personnel regarding the Coronavirus 2019 medical waste administrative and collection procedures.
   There are various limitations to this cross-sectional study that should be noted. This is a study conducted among health care employees when an overwhelming amount of coronavirus disease cases were being recorded locally and worldwide, affecting transportation ability and minimizing time spent with screening station personnel.
   FINDINGS: The outcomes of the first module of the questionnaire revealed a high degree of medical waste management knowledge and awareness among healthcare staff. On the other hand, nurses demonstrated the highest awareness and application of COVID-19 medical waste administrative procedures. Furthermore, the results of the third module revealed that the private sector fails to successfully execute national and international procedures, with the most significant negative responses among other categories.
   CONCLUSION: It was concluded that Jordan's solid waste collection and disposal methods were effectively implemented, which might aid in the virus eradication. Even though most Jordanian screening stations have effectively implemented knowledge and awareness regarding solid Coronavirus disease 2019 wastes management practices, there is a need to undertake periodic training and continuous monitoring with a specific focus on the appropriate administrative and collecting processes for both technicians, and private sector stations. (C) 2022 GJESM. All rights reserved.
C1 [Alzghoul, S. E.; Smadi, O. A.; Almomani, T. D.; Albataineh, O. M.] Hashemite Univ Zarqa, Coll Engn, Dept Biomed Engn, Zarqa, Jordan.
   [Alzghoul, M. B.] Jordan Univ Sci & Technol, Coll Vet Med, Dept Basic Med Vet Sci, Irbid, Jordan.
RP Alzghoul, SE (corresponding author), Hashemite Univ Zarqa, Coll Engn, Dept Biomed Engn, Zarqa, Jordan.
EM alzghoul@hu.edu.jo; othman.smadi@hu.edu.jo; thakir2000@hu.edu.jo;
   alzghoul@just.edu.jo; asamam@hu.edu.jo
FU Hashemite University
FX The authors are appreciative to Mrs. Alaa Mofleh Alzghoul for her help
   in data collection, to the staff at COVID 19 screening sites for
   supplying the data required for this study's development, and to The
   Hashemite University for its support.
CR Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Abu-Qdais HA, 2020, GLOB J ENVIRON SCI M, V6, P21, DOI 10.22034/GJESM.2019.06.SI.03
   Agamuthu P, 2021, WASTE MANAGE RES, V39, P18, DOI 10.1177/0734242X20959701
   Babanyara Y.Y., 2013, INT J HLTH MED ENG, V7, P780
   CDC, 2020, INT LAB BIOS GUID CO
   Dell-Kuster Salome, 2014, BMC Med Res Methodol, V14, P96, DOI 10.1186/1471-2288-14-96
   Elgibaly O, 2021, GERMS, V11, P179, DOI 10.18683/germs.2021.1255
   Filimonau V, 2021, RESOUR CONSERV RECY, V168, DOI 10.1016/j.resconrec.2020.105272
   Gao F, 2020, BIOPRESERV BIOBANK, V18, P511, DOI 10.1089/bio.2020.0099
   Haque MS, 2021, J ENVIRON CHEM ENG, V9, DOI 10.1016/j.jece.2020.104660
   Hou ZY, 2021, J MED INTERNET RES, V23, DOI 10.2196/27632
   Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652
   Isaifan RJ, 2020, GLOB J ENVIRON SCI M, V6, P275, DOI 10.22034/gjesm.2020.03.01
   Jalal SM, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9060747
   Kulkarni B, 2020, ENVIRON DEV, V33, DOI 10.1016/j.envdev.2019.100490
   Kulkarni BN, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140693
   LaGrega M.D., 2015, HAZARDOUS WASTE MANA
   Lange T, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-0912-8
   Mihai FC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155439
   Nabe-Nielsen K, 2021, OCCUP ENVIRON MED, V78, P248, DOI 10.1136/oemed-2020-106831
   NCoV-2019, 2019, LAB TEST 2019 NOV CO
   Neumeyer X, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105058
   Petrucci CJ, 2009, J SOC SERV RES, V35, P193, DOI 10.1080/01488370802678983
   Prata JC, 2020, ENVIRON SCI TECHNOL, V54, P7760, DOI 10.1021/acs.est.0c02178
   Pruss A., 2014, SAFE MANAGEMENT WAST
   Ramteke S., 2020, CASE STUD CHEM ENV E, P100029, DOI [DOI 10.1016/J.CSCEE.2020.100029, 10.1016/j.cscee.2020.100029]
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Sarkodie SA, 2021, ENVIRON DEV SUSTAIN, V23, P7951, DOI 10.1007/s10668-020-00956-y
   Sharma HB, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105052
   Shinee E, 2008, WASTE MANAGE, V28, P435, DOI 10.1016/j.wasman.2006.12.022
   Shrestha A., 2021, BMC PUBLIC HEALTH, V21
   Singh E, 2022, CHEMOSPHERE, V288, DOI 10.1016/j.chemosphere.2021.132451
   Singh N, 2022, CRIT REV ENV SCI TEC, V52, P2000, DOI 10.1080/10643389.2021.1885325
   Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2
   Tien Truong Quang, 2021, Health Serv Insights, V14, p11786329211019225, DOI 10.1177/11786329211019225
   Tripathi A., 2020, CASE STUDIES CHEM EN, V2, DOI 10.1016/j.cscee.2020.100060
   UNEP, 2020, COVID 19 WAST MAN FA
   Wong LP, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-021-00900-w
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 39
TC 0
Z9 0
U1 1
U2 1
PU Professor J. Nouri
PI Tehran
PA No. 2, Kouhestan Deadend, Janpour street, Darabad Square, P.O.Box
   1956934485, Tehran, IRAN
SN 2383-3572
EI 2383-3866
J9 GLOB J ENVIRON SCI M
JI Glob. J. Environ. Sci. Manag.
PD SUM
PY 2022
VL 8
IS 3
BP 327
EP 338
DI 10.22034/gjesm.2022.03.03
PG 12
WC Environmental Sciences
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology
GA ZW0AZ
UT WOS:000770885600002
DA 2022-04-20
ER

PT J
AU Kamenidou, I
   Stavrianea, A
   Mamalis, S
   Mylona, I
AF Kamenidou, Irene (Eirini)
   Stavrianea, Aikaterini
   Mamalis, Spyridon
   Mylona, Ifigeneia
TI Knowledge Assessment of COVID-19 Symptoms: Gender Differences and
   Communication Routes for the Generation Z Cohort
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE generation Z cohort; COVID-19 symptoms; knowledge assessment; gender
   differences; marketing communication
ID YOUNG-ADULTS; RISK-TAKING; AGE; TRANSMISSION; CORONAVIRUS; OUTBREAK;
   CONSUMERS; PATTERNS; DRINKING; STUDENTS
AB This paper explores the generation Z (Gen Z) cohort's self-assessed knowledge regarding the coronavirus disease 2019 (COVID-19) symptoms as well as their interest in acquiring information and learning more about the transmission and spread of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2 virus) and the COVID-19 symptoms. Additionally, it investigates gender differences in self-assessed knowledge of COVID-19 symptoms. Field research employing a nonprobability sampling method with an online questionnaire resulted in collecting 762 valid questionnaires. Data analysis included descriptive statistics, factor and reliability analysis, and the independent sample t-test. Results reveal that overall symptom knowledge was assessed higher than the self-assessed knowledge of the 13 specific symptoms. No gender differences were detected regarding self-assessed knowledge of the following COVID-19 symptoms: cough, dyspnea, anorexia, productive cough with expectoration (phlegm), headache, and diarrhea. On the other hand, for self-assessed overall knowledge of COVID-19 symptoms, as well as self-assessed knowledge of COVID-19 symptoms related to fever and fatigue, myalgia (muscle pain), pharyngodynia, nausea-vomitus, hemoptysis, and abdominal pain, the t-tests conducted showed that there are statistical differences in knowledge assessment between male and female subjects. Based on the outcomes, the paper provides marketing communication practices targeting this young generation cohort to raise awareness so that Gen Z'ers may react effectively if these symptoms are observed and, thus, request medical assistance.
C1 [Kamenidou, Irene (Eirini); Mamalis, Spyridon; Mylona, Ifigeneia] Int Hellen Univ, Dept Management Sci & Technol, Kavala Campus, Agios Loukas Kavala 65404, Greece.
   [Stavrianea, Aikaterini] Natl & Kapodistrian Univ Athens, Dept Commun & Media Studies, Athens 10562, Greece.
RP Kamenidou, I (corresponding author), Int Hellen Univ, Dept Management Sci & Technol, Kavala Campus, Agios Loukas Kavala 65404, Greece.
EM rkam@mst.ihu.gr; aikstavria@media.uoa.gr; mamalis@mst.ihu.gr;
   imylona@mst.ihu.gr
RI Kamenidou, Irene/AAA-5210-2021; ΜΑΜΑΛΗΣ, ΣΠΥΡΙΔΩΝ/AAO-2274-2021
OI KAMENIDOU, IRENE (EIRINI)/0000-0002-8213-5843
CR Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413
   Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04
   [Anonymous], 2020, COVID 19 DASHB CTR S
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Basch CH, 2020, JMIR PUBLIC HLTH SUR, V6, P147, DOI 10.2196/18807
   Belzunegui-Eraso A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093662
   Broadbent E., 2017, WHAT WORLDS YOUNG PE, P26
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cutler D.M., 2020, KNOWL BEHAV, DOI [10.1101/2020.05.15.20095927, DOI 10.1101/2020.05.15.20095927]
   Cvetkovic VM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114124
   De Coninck D, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110220
   Debevec K, 2013, J CONSUM BEHAV, V12, P20, DOI 10.1002/cb.1400
   Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y
   Eastman J.K., 2013, MARK MANAG, V23, P57
   Eastman JK, 2012, J CONSUM MARK, V29, P93, DOI 10.1108/07363761211206348
   Eisner M, 2002, ANN AM ACAD POLIT SS, V580, P201, DOI 10.1177/0002716202580001009
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hawley PH, 2011, J RES ADOLESCENCE, V21, P307, DOI 10.1111/j.1532-7795.2010.00732.x
   Hindson J, 2020, NAT REV GASTRO HEPAT, V17, P259, DOI 10.1038/s41575-020-0295-7
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Johnson CA, 2006, PUBLIC HEALTH, V120, P1156, DOI 10.1016/j.puhe.2006.07.023
   Kamenidou I., 2018, HIGH ED, V10, P39
   Kamenidou IC, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030837
   Kamenidou I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134633
   Kamenidou I, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062299
   Kaplan AM, 2012, BUS HORIZONS, V55, P129, DOI 10.1016/j.bushor.2011.10.009
   Karijo E., 2020, BMC PUBLIC HEALTH, DOI [10.21203/rs.3.rs-34861/v1, DOI 10.21203/RS.3.RS-34861/V1]
   Kawashima T, 2021, PUBLIC HEALTH, V192, P12, DOI 10.1016/j.puhe.2020.05.018
   Kent R., 1993, MARKETING RES ACTION
   Korn L, 2018, SUBST USE MISUSE, V53, P59, DOI 10.1080/10826084.2017.1323924
   Lambert-Pandraud R, 2005, J MARKETING, V69, P97, DOI 10.1509/jmkg.69.2.97.60757
   Lehmann D. R., 1998, MARKETING RES
   Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0
   Lester SW, 2012, J LEADERSH ORG STUD, V19, P341, DOI 10.1177/1548051812442747
   Li HOY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002604
   Lokuge K., 2020, EXIT STRATEGIES OPTI, DOI [10.1101/2020.04.19.20071217, DOI 10.1101/2020.04.19.20071217]
   Machida M, 2020, INT J INFECT DIS, V94, P139, DOI 10.1016/j.ijid.2020.04.014
   Mclntosh K., 2019, CORONAVIRUS DIS 2019
   McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Escalera-Antezana JP, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101702
   Page, 2011, J BEHAV STUD BUS, V3, P37
   Plant MA, 2009, J ADDICT DIS, V28, P294, DOI 10.1080/10550880903182978
   Priporas CV, 2020, J BUS RES, V119, P453, DOI 10.1016/j.jbusres.2019.05.019
   Rowlands I, 2008, ASLIB PROC, V60, P290, DOI 10.1108/00012530810887953
   RYDER NB, 1965, AM SOCIOL REV, V30, P843, DOI 10.2307/2090964
   Saroj A, 2020, INT J DISAST RISK RE, V48, DOI 10.1016/j.ijdrr.2020.101584
   Shulman EP, 2016, DEV COGN NEUROS-NETH, V17, P103, DOI 10.1016/j.dcn.2015.12.010
   Singh Lisa, 2020, ArXiv
   Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006
   Spector P. E., 1992, SUMMATED RATING SCAL
   Strauss W., 2020, GENERATION Z
   Pham TH, 2019, J STRATEG MARK, V27, P540, DOI 10.1080/0965254X.2018.1447984
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   Torcsik M., 2014, COMMUNICATIO, V1, P23
   Tremblay T.-G., 2006, CANADIAN J COMMUNICA, V31, DOI [10.22230/cjc.2006v31n3a1721, DOI 10.22230/CJC.2006V31N3A1721]
   Veen W., 2006, HOMOZAPPIENS GROWING
   Wang C., 2020, APPL PSYCHOL-HLTH WE, V17, P1729, DOI [10.3390/ijerph17051729, DOI 10.3390/IJERPH17051729]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Weiss Michael J., 2003, AM DEMOGR, V25, P28
   Willoughby T, 2013, BRAIN COGNITION, V83, P315, DOI 10.1016/j.bandc.2013.09.008
   Wolfinger E., 2011, ABC XYZ UNDERSTANDIN
   World Health Organization, 2019, INFECT PREVENTION CO
   Xie XR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093148
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Yang K, 2008, J CONSUM MARK, V25, P272, DOI 10.1108/07363760810890507
   Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0
   Yoon C, 1997, J CONSUM RES, V24, P329, DOI 10.1086/209514
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zhao Y., 2020, CHINESE PUBLIC ATTEN, DOI [10.1101/2020.03.18.20038026, DOI 10.1101/2020.03.18.20038026]
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 77
TC 4
Z9 5
U1 2
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD OCT
PY 2020
VL 17
IS 19
AR 6964
DI 10.3390/ijerph17196964
PG 16
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA OO2LG
UT WOS:000587215100001
PM 32977632
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Temsah, MH
   Al Huzaimi, A
   Alrabiaah, A
   Alamro, N
   Al-Sohime, F
   Al-Eyadhy, A
   Alhasan, K
   Kari, JA
   Alhaboob, A
   Alsalmi, A
   AlMuhanna, W
   Almaghlouth, I
   Aljamaan, F
   Halwani, R
   Saddik, B
   Barry, M
   Al-Zamil, F
   AlHadi, AN
   Al-Subaie, S
   Jamal, A
   Somily, AM
AF Temsah, Mohamad-Hani
   Al Huzaimi, Abdullah
   Alrabiaah, Abdulkarim
   Alamro, Nurah
   Al-Sohime, Fahad
   Al-Eyadhy, Ayman
   Alhasan, Khalid
   Kari, Jameela A.
   Alhaboob, Ali
   Alsalmi, Amro
   AlMuhanna, Wejdan
   Almaghlouth, Ibrahim
   Aljamaan, Fadi
   Halwani, Rabih
   Saddik, Basema
   Barry, Mazin
   Al-Zamil, Fahad
   AlHadi, Ahmad N.
   Al-Subaie, Sarah
   Jamal, Amr
   Somily, Ali Mohammed
TI Changes in healthcare workers' knowledge, attitudes, practices, and
   stress during the COVID-19 pandemic
SO MEDICINE
LA English
DT Article
DE changing KAP; COVID-19; healthcare worker
ID EAST RESPIRATORY SYNDROME; MERS-COV OUTBREAK; SYNDROME CORONAVIRUS;
   MENTAL-HEALTH; PSYCHOLOGICAL IMPACT; HOSPITAL OUTBREAK; SAUDI-ARABIA;
   PERCEPTIONS; POPULATION; KINGDOM
AB Coronavirus disease 2019 (COVID-19) has caused an unprecedented health crisis around the world, not least because of its heterogeneous clinical presentation and course. The new information on the pandemic emerging daily has made it challenging for healthcare workers (HCWs) to stay current with the latest knowledge, which could influence their attitudes and practices during patient care. This study is a follow-up evaluation of changes in HCWs' knowledge, attitudes, and practices as well as anxiety levels regarding COVID-19 since the beginning of the pandemic. Data were collected through an anonymous, predesigned, self-administered questionnaire that was sent online to HCWs in Saudi Arabia. The questionnaire was sent to 1500 HCWs, with a 63.8% response rate (N = 957). The majority of respondents were female (83%), and the most common age group was 31 to 40 years (52.2%). Nurses constituted 86.3% of the respondents. HCWs reported higher anxiety during the COVID-19 pandemic which increased from 4.91 +/- 2.84 to 8.6 +/- 2.27 on an 11-point Likert scale compared to other viral outbreaks. HCWs believed that their own preparedness as well as that of their hospital's intensive care unit or emergency room was higher during the COVID-19 pandemic than during the Middle East respiratory syndrome coronavirus pandemic (2012-2015). About 58% of HCWs attended one or more simulations concerning the management of COVID-19 patients in their intensive care unit/emergency room, and nearly all had undergone N95 mask fit testing. The mean score of HCWs' knowledge of COVID-19 was 9.89/12. For most respondents (94.6%), the perception of being at increased risk of infection was the main cause of anxiety related to COVID-19; the mean score of anxiety over COVID-19 increased from 4.91 +/- 2.84 before to 8.6 +/- 2.27 during the pandemic in Saudi Arabia. HCWs' anxiety levels regarding COVID-19 have increased since a pandemic was declared. It is vital that healthcare facilities provide more emotional and psychological support for all HCWs.
C1 [Temsah, Mohamad-Hani; Al Huzaimi, Abdullah; Alrabiaah, Abdulkarim; Alamro, Nurah; Al-Sohime, Fahad; Al-Eyadhy, Ayman; Alhasan, Khalid; Alhaboob, Ali; Almaghlouth, Ibrahim; Aljamaan, Fadi; Barry, Mazin; Al-Zamil, Fahad; AlHadi, Ahmad N.; Al-Subaie, Sarah; Jamal, Amr; Somily, Ali Mohammed] King Saud Univ, Coll Med, Riyadh, Saudi Arabia.
   [Temsah, Mohamad-Hani; Alrabiaah, Abdulkarim; Al-Sohime, Fahad; Al-Eyadhy, Ayman; Alhasan, Khalid; Alhaboob, Ali; Alsalmi, Amro; AlMuhanna, Wejdan; Al-Zamil, Fahad; Al-Subaie, Sarah] King Saud Univ Med, Dept Pediat, Riyadh, Saudi Arabia.
   [Temsah, Mohamad-Hani] King Saud Univ, Fac Med, Prince Abdullah Ben Khaled Coeliac Dis Chair, Riyadh, Saudi Arabia.
   [Al Huzaimi, Abdullah] King Saud Univ Med City, Cardiac Sci Dept, Riyadh, Saudi Arabia.
   [Alamro, Nurah; Jamal, Amr] King Saud Univ Med City, Dept Family & Community Med, Riyadh, Saudi Arabia.
   [Alamro, Nurah] King Saud Univ, Prince Sattam bin Abdulaziz Res Chair Epidemiol &, Riyadh, Saudi Arabia.
   [Kari, Jameela A.] King Abdulaziz Univ, Paediat Nephrol Ctr Excellence, Dept Paediat, Jeddah, Saudi Arabia.
   [Almaghlouth, Ibrahim] King Saud Univ, Coll Med Res Ctr, Riyadh, Saudi Arabia.
   [Aljamaan, Fadi] King Saud Univ, King Saud Univ Med City, Adult Crit Care Dept, King Khalid Univ Hosp, Riyadh, Saudi Arabia.
   [Halwani, Rabih; Saddik, Basema] Univ Sharjah, Coll Med, Sharjah Inst Med Res, Sharjah, U Arab Emirates.
   [Barry, Mazin] King Saud Univ, Dept Internal Med, Infect Dis Unit, Riyadh, Saudi Arabia.
   [AlHadi, Ahmad N.] King Saud Univ, Coll Med, Dept Psychiat, Riyadh, Saudi Arabia.
   [AlHadi, Ahmad N.; Somily, Ali Mohammed] King Saud Univ Med City, Riyadh, Saudi Arabia.
   [AlHadi, Ahmad N.] King Saud Univ, SABIC Psychol Hlth Res & Applicat Chair, Coll Med, Riyadh, Saudi Arabia.
   [Jamal, Amr] King Saud Univ, Evidence Based Hlth Care 8 Knowledge Translat Res, Riyadh, Saudi Arabia.
   [Somily, Ali Mohammed] King Saud Univ, Coll Med, Dept Pathol & Lab Med, Riyadh, Saudi Arabia.
RP Jamal, A (corresponding author), King Saud Univ, King Saud Univ Med City, Coll Med, POB 2925, Riyadh 11461, Saudi Arabia.
EM amrjamal@ksu.edu.sa
RI Al-Eyadhy, Ayman/AAQ-1411-2021; Barry, Mazin/AAJ-7615-2020; aljamaan,
   fadi saleh/ABA-9482-2020; Jamal, Amr A/B-9495-2009; AlHadi, Ahmad
   N./I-2695-2013; Alamro, MD. MPH. DrPH., Nurah/K-9532-2018
OI Al-Eyadhy, Ayman/0000-0002-6051-9125; Barry, Mazin/0000-0003-2274-007X;
   aljamaan, fadi saleh/0000-0001-8404-6652; Jamal, Amr
   A/0000-0002-4051-6592; AlHadi, Ahmad N./0000-0002-2298-3509; Alsubaie,
   Sarah/0000-0002-3128-5921; Temsah, Mohamad-Hani/0000-0002-4389-9322;
   alsohime, fahad/0000-0002-4979-3895; Alamro, MD. MPH. DrPH.,
   Nurah/0000-0001-9489-3994; Alhasan, Khalid/0000-0002-4291-8536
FU Deanship of Scientific Research, King Saud UniversityKing Saud
   University
FX The authors are grateful to the Deanship of Scientific Research, King
   Saud University, for funding through the Vice Deanship of Scientific
   Research Chairs. The Research team would like to thank gratefully the
   statistical data analysis consultation offered by the statistical team
   at www.hodhodata.com for their advice and consulting.
CR Al-Omari A, 2019, DIAGN MICR INFEC DIS, V93, P265, DOI 10.1016/j.diagmicrobio.2018.10.011
   Alkhamees AA, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152192
   Alsubaie S, 2019, J INFECT DEV COUNTR, V13, P920, DOI 10.3855/jidc.11753
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Balkhy HH, 2016, INFECT CONT HOSP EP, V37, P1147, DOI 10.1017/ice.2016.132
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Barry M., 2020, J NAT SCI MED, V3, P155, DOI [10.4103/JNSM.JNSM_29_20, DOI 10.4103/JNSM.JNSM_29_20]
   Barry M, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101807
   Barry M, 2020, J EPIDEMIOL GLOB HEA, V10, P1, DOI 10.2991/jegh.k.200218.003
   Brazil Victoria, 2020, Adv Simul (Lond), V5, P9, DOI 10.1186/s41077-020-00127-z
   Bukhari EE, 2016, J INFECT DEV COUNTR, V10, P845, DOI 10.3855/jidc.6925
   Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Dai Y.H. G., 2020, PSYCHOL IMPACT CORON, DOI [10.1101/2020.03.03.20030874, DOI 10.1101/2020.03.03.20030874]
   de Pablo GS, 2020, J AFFECT DISORDERS, V275, P48, DOI 10.1016/j.jad.2020.06.022
   Drosten C, 2015, CLIN INFECT DIS, V60, P369, DOI 10.1093/cid/ciu812
   Eckerle I, 2020, LANCET, V396, P514, DOI 10.1016/S0140-6736(20)31482-3
   Fagbo SF, 2015, EMERG INFECT DIS, V21, P1981, DOI 10.3201/eid2111.150944
   Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211
   Guterres, LAUNCH POLICY BRIEF
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Liu YE, 2020, PUBLIC HEALTH NURS, V37, P757, DOI 10.1111/phn.12768
   Ministry of Health (MOH), MIDDLE E RESP SYNDRO
   Mohindra R, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102084
   Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636
   Oladimeji AM, 2015, TROP MED INT HEALTH, V20, P1162, DOI 10.1111/tmi.12528
   Saudi Central Board for Accreditation of Healthcare Institutions, NAT STAND HOSP
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Temsah MH, 2020, J INFECT PUBLIC HEAL, V13, P877, DOI [10.1016/j.jiph.2020.05.021, 10.1016/j.ijph.2020.05.021]
   ul Haq N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-692
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 34
TC 7
Z9 7
U1 7
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD MAY 7
PY 2021
VL 100
IS 18
AR e25825
DI 10.1097/MD.0000000000025825
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA SO4AP
UT WOS:000658917700078
PM 33950990
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Guillet, BD
   Chu, AMC
AF Guillet, Basak Denizci
   Chu, Angela Mai Chi
TI Managing hotel revenue amid the COVID-19 crisis
SO INTERNATIONAL JOURNAL OF CONTEMPORARY HOSPITALITY MANAGEMENT
LA English
DT Article
DE Hotel industry; Crisis management; Revenue management; COVID-19
AB Purpose - The revenue management (RM) discipline is built on the principle of demand-based pricing. This study aims to examine how and to what extent RM can be implemented in the hotel industry during low-demand periods, particularly during the coronavirus disease 2019 (COVID-19) crisis.
   Design/methodology/approach - This paper used semi-structured interviews to gather information from hotel RM executives, RM consultants and RM system providers. Participants were asked to think about the impact of COVID-19 on their RM practices. This paper interviewed 26 revenue executives between January and March 2020.
   Findings - Core RM processes are still relevant during the COVID-19 crisis; however, not all components are equally important. Business analysis, pricing strategy and demand modeling and forecasting are the most critical RM processes. Inventory and price optimization and setting booking controls are not as important at this time; along with distribution channel management, these processes will become more relevant as demand picks up.
   Research limitations/implications - Future research in this area should focus on each core RM process separately and in-depth to understand how implementation changes during the crisis and recovery periods. Future studies should also investigate how these processes operate during the recovery period. The full breadth of consequences of the COVID-19 crisis in hotel RM will likely manifest gradually. Therefore, the core RM processes should also be examined when the crisis is over.
   Originality/value - Apart from a few studies that touched on RM-related strategies during economic downturns, to the knowledge, this is the first study to systematically examine the extent to which RM can be implemented during a crisis.
C1 [Guillet, Basak Denizci; Chu, Angela Mai Chi] Hong Kong Polytech Univ, Sch Hotel & Tourism Management, Hong Kong, Peoples R China.
RP Guillet, BD (corresponding author), Hong Kong Polytech Univ, Sch Hotel & Tourism Management, Hong Kong, Peoples R China.
EM basak.denizci@polyu.edu.hk
RI Chu, Angela Mai Chi/AAC-8476-2021
OI Chu, Angela Mai Chi/0000-0002-7875-0827
CR [Anonymous], 2020, PHOCUSWIRE
   BELOBABA PP, 1989, OPER RES, V37, P183, DOI 10.1287/opre.37.2.183
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Butscher SA, 2009, J REVENUE PRICING MA, V8, P405, DOI 10.1057/rpm.2009.21
   Caudillo-Fuentes LA, 2010, J REVENUE PRICING MA, V9, P185, DOI 10.1057/rpm.2009.32
   Choi SunMee, 2005, Cornell Hotel and Restaurant Administration Quarterly, V46, P444, DOI 10.1177/0010880404270032
   Creswell J., 2008, RES DESIGN QUALITATI
   Cross R., 2020, REVENUE MANAGEMENT C
   Dahles H, 2015, ANN TOURISM RES, V51, P34, DOI 10.1016/j.annals.2015.01.002
   Deloitte, 2020, IMP COVID 19 CROSS S
   Guillet BD, 2020, INT J CONTEMP HOSP M, V32, P560, DOI 10.1108/IJCHM-06-2019-0515
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Four Seasons Hong Kong, 2020, 4 SEASONS LUXURY HOT
   Gehrels S., 2013, RES HOSPITALITY MANA, V2, P9, DOI DOI 10.1080/22243534.2013.11828284
   Guba E.G., 1990, PARADIGM DIALOG
   Guillet BD, 2015, INT J CONTEMP HOSP M, V27, P526, DOI 10.1108/IJCHM-06-2014-0295
   Heo CY., 2010, INT J REVENUE MANAGE, V4, P382, DOI [10.1504/IJRM.2010.036030, DOI 10.1504/IJRM.2010.036030]
   Israeli A. A., 2003, International Journal of Hospitality Management, V22, P353, DOI 10.1016/S0278-4319(03)00070-7
   Ivanov S, 2012, TOURISM, V60, P175
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Kimes S., 2009, CORNELL HOSP Q, V9, P6, DOI DOI 10.1002/9781119200901.CH26
   Kimes S. E., 1989, J OPERATIONS MANAGEM, V8, P348, DOI DOI 10.1016/0272-6963(89)90035-1
   Kimes S.E., 1998, J SERVICE RES, V1, P22, DOI DOI 10.1177/109467059800100205
   KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214
   Lancaster, 2003, J REVENUE PRICING MA, V2, P158, DOI 10.1057/palgrave.rpm.5170061
   Laws E, 2007, CRISIS MANAGEMENT IN TOURISM, P1, DOI 10.1079/9781845930479.0000
   Lee H, 2013, CORNELL HOSP Q, V54, P95, DOI 10.1177/1938965512454218
   Noone BM, 2011, J REVENUE PRICING MA, V10, P293, DOI 10.1057/rpm.2011.12
   O'Connor J., 1981, INT J URBAN REGIONAL, V5, P301
   Peterson, 2020, FUTURE HOSPITALITY U
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Santana G., 2003, Journal of Travel & Tourism Marketing, V15, P299, DOI 10.1300/J073v15n04_05
   Santana G., 1999, Turizam, V47, P4
   Simon, 2020, HOTSTATS GLOBAL HOTE
   Sorrells, 2020, DATA SHOWS IMPACT CO
NR 35
TC 14
Z9 14
U1 24
U2 68
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-6119
EI 1757-1049
J9 INT J CONTEMP HOSP M
JI Int. J. Contemp. Hosp. Manag.
PD MAR 16
PY 2021
VL 33
IS 2
BP 604
EP 627
DI 10.1108/IJCHM-06-2020-0623
EA JAN 2021
PG 24
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA RA0HF
UT WOS:000607700700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Tartaglia, R
   La Regina, M
   Tanzini, M
   Pomare, C
   Urwin, R
   Ellis, LA
   Fineschi, V
   Venneri, F
   Seghieri, C
   Lachman, P
   Westbrook, J
   Braithwaite, J
AF Tartaglia, Riccardo
   La Regina, Micaela
   Tanzini, Michela
   Pomare, Chiara
   Urwin, Rachel
   Ellis, Louise A.
   Fineschi, Vittorio
   Venneri, Francesco
   Seghieri, Chiara
   Lachman, Peter
   Westbrook, Johanna
   Braithwaite, Jeffrey
TI International survey of COVID-19 management strategies
SO INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
LA English
DT Article
DE COVID-19; pandemic management; international survey; health systems; WHO
   regions; management control
AB Background While individual countries have gained considerable knowledge and experience in coronavirus disease of 2019 (COVID-19) management, an international, comparative perspective is lacking, particularly regarding the measures taken by different countries to tackle the pandemic. This paper elicits the views of health system staff, tapping into their personal expertise on how the pandemic was initially handled. Methods From May to July 2020, we conducted a cross-sectional, online, purpose-designed survey comprising 70 items. Email lists of contacts provided by the International Society for Quality in Health Care, the Italian Network for Safety in Health Care and the Australian Institute of Health Innovation were used to access healthcare professionals and managers across the world. We snowballed the survey to individuals and groups connected to these organizations. Key outcome measures were attitudes and information about institutional approaches taken; media communication; how acute hospitals were re-organized; primary health organization; personal protective equipment; and staffing and training. Results A total of 1131 survey participants from 97 countries across the World Health Organization (WHO) regions responded to the survey. Responses were from all six WHO regions; 57.9% were female and the majority had 10 or more years of experience in healthcare; almost half (46.5%) were physicians; and all other major clinical professional groups participated. As the pandemic progressed, most countries established an emergency task force, developed communication channels to citizens, organized health services to cope and put in place appropriate measures (e.g. pathways for COVID-19 patients, and testing, screening and tracing procedures). Some countries did this better than others. We found several significant differences between the WHO regions in how they are tackling the pandemic. For instance, while overall most respondents (71.4%) believed that there was an effective plan prior to the outbreak, this was only the case for 31.9% of respondents from the Pan American Health Organization compared with 90.7% of respondents from the South-East Asia Region (SEARO). Issues with swab testing (e.g. delay in communicating the swab outcome) were less frequently reported by respondents from SEARO and the Western Pacific Region compared with other regions. Conclusion The world has progressed in its knowledge and sophistication in tackling the pandemic after early and often substantial obstacles were encountered. Most WHO regions have or are in the process of responding well, although some countries have not yet instituted widespread measures known to support mitigation, for example, effective swab testing and social control measures.
C1 [Tartaglia, Riccardo; La Regina, Micaela; Tanzini, Michela] Italian Network Safety Hlth Care, Via Renai 23, I-50125 Florence, Italy.
   [Pomare, Chiara; Ellis, Louise A.; Braithwaite, Jeffrey] Macquarie Univ, Ctr Healthcare Resilience & Implementat Sci, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.
   [Urwin, Rachel; Westbrook, Johanna] Macquarie Univ, Ctr Hlth Syst & Safety Res, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.
   [Ellis, Louise A.; Braithwaite, Jeffrey] Macquarie Univ, NHMRC Partnership Ctr Hlth Syst Sustainabil, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.
   [Fineschi, Vittorio] Univ Roma La Sapienza, Piazzale Aldo Moro 5, I-00185 Rome, RM, Italy.
   [Venneri, Francesco] Ctr Gest Rischio Clin, Via Pietro Dazzi 1, I-50141 Florence, FI, Italy.
   [Seghieri, Chiara] St Anna Pisa Sch Adv Studies, Piazza Martiri Liberta 33, I-56127 Pisa, PI, Italy.
   [Lachman, Peter; Braithwaite, Jeffrey] Int Soc Qual Hlth Care, Huguenot House,4th Floor,35-38 St Stephens Green, Dublin D02 NY63, Ireland.
RP Braithwaite, J (corresponding author), Macquarie Univ, Fac Med Hlth & Human Sci, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.
EM jeffrey.braithwaite@mq.edu.au
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council (NHMRC) of Australia [APP9100002, APP1134459,
   APP1135048]; Medical Research Future FundMedical Research Future Fund
   (MRFF) [APP1178554]
FX The work was supported by the organizations involved. J.B. and J.W.
   report holding research grants from the National Health and Medical
   Research Council (APP9100002, APP1134459 and APP1135048) and the Medical
   Research Future Fund (APP1178554).
CR Alderwick H, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1937
   Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447
   Braithwaite J, 2021, INT J QUAL HEALTH C, V33, DOI 10.1093/intqhc/mzaa113
   Brindle ME, 2020, ANN SURG, V272, pE1, DOI 10.1097/SLA.0000000000003923
   DeForest A, 2020, NEW ENGL J MED, V383, P1708, DOI 10.1056/NEJMp2016293
   Fisher D, 2020, LANCET
   Gurses Ayse P, 2020, J Patient Saf Risk Manag, V25, P49, DOI 10.1177/2516043520917764
   Habib H, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2376
   Haffajee RL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006740
   Hollnagel E., 2011, RESILIENCE ENG PRACT, P275, DOI DOI 10.1201/9781317065265-19
   Lee K, 2009, GLOB INST, P1
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Loder E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2637
   Mario T, 2020, LANCET, V396, P71
   Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rutter H, 2020, LANCET, V396, P152, DOI 10.1016/S0140-6736(20)31184-3
   Staines A., 2020, INT J QUAL HEALTH C, DOI [10.1093/intqhc/mzaa050, DOI 10.1093/INTQHC/MZAA050]
   Tabah A, 2020, J CRIT CARE, V59, P70, DOI 10.1016/j.jcrc.2020.06.005
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   World Health Organization, 2020, 2019 NOV COR 2019 NC
   Wu AW., 2020, J PATIENT SAF RISK M, V25, P93
NR 23
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1353-4505
EI 1464-3677
J9 INT J QUAL HEALTH C
JI Int. J. Qual. Health Care
PD FEB 20
PY 2021
VL 33
IS 1
AR mzaa139
DI 10.1093/intqhc/mzaa139
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZO1HQ
UT WOS:000765478500026
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Mishra, P
   Tomar, A
   Kumar, A
   Nath, A
   Sharma, SK
   Singh, GK
AF Mishra, Priyanka
   Tomar, Anupama
   Kumar, Ajit
   Nath, Amborish
   Sharma, Suresh K.
   Singh, Girish Kumar
TI Pain management in COVID-19 pediatric patients-An evidence-based review
SO SAUDI JOURNAL OF ANAESTHESIA
LA English
DT Review
DE Analgesia; analgesic safety; COVID-19; pain management; pediatric
ID ACUTE RESPIRATORY SYNDROME; ABDOMINAL-PAIN; CHILDREN
AB Despite our growing knowledge about the COVID pandemic, not much concern has been focused upon the effective pain management in pediatric patients suffering from this SARS CoV2 virus. Symptoms with pain like myalgia (10%-40%), sore throat (5%-30%), headache (14%-40%) and abdominal pain (10%) are common in children suffering from COVID. (3-5) We conducted a systematic review regarding analgesia for COVID positive pediatric patients. Cochrane, PubMed, and Google scholar databases were searched for relevant literature. Owing to the novel status of COVID-19 with limited literature, we included randomized controlled trials (RCTs), observational studies, case series and case reports in the descending order of consideration. Articles in languages other than English, abstract only articles and non-scientific commentaries were excluded. The Primary outcome was evaluation of pain related symptoms and best strategies for their management. Our review revealed that a multidisciplinary approach starting from non-pharmacological techniques like drinking plenty of water, removing triggers like inadequate sleep, specific foods and psychotherapy including distraction, comfort and cognitive behavioural strategies should be used. Pharmacological approaches like acetaminophen, NSAIDS, spasmolytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain management in children with COVID-19. Undertreated pain is a significant contributor to increased morbidity and poor prognosis. Integration of evidence based non-pharmacotherapies in the multidisciplinary pain management will contribute towards improved functioning, early recovery and better quality care for pediatric patients suffering from COVID.
C1 [Mishra, Priyanka; Tomar, Anupama; Kumar, Ajit; Singh, Girish Kumar] AIIMS Rishikesh, Dept Anesthesiol & Crit Care, Rishikesh, Uttarakhand, India.
   [Nath, Amborish] AIIMS Rishikesh, Dept Burns & Plast Surg, Rishikesh, Uttarakhand, India.
   [Sharma, Suresh K.] All India Inst Med Sci, Coll Nursing, Rishikesh, Uttarakhand, India.
RP Mishra, P (corresponding author), AIIMS Rishikesh, Rishikesh, Uttarakhand, India.
EM pmishra15390@gmail.com
CR Ali I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138861
   Amer HM, 2018, ANIM HEALTH RES REV, V19, P113, DOI 10.1017/S1466252318000117
   Amici C, 2006, ANTIVIR THER, V11, P1021
   Asadi-Pooya AA, 2020, J NEUROL SCI, V413, DOI 10.1016/j.jns.2020.116832
   Bitnun A, 2003, PEDIATRICS, V112, pE261, DOI 10.1542/peds.112.4.e261
   Chen ZM, 2020, WORLD J PEDIATR, V16, P240, DOI 10.1007/s12519-020-00345-5
   Chiu Wa-keung, 2003, Pediatr Crit Care Med, V4, P279, DOI 10.1097/01.PCC.0000077079.42302.81
   Coakley R, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4020009
   Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086
   Dong HJ, 2000, DRUG METAB DISPOS, V28, P1397
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Hechler T, 2015, PEDIATRICS, V136, P115, DOI 10.1542/peds.2014-3319
   Hijaz NM, 2017, PEDIATR HEALTH MED T, V8, P83, DOI 10.2147/PHMT.S120156
   Hon KLE, 2003, LANCET, V361, P1701, DOI 10.1016/S0140-6736(03)13364-8
   Hurley WR, 2014, PRACTICAL MANAGEMENT, V20, P304
   Jafari A, 2020, CRIT REV ONCOL HEMAT, V151, DOI 10.1016/j.critrevonc.2020.102982
   Kanabar DJ, 2017, INFLAMMOPHARMACOLOGY, V25, P1, DOI 10.1007/s10787-016-0302-3
   Kotsiou OS, 2017, RESP MED, V123, P28, DOI 10.1016/j.rmed.2016.12.005
   Krenke K, 2018, CLIN RESPIR J, V12, P253, DOI 10.1111/crj.12524
   Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6041
   MaassenVanDenBrink A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01106-5
   Manyike PT, 2000, CLIN PHARMACOL THER, V67, P275, DOI 10.1067/mcp.2000.104736
   Messika J, 2014, J CRIT CARE, V29, P733, DOI 10.1016/j.jcrc.2014.05.021
   Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690
   Nieminen TH, 2010, EUR J CLIN PHARMACOL, V66, P977, DOI 10.1007/s00228-010-0879-1
   Parker KL, 2008, GOODMAN GILMANS MANU, P430
   Paul SP, 2016, WORLD J PEDIATR, V12, P389, DOI 10.1007/s12519-016-0044-8
   Pflugbeil S, 2020, RHEUMATOL INT, V40, P511, DOI 10.1007/s00296-020-04526-3
   Principi N, 2020, LANCET INFECT DIS, V20, P1118, DOI 10.1016/S1473-3099(20)30296-6
   Rusetsky Yu Yu, 2020, Vestnik Otorinolaringologii, V85, P63, DOI 10.17116/otorino20208502163
   Russell B, 2020, ECANCERMEDICALSCIENC, V14, DOI 10.3332/ecancer.2020.1023
   Sankar J, 2020, INDIAN J PEDIATR, V87, P433, DOI 10.1007/s12098-020-03292-1
   Simsek Yavuz S, 2020, TURK J MED SCI, V50, P611, DOI 10.3906/sag-2004-145
   Viner RM, 2020, LANCET, V395, P1741, DOI 10.1016/S0140-6736(20)31129-6
   Weikle B., 2020, WHO CLARIFIES GUIDAN
   World Health Organization, 2020, US NONST ANT DRUGS N
   Wren AA, 2019, CHILDREN-BASEL, V6, DOI 10.3390/children6020033
   Young KD, 2017, CLIN PEDIATR EMERG M, V18, P235, DOI 10.1016/j.cpem.2017.09.005
NR 39
TC 0
Z9 0
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 1658-354X
EI 0975-3125
J9 SAUDI J ANAESTH
JI Saudi J. Anaesth.
PD JAN-MAR
PY 2021
VL 15
IS 1
BP 33
EP 39
DI 10.4103/sja.SJA_635_20
PG 7
WC Anesthesiology
WE Emerging Sources Citation Index (ESCI)
SC Anesthesiology
GA PU9LU
UT WOS:000609620600006
PM 33824640
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Tartaglia, R
   La Regina, M
   Tanzini, M
   Pomare, C
   Urwin, R
   Ellis, LA
   Fineschi, V
   Venneri, F
   Seghieri, C
   Lachman, P
   Westbrook, J
   Braithwaite, J
AF Tartaglia, Riccardo
   La Regina, Micaela
   Tanzini, Michela
   Pomare, Chiara
   Urwin, Rachel
   Ellis, Louise A.
   Fineschi, Vittorio
   Venneri, Francesco
   Seghieri, Chiara
   Lachman, Peter
   Westbrook, Johanna
   Braithwaite, Jeffrey
TI International survey of COVID-19 management strategies
SO INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
LA English
DT Article
DE COVID-19; pandemic management; international survey; health systems; WHO
   regions; management control
AB Background: While individual countries have gained considerable knowledge and experience in coronavirus disease of 2019 (COVID-19) management, an international, comparative perspective is lacking, particularly regarding the measures taken by different countries to tackle the pandemic. This paper elicits the views of health system staff, tapping into their personal expertise on how the pandemic was initially handled.
   Methods: From May to July 2020, we conducted a cross-sectional, online, purpose-designed survey comprising 70 items. Email lists of contacts provided by the International Society for Quality in Health Care, the Italian Network for Safety in Health Care and the Australian Institute of Health Innovation were used to access healthcare professionals and managers across the world. We snowballed the survey to individuals and groups connected to these organizations. Key outcome measures were attitudes and information about institutional approaches taken; media communication; how acute hospitals were re-organized; primary health organization; personal protective equipment; and staffing and training.
   Results: A total of 1131 survey participants from 97 countries across the World Health Organization (WHO) regions responded to the survey. Responses were from all six WHO regions; 57.9% were female and the majority had 10 or more years of experience in healthcare; almost half (46.5%) were physicians; and all other major clinical professional groups participated. As the pandemic progressed, most countries established an emergency task force, developed communication channels to citizens, organized health services to cope and put in place appropriate measures (e.g. pathways for COVID-19 patients, and testing, screening and tracing procedures). Some countries did this better than others. We found several significant differences between the WHO regions in how they are tackling the pandemic. For instance, while overall most respondents (71.4%) believed that there was an effective plan prior to the outbreak, this was only the case for 31.9% of respondents from the Pan American Health Organization compared with 90.7% of respondents from the South-East Asia Region (SEARO). Issues with swab testing (e.g. delay in communicating the swab outcome) were less frequently reported by respondents from SEARO and the Western Pacific Region compared with other regions.
   Conclusion: The world has progressed in its knowledge and sophistication in tackling the pandemic after early and often substantial obstacles were encountered. Most WHO regions have or are in the process of responding well, although some countries have not yet instituted widespread measures known to support mitigation, for example, effective swab testing and social control measures.
C1 [Tartaglia, Riccardo; La Regina, Micaela; Tanzini, Michela] Italian Network Safety Hlth Care, Via Renai 23, I-50125 Florence, Italy.
   [Pomare, Chiara; Ellis, Louise A.; Braithwaite, Jeffrey] Macquarie Univ, Ctr Healthcare Resilience & Implementat Sci, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.
   [Urwin, Rachel; Westbrook, Johanna] Macquarie Univ, Ctr Hlth Syst & Safety Res, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.
   [Ellis, Louise A.; Braithwaite, Jeffrey] Macquarie Univ, NHMRC Partnership Ctr Hlth Syst Sustainabil, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.
   [Fineschi, Vittorio] Univ Roma La Sapienza, Piazzale Aldo Moro 5, I-00185 Rome, RM, Italy.
   [Venneri, Francesco] Ctr Gest Rischio Clin, Via Pietro Dazzi 1, I-50141 Florence, FI, Italy.
   [Seghieri, Chiara] St Anna Pisa Sch Adv Studies, Piazza Martiri Liberta 33, I-56127 Pisa, PI, Italy.
   [Lachman, Peter; Braithwaite, Jeffrey] Int Soc Qual Hlth Care, Huguenot House,4th Floor,35-38 St Stephens Green, Dublin D02 NY63, Ireland.
RP Braithwaite, J (corresponding author), Macquarie Univ, Fac Med Hlth & Human Sci, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.
EM jeffrey.braithwaite@mq.edu.au
RI Braithwaite, Jeffrey/AAN-1467-2020; Lachman, Peter/ABD-4054-2020
OI Braithwaite, Jeffrey/0000-0003-0296-4957; Lachman,
   Peter/0000-0001-5120-5776; Urwin, Rachel/0000-0001-7026-8043
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council (NHMRC) of Australia [APP9100002, APP1134459,
   APP1135048]; Medical Research Future FundMedical Research Future Fund
   (MRFF) [APP1178554]
FX The work was supported by the organizations involved. J.B. and J.W.
   report holding research grants from the National Health and Medical
   Research Council (APP9100002, APP1134459 and APP1135048) and the Medical
   Research Future Fund (APP1178554).
CR Alderwick H, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1937
   Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447
   Brindle ME, 2020, ANN SURG, V272, pE1, DOI 10.1097/SLA.0000000000003923
   DeForest A, 2020, NEW ENGL J MED, V383, P1708, DOI 10.1056/NEJMp2016293
   Gurses Ayse P, 2020, J Patient Saf Risk Manag, V25, P49, DOI 10.1177/2516043520917764
   Habib H, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2376
   Haffajee RL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006740
   Hollnagel E., 2011, RESILIENCE ENG PRACT, P275, DOI DOI 10.1201/9781317065265-19
   Loder E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2637
   Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rutter H, 2020, LANCET, V396, P152, DOI 10.1016/S0140-6736(20)31184-3
   Staines A., 2020, INT J QUAL HEALTH C, DOI [10.1093/intqhc/mzaa050, DOI 10.1093/INTQHC/MZAA050]
   WHO, 2020, NOV COR 2019 NCOV SI
   World Health Organization, REP WHO CHIN JOINT M
   Wu AW, 2020, J PATIENT SAF RISK M, V25, P93
NR 17
TC 0
Z9 0
U1 1
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1353-4505
EI 1464-3677
J9 INT J QUAL HEALTH C
JI Int. J. Qual. Health Care
PD JAN
PY 2021
VL 33
IS 1
AR mzaa139
DI 10.1093/intqhc/mzaa139
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RZ9TY
UT WOS:000648943600030
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Al Mazrouei, N
   Ibrahim, RM
   Al Meslamani, AZ
   Abdel-Qader, DH
   Sadeq, AS
   Ibrahim, OM
AF Al Mazrouei, Nadia
   Ibrahim, Rana M.
   Al Meslamani, Ahmad Z.
   Abdel-Qader, Derar H.
   Sadeq, Adel Shaban
   Ibrahim, Osama Mohamed
TI The evolving role of community pharmacists during COVID-19 in the UAE;
   assessing preparedness and knowledge
SO INTERNATIONAL JOURNAL OF PHARMACY PRACTICE
LA English
DT Article
DE COVID-19; community pharmacists; UAE; preparedness
ID SERVICES
AB Objectives To investigate community pharmacists' knowledge about COVID-19 and their preparedness for the pandemic.
   Methods This cross-sectional online survey was conducted (in community pharmacies in the United Arab Emirates) over 3 weeks (24 May 2020 to 14 June 2020). A proportionate random sample of 491 participants was invited to take part. The SPSS version 26 was used for data management and analysis.
   Key Findings The majority of participants (n = 400) had good knowledge about COVID-19 and high level of preparedness for the pandemic control. Most pharmacists agreed (212, 53.0%) or strongly agreed (91, 22.8%) that they have a major role in the management of the ongoing crisis. Most participants had good awareness about the most common methods of COVID-19 transmission (359, 89.7%) and symptoms encountered (368, 92.0%). However, approximately a quarter of participants (103, 25.7%) incorrectly thought COVID-19 was caused by a DNA virus. Participants who had 5-10 and >10 years of experience were 3.95 (P = 0.03) and 1.59 (P = 0.01) times, respectively, were more likely to have good knowledge compared to participants with less than 2 years of experience. Those with good knowledge were more likely to have a specific area for customers with suspected COVID-19 symptoms compared to those with poor knowledge (P = 0.031).
   Conclusion This study indicates that years of experience and good knowledge on COVID-19 were significant determinants of pharmacists' preparedness for the pandemic control.
C1 [Al Mazrouei, Nadia; Ibrahim, Osama Mohamed] Univ Sharjah, Coll Pharm, Dept Pharm Practice & Pharmacotherapeut, Sharjah, U Arab Emirates.
   [Ibrahim, Rana M.; Sadeq, Adel Shaban] Al Ain Univ Sci & Technol, Coll Pharm, Abu Dhabi, U Arab Emirates.
   [Al Meslamani, Ahmad Z.; Abdel-Qader, Derar H.] Univ Petra, Fac Pharm & Med Sci, Amman, Jordan.
   [Ibrahim, Osama Mohamed] Cairo Univ, Fac Pharm, Dept Clin Pharm, Cairo, Egypt.
RP Ibrahim, OM (corresponding author), Univ Sharjah, Coll Pharm, Dept Pharm Practice & Pharmacotherapeut, Sharjah, U Arab Emirates.
EM oibrahim@sharjah.ac.ae
OI Mohamed Ibrahim, Osama/0000-0002-2868-039X
CR Al-Quteimat OM, 2020, RES SOC ADMIN PHARM, DOI [10.1016/j, DOI 10.1016/J]
   Amariles P, 2021, RES SOC ADMIN PHARM, V17, P1988, DOI 10.1016/j.sapharm.2020.03.007
   Anderson C, 2000, PATIENT EDUC COUNS, V39, P285, DOI 10.1016/S0738-3991(99)00025-7
   Aruru M, 2021, RES SOC ADMIN PHARM, V17, P1967, DOI 10.1016/j.sapharm.2020.04.002
   Australian Government Department of Foreign Affairs and Trade (dfat), 2020, UNITED ARAB EMIRATES
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Basheti IA, 2021, RES SOC ADMIN PHARM, V17, P514, DOI 10.1016/j.sapharm.2020.04.020
   Benrimoj Shalom I, 2004, Aust Health Rev, V28, P238
   Bukhari N, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00210-w
   Cadogan CA, 2021, RES SOC ADMIN PHARM, V17, P2032, DOI 10.1016/j.sapharm.2020.03.015
   Carico R, 2021, RES SOC ADMIN PHARM, V17, P1984, DOI 10.1016/j.sapharm.2020.03.017
   Centers for Disease Control and Prevention, 2020, COR DIS 2019
   Col U, 2020, RES SOC ADMIN PHARM, P583, DOI [DOI 10.1016/j.sapharm.2020.02.003, 10.1016/j.sapharm.2020.02.003]
   Department of Health AD, 2020, LAT INF COR COVID 19
   Fox ER, 2014, MAYO CLIN PROC, V89, P361, DOI 10.1016/j.mayocp.2013.11.014
   Garcia CB, 2015, J APPL STAT, V42, P648, DOI 10.1080/02664763.2014.980789
   George PP, 2010, ANN ACAD MED SINGAP, V39, P861
   Google, 2020, GOOGL FORMS SURV ADM
   Hasan Sanah, 2012, Int J Pharm Pract, V20, P218, DOI 10.1111/j.2042-7174.2011.00182.x
   Hasan Sanah, 2011, Int J Pharm Pract, V19, P392, DOI 10.1111/j.2042-7174.2011.00134.x
   Hassan SA, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7355
   Hedima EW, 2021, RES SOC ADMIN PHARM, V17, P1964, DOI 10.1016/j.sapharm.2020.04.013
   Hindi AMK, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032310
   International Pharmaceutical Federation, COR SARS COV 2 OUTBR
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031
   Motulsky A, 2021, RES SOC ADMIN PHARM, V17, P428, DOI 10.1016/j.sapharm.2020.03.001
   Moullin JC, 2013, RES SOC ADMIN PHARM, V9, P989, DOI 10.1016/j.sapharm.2013.02.005
   Muhammad K, 2020, KNOWLEDGE ATTITUDE P, DOI [10.1101/2020.05.22.20108290, DOI 10.1101/2020.05.22.20108290]
   Pan L, 2020, AM J GASTROENTEROL, V115, P766, DOI 10.14309/ajg.0000000000000620
   RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273
   Raosoft L, 2004, RAOSOFT SAMPLE SIZE
   Romero JR, 2016, CLIN VIROLOGY
   Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748
   WHO, 2020, COR DIS COVID 2019 S
   Worldometers, 2020, COR UPD
   Zaman A, 2002, J EC SOC RES, V2, P1
   Zheng S-Q, 2020, RES SOCIAL ADM PHARM, DOI [10.1016/j, DOI 10.1016/J]
NR 37
TC 4
Z9 4
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0961-7671
EI 2042-7174
J9 INT J PHARM PRACT
JI Int. J. Pharm. Pract.
PD APR
PY 2021
VL 29
IS 2
BP 137
EP 144
DI 10.1093/ijpp/riaa003
PG 8
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA RJ0IM
UT WOS:000637287000007
PM 33729523
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Zhou, Q
   Li, WG
   Zhao, SY
   Li, QY
   Shi, QL
   Wang, ZJ
   Liu, H
   Liu, X
   Estill, AN
   Luo, ZX
   Li, Q
   Yang, KH
   Liu, EM
   Chen, YL
AF Zhou, Qi
   Li, Weiguo
   Zhao, Siya
   Li, Qinyuan
   Shi, Qianling
   Wang, Zijun
   Liu, Hui
   Liu, Xiao
   Estill, Janne
   Luo, Zhengxiu
   Li, Qiu
   Yang, Kehu
   Liu, Enmei
   Chen, Yaolong
TI Guidelines for the Management of Children and Adolescent with COVID-19:
   protocol for an update
SO TRANSLATIONAL PEDIATRICS
LA English
DT Article
DE Coronavirus disease 2019 (COVID-19); children; standard guideline;
   protocol
ID CLINICAL GUIDELINES; QUALITY; TOOL; NETWORK; GRADE
AB Background: Coronavirus disease 2019 (COVID-19) has become a constant threat to people's lives, bringing huge challenges to the global public health and medical service system. In order to ensure the timeliness and reliability of the recommendations in guidelines, the working group of the Rapid Advice Guidelines for Management of Children with COVID-19 decided to update the guideline to incorporate the latest evidence to guide the management of COVID-19 in children and adolescent.
   Methods: We will update the guidelines, originally developed as a rapid advice guideline, into a standard guideline. We will follow the clinical practice guideline (CPG) update manuals of the National Institute for Health and Clinical Excellence (NICE) and the Spanish National Health System (SNHS). The updated guidelines will also follow the RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist and Checklist for the Reporting of Updated Guidelines (CheckUp).
   Discussion: Through systematic search, evaluation and grading of the best available relevant clinical evidence, combined with the experience of frontline clinical experts in the fight against the epidemic and the wishes of patients and their caretakers, we will update our previous rapid advice guidelines into a high-quality, implementable standard guidelines for the management of COVID-19 in children and adolescent.
C1 [Zhou, Qi; Shi, Qianling; Yang, Kehu] Lanzhou Univ, Sch Clin Med 1, Lanzhou, Peoples R China.
   [Zhou, Qi; Wang, Zijun; Yang, Kehu; Chen, Yaolong] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.
   [Li, Weiguo; Li, Qinyuan; Luo, Zhengxiu; Liu, Enmei] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Resp Med,Chongqing Key Lab Pediat, Minist Educ,Key Lab Child Dev & Disorders,Childre, Chongqing, Peoples R China.
   [Zhao, Siya; Liu, Hui; Liu, Xiao] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China.
   [Estill, Janne] Univ Geneva, Inst Global Hlth, Geneva, Switzerland.
   [Estill, Janne] Univ Bern, Inst Math Stat & Actuarial Sci, Bern, Switzerland.
   [Li, Qiu] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Nephrol,Chongqing Key Lab Pediat, Minist Educ,Key Lab Child Dev & Disorders,Childre, Chongqing, Peoples R China.
   [Yang, Kehu; Chen, Yaolong] WHO Collaborating Ctr Guideline Implementat & Kno, Lanzhou, Peoples R China.
   [Yang, Kehu; Chen, Yaolong] GIN Asia, Lanzhou, Peoples R China.
   [Yang, Kehu; Chen, Yaolong] Chinese GRADE Ctr, Lanzhou, Peoples R China.
   [Yang, Kehu; Chen, Yaolong] Lanzhou Univ, Cochrane China Network, Lanzhou, Peoples R China.
   [Yang, Kehu; Chen, Yaolong] Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China.
RP Chen, YL (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.; Liu, EM (corresponding author), Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Resp Med,Chongqing Key Lab Pediat, Minist Educ,Key Lab Child Dev & Disorders,Childre, Chongqing, Peoples R China.; Yang, KH (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Clin Med 1, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.
EM kehuyangebm20060@126.com; emliu186@126.com; chenyaolong@lzu.edu.cn
OI Liu, Hui/0000-0001-8245-6025; Chen, Yaolong/0000-0002-9841-5233; Zhou,
   Qi/0000-0001-7884-7074
FU National Clinical Research Center for Child Health and Disorders
   (Children's Hospital of Chongqing Medical University, Chongqing, China)
   [NCRCCHD-2020-EP-01]; Special Fund for Key Research and Development
   Projects in Gansu Province in 2020; fourth batch of "Special Project of
   Science and Technology for Emergency Response to COVID-19" of Chongqing
   Science and Technology Bureau; Key Laboratory of Evidence Based Medicine
   and Knowledge Translation of Gansu Province [GSEBMKT2020YJ01];
   Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [lzujbky-2020-sp14];
   National Key R&D Program of China [2018YFC1705500]; Research on Response
   to the Coronavirus Disease 2019 Outbreak in Gansu Province [20ZD016]
FX This work was supported by grants from National Clinical Research Center
   for Child Health and Disorders (Children's Hospital of Chongqing Medical
   University, Chongqing, China) (grant number NCRCCHD-2020-EP-01); Special
   Fund for Key Research and Development Projects in Gansu Province in
   2020; The fourth batch of "Special Project of Science and Technology for
   Emergency Response to COVID-19" of Chongqing Science and Technology
   Bureau; Special funding for prevention and control of emergency of
   COVID-19 from Key Laboratory of Evidence Based Medicine and Knowledge
   Translation of Gansu Province (grant number No. GSEBMKT2020YJ01); The
   Fundamental Research Funds for the Central Universities
   (lzujbky-2020-sp14); The National Key R&D Program of China (grant number
   2018YFC1705500); Research on Response to the Coronavirus Disease 2019
   Outbreak in Gansu Province (grant number 20ZD016).
CR Chen YL, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5158
   Chen YL, 2017, ANN INTERN MED, V166, P128, DOI 10.7326/M16-1565
   Clark H, 2020, LANCET, V395, P605, DOI 10.1016/S0140-6736(19)32540-1
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, 2011, CLIN PRACTICE GUIDEL
   Laine C, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00011
   Li L, 2014, J CLIN EPIDEMIOL, V67, P1001, DOI 10.1016/j.jclinepi.2014.04.003
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li WG, 2020, ANN PALLIAT MED, V9, P2251, DOI 10.21037/apm.2020.02.33
   Liu EM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3754
   National Institute for Health and Care Excellence, GUID MAN
   Norris Susan L, 2018, J Evid Based Med, V11, P133, DOI 10.1111/jebm.12314
   Norris SL, 2016, J CLIN EPIDEMIOL, V79, P150, DOI 10.1016/j.jclinepi.2016.07.001
   O'Connell B., 2020, NEWCASTLE OTTAWA SCA
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Pieper D, 2015, J CLIN EPIDEMIOL, V68, P574, DOI 10.1016/j.jclinepi.2014.12.009
   Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009
   Schunemann HJ, 2007, PLOS MED, V4, P786, DOI 10.1371/journal.pmed.0040119
   Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10
   Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155
   UNICEF, CONV RIGHTS CHILD CONV RIGHTS CHILD
   Vernooij RWM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002207
   Vernooij RWM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-3
   Wang Q, 2019, J EVID-BASED MED, V12, P140, DOI 10.1111/jebm.12343
   Wang XQ, 2018, J CLIN EPIDEMIOL, V98, P1, DOI 10.1016/j.jclinepi.2017.12.021
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   WHO-UNICEF-Lancet Commissioners, 2020, LANCET, V396, P298, DOI 10.1016/S0140-6736(20)31481-1
   Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527
   Working Group for CPG Updates, 2009, UPD CLIN PRACT GUID
   Yang KH, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-1
NR 31
TC 1
Z9 1
U1 4
U2 4
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2224-4344
J9 TRANSL PEDIATR
JI Transl. Pediatr.
PD JAN
PY 2021
VL 10
IS 1
BP 177
EP 182
DI 10.21037/tp-20-290
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA QA9TL
UT WOS:000613786700019
PM 33633950
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Batra, K
   Urankar, Y
   Batra, R
   Gomes, AF
   Meru, S
   Kaurani, P
AF Batra, Kavita
   Urankar, Yashashri
   Batra, Ravi
   Gomes, Aaron F.
   Meru, S.
   Kaurani, Pragati
TI Knowledge, Protective Behaviors and Risk Perception of COVID-19 among
   Dental Students in India: A Cross-Sectional Analysis
SO HEALTHCARE
LA English
DT Article
DE COVID-19; dental precautions; dental students; India; infection control;
   knowledge; perception; survey
ID PREVENTIVE BEHAVIORS; PRECAUTIONS; GENDER; DENTISTRY; ATTITUDE; AGE
AB Objective: This study's objective was to examine the knowledge, performance in practicing protective behaviors, and risk perception of Coronavirus disease-19 (COVID-19) among dental students of India. Methods: A web-based cross-sectional survey was conducted from 10-30 August 2020, involving 381 dental students that were enrolled at the Uttaranchal Dental and Medical Research Institute in India. A web-based structured questionnaire assessed the COVID-19 related knowledge, protective behaviors, and risk perception performance. The independent-samples-t and analysis of variance tests were used to analyze the differences in knowledge, protective behaviors, and perception across the groups. Results: Of the dental students surveyed, 83% had adequate knowledge of COVID-19, and nearly 80% followed appropriate practices regarding COVID-19. The COVID-19 related risk perception was higher among females as compared to males. COVID-19 related knowledge was significantly correlated with preventive behaviors (r = 0.18; p < 0 center dot 01) and risk perception (r = 0.10; p < 0.05). We found a high score of COVID-19 related knowledge and precautionary behaviors and moderate risk perception among students. Conclusions: Knowledge and protective behaviors towards infectious diseases, such as COVID-19, have clinical applications in developing educational and formal training programs to promote adherence to the infection control practices among dental students. Clinical significance: The findings of this study will inform policymakers to emphasize on effective risk communication. Dental institutions can incorporate infection control modules in the current curriculum, thereby making future dental professionals capable of performing effective infection control management in the clinical settings. This is critical in improving their knowledge of infection control practices to minimize the risk of nosocomial infections.
C1 [Batra, Kavita] Univ Nevada, Sch Med, Off Res, Las Vegas, NV 89102 USA.
   [Urankar, Yashashri] Community Hlth Ctr South Cent Texas, Gonzales, TX 78629 USA.
   [Batra, Ravi] Coforge Ltd, Dept Informat Technol, Atlanta, GA 30338 USA.
   [Gomes, Aaron F.] Uttaranchal Dent & Med Res Inst, Dept Periodontol & Oral Implantol, Dehra Dun 248140, Uttarakhand, India.
   [Meru, S.] Uttaranchal Dent & Med Res Inst, Dept Oral Med & Radiol, Dehra Dun 248140, Uttarakhand, India.
   [Kaurani, Pragati] Mahatma Gandhi Dent Coll & Hosp, Dept Prosthodont, Jaipur 302022, Rajasthan, India.
RP Batra, K (corresponding author), Univ Nevada, Sch Med, Off Res, Las Vegas, NV 89102 USA.
EM Kavita.batra@unlv.edu; UrankarY@chcsct.com; ravi.batra@coforgetech.com;
   aarongomes@hotmail.com; drmeru@gmail.com;
   drpragatikaurani@rediffmail.com
RI Kaurani, Pragati/AAX-1105-2020
OI Gomes, Aaron/0000-0002-4103-136X; Batra, Kavita/0000-0002-0722-0191
CR Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Al-Hazmi A, 2018, SAUDI J BIOL SCI, V25, P572, DOI 10.1016/j.sjbs.2016.01.032
   Almulhim B, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.654524
   [Anonymous], 2020, LIVE ASIA COVID 19 S
   [Anonymous], 2020, EFF US CHLOR HYDR CO
   Askarian M, 2009, ARCH IRAN MED, V12, P48
   Atas O, 2020, PEERJ, V8, DOI 10.7717/peerj.9575
   Ayub Afreen, 2013, Med J Armed Forces India, V69, P107, DOI 10.1016/j.mjafi.2012.07.021
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bennardo F, 2020, OPEN DENT J, V14, P623, DOI 10.2174/1874210602014010623
   Bennardo F, 2020, EUR J DENT EDUC, V24, P822, DOI 10.1111/eje.12555
   Bescos R, 2020, J DENT RES, V99, P1113, DOI 10.1177/0022034520932149
   Bianchi S., 2020, EUROMEDITERRANEAN BI, V15, P100
   Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   Centers for Disease Control and Prevention, 2020, CENT DIS CONTROL PRE
   Cohen J., 1988, STAT POWER ANAL BEHA, P567
   Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003
   European Food Safety Authority, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5926
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Gautret P, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.41.20604
   Ghai S, 2020, J DENT EDUC, V84, P631, DOI 10.1002/jdd.12174
   Halboub Esam Saleh, 2015, J Int Oral Health, V7, P15
   Harte JA, 2010, J AM DENT ASSOC, V141, P572, DOI 10.14219/jada.archive.2010.0232
   Iorfa SK, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566773
   Karaaslan F., 2020, BALKAN J DENT MED, V24, P1
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Khubrani A, 2018, J INFECT PUBLIC HEAL, V11, P546, DOI 10.1016/j.jiph.2017.10.013
   Kim JS, 2016, J CLIN NURS, V25, P2542, DOI 10.1111/jocn.13295
   Kim Y, 2018, CENT EUR J PUBL HEAL, V26, P54, DOI 10.21101/cejph.a4920
   Kohli A., 2008, DENT INFECT CONTROL, P99
   Lee K, 2009, GLOB INST, P1
   Li GW, 2020, J INFECT PUBLIC HEAL, V13, P1805, DOI 10.1016/j.jiph.2020.09.013
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m986
   Maricic J, 2013, DRUS ISTRAZ, V22, P579, DOI 10.5559/di.22.4.02
   Ministry of Health Family Welfare-Government of India, 2020, NAT HLTH PROF NHP IN
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Puttaiah Raghunath, 2011, J Contemp Dent Pract, V12, P1
   Rahman HS, 2020, INT J SURG OPEN, V26, P125, DOI 10.1016/j.ijso.2020.08.017
   Shahin SY, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01361-7
   Sharma A, 2020, INT J SCI RES, V9, P6, DOI [10.36106/ijsr, DOI 10.36106/IJSR]
   Silva O, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/8027130
   Singh D.A., 2020, J MED SCI CLIN RES, V8, P645, DOI [10.18535/jmscr/v8i6.123, DOI 10.18535/JMSCR/V8I6.123]
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   ul Haq N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-692
   Umeizudike KA, 2021, J DENT EDUC, V85, P187, DOI 10.1002/jdd.12423
   Varvara G, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9040454
NR 49
TC 11
Z9 11
U1 3
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9032
J9 HEALTHCARE-BASEL
JI Healthcare
PD MAY
PY 2021
VL 9
IS 5
AR 574
DI 10.3390/healthcare9050574
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA SH6WY
UT WOS:000654277400001
PM 34067943
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Mohsen, F
   Bakkar, B
   Armashi, H
   Aldaher, N
AF Mohsen, Fatema
   Bakkar, Batoul
   Armashi, Humam
   Aldaher, Nizar
TI Crisis within a crisis, COVID-19 knowledge and awareness among the
   Syrian population: a cross-sectional study
SO BMJ OPEN
LA English
DT Article
DE public health; COVID-19
ID ATTITUDES
AB Objectives To gauge specific knowledge around clinical features, transmission pathways and prevention methods, and to identify factors associated with poor knowledge to help facilitate outbreak management in Syria during this rapid global rise of the COVID-19 pandemic. Design Web-based cross-sectional survey. Setting This study was conducted in March 2020, nearly 10 years into the Syrian war crisis. The Arabic-language survey was posted on various social media platforms including WhatsApp, Telegram, Instagram and Facebook targeting various social groups. Participants A total of 4495 participants completed the survey. Participants with a history of COVID-19 infection, residing outside Syria or who did not fully complete the survey were excluded from the study. The final sample of 3586 participants (completion rate=79.8%) consisted of 2444 (68.2%) females and 1142 (31.8%) males. Primary and secondary outcome measures First, knowledge of COVID-19 in four areas (general knowledge; transmission pathways; signs and symptoms; prevention methods). Second, factors associated with poor knowledge. Results Of the 3586 participants, 2444 (68.2%) were female, 1822 (50.8%) were unemployed and 2839 (79.2%) were college educated. The study revealed good awareness regarding COVID-19 (mean 75.6%, SD +/- 9.4%). Multiple linear regression analysis correlated poor mean knowledge scores with male gender (beta=-0.933, p=0.005), secondary school or lower education level (beta=-3.782, p<0.001), non-healthcare occupation (beta=-3.592, p<0.001), low economic status (beta=-0.669, p<0.040) and >5 household members (beta=-1.737, p<0.001). Conclusion This study revealed some potentially troubling knowledge gaps which underscore the need for a vigorous public education campaign in Syria. This campaign must reinforce the public's awareness, knowledge and vigilance towards precautionary measures against COVID-19, and most importantly aid in controlling the worldwide spread of the disease.
C1 [Mohsen, Fatema; Bakkar, Batoul; Armashi, Humam] Syrian Private Univ, Fac Med, Damascus, Syria.
   [Aldaher, Nizar] Syrian Private Univ, Fac Med, Dept Internal Med, Damascus, Syria.
   [Aldaher, Nizar] Damascus Univ, Fac Med, Dept Internal Med, Damascus, Syria.
RP Mohsen, F (corresponding author), Syrian Private Univ, Fac Med, Damascus, Syria.
EM fatemamohsena@gmail.com
OI Mohsen, Fatema/0000-0003-3472-6099
FU Syrian Private University
FX We are thankful to the management of the Syrian Private University for
   the support in the field of medical training and research. We are
   thankful to everyone who participated in this study and to Mrs Marah
   Marrawi for her statistical help. We would also like to thank Mr Rod
   Usher for his valuable comments on the paper.
CR Affairs UOftCoH Organization WH, 2021, SYR AR REP COVID 19
   Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969
   Al-awsat A, 2021, SYRIA GRAPPLES 3 COV
   Austrian K., 2020, COVID 19 RELATED KNO, DOI [10.2139/ssrn.3576785, DOI 10.2139/SSRN.3576785]
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Best M, 2004, QUAL SAF HEALTH CARE, V13, P233, DOI 10.1136/qshc.2004.010918
   Gharibah M, 2020, COVID 19 PANDEMIC SY
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hussain T., EVALUATION GEN AWARE
   Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   McKernan B, 2020, THE GUARDIAN
   McNatt Z., 2018, IMPACT SEPARATION RE, DOI [10.7916/D80P2GF9, DOI 10.7916/D80P2GF9]
   Mehraeen E., 2020, INFECT DISORD-DRUG T, V26, P125, DOI [10.1016/j.ijso.2020.08.017, DOI 10.1016/J.IJSO.2020.08.017]
   Plecher H, 2020, SYRIA AGE STRUCTURE
   Qarawi ATA, 2020, AWARENESS PREPAREDNE, DOI [10.2139/ ssrn.3550294, DOI 10.2139/SSRN.3550294]
   Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x
   reliefweb, 2019, UN SYR CRIS SIT REP
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Tachfouti N, 2012, PAN AFR MED J, V12
   Tailakh A, 2014, NURS HEALTH SCI, V16, P126, DOI 10.1111/nhs.12060
   Tncpere T., 2020, CHINA CDC WEEKLY, V2019, P113
   Vadivu TS., 2014, AWARENESS PERCEPTION
   Viner RM, 2021, ARCH DIS CHILD, V106, P802, DOI 10.1136/archdischild-2020-320972
   WHO, 2020, KEY PLANN REC MASS G
   WHO, 2021, STAT 2 M INT HLTH RE
   WHO, 2020, WATER SANITATION HYG
   World Health Organization, 2016, WEB WHO DIAB COUNTR
   World Health Organization, INTR COVID 19 METH D
   World Health organization, SAF RAM PRACT CONT C
   World Health Organization, 2020, USE NONST ANT DRUGS
   World Health Organization, 2020, PRACTICAL CONSIDERAT
   World Health Organization, Q AS COVID 19 REL HL
   World Health Organization, 2020, GETT YOUR WORKPL REA
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 37
TC 2
Z9 2
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD APR
PY 2021
VL 11
IS 4
AR e043305
DI 10.1136/bmjopen-2020-043305
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA ZM0MN
UT WOS:000764061000013
PM 33879483
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Upadhyaya, DP
   Paudel, R
   Acharya, D
   Khoshnood, K
   Lee, K
   Park, JH
   Yoo, SJ
   Shrestha, A
   Bom, BC
   Bhandari, S
   Yadav, R
   Timalsina, A
   Wagle, CN
   Das, BK
   Kunwar, R
   Chalise, B
   Bhatta, DR
   Adhikari, M
AF Upadhyaya, Dipak Prasad
   Paudel, Rajan
   Acharya, Dilaram
   Khoshnood, Kaveh
   Lee, Kwan
   Park, Ji-Hyuk
   Yoo, Seok-Ju
   Shrestha, Archana
   Bom, B. C.
   Bhandari, Sabin
   Yadav, Ramgyan
   Timalsina, Ashish
   Wagle, Chetan Nidhi
   Das, Brij Kumar
   Kunwar, Ramesh
   Chalise, Binaya
   Bhatta, Deepak Raj
   Adhikari, Mukesh
TI Frontline Healthcare Workers' Knowledge and Perception of COVID-19, and
   Willingness to Work during the Pandemic in Nepal
SO HEALTHCARE
LA English
DT Article
DE COVID-19; frontline healthcare workers; knowledge; perception;
   willingness; Nepal
ID RESPIRATORY SYNDROME; PHYSICIANS; ATTITUDES; ABILITY
AB This study investigated the contextual factors associated with the knowledge, perceptions, and the willingness of frontline healthcare workers (FHWs) to work during the COVID-19 pandemic in Nepal among a total of 1051 FHWs. Multivariable logistic regression analysis was applied to identify independent associations between predictors and outcome variables. Of the total study subjects, 17.2% reported inadequate knowledge on COVID-19, 63.6% reported that they perceived the government response as unsatisfactory, and 35.9% showed an unwillingness to work during the pandemic. Our analyses demonstrated that FHWs at local public health facilities, pharmacists, Ayurvedic health workers (HWs), and those with chronic diseases were less likely, and male FHWs were more likely, to have adequate knowledge of COVID-19. Likewise, nurses/midwives, public health workers, FHWs from Karnali and Far-West provinces, and those who had adequate knowledge of COVID-19 were more likely to have satisfactory perceptions towards the government response. Further, FHWs-paramedics, nurse/midwives, public health workers, laboratory workers-FHWs from Karnali Province and Far-West Province, and those with satisfactory perceptions of government responses to COVID-19 were predictors of willingness to work during the COVID-19 pandemic. These results suggest that prompt actions are required to improve FHWs' knowledge of COVID-19, address negative perceptions of government responses, and motivate them through specific measures to provide healthcare services during the pandemic.
C1 [Upadhyaya, Dipak Prasad] CaseWestern Reserve Univ, Sch Med, Euclid Ave, Cleveland, OH 44106 USA.
   [Upadhyaya, Dipak Prasad; Paudel, Rajan] Tribhuvan Univ, Inst Med, Cent Dept Publ Hlth, Kathmandu 44600, Nepal.
   [Acharya, Dilaram; Lee, Kwan; Park, Ji-Hyuk; Yoo, Seok-Ju] Dongguk Univ, Dept Prevent Med, Coll Med, Gyeongju 38066, South Korea.
   [Khoshnood, Kaveh] Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Shrestha, Archana] Kathmandu Univ, Sch Med Sci, Dept Publ Hlth, Dhulikhel 45200, Nepal.
   [Shrestha, Archana] Inst Implementat Sci & Hlth, Kathmandu 44600, Nepal.
   [Bom, B. C.; Yadav, Ramgyan; Timalsina, Ashish; Wagle, Chetan Nidhi; Das, Brij Kumar; Kunwar, Ramesh; Bhatta, Deepak Raj; Adhikari, Mukesh] Minist Hlth & Populat, Kathmandu 44600, Nepal.
   [Bhandari, Sabin] BP Koirala Inst Hlth Sci, Dharan 56700, Nepal.
   [Chalise, Binaya] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Hiroshima 7398527, Japan.
   [Adhikari, Mukesh] Yale Univ, Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.
RP Upadhyaya, DP (corresponding author), CaseWestern Reserve Univ, Sch Med, Euclid Ave, Cleveland, OH 44106 USA.; Upadhyaya, DP (corresponding author), Tribhuvan Univ, Inst Med, Cent Dept Publ Hlth, Kathmandu 44600, Nepal.; Yoo, SJ (corresponding author), Dongguk Univ, Dept Prevent Med, Coll Med, Gyeongju 38066, South Korea.
EM dipak.upadhyaya@cdph.tu.edu.np; paudel.rajan@gmail.com;
   dilaramacharya123@gmail.com; kaveh.khoshnood@yale.edu;
   kwaniya@dongguk.ac.kr; skeyd@naver.com; medhippo@dongguk.ac.kr;
   archana@kusms.edu.np; bombc2011@gmail.com; sabin7000@gmail.com;
   ramgderma@gmail.com; ashish.timalsina@gmail.com; uchetan@hotmail.com;
   deepakbhattaph@gmail.com; ramesh.kunwar04@gmail.com;
   binayachalise@gmail.com; deepakbhattaph@gmail.com;
   mukesh.adhikari@yale.edu
RI C., Bom B./AAN-5664-2021; C., Bom B./AAM-1162-2021; Khoshnood,
   Kaveh/AAX-1402-2020; Upadhyaya, Dipak/AAJ-3205-2021; Upadhyaya,
   Dipak/AAF-7619-2021
OI C., Bom B./0000-0003-4446-1258; Khoshnood, Kaveh/0000-0003-2795-0447;
   Upadhyaya, Dipak/0000-0001-9068-5450; Shrestha,
   Archana/0000-0002-4741-090X; Paudel, Rajan/0000-0002-9894-5656; Park,
   Ji-Hyuk/0000-0002-7359-1847; Acharya, Dilaram/0000-0003-2270-7667; Lee,
   Kwan/0000-0003-2554-4170
CR Aoyagi Y, 2015, INFLUENZA OTHER RESP, V9, P120, DOI 10.1111/irv.12310
   Balicer RD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-436
   BEYER S, 1990, J PERS SOC PSYCHOL, V59, P960, DOI 10.1037//0022-3514.59.5.960
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Cooper KM, 2018, ADV PHYSIOL EDUC, V42, P200, DOI 10.1152/advan.00085.2017
   Daugherty EL, 2009, INFECT CONT HOSP EP, V30, P1143, DOI 10.1086/648085
   Deng JF, 2006, PUBLIC HEALTH, V120, P15, DOI 10.1016/j.puhe.2005.10.001
   Ehrlinger J, 2003, J PERS SOC PSYCHOL, V84, P5, DOI 10.1037/0022-3514.84.1.5
   Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34
   Globalstats S., SOC MED STATS NEP
   Goforth C., USING INTERPRETING C
   Harrison E., FINALFIT QUICKLY CRE
   Hope K, 2010, AUST J EMERG MANAG, V25, P39
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huynh G, 2020, J TROPICAL MED, V13, P260, DOI DOI 10.4103/1995-7645.280396
   Indiana University, FEM MED STUD UND THE
   Kaiser HE, 2009, DISASTER MED PUBLIC, V3, P210, DOI 10.1097/DMP.0b013e3181aa242a
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Machhi J, 2020, J NEUROIMMUNE PHARM, V15, P359, DOI 10.1007/s11481-020-09944-5
   Madhu A., COVID 19 CITIZENS PU
   Martin SD, 2011, J NURS MANAGE, V19, P98, DOI 10.1111/j.1365-2834.2010.01190.x
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Ministry of Health and Population, COR INF MIN HLTH POP
   Ministry of Health and Population, COR DIS COVID 19 OUT
   Ministry of Health and Population, 2020, HLTH EM OP CTR HLTH
   Nepal R, 2020, RES SQ, P1, DOI [10.21203/rs.3.rs-26774/v1, DOI 10.21203/RS.3.RS-26774/V1]
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086
   Shrestha R, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa024
   Sim MR, 2020, OCCUP ENVIRON MED, V77, P281, DOI 10.1136/oemed-2020-106567
   Watt K, 2010, PREHOSP DISASTER MED, V25, P13, DOI 10.1017/S1049023X00007597
   World Health Organization, TECHN GUID PUBL
   Yonge O, 2010, PUBLIC HEALTH NURS, V27, P174, DOI 10.1111/j.1525-1446.2010.00839.x
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 34
TC 10
Z9 10
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9032
J9 HEALTHCARE-BASEL
JI Healthcare
PD DEC
PY 2020
VL 8
IS 4
AR 554
DI 10.3390/healthcare8040554
PG 14
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA PI9UT
UT WOS:000601427500001
PM 33322486
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Lo Bianco, G
   Di Pietro, S
   Mazzuca, E
   Imburgia, A
   Tarantino, L
   Accurso, G
   Benenati, V
   Vernuccio, F
   Bucolo, C
   Salomone, S
   Riolo, M
AF Lo Bianco, Giuliano
   Di Pietro, Santi
   Mazzuca, Emilia
   Imburgia, Aurelio
   Tarantino, Luca
   Accurso, Giuseppe
   Benenati, Vincenzo
   Vernuccio, Federica
   Bucolo, Claudio
   Salomone, Salvatore
   Riolo, Marianna
TI Multidisciplinary Approach to the Diagnosis and In-Hospital Management
   of COVID-19 Infection: A Narrative Review
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE COVID-19; hospital care; multispecialist care; pandemic (COVID-19);
   hospital response capability
ID CLINICAL-PRACTICE GUIDELINE; DISEASE 2019 COVID-19; CORONAVIRUS
   INFECTION; RETINAL FINDINGS; VENTILATION; RECEPTOR; ASSOCIATION;
   THERAPY; SOCIETY; PATIENT
AB Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19 disease) was declared a pandemic on 11th March 2020 by the World Health Organization. This unprecedented circumstance has challenged hospitals' response capacity, requiring significant structural and organizational changes to cope with the surge in healthcare demand and to minimize in-hospital risk of transmission. As our knowledge advances, we now understand that COVID-19 is a multi-systemic disease rather than a mere respiratory tract infection, therefore requiring holistic care and expertise from various medical specialties. In fact, the clinical spectrum of presentation ranges from respiratory complaints to gastrointestinal, cardiac or neurological symptoms. In addition, COVID-19 pandemic has created a global burden of mental illness that affects the general population as well as healthcare practitioners. The aim of this manuscript is to provide a comprehensive and multidisciplinary insight into the complexity of this disease, reviewing current scientific evidence on COVID-19 management and treatment across several medical specialties involved in the in-hospital care of these patients.
C1 [Lo Bianco, Giuliano; Bucolo, Claudio; Salomone, Salvatore] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Catania, Italy.
   [Lo Bianco, Giuliano] Fdn Ist G Giglio, Anesthesiol & Pain Dept, Cefalu, Italy.
   [Di Pietro, Santi] Univ Pavia, Emergency Med Fellowship Programme, Pavia, Italy.
   [Di Pietro, Santi] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Emergency Dept, London, England.
   [Mazzuca, Emilia] AO Osped Riuniti Villa Sofia Cervello, Unita Operat Complessa Pneumol, Palermo, Italy.
   [Imburgia, Aurelio] San Marino State Hosp, Cailungo, San Marino.
   [Tarantino, Luca] UO Elettrofisiol, Clin Humanitas Gavazzeni, Bergamo, Italy.
   [Accurso, Giuseppe] Univ Palermo, Sect Anaesthesia Analgesia Intens Care & Emergenc, Policlin Paolo Giaccone, Dept Surg Oncol & Oral Sci DiChirOnS, Palermo, Italy.
   [Benenati, Vincenzo] Polyclin Maine, Laval, Pays De La Loir, France.
   [Vernuccio, Federica] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BIND, Sect Radiol, Palermo, Italy.
   [Riolo, Marianna] Asl TO5, Osped Santa Croce Moncalieri, Struttura Complessa Neurol, Moncalieri, TO, Italy.
RP Di Pietro, S (corresponding author), Univ Pavia, Emergency Med Fellowship Programme, Pavia, Italy.; Di Pietro, S (corresponding author), Imperial Coll Healthcare NHS Trust, St Marys Hosp, Emergency Dept, London, England.
EM santi.dipietro01@universitadipavia.it
RI Vernuccio, Federica/J-5739-2018; Imburgia, Aurelio/AAA-3211-2021
OI Vernuccio, Federica/0000-0003-0350-1794; Imburgia,
   Aurelio/0000-0003-4042-1910
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2019, REV ESP CARDIOL, V72, P72, DOI [10.1161/CIR.0000000000000617, 10.1016/j.jacc.2018.08.1038, 10.1016/j.recesp.2018.11.011, 10.1093/eurheartj/ehy462]
   [Anonymous], 2020, RES EST CONT TRAC QU
   [Anonymous], 2020, OUTBR NOV COR DIS 20
   Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4
   Arabi YM, 2020, INTENS CARE MED, V46, P315, DOI 10.1007/s00134-020-05943-5
   Asperges E, 2020, J HOSP INFECT, V105, P477, DOI 10.1016/j.jhin.2020.03.020
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Bednarczyk JM, 2017, CRIT CARE MED, V45, P1538, DOI 10.1097/CCM.0000000000002554
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bentzer P, 2016, JAMA-J AM MED ASSOC, V316, P1298, DOI 10.1001/jama.2016.12310
   Bomprezzi R, 2014, THER ADV NEUROL DISO, V7, P227, DOI 10.1177/1756285614540224
   Boriani G, 2019, EUROPACE, V21, P7, DOI 10.1093/europace/euy110
   BPC-PDTA, 2020, BPC PDTA GDS SEPS IN
   Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP
   Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8
   Brugliera L, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2678
   Burry L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011749.pub2
   Caputo ND, 2020, ACAD EMERG MED, V27, P375, DOI 10.1111/acem.13994
   Carron M, 2013, BRIT J ANAESTH, V110, P896, DOI 10.1093/bja/aet070
   Caruso D, 2020, RADIOLOGY, V296, pE79, DOI 10.1148/radiol.2020201237
   CDC Discontinuation, 2020, TRANSM BAS PREC DISP
   Chen L, 2020, BRIT J OPHTHALMOL, V104, P748, DOI 10.1136/bjophthalmol-2020-316304
   Chen SC, 2020, J NURS RES, V28, DOI 10.1097/NRJ.0000000000000389
   Chen TY, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101635
   Chiumello D, 2018, CRIT CARE MED, V46, P1761, DOI 10.1097/CCM.0000000000003340
   Christ-Crain M, 2008, J INTERN MED, V264, P166, DOI 10.1111/j.1365-2796.2008.01934.x
   Circolare Ministeriale, 2020, 5443 CIRC MIN
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254
   De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166
   Di Pietro S., 2020, J ULTRASOUND, V44, P83, DOI [10.1007/s40477-020-00454-x10.1007/s40477-02000454-x, DOI 10.1007/S40477-020-00454-X10.1007/S40477-02000454-X]
   ESC Guidance, 2020, ESC GUID DIAGN MAN C
   European Centre for Disease Prevention and Control, 2020, CAS DEF EUR SURV COV
   European Centre for Disease Prevention and Control (ECDC), 2020, PUBL HLTH MAN PERS I
   Fausto J, 2020, J PAIN SYMPTOM MANAG, V60, pE21, DOI 10.1016/j.jpainsymman.2020.03.025
   Fouladseresht H, 2021, CYTOKINE GROWTH F R, V58, P32, DOI 10.1016/j.cytogfr.2020.10.002
   Gagliano A, 2020, DISASTER MED PUBLIC, V14, P372, DOI 10.1017/dmp.2020.51
   Gamper G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003709.pub4
   Gattinoni L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02880-z
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Ghezzi A, 2019, NEUROL THER, V8, P461, DOI 10.1007/s40120-019-0146-z
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Global Surveillance, 2020, GLOB SURV HUM INF NO
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Greenwood GT, 2015, INT MED CASE REP J, V8, P235, DOI 10.2147/IMCRJ.S90640
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Harari S. A., 2004, MANAGING RESP CARE P
   Heimfarth L, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106947
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hendin A, 2020, CAN J EMERG MED, V22, P414, DOI 10.1017/cem.2020.352
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Honarmand K, 2020, CAN J ANESTH, V67, P369, DOI 10.1007/s12630-019-01546-x
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Interim Infection Prevention, 2020, INT INF PREV CONTR R
   Invernizzi A, 2020, ECLINICALMEDICINE, V27, DOI 10.1016/j.eclinm.2020.100550
   Invernizzi A, 2020, OCUL IMMUNOL INFLAMM, V28, P1290, DOI 10.1080/09273948.2020.1807023
   Jin X, 2020, GUT, V69, P1002, DOI 10.1136/gutjnl-2020-320926
   Jin Y-H., 2020, MILITARY MED RES, V7, DOI DOI 10.1186/S40779-020-0233-6
   Kampf G, 2020, J HOSP INFECT, V105, P587, DOI [10.1016/j.jhin.2020.01.022, 10.1016/j.jhin.2020.06.001]
   Karan A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1040
   Khosravani H, 2020, STROKE, V51, P1891, DOI 10.1161/STROKEAHA.120.029838
   Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642
   Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405
   Kooraki S, 2020, AM J ROENTGENOL, V215, pW7, DOI 10.2214/AJR.20.23211
   Kotfis K, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02882-x
   Koumpa FS, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-238419
   Krzeminski P, 2018, POSTEP DERM ALERGOL, V35, P429, DOI 10.5114/ada.2018.77675
   Lai T. H. T., 2020, GRAEFES ARCH CLIN EX, V14, P55, DOI [10.1007/s00417-020-04662-3, DOI 10.1007/S00417-020-04662-3]
   Lai THT, 2020, GRAEF ARCH CLIN EXP, V258, P1049, DOI 10.1007/s00417-020-04641-8
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Leiva-Juarez MM, 2018, MUCOSAL IMMUNOL, V11, P21, DOI 10.1038/mi.2017.71
   Lewis SR, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub7
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li GP, 2020, J AUTOIMMUN, V112, DOI 10.1016/j.jaut.2020.102463
   Li JPO, 2020, BRIT J OPHTHALMOL, V104, P297, DOI 10.1136/bjophthalmol-2020-315994
   Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044
   Li X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02911-9
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Li YC, 2012, VIRUS RES, V163, P628, DOI 10.1016/j.virusres.2011.12.021
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Lopes N, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.572042
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   Lu KL, 2020, ANN EMERG MED, V75, P556, DOI 10.1016/j.annemergmed.2020.02.006
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Marinho PM, 2020, LANCET, V395, P1610, DOI 10.1016/S0140-6736(20)31014-X
   Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825
   Meyhoff TS, 2020, CHEST, V157, P1478, DOI 10.1016/j.chest.2019.11.050
   Ministero della salute, 2020, MIN SALUT CONS SUP S
   Mojoli F, 2019, AM J RESP CRIT CARE, V199, P701, DOI 10.1164/rccm.201802-0236CI
   Moller MH, 2018, ACTA ANAESTH SCAND, V62, P420, DOI 10.1111/aas.13089
   Moller MH, 2016, ACTA ANAESTH SCAND, V60, P1347, DOI 10.1111/aas.12780
   Mungmungpuntipantip R, 2020, GRAEF ARCH CLIN EXP, V258, P1339, DOI 10.1007/s00417-020-04662-3
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   NHS Specialty Guides, 2020, NHS SPEC GUID PAT MA
   Oldenburg CE, 2020, LANCET, V396, P936, DOI 10.1016/S0140-6736(20)31863-8
   Paganini M, 2020, DISASTER MED PUBLIC, V14, P541, DOI 10.1017/dmp.2020.57
   Paglia S., 2020, RAPPORTO 1 LINEA COV
   Pamplona J, 2021, EUR J GASTROEN HEPAT, V33, pE21, DOI 10.1097/MEG.0000000000001934
   Pan JZ, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000014453, 10.1097/md.0000000000014453]
   Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
   Pritchett MA, 2020, J THORAC DIS, V12, P1781, DOI 10.21037/jtd.2020.04.32
   Procedura Regionale Nuovo Coronavirus Sars, 2020, PROC REG NUOV COR SA
   Qing HL, 2020, ACTA OPHTHALMOL, V98, pE388, DOI 10.1111/aos.14412
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rauch B, 2020, EUR J PREV CARDIOL, V27, P1351, DOI 10.1177/2047487320920754
   Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255
   Prestes TRR, 2017, CURR DRUG TARGETS, V18, P1301, DOI 10.2174/1389450117666160727142401
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0
   Romano M. R., 2020, CURR EYE RES, V12, P27, DOI [10.1080/02713683.2020.1764053, DOI 10.1080/02713683.2020.1764053]
   Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Rubin GD, 2020, RADIOLOGY, V296, P172, DOI 10.1148/radiol.2020201365
   Salehi S, 2020, AM J ROENTGENOL, V215, P87, DOI [10.2214/AJR.20.23034, 10.2214/AJR.20.23034S.]
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Saravia SA, 2007, AM J INFECT CONTROL, V35, P324, DOI 10.1016/j.ajic.2006.10.012
   Schuetz Philipp, 2017, Cochrane Database Syst Rev, V10, pCD007498, DOI 10.1002/14651858.CD007498.pub3
   Senanayake PD, 2007, INVEST OPHTH VIS SCI, V48, P3301, DOI 10.1167/iovs.06-1024
   Shen C., 2020, JAMA-J AM MED ASSOC, V158, pA601, DOI [10.1016/j.chest.2020.08.566, DOI 10.1016/J.CHEST.2020.08.566]
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207
   Soldati G, 2020, J ULTRAS MED, V39, P1413, DOI 10.1002/jum.15285
   Soldati G, 2020, J ULTRAS MED, V39, P1459, DOI 10.1002/jum.15284
   Solomon MD, 2020, NEW ENGL J MED, V383, P691, DOI 10.1056/NEJMc2015630
   Sommer A, 2020, JAMA OPHTHALMOL, V138, P578, DOI 10.1001/jamaophthalmol.2020.1294
   Stanley AV, 2001, J NEUROIMMUNOL, V119, P175, DOI 10.1016/S0165-5728(01)00374-5
   Steardo L, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00949-5
   Tan CC, 2020, J MED VIROL, V92, P856, DOI 10.1002/jmv.25871
   Tinku J., 2020, INT PULMONOLOGISTS C
   Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191
   Turer RW, 2020, J AM MED INFORM ASSN, V27, P967, DOI 10.1093/jamia/ocaa048
   Turtle L, 2020, J MED VIROL, V92, P705, DOI 10.1002/jmv.25828
   VAVVAS DG, 2020, EYE 0709, DOI DOI 10.1038/s41433-020-1084-9
   Vernuccio F, 2020, EMERG RADIOL, V27, P623, DOI 10.1007/s10140-020-01817-x
   Wagner J, 1996, BRIT J OPHTHALMOL, V80, P159, DOI 10.1136/bjo.80.2.159
   Walkey AJ, 2014, CHEST, V146, P1187, DOI 10.1378/chest.14-0003
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wan KH, 2020, ACTA OPHTHALMOL, V98, P221, DOI 10.1111/aos.14438
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   Wee LE, 2020, ACAD EMERG MED, V27, P379, DOI 10.1111/acem.13984
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wittbold K. A., 2020, AM J EMERG MED, V7, P98, DOI [10.1016/j.ajem.2020.04.025 12, DOI 10.1016/J.AJEM.2020.04.025]
   WONG HYF, 2019, RADIOLOGY, DOI [10.1148/radiol.2020201160, DOI 10.1148/RADIOL.2020201160]
   World Health Organzation, 2020, GLOB SURV COVID 19 D
   Wu P., 2020, JAMA OPHTHALMOL, V12, P17, DOI [10.37473/fic/10.1101/2020.04.02.20050989, DOI 10.37473/FIC/10.1101/2020.04.02.20050989]
   Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia JH, 2020, J MED VIROL, V92, P589, DOI 10.1002/jmv.25725
   Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yan D., 2020, EFFICACY HYDROXYCHLO, DOI 10.1101/2020.03.22.20040758
   Yang X., 2020, Lancet Respir. Med, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhao H., 2020, LANCET NEUROL, V19, P383, DOI [10.1016/S1474-4422(20)30109-5, DOI 10.1016/S1474-4422(20)30109-5]
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zuo, 2020, SINGLE CELL RNA EXPR, DOI 10.1101/2020.01.26.919985
NR 176
TC 5
Z9 5
U1 3
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD DEC 9
PY 2020
VL 11
AR 572168
DI 10.3389/fphar.2020.572168
PG 17
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA PI9JM
UT WOS:000601398000001
PM 33362541
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ugas, MA
   Samoil, D
   Avery, L
   Berlin, A
   Giuliani, ME
   Papadakos, TJ
   Quartey, NK
   Papadakos, JK
AF Ugas, Mohamed A.
   Samoil, Diana
   Avery, Lisa
   Berlin, Alejandro
   Giuliani, Meredith E.
   Papadakos, Tina J.
   (Linda) Quartey, Naa Kwarley
   Papadakos, Janet K.
TI COVID-19 and patients with cancer: Investigating treatment impact,
   information sources, and COVID-19-related knowledge, attitudes, and
   practices
SO CANCER
LA English
DT Article
DE cancer; coronavirus disease 2019 (COVID-19); health literacy
ID HEALTH; LITERACY
AB Background The coronavirus disease 2019 (COVID-19) pandemic has caused enormous strain on public health. Patients with cancer are particularly susceptible to the disease, and their treatment plans have been threatened by public health restrictions designed to contain the spread. Methods This study examined the effects of the pandemic on cancer patients' psychology, knowledge, attitudes, and practices concerning COVID-19 as well as their perceptions of the impact of COVID-19 on their cancer health care services. A survey was sent to 5800 patients at a cancer center in Toronto, Canada. Descriptive results were summarized. Qualitative feedback was coded and summarized. To examine for potential associations, regression models were tested for the outcomes of patient psychological well-being, knowledge, attitudes, and practices, and they accounted for several demographic, health literacy, and disease variables. Results A total of 1631 surveys were completed. Most patients saw their appointments shifted to virtual visits, and for a substantial minority, there was no change. A majority of the patients (62%) expressed fears about contracting the virus. There were no independent predictors of COVID-19-related knowledge. Fears were more pronounced among patients who did not speak English and those who used social media more often. Female participants, those who scored higher on knowledge questions, and those who used cancer center materials were more likely to take preventative measures against infection. Conclusions This study provides a snapshot of the state of cancer patient treatment and the knowledge, attitudes, and practices of patients between the first 2 waves of the pandemic. The study's results can inform our understanding of adaptation to conditions during and after the outbreak.
C1 [Ugas, Mohamed A.; Samoil, Diana; Giuliani, Meredith E.; Papadakos, Tina J.; (Linda) Quartey, Naa Kwarley; Papadakos, Janet K.] Princess Margaret Canc Ctr, Canc Hlth Literacy Res Ctr, Canc Educ, 585 Univ Ave,ELLICSR PMB B-130, Toronto, ON M5G 2N2, Canada.
   [Avery, Lisa] Princess Margaret Canc Ctr, Biostat Dept, Toronto, ON, Canada.
   [Berlin, Alejandro; Giuliani, Meredith E.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada.
   [Berlin, Alejandro; Giuliani, Meredith E.] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada.
   [Berlin, Alejandro] Univ Hlth Network, Techna Inst, Toronto, ON, Canada.
   [Papadakos, Tina J.; Papadakos, Janet K.] Ontario Hlth Canc Care Ontario, Patient Educ, Toronto, ON, Canada.
   [Papadakos, Janet K.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
RP Papadakos, JK (corresponding author), Princess Margaret Canc Ctr, Canc Hlth Literacy Res Ctr, Canc Educ, 585 Univ Ave,ELLICSR PMB B-130, Toronto, ON M5G 2N2, Canada.
EM janet.papadakos@uhnresearch.ca
OI Avery, Lisa/0000-0002-8431-5143; Papadakos, Janet/0000-0001-6320-4156
FU Princess Margaret Cancer FoundationUniversity of Toronto
FX The project was funded by the Princess Margaret Cancer Foundation.
CR [Anonymous], 2021, CORONAVIRUS DIS COVI
   [Anonymous], 2020, MONITORING KNOWLEDGE
   Artino AR, 2014, MED TEACH, V36, P463, DOI 10.3109/0142159X.2014.889814
   Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005
   Berlin A, 2021, JAMA ONCOL, V7, P597, DOI 10.1001/jamaoncol.2020.6982
   Bradley, 2005, U TORONTO MED J, V82, P158
   Brown T, 2021, NEIGHBOURHOOD LEVEL, DOI [10.1101/2021.01.27.21250618, DOI 10.1101/2021.01.27.21250618]
   Bussing A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.574314
   Cardena E, 2000, J TRAUMA STRESS, V13, P719, DOI 10.1023/A:1007822603186
   Catania C, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.584612
   Chapman B, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.582014
   Chen GL, 2020, PSYCHO-ONCOLOGY, V29, P1395, DOI 10.1002/pon.5451
   Chew LD, 2004, FAM MED, V36, P588
   Ciazynska M, 2020, PSYCHO-ONCOLOGY, V29, P1377, DOI 10.1002/pon.5434
   Desai A, 2021, CANCER-AM CANCER SOC, V127, P1459, DOI 10.1002/cncr.33386
   Flower JF., 2013, SURV RES METHODS-GER
   Haddad FG, 2021, J PATIENT SAF, V17, pE35, DOI 10.1097/PTS.0000000000000797
   Haight ME, MMWR MORB MORTAL WKL
   Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Jayasinghe R, 2020, PATIENT EDUC COUNS, V103, P2594, DOI 10.1016/j.pec.2020.08.001
   Kindig, 2004, HLTH LITERACY PRESCR
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Lou E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241741
   Millar C, 2020, PSYCHO-ONCOLOGY, V29, P1402, DOI 10.1002/pon.5461
   Moraliyage H, 2021, ONCOLOGIST, V26, pE342, DOI 10.1002/onco.13604
   Papadakos J, 2021, J CONS HLTH INTERNET, V25, P50, DOI 10.1080/15398285.2020.1858258
   Reintjes R, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151258, 10.1371/journal.pone.0]
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Shim E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041839
   Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2
   Szmuda T, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2132
   van de Poll-franse LV, 2021, JAMA ONCOL, V7, P279, DOI 10.1001/jamaoncol.2020.6093
   World Health Organization, 2020, SURV TOOL GUID RAP S
   Yu J, 2020, JAMA ONCOL, V6, P1108, DOI 10.1001/jamaoncol.2020.0980
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zuliani S, 2020, EUR J CANCER, V135, P159, DOI 10.1016/j.ejca.2020.05.029
NR 40
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0008-543X
EI 1097-0142
J9 CANCER-AM CANCER SOC
JI Cancer
PD FEB 15
PY 2022
VL 128
IS 4
BP 746
EP 761
DI 10.1002/cncr.33976
EA OCT 2021
PG 16
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA YM5YH
UT WOS:000711558800001
PM 34705287
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Casalegno, C
   Civera, C
   Cortese, D
AF Casalegno, Cecilia
   Civera, Chiara
   Cortese, Damiano
TI COVID-19 in Italy and issues in the communication of politics: bridging
   the knowledge-behaviour gap
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Communication; COVID-19; institutional communication of politics;
   under-communication; over-communication; knowledge-behaviour gap
ID SOCIAL-RESPONSIBILITY CSR; RISK COMMUNICATION; OVERLOAD; TRUST;
   TRANSPARENCY; EXPERIENCE; MANAGEMENT; CRISIS
AB Our paper discusses the role of the institutional communication of politics during emergencies. We examine the impacts of that communication on the management of over-communication (excessive, confused and uncertain information and knowledge) and under-communication (deficiencies in information and knowledge) to reduce potential knowledge-behaviour gaps (KBGs) in the audience. By outlining some of the controversies and overloads within such communication in Italy during the COVID-19 emergency, we underline a situation of entropy that has increased the KGB among audiences at multiple levels. We also highlight the emergence of three patterns that could potentially mitigate the KGB and re-establish coherent and balanced communication to manage emergencies: time, power, and reactions based on relationships. We argue that communication should (1) respect synchronicity, (2) take into account the power of the audience and create a segmented form of knowledge and (3) be based on interaction, participation, and relational-based messages that will favour coherent reactions.
C1 [Casalegno, Cecilia; Civera, Chiara] Univ Turin, Dept Management, Turin, Italy.
   [Cortese, Damiano] Univ Turin, Dept Foreign Languages Literatures & Modern Cultu, Turin, Italy.
RP Civera, C (corresponding author), Univ Turin, Vicolo Bodoni 4, I-10060 Turin, Italy.
EM chiara.civera@unito.it
CR Albu OB, 2019, BUS SOC, V58, P268, DOI 10.1177/0007650316659851
   Axjonow A, 2018, J BUS ETHICS, V151, P429, DOI 10.1007/s10551-016-3225-4
   Bayer JB, 2016, COMMUN THEOR, V26, P128, DOI 10.1111/comt.12090
   Bdeir F, 2013, KNOWL MAN RES PRACT, V11, P241, DOI 10.1057/kmrp.2012.1
   Berglund T., 2014, OXFORD HDB EC I TRAN
   Burchell K, 2015, MOB MEDIA COMMUN, V3, P36, DOI 10.1177/2050157914546711
   Carrington MJ, 2014, J BUS RES, V67, P2759, DOI 10.1016/j.jbusres.2012.09.022
   Casalegno C. G., 2016, IMPRESA CSR NONCOMUN, P1
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Civera C, 2018, PSYCHOL MARKET, V35, P138, DOI 10.1002/mar.21075
   Coombs WT, 2009, COMMUN SER, P237
   Coombs WT., 2006, J PROMOTION MANAGEME, V12, P241, DOI [10.1300/J057v12n03_13, DOI 10.1300/J057V12N03_13]
   Dawkins J, 2005, J COMMUN MANAG, V9, P108, DOI 10.1108/13632540510621362
   De Cremer D., 2016, HARVARD BUSINESS REV
   Dorasamy M, 2017, TECHNOL FORECAST SOC, V121, P139, DOI 10.1016/j.techfore.2017.03.017
   Du SL, 2010, INT J MANAG REV, V12, P8, DOI 10.1111/j.1468-2370.2009.00276.x
   Eppler MJ, 2004, INFORM SOC, V20, P325, DOI 10.1080/01972240490507974
   Freberg K, 2013, PUBLIC RELAT REV, V39, P185, DOI 10.1016/j.pubrev.2013.02.010
   Granatt, 2004, J COMMUNICATION MANA, V8, P354, DOI [10.1108/13632540410807745, DOI 10.1108/09653561211278671]
   Grimmelikhuijsen S, 2012, INT REV ADM SCI, V78, P50, DOI 10.1177/0020852311429667
   Grunig, 2001, HDB PUBLIC RELATIONS, P11, DOI DOI 10.4135/9781452220727.N1
   Hur WM, 2014, J BUS ETHICS, V125, P75, DOI 10.1007/s10551-013-1910-0
   Ingram R, 2005, J BUS ETHICS, V62, P237, DOI 10.1007/s10551-005-1899-0
   Invernizzi E., 2012, RELAZIONI PUBBLICHE, P139
   ISAACS W. N., 1999, DIALOGUE ART THINKIN
   Jahdi KS, 2009, J BUS ETHICS, V88, P103, DOI 10.1007/s10551-009-0113-1
   MEIER RL, 1963, ADMIN SCI QUART, V7, P521, DOI 10.2307/2390963
   Menon KU, 2005, J COMMUN MANAG, V9, P375, DOI 10.1108/13632540510621614
   Michailova S, 2011, KNOWL MAN RES PRACT, V9, P73, DOI 10.1057/kmrp.2011.4
   Mihok P, 2011, KNOWL MAN RES PRACT, V9, P228, DOI 10.1057/kmrp.2011.22
   Morsing M, 2006, BUSINESS ETHICS EURO, V15, P4
   Newton K, 2020, POLIT QUART, V91, P502, DOI 10.1111/1467-923X.12901
   Papaoikonomou E, 2011, INT ADV ECON RES, V17, P77, DOI 10.1007/s11294-010-9288-6
   Payne, 2003, BUS SOC, V42, P7, DOI [10.1177/0007650302250505, DOI 10.1177/0007650302250505]
   Reeves M., 2020, HARVARD BUSINESS REV
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Rimal RN, 2000, HEALTH COMMUN, V12, P219, DOI 10.1207/S15327027HC1203_01
   Rolland JS, 2005, FAM PROCESS, V44, P3, DOI 10.1111/j.1545-5300.2005.00039.x
   Ropeik S., 2003, RISK PERSPECTIVE, V11, P1
   Schmidt AL, 2017, P NATL ACAD SCI USA, V114, P3035, DOI 10.1073/pnas.1617052114
   Sen S, 2001, J MARKETING RES, V38, P225, DOI 10.1509/jmkr.38.2.225.18838
   Shaw D., 1999, MARKETING INTELLIGEN, V17, P109, DOI [10.1108/02634509910260968, DOI 10.1108/02634509910260968]
   Shaw D, 2016, J BUS ETHICS, V136, P251, DOI 10.1007/s10551-014-2442-y
   Shiu EMK, 2011, PSYCHOL MARKET, V28, P584, DOI 10.1002/mar.20402
   Sligo FX, 2000, J AM SOC INFORM SCI, V51, P858, DOI 10.1002/(SICI)1097-4571(2000)51:9<858::AID-ASI80>3.0.CO;2-Q
   Stephens KK, 2017, COMMUN THEOR, V27, P269, DOI 10.1111/comt.12116
   Tarki A., 2020, HARVARD BUSINESS REV
   Turilli M, 2009, ETHICS INF TECHNOL, V11, P105, DOI 10.1007/s10676-009-9187-9
   Turoff M., 2004, J INFORM TECHNOLOGY, V5, P3
   Vaccaro A, 2009, ETHICS INF TECHNOL, V11, P113, DOI 10.1007/s10676-009-9190-1
   VACCARO JA, 2011, J BUSINESS ETHICS, V0010, DOI DOI 10.1007/S10551-011-1184-3
   Zarocostas J, 2020, LANCET, V395, P259, DOI 10.1016/S0140-6736(20)30153-7
NR 52
TC 1
Z9 1
U1 9
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 459
EP 467
DI 10.1080/14778238.2020.1860664
EA DEC 2020
PG 9
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000603768500001
OA Green Submitted, Bronze
DA 2022-04-20
ER

PT J
AU Ayoko, OB
   Caputo, A
   Mendy, J
AF Ayoko, Oluremi B.
   Caputo, Andrea
   Mendy, John
TI Management research contributions to the COVID-19: a bibliometric
   literature review and analysis of the contributions from the Journal of
   Management & Organization
SO JOURNAL OF MANAGEMENT & ORGANIZATION
LA English
DT Review
DE Bibliometric; COVID-19; Journal of Management and Organization;
   literature review; VOSViewer
ID CORPORATE SOCIAL-RESPONSIBILITY; WORK-LIFE BALANCE; CONFLICT-MANAGEMENT;
   FAMILY BUSINESSES; JOB-SATISFACTION; MEDIATING ROLE; PERFORMANCE;
   LEADERSHIP; INNOVATION; KNOWLEDGE
AB The COVID-19 health crisis triggered changes in the workplace. This paper explores the insights from scholarly work published in the Journal of Management and Organization (JMO) and systematizes this body of knowledge to build a scientific overview that looks at how the COVID-19 health crisis and its repercussions may be managed by organizations. We conducted a bibliometric investigation of JMO's most influential papers published from 1995 to June 2020 that offers insights into the management of the COVID-19 crisis. Our bibliometric investigation reveals six clusters: (1) conservation of resources theory, entrepreneurs, gender and work-family conflict; (2) corporate governance, corporate social responsibility and stakeholder salience; (3) family firms, innovation and research methods; (4) creativity, leadership and organizational change; (5) job satisfaction and psychological empowerment; and (6) team performance. We discuss the theoretical and practical implications of our findings.
C1 [Ayoko, Oluremi B.] Univ Queensland, St Lucia Campus, St Lucia, Qld, Australia.
   [Caputo, Andrea; Mendy, John] Univ Lincoln, Lincoln, England.
   [Caputo, Andrea] Univ Trento, Trento, Italy.
RP Ayoko, OB (corresponding author), Univ Queensland, St Lucia Campus, St Lucia, Qld, Australia.
EM R.Ayoko@business.uq.edu.au
OI Caputo, Andrea/0000-0003-2498-182X
CR Abrams D, 2021, GROUP PROCESS INTERG, V24, P201, DOI 10.1177/1368430220983440
   Antonakis J, 2020, GROUP PROCESSES INTE
   Aramburu N, 2011, J MANAGE ORGAN, V17, P307
   Aria M, 2017, J INFORMETR, V11, P959, DOI 10.1016/j.joi.2017.08.007
   Aydogmus C, 2018, J MANAGE ORGAN, V24, P81, DOI 10.1017/jmo.2016.59
   Ayoko OB, 2020, AUST J MANAGE, V45, P488, DOI 10.1177/0312896220921913
   Barlett CP, 2021, J SOC PSYCHOL, V161, P466, DOI 10.1080/00224545.2021.1883503
   Bartolacci F, 2020, BUS STRATEG ENVIRON, V29, P1297, DOI 10.1002/bse.2434
   BLALOCK HM, 1961, SOC FORCES, V39, P246, DOI 10.2307/2573216
   Bodla AA, 2018, J MANAGE ORGAN, V24, P711, DOI 10.1017/jmo.2016.34
   Bouckenooghe D, 2014, J MANAGE ORGAN, V20, P508, DOI 10.1017/jmo.2014.43
   Boyack KW, 2010, J AM SOC INF SCI TEC, V61, P2389, DOI 10.1002/asi.21419
   Branch S, 2007, J MANAGE ORGAN, V13, P264, DOI 10.5172/jmo.2007.13.3.264
   BROADUS RN, 1987, SCIENTOMETRICS, V12, P373, DOI 10.1007/BF02016680
   Brougham D, 2018, J MANAGE ORGAN, V24, P239, DOI 10.1017/jmo.2016.55
   CALLON M, 1983, SOC SCI INFORM, V22, P191, DOI 10.1177/053901883022002003
   Caputo A, 2021, J BUS RES, V123, P489, DOI 10.1016/j.jbusres.2020.09.053
   Caputo A, 2019, INT J CONFL MANAGE, V30, P87, DOI 10.1108/IJCMA-06-2018-0078
   Caputo A, 2018, INT J CONFL MANAGE, V29, P519, DOI 10.1108/IJCMA-02-2018-0027
   Carnevale JB, 2020, J BUS RES, V116, P183, DOI 10.1016/j.jbusres.2020.05.037
   Chong SH, 2020, J APPL PSYCHOL, V105, P1408, DOI 10.1037/apl0000843
   Chua J, 2021, J MANAGE ORGAN, V27, P523, DOI 10.1017/jmo.2018.74
   Dabic M, 2020, SMALL BUS ECON, V55, P705, DOI 10.1007/s11187-019-00181-6
   Dabic M, 2015, INT J HUM RESOUR MAN, V26, P316, DOI 10.1080/09585192.2013.845238
   De Clercq D., 2020, J MANAGE ORGAN, P1
   De Massis A, 2020, J MANAGE STUD, V57, P1727, DOI 10.1111/joms.12632
   Debowska Agata, 2020, Psychol Med, P1, DOI 10.1017/S003329172000392X
   Dowell GWS, 2011, STRATEGIC MANAGE J, V32, P1025, DOI 10.1002/smj.923
   Earle H.A., 2003, J FACIL MANAG, V2, P244, DOI [10.1108/14725960410808230, DOI 10.1108/14725960410808230]
   Fernando M., 2006, J MANAGEMENT ORG, V12, P23, DOI DOI 10.1017/S1833367200004144
   Ferrier WJ, 2001, ACAD MANAGE J, V44, P858, DOI 10.2307/3069419
   Fisher J, 2020, COMMIMITY WORK FAM, V23, P247, DOI 10.1080/13668803.2020.1756568
   Fujimoto, 2000, J AUSTR NZ ACAD MANA, V6, P14, DOI 10.5172/jmo.2000.6.1.14
   Galbreath J, 2011, J MANAGE ORGAN, V17, P17
   Gartenberg C, 2017, STRATEGIC MANAGE J, V38, P300, DOI 10.1002/smj.2481
   Goo W, J MANAGE ORGAN, DOI [10.1017/jmo.2019.26, DOI 10.1017/JMO.2019.26]
   Griffin MA, 2020, ACAD MANAGE REV, V45, P745, DOI 10.5465/amr.2018.0271
   Halbesleben JRB, 2014, J MANAGE, V40, P1334, DOI 10.1177/0149206314527130
   Halverson SK, 2004, SMALL GR RES, V35, P495, DOI 10.1177/1046496404264178
   Hambrick DC, 1996, ADMIN SCI QUART, V41, P659, DOI 10.2307/2393871
   Han Jaewoo, 2016, [JOURNAL OF TECHNOLOGY INNOVATION, 기술혁신연구], V24, P1, DOI 10.14383/SIME.2016.24.3.1
   HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513
   Hu J, 2020, J APPL PSYCHOL, V105, P1218, DOI 10.1037/apl0000620
   Huang CJ, 2010, J MANAGE ORGAN, V16, P641, DOI 10.5172/jmo.2010.16.5.641
   Huang CY, 2019, J MANAGE ORGAN, V25, P825, DOI 10.1017/jmo.2016.62
   Huang HC, 2014, J MANAGE ORGAN, V20, P100, DOI 10.1017/jmo.2014.20
   Huang YC, 2009, J MANAGE ORGAN, V15, P309, DOI 10.5172/jmo.2009.15.3.309
   Hutchinson M., 2006, J MANAGE ORGAN, V12, P235, DOI [10.5172/jmo.2006.12.3.235, DOI 10.5172/JMO.2006.12.3.235]
   Iwami S, 2020, SCIENTOMETRICS, V122, P3, DOI 10.1007/s11192-019-03284-9
   Janssen M. A., 2007, Ecology and Society, V12, P9
   Jarrod, 2006, J MANAGEMENT ORG, V12, P146, DOI [DOI 10.5172/JMO.2006.12.2.146, 10.5172/jmo.2006.12.2.146]
   Javed B, 2019, J MANAGE ORGAN, V25, P554, DOI 10.1017/jmo.2018.50
   Javed B, 2018, J MANAGE ORGAN, V24, P388, DOI 10.1017/jmo.2017.56
   Javed B, 2019, J MANAGE ORGAN, V25, P117, DOI 10.1017/jmo.2017.3
   Jebran K, 2021, INT J FINANC ECON, DOI 10.1002/ijfe.2428
   Jeong DY, 2016, J MANAGE ORGAN, V22, P328, DOI 10.1017/jmo.2015.38
   Jerez-Gomez P, 2019, J MANAGE ORGAN, V25, P189, DOI 10.1017/jmo.2017.55
   Jordan PJ, 2009, J MANAGE ORGAN, V15, P452, DOI 10.5172/jmo.15.4.452
   Jordan PJ, 2006, J MANAGEMENT ORG, V12, P131, DOI DOI 10.5172/JMO.2006.12.2.131
   Kalliath T, 2008, J MANAGE ORGAN, V14, P323, DOI 10.5172/jmo.837.14.3.323
   Kantur D, 2012, J MANAGE ORGAN, V18, P762
   Kaye M, 1995, J MANAGE ORGAN, V1, P1, DOI [10.5172/jmo.1995.1.2.1, DOI 10.5172/JMO.1995.1.2.1]
   KESSLER MM, 1963, AM DOC, V14, P10, DOI 10.1002/asi.5090140103
   Kirkwood J, 2008, J MANAGE ORGAN, V14, P285, DOI 10.5172/jmo.837.14.3.285
   Kirkwood J, 2007, J MANAGE ORGAN, V13, P366, DOI 10.5172/jmo.2007.13.4.366
   Kwak WJ, 2015, J MANAGE ORGAN, V21, P369, DOI 10.1017/jmo.2015.11
   Langerud DH, 2020, J MANAGE ORGAN, V26, P75, DOI 10.1017/jmo.2018.33
   Lin CS, 2017, J MANAGE ORGAN, V23, P483, DOI 10.1017/jmo.2016.50
   Linnenluecke MK, 2020, AUST J MANAGE, V45, P175, DOI 10.1177/0312896219877678
   Low JJQ, 2020, J BUS ETHICS, V161, P513, DOI 10.1007/s10551-018-3954-7
   Lucas RM, 2005, B WORLD HEALTH ORGAN, V83, P792
   MCCAIN KW, 1990, J AM SOC INFORM SCI, V41, P433, DOI 10.1002/(SICI)1097-4571(199009)41:6<433::AID-ASI11>3.0.CO;2-Q
   Mingers J, 2015, EUR J OPER RES, V246, P1, DOI 10.1016/j.ejor.2015.04.002
   Mishra P, 2019, J MANAGE ORGAN, V25, P58, DOI 10.1017/jmo.2017.23
   Morrison RL, 2008, J MANAGE ORGAN, V14, P330, DOI 10.5172/jmo.837.14.4.330
   Nonino F, 2013, J MANAGE ORGAN, V19, P454, DOI 10.1017/jmo.2013.20
   Nordqvist M, 2009, J MANAGE ORGAN, V15, P294, DOI 10.5172/jmo.2009.15.3.294
   PAJO K, 2003, J MANAGEMENT ORG, V9, P52
   Parkes LP, 2008, J MANAGE ORGAN, V14, P267, DOI 10.5172/jmo.837.14.3.267
   Pizzi S, 2021, J CLEAN PROD, V281, DOI 10.1016/j.jclepro.2020.125217
   Pizzi S, 2020, J CLEAN PROD, V276, DOI 10.1016/j.jclepro.2020.124033
   Prime H, 2020, AM PSYCHOL, V75, P631, DOI 10.1037/amp0000660
   Raghuram S, 2019, ACAD MANAG ANN, V13, P308, DOI 10.5465/annals.2017.0020
   Ratten V, 2010, J MANAGE ORGAN, V16, P488, DOI 10.5172/jmo.2010.16.4.488
   Remington A, 2019, J MANAGE ORGAN, V25, P516, DOI 10.1017/jmo.2018.66
   Rigotti T, 2020, APPL PSYCHOL-INT REV, V69, P1, DOI 10.1111/apps.12265
   Rousseau R., 2014, MEASURING SCHOLARLY, P285, DOI [10.1007/978-3-319-10377-8_13, DOI 10.1007/978-3-319-10377-8_13, 10.1007/978-3-319-10377-8_13(InEng.)]
   Sanchez-Famoso V, 2017, J MANAGE ORGAN, V23, P136, DOI 10.1017/jmo.2016.2
   Schreuder F., 2019, J MANAGE ORGAN, P1, DOI [10.1017/jmo.2019.52, DOI 10.1017/JMO.2019.52]
   Syed J, 2009, J MANAGE ORGAN, V15, P639, DOI 10.1017/S1833367200002479
   Teece DJ, 2018, J MANAGE ORGAN, V24, P359, DOI 10.1017/jmo.2017.75
   Thorpe R, 2005, INT J MANAG REV, V7, P257, DOI 10.1111/j.1468-2370.2005.00116.x
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Trougakos JP, 2020, J APPL PSYCHOL, V105, P1234, DOI 10.1037/apl0000739
   Van Eck NJ, 2007, STUD CLASS DATA ANAL, P299
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Vaziri H, 2020, J APPL PSYCHOL, V105, P1073, DOI 10.1037/apl0000819
   Vazquez-Bustelo D, 2019, J MANAGE ORGAN, V25, P303, DOI 10.1017/jmo.2016.69
   Walters G, 2010, J MANAGE ORGAN, V16, P566, DOI 10.5172/jmo.2010.16.4.566
   Wanberg CR, 2020, J APPL PSYCHOL, V105, P1382, DOI 10.1037/apl0000831
   Wildman JL, 2021, SMALL GR RES, V52, P119, DOI 10.1177/1046496420985185
   Yang F, 2016, J MANAGE ORGAN, V22, P291, DOI 10.1017/jmo.2015.33
   Zhai QG, 2020, J MANAGE ORGAN, V26, P168, DOI 10.1017/jmo.2017.62
   Zupic I, 2015, ORGAN RES METHODS, V18, P429, DOI 10.1177/1094428114562629
NR 104
TC 0
Z9 0
U1 33
U2 33
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1833-3672
EI 1839-3527
J9 J MANAGE ORGAN
JI J. Manag. Organ.
PD NOV
PY 2021
VL 27
IS 6
BP 1183
EP 1209
AR PII S1833367221000705
DI 10.1017/jmo.2021.70
EA JAN 2022
PG 27
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA YR7RK
UT WOS:000740873000001
OA Green Accepted
DA 2022-04-20
ER

PT J
AU Cook, TM
   McGuire, B
   Mushambi, M
   Misra, U
   Carey, C
   Lucas, N
   O'Sullivan, E
   Harrop-Griffiths, W
AF Cook, T. M.
   McGuire, B.
   Mushambi, M.
   Misra, U.
   Carey, C.
   Lucas, N.
   O'Sullivan, E.
   Harrop-Griffiths, W.
TI Airway management guidance for the endemic phase of COVID-19
SO ANAESTHESIA
LA English
DT Review
DE airway; anaesthesia; coronavirus; COVID-19; intubation
ID ENDOTRACHEAL INTUBATION; ANESTHETISTS; DIFFICULT
AB It is now apparent that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) will remain endemic for some time. Improved therapeutics and a vaccine may shorten this period, but both are far from certain. Plans must be put in place on the assumption that the virus and its disease will continue to affect the care of patients and the safety of staff. This will impact particularly on airway management due to the inherent risk to staff during such procedures. Research is needed to clarify the nature and risk of respiratory aerosol-generating procedures. Improved knowledge of the dynamics of SARS-CoV-2 infection and immunity is also required. In the meantime, we describe the current status of airway management during the endemic phase of the COVID-19 pandemic. Some controversies remain unresolved, but the safety of patients and staff remains paramount. Current evidence does not support or necessitate dramatic changes to choices for anaesthetic airway management. Theatre efficiency and training issues are a challenge that must be addressed, and new information may enable this.
C1 [Cook, T. M.] Royal United Hosp Bath NHS Fdn Trust, Dept Anaesthesia & Intens Care Med, Bath, Avon, England.
   [Cook, T. M.] Univ Bristol, Sch Med, Bristol, Avon, England.
   [McGuire, B.] Ninewells Hosp Dundee, Dept Anaesthesia, Dundee, Scotland.
   [Mushambi, M.] Univ Hosp Leicester NHS Trust, Dept Anaesthesia, Leicester, Leics, England.
   [Misra, U.] South Tyneside & Sunderland NHS Fdn Trust, Dept Anaesthesia, Sunderland, England.
   [Carey, C.] Brighton & Sussex Univ Hosp NHS Trust, Dept Anaesthesia, Brighton, E Sussex, England.
   [Lucas, N.] Northwick Pk Hosp & Clin Res Ctr, Dept Anaesthesia, Harrow, Middx, England.
   [O'Sullivan, E.] St James Hosp, Dept Anaesthesia & Intens Care Med, Dublin, Ireland.
   [Harrop-Griffiths, W.] Dept Anaesthesia, Imperial Coll Healthcare NHS Trust, London, England.
   [Harrop-Griffiths, W.] Imperial Coll, London, England.
RP Cook, TM (corresponding author), Royal United Hosp Bath NHS Fdn Trust, Dept Anaesthesia & Intens Care Med, Bath, Avon, England.
EM timcook007@gmail.com
RI O'Sullivan, Ellen/I-3555-2017
OI O'Sullivan, Ellen/0000-0003-4025-3646; cook, timothy/0000-0002-3654-497X
CR [Anonymous], 2020, BBC NEWS
   Bampoe S, 2020, INT J OBSTET ANESTH, V43, P1, DOI 10.1016/j.ijoa.2020.04.006
   Begley JL, 2020, ANAESTHESIA, V75, P1014, DOI 10.1111/anae.15115
   Bryant J, 2020, PEDIATR ANESTH, V30, P900, DOI 10.1111/pan.13934
   Chrimes N, TROUBLESHOOTING MASK
   Cook T, USE SUPRAGLOTTIC AIR
   Cook T, 2020, MANAGING THEATRE PRO
   Cook TM, 2020, ANAESTHESIA, V75, P1122, DOI 10.1111/anae.15146
   Cook TM, 2020, ANAESTHESIA, V75, P920, DOI 10.1111/anae.15071
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Cook TM, 2015, BRIT J ANAESTH, V115, P497, DOI 10.1093/bja/aev156
   Cook TM, 2020, UPDATED GUIDANCE PER
   COOK TR, 2020, E CARE SOCIETY ASSOC, V8
   COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X
   Difficult Airway Society, INTR AIRW MAN TEACH
   El-Boghdadly K, 2020, ANAESTHESIA, V75, P1437, DOI 10.1111/anae.15170
   ENT-UK, 2020, FRAM OP TRACH COVID
   Gleason JM, 2018, WEST J EMERG MED, V19, P403, DOI 10.5811/westjem.2017.12.34699
   Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2
   Goldmann K, 2006, ANASTH INTENSIV NOTF, V41, P228, DOI 10.1055/s-2005-921200
   Health Protection Scotland, 2020, SBAR ASS EV BAS MED
   Hsu SH, 2020, EMERG MED J, V37, P400, DOI 10.1136/emermed-2020-209829
   Intensive Care Society Faculty of Intensive Care Medicine Association of Anaesthetists Royal College of Anaesthetists, 2020, PPE GUID PLANN SURG
   Jazuli F, 2020, EMERG MED J, V37, P398, DOI 10.1136/emermed-2020-209785
   Lewis SR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011136.pub2
   Lim KS, 2016, BRIT J ANAESTH, V117, P828, DOI 10.1093/bja/aew368
   Lucas N, 2020, UPDATED ADVICE REGAR
   Lyons C, 2020, ANAESTHESIA, V75, P843, DOI 10.1111/anae.15073
   Macfarlane AJR, 2020, BRIT J ANAESTH, V125, P243, DOI [10.1016/j.bja.2020.05.016, 10.1016/j.bja.2020.05.029]
   Matava C, 2020, BRIT J ANAESTH, V125, pE363, DOI 10.1016/j.bja.2020.07.014
   Mushambi MC, 2015, ANAESTHESIA, V70, P1286, DOI 10.1111/anae.13260
   National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID AR
   National Tracheostomy Safety Project, 2020, CONS TRACH COVID 19
   Nicholson A, 2013, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD010105
   Office for National Statistics, 2020, COR COVID 19 INF SUR
   Pandit JJ, 2020, ANAESTHESIA, V75, P1278, DOI 10.1111/anae.15144
   Park SK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004598
   Pieters BMA, 2017, ANAESTHESIA, V72, P1532, DOI 10.1111/anae.14057
   Public Health England, PPE GUID HEALTHC CON
   Royal College of Anaesthetists, CAPP TEST
   Royal College of Anaesthetists, CCT AN COR LEV TRAIN
   Royal College of Obstetricians and Gynaecologists, 2020, COR COVID 19 INF PRE
   Royal College of Paediatrics and Child Health, 2020, NAT GUID REC EL SURG
   Royal College of Paediatrics and Child Health, 2020, COVID 19 SERV EV AUD
   Royal College of Paediatrics and Child Health, 2020, GUID PAED MULT INFL
   Simpson JP, 2020, ANAESTHESIA, V75, P1587, DOI 10.1111/anae.15188
   Turner MC, 2020, ANAESTHESIA, V75, P1566, DOI 10.1111/anae.15152
   Uppal V, 2020, ANAESTHESIA, V75, P1350, DOI 10.1111/anae.15105
   Yang YL, 2020, ANESTH ANALG, V131, pE97, DOI 10.1213/ANE.0000000000004923
NR 49
TC 8
Z9 8
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-2409
EI 1365-2044
J9 ANAESTHESIA
JI Anaesthesia
PD FEB
PY 2021
VL 76
IS 2
BP 251
EP 260
DI 10.1111/anae.15253
EA SEP 2020
PG 10
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA PR5SJ
UT WOS:000568553400001
PM 32839960
OA Green Published
DA 2022-04-20
ER

PT J
AU Rodrigues, M
   Franco, M
   Sousa, N
   Silva, R
AF Rodrigues, Margarida
   Franco, Mario
   Sousa, Nuno
   Silva, Rui
TI Reviewing COVID-19 Literature on Business Management: What It Portends
   for Future Research?
SO SUSTAINABILITY
LA English
DT Review
DE COVID-19; crisis; business; management; responses
ID BIBLIOMETRIC ANALYSIS; CRISIS; IMPACT; INNOVATION; NETWORKS; DISASTER;
   THINKING; LESSONS
AB Who could have imagined that the COVID-19 crisis would affect the whole world? This means that all aspects of society, in general, have felt the consequences of the measures imposed to reduce contagion. Firms, businesses, and their management had to be and must continue to be resilient, and entrepreneurs creative to overcome the present and future impacts of the pandemic, which will be long-lasting. This study aims to map the existing literature on the topic and identify emerging ones. To provide a robust response to this objective, qualitative methodology was adopted through content analysis of the selected documents and the use of MAXQDA software to analyze qualitative data. In addition, a descriptive analysis of the selected documents is presented. The results obtained show there is still a shortage of studies, principally empirical ones, addressing this subject, to complete existing knowledge and thereby contribute to understanding the effects of the virus on businesses and their management. The main contribution of this article lies in a first systematization and coding of the literature, to identify emerging topics for study by academics, the foremost agents of knowledge.
C1 [Rodrigues, Margarida; Franco, Mario] Univ Beira Interior, Dept Management & Econ, CEFAGE UBI Res Ctr, Estr Sineiro, P-6200209 Covilha, Portugal.
   [Sousa, Nuno; Silva, Rui] Univ Tras Os Montes & Alto Douro, CETRAD Res Ctr, P-5000801 Vila Real, Portugal.
RP Silva, R (corresponding author), Univ Tras Os Montes & Alto Douro, CETRAD Res Ctr, P-5000801 Vila Real, Portugal.
EM mmmrodrigues@sapo.pt; mfranco@ubi.pt; nsousa@utad.pt; ruisilva@utad.pt
RI Franco, Mário/C-2112-2013; Franco, Mário/ABG-1980-2021; Sousa,
   Nuno/AAS-7593-2021; Silva, Rui/I-1473-2017
OI Franco, Mário/0000-0001-7818-0206; Franco, Mário/0000-0001-7818-0206;
   Sousa, Nuno/0000-0001-5466-0408; Silva, Rui/0000-0002-0283-9462
FU FCT-Portuguese Foundation for Science and TechnologyPortuguese
   Foundation for Science and Technology [UIDB/04011/2020]
FX The work of the author Rui Silva is supported by national funds, through
   the FCT-Portuguese Foundation for Science and Technology under the
   project UIDB/04011/2020.
CR Abdalla M, 2021, INFORMATION, V12, DOI 10.3390/info12010018
   Acikgoz O, 2020, TURK J MED SCI, V50, P520, DOI 10.3906/sag-2004-6
   Addo PC, 2020, SERV IND J, V40, P471, DOI 10.1080/02642069.2020.1751823
   Adiyarta Krisna, 2020, IOP Conference Series: Materials Science and Engineering, V725, DOI 10.1088/1757-899X/725/1/012113
   Amankwah-Amoah J, 2021, EUR MANAG J, V39, P179, DOI 10.1016/j.emj.2020.09.002
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   [Anonymous], 2020, GLOBAL STATE SMALL B
   Ataguba JE, 2020, APPL HEALTH ECON HEA, V18, P325, DOI 10.1007/s40258-020-00580-x
   Atkeson, 2020, WHAT WILL BE EC IMPA
   Avgar AC, 2020, WORK OCCUPATION, V47, P267, DOI 10.1177/0730888420923126
   Baldwin R., 2020, MITIGATING COVID EC
   Bapuji H, 2020, J MANAGE, V46, P1205, DOI 10.1177/0149206320925881
   Basco R, 2015, J FAM BUS STRATEG, V6, P259, DOI 10.1016/j.jfbs.2015.04.004
   Bell DNF, 2020, NATL INST ECON REV, V252, pR52, DOI 10.1017/nie.2020.14
   Bluhm DJ, 2011, J MANAGE STUD, V48, P1866, DOI 10.1111/j.1467-6486.2010.00972.x
   Bohdan I., 2020, BANKS BANK SYSTEMS, V15, P1, DOI [10.21511/bbs.15(2).2020.01, DOI 10.21511/BBS.15(2).2020.01]
   Bozic B, 2020, J BUS RES, V109, P440, DOI 10.1016/j.jbusres.2019.12.032
   Briner R.B., 2012, HDB EVIDENCE BASED M, P112, DOI 10.1093/oxfordhb/9780199763986.013.0007
   Brockner J, 2008, J APPL BEHAV SCI, V44, P94, DOI 10.1177/0021886307313824
   Brown R, 2020, INT SMALL BUS J, V38, P380, DOI 10.1177/0266242620937464
   Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030
   Campra M., 2021, INT J BUSINESS MANAG, V16, P1
   Cankurtaran P, 2020, IND MARKET MANAG, V88, P255, DOI 10.1016/j.indmarman.2020.05.030
   Capilla-Diaz C, 2020, J ADV NURS, V76, P1182, DOI 10.1111/jan.14321
   Cheer, 2020, ASIAN J BUSINESS RES, V10, pI, DOI DOI 10.14707/AJBR.200072
   Chesbrough H, 2020, IND MARKET MANAG, V88, P410, DOI 10.1016/j.indmarman.2020.04.010
   Collins A, 2020, J RISK RES, V23, P1073, DOI 10.1080/13669877.2020.1760332
   CONNOR DO, 1981, LIBR TRENDS, V30, P9
   Coombs WT, 2007, CORP REPUT REV, V10, P163, DOI 10.1057/palgrave.crr.1550049
   Corbera E, 2020, PLAN THEORY PRACT, V21, P191, DOI 10.1080/14649357.2020.1757891
   Cortez RM, 2020, IND MARKET MANAG, V88, P125, DOI 10.1016/j.indmarman.2020.05.004
   Cucculelli M, 2020, SMALL BUS ECON, V54, P459, DOI 10.1007/s11187-018-0044-2
   D'Alpaos C, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106575
   Dane E, 2007, ACAD MANAGE REV, V32, P33, DOI 10.5465/AMR.2007.23463682
   Danylyshyn B., 2020, PROBLEMS PERSPECTIVE, V18, P13, DOI [DOI 10.21511/PPM.18(2).2020.02, 10.21511/ppm.18(2).2020.02]
   De Vito A, 2020, J ACCOUNT PUBLIC POL, V39, DOI 10.1016/j.jaccpubpol.2020.106741
   Deng P, 2012, INT J MANAG REV, V14, P408, DOI 10.1111/j.1468-2370.2011.00323.x
   Derissen S, 2011, ECOL ECON, V70, P1121, DOI 10.1016/j.ecolecon.2011.01.003
   Di Mauro, 2020, VOX CEPR POLICY PORT
   Dominic E., 2005, J SERV MARK, V19, P336
   Donato H, 2019, ACTA MEDICA PORT, V32, P227, DOI 10.20344/amp.11923
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   El-Hani CN, 2020, ETHNOBIOL CONSERV, V9, DOI 10.15451/ec2020-05-9.18-1-20
   Elliot D., 2002, J CONTING CRISIS MAN, V10, P14, DOI [10.1111/1468-5973.00177, DOI 10.1111/1468-5973.00177]
   Evenett SJ, 2020, WORLD ECON, V43, P828, DOI 10.1111/twec.12954
   Everingham P, 2020, TOURISM GEOGR, V22, P555, DOI 10.1080/14616688.2020.1762119
   Fairlie, 2020, NATL BUR EC RES, DOI [10.3386/w27309, DOI 10.3386/W27309]
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Fernandez AA, 2020, J LEADERSH STUD, V14, P39, DOI 10.1002/jls.21684
   Filipe J., 2020, INT J EC BUS ADM, VVIII, P240
   Franco, 2020, CITY CULT SOC, V20, P100326, DOI 10.1016/j.ccs.2019.100326
   Fritsch M, 2020, NATL INST ECON REV, V252, pR4, DOI 10.1017/nie.2020.16
   GARFIELD E, 1979, SCIENTOMETRICS, V1, P359, DOI 10.1007/BF02019306
   Govindan K, 2020, TRANSPORT RES E-LOG, V138, DOI 10.1016/j.tre.2020.101967
   Greiner LE, 1989, READINGS STRATEGIC M, P373, DOI DOI 10.1007/978-1-349-20317-8_25
   Guz AN, 2009, INT APPL MECH+, V45, P351, DOI 10.1007/s10778-009-0189-4
   Haak-Saheem W, 2020, ASIAN BUS MANAG, V19, P298, DOI 10.1057/s41291-020-00120-4
   Hadengue M, 2017, INT J EMERG MARK, V12, P142, DOI 10.1108/IJoEM-12-2015-0272
   Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104806
   Hale J. E., 2005, Journal of Business Communication, V42, P113, DOI 10.1177/0021943605274751
   He HW, 2020, J BUS RES, V116, P176, DOI 10.1016/j.jbusres.2020.05.030
   Helm D, 2020, ENVIRON RESOUR ECON, V76, P21, DOI 10.1007/s10640-020-00426-z
   Hills A., 1998, J CONTING CRISIS MAN, V6, P162, DOI [10.1111/1468-5973.00085, DOI 10.1111/1468-5973.00085]
   Nguyen HV, 2020, PUBLISH RES Q, V36, P437, DOI 10.1007/s12109-020-09732-2
   Hossain NUI, 2020, SYSTEMS-BASEL, V8, DOI 10.3390/systems8030023
   Huarng KH, 2018, INT ENTREP MANAG J, V14, P97, DOI 10.1007/s11365-017-0460-9
   Ilyin VA, 2020, ECON SOC CHANG, V13, P9, DOI 10.15838/esc.2020.2.68.1
   Ioannides D, 2020, TOURISM GEOGR, V22, P624, DOI 10.1080/14616688.2020.1763445
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Judge T, 2020, COLUMBIA LAW EC WORK
   Kabadayi S, 2020, J SERV MARK, V34, P809, DOI 10.1108/JSM-03-2020-0090
   Karabag SF, 2020, J APPL ECON BUS RES, V10, P1
   Karnon J, 2020, APPL HEALTH ECON HEA, V18, P335, DOI 10.1007/s40258-020-00585-6
   Karnon J, 2020, APPL HEALTH ECON HEA, V18, P329, DOI 10.1007/s40258-020-00581-w
   Knight L, 2020, J PURCH SUPPLY MANAG, V26, DOI 10.1016/j.pursup.2020.100624
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Kuckartz U., 2019, ANAL QUALITATIVE DAT
   Kuckertz A., 2020, J BUS VENTURING INSI, DOI 10.1016/j.jbvi.2020.e00169
   Lampel J, 2009, ORGAN SCI, V20, P835, DOI 10.1287/orsc.1090.0479
   Langgat J., 2020, J ECON BUS, V3, DOI [10.31014/aior.1992.03.02.241, DOI 10.31014/AIOR.1992.03.02.241]
   Lew AA, 2016, TOURISM GEOGR, V18, P18, DOI 10.1080/14616688.2015.1122664
   Li J, 2020, HUM RESOUR DEV INT, V23, P199, DOI 10.1080/13678868.2020.1752493
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Lincoln, 1994, HDB QUALITATIVE RES, P273, DOI DOI 10.1007/BF00988593
   Liu YP, 2020, ASIAN BUS MANAG, V19, P277, DOI 10.1057/s41291-020-00119-x
   Llanos-Contreras O, 2020, INT ENTREP MANAG J, V16, P221, DOI 10.1007/s11365-019-00590-9
   Lu Y, 2020, ENVIRON HAZARDS-UK, V19, P323, DOI 10.1080/17477891.2020.1763902
   Luo SW, 2020, CONTEMP ECON POLICY, V38, P583, DOI 10.1111/coep.12482
   Mac Donald K, 2020, INT J PROJ MANAG, V38, P27, DOI 10.1016/j.ijproman.2019.09.008
   Materno-infantil, 2013, J NURS UFPE, V7, P1531
   Mentzer J. T., 1995, J BUSINESS LOGISTICS, V16, P231
   Mongeon P, 2016, SCIENTOMETRICS, V106, P213, DOI 10.1007/s11192-015-1765-5
   Moradian N, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02364-2
   Mullins J, 2020, BUS HORIZONS, V63, P693, DOI 10.1016/j.bushor.2020.04.003
   Muralidhar, 2020, INT J ADV RES ENG TE, V11, P372
   Murray-Davis B, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2791-8
   OECD, 2020, SUPP PEOPL CO DEAL C, P1
   Pacces AM, 2020, EUR J RISK REGUL, V11, P283, DOI 10.1017/err.2020.36
   Paez Arsenio, 2017, J Evid Based Med, V10, P233, DOI [10.1111/jebm.12265, 10.1111/jebm.12266]
   Park Y, 2013, BUS HORIZONS, V56, P75, DOI 10.1016/j.bushor.2012.09.008
   Pfarrer MD, 2008, ACAD MANAGE REV, V33, P730, DOI 10.5465/amr.2008.32465757
   Phoenix M, 2020, DISABIL REHABIL, V42, P2151, DOI 10.1080/09638288.2018.1555618
   Powell WW, 1996, ADMIN SCI QUART, V41, P116, DOI 10.2307/2393988
   Quinlan KM., 2008, NEW DIRECTIONS EVALU, V118, P61, DOI DOI 10.1002/EV.261
   Ruiu ML, 2020, J RISK RES, V23, P1007, DOI 10.1080/13669877.2020.1758755
   Runyan R.C., 2006, J CONTING CRISIS MAN, V14, P12, DOI [DOI 10.1111/j.1468-5973.2006.00477.x, 10.1111/jccm.2006.14.issue-1]
   Saillard E. K., 2011, FORUM QUALITATIVE SO, V12, DOI [10.17169/fqs-12.1.1518, DOI 10.17169/FQS-12.1.1518]
   Santoro G, 2021, SMALL BUS ECON, V57, P455, DOI 10.1007/s11187-020-00319-x
   Lopez-Morales JS, 2018, REV INT BUS STRATEGY, V28, P331, DOI 10.1108/RIBS-05-2018-0041
   Sharma P, 2020, J BUS RES, V116, P188, DOI 10.1016/j.jbusres.2020.05.026
   Slater, 2020, ECON OUTLOOK, V44, P5
   SNS (Serviu║o Nacional de SauCde), COVID 19 PAND
   Stavins J, 2021, CONTEMP ECON POLICY, V39, P59, DOI 10.1111/coep.12477
   Suriyankietkaew S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010091
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Tsilika T., 2020, J SMALL BUSINESS ENT, P1
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Veil ShariR., 2011, J BUS COMMUN, V48, P116, DOI [10.1177/0021943610382294, DOI 10.1177/0021943610382294]
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Wang, 2020, 6 INT C SOC EC AC LE, P1
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   WHITE HD, 1981, J AM SOC INFORM SCI, V32, P163, DOI 10.1002/asi.4630320302
   Williams CC, 2020, SERV IND J, V40, P914, DOI 10.1080/02642069.2020.1757073
   Zeng ZJ, 2020, TOURISM GEOGR, V22, P724, DOI 10.1080/14616688.2020.1762118
   Zupic I, 2015, ORGAN RES METHODS, V18, P429, DOI 10.1177/1094428114562629
NR 127
TC 2
Z9 2
U1 8
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JUN
PY 2021
VL 13
IS 11
AR 5995
DI 10.3390/su13115995
PG 21
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA SR0AZ
UT WOS:000660709700001
OA gold
DA 2022-04-20
ER

PT J
AU Jalal, SM
   Akhter, F
   Abdelhafez, AI
   Alrajeh, AM
AF Jalal, Sahbanathul Missiriya
   Akhter, Fahima
   Abdelhafez, Amal Ismael
   Alrajeh, Ahmed Mansour
TI Assessment of Knowledge, Practice and Attitude about Biomedical Waste
   Management among Healthcare Professionals during COVID-19 Crises in
   Al-Ahsa
SO HEALTHCARE
LA English
DT Article
DE biomedical waste; healthcare; COVID-19; KPA; healthcare professionals
ID WORKERS; PERSPECTIVE; FACILITIES; SITUATION
AB Biomedical waste (BMW) management is an essential practice of healthcare professionals (HCPs) for preventing health and also environmental hazards. Coronavirus disease (COVID-19) has become a global pandemic, posing significant challenges for healthcare sectors. A cross-sectional study was performed to assess the knowledge, practice, and attitude on BMW management among HCPs when taking care of patients with COVID-19 and associated with demographic variables. From Al-Ahsa healthcare sectors, 256 HCPs were selected randomly, of which 105 (41%) had excellent knowledge, 87 (34%) had good knowledge, and 64 (25%) had poor knowledge with a mean score of 13.1 +/- 3.6. A higher mean score was (14.4 +/- 3.2) obtained by physicians, and (13.6 +/- 3.8) nurses than the other HCPs. Regarding practice, 72 (28.1%) HCPs used and discarded PPE while handling biomedical wastes. Additionally, 88 (34.4%) followed proper hand hygiene before and after each procedure and whenever needed. Physicians, nurses, and respiratory therapists had a more favorable attitude than other HCPs. There was a statistically significant association found among knowledge level and educational qualification (p < 0.0001), gender (p < 0.001), and work experience (p < 0.05). Emphasis is needed to train all HCPs regarding proper BMW management during this pandemic to prevent infection transmission.
C1 [Jalal, Sahbanathul Missiriya; Akhter, Fahima; Abdelhafez, Amal Ismael] King Faisal Univ, Coll Appl Med Sci, Dept Nursing, Al Hasa 31982, Saudi Arabia.
   [Alrajeh, Ahmed Mansour] King Faisal Univ, Coll Appl Med Sci, Dept Resp Therapy, Al Hasa 31982, Saudi Arabia.
RP Jalal, SM (corresponding author), King Faisal Univ, Coll Appl Med Sci, Dept Nursing, Al Hasa 31982, Saudi Arabia.
EM sjalal@kfu.edu.sa; falamin@kfu.edu.sa; aabdelhameed@kfu.edu.sa;
   amalrajeh@kfu.edu.sa
RI Missiriya, Sahbanathul/AAT-6828-2020; Missiriya,
   Sahbanathul/AAQ-6007-2020; Akhter, Fahima/AFK-8779-2022
OI Missiriya, Sahbanathul/0000-0003-1780-9896; Akhter,
   Fahima/0000-0001-9235-4137; Al Rajeh, Ahmed/0000-0003-2559-416X;
   Abdelhafez, Amal Ismael/0000-0002-2416-2843
FU King Faisal University, Al-Ahsa, Saudi Arabia [206147]; King Faisal
   University
FX This research was funded by Deanship of Scientific Research, King Faisal
   University, Al-Ahsa, Saudi Arabia for its financial support with
   reference to the Research Grant Number 206147 through Nasher Track and
   the article processing charge was funded by Deanship of Scientific
   Research, King Faisal University.
CR Aanandaswamy TC, 2019, J ANAESTH CLIN PHARM, V35, P106, DOI 10.4103/joacp.JOACP_196_16
   Akkajit P, 2020, J ENVIRON PUBLIC HEA, V2020, DOI 10.1155/2020/8745472
   Albalushi AY, 2018, GLOB J HLTH SCI, V10, P70
   Alshahrani N.Z., 2021, INT J PHARM RES, V13, DOI [10.31838/ijpr/2021.13.02.224, DOI 10.31838/IJPR/2021.13.02.224]
   Ammendolia J, 2021, ENVIRON POLLUT, V269, DOI 10.1016/j.envpol.2020.116160
   Bhagawati G, 2015, INDIAN J MED MICROBI, V33, P580, DOI 10.4103/0255-0857.167323
   Bokhoree C., 2014, APCBEE Procedia, V9, P36, DOI 10.1016/j.apcbee.2014.01.007
   Chethana T, 2014, J COMMUN HEALTH, V39, P310, DOI 10.1007/s10900-013-9761-2
   Datta P, 2018, J LAB PHYS, V10, P6, DOI 10.4103/JLP.JLP_89_17
   Deress T, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/7672981
   Dona D, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030311
   Goswami M, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06313
   Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652
   Khoironi A, 2020, MAR POLLUT BULL, V151, DOI 10.1016/j.marpolbul.2019.110868
   Kumar Ramesh, 2013, J Ayub Med Coll Abbottabad, V25, P109
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Letho Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243817
   Mihai FC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155439
   Mugabi B, 2018, NIGER J CLIN PRACT, V21, P1627, DOI 10.4103/njcp.njcp_270_17
   Musa F, 2020, CUREUS, V12, DOI 10.7759/cureus.8281
   Pandey A, 2016, J CLIN DIAGN RES, V10, pDC1, DOI 10.7860/JCDR/2016/22595.8822
   Parida A, 2019, J LAB PHYS, V11, P292, DOI 10.4103/JLP.JLP_88_19
   Rao D., 2018, BIOMED PHARMACOL J, V11, P1737, DOI DOI 10.13005/bpj/1543
   Rashidian A, 2015, IRAN J PUBLIC HEALTH, V44, P352
   Sachan R, 2012, INT J SCI RES PUBLIC, V2, P1
   Shaheen T, 2020, CUREUS, V12, DOI 10.7759/cureus.12196
   Shammi M, 2021, ENVIRON SCI TECHNOL, V55, P4087, DOI 10.1021/acs.est.0c05117
   Short, 2020, CASE STUD CHEM ENV E, V1, DOI DOI 10.1016/J.CSCEE.2020.100006
   Singh S, 2020, J EDUC HEALTH PROMOT, V9, DOI 10.4103/jehp.jehp_704_19
   Singh T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1742326
   Sunmeet GA, 2017, INT J INNOV RES SCI, V3, P307
   Thind PS, 2021, ENVIRON POLLUT, V276, DOI 10.1016/j.envpol.2021.116621
   Yadavannavar Mc, 2010, Indian J Community Med, V35, P170, DOI 10.4103/0970-0218.62591
   Yousefi M, 2021, ENVIRON SCI POLLUT R, V28, P32200, DOI 10.1007/s11356-021-14214-9
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 35
TC 2
Z9 2
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9032
J9 HEALTHCARE-BASEL
JI Healthcare
PD JUN
PY 2021
VL 9
IS 6
AR 747
DI 10.3390/healthcare9060747
PG 13
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA SY5ME
UT WOS:000665931100001
PM 34207056
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Jiang, YY
   Wen, J
AF Jiang, Yangyang
   Wen, Jun
TI Effects of COVID-19 on hotel marketing and management: a perspective
   article
SO INTERNATIONAL JOURNAL OF CONTEMPORARY HOSPITALITY MANAGEMENT
LA English
DT Article
DE Artificial intelligence and robotics; Hygiene and cleanliness; Health
   and health care; Hotel management; COVID-19 pandemic
ID INTELLIGENCE; CLEANLINESS; INDUSTRY; SARS
AB Purpose This paper aims to discuss the effects of COVID-19 on hotel marketing and management practices and outlines a three-pronged research agenda to stimulate knowledge development in the hotel sector. Design/methodology/approach This paper is based on an overview of the relevant literature on hotel marketing and management and the hotel guest behavior. The authors also investigated hospitality service trends to propose a research agenda. Findings This paper presents a research agenda from three dimensions - artificial intelligence (AI) and robotics, hygiene and cleanliness and health and health care. First, different types of AI (mechanical, thinking and feeling) might open up distinct research streams at the intersection of health crises and hotel management, in light of the COVID-19 pandemic. Additionally, this paper recommends that researchers move beyond typical perspectives on the antecedents and outcomes of hotel hygiene and cleanliness to delve into guests' perceptions of the cleanliness of specific hotel surfaces. Furthermore, a more in-depth analysis is warranted about the evolving relationship between hotels and the health-care sector. Practical implications The recommended research areas are intended to advance the knowledge base to help hotels recover from the COVID-19 pandemic. The suggested research streams are expected to provide actionable insights to promote the development and sustainability of the hotel sector. Originality/value This paper appears to be a frontier study, critically examining possible effects of the COVID-19 pandemic on hotel marketing and management practices and how hoteliers may respond to such challenges to recover after this pandemic.
C1 [Jiang, Yangyang] Univ Nottingham Ningbo China, Nottingham Univ Business Sch China, Ningbo, Peoples R China.
   [Wen, Jun] Edith Cowan Univ, Sch Business & Law, Joondalup, Australia.
RP Wen, J (corresponding author), Edith Cowan Univ, Sch Business & Law, Joondalup, Australia.
EM yangyang.jiang@nottingham.edu.cn; j.wen@ecu.edu.au
RI Wen, Jun/AAC-3537-2019
OI Wen, Jun/0000-0002-1110-824X; wen, Jun/0000-0002-7544-1076
CR Balaji MS, 2019, INT J CONTEMP HOSP M, V31, P3287, DOI 10.1108/IJCHM-09-2018-0742
   Barber N, 2010, MANAG SERV QUAL, V20, P70, DOI 10.1108/09604521011011630
   Chan ESW, 2013, INT J HOSP MANAG, V32, P202, DOI 10.1016/j.ijhm.2012.05.010
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen Ming-Hsiang, 2007, Int J Hosp Manag, V26, P200, DOI 10.1016/j.ijhm.2005.11.004
   Chen MH, 2011, INT J HOSP MANAG, V30, P200, DOI 10.1016/j.ijhm.2010.06.005
   Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9
   Chien Grace C L, 2003, Int J Hosp Manag, V22, P327, DOI 10.1016/S0278-4319(03)00041-0
   Choi J, 2019, J ENVIRON HEALTH, V82, P16
   Courtney E.J., 2020, COVID 19 WILL CAUSE
   Gu HM, 2008, INT J HOSP MANAG, V27, P337, DOI 10.1016/j.ijhm.2007.10.005
   Guevara G., 2020, OPEN LETT WTTC GOVER
   Han H, 2015, J BUS RES, V68, P1869, DOI 10.1016/j.jbusres.2015.01.015
   Han H, 2013, INT J HOSP MANAG, V35, P100, DOI 10.1016/j.ijhm.2013.05.011
   Han H, 2013, TOURISM MANAGE, V36, P257, DOI 10.1016/j.tourman.2012.11.016
   Hecht J. A., 2006, International Journal of Contemporary Hospitality Management, V18, P69, DOI 10.1108/09596110610641993
   Henderson J. C., 2004, International Journal of Tourism Research, V6, P411, DOI 10.1002/jtr.505
   Hoffman K.D., 2003, J SERVICES MARKETING, V17, P322, DOI [DOI 10.1108/08876040310482757, 10.1108/08876040310482757]
   Hoisington A., 2020, 5 INSIGHTS COVID 19
   Huang MH, 2021, J SERV RES-US, V24, P30, DOI 10.1177/1094670520902266
   Huang MH, 2018, J SERV RES-US, V21, P155, DOI 10.1177/1094670517752459
   Hung KKC, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0438-6
   Jiang YY, 2020, J TRAVEL RES, V59, P1029, DOI 10.1177/0047287519872827
   Jiang YY, 2019, INT J HOSP MANAG, V82, P169, DOI 10.1016/j.ijhm.2019.05.004
   Johns Hopkins University, 2020, COVID 19 MAP
   Kim SeongSeop [Kim S. S. S.], 2005, Asia Pacific Journal of Tourism Research, V10, P369, DOI 10.1080/10941660500363694
   Kuo CM, 2017, INT J CONTEMP HOSP M, V29, P1305, DOI [10.1108/IJCHM-08-2015-0414, 10.1108/ijchm-08-2015-0414]
   Law R., 2006, ASIA PACIFIC J TOURI, V11, P65
   Li J, 2019, TOURISM MANAGE, V73, P172, DOI 10.1016/j.tourman.2019.02.006
   Lockyer T, 2005, TOURISM MANAGE, V26, P529, DOI 10.1016/j.tourman.2004.03.009
   Lu L, 2019, INT J HOSP MANAG, V80, P36, DOI 10.1016/j.ijhm.2019.01.005
   Magnini VP, 2011, J TRAVEL RES, V50, P535, DOI 10.1177/0047287510379162
   Mao CK, 2010, TOURISM MANAGE, V31, P855, DOI 10.1016/j.tourman.2009.09.003
   Mariani M., 2020, PSYCHOL MARKETING
   Mariani M, 2020, TOUR REV, V75, P299, DOI 10.1108/TR-06-2019-0259
   Mariani M, 2018, INT J CONTEMP HOSP M, V30, P3514, DOI 10.1108/IJCHM-07-2017-0461
   Min H, 2009, SERV IND J, V29, P835, DOI 10.1080/02642060902749393
   Nguyen DN, 2017, TOURISM MANAGE, V61, P129, DOI 10.1016/j.tourman.2017.02.003
   Oh H, 2016, J TRAVEL RES, V55, P205, DOI 10.1177/0047287514546228
   Paraskevas A, 2013, INT J CONTEMP HOSP M, V25, P140, DOI 10.1108/09596111311290264
   Park H, 2019, ANN OCCUP ENVIRON ME, V31, DOI 10.1186/s40557-019-0282-z
   Racherla P, 2009, CORNELL HOSP Q, V50, P561, DOI 10.1177/1938965509341633
   Tew P. J., 2008, International Journal of Contemporary Hospitality Management, V20, P332, DOI 10.1108/09596110810866145
   Tung VWS, 2017, INT J CONTEMP HOSP M, V29, P2498, DOI 10.1108/IJCHM-09-2016-0520
   Tussyadiah I, 2020, ANN TOURISM RES, V81, DOI 10.1016/j.annals.2020.102883
   Vilnai-Yavetz I., 2010, SERVICES MARKETING Q, V31, P213
   Wallis G., 2020, UPDATED COVID 19 IMP
   Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X
   WEN J, 2020, ANATOLIA 0317, DOI DOI 10.1080/13032917.2020.1742750
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   WHO, 2020, COVID 19 RISK COMM P
   WHO, 2020, Q A COR COVID 19
   Xu SJ, 2017, TOURISM MANAGE, V61, P321, DOI 10.1016/j.tourman.2017.02.012
   Zabin J., 2019, ARTIFICIAL INTELLIGE
   Zemke DMV, 2015, INT J CONTEMP HOSP M, V27, P690, DOI 10.1108/IJCHM-01-2014-0020
   Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 57
TC 197
Z9 202
U1 67
U2 243
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-6119
EI 1757-1049
J9 INT J CONTEMP HOSP M
JI Int. J. Contemp. Hosp. Manag.
PD AUG 4
PY 2020
VL 32
IS 8
BP 2563
EP 2573
DI 10.1108/IJCHM-03-2020-0237
EA JUN 2020
PG 11
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA NA4WR
UT WOS:000544431600001
OA Green Accepted
DA 2022-04-20
ER

PT J
AU Tian, Y
   Nian, BX
   Ma, YC
   Guo, XY
   Wang, F
   Rong, L
AF Tian, Yuan
   Nian, Bixiao
   Ma, Yongchen
   Guo, Xinyue
   Wang, Feng
   Rong, Long
TI The Status of Occupational Protection During COVID-19 Pandemic:
   Knowledge, Attitudes, and Practice of Healthcare Workers in Endoscopy
   Units, China
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE occupational protection; COVID-19; endoscopy; knowledge; attitudes;
   practice
ID RESPIRATORY VIRUSES; OUTBREAK; KAP
AB Background: SARS-CoV-2 spreads rapidly around the world, and some patients present gastrointestinal symptoms. The existence of the virus in the gastrointestinal tract makes digestive endoscopy a high-risk operation, which associated with an increased risk of infection rate in healthcare workers. This study aimed at exploring current knowledge, practice and attitudes of healthcare workers in endoscopy units in China regarding the status of occupational protection during COVID-19 pandemic.
   Methods: A cross-sectional study of a national online survey involving 717 healthcare workers in endoscopy units from 94 medical structures in 24 provinces and municipalities around China was conducted online via a questionnaire platform called Wenjuanxing (wjx.cn). The data were analyzed using correlation approaches, Kruskal-Wallis test for independent samples, and linear regression models.
   Results: Most Chinese healthcare workers in endoscopy units had a good knowledge of COVID-19 (median: 10; range: 7-12), showed a strikingly positive attitude (median: 65; range: 39-65), and carried out good practice (median: 47; range: 14-50) in strengthening the protection, disinfection and management of COVID-19. In terms of attitudes, female staff was more concerned about protection against COVID-19 than male staff (KW = 8.146, P = 0.004). Nurses performed better in both attitude (KW = 2.600, P = 0.009) and practice (KW = 6.358, P < 0.001) than endoscopic physicians when carrying out personal protection, patient care and environmental disinfection against SARS-CoV-2 infection. More positive attitudes in protection were related to better protective behavior in endoscopic daily medical work (r = 0.312; P < 0.001).
   Conclusion: The findings of this study suggest that Chinese endoscopy healthcare workers have an excellent mastery of knowledge about COVID-19, which is transformed into positive beliefs and attitudes, contributing to good practice during daily endoscopic procedures. Medical staff may benefit from further education. With the gradual normalization amid the ongoing COVID-19 pandemic, protection and management in endoscopy units may be changed accordingly.
C1 [Tian, Yuan; Nian, Bixiao; Ma, Yongchen; Guo, Xinyue; Wang, Feng; Rong, Long] Peking Univ, Hosp 1, Dept Endoscopy Ctr, Beijing, Peoples R China.
RP Rong, L (corresponding author), Peking Univ, Hosp 1, Dept Endoscopy Ctr, Beijing, Peoples R China.
EM drronglong@foxmail.com
FU Youth Clinical Research Project of Peking University First Hospital
   [2018CR28]
FX This research was funded by Youth Clinical Research Project of Peking
   University First Hospital (2018CR28).
CR Alzghoul Bashar I, 2015, Glob J Health Sci, V8, P154, DOI 10.5539/gjhs.v8n6p154
   Assefa EM, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0835-x
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Buonanno G, 2020, ENVIRON INT, V145, DOI 10.1016/j.envint.2020.106112
   Buonanno G, 2020, ENVIRON INT, V141, DOI 10.1016/j.envint.2020.105794
   CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6
   Cherrie JW, 2020, OCCUP MED-OXFORD, V70, P335, DOI 10.1093/occmed/kqaa077
   Chinese Society of Digestive Endoscopology, 2020, GUID DIG END DIAGN T
   Chiu PWY, 2020, GUT, V69, P991, DOI 10.1136/gutjnl-2020-321185
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Dopelt K, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081359
   Goni MD, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224569
   Jones RM, 2020, J OCCUP ENVIRON HYG, V17, P408, DOI 10.1080/15459624.2020.1784427
   Lee K, 2009, GLOB INST, P1
   Li L, 2020, LANCET RESP MED, V8, pE23, DOI 10.1016/S2213-2600(20)30125-9
   Liang MM, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101751
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939
   Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832
   Odeyemi OA, 2019, FOOD RES INT, V116, P1386, DOI 10.1016/j.foodres.2018.10.030
   Phan LT, 2020, INFECT CONT HOSP EP, V41, P259, DOI 10.1017/ice.2019.299
   Phan LT, 2019, INFECT CONT HOSP EP, V40, P1356, DOI 10.1017/ice.2019.298
   Sakr S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08676-8
   Spinazze A, 2020, ANN WORK EXPOS HEAL, V64, P559, DOI 10.1093/annweh/wxaa044
   Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731
   ul Haq I, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5897478
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   World Health Organization, 2021, COR DIS COVID 19 WEE
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Yu H., 2020, LANCET, DOI 10.2139/ssrn.3532530
   Zhang YF, 2020, ENDOSCOPY, V52, P312, DOI 10.1055/a-1128-4313
   Zietsman M, 2019, J OCCUP ENVIRON HYG, V16, P707, DOI 10.1080/15459624.2019.1649414
NR 32
TC 1
Z9 2
U1 3
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD MAR 22
PY 2021
VL 9
AR 632608
DI 10.3389/fpubh.2021.632608
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA RI1IC
UT WOS:000636662400001
PM 33829007
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Guidetti, G
   Cortini, M
   Fantinelli, S
   Di Fiore, T
   Galanti, T
AF Guidetti, Gloria
   Cortini, Michela
   Fantinelli, Stefania
   Di Fiore, Teresa
   Galanti, Teresa
TI Safety Management and Wellbeing during COVID-19: A Pilot Study in the
   Manufactory Sector
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19 pandemic; wellbeing; safety management; manufacturing sector
ID CLIMATE; HEALTH; CITIZENSHIP; BEHAVIORS
AB Background: The rapid spread of COVID-19 has generated anxiety and concerns among the whole population, by also affecting people's working life quality. Although several studies underlined the impact of the COVID-19 pandemic in the healthcare sector, very few studies investigated the consequences in the occupational sectors with low risk of contagion. Method: 220 full-time in-presence workers of the manufacturing sector agreed to participate in a study of cross-sectional design during September and October 2020. Data were collected by means of a self-reported questionnaire conceived to investigate the constructs of the COVID-19 concerns, both the personal contribution and the supervisor support to workplace safety, the organizational commitment to safety, and finally, the level of workers' exhaustion. Results: This study highlights that COVID-19 concerns represent a significant source of stress since it is significantly associated to higher levels of exhaustion among workers. Furthermore, the findings show the relevance of resources related to employee's personal contribution to safety management as well as the role of climate variables. Conclusions: These results promote knowledge on the role of COVID-19 concerns in affecting psychological wellbeing at work, as well as the impact of both individual and job-related resources that may prevent exhaustion at work. Finally, the present findings also have implications for organizations and the maintenance of their commitment to safety.
C1 [Guidetti, Gloria; Cortini, Michela; Di Fiore, Teresa; Galanti, Teresa] Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, I-66100 Chieti, Italy.
   [Fantinelli, Stefania] Univ Foggia, Dept Humanities Literature Cultural Heritage Educ, I-71100 Foggia, Italy.
RP Galanti, T (corresponding author), Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, I-66100 Chieti, Italy.
EM gloria.guidetti@unich.it; michela.cortini@unich.it;
   stefania.fantinelli@unifg.it; teresa.difiore@unich.it;
   teresa.galanti@unich.it
CR Bandini J, 2021, NEW SOLUT, V31, P20, DOI 10.1177/1048291120987845
   Brennan PA, 2020, BRIT J ORAL MAX SURG, V58, P254, DOI 10.1016/j.bjoms.2020.03.011
   Brown CE, 2021, J OCCUP ENVIRON MED, V63, P81, DOI 10.1097/JOM.0000000000002080
   Castelli L, 2020, CAN J PSYCHIAT, V65, P731, DOI 10.1177/0706743720938598
   Charoensukmongkol P, 2021, J GEN PSYCHOL, V148, P431, DOI 10.1080/00221309.2020.1795613
   Chatzittofis A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041435
   Clarke S, 2010, J OCCUP ORGAN PSYCH, V83, P553, DOI 10.1348/096317909X452122
   Converso D, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18115986
   Curcuruto M, 2015, SAFETY SCI, V80, P317, DOI 10.1016/j.ssci.2015.07.032
   Curcuruto M, 2018, SAFETY SCI, V104, P29, DOI 10.1016/j.ssci.2017.12.010
   De Kock JH, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10070-3
   Neto GCD, 2021, SAFETY SCI, V141, DOI 10.1016/j.ssci.2021.105331
   Dehghani F, 2020, WORK, V67, P771, DOI 10.3233/WOR-203330
   Demerouti E., 2008, HDB STRESS BURNOUT H, P65
   Dennerlein JT, 2020, HUM FACTORS, V62, P689, DOI 10.1177/0018720820932699
   Di Fiore T., 2021, QUADERNI ACP, V28, P21, DOI [10.53141/QACP.2021.21-24, DOI 10.53141/QACP.2021.21-24]
   Dimoff JK, 2016, INT J STRESS MANAGE, V23, P167, DOI 10.1037/a0039479
   Gaitens J, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041446
   Galanti T, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13105485
   Galanti T, 2021, J OCCUP ENVIRON MED, V63, pE426, DOI 10.1097/JOM.0000000000002236
   Galanti T, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052685
   Giorgi G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217857
   Guidetti G, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19041995
   Hofmann DA, 2003, J APPL PSYCHOL, V88, P170, DOI 10.1037/0021-9010.88.1.170
   Iavicoli S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248874
   International Labor Organization (ILO), FAC PAND ENS SAF HLT
   Kniffin KM, 2021, AM PSYCHOL, V76, P63, DOI 10.1037/amp0000716
   Li L., 2015, CHIN NURS RES, V2, P45, DOI [10.1016/j.cnre.2015.04.003, DOI 10.1016/J.CNRE.2015.04.003]
   Martinez-Lopez JA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9093029
   Mearns K, 2010, ACCIDENT ANAL PREV, V42, P1445, DOI 10.1016/j.aap.2009.08.009
   Nahrgang JD, 2011, J APPL PSYCHOL, V96, P71, DOI 10.1037/a0021484
   Parker S K, 2001, J Occup Health Psychol, V6, P211, DOI 10.1037/1076-8998.6.3.211
   Petitta L, 2021, SAFETY SCI, V140, DOI 10.1016/j.ssci.2021.105317
   Pink J, 2021, J OCCUP ORGAN PSYCH, V94, P789, DOI 10.1111/joop.12364
   Prikhidko A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.567250
   Reinwald M, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.654126
   Romero CS, 2022, PSYCHOL MED, V52, P188, DOI 10.1017/S0033291720001671
   Rudolph CW, 2021, IND ORGAN PSYCHOL-US, V14, P1, DOI 10.1017/iop.2020.48
   Ruiz-Frutos C, 2021, SAFETY SCI, V133, DOI 10.1016/j.ssci.2020.104996
   Salanova M, 2012, GROUP ORGAN MANAGE, V37, P785, DOI 10.1177/1059601112470405
   Semple S, 2020, ANN WORK EXPOS HEAL, V64, P461, DOI 10.1093/annweh/wxaa033
   Sinclair RR, 2020, OCCUP HEALTH SCI, V4, P1, DOI 10.1007/s41542-020-00064-3
   Singh J., 2009, IUP J OPER MANAG, V8, P51
   Spagnoli P, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.620310
   Taylor WD, 2017, SAFETY SCI, V95, P116, DOI 10.1016/j.ssci.2017.02.011
   Vu TV, 2022, SAFETY SCI, V145, DOI 10.1016/j.ssci.2021.105527
   Toscano F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12239804
   Trumello C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228358
   Van Dyne L, 1998, ACAD MANAGE J, V41, P108, DOI 10.2307/256902
   Weissberg D, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00861-z
   White RG, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2020.79
   Yanar B, 2019, SAF HEALTH WORK-KR, V10, P172, DOI 10.1016/j.shaw.2018.11.001
   ZOHAR D, 1980, J APPL PSYCHOL, V65, P96, DOI 10.1037/0021-9010.65.1.96
NR 53
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2022
VL 19
IS 7
AR 3981
DI 10.3390/ijerph19073981
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 0K0UA
UT WOS:000780511200001
PM 35409664
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kumar, A
   Rai, AK
   Chiluveri, AC
   Chiluveri, SK
   Londhe, D
   Singh, R
   Kumar, S
   Goel, S
AF Kumar, A.
   Rai, A. K.
   Chiluveri, A. C.
   Chiluveri, S. K.
   Londhe, D.
   Singh, R.
   Kumar, S.
   Goel, S.
TI Ayurvedic paradigm for COVID-19 prophylaxis and management strategies
SO INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE
LA English
DT Article
DE Ayurveda; COVID-19 pandemic; Immunomodulator; Integrative medicine;
   Prophylaxis; Traditional medicine
ID WITHANIA-SOMNIFERA; GLYCYRRHIZA-GLABRA; ANTIVIRAL ACTIVITY; AQUEOUS
   EXTRACT; VIRUS; MACROPHAGES; INHIBITION; INFECTION; GINGER; CELL
AB The prophylactic and therapeutic potential of traditional systems of medicine like Ayurveda has not being explored to its maximum in the search for effective solutions to the COVID-19 crisis. The present work is an attempt to strategize the strength of Ayurveda in the prophylaxis and management of COVID-19 as a standalone system or integrated with conventional medicine. The restorative protocols for COVID-19 may be planned on the line of management principles described for infectious diseases, epidemics, fever, and respiratory ailments in Ayurveda with single herb and formulations having proven immunomodulatory and anti-viral properties. The way forward is to adopt an integrative approach by taking leads from Ayurveda and incorporating it into the action strategy to fight this pandemic.
C1 [Kumar, A.] Reg Ayurveda Res Inst, Itanagar 791111, Arunachal Prade, India.
   [Rai, A. K.; Londhe, D.; Singh, R.; Kumar, S.; Goel, S.] Cent Council Res Ayurved Sci, New Delhi 110058, India.
   [Chiluveri, A. C.; Chiluveri, S. K.] Cent Ayurveda Res Inst Cardiovasc Dis, New Delhi 110026, India.
RP Kumar, A (corresponding author), Reg Ayurveda Res Inst, Itanagar 791111, Arunachal Prade, India.
EM dr.arvindaggarwal@gmail.com
CR Acharya M, 2011, CH CRC DATA MIN KNOW, P113
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P570
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P533
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P201
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P180
   Acharya V Y T, 2012, SUSHRUTA SAMHITA SUS, P105
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P54
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P235
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P418
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P108
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P407
   Acharya V Y T, 2012, SUSHRUTA SAMHITA SUS, P106
   Acharya V Y T, 2012, SUSHRUTA SAMHITA SUS, P28
   Acharya V Y T, 2012, SUSHRUTA SAMHITA SUS, P103
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P406
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P58
   Acharya V Y T, 2012, SUSHRUTA SAMHITA SUS, P289
   Acharya V Y T, 2012, SUSHRUTA SAMHITA SUS, P75
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P242
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P212
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P388
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P74
   Acharya V Y T, 2011, CHARAKA SAMHITA AGNI, P376
   Acharya VV, 2011, WILEY FINANC SER, P241
   Acharya VV, 2011, GUARANTEED TO FAIL: FANNIE MAE, FREDDIE MAC AND THE DEBACLE OF MORTGAGE FINANCE, P178
   Acharya VV, 2011, GUARANTEED TO FAIL: FANNIE MAE, FREDDIE MAC AND THE DEBACLE OF MORTGAGE FINANCE, P41
   Acharya VYT, 2012, SUSHRUTA SAMHITA SUS, P316
   Aranha I, 2012, J ETHNOPHARMACOL, V139, P366, DOI 10.1016/j.jep.2011.11.013
   Aronson J K, COVID 19 REGISTERED
   Balasubramani SP, 2011, CHIN J INTEGR MED, V17, P88, DOI 10.1007/s11655-011-0659-5
   Bani S, 2006, J ETHNOPHARMACOL, V107, P107, DOI 10.1016/j.jep.2006.02.016
   Cai WT, 2016, ANTIVIR RES, V133, P95, DOI 10.1016/j.antiviral.2016.07.020
   Cai Z, 2015, CELL BIOCHEM BIOPHYS, V72, P727, DOI 10.1007/s12013-015-0524-9
   Cao Y, 2019, ADVANCES IN MEMBRANE PROTEINS: BUILDING, SIGNALING AND MALFUNCTION, P1, DOI 10.1007/978-981-13-9077-7
   Chang JS, 2013, J ETHNOPHARMACOL, V145, P146, DOI 10.1016/j.jep.2012.10.043
   Gautam M, 2004, INT IMMUNOPHARMACOL, V4, P841, DOI 10.1016/j.intimp.2004.03.005
   Hemalatha R., 2011, TRENDS MED RES, V6, P23
   Hussain K, 2017, INT J AGRIC BIOL, V19, P928, DOI [10.17957/ijab/15.0397, 10.17957/IJAB/15.0397]
   Ippoushi K, 2003, LIFE SCI, V73, P3427, DOI 10.1016/j.lfs.2003.06.022
   Kesharwani A, 2017, BMC COMPLEM ALTERN M, V17, P1, DOI 10.1186/s12906-017-1620-8
   Kim DH, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e35
   LEBISH IJ, 1987, TOXICOL PATHOL, V15, P338, DOI 10.1177/019262338701500312
   Mishra B S, 2005, BHAVAPRAKASHA SRI BH, P562
   Momtazi-Borojeni AA, 2018, AUTOIMMUN REV, V17, P125, DOI 10.1016/j.autrev.2017.11.016
   Mondal S, 2011, J ETHNOPHARMACOL, V136, P452, DOI 10.1016/j.jep.2011.05.012
   Nose M, 1998, BIOL PHARM BULL, V21, P1110, DOI 10.1248/bpb.21.1110
   Paradakara P H S S, 2017, ASHTANGA HRIDAYAM VA, P789
   Paradakara P H S S, 2017, ASHTANGA HRIDAYAM VA, P448
   Paradakara P H S S, 2017, ASHTANGA HRIDAYAM VA, P743
   Paradakara P H S S, 2017, ASHTANGA HRIDAYAM VA, P166
   Paradakara P H S S, 2017, ASHTANGA HRIDAYAM VA, P469
   Park SH, 2012, BIOCHEM BIOPH RES CO, V419, P735, DOI 10.1016/j.bbrc.2012.02.091
   POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0
   Rasool A, 2017, PAK J PHARM SCI, V30, P1341
   Rastogi Sanjeev, 2022, J Ayurveda Integr Med, V13, P100312, DOI 10.1016/j.jaim.2020.04.002
   Rege A. A., 2010, Indian Journal of Natural Products and Resources, V1, P193
   Sachan S, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030106
   Saikia S, 2019, DRUG DEVELOP RES, V80, P106, DOI 10.1002/ddr.21475
   Samal Janmejaya, 2015, Ayu, V36, P5, DOI 10.4103/0974-8520.169010
   Sampangi-Ramaiah MH, 2020, CURR SCI INDIA, V118, P1087, DOI 10.18520/cs/v118/i7/1087-1092
   Shastri L P, 2018, YOGARATNAKARA VIDYOT, P190
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Singh MK, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-193
   Sornpet B, 2017, ASIAN PAC J TROP MED, V10, P871, DOI 10.1016/j.apjtm.2017.08.010
   SURESH K, 1994, J ETHNOPHARMACOL, V44, P55, DOI 10.1016/0378-8741(94)90099-X
   Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI 10.1002/lary.28692
   WHO, 2019, GLOB REP TRAD COMPL
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Yukawa TA, 1996, ANTIVIR RES, V32, P63, DOI 10.1016/0166-3542(95)00978-7
NR 69
TC 1
Z9 1
U1 0
U2 2
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0972-5938
EI 0975-1068
J9 INDIAN J TRADIT KNOW
JI Indian J. Tradit. Knowl.
PD DEC
PY 2020
VL 19
IS 4
SI SI
BP S25
EP S36
PG 12
WC Plant Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences
GA QJ6AA
UT WOS:000619769800005
DA 2022-04-20
ER

PT J
AU Slawinska, M
   Nowicki, RJ
AF Slawinska, Martyna
   Nowicki, Roman J.
TI Dermatological manifestations of COVID-19: a practical summary of the
   current state of knowledge
SO PRZEGLAD DERMATOLOGICZNY
LA English
DT Review
DE COVID-19; SARS-CoV-2; skin; nail apparatus
AB While COVID-19 initially appeared to be manifested primarily by respiratory symptoms, it is now known to be a multi-organ disease, also with dermatological manifestations. Cutaneous symptoms in patients with COVID-19 have a wide clinical spectrum. They may appear at any stage of the disease or as its sole manifestation. Further research is necessary to clarify the pathogenesis of these changes, their prognostic significance and therapeutic management. This article summarizes the current knowledge about changes occurring in the skin, mucous membranes and nails of patients diagnosed with COVID-19 and addresses the issue of drug-induced skin changes associated most common treatments of COVID-19.
C1 [Slawinska, Martyna; Nowicki, Roman J.] Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland.
RP Slawinska, M (corresponding author), Gdanski Uniwersytet Med, Katedra & Klin Dermatol Wenerol & Alergol, Ul Smoluchowskiego 17, PL-80214 Gdansk, Poland.
EM mslawinska@gumed.edu.pl
RI Sławinska, Martyna/ABG-2903-2020; Nowicki, Roman J./U-3148-2018
OI Nowicki, Roman J./0000-0003-4768-1387
CR de Masson A, 2020, J AM ACAD DERMATOL, V83, P667, DOI 10.1016/j.jaad.2020.04.161
   Fernandez-Nieto D, 2020, CLIN EXP DERMATOL, V45, P872, DOI 10.1111/ced.14277
   Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163
   Gianotti R, 2020, AM J DERMATOPATH, V42, P564, DOI 10.1097/DAD.0000000000001707
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Joob B, 2020, J AM ACAD DERMATOL, V82, pE177, DOI 10.1016/j.jaad.2020.03.036
   Mahe A, 2020, J EUR ACAD DERMATOL, V34, pE246, DOI 10.1111/jdv.16471
   Manalo IF, 2020, J AM ACAD DERMATOL, V83, P700, DOI 10.1016/j.jaad.2020.04.018
   Marzano AV, 2020, J AM ACAD DERMATOL, V83, P280, DOI 10.1016/j.jaad.2020.04.044
   Neri I, 2020, J EUR ACAD DERMATOL, V34, pE663, DOI 10.1111/jdv.16747
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387
   Sachdeva M, 2020, J DERMATOL SCI, V98, P75, DOI 10.1016/j.jdermsci.2020.04.011
   Slawinski G, 2020, KARDIOL POL, V78, P278, DOI 10.33963/KP.15302
   Suchonwanit P, 2020, J AM ACAD DERMATOL, V83, pE57, DOI 10.1016/j.jaad.2020.04.094
   Torrelo A, 2020, PEDIATR DERMATOL, V37, P442, DOI 10.1111/pde.14246
   Tursen U, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13476
   van Damme C, 2020, J EUR ACAD DERMATOL, V34, pE300, DOI 10.1111/jdv.16523
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Wollina U, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13549
NR 19
TC 2
Z9 2
U1 0
U2 1
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA KLEEBERGA ST 2, POZNAN, 61-615, POLAND
SN 0033-2526
EI 2084-9893
J9 PRZ DERMATOL
JI Prz. Dermatol.
PY 2020
VL 107
IS 3
BP 228
EP 233
DI 10.5114/dr.2020.97990
PG 6
WC Dermatology
WE Emerging Sources Citation Index (ESCI)
SC Dermatology
GA NJ2GT
UT WOS:000565864500003
OA gold
DA 2022-04-20
ER

PT J
AU Kaim, A
   Jaffe, E
   Siman-Tov, M
   Khairish, E
   Adini, B
AF Kaim, Arielle
   Jaffe, Eli
   Siman-Tov, Maya
   Khairish, Ella
   Adini, Bruria
TI Impact of a Brief Educational Intervention on Knowledge, Perceived
   Knowledge, Perceived Safety, and Resilience of the Public During
   COVID-19 Crisis
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; knowledge; trust; practices; educational intervention;
   resilience; pandemic
ID PERSONAL RESILIENCE; PREVENTIVE MEASURES; SARS; CORONAVIRUS; PERCEPTION;
   LESSONS
AB Extraordinary and unprecedented public health measures have been implemented to contain the ongoing spread of the coronavirus disease 2019 (COVID-19) pandemic. There is paramount importance of cooperation and population engagement in reducing disease infection rates and relieving an outbreak's burden on society. The civil society's engagement may be achieved through disaster education interventions. In this cross-sectional study, a pre-post questionnaire was used to investigate the impact of a brief educational intervention on knowledge, perceived knowledge, perceived safety, and the individual resilience of the population relating to the COVID-19 outbreak. The results of the study display the benefits of the educational intervention to include a significant overall increase in all examined variables. The study also reviewed the overall trust of the public concerning the main responding authorities, as well as practices concerning protective measures for COVID-19. This study demonstrates that educational interventions, such as the brief video, provide an easily implementable design and effective means for educating and empowering the public and should, thus, be considered as a component of future outbreak responses.
C1 [Kaim, Arielle; Adini, Bruria] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Emergency Management & Disaster Med, POB 39040, IL-6139001 Tel Aviv, Israel.
   [Jaffe, Eli; Siman-Tov, Maya; Khairish, Ella] Magen David Adom, PR Training & Volunteers Div, Igal Alon 70, IL-6706215 Tel Aviv, Israel.
   [Jaffe, Eli] Ben Gurion Univ Negev, Dept Emergency Med, POB 653, IL-8410501 Beer Sheva, Israel.
RP Adini, B (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Emergency Management & Disaster Med, POB 39040, IL-6139001 Tel Aviv, Israel.
EM ariellekaim@mail.tau.ac.il; Eliy@mda.org.il; maylev90@gmail.com;
   EllaK@mda.org.il; adini@tauex.tau.ac.il
RI Adini, Bruria/AAS-2434-2021; Adini, Bruria/AAW-4717-2020
OI Adini, Bruria/0000-0002-4358-0872; Jaffe, Eli/0000-0002-8380-0219; Kaim,
   Arielle/0000-0003-1251-3551
CR Adini B., 2017, HDB INTEGRATED CARE, P439, DOI DOI 10.1007/978-3-319-56103-5_27
   Aguero F, 2011, PREV MED, V53, P203, DOI 10.1016/j.ypmed.2011.06.018
   Ahmed F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5446-1
   Ainuddin S, 2012, INT J DISAST RISK RE, V2, P25, DOI 10.1016/j.ijdrr.2012.07.003
   Al-Mohrej A, 2017, J INFECT PUBLIC HEAL, V10, P388, DOI 10.1016/j.jiph.2016.06.013
   Bateman J.M., 2002, NAT HAZARDS REV, V3, P107, DOI [DOI 10.1061/(ASCE)1527-6988(2002)3:3(107), 10.1061/(ASCE)1527-6988(2002)3:3(107)]
   Becker JS, 2013, RISK ANAL, V33, P1710, DOI 10.1111/risa.12014
   Bodas M, 2020, HEALTH AFFAIR, V39, P936, DOI 10.1377/hlthaff.2020.00382
   Bodas M, 2019, INT J DISAST RISK RE, V36, DOI 10.1016/j.ijdrr.2019.101089
   Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671
   Brame CJ, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-03-0125
   Burkam DT, 2002, INEQUALITY STARTING
   Chan SSC, 2007, INT J NURS STUD, V44, P1120, DOI 10.1016/j.ijnurstu.2006.04.019
   Condon BJ, 2010, HEALTH POLICY, V95, P50, DOI 10.1016/j.healthpol.2009.11.009
   Crane M.F., 2017, J ORG PSYCHOL, V10, P10, DOI [10.1017/orp.2017.3, DOI 10.1017/ORP.2017.3]
   Drury J, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00141
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Fernandez ME, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00209
   Fung ICH, 2006, TROP MED INT HEALTH, V11, P1749, DOI 10.1111/j.1365-3156.2006.01734.x
   Goni MD, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224569
   Goodman K, 2015, J REPROD MED, V60, P471
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hays RD, 2015, BEHAV RES METHODS, V47, P685, DOI 10.3758/s13428-015-0617-9
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jaffe E., 2010, PREHOSP DISASTER MED, V25, pS72, DOI [10.1017/S1049023X00023633, DOI 10.1017/S1049023X00023633]
   Kitagawa K, 2019, COMPARE, V49, P851, DOI 10.1080/03057925.2018.1464385
   Kupika OL, 2019, SCIENTIFICA, V2019, DOI 10.1155/2019/3069254
   Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350
   Lopes R., 2000, P PLANN EARTHQ NZ C
   Maslen S, 2016, J RISK RES, V19, P1246, DOI 10.1080/13669877.2015.1057204
   Masten AS, 2006, ANN NY ACAD SCI, V1094, P13, DOI 10.1196/annals.1376.003
   Mizrahi S, 2021, PUBLIC MANAG REV, V23, P233, DOI 10.1080/14719037.2019.1674367
   Noe A, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0344-8
   Paton D., 2017, DISASTER RESILIENCE
   Rice V, 2016, WORK, V54, P325, DOI 10.3233/WOR-162300
   Rosenbloom T, 2016, TRANSPORT RES F-TRAF, V41, P66, DOI 10.1016/j.trf.2016.04.003
   Schaap D., 2018, POLICE PUBLIC PURSUI
   Sim K, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.113015
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Stirling BV, 2015, BMC NURS, V14, DOI 10.1186/s12912-015-0065-y
   Tiargan-Orr R, 2016, ARMED FORCES SOC, V42, P324, DOI 10.1177/0095327X15592214
   Tognotti E, 2013, EMERG INFECT DIS, V19, P254, DOI 10.3201/eid1902.120312
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WHO-World Health Organization, 2018, MAN EP KEY FACTS MAJ
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Zakrison TL, 2004, J URBAN HEALTH, V81, P596, DOI 10.1093/jurban/jth143
NR 47
TC 11
Z9 11
U1 5
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG
PY 2020
VL 17
IS 16
AR 5971
DI 10.3390/ijerph17165971
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA NI1SF
UT WOS:000565136900001
PM 32824591
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Alennu, T
   Annare, S
   Legesse, S
   Abera, A
   Ayalew, M
   Bezabih, B
AF Alennu, Tefera
   Annare, Semagn
   Legesse, Seid
   Abera, Abtew
   Ayalew, Misganaw
   Bezabih, Belay
TI COVID-19 Knowledge, Attitude, Practices and Their Associated Factors
   Among Dessie City Residents, Northeast Ethiopia: A Cross-Sectional Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE attitude; COVID-19; knowledge; practice; Dessie city
AB Background: Sufficient knowledge and favorable attitude are among the key determinants for people's adherence to coronavirus disease (COVID-19) precaution measures. Hence, this study assessed Dessie city resident's knowledge, attitude, and practice on COVID-19.
   Methods: We used a facility-based cross-sectional study among 424 Dessie city residents from 17 to 21/05/2020. We dichotomized knowledge, attitude and practice scores based on the mean value. We entered the data into EpiData manager software 4.2 and exported to SPSS-20 for data analysis. We run three independent logistic regression analyses to determine factors associated with sufficient knowledge, a favorable attitude, and adequate practice. We defined significant association at a p-value of < 0.05.
   Results: Among 424 participants, 92.7% have sufficient knowledge about COVID-19, while 96% have a favorable attitude to prevent and control the pandemic. However, the practice was adequate only in 44.6% of the participants. Increasing educational status (AOR: 6.5, 95% CI: 2-21.4), availability of television (AOR: 3.8, 95% CI: 1.4-10.5), having a telephone (AOR: 3.4, 95% CI: 1.3-9.1) and radio (AOR: 4.2, 95% CI: 1.1-15.5) are the factors associated with sufficient knowledge, while sufficient knowledge (AOR: 5.4, 95% CI: 1.7-17.2), is the only predictor identified for favorable attitude. Similarly, being a farmer (AOR: 0.14, 95% CI: 0.047- 0.4), availability of telephone (AOR: 3.1, 95% CI: 1.2- 8.2), and sufficient knowledge (AOR: 15.2, 95% CI: 1.9- 118) are the predictors of adequate practice.
   Conclusion: In the study area, the participant's knowledge and attitude are found to be sufficient to halt coronavirus transmission. However, practice in the vast majority is not adequate to stop coronavirus transmission. Educational status, television, telephone, radio, occupation and knowledge are the significant factors for successful prevention and control of coronavirus. Despite escalating public knowledge, our finding suggests the government to follow some compulsory regulations for uniform implementation of preventive measures.
C1 [Alennu, Tefera] Amhara Publ Hlth Inst, Publ Hlth Emergency Management Directorate, Bahir Dar, Ethiopia.
   [Annare, Semagn; Legesse, Seid; Abera, Abtew; Ayalew, Misganaw; Bezabih, Belay] Amhara Publ Hlth Inst, Dessie Branch, Dessie, Ethiopia.
   [Ayalew, Misganaw] ICAP Ethiopia, Bahir Dar Reg Off, Bahir Dar, Ethiopia.
   [Bezabih, Belay] World Hlth Org WHO, Addis Ababa, Ethiopia.
RP Alennu, T (corresponding author), Amhara Publ Hlth Inst, POB 47764, Bahir Dar, Ethiopia.
EM teferaalemu2@gmail.com
OI Ayalew, Misganaw/0000-0003-0499-9053
FU World Health OrganizationWorld Health Organization [001] Funding Source:
   Medline
CR Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Alobuia WM, 2020, J PUBLIC HEALTH-UK, V42, P470, DOI 10.1093/pubmed/fdaa069
   Asmelash D, 2020, RISK MANAG HEALTHC P, V13, P2239, DOI 10.2147/RMHP.S277846
   Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Austrian K, 2020, COVID 19 RELATED KNO, P1
   Bekele D, 2020, BIORXIV, V06, P127381, DOI [10.1101/2020.06.01.12738115, DOI 10.1101/2020.06.01.12738115]
   Defar A, 2020, KNOWLEDGE PRACTICE A
   Degu A, 2020, KNOWLEDGE PRACTICE P, P1, DOI [10.21203/rs.3.rs-50212/v1, DOI 10.21203/RS.3.RS-50212/V1]
   Ethiopian Ministry Of Health, ETH CONF 1 CAS COVID
   Fantaye T, 2020, GLOB SCI J
   Feyissa D, 2020, COMMUNITYS KNOWLEDGE
   Haftom M, 2020, INFECT DRUG RESIST, V13, P3727, DOI 10.2147/IDR.S275744
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744
   Kevin C, 2020, KNOWLEDGE ATTITUDE P, DOI [10.21203/rs.3.rs-40966/v119, DOI 10.21203/RS.3.RS-40966/V119]
   Narayana Goruntla, 2020, Curr Med Res Pract, V10, P153, DOI 10.1016/j.cmrp.2020.07.013
   Ssebuufu R, 2020, AWARENESS KNOWLEDGE, DOI [10.1101/2020.05.05.2009224718, DOI 10.1101/2020.05.05.2009224718]
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
NR 18
TC 3
Z9 3
U1 1
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 439
EP 451
DI 10.2147/RMHP.S287600
PG 13
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA QE2XS
UT WOS:000616074900001
PM 33574719
OA Green Published
DA 2022-04-20
ER

PT J
AU Mansour, AH
   Al Shibi, AN
   Khalifeh, AH
   Mansour, LHA
AF Hamdan Mansour, Ayman
   Al Shibi, Ahmad N.
   Khalifeh, Anas H.
   Hamdan Mansour, Laith A.
TI Health-care workers' knowledge and management skills of psychosocial and
   mental health needs and priorities of individuals with COVID-19
SO MENTAL HEALTH AND SOCIAL INCLUSION
LA English
DT Article
DE COVID-19; Mental health; Psychosocial care; Health-care providers;
   Mental health priorities; Mental health needs
AB Purpose The purpose of this study is to identify the knowledge and management skills of health-care workers regarding psychosocial and mental health priorities and needs of individuals with COVID-19. Design/methodology/approach This is a cross-sectional descriptive study. The data collected conveniently from 101 health-care workers in Jordan directly managing care of individuals with COVID-19. Findings Health-care workers have moderate-to-high level of knowledge and management skills of psychological distress related to COVID-19; means ranged from 50%-70% agreement and confidence. In general, health-care workers were able to identify mental and psychosocial health needs and priorities at a moderate level. Health-care workers knowledge had a positive and significant correlation with age (r =0.24,p= 0.012) and years of experience (r =0.28,p= 0.004), and a significant difference was found in their management between those who are trained on psychological first aids and those who are not (t= -3.11,p= 0.003). Practical implications There is a need to train health-care workers to integrate psychosocial and mental health care to manage care psychological distress related to COVID-19. Originality/value This study is emphasizing the need for mental health psychosocial support training and in integration. Health-care workers providing care to individuals with COVID-19 are not aware of mental health priorities and needs of their patients. This paper contributes to the body of knowledge adding more understanding about competencies of health-care workers providing care and their preparedness to manage care individuals with COVID-19.
C1 [Hamdan Mansour, Ayman] Al Ahliyya Amman Univ, Fac Nursing, Amman, Jordan.
   [Hamdan Mansour, Ayman; Khalifeh, Anas H.] Univ Jordan, Sch Nursing, Amman, Jordan.
   [Al Shibi, Ahmad N.] United Nations High Commissioner Refugees, Amman, Jordan.
   [Khalifeh, Anas H.] Prince Hamzah Hosp, Minist Hlth, Amman, Jordan.
   [Hamdan Mansour, Laith A.] Univ Jordan, Sch Med, Amman, Jordan.
RP Mansour, AH (corresponding author), Al Ahliyya Amman Univ, Fac Nursing, Amman, Jordan.; Mansour, AH (corresponding author), Univ Jordan, Sch Nursing, Amman, Jordan.
EM a.mansour@ju.edu.jo; a_alshibi@hotmail.com; anaskhalifeh@yahoo.com;
   laithayman34523@gmail.com
RI Khalifeh, Anas Husam/M-5757-2016; Hamdan-Mansour, Ayman M/C-1257-2015
OI Khalifeh, Anas Husam/0000-0002-5649-5124; Hamdan-Mansour, Ayman
   M/0000-0002-9855-951X; Hamdan Mansour, Laith/0000-0001-7826-0329
CR Al Shibi A., 2020, OPEN NURSING J, V14, DOI [10.2174/187443460201401, DOI 10.2174/187443460201401]
   Beaujouan J., 2020, SYRIAN CRISIS SYRIAN
   Calado F, 2017, J GAMBL STUD, V33, P397, DOI 10.1007/s10899-016-9627-5
   Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0
   Fawaz M.A., 2018, INT J AFR NURS SCI, V9, P105, DOI [10.1016/j.ijans.2018.10.005, DOI 10.1016/J.IJANS.2018.10.005]
   Fawaz MA., 2016, OPEN J NURS, V6, P853, DOI [10.4236/ojn.2016.610084, DOI 10.4236/OJN.2016.610084]
   Inter-Agency Standing Committee (IASC), 2007, 2020 GUID MENT HLTH
   International Council of Nurses (ICN), 2013, PALL CAR DIGN DYING
   Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032
   Liebrenz Michael, 2020, Forensic Sci Int Mind Law, V1, P100013, DOI 10.1016/j.fsiml.2020.100013
   Ratrout HF, 2020, INT J NURS PRACT, V26, DOI 10.1111/ijn.12767
   Sivakumar S, 2011, EMERG MED AUSTRALAS, V23, P697, DOI 10.1111/j.1742-6723.2011.01472.x
   World Health Organization, 2020, WHO 2019 NCOV MENT 2
   World Health Organization (WHO), 2019, PSYCH 1 AID GUID FIE
NR 14
TC 5
Z9 5
U1 3
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2042-8316
EI 2042-8308
J9 MENT HEALTH SOC INCL
JI Ment. Health Soc. Incl.
PD AUG 6
PY 2020
VL 24
IS 3
BP 135
EP 144
DI 10.1108/MHSI-04-2020-0022
EA JUN 2020
PG 10
WC Social Work
WE Emerging Sources Citation Index (ESCI)
SC Social Work
GA PB3NF
UT WOS:000546047100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Surmelioglu, N
   Yalcin, N
   Kuscu, F
   Candevir, A
   Inal, AS
   Komur, S
   Kurtaran, B
   Demirkan, K
   Tasova, Y
AF Surmelioglu, Nursel
   Yalcin, Nadir
   Kuscu, Ferit
   Candevir, Aslihan
   Inal, Ayse Seza
   Komur, Suheyla
   Kurtaran, Behice
   Demirkan, Kutay
   Tasova, Yesim
TI Physicians' knowledge of potential covid-19 drug-drug interactions: An
   online survey in turkey
SO POSTGRADUATE MEDICINE
LA English
DT Article
DE COVID-19; drug-drug interactions; physicians; approach; awareness
ID PRESCRIBERS
AB Objectives Given the many medications used to treat novel coronavirus disease (COVID-19) and its comorbidities and complications, the risk of drug-drug interactions (DDIs) and resulting patient harm is concerning. This study aimed to shed light on physicians' knowledge of potential DDIs related to COVID-19 treatment, to determine the effect of an information brief about these DDIs on their correct response rates, and to identify factors associated with higher levels of knowledge about these DDIs. Methods The knowledge of physicians regarding the clinical significance and intervention of 7 common potential DDIs during COVID-19 treatment was evaluated via an online survey. Using a pretest-posttest design, the physicians completed a multiple-choice questionnaire first using their existing knowledge, then received an information brief about the DDIs and completed the same questionnaire again. Pretest and posttest scores were evaluated and factors affecting correct response rates were determined using correlation, regression, and post-hoc analyzes. Results A total of 244 physicians participated in the survey, 147 (60.2%) of whom were involved in the treatment of COVID-19 patients. After the information brief, there were significant increases in the number of correct responses for both clinical significance and interventions (p< 0.0001). In comparisons of pretest knowledge, physicians involved in the treatment of COVID-19 patients showed significantly higher correct response rate for interventions compared to physicians who had not treated COVID-19 patients (p= 0.003). Post-hoc analysis to compare pretest correct intervention responses among all medical specialties revealed significant differences between infectious diseases and family practice (mean difference: 1.059;p= 0.005) and between internal medicine and family practice (mean difference: 1.771;p< 0.0001). Conclusion Physicians involved in the treatment of COVID-19 patients had more knowledge regarding clinical significance and appropriate management of potential DDIs than those not involved. Therefore, it may be beneficial to organize trainings and issue guidelines about potential DDIs for physicians during the COVID-19 pandemic.
C1 [Surmelioglu, Nursel] Cukurova Univ, Dept Clin Pharm, Fac Pharm, Adana, Turkey.
   [Yalcin, Nadir; Demirkan, Kutay] Hacettepe Univ, Dept Clin Pharm, Fac Pharm, TR-06230 Ankara, Turkey.
   [Kuscu, Ferit; Candevir, Aslihan; Inal, Ayse Seza; Komur, Suheyla; Kurtaran, Behice; Tasova, Yesim] Cukurova Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Adana, Turkey.
RP Yalcin, N (corresponding author), Hacettepe Univ, Dept Clin Pharm, Fac Pharm, TR-06230 Ankara, Turkey.
EM nadir.yalcin@hotmail.com
RI Inal, Ayse Seza/B-7367-2016; Candevir, Aslihan/A-8016-2015; Yalcin,
   Nadir/AAJ-9513-2020
OI Inal, Ayse Seza/0000-0002-1182-7164; Candevir,
   Aslihan/0000-0001-9340-516X; Demirkan, Kutay/0000-0002-6427-5826; komur,
   suheyla/0000-0003-2414-559X; Yalcin, Nadir/0000-0002-2280-8727
CR Al-Quteimat OM, 2021, RES SOC ADMIN PHARM, V17, P480, DOI 10.1016/j.sapharm.2020.03.018
   Back D, 2021, BRIT J CLIN PHARMACO, V87, P212, DOI 10.1111/bcp.14358
   Bartiromo M, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13286
   Ko Y, 2008, DRUG SAFETY, V31, P525, DOI 10.2165/00002018-200831060-00007
   Ko Y, 2008, RES SOC ADMIN PHARM, V4, P355, DOI 10.1016/j.sapharm.2007.10.004
   Kretchy IA, 2021, RES SOC ADMIN PHARM, V17, P2023, DOI 10.1016/j.sapharm.2020.04.007
   Li HB, 2021, RES SOC ADMIN PHARM, V17, P1813, DOI 10.1016/j.sapharm.2020.04.003
   Liu S, 2020, INT J CLIN PHARM-NET, V42, P299, DOI 10.1007/s11096-020-01017-0
   Lverpool Drug Interactions Group, INT COVID 19 THER
   Malone DC, 2013, J MANAGE CARE PHARM, V19, P549, DOI 10.18553/jmcp.2013.19.7.549
   Nabovati E, 2017, INT J CLIN PHARM-NET, V39, P560, DOI 10.1007/s11096-017-0453-3
   Pirnejad H, 2019, INT J MED INFORM, V127, P18, DOI 10.1016/j.ijmedinf.2019.04.006
   Rismanbaf A, 2020, ARCH ACAD EMERG MED, V8
   Roden DM, 2020, CIRCULATION, V141, pE906, DOI 10.1161/CIRCULATIONAHA.120.047521
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Sarayani A, 2021, RES SOC ADMIN PHARM, V17, P483, DOI 10.1016/j.sapharm.2020.04.016
   Scavone C, 2020, BRIT J PHARMACOL, V177, P4813, DOI 10.1111/bph.15072
   Song ZW, 2021, RES SOC ADMIN PHARM, V17, P2027, DOI 10.1016/j.sapharm.2020.03.027
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   World Health Organization, 119 WHO
   Ying W, 2021, RES SOC ADMIN PHARM, V17, P1978, DOI 10.1016/j.sapharm.2020.04.001
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 22
TC 2
Z9 2
U1 2
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0032-5481
EI 1941-9260
J9 POSTGRAD MED
JI Postgrad. Med.
PD FEB 17
PY 2021
VL 133
IS 2
BP 237
EP 241
DI 10.1080/00325481.2020.1807809
EA AUG 2020
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA QS5WJ
UT WOS:000562603400001
PM 32780961
OA Bronze
DA 2022-04-20
ER

PT J
AU Aldhuwayhi, S
   Mallineni, SK
   Sakhamuri, S
   Thakare, AA
   Mallineni, S
   Sajja, R
   Sethi, M
   Nettam, V
   Mohammad, AM
AF Aldhuwayhi, Sami
   Mallineni, Sreekanth Kumar
   Sakhamuri, Srinivasulu
   Thakare, Amar Ashok
   Mallineni, Sahana
   Sajja, Rishitha
   Sethi, Mallika
   Nettam, Venkatesh
   Mohammad, Azher Mohiuddin
TI Covid-19 Knowledge and Perceptions Among Dental Specialists: A
   Cross-Sectional Online Questionnaire Survey
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; dentists; infection; questionnaire; dentistry
ID ATTITUDES; RESIDENTS; STUDENTS
AB Background: The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. Aim: To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Settings and Design: Cross-sectional online survey. Materials and Methods: This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source of information-1; Knowledge-10 and Perceptions-8]. The comparison of mean scores of knowledge and perceptions were interpreted based on the occupation of dental specialists. Statistical Analysis Used: The association between demographic variables and dental specialists' knowledge and perception scores was carried out using SPSS (Version IBM 21.0, NY, USA). Results: A total of 429 dentists from various specialties participated in the present study. The study had obtained a overall good knowledge score (92.7%) with a mean value of 8.86 + 0.22, and a perception score (70.7%) with a mean value of 5.4+0.3. The present study reports a statistically significant difference between age (p=0.03) and knowledge source (p<0.05). The multi variate regression analysis showed that dentists' specialty had no significant effect on knowledge and perception. Conclusion: The study reports sufficient knowledge and perception scores. Oral maxillofacial surgeons showed higher knowledge scores, while prosthodontics and periodontics achieved good mean scores for perception on COVID-19. Social media and health authorities played an equally important role in the overall knowledge of the source of information related to COVID-19.
C1 [Aldhuwayhi, Sami; Thakare, Amar Ashok] Majmaah Univ, Dept Prosthodont, Coll Dent, Al Majmaah 11952, Saudi Arabia.
   [Mallineni, Sreekanth Kumar] Majmaah Univ, Dept Prevent Dent Sci, Coll Dent, Al Majmaah 11952, Saudi Arabia.
   [Mallineni, Sreekanth Kumar] Narayana Dent Coll & Hosp, Dept Pediat & Prevent Dent, Nellore, Andhra Pradesh, India.
   [Mallineni, Sreekanth Kumar] Saveetha Inst Med & Tech Sci, Dept Pediat & Prevent Dent, Saveetha Dent Coll & Hosp, Chennai, Tamil Nadu, India.
   [Sakhamuri, Srinivasulu] Narayana Dent Coll & Hosp, Dept Conservat Dent & Endodont, Nellore, Andhra Pradesh, India.
   [Mallineni, Sahana] Krishna Inst Med Sci, Dept Periodontol, Nellore, AP, India.
   [Sajja, Rishitha] Bristol Myers Squibb, New Brunswick, NJ USA.
   [Sethi, Mallika] ITS Dent Coll, Dept Periodontol, Ghaziabad, Uttar Pradesh, India.
   [Nettam, Venkatesh] Narayana Dent Coll & Hosp, Dept Orthodont, Nellore, Andhra Pradesh, India.
   [Mohammad, Azher Mohiuddin] Mil Hosp, Oral Maxillofacial Surg, Riyadh, Saudi Arabia.
RP Mallineni, SK (corresponding author), Majmaah Univ, Pediat Dent, Dept Prevent Dent Sci, Coll Dent, Al Majmaah 11952, Saudi Arabia.
EM s.mallineni@mu.edu.sa
RI Mallineni, Sreekanth Kumar/G-9689-2012; Sakhamauri,
   Sreenivasulu/AAY-2351-2021; mallineni, Sreekanth Kumar/AAO-7342-2020
OI Mallineni, Sreekanth Kumar/0000-0002-9432-2590; Sakhamauri,
   Sreenivasulu/0000-0001-8615-3312; mallineni, Sreekanth
   Kumar/0000-0002-9432-2590; sajja, Rishitha/0000-0003-1501-5726
FU Deanship of Scientific Research at Majmaah University [R-2021-144]
FX The authors would like to thank the Deanship of Scientific Research at
   Majmaah University for supporting this work (R-2021-144).
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Al Jasser R, 2020, J MULTIDISCIP HEALTH, V13, P1317, DOI [10.2147/JMDH.S267956, 10.2147/JMADH.S267956]
   Alennu T, 2021, RISK MANAG HEALTHC P, V14, P439, DOI 10.2147/RMHP.S287600
   Ammar N, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02308-w
   Arora S, 2020, J MULTIDISCIP HEALTH, V13, P841, DOI 10.2147/JMDH.S268891
   Bakaeen LG, 2021, J AM DENT ASSOC, V152, P16, DOI 10.1016/j.adaj.2020.09.022
   Bennardo F, 2020, OPEN DENT J, V14, P623, DOI 10.2174/1874210602014010623
   Bennardo F, 2020, EUR J DENT EDUC, V24, P822, DOI 10.1111/eje.12555
   Bhumireddy J, 2021, ENVIRON SCI POLLUT R, V28, P1275, DOI 10.1007/s11356-020-10983-x
   Bordea IR, 2021, RISK MANAG HEALTHC P, V14, P453, DOI 10.2147/RMHP.S284557
   Cagetti MG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113835
   Chughtai AA, 2020, INT J NURS STUD, V105, DOI 10.1016/j.ijnurstu.2020.103567
   Duruk G, 2020, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0054
   Islam MS, 2020, INFECT CONT HOSP EP, V41, P1196, DOI 10.1017/ice.2020.237
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Kinariwala N, 2021, ORAL DIS, V27, P730, DOI 10.1111/odi.13459
   Kochlamazashvili M, 2018, J INFECT DEV COUNTR, V12, P864, DOI 10.3855/jidc.9911
   Lai XQ, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00746-1
   Mallineni SK, 2021, CHILD YOUTH SERV REV, V120, DOI 10.1016/j.childyouth.2020.105734
   Mallineni SK, 2020, INT J PAEDIATR DENT, V30, P245, DOI 10.1111/ipd.12653
   Martina S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124384
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Namineni Srinivas, 2020, J Dent Anesth Pain Med, V20, P261, DOI 10.17245/jdapm.2020.20.4.261
   Pereira LJ, 2020, BRAZ ORAL RES, V34, DOI [10.1590/1807-3107bor-2020.vol34.0041, 10.1590/1807.3107bor-2020.vol34.0041]
   Putrino A, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01187-3
   Rabbani U, 2021, J EPIDEMIOL GLOB HEA, V11, P60, DOI 10.2991/jegh.k.200819.002
   Sarfaraz S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030232
   Sezgin GP, 2021, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0112
   Singh Gambhir Ramandeep, 2020, Rocz Panstw Zakl Hig, V71, P223, DOI 10.32394/rpzh.2020.0115
   Song Y, 2015, J KOREAN ACAD NURS, V45, P323, DOI 10.4040/jkan.2015.45.3.323
   Srivastava KC, 2020, J INT MED RES, V48, DOI 10.1177/0300060520977593
   Tucho GT, 2021, RISK MANAG HEALTHC P, V14, P511, DOI 10.2147/RMHP.S298687
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Verbeek JH, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011621.pub5, 10.1002/14651858.CD011621.pub4]
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 36
TC 6
Z9 7
U1 5
U2 5
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 2851
EP 2861
DI 10.2147/RMHP.S306880
PG 11
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA TF4EI
UT WOS:000670668300001
PM 34262372
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Badawood, A
   AlBadri, H
AF Badawood, Ashraf
   AlBadri, Hamad
TI Information Technology Knowledge Management taxonomy to enhance
   government electronic services in existence of COVID 19 outbreak
SO INTERNATIONAL JOURNAL OF COMPUTER SCIENCE AND NETWORK SECURITY
LA English
DT Article
DE Information Technology; Knowledge Management; Government E-services;
   Performance Expectancy; Effort Expectancy
AB Information technology and the need for timely and effective communication during the Covid-19 have made most governments adopt technological approaches to provide their services. E-government services have been adopted by most governments especially in developed countries to quickly and effectively share information. This study discusses the reasons why governments in the Gulf region should develop a new model for information technology knowledge management practices. To achieve this, the author identified possible benefits of adopting information technology knowledge management practices and why most governments in the Gulf find it hard to adopt them. Knowledge management allows for learning, transfer as well as sharing of information between government organizations and citizens and with the development of technology, the effectiveness of electronic services can easily be achieved. Also, effective adoption of information technology can improve knowledge management with the help of techniques that enhance capture, storage, retrieval as well as sharing of information. The author used systematic literature review to select 28 journals and articles published post 2019. IEEE, Google Scholar and Science Direct were used to select potential studies from which 722 journals and articles were selected. Through screening and eligibility assessment, 21 articles were retained while the back and forward search had 7 more articles which were also included in the study. Using information gathered from these articles and journals a new conceptual model was developed to help improve information technology knowledge management for governments in the Gulf region to effectively deliver e-services during Covid-19. This model was developed based on the process of KM, Theory of Planned Behavior and Unified Theory of Acceptance and Use of Technology. Based on the developed model. From UTAUT model, performance expectancy, effort expectancy as well as social influence had a great impact.
C1 [Badawood, Ashraf; AlBadri, Hamad] Univ Jeddah, Coll Business, MIS, Jeddah, Saudi Arabia.
RP Badawood, A (corresponding author), Univ Jeddah, Coll Business, MIS, Jeddah, Saudi Arabia.
CR Abdulrahim H., 2020, ASIAN J DIS ED, V15, P291
   Abusweilem M., 2019, MANAGEMENT SCI LETT, V9, P2143
   Al Ahbabi SA, 2019, J KNOWL MANAG, V23, P351, DOI 10.1108/JKM-08-2017-0348
   Al Yami M, 2019, VINE J INF KNOWL MAN, V49, P568, DOI 10.1108/VJIKMS-05-2019-0068
   AlBadri H., 2020, INDIAN J SCI TECHNOL, V13, P1486, DOI DOI 10.17485/IJST/v13i14.119
   Alhuwail D, 2019, J MED INTERNET RES, V21, DOI 10.2196/11174
   Alkhowaiter WA, 2020, INT J INFORM MANAGE, V53, DOI 10.1016/j.ijinfomgt.2020.102102
   Alshahrani A, 2019, INT J MED INFORM, V128, P7, DOI 10.1016/j.ijmedinf.2019.05.007
   Alvarenga A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145824
   Areed S., 2021, RECENT ADV INTELLIGE, P143
   Badawood A., 2021, CONCEPTUAL MODEL ORG
   Butt AS, 2019, J KNOWL MANAG, V23, P1605, DOI 10.1108/JKM-04-2019-0204
   Chen Q, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106380
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   Elavarasan RM, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138858
   Elnaghi M, 2019, GOV INFORM Q, V36, P196, DOI 10.1016/j.giq.2018.11.011
   Hock-Doepgen M, 2021, J BUS RES, V130, P683, DOI 10.1016/j.jbusres.2019.12.001
   Israilidis J, 2021, INT J INFORM MANAGE, V56, DOI 10.1016/j.ijinfomgt.2019.07.015
   Mc Evoy PJ, 2019, KNOWL MAN RES PRACT, V17, P39, DOI 10.1080/14778238.2018.1538670
   Mittal S., 2019, INT J KNOWLEDGE MANA, V10, P322, DOI DOI 10.1504/11KMS.2019.101491
   Ncoyini S. S., 2020, SA J HUMAN RESOURCE, V18, P1
   Oktari RS, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101881
   Rashid M. S., 2020, EUROPEAN J MULTIDISC, V5, P47
   Raudeliuniene J, 2021, J KNOWL MANAG, V25, P871, DOI 10.1108/JKM-03-2020-0168
   Santoro G, 2021, IEEE T ENG MANAGE, V68, P378, DOI 10.1109/TEM.2019.2907874
   Sfeir, 2019, INT J APPL MANAGEMEN, V1, P16
   Tong S., 2019, HUMANITIES SOCIAL SC, V7, P1
   Weir D, 2019, CONTRIB MANAG SCI, P323, DOI 10.1007/978-3-030-11766-5_12
   Xiao Y, 2019, J PLAN EDUC RES, V39, P93, DOI 10.1177/0739456X17723971
   Yunus N. K. Y., 2019, EUROPEAN J INTERDISC, V5, P64
   Zaim H, 2019, KNOWL MAN RES PRACT, V17, P24, DOI 10.1080/14778238.2018.1538669
NR 31
TC 0
Z9 0
U1 10
U2 10
PU INT JOURNAL COMPUTER SCIENCE & NETWORK SECURITY-IJCSNS
PI SEOUL
PA DAE-SANG OFFICE 301, SANGDO 5 DONG 509-1, SEOUL, 00000, SOUTH KOREA
SN 1738-7906
J9 INT J COMPUT SCI NET
JI Int. J. Comput. Sci. Netw. Secur.
PD AUG 30
PY 2021
VL 21
IS 8
BP 353
EP 359
DI 10.22937/IJCSNS.2021.21.8.44
PG 7
WC Computer Science, Information Systems
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA UR8XP
UT WOS:000697025200044
DA 2022-04-20
ER

PT J
AU Chandran, NS
   Lee, JH
   Kurokawa, I
AF Chandran, Nisha Suyien
   Lee, Ji Hae
   Kurokawa, Ichiro
TI Anti-COVID-19 measurements for hidradenitis suppurativa patients
SO EXPERIMENTAL DERMATOLOGY
LA English
DT Article
DE COVID-19; hidradenitis suppurativa; SARS-CoV2; vaccine
ID COVID-19; COMORBIDITIES; SARS-COV-2; ADALIMUMAB
AB The reported incidence of COVID-19 among cohorts of patients with inflammatory bowel and skin diseases under treatment with biologicals is low. Treatment may further modify disease severity as some biological modifiers, such as anakinra, are also proposed for the management of COVID-19 patients potentially providing HS patients with an advantage.
   The above preliminary evidence suggests that hidradenitis suppurativa (HS) does probably not provide an increased susceptibility for COVID-19 and that any susceptibility is unlikely to be modified negatively by treatment with biologicals.
   On the occasion of its 10th International Conference, experts of the European Hidradenitis Suppurativa Foundation e.V. have prepared a consensus statement regarding anti-COVID-19 measurements for HS patients. Based on the available knowledge, patients with HS may be vaccinated against SARS-CoV2 and patients affected by metabolic syndrome constitute a high-risk group for COVID-19 and should be vaccinated at the earliest convenient point in time. HS patients on treatment with adalimumab can be vaccinated with non-living virus anti-SARS-CoV2 vaccines. A possible suboptimal effect of the vaccine may be suspected but might not be expected universally. The management of the biological treatment in HS patients is at the discretion of the dermatologist / responsible physician.
C1 [Chandran, Nisha Suyien] Natl Univ Singapore Hosp, Div Dermatol, Dept Med, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.
   [Chandran, Nisha Suyien] NUS Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
   [Lee, Ji Hae] Catholic Univ Korea, Coll Med, Dept Dermatol, St Vincents Hosp, Suwon, South Korea.
   [Kurokawa, Ichiro] Meiwa Hosp, Dept Dermatol, Nishinomiya, Hyogo, Japan.
   [Kurokawa, Ichiro] European Hidradenitis Suppurativa Fdn eV, Dessau, Germany.
RP Chandran, NS (corresponding author), Natl Univ Singapore Hosp, Div Dermatol, Dept Med, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.
EM nisha_suyien_chandran@nuhs.edu.sg
CR Benucci M, 2021, CLIN EXP RHEUMATOL, V39, P196
   Bossa F, 2021, DIGEST LIVER DIS, V53, P277, DOI 10.1016/j.dld.2020.12.120
   Creech CB, 2021, JAMA-J AM MED ASSOC, V325, P1318, DOI 10.1001/jama.2021.3199
   Dotan A, 2021, AUTOIMMUN REV, V20, DOI 10.1016/j.autrev.2021.102792
   Fimmel S, 2010, DERM-ENDOCRINOL, V2, P9, DOI 10.4161/derm.2.1.12490
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Gisondi P, 2021, J ALLERGY CLIN IMMUN, V147, P558, DOI 10.1016/j.jaci.2020.10.032
   Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8
   Jeyanathan M, 2020, NAT REV IMMUNOL, V20, P615, DOI 10.1038/s41577-020-00434-6
   Kanni T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130522
   Karagiannidis L, 2016, DERMATOL CLIN, V34, P45, DOI 10.1016/j.det.2015.08.005
   Koutsakos M, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100208
   Kurzen H, 2008, EXP DERMATOL, V17, P455, DOI [10.1111/j.1600-0625.2008.00712_1.x, 10.1111/j.1600-0625.2008.00712.x]
   Lakota K, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.611318
   Lima XT, 2021, BRIT J DERMATOL, V184, P182, DOI 10.1111/bjd.19492
   Marzano AV, 2020, EUR J DERMATOL, V30, P748, DOI 10.1684/ejd.2020.3927
   Molinelli E, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14256
   Naik HB, 2020, BRIT J DERMATOL, V183, P780, DOI 10.1111/bjd.19345
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Poly TN, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.620044
   Siegrist C-A, 2020, VACCINE IMMUNOLOGY
   Strangfeld A, 2021, ANN RHEUM DIS, V80, P930, DOI 10.1136/annrheumdis-2020-219498
   Tricarico PM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00892
   Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421
   Tzellos T, 2020, DERMATOLOGY THER, V10, P63, DOI 10.1007/s13555-020-00354-2
   Welzel T, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040605
   Zouboulis CC, 2021, J EUR ACAD DERMATOL, V35, pE541, DOI 10.1111/jdv.17325
   Zouboulis CC, 2020, EXP DERMATOL, V29, P1154, DOI 10.1111/exd.14214
   Zouboulis CC, 2016, EXPERT REV CLIN IMMU, V12, P1015, DOI 10.1080/1744666X.2016.1221762
   Zouboulis CC, 2015, DERMATOLOGY, V231, P184, DOI 10.1159/000431175
NR 30
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0906-6705
EI 1600-0625
J9 EXP DERMATOL
JI Exp. Dermatol.
PD JUN
PY 2021
VL 30
SU 1
SI SI
BP 23
EP 26
DI 10.1111/exd.14340
PG 4
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA SM5ID
UT WOS:000657638100004
PM 34085331
OA Bronze
DA 2022-04-20
ER

PT J
AU Misra, SS
   Ahirwar, AK
   Sakarde, A
   Kaim, K
   Ahirwar, P
   Jahid, M
   Sorte, SR
   Lokhande, SL
   Kaur, AP
   Kumawat, R
AF Misra, Swayam Swaroop
   Ahirwar, Ashok Kumar
   Sakarde, Apurva
   Kaim, Kirti
   Ahirwar, Pradeep
   Jahid, Mohd
   Sorte, Smita R.
   Lokhande, Suryabhan Lahanu
   Kaur, Amar Preet
   Kumawat, Rajani
TI COVID-19 infection in pregnancy: a review of existing knowledge
SO HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION
LA English
DT Review; Early Access
DE complications; COVID-19; delivery; fetus; pregnancy; SARS-CoV-2
ID MANAGEMENT; 2019-NCOV
AB The world has been coping up with the grave pandemic of COVID-19 since its inception into the human race in December, 2019. By entering the host through the spike (S) glycoprotein, it paves way for its own survival and multiplication. Respiratory tract being the point of entry causes pulmonary compromise and leads to development of ARDS. Having non-specific clinical features that resemble flu makes the clinical diagnosis much more difficult. Pregnancy being an immunocompromised and a hypercoagulable state is prone to be a high-risk group for COVID-19. This study is an attempt to understand the maternal and fetal outcomes in COVID-19 and the vertical transmissibility of the virus. Evidence suggests that the contribution of COVID-19 is not very significant in maternal morbidity and mortality. However, due to some factors such as the immunological response in the mother, certain complications may arise in the neonate in the post-natal period. No vertical transmission of the virus has been reported yet. However, the management remains crucial as two lives are at stake. Some of the precautionary measures that can be implemented to prevent COVID-19 can be segregation of medical services from that of the general population in settings of outpatient care, inpatient care and labor room care. Also, triaging the patients into low risk, moderate risk and high risk can aid in faster delivery of health-care facilities to the pregnant and the newborn.
C1 [Ahirwar, Ashok Kumar; Jahid, Mohd] Univ Coll Med Sci, Dept Biochem, New Delhi 110095, India.
   [Misra, Swayam Swaroop] All India Inst Med Sci, Nagpur, Maharashtra, India.
   [Sakarde, Apurva] All India Inst Med Sci, Dept Biochem, Nagpur, Maharashtra, India.
   [Kaim, Kirti] ESI Hosp, New Delhi, India.
   [Ahirwar, Pradeep] Index Med Coll Hosp & Res Ctr, Dept Radiodiag, Indore, Madhya Pradesh, India.
   [Sorte, Smita R.] All India Inst Med Sci, Dept Physiol, Nagpur, Maharashtra, India.
   [Lokhande, Suryabhan Lahanu] All India Inst Med Sci, Dept Biochem, Bhopal, Madhya Pradesh, India.
   [Kaur, Amar Preet] All India Inst Med Sci, Dept Biochem, Gorakhpur, Uttar Pradesh, India.
   [Kumawat, Rajani] All India Inst Med Sci, Dept Biochem, Bathinda, Punjab, India.
RP Ahirwar, AK (corresponding author), Univ Coll Med Sci, Dept Biochem, New Delhi 110095, India.
EM swayam.swaroop@hotmail.com; drashoklhmc@gmail.com; aforapurva@gmail.com;
   kirti.kaim@gmail.com; pradeepahirwar21@gmail.com;
   zahidkhan780@gmail.com; drsmyta@gmail.com; lokhandesuryabhan@gmail.com;
   amar_0044@yahoo.com; dr.rajanikumawat@gmail.com
OI Sakarde, Apurva/0000-0003-0645-1227
CR Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Chen DJ, 2020, INT J GYNECOL OBSTET, V149, P130, DOI 10.1002/ijgo.13146
   Chen L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009226
   Chen Y, 2020, BIOCHEM BIOPH RES CO, V525, P135, DOI 10.1016/j.bbrc.2020.02.071
   Alzamora MC, 2020, AM J PERINAT, V37, P861, DOI 10.1055/s-0040-1710050
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   Ferrazzi EM, 2020, INT J GYNECOL OBSTET, V149, P377, DOI 10.1002/ijgo.13162
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Karimi-Zarchi M, 2020, FETAL PEDIATR PATHOL, V39, P246, DOI 10.1080/15513815.2020.1747120
   Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5
   Liang H, 2020, ACTA OBSTET GYN SCAN, V99, P439, DOI 10.1111/aogs.13836
   Liu DH, 2020, AM J ROENTGENOL, V215, P127, DOI 10.2214/AJR.20.23072
   Luo YW, 2020, LANCET INFECT DIS, V20, P513, DOI 10.1016/S1473-3099(20)30191-2
   Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017
   Saccone G, 2020, EUR J OBSTET GYN R B, V249, P92, DOI 10.1016/j.ejogrb.2020.04.006
   Sahu KK, 2020, MONALDI ARCH CHEST D, V90, DOI 10.4081/monaldi.2020.1292
   Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0
   Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P799, DOI 10.5858/arpa.2020-0901-SA
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Yang H, 2020, J INFECTION, V81, pE40, DOI 10.1016/j.jinf.2020.04.003
   Yu N, 2020, LANCET INFECT DIS, V20, P559, DOI 10.1016/S1473-3099(20)30176-6
   Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang L, 2020, Zhonghua Fu Chan Ke Za Zhi, V55, P166, DOI 10.3760/cma.j.cn112141-20200218-00111
NR 26
TC 0
Z9 0
U1 1
U2 1
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1868-1883
EI 1868-1891
J9 HORM MOL BIOL CLIN I
JI Horm. Mol. Biol. Clin. Investig.
DI 10.1515/hmbci-2021-0081
EA FEB 2022
PG 6
WC Biochemistry & Molecular Biology
WE Emerging Sources Citation Index (ESCI)
SC Biochemistry & Molecular Biology
GA ZA7PC
UT WOS:000756350200001
PM 35172416
OA Bronze
DA 2022-04-20
ER

PT J
AU Menez, S
   Parikh, CR
AF Menez, Steven
   Parikh, Chirag R.
TI Overview of acute kidney manifestations and management of patients with
   COVID-19
SO AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
LA English
DT Review
DE acute kidney injury; chronic kidney disease; COVID-19; dialysis
ID INJURY; PATHOLOGY; DISEASE
AB Since the start of the COVID-19 pandemic, several manifestations of kidney involvement associated with infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus have been described, including proteinuria, hematuria, and acute kidney injury. A growing body of literature has explored the risk factors and pathogenesis of COVID-19-associated acute kidney injury (AKI), including direct and indirect mechanisms, as well as early postdischarge outcomes that may result from various manifestations of kidney involvement. In this review, we explore the current state of knowledge of the epidemiology of COVID-19-associated AKI, potential mechanisms and pathogenesis of AKI, and various management strategies for patients in the acute setting. We highlight how kidney replacement therapy for patients with COVID-19-associated AKI has been affected by the increasing demand for dialysis and how the postacute management of patients, including outpatient follow-up, is vitally important. We also review what is presently known about long-term kidney outcomes after the initial recovery from COVID-19. We provide some guidance as to the management of patients hospitalized with COVID-19 who are at risk for AKI as well as for future clinical research in the setting of COVID-19 and the significance of early identification of patients at highest risk for adverse kidney outcomes.
C1 [Menez, Steven; Parikh, Chirag R.] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA.
RP Parikh, CR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA.
EM chirag.parikh@jhmi.edu
OI Parikh, Chirag/0000-0001-9051-7385
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HL085757,
   1K23DK128538-01, DK082185]
FX This work was supported by National Institutes of Health Grants HL085757
   (to C.R.P.), 1K23DK128538-01 (to S.M.), and DK082185 (to C.R.P.).
CR Al-Aly Z, 2021, NATURE, V594, P259, DOI 10.1038/s41586-021-03553-9
   Atta MG, 2004, J ULTRAS MED, V23, P603, DOI 10.7863/jum.2004.23.5.603
   BHALLA V, IN PRESS, DOI DOI 10.1038/S41371-020-00459-3
   Bowe B, 2021, CLIN J AM SOC NEPHRO, V16, P14, DOI 10.2215/CJN.09610620
   Brown EA, 2020, J AM SOC NEPHROL, V31, P1928, DOI 10.1681/ASN.2020050729
   Caceres PS, 2021, J AM SOC NEPHROL, V32, P2517, DOI 10.1681/ASN.2021010059
   Centers for Disease Control and Prevention, 2021, CDC GUID J J COVID 1
   Cerda J, 2015, CLIN J AM SOC NEPHRO, V10, P1859, DOI 10.2215/CJN.01170215
   Chan LL, 2021, J AM SOC NEPHROL, V32, P151, DOI [10.1681/ASN.2020050615, 10.33982/clr.2021.11.30.151]
   Chandra P, 2013, CLIN KIDNEY J, V6, P1, DOI 10.1093/ckj/sft002
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Coronavirus Resource Center, 2021, J HOPK GLOB COR 2019
   D'Agati VD, 2021, KIDNEY INT, V100, P461, DOI 10.1016/j.kint.2021.04.035
   Delsante M, 2020, J AM SOC NEPHROL, V31, P2224, DOI 10.1681/ASN.2020050630
   Dennis A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-048391
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   El Shamy O, 2020, KIDNEY MED, V2, P377, DOI 10.1016/j.xkme.2020.04.001
   Endres P, 2021, J THROMB THROMBOLYS, V51, P966, DOI 10.1007/s11239-020-02301-6
   Fontana F, 2020, KIDNEY INT REP, V5, P1815, DOI 10.1016/j.ekir.2020.07.008
   Frithiof R, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03302-w
   Gupta S, 2021, J AM SOC NEPHROL, V32, P161, DOI 10.1681/ASN.2020060897
   Hasbal NB, 2020, KIDNEY INT, V98, P1619, DOI 10.1016/j.kint.2020.08.030
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Hsu CY, 2020, JAMA INTERN MED, V180, P402, DOI 10.1001/jamainternmed.2019.6390
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Husain-Syed F, 2020, NEPHROL DIAL TRANSPL, V35, P1271, DOI 10.1093/ndt/gfaa162
   Khan S, 2020, J AM SOC NEPHROL, V31, P2746, DOI 10.1681/ASN.2020081229
   Khoo BZE, 2021, BMC NEPHROL, V22, DOI 10.1186/s12882-021-02357-3
   Kissling S, 2020, KIDNEY INT, V98, P228, DOI 10.1016/j.kint.2020.04.006
   Laboux T, 2021, J NEPHROL, V34, P373, DOI 10.1007/s40620-020-00935-6
   Lebedev L, 2021, AM J KIDNEY DIS, V78, P142, DOI 10.1053/j.ajkd.2021.03.010
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Menez S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.147464
   Menez S, 2021, KIDNEY INT, V99, P716, DOI 10.1016/j.kint.2020.06.037
   Moledina DG, 2021, AM J KIDNEY DIS, V77, P490, DOI 10.1053/j.ajkd.2020.12.007
   Nadim MK, 2020, NAT REV NEPHROL, V16, P747, DOI 10.1038/s41581-020-00356-5
   Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z
   Nasr SH, 2021, AM J KIDNEY DIS, V77, P465, DOI 10.1053/j.ajkd.2020.11.002
   Nassiri AA, 2021, CARDIORENAL MED, V11, P1, DOI 10.1159/000513496
   Ng JH, 2020, ADV CHRONIC KIDNEY D, V27, P365, DOI 10.1053/j.ackd.2020.09.003
   Ng JH, 2021, AM J KIDNEY DIS, V77, P204, DOI 10.1053/j.ajkd.2020.09.002
   Ni WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03120-0
   Nugent J, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1095
   Parapiboon W, 2020, PERITON DIALYSIS INT, V40, P359, DOI 10.1177/0896860820931235
   Phillips T, 2021, NEPHROLOGY, V26, P420, DOI 10.1111/nep.13847
   Puthumana J, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI139927
   Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0
   Rossi GM, 2020, KIDNEY INT REP, V5, P1100, DOI 10.1016/j.ekir.2020.05.005
   Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744
   Sekar A, 2021, KIDNEY INT, V100, P473, DOI 10.1016/j.kint.2021.05.017
   Shaikh S, 2020, ADV CHRONIC KIDNEY D, V27, P377, DOI 10.1053/j.ackd.2020.08.002
   Shetty AA, 2021, J AM SOC NEPHROL, V32, P33, DOI 10.1681/ASN.2020060804
   Silver SA, 2021, KIDNEY MED, V3, P83, DOI 10.1016/j.xkme.2020.11.008
   South AM, 2019, CLIN SCI, V133, P55, DOI 10.1042/CS20171550
   Sparks MA, 2020, HYPERTENSION, V76, P1350, DOI 10.1161/HYPERTENSIONAHA.120.15948
   Stockmann H, 2021, KIDNEY INT, V99, P1021, DOI 10.1016/j.kint.2021.01.005
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Thakare S, 2021, KIDNEY INT REP, V6, P206, DOI 10.1016/j.ekir.2020.10.005
   Velez JCQ, 2020, NAT REV NEPHROL, V16, P565, DOI 10.1038/s41581-020-0332-3
   Wang FL, 2021, BLOOD PURIFICAT, V50, P499, DOI 10.1159/000512371
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu HJ, 2020, J AM SOC NEPHROL, V31, P1688, DOI 10.1681/ASN.2020050558
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 63
TC 1
Z9 1
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 1931-857X
EI 1522-1466
J9 AM J PHYSIOL-RENAL
JI Am. J. Physiol.-Renal Physiol.
PD OCT
PY 2021
VL 321
IS 4
BP F403
EP F410
DI 10.1152/ajprenal.00173.2021
PG 8
WC Physiology; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Urology & Nephrology
GA US3EE
UT WOS:000697315900001
PM 34448642
DA 2022-04-20
ER

PT J
AU Hansen, AS
   Beery, T
   Fredman, P
   Wolf-Watz, D
AF Hansen, Andreas Skriver
   Beery, Thomas
   Fredman, Peter
   Wolf-Watz, Daniel
TI Outdoor recreation in Sweden during and after the Covid-19 pandemic -
   management and policy implications
SO JOURNAL OF ENVIRONMENTAL PLANNING AND MANAGEMENT
LA English
DT Article; Early Access
DE Covid-19; Sweden; outdoor recreation; management; policy; implications
ID PUBLIC-ACCESS; TOURISM
AB This paper reports results from three studies concerning outdoor recreation participation and trends during the Covid-19 pandemic in Sweden. The studies, undertaken at national, regional and local levels, used surveys, interviews and PPGIS approaches, to build a solid knowledge base. Results are analyzed with particular attention given to management and policy implications based on the following observations: increased outdoor recreation participation, changes in lifestyle and routines, new visitor profiles and activity trends, spatial changes, visitor displacement, spatial redistribution, and indications of post-pandemic outdoor recreation behavior. The Swedish case is of special interest because of high accessibility to nature areas and few restrictions to recreate in nature due to the pandemic. Hence, this study could serve as a reference for other countries with more Covid-19 related restrictions and less accessible nature for recreation.
C1 [Hansen, Andreas Skriver] Univ Gothenburg, Dept Econ & Soc, Gothenburg, Sweden.
   [Beery, Thomas] Kristianstad Univ, Man & Biosphere Hlth Res Grp, Fac Teacher Training, Kristianstad, Sweden.
   [Fredman, Peter; Wolf-Watz, Daniel] Mid Sweden Univ, Dept Econ Geog Law & Tourism EJT, Ostersund, Sweden.
RP Hansen, AS (corresponding author), Univ Gothenburg, Dept Econ & Soc, Gothenburg, Sweden.
EM andreas.hansen@geography.gu.se
FU Mistra Sport & Outdoors, Mistra [DIA 2016/36]
FX The authors acknowledge funding received from Mistra Sport & Outdoors,
   Mistra grant number DIA 2016/36.
CR Beery T, 2021, J OUTDOOR REC TOUR, V36, DOI 10.1016/j.jort.2021.100457
   Beery TH, 2013, ENVIRON EDUC RES, V19, P94, DOI 10.1080/13504622.2012.688799
   Brown G, 2014, APPL GEOGR, V46, P122, DOI 10.1016/j.apgeog.2013.11.004
   Creswell JW, 2007, DESIGNING CONDUCTING
   Derks J, 2020, FOREST POLICY ECON, V118, DOI 10.1016/j.forpol.2020.102253
   Elmahdy Y.M., 2017, 42 MINA NORW U LIF S, P74
   Erkkonen J., 2007, VISITOR MONITORING N, P534
   Fredman P., 2021, RAPPORT
   Fredman P, 2012, FORESTS, V3, P1, DOI 10.3390/f3010001
   Galway LP, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152662
   Godtman-Kling K., 2022, THESIS MID SWEDEN U
   Grima N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243344
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   Hansen A. S., 2018, Tourism, health, wellbeing and protected areas, P125, DOI 10.1079/9781786391315.0125
   Hansen A.S., 2021, 20211 MISTR SPORT OU
   Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443
   Hedenborg S., 2022, ANN LEIS RES
   Honey-Roses J., 2020, CITIES HLTH, P1, DOI DOI 10.1080/23748834.2020.1780074
   Jackson SB, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052506
   Jacobs L.A., 2020, PARKS STEWARD FORUM, V36, P483, DOI [DOI 10.5070/P536349860, 10.5070/P536349860]
   Kane B, 2021, OCEAN COAST MANAGE, V205, DOI 10.1016/j.ocecoaman.2021.105533
   Larson LR, 2018, SOC NATUR RESOUR, V31, P871, DOI 10.1080/08941920.2018.1447714
   McGinlay J, 2020, FORESTS, V11, DOI 10.3390/f11111214
   Mortazavi R, 1997, ANN TOURISM RES, V24, P609, DOI 10.1016/S0160-7383(97)00010-8
   Oian H., 2018, TEMANORD, V534
   Onwuegbuzie AJ, 2012, QUAL REP, V17
   Otmani M, 2020, NORDIC LIFE SCI 0519
   Pigram J.J., 2006, OUTDOOR RECREATION M, V2nd ed, P440
   Pouso S, 2021, SCI TOTAL ENVIRON, V756, DOI 10.1016/j.scitotenv.2020.143984
   Rose S, 2020, OSTRICH, V91, P188, DOI 10.2989/00306525.2020.1783589
   Sandell K, 2010, SCAND J HOSP TOUR, V10, P291, DOI 10.1080/15022250.2010.502366
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Swedish Government Writ, 2012, MAL FRIL
   Uchiyama Y, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12239842
   van den Berg A.E., 2018, ENV PSYCHOL INTRO, V2nd, P47, DOI [10.1002/9781119241072.ch6, DOI 10.1002/9781119241072.CH6]
   van Leeuwen M, 2020, WORLD LEISURE J, V62, P339, DOI 10.1080/16078055.2020.1825255
   Venter ZS, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abb396
   Vitestam, 2021, EXAM WORK
NR 38
TC 0
Z9 0
U1 2
U2 2
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0964-0568
EI 1360-0559
J9 J ENVIRON PLANN MAN
JI J. Environ. Plan. Manag.
DI 10.1080/09640568.2022.2029736
EA JAN 2022
PG 22
WC Development Studies; Regional & Urban Planning
WE Social Science Citation Index (SSCI)
SC Development Studies; Public Administration
GA ZC7FN
UT WOS:000757681200001
OA hybrid
DA 2022-04-20
ER

PT J
AU Nahidi, S
   Sotomayor-Castillo, C
   Li, C
   Currey, J
   Elliott, R
   Shaban, RZ
AF Nahidi, Shizar
   Sotomayor-Castillo, Cristina
   Li, Cecilia
   Currey, Judy
   Elliott, Rosalind
   Shaban, Ramon Z.
TI Australian critical care nurses' knowledge, preparedness, and
   experiences of managing SARS-COV-2 and COVID-19 pandemic
SO AUSTRALIAN CRITICAL CARE
LA English
DT Article
DE Critical care; COVID-19; SARS-CoV-2; Nurse; Preparedness; Knowledge
   acquisition; Clinical experience
ID SARS
AB Background: Coronavirus disease 2019 (COVID-19) has again highlighted the crucial role of healthcare workers in case management, disease surveillance, policy development, and healthcare education and training. The ongoing pandemic demonstrates the importance of having an emergency response plan that accounts for the safety of frontline healthcare workers, including those working in critical care settings.
   Objectives: The aim of the study was to explore Australian critical care nurses' knowledge, preparedness, and experiences of managing patients diagnosed with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) and COVID-19.
   Methods: An exploratory cross-sectional study of Australian critical care nurses was conducted between June and September 2020. An anonymised online survey was sent to Australian College of Critical Care Nurses' members to collect information about their knowledge, preparedness, and experiences during the COVID-19 pandemic. Descriptive statistics were used to summarise and report data.
   Results: A total of 157 critical care nurses participated, with 138 fully complete surveys analysed. Most respondents reported 'good' to 'very good' level of knowledge about COVID-19 and obtained up-to-date COVID-19 information from international and local sources. Regarding managing patients with COVID-19, 82.3% felt sufficiently prepared at the time of data collection, and 93.4% had received specific education, training, or instruction. Most participants were involved in assessing (89.3%) and treating (92.4%) patients with COVID-19. Varying levels of concerns about SARS-CoV-2 infection were expressed by respondents, and 55.7% thought the pandemic had increased their workload. The most frequent concerns expressed by participants were a lack of appropriate personal protective equipment (PPE) and fear of PPE shortage.
   Conclusions: While most nurses expressed sufficient preparedness for managing COVID-19 patients, specific education had been undertaken and experiential learning was evident. Fears of insufficient or lack of appropriate PPE made the response more difficult for nurses and the community. Preparedness and responsiveness are critical to successful management of the COVID-19 pandemic and future outbreaks of emerging infectious diseases. (C) 2021 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.
C1 [Nahidi, Shizar; Sotomayor-Castillo, Cristina; Li, Cecilia; Shaban, Ramon Z.] Univ Sydney, Fac Med & Hlth, Susan Wakil Sch Nursing & Midwifery, Camperdown, NSW, Australia.
   [Nahidi, Shizar; Sotomayor-Castillo, Cristina; Li, Cecilia; Shaban, Ramon Z.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Camperdown, NSW, Australia.
   [Currey, Judy] Deakin Univ, Ctr Qual & Patient Safety Res, Inst Hlth Transformat, Geelong, Vic, Australia.
   [Currey, Judy] Deakin Univ, Sch Nursing & Midwifery, Geelong, Vic, Australia.
   [Currey, Judy] Deakin Univ, Off Deputy Vice Chancellor Educ, Geelong, Vic, Australia.
   [Elliott, Rosalind] Northern Sydney Local Hlth Dist, Nursing & Midwifery Res Ctr, Nursing & Midwifery Directorate, Sydney, NSW, Australia.
   [Elliott, Rosalind] Northern Sydney Local Hlth Dist, Intens Care Unit, Royal North Shore Hosp, Sydney, NSW, Australia.
   [Elliott, Rosalind] Univ Technol, Fac Hlth, Ultimo, NSW, Australia.
   [Shaban, Ramon Z.] Westmead Hosp, Div Infect Dis & Sexual Hlth, Westmead, NSW, Australia.
   [Shaban, Ramon Z.] Western Sydney Local Hlth Dist, Westmead, NSW, Australia.
   [Shaban, Ramon Z.] Western Sydney Local Hlth Dist & New South Wales, New South Wales Biocontainment Ctr, Sydney, NSW, Australia.
RP Shaban, RZ (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Camperdown, NSW, Australia.; Shaban, RZ (corresponding author), Univ Sydney, 176 Hawkesbury Rd, Westmead, NSW 21645, Australia.; Shaban, RZ (corresponding author), Westmead Inst Med Res, Western Sydney Local Hlth Dist Off 0 4 20, 176 Hawkesbury Rd, Westmead, NSW 21645, Australia.
EM Shizar.nahidi@sydney.edu.au; cristina.sotomayor@sydney.edu.au;
   cecilia.z.li@sydney.edu.au; judy.currey@deakin.edu.au;
   Rosalind.Elliott@health.nsw.gov.au; ramon.shaban@sydney.edu.au
RI Li, Cecilia/AAL-7437-2021
OI Li, Cecilia/0000-0002-4100-4580; Nahidi, Shizar/0000-0003-0443-4626;
   Elliott, Rosalind/0000-0002-9239-7126; Sotomayor Castillo, Cristina
   Fabiola/0000-0002-9844-7905; Shaban, Ramon/0000-0002-5203-0557
CR Al-Dorzi HM, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0203-z
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   Arabi YM, 2020, INTENS CARE MED, V46, P833, DOI 10.1007/s00134-020-05955-1
   Australian and New Zealand Intensive Care Society, 2020, COVID 19 GUID
   Australian and New Zealand Intensive Care Society, 2020, COVID 19 GUID
   Australian Department of Health, 2020, 1 CONF CAS NOV COR A
   Blecher GE, 2020, MED J AUSTRALIA, V213, P196, DOI 10.5694/mja2.50730
   Caly L, 2020, MED J AUSTRALIA, V212, P459, DOI 10.5694/mja2.50569
   Deng JF, 2006, PUBLIC HEALTH, V120, P15, DOI 10.1016/j.puhe.2005.10.001
   Desborough J, 2020, MED J AUSTRALIA, V213, P104, DOI 10.5694/mja2.50693
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   El-Masri Maher M, 2004, AACN Clin Issues, V15, P150, DOI 10.1097/00044067-200401000-00013
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Jalloh MF, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000471
   Johnson SS, 2015, AACN ADV CRIT CARE, V26, P262, DOI 10.1097/NCI.0000000000000103
   Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Litton E, 2020, MED J AUSTRALIA, V212, P463, DOI 10.5694/mja2.50596
   Marshall AP, 2021, AUST CRIT CARE, V34, P123, DOI 10.1016/j.aucc.2020.08.007
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42
   Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077
   O'Sullivan D., 2020, INT J COMMUNITY SOC, V2, P134, DOI DOI 10.1177/2516602620937922
   World Health Organization, 2020, WHO DIR GEN STAT IHR
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 24
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1036-7314
EI 1878-1721
J9 AUST CRIT CARE
JI Aust. Crit. Care
PD JAN
PY 2022
VL 35
IS 1
BP 22
EP 27
DI 10.1016/j.aucc.2021.04.008
PG 6
WC Critical Care Medicine; Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine; Nursing
GA YL6SY
UT WOS:000746020200005
PM 34462194
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Nabe-Nielsen, K
   Fuglsang, NV
   Larsen, I
   Nilsson, CJ
AF Nabe-Nielsen, Kirsten
   Fuglsang, Nina Vibe
   Larsen, Inge
   Nilsson, Charlotte Juul
TI COVID-19 Risk Management and Emotional Reactions to COVID-19 Among
   School Teachers in Denmark Results From the CLASS Study
SO JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
LA English
DT Article
DE COVID-19; cross-sectional; mental health; occupational health; school
   teacher
ID HEALTH-CARE WORKERS; TRANSMISSION
AB Objectives: We explored teachers' emotional reactions to the COVID-19 pandemic, and the association between COVID-19 risk management and these emotional reactions. Methods: We used cross-sectional data from 2665 teachers working at public schools. Participants responded to a questionnaire in May 2020. The analyses were adjusted for sex, age, cohabitation, and region. Results: Knowledge about adequate test behavior and feeling secure regarding colleagues' actions to hinder spread of virus were associated with less frequent emotional reactions. Lack of access to personal protective equipment and exposure to infected pupils, parents or colleagues were associated with more frequent emotional reactions. Conclusion: Similar to other groups of frontline employees, teachers experience negative emotional reactions to the COVID-19 pandemic. Gaining knowledge about teachers' worries and fears during pandemics is an important first step enabling leaders and occupational health professionals to address these.
C1 [Nabe-Nielsen, Kirsten; Nilsson, Charlotte Juul] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Oster Farimagsgade 5, DK-1014 Copenhagen, Denmark.
   [Fuglsang, Nina Vibe; Larsen, Inge] Danish Union Teachers, Copenhagen, Denmark.
RP Nabe-Nielsen, K (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Oster Farimagsgade 5, DK-1014 Copenhagen, Denmark.
EM nabe@sund.ku.dk
OI Nilsson, Charlotte Juul/0000-0002-3364-7412
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   [Anonymous], 2020, LANCET, V395, P1587, DOI 10.1016/S0140-6736(20)31200-9
   [Anonymous], 2020, COVID 19 DANM EP OV
   Aoyagi Y, 2015, INFLUENZA OTHER RESP, V9, P120, DOI 10.1111/irv.12310
   Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114095
   Baker MG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232452
   Belingheri M, 2020, OCCUP MED-OXFORD, V70, P82, DOI 10.1093/occmed/kqaa048
   Bitan DT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113100
   Burdorf A, 2020, SCAND J WORK ENV HEA, V46, P229, DOI 10.5271/sjweh.3893
   Ghinai I, 2020, MMWR-MORBID MORTAL W, V69, P446, DOI 10.15585/mmwr.mm6915e1
   Halperin DT, 2020, GLOB HEALTH-SCI PRAC, V8, P155, DOI 10.9745/GHSP-D-20-00189
   Horby Jorgensen, 2020, NEDLUKNINGEN CORONA
   Houghton C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013582
   Koh YW, 2011, INT J EVID-BASED HEA, V9, P403, DOI 10.1111/j.1744-1609.2011.00242.x
   Leask J, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3022007
   Li QM, 2020, J AFFECT DISORDERS, V277, P153, DOI 10.1016/j.jad.2020.08.017
   McConnell D, 2020, J MED ETHICS, V46, P360, DOI 10.1136/medethics-2020-106250
   Nabe-Nielsen K, 2021, OCCUP ENVIRON MED, V78, P248, DOI 10.1136/oemed-2020-106831
   Nilsson CJ., 2020, CLASS ET FORSKNINGSP
   Prescott K, 2020, J HOSP INFECT, V105, P142, DOI 10.1016/j.jhin.2020.04.031
   Preskorn SH, 2020, J PSYCHIATR PRACT, V26, P219, DOI 10.1097/PRA.0000000000000475
   Primdahl NL, 2021, VULNERABLE CHILD YOU, V16, P75, DOI 10.1080/17450128.2020.1829228
   Qvortrup A., 2020, BORNS SOCIOEMOTIONEL
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Sim MR, 2020, OCCUP ENVIRON MED, V77, P281, DOI 10.1136/oemed-2020-106567
   Stebbins S, 2009, J PUBLIC HEALTH MAN, V15, P112, DOI 10.1097/01.PHH.0000346007.66898.67
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Vu CT, 2020, DATA BRIEF, V31, DOI 10.1016/j.dib.2020.105788
   Walger P, 2020, GMS HYG INFECT CONTR, V15, DOI 10.3205/dgkh000346
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
   Zhou X, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1779494
NR 32
TC 6
Z9 6
U1 8
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1076-2752
EI 1536-5948
J9 J OCCUP ENVIRON MED
JI J. Occup. Environ. Med.
PD MAY
PY 2021
VL 63
IS 5
BP 357
EP 362
DI 10.1097/JOM.0000000000002136
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA TT6AU
UT WOS:000680430200011
PM 33928933
OA Green Published, Bronze
DA 2022-04-20
ER

PT C
AU Long, W
   Zhong, YQ
   Li, RQ
   Zhao, MY
AF Long, Wen
   Zhong, Yanqiang
   Li, Ruiqin
   Zhao, Manyi
BE Liu, Y
   Shi, Y
   Wang, Y
   Ergu, D
   Berg, D
   Tien, J
   Li, J
   Tian, Y
TI Does the emotional tendency of COVID-19 news affect financial markets?
SO 8TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND QUANTITATIVE
   MANAGEMENT (ITQM 2020 & 2021): DEVELOPING GLOBAL DIGITAL ECONOMY AFTER
   COVID-19
SE Procedia Computer Science
LA English
DT Proceedings Paper
CT 8th International Conference on Information Technology and Quantitative
   Management (ITQM) - Developing Global Digital Economy after COVID-19
CY JUL 09-11, 2021
CL Chengdu, PEOPLES R CHINA
DE COVID-19 news; Emotional tendency; Financial markets; Semantic
   orientation
AB The influence of internet financial news on financial markets has been verified from multiple perspectives. This paper examines whether the emotional tendency of COVID-19 news affect financial markets. Based on constructing the sentiment dictionary of COVID-19 news, we measure the sentiment indicators of COVID-19 news, and then study the dynamic relationship between the emotional tendency of COVID-19 news and the rate of return in financial markets. Compared with the news before the outbreak of COVID-19, our results show that the emotional tendency of COVID-19 news does affect the rate of return in the stock and bond markets. (C) 2021 The Authors. Published by Elsevier B.V.
C1 [Long, Wen; Li, Ruiqin; Zhao, Manyi] Univ Chinese Acad Sci, Sch Econ & Management, Beijing 100190, Peoples R China.
   [Long, Wen; Zhong, Yanqiang; Li, Ruiqin; Zhao, Manyi] Chinese Acad Sci, Res Ctr Fictitious Econ & Data Sci, Beijing 100190, Peoples R China.
   [Long, Wen; Zhong, Yanqiang; Li, Ruiqin; Zhao, Manyi] Chinese Acad Sci, Key Lab Big Data Min & Knowledge Management, Beijing 100190, Peoples R China.
   [Zhong, Yanqiang] Univ Chinese Acad Sci, Sino Danish Coll, Beijing 100049, Peoples R China.
RP Li, RQ (corresponding author), Univ Chinese Acad Sci, Sch Econ & Management, Beijing 100190, Peoples R China.; Li, RQ (corresponding author), Chinese Acad Sci, Res Ctr Fictitious Econ & Data Sci, Beijing 100190, Peoples R China.; Li, RQ (corresponding author), Chinese Acad Sci, Key Lab Big Data Min & Knowledge Management, Beijing 100190, Peoples R China.
EM ruiqinli163@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71771204]; Fundamental Research Funds for
   the Central UniversitiesFundamental Research Funds for the Central
   Universities
FX This research was supported by the grants from National Natural Science
   Foundation of China (No.71771204) and the Fundamental Research Funds for
   the Central Universities.
CR Birz G, 2017, J ECON PSYCHOL, V61, P87, DOI 10.1016/j.joep.2017.03.002
   Chen Y., 2020, J FINANC RES, V06, P20
   Heyes A., 2016, EFFECT AIR POLLUTION
   Humphrey P, 2016, J RISK FINANC, V17, P2, DOI 10.1108/JRF-08-2015-0072
   Kong X. Y., 2016, MATH STAT MANAGEMENT, V35, P215
   Li C. R., 2020, DIGITAL LIB FORUM, P32
   Mann C. L., 2020, EC TIME COVID 19, P81
   PARK S., 2016, IEEE INT C SOFTW ENG
   Thorsrud LA, 2020, J BUS ECON STAT, V38, P393, DOI 10.1080/07350015.2018.1506344
   Zhang SX, 2018, FUTURE GENER COMP SY, V81, P395, DOI 10.1016/j.future.2017.09.048
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-0509
J9 PROCEDIA COMPUT SCI
PY 2022
VL 199
BP 532
EP 539
DI 10.1016/j.procs.2022.01.065
PG 8
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS7PM
UT WOS:000765802100068
OA gold
DA 2022-04-20
ER

PT J
AU Wu, XL
   Munthali, GNC
AF Wu, Xue-Lian
   Munthali, George N. Chidimbah
TI Knowledge, Attitudes, and Preventative Practices (KAPs) Towards COVID-19
   Among International Students in China
SO INFECTION AND DRUG RESISTANCE
LA English
DT Article
DE coronavirus disease 2019 (COVID-19); pandemics; prevention and control;
   knowledge; attitudes; perception; international students
ID PERCEPTION
AB Purpose: The study aimed to find out about the knowledge, attitudes, and preventative practices of COVID-19 among international students in China during the pandemic.
   Material and Methods: A cross-section survey was conducted among 300 international students from 13 different universities in Hubei province of China between March and April 2020 which relied upon convenience sampling method.
   Results: Out of 300 respondents, 153 (51%) of the respondents were female students, of which the majority were single, undergraduate students who were doing medicine (163, 54.3%) and engineering programs (68, 22.7%). The majority of international students had an impressive knowledge on the causes, risks, and spread of COVID-19, and that they were no misconception of the pandemic 229 (76%) to 281 (98%) respectively. These students also demonstrated a markedly positive attitude towards the virus and a feeling that they were almost completely safe being in China (264, 84%). Variations were found on Knowledge scores in age group (P<0.01) and majors (P=0.025), attitude scores on major of study (P=0.015), and experience (P<0.01). Furthermore, the results revealed that all the students (300, 100%) adhered to and practiced set preventive measures against COVID-19 and that there was a positive correlation between attitudes and preventative practices (r=0.219, P<0.01).
   Conclusion: This study found that social media platform was contributing enormously towards information dissemination and Chinese universities were commended for their continuous notifications on COVID-19 which helped students to have full knowledge. This, in turn, was instrumental in helping students to form good attitudes and practices towards COVID-19.
C1 [Wu, Xue-Lian] Yangtze Univ, Sch Econ & Management, Jingzhou, Hubei, Peoples R China.
   [Munthali, George N. Chidimbah] Mzuzu Univ, Finance Dept, Luwinga, Malawi.
   [Munthali, George N. Chidimbah] Chidimbah Res Ctr, Mzuzu 0716, Malawi.
RP Munthali, GNC (corresponding author), Mzuzu Univ, Finance Dept, Luwinga, Malawi.; Munthali, GNC (corresponding author), Chidimbah Res Ctr, Mzuzu 0716, Malawi.
EM ndazionaacca@yahoo.com
RI Munthali, George N. Chidimbah/AAN-6460-2020
OI Munthali, George N. Chidimbah/0000-0002-1513-7312
CR Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413
   Al-Naggar RA, 2011, J MENS HEALTH, V8, pS87, DOI 10.1016/S1875-6867(11)60031-6
   Amaah P, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.253.2799
   Amponsah R., 2020, OPEN J BUSINESS MANA, V8, P1404, DOI [https://doi.org/10.4236/ojbm.2020.84089, DOI 10.4236/OJBM.2020.84089]
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Bates BR, 2020, J COMMUN HEALTH, V45, P1158, DOI 10.1007/s10900-020-00916-7
   Dkhar SA, 2020, INDIAN J PUBLIC HLTH, V64, P205, DOI 10.4103/ijph.IJPH_469_20
   Ejeh FE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05557
   Gao W, 2020, J POLIT LAW, V13, P135, DOI 10.5539/jpl.v13n1p135
   Haftom M, 2020, INFECT DRUG RESIST, V13, P3727, DOI 10.2147/IDR.S275744
   Ilesanmi O, 2016, PLOS CURR, DOI [10.1371/currents.out-breaks.c04b88cd5cd03cccb99e125657eecd76, DOI 10.1371/CURRENTS.OUT-BREAKS.C04B88CD5CD03CCCB99E125657EECD76]
   Israel GD, USING PUBLISHED TABL
   Klaiman T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-73
   Latief R, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072112
   Li DY, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2481-6
   Moe.gov.cn, 2020, STAT REP INT STUD CH
   Mpazi VM, 2005, E AFR J PUBLIC HLTH, V2, P6
   Munthali C, 2020, TECH SOC SCI J, V7, P295, DOI [10.47577/tssj.v7i1.394, DOI 10.47577/TSSJ.V7I1.394]
   Munthali GNC, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7871
   Muoghalu CO, 2013, SAHARA J-J SOC ASP H, V10, P42, DOI 10.1080/17290376.2013.807052
   Nauja RH, 2019, INT J RES, V7, P28, DOI [10.5281/zenodo.3556864, DOI 10.5281/ZENODO.3556864]
   Ngwewondo A, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008700
   Nwabueze S. A., 2014, Open Journal of Preventive Medicine, V4, P708, DOI 10.4236/ojpm.2014.49080
   Nyland C, 2010, HIGH EDUC RES DEV, V29, P89, DOI 10.1080/07294360903277364
   Otekunrin O. A., 2018, Current Agriculture Research Journal, V6, P328, DOI 10.12944/CARJ.6.3.11
   Parajuli Janaki, 2020, J Nepal Health Res Counc, V18, P466, DOI 10.33314/jnhrc.v18i3.2816
   Pathrudu GB, 2015, J EVID BASED MED HEA, V2, P7695, DOI [10.18410/jebmh/2015/1039, DOI 10.18410/JEBMH/2015/1039]
   Prati G, 2016, RISK ANAL, V36, P2000, DOI 10.1111/risa.12537
   Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223
   Song GW, 2020, CITIES, V99, DOI 10.1016/j.cities.2020.102624
   Srichan P, 2020, KNOWLEDGE ATTITUDE P
   Training A-D, 2016, CHINA OUTBOUND INBOU
   van der Merwe J, 2016, INT POLIT ECON SER, P1, DOI 10.1007/978-3-319-40736-4_1
   Wahed T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-242
   WHO, 2020, 1 WHO, V2020
   Wong CL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217878
   Xuelian, 2020, BIOMED J SCI TECH RE, V27, P21104, DOI [10.26717/BJSTR.2020.27.004566, DOI 10.26717/BJSTR.2020.27.004566]
   Yang KH, 2021, J ADV NURS, V77, P1839, DOI 10.1111/jan.14718
   Yap J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-442
   Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 41
TC 7
Z9 7
U1 6
U2 16
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6973
J9 INFECT DRUG RESIST
JI Infect. Drug Resistance
PY 2021
VL 14
BP 507
EP 518
DI 10.2147/IDR.S291199
PG 12
WC Infectious Diseases; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Infectious Diseases; Pharmacology & Pharmacy
GA QI3AM
UT WOS:000618851100001
PM 33603415
OA Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Depagne, C
   Calafiore, M
   Favre, J
   Billy, E
   Rossinot, H
   Zores, F
   Rochoy, M
AF Depagne, Corinne
   Calafiore, Matthieu
   Favre, Jonathan
   Billy, Eric
   Rossinot, Helene
   Zores, Florian
   Rochoy, Michael
TI Persistent symptoms after a Covid-19: current state of knowledge
SO EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE
LA French
DT Article
DE SARS-CoV-2; Covid-19; post-acute Covid-19 syndrome; chronic Covid
   syndrome; long-hauler Covid
ID OUTCOMES; FATIGUE; SARS-COV-2; INFECTION; SURVIVORS; CHILDREN; LESIONS;
   VERSION; SARS
AB The lungs are the main organ for SARS-CoV-2 infection and the obvious prognostic factor in the acute phase; however, the virus can spread to many different organs, including the heart, blood vessels, gastrointestinal tract, liver, central nervous system and kidneys. Since the beginning of the pandemic, persistent symptoms after Covid-19 have been reported, as it was the case in the SARS-CoV-1 epidemic, including in people who initially suffered from a mild form. The frequency of these symptoms after Covid-19 is difficult to assess; however, the rate appears to be higher in patients after hospitalization, due to the severity of the acute infection. Approximately 10% of patients appear to have persistent symptoms 3 months after Covid-19, including fatigue, dyspnea, chest pain, inadaptation to exercise, neurocognitive disorders and cardiovascular abnormalities. These prolonged symptoms after Covid-19 seem to persist beyond 3 months, and even 9 months in some cases, as in SARS. Their pathophysiology is not yet clear: understanding them will probably lead to better personalized management. In the meantime, the medical profession must be able to identify, evaluate and manage these prolonged symptoms with the available means (including re-education and rehabilitation), in the absence of specific treatment.
C1 [Depagne, Corinne] Pneumologue Liberale, F-69007 Lyon, France.
   [Calafiore, Matthieu; Favre, Jonathan; Rochoy, Michael] Univ Lille, Dept Med Gen, CHU Lille, ULR 2694, F-59000 Lille, France.
   [Billy, Eric] Univ Louis Pasteur, Immunooncol, F-67000 Strasbourg, France.
   [Rossinot, Helene] Sharecare Europe, 8 Rue Hotel Ville, F-92200 Neuilly Sur Seine, France.
   [Zores, Florian] Grp Med Specialise, F-67000 Strasbourg, France.
   [Zores, Florian] Ctr Ellipse, F-67000 Strasbourg, France.
RP Rochoy, M (corresponding author), Univ Lille, Dept Med Gen, CHU Lille, ULR 2694, F-59000 Lille, France.
EM michael.rochoy@gmail.com
RI Zores, Florian/AAL-3987-2020
OI Zores, Florian/0000-0002-6590-0929
CR Abbas AM, 2021, J OBSTET GYNAECOL, V41, P331, DOI 10.1080/01443615.2020.1819214
   Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221
   Andrejak C, 2020, REV MAL RESPIR, V37, P505, DOI 10.1016/j.rmr.2020.05.001
   Asadi-Pooya AA, 2020, J NEUROL SCI, V413, DOI 10.1016/j.jns.2020.116832
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P4017, DOI 10.1021/acschemneuro.0c00725
   Bakken IJ, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0167-5
   Beaglehole B, 2018, BRIT J PSYCHIAT, V213, P716, DOI 10.1192/bjp.2018.210
   Blomberg B, 2021, NAT MED, V27, P1607, DOI 10.1038/s41591-021-01433-3
   Bougakov D, 2021, MOL NEUROBIOL, V58, P564, DOI 10.1007/s12035-020-02152-5
   Brackel CLH, 2021, PEDIATR PULM, V56, P2495, DOI 10.1002/ppul.25521
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Stella AB, 2022, J NEUROL, V269, P587, DOI 10.1007/s00415-021-10735-y
   Buonsenso Danilo, 2021, Acta Paediatr, V110, P2208, DOI 10.1111/apa.15870
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Cleare Anthony J, 2015, BMJ Clin Evid, V2015
   Colling ME, 2020, VASC MED, V25, P471, DOI 10.1177/1358863X20932640
   Colonna C, 2020, J AM ACAD DERMATOL, V83, P965, DOI 10.1016/j.jaad.2020.06.019
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E
   Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7
   Cowan LT, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009683
   Dalan R, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3402
   Dani M, 2021, CLIN MED, V21, pE63, DOI 10.7861/clinmed.2020-0896
   Davis HE, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101019
   de Melo GD, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf8396
   Desai AD, 2021, CURR CARDIOL REP, V23, DOI 10.1007/s11886-020-01434-7
   Dherange P, 2020, JACC-CLIN ELECTROPHY, V6, P1193, DOI 10.1016/j.jacep.2020.08.002
   DUBOIS RE, 1984, SOUTHERN MED J, V77, P1376, DOI 10.1097/00007611-198411000-00007
   Fan BE, 2021, J THROMB THROMBOLYS, V51, P971, DOI 10.1007/s11239-020-02332-z
   Fonda G, 2021, ENCEPHALE, V47, P399, DOI 10.1016/j.encep.2021.08.001
   da Silva FAF, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0714-2020
   Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]
   Gavriatopoulou M, 2020, CLIN EXP MED, V20, P493, DOI 10.1007/s10238-020-00648-x
   Gemelli Against Covid 19 Post, 2020, AGING CLIN EXP RES, V32, P1613, DOI 10.1007/s40520-020-01616-x
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Halushka MK, 2021, CARDIOVASC PATHOL, V50, DOI 10.1016/j.carpath.2020.107300
   Hartley C, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040594
   Haute Autorite de sante, 2020, REP RAP CADR COV 19
   Haute AutoritU de santU, 2021, SYMPT PROL SIT COV 1
   Henderson LA, 2021, NAT REV RHEUMATOL, V17, P75, DOI 10.1038/s41584-020-00566-y
   Heneka MT, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00640-3
   Hu FY, 2020, CELL MOL IMMUNOL, V17, P1119, DOI 10.1038/s41423-020-00550-2
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Huang LX, 2021, LANCET, V398, P747, DOI 10.1016/S0140-6736(21)01755-4
   Hui DS, 2005, THORAX, V60, P401, DOI 10.1136/thx.2004.030205
   Institute of Medicine Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Board on the Health of Select Populations, 2015, MYALGIC ENCEPHALOMYE
   Kamal M, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13746
   Kaya G, 2020, DERMATOPATHOL-BASEL, V7, P3, DOI 10.3390/dermatopathology7010002
   Kim JH, 2021, JAMA CARDIOL, V6, P219, DOI 10.1001/jamacardio.2020.5890
   Lamprecht B, 2020, PNEUMOLOGE, V17, P398, DOI 10.1007/s10405-020-00347-0
   Lara B, 2020, EUR J NEUROL, V27, P1744, DOI 10.1111/ene.14339
   Lechien JR, 2020, J INTERN MED, V288, P335, DOI 10.1111/joim.13089
   Lim EJ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02455-0
   Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551
   Loebel M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179124
   Logue JK, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0830
   Ludvigsson JF, 2021, ACTA PAEDIATR, V110, P914, DOI 10.1111/apa.15673
   LUvesque-Boissonneault C, 2021, CHEM SENSES
   Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3981
   Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2815
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Marshall M, 2020, NATURE, V585, P339, DOI 10.1038/d41586-020-02598-6
   Matteudi T, 2021, ACTA PAEDIATR, V110, P3331, DOI 10.1111/apa.16071
   Mawhirt SL, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00974-w
   Moldofsky H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-37
   Molteni E, 2021, LANCET CHILD ADOLESC, V5, P708, DOI 10.1016/S2352-4642(21)00198-X
   Morasaei A, 2021, ENG COMPUT-GERMANY, DOI 10.1007/s00366-020-01228-z
   Nath A, 2021, NEUROSCI LETT, V742, DOI 10.1016/j.neulet.2020.135533
   Nehme M, 2021, ANN INTERN MED, V174, P723, DOI 10.7326/M20-5926
   Lopez JN, 2021, ACTA PAEDIATR, V110, P2282, DOI 10.1111/apa.15849
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763
   Pedersen M, 2019, BRAIN BEHAV IMMUN, V75, P94, DOI 10.1016/j.bbi.2018.09.023
   PERNEGER TV, 1995, J CLIN EPIDEMIOL, V48, P1051, DOI 10.1016/0895-4356(94)00227-H
   Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Radtke T, 2021, JAMA-J AM MED ASSOC, V326, P869, DOI 10.1001/jama.2021.11880
   Rochoy M, 2021, EXERCER, P33
   Rossinot H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228444
   Samies NL, 2021, J PEDIAT INF DIS SOC, V10, P57, DOI 10.1093/jpids/piaa125
   Say D, 2021, LANCET CHILD ADOLESC, V5, pE22, DOI 10.1016/S2352-4642(21)00124-3
   Sonnweber T, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03481-2020
   Stavem K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18042030
   Tancheva L, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110852
   Tansey CM, 2007, ARCH INTERN MED, V167, P1312, DOI 10.1001/archinte.167.12.1312
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]
   Tsivgoulis G, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420978004
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Wang FZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.928996
   Wathelet M, 2021, ACTA PSYCHIAT SCAND, V144, P310, DOI 10.1111/acps.13336
   Wise J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2157
   Wu F., 2020, NEUTRALIZING ANTIBOD, DOI [10.1101/2020.03.30.20047365v1, DOI 10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365]
   Wu Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09536-z
   Wu XJ, 2021, LANCET RESP MED, V9, P747, DOI 10.1016/S2213-2600(21)00174-0
   Xiong QT, 2021, CLIN MICROBIOL INFEC, V27, P89, DOI 10.1016/j.cmi.2020.09.023
   Yavarpour-Bali H, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118063
   Yende S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8686
   Younger DS, 2021, NEUROL SCI, V42, P3959, DOI 10.1007/s10072-021-05345-5
   Zhao YM, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100463
NR 100
TC 0
Z9 0
U1 2
U2 2
PU COLL NATL GENERALISTES ENSEIGNANTS
PI MONTREUIL SOUS BOIS
PA 3, RUE PARMENTIER, MONTREUIL SOUS BOIS, 93100, FRANCE
SN 0998-3953
EI 1961-9138
J9 EXERCER
JI Exercer
PD DEC
PY 2021
IS 178
BP 465
EP 472
PG 8
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA XO5HS
UT WOS:000730216900006
DA 2022-04-20
ER

PT J
AU Fernandez-Quintela, A
   Milton-Laskibar, I
   Trepiana, J
   Gomez-Zorita, S
   Kajarabille, N
   Leniz, A
   Gonzalez, M
   Portillo, MP
AF Fernandez-Quintela, Alfredo
   Milton-Laskibar, Inaki
   Trepiana, Jenifer
   Gomez-Zorita, Saioa
   Kajarabille, Naroa
   Leniz, Asier
   Gonzalez, Marcela
   Portillo, Maria P.
TI Key Aspects in Nutritional Management of COVID-19 Patients
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE COVID-19; SARS-CoV-2; nutrition; malnutrition; nutritional support;
   bioactive compounds
ID VITAMIN-D CONCENTRATIONS; PROLIFERATOR-ACTIVATED RECEPTORS; ANTIVIRAL
   ACTIVITIES; D SUPPLEMENTATION; OXIDATIVE STRESS; CARNOSIC ACID;
   DOUBLE-BLIND; FATTY-ACIDS; PPAR-GAMMA; INFLAMMATION
AB This review deals with the relationship among nutrition, the immune system, and coronavirus disease 2019 (COVID-19). The influence of nutrients and bioactive molecules present in foodstuffs on immune system activity, the influence of COVID-19 on the nutritional status of the patients, and the dietary recommendations for hospitalized patients are addressed. Deficient nutritional status is probably due to anorexia, nausea, vomiting, diarrhea, hypoalbuminemia, hypermetabolism, and excessive nitrogen loss. There is limited knowledge regarding the nutritional support during hospital stay of COVID-19 patients. However, nutritional therapy appears as first-line treatment and should be implemented into standard practice. Optimal intake of all nutrients, mainly those playing crucial roles in immune system, should be assured through a diverse and well-balanced diet. Nevertheless, in order to reduce the risk and consequences of infections, the intakes for some micronutrients may exceed the recommended dietary allowances since infections and other stressors can reduce micronutrient status. In the case of critically ill patients, recently published guidelines are available for their nutritional management. Further, several natural bioactive compounds interact with the angiotensin-converting enzyme 2 (ACE2) receptor, the gateway for severe acute respiratory syndrome (SARS) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Natural bioactive compounds can also reduce the inflammatory response induced by SARS-CoV-2. These compounds are potential beneficial tools in the nutritional management of COVID-19 patients.
C1 [Fernandez-Quintela, Alfredo; Milton-Laskibar, Inaki; Trepiana, Jenifer; Gomez-Zorita, Saioa; Kajarabille, Naroa; Leniz, Asier; Portillo, Maria P.] Univ Basque Country UPV EHU, Nutr & Obes Grp, Dept Pharm & Food Sci, Vitoria 01006, Spain.
   [Fernandez-Quintela, Alfredo; Milton-Laskibar, Inaki; Trepiana, Jenifer; Gomez-Zorita, Saioa; Kajarabille, Naroa; Leniz, Asier; Portillo, Maria P.] Lucio Lascaray Res Inst, Vitoria 01006, Spain.
   [Fernandez-Quintela, Alfredo; Milton-Laskibar, Inaki; Trepiana, Jenifer; Gomez-Zorita, Saioa; Kajarabille, Naroa; Portillo, Maria P.] Inst Hlth Carlos III, CIBEROBN Physiopathol Obes & Nutr, Vitoria 01006, Spain.
   [Fernandez-Quintela, Alfredo; Milton-Laskibar, Inaki; Trepiana, Jenifer; Gomez-Zorita, Saioa; Kajarabille, Naroa; Leniz, Asier; Portillo, Maria P.] Bioaraba Hlth Res Inst, Vitoria 01009, Spain.
   [Leniz, Asier] Integrated Hlth Care Org Araba, Basque Hlth Serv Osakidetza, Alava 01009, Spain.
   [Gonzalez, Marcela] Natl Univ Litoral, Nutr & Food Sci Dept, Fac Biochem & Biol Sci, RA-3000 Santa Fe, Argentina.
   [Gonzalez, Marcela] Natl Sci & Tech Res Council CONICET, RA-3000 Santa Fe, Argentina.
RP Trepiana, J; Gomez-Zorita, S (corresponding author), Univ Basque Country UPV EHU, Nutr & Obes Grp, Dept Pharm & Food Sci, Vitoria 01006, Spain.; Trepiana, J; Gomez-Zorita, S (corresponding author), Lucio Lascaray Res Inst, Vitoria 01006, Spain.; Trepiana, J; Gomez-Zorita, S (corresponding author), Inst Hlth Carlos III, CIBEROBN Physiopathol Obes & Nutr, Vitoria 01006, Spain.; Trepiana, J; Gomez-Zorita, S (corresponding author), Bioaraba Hlth Res Inst, Vitoria 01009, Spain.
EM alfredo.fernandez@ehu.eus; inaki.milton@ehu.eus;
   jenifer.trepiana@ehu.eus; saioa.gomez@ehu.eus;
   naroa.kajarabille@ehu.eus; asier.leniz@gmail.com;
   maidagon@fbcb.unl.edu.ar; mariapuy.portillo@ehu.eus
RI Portillo, Maria Puy/ABH-2374-2020; Milton-Laskibar, Iñaki/U-2254-2019
OI Portillo, Maria Puy/0000-0003-0210-6549; Milton-Laskibar,
   Iñaki/0000-0003-4312-9720; Gomez Zorita, Saioa/0000-0002-6110-6605;
   Leniz Rodriguez, Asier/0000-0003-0784-5906; Fernandez-Quintela,
   Alfredo/0000-0003-2709-4118; Trepiana, Jenifer/0000-0003-1316-5923
FU Instituto de Salud Carlos III (CIBERobn)Instituto de Salud Carlos III;
   University of the Basque Country [GIU18-173]
FX This research was supported by Instituto de Salud Carlos III (CIBERobn)
   and University of the Basque Country (GIU18-173).
CR Abbaspour N, 2014, J RES MED SCI, V19, P164
   Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010
   Alwarawrah Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01055
   Anderson Liz, 2020, Br J Nurs, V29, P458, DOI 10.12968/bjon.2020.29.8.458
   [Anonymous], 2020, INT SOC INF DIS PROM
   Arkin N, 2020, CLIN NUTR, V39, P2327, DOI 10.1016/j.clnu.2020.05.007
   Autier P, 2017, LANCET DIABETES ENDO, V5, P986, DOI [10.1016/S2213-8587(17)30357-1, 10.1016/s2213-8587(17)30357-1]
   Avasarala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057285
   Bailey RL, 2015, ANN NUTR METAB, V66, P22, DOI 10.1159/000371618
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   Bassaganya-Riera J, 2011, BRIT J NUTR, V106, P878, DOI 10.1017/S0007114511001188
   Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007
   Bergman P., 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0065835
   Bird JK, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070655
   Boscolo-Rizzo P, 2020, EUR ARCH OTO-RHINO-L, V277, P2637, DOI 10.1007/s00405-020-06066-9
   Bourke CD, 2016, TRENDS IMMUNOL, V37, P386, DOI 10.1016/j.it.2016.04.003
   Briguglio M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00146
   Brodsky MB, 2018, CRIT CARE MED, V46, P2010, DOI 10.1097/CCM.0000000000003368
   Brugliera L, 2020, EUR J CLIN NUTR, V74, P860, DOI 10.1038/s41430-020-0664-x
   Caccialanza R, 2020, NUTRITION, V74, DOI 10.1016/j.nut.2020.110835
   Calder PC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041181
   Calder PC, 2013, P NUTR SOC, V72, P326, DOI 10.1017/S0029665113001031
   Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x
   Carignan A, 2020, CAN MED ASSOC J, V192, pE702, DOI 10.1503/cmaj.200869
   Carlson JL, 2018, CURR DEV NUTR, V2, DOI 10.1093/cdn/nzy005
   Carr AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02851-4
   Carr AC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111211
   Cena H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00944
   Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685
   Chen Bi, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P257
   Ciavarella C, 2020, MOLECULES, V25, DOI 10.3390/molecules25092076
   Cintoni M, 2020, EUR J CLIN NUTR, V74, P846, DOI 10.1038/s41430-020-0625-4
   COSTAGLIOLA DG, 1994, BRIT J HAEMATOL, V87, P849, DOI 10.1111/j.1365-2141.1994.tb06750.x
   D'Avolio A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051359
   Dana N, 2019, ADV PHARM BULL, V9, P12, DOI 10.15171/apb.2019.003
   Di Renzo L, 2020, EUR REV MED PHARMACO, V24, P4062, DOI 10.26355/eurrev_202004_20977
   Diaz Ballve Ladislao Pablo, 2017, Rev. bras. ter. intensiva, V29, P466, DOI [10.5935/0103-507X.20170063, 10.5935/0103-507x.20170063]
   Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001
   Enaud R, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00009
   Felder S, 2015, NUTRITION, V31, P1385, DOI 10.1016/j.nut.2015.06.007
   Fenton JI, 2013, PROSTAG LEUKOTR ESS, V89, P379, DOI 10.1016/j.plefa.2013.09.011
   Ghaffari S, 2020, ARCH MED RES, V51, P464, DOI 10.1016/j.arcmed.2020.04.006
   Gill HS, 2000, BRIT J NUTR, V84, pS111
   Gombart AF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010236
   Gomes F, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15138
   Grant WB, 2020, DIABETES METAB SYND, V14, P893, DOI 10.1016/j.dsx.2020.05.046
   GRANT WB, 2020, NUTRIENTS, V12, DOI [DOI 10.3390/NU12040988, 10.3390/nu12040988]
   Green DA, 2001, CLIN CANCER RES, V7, P3574
   Gupta R, 2020, EUR J CLIN NUTR, V74, P864, DOI 10.1038/s41430-020-0652-1
   Habtemariam S, 2020, PHYTOTHER RES, V34, P1189, DOI 10.1002/ptr.6711
   Han JE, 2016, J CLIN TRANSL ENDOCR, V4, P59, DOI 10.1016/j.jcte.2016.04.004
   Han SW, 2003, CLIN CANCER RES, V9, P4627
   Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050
   HEMILA H, 2013, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD005532.PUB3, 10.1002/14651858.CD005532.pub3]
   Hemila H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000980.pub4
   Horne JR, 2020, AM J PHYSIOL-ENDOC M, V318, pE830, DOI 10.1152/ajpendo.00150.2020
   Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200
   Hou JC, 1997, BIOL TRACE ELEM RES, V56, P125, DOI 10.1007/BF02778988
   HUNT C, 1994, INT J VITAM NUTR RES, V64, P212
   Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16
   Iddir M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061562
   Ilie PC, 2020, AGING CLIN EXP RES, V32, P1195, DOI 10.1007/s40520-020-01570-8
   Infusino F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061718
   Iwata-Yoshikawa N, 2019, J VIROL, V93, DOI 10.1128/JVI.01815-18
   Jie B, 2010, NUTRITION, V26, P1088, DOI 10.1016/j.nut.2009.08.027
   Katsukawa M, 2010, BBA-MOL CELL BIOL L, V1801, P1214, DOI 10.1016/j.bbalip.2010.07.004
   Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221
   Kim EN, 2018, ATHEROSCLEROSIS, V270, P123, DOI 10.1016/j.atherosclerosis.2018.01.043
   Kizilarslanoglu MC, 2016, J ANESTH, V30, P884, DOI 10.1007/s00540-016-2211-4
   Laviano A, 2020, NUTRITION, V74, DOI 10.1016/j.nut.2020.110834
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Li T, 2020, EUR J CLIN NUTR, V74, P871, DOI 10.1038/s41430-020-0642-3
   Liu GL, 2020, EUR J CLIN NUTR, V74, P876, DOI 10.1038/s41430-020-0659-7
   Liu L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00234
   Liu W, 2020, CURR CLIN MICROBIOL, V7, P13, DOI [10.1080/15384101.2020.1731644, 10.1007/s40588-020-00140-w]
   Lordan R, 2021, BLOOD REV, V45, DOI 10.1016/j.blre.2020.100694
   Lovato A, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102548
   Maggini S., 2008, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V3, P1, DOI 10.1079/PAVSNNR20083098
   Maggini S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101531
   Maione F, 2017, BRIT J PHARMACOL, V174, P1497, DOI 10.1111/bph.13545
   Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW
   Martineau AR, 2019, HEALTH TECHNOL ASSES, V23, P1, DOI 10.3310/hta23020
   Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583
   Mazidi Mohsen, 2016, World J Methodol, V6, P112, DOI 10.5662/wjm.v6.i1.112
   McCarty MF, 2020, PROG CARDIOVASC DIS, V63, P383, DOI 10.1016/j.pcad.2020.02.007
   McCullough FSW, 1999, P NUTR SOC, V58, P289, DOI 10.1017/S0029665199000403
   Mochalkin N I, 1970, Voen Med Zh, V9, P17
   Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681
   Moran CS, 2017, ARTERIOSCL THROM VAS, V37, P2195, DOI 10.1161/ATVBAHA.117.310129
   Mossad SB, 1996, ANN INTERN MED, V125, P81, DOI 10.7326/0003-4819-125-2-199607150-00001
   Muscogiuri G, 2020, EUR J CLIN NUTR, V74, P850, DOI 10.1038/s41430-020-0635-2
   Naja F, 2020, EUR J CLIN NUTR, V74, P1117, DOI 10.1038/s41430-020-0634-3
   Nardini S, 2020, MULTIDISCIP RESP MED, V15, DOI 10.4081/mrm.2020.672
   Ng T, 2015, APPL MICROBIOL BIOT, V99, P6997, DOI 10.1007/s00253-015-6818-4
   Andrade JMO, 2014, PEPTIDES, V55, P158, DOI 10.1016/j.peptides.2014.03.006
   Park JY, 2004, FEBS LETT, V572, P266, DOI 10.1016/j.febslet.2004.06.084
   Payahoo L, 2018, ADV PHARM BULL, V8, P479, DOI 10.15171/apb.2018.056
   Printza A, 2020, EUR ARCH OTO-RHINO-L, V277, P2625, DOI 10.1007/s00405-020-06069-6
   Ran L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1837634
   Rau O, 2006, PLANTA MED, V72, P881, DOI 10.1055/s-2006-946680
   Rejnmark L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180512
   Romano L, 2020, Eur Rev Med Pharmacol Sci, V24, P4035, DOI 10.26355/eurrev_202004_20874
   Rondanelli M, 2020, NUTRITION, V72, DOI 10.1016/j.nut.2019.110667
   Roy AS, 2020, DIABETES METAB SYND, V14, P777, DOI 10.1016/j.dsx.2020.05.049
   Sayin I, 2020, OTOLARYNG HEAD NECK, V163, P473, DOI 10.1177/0194599820931820
   Shi K, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01276
   Singer P, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2415-8
   Singer Pierre, 2016, Rev. bras. ter. intensiva, V28, P369, DOI [10.5935/0103-507X.20160070, 10.5935/0103-507x.20160070]
   Singh M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001364.pub4
   Smith EM, 2018, JPEN-PARENTER ENTER, V42, P87, DOI 10.1177/0148607116678197
   Stark KD, 2016, PROG LIPID RES, V63, P132, DOI 10.1016/j.plipres.2016.05.001
   Steinbrenner H, 2015, ADV NUTR, V6, P73, DOI 10.3945/an.114.007575
   Taylor EW, 2016, CURR TOP MED CHEM, V16, P1530, DOI 10.2174/1568026615666150915121633
   te Velthuis Aartjan J W, 2010, PLoS Pathog, V6, pe1001176, DOI 10.1371/journal.ppat.1001176
   Tiao MM, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0824-3
   TILG H, 2020, NAT REV IMMUNOL, V20, P40, DOI DOI 10.1038/S41577-019-0198-4
   Timoneda J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091132
   Ting D, 2018, ACS APPL NANO MATER, V1, P5451, DOI 10.1021/acsanm.8b00779
   Tong, 2020, ZHONGHUA JIE HE HE H, V43, pE26, DOI [DOI 10.3760/CMA.J.CN112147-20200224-00159, 10.3760/cma.j.cn112147-20200224-00159]
   Volkert D, 2019, CLIN NUTR, V38, P10, DOI 10.1016/j.clnu.2018.05.024
   Wang Y, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0532-9
   Wei YJ, 2017, J IMMUNOTOXICOL, V14, P228, DOI 10.1080/1547691X.2017.1394933
   Wen CC, 2007, J MED CHEM, V50, P4087, DOI 10.1021/jm070295s
   Wernerman J, 2005, CRIT CARE, V9, P251, DOI 10.1186/cc3530
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu J, 2017, MOL MED REP, V16, P7432, DOI 10.3892/mmr.2017.7546
   Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065
   Zabetakis I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051466
   Zahedipour F, 2020, PHYTOTHER RES, V34, P2911, DOI 10.1002/ptr.6738
   Zayet S, 2021, INFECTION, V49, P361, DOI 10.1007/s15010-020-01442-3
   Zhang JS, 2020, AM J CLIN NUTR, V111, P1297, DOI 10.1093/ajcn/nqaa095
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou SS, 2020, J OBES, V2020, DOI 10.1155/2020/2962138
   Zuo T, 2020, GASTROENTEROLOGY, V159, P944, DOI 10.1053/j.gastro.2020.05.048
NR 134
TC 37
Z9 41
U1 1
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD AUG
PY 2020
VL 9
IS 8
AR 2589
DI 10.3390/jcm9082589
PG 24
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA NM4OR
UT WOS:000568078000001
PM 32785121
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Kothari, R
   Sahab, S
   Singh, HM
   Singh, RP
   Singh, B
   Pathania, D
   Singh, A
   Yadav, S
   Allen, T
   Singh, S
   Tyagi, VV
AF Kothari, Richa
   Sahab, Sinha
   Singh, Har Mohan
   Singh, Rajeev Pratap
   Singh, Bhaskar
   Pathania, Deepak
   Singh, Anita
   Yadav, Shweta
   Allen, Tanu
   Singh, Sohini
   Tyagi, Vineet Veer
TI COVID-19 and waste management in Indian scenario: challenges and
   possible solutions
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Review
DE COVID-19; Biomedical waste; Sustainable solutions; Environment
ID ACUTE RESPIRATORY SYNDROME; CORONAVIRUSES; INACTIVATION; PYROLYSIS;
   HEALTH
AB The outbreak of COVID-19 pandemic has created havoc all across the globe causing exponential casualties and tremendous health and economic loss. With increasing COVID-19 cases, the amount of biomedical waste has increased manifolds making more people vulnerable to the pandemic. The developing and underdeveloped countries are already facing the challenges of waste management, and the waste generated during the pandemic scenario has added to the already existing challenges. The improper waste management practices need to be corrected; otherwise, the world will be facing a new disaster that could be termed as 'waste disaster'. The increase in COVID-19-associated waste (CAW) quantity and their availability in the environment will result in their easy approach to other organisms, which will possibly increase the potential risk of food chain contamination. Some of the countries have already started to make backup plans and are struggling to overcome the 'waste disaster'. In light of the limited knowledge available on the mutational properties and possible hosts of this newly emerged COVID-19, there is a great demand to have an efficient strategy to prevent the environment from further contamination in India. The necessity of the prevailing time is to create a more efficient, automatic, mechanized, and well-modified waste management system for handling the present situation and delaying the projected waste disaster in the near future in the era of COVID-19. The article aims to address the issues that originated from waste discharges, their potential sources along with possible sustainable solutions.
C1 [Kothari, Richa; Pathania, Deepak; Singh, Anita; Yadav, Shweta] Cent Univ Jammu, Dept Environm Sci, Samba 181143, J&K, India.
   [Sahab, Sinha; Singh, Rajeev Pratap] Banaras Hindu Univ, Inst Environm & Sustainable Dev, Varanasi 221005, Uttar Pradesh, India.
   [Singh, Har Mohan; Tyagi, Vineet Veer] Shri Mata Vaishno Devi Univ, Sch Energy Management, Jammu 182320, J&K, India.
   [Singh, Bhaskar] Cent Univ Jharkhand, Dept Environm Sci, Ranchi 835205, Jharkhand, India.
   [Pathania, Deepak] Sardar Vallabhai Patel Cluster Univ, Dept Chem, Mandi 175001, Himachal Prades, India.
   [Allen, Tanu; Singh, Sohini] Amity Univ, Amity Inst Biotechnol, Sect 125, Noida, UP, India.
RP Kothari, R (corresponding author), Cent Univ Jammu, Dept Environm Sci, Samba 181143, J&K, India.
EM kothariricha21@gmail.com
RI Singh, Sohini/G-7854-2014; Tyagi, Vineet V/I-4869-2014
OI Singh, Sohini/0000-0003-4946-1556; Singh, Anita/0000-0003-1564-5904
CR Aderibigbe BA, 2017, MOLECULES, V22, DOI 10.3390/molecules22081370
   Ahmed W, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.139960
   [Anonymous], 2020, ABP NEWS BUREAU 0709
   Aysegul M., 2020, EMER INFE DIS, V26
   Barcelo D, 2020, J ENVIRON CHEM ENG, V8, DOI 10.1016/j.jece.2020.104006
   Barhate RS, 2008, FILTR SEPARAT, V45, P32, DOI 10.1016/S0015-1882(08)70092-2
   Bhowmick GD, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0079-1
   Boyle L., 2020, INDEPENDENT
   Brouwer A., 2020, PRESENCE SARS CORONA, V2020, DOI [10.1101/2020.03.29.20045880, DOI 10.1101/2020.03.29.20045880]
   Canopoli L, 2020, SCI TOTAL ENVIRON, V698, DOI 10.1016/j.scitotenv.2019.134125
   Casanova L, 2009, WATER RES, V43, P1893, DOI 10.1016/j.watres.2009.02.002
   Chamas A, 2020, ACS SUSTAIN CHEM ENG, V8, P3494, DOI 10.1021/acssuschemeng.9b06635
   Chatterjee A, 2020, AEROSOL AIR QUAL RES, V20, P1516, DOI 10.4209/aaqr.2020.05.0253
   Chaurasia S, 2019, SOCIOECONOMIC SCENAR
   Chen C, 2006, BIOMED ENVIRON SCI, V19, P173
   China Citywater,, 2020, MEAS REV TRANSM SARS
   CPCB, 2020, SUB GUID HANDL TREAT
   Czajczynska D, 2017, ENRGY PROCED, V123, P387, DOI 10.1016/j.egypro.2017.07.275
   Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006
   Das P.K., 2020, AM INT J SOC SCI RES, V5, P22, DOI [10.46281/aijssr.v5i1.481, DOI 10.46281/AIJSSR.V5I1.481]
   Di Gianvincenzo P, 2010, BIOORG MED CHEM LETT, V20, P2718, DOI 10.1016/j.bmcl.2010.03.079
   Dutta A, 2020, J AIR WASTE MANAGE, V70, P491, DOI 10.1080/10962247.2020.1738285
   Faizan M., 2020, CHALL SOLUT, V9
   Fiorillo L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093132
   Fusheng W., 2020, VIRUS SHEDDING PATTE, DOI [10.1101/2020.03.28.20043059v1.full.pdf, DOI 10.1101/2020.03.28.20043059V1.FULL.PDF]
   Gehrke I, 2015, NANOTECHNOL SCI APPL, V8, P1, DOI 10.2147/NSA.S43773
   Gormley M, 2020, LANCET GLOB HEALTH, V8, pE643, DOI 10.1016/S2214-109X(20)30112-1
   Guo X, 2019, MAR POLLUT BULL, V142, P1, DOI 10.1016/j.marpolbul.2019.03.019
   Harris M, 2020, NAT MED, V26, P814, DOI 10.1038/s41591-020-0889-1
   Jain S, 2020, BIOFUELS-UK, DOI 10.1080/17597269.2020.1797350
   Jayaweera M, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109819
   Joshi R, 2016, COGENT ENVIRON SCI, V2, DOI 10.1080/23311843.2016.1139434
   Kalina M, 2020, WASTE MANAGE, V108, P202, DOI 10.1016/j.wasman.2020.05.006
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kawamura H., 2014, LIKELIHOOD 24 LEAST
   Keil SD, 2020, VOX SANG, V115, P495, DOI 10.1111/vox.12937
   Kerry RG, 2019, NANOMED-NANOTECHNOL, V18, P196, DOI 10.1016/j.nano.2019.03.004
   Kharel T.P., 2020, INT J MULTIDISCIPLIN, V1, P116
   Kim HP, 2020, NANOIMPACT, V19, DOI 10.1016/j.impact.2020.100231
   Klangsin P, 1998, J AIR WASTE MANAGE, V48, P516, DOI 10.1080/10473289.1998.10463706
   Klemes JJ, 2020, RENEW SUST ENERG REV, V127, DOI 10.1016/j.rser.2020.109883
   Li WC, 2016, SCI TOTAL ENVIRON, V566, P333, DOI 10.1016/j.scitotenv.2016.05.084
   Lu HJ, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/4964828
   Ma Yufeng, 2020, Waste Dispos Sustain Energy, P1, DOI 10.1007/s42768-020-00039-8
   Silva PM, 2020, WATER-SUI, V12, DOI 10.3390/w12041210
   MOULIN L., 2020, TIME COURSE QUANTITA, DOI 10.1101/2020.04.12.20062679
   Nakamura S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153620
   Nema SK, 2002, CURR SCI INDIA, V83, P271
   Nzediegwu C, 2020, RESOUR CONSERV RECY, V161, DOI 10.1016/j.resconrec.2020.104947
   Padmapriya KT, 2013, CVR J SCI TECHNOL, V5, P71, DOI [10.32377/cvrjst0512, DOI 10.32377/CVRJST0512]
   Panagiotakis D, 2018, APPL NANOTECHNOLOGY, V36, P197, DOI [10.1177/0734242X18758820, DOI 10.1177/0734242X18758820]
   Silva ALP, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140565
   Pechter E, 2016, AM J INFECT CONTROL, V44, P1755, DOI 10.1016/j.ajic.2016.08.020
   Poirier MJP, 2020, SOC INDIC RES, V148, P1, DOI 10.1007/s11205-019-02187-9
   Ragan I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233947
   Ranjan MR., 2020, ASIAN J ENV ECOLOGY, V13, P10, DOI DOI 10.9734/AJEE/2020/V13I130171
   Reinhart DR, 2000, LAB MED, V31, P141, DOI 10.1309/MUF3-H904-Y8R1-JTC8
   Reinoso R, 2008, SCI TOTAL ENVIRON, V395, P80, DOI 10.1016/j.scitotenv.2008.02.039
   Rutala WA., 2008, CDC GUIDELINE DISINF
   Saadat S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138870
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Sharma HB, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105052
   Short, 2020, CASE STUD CHEM ENV E, V1, DOI DOI 10.1016/J.CSCEE.2020.100006
   Singh B, 2008, POLYM DEGRAD STABIL, V93, P561, DOI 10.1016/j.polymdegradstab.2007.11.008
   Singh V., 2020, INNOVATION MAKE INDI
   Sohaib MB., 2020, SOCIAL ENV IMPACT CO
   Srivastava V, 2015, REV ENVIRON SCI BIO, V14, P317, DOI 10.1007/s11157-014-9352-4
   Syakti AD, 2017, MAR POLLUT BULL, V122, P217, DOI 10.1016/j.marpolbul.2017.06.046
   Tang CC, 2019, MAR POLLUT BULL, V149, DOI 10.1016/j.marpolbul.2019.110626
   ter Halle A, 2017, ENVIRON POLLUT, V227, P167, DOI 10.1016/j.envpol.2017.04.051
   Thakur Y, 2012, CHEM ENGINEER TRANS, V29, P787, DOI 10.3303/CET1229132
   Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   Wang J, 2020, ENVIRON POLLUT, V262, DOI 10.1016/j.envpol.2020.114665
   Wang XW, 2005, J VIROL METHODS, V126, P171, DOI 10.1016/j.jviromet.2005.02.005
   Weidemann E, 2016, ENVIRON SCI POLLUT R, V23, P22843, DOI 10.1007/s11356-016-7495-2
   Williamson VG, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010167
   World Bank, 2020, WORLD DEV IND 2019 S
   World Health Organization, 2020, TRANSM SARS COV 2 IM
   World Health Organization, 2020, SHORT PERS PROT EQ E, P3
   World Health Organization (WHO), 2020, WATER SANITATION HYG
   Yu H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051770
NR 83
TC 3
Z9 3
U1 8
U2 11
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD OCT
PY 2021
VL 28
IS 38
BP 52702
EP 52723
DI 10.1007/s11356-021-15028-5
EA AUG 2021
PG 22
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA UX0YH
UT WOS:000691236500009
PM 34462854
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Asadzadeh, A
   Mohammadzadeh, Z
   Fathifar, Z
   Jahangiri-Mirshekarlou, S
   Rezaei-Hachesu, P
AF Asadzadeh, Afsoon
   Mohammadzadeh, Zeinab
   Fathifar, Zahra
   Jahangiri-Mirshekarlou, Soheila
   Rezaei-Hachesu, Peyman
TI A framework for information technology-based management against COVID-19
   in Iran
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Information technology; COVID-19; Infectious disease; Outbreak; Epidemic
ID CHALLENGES; IOT; AI
AB Background The COVID-19 pandemic has become a global concern. Iran is one of the countries affected most by the SARS-CoV-2 outbreak. As a result, the use of information technology (IT) has a variety of applications for pandemic management. The purpose of this study was to develop a conceptual framework for responding to the COVID-19 pandemic via IT management, based on extensive literature review and expert knowledge. Methods The conceptual framework is developed in three stages: (1) a literature review to gather practical experience with IT applications for managing the COVID-19 pandemic, (2) a study of Iranian documents and papers that present Iran's practical experience with COVID-19, and (3) developing a conceptual framework based on the previous steps and validating it through a Delphi approach in two rounds, and by 13 experts. Results The proposed conceptual framework demonstrates that during pandemics, 22 different types of technologies were used for various purposes, including virtual education, early warning, rapid screening and diagnosis of infected individuals, and data management. These objectives were classified into six categories, with the following applications highlighted: (1) Prevention (M-health, Internet search queries, telehealth, robotics, Internet of things (IoT), Artificial Intelligence (AI), big data, Virtual Reality (VR), social media); (2) Diagnosis (M-health, drones, telehealth, IoT, Robotics, AI, Decision Support System (DSS), Electronic Health Record (EHR)); (3) Treatment (Telehealth, M-health, AI, Robotic, VR, IoT); (4) Follow-up (Telehealth, M-health, VR), (5) Management & planning (Geographic information system, M-health, IoT, blockchain), and (6) Protection (IoT, AI, Robotic and automatic vehicles, Augmented Reality (AR)). In Iran, the use of IT for prevention has been emphasized through M-health, internet search queries, social media, video conferencing, management and planning objectives using databases, health information systems, dashboards, surveillance systems, and vaccine coverage. Conclusions IT capabilities were critical during the COVID-19 outbreak. Practical experience demonstrates that various aspects of information technologies were overlooked. To combat this pandemic, the government and decision-makers of this country should consider strategic planning that incorporates successful experiences against COVID-19 and the most advanced IT capabilities.
C1 [Asadzadeh, Afsoon; Fathifar, Zahra; Jahangiri-Mirshekarlou, Soheila] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran.
   [Asadzadeh, Afsoon; Mohammadzadeh, Zeinab; Fathifar, Zahra; Jahangiri-Mirshekarlou, Soheila; Rezaei-Hachesu, Peyman] Tabriz Univ Med Sci, Sch Management & Med Informat, Hlth Informat Technol Dept, Daneshgah St, Tabriz 5165665811, Iran.
RP Rezaei-Hachesu, P (corresponding author), Tabriz Univ Med Sci, Sch Management & Med Informat, Hlth Informat Technol Dept, Daneshgah St, Tabriz 5165665811, Iran.
EM rezaeip@tbzmed.ac.ir
RI rezaei-hachesu, peyman/G-3876-2015
OI rezaei-hachesu, peyman/0000-0002-3980-5100
CR Adans-Dester CP, 2020, IEEE OPEN J ENG MED, V1, P243, DOI 10.1109/OJEMB.2020.3015141
   Almalki M, 2021, JMIR MHEALTH UHEALTH, V9, DOI 10.2196/24322
   Alsunaidi SJ, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21072282
   [Anonymous], A review of 40 actions of the Welfare Organization of the country (Iran).
   Anthony B, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01596-5
   Anthony B Jnr, 2021, INFORM HEALTH SOC CA, V46, P68, DOI 10.1080/17538157.2020.1839467
   Asadzadeh A., 2021, INFORM MED UNLOCKED, V23, P100558, DOI [10.1016/j.imu.2021.100558, DOI 10.1016/J.IMU.2021.100558]
   Asadzadeh Afsoon, 2021, Inform Med Unlocked, V24, P100579, DOI 10.1016/j.imu.2021.100579
   Asadzadeh Afsoon, 2020, Inform Med Unlocked, V21, P100475, DOI 10.1016/j.imu.2020.100475
   Bahl S, 2020, J IND INTEGR MANAG, V5, P547, DOI 10.1142/S2424862220300057
   Baj J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061753
   Bragazzi NL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093176
   Center for Presidential Strategic Studies, 2020, EV IR EXP US CAP NEW
   Chamola V, 2020, IEEE ACCESS, V8, P90225, DOI 10.1109/ACCESS.2020.2992341
   Cozzarin BP, 2017, ECON INNOV NEW TECH, V26, P405, DOI 10.1080/10438599.2016.1204779
   Ding XR, 2021, IEEE REV BIOMED ENG, V14, P48, DOI 10.1109/RBME.2020.2992838
   Dixit S, 2021, REV CARDIOVASC MED, V22, P115, DOI 10.31083/j.rcm.2021.01.187
   Doosti-Irani A, 2020, J RES HEALTH SCI, V20, DOI 10.34172/jrhs.2020.27
   Eslami P., 2021, MED J ISLAMIC REPUBL, V35, P1, DOI [10.34171/mjiri.35.43, DOI 10.34171/MJIRI.35.43]
   Franch-Pardo I, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.140033
   Haleem A, 2020, J IND INTEGR MANAG, V5, P531, DOI 10.1142/S2424862220300045
   Hosseini P, 2020, ARXIV PREPRINT ARXIV
   Ikram Talha, 2020, 2020 IEEE 17th International Conference on Smart Communities: Improving Quality of Life Using ICT, IoT and AI (HONET), P194, DOI 10.1109/HONET50430.2020.9322821
   Islam MM, 2021, IEEE ACCESS, V9, P30551, DOI 10.1109/ACCESS.2021.3058537
   Islam MN, 2020, IEEE ACCESS, V8, P145601, DOI 10.1109/ACCESS.2020.3015102
   Islam MN, 2020, IEEE ACCESS, V8, P114078, DOI 10.1109/ACCESS.2020.3002445
   Ito R, 2020, DIAGN INTERV RADIOL, V26, P443, DOI 10.5152/dir.2019.20294
   Iyengar K, 2020, DIABETES METAB SYND, V14, P733, DOI 10.1016/j.dsx.2020.05.033
   Kalhori SRN, 2021, J MED INTERNET RES, V23, DOI 10.2196/19473
   Kolifarhood G, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.620
   Kondylakis H, 2020, J MED INTERNET RES, V22, DOI 10.2196/23170
   Kumar A, 2020, DIABETES METAB SYND, V14, P569, DOI 10.1016/j.dsx.2020.05.008
   Latif S, 2020, IEEE T ARTIF INTELL, V1, P85, DOI [DOI 10.1109/TAI.2020.3020521, 10.36227/techrxiv.12212516.v2]
   Malden S, 2021, J AM MED INFORM ASSN, V28, P1555, DOI 10.1093/jamia/ocab057
   Maserat E, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11419-y
   Mbunge E, 2020, DIABETES METAB SYND, V14, P1631, DOI 10.1016/j.dsx.2020.08.029
   Mohammadzadeh Z., 2021, RAPID REV DEPICTION, V12, P78
   Mohsenzadeh F, 2009, ELECTRON LIBR, V27, P986, DOI 10.1108/02640470911004075
   Moore JH, 2020, BIODATA MIN, V13, DOI 10.1186/s13040-020-00213-y
   Ndiaye M, 2020, IEEE ACCESS, V8, P186821, DOI 10.1109/ACCESS.2020.3030090
   Ozsahin I, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/9756518
   Papadopoulos T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102192
   Rahayu P., 2021, Journal of Physics: Conference Series, V1844, DOI 10.1088/1742-6596/1844/1/012029
   Raoofi A, 2020, ARCH IRAN MED, V23, P220, DOI 10.34172/aim.2020.02
   Ricci L, 2021, IEEE ACCESS, V9, P37936, DOI 10.1109/ACCESS.2021.3063152
   Sadighbayan D, 2021, IEEE SENS J, V21, P10219, DOI 10.1109/JSEN.2021.3059970
   Saran S, 2020, J INDIAN SOC REMOTE, V48, P1121, DOI 10.1007/s12524-020-01140-5
   Sarbadhikari S, 2020, INDIAN J PUBLIC HLTH, V64, P117, DOI 10.4103/ijph.IJPH_457_20
   Senthilraja M, 2021, SLAS TECHNOL, V26, P123, DOI 10.1177/2472630320983813
   Swayamsiddha S, 2020, DIABETES METAB SYND, V14, P911, DOI 10.1016/j.dsx.2020.06.014
   Ulhaq A, 2020, IEEE ACCESS, V8, P179437, DOI 10.1109/ACCESS.2020.3027685
   Vaishya R, 2020, DIABETES METAB SYND, V14, P337, DOI 10.1016/j.dsx.2020.04.012
   Vargo D, 2021, HUM BEHAV EMERG TECH, V3, P13, DOI 10.1002/hbe2.242
   Ye Q, 2020, JMIR MED INF, V8, DOI 10.2196/19515
NR 54
TC 0
Z9 0
U1 5
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 26
PY 2022
VL 22
IS 1
AR 402
DI 10.1186/s12889-022-12781-1
PG 15
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA ZI0OK
UT WOS:000761326200002
PM 35219292
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Chan, J
   Gao, YX
   McGinley, S
AF Chan, Janelle
   Gao, Yixing (Lisa)
   McGinley, Sean
TI Updates in service standards in hotels: how COVID-19 changed operations
SO INTERNATIONAL JOURNAL OF CONTEMPORARY HOSPITALITY MANAGEMENT
LA English
DT Article
DE Crisis management; Servicescape; Service standards; COVID-19
ID CUSTOMER SATISFACTION; QUALITATIVE RESEARCH; INNOVATION; CRISIS;
   INDUSTRY; IMPACT; INTENTIONS; EXPERIENCE; MANAGEMENT; FRAMEWORK
AB Purpose
   The COVID-19 pandemic has tremendously affected the hospitality industry. With the experiences of severe acute respiratory syndrome in 2003 and commitments to ensure guests' health and safety, many hotels in Asia have actively engaged in updating and implementing new service standards and measures. This study aims to investigate hotels' service standard changes, processes of management decisions and preparations for the future.
   Design/methodology/approach
   Using grounded theory methodology, this research interviews 24 hotel managers from mainland China and Hong Kong. It examines the differences among hotels with different operation types, classifications and locations, and analyzes the service standards in physical and social services cape.
   Findings
   Building on the service marketing and crisis management literature, this research provides a synthesis that reflects how hotels have coped with the COVID-19 crisis. It depicts the service standard update process during the COVID-19.
   Research limitations/implications
   In line with the literature in disaster management, hotels experienced the outbreak, response and recovery phases of the crisis management procedure. However, given the severity and scope of the COVID-19 pandemic, undertaking particular processes is necessary at every procedure such as following local guidelines and updating local standard operating procedures (LSOPs). This research also expands the literature on the process of adopting new technology in hotels during crisis management.
   Practical implications
   The paper suggests that hotel managers should update and use well-thought-out standards on the bases of available scientific evidence. For example, hotels should use LSOPs according to the local situations. Hotels are also suggested to exert additional efforts and attention in service innovation, guest experience and enhancing hospitableness.
   Originality/value
   To the best of the authors' knowledge, this paper is one of the first efforts to investigate the impact of COVID-19 on hotel operations. It offers empirical evidence from hotel operators who worked against the crisis during the pandemic and provides valuable theoretical contribution to the hospitality service literature as well as managerial implications for hotel operators globally.
C1 [Chan, Janelle; Gao, Yixing (Lisa)] Hong Kong Polytech Univ, Sch Hotel & Tourism Management, Kowloon, Hong Kong, Peoples R China.
   [McGinley, Sean] Florida State Univ, Dedman Sch Hospitality, Tallahassee, FL 32306 USA.
RP Gao, YX (corresponding author), Hong Kong Polytech Univ, Sch Hotel & Tourism Management, Kowloon, Hong Kong, Peoples R China.
EM lisa.gao@polyu.edu.hk
OI Gao, Lisa/0000-0001-6919-434X; Chan, Janelle/0000-0001-9190-7481
CR Aguinis H, 2019, STRATEGIC MANAGE J, V40, P1291, DOI 10.1002/smj.3015
   Aliperti G, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102808
   Barrett M, 2015, MIS QUART, V39, P135
   Baum T, 2020, INT J CONTEMP HOSP M, V32, P2813, DOI 10.1108/IJCHM-04-2020-0314
   Baum T, 2020, INT J CONTEMP HOSP M, V32, P2397, DOI 10.1108/IJCHM-03-2020-0242
   Best Western, 2020, SEL CORP HOT IN
   Bitner MJ, 2008, CALIF MANAGE REV, V50, P66, DOI 10.2307/41166446
   BITNER MJ, 1992, J MARKETING, V56, P57, DOI 10.2307/1252042
   Butcher K., 2005, International Journal of Contemporary Hospitality Management, V17, P125, DOI 10.1108/09596110510582323
   Campo S, 2014, INT J CONTEMP HOSP M, V26, P1292, DOI 10.1108/IJCHM-08-2013-0373
   Charmaz K., 2011, 4 SAGE HDB QUALITATI, P359, DOI DOI 10.4236/IB.2011.33031
   Chen WJ, 2011, INT J HOSP MANAG, V30, P64, DOI 10.1016/j.ijhm.2010.07.006
   Chien Grace C L, 2003, Int J Hosp Manag, V22, P327, DOI 10.1016/S0278-4319(03)00041-0
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Corbin J.M., 2008, BASICS QUALITATIVE R, V3rd ed., P127, DOI DOI 10.4135/9781452230153
   Creswell JW, 2012, QUALITATIVE INQUIRY
   Dominic E., 2005, J SERV MARK, V19, P336
   Driver C., 2001, J SERV RES-US, V4, DOI [10.1177/109467050142005, DOI 10.1177/109467050142005]
   Durna U, 2015, INT J CONTEMP HOSP M, V27, P1728, DOI 10.1108/IJCHM-04-2014-0173
   Enz C. A., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P119, DOI 10.1016/S0010-8804(02)80062-3
   Evans N., 2005, International Journal of Tourism Research, V7, P135, DOI 10.1002/jtr.527
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Geerts W, 2014, INT J HOSP MANAG, V39, P87, DOI 10.1016/j.ijhm.2014.02.007
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Hanks L, 2018, INT J HOSP MANAG, V74, P13, DOI 10.1016/j.ijhm.2018.01.022
   Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636
   He J, 2021, INT J CONTEMP HOSP M, V33, P346, DOI 10.1108/IJCHM-04-2020-0300
   Hemmington N, 2018, J SERV THEOR PRACT, V28, P2, DOI 10.1108/JSTP-06-2017-0103
   Henderson J. C., 2004, International Journal of Tourism Research, V6, P411, DOI 10.1002/jtr.505
   Hilliard TW, 2011, J HOSP MARKET MANAG, V20, P638, DOI 10.1080/19368623.2011.536077
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Jones P, 2020, INT J CONTEMP HOSP M, V32, P3037, DOI 10.1108/IJCHM-04-2020-0357
   Kelle U., 2007, SAGE HDB GROUNDED TH, P191, DOI DOI 10.4135/9781848607941.N9
   Kindstrom D, 2013, J BUS RES, V66, P1063, DOI 10.1016/j.jbusres.2012.03.003
   King C. A., 1984, Cornell Hotel and Restaurant Administration Quarterly, V25, P92, DOI 10.1177/001088048402500318
   Lai IKW, 2020, INT J CONTEMP HOSP M, V32, P3135, DOI 10.1108/IJCHM-04-2020-0325
   Langley A., 2009, SAGE HDB ORG RES MET, P409
   Lin I. Y., 2004, International Journal of Hospitality Management, V23, P163, DOI 10.1016/j.ijhm.2003.01.001
   Lincoln Y.S., 1985, NATURALISTIC INQUIRY
   Liu MT, 2021, INT J CONTEMP HOSP M, V33, P1249, DOI 10.1108/IJCHM-07-2020-0678
   Liu YW, 2020, J AM STAT ASSOC, DOI 10.1080/01621459.2020.1831926
   Lo A., 2006, Asia Pacific Journal of Tourism Research, V11, P65, DOI 10.1080/10941660500500733
   Lo YC, 2018, INT J CONTEMP HOSP M, V30, P1705, DOI [10.1108/IJCHM-04-2017-0206, 10.1108/ijchm-04-2017-0206]
   Lockyer T., 2003, International Journal of Hospitality Management, V22, P297, DOI 10.1016/S0278-4319(03)00024-0
   Lothane HZ, 2011, ARCH PSYCHIATR PSYCH, V13, P29
   Lu C, 2015, INT J CULT TOUR HOSP, V9, P168, DOI 10.1108/IJCTHR-10-2014-0087
   Manhas PS, 2015, INT J HOSP MANAG, V45, P77, DOI 10.1016/j.ijhm.2014.11.010
   Mattila S.A., 1999, J SERV RES-US, V1, P250, DOI DOI 10.1177/109467059913006
   McGinley S, 2021, CORNELL HOSP Q, V62, P8, DOI 10.1177/1938965520940294
   Min H., 2002, J SERV MARK, V16, P302
   Mody M, 2019, INT J HOSP MANAG, V76, P286, DOI 10.1016/j.ijhm.2018.05.017
   Nasution HN, 2008, INT J HOSP MANAG, V27, P204, DOI 10.1016/j.ijhm.2007.02.003
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   Nunkoo R, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2019.102414
   Okumus F, 2005, TOURISM MANAGE, V26, P95, DOI 10.1016/j.tourman.2003.08.013
   Ordanini A, 2011, J SERV RES-US, V14, P3, DOI 10.1177/1094670510385332
   Pappas N, 2018, TOURISM MANAGE, V68, P450, DOI 10.1016/j.tourman.2018.04.009
   Paraschiv, 2020, WILL COVID 19 FORCE
   PARASURAMAN A, 1985, J MARKETING, V49, P41, DOI 10.2307/1251430
   Park H, 2019, INT J CONTEMP HOSP M, V31, P2933, DOI 10.1108/IJCHM-02-2018-0105
   Prideaux B, 2003, TOURISM MANAGE, V24, P475, DOI 10.1016/S0261-5177(02)00115-2
   Ritchie BW, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102812
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Robinson OC, 2014, QUAL RES PSYCHOL, V11, P25, DOI 10.1080/14780887.2013.801543
   Sausmarez N. de, 2007, Journal of Sustainable Tourism, V15, P700, DOI 10.2167/jost653.0
   Senior M., 1990, INT J CONT HOSPITALI, V2
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Shin H, 2019, INT J HOSP MANAG, V80, P101, DOI 10.1016/j.ijhm.2019.01.012
   STR, 2020, COVID 19 WEB SUMM 5
   Strauss A.L., 1987, QUALITATIVE ANAL SOC
   Strauss AL, 2017, DISCOVERY GROUNDED T
   Sutthijakra S, 2011, SERV IND J, V31, P545, DOI 10.1080/02642069.2010.504824
   Tombs A., 2003, MARKET THEOR, V3, P447
   Tse Alan C B, 2006, Int J Hosp Manag, V25, P3, DOI 10.1016/j.ijhm.2004.12.001
   Ueno A, 2010, J SERV MARK, V24, P74, DOI 10.1108/08876041011017907
   Victorino L., 2005, MANAGING SERVICE QUA, V15
   Walls A, 2011, J HOSP MARKET MANAG, V20, P166, DOI 10.1080/19368623.2011.536074
   Wang WD, 2004, J THEOR BIOL, V227, P369, DOI 10.1016/j.jtbi.2003.11.014
   Whitla P., 2007, International Journal of Hospitality Management, V26, P777, DOI 10.1016/j.ijhm.2006.08.001
   Wu HC, 2018, J HOSP TOUR MANAG, V37, P42, DOI 10.1016/j.jhtm.2018.09.003
   Xu X, 2016, INT J HOSP MANAG, V55, P57, DOI 10.1016/j.ijhm.2016.03.003
   Yasin M. M., 1995, International Journal of Contemporary Hospitality Management, V7, P27, DOI 10.1108/09596119510083238
   Zeithaml V.A., 2018, SERVICES MARKETING I
   Zemke DMV, 2015, INT J CONTEMP HOSP M, V27, P690, DOI 10.1108/IJCHM-01-2014-0020
NR 85
TC 12
Z9 12
U1 20
U2 44
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-6119
EI 1757-1049
J9 INT J CONTEMP HOSP M
JI Int. J. Contemp. Hosp. Manag.
PD JUL 6
PY 2021
VL 33
IS 5
BP 1668
EP 1687
DI 10.1108/IJCHM-09-2020-1013
EA MAY 2021
PG 20
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA TH6DN
UT WOS:000649805800001
OA Bronze
DA 2022-04-20
ER

PT J
AU Burgos, R
   Garcia-Almeida, JM
   Matia-Martin, P
   Palma, S
   Sanz-Paris, A
   Zugasti, A
   Alfaro, JJ
   Fullana, AA
   Continente, AC
   Chicetru, MJ
   Malpartida, KG
   Faes, AG
   Sanchez, VG
   Lopez, ML
   Ortega, AJM
   Roldan, JO
   Moreno, CS
   Llanos, PS
AF Burgos, Rosa
   Manuel Garcia-Almeida, Jose
   Matia-Martin, Pilar
   Palma, Samara
   Sanz-Paris, Alejandro
   Zugasti, Ana
   Joaquin Alfaro, Jose
   Artero Fullana, Ana
   Calanas Continente, Alfonso
   Jesus Chicetru, Maria
   Garcia Malpartida, Katherine
   Gonzalez Faes, Angela
   Gonzalez Sanchez, Victor
   Lainez Lopez, Maria
   Martinez Ortega, Antonio Jesus
   Oliva Roldan, Juana
   Serrano Moreno, Clara
   Suarez Llanos, Pablo
TI Malnutrition management of hospitalized patients with
   diabetes/hyperglycemia and COVID-19 infection
SO REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
LA English
DT Article
DE COVID-19; Diabetes; Hyperglycemia; Malnutrition; Medical nutrition
ID PREVALENCE; NUTRITION; SEVERITY; OUTCOMES; CARE; TOOL
AB Diabetes mellitus and/or hyperglycemia are highly prevalent medical conditions in patients hospitalized for coronavirus disease 2019 (COVID-19) and are associated with adverse outcomes. In addition, COVID-19 itself can provoke fluctuating and high glucose levels that can be difficult to manage upon hospitalization. Hospitalized patients with COVID-19 are at high risk of malnutrition due to an increase in nutritional requirements and a severe acute inflammatory response. The management of patients with diabetes/hyperglycemia and COVID-19 is challenging and requires a specific nutritional approach, the purpose of which is to fulfill the nutritional requirements while maintaining an optimal glycemic control. In this study, an expert group of nutritional endocrinologists carried out a qualitative literature review and provided recommendations based on evidence and guidelines, when available, or on their own experience. The optimal care based on these recommendations was compared with the routine bedside care as reported by a panel of physicians (mainly, endocrinologists, geriatricians, and internists) treating patients with diabetes/hyperglycemia and COVID-19 in their daily practice. Early screening and diagnosis, a diabetes-specific therapeutic approach, and a close malnutrition monitoring are essential to improve the clinical outcomes of these patients. In conclusion, the proposed recommendations are intended to provide a useful guide on the clinical management of malnutrition in patients with COVID-19 and diabetes/hyperglycemia, in order to improve their outcomes and accelerate their recovery. The comparison of the recommended optimal care with routine clinical practice could aid to identify gaps in knowledge, implementation difficulties, and areas for improvement in the management of malnutrition in this population.
C1 [Burgos, Rosa] Hosp Univ Vall dHebron, Unidad Soporte Nutr, Barcelona, Spain.
   [Manuel Garcia-Almeida, Jose] Hosp Virgen de La Victoria, Unidad Gest Clin Endocrinol & Nutr, Malaga, Spain.
   [Matia-Martin, Pilar] Hosp Clin San Carlos, Dept Endocrinol & Nutr, Madrid, Spain.
   [Palma, Samara] Hosp Univ La Paz, Unidad Nutr Clin & Dietet, Madrid, Spain.
   [Sanz-Paris, Alejandro] Miguel Servet Univ Hosp, Nutr Dept, Zaragoza 50009, Spain.
   [Sanz-Paris, Alejandro] Inst Invest Sanitaria IIS Aragon, Zaragoza 50009, Spain.
   [Zugasti, Ana] Hosp Univ Navarra, Unidad Nutr Clin, Pamplona 31008, Spain.
   [Joaquin Alfaro, Jose] Complejo Hosp Univ Albacete, Albacete, Spain.
   [Artero Fullana, Ana] Hosp Univ Gen, Valencia, Spain.
   [Calanas Continente, Alfonso] Hosp Univ Reina Sofia, Cordoba, Spain.
   [Jesus Chicetru, Maria] Hosp San Pedro, La Rioja, Spain.
   [Garcia Malpartida, Katherine] Hosp Univ Politecn La Fe, Valencia, Spain.
   [Gonzalez Faes, Angela] Hosp Marques de Valdecilla, Santander, Spain.
   [Gonzalez Sanchez, Victor] Hosp Alcorcon, Madrid, Spain.
   [Lainez Lopez, Maria] Hosp Juan Ramon Jimenez, Huelva, Spain.
   [Martinez Ortega, Antonio Jesus] Hosp Univ Torrecardenas, Huelva, Spain.
   [Oliva Roldan, Juana] Hosp Univ Infanta Sofia, Madrid, Spain.
   [Serrano Moreno, Clara] Hosp Univ Gregorio Maranon, Madrid, Spain.
   [Suarez Llanos, Pablo] Hosp Nuestra Senora de La Candelaria, Tenerife, Spain.
RP Sanz-Paris, A (corresponding author), Miguel Servet Univ Hosp, Nutr Dept, Zaragoza 50009, Spain.; Sanz-Paris, A (corresponding author), Inst Invest Sanitaria IIS Aragon, Zaragoza 50009, Spain.
EM asanzp@salud.aragon.es
FU AbbottAbbott Laboratories
FX This study was funded by Abbott. Abbott Nutrition was the sponsor of the
   study, but it didn't participate in the design, research, data
   collection and data review.
CR Apicella M, 2020, LANCET DIABETES ENDO, V8, P782, DOI 10.1016/S2213-8587(20)30238-2
   Argenziano Michael G, 2020, medRxiv, DOI 10.1101/2020.04.20.20072116
   Barazzoni R, 2020, REV ENDOCR METAB DIS, V21, P307, DOI 10.1007/s11154-020-09578-1
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   Bedock D, 2020, CLIN NUTR ESPEN, V40, P214, DOI 10.1016/j.clnesp.2020.09.018
   Bravata DM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.34266
   Bray GA, 2013, DIABETES CARE, V36, P11, DOI 10.2337/dc12-1631
   Burgos R, 2020, CLIN NUTR, V39, P1447, DOI 10.1016/j.clnu.2019.06.006
   Caccialanza R, 2020, NUTRITION, V74, DOI 10.1016/j.nut.2020.110835
   Carriel J, 2022, REV CLIN ESP, V222, P37, DOI 10.1016/j.rce.2020.10.001
   Casas-Rojo JM, 2020, REV CLIN ESP, V220, P480, DOI 10.1016/j.rce.2020.07.003
   Chiodini I, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.736665
   Corona G, 2021, REV ENDOCR METAB DIS, V22, P275, DOI 10.1007/s11154-021-09630-8
   Elia M., 2003, MUST REPORT NUTR SCR
   Fiaccadori E, 2021, CLIN NUTR, V40, P1644, DOI 10.1016/j.clnu.2021.01.028
   Fiorindi C, 2021, CLIN NUTR ESPEN, V45, P351, DOI 10.1016/j.clnesp.2021.07.020
   Flood A, 2014, CLIN NUTR, V33, P106, DOI 10.1016/j.clnu.2013.03.003
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Goyal H, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.603276
   Hicks C, 2012, ANN HEMATOL, V91, P1795, DOI 10.1007/s00277-012-1523-1
   Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7
   Kapoor R, 2020, J CLIN MED, P9
   Krznaric Z, 2020, CLIN NUTR, V39, P1983, DOI 10.1016/j.clnu.2020.05.006
   Liu H, 2020, AGING DIS, V11, P668, DOI 10.14336/AD.2020.0502
   Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048
   Mehta AA, 2021, DIABETES METAB SYND, V15, P535, DOI 10.1016/j.dsx.2021.02.020
   Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925
   Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]
   Radujkovic A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092757
   Roncon L, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104354
   Rouget A, 2021, BRIT J NUTR, V126, P1296, DOI 10.1017/S0007114520005127
   Paris AS, 2013, NUTR HOSP, V28, P592, DOI 10.3305/nh.2013.28.3.6472
   Sardu C, 2020, DIABETES CARE, V43, P1408, DOI 10.2337/dc20-0723
   Shen Yun, 2021, Obes Med, V22, P100328, DOI 10.1016/j.obmed.2021.100328
   Silvah JH, 2021, CLIN NUTR ESPEN, V45, P507, DOI 10.1016/j.clnesp.2021.07.005
   Singh AK, 2020, DIABETES OBES METAB, V22, P1915, DOI 10.1111/dom.14124
   Skrajnowska D, 2021, NUTRIENTS, V13
   Slee A, 2015, CLIN NUTR, V34, P296, DOI 10.1016/j.clnu.2014.04.013
   Tappenden KA, 2013, JPEN-PARENTER ENTER, V37, P482, DOI 10.1177/0148607113484066
   Tastle WJ, 2007, INT J APPROX REASON, V45, P531, DOI 10.1016/j.ijar.2006.06.024
   Thakur B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88130-w
   Wang WJ, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.791476
   Whyte MB, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108217
   Wu CT, 2021, CELL METAB, V33, P1565, DOI 10.1016/j.cmet.2021.05.013
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yang Y, 2020, OBESITY, V28, P2040, DOI 10.1002/oby.22971
   Zhu L, 2020, CARDIORENAL MED, V10, P470, DOI 10.1159/000510916
NR 47
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-9155
EI 1573-2606
J9 REV ENDOCR METAB DIS
JI Rev. Endocr. Metab. Disord.
PD APR
PY 2022
VL 23
IS 2
SI SI
BP 205
EP 213
DI 10.1007/s11154-022-09714-z
EA MAR 2022
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA ZU6DT
UT WOS:000764514800001
PM 35244834
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Schwartz, RA
   Pradhan, S
   Murrell, DF
   Jafferany, M
   Olisova, OY
   Lomonosov, KM
   Lotti, T
   Goldust, M
AF Schwartz, Robert A.
   Pradhan, Swetalina
   Murrell, Dedee F.
   Jafferany, Mohammad
   Olisova, Olga Y.
   Lomonosov, Konstantin M.
   Lotti, Torello
   Goldust, Mohamad
TI COVID-19 and immunosuppressive therapy in dermatology
SO DERMATOLOGIC THERAPY
LA English
DT Review
DE COVID 19; dermatology; immunosuppressive therapy
ID ATOPIC-DERMATITIS; DIAGNOSIS
AB Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID-19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID-19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID-19 infection.
C1 [Schwartz, Robert A.] Rutgers New Jersey Med Sch, Dept Dermatol, Newark, NJ USA.
   [Pradhan, Swetalina] All India Inst Med Sci, Dept Dermatol & Venereol, Patna, Bihar, India.
   [Murrell, Dedee F.] Univ New South Wales, St George Hosp, Dept Dermatol, Fac Med, Sydney, NSW, Australia.
   [Jafferany, Mohammad] Cent Michigan Univ, Coll Med, Saginaw, MI USA.
   [Olisova, Olga Y.; Lomonosov, Konstantin M.; Lotti, Torello] IM Sechenov First Moscow State Med Univ, Dept Dermatol & Venereol, Moscow, Russia.
   [Lotti, Torello] Univ Studies Guglielmo Marconi, Dept Dermatol, Rome, Italy.
   [Goldust, Mohamad] Univ Studies Guglielmo Marconi, Rome, Italy.
   [Goldust, Mohamad] Univ Hosp Basel, Dept Dermatol, Basel, Switzerland.
RP Goldust, M (corresponding author), Univ Basel Hosp, Dept Dermatol & Allergy, Basel, Switzerland.
EM mohamad.goldust@usb.ch
OI Schwartz, Robert/0000-0003-3036-3825; Jafferany,
   Mohammad/0000-0001-6358-9068
CR Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x
   Arora G, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13359
   Choy EH, 2005, COCHRANE DB SYST REV, V3
   Darsow U, 2010, J EUR ACAD DERMATOL, V24, P317, DOI 10.1111/j.1468-3083.2009.03415.x
   Didona D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01418
   Heller M, 2007, BRIT J DERMATOL, V157, P127, DOI 10.1111/j.1365-2133.2007.07947.x
   Jadotte YT, 2012, J AM ACAD DERMATOL, V66, P187, DOI 10.1016/j.jaad.2011.09.039
   Kasperkiewicz M, 2020, J EUR ACAD DERMATOL, V34, pE302, DOI 10.1111/jdv.16525
   Kroger AT, GEN BEST PRACTICE GU
   Kumar R, 2018, INDIAN J DERMATOL, V63, P117, DOI 10.4103/ijd.IJD_583_17
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Marie I, 2012, CURR RHEUMATOL REP, V14, P275, DOI 10.1007/s11926-012-0249-3
   Megna Matteo, 2020, J Dermatolog Treat, V31, P328, DOI [10.1080/09546634.2020.1781044, 10.1080/09546634.2020.1757605]
   Murrell DF, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13538
   Okogbaa J, 2019, CLIN MED INSIGHT-CAS, V12, DOI 10.1177/1179547619855370
   Olenak JL, 2012, KODA KIMBLE YOUNGS A
   Papp KA, 2019, J CUTAN MED SURG, V23, P50, DOI 10.1177/1203475418811335
   Rendon A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061475
   Ring J, 2012, J EUR ACAD DERMATOL, V26, P1045, DOI 10.1111/j.1468-3083.2012.04635.x
   Robinson AB, 2011, NAT REV RHEUMATOL, V7, P664, DOI 10.1038/nrrheum.2011.139
   Rudnicka L, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13361
   Shakshouk H, 2020, J AM ACAD DERMATOL, V82, pE235, DOI 10.1016/j.jaad.2020.04.005
   Sharma A, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13398
   Tanriover MD, 2016, EUR J RHEUMATOL, V3, P29, DOI 10.5152/eurjrheum.2016.16100
   Wollenberg A, 2020, J EUR ACAD DERMATOL, V34, pE241, DOI 10.1111/jdv.16411
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 26
TC 3
Z9 4
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1396-0296
EI 1529-8019
J9 DERMATOL THER
JI Dermatol. Ther.
PD NOV
PY 2020
VL 33
IS 6
AR e14140
DI 10.1111/dth.14140
EA SEP 2020
PG 6
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA PO5WO
UT WOS:000565397700001
PM 32770592
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Lakew, S
   Gilano, G
   Feleke, T
AF Lakew, Serawit
   Gilano, Girma
   Feleke, Tesfaye
TI Covid-19 Community Mitigation Status at Selected Districts of Southwest
   Ethiopia: A Mixed Design Survey
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE covid-19; mitigation; community; Gamo; Southwest Ethiopia
AB Background: The spread of covid-19 was alarmingly continued in Ethiopia. This survey assessed the status of community mitigations to fight the pandemic. The ongoing forward effort by local task forces can be assessed to note the achievements.
   Methods: A mixed design using quantitative and qualitative triangulations used. Data was collected through interviewer administration using a structured W.H.O tool. The univariate and bivariate analysis employed to analyze descriptive statistics. The logistic regression model was applied to control confounders and determine potent predictors.
   Objective: This study assessed community mitigation status on covid-19 pandemic at four selected districts of southwest Ethiopia: a mixed design survey.
   Results: From the total of 624 participants interviewed, nearly half reported good mitigations toward fighting the covid-19 epidemic. This study suggested that nearly half (54.2%) of the participants had good knowledge about the newly emerged epidemic symptoms. Three out of five participants had good Knowledge of preventive practices (63.1%). Nearly four out of five (72.6%) participants were knowledgeable about 14 days incubation period. The odds of having good mitigation to prevent covid-19 among the participants who had single marital status were 55% lower than those married union (AOR=0.45, 95% CI: 0.24, 0.86). The odds of having good mitigation to prevent covid-19 among the participants (good knowledge symptoms) were 3.4 times higher than those with poor knowledge (AOR= 3.39, 95% CI: 2.19, 5.23).
   Conclusions and Recommendations: Participants' mitigation status to fight covid-19 was promising. Handwashing with soap and water, disinfecting surfaces, and covering mouth or nose while coughing were mitigated practices by the vast majority. Home staying was the least mitigated practice. Participants' demographic status, knowledge of the epidemic symptoms, and knowledge of preventive measures were potent predictors of mitigations to fight covid-19. HID services should be extended to the rural population through HCWs and task forces.
C1 [Lakew, Serawit] Arba Minch Univ, Coll Med & Hlth Sci, Maternal Reprod Hlth Nursing, Nech Sar Campus, Arba Minch, Southwest Ethio, Ethiopia.
   [Gilano, Girma] Arba Minch Univ, Coll Med & Hlth Sci, Hlth Informat, Sch Publ Hlth, Nech Sar Campus, Arba Minch, Southwest Ethio, Ethiopia.
   [Feleke, Tesfaye] Arba Minch Univ, Coll Med & Hlth Sci, Hlth Educ, Sch Publ Hlth, Nech Sar Campus, Arba Minch, Southwest Ethio, Ethiopia.
RP Lakew, S (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Maternal Reprod Hlth Nursing, Nech Sar Campus, Arba Minch, Southwest Ethio, Ethiopia.
EM Iserawit@yahoo.com
RI Gilano, Girma/AAU-4939-2021
OI Gilano, Girma/0000-0002-5847-1425
FU Arbaminch University covid-19 special committee
FX Our special gratitude and appreciation goes to the Arbaminch University
   covid-19 special committee for funding data collection of this research
   project. We were also grateful to Gamo Zone administrators, District
   Health Bureau, village administrators, respondents and supervisors for
   their unreserved effort to the success of this work.
CR [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   [Anonymous], UN POLICY BRIEF IMPA
   Bekele D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0234585
   Byanaku A., 2020, KNOWLEDGE ATTITUDES, DOI 10.1101/2020.04.26.20080820v2
   Centers for Disease Control and Prevention (CDC), CORONAVIRUS DIS 2019
   Chen XW, 2019, J RURAL HEALTH, V35, P405, DOI 10.1111/jrh.12335
   Ebrahim SH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1066
   Ethiopia, 2020, COVID 19 HUMANITARIA
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Food Security Group, 2020, AWARENESS RISK PERCE
   Mengistua H., 2013, AM SCI RES J ENG TEC, V3, P1
   Negera E, 2020, INADEQUATE LEVEL KNO, DOI [10.1101/2020.07.22.215590, DOI 10.1101/2020.07.22.215590]
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Paykani T, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09759-2
   Ssebuufu R., 2020, AWARENESS KNOWLEDGE, DOI [10.1101/2020.05.05.20092247, DOI 10.1101/2020.05.05.20092247]
   The World Bank, COVID 19 CORONAVIRUS
   WHO (COVID-19) Homepage, WHO CORONAVIRUS DIS
   WHO Regional Office for Europe, 2020, SURVEY TOOL GUIDANCE
   World Health Organization, PNEUMONIA UNKNOWN CA
   World Health Organization, 2020, COR DIS 2019 COVID 1
   World Health Organization, 2020, Q A CORONAVIRUSES CO
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 23
TC 0
Z9 0
U1 1
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 1763
EP 1775
DI 10.2147/RMHP.S292835
PG 13
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RU8UE
UT WOS:000645415400001
PM 33958901
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Chin, WL
   Musa, SFPD
AF Chin, Wei Lee
   Musa, Siti Fatimahwati Pehin Dato
TI Agritourism resilience against Covid-19: Impacts and management
   strategies
SO COGENT SOCIAL SCIENCES
LA English
DT Article
DE Agritourism; Covid-19 impacts; crisis management; tourism resilience;
   economic diversification; digital tourism; community capacity-building
ID GREEN CARE; AGRICULTURE; TOURISM; FOOD
AB The current Covid-19 pandemic has impacted tourism industry the hardest and has steered a total standstill in the multibillion industry, causing economic crisis globally. This paper attempts to assess the impacts and management strategies of agritourism in Brunei. Due to the constant evolvement of knowledge and management strategies during this unprecedented time, qualitative approach using semi-structured interviews was deemed appropriate for this research. This paper focuses on agritourism farms in Brunei during Covid-19 to study the implication and contingency plans to divert such crises. Findings from this study indicates that strategies employed by the Brunei agritourism farms were (1) the diversification of economic activities towards product innovation and agribusiness expansion to mitigate tourism revenue loss; (2) digital transformation such as, contact tracing app, the introduction of virtual tourism as well as the use of social media to promote agritourism as lower-risk tourism; (3) adaptive human resources strategy by encouraging community capacity building such as upskilling and training of local farmers to stimulate new agritourism skills and establish more future-ready workforce. The strategies adopted by the agritourism farms in Brunei could provide lessons to neighbouring countries and the ASEAN region to prepare for a crisis-resistant agritourism in the future.
C1 [Chin, Wei Lee] Univ Brunei Darussalam, Fac Arts & Social Sci, Jalan Tungku Link, BE-1410 Gadong, Brunei.
   [Musa, Siti Fatimahwati Pehin Dato] Univ Brunei Darussalam, UBD Sch Business & Econ, Jalan Tungku Link, BE-1410 Gadong, Brunei.
RP Chin, WL (corresponding author), Univ Brunei Darussalam, Fac Arts & Social Sci, Jalan Tungku Link, BE-1410 Gadong, Brunei.
EM weilee.chin@ubd.edu.bn; fatimahwati.musa@ubd.edu.bn
RI Chin, Shirley/AAX-9484-2021
OI Chin, Shirley/0000-0002-9297-283X; Pehin Dato Musa, Siti
   Fatimahwati/0000-0003-1987-4595
FU Universiti Brunei Darussalam [UBD/RSCH/URC/NIG/4.0/2020/002]
FX This work was supported by the Universiti Brunei Darussalam
   [UBD/RSCH/URC/NIG/4.0/2020/002]; Universiti Brunei Darussalam
   [UBD/RSCH/URC/NIG/4.0/2020/002].
CR [Anonymous], 2020, UNWTO WORLD TOUR BAR, V18, P1, DOI [10.18111/wtobarometereng.2020.18.1.1, DOI 10.18111/WTOBAROMETERENG]
   ASEAN Coordinating Committee on Micro Small and Medium Enterprises (ACCMSME), 2020, POLICY INSIGHT
   Barbieri C, 2009, P 2008 NE RECREATION
   Bhatta K., 2020, TOUR HOSP, V1, P23, DOI DOI 10.3390/TOURHOSP1010003
   Bulletin B., 2020, BORNEO B
   Bulletin B., 2020, BORNEO B
   Chan YW, 2016, ASIA PAC VIEWP, V57, P313, DOI 10.1111/apv.12130
   Chin W.L., 2018, BORNEO RES J, V12, P36, DOI [10.22452/brj.vol12no1.3, DOI 10.22452/BRJ.VOL12NO1.3]
   Chin W.L., 2017, TOURISM COMMUNITIES
   Chin WL, 2020, TOUR HOSP MANAG-CROA, V26, P311, DOI 10.20867/thm.26.2.3
   Chin WL, 2017, CURR ISSUES TOUR, V20, P1265, DOI 10.1080/13683500.2015.1111315
   de Boer B, 2017, J AM MED DIR ASSOC, V18, P40, DOI 10.1016/j.jamda.2016.10.013
   Djalante R, 2020, PROG DISASTER SCI, V8, DOI 10.1016/j.pdisas.2020.100129
   Dzisi Emmanuel Komla Junior, 2020, Transp Res Interdiscip Perspect, V7, P100191, DOI 10.1016/j.trip.2020.100191
   Edwards M.R, 2005, AGR EC ASS GEORGIA, V23, P57, DOI [10.22004/ag.econ.59611, DOI 10.22004/AG.ECON.59611]
   Fu YK, 2020, COGENT SOC SCI, V6, DOI 10.1080/23311886.2020.1829806
   Garibaldi R., 2020, TOURISM FACING PANDE, P45
   Gasser U, 2020, DIGITAL TOOLS COVID, P1
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Gretzel U, 2020, INF TECHNOL TOUR, V22, P187, DOI 10.1007/s40558-020-00181-3
   Hardesty S, 2020, CALIF AGR, V74, P123, DOI 10.3733/ca.2020a0026
   Haubenhofer DK, 2010, EXPLORE-NY, V6, P106, DOI 10.1016/j.explore.2009.12.002
   Jamaludin S, 2020, ANN MED SURG, V59, P165, DOI 10.1016/j.amsu.2020.09.046
   Kock F, 2020, ANN TOURISM RES, V85, DOI 10.1016/j.annals.2020.103053
   Leite H., 2020, TQM J, V33, P247, DOI DOI 10.1108/TQM-05-2020-0111
   Li JX, 2021, ANN TOURISM RES, V86, DOI 10.1016/j.annals.2020.102964
   Li ZY, 2020, J DESTIN MARK MANAGE, V18, DOI 10.1016/j.jdmm.2020.100502
   Liu Y, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12239910
   Lopes RO, 2019, 2019 IEEE FIFTH INTERNATIONAL CONFERENCE ON MULTIMEDIA BIG DATA (BIGMM 2019), P383, DOI [10.1109/BigMM.2019.00067, 10.1109/BigMM.2019.00019]
   Mackenzie JS, 2020, MICROBIOL AUST, V41, P45, DOI 10.1071/MA20013
   Martinus K., 2020, FACTBASE B, V69, P1
   Mastronardi L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145709
   Mbunge E, 2020, DIABETES METAB SYND, V14, P1631, DOI 10.1016/j.dsx.2020.08.029
   Milestad R., 2012, FARMING SYSTEMS RES, P365, DOI DOI 10.1007/978-94-007-4503-2_16
   Palmi P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155389
   Roman M, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10110569
   Roman M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12124858
   Ryu S, 2020, EMERG INFECT DIS, V26, P961, DOI 10.3201/eid2605.190993
   Schnell SM, 2013, AGR HUM VALUES, V30, P615, DOI 10.1007/s10460-013-9436-8
   Scoop T., 2020, ARCHIVE
   Scoop T, 2020, COVID 19 LIVE UPDATE
   Shamshiripour Ali, 2020, Transp Res Interdiscip Perspect, V7, P100216, DOI 10.1016/j.trip.2020.100216
   Shin H, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102664
   Sigala M., 2011, Information Technology and Tourism, V13, P269, DOI 10.3727/109830512X13364362859812
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Toh A, 2020, HUMAN RIGHTS WATCH
   Ullah A. K. M. A, 2020, GLOBAL AFFAIRS, V6, P203, DOI [10.1080/23340460.2020.1738951, DOI 10.1080/23340460.2020.1738951]
   Watch H.R., 2020, JOINT CIVIL SOC STAT
   Watch H.R., 2020, HUMAN RIGHTS WATCH
   Wilson ME, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa015
   Wojcieszak-Zbierska MM, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10090397
   Yu Y.W., 2020, ARXIV PREPRINT 20031
   Zheng DN, 2021, TOURISM MANAGE, V83, DOI 10.1016/j.tourman.2020.104261
NR 53
TC 4
Z9 4
U1 11
U2 19
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 2331-1886
J9 COGENT SOC SCI
JI Cogent Soc. Sci.
PD JAN 1
PY 2021
VL 7
IS 1
AR 1950290
DI 10.1080/23311886.2021.1950290
PG 19
WC Social Sciences, Interdisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA TK9JX
UT WOS:000674472200001
OA gold
DA 2022-04-20
ER

PT J
AU Martinez, MGA
   Costa, CL
   Lopez, JAG
   Ganfornina, MT
   Morcillo, AJR
   Ruiperez, TH
   Palenciano, CG
   Agea, JLD
AF Adanez Martinez, Maria Gracia
   Leal Costa, Cesar
   Garcia Lopez, Jose Antonio
   Torres Ganfornina, Maximo
   Ramos Morcillo, Antonio Jesus
   Hernandez Ruiperez, Tomas
   Garcia Palenciano, Carlos
   Diaz Agea, Jose Luis
TI Perception of level of knowledge, skills, and safety before and after
   training to perform videolaryngoscopy with the Intubox barrier system
   for airway management in patients with COVID-19
SO EMERGENCIAS
LA Spanish
DT Article
DE Training; Simulation; Airway management; Safety; COVID-19
ID SIMULATION
AB Objectives. The main objective was to describe physicians' perception of their knowledge, skill, and safety before and after training to perform videolaryngoscopy while using the Intubox barrier system when managing the airway of a patient with the coronavirus 2019 disease (COVID-19). The secondary objective was to assess the safety afforded by the barrier by means of visually evaluating particle dispersion during intubation.
   Methods. Single-arm clinical simulation trial. The participants were physicians who received training in both a lowfidelity and a high-fidelity simulation zone. The participants assessed their knowledge, skill, and safety when using the Intubox before and after training using a specially designed and validated questionnaire. Droplet contamination was estimated visually.
   Results. Twenty-seven physicians with a mean (SD) age of 40 (10.8) years participated; 63% were women. They perceived their knowledge, skill, and safety to be significantly higher after training. Droplet contamination was seen to decrease when airway management maneuvers were done with the barrier in place.
   Conclusions. After simulation training the emergency physicians judged their knowledge, skill, and safety to be greater when they used the barrier during airway management in patients with COVID-19. The combined use of a laryngoscope and the Intubox barrier resulted in less particle dispersion during intubation.
C1 [Adanez Martinez, Maria Gracia] Univ Murcia, Hosp Clin Univ Virgen de la Arrixaca, Serv Urgencias Hospitalarias, Murcia, Spain.
   [Leal Costa, Cesar; Ramos Morcillo, Antonio Jesus] Univ Murcia, Fac Enfermeria, Murcia, Spain.
   [Garcia Lopez, Jose Antonio; Torres Ganfornina, Maximo; Garcia Palenciano, Carlos] Hosp Clin Univ Virgen de la Arrixaca, Serv Anestesiol & Reanimac, El Palmar, Spain.
   [Hernandez Ruiperez, Tomas] Univ Catolica Murcia UCAM, Hosp Clin Univ Virgen de la Arrixaca, Serv Urgencias Hosp, Murcia, Spain.
   [Diaz Agea, Jose Luis] Univ Catolica Murcia, Fac Enfermeria, Murcia, Spain.
RP Costa, CL (corresponding author), Univ Murcia, Edif D,3a Planta,Despacho 20, Murcia 30100, Spain.
EM cleal@um.es
RI Costa, César Leal/S-8703-2016
OI Costa, César Leal/0000-0002-7711-3877
CR Ali AA, 2018, CLIN SIMUL NURS, V16, P15, DOI 10.1016/j.ecns.2017.09.009
   Ali Y, 2020, INT J SURG, V78, P66, DOI 10.1016/j.ijsu.2020.04.051
   Almanasreh E, 2019, RES SOC ADMIN PHARM, V15, P214, DOI 10.1016/j.sapharm.2018.03.066
   [Anonymous], COMPL SCEN PREP COVI
   Bland JM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2622
   Brewster DJ, 2020, MED J AUSTRALIA, V212, P472, DOI 10.5694/mja2.50598
   Canelli R, 2020, NEW ENGL J MED, V382, P1957, DOI 10.1056/NEJMc2007589
   Carratala Perales J, 2020, EMERGENCIAS, V32, P197
   Angulo CC, 2020, EMERGENCIAS, V32, P135
   Centro de Coordinacion de Alertas y Emergencias Sanitarias Direccion General de Salud PGblica Calidad e Innovacion, 2020, MAN CLIN COVID 19 UN
   Cheng A, 2016, SIMUL HEALTHC, V11, P238, DOI 10.1097/SIH.0000000000000150
   Cheng A, 2014, MED EDUC, V48, P657, DOI 10.1111/medu.12432
   Cheung JCH, 2020, LANCET RESP MED, V8, pE19, DOI 10.1016/S2213-2600(20)30084-9
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Feldman O, 2020, JAMA-J AM MED ASSOC, V323, P2091, DOI 10.1001/jama.2020.6633
   Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808
   Armengol JG, 2020, EMERGENCIAS, V32, P155
   INACSL Stand Comm, 2016, CLIN SIMUL NURS, V12, pS5, DOI 10.1016/j.ecns.2016.09.005
   Johns Hopkins University, COV 19 DASHB CTR SYS
   Kennedy CC, 2014, CRIT CARE MED, V42, P169, DOI 10.1097/CCM.0b013e31829a721f
   Naylor KA, 2019, J TAIBAH UNIV MED SC, V14, P481, DOI 10.1016/j.jtumed.2019.10.006
   Paik MC, 2013, STAT METHODS RATES P, P716
   Red Nacional de Vigilancia Epidemiologica, INF SIT COVID 19 PER
   Roussin CJ, 2017, ACAD MED, V92, P1114, DOI 10.1097/ACM.0000000000001746
   Rudolph JW, 2014, SIMUL HEALTHC, V9, P339, DOI 10.1097/SIH.0000000000000047
   Sarmah P, 2017, CURR OPIN UROL, V27, P316, DOI 10.1097/MOU.0000000000000401
   Tan SH., 2011, SAMPLE SIZE TABLES C, P314
   Tseng JY, 2020, J CHIN MED ASSOC, V83, P582, DOI 10.1097/JCMA.0000000000000324
   Vanderbilt AA, 2014, ADV MED EDUC PRACT, V5, P15, DOI 10.2147/AMEP.S51963
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yong PSA, 2020, BRIT J ANAESTH, V125, pE176, DOI 10.1016/j.bja.2020.04.007
NR 32
TC 0
Z9 0
U1 0
U2 0
PU Soc Espanola Medicina Urgencias & Emergencias - SEMES
PI Madrid
PA Nunez de Balboa 116, 3rd floor, office 9, Madrid, SPAIN
SN 1137-6821
EI 2386-5857
J9 EMERGENCIAS
JI Emergencias
PD APR
PY 2021
VL 33
IS 2
BP 93
EP 99
PG 7
WC Emergency Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Emergency Medicine
GA WI8CS
UT WOS:000708584100004
PM 33750049
DA 2022-04-20
ER

PT J
AU Sulistyawati, S
   Rokhmayanti, R
   Aji, B
   Wijayanti, SPM
   Hastuti, SKW
   Sukesi, TW
   Mulasari, SA
AF Sulistyawati, Sulistyawati
   Rokhmayanti, Rokhmayanti
   Aji, Budi
   Wijayanti, Siwi Pramatama Mars
   Hastuti, Siti Kurnia Widi
   Sukesi, Tri Wahyuni
   Mulasari, Surahma Asti
TI Knowledge, Attitudes, Practices and Information Needs During the
   COVID-19 Pandemic in Indonesia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; KAP; information needs; information-seeking behaviour
AB Introduction: In the absence of vaccines and specific drugs, prevention effort has been attributed as the primary control mechanism of COVID-19. Knowledge, attitude, and practice are used to determine the current situation and formulate appropriate control interventions as well as risk communication. This study, therefore, aims to assess knowledge, attitude, practice and information needs about COVID-19 in Indonesian society.
   Methods: A cross-sectional study was conducted through an online survey in the third week of August 2020. Purposive and random sampling was used to select the respondents. People with a minimum age of 18 years and residing in Indonesia were allowed to participate in this study. The survey was conducted with an online questionnaire that spread on several platforms such as WhatsApp, Instagram and Facebook by distributing the link and continuous chain messages on that platform. Data were analysed using descriptive, chi-square and logistic regression test.
   Results: A total of 816 respondents were included in this study. In general, public knowledge about COVID-19 was sufficient, but some topic areas were still low. Most people had a positive attitude about the COVID-19, but they provided a negative response to government policies. Most of the community has taken preventive measures for COVID-19. However, some behaviours received a low percentage. Information about how to prevent COVID-19 was the most wanted information during this pandemic. Social media was a favourite source of information, with the most popular type of visualisation was a table containing numbers. Age and education were significantly associated with knowledge. Some attitudes were affected by age and occupation scope. Gender and health insurance ownership significantly associated with preventive measures.
   Conclusion: This research highlights the importance of providing valid, effective, efficient, and continuous information to the public through appropriate channels to increase understanding about COVID-19 precautions.
C1 [Sulistyawati, Sulistyawati; Rokhmayanti, Rokhmayanti; Hastuti, Siti Kurnia Widi; Sukesi, Tri Wahyuni; Mulasari, Surahma Asti] Univ Ahmad Dahlan, Dept Publ Hlth, Jl Prof Dr Soepomo, Umbulharjo 55164, Yogyakarta, Indonesia.
   [Aji, Budi; Wijayanti, Siwi Pramatama Mars] Jenderal Soedirman Univ, Fac Hlth Sci, Dept Publ Hlth, Purwokerto 53122, Indonesia.
RP Sulistyawati, S (corresponding author), Univ Ahmad Dahlan, Dept Publ Hlth, Jl Prof Dr Soepomo, Umbulharjo 55164, Yogyakarta, Indonesia.
EM sulistyawati.suyanto@ikm.uad.ac.id
RI , Sulistyawati/AAC-3705-2021; Sulistyawati, Sulistyawati/C-2748-2016;
   Sukesi, Tri Wahyuni/AAJ-9659-2021
OI , Sulistyawati/0000-0002-7299-0360; Sulistyawati,
   Sulistyawati/0000-0002-7299-0360; Sukesi, Tri
   Wahyuni/0000-0002-8919-9700; Rokhmayanti,
   Rokhmayanti/0000-0002-6670-9325
FU Ministry of Research and Technology of Indonesia (KEMENRISTEK/BRIN)
   [PDUPT-001/SKPP, TJ/LPPM UAD/VI/2020]
FX This research was funded by the Ministry of Research and Technology of
   Indonesia (KEMENRISTEK/BRIN) to finance this research, grant number
   PDUPT-001/SKPP. TJ/LPPM UAD/VI/2020.
CR Adi GN, 2020, JAKARTA POST
   AlTakarli NS, 2020, DUBAI MED J, V3, P13, DOI 10.1159/000506678
   Andika S, 2020, REPUBLIKA ONLINE
   [Anonymous], 2020, FEMINA
   [Anonymous], 2020, EKONID NEWS
   [Anonymous], 2020, COR DIS 2019 COVID 1
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Begley S, 2020, STAT
   Bo YC, 2021, INT J INFECT DIS, V102, P247, DOI 10.1016/j.ijid.2020.10.066
   Center for Disease Control and Prevention. [CDC], 2020, PROT YOURS OTH
   Colfer CJP, 2015, WORLD DEV, V76, P147, DOI 10.1016/j.worlddev.2015.06.008
   Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638
   Djalante R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100091
   Donner NC, 2013, PFLUG ARCH EUR J PHY, V465, P601, DOI 10.1007/s00424-013-1271-7
   Dunleavy BP, 2020, STUDY YOUNG PEOPLE L
   EKONID Insight, 2020, COVID 19 DEV IND
   Farisa FC, 2020, KOMPAS          0318
   Green House, 2019, IND SOC MED LANDSC O
   Honarvar B, 2020, INT J PUBLIC HEALTH, V65, P731, DOI 10.1007/s00038-020-01406-2
   Jerant A, 2013, J AM BOARD FAM MED, V26, P759, DOI 10.3122/jabfm.2013.06.130054
   Khaled A, 2020, RISK MANAG HEALTHC P, V13, P1825, DOI 10.2147/RMHP.S271899
   Kurnia D., 2020, FRIDAY PEKANBAR 0821
   Kurniawan R., 2020, CNN TV
   Lee M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010121
   Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951
   Liu PL, 2020, CYBERPSYCH BEH SOC N, V23, P677, DOI 10.1089/cyber.2020.0250
   Loasana N., 2020, JAKARTA POST
   Mashabi Sania, 2020, KOMPAS
   Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223
   Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282
   Schroder I, 2020, ACS CHEM HEALTH SAFE, V27, P160, DOI 10.1021/acs.chas.0c00035
   Singer E, 2000, PUBLIC OPIN QUART, V64, P171, DOI 10.1086/317761
   Suciu P, 2020, FORBES
   Sulistyawati S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061013
   Sutrisno B., 2020, JAKARTA POST
   The Indonesian COVID-19 Task Force, 2020, INF COVID 19 22 AG 2, P2020
   The Jakarta Post The Jakarta Post, 2020, JAKARTA POST
   The Ministry of Health of Indonesia, 2020, GUID PREV CONTR COR
   The US Food and Drug, 2020, COR COVID 19 UPD FDA
   USAID and SPRING, 2011, KAP SURV MOD KNOWL A
   Wargadiredja AT, 2017, INDONESIANS WALK LES
   WHO Western Pacific, 2020, COVID 19 ADV PROT YO
   WHO-Europe, 2020, STAT OLD PEOPL AR HI
   World Health Organization, 2008, WHOHTMSTB200846
   Worldometer, 2020, COR CAS
NR 45
TC 7
Z9 7
U1 7
U2 12
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 163
EP 175
DI 10.2147/RMHP.S288579
PG 13
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA PV6KK
UT WOS:000610094800001
PM 33488129
OA Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Kakemam, E
   Ghoddoosi-Nejad, D
   Chegini, Z
   Momeni, K
   Salehiniya, H
   Hassanipour, S
   Ameri, H
   Arab-Zozani, M
AF Kakemam, Edris
   Ghoddoosi-Nejad, Djavad
   Chegini, Zahra
   Momeni, Khalil
   Salehiniya, Hamid
   Hassanipour, Soheil
   Ameri, Hosein
   Arab-Zozani, Morteza
TI Knowledge, Attitudes, and Practices Among the General Population During
   COVID-19 Outbreak in Iran: A National Cross-Sectional Online Survey
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE knowledge; attitudes; practices; COVID-19; online survey; Iran
ID AWARENESS
AB Background: Emerged in December 2019, coronavirus disease 2019 (COVID-19) is one of the largest pandemics ever. During the early phase, little was known about public knowledge, attitudes, and practices (KAP) relating to coronavirus disease. This study was designed to determine KAP of Iranians toward COVID-19.
   Methods: A cross-sectional online survey was carried out in Iran from February 25 to April 25 using a self-administered questionnaire on 1,480 people. COVID-19-related KAP questions were adapted from other internationally validated questionnaires specific for infectious diseases.
   Results: All participants were aware of COVID-19. When asked unprompted, 80% of respondents could correctly cite fever, difficulty in breathing, and cough as signs/symptoms of COVID-19. Most of our sample population knew that staying at home and isolated (95.3%) as well as constant handwashing and using disinfectants (92.5%) could prevent COVID-19. However, there were also widespread misconceptions such as the belief that COVID-19 can be transmitted by wild animals (58%) and by air (48.3%). Unprompted, self-reported actions taken to avoid COVID-19 infection included handwashing with soap and water (95.4%), avoiding crowded places (93%), cleansing hands with other disinfectants (80.), and covering mouth and nose when coughing or sneezing (76.1%). The Internet and social media (94.5%) were the main coronavirus information sources. However, the most trusted information sources on coronavirus were health and medical professionals (79.3%). The majority of participants (77.0%) wanted more information about coronavirus to be available.
   Conclusion: Our findings suggest that people's knowledge and attitude toward COVID-19 at the time of its outbreak was at a high level.
C1 [Kakemam, Edris] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran.
   [Ghoddoosi-Nejad, Djavad] Birjand Univ Med Sci, Sch Hlth, Dept Publ Hlth, Birjand, Iran.
   [Chegini, Zahra] Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Qazvin, Iran.
   [Momeni, Khalil] Ilam Univ Med Sci, Sch Hlth, Dept Publ Hlth, Ilam, Iran.
   [Salehiniya, Hamid] Birjand Univ Med Sci, Sch Hlth, Dept Publ Hlth, Birjand, Iran.
   [Hassanipour, Soheil] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran.
   [Ameri, Hosein] Shahid Sadoughi Univ Med Sci, Sch Publ Hlth, Dept Hlth Serv Management, Hlth Policy & Management Res Ctr, Yazd, Iran.
   [Arab-Zozani, Morteza] Birjand Univ Med Sci, Social Determinants Hlth Res Ctr, Birjand, Iran.
RP Arab-Zozani, M (corresponding author), Birjand Univ Med Sci, Social Determinants Hlth Res Ctr, Birjand, Iran.
EM morteza.arab.zozani@gmail.com
RI Hassanipour, Soheil/Y-7903-2019; Chegini, Zahra/N-5684-2019; Salehiniya,
   Hamid/ABG-4135-2021; Ameri, Hosein/V-7407-2018
OI Chegini, Zahra/0000-0001-9125-9453; Ameri, Hosein/0000-0002-9914-034X
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   ALdowyan N., 2017, INT ARCHIV MED, V10, P1, DOI [10.3823/2524sph.2016.15012016330, DOI 10.3823/2524SPH.2016.15012016330, DOI 10.3823/2524]
   Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082
   Arab-Zozani M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039730
   Arab-Zozani M, 2021, DISASTER MED PUBLIC, V15, pE43, DOI 10.1017/dmp.2020.261
   Arab-Zozani M, 2020, BALK MED J, V37, P231, DOI 10.4274/balkanmedj.galenos.2020.2020.4.67
   Clements JM, 2020, KNOWLEDGE BEHAV COVI, DOI [10.1101/2020.03.31.2004896, DOI 10.1101/2020.03.31.2004896]
   Gostic K, 2020, ELIFE, V9, DOI 10.7554/eLife.55570
   He N, 2009, AIDS EDUC PREV, V21, P570, DOI 10.1521/aeap.2009.21.6.570
   Jalloh MF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000285
   Johnson EJ, 2017, J PUBLIC HEALTH-HEID, V25, P333, DOI 10.1007/s10389-017-0790-7
   Kakemam E, 2020, KNOWLEDGE ATTITUDES, DOI [10.1101/2020.06.10.20127258, DOI 10.1101/2020.06.10.20127258]
   Kharma MY, 2015, J INT SOC PREV COMMU, V5, P163, DOI 10.4103/2231-0762.159951
   Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125
   McCloskey B, 2020, LANCET, V395, P1096, DOI 10.1016/S0140-6736(20)30681-4
   Moftakhar L, 2020, ARCH IRAN MED, V23, P235, DOI [10.34172/aim.2020.03, 10.34172/aim.2020.03 Abstract View:]
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Shokoohi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147587
   Signorelli Carlo, 2020, Acta Biomed, V91, P7, DOI [10.23750/abm.v91i9-S.10134, 10.23750/abm.v91i3-S.9507]
   World Health Organization, 2020, ROLL UPD COR DIS COV
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490
NR 24
TC 15
Z9 15
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD DEC 10
PY 2020
VL 8
AR 585302
DI 10.3389/fpubh.2020.585302
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA PI7MS
UT WOS:000601271200001
PM 33363083
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Sawalha, K
   Abozenah, M
   Kadado, AJ
   Battisha, A
   Al-Akchar, M
   Salerno, C
   Hernandez-Montfort, J
   Islam, AM
AF Sawalha, Khalid
   Abozenah, Mohammed
   Kadado, Anis John
   Battisha, Ayman
   Al-Akchar, Mohammad
   Salerno, Colby
   Hernandez-Montfort, Jaime
   Islam, Ashequl M.
TI Systematic Review of COVID-19 Related Myocarditis: Insights on
   Management and Outcome
SO CARDIOVASCULAR REVASCULARIZATION MEDICINE
LA English
DT Review
DE Myocarditis; COVID-19; Glucocorticoids; Tocilizumab; Pandemic
ID SARS; INFLAMMATION; PATIENT
AB Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also referred to as COVID-19, was declared a pandemic by the World Health Organization in March 2020. The manifestations of COVID-19 are widely variable and range from asymptomatic infection to multi-organ failure and death. Like other viral illnesses, acute myocarditis has been reported to be associated with COVID-19 infection. However, guidelines for the diagnosis of COVID-19 myocarditis have not been established.
   Methods: Using a combination of search terms in the PubMed/Medline, Ovid Medline and the Cochrane Library databases and manual searches on Google Scholar and the bibliographies of articles identified, we reviewed all cases reported in the English language citing myocarditis associated with COVID-19 infection.
   Results: Fourteen records comprising a total of fourteen cases that report myocarditis/myopericarditis secondary to COVID-19 infection were identified. There was a male predominance (58%), with the median age of the cases described being 50.4 years. The majority of patients did not have a previously identified comorbid condition (50%), but of those with a past medical history, hypertension wasmost prevalent (33%). Electrocardiogram findings were variable, and troponin was elevated in 91% of cases. Echocardiography was performed in 83% of cases reduced function was identified in 60%. Endotracheal intubation was performed in the majority of cases. Glucocorticoids were most commonly used in treatment of myocarditis (58%). Majority of patients survived to discharge (81%) and 85% of those that received steroids survived to discharge.
   Conclusion: Guidelines for diagnosis and management of COVID-19 myocarditis have not been established and our knowledge on management is rapidly changing. The use of glucocorticoids and other agents including IL-6 inhibitors, IVIG and colchicine in COVID-19 myocarditis is debatable. In our review, there appears to be favorable outcomes related to myocarditis treated with steroid therapy. However, until larger scale studies are conducted, treatment approaches have to be made on an individualized case-by-case basis. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Sawalha, Khalid; Abozenah, Mohammed; Battisha, Ayman; Salerno, Colby] Univ Massachusetts, Med Sch, Baystate Med Ctr, Dept Internal Med, Springfield, MA 01199 USA.
   [Kadado, Anis John; Islam, Ashequl M.] Univ Massachusetts, Med Sch, Baystate Med Ctr, Dept Cardiol, Springfield, MA 01199 USA.
   [Al-Akchar, Mohammad] Southern Illinois Univ, Dept Internal Med, Div Cardiol, Sch Med, Springfield, IL USA.
   [Hernandez-Montfort, Jaime] Cleveland Clin Florida, Heart & Vasc Inst, Weston, FL 33331 USA.
RP Sawalha, K (corresponding author), Univ Massachusetts, Med Sch, Baystate Med Ctr, 759 Chestnut St, Springfield, MA 01199 USA.
EM khalid.sawalhamd@baystatehealth.org
RI sawalha, khalid/AAU-4015-2021; Kadado, Anis John/J-1552-2017
OI Kadado, Anis John/0000-0003-4029-2020
CR [Anonymous], 2020, LOW COST DEX RED DEA
   Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006
   Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885
   Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1
   Channappanavar R, 2019, J CLIN INVEST, V129, P3625, DOI 10.1172/JCI126363
   Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z
   Chen HS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004471.pub3
   Cizgici AY, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.04.080
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093
   Coyle Justin, 2020, JACC Case Rep, V2, P1331, DOI 10.1016/j.jaccas.2020.04.025
   Dabbagh Mohammed F, 2020, JACC Case Rep, V2, P1326, DOI 10.1016/j.jaccas.2020.04.009
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Doyen D, 2020, LANCET, V395, P1516, DOI 10.1016/S0140-6736(20)30912-0
   Felker GM, 2000, J AM COLL CARDIOL, V36, P227, DOI 10.1016/S0735-1097(00)00690-2
   Fitzgerald JC, 2017, CRIT CARE MED, V45, pE124, DOI 10.1097/CCM.0000000000002053
   Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164
   Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Hua A, 2020, EUR HEART J, V41, P2130, DOI 10.1093/eurheartj/ehaa253
   Huang X, 2019, INT HEART J, V60, P359, DOI 10.1536/ihj.18-299
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Irabien-Ortiz A, 2020, REV ESP CARDIOL, V73, P503, DOI 10.1016/j.recesp.2020.04.001
   Kim ES, 2016, J KOREAN MED SCI, V31, P1717, DOI 10.3346/jkms.2016.31.11.1717
   Kim IC, 2020, EUR HEART J, V41, P1859, DOI 10.1093/eurheartj/ehaa288
   Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074
   Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801
   NIEMINEN MS, 1984, AM J CARDIOL, V53, P1331, DOI 10.1016/0002-9149(84)90089-4
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Radbel J, 2020, CHEST, V158, pE15, DOI 10.1016/j.chest.2020.04.024
   Rehman M, 2020, CUREUS, V12, DOI 10.7759/cureus.8685
   Sala S, 2020, EUR HEART J, V41, P1861, DOI 10.1093/eurheartj/ehaa286
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Wang CH, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-42
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   World Health Organization, 2020, ROLL UPD COR DIS COV
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Yuan WF, 2020, CARDIOVASC DIAGN THE, V10, P242, DOI 10.21037/cdt.2020.03.08
   Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427
   Zeng J, 2020, INFECTION 0410, DOI [10.20944/preprints202003.0180.v1, DOI 10.1007/S15010-020-01424-5, 10.1007/s15010-020-01424-5]
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 47
TC 49
Z9 51
U1 1
U2 4
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1553-8389
EI 1878-0938
J9 CARDIOVASC REVASCULA
JI Cardiovasc. Revascularization Med.
PD FEB
PY 2021
VL 23
BP 107
EP 113
DI 10.1016/j.carrev.2020.08.028
EA MAR 2021
PG 7
WC Cardiac & Cardiovascular Systems
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA QR6OK
UT WOS:000625335600023
PM 32847728
OA Green Published
DA 2022-04-20
ER

PT J
AU Tsitsani, P
AF Tsitsani, Pelagia
TI The necessity of strategic management-proper planning in Health during
   the COVID 19 pandemic
SO SCIENTIFIC CHRONICLES
LA Greek
DT Review
DE Programming; management; Healthcare; administration; COVID 19 pandemic
AB The provision of health services is an evolving system, as epidemiological and demographic data are changing dynamically and new techniques are being developed rapidly. In addition, there is an emerging need to satisfy the increasingly aware and demanding patient-user. The article discusses the necessity, during the COVID 19 pandemic, to further develop the principles of management in a scientific way and with measurable results in Healthcare. To a large extent, Greek hospitals lack both strategic planning with specific goals, as well as the setting of standards for the scientifically structured comparison between goals and actual achievements. In addition, good practices of human resources management in all sectors involved (administrative, health, technical) are not effectively cultivated. In addition, hospital managers should be administrative scientists with specialized knowledge in the coherent distribution of financial and human resources. At the same time, however, hospitals require leaders with vision, able to inspire "organizational culture" resulting to spontaneous commitment of employees to the action plan and adherence to quality principles.
C1 [Tsitsani, Pelagia] Gen Hosp Pella, Edessa Hosp Unit, Pediat Clin, Publ Adm Healthcare Management, Edessa, Greece.
RP Tsitsani, P (corresponding author), Gen Hosp Pella, Edessa Hosp Unit, Pediat Clin, Publ Adm Healthcare Management, Edessa, Greece.
EM plgtsi@gmail.com
CR Aggarwal Anubha, 2019, J Oral Biol Craniofac Res, V9, P180, DOI 10.1016/j.jobcr.2018.06.006
   Alleyne Jo, 2007, J Nurs Manag, V15, P230, DOI 10.1111/j.1365-2834.2007.00750.x
   Clark CM, 2019, INT REV ENTREP, V17, P347
   Hadley S., 2020, REV PUBLIC FINANCIAL
   Helms MM, 2008, INT J HEALTHC INF SY, V3, P75, DOI 10.4018/jhisi.2008010105
   Hillebrand B, 2001, IND MARKET MANAG, V30, P651, DOI 10.1016/S0019-8501(00)00115-2
   Koinis A, 2015, HEALTH PSYCHOL RES, V3, P12, DOI 10.4081/hpr.2015.1984
   Langabeer RJ, 2016, HLTH CARE OPERATIONS
   Lynn J, 2011, BMJ QUAL SAF, V20, pI58, DOI 10.1136/bmjqs.2010.046508
   Ratnapalan S, 2020, HEALTH CARE MANAG, V39, P18, DOI 10.1097/HCM.0000000000000284
   Perera FDR, 2012, REV ESP CARDIOL, V65, P749, DOI 10.1016/j.rec.2012.04.004
   Swayne L, 2008, STRATEGIC MANAGEMENT
   Zuckerman Alan M, 2006, Front Health Serv Manage, V23, P3
NR 13
TC 0
Z9 0
U1 1
U2 1
PU TZANEIO GENERAL HOSPITAL
PI PIRAEUS
PA ZANNI & 1 AFENTOULI STRS, PIRAEUS, GR-18536, GREECE
SN 1791-1362
EI 2241-1666
J9 SCI CHRON
JI Sci. Chron.
PY 2021
VL 26
IS 3
BP 434
EP 444
PG 11
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA YV4RB
UT WOS:000752716000006
DA 2022-04-20
ER

PT C
AU Zieba, K
AF Zieba, Krzysztof
BE GarciaPerez, A
   Simkin, L
TI How can Systems Thinking Help Us Handling the COVID-19 Crisis?
SO PROCEEDINGS OF THE 21ST EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2020)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 21st European Conference on Knowledge Management (ECKM)
CY DEC 02-04, 2020
CL Conventry Univ, ELECTR NETWORK
HO Conventry Univ
DE COVID-19 crisis; Systems Thinking; continuous learning; adaptive
   business management; global knowledge economy
AB Purpose: COVID-19 pandemic outbreak remains one of the most influential events in the global economy over the recent years. While being primarily public health-related, it has a tremendous impact on many other aspects, such as public transport, education, and business management. Many businesses were forced to introduce rapid changes to their business models in order to survive. The aim of this paper is to show the complexity and inter-relations of changes triggered by COVID-19 outbreak. Understanding of this complexity is crucial for developing business resilience to similar events in the future. Methodology: The paper uses Systems Thinking approach to analyse influence of COVID-19 pandemic on business operations. Causal loop diagrams are used to show the complicated mechanisms behind the impact of pandemic on several aspects of business operation and management. Findings: Causal loop diagrams indicate that complicated relations between various elements may produce surprising and unexpected outcomes. The existing delays may result in actions bringing counterintuitive results. Perceptions of some variables play more important roles than actual variables and it often requires more than one actor to solve a particular problem - hence the need for organisational, as well as social learning. Adaptive business management may prove to be a particular challenge for small business owners. Research limitations: The paper is mostly of a conceptual nature. Causal loop diagrams require extensive data in order to be transformed into full Systems Thinking models. Hence this paper may serve as a basis for further development. Practical implications: The paper provides useful insights into the complex nature of contemporary business operation and management in the wake of a major epidemiological crisis. It may contribute to a better understanding of important factors that often tend to be disregarded and not paid enough attention to by business owners/managers. Originality/value: The paper links one of the major current challenges for the global economy with Systems Thinking, which offers a holistic perspective on business operation and management with emphasis on linkages and interactions between numerous stakeholders involved. It offers food for thought not only for academics, but also to business owners/managers, aware of the complexity of contemporary world.
C1 [Zieba, Krzysztof] Gdansk Univ Technol, Dept Entrepreneurship, Gdansk, Poland.
RP Zieba, K (corresponding author), Gdansk Univ Technol, Dept Entrepreneurship, Gdansk, Poland.
EM Krzysztof.Zieba@pg.edu.pl
CR Araz OM, 2020, HEALTH SYST, V9, P119, DOI 10.1080/20476965.2020.1758000
   Atkeson, 2020, WHAT WILL BE EC IMPA
   Baker S. R., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts)
   Bradley DT, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100325
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   Hassan I, 2020, E MEDITERR HEALTH J, V26, P872, DOI 10.26719/emhj.20.090
   Kaakinen M, 2020, MEDIA PSYCHOL, V23, P25, DOI 10.1080/15213269.2018.1544910
   Lee E, 2020, SYSTEMS-BASEL, V8, DOI 10.3390/systems8020018
   Leischow SJ, 2008, AM J PREV MED, V35, pS196, DOI 10.1016/j.amepre.2008.05.014
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Monat J.P., 2015, AM J SYSTEMS SCI, V4, P11, DOI [10.5923/j.ajss.20150401.02, DOI 10.5923/J.AJSS.20150401.02]
   Pennycook G., 2020, FIGHTING COVID 19 MI, DOI [10.31234/OSF.IO/UHBK9, DOI 10.31234/OSF.IO/UHBK9, 10.1177/0956797620939054, 10.31234/osf.io/uhbk9]
   Pentina I, 2014, COMPUT HUM BEHAV, V35, P211, DOI 10.1016/j.chb.2014.02.045
   Ramnath VR, 2020, RESPIROLOGY, V25, P800, DOI 10.1111/resp.13894
   Sahin O, 2020, SYSTEMS-BASEL, V8, DOI 10.3390/systems8020020
   Spohr Dominic., 2017, BUSINESS INFORM REV, V34, P150, DOI [10.1177/0266382117722446, DOI 10.1177/0266382117722446]
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
NR 19
TC 1
Z9 1
U1 4
U2 4
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-912764-82-2
J9 PROC EUR CONF KNOWL
PY 2020
BP 888
EP 894
DI 10.34190/EKM.20.256
PG 7
WC Business; Information Science & Library Science; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics; Information Science & Library Science
GA BS0SF
UT WOS:000684204300104
DA 2022-04-20
ER

PT J
AU Hargitai, DM
   Pinzaru, F
   Veres, Z
AF Hargitai, David Mate
   Pinzaru, Florina
   Veres, Zoltan
TI Integrating Business Students' E-Learning Preferences into Knowledge
   Management of Universities after the COVID-19 Pandemic
SO SUSTAINABILITY
LA English
DT Article
DE online learning; e-learning systems; educational knowledge management;
   business education
AB The COVID-19 pandemic forced many universities to close doors and keep students completely online-a phenomenon that raised unprecedented challenges with lessons learned that should be integrated into future educational knowledge management strategies and practices. Special attention should be given to students' learning habits. This paper presents the results of a semi-systematic literature review on the research problem and a survey of a sample of business students regarding their learning habits and preferences. Learnings of the research can be useful for the transition to an entirely online distance education, integrated in the framework of knowledge management strategies regarding e-learning in universities. The primary quantitative research was conducted before the start of the lockdown, and the results give useful insights that can be translated into mandatory elements for any strategy designed to assure a smooth and effective passage from in-class education to online teaching and learning. Students' pre-epidemic learning habits, their use of communication tools and their preferences for solutions usable in distance education, with a special focus on gender and education level, have been investigated. Results are correlated in the paper with possible knowledge management strategies in universities as part of an approach with both academic and practical implications.
C1 [Hargitai, David Mate; Veres, Zoltan] Univ Pannonia, Dept Mkt, Egyet Utca 10, H-8200 Veszprem, Hungary.
   [Pinzaru, Florina] Natl Univ Polit Studies & Publ Adm SNSPA, Fac Management, Bd Expozitiei 30A S 1, Bucharest 012104, Romania.
RP Pinzaru, F (corresponding author), Natl Univ Polit Studies & Publ Adm SNSPA, Fac Management, Bd Expozitiei 30A S 1, Bucharest 012104, Romania.
EM hargitai.david@gtk.uni-pannon.hu;
   florina.pinzaru@facultateademanagement.ro;
   veres.zoltan@gtk.uni-pannon.hu
RI Pinzaru, Florina/ABC-5633-2021
OI Pinzaru, Florina/0000-0002-8371-5284; Veres, Zoltan/0000-0001-7072-7203
FU Szechenyi 2020 [EFOP-3.6.1-16-2016-00015]
FX We acknowledge the financial support of Szechenyi 2020 under the
   EFOP-3.6.1-16-2016-00015.
CR Abaidoo N., 2015, INT J INSTRUCTIONAL, V12, P29, DOI DOI 10.1016/J.PR0CS.2012.10.037
   Akhavan A, 2011, IN C IND ENG ENG MAN, P1591, DOI 10.1109/IEEM.2011.6118185
   Al Shehab N., 2020, P ECEL 2020 19 EUR C, P10
   Al-Saud LMS, 2013, J DENT EDUC, V77, P1371
   Alharthi AD, 2019, REQUIR ENG, V24, P523, DOI 10.1007/s00766-018-0299-9
   Alkhasawneh IM, 2008, NURS EDUC TODAY, V28, P572, DOI 10.1016/j.nedt.2007.09.012
   Almaiah MA, 2020, EDUC INF TECHNOL, V25, P5261, DOI 10.1007/s10639-020-10219-y
   Aparicio M, 2016, EDUC TECHNOL SOC, V19, P292
   Bovill C., 2017, INT J STUDENTS PARTN, V1, P1, DOI [10.15173/ijsap.v1i1.3062, DOI 10.15173/IJSAP.V1I1.3062]
   Bracci E, 2019, MEDITARI ACCOUNT RES, V28, P391, DOI 10.1108/MEDAR-02-2018-0286
   Bratianu C, 2018, STRATEGICA, P545
   Campbell L., 2004, REPORT U MELBOURNE
   Cantoni V, 2004, J VISUAL LANG COMPUT, V15, P333, DOI 10.1016/j.jvlc.2003.10.002
   Cetin S.Y., 2018, SHS WEB C, V48, DOI [10.1051/shsconf/20184801026, DOI 10.1051/SHSCONF/20184801026]
   Chamorro-Premuzic T, 2019, HARVARD BUS REV
   Chugh Ritesh, 2015, IC3K 2015. 7th International Joint Conference on Knowledge Discovery, Knowledge Engineering and Knowledge Management, P128
   Clifton A, 2011, NURS EDUC TODAY, V31, P311, DOI 10.1016/j.nedt.2010.10.004
   Correia Ana-Paula., 2020, Q REV DISTANCE ED, V21, P13
   DALMOLIN Ana Cláudia, 2018, Rev. odontol. UNESP, V47, P175, DOI 10.1590/1807-2577.05118
   Deloitte, 2019, GLOBAL DEV AI BASED
   Demirbas OO, 2007, LEARN INSTR, V17, P345, DOI 10.1016/j.learninstruc.2007.02.007
   Demirkan H, 2016, DESIGN STUD, V44, P28, DOI 10.1016/j.destud.2015.12.009
   Felder R., 1991, INDEX LEARNING STYLE
   Flavin M, 2018, RES LEARN TECHNOL, V26, DOI 10.25304/rlt.v26.1987
   Francis B, 2000, OXFORD REV EDUC, V26, P35, DOI 10.1080/030549800103845
   Gallagher S., 2020, HARVARD BUS REV
   Gappi L. L., 2013, INT J ED RES TECHNOL, V4, P70
   Garber LL, 2017, INT J MANAG EDUC-OXF, V15, P11, DOI 10.1016/j.ijme.2017.02.001
   Gogus Aytac, 2020, International Journal of Information and Education Technology, V10, P715, DOI 10.18178/ijiet.2020.10.10.1448
   Gogus A, 2016, PROCD SOC BEHV, V217, P779, DOI 10.1016/j.sbspro.2016.02.145
   Goh CF, 2017, J E-LEARN KNOWL SOC, V13, P117, DOI 10.20368/1971-8829/1298
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   Guilbault M, 2018, J RETAIL CONSUM SERV, V40, P295, DOI 10.1016/j.jretconser.2017.03.006
   Gurteen D., CREATING KNOWLEDGE S
   Iqbal A, 2019, J ENTERP INF MANAG, V32, P36, DOI 10.1108/JEIM-04-2018-0083
   Irwin C, 2012, AUSTRALAS J EDUC TEC, V28, P1221
   Journell W., 2007, E-LEARNING DIGITAL M, V4, P138, DOI [https://doi.org/10.2304/elea.2007.4.2.138, DOI 10.2304/ELEA.2007.4.2.138]
   Karagiannopoulou E, 2020, EDUC PSYCHOL-UK, V40, P570, DOI 10.1080/01443410.2019.1600661
   Keri G., 2002, COLL, V36, P433
   Khalidi M., 2012, 2012 INT C INF TECHN, P12, DOI [10.1109/ITHET.2012.6246045, DOI 10.1109/ITHET.2012.6246045]
   Kidwell J. J., 2000, EDUCAUSE Q, V23, P28
   Kolb DA, 1999, LEARNING STYLE INVEN
   Krishnamurthy S, 2020, J BUS RES, V117, P1, DOI 10.1016/j.jbusres.2020.05.034
   Li C., 2020, THIS IS WORLD EC FOR
   Liao S., 2009, INT J BUSINESS MANAG, V4, P64
   Lone, 2020, HLTH PROF ED, DOI DOI 10.1016/J.HPE.2020.04.011
   Pham L, 2018, INT J ENTERP INF SYS, V14, P19, DOI 10.4018/IJEIS.2018070102
   Lopez-Nicolas C, 2011, INT J INFORM MANAGE, V31, P502, DOI 10.1016/j.ijinfomgt.2011.02.003
   Mandi OR, 2019, J BUS RES, V94, P320, DOI 10.1016/j.jbusres.2018.02.013
   Nunez JLM, 2017, IEEE T EDUC, V60, P134, DOI 10.1109/TE.2016.2607693
   Matthews D.B., 1994, J HUMANIST ED DEV, V33, P65, DOI [10.1002/j.2164-4683.1994.tb00086.x, DOI 10.1002/J.2164-4683.1994.TB00086.X]
   McGraw-Hill Education, 2017, DIGITAL STUDY TRENDS
   McKinsey & Company, 2012, TRANSFORMING LEARNIN
   Moghavvemi S, 2018, INT J MANAG EDUC-OXF, V16, P37, DOI 10.1016/j.ijme.2017.12.001
   Moran M., 2011, TEACHING LEARNING SH
   Muqadas F, 2017, VINE J INF KNOWL MAN, V47, P2, DOI 10.1108/VJIKMS-06-2016-0036
   Muresan M, 2014, ELEARN SOFTW EDUC, P310
   Ngah R, 2016, KNOWL PROCESS MANAG, V23, P184, DOI 10.1002/kpm.1504
   Nicolescu O, 2014, J ORGAN CHANGE MANAG, V27, P299, DOI 10.1108/JOCM-04-2013-0047
   Nixon E, 2018, STUD HIGH EDUC, V43, P927, DOI 10.1080/03075079.2016.1196353
   Orus C, 2016, COMPUT EDUC, V95, P254, DOI 10.1016/j.compedu.2016.01.007
   Othman R., 2016, NEW EDUC REV, V44, P125
   Pack S.M., 2020, J PHYS ED, V7, P74
   Paechter M, 2010, COMPUT EDUC, V54, P222, DOI 10.1016/j.compedu.2009.08.005
   Petrides L., 2003, KNOWLEDGE MANAGEMENT
   Pinzaru F., 2013, OR MANAG, V1, P221
   Ramjeawon PV, 2017, LEARN ORGAN, V24, P366, DOI 10.1108/TLO-03-2017-0030
   Ras E, 2005, LECT NOTES ARTIF INT, V3782, P155
   Ricci M, 2018, PERSPECT MED EDUC, V7, P352, DOI 10.1007/s40037-018-0480-3
   Richardson JTE, 2006, BRIT J EDUC PSYCHOL, V76, P867, DOI 10.1348/000709905X69690
   Rogowsky BA, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00164
   Rowley J., 2000, INT J EDUC DEV, V14, P325, DOI DOI 10.1108/09513540010378978
   Sarabi-Asiabar A, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.18250
   Sep?lveda A., 2020, DIGITAL TRANSFORMATI
   SEVERIENS SE, 1994, HIGH EDUC, V27, P487, DOI 10.1007/BF01384906
   Shah RK, 2018, RES LEARN TECHNOL, V26, DOI 10.25304/rlt.v26.2070
   Sharifzadeh M., 2019, J MED EDUC, V12, P89
   Snyder H, 2019, J BUS RES, V104, P333, DOI 10.1016/j.jbusres.2019.07.039
   Sun PC, 2008, COMPUT EDUC, V50, P1183, DOI 10.1016/j.compedu.2006.11.007
   Tan CNL, 2016, HIGH EDUC, V71, P525, DOI 10.1007/s10734-015-9922-6
   Tessier D, 2016, KNOWL MANAG E-LEARN, V8, P414
   Townley C.T., 2003, ED Q, V2, P8
   Urdan T. A., 2000, CORPORATE E LEARNING
   Velasquez R.M.A., 2020, KNOWLEDGE MANAGEMENT
   Wang QY, 2012, BRIT J EDUC TECHNOL, V43, P428, DOI 10.1111/j.1467-8535.2011.01195.x
   Weichhart G, 2018, KNOWL MANAG E-LEARN, V10, P25
   Yousef D.A., 2016, QUAL ASSUR EDUC
NR 87
TC 2
Z9 2
U1 1
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD MAR
PY 2021
VL 13
IS 5
AR 2478
DI 10.3390/su13052478
PG 21
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA QW3PA
UT WOS:000628564600001
OA gold
DA 2022-04-20
ER

PT J
AU Sagris, D
   Papanikolaou, A
   Kvernland, A
   Korompoki, E
   Frontera, JA
   Troxel, AB
   Gavriatopoulou, M
   Milionis, H
   Lip, GYH
   Michel, P
   Yaghi, S
   Ntaios, G
AF Sagris, Dimitrios
   Papanikolaou, Aikaterini
   Kvernland, Alexandra
   Korompoki, Eleni
   Frontera, Jennifer A.
   Troxel, Andrea B.
   Gavriatopoulou, Maria
   Milionis, Haralampos
   Lip, Gregory Y. H.
   Michel, Patrik
   Yaghi, Shadi
   Ntaios, George
TI COVID-19 and ischemic stroke
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Review
DE COVID-19; ischemic stroke; pathophysiology; SARS-CoV-2
ID ANGIOTENSIN-CONVERTING ENZYME-2; HOSPITALIZED-PATIENTS;
   SARS-CORONAVIRUS; TYPE-2 RECEPTOR; OPEN-LABEL; EXPRESSION; ACE2;
   COAGULOPATHY; RECOGNITION; MANAGEMENT
AB Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment of stroke in the setting of COVID-19 particularly challenging. In this review, we summarize the current knowledge on epidemiology, clinical manifestation, and pathophysiology of ischemic stroke in patients with COVID-19 to bridge the gap from bench to bedside and clinical practice during the most challenging global health crisis of the last decades.
C1 [Sagris, Dimitrios; Papanikolaou, Aikaterini; Ntaios, George] Univ Thessaly, Sch Hlth Sci, Dept Internal Med, Fac Med, Larisa, Greece.
   [Kvernland, Alexandra; Frontera, Jennifer A.; Yaghi, Shadi] NYU, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA.
   [Korompoki, Eleni; Gavriatopoulou, Maria] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Athens, Greece.
   [Korompoki, Eleni] Imperial Coll London, Div Brain Sci, London, England.
   [Troxel, Andrea B.] NYU, Grossman Sch Med, Dept Populat Hlth, New York, NY USA.
   [Milionis, Haralampos] Univ Ioannina, Sch Hlth Sci, Dept Internal Med, Fac Med, Ioannina, Greece.
   [Lip, Gregory Y. H.] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England.
   [Lip, Gregory Y. H.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England.
   [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg, Denmark.
   [Michel, Patrik] Lausanne Univ Hosp, Stroke Ctr, Neurol Serv, Lausanne, Switzerland.
RP Ntaios, G (corresponding author), Univ Thessaly, Sch Hlth Sci, Dept Internal Med, Fac Med, Larisa, Greece.
EM gntaios@med.uth.gr
RI Ntaios, George/AAG-1908-2019
OI Ntaios, George/0000-0002-0629-9248; Troxel, Andrea/0000-0002-1393-3075
CR Agarwal S, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105068
   Annie F, 2020, AM J CARDIOL, V130, P169, DOI 10.1016/j.amjcard.2020.06.010
   [Anonymous], 2020, ROLE MICROPARTICLES
   Aragao MFVV, 2020, AM J NEURORADIOL, V41, P1703, DOI 10.3174/ajnr.A6675
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Beun R, 2020, INT J LAB HEMATOL, V42, P19, DOI 10.1111/ijlh.13230
   Bohmwald K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00386
   Bowles L, 2020, NEW ENGL J MED, V383, P288, DOI 10.1056/NEJMc2013656
   Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801
   Bullrich MB, 2020, CAN J NEUROL SCI, V47, P693, DOI 10.1017/cjn.2020.101
   Cantador E, 2020, J THROMB THROMBOLYS, V50, P543, DOI 10.1007/s11239-020-02176-7
   Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6
   Chougar L, 2020, RADIOLOGY, V297, pE313, DOI 10.1148/radiol.2020202422
   Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786
   de Havenon Adam, 2020, medRxiv, DOI 10.1101/2020.05.07.20083386
   Desai SM, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104988
   Diegoli H, 2020, STROKE, V51, P2315, DOI 10.1161/STROKEAHA.120.030481
   Escalard S, 2020, STROKE, V51, P2540, DOI 10.1161/STROKEAHA.120.030574
   Fan SY, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00806
   Ford James S, 2020, Clin Pract Cases Emerg Med, V4, P332, DOI 10.5811/cpcem.2020.6.47856
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Fraga-Silva RA, 2008, MOL MED, V14, P28, DOI 10.2119/2007-00073.Fraga-Silva
   Fridman S, 2020, NEUROLOGY, V95, pE3373, DOI 10.1212/WNL.0000000000010851
   Frisullo G, 2020, NEUROL SCI, V41, P2309, DOI 10.1007/s10072-020-04545-9
   Frontera J, 2020, NEUROCRIT CARE, V33, P25, DOI 10.1007/s12028-020-00995-3
   Frontera JA, 2021, NEUROLOGY, V96, pE575, DOI 10.1212/WNL.0000000000010979
   Gencer S, 2020, THROMB HAEMOSTASIS, V120, P1629, DOI 10.1055/s-0040-1718735
   Gerotziafas GT, 2020, THROMB HAEMOSTASIS, V120, P1597, DOI 10.1055/s-0040-1715798
   Goshua George, 2020, Lancet Haematol, V7, pe575, DOI 10.1016/S2352-3026(20)30216-7
   Gunst JD, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100849
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Hajdu SD, 2020, STROKE, V51, P2593, DOI 10.1161/STROKEAHA.120.030794
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hernandez-Fernandez F, 2020, BRAIN, V143, P3089, DOI 10.1093/brain/awaa239
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hoyer C, 2020, STROKE, V51, P2224, DOI 10.1161/STROKEAHA.120.030395
   Hsiao J, 2020, STROKE, V51, pE211, DOI 10.1161/STROKEAHA.120.030499
   ICD10, 2021, CYT REL SYNDR 2021 I
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Inciardi RM, 2020, EUR HEART J, V41, P1821, DOI 10.1093/eurheartj/ehaa388
   Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80
   Jain R, 2020, J NEUROL SCI, V414, DOI 10.1016/j.jns.2020.116923
   Jasne AS, 2020, STROKE, V51, P2664, DOI 10.1161/STR.0000000000000347
   John S, 2020, AM J NEURORADIOL, V41, P2263, DOI 10.3174/ajnr.A6799
   Karadas O, 2020, NEUROL SCI, V41, P1991, DOI 10.1007/s10072-020-04547-7
   Kariyanna Pramod Theetha, 2020, Am J Med Case Rep, V8, P350
   Katsanos AH, 2021, ANN NEUROL, V89, P380, DOI [10.1002/ana.25967, 10.1002/ana.25967Citations:1]
   Katz JM, 2020, STROKE, V51, pE227, DOI 10.1161/STROKEAHA.120.031265
   Kerleroux B, 2020, STROKE, V51, P2012, DOI 10.1161/STROKEAHA.120.030373
   Kihira S, 2021, AM J ROENTGENOL, V216, P150, DOI 10.2214/AJR.20.23847
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Knight, 2020, DIPYRIDAMOLE PREVENT
   Kristoffersen ES, 2020, ACTA NEUROL SCAND, V142, P632, DOI 10.1111/ane.13307
   Kyriazopoulou E, 2021, ELIFE, V10, DOI 10.7554/eLife.66125
   Lazzerini PE, 2020, CIRCULATION, V142, P7, DOI 10.1161/CIRCULATIONAHA.120.047293
   Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431
   Liang B, 2015, CELL PHYSIOL BIOCHEM, V35, P2472, DOI 10.1159/000374047
   Liberale L, 2018, EUR HEART J, V39, P3511, DOI 10.1093/eurheartj/ehy286
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Makino I, 1996, NEUROPEPTIDES, V30, P596, DOI 10.1016/S0143-4179(96)90043-8
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Mateo, 2021, CLIN TRIAL USE ANAKI
   Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2
   Mecca AP, 2011, EXP PHYSIOL, V96, P1084, DOI 10.1113/expphysiol.2011.058578
   Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730
   Merkler AE, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010782
   Meza HT, 2020, INT J STROKE, V15, P755, DOI 10.1177/1747493020938301
   Montaner J, 2020, STROKE, V51, P2307, DOI 10.1161/STROKEAHA.120.030106
   Naccarato M, 2020, J NEUROL SCI, V414, DOI 10.1016/j.jns.2020.116889
   Nannoni S, 2021, INT J STROKE, V16, P137, DOI 10.1177/1747493020972922
   Briard JN, 2021, CAN J NEUROL SCI, V48, P122, DOI 10.1017/cjn.2020.160
   Nguyen-Huynh MN, 2020, STROKE, V51, P2918, DOI 10.1161/STROKEAHA.120.031099
   Nicolai L, 2020, CIRCULATION, V142, P1176, DOI 10.1161/CIRCULATIONAHA.120.048488
   Ntaios G, 2020, STROKE, V51, pE254, DOI 10.1161/STROKEAHA.120.031208
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Owen KPaD, RAS COAGULOPATHY COV
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Paliwal PR, 2020, J THROMB THROMBOLYS, V50, P596, DOI 10.1007/s11239-020-02225-1
   Panigrahy D, 2020, CANCER METAST REV, V39, P1, DOI [10.1007/s10555-020-09862-1, 10.1007/s10555-020-09889-4]
   Park WB, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e84
   Pena-Martinez C, 2019, STROKE, V50, P3228, DOI 10.1161/STROKEAHA.119.026848
   Pinna P, 2020, J NEUROL SCI, V415, DOI 10.1016/j.jns.2020.116969
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Pons-Escoda A, 2020, AM J NEURORADIOL, V41, P1365, DOI 10.3174/ajnr.A6627
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Rinkel LA, 2021, J NEUROL, V268, P403, DOI 10.1007/s00415-020-10069-1
   Romero-Sanchez CM, 2020, NEUROLOGY, V95, pE1060, DOI 10.1212/WNL.0000000000009937
   Rothstein A, 2020, STROKE, V51, pE219, DOI 10.1161/STROKEAHA.120.030995
   Rudilosso S, 2020, STROKE, V51, P1991, DOI 10.1161/STROKEAHA.120.030329
   Sala S, 2020, EUR HEART J, V41, P1861, DOI 10.1093/eurheartj/ehaa286
   Sanchis-Gomar F, 2020, MAYO CLIN PROC, V95, P1222, DOI 10.1016/j.mayocp.2020.03.026
   Sangalli D, 2020, NEUROL SCI, V41, P2325, DOI 10.1007/s10072-020-04591-3
   Sarfo FS, 2020, J NEUROL SCI, V416, DOI 10.1016/j.jns.2020.117044
   Schalekamp MADH, 2013, J HYPERTENS, V31, P705, DOI 10.1097/HJH.0b013e32835d6d11
   SCHELLING P, 1976, CLIN SCI MOL MED, V51, pS399, DOI 10.1042/cs051399s
   Schirmer CM, 2020, J NEUROINTERV SURG, V12, P639, DOI 10.1136/neurintsurg-2020-016299
   Shahjouei S, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102939
   Sheth SA, 2020, STROKE, V51, P2268, DOI 10.1161/STROKEAHA.120.030154
   Shi KB, 2019, LANCET NEUROL, V18, P1058, DOI 10.1016/S1474-4422(19)30078-X
   Shoirah H, 2019, J STROKE CEREBROVASC, V28, P1926, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.046
   SIEGLER JE, 2020, J STROKE CEREBROVASC, V29, DOI DOI 10.1016/J.JSTROKECEREBROVASDIS.2020.104953
   Sierra-Hidalgo F, 2020, J NEUROL, V267, P3441, DOI 10.1007/s00415-020-09967-1
   Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374
   Smith CJ, 2018, STROKE, V49, P1210, DOI 10.1161/STROKEAHA.118.020750
   Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373
   Song Eric, 2020, bioRxiv, DOI 10.1101/2020.06.25.169946
   Stefanini GG, 2020, CIRCULATION, V141, P2113, DOI 10.1161/CIRCULATIONAHA.120.047525
   Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836
   Sweid A, 2020, INT J STROKE, V15, P733, DOI 10.1177/1747493020937189
   Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828
   Meza HT, 2020, EUR J NEUROL, V27, P1788, DOI 10.1111/ene.14327
   Teo KC, 2020, STROKE, V51, P2228, DOI 10.1161/STROKEAHA.120.030105
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Tremblay D, 2020, BLOOD, V136, P144, DOI 10.1182/blood.2020006941
   Uchino K, 2020, STROKE, V51, P2544, DOI 10.1161/STROKEAHA.120.030331
   Urwyler P, 2021, TRIALS, V22, DOI 10.1186/s13063-020-04976-x
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vlaar APJ, 2020, LANCET RHEUMATOL, V2, pE764, DOI 10.1016/S2665-9913(20)30341-6
   Walkey AJ, 2014, CHEST, V146, P1187, DOI 10.1378/chest.14-0003
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yaghi S, 2020, STROKE, V51, P2002, DOI 10.1161/STROKEAHA.120.030335
   Yang B, 2020, J NEUROINTERV SURG, V12, P664, DOI 10.1136/neurintsurg-2020-016177
   Zeng JH, 2020, INFECTION, V48, P773, DOI 10.1007/s15010-020-01424-5
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhao J, 2020, STROKE, V51, P1996, DOI 10.1161/STROKEAHA.120.030225
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu YZ, 2000, NEUROREPORT, V11, P1191, DOI 10.1097/00001756-200004270-00009
   Zuo Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd3876
NR 134
TC 1
Z9 1
U1 5
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD NOV
PY 2021
VL 28
IS 11
BP 3826
EP 3836
DI 10.1111/ene.15008
EA JUL 2021
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA WH4FA
UT WOS:000673704100001
PM 34224187
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Bhushan, V
   Rai, S
AF Bhushan, Vidya
   Rai, Shilpa
TI Knowledge, attitude, and practices regarding COVID-19 outbreak among the
   personnel providing emergency services in India
SO INTERNATIONAL JOURNAL OF ACADEMIC MEDICINE
LA English
DT Article
DE Attitude; barriers; COVID-19; knowledge; outbreak; practice
AB Introduction: The threat of contracting coronavirus persists among individuals constantly coming in direct or indirect contact with positive cases. Therefore, this study was conducted to assess the knowledge, attitude, and practices (KAPs) regarding the COVID19 outbreak among the personnel providing emergency services in India and also assess their perception toward government measures during this pandemic. Materials and Methods: An online survey was conducted among individuals providing services during the period of COVID-19 outbreak. A total of 234 people consented to continue with the survey. Data collection was carried out from April 2020 to June 2020. Data analysis was carried out using Chi-square statistics and Fisher-Freeman-Halton test. The level of statistical significance was set at 0.05 with a confidence interval of 95%. Results: Majority of the participants were male and belonged to the age group of 18-54 years. Almost all were aware that COVID-19 is a virus and had knowledge regarding its mode of spread and modes of prevention. Precautions such as covering face with mask, avoiding shaking hands, and washing hands before touching the eyes, nose, and mouth were undertaken by 34.6% of the total participants. Around 70.5% of the males, 53.7% of the females, and 33.3% of the participants from the others' category felt that the funds released by the government to combat corona were efficiently reaching the poor or the needy. Some of the barriers preventing the fair distribution of funds/services to the poor and needy as reported by the participants were corruption, lack of knowledge, delay in delivery and lack of personal protective kits, limited workforce, and no bank account of poor people. Conclusion: KAP of personnel providing emergency services is crucial to the containment of this disease. Understanding of the barriers shall aid policymakers to assess the impact of their preventive programs and also take crucial decisions toward its management. The following core competencies are addressed in this article: Medical knowledge, practice-based learning and improvement, and systems-based practice.
C1 [Rai, Shilpa] KIIT Deemed be Univ, Kalinga Inst Dent Sci, Dept Publ Hlth Dent, Bhubaneswar, Odisha, India.
RP Rai, S (corresponding author), KIIT Deemed be Univ, Kalinga Inst Dent Sci, Dept Publ Hlth Dent, Bhubaneswar, Odisha, India.
EM vidyabhushankashyap@gmail.com
CR ALdowyan N., 2017, INT ARCHIV MED, V10, P1, DOI [10.3823/2524sph.2016.15012016330, DOI 10.3823/2524SPH.2016.15012016330, DOI 10.3823/2524]
   [Anonymous], COVID 19 DASHBOARD
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Khanna M, 2012, INDIAN J VIROL, V23, P12, DOI 10.1007/s13337-012-0066-3
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 6
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
EI 2455-5568
J9 INT J ACAD MED
JI Int. J. Acad. Med.
PD APR-JUN
PY 2021
VL 7
IS 2
BP 107
EP 112
DI 10.4103/IJAM.IJAM_2_21
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA TH7XN
UT WOS:000672298300006
DA 2022-04-20
ER

PT J
AU Nindrea, RD
   Sari, NP
   Harahap, WA
   Haryono, SJ
   Kusnanto, H
   Dwiprahasto, I
   Lazuardi, L
   Aryandono, T
AF Nindrea, Ricvan Dana
   Sari, Nissa Prima
   Harahap, Wirsma Arif
   Haryono, Samuel J.
   Kusnanto, Hari
   Dwiprahasto, Iwan
   Lazuardi, Lutfan
   Aryandono, Teguh
TI Survey data of COVID-19 awareness, knowledge, preparedness and related
   behaviors among breast cancer patients in Indonesia
SO DATA IN BRIEF
LA English
DT Article; Data Paper
DE COVID-19; Breast cancer; Indonesia; Awareness; Knowledge; Preparedness;
   Behaviors
AB This dataset presents a survey data describing COVID-19 awareness, knowledge, preparedness and related behaviors among breast cancer patients in Indonesia. The data were collected from breast cancer patients through a survey distributed by an online questionnaire, assesing social-demographic characteristics (6 items), COVID-19 awareness (5 items), knowledge (2 items), preparedness (2 items) and related behaviors (2 items), from 20th June until 14th July 2020. The samples were gathered 500 breast cancer patients in Indonesia who were willing to fill an online questionnaire. SPSS version 23.0 was used to analyzed the data by descriptive and inferential statistics and SmartPLS 3 to created the partial least square path modeling. The data will help in preventing the transmission of COVID-19 among breast cancer patients and can support for health education and promotion interventions. (C) 2020 The Author(s). Published by Elsevier Inc.
C1 [Nindrea, Ricvan Dana] Univ Gadjah Mada, Doctoral Program, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia.
   [Sari, Nissa Prima] Univ Andalas, Dept Midwifery, Fac Med, Padang, Indonesia.
   [Harahap, Wirsma Arif] Univ Andalas, Div Surg Oncol, Fac Med, Padang, Indonesia.
   [Haryono, Samuel J.] Dharmais Canc Hosp, Div Surg Oncol, Jakarta, Indonesia.
   [Kusnanto, Hari] Univ Gadjah Mada, Dept Family & Community Med, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia.
   [Dwiprahasto, Iwan] Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia.
   [Lazuardi, Lutfan] Univ Gadjah Mada, Dept Hlth Policy & Management, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia.
   [Aryandono, Teguh] Univ Gadjah Mada, Dept Surg Oncol, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia.
RP Nindrea, RD (corresponding author), Univ Gadjah Mada, Doctoral Program, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia.
EM ricvan.dana.n@mail.ugm.ac.id
RI Nindrea, Ricvan Dana/AAC-9353-2021
OI Nindrea, Ricvan Dana/0000-0002-1844-3323; Sari, Nissa
   Prima/0000-0002-1115-1475
CR Kelly B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2441-7
   Nindrea Ricvan Dana, 2018, Asian Pac J Cancer Prev, V19, P885
   Nindrea Ricvan Dana, 2017, Asian Pac J Cancer Prev, V18, P3201, DOI 10.22034/APJCP.2017.18.12.3201
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
NR 4
TC 5
Z9 5
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3409
J9 DATA BRIEF
JI Data Brief
PD OCT
PY 2020
VL 32
AR 106145
DI 10.1016/j.dib.2020.106145
PG 6
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA OI4CP
UT WOS:000583229100106
PM 32835041
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Faradina, A
   Tseng, SH
   Ho, DKN
   Nurwanti, E
   Hadi, H
   Purnamasari, SD
   Rochmah, IY
   Chang, JS
AF Faradina, Amelia
   Tseng, Sung-Hui
   Ho, Dang Khanh Ngan
   Nurwanti, Esti
   Hadi, Hamam
   Purnamasari, Sintha Dewi
   Rochmah, Imaning Yulia
   Chang, Jung-Su
TI Adherence to COVID-19 Nutrition Guidelines Is Associated with Better
   Nutritional Management Behaviors of Hospitalized COVID-19 Patients
SO NUTRIENTS
LA English
DT Article
DE COVID-19; nutrition care; guidelines adherence; length of stay;
   mortality; Indonesia
AB Good nutritional support is crucial for the immune system to fight against coronavirus disease 2019 (COVID-19). However, in the context of a pandemic with a highly transmissible coronavirus, implementation of nutrition practice may be difficult. A multicenter electronic survey involving 62 dieticians was conducted, in order to understand barriers associated with dieticians' adherence to nutrition guidelines for hospitalized COVID-19 patients in Indonesia. 69% of dieticians felt under stress when performing nutrition care, and 90% took supplements to boost their own immunity against the coronavirus. The concerns related to clinical practice included a lack of clear guidelines (74%), a lack of access to medical records (55%), inadequate experience or knowledge (48%), and a lack of self-efficacy/confidence (29%) in performing nutritional care. Half (52%) of the dieticians had performed nutrition education/counseling, 47% had monitored a patient's body weight, and 76% had monitored a patient's dietary intake. An adjusted linear regression showed that guideline adherence independently predicted the dieticians' nutrition care behaviors of nutrition counselling (ss: 0.24 (0.002, 0.08); p = 0.04), and monitoring of body weight (ss: 0.43 (0.04, 0.11); p = 0.001) and dietary intake (ss: 0.47(0.03, 0.10); p = 0.001) of COVID-19 patients. Overall, adherence to COVID-19 nutrition guidelines is associated with better nutritional management behaviors in hospitalized COVID-19 patients.
C1 [Faradina, Amelia; Ho, Dang Khanh Ngan; Chang, Jung-Su] Taipei Med Univ, Coll Nutr, Sch Nutr & Hlth Sci, Taipei 110, Taiwan.
   [Tseng, Sung-Hui] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei 110, Taiwan.
   [Tseng, Sung-Hui] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei 110, Taiwan.
   [Nurwanti, Esti] Univ Pembangunan Nas Veteran, Fac Hlth Sci, Dept Nutr, Jakarta 12450, Indonesia.
   [Hadi, Hamam; Purnamasari, Sintha Dewi] Alma Ata Univ, Fac Hlth Sci, Dept Nutr, Yogyakarta 55183, Indonesia.
   [Hadi, Hamam; Purnamasari, Sintha Dewi] Alma Ata Univ, Fac Hlth Sci, Dept Publ Hlth, Yogyakarta 55183, Indonesia.
   [Hadi, Hamam; Purnamasari, Sintha Dewi] Alma Ata Univ, Alma Ata Ctr Hlth Life & Foods ACHEAF, Yogyakarta 55183, Indonesia.
   [Rochmah, Imaning Yulia] Hermina Tangkubanprahu Hosp, Nutr Dept, Malang 651194, Indonesia.
   [Chang, Jung-Su] Taipei Med Univ, Coll Nutr, Grad Inst Metab & Obes Sci, Taipei 110, Taiwan.
   [Chang, Jung-Su] Taipei Med Univ Hosp, Nutr Res Ctr, Taipei 110, Taiwan.
   [Chang, Jung-Su] Chinese Taipei Soc Study Obes CTSSO, Taipei 110, Taiwan.
RP Chang, JS (corresponding author), Taipei Med Univ, Coll Nutr, Sch Nutr & Hlth Sci, Taipei 110, Taiwan.; Chang, JS (corresponding author), Taipei Med Univ, Coll Nutr, Grad Inst Metab & Obes Sci, Taipei 110, Taiwan.; Chang, JS (corresponding author), Taipei Med Univ Hosp, Nutr Res Ctr, Taipei 110, Taiwan.; Chang, JS (corresponding author), Chinese Taipei Soc Study Obes CTSSO, Taipei 110, Taiwan.
EM amelia.faradinaa@gmail.com; d301091012@tmu.edu.tw; nganhdk91@gmail.com;
   estinurwanti@upnvj.ac.id; hhadi@almaata.ac.id;
   sinthadewips@almaata.ac.id; rochmah.imaning@gmail.com;
   susanchang@tmu.edu.tw
RI Hadi, Hamam/AAT-3473-2021
OI Hadi, Hamam/0000-0002-1945-2539; Nurwanti, Esti/0000-0001-7633-3432;
   Chang, Jung-Su/0000-0001-8608-9349
FU Taipei Medical University Hospital [110TMUTMUH-09]; Ministry of Science
   and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST
   107-2320-B-038-010-MY3, MOST 109-2923-B-038-001-MY3]
FX Jung-Su Chang was supported by grants from Taipei Medical University
   Hospital (110TMUTMUH-09) and the Ministry of Science and Technology,
   Taiwan (MOST 107-2320-B-038-010-MY3 and MOST 109-2923-B-038-001-MY3).
CR Arkin N, 2020, CLIN NUTR, V39, P2327, DOI 10.1016/j.clnu.2020.05.007
   Azzolino D, 2020, J NUTR HEALTH AGING, V24, P696, DOI 10.1007/s12603-020-1400-x
   Azzolino D, 2021, EUR J CLIN NUTR, V75, P728, DOI 10.1038/s41430-020-00795-0
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   Bartsch SM, 2020, HEALTH AFFAIR, V39, P927, DOI 10.1377/hlthaff.2020.00426
   Briassoulis G, 2019, PEDIATR CRIT CARE ME, V20, P89, DOI 10.1097/PCC.0000000000001774
   Briassoulis G, 2018, PEDIATR CRIT CARE ME, V19, P1087, DOI 10.1097/PCC.0000000000001717
   Buchanan EA, 2009, J EMPIR RES HUM RES, V4, P37, DOI 10.1525/jer.2009.4.2.37
   Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458
   Haraj NE, 2021, CLIN NUTR ESPEN, V41, P423, DOI 10.1016/j.clnesp.2020.09.214
   Hiedra R, 2020, EXPERT REV ANTI-INFE, V18, P1259, DOI 10.1080/14787210.2020.1794819
   John Hopkins University and Medicine Coronavirus Resource Center, MORT MOST AFF COUNTR
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Lawrence V, 2021, J HUM NUTR DIET, V34, P660, DOI 10.1111/jhn.12896
   Lu AH, 2010, J HUM NUTR DIET, V23, P144, DOI 10.1111/j.1365-277X.2009.01024.x
   Martindale R., 2020, SOC CRIT CARE MED, P1
   Mayasari NR, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103103
   National Institutes of Health USA, COVID 19 TREATM GUID
   Rees EM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01726-3
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037
   Thibault R, 2021, EUR J CLIN NUTR, V75, P407, DOI 10.1038/s41430-020-00757-6
   Thibault R, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03159-z
   Whittle J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03286-7
   Zhang J, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-020-00792-3
   Zhao XB, 2021, JPEN-PARENTER ENTER, V45, P32, DOI 10.1002/jpen.1953
NR 26
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2021
VL 13
IS 6
AR 1918
DI 10.3390/nu13061918
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA SY9JK
UT WOS:000666195200001
PM 34204893
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Nguyen, HB
   Nguyen, THM
   Tran, TTT
   Vo, THN
   Tran, VH
   Do, TNP
   Truong, QB
   Nguyen, TH
   Ly, LK
AF Hoang Bac Nguyen
   Thi Hong Minh Nguyen
   Thi Thanh Tam Tran
   Thi Hong Nhan Vo
   Van Hung Tran
   Thi Nam Phuong Do
   Quang Binh Truong
   Thi Hiep Nguyen
   Loan Khanh Ly
TI Knowledge, Attitudes, Practices, and Related Factors Towards COVID-19
   Prevention Among Patients at University Medical Center Ho Chi Minh City,
   Vietnam
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE knowledge; attitudes; practices; COVID-19 prevention; patients; Vietnam
ID OUTBREAK; BEHAVIOR
AB Aim: This study measured the level of knowledge, attitudes and practices towards COVID-19 prevention and examined associated factors among patients at a national tertiary general hospital in Vietnam.
   Methods: Adult patients admitted to University Medical Center during research period were recruited in a cross-sectional study, which employed a convenience sampling method with a 4-component questionnaire in order to examine the patients' consciousness towards COVID-19 spreading prevention based on four aspects: demographic characteristics (10 items), knowledge (14 items), attitudes (6 items), and practices (7 items).
   Results: The study involved 2769 respondents (18-90 years) with the mean age of 38.05 +/- 13.91 years. About two thirds of the respondents obtained diploma degree or higher (63.4%) and shared their living space with others (64.4%). The majority of patients settled in urban area (74.9%). All participants stayed informed about COVID-19, with the most commonly used channels like television (75.2%), the Internet (72.2%) and phone (69.8%). The vast majority showed sufficient knowledge (93.7%) and positive attitudes (76.3%). Just over half of participants remained good practiced of COVID-19 prevention (57.7%). On average, the factors of younger age, higher educational level, frequency and department of admission, and the number of COVID-19 informative channels were significantly associated with sufficient knowledge, positive attitudes, and good practices regarding preventive action against COVID-19 spreading. The optimistic attitude and having more undergoing chronic diseases were associated with the likelihood of well-practiced COVID-19 preventive measures (OR 3.63, 95% CI 1.54-8.55, p=0.003 and OR 0.86, 95% CI 0.78-0.98, p=0.02, respectively).
   Conclusion: The results of this study demonstrated that the likelihood of good preventive practices in the fight against COVID-19 pandemic was influenced by attitudes and several sociodemographic factors. More drastic interventions for the prevention of COVID-19 should be widely furnished and equipped in hospitals, through various routes to maximize the efficiency and adherence to prevention practices.
C1 [Hoang Bac Nguyen; Thi Hong Minh Nguyen; Thi Thanh Tam Tran; Thi Hong Nhan Vo; Van Hung Tran; Thi Nam Phuong Do; Quang Binh Truong] Univ Med Ctr Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam.
   [Hoang Bac Nguyen; Quang Binh Truong] Univ Med & Pharm Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam.
   [Thi Hiep Nguyen; Loan Khanh Ly] Int Univ, Sch Biomed Engn, Tissue Engn & Regenerat Med Dept, Ho Chi Minh City 700000, Vietnam.
   [Thi Hiep Nguyen; Loan Khanh Ly] Vietnam Natl Univ, Ho Chi Minh City 700000, Vietnam.
RP Nguyen, THM (corresponding author), Univ Med Ctr Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam.
EM minh.nth@umc.edu.vn
RI VO THI HONG, NHAN/ABA-2016-2021; Ly, Khanh/V-6131-2019
OI VO THI HONG, NHAN/0000-0002-0146-5729; Ly, Khanh/0000-0002-6868-8994;
   TRAN, THI THANH TAM/0000-0002-3872-1570; Nguyen, Hoang
   Bac/0000-0003-3234-5073
CR Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   BETTINGHAUS EP, 1986, PREV MED, V15, P475, DOI 10.1016/0091-7435(86)90025-3
   Bezabih B, 2014, SJPH, V2, P15, DOI DOI 10.11648/J.SJPH.20140201.13
   Cavana R., 2001, APPL BUSINESS RES QU, V3rd ed.
   CDC CfDCaP, 2020, PEOPLE CERTAIN MEDIC
   City UMCHCM, 2021, BENH VIEN DAI HOC DU
   CoronaBoard, 2020, COVID 19 DASHBORAD
   Do CD, 2021, EMERG INFECT DIS, V27, P10, DOI 10.3201/eid2701.202656
   Ejeh FE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05557
   Faber Jorge, 2014, Dental Press J. Orthod., V19, P27, DOI 10.1590/2176-9451.19.4.027-029.ebo
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Huynh G, 2020, RISK MANAG HEALTHC P, V13, P1571, DOI 10.2147/RMHP.S268876
   Nhu HV, 2020, J COMMUN HEALTH, V45, P1263, DOI 10.1007/s10900-020-00919-4
   Haque T, 2020, J INFECT DEV COUNTR
   Health Mo, 2020, 800 PM AUGUST 19 HOS
   Health Mo, 2020, TRANG TIN DICH BENH
   Hu Victor H, 2020, Community Eye Health, V33, pS1
   Hui-Chin K., 2015, INTJ FOOD SCI NUTR D, V04, P171, DOI DOI 10.19070/2326-3350-1500032
   Jenn Ng Chirk, 2006, Malays Fam Physician, V1, P32
   Kemp S., 2021, DIGITAL 2020 VIETNAM
   LIPSON JG, 1983, WESTERN J MED, V139, P854
   Oheneba-Sakyi Y., 2006, AFRICAN FAMILIES TUR
   Rahbar T., 2007, Journal of Communicable Diseases, V39, P179
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Seid MA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3199-1
   Spagnuolo R, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56080407
   Tran TPT, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020502
   University Medical Center HCMC, 2021, SANG LOC COVID 19 TA
   La VP, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072931
   WHO, 2020, COR DIS COVID 2019 S
   World Health Organization, 2020, COVID 19 STRATEGY UP
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 34
TC 1
Z9 1
U1 0
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 2119
EP 2132
DI 10.2147/RMHP.S305959
PG 14
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA SJ7IY
UT WOS:000655705400001
PM 34079399
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Putrino, A
   Raso, M
   Magazzino, C
   Galluccio, G
AF Putrino, Alessandra
   Raso, Mario
   Magazzino, Cosimo
   Galluccio, Gabriella
TI Coronavirus (COVID-19) in Italy: knowledge, management of patients and
   clinical experience of Italian dentists during the spread of contagion
SO BMC ORAL HEALTH
LA English
DT Article
DE 2019 novel coronavirus; COVID-19; Dentistry; Health management;
   Knowledge; Survey
AB BackgroundThe coronavirus infection that emerged in China in the last few months of 2019 has now spread globally. Italy registered its first case in the second half of February, and in a short time period, it became the top country in Europe in terms of the number of infected people and the first in the world in terms of deaths. The medical and scientific community has been called upon to manage the emergency and to take measures. Dentists also need to take new precautions during their clinical activity to protect themselves, coworkers and patients from the risks of contagion and to avoid further spread of infection.MethodsFollowing the data published in the international literature as well as the guidelines and directives constantly updated by the WHO and by the national health authorities, a questionnaire to be completed anonymously was submitted online to Italian dentists using social tools and online professional platforms. The collected data were processed statistically, providing descriptive data and analysis of correlations of the most significant parameters using the Pearson's chi 2, the Likelihood-Ratio chi 2, Cramer's V, Fisher's exact test, Goodman and Kruskal's gamma, and Kendall's tau b (p<0.05).ResultsA total of 535 dentists from Italy participated in the survey. A good level of scientific knowledge about coronavirus and the extra precautionary measures needed to limit the spread was related to the age of respondents and their sex. Coming from areas with higher concentrations of cases affected knowledge, level of attention and perception of risk related to dental activity.ConclusionsAt the moment, there are no therapies or vaccines to contain the infection with the new coronavirus that is causing many infections, many of which are fatal, worldwide. Dentists are one of the categories at highest risk of encountering diseases and infections because they work in close proximity with patients, and in their procedures, there is always contact with aerosols with high bacterial and viral potential. Therefore, during this COVID-19 emergency, it is important that dentists are properly informed and take the appropriate precautionary measures.
C1 [Putrino, Alessandra] Univ Sapienza Rome, Adv Training Course Risk Management Healthcare &, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Raso, Mario] Italian Soc Appl & Ind Math SIMAI, Rome, Italy.
   [Magazzino, Cosimo] Univ Roma Tre, Dept Polit Sci, Rome, Italy.
   [Galluccio, Gabriella] Univ Sapienza, Dept Oral & Maxillofacial Sci, Rome, Italy.
RP Putrino, A (corresponding author), Univ Sapienza Rome, Adv Training Course Risk Management Healthcare &, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM alessanda.putrino@gmail.com
RI Magazzino, Cosimo/K-5030-2015; GALLUCCIO, Gabriella/AAR-7459-2020
OI Magazzino, Cosimo/0000-0002-3176-9838; GALLUCCIO,
   Gabriella/0000-0002-6876-8839; Raso, Mario/0000-0001-9495-3037; Putrino,
   Alessandra/0000-0001-5278-145X
CR Albarello F, 2020, INT J INFECT DIS, V93, P192, DOI 10.1016/j.ijid.2020.02.043
   [Anonymous], 2020, EM COR
   [Anonymous], 2020, EL MED CAD NEL CORS
   [Anonymous], 2020, NUOV COR SARS COV 2
   [Anonymous], 2020, COR
   [Anonymous], 2020, COR DIS 2019 COVID 1
   [Anonymous], 2020, AGG COR
   Bordi L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.8.2000170
   Centre for Health Protection, SEV RESP DIS ASS NOV
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cramer H., 1946, MATH METHODS STAT
   Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435
   Gamio L., 2020, NY TIMES
   GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536
   HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   KENDALL MG, 1945, BIOMETRIKA, V33, P239, DOI 10.1093/biomet/33.3.239
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Sabino-Silva R, 2020, CLIN ORAL INVEST, V24, P1619, DOI 10.1007/s00784-020-03248-x
   Shen ZJ, 2020, CLIN INFECT DIS, V71, P713, DOI 10.1093/cid/ciaa203
   Tsang OTY, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciia149, DOI 10.1093/CID/CIIA149]
   World Health Organization, 2020, SHORT PERS PROT EQ E
   World Health Organization, COR
   World Health Organization, RAT US PERS PROT EQ
   World Health Organization (WHO), 1 WHO
   Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 32
TC 25
Z9 26
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1472-6831
J9 BMC ORAL HEALTH
JI BMC Oral Health
PD JUL 10
PY 2020
VL 20
IS 1
AR 200
DI 10.1186/s12903-020-01187-3
PG 15
WC Dentistry, Oral Surgery & Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dentistry, Oral Surgery & Medicine
GA MP2FN
UT WOS:000552025200003
PM 32650753
OA Green Published, Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Nasa, P
   Azoulay, E
   Khanna, AK
   Jain, R
   Gupta, S
   Javeri, Y
   Juneja, D
   Rangappa, P
   Sundararajan, K
   Alhazzani, W
   Antonelli, M
   Arabi, YM
   Bakker, J
   Brochard, LJ
   Deane, AM
   Du, B
   Einav, S
   Esteban, A
   Gajic, O
   Galvagno, SM
   Guerin, C
   Jaber, S
   Khilnani, GC
   Koh, Y
   Lascarrou, JB
   Machado, FR
   Malbrain, MLNG
   Mancebo, J
   McCurdy, MT
   McGrath, BA
   Mehta, S
   Mekontso-Dessap, A
   Mer, M
   Nurok, M
   Park, PK
   Pelosi, P
   Peter, JV
   Phua, J
   Pilcher, DV
   Piquilloud, L
   Schellongowski, P
   Schultz, MJ
   Shankar-Hari, M
   Singh, S
   Sorbello, M
   Tiruvoipati, R
   Udy, AA
   Welte, T
   Myatra, SN
AF Nasa, Prashant
   Azoulay, Elie
   Khanna, Ashish K.
   Jain, Ravi
   Gupta, Sachin
   Javeri, Yash
   Juneja, Deven
   Rangappa, Pradeep
   Sundararajan, Krishnaswamy
   Alhazzani, Waleed
   Antonelli, Massimo
   Arabi, Yaseen M.
   Bakker, Jan
   Brochard, Laurent J.
   Deane, Adam M.
   Du, Bin
   Einav, Sharon
   Esteban, Andres
   Gajic, Ognjen
   Galvagno, Samuel M., Jr.
   Guerin, Claude
   Jaber, Samir
   Khilnani, Gopi C.
   Koh, Younsuck
   Lascarrou, Jean-Baptiste
   Machado, Flavia R.
   Malbrain, Manu L. N. G.
   Mancebo, Jordi
   McCurdy, Michael T.
   McGrath, Brendan A.
   Mehta, Sangeeta
   Mekontso-Dessap, Armand
   Mer, Mervyn
   Nurok, Michael
   Park, Pauline K.
   Pelosi, Paolo
   Peter, John V.
   Phua, Jason
   Pilcher, David V.
   Piquilloud, Lise
   Schellongowski, Peter
   Schultz, Marcus J.
   Shankar-Hari, Manu
   Singh, Suveer
   Sorbello, Massimiliano
   Tiruvoipati, Ravindranath
   Udy, Andrew A.
   Welte, Tobias
   Myatra, Sheila N.
TI Expert consensus statements for the management of COVID-19-related acute
   respiratory failure using a Delphi method
SO CRITICAL CARE
LA English
DT Article
DE Respiratory distress syndrome adult; COVID-19 ventilatory management;
   COVID-19 respiratory management; COVID-19 acute respiratory distress
   syndrome; COVID-19 high flow nasal oxygen; COVID 19 invasive mechanical
   ventilation
ID FLOW NASAL OXYGEN; MULTICENTER; VENTILATION
AB Background Coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented pressure on healthcare system globally. Lack of high-quality evidence on the respiratory management of COVID-19-related acute respiratory failure (C-ARF) has resulted in wide variation in clinical practice. Methods Using a Delphi process, an international panel of 39 experts developed clinical practice statements on the respiratory management of C-ARF in areas where evidence is absent or limited. Agreement was defined as achieved when > 70% experts voted for a given option on the Likert scale statement or > 80% voted for a particular option in multiple-choice questions. Stability was assessed between the two concluding rounds for each statement, using the non-parametric Chi-square (chi(2)) test (p < 0 center dot 05 was considered as unstable). Results Agreement was achieved for 27 (73%) management strategies which were then used to develop expert clinical practice statements. Experts agreed that COVID-19-related acute respiratory distress syndrome (ARDS) is clinically similar to other forms of ARDS. The Delphi process yielded strong suggestions for use of systemic corticosteroids for critical COVID-19; awake self-proning to improve oxygenation and high flow nasal oxygen to potentially reduce tracheal intubation; non-invasive ventilation for patients with mixed hypoxemic-hypercapnic respiratory failure; tracheal intubation for poor mentation, hemodynamic instability or severe hypoxemia; closed suction systems; lung protective ventilation; prone ventilation (for 16-24 h per day) to improve oxygenation; neuromuscular blocking agents for patient-ventilator dyssynchrony; avoiding delay in extubation for the risk of reintubation; and similar timing of tracheostomy as in non-COVID-19 patients. There was no agreement on positive end expiratory pressure titration or the choice of personal protective equipment. Conclusion Using a Delphi method, an agreement among experts was reached for 27 statements from which 20 expert clinical practice statements were derived on the respiratory management of C-ARF, addressing important decisions for patient management in areas where evidence is either absent or limited. Trial registration: The study was registered with Clinical trials.gov Identifier: NCT04534569.
C1 [Nasa, Prashant] NMC Special Hosp, Crit Care Med, Dubai, U Arab Emirates.
   [Azoulay, Elie] St Louis Teaching Hosp, AP HP, Paris, France.
   [Azoulay, Elie] Univ Paris, Paris, France.
   [Khanna, Ashish K.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA.
   [Khanna, Ashish K.] Outcomes Res Consortium, Cleveland, OH USA.
   [Jain, Ravi] Mahatma Gandhi Med Coll & Hosp, Jaipur, Rajasthan, India.
   [Gupta, Sachin] Narayana Super Special Hosp, Gurugram, India.
   [Javeri, Yash] Regency Super Special Hosp, Lucknow, Uttar Pradesh, India.
   [Juneja, Deven] Max Super Special Hosp, New Delhi, India.
   [Rangappa, Pradeep] Columbia Asia Referral Hosp, Bengaluru, India.
   [Sundararajan, Krishnaswamy] Royal Adelaide Hosp, Adelaide, SA, Australia.
   [Sundararajan, Krishnaswamy] Univ Adelaide, Adelaide, SA, Australia.
   [Alhazzani, Waleed] McMaster Univ, Hamilton, ON, Canada.
   [Antonelli, Massimo] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy.
   [Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia.
   [Arabi, Yaseen M.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.
   [Bakker, Jan] NYU, Sch Med, New York, NY USA.
   [Bakker, Jan] Columbia Univ, Coll Phys & Surg, New York, NY USA.
   [Bakker, Jan] Erasmus MC, Univ Med Ctr, Rotterdam, Netherlands.
   [Bakker, Jan] Pontificia Univ Catolica Chile, Santiago, Chile.
   [Brochard, Laurent J.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Unity Hlth Toronto, Toronto, ON, Canada.
   [Brochard, Laurent J.; Mehta, Sangeeta] Univ Toronto, Toronto, ON, Canada.
   [Deane, Adam M.] Royal Melbourne Hosp, Melbourne, Vic, Australia.
   [Deane, Adam M.] Univ Melbourne, Melbourne, Vic, Australia.
   [Du, Bin] Peking Union Med Coll Hosp, Beijing, Peoples R China.
   [Einav, Sharon] Shaare Zedek Med Ctr, Jerusalem, Israel.
   [Esteban, Andres] Hosp Univ Getafe, CIBER Enfermedades Resp, Madrid, Spain.
   [Gajic, Ognjen] Mayo Clin, Rochester, MN USA.
   [Galvagno, Samuel M., Jr.] Univ Maryland, College Pk, MD 20742 USA.
   [Guerin, Claude] Univ Lyon, Lyon, France.
   [Guerin, Claude] Med Intens Reanimat Hop Edouard Herriot Lyon, Inst Mondor Rech Biomed, Creteil, France.
   [Guerin, Claude] Med Intens Reanimat Hop Edouard Herriot Lyon, Creteil, France.
   [Jaber, Samir] Montpellier Univ Hosp, Montpellier, France.
   [Jaber, Samir] Univ Montpellier, CHU Montpellier, Hop St Eloi, Phy Med Exp, Montpellier, France.
   [Khilnani, Gopi C.] PSRI Hosp, New Delhi, India.
   [Koh, Younsuck] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea.
   [Lascarrou, Jean-Baptiste] Nantes Univ Hosp, Nantes, France.
   [Machado, Flavia R.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Malbrain, Manu L. N. G.] Int Fluid Acad, Lovenjoel, Belgium.
   [Malbrain, Manu L. N. G.] Vrije Univ Brussel VUB, Dept Elect & Informat, Fac Engn, Brussels, Belgium.
   [Mancebo, Jordi] Hosp Univ St Pau, Barcelona, Spain.
   [McCurdy, Michael T.] Univ Maryland, Sch Med, College Pk, MD 20742 USA.
   [McGrath, Brendan A.] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England.
   [McGrath, Brendan A.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Infect Immun & Resp Med,Acad Hlth Sci Ctr, Manchester, Lancs, England.
   [Mehta, Sangeeta] Sinai Hlth, Toronto, ON, Canada.
   [Mekontso-Dessap, Armand] Hop Univ Henri Mondor, AP HP, Serv Med Intens Reanimat, Creteil, France.
   [Mekontso-Dessap, Armand] Univ Paris Est Creteil, CARMAS, Creteil, France.
   [Mer, Mervyn] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa.
   [Mer, Mervyn] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa.
   [Nurok, Michael] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA.
   [Park, Pauline K.] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Pelosi, Paolo] San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Genoa, Italy.
   [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Sci, Genoa, Italy.
   [Peter, John V.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India.
   [Phua, Jason] Alexandra Hosp, Singapore, Singapore.
   [Phua, Jason] Natl Univ Singapore Hosp, Singapore, Singapore.
   [Pilcher, David V.] Alfred Hlth, Melbourne, Vic, Australia.
   [Pilcher, David V.; Tiruvoipati, Ravindranath; Udy, Andrew A.] Monash Univ, Melbourne, Vic, Australia.
   [Piquilloud, Lise] Lausanne Univ Hosp, Lausanne, Switzerland.
   [Piquilloud, Lise] Lausanne Univ, Lausanne, Switzerland.
   [Schellongowski, Peter] Med Univ Vienna, Vienna, Austria.
   [Schultz, Marcus J.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.
   [Schultz, Marcus J.] Mahidol Univ, Bangkok, Thailand.
   [Schultz, Marcus J.] Univ Oxford, Oxford, England.
   [Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, London, England.
   [Shankar-Hari, Manu] Kings Coll London, London, England.
   [Singh, Suveer] Imperial Coll, Royal Brompton Hosp, London, England.
   [Singh, Suveer] Imperial Coll, Chelsea & Westminster Hosp, London, England.
   [Sorbello, Massimiliano] AOU Policlin San Marco, Anesthesia & Intens Care, Catania, Italy.
   [Tiruvoipati, Ravindranath] Peninsula Hlth, Melbourne, Vic, Australia.
   [Welte, Tobias] German Ctr Lung Res, Dept Resp Med, Hannover, Germany.
   [Myatra, Sheila N.] Tata Mem Hosp, Homi Bhabha Natl Inst, Dept Anaesthesia Crit Care & Pain, Dr Ernest Borges Rd, Mumbai, Maharashtra, India.
RP Myatra, SN (corresponding author), Tata Mem Hosp, Homi Bhabha Natl Inst, Dept Anaesthesia Crit Care & Pain, Dr Ernest Borges Rd, Mumbai, Maharashtra, India.
EM sheila150@hotmail.com
RI Shankar-Hari, Manu/Q-9056-2019; McCurdy, Michael/T-5518-2019;
   Piquilloud, Lise/ABC-4402-2021; McGrath, Brendan/D-7202-2013; Malbrain,
   Manu/B-3680-2017
OI Shankar-Hari, Manu/0000-0002-5338-2538; McCurdy,
   Michael/0000-0001-5319-0475; Schultz, Marcus/0000-0003-3969-7792;
   McGrath, Brendan/0000-0003-3048-3480; Malbrain,
   Manu/0000-0002-1816-5255; Bakker, Jan/0000-0003-2236-7391; jain,
   ravi/0000-0001-9260-479X
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Agarwal A, 2020, CAN J ANESTH, V67, P1217, DOI 10.1007/s12630-020-01740-2
   AHN J, 2020, LANCET RESP MED, V106, P570, DOI DOI 10.1016/J.JHIN.2020.08.014
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Alhazzani W, 2020, INTENS CARE MED, V46, P1977, DOI 10.1007/s00134-020-06227-8
   ALIBERTI S, 2020, RESP PHYSIOL NEUROBI, V56, P1935, DOI DOI 10.1183/13993003.01935-2020
   Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201
   Ashish A, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000692
   Aviles-Jurado FX, 2021, JAMA OTOLARYNGOL, V147, P41, DOI 10.1001/jamaoto.2020.3641
   Azoulay E, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03194-w
   BARBARO R, 2020, RESP MED, V396, P1071, DOI DOI 10.1016/S0140-6736(20)32008-0
   Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/ajcp/aqaa062, 10.1093/AJCP/AQAA062]
   Belenguer-Muncharaz A., 2020, MED INTENSIVA
   Bellani G, 2017, AM J RESP CRIT CARE, V195, P67, DOI 10.1164/rccm.201606-1306OC
   Brown J, 2021, ANAESTHESIA, V76, P174, DOI 10.1111/anae.15292
   CHERIAN S, 2018, INTENS CARE MED, V141, P150, DOI DOI 10.1016/J.RMED.2018.06.030
   Chiumello D, 2020, INTENS CARE MED, V46, P2187, DOI 10.1007/s00134-020-06281-2
   Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385
   Combes A, 2020, INTENS CARE MED, V46, P2048, DOI 10.1007/s00134-020-06248-3
   Coppo A, 2020, LANCET RESP MED, V8, P765, DOI 10.1016/S2213-2600(20)30268-X
   DEJONG A, 2020, NEW ENGL J MED, V8, P555, DOI DOI 10.1016/S2213-2600(20)30221-6
   Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002
   Ding L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2738-5
   Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985
   ELSO, COVID 19 REG DASHB
   European Centre for Disease Prevention and Control (ECDC), 2020, COVID 19 SURV REP
   Fan E, 2020, LANCET RESP MED, V8, P816, DOI 10.1016/S2213-2600(20)30304-0
   Fan E, 2017, ANN AM THORAC SOC, V14, P441, DOI 10.1513/AnnalsATS.201612-993CME
   Ferrando C, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03314-6
   Ferrando C, 2020, INTENS CARE MED, V46, P2200, DOI 10.1007/s00134-020-06192-2
   Gattinoni L, 2020, INTENS CARE MED, V46, P1438, DOI 10.1007/s00134-020-06103-5
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Goligher EC, 2017, CHEST, V151, P1399, DOI 10.1016/j.chest.2017.02.033
   Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Grieco DL, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03253-2
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Haymet A, 2020, INTENS CARE MED, V46, P2248, DOI 10.1007/s00134-020-06314-w
   Ho ATN, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-0431-z
   HORBY P, 2020, NEW ENGL J MED, DOI 10.1101/2020.07.15.20151852
   Hraiech S, 2020, INTENS CARE MED, V46, P2357, DOI 10.1007/s00134-020-06297-8
   Hui DS, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02339-2018
   Kim S, 2021, CLIN INFECT DIS, DOI 10.1093/cid/ciab668
   Kumar R, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00405-2020
   Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379
   LAZZERI M, 2020, COCHRANE DB SYST REV, DOI DOI 10.4081/MONALDI.2020.1285
   Lorusso R, 2021, INTENS CARE MED, V47, P344, DOI 10.1007/s00134-020-06272-3
   Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020
   MCGRATH B, 2020, INTENS CARE MED, V8, P717, DOI DOI 10.1016/S2213-2600(20)30230-7
   MCGRATH B, 2020, LANCET RESP MED, V125, P867, DOI DOI 10.1016/J.BJA.2020.08.048
   Mukhtar A, 2020, ANAESTH CRIT CARE PA, V39, P579, DOI 10.1016/j.accpm.2020.07.012
   NHS England, GUID ROL US NON RESP
   Padrao EMH, 2020, ACAD EMERG MED, V27, P1249, DOI 10.1111/acem.14160
   PAGANO A, 2020, EUR RESPIR J, V280, P3489, DOI DOI 10.1016/J.RESP.2020.103489
   Papazian L, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0540-9
   Patel M, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000650
   Pensier J, 2019, INTENS CARE MED, V45, P1691, DOI 10.1007/s00134-019-05821-9
   Rochwerg B, 2020, INTENS CARE MED, V46, P2226, DOI 10.1007/s00134-020-06312-y
   ROESTHUIS L, 2020, BRIT J ANAESTH, V24, P230, DOI DOI 10.1186/S13054-020-02953-Z
   Schmidt M, 2020, LANCET RESP MED, V8, P1121, DOI 10.1016/S2213-2600(20)30328-3
   SCHULTZ M, 2020, CRIT CARE, V8, DOI DOI 10.1016/S2213-2600(20)30180-6
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   SUBIRA C, 2019, ANN AM THORAC SOC, V321, P2175, DOI DOI 10.1001/JAMA.2019.7234
   Tarazan N, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00348-6
   Taylor E, 2020, HERD-HEALTH ENV RES, V13, P11, DOI 10.1177/1937586719887709
   Tipping CJ, 2017, INTENS CARE MED, V43, P171, DOI 10.1007/s00134-016-4612-0
   Tobin MJ, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00724-1
   Tobin MJ, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00692-6
   Tobin MJ, 2020, AM J RESP CRIT CARE, V201, P1319, DOI 10.1164/rccm.202004-1076ED
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   VERBEEK JH, 2019, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD011621.pub3
   Vianello A, 2020, THORAX, V75, P998, DOI 10.1136/thoraxjnl-2020-214993
   VITACCA M, 2020, ANAESTH CRIT CARE PA, V55, P632, DOI DOI 10.1183/13993003.00632-2020
   WARD J, 2021, ANAESTHESIA, V76, P182, DOI DOI 10.1111/ANAE.15301
   Wei HF, 2021, BRIT J ANAESTH, V126, P361, DOI 10.1016/j.bja.2020.10.029
   Xia JE, 2020, CRIT CARE MED, V48, pE1079, DOI 10.1097/CCM.0000000000004558
NR 77
TC 37
Z9 37
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1364-8535
EI 1466-609X
J9 CRIT CARE
JI Crit. Care
PD MAR 16
PY 2021
VL 25
IS 1
AR 106
DI 10.1186/s13054-021-03491-y
PG 17
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA QY4EF
UT WOS:000629994000002
PM 33726819
OA Green Published, gold
DA 2022-04-20
ER

PT C
AU Bhushan, V
   Attili, VSP
AF Bhushan, Vishwa
   Attili, V. S. Prakash
GP Assoc Informat Syst
TI Role of Knowledge Management in Agile Execution during Pandemic
SO DIGITAL INNOVATION AND ENTREPRENEURSHIP (AMCIS 2021)
LA English
DT Proceedings Paper
CT 27th Annual Americas Conference on Information Systems (AMCIS)
CY AUG 09-13, 2021
CL ELECTR NETWORK
DE Agile; Software Development; SDLC; COVID-19; Knowledge Management;
   Knowledge Repository
AB The COVID-19 pandemic brought an unprecedented time for everyone. IT Industry was not an exception. Some had to cut the workforce whereas some sustained in this pandemic. In this paper, we will try to look at how agile setup has helped the organization to sail through pandemic and how knowledge management becomes important when a resource leaves the project at different stages of the project.
C1 [Bhushan, Vishwa; Attili, V. S. Prakash] IIM Lucknow, Lucknow, Uttar Pradesh, India.
RP Bhushan, V (corresponding author), IIM Lucknow, Lucknow, Uttar Pradesh, India.
EM wmp15062@iiml.ac.in; prakash.attili@iiml.ac.in
CR Abbas N., 2008, HIST ROOTS AGILE MET, P94
   Alavi M., 1999, COMMUN ASSOC INF SYS, V1, P7, DOI DOI 10.17705/1CAIS.00107
   Andres, 2004, EXTREME PROGRAMMING
   Beck K., 2001, MANIFESTO AGILE SOFT
   Bollinger A.S., 2001, J KNOWL MANAG, V5, P8, DOI [http://doi.org/10.1108/13673270110384365, DOI 10.1108/13673270110384365]
   Digital.ai, 2020, 14 ANN STAT AG REP, V14
   Khalil C, 2020, INT ENTREP MANAG J, V16, P555, DOI 10.1007/s11365-019-00582-9
   Lee G, 2010, MIS QUART, V34, P87
   McKinsey & Company, 2020, OP MOD NEXT NORM LES
   Sivanantham V., 2012, COGNIZANT 20 20 INSI
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ASSOC INFORMATION SYSTEMS
PI ATLANTA
PA P.O. BOX 2712, ATLANTA, GA 30301-2712 USA
PY 2021
PG 5
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BR8LY
UT WOS:000672599802028
DA 2022-04-20
ER

PT J
AU Almutairi, NF
   Almaymuni, AA
   Thomas, JT
   Thomas, T
   Almalki, A
   Uthappa, R
AF Almutairi, Nada Faleh
   Almaymuni, Amani Abdullah
   Thomas, Julie Toby
   Thomas, Toby
   Almalki, Abdullah
   Uthappa, Roshan
TI Comprehensive Knowledge and Preparedness among Dental Community to
   Confront COVID-19-A Multicentric Cross-Sectional Study
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; dental community; infection control; awareness; preparedness;
   pandemic
ID UNIVERSITY; RIYADH
AB The healthcare policy changes need to be updated for better management of the COVID-19 outbreak; hence, there is an urgent need to understand the knowledge and preparedness of healthcare workers regarding the infection control COVID-19. Therefore, the present study aims to assess the knowledge and preparedness towards COVID-19 among dentists, undergraduate, and postgraduates in dental universities one year after the COVID-19 outbreak. The multi-centric cross-sectional study was conducted by evaluating 395 structured, pre-coded, and validated questionnaires obtained from sample units comprising full-time dental students (undergraduates, interns, and postgraduates) and dentists who were currently in practice and who were able to comprehend the languages English or Arabic. The first part of the questionnaire included questions related to demographic characteristics. The second part of the survey consisted of questions that address knowledge concerning COVID-19. The third part of the survey addressed questions based on the preparedness to fight against COVID-19 including sharp injuries during this period. Comparing the knowledge scores of dentists, dental undergraduates, and postgraduates using the ANOVA test, dentists have higher knowledge and preparedness scores than postgraduates and undergraduates (p-value < 0.05). Univariate logistic regression analysis demonstrated that undergraduates and postgraduates were 2.567 and 1.352 times less aware of the personal protective measures against COVID-19 than dentists, respectively. Dentists had the comparatively better perception in knowledge and awareness of COVID-19 than undergraduates and postgraduates.
C1 [Almutairi, Nada Faleh; Almaymuni, Amani Abdullah] Majmaah Univ, Coll Dent, Al Majmaah 11952, Saudi Arabia.
   [Thomas, Julie Toby; Almalki, Abdullah] Majmaah Univ, Dept Prevent Dent Sci, Coll Dent, Al Majmaah 11952, Saudi Arabia.
   [Thomas, Toby; Uthappa, Roshan] Majmaah Univ, Dept Restorat Dent Sci, Coll Dent, Al Majmaah 11952, Saudi Arabia.
RP Thomas, JT (corresponding author), Majmaah Univ, Dept Prevent Dent Sci, Coll Dent, Al Majmaah 11952, Saudi Arabia.
EM nada2.almutairi@gmail.com; Ammman23i@gmail.com; j.thomas@mu.edu.sa;
   t.thomas@mu.edu.sa; ae.almalki@mu.edu.sa; r.uthappa@mu.edu.sa
OI ALMALKI, ABDULLAH/0000-0002-3064-3547; Almaymuni,
   Amani/0000-0002-1087-9894; Almutairi, Nada/0000-0001-7723-1163
FU Deanship of scientific research, Majmaah University, Saudi Arabia; 
   [R-2021-319]
FX This research received no external funding. The funding for the project
   was approved by the Deanship of scientific research, Majmaah University,
   Saudi Arabia.
CR Al Jasser R, 2020, J MULTIDISCIP HEALTH, V13, P1317, DOI [10.2147/JMDH.S267956, 10.2147/JMADH.S267956]
   Al-Khalifa KS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237630
   Alharbi A, 2020, SAUDI DENT J, V32, P181, DOI 10.1016/j.sdentj.2020.04.001
   Alharbi TM, 2021, OPEN DENT J, V15, P479, DOI 10.2174/1874210602115010479
   Althomairy SA, 2018, J INT SOC PREV COMMU, V8, P137, DOI [10.4103/jispcd.JISPCD_9_18, 10.4103/jispcd.jispcd_9_18]
   Arora S, 2020, J MULTIDISCIP HEALTH, V13, P841, DOI 10.2147/JMDH.S268891
   Bains VK, 2021, J EDUC HEALTH PROMOT, V10, DOI 10.4103/jehp.jehp_763_20
   Baseer Mohammad-Abdul, 2016, J Clin Exp Dent, V8, pe379
   Batra K, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9050574
   Coulthard P, 2020, BRIT DENT J, V228, P503, DOI 10.1038/s41415-020-1482-1
   Hajian-Tilaki K, 2011, CASP J INTERN MED, V2, P289
   Kumar PS, 2021, J PERIODONTOL, V92, P784, DOI 10.1002/JPER.20-0567
   Matsumoto H, 2019, J ORAL SCI, V61, P164, DOI 10.2334/josnusd.18-0127
   Passarelli PC, 2020, EXP BIOL MED, V245, P940, DOI 10.1177/1535370220928905
   Pylinska-Dabrowska D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103344
   Rajeh M, 2020, OPEN DENT J, V14, P489, DOI 10.2174/1874210602014010489
   Rexhepi I, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147472
   Singh YP, 2021, ANN MED HEALTH SCI R, V11, P1331
   Sinjari B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165780
   Srivastava KC, 2020, J INT MED RES, V48, DOI 10.1177/0300060520977593
   Wong SCY, 2020, J HOSP INFECT, V105, P119, DOI 10.1016/j.jhin.2020.03.036
   Xin KY, 2020, WORK, V67, P165, DOI 10.3233/WOR-203262
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 23
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN
PY 2022
VL 19
IS 1
AR 210
DI 10.3390/ijerph19010210
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA YE5XG
UT WOS:000741197700001
PM 35010471
OA gold, Green Published
DA 2022-04-20
ER

PT C
AU Viseur, R
AF Viseur, Robert
GP ACM
TI Open data in digital strategies against COVID-19: the case of Belgium
SO PROCEEDINGS OF THE 17TH INTERNATIONAL SYMPOSIUM ON OPEN COLLABORATION
   (OPENSYM)
LA English
DT Proceedings Paper
CT 17th International Symposium on Open Collaboration (OpenSym)
CY SEP 15-17, 2021
CL ELECTR NETWORK
SP Univ Rey Juan Carlos, ACM In Cooperat, ACM Special Interest Grp Software Engn, ACM SIGWEB
DE open data; COVID-19; open science; knowledge management; health
AB COVID-19 has highlighted the importance of digital in the fight against the pandemic (control at the border, automated tracing, creation of databases...). In this research, we analyze the Belgian response in terms of open data. First, we examine the open data publication strategy in Belgium (a federal state with a sometimes complex functioning, especially in health), second, we conduct a case study (anatomy of the pandemic in Belgium) in order to better understand the strengths and weaknesses of the main COVID-19 open data repository. And third, we analyze the obstacles to open data publication. Finally, we discuss the Belgian COVID-19 open data strategy in terms of data availability, data relevance and knowledge management. In particular, we show how difficult it is to optimize the latter in order to make the best use of governmental, private and academic open data in a way that has a positive impact on public health policy.
C1 [Viseur, Robert] Univ Mons, Mons, Belgium.
RP Viseur, R (corresponding author), Univ Mons, Mons, Belgium.
EM robert.viseur@umons.ac.be
CR Bhagat RK, 2020, J FLUID MECH, V903, DOI 10.1017/jfm.2020.720
   Breitman K, 2012, IEEE INTELL SYST, V27, P45, DOI 10.1109/MIS.2012.25
   Brugiere A, 2011, GUIDE PRATIQUE OUVER
   Sierra NB, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00496-x
   Cao SY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19802-w
   Capron H., 2009, REFLETS PERSPECTIVES, V48, P115
   Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3
   Chignard S., 2021, ANN MINES, P73
   Chignard S, 2012, OPEN DATA
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Ermine J. L., 2012, MANAGEMENT INT, V16, P29
   Faes C., 2020, CELGIAN COVID 19 MOR
   Friesike S., 2014, OPENING SCI EVOLVING, P17, DOI 10.1007/978-3-319-00026-8_2
   Greenhalgh T, 2021, LANCET, V397, P1603, DOI 10.1016/S0140-6736(21)00869-2
   He JJ, 2021, J MED VIROL, V93, P820, DOI 10.1002/jmv.26326
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Kupferschmidt K, 2021, SCIENCE, V371, P329, DOI 10.1126/science.371.6527.329
   Lau EHY, 2020, NAT MED, V26, P1534, DOI 10.1038/s41591-020-1049-3
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Lindman J, 2011, IFIP ADV INF COMM TE, V365, P330
   Lobre K, 2012, AIM 2012
   Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756
   Nikiforova Anastasija, 2020, 2020 Fourth International Conference on Multimedia Computing, Networking and Applications (MCNA), P131, DOI 10.1109/MCNA50957.2020.9264298
   Omori R, 2020, INT J INFECT DIS, V94, P116, DOI 10.1016/j.ijid.2020.04.021
   Perrin N., 2006, PAUVRETE CHEZ PERSON
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Reix R., 2011, SYSTEMES INFORM MANA, V6
   Ronai M., 2021, ANN MINES
   Rowe F., 2011, SYSTEMES INFORM MANA
   Rowe F, 2020, EUR J INFORM SYST, V29, P545, DOI 10.1080/0960085X.2020.1803155
   Saglietto A, 2020, LANCET, V395, P1110, DOI 10.1016/S0140-6736(20)30690-5
   Slifka MK, 2020, NAT MED, V26, P1531, DOI 10.1038/s41591-020-1046-6
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Van den Broek N, 2011, EUROPEAN J EPRACTICE, V12, P4
   Viseur R, 2021, C INFORSID DIJ
   Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0
   Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351
NR 37
TC 0
Z9 0
U1 1
U2 1
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY, UNITED STATES
BN 978-1-4503-8500-8
PY 2021
DI 10.1145/3479986.3479988
PG 10
WC Computer Science, Information Systems; Computer Science, Software
   Engineering; Computer Science, Theory & Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS8ET
UT WOS:000771787400002
DA 2022-04-20
ER

PT J
AU Pettus, J
   Skolnik, N
AF Pettus, Jeremy
   Skolnik, Neil
TI Importance of diabetes management during the COVID-19 pandemic
SO POSTGRADUATE MEDICINE
LA English
DT Review
DE COVID-19; diabetes; hyperglycemia; hemoglobin A1c; primary care
ID RECEPTOR; TYPE-1; CORONAVIRUS; OUTCOMES
AB Uncontrolled diabetes and/or hyperglycemia is associated with severe COVID-19 disease and increased mortality. It is now known that poor glucose control before hospital admission can be associated with a high risk of in-hospital death. By achieving and maintaining glycemic control, primary care physicians (PCPs) play a critical role in limiting this potentially devastating outcome. Further, despite the hope that mass vaccination will help control the pandemic, genetic variants of the virus are causing surges in some countries. As such, PCPs will treat an increasing number of patients with diabetes who have symptoms of post-COVID-19 infection, or even have new-onset type 2 diabetes as a result of COVID-19 infection. However, much of the literature published focuses on the effects of COVID-19 in hospitalized patients, with few publications providing information and advice to those caring for people with diabetes in the primary care setting. This manuscript reviews the current knowledge of the risk and outcomes of individuals with diabetes who are infected with COVID-19 and provides information for PCPs on the importance of glucose control, appropriate treatment, and use of telemedicine and online prescription delivery systems to limit the potentially devastating effects of COVID-19 in people with hyperglycemia.
C1 [Pettus, Jeremy] Univ Calif San Diego, Sch Med, San Diego, CA 92093 USA.
   [Skolnik, Neil] Abington Jefferson Hlth, Family Med Residency Program, Abington, PA USA.
RP Pettus, J (corresponding author), Univ Calif San Diego, Sch Med, San Diego, CA 92093 USA.
EM ejpettus@health.ucsd.edu
FU Sanofi US
FX Writing support for this manuscript was funded by Sanofi US.
CR Al-Aly Z, 2021, NATURE, V594, P259, DOI 10.1038/s41586-021-03553-9
   Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS73, DOI 10.2337/dc21-S006
   Apicella M, 2020, LANCET DIABETES ENDO, V8, P782, DOI 10.1016/S2213-8587(20)30238-2
   Ayoubkhani D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n693
   Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2
   Bode Bruce, 2020, J Diabetes Sci Technol, V14, P813, DOI 10.1177/1932296820924469
   Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2
   Bramante Carolyn, 2020, medRxiv, DOI 10.1101/2020.09.01.20185850
   Callaway E, 2021, NATURE, V589, P177, DOI 10.1038/d41586-021-00031-0
   Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253
   Centers for Disease Control and Prevention, SARS COV 2 VAR CLASS
   Centers for Disease Control and Prevention, 2020, DIAB MAN SICK DAYS
   Chao LC, 2021, DIABETES CARE, V44, P1451, DOI 10.2337/dc20-2733
   Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5
   de Abajo FJ, 2020, LANCET, V395, P1705, DOI 10.1016/S0140-6736(20)31030-8
   Deng Xianding, 2021, medRxiv, DOI 10.1101/2021.03.07.21252647
   Ding L, 2020, J MED INTERNET RES, V22, DOI 10.2196/19678
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Ghoneim Sara, 2020, Metabol Open, V8, P100057, DOI 10.1016/j.metop.2020.100057
   Gianchandani R, 2020, DIABETES, V69, P2048, DOI 10.2337/dbi20-0022
   Gonzalez-Molero I, 2012, J TELEMED TELECARE, V18, P328, DOI 10.1258/jtt.2012.120103
   Gregory JM, 2021, DIABETES CARE, V44, P526, DOI 10.2337/dc20-2260
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Guo XM, 2020, HYPERTENSION, V76, pE13, DOI 10.1161/HYPERTENSIONAHA.120.15572
   Hariyanto TI, 2021, J DIABETES METAB DIS, V20, P543, DOI 10.1007/s40200-021-00777-4
   Hariyanto Timotius Ivan, 2020, Obes Med, V19, P100290, DOI 10.1016/j.obmed.2020.100290
   Hartmann-Boyce J, 2020, DIABETES CARE, V43, P1695, DOI 10.2337/dc20-1192
   Hippisley-Cox J, 2020, HEART, V106, P1503, DOI [10.1136/heartjnl-2020-317393, 10.1136/heartjnl-2020-318312]
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0
   Johns Hopkins University,, 2020, COVID 19 DASHB CTR S
   Kosiborod, 2021, AM COLL CARD VIRT AN
   Lalau JD, 2020, LANCET DIABETES ENDO, V8, P666, DOI 10.1016/S2213-8587(20)30231-X
   Liu LW, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19417
   Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4944
   Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923
   McGloin H, 2020, J MED INTERNET RES, V22, DOI 10.2196/16161
   Pal R, 2020, DIABETES RES CLIN PR, V163, DOI 10.1016/j.diabres.2020.108146
   Patel SY, 2021, JAMA INTERN MED, V181, P1412, DOI 10.1001/jamainternmed.2021.3047
   Paul SK, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0260-x
   Peng XV, 2020, DIABETES THER, V11, P2629, DOI 10.1007/s13300-020-00905-y
   Peng XV, 2020, DIABETES THER, V11, P995, DOI 10.1007/s13300-020-00783-4
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975
   Rodriguez-Fortunez P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028467
   Rubino F, 2020, NEW ENGL J MED, V383, P789, DOI [10.1056/NEJMc2021832, 10.1056/NEJMc2018688]
   Sardu C, 2020, DIABETOLOGIA, V63, P2486, DOI 10.1007/s00125-020-05216-2
   Sardu C, 2020, DIABETES CARE, V43, P1408, DOI 10.2337/dc20-0723
   Silhol F, 2020, HYPERTENS RES, V43, P854, DOI 10.1038/s41440-020-0476-3
   Singh AK, 2020, DIABETES METAB SYND, V14, P303, DOI 10.1016/j.dsx.2020.04.004
   Solerte SB, 2020, DIABETES CARE, V43, P2999, DOI 10.2337/dc20-1521
   Turner Jane, 2009, Inform Prim Care, V17, P47
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   Wargny M, 2020, DIABETES CARE, V43, pE174, DOI 10.2337/dc20-1217
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Yang G, 2020, HYPERTENSION, V76, P51, DOI 10.1161/HYPERTENSIONAHA.120.15143
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhou J, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154216
   Zhu L, 2020, CARDIORENAL MED, V10, P470, DOI 10.1159/000510916
NR 62
TC 2
Z9 2
U1 2
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0032-5481
EI 1941-9260
J9 POSTGRAD MED
JI Postgrad. Med.
PD NOV 17
PY 2021
VL 133
IS 8
BP 912
EP 919
DI 10.1080/00325481.2021.1978704
EA OCT 2021
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XJ1ST
UT WOS:000703436400001
PM 34602003
DA 2022-04-20
ER

PT C
AU Petrovic, NN
   Dimovski, V
   Peterlin, J
   Mesko, M
   Roblek, V
AF Petrovic, Nenad N.
   Dimovski, Vlado
   Peterlin, Judita
   Mesko, Maja
   Roblek, Vasja
GP ASSOC COMP MACHINERY
TI Data-Driven Solutions in Smart Cities: The case of Covid-19
SO WEB CONFERENCE 2021: COMPANION OF THE WORLD WIDE WEB CONFERENCE (WWW
   2021)
LA English
DT Proceedings Paper
CT 30th World Wide Web (WWW) Conference (WebConf)
CY APR 19-23, 2021
CL ELECTR NETWORK
SP Assoc Comp Machinery, Microsoft Res, Amazon, Sci, Facebook, Pinterest, Finvolution, Megagon Labs, Google, Yahoo! Res, Posta Slovenije, QLector, EventRegistry, Natl Sci Fdn, Web4Good Fdn, Bloomberg, Outbrain
DE Smart cities; Covid-19; systems thinking; mobile applications; knowledge
   management; augmented reality
ID SYSTEMS
AB This paper aims to give a systemic vision about the data-driven mobile applications in urban data management processes, which is essential to ensure a sustainable smart city ecosystem for what is needed to ensure diversification between stakeholders and data sources. The realization of sustainable data-driven smart solutions based on an urban data platform that will enable citizen wellbeing in the smart city is needed to develop data-driven applications. In this paper, we present five case study mobile applications developed using AppSheet and Google Apps Script technologies to prevent the spread of COVID-19 and provide support to (potentially) infected citizens. Several aspects relevant to coronavirus pandemic are considered: quick COVID-19 patient assessment based on user-provided symptoms integrated with contact tracing; volunteer help during quarantine; UAV-based COVID-19 outdoor safety surveillance; test scheduling and AR-based pharmacy shop assistant.
C1 [Petrovic, Nenad N.] Univ Nis, Fac Elect Engn, Nish, Serbia.
   [Dimovski, Vlado; Peterlin, Judita] Univ Ljubljana, Sch Econ & Business, Ljubljana, Slovenia.
   [Mesko, Maja] Univ Maribor, Fac Org Sci, Maribor, Slovenia.
   [Mesko, Maja] Univ Primorska, Fac Management, Primorska, Slovenia.
   [Roblek, Vasja] Fac Org Studies, Novo Mesto, Slovenia.
RP Petrovic, NN (corresponding author), Univ Nis, Fac Elect Engn, Nish, Serbia.
EM nenad.petrovic@elfak.ni.ac.rs; vlado.dimovski@ef.uni-lj.si;
   judita.peterlin@ef.uni-lj.si; maja.mesko@fm-kp.si; vasja.roblek@gmx.com
OI Petrovic, Nenad/0000-0003-2264-7369
FU Slovenian Research AgencySlovenian Research Agency - Slovenia [P5-0364]
FX The Slovenian Research Agency. Grant no: Program P5-0364 -The Impact of
   Corporate Governance, Organizational Learning, and Knowledge Management
   on Modern Organization.
CR Abbas H, 2018, SUSTAIN COMPUT-INFOR, V19, P204, DOI 10.1016/j.suscom.2018.05.005
   Abbas R, 2020, IEEE CONSUM ELECTR M, V9, P65, DOI 10.1109/MCE.2020.3002490
   Abusaada Hisham, 2020, Int J Community Wellbeing, V3, P417, DOI 10.1007/s42413-020-00068-5
   Anthopoulos LG, 2017, PUB ADMIN INF TECH, V22, P1, DOI 10.1007/978-3-319-57015-0
   Arakpogun EO, 2020, WORLD DEV, V136, DOI 10.1016/j.worlddev.2020.105105
   Arumugam SK, 2020, IOP CONF SER-MAT SCI, V849, DOI 10.1088/1757-899X/849/1/012046
   Batty M, 2014, ENVIRON PLANN B, V41, P388, DOI 10.1068/b4103c2
   Beinhocker E. D., 1997, MCKINSEY Q, V1, P24
   Bunker D, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102201
   Cavalcante E., 2016, P 2 INT WORKSH SMART, P1
   Colander D., 2016, COMPLEXITY ART PUBLI
   Costa Daniel G., 2020, IET Smart Cities, V2, P64, DOI 10.1049/iet-smc.2020.0044
   DeBell T, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00137
   European Commission, 2020, MOB CONT TRAC APPS E
   Freeman Shirra., 2020, COVID 19 OUTD CONS U
   Gharajedaghi J., 2011, SYSTEMS THINKING MAN
   Guida C, 2021, CITIES, V110, DOI 10.1016/j.cities.2020.103038
   HOLLING CS, 1971, J AM I PLANNERS, V37, P221, DOI 10.1080/01944367108977962
   Javaid M, 2020, DIABETES METAB SYND, V14, P419, DOI 10.1016/j.dsx.2020.04.032
   John Leon Singh Hanson, 2020, JMIR Nurs, V3, pe20596, DOI 10.2196/20596
   Kocic D., 2020, P ICETRAN
   Krivy M, 2018, PLAN THEOR, V17, P8, DOI 10.1177/1473095216645631
   McDaniel RR, 2007, PERFORM IMPROV Q, V20, P21, DOI 10.1111/j.1937-8327.2007.tb00438.x
   Moran E. F., 2018, HUMAN ADAPTABILITY I
   Nam T., 2011, P 12 ANN INT DIG GOV, P282
   Park S, 2020, JAMA-J AM MED ASSOC, V323, P2129, DOI 10.1001/jama.2020.6602
   Peirce JC, 2000, HEALTH CARE MANAGE R, V25, P7, DOI 10.1097/00004010-200001000-00002
   Petrovic N, 2020, 2020 55TH INTERNATIONAL SCIENTIFIC CONFERENCE ON INFORMATION, COMMUNICATION AND ENERGY SYSTEMS AND TECHNOLOGIES (IEEE ICEST 2020), P33, DOI 10.1109/ICEST49890.2020.9232713
   Petrovic Nenad, 2020, P 6 VIRT C ENERGETIC
   Petrovic Nenad, P 10 INT C APPL INT
   Radenkovic Masa, 2020, P IEEESTEC 13 C U NI
   Rajput Pruthvish, 2020, 2020 IEEE INT C EL C, P1, DOI [10.1109/CONECCT50063.2020.9198374, DOI 10.1109/CONECCT50063.2020.9198374]
   Ryan PJ, 2017, SYSTEMS, V5, DOI 10.3390/systems5010024
   Sauser B, 2010, IEEE T SYST MAN CY A, V40, P803, DOI 10.1109/TSMCA.2010.2048024
   Sharma T, 2020, NAT MED, V26, P1165, DOI 10.1038/s41591-020-0928-y
   Sodiq A, 2019, J CLEAN PROD, V227, P972, DOI 10.1016/j.jclepro.2019.04.106
   The Institute for Human Systems Dynamics, 2020, COMPLEX ADAPTIVE SYS
   Troise Ciro, 2020, INT BUS RES, V13, P1, DOI [10.5539/ibr.v13n3p1, DOI 10.5539/IBR.V13N3P1]
   Yan JH, 2020, TECHNOL FORECAST SOC, V153, DOI 10.1016/j.techfore.2018.07.009
NR 39
TC 2
Z9 2
U1 0
U2 1
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY, UNITED STATES
BN 978-1-4503-8313-4
PY 2021
BP 648
EP 656
DI 10.1145/3442442.3453469
PG 9
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Interdisciplinary Applications; Computer
   Science, Theory & Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS6LP
UT WOS:000749534900110
DA 2022-04-20
ER

PT J
AU Zhuang, SF
   Hu, J
   Qiao, N
   Lan, ZH
   Lai, JY
   Wu, JG
   Wu, XY
AF Zhuang, Shu-Fan
   Hu, Jia
   Qiao, Nan
   Lan, Zhi-Hui
   Lai, Jun-Yu
   Wu, Jian-Guang
   Wu, Xiao-Yong
TI Low-grade fever during COVID-19 convalescence: A report of 3 cases
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Article
DE COVID-19; Convalescence; Low-grade fever; Clinical characteristics;
   SARS-CoV-2; Case report
ID RNA
AB BACKGROUND Low-grade fever during convalescence is an atypical symptom of coronavirus disease 2019 (COVID-19). Reports of such cases are rare, and the mechanism and outcome of low-grade fever during COVID-19 convalescence are not completely clear. We report 3 cases with low-grade fever during COVID-19 convalescence and highlight the main clinical, radiographic, and laboratory characteristics, thereby increasing the level of expertise in the clinical management of COVID-19 during convalescence and facilitating individualized decision-making. CASE SUMMARY We describe 3 patients with COVID-19, two females aged 62 and 66 years and a male 55 years, who had low-grade fever during COVID-19 convalescence. All 3 patients had no other discomfort or comorbidities during low-grade process. Lesions on computed tomography in all 3 patients had resolved during this period. Two patients tested negative on two consecutive severe acute respiratory syndrome coronavirus 2 tests with an interval of at least 24 h between tests. Body temperature in all 3 patients returned to normal after several days without treatment, and fever recurrence was not observed. CONCLUSION Enhancing the knowledge of low-grade fever during COVID-19 convalescence may increase the expertise in the delivery of optimal healthcare services.
C1 [Zhuang, Shu-Fan; Hu, Jia] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Gastroenterol, Nanchang 330006, Jiangxi, Peoples R China.
   [Qiao, Nan] Jiangxi Inst Econ Administrators, Dept Student Affairs, Nanchang 330088, Jiangxi, Peoples R China.
   [Lan, Zhi-Hui] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Respirat, Nanchang 330006, Jiangxi, Peoples R China.
   [Lai, Jun-Yu; Wu, Jian-Guang] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Cardiol, Nanchang 330006, Jiangxi, Peoples R China.
   [Wu, Xiao-Yong] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Radiol, Nanchang 330006, Jiangxi, Peoples R China.
RP Hu, J (corresponding author), Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Gastroenterol, Acad Res, 445 Bayi Ave, Nanchang 330006, Jiangxi, Peoples R China.
EM 356529216003@email.ncu.edu.cn
FU Emergency Special Project on Prevention and Treatment of COVID-19 with
   Traditional Chinese Medicine [2020YBBGWL007]
FX Supported by Emergency Special Project on Prevention and Treatment of
   COVID-19 with Traditional Chinese Medicine, No. 2020YBBGWL007.
CR Hastreiter AA, 2020, NUTRITION, V69, DOI 10.1016/j.nut.2019.06.021
   Boergeling Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004924
   Chen DB, 2020, INT J INFECT DIS, V93, P297, DOI 10.1016/j.ijid.2020.03.003
   He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ismail SNFB, 2019, J FISH DIS, V42, P1761, DOI 10.1111/jfd.13093
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Li Y X, 2020, Zhonghua Nei Ke Za Zhi, V59, pE003, DOI 3760.10/cma.j.cn112138-20200221-00114
   Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727
   Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Saira K, 2013, J VIROL, V87, P8064, DOI 10.1128/JVI.00240-13
   Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Wen JX, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/8586596
   Xu YY, 2020, MICROB PATHOGENESIS, V140, DOI 10.1016/j.micpath.2020.103970
   Zhou SC, 2020, AM J ROENTGENOL, V214, P1287, DOI 10.2214/AJR.20.22975
NR 17
TC 3
Z9 3
U1 2
U2 4
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD JUN 26
PY 2020
VL 8
IS 12
BP 2655
EP 2661
DI 10.12998/wjcc.v8.i12.2655
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA MV9WF
UT WOS:000556698200028
PM 32607346
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mahdi, SS
   Ahmed, Z
   Allana, R
   Peretti, A
   Amenta, F
   Bijle, MN
   Seow, LL
   Daood, U
AF Mahdi, Syed Sarosh
   Ahmed, Zohaib
   Allana, Raheel
   Peretti, Alessandro
   Amenta, Francesco
   Bijle, Mohammed Nadeem
   Seow, Liang Lin
   Daood, Umer
TI Pivoting Dental Practice Management during the COVID-19 Pandemic-A
   Systematic Review
SO MEDICINA-LITHUANIA
LA English
DT Review
DE COVID-19; pandemic; simulation; dentistry; oral health; infection
   control; dental practice; management
ID RUBBER DAM; KNOWLEDGE; TRANSMISSION; EFFICACY; AEROSOLS; RISK
AB Background and Objectives: The aims of this systematic review were to identify additional infection control measures implemented in dental practice globally to prevent cross-infection and evaluate the psychological impacts of the pandemic among dental professionals. Materials and Methods: A sequential systematic literature search was conducted from December 2019 to 30 April 2020 through PubMed, CINAHL, Scopus, Google Scholar, Embase, and Web of Science databases. The search yielded the following results: "COVID-19" (n = 12,137), "Novel corona virus" (n = 63), "COVID-19 and dentistry" (n = 46), "COVID-19 and oral health" (n = 41), "Novel Corona virus and Dentistry" (n = 0), "dental health and Novel Coronavirus" (n = 26), and "dental practice and Novel Coronavirus" (n = 6). Results: After a careful review and eliminating articles based on inclusion and exclusion criteria, the final review included 13 articles. Management of infection control is discussed extensively in the literature and remains the main theme of many Coronavirus Disease 2019 (COVID-19) articles on dentistry. Telephone triage using a questionnaire, hand hygiene, personal protective equipment (PPE) for clinical and nonclinical staff, a preprocedural mouth rinse, and aerosol management have been discussed and implemented in few countries. Three studies recommended that elective treatments for patients with a temperature of >100.4 F or 38 degrees C should be postponed or performed in an airborne infection isolation room (AIIR) or negative-pressure room. Limiting the number of patients in the waiting area, the removal of shared objects, proper ventilation, and physical distancing were highly recommended. Psychological distress among dental professionals in relation to existing medical conditions and self-efficacy has been discussed. Conclusions: Although the COVID-19 pandemic has had a substantial impact on the dental profession worldwide, our review highlights many practice management approaches to adopt the new norm. More research highlighting evidence-based safety practices and multisectoral collaboration is required to help dental professionals make informed decisions and make the profession safe, both for the patient and dental professionals.
C1 [Mahdi, Syed Sarosh] Sohail Univ, Jinnah Med & Dent Coll, Fac Dent, Dept Community Dent, Karachi 74800, Pakistan.
   [Mahdi, Syed Sarosh; Peretti, Alessandro; Amenta, Francesco] Univ Camerino, Ctr Clin Res Telemed & Tele Pharm, Sch Med & Hlth Prod Sci, I-62032 Camerino, Italy.
   [Ahmed, Zohaib] Columbia Univ, Coll Dent Med, New York, NY 10027 USA.
   [Allana, Raheel] Aga Khan Univ Hosp, Dept Paediat & Child Hlth, Karachi 74800, Pakistan.
   [Bijle, Mohammed Nadeem] Univ Hong Kong, Fac Dent, Paediat Dent, Hong Kong 999077, Peoples R China.
   [Seow, Liang Lin; Daood, Umer] Int Med Univ Kuala Lumpur, Sch Dent, Div Clin Dent, 126,Jalan Jalil Perkasa 19, Kuala Lumpur 57000, Malaysia.
RP Mahdi, SS (corresponding author), Sohail Univ, Jinnah Med & Dent Coll, Fac Dent, Dept Community Dent, Karachi 74800, Pakistan.; Mahdi, SS (corresponding author), Univ Camerino, Ctr Clin Res Telemed & Tele Pharm, Sch Med & Hlth Prod Sci, I-62032 Camerino, Italy.
EM syedsarosh.mahdi@unicam.it; dr.zohaib@live.com;
   dr.raheelallana@hotmail.com; alessandro.peretti@unicam.it;
   francesco.amenta@unicam.it; mnbijle@connect.hku.hk;
   lianglin_seow@imu.edu.my; umerdaood@imu.edu.my
RI Allana, Raheel/AAQ-2192-2020; Bijle, Mohammed Nadeem A/I-1471-2014
OI Allana, Raheel/0000-0001-7547-8154; Bijle, Mohammed Nadeem
   A/0000-0002-7205-9891; Francesco, Amenta/0000-0002-0555-1034
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Al-Amad SH, 2017, J INFECT PUBLIC HEAL, V10, P195, DOI 10.1016/j.jiph.2016.04.014
   Alharbi A, 2020, SAUDI DENT J, V32, P181, DOI 10.1016/j.sdentj.2020.04.001
   Amato A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134769
   [Anonymous], CORONAVIRUS UPDATE L
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Cagetti MG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113835
   Cai J, 2020, EMERG INFECT DIS, V26, P1343, DOI 10.3201/eid2606.200412
   Chandy PE, 2020, DIAGN INTERV RADIOL, V26, P236, DOI 10.5152/dir.2020.20166
   Chen C, 2010, J R SOC INTERFACE, V7, P1105, DOI 10.1098/rsif.2009.0516
   Consolo U, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103459
   Dexter F, 2020, ANESTH ANALG, V131, P37, DOI 10.1213/ANE.0000000000004829
   Diaz KT, 2010, AM J INFECT CONTROL, V38, P501, DOI 10.1016/j.ajic.2010.06.002
   Duda-Chodak A, 2020, TRENDS FOOD SCI TECH, V105, P145, DOI 10.1016/j.tifs.2020.08.020
   Evans KL, 2020, ANIM CONSERV, V23, P235, DOI 10.1111/acv.12601
   Fallahi HR, 2020, MAX PLAST RECONSTR S, V42, DOI 10.1186/s40902-020-00256-5
   FINE DH, 1992, J PERIODONTOL, V63, P821, DOI 10.1902/jop.1992.63.10.821
   Gambarini Gianluca, 2020, J Contemp Dent Pract, V21, P599
   Ge ZY, 2020, J ZHEJIANG UNIV-SC B, V21, P361, DOI 10.1631/jzus.B2010010
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Gurzawska-Comis K., 2020, CLIN ORAL IMPLAN RES, V31, P158, DOI [10.1111/clr.100_13644, DOI 10.1111/CLR.100_13644]
   Hallier C, 2010, BRIT DENT J, V209, DOI 10.1038/sj.bdj.2010.975
   Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207
   Horzov L., 2020, The Open Public Health Journal, V13, P459, DOI 10.2174/1874944502013010459
   Hu T, 2007, INFECT CONT HOSP EP, V28, P80, DOI 10.1086/510808
   Izzetti R, 2020, J DENT RES, V99, P1030, DOI 10.1177/0022034520920580
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Kowalski LP, 2020, HEAD NECK-J SCI SPEC, V42, P1259, DOI 10.1002/hed.26164
   Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron
   Li GW, 2020, J INFECT PUBLIC HEAL, V13, P1805, DOI 10.1016/j.jiph.2020.09.013
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Mousavi ES, 2021, ENVIRON SCI TECHNOL, V55, P4134, DOI 10.1021/acs.est.0c03247
   Nicola M, 2020, INT J SURG, V77, P206, DOI 10.1016/j.ijsu.2020.04.001
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Ramos-Gomez F., 2020, CAD J, V48, P507
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Roy SJM, 2020, COVID 19 PANDEMIC IM
   SAMARANAYAKE LP, 1989, J DENT CHILD, V56, P442
   Sarfaraz S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030232
   Shacham M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082900
   Simon L., 2020, JAMA HLTH FORUM, V1, pe200625, DOI 10.1001/jamahealthforum.2020.0625
   Singh Gambhir Ramandeep, 2020, Rocz Panstw Zakl Hig, V71, P223, DOI 10.32394/rpzh.2020.0115
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y
   Tugwell, 2011, NEWCASTLE OTTAWA SCA
   Tysiac-Mista M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134703
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wenzel RP, 2003, NEW ENGL J MED, V348, P1947, DOI 10.1056/NEJMp030072
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   World Health Organization, COR DIS COVID 19 DAS
   Xu RB, 2020, IEEE PHOTONICS J, V12, DOI 10.1109/JPHOT.2020.2979564
   Yang Y, 2020, CLIN ORAL INVEST, V24, P1861, DOI 10.1007/s00784-020-03267-8
   Zhang J, 2020, PRECIS CLIN MED, V3, P3, DOI 10.1093/pcmedi/pbaa006
   Zimmermann M, 2020, J CRANIO MAXILL SURG, V48, P521, DOI 10.1016/j.jcms.2020.03.011
NR 58
TC 6
Z9 6
U1 1
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1010-660X
EI 1648-9144
J9 MEDICINA-LITHUANIA
JI Med. Lith.
PD DEC
PY 2020
VL 56
IS 12
AR 644
DI 10.3390/medicina56120644
PG 16
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PK0PU
UT WOS:000602158200001
PM 33255716
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Siddiqui, AA
   Alshammary, F
   Amin, J
   Rathore, HA
   Hassan, I
   Ilyas, M
   Alam, MK
AF Siddiqui, Ammar Ahmed
   Alshammary, Freah
   Amin, Junaid
   Rathore, Hassaan Anwer
   Hassan, Ibne
   Ilyas, Muhammad
   Alam, Mohammad Khursheed
TI Knowledge and practice regarding prevention of COVID-19 among the Saudi
   Arabian population
SO WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION
LA English
DT Article
DE Awareness; attitude; coronavirus; hygiene practice; infectious diseases;
   pandemic; COVID-19
ID ATTITUDES; SARS
AB BACKGROUND: Prevention is the best way to manage a pandemic like COVID-19. The World Health Organization has issued public advice to create awareness by providing people knowledge to prevent/protect them from COVID-19. Hence, the present study was planned to assess knowledge of prevention and its practical use amongst samples from the Saudi Arabian population. It can be used to bring awareness among the masses not only in expanding their knowledge about COVID-19 but also on how to enforce a practicing behavior in relation to the prevention of COVID-19. The study is among the pioneer studies on the issue related to knowledge and practice of the prevention of COVID-19 among Saudis and foreign nationals residing in Saudi Arabia.
   OBJECTIVE: The prime objective of this study is to examine the existence of knowledge among the Saudi and non-Saudi nationals about COVID-19 and its impact on their behavior to practice the protocols to prevent the disastrous infection of COVID-19. This study has also examined how the residents in Saudi Arabia react to the methods and protection measures adopted by the government for their dominions to eradicate the spread of COVID-19.
   METHODS: The study used a survey-based methodology and data was collected from Saudi nationals as well as expatriates living and working in five different regions of Saudi Arabia. Non-probability snowball sampling was used to reach and select the population of the current study. A self-designed, structured, and validated questionnaire was electronically distributed among the respondents. SPSS version 21 was used to analyze the data of the current study.
   RESULTS: Out of the 443 respondents, 356 respondents (84%) knew they had to wash their hands for 20 seconds and did this as well, 303 respondents (75%) knew that sneezing or coughing into the arm/elbow can prevent the spread of COVID-19 and were doing this as well, 357 respondents (82%) knew that COVID-19 can be transferred by shaking hands and avoided this, 333 respondents (79%) knew that they had to maintain a safe distance of at least one meter and kept this distance, 315 respondents (76%) knew that touching one's face can transfer the virus and avoid this, and 414 respondents (95%) knew that staying at home can decrease the chances of getting infected. The relationship between different regions and most of the knowledge-based and practice-based questions was significant (p < 0.05).
   CONCLUSION: Results reveal that there is a significant relationship between knowledge and practice, but the strength of association is weak. It was found that knowledge and practice of COVID-19 was followed differently in the five regions of Saudi Arabia and the level of education of the respondents influenced their choice of practice to protect themselves from the effects of COVID-19. The study has contributed in the body of literature by examining the inter-relationship between knowledge and practice and their use in prevention of COVID-19 among the Saudi population.
C1 [Siddiqui, Ammar Ahmed; Alshammary, Freah] Univ Hail, Coll Dent, Dept Prevent Dent Sci, Hail, Saudi Arabia.
   [Amin, Junaid] Univ Hail, Coll Appl Med Sci, Dept Physiotherapy, Hail, Saudi Arabia.
   [Rathore, Hassaan Anwer] Univ Hail, Coll Pharm, Hail, Saudi Arabia.
   [Hassan, Ibne; Ilyas, Muhammad] Univ Hail, Coll Business Adm, Dept Management, Hail, Saudi Arabia.
   [Hassan, Ibne; Ilyas, Muhammad] Univ Hail, Coll Business Adm, MIS, Hail, Saudi Arabia.
   [Alam, Mohammad Khursheed] Jouf Univ, Coll Dent, Dept Prevent Dent Sci, Sakakah, Saudi Arabia.
RP Siddiqui, AA (corresponding author), Univ Hail, Coll Dent, Dent Publ Hlth, Hail, Saudi Arabia.
EM ammarqta2002@hotmail.com
RI Rathore, Hassaan A/A-6016-2012; Rathore, Hassaan Anwer/P-1407-2015;
   Siddiqui, Ahmed/M-3442-2015; Alam, Mohammad Khursheed/D-3062-2012; Amin,
   junaid/AAH-6450-2019
OI Rathore, Hassaan A/0000-0002-1154-9395; Rathore, Hassaan
   Anwer/0000-0002-1154-9395; Siddiqui, Ahmed/0000-0002-8816-6421; Alam,
   Mohammad Khursheed/0000-0001-7131-1752; Amin, junaid/0000-0002-4343-2255
FU Scientific Research Deanship at the University of Hai'l, Saudi Arabia
   [COVID-1903]
FX This project was funded by the Scientific Research Deanship at the
   University of Hai'l, Saudi Arabia through project number COVID-1903.
CR Ajansi Anadolu, SAUD AR CUT 2020 BUD
   ALdowyan N, 2017, INT ARCH MED, V10
   AlHasan SM, 2020, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.20.253153, DOI 10.2471/BLT.20.253153]
   [Anonymous], 2020, SAUDIGAZETTE NEWSPAP
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Biscayart C, 2020, NEXT BIG THREAT GLOB
   Chen S, 2003, CHINESE RURAL HLTH S, V6
   Crossley Gabriel, 2020, REUTERS
   de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Deng JF, 2006, PUBLIC HEALTH, V120, P15, DOI 10.1016/j.puhe.2005.10.001
   Ebrahim SH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa029
   Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210
   Lu H, 2020, J MED VIROL
   MOH.Novel Coronavirus (COVID-19), MOH NOV COR COVID 19
   Morishima M, 2018, WORK, V61, P303, DOI 10.3233/WOR-182801
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   WHO, ADV PUBL
   Wu J, 2020, ADV ELECTRON MATER, V6, DOI 10.1002/aelm.202000451
   Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 21
TC 18
Z9 18
U1 2
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1051-9815
EI 1875-9270
J9 WORK
JI Work
PY 2020
VL 66
IS 4
BP 767
EP 775
DI 10.3233/WOR-203223
PG 9
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA NT2OA
UT WOS:000572785500008
PM 32925138
OA Bronze
DA 2022-04-20
ER

PT J
AU Thomas, B
   Pallivalapila, A
   El Kassem, W
   Tarannum, A
   Al Hail, F
   Rijims, M
   Parappil, H
   Bayo, AI
   Ahmad, S
   Nazar, Z
   Stewart, D
   Al Hail, M
AF Thomas, Binny
   Pallivalapila, Abdulrouf
   El Kassem, Wessam
   Tarannum, Asma
   Al Hail, Fatema
   Rijims, Mohammed
   Parappil, Hussain
   Bayo, Arabo Ibrahim
   Ahmad, Shamsa
   Nazar, Zachariah
   Stewart, Derek
   Al Hail, Moza
TI Maternal and perinatal outcomes and pharmacological management of
   Covid-19 infection in pregnancy: a systematic review protocol
SO SYSTEMATIC REVIEWS
LA English
DT Review
DE COVID-19; Maternal; Perinatal; Pharmacological management; Pregnant
AB Background: Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and immunological response during pregnancy makes it more susceptible to infections. Furthermore, during pregnancy, a woman undergoes multiple interactions with the health care system that increases her chance of getting infected; therefore, managing pregnant population presents a unique challenge.
   Research questions: This systematic review seeks to answer the following questions in relation to COVID-19:
   What are the different clinical characteristics presented in maternal and perinatal population?
   What are the different maternal and perinatal outcome measures reported?
   What are the distinct therapeutic interventions reported to treat COVID-19?
   Is it safe to use "medications" used in the treatment of COVID-19 during antenatal, perinatal, postnatal, and breastfeeding?
   Method: The search will follow a comprehensive, sequential three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including Medline, CINAHL, and LitCovid will be searched from the inception of the disease until the completion of data collection. The quality of this search strategy will be assessed using Peer Review of Electronic Search Strategies Evidence-Based Checklist (PRESS EBC). An eligibility form will be developed for a transparent screening and inclusion/exclusion of studies. All studies will be sent to RefWorks, and abstraction will be independently performed by two researchers. Risk of bias will be assessed using Cochrane Risk of Bias tool for randomized controlled trials, Newcastle-Ottawa Quality Assessment Scale for non-randomized studies, and for case reports, Murad et al. tool will be used. Decision to conduct meta-analysis will be based on several factors including homogeneity and outcome measures reported; otherwise, a narrative synthesis will be deemed appropriate.
   Discussion: This systematic review will summarize the existing data on effect of COVID-19 on maternal and perinatal population. Furthermore, to the best of our knowledge, this is the first systematic review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and breastfeeding.
C1 [Thomas, Binny; Pallivalapila, Abdulrouf; El Kassem, Wessam; Al Hail, Moza] Hamad Med Corp, Pharm Execut Off, Doha, Qatar.
   [Tarannum, Asma; Al Hail, Fatema; Bayo, Arabo Ibrahim; Ahmad, Shamsa] Hamad Med Corp, Womens Wellness & Res Ctr, Doha, Qatar.
   [Rijims, Mohammed; Parappil, Hussain] Hamad Med Corp, Neonatal Intens Care Unit, Doha, Qatar.
   [Nazar, Zachariah; Stewart, Derek] Qatar Univ, Coll Pharm, QU Hlth, Doha, Qatar.
RP Thomas, B (corresponding author), Hamad Med Corp, Pharm Execut Off, Doha, Qatar.
EM binnyinhmc@gmail.com
RI Thomas, Binny/AFT-6887-2022; Thomas, Binny/H-6129-2017
OI Thomas, Binny/0000-0003-1065-8343; Nazar, Zachariah/0000-0003-4104-4221
FU Hamad Medical Corporation's Medical Research Center
FX The project will seek funding from the Hamad Medical Corporation's
   Medical Research Center.
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Della Gatta AN, 2020, AM J OBSTET GYNECOL, V223, P36, DOI 10.1016/j.ajog.2020.04.013
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663
   GRADE Working Group, 2017, GRA REC ASS DEV EV
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Karami Parisa, 2020, Travel Med Infect Dis, P101665, DOI 10.1016/j.tmaid.2020.101665
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021
   MOHER D, 2015, SYST REV, V4, DOI DOI 10.1186/2046-4053-4-1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014
   Murad MH, 2018, BMJ EVID-BASED MED, V23, P60, DOI 10.1136/bmjebm-2017-110853
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Royal College of Obstetricians and Gynaecologists, 2020, COR COVID 19 INF PRE
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Thomas B, 2020, CLIN CHARACTERISTICS
   Tobaiqy M, 2020, THERAPEUTIC MANAGEME, DOI DOI 10.1016/J.INFPIP.2020.100061
   Wang X, 2020, ADV ELECTRON MATER, V6, DOI 10.1002/aelm.202000119
   Wells G, 2017, CLIN EPIDEMIOL, P1
   WHO (World Health Organization), 2020, COR DIS COVID 19 OUT
   World Health Organization, 2020, COR DIS COVID 19 PAN
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang S, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.66
   ZENG JH, 2020, INFECTION 0410, DOI DOI 10.1007/S15010-020-01424-5
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 30
TC 6
Z9 6
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2046-4053
J9 SYST REV-LONDON
JI Syst. Rev.
PD JUL 18
PY 2020
VL 9
IS 1
AR 161
DI 10.1186/s13643-020-01418-2
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA MP8EN
UT WOS:000552432900003
PM 32682444
OA Green Published, Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Alaluf, MG
   Pasqualini, A
   Fiszbajn, G
   Botti, G
   Estofan, G
   Ruhlmann, C
   Solari, L
   Bisioli, C
   Pene, A
   Branzini, C
   Retamar, AQ
   Checkherdemian, V
   Pesce, R
   Serpa, I
   Lorenzo, F
   Avendano, C
   Sedo, CA
   Lancuba, S
AF Alaluf, Maria Graciela
   Pasqualini, Agustin
   Fiszbajn, Gabriel
   Botti, Gustavo
   Estofan, Gustavo
   Ruhlmann, Claudio
   Solari, Leticia
   Bisioli, Claudio
   Pene, Alicia
   Branzini, Constanza
   Quintero Retamar, Andrea
   Checkherdemian, Valeria
   Pesce, Romina
   Serpa, Idelma
   Lorenzo, Fabian
   Avendano, Conrado
   Alvarez Sedo, Cristian
   Lancuba, Stella
TI COVID-19 risk assessment and safety management operational guidelines
   for IVF center reopening
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Editorial Material
DE COVID-19; IVF; Risk; Management; Guidelines; Safety
AB Purpose To promote nationwide dissemination and implementation of COVID-19 Risk Assessment and Safety Management Operational Guidelines, drawn up by SAMeR Task Force in ART centers in Argentina. Our objective is to prevent and mitigate the transmission of SARS-CoV-2 at an institutional level, while reducing the risk of infection among both physicians and patients in the context of a critical scenario in the local and Latin American healthcare system.
   Methods SAMeR Executive Committee set up a crisis committee which was made up of specialists in reproductive medicine, embryology, and healthcare management. A critical and updated review of the advances in science, documents, and recommendations released by other societies (ASRM, ESHRE, IFFS, Red LARA, societies of anesthesiologists, infectious diseases, and Occupational Safety and Health Administration-OSHA) was carried out. Likewise, there were joint meetings with the Ministry of Health of Argentina in order to draw up the guidelines. Simultaneously, ongoing medical training was carried out, thus providing added value to them, including two status surveys of the activities of the monovalent and polyvalent centers according to the country's epidemiological mapping. Four additional recommendations were made, and online training was given to healthcare workers. The aforementioned regulations were first analyzed by the healthcare providers and their practical suggestions were then added to the guidelines.
   Results The one-off collaborative work and the actions coordinated with the National ART Program of the Ministry of Health of Argentina resulted in the development and implementation of the present COVID-19 Risk Assessment and Safety Management Operational Guidelines at a national level. SAMeR gave recommendations for the implementation of the Management Guidelines for the center reopening, providing new safety criteria against the threat of viral contagion. A new organizational culture was promoted through the awareness of all the healthcare workers and teaching responsibility. We continue working on the compliance with a new "Code of Conduct and Commitment in Healthcare" and with workplace safety measures. We helped with transforming the theoretical knowledge into practical measures for the healthcare workers in different services, with the aim to prevent, mitigate, and/or handle contingencies at the centers/services and gamete banks, in line with the actions agreed upon with the Ministry of Health.
   Conclusions As an extraordinary and uncertain event, the SARS-CoV-2 pandemic helped consolidate a volunteer-based and collaborative panel of SAMeR experts who developed the COVID-19 Risk Assessment and Safety Management Operational Guidelines as a new and readily available tool for physicians, patients, and gamete banks care. Their implementation has provided specific guidelines to minimize risk for professionals in ART clinics, as well as guaranteeing patient safety.
C1 [Alaluf, Maria Graciela; Pasqualini, Agustin; Fiszbajn, Gabriel; Botti, Gustavo; Estofan, Gustavo; Ruhlmann, Claudio; Solari, Leticia; Bisioli, Claudio; Pene, Alicia; Branzini, Constanza; Quintero Retamar, Andrea; Checkherdemian, Valeria; Pesce, Romina; Serpa, Idelma; Lorenzo, Fabian; Avendano, Conrado; Alvarez Sedo, Cristian; Lancuba, Stella] SAMeR Argentine Soc Reprod Med, Buenos Aires, DF, Argentina.
RP Alaluf, MG (corresponding author), SAMeR Argentine Soc Reprod Med, Buenos Aires, DF, Argentina.
EM dqc.gralaluf@yahoo.com.ar
CR Alteri A, 2020, HUM REPROD, V35, P2650, DOI 10.1093/humrep/deaa210
   American Society for Reproductive Medicine (ASRM), 2020, PAT MAN CLIN REC COR
   [Anonymous], 2019, GUIA REGL REL TRANSP
   [Anonymous], 2020, GUIA CONS US CORR SE
   [Anonymous], 2020, 4 SAEC
   Card KJ, 2020, UV STERILIZATION PER, DOI [10.1101/2020.03.25.20043489, DOI 10.1101/2020.03.25.20043489]
   Castilla JA, RECOMENDACIONES SEGU
   Centers for Disease Control and Prevention, COM LIMP DES EST
   Centers for Disease Control and Prevention, 2019, COR DIS 2019 COVID 1
   Cobo A, 2012, FERTIL STERIL, V97, P74, DOI 10.1016/j.fertnstert.2011.10.006
   ESHRE, 2020, ESHRE GUID REC ART T
   Levi-Setti PE, 2018, FERTIL STERIL, V109, P1038, DOI 10.1016/j.fertnstert.2018.02.002
   Li D, 2020, JAMA NETW OPEN, V3, P5, DOI [10.1001/jamanetworkopen.2020.82927206502, DOI 10.1001/JAMANETWORKOPEN.2020.82927206502]
   Meselson M, 2020, NEW ENGL J MED, V382, P2063, DOI 10.1056/NEJMc2009324
   Ministerio de Salud de la Nacion Argentina, 2020, PLAN OP PREP RESP CO
   Ministerio de Salud de la Nacion Argentina, 2020, DEF CAS DEF CONT EST
   Ministerio de Salud de la Nacion Argentina, 2020, REC IMPL TRIAG RESP
   Ministerio de Sanidad Espana., INF CIENT TECN ENF C
   Mortimer D, 2018, REPROD BIOMED ONLINE, V36, P658, DOI 10.1016/j.rbmo.2018.02.005
   Organizacion Mundial de la Salud, 2014, PAS PON QUIT EQ PROT
   Organizacion Panamericana de la Salud, 2020, REQ US EQ PROT PERS
   Pan F, 2020, FERTIL STERIL, V113, P1135, DOI 10.1016/j.fertnstert.2020.04.024
   Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008
   Public Health England, 2020, GUID COVID 19 CLEAN
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   World Health Organization, AT DOM PAC PRES INF
   Yakass MB, 2020, REPROD BIOMED ONLINE, V40, P905, DOI 10.1016/j.rbmo.2020.04.004
NR 27
TC 4
Z9 4
U1 0
U2 4
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD NOV
PY 2020
VL 37
IS 11
BP 2669
EP 2686
DI 10.1007/s10815-020-01958-5
EA OCT 2020
PG 18
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA OM3LM
UT WOS:000576092000001
PM 33029755
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Ceriello, A
   Prattichizzo, F
AF Ceriello, Antonio
   Prattichizzo, Francesco
TI Pharmacological management of COVID-19 in type 2 diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE ACE2; Cardiovascular disease; Corticosteroids; COVID-19; Diabetes;
   Guidelines; Hydroxychloroquine; Hyperglycemia; SARS-COV-2; Thrombosis
ID OUTCOMES; HYPERGLYCEMIA; MORTALITY; GLUCOSE; RISK; ASSOCIATION
AB Evidence suggests that diabetes is one the most relevant comorbidity in affecting the prognosis of COVID-19. Al-beit there are no specific trials nor subgroup analysis showing the effect of COVID-19 therapies in patients with diabetes, selected features of this disease and the side effects associated with certain drugs require a proper knowledge to optimize the pharmacological therapy of patients with diabetes and COVID-19. While chronic anti-hypertensive and glucose-lowering therapies should not be discontinued nor preferred for preventive pur-poses, the low-grade pro-inflammatory, the thrombosis-prone status of diabetes, the role of acute hyperglycaemia in promoting adverse outcomes in patients admitted to ICU, and the observed increased mortal-ity in patients with poor long-term glycaemic control delineate a delicate balance in case of severe forms of COVID-19. Here, we briefly summarized some of the key pharmacological issues linked to the management of pa-tients with diabetes and COVID-19, in order to provide indications to minimize the deleterious effects of the con-comitant presentation of these diseases and to use the existing pharmacological options in an appropriate manner. (c) 2021 Elsevier Inc. All rights reserved.
C1 [Ceriello, Antonio; Prattichizzo, Francesco] IRCCS MultiMed, Via Gaudenzio Fantoli 16-15, I-20138 Milan, Italy.
RP Ceriello, A; Prattichizzo, F (corresponding author), IRCCS MultiMed, Via Gaudenzio Fantoli 16-15, I-20138 Milan, Italy.
EM antonio.ceriello@multimedica.it; francesco.prattichizzo@multimedica.it
RI Prattichizzo, Francesco/J-3046-2018
OI Prattichizzo, Francesco/0000-0002-2959-2658
FU Italian Ministry of Health - Ricerca Corrente to IRCCS MultiMedica
FX This work has been supported by the Italian Ministry of Health - Ricerca
   Corrente to IRCCS MultiMedica.
CR Agarwal S, 2020, DIABETES CARE, V43, P2339, DOI 10.2337/dc20-1543
   Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS99, DOI 10.2337/dc16-S016
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, TRENDS IMMUNOL
   [Anonymous], Fact Sheet for Patients And Parent/Caregivers Emergency Use Authorization (EUA) Of Remdesivir For Coronavirus Disease 2019 (COVID-19)
   [Anonymous], LANCET DIABETES ENDO
   [Anonymous], 2020, DIABETES CARE
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bellaver P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55080-3
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Bode Bruce, 2020, J Diabetes Sci Technol, V14, P813, DOI 10.1177/1932296820924469
   Bonafe M, 2020, CYTOKINE GROWTH F R, V53, P33, DOI 10.1016/j.cytogfr.2020.04.005
   Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2
   Bramante CT, 2021, LANCET HEALTH LONGEV, V2, pE34, DOI 10.1016/S2666-7568(20)30033-7
   Caballero AE, 2020, J DIABETES COMPLICAT, V34, DOI 10.1016/j.jdiacomp.2020.107671
   Calabrese F, 2020, VIRCHOWS ARCH, V477, P359, DOI 10.1007/s00428-020-02886-6
   Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x
   Cavalli G, 2021, LANCET RHEUMATOL, V3, pE252, DOI 10.1016/S2665-9913(21)00012-6
   CERIELLO A, 1993, DIABETOLOGIA, V36, P1119, DOI 10.1007/BF00401055
   Ceriello A, 2005, EUR HEART J, V26, P328, DOI 10.1093/eurheartj/ehi049
   CERIELLO A, 1995, DIABETES, V44, P924, DOI 10.2337/diabetes.44.8.924
   CERIELLO A, 1989, METABOLISM, V38, P1162, DOI 10.1016/0026-0495(89)90152-2
   Ceriello A, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108383
   Ceriello A, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01089-2
   Ceriello A, 2020, DIABETES OBES METAB, V22, P1951, DOI 10.1111/dom.14098
   Ceriello A, 2020, DIABETES CARE, V43, P1427, DOI 10.2337/dc20-0941
   Ceriello A, 2009, J AM COLL CARDIOL, V53, pS9, DOI 10.1016/j.jacc.2008.09.054
   Chatterjee Kshitij, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc059
   Cohen MS, 2021, NEW ENGL J MED, V384, P289, DOI 10.1056/NEJMe2034495
   Cortegiani A, 2020, J CRIT CARE, V59, P176, DOI 10.1016/j.jcrc.2020.06.019
   Dai W, 2021, J MED VIROL, V93, P2321, DOI 10.1002/jmv.26712
   Dal Canto E, 2019, EUR J PREV CARDIOL, V26, P25, DOI 10.1177/2047487319878371
   de Candia P, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00451
   Fadini GP, 2020, DIABETES RES CLIN PR, V168, DOI 10.1016/j.diabres.2020.108374
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Hernandez AV, 2020, ANN INTERN MED, V173, pW128, DOI 10.7326/L20-1054
   Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812
   Jin LH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2924
   Klassen Stephen A, 2021, medRxiv, DOI 10.1101/2020.07.29.20162917
   Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1101/2020.04.20.20072702, 10.1016/j.jacc.2020.06.007]
   Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Lemkes BA, 2010, J THROMB HAEMOST, V8, P1663, DOI 10.1111/j.1538-7836.2010.03910.x
   Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006
   Liao WI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001525
   Lim S, 2021, NAT REV ENDOCRINOL, V17, P11, DOI 10.1038/s41574-020-00435-4
   Lopez-Medina E, 2021, JAMA-J AM MED ASSOC, V325, P1426, DOI 10.1001/jama.2021.3071
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Mirani M, 2020, DIABETES CARE, V43, P3042, DOI 10.2337/dc20-1340
   Mittal S, 2021, J MED VIROL, V93, P4166, DOI 10.1002/jmv.26457
   Nusca A, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0952-8
   Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y
   Pal R, 2020, DIABETES RES CLIN PR, V163, DOI 10.1016/j.diabres.2020.108146
   Pal Rimesh, 2020, Diabetes Res Clin Pract, V162, P108132, DOI 10.1016/j.diabres.2020.108132
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Piechotta V, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013600.pub2
   Pollack RM, 2016, DIABETES CARE, V39, pS244, DOI 10.2337/dcS15-3015
   Prattichizzo F, 2021, LANCET HEALTH LONGEV, V2, pE191, DOI 10.1016/S2666-7568(21)00053-2
   Prattichizzo F, 2020, DIABETES OBES METAB, V22, P1696, DOI 10.1111/dom.14081
   Prattichizzo F, 2019, EUR J PREV CARDIOL, V26, P73, DOI 10.1177/2047487319880040
   Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Sardu C, 2020, DIABETES CARE, V43, P1408, DOI 10.2337/dc20-0723
   Sarkar S, 2021, J MED VIROL, V93, P1111, DOI 10.1002/jmv.26408
   Self WH, 2020, JAMA-J AM MED ASSOC, V324, P2165, DOI 10.1001/jama.2020.22240
   Singh AK, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108382
   Sobczak AIS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246345
   Solerte SB, 2020, DIABETES CARE, V43, P2999, DOI 10.2337/dc20-1521
   Solerte SB, 2020, ACTA DIABETOL, V57, P779, DOI 10.1007/s00592-020-01539-z
   Sriram K, 2020, BRIT J PHARMACOL, V177, P4825, DOI 10.1111/bph.15082
   Stevenson A, 2020, OPEN HEART, V7, DOI 10.1136/openhrt-2020-001362
   Stoian AP, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3379
   Tang YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01708
   Valensi P, 2019, EUR J PREV CARDIOL, V26, P64, DOI 10.1177/2047487319885456
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wu JF, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001476
   Xu ZH, 2020, J DIABETES, V12, P909, DOI 10.1111/1753-0407.13084
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhu LH, 2020, CELL METAB, V31, P1068, DOI 10.1016/j.cmet.2020.04.021
NR 86
TC 5
Z9 6
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL
PY 2021
VL 35
IS 7
AR 107927
DI 10.1016/j.jdiacomp.2021.107927
EA MAY 2021
PG 5
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA SJ6MH
UT WOS:000655646300001
PM 33896714
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Salabei, JK
   Fishman, TJ
   Asnake, ZT
   Ali, A
   Iyer, UG
AF Salabei, Joshua K.
   Fishman, Troy J.
   Asnake, Zekarias T.
   Ali, Arroj
   Iyer, Uma G.
TI COVID-19 Coagulopathy: Current knowledge and guidelines on
   anticoagulation
SO HEART & LUNG
LA English
DT Article
DE Covid-19; Sars-cov-2; Anticoagulation; D-dimers; Coagulation; Thrombosis
ID MANAGEMENT; SEPSIS
AB COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead to various thrombotic complications and death. In this review, we briefly highlight possible etiologies, including direct cytotoxicity caused by the SARS-CoV-2 virus, and the activation of proinflammatory molecules such as cytokines, underlying coagulopathy. Endothelial dysfunction has been highlighted as pivotal, irrespective of the mechanism involved in CAC. Specific features of CAC distinguishing it from disseminated intravascular coagulopathy and sepsis or ARDS-associated coagulopathy have been discussed. We have also highlighted some hematological parameters, such as elevated D-dimers and partial prothrombin and prothrombin times prolongation, which can guide the use of anticoagulation in critically ill patients. We conclude by highlighting the importance of prophylactic anticoagulation in all COVID-19 hospitalized patients and reiterate the need for institution-specific guidelines for anticoagulation COVID-19 patients since individual institutions have different patient populations. (C) 2021 Elsevier Inc. All rights reserved.
C1 [Salabei, Joshua K.; Fishman, Troy J.; Asnake, Zekarias T.; Ali, Arroj; Iyer, Uma G.] Univ Cent Florida, North Florida Reg Med Ctr, Sch Med, 6500W Newberry Rd, Gainesville, FL 32605 USA.
   [Iyer, Uma G.] Florida Canc Specialists & Res Inst, 6420W Newberry Rd East Wing,Suite 100, Gainesville, FL 32605 USA.
RP Salabei, JK (corresponding author), Univ Cent Florida, North Florida Reg Med Ctr, Sch Med, 6500W Newberry Rd, Gainesville, FL 32605 USA.
EM Joshua.Salabei@hcahealthcare.com
FU HCA Healthcare
FX This work was supported by HCA Healthcare and/or an HCA healthcare
   affiliated entity. The views expressed in this publication represent
   those of the author(s) and do not necessarily represent the official
   views of HCA Healthcare or any of its affiliated entities.
CR Abdolahi N, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04499-5
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   [Anonymous], 2020, BRIGH WOM HOSP COVID
   Banwait RS., 2020, HCA HEALTHCARE J, V1, P139
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Bowles L, 2020, NEW ENGL J MED, V383, P288, DOI 10.1056/NEJMc2013656
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   GOSHUA G, 2020, NEW ENGL J MED, DOI DOI 10.1016/S2352-3026(20)30216-7
   Guan Wei-Jie, 2020, N Engl J Med, V382, P1861, DOI 10.1056/NEJMc2005203
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   HELMS J, 2020, INTENS CARE MED 0504, DOI DOI 10.1007/S00134-020-06062-X
   Iba T, 2019, J THROMB HAEMOST, V17, P1989, DOI 10.1111/jth.14578
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Liao DY, 2020, LANCET HAEMATOL, V7, pE671, DOI 10.1016/S2352-3026(20)30217-9
   Maier CL, 2020, LANCET, V395, P1758, DOI 10.1016/S0140-6736(20)31209-5
   Marietta M, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04475-z
   NAHUM J, 2020, LANCET, V3
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Pesavento R, 2020, J THROMB HAEMOST, V18, P2629, DOI 10.1111/jth.15022
   Poterucha TJ, 2017, THROMB HAEMOSTASIS, V117, P437, DOI 10.1160/TH16-08-0620
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289
   Song JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17240-2
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Thachil J, 2020, J THROMB HAEMOST, V18, P1023, DOI 10.1111/jth.14810
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Wang T, 2020, LANCET HAEMATOL, V7, pE362, DOI 10.1016/S2352-3026(20)30109-5
   Wang YM, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04352-9
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wilson JG, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140289
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   ZHANG Y, 2020, NEW ENGL J MED, DOI [DOI 10.1056/NEJMC2007575, 10.1056/NEJMc2007575]
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 39
TC 18
Z9 19
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0147-9563
EI 1527-3288
J9 HEART LUNG
JI Heart Lung
PD MAR-APR
PY 2021
VL 50
IS 2
BP 357
EP 360
DI 10.1016/j.hrtlng.2021.01.011
EA FEB 2021
PG 4
WC Cardiac & Cardiovascular Systems; Nursing; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Nursing; Respiratory System
GA QW8OZ
UT WOS:000628908900037
PM 33524866
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Melhaoui, I
   Oujidi, Y
   El Heddad, IA
   Bensaid, A
   Bkiyar, H
   Bentata, Y
   Housni, B
AF Melhaoui, Imane
   Oujidi, Younes
   El Heddad, Inass Arhoun
   Bensaid, Amine
   Bkiyar, Houssam
   Bentata, Yassamine
   Housni, Brahim
TI Management of post cardiac transplantation immunosuppression and
   COVID-19: A case report
SO ANNALS OF MEDICINE AND SURGERY
LA English
DT Article
DE Heart transplant; COVID-19; SARS-CoV-2; Immunosuppressors
AB Background: There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
   Case details: We report the case of a 60-year-old male, heart transplant recipient patient, admitted in our ICU for severe COVID-19. His immunosuppressors were discontinued. He presented an ARDS, a multiple organ failure and a refractory septic shock that eventually resulted in his death.
   Discussion: Multiple studies reported a lower incidence of SARS-Cov-2 infection in HT recipients compared to the general population, probably due to their prior knowledge and use of protective and barrier measures; but when infected they tend to have poorer outcomes and higher fatality; on account of their pre-existing comorbidities and immunodeficiency. Therefore, the management of the immunosuppressive therapy raises a challenge, in the absence of trials. Physicians rely on experts' recommendations, to maintain the immunosuppressors in case of mild COVID-19, lower to the bare minimum or even discontinue them in case of critical COVID-19 or systemic complications.
   Conclusion: COVID-19 infection is associated with poor outcomes and high mortality in HT recipients, and their immunosuppressive therapy management still raises questions and challenges in the absence of trial-validated data.
C1 [Melhaoui, Imane; Bentata, Yassamine] Mohammed VI Univ Hosp, Fac Med & Pharm, Nephrol Dept, Oujda, Morocco.
   [Oujidi, Younes; El Heddad, Inass Arhoun; Bensaid, Amine; Bkiyar, Houssam; Housni, Brahim] Mohammed Premier Univ, Hosp Univ Mohammed VI Oujda, Oujda Fac Med & Pharm, Anaesthesia & Resuscitat Serv, Oujda, Morocco.
RP Melhaoui, I (corresponding author), Mohammed VI Univ Hosp, Fac Med & Pharm, Nephrol Dept, Oujda, Morocco.
EM imanemelhaoui@gmail.com; younesoujidi@gmail.com;
   iarhounelhaddad@gmail.com; aminebenz94@gmail.com; 7b.houssam@gmail.com;
   bentatayassamine@yahoo.fr; brahimhousni@yahoo.fr
CR Agha RA, 2020, INT J SURG, V84, P226, DOI 10.1016/j.ijsu.2020.10.034
   Ahluwalia M, 2020, CLIN TRANSPLANT, V34, DOI 10.1111/ctr.14032
   Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117
   Fishman JA, 2020, J AM SOC NEPHROL, V31, P1147, DOI 10.1681/ASN.2020040416
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Kunins G, 2020, CORONAVIRUS DIS 2019
   Li HS, 2018, ANTIVIR RES, V155, P89, DOI 10.1016/j.antiviral.2018.05.007
   Rammohan Ashwin, 2020, World J Transplant, V10, P267, DOI 10.5500/wjt.v10.i9.267
   Ren ZL, 2020, J HEART LUNG TRANSPL, V39, P412, DOI 10.1016/j.healun.2020.03.008
   Rivinius R, 2020, CLIN RES CARDIOL, V109, P1531, DOI 10.1007/s00392-020-01722-w
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2049-0801
J9 ANN MED SURG
JI Ann. Med. Surg.
PD NOV
PY 2021
VL 71
AR 102875
DI 10.1016/j.amsu.2021.102875
EA OCT 2021
PG 3
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA WN8OH
UT WOS:000712026000009
PM 34567547
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Fattah, FAMA
   Dahleez, KA
   Mohamed, AHHM
   Okour, MK
   AL Alawi, AMM
AF Abdel Fattah, Fadi Abdel Muniem
   Dahleez, Khalid Abed
   Mohamed, Abdul Hakim H. M.
   Okour, Mohammad Khaleel
   AL Alawi, Abrar Mohammed Mubarak
TI Public health awareness: knowledge, attitude and behaviors of the public
   on health risks during COVID-19 pandemic in sultanate of Oman
SO GLOBAL KNOWLEDGE MEMORY AND COMMUNICATION
LA English
DT Article
DE Attitude; Awareness; Health knowledge; Covid-19; Preventive behavior;
   Pandemic outbreak
ID RESPIRATORY SYNDROME CORONAVIRUS; PLS-SEM; INFLUENZA; INFECTION;
   SECURITY; INDIA
AB Purpose - This study aims to measure the level of public awareness about the threat of the emerging coronavirus (COVID-19) pandemic among the Omani population. It also aims to investigate the mediating effect of the Omanis' attitudes and behaviors with underlying conditions of COVID-19.
   Design/methodology/approach - A cross-sectional study was conducted to collect data via an online survey of Omani citizens and residents from various geographic areas in Oman, 305 responses were received. SPSS and partial least square-structural equation modeling were used for data analysis.
   Findings - The study revealed that public awareness regarding the COVID-19 pandemic was significantly influenced by people's perceived risk, information source and health-related knowledge. Further, preventive behavior during the disease spread has a significant direct and indirect impact on their awareness. However, an insignificant mediation effect of public attitude was found between the source of information and public awareness.
   Research limitations/implications - This study is limited by the scarcity of related literature in the Omani context. It is recommended that future research complete an in-depth study of public awareness regarding COVID-19, using other constructs and/or other data collection techniques.
   Practical implications - This research will provide governmental health authorities and policymakers with a guideline to establish more efficient pandemic containment strategies to control public behavior toward the COVID-19 pandemic and curb viral prevalence.
   Social implications - This research will help in improving prevention measures against COVID-19 are recommended to be more educated through a more effective mechanism to raise public attitude regarding pandemic prevalence positively.
   Originality/value - The originality of this research can be drawn from key findings that indicate that people overall gained knowledge about how to deal with the COVID-19 pandemic and the accuracy of information significantly impacts public awareness.
C1 [Abdel Fattah, Fadi Abdel Muniem; Dahleez, Khalid Abed; AL Alawi, Abrar Mohammed Mubarak] A Sharqiyah Univ, Dept Management, Ibra, Oman.
   [Mohamed, Abdul Hakim H. M.] A Sharqiyah Univ, Dept Management Informat Syst, Ibra, Oman.
   [Okour, Mohammad Khaleel] Luminus Tech Univ Coll, Business Dept, Irbid, Jordan.
RP Fattah, FAMA (corresponding author), A Sharqiyah Univ, Dept Management, Ibra, Oman.
EM fadi.fattah@asu.edu.om; khalid.dahleez@asu.edu.om;
   abdulhakim.mohamed@asu.edu.om; mohamedokour@yahoo.com;
   abraralalawi96@gmail.com
RI AbdelFattah, Fadi AbdelMuniem/L-7441-2014; Dahleez, Khalid
   Abed/M-6157-2017; Mohamed, Abdul Hakim/ABH-1980-2020; Okour,
   Mohammad/AAF-9777-2020
OI AbdelFattah, Fadi AbdelMuniem/0000-0002-4665-4777; Dahleez, Khalid
   Abed/0000-0002-1526-8750; Mohamed, Abdul Hakim/0000-0001-5879-5385;
   Okour, Mohammad/0000-0003-0980-9431
CR Fattah FAMA, 2021, GLOB KNOWL MEM COMMU, V70, P611, DOI 10.1108/GKMC-07-2020-0104
   Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Abdelfattah FA, 2015, J IND ENG MANAG-JIEM, V8, P1639, DOI 10.3926/jiem.1494
   Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Afzal MS, 2021, J COMMUN HEALTH, V46, P476, DOI 10.1007/s10900-020-00875-z
   Ahmed J., 2019, INT J ADV COMMUNITY, V2, P23
   Aker S, 2020, J COMMUN HEALTH, V45, P684, DOI 10.1007/s10900-020-00841-9
   Al Gharbawi, 2020, INT J BUSINESS INFOR, V1, DOI [10.1504/ijbis.2020.10023793, DOI 10.1504/IJBIS.2020.10023793]
   Al Omari O, 2021, J COMMUN HEALTH, V46, P450, DOI 10.1007/s10900-020-00874-0
   Al-Tawfiq JA, 2014, TRAVEL MED INFECT DI, V12, P422, DOI 10.1016/j.tmaid.2014.06.007
   Ali SA, 2020, J INFECT PUBLIC HEAL, V13, P644, DOI [10.1016/j.jiph.2019.02.033, 10.1016/j.jiph.2020.02.033]
   Andualem Yimer, 2017, Journal of Veterinary Medicine and Animal Health, V9, P39, DOI 10.5897/JVMAH2016.0519
   Anusha M, 2018, J MED SCI CLIN RES, V6, P323
   Aslan G, 2021, J COMMUN HEALTH, V46, P428, DOI 10.1007/s10900-020-00888-8
   Bakhtiari Z, 2020, ANN PURE APPL LOGIC, V171, DOI 10.1016/j.apal.2020.102790
   Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Benajiba N, 2020, J COMMUN HEALTH, V45, P661, DOI 10.1007/s10900-019-00750-6
   Betsch C., 2020, PSYCHARCHIVES, DOI [https://doi.org/10.23668/psycharchives.2776, DOI 10.23668/PSYCHARCHIVES.2776, 10.23668/psycharchives.2776]
   Bonilla-Aldana D., 2020, ADV ANIM VET SCI, V8, P1, DOI [10.17582/journal.aavs/2020/8.3.234.237, DOI 10.17582/JOURNAL.AAVS/2020/8.3.234.237]
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Bullock J, 2020, J ARTIF INTELL RES, V69, P807
   Bulmash B, 2020, J COMMUN HEALTH, V45, P1211, DOI 10.1007/s10900-020-00857-1
   Carrion G.C., 2017, MEDIATION ANALYSES P, DOI 10.1007/978-3-319-64069-3_8
   Carter G, 2020, J COMMUN HEALTH, V45, P554, DOI 10.1007/s10900-019-00775-x
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161
   Cuc I., 2015, FOCUS COVID 2019 NOV, V11, P63
   Dahleez KA, 2021, J ENTERP INF MANAG, V34, P1004, DOI 10.1108/JEIM-01-2019-0023
   Dehkordi AH, 2020, J MED VIROL, V92, P868, DOI 10.1002/jmv.25885
   Del Brutto OH, 2021, J COMMUN HEALTH, V46, P292, DOI 10.1007/s10900-020-00887-9
   Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575
   Dharmshaktu NS, 2020, EPIDEMIOL INT, V5, P1
   Effenberger M, 2020, INT J INFECT DIS, V95, P192, DOI 10.1016/j.ijid.2020.04.033
   El-Zoghby SM, 2020, J COMMUN HEALTH, V45, P689, DOI 10.1007/s10900-020-00853-5
   Elkind MSV, 2020, CIRCULATION, V141, pE743, DOI 10.1161/CIRCULATIONAHA.120.046749
   Farooq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19128
   Felice C, 2020, J COMMUN HEALTH, V45, P675, DOI 10.1007/s10900-020-00845-5
   Gambhir RS, 2016, J CLIN DIAGN RES, V10, pZE10, DOI 10.7860/JCDR/2016/20387.8536
   Gardner LM, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw063
   Garrido MA, 2020, J COMMUN HEALTH, V45, P569, DOI 10.1007/s10900-019-00777-9
   Gostic K, 2020, ELIFE, V9, DOI 10.7554/eLife.55570
   Gotz O., 2010, HDB PARTIAL LEAST SQ, P691, DOI DOI 10.1007/978-3-540-32827-8_30
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128
   Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203
   Hamza MS, 2021, J COMMUN HEALTH, V46, P139, DOI 10.1007/s10900-020-00859-z
   He S, 2021, J COMMUN HEALTH, V46, P278, DOI 10.1007/s10900-020-00870-4
   Henseler J, 2016, INT MARKET REV, V33, P405, DOI 10.1108/IMR-09-2014-0304
   Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382
   Hoda J, 2016, HEALTH EDUC RES, V31, P12, DOI 10.1093/her/cyv061
   Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0
   Jain VK, 2015, PROCEDIA COMPUT SCI, V70, P801, DOI 10.1016/j.procs.2015.10.120
   James K, 2021, J COMMUN HEALTH, V46, P174, DOI 10.1007/s10900-020-00865-1
   Johnson EJ, 2017, J PUBLIC HEALTH-HEID, V25, P333, DOI 10.1007/s10389-017-0790-7
   Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5
   Tetik BK, 2021, J COMMUN HEALTH, V46, P471, DOI 10.1007/s10900-020-00880-2
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Khose S, 2020, J COMMUN HEALTH, V45, P696, DOI 10.1007/s10900-020-00854-4
   Kliger AS, 2020, CLIN J AM SOC NEPHRO, V15, P707, DOI 10.2215/CJN.03340320
   Krenke K, 2015, ADV EXP MED BIOL, V857, P9, DOI 10.1007/5584_2014_99
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]
   Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032
   Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350
   Lim S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114148
   Louis-Jean J, 2020, J COMMUN HEALTH, V45, P437, DOI 10.1007/s10900-020-00825-9
   Villela DAM, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0135-2020
   Mahajan P, 2020, J COMMUN HEALTH, V45, P1291, DOI 10.1007/s10900-020-00863-3
   Malik YS, 2020, INDIAN J ANIM SCI, V90, P303
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Naranjo-Zolotov M, 2019, GOV INFORM Q, V36, P536, DOI 10.1016/j.giq.2019.05.009
   Nathan AJ, 2012, FOREIGN AFF, V91, P32
   Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848
   Nicomedes CJC, 2020, J AFFECT DISORDERS, V276, P14, DOI 10.1016/j.jad.2020.06.046
   Niraj Bharadva, 2018, National Journal of Community Medicine, V9, P1
   Nusbaum N, 2020, J COMMUN HEALTH, V45, P435, DOI 10.1007/s10900-020-00821-z
   Park SW, 2015, ANN TOURISM RES, V50, P67, DOI 10.1016/j.annals.2014.10.007
   Peters A, 2020, J HOSP INFECT, V104, P440, DOI 10.1016/j.jhin.2020.02.023
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Poletto C, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.23.20824
   Poletto C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1787-5
   Qazi A, 2020, J MED VIROL, V92, P849, DOI 10.1002/jmv.25840
   Qian MC, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040910
   Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048
   Rahman MS, 2021, GLOB KNOWL MEM COMMU, V70, P1, DOI 10.1108/GKMC-10-2019-0122
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Rigdon EE, 2012, LONG RANGE PLANN, V45, P341, DOI 10.1016/j.lrp.2012.09.010
   Rogers CJ, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6041-1
   Rosenbaum Lisa, 2020, Recenti Prog Med, V111, P192, DOI 10.1701/3347.33179
   Sari DK, 2021, J COMMUN HEALTH, V46, P182, DOI 10.1007/s10900-020-00866-0
   Sarstedt M, 2020, INT J MARKET RES, V62, P288, DOI 10.1177/1470785320915686
   Sarstedt M, 2011, ADV INT MARKETING, V22, P195, DOI 10.1108/S1474-7979(2011)0000022012
   Saunders M., 2020, RES METHODS BUSINESS
   Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x
   Seidel EJ, 2020, J COMMUN HEALTH, V45, P1259, DOI 10.1007/s10900-020-00905-w
   Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111
   Sethi T, 2020, MACHINE LEARNING APP
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Shmueli G, 2019, EUR J MARKETING, V53, P2322, DOI 10.1108/EJM-02-2019-0189
   Singh DR, 2020, J COMMUN HEALTH, V45, P1116, DOI 10.1007/s10900-020-00839-3
   Stout ME, 2020, J COMMUN HEALTH, V45, P1187, DOI 10.1007/s10900-020-00837-5
   Strunk J.L., 2014, ESSENTIALS RADIOLOGI, V80, P1
   Student P., 2018, EUROPEAN J BIOMEDICA, V5, P290
   Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1
   Suresh Aneena, 2019, Journal of Communicable Diseases, V51, P41, DOI 10.24321/0019.5138.201935
   Thabit M.F., 2011, QMJ, V7, P85
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Venkatesan S, 2019, PLOS ONE, V14, DOI [10.1371/journal.pone.0223946, 10.1371/journal.pon]
   La VP, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072931
   Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X
   WHO, 2020, COR DIS COVID 19 WEE
   WHO, 2020, HOUS TRANSM INV PROT, V2019
   WHO, 2020, OP CONS MAN COVID 19
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   Woodall J., 2020, EMERALD OPEN RES, V2, P1
   Yasir A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082954
   Yue ST, 2021, J COMMUN HEALTH, V46, P286, DOI 10.1007/s10900-020-00877-x
NR 119
TC 4
Z9 4
U1 2
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2514-9342
EI 2514-9350
J9 GLOB KNOWL MEM COMMU
JI Glob. Knowl. Mem. Commun.
PD JAN 19
PY 2022
VL 71
IS 1-2
BP 27
EP 51
DI 10.1108/GKMC-10-2020-0152
EA MAY 2021
PG 25
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA YN5BO
UT WOS:000649025500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Arslan, A
   Golgeci, I
   Khan, Z
   Ahokangas, P
   Haapanen, L
AF Arslan, Ahmad
   Golgeci, Ismail
   Khan, Zaheer
   Ahokangas, Petri
   Haapanen, Lauri
TI COVID-19 driven challenges in international B2B customer relationship
   management: empirical insights from Finnish high-tech industrial
   microenterprises
SO INTERNATIONAL JOURNAL OF ORGANIZATIONAL ANALYSIS
LA English
DT Article
DE Business-to-business marketing; Microenterprises; COVID-19; B2B
   relationships; COVID-19; Customer relationship management;
   Microenterprises; Trust
ID KNOWLEDGE; TRUST; PERFORMANCE; FIRM; STRATEGIES; CRISIS
AB Purpose This paper aims to focus on the influences of the COVID-19 pandemic on business-to-business (B2B) firms' relationship initiation and customer relationship management in an under-explored and unique context of high-tech industrial microenterprises. The authors analyze the challenges posed by the COVID-19 pandemic in the specific context of B2B relationship initiation and customer relationship management dynamics by examining Finnish B2B industrial microenterprises. Design/methodology/approach The paper uses exploratory in-depth case studies undertaken in three Finnish industrial microenterprises to analyze the influences of the COVID-19 pandemic on their new business relationship initiation and relationship management with the current customers. Findings The case firms quickly adjusted to the "new normal" and used a number of technological resources, including online meetings and three-dimensional demonstrations, among others. A key reason for this quick adjustment was them being microenterprises. However, despite this, lack of access to customer sites remained a hindrance as their products need to fit certain production processes, which cannot be done without physical visits. Furthermore, the development of trust with new customers, especially those based in emerging markets, was challenging due to the lack of physical meetings and site visits. Research limitations/implications The research highlights the challenges posed by the COVID-19 pandemic to B2B relationships and gives an account of the changing dynamics of relationship initiation and customer relationship management amid technological and societal disruptions. It also highlights the continued role of personal relationships and psychical meetings in such relationships. As such, the research informs B2B research that examines the role of personal relationships in B2B marketing. Practical implications The study offers industrial microenterprise executives insights into how to face and tackle COVID-19 driven challenges in B2B customer relationship management and how to integrate technological tools in relationship management practices while understanding where face-to-face meetings are indispensable. Originality/value The study demonstrates areas in which virtual tools can and cannot be substitutes for conventional means of B2B relationship initiation and customer relationship management across developed and emerging markets. It also highlights the specificities of industrial microenterprises and their business development and customer relationship management dynamics mechanisms, a research area that has been rather ignored by prior studies.
C1 [Arslan, Ahmad; Haapanen, Lauri] Univ Oulu, Dept Mkt Management & Int Business, Oulu, Finland.
   [Golgeci, Ismail] Aarhus Univ, Dept Business Dev & Technol, Herning, Denmark.
   [Khan, Zaheer] Univ Aberdeen, Sch Business, Aberdeen, Scotland.
   [Ahokangas, Petri] Univ Oulu, Martti Ahtisaari Inst, Oulu, Finland.
RP Arslan, A (corresponding author), Univ Oulu, Dept Mkt Management & Int Business, Oulu, Finland.
EM ahmad.arslan@oulu.fi; i.golgeci@btech.au.dk; zaheer.khan@abdn.ac.uk;
   petri.ahokangas@oulu.fi; lauri.haapanen@oulu.fi
OI Khan, Zaheer/0000-0001-5538-3123
CR ALHussan FB, 2017, J BUS IND MARK, V32, P825, DOI 10.1108/JBIM-05-2015-0091
   Arslan A, 2021, Routledge Frontiers, P156
   Arslan A, 2021, MULTINATL BUS REV, V29, P21, DOI 10.1108/MBR-07-2020-0153
   Arslan A, 2020, INT MARKET REV, V37, P885, DOI 10.1108/IMR-05-2019-0143
   Autry CW, 2010, J OPER MANAG, V28, P87, DOI 10.1016/j.jom.2009.07.003
   Baluku MM, 2018, J GLOB ENTREP RES, V8, DOI 10.1186/s40497-018-0113-7
   Barmeyer C, 2020, MULTINATL BUS REV, V28, P521, DOI 10.1108/MBR-04-2019-0027
   Calhoun M, 2015, MULTINATL BUS REV, V23, P200, DOI 10.1108/MBR-12-2014-0067
   Cankurtaran P, 2020, IND MARKET MANAG, V88, P255, DOI 10.1016/j.indmarman.2020.05.030
   Chandler JD, 2019, J SERV RES-US, V22, P75, DOI 10.1177/1094670518797479
   Corbin J., 2008, BASICS QUALITATIVE R, P65, DOI [10.4135/9781452230153., DOI 10.4135/9781452230153]
   Cortez RM, 2020, IND MARKET MANAG, V88, P125, DOI 10.1016/j.indmarman.2020.05.004
   Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2
   Crick JM, 2020, IND MARKET MANAG, V88, P206, DOI 10.1016/j.indmarman.2020.05.016
   CROSBY LA, 1990, J MARKETING, V54, P68, DOI 10.2307/1251817
   Davies A., 2005, BUSINESS PROJECTS MA
   Doney PM, 1997, J MARKETING, V61, P35, DOI 10.2307/1251829
   du Plessis M, 2004, INT J INFORM MANAGE, V24, P73, DOI 10.1016/j.ijinfomgt.2003.10.002
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   FISCHER CS, 1982, SOC NETWORKS, V3, P287, DOI 10.1016/0378-8733(82)90004-1
   Gligor DM, 2012, J SUPPLY CHAIN MANAG, V48, P24, DOI 10.1111/j.1745-493X.2011.03240.x
   Golgeci I, 2018, EUR MANAG J, V36, P278, DOI 10.1016/j.emj.2017.03.011
   Hakansson H., 1989, SCAND J MANAG, V5, P187, DOI [DOI 10.1016/J.SCAMAN.2006.10.005, 10.1016/0956-5221(89)90026-2]
   Hartmann NN, 2020, IND MARKET MANAG, V88, P101, DOI 10.1016/j.indmarman.2020.05.005
   Hofacker C, 2020, EUR J MARKETING, V54, P1161, DOI 10.1108/EJM-04-2020-0247
   Hurley RF, 2005, IND MARKET MANAG, V34, P281, DOI 10.1016/j.indmarman.2004.07.006
   Jeong SW, 2016, MULTINATL BUS REV, V24, P47, DOI 10.1108/MBR-08-2015-0039
   Khan Z, 2014, INT BUS REV, V23, P1212, DOI 10.1016/j.ibusrev.2014.05.001
   KOGUT B, 1992, ORGAN SCI, V3, P383, DOI 10.1287/orsc.3.3.383
   Kotabe M, 2003, STRATEGIC MANAGE J, V24, P293, DOI 10.1002/smj.297
   Lankinen M., 2009, FACULTY EC BUSINESS, V29, P76
   Luo XM, 2004, J INT MARKETING, V12, P25, DOI 10.1509/jimk.12.4.25.53216
   Matanda MJ, 2009, INT BUS REV, V18, P89, DOI 10.1016/j.ibusrev.2008.12.004
   MOHR J, 1994, STRATEGIC MANAGE J, V15, P135, DOI 10.1002/smj.4250150205
   Mullins RR, 2019, IND MARKET MANAG, V77, P1, DOI 10.1016/j.indmarman.2018.03.001
   Murphy M, 2018, IND MARKET MANAG, V68, P1, DOI 10.1016/j.indmarman.2017.08.020
   Natti S, 2014, IND MARKET MANAG, V43, P977, DOI 10.1016/j.indmarman.2014.05.010
   Padmavathy C, 2012, INT J BANK MARK, V30, P246, DOI 10.1108/02652321211236888
   Patton M. Q., 2002, QUAL SOC WORK, V1, P261, DOI [DOI 10.1177/1473325002001003636, 10.1177/1473325001003636]
   Ponce DKP, 2017, QUAL INNOV PROSPER, V21, P1, DOI 10.12776/QIP.V21I3.933
   Price LL, 1999, J MARKETING, V63, P38, DOI 10.2307/1251973
   Rowlinson S., 2007, PROCUREMENT SYSTEMS
   Schilke O, 2013, STRATEG ORGAN, V11, P281, DOI 10.1177/1476127012472096
   Takala J, 2007, IND MANAGE DATA SYST, V107, P326, DOI 10.1108/02635570710734253
   Tatoglu I, 2019, J INT MANAG, V100711
   Varoutsa E, 2018, ACCOUNT AUDIT ACCOUN, V31, P112, DOI 10.1108/AAAJ-02-2013-1218
   Williams P, 2002, PUBLIC ADMIN, V80, P103, DOI 10.1111/1467-9299.00296
   Williams TA, 2017, ACAD MANAG ANN, V11, P733, DOI 10.5465/annals.2015.0134
   Yin R.K., 2013, CASE STUDY RES DESIG, V3rd ed.
NR 49
TC 0
Z9 0
U1 5
U2 7
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1934-8835
EI 1758-8561
J9 INT J ORGAN ANAL
JI Int. J. Organ. Anal.
PD DEC 19
PY 2022
VL 30
IS 7
BP 49
EP 66
DI 10.1108/IJOA-04-2021-2719
EA AUG 2021
PG 18
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZD5IO
UT WOS:000686585800001
OA Green Submitted, hybrid
DA 2022-04-20
ER

PT J
AU Gu, SX
   Zhang, AJ
   Huo, G
   Yuan, WQ
   Li, Y
   Han, JL
   Shen, N
AF Gu, Shixian
   Zhang, Aijing
   Huo, Gang
   Yuan, Wenqing
   Li, Yan
   Han, Jiangli
   Shen, Ning
TI Application of PDCA cycle management for postgraduate medical students
   during the COVID-19 pandemic
SO BMC MEDICAL EDUCATION
LA English
DT Article
DE Postgraduate medical students; COVID-19; Plan-do-check-act cycle
AB Background The COVID-19 outbreak has exerted an enormous impact on various industries worldwide. During this pandemic, clinical teaching hospitals have faced unprecedented challenges regarding the management of postgraduate medical students since postgraduate students in clinical medicine have both student and resident identity characteristics. The purpose of this study was to explore the management effectiveness of Peking University Third Hospital (PUTH) based on PDCA (plan-do-check-act) cycle management and to further develop the medical student management system during the pandemic. Methods The methods of document review, questionnaire surveys and interviews were used to continuously improve the management measures for postgraduate medical students during the COVID-19 pandemic by using the PDCA cycle. Results Investigations were conducted on the management system, back-to-school arrangements, laboratory management, COVID-19 prevention and control training, online teaching, mentoring, dissertation progress, and emotional state of postgraduate medical students during the COVID-19 pandemic. We found that strengthening public health management knowledge training, increasing infectious-disease-related knowledge training, innovating online teaching methods, improving PDCA management model maps, and formulating improvement programmes are conducive to improving the quality of such management. Conclusion Given the difficulties involved in the management of postgraduate medical students during the COVID-19 pandemic, managers need to comprehensively consider and conduct overall planning and use the PDCA management model to improve the management of postgraduate medical students during this period.
C1 [Gu, Shixian; Zhang, Aijing; Huo, Gang; Yuan, Wenqing; Li, Yan; Han, Jiangli] Peking Univ Third Hosp, Dept Educ, Beijing 100191, Peoples R China.
   [Han, Jiangli] Peking Univ Third Hosp, Dept Cardiol, Beijing 100191, Peoples R China.
   [Shen, Ning] Peking Univ Third Hosp, Dept Pulm & Crit Care Med, Beijing 100191, Peoples R China.
RP Han, JL (corresponding author), Peking Univ Third Hosp, Dept Educ, Beijing 100191, Peoples R China.; Shen, N (corresponding author), Peking Univ Third Hosp, Dept Pulm & Crit Care Med, Beijing 100191, Peoples R China.
EM dr_hanjiangli@126.com; shenning1972@126.com
FU General Affairs Office of Peking University Third Hospital
FX We thank the support of the General Affairs Office of Peking University
   Third Hospital.
CR Deming W.E., 2000, NEW EC IND GOVT ED, V2nd ed.
   General Office of the State Council, 2020, OP GEN OFF STAT COUN
   Ministry of education, 2014, OP 6 DEP INCL MIN ED
   Ministry of education, 2020, MIN ED ISS GUID ORG
   People's Daily online, 2020, PEOPLES DAILY ONLINE
   Kazerooni AR, 2020, MED EDUC, V54, P762, DOI 10.1111/medu.14206
   Shewhart WA, 1930, BELL SYST TECH J, V9, P364, DOI 10.1002/j.1538-7305.1930.tb00373.x
   Shewhart WA., 1939, STAT METHOD VIEWPOIN
   Theoret C, 2020, MED EDUC, V54, P591, DOI 10.1111/medu.14181
   Torda AJ, 2020, MED J AUSTRALIA, V213, P188, DOI 10.5694/mja2.50705
NR 10
TC 2
Z9 2
U1 5
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6920
J9 BMC MED EDUC
JI BMC Med. Educ.
PD MAY 29
PY 2021
VL 21
IS 1
AR 308
DI 10.1186/s12909-021-02740-6
PG 11
WC Education & Educational Research; Education, Scientific Disciplines
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Education & Educational Research
GA SK1HL
UT WOS:000655971900001
PM 34051784
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Falcon, VV
   Martinez, BS
AF Vega Falcon, Vladimir
   Sanchez Martinez, Belkis
TI THE BLACK SWAN OF COVID-19 AND THE FIGURE OF THE CONTROLLER IN BUSINESS
   MANAGEMENT
SO REVISTA UNIVERSIDAD Y SOCIEDAD
LA Spanish
DT Article
DE Controller; business management; black swan; COVID-19; Category Matrix
AB The COVID-19 significantly transforms universal life, particularly in the business environment, forcing systematic transformations to face uncertainties and the competitive environment. Objective: The aim of this study was to identify the profile of the Controller in business management. Methods: A descriptive, retrospective, observational and cross-sectional perceptual research was carried out. The documentary review technique was used, and the Category Matrix was designed as a data collection instrument. Results: It was evidenced that COVID-19 causes the labor market to go through a difficult moment, characterized by uncertainty and deep business transformations, in which the Controller is the most relevant figure. It was found that the Controller's tasks include the analysis and interpretation of financial statements; analytical breakdowns of information; budget design; systematic reporting to management; coordination of internal audits; with a leading role in strategy and the Balanced Scorecard. A profile for this position was evidenced characterized by: male between 30 and 50 years old, mainly within the industrial sector, who dedicates most of his time to the organization's operations, data extraction and analysis, with analytical and visionary capacity, together with general knowledge of the organization. Conclusions: It was concluded that the Controller with his proactivity links his protagonism as a strategist with business operational management, being a key professional in management control, fundamentally in periods of crisis such as the one caused by the COVID-19 black swan.
C1 [Vega Falcon, Vladimir; Sanchez Martinez, Belkis] Univ Reg Autonoma Los Andes, Quevedo, Ecuador.
RP Falcon, VV (corresponding author), Univ Reg Autonoma Los Andes, Quevedo, Ecuador.
EM ua.vladimirvega@uniandes.edu.ec; ua.belkissanchez@uniandes.edu.ec
CR Aslan T., 2021, CORP GOV-OXFORD, V5, P17
   Barrera M., 2007, MODELOS EPISTEMICOS
   Cartagena J. P, 2013, ESTRATEGIA FINANCIER, P8
   Falcon V. V., 2020, REV ORBIS, V16, P5
   Fernandez de la Cigona JR., 2017, TODO QUE NECESITAS S
   Global Chartered Controller Institute GCCI, 2021, CONTR COM NEX UN ENT
   Global Chartered Controller Institute GCCI, 2020, WEBINAR COM CONTR PU
   Global Chartered Controller Institute GCCI, 2021, AN DAT FACT DIF CONT
   Global Chartered Controller Institute GCCI, 2021, WEB ROL CONTR GEST E
   Global Chartered Controller Institute GCCI, 2021, PAND EMP CONTR EMPR
   Global Chartered Controller Institute GCCI, 2021, CONTR GEST SER FIG M
   Global Chartered Controller Institute GCCI, 2020, CONTR PERF MAS DEM F
   Lozano Lola, 2021, PREPARAR ORG CAMBIO
   Mucharraz Y, 2021, ANAHUAC J, V21, P40
   Rivas L., 2015, COMO HACER TESIS
   Sage Spain, 2017, COM PAS CONT CONTR G, V1 1
   Schoemaker P.J., 2019, SEE SOONER ACT FASTE
   Spring Professional, 2020, GUIA SPRING MERC LAB
   Supo J, 2020, METODOLOGIA INVESTIG
   Suryaningtyas D., 2019, ACAD STRAT MANAGE J, V18, P1
   Taleb N. N., 2008, CISNE NEGRO IMPACTO
   Useche M. C., 2019, TECNICAS INSTRUMENTO, VPrimera
   Vega V., 2021, U SOC, V13, P74
NR 23
TC 0
Z9 0
U1 0
U2 0
PU UNIV CIENFUEGOS
PI CIENFUEGOS
PA CARRETERA RODAS KM 4, CUATRO CAMINOS, CIENFUEGOS, 00000, CUBA
SN 2218-3620
J9 REV UNIV SOC
JI Rev. Univ. Soc.
PD DEC
PY 2021
VL 13
SU 3
BP 196
EP 202
PG 7
WC Social Sciences, Interdisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA XJ1ME
UT WOS:000726560400026
DA 2022-04-20
ER

PT J
AU Honarvar, B
   Lankarani, KB
   Kharmandar, A
   Shaygani, F
   Zahedroozgar, M
   Haghighi, MRR
   Ghahramani, S
   Honarvar, H
   Daryabadi, MM
   Salavati, Z
   Hashemi, SM
   Joulaei, H
   Zare, M
AF Honarvar, Behnam
   Lankarani, Kamran B.
   Kharmandar, Ali
   Shaygani, Fatemeh
   Zahedroozgar, Mohammadhassan
   Haghighi, Mohammad Reza Rahmanian
   Ghahramani, Sulmaz
   Honarvar, Hossein
   Daryabadi, Mohammad Mehdi
   Salavati, Zahra
   Hashemi, Seyed Mohammad
   Joulaei, Hassan
   Zare, Marziyeh
TI Knowledge, attitudes, risk perceptions, and practices of adults toward
   COVID-19: a population and field-based study from Iran
SO INTERNATIONAL JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Knowledge; Attitude; Risk perception; Practice; Health belief model;
   COVID-19
ID OUTBREAK
AB Objectives To determine peoples' knowledge, attitudes, risk perceptions, and practices to provide policymakers pieces of field-based evidence and help them in the management of the COVID-19 epidemic. Methods This population-based survey was conducted using multi-stage stratified and cluster sampling in Shiraz, Iran. A total of 1331 persons were interviewed. The questionnaires were completed by face-to-face interviews. Univariable and multivariable (linear regression) data analyses were done using SPSS. Results The participants answered 63% of questions regarding knowledge, and 78% of questions regarding practice correctly. Only, 4.8% knew about common symptoms of COVID-19 and 7.3% about warning signs that require referral to hospitals. Males, lower educated people, and elders had a lower level of knowledge and poorer practices. Knowledge was also lower in the marginalized (socially deprived) people. Knowledge and practices' correlation was 37%. Overall, 43.6% considered themselves at high risk of COVID-19, and 50% considered it as a severe disease. This disease had negative effects on most participants' routine activities (69.1%). The participants preferred to follow the news from the national TV/Radio, social networks, and foreign satellite channels, respectively. Conclusions Encouragement of people to observe preventive measures and decreasing social stress, especially among males, lower educated people, elders, and marginalized groups, are highly recommended.
C1 [Honarvar, Behnam; Lankarani, Kamran B.; Kharmandar, Ali; Shaygani, Fatemeh; Zahedroozgar, Mohammadhassan; Haghighi, Mohammad Reza Rahmanian; Ghahramani, Sulmaz; Joulaei, Hassan; Zare, Marziyeh] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Shiraz, Iran.
   [Kharmandar, Ali] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.
   [Honarvar, Hossein; Daryabadi, Mohammad Mehdi; Salavati, Zahra] Islamic Azad Univ, Sch Vet Med, Kazerun, Iran.
   [Hashemi, Seyed Mohammad] Shiraz Univ Med Sci, Sch Rehabil, Shiraz, Iran.
   [Joulaei, Hassan] Shiraz Univ Med Sci, Shiraz HIV AIDS Res Ctr, Inst Hlth, Shiraz, Iran.
RP Kharmandar, A (corresponding author), Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Shiraz, Iran.; Kharmandar, A (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.
EM ali.kh.sampad@gmail.com
RI Shaygani, Fatemeh/AGF-5463-2022; Honarvar, Behnam/K-1623-2013
OI Shaygani, Fatemeh/0000-0002-9342-216X; Kharmandar,
   Ali/0000-0003-0707-4857; Rahmanian Haghighi, Mohammad
   Reza/0000-0003-3820-4685; Honarvar, Behnam/0000-0002-1081-5778;
   Zahedroozegar, Mohammadhassan/0000-0003-4388-8962; Zare,
   Marziyeh/0000-0002-3395-2337
CR Ajzen I., 2005, HDB ATTITUDES, DOI DOI 10.1007/BF02294218
   Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082
   Chen Y, 2020, Zhonghua Yu Fang Yi Xue Za Zhi, V54, pE004, DOI 10.3760/cma.j.issn.0253-9624.2020.0004
   Cheng ZKJ, 2020, INFECTION, V48, P155, DOI 10.1007/s15010-020-01401-y
   Chitra K., 2020, OUR HERITAGE, V68, P60
   Choi JS, 2018, J INFECT PUBLIC HEAL, V11, P840, DOI 10.1016/j.jiph.2018.07.002
   Glanz K., 2008, HLTH BEHAV HLTH ED T, V4
   Lee DTS, 2006, J PSYCHOSOM RES, V61, P707, DOI 10.1016/j.jpsychores.2006.08.005
   Li JP, 2021, COMBUST SCI TECHNOL, V193, P1639, DOI 10.1080/00102202.2019.1706501
   Madhav N., 2018, DIS CONTROL PRIORITI, V9, P315
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10
   Sadati A.K.B., 2020, ADV SHIRAZ E MED J, V21, DOI [DOI 10.5812/SEMJ.102263, 10.5812/semj.102263]
   Sahu KK, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.92
   Sheeran P, 2016, SOC PERSONAL PSYCHOL, V10, P503, DOI 10.1111/spc3.12265
   Srichan P, 2020, KNOWLEDGE ATTITUDE P
   SUMS, 2020, DAIL REP COVID 19 FA
   Tavakoli Ahmad, 2020, IRAN S MED J, V22, P432, DOI DOI 10.29252/ISMJ.22.6.432
   WHO, 2020, WHO CHARACTERIZES CO
   WHO, 2020, COR DIS COVID 2019 S
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   World Health Organization, 2020, HLTH TOP COR
   Yap J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-442
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 23
TC 64
Z9 67
U1 11
U2 27
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1661-8556
EI 1661-8564
J9 INT J PUBLIC HEALTH
JI Int. J. Public Health
PD JUL
PY 2020
VL 65
IS 6
BP 731
EP 739
DI 10.1007/s00038-020-01406-2
EA JUN 2020
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA NC2MZ
UT WOS:000543132100001
PM 32583009
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Fatima, M
   Habib, A
   Khan, S
   Butt, MH
   Mallhi, TH
   Khan, YH
   Zaheer, A
   Habib, MU
   Khan, AQ
   Khan, MI
   Iqbal, A
   Mehmood, MH
   Masood, I
AF Fatima, Madeeha
   Habib, Aamna
   Khan, Saira
   Butt, Muhammad Hammad
   Mallhi, Tauqeer Hussain
   Khan, Yusra Habib
   Zaheer, Asifa
   Habib, Muhammad Umar
   Khan, Abdul Qayyum
   Khan, Muhammad Imran
   Iqbal, Azhar
   Mehmood, Malik Hassan
   Masood, Imran
TI Knowledge, Attitude, Practice, Behavior and Risk Perception of COVID-19
   Pandemic among Medical and non-Medical University Students
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article; Early Access
DE COVID-19; knowledge; attitude; practice; risk perception; students;
   university
AB Objective: Coronavirus disease 2019 (COVID-19) pandemic has substantially affected students around the globe due to the closure of educational institutes. However, student involvements and contributions are important in combating the disease; for this reason, the current study was designed to assess the knowledge-attitude-practice (KAP), preventive behavior, and risk perception among university students. Methods: A cross-sectional survey-based study was conducted among medical and non-medical university students, from April 1 to June 30, 2020. The 68-item questionnaire was used to evaluate responses using statistical approaches (Student's t-test, regression-analysis, and co-relation analysis) by considering a P-value Results: A total of 503 university students (medical and nonmedical) were selected, where majority of participants were females (83%) and 64.5% were of age ranged from 16 to 21 years old. The participants (80%) reported good disease knowledge with a mean score of 12.06 +/- 1.75, which substantially higher among medical students (P < 0.05). Most of the respondents (72%) believed that COVID-19 will be effectively controlled through precautionary measures. In correlation subgroup analysis, a significant relationship (P = 0.025) between knowledge and positive attitude were indicated. Fear and knowledge of COVID-19 emerged as strong predictors (P < 0.001) of preventive behaviors towards disease. Conclusion: This study demonstrated satisfactory knowledge, positive attitudes, and suitable practices among students toward COVID-19. University students can be involved in public education to aid the health authorities in achieving the targets of educational campaigns with maximum population coverage.
C1 [Fatima, Madeeha; Habib, Aamna] Univ Faisalabad, Dept Pharm, Faisalabad, Pakistan.
   [Khan, Saira] Govt Coll Women Univ, Dept Appl Psychol, Faisalabad, Pakistan.
   [Butt, Muhammad Hammad] Univ Cent Punjab, Fac Pharm, Lahore, Pakistan.
   [Mallhi, Tauqeer Hussain; Khan, Yusra Habib] Jouf Univ, Coll Pharm, Dept Clin Pharm, Sakaka, Saudi Arabia.
   [Zaheer, Asifa] Faisalabad Med Univ, Dept Physiol, Allied Hosp, Faisalabad, Pakistan.
   [Habib, Muhammad Umar] Dist Head Quarter Hosp, Dept Surg, Chiniot, Pakistan.
   [Khan, Abdul Qayyum] Univ Management & Technol, Sch Pharm, Lahore, Punjab, Pakistan.
   [Khan, Muhammad Imran] Riphah Int Univ, Dept Pharm, Lahore, Punjab, Pakistan.
   [Iqbal, Azhar] Frontier Med & Dent Coll, Dept Operat Dent & Endodont, Abbottabad, Pakistan.
   [Iqbal, Azhar] Jouf Univ, Coll Dent, Dept Operat Dent & Endodont, Sakaka, Saudi Arabia.
   [Mehmood, Malik Hassan] Govt Coll Univ Faisalabad, Fac Pharmaceut Sci, Dept Pharmacol, Faisalabad, Punjab, Pakistan.
   [Masood, Imran] Islamia Univ Bahawalpur, Fac Pharm, Bahawalpur, Punjab, Pakistan.
RP Mallhi, TH; Khan, YH (corresponding author), Jouf Univ, Coll Pharm, Dept Clin Pharm, Sakaka, Saudi Arabia.
EM thhussain@ju.edu.sa; yhkhan@ju.edu.sa
RI Mallhi, Tauqeer Hussain/W-5155-2017; Iqbal, Azhar/AAE-3715-2022
OI Mallhi, Tauqeer Hussain/0000-0001-9957-5362; Iqbal,
   Azhar/0000-0002-4769-6653; Butt, Muhammad Hammad/0000-0003-4387-1351
FU Deanship of Scientific Research at Jouf University [DSR-2021-01-0341]
FX This work was funded by Deanship of Scientific Research at Jouf
   University under grant number (DSR-2021-01-0341).
CR Butt MH, 2021, DISASTER MED PUBLIC, DOI 10.1017/dmp.2021.55
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Maheshwari S, 2020, J ACUTE DIS, V9, P100, DOI 10.4103/2221-6189.283886
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Misbah S, 2020, JCPSP-J COLL PHYSICI, V30, pS9, DOI [10.29271/jcpsp.2020.Supp2.S9, 10.29271/jcpsp.2020.Supp1.S9]
   Muhammad K, 2021, DISASTER MED PUBLIC, DOI 10.1017/dmp.2021.54
   Olum R, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/19847
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Saleem RT, 2021, LAT AM J PHARM, V40, P1946
   Salman Muhammad, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.397
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 12
TC 0
Z9 0
U1 2
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
AR PII S1935789322000015
DI 10.1017/dmp.2022.1
EA JAN 2022
PG 4
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZJ2UL
UT WOS:000762165200001
PM 35000664
OA Green Published
DA 2022-04-20
ER

PT J
AU Cyfert, S
   Glabiszewski, W
   Zastempowski, M
AF Cyfert, Szymon
   Glabiszewski, Waldemar
   Zastempowski, Maciej
TI Impact of Management Tools Supporting Industry 4.0 on the Importance of
   CSR during COVID-19. Generation Z
SO ENERGIES
LA English
DT Article
DE CSR; management tools; Industry 4; 0; COVID-19; Gen Z
ID CORPORATE SOCIAL-RESPONSIBILITY; CHALLENGES; PERCEPTIONS; PERFORMANCE;
   ATTITUDES; GENDER; FIRMS
AB Taking into account the impact of the COVID-19 and adopting the assessment optics of students from Generation Z currently entering the labor market, we have made the aim of this article to provide better insight into the relationship between Industry 4.0 and corporate social responsibility. The survey was conducted in the form of an online survey in two leading universities in Poland in the field of economic education. 646 students took part in the survey. The data were analyzed using logit regression models. The results of the study suggest that the increase in the use of management solutions supporting Industry 4.0 in the wake of the COVID-19 crisis will increase the importance of the economic, social, and environmental dimensions of corporate social responsibility. Pointing to the forecasted increase importance of corporate social responsibility, we suggest linking management solutions supporting Industry 4.0 with corporate social responsibility. However, we also draw attention to the impact of individual management solutions supporting Industry 4.0 on specific Corporate Social Responsibility (CSR) dimensions.
C1 [Cyfert, Szymon] Poznan Univ Econ & Business, Inst Management, Al Niepodleglosci 10, PL-61875 Poznan, Poland.
   [Glabiszewski, Waldemar; Zastempowski, Maciej] Nicolaus Copernicus Univ Torun, Fac Econ Sci & Management, Ul Gagarina 13a, PL-87100 Torun, Poland.
RP Cyfert, S (corresponding author), Poznan Univ Econ & Business, Inst Management, Al Niepodleglosci 10, PL-61875 Poznan, Poland.
EM s.cyfert@ue.poznan.pl; waldemar.glabiszewski@umk.pl; mz@umk.pl
RI Zastempowski, Maciej/E-7792-2014
OI Zastempowski, Maciej/0000-0001-8196-3236; Cyfert,
   Szymon/0000-0002-5563-1403
FU NCBiR [POWR.03.01.00-00-O001/17, 01/09/2018-31/08/2021]
FX This study was carried out as part of the project Directions of Changes
   in the Management of Companies in the COVID-19 crisis carried out under
   the NCBiR grant No. POWR.03.01.00-00-O001/17, entitled "Competences in
   process improvement with the use of ICT tools", implemented by the
   Nicolaus Copernicus University in Toru in the period:
   01/09/2018-31/08/2021, under the Operational Program Knowledge Education
   Development (Priority axis: III. Higher education for economy and
   development; Action: 3.1. Competences in higher education). The authors
   would like to thank all students participating in the survey for their
   contribution in completing the questionnaire.
CR Aguilera RV, 2007, ACAD MANAGE REV, V32, P836, DOI 10.5465/AMR.2007.25275678
   Aguinis H, 2010, ORG RESPONSIBILITY D, P855
   Aguinis H, 2020, MANAG RES, V18, P421, DOI 10.1108/MRJIAM-06-2020-1053
   Alferaih A, 2020, SOC RESPONSIB J, V16, P1357, DOI 10.1108/SRJ-08-2018-0197
   Ardanza A, 2019, INT J PROD RES, V57, P4045, DOI 10.1080/00207543.2019.1572932
   Ariker C, 2017, KAFKAS UNIV VET FAK, DOI [10.9775/kauiibfd.2017.023, DOI 10.9775/KAUIIBFD.2017.023]
   Attar M., 2020, AGILE BUSINESS LEADE, P171, DOI [10.1108/978-1-80043-380-920201011, DOI 10.1108/978-1-80043-380-920201011]
   Baden D., 2016, INT J CORPORATE SOC, V1, P8, DOI [10.1186/s40991-016-0008-2, DOI 10.1186/S40991-016-0008-2]
   Benlemlih M, 2018, J BUS ETHICS, V148, P647, DOI 10.1007/s10551-016-3020-2
   Bhattacharya A, 2020, EUR J MARKETING, V54, P2049, DOI 10.1108/EJM-01-2019-0088
   Bibby L, 2018, PROD PLAN CONTROL, V29, P1030, DOI 10.1080/09537287.2018.1503355
   Brown ME, 2002, LEADERSHIP QUART, V13, P397, DOI 10.1016/S1048-9843(02)00123-6
   Calabrese A, 2022, PROD PLAN CONTROL, V33, P492, DOI 10.1080/09537287.2020.1830315
   Calabrese A, 2021, PROD PLAN CONTROL, V32, P213, DOI 10.1080/09537287.2020.1719715
   Carroll A.B., 1991, BUS HORIZONS, V34, P39, DOI [10.1016/0007-6813(91)90005-G, DOI 10.1016/0007-6813(91)90005-G]
   Chia Y., 1995, J BUSINESS FINANCE A, V22, P811, DOI DOI 10.1111/J.1468-5957.1995.TB00390.X
   Chiarini A, 2020, PROD PLAN CONTROL, V31, P1385, DOI 10.1080/09537287.2019.1710304
   Chillakuri B, 2020, J ORGAN CHANGE MANAG, V33, P1277, DOI 10.1108/JOCM-02-2020-0058
   Conforto EC, 2016, J ENG TECHNOL MANAGE, V40, P1, DOI 10.1016/j.jengtecman.2016.02.003
   Coombs T, 2015, CORP COMMUN, V20, P144, DOI 10.1108/CCIJ-10-2013-0078
   Cucari N, 2018, CORP SOC RESP ENV MA, V25, P250, DOI 10.1002/csr.1452
   da Silva A, 2018, SOC RESPONSIB J, V16, P50, DOI 10.1108/SRJ-01-2018-0013
   Da Silva VL, 2020, INT J COMPUT INTEG M, V33, P325, DOI 10.1080/0951192X.2019.1699258
   Dahlsrud A, 2008, CORP SOC RESP ENV MA, V15, P1, DOI 10.1002/csr.132
   Delmotte J, 2008, PERS REV, V37, P543, DOI 10.1108/00483480810891673
   da Silva EHDR, 2019, PROC CIRP, V81, P240, DOI 10.1016/j.procir.2019.03.042
   Dirani KM, 2020, HUM RESOUR DEV INT, V23, P380, DOI 10.1080/13678868.2020.1780078
   Dubey R, 2017, J CLEAN PROD, V141, P56, DOI 10.1016/j.jclepro.2016.09.035
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   Ellouze D, 2020, MANAG FINANC, V46, P955, DOI 10.1108/MF-11-2018-0575
   Epstein M.J., 2018, MAKING SUSTAINABILIT
   Fatorachian H, 2018, PROD PLAN CONTROL, V29, P633, DOI 10.1080/09537287.2018.1424960
   Fehre K, 2016, MANAG RES REV, V39, P1410, DOI 10.1108/MRR-03-2015-0063
   Fox C, 2020, MANAGE DECIS, V58, P2213, DOI 10.1108/MD-08-2020-1073
   Ghobakhloo M, 2020, J CLEAN PROD, V252, DOI 10.1016/j.jclepro.2019.119869
   GOVINDARAJAN V, 1986, ACAD MANAGE REV, V11, P844, DOI 10.2307/258401
   Hamzeh R, 2018, PROCEDIA MANUF, V26, P49, DOI 10.1016/j.promfg.2018.07.007
   Haseeb M, 2019, SOC SCI-BASEL, V8, DOI 10.3390/socsci8050154
   Haski-Leventhal D, 2017, J BUS ETHICS, V146, P219, DOI 10.1007/s10551-015-2936-2
   Hermann M, 2016, P ANN HICSS, P3928, DOI 10.1109/HICSS.2016.488
   Hermawati A, 2021, VINE J INF KNOWL MAN, V51, P92, DOI 10.1108/VJIKMS-08-2019-0121
   Hopkins Michael, 1999, PLANETARY BARGAIN
   Hur WM, 2016, CORP SOC RESP ENV MA, V23, P345, DOI 10.1002/csr.1380
   Izzo MF, 2018, SOC RESPONSIB J, V14, P633, DOI 10.1108/SRJ-08-2017-0148
   Jayakumar T., 2017, J WORK-APPL MANAG, V9, P51, DOI [10.1108/JWAM-02-2017-0004, DOI 10.1108/JWAM-02-2017-0004]
   Kim M, 2019, J COMMUN MANAG, V23, P427, DOI 10.1108/JCOM-01-2019-0009
   Kim S, 2020, CORP COMMUN, V25, P299, DOI 10.1108/CCIJ-07-2018-0077
   Klein J, 2004, INT J RES MARK, V21, P203, DOI 10.1016/j.ijresmar.2003.12.003
   Knaut A., 2017, SUSTAINABILITY DIGIT, P249, DOI DOI 10.1007/978-3-319-54603-2
   KNIGHT RF, 1999, COPORATE REPUTATION, V2, P363, DOI DOI 10.1057/PALGRAVE.CRR.1540092
   Kylaheiko K., 2020, TECHNICAL EC SOC EFF, P169
   Lanier K, 2017, STRATEGIC HR REV, V16, P288
   Li Jin-Hai, 2003, Business Process Management Journal, V9, P170, DOI 10.1108/14637150310468380
   Lu Y, 2017, J IND INF INTEGR, V6, P1, DOI 10.1016/j.jii.2017.04.005
   Mahdiraji HA, 2020, ECON RES-EKON ISTRAZ, V33, P1600, DOI 10.1080/1331677X.2020.1753090
   Mahmud M, 2020, J CLEAN PROD, V264, DOI 10.1016/j.jclepro.2020.121633
   Mercade-Mele P, 2018, J BUS ECON MANAG, V19, P431, DOI 10.3846/jbem.2018.5203
   Meski O, 2019, PROC CIRP, V84, P118, DOI 10.1016/j.procir.2019.04.250
   Miskiewicz R, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145776
   Moeuf A, 2018, INT J PROD RES, V56, P1118, DOI 10.1080/00207543.2017.1372647
   Mourtzis D, 2018, PROC CIRP, V70, P368, DOI 10.1016/j.procir.2018.02.045
   Muethel M, 2010, J INT MANAG, V16, P234, DOI 10.1016/j.intman.2010.06.003
   Muller A., 2006, European Management Journal, V24, P189, DOI 10.1016/j.emj.2006.03.008
   Oztemel E, 2020, J INTELL MANUF, V31, P127, DOI 10.1007/s10845-018-1433-8
   Pereira T, 2017, PROCEDIA MANUF, V13, P1253, DOI 10.1016/j.promfg.2017.09.047
   Potluri RM, 2022, J ISLAMIC MARK, V13, P763, DOI 10.1108/JIMA-07-2020-0197
   Pravadelli Cunha Tairine, 2020, TQM Journal, V32, P741, DOI 10.1108/TQM-10-2019-0249
   Robertson D, 1992, J ENG TECHNOL MANAG, V9, P87, DOI [10.1016/0923-4748(92)90013-U, DOI 10.1016/0923-4748(92)90013-U]
   Rocha CF, 2019, TECHNOL ANAL STRATEG, V31, P1474, DOI 10.1080/09537325.2019.1628938
   Rojko Andreja, 2017, International Journal of Interactive Mobile Technologies, V11, P77, DOI 10.3991/ijim.v11i5.7072
   Seles BMRP, 2018, J ORGAN CHANGE MANAG, V31, P4, DOI 10.1108/JOCM-05-2017-0159
   Rosin F, 2020, INT J PROD RES, V58, P1644, DOI 10.1080/00207543.2019.1672902
   Santos C, 2017, PROCEDIA MANUF, V13, P972, DOI 10.1016/j.promfg.2017.09.093
   Sarkar S, 2016, J KNOWL ECON, V7, P1000, DOI 10.1007/s13132-016-0415-3
   Scavarda A, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11185130
   Schneider P, 2018, REV MANAG SCI, V12, P803, DOI 10.1007/s11846-018-0283-2
   Seeger MW, 2005, J ORGAN CHANGE MANAG, V18, P78, DOI 10.1108/09534810510579869
   Self TT, 2019, INT J CONTEMP HOSP M, V31, P4126, DOI 10.1108/IJCHM-11-2018-0915
   Shamsie J, 2009, STRATEGIC MANAGE J, V30, P1440, DOI 10.1002/smj.789
   Shi Z, 2020, SYST RES BEHAV SCI, V37, P607, DOI 10.1002/sres.2704
   Sinn H.-W, 2004, DILEMMA GLOBALISATIO, V100
   Snieska V, 2020, J BUS ECON MANAG, V21, P1269, DOI 10.3846/jbem.2020.12279
   Sony M, 2020, PROD PLAN CONTROL, V31, P799, DOI 10.1080/09537287.2019.1691278
   Souto B., 2009, INT J EC SCI APPL RE, V1, P36
   Stekelorum R., 2018, SUPPLY CHAIN FORUM I, V19, P233, DOI 10.1080/16258312.2018.1497922
   Teixeira A, 2018, INT REV PUB NON MARK, V15, P235, DOI 10.1007/s12208-018-0199-1
   Tesfom G, 2008, SOC RESPONSIB J, V4, P428, DOI 10.1108/17471110810909849
   Theotokas I., 2011, INT J MARKETING STUD, V3, P2, DOI DOI 10.5539/IJMS.V3N1P2
   Thompson G, 2009, LECT NOTES BUS INF P, V29, P1
   Trotta D, 2018, 2018 7TH INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY AND MANAGEMENT (ICITM 2018), P113, DOI 10.1109/ICITM.2018.8333930
   Tsoy M, 2021, INFORM SYST MANAGE, V38, P324, DOI 10.1080/10580530.2020.1818899
   Turner, 2015, J INDIV PSYCHOL, V71, P103, DOI [10.1353/JIP.2015.0021, DOI 10.1353/JIP.2015.0021, 10.1353/jip.2015.0021]
   Ugwuozor FO, 2020, BUS ETHICS, V29, P737, DOI 10.1111/beer.12306
   Ustundag A, 2018, SPRINGER SER ADV MAN, P1, DOI 10.1007/978-3-319-57870-5
   van Marrewijk M, 2003, J BUS ETHICS, V44, P95, DOI 10.1023/A:1023331212247
   Veile JW, 2020, J MANUF TECHNOL MANA, V31, P977, DOI 10.1108/JMTM-08-2018-0270
   Voegtlin C, 2012, J BUS ETHICS, V105, P1, DOI 10.1007/s10551-011-0952-4
   Wang L, 2018, J STRATEGY MANAG, V11, P52, DOI 10.1108/JSMA-11-2016-0083
   Winter SG, 2003, STRATEGIC MANAGE J, V24, P991, DOI 10.1002/smj.318
   Ying Ling Cheuk, 2018, Academy of Asian Business Review, V4, P25, DOI 10.26816/aabr.4.2.201812.25
   Zafar MB, 2020, INT J ISLAMIC MIDDLE, V13, P357, DOI 10.1108/IMEFM-05-2019-0227
NR 101
TC 9
Z9 9
U1 5
U2 18
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1996-1073
J9 ENERGIES
JI Energies
PD MAR
PY 2021
VL 14
IS 6
AR 1642
DI 10.3390/en14061642
PG 13
WC Energy & Fuels
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Energy & Fuels
GA RE8NC
UT WOS:000634406300001
OA gold
DA 2022-04-20
ER

PT J
AU Eriksson, E
   Gadolin, C
   Lindahl, G
   Alexandersson, P
   Eriksson, J
AF Eriksson, Erik
   Gadolin, Christian
   Lindahl, Goran
   Alexandersson, Patrik
   Eriksson, Johanna
TI Public management in turbulent times: COVID-19 as an ecosystem disruptor
SO AUSTRALIAN JOURNAL OF PUBLIC ADMINISTRATION
LA English
DT Article
DE COVID-19; ecosystem; healthcare; public service logic; resource
   integration
ID VALUE CO-CREATION; HEALTH-CARE; COPRODUCTION; GOVERNANCE; INNOVATION;
   SERVICES; IDENTITY; QUALITY; PEOPLE
AB The decentralisation of Swedish healthcare closer to citizens has been slow. Drawing from empirical material of the reform prior and amidst the COVID-19 pandemic, this paper argues that the pandemic has disrupted the healthcare ecosystem. Consequently, citizen-centred collaborations have accelerated integration of resources (such as knowledge and skills) across organisational, hierarchical and professional borders. However, collaborations have been delimited to traditional healthcare providers, neglecting the resources of citizens and other actors to be used to improve service delivery. The pandemic has revealed strengths and weaknesses with the prevailing healthcare ecosystem that post-COVID-19 public management must address, both theoretically and practically. Theoretically, the paper contributes to the development of a public service logic, addressing both strengths and difficulties with the logic in turbulent times. Practically, the empirical descriptions contribute to improved understanding of public service delivery reform and how it is impacted during the pandemic.
C1 [Eriksson, Erik; Alexandersson, Patrik] Chalmers Univ Technol, Ctr Healthcare Improvement, Dept Technol Management & Econ, Div Serv Management & Logist, SE-41296 Gothenburg, Sweden.
   [Eriksson, Erik] Univ Boras, Dept Work Life & Social Welf, Boras, Sweden.
   [Gadolin, Christian] Univ West, Dept Hlth Sci, Trollhattan, Sweden.
   [Lindahl, Goran; Eriksson, Johanna] Chalmers Univ Technol, Ctr Healthcare Architecture, Dept Architecture & Civil Engn, Div Bldg Design, Gothenburg, Sweden.
RP Eriksson, E (corresponding author), Chalmers Univ Technol, Ctr Healthcare Improvement, Dept Technol Management & Econ, Div Serv Management & Logist, SE-41296 Gothenburg, Sweden.
EM erik.eriksson@chalmers.se
OI Gadolin, Christian/0000-0003-2476-4411
FU Region Vastra Gotaland
FX Swedish Association of LocalAuthorities andRegions; Region Vastra
   Gotaland
CR Agranoff R., 2004, COLLABORATIVE PUBLIC
   Akaka MA, 2013, J INT MARKETING, V21, P1, DOI 10.1509/jim.13.0032
   Alford J, 2016, PUBLIC MANAG REV, V18, P673, DOI 10.1080/14719037.2015.1111659
   Alvesson M, 2003, ACAD MANAGE REV, V28, P13, DOI 10.2307/30040687
   Alvesson M, 2012, HUM RELAT, V65, P367, DOI 10.1177/0018726711430555
   Ansell C, 2008, J PUBL ADM RES THEOR, V18, P543, DOI 10.1093/jopart/mum032
   Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Ansell C, 2018, PERSPECT PUBLIC MAN, V1, P43, DOI 10.1093/ppmgov/gvx013
   Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046
   Bauman Zygmunt, 2000, LIQUID MODERNITY
   Bouckaert G., 2017, PUBLIC MANAGEMENT RE
   Bryson J, 2017, PUBLIC MANAG REV, V19, P640, DOI 10.1080/14719037.2016.1192164
   Chowdhury IN, 2016, IND MARKET MANAG, V55, P97, DOI 10.1016/j.indmarman.2016.02.016
   Christensen CM, 2018, J MANAGE STUD, V55, P1043, DOI 10.1111/joms.12349
   Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241
   Christensen Tom., 2012, MEIJI J POLITICAL SC, V1, P1
   Clarke J, 2013, COMMUN CULT CRIT, V6, P208, DOI 10.1111/cccr.12011
   Cluley V, 2021, PUBLIC MONEY MANAGE, V41, P656, DOI 10.1080/09540962.2020.1737392
   Corley KG, 2004, ADMIN SCI QUART, V49, P173
   Crosby BC, 2017, PUBLIC MANAG REV, V19, P655, DOI 10.1080/14719037.2016.1192165
   Doolin B, 2002, ORGAN STUD, V23, P369, DOI 10.1177/0170840602233003
   du Gay, 2000, PRAISE BUREAUCRACY W
   Dudau A, 2019, PUBLIC MANAG REV, V21, P1577, DOI 10.1080/14719037.2019.1653604
   Dunleavy P, 2006, J PUBL ADM RES THEOR, V16, P467, DOI 10.1093/jopart/mui057
   Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008
   Engen M, 2021, PUBLIC MANAG REV, V23, P886, DOI 10.1080/14719037.2020.1720354
   Eriksson E, 2021, BRIT J MANAGE, V32, P456, DOI 10.1111/1467-8551.12414
   Eriksson E, 2020, PUBLIC MANAG REV, V22, P791, DOI 10.1080/14719037.2019.1604793
   Eriksson EM, 2019, PUBLIC MANAG REV, V21, P291, DOI 10.1080/14719037.2018.1487575
   Geuijen K, 2017, PUBLIC MANAG REV, V19, P621, DOI 10.1080/14719037.2016.1192163
   Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151
   Greenwood D.J., 2007, INTRO ACTION RES SOC
   Gronroos C, 2019, PUBLIC MANAG REV, V21, P775, DOI 10.1080/14719037.2018.1529879
   Hardyman W, 2015, PUBLIC MANAG REV, V17, P90, DOI 10.1080/14719037.2014.881539
   Jacquez F, 2013, AM J COMMUN PSYCHOL, V51, P176, DOI 10.1007/s10464-012-9533-7
   Jarvi H, 2018, SCAND J MANAG, V34, P63, DOI 10.1016/j.scaman.2018.01.002
   Jorgensen TB, 2007, ADMIN SOC, V39, P354, DOI 10.1177/0095399707300703
   Kinder T, 2022, PUBLIC MANAG REV, V24, P8, DOI 10.1080/14719037.2020.1786149
   Klijn EH, 2012, POLICY POLIT, V40, P587, DOI 10.1332/030557312X655431
   Leite H, 2021, AUST J PUBL ADMIN, V80, P300, DOI 10.1111/1467-8500.12473
   Lincoln Y.S., 1985, NATURALISTIC INQUIRY
   Malmmose M, 2015, CRIT PERSPECT ACCOUN, V27, P144, DOI 10.1016/j.cpa.2014.05.002
   Mandell M, 2008, PUBLIC MANAG REV, V10, P715, DOI 10.1080/14719030802423079
   Martin-Howard S, 2020, PUBLIC ADMIN REV, V80, P839, DOI 10.1111/puar.13265
   Mattei P, 2006, PUBLIC ADMIN, V84, P1007, DOI 10.1111/j.1467-9299.2006.00624.x
   Melchiorre MG, 2018, HEALTH POLICY, V122, P53, DOI 10.1016/j.healthpol.2017.08.006
   Mintzberg H., 2015, RADICAL RENEWAL LEFT
   Mintzberg H., 2017, MANAGING MYTHS HLTH
   Morgan DL, 1996, ANNU REV SOCIOL, V22, P129, DOI 10.1146/annurev.soc.22.1.129
   Morgan S, 2012, J HOLIST NURS, V30, P6, DOI 10.1177/0898010111412189
   Moynihan D, 2015, J PUBL ADM RES THEOR, V25, P43, DOI 10.1093/jopart/muu009
   Normann R., 2001, REFRAMING BUSINESS M
   Olsson E, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0062-x
   Osborne Stephen., 2020, PUBLIC SERVICE LOGIC
   Osborne SP, 2015, BRIT J MANAGE, V26, P424, DOI 10.1111/1467-8551.12094
   PARASURAMAN A, 1985, J MARKETING, V49, P41, DOI 10.2307/1251430
   Petrescu M, 2019, PUBLIC MANAG REV, V21, P1733, DOI 10.1080/14719037.2019.1619811
   Pierre, 2017, NEXT PUBLIC ADM DEBA
   Pierre J, 2020, POLICY SOC, V39, P478, DOI 10.1080/14494035.2020.1783787
   Ple L, 2010, J SERV MARK, V24, P430, DOI 10.1108/08876041011072546
   Provan KG, 2008, J PUBL ADM RES THEOR, V18, P229, DOI 10.1093/jopart/mum015
   Radnor Z, 2014, PUBLIC MANAG REV, V16, P402, DOI 10.1080/14719037.2013.848923
   Rauhaus BM, 2020, AM REV PUBLIC ADM, V50, P668, DOI 10.1177/0275074020942079
   Sch?n, 1983, REFLECTIVE PRACTITIO, V5126
   Skalen P, 2018, AUST J PUBL ADMIN, V77, P700, DOI 10.1111/1467-8500.12308
   Sorensen E, 2011, ADMIN SOC, V43, P842, DOI 10.1177/0095399711418768
   Statens offentlig utredningar SOU, 2020, ELD CAR PAND INT REP
   Statens offentliga utredningar SOU, 2016, EFFEKTIV V RD
   Statens offentliga utredningar SOU, 2020, GOD NAR VARD REF HAL
   Thomsson, 2010, REFLEXIVA INTERVJUER
   V?rdanalys, 2014, VARD UR PAT PERSP JA
   Vargo S.L., 2012, SERV SCI, V4, P207, DOI DOI 10.1287/SERV.1120.0019
   Vargo SL, 2016, J ACAD MARKET SCI, V44, P5, DOI 10.1007/s11747-015-0456-3
NR 73
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0313-6647
EI 1467-8500
J9 AUST J PUBL ADMIN
JI Aust. J. Public Adm.
PD DEC
PY 2021
VL 80
IS 4
BP 732
EP 747
DI 10.1111/1467-8500.12525
EA NOV 2021
PG 16
WC Public Administration
WE Social Science Citation Index (SSCI)
SC Public Administration
GA YL5PI
UT WOS:000721459900001
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Koc, Y
   Akyuz, S
   Aksit-Bicak, D
AF Koc, Yelda
   Akyuz, Serap
   Aksit-Bicak, Damla
TI Clinical Experience, Knowledge, Attitudes and Practice of Turkish
   Pediatric Dentists during the COVID-19 Pandemic
SO MEDICINA-LITHUANIA
LA English
DT Article
DE anxiety; behavior management; children; coronavirus; COVID-19; infection
   control; oral health; pediatric dentistry; personal protective
   equipment; questionnaire
ID CORONAVIRUS DISEASE 2019; MAXILLOFACIAL SURGERY; INFECTION-CONTROL;
   IMPACT; ORTHODONTISTS; PERCEPTION; AWARENESS
AB Background and Objectives: "Coronavirus Disease 2019 " (COVID-19) is a critical public health problem that has affected all fields, including dentistry. The dental management of children has become even more difficult during the COVID-19 pandemic. The purpose of this study was to evaluate the current knowledge, attitudes and practices of Turkish pediatric dentists who have been providing dental treatments to children during the COVID-19 pandemic. Materials and Methods: After receiving ethical approval, this cross-sectional study was conducted using the Google Forms online survey instrument. An online questionnaire link was sent to all the members of the Turkish Society of Paediatric Dentistry by e-mail and through social media. Statistical analyses were performed using descriptive statistics and Chi-square test; a p-value less than 0.05 was considered statistically significant. Results: A total of 200 pediatric dentists participated in this study and most of them (82%) only performed emergency dental treatments, whereas 18.5% performed both emergency and routine dental practices during the COVID-19 pandemic. The vast majority (72.5%) of pediatric dentists prescribed antibiotics and analgesics to their patients who were not cooperative with non-pharmacological behavior management techniques. The findings of the current study showed that the Turkish pediatric dentists had a good level of knowledge about COVID-19, satisfactorily conducted most of the infection control measures before and after the dental treatments, and attached importance to the use of PPEs; however, infection control measures during the dental treatments could be implemented better. Conclusions: Along with all precautions, the vaccination of healthcare workers and requesting a recent test result from patients showing a lack of COVID-19 disease before dental appointments could be used as effective infection control measures. Additionally, pediatric dentists should continue to follow local and universal guidelines, and education programmes should be frequently implemented in order to keep their COVID-19 management strategies up to date.
C1 [Koc, Yelda; Aksit-Bicak, Damla] Near East Univ, Fac Dent, Dept Pediat Dent, Mersin 10, TR-99138 Nicosia, Turkey.
   [Akyuz, Serap] Marmara Univ, Fac Dent, Dept Pediat Dent, TR-34854 Istanbul, Turkey.
RP Aksit-Bicak, D (corresponding author), Near East Univ, Fac Dent, Dept Pediat Dent, Mersin 10, TR-99138 Nicosia, Turkey.
EM kocyelda1994@gmail.com; sakyuz@marmara.edu.tr; damlaaksit@gmail.com
OI Aksit-Bicak, Damla/0000-0002-0375-9026
CR Acharya S, 2020, EUR J PAEDIATR DENT, V21, P173, DOI 10.23804/ejpd.2020.21.03.02
   Ahmed N, 2020, PAK J MED SCI, V36, pS49, DOI 10.12669/pjms.36.COVID19-S4.2704
   Al-Halabi M, 2020, EUR ARCH PAEDIATR DE, V21, P543, DOI 10.1007/s40368-020-00547-5
   Al-Khalifa KS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237630
   Alduraywish AA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207415
   Allevi F, 2020, BRIT J ORAL MAX SURG, V58, P692, DOI 10.1016/j.bjoms.2020.04.035
   Alsaleh Majd M, 2020, Int J Clin Pediatr Dent, V13, pS125, DOI 10.5005/jp-journals-10005-1885
   Ammar N, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02308-w
   Arora S, 2020, J MULTIDISCIP HEALTH, V13, P841, DOI 10.2147/JMDH.S268891
   Atas O, 2020, PEERJ, V8, DOI 10.7717/peerj.9575
   Ates AA, 2020, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0122
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Ayyed Ahmed Basheer, 2020, Int J Clin Pediatr Dent, V13, P279, DOI 10.5005/jp-journals-10005-1770
   Bahramian H, 2020, JDR CLIN TRANSL RES, V5, P307, DOI 10.1177/2380084420941503
   Banakar M, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01270-9
   Becker K, 2020, CLIN ORAL IMPLAN RES, V31, P1253, DOI 10.1111/clr.13676
   Bekes K, 2021, J MULTIDISCIP HEALTH, V14, P161, DOI 10.2147/JMDH.S285093
   Bellini P, 2021, MINERBA DENT ORAL SC, V70, P32, DOI [10.23736/S0026-4970.20.04430-1, 10.23736/S2724-6329.20.04430-1]
   Bhanushali P, 2020, INT J DENT, V2020, DOI 10.1155/2020/8817424
   Bonta G, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05842-x
   Cagetti MG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113835
   Cai XF, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00258
   Chen XC, 2020, CHIN J DENT RES, V23, P99, DOI 10.3290/j.cjdr.a44745
   Consolo U, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103459
   Cotrin P, 2020, AM J ORTHOD DENTOFAC, V158, P661, DOI 10.1016/j.ajodo.2020.06.028
   Candeiro GTD, 2020, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0117
   De Stefani A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113867
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Duruk G, 2020, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0054
   Esposito S, 2020, EUR J PEDIATR, V179, P1267, DOI 10.1007/s00431-020-03674-9
   Estrich CG, 2020, J AM DENT ASSOC, V151, P815, DOI 10.1016/j.adaj.2020.09.005
   Faccini Melissa, 2020, Eur J Dent, V14, pS14, DOI 10.1055/s-0040-1715990
   Falahchai M, 2020, SPEC CARE DENT, V40, P539, DOI 10.1111/scd.12523
   Ferrazzano GF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103642
   Gallagher JE, 2020, BRIT DENT J, V229, P121, DOI 10.1038/s41415-020-1843-9
   Hakim M, 2021, HEALTH SECUR, V19, P140, DOI 10.1089/hs.2020.0142
   Hua F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00481
   Huntley RE, 2020, J ORAL MAXIL SURG, V78, P1257, DOI 10.1016/j.joms.2020.05.026
   Ilyas N, 2020, BRIT DENT J, V228, P927, DOI 10.1038/s41415-020-1702-8
   Isiekwe IG, 2020, J WORLD FED ORTHOD, V9, P123, DOI 10.1016/j.ejwf.2020.07.001
   Izzetti R, 2021, ORAL DIS, V27, P694, DOI 10.1111/odi.13606
   Key Thomas, 2020, Bone Jt Open, V1, P131, DOI 10.1302/2633-1462.15.BJO-2020-0027.R1
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Kumar G., 2021, J S ASIAN ASS PEDIAT, V4, P34
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Limbu S., 2021, J NEPAL ASS PEDIAT D, V2, P3
   Luzzi V, 2021, INT J PAEDIATR DENT, V31, P20, DOI 10.1111/ipd.12737
   Maffia F, 2020, INT J ORAL MAX SURG, V49, P827, DOI 10.1016/j.ijom.2020.04.015
   Mallineni SK, 2020, INT J PAEDIATR DENT, V30, P245, DOI 10.1111/ipd.12653
   Martina S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124384
   Martinho FC, 2021, J ENDODONT, V47, P28, DOI 10.1016/j.joen.2020.10.002
   Maru V, 2020, J CLIN PEDIATR DENT, V44, P211, DOI 10.17796/1053-4625-44.4.1
   Melo Neto Clovis Lamartine de Moraes, 2020, Eur J Dent, V14, pS130, DOI 10.1055/s-0040-1716438
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   Moheb D, 2021, EGYPT DENT J, V67, P85, DOI [10.21608/edj.2020.51601.1370, DOI 10.21608/EDJ.2020.51601.1370]
   Nasser Z, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01273-6
   Nibali L, 2020, J DENT, V102, DOI 10.1016/j.jdent.2020.103481
   Patel M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05402
   Putrino A, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01187-3
   Quadri MFA, 2020, J INFECT PUBLIC HEAL, V13, P856, DOI 10.1016/j.jiph.2020.05.010
   Ren YF, 2020, JDR CLIN TRANSL RES, V5, P202, DOI 10.1177/2380084420924385
   Sa Y, 2021, J PROSTHET DENT, V126, P41, DOI 10.1016/j.prosdent.2020.06.004
   Sabino-Silva R, 2020, CLIN ORAL INVEST, V24, P1619, DOI 10.1007/s00784-020-03248-x
   Sah MK, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05620-4
   Sarfaraz S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030232
   Sezgin GP, 2021, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0112
   Sinjari B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165780
   Tahamtan A, 2020, EXPERT REV MOL DIAGN, V20, P453, DOI 10.1080/14737159.2020.1757437
   Ustun N, 2021, CLIN ORAL INVEST, V25, P6185, DOI 10.1007/s00784-021-03917-5
NR 70
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1010-660X
EI 1648-9144
J9 MEDICINA-LITHUANIA
JI Med. Lith.
PD NOV
PY 2021
VL 57
IS 11
AR 1140
DI 10.3390/medicina57111140
PG 23
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XK2BI
UT WOS:000727276700001
PM 34833358
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Lin, H
   Hwang, YJ
AF Lin, Hui
   Hwang, Yujong
TI The effects of personal information management capabilities and
   social-psychological factors on accounting professionals'
   knowledge-sharing intentions: Pre and post COVID-19
SO INTERNATIONAL JOURNAL OF ACCOUNTING INFORMATION SYSTEMS
LA English
DT Article
DE Image; Knowledge-sharing intention; Loss of knowledge power; Personal
   information management capabilities; Reciprocity
ID ORGANIZATIONAL KNOWLEDGE; REPOSITORIES; REPUTATION; SYSTEMS; DESIGN
AB Given the increased emphasis on individual factors in knowledge management research, this study proposes a research model that examines the effects of personal information management capabilities and social-psychological factors on the knowledge-sharing intention of accounting professionals. The survey results from 136 accounting professionals reveal that both personal information management capabilities and perceived image can positively influence knowledgesharing behavior. Conversely, reciprocity and loss of knowledge power do not exhibit a significant role in knowledge-sharing intentions. The comparison analyses between pre- and postCOVID-19 sample groups indicate similar results for the hypothesized relationships while there are notable mean differences in knowledge sharing intention, image and information processing capabilities. This study extends current research by incorporating personal information management capabilities to examine the power of the "individual" in knowledge sharing and offers timely evidence of accounting professionals' personal knowledge management practices during the period of COVID-19. This study raises implications for researchers and practitioners interested in knowledge management in the accounting profession.
C1 [Lin, Hui; Hwang, Yujong] DePaul Univ, Sch Accountancy & MIS, Suite 6000,1 East Jackson Blvd, Chicago, IL 60604 USA.
RP Hwang, YJ (corresponding author), DePaul Univ, Sch Accountancy & MIS, Suite 6000,1 East Jackson Blvd, Chicago, IL 60604 USA.
EM hlin14@depaul.edu; yhwang1@depaul.edu
CR Alavi M., 2000, FRAMING DOMAINS IT M, P15
   Ba SL, 2001, INFORM SYST RES, V12, P225, DOI 10.1287/isre.12.3.225.9712
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Blau P., 1964, EXCHANGE POWER SOCIA
   Bock GW, 2009, J COMPUT INFORM SYST, V50, P95
   Bock GW, 2005, MIS QUART, V29, P87, DOI 10.2307/25148669
   Bontis N, 2007, MANAGE DECIS, V45, P1426, DOI 10.1108/00251740710828681
   CAPA, 2020, COVID 19 IMP CHALL F COVID 19 IMP CHALL F
   Chang HH, 2011, INFORM MANAGE-AMSTER, V48, P9, DOI 10.1016/j.im.2010.11.001
   Chaudhuri A, 2002, J ADVERTISING RES, V42, P33, DOI 10.2501/JAR-42-3-33-43
   Chin WW, 1998, QUANT METH SER, P295
   Chou TC, 2007, INFORM MANAGE-AMSTER, V44, P408, DOI 10.1016/j.im.2007.03.003
   Cockrell RC, 2018, J INF SYST, V32, P45, DOI 10.2308/isys-51677
   Curtis MB, 2018, J KNOWL MANAG, V22, P142, DOI 10.1108/JKM-03-2017-0097
   Davenport T., 1998, WORKING KNOWLEDGE OR
   Diamantopoulos A, 2001, J MARKETING RES, V38, P269, DOI 10.1509/jmkr.38.2.269.18845
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   He W, 2009, DECIS SUPPORT SYST, V46, P826, DOI 10.1016/j.dss.2008.11.007
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   HUBER GP, 1990, ACAD MANAGE REV, V15, P47, DOI 10.2307/258105
   Hwang Y, 2016, ASLIB J INFORM MANAG, V68, P138, DOI 10.1108/AJIM-06-2015-0093
   Kankanhalli A, 2005, MIS QUART, V29, P113, DOI 10.2307/25148670
   Lin HF, 2007, J INF SCI, V33, P135, DOI 10.1177/0165551506068174
   Lin H, 2014, COMPUT HUM BEHAV, V30, P191, DOI 10.1016/j.chb.2013.07.056
   Lin H, 2011, BEHAV RES ACCOUNT, V23, P147, DOI 10.2308/bria-10062
   Malone D., 2002, INT J ACCOUNT INF SY, V3, P111
   Molm L.D., 1997, COERCIVE POWER SOCIA
   Peters MD, 2018, INT J ACCOUNT INF SY, V29, P1, DOI 10.1016/j.accinf.2018.03.005
   Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452
   Rheinghold H., 2000, GLOBAL NETWORKS COMP, P57
   Ringle C.M., 2015, SMART PLS 3
   Simone S., 2020, KNOWLEDGE MANAGEMENT
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Wasko MM, 2005, MIS QUART, V29, P35, DOI 10.2307/25148667
   Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257
NR 36
TC 1
Z9 1
U1 9
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1467-0895
EI 1873-4723
J9 INT J ACCOUNT INF SY
JI Int. J. Account. Inf. Syst.
PD SEP
PY 2021
VL 42
AR 100522
DI 10.1016/j.accinf.2021.100522
EA JUL 2021
PG 11
WC Business; Business, Finance; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA UA3XR
UT WOS:000685095400001
DA 2022-04-20
ER

PT J
AU Dermitzakis, I
   Evangelidis, N
   Evangelidis, P
   Anestis, A
AF Dermitzakis, I
   Evangelidis, N.
   Evangelidis, P.
   Anestis, A.
TI Knowledge, attitudes, and perceptions regarding COVID-19 outbreak in
   Greece in September 2020: a cross-sectional web-based survey
SO HIPPOKRATIA
LA English
DT Article
DE Coronavirus disease 2019; COVID-19; knowledge; attitudes; perceptions;
   survey; Greece
AB Background: Decreasing the transmission rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is related to people's knowledge, attitudes, and perceptions towards the novel coronavirus. Our study investigated the above factors aiming at pandemic's successful management.
   Methods: A web-based survey was conducted among the general Greek population from 11th September to 7th October 2020 after institutional ethics approval, using a non-probability, convenience sampling method. The survey consisted of socio-demographic, knowledge, attitude, and perception questions towards coronavirus disease 2019 (COVID-19). Statistical analyses conducted were appropriate according to the type of variable and the research question.
   Results: We collected a total of 9,309 questionnaires with a completeness rate estimated at 98.3 %. The median knowledge score regarding COVID-19 was 72.7 %, exhibiting variation depending on socio-demographic subgroups. Individuals were better informed about coronavirus modes of transmission (86.4 %). The acceptance of the COVID-19 vaccine among the general population was 25.9 %, while 43 % of participants remained undecided about being vaccinated. A significant part of the respondents experienced a health issue for which they had to visit a hospital, but they did not do so due to the fear of possible infection by SARS-CoV-2.
   Conclusions: Our findings suggest a moderately high level of knowledge in the Greek population towards COVID-19 at the study time. Educational programs, health actions, and vaccination campaigns are essential for filling knowledge gaps in particular demographic groups, such as the low educated and over 65 years old people. Interventions may be needed for the National Healthcare System to recover citizens' confidence. Measures strengthening individual wellbeing and social solidarity during the pandemic should also be of high priority.
C1 [Dermitzakis, I; Evangelidis, N.; Evangelidis, P.; Anestis, A.] Aristotle Univ Thessaloniki, Fac Med, Lab Hyg Social & Prevent Med & Med Stat, Thessaloniki, Greece.
RP Dermitzakis, I (corresponding author), Aristotle Univ Thessaloniki, Fac Med, Lab Hyg Social & Prevent Med & Med Stat, Thessaloniki, Greece.
EM iasonasd@auth.gr
OI Dermitzakis, Iasonas/0000-0002-9134-1083
CR Anestis A, 2020, KNOWLEDGE ATTITUDES, DOI [10.1101/2020.12.19.20248550v1, DOI 10.1101/2020.12.19.20248550V1]
   [Anonymous], 2020, CURR STAT COV 19 OUT
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Bates BR, 2020, J COMMUN HEALTH, V45, P1158, DOI 10.1007/s10900-020-00916-7
   Center for clinical epidemiology and outcomes research, 2016, HOSP ACQUIRED INFECT
   Claude KM, 2018, LANCET, V392, P1399, DOI 10.1016/S0140-6736(18)32419-X
   Erfani A, 2020, B WORLD HEALTH ORGAN, V76, P648, DOI DOI 10.2471/BLT.20.256651
   Fountoulakis KN, 2021, J AFFECT DISORDERS, V279, P624, DOI 10.1016/j.jad.2020.10.061
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Hellenic Republic Ministry of Development and Investments, 2020, PLAN GRAD DE ESC RES
   Hellenic Statistical Authority, 2020, GREEC FIG
   Kourlaba G, 2021, GLOB HEALTH RES POL, V6, DOI 10.1186/s41256-021-00188-1
   Louvardi M, 2020, PALLIAT SUPPORT CARE, V18, P394, DOI 10.1017/S1478951520000528
   Luan RR, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.583971
   Min JW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244273
   Mouchtouri VA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238854
   National Public Health Organization, DAIL SURV REP COV 19
   Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6
   Nguyen Trang, 2011, Infect Drug Resist, V4, P197, DOI 10.2147/IDR.S23174
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Parlapani E, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00821
   Puspitasari IM, 2020, J MULTIDISCIP HEALTH, V13, P727, DOI 10.2147/JMDH.S265527
   Raosoft, SAMPL SIZ CALC
   Sypsa V, 2009, EUROSURVEILLANCE, V14, P2
   WHO, 2020, NOV COR 2019 NCOV SI
   World Health Organization, 2020, SURV TOOL GUID RAP S
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 27
TC 0
Z9 0
U1 0
U2 0
PU LITHOGRAPHIA
PI THESSALONIKI
PA ANTONIADIS I-PSARRAS TH G P, NEA REDESTOS, THESSALONIKI, 00000, GREECE
SN 1108-4189
J9 HIPPOKRATIA
JI Hippokratia
PY 2021
VL 25
IS 1
BP 15
EP 21
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA ZG9IN
UT WOS:000760564400003
PM 35221651
DA 2022-04-20
ER

PT J
AU Kutikuppala, LVS
   Kiran, ANS
   Suvvari, TK
AF Kutikuppala, Lakshmi Venkata Simhachalam
   Kiran, A. N. Syamasundara
   Suvvari, Tarun Kumar
TI Knowledge, attitude, and practices toward the COVID-19 pandemic among
   the indian general population: A cross-sectional survey
SO INDIAN JOURNAL OF RESPIRATORY CARE
LA English
DT Article
DE 2019-nCoV disease; COVID-19; COVID-19 pandemic; SARS-CoV-2 infection
AB Background: Coronavirus disease 2019 (COVID-19) disease is highly infectious, and fever, dry cough, fatigue, myalgia, and dyspnea are the main clinical symptoms of the disease. There is a necessity to understand the public's awareness of COVID-19 to facilitate the outbreak management of COVID-19 in India. Collection of knowledge, attitude, and practice (KAP) information regarding outbreaks has long been useful in apprising prevention, control, and mitigation measures during such outbreaks. Objectives: The study objective was to evaluate knowledge levels, prevailing attitudes, and practices among the general population of India about the COVID-19 pandemic and to rule out barriers concerned with practicing risk reduction behaviors. Methodology: A cross-sectional study was conducted online among the general population of India during the lockdown period. The KAP toward COVID-19/severe acute respiratory syndrome-coronavirus-2 infection and prevention were assessed by using a self-administered questionnaire with 32 questions. The KAP assessment was carried out by assigning scores to the variables. SPSS version 24.0 and Chi-square test were used for statistical analysis. Results: A total of 1292 people had participated in the survey, and their mean age was 29.43 years. Overall, 81% of the participants had good knowledge, 77% of the participants had a positive attitude, and 83.5% of the participants were following good practices. Nearly 94% of the participants are confident that India can overcome COVID-19, and 97.7% of the participants wore masks when they went out. Conclusion: Health education campaigns and awareness events targeting the general population can enhance knowledge and attitudes of the people to the pandemic and potentiate better practices in facing the crisis.
C1 [Kutikuppala, Lakshmi Venkata Simhachalam] Konaseema Inst Med Sci & Res Fdn, Amalapuram, India.
   [Suvvari, Tarun Kumar] Rangaraya Med Coll, Kakinada, Andhra Pradesh, India.
   [Kiran, A. N. Syamasundara] Govt Inst Med Sci, Dept Physiol, Greater Noida, Uttar Pradesh, India.
RP Suvvari, TK (corresponding author), Rangaraya Med Coll, Kakinada, Andhra Pradesh, India.
EM tarunkumarsuvvari234@gmail.com
RI Kutikuppala, L V Simhachalam/AAL-4124-2021; Suvvari, Tarun
   Kumar/AAN-5135-2021
OI Kutikuppala, L V Simhachalam/0000-0002-5685-6049; Suvvari, Tarun
   Kumar/0000-0003-0063-0339
CR Byanaku A., 2020, KNOWLEDGE ATTITUDES, DOI 10.1101/2020.04.26.20080820v2
   Chan EYY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2245-9
   Clements JM, 2020, KNOWLEDGE BEHAV COVI, DOI [10.1101/2020.03.31.20048967, DOI 10.1101/2020.03.31.20048967]
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Suvvari TK, 2020, J CURR RES SCI MED, V6, P3, DOI [10.4103/jcrsm.jcrsm_30_20, DOI 10.4103/JCRSM.JCRSM_30_20]
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 6
TC 2
Z9 2
U1 1
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2277-9019
EI 2321-4899
J9 INDIAN J RESPIR CARE
JI Indian J. Respir. Care
PD JAN-APR
PY 2021
VL 10
IS 1
BP 88
EP 92
DI 10.4103/ijrc.ijrc_73_20
PG 5
WC Respiratory System
WE Emerging Sources Citation Index (ESCI)
SC Respiratory System
GA QM3GC
UT WOS:000621669000017
OA gold
DA 2022-04-20
ER

PT J
AU Qalati, SA
   Ostic, D
   Fan, MY
   Dakhan, SA
   Vela, EG
   Zufar, Z
   Suho, JM
   Mei, JL
   Thuy, TTH
AF Qalati, Sikandar Ali
   Ostic, Dragana
   Fan, Mingyue
   Dakhan, Sarfaraz Ahmed
   Vela, Esthela Galvan
   Zufar, Zuhaib
   Suho, Jan Muhammmad
   Mei, Jinlan
   Thuy, Troung Thi Hong
TI The General Public Knowledge, Attitude, and Practices Regarding COVID-19
   During the Lockdown in Asian Developing Countries
SO INTERNATIONAL QUARTERLY OF COMMUNITY HEALTH EDUCATION
LA English
DT Article; Early Access
DE knowledge; attitude; practices; developing countries; the general
   public; lockdown; COVID-19
ID OUTBREAK; INDIA
AB The recent outbreak of coronavirus disease (COVID-19) is the worst global crisis. Since no successful treatment and vaccine have been reported, efforts to improve the public's knowledge, attitudes, and practices are critical to reducing the spread of COVID-19. This study aims to investigate the general public knowledge, attitude, and practices regarding COVID-19. A cross-sectional online survey was conducted in three developing countries (China, India, and Pakistan). The reason for choosing only three countries is to identify the cross-border effect statistically and data collection constraints. The IBM SPSS version 23.0 was used for descriptive, univariate, and multivariate analysis of the study. One thousand one hundred and sixty participants completed the study, one-quarter of them were female, and three-quarters were male. The study's findings evidenced that the knowledge and attitude correlation was 58.4% and between knowledge and practices 18.2%. Furthermore, the knowledge was found lower in females, among India and Pakistan, and people aged less and equivalent to 30 years. The attitudes among respondents were found poorer among unmarried females and India and Pakistan residents. While the practices found lower among employed, unemployed and, respondents had a bachelor's degree, and females reside in India. And future studies should focus on factors that influence the government regarding the imposition of lockdown, boost the economy in the pandemic, and motivate the general public to follow the health institution's instructions.
C1 [Qalati, Sikandar Ali; Zufar, Zuhaib; Suho, Jan Muhammmad] Jiangsu Univ, Sch Management, Dept Management, Zhenjiang, Jiangsu, Peoples R China.
   [Ostic, Dragana] Jiangsu Univ, Sch Finance & Econ, Dept Int Trade, Zhenjiang, Jiangsu, Peoples R China.
   [Fan, Mingyue] Jiangsu Univ, Sch Management, Dept Informat Management & Informat Syst, Zhenjiang, Jiangsu, Peoples R China.
   [Dakhan, Sarfaraz Ahmed] Sukkur IBA Univ, Dept Business Adm, Sindh, Pakistan.
   [Vela, Esthela Galvan] CETYS Univ, Escuela Adm & Negocios, Tijuana, Mexico.
   [Mei, Jinlan] Jiangsu Univ, Sch Law, Zhenjiang, Jiangsu, Peoples R China.
   [Thuy, Troung Thi Hong] Minnan Normal Univ, Sch Educ, Zhangzhou, Peoples R China.
RP Qalati, SA (corresponding author), Jiangsu Univ, Sch Management, 301 Xuefu Rd, Zhenjiang, Jiangsu, Peoples R China.
EM 5103180243@stmail.ujs.edu.cn
RI Fan, Mingyue/ABD-3909-2021; Qalati, Sikandar Ali/AAQ-3265-2020; Sohu,
   Jan Muhammad/AAV-6442-2020; Galván Vela, Esthela/AAA-3550-2022
OI Fan, Mingyue/0000-0001-9678-0205; Qalati, Sikandar
   Ali/0000-0001-7235-6098; Sohu, Jan Muhammad/0000-0001-6594-0157; Galván
   Vela, Esthela/0000-0002-8778-3989; Qalati, Dr Sikandar
   Ali/0000-0002-7451-6443; Ostic, Dragana/0000-0002-0469-1342
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Acharya R., 2020, COVID 19 RELATED KNO
   Ajzen I, 2005, HDB ATTITUDES
   Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015
   Alhomoud F, 2017, J INFECT CHEMOTHER, V23, P286, DOI 10.1016/j.jiac.2017.01.006
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bates BR, 2020, J COMMUN HEALTH, V45, P1158, DOI 10.1007/s10900-020-00916-7
   Chakraborty I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138882
   Chen Y, 2020, Zhonghua Yu Fang Yi Xue Za Zhi, V54, pE004, DOI 10.3760/cma.j.issn.0253-9624.2020.0004
   Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001
   Field A., 2017, DISCOVERING STAT USI, V5th ed.
   Glanz K, 2008, HLTH BEHAV HLTH ED T
   Gualano MR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134779
   Honarvar B, 2020, INT J PUBLIC HEALTH, V65, P731, DOI 10.1007/s00038-020-01406-2
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Lamba I, 2020, AM J EMERG MED, V38, P1528, DOI 10.1016/j.ajem.2020.04.026
   Lee DTS, 2006, J PSYCHOSOM RES, V61, P707, DOI 10.1016/j.jpsychores.2006.08.005
   Lee K., 2020, JOB LOSS BEHAV CHANG
   Margusino-Framinan L., 2020, EC EFFECTS CORONAVIR, V0, P1
   Mbirimtengerenji ND, 2007, CROAT MED J, V48, P605
   McDermott E, 2008, J PAIN SYMPTOM MANAG, V35, P583, DOI 10.1016/j.jpainsymman.2007.07.012
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Qalati SA., 2020, STAY HOME STAY SAFE
   Reinartz W, 2009, INT J RES MARK, V26, P332, DOI 10.1016/j.ijresmar.2009.08.001
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Sahin AR, 2020, EURASIAN J MED ONCOL, V4, P1, DOI 10.14744/ejmo.2020.12220
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Srichan P, 2020, KNOWLEDGE ATTITUDE P
   Tabachnick B., 2007, USING MULTIVARIATE S, V5
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   Usman IM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00340
   WHO, 2020, 91 WHO
   World Health Organisation W, 2020, COR DIS COVID 19 ADV
NR 38
TC 6
Z9 6
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0272-684X
EI 1541-3519
J9 INT Q COMMUNITY HEAL
JI Int. Q. Community Health Educ.
AR 0272684X211004945
DI 10.1177/0272684X211004945
EA APR 2021
PG 10
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA RL4VY
UT WOS:000638974100001
PM 33832371
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Zheng, WB
   Yan, L
   Gou, C
   Zhang, ZC
   Zhang, JJ
   Hu, M
   Wang, FY
AF Zheng, Wenbo
   Yan, Lan
   Gou, Chao
   Zhang, Zhi-Cheng
   Zhang, Jun J.
   Hu, Ming
   Wang, Fei-Yue
TI Learning to learn by yourself: Unsupervised meta-learning with
   self-knowledge distillation for COVID-19 diagnosis from pneumonia cases
SO INTERNATIONAL JOURNAL OF INTELLIGENT SYSTEMS
LA English
DT Article
DE biomedical imaging; COVID-19; knowledge distillation; meta-learning;
   unsupervised learning
ID AUTOMATIC DETECTION; IMAGES
AB The goal of diagnosing the coronavirus disease 2019 (COVID-19) from suspected pneumonia cases, that is, recognizing COVID-19 from chest X-ray or computed tomography (CT) images, is to improve diagnostic accuracy, leading to faster intervention. The most important and challenging problem here is to design an effective and robust diagnosis model. To this end, there are three challenges to overcome: (1) The lack of training samples limits the success of existing deep-learning-based methods. (2) Many public COVID-19 data sets contain only a few images without fine-grained labels. (3) Due to the explosive growth of suspected cases, it is urgent and important to diagnose not only COVID-19 cases but also the cases of other types of pneumonia that are similar to the symptoms of COVID-19. To address these issues, we propose a novel framework called Unsupervised Meta-Learning with Self-Knowledge Distillation to address the problem of differentiating COVID-19 from pneumonia cases. During training, our model cannot use any true labels and aims to gain the ability of learning to learn by itself. In particular, we first present a deep diagnosis model based on a relation network to capture and memorize the relation among different images. Second, to enhance the performance of our model, we design a self-knowledge distillation mechanism that distills knowledge within our model itself. Our network is divided into several parts, and the knowledge in the deeper parts is squeezed into the shallow ones. The final results are derived from our model by learning to compare the features of images. Experimental results demonstrate that our approach achieves significantly higher performance than other state-of-the-art methods. Moreover, we construct a new COVID-19 pneumonia data set based on text mining, consisting of 2696 COVID-19 images (347 X-ray + 2349 CT), 10,155 images (9661 X-ray + 494 CT) about other types of pneumonia, and the fine-grained labels of all. Our data set considers not only a bacterial infection or viral infection which causes pneumonia but also a viral infection derived from the influenza virus or coronavirus.
C1 [Zheng, Wenbo] Xi An Jiao Tong Univ, Sch Software Engn, Xian, Peoples R China.
   [Zheng, Wenbo; Yan, Lan; Zhang, Jun J.; Wang, Fei-Yue] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China.
   [Yan, Lan] Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China.
   [Gou, Chao] Sun Yat Sen Univ, Sch Intelligent Syst Engn, Guangzhou, Peoples R China.
   [Zhang, Zhi-Cheng] Gen Hosp Peoples Liberat Army, Med Ctr 7, Beijing, Peoples R China.
   [Zhang, Jun J.] Wuhan Univ, Sch Elect Engn & Automat, Wuhan, Peoples R China.
   [Hu, Ming] Wuhan Pulm Hosp, Intens Care Unit, Wuhan, Peoples R China.
RP Wang, FY (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China.
EM feiyue.wang@ia.ac.cn
OI Gou, Chao/0000-0002-4128-886X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [61533019, 61806198, U1811463]; Key Research
   and Development Program of Guangzhou [202007050002]; National Key
   Research and Development Program [2018AAA0101502]; National Key RAMP;D
   Program of China [2020YFB1600400]
FX National Natural Science Foundation of China, Grant/Award Numbers:
   61533019, 61806198, U1811463; Key Research and Development Program of
   Guangzhou, Grant/Award Number: 202007050002; National Key Research and
   Development Program, Grant/Award Number: 2018AAA0101502; National Key
   R&D Program of China, Grant/Award Number: 2020YFB1600400
CR Adôrno Isa Félix, 2019, Radiol Bras, V52, P78, DOI 10.1590/0100-3984.2018.0030
   Afshar P, 2020, PATTERN RECOGN LETT, V138, P638, DOI 10.1016/j.patrec.2020.09.010
   Antoniou A., 2019, ARXIV PREPRINT ARXIV
   Asano YM., 2020, LABELLING UNLABELLED
   Banerjee A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010041
   Bertinetto L., 2019, META LEARNING DIFFER
   Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7
   Cao Y., 2020, DEV EVALUATION AI SY
   Castiglione A, 2021, IEEE T IND INFORM, V17, P6480, DOI 10.1109/TII.2021.3057524
   Chen C., IEEE T IND INFORM, V2021, P1
   Chen HX, 2020, INT J PATTERN RECOGN, V34, DOI [10.1080/00207454.2020.1858824, 10.1142/S0218001420580124]
   Chen RC, 2020, J ALLERGY CLIN IMMUN, V146, P89, DOI 10.1016/j.jaci.2020.05.003
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Cohen J.P., 2020, ARXIV PREPRINT ARXIV
   Dai LP, 2020, CELL, V182, P722, DOI 10.1016/j.cell.2020.06.035
   Das KM, 2015, AM J ROENTGENOL, V205, pW267, DOI 10.2214/AJR.15.14445
   Estrach JB., 2018, FEW SHOT LEARNING GR
   Faes L, 2019, LANCET DIGIT HEALTH, V1, pE232, DOI 10.1016/S2589-7500(19)30108-6
   Farooq, 2020, ARXIV PREPRINT ARXIV
   Finn C, 2017, PR MACH LEARN RES, V70
   Flennerhag S., 2020, METALEARNING WARPED
   Ge Y., 2020, MUTUAL MEAN TEACHING
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Gu XW, 2020, INT J INTELL SYST, V35, P923, DOI 10.1002/int.22230
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guo HT, 2020, IEEE J BIOMED HEALTH, V24, P457, DOI 10.1109/JBHI.2019.2946066
   Guo T., 2019, IEEE T NEURAL NETW L, P1
   He J., 2020, REVISITING SELF TRAI
   He K., 2016, P IEEE C COMPUTER VI, P770
   Hinton Geoffrey, 2015, NEURIPS DEEP LEARN R
   Hospedales T. M., 2020, ARXIV PREPRINT ARXIV
   Hsu K., 2019, UNSUPERVISED LEARNIN
   Huang GL, 2017, IEEE ICC
   Iandola F., 2014, ARXIV PREPRINT ARXIV
   Ikizler TA, 2020, NAT REV NEPHROL, V16, P311, DOI 10.1038/s41581-020-0280-y
   Isensee F, 2021, NAT METHODS, V18, P203, DOI 10.1038/s41592-020-01008-z
   Ji Z., 2019, ARXIV PREPRINT ARXIV
   Jia JSS, 2020, NATURE, V582, P389, DOI [10.1038/s41586-020-2284-y, 10.1109/LGRS.2020.3028443]
   Jung HG, 2020, IEEE T NEUR NET LEAR, V31, P4660, DOI 10.1109/TNNLS.2019.2957187
   Kahn J, 2020, INT CONF ACOUST SPEE, P7084, DOI 10.1109/ICASSP40776.2020.9054295
   Kanne JP, 2020, RADIOLOGY, V295, P16, DOI 10.1148/radiol.2020200241
   Khodadadeh S., 2019, UNSUPERVISED META LE, P10132
   Lai SJ, 2020, NATURE, V585, P410, DOI 10.1038/s41586-020-2293-x
   Lee DH., 2013, PSEUDO LABEL SIMPLE
   Lei JQ, 2020, RADIOLOGY, V295, P18, DOI 10.1148/radiol.2020200236
   Li HY, 2019, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2019.00009
   Li HY, 2019, PR MACH LEARN RES, V97
   Li JX, 2021, IEEE J BIOMED HEALTH, V25, P1336, DOI 10.1109/JBHI.2021.3058293
   Liang WH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17280-8
   Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033
   Lin TY, 2017, IEEE I CONF COMP VIS, P2999, DOI 10.1109/ICCV.2017.324
   Liu WY, 2016, PR MACH LEARN RES, V48
   Liu WJ, 2017, J IMMUNOL, V198, P873, DOI 10.4049/jimmunol.1601542
   Liu Y., 2019, LEARNING PROPAGATE L
   Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1
   Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621
   Mei XY, 2020, NAT MED, V26, P1224, DOI 10.1038/s41591-020-0931-3
   Mo XN, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01217-2020
   Movshovitz-Attias Y, 2017, IEEE I CONF COMP VIS, P360, DOI 10.1109/ICCV.2017.47
   Munkhdalai T, 2017, PR MACH LEARN RES, V70
   Niu L, 2017, IEEE T NEUR NET LEAR, V28, P1290, DOI 10.1109/TNNLS.2016.2518700
   Nobrega dRVM., 2018, NEURAL COMPUT APPL
   Ohata EF, 2021, IEEE-CAA J AUTOMATIC, V8, P239, DOI 10.1109/JAS.2020.1003393
   Olson G, 2020, JAMA-J AM MED ASSOC, V323, P885, DOI 10.1001/jama.2019.21118
   Oreshkin BN, 2018, ADV NEUR IN, V31
   Paluru N, 2021, IEEE T NEUR NET LEAR, V32, P932, DOI 10.1109/TNNLS.2021.3054746
   Pang JB, 2019, IEEE T NEUR NET LEAR, V30, P2397, DOI 10.1109/TNNLS.2018.2872997
   Park D.S., 2020, ARXIV200509629
   Passalis N, 2021, IEEE T NEUR NET LEAR, V32, P925, DOI 10.1109/TNNLS.2020.2979745
   Passalis N, 2019, IEEE T NEUR NET LEAR, V30, P946, DOI 10.1109/TNNLS.2018.2851924
   Qian Q, 2019, IEEE I CONF COMP VIS, P6459, DOI 10.1109/ICCV.2019.00655
   Qureshi HN., 2020, ARXIV PREPRINT ARXIV
   Ravi Sachin, 2017, ICLR
   Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975
   Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474
   Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682
   SDCT-AuxNet, 2020, MED IMAGE ANAL, V61
   Shamsi A, 2021, IEEE T NEUR NET LEAR, V32, P1408, DOI 10.1109/TNNLS.2021.3054306
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Simonyan K., 2014, ARXIV14091556
   Snell Jake, 2017, NEURAL INF PROCESS S, P4077
   Sohn K, 2016, ADV NEUR IN, V29
   Song HO, 2016, PROC CVPR IEEE, P4004, DOI 10.1109/CVPR.2016.434
   Souza JC, 2019, COMPUT METH PROG BIO, V177, P285, DOI 10.1016/j.cmpb.2019.06.005
   Sun J, 2020, CELL, V182, P734, DOI 10.1016/j.cell.2020.06.010
   Sun QR, 2019, PROC CVPR IEEE, P403, DOI 10.1109/CVPR.2019.00049
   Sung F, 2018, PROC CVPR IEEE, P1199, DOI 10.1109/CVPR.2018.00131
   Sygnowski J., 2019, METALEARNING LATENT
   Szegedy C, 2017, THIRTY-FIRST AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4278
   Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308
   Tan D., 2016, J THORACIC DIS, V8, P5
   Tan MX, 2019, PR MACH LEARN RES, V97
   Tang S., IEEE T IND INFORM, V2021, P1
   Taylor AG, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002697
   Tian LX, 2013, INT J INTELL SYST, V28, P242, DOI 10.1002/int.21567
   TiexinQin YS., 2020, UNSUPERVISED FEW SHO
   van de Haar J, 2020, NAT MED, V26, P665, DOI [10.1038/s41591-020-0874-8, 10.1038/s41591-020-0948-7]
   Vinyals Oriol, 2016, NEURIPS, V29
   Wang LD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76550-z
   Wang YQ, 2020, ACM COMPUT SURV, V53, DOI 10.1145/3386252
   Wang YX, 2019, IEEE I CONF COMP VIS, P9924, DOI 10.1109/ICCV.2019.01002
   Wang YX, 2016, LECT NOTES COMPUT SC, V9910, P616, DOI 10.1007/978-3-319-46466-4_37
   Wang YB, 2017, PROC CVPR IEEE, P2097, DOI 10.1109/CVPR.2017.226
   Wang YX., 2017, LEARNING MODEL TAIL, P7029
   Weitz JS, 2020, NAT MED, V26, P849, DOI 10.1038/s41591-020-0895-3
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   Wong ACP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020174
   Xie Q., 2020, QV SELF TRAINING NOI
   Xu TB, 2019, THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P5565
   Yalniz IZ., 2019, BILLION SCALE SEMI S
   Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7
   Ye HJ., 2020, FEW SHOT LEARNING VI
   Yun S., 2020, REGULARIZING CLASS W
   Zhang J., 2020, ARXIV PREPRINT ARXIV, P12338
   Zhang LF, 2019, IEEE I CONF COMP VIS, P3712, DOI 10.1109/ICCV.2019.00381
   Zhang RX, 2018, ADV NEUR IN, V31
   Zhang S., 2020, INT J RESP, DOI [10.3760/cma.j.cn131368-20200409-00266, DOI 10.3760/CMA.J.CN131368-20200409-00266]
   Zhang WS, 2021, IEEE INTERNET THINGS, V8, P15884, DOI 10.1109/JIOT.2021.3056185
   Zhang XN, 2020, NATURE, V583, P437, DOI 10.1038/s41586-020-2355-0
   Zhang Z., 2020, DISTILLING EFFECTIVE
   Zhao J., 2020, ARXIV PREPRINT ARXIV
   Zheng RH, 2021, EXP HEMATOL ONCOL, V10, DOI 10.1186/s40164-021-00202-9
   Zheng WB, 2019, LECT NOTES COMPUT SC, V11861, P115, DOI 10.1007/978-3-030-32692-0_14
   Zheng WB, 2019, IEEE INT CON MULTI, P1510, DOI 10.1109/ICME.2019.00261
   Zhou MH, 2006, J IMMUNOL, V177, P2138, DOI 10.4049/jimmunol.177.4.2138
   Zoph B., 2020, ARXIV PREPRINT ARXIV
NR 127
TC 3
Z9 3
U1 6
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-8173
EI 1098-111X
J9 INT J INTELL SYST
JI Int. J. Intell. Syst.
PD AUG
PY 2021
VL 36
IS 8
BP 4033
EP 4064
DI 10.1002/int.22449
EA MAY 2021
PG 32
WC Computer Science, Artificial Intelligence
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA TB9PI
UT WOS:000649729200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Khoiwal, K
   Kapur, D
   Gaurav, A
   Chaturvedi, J
AF Khoiwal, Kavita
   Kapur, Dhriti
   Gaurav, Amrita
   Chaturvedi, Jaya
TI Management of Pregnant Women in Times of Covid-19: A Review of Current
   Literature
SO JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA
LA English
DT Review
DE COVID-19; SARS-CoV; Pregnant women; Postpartum care
AB Abstarct COVID-19 is a Public Health Emergency of International Concern. Its impact on pregnant women is not yet clear owing to limited data and the knowledge is evolving in several aspects. Based on the available evidences, various clinical guidelines for management of COVID-19 have been formulated. This article intends to compile and summarise guidelines from esteemed organisations, along with their implication in the Indian scenario, and offers an easy tool for clinicians managing pregnant women in times of COVID-19.
C1 [Khoiwal, Kavita; Kapur, Dhriti; Gaurav, Amrita; Chaturvedi, Jaya] All India Inst Med Sci, Dept Obstet & Gynecol, Rishikesh, India.
RP Khoiwal, K (corresponding author), All India Inst Med Sci, Dept Obstet & Gynecol, Rishikesh, India.
EM kavita.kh27@gmail.com
OI Chaturvedi, Jaya/0000-0003-1222-4565; Khoiwal,
   Kavita/0000-0002-3156-7486
CR Al-Tawfiq JA, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101608
   CDC, 2020, COR DIS 2019 COVID 1
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   Gandhi A, 2020, FOGSI GCPR PREGNANCY
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Poon LC, 2020, INT J GYNECOL OBSTET, V149, P273, DOI 10.1002/ijgo.13156
   Royal College of Obstetricians and Gynaecologists, COR COVID 19 INF PRE
   The Indian Council for Medical Research, 2020, GUID MAN PREGN WOM C
   Wang LS, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105948
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 12
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0971-9202
EI 0975-6434
J9 J OBSTET GYN INDIA
JI J. Obstet. Gynecol. India
PD AUG
PY 2020
VL 70
IS 4
BP 262
EP 266
DI 10.1007/s13224-020-01342-4
EA JUL 2020
PG 5
WC Obstetrics & Gynecology
WE Emerging Sources Citation Index (ESCI)
SC Obstetrics & Gynecology
GA MP0WH
UT WOS:000546209400003
PM 32760170
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Wang, CS
   Gao, Y
   Kang, K
   Fei, DS
   Meng, XL
   Liu, HT
   Luo, YP
   Yang, W
   Dai, QQ
   Gao, Y
   Zhao, MY
   Yu, KJ
AF Wang, Chang-Song
   Gao, Yang
   Kang, Kai
   Fei, Dong-Sheng
   Meng, Xiang-Lin
   Liu, Hai-Tao
   Luo, Yun-Peng
   Yang, Wei
   Dai, Qing-Qing
   Gao, Yan
   Zhao, Ming-Yan
   Yu, Kai-Jiang
TI Standardization of critical care management of non-critically ill
   patients with COVID-19
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Review
DE Non-critically ill patients; COVID-19; SARS-CoV-2 infection;
   Standardized management; Isolation management; Hierarchical monitoring
   and intervention; Different management objectives
AB The large global outbreak of coronavirus disease 2019 (COVID-19) has seriously endangered the health care system in China and globally. The sudden surge of patients with severe acute respiratory syndrome coronavirus 2 infection has revealed the shortage of critical care medicine resources and intensivists. Currently, the management of non-critically ill patients with COVID-19 is performed mostly by non-intensive care unit (ICU) physicians, who lack the required professional knowledge, training, and practice in critical care medicine, especially in terms of continuous monitoring of the respiratory function, intervention, and feedback on treatment effects. This clinical problem needs an urgent solution. Therefore, here, we propose a series of clinical strategies for non-ICU physicians aimed at the standardization of the management of non-critically ill patients with COVID-19 from the perspective of critical care medicine. Isolation management is performed to facilitate the implementation of hierarchical monitoring and intervention to ensure the reasonable distribution of scarce critical care medical resources and intensivists, highlight the key patients, timely detection of disease progression, and early and appropriate intervention and organ function support, and thus improve the prognosis. Different management objectives are also set based on the high-risk factors and the severity of patients with COVID-19. The approaches suggested herein will facilitate the timely detection of disease progression, and thus ensure the provision of early and appropriate intervention and organ function support, which will eventually improve the prognosis.
C1 [Wang, Chang-Song; Liu, Hai-Tao] Harbin Med Univ, Dept Crit Care Med, Canc Hosp, Harbin 150081, Heilongjiang, Peoples R China.
   [Gao, Yang; Kang, Kai; Fei, Dong-Sheng; Meng, Xiang-Lin; Luo, Yun-Peng; Yang, Wei; Zhao, Ming-Yan; Yu, Kai-Jiang] Harbin Med Univ, Dept Crit Care Med, Affiliated Hosp 1, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China.
   [Dai, Qing-Qing] Harbin Med Univ, Dept Crit Care Med, Affiliated Hosp 2, Harbin 150086, Heilongjiang, Peoples R China.
   [Gao, Yan] Harbin Med Univ, Dept Crit Care Med, Affiliated Hosp 4, Harbin 150001, Heilongjiang, Peoples R China.
   [Yu, Kai-Jiang] Harbin Med Univ, Inst Crit Care Med, Sino Russian Med Res Ctr, Harbin 150081, Heilongjiang, Peoples R China.
RP Yu, KJ (corresponding author), Harbin Med Univ, Dept Crit Care Med, Affiliated Hosp 1, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China.
EM yukaijiang002@sina.com
RI Yang, Gao/AFT-7226-2022
OI wang, changsong/0000-0002-0079-5259
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81770276]; Nn10 Program of Harbin Medical
   University Cancer Hospital; Novel Coronavirus Pneumonia Emergency
   Treatment and Diagnosis Technology Research Project of Heilongjiang
   Provincial Science and Technology Department; Scientific Research
   Project of Heilongjiang Health and Family Planning Commission [2018086]
FX Supported by The National Natural Science Foundation of China, No.
   81770276; Nn10 Program of Harbin Medical University Cancer Hospital; and
   Novel Coronavirus Pneumonia Emergency Treatment and Diagnosis Technology
   Research Project of Heilongjiang Provincial Science and Technology
   Department and Scientific Research Project of Heilongjiang Health and
   Family Planning Commission, No. 2018086.
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Caruso D, 2020, WORLD J CLIN CASES, V8, P3177, DOI 10.12998/wjcc.v8.i15.3177
   Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230
   Dahan S, 2020, ISR MED ASSOC J, V22, P428
   Feng ZC, 2020, AGING DIS, V11, P1069, DOI 10.14336/AD.2020.0630
   Feng ZC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18786-x
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394
   Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951
   Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Pan Y., 2020, EXP LUNG RES, V30, P3306, DOI DOI 10.1080/01902148.2018.1479898
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Qiu HB, 2020, INTENS CARE MED, V46, P576, DOI 10.1007/s00134-020-05966-y
   Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722
   Tabatabaei SMH, 2020, EUR J RADIOL, V132, DOI 10.1016/j.ejrad.2020.109298
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang B, 2020, WORLD J CLIN CASES, V8, P5513, DOI 10.12998/wjcc.v8.i22.5513
   Yang CT, 2021, INT J CARDIOL, V326, P230, DOI 10.1016/j.ijcard.2020.09.048
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Ye Q, 2020, J MED VIROL, V92, P755, DOI 10.1002/jmv.25813
   Zhang J.J., 2020, China Allergy, V75, P1741, DOI 10.1111/all.14238
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490
NR 26
TC 0
Z9 0
U1 1
U2 1
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD APR 26
PY 2021
VL 9
IS 12
BP 2696
EP 2702
DI 10.12998/wjcc.v9.i12.2696
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA RT1QV
UT WOS:000644241600001
PM 33969052
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Viola, C
   Toma, P
   Manta, F
   Benvenuto, M
AF Viola, Carmine
   Toma, Pierluigi
   Manta, Francesco
   Benvenuto, Marco
TI The more you know, the better you act? Institutional communication in
   Covid-19 crisis management
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE Institutional communication; Health literacy; Covid-19; Crisis
   management; Risk communication; Community engagement
ID HEALTH LITERACY; INFORMATION QUALITY; RISK; EDUCATION; INTERNET;
   DISSEMINATION; STRATEGIES; PERCEPTION; KNOWLEDGE; CARE
AB The plurality of communication channels and the spread of fake news are widespread phenomena in today's society. Those constituted a serious risk during the Covid-19 pandemic crisis management, increasing the confusion among the population. This research aims at assessing the effectiveness of institutional communication amid the management of the Covid-19 pandemic crisis in Italy. We first assessed the phenomenon by building a structured theoretical background stressing the concepts of risk communication, community engagement, and health literacy, highlighting the dynamic and continuously changing scenario of communication strategies, also due to the spread of social media and the mutation of conventional media outlets. We sent a questionnaire to a sample of citizens to assess the impact of three predictors, i.e., the perceived communication, the perceived knowledge, and the perceived information. Based on answers, we built an ordered logit model assigning continuous intervals as values for the dependent variables. The observed results enhanced the crucial role of the phenomenon of health literacy and the impact of asymmetric information on the effectiveness of institutional communication. Education played a fundamental role in understanding communication pillars and building an individual consciousness about health risks prevention.
C1 [Viola, Carmine; Toma, Pierluigi; Benvenuto, Marco] Univ Salento, Dipartimento Sci Econ, Lecce, Italy.
   [Manta, Francesco] LUM G Degennaro Univ, Dept Management Finance & Technol, Bari, Italy.
RP Toma, P (corresponding author), Univ Salento, Dipartimento Sci Econ, Lecce, Italy.
EM carmine.viola@unisalento.it; pierluigi.toma@unisalento.it;
   manta.phdstudent@lum.it; marco.benvenuto@unisalento.it
OI Manta, Francesco/0000-0001-5632-7975; Benvenuto,
   Marco/0000-0003-3818-3124
FU Italian Ministry of University, Project PON Attraction and International
   Mobility [AIM1823220]
FX Pierluigi Toma received Research support from the Italian Ministry of
   University, Project PON Attraction and International Mobility, n.
   AIM1823220. The authors would like to thank the editor who managed the
   submission process of the mauscript and the reviewers who kindly
   contribute to improved the presentation of the study.
CR Andreasson S, 2000, ALCOHOL ALCOHOLISM, V35, P525, DOI 10.1093/alcalc/35.5.525
   [Anonymous], 2020, SINA NEWS AGENC 0310
   Armstrong-Heimsoth A, 2017, J CONS HLTH INTERNET, V21, P111, DOI 10.1080/15398285.2017.1308191
   Benvenuto G, 2020, MECOSAN, V113, P243, DOI [10.3280/MESA2020-113029, DOI 10.3280/MESA2020-113029]
   Benvenuto M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124470
   Cerna L, 2012, RES PAP FACULTY MAT, V20, P86
   Chundakkadan R, 2020, WORLD DEV, V136, DOI 10.1016/j.worlddev.2020.105112
   Comfort LK, 2020, PUBLIC ADMIN REV, V80, P616, DOI 10.1111/puar.13252
   Covolo L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-83
   Cowper A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m919
   Dahlgren P, 2005, POLIT COMMUN, V22, P147, DOI 10.1080/10584600590933160
   Dyson MP, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7819
   Dziak JJ, 2020, BRIEF BIOINFORM, V21, P553, DOI 10.1093/bib/bbz016
   EDWARDS S, 1995, LIBR INFORM SCI RES, V17, P163, DOI 10.1016/0740-8188(95)90020-9
   EPPLER MJ, 2006, MANAGING INFORM QUAL, DOI DOI 10.1007/3-540-32225-6
   Eysenbach G, 1998, BRIT MED J, V317, P1496, DOI 10.1136/bmj.317.7171.1496
   Fahy E, 2014, AUSTRALAS MED J, V7, P24, DOI 10.4066/AMJ.2014.1900
   Feldman J.J., 1966, MONOGRAPHS SOCIAL RE, V11
   Gabarron E, 2013, INTERACT J MED RES, V2, P101, DOI 10.2196/ijmr.2465
   Gao PC, 2020, ENVIRON PLANN A, V52, P698, DOI 10.1177/0308518X20910162
   Gorla N, 2010, J STRATEGIC INF SYST, V19, P207, DOI 10.1016/j.jsis.2010.05.001
   Gravili G, 2021, J INTELLECT CAP, V22, P260, DOI 10.1108/JIC-02-2020-0067
   Habermas J, 1996, FACTS NORMS CONTRIBU
   Hernandez-Garcia I, 2020, JMIR PUBLIC HLTH SUR, V6, P110, DOI 10.2196/18717
   Howard PN, 2018, J INF TECHNOL POLITI, V15, P81, DOI 10.1080/19331681.2018.1448735
   김성수, 2005, [KOREAN JOURNAL OF HEALTH EDUCATION AND PROMOTION, 보건교육건강증진학회지], V22, P215
   Kazis LE, 2006, J AMBUL CARE MANAG, V29, P182, DOI 10.1097/00004479-200610000-00007
   Kickbusch IS, 2001, HEALTH PROMOT INT, V16, P289, DOI 10.1093/heapro/16.3.289
   Kosec K, 2020, WORLD DEV, V125, DOI 10.1016/j.worlddev.2018.07.017
   Kott A, 2016, SOC SCI MED, V169, P42, DOI 10.1016/j.socscimed.2016.09.029
   Lillrank P., 2003, International Journal of Quality Reliability Management, V20, P691, DOI 10.1108/02656710310482131
   Maltz E, 2000, J PROD INNOVAT MANAG, V17, P110, DOI 10.1016/S0737-6782(99)00030-2
   MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109
   Nicolaou AI, 2006, INFORM SYST RES, V17, P332, DOI 10.1287/isre.1060.0103
   Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259
   Pauer F, 2016, INTERACT J MED RES, V5, P15, DOI 10.2196/ijmr.5822
   Rolker, 2005, ASSESSMENT METHODS I, DOI [10.18452/9207, DOI 10.18452/9207]
   ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319
   Schafer S, 2020, COMPUT HUM BEHAV, V103, P1, DOI 10.1016/j.chb.2019.08.031
   Shepperd S, 1999, BMJ-BRIT MED J, V319, P764, DOI 10.1136/bmj.319.7212.764
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   STANOVICH KE, 1993, J EDUC PSYCHOL, V85, P211, DOI 10.1037/0022-0663.85.2.211
   van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668
   Wahlberg AAF., 2000, J RISK RES, V3, P31, DOI [10.1080/136698700376699, DOI 10.1080/136698700376699]
   Waisbord S., 2016, C INT COMM ASS FUK J
   WALKER SH, 1967, BIOMETRIKA, V54, P167, DOI 10.2307/2333860
   Weber EU, 1998, MANAGE SCI, V44, P1205, DOI 10.1287/mnsc.44.9.1205
   World Health Organization (WHO), 2020, RISK COMM COMM ENG R
   Yang ZL, 2005, INFORM MANAGE-AMSTER, V42, P575, DOI [10.1016/S0378-7206(04)00073-4, 10.1016/j.im.2004.03.001]
   Zhu WW, 2016, ENERG POLICY, V88, P168, DOI 10.1016/j.enpol.2015.10.009
NR 50
TC 1
Z9 1
U1 14
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0040-1625
EI 1873-5509
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD SEP
PY 2021
VL 170
AR 120929
DI 10.1016/j.techfore.2021.120929
EA JUN 2021
PG 12
WC Business; Regional & Urban Planning
WE Social Science Citation Index (SSCI)
SC Business & Economics; Public Administration
GA TI1SF
UT WOS:000672564400007
PM 34898725
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Shahwan, M
   Suliman, A
   Jairoun, AA
   Alkhoujah, S
   Al-hemyari, SS
   Al-Tamimi, SK
   Godman, B
   Mothana, RA
AF Shahwan, Moyad
   Suliman, Abdulhaq
   Jairoun, Ammar Abdulrahman
   Alkhoujah, Sahib
   Al-hemyari, Sabaa Saleh
   Al-Tamimi, Saleh Karamah
   Godman, Brian
   Mothana, Ramzi A.
TI Prevalence, Knowledge and Potential Determinants of COVID-19 Vaccine
   Acceptability Among University Students in the United Arab Emirates:
   Findings and Implications
SO JOURNAL OF MULTIDISCIPLINARY HEALTHCARE
LA English
DT Article
DE acceptance; knowledge; vaccine; COVID-19; university student; concerns;
   Ajman University
ID CHALLENGES; PERCEPTION; HESITANCY
AB Objective: To evaluate the prevalence, knowledge, attitude and acceptance of the COVID-19 vaccines and related factors among university students in the United Arab Emirates.
   Methods: Analytical cross-sectional study undertaken among a convenient sample of medical and non-medical colleges of Ajman University using a self-administrated questionnaire. The questionnaire included demographic data as well as assessing knowledge of COVID-19, attitudes and acceptance of COVID-19 vaccines.
   Results: A total of 467 students participated in the study and completed the questionnaire. A total of 181 (38.8%) participants reported that they have been vaccinated against COVID-19 virus, principally with the Sinopharm vaccine (84%). Vaccination against the COVID-19 virus was less prevalent among Arabic nationalities compared to other nationalities, but more prevalent among students from health science colleges compared to those from non-health science colleges. The acceptance rate of COVID-19 vaccine among study participants was 56.3%, exacerbated by worries regarding unforeseen problems (65.5%, 306), general mis-trust (47.3%, 221) and unforeseen impacts (35.1%, 164). The average knowledge score was 60.1%, with 142 (30.4%) having poor knowledge, 127 (27.2%) acceptable knowledge and 198 (42.4%) good knowledge. There were common misconceptions about symptoms including nausea and diarrhoea, as well as the route of transmission, with half believing antibiotics are effective treatment.
   Conclusion: There was variable knowledge of COVID-19 among students. Misconceptions need addressing going forward. To enhance COVID-19 vaccination uptake in the country and world-wide, health education targeting diverse sociodemographic categories should be prioritized.
C1 [Shahwan, Moyad; Alkhoujah, Sahib] Ajman Univ, Coll Pharm & Hlth Sci, Ajman, U Arab Emirates.
   [Shahwan, Moyad; Suliman, Abdulhaq; Godman, Brian] Ajman Univ, Ctr Med & Bioallied Hlth Sci Res, Ajman 346, U Arab Emirates.
   [Suliman, Abdulhaq] Ajman Univ, Coll Dent, Ajman, U Arab Emirates.
   [Jairoun, Ammar Abdulrahman] Dubai Municipal, Hlth & Safety Dept, Dubai 67, U Arab Emirates.
   [Al-hemyari, Sabaa Saleh] Emirates Hlth Serv, Pharm Dept, Dubai, U Arab Emirates.
   [Al-Tamimi, Saleh Karamah] Aden Univ, Fac Pharm, Aden, Yemen.
   [Godman, Brian] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland.
   [Godman, Brian] Sefako Makgatho Hlth Sci Univ, Sch Pharm, Div Publ Hlth Pharm & Management, Pretoria, South Africa.
   [Jairoun, Ammar Abdulrahman; Al-hemyari, Sabaa Saleh; Godman, Brian] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia.
   [Mothana, Ramzi A.] King Saud Univ, Coll Pharm, Dept Pharmacognosy, Riyadh, Saudi Arabia.
RP Shahwan, M (corresponding author), Ajman Univ, Ctr Med & Bioallied Hlth Sci Res, Ajman 346, U Arab Emirates.; Jairoun, AA (corresponding author), Dubai Municipal, Hlth & Safety Dept, Dubai 67, U Arab Emirates.; Shahwan, M (corresponding author), Ajman Univ, Coll Pharm & Hlth Sci, Dept Clin Sci, Ajman 346, Saudi Arabia.
EM moyad76@hotmail.com; Dr_ammar_91_@hotmail.com
RI ; AL-Tamimi, Saleh Karamah/J-6899-2015
OI Godman, Brian/0000-0001-6539-6972; AL-Tamimi, Saleh
   Karamah/0000-0002-3420-4752
FU King Saud University, Riyadh, Saudi ArabiaKing Saud University
   [RSP-2021/119]
FX The authors extend their appreciation to Researchers Supporting Project
   number (RSP-2021/119) , King Saud University, Riyadh, Saudi Arabia for
   funding this work.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Abena PM, 2020, AM J TROP MED HYG, V102, P1184, DOI 10.4269/ajtmh.20-0290
   Abubakar AR, 2020, INFECT DRUG RESIST, V13, P4673, DOI 10.2147/IDR.S289037
   Acheampong T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080814
   Afriyie DK, 2020, J INFECT DEV COUNTR, V14, P838, DOI 10.3855/jidc.12909
   Alamer E, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9111259
   Albahri AH, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.614499
   Almalki MJ, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090943
   Aloweidi A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105111
   Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04
   Barello S, 2020, EUR J EPIDEMIOL, V35, P781, DOI 10.1007/s10654-020-00670-z
   Bell S, 2020, VACCINE, V38, P7789, DOI 10.1016/j.vaccine.2020.10.027
   Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088
   Biswas Md Rafiul, 2021, Vaccines (Basel), V9, DOI 10.3390/vaccines9111243
   Biswas N, 2021, J COMMUN HEALTH, V46, P1244, DOI 10.1007/s10900-021-00984-3
   Cerda AA, 2022, HEALTH EXPECT, V25, P506, DOI 10.1111/hex.13274
   Cerda AA, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.626852
   Cerda AA, 2021, APPL HEALTH ECON HEA, V19, P343, DOI 10.1007/s40258-021-00644-6
   Chen MS, 2021, HUM VACC IMMUNOTHER, V17, P2279, DOI 10.1080/21645515.2020.1853449
   Chowdhury N, 2021, J PUBLIC HEALTH-HEID, DOI 10.1007/s10389-021-01565-3
   de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0
   Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041
   Dias-Godoi IP, 2022, EXPERT REV PHARM OUT, V22, P119, DOI 10.1080/14737167.2021.1931128
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   El-Elimat T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250555
   Enitan S., 2020, INT J VACCINE IMMUN, V4, P1, DOI [DOI 10.16966/2470-9948.123, 10.16966/2470-9948.123]
   Faasse K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.551004
   Farhana, 2020, INT RES J BUS SOC SC, V6, P1, DOI [10.2139/ssrn.3763373, DOI 10.2139/SSRN.3763373]
   Gagneux-Brunon A, 2021, J HOSP INFECT, V108, P168, DOI [10.1016/j.jhin.2020.11.0200195-6701, 10.1016/j.jhin.2020.11.020]
   Garcia LY, 2021, HLTH POLICY, V19, P623, DOI [10.1007/s40258-021-00657-1, DOI 10.1007/S40258-021-00657-1]
   Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029
   Godman B, 2020, BANGLADESH J MED SCI, V19, pS103, DOI [10.3329/bjms.v19i0.48413, DOI 10.3329/BJMS.V19I0.48413]
   Godman B, 2021, LIFE-BASEL, V11, DOI 10.3390/life11060528
   Habib MA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245176
   Haque A, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040739
   Haque M, 2021, BANGLADESH J MED SCI, V20, pS199, DOI 10.3329/bjms.v20i5.55616
   Harapan H, 2020, HUM VACC IMMUNOTHER, V16, P3074, DOI 10.1080/21645515.2020.1819741
   Harapan H, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00381
   Hsu J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1983
   Islam MS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11880-9
   Islam MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251605
   Jin Q, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070757
   Kanyike AM, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00331-1
   Kayode OR, 2021, J INFECT DIS EPIDEMI, V7, P205
   Khan YH, 2020, AM J TROP MED HYG, V103, P603, DOI 10.4269/ajtmh.20-0654
   Klompas M, 2020, JAMA-J AM MED ASSOC, V324, P441, DOI 10.1001/jama.2020.12458
   Kwok KO, 2021, INT J NURS STUD, V114, DOI 10.1016/j.ijnurstu.2020.103854
   Langford BJ, 2021, CLIN MICROBIOL INFEC, V27, P520, DOI 10.1016/j.cmi.2020.12.018
   Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Leng AL, 2021, VACCINE, V39, P247, DOI 10.1016/j.vaccine.2020.12.009
   Lim LJ, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101141
   Machida M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030210
   Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3205
   Malande O.O., 2021, EC PAEDIAT, V10, P22
   Malik A.A., 2020, ECLINICALMEDICINE, V26, P100495, DOI [10.1016/j.eclinm.2020.100495, DOI 10.1016/J.ECLINM.2020.100495]
   Ministry of Health and WHO, 2021, WHO INT
   Musa S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090981
   Nguyen Trang, 2011, Infect Drug Resist, V4, P197, DOI 10.2147/IDR.S23174
   Nzaji MK, 2020, PRAGMAT OBS RES, V11, P103, DOI 10.2147/POR.S271096
   O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Ogunleye OO, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01205
   Patelarou E, 2021, NURS EDUC TODAY, V104, DOI 10.1016/j.nedt.2021.105010
   Paudel S, 2021, RISK MANAG HEALTHC P, V14, P2253, DOI 10.2147/RMHP.S310289
   Puri N, 2020, HUM VACC IMMUNOTHER, V16, P2586, DOI 10.1080/21645515.2020.1780846
   Qattan AMN, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.644300
   Qunaibi EA, 2021, ELIFE, V10, DOI 10.7554/eLife.68038
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Riad A, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14101049
   Riad A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18157859
   Riad A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060566
   Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910
   Sallam M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052407
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010042
   Salmon DA, 2020, LANCET, V396, P870, DOI 10.1016/S0140-6736(20)31603-2
   Sefah IA, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.588106
   Sherman SM, 2021, HUM VACC IMMUNOTHER, V17, P1612, DOI 10.1080/21645515.2020.1846397
   Sprengholz P, 2021, APPL HEALTH ECON HEA, V19, P619, DOI 10.1007/s40258-021-00656-2
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Verger P, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.3.2002047
   Walkowiak MP, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101153
   Wang FZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.928996
   Wang PW, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040380
   Wilson SL, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004206
   Wiysonge CS, 2022, HUM VACC IMMUNOTHER, V18, P1, DOI 10.1080/21645515.2021.1893062
   World meter, 2021, COR UPD LIV 12267291
   World meter corona virus, 2021, COVID 19 COR VIR PAN
   Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018
NR 89
TC 2
Z9 2
U1 1
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2390
J9 J MULTIDISCIP HEALTH
JI J. Multidiscip. Healthc.
PY 2022
VL 15
BP 81
EP 92
DI 10.2147/JMDH.S341700
PG 12
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services
GA YH9RL
UT WOS:000743496400001
PM 35046663
OA gold, Green Published, Green Accepted
DA 2022-04-20
ER

PT J
AU Wallia, A
   Prince, G
   Touma, E
   El Muayed, M
   Seley, JJ
AF Wallia, Amisha
   Prince, Grace
   Touma, Emilie
   El Muayed, Malek
   Seley, Jane Jeffrie
TI Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia,
   and COVID-19: Bridging the Remaining Knowledge Gaps
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Diabetes; Covid-19; SARS-CoV2; Inpatient management; Hyperglycemia
ID DIPEPTIDYL PEPTIDASE 4; INTENSIVE INSULIN THERAPY; GLYCEMIC CONTROL;
   CELL-DEATH; INHIBITORS; ASSOCIATION; CORONAVIRUS; OUTCOMES; SAFETY;
   KETOACIDOSIS
AB Purpose of Review This review discusses the interplay between coronavirus disease 2019 (COVID-19, caused by SARS-CoV-2 infection), diabetes mellitus, and hyperglycemia in the hospital setting. There are data emerging about diabetes and hyperglycemia, their prevalence, and potential risks in the setting of SARS-CoV-2 infection and COVID-19. Recent Findings It is known that viral infections exert effects on beta cell function and insulin resistance. Therefore, much can be learned about SARS-CoV-2/COVID-19 from examining these known relationships. Such pathophysiological underpinnings may unlock greater understanding as we navigate atypical cases of hyperglycemia, severe insulin resistance, and diabetic ketoacidosis amidst COVID-19. Glycemic outcomes likely have beneficial effects on morbidity and mortality, but this needs to be studied. Changes in diabetes-related protocols and new technology can be deployed in the inpatient setting to potentially improve healthcare worker and patient safety; however, one must weigh the risks and benefits of implementation during a pandemic. Ultimately, knowledge and research must be shared at record speed to combat this global crisis.
C1 [Wallia, Amisha; Prince, Grace; El Muayed, Malek] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.
   [Wallia, Amisha; Touma, Emilie] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth, Chicago, IL 60611 USA.
   [Seley, Jane Jeffrie] Weill Cornell Med, Div Endocrinol Diabet & Metab, New York, NY USA.
RP Wallia, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.; Wallia, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth, Chicago, IL 60611 USA.
EM a-wallia@northwestern.edu; grace.prince@northwestern.edu;
   emilie.touma@northwestern.edu; m-muayed@northwestern.edu;
   jas9067@med.cornell.edu
FU Novo NordiskNovo Nordisk
FX Amisha Wallia is a section editor for Current Diabetes Reports and
   recieves grant funding from Novo Nordisk, and research salary support
   from United Health Group and Eli Lilly. Grace Prince, Emilie Touma, and
   Malek El Muayed each declare no potential conflicts of interest. Jane
   Jeffrie Seley is a section editor for Current Diabetes Reports.
CR Agarwal S, 2019, DIABETES CARE, V43, P2020
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Aloi Joseph, 2017, J Diabetes Sci Technol, V11, P12, DOI 10.1177/1932296816664746
   Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS193, DOI 10.2337/dc20-S015
   Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194
   Andersen SK, 2004, J LEUKOCYTE BIOL, V75, P413, DOI 10.1189/jlb.0503195
   [Anonymous], 2020, COR COVID 19 GLOB CA
   [Anonymous], 2020, FAQS HOM US BLOOD GL
   [Anonymous], 2004, 64 AM DIAB ASS SCI S
   [Anonymous], 2020, FACT SHEET HEALTHC P
   [Anonymous], COLL OP ACC VIRTUAL
   [Anonymous], 2020, REPORT WHO CHINA JOI
   [Anonymous], 2020, ABB FREEST LIBR 14 D
   Ansorge S, 2009, CLIN CHEM LAB MED, V47, P253, DOI 10.1515/CCLM.2009.063
   Apicella M, 2020, LANCET DIABETES ENDO, V8, P782, DOI 10.1016/S2213-8587(20)30238-2
   Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7
   Balasubramanyam A, 2008, ENDOCR REV, V29, P292, DOI 10.1210/er.2007-0026
   Bode Bruce, 2020, J Diabetes Sci Technol, V14, P813, DOI 10.1177/1932296820924469
   Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2
   Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842
   Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x
   Chee YJ, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108166
   Chen YC, 2020, DIABETES CARE, V43, P1399, DOI 10.2337/dc20-0660
   Deng HP, 2009, INT IMMUNOPHARMACOL, V9, P1251, DOI 10.1016/j.intimp.2009.07.009
   DiMeglio LA, 2018, LANCET, V391, P2449, DOI 10.1016/S0140-6736(18)31320-5
   Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033
   Drucker DJ, 2020, ENDOCR REV, V41, P457, DOI 10.1210/endrev/bnaa011
   Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5
   ECDC, 2020, COR DIS 2019 COVID 1
   Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE
   Ettleson MD, 2014, J CLIN ENDOCR METAB, V99, pE2010, DOI 10.1210/jc.2014-1449
   EUA, 2020, EUA AUTH SER TEST PE
   Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023
   Fortmann AL, 2020, DIABETES CARE, V43, P2873, DOI 10.2337/dc20-1016
   Gala-Lopez BL, 2018, TRANSPLANTATION, V102, P978, DOI 10.1097/TP.0000000000002083
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Gianchandani R, 2020, DIABETES, V69, P2048, DOI 10.2337/dbi20-0022
   Hanson KE, 2021, CLIN INFECT DIS, DOI [10.1093/cid/ciaa760, 10.1093/cid/ciab557]
   Hoffman Tove, 2020, Infection Ecology & Epidemiology, V10, P1754538, DOI 10.1080/20008686.2020.1754538
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0
   Honeyman MC, 1998, MOL MED, V4, P231, DOI 10.1007/BF03401920
   Honeyman MC, 2000, DIABETES, V49, P1319, DOI 10.2337/diabetes.49.8.1319
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3
   Iacobellis G, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108125
   Illuri Vidhya D S, 2016, Clin Diabetes, V34, P158, DOI 10.2337/diaclin.34.3.158
   Inpatient Insulin Protocols-COVID-19, INP INS PROT COVID 1
   Jones MS, 2020, DIABETES TECHNOL THE, V22, P444, DOI 10.1089/dia.2020.0206
   Kim NY, 2020, DIABETES METAB J, V44, P349, DOI 10.4093/dmj.2020.0091
   Korytkowski M, 2020, J CLIN ENDOCR METAB, V105, P3076, DOI 10.1210/clinem/dgaa342
   Kumar S, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1183-9
   Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385
   Lecube A, 2006, DIABETES CARE, V29, P1140, DOI 10.2337/dc05-1995
   Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, pE1826, DOI 10.1073/pnas.1519286113
   LeRoith D, 2003, DIABETES MELLITUS FU
   Liu FR, 2020, CLIN GASTROENTEROL H, V18, P2128, DOI 10.1016/j.cgh.2020.04.040
   Lorenzo-Gonzalez C, 2020, ENDOCR PRACT, V26, P722, DOI 10.4158/EP-2019-0481
   Meyerholz DK, 2016, AM J PATHOL, V186, P78, DOI 10.1016/j.ajpath.2015.09.014
   Meyers DC, 2012, AM J COMMUN PSYCHOL, V50, P462, DOI 10.1007/s10464-012-9522-x
   Mikhail N, 2011, CURR DRUG SAF, V6, P304, DOI 10.2174/157488611798918700
   Mulvihill EE, 2014, ENDOCR REV, V35, P992, DOI 10.1210/er.2014-1035
   Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020
   Naylor R, 1993, GENEREVIEWS
   Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x
   Oo YH, 2013, CASE REP ENDOCRINOL, V2013, DOI 10.1155/2013/520904
   Ovalle F, 2010, DIABETES RES CLIN PR, V90, P231, DOI 10.1016/j.diabres.2010.06.025
   Pal R, 2020, DIABETES METAB SYND, V14, P1563, DOI 10.1016/j.dsx.2020.08.015
   Palermo NE, 2020, J CLIN ENDOCR METAB, V105, P2819, DOI 10.1210/clinem/dgaa360
   Pasquel FJ, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1184-8
   Pedapenki KK, 2015, 2015 INTERNATIONAL CONFERENCE ON CONTROL, INSTRUMENTATION, COMMUNICATION AND COMPUTATIONAL TECHNOLOGIES (ICCICCT), P214, DOI 10.1109/ICCICCT.2015.7475278
   Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]
   Pilla SJ, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0792-9
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Reichetzeder C, 2017, BRIT J PHARMACOL, V174, P2273, DOI 10.1111/bph.13822
   Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2
   Reutrakul S, 2020, DIABETES CARE
   Roivainen M, 2006, INT J BIOCHEM CELL B, V38, P721, DOI 10.1016/j.biocel.2005.08.019
   Rushakoff RJ, 2017, ANN INTERN MED, V166, P621, DOI 10.7326/M16-1413
   Sardu C, 2020, DIABETES CARE, V43, P1408, DOI 10.2337/dc20-0723
   Schnapp G, 2016, J MED CHEM, V59, P7466, DOI 10.1021/acs.jmedchem.6b00475
   Schwartz J, 2020, CLIN INFECT DIS, V53, P363
   Shehav-Zaltzman G, 2020, DIABETES CARE, V43, pE75, DOI 10.2337/dc20-0696
   Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831
   Singh LG, 2020, DIABETES CARE, V43, P2736, DOI 10.2337/dc20-0840
   Sjoholm A, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00684
   Stefan N, 2020, NAT REV ENDOCRINOL, V16, P341, DOI 10.1038/s41574-020-0364-6
   Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4
   Tartof SY, 2020, ANN INTERN MED, V173, P773, DOI 10.7326/M20-3742
   Tersey SA, 2016, JOVE-J VIS EXP, DOI 10.3791/54838
   Tikellis C, 2004, DIABETES, V53, P989, DOI 10.2337/diabetes.53.4.989
   Uhteg K, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104384
   Umpierrez GE, 2004, DIABETES CARE, V27, P1873, DOI 10.2337/diacare.27.8.1873
   Ushigome E, 2021, DIABETES TECHNOL THE, V23, P78, DOI 10.1089/dia.2020.0237
   Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Vanhorebeek I, 2005, CURR OPIN CRIT CARE, V11, P304, DOI 10.1097/01.ccx.0000170506.61281.94
   Vellanki P, 2019, DIABETES OBES METAB, V21, P837, DOI 10.1111/dom.13587
   Venetsanaki V, 2019, CURR ONCOL, V26, pE111, DOI 10.3747/co.26.4151
   Wallia Amisha, 2017, J Diabetes Sci Technol, V11, P1036, DOI 10.1177/1932296817706151
   Wallia A, 2017, J CLIN ENDOCR METAB, V102, P451, DOI 10.1210/jc.2016-3279
   Wang SF, 2020, DIABETOLOGIA, V63, P2102, DOI 10.1007/s00125-020-05209-1
   Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574
   Willemen MJ, 2011, DIABETES CARE, V34, P369, DOI 10.2337/dc10-1771
   Winter EM, 2011, BMJ CASE REP, pbcr0620114393
   World Health Organization, 2020, RAT US PERS PROT EQ
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xu J, 2018, LAB INVEST, V98, P1333, DOI 10.1038/s41374-018-0080-1
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Yen MY, 2011, J HOSP INFECT, V77, P332, DOI 10.1016/j.jhin.2010.12.002
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zhu L, 2020, CARDIORENAL MED, V10, P470, DOI 10.1159/000510916
NR 113
TC 4
Z9 4
U1 0
U2 0
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD DEC
PY 2020
VL 20
IS 12
AR 77
DI 10.1007/s11892-020-01366-0
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA OW7JN
UT WOS:000593058300001
PM 33244614
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Karimian, Z
   Farrokhi, MR
   Moghadami, M
   Zarifsanaiey, N
   Mehrabi, M
   Khojasteh, L
   Salehi, N
AF Karimian, Zahra
   Farrokhi, Majid Reza
   Moghadami, Mohsen
   Zarifsanaiey, Nahid
   Mehrabi, Manoosh
   Khojasteh, Laleh
   Salehi, Nasim
TI Medical education and COVID-19 pandemic: a crisis management model
   towards an evolutionary pathway
SO EDUCATION AND INFORMATION TECHNOLOGIES
LA English
DT Article
DE COVID-19; Medical education; Crisis management; SWOT; Pandemic
ID KNOWLEDGE; STUDENTS; HEALTH
AB The COVID-19 crisis has had a profound effect on higher education, especially medical education due to its sensitive nature, dealing with people's life and wellbeing. This study presented a crisis management model of how to direct medical education during crises. A qualitative design was used via a focus group among 83 medical education administrators at Shiraz University of Medical Sciences. Four major challenges emerged regarding medical education during the COVID-19 pandemic including "The health and wellbeing of faculty members and students"; "Spatial constraints"; "Time constraints", and "Access to resources". A total of 13 strategies were suggested to tackle the challenges, including virtualization, technological support, empowerment, participation, sharing, helping, integration, compression, omission, flexibility and diversity, severance, protection; and monitoring. For a sustainable educational pathway in medical education, personalized approach to education via the incorporation of technology is essential. This provides opportunities to tackle the issues caused by the crisis, by provision of any time and anywhere approach to education via flexible technologies/platforms adjusted based on the audiences. The scope of crisis management expands not only on individual and academic levels but also on social and global relations.
C1 [Karimian, Zahra; Zarifsanaiey, Nahid; Mehrabi, Manoosh] Shiraz Univ Med Sci, Dept E Learning Med Sci, Virtual Sch, Shiraz, Iran.
   [Karimian, Zahra; Zarifsanaiey, Nahid; Mehrabi, Manoosh] Shiraz Univ Med Sci, Ctr Excellence E Learning, Shiraz, Iran.
   [Karimian, Zahra] Virtual Univ Med Sci, Tehran, Iran.
   [Farrokhi, Majid Reza] Shiraz Univ Med Sci, Sch Med, Dept Neurosurg, Shiraz, Iran.
   [Farrokhi, Majid Reza] Shiraz Univ Med Sci, Neurosci Res Ctr, Shiraz, Iran.
   [Moghadami, Mohsen] Shiraz Univ Med Sci, Sch Med, Dept Internal Med, Shiraz, Iran.
   [Khojasteh, Laleh] Shiraz Univ Med Sci, Sch Paramed Sci, Dept English Language, Shiraz, Iran.
   [Salehi, Nasim] Southern Cross Univ, Fac Hlth, Gold Coast, Qld, Australia.
RP Farrokhi, MR (corresponding author), Shiraz Univ Med Sci, Sch Med, Dept Neurosurg, Shiraz, Iran.; Farrokhi, MR (corresponding author), Shiraz Univ Med Sci, Neurosci Res Ctr, Shiraz, Iran.
EM Karimian@sums.ac.ir; Farokhim@sums.ac.ir; Moghadami@sums.ac.ir;
   Nzarifsanaee@gmail.com; Mehrabi.manoosh@gmail.com;
   Khojastehlaleh@yahoo.com; Nasim.Salehi@scu.edu.au
RI Zarifsanaiey, Nahid/M-8789-2017; khojasteh, laleh/G-7409-2017
OI Zarifsanaiey, Nahid/0000-0002-1297-8271; khojasteh,
   laleh/0000-0002-6393-2759; Farrokhi, Majid Reza/0000-0003-1252-3215
CR Aghakhania K, 2020, MED EDUC ONLINE, V25, DOI 10.1080/10872981.2020.1770567
   Ahmed H, 2020, LANCET INFECT DIS, V20, P777, DOI 10.1016/S1473-3099(20)30226-7
   Bradley Declan T, 2014, PLoS Curr, V6, DOI 10.1371/currents.dis.349062e0db1048bb9fc3a3fa67d8a4f8
   Burki TK, 2020, LANCET ONCOL, V21, P758, DOI 10.1016/S1470-2045(20)30287-4
   Chen Cathy Hsi, 2020, JMIR Med Educ, V6, pe19725, DOI 10.2196/19725
   Choi B, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02117-1
   Clark Jocalyn, 2003, BMJ, V326, P784
   Cole, 2020, NEWSWEEK
   Czerniewicz L, 2019, INT J EDUC TECHNOL H, V16, DOI 10.1186/s41239-019-0170-1
   Dar O, 2014, AM J PUBLIC HEALTH, V104, P1811, DOI 10.2105/AJPH.2014.302134
   Di Napoli, 2021, STATPEARLS
   Doshmangir P., 2020, MANAGEMENT STRATEGIE, V4, P370
   Ebrahimi Alireza, 2020, J Adv Med Educ Prof, V8, P144, DOI 10.30476/jamp.2020.86090.1217
   Ferrel MN, 2020, CUREUS, V12, DOI 10.7759/cureus.7492
   Gaillard JC, 2013, PROG HUM GEOG, V37, P93, DOI 10.1177/0309132512446717
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Guo Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P642, DOI 10.3760/cma.j.cn112338-20200301-00222
   Harvey A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1227
   Hilburg R, 2020, ADV CHRONIC KIDNEY D, V27, P412, DOI 10.1053/j.ackd.2020.05.017
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Kenneth McIntosh M, COVID 19 EPIDEMIOLOG
   Khlaif ZN, 2020, MED SCI, V11, P135, DOI DOI 10.30476/IJVLMS.2020.86120.1033
   KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299
   Lankarani Kamran Bagheri, 2013, Med J Islam Repub Iran, V27, P42
   Lomis K, 2017, ACAD MED, V92, P765, DOI 10.1097/ACM.0000000000001543
   Marandi A, 1996, MED EDUC, V30, P4, DOI 10.1111/j.1365-2923.1996.tb00709.x
   Mehrabi N, 2014, PARAMEDICAL SCI MILI, V9, P48
   Mofijur M, 2021, SUSTAIN PROD CONSUMP, V26, P343, DOI 10.1016/j.spc.2020.10.016
   O'Byrne L, 2020, J MED ETHICS, V46, P623, DOI 10.1136/medethics-2020-106353
   Patil NG, 2003, MED EDUC, V37, P1127, DOI 10.1046/j.1365-2923.2003.01723.x
   Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126
   Rand EC, 2008, J HOPKINS RED CROSS
   Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227
   Sahi PK, 2020, INDIAN PEDIATR, V57, P652, DOI 10.1007/s13312-020-1894-7
   Salha S., 2020, INTERDISCIPLINARY J, V11, P130, DOI [10.30476/ijvlms.2020.86119.1034, DOI 10.30476/IJVLMS.2020.86119.1034]
   Sandars J., 2020, MEDEDPUBLISH, V9, P49, DOI [10.15694/mep.2020.000049.1, DOI 10.15694/MEP.2020.000049.1]
   Shraim K, 2010, INFORM TECHNOL DEV, V16, P159, DOI 10.1080/02681102.2010.501782
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Traxler J, 2019, RES LEARN TECHNOL, V27, DOI 10.25304/rlt.v27.2263
   Wayne DB, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc7110
NR 40
TC 1
Z9 1
U1 10
U2 10
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1360-2357
EI 1573-7608
J9 EDUC INF TECHNOL
JI Educ. Inf. Technol.
PD APR
PY 2022
VL 27
IS 3
BP 3299
EP 3320
DI 10.1007/s10639-021-10697-8
EA SEP 2021
PG 22
WC Education & Educational Research
WE Social Science Citation Index (SSCI)
SC Education & Educational Research
GA 0M3FS
UT WOS:000697759900001
PM 34566468
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Farah, E
   Ali, R
   Tope, P
   El-Zein, M
   Franco, EL
AF Farah, Eliya
   Ali, Rami
   Tope, Parker
   El-Zein, Mariam
   Franco, Eduardo L.
CA McGill Task Force COVID-19 Canc
TI A Review of Canadian Cancer-Related Clinical Practice Guidelines and
   Resources during the COVID-19 Pandemic
SO CURRENT ONCOLOGY
LA English
DT Review
DE COVID-19; cancer care; cancer control; clinical practice guidelines;
   cancer resources
ID IMPACT; DELAYS; UK
AB (1) Background: Preventive measures taken in response to the coronavirus disease 2019 (COVID-19) pandemic have adversely affected an entire range of cancer-related medical activities. The reallocation of medical resources, staff, and ambulatory services, as well as critical shortages in pharmaceutical and medical supplies have compelled healthcare professionals to prioritize patients with cancer to treatment and screening services based on a set of classification criteria in cancer-related guidelines. Cancer patients themselves have been affected on multiple levels, and addressing their concerns poses another challenge to the oncology community. (2) Methods: We conducted a Canada-wide search of cancer-related clinical practice guidelines on the management and prioritization of individuals into treatment and screening services. We also outlined the resources provided by Canadian cancer charities and patient advocacy groups to provide cancer patients, or potential cancer patients, with useful information and valuable support resources. (3) Results: The identified provincial guidelines emphasized cancer care (i.e., treatment) more than cancer control (i.e., screening). For cancer-related resources, a clear significance was placed on knowledge & awareness and supportive resources, mainly relating to mental health. (4) Conclusion: We provided a guidance document outlining cancer-related guidelines and resources that are available to healthcare providers and patients across Canada during the COVID-19 pandemic.
C1 [Farah, Eliya; Ali, Rami; Tope, Parker; El-Zein, Mariam; Franco, Eduardo L.; McGill Task Force COVID-19 Canc] McGill Univ, Div Canc Epidemiol, Gerald Bronfman Dept Oncol, 5100 Maisonneuve Blvd West,Suite 720, Montreal, PQ H4A 3T2, Canada.
RP El-Zein, M (corresponding author), McGill Univ, Div Canc Epidemiol, Gerald Bronfman Dept Oncol, 5100 Maisonneuve Blvd West,Suite 720, Montreal, PQ H4A 3T2, Canada.
EM eliya.farah@mail.mcgill.ca; rami.ali2@mail.mcgill.ca;
   parker.tope@mcgill.ca; mariam.elzein@mcgill.ca; eduardo.franco@mcgill.ca
RI ; Franco, Eduardo/C-6445-2014
OI El-Zein, Mariam/0000-0002-5190-0370; Franco,
   Eduardo/0000-0002-4409-8084; Tope, Parker/0000-0001-7903-1413
FU Canadian Institutes of Health Research (CIHR-COVID-19 Rapid Research
   Funding opportunity)Canadian Institutes of Health Research (CIHR)
   [VR5-172666]
FX This research was funded by the Canadian Institutes of Health Research
   (CIHR-COVID-19 Rapid Research Funding opportunity, grant number
   VR5-172666 to Eduardo L. Franco). Eliya Farah and Rami Ali received MSc.
   stipends from the Gerald Bronfman Department of Oncology, McGill
   University.
CR Al-Quteimat OM, 2020, AM J CLIN ONCOL-CANC, V43, P452, DOI 10.1097/COC.0000000000000712
   Alberta Health Services, 2020, RET IMM CANC PAT POS
   Alberta Health Services, 2019, CANC GUID ALB HLTH S
   Alberta Health Services, 2020, COVID 19 SCI ADV GRO
   Alberta Health Services, 2020, CANC CONTR ALB CANC
   BC Cancer, 2020, CANC MAN GUID BC CAN
   BC Cancer, 2019, PROV CANC CLIN MAN G
   BC Cancer, 2020, TUM GROUP SPEC PRIOR
   Belkacemi Y, 2020, EUR J CANCER, V135, P130, DOI 10.1016/j.ejca.2020.05.015
   Canadian Breast Cancer Network, 2020, COVID 19 BREAST CANC
   Canadian Cancer Society, 2020, CANC COVID 19 WEB SE
   Canadian Cancer Survivor Network, 2020, CANC PAT FAC DOUBL J
   Canadian Partnership against Cancer, 2020, CANC SCREEN COVID 19
   Canas AJ, 2004, P 1 INT C CONC MAPP
   Cancer Care Manitoba, 2020, COVID 19 IMP INF HLT
   Cancer Care Manitoba, 2019, CANC MAN GUID CANC C
   Cancer Care Manitoba, 2020, INFORM HLTH CARE PRO
   Cancer Care Ontario, 2020, COVID 19 SUPPL CLIN
   Cancer Care Ontario, 2017, GUID ADV CANC CAR ON
   Cancer Care Ontario, 2020, PAND PLANN CLIN GUID
   Cancino RS, 2020, JMIR CANCER, V6, DOI 10.2196/21697
   Childhood Cancer Canada, 2020, COVID 19 EM FUND
   Colorectal Cancer Canada, 2020, COL CANC COVID 19 SU
   de Joode K, 2020, EUR J CANCER, V136, P132, DOI 10.1016/j.ejca.2020.06.019
   Eastern Health Cancer Care, 2019, GUID E HLTH CANC CAR
   Epic Health Research Network, 2020, DEL CANC SCREEN
   Government of Canada, 2020, COVID 19 SELF ASS TO
   Jazieh AR, 2020, JCO GLOB ONCOL, V6, P1428, DOI 10.1200/GO.20.00351
   Kidney Cancer Canada, 2020, COVID 19 INF KIDN CA
   Kutikov A, 2020, ANN INTERN MED, V172, P756, DOI 10.7326/M20-1133
   Marie-Pascale Pomey E.V, 2020, SURVEY SUMMARY REPOR
   Maringe C, 2020, LANCET ONCOL, V21, P1023, DOI 10.1016/S1470-2045(20)30388-0
   Ministere de la Sante et des Services Sociaux, 2019, REC CONC GUID EX COL
   Ministere de la Sante et des Services Sociaux, 2020, DIR COVID 19 MIN SAN
   Nova Scotia Health Authority, 2020, COVID 19 HUB NOV SCO
   Nova Scotia Health Authority, 2020, PER INT RAD SERV COV
   Nova Scotia Health Authority, 2019, CANC CAR PROGR NOV S
   Novaak J.D, 2006, THEORY UNDERLYING CO
   Ogimi C, 2019, J PEDIAT INF DIS SOC, V8, P21, DOI 10.1093/jpids/pix093
   Ruggiero Antonio, 2020, Drugs Context, V9, DOI 10.7573/dic.2020-4-12
   Saskatchewan Cancer Agency, 2020, CLIN PRACTICE GUIDEL
   Saskatchewan Cancer Agency, 2020, FOLL UP GUID SASK CA
   Saud M, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2417
   Staehler MD, 2021, WORLD J UROL, V39, P2559, DOI 10.1007/s00345-020-03476-6
   Sud A, 2020, LANCET ONCOL, V21, P1035, DOI 10.1016/S1470-2045(20)30392-2
   Vogel L., 2020, CMAJ NEWS
NR 46
TC 3
Z9 3
U1 3
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1198-0052
EI 1718-7729
J9 CURR ONCOL
JI Curr. Oncol.
PD APR
PY 2021
VL 28
IS 2
DI 10.3390/curroncol28020100
PG 14
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA RS4DR
UT WOS:000643731800001
PM 33669102
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Caramidaru, I
   Ionica, A
   Leba, M
AF Caramidaru, Ibrian
   Ionica, Andreea
   Leba, Monica
TI A learning-by-doing based framework for micro-knowledge management in
   project contexts
SO HUMAN SYSTEMS MANAGEMENT
LA English
DT Article
DE Experiential education; knowledge deliverables; projects management;
   human resources management; COVID-19
ID COMMUNITIES; CAPTURE
AB BACKGROUND: There is a general acknowledgement of projects as sites of knowledge creation, but in multi-project contexts, we witness at times a lack of robust procedures that would ensure harvesting the lessons learned.
   OBJECTIVE: This paper aims at providing an operational conceptual framework for micro-knowledge management, depicting knowledge as created by individuals performing project activities.
   METHODS: Documentation on relevant literature and observation of current managerial practices and tools, in order to use the underpinnings of experiential education for managing learning-by-doing knowledge creation.
   RESULTS: Developing the framework led to identifying the decision-making processes in micro-knowledge management and their correlation with human resources management Secondly - we have shown the need for a coherent integration of knowledge deliverables into the project management tools and practices, especially in the context of the COVID-19 pandemic.
   CONCLUSIONS: Micro-knowledge management points to a recurrent assessment of the opportunity for micro-knowledge codification and/or staff retention based on tacit professional or biographical knowledge of the project team members. The framework offers a balance between the detachment of knowledge from the owners, in codification, and affirming the irreducible tacit and personal dimensions of learning-by-doing.
C1 [Caramidaru, Ibrian; Ionica, Andreea] Univ Petrosani, Engn & Management Dept, Petrosani, Romania.
   [Leba, Monica] Univ Petrosani, Comp & Elect Engn Dept, Syst Control Engn, Petrosani, Romania.
RP Caramidaru, I (corresponding author), Univ Petrosani, Engn & Management Dept, Petrosani, Romania.
EM ibriancaramidaru@upet.ro
RI Ionica, Andreea C/B-9657-2015; Caramidaru, Vasile-Ibrian/AAC-7326-2022;
   Leba, Monica/B-9620-2015
OI Ionica, Andreea C/0000-0003-1988-9340; Leba, Monica/0000-0002-4083-9121
CR Alvesson M., 2000, J APPL BEHAV SCI, V36, P136
   Ayas K, 2001, MANAGE LEARN, V32, P61, DOI 10.1177/1350507601321005
   AYAS K, 1996, INT J PROJ MANAG, V14, P131, DOI DOI 10.1016/0263-7863(95)00080-1
   Buchan L, 2020, PROJ MANAG J, V51, P38, DOI 10.1177/8756972819891277
   Gasik S, 2011, PROJ MANAG J, V42, P23, DOI 10.1002/pmj.20239
   Gibbs Graham., 1988, LEARNING DOING GUIDE
   Hansen MT, 1999, HARVARD BUS REV, V77, P106
   Jensen A, 2016, PROJ MANAG J, V47, P21, DOI 10.1177/875697281604700303
   Karikari AF, 2018, HUM SYST MANAGE, V37, P311, DOI 10.3233/HSM-17186
   Kolb D. A, 2015, EXPERIENTIAL LEARNIN
   Kotler P, 2009, BUSINESS MANAGEMENT
   Kotnour T, 2002, IIE ANN C ORL FL
   Kotnour T., 1999, PROJECT MANAGEMENT J, V30, P32, DOI DOI 10.1177/875697289903000206
   NEWELL S, 2002, MANAGING KNOWLEDGE W
   Nonaka I., 1995, KNOWLEDGE CREATING C
   Nonaka I, 2009, ORGAN SCI, V20, P635, DOI 10.1287/orsc.1080.0412
   PMI (Project Management Institute), 2017, GUID PROJ MAN BOD KN, V6th
   Prencipe A, 2001, RES POLICY, V30, P1373, DOI 10.1016/S0048-7333(01)00157-3
   Rajabion L, 2019, HUM SYST MANAGE, V38, P365, DOI 10.3233/HSM-190516
   Scarborough H., 2000, INVESTIGATING KNOWLE
   Schindler M., 2003, International Journal of Project Management, V21, P219, DOI 10.1016/S0263-7863(02)00096-0
   Schon D.A., 1983, REFLECTIVE PRACTITIO
   Tan HC, 2007, J MANAGE ENG, V23, P18, DOI [10.1061/(ASCE)0742-597X(2007)23:1(18), 10.1061/(ASCE)0742-597X]
   Udeaja CE, 2008, AUTOMAT CONSTR, V17, P839, DOI 10.1016/j.autcon.2008.02.009
   VANAKEN EM, 1994, ORGAN DYN, V22, P38, DOI 10.1016/0090-2616(94)90077-9
   Vuorinen L, 2018, INT J PROJ MANAG, V36, P583, DOI 10.1016/j.ijproman.2018.02.003
   Winship K, 2012, J EVID-INFORM SOC WO, V9, P100, DOI 10.1080/15433714.2012.636315
   Yin R.K., 1994, CASE STUDY RES DESIG, V2nd ed.
   Zollo M, 2002, ORGAN SCI, V13, P339, DOI 10.1287/orsc.13.3.339.2780
NR 29
TC 1
Z9 1
U1 4
U2 10
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0167-2533
EI 1875-8703
J9 HUM SYST MANAGE
JI Hum. Syst. Manag.
PY 2020
VL 39
IS 4
BP 529
EP 536
DI 10.3233/HSM-201039
PG 8
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA OW3PO
UT WOS:000592803300005
DA 2022-04-20
ER

PT J
AU Giudice, A
   Bennardo, F
   Antonelli, A
   Barone, S
   Fortunato, L
AF Giudice, Amerigo
   Bennardo, Francesco
   Antonelli, Alessandro
   Barone, Selene
   Fortunato, Leonzio
TI COVID-19 is a New Challenge for Dental Practitioners: Advice on
   Patients' Management from Prevention of Cross Infections to Telemedicine
SO OPEN DENTISTRY JOURNAL
LA English
DT Article
DE COVID-19; Dental public health; Emergency dental treatment; Guidelines;
   Infection control; Telemedicine
ID CORONAVIRUSES; DENTISTRY; AEROSOLS; EFFICACY; SARS; MERS
AB Background:
   The COVID-19, originated in China in December 2019, has spread worldwide pandemically. Infection control measures are especially needed for healthcare professionals who meet potentially infected patients.
   Objective:
   The authors aimed to provide general knowledge about COVID-19 disease and indications for the management of emergency dental procedures based on recent literature and experience gained.
   Methods:
   A literature search was performed to identify scientific information on COVID-19 and prevention of cross infection appropriate for the practice of dentistry.
   Results:
   The authors provided relevant information about SARS-CoV-2 virus, COVID-19 disease, and prevention of cross infections in the dental office. Furthermore, the authors described their experience and highlighted the potential of telemedicine.
   Conclusion:
   This article, based on relevant researches, guidelines and Authors' experience in a COVID-19 Hospital, introduces essential knowledge about COVID-19 and transmission routes and provides recommended management protocols for dental practitioners.
C1 [Giudice, Amerigo; Bennardo, Francesco; Antonelli, Alessandro; Barone, Selene; Fortunato, Leonzio] Magna Graecia Univ Catanzaro, Sch Dent, Dept Hlth Sci, Viale Europa, I-88100 Catanzaro, Italy.
   [Giudice, Amerigo; Bennardo, Francesco; Antonelli, Alessandro; Barone, Selene; Fortunato, Leonzio] Mater Domini Hosp, COVID 19 Reference Hosp Calabria Reg, Unit Dent, Catanzaro, Italy.
RP Giudice, A (corresponding author), Magna Graecia Univ Catanzaro, Sch Dent, Dept Hlth Sci, Viale Europa, I-88100 Catanzaro, Italy.
EM a.giudice@unicz.it
RI Bennardo, Francesco/V-3115-2019
OI Bennardo, Francesco/0000-0002-6528-2681; Antonelli,
   Alessandro/0000-0002-9557-3586
CR Al-Tawfiq JA, 2014, CURR OPIN INFECT DIS, V27, P411, DOI 10.1097/QCO.0000000000000089
   [Anonymous], NEW YORK TIMES
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Bauch CT, 2013, LANCET, V382, P662, DOI 10.1016/S0140-6736(13)61504-4
   Bennardo F, 2020, ORAL ONCOL, V106, DOI 10.1016/j.oraloncology.2020.104659
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004
   Colson DG, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/517391
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Eggers M, 2018, INFECT DIS THER, V7, P249, DOI 10.1007/s40121-018-0200-7
   FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]
   Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017
   Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m998
   Guarner J, 2020, AM J CLIN PATHOL, V153, P420, DOI 10.1093/ajcp/aqaa029
   Hallier C, 2010, BRIT DENT J, V209, DOI 10.1038/sj.bdj.2010.975
   Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207
   Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078
   Horton R, 2020, LANCET, V395, P400, DOI 10.1016/S0140-6736(20)30299-3
   Hossainian N, 2011, INT J DENT HYG, V9, P171, DOI 10.1111/j.1601-5037.2010.00492.x
   Italian Society of Periodontology, COVID 2019 CRIT DENT
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lancet T, 2013, LANCET, V381, P1960
   Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Marui VC, 2019, J AM DENT ASSOC, V150, P1015, DOI 10.1016/j.adaj.2019.06.024
   Matusitz J, 2007, HEALTH COMMUN, V21, P73, DOI 10.1080/10410230701283439
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   MICIK RE, 1969, J DENT RES, V48, P49, DOI 10.1177/00220345690480012401
   Moreira MS, 2017, J ENDODONT, V43, P864, DOI 10.1016/j.joen.2017.01.021
   Mupparapu M, 2019, QUINTESSENCE INT, V50, P58, DOI 10.3290/j.qi.a41337
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   SAMARANAYAKE LP, 1989, J DENT CHILD, V56, P442
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002
   World Health Organization, 2020, 111 WHO, P2020
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 41
TC 8
Z9 8
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1874-2106
J9 OPEN DENT J
JI Open Dent. J.
PY 2020
VL 14
BP 298
EP 304
DI 10.2174/1874210602014010298
PG 7
WC Dentistry, Oral Surgery & Medicine
WE Emerging Sources Citation Index (ESCI)
SC Dentistry, Oral Surgery & Medicine
GA NK9MW
UT WOS:000567053700045
DA 2022-04-20
ER

PT J
AU Bratianu, C
   Bejinaru, R
AF Bratianu, Constantin
   Bejinaru, Ruxandra
TI COVID-19 induced emergent knowledge strategies
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article
AB The pandemic of COVID-19 is considered the most complex global process generated so far due to its unprecedented power of disruption, interconnection, and lockdowns in all the domains of our life, from health to economy, education, research, culture, sports, and social isolation. The COVID-19 crisis came like any other natural disaster, finding people and organizations unprepared for disruptive power and social nexus. The unthinkable became a reality, and people realized that organizations and governments have no strategies to fight against such a pandemic. They found out that the strategic knowledge gap is enormous, and the only way to navigate this crisis is to create emergent knowledge strategies. This paper aims to analyze the characteristics of emergent knowledge strategies by comparing them with deliberate knowledge strategies and showing how people can develop such new kinds of strategies. The analysis is based on criteria like time perception, systems thinking, type of knowledge, type of changes, and complexity.
C1 [Bratianu, Constantin] Univ Econ Studies, UNESCO Dept Business Adm, Bucharest, Romania.
   [Bejinaru, Ruxandra] Stefan Cel Mare Univ Suceava, Dept Management Business Adm & Tourism, Suceava, Romania.
RP Bratianu, C (corresponding author), Univ Econ Studies, UNESCO Dept Business Adm, Bucharest, Romania.
EM constantin.bratianu@gmail.com
RI Bejinaru, Ruxandra/AAW-4372-2021; Bratianu, Constantin/L-3402-2018
OI Bejinaru, Ruxandra/0000-0003-2331-155X; Bratianu,
   Constantin/0000-0002-1029-7384
CR Ale-Chilet J., 2020, COVID EC VETTED REAL, V14, P57
   Alvarez A, 2020, ETIKK PRAKSIS, V14, P1
   Argote L., 2013, ORG LEARNING CREATIN
   Baba C.A., 2020, THEORETICAL APPL EC, V27, P271
   Baldwin R., 2020, MITIGATING COVID EC
   Bereiter C., 2002, ED MIND KNOWLEDGE AG
   Bolisani E., 2018, EMERGENT KNOWLEDGE S
   Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6
   Bratianu C., 2015, J DYNAMICS KNOWLEDGE, V3, P409
   Bratianu C., 2019, MANAGEMENT DYNAMICS, V7, P353
   Bratianu C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041348
   Bratianu C, 2020, KYBERNETES, V49, P6, DOI 10.1108/K-02-2019-0122
   Bratianu C, 2019, SYSTEMS-BASEL, V7, DOI 10.3390/systems7020020
   Bratianu C, 2015, PROC CONF EUR MANAG, P28
   Bratianu C, 2014, PROC INT CONF INTELL, P83
   Bratianu C, 2011, PROCEEDINGS OF THE 3RD EUROPEAN CONFERENCE ON INTELLECTUAL CAPITAL, P94
   Bratianu C, 2010, INT J INNOV LEARN, V8, P393, DOI 10.1504/IJIL.2010.035749
   Cegarra-Navarro JG, 2005, J STRATEG MARK, V13, P3, DOI 10.1080/0965254042000328686
   Ceruti M., 2020, TRANSLATING KNOWLEDG
   Coibion O, 2020, 8238 CESIFO
   Cornelissen JP, 2008, ORGAN STUD, V29, P7, DOI 10.1177/0170840607086634
   De Meyer A., 2002, MIT SLOAN MANAGEMENT
   Donate MJ, 2012, J KNOWL MANAG, V16, P22, DOI 10.1108/13673271211198927
   Fauconnier Gilles., 2002, WAY WE THINK CONCEPT
   Cegarra-Navarro JG, 2019, J ORGAN CHANGE MANAG, V32, P67, DOI 10.1108/JOCM-04-2018-0107
   Garcia-Perez A., 2020, CRITICAL CAPABILITIE
   Gentner D, 2001, ANALOGICAL MIND PERS
   Google, 2020, GUID HELP BUS AD THE
   Gourinchas P.-O., 2020, MITIGATING COVID EC, P31
   Grant RM, 1997, LONG RANGE PLANN, V30, P450, DOI 10.1016/S0024-6301(97)00025-3
   Hasanat M., 2020, ASIAN J MULTIDISC ST, V3, P85
   Jackson M.C., 2019, CRITICAL SYSTEMS THI
   Kahneman D., 2011, THINKING
   Kuhn T., 1970, STRUCTURE SCI REVOLU
   Kumudumali S.H.T., 2020, IMPACT COVID 19 TOUR
   Lafayette B., 2019, KNOWLEDGE EC KNOWLED
   Lakoff G., 1999, PHILOS FLESH EMBODIE
   Martinez-Martinez A, 2019, MANAG RES REV, V42, P662, DOI 10.1108/MRR-02-2018-0091
   Martinez-Martinez A, 2018, ANATOLIA, V29, P605, DOI 10.1080/13032917.2018.1519180
   McKibbin W., 2018, 172018 CAMA AUSTR NA
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Michael Porter M., 1985, COMPETITIVE ADVANTAG
   Mintzberg H, 2000, RISE FALL STRATEGIC
   Murgatroyd S., 2015, RETHINK FUTURE MAKIN
   Nonaka I., 1995, KNOWLEDGE CREATING C
   Peeri NC, 2020, INT J EPIDEMIOLOGY
   Pinker S, 2008, STUFF THOUGHT LANGUA
   Reeves M., 2020, HARVARD BUS REV
   Senge P. M., 1990, 5 DISCIPLINE ART PRA
   Snyman R., 2004, Journal of Knowledge Management, V8, P5, DOI 10.1108/13673270410523871
   Solnit R., 2020, GUARDIAN
   Spender J.-C., 2014, BUSINESS STRATEGY MA
   Spender JC, 1996, STRATEGIC MANAGE J, V17, P45, DOI 10.1002/smj.4250171106
   Spender JC, 2014, STRATEGIC CONVERSATIONS: CREATING AND DIRECTING THE ENTREPRENEURIAL WORKFORCE, P1, DOI 10.1017/CBO9781139566940
   Stacey, 2001, COMPLEX RESPONSIVE P
   Sveiby K.E., 2001, J INTELLECT CAP, V2, P344, DOI DOI 10.1108/14691930110409651
   Syrett M, 2012, MANAGING UNCERTAINTY
   Taleb N.N., 2007, BLACK SWAN IMPACT HI
   Vatamanescu EM, 2020, J KNOWL MANAG, V24, P1369, DOI 10.1108/JKM-01-2020-0010
   Vatamanescu EM, 2014, STRATEGICA, P537
   Wang CY, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020036
   World Health Organization, 2020, 177 WHO
   Zack MH, 1999, CALIF MANAGE REV, V41, P125, DOI 10.2307/41166000
   Zhong N., 2020, CORONAVIRUS PREVENTI
NR 64
TC 15
Z9 15
U1 6
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
PD JAN
PY 2021
VL 28
IS 1
BP 11
EP 17
DI 10.1002/kpm.1656
EA DEC 2020
PG 7
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA QA5TI
UT WOS:000595273200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Amos, D
   Au-Yong, CP
   Musa, ZN
AF Amos, Daniel
   Au-Yong, Cheong Peng
   Musa, Zairul Nisham
TI Enhancing the role of facilities management in the fight against the
   COVID-19 (SARS-CoV-2) pandemic in developing countries' public hospitals
SO JOURNAL OF FACILITIES MANAGEMENT
LA English
DT Article
DE Africa; Viewpoint; Pandemic; COVID-19; FM interventions; Health-care
   facilities management
ID PERFORMANCE-MEASUREMENT
AB Purpose
   This paper aims to present a review of the current COVID-19 pandemic with particular emphasis on developing countries in Africa. It aims to demonstrate how facilities management (FM) services delivery in public hospitals can be improved for the fight against the COVID-19 pandemic.
   Design/methodology/approach
   This paper embraces a review of current literature on COVID-19 and FM together with credible media updates. The paper critically synthesizes knowledge on the pandemic to position a technical view on how FM can be improved in the fight against the COVID-19 pandemic.
   Findings
   The COVID-19 pandemic presents unprecedented challenges and realities to the health-care system of most African countries. Despite the significant efforts being made by various governments, there appears to be a lack of a coherent and strategic FM plan to fight the pandemic. To create the necessary antivirus built environment, actionable and timely FM interventions are needed.
   Research limitations/implications
   The report herein is case guarded, based on the prevailing data and information as at the time of writing the paper. Nevertheless, the recommendations from the paper are useful for a worse future trajectory of the pandemic.
   Practical implications
   Knowledge of the proposed interventions will inform and assist health-care facilities managers in the fight against the COVID-19 pandemic.
   Originality/value
   The paper presents the first step towards encapsulating knowledge on FM and the COVID-19 pandemic. It sets forth recommendations that are useful for most developing countries' public hospitals' FM practices in the fight against this global pandemic. The authors intend to follow-up with future empirical studies for more objective assessments of FM and the COVID-19 pandemic.
C1 [Amos, Daniel] Kumasi Tech Univ, Dept Estate Management, Kumasi, Ghana.
   [Amos, Daniel; Au-Yong, Cheong Peng] Univ Malaya, Fac Built Environm, Ctr Bldg Construct & Trop Architecture, Dept Bldg Surveying, Kuala Lumpur, Malaysia.
   [Musa, Zairul Nisham] Univ Malaya, Fac Built Environm, Dept Estate Management, Kuala Lumpur, Malaysia.
RP Amos, D (corresponding author), Kumasi Tech Univ, Dept Estate Management, Kumasi, Ghana.; Amos, D (corresponding author), Univ Malaya, Fac Built Environm, Ctr Bldg Construct & Trop Architecture, Dept Bldg Surveying, Kuala Lumpur, Malaysia.
EM amosdaniel20@yahoo.com; auyongcp@um.edu.my; zairul@um.edu.my
RI Au-Yong, Cheong Peng/K-7599-2012; AMOS, DANIEL/AAV-1272-2021; MUSA,
   ZAIRUL NISHAM/C-1125-2010
OI Au-Yong, Cheong Peng/0000-0003-1306-9595; AMOS,
   DANIEL/0000-0002-7870-5735; MUSA, ZAIRUL NISHAM/0000-0003-3581-1893
CR Adzei, 2012, CLIN GOVERNANCE INT, V17, P178, DOI [10.1108/14777271211251291, DOI 10.1108/14777271211251291]
   Akortsu Mercy Akosua, 2011, J Health Organ Manag, V25, P128
   Amankwah O, 2019, ENVIRON HEALTH INSIG, V13, DOI 10.1177/1178630219852115
   Amos D., 2020, FACILITIES, V38, P715
   Amos D, 2020, BUILD RES INF, V48, P218, DOI 10.1080/09613218.2019.1660607
   Atinga RA, 2013, INT J SOC ECON, V40, P852, DOI 10.1108/IJSE-2011-0075
   British Broadcasting Corporation (BBC), 2018, COR VIS AFR CONT UN
   Dietz L, 2020, MSYSTEMS, V5, DOI [10.1128/mSystems.00245-20, 10.1128/mSystems.00245-20.]
   Eykelbosh A., 2020, COVID 19 PRECAUTIONS
   Goniewicz K, 2020, SUSTAINABILITY, V12, P1
   Horve PF, 2020, J EXPO SCI ENV EPID, V30, P219, DOI 10.1038/s41370-019-0157-y
   Kashdan R., 2020, 6 WAYS URBAN SPACES
   Koleoso HA, 2017, J FACIL MANAG, V15, P128, DOI 10.1108/JFM-04-2016-0015
   Lucas J, 2013, J PERFORM CONSTR FAC, V27, P748, DOI 10.1061/(ASCE)CF.1943-5509.0000364
   Makoni M, 2020, LANCET, V395, P483, DOI 10.1016/S0140-6736(20)30355-X
   Megahed NA, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102350
   Molla R, 2020, THIS IS END OFFICE W
   National Health Service (NHS), 1998, HLTH FAC NOT HFN 17
   Njuangang S, 2016, FACILITIES, V34, P766, DOI 10.1108/F-12-2014-0107
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Ozili P, 2022, INT J SOCIOL SOC POL, V42, P177, DOI 10.1108/IJSSP-05-2020-0171
   Pinheiro MD, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145863
   Robbins T, 2020, DIGIT HEALTH, V6, DOI 10.1177/2055207620920083
   Rodriguez-Labajos L, 2018, J FACIL MANAG, V16, P217, DOI 10.1108/JFM-10-2017-0052
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Shohet IM, 2017, INT J STRATEG PROP M, V21, P58, DOI 10.3846/1648715X.2016.1245684
   Sizun J, 2000, J HOSP INFECT, V46, P55, DOI 10.1053/jhin.2000.0795
   WHO, 2020, COVID 19 STRAT RESP
   World Health Organization (WHO), 2016, 2016 ANN REP
NR 29
TC 2
Z9 2
U1 3
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1472-5967
EI 1741-0983
J9 J FACIL MANAG
JI J. Facil. Manag.
PD JAN 25
PY 2021
VL 19
IS 1
BP 22
EP 31
DI 10.1108/JFM-06-2020-0034
EA NOV 2020
PG 10
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA PV2LS
UT WOS:000590177200001
DA 2022-04-20
ER

PT J
AU Vanassche, T
   Orlando, C
   Vandenbosch, K
   Gadisseur, A
   Hermans, C
   Jochmans, K
   Minon, JM
   Motte, S
   Peperstraete, H
   Peters, P
   Sprynger, M
   Lancellotti, P
   Dehaene, I
   Emonts, P
   Vandenbriele, C
   Verhamme, P
   Oury, C
AF Vanassche, Thomas
   Orlando, Christelle
   Vandenbosch, Kristel
   Gadisseur, Alain
   Hermans, Cedric
   Jochmans, Kristin
   Minon, Jean-Marc
   Motte, Serge
   Peperstraete, Harlinde
   Peters, Pierre
   Sprynger, Muriel
   Lancellotti, Patrizio
   Dehaene, Isabelle
   Emonts, Patrick
   Vandenbriele, Christophe
   Verhamme, Peter
   Oury, Cecile
TI Belgian clinical guidance on anticoagulation management in hospitalised
   and ambulatory patients with COVID-19
SO ACTA CLINICA BELGICA
LA English
DT Article
DE Practice guideline; primary health care; COVID-19
AB Objectives COVID-19 predisposes patients to thrombotic disease. The aim of this guidance document is to provide Belgian health-care workers with recommendations on anticoagulation management in COVID-19 positive patients. Methods These recommendations were based on current knowledge and a limited level of evidence. Results We formulated recommendations for the prophylaxis and treatment of COVID-related venous thromboembolism in ambulatory and hospitalised patients, as well as recommendations for the use of antithrombotic drugs in patients with prior indication for anticoagulation who develop COVID-19. Conclusions These recommendations represent an easy-to-use practical guidance that can be implemented in every Belgian hospital and be used by primary care physicians and gynaecologists. Of note, they are likely to evolve with increased knowledge of the disease and availability of data from ongoing clinical trials.
C1 [Vanassche, Thomas; Vandenbriele, Christophe; Verhamme, Peter] Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium.
   [Orlando, Christelle; Jochmans, Kristin] Univ Ziekenhuis Brussel, Vrije Univ Brussel VUB, Dept Haematol, Brussels, Belgium.
   [Vandenbosch, Kristel; Peters, Pierre] CHU Univ Hosp Liege, Dept Lab Haematol, Liege, Belgium.
   [Gadisseur, Alain] Antwerp Univ Hosp, Dept Haematol, Antwerp, Belgium.
   [Hermans, Cedric] Clin Univ St Luc, Dept Haematol, Brussels, Belgium.
   [Minon, Jean-Marc] CHR Citadelle, Thrombosis Haemostasis & Transfus Unit, Dept Lab Med, Liege, Belgium.
   [Motte, Serge] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Vasc Dis, Brussels, Belgium.
   [Peperstraete, Harlinde] Ghent Univ Hosp, Dept Cardiac Intens Care, Ghent, Belgium.
   [Sprynger, Muriel; Lancellotti, Patrizio] CHU Univ Hosp Liege, Dept Cardiol, Liege, Belgium.
   [Dehaene, Isabelle] Univ Ziekenhuis Gent, Vlaamse Vereniging Obstet Gynaecol, Ghent, Belgium.
   [Emonts, Patrick] CHU Univ Hosp Liege, Grp Gynecologues Obstetriciens Langue Francaise B, Liege, Belgium.
   [Oury, Cecile] Univ Liege, GIGA Inst, Lab Cardiol, Liege, Belgium.
RP Oury, C (corresponding author), Univ Liege, GIGA Cardiovasc Sci, Lab Cardiol, B-4000 Liege, Belgium.; Vanassche, T (corresponding author), Ctr Mol Vasc Biol, UZ Herestr 49, B-3000 Leuven, Belgium.
EM thomas.vanassche@kuleuven.be; cecile.oury@uliege.be
RI Gadisseur, Alain/AAW-9867-2021; sprynger, muriel/ABB-2766-2020;
   Sprynger, Muriel/ABD-6552-2021
OI Orlando, Christelle/0000-0003-2163-8778
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   Atallah B, 2020, EUR HEART J-CARD PHA, V6, P260, DOI 10.1093/ehjcvp/pvaa036
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Bikdeli B, 2020, THROMB HAEMOSTASIS, V120, P1004, DOI 10.1055/s-0040-1713152
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Giusti B, 2020, THROMB HAEMOSTASIS, V120, P1233, DOI 10.1055/s-0040-1712918
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   HELMS J, 2020, INTENS CARE MED 0504, DOI DOI 10.1007/S00134-020-06062-X
   Kirchhof P, 2016, EUROPACE, V18, DOI [10.5603/KP.2016.0172, 10.1093/europace/euw295]
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Konstantinides Stavros V, 2019, Eur Respir J, V54, DOI 10.1183/13993003.01647-2019
   Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561
   Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9
   Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869
   McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Sebaaly J, 2018, ANN PHARMACOTHER, V52, P898, DOI 10.1177/1060028018768449
   Shang Y, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00689-1
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829
   Testa S, 2020, J THROMB HAEMOST, V18, P1320, DOI 10.1111/jth.14871
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Thachil J, 2020, J THROMB HAEMOST, V18, P1020, DOI 10.1111/jth.14821
   Wada Kai, 2013, J Circadian Rhythms, V11, P4, DOI 10.1186/1740-3391-11-4
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wiegers HMG, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620914222
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yu  BL, 2020, J THROMB THROMBOLYS, V50, P548, DOI 10.1007/s11239-020-02171-y
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 36
TC 4
Z9 4
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1784-3286
EI 2295-3337
J9 ACTA CLIN BELG
JI Acta Clin. Belg.
PD MAR 4
PY 2022
VL 77
IS 2
BP 280
EP 285
DI 10.1080/17843286.2020.1829252
EA OCT 2020
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA ZN8RJ
UT WOS:000574979100001
PM 33012274
OA Bronze, Green Accepted, Green Submitted
DA 2022-04-20
ER

PT J
AU Alshammary, F
   Siddiqui, AA
   Amin, J
   Ilyas, M
   Rathore, HA
   Hassan, I
   Alam, MK
   Kamal, MA
AF Alshammary, Freah
   Siddiqui, Ammar Ahmed
   Amin, Junaid
   Ilyas, Muhammad
   Rathore, Hassaan Anwer
   Hassan, Ibne
   Alam, Mohammad Khursheed
   Kamal, Mohammad Amjad
TI Prevention Knowledge and Its Practice Towards COVID-19 Among General
   Population of Saudi Arabia: A Gender-based Perspective
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE COVID-19; Corona virus; preventive knowledge; practice; saudi males and
   females; gender-based
ID BEHAVIOR
AB Background: This study is an original contribution to the gender-based perspective of measuring knowledge and practice towards COVID-19 among the Saudi population.
   Objective: This study investigates the existing knowledge of COVID-19 among both genders and its likely use in practice to combat COVID-19.
   Design and Setting: Cross-sectional study with an online survey and data collected from all the five regions of Saudi Arabia.
   Participants and Methods: A structured, self-reported validated questionnaire was developed based on the World Health Organization (WHO) general public advice towards COVID-19 prevention. This study has employed snow-ball sampling technique. Sample Size: 627 participants (Male n=343, 54.7%) and (Females n=284, 45.3%).
   Results: This study has found that women not only carry better knowledge, but their practicing behavior is far better than the male respondents. Females practiced their knowledge of hands hygiene more in comparison to males (86% vs. 80 %, p > 0.05). Female respondents were also practicing more about sneezing/coughing into their elbows as compared to males (79% vs. 71%, p < 0.05). Likewise, the practice of knowledge of staying at home to prevent infection (females 98.2% vs males 95.5%, p > 0.05), and (females 83.2% vs. males 81.5%, p > 0.05), respectively.
   Conclusion: This study shows that women were more compliant with the WHO public health COVID-19 prevention advice than men, which can decrease the chances of COVID-19 infection.
C1 [Alshammary, Freah; Siddiqui, Ammar Ahmed] Univ Hail, Coll Dent, Prevent Dent Sci, Hail, Saudi Arabia.
   [Amin, Junaid] Univ Hail, Coll Appl Med Sci, Hail, Saudi Arabia.
   [Ilyas, Muhammad; Hassan, Ibne] Univ Hail, Coll Business Management, Hail, Saudi Arabia.
   [Rathore, Hassaan Anwer] Univ Hail, Coll Pharm, Hail, Saudi Arabia.
   [Alam, Mohammad Khursheed] Jouf Univ, Coll Dent, Prevent Dent Sci Sakakah, Sakakah, Saudi Arabia.
   [Kamal, Mohammad Amjad] King Abdulaziz Univ, King Fahad Med Res Ctr, Jeddah, Saudi Arabia.
RP Siddiqui, AA (corresponding author), Univ Hail, Coll Dent, Dept Prevent Dent, Hail, Saudi Arabia.
EM ammarqta2002@hotmail.com
RI Kamal, Mohammad Amjad/J-2918-2014; Rathore, Hassaan A/A-6016-2012;
   Ilyas, Muhammad/AAS-6694-2020; Siddiqui, Ahmed/M-3442-2015; Rathore,
   Hassaan Anwer/P-1407-2015; Amin, junaid/AAH-6450-2019
OI Kamal, Mohammad Amjad/0000-0003-0088-0565; Rathore, Hassaan
   A/0000-0002-1154-9395; Siddiqui, Ahmed/0000-0002-8816-6421; Rathore,
   Hassaan Anwer/0000-0002-1154-9395; Amin, junaid/0000-0002-4343-2255
FU Scientific Research Deanship at the University of Hail, Saudi Arabia
   [COVID1906]
FX This research was funded by Scientific Research Deanship at the
   University of Hail, Saudi Arabia with project no. COVID1906.
CR [Anonymous], 2020, LANCET, V395, P1168, DOI 10.1016/S0140-6736(20)30823-0
   CENTERS FOR DISEASE CONTROL AND PREVENTION, INT GUID PERS WHO MA
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Kim, 2016, PSYCHOSOCIAL ASPECTS, P287
   Liu SW, 2017, J EPIDEMIOL COMMUN H, V71, P154, DOI 10.1136/jech-2016-207805
   Mariwah S, 2012, TROP MED INT HEALTH, V17, P447, DOI 10.1111/j.1365-3156.2011.02950.x
   MOH, NOV COR VIR COVID 19
   Smith J., 2019, Gender and Development, V27, P355, DOI 10.1080/13552074.2019.1615288
   Suen LKP, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6705-5
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   Wenham C, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0489-3
   World Health Organization, SIT REP
   World Health Organization, NOV COR VIR
   World Health Organization World Health Organization, REP WHO CHIN JOINT M
   Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 18
TC 5
Z9 5
U1 2
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD APR
PY 2021
VL 27
IS 13
BP 1642
EP 1648
DI 10.2174/1381612826666200818213558
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA SM3BA
UT WOS:000657483200011
PM 32811408
DA 2022-04-20
ER

PT J
AU Jouzdani, J
AF Jouzdani, Javid
TI Fight against COVID-19: A global outbreak response management
   performance view
SO JOURNAL OF PROJECT MANAGEMENT
LA English
DT Article
DE COVID-19; Outbreak Response Management; Statistical Data Analysis
AB Outbreak response can be viewed as a project for which the window of opportunity for planning is often quite limited. Therefore, regular evaluation for sharing the lessons learned is crucial, especially in the cases of national and global crises. As one of the major global concerns, the novel coronavirus, also known as COVID-19, has infected and killed many people in several countries worldwide. Hence, it is worth analyzing the performance of different countries in this regard. In this paper, the confirmed Case Fatality Rate (cCFR), and the confirmed Case Recovery Rate (cCRR) are considered as the main performance criteria, and the data are analyzed utilizing statistical confidence intervals (CIs) implemented in Python. The results identify the regions with high cCFR and low cCRR, as well as the regions with low cCFR and high cCRR. Finally, it is suggested to systematically transfer the knowledge and lessons learned from the high performing countries to where such information and knowledge is needed. (C) 2020 by the authors; licensee Growing Science, Canada.
C1 [Jouzdani, Javid] Golpayegan Univ Technol, Dept Ind Engn, Golpayegan, Iran.
RP Jouzdani, J (corresponding author), Golpayegan Univ Technol, Dept Ind Engn, Golpayegan, Iran.
EM jouzdani@gut.ac.ir
CR [Anonymous], 2020, 2019 NOV COR COVID 1
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230
   Jung SM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020523
   Montgomery D.C., 2010, APPL STAT PROBABILIT
   Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852
   Rosen W., 2010, JUSTINIANS FLEA PLAG
   Velavan TP, 2020, TROPICAL MED INT HLT
NR 8
TC 2
Z9 3
U1 2
U2 8
PU GROWING SCIENCE
PI TORONTO
PA 611, 141 DAVISVILLE AVE, TORONTO, ON M4S 1G7, CANADA
SN 2371-8366
EI 2371-8374
J9 J PROJ MANAGE
JI J. Proj. Manag.
PY 2020
VL 5
IS 3
BP 151
EP 156
DI 10.5267/j.jpm.2020.3.001
PG 6
WC Engineering, Industrial; Management
WE Emerging Sources Citation Index (ESCI)
SC Engineering; Business & Economics
GA MA2PZ
UT WOS:000541761000001
OA gold
DA 2022-04-20
ER

PT J
AU Tonnessen, O
   Dhir, A
   Flaten, BT
AF Tonnessen, Oystein
   Dhir, Amandeep
   Flaten, Bjorn-Tore
TI Digital knowledge sharing and creative performance: Work from home
   during the COVID-19 pandemic
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE COVID-19 pandemic; Creative performance; Digital knowledge sharing;
   Social capital; Work from home
ID PROMOTING EMPLOYEE CREATIVITY; TRANSFORMATIONAL LEADERSHIP; INNOVATIVE
   CLIMATE; SOCIAL NETWORKS; IMPACT; ORGANIZATIONS; TECHNOLOGY; TELEWORKER;
   DIVERSITY; IDEAS
AB The outbreak of the COVID-19 pandemic and the resulting social distancing requirements have led to major disruptions in the world of work. The outcomes of the enforced and large-scale work from home (WFH) practices are currently largely unexplored. This study aims to address this gap in the research by investigating the external and internal digital knowledge sharing (DKS) and creative performance (CP) of employees under these extraordinary circumstances. The social capital theory was utilized as the theoretical lens for examining the associations of DKS and CP with demographic, individual, and organizational factors. An online cross-sectional survey was carried out among knowledge workers based in Norway during the pandemic lockdown. The study results indicate that internal and external DKS are significant predictors of CP in the WFH context during the COVID-19 pandemic. Females and older employees are more likely to engage in external DKS than their counterparts. Furthermore, individual motivation is found to be positively associated with internal DKS, external DKS, and CP. The findings suggest that increased use of digital platforms helps increase CP in the WFH setting resulting from the pandemic. Various theoretical and practical implications are discussed, and future research avenues are proposed.
C1 [Tonnessen, Oystein; Dhir, Amandeep; Flaten, Bjorn-Tore] Univ Agder, Sch Business & Law, Dept Management, Kristiansand, Norway.
   [Tonnessen, Oystein] Egde Consulting AS, Kristiansand, Norway.
   [Dhir, Amandeep] Univ Stavanger, Norwegian Sch Hotel Management, Stavanger, Norway.
   [Dhir, Amandeep] North West Univ, Optentia Res Focus Area, Vanderbijlpark, South Africa.
RP Tonnessen, O (corresponding author), Univ Agder, Sch Business & Law, Dept Management, Kristiansand, Norway.; Tonnessen, O (corresponding author), Egde Consulting AS, Kristiansand, Norway.
EM oystein.tonnessen@egde.no
RI Dhir, Amandeep/F-1826-2013
OI Dhir, Amandeep/0000-0002-6006-6058; Tonnessen,
   Oystein/0000-0003-3985-8592
CR Aastveit KA, 2012, EMPIR ECON, V42, P95, DOI 10.1007/s00181-010-0429-9
   Alge BJ, 2006, J APPL PSYCHOL, V91, P221, DOI 10.1037/0021-9010.91.1.221
   Allen TD, 2015, PSYCHOL SCI PUBL INT, V16, P40, DOI 10.1177/1529100615593273
   Alonso AD, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102654
   Alstadsaeter A, 2020, NATL TAX J, V73, P805, DOI 10.17310/ntj.2020.3.08
   Amabile T.M., 1996, CREATIVITY CONTEXT
   AMABILE TM, 1988, RES ORGAN BEHAV, V10, P123
   Amabile TM, 2002, HARVARD BUS REV, V80, P52
   Anderson D.M., 2005, J ASYNCHRONOUS LEARN, V9, P3
   Anderson N, 2004, J ORGAN BEHAV, V25, P147, DOI 10.1002/job.236
   Anderson N, 2014, J MANAGE, V40, P1297, DOI 10.1177/0149206314527128
   Aral S, 2007, ORGAN SCI, V18, P763, DOI 10.1287/orsc.1070.0306
   Baert S., 2020, 13229 IZA
   Bailey D, 2020, REG STUD, V54, P1163, DOI 10.1080/00343404.2020.1798611
   Bakko E, 2002, TAX MANAG INT J, V31, P387
   Belanger F, 2008, INFORM SYST J, V18, P101, DOI 10.1111/j.1365-2575.2007.00252.x
   Blankenship SS, 2009, ADV DEV HUM RESOUR, V11, P290, DOI 10.1177/1523422309338578
   Breene K., 2016, WORLD EC FORUM
   Brem A, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120451
   Brown JS, 2001, ORGAN SCI, V12, P198, DOI 10.1287/orsc.12.2.198.10116
   Cai WJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17031038
   Carmeli A, 2013, HUM RESOUR MANAGE-US, V52, P95, DOI 10.1002/hrm.21514
   Chandra S, 2020, TECHNOL FORECAST SOC, V161, DOI 10.1016/j.techfore.2020.120320
   Charband Y, 2016, INFORM SYST FRONT, V18, P1131, DOI 10.1007/s10796-016-9628-z
   Chen MH, 2008, R&D MANAGE, V38, P21, DOI 10.1111/j.1467-9310.2007.00494.x
   Chen MH, 2015, CREAT INNOV MANAG, V24, P493, DOI 10.1111/caim.12108
   Chen XY, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106421
   Chesbrough H, 2020, IND MARKET MANAG, V88, P410, DOI 10.1016/j.indmarman.2020.04.010
   Choudhury P., 2020, WORKING HOME CRISIS WORKING HOME CRISIS
   Cohen AK, 2021, POPUL HEALTH MANAG, V24, P153, DOI 10.1089/pop.2020.0119
   Cross R, 2004, ACAD MANAGE J, V47, P928, DOI 10.2307/20159632
   Cummings JN, 2004, MANAGE SCI, V50, P352, DOI 10.1287/mnsc.1030.0134
   Davenport T., 2005, THINKING LIVING GET
   Davison C., 2020, LEVERAGE COVID 19 PA
   dOvidio M., 2019, SOCIOLOGICA, V13, P16, DOI [10.6092/issn.1971-8853/9388, DOI 10.6092/ISSN.1971-8853/9388]
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   Elia G, 2020, TECHNOL FORECAST SOC, V150, DOI 10.1016/j.techfore.2019.119791
   European Commission, 2020, DIG EC SOC IND DESI
   Ferraris A, 2020, J INT MANAG, V26, DOI 10.1016/j.intman.2020.100794
   Ferraris A, 2021, BRIT FOOD J, V123, P143, DOI 10.1108/BFJ-07-2019-0502
   Ford C.M., 1999, CREATIVITY INNOVATIO, V8, P188
   Ford CM, 1996, ACAD MANAGE REV, V21, P1112, DOI 10.5465/amr.1996.9704071865
   Ford CM., 2008, CREAT INNOV MANAG, V17, P171
   Foss L, 2013, INT J GEND ENTREP, V5, P298, DOI 10.1108/IJGE-09-2012-0049
   Garfin DR, 2020, STRESS HEALTH, V36, P555, DOI 10.1002/smi.2975
   Garrett RK, 2007, SOC SCI COMPUT REV, V25, P27, DOI 10.1177/0894439306293819
   Goh S.-.K., 2020, ELECT J KNOWLEDGE MA, V18, P1
   Golden TD, 2006, J ORGAN BEHAV, V27, P319, DOI 10.1002/job.369
   Golden TD, 2019, J BUS PSYCHOL, V34, P55, DOI 10.1007/s10869-018-9530-4
   Golden TD, 2010, J ORGAN BEHAV, V31, P1061, DOI 10.1002/job.652
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469
   Grant AM, 2011, ACAD MANAGE J, V54, P73, DOI 10.5465/AMJ.2011.59215085
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Hartley J, 2006, PUBLIC MONEY MANAGE, V26, P101, DOI 10.1111/j.1467-9302.2006.00508.x
   Hoff EV, 2015, INT J HUM RESOUR MAN, V26, P1889, DOI 10.1080/09585192.2014.971842
   Hon AHY, 2013, INT J HOSP MANAG, V33, P416, DOI 10.1016/j.ijhm.2012.11.001
   Hu LY, 2014, GROUP ORGAN MANAGE, V39, P213, DOI 10.1177/1059601114520969
   Inkpen AC, 2005, ACAD MANAGE REV, V30, P146, DOI 10.5465/AMR.2005.15281445
   Jackson D., 2020, J CLIN NURS
   Jaiswal A., 2020, UNLOCKING COVID 19 L
   Jaiswal NK, 2015, INT J HOSP MANAG, V51, P30, DOI 10.1016/j.ijhm.2015.07.002
   Jensen R, 2004, J INT BUS STUD, V35, P508, DOI 10.1057/palgrave.jibs.8400107
   Kim SK, 2018, J CREATIVE BEHAV, V52, P285, DOI 10.1002/jocb.153
   Kirchner K, 2021, KNOWL MAN RES PRACT, V19, P493, DOI 10.1080/14778238.2021.1877579
   Korzynski P, 2020, MANAGE DECIS, V58, P1100, DOI 10.1108/MD-05-2018-0586
   Kremer H, 2019, BUS HORIZONS, V62, P65, DOI 10.1016/j.bushor.2018.08.010
   Kumar P, 2021, CURR PSYCHOL, V40, P6308, DOI 10.1007/s12144-021-01567-0
   Lee ASH, 2021, J COMPUT INFORM SYST, V61, P458, DOI 10.1080/08874417.2020.1752850
   Lee JN, 2001, INFORM MANAGE, V38, P323, DOI 10.1016/S0378-7206(00)00074-4
   Lee J, 2018, ADM SCI, V8, DOI [10.3390/admsci8020021, 10.21742/AJMAHS.2018.07.12]
   Lee SM, 2021, TECHNOL FORECAST SOC, V167, DOI 10.1016/j.techfore.2021.120712
   Lin HF, 2007, J INF SCI, V33, P135, DOI 10.1177/0165551506068174
   Lin N., 2002, SOCIAL CAPITAL THEOR, V19
   Liu Feng-Chuan, 2012, Chang Gung Med J, V35, P408
   Luo C, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120438
   Ma W, 2011, GENDER DIFFERENCES K, DOI [10.1007/978-3-642-22763-9_11, DOI 10.1007/978-3-642-22763-9_11]
   Margherita A, 2021, TECHNOL FORECAST SOC, V166, DOI 10.1016/j.techfore.2021.120656
   Marquie JC, 2002, BEHAV INFORM TECHNOL, V21, P273, DOI 10.1080/0144929021000020998
   Mercier M, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.601150
   Mimoun E, 2020, PSYCHOL TRAUMA-US, V12, pS183, DOI 10.1037/tra0000769
   Moolenaar NM, 2014, J EDUC CHANG, V15, P99, DOI 10.1007/s10833-014-9230-4
   Moolenaar NM, 2010, EDUC ADMIN QUART, V46, P623, DOI 10.1177/0013161X10378689
   Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373
   Naotunna N.P.G, 2018, INT J ORG INNOVAT, V10
   Newton K, 2001, INT POLIT SCI REV, V22, P201, DOI 10.1177/0192512101222004
   Ng TWH, 2013, J OCCUP ORGAN PSYCH, V86, P585, DOI 10.1111/joop.12031
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Nielsen J, 2002, USABILITY SENIOR CIT, P28
   Nonaka I., 1995, KNOWLEDGE CREATING C
   OECD, 2020, OECD INT EC ASS SEP OECD INT EC ASS SEP
   Oldham GR, 2015, COMPUT HUM BEHAV, V42, P5, DOI 10.1016/j.chb.2013.10.041
   Pacheco V., 2020, MACHESTER J ARTIFIC, V1, P28
   Perry-Smith JE, 2003, ACAD MANAGE REV, V28, P89
   Rese A, 2020, J KNOWL MANAG, V24, P2327, DOI 10.1108/JKM-04-2020-0243
   Romero M., 2012, CREATIVE ED, V3, P422, DOI DOI 10.4236/CE.2012.34066
   Roskes M, 2015, CREAT INNOV MANAG, V24, P197, DOI 10.1111/caim.12086
   Sandhu MS, 2011, INT J PUBLIC SECT MA, V23, P206, DOI 10.1108/09513551111121347
   Savic D, 2020, GREY J TGJ, V16
   Serenko A., 2007, J INTELL CAPITAL, V8
   Shalley CE, 2001, ORGAN BEHAV HUM DEC, V84, P1, DOI 10.1006/obhd.2000.2918
   Soda G, 2019, J MANAGE, V45, P1739, DOI 10.1177/0149206317724509
   Sosa ME, 2011, ORGAN SCI, V22, P1, DOI 10.1287/orsc.1090.0519
   Sousa CMP, 2011, EUR J MARKETING, V45, P1029, DOI 10.1108/03090561111137598
   Tassabehji R, 2019, PROD PLAN CONTROL, V30, P935, DOI 10.1080/09537287.2019.1582101
   Tortoriello M, 2012, ORGAN SCI, V23, P1024, DOI 10.1287/orsc.1110.0688
   Nguyen TM, 2019, VINE J INF KNOWL MAN, V50, P75, DOI 10.1108/VJIKMS-02-2019-0019
   van der Meulen N, 2019, J INF TECHNOL, V34, P243, DOI 10.1177/0268396218816531
   van der Vegt GS, 2005, ACAD MANAGE J, V48, P1171, DOI 10.2307/20159736
   Vega RP, 2015, J BUS PSYCHOL, V30, P313, DOI 10.1007/s10869-014-9359-4
   Venkatesh V, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102197
   Wagner M, 2020, RAUMFORSCH RAUMORDN, V78, P53, DOI 10.2478/rara-2019-0039
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   Wang B, 2021, APPL PSYCHOL-INT REV, V70, P16, DOI 10.1111/apps.12290
   Wang S, 2010, HUM RESOUR MANAGE R, V20, P115, DOI 10.1016/j.hrmr.2009.10.001
   Wasko MM, 2005, MIS QUART, V29, P35, DOI 10.2307/25148667
   Whiteside D.T, 1966, NEWTONS MARVELLOUS Y, V21, P32, DOI [10.1098/rsnr.1966.0004, DOI 10.1098/RSNR.1966.0004]
   WHO, 2021, **NON-TRADITIONAL**
   WOODMAN RW, 1993, ACAD MANAGE REV, V18, P293, DOI 10.2307/258761
   Yang J.T., 2004, J KNOW MANAG
   Yang L., 2020, WORK HOME AFFECTS CO
   Yoo S, 2020, TECHNOL FORECAST SOC, V160, DOI 10.1016/j.techfore.2020.120231
   Zhang YD, 2021, JPN J NURS SCI, V18, DOI 10.1111/jjns.12376
   Zhou J, 2001, J CREATIVE BEHAV, V35, P151, DOI 10.1002/j.2162-6057.2001.tb01044.x
NR 124
TC 13
Z9 13
U1 55
U2 85
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0040-1625
EI 1873-5509
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD SEP
PY 2021
VL 170
AR 120866
DI 10.1016/j.techfore.2021.120866
EA MAY 2021
PG 13
WC Business; Regional & Urban Planning
WE Social Science Citation Index (SSCI)
SC Business & Economics; Public Administration
GA TI1SD
UT WOS:000672564200007
PM 35068596
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Hadriana
   Mahdum
   Isjoni
   Futra, D
   Primahardani, I
AF Hadriana
   Mahdum
   Isjoni
   Futra, Dedi
   Primahardani, Indra
TI ONLINE LEARNING MANAGEMENT IN THE ERA OF COVID-19 PANDEMIC AT JUNIOR
   HIGH SCHOOLS IN INDONESIA
SO JOURNAL OF INFORMATION TECHNOLOGY EDUCATION-RESEARCH
LA English
DT Article
DE online learning; management; COVID-19 pandemic; principals
ID ICT; TEACHERS; LEADERSHIP; STUDENTS
AB Aim/Purpose The purposes of this research are to analyze online learning management activities conducted by the principals of junior high schools in Indonesia in facing COVID-19 as well as to discuss their perspective and expectations towards online learning activities when facing COVID-19 and after COVID-19 has passed.
   Background Due to the rapid spread of the COVID-19 pandemic, the Indonesian Minister of Education and Culture instructed that teaching and learning activities for all levels of education in Indonesia must be carried out online from home. There have been comprehensive reports about the various forms of online learning, its effects on students, the challenges, the learning transition from offline to online, and teachers' views on this new approach. Very few, if any, focus on how principals act upon the transition during this COVID-19 pandemic. Therefore, this research focuses on how principals overcome various problems that arise in the implementation of online learning activities.
   Methodology As many as 309 principals of junior high school from twelve districts in Indonesia were asked to give their responses to a set of questionnaires. The reliability of the questionnaire was analyzed using Cronbach's Alpha with the help of SmartPLS 3.0 software. The percentage was mainly used in the descriptive analysis. To obtain the influence among variables, the statistical inferential analysis was used.
   Contribution Although the sample size of this research is limited, the results may contribute to the existing theory and practice related to the implementation of online learning in Indonesia. The findings of this research could be a guide for principals to manage online learning in the future.
   Findings The data analysis showed that the constructs of organizing and monitoring-evaluation were found to play an important role as a mediator between the variables of planning with implementation of principal management in online learning. Path analysis demonstrated that the implementation variable was significantly influenced by the variables of planning, organizing and monitoring-evaluation, with a contribution value of 78.20%. Thus, it indicated that the planning, organizing and monitoring-evaluation variables contributed directly or indirectly to the implementation of principal management in online learning. Generally, the online learning management activities conducted by the principals of junior high schools in Indonesia have been carried out well, especially in the Implementing aspect. However, the aspects of Planning, as well as Monitoring and Evaluation, still need to be improved.
   Recommendations for Practitioners The government is recommended to provide adequate online learning supporting facilities as well as to facilitate teachers to increase insight and knowledge in terms of technology use, especially in designing, implementing, and providing assessments of online learning. So far, the government has provided some facilities and conveniences to principals and teachers. However, some information and ICT related trainings from the government during the COVID-19 pandemic is not widely known by the principals and the teachers. Socialization about these is needed.
   Recommendations for Researchers This work offers a theoretical understanding of the problems faced by school principals in facing COVID-19. Further research on how principals and teachers manage online learning activities needs to be carried out to solve various problems which might arise during the process of implementation.
   Impact on Society This research suggests that the principals in Indonesia have good online learning management. However, to reach the stated learning objectives efficiently and effectively, the principals need to collaborate with the teachers as the main facilitators of the teaching and learning process. Cooperation with parents is also highly recommended.
   Future Research Further research should focus on how the application of online learning can improve students' achievement through good management and collaboration with teachers, other administration staff at schools, and parents.
C1 [Hadriana; Mahdum; Isjoni; Futra, Dedi; Primahardani, Indra] Univ Riau, Pekanbaru, Indonesia.
RP Hadriana (corresponding author), Univ Riau, Pekanbaru, Indonesia.
EM hadriana@lecturer.unri.ac.id; mahdum.adanan@lecturer.unri.ac.id;
   isjoni@yahoo.com; futra.dedi@yahoo.com;
   indra.primahardani@lecturer.unri.ac.id
RI Hadriana, Hadriana/AAC-3532-2021
OI Hadriana, Hadriana/0000-0002-4323-5622
CR Abou El-Seoud MS, 2014, INT J EMERG TECHNOL, V9, P20, DOI 10.3991/ijet.v9i4.3465
   Adnan, 2020, J PEDAGOGICAL SOCIOL, V1, P45, DOI [10.33902/jpsp.2020261309, DOI 10.33902/JPSP.2020261309]
   Agarwal S, 2020, INDIAN J PEDIATR, V87, P554, DOI 10.1007/s12098-020-03327-7
   Alawamleh M, 2022, ASIAN EDUC DEV STUD, V11, P380, DOI 10.1108/AEDS-06-2020-0131
   Alghamdi A., 2015, AUSTR ED COMPUTING, V30
   Ali W., 2020, HIGH ED STUD, V10, P16, DOI [10.5539/hes.v10n3p16, DOI 10.5539/HES.V10N3P16]
   Almaiah MA, 2020, EDUC INF TECHNOL, V25, P5261, DOI 10.1007/s10639-020-10219-y
   Alt D, 2018, TEACH TEACH EDUC, V73, P141, DOI 10.1016/j.tate.2018.03.020
   Amtu O., 2013, MANAJEMEN PENDIDIKAN
   Besser A., 2020, SCHOLARSH TEACH LEAR, DOI [10.1037/stl0000198, DOI 10.1037/STL0000198]
   Bostan S, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7944
   BPS-Statistics Indonesia, 2021, STAT YB IND 2021
   Bredeson P.V., 2000, J IN SERVICE ED, V26, P385, DOI [10.1080/13674580000200114, DOI 10.1080/13674580000200114]
   Brislin R.W., 1980, TRANSLATION CONTENT, V2, P389
   Brown N., 2020, LEARNING HOME COVID
   Bryman A., 2009, HDB DATA ANAL, P65, DOI DOI 10.4135/9781848608184.
   Cavicchi C, 2018, J ACCOUNT ORGAN CHAN, V14, P138, DOI 10.1108/JAOC-04-2016-0022
   Chen TG, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030200
   Christensen C.M., 2008, DISRUPTING CLASS
   Cleland D.L., 2006, GLOBAL PROJECT MANAG
   Dean J, 1993, MANAGING SECONDARY S, DOI [10.4324/9780203307151, DOI 10.4324/9780203307151]
   Deng F, 2014, EDUC TECHNOL SOC, V17, P245
   Denscombe M, 2010, GOOD RES GUIDE SMALL, V4th
   Dhawan Shivangi, 2020, Journal of Educational Technology Systems, V49, P5, DOI 10.1177/0047239520934018
   Djalante R., 2020, PROGR DISASTER SCI, V6
   Drossel K, 2017, EDUC INF TECHNOL, V22, P551, DOI 10.1007/s10639-016-9476-y
   Ekwonwune E. N., 2019, J SOFTWARE ENG APPL, V12, P21
   Everard K, 2004, EFFECTIVE SCH MANAGE
   Fernandez-Gutierrez M, 2020, COMPUT EDUC, V157, DOI 10.1016/j.compedu.2020.103969
   Ferri F, 2020, SOCIETIES, V10, DOI 10.3390/soc10040086
   Fessehatsion, 2017, J ED PRACTICE, V8, P134
   Fowler FC., 2013, POLICY STUDIES ED LE
   Fullan, 2001, LEADING CULTURE CHAN
   Garrison DR, 2013, INTERNET HIGH EDUC, V18, P24, DOI 10.1016/j.iheduc.2012.09.001
   Gil-Flores J, 2017, COMPUT HUM BEHAV, V68, P441, DOI 10.1016/j.chb.2016.11.057
   Gilbert B., 2015, THESIS SCH ED
   Gold A., 1998, REFLECTING SCH MANAG
   Goodyear P, 2001, ETR&D-EDUC TECH RES, V49, P65, DOI 10.1007/BF02504508
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Hair JF., 2009, MULTIVARIATE DATA AN
   Hale E., 2003, PREPARING SCH PRINCI
   Hamzah D. S., 2018, MALAYSIAN J ED MANAG, V6, P83, DOI [10.22452/mojem.vol6no2.5, DOI 10.22452/MOJEM.VOL6NO2.5]
   Harris A, 2020, SCH LEADERSH MANAG, V40, P243, DOI 10.1080/13632434.2020.1811479
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Jones J., 2004, MANAGEMENT SKILLS SC
   Kapasia N, 2020, CHILD YOUTH SERV REV, V116, DOI 10.1016/j.childyouth.2020.105194
   Ketterlin-Geller LR, 2015, INTERV SCH CLIN, V51, P51, DOI 10.1177/1053451214542044
   Khalil R, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02208-z
   Lamond D., 2004, MANAGE DECIS, V42, P330, DOI [10.1108/00251740410513845, DOI 10.1108/00251740410513845]
   Layland A., 2020, STRATEGIC PERFORMANC
   Leithwood K, 2008, SCH LEADERSH MANAG, V28, P27, DOI 10.1080/13632430701800060
   Lindberg OJ, 2017, INT J INF LEARN TECH, V34, P122, DOI 10.1108/IJILT-09-2016-0043
   Lorenzetti, 2013, ACAD ADM RUNNING MOO
   Lubis AH, 2018, J KOMUN, V34, P284, DOI 10.17576/JKMJC-2018-3401-17
   Mailizar M., 2020, EURASIA J MATH SCI T, V16, DOI 10.29333/ejmste/8240
   Mandefro E, 2020, ISS EDUC RES, V30, P866
   Mandum M, 2019, J INF TECHNOL EDUC-R, V18, P293, DOI 10.28945/4366
   Martin J. L. O., 2006, INT J LEARNING, V12, P259, DOI [10.18848/1447-9494/CGP/v12i03/46807, DOI 10.18848/1447-9494/CGP/V12I03/46807]
   Matuga JM, 2009, EDUC TECHNOL SOC, V12, P4
   Megatsari H, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05136
   Mishra Lokanath, 2020, Int J Educ Res Open, V1, P100012, DOI 10.1016/j.ijedro.2020.100012
   Muhdi M, 2019, UNIVERSAL J ED RES, V7, P2717, DOI [10.13189/ujer.2019.071220, DOI 10.13189/UJER.2019.071220]
   Mulwa A. S., 2013, EUROPEAN SCI J, V9, P183
   Neyland E, 2011, AUSTRALAS J EDUC TEC, V27, P152
   Nguyen T., 2015, MERLOT J ONLINE LEAR, V11, P309
   Owen SM, 2020, J INF TECHNOL EDUC-R, V19, P571, DOI 10.28945/4625
   Hernandez-Ramos JP, 2014, COMPUT HUM BEHAV, V31, P509, DOI 10.1016/j.chb.2013.04.039
   Papaioannou P, 2011, J INF TECHNOL EDUC-R, V10, P349
   Peterson RA, 2000, CONSTRUCTING EFFECTI, DOI [10.4135/9781483349022, DOI 10.4135/9781483349022]
   Polizzi G., 2011, J MEDIA LITERACY ED, V3, P113
   Rees CE, 2020, ADV HEALTH SCI EDUC, V25, P523, DOI 10.1007/s10459-019-09937-x
   Reid DB, 2021, EDUC MANAG ADM LEAD, V49, P251, DOI 10.1177/1741143219896072
   Rupp N. K, 2016, THESIS OLD DOMINION, DOI [10.25777/kwcm-gg91, DOI 10.25777/KWCM-GG91]
   Sahlberg P, 2013, WHAT FINLANDS GREAT
   Serhan D, 2007, TURK ONLINE J EDUC T, V6
   Shah M, 2014, PROCD SOC BEHV, V116, P2799, DOI 10.1016/j.sbspro.2014.01.659
   Simmon D. E, 2002, FORUM REPORT E LEARN
   Smaldino S. E., 2005, INSTRUCTIONAL TECHNO
   Sumintono B, 2015, ASIA PAC J EDUC, V35, P342, DOI 10.1080/02188791.2015.1056595
   Terry G. R., 2005, INTRO MANAGEMENT
   van Braak J, 2004, EUR J PSYCHOL EDUC, V19, P407, DOI 10.1007/BF03173218
   Vijayabanu C., 2016, J ORG TRANSFORMATION, V13, P220, DOI [10.1080/14779633.2016.1237147, DOI 10.1080/14779633.2016.1237147]
   Virgana V., 2019, MALAYSIAN ONLINE J E, V7, P1
   Wang TJ, 2009, TEACH TEACH EDUC, V25, P1132, DOI 10.1016/j.tate.2009.04.007
   Waxman H. C., 2013, CONT ED TECHNOLOGY, V4, P187
   Wong CP, 2021, INT J EDUC MANAG, V35, P249, DOI 10.1108/IJEM-06-2020-0283
   World Health Organization (WHO), 2020, COR COVID 2019
   You JW, 2014, COMPUT EDUC, V77, P125, DOI 10.1016/j.compedu.2014.04.018
   Yusri Iin Karmila, 2013, International Journal of e-Education, e-Business, e-Management and e-Learning, V3, P293, DOI 10.7763/IJEEEE.2013.V3.243
NR 90
TC 0
Z9 0
U1 9
U2 13
PU INFORMING SCIENCE INST
PI SANTA ROSA
PA 131 BROOKHILL CT, SANTA ROSA, CA 95409 USA
SN 1547-9714
EI 1539-3585
J9 J INF TECHNOL EDUC-R
JI J. Inf. Technol. Educ.-Res.
PY 2021
VL 20
BP 351
EP 383
DI 10.28945/4819
PG 33
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA TQ7XI
UT WOS:000678492900001
OA gold
DA 2022-04-20
ER

PT J
AU Rehman, FU
   Ismail, H
   Al Ghazali, BM
   Asad, MM
   Shahbaz, MS
   Zeb, A
AF Rehman, Fazal Ur
   Ismail, Hishamuddin
   Al Ghazali, Basheer M.
   Asad, Muhammad Mujtaba
   Shahbaz, Muhammad Saeed
   Zeb, Ali
TI Knowledge management process, knowledge based innovation: Does academic
   researcher's productivity mediate during the pandemic of covid-19?
SO PLOS ONE
LA English
DT Article
ID HUMAN-RESOURCE PRACTICES; DYNAMIC CAPABILITIES; PERFORMANCE; WORK;
   DETERMINANTS; CREATION; TRUST; DIMENSIONS; READINESS; BEHAVIOR
AB Drucker's knowledge-worker productivity theory and knowledge-based view of the firm theory are widely employed in many disciplines but there is little application of these theories in knowledge-based innovation among academic researchers. Therefore, this study intends to evaluate the effects of the knowledge management process on knowledge-based innovation alongside with mediating role of Malaysian academic researchers' productivity during the Pandemic of COVID-19. Using a random sampling technique, data was collected from 382 academic researchers. Questionnaires were self-administered and data was analyzed via Smart PLS-SEM. Knowledge management process and knowledge workers' productivity have a positive and significant relationship with the knowledge-based innovation among academic researchers during the Pandemic of COVID-19. In addition, knowledge workers' productivity mediates the relationship between the knowledge management process (knowledge creation, knowledge acquisition, knowledge sharing, and knowledge utilization) and knowledge-based innovation during the Pandemic of COVID-19. Results have also directed knowledge sharing as the key factor in knowledge-based innovation and a stimulating task for management discipline around the world during the Pandemic of COVID-19. This study provides interesting insights on Malaysian academic researchers' productivity by evaluating the effects of knowledge creation, acquisition, sharing, and application on the knowledge-based innovation among academic researchers during the Pandemic of COVID-19. These useful insights would enable policymakers to develop more influential educational strategies. By assimilating the literature of defined variables, the main contribution of this study is the evaluation of knowledge creation, acquisition, sharing, and utilization into knowledge-based innovation alongside the mediating role of knowledge workers productivity in the higher education sector of Malaysia during the Pandemic of COVID-19.
C1 [Rehman, Fazal Ur] Univ Lakki Marwat, Lakki Marwat, Pakistan.
   [Ismail, Hishamuddin] Multimedia Univ Malaysia, Cyberjaya, Malaysia.
   [Al Ghazali, Basheer M.] King Fahd Univ Petr & Minerals, Dhahran, Saudi Arabia.
   [Asad, Muhammad Mujtaba] IBA Sukkar Univ, Sukkur, Pakistan.
   [Shahbaz, Muhammad Saeed] SZABIST, Karachi, Pakistan.
   [Zeb, Ali] UTHM, Parit Raja, Malaysia.
RP Rehman, FU (corresponding author), Univ Lakki Marwat, Lakki Marwat, Pakistan.
EM fazal_marwatpk@yahoo.com
RI Shahbaz, Muhammad Saeed/Q-8073-2017
OI Shahbaz, Muhammad Saeed/0000-0002-4167-4592; Ismail,
   Hishamuddin/0000-0001-8296-0125; REHMAN, FAZAL UR/0000-0001-9856-9091
CR Ahmad N, 2017, J KNOWL ECON, V8, P859, DOI 10.1007/s13132-015-0282-3
   Al-Husseini S., 2015, INT J SOCIAL SCI HUM, V5, P182
   Alguezaui Salma, 2014, International Journal of Agile Systems and Management, V7, P116, DOI 10.1504/IJASM.2014.061434
   Ali A. H. A, 2013, THESIS BRIT U DUBAI
   Andreeva T, 2011, J KNOWL MANAG, V15, P1016, DOI 10.1108/13673271111179343
   Asgarian N., 2012, MANAGEMENT SCI LETT, V2, P2739
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Butt MA, 2019, COMPUT MATH ORGAN TH, V25, P336, DOI 10.1007/s10588-018-9270-z
   CEN, 2004, EUR GUID GOOD PRACT
   Chen CJ, 2009, J BUS RES, V62, P104, DOI 10.1016/j.jbusres.2007.11.016
   CIS IV, 2004, 4 COMM INN SURV
   Collins CJ, 2006, ACAD MANAGE J, V49, P544, DOI 10.5465/AMJ.2006.21794671
   Costa V, 2016, VINE J INF KNOWL MAN, V46, P386, DOI 10.1108/VJIKMS-02-2015-0017
   Dahlin KB, 2005, RES POLICY, V34, P717, DOI 10.1016/j.respol.205.03.009
   Denford JS, 2013, J KNOWL MANAG, V17, P175, DOI 10.1108/13673271311315150
   Drucker P.F., 1998, FORBES MAGAZINE, V10, P98
   Drucker PF, 1999, CALIF MANAGE REV, V41, P79, DOI 10.2307/41165987
   Edwards-Schachter M., 2018, INT J INNOVATION STU, V2, P65, DOI DOI 10.1016/J.IJIS.2018.08.004
   Erden Z, 2014, J BUS RES, V67, P2777, DOI 10.1016/j.jbusres.2012.09.001
   Fernandez R, 2013, FACTORS DETERMINING
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gomez, 2007, KNOWLEDGE MANAGEMENT
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Haas MR, 2007, STRATEG MANAGE J, V28, P1133, DOI 10.1002/smj.631
   Hair J., 2006, MULTIVARIATE DATA AN
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Hajir J.A., 2015, JORDAN EUROPEAN J SO, V50, P313
   Hasani K, 2016, KYBERNETES, V45, P337, DOI 10.1108/K-04-2014-0077
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Henseler J, 2013, COMPUTATION STAT, V28, P565, DOI 10.1007/s00180-012-0317-1
   Honarpour A, 2016, TOTAL QUAL MANAG BUS, P1
   Hsu MH, 2007, INT J HUM-COMPUT ST, V65, P153, DOI 10.1016/j.ijhcs.2006.09.003
   Huang YC, 2010, MANAGE DECIS, V48, P580, DOI 10.1108/00251741011041364
   Hulland J, 1999, STRATEGIC MANAGE J, V20, P195, DOI 10.1002/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.3.CO;2-Z
   Hussain S, 2018, J ORGAN EFF-PEOPLE P, V5, P39, DOI 10.1108/JOEPP-11-2016-0063
   Iazzolino G, 2017, MEAS BUS EXCELL, V21, P152, DOI 10.1108/MBE-11-2015-0050
   Iazzolino G, 2016, J INTELLECT CAP, V17, P457, DOI 10.1108/JIC-09-2015-0082
   Iqbal MJ, 2011, AFR J BUS MANAGE, V5, P11051, DOI 10.5897/AJBM11.576
   Iranzadeh S., 2014, PRODUCTIVITY MANAGEM, V7, P51
   Jayachandran S, 2004, J ACAD MARKET SCI, V32, P219, DOI 10.1177/0092070304263334
   Joo BK, 2016, PERS REV, V45, P1069, DOI 10.1108/PR-01-2015-0011
   Ketkar S, 2012, INT BUS REV, V21, P782, DOI 10.1016/j.ibusrev.2011.09.003
   Kianto A, 2016, J KNOWL MANAG, V20, P621, DOI 10.1108/JKM-10-2015-0398
   Kim S, 2010, ASIA-PAC J BUS ADM, V2, P133, DOI 10.1108/17574321011078184
   Lai HJ, 2018, EURASIA J MATH SCI T, V14, P505, DOI 10.12973/ejmste/80355
   Lai HJ, 2012, MALAYS J LIBR INF SC, V17, P101
   Lai YL, 2014, J BUS RES, V67, P734, DOI 10.1016/j.jbusres.2013.11.036
   Lane PJ, 2006, ACAD MANAGE REV, V31, P833, DOI 10.5465/AMR.2006.22527456
   Lee VH, 2013, J KNOWL MANAG, V17, P848, DOI 10.1108/JKM-08-2013-0315
   Lerner D, 2001, MED CARE, V39, P72, DOI 10.1097/00005650-200101000-00009
   Locke J, 2001, ESSAY HUMAN UNDERSTA
   Mack E., 2009, MAJOR CONSERVATIVE L
   Mathew R.M., 1985, THEORETICAL PROBLEMS, P37
   Merat A, 2013, J KNOWL MANAG, V17, P3, DOI 10.1108/13673271311300697
   Merono-Cerdan AL, 2017, INNOV-ORGAN MANAG, V19, P208, DOI 10.1080/14479338.2016.1276407
   Mladkova L, 2015, PROCD SOC BEHV, V207, P768, DOI 10.1016/j.sbspro.2015.10.163
   Morgeson FP, 2006, J APPL PSYCHOL, V91, P1321, DOI 10.1037/0021-9010.91.6.1321
   Moussa M, 2017, INT J PRODUCT PERFOR, V66, P822, DOI 10.1108/IJPPM-08-2016-0161
   Numprasertchai S, 2009, INT J INNOV LEARN, V6, P568, DOI 10.1504/IJIL.2009.025066
   Nunnally J.C, 1994, PSYCHOMETRIC THEORY
   Ologbo A.C., 2015, INT J HUMAN RESOURCE, V5, P102
   Palvalin M, 2017, J FACIL MANAG
   Palvalin M, 2017, MEAS BUS EXCELL, V21, P175, DOI 10.1108/MBE-05-2016-0025
   Palvalin M, 2015, INT J PRODUCT PERFOR, V64, P479, DOI 10.1108/IJPPM-06-2013-0122
   Parker K.I., 2004, BIBLICAL POLITICS J
   Ram?rez Y.W., 2004, J INTELLECT CAP, V5, P602, DOI DOI 10.1108/14691930410567040
   Ramezan M., 2012, ED BUSINESS SOC CONT, V5, P200
   Reguia C, 2014, EUROPEAN SCI J, V1, P140
   Rehman FU, 2017, YOUNG CONSUM, V18, P408, DOI 10.1108/YC-06-2017-00705
   Sabherwal, 2004, KNOWLEDGE MANAGEMENT
   Segarra-Cipres M., 2013, KNOWLEDGE MANAGEMENT, P1
   Shang SSC, 2017, R&D MANAGE, V47, P337, DOI 10.1111/radm.12130
   Shih TY, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061871
   Shu CL, 2012, J PROD INNOVAT MANAG, V29, P125, DOI 10.1111/j.1540-5885.2011.00883.x
   Shujahat M, 2018, HUM FACTOR ERGON MAN, V28, P200, DOI 10.1002/hfm.20735
   Shujahat M, 2017, VINE J INF KNOWL MAN, V47, P55, DOI 10.1108/VJIKMS-06-2016-0035
   Si-hua Chen, 2012, International Journal of Networking and Virtual Organisations, V11, P315, DOI 10.1504/IJNVO.2012.048913
   Smith KG, 2005, ACAD MANAGE J, V48, P346, DOI 10.5465/amj.2005.16928421
   Song M, 2005, J PROD INNOVAT MANAG, V22, P430, DOI 10.1111/j.1540-5885.2005.00139.x
   Soto-Acosta P, 2016, TECHNOL ECON DEV ECO, V22, P885, DOI 10.3846/20294913.2015.1074126
   Soto-Acosta P, 2014, KNOWL MAN RES PRACT, V12, P103, DOI 10.1057/kmrp.2013.31
   Tabachnick B.G., 2001, USING MULTIVARIATE A
   Taminiau Y, 2009, J KNOWL MANAG, V13, P42, DOI 10.1108/13673270910931152
   Tangen S, 2005, INT J PRODUCT PERFOR, V54, P34, DOI 10.1108/17410400510571437
   Tomei L., 2009, LEXICON ONLINE DISTA
   Turriago-Hoyos A, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016639631
   Urumsah D., 2015, E SERVICES ADOPTION
   van den Hooff B., 2004, Journal of Knowledge Management, V8, P117, DOI 10.1108/13673270410567675
   Wang C-L., 2004, EUR J INNOV MANAG, V7, P303, DOI DOI 10.1108/14601060410565056
   Wong K.K.K., 2013, MARKETING B, V24, P1, DOI DOI 10.1108/EBR-10-2013-0128
   Wong SKS, 2013, BUS STRATEG ENVIRON, V22, P321, DOI 10.1002/bse.1746
   Yen HR, 2012, DECIS SUPPORT SYST, V53, P813, DOI 10.1016/j.dss.2012.05.015
   Yesil S, 2013, PROCD SOC BEHV, V75, P217, DOI 10.1016/j.sbspro.2013.04.025
   Zack M, 2009, J KNOWL MANAG, V13, P392, DOI 10.1108/13673270910997088
   Zhang JF, 2009, J INT MARKETING, V17, P42, DOI 10.1509/jimk.17.2.42
   Zheng SL, 2011, J KNOWL MANAG, V15, P1035, DOI 10.1108/13673271111179352
NR 97
TC 1
Z9 1
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 22
PY 2021
VL 16
IS 12
AR e0261573
DI 10.1371/journal.pone.0261573
PG 20
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics
GA YZ1OD
UT WOS:000755251000040
PM 34937055
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Tang, ZW
   Li, MZ
   Chen, W
   Ran, X
   Li, HY
   Chen, ZW
AF Tang, Zhengwu
   Li, Muzhe
   Chen, Wei
   Ran, Xun
   Li, Huiyun
   Chen, Zhiwei
TI Clinical symptoms of COVID-19 pneumonia in children A protocol for
   systematic review and meta-analysis
SO MEDICINE
LA English
DT Review
DE COVID-19; meta-analysis; nonsevere; severe
ID RISK
AB Background: This meta-analysis aimed to compare the clinical symptoms of COVID-19 pneumonia in children. Methods and analysis: Electronic databases including PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI) database, Wanfang Database, and Chinese Biomedical Literature Database (CBM) were searched from its inception to June 21, 2020. We only included studies that reported clinical symptoms of COVID pneumonia in children. Quality of the included studies was assessed by 2 authors. Pooled results were summarized by STATA 12.0 software. The heterogeneity was measured by I-2 tests (I-2 < 50 indicates little heterogeneity, I-2 >= 50 indicates high heterogeneity). Publication bias was performed by funnel plot and statistically assessed by Begg test (P > .05 as no publication bias). Results: Results will be shown as figures or tables. Conclusion: Our study aims to systematically present the clinical symptoms of COVID-19 pneumonia patients in children, so as to further provide guidance for clinical management.
C1 [Tang, Zhengwu; Li, Muzhe; Chen, Wei; Ran, Xun; Li, Huiyun; Chen, Zhiwei] Univ South China, Affiliated Hosp 1, Dept Orthopaed, 69 Chuanshan Rd, Hengyang 421001, Hunan, Peoples R China.
RP Chen, ZW (corresponding author), Univ South China, Affiliated Hosp 1, Dept Orthopaed, 69 Chuanshan Rd, Hengyang 421001, Hunan, Peoples R China.
EM czw9915@sina.com
FU Hengyang city for Prevention and Control of COVID-19 [2020hcjz6718];
   University of South China for Prevention and Control of COVID-19
   [2020-23]; Innovation Guidance Plan of Hunan Science and Technology
   Department [2018SK51602]
FX This study was funded by Fund Project of Hengyang city for Prevention
   and Control of COVID-19 (2020hcjz6718), Fund Project of University of
   South China for Prevention and Control of COVID-19 (No. 2020-23);
   Innovation Guidance Plan of Hunan Science and Technology Department
   (2018SK51602) and through a protocol registry.
CR Deng XL, 2020, CLIN CHEM LAB MED, V58, P1172, DOI 10.1515/cclm-2020-0338
   Grover A, 2021, EUR HEART J-CARD PHA, V7, P148, DOI 10.1093/ehjcvp/pvaa064
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928
   Kronbichler A, 2020, INT J INFECT DIS, V98, P180, DOI 10.1016/j.ijid.2020.06.052
   Li J, 2021, AM J INFECT CONTROL, V49, P82, DOI 10.1016/j.ajic.2020.06.008
   Mantovani A, 2021, PEDIATR RES, V89, P733, DOI 10.1038/s41390-020-1015-2
   Raba AA, 2020, ACTA PAEDIATR, V109, P1948, DOI 10.1111/apa.15422
   Sossai P, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13592
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Zhang RY, 2014, GENE, V535, P79, DOI 10.1016/j.gene.2013.07.087
NR 11
TC 1
Z9 1
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JAN 8
PY 2021
VL 100
IS 1
AR e24108
DI 10.1097/MD.0000000000024108
PG 3
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PZ5QI
UT WOS:000612794500054
PM 33429778
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Bazzanella, F
   Muratore, N
   Schlemmer, PA
   Happ, E
AF Bazzanella, Filippo
   Muratore, Nunzio
   Schlemmer, Philipp Alexander
   Happ, Elisabeth
TI How the Covid-19 Pandemic Influenced the Approach to Risk Management in
   Cycling Events
SO JOURNAL OF RISK AND FINANCIAL MANAGEMENT
LA English
DT Article
DE sports events; Covid- 19; risk management; SARS-CoV-2; cycling events;
   organization; crisis
ID SPORTING EVENTS; PERFORMANCE; IMPACT
AB The COVID-19 pandemic has taught us to live in social isolation and has brought an important element of social life, the events industry, to a complete standstill. In resurrecting the events industry, the most urgent focus is on managing the risk of any crowd-control measures with a view to reducing to zero the danger of the virus spreading. This research focuses on the main issue of the impact of the coronavirus disease 2019 (COVID-19) on the organization of sports events (SEs), and in particular, cycling competitions. This study, therefore, aims to provide deeper insights into (a) the measures introduced to face the health emergency situation in cycling events, (b) the comparison of these measures with previous experiences in similar SE contexts, and (c) the possible evolution of organizational models for cycling events in the post-pandemic era. Fifteen semi-structured interviews with cycling athletes, managers, and officials constitute the methodological basis for this study. The results show that countermeasures have been taken that are effective in dealing with pandemic characteristics and are likely to be applied in the future, while others will be phased out or used again only when necessary. This study enhances scientific knowledge by analyzing a renewed approach to risk management for SEs, with a specific focus on pandemics and medical risks. Finally, the study shows that cycling events need to adapt the specifics of such a new approach to the standards projected on future scenarios for which the COVID-19 pandemic has paved the way.
C1 [Bazzanella, Filippo] Univ Innsbruck, Dept Strateg Management Mkt & Tourism, Karl Schonherr Str 3, A-6020 Innsbruck, Austria.
   [Muratore, Nunzio] Luiss Business Sch, Management Sch, Via Nomentana 216, I-00162 Rome, Italy.
   [Schlemmer, Philipp Alexander; Happ, Elisabeth] Univ Innsbruck, Dept Sport Sci, Furstenweg 185, A-6020 Innsbruck, Austria.
RP Bazzanella, F (corresponding author), Univ Innsbruck, Dept Strateg Management Mkt & Tourism, Karl Schonherr Str 3, A-6020 Innsbruck, Austria.
EM Filippo.Bazzanella@student.uibk.ac.at; nmura90@gmail.com;
   Philipp.Schlemmer@uibk.ac.at; Elisabeth.Happ@uibk.ac.at
FU University of Innsbruck-Austria
FX This research received funding from Vice Rector of Research of the
   University of Innsbruck-Austria.
CR Appenzeller Herb., 2005, RISK MANAGEMENT, V2nd ed.
   Barbosa BT, 2020, J SPORT MED PHYS FIT, V60, P1507, DOI 10.23736/S0022-4707.20.11309-4
   Barget E, 2007, J SPORT ECON, V8, P165, DOI 10.1177/1527002505279349
   Berlonghi A.E., 1990, SPECIAL EVENT RISK M
   Bjarnason Halldor., 1999, ORG EVENTS AVOIDING
   Blumberg L, 2016, INT J INFECT DIS, V47, P38, DOI 10.1016/j.ijid.2016.06.011
   Bond AJ, 2022, MANAG SPORT LEIS, V27, P102, DOI 10.1080/23750472.2020.1841449
   Borovcanin D, 2020, SOCIETIES, V10, DOI 10.3390/soc10040090
   Bowdin G., 2011, EVENTS MANAGEMENT
   Bowles HR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-39
   Chalip L., 2004, Journal of Sport Tourism, V9, P267, DOI 10.1080/1477508042000320241
   Chalip Laurence., 2004, IMPACT GEN MODEL SPO
   Chang P. C., 1990, Tourism Management, V11, P45, DOI 10.1016/0261-5177(90)90007-V
   Chappelet JL, 2012, PAPELES EUR, V25, P76
   Chappelet Jean-Loup., 2001, EUROPEAN J SPORT MAN, V8, P6
   Ciucci Filippo., 2012, INTERVISTA NELLA VAL INTERVISTA NELLA VAL
   Cserhati G, 2014, INT J PROJ MANAG, V32, P613, DOI 10.1016/j.ijproman.2013.08.008
   Cuskelly G., 2006, WORKING VOLUNTEERS S
   Dawkins ShoniS., 2004, 2 INT WORKSH CLIM TO 2 INT WORKSH CLIM TO
   Dove James, 2020, R I Med J (2013), V103, P15
   Frosdick S., 1997, SPORT SAFETY MANAGEM
   Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001
   Garcia-Garcia B, 2020, INT SPORTS LAW J, V20, P115, DOI 10.1007/s40318-020-00174-8
   Getz D., 2005, EVENT MANAGEMENT EVE, V2nd ed.
   Getz D., 2020, EVENT STUDIES THEORY, V4th
   GETZ D, 1998, SPORT MARKET Q, V7, P8
   Getz D., 2013, EVENT TOURISM CONCEP
   Giulianotti R, 2010, J SPORT SOC ISSUES, V34, P49, DOI 10.1177/0193723509354042
   Glasser B. G., 1967, DISCOVERY GROUNDED T
   Goldblatt J., 2014, SPECIAL EVENTS CREAT
   Gratton C., 2000, Managing Leisure, V5, P17
   Grix J, 2021, INT J SPORT POLICY P, V13, P1, DOI 10.1080/19406940.2020.1851285
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   Hall MichaelC., 2001, SPORT CITY ROLE SPOR
   Higham JES, 2003, J SPORT MANAGE, V17, P235, DOI 10.1123/jsm.17.3.235
   Hytner Mike, 2020, THE GUARDIAN 1013 THE GUARDIAN 1013
   Kinoshita K, 2021, EUR SPORT MANAG Q, DOI 10.1080/16184742.2021.1889636
   Kyrylov Y, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13120303
   Leopkey B, 2009, EUR SPORT MANAG Q, V9, P187, DOI 10.1080/16184740802571443
   Loncarevic Goranka., 2009, EURO SURVEILLANCE B, V14, DOI [10.2807/ese.14.31.19296-en, DOI 10.2807/ESE.14.31.19296-EN]
   Ludvigsen JAL, 2021, MANAG SPORT LEIS, DOI 10.1080/23750472.2021.1928538
   Ludvigsen JAL, 2022, MANAG SPORT LEIS, V27, P129, DOI 10.1080/23750472.2020.1782252
   Masterman G., 2009, STRATEGIC SPORTS EVE
   Masterman G, 2014, STRATEGIC SPORTS EVE
   Mastromartino B, 2020, SPORT SOC, V23, P1707, DOI 10.1080/17430437.2020.1804108
   Mayring P., 2000, QUALITATIVE CONTENT
   McCloskey B, 2020, LANCET, V395, P1096, DOI 10.1016/S0140-6736(20)30681-4
   McHill AW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78901-2
   MINNAERT L, 2012, TOURISM MANAGE, V33, P361, DOI DOI 10.1016/j.tourman.2011.04.005
   Moran DS, 2001, SPORTS MED, V31, P909, DOI 10.2165/00007256-200131130-00002
   Neuman WL, 2003, SOCIAL RES METHODS Q
   OToole W., 2011, EVENTS FEASIBILITY D, V1st
   Patsantaras N., 2008, Choregia: Sport Management International Journal, V4, P45, DOI 10.4127/ch.2008.4.1.45-55
   Pelzer Peter., 7 CYCL SOC S OXF UK 7 CYCL SOC S OXF UK, P1
   Peterson JamesAlbert., 2003, RISK MANAGEMENT PARK, V4th ed.
   Pielichaty Hanya., 2017, EVENTS PROJECT MANAG
   Preuss H, 2015, LEISURE STUD, V34, P643, DOI 10.1080/02614367.2014.994552
   Preuss Holger, 2013, IMPACT EVALUATION MA
   Rapley Tim., 2004, QUALITATIVE RES PRAC, P16
   Rico-Gonzalez M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020568
   Ritchie J., 2014, QUALITATIVE RES PRAC, V2nd edn
   Rodriguez-Valero N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201943
   Schnitzer M, 2020, PUBLIC HEALTH, V185, P218, DOI 10.1016/j.puhe.2020.06.042
   Scott J., 2000, SOCIAL NETWORK ANAL, V2nd
   Silvers J.R., 2008, RISK MANAGEMENT M EV, V1
   Skare M, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120469
   Smith-Swan S., 2013, MANAGING MAJOR SPORT
   Spengler JohnO., 2006, RISK MANAGEMENT SPOR
   Thomson A., 2013, Event Management, V17, P111, DOI 10.3727/152599513X13668224082260
   Vancini RL, 2016, J HUM KINET, V53, P5, DOI 10.1515/hukin-2016-0005
   Westmattelmann D, 2021, EUR J INFORM SYST, V30, P119, DOI 10.1080/0960085X.2020.1850186
   Whelan Chad., 2018, SECURING MEGA EVENTS
   Windholz Eric, 2016, SPORTS LAW EJOURNAL
   Wong AYY, 2020, ASIA-PAC J SPORT MED, V22, P39, DOI 10.1016/j.asmart.2020.07.006
NR 74
TC 0
Z9 0
U1 6
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1911-8066
EI 1911-8074
J9 J RISK FINANC MANAG
JI J. Risk Financ. Manag.
PD JUL
PY 2021
VL 14
IS 7
AR 296
DI 10.3390/jrfm14070296
PG 20
WC Business, Finance
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA TN6BZ
UT WOS:000676319100001
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mushi, A
   Yassin, Y
   Khan, A
   Yezli, S
   Almuzaini, Y
AF Mushi, Abdulaziz
   Yassin, Yara
   Khan, Anas
   Yezli, Saber
   Almuzaini, Yasir
TI Knowledge, Attitude, and Perceived Risks Towards COVID-19 Pandemic and
   the Impact of Risk Communication Messages on Healthcare Workers in Saudi
   Arabia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19 pandemic; knowledge; attitude; risk communication; perceived
   benefits; Saudi Arabia
ID HONG-KONG; PREVENTION; OUTBREAK
AB Purpose: To investigate knowledge, attitude, and perceived risks towards COVID-19 pandemic among healthcare workers (HCWs) in Saudi Arabia. Besides, the impact of risk communication strategy on the attitude and practice of HCWs was investigated. Patients and Methods: We conducted a cross-sectional study that targeted HCWs from various Saudi health facilities. We utilized a self-administrated, online-based questionnaire designed to assess basic knowledge of COVID-19, attitude and disease perception, and the impact of risk communication messages among HCWs. Results: A total of 1691 responses were received in the study. The HCWs exhibited good levels of knowledge (total maximum score is 1) of COVID-19 concerning the modes of transportation of COVID-19 (0.82 +/- 0.16), sample collection method for COVID-19 diagnosis (0.98 +/- 0.08), transmission of infection from asymptomatic individuals (0.99 +/- 0.11), and that antibiotics are not effective against the new COVID-19 (0.83 +/- 0.38). Nearly onethird of the participants considered a high/very high possibility of acquiring COVID-19 infection. HCWs had good attitude scores concerning their willingness to deal with new COVID-19 patients (0.87 +/- 0.33) and their beliefs in being educated on COVID-19 (0.99 +/- 0.11). Almost all participants strongly agree/agree that it is important to take action to prevent the spread of COVID-19 within healthcare facilities and received health information messages. Notably, 93.4% of the participants stated that the received messages changed their attitude towards COVID-19 and its preventive measures. Good knowledge scores were significantly associated with age > 49 years old, higher educational level, and physician occupation. Similarly, good attitude scores were higher among males, HCWs aged 40-49 years old, non-Saudi nationals, and physician and nurse occupations. Conclusion: HCWs have fair knowledge and attitude towards the COVID-19 pandemic. The risk communication is an effective strategy to improve the attitude and practice of HCWs towards COVID-19 in Saudi Arabia.
C1 [Mushi, Abdulaziz; Yassin, Yara; Khan, Anas; Yezli, Saber; Almuzaini, Yasir] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia.
   [Khan, Anas] King Saud Univ, Coll Med, Dept Emergency Med, Riyadh, Saudi Arabia.
RP Mushi, A (corresponding author), Minist Hlth, Publ Hlth Directorate, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia.
EM abhmashi@moh.gov.sa
RI ; Khan, Anas/Q-7349-2017
OI Almuzaini, Yasir/0000-0001-6483-0028; Yassin, Yara/0000-0002-8762-5403;
   Khan, Anas/0000-0001-5075-7392
CR Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Abolfotouh MA, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05443-3
   Abrams EM, 2020, J ALLER CL IMM-PRACT, V8, P1791, DOI 10.1016/j.jaip.2020.04.012
   Alhazmi AM, 2019, J FAM COMMUNITY MED, V26, P173, DOI 10.4103/jfcm.JFCM_4_19
   Alhazmi A, 2020, J PUBLIC HEALTH RES, V9, P345, DOI 10.4081/jphr.2020.1867
   Ali S, 2020, PAK J MED SCI, V36, pS99, DOI 10.12669/pjms.36.COVID19-S4.2790
   Almofada SK, 2020, CUREUS, V12, DOI 10.7759/cureus.8905
   Alzyood M, 2020, J CLIN NURS, V29, P2760, DOI 10.1111/jocn.15313
   [Anonymous], NTR
   Atique S, 2020, INFECT DIS HEALTH, V25, P219, DOI 10.1016/j.idh.2020.04.001
   Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42
   Beiu C, 2020, CUREUS, V12, DOI 10.7759/cureus.7506
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Bragazzi NL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093176
   Chen P, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020308
   Cinelli E, 2020, SUPPORT CARE CANCER, V28, P3991, DOI 10.1007/s00520-020-05563-1
   Cope JR, 2014, DISASTER MED PUBLIC, V8, P199, DOI 10.1017/dmp.2014.29
   Cristaudo A, 2020, CONTACT DERMATITIS, V83, P536, DOI 10.1111/cod.13683
   Damiani G, 2021, CLIN EXP DERMATOL, V46, P1106, DOI 10.1111/ced.14631
   Damiani G, 2021, DERMATOL THER, V34, DOI 10.1111/dth.14848
   Damiani G, 2021, DERMATOL THER, V34, DOI 10.1111/dth.14823
   Dil S, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8582
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117
   Glabska D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12124930
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Guner R, 2020, TURK J MED SCI, V50, P571, DOI 10.3906/sag-2004-146
   Kassie BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238415
   Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18
   Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004
   Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864
   Liyew B, 2020, CRIT CARE RES PRACT, V2020, DOI 10.1155/2020/9145105
   Ministry of Health Saudi Arabia, 2020, SAUD AR EXP HLTH PRE
   MOH News, MOH NEWS
   Mohammed S, 2021, SOHAG MED J, V25
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Saudi Arabia Ministry of Health, E SERV
   Saudi Arabia Ministry of Health, 2020, PROT COVID 19
   Saudi Arabia Ministry of Health, 2020, TET APP E SERV
   Selvaraj SA, 2018, J INFECT DIS, V218, pS679, DOI 10.1093/infdis/jiy435
   Seng YW., 2008, ANN ACAD MED SINGAPO
   Sumo J, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.supp.2019.33.2.16877
   Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887
   Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537
   Walston S, 2008, ANN SAUDI MED, V28, P243
   WHO, 2020, ZONE ISSUE
   World Health Organization, COR DIS COVID 19 OUT
   World Health Organization, GEN INF RISK COMM
   Yezli S, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101692
   Yezli S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173215
   Yezli S, 2019, TRAVEL MED INFECT DI, V28, P52, DOI 10.1016/j.tmaid.2018.08.004
   Zhang LW, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010064
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 56
TC 1
Z9 1
U1 3
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 2811
EP 2824
DI 10.2147/RMHP.S306402
PG 14
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA TD7NV
UT WOS:000669509700001
PM 34262368
OA Green Published
DA 2022-04-20
ER

PT J
AU Afzal, MS
   Khan, A
   Qureshi, UUR
   Saleem, S
   Saqib, MAN
   Shabbir, RMK
   Naveed, M
   Jabbar, M
   Zahoor, S
   Ahmed, H
AF Afzal, Muhammad Sohail
   Khan, Aisha
   Qureshi, Ubaid Ur Rahman
   Saleem, Sadia
   Saqib, Muhammad Arif Nadeem
   Shabbir, Rana Muhammad Kamran
   Naveed, Muhammad
   Jabbar, Muhammad
   Zahoor, Sarmad
   Ahmed, Haroon
TI Community-Based Assessment of Knowledge, Attitude, Practices and Risk
   Factors Regarding COVID-19 Among Pakistanis Residents During a Recent
   Outbreak: A Cross-Sectional Survey
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE COVID-19; Knowledge; Attitude; Practices; Correlation; Pakistan
AB Exceptional precautionary measures have been adopted to stop the transmission and control of COVID-19 through the world and Pakistan is facing lockdown in this scenario. Public loyalty to precautionary measures is affected by their knowledge, attitude, risk factors and practices (KAP) towards COVID-19. The present study was conducted among the Pakistani residents to observe the knowledge, attitude, practices and risk factors towards COVID-19 outbreak in Pakistan. A questionnaire was designed, and a cross-sectional survey was conducted among participants of the study area. Participants were asked the questions regarding knowledge, attitude, practices and risk factors towards COVID-19. Data were analyzed by SPSS andt/Ftest and correlation was applied among the knowledge, attitude, risk factors and practices. A total of 1060 questionnaires were received. 1004 were included while 56 were excluded. The highest representation was from Punjab province (65.6%), female (63%) and age group of 21-30 years (62.1%). Most participants were single (85%), Muslim (99.4%), Urdu speaking (45.6%) and were graduates (51.5%). Most of the participants were students (52.9%) and were from economically middle-class families (40.8%). The knowledge was positively correlated with attitude and practices whereas negatively correlated with risk factors (P < 0.05). The attitude was negatively correlated with risk factor and positively correlated with practices. The risk factors and practices were positively correlated with each other. Health education program to improve the COVID-19 knowledge, attitude, practices and risk factors should be initiated to combat current health challenge.
C1 [Afzal, Muhammad Sohail; Saqib, Muhammad Arif Nadeem] Univ Management & Technol UMT, Sch Sci, Dept Life Sci, Lahore, Pakistan.
   [Khan, Aisha; Saleem, Sadia; Ahmed, Haroon] COMSATS Univ Islamabad CUI, Dept Biosci, Pk Rd, Islamabad, Pakistan.
   [Qureshi, Ubaid Ur Rahman] Firat Univ, Inst Hlth Sci, Elazig, Turkey.
   [Shabbir, Rana Muhammad Kamran] Quaid I Azam Univ, Fac Biol Sci, Dept Zool, Islamabad, Pakistan.
   [Naveed, Muhammad] Univ Cent Punjab UCP, Dept Biotechnol, Lahore, Pakistan.
   [Jabbar, Muhammad] Laval Univ, Dept Math & Stat, Laval, PQ, Canada.
   [Jabbar, Muhammad] Univ Gujrat, Dept Stat, Gujrat, Pakistan.
   [Zahoor, Sarmad] Mayo Hosp, Dept Internal Med, Lahore, Pakistan.
   [Saqib, Muhammad Arif Nadeem] Hlth Res Council PHRC, Head Off, Islamabad, Pakistan.
RP Ahmed, H (corresponding author), COMSATS Univ Islamabad CUI, Dept Biosci, Pk Rd, Islamabad, Pakistan.
EM haroonahmad12@yahoo.com
RI Ahmed, Haroon/S-4085-2019; Naveed, Muhammad/E-4965-2013
OI Ahmed, Haroon/0000-0002-0382-3569; Naveed, Muhammad/0000-0002-4333-8226;
   Saqib, Muhammad Arif/0000-0001-6365-5520
CR Ahmad T, 2020, HUM VACC IMMUNOTHER, V16, P736, DOI 10.1080/21645515.2020.1724000
   Ahmad T, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101607
   Bassetti M, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13209
   Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008
   Carlos WG, 2020, AM J RESP CRIT CARE, V201, pP7, DOI 10.1164/rccm.2014P7
   Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Jiao JieGe, 2005, China Tropical Medicine, V5, P703
   Kabir M, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101661
   Khan S, 2020, J MED VIROL, V92, P824, DOI 10.1002/jmv.25814
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Pawlowski B, 2008, EVOL PSYCHOL-US, V6, P29, DOI 10.1177/147470490800600104
   Qureshi UUR, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101571
   Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Zhang X, 2003, CHIN J DIS CONTR PRE, V7, P280
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 18
TC 33
Z9 34
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD JUN
PY 2021
VL 46
IS 3
BP 476
EP 486
DI 10.1007/s10900-020-00875-z
EA JUL 2020
PG 11
WC Health Policy & Services; Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA SC4GJ
UT WOS:000548110700001
PM 32661860
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Flannery, DD
   Puopolo, KM
AF Flannery, Dustin D.
   Puopolo, Karen M.
TI Perinatal COVID-19: guideline development, implementation, and
   challenges
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE COVID-19; neonatal; pandemic; SARS-CoV-2
ID MANAGEMENT; PREGNANCY; INFLUENZA; OUTCOMES; MOTHERS; BORN
AB Purpose of review The aim of this review was to describe the process of and challenges in developing national guidance for management of infants born to mothers with COVID-19. Recent findings Beginning in January 2020, infection with the novel coronavirus SARS-CoV-2 spread across the USA, causing the illness COVID-19. As pregnant women began to present for delivery while sick with COVID-19, the American Academy of Pediatrics (AAP) convened a writing group in March 2020 to develop guidance for the management of their newborns. The initial guidance was developed emergently and was forced to rely on extremely limited data from China. The initial guidance advocated for a conservative approach that included temporary physical separation of infected mother and newborn. To address the knowledge deficit, the AAP sponsored a volunteer registry to collect data on perinatal infection and management. As data have emerged informing the natural history of COVID-19, the performance of PCR-based diagnostics, the value of infection control measures and the risk of infant disease, AAP has issued serial updates to newborn guidance. Evolving knowledge on the epidemiology of perinatal COVID-19 has informed newborn guidance. The most recent guidance focuses on the use of infection control measures to support maternal-newborn contact and breastfeeding.
C1 [Flannery, Dustin D.; Puopolo, Karen M.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19107 USA.
   [Flannery, Dustin D.; Puopolo, Karen M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Flannery, Dustin D.; Puopolo, Karen M.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19107 USA.
RP Puopolo, KM (corresponding author), Childrens Hosp Philadelphia, Newborn Care Penn Hosp, 800 Spruce St, Philadelphia, PA 19107 USA.
EM karen.puopolo@pennmedicine.upenn.edu
RI Puopolo, Karen/AAY-7748-2021
FU Agency for Healthcare Research and QualityUnited States Department of
   Health & Human ServicesAgency for Healthcare Research & Quality
   [K08HS027468]; Centers for Disease Control and PreventionUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA; Children's Hospital of Philadelphia; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
FX Dr Flannery reports receiving research funding from the Agency for
   Healthcare Research and Quality (K08HS027468), from two contracts with
   the Centers for Disease Control and Prevention, and from the Children's
   Hospital of Philadelphia. Dr Puopolo reports receiving research funding
   from the National Institutes of Health, from two contracts with the
   Centers for Disease Control and Prevention, and from the Children's
   Hospital of Philadelphia.
CR Alger HM, 2020, CIRC-CARDIOVASC QUAL, V13, P264, DOI 10.1161/CIRCOUTCOMES.120.006766
   [Anonymous], ABC NEWS
   [Anonymous], CTR DIS CONTROL PREV
   [Anonymous], FAQS MANAGEMENT INFA
   [Anonymous], 2002, **NON-TRADITIONAL**
   [Anonymous], CDC CONSIDERATIONS I
   [Anonymous], WYCKOFF AS AAP ISSUE
   [Anonymous], NATL PERINATAL COVID
   [Anonymous], PREGNANCY NEONATAL S
   Bartick, 2020, TRENDS MED
   Bastug A, 2020, BREASTFEED MED, V15, P488, DOI 10.1089/bfm.2020.0161
   Biasucci G, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.565522
   Brady MT, 2018, RED BOOK 2018 REPORT, P869
   Chambers C, 2020, JAMA-J AM MED ASSOC, V324, P1347, DOI 10.1001/jama.2020.15580
   DeBiasi RL, 2020, J PEDIATR-US, V223, P199, DOI 10.1016/j.jpeds.2020.05.007
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Dumitriu D, 2021, JAMA PEDIATR, V175, P157, DOI 10.1001/jamapediatrics.2020.4298
   Elgin T G, 2020, J Neonatal Perinatal Med, V13, P293, DOI 10.3233/NPM-200460
   Fang F, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.553394
   Flannery DD, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd5709
   Gale Chris, 2021, Lancet Child Adolesc Health, V5, P113, DOI 10.1016/S2352-4642(20)30342-4
   Jung YE, 2021, JAMA INTERN MED, V181, P395, DOI 10.1001/jamainternmed.2020.6629
   Kambhampati Srinivas B S, 2020, J Clin Orthop Trauma, V11, pS304, DOI 10.1016/j.jcot.2020.04.030
   Khoury R, 2020, OBSTET GYNECOL, V136, P273, DOI 10.1097/AOG.0000000000004025
   King LP., SHOULD NEW MOTHERS C
   Meister TL, 2020, PEDIATRICS
   Mithal LB, 2020, J PEDIATR-US, V224, P150, DOI 10.1016/j.jpeds.2020.06.047
   Parri N, 2020, EUR J PEDIATR, V179, P1315, DOI 10.1007/s00431-020-03683-8
   Qiao J, 2020, LANCET, V395, P760, DOI 10.1016/S0140-6736(20)30365-2
   Rasmussen SA, 2014, NEW ENGL J MED, V371, P1373, DOI 10.1056/NEJMp1403496
   Rasmussen SA, 2012, CLIN OBSTET GYNECOL, V55, P487, DOI 10.1097/GRF.0b013e31824df23e
   Saffery R, 2020, JAMA PEDIATR, DOI [10.1038/s41372-021-01019-4, DOI 10.1038/S41372-021-01019-4]
   Salvatore CM, 2020, LANCET CHILD ADOLESC, V4, P721, DOI 10.1016/S2352-4642(20)30235-2
   Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194
   Shek CC, 2003, PEDIATRICS, V112, pE254, DOI 10.1542/peds.112.4.e254
   Stuebe A, 2020, BREASTFEED MED, V15, P351, DOI 10.1089/bfm.2020.29153.ams
   Tam PCK, 2021, CLIN INFECT DIS, V72, P128, DOI 10.1093/cid/ciaa673
   Wang SS, 2020, CLIN INFECT DIS, V71, P853, DOI 10.1093/cid/ciaa225
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Wang XT, 2020, CLIN INFECT DIS, V71, P844, DOI 10.1093/cid/ciaa200
   White A, 2021, NEONATOLOGY, V117, P641, DOI 10.1159/000508962
   WHO, PNEUM UNKN CAUS CHIN
   Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019
   Woodworth KR, 2020, MMWR-MORBID MORTAL W, V69, P1635, DOI 10.15585/mmwr.mm6944e2
   Zachariah P, 2020, JAMA PEDIATR, V174, DOI 10.1001/jamapediatrics.2020.2430
   Zeng LK, 2020, JAMA PEDIATR, V174, P722, DOI 10.1001/jamapediatrics.2020.0878
   Zhang Q, 2020, TITLE CORONAVIRUS DI
   Zhang ZJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00697-2020
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 50
TC 7
Z9 8
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD APR
PY 2021
VL 33
IS 2
BP 188
EP 194
DI 10.1097/MOP.0000000000000997
PG 7
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA SS8VM
UT WOS:000662030800004
PM 33534424
OA Green Published
DA 2022-04-20
ER

PT J
AU Muhammad, K
   Saqlain, M
   Muhammad, G
   Hamdard, A
   Naveed, M
   Butt, MH
   Khan, S
   Ismael, NS
   Khan, Z
   Karatas, Y
AF Muhammad, Khayal
   Saqlain, Muhammad
   Muhammad, Gul
   Hamdard, Ataullah
   Naveed, Muhammad
   Butt, Muhammad Hammad
   Khan, Siraj
   Ismael, Najlaa Saadi
   Khan, Zakir
   Karatas, Yusuf
TI Knowledge, Attitude, and Practices (KAPs) of Community Pharmacists
   Regarding COVID-19: A Cross-Sectional Survey in 2 Provinces of Pakistan
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article; Early Access
DE awareness; community pharmacists; COVID-19; infections; KAPs study
ID DISEASE; SYSTEM
AB Objective: The 2019 coronavirus disease (COVID-19) is a global pandemic with no therapy, and pharmacists being a part of the health care system have a vital role in the management of COVID-19. The purpose of this study is to assess the knowledge, attitude, and practices of community pharmacists (CPs) regarding COVID-19. Method: An online survey was conducted among 393 CPs in 2 provinces of Pakistan during the lockdown period. A validated questionnaire (Cronbach's alpha, 0.745) was used for data collection. All statistical analyses were analyzed by using SPSS, version 21 (IBM Corp, Armonk, NY). Results: Among 393 participants, 71.5% (n = 281) had good knowledge, 44% (n = 175) had a positive attitude, and 57.3% (n = 225) had good practices regarding COVID-19. Social media (45.29%, n = 178) were reported as the main source to seek information of COVID-19. Good knowledge, age >= 26 years, and a PhD degree level were the substantial determinants (P = < 0.05) of a good attitude. Similarly, a CP with experience of > 5 years, a PhD degree, good knowledge, and a good attitude has higher odds of having good practices as compared with reference categories (P = < 0.05). Conclusion: In short, a majority of the CPs had good knowledge but had a poor attitude and practice toward the management of COVID-19. Standard-structured educational and counseling programs for CPs regarding COVID-19 are needed for effective management.
C1 [Muhammad, Khayal] Near East Univ, Fac Pharm, Dept Clin Pharm, Nicosia, North Cyprus, Turkey.
   [Saqlain, Muhammad; Khan, Siraj] Quaid I Azam Univ, Dept Pharm, Islamabad, Pakistan.
   [Muhammad, Gul] Hayatabad Med Complex, Dept Med, Peshawar, Khyber Pakhtunk, Pakistan.
   [Hamdard, Ataullah] Cukurova Univ, Fac Sci & Arts, Dept Stat, Adana, Turkey.
   [Naveed, Muhammad] Univ Szeged, Fac Med, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary.
   [Butt, Muhammad Hammad] Univ Cent Punjab, Fac Pharm, Lahore, Pakistan.
   [Ismael, Najlaa Saadi] Philadelphia Univ, Fac Pharm, Dept Clin Sci, Amman, Jordan.
   [Khan, Zakir; Karatas, Yusuf] Cukurova Univ, Tibbi Farmakol Anabilim Dali, Tip Fak, Adana, Turkey.
   [Karatas, Yusuf] Cukurova Univ, Balcali Hosp, Adana, Turkey.
RP Muhammad, K (corresponding author), Near East Univ, Fac Pharm, Dept Clin Pharm, Nicosia, North Cyprus, Turkey.; Butt, MH (corresponding author), Univ Cent Punjab, Fac Pharm, Lahore, Pakistan.
EM khayal866@gmail.com; hmdbut@ucp.edu.pk
RI ; Ismael, Najlaa Saadi/AAJ-9423-2021
OI Naveed, Muhammad/0000-0003-4316-8877; Butt, Muhammad
   Hammad/0000-0003-4387-1351; Khan, Zakir/0000-0003-1365-548X; Khan,
   Siraj/0000-0003-1948-452X; Ismael, Najlaa Saadi/0000-0003-0858-6686
CR Albarrak AI, 2021, J INFECT PUBLIC HEAL, V14, P89, DOI 10.1016/j.jiph.2019.06.029
   Amariles P, 2021, RES SOC ADMIN PHARM, V17, P1988, DOI 10.1016/j.sapharm.2020.03.007
   Athiyah U, 2019, PHARM PRACT-GRANADA, V17, DOI [10.18549/pharmpract.2019.3.1518, 10.18549/PharmPract.2019.3.1518]
   Azhar S, 2013, TROP J PHARM RES, V12, P635, DOI 10.4314/tjpr.v12i4.29
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Basheti IA, 2021, RES SOC ADMIN PHARM, V17, P514, DOI 10.1016/j.sapharm.2020.04.020
   Butt MH, 2021, J MED VIROL, V93, P671, DOI 10.1002/jmv.26464
   Butt MH, 2021, J MED VIROL, V93, P618, DOI 10.1002/jmv.26388
   Col U, 2020, RES SOC ADMIN PHARM, P583, DOI [DOI 10.1016/j.sapharm.2020.02.003, 10.1016/j.sapharm.2020.02.003]
   COVID-19 Clinical Res Coalition, 2020, LANCET, V395, P1322, DOI 10.1016/S0140-6736(20)30798-4
   Dawoud D, 2021, RES SOC ADMIN PHARM, V17, P1950, DOI 10.1016/j.sapharm.2020.05.011
   FIP, 2020, COVID 19 GUID PHARM
   Government of Pakistan, 2020, NAT ACT PLAN COR VIR
   Hamza MS, 2021, J COMMUN HEALTH, V46, P139, DOI 10.1007/s10900-020-00859-z
   Hashmi Furqan Khurshid, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.492
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Jamal A, 2015, VALUE HEALTH, V18, pA246, DOI 10.1016/j.jval.2015.03.1432
   Kara E, 2020, TURK J PHARM SCI, V17, P242, DOI 10.4274/tjps.galenos.2020.72325
   Khan Z, 2020, ADV THER, V37, P2575, DOI 10.1007/s12325-020-01351-9
   Khan Z, 2020, DRUGS THER PERSPECT, V36, P215, DOI 10.1007/s40267-020-00717-x
   Khokhar A, 2020, INT J CLIN PHARM-NET, V42, P625, DOI 10.1007/s11096-020-00982-w
   Mallhi TH, 2015, VALUE HEALTH, V18, pA843, DOI 10.1016/j.jval.2015.09.390
   Mallhi TH, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.561924
   Mallhi TH, 2020, JCPSP-J COLL PHYSICI, V30, pS124, DOI [10.29271/jcpsp.2020.supp2.124, 10.29271/jcpsp.2020.Supp2.S124]
   Mallhi TH, 2020, DISASTER MED PUBLIC, V14, pE40, DOI 10.1017/dmp.2020.278
   Misbah S, 2020, JCPSP-J COLL PHYSICI, V30, pS9, DOI [10.29271/jcpsp.2020.Supp2.S9, 10.29271/jcpsp.2020.Supp1.S9]
   Naser AY., 2020, KNOWLEDGE PRACTICES, P1
   Pharmacy Council of Pakistan, 2017, REG PHARM PAK
   Raosoft, 2004, SAMPL SIZ CALC
   Salman Muhammad, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.397
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Saqlain M., 2020, PUBLIC KNOWLEDGE PRA, P1
   Srichan P., 2020, SSRN ELECT J
   Ul-Haq Z, 2019, E MEDITERR HEALTH J, V25, P553, DOI 10.26719/emhj.18.072
   WHO, 2020, 180 WHO
   Zheng SQ, 2021, RES SOC ADMIN PHARM, V17, P1819, DOI 10.1016/j.sapharm.2020.03.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 38
TC 6
Z9 6
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
AR PII S1935789321000549
DI 10.1017/dmp.2021.54
EA FEB 2021
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZB8QQ
UT WOS:000757100500001
PM 33588970
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Hernandez-Diaz, Y
   Genis-Mendoza, AD
   Fresan, A
   Gonzalez-Castro, TB
   Tovilla-Zarate, CA
   Juarez-Rojop, IE
   Lopez-Narvaez, ML
   Martinez-Magana, JJ
   Nicolini, H
AF Hernandez-Diaz, Yazmin
   Delia Genis-Mendoza, Alma
   Fresan, Ana
   Beatriz Gonzalez-Castro, Thelma
   Alfonso Tovilla-Zarate, Carlos
   Esther Juarez-Rojop, Isela
   Lilia Lopez-Narvaez, Maria
   Jaime Martinez-Magana, Jose
   Nicolini, Humberto
TI Knowledge, Emotions and Stressors in Front-Line Healthcare Workers
   during the COVID-19 Outbreak in Mexico
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; SARS-CoV-2; healthcare workers; Mexico; stress
ID MENTAL-HEALTH; SARS-COV-2
AB The aim of this study was to explore the knowledge, emotions and perceived stressors by healthcare workers who were in contact with infected patients during the COVID-19 outbreak. An online cross-sectional survey was applied. Data were collected from N = 263 healthcare workers in Tabasco State, Mexico. We developed and administered a questionnaire, which consisted of sociodemographic characteristics, plus four sections. The sections evaluated were (1) knowledge of COVID-19; (2) feelings/emotions during the COVID-19 outbreak; (3) factors that caused stress and (4) factors that helped to reduce stress. Surveyed individuals were divided into three groups: physicians, nurses and other healthcare workers. When we evaluated their knowledge of COVID-19 we observed that the majority of healthcare workers in the three groups reported that they knew about COVID-19. Physicians indicated that they felt insecure about practicing their profession (62.5%) due to the high risk of being in contact with SARS-CoV-2. With regards to stressor factors, the risk of transmitting COVID-19 to their families was the main factor causing moderate to high stress (95.4%). Finally, we found that "your profession puts your life at risk" was the only factor associated with feeling nervous and scared (PR: 3.15; 95% CI: 1.54-6.43). We recommended health education campaigns, introductory courses on COVID-19 and other infectious diseases, management protocols and the provision of protection equipment to health workers in order to reduce personal and professional fears of contagion and to improve the health system in Mexico when facing epidemics.
C1 [Hernandez-Diaz, Yazmin; Beatriz Gonzalez-Castro, Thelma] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Jalpa de Mendez, Jalpa De Mendez 86205, Tabasco, Mexico.
   [Delia Genis-Mendoza, Alma] Inst Nacl Med Genom, Serv Atenc Psiquiatr, Secretaria Salud, Ciudad De Mexico 14610, Mexico.
   [Fresan, Ana] Inst Nacl Psiquiatria Ramon Fuente Muniz, Subdirecc Invest Clin, Ciudad De Mexico 14370, Mexico.
   [Alfonso Tovilla-Zarate, Carlos] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco 86650, Tabasco, Mexico.
   [Esther Juarez-Rojop, Isela] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Salud, Villahermosa 86150, Tabasco, Mexico.
   [Lilia Lopez-Narvaez, Maria] Hosp Gen Yajalon Dr Jose Manuel Velasco Siles, Secretaria Salud, Yajalon 29932, Chiapas, Mexico.
   [Jaime Martinez-Magana, Jose; Nicolini, Humberto] Inst Nacl Med Genom, Lab Enfermedades Psiquidtr Neurodegenerat & Adicc, Ciudad De Mexico 14610, Mexico.
RP Tovilla-Zarate, CA (corresponding author), Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco 86650, Tabasco, Mexico.; Nicolini, H (corresponding author), Inst Nacl Med Genom, Lab Enfermedades Psiquidtr Neurodegenerat & Adicc, Ciudad De Mexico 14610, Mexico.
EM yazmin.hdez.diaz@gmail.com; adgenis@inmegen.gob.mx; fresan@imp.edu.mx;
   thelma.glez.castro@gmail.com; alfonso_tovillaz@yahoo.com.mx;
   iselajuarezrojop@hotmail.com; dralilialonar@yahoo.com.mx;
   jimy.10.06@gmail.com; hnicolini@inmegen.gob.mx
RI González-Castro, Thelma/M-6776-2019; Hernández-Díaz,
   Yazmín/AAQ-6326-2021
OI Nicolini, Humberto/0000-0003-2494-0067; Martinez Magana, Jose
   Jaime/0000-0003-0390-8252; Tovilla-Zarate, Carlos
   Alfonso/0000-0001-8170-8171; Gonzalez Castro, Thelma
   Beatriz/0000-0001-8046-6908; Hernandez-Diaz, Yazmin/0000-0003-1200-2292;
   Fresan, Ana/0000-0001-9160-6988
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Baldassarre A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176341
   Bardhan R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183243
   Chamorro-Petronacci C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145139
   Chatterjee SS, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.611314
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Cuschieri S, 2019, SAUDI J ANAESTH, V13, P31, DOI 10.4103/sja.SJA_543_18
   Dalewski B, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031281
   Gobierno de Muxico, COR
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hu XL, 2020, NURS HEALTH SCI, V22, P837, DOI 10.1111/nhs.12727
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Irigoyen-Camacho ME, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207418
   Kamerow D, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1260
   Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Li L, 2020, LANCET RESP MED, V8, pE23, DOI 10.1016/S2213-2600(20)30125-9
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Lopez-Ortiz E, 2020, GAC MED MEX, V156, P132, DOI 10.24875/GMM.M20000346
   Ro JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173234
   Neto MLR, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112972
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Ruiz-Fernandez MD, 2020, J CLIN NURS, V29, P4321, DOI 10.1111/jocn.15469
   SEGOB, 2020, DIARIO OFICIAL FEDER
   Shi Y, 2020, J ZHEJIANG UNIV-SC B, V21, P343, DOI 10.1631/jzus.B2000083
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055
   Tsai YC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-199
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   WHO, SPOTL 10 THREATS GLO
   World Health Organization, 2021, WHO COR DIS COVID 19
   Wu WZ, 2020, J MED VIROL, V92, P1962, DOI 10.1002/jmv.25914
   Zhang M, 2021, J CLIN NURS, V30, P1584, DOI 10.1111/jocn.15707
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 38
TC 2
Z9 2
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2021
VL 18
IS 11
AR 5622
DI 10.3390/ijerph18115622
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA SP9DI
UT WOS:000659962200001
PM 34070295
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Sombultawee, K
   Boon-itt, S
   Bussanit, V
AF Sombultawee, Kedwadee
   Boon-itt, Sakun
   Bussanit, Vipa
TI The Adoption of Protective Health Behaviors During the COVID-19 Pandemic
   in Thailand
SO JOURNAL OF BEHAVIORAL SCIENCE
LA English
DT Article
DE COVID-19; public perceptions; perceived risk; health knowledge;
   communication
ID KNOWLEDGE
AB The objective of the research was to investigate acceptance of public health recommendations regarding COVID-19 in Thailand. The hypothesized framework included COVID-19 knowledge, communication, perceived risk, and perceived government response as predictors, with protective health behavior adoption as the outcome variable. A sample of Thai residents selected from across the country (n = 322) completed an online survey, which was analyzed using a structural equation modelling technique. Findings showed that COVID-19 knowledge influenced perceived risk (beta = .20, p < .001), communication behavior (beta = .16, p < .001), and government response (beta = .17, p < .001), perceived risk (beta = .47, p < .001), communication behavior (beta = .54, p < .001), and government response (beta = .52, p < .001), influenced adoption of protective health behaviors; and that the effect of knowledge on protective health behaviors was partially mediated by perceived risk, communication behavior and government response. These findings illustrated that protective health behavior of Thai residents against COVID-19 was influenced by perceived risk, communication surrounding COVID-19, and perceptions of government response. The main implication is that simply providing more knowledge about COVID-19 is insufficient to improve public health response. Instead, individuals need to understand their risk, through accurate communication and a strong government response to encourage adoption of protective health behavior. Academically, the research provided insight into protective health behavior, especially in relation to government response. However, more research is needed, especially regarding adoption of new and changed behavioral recommendations and the potential for resistance.
C1 [Sombultawee, Kedwadee] Thammasat Business Sch, Dept Mkt, Khlong Nueng, Thailand.
   [Boon-itt, Sakun] Thammasat Business Sch, Dept Operat Management, Khlong Nueng, Thailand.
   [Bussanit, Vipa] Peri Formwork & Scaffolding Thailand Co Ltd, Bangkok, Thailand.
RP Sombultawee, K (corresponding author), Thammasat Business Sch, Dept Mkt, Khlong Nueng, Thailand.
EM kedwadee@tbs.tu.ac.th
CR Abuza Z., 2020, THE DIPLOMAT
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Berg MB, 2020, TRANSL BEHAV MED, V10, P843, DOI 10.1093/tbm/ibaa085
   Brennen J. S., 2020, TYPES SOURCES CLAIMS
   Brennen JS, 2021, INT J PRESS/POLIT, V26, P277, DOI 10.1177/1940161220964780
   Brown TA., 2006, CONFIRMATORY FACTOR, DOI [10.1007/978-3-319-65361-7_8, DOI 10.1007/978-3-319-65361-7_8]
   Chookajorn T, 2020, P NATL ACAD SCI USA, V117, P12520, DOI 10.1073/pnas.2007076117
   Chu HR, 2021, PATIENT EDUC COUNS, V104, P1878, DOI 10.1016/j.pec.2021.02.031
   Ciotti M, 2020, CRIT REV CL LAB SCI, V57, P365, DOI 10.1080/10408363.2020.1783198
   Dang HL., 2021, AUSTRIAN J S-EAST AS, V14, P37
   Faasse K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.551004
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Hanafiah K. M., 2020, PUBLIC KNOWLEDGE PER
   Hoffmann R, 2019, EUR J HEALTH ECON, V20, P27, DOI 10.1007/s10198-017-0950-2
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huo CG, 2018, INFORM DEV, V34, P346, DOI 10.1177/0266666917700231
   Kenny DA, 2015, SOCIOL METHOD RES, V44, P486, DOI 10.1177/0049124114543236
   Kowalski RM, 2021, HEALTH COMMUN, V36, P15, DOI 10.1080/10410236.2020.1847448
   Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011
   Lee M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10285-y
   Lindley D.V., 1984, NEW CAMBRIDGE STAT T
   Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1
   MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542
   Namwat C., 2020, OSIR J, V13, P33
   Nowak B, 2020, PERS INDIV DIFFER, V167, DOI 10.1016/j.paid.2020.110232
   Osterrieder A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046863
   Pan-ngum W., 2021, WELLCOME OPEN RES, V5, P1
   Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054
   Ranjit YS, 2021, J RISK RES, V24, P449, DOI 10.1080/13669877.2021.1887328
   Roozenbeek J, 2021, PSYCHOL SCI, V32, P1169, DOI 10.1177/09567976211024535
   Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199
   Rosi A, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.646558
   Soper D., 2020, FREE STAT CALCULATOR
   Sylvester SM, 2021, SOC SCI QUART, V102, P2341, DOI 10.1111/ssqu.12989
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Prasetyo YT, 2020, INT J INFECT DIS, V99, P312, DOI 10.1016/j.ijid.2020.07.074
   Tyupa S., 2011, NEW VOICES TRANSLATI, V7, P35
   Van Der Linden S., 2021, BIG DATA SOC, V8, p205395172110138, DOI [10.1177/20539517211013868, DOI 10.1177/20539517211013868, https://doi.org/10.1177/20539517211013868]
   Velavan TP, 2021, INT J INFECT DIS, V103, P278, DOI 10.1016/j.ijid.2020.11.189
   Westland JC, 2010, ELECTRON COMMER R A, V9, P476, DOI 10.1016/j.elerap.2010.07.003
   WHO, 2021, WHO COR DASHB
   Zheng DN, 2021, TOURISM MANAGE, V83, DOI 10.1016/j.tourman.2020.104261
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 43
TC 0
Z9 0
U1 0
U2 0
PU BEHAVIORAL SCIENCE RESEARCH INST, SRINAKHARINWIROT UNIV
PI BANGKOK
PA 114 SUKHUMVIT 23, WATTANA, BANGKOK, 10110, THAILAND
SN 1906-4675
J9 J BEHAV SCI
JI J. Behav. Sci.
PD SEP
PY 2021
VL 16
IS 3
BP 72
EP 83
PG 12
WC Social Sciences, Interdisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA WB3ZR
UT WOS:000703514500005
DA 2022-04-20
ER

PT J
AU Maguire, H
   Harper, JM
   Gardner, RM
   Luiselli, JK
AF Maguire, Helena
   Harper, Jill M.
   Gardner, Rita M.
   Luiselli, James K.
TI Behavioral Training and Performance Management of Human Services
   Organization Care Providers During the COVID-19 Pandemic
SO ADVANCES IN NEURODEVELOPMENTAL DISORDERS
LA English
DT Article; Early Access
DE Applied behavior analysis; Care provider training; COVID-19; Human
   services organizations; Organizational behavior management; Performance
   management
AB Objectives This report describes a model of training and performance management that was designed for and implemented with care providers at a residential school for children with neurodevelopmental and intellectual disabilities in response to the COVID-19 pandemic. The model focused on health and safety concerns, risk mitigation, and intervention integrity.
   Methods Procedures followed an applied behavior analysis (ABA) and organizational behavior management (OBM) framework. Action plans addressed (a) critical COVID-19 protocols, (b) behavior-specific implementation guidelines, (c) remote and in-person training formats, (d) in vivo supervision, and (e) knowledge and performance assessments.
   Results A competency evaluation (field study) revealed that participant care providers (N= 25) acquired and maintained COVID-19 protocols at near 100% proficiency immediately following and 1-month post-training. Supervisors had uniformly positive approval and acceptance ratings of school responsiveness to the COVID-19 pandemic.
   Conclusions Integrated and evidence-based care provider training and supervisory practices can promote risk mitigation and performance effectiveness during health crises such as the COVID-19 pandemic. More controlled research that includes multiple dependent measures is needed to replicate and extend our findings to similar human services settings.
C1 [Maguire, Helena; Harper, Jill M.; Luiselli, James K.] Melmark New England, Clin Dev & Res, 461 River Rd, Andover, MA 01801 USA.
   [Gardner, Rita M.] Melmark, Berwyn, PA USA.
RP Luiselli, JK (corresponding author), Melmark New England, Clin Dev & Res, 461 River Rd, Andover, MA 01801 USA.
EM jluiselli@melmarkne.org
OI Luiselli, James/0000-0001-6989-9155
CR [Anonymous], MASSACHUSETTS DEP PU
   Bailey J., 2016, ETHICS BEHAV ANAL, DOI [10.4324/9781315669212, DOI 10.4324/9781315669212]
   Behavior Analyst Certification Board, 2021, PROF ETH COMPL COD
   Belisle J, 2016, J ORGAN BEHAV MANAGE, V36, P71, DOI 10.1080/01608061.2016.1152210
   Carr JE, 2013, BEHAV ANAL PRACT, V6, P16
   Casella SE, 2010, J APPL BEHAV ANAL, V43, P729, DOI 10.1901/jaba.2010.43-729
   Centers for Disease Control, 2020, GUID CHILD CAR PROGR
   Columbo R. A., 2020, BEHAV ANAL PRACT, DOI [10.1007/s40617-020-00432-z, DOI 10.1007/S40617-020-00432-Z]
   Cox DJ, 2020, BEHAV ANAL PRACT, V13, P299, DOI 10.1007/s40617-020-00430-1
   Culig KM, 2005, J ORGAN BEHAV MANAGE, V25, P35, DOI 10.1300/J075v25n01_02
   DiGennaro Reed F.D., 2013, HDB CRISIS INTERVENT, P71, DOI [10.1007/978-1-4614-6531-7_5, DOI 10.1007/978-1-4614-6531-7_5]
   Ferguson J, 2019, J AUTISM DEV DISORD, V49, P582, DOI 10.1007/s10803-018-3724-5
   Gardner RM., 2020, BEHAV HLTH NEWS, V8, P15
   Gravina N, 2020, J APPL BEHAV ANAL, V53, P1935, DOI 10.1002/jaba.779
   Jess RL, 2020, J APPL BEHAV ANAL, V53, P1219, DOI 10.1002/jaba.732
   Kazdin A. E., 2011, SINGLE CASE RES DESI
   Kornack J, 2020, BEHAV ANAL PRACT, V13, P543, DOI 10.1007/s40617-020-00462-7
   LeBlanc LA, 2020, BEHAV ANAL PRACT, V13, P604, DOI 10.1007/s40617-020-00446-7
   Lerman D.C., 2015, CLIN ORG APPL APPL B, P321
   Lerman DC, 2020, J BEHAV EDUC, V29, P195, DOI 10.1007/s10864-020-09378-2
   Luiselli J.K., 2021, ORG BEHAV MANAGEMENT
   Luiselli J.K., 2021, ORG BEHAV MANAGEMENT, P100
   Luiselli JK, 2015, AUT CHILD PSYCHO, P465, DOI 10.1007/978-1-4939-2656-5_17
   Parsons MB, 2013, BEHAV ANAL PRACT, V6, P4
   Parsons MB, 2012, BEHAV ANAL PRACT, V5, P2
   Reid D.H., 2017, APPL BEHAV ANAL ADV, P21
   Rodriguez K, 2020, BEHAV ANAL PRACT, V13, P291, DOI 10.1007/s40617-020-00429-8
   Russ S, 2013, ANN SURG, V258, P856, DOI 10.1097/SLA.0000000000000206
   Schieltz KM, 2020, J APPL BEHAV ANAL, V53, P1242, DOI 10.1002/jaba.742
   Thompson JR, 2020, INTELLECT DEV DISAB, V58, P257, DOI 10.1352/1934-9556-58.4.257
   Tomlinson SRL, 2018, J BEHAV EDUC, V27, P172, DOI 10.1007/s10864-018-9292-0
   Whiting SW, 2014, J ORGAN BEHAV MANAGE, V34, P265, DOI 10.1080/01608061.2014.973632
   Wilder DA, 2020, J APPL BEHAV ANAL, V53, P1170, DOI 10.1002/jaba.676
NR 33
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2366-7532
EI 2366-7540
J9 ADV NEURODEV DISORD
JI Adv. Neurodev. Disord.
DI 10.1007/s41252-021-00234-6
EA JAN 2022
PG 9
WC Education, Special; Psychology, Developmental; Rehabilitation
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research; Psychology; Rehabilitation
GA XZ5WP
UT WOS:000737722300001
PM 35005217
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Lowe, B
   Bopp, B
AF Lowe, Belinda
   Bopp, Benjamin
TI COVID-19 vaginal delivery - A case report
SO AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
LA English
DT Article
DE breastfeeding; coronavirus; COVID-19; neonatal; vaginal delivery
AB The novel coronavirus termed SARS-CoV-2 (COVID-19) is a major public health challenge. Many maternity units around the country are currently considering management protocols for these patients. We report a case from a tertiary Australian hospital describing an uncomplicated vaginal birth in a COVID-19 positive mother. To our knowledge this is also the first case described of a mother with COVID-19 not separated from her infant. Management provided supports the current Royal College of Obstetricians and Gynaecologists and World Health Organization guidelines suggesting that it is possible to consider rooming in post-delivery for COVID-19 positive parents. Encouragement of breastfeeding appears possible and safe when viral precautions are observed.
C1 [Lowe, Belinda; Bopp, Benjamin] Gold Coast Univ Hosp, Dept Obstet & Gynaecol, 1 Hosp Blvd, Southport, Qld, Australia.
   [Lowe, Belinda] Bond Univ, Gold Coast, Qld, Australia.
RP Lowe, B (corresponding author), Gold Coast Univ Hosp, Dept Obstet & Gynaecol, 1 Hosp Blvd, Southport, Qld, Australia.
EM Belinda.lowe2@health.qld.gov.au
OI Lowe, Belinda/0000-0001-5626-4433
CR Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Dashraath P, 2020, AM J OBSTET GYNECOL, P1
   Royal College of Obstetricians and Gynaecologists, 2020, COR COVID 19 INF PRE
   Schwartz DA, 2020, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2020-0901-SA, DOI 10.5858/ARPA.2020-0901-SA]
   World Health Organization, 2020, Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-nCoV) Infection Is Suspected: Interim Guidance. (
NR 5
TC 55
Z9 56
U1 3
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0004-8666
EI 1479-828X
J9 AUST NZ J OBSTET GYN
JI Aust. N. Z. J. Obstet. Gynaecol.
PD JUN
PY 2020
VL 60
IS 3
BP 465
EP 466
DI 10.1111/ajo.13173
EA MAY 2020
PG 2
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA LV3AI
UT WOS:000535947100001
PM 32294229
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Ali, H
   Amin, HMG
   Mostafa, D
   Mohamed, EKA
AF Ali, Heba
   Amin, Hala M. G.
   Mostafa, Diana
   Mohamed, Ehab K. A.
TI Earnings management and investor protection during the COVID-19
   pandemic: evidence from G-12 countries
SO MANAGERIAL AUDITING JOURNAL
LA English
DT Article; Early Access
DE Earnings management; Investor protection institutions; COVID-19
   pandemic; G-12
ID CORPORATE GOVERNANCE; FINANCIAL CRISIS; AUDIT QUALITY; FAMILY FIRMS;
   INCOME; INCENTIVES; ACCRUALS; LEVERAGE; IMPACT; BOARDS
AB Purpose - The purpose of this paper is to examine the inter-relations among the strength of investor protection institutions, earnings management (EM) and the COVID-19 pandemic.
   Design/methodology/approach - As a proxy for EM, the authors use discretionary accruals measure, estimated using the modified Jones model (1991). As a proxy for the strength of investor protection institutions, the study uses the Investor Protection Index, extracted from the Global Competitiveness Reports. The sample consists of 5,519 firms listed in the Group of Twelve countries during 2015-2020.
   Findings - The study shows that firms tend to engage less in EM during the pandemic period. The authors also find a significantly negative relation between the strength of investor protection institutions and EM practices, and interestingly, this negative relation was found to be more pronounced during the pandemic period.
   Research limitations/implications - For investors and practitioners, the findings help get insights into the behavior of firms in response of the pandemic shock in countries with solid institutional and legal protection. For policymakers, the findings reaffirm the critical role that institutional incentives and reforms can play, in influencing firms to exert more efforts to promote their financial reporting quality.
   Originality/value - To the best of our knowledge, the study is one of the first attempts to examine the link between EM practices and investor protection during the COVID-19 pandemic. The findings extend both the literature on the role of institutional factors in promoting the earnings quality and the literature on COVID-19's effect on firm performance and practices.
C1 [Ali, Heba; Amin, Hala M. G.; Mostafa, Diana; Mohamed, Ehab K. A.] German Univ Cairo, Fac Management Technol, Dept Accounting & Finance, Cairo, Egypt.
RP Mohamed, EKA (corresponding author), German Univ Cairo, Fac Management Technol, Dept Accounting & Finance, Cairo, Egypt.
EM ehab.kamel@guc.edu.eg
CR ABED S., 2012, INT J EC FINANCE, V4, P78, DOI DOI 10.5539/IJEF.V4N6P78
   Aguilera RV, 2003, ACAD MANAGE REV, V28, P447, DOI 10.5465/amr.2003.10196772
   Ahmad-Zaluki NA, 2011, INT J ACCOUNT, V46, P111, DOI 10.1016/j.intacc.2011.04.001
   Ali A, 2007, J ACCOUNT ECON, V44, P238, DOI 10.1016/j.jacceco.2007.01.006
   Aubert F, 2014, ADV ACCOUNT, V30, P154, DOI 10.1016/j.adiac.2014.03.008
   Bao SR, 2017, INT BUS REV, V26, P828, DOI 10.1016/j.ibusrev.2017.02.002
   Burgstahler DC, 2006, ACCOUNT REV, V81, P983, DOI 10.2308/accr.2006.81.5.983
   Cahan SF, 2008, J INT ACCOUNT RES, V7, P1, DOI 10.2308/jiar.2008.7.1.1
   Chen T., 2010, LINGNAN J BANKING FI, V2, P57
   Chia YM, 2007, MANAG AUDIT J, V22, P177, DOI 10.1108/02686900710718672
   Chintrakarn P, 2018, INT REV FINANC, V18, P477, DOI 10.1111/irfi.12135
   Davidson WN, 2004, ACAD MANAGE J, V47, P267, DOI 10.2307/20159577
   DECHOW PM, 1995, ACCOUNT REV, V70, P193
   Dechow PM, 2002, ACCOUNT REV, V77, P35, DOI 10.2308/accr.2002.77.s-1.35
   Defond ML, 2005, J ACCOUNT RES, V43, P153, DOI 10.1111/j.1475-679x.2005.00166.x
   Dimitras AI, 2015, RES INT BUS FINANC, V34, P338, DOI 10.1016/j.ribaf.2015.02.017
   Dou YW, 2013, ACCOUNT REV, V88, P1629, DOI 10.2308/accr-50489
   Enomoto, 2015, J CONTEMP ACCOUNT EC, V11, P183, DOI [10.1016/j.jcae.2015.07.001, DOI 10.1016/J.JCAE.2015.07.001]
   Filatotchev I, 2013, ASIA PAC J MANAG, V30, P965, DOI 10.1007/s10490-012-9293-9
   Filip A, 2014, INT J ACCOUNT, V49, P455, DOI 10.1016/j.intacc.2014.10.004
   Francis B, 2013, ACCOUNT HORIZ, V27, P319, DOI 10.2308/acch-50431
   Francis JR, 2008, CONTEMP ACCOUNT RES, V25, P157, DOI 10.1506/car.25.1.6
   Guenther DA, 2000, J ACCOUNT ECON, V29, P53, DOI 10.1016/S0165-4101(00)00013-6
   Han S, 2010, J INT BUS STUD, V41, P123, DOI 10.1057/jibs.2008.78
   Healy P., 1999, ACCOUNT HORIZ, V13, P365, DOI DOI 10.2308/ACCH.1999.13.4.365
   Hoenen AK, 2015, J INT BUS STUD, V46, P104, DOI 10.1057/jibs.2014.31
   Holthausen RW, 2003, J ACCOUNT ECON, V36, P271, DOI 10.1016/j.jacceco.2003.10.004
   Houcine Asma, 2017, International Journal of Managerial and Financial Accounting, V9, P19
   Houqe MN, 2012, INT J ACCOUNT, V47, P333, DOI 10.1016/j.intacc.2012.07.003
   Islam A., 2011, INT J EC FINANCE, V3, P116
   Jaggi B, 2011, INT J ACCOUNT, V46, P241, DOI 10.1016/j.intacc.2011.07.003
   Kim YU, 2014, CORP GOV-OXFORD, V22, P266, DOI 10.1111/corg.12062
   Klein A, 2002, J ACCOUNT ECON, V33, P375, DOI 10.1016/S0165-4101(02)00059-9
   Kousenidis DV, 2013, INT REV FINANC ANAL, V30, P351, DOI 10.1016/j.irfa.2013.03.004
   La Porta R, 2000, J FINANC, V55, P1, DOI 10.1111/0022-1082.00199
   La Porta R, 1998, J POLIT ECON, V106, P1113, DOI 10.1086/250042
   Lazzem S, 2018, RES INT BUS FINANC, V44, P350, DOI 10.1016/j.ribaf.2017.07.103
   Leuz C, 2003, J FINANC ECON, V69, P505, DOI 10.1016/S0304-405X(03)00121-1
   Li ZG, 2020, PAC ACCOUNT REV, V32, P495, DOI 10.1108/PAR-09-2019-0119
   Lopes A.P., 2018, ATHENS J BUSINESS EC, V4, P179
   McNichols MF, 2002, ACCOUNT REV, V77, P61, DOI 10.2308/accr.2002.77.s-1.61
   Muttakin MB, 2017, MANAG AUDIT J, V32, P427, DOI 10.1108/MAJ-01-2016-1310
   NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610
   Ning LT, 2014, INT BUS REV, V23, P811, DOI 10.1016/j.ibusrev.2013.12.003
   Ohlson J., 1995, CONTEMP ACCOUNT RES, V11, P661, DOI [DOI 10.1111/J.1911-3846.1995.TB00461.X, 10.1111/j.1911-3846.1995.tb00461.x]
   Orazalin N, 2019, MANAG AUDIT J, V34, P696, DOI 10.1108/MAJ-12-2017-1730
   Ozili P., 2020, SPILLOVER COVID 19 I, DOI [DOI 10.2139/SSRN.3562570, 10.2139/ssrn.3562570]
   Ozili PK, 2017, INT J MANAG FINANC, V13, P419, DOI 10.1108/IJMF-11-2016-0213
   Persakis A, 2015, J MULTINATL FINANC M, V30, P1, DOI 10.1016/j.mulfin.2014.12.002
   Prencipe A, 2008, FAM BUS REV, V21, P71, DOI 10.1111/j.1741-6248.2007.00112.x
   Prencipe A, 2011, J ACCOUNT AUDIT FINA, V26, P199, DOI 10.1177/0148558X11401212
   PWC, 2021, GLOB CRIS SURV 2021
   Gonzalez JS, 2014, J BUS ETHICS, V121, P419, DOI 10.1007/s10551-013-1700-8
   Saleh N.M., 2005, ACCOUNT BUS RES, V35, P69
   Seal, 2006, MANAGE ACCOUNT RES, V17, P389, DOI DOI 10.1016/J.MAR.2006.05.001
   Shen CH, 2005, J BANK FINANC, V29, P2675, DOI 10.1016/j.jbankfin.2004.10.004
   SWEENEY AP, 1994, J ACCOUNT ECON, V17, P281, DOI 10.1016/0165-4101(94)90030-2
   Tahinakis P.D., 2014, J EC ASYMMETRIES, V11, P104
   Teoh SH, 1998, J FINANC ECON, V50, P63, DOI 10.1016/S0304-405X(98)00032-4
   Turegun N, 2020, J CORP ACCOUNT FINAN, V31, P64, DOI 10.1002/jcaf.22418
   Vieira EFS, 2016, AUST ACCOUNT REV, V26, P190, DOI 10.1111/auar.12096
   WATTS RL, 1990, ACCOUNT REV, V65, P131
   Waweru NM, 2018, MANAG AUDIT J, V33, P171, DOI 10.1108/MAJ-09-2016-1438
   World Economic Forum, 2020, GLOBAL COMPETITIVENE
   Xiao H., 2021, J ACCOUNTING TAXATIO, V13, P59
   Yasar A., 2013, INT J BUSINESS SOCIA, V4, P153
   Yurt C., 2015, INT J EC COMMERCE MA, V3, P33
   Zamri N, 2013, PROC ECON FINANC, V7, P86, DOI 10.1016/S2212-5671(13)00222-0
NR 68
TC 0
Z9 0
U1 6
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0268-6902
EI 1758-7735
J9 MANAG AUDIT J
JI Manag. Audit. J.
DI 10.1108/MAJ-07-2021-3232
EA JAN 2022
PG 23
WC Business, Finance; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA YO5GN
UT WOS:000747967700001
DA 2022-04-20
ER

PT J
AU Karakose, T
   Yirci, R
   Papadakis, S
   Ozdemir, TY
   Demirkol, M
   Polat, H
AF Karakose, Turgut
   Yirci, Ramazan
   Papadakis, Stamatios
   Ozdemir, Tuncay Yavuz
   Demirkol, Murat
   Polat, Hakan
TI Science Mapping of the Global Knowledge Base on Management, Leadership,
   and Administration Related to COVID-19 for Promoting the Sustainability
   of Scientific Research
SO SUSTAINABILITY
LA English
DT Article
DE COVID-19; coronavirus; bibliometric analysis; visualization; management;
   leadership; administration; sustainability
ID BIBLIOMETRIC ANALYSIS; IMPACT; DISEASE
AB The pandemic caused by the COVID-19 virus has resulted in inevitable radical changes across almost all areas of daily life, with the pandemic having revealed perhaps the greatest crisis humanity has faced in modern history. This study aims to provide thematic and methodological recommendations for future sustainable research programs through a bibliometric analysis of publications focused on management, leadership, and administration related to COVID-19. The data for the study were obtained from the Web of Science Core Collection (WoSCC) bibliographic database and then analyzed according to thematic content analysis and bibliometric methodology. The study's units of analysis include countries, journals, keywords, research models, sample/study group, and time to publication. VOSviewer software and visualization maps were used to report the findings obtained from the analyzed data. When the study's results are evaluated regarding the number of related publications and total citations, it can be revealed that Anglo-American-, Chinese-, and European-centered dominance continues in COVID-19-related studies. The vast majority of publications on this subject area are concentrated in the field of health. In addition, the study's findings revealed that the examined articles were generally published in journals considered as prestigious, have high impact factors, are published in the English language, and with articles published in a short time after a much-reduced editorial/review and publishing process. Unlike previous bibliometric reviews, this research comprehensively analyzed the management-, leadership-, and administration-oriented publications related to COVID-19 with a holistic approach, providing essential findings and recommendations for future sustainable thematic research opportunities.
C1 [Karakose, Turgut] Kutahya Dumlupinar Univ, Dept Educ Sci, Fac Educ, TR-43100 Kutahya, Turkey.
   [Yirci, Ramazan] Sutcuimam Univ, Dept Educ Sci, Fac Educ, TR-46050 Kahramanmaras, Turkey.
   [Papadakis, Stamatios] Univ Crete, Dept Educ, Iraklion 68333, Greece.
   [Ozdemir, Tuncay Yavuz; Demirkol, Murat; Polat, Hakan] Firat Univ, Dept Educ Sci, Fac Educ, TR-23119 Elazig, Turkey.
RP Papadakis, S (corresponding author), Univ Crete, Dept Educ, Iraklion 68333, Greece.
EM tkarakose@yahoo.com; ryirci@gmail.com; stpapadakis@uoc.gr;
   tyavuz23@gmail.com; mdkol@hotmail.com; hakanpolat@firat.edu.tr
RI KARAKOSE, TURGUT/AAR-2642-2021; Papadakis, Stamatis/S-1483-2016; POLAT,
   HAKAN/ABG-2858-2021; Yirci, Ramazan/N-8738-2015
OI KARAKOSE, TURGUT/0000-0003-0346-8154; Papadakis,
   Stamatis/0000-0003-3184-1147; POLAT, HAKAN/0000-0002-0271-3747; Yirci,
   Ramazan/0000-0003-4696-7420; OZDEMIR, Tuncay Yavuz/0000-0002-5361-7261
CR Acuto M, 2020, ONE EARTH, V2, P317, DOI 10.1016/j.oneear.2020.04.004
   Aggarwal A, 2016, J THORAC ONCOL, V11, P1040, DOI 10.1016/j.jtho.2016.03.010
   Aldrich AS, 2020, POLIT GENDER, V16, P960, DOI 10.1017/S1743923X20000549
   Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Antonakis J, 2021, GROUP PROCESS INTERG, V24, P210, DOI 10.1177/1368430220981418
   Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12219132
   Arora, 2021, JAMA HLTH FORUM, V2
   Aslan A.E, 2001, CONTENT ANAL APPL EX
   Bagdasarian N, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01650-6
   Baltaci A., 2019, AHI EVRAN U SOSYAL B, V5, P368, DOI [10.31592/aeusbed.598299, DOI 10.31592/AEUSBED.598299]
   Baum F, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n91
   Blundell R, 2020, FISC STUD, V41, P291, DOI 10.1111/1475-5890.12232
   Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447
   Burgess RA, 2021, LANCET, V397, P8, DOI 10.1016/S0140-6736(20)32642-8
   Burstrom B, 2020, EUR J PUBLIC HEALTH, V30, P617, DOI 10.1093/eurpub/ckaa095
   Cao JY, 2020, PSYCHOTHER PSYCHOSOM, V89, P252, DOI 10.1159/000507453
   Ceylan Z, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138817
   Cobo MJ, 2014, IEEE T INTELL TRANSP, V15, P901, DOI 10.1109/TITS.2013.2284756
   Corbin Juliet, 2008, BASICS QUALITATIVE R, V3rd
   Dash DP, 2021, METHODSX, V8, DOI 10.1016/j.mex.2020.101202
   Davico C, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.572997
   Davis W, 2020, UNRAVELLING AM
   Demirkol M., 2021, ED PROCESS INT J, V10, P7, DOI DOI 10.22521/EDUPIJ.2021.102.1
   Dirani KM, 2020, HUM RESOUR DEV INT, V23, P380, DOI 10.1080/13678868.2020.1780078
   Fidahic M, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01047-2
   Flanagan EW, 2021, OBESITY, V29, P438, DOI 10.1002/oby.23066
   Gale RP, 2020, BRIT J HAEMATOL, V190, P358, DOI 10.1111/bjh.16905
   Gok S.G, 2020, KAPADOKYA AKAD BAK, V4, P73
   Gul S, 2020, PSYCHIAT DANUB, V32, P463, DOI 10.24869/psyd.2020.463
   Gumus S, 2020, SCH LEADERSH MANAG, V40, P23, DOI 10.1080/13632434.2019.1578737
   Hallinger P, 2020, PROF DEV EDUC, V46, P521, DOI 10.1080/19415257.2019.1623287
   Hallinger P, 2020, EDUC MANAG ADM LEAD, V48, P595, DOI 10.1177/1741143219836684
   Hegele Y, 2021, WEST EUR POLIT, V44, P1052, DOI 10.1080/01402382.2021.1873529
   Irez T, 2021, INT J SPORTS MED, V7, P184, DOI [10.23937/2469-5718/1510184, DOI 10.23937/2469-5718/1510184]
   Jaeger MM, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100524
   Joffe AR, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.625778
   Jung JS, 2021, STUD HIGH EDUC, V46, P107, DOI 10.1080/03075079.2020.1859685
   Karakose T, 2021, ED PROCESS INT J, V10, P53, DOI DOI 10.22521/EDUPIJ.2021.103.4
   Karakose T., 2020, ED PROCESS INT J, V9, P201, DOI [10.22521/edupij.2020.94.1, DOI 10.22521/EDUPIJ.2020.94.1]
   Karakose T, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13158654
   Karakose T, 2021, PROG NUTR, V23, DOI 10.23751/pn.v23i2.11656
   Karakose T, 2021, ACTA MEDICA MEDITERR, V37, P437, DOI 10.19193/0393-6384_2021_1_68
   Karakose T, 2021, SOC BEHAV PERSONAL, V49, DOI 10.2224/sbp.9890
   Karakose T, 2014, PAK J STAT, V30, P1365
   Karakose T, 2009, AFR J BUS MANAGE, V3, P504
   Karakose T, 2008, KURAM UYGUL EGIT BIL, V8, P569
   Kim HS, 2021, RELIGIOUS EDUC, V116, P41, DOI 10.1080/00344087.2021.1873662
   Kirchner K, 2021, KNOWL MAN RES PRACT, V19, P493, DOI 10.1080/14778238.2021.1877579
   Kohler T, 1997, EUR J PERSONALITY, V11, P69, DOI 10.1002/(SICI)1099-0984(199703)11:1<69::AID-PER277>3.0.CO;2-G
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Liu N, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01059-y
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Merriam S.B., 2019, QUALITATIVE RES PRAC
   Ministry of Health of the Republic of Turkey, 2020, COVID 19 PAND MAN WO
   Mizrahi S, 2021, PUBLIC ADMIN REV, V81, P1120, DOI 10.1111/puar.13370
   Mochida S, 2021, EUR EARLY CHILD EDUC, V29, P51, DOI 10.1080/1350293X.2021.1872669
   Morris SA, 2008, ANNU REV INFORM SCI, V42, P213
   Mubarak M, 2020, JCPSP-J COLL PHYSICI, V30, pS92, DOI [10.29271/jcpsp.2020.supp2.92, 10.29271/jcpsp.2020.Supp2.S92, 10.29271/jcpsp.2020.Supp3.S92]
   National Institutes of Health, THER MAN AD COVID 19
   O'Flynn J, 2021, PUBLIC MANAG REV, V23, P961, DOI 10.1080/14719037.2020.1820273
   Padhan R, 2021, ECON ANAL POLICY, V70, P220, DOI 10.1016/j.eap.2021.02.012
   Palayew A, 2020, NAT HUM BEHAV, V4, P666, DOI 10.1038/s41562-020-0911-0
   Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Piccarozzi M, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13073791
   Rahim F., 2020, BIBLIOMETRIC ANAL GL, DOI [10.1101/2020.03.19.20038752, DOI 10.1101/2020.03.19.20038752]
   Rasul G, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.589681
   Raynaud M, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-020-01190-w
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rousseau R., 2014, MEASURING SCHOLARLY, P285, DOI [10.1007/978-3-319-10377-8_13, DOI 10.1007/978-3-319-10377-8_13, 10.1007/978-3-319-10377-8_13(InEng.)]
   Rubin EJ, 2020, NEW ENGL J MED, V382, P866, DOI 10.1056/NEJMe2001329
   Shamsi A, 2020, J DIABETES METAB DIS, V19, P1845, DOI 10.1007/s40200-020-00606-0
   Shen HY, 2020, EMERG MARK FINANC TR, V56, P2213, DOI 10.1080/1540496X.2020.1785863
   Siche R, 2020, SCI AGROPEC, V11, P3, DOI 10.17268/sci.agropecu.2020.01.00
   Soga M, 2021, ECOL APPL, V31, DOI 10.1002/eap.2248
   Stoye Emma, 2020, Nature, DOI 10.1038/d41586-020-00253-8
   Tasci, 2021, INT J CURRIC INSTR, V13, P522
   Tee ML, 2020, J AFFECT DISORDERS, V277, P379, DOI 10.1016/j.jad.2020.08.043
   da Silva JTA, 2021, SCIENTOMETRICS, V126, P831, DOI 10.1007/s11192-020-03675-3
   Turan S, 2020, MILLI EGITIM DERGISI, V49, P175, DOI [10.37669/milliegitim.788133, DOI 10.37669/MILLIEGITIM.788133]
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Walters AS., 2020, BROWN U CHILD ADOLES, V36, P8, DOI [DOI 10.1002/CBL.30483, 10.1002/cbl.30497]
   Wang JH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022849
   Wolkewitz M, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-00972-6
   World Health Organization, COVID 19 CLIN MAN LI
   Xiang YT, 2020, LANCET, V395, P684, DOI 10.1016/S0140-6736(20)30375-5
   Yu YT, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-4235
   Zhai F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113766
   Zhai X, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015317
   Zhang Longhao, 2020, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V37, P236, DOI 10.7507/1001-5515.202002034
   Zou X, 2018, ACCIDENT ANAL PREV, V118, P131, DOI 10.1016/j.aap.2018.06.010
NR 94
TC 10
Z9 10
U1 11
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD SEP
PY 2021
VL 13
IS 17
AR 9631
DI 10.3390/su13179631
PG 22
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA UO2DV
UT WOS:000694511300001
OA gold
DA 2022-04-20
ER

PT J
AU Kanellopoulou, A
   Koskeridis, F
   Markozannes, G
   Bouras, E
   Soutziou, C
   Chaliasos, K
   Doumas, MT
   Sigounas, DE
   Tzovaras, VT
   Panos, A
   Stergiou, Y
   Mellou, K
   Papamichail, D
   Aretouli, E
   Chatzidimitriou, D
   Chatzopoulou, F
   Bairaktari, E
   Tzoulaki, I
   Evangelou, E
   Rizos, EC
   Ntzani, E
   Vakalis, K
   Tsilidis, KK
AF Kanellopoulou, Afroditi
   Koskeridis, Fotios
   Markozannes, Georgios
   Bouras, Emmanouil
   Soutziou, Chrysa
   Chaliasos, Konstantinos
   Doumas, Michail T.
   Sigounas, Dimitrios E.
   Tzovaras, Vasilios T.
   Panos, Agapios
   Stergiou, Yiolanda
   Mellou, Kassiani
   Papamichail, Dimitrios
   Aretouli, Eleni
   Chatzidimitriou, Dimitrios
   Chatzopoulou, Fani
   Bairaktari, Eleni
   Tzoulaki, Ioanna
   Evangelou, Evangelos
   Rizos, Evangelos C.
   Ntzani, Evangelia
   Vakalis, Konstantinos
   Tsilidis, Konstantinos K.
TI Awareness, knowledge and trust in the Greek authorities towards COVID-19
   pandemic: results from the Epirus Health Study cohort
SO BMC PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Knowledge; Trust in authorities; Cohort study; Epirus health
   study; Exposure-wide association analysis
AB Background To assess the level of knowledge and trust in the policy decisions taken regarding the coronavirus disease (COVID-19) pandemic among Epirus Health Study (EHS) participants. Methods The EHS is an ongoing and deeply-phenotyped prospective cohort study that has recruited 667 participants in northwest Greece until August 31st, 2020. Level of knowledge on coronavirus (SARS-CoV-2) transmission and COVID-19 severity was labeled as poor, moderate or good. Variables assessing knowledge and beliefs towards the pandemic were summarized overall and by sex, age group (25-39, 40-49, 50-59, >= 60 years) and period of report (before the lifting of lockdown measures in Greece: March 30th to May 3rd, and two post-lockdown time periods: May 4th to June 31st, July 1st to August 31st). A hypothesis generating exposure-wide association analysis was conducted to evaluate the associations between 153 agnostically-selected explanatory variables and participants' knowledge. Correction for multiple comparisons was applied using a false discovery rate (FDR) threshold of 5%. Results A total of 563 participants (49 years mean age; 60% women) had available information on the standard EHS questionnaire, the clinical and biochemical measurements, and the COVID-19-related questionnaire. Percentages of poor, moderate and good knowledge status regarding COVID-19 were 4.5, 10.0 and 85.6%, respectively. The majority of participants showed absolute or moderate trust in the Greek health authorities for the management of the epidemic (90.1%), as well as in the Greek Government (84.7%) and the official national sources of information (87.4%). Trust in the authorities was weaker in younger participants and those who joined the study after the lifting of lockdown measures (p-value <= 0.001). None of the factors examined was associated with participants' level of knowledge after correction for multiple testing. Conclusions High level of knowledge about the COVID-19 pandemic and trust in the Greek authorities was observed, possibly due to the plethora of good quality publicly available information and the timely management of the pandemic at its early stages in Greece. Information campaigns for the COVID-19 pandemic should be encouraged even after the lifting of lockdown measures to increase public awareness.
C1 [Kanellopoulou, Afroditi; Koskeridis, Fotios; Markozannes, Georgios; Bouras, Emmanouil; Chaliasos, Konstantinos; Panos, Agapios; Stergiou, Yiolanda; Tzoulaki, Ioanna; Evangelou, Evangelos; Ntzani, Evangelia; Tsilidis, Konstantinos K.] Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, Ioannina, Greece.
   [Bouras, Emmanouil] Aristotle Univ Thessaloniki, Dept Hyg Social Prevent Med & Med Stat, Sch Med, Thessaloniki, Greece.
   [Soutziou, Chrysa; Doumas, Michail T.; Sigounas, Dimitrios E.; Tzovaras, Vasilios T.; Vakalis, Konstantinos] Ioannina Med Care, Ioannina, Greece.
   [Mellou, Kassiani] Hellen Natl Publ Hlth Org, Directorate Epidemiol Surveillance & Intervent In, Athens, Greece.
   [Papamichail, Dimitrios] Univ West Attica, Sch Publ Hlth, Dept Publ Hlth Policy, Athens, Greece.
   [Aretouli, Eleni] Univ Ioannina, Sch Social Sci, Ioannina, Greece.
   [Aretouli, Eleni] Aristotle Univ Thessaloniki, Sch Psychol, Lab Cognit Neurosci, Thessaloniki, Greece.
   [Chatzidimitriou, Dimitrios; Chatzopoulou, Fani] Aristotle Univ Thessaloniki, Lab Microbiol, Sch Med, Thessaloniki, Greece.
   [Bairaktari, Eleni] Univ Ioannina, Biochem Dept, Ioannina, Greece.
   [Tzoulaki, Ioanna; Evangelou, Evangelos; Tsilidis, Konstantinos K.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, St Marys Campus,Norfolk Pl, London, England.
   [Rizos, Evangelos C.] Univ Hosp Ioannina, Dept Internal Med, Ioannina, Greece.
   [Rizos, Evangelos C.] European Univ Cyprus, Sch Med, Nicosia, Cyprus.
   [Ntzani, Evangelia] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Ctr Evidence Based Med, Providence, RI 02912 USA.
   [Ntzani, Evangelia] Univ Ioannina, Univ Res Ctr Ioannina, Inst Biosci, Ioannina, Greece.
RP Tsilidis, KK (corresponding author), Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, Ioannina, Greece.; Tsilidis, KK (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, St Marys Campus,Norfolk Pl, London, England.
EM k.tsilidis@imperial.ac.uk
RI Tzoulaki, Ioanna/ABE-6269-2020; Evangelou, Evangelos/C-3033-2013;
   Markozannes, Georgios/AAS-7269-2020
OI Tzoulaki, Ioanna/0000-0002-4275-9328; Evangelou,
   Evangelos/0000-0002-5488-2999; Markozannes,
   Georgios/0000-0001-8481-579X; Mellou, Kassiani/0000-0002-0065-5766;
   Ntzani, Evangelia/0000-0003-3712-4181
FU Operational Programme Epirus 2014-2020 of the Prefecture of Epirus
   [HPi1AB-0028180]
FX This study was funded by the Operational Programme Epirus 2014-2020 of
   the Prefecture of Epirus (H Pi 1AB-0028180).
CR AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011
   Alsan M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12403
   Martinez-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043134
   [Anonymous], 2020, DISASTER MED PUBLIC
   [Anonymous], WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data
   [Anonymous], Timeline of WHO's response to COVID-19
   [Anonymous], 2012, NEUROPSYCHOLOGICAL A
   [Anonymous], Greece: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data
   [Anonymous], 2002, PSICHOLOGIA
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Benjamini Y., 1995, J R STAT SOC B, V57, P289
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Franssen PML, 2010, BLOOD PRESS MONIT, V15, P229, DOI 10.1097/MBP.0b013e328339be38
   Furukawa Nathan W, 2020, Emerg Infect Dis, V26, DOI 10.3201/eid2607.201595
   Gesser-Edelsburg A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19370
   Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744
   Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   Liu J., 2020, J MED VIROL, V92, P491, DOI [10.1002/jmv.25709, DOI 10.1002/jmv.25709]
   National Public Health Organization, CURR STAT COVID 19 O
   Olaimat AN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00254
   Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Putrino A, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01187-3
   REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   WHO World Health Organization, TRANSM SARS COV 2 IM
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 36
TC 3
Z9 3
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUN 12
PY 2021
VL 21
IS 1
AR 1125
DI 10.1186/s12889-021-11193-x
PG 14
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA SU3GY
UT WOS:000663030300007
PM 34118917
OA Green Published, Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Bouchard, L
   Meunier, S
AF Bouchard, Laurence
   Meunier, Sophie
TI Promoting remote workers' psychological health: Effective management
   practices during the COVID-19 crisis
SO CANADIAN JOURNAL OF ADMINISTRATIVE SCIENCES-REVUE CANADIENNE DES
   SCIENCES DE L ADMINISTRATION
LA English
DT Article; Early Access
DE COVID-19; crisis management; management practices; psychological health
   at work; remote workers
ID MENTAL-HEALTH; TRANSFORMATIONAL LEADERSHIP; WORKPLACE ISOLATION;
   RESOURCES; SUPPORT; STRESS; METAANALYSIS; INFORMATION; PERCEPTIONS;
   TELEWORKERS
AB The aim of this study was to identify specific management practices that promote the psychological health of remote workers in the context of the COVID-19 crisis. A two-round Delphi study was conducted among 28 teleworkers and 22 managers. A list of 60 specific management practices was presented and participants had to identify whether each one could be used in the current remote working context and, if so, how useful it was to promote psychological health at work. Results indicate that most specific management practices usually used in a face-to-face setting can also be used in a remote context (85%). Practices that show consideration, establishing work structure, and allowing flexibility were also identified as the most useful to promote remote workers' psychological health during the pandemic. This study contributes to the advancement of knowledge about specific management practices, remote working, and crisis management. It also suggests specific practices that managers can adopt to promote the psychological health of their employees during a period of crisis, even while managing from a distance.
C1 [Bouchard, Laurence; Meunier, Sophie] Univ Quebec Montreal, Dept Psychol, Montreal, PQ H3C 3P8, Canada.
RP Bouchard, L (corresponding author), Univ Quebec Montreal, Dept Psychol, Montreal, PQ H3C 3P8, Canada.
EM bouchard.laurence.2@courrier.uqam.ca
OI Bouchard, Laurence/0000-0001-5957-4058
CR [Anonymous], 1946, Am J Public Health Nations Health, V36, P1315
   Antonakis J, 2003, LEADERSHIP QUART, V14, P261, DOI 10.1016/S1048-9843(03)00030-4
   Antonakis J, 2002, LEADERSHIP QUART, V13, P673, DOI 10.1016/S1048-9843(02)00155-8
   Arnold KA, 2007, J OCCUP HEALTH PSYCH, V12, P193, DOI 10.1037/1076-8998.12.3.193
   Arnold KA, 2017, J OCCUP HEALTH PSYCH, V22, P381, DOI 10.1037/ocp0000062
   Belzunegui-Eraso A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093662
   Bentley TA, 2016, APPL ERGON, V52, P207, DOI 10.1016/j.apergo.2015.07.019
   Biggs A, 2014, INT J STRESS MANAGE, V21, P255, DOI 10.1037/a0037297
   Biron C., 2016, CONDITIONS FACILITAN
   Brooks S, 2020, BMJ MILITARY HEALTH, V166, P52, DOI 10.1136/jramc-2017-000876
   Bruchon-Schweitzer M., 2002, PSYCHOL SANTE MODELE
   Brun J.-P., 2003, EVALUATION SANTE MEN
   Camacho S, 2018, INFORM MANAGE-AMSTER, V55, P494, DOI 10.1016/j.im.2017.11.004
   Cooper CD, 2002, J ORGAN BEHAV, V23, P511, DOI 10.1002/job.145
   Coutu M.F., 2011, APPROCHE SYSTEMATIQU
   Cox T., 2000, RES WORK RELATED STR
   Danna K, 1999, J MANAGE, V25, P357, DOI 10.1177/014920639902500305
   Day A, 2012, J OCCUP HEALTH PSYCH, V17, P473, DOI 10.1037/a0029837
   Fonner KL, 2012, COMMUN MONOGR, V79, P205, DOI 10.1080/03637751.2012.673000
   Fonner KL, 2010, J APPL COMMUN RES, V38, P336, DOI 10.1080/00909882.2010.513998
   Gajendran RS, 2007, J APPL PSYCHOL, V92, P1524, DOI 10.1037/0021-9010.92.6.1524
   Gilbert MH, 2017, LEADERSHIP ORG DEV J, V38, P320, DOI 10.1108/LODJ-08-2015-0173
   Gilbreath B, 2004, WORK STRESS, V18, P255, DOI 10.1080/02678370412331317499
   Greer TW, 2014, PSYCHOL-MANAG J, V17, P87, DOI 10.1037/mgr0000014
   Hamouche S., 2020, EMERALD OPEN RES, V2, P15, DOI [DOI 10.35241/EMERALDOPENRES.13550.1, 10.35241/emeraldopenres.13550.1]
   Hern A., 2020, GUARDIAN
   Howell JM, 2005, LEADERSHIP QUART, V16, P273, DOI 10.1016/j.leaqua.2005.01.004
   Igbaria M., 1999, Journal of Management Information Systems, V16, P147
   Jorm AF, 2015, AUST NZ J PSYCHIAT, V49, P887, DOI 10.1177/0004867415600891
   Karimi, 2012, INT J LEADERSHIP STU, V7, P114
   Keeney S., 2010, DELPHI TECHNIQUE NUR
   Kelliher C, 2010, HUM RELAT, V63, P83, DOI 10.1177/0018726709349199
   Kelloway EK, 2010, WORK STRESS, V24, P260, DOI 10.1080/02678373.2010.518441
   Kelloway EK, 2005, CAN J BEHAV SCI, V37, P309, DOI 10.1037/h0087265
   Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539
   Keyes CLM, 2003, FLOURISHING: POSITIVE PSYCHOLOGY AND THE LIFE WELL-LIVED, P293, DOI 10.1037/10594-013
   Kossek EE, 2006, J VOCAT BEHAV, V68, P347, DOI 10.1016/j.jvb.2005.07.002
   Kuoppala J, 2008, J OCCUP ENVIRON MED, V50, P904, DOI 10.1097/JOM.0b013e31817e918d
   Leka S., 2010, OCCUPATIONAL HLTH PS
   Madlock PE, 2013, HUM RESOUR MANAG J, V23, P196, DOI 10.1111/j.1748-8583.2012.00191.x
   Marshall GW, 2007, PSYCHOL MARKET, V24, P195, DOI 10.1002/mar.20158
   Martin BH, 2012, MANAG RES REV, V35, P602, DOI 10.1108/01409171211238820
   Mulki JP, 2011, INT J HUM RESOUR MAN, V22, P902, DOI 10.1080/09585192.2011.555133
   Mullen JE, 2009, J OCCUP ORGAN PSYCH, V82, P253, DOI 10.1348/096317908X325313
   Nayani RJ, 2018, WORK STRESS, V32, P124, DOI 10.1080/02678373.2017.1390797
   Nielsen K, 2019, WORK STRESS, V33, P173, DOI 10.1080/02678373.2018.1509402
   Nielsen K, 2017, WORK STRESS, V31, P101, DOI 10.1080/02678373.2017.1304463
   Prasad K.D.V., 2020, INDIAN J COMMERCE MA, V11, P1, DOI [https://doi.org/10.18843/ijcms/v11i2/01, DOI 10.18843/IJCMS/V11I2/01]
   Riggio, 2006, TRANSFORMATIONAL LEA
   Sehmi R, 2020, BRIT J PSYCHIAT, V217, P638, DOI 10.1192/bjp.2019.25
   Seligman MEP, 2008, APPL PSYCHOL-INT REV, V57, P3, DOI 10.1111/j.1464-0597.2008.00351.x
   Skakon J, 2010, WORK STRESS, V24, P107, DOI 10.1080/02678373.2010.495262
   St-Hilaire F., 2012, THESIS U LAVAL
   St-Hilaire F, 2018, CAN J ADM SCI, V35, P535, DOI 10.1002/CJAS.1506
   Statistic Canada, 2020, STAT CAN PUBL
   Suzuki Y, 2014, J EPIDEMIOL, V24, P287, DOI 10.2188/jea.JE20130138
   Sytch M., 2020, IS YOUR ORG READY PE
   ter Hoeven CL, 2015, NEW TECH WORK EMPLOY, V30, P237, DOI 10.1111/ntwe.12052
   Wang B, 2021, APPL PSYCHOL-INT REV, V70, P16, DOI 10.1111/apps.12290
   Watson K.D., 2007, THESIS KANSAS STATE
   Westerlund H, 2010, WORK, V37, P71, DOI 10.3233/WOR-2010-1058
   Yap MBH, 2014, J AFFECT DISORDERS, V156, P67, DOI 10.1016/j.jad.2013.11.017
NR 62
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0825-0383
EI 1936-4490
J9 CAN J ADM SCI
JI Can. J. Adm. Sci.
DI 10.1002/cjas.1664
EA MAR 2022
PG 12
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA ZK9JM
UT WOS:000763298300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Gheorghe, AS
   Negru, SM
   Nitipir, C
   Mazilu, L
   Marinca, M
   Gafton, B
   Ciuleanu, TE
   Schenker, M
   Dragomir, RD
   Gheorghe, AD
   Stovicek, PO
   Bandi-Vasilica, M
   Bot, AC
   Mihaila, RI
   Zob, DL
   Kajanto, AL
   Stanculeanu, DL
AF Gheorghe, A. S.
   Negru, S. M.
   Nitipir, C.
   Mazilu, L.
   Marinca, M.
   Gafton, B.
   Ciuleanu, T. E.
   Schenker, M.
   Dragomir, R. D.
   Gheorghe, A. D.
   Stovicek, P. O.
   Bandi-Vasilica, M.
   Bot, A. C.
   Mihaila, R., I
   Zob, D. L.
   Kajanto, A. L.
   Stanculeanu, D. L.
TI Knowledge, attitudes and practices related to the COVID-19 outbreak
   among Romanian adults with cancer: a cross-sectional national survey
SO ESMO OPEN
LA English
DT Article
DE SARS-CoV-2; knowledge; attitudes and practices; COVID-19 outbreak;
   health survey; Romania
AB Background: The coronavirus disease 2019 (COVID-19) pandemic outbreak forced cancer care providers to face different challenges in terms of prevention and treatment management due to specific precautions implemented for oncological patients. We aimed to describe the level of knowledge, attitude and practices (KAP) among cancer patients, with the purpose to provide an image of the impact of COVID-19 and evaluate the effectiveness of pandemic response measures.
   Patients and methods: We developed a cross-sectional multicentric study that targeted adults with active cancer during the COVID-19 outbreak, aiming to describe KAP related to COVID-19 among Romanian oncological patients. A questionnaire investigating 64 items on KAP related to the novel coronavirus was designed and applied in seven Romanian hospitals. The group of participants consisted of 1585 oncological patients who completed the questionnaire during the outbreak (April-May 2020).
   Results: Only 172 patients (10.8%) had very good knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection symptoms, treatment options and incubation period. Only 44.3% of patients identified diarrhoea as a sign of COVID-19. About one-third of patients (32.6%) declared that they are 'very worried' about getting infected with the novel coronavirus. More than two-thirds of participants (68%) considered that having cancer represents an additional risk for infection with SARS-CoV-2, but 27.8% would rather not vaccinate against SARS-CoV-2 should a vaccine be available. A small percentage (8.8%) believed that the risk of infection justifies delaying/stopping oncological treatment until after the pandemic. Around half of the participants (55.5%) declared being compliant with all the protective measures against coronavirus infection listed in the questionnaire.
   Conclusion: Romanian oncological patients have a less than expected knowledge about SARS-CoV-2, appropriate prevention behaviours, with limited trust in their efficacy, optimistic attitudes towards COVID-19 and low level of trust in information sources. Good COVID-19 knowledge was associated with appropriate practices towards COVID-19 and optimistic attitudes.
C1 [Gheorghe, A. S.; Nitipir, C.; Mihaila, R., I; Kajanto, A. L.; Stanculeanu, D. L.] Carol Davila Univ Med & Pharm, Fac Gen Med, Dept Oncol, Bucharest, Romania.
   [Negru, S. M.] Victor Babes Univ Med & Pharm, Fac Gen Med, Dept Oncol, Timisoara, Romania.
   [Mazilu, L.; Gheorghe, A. D.] Ovidius Univ Constana, Fac Gen Med, Dept Oncol, Constana, Romania.
   [Marinca, M.; Gafton, B.] Grigore T Popa Univ Med & Pharm, Fac Gen Med, Dept Oncol, Iasi, Romania.
   [Ciuleanu, T. E.; Bot, A. C.] Iuliu Hatieganu Univ Med & Pharm, Fac Gen Med, Dept Oncol, Cluj Napoca, Romania.
   [Schenker, M.] Univ Med & Pharm, Fac Gen Med, Dept Oncol, Craiova, Romania.
   [Dragomir, R. D.] Victor Babes Univ Med & Pharm, Fac Gen Med, Dept Obstet & Gynaecol, Timisoara, Romania.
   [Stovicek, P. O.] Titu Maiorescu Univ, Fac Nursing, Dept Pharmacol, Targu Jiu Subsidiary, Bucharest, Romania.
   [Bandi-Vasilica, M.] Prof Dr Ion Chiricuta Inst Oncol, Dept Med Oncol, Cluj Napoca, Romania.
   [Zob, D. L.] Prof Dr Alexandru Trestioreanu Inst Oncol, Dept Med Oncol, Bucharest, Romania.
RP Negru, SM (corresponding author), Victor Babes Univ Med & Pharm, Piata Eftimie Murgu 2, Timisoara 300041, Romania.
EM serban.negru@oncohelp.ro
RI Stovicek, Puiu Olivian/AAB-4010-2020; Gheorghe, Silvana
   Adelina/AAZ-6945-2021; Negru, Serban/AAL-9746-2020; Stanculeanu, Dana
   Lucia/AAB-7964-2019; Schenker, Michael/AAD-6920-2022; Gheorghe,
   Andreea/AAI-4249-2020; Zob, Daniela Luminita/ABF-7590-2020; Mazilu,
   Laura/S-5111-2018
OI Stovicek, Puiu Olivian/0000-0002-9748-1394; Stanculeanu, Dana
   Lucia/0000-0003-3930-2543; Schenker, Michael/0000-0003-2645-6391; Zob,
   Daniela Luminita/0000-0003-1915-1493; Mazilu, Laura/0000-0001-6195-4500;
   Gheorghe, Adelina Silvana/0000-0003-3589-799X
FU National Society of Medical Oncology from Romania (SNOMR)
FX This work was supported by the National Society of Medical Oncology from
   Romania (SNOMR) (no grant number).
CR Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008
   Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2
   de Azambuja E, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000947
   European Centre for Disease Prevention and Control (ECDC), COVID 19 SIT DASHB
   Gosain R, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00934-7
   IARC, CANC TOD FACT SHEET
   Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Mantwill S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145455
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Sah GS, 2020, CANCER MANAG RES, V12, P10173, DOI 10.2147/CMAR.S271910
   Sentell T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093010
   SNOMR, LETT SNOMR MIN HLTH
   Tagliamento M, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13315
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   WHO Regional Office for Europe, SURV TOOL GUID RAP S
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   World Health Organization, COR DIS COVID 19 DAS
   Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 22
TC 3
Z9 3
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2059-7029
J9 ESMO OPEN
JI ESMO Open
PD FEB
PY 2021
VL 6
IS 1
AR 100027
DI 10.1016/j.esmoop.2020.100027
EA JAN 2021
PG 9
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA RA4QQ
UT WOS:000631402900025
PM 33399089
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Patelarou, AE
   Konstantinidis, T
   Kartsoni, E
   Mechili, EA
   Galanis, P
   Zografakis-Sfakianakis, M
   Patelarou, E
AF Patelarou, Athina E.
   Konstantinidis, Theocharis
   Kartsoni, Evangelia
   Mechili, Enkeleint A.
   Galanis, Petros
   Zografakis-Sfakianakis, Michail
   Patelarou, Evridiki
TI Development and Validation of a Questionnaire to Measure Knowledge of
   and Attitude toward COVID-19 among Nursing Students in Greece
SO NURSING REPORTS
LA English
DT Article
DE COVID-19; attitude; compliance; knowledge; nursing students; validation
ID HEALTH LITERACY; READINESS
AB Background: During the COVID-19 pandemic, nursing students have had a key role in supporting the healthcare sector. They can join healthcare professionals in clinical practice or provide information to increase citizens' levels of knowledge and their compliance with the restriction measures. The study aimed to develop and validate a tool to measure knowledge of and attitudes toward COVID-19 among nursing students in Greece. Methods: A questionnaire was developed through theoretical research and expert consultation. A cross-sectional study was conducted among 348 undergraduate nursing students of the Department of Nursing, Hellenic Mediterranean University, recruited by convenient sampling. Validity and reliability were analyzed. Results: The Kaiser-Meyer-Olkin measure was 0.84, indicating that the sample size was adequate for factor analysis. In addition, the p-value for Bartlett's test of sphericity was <0.001, denoting that the correlation matrix was suitable for factor analysis. The construct validity of the questionnaire was determined through exploratory factor analysis (EFA), which revealed that 16 items lead to four factors: knowledge, attitude toward restriction measures, compliance with them, and volunteering. One of the key findings of this study was that participants preferred to receive information from valid sources rather than social media during the crucial period of the "infodemic". Conclusions: The questionnaire was shown to have satisfying psychometric properties and, therefore, can be used as a tool in future research in the area of nursing students' knowledge, attitudes, compliance, and volunteering during the COVID-19 pandemic.
C1 [Patelarou, Athina E.; Konstantinidis, Theocharis; Kartsoni, Evangelia; Zografakis-Sfakianakis, Michail; Patelarou, Evridiki] Hellen Mediterranean Univ, Dept Nursing, Fac Hlth Sci, Iraklion 71140, Greece.
   [Mechili, Enkeleint A.] Univ Crete, Sch Med, Clin Social & Family Med, Iraklion 70013, Greece.
   [Mechili, Enkeleint A.] Univ Vlora, Fac Publ Hlth, Dept Healthcare, Vlora 9401, Albania.
   [Galanis, Petros] Natl & Kapodistrian Univ Athens, Fac Nursing, Ctr Hlth Serv Management & Evaluat, Athens 15772, Greece.
RP Patelarou, AE (corresponding author), Hellen Mediterranean Univ, Dept Nursing, Fac Hlth Sci, Iraklion 71140, Greece.
EM apatelarou@hmu.gr; harriskon@hmu.gr; evikartsoni@gmail.com;
   mechili@univlora.edu.al; pegalan@nurs.uoa.gr; mechili@univlora.edu.al;
   epatelarou@hmu.gr
RI Zografakis Sfakianakis, Michail/ABD-6174-2020; Galanis,
   Petros/AAG-3888-2021; Patelarou, Athina/AAZ-5643-2020
OI Zografakis Sfakianakis, Michail/0000-0002-5376-9580; Galanis,
   Petros/0000-0002-1308-5782; Patelarou, Athina/0000-0002-0300-0650;
   KARTSONI, EVANGELIA/0000-0002-1432-8715; Patelarou,
   Evridiki/0000-0002-0892-3200
CR Adesegun Oluwaseyitan A, 2020, Am J Trop Med Hyg, V103, P1997, DOI 10.4269/ajtmh.20-0461
   Aslan H, 2021, PERSPECT PSYCHIATR C, V57, P695, DOI 10.1111/ppc.12597
   Buckland R, 2020, J INTERPROF CARE, V34, P679, DOI 10.1080/13561820.2020.1822790
   Choi B, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02117-1
   Dardas LA, 2020, J SCH NURS, V36, P430, DOI 10.1177/1059840520957069
   DeVellis RF., 2016, SCALE DEV THEORY APP
   European Union Agency for Fundamental Rights, COR COVID 19 OUTBR E
   Eysenbach G, 2020, J MED INTERNET RES, V22, DOI 10.2196/21820
   Fouda A, 2020, HEALTH POLICY TECHN, V9, P510, DOI 10.1016/j.hlpt.2020.08.015
   Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912
   Gemuhay HM, 2019, NURS RES PRACT, V2019, DOI 10.1155/2019/3453085
   Gishen F, COVID 19 IMPACT OUR
   Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008
   Hashemi-Shahri Seyed Mohammad, 2020, Med J Islam Repub Iran, V34, P63, DOI 10.34171/mjiri.34.63
   Ikhlaq A, 2020, PAK J MED SCI, V36, pS32, DOI 10.12669/pjms.36.COVID19-S4.2636
   Jarab AS, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13696
   Johns Hopkins Coronavirus Resource Center, GLOB MAP
   Kwiecien-Jagus K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114116
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Li XJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/19684
   Nguyen HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114164
   Nnama-Okechukwu CU, 2020, SOC WORK PUBLIC HLTH, V35, P590, DOI 10.1080/19371918.2020.1806985
   Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259
   Okan O, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155503
   Paakkari L, 2020, LANCET PUBLIC HEALTH, V5, pE249, DOI 10.1016/S2468-2667(20)30086-4
   Patelarou AE, 2017, APPL NURS RES, V35, P64, DOI 10.1016/j.apnr.2017.02.003
   Patelarou AE, 2015, INT J EVID-BASED HEA, V13, P77, DOI 10.1097/XEB.0000000000000043
   Pickell Z, 2020, MED HUMANIT, V46, P537, DOI 10.1136/medhum-2020-011956
   Rajab MH, 2020, CUREUS, V12, DOI 10.7759/cureus.8966
   Rakhmanov O, 2020, J RES MED DENT SCI, V8, P53
   Ramos-Morcillo AJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155519
   Rawls A., 2020, ASA, V48, P3
   Solomou I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144924
   Spring H, 2020, HEALTH INFO LIBR J, V37, P171, DOI 10.1111/hir.12322
   Srichan Peeradone, 2020, WHO South East Asia J Public Health, V9, P118, DOI 10.4103/2224-3151.294305
   Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI 10.1093/med/9780199685219.001.0001
   TANGCHAROENSATHIEN, 2020, J MED INTERNET RES, V22, DOI DOI 10.2196/19659
   WHO, DIR GEN STAT IHR EM
   World Health Organization, I REP INF SHAR
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 40
TC 4
Z9 4
U1 3
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2039-439X
EI 2039-4403
J9 NURS REP
JI Nurs. Rep.
PD DEC
PY 2020
VL 10
IS 2
BP 82
EP 94
DI 10.3390/nursrep10020012
PG 13
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA PL2RD
UT WOS:000602974600001
PM 34968353
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Apodaca, E
   Hernandez-Perez, CR
   Rodriguez-Gonzalez, MG
AF Apodaca, Elia
   Hernandez-Perez, Carlos R.
   Guadalupe Rodriguez-Gonzalez, Ma
TI Management of patients with Myelodysplastic Syndrome in the COVID-19 era
SO GACETA MEDICA DE MEXICO
LA Spanish
DT Article
DE COVID-19; Myelodysplastic syndrome (MDS); Patients
AB SARS-CoV-2 infection has caused a change in the way we care for patients with hematological diseases around the world. Patients with myelodysplastic syndrome (MDS) have been affected by the lack of knowledge of the behavior of COVID-19 in this type of condition. International guidelines have been established that have made it possible to continue caring for these patients. The main objective of this review is to define the preventive measures and treatment strategies that should be taken when evaluating a patient with myelodysplastic syndrome in the COVID-19 era.
C1 [Apodaca, Elia] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hematol, Ciudad De Mexico, Mexico.
   [Hernandez-Perez, Carlos R.] Hosp Especialidades CMN Siglo XXI, IMSS, Dept Hematol, Ciudad De Mexico, Mexico.
   [Guadalupe Rodriguez-Gonzalez, Ma] Hosp Especialidades CMN La Raza, IMSS, Dept Hematol, Ciudad De Mexico, Mexico.
RP Apodaca, E (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hematol, Ciudad De Mexico, Mexico.
EM eliapanda08@gmail.com
CR [Anonymous], COVID- 19 Coronavirus pandemic [
   Garnica M, 2020, HEMATOL TRANSF CELL, V42, P111, DOI 10.1016/j.htct.2020.04.001
   Gosain R, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00934-7
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Latagliata R, 2020, HEMATOL ONCOL, V38, P189, DOI 10.1002/hon.2710
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Percival MEM, 2020, JCO ONCOL PRACT, V16, P571, DOI 10.1200/OP.20.00241
   Raza Azra, 2020, Leuk Res Rep, V13, P100201, DOI 10.1016/j.lrr.2020.100201
   Sahu KK, 2020, EXPERT REV HEMATOL, V13, P787, DOI 10.1080/17474086.2020.1787147
   Trubiano JA, 2017, LEUKEMIA LYMPHOMA, V58, P2379, DOI 10.1080/10428194.2017.1295141
   World Health Organization, 51 WHO
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ACAD NACIONAL MEDICINA MEXICO
PI MEXICO
PA CENTRO MEDICO NACIONAL SIGLO XXI, UNIDAD CONGRESOS, GLOQUE B, PROMER
   PISO, MEXICO, DF 06725, MEXICO
SN 0016-3813
J9 GAC MED MEX
JI Gac. Med. Mex.
PD DEC
PY 2021
VL 157
SU 3
BP 47
EP 51
DI 10.24875/GMM.M21000470
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA YV0BC
UT WOS:000752397500009
OA gold
DA 2022-04-20
ER

PT J
AU Hudaefi, FA
   Caraka, RE
   Wahid, H
AF Hudaefi, Fahmi Ali
   Caraka, Rezzy Eko
   Wahid, Hairunnizam
TI Zakat administration in times of COVID-19 pandemic in Indonesia: a
   knowledge discovery via text mining
SO INTERNATIONAL JOURNAL OF ISLAMIC AND MIDDLE EASTERN FINANCE AND
   MANAGEMENT
LA English
DT Article; Early Access
DE Text Mining; Indonesia; COVID-19; RStudio; Socio-economic Zakat
ID IMPACT; SUPPORT; GROWTH; AIDS
AB Purpose
   Zakat during the COVID-19 outbreak has played a vital role and has been significantly discussed in the virtual environment. Such information about zakat in the virtual world creates unstructured data, which contains important information and knowledge. This paper aims to discover knowledge related to zakat administration during the pandemic from the information in a virtual environment. Furthermore, the discussion is contextualised to the socio-economic debates.
   Design/methodology/approach
   This is a qualitative study operated via text mining to discover knowledge of zakat administration during the COVID-19 pandemic. The National Board of Zakat Republic of Indonesia (BAZNAS RI) is selected for a single case study. This paper samples BAZNAS RI's situation report on COVID-19 from its virtual website. The data consists of 40 digital pages containing 19,812 characters, 3,004 words and 3,003 white spaces. The text mining analytical steps are performed via RStudio. The following R packages, networkD3, igraph, ggraph and ggplot2 are used to run the Latent Dirichlet Allocation (LDA) for topic modelling.
   Findings
   The machine learning analysis via RStudio results in the 16 topics associated with the 3 primary topics (i.e. Education, Sadaqah and Health Services). The topic modelling discovers knowledge about BAZNAS RI's assistance for COVID-19 relief, which may help the readers understand zakat administration in times of the pandemic from BAZNAS RI's virtual website. This finding may draw the theory of socio-economic zakat, which explains that zakat as a religious obligation plays a critical role in shaping a Muslim community's social and economic processes, notably during the unprecedented times of COVID-19.
   Research limitations/implications
   This study uses data from a single zakat institution. Thus, the generalisation of the finding is limited to the sampled institution.
   Practical implications
   This research is both theoretically and practically important for academics and industry professionals. This paper contributes to the novelty in performing text mining via R in gaining knowledge about the recent zakat administration from a virtual website. The finding of this study (i.e. the topic modelling) is practically essential for zakat stakeholders to understand the contribution of zakat in managing the COVID-19 impacts.
   Social implications
   This work derives a theory of "socio-economic zakat" that explains the importance of a zakat institution in activating zakat for managing socio-economic issues during the pandemic. Thus, paying zakat to an authorised institution may actualise more maslahah (public interest) compared to paying it directly to the asnaf (zakat beneficiaries) without any measurement
   Originality/value
   This study is among the pioneers in gaining knowledge from Indonesia's zakat management during the COVID-19 outbreak via text mining. The authors' way of analysing data from the virtual website using RStudio can advance Islamic economics literature.
C1 [Hudaefi, Fahmi Ali] Inst Againa Islam Darussalam IAID, Ciamis, Indonesia.
   [Hudaefi, Fahmi Ali] BAZNAS Ctr Strateg Studies, Dept Publicat & Networking, Jakarta, Indonesia.
   [Caraka, Rezzy Eko] Univ Indonesia, Fac Econ & Business, Depok, Indonesia.
   [Caraka, Rezzy Eko] Seoul Natl Univ, Dept Stat, Seoul, South Korea.
   [Wahid, Hairunnizam] Univ Kebangsaan Malaysia, Fac Econ & Management, Bangi, Malaysia.
RP Hudaefi, FA (corresponding author), Inst Againa Islam Darussalam IAID, Ciamis, Indonesia.; Hudaefi, FA (corresponding author), BAZNAS Ctr Strateg Studies, Dept Publicat & Networking, Jakarta, Indonesia.; Caraka, RE (corresponding author), Univ Indonesia, Fac Econ & Business, Depok, Indonesia.; Caraka, RE (corresponding author), Seoul Natl Univ, Dept Stat, Seoul, South Korea.
EM alihudzaifi@gmail.com; rezzy.eko@ui.ac.id
RI Hairunnizam, Wahid/AAJ-1747-2021; Hudaefi, Fahmi Ali/AAI-7135-2020
OI Hudaefi, Fahmi Ali/0000-0002-1557-837X
CR Abdullah MF, 2015, INT J ISLAMIC MIDDLE, V8, P310, DOI 10.1108/IMEFM-11-2014-0113
   Abuznaid SA, 2009, INT J ISLAMIC MIDDLE, V2, P278, DOI 10.1108/17538390911006340
   Alfaizin A.W., 2018, J ISLAMIC MONETARY E, V4, P117
   Ali SN, 2019, INT J ISLAMIC MIDDLE, V12, P346, DOI 10.1108/IMEFM-11-2017-0301
   Alkhan AM, 2020, J ISLAMIC ACCOUNT BU, V11, P1677, DOI 10.1108/JIABR-02-2020-0044
   Alsarhan F, 2021, INT J ISLAMIC MIDDLE, V14, P114, DOI 10.1108/IMEFM-02-2019-0072
   Andrew AM., 2001, AI MAG, V30, P103, DOI [10.1108/k.2001.30.1.103.6, DOI 10.1108/K.2001.30.1.103.6]
   Angelino E., 2015, ADV NEURAL INFORM PR
   Ariyani, 2016, INT J ZAKAT, V1, P88
   Baehaqi A, 2020, J ISLAMIC ACCOUNT BU, V11, P2035, DOI 10.1108/JIABR-09-2018-0155
   Bhagava A, 2001, J HEALTH ECON, V20, P423, DOI 10.1016/S0167-6296(01)00073-X
   Bin-Nashwan SA, 2021, J FINANC REPORT ACCO, V19, P392, DOI 10.1108/JFRA-03-2020-0057
   Bin-Nashwan SA, 2020, INT J ETHICS SYST, V36, P285, DOI 10.1108/IJOES-09-2019-0145
   Bloom DE, 1998, BROOKINGS PAP ECO AC, P207, DOI 10.2307/2534695
   Bodolica V, 2020, INT J ISLAMIC MIDDLE, V13, P323, DOI 10.1108/IMEFM-12-2019-0521
   Boon-Itt S., 2020, J MED INTERNET RES P, V6, P1
   Campbell J.C., 2015, ART SCI ANAL SOFTWAR, P139
   Canini Kevin Robert, 2009, INT C ART INT STAT, P65
   Caraka RE, 2020, GLOB J ENVIRON SCI M, V6, P65, DOI 10.22034/GJESM.2019.06.SI.07
   Caraka R.E., 2019, 9 RES DIVE DEV HOUSE, V9, P10
   Caraka RE, 2021, IEEE ACCESS, V9, P1972, DOI 10.1109/ACCESS.2020.3038883
   Caraka RE, 2020, IEEE ACCESS, V8, P194795, DOI 10.1109/ACCESS.2020.3033796
   Caraka RE, 2020, COMMUN MATH BIOL NEU, DOI 10.28919/cmbn/4584
   Carlo M, 2004, NOTES, DOI [10.2174/157015909788848875, DOI 10.2174/157015909788848875]
   Cheerkoot-Jalim S, 2021, J KNOWL MANAG, V25, P642, DOI 10.1108/JKM-09-2019-0524
   Chen MS, 1996, IEEE T KNOWL DATA EN, V8, P866, DOI 10.1109/69.553155
   CHOUDHURY MA, 1989, INT J SOC ECON, V16, P13, DOI 10.1108/03068298910133043
   Creswell, 2012, CONDUCTING EVALUATIN
   CUDDINGTON JT, 1994, J DEV ECON, V43, P363, DOI 10.1016/0304-3878(94)90013-2
   Dartanto T., 2013, JICA RES I, V54, P1
   Dartanto T, 2020, B INDONES ECON STUD, V56, P193, DOI 10.1080/00074918.2019.1657795
   Dartanto T, 2013, B INDONES ECON STUD, V49, P61, DOI 10.1080/00074918.2013.772939
   Djaghballou CE, 2018, INT J ISLAMIC MIDDLE, V11, P374, DOI 10.1108/IMEFM-07-2017-0185
   Esa M.S.M., 2018, JURNAL EKONOMI MALAY, V52, P145
   Felt M, 2016, BIG DATA SOC, V3, DOI 10.1177/2053951716645828
   Fleuren WWM, 2015, METHODS, V74, P97, DOI 10.1016/j.ymeth.2015.01.015
   Ghani AR, 2020, ZAKAT TIME COVID 19
   Ghanny AR, 2019, " Pengaruh zakat terhadap perekonomian makro Indonesia: Studi kasus badan amil zakat nasional (BAZNAS)
   Hachicha N, 2015, INT J ISLAMIC MIDDLE, V8, P349, DOI 10.1108/IMEFM-07-2014-0063
   Hafidhuddin D., 2002, ZAKAT DALAM PEREKONO
   Hand D.J., 2015, WILEY STATSREF STAT, P1, DOI DOI 10.1002/9781118445112.STAT06466.PUB2
   Hand DJ, 2007, DRUG SAFETY, V30, P621, DOI 10.2165/00002018-200730070-00010
   Hashimi H, 2015, COMPUT HUM BEHAV, V51, P729, DOI 10.1016/j.chb.2014.10.062
   Hassan M.K., 2020, J EC COOPERATION DEV, V41
   Hayakawa H, 2019, EURASIAN ECON REV, V9, P285, DOI 10.1007/s40822-018-0110-8
   Hellmich SN, 2017, FORUM SOC ECON, V46, P3, DOI 10.1080/07360932.2014.999696
   Hornik K., 2009, INTRO TIME SERIES R, DOI [10.1007/978-0-387-88698-5, DOI 10.1007/978-0-387-88698-5]
   Hossain I, 2019, INT J ISLAMIC MIDDLE, V12, P154, DOI 10.1108/IMEFM-11-2018-0371
   Hudaefi F.A., 2020, J ISLAMIC MONETARY E, V6, P239
   Hudaefi FA, 2021, J ISLAMIC MARK, DOI 10.1108/JIMA-03-2020-0081
   Hudaefi FA, 2021, J ISLAMIC MARK, V12, P498, DOI 10.1108/JIMA-09-2020-0299
   Hudaefi FA, 2020, QUAL RES FINANC MARK, V12, P353, DOI 10.1108/QRFM-05-2019-0058
   Hudaefi FA, 2019, INT J ISLAMIC MIDDLE, V12, P625, DOI 10.1108/IMEFM-08-2018-0279
   Husna S, 2018, EFFECTIVENESS ZAKAT
   Ibrahim AA, 2014, INT J ISLAMIC MIDDLE, V7, P6, DOI 10.1108/IMEFM-06-2012-0053
   Keizer P, 2005, INT J SOC ECON, V32, P155, DOI 10.1108/03068290510575694
   Koch KR, 2018, GEM INT J GEOMATHEMA, V9, P117, DOI 10.1007/s13137-017-0101-z
   Lee Y., 2017, DATA ANAL USING HIER, V1st ed., DOI [10.1201/9781315211060, DOI 10.1201/9781315211060]
   Lohmeier C, 2014, STUD QUAL METHODOL, V13, P75
   McKibbin, 2004, ASIAN ECON PAP, V3, P113, DOI [DOI 10.1162/1535351041747932, 10.1162/1535351041747932]
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   McLeod A. I., 2011, HDB STAT, V30, P1
   Mikail SA, 2017, ISRA INT J ISLAMIC F, V9, P100, DOI 10.1108/IJIF-07-2017-010
   Mullner D, 2013, J STAT SOFTW, V53, P1
   Nailah N., 2020, BAZNAS CTR STRATEGIC, V5, P88
   Newman D, 2010, J WEB SEMANT, V8, P169, DOI 10.1016/j.websem.2010.03.005
   Ordenes FV, 2019, J SERV MANAGE, V30, P593, DOI 10.1108/JOSM-08-2019-0254
   Ozdemir M, 2021, INT J ISLAMIC MIDDLE, V14, P767, DOI 10.1108/IMEFM-06-2020-0277
   Prasetyia F, 2019, EURASIAN ECON REV, V9, P139, DOI 10.1007/s40822-018-0101-9
   Pratama S.D., 2020, INT J ISLAMIC EC FIN, V3, P145
   Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149
   R Core-Team, 2008, R FDN STAT COMP
   Raimi L, 2014, WORLD J ENTREP MANAG, V10, P228, DOI 10.1108/WJEMSD-09-2013-0052
   Robalino DA, 2002, J POLICY MODEL, V24, P195, DOI 10.1016/S0161-8938(02)00097-2
   Sakti MRP, 2016, QUAL RES FINANC MARK, V8, P168, DOI 10.1108/QRFM-06-2015-0024
   Sanchez G, 2013, PLS PATH MODELING R
   Sani N.S., 2018, INT J ADV SCI ENG IN, V8, P1698, DOI [10.18517/ijaseit.8.4-2.6829, DOI 10.18517/IJASEIT.8.4-2.6829]
   Saputro E.G., 2020, INT J ISLAMIC EC FIN, V3, P63, DOI [10.18196/ijief.3234, DOI 10.18196/IJIEF.3234]
   SCHOENBAUM SC, 1987, AM J MED, V82, P26, DOI 10.1016/0002-9343(87)90557-2
   Shome A, 2018, INT J ISLAMIC MIDDLE, V11, P79, DOI 10.1108/IMEFM-03-2017-0066
   Smith RD, 2005, J HEALTH ECON, V24, P1055, DOI 10.1016/j.jhealeco.2005.02.003
   Suhartono, 2019, SAINS MALAYS, V48, P1787, DOI 10.17576/jsm-2019-4808-26
   Sulistyowati S, 2019, J ISLAMIC MONETARY E, V4, P347
   Suprayitno E., 2017, INT J ZAKAT, V2, P61
   Sutiksno DU, 2018, J PHYS CONF SER, V1028, DOI 10.1088/1742-6596/1028/1/012244
   Suyadi, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101848
   Talattov A.G., 2016, J ISLAMIC MONETARY E, V1, P259
   Tlemsani I, 2020, J ISLAMIC ACCOUNT BU, V11, P1889, DOI 10.1108/JIABR-05-2020-0159
   Tsou M.-H., 2015, CARTOGRAPHY GEOGR S1, V42, P70, DOI [10.1080/15230406.2015.1059251, DOI 10.1080/15230406.2015.1059251]
   Ucal M, 2019, EURASIAN ECON REV, V9, P373, DOI 10.1007/s40822-017-0089-6
   Usai A, 2018, J KNOWL MANAG, V22, P1471, DOI 10.1108/JKM-11-2017-0517
   Van Mahendradhata Y., 2020, PSYARXIV, P368
   Yusoff M.N.H.B., 2019, J EC COOPERATION DEV, V40, P1
   Zaenal MH, 2019, The role of zakat in improving mustahik welfare: Case of BAZNAS economic empowerment program
   Zafirovski M., 2016, AM SOCIOLOGIST, V47, P56
   Zuur AF., 2010, J R STAT SOC, V173, P938
NR 96
TC 3
Z9 3
U1 4
U2 10
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1753-8394
EI 1753-8408
J9 INT J ISLAMIC MIDDLE
JI Int.J. Islamic Middle Eastern Finance Manag.
DI 10.1108/IMEFM-05-2020-0250
EA JUN 2021
PG 16
WC Business, Finance; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA SV3HH
UT WOS:000663713100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Dakhesh, S
   Zareivenovel, M
   Hamidi, A
AF Dakhesh, Sara
   Zareivenovel, Mojgan
   Hamidi, Ali
TI Infodemic Management in Iran: A Necessity to Control and response to
   COVID-19
SO GAZI MEDICAL JOURNAL
LA English
DT Editorial Material
DE COVID-19; Misinformation; Infodemic
AB Coronavirus disease (COVID-19) outbreak has spread from Wuhan, China in December 2019. The world will be accompanied by a tsunami of information. Therefore, it can be stated that we have been encountered "infodemic" through the Covid-19 global crisis. "We're not just fighting an epidemic; we're fighting an infodemic", said WHO Director-General Tedros Adhanom Ghebreyesus. COVID19 epidemic has been spreaded in Iran, in February 2020. According to a general classifications, the Ministry of Health and Medical Education (MoHME) of Iran actions to manage infodemic presented in five major domains; a) Releasing guidelines and protocol; b) Launching systems, websites and applications; c) Allocation of call center; d) Educational program on national TV and the Media; e) Establishment of different national campaigns. In order to have effective infodemic management, two phases are recommended; 1) Disseminate accurate and timely information through official channels and resources. 2) Educate the necessary skills to the information stakeholders. These skills include information literacy, media literacy, and health literacy.
C1 [Dakhesh, Sara] Shahid Chamran Univ, Knowledge & Informat Sci, Ahvaz, Iran.
   [Zareivenovel, Mojgan] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Med Librarianship & Informat Sci, Tehran, Iran.
   [Hamidi, Ali] Bushehr Univ Med Sci, Fac Paramed, Dept Med Lib & Informat Sci, Bushehr, Iran.
RP Hamidi, A (corresponding author), Bushehr Univ Med Sci, Fac Paramed, Dept Med Lib & Informat Sci, Bushehr, Iran.
EM a.hamidi@bpums.ac.ir
RI Dakhesh, Sara/M-3783-2017; Hamidi, Ali/R-7495-2018
OI Dakhesh, Sara/0000-0002-9616-782X; Hamidi, Ali/0000-0002-1096-5119
CR Ashrafi-rizi H, 2020, ARCH ACAD EMERG MED, V8
   Farouk S, 2020, TRENDS CARDIOVAS MED, V30, P36, DOI 10.1016/j.tcm.2019.02.002
   Islamic World Science Citation Center (ISC), ISC LAT REP ISC COVI
   Raoofi A, 2020, ARCH IRAN MED, V23, P220, DOI 10.34172/aim.2020.02
   WHO, COR DIS 2019 COVID 1
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 6
TC 1
Z9 1
U1 4
U2 10
PU GAZI UNIV, FAC MED
PI ANKARA
PA GAZI UNIV, FAC MED, ANKARA, 06500, TURKEY
SN 2147-2092
J9 GAZI MED J
JI Gazi Med. J.
PY 2020
VL 31
IS 4
BP 712
EP 713
DI 10.12996/gmj.2020.165
PG 2
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA NT7GR
UT WOS:000573105000040
OA Green Accepted, gold
DA 2022-04-20
ER

PT J
AU Gasperetti, A
   Schiavone, M
   Tondo, C
   Mitacchione, G
   Viecca, M
   Galli, M
   Sarzi-Puttini, P
   Forleo, GB
AF Gasperetti, Alessio
   Schiavone, Marco
   Tondo, Claudio
   Mitacchione, Gianfranco
   Viecca, Maurizio
   Galli, Massimo
   Sarzi-Puttini, Piercarlo
   Forleo, Giovanni B.
TI QT Interval Monitoring and Drugs Management During COVID-19 Pandemic
SO CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY
LA English
DT Review
DE QT interval; COVID-19; cardiac arrhythmias; torsades de point; drugs
   management; non-arrhythmic mortality
ID TORSADE-DE-POINTES; AMERICAN-HEART-ASSOCIATION; OF-CARDIOLOGY
   FOUNDATION; INDUCED LONG QT; CORRECTED QT; VENTRICULAR REPOLARIZATION;
   EARLY AFTERDEPOLARIZATIONS; RHEUMATOID-ARTHRITIS; SCIENTIFIC STATEMENT;
   FATAL ARRHYTHMIAS
AB While facing potentially high morbidity from COVID-19 without known effective therapies, the off-label use of several non-specific drugs has been advocated, including re-purposed anti-viral (e.g., remdesivir or the lopinavir/ritonavir combination), biologic agents (e.g., tocilizumab), and antimalarial drugs such as chloroquine and hydroxychloroquine, in association with or without azithromycin. Data regarding the effectiveness of these drugs in treating COVID-19 has been shown in some trials and clinical settings, but further randomised controlled trials are still being carried out.
   One of the main concerns regarding their widespread use, however, is their possible effects on the QT interval and arrhythmogenic potential. Some of these drugs have been associated with QT prolongation and Torsades de Point, a potentially lethal ventricular arrhythmia.
   The review aims to highlight the magnitude of this problem, to quickly refresh clinically impacting cornerstones of QT interval and TdP pathophysiology, to summarize the available evidence regarding the QT and arrhythmia impact of drugs used in different clinical settings in COVID-19 patients, and to help the physicians dealing with the knowledge needed in the everyday clinical duties in case of doubts regarding QT-induced arrhythmias in this time of emergency.
C1 [Gasperetti, Alessio; Schiavone, Marco; Mitacchione, Gianfranco; Viecca, Maurizio; Forleo, Giovanni B.] Luigi Sacco Univ Hosp, Dept Cardiol, ASST Fatebenefratelli Sacco, Milan, Italy.
   [Tondo, Claudio] IRCCS Ctr Cardiol Monzino, Milan, Italy.
   [Tondo, Claudio] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.
   [Galli, Massimo] Luigi Sacco Univ Hosp, Dept Infect Dis, ASST Fatebenefratelli Sacco, Milan, Italy.
   [Galli, Massimo] Univ Milan, Luigi Sacco Dept Biomed & Clin Sci, Milan, Italy.
   [Sarzi-Puttini, Piercarlo] Luigi Sacco Univ Hosp, Rheumatol Unit, ASST Fatebenefratelli Sacco, Milan, Italy.
RP Forleo, GB (corresponding author), Luigi Sacco Univ Hosp, Dept Cardiol, ASST Fatebenefratelli Sacco, Milan, Italy.; Forleo, GB (corresponding author), IRCCS Ctr Cardiol Monzino, Milan, Italy.
EM forleo@me.com
RI Mitacchione, Gianfranco/AAD-3680-2020
OI Mitacchione, Gianfranco/0000-0002-3774-0104; Schiavone,
   Marco/0000-0003-0720-3380; Forleo, Giovanni
   Battista/0000-0001-8895-8915; Tondo, Claudio/0000-0002-8500-8313
CR Anson BD, 2005, LANCET, V365, P682, DOI 10.1016/S0140-6736(05)70936-3
   Batchvarov VN, 2002, AM J PHYSIOL-HEART C, V282, pH2356, DOI 10.1152/ajpheart.00860.2001
   Bauman JL, 2001, EUR HEART J SUPPL, V3, pK93, DOI 10.1016/S1520-765X(01)90012-4
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Beitland S, 2014, ACTA ANAESTH SCAND, V58, P266, DOI 10.1111/aas.12257
   Bernardini A, 2021, INT J CARDIOL, V324, P242, DOI [10.1016/j.ijcard.2020.09.038, 10.5281/ZENODO.5184732, 10.5281/ZENODO.5184733]
   Bessiere F, 2020, JAMA CARDIOL, V5, P1067, DOI 10.1001/jamacardio.2020.1787
   Briasoulis A, 2011, CARDIOLOGY, V120, P103, DOI 10.1159/000334441
   Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Chen A, 2004, CHEST, V125, P1974, DOI 10.1378/chest.125.6.1974
   Choi BR, 2002, J PHYSIOL-LONDON, V543, P615, DOI 10.1113/jphysiol.2002.024570
   Chorin E, 2020, HEART RHYTHM, V17, P1425, DOI 10.1016/j.hrthm.2020.05.014
   Chugh SS, 2009, CIRCULATION, V119, P663, DOI 10.1161/CIRCULATIONAHA.108.797035
   CHVILICEK JP, 1995, CAN J ANAESTH, V42, P1137, DOI 10.1007/BF03015102
   Crow RS, 2003, CIRCULATION, V108, P1985, DOI 10.1161/01.CIR.0000095027.28753.9D
   Cubeddu LX, 2009, CURR CARDIOL REV, V5, P166, DOI 10.2174/157340309788970397
   Cupisti A, 1999, NEPHRON, V82, P122, DOI 10.1159/000045387
   DAVIS TME, 1995, BRIT HEART J, V73, P523
   Drew BJ, 2010, J AM COLL CARDIOL, V55, P934, DOI [10.1016/j.jacc.2010.01.001, 10.1161/CIRCULATIONAHA.109.192704]
   Elfiky AA, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117592
   Etchegoyen CV, 2017, CURR CLIN PHARMACOL, V12, P210, DOI 10.2174/1574884713666180223123947
   Fantini J, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105960
   Favalli EG, 2020, LANCET INFECT DIS, V20, P1012, DOI 10.1016/S1473-3099(20)30262-0
   Fleischmann R, 2020, RHEUMATOLOGY, V59, P292, DOI 10.1093/rheumatology/kez265
   Foglia PEG, 2004, NEPHROL DIAL TRANSPL, V19, P1398, DOI 10.1093/ndt/gfh204
   Food and Drug Administration HHS, 2005, Fed Regist, V70, P61133
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gasperetti A, 2020, EUROPACE, V22, P1855, DOI 10.1093/europace/euaa216
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024
   Guaraldi G, 2020, LANCET RHEUMATOL, V2, pE474, DOI 10.1016/S2665-9913(20)30173-9
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hosseinpoor Zeinab, 2019, Drug Metabolism and Personalized Therapy, V34, P20190022, DOI 10.1515/dmpt-2019-0022
   Isbister GK, 2009, CLIN TOXICOL, V47, P884, DOI 10.3109/15563650903333820
   Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742
   Kannankeril PJ, 2007, CURR OPIN CARDIOL, V22, P39, DOI 10.1097/HCO.0b013e32801129eb
   Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021
   Kasamaki Y, 2011, ANN NONINVAS ELECTRO, V16, P156, DOI 10.1111/j.1542-474X.2011.00423.x
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lakkireddy DR, 2020, CIRCULATION, V141, pE823, DOI 10.1161/CIRCULATIONAHA.120.047063
   Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1101/2020.04.20.20072702, 10.1016/j.jacc.2020.06.007]
   Lazzerini PE, 2020, CIRCULATION, V142, P7, DOI 10.1161/CIRCULATIONAHA.120.047293
   Lazzerini PE, 2017, EUR HEART J, V38, P1717, DOI 10.1093/eurheartj/ehw208
   Lazzerini PE, 2015, ARTHRIT CARE RES, V67, P332, DOI 10.1002/acr.22455
   Lu CC, 2020, J CHIN MED ASSOC, V83, P534, DOI 10.1097/JCMA.0000000000000318
   Malik M, 2000, J AM COLL CARDIOL, V36, P1749, DOI 10.1016/S0735-1097(00)00962-1
   Malik M, 2001, DRUG SAFETY, V24, P323, DOI 10.2165/00002018-200124050-00001
   Mangoni AA, 2003, AGE AGEING, V32, P326, DOI 10.1093/ageing/32.3.326
   Mazzanti A, 2020, CIRCULATION, V142, P513, DOI 10.1161/CIRCULATIONAHA.120.048476
   Mercuro Nicholas J, 2020, JAMA Cardiol, V5, P1036, DOI 10.1001/jamacardio.2020.1834
   Mitacchione G, 2020, EUR HEART J-CASE REP, V4, DOI 10.1093/ehjcr/ytaa217
   Molnar J, 1996, J AM COLL CARDIOL, V27, P76, DOI 10.1016/0735-1097(95)00426-2
   Morena V, 2020, EUR J INTERN MED, V76, P36, DOI 10.1016/j.ejim.2020.05.011
   Moss AJ, 1999, DRUG SAFETY, V21, P5, DOI 10.2165/00002018-199921001-00002
   Panoulas VF, 2014, RHEUMATOLOGY, V53, P131, DOI 10.1093/rheumatology/ket338
   Postema PG, 2008, HEART RHYTHM, V5, P1015, DOI 10.1016/j.hrthm.2008.03.037
   Praveen D, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105967
   Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147
   Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Ramireddy A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017144
   Rana BS, 2005, HEART, V91, P44, DOI 10.1136/hrt.2003.017632
   Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014
   Reardon M, 1996, CLIN CARDIOL, V19, P949, DOI 10.1002/clc.4960191209
   Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5
   Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556
   Roden DM, 2016, J PHYSIOL-LONDON, V594, P2459, DOI 10.1113/JP270526
   Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x
   Rothman AMK, 2020, HYPERTENSION, V75, P477, DOI 10.1161/HYPERTENSIONAHA.119.13642
   Saleh M, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008937
   SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2
   SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195
   Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057
   Schiavone M, 2020, J HOSP INFECT, V105, P580, DOI 10.1016/j.jhin.2020.04.045
   Schiavone M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103263
   Schiavone M, 2021, INT J CARDIOL, V323, P276, DOI 10.1016/j.ijcard.2020.09.001
   Schiavone M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061683
   Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209
   Severi S, 2008, NEPHROL DIAL TRANSPL, V23, P1378, DOI 10.1093/ndt/gfm765
   Shah A, 2020, MAYO CLIN PROC, V95, P646, DOI 10.1016/j.mayocp.2020.02.003
   Simpson TF, 2020, JAMA INTERN MED, V180, P698, DOI 10.1001/jamainternmed.2020.0148
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   StrambaBadiale M, 1997, EUR HEART J, V18, P1000
   Taneja T, 2001, PACE, V24, P16, DOI 10.1046/j.1460-9592.2001.00016.x
   Tisdale JE, 2013, CIRC-CARDIOVASC QUAL, V6, P479, DOI 10.1161/CIRCOUTCOMES.113.000152
   Toldo S, 2012, CARDIOVASC DRUG THER, V26, P273, DOI 10.1007/s10557-012-6389-x
   van de Loo A, 1996, J Cardiovasc Pharmacol Ther, V1, P75, DOI 10.1177/107424849600100111
   Vandenberk B, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003264
   Vink AS, 2018, CIRCULATION, V138, P2345, DOI 10.1161/CIRCULATIONAHA.118.033943
   Viskin S, 2005, HEART RHYTHM, V2, P569, DOI 10.1016/j.hrthm.2005.02.011
   Wang LS, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106137
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang WJ, 2019, EUROPACE, V21, P9, DOI 10.1093/europace/euy063
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Wilders R, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00106
   Wu JS, 2002, CIRCULATION, V105, P675, DOI 10.1161/circ.105.6.675
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang T, 1996, CIRCULATION, V93, P407, DOI 10.1161/01.CIR.93.3.407
   Yang ZJ, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.115.003560
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yokota Shumpei, 2017, Clin Exp Rheumatol, V35 Suppl 108, P19
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zhang CT, 2020, J MED VIROL, V92, P1441, DOI 10.1002/jmv.25788
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
NR 106
TC 0
Z9 0
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 2772-4328
EI 2772-4336
J9 CURR REV CLIN EXP PH
JI Curr. Rev. Clin. Exper. Pharmacol.
PY 2021
VL 16
IS 4
BP 306
EP 317
DI 10.2174/1574884715666201224155042
PG 12
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA XW4ZI
UT WOS:000735628900003
PM 33357185
DA 2022-04-20
ER

PT J
AU Fernandez-Avila, DG
   Barahona-Correa, J
   Romero-Alvernia, D
   Kowalski, S
   Sapag, A
   Cachafeiro-Vilar, A
   Melendez, B
   Pastelin, C
   Palleiro, D
   Arrieta, D
   Reyes, G
   Pons-Estel, GJ
   Then-Baez, J
   Ugarte-Gil, MF
   Cardiel, MH
   Colman, N
   Chavez, N
   Burgos, PI
   Montufar, R
   Sandino, S
   Fuentes-Silva, YJ
   Soriano, ER
AF Fernandez-Avila, Daniel G.
   Barahona-Correa, Julian
   Romero-Alvernia, Diana
   Kowalski, Sergio
   Sapag, Ana
   Cachafeiro-Vilar, Antonio
   Melendez, Belia
   Pastelin, Carlos
   Palleiro, Daniel
   Arrieta, Dina
   Reyes, Gil
   Pons-Estel, Guillermo J.
   Then-Baez, Jossiell
   Ugarte-Gil, Manuel F.
   Cardiel, Mario H.
   Colman, Nelly
   Chavez, Nilmo
   Burgos, Paula, I
   Montufar, Ruben
   Sandino, Sayonara
   Fuentes-Silva, Yurilis J.
   Soriano, Enrique R.
TI Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin
   America
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Article
DE COVID-19; Rheumatology; Telehealth; Adherence; Knowledge; Behavior
ID ATTITUDES; INFLUENZA; KNOWLEDGE
AB The objective of our study was to describe knowledge, attitudes and practices of Latin-American rheumatology patients regarding management and follow-up of their disease during COVID-19 pandemic. A cross-sectional observational study was conducted using a digital anonymous survey. Rheumatic patients >= 18 years from non-English-speaking PANLAR countries were included. Our survey included 3502 rheumatic patients living in more than 19 Latin-American countries. Median age of patients was 45.8(36-55) years and the majority (88.9%) was female. Most frequently self-reported disease was rheumatoid arthritis (48.4%). At least one anti-rheumatic treatment was suspended by 23.4% of patients. Fear of contracting SARS-Cov2 (27.7%) and economic issues (25%) were the most common reasons for drug discontinuation. Self-rated disease activity increased from 30 (7-50) to 45 (10-70) points during the pandemic. Communication with their rheumatologist during the pandemic was required by 55.6% of patients, mainly by telephone calls (50.2%) and social network messages (47.8%). An adequate knowledge about COVID-19 was observed in 43% of patients. Patients with rheumatic diseases in Latin America were negatively affected by the COVID-19 pandemic. An increase in self-rated disease activity, a reduction in medication adherence, and hurdles for medical follow-up were reported. Teleconsultation was perceived as a valid alternative to in-person visits during the pandemic.
C1 [Fernandez-Avila, Daniel G.] Pontificia Univ Javeriana, Unidad Reumatol, Hosp Univ San Ignacio, Cra 7 40-62 Piso 7, Bogota, Colombia.
   [Barahona-Correa, Julian; Romero-Alvernia, Diana] Pontificia Univ Javeriana, Dept Med Interna, Hosp Univ San Ignacio, Bogota, Colombia.
   [Kowalski, Sergio] Univ Fed Parana, Curitiba, Parana, Brazil.
   [Sapag, Ana] Hosp Univ Japones, Santa Cruz, Bolivia.
   [Cachafeiro-Vilar, Antonio] Pacifica Salud Hosp Punta Pacifica, Panama City, Panama.
   [Melendez, Belia] Hosp Policia Nacl N1 Quito, Quito, Ecuador.
   [Pastelin, Carlos] Inst Hondureno Seguridad Social, Tegucigalpa, Honduras.
   [Palleiro, Daniel] Univ Republica, Inst Nacl Reumatol Uruguay, Montevideo, Uruguay.
   [Arrieta, Dina] Hosp Mexico, San Jose, Costa Rica.
   [Reyes, Gil] Univ Ciencias Med Habana, Havana, Cuba.
   [Pons-Estel, Guillermo J.] Ctr Reg Enfermedades Autoinmunes & Reumat CREAR, Rosario, Argentina.
   [Then-Baez, Jossiell] Hosp Metropolitano Santiago HOMS, Santiago, Dominican Rep.
   [Ugarte-Gil, Manuel F.] EsSalud Univ Cient Sur, Hosp Nacl Guillermo Almenara Irigoyen, Lima, Peru.
   [Cardiel, Mario H.] Ctr Invest Clin Morelia, Morelia, Michoacan, Mexico.
   [Colman, Nelly] Univ Nacl Asuncion, Hosp Clin, Asuncion, Paraguay.
   [Chavez, Nilmo] Univ San Carlos, Inst Guatemalteco Seguridad Social, Guatemala City, Guatemala.
   [Burgos, Paula, I] Pontificia Univ Catolica Chile, Santiago, Chile.
   [Montufar, Ruben] Consultorio Especialidades Inst Salvadoreno Segur, San Salvador, El Salvador.
   [Sandino, Sayonara] Inst Med Ganna, Managua, Nicaragua.
   [Fuentes-Silva, Yurilis J.] Univ Oriente, Ctr Clin Univ Oriente, Ciudad Bolivar, Venezuela.
   [Soriano, Enrique R.] Inst Univ Hosp Italiano Buenos Aires, Secc Reumatol, Serv Clin, Med Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina.
RP Fernandez-Avila, DG (corresponding author), Pontificia Univ Javeriana, Unidad Reumatol, Hosp Univ San Ignacio, Cra 7 40-62 Piso 7, Bogota, Colombia.
EM daniel.fernandez@javeriana.edu.co
OI Santiago Pastelin, Carlos Benito/0000-0002-2835-6282; Cachafeiro,
   Antonio/0000-0002-8219-6814; Palleiro, Daniel/0000-0001-9526-5527;
   Fernandez-Avila, Daniel/0000-0003-1490-1822; Barahona-Correa, Julian
   E/0000-0002-8244-2958; Fernandez Sanchez, Maria
   Jose/0000-0001-6461-2725; Arrieta, Dina/0000-0003-4052-7184
FU Pan American League of Rheumatology Associations (PANLAR)
FX This study was supported by an unrestricted grant from Pan American
   League of Rheumatology Associations (PANLAR).
CR Abbate R, 2006, EMERG INFECT DIS, V12, P1762, DOI 10.3201/eid1211.060671
   Santagelo FA, 2011, REV ESP SALUD PUBLIC, V85, P73, DOI 10.1590/S1135-57272011000100009
   Ávila Jeannette, 2009, Rev. perú. med. exp. salud publica, V26, P328
   Bhatia A, 2021, RHEUMATOL INT, V41, P843, DOI 10.1007/s00296-021-04829-z
   Bults M, 2015, DISASTER MED PUBLIC, V9, P207, DOI 10.1017/dmp.2014.160
   Chaleshgar-Kordasiabi M, 2018, MUSCULOSKELET CARE, V16, P241, DOI 10.1002/msc.1221
   Costantino F, 2021, JOINT BONE SPINE, V88, DOI 10.1016/j.jbspin.2020.105095
   Deng JF, 2006, PUBLIC HEALTH, V120, P15, DOI 10.1016/j.puhe.2005.10.001
   England BR, 2021, ARTHRIT CARE RES, V73, P1809, DOI 10.1002/acr.24429
   Favalli EG, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102523
   Figueroa-Parra G, 2020, ANN RHEUM DIS, V79, P839, DOI 10.1136/annrheumdis-2020-217322
   Gaur PS, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e398
   Gkrouzman E, 2020, HSS J, V16, P108, DOI 10.1007/s11420-020-09810-3
   Gomez-Marin Jorge E., 2020, Infect., V24, P1, DOI 10.22354/in.v24i3.896
   Grady PA, 2014, AM J PUBLIC HEALTH, V104, pE25, DOI 10.2105/AJPH.2014.302041
   Guidry JPD, 2019, EMERG INFECT DIS, V25, P179, DOI 10.3201/eid2501.180824
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Hassen LM, 2020, INT J RHEUM DIS, V23, P1541, DOI 10.1111/1756-185X.13959
   Hausmann JS, 2021, LANCET RHEUMATOL, V3, pE707, DOI 10.1016/S2665-9913(21)00175-2
   Keesara S, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005835
   Lee T. H., 2020, NEJM CATAL INNOV CAR, V1, DOI [10.1056/CAT.20.0076, DOI 10.1056/CAT.20.0076]
   Lin YL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-128
   Mehrota A., 2020, NEJM CATAL INNOV CAR, DOI [10.1056/CAT.20.0091, DOI 10.1056/CAT.20.0091]
   Nune A, 2020, CLIN RHEUMATOL, V39, P2817, DOI 10.1007/s10067-020-05312-z
   Oshotse C, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.180218
   Patel A, 2020, MMWR-MORBID MORTAL W, V69, P140, DOI 10.15585/mmwr.mm6905e1
   Richter J., 2016, PATIENT REPORTED OUT, P371, DOI [DOI 10.1007/978-3-319-32851-5_15, 10.1007/978-3-319-32851-5_15]
   Rivera LMS, 2020, REUMATOL CLIN, V16, P437, DOI 10.1016/j.reuma.2020.06.011
   van Zanten JJCSV, 2015, SPORTS MED, V45, P1401, DOI 10.1007/s40279-015-0363-2
   Yang P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236857
   Zhu WD, 2021, RHEUMATOLOGY, V60, P3478, DOI 10.1093/rheumatology/keab201
   Zucchi D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245274
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD JAN
PY 2022
VL 42
IS 1
BP 41
EP 49
DI 10.1007/s00296-021-05014-y
EA NOV 2021
PG 9
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA YG2ZS
UT WOS:000714833400001
PM 34739574
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Nymark, P
   Sachana, M
   Leite, SB
   Sund, J
   Krebs, CE
   Sullivan, K
   Edwards, S
   Viviani, L
   Willett, C
   Landesmann, B
   Wittwehr, C
AF Nymark, Penny
   Sachana, Magdalini
   Leite, Sofia Batista
   Sund, Jukka
   Krebs, Catharine E.
   Sullivan, Kristie
   Edwards, Stephen
   Viviani, Laura
   Willett, Catherine
   Landesmann, Brigitte
   Wittwehr, Clemens
TI Systematic Organization of COVID-19 Data Supported by the Adverse
   Outcome Pathway Framework
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE adverse outcome pathways; COVID-19; systematic organization;
   interdisciplinarity; mechanisms; data integration
ID DECISION-MAKING; EXPRESSION
AB Adverse Outcome Pathways (AOP) provide structured frameworks for the systematic organization of research data and knowledge. The AOP framework follows a set of key principles that allow for broad application across diverse disciplines related to human health, including toxicology, pharmacology, virology and medical research. The COVID-19 pandemic engages a great number of scientists world-wide and data is increasing with exponential speed. Diligent data management strategies are employed but approaches for systematically organizing the data-derived information and knowledge are lacking. We believe AOPs can play an important role in improving interpretation and efficient application of scientific understanding of COVID-19. Here, we outline a newly initiated effort, the CIAO project (https://www.ciao-covid.net/), to streamline collaboration between scientists across the world toward development of AOPs for COVID-19, and describe the overarching aims of the effort, as well as the expected outcomes and research support that they will provide.
C1 [Nymark, Penny] Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
   [Sachana, Magdalini] Org Econ Cooperat & Dev, Environm Directorate, Environm Hlth & Safety Div, Paris, France.
   [Leite, Sofia Batista; Sund, Jukka; Landesmann, Brigitte; Wittwehr, Clemens] European Commiss, Joint Res Ctr, Ispra, Italy.
   [Krebs, Catharine E.; Sullivan, Kristie] Phys Comm Responsible Med, Washington, DC USA.
   [Edwards, Stephen] RTI Int, GenOmics, Bioinformat & Translat Res Ctr, Res Triangle Pk, NC USA.
   [Viviani, Laura; Willett, Catherine] Humane Soc Int, Washington, DC USA.
RP Nymark, P (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.; Wittwehr, C (corresponding author), European Commiss, Joint Res Ctr, Ispra, Italy.
EM penny.nymark@ki.se; clemens.wittwehr@ec.europa.eu
RI Sund, Jukka/AAP-4202-2021; Nymark, Penny/AAC-9890-2019
OI Sund, Jukka/0000-0002-8007-3837; Nymark, Penny/0000-0002-3435-7775;
   Batista Leite, Sofia/0000-0002-9498-3030; Edwards,
   Stephen/0000-0002-7985-111X
FU European Commission's Exploratory Research project CIAO; Funding Program
   of strategic grants for COVID-19 research at the Institute of
   Environmental Medicine, Karolinska Institute
FX This work has been funded by the European Commission's Exploratory
   Research project CIAO (https://www.ciao-covid.net/) and the Funding
   Program of strategic grants for COVID-19 research at the Institute of
   Environmental Medicine, Karolinska Institute.
CR Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   [Anonymous], 2017, OECD SERIES TESTING
   Bal-Price A, 2017, NEUROTOXICOLOGY, V59, P240, DOI 10.1016/j.neuro.2016.05.010
   Busquet F, 2020, ARCH TOXICOL, V94, P2263, DOI 10.1007/s00204-020-02787-2
   Carusi A, 2018, SCI TOTAL ENVIRON, V628-629, P1542, DOI 10.1016/j.scitotenv.2018.02.015
   Delrue N, 2016, ATLA-ALTERN LAB ANIM, V44, P417, DOI 10.1177/026119291604400504
   Edwards SW, 2016, J PHARMACOL EXP THER, V356, P170, DOI 10.1124/jpet.115.228239
   Gagliardi MC, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0276-1
   Garvin MR, 2020, ELIFE, V9, DOI 10.7554/eLife.59177
   George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3
   Gijbels Eva, 2017, Appl In Vitro Toxicol, V3, P283, DOI 10.1089/aivt.2017.0027
   Grafstrom RC, 2015, ATLA-ALTERN LAB ANIM, V43, P325, DOI 10.1177/026119291504300506
   Halappanavar S, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00344-4
   Halappanavar S, 2019, NANOIMPACT, V15, DOI 10.1016/j.impact.2019.100178
   Howard C, 2019, Can Commun Dis Rep, V45, P114, DOI 10.14745/ccdr.v45i05a01
   Hutson Matthew, 2020, Nature, DOI 10.1038/d41586-020-01733-7
   Jaiswal J, 2020, AIDS BEHAV, V24, P2776, DOI 10.1007/s10461-020-02925-y
   Jordan W., 2014, 2 THIRDS BRIT PEOPLE
   Keller KG, 2020, J ADV NURS, V76, P3235, DOI 10.1111/jan.14558
   Kim Y., 2020, APPL ADVERSE OUTCOME
   Kim Y., 2021, PREPRINTS, DOI [10.20944/preprints202101.0065.v1, DOI 10.20944/PREPRINTS202101.0065.V1]
   Kohonen P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15932
   Kohonen P, 2014, BASIC CLIN PHARMACOL, V115, P50, DOI 10.1111/bcpt.12257
   Langley GR, 2017, DRUG DISCOV TODAY, V22, P327, DOI 10.1016/j.drudis.2016.10.011
   Martens M, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00661
   Nymark P., 2021, PREPRINTS, DOI [10.20944/preprints202101.0573.v1, DOI 10.20944/PREPRINTS202101.0573.V1]
   Nymark P, 2018, ANN AM THORAC SOC, V15, pS91, DOI 10.1513/AnnalsATS.201706-478MG
   Nymark P, 2018, TOXICOL SCI, V162, P264, DOI 10.1093/toxsci/kfx252
   Renu K, 2020, LIFE SCI, V255, DOI 10.1016/j.lfs.2020.117839
   Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199
   Sachana M., 2017, APPL IN VITRO TOXICO, V3, P227
   Sakuratani Y, 2018, BASIC CLIN PHARMACOL, V123, P20, DOI 10.1111/bcpt.12955
   Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8
   Sienkiewicz, 2020, SCI POLICY HDB
   van Baalen S, 2019, SYNTHESE, V196, P4469, DOI 10.1007/s11229-017-1475-z
   Villeneuve DL, 2018, TOXICOL SCI, V163, P346, DOI 10.1093/toxsci/kfy047
   Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199
   Vinken M, 2020, ARCH TOXICOL, V94, P3343, DOI 10.1007/s00204-020-02860-w
   Williams A, 2015, BEILSTEIN J NANOTECH, V6, DOI 10.3762/bjnano.6.252
NR 39
TC 1
Z9 1
U1 2
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD MAY 19
PY 2021
VL 9
AR 638605
DI 10.3389/fpubh.2021.638605
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA SL5EO
UT WOS:000656941000001
PM 34095051
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Zhao, B
   Kong, FL
   Aung, MN
   Yuasa, M
   Nam, EW
AF Zhao, Bo
   Kong, Fanlei
   Aung, Myo Nyein
   Yuasa, Motoyuki
   Nam, Eun Woo
TI Novel Coronavirus (COVID-19) Knowledge, Precaution Practice, and
   Associated Depression Symptoms among University Students in Korea,
   China, and Japan
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; knowledge; Korea; China; Japan; university adults;
   preventative practices; depression
ID SOCIAL-ISOLATION; MENTAL-HEALTH; LONELINESS
AB This study assessed university students' knowledge and precaution practices of Novel Coronavirus (COVID-19) in South Korea, China, and Japan, and investigated their depressive states during the pandemic. This cross-sectional survey collected data from 821 respondents, using an anonymous online questionnaire designed by the Yonsei Global Health Center, from 23 March to 20 April 2020, which included socio-demographic questions, knowledge and perceptions of COVID-19, preventative practices, and the Patient Health Questionnaire-9 (PHQ-9) scale to assess mental health. High proportions of respondents showed good knowledge of the transmission pathways and information related to COVID-19. Contact history as well as concerns about family members and the disease showed statistically significant distinctions by nationality and gender. On the whole, all participants reported good levels of preventative practices. The Chinese group reported the highest preventative practice scores; and females scored higher than males. Moreover, the Japanese group showed the most severe depressive states; overall, females experienced more severe depression than males. Thus, authorities should especially emphasize the importance of COVID-19 precautions to males. Educational departments and health authorities should observe the mental health of university adults during the pandemic and plan interventions to improve it.
C1 [Zhao, Bo; Nam, Eun Woo] Yonsei Univ, Grad Sch, Dept Hlth Adm, 1 Yonseidae Gil, Wonju 26493, Gangwon Do, South Korea.
   [Kong, Fanlei] Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan 250012, Peoples R China.
   [Kong, Fanlei] Shandong Univ, NHC Key Lab Hlth Econ & Policy Res, Jinan 250012, Peoples R China.
   [Aung, Myo Nyein] Juntendo Univ, Juntendo Adv Res Inst Hlth Sci, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.
   [Aung, Myo Nyein; Yuasa, Motoyuki] Juntendo Univ, Fac Int Liberal Arts, Global Hlth Serv Course, Bumkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.
   [Nam, Eun Woo] Yonsei Univ, Hlth City Res Ctr, Inst Hlth & Welf, 1 Yonseidae Gil, Wonju 26493, Gangwon Do, South Korea.
RP Nam, EW (corresponding author), Yonsei Univ, Grad Sch, Dept Hlth Adm, 1 Yonseidae Gil, Wonju 26493, Gangwon Do, South Korea.; Kong, FL (corresponding author), Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan 250012, Peoples R China.; Kong, FL (corresponding author), Shandong Univ, NHC Key Lab Hlth Econ & Policy Res, Jinan 250012, Peoples R China.; Nam, EW (corresponding author), Yonsei Univ, Hlth City Res Ctr, Inst Hlth & Welf, 1 Yonseidae Gil, Wonju 26493, Gangwon Do, South Korea.
EM zhaobo@yonsei.ac.kr; kongfanlei@sdu.edu.cn; myo@juntendo.ac.jp;
   moyuasa@juntendo.ac.jp; ewnam@yonsei.ac.kr
RI ‍ZHAO, BO/AAP-1850-2021; Aung, Myo Nyein/AAA-6367-2021
OI ‍ZHAO, BO/0000-0002-6780-1633; Aung, Myo Nyein/0000-0001-8175-6309;
   Kong, Fanlei/0000-0001-7792-4488; Nam, Eun Woo/0000-0002-3517-6247
FU  [1041849-202005-SB-057-02]
FX All subjects gave their informed consent for inclusion before they
   participated in the study. This study was approved by Yonsei University
   Institutional Review Committee (IRB) before the data collection (Task
   No. 1041849-202005-SB-057-02).
CR Ahn N.Y., ARXIV200414495
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], 2017, GLOBAL GENDER GAP RE
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], SAV LIV CLEAN YOUR H
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], 2020, COVID 19 DASHBOARD C
   [Anonymous], 2020, CHINA PROPOSES TRILA
   Apatoff B., 2007, INT J MS CARE, V9, P99, DOI [10.7224/1537-2073-9.3.99, DOI 10.7224/1537-2073-9.3.99]
   Brick B, 2014, PEDAGOGICAL CONSIDERATIONS AND OPPORTUNITIES FOR TEACHING AND LEARNING ON THE WEB, P1, DOI 10.4018/978-1-4666-4611-7.ch001
   Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   CDC, 2020, SYMPT COR
   Chang HC, 1997, J LANG SOC PSYCHOL, V16, P107, DOI 10.1177/0261927X970162001
   Choi J.S., 2010, J KOREAN ACAD ADULT, V2213, P250
   Harazneh L, 2015, J ED PRACTICE, V6, P79
   Holt-Lunstad J., 2017, PUBLIC POLICY AGING, V27, P127, DOI [10.1093/ppar/prx030, DOI 10.1093/PPAR/PRX030]
   Hopkins N, LOSS SENSE SMELL MAR
   Houri D, 2012, GLOB HEALTH PROMOT, V19, P32, DOI 10.1177/1757975912453183
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Hussain ZA, 2012, AM J INFECT CONTROL, V40, pE11, DOI 10.1016/j.ajic.2011.12.004
   Jacobs A.J., 2011, STUD RES, DOI [10.1155/2011/692764, DOI 10.1155/2011/692764]
   Kanamori H, 2011, INFECT CONT HOSP EP, V32, P824, DOI 10.1086/661224
   Kelly AC, 2014, BODY IMAGE, V11, P446, DOI 10.1016/j.bodyim.2014.07.005
   Khanna RC, 2020, INDIAN J OPHTHALMOL, V68, P703, DOI 10.4103/ijo.IJO_843_20
   Kim E, 2018, WOMEN STUD INT FORUM, V69, P143, DOI 10.1016/j.wsif.2018.06.006
   Kim T., 2009, S KOREA JAPAN INT HD, P857
   Klinenberg E, 2016, AM J PUBLIC HEALTH, V106, P786, DOI 10.2105/AJPH.2016.303166
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kupferschmidt K, 2020, SCIENCE, V367, P1061, DOI 10.1126/science.367.6482.1061
   Lampard AM, 2014, J YOUTH ADOLESCENCE, V43, P1770, DOI 10.1007/s10964-013-0086-3
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Leigh-Hunt N, 2017, PUBLIC HEALTH, V152, P157, DOI 10.1016/j.puhe.2017.07.035
   Lim GY, 2018, SCI REP-UK, V8, P2861, DOI [10.1038/s41598-018-21243-x, DOI 10.1038/s41598-018-21243-x]
   Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8
   Ministry of Health Labor and Welfare, JAP COR DIS 2019 COV
   Ministry of Health Labour and Welfare, JAP NUMB COVID 19 CA
   Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574
   Olapegba PO, 2020, SOC SCI HUM OPEN, DOI [10.2139/ssrn.3584408, DOI 10.2139/SSRN.3584408]
   Osazuwa-Peters N., 2012, Southern African Journal of Epidemiology & Infection, V27, P61
   Pan SL, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102143
   Patel Vikram, 2005, Promot Educ, VSuppl 2, P26
   Sarani Hamed, 2015, Glob J Health Sci, V8, P193, DOI 10.5539/gjhs.v8n3p193
   Sham NIBB, 2020, PROTEOM CLIN APPL, V14, DOI 10.1002/prca.201900043
   Shankar A, 2013, PSYCHOSOM MED, V75, P161, DOI 10.1097/PSY.0b013e31827f09cd
   Shin H., ZOMBIE APOCALYPSE RE
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Takeuchi I, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.506
   TANNE JH, 2020, BMJ BRIT MED J, V0368, DOI DOI https://doi.org/10.1136/bmj.m1090
   Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5
   Tokyo Gakugei University, 2009, NEWS2U NET
   Twenge JM, 2019, J SOC PERS RELAT, V36, P1892, DOI 10.1177/0265407519836170
   Twenge JM, 2019, J ABNORM PSYCHOL, V128, P185, DOI 10.1037/abn0000410
   U.S. Centers for Disease Control and Prevention (CDC), 2020, COVID 19 SPR
   WANG CY, 2020, INT J ENV RES PUB HE, V0017
   Wang Z., 2008, DEMOCRATIZATION CONF
   WHO, 2020, Q A COR COVID 19
   Yan B, 2020, AM REV PUBLIC ADM, V50, P762, DOI 10.1177/0275074020942445
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhang YB, 2005, COMMUN RES REP, V22, P107, DOI 10.1080/00036810500130539
NR 66
TC 27
Z9 27
U1 7
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD SEP
PY 2020
VL 17
IS 18
AR 6671
DI 10.3390/ijerph17186671
PG 17
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA OF6NM
UT WOS:000581321800001
PM 32933212
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Wastnedge, EAN
   Reynolds, RM
   van Boeckel, SR
   Stock, SJ
   Denison, FC
   Maybin, JA
   Critchley, HOD
AF Wastnedge, Elizabeth A. N.
   Reynolds, Rebecca M.
   van Boeckel, Sara R.
   Stock, Sarah J.
   Denison, Fiona C.
   Maybin, Jacqueline A.
   Critchley, Hilary O. D.
TI PREGNANCY AND COVID-19
SO PHYSIOLOGICAL REVIEWS
LA English
DT Review
DE COVID-19; neonatal outcomes; pathophysiology; placenta; pregnancy
ID PLASMACYTOID DENDRITIC CELLS; PERINATAL OUTCOMES; REPRODUCTIVE HEALTH;
   PRENATAL EXPOSURE; UNITED-STATES; T-CELLS; SARS-COV-2; WOMEN; INFLUENZA;
   INFECTION
AB There are many unknowns for pregnant women during the coronavirus disease 2019 (COVID-19) pandemic. Clinical experience of pregnancies complicated with infection by other coronaviruses e.g., Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome, has led to pregnant woman being considered potentially vulnerable to severe SARS-CoV-2 infection. Physiological changes during pregnancy have a significant impact on the immune system, respiratory system, cardiovascular function, and coagulation. These may have positive or negative effects on COVID-19 disease progression. The impact of SARS-CoV-2 in pregnancy remains to be determined, and a concerted, global effort is required to determine the effects on implantation, fetal growth and development, labor, and neonatal health. Asymptomatic infection presents a further challenge regarding service provision, prevention, and management. Besides the direct impacts of the disease, a plethora of indirect consequences of the pandemic adversely affect maternal health, including reduced access to reproductive health services, increased mental health strain, and increased socioeconomic deprivation. In this review, we explore the current knowledge of COVID-19 in pregnancy and highlight areas for further research to minimize its impact for women and their children.
C1 [Wastnedge, Elizabeth A. N.; Reynolds, Rebecca M.; van Boeckel, Sara R.; Stock, Sarah J.; Denison, Fiona C.; Maybin, Jacqueline A.; Critchley, Hilary O. D.] Univ Edinburgh, Queens Med Res Inst, Med Res Council MRC, Ctr Reprod Hlth,Tommys Ctr Maternal Hlth, Edinburgh, Midlothian, Scotland.
   [Wastnedge, Elizabeth A. N.; Reynolds, Rebecca M.; van Boeckel, Sara R.; Stock, Sarah J.; Denison, Fiona C.; Maybin, Jacqueline A.; Critchley, Hilary O. D.] Univ Edinburgh, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.
   [Wastnedge, Elizabeth A. N.; Reynolds, Rebecca M.; van Boeckel, Sara R.; Stock, Sarah J.; Denison, Fiona C.; Maybin, Jacqueline A.; Critchley, Hilary O. D.] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland.
   [Wastnedge, Elizabeth A. N.; Reynolds, Rebecca M.; van Boeckel, Sara R.; Stock, Sarah J.; Denison, Fiona C.; Maybin, Jacqueline A.; Critchley, Hilary O. D.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.
RP Critchley, HOD (corresponding author), Univ Edinburgh, Queens Med Res Inst, Med Res Council MRC, Ctr Reprod Hlth,Tommys Ctr Maternal Hlth, Edinburgh, Midlothian, Scotland.
EM hilary.critchley@ed.ac.uk
RI Maybin, Jacqueline/E-4577-2010; CRITCHLEY, HILARY OD/C-7575-2013
FU Medical Research Council Centre for Reproductive Health (MRC CRH)
   [MR/N022556/1]; British Heart FoundationBritish Heart Foundation
   [RE/18/5/34216]; Wellcome Trust Clinical Career Development
   FellowshipsWellcome Trust [209560/Z/17/Z, 209589/Z/17/Z]; Tommy's
   [RE/18/5/34216]; MRCUK Research & Innovation (UKRI)Medical Research
   Council UK (MRC) [MR/N022556/1, G0500047] Funding Source: UKRI
FX We acknowledge the Medical Research Council Centre for Reproductive
   Health (MRC CRH) Grant MR/N022556/1 and the support of Tommy's and the
   British Heart Foundation (RE/18/5/34216). S. J. Stock and J. A. Maybin
   are supported by Wellcome Trust Clinical Career Development Fellowships
   209560/Z/17/Z and 209589/Z/17/Z, respectively.
CR Abdoli A, 2020, J PSYCHOSOM OBST GYN, V41, P247, DOI 10.1080/0167482X.2020.1761321
   Ahmed I, 2020, BRIT J HAEMATOL, V190, pE37, DOI 10.1111/bjh.16849
   al-Haddad BJS, 2019, JAMA PSYCHIAT, V76, P594, DOI 10.1001/jamapsychiatry.2019.0029
   Alhusen JL, 2015, J WOMENS HEALTH, V24, P100, DOI 10.1089/jwh.2014.4872
   Amirchaghmaghi E, 2013, INT J FERTIL STERIL, V7, P147
   Baergen RN, 2020, PEDIATR DEVEL PATHOL, V23, P177, DOI 10.1177/1093526620925569
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233
   Bayefsky MJ, 2020, NEW ENGL J MED, V382, pE47, DOI 10.1056/NEJMp2008006
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Blitz MJ, 2020, AM J OBSTET GYNECOL, V223, P595, DOI 10.1016/j.ajog.2020.06.020
   Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012
   Bourne T, 2020, ULTRASOUND OBST GYN, V55, P871, DOI 10.1002/uog.22046
   Bradbury-Jones C, 2020, J CLIN NURS, V29, P2047, DOI 10.1111/jocn.15296
   Brandstadter JD, 2011, J INNATE IMMUN, V3, P274, DOI 10.1159/000324176
   Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8
   Buekens P, 2020, LANCET GLOB HEALTH, V8, pE877, DOI 10.1016/S2214-109X(20)30206-0
   Burton GJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2381
   Burton GJ, 2016, PHYSIOL REV, V96, P1509, DOI 10.1152/physrev.00029.2015
   Canetta SE, 2014, AM J PSYCHIAT, V171, P557, DOI 10.1176/appi.ajp.2013.13070943
   Centers for Disease Control and Prevention, 2020, PREG BREASTF CAR NEW
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen R, 2020, CAN J ANESTH, V67, P655, DOI 10.1007/s12630-020-01630-7
   Chen S, 2020, ZHONGHUA BING LI XUE, V49, P418, DOI DOI 10.3760/cma.j.cn112151-20200225-00138
   Chen SY, 2020, J MED VIROL, V92, P1556, DOI 10.1002/jmv.25789
   Cheng VCC, 2020, INFECT CONT HOSP EP, V41, P1258, DOI 10.1017/ice.2020.282
   Chia PY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16670-2
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Coughlan M, 2020, NEW J PHYS, V22, DOI 10.1088/1367-2630/abbae8
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Creanga AA, 2017, OBSTET GYNECOL, V130, P366, DOI 10.1097/AOG.0000000000002114
   Daoud N, 2015, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0393-z
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   Di Napoli R, 2020, FEATURES EVALUATION
   Di Renzo GC, 2020, AM J OBSTET GYNECOL, V223, P135, DOI 10.1016/j.ajog.2020.04.017
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Dorelien A, 2019, POPUL DEV REV, V45, P489, DOI 10.1111/padr.12232
   Druckmann R, 2005, J STEROID BIOCHEM, V97, P389, DOI 10.1016/j.jsbmb.2005.08.010
   Ellington S, 2020, MMWR-MORBID MORTAL W, V69, P769, DOI 10.15585/mmwr.mm6925a1externalicon
   Faridi S, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138401
   Ferrazzi E, 2020, BJOG-INT J OBSTET GY, V127, P1116, DOI 10.1111/1471-0528.16278
   Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66
   Govind A, 2020, EUR J OBSTET GYN R B, V251, P272, DOI 10.1016/j.ejogrb.2020.05.004
   GroSS Rudiger, 2020, Lancet, V395, P1757, DOI 10.1016/S0140-6736(20)31181-8
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo ZD, 2020, EMERG INFECT DIS, V26, P1586, DOI 10.3201/eid2607.200885
   Hall KS, 2020, LANCET, V395, P1175, DOI 10.1016/S0140-6736(20)30801-1
   Hall OJ, 2017, MUCOSAL IMMUNOL, V10, P1097, DOI 10.1038/mi.2017.35
   Hall OJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02160-16
   Hedermann G, 2020, CHANGES PREMATURE BI, DOI [10.1101/2020.05.22.20109793, DOI 10.1101/2020.05.22.20109793]
   Heller KN, 2006, J EXP MED, V203, P805, DOI 10.1084/jem.20060215
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hosier H, 2020, J CLIN INVEST, V130, P4947, DOI 10.1172/JCI139569
   Hu XL, 2020, OBSTET GYNECOL, V136, P65, DOI 10.1097/AOG.0000000000003926
   Jaimes JA, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101212
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Ji HL, 2020, PHYSIOL REV, V100, P1065, DOI 10.1152/physrev.00013.2020
   John E, 2012, RECENT ADV RES HUMAN
   Juusela A, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100113
   Kemp MW, 2016, HUM REPROD UPDATE, V22, P240, DOI 10.1093/humupd/dmv047
   Khan S, 2020, CLIN MICROBIOL INFEC, V26, P788, DOI 10.1016/j.cmi.2020.03.034
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Knight M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2107
   Kreis NN, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081777
   Lau LS, 2020, NAT MED, V26, P647, DOI 10.1038/s41591-020-0851-2
   Li N, 2020, CLIN INFECT DIS, V71, P2035, DOI 10.1093/cid/ciaa352
   Li XR, 2019, CELL METAB, V30, P414, DOI 10.1016/j.cmet.2019.08.011
   Liao J, 2020, INT J GYNECOL OBSTET, V150, P53, DOI 10.1002/ijgo.13188
   Liu DH, 2020, AM J ROENTGENOL, V215, P127, DOI 10.2214/AJR.20.23072
   Liu H, 2020, J REPROD IMMUNOL, V139, DOI 10.1016/j.jri.2020.103122
   Liu HH, 2020, J INFECTION, V80, pE7, DOI 10.1016/j.jinf.2020.03.007
   Liu Yangli, 2020, J Infect, DOI 10.1016/j.jinf.2020.02.028
   Lokken EM, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.05.031
   Machon RA, 1997, ARCH GEN PSYCHIAT, V54, P322
   Gabriel MMA, 2020, ACTA PAEDIATR, V109, P2302, DOI 10.1111/apa.15474
   Marmot M, 2020, MARMOT REV 10 YEARS
   MBRRACE-UK, 2020, LESS LEARN INF MAT C
   McNeil SA, 2011, AM J OBSTET GYNECOL, V204, pS54, DOI 10.1016/j.ajog.2011.04.031
   MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013
   Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033
   Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014
   Nair M, 2015, BJOG-INT J OBSTET GY, V122, P653, DOI 10.1111/1471-0528.13279
   Navti O, 2016, OBSTET GYNAECOL, V18, P301, DOI 10.1111/tog.12309
   Ness T., 2020, TRANEXAMIC ACID TXA
   Nile SH, 2020, CYTOKINE GROWTH F R, V53, P66, DOI 10.1016/j.cytogfr.2020.05.002
   Niquini RP, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00149420, 10.1590/0102-311X00149420]
   Oncel MY, 2021, EUR J PEDIATR, V180, P733, DOI 10.1007/s00431-020-03767-5
   Pal A, 2020, LABOUR ROOM EMERGENCIES, P515, DOI 10.1007/978-981-10-4953-8_52
   Pavlicev M, 2017, GENOME RES, V27, P349, DOI 10.1101/gr.207597.116
   Penfield CA, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100133
   Perrone Serafina, 2020, Acta Biomed, V91, P251, DOI 10.23750/abm.v91i2.9743
   Philip RK, 2020, REDUCTION PRETERM BI, DOI [10.1101/2020.06.03.20121442, DOI 10.1101/2020.06.03.20121442]
   Piccinni MP, 1996, IMMUNOL RES, V15, P141, DOI 10.1007/BF02918503
   Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214
   Pique-Regi R, 2020, ELIFE, V9, DOI 10.7554/eLife.58716
   Poon LC, 2020, INT J GYNECOL OBSTET, V149, P273, DOI 10.1002/ijgo.13156
   Rabi FA, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030231
   Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027
   Riley T, 2020, INT PERSPECT SEX R H, V46, P73, DOI 10.1363/46e9020
   Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1
   Royal College for Obstetrics and Gynaecology, GUID ANT POSTN SERV
   Saad AF, 2020, OBSTET GYNECOL, V136, P823, DOI 10.1097/AOG.0000000000004103
   SANTARPIA JL, 2020, TRANSMISSION POTENTI, DOI [10.1101/2020.03.23.20039446, DOI 10.1038/S41598-020-69286-3]
   Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089
   Shang J, 2020, TREATMENT OUTCOMES P, DOI [10.2139/ssrn.3546060, DOI 10.2139/SSRN.3546060]
   SIITERI PK, 1977, ANN NY ACAD SCI, V286, P384, DOI 10.1111/j.1749-6632.1977.tb29431.x
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Sochas L, 2017, HEALTH POLICY PLANN, V32, P32, DOI 10.1093/heapol/czx108
   Staton B., 2020, EFFECTS PANDEMIC WIL
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316
   Takemoto MLS, 2020, INT J GYNECOL OBSTET, V151, P154, DOI 10.1002/ijgo.13300
   Tanacan A, 2020, EUR J OBSTET GYN R B, V253, P31, DOI 10.1016/j.ejogrb.2020.07.051
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Tekbali A, 2020, AM J OBSTET GYNECOL, V223, P126, DOI 10.1016/j.ajog.2020.04.012
   Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0
   The Royal College of Obstetricians and Gynaecologists, INF HEALTHC PROF COR
   UNFPA, 2020, IMP COVID 19 PAND FA
   UNFPA, 2020, UNFPA SUPPL COVID 19
   van Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026
   Vanders RL, 2013, J INFECT DIS, V208, P1062, DOI 10.1093/infdis/jit296
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6
   VIVANTI AJ, 2020, NAT COMMUN, V11, DOI DOI 10.1038/S41467-020-17436-6.
   Weatherbee BAT, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200162
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   Whitehead CL, 2020, LANCET, V395, pE92, DOI 10.1016/S0140-6736(20)31029-1
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   WHO, BRESTF COVID 19 HEAL
   Wong SCY, 2020, J HOSP INFECT, V105, P119, DOI 10.1016/j.jhin.2020.03.036
   Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   World Health Organization, 2020, WHO EUR COR DIS COVI
   Wu CC, 2020, VIROL SIN, V35, P305, DOI 10.1007/s12250-020-00227-0
   Wu XQ, 2020, INT J GYNECOL OBSTET, V150, P58, DOI 10.1002/ijgo.13165
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang H, 2020, J INFECTION, V81, pE40, DOI 10.1016/j.jinf.2020.04.003
   Yang MM, 2015, J REPROD MED, V60, P423
   Young BC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.037
   Yu N, 2020, LANCET INFECT DIS, V20, P559, DOI 10.1016/S1473-3099(20)30176-6
   Zamaniyan M, 2020, PRENATAL DIAG, V40, P1759, DOI 10.1002/pd.5713
   Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861
   Zhang CC, 2020, APPL PHYS EXPRESS, V13, DOI 10.35848/1882-0786/aba06a
   Zhang L, 2020, Zhonghua Fu Chan Ke Za Zhi, V55, P166, DOI 10.3760/cma.j.cn112141-20200218-00111
   Zheng QL, 2020, REPROD DEV MED, V4, P7, DOI 10.4103/2096-2924.278679
   Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
   ZHU S, 2020, AM J OBSTET GYNECOL, DOI DOI 10.1016/J.AJOG.2020.05.005.
NR 150
TC 114
Z9 118
U1 32
U2 51
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0031-9333
EI 1522-1210
J9 PHYSIOL REV
JI Physiol. Rev.
PD JAN
PY 2021
VL 101
IS 1
BP 303
EP 318
DI 10.1152/physrev.00024.2020
PG 16
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA QU2OS
UT WOS:000627123700001
PM 32969772
OA Green Published
DA 2022-04-20
ER

PT J
AU Fonseca, LM
   Azevedo, AL
AF Fonseca, Luis Miguel
   Azevedo, Americo Lopes
TI COVID- 19: outcomes for Global Supply Chains
SO MANAGEMENT & MARKETING-CHALLENGES FOR THE KNOWLEDGE SOCIETY
LA English
DT Article
DE Supply Chain Management; Lean; Just in time; Performance; COVID-19;
   crisis; research propositions
ID PERFORMANCE; MANAGEMENT; IMPACT; DETERMINANTS; INTEGRATION; FRAMEWORK;
   SMES
AB The COVID-19 crisis exposed the vulnerability and poor resilience of the global supply chains. The objective of this research is to reflect on the possible impacts of the Coronavirus crisis in the global supply chains and provide some recommendations to overcome the present situation, offering suggestions for future research: (1) What are the contingency factors affecting Supply Chains in the complex COVID-19 operating environment? (2) How do these factors affect post-COVID-19 operating performance? After a contextualization of the COVID-19 pandemic crisis and its impacts, theoretical background on Supply Chains and Supply Chain Management are presented, and a summary of the main scenarios for the post-COVID-19 crisis are discussed. The propositions regarding the contingency factors and their impact on the Supply Chain operating performance in post-COVID-19 suggest that successful companies will focus on creating a new kind of operational performance and minimize risks. To that end, companies will aim to improve their operations' resilience (ability to resist, hold on, and recover from shocks) and accelerate the end-to-end digital transformation. Consumers will have to adapt to the contact-free economy, less low-cost supply chains, and put additional emphasis on service levels. Governments will reinforce the focus in the health sector supply chain and increase spending in the health and social care sectors. Furthermore, the longer, the more concentrated, the less transparent, and the more price sensitivity is the supply chain, the more challenging the adaptation to the new pos pandemic realities. Suggestions for future research are also provided.
C1 [Fonseca, Luis Miguel] Polytech Porto, Sch Engn Porto ISEP, Ctr Res & Dev Mech Engn CIDEM, P-4249015 Porto, Portugal.
   [Azevedo, Americo Lopes] Univ Porto, Fac Engn, Porto, Portugal.
   [Azevedo, Americo Lopes] Inesc TEC, Campus FEUP, P-4200465 Porto, Portugal.
RP Fonseca, LM (corresponding author), Polytech Porto, Sch Engn Porto ISEP, Ctr Res & Dev Mech Engn CIDEM, P-4249015 Porto, Portugal.
EM lmf@isep.ipp.pt
RI da Fonseca, Luis Miguel Ciravegna Martins/L-4285-2014; Azevedo,
   Americo/G-2763-2015
OI da Fonseca, Luis Miguel Ciravegna Martins/0000-0001-5668-0656; Azevedo,
   Americo/0000-0002-9659-5488
CR Anagnoste S, 2017, P INT CONF BUS EXCEL, V11, P676, DOI 10.1515/picbe-2017-0072
   Barbosa C, 2019, INT J PROD RES, V57, P3577, DOI 10.1080/00207543.2018.1543970
   Bogle JC, 2009, FINANC ANAL J, V65, P17, DOI 10.2469/faj.v65.n1.3
   Bratianu C, 2020, MANAG MARK, V15, P154, DOI 10.2478/mmcks-2020-0010
   Bratianu C, 2018, MANAG MARK, V13, P859, DOI 10.2478/mmcks-2018-0010
   Catte P, 2011, J POLICY MODEL, V33, P787, DOI 10.1016/j.jpolmod.2011.06.001
   Chopra S., 2007, SUPPLY CHAIN MANAGEM
   Clutterbuck D., 1978, INT MANAG, V33, P17
   Deloitte, 2020, ADDR FIN IMP COV 19
   Dinca VM, 2019, J BUS ECON MANAG, V20, P798, DOI 10.3846/jbem.2019.9856
   Editorial Board of the Wall Street Journal, 2020, WALL STREET J
   Fonseca Luis Miguel, 2018, TQM Journal, V30, P321, DOI 10.1108/TQM-12-2017-0173
   Fonseca LM, 2017, MANAG MARK, V12, P443, DOI 10.1515/mmcks-2017-0027
   Fonseca LM, 2015, QUAL INNOV PROSPER, V19, P32, DOI 10.12776/QIP.V19I2.592
   Funda SA, 2005, J OPER MANAG, V23, P579, DOI 10.1016/j.jom.2004.08.007
   Gunasekaran A, 2004, INT J PROD ECON, V87, P333, DOI 10.1016/j.ijpe.2003.08.003
   Herbig J., 2003, DISASTER RECOVERY J, V16, P1
   Huo BF, 2012, SUPPLY CHAIN MANAG, V17, P596, DOI 10.1108/13598541211269210
   International Monetary Fund, 2020, IMF COV 19
   Irwin N, 2020, NY TIMES
   Lao Y, 2010, J SUPPLY CHAIN MANAG, V46, P6
   LeDuc JW., 2004, EMERG INFECT DIS, V10, DOI [10.3201/eid1011.040797_02, DOI 10.3201/EID1011.04079702]
   Lee CW, 2007, SUPPLY CHAIN MANAG, V12, P444, DOI 10.1108/13598540710826371
   Li SH, 2006, OMEGA-INT J MANAGE S, V34, P107, DOI 10.1016/j.omega.2004.08.002
   Mackelprang AW, 2010, J OPER MANAG, V28, P283, DOI 10.1016/j.jom.2009.10.002
   MacKenzie D, 2020, NEW SCI, V245, P7, DOI 10.1016/S0262-4079(20)30424-3
   Maestrini V, 2018, INT J OPER PROD MAN, V38, P934, DOI 10.1108/IJOPM-07-2015-0455
   Mckinsey & Company a, 2020, UMP START RES REIM O
   Mckinsey & Company b, 2020, FUT IS NOT WHAT IT U
   Mckinsey Global Institute, 2020, RISK RES REB GLOB VA
   Mercy Corps, 2019, DOES EB AFF EC
   Fonseca LM, 2015, QUAL-ACCESS SUCCESS, V16, P54
   Paunescu C., MANAGEMENT MARKETING, V8, P63
   Rother M., 2003, LEARNING SEE VALUE S
   Schonberger Richard., 1982, JAPANESE MANUFACTURI
   Shingo S., 1989, STUDY TOYOTA PRODUCT
   Simchi-Levi D., 2015, MITSLOAN MANAGEMENT, P2020
   SimchiLevi D., 2015, HARVARD BUSINESS REV
   Slintak P., 2003, FALL WORLD 2003 DIS
   Stavrulaki E, 2010, INT J LOGIST MANAG, V21, P127, DOI 10.1108/09574091011042214
   Womack J., 1996, LEAN THINKING BANISH
   Womack J.P., 1990, MACHINE CHANGED WORL
NR 42
TC 20
Z9 20
U1 26
U2 64
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 1842-0206
EI 2069-8887
J9 MANAG MARK
JI Manag. Mark.
PD OCT
PY 2020
VL 15
SU 1
BP 424
EP 438
DI 10.2478/mmcks-2020-0025
PG 15
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA OH5NR
UT WOS:000582631600002
OA Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Evers, JM
   Pehlke, SJ
   Jones, LL
   Urquhart, MG
AF Evers, Julianne M.
   Pehlke, Sarah J.
   Jones, Lauren L.
   Urquhart, Michelle G.
TI Oxygenation Strategies in Critically Ill Patients With COVID-19
SO DIMENSIONS OF CRITICAL CARE NURSING
LA English
DT Article
DE Coronavirus; COVID-19 hypoxia; COVID-19
AB Background: Severe acute respiratory syndrome coronavirus 2 is the virus that causes coronavirus disease 2019 (COVID-19). COVID-19 is a disease characterized by a range of clinical syndromes including variable degrees of respiratory symptoms from mild respiratory illness and severe interstitial pneumonia to acute respiratory distress syndrome, septic shock, coagulopathies, and multiorgan dysfunction. This virus carries the potential to manifest in a wide range of pulmonary findings and hypoxemias, from mild respiratory symptoms to more severe syndromes, such as acute respiratory distress syndrome. The rapid accumulation of evidence and persistent gaps in knowledge related to the virus presents a host of challenges for clinicians. This creates a complex environment for clinical decision-making.
   Objective: To examine oxygenation strategies in critically ill patients with hypoxia who are hospitalized with COVID-19.
   Discussion: These proposed strategies may help to improve the respiratory status and oxygenation of those affected by COVID-19. However, additional high-quality research is needed to provide further evidence for improved respiratory management strategies. Areas of future research should focus on improving understanding of the inflammatory and clotting processes associated with the virus, particularly in the lungs. High-level evidence and randomized controlled trials should target the most effective strategies for improving oxygenation, time requiring mechanical ventilation, and survival for hospitalized patients with COVID-19 presenting with hypoxemia.
C1 [Evers, Julianne M.; Pehlke, Sarah J.] Bellarmine Univ, Lansing Sch Nursing & Clin Sci, Miles Hall 201,2001 Newburg Rd, Louisville, KY 40205 USA.
   [Evers, Julianne M.] Univ Louisville, Div Blood & Bone Marrow Transplantat, Louisville, KY 40292 USA.
   [Pehlke, Sarah J.] Norton Womens & Childrens Hosp, Louisville, KY USA.
   [Jones, Lauren L.] Bellarmine Univ, Lansing Sch Nursing & Clin Sci, Clin Educ Resp Therapy, Louisville, KY 40205 USA.
   [Urquhart, Michelle G.] Norton Audubon Hosp, Louisville, KY USA.
RP Evers, JM (corresponding author), Bellarmine Univ, Lansing Sch Nursing & Clin Sci, Miles Hall 201,2001 Newburg Rd, Louisville, KY 40205 USA.
EM jevers01@bellarmine.edu
NR 0
TC 0
Z9 0
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0730-4625
EI 1538-8646
J9 DIMENS CRIT CARE NUR
JI Dimens. Crit. Care Nurs.
PD MAR-APR
PY 2021
VL 40
IS 2
BP 75
EP 82
DI 10.1097/DCC.0000000000000463
PG 8
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA QK9YH
UT WOS:000620735700003
PM 33961375
DA 2022-04-20
ER

PT C
AU Piaggesi, D
   Wills, JA
   Landazuri, H
   Zambrano, C
   Jia, B
AF Piaggesi, Danilo
   Wills, Jorge Andres
   Landazuri, Helena
   Zambrano, Carol
   Jia, Bo
BE GarciaPerez, A
   Simkin, L
TI Innovating Sustainable Development: A Best Practice from Ecuador During
   COVID-19
SO PROCEEDINGS OF THE 21ST EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2020)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 21st European Conference on Knowledge Management (ECKM)
CY DEC 02-04, 2020
CL Conventry Univ, ELECTR NETWORK
HO Conventry Univ
DE COVID-19; ICT; knowledge society; telemedicine; developing countries;
   sustainable development
AB The improvement in the delivery of health care services in geographically remote and rural areas is one of the most promising and clearly demonstrated applications of Information and Communication Technology (ICT) in sustainable development. Evidence suggests that improved health outcomes have been achieved through various applications of ICT solutions. In particular, ICT is being used in many developing countries and communities to facilitate: (a) remote consultation, diagnosis and treatment through the use of digital cameras to download images onto a computer and transfer them to doctors in nearby towns; (b) collaboration and information exchange among physicians; (c) ICT-based medical research through the use of a network of satellites and ground stations to submit data for clinical trials; (d) medical training through ICT-enabled delivery mechanisms; and (e) access to centralized data repositories connected to ICT networks that enable remote healthcare professionals to keep abreast of medical knowledge. Moreover, ICT provides considerable benefits and capabilities when applied to disease prevention and response efforts during epidemics and pandemics. ICT is an effective means to disseminate public health messages and disease prevention techniques in developing countries. It also enables better monitoring and response mechanisms. Also, ICT is helping improve the efficiency of public health systems and medical facilities by, for example, streamlining medical procurement or creating and managing patient records. The expansion of the COVID-19 outbreak that began in Wuhan, China, alerted all the countries of the world from the beginning of 2020 and reached Latin America in mid-February 2020. In this paper VERIS, an Ecuadorian successful practice of telemedicine during the COVID-19 times, is presented. VERIS allows remote consultation with a certified Doctor, following the WHO protocol, and other relevant services provided also remotely. The VERIS experience is particularly relevant during the present COVID19 pandemic, because it eliminates the risks of contagion deriving from visiting hospitals in person, and could be particularly useful for emerging economies, with practical implications for mature ones.
C1 [Piaggesi, Danilo; Landazuri, Helena] Knowledge Dev, Alexandria, VA 22307 USA.
   [Wills, Jorge Andres; Zambrano, Carol] VERIS, Quito, Ecuador.
   [Jia, Bo] Tsinghua Univ, Beijing, Peoples R China.
RP Piaggesi, D (corresponding author), Knowledge Dev, Alexandria, VA 22307 USA.
EM danilopiaggesi@gmail.com; mgr@k4d.org; ecops@k4d.org;
   carol.zambrano@veris.com.ec; jia-b15@tsinghua.org.cn
CR Adewara F., 2020, USING TELEMEDICINE F
   Central Bank of Ecuador, 2020, COVID 19 PASA FACTUR
   Chetley A., 2006, IMPROVING HLTH CONNE, P1
   CoronaTracker, 2020, ECUADOR OVERVIEW
   Das N., 2020, ATTITUDE TELEMEDICIN
   Dasgupta D., 2020, TELEMEDICINE WITNESS
   Davis L.F, 2020, SENIORS CHILDREN BEN
   Health Management, 2020, COVID 19 TEL MENT HL COVID 19 TEL MENT HL
   ITU, 2020, IND OPP CHALL TEL CO IND OPP CHALL TEL CO
   Lahiri D, 2020, J FAM MED PRIM CARE, V9, P3785, DOI 10.4103/jfmpc.jfmpc_580_20
   Lucas H, 2008, SOC SCI MED, V66, P2122, DOI 10.1016/j.socscimed.2008.01.033
   Ministry of Public Health of Ecuador, 2020, COVID 19 SIT EC COVID 19 SIT EC
   Onaleye T., 2020, TELEMEDICINE COULD B
   PlanV, 2020, DUR CIFR SIST SAL EC DUR CIFR SIST SAL EC
   Rao P, 2020, NIGERIAN DIGITAL HEA
   United Nations, 2020, PLAN DE RESPUESTA HU PLAN DE RESPUESTA HU
   Westbrook JI, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-201
   WHO, 2020, SUPP PRIV SECT ENG C SUPP PRIV SECT ENG C
   Word Bank, 2020, COVID 19 COR AFF PRI COVID 19 COR AFF PRI
NR 19
TC 0
Z9 0
U1 0
U2 1
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-912764-82-2
J9 PROC EUR CONF KNOWL
PY 2020
BP 630
EP 638
DI 10.34190/EKM.20.700
PG 9
WC Business; Information Science & Library Science; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics; Information Science & Library Science
GA BS0SF
UT WOS:000684204300074
DA 2022-04-20
ER

PT J
AU Gong, Y
   Ma, TC
   Xu, YY
   Yang, R
   Gao, LJ
   Wu, SH
   Li, J
   Yue, ML
   Liang, HG
   He, X
   Yun, T
AF Gong, Yue
   Ma, Ting-Can
   Xu, Yang-Yang
   Yang, Rui
   Gao, Lan-Jun
   Wu, Si-Hua
   Li, Jing
   Yue, Ming-Liang
   Liang, Hui-Gang
   He, Xiao
   Yun, Tao
TI Early Research on COVID-19: A Bibliometric Analysis
SO INNOVATION
LA English
DT Article
DE COVID-19; SARS-COV-2; BIBLIOMETRIC ANALYSIS; RESEARCH STATUS; KNOWLEDGE
   SCAPE; KNOWLEDGE MAP
ID CORONAVIRUS 2019-NCOV; TRANSMISSION; WUHAN; PNEUMONIA; OUTBREAK;
   DISEASE; RISK
AB In December 2019, an outbreak of pneumonia, which was named COVID-2019, emerged as a global health crisis. Scientists worldwide are engaged in attempts to elucidate the transmission and pathogenic mechanisms of the causative coronavirus. COVID-19 was declared a pandemic by the World Health Organization in March 2020, making it critical to track and review the state of research on COVID-19 to provide guidance for further investigations. Here, bibliometric and knowledge mapping analyses of studies on COVID-19 were performed, including more than 1,500 papers on COVID-19 available in the PubMed and China National Knowledge Infrastructure databases from January 1, 2020 to March 8, 2020. In this review, we found that because of the rapid response of researchers worldwide, the number of COVID-19-related publications showed a high growth trend in the first 10 days of February; among these, the largest number of studies originated in China, the country most affected by pandemic in its early stages. Our findings revealed that the epidemic situation and data accessibility of different research teams have caused obvious difference in emphases of the publications. Besides, there was an unprecedented level of close cooperation and information sharing within the global scientific community relative to previous coronavirus research. We combed and drew the knowledge map of the SARS-CoV-2 literature, explored early status of research on etiology, pathology, epidemiology, treatment, prevention, and control, and discussed knowledge gaps that remain to be urgently addressed. Future perspectives on treatment, prevention, and control are also presented to provide fundamental references for current and future coronavirus research.
C1 [Gong, Yue; He, Xiao] Chinese Acad Sci, Natl Sci Lib, Beijing 100190, Peoples R China.
   [Ma, Ting-Can; Yue, Ming-Liang; Liang, Hui-Gang] Chinese Acad Sci, Wuhan Lib, Wuhan 430071, Peoples R China.
   [Ma, Ting-Can] Univ Chinese Acad Sci, Dept Lib Informat & Arch Management, Beijing 100190, Peoples R China.
   [Xu, Yang-Yang] China Ctr Informat Ind Dev, Beijing 100036, Peoples R China.
   [Yang, Rui] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing 100093, Peoples R China.
   [Yang, Rui] Chinese Acad Sci, Inst Bot, Beijing Bot Garden, Beijing 100093, Peoples R China.
   [Yang, Rui; Li, Jing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Gao, Lan-Jun] Beijing Univ Chinese Med, Dongfang Hosp, Beijing 100078, Peoples R China.
   [Wu, Si-Hua] Yangzhou Univ, Clin Med Coll, Yangzhou 225001, Jiangsu, Peoples R China.
   [Li, Jing] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Yun, Tao] China Sci & Technol Exchange Ctr, Beijing 100045, Peoples R China.
RP Gong, Y (corresponding author), Chinese Acad Sci, Natl Sci Lib, Beijing 100190, Peoples R China.; Yun, T (corresponding author), China Sci & Technol Exchange Ctr, Beijing 100045, Peoples R China.
EM gongy@mail.las.ac.cn; yunt@cstec.org.cn
CR Ahmed I, 2020, BRIT J HAEMATOL, V190, pE37, DOI 10.1111/bjh.16849
   Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Berngruber TW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003209
   Burley SK, 2020, NATURE, V580, P167, DOI 10.1038/d41586-020-00888-7
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chen C, 2020, Zhonghua Shao Shang Za Zhi, V36, P471, DOI 10.3760/cma.j.cn501120-20200224-00088
   Chen D, 2020, CHIN J CLIN MED, V27, P1
   Chen J.Y., 2020, J BIOINFORM, V18, P96, DOI DOI 10.25236/AJCIS.010101
   Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004
   Chen L., 2020, CHINESE J CLIN MED, V27, P32
   Cheng Jinquan, 2020, Zhonghua Yufang Yixue Zazhi, V54, P475, DOI 10.3760/cma.j.cn112150-20200221-00151
   [程玖玲 Cheng Jiuling], 2020, [中华结核和呼吸杂志, Chinese Journal of Tuberculosis and Respiratiory Diseases], V43, P327
   Cheng VCC, 2020, INFECT CONT HOSP EP, V41, P1258, DOI 10.1017/ice.2020.282
   [科睿唯安 Clarivate Analytics], 2020, [中国生物工程杂志, Chinese Biotechnology], V40, P1
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Du ZW, 2020, EMERG INFECT DIS, V26, P1049, DOI 10.3201/eid2605.200146
   Fu YJ, 2020, VIROL SIN, V35, P266, DOI 10.1007/s12250-020-00207-4
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   [巩玥 Gong Yue], 2020, [中国生物工程杂志, Chinese Biotechnology], V40, P21
   Guan G W, 2020, Zhonghua Gan Zang Bing Za Zhi, V28, P100, DOI 10.3760/cma.j.issn.1007-3418.2020.02.002
   Haider N, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000424
   Hardy RS, 2020, NAT REV RHEUMATOL, V16, P133, DOI 10.1038/s41584-020-0371-y
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Hu L L, 2020, Zhonghua Gan Zang Bing Za Zhi, V28, P97, DOI 10.3760/cma.j.issn.1007-3418.2020.02.001
   Jalava K, 2020, INT J HYG ENVIR HEAL, V226, DOI 10.1016/j.ijheh.2020.113490
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Ki M, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020007
   Kruse Robert L, 2020, F1000Res, V9, P72, DOI 10.12688/f1000research.22211.2
   Lai AL, 2020, J MED VIROL, V92, P675, DOI 10.1002/jmv.25723
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lee Y, 2020, ACS APPL MATER INTER, V12, P12533, DOI 10.1021/acsami.9b23591
   Li H, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE002, DOI 10.3760/cma.j.issn.1001-0939.2020.0002
   Li J, 2020, PROTEIN CELL, V11, P235, DOI 10.1007/s13238-020-00693-y
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liang H, 2020, ACTA OBSTET GYN SCAN, V99, P439, DOI 10.1111/aogs.13836
   Liu C, 2020, Zhonghua Gan Zang Bing Za Zhi, V28, P107, DOI 10.3760/cma.j.issn.1007-3418.2020.02.003
   Liu J., 2020, J MED VIROL, V92, P491, DOI [10.1002/jmv.25709, DOI 10.1002/jmv.25709]
   Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Lucas M, 2001, INT J EXP PATHOL, V82, P269, DOI 10.1046/j.1365-2613.2001.00204.x
   Malik YS, 2020, VET QUART, V40, P68, DOI 10.1080/01652176.2020.1727993
   Ming Wang, 2020, Zhonghua Yufang Yixue Zazhi, V54, P480, DOI 10.3760/cma.j.cn112150-20200220-00149
   Moberly T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m806
   Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047
   Park Sang Woo, 2020, medRxiv, DOI 10.1101/2020.03.09.20033514
   Patel A, 2020, MMWR-MORBID MORTAL W, V69, P140, DOI 10.15585/mmwr.mm6905e1
   Perrella A, 2020, EUR REV MED PHARMACO, V24, P2162, DOI 10.26355/eurrev_202002_20396
   Pullano G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.4.2000057
   Qiu Y Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P494, DOI 10.3760/cma.j.cn112338-20200221-00147
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Savarimuthu S, 2020, J CARDIAC SURG, V35, P1298, DOI 10.1111/jocs.14635
   Shen ZJ, 2020, CLIN INFECT DIS, V71, P713, DOI 10.1093/cid/ciaa203
   Shiraki K, 2020, PHARMACOL THERAPEUT, V209, DOI 10.1016/j.pharmthera.2020.107512
   Stephen K.B, 2020, CORONAVIRUS 3 THINGS
   Stoecklin SB, 2020, EUROSURVEILLANCE, V25, P20, DOI 10.2807/1560-7917.ES.2020.25.6.2000094
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   Wang D, 2020, Zhonghua Er Ke Za Zhi, V58, P269, DOI 10.3760/cma.j.cn112140-20200225-00138
   Wang K, 2020, CHIN J CLIN MED, V27, P27
   Wang X, 2020, BIOSCI TRENDS, V14, P3, DOI 10.5582/bst.2020.01043
   Wertheim J.O, 2020, CLIN INFECT DIS, V4
   Wong JEL, 2020, JAMA-J AM MED ASSOC, V323, P1243, DOI 10.1001/jama.2020.2467
   Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001
   [徐燕 Xu Yan], 2020, [中国肺癌杂志, Chinese Journal of Lung Cancer], V23, P136
   Xuan Zi-xue, 2020, Chinese Pharmacological Bulletin, V36, P591, DOI 10.3969/j.issn.1001-1978.2020.04.026
   Yang Xiao-ming, 2020, Chinese Journal of Biologicals, V33, P241, DOI 10.13200/j.cnki.cjb.003023
   Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0
   Yi HG, 2020, CLIN INFECT DIS, V71, P884, DOI 10.1093/cid/ciaa219
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang W, 2020, MED J CHIN PEOPLES L, V45, P1
   Zhao S, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa022
   Zheng XW, 2020, ZHONGHUA NEI KE ZA Z, V59
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou SC, 2020, AM J ROENTGENOL, V214, P1287, DOI 10.2214/AJR.20.22975
NR 78
TC 15
Z9 16
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2666-6758
J9 INNOVATION-AMSTERDAM
JI Innovation-Amsterdam
PD AUG 28
PY 2020
VL 1
IS 2
AR 100027
DI 10.1016/j.xinn.2020.100027
PG 11
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA VK7GO
UT WOS:000747222600007
PM 32914141
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Seruwagi, G
   Nakidde, C
   Otieno, F
   Kayiwa, J
   Luswata, B
   Lugada, E
   Ochen, EA
   Muhangi, D
   Okot, B
   Ddamulira, D
   Masaba, A
   Lawoko, S
AF Seruwagi, Gloria
   Nakidde, Catherine
   Otieno, Felix
   Kayiwa, Joshua
   Luswata, Brian
   Lugada, Eric
   Ochen, Eric Awich
   Muhangi, Denis
   Okot, Betty
   Ddamulira, Dunstan
   Masaba, Andrew
   Lawoko, Stephen
TI Healthworker preparedness for COVID-19 management and implementation
   experiences: a mixed methods study in Uganda's refugee-hosting districts
SO CONFLICT AND HEALTH
LA English
DT Article
DE Health care workers (HCWs); Preparedness; Resilience; Health system;
   KAP; COVID-19
ID WORKERS KNOWLEDGE; CARE WORKERS; LESSONS; SYSTEM; EBOLA
AB Background The negative impact of COVID-19 on population health outcomes raises critical questions on health system preparedness and resilience, especially in resource-limited settings. This study examined healthworker preparedness for COVID-19 management and implementation experiences in Uganda's refugee-hosting districts. Methods A cross sectional, mixed-method descriptive study in 17 health facilities in 7 districts from 4 major regions. Total sample size was 485 including > 370 health care workers (HCWs). HCW knowledge, attitude and practices (KAP) was assessed by using a pre-validated questionnaire. The quantitative data was processed and analysed using SPSS 26, and statistical significance assumed at p < 0.05 for all statistical tests. Bloom's cutoff of 80% was used to determine threshold for sufficient knowledge level and practices with scores classified as high (80.0-100.0%), average (60.0-79.0%) and low (<= 59.0%). HCW implementation experiences and key stakeholder opinions were further explored qualitatively using interviews which were audio-recorded, coded and thematically analysed. Results On average 71% of HCWs were knowledgeable on the various aspects of COVID-19, although there is a wide variation in knowledge. Awareness of symptoms ranked highest among 95% (p value < 0.0001) of HCWs while awareness of the criteria for intubation for COVID-19 patients ranked lowest with only 35% (p value < 0.0001). Variations were noted on falsehoods about COVID-19 causes, prevention and treatment across Central (p value < 0.0356) and West Nile (p value < 0.0161) regions. Protective practices include adequate ventilation, virtual meetings and HCW training. Deficient practices were around psychosocial and lifestyle support, remote working and contingency plans for HCW safety. The work environment has immensely changed with increased demands on the amount of work, skills and variation in nature of work. HCWs reported moderate control over their work environment but with a high level of support from supervisors (88%) and colleagues (93%). Conclusions HCWs preparedness is inadequate in some aspects. Implementation of healthcare interventions is constrained by the complexity of Uganda's health system design, top-down approach of the national response to COVID-19 and longstanding health system bottlenecks. We recommend continuous information sharing on COVID-19, a design review with capacity strengthening at all health facility levels and investing in community-facing strategies.
C1 [Seruwagi, Gloria; Nakidde, Catherine; Otieno, Felix; Lugada, Eric; Ochen, Eric Awich; Muhangi, Denis; Okot, Betty] Makerere Univ, Dept Social Work & Social Adm SWSA, Ctr Hlth & Social Econ Improvement CHASE I, Kampala, Uganda.
   [Seruwagi, Gloria] Makerere Univ, Dept Hlth Policy Planning & Management HPPM, Sch Publ Hlth MakSPH, Kampala, Uganda.
   [Otieno, Felix] Infotrak Res Consulting, Nairobi, Kenya.
   [Kayiwa, Joshua] Minist Hlth, Publ Hlth Emergency Operat Ctr PHEOC, Kampala, Uganda.
   [Luswata, Brian] Minist Hlth, Directorate Hlth Governance & Regulat, Kampala, Uganda.
   [Ddamulira, Dunstan] Agcy Cooperat Res & Dev ACORD, Nairobi, Kenya.
   [Masaba, Andrew] LWF, Lutheran World Federat LWF, Kampala, Uganda.
   [Lawoko, Stephen] Gulu Univ, Fac Med, Dept Publ Hlth, Gulu, Uganda.
RP Seruwagi, G (corresponding author), Makerere Univ, Dept Social Work & Social Adm SWSA, Ctr Hlth & Social Econ Improvement CHASE I, Kampala, Uganda.; Seruwagi, G (corresponding author), Makerere Univ, Dept Hlth Policy Planning & Management HPPM, Sch Publ Hlth MakSPH, Kampala, Uganda.
EM gseruwagi@musph.ac.ug
OI Seruwagi, Gloria/0000-0002-7280-6164
FU Elrha/R2HC (Research for Health in Humanitarian Crises) - UKAID [50530];
   Welcome; National Institute for Health Research (NIHR)National Institute
   for Health Research (NIHR)
FX This research was made possible by a grant (#50530 REFLECT in COVID-19)
   funded by Elrha/R2HC (Research for Health in Humanitarian Crises)
   supported by UKAID, Welcome and National Institute for Health Research
   (NIHR). The views expressed in this paper are those of the authors and
   not the funder.
CR Ajari EE, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020305
   Ajeani J, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1345497
   Arshid M.A., 2020, ARAB J BASIC APPL SC, P1, DOI [10.1080/25765299.2020.1824395, DOI 10.1080/25765299.2020.1824395]
   Asnakew S, 2021, NEUROPSYCH DIS TREAT, V17, P1375, DOI 10.2147/NDT.S306300
   Baine SO, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0282-z
   Bloom B. S., 1956, HANDBOOK
   Boluarte Carbajal A, 2020, J Healthc Qual Res, V35, P401, DOI 10.1016/j.jhqr.2020.08.002
   Bon Tempo J., 2012, EFFECTIVE IN SERVICE
   Bukuluki Paul, 2020, Soc Sci Humanit Open, V2, P100045, DOI 10.1016/j.ssaho.2020.100045
   Burti Lorenzo, 2003, Epidemiol Psichiatr Soc, V12, P227
   Bustreo F, 2003, B WORLD HEALTH ORGAN, V81, P886
   Chirico F, 2020, INFECT CONT HOSP EP, V41, P1117, DOI 10.1017/ice.2020.148
   Crowley T, 2015, AFR J PRIM HEALTH CA, V7, DOI [10.4102/PHCFM.V7I1.807, 10.4102/phcfm.v7i1.807]
   Deller B, 2015, INT J GYNECOL OBSTET, V130, pS25, DOI 10.1016/j.ijgo.2015.03.005
   Dieleman Marjolein, 2009, Health Res Policy Syst, V7, P7, DOI 10.1186/1478-4505-7-7
   Ejeh FE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05557
   Erdem H, 2021, INT J INFECT DIS, V102, P239, DOI 10.1016/j.ijid.2020.10.064
   Federica M., 2020, INITIAL COVID 19 RES
   Fetansa Getahun, 2021, SAGE Open Med, V9, p20503121211012220, DOI 10.1177/20503121211012220
   Firew T, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042752
   Flynn D, 2020, HEALTH POLICY TECHN, V9, P673, DOI 10.1016/j.hlpt.2020.08.003
   Golooba-Mutebi F, 2018, POLITICAL EC REFUGEE
   Gooch K., 2020, 79 NURSES SAY HEALTH
   Government of Uganda, 2020, NATL COMM ENG STRAT
   Government of Uganda (GoU), COVID 19 RESP INF HU
   Hattem J., 2017, GUARDIAN
   Hughes GD, 2006, JEMDSA, V11, P10, DOI 10.1080/22201009.2006.10872134
   Kalibala S, RETROSPECTIVE REV TA
   Kamya C, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10178-0
   Kanu S, 2021, J MULTIDISCIP HEALTH, V14, P67, DOI 10.2147/JMDH.S287156
   Kisakye AN, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1345496
   Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023
   Konde-Lule J, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-29
   Koutsoumpa M., 2020, EUR J PUBLIC HEALTH, V30, DOI [10.1093/eurpub/ckaa165.525, DOI 10.1093/EURPUB/CKAA165.525]
   Kruk ME, 2008, AM J PREV MED, V34, P529, DOI 10.1016/j.amepre.2008.02.012
   Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3
   Lamunu M, 2004, INT J INFECT DIS, V8, P27, DOI 10.1016/j.ijid.2003.04.001
   Leslie HH, 2016, HEALTH AFFAIR, V35, P1716, DOI 10.1377/hlthaff.2016.0261
   Matovu JKB, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-8
   Medical Teams International, 2020, FIGHT COR UG US TAL
   MedScape, 2020, MEM HEALTHC WORK WHO
   Ministry of Finance Planning and Economic Development (MoFPED), 2018, NATL BUDG FRAMEW PAP
   Ministry of Health, 2015, HLTH SECT DEV PLAN 2
   Ministry of Health Health Systems 20/20 and Makerere University School of Public Health, 2012, UG HLTH SYST ASS 201
   Ministry of Health (MoH), 2021, UG HOSP
   Murray CJ, 2020, FOR IMP 1 WAV COVID
   Nampala MP, 2018, BIOMED J, V2, P6
   Ndejjo R, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10519-z
   Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X
   Nouri S, 2019, INT J PUBLIC HLTH SC, V8, P359, DOI [10.11591/ijphs.v8i3.18590, DOI 10.11591/IJPHS.V8I3.18590]
   Nyashanu M, 2020, J INTERPROF CARE, V34, P655, DOI 10.1080/13561820.2020.1792425
   Okware SI, 2015, AFR HEALTH SCI, V15, P312, DOI 10.4314/ahs.v15i1.45
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39
   Roupa Z, 2021, J COMMUN HEALTH, V46, P251, DOI 10.1007/s10900-020-00949-y
   Sekiziyivu BA, 2021, JAIDS-J ACQ IMM DEF, V86, pE71, DOI 10.1097/QAI.0000000000002567
   Sengwana M J, 2004, Curationis, V27, P65
   Shreffler J, 2020, WEST J EMERG MED, V21, P1059, DOI 10.5811/westjem.2020.7.48684
   Sundararaman T, 2021, J SOCIAL EC DEV, V23, P290, DOI 10.1007/s40847-020-00133-x
   Sutherland K, 2006, REGULATION QUALITY I
   Tarwirei F, CANC CERVIX KNOWLEDG
   Tashobya C. K., 2018, BMC Health Services Research, V18
   The Strategic Purchasing Africa Resource Center-SPARC, 2021, STRAT HLTH PURCH UG
   Theorell T, 2020, PSYCHOTHER PSYCHOSOM, V89, P193, DOI 10.1159/000507765
   Tumwesigye NM, 2021, 571 CGD
   UNHCR, 2017, UG REF AS SEEK
   Williams G. A., 2020, Eurohealth, V26, P51
   World Bank, 2018, INF REF POL RESP UG
   World Bank Group, 2016, ASS UG PROGR APPR RE
   World Health Organization, WHO2019NCOVIPCPPEUSE
   World Health Organization, 2007, EV BUS STRENGTH HLTH
   Yemeke TT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235250
   Zhang Y, 2020, ISSUES MENT HEALTH N, V41, P525, DOI 10.1080/01612840.2020.1752865
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zikusooka CM, 2009, AFR HEALTH SCI, V9, P552
NR 75
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1752-1505
J9 CONFL HEALTH
JI Confl. Health
PD NOV 3
PY 2021
VL 15
IS 1
AR 79
DI 10.1186/s13031-021-00415-z
PG 22
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA WR2SO
UT WOS:000714355400001
PM 34732235
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Bennett, K
   Mayouf, M
AF Bennett, Kieran
   Mayouf, Mohammad
TI Value Management Integration for Whole Life Cycle: Post COVID-19
   Strategy for the UK Construction Industry
SO SUSTAINABILITY
LA English
DT Article
DE value management; whole life cycle; strategy; COVID-19
ID DESIGN; BIM
AB Value management (VM) and its integration in the whole life cycle (WLC) have become huge concepts for construction projects to provide additional value of an asset for the end user or client. However, the role of VM and its integration as part of the WLC in a construction project remain reactive, and highly impacted by nature of the project, and this has become more challenging with the epidemic impact of COVID-19. This research aims to investigate the mechanisms that delivers value management as part of the "re-invent" strategy proposed by the Construction Leadership Council in the UK government to improve WLC for buildings. In addition to existing secondary data from the literature, primary data were attained using a focus group with six quantity surveyors from different cost consultancies in the UK to gather qualitative evidence using their experiences, perceptions, and key challenges they face when integrating VM. Findings revealed that value management is primarily being used as a cost-cutting tool, the majority of quantity surveyors lack knowledge of what it encompasses, hence the industry needs a more proactive strategy towards it. Analysis revealed that value management is primarily implemented as a cost-cutting solution, key stakeholders (e.g., facility managers) need to be integrated, and there is no standardised process to incorporate value management in projects. The study proposes a four-dimensional (governance and policies, sustainability, industry's best practice, and innovation and technology) strategy to facilitate more holistic considerations of value management post COVID-19. Future work looks into evaluating the strategy proposed while acknowledging different procurement routes.
C1 [Bennett, Kieran; Mayouf, Mohammad] Sch Engn & Built Environm, Birmingham B4 7XG, W Midlands, England.
RP Mayouf, M (corresponding author), Sch Engn & Built Environm, Birmingham B4 7XG, W Midlands, England.
EM Kieran.Bennett@mail.bcu.ac.uk; Mohammad.Mayouf@bcu.ac.uk
OI Mayouf, Mohammad/0000-0003-2342-5370
CR Actavo, 2020, 4 REAS WHY MOD IS MO
   Aecom, 2017, COST MOD MOD CONSTR
   Aghimien DO, 2018, ENG CONSTR ARCHIT MA, V25, P818, DOI 10.1108/ECAM-04-2017-0070
   Atabay S., 2016, J TRAFFIC TRANSP ENG, V6, P25, DOI [10.17265/2328-2142/2013.12.005, DOI 10.17265/2328-2142/2013.12.005]
   Azmy N., 2010, P AEC C PORT ARTH TX, P1
   Bajjou MS, 2018, J MECH ENG SCI, V12, P4141, DOI 10.15282/jmes.12.4.2018.12.0358
   Bello SA, 2021, AUTOMAT CONSTR, V122, DOI 10.1016/j.autcon.2020.103441
   Booth J., 2019, VALUE ENG MODULAR CO
   Bourke K., 2015, ACHIEVING WHOLE LIFE
   Braddock S., 2017, REPORT CONSTRUCTION
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Bruce-Hyrkas T, 2018, PROC CIRP, V69, P178, DOI 10.1016/j.procir.2017.11.127
   Bull J.W., 2003, LIFE CYCLE COSTING C
   Carling L., 2020, OFFICE DESIGNS COVID
   Chakravarthy P.R., 2018, INT J CIVIL ENG TECH, V9, P900
   Cheah C. Y. J., 2005, International Journal of Project Management, V23, P151, DOI 10.1016/j.ijproman.2004.07.008
   Chigangacha P., 2017, P ASOCSA 11 BUILT EN, P249
   CIOB, 2015, DIG CONSTR
   Clift M., 2005, STUDY WHOLE LIFE COS
   CMS, 2017, CMS GUID BUILD INF M
   Connaughton J.N., 1996, VALUE MANAGEMENT CON
   Constantinescu A., 2014, J KNOWLEDGE MANAGEME
   Constructing Excellence, 2004, VALUE MANAGEMENT
   Construction Industry Institute, 2015, IND MOD OPT MAX BEST
   Construction Innovation Hub, 2021, VAL TOOLK DRIV BETT
   Construction Leadership Council, 2020, ROADM REC IND REC PL
   Construction Online, 2020, IMP COVID 19 CONSTR
   Dulaimi M., 2001, P 9 INT GROUP LEAN C, P1
   Eastman C.M., 2011, BIM HDB GUIDE BUILDI
   Edwards DJ, 2017, J BUS RES, V70, P391, DOI 10.1016/j.jbusres.2016.08.012
   Egan J., 1998, RETHINKING CONSTRUCT
   Ekanayake EMAC, 2017, BUILT ENVIRON PROJ A, V7, P518, DOI 10.1108/BEPAM-11-2016-0071
   El-Haram M.A., 2002, J QUALITY MAINTENANC, DOI 10.1108/13552510210430017
   Ellis RCT, 2005, CONSTR MANAG ECON, V23, P483, DOI 10.1080/01446190500040711
   EVANS R, 1998, LONG TERM COSTS OWNI
   Fisher LH, 2018, FACILITIES, V36, P349, DOI 10.1108/F-06-2017-0062
   Flanagan R, 2005, WHOLE LIFE APPRAISAL FOR CONSTRUCTION, P129
   Fulford R, 2014, INT J PROJ MANAG, V32, P315, DOI 10.1016/j.ijproman.2013.05.007
   Gallagher S., 2021, LEAN LED RECOVERY CO
   Gamil Y, 2020, J ENG DES TECHNOL, V18, P1091, DOI 10.1108/JEDT-06-2019-0164
   Gibb, 2020, COVID 19 CONSTRUCTIO
   Hammarberg K, 2016, HUM REPROD, V31, P498, DOI 10.1093/humrep/dev334
   Hughes W.P., 2004, 20 ANN ARCOM C 1 3 S, P373
   Hutchins G., 2005, WHY IT PAYS GET WHOL
   Hyams A., 2018, CONSTRUCTION METHODS
   Jaapar A., 2009, J SUSTAINABLE DEV, V2, P210, DOI [10.5539/jsd.v2n2p210, DOI 10.5539/JSD.V2N2P210]
   Jay CI, 2015, J ENG DES TECHNOL, V13, P123, DOI 10.1108/JEDT-03-2013-0021
   Kelly J., 2014, VALUE MANAGEMENT CON
   Kelly J, 2002, BEST VALUE CONSTRUCT
   Kishk M, 2003, RICS FDN RES PAPER S, V4
   Lateef A., 2013, CRITICAL REV VALUE M
   Latham M., 1994, CONSTRUCTING TEAM
   Lawson R.M., 2014, CIB WORK PAP, P38
   Lehman T., 2000, LEAN CONSTR I, V1, P1
   Leung M.Y., 2003, CONSTRUCTION MANAGEM, V21, P11, DOI DOI 10.1080/0144619032000065081
   Male S., 2003, VALUE MANAGEMENT DES
   Mayouf M., 2015, USING SOFT SYSTEMS E
   Mayouf M, 2019, J ENG DES TECHNOL, V17, P537, DOI 10.1108/JEDT-05-2018-0080
   McElligott W.C., 1995, VALUE MANAGEMENT CON
   Michalski G, 2008, AGR ECON-CZECH, V54, P187, DOI 10.17221/251-AGRICECON
   Modular Building Institute, 2018, WHAT IS MOD CONSTR M
   Nyumba TO, 2018, METHODS ECOL EVOL, V9, P20, DOI 10.1111/2041-210X.12860
   Office for National Statistics, 2020, COR IMP OUTP UK EC
   Oke A., 2015, P 2015 ANN C REG QUA, P1
   Oke A.E., 2017, SUSTAINABLE VALUE MA
   Oke A.E., 2009, P COBRA 2009 CONSTR, P23
   OPOKU A, 2013, INT J ARCH ENG CONST, V2, P35, DOI DOI 10.7492/IJAEC.2013.004
   Othman I, 2021, AIN SHAMS ENG J, V12, P21, DOI 10.1016/j.asej.2020.08.004
   Oyedolapo O., 2011, RICS CONSTR PROP C, V9, P696
   Parn EA, 2018, AUTOMAT CONSTR, V85, P209, DOI 10.1016/j.autcon.2017.09.010
   Perera O., 2009, LIFE CYCLE COSTING Q
   Perera S, 2011, J FINANC MANAG PROP, V16, P94, DOI 10.1108/13664381111153097
   Punnyasoma J., 2019, P 8 WORLD CONSTR S C
   Rachwan R, 2016, PROCEDIA ENVIRON SCI, V34, P431, DOI 10.1016/j.proenv.2016.04.038
   Rahman SHA, 2014, PROCD SOC BEHV, V129, P414, DOI 10.1016/j.sbspro.2014.03.695
   Ramya G, 2020, RES SQUARE, V1, P1
   Rane N.L., 2016, INT J LATEST TRENDS, V6, P286
   Rangelova F., 2014, P 1 SCI APPL C INT P, P4
   Rhodes C., 2019, CONSTRUCTION IND STA
   RICS, 2018, PATHW GUID QUANT SUR
   RICS, 2021, RICS DEL CONF RESP G
   RICS, 2017, VAL MAN VAL ENG
   Roufechaei K.M., 2015, ADV ENVIRON BIOL, V9, P4
   Skitmore M., 2012, AUST J CONSTR EC BUI, V4, P11
   Social Housing, 2020, GRENF INQ FOC VAL EN
   Taherdoost H., 2016, INT J ACAD RES MANAG, V5, P18, DOI [10.2139/ssrn.3205035, DOI 10.2139/SSRN.3205035]
   Thurston Group, 2020, MOD BUILD UK RIS PRO
   Tzanakakis K., 2013, RAILWAY TRACK ITS LO, P305
   Wandahl S, 2015, J CIV ENG MANAG, V21, P1027, DOI 10.3846/13923730.2014.897971
   Wilberg J., 2016, NORDDESIGN, P1
   Wong I., 2010, P 5 INT C RESP MAN G
   Yilmaz M, 2015, WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP, P2253, DOI 10.1016/j.sbspro.2015.06.312
NR 92
TC 2
Z9 2
U1 15
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD AUG
PY 2021
VL 13
IS 16
AR 9274
DI 10.3390/su13169274
PG 26
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA UH8JI
UT WOS:000690169400001
OA Green Accepted, gold
DA 2022-04-20
ER

PT J
AU Smith, IM
   Bayliss, E
   Salisbury, H
   Wheeler, A
AF Smith, Iain M.
   Bayliss, Elaine
   Salisbury, Hollie
   Wheeler, Ali
TI Operations management on the front line of COVID-19 vaccination:
   building capability at scale via technology-enhanced learning
SO BMJ OPEN QUALITY
LA English
DT Article
DE COVID-19; vaccination; lean management; continuous quality improvement
ID HEALTH; CARE
AB The globe is gripped by the COVID-19 pandemic. Mass population vaccination is seen as the solution. As vaccines become available, governments aim to deploy them as rapidly as possible. It is important, therefore, that the efficiency of vaccination processes is optimal. Operations management is concerned with improving processes and comprises systematic approaches such as Lean. Lean focuses explicitly on process efficiency through the elimination of non-value adding steps to optimise processes for those who use and depend on them. Technology-enhanced learning can be a strategy to build improvement capability at scale. A massive online programme to build capability in Lean has been developed by the regulator of England's National Health Service. Beta testing of this programme has been used by some test sites to refine their COVID-19 vaccination processes. The paper presents a case example of massive online learning supporting the use of Lean in the day-to-day operations management of COVID-19 vaccine processes. The case example illustrates the challenges that vaccination processes may present and the need for responsive and effective operations management. Building capability to respond rapidly and systematically in dynamic situations to optimise flow, safety and patient experience may be beneficial. Given the national imperative to achieve mass vaccination as rapidly as possible, systematic improvement methods such as Lean may have a contribution to make. Massive online programmes, such as that described here, may help with this effort by achieving timely knowledge transfer at large scale.
C1 [Smith, Iain M.] NHS England, Improvement Capabil Bldg & Delivery Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bayliss, Elaine] NHS England, Improvement Capabil Bldg & Delivery Grp, Coventry, W Midlands, England.
   [Salisbury, Hollie; Wheeler, Ali] Countess Chester Hosp NHS Fdn Trust, Chester, Cheshire, England.
RP Smith, IM (corresponding author), NHS England, Improvement Capabil Bldg & Delivery Grp, Newcastle Upon Tyne, Tyne & Wear, England.
EM iain.smith@nhs.net
CR Blackmore CC, 2017, BMJ QUAL SAF, V26, P85, DOI 10.1136/bmjqs-2016-005273
   Boaden R, 2008, QUALITY IMPROVEMENT
   Burgess N., 2020, EVALUATION NHS PARTN
   Burgess N, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6392
   Dai TL, 2020, M&SOM-MANUF SERV OP, V22, P869, DOI 10.1287/msom.2019.0778
   Department of Health Social Care, 2021, UK COV 19 VACC DEL P, P46
   Furnival J, 2019, J HEALTH ORGAN MANAG, V33, P821, DOI 10.1108/JHOM-11-2018-0342
   Guerrero M, 2021, TECHNOVATION, V99, DOI 10.1016/j.technovation.2020.102139
   Guest C, 2021, BMJ OPEN QUAL, V10, DOI 10.1136/bmjoq-2019-000781
   Ham C, 2016, IMPROVING QUALITY EN
   Health Education England, TECHNOLOGY ENHANCED
   Joint Committee on Vaccination and Immunisation, 2020, PRIOR GROUP COR COVI
   Khurshid Z, 2020, HUM RESOUR HEALTH, V18, DOI 10.1186/s12960-020-00527-2
   Kirkwood A, 2014, LEARN MEDIA TECHNOL, V39, P6, DOI 10.1080/17439884.2013.770404
   Mahajan R, 2019, INDIAN PEDIATR, V56, P489, DOI 10.1007/s13312-019-1575-6
   McNicholas C, 2019, BMJ QUAL SAF, V28, P356, DOI 10.1136/bmjqs-2017-007605
   Medicines and Healthcare products Regulatory Agency, 2020, REG APPR PFIZ VACC C
   NHS England, 2019, NHS LONG TERM PLAN
   NHS England, 2014, 5 YEAR FORW VIEW
   NHS Improvement, 2016, NHS PARTN VIRG MAS I
   Nicoll P, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9085
   Proudlove N., 2020, 27 EU OP MAN ASS C E, P1818
   Rother M., 2017, TOYOTA KATA PRACTICE
   Sikka R, 2015, BMJ QUAL SAF, V24, P608, DOI 10.1136/bmjqs-2015-004160
   Smith I, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m35
   Smith IM, 2021, BMJ OPEN QUAL, V10, DOI 10.1136/bmjoq-2020-000980
   Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862
   The World Health Organization, 2021, COVID 19 VACC
NR 28
TC 3
Z9 3
U1 2
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 2399-6641
J9 BMJ OPEN QUAL
JI BMJ Open Qual.
PY 2021
VL 10
IS 3
AR e001372
DI 10.1136/bmjoq-2021-001372
PG 6
WC Health Care Sciences & Services; Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services; General & Internal Medicine
GA TK7IU
UT WOS:000674329800001
PM 34244176
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Tejamaya, M
   Widanarko, B
   Erwandi, D
   Putri, AA
   Sunarno, SDAM
   Wirawan, IMA
   Kurniawan, B
   Thamrin, Y
AF Tejamaya, Mila
   Widanarko, Baiduri
   Erwandi, Dadan
   Putri, Amelia Anggarawati
   Sunarno, Stevan D. A. M.
   Wirawan, I. Made Ady
   Kurniawan, Bina
   Thamrin, Yahya
TI Risk Perception of COVID-19 in Indonesia During the First Stage of the
   Pandemic
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE COVID-19; risk perception; Indonesia; risk tolerance; pandemic
ID EBOLA
AB Community perceptions of early-stage pandemics may have significant implications for subsequent disease control and management. Perceptions of COVID-19 among Indonesian citizens were assessed 2 months after the first reported case in the country. The study used an online survey tool, which was adapted from a standardized questionnaire for risk perception of an infectious disease outbreak. The questions of the survey involved respondents' perceived level of knowledge, preparedness, efficacy of control measures, newness, infectiousness, seriousness, motivating and hindering factors, and effectiveness of prevention methods, as well as questions that assessed actual level of knowledge of respondents such as causative agents, modes of transmission, number of total cases, and available control measures. A total of 1,043 respondents participated in this study. The main sources of information of respondents were social media (85.2%) and online news (82.2%). Nearly all respondents were aware that COVID-19 is a viral disease with saliva droplets (97.1%) and contaminated surfaces (86.5%) being its main modes of transmission. Participants showed a good level of knowledge pertaining to control measures, an adequate level of belief toward their efficacy, and a willingness to implement such measures. More than 95% of the respondents perceived COVID-19 to be either serious or very serious. However, the level of anxiety among respondents was moderate, suggesting the presence of risk tolerance in the community. Individual characteristics such as gender, educational background, and occupation were found to have a statistically significant relationship with risk perception and tolerance, but voluntary participation in control measures was high and similar. This indicates that the COVID-19 health campaign during early pandemic in Indonesia was a success. This research also revealed certain areas where health promotion, education, and awareness might be improved.
C1 [Tejamaya, Mila; Widanarko, Baiduri; Erwandi, Dadan; Putri, Amelia Anggarawati; Sunarno, Stevan D. A. M.] Univ Indonesia, Fac Publ Hlth, Dept Occupat Hlth & Safety, Depok City, Indonesia.
   [Wirawan, I. Made Ady] Udayana Univ, Fac Med, Dept Publ Hlth & Prevent Med, Denpasar, Indonesia.
   [Kurniawan, Bina] Diponegoro Univ, Fac Publ Hlth, Dept Occupat Safety & Hlth, Semarang, Indonesia.
   [Thamrin, Yahya] Hasanuddin Univ, Fac Publ Hlth, Dept Occupat Safety & Hlth, Makassar, Indonesia.
RP Tejamaya, M (corresponding author), Univ Indonesia, Fac Publ Hlth, Dept Occupat Hlth & Safety, Depok City, Indonesia.
EM tejamaya@ui.ac.id
RI Wirawan, I Md Ady/W-3477-2019
OI Wirawan, I Md Ady/0000-0003-2464-5260
FU Directorate of the Research and Community Service, Universitas Indonesia
   through PUTI Penugasan COVID-19 [NKB-2606/UN2.RST/HKP.05.00/2020]
FX The authors are grateful to the Directorate of the Research and
   Community Service, Universitas Indonesia for funding this study through
   PUTI Penugasan COVID-19 Grant (Contract Number:
   NKB-2606/UN2.RST/HKP.05.00/2020). We would like to also acknowledge the
   support from Siti Fajrina and Julia Rantetampang who have helped with
   statistics in this study.
CR Abraham C, 2007, CAMBRIDGE HANDBOOK OF PSYCHOLOGY, HEALTH AND MEDICINE, 2ND EDITION, P97
   Ali SH, 2020, JMIR PUBLIC HLTH SUR, V6, P154, DOI 10.2196/21071
   Atchison Kathryn A, 2003, Dent Clin North Am, V47, P21, DOI 10.1016/S0011-8532(02)00051-4
   Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008
   Betsch C, 2020, LANCET, V395, P1255, DOI 10.1016/S0140-6736(20)30729-7
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Bridgman A, 2020, HARVARD KENNEDY SCH, V1, DOI [10.37016/mr-2020-028, DOI 10.37016/MR-2020-028, 10.37016/mr-2020-38]
   Bults M, 2015, DISASTER MED PUBLIC, V9, P207, DOI 10.1017/dmp.2014.160
   Campbell Institute, 2014, RISK PERC THEOR STRA
   Chen L, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/13987
   Courtenay WH, 2000, PSYCHOL MEN MASCULIN, V1, P4, DOI DOI 10.1037/1524-9220.1.1.4
   de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2
   Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012
   Fischhoff B, 2013, RISK ANAL HUMAN BEHA, P17, DOI DOI 10.4324/9780203140710
   Gesser-Edelsburg A, 2015, AM J INFECT CONTROL, V43, P669, DOI 10.1016/j.ajic.2015.03.005
   Heffner J, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-021-00816-8
   Hofstede G., 1980, INT STUD MANAG ORG, V10, P15, DOI [10.1080/00208825.1980.11656300, DOI 10.1080/00208825.1980.11656300]
   Hou FS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09738-7
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152
   Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198
   Kim HK, 2020, SCI COMMUN, V42, P586, DOI 10.1177/1075547020959670
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Kyaw S, 2020, INT J COMMUNITY MED, V7, P1627, DOI DOI 10.18203/2394-6040.IJCMPH20201530
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lembaga Demografi FEB UI, 2020, PERS RIS VIR COV 19
   Li Q, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062864
   Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258
   Olaimat AN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00254
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Pemkot Bogor Lapor Covid-19 and Nanyang Technological Institute, 2020, HAS SURV PERS RIS CO
   Pulido CM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072430
   Raphael D., 2000, WHAT BOYS LIT REV HL
   RATNER PA, 1994, RES NURS HEALTH, V17, P341, DOI 10.1002/nur.4770170505
   Reintjes R, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151258, 10.1371/journal.pone.0]
   Rinaldi MR., 2020, KECEMASAN PADA MASYA, V1st ed
   Rubsamen N, 2015, EMERG INFECT DIS, V21, P1012, DOI 10.3201/eid2106.150013
   Russell Timothy W, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.12.2000256
   Sell TK, 2017, EMERG INFECT DIS, V23, P108, DOI 10.3201/eid2301.160589
   Shahin MAH., 2020, MIDDLE E CURR PSYCHI, V27, P1, DOI [10.1186/s43045-020-00080-7, DOI 10.1186/S43045-020-00080-7]
   Singh S., 2020, GENDER BASED DISPARI
   Wang PW, 2020, J MED INTERNET RES, V22, DOI 10.2196/20021
   Wei X, 2020, ARXIV200313547
   West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9
   WHO, 2018, HLTH WELL BEING MEN
   WHO, 2020, WHO TIM COV 19
   WHO, 2020, Q A COR COV 19
   Wilde GJS, 1994, TARGET RISK DEALING
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
NR 50
TC 0
Z9 0
U1 7
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD OCT 21
PY 2021
VL 9
AR 731459
DI 10.3389/fpubh.2021.731459
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA WU6DE
UT WOS:000716633300001
PM 34746079
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Chun, DJY
   Nabsiah, WA
   Tan, CL
AF Chun, Daniel Jung Yue
   Nabsiah, Wahid Abdul
   Tan, Cheng Ling
TI Successful collaboration between smart city consortium and Hong Kong
   Government in Covid-19 dashboard: the case of leadership in practice
SO INTERNATIONAL JOURNAL OF ORGANIZATIONAL ANALYSIS
LA English
DT Article; Early Access
DE Smart city; Knowledge management; Leadership; Collaboration; Covid-19
ID KNOWLEDGE MANAGEMENT; COMMUNITY; LESSONS; TRUST
AB Purpose This paper aims to discover why such a public partnership project had been successful with a non-profit third-party alliance such as a smart city consortium (SCC) promoting smart city development. Design/methodology/approach This descriptive case study is primarily based on analysing data collected from various texts, public statements, media interviews and three semi-structured interviews with key members involved in the Covid-19 dashboard project. Findings The data and analysis reviews that both interpersonal and interorganisational trust, dedication and proactiveness of the leaders at SCC were major contributing factors to why SCC was able to partner with the Hong Kong Government in the Covid-19 dashboard in the first place and that the success was also a direct outcome of effective mass collaborative knowledge management activities. Research limitations/implications The research in leadership attributes and activities in the non-profit alliance has been few and this collaborative partnership between the alliance and the government is an example of the importance of further research in smart city leadership. Practical implications In deploying projects for mass collaboration and knowledge sharing in smart city development (which is multi-disciplinary in nature). there are still many new and evolving organisational practices and leadership matters that many business leaders and city managers can learn from. Social implications Smart city development projects involve the notion of sharing data in an open environment enabled by software and mediating tools. Successful projects such as this Hong Kong Covid-19 dashboard which serves a diverse audience can further promote the importance of an open data policy regime for the benefit of the public. Originality/value This case study covers a highly original and unique case study with the leaders at the SCC and representatives from the Hong Kong Government.
C1 [Chun, Daniel Jung Yue; Nabsiah, Wahid Abdul; Tan, Cheng Ling] Univ Sains Malaysia, Grad Sch Business, George Town, Malaysia.
RP Chun, DJY (corresponding author), Univ Sains Malaysia, Grad Sch Business, George Town, Malaysia.
EM daniel.chung@student.usm.my
CR Akhter S., 2016, PALGRAVE HDB VOLUNTE, P915
   Alahmad A., 2010, J DIVERSITY MANAGEME, V5
   ALDRICH HE, 1994, ACAD MANAGE REV, V19, P645, DOI 10.2307/258740
   Borjigen C, 2015, PROGRAM-ELECTRON LIB, V49, P325, DOI 10.1108/PROG-02-2015-0023
   Bouckaert L, 1998, J BUS ETHICS, V17, P1073, DOI 10.1023/A:1006071416514
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8
   Budd J, 2020, NAT MED, V26, P1183, DOI 10.1038/s41591-020-1011-4
   Chourabi H., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P2289, DOI 10.1109/HICSS.2012.615
   Chun J.Y.D., 2020, INT J IND MANAGEMENT, V5, DOI [10.15282/ijim.5.0.2020.5617, DOI 10.15282/IJIM.5.0.2020.5617]
   CIC BIM Channel, 2020, YOUTUBE
   Cocchia A, 2014, PROGR IS, P13, DOI 10.1007/978-3-319-06160-3_2
   Den Hartog DN, 1999, LEADERSHIP QUART, V10, P219, DOI 10.1016/S1048-9843(99)00018-1
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   EJ Insight, 2020, INF TRANSP HELPS EP
   ESRI, 2020, ARCGIS DASHBOARD USE
   ESRI, 2020, ARCGIS DASHB SOFTW O
   ESRI, 2020, WHIT GEOGR INF SYST
   ESRI, 2020, INT MAP DASHB REV VI
   Everts J, 2020, DIALOGUES HUM GEOGR, V10, P260, DOI 10.1177/2043820620935355
   Gerring J, 2004, AM POLIT SCI REV, V98, P341
   GERSTNER CR, 1994, LEADERSHIP QUART, V5, P121, DOI 10.1016/1048-9843(94)90024-8
   Gil-Garcia J. Ramon, 2015, Information Polity, V20, P61, DOI 10.3233/IP-150354
   Gutierrez K., 2009, LEARNING EXPANDING A, P75, DOI [10.1017/CBO9780511809989, DOI 10.1017/CB09780511809989.006]
   Hielkema H, 2013, J KNOWL ECON, V4, P190, DOI 10.1007/s13132-012-0087-6
   HKCD, 2020, NEWS ARTICLE CHINESE
   HKSAR, 2020, HKSARG ENH DISS ANT
   HKSAR, 2020, ANT EP INF CHANN LAU
   HKSAR, 2021, SMART CIT BLUEPR 2 0
   HKSAR, 2020, PRESS INF VID 7 MARC
   HKSAR, 2020, DAT COR DIS COVID 1
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Hung LS, 2003, J ROY SOC MED, V96, P374, DOI 10.1258/jrsm.96.8.374
   Huxham C., 2001, WHAT MAKES PRACTITIO, P1
   Israilidis J., 2019, INT J INFORM MANAGE
   Kramer RM, 1999, ANNU REV PSYCHOL, V50, P569, DOI 10.1146/annurev.psych.50.1.569
   Lakpetch P, 2012, INT J ORGAN ANAL, V20, P128, DOI 10.1108/19348831211227819
   Law D., 2020, BLOGPOST
   McGuirk P, 2021, GEOGR RES-AUST, V59, P188, DOI 10.1111/1745-5871.12456
   Meijer A, 2016, INT REV ADM SCI, V82, P392, DOI 10.1177/0020852314564308
   Mervyn K., 2019, INT J ORGAN ANAL, V27
   Nguyen H.N., 2011, J MANAG DEV
   O'Leary R, 2012, AM REV PUBLIC ADM, V42, P507, DOI 10.1177/0275074012445780
   Pereira GV, 2017, INFORM SYST FRONT, V19, P213, DOI 10.1007/s10796-016-9673-7
   Safari A, 2020, INT J ORGAN ANAL, V28, P1149, DOI 10.1108/IJOA-08-2019-1850
   Sancino A, 2020, PUBLIC MANAG REV, V22, P701, DOI 10.1080/14719037.2020.1718189
   SCC, 2021, HONG KONG SMART CITY
   SCC, 2020, US VIS MISS
   Scuotto V, 2017, INFORM SYST MANAGE, V34, P280, DOI 10.1080/10580530.2017.1330006
   Shelton T, 2020, BIG DATA SOC, V7, DOI 10.1177/2053951720965612
   Silvia C., 2011, STATE LOCAL GOVT REV, V43, P66
   Silvia C, 2010, LEADERSHIP QUART, V21, P264, DOI 10.1016/j.leaqua.2010.01.006
   Snow CC, 2016, CALIF MANAGE REV, V59, P92, DOI 10.1177/0008125616683954
   Tang W., 2020, BLOGPOST
   Tang W., 2020, USE BIG DATA ANAL CA
   Tang W., 2020, PREPARING NEXT OUTBR
   The University of Hong Kong, 2020, WINN TANG LEADS TEAM
   Think HK, 2020, USE GIS BETT INF SER
   Toppeta D., 2010, INNOV KNOWL FOUND, V5, P1
   United Nations, 2018, WORLD CIT 2018
   Vangen S, 2003, BRIT J MANAGE, V14, pS61, DOI 10.1111/j.1467-8551.2003.00393.x
   Vangen S, 2014, PUBLIC MANAG REV, V16, P686, DOI 10.1080/14719037.2012.743579
   Vygotsky L., 1978, READINGS DEV CHILDRE, V23, P34, DOI DOI 10.2307/J.CTVJF9VZ4.11
   Wan KM, 2020, WORLD DEV, V134, DOI 10.1016/j.worlddev.2020.105055
   Wong JKW, 2021, GRAEF ARCH CLIN EXP, V259, P1663, DOI 10.1007/s00417-020-04753-1
   Wong SYS, 2020, CAN MED ASSOC J, V192, pE511, DOI 10.1503/cmaj.200563
   Yin R.K., 2012, APA HDB RES METHODS, V2, P141, DOI DOI 10.1037/13620-009
   Zaheer A, 1998, ORGAN SCI, V9, P141, DOI 10.1287/orsc.9.2.141
NR 67
TC 0
Z9 0
U1 4
U2 4
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1934-8835
EI 1758-8561
J9 INT J ORGAN ANAL
JI Int. J. Organ. Anal.
DI 10.1108/IJOA-01-2021-2604
EA AUG 2021
PG 16
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA UE1IS
UT WOS:000687650500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Galle, F
   Veshi, A
   Sabella, EA
   Citozi, M
   Da Molin, G
   Ferracuti, S
   Liguori, G
   Orsi, GB
   Napoli, C
   Napoli, C
AF Galle, Francesca
   Veshi, Arjeta
   Sabella, Elita Anna
   Citozi, Morena
   Da Molin, Giovanna
   Ferracuti, Stefano
   Liguori, Giorgio
   Orsi, Giovanni Battista
   Napoli, Christian
   Napoli, Christian
TI Awareness and Behaviors Regarding COVID-19 among Albanian Undergraduates
SO BEHAVIORAL SCIENCES
LA English
DT Article
DE COVID-19; knowledge; behaviors; lockdown; undergraduates
AB The coronavirus disease 2019 (COVID-19) pandemic has led to the adoption of restriction measures that have had notable consequences on the health and wellbeing of individuals. This survey was carried out on a sample of 905 Albanian undergraduates to assess their knowledge about COVID-19 and their health-related behaviors and communication changes during lockdown. The students were invited to complete a pre-validated questionnaire during lessons. The results show that the majority of the surveyed students were able to answer correctly about the main epidemiological features of the disease. The level of knowledge was proven to be proportional to the students' education level (enrollment year and age). No considerable relationship emerged with respect to diet or smoking. On the other hand, a relevant portion of the sample (37.6%) declared decreased physical activity (PA). Finally, a notable increase in the intensity and frequency of communication with their peers and with their parents was declared by 34.7% and 50.8% of the sample, respectively. Lifestyle variables were found to be mutually related, as were communication outcomes. The participants showed a satisfactory awareness regarding the COVID-19 epidemic. However, the registered reduction in PA may represent a public health issue and should be addressed with adequate policies. The use of electronic media seems to have increased communication habits in this population group.
C1 [Galle, Francesca; Liguori, Giorgio] Univ Naples Parthenope, Dept Movement Sci & Wellbeing, Via Medina 40, I-80133 Naples, Italy.
   [Veshi, Arjeta] Univ Mesdhetar Shqiperise, Fak Shkencave Psikol Sociale & Politike, Blvd Gjergj Fishta 52, Tirana 1023, Albania.
   [Sabella, Elita Anna; Da Molin, Giovanna] Univ Bari Aldo Moro, Interuniv Res Ctr Populat Environm & Hlth, Piazza Umberto I, I-70121 Bari, Italy.
   [Citozi, Morena] Univ Mesdhetar Shqiperise, Fak & Shkencave Juridike & Marredhenieve Nderkomb, Blvd Gjergj Fishta 52, Tirana 1023, Albania.
   [Ferracuti, Stefano] Sapienza Univ Rome, Dept Human Neurosci, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Orsi, Giovanni Battista] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Napoli, Christian] Sapienza Univ Rome, Dept Comp Control & Management Engn Antonio Ruber, Via Ariosto 25, I-00185 Rome, Italy.
   [Napoli, Christian] Sapienza Univ Rome, Dept Med Surg Sci & Translat Med, Via Grottarossa 1035-1039, I-00189 Rome, Italy.
RP Galle, F (corresponding author), Univ Naples Parthenope, Dept Movement Sci & Wellbeing, Via Medina 40, I-80133 Naples, Italy.
EM francesca.galle@uniparthenope.it; arjeta.veshi@umsh.edu.al;
   elita.sabella@uniba.it; morena.citozi@umsh.edu.al;
   giovanna.damolin@uniba.it; stefano.ferracuti@uniroma1.it;
   giorgio.liguori@uniparthenope.it; giovanni.orsi@uniroma1.it;
   cnapoli@diag.uniroma.it; christian.napoli@uniroma1.it
RI Napoli, Christian/H-9398-2012; napoli, christian/H-1862-2012; napoli,
   christian/B-9924-2018; Gallè, Francesca/AAF-6054-2020; Ferracuti,
   Stefano/K-8437-2012
OI Napoli, Christian/0000-0002-3336-5853; napoli,
   christian/0000-0002-5775-2276; napoli, christian/0000-0002-5775-2276;
   Gallè, Francesca/0000-0002-0504-9562; Ferracuti,
   Stefano/0000-0003-1150-1460
CR Bergeron SL, 2005, EMERG INFECT DIS, V11, P732, DOI 10.3201/eid1105.040512
   Boniel-Nissim M, 2015, INT J PUBLIC HEALTH, V60, P189, DOI 10.1007/s00038-014-0636-9
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Carter SJ, 2020, OBESITY, V28, P1176, DOI 10.1002/oby.22838
   Coccia M, NATL LOCKDOWN COPE C
   Cvetkovic VM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114124
   Fransen HP, 2017, EUR J PUBLIC HEALTH, V27, P274, DOI 10.1093/eurpub/ckw190
   Galle F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186654
   Galle F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176171
   Galle F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103481
   Galle F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7695-z
   Mechili EA, 2021, J PSYCHIATR MENT HLT, V28, P317, DOI 10.1111/jpm.12672
   Napoli C, 2015, INT J ENV RES PUB HE, V12, P15550, DOI 10.3390/ijerph121215002
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   Adem O, 2020, GEOMAT NAT HAZ RISK, V11, P1864, DOI 10.1080/19475705.2020.1811405
   Olaimat AN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00254
   Olawuni P., 2020, INT J DISASTER RISK, V2, P1, DOI [10.18485/ijdrm.2020.2.2.1, DOI 10.18485/IJDRM.2020.2.2.1]
   Padron I, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.589927
   Roma P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197252
   Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662
   Sobaih AE, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166520
   Stockwell S, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-000960
   Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Tang SQ, 2021, J AFFECT DISORDERS, V279, P353, DOI 10.1016/j.jad.2020.10.016
   The World Bank, 2020, INDICATORS
   Uzun H, 2021, CHILD YOUTH SERV REV, V120, DOI 10.1016/j.childyouth.2020.105748
   World Health Organization, CORONAVIRUS DIS 2019
   World Health Organization, 2020, 2019 NOVEL CORONAVIR
   Xhelili P., 2021, INT J STUDIES ED, V3, P103, DOI DOI 10.46328/IJONSE.49
   Yang SJ, 2020, CLIN OBES, V10, DOI 10.1111/cob.12416
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 32
TC 6
Z9 6
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-328X
J9 BEHAV SCI-BASEL
JI Behav. Sci.
PD APR
PY 2021
VL 11
IS 4
AR 45
DI 10.3390/bs11040045
PG 12
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA RQ9MW
UT WOS:000642736700001
PM 33807250
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Hamzah, S
   Fatimah, A
   Aswad, I
   Kurniaty
AF Hamzah, Suhartina
   Fatimah, Ainun
   Aswad, Iqra
   Kurniaty
TI Management of COVID-19 in pregnant women and neonates
SO GACETA SANITARIA
LA English
DT Article
DE COVID-19; Neonates; Pregnant womena
AB Objective: Coronaviruses are a large family of viruses that cause disease in humans and animals. In humans, it usually causes respiratory infections, from the common cold to serious illnesses such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The disease is mainly spread between people through respiratory droplets from coughs and sneezes. This virus can last up to three days with plastic and stainless steel SARS CoV-2 can last up to three days, or in aerosols for 3 h.
   Method: The methodology of this research is indirect observation. Existing data analyzed with a preventive intervention approach and then described with a qualitative descriptive method.
   Result: Based on research that has been carried out, infection with the COVID-19 virus in pregnant women can not only cause severe symptoms in the mother, but also poses a risk of harm to the baby they are carrying. Therefore, preventive measures need to be taken so that pregnant women are not easily infected with the Corona virus.
   Conclusion: COVID-19 is a new disease that has become a pandemic. This disease should be watched out for because transmission is relatively fast, has a mortality rate that cannot be ignored, and there is no definitive therapy. There are still many knowledge gaps in this field, so further studies are needed. (C) 2021 SESPAS. Published by Elsevier Espana, S.L.U.
C1 [Hamzah, Suhartina] Hasanuddin Univ, Fac Pharm, Makassar, Indonesia.
   [Fatimah, Ainun] Hasanuddin Univ, Fac Cultural Sci, Makassar, Indonesia.
   [Aswad, Iqra] Hasanuddin Univ, Fac Engn, Makassar, Indonesia.
   [Kurniaty] Hasanuddin Univ, Grad Sch, Makassar, Indonesia.
RP Hamzah, S (corresponding author), Hasanuddin Univ, Fac Pharm, Makassar, Indonesia.
EM suhartinahamzah@unhas.ac.id
OI Fatimah, Ainun/0000-0003-3489-3938
CR Bernheim A, 2020, RADIOLOGY, V295, P685, DOI 10.1148/radiol.2020200463
   Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Kesehatan M, 2015, PANDUAN PENCEGAHAN D
   Monardo D, 2019, PEDOMAN TATA LAKSANA
   Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang Z, 2020, HDB 2019 NCOV PNEUMO
   WHO, 2020, NAM COR DIS COVID 19
   World Health Organization Mission China Joint World Health Organization Mission China Joint, 2020, REP WHO CHIN JOINT M
NR 10
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0213-9111
EI 1578-1283
J9 GAC SANIT
JI Gac. Sanit.
PY 2021
VL 35
SU 2
BP S588
EP S590
DI 10.1016/j.gaceta.2021.10.089
EA DEC 2021
PG 3
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA XS3QZ
UT WOS:000732829000120
PM 34929907
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Cerda-Mansilla, E
   Rubio, N
   Campo, S
AF Cerda-Mansilla, Elena
   Rubio, Natalia
   Campo, Sara
TI Critical success factors for sharing information and knowledge of
   COVID-19 through Twitter
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Coronavirus; covid-19; sars-CoV-2; sns; twitter; qca
AB The Coronavirus 2019 (COVID-19) outbreak represents the first time that an international health crisis of this level has been experienced in the digital age. This research aims to determine the causal configurations of different types of content that led to a high rate of dissemination. Firstly, we identify possible explanatory variables of information and knowledge dissemination through Twitter. The variables were organised into two blocks (content richness and psychological content). An analysis was then performed of two Twitter accounts (official vs. unofficial) using Qualitative Comparative Analysis. For the unofficial source, the results reveal the importance of a combination of emotional, identifying, and video content factors. For the official account, in contrast, the dissemination is determined by the absence of emotional, identifying, and untrustworthy content and the presence of image content. These configurations are useful for public and private management of a health crisis.
C1 [Cerda-Mansilla, Elena; Rubio, Natalia; Campo, Sara] Univ Autonoma Madrid, Finance & Mkt Res, Madrid, Spain.
RP Cerda-Mansilla, E (corresponding author), Univ Autonoma Madrid, Finance & Mkt Res, Madrid, Spain.
EM elena.cerda@uam.es
RI Rubio, Natalia/A-5166-2013; CAMPO MARTINEZ, SARA/L-2961-2014
OI Rubio, Natalia/0000-0002-6665-8521; CAMPO MARTINEZ,
   SARA/0000-0002-8918-0639
FU Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish
   GovernmentEuropean Commission [FPU2018/05131]; Government of Madrid;
   Autonomous University of Madrid; Professorship Excellence Program
FX This work was supported by the Ministerio de Ciencia e Innovacion
   [FPU2018/05131] and this work was supported too by the Professorship
   Excellence Program in accordance with the multi-year agreement signed by
   the Government of Madrid and the Autonomous University of Madrid.
CR Alvarez MD, 2014, TOURISM MANAGE, V40, P70, DOI 10.1016/j.tourman.2013.05.009
   Aslam U, 2018, J ORGAN CHANGE MANAG, V31, P1084, DOI 10.1108/JOCM-08-2017-0300
   Bergner D, 2009, CH CRC DATA MIN KNOW, P19
   Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007
   Brewer M. B., 2001, INDIVIDUAL SELF RELA, P1, DOI DOI 10.1177/1948550612469819
   Broniatowski D.A., 2020, ARXIV200709682CSSI
   Budhwani H, 2020, J MED INTERNET RES, V22, DOI 10.2196/19301
   Casero-Ripolles A, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.mar.23
   Chen Q, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106380
   Choi G, 2013, INT J HUM-COMPUT INT, V29, P619, DOI 10.1080/10447318.2012.756333
   DAFT RL, 1986, MANAGE SCI, V32, P554, DOI 10.1287/mnsc.32.5.554
   Damiano AD, 2020, CYBERPSYCH BEH SOC N, V23, P889, DOI 10.1089/cyber.2020.0425
   de Vries L, 2012, J INTERACT MARK, V26, P83, DOI 10.1016/j.intmar.2012.01.003
   Galvez-Rodriguez MD, 2019, ONLINE INFORM REV, V43, P219, DOI 10.1108/OIR-09-2016-0286
   Edghiem F, 2021, KNOWL MAN RES PRACT, V19, P439, DOI 10.1080/14778238.2020.1848364
   Fortin DR, 2005, J BUS RES, V58, P387, DOI 10.1016/S0148-2963(03)00106-1
   Gao PX, 2015, 2015 18TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P590
   Gerrits L, 2021, INT J SOC RES METHOD, V24, P501, DOI 10.1080/13645579.2020.1799636
   Index, 2013, SOCIAL INTELLIGENCE
   Jetten J., 2020, TOGETHER APART PSYCH
   Jopke N, 2019, INT J SOC RES METHOD, V22, P599, DOI 10.1080/13645579.2019.1625236
   Keib K, 2018, COMPUT HUM BEHAV, V85, P106, DOI 10.1016/j.chb.2018.03.025
   Khan ML, 2017, COMPUT HUM BEHAV, V66, P236, DOI 10.1016/j.chb.2016.09.024
   Lee JY, 2013, HEALTH COMMUN, V28, P509, DOI 10.1080/10410236.2012.700391
   Lee SA, 2021, J HOSP TOUR MANAG, V46, P215, DOI 10.1016/j.jhtm.2020.12.010
   Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941
   Medina I., 2017, ANALISIS CUALITATIVO, V56
   Milan S, 2015, INFORM COMMUN SOC, V18, P887, DOI 10.1080/1369118X.2015.1043135
   Moran G, 2020, J PROD BRAND MANAG, V29, P533, DOI 10.1108/JPBM-09-2018-2014
   Naeem M, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102226
   Nobles AL, 2020, AIDS BEHAV, V24, P2045, DOI 10.1007/s10461-019-02765-5
   Pleasure SJ, 2020, JAMA NEUROL, V77, P679, DOI 10.1001/jamaneurol.2020.1065
   Pulido CM, 2020, INT SOCIOL, V35, P377, DOI 10.1177/0268580920914755
   Ragin C.C., 2014, COMP METHOD MOVING Q
   Ragin CC, 2006, POLIT ANAL, V14, P291, DOI 10.1093/pan/mpj019
   Riedl R, 2013, DATA BASE ADV INF SY, V44, P18, DOI 10.1145/2436239.2436242
   Sabate F, 2014, EUR MANAG J, V32, P1001, DOI 10.1016/j.emj.2014.05.001
   Shim M, 2015, ASIAN J COMMUN, V25, P48, DOI 10.1080/01292986.2014.989242
   Strubing J., 2014, GROUNDED THEORY SOZI
   Su Y, 2019, J INF TECHNOL POLITI, V16, P236, DOI 10.1080/19331681.2019.1641451
   Tovstiga N, 2021, KNOWL MAN RES PRACT, V19, P427, DOI 10.1080/14778238.2020.1806749
   von Oertzen J., 2006, METHODEN POLITIKWISS, P145
NR 42
TC 1
Z9 1
U1 10
U2 28
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 445
EP 453
DI 10.1080/14778238.2021.1895688
EA MAR 2021
PG 9
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000627682100001
DA 2022-04-20
ER

PT J
AU Abbo, A
   Miller, A
   Gazit, T
   Savir, Y
   Caspi, O
AF Abbo, Aharon (Ronnie)
   Miller, Asaf
   Gazit, Talya
   Savir, Yonatan
   Caspi, Oren
TI Technological Developments and Strategic Management for Overcoming the
   COVID-19 Challenge within the Hospital Setting in Israel
SO RAMBAM MAIMONIDES MEDICAL JOURNAL
LA English
DT Review
DE COVID-19; health care technology; information management; strategic
   patient management
AB The coronavirus disease 2019 (COVID-19) pandemic has remarkably challenged health care organizations and societies. A key strategy for confronting the disease implications on individuals and communities was based on harnessing multidisciplinary efforts to develop technologies for mitigating the disease spread and its deleterious clinical implications. One of the main challenging characteristics of COVID-19 is the provision of medical care to patients with a highly infective disease mandating the use of isolation measures. Such care is complicated by the need for complex critical care, dynamic treatment guidelines, and a vague knowledge regarding the disease's pathophysiology. A second key component of this challenge was the overwhelming surge in patient burden and the relative lack of trained staff and medical equipment which required rapid re-organization of large systems and augmenting health care efficiencies to unprecedented levels. In contrast to the risk management strategies employed to mitigate other serious threats and the billions of dollars that are invested in reducing these risks annually by governments around the world, no such preparation has been shown to be of effect during the current COVID-19 pandemic. Unmet needs were identified within the newly opened COVID-19 departments together with the urgent need for reliable information for effective decision-making at the state level.
   This review article describes the early research and development response in Israel under the scope of in-hospital patient care, such as non-contact sensing of patients' vital signs, and how it could potentially be weaved into a practical big picture at the hospital or national level using a strategic management system. At this stage, some of the described technologies are still in developmental or clinical evidence generation phases with respect to COVID-19 settings. While waiting for future publications describing the results of the ongoing evidence generation efforts, one should be aware of this trend as these emerging tools have the potential to further benefit patients as well as caregivers and health care systems beyond the scope of the current pandemic as well as confronting future surges in the number of cases.
C1 [Abbo, Aharon (Ronnie)] Rambam Hlth Care Campus, Dept Cardiol, Haifa, Israel.
   [Miller, Asaf; Caspi, Oren] Rambam Hlth Care Campus, Med Intens Care Unit, Haifa, Israel.
   [Gazit, Talya] Israel Def Forces, Technol & Cyber Def Unit, MAMRAM, Ramat Gan, Israel.
   [Savir, Yonatan; Caspi, Oren] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.
RP Abbo, A (corresponding author), Rambam Hlth Care Campus, Dept Cardiol, Haifa, Israel.; Caspi, O (corresponding author), Rambam Hlth Care Campus, Med Intens Care Unit, Haifa, Israel.; Caspi, O (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.
EM ro_abbo@rambam.health.gov.il; o_caspi@rambam.health.gov.il
CR Abraham WT, 2015, J CARD FAIL, V21, pS77, DOI 10.1016/j.cardfail.2015.06.240
   AL-Khalidi FQ, 2011, PEDIATR PULM, V46, P523, DOI 10.1002/ppul.21416
   Al-Sadr H, 2019, INT J DATA MIN BIOIN, V22, P301
   Amir O, 2016, INT J CARDIOL, V221, P841, DOI 10.1016/j.ijcard.2016.06.323
   [Anonymous], 2020, ELBIT SYSTEMS N 0406
   Care Tyto, TYTO CAR HELPS FIGHT
   Coats TJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201562
   EarlySense, EARLYSENSE SOL US CO
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Gatt A, 2018, PRIM CARE DIABETES, V12, P312, DOI 10.1016/j.pcd.2018.01.001
   Halbfinger, 2020, NEW YORK TIMES
   Hale C., 2020, FIERCE BIOTECH  0528
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Huang Y, 2020, RES SQUARE, DOI [10.21203/rs. 2.24369/v1, DOI 10.21203/RS.2.24369/V1]
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Lahiri BB, 2012, INFRARED PHYS TECHN, V55, P221, DOI 10.1016/j.infrared.2012.03.007
   Lee YS, 2014, IEEE J TRANSL ENG HE, V2, DOI 10.1109/JTEHM.2014.2365776
   Lewis GF, 2011, PSYCHOPHYSIOLOGY, V48, P877, DOI 10.1111/j.1469-8986.2010.01167.x
   Magnin M, 2020, BIOMED OPT EXPRESS, V11, P2431, DOI 10.1364/BOE.387481
   Maki KA, 2019, CARDIOVASC REVASCULA, V20, P496, DOI 10.1016/j.carrev.2018.07.024
   Massaroni C, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19040908
   Mutlu K, 2018, J NEUROSCI METH, V301, P1, DOI 10.1016/j.jneumeth.2018.02.017
   Ng EYK, 2004, MICROVASC RES, V68, P104, DOI 10.1016/j.mvr.2004.05.003
   Nguyen AV, 2010, EMERG INFECT DIS, V16, P1710, DOI 10.3201/eid1611.100703
   Schoun B., 2018, SMART HLTH, V9, P37, DOI DOI 10.1016/j.smhl.2018.07.018
   Soldati G, 2020, J ULTRAS MED, V39, P1459, DOI 10.1002/jum.15284
   Technion-Israel Institute of Technology, 2020, RAD OPT SENS REM MON
   Uriel N, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009175
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 32
TC 3
Z9 3
U1 2
U2 3
PU RAMBAM HEALTH CARE CAMPUS
PI HAIFA
PA 6 HA ALIYA ST, HAIFA, 31096, ISRAEL
SN 2076-9172
J9 RAMBAM MAIMONIDES ME
JI Rambam Maimonides Med. J.
PD JUL
PY 2020
VL 11
IS 3
AR e0026
DI 10.5041/RMMJ.10417
PG 9
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA MV9II
UT WOS:000556661900007
PM 32792042
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Bafarasat, AZ
AF Ziafati Bafarasat, Abbas
TI Meta-synthesis of COVID-19 lessons: charting sustainable management of
   future pandemics
SO INTERNATIONAL JOURNAL OF URBAN SCIENCES
LA English
DT Article
DE COVID-19 (coronavirus) pandemic; epidemiological determinants;
   elimination; suppression; mitigation; SWOT analysis
ID METEOROLOGICAL FACTORS; GOVERNMENT RESPONSES; CHALLENGES; MITIGATION;
   SCENARIOS; OUTBREAK; IMPACTS; ECONOMY; SPREAD; CHINA
AB Development of the COVID-19 vaccines has been creating a lot of hope for an ultimate return to normality, but returning to normality as we had before would mean we will continue to ignore life-ravaging lessons, as we did for severe acute respiratory syndrome, Ebola, and Middle East respiratory syndrome. This meta-synthesis of COVID-19 lessons charts sustainable pandemic management in terms of choosing strategies that are situated in their contextual specifications and beginning preparations for future application of such strategies from now. To guide selection of a situated strategy, the paper provides a comprehensive list of epidemiological determinants (e.g. communicativeness, poverty, supply chain, density, wind, remoteness); consolidates knowledge about strategies of elimination, suppression and mitigation; and proposes a quantified SWOT analysis of epidemiological determinants that produces coordinates for strategy identification in a Cartesian plane divided into twelve strategy quarters. To guide prior preparations for future application of pandemic management strategies, the paper consolidates lessons learned in implementation of situated strategies and proposes preparations at the national level for elimination, at the local/community level for suppression, and at the regional level for mitigation.
   Highlights:
   Lessons of COVID-19 (coronavirus) chart sustainable management of future pandemics.
   Epidemiological determinants and their mechanisms of impact are listed.
   Knowledge about elimination, suppression and mitigation strategies is consolidated.
   A quantified SWOT and Cartesian plane enable selecting context-specific strategies.
   Preparations for future elimination, suppression and mitigation are listed
C1 [Ziafati Bafarasat, Abbas] Izmir Inst Technol, Fac Architecture, Dept City & Reg Planning, Urla, Turkey.
RP Bafarasat, AZ (corresponding author), Fac Architecture, Gulbahe Campus, TR-35430 Urla Izmir, Turkey.
EM abbas.ziafatibafarasat@tu-dortmund.de
CR Acuto M, 2020, ONE EARTH, V2, P317, DOI 10.1016/j.oneear.2020.04.004
   Adelodun B, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140680
   Agoramoorthy G, 2021, J RACIAL ETHN HEALTH, V8, P1, DOI 10.1007/s40615-020-00905-5
   Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Al-Sabbagh MQ, 2022, PSYCHOL HEALTH MED, V27, P215, DOI 10.1080/13548506.2021.1871770
   Alanezi F, 2020, J HEALTHC LEADERSH, V12, P117, DOI 10.2147/JHL.S266491
   Amante A, 2020, REUTERS         1028
   [Anonymous], 2021, ALJAZEERA       0412
   [Anonymous], 2020, VOA             0617
   [Anonymous], 2021, ALJAZEERA       0415
   [Anonymous], 2021, ENTREPRENEUR
   [Anonymous], 2021, REUTERS 0325
   Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Anttiroiko AV, 2021, INT J E-PLAN RES, V10, P1, DOI 10.4018/IJEPR.20210401.oa1
   Aquino EML, 2020, CIENC SAUDE COLETIVA, V25, P2423, DOI 10.1590/1413-81232020256.1.10502020
   Arslan M, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140709
   Baker MG, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4907
   Baker MG, 2020, MED J AUSTRALIA, V213, P198, DOI 10.5694/mja2.50735
   Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203
   Baker MG, 2020, NEW ZEAL MED J, V133, P10
   Baniamin HM, 2020, ASIA PAC J PUBLIC AM, V42, P153, DOI 10.1080/23276665.2020.1784769
   Barrios JM, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104310
   Baxter D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125097
   Baxter D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135253
   Bhowmick GD, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0079-1
   Blay-Palmer A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031325
   Bontempi E, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110476
   Boyd M, 2020, AUST NZ J PUBL HEAL, V44, P89, DOI 10.1111/1753-6405.12991
   Brouard S, 2020, CAN J POLIT SCI, V53, P253, DOI 10.1017/S0008423920000335
   Burki TK, 2020, LANCET RESP MED, V9, pE46, DOI 10.1016/S2213-2600(21)00090-4
   Cai QC, 2007, PUBLIC HEALTH, V121, P258, DOI 10.1016/j.puhe.2006.09.023
   Capolongo Stefano, 2020, Acta Biomed, V91, P13, DOI 10.23750/abm.v91i2.9615
   Carteni A, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140489
   Cavallo C, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05676
   Chigbu UE, 2021, TOWN PLAN REV, V92, P115, DOI 10.3828/tpr.2020.74
   Chowdhury R, 2020, EUR J EPIDEMIOL, V35, P743, DOI 10.1007/s10654-020-00660-1
   Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241
   Clau&beta; F, 2020, GERMANS SPLIT LIFTIN
   Coccia M, 2021, SCI TOTAL ENVIRON, V775, DOI 10.1016/j.scitotenv.2021.145801
   Coccia M, 2021, ENVIRON SCI POLLUT R, V28, P19147, DOI 10.1007/s11356-020-11662-7
   Coccia M, 2021, ATMOS POLLUT RES, V12, P437, DOI 10.1016/j.apr.2020.10.002
   Coccia M, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110155
   Combs T.S., TRANSP RES INTERDISC, V9, DOI [10.1016/j.trip.2021.100322, DOI 10.1016/J.TRIP.2021.100322]
   Connolly C, 2021, URBAN STUD, V58, P245, DOI 10.1177/0042098020910873
   Cronin Patricia, 2008, Br J Nurs, V17, P38
   Dar AB, 2020, COMPUT SCI REV, V38, DOI 10.1016/j.cosrev.2020.100307
   Das D, 2021, URBAN GEOGR, V42, P408, DOI 10.1080/02723638.2020.1807168
   Davies S, 2020, THIS IS CORONAVIRUS
   de Oliveira WK, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/s1679-49742020000200023, 10.5123/S1679-49742020000200023]
   de Sousa Jabbour A.B.L., 2020, MODERN SUPPLY CHAIN, DOI DOI 10.1108/MSCRA-05-2020-0011
   DeFranza D, 2021, AM PSYCHOL, V76, P744, DOI 10.1037/amp0000717
   Desson Z, 2020, HEALTH POLICY TECHN, V9, P405, DOI 10.1016/j.hlpt.2020.09.003
   Dodds K, 2020, TERRIT POLIT GOV, V8, P289, DOI 10.1080/21622671.2020.1771022
   Dowell SF, 2004, LANCET INFECT DIS, V4, P704, DOI 10.1016/S1473-3099(04)01177-6
   Drury J, 2020, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2020.139
   Durante R, 2021, J PUBLIC ECON, V194, DOI 10.1016/j.jpubeco.2020.104342
   Dyson RG, 2004, EUR J OPER RES, V152, P631, DOI 10.1016/S0377-2217(03)00062-6
   Elavarasan RM, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138858
   Ferguson NM, 2020, 9 IMP COLL COVID 19
   Follain J, 2020, BLOOMBERG
   Freestone R., 2015, ROUTLEDGE HDB PLANNI
   Ghosh A, 2020, DIABETES METAB SYND, V14, P273, DOI 10.1016/j.dsx.2020.04.001
   Ghosh J, 2020, J IND BUS ECON, V47, P519, DOI 10.1007/s40812-020-00170-x
   Giudice F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12197939
   Gollwitzer M, 2021, INT J PSYCHOL, V56, P551, DOI 10.1002/ijop.12721
   Graziano T, 2021, INT J E-PLAN RES, V10, P80, DOI 10.4018/IJEPR.20210401.oa7
   Grydehoj A, 2020, TIJDSCHR ECON SOC GE, V111, P288, DOI 10.1111/tesg.12423
   Guo C, 2021, SCI TOTAL ENVIRON, V757, DOI 10.1016/j.scitotenv.2020.143783
   Hambleton IR, 2020, LANCET GLOB HEALTH, V8, pE1114, DOI 10.1016/S2214-109X(20)30291-6
   Handel A., 2020, LONG TERM SUPPRESSIO
   Hansen Gregory, 2020, JMIR Public Health Surveill, V6, pe20343, DOI 10.2196/20343
   Hanzl M., 2020, CITIES HLTH, P1, DOI [10.1080/23748834.2020.1791441, DOI 10.1080/23748834.2020.1791441]
   Herr R., 2021, ROUND TABLE COMMONWE, V110, P138
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Hodgins S, 2020, GLOB HEALTH-SCI PRAC, V8, P136, DOI 10.9745/GHSP-D-20-00217
   Hollingsworth J., 2020, THE CNN
   Honey-Roses J., 2020, CITIES HLTH, P1, DOI DOI 10.1080/23748834.2020.1780074
   Hu MG, 2021, CLIN INFECT DIS, V72, P604, DOI 10.1093/cid/ciaa1057
   Hughes KA, 2020, ANTARCT SCI, V32, P426, DOI 10.1017/S095410202000053X
   Hunt E, 2021, THE GUARDIAN    0309
   Ibn-Mohammed T, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105169
   Intawong K, 2021, BIOCHEM BIOPH RES CO, V534, P830, DOI 10.1016/j.bbrc.2020.10.097
   Issanov A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8346
   Jamieson T, 2020, AM REV PUBLIC ADM, V50, P598, DOI 10.1177/0275074020941721
   Janssen M, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102180
   Jefferies S, 2020, LANCET PUBLIC HEALTH, V5, pE612, DOI 10.1016/S2468-2667(20)30225-5
   Jung F, 2020, CLIN HEMORHEOL MICRO, V74, P363, DOI 10.3233/CH-209004
   Kassem AM, 2020, ARAB J GASTROENTEROL, V21, P1, DOI 10.1016/j.ajg.2020.04.010
   Kayi I, 2020, INFECT DIS CLIN MICR, V2, P30, DOI [10.36519/idcm.2020. 0009, DOI 10.36519/IDCM.2020.0009]
   Khalifa SAM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165813
   Khanna RC, 2020, INDIAN J OPHTHALMOL, V68, P703, DOI 10.4103/ijo.IJO_843_20
   Klepac P, 2015, EPIDEMICS-NETH, V10, P97, DOI 10.1016/j.epidem.2014.12.001
   Kummitha RKR, 2020, GOV INFORM Q, V37, DOI 10.1016/j.giq.2020.101481
   Kvalsvig A, 2021, J ROY SOC NEW ZEAL, V51, pS143, DOI 10.1080/03036758.2021.1891943
   Kwok KO, 2020, J INFECTION, V80, pE32, DOI 10.1016/j.jinf.2020.03.027
   Lachal J, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00269
   Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1
   Lee A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3410
   Leigh D., 2009, HDB IMPROVING PERFOR, V1-3, P115, DOI 10.1002/9780470592663.ch24
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Loayza N.V., 2020, NTR, V35, P1, DOI 10.1596/33764
   Lolli S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73197-8
   Lu GY, 2021, GLOBAL HEALTH ACTION, V14, DOI 10.1080/16549716.2021.1875601
   Luo KW, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa430
   Menon P, 2020, REUTERS         0811
   Menoni Scira, 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09775-y
   Ministry of Health, 2017, NZ INFL PAND PLAN FR, V2nd ed.
   Mofijur M, 2021, SUSTAIN PROD CONSUMP, V26, P343, DOI 10.1016/j.spc.2020.10.016
   Naumann E, 2020, EUR POLICY ANAL, V6, P191, DOI 10.1002/epa2.1091
   Ndung'u N, 2020, COVID 19 CRISIS AMPL
   Normile D, 2020, SCIENCE         0812
   OECD, 2020, COVID 19 GLOB FOOD S
   Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006
   Paterlini M, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4279
   Peyrony J, 2021, EFFECTS COVID 19 IND
   Pisano M, 2020, NEJM CATALYST, V1, P1, DOI [10.1056/CAT.20.0080, DOI 10.1056/CAT.20.0080]
   de la Cruz ERE, 2020, PUBLIC ADMIN REV, V80, P683, DOI 10.1111/puar.13259
   Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa030
   Rogers A, 2021, BLOOMBERG
   Saez M, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138761
   Santos, 2020, WIDER WORKING PAPER, DOI [10.35188/UNU-WIDER/2020/833-7, DOI 10.35188/UNU-WIDER/2020/833-7]
   Science Media Centre, 2020, EXP REACT IND SAGE R
   Sharifi A, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.142391
   Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090
   Shibuya K., 2021, BMJ-BRIT MED J, V372
   Sjodin H, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.13.2000280
   Smyth J, 2021, FINANCIAL TIMES 0318
   Sonn JW, 2020, EURASIAN GEOGR ECON, V61, P482, DOI 10.1080/15387216.2020.1768423
   Summers J, 2020, LANCET REG HEALTH-W, V4, DOI 10.1016/j.lanwpc.2020.100044
   Szylovec A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020555
   Teller J., 2021, BUILDINGS CITIES, V2, P150, DOI [DOI 10.5334/BC.89, 10.5334/bc.89]
   The World Health Organization, 2020, STRENGTH PREP COVID
   Thomasson E, 2021, REUTERS         0401
   Thorpe Vanessa, 2020, THE GUARDIAN 0314
   Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5
   Torjesen I, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3071
   Travaglio M, 2021, ENVIRON POLLUT, V268, DOI 10.1016/j.envpol.2020.115859
   van den Oord S, 2020, PUBLIC ADMIN REV, V80, P880, DOI 10.1111/puar.13256
   Walker P., 2020, GLOBAL IMPACT COVID
   Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035
   Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4
   WEIHRICH H, 1982, LONG RANGE PLANN, V15, P54, DOI 10.1016/0024-6301(82)90120-0
   Wilkinson A, 2020, ENVIRON URBAN, V32, P503, DOI 10.1177/0956247820922843
   Williamson Myra E. J. B., 2020, [مجلة كلية القانون الكويتية العالمية, kuwait International law School Journal, Magallat kulliyyat al-qanun al-kuwaytiyyat al-ʿalamiyyat], V8, P55, DOI 10.54032/2203-008-998-014
   Wilson N., 2020, Potential health impacts from the COVID-19 pandemic for New Zealand if eradication fails: report to the NZ Ministry of Health
   Wilson N., 2021, CONVERSATION    0225
   Wilson S, 2020, LEADERSHIP-LONDON, V16, P279, DOI 10.1177/1742715020929151
   Wright AL, 2020, J ECON BEHAV ORGAN, V180, P544, DOI 10.1016/j.jebo.2020.10.008
   Wu T, 2021, AMBIO, V50, P822, DOI 10.1007/s13280-020-01497-4
   Wuyts W, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105016
   Yang X, 2020, J HAZARD MATER, V397, DOI 10.1016/j.jhazmat.2020.122609
   Yuan J, 2021, SCI TOTAL ENVIRON, V780, DOI 10.1016/j.scitotenv.2021.146538
   Zhang J, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13084208
   Zhao PJ, 2020, HEALTH PLACE, V65, DOI 10.1016/j.healthplace.2020.102406
   Zhu GY, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145858
   Zwald ML, 2020, MMWR-MORBID MORTAL W, V69, P419, DOI 10.15585/mmwr.mm6914e3
NR 157
TC 0
Z9 0
U1 7
U2 11
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1226-5934
EI 2161-6779
J9 INT J URBAN SCI
JI Int. J. Urban Sci.
PD JUL 3
PY 2021
VL 25
IS 3
SI SI
BP 299
EP 322
DI 10.1080/12265934.2021.1936136
EA JUN 2021
PG 24
WC Environmental Studies; Urban Studies
WE Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Urban Studies
GA TT9QD
UT WOS:000665652400001
DA 2022-04-20
ER

PT J
AU Windarwati, HD
   Oktaviana, W
   Mukarromah, I
   Ati, NAL
   Rizzal, AF
   Sulaksono, AD
AF Windarwati, Heni Dwi
   Oktaviana, Wita
   Mukarromah, Indah
   Ati, Niken Asih Laras
   Rizzal, Alfunnafi' Fahrul
   Sulaksono, Ari Dwi
TI In the middle of the COVID-19 outbreak: Early practical guidelines for
   psychosocial aspects of COVID-19 in East Java, Indonesia
SO PSYCHIATRY RESEARCH
LA English
DT Article
DE Intervention; Psychosocial; COVID-19
AB It is generally recognized that psychosocial interventions are an essential component in dealing with the COVID19 outbreak. Research focusing on the handling of psychosocial conditions in the COVID-19 outbreak seems sparse. After reviewing several scholarly articles, we recommend several things that can be used as a basis for developing practical guidelines for handling psychosocial problems, especially in East Java Province, Indonesia.
   Development of practical guidelines for first-hand response and early treatment of psychosocial aspects of COVID-19 in East Java Province, Indonesia, based on the recommendations of 14 articles related to COVID-19 psychosocial handling was carried out.
   Some evidence strongly supports the need for knowledge about the stages of COVID-19, understanding of psychosocial responses, understanding of psychosocial interventions, and availability of hotline services in psychosocial interventions at each stage of the COVID-19 outbreak.
   It is important to provide practical guidance for the early management of psychosocial aspects of the innovative COVID-19 in providing more comprehensive care. There is strong evidence of the need for practical guidance on initial handling of the psychosocial aspects of COVID-19 for the community, especially in Indonesia's East Java Province.
C1 [Windarwati, Heni Dwi; Ati, Niken Asih Laras; Sulaksono, Ari Dwi] Univ Brawijaya, Fac Med, Sch Nursing, Malang, Indonesia.
   [Oktaviana, Wita; Rizzal, Alfunnafi' Fahrul] Tech Team Handling Mental Hlth Problems Hlth Off, Yogyakarta, Central Java, Indonesia.
   [Mukarromah, Indah] Univ Pesantren Tinggi DarulUlum, Fac Hlth Sci, Kabupaten Jombang, Jawa Timur, Indonesia.
RP Windarwati, HD (corresponding author), Univ Brawijaya, Mental Hlth & Psychiat Nursing Dept, Jl Vet, Malang 64145, East Java, Indonesia.
EM henipsik.fk@ub.ac.id; indahmukarromah@fik.unipdu.ac.id
OI Ati, Niken Asih Laras/0000-0002-6006-2313; Rizzal, Alfunnafi'
   Fahrul/0000-0001-9718-1124; Dwi Sulaksono, Ari/0000-0002-9058-5430
FU East Java Provincial Health Office
FX The authors are thankful for the support from East Java Provincial
   Health Office and all those helped this research.
CR Abdul-Khalek R.A., 2017, J GLOB HEALTH, P1, DOI [10.7189/jogh.07.020412., DOI 10.7189/JOGH.07.020412.]
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   CDC, 2020, MENT HLTH COP COVID
   De Sousa A, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102128
   Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575
   Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0
   Greenberg N, 2020, BMJ-BRIT MED J, V1211, P1, DOI DOI 10.1136/BMJ.M1211
   Hyun J, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e211
   Ifdil I, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102153
   Inter-Agency Standing Committee Reference Group for Mental Health and Psychosocial Support in Emergency Settings, 2020, BRIEF NOT ADDR MENT, P1
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Li W, 2020, INT J BIOL SCI, V16, P1732, DOI 10.7150/ijbs.45120
   Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921
   Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8
   Practice B. B., 2019, CORONAVIRUS DIS 2019, P2633, DOI [10.1001/jama.2020.2633., DOI 10.1001/JAMA.2020.2633.]
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Whaibeh Emile, 2020, Curr Treat Options Psychiatry, V7, P198, DOI 10.1007/s40501-020-00210-2
   WHO, 2020, WATER SANITATION HYG
   World Health Organization, 2020, MENT HLTH PSYCH CONS
   Yang Y., 2020, LANCET PSYCHIAT, V7, DOI [10.1016/S2215-0366(20)30079-1.e19., DOI 10.1016/S2215-0366(20)30079-1.E19.]
   Yao H, 2020, LANCET PSYCHIAT, V7, pE21, DOI 10.1016/S2215-0366(20)30090-0
   ZHANG J, 2020, PRECIS CLIN MED, DOI DOI 10.1093/PCMEDI/PBAA006.
NR 22
TC 1
Z9 1
U1 3
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-1781
J9 PSYCHIAT RES
JI Psychiatry Res.
PD NOV
PY 2020
VL 293
AR 113395
DI 10.1016/j.psychres.2020.113395
PG 6
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA OU5SJ
UT WOS:000591588300063
PM 32866795
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Wong, MD
   Thai, T
   Li, YH
   Liu, H
AF Wong, Molly D.
   Thai, Theresa
   Li, Yuhua
   Liu, Hong
TI The role of chest computed tomography in the management of COVID-19: A
   review of results and recommendations
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE COVID-19; chest computed tomography; COVID-19 severity; COVID-19
   progression
ID RESPIRATORY SYNDROME CORONAVIRUS; TEMPORAL LUNG-CHANGES; CT FINDINGS;
   PNEUMONIA
AB The rapid and dramatic increase in confirmed cases of COVID-19 has led to a global pandemic. Early detection and containment are currently the most effective methods for controlling the outbreak. A positive diagnosis is determined by laboratory real-time reverse transcriptase polymerase chain reaction (rRT-PCR) testing, but the use of chest computed tomography (CT) has also been indicated as an important tool for detection and management of the disease. Numerous studies reviewed in this paper largely concur in their findings that the early hallmarks of COVID-19 infection are ground-glass opacities (GGOs), often with a bilateral and peripheral lung distribution. In addition, most studies demonstrated similar CT findings related to the progression of the disease, starting with GGOs in early disease, followed by the development of crazy paving in middle stages and finally increasing consolidation in the later stages of the disease. Studies have reported a low rate of misdiagnosis by chest CT, as well as a high rate of misdiagnosis by the rRT-PCR tests. Specifically, chest CT provides more accurate results in the early stages of COVID-19, when it is critical to begin treatment as well as isolate the patient to avoid the spread of the virus. While rRT-PCR will probably remain the definitive final test for COVID-19, until it is more readily available and can consistently provide higher sensitivity, the use of chest CT for early stage detection has proven valuable in avoiding misdiagnosis as well as monitoring the progression of the disease. With the understanding of the role of chest CT, researchers are beginning to apply deep learning and other algorithms to differentiate between COVID-19 and non-COVID-19 CT scans, determine the severity of the disease to guide the course of treatment, and investigate numerous additional COVID-19 applications. Impact statement The impact of the COVID-19 pandemic has been worldwide, and clinicians and researchers around the world have been working to develop effective and efficient methods for early detection as well as monitoring of the disease progression. This minireview compiles the various agency and expert recommendations, along with results from studies published in numerous countries, in an effort to facilitate the research in imaging technology development to benefit the detection and monitoring of COVID-19. To the best of our knowledge, this is the first review paper on the topic, and it provides a brief, yet comprehensive analysis.
C1 [Wong, Molly D.; Li, Yuhua; Liu, Hong] Univ Oklahoma, Adv Med Imaging Ctr, Norman, OK 73019 USA.
   [Wong, Molly D.; Li, Yuhua; Liu, Hong] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA.
   [Thai, Theresa] Univ Oklahoma, Hlth Sci Ctr, Dept Radiol Sci, Oklahoma City, OK 73104 USA.
RP Liu, H (corresponding author), Univ Oklahoma, Adv Med Imaging Ctr, Norman, OK 73019 USA.; Liu, H (corresponding author), Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA.
EM liu@ou.edu
OI Wong, Molly/0000-0003-4790-0586
FU University of Oklahoma Charles and Peggy Stephenson Cancer Center -
   Oklahoma Tobacco Settlement Endowment Trust; Charles Jean Smith Chair
   endowment fund
FX This research was supported in part by a grant from the University of
   Oklahoma Charles and Peggy Stephenson Cancer Center funded by the
   Oklahoma Tobacco Settlement Endowment Trust. We would also like to
   gratefully acknowledge the support of Charles Jean Smith Chair endowment
   fund.
CR ACR, ACR REC US CHEST RAD
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Ajlan AM, 2014, AM J ROENTGENOL, V203, P782, DOI 10.2214/AJR.14.13021
   Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823
   Betz ME, 2020, J MED INTERNET RES, V22, DOI 10.2196/16253
   Butt C, 2020, APPL INTELL, DOI 10.1007/s10489-020-01714-3
   Chan MSM, 2004, AM J ROENTGENOL, V182, P49, DOI 10.2214/ajr.182.1.1820049
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen R, 2020, CAN J ANESTH, V67, P754, DOI 10.1007/s12630-020-01625-4
   Chen ZH, 2020, EUR J RADIOL, V126, DOI 10.1016/j.ejrad.2020.108972
   Cheng ZH, 2020, AM J ROENTGENOL, V215, P121, DOI 10.2214/AJR.20.22959
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Das KM, 2016, AM J ROENTGENOL, V206, P1193, DOI 10.2214/AJR.15.15363
   Das KM, 2015, AM J ROENTGENOL, V205, pW267, DOI 10.2214/AJR.15.14445
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Ge Y., 2020, BIORXIV, DOI [10.1101/2020.03.11.986836%, 10.1101/2020.03.11.986836, DOI 10.1101/2020.03.11.986836]
   Han R, 2020, AM J ROENTGENOL, V215, P338, DOI 10.2214/AJR.20.22961
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Inui Shohei, 2020, Radiol Cardiothorac Imaging, V2, pe200110, DOI 10.1148/ryct.2020200110
   Khatami M, 2020, J EARTHQ TSUNAMI, V14, DOI 10.1142/S1793431120500086
   Koks S, 2020, EXP BIOL MED, V245, P677, DOI 10.1177/1535370220919349
   Li L., 2020, RADIOLOGY, DOI [10.1148/radiol.2020200905, DOI 10.1148/RADIOL.2020200905]
   Li Y, 2020, AM J ROENTGENOL, V214, P1, DOI [DOI 10.2214/AJR.20.22954, 10.2214/AJR.20.22954]
   Li Z, 2020, EUR RADIOL, V30, P6828, DOI 10.1007/s00330-020-07042-x
   Liu KC, 2020, EUR J RADIOL, V126, DOI 10.1016/j.ejrad.2020.108941
   Long CQ, 2020, EUR J RADIOL, V126, DOI 10.1016/j.ejrad.2020.108961
   Metsky H.C., 2020, BIORXIV
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Mossa-Basha M, 2020, RADIOLOGY, DOI [10.1148/radiol.2020201326, DOI 10.1148/RADIOL.2020201326]
   Muller NL, 2003, AM J ROENTGENOL, V181, P3, DOI 10.2214/ajr.181.1.1810003
   Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020
   Ong Edison, 2020, bioRxiv, DOI 10.1101/2020.03.20.000141
   Ooi GC, 2004, RADIOLOGY, V230, P836, DOI 10.1148/radiol.2303030853
   Orsi MA, 2020, RADIOLOGY, V295, pE8, DOI 10.1148/radiol.2020201214
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Patrick, 2020, ARXIV200305037
   Qian Lijuan, 2020, Radiol Cardiothorac Imaging, V2, pe200033, DOI 10.1148/ryct.2020200033
   RadiologyInfo.org,, 2020, RAD DOS XRAY CT EX
   Randhawa GS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232391
   RSNA, 2020, COVID 19 RES RAD SOC
   Rubin G. D., 2020, CHEST
   Salehi S, 2020, AM J ROENTGENOL, V215, P87, DOI [10.2214/AJR.20.23034, 10.2214/AJR.20.23034S.]
   Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Tang C, 2020, LANCET, DOI [10.2139/ssrn.3571542, DOI 10.2139/SSRN.3571542]
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang S, 2021, EUR RADIOL, V31, P6096, DOI [10.1079/9781789246070.0001, 10.1007/s00330-021-07715-1]
   Wang Y, 2020, ARCH DERMATOL RES, V312, P581, DOI 10.1007/s00403-020-02044-7
   WHO, 2021, STAT 2 M INT HLTH RE
   WONG HYF, 2019, RADIOLOGY, DOI [10.1148/radiol.2020201160, DOI 10.1148/RADIOL.2020201160]
   Wu XJ, 2020, EUR J RADIOL, V128, DOI 10.1016/j.ejrad.2020.109041
   Wu Yan, 2020, Radiol Cardiothorac Imaging, V2, pe200031, DOI 10.1148/ryct.2020200031
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Xu Z, 2020, EXUBERANT ELEVATION, DOI 10.1101/2020.02.11.20021493
   Yan L, 2020, PREDICTION SURVIVAL, DOI [10.1101/2020.02.27.20028027, DOI 10.1101/2020.02.27.20028027]
   Yan Q., 2020, ARXIV200410987
   Yijiu X., 2020, CHINAS HUBEI REPORTS
   Zhao W, 2020, AM J ROENTGENOL, V214, P1, DOI DOI 10.2214/AJR.20.22976
   Zhao W, 2020, THERANOSTICS, V10, P4606, DOI 10.7150/thno.45016
   Zhavoronkov A, 2020, PREPRINT
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 61
TC 4
Z9 4
U1 1
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD JUL
PY 2020
VL 245
IS 13
SI SI
BP 1096
EP 1103
AR 1535370220938315
DI 10.1177/1535370220938315
EA JUN 2020
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA MZ1XL
UT WOS:000544016600001
PM 32588660
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Waller, G
   Abbasian, S
AF Waller, Gary
   Abbasian, Saeid
TI An assessment of crisis management techniques in hotels in London and
   Stockholm as response to COVID-19's economic impact
SO INTERNATIONAL JOURNAL OF CONTEMPORARY HOSPITALITY MANAGEMENT
LA English
DT Article; Early Access
DE Hotel management; London; Stockholm; Pandemic; COVID-19; Crisis
   management techniques; Economic impact
ID TOURISM; RESILIENCE; FRAMEWORK; INDUSTRY; SECTOR
AB Purpose The purpose of this study is to gain a deeper understanding on if and how hotel senior managers (HSMs) in four-star chain hotels in London and Stockholm implemented crisis management techniques (CMTs) as a response to the economic impacts of the COVID-19 pandemic in 2020. Design/methodology/approach Qualitative questionnaires were sent to 30 HSMs in London and Stockholm. From the feedback, this paper assesses, using thematic analysis, differences in CMTs used, past and present, alluding to COVID-19's economic impacts on hotels. Findings Results determined that crises broadly economically impacted destinations similarly through loss of travellers and thus revenue. However, with a more intricate and specific assessment, destinations are impacted differently; thus, CMTs must alter. Findings show many CMTs can be implemented to reduce crises' economic impacts. The literature review and empirical results allude to many previous and current CMTs, although these must be relevant and specific to the crisis, hotel and/or destination. Practical implications This paper has theoretical implications for academics on, among other things, theory building. Practically, it supports hotels in developing and determining CMTs to reduce the economic impacts of crises, to be better prepared when another pandemic emerges and contributes to the tourism and hospitality industry's knowledge of management strategy within crises. Originality/value To the best of the authors' knowledge, this is the first Swedish study focusing on post-COVID-19 crisis management in hotels in London and Stockholm.
C1 [Waller, Gary; Abbasian, Saeid] Sodertorn Univ, Dept Informat & Tourism Studies, Stockholm, Sweden.
RP Abbasian, S (corresponding author), Sodertorn Univ, Dept Informat & Tourism Studies, Stockholm, Sweden.
EM saeid.abbasian@sh.se
CR Ahmad A, 2021, CURR ISSUES TOUR, V24, P2392, DOI 10.1080/13683500.2020.1842342
   Altig D, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104274
   Altuntas F, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102719
   Alvesson M, 2011, ACAD MANAGE REV, V36, P247, DOI 10.5465/AMR.2011.59330882
   Amir AF, 2015, PROCD SOC BEHV, V168, P123, DOI 10.1016/j.sbspro.2014.10.218
   Andriotis K., 2018, DEGROWTH TOURISM CON
   Arbelo A, 2021, J HOSP TOUR RES, V45, P68, DOI 10.1177/1096348020944450
   Baum T, 2020, INT J CONTEMP HOSP M, V32, P2397, DOI 10.1108/IJCHM-03-2020-0242
   Bernard H.R., 2013, SOCIAL RES METHODS Q
   Bharwani S, 2021, WORLDW HOSP TOUR THE, V13, P569, DOI 10.1108/WHATT-05-2021-0072
   Braje IN, 2022, INT J CONTEMP HOSP M, V34, P159, DOI 10.1108/IJCHM-04-2021-0438
   Braun V, 2021, COUNS PSYCHOTHER RES, V21, P37, DOI 10.1002/capr.12360
   Brown NA, 2017, INT J DISAST RISK RE, V22, P362, DOI 10.1016/j.ijdrr.2017.02.005
   Bryman A, 2012, SOCIAL RES METHODS
   Bryman A., 2016, SOCIAL RES METHODS
   Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030
   Carree MA, 2010, INT HANDB SER ENTREP, P557, DOI 10.1007/978-1-4419-1191-9_20
   Chan J, 2021, INT J CONTEMP HOSP M, V33, P1668, DOI 10.1108/IJCHM-09-2020-1013
   Chien Grace C L, 2003, Int J Hosp Manag, V22, P327, DOI 10.1016/S0278-4319(03)00041-0
   Chin C., 2000, RES SCI EDUC, V30, P173
   Chin C., 2002, RES SCI TECHNOL EDUC, V20, P269
   Clarke V, 2017, J POSIT PSYCHOL, V12, P297, DOI 10.1080/17439760.2016.1262613
   Coombs WT, 2007, PUBLIC RELAT REV, V33, P135, DOI 10.1016/j.pubrev.2006.11.016
   Alonso-Almeida MD, 2013, INT J HOSP MANAG, V32, P141, DOI 10.1016/j.ijhm.2012.05.004
   Denzin N.K., 2005, SAGE HDB QUALITATIVE, V3rd, P1
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Freeman M, 2014, QUAL INQ, V20, P119, DOI 10.1177/1077800413510270
   Gelo O, 2008, INTEGR PSYCHOL BEHAV, V42, P266, DOI 10.1007/s12124-008-9078-3
   Giousmpasoglou C, 2021, INT J CONTEMP HOSP M, V33, P1297, DOI 10.1108/IJCHM-07-2020-0741
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   GRAESSER AC, 1994, AM EDUC RES J, V31, P104, DOI 10.2307/1163269
   Guillet BD, 2021, INT J CONTEMP HOSP M, V33, P604, DOI 10.1108/IJCHM-06-2020-0623
   Gursoy D, 2020, J HOSP MARKET MANAG, V29, P527, DOI 10.1080/19368623.2020.1788231
   Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636
   Heath R., 1998, FINANC TIMES
   Henderson J. C., 2004, International Journal of Tourism Research, V6, P411, DOI 10.1002/jtr.505
   Hung KKC, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0438-6
   Joffe H, 2004, RES METHODS CLIN HLT, V56
   Kallio H, 2016, J ADV NURS, V72, P2954, DOI 10.1111/jan.13031
   Kallis G., 2014, DEGROWTH VOCABULARY, P1
   Kash T.J., 1998, LEADERSHIP ORG DEV J, V19, P179
   Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1
   Keown-McMullan C., 1997, DISASTER PREVENTION, V6, P4, DOI [https://doi.org/10.1108/09653569710162406, DOI 10.1108/09653569710162406]
   Kim W. G., 2006, Journal of Hospitality & Tourism Research, V30, P143, DOI 10.1177/1096348005285086
   Krystallis A, 2005, BRIT FOOD J, V107, P320, DOI 10.1108/00070700510596901
   Lai IKW, 2020, INT J CONTEMP HOSP M, V32, P3135, DOI 10.1108/IJCHM-04-2020-0325
   Laws E, 2007, CRISIS MANAGEMENT IN TOURISM, P1, DOI 10.1079/9781845930479.0001
   Le D, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102808
   Lee Y.F., 1999, DISASTER PREV MANAG, V8, P184
   Locke K, 1997, ACAD MANAGE J, V40, P1023, DOI 10.2307/256926
   Lopes AS, 2021, INT J CONTEMP HOSP M, V33, P1850, DOI 10.1108/IJCHM-11-2020-1345
   Maguire M., 2017, ALL IRELAND J HIGHER, V8, P14
   Maher AA, 2022, INT J CONTEMP HOSP M, V34, P972, DOI 10.1108/IJCHM-07-2021-0855
   Marshall C., 1999, DESIGNING QUALITATIV, V3rd
   McKinsey, 2020, HOSP COVID 19 LONG N
   Merriam S.B., 2009, QUALITATIVE RES GUID
   MEYER AD, 1982, ADMIN SCI QUART, V27, P515, DOI 10.2307/2392528
   MITROFF II, 1988, TECHNOL FORECAST SOC, V33, P83, DOI 10.1016/0040-1625(88)90075-3
   Morton P, 2006, J INFORM TECHNOLOGY, V8, P3
   Nepal SK, 2020, TOURISM GEOGR, V22, P646, DOI 10.1080/14616688.2020.1760926
   NHS, 2020, PAND FLU GUID HOSP I
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847
   Page S, 2012, J TRAVEL RES, V51, P142, DOI 10.1177/0047287511400754
   Patton M.Q., 2002, QUALITATIVE RES EVAL, V3rd
   Pearson CM, 1998, ACAD MANAGE REV, V23, P59, DOI 10.2307/259099
   Perrow C, 1984, NORMAL ACCIDENTS LIV
   Polit DF, 2010, INT J NURS STUD, V47, P1451, DOI 10.1016/j.ijnurstu.2010.06.004
   PwC, 2020, UK HOT FOR 2020 2021
   PwC, 2020, CALM WAT AH TRAV IND
   Quine W.V., 1990, PURSUIT TRUTH
   Randhawa P, 2016, CORNELL HOSP Q, V57, P93, DOI 10.1177/1938965515586791
   Ritchie BW, 2009, ASPEC TOUR, V38, P1
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Rodriguez-Anton JM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208599
   Rousaki B, 2006, TOUR HOSP RES, V7, P27, DOI 10.1057/palgrave.thr.6050030
   SCB, 2021, ANT GASTN PREL STAT
   Seeger M.W., 2003, COMMUNICATION ORG CR
   Seraphin H, 2018, J DESTIN MARK MANAGE, V9, P374, DOI 10.1016/j.jdmm.2018.01.011
   Shi FF, 2021, INT J CONTEMP HOSP M, V33, P2886, DOI 10.1108/IJCHM-10-2020-1194
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Silverman, 2010, DOING QUALITATIVE RE
   Silverman D, 2000, DOING QUALITATIVE RE
   SITKIN SB, 1992, RES ORGAN BEHAV, V14, P231
   Skare M, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120469
   Smith D., 2006, KEY READINGS CRISIS
   Stafford G., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P27, DOI 10.1016/S0010-8804(02)80054-4
   STR, 2021, PREL DAT LOND HOT
   Sun SL, 2022, INT J CONTEMP HOSP M, V34, P382, DOI 10.1108/IJCHM-03-2021-0356
   Taylor M. S., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P7, DOI 10.1177/0010880402431001
   Tew P. J., 2008, International Journal of Contemporary Hospitality Management, V20, P332, DOI 10.1108/09596110810866145
   Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748
   Ugur NG, 2020, TOUR MANAG PERSPECT, V36, DOI 10.1016/j.tmp.2020.100744
   UNWTO, 2021, 2020 WORST YEAR TOUR
   UNWTO, 2020, IMP ASS COVID 19 OUT
   UNWTO, 2021, COVID 19 TOUR 2020 Y
   Vogus TJ, 2007, IEEE SYS MAN CYBERN, P3476
   Volo S., 2007, Journal of Travel & Tourism Marketing, V23, P83
   Williams TA, 2017, ACAD MANAG ANN, V11, P733, DOI 10.5465/annals.2015.0134
   World Health Organization, 2020, TIM WHOS COVID 19 RE
   WTTC, 2021, WTTC RES REV GLOB TR
   Yacoub L, 2021, INT J CONTEMP HOSP M, V33, P929, DOI 10.1108/IJCHM-08-2020-0814
NR 102
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-6119
EI 1757-1049
J9 INT J CONTEMP HOSP M
JI Int. J. Contemp. Hosp. Manag.
DI 10.1108/IJCHM-08-2021-1007
EA MAR 2022
PG 20
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA 0D7RJ
UT WOS:000776187700001
OA hybrid
DA 2022-04-20
ER

PT J
AU Chai, CS
   Ng, DLC
   Chua, WJ
   Tung, YZ
   Sindeh, W
   Ibrahim, MA
   Sham, SFB
   Tan, SB
AF Chai, Chee-Shee
   Ng, Diana-Leh-Ching
   Chua, Wei-Jing
   Tung, Yu-Zhen
   Sindeh, Woweham
   Ibrahim, Muhammad Amin
   Sham, Siti Fatimah Badlishah
   Tan, Seng-Beng
TI Knowledge, Attitude, and Practices Among the General Population During
   the Later Stage of the COVID-19 Pandemic in Malaysia: A Cross-Sectional
   Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE knowledge; attitude; practices; COVID-19 pandemic; pandemic fatigue;
   late pandemic
ID OUTBREAK; PERIOD; SARS
AB Purpose: A different pattern of mental health issues was reported during the later stage of the COVID-19 pandemic; however, few studies have examined Malaysians' knowledge, attitudes, and practices (KAP) prevalent during this time. Patients and Methods: A nationwide online cross-sectional study was conducted in Malaysia from June 1, 2021 to June 14, 2021, ie, 18-months from the first reported COVID-19 case in the country. Citizens aged 18 years and above were recruited by means of the snowball sampling method. ANOVA, Pearson correlation, and linear regression tests were used. Results: Of the 2168 respondents, most were young adults (62.7%), females (62.4%), tertiary educated individuals (84%), non-health care workers (85.9%), and individuals who knew someone diagnosed with COVID-19 (75.2%). The mean score for knowledge was 10.0 +/- 1.52 (maximum score = 12); correct response rate for each question ranged from 54.2% to 99%. The mean score in terms of attitude was 1.3 +/- 0.85 (maximum score = 2); 68.7% respondents agreed that control over COVID-19 would finally be achieved; and 62.3% believed that Malaysia could conquer COVID-19. The mean score for practices was 5.1 +/- 1.10 (maximum score = 6); 81.5%, 88.1%, and 74.1% respondents avoided crowded places, confined spaces, and conversations in close physical proximity, respectively. Furthermore, 94.2% wore masks when leaving home; 89.0% practiced hand hygiene; and 83.8% adhering to COVID-19 warnings. Small but significant correlations were found between knowledge and attitude (r = 0.078, p < 0.001) as well as between knowledge and practices (r = 0.070, p = 0.001). Conclusion: Malaysians exhibited sound knowledge but negative attitudes and inadequate practices pertaining to COVID-19 during the pandemic's later stage. At this phase, unlike at the early stage, the public's sound knowledge ensured little improvement in their attitudes and practices. Therefore, health education at the later pandemic stage should focus on promoting positive attitudes and developing better practices.
C1 [Chai, Chee-Shee; Ng, Diana-Leh-Ching] Univ Malaysia Sarawak, Fac Med & Hlth Sci, Dept Med, Sarawak, Malaysia.
   [Chua, Wei-Jing; Tung, Yu-Zhen; Tan, Seng-Beng] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia.
   [Sindeh, Woweham] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia.
   [Ibrahim, Muhammad Amin] Univ Teknol MARA, Fac Med, Dept Internal Med, Sungai Buloh, Selangor, Malaysia.
   [Sham, Siti Fatimah Badlishah] Univ Teknol MARA, Fac Med, Dept Primary Care Med, Sungai Buloh, Selangor, Malaysia.
RP Ng, DLC (corresponding author), Univ Malaysia Sarawak, Fac Med & Hlth Sci, Dept Med, Sarawak, Malaysia.; Tan, SB (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia.
EM diananglehching@gmail.com; pramudita_1@hotmail.com
OI Ibrahim, Muhammad Amin/0000-0001-8336-8510
CR Al Ahdab S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10353-3
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Andrade C, 2020, INDIAN J PSYCHOL MED, V42, P478, DOI 10.1177/0253717620946111
   [Anonymous], 2021, NEW STRAITS TIMES CO
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Blue C, 2021, FACTORIES OPEN MCO D
   Bonny-Noach H, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00484-8
   Centers for Disease Control and Prevention, 2021, SCI BRIEF SARS COV 2
   Charan J, 2013, INDIAN J PSYCHOL MED, V35, P121, DOI 10.4103/0253-7176.116232
   Cohen J., 1988, STAT POWER ANAL BEHA
   Cushing E, 2021, LATE STAGE PANDEMIC
   de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Gao HM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09961-2
   Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912
   Good BJ, 1994, MED RATIONALITY EXPE
   Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918
   Halim DA, 2020, ASIA-PAC J PUBLIC HE, V32, P363, DOI 10.1177/1010539520940933
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   International Labours Organisation, 2020, SOCIOECONOMIC IMPACT
   Jalli N., 2020, LACK INTERNET ACCESS
   Lachman ME, 2015, INT J BEHAV DEV, V39, P20, DOI 10.1177/0165025414533223
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   Lee M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10285-y
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Masoud AT, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043971
   Ministry of Health Malaysia, 2021, CURR SIT COVID 19 PA
   National Recovery Plan, 2021, GUID MAL COV 19 PAND
   Organisation WH, 2020, NAMING CORONAVIRUS D
   Pawlowski B, 2008, EVOL PSYCHOL-US, V6, P29, DOI 10.1177/147470490800600104
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   Rahman AA, 2020, VULNERABILITY JOBS C
   Shah AUM, 2020, INT J INFECT DIS, V97, P108, DOI 10.1016/j.ijid.2020.05.093
   Sim BLH, 2020, LANCET REG HEALTH-W, V4, DOI 10.1016/j.lanwpc.2020.100055
   Singh J, 2021, NAT MED, V27, P1131, DOI 10.1038/s41591-021-01397-4
   Skinner CS, 2015, HLTH BEHAV THEORY RE, P75
   Srichan Peeradone, 2020, WHO South East Asia J Public Health, V9, P118, DOI 10.4103/2224-3151.294305
   Sulaiman NFC, 2020, DATA BRIEF, V28, DOI 10.1016/j.dib.2019.104910
   Tan C., 2020, Journal of Epidemiology and Public Health, V5, P477, DOI 10.26911/jepublichealth.2020.05.04.10
   Tang KHD, 2022, J PUBLIC HEALTH-HEID, V30, P583, DOI 10.1007/s10389-020-01316-w
   Thomas PA, 2017, INNOV AGING, V1, DOI 10.1093/geroni/igx025
   Umair S, 2021, POSTGRAD MED J, V97, P130, DOI 10.1136/postgradmedj-2020-138079
   Wilder-Smith A, 2021, TROP DIS TRAVEL MED, V7, DOI 10.1186/s40794-020-00129-9
   Wong CL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217878
   World Health Organisation, 2020, PAND FAT REINV PUBL
   World Health Organisation, 2020, STAT 2 M INT HLTH RE
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Worldometers, 2021, COVID 19 COR PAND
   Xiang NJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-34
   Xu H, 2020, J MED INTERNET RES, V22, DOI 10.2196/21372
   Yoder PS, 1997, MED ANTHROPOL Q, V11, P131, DOI 10.1525/maq.1997.11.2.131
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 54
TC 0
Z9 0
U1 2
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2022
VL 15
BP 389
EP 401
DI 10.2147/RMHP.S349798
PG 13
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZP7RX
UT WOS:000766618600002
PM 35283653
OA Green Published, Green Accepted
DA 2022-04-20
ER

PT C
AU Dimitrov, D
   Baran, E
   Fafalios, P
   Yu, R
   Zhu, XF
   Zloch, M
   Dietze, S
AF Dimitrov, Dimitar
   Baran, Erdal
   Fafalios, Pavlos
   Yu, Ran
   Zhu, Xiaofei
   Zloch, Matthaus
   Dietze, Stefan
GP ASSOC COMP MACHINERY
TI TweetsCOV19-A Knowledge Base of Semantically Annotated Tweets about the
   COVID-19 Pandemic
SO CIKM '20: PROCEEDINGS OF THE 29TH ACM INTERNATIONAL CONFERENCE ON
   INFORMATION & KNOWLEDGE MANAGEMENT
LA English
DT Proceedings Paper
CT 29th ACM International Conference on Information and Knowledge
   Management (CIKM)
CY OCT 19-23, 2020
CL ELECTR NETWORK
SP Assoc Comp Machinery, ACM SIGIR, ACM SIGWEB
DE Twitter; RDF; Entity Linking; Sentiment Analysis; Social Media Archives;
   COVID-19; Coronavirus
AB Publicly available social media archives facilitate research in the social sciences and provide corpora for training and testing a wide range of machine learning and natural language processing methods. With respect to the recent outbreak of the Coronavirus disease 2019 (COVID-19), online discourse on Twitter reflects public opinion and perception related to the pandemic itself as well as mitigating measures and their societal impact. Understanding such discourse, its evolution, and interdependencies with real-world events or (mis)information can foster valuable insights. On the other hand, such corpora are crucial facilitators for computational methods addressing tasks such as sentiment analysis, event detection, or entity recognition. However, obtaining, archiving, and semantically annotating large amounts of tweets is costly. In this paper, we describe TweetsCOV19, a publicly available knowledge base of currently more than 8 million tweets, spanning October 2019 - April 2020. Metadata about the tweets as well as extracted entities, hashtags, user mentions, sentiments, and URLs are exposed using established RDF/S vocabularies, providing an unprecedented knowledge base for a range of knowledge discovery tasks. Next to a description of the dataset and its extraction and annotation process, we present an initial analysis and use cases of the corpus.
C1 [Dimitrov, Dimitar; Baran, Erdal; Yu, Ran; Zloch, Matthaus; Dietze, Stefan] GESIS Leibniz Inst Social Sci, Cologne, Germany.
   [Fafalios, Pavlos] FORTH ICS, Inst Comp Sci, Iraklion, Greece.
   [Zhu, Xiaofei] Chongqing Univ Technol, Chongqing, Peoples R China.
   [Dietze, Stefan] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany.
   [Dietze, Stefan] L3S Res Ctr, Hannover, Germany.
RP Dimitrov, D (corresponding author), GESIS Leibniz Inst Social Sci, Cologne, Germany.
EM dimitar.dimitrov@gesis.org; erdal.baran@gesis.org;
   fafalios@ics.forth.gr; ran.yu@gesis.org; zxf@cqut.edu.cn;
   matthaeus.zloch@gesis.org; stefan.dietze@gesis.org
CR Alqurashi S, 2020, ARXIV PREPRINT ARXIV
   Blanco R, 2015, WSDM'15: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P179, DOI 10.1145/2684822.2685317
   Breslin John G, 2006, INT J WEB BASED COMM, V2
   Bruns A, 2016, PROCEEDINGS OF THE 2016 ACM WEB SCIENCE CONFERENCE (WEBSCI'16), P183, DOI 10.1145/2908131.2908174
   Chakraborty Abhijnan, 2017, WHO MAKES TRENDS UND
   Chen Emily, 2020, JMIR Public Health Surveill, V6, pe19273, DOI 10.2196/19273
   Chung JE, 2017, COMPUT HUM BEHAV, V74, P112, DOI 10.1016/j.chb.2017.04.025
   Fafalios Pavlos, 2018, The Semantic Web. 15th International Conference, ESWC 2018. Proceedings: LNCS 10843, P177, DOI 10.1007/978-3-319-93417-4_12
   Fafalios P, 2015, INT J ARTIF INTELL T, V24, DOI 10.1142/S0218213015400126
   Sanchez-Rada JF, 2016, INFORM PROCESS MANAG, V52, P99, DOI 10.1016/j.ipm.2015.03.007
   Gao Z., 2020, ARXIV200408145
   Gasquet Malo, 2019, ISWC 2019 SAT TRACKS
   Guha RV, 2016, COMMUN ACM, V59, P44, DOI 10.1145/2844544
   Gupta M, 2012, P AM SOC INFORM SCI, V49, P1, DOI DOI 10.1002/meet.14504901207
   Haouari F, 2020, ARXIV200405861
   Kim E, 2014, COMPUT HUM BEHAV, V37, P18, DOI 10.1016/j.chb.2014.04.020
   Kogan M, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P981, DOI 10.1145/2675133.2675218
   Lumezanu Cristian, 2012, BIAS MEASURING TWEET
   Mittal A., 2019, 7 INT C COMP COMM MA, P91
   Muller MM, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00081
   Popat K, 2017, WWW'17 COMPANION: PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P1003, DOI 10.1145/3041021.3055133
   Qazi Umair, 2020, ACM SIGSPATIAL SPECI, V12, P1
   Sedhai Surendra, 2015, 38 INT C RES DEV INF, P223
   Stieglitz S., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P3500, DOI 10.1109/HICSS.2012.476
   Sun YZ, 2020, INT CONF WIRE COMMUN, P19, DOI 10.1109/WCSP49889.2020.9299848
   Tchechmedjiev A., 2019, 18 INT SEM WEB C SPR, P309
   Thelwall M, 2012, J AM SOC INF SCI TEC, V63, P163, DOI 10.1002/asi.21662
   Tschiatschek S, 2018, COMPANION PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE 2018 (WWW 2018), P517, DOI 10.1145/3184558.3188722
   Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559
NR 29
TC 7
Z9 7
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY, UNITED STATES
BN 978-1-4503-6859-9
PY 2020
BP 2991
EP 2998
DI 10.1145/3340531.3412765
PG 8
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS6LW
UT WOS:000749561302165
OA Green Submitted
DA 2022-04-20
ER

PT J
AU Ferreira, TTD
   de Carvalho, RF
AF da Silva Ferreira, Thiago Tavares
   de Carvalho, Roberto Francisco
TI Judicialization of the right to education: democratic management in
   times of COVID-19
SO REVISTA BRASILEIRA DE EDUCACAO DO CAMPO-BRAZILIAN JOURNAL OF RURAL
   EDUCATION
LA Portuguese
DT Article
DE Judicialization; COVID-19; Right to Education
AB The United Nations Educational, Scientific and Cultural Organization - Unesco, revealed that the pandemic caused by COVID-19 affected more than 90% of the world's students due to the temporary closure of schools (Unesco, 2020). The Federal Constitution of 1988 guarantees the right of all to quality education and recognizes it as a subjective public right, as established by articles 205, 206 and its items VI and VII, both of CF / 88 (Brazil, 1988). The present article, of a documental theoretical nature, presents a qualitative approach and uses the Gramscian theory (Gramsci, 1982) to analyze the democratic educational management, as well as the quality standard of education (Cabral, 2008), which made it possible to verify the influence of capitalist ideology in the Brazilian educational process. Due to the citizens' lack of knowledge about the judicial system (Sadek, 2010) this study aims to discuss the right to education and present the judicialization of that right as a tool of democratic management (Ferreira, 2008) considering the historical context that comprises the decade of 1980 to 2020, in which the guarantee of this right has been increasingly undermined due to the crisis caused by the pandemic of COVID-19.
C1 [da Silva Ferreira, Thiago Tavares] Tavares Advocacia, Ave Murilo Braga 1384, Porto Nacl, TO, Brazil.
   [de Carvalho, Roberto Francisco] Univ Fed Tocantins UFT, Palmas, Brazil.
RP Ferreira, TTD (corresponding author), Tavares Advocacia, Ave Murilo Braga 1384, Porto Nacl, TO, Brazil.
EM ttavares.jus@gmail.com
RI de Carvalho, Roberto Francisco/AAF-3885-2021
OI de Carvalho, Roberto Francisco/0000-0001-7278-181X
CR Arantes R. B., 2004, SISTEMA POLITICO BRA, P79
   Bastos J. B., 1999, GESTAO DEMOCRATICA
   Batista J. B., 1999, REV CIENCIAS LETRAS, V26, P231
   Biesta G., 2013, BEAUTIFUL RISK ED
   Brasil, 1988, CONSTITUICAO REPUBLI
   Cabral K. M., 2008, THESIS
   Carvalho R. N., 2011, THESIS
   Casagrande C., 2008, MINISTERIO PUBLICO J
   Coutinho C. N., 2007, GRAMSCI ESTUDO SEU P
   COUTINHO Carlos Nelson, 1999, GRAMSCI ESTUDO SEU P
   Cury C. R. A., 2010, EDUCACAO FEDERALISMO, P149
   Dourado L. F., 2001, GESTAO DEMOCRATICA E, P77
   Ferreira L. A. Miguel, 2008, ESTATUTO CRIANCA ADO
   Ferreiro E., 1994, LECT Y VIDA, V3, P5
   Frigotto G., 2009, CRISE ESCOLA POLITIC, P65
   Gadotti M., 1997, GESTAO DEMOCRATICA Q
   GADOTTI Moacir, 2001, CONCEPCAO DIALETICA, V12
   Gaulejac V., 2007, GESTAO COMO DOENCA S
   GRAMSCI A., 1982, INTELECTUAIS ORG CUL, V4
   Gramsci A., 2007, CADERNOS CARCERE V 3
   GRAMSCI Antonio, 1978, MAQUIAVEL POLITICA E, V3
   Habermas J., 2009, TECNICA CIENCIA COMO
   LAGARES Rosilene, 2014, REV INTERDISCIPLINAR, V1, P95, DOI [10.20873/uft.2359-3652.2014v1n1p95, DOI 10.20873/UFT.2359-3652.2014V1N1P95]
   Libaneo J. C., 2003, EDUCACAO ESCOLAR POL
   Motta L. E., 2007, ACESSO JUSTICA CIDAD
   Muniz R. M. F., 2002, DIREITO EDUCACAO
   NEVES M., 2007, CONSTITUCIONALIZACAO
   Oliveira Carlindo Rodrigues de, 2011, Serv. Soc. Soc., P5
   Oliveira Rafaela Reis Azevedo de, 2019, Soc. estado., V34, P185, DOI 10.1590/s0102-6992-201934010008
   Rodrigues R. V., 2017, REV BRASILEIRA INICI, V4, P128
   Croda JHR, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/S1679-49742020000100021, 10.5123/s1679-49742020000100021]
   Sadek M. T., 2010, SISTEMA JUSTICA, DOI [10.7476/9788579820397, DOI 10.7476/9788579820397]
   Santos M. A. L., 2006, MODELOS GESTAO QUALI
   SAVIANI Dermeval, 1999, ESCOLA DEMOCRACIA TE, V32
   Schumpeter J., 1984, CAPITALISMO SOCIALIS
   Silva MLN, 2018, THESIS
   SILVEIRA A. A. D., 2008, RBPAE, V24, P537
   Silveira Adriana Dragone, 2013, Educ. Soc., V34, P371, DOI 10.1590/S0101-73302013000200003
   SOUSA SANTOS B., 2020, CRUEL PEDAGOGIA VIRU
   Unesco, 2020, COM FUT ED UN AP PLA
   Vianna I. 0. A., 1986, PLANEJAMENTO PARTICI
   Vieira K. M., 2008, MONOGRAFIA CONCLUSAO
   Vieira L. M. F., 2007, AN 30 REUN AN ANP CA
   VIEIRA Sofia Lerche, 2007, RBPAE, V23, P53
   Voirol Olivier, 2012, Novos estud. - CEBRAP, P81, DOI 10.1590/S0101-33002012000200007
   Zeichner K., 2002, PROFESSORAPESQUISADO, P35
NR 46
TC 0
Z9 0
U1 2
U2 3
PU UNIV FEDERAL TOCANTINS, CAMPUS TOCANTINOPOLIS
PI TOCANTINOPOLIS
PA DEPT EDUC CAMPO A, NOSSA SENHORA FATIMA, N 1588, TOCANTINOPOLIS,
   CEP77900-000, BRAZIL
SN 2525-4863
J9 REV BRAS EDUC CAMPO
JI Rev. Bras. Educ. Campo-Braz. J. Rural Educ.
PY 2020
VL 5
AR e10665
DI 10.20873/uft.rbec.e10665
PG 19
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA PZ5QM
UT WOS:000612794900001
OA gold
DA 2022-04-20
ER

PT J
AU Xu, H
   Gan, Y
   Zheng, DK
   Wu, B
   Zhu, X
   Xu, C
   Liu, CL
   Tao, Z
   Hu, YY
   Chen, M
   Li, MJ
   Lu, ZX
   Chen, J
AF Xu, Hong
   Gan, Yong
   Zheng, Daikun
   Wu, Bo
   Zhu, Xian
   Xu, Chang
   Liu, Chenglu
   Tao, Zhou
   Hu, Yaoyue
   Chen, Min
   Li, Mingjing
   Lu, Zuxun
   Chen, Jack
TI Relationship Between COVID-19 Infection and Risk Perception, Knowledge,
   Attitude, and Four Nonpharmaceutical Interventions During the Late
   Period of the COVID-19 Epidemic in China: Online Cross-Sectional Survey
   of 8158 Adults
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; nonpharmaceutical personal interventions; NPI; public health;
   mask wearing; intervention; infection; risk perception; knowledge;
   attitude; online survey; China
ID OUTBREAK
AB Background: So far, there have been no published population studies on the relationship between a COVID-19 infection and public risk perception, information source, knowledge, attitude, and behaviors during the COVID-19 outbreak in China.
   Objective: This study aims to understand the relationships between COVID-19 infection; four personal nonpharmaceutical interventions (NPIs; handwashing, proper coughing habits, social distancing, and mask wearing); and public risk perception, knowledge, attitude, and other social demographic variables.
   Methods: An online survey of 8158 Chinese adults between February 22 and March 5, 2020, was conducted. Bivariate associations between categorical variables were examined using Fisher exact test. We also explored the determinants of four NPIs as well as their association with COVID-19 infection using logistic regression.
   Results: Of 8158 adults included, 57 (0.73%) were infected with COVID-19. The overwhelming majority of respondents showed a positive attitude (n=8094, 99.2%), positive risk perception (n=8146, 99.9%), and high knowledge levels that were among the strongest predictors of the four adopted NPIs (handwashing: n=7895, 96.8%; proper coughing: 5997/6444, 93.1%; social distancing: n=7104/8158, 87.1%; and mask wearing: 5011/5120, 97.9%). There was an increased risk of COVID-19 infection for those who did not wash their hands (2.28% vs 0.65%; risk ratio [RR] 3.53, 95% CI 1.53-8.15; P=.009), did not practice proper coughing (1.79% vs 0.73%; RR 2.44, 95% CI 1.15-5.15; P=.03), did not practice social distancing (1.52% vs 0.58%; RR 2.63, 95% CI 1.48-4.67; P=.002), and did not wear a mask (7.41% vs 0.6%; RR 12.38, 95% CI 5.81-26.36; P<.001). For those who did practice all other three NPIs, wearing a mask was associated with a significantly reduced risk of infection compared to those who did not wear a mask (0.6% vs 16.7%; P=.04). Similarly, for those who did not practice all or part of the other three NPIs, wearing a mask was also associated with a significantly reduced risk of infection. In a penalized logistic regression model including all four NPIs, wearing a mask was the only significant predictor of COVID-19 infection among the four NPIs (odds ratio 7.20, 95% CI 2.24-23.11; P<.001).
   Conclusions: We found high levels of risk perception, positive attitude, desirable knowledge, as well as a high level of adopting the four NPIs. The relevant knowledge, risk perception, and attitude were strong predictors of adapting the four NPIs. Mask wearing, among the four personal NPIs, was the most effective protective measure against COVID-19 infection, with added preventive effect among those who practiced all or part of the other three NPIs.
C1 [Xu, Hong; Gan, Yong; Lu, Zuxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, 13 Hangkong Rd, Wuhai 430030, Hubei, Peoples R China.
   [Xu, Hong; Zhu, Xian; Xu, Chang; Liu, Chenglu; Tao, Zhou; Hu, Yaoyue; Chen, Min; Li, Mingjing; Chen, Jack] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China.
   [Zheng, Daikun] Chongqing Three Gorges Med Coll, Chongqing, Peoples R China.
   [Wu, Bo] Wanzhou Dist Ctr Dis Control & Prevent, Chongqing, Peoples R China.
   [Chen, Jack] Ingham Inst, Sydney, NSW, Australia.
   [Chen, Jack] Univ New South Wales, Sydney, NSW, Australia.
RP Lu, ZX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, 13 Hangkong Rd, Wuhai 430030, Hubei, Peoples R China.
EM zuxunlu@yahoo.com; jackchen@unsw.edu.au
OI Zheng, Daikun/0000-0002-6414-2548; Wu, Bo/0000-0002-7371-3285; tao,
   zhou/0000-0003-0323-9917; Xu, Hong/0000-0001-5751-9784; Hu,
   Yaoyue/0000-0001-6517-1503; Gan, Yong/0000-0002-7330-2937
FU School of Public Health and Management of Chongqing Medical University;
   Science and Technology Association of Chongqing Municipal Government
FX We would like to acknowledge the School of Public Health and Management
   of Chongqing Medical University and The Science and Technology
   Association of Chongqing Municipal Government for the financial support
   of this research project. The funding bodies played no roles in the
   design, conduct, and analysis of the study as well as in the publishing
   of the study results.
CR Abdullah ASM, 2003, EMERG INFECT DIS, V9, P1042
   [Anonymous], 2020, COVID 19 DASHB CTR S
   Baguelin, 2020, REPORT 9 IMPACT NONP, P1, DOI DOI 10.25561/77482
   Bradsher Keith, 2020, NY TIMES
   Centers for Disease Control and Prevention, 2020, NONPH INT NPIS
   Centers for Disease Control and Prevention, 2020, REC REG US CLOTH FAC
   FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   Javid B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1442
   Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2
   Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630
   Macintyre C Raina, 2010, Evid Based Med, V15, P48, DOI 10.1136/ebm1043
   Mokhtar F, 2020, SINGAPORE U TURNS WE
   Rubin Eric J, 2020, N Engl J Med, V382, pe30, DOI 10.1056/NEJMe2005759
   Rubin Eric J, 2020, N Engl J Med, V382, pe25, DOI 10.1056/NEJMe2004856
   Spinney Laura., 2020, GUARDIAN
   Tay JK, 2020, JAMA OTOLARYNGOL, V146, P517, DOI 10.1001/jamaoto.2020.0764
   van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618
   WHO, 2020, WHO DIR GEN OP REM M
   World Health Organisation W, 2020, COR DIS COVID 19 ADV
   World Health Organization, 2020, BOD MASS IND BMI
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 22
TC 19
Z9 18
U1 3
U2 9
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD NOV 13
PY 2020
VL 22
IS 11
AR e21372
DI 10.2196/21372
PG 19
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Medical Informatics
GA OR1YC
UT WOS:000589270800003
PM 33108317
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Nazar, W
   Leszkowicz, J
   Pienkowska, A
   Brzezinski, M
   Szlagatys-Sidorkiewicz, A
   Plata-Nazar, K
AF Nazar, Wojciech
   Leszkowicz, Julia
   Pienkowska, Agata
   Brzezinski, Michal
   Szlagatys-Sidorkiewicz, Agnieszka
   Plata-Nazar, Katarzyna
TI Before-and-after online community survey on knowledge and perception of
   COVID-19 pandemic
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Online survey; COVID-19; Medical personnel; Before-and-after study
ID HEALTH-CARE WORKERS; PSYCHOLOGICAL IMPACT; RESIDENTS; STUDENTS;
   EXPOSURE; OUTBREAK; RISK
AB BackgroundCOVID-19 pandemic impacts many communities worldwide. In this study the Poles' knowledge about COVID-19 as well as people's behaviours, attitudes and fears during the pandemic were assessed. Changes in these between the outset of the pandemic and the imposition of the strictest lockdown measures in Poland were investigated.MethodsPhysicians, nurses, students of medicine-oriented faculties, non-medical professionals, students of non-medicine-oriented faculties and secondary school students were surveyed by an anonymous online questionnaire two times: at the onset of the pandemic and in the second week of the strictest lockdown. Statistical analyses were performed using non-parametric tests - Pearson Chi Square, Kruskal-Wallis tests.ResultsIn total 2618 responses were collected. At the beginning people knew that the respiratory system was attacked (97.9%); correctly identified the major symptoms of COVID-19 (95.0%) and ways to prevent infection: hand washing (99.8%), covering mouth (85.9%) and the need to call sanitary-epidemiological services if one experienced COVID-19-like symptoms (92.1%).The biggest changes between the first and second phase of the study concerned behaviours: more people wearing facial masks (+37.5%) and staying at home (+66.1%). Respondents in the second wave of the survey were also more scared of the pandemic (+19.6%), economic crisis (+64.1%), and worried about their families (+26.5%). However, they were less afraid of the quarantine (lockdown) (-18.2%). Nurses and physicians were the most worried groups.ConclusionsThe study showed that even at the outset of the pandemic Polish population had a good initial knowledge about symptoms, transmission, and preventive behaviours regarding COVID-19. People revealed more short-term concerns, such as the worries about coping with quarantine and isolation. After a month, the knowledge and the concerns among the respondents changed. A shift towards long-term pandemic management issues was observed. Respondents reported to experience more fears concerning the pandemic in general, as well as economic and healthcare crises. Medical professionals reported higher level of fear of the pandemic than other groups included in this study. This study uses before-and-after approach which highlights the changes in people's knowledge and perception of the COVID-19 pandemic during the pandemic's progression.
C1 [Nazar, Wojciech; Leszkowicz, Julia; Pienkowska, Agata] Med Univ Gdask, Marii Sklodowskiej Curie 3a, PL-80210 Gdansk, Poland.
   [Brzezinski, Michal; Szlagatys-Sidorkiewicz, Agnieszka; Plata-Nazar, Katarzyna] Med Univ Gdask, Dept Pediat Gastroenterol Allergol & Nutr, Nowe Ogrody 1, PL-80803 Gdansk, Poland.
RP Nazar, W (corresponding author), Med Univ Gdask, Marii Sklodowskiej Curie 3a, PL-80210 Gdansk, Poland.
EM wojciech.nazar@gumed.edu.pl
RI Nazar, Wojciech/AAT-4640-2021; Szlagatys-Sidorkiewicz,
   Agnieszka/AAH-1552-2019
OI Nazar, Wojciech/0000-0002-8448-0800; Szlagatys-Sidorkiewicz,
   Agnieszka/0000-0002-5992-4414; Brzezinski, Michal/0000-0002-3426-507X
CR Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chen Yan, 2020, Zhonghua Yufang Yixue Zazhi, V54, P367, DOI [10.3760/cma.j.cn112150-20200205-00069, 10.3760/cma.j.cn112150.20200205.00069]
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790
   Khan S, 2020, J MED VIROL, V92, P824, DOI 10.1002/jmv.25814
   Laborde D, 2020, SCIENCE, V369, P500, DOI 10.1126/science.abc4765
   Li ZY, 2020, BRAIN BEHAV IMMUN, V88, P916, DOI 10.1016/j.bbi.2020.03.007
   McDermott John., 2020, COVID19 GLOBAL FOOD, P78
   Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848
   Newby JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236562
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Temsah MH, 2020, J INFECT PUBLIC HEAL, V13, P877, DOI [10.1016/j.jiph.2020.05.021, 10.1016/j.ijph.2020.05.021]
   Varshney M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233874
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   World Health Organization, Q A COR COVID 19
   World Health Organization, 5 WHO
   World Health Organization, 44 WHO
   Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504
   Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921
   Zhai YS, 2020, LANCET PSYCHIAT, V7, pE22, DOI 10.1016/S2215-0366(20)30089-4
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 26
TC 4
Z9 4
U1 5
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD DEC 19
PY 2020
VL 20
IS 1
AR 861
DI 10.1186/s12879-020-05602-6
PG 14
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA PA1JK
UT WOS:000595374900003
PM 33213394
OA Green Submitted, gold, Green Published
DA 2022-04-20
ER

PT J
AU Kanga, S
   Sudhanshu
   Meraj, G
   Farooq, M
   Nathawat, MS
   Singh, SK
AF Kanga, Shruti
   Sudhanshu
   Meraj, Gowhar
   Farooq, Majid
   Nathawat, M. S.
   Singh, Suraj Kumar
TI Reporting the management of COVID-19 threat in India using remote
   sensing and GIS based approach
SO GEOCARTO INTERNATIONAL
LA English
DT Article; Early Access
DE COVID-19; remote sensing; GIS; risk zonation; proximity analysis;
   network analysis
ID DISEASES
AB Worldwide COVID-19 is playing havoc, and in India, the situation is similarly bleak. Due to the higher population density and weak health sector, the Indian government's approach to curb the spread of this deadly virus, has been the imposition of tougher lockdowns. Perhaps, isolating and quarantining the infected and asymptomatic people is the only strategy that seems to work right now. Local administrations in India have categorized areas in different risk zones to deal with this pandemic effectively. Here, we report a COVID -19 management strategy of Ramganj, Jaipur India, using an integrated satellite remote sensing, geographic information system (GIS), and local knowledge-based approach to effectively tackle the contagion of this disease. We spatially defined various risk zones and the activities that can be allowed in them, in consultation with the local authorities. The study shall serve as a replica study for managing COVID-19 in India or elsewhere.
C1 [Kanga, Shruti; Sudhanshu; Meraj, Gowhar; Farooq, Majid] Suresh Gyan Vihar Univ, Ctr Climate Change & Water Res C3WR, Jaipur, Rajasthan, India.
   [Singh, Suraj Kumar] Suresh Gyan Vihar Univ, Ctr Sustainable Dev, Jaipur, Rajasthan, India.
   [Meraj, Gowhar; Farooq, Majid] Govt Jammu & Kashmir, Dept Ecol Environm & Remote Sensing, Kashmir, India.
   [Nathawat, M. S.] Indira Gandhi Natl Open Univ IGNOU, Dept Geog, New Delhi, India.
RP Singh, SK (corresponding author), Suresh Gyan Vihar Univ, Ctr Sustainable Dev, Jaipur, Rajasthan, India.
EM suraj.kumar@mygyanvihar.com
RI KANGA, SHRUTI/AAV-4586-2021; singh, suraj/E-3656-2019; Meraj,
   Gowhar/G-5544-2015
OI KANGA, SHRUTI/0000-0003-0275-5493; singh, suraj/0000-0003-0743-4963;
   Meraj, Gowhar/0000-0003-2913-9199; FAROOQ, MAJID/0000-0002-7813-3474;
   Singh, Suraj/0000-0002-9420-2804; Nathawat, Mahendra
   Singh/0000-0003-1516-3112
FU Suresh Gyan Vihar University Jaipur
FX We are thankful to Suresh Gyan Vihar University Jaipur, for providing
   financial assistance in conducting this research. We are also grateful
   to Health, Municipal and other agencies of the Jaipur city for giving
   information and necessary help in formulating the management strategy to
   curb COVID-19 in Ramganj area of Jaipur. The authors further express
   their gratefulness to the two anonymous reviewers for their timely
   valuable comments and suggestions on the earlier version of the
   manuscript that significantly improved its content and structure.
CR Ali SA, 2019, MODEL EARTH SYST ENV, V5, P1135, DOI 10.1007/s40808-019-00586-y
   British Broadcasting Service (BBC), 2020, BRIT BROADCASTING SE
   DESA U., 2019, WORLD POP PROSP 2019
   Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210
   Farooq M, 2012, INT J REMOTE SENS GE, V2, P16
   Gettleman J., 2020, NY TIMES
   Haile G, 2019, MODEL EARTH SYST ENV, V5, P353, DOI 10.1007/s40808-018-0537-7
   Kickbusch I., 2012, NEGOTIATING NAVIGATI, P161, DOI DOI 10.1142/9789814368049_0008
   Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Prabhakaran D, 2016, CIRCULATION, V133, P1605, DOI 10.1161/CIRCULATIONAHA.114.008729
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   WHO, 2019, WHOMERSIPC151
   WHO, 2020, 27 WHO
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
NR 15
TC 9
Z9 9
U1 7
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1010-6049
EI 1752-0762
J9 GEOCARTO INT
JI Geocarto Int.
DI 10.1080/10106049.2020.1778106
EA JUN 2020
PG 8
WC Environmental Sciences; Geosciences, Multidisciplinary; Remote Sensing;
   Imaging Science & Photographic Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Geology; Remote Sensing; Imaging
   Science & Photographic Technology
GA MG1ZF
UT WOS:000545830100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Galluccio, F
   Ergonenc, T
   Martos, AG
   Allam, AE
   Perez-Herrero, M
   Aguilar, R
   Emmi, G
   Spinicci, M
   Juan, IT
   Fajardo-Perez, M
AF Galluccio, Felice
   Ergonenc, Tolga
   Garcia Martos, Alvaro
   Allam, Abdallah El-Sayed
   Perez-Herrero, Maria
   Aguilar, Ricardo
   Emmi, Giacomo
   Spinicci, Michele
   Terrancle Juan, Ignacio
   Fajardo-Perez, Mario
TI Treatment algorithm for COVID-19: a multidisciplinary point of view
SO CLINICAL RHEUMATOLOGY
LA English
DT Review
DE Algorithm; COVID-19; Management; Sars-CoV-2
ID EBOLA-VIRUS DISEASE; CONVALESCENT PLASMA; HEMOPHAGOCYTIC
   LYMPHOHISTIOCYTOSIS; REDUCED MORTALITY; PNEUMONIA; EFFICACY
AB The novel coronavirus (Sars-CoV-2) pandemic has spread rapidly, from December to the end of March, to 185 countries, and there have been over 3,000,000 cases identified and over 200,000 deaths. For a proportion of hospitalized patients, death can occur within a few days, mainly for adult respiratory distress syndrome or multi-organ dysfunction syndrome. In these patients, clinical signs and symptoms, as well as laboratory abnormalities, suggest a cytokine storm syndrome in response to the viral infection. No current targeted treatment is yet available for COVID-19, an unknown disease up to 2 months ago, which challenges doctors and researchers to find new drugs or reallocate other treatments for these patients. Since the beginning of the COVID-19 outbreak, a growing body of information on diagnostic and therapeutic strategies has emerged, mainly based on preliminary experience on retrospective studies or small case series. Antivirals, antimalarials, corticosteroids, biotechnological and small molecules, convalescent plasma and anticoagulants are among the drugs proposed for the treatment or in tested for COVID-19. Given the complexity of this new condition, a multidisciplinary management seems to be the best approach. Sharing and integrating knowledge between specialists, to evaluate the correct timing and setting of every treatment, could greatly benefit our patients. We reviewed the literature, combining it with our experiences and our specialist knowledge, to propose a management algorithm, correlating the clinical features with laboratory and imaging findings to establish the right timing for each treatment.
C1 [Galluccio, Felice] Univ Florence, Dept Expt & Clin Med, Div Rheumatol, Florence, Italy.
   [Ergonenc, Tolga] Sakarya Univ Educ & Res Hosp, Dept Anesthesia & Reanimat, Sakarya, Turkey.
   [Garcia Martos, Alvaro] Hosp Univ Tajo, Div Rheumatol, Madrid, Spain.
   [Allam, Abdallah El-Sayed] Tanta Univ, Tanta Univ Hosp, Dept Phys Med Rheumatol & Rehabil, Tanta 31527, Egypt.
   [Allam, Abdallah El-Sayed] Tanta Univ, Fac Med, Tanta 31527, Egypt.
   [Perez-Herrero, Maria] Hosp Clin Univ, Dept Anaesthesia & Reanimat, Valladolid, Spain.
   [Aguilar, Ricardo] Univ Costa Rica, Natl Ctr Rehabil Social Secur, Anaesthesia & Recovery Dept, San Jose 20603, Costa Rica.
   [Emmi, Giacomo; Spinicci, Michele] Univ Florence, Dept Expt & Clin Med, Florence, Italy.
   [Terrancle Juan, Ignacio] Hosp Univ Tajo, Dept Internal Med, Div Infect Dis, Madrid, Spain.
   [Fajardo-Perez, Mario] Hosp Univ Mostoles, Dept Anesthesia & Reanimat, Madrid, Spain.
RP Galluccio, F (corresponding author), Univ Florence, Dept Expt & Clin Med, Div Rheumatol, Florence, Italy.
EM felicegalluccio@gmail.com
RI Spinicci, MIchele/AAC-6187-2022; Galluccio, Felice/AAL-9481-2020;
   ERGÖNENÇ, Tolga/E-9868-2016
OI Galluccio, Felice/0000-0001-7485-471X; ERGÖNENÇ,
   Tolga/0000-0002-4325-695X; Emmi, Giacomo/0000-0001-9575-8321; SPINICCI,
   MICHELE/0000-0002-5377-7118
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bergsten E, 2017, BLOOD, V130, P2728, DOI 10.1182/blood-2017-06-788349
   Brudno JN, 2019, BLOOD REV, V34, P45, DOI 10.1016/j.blre.2018.11.002
   Burnouf T, 2003, HAEMOPHILIA, V9, P24, DOI 10.1046/j.1365-2516.2003.00701.x
   Caly L, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104787
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Chan C, HONG KONG MED J, V9
   Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cunningham AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2818-6
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Eloseily EM, 2020, ARTHRITIS RHEUMATOL, V72, P326, DOI 10.1002/art.41103
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Golden EB, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.12.FOCUS14748
   Goldsmith SR, 2019, BLOOD ADV, V3, P4131, DOI 10.1182/bloodadvances.2019000898
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Han QM, 2020, INFLUENZA OTHER RESP, V14, P470, DOI 10.1111/irv.12735
   Hindson J, 2020, NAT REV GASTRO HEPAT, V17, P259, DOI 10.1038/s41575-020-0295-7
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Karakike E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00055
   Kraft CS, 2015, CLIN INFECT DIS, V61, P496, DOI 10.1093/cid/civ334
   Kupferschmidt K, 2020, SCIENCE, V367, P1412, DOI 10.1126/science.367.6485.1412
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lei C, 2020, CHIN J TUBERC RESP D
   Lillicrap D, 2020, J THROMB HAEMOST, V18, P786, DOI 10.1111/jth.14781
   Lin L, 2020, EMERG MICROBES INFEC, V9, P727, DOI 10.1080/22221751.2020.1746199
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939.2020.03.009, 10.3760/cma.j.issn.1001-0939.2020.0019]
   Nicastri E, 2020, INFECT DIS REP, V12, P3, DOI 10.4081/idr.2020.8543
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Pan YY, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05067-7
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Qu R, 2020, J MED VIROL, V92, P1533, DOI 10.1002/jmv.25767
   Ramos-Casals M, 2014, LANCET, V383, P1503, DOI 10.1016/S0140-6736(13)61048-X
   Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402
   Shang LH, 2020, LANCET, V395, P683, DOI 10.1016/S0140-6736(20)30361-5
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Simon DW, 2014, PEDIATR CRIT CARE ME, V15, P486, DOI 10.1097/PCC.0000000000000098
   Soldati G, 2020, J ULTRAS MED, V39, P1459, DOI 10.1002/jum.15284
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Vallurupalli M, 2019, BLOOD, V134, P1783, DOI 10.1182/blood.2019002289
   van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   WONG HYF, 2019, RADIOLOGY, DOI [10.1148/radiol.2020201160, DOI 10.1148/RADIOL.2020201160]
   Xu X., EFFECTIVE TREATMENT
   Yan D., 2020, EFFICACY HYDROXYCHLO, DOI 10.1101/2020.03.22.20040758
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359
NR 58
TC 24
Z9 25
U1 0
U2 5
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD JUL
PY 2020
VL 39
IS 7
BP 2077
EP 2084
DI 10.1007/s10067-020-05179-0
PG 8
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA LY1IL
UT WOS:000540275600010
PM 32472459
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Yuriditsky, E
   Horowitz, JM
   Nair, S
   Kaufman, BS
AF Yuriditsky, Eugene
   Horowitz, James M.
   Nair, Sunil
   Kaufman, Brian S.
TI Simulation-based uptraining improves provider comfort in the management
   of critically ill patients with COVID-19
SO JOURNAL OF CRITICAL CARE
LA English
DT Article
DE COVID-19; Simulation; Shock; Respiratory failure
AB Purpose: The COVID-19 surge required the deployment of large numbers of non-intensive care providers to assist in the management of the critically ill. Institutions took a variety of approaches to "uptraining" such providers though studies describing methods and effectiveness are lacking.
   Materials and methods: One hundred and seventy-five providers underwent a 3 h simulation-based session focused on management of shock, mechanical ventilation, acute respiratory distress syndrome, and critical care ultrasound. All participants were sent surveys to assess their comfort with various aspects of critical care following return to their usual work environments.
   Results: One hundred and eight providers of 175 (62%) completed the survey. Overall, 104/108 responders (96%) felt training either significantly or somewhat improved their knowledge in the management of ICU patients. Responders felt most comfortable in the management of hypoxemia in intubated patients and the management of ventilated patients with acute respiratory distress syndrome (93% strongly agree or agree, and 86% strongly agree or agree, respectively). Fewer responders felt more comfortable using focused echocardiography (70% strongly agree or agree) and lung ultrasonography in following progression of COVID-19 (76% strongly agree or agree).
   Conclusions: Simulation-based training improved provider comfort in the management of critically ill patients with COVID-19. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Yuriditsky, Eugene; Horowitz, James M.] NYU, Dept Med, Langone Med Ctr, Div Cardiol, 550 1St Ave, New York, NY 10016 USA.
   [Nair, Sunil; Kaufman, Brian S.] NYU, Dept Med, Langone Med Ctr, Div Pulm,Crit Care,Sleep Med, 550 1St Ave, New York, NY 10016 USA.
   [Kaufman, Brian S.] NYU, Dept Anesthesiol, Langone Med Ctr, New York, NY 10016 USA.
RP Yuriditsky, E (corresponding author), 530 First Ave Skirball 9R, New York, NY 10016 USA.
EM Eugene.Yuriditsky@nyulangone.org
OI Kaufman, Brian/0000-0002-4236-3374; Yuriditsky,
   Eugene/0000-0003-2263-9297
CR Abrahamson SD, 2006, CRIT CARE, V10, DOI 10.1186/cc3916
   Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575
   Cummings Matthew J, 2020, medRxiv, DOI 10.1101/2020.04.15.20067157
   Goh KJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02916-4
   Hasan Z, 2020, CHEST, V157, P1420, DOI 10.1016/j.chest.2020.03.027
   Li L, 2020, BMJ SIMUL TECHNOL EN, V6, P196, DOI 10.1136/bmjstel-2020-000609
   Moldovan C, 2016, AMM, V62, P27, DOI [10.1515/amma-2015-0105, DOI 10.1515/AMMA-2015-0105]
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775
   Society of Critical Care Medicine, 2020, FUNDAMENTAL CRITICAL
NR 10
TC 3
Z9 3
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0883-9441
EI 1557-8615
J9 J CRIT CARE
JI J. Crit. Care
PD FEB
PY 2021
VL 61
BP 14
EP 17
DI 10.1016/j.jcrc.2020.09.035
PG 4
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PI5IA
UT WOS:000601122700005
PM 33049487
OA Bronze, Green Published
DA 2022-04-20
ER

PT C
AU Lopez-Fresno, P
   Savolainen, T
   Miranda, S
AF Lopez-Fresno, Palmira
   Savolainen, Taina
   Miranda, Silvia
BE GarciaPerez, A
   Simkin, L
TI Trust Building for Integrative Trade Negotiations: Challenges posed by
   Covid-19
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE cross-cultural; culture; Covid-19; international trade; knowledge;
   negotiations; meetings; trust; virtual meetings
ID COMMUNICATION
AB This paper discusses and examines trust building in the remote-digital negotiations. More specifically, the paper focuses on international trade negotiations aimed at being integrative, and how the Covid-19 pandemic affected the way they have been conducted over the years, mainly relying in face-to-face meetings. Information exchange and knowledge sharing is essential part of negotiations, occurring in interactive processes between actors involved. Trust is a prerequisite for effective information exchange and knowledge sharing and creation. Trust creates openness, willingness to collaborate, and freedom to be productive, and is a foundation for integrative negotiations. Trust manifests in different ways, affecting time, intensity, process, and results of the overall negotiation process. Remote working and remote-digital meetings have become prevalent these days, especially due to the disruption caused by Covid-19. Remote communication necessarily carries inescapable restrictions compared to face-to-face encountering and discussion. Therefore, the technology mediated (TM) remote context highlights the meaning of trust, as interaction and collaboration emerge more restricted than in faceto-face contacts. This paper builds on previous research on integrative negotiations, role of trust, and meetings. By analysing and discussing the academic literature, the purpose of the paper is to provide theoretical views and insights for further research, and practical implications for negotiators and professionals in general. The exploratory research questions are: i) what challenges did the Covid-19 pandemic pose to international trade negotiations? ii) how do virtual-TM meetings may affect trust building for integrative negotiations? iii) how does country culture and technology mediate the impact of virtual meetings in trade negotiations? By responding to these research questions, the paper focuses on intangible factors that may contribute to trust building or trust destroying in virtual meetings and how they may affect information exchange, knowledge sharing and knowledge dynamics leading to successful integrative negotiations.
C1 [Lopez-Fresno, Palmira] Qual Funct Deployment Spain QfD Spain, Madrid, Spain.
   [Savolainen, Taina] Univ Eastern Finland, Business Sch, Joensuu, Finland.
   [Miranda, Silvia] Expert Int Trade, San Jose, Costa Rica.
RP Lopez-Fresno, P (corresponding author), Qual Funct Deployment Spain QfD Spain, Madrid, Spain.
EM correo@palmiralopezfresno.com; taina.savolainen@uef.fi;
   simirex@hotmail.es
CR Allen JosephA., 2015, CAMBRIDGE HDB M SCI, P3
   Bachmann R., 2010, ORG TRUST CULTURAL P, P87
   Burke CS, 2007, LEADERSHIP QUART, V18, P606, DOI 10.1016/j.leaqua.2007.09.006
   Cichomska K., 2015, CAMBRIDGE HDB M SCI, P663
   COHEN R, 1991, NEGOTIATING CULTURES
   Crump L, 2013, ELGAR ORIG REF, P387
   Fang XW, 2011, COMPUT SCI INF SYST, V8, P843, DOI 10.2298/CSIS100411031F
   Grosse C.U., 2002, BUSINESS COMMUNICATI, V65, P22
   Hall E.T., 1977, CULTURE
   Hofstede G.H., 2001, CULTURES CONSEQUENCE, V2
   Horan Anne Puidk, 2002, Work, V18, P3
   House R.J., 1998, J MANAGERIAL PSYCHOL, V13, P230, DOI DOI 10.1108/02683949810215048
   Jarvenpaa SL, 1999, ORGAN SCI, V10, P791, DOI 10.1287/orsc.10.6.791
   Kohler Tine., 2015, CAMBRIDGE HDB M SCI, P119
   Lewicki RJ, 2006, J MANAGE, V32, P991, DOI 10.1177/0149206306294405
   Lopez-Fresno Palmira, 2018, Electronic Journal of Knowledge Management, V16, P13
   Lopez-Fresno Palmira, 2014, Electronic Journal of Knowledge Management, V12, P137
   Lopez-Fresno P, 2014, REUNIONES VIRTUALES
   Lopez-Fresno P., 2017, ECKM
   Lopez-Fresno P., 2020, P 17 INT C INT CAP K
   Lopez-Fresno P, 2018, ESTUDIO EXPLORATORIO
   Lopez-Fresno P., 2020, FORUM CALIDAD, P34
   MCALLISTER DJ, 1995, ACAD MANAGE J, V38, P24, DOI 10.2307/256727
   Meinecke A. L., 2015, CAMBRIDGE HDB M SCI, P3
   Paul S, 2004, INFORM MANAGE-AMSTER, V41, P303, DOI 10.1016/S0378-7206(03)00076-4
   Rogelberg S. G., 2006, ENCY IND ORG PSYCHOL, P474
   Rogelberg SG, 2007, MIT SLOAN MANAGE REV, V48, P18
   Savolainen, 2014, J GLOBAL BUSINESS IS, V8, P45
   Savolainen T., 2011, AINEETON PAAOMA ORGA, P117
   Savolainen T., 2008, 12 ICIT C BEST PRACT, P1
   Savolainen T., 2008, RES REPORTS, P676
   Savolainen T., 2016, TRUST ORG SOCIAL INT, P360
   Savolainen T, 2019, PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON TOURISM RESEARCH (ICTR 2019), P282
   Savolainen T, 2018, PROC EUR CONF KNOWL, P765
   Schwartzman H. B., 1986, RES ORG BEHAV, P233
   Scott Cliff., 2015, CAMBRIDGE HDB M SCI, P20
   Shachaf P, 2008, INFORM MANAGE-AMSTER, V45, P131, DOI 10.1016/j.im.2007.12.003
   Stray VG, 2012, LECT NOTES BUS INF P, V111, P153
   Vartiainen M., 2008, INTRO WORK ORG PSYCH, P209
   World Trade Organization, 2021, FACTAND FIG
   Yoerger M., 2015, CAMBRIDGE HDB M SCI, P153
   Zakaria N., 2004, CREATIVITY INNOVATIO, V13, P15, DOI [10.1111/j.1467-8691.2004.00290.x, DOI 10.1111/J.1467-8691.2004.00290.X]
NR 42
TC 0
Z9 0
U1 1
U2 1
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 501
EP 508
DI 10.34190/EKM.21.172
PG 8
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900059
DA 2022-04-20
ER

PT J
AU Lakshmi, KSSM
   Krithika, CL
   Kannan, A
   Aniyan, Y
AF Lakshmi, K. S. Sethna Muth
   Krithika, C. L.
   Kannan, A.
   Aniyan, Yesoda
TI Knowledge, awareness and outlook on the COVID-19 disease among the
   dental professionals in Tamil Nadu
SO JOURNAL OF INDIAN ACADEMY OF ORAL MEDICINE AND RADIOLOGY
LA English
DT Article
DE COVID-19; dental office; dental professionals; SARS-CoV-2; universal
   precautions
AB Aim: The aim of this study was to analyze the knowledge, level of awareness, and the attitude of the dental professionals towards the pandemic disease (COVID-19). Materials and Methods: This questionnaire-based survey was conducted among 295 dental professionals residing in Tamil Nadu through an online portal. The questionnaire consisted of four sections that addressed the demographic data, knowledge, awareness, and outlook of the COVID-19 disease by dental professionals. All the received responses were tabulated and the results were represented graphically. Result: The result of the study showed significant awareness among dental professionals towards COVID-19. The dental professionals needed more attention towards the precautions to be followed during this pandemic as personal protection and a safe environment are essential for a secure practice. Conclusion: This study emphasizes the role of oral health professionals in the prevention of the transmission of coronavirus among the public along with the management of dental emergencies with appropriate personal protective measures. This study also enforced the need to enrich the knowledge about infection, transmission, prevention, and control towards COVID-19. This may act as a source of information for the future pandemic crisis.
C1 [Lakshmi, K. S. Sethna Muth; Krithika, C. L.; Kannan, A.; Aniyan, Yesoda] SRM Dent Coll, Dept Oral Med & Radiol, Chennai 600089, Tamil Nadu, India.
RP Lakshmi, KSSM (corresponding author), SRM Dent Coll, Dept Oral Med & Radiol, Chennai 600089, Tamil Nadu, India.
EM korkaisethna@gmail.com
OI Aniyan, Yesoda/0000-0001-9686-7896
CR [Anonymous], IND FIGHTS COR COVID
   [Anonymous], GUID PERS PROT EQ SE
   [Anonymous], 2020, INT J SCI HEALTHC RE
   [Anonymous], 2020, ADA INT GUID MAN EM
   [Anonymous], SAV LIV CLEAN YOUR H
   [Anonymous], GUID HAND HYG HLTH C
   [Anonymous], COVID-19 India update
   [Anonymous], 2020, COVID 19 GUID DENT C
   [Anonymous], ENDODONTIC DENT PRAC
   [Anonymous], 2020, UPDATE DENT COLL J
   [Anonymous], GUID SEL US PERS PRO
   [Anonymous], NEW YORK TIMES
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Centers for Disease Control and Prevention, TRANSM COR DIS 2019
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Farooq I, 2020, POSTGRAD MED J, V96, P791, DOI 10.1136/postgradmedj-2020-137781
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Kwok YLA, 2015, AM J INFECT CONTROL, V43, P112, DOI 10.1016/j.ajic.2014.10.015
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Sabino-Silva R, 2020, CLIN ORAL INVEST, V24, P1619, DOI 10.1007/s00784-020-03248-x
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   World Health Organization, COR DIS COVID 19 PAN
   World Health Organization, DIR GEN REM MED BRIE
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 32
TC 0
Z9 0
U1 1
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0972-1363
EI 0975-1572
J9 J INDIAN ACAD ORAL M
JI J. Indian Acad. Oral Med. Radiol.
PD JAN-MAR
PY 2021
VL 33
IS 1
BP 40
EP 46
DI 10.4103/jiaomr.jiaomr_149_20
PG 7
WC Dentistry, Oral Surgery & Medicine
WE Emerging Sources Citation Index (ESCI)
SC Dentistry, Oral Surgery & Medicine
GA SL3GX
UT WOS:000656807600009
DA 2022-04-20
ER

PT J
AU Liu, JF
   Lu, CY
   Lu, SJH
AF Liu, Jingfang
   Lu, Caiying
   Lu, Shuangjinhua
TI Research on the Influencing Factors of Audience Popularity Level of
   COVID-19 Videos during the COVID-19 Pandemic
SO HEALTHCARE
LA English
DT Article
DE COVID-19; information adoption model; text analysis; public health
   emergency
ID SOCIAL MEDIA; INFORMATION; ACCEPTANCE; YOUTUBE
AB (1) Background: During the COVID-19 pandemic, users share and obtain COVID-19 information through video platforms, but only a few COVID-19 videos become popular among most audiences. Therefore, it is a very interesting and important research question to explore the influencing factors of the popularity of COVID-19 videos during the COVID-19 pandemic; (2) Our research collects video data related to the keyword "COVID-19" on video platform, the data are analyzed by content analysis and empirical analysis. We then constructed a theoretical model based on the information adoption model; (3) A total of 251 videos were divided into three categories. The least common category was the data and analysis category (11.2%), followed by the prevention and control status category (13.5%); the knowledge and general science category was the most common (75.3%). From the perspective of video quality, the information sources of most videos are relatively reliable, and the content of medical information is low. The research results showed that short video lengths, longer descriptions, more reliable video sources and lower medical information content were more popular with audiences. Audiences are more likely to be attracted to videos in the prevention and control status category and knowledge and general science category. Videos uploaded by uploaders who have a higher influence are more popular with audiences; (4) Conclusions: During the COVID-19 pandemic, information quality (video length, description length, video content type, and medical information and content index) and source credibility (information source reliability, influence and certification type) all significantly influence the popularity level of COVID-19 videos. Our research conclusions can provide management suggestions for the platform, make videos released by uploaders more popular with audiences, and help audiences better understand COVID-19 information and make prevention and control efforts.
C1 [Liu, Jingfang; Lu, Caiying; Lu, Shuangjinhua] Shanghai Univ, Sch Management, Shanghai 200444, Peoples R China.
RP Lu, CY (corresponding author), Shanghai Univ, Sch Management, Shanghai 200444, Peoples R China.
EM jingfangliu2014@hotmail.com; lucaiying2020@shu.edu.cn;
   lushuangjinhua@shu.edu.cn
OI Lu, Caiying/0000-0002-3128-4179; Lu, Shuangjinhua/0000-0002-5155-6397
FU Natural Science Foundation of ShanghaiNatural Science Foundation of
   Shanghai [19ZR1419400]
FX This research was funded by the Natural Science Foundation of Shanghai
   under grant number 19ZR1419400.
CR ABDALRAZAQ A, 2020, J MED INTERNET RES, V22, DOI DOI 10.2196/19016
   Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/19458
   Alvarado M, 2020, WINT SIMUL C PROC, P3248, DOI 10.1109/WSC48552.2020.9383950
   Andika R, 2021, J COMMUNITY HOSP INT, V11, P39, DOI 10.1080/20009666.2020.1837412
   Apuke OD, 2021, ONLINE INFORM REV, V45, P220, DOI 10.1108/OIR-03-2020-0116
   Atac O, 2020, CUREUS, V12, DOI 10.7759/cureus.10795
   Basch CH, 2020, HUM VACC IMMUNOTHER, V16, P2582, DOI 10.1080/21645515.2020.1790280
   Bhattacherjee A, 2006, MIS QUART, V30, P805
   Castaldo M, 2021, EPJ DATA SCI, V10, DOI 10.1140/epjds/s13688-021-00262-1
   Cervi L, 2021, THEATR DANCE PERFORM, V12, P198, DOI 10.1080/19443927.2021.1915617
   CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752
   Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Q, 2021, J MED INTERNET RES, V23, DOI 10.2196/21463
   Chen Q, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106380
   Choi W, 2015, J ASSOC INF SCI TECH, V66, P2399, DOI 10.1002/asi.23543
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   Galvez-Rodriguez MD, 2018, PUBLIC RELAT REV, V44, P265, DOI 10.1016/j.pubrev.2018.03.003
   Dutta A, 2020, CUREUS, V12, DOI 10.7759/cureus.8622
   Grizzle A, 2017, UNESCO SERIES INTERN, P1
   Haimson OL, 2019, J AM MED INFORM ASSN, V26, P749, DOI 10.1093/jamia/ocz056
   He Y.N., 2018, PRAGMATIC RES NEW ME
   Jia W.L, 2019, LIB WORK STUDY, V2, P121, DOI [10.16384/j.cnki.lwas.2019.02.018, DOI 10.16384/J.CNKI.LWAS.2019.02.018]
   Khatri P, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101636
   Koole, 2020, POSTDIGITAL SCI EDUC, V2, P923, DOI [10.1007/s42438-020-00155-y, DOI 10.1007/S42438-020-00155-Y]
   Laato S, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102224
   Lee CH, 2020, IND MANAGE DATA SYST, V120, P1501, DOI 10.1108/IMDS-12-2019-0711
   Li HOY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002604
   Liu X, 2020, MIS QUART, V44, P257, DOI 10.25300/MISQ/2020/15107
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m408
   MASON CH, 1991, J MARKETING RES, V28, P268, DOI 10.2307/3172863
   Nagpal SJS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1251-9
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Palley W, JWT INTELLIGENDCE
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   Petty Richard E, 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI DOI 10.1016/S0065-2601(08)60214-2
   Prensky M., 2001, HORIZON, V9, P1, DOI [10.1108/10748120110424816, 10.1108/10748120110424816(, https://doi.org/10.1108/10748120110424816, DOI 10.1108/10748120110424816]
   Rodriguez CP, 2020, INT MULTIDISCIP J SO, V9, P107, DOI 10.17583/rimcis.2020.5386
   Ramos TB, 2020, JCOM-J SCI COMMUN, V19, DOI 10.22323/2.19070206
   Sbaffi L, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7579
   Shu M, 2014, J TRAVEL TOUR MARK, V31, P286, DOI 10.1080/10548408.2014.873318
   Singh AG, 2012, J RHEUMATOL, V39, P899, DOI 10.3899/jrheum.111114
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Stephens K. K., 2005, Journal of Business Communication, V42, P390, DOI 10.1177/0021943605279057
   Sussman SW, 2003, INFORM SYST RES, V14, P47, DOI 10.1287/isre.14.1.47.14767
   Szmuda T, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2132
   Szmuda T, 2020, WORLD NEUROSURG, V138, pE469, DOI 10.1016/j.wneu.2020.02.149
   Tejedor S., 2021, J OPEN INNOVATION TE, V7, P43, DOI 10.3390/joitmc7010043
   Thackeray R, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.3002
   Thon FM, 2017, HEALTH COMMUN, V32, P828, DOI 10.1080/10410236.2016.1172296
   van den Bos K, 2002, ADV EXP SOC PSYCHOL, V34, P1, DOI 10.1016/S0065-2601(02)80003-X
   Wang YW, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106373
   Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270
   Xu WA, 2018, COMPUT HUM BEHAV, V89, P199, DOI 10.1016/j.chb.2018.07.041
   Yaacob Z, 2020, TEM J, V9, P1732, DOI 10.18421/TEM94-54
   Zhang L., 2019, J WRIT, V6, P23
   Zhao Y.L, 2018, STUDY PROPAGATION EF
   Zhu DH, 2016, TELEMAT INFORM, V33, P8, DOI 10.1016/j.tele.2015.06.001
NR 59
TC 0
Z9 0
U1 38
U2 38
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9032
J9 HEALTHCARE-BASEL
JI Healthcare
PD SEP
PY 2021
VL 9
IS 9
AR 1159
DI 10.3390/healthcare9091159
PG 16
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA UV7KC
UT WOS:000699651300001
PM 34574933
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Karamchandani, K
   Dalal, R
   Patel, J
   Modgil, P
   Quintili, A
AF Karamchandani, Kunal
   Dalal, Rajeev
   Patel, Jina
   Modgil, Puneet
   Quintili, Ashley
TI Challenges in Sedation Management in Critically Ill Patients with
   COVID-19: a Brief Review
SO CURRENT ANESTHESIOLOGY REPORTS
LA English
DT Review
DE COVID-19; SARS-CoV-2; Sedation; Analgesia; Critically ill patients
ID INTENSIVE-CARE-UNIT; KETAMINE; DELIRIUM; PAIN; PROPOFOL; TRAUMA;
   DEXMEDETOMIDINE; ANALGOSEDATION; MEDICATIONS; LORAZEPAM
AB Purpose of Review To highlight the challenges associated with providing sedation and analgesia to critically ill patients with coronavirus disease 2019 (COVID-19) and also understand the pathophysiological alterations induced by the disease process as well as the logistical difficulties encountered by providers caring for these patients. We also discuss the rationale and risks associated with the use of common sedative agents specifically within the context of COVID-19 and provide evidence-based management strategies to help manage sedation and analgesia in such patients. Recent Findings A significant proportion of patients with COVID-19 require intensive care and mechanical ventilation, thus requiring sedation and analgesia. These patients tend to require higher doses of sedative medications and often for long periods of time. Most of the commonly used sedative and analgesic agents carry unique risks that should be considered within the context of the unique pathophysiology of COVID-19, the logistical issues the disease poses, and the ongoing drug shortages. With little attention being paid to sedation practices specific to patients with COVID-19 in critical care literature and minimal mention in national guidelines, there is a significant gap in knowledge. We review the existing literature to discuss the unique challenges that providers face while providing sedation and analgesia to critically ill patients with COVID-19 and propose evidence-based management strategies.
C1 [Karamchandani, Kunal; Dalal, Rajeev] Penn State Hlth Milton S Hershey Med Ctr, Dept Anesthesiol & Perioperat Med, 500 Univ Dr, Hershey, PA 17033 USA.
   [Patel, Jina; Quintili, Ashley] Penn State Hlth Milton S Hershey Med Ctr, Dept Pharm, 500 Univ Dr, Hershey, PA 17033 USA.
   [Modgil, Puneet] Penn State Univ, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.
RP Karamchandani, K (corresponding author), Penn State Hlth Milton S Hershey Med Ctr, Dept Anesthesiol & Perioperat Med, 500 Univ Dr, Hershey, PA 17033 USA.
EM kkaramchandani@pennstatehealth.psu.edu
CR Alhazzani W, 2020, CRIT CARE MED
   Anand Vijay G, 2012, Int J Crit Illn Inj Sci, V2, P3, DOI 10.4103/2229-5151.94866
   Arulkumaran N, 2012, BRIT J ANAESTH, V108, P183, DOI 10.1093/bja/aer461
   Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72
   Bell RF, 2006, COCHRANE DATABASE SY, V1
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Brummel NE, 2019, HAND CLINIC, V167, P357, DOI 10.1016/B978-0-12-804766-8.00019-4
   Cammarano WB, 1998, CRIT CARE MED, V26, P676, DOI 10.1097/00003246-199804000-00015
   Chanques G, 2007, ANESTHESIOLOGY, V107, P858, DOI 10.1097/01.anes.0000287211.98642.51
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Craven R, 2007, ANAESTHESIA, V62, P48, DOI 10.1111/j.1365-2044.2007.05298.x
   Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI 10.1097/CCM.0000000000003259
   Diedrich Daniel A, 2011, J Intensive Care Med, V26, P59, DOI 10.1177/0885066610384195
   ELLIOTT HW, 1976, BRIT J ANAESTH, V48, P1017, DOI 10.1093/bja/48.10.1017
   Ford ES, 2009, ARCH INTERN MED, V169, P572, DOI 10.1001/archinternmed.2008.599
   Gagnon DJ, 2015, PHARMACOTHERAPY, V35, P251, DOI 10.1002/phar.1559
   Garber PM, 2019, PHARMACOTHERAPY, V39, P288, DOI 10.1002/phar.2223
   Gelissen HPMM, 1996, ANESTHESIOLOGY, V84, P397, DOI 10.1097/00000542-199602000-00019
   George MR, 2014, J BLOOD MED, V5, P69, DOI 10.2147/JBM.S46255
   Gommers D, 2008, CRIT CARE, V12, DOI 10.1186/cc6150
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Green SM, 2000, ACAD EMERG MED, V7, P278, DOI 10.1111/j.1553-2712.2000.tb01076.x
   Greenland JR, 2020, ANESTHESIOLOGY, V132, P1346, DOI 10.1097/ALN.0000000000003303
   Hemphill S, 2019, BRIT J ANAESTH, V122, P448, DOI 10.1016/j.bja.2018.12.025
   Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285
   Hughes CG, 2012, CLIN PHARMACOL-ADV A, V4, P53, DOI 10.2147/CPAA.S26582
   HUGHES MA, 1992, ANESTHESIOLOGY, V76, P334, DOI 10.1097/00000542-199203000-00003
   Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x
   Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45
   Kapp CM, 2020, ANESTH ANALG
   Kok L, 2018, CRIT CARE MED, V46, P1673, DOI 10.1097/CCM.0000000000003300
   함성연, 2016, Acute and Critical Care, V31, P118
   Malchow RJ, 2008, CRIT CARE MED, V36, pS346, DOI 10.1097/CCM.0b013e31817e2fc9
   Manasco AT, 2020, J CRIT CARE, V56, P80, DOI 10.1016/j.jcrc.2019.12.004
   Marik PE, 2004, CURR PHARM DESIGN, V10, P3639, DOI 10.2174/1381612043382846
   Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122
   Martyn JAJ, 2019, NEW ENGL J MED, V380, P365, DOI 10.1056/NEJMra1800222
   Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020
   Matthay MA, 2020, LANCET RESP MED, V8, P433, DOI 10.1016/S2213-2600(20)30127-2
   McKenzie CA, 2005, CRIT CARE, V9, pR32, DOI 10.1186/cc3010
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mirrakhimov AE, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/260385
   Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Piao GY, 2014, ARCH MED SCI, V10, P19, DOI 10.5114/aoms.2014.40730
   Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC
   Pruskowski KA, 2017, PHARMACOTHERAPY, V37, P1537, DOI 10.1002/phar.2042
   Puntillo KA, 2014, AM J RESP CRIT CARE, V189, P39, DOI 10.1164/rccm.201306-1174OC
   Puntillo KA, 2010, CRIT CARE MED, V38, P2155, DOI 10.1097/CCM.0b013e3181f267ee
   Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705
   Roan JP, 2018, ANN INTERN MED, V168, P678, DOI 10.7326/L17-0612
   Roberts DJ, 2012, DRUGS, V72, P1881, DOI 10.2165/11636220-000000000-00000
   Rotondi AJ, 2002, CRIT CARE MED, V30, P746, DOI 10.1097/00003246-200204000-00004
   SAEGUSA K, 1986, J CARDIOVASC PHARM, V8, P414, DOI 10.1097/00005344-198603000-00027
   Sahinovic MM, 2018, CLIN PHARMACOKINET, V57, P1539, DOI 10.1007/s40262-018-0672-3
   Sessler Curtis N, 2011, Anesthesiol Clin, V29, P625, DOI 10.1016/j.anclin.2011.09.004
   Shehabi Y, 2019, NEW ENGL J MED, V380, P2506, DOI 10.1056/NEJMoa1904710
   Skrobik Y, 2018, AM J RESP CRIT CARE, V197, P1147, DOI 10.1164/rccm.201710-1995OC
   Tedders KM, 2014, PHARMACOTHERAPY, V34, P643, DOI 10.1002/phar.1429
   Terry K, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115621767
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang JG, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1610-8
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wilson KC, 2005, CHEST, V128, P1674, DOI 10.1378/chest.128.3.1674
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yahwak JA, 2008, PHARMACOTHERAPY, V28, P984, DOI 10.1592/phco.28.8.984
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 68
TC 2
Z9 2
U1 2
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2167-6275
J9 CURR ANESTHESIOL REP
JI Curr. Anesthesiol. Rep.
PD JUN
PY 2021
VL 11
IS 2
BP 107
EP 115
DI 10.1007/s40140-021-00440-x
PG 9
WC Anesthesiology
WE Emerging Sources Citation Index (ESCI)
SC Anesthesiology
GA TD5YK
UT WOS:000669401900004
PM 33654458
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Machino, H
   Irie, J
   Hiraki, K
   Ukaji, Y
   Sawaya, S
   Nomura, O
   Hanada, H
AF Machino, Hiromi
   Irie, Jin
   Hiraki, Katsushige
   Ukaji, Yukari
   Sawaya, Shunnosuke
   Nomura, Osamu
   Hanada, Hiroyuki
TI Japanese medical students' awareness of cardiopulmonary resuscitation in
   the context of the COVID-19 pandemic
SO ACUTE MEDICINE & SURGERY
LA English
DT Article
DE Airway management; cardiopulmonary resuscitation; COVID-19; education
   curriculum; medical student
AB Aim: To evaluate Japanese medical students' awareness of newly recommended cardiopulmonary resuscitation (CPR) and airway management procedures in the context of the coronavirus disease (COVID-19) pandemic.
   Methods: An online survey was sent in December 2020 to all medical students at Hirosaki University in Japan. The survey included 15 questions and quizzes regarding prior experience of learning the new CPR guidelines in response to COVID-19, knowledge of conventional CPR, and COVID-19 context CPR and airway management procedures.
   Results: Of all medical students at the university, 457 (57.1%) responded to the survey. Among these, 22% reported that they were knowledgeable about CPR procedure in the COVID-19 pandemic setting. Prior knowledge of CPR in the context of COVID-19 was a significant positive predictor of quiz score regarding the CPR procedure (beta = 0.60, P < 0.01) and the airway management procedure (beta = 0.34, P = 0.02) in the context of the COVID-19 pandemic.
   Conclusions: Medical students with experience learning the new COVID-19 context CPR guidelines had sufficient knowledge of CPR and advanced airway management procedures in the setting of the COVID-19 pandemic. Implementation of a formal medical education curriculum based on the newly recommended CPR and advanced life support guidelines is needed to improve medical students' awareness and skills of CPR and airway management in the context of the COVID-19 pandemic.
C1 [Machino, Hiromi; Hiraki, Katsushige; Ukaji, Yukari; Sawaya, Shunnosuke] Hirosaki Univ, Sch Med, Hirosaki, Aomori, Japan.
   [Irie, Jin; Nomura, Osamu; Hanada, Hiroyuki] Hirosaki Univ, Dept Emergency & Disaster Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.
RP Irie, J (corresponding author), Hirosaki Univ, Dept Emergency & Disaster Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.
EM jin-irie@hirosaki-u.ac.jp
RI Nomura, Osamu/ABI-4500-2020
OI Nomura, Osamu/0000-0003-1296-1768
CR Abd Samat AH, 2020, ANN ACAD MED SINGAP, V49, P643
   Ali DM, 2021, SCAND J TRAUMA RESUS, V29, DOI 10.1186/s13049-021-00869-3
   [Anonymous], 2020, GUID EM RES PROC LAY
   Caliskan F, 2020, POSTGRAD MED, V132, P764, DOI 10.1080/00325481.2020.1795486
   Chong KM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252841
   Edelson DP, 2020, CIRCULATION, V141, pE933, DOI 10.1161/CIRCULATIONAHA.120.047463
   Hsu CH, 2021, RESUSCITATION, V159, P28, DOI 10.1016/j.resuscitation.2020.12.004
   International Liaison Committee on Resuscitation, COVID 19 PRACT GUID
   International Liaison Committee on Resuscitation. Consensus on Science with Treatment Recommendations (CoSTR) 2020 draft version, COVID 19 INF RISK RE
   Japan Resuscitation Council, 2021, JRC RES GUID 2020
   Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244
   Medical Education Model Core Curriculum Coordination Committee Medical Education and Model Core Curriculum Expert Research Committee, MOD COR CURR MED ED
   Nomura O, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18137113
   Resuscitation Council UK, STAT COVID 19 COR CP
NR 14
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2052-8817
J9 ACUTE MED SURG
JI Acute Med. Surg.
PD JAN
PY 2022
VL 9
IS 1
AR e745
DI 10.1002/ams2.745
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA ZY4PZ
UT WOS:000772570500001
PM 35356484
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Gupta, S
   Kaushik, A
   Gupta, J
AF Gupta, Sandeep
   Kaushik, Ashlesha
   Gupta, Jitendra
TI Management and outcomes of patients hospitalized with severe COVID-19 at
   a tertiary care center in midwestern United States
SO MONALDI ARCHIVES FOR CHEST DISEASE
LA English
DT Article
DE Outcomes; hospitalized; management; SARS-CoV-2; COVID-19
AB Knowledge of treatment regimens and outcomes for novel coronavirus disease 2019 (COVID-19) is evolving. Recent studies have reported mortality rates ranging from 39-50% among hospitalized patients with COVID-19. We report our experience of management and outcomes of hospitalized patients with COVID-19 at a large tertiary-care center in Midwestern United States. Of 658 patients presenting to our tertiary care center, 217 needed hospitalization, majority (77%) of whom were severely sick requiring admission to the intensive care unit (ICU). All received corticosteroids, and 78% of the patients received tocilizumab. More than two-thirds of the patients received anticoagulation and 80% of patients in the ICU had prone-positioning. The median duration of hospitalization was 12 days (interquartile range, 8 to 16), median duration of intensive care unit stay was 7 days (interquartile range, 5 to 9) and requirement of mechanical ventilation was 6 days (interquartile range, 5 to 8) in our cohort. Of the 217 patients, 27 died (12% mortality).
   The majority of our patients received corticosteroids, tocilizumab, anticoagulation and prone positioning. While higher mortality rates of >30% have been reported in various studies among hospitalized patients with COVID-19, the majority of hospitalized patients in our cohort survived with a low mortality rate.
C1 [Gupta, Sandeep; Gupta, Jitendra] Unity Point Hlth St Lukes Reg Med Ctr, Div Pulm Crit Care & Sleep Med, 2720 Stone Pk Blvd, Sioux City, IA 51104 USA.
   [Kaushik, Ashlesha] Unity Point Hlth St Lukes Reg Med Ctr, Pediat Infect Dis, Sioux City, IA 51104 USA.
RP Gupta, S (corresponding author), Unity Point Hlth St Lukes Reg Med Ctr, Div Pulm Crit Care & Sleep Med, 2720 Stone Pk Blvd, Sioux City, IA 51104 USA.
EM sandynoida@gmail.com
CR Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2
   Ledford H, 2020, NATURE, V582, P469, DOI 10.1038/d41586-020-01824-5
   Price CC, 2020, CHEST, V158, P1397, DOI 10.1016/j.chest.2020.06.006
NR 4
TC 1
Z9 1
U1 0
U2 1
PU FONDAZIONE SALVATORE MAUGERI
PI PAVIA
PA VIA GIUSEPPE BELLI 4, PAVIA, 27100, ITALY
SN 1122-0643
EI 2532-5264
J9 MONALDI ARCH CHEST D
JI Monaldi Arch. Chest Dis.
PY 2020
VL 90
IS 4
BP 612
EP 613
AR 1592
DI 10.4081/monaldi.2020.1592
PG 2
WC Respiratory System
WE Emerging Sources Citation Index (ESCI)
SC Respiratory System
GA PT4LZ
UT WOS:000608587900021
PM 33059413
OA gold
DA 2022-04-20
ER

PT J
AU Simpeh, F
   Amoah, C
AF Simpeh, Fredrick
   Amoah, Christopher
TI COVID-19 guidelines incorporated in the health and safety management
   policies of construction firms
SO JOURNAL OF ENGINEERING DESIGN AND TECHNOLOGY
LA English
DT Article
DE Construction site; COVID-19; Guidelines; Health; Safety; Workers
AB Purpose
   COVID-19 pandemic has ushered in a new norm of operation and has further presented new health and safety challenges in all sectors, including the construction sector. Consequently, several guidelines have been developed and instituted by various countries to prevent the spread of the disease among the citizenry. This paper aims to explore the COVID-19 guidelines incorporated in the health and safety management policies of construction firms in South Africa.
   Design/methodology/approach
   A qualitative approach was adopted for the study. Data was collected from construction companies by means of an open-ended questionnaire. The open-ended questionnaire was distributed by using the purposive sampling technique. The collected data was analysed with thematic content analysis.
   Findings
   The findings show that most construction companies have incorporated aspects of COVID-19 guidelines into the site health and safety policies, whereas the majority of the companies had incorporated guidelines such as site access, handling of COVID-19 cases, induction, screening and social distancing; only a few had incorporated guidelines such as compliance, sanitisation, sick leave, wearing of personal protective equipment, audit and risk assessment, lunchtime rules and grouping of workers into the health and safety policies on site.
   Research limitations/implications
   Data was collected from higher grade firms; therefore, the research findings may not be applied to smaller construction firms. A study that focuses on lower grades is recommended.
   Practical implications
   Construction companies could use the recommendations provided to improve upon the policies developed/adopted to curb the spread of CVID-19 on-site.
   Originality/value
   Research on COVID-19 construction site health and safety measures are still being developed. Thus, this study contributes to advancing the body of knowledge in this evolving field.
C1 [Simpeh, Fredrick; Amoah, Christopher] Univ Free State, Dept Quant Surveying & Construct Management, Bloemfontein, South Africa.
RP Simpeh, F (corresponding author), Univ Free State, Dept Quant Surveying & Construct Management, Bloemfontein, South Africa.
EM simfredy24@yahoo.com
CR Abrey M, 2014, PROCEDIA ENGINEER, V85, P3, DOI 10.1016/j.proeng.2014.10.522
   Agumba J., 2016, S AFRICA J CONSTRUCT, V9, P1
   Akintayo O., 2018, P 12 BUILT ENV C 6 7, P62
   Avice T, 2020, J PEDIATR REHAB MED, V13, P433, DOI 10.3233/PRM-200808
   Beck C.T., 2017, NURSING RES GENERATI
   Blumberg B.C., 2008, BUSINESS RES METHODS
   Bsisu K. A. D., 2020, INT J ENG RES TECH, V13, P828
   CDC, 2020, COR DIS 2019 COVID 1
   Cidb, 2015, APPL CONTRACTOR REGI
   Creswell J.W, 2014, RES DESIGN QUALITATI, V4th
   Dejus T, 2013, J CIV ENG MANAG, V19, P728, DOI 10.3846/13923730.2013.812578
   Du Toit W.J., 2012, THESIS NELSON MANDEL
   Emuze F., 2016, J CONSTRUCTION ASS S, V9, P14
   Gamil Y., 2020, MEDITERRANEAN J SOCI, V11, P122, DOI 10.36941/mjss-2020-0047
   Geller, 2001, WORKING SAFE HELP PE
   Ghanem W., 2012, COMPREHENSIVE APPROA
   Hansson, 2007, CIB WORLD BUILD C CO, P1208
   Harinarain N., 2020, J CONSTRUCTION, V13, P52
   Haslam RA, 2005, APPL ERGON, V36, P401, DOI 10.1016/j.apergo.2004.12.002
   Health and Safety Executive (HSE), 2002, REV HLTH SAF CONSTR
   Hinze J, 2008, SAFETY SCI, V46, P634, DOI 10.1016/j.ssci.2007.06.015
   Ifelunini I., 2020, EC CONSEQUENCES STRA
   International Labour Organization, 2017, GLOB EST MOD SLAV FO
   Jallow H, 2021, SMART SUSTAIN BUILT, V10, P581, DOI 10.1108/SASBE-05-2020-0068
   Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036
   Kothari, 2007, REMETHODOLOGY METH
   Lees H, 2011, PROC INST CIV ENG-MA, V164, P3, DOI 10.1680/mpal900074
   Legg SJ, 2015, SAFETY SCI, V71, P189, DOI 10.1016/j.ssci.2014.11.007
   Lemke MK, 2020, AM J IND MED, V63, P659, DOI 10.1002/ajim.23138
   Madalena I., 2020, COVID 19 CURRENT IMP
   Maiti S, 2021, INT J CONSTR MANAG, V21, P997, DOI 10.1080/15623599.2019.1602580
   Malecka M, 2020, CLIN CHEM LAB MED, V58, pE205, DOI 10.1515/cclm-2020-0764
   Ogunnusi M, 2020, INT J REAL ESTATE ST, V14
   Okorie VN, 2020, INT J CONSTR MANAG, V20, P357, DOI 10.1080/15623599.2018.1531808
   Othman AAE, 2012, ARCHIT ENG DES MANAG, V8, P180, DOI 10.1080/17452007.2012.683242
   Pinto A, 2011, SAFETY SCI, V49, P616, DOI 10.1016/j.ssci.2011.01.003
   Rosemberg MAS, 2020, OCCUP MED-OXFORD, V70, P382, DOI 10.1093/occmed/kqaa053
   Safman RM, 2004, HEALTH EDUC BEHAV, V31, P9, DOI 10.1177/1090198103259185
   Saunders M., 2016, RES METHODS BUSINESS
   Schutt, 2012, PROCESS PRACTICE RES
   South African Government Gazette No. 43400, 2020, OCCUPATIONAL HLTH SA
   Squires A, 2018, J NURS REGUL, V9, P15, DOI 10.1016/S2155-8256(18)30150-9
   Stiles S, 2021, HUM FACTOR ERGON MAN, V31, P425, DOI 10.1002/hfm.20882
   Umeokafor N, 2020, INT J CONSTR MANAG, DOI 10.1080/15623599.2019.1707853
   VERTIC, 2020, MAY 2020 FACT SHEET
   Vitharana VHP, 2015, ENG-J INST ENG SRI L, V48, P35, DOI 10.4038/engineer.v48i3.6840
   Wang Z., 2020, ADV MATER SCI ENG, V2020, P1, DOI [10.21203/rs.3.rs-23885/v1, DOI 10.21203/RS.3.RS-23885/V1, 10.1155/2020/6563520, DOI 10.1155/2020/6563520]
   WHO, 2020, Q A COR COVID 19
   World Health Organization, 2020, WHO COR DIS COVID 19
NR 49
TC 4
Z9 4
U1 2
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1726-0531
J9 J ENG DES TECHNOL
JI J. Eng. Des. Technol.
PD JAN 3
PY 2022
VL 20
IS 1
SI SI
BP 6
EP 23
DI 10.1108/JEDT-01-2021-0042
EA JUN 2021
PG 18
WC Engineering, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Engineering
GA XZ8UW
UT WOS:000663592300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Katulanda, P
   Dissanayake, HA
   Ranathunga, I
   Ratnasamy, V
   Wijewickrama, PSA
   Yogendranathan, N
   Gamage, KKK
   de Silva, NL
   Sumanatilleke, M
   Somasundaram, NP
   Matthews, DR
AF Katulanda, Prasad
   Dissanayake, Harsha A.
   Ranathunga, Ishara
   Ratnasamy, Vithiya
   Wijewickrama, Piyumi S. A.
   Yogendranathan, Nilukshana
   Gamage, Kavinga K. K.
   de Silva, Nipun L.
   Sumanatilleke, Manilka
   Somasundaram, Noel P.
   Matthews, David R.
TI Prevention and management of COVID-19 among patients with diabetes: an
   appraisal of the literature
SO DIABETOLOGIA
LA English
DT Review
DE Coronavirus; COVID-19; Diabetes; SARS-CoV-2
ID CORONAVIRUS; RECEPTOR; GLUCOSE; MORTALITY; HYDROXYCHLOROQUINE;
   PATHOGENESIS; ASSOCIATION; POPULATION; PNEUMONIA; STATEMENT
AB The coronavirus disease 2019 (COVID-19) pandemic has emerged as one of the greatest challenges faced by humankind in the recent past. People with diabetes and related comorbidities are at increased risk of its complications and of COVID-19-related death. Older age, multi-morbidity, hyperglycaemia, cardiac injury and severe inflammatory response are predictors of poor outcome. The complex interplay between COVID-19, diabetes and the effects of related therapies is being explored. Most patients experience a mild illness with COVID-19, while people with diabetes are at increased risk of severe disease. Optimising glycaemic control and adopting measures to prevent disease spread are critical aspects. The management of mild disease is supportive, while very many immunomodulatory and antiviral therapies are being investigated for the treatment of severe disease. Several of these agents have specific considerations for use in people with diabetes. Since mass population lockdowns are considered a key step in controlling disease spread, it follows that, in addition to the direct vulnerability to severe COVID-19, people with diabetes can be affected by limited access to healthcare, insulin, other medications and blood glucose monitoring equipment. Measures to prevent disease spread at the individual and community level are the key to mitigating the rapidly escalating pandemic, while agents for chemoprophylaxis and vaccines are being explored. People with diabetes should be recognised as a vulnerable group for complicated disease and are at risk during times of disturbed social systems. Strategies are needed to safeguard the health of patients with diabetes during the pandemic. This review summarises the current knowledge and perceived challenges for prevention and management of COVID-19 in people with diabetes.
C1 [Katulanda, Prasad; Dissanayake, Harsha A.; Yogendranathan, Nilukshana] Natl Hosp Sri Lanka, Univ Med Unit, Colombo, Sri Lanka.
   [Katulanda, Prasad] Univ Colombo, Fac Med, Dept Clin Med, Diabet Res Unit, 25 Kynsey Rd, Colombo 00800, Sri Lanka.
   [Katulanda, Prasad; Matthews, David R.] Univ Oxford, Harris Manchester Coll, Oxford, England.
   [Katulanda, Prasad; Matthews, David R.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England.
   [Ranathunga, Ishara; Ratnasamy, Vithiya; Wijewickrama, Piyumi S. A.; Gamage, Kavinga K. K.; de Silva, Nipun L.; Sumanatilleke, Manilka; Somasundaram, Noel P.] Natl Hosp Sri Lanka, Diabet & Endocrine Unit, Colombo, Sri Lanka.
   [de Silva, Nipun L.] Gen Sir John Kotelawala Def Univ, Fac Med, Dept Clin Sci, Colombo, Sri Lanka.
RP Katulanda, P (corresponding author), Natl Hosp Sri Lanka, Univ Med Unit, Colombo, Sri Lanka.; Katulanda, P (corresponding author), Univ Colombo, Fac Med, Dept Clin Med, Diabet Res Unit, 25 Kynsey Rd, Colombo 00800, Sri Lanka.; Katulanda, P; Matthews, DR (corresponding author), Univ Oxford, Harris Manchester Coll, Oxford, England.; Katulanda, P; Matthews, DR (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England.
EM prasad.katulanda@clinmed.cmb.ac.lk; david.matthews@ocdem.ox.ac.uk
OI Wijewickrama, Piyumi/0000-0001-7260-1727
FU National Science Foundation, Sri LankaNational Science Foundation (NSF);
   National Institute for Health Research, UKNational Institute for Health
   Research (NIHR)
FX We acknowledge National Science Foundation, Sri Lanka and National
   Institute for Health Research, UK for research funding for Diabetes
   Research Unit, Faculty of Medicine, University of Colombo, Sri Lanka.
CR Allard R, 2010, DIABETES CARE, V33, P1491, DOI 10.2337/dc09-2215
   American Diabetes Association, 2019, Diabetes Care, V42, pS173, DOI 10.2337/dc19-S015
   American Diabetes Association, 2020, COVID 19 AFF PEOPL D
   Anesi GL., 2020, CORONAVIRUS DIS 2019
   Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4
   Cansu DU, 2008, RHEUMATOLOGY, V47, P378, DOI 10.1093/rheumatology/kem378
   Carey IM, 2018, DIABETES CARE, V41, P513, DOI 10.2337/dc17-2131
   Center for Disease Control and Prevention, 2020, PROT YOURS COR DIS 2
   Chang R, 2020, REPOSITIONING CHLORO, DOI [10.20944/preprints202003.0279.v1, DOI 10.20944/PREPRINTS202003.0279.V1]
   Chen C, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P567, DOI 10.3760/cma.j.cn112148-20200225-00123
   Chen G, 2020, J CLIN INVEST, DOI [10.1172/JCI137244, DOI 10.1172/JCI137244]
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086
   Deane AM, 2014, DIABETES CARE, V37, pE40, DOI 10.2337/dc13-1616
   DeFronzo R, 2016, METABOLISM, V65, P20, DOI 10.1016/j.metabol.2015.10.014
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Diabetes UK, 2020, UPD COR DIAB
   Dietz W, 2020, OBESITY, V28, P1005, DOI 10.1002/oby.22818
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Fadimu GJ, 2020, J FOOD MEAS CHARACT, V14, P1784, DOI 10.1007/s11694-020-00426-z
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   FDA, 2020, REMD EUA LETT AUTH
   Feng Y, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-019-1492-6
   Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625
   Furuhashi M, 2015, AM J HYPERTENS, V28, P15, DOI 10.1093/ajh/hpu086
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Garbati MA, 2016, PLOS ONE, V11, DOI [10.1371/journal.Pone.0165978, 10.1371/journal.pone.0165978]
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X
   Gomez-Peralta F, 2018, DIABETES THER, V9, P1775, DOI 10.1007/s13300-018-0488-z
   Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Gupta R, 2020, DIABETES METAB SYND, V14, P211, DOI 10.1016/j.dsx.2020.03.002
   Iacobellis G, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108125
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   International Society for Paediatric and Adolescent Diabetes, 2020, SUMM REC REG COVID 1
   Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0
   Iwai M, 2009, HYPERTENS RES, V32, P533, DOI 10.1038/hr.2009.74
   Khan A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1823-x
   Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417
   Kulcsar KA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131774
   Letko Michael, 2020, bioRxiv, DOI 10.1101/2020.01.22.915660
   Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431
   Lin L, 2020, EMERG MICROBES INFEC, V9, P727, DOI 10.1080/22221751.2020.1746199
   Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095
   Maahs DM, 2015, DIABETES CARE, V38, pE158, DOI 10.2337/dc15-1096
   MacIntosh K, 2020, CORONAVIRUS DIS 2019
   Matthews R, 2020, GLUCOSE CONTROL KEY
   Mendez Carlos E, 2014, Diabetes Spectr, V27, P180, DOI 10.2337/diaspect.27.3.180
   Meyer EJ, 2018, DIABETES CARE, V41, pE47, DOI 10.2337/dc17-1721
   Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812
   Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Serfozo P, 2020, HYPERTENSION, V75, P173, DOI 10.1161/HYPERTENSIONAHA.119.14071
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Touret F, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104762
   Tsalamandris S, 2019, EUR CARDIOL REV, V14, P50, DOI 10.15420/ecr.2018.33.1
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang AH, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108118
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Whitworth J, 2020, T ROY SOC TROP MED H, V114, P227, DOI 10.1093/trstmh/traa025
   WHO, 2020, MENT HLTH PSYCH CONS, P1
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wilding J, 2018, DIABETES THER, V9, P1757, DOI 10.1007/s13300-018-0471-8
   Woldometer, 2020, COVID 19 COR PAND
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Yang YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39883
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yu LL, 2018, EUR REV MED PHARMACO, V22, P5355, DOI 10.26355/eurrev_201808_15737
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhou D, 2020, J ANTIMICROB CHEMOTH, V75, P1667, DOI 10.1093/jac/dkaa114
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zumla A, 2020, LANCET, V395, pE35, DOI 10.1016/S0140-6736(20)30305-6
NR 81
TC 81
Z9 82
U1 1
U2 10
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD AUG
PY 2020
VL 63
IS 8
BP 1440
EP 1452
DI 10.1007/s00125-020-05164-x
EA MAY 2020
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA MH8GC
UT WOS:000532661900001
PM 32405783
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Kotfis, K
   Roberson, SW
   Wilson, JE
   Dabrowski, W
   Pun, BT
   Ely, EW
AF Kotfis, Katarzyna
   Williams Roberson, Shawniqua
   Wilson, Jo Ellen
   Dabrowski, Wojciech
   Pun, Brenda T.
   Ely, E. Wesley
TI COVID-19: ICU delirium management during SARS-CoV-2 pandemic
SO CRITICAL CARE
LA English
DT Review
DE COVID-19; Pandemic; SARS-CoV-2; Delirium; Sedation; Pain; PICS; PTSD
ID INTENSIVE-CARE-UNIT; RESPIRATORY SYNDROME-CORONAVIRUS; CONFUSION
   ASSESSMENT METHOD; CENTRAL-NERVOUS-SYSTEM; MECHANICALLY VENTILATED
   PATIENTS; TERM COGNITIVE IMPAIRMENT; SCREENING CHECKLIST; CRITICAL
   ILLNESS; ABCDEF BUNDLE; CENTERED CARE
AB The novel coronavirus, SARS-CoV-2-causing Coronavirus Disease 19 (COVID-19), emerged as a public health threat in December 2019 and was declared a pandemic by the World Health Organization in March 2020. Delirium, a dangerous untoward prognostic development, serves as a barometer of systemic injury in critical illness. The early reports of 25% encephalopathy from China are likely a gross underestimation, which we know occurs whenever delirium is not monitored with a valid tool. Indeed, patients with COVID-19 are at accelerated risk for delirium due to at least seven factors including (1) direct central nervous system (CNS) invasion, (2) induction of CNS inflammatory mediators, (3) secondary effect of other organ system failure, (4) effect of sedative strategies, (5) prolonged mechanical ventilation time, (6) immobilization, and (7) other needed but unfortunate environmental factors including social isolation and quarantine without family. Given early insights into the pathobiology of the virus, as well as the emerging interventions utilized to treat the critically ill patients, delirium prevention and management will prove exceedingly challenging, especially in the intensive care unit (ICU). The main focus during the COVID-19 pandemic lies within organizational issues, i.e., lack of ventilators, shortage of personal protection equipment, resource allocation, prioritization of limited mechanical ventilation options, and end-of-life care. However, the standard of care for ICU patients, including delirium management, must remain the highest quality possible with an eye towards long-term survival and minimization of issues related to post-intensive care syndrome (PICS). This article discusses how ICU professionals (e.g., physicians, nurses, physiotherapists, pharmacologists) can use our knowledge and resources to limit the burden of delirium on patients by reducing modifiable risk factors despite the imposed heavy workload and difficult clinical challenges posed by the pandemic.
C1 [Kotfis, Katarzyna] Pomeranian Med Univ, Dept Anaesthesiol Intens Therapy & Acute Intoxica, Al Powstancow Wielkopolskich 72, PL-70111 Szczecin, Poland.
   [Williams Roberson, Shawniqua; Wilson, Jo Ellen; Pun, Brenda T.; Ely, E. Wesley] Vanderbilt Univ, Crit Illness Brain Dysfunct & Survivorship CIBS C, Med Ctr, Nashville, TN USA.
   [Williams Roberson, Shawniqua] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA.
   [Williams Roberson, Shawniqua] Vanderbilt Univ, Dept Bioengn, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Wilson, Jo Ellen] Vanderbilt Univ, Dept Psychiat & Behav Sci, Med Ctr, Nashville, TN USA.
   [Wilson, Jo Ellen; Ely, E. Wesley] Tennessee Valley Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Nashville, TN USA.
   [Dabrowski, Wojciech] Med Univ Lublin, Dept Anaesthesiol & Intens Care, Lublin, Poland.
   [Ely, E. Wesley] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Med Ctr, Nashville, TN USA.
RP Kotfis, K (corresponding author), Pomeranian Med Univ, Dept Anaesthesiol Intens Therapy & Acute Intoxica, Al Powstancow Wielkopolskich 72, PL-70111 Szczecin, Poland.
EM katarzyna.kotfis@pum.edu.pl
RI Kotfis, Katarzyna/O-4355-2014
OI Kotfis, Katarzyna/0000-0001-8430-1369; Dabrowski,
   Wojciech/0000-0003-0449-2375
FU NCATSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [KL2TR002245]; NIGMSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM120484]; NHLBIUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R01HL14678-01]; NIAUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute on Aging (NIA) [R01AG058639]
FX JEW is currently receiving grant funding from NCATS (#KL2TR002245) and
   NIGMS (#R01GM120484). BTP is currently receiving grant funding from
   NHLBI (#R01HL14678-01). EWE is currently receiving grant funding from
   NIA (#R01AG058639) and NIGMS (#R01GM120484) serves as a consultant for
   Pfizer and Eli Lilly. The funding sources had no role in the
   preparation, review, or approval of the manuscript and decision to
   submit the manuscript for publication.
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]
   Arbour N, 2000, J VIROL, V74, P8913, DOI 10.1128/JVI.74.19.8913-8921.2000
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Balas M, 2012, CRIT CARE MED, V40, pU18
   Barnes-Daly MA, 2018, WORLDV EVID-BASED NU, V15, P206, DOI 10.1111/wvn.12290
   Barnes-Daly MA, 2017, CRIT CARE MED, V45, P171, DOI 10.1097/CCM.0000000000002149
   Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72
   Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909
   Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343
   Caridi-Scheible M, 2019, COVID 19 CLIN ROUNDS
   Davidson JE, 2017, CRIT CARE MED, V45, P103, DOI 10.1097/CCM.0000000000002169
   Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560
   Dube M, 2018, J VIROL, V92, DOI 10.1128/JVI.00404-18
   Elie M, 2000, CAN MED ASSOC J, V163, P977
   Ely EW, 2017, CRIT CARE MED, V45, P321, DOI 10.1097/CCM.0000000000002175
   Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703
   Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012
   Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2
   Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097
   Girard TD, 2018, NEW ENGL J MED, V379, P2506, DOI 10.1056/NEJMoa1808217
   Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6
   Girard TD, 2016, ANNU REV MED, V67, P497, DOI 10.1146/annurev-med-050913-015722
   Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030
   Grossmann FF, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-19
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407
   Han JH, 2009, ACAD EMERG MED, V16, P193, DOI 10.1111/j.1553-2712.2008.00339.x
   Han L, 2001, ARCH INTERN MED, V161, P1099, DOI 10.1001/archinte.161.8.1099
   Hsieh SJ, 2019, CRIT CARE MED, V47, P885, DOI 10.1097/CCM.0000000000003765
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DSC, 2003, RESPIROLOGY, V8, pS20, DOI 10.1046/j.1440-1843.2003.00520.x
   Iacono KT, 2006, J VIROL, V80, P6834, DOI 10.1128/JVI.00432-06
   Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467
   Iwashyna TJ, 2012, SEMIN RESP CRIT CARE, V33, P327, DOI 10.1055/s-0032-1321982
   Khan BA, 2017, CRIT CARE MED, V45, P851, DOI 10.1097/CCM.0000000000002368
   Khan S, 2020, J HOSP INFECT, V104, P252, DOI 10.1016/j.jhin.2020.01.019
   Kim LJ, 2015, BRAIN RES, V1597, P28, DOI 10.1016/j.brainres.2014.11.052
   Kotfis K, 2020, ANAESTH INTENSIVE TH, V52, P171, DOI 10.5114/ait.2020.93867
   Kotfis K, 2018, ANAESTH INTENSIVE TH, V50, P128, DOI 10.5603/AIT.a2018.0011
   Lau KK, 2004, EMERG INFECT DIS, V10, P342, DOI 10.3201/eid1002.030638
   Li K, 2016, J INFECT DIS, V213, P712, DOI 10.1093/infdis/jiv499
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Li YC, 2013, J COMP NEUROL, V521, P203, DOI 10.1002/cne.23171
   Li YC, 2012, VIRUS RES, V163, P628, DOI 10.1016/j.virusres.2011.12.021
   Li YY, 2016, INTERVIROLOGY, V59, P163, DOI 10.1159/000453066
   Maldonado JR, 2018, INT J GERIATR PSYCH, V33, P1428, DOI 10.1002/gps.4823
   Mao L, 2020, JAMA NEUROL, P1, DOI [10.1001/jamaneurol.2020.1127, 10.2139/ssrn.3544840, 10.1101/ 2020.02.22.20026500, DOI 10.1101/2020.02.22.20026500]
   Marra A, 2019, AM J CRIT CARE, V28, P127, DOI 10.4037/ajcc2019874
   Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001
   Meng LZ, 2020, ANESTHESIOLOGY, V132, P1317, DOI 10.1097/ALN.0000000000003296
   MENGELING WL, 1972, AM J VET RES, V33, P297
   Nath A, 2020, NEUROLOGY, V94, P809, DOI 10.1212/WNL.0000000000009455
   Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Palmer JC, 2013, J ALZHEIMERS DIS, V36, P577, DOI 10.3233/JAD-130383
   Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005
   Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372
   Pandharipande PP, 2004, CRIT CARE MED, V32, pA19, DOI [10.1097/00003246-200412001-00075, DOI 10.1097/00003246-200412001-00075]
   Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d
   Pilli D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00652
   Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
   Pun BT, 2019, CRIT CARE MED, V47, P3, DOI 10.1097/CCM.0000000000003482
   Qiu H., 2020, ZHONGHUA JIE HE HE H, V43, pE022, DOI DOI 10.3760/CMA.J.CN112147-20200222-00151
   Radtke FM, 2009, ANASTH INTENSIV NOTF, V44, P80, DOI 10.1055/s-0029-1202647
   Rygiel K, 2016, J POSTGRAD MED, V62, P242, DOI 10.4103/0022-3859.188553
   Spronk PE, 2009, INTENS CARE MED, V35, P1276, DOI 10.1007/s00134-009-1466-8
   Sun JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14235
   TALBOT PJ, 1993, ADV EXP MED BIOL, V342, P339
   Templeton SP, 2008, BRAIN PATHOL, V18, P40, DOI 10.1111/j.1750-3639.2007.00098.x
   Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229
   Tsuruta R, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0145-4
   van den Boogaard M, 2018, JAMA-J AM MED ASSOC, V319, P680, DOI 10.1001/jama.2018.0160
   van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118
   Vasilevskis E, 2013, AM J RESP CRIT CARE, V187
   Vasilevskis EE, 2018, MED CARE, V56, P890, DOI 10.1097/MLR.0000000000000975
   Vincent JL, 2016, INTENS CARE MED, V42, P962, DOI 10.1007/s00134-016-4297-4
   Wiesmann M, 2013, J CEREBR BLOOD F MET, V33, P1696, DOI 10.1038/jcbfm.2013.159
   Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461
   Yeh EA, 2004, PEDIATRICS, V113, pE73, DOI 10.1542/peds.113.1.e73
   Zhou JH, 2003, J IMMUNOL, V170, P3331, DOI 10.4049/jimmunol.170.6.3331
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 84
TC 214
Z9 221
U1 18
U2 50
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1364-8535
EI 1466-609X
J9 CRIT CARE
JI Crit. Care
PD APR 28
PY 2020
VL 24
IS 1
AR 176
DI 10.1186/s13054-020-02882-x
PG 9
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LL2UL
UT WOS:000531412200007
PM 32345343
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Cirakli, U
   Dogan, I
   Gozlu, M
AF Cirakli, Umit
   Dogan, Ibrahim
   Gozlu, Mehmet
TI The Relationship Between COVID-19 Cases and COVID-19 Testing: a Panel
   Data Analysis on OECD Countries
SO JOURNAL OF THE KNOWLEDGE ECONOMY
LA English
DT Article; Early Access
DE COVID-19; COVID-19 test number; OECD countries; Panel autoregressive
   distributed lag model
ID UNIT-ROOT TESTS
AB Testing, one of the methods to combat the COVID-19 outbreak, is highly recommended in all countries. Empirical studies on how testing relates to the control of new cases will help highlight the importance of testing in efforts to combat the epidemic. Therefore, this study aims to investigate the relationship between COVID-19 testing and COVID-19 cases. We use panel autoregressive distributed lag analysis to test the effect of COVID-19 test number on the COVID-19 new cases. The data of the study cover the period from March 19, 2020, to May 01, 2020, for 14 OECD countries. Data were obtained from the website. According to the results, this study shows that increasing the COVID-19 test number will help to reduce new COVID-19 cases. On the other hand, increase in the test number per thousand will probably not contribute to reducing new COVID-19 cases, because countries do not already test by random selection, and even if they do, it will not contribute to detection and isolating of the new cases without identifying risky groups.
C1 [Cirakli, Umit] Yozgat Bozok Univ, Fac Econ & Adm Sci, Dept Hlth Management, Yozgat, Turkey.
   [Dogan, Ibrahim] Yozgat Bozok Univ, Fac Econ & Adm Sci, Dept Econ, Yozgat, Turkey.
   [Gozlu, Mehmet] Gaziantep Univ, Hlth Sci Inst, Gaziantep, Turkey.
RP Cirakli, U (corresponding author), Yozgat Bozok Univ, Fac Econ & Adm Sci, Dept Hlth Management, Yozgat, Turkey.
EM cirakli@hacettepe.edu.tr; ibrahim.dogan@yobu.edu.tr;
   mgozlu@gantep.edu.tr
RI CIRAKLI, UMIT/AAL-2640-2021
OI CIRAKLI, UMIT/0000-0002-3134-8830
CR Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9
   Brotherhood L., 2020, CESIFO WORKING PAPER
   Choi I, 2001, J INT MONEY FINANC, V20, P249, DOI 10.1016/S0261-5606(00)00048-6
   Ciftci F., 2015, BUS ECON RES J, V6, P71
   Cleevely M, 2020, OXFORD REV ECON POL, V36, pS14, DOI 10.1093/oxrep/graa029
   Greninger A.L., 2020, CLIN INFECT DIS
   Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7
   Kumleben N, 2020, PUBLIC HEALTH, V185, P88, DOI 10.1016/j.puhe.2020.06.006
   Levin A, 2002, J ECONOMETRICS, V108, P1, DOI 10.1016/S0304-4076(01)00098-7
   Maddala GS, 1999, OXFORD B ECON STAT, V61, P631, DOI 10.1111/1468-0084.61.s1.13
   Marcel S, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20225
   Pedroni P, 1999, OXFORD B ECON STAT, V61, P653, DOI 10.1111/1468-0084.61.s1.14
   Pesaran MH, 1999, J AM STAT ASSOC, V94, P621, DOI 10.2307/2670182
   Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20
   Thunstrom L., 2021, BEHAV PUBLIC POLICY, V5, P135, DOI 10.1017/bpp.2020.15
   West CP, 2020, MAYO CLIN PROC, V95, P1127, DOI 10.1016/j.mayocp.2020.04.004
   World Health Organization-China Joint Mission on Coronavirus Disease, 2019, REPORT WHO CHINA JOI
   Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3
NR 18
TC 1
Z9 1
U1 7
U2 13
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1868-7865
EI 1868-7873
J9 J KNOWL ECON
JI J. Knowl. Econ.
DI 10.1007/s13132-021-00792-z
EA APR 2021
PG 14
WC Economics
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA RM6TJ
UT WOS:000639793200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Grewal, VS
   Bandyopdhyay, K
   Sharma, PA
   Rani, R
   Kotwal, A
AF Grewal, Vikram S.
   Bandyopdhyay, Kuntal
   Sharma, Punita A.
   Rani, Rekha
   Kotwal, Atul
TI Knowledge, attitude, practices and behaviour study regarding COVID-19
   amongst health care workers of armed forces in North-Western part of
   India
SO JOURNAL OF MARINE MEDICAL SOCIETY
LA English
DT Article
DE Attitude; behavior; COVID-19; health-care worker; knowledge; practice
ID RESIDENTS
AB Background: A concerted effort has been made by the Government of India and the Armed Forces to train all health-care workers (HCWs) in various aspects of the prevention and management of COVID-19. This study was conducted to evaluate the efforts by assessing their knowledge, attitudes, practice, and behavior regarding COVID-19. Materials and Methods: A quick online survey, using a web portal and social media platform with a pretested questionnaire, was conducted. Responses were collected for 3 days and analyzed. Results: A total of 988 HCWs participated, including 61 (6.17%) specialist officers, 98 (9.91%) medical officers, 17 (1.72%) dental officers, 135 (13.66%) nursing officers, 518 (52.4%) paramedical staff, and 159 (16.09%) supporting staff. There was a high prevalence (>90%) of knowledge related to symptoms and transmission of the disease with no statistically significant difference in knowledge based on the category of HCW except for bleaching powder requirement (0.001) and chemoprophylaxis (0.001). The majority of the participants (>95%) agreed that lockdown, infection control programs, and repeated training of HCWs are good measures to control COVID-19 spread. Observing full precaution while handling personal protective equipment was the only practice which demonstrated a significant association with increasing qualification of the participant (P < 0.001). Conclusions: Levels of knowledge, positive attitude, and good practices are high among HCWs in the Armed Forces, however, feeling of anxiousness and worry prevail being frontline workers with maximum proximity toward patients. Aggressive, continuous, relevant target population-oriented information, education, and communication is the need of the hour, with structured and programmed interventions for positive mental health during course of the pandemic.
C1 [Grewal, Vikram S.] HQ SWC Med Branch, Col Hlth, Jaipur, Rajasthan, India.
   [Bandyopdhyay, Kuntal] 48 FHO, Bathinda, India.
   [Sharma, Punita A.] HQ SWC Med Branch, Brig MNS, Jaipur, Rajasthan, India.
   [Rani, Rekha] HQ SWC Med Branch, Jaipur, Rajasthan, India.
   [Kotwal, Atul] HQ SWC Med Branch, MG Med, Jaipur, Rajasthan, India.
RP Bandyopdhyay, K (corresponding author), 48 Field Hlth Org, Bathinda 151004, Punjab, India.
EM bandykuntal@gmail.com
CR Alkot M., 2016, International Journal of Medical Science and Public Health, V5, P952
   Asaad AM, 2019, E MEDITERR HEALTH J, V25, P564
   Askarian M, 2013, INT J PREVENTIVE MED, V4, P396
   Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Banerji A, 2020, INDIAN J PUBLIC HLTH, V64, P94, DOI 10.4103/ijph.IJPH_516_20
   Bhagavathula AS, 2020, NOVEL CORONAVIRUS CO, V4, P396
   Datta R, 2020, MED J ARMED FORCES I, V3, P357
   Di Napoli R., 2020, FEATURES EVALUATION
   Erfani A., 2020, B WORLD HEALTH ORGAN, V30, P155
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Lillie PJ, 2020, J INFECTION, V80, P600, DOI 10.1016/j.jinf.2020.02.020
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 16
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0975-3605
EI 2589-1235
J9 J MAR MED SOC
JI J. Mar. Med. Soc.
PD NOV
PY 2020
VL 22
IS 3
SI SI
BP 72
EP 77
DI 10.4103/jmms.jmms_95_20
PG 6
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA PA7EE
UT WOS:000595793200014
OA gold
DA 2022-04-20
ER

PT J
AU Baker, TL
   Greiner, JV
AF Baker, Terrance L.
   Greiner, Jack, V
TI Guidelines: Discharge Instructions for Covid-19 Patients
SO JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH
LA English
DT Article
DE anxiety; community health; disease management; efficiency; triage;
   COVID-19; guidelines; discharge instructions
ID TRANSMISSION; STATES
AB Introduction/Objectives: Clinicians treating COVID-19 patients face a major challenge in providing an effective relationship with patients who are discharged to return to home in order to optimize patient self-management after discharge. The purpose of these discharge instructions is to assist and provide guidance for physicians, nurses, and other health care personnel involved in discharging COVID-19 patients to home after encounters at hospitals, emergency departments, urgent care settings, and medical offices. Methods: A systematic literature-search of studies evaluating both symptoms and signs of COVID-19 was performed in order to establish specific optimal performance criteria in monitoring a patient's status with regard to disease safety. These optimal performance criteria parameters were considered with regard to the severity of morbidity and mortality. Strategies used to develop the discharge instructions included review of a broad spectrum of literature to develop the discharge criteria. Results: These guidelines are presented for patient education and should achieve the essential goals including: enabling patients to understand their medical situation, preventing complications, supporting patients by providing instructions, helping patients make more effective use of available health services, and managing patient stress by giving patients comfort through the knowledge of specific recommendations including how to respond to situations. Conclusion: The COVID-19 pandemic requires clinicians to efficiently teach their patients self-management strategies and to provide a safe educated response to the patient and the surrounding community environment. The primary goal of the patient education discharge-instructions (PEDI) is to provide self-management strategies for preventing complications and disease transmission.
C1 [Baker, Terrance L.] Johns Hopkins Community Phys, Baltimore, MD USA.
   [Baker, Terrance L.] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA.
   [Baker, Terrance L.] SUNY Stony Brook, Sch Nursing, Brookhaven, NY USA.
   [Baker, Terrance L.] Katani Hosp, Sollay Kenyan Fdn, Sollay Med Ctr, Katani, Kenya.
   [Greiner, Jack, V] Schepens Eye Res Inst Massachusetts Eye & Ear, Boston, MA USA.
   [Greiner, Jack, V] Harvard Med Sch, Dept Ophthalmol, Boston, MA USA.
   [Greiner, Jack, V] Tufts Univ, Dept Ophthalmol, Sch Med, Medford, MA USA.
RP Greiner, JV (corresponding author), Eye Res Inst Massachusetts Eye & Ear, 20 Staniford St,W239, Boston, MA 02114 USA.
EM jack_greiner@meei.harvard.edu
OI Greiner, Jack/0000-0003-1659-1020
FU American Association of Physician Specialists Foundation, Tampa, FL;
   Sollay Kenyan Foundation, Baltimore, MD; New African Broadcasting
   Network-TV, East Orange, NJ
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This study was
   supported in part by the American Association of Physician Specialists
   Foundation, Tampa, FL; Sollay Kenyan Foundation, Baltimore, MD, and New
   African Broadcasting Network-TV, East Orange, NJ.
CR Academy of Pediatric Physical Therapy, VIT SIGN CONS PHYS T
   Almutairi A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9446
   Alpert JS, 2020, AM J MED, V133, P1363, DOI 10.1016/j.amjmed.2020.08.003
   Anderson KM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010180
   [Anonymous], DISP NONH PAT COVID
   [Anonymous], US MASKS
   Arnold C, 2020, NATURE, V588, P22, DOI 10.1038/d41586-020-03360-8
   Baker Terrance L, 2021, Nursing, V51, P32, DOI 10.1097/01.NURSE.0000733932.88107.44
   Baker TL, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720938046
   Balachandar UV, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139021
   Basaranoglu G, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1360-5
   Beck F, 2021, SLEEP MED, V78, P115, DOI 10.1016/j.sleep.2020.11.029
   Bi Q., 2020, Lancet Infect Dis, V20, P911
   Bielicki Julia A, 2020, Lancet Infect Dis, V20, pe261, DOI 10.1016/S1473-3099(20)30458-8
   Birgand G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.33232
   Breakthroughs, 14 DAY QUAR UND COR
   Brooks JT, 2021, JAMA-J AM MED ASSOC, V325, P998, DOI 10.1001/jama.2021.1505
   Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1
   Calo F, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00756-6
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Center for Disease Control and Prevention, YOU HAV PETS
   Center for Disease Control and Prevention, HOUS LIV CLOS Q
   Center for Disease Control and Prevention, FREQ QUEST HAND HYG
   Center for Disease Control and Prevention, CLEAN DIS YOUR FAC
   Center for Disease Control and Prevention, WHAT DO YOUR PET TES
   Center for Disease Control and Prevention, SCREEM K12 STUD SYMP
   Center for Disease Control and Prevention, IS YOU AR SICK
   Center for Disease Control and Prevention, COVID 19 QUAR
   Center for Disease Control and Prevention, RET WORK
   Center for Disease Control and Prevention, TRANSM IS
   Center for Disease Control and Prevention, PROT YOUR HOM COVID
   Center for Disease Control and Prevention, COVID19 CAR SOM SICK
   Center for Disease Control and Prevention, SCI BRIEF OPT RED QU
   Center for Disease Control and Prevention, GUID MAN COR DIS 201
   Center for Disease Control and Prevention, 2020, MMWR MORB MORTAL WKL, V69, P1443
   Center for Disease Control and Prevention, YOU CAN BE OTH YOU H
   Center for Disease Control and Prevention, SHOW ME SCI WHY WASH
   Center for Disease Control and Prevention, SYMPT COR
   Center for Disease Control and Prevention. Coronavirus disease, 2019, COVID 19 CHECKL TEAC
   Center for Disease Control and Protection, PROT YOUR HOM COVID
   Centers for Disease Control and Prevention, PROT YOURS OTH
   Centers for Disease Control and Prevention, COR COVID 19 FREQ AS
   Centers for Disease Control and Prevention, PUBL HLTH GUID COMM
   Centers for Disease Control and Prevention, CLIN QUEST COVID 19
   Centers for Disease Control and Prevention, COR DIS 2019 COVID 1
   Centers for Disease Control and Prevention, INT GUID SHIPS MAN S
   Centers for Disease Control and Prevention, WHAT DO YOU AR SICK
   Centers for Disease Control and Prevention, SOC DIST
   Centers for Disease Control and Prevention, INT CLIN GUID MAN PA
   Centers for Disease Control and Prevention, MENT HLTH COP COVID
   Centers for Disease Control and Prevention, COVID 19 AN
   Centers for Disease Control and Prevention, WASH YOUR HANDS
   Centers for Disease Control and Prevention, INT GUID DUR IS PREC
   Children's Hospital of Philadelphia, PROT YOURS YOUR FAM
   Cho P, 2020, CONTACT LENS ANTERIO, V43, P313, DOI 10.1016/j.clae.2020.05.011
   Chu DK, 2020, LANCET, V6736, P1, DOI [10.1016/S0140-6736(20)31142-9, DOI 10.1016/S0140-6736(20)31142-9]
   Clinical Trials.gov, SENS BAS VIT SIGNS M
   Courtney JM., 2021, BIOPHYS J, V120, P944
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   D'Amico F, 2020, CLIN GASTROENTEROL H, V18, P1663, DOI 10.1016/j.cgh.2020.04.001
   Department of Mental Health and Addiction Services, COVID 19 PROT QUAR I
   Dicpinigaitis PV, 2020, LUNG, V198, P863, DOI 10.1007/s00408-020-00406-6
   Ding Z, 2021, SCI TOTAL ENVIRON, V753, DOI 10.1016/j.scitotenv.2020.141710
   Esposito S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01260-2020
   Faust JS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.34273
   Federal Drug Administration, PULS OX ACC LIM FDA
   Federal Drug Agency, HELP STOP SPREAD COR
   Federal Drug Agency, COR COVID 19 UPD FDA
   Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875
   Ghinai I, 2020, MMWR-MORBID MORTAL W, V69, P446, DOI 10.15585/mmwr.mm6915e1
   Gordon WJ, 2020, APPL CLIN INFORM, V11, P792, DOI 10.1055/s-0040-1721039
   Greenhalgh T, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n677
   Guihur A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.564170
   Harvard Health, COVID 19 BAS
   Harvard Health Publishing, HARV MED SCH PREV SP
   Harvard Health Publishing, PREV SPREAD COR
   Harvard Health Publishing, HARV MED SCH YOUVE B
   Hawkins M, 2021, J PSYCHOSOM RES, V141, DOI 10.1016/j.jpsychores.2020.110350
   Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Johansson MA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35057
   Johns Hopkins Medicine, VIT SIGNS BOD TEMP P
   Johns Hopkins Medicine, HAND WASH COR PREV C
   Johns Hopkins Medicine, COVID 19 LUNG DAM
   Johns Hopkins Medicine, COR SOC PHYS DIST SE
   Johns Hopkins Medicine, CAN I PROT MYS OTH N
   Khan MH., 2020, T INDIAN NATL ACAD E, V1, P1
   Lai CC, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106024
   Lauc G, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010344
   Lesmandjaja, 2020, MIDDLE E CURR PSYCHI, V27, P72, DOI DOI 10.1186/S43045-020-00075-4
   Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757
   Lin LY, 2021, SLEEP MED, V77, P348, DOI 10.1016/j.sleep.2020.05.018
   Lippi G, 2020, ANN CLIN BIOCHEM, V57, P262, DOI 10.1177/0004563220922255
   Mamontov E, 2020, J PHYS CHEM LETT, V11, P10256, DOI 10.1021/acs.jpclett.0c02642
   Marraha F, 2020, DERMAT RES PRACT, V2020, DOI 10.1155/2020/9360476
   Marshall M, 2020, NATURE, V585, P342, DOI 10.1038/d41586-020-02599-5
   Massabeti R, 2020, J POPUL THER CLIN PH, V27, pE26, DOI 10.15586/jptcp.v27iSP1.691
   Mayo Clinic, TREAT COVID 19 HOM C
   Mayo Clinic, REM PAT MON
   Mayo Clinic, HEART RAT WHATS NORM
   Mayo Clinic, COVID 19 COR QUAR SE
   Mayor S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3484
   Mazza MG, 2020, BRAIN BEHAV IMMUN, V89, P594, DOI 10.1016/j.bbi.2020.07.037
   Medina Michelle, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc028
   Medline A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09817-9
   Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2
   Miller DJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243693
   Moreland A, 2020, MMWR-MORBID MORTAL W, V69, P1198, DOI 10.15585/mmwr.mm6935a2
   Mount Sinai, SKIN DISC BLUISH INF
   Natarajan A, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00363-7
   National Institute for Health and Care Excellence, GUID US PULS OX COV
   National Institute of Mental Health, 2016, PAN DIS FEAR OV
   Needleman JS, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02282-8
   Nemours KidsHealth, COR COVID 19 WHAT DO
   Nemours KidsHealth, COR COVID 19 QUAR IS
   Nicklaus Children's Hospital, CYAN
   Nursing World, COR CLIN INF
   Office EE, 2020, J AM MED DIR ASSOC, V21, P948, DOI 10.1016/j.jamda.2020.06.003
   Olaimat AN, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01854
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012
   Panchal N, IMPLICATIONS COVID 1
   Peak CM, 2020, LANCET INFECT DIS, V20, P1025, DOI 10.1016/S1473-3099(20)30361-3
   Pellicori P, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013879
   Public Health Ontario, COVID 19 ROUT TRANSM
   Quintana-Diaz MA, 2020, REV INVEST CLIN, V72, P144, DOI 10.24875/RIC.20000196
   Rader B, 2021, LANCET DIGIT HEALTH, V3, pE148, DOI 10.1016/S2589-7500(20)30293-4
   Robb CE, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.591120
   Rokkas T, 2020, ANN GASTROENTEROL, V33, P355, DOI 10.20524/aog.2020.0506
   Routasalo P, 1996, NURS ETHICS, V3, P165, DOI 10.1177/096973309600300209
   Savaris RF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84092-1
   Shenoy N, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01735-2
   Siebenhaar KU, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567905
   Song WJ, 2021, LANCET RESP MED, V9, P533, DOI 10.1016/S2213-2600(21)00125-9
   Soosaipillai G, 2020, J MED EDUC CURRIC DE, V7, DOI 10.1177/2382120520938706
   Srivastav A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195085
   St Jude Organization, 2021, COVID 19 FEV
   Stainback Kevin, 2020, SOCIOLOGICAL RES DYN, V6, P1, DOI DOI 10.1177/2378023120969339
   Stookey JD, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110237
   Sun SY, 2021, ENVIRON CHEM LETT, V19, P787, DOI 10.1007/s10311-020-01143-1
   Torjesen I, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4151
   Ueki H, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00637-20
   Verhoeven V, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039674
   Wang Q, 2020, INFECT CONT HOSP EP, V41, P746, DOI 10.1017/ice.2020.83
   WHO, THER PAT ED CONT ED
   WHO, ADV PUBL
   World Health Organization, FOOD NUTR TIPS SELF
   World Health Organization (WHO), MOD TRANSM VIR CAUS
   Xiao F, 2020, EMERG INFECT DIS, V26, P1920, DOI 10.3201/eid2608.200681
   Yale Medicine, PULSE OXIMETRY
   Zakout Yosef Mohamed-Azzam, 2020, AIMS Public Health, V7, P664, DOI 10.3934/publichealth.2020052
   Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117
   Zhang T., J MICROBIOL IMMUNOL, DOI [10.1016/j.jmii.2020.10.005, DOI 10.1016/J.JMII.2020.10.005]
NR 153
TC 2
Z9 2
U1 7
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2150-1319
EI 2150-1327
J9 J PRIM CARE COMMUNIT
JI J. Prim. Care Community Health
PD JUN
PY 2021
VL 12
AR 21501327211024400
DI 10.1177/21501327211024400
PG 13
WC Primary Health Care
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA UE6EI
UT WOS:000687978600001
PM 34142617
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Saleem, T
   Sheikh, N
   Abbasi, MH
   Javed, I
   Khawar, MB
AF Saleem, Tayyaba
   Sheikh, Nadeem
   Abbasi, Muddasir Hassan
   Javed, Iram
   Khawar, Muhammad Babar
TI COVID-19 containment and its unrestrained impact on epilepsy management
   in resource-limited areas of Pakistan
SO EPILEPSY & BEHAVIOR
LA English
DT Article
DE COVID-19; Epilepsy; Outcomes; Lockdown; Pandemic; Telemedicine
ID CHALLENGES
AB The current pandemic of coronavirus disease 2019 (COVID-19) that led to an unprecedented crisis with significant health, social, and economic repercussions presented more serious concerns for those living with some chronic conditions such as epilepsy. This study was aimed to find out impact of the COVID-19 pandemic on management of epilepsy. A cross-sectional study was conducted through telephone interviews, targeting 213 caregivers of pediatric patients with epilepsy, belonging to underserved areas of Faisalabad, Punjab, Pakistan. A simple questionnaire was designed to record the responses of participants relevant to the direct and indirect effects of COVID-19 pandemic and their knowledge about possible ways that can be accessed for the management of epilepsy during an ongoing pandemic. The current study, which holds 77% of the respondents from rural areas and 23% from urban settings, showed that partial measures of lockdown taken to stop or slow the spread of COVID-19 resulted in adverse economic and health outcomes in the said population including cancelation of follow-up visits, worsening of seizures, job loss, burden of antiepileptic drugs (AEDs) costs, and discontinuation of medicines. Furthermore, knowledge about alternative ways to access health facilities was found very poor among caregivers. Income sources of poor people disrupted by lockdown can lead to unintentional nonadherence to medication, which is a clear picture of inequitable distribution of resources. This study highlights the major issues faced by the caregivers during this ongoing pandemic of COVID-19. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Saleem, Tayyaba; Sheikh, Nadeem; Khawar, Muhammad Babar] Univ Punjab, Dept Zool, Cell & Mol Biol Lab, Lahore 54590, Pakistan.
   [Abbasi, Muddasir Hassan] Univ Okara, Dept Zool, Renala Khurd 56300, Pakistan.
   [Javed, Iram] Children Hosp & Inst Child Hlth Faisalabad, Dept Pediat Neurol, Faisalabad 38000, Pakistan.
   [Khawar, Muhammad Babar] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China.
   [Khawar, Muhammad Babar] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Sheikh, N (corresponding author), Univ Punjab, Dept Zool, Cell & Mol Biol Lab, Lahore 54590, Pakistan.
EM nadeem.zool@pu.edu.pk
OI Khawar, Muhammad Babar/0000-0002-1812-0591; saleem,
   tayyaba/0000-0003-4920-1463
FU Higher Education Commission, Govt. of PakistanHigher Education
   Commission of Pakistan [8369/PUNJAB/NRPU/RD/HEC/2017]
FX The authors highly acknowledge the role of Higher Education Commission,
   Govt. of Pakistan for Providing funds under grant No.
   8369/PUNJAB/NRPU/R&D/HEC/2017.
CR Adan GH, 2020, CLIN MED, V20, pE104, DOI 10.7861/clinmed.2020-0207
   Ahmed A, 2018, J PAK MED ASSOC, V68, P1820
   Aledo-Serrano A, 2020, EPILEPSIA, V61, P1312, DOI 10.1111/epi.16537
   Basu Saurav, 2020, Indian J Med Ethics, VV, P103, DOI 10.20529/IJME.2020.041
   Beghi E, 2013, EPILEPSIA, V54, P2, DOI 10.1111/epi.12305
   Brigo F, 2020, EPILEPSY BEHAV, V110, DOI 10.1016/j.yebeh.2020.107164
   Chalkidou K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3651
   Chen D, 2020, ACTA EPILEPTOL, V2, P1, DOI [10.1186/s42494-020-00015-z, DOI 10.1186/S42494-020-00015-Z]
   Crepin S, 2009, CLIN NUTR, V28, P219, DOI 10.1016/j.clnu.2009.03.010
   Finance Mo, 2018, PAK EC SURV 2017 18
   French JA, 2020, NEUROLOGY, V94, P1032, DOI 10.1212/WNL.0000000000009632
   Gayatri NA, 2006, DEV MED CHILD NEUROL, V48, P394, DOI 10.1017/S0012162206000843
   Grossman SN, 2020, NEUROLOGY, V94, P1077, DOI 10.1212/WNL.0000000000009677
   Hamed SA, 2014, EPILEPSY BEHAV, V41, P290, DOI 10.1016/j.yebeh.2014.07.003
   Hamza M, 2020, BRIT J SURG, V107, pE193, DOI 10.1002/bjs.11661
   Keezer MR, 2016, LANCET NEUROL, V15, P106, DOI 10.1016/S1474-4422(15)00225-2
   Khan F, 2017, J REHABIL MED, V49, P10, DOI 10.2340/16501977-2149
   Khatri I A, 2003, J Pak Med Assoc, V53, P594
   Kissani N, 2020, EPILEPSY BEHAV, V103, DOI 10.1016/j.yebeh.2019.106854
   Krijgh EJC, 2018, NEUROPEDIATRICS, V49, P279, DOI 10.1055/s-0038-1654708
   Manji H, 2020, J NEUROL NEUROSUR PS, V91, P568, DOI 10.1136/jnnp-2020-323414
   Mogal Z, 2020, EPILEPSY BEHAV, V102, DOI 10.1016/j.yebeh.2019.106637
   Musselwhite K, 2007, INT J NURS STUD, V44, P1064, DOI 10.1016/j.ijnurstu.2006.05.014
   Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6
   Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x
   Radhakrishnan K, 2009, NAT REV NEUROL, V5, P323, DOI 10.1038/nrneurol.2009.53
   Sinha A, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/869572
   Sveinsson O, 2020, NEUROLOGY, V94, pE419, DOI 10.1212/WNL.0000000000008741
   Tatum WO, 2020, JAMA NEUROL, V77, P593, DOI 10.1001/jamaneurol.2019.4785
   Vancini RL, 2020, EPILEPSY BEHAV, V110, DOI 10.1016/j.yebeh.2020.107154
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 31
TC 5
Z9 5
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-5050
EI 1525-5069
J9 EPILEPSY BEHAV
JI Epilepsy Behav.
PD NOV
PY 2020
VL 112
AR 107476
DI 10.1016/j.yebeh.2020.107476
PG 5
WC Behavioral Sciences; Clinical Neurology; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Neurosciences & Neurology; Psychiatry
GA OP3TK
UT WOS:000588004200117
PM 33181895
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Teng, LY
   Tan, QY
   Ehsani, A
AF Teng, Luyan
   Tan, Qinyi
   Ehsani, Ali
TI Assessing the impact of cultural characteristics, economic situations,
   skills and knowledge on the development and success of cloud-based
   e-learning systems in the COVID-19 era
SO KYBERNETES
LA English
DT Article; Early Access
DE Information technology; Cloud computing; Internet; Knowledge; CELS;
   COVID-19
AB Purpose One of the most significant threats of COVID-19 in the world is the closure of universities, schools, training courses and even companies and organizations. In such a situation and with the free time that has arisen, this threat of education closure can become a golden opportunity for learning and progress in virtual education. E-learning uses information technology (IT) to distribute knowledge and information for training and education. Also, cloud computing is a technology utilized in the IT domain. It can be employed in performing e-learning. Therefore, the main goal of this study is to assess the impact of cultural characteristics, economic situations, skills and knowledge on the development and success of CELS in the COVID-19 era. Design/methodology/approach Cloud-based e-learning system (CELS) provides all e-learning requirements like software and hardware resources to promote conventional e-learning technologies. The CELS stands on several factors of diverse aspects that have been of high significance in CELS success. So, these systems must be checked to analyze their significance rate and successfully carry out their effectiveness. On the other hand, these days, the 2019 coronavirus disease (COVID-19) changes our daily lifestyles. Therefore, the present investigation provides a new model investigating the development and success of CELS in the COVID-19 era. Also, an online questionnaire was used to gather the data. The content validity of the questionnaire was obtained by applying the opinions of ten experts from e-learning specialists. The collected data are analyzed using LISREL and Smart PLS software. Findings The results from the path coefficient and the sample t-test have implied that skills and knowledge positively influence CELS in the COVID-19 era. In addition, the relationship between cultural characteristics and CELS in the COVID-19 era has been positive and significant. The relationship between the economic situations and the CELS in the COVID-19 era is positive and significant. Practical implications The proposed model helps managers get a big picture of CELS necessities and more effectively in the COVID-19 era. This research has a unique impact on universities to develop an e-learning platform to facilitate the education process in the COVID-19 era. It provides guidelines for educational institutions to effectively implement the learning management system to facilitate students' education. Originality/value CELS are getting increasingly essential to offer training courses more efficiently in educational institutions. Although the intersection between cloud computing and e-learning has increasingly grown in both practical and academic contexts, few studies on the impact of cultural characteristics, economic situations, skills and knowledge on the development and success of CELS in the COVID-19 era. This paper explores the ignored but critically important subject of CELS. This paper's main contribution is to present a new and integrated model containing the essential aspects of the development and success of CELS in the COVID-19 era. The proposed framework comprises cultural characteristics, economic situations, skills and knowledge aspects simultaneously, as well as sub-criteria denoting each element.
C1 [Teng, Luyan] South China Normal Univ, Sch Educ, Guangzhou, Guangdong, Peoples R China.
   [Teng, Luyan] Shenzhen Inst Educ Sci, Guangzhou, Guangdong, Peoples R China.
   [Tan, Qinyi] Southwest Univ, Ctr Studies Educ & Psychol Ethn Minor Southwest C, Chongqing, Peoples R China.
   [Ehsani, Ali] Arak Univ, Fac Adm Sci & Econ, Dept Ind Management, Arak, Iran.
RP Tan, QY (corresponding author), Southwest Univ, Ctr Studies Educ & Psychol Ethn Minor Southwest C, Chongqing, Peoples R China.
EM luyanteng2@gmail.com; qinyitan2021@gmail.com; a-ehsani@araku.ac.ir
RI Ehsani, Ali/ABF-2713-2020
OI Ehsani, Ali/0000-0001-7873-5371; Tan, Qinyi/0000-0002-2291-4554
FU MOE (Ministry of Education in China) Project of Humanities and Social
   Sciences [16XJC880003]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [SWU1909325]
FX This study was supported by MOE (Ministry of Education in China) Project
   of Humanities and Social Sciences [Grant No. 16XJC880003] and the
   Fundamental Research Funds for the Central Universities [Grant No.
   SWU1909325].
CR Aghajani G, 2018, ENERGY REP, V4, P218, DOI 10.1016/j.egyr.2017.10.002
   Al-Fraihat D, 2020, COMPUT HUM BEHAV, V102, P67, DOI 10.1016/j.chb.2019.08.004
   Alqaralleh B.A., 2019, INT J ENG TECHNOLOGY, V8, P517
   Aoki, 2010, WORLD ACADEMY OF SCI, V66, P868
   Aparicio M, 2017, COMPUT HUM BEHAV, V66, P388, DOI 10.1016/j.chb.2016.10.009
   Aparicio M, 2016, INTERNET HIGH EDUC, V31, P58, DOI 10.1016/j.iheduc.2016.06.003
   Bratianu C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041348
   Cai W, 2019, RENEW ENERG, V143, P1, DOI 10.1016/j.renene.2019.05.008
   Chang JH, 2018, INT REV RES OPEN DIS, V19, P1
   Chang JS, 2020, INT J INJ CONTROL SA, V27, P447, DOI 10.1080/17457300.2020.1810073
   Cheng YM, 2021, J ENTERP INF MANAG, V34, P1169, DOI 10.1108/JEIM-12-2019-0401
   Chin WW, 1998, QUANT METH SER, P295
   Chiregi Matin, 2018, Journal of Electrical Systems and Information Technology, V5, P608, DOI 10.1016/j.jesit.2017.09.001
   Cidral WA, 2018, COMPUT EDUC, V122, P273, DOI 10.1016/j.compedu.2017.12.001
   Cooperation  O.F.E. Development, 2018, WORKING PAPERS
   Darbandi M, 2012, P INT C SCI COMP CSC
   Darbi M., 2017, HCTL INT J TECHNOLOG, V24, P1, DOI DOI 10.5281/ZENODO.1034475
   Dominici G, 2013, BUS HORIZONS, V56, P87, DOI 10.1016/j.bushor.2012.09.011
   El Mhouti A, 2018, EDUC INF TECHNOL, V23, P893, DOI 10.1007/s10639-017-9642-x
   Eom SB, 2018, DECIS SCI-J INNOV ED, V16, P42, DOI 10.1111/dsji.12144
   Falk R. F, 1992, PRIMER SOFT MODELING
   Fasihuddin H., 2012, IEEE INT C TEACH ASS IEEE INT C TEACH ASS
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gefen D, 2005, COMMUN ASSOC INF SYS, V16, P91, DOI 10.17705/1CAIS.01605
   Ghadimi N., 2015, INT J PHYS SCI, V10, P123, DOI DOI 10.5897/IJPS2014.4231
   Ghomi EJ, 2017, J NETW COMPUT APPL, V88, P50, DOI 10.1016/j.jnca.2017.04.007
   Hajizadeh R, 2017, KYBERNETES, V46, P1245, DOI 10.1108/K-02-2017-0070
   Hamian M, 2018, ENG APPL ARTIF INTEL, V72, P203, DOI 10.1016/j.engappai.2018.03.022
   Hashim N.A., 2019, 2019 INT C EL ENG IN 2019 INT C EL ENG IN
   Hinon K., 2019, INT C INT COLL LEARN INT C INT COLL LEARN
   Islam AKMN, 2013, COMPUT EDUC, V69, P387, DOI 10.1016/j.compedu.2013.07.037
   Lee MC, 2010, COMPUT EDUC, V54, P506, DOI 10.1016/j.compedu.2009.09.002
   Lin HM, 2020, BRIT J EDUC TECHNOL, V51, P1354, DOI 10.1111/bjet.12890
   Mayer RE, 2017, J COMPUT ASSIST LEAR, V33, P403, DOI 10.1111/jcal.12197
   Mayer RE, 2020, LEARN INSTR, V70, DOI 10.1016/j.learninstruc.2019.05.010
   Navimipour NJ, 2015, COMPUT HUM BEHAV, V53, P475, DOI 10.1016/j.chb.2015.07.026
   Nguyen T.D., 2014, INT C COMP SCI ITS A INT C COMP SCI ITS A
   Pisirir E, 2020, KYBERNETES, V49, P982, DOI 10.1108/K-12-2018-0663
   Popel M.V., 2019, P 6 WORKSH CLOUD TEC P 6 WORKSH CLOUD TEC
   Rahim S., 2021, INT C COMP INT INF S INT C COMP INT INF S
   Rodrigues MW, 2018, TELEMAT INFORM, V35, P1701, DOI 10.1016/j.tele.2018.04.015
   Shahzad Arfan, 2020, Qual Quant, P1, DOI 10.1007/s11135-020-01028-z
   Singh U., 2017, INT RES J ENG TECHNO, V9, P10
   Subramanian N, 2018, COMPUT ELECTR ENG, V71, P28, DOI 10.1016/j.compeleceng.2018.06.006
   Sun PC, 2008, COMPUT EDUC, V50, P1183, DOI 10.1016/j.compedu.2006.11.007
   Tashkandi AN, 2015, CLUSTER COMPUT, V18, P1527, DOI 10.1007/s10586-015-0490-4
   Vu D. H., 2019, J CRITICAL REV, V6, P1, DOI DOI 10.22159/JCR.06.04.01
   Wolfschwenger P, 2020, PROC FRONT EDUC CONF
   Wu JH, 2010, COMPUT EDUC, V55, P155, DOI 10.1016/j.compedu.2009.12.012
NR 49
TC 0
Z9 0
U1 3
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0368-492X
EI 1758-7883
J9 KYBERNETES
JI Kybernetes
DI 10.1108/K-12-2020-0838
EA JUL 2021
PG 19
WC Computer Science, Cybernetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA TI4PT
UT WOS:000672782500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Russo, A
   Minichini, C
   Starace, M
   Astorri, R
   Calo, F
   Coppola, N
AF Russo, Antonio
   Minichini, Carmine
   Starace, Mario
   Astorri, Roberta
   Calo, Federica
   Coppola, Nicola
CA Vanvitelli Covid-19 Grp
TI Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review
SO INFECTION AND DRUG RESISTANCE
LA English
DT Review
DE COVID-19; SARS-CoV-2; laboratory diagnosis; serological test; PCR
ID SARS CORONAVIRUS; SPIKE; 2019-NCOV; EVOLUTION; WUHAN
AB The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the related disease (COVID-19) has spread rapidly to pandemic proportions, increasing the demands on healthcare systems for the containment and management of COVID-19. One of the critical issues to be addressed is the improvement in laboratory diagnosis and screening of large portions of the population to stop the virus spreading. Currently, the laboratory diagnosis of SARS-CoV-2 infection and the related disease is based on the research of viral RNA with rt-PCR methods in upper and lower respiratory airways. Serological tests to detect SARS-CoV-2 antibodies could help physicians and healthcare workers to support COVID-19 diagnosis and follow-up and perform population screening. Our review, using MEDLINE and EMBASE, summarizes the current knowledge of direct and serological tests performed to research RNA, antigens, or antibodies for SARS-CoV-2, evaluating the advantages and drawbacks for specific tests.
C1 [Russo, Antonio; Minichini, Carmine; Starace, Mario; Astorri, Roberta; Calo, Federica; Coppola, Nicola; Vanvitelli Covid-19 Grp] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Publ Med, Infect Dis Unit, Via L Armanni 5, I-80131 Naples, Italy.
RP Coppola, N (corresponding author), Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Publ Med, Infect Dis Unit, Via L Armanni 5, I-80131 Naples, Italy.
EM nicola.coppola@unicampania.it
OI Russo, Antonio/0000-0002-4224-5343
CR [Anonymous], 2020, CLIN CHEM, DOI DOI 10.1093/CLINCHEM/HVAA099
   Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005
   Baek YH, 2020, EMERG MICROBES INFEC, V9, P998, DOI 10.1080/22221751.2020.1756698
   Cassaniti I, 2020, J MED VIROL, V92, P1724, DOI 10.1002/jmv.25800
   Castro R, 2020, BRAZ J INFECT DIS, V24, P180, DOI 10.1016/j.bjid.2020.04.003
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Che XY, 2005, J INFECT DIS, V191, P2033, DOI 10.1086/430355
   Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301
   Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   European Centre for Disease Prevention and Control, OV RAP TEST SIT COVI
   GUO GQ, 2020, FRONT CELL DEV BIOL, V8, DOI DOI 10.3389/FCELL.2020.004107
   Guo WL, 2020, CLIN INFECT DIS, V71, P1980, DOI 10.1093/cid/ciaa416
   Han Y, 2020, J MED VIROL, V92, P639, DOI 10.1002/jmv.25749
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang WE, 2020, MICROB BIOTECHNOL, V13, P950, DOI 10.1111/1751-7915.13586
   Kang ST, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105950
   Khailany RA, 2020, GENE REP, V19, DOI 10.1016/j.genrep.2020.100682
   Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343
   Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200
   Kumar Swatantra, 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00571-5
   Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Li YC, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100984
   Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727
   Lippi G, 2020, CLIN CHEM LAB MED, DOI [10.1515/cclm-2020-0285, DOI 10.1515/CCLM-2020-028543]
   Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158
   LIU Y, 2020, LANCET INFECT DIS
   Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095
   Long Q.-X., 2020, NAT MED, P1, DOI [10.1038/s41591-020-0897-1, DOI 10.1038/S41591-020-0897-1]
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mahmood S, 2020, JMIR PUBLIC HLTH SUR, V6, P226, DOI 10.2196/18980
   Marfella R, 2020, DIABETES METAB, V46, P403, DOI 10.1016/j.diabet.2020.05.005
   Mousavizadeh L, 2020, J MICROBIOL IMMUNOL, DOI [10.1016/j.jmii.2020.03.02222, DOI 10.1016/J.JMII.2020.03.02222]
   Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9
   Padoan A, 2020, CLIN CHEM LAB MED, V58, P1081, DOI 10.1515/cclm-2020-0443
   Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212
   Petherick A, 2020, LANCET, V395, P1101, DOI 10.1016/S0140-6736(20)30788-1
   Sagnelli C, 2020, J INFECTION, V81, P980, DOI 10.1016/j.jinf.2020.05.043
   Sardu C, 2020, DIABETES CARE, V43, P1408, DOI 10.2337/dc20-0723
   To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1
   VASHIST SK, 2020, DIAGNOSTICS, V10, DOI DOI 10.3390/DIAGN0STICS10040202
   Vermeiren C, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00669-20
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang Q, 2020, CELL, DOI 10.1016/j.cell.2020.03.045
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001
   Xiao AT, 2020, J MED VIROL, V92, P1755, DOI 10.1002/jmv.25855
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762
   Yang PH, 2020, CELL MOL IMMUNOL, V17, P555, DOI 10.1038/s41423-020-0407-x
   Yang RR, 2020, RESP MED, V165, DOI 10.1016/j.rmed.2020.105935
   YANG T, 2020, DIAGNOSTICS, V10, DOI DOI 10.3390/DIAGN0STICS10030165.47
   Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
   Zhang LQ, 2006, J MED VIROL, V78, P1, DOI 10.1002/jmv.20499
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 64
TC 30
Z9 31
U1 17
U2 23
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6973
J9 INFECT DRUG RESIST
JI Infect. Drug Resistance
PY 2020
VL 13
BP 2657
EP 2665
DI 10.2147/IDR.S264020
PG 9
WC Infectious Diseases; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Pharmacology & Pharmacy
GA MU7BE
UT WOS:000555824100001
PM 32801804
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Akkus, MH
   Kaman, O
   Dogan, M
AF Akkus, Mehmet Hadi
   Kaman, Omur
   Dogan, Mutlu
TI Alectinib continuation during COVID 19 'antiviral' treatment: Risk or
   benefit?
SO JOURNAL OF ONCOLOGY PHARMACY PRACTICE
LA English
DT Article
DE Alectinib; covid 19; favipiravir
ID LUNG-CANCER
AB Introduction
   Serious Acute Respiratory Syndrome Coronavirus 2 (SARSCoV2) has led to COVID 19 pandemic a year ago and it has not been globally taken under control yet. COVID 19 tends to have poorer prognosis in cancer patients. Additionally, we have no well-established guidelines for management of these patients during pandemic, in terms of treatment of 'cancer' and treatment of 'COVID 19'. Tyrosine kinase inhibitors (TKIs) are given without any break in cancer patients to have better survival outcomes in daily routine. However, there is no well-established data to continue or delay ALK inhibitors in lung cancer patients infected with SARS-CoV2. Concomittant use of ALK inhibitors and COVID 19 antiviral treatment is a dilemma because of the lack of data in this area.
   Case Report
   A 47-year old female metastatic ALK positive nonsquamous cell lung cancer patient on alectinib, a second generation ALK inhibitor was diagnosed with symptomatic COVID 19. She was given favipiravir for COVID 19 while continuing alectinib.
   Management and outcome: The patient continued alectinib during COVID 19 antiviral treatment without any break. She tolerated 'concomittant' alectinib & favipiravir. She had partial remission after three months of alectinib without any dose adjustment despite active COVID 19 medication.
   Discussion
   To best of our knowledge, this is the first case who continued alectinib without dose adjustment during antiviral COVID-19 medication without clinically worsening. There is limited data about 'concomittant' use of TKIs and antiviral COVID 19 medication in the literature. There are some case reports, but they generally tended to delay or suspend TKIs during COVID 19 antiviral medication. Our case differs from them in terms of continuation of alectinib without any break or additional side effects during favipiravir for symptomatic COVID 19. We consider that our case might contribute to the literature in terms of management of cancer patients on targeted therapy during COVID 19 antiviral treatment. However, clinical trials are needed in this area.
C1 [Akkus, Mehmet Hadi; Kaman, Omur; Dogan, Mutlu] Univ Hlth Sci, Dr Abdurrahman Yurtaslan Ankara Oncol Training &, Dept Med Oncol, TR-06200 Ankara, Turkey.
RP Dogan, M (corresponding author), Univ Hlth Sci, Dr Abdurrahman Yurtaslan Ankara Oncol Training &, Dept Med Oncol, TR-06200 Ankara, Turkey.
EM mutludogan1@yahoo.com
OI Dogan, Mutlu/0000-0001-9359-3770
CR Agrawal Umang, 2020, Med J Armed Forces India, V76, P370, DOI 10.1016/j.mjafi.2020.08.004
   Al-Shamsi HO, 2020, ONCOLOGIST, V25, pE936, DOI 10.1634/theoncologist.2020-0213
   [Anonymous], 2021, TURKISH NATL COVID 1
   [Anonymous], 2020, WHO ANNOUNCES COVID
   Desai A, 2020, JCO GLOB ONCOL, V6, P557, DOI 10.1200/GO.20.00097
   Dingemans AMC, 2020, J THORAC ONCOL, V15, P1119, DOI 10.1016/j.jtho.2020.05.001
   Erdem HA, 2021, TURK J MED SCI, V51, P912, DOI 10.3906/sag-2008-33
   Ghasemnejad-Berenji M, 2021, DRUG RES, V71, P166, DOI 10.1055/a-1296-7935
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Karacin C, 2021, SUPPORT CARE CANCER, V29, P4587, DOI 10.1007/s00520-021-06001-6
   Leonetti A, 2020, EUR J CANCER, V132, P122, DOI 10.1016/j.ejca.2020.04.004
   Montrone M, 2020, EUR J CANCER, V138, P109, DOI 10.1016/j.ejca.2020.07.030
   Nakagawa T, 2018, XENOBIOTICA, V48, P546, DOI 10.1080/00498254.2017.1344910
   Piroth L, 2021, LANCET RESP MED, V9, P251, DOI 10.1016/S2213-2600(20)30527-0
   Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2
   Surmelioglu N, 2020, J CRIT INTENS CARE, V11, P43, DOI 10.37678/dcybd.2020.2409
NR 16
TC 1
Z9 1
U1 1
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1078-1552
EI 1477-092X
J9 J ONCOL PHARM PRACT
JI J. Oncol. Pharm. Pract.
PD JUL
PY 2021
VL 27
IS 5
BP 1251
EP 1254
AR 10781552211020100
DI 10.1177/10781552211020100
EA MAY 2021
PG 4
WC Oncology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pharmacology & Pharmacy
GA TC4GF
UT WOS:000656014800001
PM 34038226
DA 2022-04-20
ER

PT J
AU Wexner, SD
   Cortes-Guiral, D
   Gilshtein, H
   Kent, I
   Reymond, MA
AF Wexner, S. D.
   Cortes-Guiral, D.
   Gilshtein, H.
   Kent, I.
   Reymond, M. A.
TI COVID-19: impact on colorectal surgery
SO COLORECTAL DISEASE
LA English
DT Article
DE Coronavirus; COVID-19; pandemic; transmission
ID PERITONEAL CARCINOMATOSIS; CHEMOTHERAPY; AEROSOL; SAFETY
AB Aim The rapid spread of the COVID-19 pandemic has created unprecedented challenges for the medical and surgical healthcare systems. With the ongoing need for urgent and emergency colorectal surgery, including surgery for colorectal cancer, several questions pertaining to operating room (OR) utilization and techniques needed to be rapidly addressed.
   Method This manuscript discusses knowledge related to the critical considerations of patient and caregiver safety relating to personal protective equipment (PPE) and the operating room environment.
   Results During the COVID-19 pandemic, additional personal protective equipment (PPE) may be required contingent upon local availability of COVID-19 testing and the incidence of known COVID-19 infection in the respective community. In addition to standard COVID-19 PPE precautions, a negative-pressure environment, including an OR, has been recommended, especially for the performance of aerosol-generating procedures (AGPs). Hospital spaces ranging from patient wards to ORs to endoscopy rooms have been successfully converted from standard positive-pressure to negative-pressure spaces. Another important consideration is the method of surgical access; specifically, minimally invasive surgery with pneumoperitoneum is an AGP and thus must be carefully considered. Current debate centres around whether it should be avoided in patients known to be infected with SARS-CoV-2 or whether it can be performed under precautions with safety measures in place to minimize exposure to aerosolized virus particles. Several important lessons learned from pressurized intraperitoneal aerosolized chemotherapy procedures are demonstrated to help improve our understanding and management.
   Conclusion This paper evaluates the issues surrounding these challenges including the OR environment and AGPs which are germane to surgical practices around the world. Although there is no single universally agreed upon set of answers, we have presented what we think is a balanced cogent description of logical safe approaches to colorectal surgery during the COVID-19 pandemic.
C1 [Wexner, S. D.; Gilshtein, H.; Kent, I.] Cleveland Clin Florida, Dept Colorectal Surg, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA.
   [Cortes-Guiral, D.] King Khalid Hosp, Dept Colorectal Surg, Nejran, Saudi Arabia.
   [Reymond, M. A.] Natl Ctr Pleura & Peritoneum NCPP, Dept Gen & Transplant Surg, Tubingen, Germany.
RP Wexner, SD (corresponding author), Cleveland Clin Florida, Dept Colorectal Surg, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA.
EM wexners@ccf.org
CR Alyami M, 2019, LANCET ONCOL, V20, pE368, DOI 10.1016/S1470-2045(19)30318-3
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Cazauran JB, 2018, J GASTROINTEST SURG, V22, P374, DOI 10.1007/s11605-017-3565-0
   Chan Jasper FW, 2019, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chow TT, 2006, J HOSP INFECT, V64, P371, DOI 10.1016/j.jhin.2006.07.020
   Di Napoli R, 2020, FEATURES EVALUATION
   GLOSTER HM, 1995, J AM ACAD DERMATOL, V32, P436, DOI 10.1016/0190-9622(95)90065-9
   Graversen M, 2016, PLEURA PERITONEUM, V1, P203, DOI [10.1515/pap-2016-0019, 10.1515/pp-2016-0019]
   Guggemos, 2020, NATURE          0401, V581, DOI [10.1038/s41586-020-2196-x, DOI 10.1038/s41586-020-2196-x]
   Hensman C, 1998, SURG ENDOSC-ULTRAS, V12, P1017, DOI 10.1007/s004649900771
   Kettleson EM, 2009, ENVIRON SCI TECHNOL, V43, P5940, DOI 10.1021/es803289w
   Ladhani L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174314
   Mintz Y, 2020, ANN SURG, V272, pE7, DOI 10.1097/SLA.0000000000003965
   Odendahl K, 2015, EJSO-EUR J SURG ONC, V41, P1379, DOI 10.1016/j.ejso.2015.06.001
   Repici A, 2020, GASTROINTEST ENDOSC, V92, P192, DOI 10.1016/j.gie.2020.03.019
   Robella M, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0892-7
   Sadrizadeh S, 2014, J INFECT PUBLIC HEAL, V7, P508, DOI 10.1016/j.jiph.2014.07.011
   Seitenfus Rafael, 2018, Rev Col Bras Cir, V45, pe1909, DOI 10.1590/0100-6991e-20181909
   Solass W, 2014, ANN SURG ONCOL, V21, P553, DOI 10.1245/s10434-013-3213-1
   Solass W, 2013, ANN SURG ONCOL, V20, P3504, DOI 10.1245/s10434-013-3039-x
   Ti LK, 2020, CAN J ANESTH, V67, P756, DOI 10.1007/s12630-020-01617-4
   Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731
   WHO, PNEUM UNKN CAUS CHIN
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924
NR 25
TC 34
Z9 40
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8910
EI 1463-1318
J9 COLORECTAL DIS
JI Colorectal Dis.
PD JUN
PY 2020
VL 22
IS 6
BP 635
EP 640
DI 10.1111/codi.15112
EA MAY 2020
PG 6
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA LY1SX
UT WOS:000534597500001
PM 32359223
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Geleta, TA
   Deriba, BS
   Jemal, K
AF Geleta, Tinsae Abeya
   Deriba, Berhanu Senbeta
   Jemal, Kemal
TI Evaluation of the Knowledge, Attitude, and Practice of COVID-19
   Prevention Methods Among Hypertensive Patients in North Shoa, Ethiopia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19 pandemic; hypertension patients; coronavirus
ID RESIDENTS
AB Introduction: The occurrence of coronavirus diseases 2019 (COVID-19) has affected more than 247 million populations around the world. People with comorbidities such as hypertension, diabetes mellitus, congestive heart failure, kidney disease, elderly people, and people with weak immunity develop severe types of COVID-19 if exposed to the disease. Therefore, this study aimed to assess knowledge, attitude, and practice of COVID-19 prevention methods among hypertensive patients in North Shoa, Oromia region, Ethiopia. Methods: An institutional-based cross-sectional study was conducted from May 5/2020 to June 5/2020 in public hospitals in the North Shoa zone, Ethiopia. Data were collected using a structured questionnaire and study participants were recruited using a simple random sampling technique. The data were checked for completeness and entered into the EpiData manager version 4.4.1 and transferred to SPSS version 23 for analysis purposes. Bivariate and multivariate logistic regression were computed and a significant association was declared with a p-value less than 0.05. Results: A total of 360 (97.0%) hypertension patients responded. This study revealed that 210 (58.3%) study participants had good knowledge of COVID-19 prevention methods, 199 (55.3%) had a favorable attitude towards COVID-19 prevention methods, and 210 (58.3%) hypertension patients at follow-up practiced COVID-19 prevention methods. Respondents who received less than two thousand Ethiopian birrs monthly and respondents who followed electronic news media were significantly associated with the use of sanitizer, respondents who had a favorable attitude towards the COVID-19 prevention method were significantly associated with mask-wearing, and respondents who received less than two thousand Ethiopian birrs monthly were significantly associated with maintaining a physical distance. Conclusion: Generally, this study finding revealed that the level of knowledge, attitude, and practice towards COVID-19 prevention among hypertension patients was low. Therefore, increasing knowledge, attitude, and practice on COVID-19 among hypertension patients requires a coordinated effort from the government, non-government, and health professionals.
C1 [Geleta, Tinsae Abeya; Deriba, Berhanu Senbeta] Salale Univ, Dept Publ Hlth, Coll Hlth Sci, Fitche, Ethiopia.
   [Jemal, Kemal] Salale Univ, Coll Hlth Sci, Dept Nursing, Fitche, Ethiopia.
RP Geleta, TA (corresponding author), Salale Univ, Dept Publ Hlth, Coll Hlth Sci, Fitche, Ethiopia.
EM bakoabeya@gmail.com
OI Jemal, Kemal/0000-0001-8922-1827; Senbeta, Berhanu/0000-0002-4282-1427
FU Salale University
FX The Salale University supports this research work. The sponsors had no
   role in study design, data collection, analysis, decision to publish, or
   manuscript preparation.
CR Ajay K, 2020, EUR SCI J, V16, P53
   Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Amsalu B, 2021, J MULTIDISCIP HEALTH, V14, P219, DOI 10.2147/JMDH.S292409
   Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Bekele D, 2020, KNOWLEDGE PRACTICE C, DOI [10.1101/2020.06.01.127381, DOI 10.1101/2020.06.01.127381]
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chuka A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237333
   Deriba BS, 2020, PATIENT PREFER ADHER, V14, P1923, DOI 10.2147/PPA.S276254
   Desalegn Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244780
   ECDC, 2020, EUR CENT DIS CONTR P, V2019, P1
   Erfani A, 2020, KBS NEWS
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   FMOH, 2020, NAT COMPR COVID19 MA
   Gebretsadik D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246154
   Ghosh A, 2020, DIABETES METAB SYND, V14, P917, DOI 10.1016/j.dsx.2020.05.044
   Iradukunda PG, 2021, J COMMUN HEALTH, V46, P245, DOI 10.1007/s10900-020-00938-1
   Kassa AM, 2020, RES REP TROP MED, V11, P129, DOI 10.2147/RRTM.S283043
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744
   Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z
   Kumar Sanjiv, 2012, Indian J Community Med, V37, P5, DOI 10.4103/0970-0218.94009
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   Mackenzie JS, 2020, MICROBIOL AUST, V41, P45, DOI 10.1071/MA20013
   Mechessa DF, 2020, INT J GEN MED, V13, P507, DOI 10.2147/IJGM.S263665
   Negera E, 2020, INADEQUATE LEVEL KNO, DOI [10.1101/2020.07.22.215590, DOI 10.1101/2020.07.22.215590]
   Nigussie TF, 2020, GLOB SCI J, V8, P1283
   Pal R, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108344
   Raghupathi W, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030431
   Taye GM, 2020, INFECT DRUG RESIST, V13, P4203, DOI 10.2147/IDR.S283999
   WHO, 2021, STAT 2 M INT HLTH RE
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Yoseph A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246283
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 33
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2022
VL 15
BP 457
EP 471
DI 10.2147/RMHP.S347105
PG 15
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZU9TY
UT WOS:000770181500001
PM 35300276
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Assiri, A
   Iqbal, MJ
   Gramish, J
   Assiri, A
   Meraya, A
   Alhossan, A
   Khobrani, M
AF Assiri, Abdullah
   Iqbal, Mir Javid
   Gramish, Jawaher
   Assiri, Ahmed
   Meraya, Abdulkarim
   Alhossan, Abdulaziz
   Khobrani, Moteb
TI Pharmacists' satisfaction with their involvement in the management of
   COVID-19 patients in Saudi Arabia
SO SAUDI PHARMACEUTICAL JOURNAL
LA English
DT Article
DE Pharmacist; COVID-19; Satisfaction; Underutilized; Saudi Arabia
AB Introduction: The Coronavirus Disease 2019 (COVID-19) is a public health emergency and during this unprecedented situation, health care providers across the globe are at the frontline in the fight against this disease. Countries that have been severely hit by the pandemic are using pharmacists to help triage patients. In order to ensure the continuity of these services, it is of paramount importance that pharmacists be formally involved and engaged in the management of this pandemic. In response to the underlying knowledge deficit, this study was undertaken as the first of its kind in the entirety of Saudi Arabia.
   Methods: This study is a questionnaire based cross-sectional study that was carried out for a period of five months from March 2020 to July 2020 to assess the role of working pharmacists in the management of the COVID-19 pandemic under different health care settings across Saudi Arabia.
   Results: A total of 398 responses were recorded, in which 51.1% of the respondents were not involved in any learning or awareness activities involving health care providers (HCPs) or patients. The majority of respondents (62.9%) were not involved in creating or evaluating therapeutic plans for COVID19 patients, and 55% were not involved in therapeutic mentoring of COVID19 patients. Only a very low percentage of respondents were participating in COVID19-related research within their institution. Only 37% of respondents reported being satisfied with their role and contribution in the management of COVID-19.
   Conclusion: The present study reveals that pharmacists are underutilized in the management of COVID-19 patients in Saudi Arabia. As such, the findings emphasize the importance of enhancing the role and contribution of pharmacists in patient care management across all hospitals and especially under health care crisis conditions. The establishment of a crisis standard of care guideline for all HCPs, including pharmacists, would help in improving patient overall care under crisis conditions like the present COVID-19 pandemic. (C) 2020 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
C1 [Assiri, Abdullah; Iqbal, Mir Javid; Khobrani, Moteb] King Khalid Univ, Dept Clin Pharm, Coll Pharm, Abha, Saudi Arabia.
   [Gramish, Jawaher] King Saud Bin Abdulaziz Univ Hlth Sci, Dept Pharm Practice, Coll Pharm, Riyadh, Saudi Arabia.
   [Assiri, Ahmed] Asir Cent Hosp, Dept Pharm Serv, Abha, Saudi Arabia.
   [Meraya, Abdulkarim] Jazan Univ, Dept Clin Pharm, Coll Pharm, Jazan, Saudi Arabia.
   [Alhossan, Abdulaziz] King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia.
RP Alhossan, A (corresponding author), King Saud Univ, Dept Clin Pharm, Riyadh, Saudi Arabia.
EM alhossan@ksu.edu.sa
FU Institute of Research and Consulting Studies at King Khalid University
   [13-68-S-2020]
FX The authors are thankful to the Institute of Research and Consulting
   Studies at King Khalid University for supporting this research through
   grant number #13-68-S-2020. In addition, the authors would like to
   acknowledge with great appreciation the Scientific Deanship at King
   Khalid University, Abha, Saudi Arabia for their administrative and
   technical support.
CR Ahmad A, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00243-1
   Al-jedai A, 2016, CAN J HOSP PHARM, V69, P231
   Alan E, 2020, J AM COLL CLIN PHARM, V3, P564, DOI 10.1002/jac5.1253
   [Anonymous], R PROJECT STAT COMPU
   Benslimane N, 2016, STUD HEALTH TECHNOL, V226, P201, DOI 10.3233/978-1-61499-664-4-201
   Bukhari N, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00210-w
   Foddy W, 1996, QUAL QUANT, V30, P361
   Hilton CE, 2017, INT J SOC RES METHOD, V20, P21, DOI 10.1080/13645579.2015.1091640
   Jalil MA, 2020, DISASTER MED PUBLIC, V14, P782, DOI 10.1017/dmp.2020.186
   Kalton, 1991, J OFF STAT, V7, P349
   NCPA, 2020, PHARMACISTS FRONT LI
   Rasheed MK, 2019, J PHARM HEALTH SERV, V10, P101, DOI 10.1111/jphs.12264
   Tan SL, 2020, AM J HEALTH-SYST PH, V77, P1096, DOI 10.1093/ajhp/zxaa120
   Visacri M.B., 2020, RES SOC ADMINIS PHAR
   WHO, 2020, PANDEMIC COVID 19 PR
NR 15
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-0164
EI 2213-7475
J9 SAUDI PHARM J
JI Saudi Pharm. J.
PD JAN
PY 2021
VL 29
IS 1
BP 85
EP 90
DI 10.1016/j.jsps.2020.12.009
EA FEB 2021
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA QL3TW
UT WOS:000621003400009
PM 33437172
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Glowacka, M
   Lipka, S
   Mlynarska, E
   Franczyk, B
   Rysz, J
AF Glowacka, Marta
   Lipka, Sara
   Mlynarska, Ewelina
   Franczyk, Beata
   Rysz, Jacek
TI Acute Kidney Injury in COVID-19
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE COVID-19; acute kidney injury; RRT; dialysis
ID AKI
AB COVID-19 is mainly considered a respiratory illness, but since SARS-CoV-2 uses the angiotensin converting enzyme 2 receptor (ACE2) to enter human cells, the kidney is also a target of the viral infection. Acute kidney injury (AKI) is the most alarming condition in COVID-19 patients. Recent studies have confirmed the direct entry of SARS-CoV-2 into the renal cells, namely podocytes and proximal tubular cells, but this is not the only pathomechanism of kidney damage. Hypovolemia, cytokine storm and collapsing glomerulopathy also play an important role. An increasing number of papers suggest a strong association between AKI development and higher mortality in COVID-19 patients, hence our interest in the matter. Although knowledge about the role of kidneys in SARS-CoV-2 infection is changing dynamically and is yet to be fully investigated, we present an insight into the possible pathomechanisms of AKI in COVID-19, its clinical features, risk factors, impact on hospitalization and possible ways for its management via renal replacement therapy.
C1 [Glowacka, Marta; Lipka, Sara; Mlynarska, Ewelina; Franczyk, Beata; Rysz, Jacek] Med Univ Lodz, Dept Nephrol Hypertens & Family Med, PL-90549 Lodz, Poland.
RP Mlynarska, E (corresponding author), Med Univ Lodz, Dept Nephrol Hypertens & Family Med, PL-90549 Lodz, Poland.
EM marta.glowacka96@gmail.com; saralipka@wp.pl; emmlynarska@gmail.com;
   bfranczyk-skora@wp.pl; jacek.rysz@umed.lodz.pl
RI Franczyk, Beata/AAG-2657-2019; Rysz, Jacek/L-8313-2013
OI Franczyk, Beata/0000-0003-4060-8822; Rysz, Jacek/0000-0002-2757-6443;
   Mlynarska, Ewelina/0000-0002-6799-4746; Glowacka,
   Marta/0000-0002-6599-1752
CR Ahmed Adeel Rafi, 2020, World J Nephrol, V9, P18, DOI 10.5527/wjn.v9.i2.18
   Arnold F, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-02150-8
   Behzad S, 2020, CLIN IMAG, V66, P35, DOI 10.1016/j.clinimag.2020.05.013
   Braun F, 2020, LANCET, V396, P597, DOI 10.1016/S0140-6736(20)31759-1
   Chan LL, 2021, J AM SOC NEPHROL, V32, P151, DOI [10.1681/ASN.2020050615, 10.33982/clr.2021.11.30.151]
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Costa Rafael Lessa da, 2021, Braz. J. Nephrol., V43, P349, DOI [10.1590/2175-8239-JBN-2020-0144, 10.1590/2175-8239-jbn-2020-0144]
   Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2
   D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556
   Di Mario F, 2021, J CRIT CARE, V63, P22, DOI 10.1016/j.jcrc.2021.01.013
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   European Society of Cardiology, 2020, POS STAT ESC COUNC H
   Farkash EA, 2020, J AM SOC NEPHROL, V31, P1683, DOI 10.1681/ASN.2020040432
   Ferlicot S, 2021, NEPHROL DIAL TRANSPL, V36, P1253, DOI 10.1093/ndt/gfab042
   Fisher M, 2020, J AM SOC NEPHROL, V31, P2145, DOI 10.1681/ASN.2020040509
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Henry BM, 2020, INT UROL NEPHROL, V52, P1193, DOI 10.1007/s11255-020-02451-9
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Khan S, 2020, J AM SOC NEPHROL, V31, P2746, DOI 10.1681/ASN.2020081229
   Kissling S, 2020, KIDNEY INT, V98, P228, DOI 10.1016/j.kint.2020.04.006
   [李仲平 Li Zhongping], 2020, [中国软科学, China Soft Science], P1
   Morales DR, 2021, LANCET DIGIT HEALTH, V3, pe98, DOI 10.1016/S2589-7500(20)30289-2
   Nadim MK, 2020, NAT REV NEPHROL, V16, P747, DOI 10.1038/s41581-020-00356-5
   Nugent J, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1095
   Oran DP, 2021, ANN INTERN MED, V174, P655, DOI 10.7326/M20-6976
   Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1
   Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276
   Peleg Y, 2020, KIDNEY INT REP, V5, P940, DOI 10.1016/j.ekir.2020.04.017
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Rahman N, 2020, MOLECULES, V25, DOI 10.3390/molecules25102271
   Ramirez-Sandoval Juan C, 2021, Blood Purif, V50, P355, DOI 10.1159/000510996
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2098, DOI 10.1001/jama.2020.7681
   Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0
   Ronco C, 2020, NAT REV NEPHROL, V16, P308, DOI 10.1038/s41581-020-0284-7
   Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744
   Sharma P, 2020, J AM SOC NEPHROL, V31, P1948, DOI 10.1681/ASN.2020050699
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   ZHOU P, 2020, NATURE          0203, pNIL1, DOI DOI 10.1038/s41586-020-2012-7
NR 43
TC 4
Z9 4
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2021
VL 22
IS 15
AR 8081
DI 10.3390/ijms22158081
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA TV7QY
UT WOS:000681914500001
PM 34360866
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Van Assche, A
   Lundan, S
AF Van Assche, Ari
   Lundan, Sarianna
TI From the editor: COVID-19 and international business policy
SO JOURNAL OF INTERNATIONAL BUSINESS POLICY
LA English
DT Editorial Material
DE COVID-19; MNE; policy; intangibles; globalization
ID KNOWLEDGE; BUZZ
AB We introduce a special collection of papers on COVID-19 and international business policy that looks at the global policy challenge from different perspectives. The combination of confinement and protectionist measures including export bans, import tariffs and border closures that were introduced in response to the COVID-19 pandemic affect MNEs by increasing trade costs and amplifying the costs of communicating tacit knowledge. In this editorial, we draw specific attention to how these policies impact the heart of MNEs' activities - the knowledge-intensive intangibles. Physical distancing limits the face-to-face meetings that undergird the production of intangibles in large urban hotspots. At the same time, travel restrictions constrain MNEs' abilities to connect to and source knowledge from their foreign partners. Virtual conferencing has helped MNEs to cope with these challenges but it remains an imperfect substitute. A protracted public health crisis that would require limiting social interactions in the medium term might push MNEs to reconfigure their knowledge management strategies both locally and globally.
C1 [Van Assche, Ari] HEC Montreal, 3000 Chemin Cote St Catherine, Montreal, PQ H3T2A7, Canada.
   [Lundan, Sarianna] Univ Bremen, Fac Business Studies & Econ, Enrique Schmidt Str 1, D-28359 Bremen, Germany.
RP Van Assche, A (corresponding author), HEC Montreal, 3000 Chemin Cote St Catherine, Montreal, PQ H3T2A7, Canada.
EM ari.van-assche@hec.ca
OI Lundan, Sarianna/0000-0001-5348-0106; Van Assche,
   Ari/0000-0003-2895-6736
CR Alcacer J, 2016, J INT BUS STUD, V47, P499, DOI 10.1057/jibs.2016.22
   Altman S.A., 2020, HARVARD BUS REV
   Baldwin R., 2016, GREAT CONVERGENCE
   Baldwin R., 2020, SUPPLY SIDE MATTERS
   Balland PA, 2020, NAT HUM BEHAV, V4, P248, DOI 10.1038/s41562-019-0803-3
   Bathelt H, 2004, PROG HUM GEOG, V28, P31, DOI 10.1191/0309132504ph469oa
   Bathelt H, 2018, J ECON GEOGR, V18, P1001, DOI 10.1093/jeg/lby047
   Bown C., 2020, FOREIGN AFF
   Bown CP, 2019, FOREIGN AFF, V98, P125
   Buckley PJ, 2015, ACAD MANAGE PERSPECT, V29, P237, DOI 10.5465/amp.2013.0113
   Cano-Kollmann M, 2016, J INT BUS STUD, V47, P255, DOI 10.1057/jibs.2016.8
   Cantwell John., 1989, TECHNOLOGICAL INNOVA
   Chugh A., 2020, WORLD EC FORUM
   Crescenzi R., 2019, 57 WIPO 57 WIPO
   D'Este P, 2013, J ECON GEOGR, V13, P537, DOI 10.1093/jeg/lbs010
   Evenett SJ, 2020, WORLD ECON, V43, P828, DOI 10.1111/twec.12954
   Evenett SJ, 2019, J INT BUS POLICY, V2, P9, DOI 10.1057/s42214-019-00021-0
   Fleming S., 2020, WORLD EC FORUM
   Glaeser EL, 2009, J ECON LIT, V47, P983, DOI 10.1257/jel.47.4.983
   Heiland I., 2020, UNINTENDED CRISIS CO
   Irwin DA, 2020, PANDEMIC ADDS MOMENT
   Javorcik B, 2020, GREATER TRADE COLLAP
   Jones Geoffrey, 2005, MULTINATIONALS GLOBA
   Kilic K, 2020, COVID 19 IS TRANSFOR
   Kobrin SJ, 2020, J INT BUS POLICY, V3, P280, DOI 10.1057/s42214-020-00060-y
   KOGUT B, 1993, J INT BUS STUD, V24, P625, DOI 10.1057/palgrave.jibs.8490248
   Lev B., 2001, INTANGIBLES MANAGEME
   Lorenzen M, 2020, J INT BUS STUD, V51, P1199, DOI 10.1057/s41267-020-00339-5
   Lundan SM, 2018, J INT BUS POLICY, V1, P1, DOI 10.1057/s42214-018-0007-y
   Moretti E., 2019, EFFECT HIGH TECH CLU, pW26270, DOI [10.3386/w26270, DOI 10.3386/W26270]
   Rodrik D, 2018, J INT BUS POLICY, V1, P12, DOI 10.1057/s42214-018-0001-4
   Seric A, 2020, COVID 19 COULD SPUR
   Storper M, 2004, J ECON GEOGR, V4, P351, DOI 10.1093/jnlecg/lbh027
   Sturgeon TimothyJ., 2009, FRONTIERS COMMODITY, P110
   Teece DJ, 2018, LONG RANGE PLANN, V51, P40, DOI 10.1016/j.lrp.2017.06.007
   Van Assche A, 2020, POLICY OPTIONS
   Van Assche A, 2018, J INT BUS POLICY, V1, P117, DOI 10.1057/s42214-018-0013-0
   Verbeke A, 2018, J INT BUS STUD, V49, P1101, DOI 10.1057/s41267-018-0192-2
   Yalaman C, 2020, EC POLICY RESPONSES
NR 39
TC 11
Z9 11
U1 6
U2 8
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2522-0691
EI 2522-0705
J9 J INT BUS POLICY
JI J. Int. Bus. Policy
PD SEP
PY 2020
VL 3
IS 3
BP 273
EP 279
DI 10.1057/s42214-020-00065-7
PG 7
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA TG2MK
UT WOS:000671243600005
OA Bronze
DA 2022-04-20
ER

PT J
AU Mobin, MA
   Mahi, M
   Hassan, MK
   Habib, M
   Akter, S
   Hassan, T
AF Mobin, Mohammad Ashraful
   Mahi, Masnun
   Hassan, M. Kabir
   Habib, Marzia
   Akter, Shabiha
   Hassan, Tahmina
TI An analysis of COVID-19 and WHO global research roadmap: knowledge
   mapping and future research agenda
SO EURASIAN ECONOMIC REVIEW
LA English
DT Article; Early Access
DE COVID-19; Pandemic; Bibliometric; Knowledge mapping; Science mapping;
   World Health Organization
ID MANAGEMENT; TOOL
AB In this study, we review the publications on the COVID-19 pandemic indexed in the Scopus database from 1st January to 15th October 2020, using bibliometric analysis. In essence, we evaluate the publications against the global research roadmap outlined by the World Health Organization (WHO). We find that academic publications are contributed by researchers worldwide, with the USA and China being the top contributors in several parameters. We show that most publications are clustered around the issues related to the outbreak, diagnosis, candidate medicine, and disease treatment by analyzing publication keywords. Besides, considerable importance is given to unravel the connection between the present viral disease with its previous strains and the anxiety and stress-related problems that arise from the COVID-19. We further visualize the knowledge structure of the publication with thematic mapping and illustrate that mental health-related research denotes a specialized research theme besides public health issues being the basic theme. Our findings aid to comprehend how the scholarly publications have developed to address the prioritized research agendas by the WHO. Thus, our study can guide researchers to explore the less studied areas. Consequently, it will assist policymakers and governments in developing integrated and effective policies to fight the pandemic.
C1 [Mobin, Mohammad Ashraful; Mahi, Masnun; Akter, Shabiha] iFINTELL Business Intelligence, Cyberjaya, Malaysia.
   [Mobin, Mohammad Ashraful] Univ Sains Malaysia, Grad Sch Business, George Town, Malaysia.
   [Mahi, Masnun] Univ Malaya, Fac Business & Accountancy, Kuala Lumpur, Malaysia.
   [Hassan, M. Kabir] Univ New Orleans, Dept Econ & Finance, New Orleans, LA 70148 USA.
   [Habib, Marzia] iFINTELL Business Intelligence, Med Analyt Team, Cyberjaya, Malaysia.
   [Akter, Shabiha] Taylors Univ, Sch Accounting & Finance, Subang Jaya, Malaysia.
RP Hassan, MK (corresponding author), Univ New Orleans, Dept Econ & Finance, New Orleans, LA 70148 USA.
EM mobin@ifintell.org; masnunmahi@um.edu.my; mhassan@uno.edu;
   marziahabib@hotmail.com; shabihaakter@sd.taylors.edu.my
RI Hassan, M. Kabir/D-5053-2012; Hassan, M. Kabir/AAA-6654-2022; Mahi,
   Masnun Al/AAI-6121-2020
OI Hassan, M. Kabir/0000-0001-6274-3545; Hassan, M.
   Kabir/0000-0001-6274-3545; Mahi, Masnun Al/0000-0001-9137-4822; Mobin,
   Mohammad Ashraful/0000-0002-4924-7835; Akter,
   Shabiha/0000-0001-6678-2795
CR Aria M, 2017, J INFORMETR, V11, P959, DOI 10.1016/j.joi.2017.08.007
   Azer SA, 2015, ACAD MED, V90, P1147, DOI 10.1097/ACM.0000000000000780
   Bieri DS, 2019, GREAT HALF CENTURY P, DOI [10.2139/ssrn.3345700, DOI 10.2139/SSRN.3345700]
   Campbell D, 2010, AM J EVAL, V31, P66, DOI 10.1177/1098214009354774
   Cobo MJ, 2011, J AM SOC INF SCI TEC, V62, P1382, DOI 10.1002/asi.21525
   Danesh F., 2020, IRANIAN J MED MICROB, V14, P1, DOI [DOI 10.30699/IJMM.14.1.1, 10.30699/ijmm.14.1.1]
   Della Corte V, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11216114
   Demiroz F, 2019, LOCAL GOV STUD, V45, P308, DOI 10.1080/03003930.2018.1541796
   El Mohadab M, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110052
   Ellegaard O, 2015, SCIENTOMETRICS, V105, P1809, DOI 10.1007/s11192-015-1645-z
   Esfahani H., 2019, INT J DATA NETWORK S, V3, P145, DOI [10.5267/j.ijdns.2019.2.007, DOI 10.5267/J.IJDNS.2019.2.007, https://doi.org/10.5267/j.ijdns.2019.2.007]
   Feng YT, 2017, J CLEAN PROD, V158, P296, DOI 10.1016/j.jclepro.2017.05.018
   Frandsen TF, 2005, J AM SOC INF SCI TEC, V56, P58, DOI 10.1002/asi.20100
   Gong Y, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100027
   Hendrix D, 2008, J MED LIBR ASSOC, V96, P324, DOI 10.3163/1536-5050.96.4.007
   Hirsch JE, 2010, SCIENTOMETRICS, V85, P741, DOI 10.1007/s11192-010-0193-9
   Homolak J, 2020, SCIENTOMETRICS, V124, P2687, DOI 10.1007/s11192-020-03587-2
   Hou Q, 2015, INT J LIFE CYCLE ASS, V20, P541, DOI 10.1007/s11367-015-0846-2
   Ji L, 2018, RESOUR CONSERV RECY, V134, P34, DOI 10.1016/j.resconrec.2018.03.005
   Bonilla-Aldana DK, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101566
   Ki EJ, 2019, J PUBLIC RELAT RES, V31, P5, DOI 10.1080/1062726X.2019.1577739
   Liao HC, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010166
   Linnenluecke MK, 2020, AUST J MANAGE, V45, P175, DOI 10.1177/0312896219877678
   Merigo JM, 2015, APPL SOFT COMPUT, V27, P420, DOI 10.1016/j.asoc.2014.10.035
   Nowakowska J, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110451
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Secinaro S, 2020, J CLEAN PROD, V264, DOI 10.1016/j.jclepro.2020.121503
   Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2419, DOI 10.1002/asi.22708
   WHO (World Health Organisation), 2020, COORD GLOB RES ROADM
   Zupic I, 2015, ORGAN RES METHODS, V18, P429, DOI 10.1177/1094428114562629
NR 30
TC 1
Z9 1
U1 7
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1309-422X
EI 2147-429X
J9 EURASIAN ECON REV
JI Eurasian Econ. Rev.
DI 10.1007/s40822-021-00193-2
EA NOV 2021
PG 22
WC Economics
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WU0ZD
UT WOS:000716281700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Nanda, A
   Vura, NVRK
   Gravenstein, S
AF Nanda, Aman
   Vura, Naga Venkata Rama Krishna
   Gravenstein, Stefan
TI COVID-19 in older adults
SO AGING CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE COVID-19; SARS-CoV-2; Elderly; Management; Transmission; Prevention
ID CORONAVIRUS; WUHAN; ACE2
AB The advent of the SARS-CoV-2 and COVID-19 pandemic has generated a lot of publications at a rapid pace. We know that older adults disproportionately suffer the most severe of COVID outcomes. Here we attempt to coalesce the key knowledge of SARS-CoV-2 biology to the disease and clinical care concepts in the context of older adults.
C1 [Nanda, Aman; Vura, Naga Venkata Rama Krishna; Gravenstein, Stefan] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Geriatr & Palliat Med,Dept Med, 593 Eddy St,POB 438, Providence, RI 02903 USA.
   [Gravenstein, Stefan] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.
   [Gravenstein, Stefan] Providence Vet Adm Med Ctr, Providence, RI 02908 USA.
RP Gravenstein, S (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Geriatr & Palliat Med,Dept Med, 593 Eddy St,POB 438, Providence, RI 02903 USA.; Gravenstein, S (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.; Gravenstein, S (corresponding author), Providence Vet Adm Med Ctr, Providence, RI 02908 USA.
EM Stefan_Gravenstein@brown.edu
RI Vura, Naga Venkata Rama Krishna/AAC-8574-2021
OI Nanda, Aman/0000-0002-3860-3267; Gravenstein, Stefan/0000-0001-6000-6859
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   CDC, 2020, COR DIS 2019 COVID 1
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   COVID-19 Map, 2020, COVID 19 MAP
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415
   McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   SANTARPIA JL, 2020, TRANSMISSION POTENTI, DOI [10.1101/2020.03.23.20039446, DOI 10.1038/S41598-020-69286-3]
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 17
TC 43
Z9 44
U1 3
U2 14
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1594-0667
EI 1720-8319
J9 AGING CLIN EXP RES
JI Aging Clin. Exp. Res.
PD JUL
PY 2020
VL 32
IS 7
BP 1199
EP 1202
DI 10.1007/s40520-020-01581-5
EA MAY 2020
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA NI2AO
UT WOS:000531457000001
PM 32390064
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Fouogue, JT
   Noubom, M
   Kenfack, B
   Dongmo, NT
   Tabeu, M
   Megozeu, L
   Alima, JM
   Fogang, YF
   Nyam, LCRA
   Fouelifack, FY
   Fouedjio, JH
   Manebou, PLFN
   Ze, CDB
   Kouam, BF
   Fomete, LN
   Tebeu, PM
   Kemfang, JDN
   Foumane, P
   Sando, Z
   Orock, GEE
AF Fouogue, Jovanny Tsuala
   Noubom, Michel
   Kenfack, Bruno
   Dongmo, Norbert Tanke
   Tabeu, Maxime
   Megozeu, Linda
   Alima, Jean Marie
   Fogang, Yannick Fogoum
   Nyam, Landry Charles Rim A.
   Fouelifack, Florent Ymele
   Fouedjio, Jeanne Hortence
   Manebou, Pamela Leonie Fouogue Nzogning
   Ze, Clotaire Damien Bibou
   Kouam, Brice Foubi
   Fomete, Lauriane Nomene
   Tebeu, Pierre Marie
   Kemfang, Jean Dupont Ngowa
   Foumane, Pascal
   Sando, Zacharie
   Orock, George Enownchong Enow
TI Poor knowledge of COVID-19 and unfavourable perception of the response
   to the pandemic by healthcare workers at the Bafoussam Regional Hospital
   (West Region-Cameroon)
SO PAN AFRICAN MEDICAL JOURNAL
LA English
DT Article
DE Health care workers; Bafoussam; knowledge; perception; COVID-19;
   response
ID SUB-SAHARAN AFRICA; MANAGEMENT
AB Introduction: WHO warned against a dramatic impact of COVID-19 in Africa unless adequate response strategies are implemented. Whatever the strategy, the role of health staff is pivotal. Objective: Assess knowledge and perception of the response to COVID-19 among health staff. Methods: we used a convenience non probabilistic sample to conduct a survey with a self- administered questionnaire from April 14 - 29, 2020 at the Bafoussam Regional Hospital (BRH). All the staff was invited to participate. Analyses were done with Microsoft Excel 2010 and Epi-Info version 7.1.5.2. Results: response rate was 76.1% (464/610). Mean age (SD) was 35.0 (8.9) years. Sex ratio (M/F) was 101/356. Nursing/midwifery staff (56.8%) and inpatients units (49.94%) were predominant. Origin and transmission of SARS-CoV-2 were poorly known while knowledge of clinical signs and the role of laboratory tests were good. For 53.2% of respondents all therapeutic regimens are supportive and only 31.6% trusted staterecommended drugs. For 169 of respondents (36.9%), herbal remedies prevent/cure COVID-19. Seventy percent (70%) felt they were not knowledgeable enough to handle COVID-19 cases. Eighty-five point six percent (85.6%) thought the BRH had insufficient resources to fight COVID-19 and 55.6% were dissatisfied with its response (weaknesses: medicines/technologies (74.5%), service delivery (28.1%), staff (10.9%)). Sixty-eight percent (68%) reported insufficient protection on duty. Seventy-six point five percent (76.5%) reported a drop in non-COVID-19 services. Eightyfive point five (85.5%) percent said they complied with community preventive measures. For 44% of respondents, regulations on COVID-19 corpses should be made more culture-sensitive. Fifty one point two percent (51.2%) of respondents were against vaccine trial in their community. Conclusion: knowledge was poor and perception of the response to COVID-19 was unfavourable.
C1 [Fouogue, Jovanny Tsuala; Noubom, Michel; Kenfack, Bruno; Fogang, Yannick Fogoum] Univ Dschang, Fac Med & Pharmaceut Sci, Dschang, West Region, Cameroon.
   [Fouogue, Jovanny Tsuala; Noubom, Michel; Tabeu, Maxime; Megozeu, Linda; Alima, Jean Marie; Fogang, Yannick Fogoum; Nyam, Landry Charles Rim A.; Kouam, Brice Foubi; Orock, George Enownchong Enow] Bafoussam Reg Hosp, Bafoussam, West Region, Cameroon.
   [Dongmo, Norbert Tanke] Cameroon Soc Epidemiol, Yaounde, Centre Region, Cameroon.
   [Fouelifack, Florent Ymele] Inst Super Technol Med, Yaounde, Centre Region, Cameroon.
   [Tebeu, Pierre Marie; Kemfang, Jean Dupont Ngowa; Foumane, Pascal; Sando, Zacharie] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.
   [Ze, Clotaire Damien Bibou] Yagoua Hlth Dist, Yagoua, Far North Regio, Cameroon.
   [Fomete, Lauriane Nomene] Agence Natl Rech Sida & Hepatite Virales Site Cam, Yaounde, Centre Region, Cameroon.
RP Fouogue, JT (corresponding author), Univ Dschang, Fac Med & Pharmaceut Sci, Dschang, West Region, Cameroon.
EM fotsujo@outlook.com
CR Abdelaziz AB, 2020, TUNISIE MED, V98, P266
   Abena PM, 2020, AM J TROP MED HYG, V102, P1184, DOI 10.4269/ajtmh.20-0290
   AFRICA CDC, 2020, AFRICAN UNION COMMIS
   AFRICA CDC, 2020, COVID 19 VACCINE DEV
   Amimo F, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00219-6
   [Anonymous], 2020, CAMEROUN CORONAVIRUS
   Ben Abdelaziz Ahmed, 2020, Tunis Med, V98, P324
   Bihina F., 2020, CAMEROUN CAMEROUN RA
   BUCREP, PROJECTIONS DEMOGRAP
   Cabore JW, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002647
   CamerounWeb, 2020, CORONAVIRUS BAFOUSSA
   Chersich MF, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00574-3
   Chu K, 2015, WORLD J SURG, V39, P350, DOI 10.1007/s00268-014-2840-4
   Coutsoudis Anna, 2009, Bull World Health Organ, V87, P0
   Davanzo R, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.13010
   Drame M, 2020, EUR GERIATR MED, V11, P709, DOI 10.1007/s41999-020-00324-z
   El-Sadr WM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2008193
   Jeon YW, 2020, YONSEI MED J, V61, P631, DOI 10.3349/ymj.2020.61.7.631
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Kenne Yannick A, CAMEROUN LUTTE COVID
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Mbongoo GC, 2020, HLTH SCI DIS, V21, P1
   Ngaroua, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.171.9754
   Ngowa JDK, 2015, PAN AFR MED J, V21, DOI [10.11604/pamj.2015.21.265.6967, 10.11604/pamj.2015.22.264.8028]
   Njonnou SRS, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.2020.35.2.23698, 10.11604/pamj.supp.2020.35.2.23698]
   Njonnou SRS, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.supp.2020.35.24368
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Osseni IA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00240-9
   Osuchowski MF, 2020, SHOCK, V54, P416, DOI 10.1097/SHK.0000000000001565
   Peyronnet V, 2020, GYNECOL OBST FERT SE, V48, P436, DOI 10.1016/j.gofs.2020.03.014
   Rodriguez-Bolanos R, 2020, MED CARE, V58, P663, DOI 10.1097/MLR.0000000000001365
   Rosenthal PJ, 2020, AM J TROP MED HYG, V102, P1145, DOI 10.4269/ajtmh.20-0380
   Scafetta N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103493
   Semaan A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002967
   Timtchueng M, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.supp.2020.35.148.25253
   Tobaiqy M, 2020, Infect Prev Pract, V2, P100061, DOI 10.1016/j.infpip.2020.100061
   van Prooijen JW, 2018, PERSPECT PSYCHOL SCI, V13, P770, DOI 10.1177/1745691618774270
   Wadoum REG, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.supp.2020.35.2.22665
   WHO-AFRO, 2020, 10 000 HLTH WORKERS
   World Health Organization, 2018, WHO GLOBAL HLTH WORK, DOI DOI 11/44679/INDEX.HTM
   World Health Organization, COUNTRY RESPONSE CAM
   World Health Organization, 2020, INFECT PREVENTION CO
   World Health Organization (WHO), WHO TRADITIONAL MED
   Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y
NR 45
TC 4
Z9 4
U1 0
U2 2
PU AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET
PI KAMPALA
PA PO BOX 12874, KAMPALA, 00000, UGANDA
EI 1937-8688
J9 PAN AFR MED J
JI Pan Afr. Med. J.
PD SEP
PY 2020
VL 37
SU 1
AR 19
DI 10.11604/pamj.supp.2020.37.19.25688
PG 20
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA QF0PK
UT WOS:000616602900019
PM 33343798
DA 2022-04-20
ER

PT J
AU Zhou, CH
   Su, FZ
   Pei, T
   Zhang, A
   Du, YY
   Luo, B
   Cao, ZD
   Wang, JL
   Yuan, W
   Zhu, YQ
   Song, C
   Chen, J
   Xu, J
   Li, FJ
   Ma, T
   Jiang, LL
   Yan, FQ
   Yi, JW
   Hu, YF
   Liao, YL
   Xiao, H
AF Zhou, Chenghu
   Su, Fenzhen
   Pei, Tao
   Zhang, An
   Du, Yunyan
   Luo, Bin
   Cao, Zhidong
   Wang, Juanle
   Yuan, Wen
   Zhu, Yunqiang
   Song, Ci
   Chen, Jie
   Xu, Jun
   Li, Fujia
   Ma, Ting
   Jiang, Lili
   Yan, Fengqin
   Yi, Jiawei
   Hu, Yunfeng
   Liao, Yilan
   Xiao, Han
TI COVID-19: Challenges to GIS with Big Data
SO GEOGRAPHY AND SUSTAINABILITY
LA English
DT Article
DE COVID-19; Big data; GIS; Spatial transmission; Social management
ID CHINA; MIGRATION; MODELS
AB The outbreak of the 2019 novel coronavirus disease (COVID-19) has caused more than 100,000 people infected and thousands of deaths. Currently, the number of infections and deaths is still increasing rapidly. COVID-19 seriously threatens human health, production, life, social functioning and international relations. In the fight against COVID-19, Geographic Information Systems (GIS) and big data technologies have played an important role in many aspects, including the rapid aggregation of multi-source big data, rapid visualization of epidemic information, spatial tracking of confirmed cases, prediction of regional transmission, spatial segmentation of the epidemic risk and prevention level, balancing and management of the supply and demand of material resources, and social-emotional guidance and panic elimination, which provided solid spatial information support for decision-making, measures formulation, and effectiveness assessment of COVID-19 prevention and control. GIS has developed and matured relatively quickly and has a complete technological route for data preparation, platform construction, model construction, and map production. However, for the struggle against the widespread epidemic, the main challenge is finding strategies to adjust traditional technical methods and improve speed and accuracy of information provision for social management. At the data level, in the era of big data, data no longer come mainly from the government but are gathered from more diverse enterprises. As a result, the use of GIS faces difficulties in data acquisition and the integration of heterogeneous data, which requires governments, businesses, and academic institutions to jointly promote the formulation of relevant policies. At the technical level, spatial analysis methods for big data are in the ascendancy. Currently and for a long time in the future, the development of GIS should be strengthened to form a data-driven system for rapid knowledge acquisition, which signifies that GIS should be used to reinforce the social operation parameterization of models and methods, especially when providing support for social management.
C1 [Zhou, Chenghu; Su, Fenzhen; Pei, Tao; Zhang, An; Du, Yunyan; Luo, Bin; Wang, Juanle; Yuan, Wen; Zhu, Yunqiang; Song, Ci; Chen, Jie; Xu, Jun; Li, Fujia; Ma, Ting; Jiang, Lili; Yan, Fengqin; Yi, Jiawei; Hu, Yunfeng; Liao, Yilan; Xiao, Han] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China.
   [Cao, Zhidong] Chinese Acad Sci, Inst Automat, Beijing 100190, Peoples R China.
   [Zhou, Chenghu; Su, Fenzhen; Pei, Tao; Du, Yunyan; Wang, Juanle; Zhu, Yunqiang; Ma, Ting; Xiao, Han] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.
   [Cao, Zhidong] Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing 100049, Peoples R China.
   [Su, Fenzhen; Xu, Jun] Int Geog Union, Commiss Geog Informat Sci, Beijing 100101, Peoples R China.
RP Zhou, CH; Su, FZ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China.; Zhou, CH; Su, FZ (corresponding author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.; Su, FZ (corresponding author), Int Geog Union, Commiss Geog Informat Sci, Beijing 100101, Peoples R China.
EM zhouch@lreis.ac.cn; sufz@lreis.ac.cn
RI , 冰菓/AAQ-3191-2021; Yi, Jiawei/ABA-1970-2021
OI Yi, Jiawei/0000-0003-0325-7146
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [41421001, 42041001, 41525004]; State Key
   Laboratory of Resources and Environmental Information System, Institute
   of Geographic Sciences and Natural Resources Research, Chinese Academy
   of Sciences
FX This work was funded by the National Natural Science Foundation of China
   (41421001, 42041001 and 41525004). We thank the reviewers who provided
   valuable comments on this paper. We are very grateful to those who
   participated in the data preparation, processing and analysis for this
   study. We ackonwledge Professor Michael E Meadows and colleagues in
   International Geographic Union and in its Commission on Geographical
   information Science. We also acknowledge all the support from the State
   Key Laboratory of Resources and Environmental Information System,
   Institute of Geographic Sciences and Natural Resources Research, Chinese
   Academy of Sciences.
CR [Anonymous], 2020, HLTH COMMISSION HUBE
   [Anonymous], 2020, NEWS CHINA
   [Anonymous], 2020, CHINA DAILY
   CAICT: China Academy of Information and Communications Technology, 2020, RES REP DAT INT APPL
   CDC, 2020, HEALTHC PROF FREQ AS
   Field K., 2020, MAPPING CORONAVIRUS
   Goodchild MF, 2010, INT J DIGIT EARTH, V3, P231, DOI 10.1080/17538941003759255
   Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845
   Hu MG, 2019, ENVIRON PLANN A, V51, P1618, DOI 10.1177/0308518X19845908
   Miller HJ, 2015, GEOJOURNAL, V80, P449, DOI 10.1007/s10708-014-9602-6
   National Health Commission of the PRC, 2020, COVID 19 EP SIT 24 0
   New.cn, 2020, COVID 19 IS URG UN S
   Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695
   [史秀保 Shi Xiubao], 2017, [测绘科学, Science of Surveying and Mapping], V42, P191
   United Nations Development Programme, 2015, WHAT AR SUST DEV GOA
   Wang YX, 2019, HABITAT INT, V86, P71, DOI 10.1016/j.habitatint.2019.03.002
   Wei Y, 2018, APPL GEOGR, V96, P77, DOI 10.1016/j.apgeog.2018.05.009
   WHO, 2020, COR DIS COVID 2019 S
   Xu J, 2017, APPL GEOGR, V87, P85, DOI 10.1016/j.apgeog.2017.07.014
   Zhao S, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101568
   Zhou C., 2016, SPATIAL DATA HANDLIN
NR 21
TC 185
Z9 204
U1 26
U2 40
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2096-7438
EI 2666-6839
J9 GEOGR SUSTAIN
JI Geogr. Sustain.
PD MAR
PY 2020
VL 1
IS 1
BP 77
EP 87
DI 10.1016/j.geosus.2020.03.005
PG 11
WC Green & Sustainable Science & Technology; Geography, Physical
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics; Physical Geography
GA RW6HA
UT WOS:000646621900009
OA gold
DA 2022-04-20
ER

PT J
AU Alrajhi, AM
   Hussain, WAH
   Rafie, BA
   Taj, M
   Elgarf, AM
AF Alrajhi, Asrar Mansoor
   Hussain, Waleed Abdul-Halim
   Rafie, Basmah Amin
   Taj, Mehar
   Elgarf, Abdelaziz Moustafa
TI Knowledge and awareness of COVID-19 epidemic preparedness and response
   among health care workers in Makkah city
SO THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE
LA English
DT Article
DE knowledge; health care workers; COVID-19; response; Makkah city
ID PROVIDERS; ATTITUDE
AB Objective: This study determined and examined the knowledge and awareness of COVID-19 pandemic preparedness and response measures by health care workers (HCWs) in Makkah city.
   Methods: This descriptive study used a quantitative method with a cross-sectional design. A survey (questionnaire) collected data from 251 HCWs working in 10 hospitals and 80 health care centers.
   Results: The total score for the knowledge level was high (range: 50-76, mean +/- SD = 65.370 +/- 4.805). There was a relationship between the participants' workplace and education levels to the nature of the disease (p = 0.009*, 0.037*, respectively). Job descriptions were related to the transmission of the disease (p = 0.003*). The participants' age groups and years of experience were also associated with their actions in suspected, probable, and confirmed cases (p = 0.015*, 0.03*, respectively). The HCWs' knowledge of precautionary measures was not related to their demographic data, except for the education level shown (p = 0.037*).
   Discussion: A similar level of knowledge and awareness was detected in Saudi Arabia in Riyadh and Al-Jouf, the UAE, Vietnam, and Uganda. Further study is recommended to measure the factors affecting HCWs' knowledge and awareness during an epidemic situation.
C1 [Alrajhi, Asrar Mansoor] Minist Hlth, Makkah Healthcare Cluster, Execut Adm Qual & Patient Safety, Emergency & Disaster Nursing Management, Mecca 7853, Saudi Arabia.
   [Hussain, Waleed Abdul-Halim] Hera Gen Hosp Makkah, Healthcare Cluster, Mecca, Saudi Arabia.
   [Rafie, Basmah Amin] Healthcare Cluster, Mecca, Saudi Arabia.
   [Taj, Mehar] Hera Gen Hosp, Qual & Patient Safety Dept, Makkah Healthcare Cluster, Mecca, Saudi Arabia.
   [Elgarf, Abdelaziz Moustafa] Minist Hlth, Mecca, Saudi Arabia.
RP Alrajhi, AM (corresponding author), Minist Hlth, Makkah Healthcare Cluster, Execut Adm Qual & Patient Safety, Emergency & Disaster Nursing Management, Mecca 7853, Saudi Arabia.
EM Asrar_alraghi@hotmail.com
CR Al-Dossary R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218269
   AL-Rasheedi M, 2021, SAUDI J BIOL SCI, V28, P90, DOI 10.1016/j.sjbs.2020.08.035
   Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015
   Algaissi AA, 2020, J INFECT PUBLIC HEAL, V13, P834, DOI 10.1016/j.jiph.2020.04.016
   Aljondi R, 2021, J RADIAT RES APPL SC, V14, P51, DOI 10.1080/16878507.2020.1856587
   Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1
   European Centre for Disease Prevention and Control, 2020, COVID 19
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Kaplow Roberta, 2003, Crit Care Nurse, VSuppl, P27
   Khan N., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3548292, DOI 10.2139/SSRN.3548292]
   Ministry of Health (MOH), 2020, MOH NEWS MOH ISS COV
   Nooh HZ, 2021, J PUBLIC HEALTH-HEID, V29, P1107, DOI 10.1007/s10389-020-01209-y
   Nour MO, 2017, E MEDITERR HEALTH J, V23, P534, DOI 10.26719/2017.23.8.534
   Nsubuga P., 2006, PUBLIC HLTH SURVEILL, V2nd
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Organisation for Economic Co-operation and Development (OECD), 2021, TERR IMP COVID 19 MA
   Qadah T, 2020, J INFECT DEV COUNTR, V14, P1090, DOI 10.3855/jidc.13083
   Rabbani S. A., 2020, International Journal of Medicine and Public Health, V10, P8, DOI 10.5530/ijmedph.2020.1.2
   Saadeh D, 2021, PERSPECT PSYCHIATR C, V57, P1212, DOI 10.1111/ppc.12676
   Tadesse DB, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100787
   The-Saudi.Net, 2021, MAKK CIT PROF
   Tripathi R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00482
   World Health Organization (WHO), 2020, COR
   Worldometers, 2021, COVID LIV UPD 141984
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2049-9361
EI 2049-937X
J9 THER ADV INFECT DIS
JI Ther. Adv. Infect. Dis.
PD MAR
PY 2022
VL 9
DI 10.1177/20499361221079452
PG 18
WC Infectious Diseases
WE Emerging Sources Citation Index (ESCI)
SC Infectious Diseases
GA ZS3NC
UT WOS:000768374200001
PM 35281764
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Arslan, A
   Kamara, S
   Golgeci, I
   Tarba, SY
AF Arslan, Ahmad
   Kamara, Samppa
   Golgeci, Ismail
   Tarba, Shlomo Yedidia
TI Civil society organisations' management dynamics and social value
   creation in the post-conflict volatile contexts pre and during COVID-19
SO INTERNATIONAL JOURNAL OF ORGANIZATIONAL ANALYSIS
LA English
DT Article
DE Civil society organisations; Covid-19; Management; Liberia; Sierra
   Leone; Social value creation; Volatile
ID DIMENSIONS; POLITICS; VIOLENCE; SECTOR
AB Purpose
   The current paper aims to address the management dynamics of civil society organisations (CSOs) in volatile contexts. Along with analysing CSOs' management dynamics at a general level, it also offers specific insights into their management strategies in response to COVID-19 pandemic.
   Design/methodology/approach
   This study uses a qualitative research design, where in-depth case studies are undertaken with four CSOs operating in post-conflict volatile Sub-Saharan African economies of Liberia and Sierra Leone.
   Findings
   Findings revealed that multiple stakeholder management plays an important role in social value creation by CSOs. The findings further state that, in volatile contexts, CSOs appear to have more legitimacy than state functionaries due to their capabilities in dealing with political pressures and conflict sensitivities. The findings also revealed that case CSOs operating in Liberia and Sierra Leone were quick to respond to the COVID-19 pandemic by adjusting their working routines accordingly by switching to online working where possible and repurposing their management strategies. This repurposing of management strategies focussed on minimising economic disruptions caused by COVID-19 and continuing to create social value by helping youth and farmers particularly.
   Originality/value
   This paper contributes to the extant literature by being one of the first studies, highlighting the specificities of CSO management in volatile (especially Sub-Saharan African post-conflict) contexts and contributes to the literature streams on multiple stakeholder management and social value creation. To the best of the authors' knowledge, the current paper is also one the first study to address the management strategies of case CSOs in response to the ongoing Covid-19 pandemic in Liberia and Sierra Leone.
C1 [Arslan, Ahmad; Kamara, Samppa] Univ Oulu, Oulu Business Sch, Dept Mkt Management & Int Business, Oulu, Finland.
   [Golgeci, Ismail] Aarhus Univ, Dept Business Dev & Technol, Aarhus, Denmark.
   [Tarba, Shlomo Yedidia] Univ Birmingham, Birmingham Business Sch, Birmingham, W Midlands, England.
RP Arslan, A (corresponding author), Univ Oulu, Oulu Business Sch, Dept Mkt Management & Int Business, Oulu, Finland.
EM ahmad.arslan@oulu.fi; samppa.kamara@oulu.fi; i.golgeci@btech.au.dk;
   tarba2003@gmail.com
RI Kamara, Samppa/AAS-6547-2021
OI Kamara, Samppa/0000-0002-6696-0544; Golgeci, Ismail/0000-0002-6853-3255
CR Alaassar A, 2020, TECHNOL FORECAST SOC, V160, DOI 10.1016/j.techfore.2020.120257
   Albareda A, 2018, VOLUNTAS, V29, P1216, DOI 10.1007/s11266-018-00051-x
   Appe S, 2018, VOLUNTAS, V29, P245, DOI 10.1007/s11266-017-9846-0
   Appe S, 2017, PUBLIC ADMIN DEVELOP, V37, P122, DOI 10.1002/pad.1787
   Arslan A, 2021, MULTINATL BUS REV, V29, P21, DOI 10.1108/MBR-07-2020-0153
   Atwood B.J., 2012, CIVIL SOC MULTITUDE
   Felicio JA, 2013, J BUS RES, V66, P2139, DOI 10.1016/j.jbusres.2013.02.040
   Ayivor JS, 2020, J ENVIRON POL PLAN, V22, P239, DOI 10.1080/1523908X.2019.1705153
   Bangura J.J., 2016, DEMOCRATIZATION HUMA
   Bendell J, 2017, TERMS ENDEARMENT BUS
   Bennett E, 2019, VOLUNT SECT REV, V10, P213, DOI 10.1332/204080519X15617330887624
   Brynjolfsson Erik., 2020, 27344 NBER
   Court, 2005, 249 OV DEV I
   Dai L, 2017, STRATEGIC MANAGE J, V38, P1478, DOI 10.1002/smj.2599
   Downes T, 2016, J KNOWL MANAG, V20, P49, DOI 10.1108/JKM-11-2014-0483
   Dubois A, 2002, J BUS RES, V55, P553, DOI 10.1016/S0148-2963(00)00195-8
   Egholm L, 2020, VOLUNTAS, V31, P1, DOI 10.1007/s11266-019-00171-y
   Gambhir M, 2017, ARTIF INTELL REV, V47, P1, DOI 10.1007/s10462-016-9475-9
   Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151
   Golgeci I, 2021, TECHNOL FORECAST SOC, V162, DOI 10.1016/j.techfore.2020.120376
   Golgeci I, 2020, J ORGAN CHANGE MANAG, V33, P100, DOI 10.1108/JOCM-02-2019-0033
   Hoffman D, 2011, WAR MACHINES YOUNG M
   Kalogeraki S, 2020, J CIV SOC, V16, P120, DOI 10.1080/17448689.2020.1769327
   Kamara S., 2019, STATE POLICY FRAMEWO
   Kapyepye M, 2013, RESOURCE MOBILISATIO
   Keen, 2003, INT POLITICS SOC, V2, P67
   Kontinen T, 2018, LEARNING FORGETTING
   Koops, 2017, PALGRAVE HDB INTEROR
   Lee ThomasW., 1999, USING QUALITATIVE ME
   Li WJ, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P369
   Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444
   Managa A., 2012, UNFULFILLED PROMISES
   Mathenge M.I., 2020, STRATEGIC RESPONSE R
   Meyer M, 2013, VOLUNTAS, V24, P167, DOI 10.1007/s11266-012-9306-9
   Micheletti, 2017, CIVIL SOC STATE RELA
   Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183
   Muddiman E, 2019, J CIV SOC, V15, P82, DOI 10.1080/17448689.2018.1550903
   Mullins D., 2013, EVIDENCE BRIEFINGS E
   Nahme, 2020, ACAD MANAGEMENT P, V2020, P15089
   Nolte I, 2004, J MOD AFR STUD, V42, P61, DOI 10.1017/S0022278X03004464
   Nyan, 2011, THESIS PENNSYLVANIA
   Pallas C.L., 2016, J PEACEBUILDING DEV, V11, P105
   Pausewang, 2012, ETHIOPIA CHALLENGE D, P103
   Richards P, 2005, AFR AFFAIRS, V104, P571, DOI 10.1093/afraf/adi068
   Ruggiero V., 2019, VISIONS POLITICAL VI
   Scaramuzzino R, 2020, J CIV SOC, V16, P174, DOI 10.1080/17448689.2020.1769326
   Shaffer, 2017, PARTICIPATORY GOVERN
   Sherlock S, 2020, POLITICS GOV, V8, P147, DOI 10.17645/pag.v8i4.3347
   Teegen, 2002, I INT BUSINESS, V11, P665
   Teegen H, 2004, J INT BUS STUD, V35, P463, DOI 10.1057/palgrave.jibs.8400112
   van Dyk S, 2018, WORK EMPLOY SOC, V32, P528, DOI 10.1177/0950017018755663
   Weber C, 2017, J MANAGE STUD, V54, P929, DOI 10.1111/joms.12272
   Youngs, 2020, CIVIL SOC CORONAVIRU
NR 53
TC 1
Z9 1
U1 4
U2 4
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1934-8835
EI 1758-8561
J9 INT J ORGAN ANAL
JI Int. J. Organ. Anal.
PD DEC 19
PY 2022
VL 30
IS 7
BP 20
EP 33
DI 10.1108/IJOA-01-2021-2573
EA JUN 2021
PG 14
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZD5IO
UT WOS:000660621100001
OA hybrid, Green Submitted
DA 2022-04-20
ER

PT J
AU Habas, K
   Nganwuchu, C
   Shahzad, F
   Gopalan, R
   Haque, M
   Rahman, S
   Majumder, AA
   Nasim, T
AF Habas, Khaled
   Nganwuchu, Chioma
   Shahzad, Fanila
   Gopalan, Rajendran
   Haque, Mainul
   Rahman, Sayeeda
   Majumder, Anwarul Azim
   Nasim, Talat
TI Resolution of coronavirus disease 2019 (COVID-19)
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE SARS-CoV-2; COVID-19; severe acute respiratory syndrome coronavirus-2;
   diagnosis; treatment
ID FOMIVIRSEN; PNEUMONIA; 2019-NCOV; SARS; RNA
AB Introduction Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COVID-19 is based generally on supportive therapy and treatment to prevent respiratory failure. The effective option of antiviral therapy and vaccination are currently under evaluation and development. Areas covered A literature search was performed using PubMed between December 1, 2019-June 23, 2020. This review highlights the current state of knowledge on the viral replication and pathogenicity, diagnostic and therapeutic strategies, and management of COVID-19. This review will be of interest to scientists and clinicians and make a significant contribution toward development of vaccines and targeted therapies to contain the pandemic. Expert opinion The exit strategy for a path back to normal life is required, which should involve a multi-prong effort toward development of new treatment and a successful vaccine to protect public health worldwide and prevent future COVID-19 outbreaks. Therefore, the bench to bedside translational research as well as reverse translational works focusing bedside to bench is very important and would provide the foundation for the development of targeted drugs and vaccines for COVID-19 infections.
C1 [Habas, Khaled; Nganwuchu, Chioma; Shahzad, Fanila; Gopalan, Rajendran; Nasim, Talat] Univ Bradford, Fac Life Sci, Bradford, W Yorkshire, England.
   [Haque, Mainul] Natl Def Univ Malaysia, Fac Med & Def Hlth, Kuala Lumpur, Malaysia.
   [Rahman, Sayeeda] Amer Univ Integrat Sci, Sch Med, Bridgetown, Barbados.
   [Majumder, Anwarul Azim] Univ West Indies, Fac Med Sci, Cave Hill Campus, Bridgetown, Barbados.
   [Nasim, Talat] Ctr Hlth Agr & Socioecon Adv CHASA, Res Div, Lalmonirhat, Bangladesh.
RP Nasim, T (corresponding author), Univ Bradford, Fac Life Sci, Sch Pharm & Med Sci, Bradford BD7 1DP, W Yorkshire, England.
EM t.nasim@bradford.ac.uk
RI Haque, Mainul/ABG-2866-2020; Lin, Chen/AFV-2163-2022
OI Haque, Mainul/0000-0002-6124-7993; Gopalan,
   Rajendran/0000-0003-3873-0079
FU GrowMedtech; Royal SocietyRoyal Society of LondonEuropean Commission;
   University of Bradford
FX Research carried out at TN laboratories are funded by the GrowMedtech,
   The Royal Society and University of Bradford. KH is supported by a
   project grant by the GrowMedtech awarded to TN. CW is funded by a Ph.D
   studentship. The authors express sincere thanks to Prof. Mohammad
   Razzaque. Department of Oral Health Policy & Epidemiology, Harvard
   School of Dental Medicine, Boston, MA, USA for his valuable suggestions
   to improve the paper. Table 1 reprinted from Clinical Immunology, Vol
   215, Yuki K, Fujiogi M, Koutsogiannaki S., COVID-19 pathophysiology: A
   review, 2020, with permission from Elsevier.
CR Al-Tawfiq JA, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101615
   [Anonymous], 2020, AUD TRANSCR NEWS BRI
   Association CM, 2020, CHIN J RADIOL, V54
   Babyn PS, 2004, PEDIATR RADIOL, V34, P47, DOI 10.1007/s00247-003-1081-8
   Bajwah S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00815-2020
   Belfort R, 2002, AM J OPHTHALMOL, V133, P467
   Bhowmik D, 2020, EVALUATION FLAVONOID
   Bruning A. H. L., 2018, New Microbes and New Infections, V24, P52, DOI 10.1016/j.nmni.2018.04.007
   Carradori Simone, 2020, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V19, P85, DOI 10.2174/1871523019999200228100917
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896
   Choi J, 2017, EXPERT OPIN THER PAT, V27, P721, DOI 10.1080/13543776.2017.1281248
   Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13
   Committee GOoNH, 2020, OFF STAT ADM TRAD CH
   Crooke ST, 2018, CELL METAB, V27, P714, DOI 10.1016/j.cmet.2018.03.004
   Dhama K, 2020, HUM VACC IMMUNOTHER, V16, P1232, DOI 10.1080/21645515.2020.1735227
   Dorward J, 2020, RAPID REV EFFECTIVEN, V19
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   El-Sahly HM, 2000, CLIN INFECT DIS, V31, P96, DOI 10.1086/313937
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Folz RJ, 1999, CHEST, V115, P901, DOI 10.1378/chest.115.3.901
   Fusi-Schmidhauser T, 2020, J PAIN SYMPTOM MANAG, V60, pE27, DOI 10.1016/j.jpainsymman.2020.03.030
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Haveri A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.11.2000266
   Himoto Y, 2020, JPN J RADIOL, V38, P400, DOI 10.1007/s11604-020-00958-w
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   HORBY P, 2020, NEW ENGL J MED, DOI 10.1101/2020.07.15.20151852
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   HUSSAN H, 2020, MBIO, V11, DOI DOI 10.1128/MBI0.00722-20
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152
   Kanne J.P., 2020, FINDINGS 2019 NOVEL
   Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1548
   Kirby T, 2020, LANCET RESP MED, V8, P547, DOI 10.1016/S2213-2600(20)30228-9
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Li B, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00807-19
   Li H, 2020, ZHONGHUA JIE HE HE H, V43, P170, DOI [10.3760/cma.j.issn.1001-0939.2020.0002, DOI 10.3760/CMA.J.ISSN.1001-0939.2020.0002]
   Li XG, 2020, J MED VIROL, V92, P501, DOI 10.1002/jmv.25701
   Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mahase E., 2020, BRIT MED J, DOI DOI 10.1136/BMJ.M265
   Mantlo E, 2020, ANTIVIR RES, V179, DOI 10.1016/j.antiviral.2020.104811
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   McCreary EK, 2020, CORONAVIRUS DIS 2019, DOI [10.1093/ofid/ofaa105, DOI 10.1093/0FID/0FAA105]
   Monchatre-Leroy E, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120364
   Neurath MF, 2020, GUT, V69, P1335, DOI 10.1136/gutjnl-2020-321269
   Organization WH, 2020, ORG WH REP WHO CHIN
   Orr RM, 2001, CURR OPIN MOL THER, V3, P288
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5
   Radbruch L, 2020, LANCET, V395, P1467, DOI 10.1016/S0140-6736(20)30964-8
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149
   Rosales-Mendoza S, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020183
   Rossi JJ, 2020, OLIGONUCLEOTIDES COV
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Ryu S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020006
   Sallard E, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104791
   Sun JM, 2020, TRENDS MOL MED, V26, P483, DOI 10.1016/j.molmed.2020.02.008
   To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362
   Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008
   Wu HS, 2004, EMERG INFECT DIS, V10, P304
   Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270
   Xia S, 2020, CELL MOL IMMUNOL, V17, P765, DOI 10.1038/s41423-020-0374-2
   Yan J, 2020, MOL HUM REPROD, V26, P367, DOI 10.1093/molehr/gaaa030
   Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762
   Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 79
TC 24
Z9 26
U1 4
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD DEC 1
PY 2020
VL 18
IS 12
BP 1201
EP 1211
DI 10.1080/14787210.2020.1797487
EA AUG 2020
PG 11
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA OW7KG
UT WOS:000555629200001
PM 32749914
OA Bronze
DA 2022-04-20
ER

PT J
AU Barbieri, D
   Giuliani, E
   Del Prete, A
   Losi, A
   Villani, M
   Barbieri, A
AF Barbieri, Davide
   Giuliani, Enrico
   Del Prete, Anna
   Losi, Amanda
   Villani, Matteo
   Barbieri, Alberto
TI How Artificial Intelligence and New Technologies Can Help the Management
   of the COVID-19 Pandemic
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE artificial intelligence; new technologies; pandemic management; COVID-19
ID CARE; TELEMEDICINE; CHALLENGES; MODEL
AB The COVID-19 pandemic has worked as a catalyst, pushing governments, private companies, and healthcare facilities to design, develop, and adopt innovative solutions to control it, as is often the case when people are driven by necessity. After 18 months since the first case, it is time to think about the pros and cons of such technologies, including artificial intelligence-which is probably the most complex and misunderstood by non-specialists-in order to get the most out of them, and to suggest future improvements and proper adoption. The aim of this narrative review was to select the relevant papers that directly address the adoption of artificial intelligence and new technologies in the management of pandemics and communicable diseases such as SARS-CoV-2: environmental measures; acquisition and sharing of knowledge in the general population and among clinicians; development and management of drugs and vaccines; remote psychological support of patients; remote monitoring, diagnosis, and follow-up; and maximization and rationalization of human and material resources in the hospital environment.
C1 [Barbieri, Davide] Univ Ferrara, Dept Neurosci & Rehabil, Via Savonarola 9, I-44121 Ferrara, Italy.
   [Giuliani, Enrico; Losi, Amanda] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurosci Sci, Via Pozzo 71, I-41125 Modena, Italy.
   [Del Prete, Anna; Barbieri, Alberto] Univ Modena & Reggio Emilia, Sch Anesthesiol & Intens Care, Via Pozzo 71, I-41125 Modena, Italy.
   [Villani, Matteo] Azienda USL Piacenza, Dept Anesthesiol & Intens Care, Via Antonio Anguissola 15, I-29121 Piacenza, Italy.
RP Losi, A (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurosci Sci, Via Pozzo 71, I-41125 Modena, Italy.
EM davide.barbieri@unife.it; en.giuliani@gmail.com;
   annadelprete@hotmail.it; losi.amanda@gmail.com; mvillani@live.it;
   alberto.barbieri@unimore.it
OI Villani, Matteo/0000-0003-4269-6096; Barbieri,
   Davide/0000-0002-7324-8811; Del Prete, Anna/0000-0003-4424-9855
CR Ahmed Z, 2020, DATABASE-OXFORD, V2020, DOI 10.1093/database/baaa010
   Alimadadi A, 2020, PHYSIOL GENOMICS, V52, P200, DOI 10.1152/physiolgenomics.00029.2020
   Andelic N, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030959
   [Anonymous], 2020, NATURE, V580, P563, DOI 10.1038/d41586-020-01264-1
   [Anonymous], IMMUNI SITO UFFICIAL
   Arshadi AK, 2020, FRONT ARTIF INTELL, V3, DOI 10.3389/frai.2020.00065
   Asgary A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010268
   Baig MA, 2019, STUD HEALTH TECHNOL, V262, P43, DOI 10.3233/SHTI190012
   Banerjee D., 2021, J PHYS C SER, V1797
   Barbieri D., 2018, J EUR AM INTELL STUD, V53, P25
   Barbieri D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217923
   Bengio Y, 2021, J AM MED INFORM ASSN, V28, P193, DOI 10.1093/jamia/ocaa153
   Beyene LS, 2019, J PSYCHIATR MENT HLT, V26, P368, DOI 10.1111/jpm.12548
   Birrell PJ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8455-9
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8
   Bubar KM, 2021, SCIENCE, V371, P916, DOI 10.1126/science.abe6959
   Cioffi A, 2020, Ethics Med Public Health, V15, P100575, DOI 10.1016/j.jemep.2020.100575
   Dantas LF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248920
   Donaghy E, 2019, BRIT J GEN PRACT, V69, pE586, DOI 10.3399/bjgp19X704141
   Du L, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/23194
   Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936
   Gao W, 2019, ACCOUNTS CHEM RES, V52, P523, DOI 10.1021/acs.accounts.8b00500
   Giuliani E, 2020, J EVAL CLIN PRACT, V26, P520, DOI 10.1111/jep.13300
   Goncalves-Ferreira D, 2019, JMIR MED INF, V7, DOI 10.2196/medinform.9845
   Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m998
   Halasz G, 2021, J MED INTERNET RES, V23, DOI 10.2196/29058
   Hofer IS, 2020, ANESTH ANALG, V130, P1115, DOI 10.1213/ANE.0000000000004575
   Javaid M, 2020, DIABETES METAB SYND, V14, P419, DOI 10.1016/j.dsx.2020.04.032
   Jiang LS, 2021, J INT MED RES, V49, DOI 10.1177/03000605211000157
   Johns Hopkins Coronavirus Resource Center, COVID 19 MAP
   Kabra R, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2020.165978
   Kang S, 2020, EYE, V34, P1193, DOI 10.1038/s41433-020-0953-6
   Khan O, 2020, WORLD NEUROSURG, V140, P512, DOI 10.1016/j.wneu.2020.04.022
   Kondylakis H, 2020, J MED INTERNET RES, V22, DOI 10.2196/23170
   Kongats K, 2019, PUBLIC HEALTH NUTR, V22, P1492, DOI 10.1017/S1368980018004068
   Legare F, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub3
   Li Fangyu, 2021, Smart Health (Amst), V19, P100147, DOI 10.1016/j.smhl.2020.100147
   Li HL, 2020, ANN VASC SURG, V68, P76, DOI 10.1016/j.avsg.2020.06.023
   Loeb AE, 2020, J AM ACAD ORTHOP SUR, V28, pE469, DOI 10.5435/JAAOS-D-20-00380
   Lorencin I, 2021, J PERS MED, V11, DOI 10.3390/jpm11010028
   Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8
   McCullough PA, 2020, REV CARDIOVASC MED, V21, P1, DOI 10.31083/j.rcm.2020.01.42
   Melegari G, 2020, MED INTENSIVA, V44, P583, DOI 10.1016/j.medin.2020.04.007
   Ming LC, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19796
   Musulin J, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084287
   Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15
   Ong E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01581
   Park YG, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19204353
   Rivi V, 2021, BMJ EVID-BASED MED, V26, P141, DOI 10.1136/bmjebm-2020-111513
   Sjodin H, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.13.2000280
   Stifanic D, 2020, COMPLEXITY, V2020, DOI 10.1155/2020/1846926
   ul Qamar MT, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00752-w
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8
   Williams Faustine, 2008, Inform Prim Care, V16, P139
   Zaccagni L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18126416
   Zaccagni L, 2019, BIOL SPORT, V36, P17, DOI 10.5114/biolsport.2018.78901
   Zhang M, 2020, J MED INTERNET RES, V22, DOI 10.2196/21572
NR 59
TC 1
Z9 1
U1 8
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2021
VL 18
IS 14
AR 7648
DI 10.3390/ijerph18147648
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA TN4GW
UT WOS:000676196200001
PM 34300099
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Antwi-Boasiako, J
   Nyarkoh, E
AF Antwi-Boasiako, Joseph
   Nyarkoh, Enoch
TI Government Communication during the Covid-19 Pandemic in Ghana
SO INTERNATIONAL JOURNAL OF PUBLIC ADMINISTRATION
LA English
DT Article
DE COVID-19; Ghana; government communication; policy response
ID DECENTRALIZATION; RESPONSES
AB One key approach to managing a pandemic is through effective government communication. How countries have utilized communication strategies during this novel Covid-19 pandemic has not yet been well documented in the literature. Using a qualitative document analysis approach, this paper seeks to answer the question; what communication strategies have been used by the government of Ghana to fight against the Covid-19 pandemic? The study identified that the government of Ghana has been using frequent Presidential Addresses, Minister's Press Briefings, designated Covid-19 Website, and Social and Traditional Media to communicate to its citizens. We argue that these communication strategies used by the government to "Spread Calm, Not Fear" seems to have had a positive effect on the Covid-19 fight in Ghana. Documenting the experiences of Ghana in the literature will greatly contribute to knowledge especially as Ghana has been one of the highlights in the management of the Covid-19 pandemic.
C1 [Antwi-Boasiako, Joseph] Univ Ghana, Business Sch, Dept Publ Adm & Hlth Serv Management, Accra, Ghana.
   [Nyarkoh, Enoch] Univ Queensland, Sch Educ, Brisbane, Qld, Australia.
RP Antwi-Boasiako, J (corresponding author), Univ Ghana, Dept Publ Adm & Hlth Serv Management, POB LG 78, Legon, Accra, Ghana.
EM joelisk1@hotmail.com
CR Abbey, 2020, CAP 20 COVID 19 CASE
   Akufo-Addo, 2020, AKUFO ADDO 0327
   Akufo-Addo, 2021, AKUFO ADDO 0331
   Antwi-Boasiako J, 2021, REV ADM PUBL-RIO JAN, V55, P122, DOI 10.1590/0034-761220200507
   Antwi-Boasiako K.B., 2010, J AFRICAN STUDIES DE, V2, P166
   Arun T., 2020, 99850 MUN PERS REPEC
   Ataguba OA, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1788263
   Ayee J.R.A., 2008, FDN LOCAL GOVERNANCE, P223, DOI [10.1007/978-3-7908-2006-5_11, DOI 10.1007/978-3-7908-2006-5_11]
   Bawole N.J., 2017, ADM THEORY PRAXIS, V39, P2, DOI [10.1080/10841806.2017.1309801, DOI 10.1080/10841806.2017.1309801, https://doi.org/10.1080/10841806.2017.1309801]
   Berger M., 2020, WASH POST
   Bonful HA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238971
   Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027
   Chan AKM, 2020, ANAESTHESIA, V75, P1579, DOI 10.1111/anae.15057
   Coombs WT, 2015, BUS HORIZONS, V58, P141, DOI 10.1016/j.bushor.2014.10.003
   Crawford G, 2008, OXF DEV STUD, V36, P235, DOI 10.1080/13600810701702002
   Creswell J.W., 1998, QUAL INQ
   Crozier M, 2007, POLIT COMMUN, V24, P1, DOI 10.1080/10584600601128382
   Department of Health, 2020, COVID 19 COR VIR S A
   Dye, 2007, UNDERSTANDING PUBLIC
   Dye T.R., 2013, UNDERSTANDING PUBLIC
   Fairbanks J, 2007, J PUBLIC AFF, V7, P23, DOI 10.1002/pa.245
   Garnett, 1992, COMMUNICATING RESULT
   Ghana, 2021, REPORT SOC AUDIT GHA
   Ghana Health Service, 2020, COVID 19 WEBS
   Gil-Garcia J.R., 2018, J PUBL ADM RES THEOR
   Hale T, 2020, VARIATION GOVT RESPO
   Hartel, 2005, RES EMOTION ORG, P271
   Holladay, 2010, HDB CRISIS COMMUNICA, P677, DOI [10.1002/9781444314885.ch33, DOI 10.1002/9781444314885.CH33]
   Hood C., 1986, TOOLS GOVT
   Howlett M, 2009, CAN POLITICAL SCI RE, V3, P23
   Husnayain A, 2020, INT J INFECT DIS, V95, P221, DOI 10.1016/j.ijid.2020.03.021
   Hyland-Wood B, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-020-00701-w
   Kamstra J, 2014, DEMOCRATIZATION, V21, P583, DOI 10.1080/13510347.2012.751975
   Kemp S., 2020, DIGITAL 2020 GHANADA
   Krotel SML, 2021, INT J PUBLIC ADMIN, V44, P132, DOI 10.1080/01900692.2019.1672182
   Lanard J, 2004, WORLD HLTH ORG C OUT
   Liu BF, 2011, PUBLIC RELAT REV, V37, P345, DOI 10.1016/j.pubrev.2011.08.004
   Martuscelli PN, 2020, REV ADM PUBL-RIO JAN, V54, P1446, DOI 10.1590/0034-761220200516x
   Ministry of Health, 2020, 1 CONF COVID 19 CAS
   Minkenberg M, 2001, WEST EUR POLIT, V24, P1, DOI 10.1080/01402380108425462
   NCDC, 2020, COV 19 NIG
   Peci A, 2021, REV ADM PUBL-RIO JAN, V55, P1, DOI 10.1590/0034-761220210023
   Rainie L, 2005, PEW INTERNET AM LIFE
   Rapley T., 2007, DOING CONVERSATION D
   Sakyi EK, 2010, LEADERSH HEALTH SERV, V23, P156, DOI 10.1108/17511871011040733
   Salmon C., 1989, INFORM CAMPAIGNS MAN
   Sandman, 2003, STRAITS TIMES, V6
   Seltzer T, 2007, PUBLIC RELAT REV, V33, P227, DOI 10.1016/j.pubrev.2007.02.011
   SEND-Ghana, 2020, CIT ASS GHAN GOV COV
   Smulowitz, 2017, DOCUMENT ANAL INT EN, P1, DOI [10.1002/9781118901731.iecrm0071, DOI 10.1002/9781118901731.IECRM0071]
   Sulitzeanu-Kenan R, 2007, POLICY POLIT, V35, P629, DOI 10.1332/030557307782452985
   Thelwall M, 2007, J COMPUT-MEDIAT COMM, V12, P523, DOI 10.1111/j.1083-6101.2007.00336.x
   Thomas JC, 2003, J PUBL ADM RES THEOR, V13, P83, DOI 10.1093/jpart/mug010
   Torjman, 2005, WHAT IS POLICY
   Varone Frederic., 2014, PUBLIC POLICY PROCES
   Vedung, 1998, CARROTS STICKS SERMO, P103128
   Vraga EK, 2020, WORLD MED HEALTH POL, V12, P233, DOI 10.1002/wmh3.359
   Wach E., 2013, LEARNING QUALITATIVE
   West DM, 2004, PUBLIC ADMIN REV, V64, P15, DOI 10.1111/j.1540-6210.2004.00343.x
   World Health Organization, 2021, NEW COVID 19 VAR FUE
   World Health Organization (WHO), 2020, RISK COMM COMM ENG R
   Yeboah-Assiamah E, 2016, J ASIAN AFR STUD, V51, P683, DOI 10.1177/0021909614555349
   Zhang J., 2020, WELL IS GHANA WITH O
NR 63
TC 1
Z9 1
U1 9
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0190-0692
EI 1532-4265
J9 INT J PUBLIC ADMIN
JI Int. J. Public Adm.
PD OCT 3
PY 2021
VL 44
IS 13
BP 1175
EP 1188
DI 10.1080/01900692.2021.1956950
EA SEP 2021
PG 14
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA WB1LW
UT WOS:000694749800001
DA 2022-04-20
ER

PT J
AU Vaz, E
AF Vaz, Eric
TI COVID-19 in Toronto: A Spatial Exploratory Analysis
SO SUSTAINABILITY
LA English
DT Article
DE COVID-19; Toronto; spatial analysis
AB COVID-19 has had a significant impact on a global scale. Evident signs of spatial-explicit characteristics have been noted. Nevertheless, publicly available data are scarce, impeding a complete picture of the locational impacts of COVID-19. This paper aimed to assess, confirm, and validate several geographical attributes of the geography of the pandemic. A spatial modeling framework defined whether there was a clear spatial profile to COVID-19 and the key socio-economic characteristics of the distribution in Toronto. A stepwise backward regression model was generated within a geographical information systems framework to establish the key variables influencing the spread of COVID-19 in Toronto. Further to this analysis, spatial autocorrelation was performed at the global and local levels, followed by an error and lag spatial regression to understand which explanatory framework best explained disease spread. The findings support that COVID-19 is strongly spatially explicit and that geography matters in preventing spread. Social injustice, infrastructure, and neighborhood cohesion are evident characteristics of the increasing spread and incidence of COVID-19. Mitigation of incidents can be carried out by intertwining local policies with spatial monitoring strategies at the neighborhood level throughout large cities, ensuring open data and adequacy of information management within the knowledge chain.
C1 [Vaz, Eric] Ryerson Univ, Dept Geog & Environm Studies, Toronto, ON M5B 2K3, Canada.
RP Vaz, E (corresponding author), Ryerson Univ, Dept Geog & Environm Studies, Toronto, ON M5B 2K3, Canada.
EM evaz@ryerson.ca
CR Atkeson A., 2020, WHAT WILL BE EC IMPA
   Barber K, 2019, J URBAN TECHNOL, V26, P107, DOI 10.1080/10630732.2018.1558573
   Batty M, 2020, ENVIRON PLAN B-URBAN, V47, P547, DOI 10.1177/2399808320926912
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8
   de Noronha T, 2015, HABITAT INT, V45, P147, DOI 10.1016/j.habitatint.2014.06.025
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3
   Esch T, 2013, IEEE GEOSCI REMOTE S, V10, P1617, DOI 10.1109/LGRS.2013.2272953
   Esch T, 2017, ISPRS J PHOTOGRAMM, V134, P30, DOI 10.1016/j.isprsjprs.2017.10.012
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   Ganem F, 2020, MEDRXIV, DOI [10.1101/2020.04.06.20055103, DOI 10.1101/2020.04.06.20055103]
   Getis A., 2009, HDB APPL SPATIAL ANA
   Gleditsch K., 2008, SPATIAL REGRESSION M
   Graham A.J., 2004, SPATIAL ANAL EPIDEMI
   Greenough PG, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0234-9
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Robertson C, 2017, GEOJOURNAL, V82, P397, DOI 10.1007/s10708-015-9688-5
   Rytkonen Mika J, 2004, Int J Circumpolar Health, V63, P9
   Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627
   Sun JM, 2020, TRENDS MOL MED, V26, P483, DOI 10.1016/j.molmed.2020.02.008
   Taubenbock H, 2019, REMOTE SENS ENVIRON, V232, DOI 10.1016/j.rse.2019.111353
   Vaz E, 2015, J ENVIRON INFORM, V25, P71, DOI 10.3808/jei.201500299
   Vaz E., 2020, REGIONAL INTELLIGENC
   Vaz E, 2017, HABITAT INT, V68, P24, DOI 10.1016/j.habitatint.2017.07.010
   Vaz E, 2017, J SPAT ORGAN DYN, V5, P37
   Vaz E, 2017, HABITAT INT, V59, P118, DOI 10.1016/j.habitatint.2016.12.001
   Vaz E, 2016, HABITAT INT, V56, P52, DOI 10.1016/j.habitatint.2016.04.006
   Vaz E, 2013, J SPAT ORGAN DYN, V1, P241
   Walker PG, 2020, 12 IMP COLL LOND
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151
   Wang YQ, 2020, SCI TOTAL ENVIRON, V740, DOI 10.1016/j.scitotenv.2020.139984
   WHO, 2020, PREP PREV CONTR COR
   Zandy M, 2019, HEALTH PROMOT CHRON, V39, P35, DOI 10.24095/hpcdp.39.2.01
NR 36
TC 9
Z9 9
U1 9
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JAN
PY 2021
VL 13
IS 2
AR 498
DI 10.3390/su13020498
PG 15
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA PY1ES
UT WOS:000611792300001
OA gold
DA 2022-04-20
ER

PT J
AU Gombos, K
   Herczeg, R
   Eross, B
   Kovacs, SZ
   Uzzoli, A
   Nagy, T
   Kiss, S
   Szakacs, Z
   Imrei, M
   Szentesi, A
   Nagy, A
   Fabian, A
   Hegyi, P
   Gyenesei, A
AF Gombos, Katalin
   Herczeg, Robert
   Eross, Balint
   Kovacs, Sandor Zsolt
   Uzzoli, Annamaria
   Nagy, Tamas
   Kiss, Szabolcs
   Szakacs, Zsolt
   Imrei, Marcell
   Szentesi, Andrea
   Nagy, Aniko
   Fabian, Attila
   Hegyi, Peter
   Gyenesei, Attila
CA KETLAK consortium
TI Translating Scientific Knowledge to Government Decision Makers Has
   Crucial Importance in the Management of the COVID-19 Pandemic
SO POPULATION HEALTH MANAGEMENT
LA English
DT Article
DE COVID-19; mortality; interdisciplinary; ICU capacity; testing; modeling
AB In times of epidemics and humanitarian crises, it is essential to translate scientific findings into digestible information for government policy makers who have a short time to make critical decisions. To predict how far and fast the disease would spread across Hungary and to support the epidemiological decision-making process, a multidisciplinary research team performed a large amount of scientific data analysis and mathematical and socioeconomic modeling of the COVID-19 epidemic in Hungary, including modeling the medical resources and capacities, the regional differences, gross domestic product loss, the impact of closing and reopening elementary schools, and the optimal nationwide screening strategy for various virus-spreading scenarios and R metrics. KETLAK prepared 2 extensive reports on the problems identified and suggested solutions, and presented these directly to the National Epidemiological Policy-Making Body. The findings provided crucial data for the government to address critical measures regarding health care capacity, decide on restriction maintenance, change the actual testing strategy, and take regional economic, social, and health differences into account. Hungary managed the first part of the COVID-19 pandemic with low mortality rate. In times of epidemics, the formation of multidisciplinary research groups is essential for policy makers. The establishment, research activity, and participation in decision-making of these groups, such as KETLAK, can serve as a model for other countries, researchers, and policy makers not only in managing the challenges of COVID-19, but in future pandemics as well.
C1 [Gombos, Katalin; Nagy, Tamas] Univ Pecs, Med Sch, Dept Lab Med, Pecs, Hungary.
   [Herczeg, Robert; Gyenesei, Attila] Univ Pecs, Genom & Bioinformat Core Facil, Szentagothai Res Ctr, Bioinformat Res Grp, Pecs, Hungary.
   [Eross, Balint; Kiss, Szabolcs; Szakacs, Zsolt; Imrei, Marcell; Szentesi, Andrea; Hegyi, Peter] Univ Pecs, Med Sch, Inst Translat Med, Pecs, Hungary.
   [Kovacs, Sandor Zsolt] Ctr Econ & Reg Studies, Inst Reg Studies, Pecs, Hungary.
   [Uzzoli, Annamaria] Ctr Econ & Reg Studies, Inst Reg Studies, Budapest, Hungary.
   [Kiss, Szabolcs; Szentesi, Andrea] Univ Szeged, Dept Med, Ctr Translat Med, Szeged, Hungary.
   [Nagy, Aniko] Heim Pal Natl Pediat Inst, Budapest, Hungary.
   [Fabian, Attila] Univ Sopron, Inst Int & Reg Econ, Alexandre Lamfalussy Fac Econ, Sopron, Hungary.
   [Gyenesei, Attila] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland.
RP Hegyi, P (corresponding author), Univ Pecs, KETLAK Consortium Ctr Translat Med, 12 Szigeti Ut, H-7624 Pecs, Hungary.; Gyenesei, A (corresponding author), Univ Pecs, KETLAK Consortium Bioinformat Res Grp, Genom & Bioinformat Core Facil, Szentagothai Res Ctr, 20 Ifjusag Utja, H-7624 Pecs, Hungary.
EM hegyi.peter@pte.hu; gyenesei.attila@pte.hu
OI Nagy, Tamas/0000-0001-5437-1411; Imrei, Marcell/0000-0003-0175-7462;
   Juhasz, Mark Felix/0000-0001-7583-5211
CR Al-qaness MAA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030674
   [Anonymous], 2020, HUNGARY TODAY
   [Anonymous], 2016, NIHR DISSEMINATION, DOI [10.3310/themedreview-000827, DOI 10.3310/THEMEDREVIEW-000827]
   Azizi A, 2020, INFECT DIS MODEL, V5, P12, DOI 10.1016/j.idm.2019.11.002
   Badawi O., 2020, IMPACT COVID 19 PAND, DOI [10.1101/2020.04.08.20058180, DOI 10.1101/2020.04.08.20058180]
   Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26
   Chen TM, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00640-3
   Choi S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020011
   Clark TW, 2020, J INFECT
   Colombo S, 2018, EPIDEMIOL PREV, V42, P214, DOI 10.19191/EP18.3-4.P214.069
   Dietz L, 2020, MSYSTEMS, V5, DOI [10.1128/mSystems.00245-20, 10.1128/mSystems.00245-20.]
   Glass K, 2006, EPIDEMIOL INFECT, V134, P1092, DOI 10.1017/S0950268806005863
   Gonzalez-Reiche AS, 2020, SCIENCE, V369, P297, DOI 10.1126/science.abc1917
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Hanna E, 2018, HEALTH POLICY, V122, P217, DOI 10.1016/j.healthpol.2017.11.012
   He LH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01388
   Iyer M, 2020, BMB REP, V53, P191, DOI 10.5483/BMBRep.2020.53.4.080
   Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297
   Keil R., 2006, TOPIA, V16, P23, DOI DOI 10.3138/TOPIA.16.23
   Kim K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091064
   Kovacs SZ, 2018, DETUROPE, V10, P108
   Kovacs SZ., KORONAVIRUS JARVANY
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Moeckli B, 2020, AM J TRANSPLANT, V20, P1935, DOI 10.1111/ajt.15939
   N.N.K.N.C.f.P, ELJ 2020 EVB AZ UJ K, DOI [1272454/retrieve,https://www.nnk.gov.hu/index.php/component/content/article/140-koronavirus-tajekoztatok/567-eljarasrend-a-2020-evben-azonositott-uj-koronavirussal-kapcsolatban-2020-03-16?Itemid=135, DOI 1272454/RETRIEVE,HTTPS://WWW.NNK.GOV.HU/INDEX.PHP/COMPONENT/CONTENT/ARTICLE/140-KORONAVIRUS-TAJEKOZTATOK/567-ELJARASREND-A-2020-EVBEN-AZONOSITOTT-UJ-KORONAVIRUSSAL-KAPCSOLATBAN-2020-03-16?ITEMID=135]
   Oh J, 2020, HEALTH SYST REFORM, V6, DOI 10.1080/23288604.2020.1753464
   Preuss KD, 2009, INT J CANCER, V125, P656, DOI 10.1002/ijc.24427
   R Development Core Team, 2013, R LANGUAGE ENV STAT
   Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135
   Salehi R, 2006, CAN PUBLIC POL, V32, P373
   Selko A.U.S., 2009, RANKS 8 GLOBAL INNOV
   Skevaki C, 2020, J INFECTION, V81, P205, DOI 10.1016/j.jinf.2020.06.039
   Surkis A, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0992-8
   Szirmai V., 2016, ARTIFICIAL TOWNS 21
   Wang ZL, 2020, J INFECTION, V81, P179, DOI 10.1016/j.jinf.2020.03.040
   Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4
   Yamey G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1643
   Yen MY, 2014, J HOSP INFECT, V87, P185, DOI 10.1016/j.jhin.2014.05.005
   Zhang JS, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00264
   Zhen W, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00743-20
NR 40
TC 6
Z9 7
U1 1
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1942-7891
EI 1942-7905
J9 POPUL HEALTH MANAG
JI Popul. Health Manag.
PD FEB 1
PY 2021
VL 24
IS 1
BP 35
EP 45
DI 10.1089/pop.2020.0159
PG 11
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA QB6JU
UT WOS:000614245500009
PM 32882160
DA 2022-04-20
ER

PT J
AU Beng, TS
   Kim, CLC
   Shee, CC
   Ching, DNL
   Liang, TJ
   Kumar, MKN
   Guan, NC
   Khuen, LP
   Loong, LC
   Chin, LE
   Zainuddin, SI
   Capelle, DP
   Munn, AC
   Yen, LK
   Isahak, NNHN
AF Tan Seng Beng
   Kim, Carol Lai Cheng
   Shee, Chai Chee
   Diana Ng Leh Ching
   Tan Jiunn Liang
   Kumar, Mehul Kumar Narendra
   Ng Chong Guan
   Lim Poh Khuen
   Loong, Lam Chee
   Chin, Loh Ee
   Zainuddin, Sheriza Izwa
   Capelle, David Paul
   Munn, Ang Chui
   Yen, Lim Kah
   Isahak, Nik Nathasha Hani Nik
TI COVID-19, Suffering and Palliative Care: A Review
SO AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE
LA English
DT Review; Early Access
DE COVID-19; suffering; palliative care; symptom control; communication;
   team care
ID REFRACTORY CHRONIC COUGH; EXERCISE TOLERANCE; DIHYDROCODEINE;
   BREATHLESSNESS; OPIOIDS; MANAGEMENT; SEDATIVES; SURVIVAL; OUTCOMES;
   ANXIETY
AB According to the WHO guideline, palliative care is an integral component of COVID-19 management. The relief of physical symptoms and the provision of psychosocial support should be practiced by all healthcare workers caring for COVID-19 patients. In this review, we aim to provide a simple outline on COVID-19, suffering in COVID-19, and the role of palliative care in COVID-19. We also introduce 3 principles of palliative care that can serve as a guide for all healthcare workers caring for COVID-19 patients, which are (1) good symptom control, (2) open and sensitive communication, and (3) caring for the whole team. The pandemic has brought immense suffering, fear and death to people everywhere. The knowledge, skills and experiences from palliative care could be used to relieve the suffering of COVID-19 patients.
C1 [Tan Seng Beng; Kim, Carol Lai Cheng; Tan Jiunn Liang; Loong, Lam Chee; Chin, Loh Ee; Zainuddin, Sheriza Izwa; Capelle, David Paul; Munn, Ang Chui; Yen, Lim Kah; Isahak, Nik Nathasha Hani Nik] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 59100, Malaysia.
   [Shee, Chai Chee; Diana Ng Leh Ching] Univ Sarawak Malaysia, Fac Med & Hlth Sci, Dept Med, Sarawak, Malaysia.
   [Kumar, Mehul Kumar Narendra; Ng Chong Guan; Lim Poh Khuen] Univ Malaya, Fac Med, Dept Psychol Med, Kuala Lumpur, Malaysia.
RP Beng, TS (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 59100, Malaysia.
EM pramudita_1@hotmail.com
RI Capelle, David Paul/ABG-9789-2021
OI Capelle, David Paul/0000-0001-7322-3342; , POH KHUEN/0000-0001-8779-5958
CR Abu Esba LC, 2021, INFECT DIS THER, V10, P253, DOI 10.1007/s40121-020-00363-w
   Ahmed S., 2020, BMJ INNOV, DOI [10.1136/bmjinnov-2020-000440, DOI 10.1136/BMJINNOV-2020-000440]
   Ammar MA, 2021, J INTENSIVE CARE MED, V36, P157, DOI 10.1177/0885066620951426
   [Anonymous], 2021, LANCET RHEUMATOL, V3, pE465, DOI 10.1016/S2665-9913(21)00144-2
   Arenliu A, 2020, PSYCHIAT DANUB, V32, P570, DOI 10.24869/psyd.2020.570
   Back AL., 2020, VITALTALK SEATTLE VI
   Bajwah S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00815-2020
   Buck C., 1996, European Respiratory Journal Supplement, V9, p344S
   Busana M, 2021, MINERVA ANESTESIOL, V87, P325, DOI 10.23736/S0375-9393.21.15245-9
   Cardona-Morrell M, 2016, INT J QUAL HEALTH C, V28, P456, DOI 10.1093/intqhc/mzw060
   Chen CH, 2021, AM J HOSP PALLIAT ME, V38, P869, DOI 10.1177/10499091211006914
   Chen YR, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03076-7
   Chua TP, 1997, J AM COLL CARDIOL, V29, P147, DOI 10.1016/S0735-1097(96)00446-9
   CNA, 2021, LEAST 115000 HEALTHC
   Deng JW, 2021, ANN NY ACAD SCI, V1486, P90, DOI 10.1111/nyas.14506
   Devabhakthuni S, 2012, ANN PHARMACOTHER, V46, P530, DOI 10.1345/aph.1Q525
   Dicpinigaitis PV, 2008, LUNG, V186, P369, DOI 10.1007/s00408-008-9114-6
   Ding H, 2021, EUR REV MED PHARMACO, V25, P1087, DOI 10.26355/eurrev_202101_24679
   Ferrell BR, 2020, J PAIN SYMPTOM MANAG, V60, pE7, DOI 10.1016/j.jpainsymman.2020.06.034
   Finset A, 2020, PATIENT EDUC COUNS, V103, P873, DOI 10.1016/j.pec.2020.03.027
   Francis B, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102240
   Fukuti P, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1963
   Gilmartin H, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2017.05.041
   Goncalves Junior J., 2020, FRONT PSYCHIATRY, V11
   Good PD, 2005, INTERN MED J, V35, P512, DOI 10.1111/j.1445-5994.2005.00888.x
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   Hall E, 1993, Palliat Med, V7, P339
   Hanh T.N., 2012, PEACE IS EVERY BREAT
   Hanna JR, 2021, PALLIATIVE MED, V35, P843, DOI 10.1177/02692163211004210
   Haryalchi K, 2021, ANAESTH PAIN MED, V11
   Hoertel N, 2021, MOL PSYCHIATR, V26, P5199, DOI 10.1038/s41380-021-01021-4
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Janssen DJA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02583-2020
   Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939
   JOHNSON MA, 1983, BRIT MED J, V286, P675, DOI 10.1136/bmj.286.6366.675
   Kamal AH., 2021, J PALLIAT MED
   Kaplan M, 2010, CLIN J ONCOL NURS, V14, P514, DOI 10.1188/10.CJON.514-516
   Keeley P, 2020, BMJ SUPPORT PALLIAT, V10, P381, DOI 10.1136/bmjspcare-2020-002368
   Khawam E., 2020, CLEVE CLIN J MED
   Koch R., 2000, 80 20 PRINCIPLE SECR
   Kong XY, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.586355
   Lenhart SE, 2001, ANN PHARMACOTHER, V35, P1449
   Lenze EJ, 2020, JAMA-J AM MED ASSOC, V324, P2292, DOI 10.1001/jama.2020.22760
   Liberman T, 2022, AM J HOSP PALLIAT ME, V39, P584, DOI 10.1177/10499091211036702
   Lim HM, 2021, JMIR MED INF, V9, DOI 10.2196/23427
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Lopez S, 2021, J PAIN SYMPTOM MANAG, V62, P267, DOI 10.1016/j.jpainsymman.2020.12.015
   Lopez S, 2020, AM J HOSP PALLIAT ME, V37, P980, DOI 10.1177/1049909120942494
   Lovell N, 2020, J PAIN SYMPTOM MANAG, V60, pE77, DOI 10.1016/j.jpainsymman.2020.04.015
   Lovell N, 2018, PALLIATIVE MED, V32, P1518, DOI 10.1177/0269216318787450
   Minihan E, 2020, IRISH J PSYCHOL MED, V37, P259, DOI 10.1017/ipm.2020.41
   Moradi Y, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-03009-w
   Mori M, 2020, SUPPORT CARE CANCER, V28, P3051, DOI 10.1007/s00520-019-05081-9
   Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5
   Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441
   National Institute for Health and Care Excellence (NICE) in collaboration with NHS England and NHS Improvement, 2020, BMJ, V369, pm1461, DOI 10.1136/bmj.m1461
   Nguyen Long H, 2020, medRxiv, DOI [10.1016/S2468-2667(20)30164-X, 10.1101/2020.04.29.20084111]
   Okamoto K, 2019, INFECT CONT HOSP EP, V40, P559, DOI 10.1017/ice.2019.33
   Park SH, 2020, INFECT CHEMOTHER, V52, P165, DOI 10.3947/ic.2020.52.2.165
   Petriceks AH, 2020, PALLIAT SUPPORT CARE, V18, P379, DOI 10.1017/S1478951520000474
   Radbruch L, 2020, J PAIN SYMPTOM MANAG, V60, P754, DOI 10.1016/j.jpainsymman.2020.04.027
   Ramlall Vijendra, 2020, medRxiv, DOI 10.1101/2020.10.15.20213546
   Ryan NM, 2012, LANCET, V380, P1583, DOI 10.1016/S0140-6736(12)60776-4
   Sahu AK, 2020, AM J EMERG MED, V38, P1727, DOI 10.1016/j.ajem.2020.05.113
   Salari N, 2020, HUM RESOUR HEALTH, V18, DOI 10.1186/s12960-020-00544-1
   Schlogl M, 2021, EUR GERIATR MED, V12, P1181, DOI 10.1007/s41999-021-00532-1
   Schlogl M, 2020, J AM GERIATR SOC, V68, pE12, DOI 10.1111/jgs.16488
   Shaygan M, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03085-6
   Spoorthy MS, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102119
   Stege G, 2008, RESP MED, V102, P801, DOI 10.1016/j.rmed.2007.12.026
   Subramanyam AA, 2018, INDIAN J PSYCHIAT, V60, P371, DOI 10.4103/0019-5545.224476
   Tan L, 2020, ANZ J SURG, V90, P1566, DOI [10.1111/ans.16194, 10.1111/ans.16455]
   The Lancet, 2020, Lancet, V395, P537, DOI 10.1016/S0140-6736(20)30379-2
   Ting R, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2710
   Trougakos IP, 2021, J BIOMED SCI, V28, DOI 10.1186/s12929-020-00703-5
   Verberkt CA, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01153-2017
   Vertigan AE, 2016, CHEST, V149, P639, DOI 10.1378/chest.15-1271
   Wang MH, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01259-0
   WHO, 2020, NAM COR DIS COVID 19
   WOODCOCK AA, 1981, BRIT MED J, V283, P343, DOI 10.1136/bmj.283.6287.343
   WOODCOCK AA, 1981, NEW ENGL J MED, V305, P1611, DOI 10.1056/NEJM198112313052703
   World Health Organization, 2020, CLIN MAN COVID 19 IN
   World Health Organization, 2021, PSYCH 1 AID GUID FIE
   World Health Organization, COVID 19 CLIN MAN LI
   World Health Organization (WHO), 2021, PALL CAR
   Worsham CM, 2020, ANN AM THORAC SOC, V17, P926, DOI 10.1513/AnnalsATS.202004-322VP
   Yoganandhan A, 2021, Vacunas, V22, P98, DOI 10.1016/j.vacun.2020.12.004
NR 87
TC 0
Z9 0
U1 4
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1049-9091
EI 1938-2715
J9 AM J HOSP PALLIAT ME
JI Am. J. Hosp. Palliat. Med.
AR 10499091211046233
DI 10.1177/10499091211046233
EA SEP 2021
PG 10
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services
GA UQ9BA
UT WOS:000696351800001
PM 34525862
OA hybrid, Green Accepted
DA 2022-04-20
ER

PT J
AU Cecchi, MA
   Grant, S
   Seiler, M
   Turner, N
   Adams, R
   Goffin, K
AF Cecchi, Michele Angelo
   Grant, Stuart
   Seiler, Matthias
   Turner, Neil
   Adams, Richard
   Goffin, Keith
TI How COVID-19 Impacted The Tacit Knowledge and Social Interaction of
   Global NPD Project Teams The complexity framework offers managers an
   effective way to analyze problems and to generate solutions to manage
   tacit knowledge and social interaction in dispersed global NPD project
   teams.
SO RESEARCH-TECHNOLOGY MANAGEMENT
LA English
DT Article
DE COVID-19; NPD team; Social interaction; Tacit knowledge; Complexity
ID PRODUCT DEVELOPMENT TEAMS; ECONOMIC-CRISIS; INNOVATION; GLOBALIZATION;
   INTERNATIONALIZATION; COORDINATION; PERFORMANCE; PARTNERS; SUCCESS;
   CONTEXT
AB Overview: Multinational, technology-intensive companies routinely use globally distributed R&D teams, but COVID-19 represented an additional challenge. Lockdowns and home-office working severely limit human interaction and can impact the communication, social interaction, and knowledge sharing critical to successful R&D. Our study investigated how COVID-19 affected R&D processes at three global companies, using a project complexity perspective. Although R&D managers responsible for global projects are accustomed to the challenges of managing communications, the fact that teams were forced into home-office working made new product development more difficult in several ways. Ensuring that technical details are understood by all members of dispersed teams is crucial. Of particular note, and central to our findings, is the emphasis that R&D managers placed on maintaining a high level of social interaction in their teams, and special efforts were needed to keep interactions at a sufficient level to foster the generation and transfer of tacit knowledge. The findings have strong implications for the way that R&D project management is likely to be conducted in a post-COVID-19 world, and we demonstrate how the complexity framework we used can benefit managers in navigating this and other challenges.
C1 [Cecchi, Michele Angelo; Grant, Stuart] Cranfield Univ, Sch Management, Cranfield, Beds, England.
   [Seiler, Matthias] BFI GmbH, Dusseldorf, Germany.
   [Seiler, Matthias] Innovat Management Business Dev GmbH, Dusseldorf, Germany.
   [Turner, Neil] Cranfield Univ, Sch Management, Project Management, Cranfield, Beds, England.
   [Adams, Richard] Cranfield Univ, Bettany Ctr Entrepreneurship, Entrepreneurship, Cranfield, Beds, England.
   [Goffin, Keith] Stockholm Sch Econ, Dept Entrepreneurship Innovat & Technol, Stockholm, Sweden.
RP Cecchi, MA (corresponding author), Cranfield Univ, Sch Management, Cranfield, Beds, England.
EM michele-angelo.cecchi@cranfield.ac.uk; stuart.grant@cranfield.ac.uk;
   matthias.seiler@uni-duesseldorf.de; neil.turner@cranfield.ac.uk;
   r.j.adams@cranfield.ac.uk; k.goffin@cranfield.ac.uk
FU European UnionEuropean Commission [810329]
FX We acknowledge the support of the respondents and their willingness to
   be interviewed during a challenging time. Due to the nature of this
   research, participants of this study did not agree for their data to be
   shared publicly, so supporting data are not available. Richard Adams
   acknowledges support from the European Union's Horizon 2020 Research and
   Innovation Programme under grant agreement No 810329 (KEEN).
CR ACKOFF RL, 1979, J OPER RES SOC, V30, P93, DOI 10.2307/3009290
   Anderson NR, 1998, J ORGAN BEHAV, V19, P235, DOI 10.1002/(SICI)1099-1379(199805)19:3<235::AID-JOB837>3.0.CO;2-C
   Archibugi D, 2013, TECHNOL FORECAST SOC, V80, P1247, DOI 10.1016/j.techfore.2013.05.005
   Archibugi D, 2011, JCMS-J COMMON MARK S, V49, P1153, DOI 10.1111/j.1468-5965.2011.02191.x
   Ardito L, 2018, R&D MANAGE, V48, P165, DOI 10.1111/radm.12270
   Athreye S, 2016, J BUS RES, V69, P5694, DOI 10.1016/j.jbusres.2016.02.043
   Baccarini D., 1996, International Journal of Project Management, V14, P201, DOI 10.1016/0263-7863(95)00093-3
   Baxter D, 2013, CREAT INNOV MANAG, V22, P408, DOI 10.1111/caim.12041
   Bierly PE, 2009, J PROD INNOVAT MANAG, V26, P551, DOI 10.1111/j.1540-5885.2009.00680.x
   Boehme T, 2021, SUPPLY CHAIN MANAG, V26, P767, DOI 10.1108/SCM-07-2020-0350
   Boutellier R, 1998, R&D MANAGE, V28, P13, DOI 10.1111/1467-9310.00077
   Braganza A., 2002, KNOWLEDGE PROCESS MA, V9, P23
   Brencic MM, 2012, J BUS IND MARK, V27, P436, DOI 10.1108/08858621211251442
   Cai Z, 2019, R&D MANAGE, V49, P421, DOI 10.1111/radm.12305
   Cefis E, 2020, STRUCT CHANGE ECON D, V52, P63, DOI 10.1016/j.strueco.2019.10.001
   Chiesa V, 1996, IEEE T ENG MANAGE, V43, P7, DOI 10.1109/17.491264
   Cincera M, 2012, EUR PLAN STUD, V20, P1525, DOI 10.1080/09654313.2012.709064
   Comstock B., 2013, HARVARD BUS REV
   de Brentani U, 2010, J PROD INNOVAT MANAG, V27, P143, DOI 10.1111/j.1540-5885.2010.00707.x
   Dutton C, 2014, INT J PROJ MANAG, V32, P747, DOI 10.1016/j.ijproman.2014.02.003
   Dvir D, 1998, RES POLICY, V27, P915, DOI 10.1016/S0048-7333(98)00085-7
   DYNES RR, 1979, DISASTERS, V3, P71, DOI 10.1111/j.1467-7717.1979.tb00200.x
   Eppinger SD, 2006, MIT SLOAN MANAGE REV, V47, P22
   Farrington T, 2020, RES TECHNOL MANAGE, V63, P22, DOI 10.1080/08956308.2020.1813491
   Forman C, 2012, MANAGE SCI, V58, P1549, DOI 10.1287/mnsc.1110.1505
   Gassmann O, 2003, R&D MANAGE, V33, P243, DOI 10.1111/1467-9310.00296
   Geraldi J, 2011, INT J OPER PROD MAN, V31, P966, DOI 10.1108/01443571111165848
   Gerybadze A, 1999, RES POLICY, V28, P251, DOI 10.1016/S0048-7333(98)00111-5
   Glodzinski E., 2016, EC BUSINESS, V28, P26, DOI [10.1515/eb-2016-0004, DOI 10.1515/EB-2016-0004]
   Goffin K, 2011, J PROD INNOVAT MANAG, V28, P300, DOI 10.1111/j.1540-5885.2010.00798.x
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Hauptman O, 1999, R&D MANAGE, V29, P179, DOI 10.1111/1467-9310.00128
   Hill LA, 2014, HARVARD BUS REV, V92, P94
   HOWELLS JR, 1995, RES POLICY, V24, P169, DOI 10.1016/0048-7333(93)00760-Q
   Hull R, 2000, INT J TECHNOL MANAGE, V20, P633, DOI 10.1504/IJTM.2000.002885
   Jaafari A., 2003, PROJECT MANAGEMENT J, V34, P47, DOI DOI 10.1177/875697280303400407
   Jaruzelski B., 2015, STRATEGY BUSINESS, V27, P81
   Johannessen JA, 1997, INT J INFORM MANAGE, V17, P153, DOI 10.1016/S0268-4012(96)00058-8
   Lee-Kelley L, 2017, INT J PROJ MANAG, V35, P64, DOI 10.1016/j.ijproman.2016.09.014
   Leonard-Barton D, 1998, WELLSPRINGS KNOWLEDG
   Lewis R, 1998, R&D MANAGE, V28, P5, DOI 10.1111/1467-9310.00076
   Marabelli M, 2013, INT J MANAG PROJ BUS, V6, P310, DOI 10.1108/17538371311319043
   Marheineke M, 2016, R&D MANAGE, V46, P1084, DOI 10.1111/radm.12216
   Marion TJ, 2014, J PROD INNOVAT MANAG, V31, P18, DOI 10.1111/jpim.12189
   Markham SK, 2013, J PROD INNOVAT MANAG, V30, P408, DOI 10.1111/jpim.12025
   Maylor H, 2017, INT J OPER PROD MAN, V37, P1076, DOI 10.1108/IJOPM-05-2016-0263
   Maylor HR, 2013, RES TECHNOL MANAGE, V56, P45, DOI 10.5437/08956308X5602125
   McCausland T, 2020, RES TECHNOL MANAGE, V63, P54, DOI 10.1080/08956308.2020.1813506
   Mehra K, 2003, TECHNOVATION, V23, P121, DOI 10.1016/S0166-4972(01)00089-X
   Moncada-Paterno-Castello P., 2011, IPTS WORKING PAPERS
   Montoya MM, 2009, J PROD INNOVAT MANAG, V26, P139, DOI 10.1111/j.1540-5885.2009.00342.x
   Muethel M, 2012, R&D MANAGE, V42, P31, DOI 10.1111/j.1467-9310.2011.00667.x
   Nambisan S, 2017, MIS QUART, V41, P223, DOI 10.25300/MISQ/2017/41:1.03
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Papanastassiou M, 2020, J INT BUS STUD, V51, P623, DOI 10.1057/s41267-019-00258-0
   Pearson CM, 1998, ACAD MANAGE REV, V23, P59, DOI 10.2307/259099
   Pich MT, 2002, MANAGE SCI, V48, P1008, DOI 10.1287/mnsc.48.8.1008.163
   Prabhu Jaideep, 2010, Strategic HR Review, V9, P5, DOI 10.1108/14754391011022208
   Rainmaker, 2020, WHY CRIS CALL INN NO
   Rao J, 2013, MIT SLOAN MANAGE REV, V54, P29
   Richardson, 2009, EXPLORING COMPLEXITY
   Roth Erik., 2020, INNOVATION CRISIS WH
   Salomo S, 2010, J PROD INNOVAT MANAG, V27, P955, DOI 10.1111/j.1540-5885.2010.00764.x
   Slade K, 2020, RES TECHNOL MANAGE, V63, P31, DOI 10.1080/08956308.2020.1813495
   Soderlund J, 2002, R&D MANAGE, V32, P419, DOI 10.1111/1467-9310.00273
   Sole D, 2002, BRIT J MANAGE, V13, pS17, DOI 10.1111/1467-8551.13.s2.3
   Song JY, 2008, J INT BUS STUD, V39, P291, DOI 10.1057/palgrave.jibs.8400348
   Sosa ME, 2007, HARVARD BUS REV, V85, P133
   Stark EM, 2009, R&D MANAGE, V39, P461, DOI 10.1111/j.1467-9310.2009.00571.x
   Turner N, 2018, INT J OPER PROD MAN, V38, P1443, DOI 10.1108/IJOPM-01-2017-0062
   von Zedtwitz M, 2002, RES POLICY, V31, P569, DOI 10.1016/S0048-7333(01)00125-1
   Von Zedtwitz M.J., 2020, MANAGING INNOVATION
   Williams T, 2005, IEEE T ENG MANAGE, V52, P497, DOI 10.1109/TEM.2005.856572
   Wilson K, 2012, HARVARD BUS REV, V90, P84
   Xia WD, 2005, J MANAGE INFORM SYST, V22, P45, DOI 10.1080/07421222.2003.11045831
NR 75
TC 0
Z9 0
U1 7
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0895-6308
EI 1930-0166
J9 RES TECHNOL MANAGE
JI Res.-Technol. Manage.
PD FEB 22
PY 2022
VL 65
IS 2
BP 41
EP 52
DI 10.1080/08956308.2022.2020566
PG 12
WC Business; Engineering, Industrial; Management
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Business & Economics; Engineering
GA ZC6MR
UT WOS:000757632200006
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Verma, SK
   Kumar, BD
   Chandra, S
   Singh, N
   Kumari, P
   Verma, A
AF Verma, Santosh Kumar
   Kumar, Barun Dev
   Chandra, Subhash
   Singh, Neha
   Kumari, Priyanka
   Verma, Abhishek
TI Knowledge, Attitude, and Psychological Effect on
   Undergraduate/Postgraduate Students in Lockdown COVID-19 Situation
SO JOURNAL OF PHARMACY AND BIOALLIED SCIENCES
LA English
DT Article
DE Anxiety; college student; COVID-19; mental health; pandemic;
   self-management; stress
ID STRESS
AB Background: Student psychological health has been an increasing concern. The COVID-19 pandemic situation has brought this vulnerable population into renewed focus. Objective: Our study aims to conduct a timely assessment of the effects of the COVID-19 pandemic on the mental health of college graduates and postgraduates. Methodology: We conducted online survey with 550 students to understand the effects of the pandemic on their psychology and well-being. The data were analyzed through quantitative and qualitative methods. Results: Of the 550 students, 138 (71%) indicated increased stress and anxiety due to the COVID-19 outbreak. When asked about how the lockdown in COVID-19 situation affecting them, 97% said that it is severely affecting them. When asked about what the problems do you faced during online class, 5% said the Internet, 83.8% said noninteractive, and 11.2% said lack of explanatory mediums. When asked about number of hours spent on the Internet, 100% said more than 10 h. When asked about the activities to keep yourself busy during lockdown in COVID-19 situation, 37% said social media followed by 23% who mentioned cooking. Conclusion: Due to the long-lasting pandemic situation and onerous measures such as lockdown and stay-at-home orders, the COVID-19 pandemic brings negative impacts on education. The findings of our study highlight the urgent need to develop interventions and preventive strategies to address the psychological health of college students.
C1 [Verma, Santosh Kumar; Singh, Neha; Kumari, Priyanka] RIMS, Dent Inst, Dept Periodontol & Oral Implantol, Ranchi, Jharkhand, India.
   [Kumar, Barun Dev; Chandra, Subhash] RIMS, Dent Inst, Dept Orthodont & Dentofacial Orthoped, Ranchi, Jharkhand, India.
   [Verma, Abhishek] Buddha Inst Dent Sci & Hosp, Dept Peridontol & Oral Implantol, Patna, Bihar, India.
RP Chandra, S (corresponding author), RIMS, Dent Inst, Dept Orthodont & Dentofacial Orthoped, Ranchi, Jharkhand, India.
EM santoshvermakr@gmail.com
CR Ammar N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239961
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005
   Kmietowicz Z, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m707
   Kwaah CY, 2017, TURK ONLINE J DISTAN, V18, P120
   Odriozola-Gonzalez P, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113108
   Rosenfield S., 2013, HDB SOCIOLOGY MENTAL, DOI DOI 10.1007/978-94-007-4276-5_14
   Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541
   Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
   Xiao CF, 2020, PSYCHIAT INVEST, V17, P175, DOI 10.30773/pi.2020.0047
   Zandifar A, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.101990
   Zhang J, 2020, PRECIS CLIN MED, DOI [10.1093/pcmedi/pbaa006, DOI 10.1093/pcmedi/pbaa006]
NR 14
TC 0
Z9 0
U1 3
U2 8
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0975-7406
J9 J PHARM BIOALLIED SC
JI J. Pharm. Bioallied Sci.
PD JUN
PY 2021
VL 13
IS 5
SI SI
BP 696
EP 698
DI 10.4103/jpbs.JPBS_829_20
PG 3
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA SU1FH
UT WOS:000662885700154
PM 34447184
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Islam, MM
   Islam, MM
   Ahmed, F
   Rumana, AS
AF Islam, Md Monirul
   Islam, Md Mazharul
   Ahmed, Faroque
   Rumana, Afrin Sadia
TI Creative social media use for Covid-19 prevention in Bangladesh: a
   structural equation modeling approach
SO SOCIAL NETWORK ANALYSIS AND MINING
LA English
DT Article
DE Creative social media use; Knowledge of Covid-19 precautions online;
   Covid-19 prevention; SEM approach; Bangladesh
ID INTERNET USE; HEALTH
AB In recent years, information dissemination has been quicker than earlier years with the sky-high development of diverse social media platforms, e.g., Facebook, WhatsApp, Twitter, YouTube and so on, which are more used in creative production. This advancement of social media disclosures has numerous merits and demerits to prevent and control contagious diseases like the Covid-19 pandemic. In this respect, this research scrutinizes the role of creative social media use in preventing the Covid-19 outbreak in Bangladesh utilizing the structural equation modeling (SEM) approach. To this end, this study uses an online survey from June to October 2020 engaging 265 (N = 265) Bangladeshi people as respondents at different ages. The study results establish that creative social media use helps enhance the knowledge of Covid-19 precautions online, and this pertinent knowledge contributes to preventing Covid-19 outbreak in Bangladesh. It implies that creative social media use has a significant indirect effect on Covid-19 prevention, whereas knowledge of Covid-19 precautions online mediates this relationship between creative social media use and Covid-19 prevention. The results also discover that the educational level of the people has a significant direct and positive impact on Covid-19 prevention. Therefore, the study suggests more creative use of social media in preventing the spread of the Covid-19 epidemic in Bangladesh.
C1 [Islam, Md Monirul] Univ Dhaka, Bangladesh Inst Governance & Management BIGM, Dept Governance & Publ Policy, Dhaka, Bangladesh.
   [Islam, Md Mazharul; Ahmed, Faroque] Univ Dhaka, Bangladesh Inst Governance & Management BIGM, Dhaka, Bangladesh.
   [Rumana, Afrin Sadia] Bangladesh Univ Professionals BUP, Fac Business Studies, Dhaka, Bangladesh.
RP Islam, MM (corresponding author), Univ Dhaka, Bangladesh Inst Governance & Management BIGM, Dhaka, Bangladesh.
EM monirdu1981@gmail.com; mislam6@isrt.ac.bd; faroque.ahmed@bigm.edu.bd;
   arumana@isrt.ac.bd
RI Ahmed, Faroque/AAW-1739-2020; Islam, Md. Monirul/AAM-2783-2021
OI Ahmed, Faroque/0000-0002-8434-1536; Islam, Md.
   Monirul/0000-0002-9818-1676; Islam, Md. Mazharul/0000-0003-1025-1455
CR Acar S, 2021, J CREATIVE BEHAV, V55, P39, DOI 10.1002/jocb.432
   Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556
   Al Zubayer A, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05057
   Al-Dossary R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218269
   Al-Zaman MS, 2020, AM J TROP MED HYG, V103, P1357, DOI 10.4269/ajtmh.20-0826
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Basch Corey H, 2020, Int J Adolesc Med Health, DOI 10.1515/ijamh-2020-0111
   Basch CH, 2020, JMIR PUBLIC HLTH SUR, V6, P147, DOI 10.2196/18807
   Bastani Peivand, 2020, J Med Internet Res, DOI 10.2196/18932
   Beaudoin CE, 2008, J COMPUT-MEDIAT COMM, V13, P550, DOI 10.1111/j.1083-6101.2008.00410.x
   Bender JL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2661
   Bin Naeem S, 2021, HEALTH INFO LIBR J, V38, P143, DOI 10.1111/hir.12320
   Bodrud-Doza M, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00341
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Cellan-Jones R., 2020, RETRIEVED, V5, P2020
   Chan AKM, 2020, ANAESTHESIA, V75, P1579, DOI 10.1111/anae.15057
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031
   Didar-Ul Islam SM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04399
   Ekstrom M, 2015, COMMUN RES, V42, P796, DOI 10.1177/0093650213476295
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Eynon R, 2011, COMPUT EDUC, V56, P585, DOI 10.1016/j.compedu.2010.09.020
   Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012
   Fan Yi, 2016, Ecological Processes, V5, P19
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Fontain J. R. J., 2005, ENCY SOCIAL MEASUREM, P803
   GlobalStat, 2021, SOCIAL MEDIA STATS B
   González-Padilla Daniel A., 2020, Int. braz j urol., V46, P120, DOI [10.1590/S1677-5538.IBJU.2020.S121, 10.1590/s1677-5538.ibju.2020.s121]
   Gough Aisling, 2017, JMIR Public Health Surveill, V3, pe14, DOI 10.2196/publichealth.6313
   Gray DJ, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00695-2
   Hao, 2020, CORONAVIRUS IS 1 TRU
   Holmbom M., 2015, YOUTUBER QUALITATIVE
   Hossain MT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238974
   Hossain MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239646
   Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162
   Islam MM, 2021, OPEC ENERGY REV, V45, P191, DOI 10.1111/opec.12195
   Islam Md Saiful, 2020, Addict Behav Rep, V12, P100311, DOI 10.1016/j.abrep.2020.100311
   Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812
   Islam R, 2020, COVID 19 RESILIENT V
   Jenatabadi HS, 2014, J AIR TRANSP MANAG, V40, P25, DOI 10.1016/j.jairtraman.2014.05.005
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Leung L, 2009, NEW MEDIA SOC, V11, P1327, DOI 10.1177/1461444809341264
   Li CL, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.10.2000199
   Lin CY, 2020, INTERNET INTERV, V21, DOI 10.1016/j.invent.2020.100345
   Livingstone S., 2005, Information Communication & Society, V8, P287, DOI 10.1080/13691180500259103
   Lohiniva AL, 2020, EUROSURVEILLANCE, V25, P17, DOI 10.2807/1560-7917.ES.2020.25.13.2000317
   Mian A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01556-3
   Mohiuddin A, 2019, INT J DIAB RES, V2, P14, DOI DOI 10.17554/IJDR.V2I1.2457
   Mueller R.O., 2001, INT ENCY SOCIAL BEHA, P5239, DOI 10.1016/B0-08-043076-7/00426-5
   Nawan N., 2020, JURNAL ADM KESEHATAN, V8, P4, DOI [10.20473/jaki.v8i2.2020.4%26%23x2013%3B14, DOI 10.20473/JAKI.V8I2.2020.4-14]
   Ng FK, 2020, ANAESTHESIA, V75, P227, DOI 10.1111/anae.14747
   Ni MY, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/19009
   Radwan E, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05807
   Robinson R.S., 2014, ENCY QUALITY LIFE WE, P5243, DOI DOI 10.1007/978-94-007-0753-5_2337
   Ruggiero T.E., 2000, MASS COMMUNICATION S, V3, P3, DOI DOI 10.1207/S15327825MCS0301_02
   Rzymski P, 2020, SCIENCE, V367, P1313, DOI 10.1126/science.abb4870
   Sahni H, 2020, INT J ACAD MED, V6, P70, DOI 10.4103/IJAM.IJAM_50_20
   Sampa MB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134709
   Schutt R. K, 2018, INVESTIGATING SOCIAL
   Shah DV, 2001, POLIT COMMUN, V18, P141, DOI 10.1080/105846001750322952
   Shimizu K, 2020, LANCET, V395, P685, DOI 10.1016/S0140-6736(20)30357-3
   Simon Kemp, 2020, DIGITAL 2020 BANGLAD
   Soltaninejad K, 2020, INT J OCCUP ENV MED, V11, P148, DOI 10.34172/ijoem.2020.1983
   Srivastava Kumar Chandan, 2020, INT J RES PHARM SCI, V11, P142, DOI [10.26452/ijrps.v11iSPL1.2288, DOI 10.26452/IJRPS.V11ISPL1.2288]
   Swazo NK, 2020, PHILOS ETHICS HUM ME, V15, DOI 10.1186/s13010-020-00091-6
   Tasnim Samia, 2020, J Prev Med Public Health, V53, P171, DOI 10.3961/jpmph.20.094
   The Lancet, 2020, Lancet, V395, P537, DOI 10.1016/S0140-6736(20)30379-2
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Whiting A, 2013, QUAL MARK RES, V16, P362, DOI 10.1108/QMR-06-2013-0041
   WHO, 2020, NOV COR 2019 NCOV SI
   Williamson K., 2002, RES METHODS STUDENTS, DOI [10.1533/9781780634203, DOI 10.1533/9781780634203]
   Wong JEL, 2020, JAMA-J AM MED ASSOC, V323, P1243, DOI 10.1001/jama.2020.2467
   Worldometer, 2020, COVID 19 CORONAVIRUS
   Yadav M, 2015, PROCD SOC BEHV, V189, P335, DOI 10.1016/j.sbspro.2015.03.229
   Zhao YH, 2017, HEALTH INFO LIBR J, V34, P268, DOI 10.1111/hir.12192
NR 76
TC 0
Z9 0
U1 9
U2 16
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 1869-5450
EI 1869-5469
J9 SOC NETW ANAL MIN
JI Soc. Netw. Anal. Min.
PD APR 10
PY 2021
VL 11
IS 1
AR 38
DI 10.1007/s13278-021-00744-0
PG 14
WC Computer Science, Information Systems
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA RL6QR
UT WOS:000639095600002
PM 33868509
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Deng, YM
   Wu, HW
   Liao, HE
AF Deng, Yueen-Mei
   Wu, Hong-Wei
   Liao, Hung-En
TI Utilization Intention of Community Pharmacy Service under the Dual
   Threats of Air Pollution and COVID-19 Epidemic: Moderating Effects of
   Knowledge and Attitude toward COVID-19
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE air pollution; COVID-19; health belief model; pharmacy service; disease
   prevention
ID HEALTH BELIEF MODEL; MANAGEMENT; PARADOX; METAANALYSIS; PREDICTORS;
   VARIABLES; DISEASE
AB The utilization of pharmacy services in response to the threat of COVID-19 infection remains unclear in areas suffering from air pollution, and little is known regarding the effects of knowledge and attitude (KA) toward COVID-19 on this preventive behavior. This study aimed to explore how the residents perceived and reacted to the new threats of the epidemic and how KA may affect the correlation. Based on the health belief model (HBM), this research took the pharmacy service utilization (PSU) as an example to explain the preventive behavior. The samples were 375 respondents recruited from five districts near the industrial parks. T-test, ANOVA, and regression analyses of SPSS 22.0 were used to analyze the data. Test results show that self-efficacy was the strongest predictor, followed by the net perceived benefit. KA moderated the association of perceived threat and PSU intention. The levels of air pollution of a district may not be a good predictor for the preventive behavior against COVID-19.
C1 [Deng, Yueen-Mei; Liao, Hung-En] Asia Univ, Dept Healthcare Management, 500 Lioufeng Rd, Taichung 41354, Taiwan.
   [Wu, Hong-Wei] Tajen Univ, Dept Pharm, 2 Wexin Rd, Yampu 906, Taiwan.
RP Deng, YM; Liao, HE (corresponding author), Asia Univ, Dept Healthcare Management, 500 Lioufeng Rd, Taichung 41354, Taiwan.
EM dengym900@gmail.com; away7344@yahoo.com.tw; heliao@asia.edu.tw
OI LIAO, HUNG-EN/0000-0003-2840-6988
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1
   Askew C, 2007, BEHAV RES THER, V45, P2616, DOI 10.1016/j.brat.2007.06.008
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Baldoni S, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55070327
   Bandura A, 1997, AM J HEALTH PROMOT, V12, P8, DOI 10.4278/0890-1171-12.1.8
   BANDURA A, 1986, J SOC CLIN PSYCHOL, V4, P359, DOI 10.1521/jscp.1986.4.3.359
   Bandura A., 1986, SOCIAL FDN THOUGHT A
   Bandura A., 1997, SELF EFFICACY EXERCI
   Bechard LE, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.609893
   Cai GW, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010145
   Carcioppolo N, 2019, HEALTH SYST, V8, P44, DOI 10.1080/20476965.2017.1414740
   Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906
   Champion V.L., 2008, HLTH BEHAV HLTH ED T, P45
   Daoust JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235590
   Determann D, 2016, SOC SCI MED, V165, P10, DOI 10.1016/j.socscimed.2016.07.022
   Dewey J., 1895, PSYCHOL REV, V2, P13, DOI [10.1037/h0070927, DOI 10.1037/H0070927]
   Dumitrescu AL, 2014, ORAL HLTH PREV DENT, V12, P345, DOI 10.3290/j.ohpd.a31662
   Environment Protection Administration (EPA), MONTH REP DAYS POOR
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8
   Galle F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176171
   GIOIA DA, 1985, ACAD MANAGE REV, V10, P527
   Glasgow RE, 2008, DIABETES CARE, V31, P1046, DOI 10.2337/dc07-1845
   Govaerts MJB, 2019, MED EDUC, V53, P64, DOI 10.1111/medu.13656
   Gupta A, 2021, ENVIRON DEV SUSTAIN, V23, P6408, DOI 10.1007/s10668-020-00878-9
   HARRISON JA, 1992, HEALTH EDUC RES, V7, P107, DOI 10.1093/her/7.1.107
   Hogan C, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00309-6
   HYMAN RB, 1994, J BEHAV MED, V17, P391, DOI 10.1007/BF01858010
   Industry Development Bureau (IDB), IND LAND US SUPPL SE
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Jing RZ, 2021, EXPERT REV VACCINES, V20, P1351, DOI 10.1080/14760584.2021.1969917
   Kim JY, 2007, ACAD MANAGE J, V50, P687
   Ko NY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124282
   Landrigan PJ, 2017, LANCET PUBLIC HEALTH, V2, pE4, DOI 10.1016/S2468-2667(16)30023-8
   Lee K, 2009, GLOB INST, P1
   Lewis MW, 2014, J APPL BEHAV SCI, V50, P127, DOI 10.1177/0021886314522322
   Liu M.C., 2010, J TAIWAN PHAR, V26, P144
   Luceno-Moreno L, 2020, PROF PSYCHOL-RES PR, V51, P297, DOI 10.1037/pro0000285
   Ibrahim OM, 2021, TELEMED E-HEALTH, V27, P649, DOI 10.1089/tmj.2020.0283
   National Health Insurance Administration (NHIA), MED SERV IND
   Ng TWH, 2009, J ORGAN BEHAV, V30, P1053, DOI 10.1002/job.599
   Nino M, 2021, SSM-POPUL HLTH, V13, DOI 10.1016/j.ssmph.2020.100717
   Okoro RN, 2021, RES SOC ADMIN PHARM, V17, P1925, DOI 10.1016/j.sapharm.2020.07.008
   Ozdin S, 2020, INT J SOC PSYCHIATR, V66, P504, DOI 10.1177/0020764020927051
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   POOLE MS, 1989, ACAD MANAGE REV, V14, P562, DOI 10.2307/258559
   Pope CA, 2000, ENVIRON HEALTH PERSP, V108, P713, DOI 10.2307/3454408
   Roberts Debbie, 2010, Nurse Educ Pract, V10, P13, DOI 10.1016/j.nepr.2009.01.017
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Sari DK, 2021, J COMMUN HEALTH, V46, P182, DOI 10.1007/s10900-020-00866-0
   Servadio JL, 2019, J URBAN HEALTH, V96, P219, DOI 10.1007/s11524-018-0318-7
   Sleesman DJ, 2019, ORGAN BEHAV HUM DEC, V155, P83, DOI 10.1016/j.obhdp.2019.03.008
   Spagnolo PA, 2020, ANN INTERN MED, V173, P385, DOI 10.7326/M20-1941
   Suess C, 2022, TOURISM MANAGE, V88, DOI 10.1016/j.tourman.2021.104405
   Syed MH, 2021, SAUDI PHARM J, V29, P1329, DOI 10.1016/j.jsps.2021.09.010
   Taiwan Centers for Diseases Control (CDC), COVID 19 SARS COV 2
   Tanner-Smith EE, 2010, SOC THEOR HEALTH, V8, P95, DOI 10.1057/sth.2009.23
   Tibuakuu M, 2018, CURR EPIDEMIOL REP, V5, P370, DOI 10.1007/s40471-018-0166-8
   Tong KK, 2020, APPL PSYCHOL-HLTH WE, V12, P1205, DOI 10.1111/aphw.12230
   TOOTHMAKER LE, 1994, J OPER RES SOC, V45, P119
   VALENCE G, 1988, J CONSUM POLICY, V11, P419, DOI 10.1007/BF00411854
   Venter ZS, 2021, ENVIRON RES, V192, DOI 10.1016/j.envres.2020.110403
   Wu XY, 2021, J MED INTERNET RES, V23, DOI 10.2196/23126
   Yang H.L., 2020, FORMOSA J MED, V24, P586
NR 67
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAR
PY 2022
VL 19
IS 6
AR 3744
DI 10.3390/ijerph19063744
PG 19
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 0C3ZB
UT WOS:000775254200001
PM 35329431
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Fenitra, RM
   Praptapa, A
   Suyono, E
   Kusuma, PDI
   Usman, I
AF Fenitra, Rakotoarisoa Maminirina
   Praptapa, Agung
   Suyono, Eko
   Kusuma, Poppy Dian Indira
   Usman, Indrianawati
TI Factors Influencing Preventive Intention Behavior Towards COVID-19 in
   Indonesia
SO JOURNAL OF BEHAVIORAL SCIENCE
LA English
DT Article
DE attitude; COVID-19; knowledge; preventive intention behavior; risk
   perception
ID RESPIRATORY SYNDROME-CORONAVIRUS; HEALTH; ADULTS
AB Since early 2020, the COVID-19 outbreak and its spread across the globe have disrupted many sectors. In Indonesia the COVID-19 have caused a severe impact on the economic, social, and political. Various actions were considered as preventive measures to slow down the virus propagation. This study aimed to investigate the relationship between attitude, knowledge, risk perception, information exposure and preventive intention behavior toward COVID-19 in Indonesia. An empirical quantitative study was conducted using data collected in March and April 2020. The sample consisted of 214 respondents in Indonesia through online survey questionnaires based on convenience sampling methods. The regression analysis results showed that 42% of the variance in behavioral change on the infection was explained by the dependent variables. Attitude had a strong positive relationship with intention behavior with (beta = .37, p = .000). This study found that intention behavior was elicited by attitude (beta = .37, p = .000), information exposure (beta = .10, p = .01), and risk perception (beta = .29, p = .000). However, knowledge did not influence preventive intention behavior (beta = .00, p = .94). These findings contribute towards preventive intention literature to support practitioners, public health authorities, health care policymakers, and the government to shape effective prevention communication.
C1 [Fenitra, Rakotoarisoa Maminirina; Usman, Indrianawati] Univ Airlangga, Fac Econ & Business, Dept Management, Surabaya, Indonesia.
   [Praptapa, Agung; Suyono, Eko; Kusuma, Poppy Dian Indira] Univ Jenderal Soedirman, Fac Econ & Business, Int Program, Purwokerto, Indonesia.
RP Fenitra, RM (corresponding author), Univ Airlangga, Fac Econ & Business, Dept Management, Surabaya, Indonesia.
EM maminirina.fenitra.r-2018@feb.unair.ac.id
CR Ajzen I, 2001, ANNU REV PSYCHOL, V52, P27, DOI 10.1146/annurev.psych.52.1.27
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I., 1980, UNDERSTANDING ATTITU
   Alsubaie S, 2019, J INFECT DEV COUNTR, V13, P920, DOI 10.3855/jidc.11753
   American Library Association, 2020, COVID 19 COR VIR PAN
   Andarge E, 2020, J MULTIDISCIP HEALTH, V13, P1863, DOI 10.2147/JMDH.S284707
   Bashirian S, 2020, J HOSP INFECT, V105, P430, DOI 10.1016/j.jhin.2020.04.035
   Bates BR, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007987
   Baudouin BS, 2020, INT J ADOLESC YOUTH, V25, P364, DOI 10.1080/02673843.2019.1657025
   Chan DKC, 2021, INFECT CONT HOSP EP, V42, P375, DOI 10.1017/ice.2020.245
   Chen XY, 2020, INT J ENV RES PUB HE, V17, DOI [10.3390/ijerph17082893, 10.3390/ijerph17124437]
   Choi JS, 2016, NURS EDUC TODAY, V40, P168, DOI 10.1016/j.nedt.2016.03.006
   Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006
   Djalante R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100091
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Engle R, 2001, J ECON PERSPECT, V15, P157, DOI 10.1257/jep.15.4.157
   Errett Nicole A, 2020, J Emerg Manag, V18, P7, DOI 10.5055/jem.2020.0446
   Farooq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19128
   Gajdacs M, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9020041
   Ghozali I., 2018, APLIKASI ANALISIS MU
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Huang F, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09674-6
   Hubner AY, 2020, RISK ANAL, V40, P1212, DOI 10.1111/risa.13456
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Hutt R., 2020, EC EFFECTS COVID 19
   Jang K, 2018, J HEALTH COMMUN, V23, P670, DOI 10.1080/10810730.2018.1501440
   Jang WM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033026
   Jang WM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122161
   Ju Y, 2021, HEALTH COMMUN, V36, P866, DOI 10.1080/10410236.2020.1723046
   Ko NY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124282
   Kurniawan I., 2021, PRFMNEWS        0111
   Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977
   Lennon Robert P, 2020, Health Lit Res Pract, V4, pe161, DOI 10.3928/24748307-20200708-01
   Liu LQ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217990
   Memish ZA, 2019, LANCET, V393, P2073, DOI 10.1016/S0140-6736(19)30501-X
   Mitchell KC, 2018, VECTOR-BORNE ZOONOT, V18, P173, DOI 10.1089/vbz.2017.2188
   Nawan N., 2020, JURNAL ADM KESEHATAN, V8, P4, DOI [10.20473/jaki.v8i2.2020.4%26%23x2013%3B14, DOI 10.20473/JAKI.V8I2.2020.4-14]
   Oh SH, 2021, HEALTH COMMUN, V36, P972, DOI 10.1080/10410236.2020.1724639
   Orset C, 2018, EUR J HEALTH ECON, V19, P1335, DOI 10.1007/s10198-018-0978-y
   Park T, 2021, RES SOC ADMIN PHARM, V17, P1859, DOI 10.1016/j.sapharm.2020.06.004
   Raza A, 2021, ENVIRON SCI POLLUT R, V28, P40329, DOI 10.1007/s11356-020-10931-9
   Saifulloh M., 2020, OKEZONE
   Sekaran U., 2016, RES METHODS BUSINESS, V7th Edition
   Seo M, 2021, J MASS COMMUN Q, V98, P221, DOI 10.1177/1077699019857693
   Shahin M. A. H., 2020, MIDDLE E CURRENT PSY, V27
   Sobkow A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.582720
   Song SJ, 2021, INFORM PROCESS MANAG, V58, DOI 10.1016/j.ipm.2020.102407
   Tomczyk S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01821
   Prasetyo YT, 2020, INT J INFECT DIS, V99, P312, DOI 10.1016/j.ijid.2020.07.074
   Usuwa IS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8299-3
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Vargas Gabriele, 2020, Brain Behav Immun Health, V7, P100127, DOI 10.1016/j.bbih.2020.100127
   Volterrani A., 2017, P 3 WORLD C MED MASS, V2, P82, DOI [10.17501/medcom.2017.2110, DOI 10.17501/MEDCOM.2017.2110]
   Wen J, 2020, ANATOLIA, V31, P331, DOI 10.1080/13032917.2020.1730621
   Weston D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5223-1
   Witzling L, 2015, SCI COMMUN, V37, P551, DOI 10.1177/1075547015593085
   World Health Organization, 2021, WEEKL OP UPD COVID 1
   Xu YF, 2020, TRENDS MICROBIOL, V28, P239, DOI 10.1016/j.tim.2020.02.001
   Yazdanpanah M, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.562300
NR 59
TC 2
Z9 2
U1 0
U2 0
PU BEHAVIORAL SCIENCE RESEARCH INST, SRINAKHARINWIROT UNIV
PI BANGKOK
PA 114 SUKHUMVIT 23, WATTANA, BANGKOK, 10110, THAILAND
SN 1906-4675
J9 J BEHAV SCI
JI J. Behav. Sci.
PD JAN
PY 2021
VL 16
IS 1
BP 14
EP 27
PG 14
WC Social Sciences, Interdisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA QY0OH
UT WOS:000629740800002
DA 2022-04-20
ER

PT J
AU Salamanna, F
   Maglio, M
   Landini, MP
   Fini, M
AF Salamanna, Francesca
   Maglio, Melania
   Landini, Maria Paola
   Fini, Milena
TI Platelet functions and activities as potential hematologic parameters
   related to Coronavirus Disease 2019 (Covid-19)
SO PLATELETS
LA English
DT Article
DE COVID-19; hematological parameters; platelets
ID ACUTE RESPIRATORY SYNDROME; ESSENTIAL THROMBOCYTHEMIA; CLINICAL
   CHARACTERISTICS; VOLUME; THROMBOSIS; MICROPARTICLES; COMPLICATIONS;
   ANTICOAGULANT; AGGREGATION; ACTIVATION
AB Coronavirus disease 2019 (COVID-19) is a new infectious disease that currently lacks standardized and established laboratory markers to evaluate its severity. In COVID-19 patients, the number of platelets (PLTs) and dynamic changes of PLT-related parameters are currently a concern. The present paper discusses the potential link between PLT parameters and COVID-19. Several studies have identified a link between severe COVID-19 patients and specific coagulation index, in particular, high D-dimer level, prolonged prothrombin time, and low PLT count. These alterations reflect the hypercoagulable state present in severe COVID-19 patients, which could promote microthrombosis in the lungs, as well as in other organs. Further information and more advanced hematological parameters related to PLTs are needed to better estimate this link, also considering COVID-19 patients at different disease stages and stratified in different cohorts based on preexisting co-morbidity, age, and gender. Increasing the understanding of PLT functions in COVID-19 will undoubtedly improve our knowledge on disease pathogenesis, clinical management, and therapeutic options, but could also lead to the development of more precise therapeutic strategies for COVID-19 patients.
C1 [Salamanna, Francesca; Maglio, Melania; Fini, Milena] IRCCS Ist Ortoped Rizzoli, Lab Preclin & Surg Studies, Via Barbiano 1-10, I-40136 Bologna, Italy.
   [Landini, Maria Paola] IRCCS Ist Ortoped Rizzoli, Sci Direct, Bologna, Italy.
RP Maglio, M (corresponding author), IRCCS Ist Ortoped Rizzoli, Lab Preclin & Surg Studies, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM melania.maglio@ior.it
RI Salamanna, Francesca/J-6032-2016; Fini, Milena/J-4808-2016; Maglio,
   Melania/K-3159-2018
OI Salamanna, Francesca/0000-0001-7402-4054; Fini,
   Milena/0000-0002-3732-3570; Maglio, Melania/0000-0002-3778-4406
FU IRCCS Istituto Ortopedico Rizzoli (Ricerca Corrente)
FX This work was supported by grants from IRCCS Istituto Ortopedico Rizzoli
   (Ricerca Corrente). The authors gratefully acknowledge Silvia Bassini
   for the support in the realization of the Figure related to COVID-19 and
   platelet parameters.
CR Arellano-Rodrigo E, 2009, AM J HEMATOL, V84, P102, DOI 10.1002/ajh.21338
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Balduini CL, 2014, HAEMATOLOGICA, V99, P953, DOI 10.3324/haematol.2014.106260
   Biino G, 2013, AGE SEX RELATED VARI
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x
   Buoro S, 2020, INT J LAB HEMATOL, V42, P8, DOI 10.1111/ijlh.13207
   Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen SY, 2020, J MED VIROL, V92, P1556, DOI 10.1002/jmv.25789
   Chen SY, 2004, ANN EMERG MED, V43, P1, DOI 10.1016/S0196-0644(03)00817-5
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Colkesen Y, 2012, CLIN CHEM LAB MED, V50, P631, DOI 10.1515/CCLM.2011.806
   Connors JM, 2020, J THROMB HAEMOST, V18, P1559, DOI 10.1111/jth.14849
   Cunningham AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2818-6
   Extance A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1174
   Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x
   Gkaliagkousi E, 2010, AM J HYPERTENS, V23, P229, DOI 10.1038/ajh.2009.247
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020
   Hekimsoy Z, 2004, J DIABETES COMPLICAT, V18, P173, DOI 10.1016/S1056-8727(02)00282-9
   Hottz ED, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00121
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang YH, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101606
   Hwang SM, 2019, JPN J INFECT DIS, V72, P160, DOI 10.7883/yoken.JJID.2018.187
   Ikizler TA, 2020, AM J KIDNEY DIS
   Jurasz P, 2004, BRIT J PHARMACOL, V143, P819, DOI 10.1038/sj.bjp.0706013
   Kissova J, 2014, INT J HEMATOL, V100, P429, DOI 10.1007/s12185-014-1673-0
   Kurosawa S, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0061-4
   Lang ZW, 2003, CHINESE MED J-PEKING, V116, P976
   Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2009.07600.x, 10.1111/j.1365-2141.2008.07445.x]
   Levi M, 1999, THROMB HAEMOSTASIS, V82, P695
   Li K, 2016, J INFECT DIS, V213, P712, DOI 10.1093/infdis/jiv499
   Li R, 2020, J INFECTION, V80, P469, DOI 10.1016/j.jinf.2020.02.013
   Liao JK, 2013, J CLIN INVEST, V123, P540, DOI 10.1172/JCI66843
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Mazumder H, 2020, J GERONTOL SOC WORK, V63, P257, DOI 10.1080/01634372.2020.1746723
   Michiels JJ, 2006, SEMIN THROMB HEMOST, V32, P174, DOI 10.1055/s-2006-939431
   Mitra A, 2020, AM J HEMATOL, V95, P999, DOI 10.1002/ajh.25793
   Muronoi T, 2016, THROMB RES, V144, P169, DOI 10.1016/j.thromres.2016.06.002
   Ng KHL, 2005, POSTGRAD MED J, V81, DOI 10.1136/pgmj.2004.030049
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Poterucha TJ, 2017, THROMB HAEMOSTASIS, V117, P437, DOI 10.1160/TH16-08-0620
   Qi H, 2011, INT J NANOMED, V6, P3033, DOI 10.2147/IJN.S25684
   Rinder HM, 1998, BLOOD, V91, P1288, DOI 10.1182/blood.V91.4.1288
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sevuk U, 2015, THER CLIN RISK MANAG, V11, P1243, DOI 10.2147/TCRM.S89355
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Santos RAS, 2019, AM J PHYSIOL-HEART C, V316, pH958, DOI 10.1152/ajpheart.00723.2018
   Sugiyama C, 2007, PLATELETS, V18, P128, DOI 10.1080/09537100600819115
   Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tsuruo T, 2008, P JPN ACAD A-MATH, V84, P189, DOI 10.2183/pjab/84.189
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang ML, 2018, EXP THER MED, V16, P3099, DOI 10.3892/etm.2018.6579
   Wang RT, 2013, RESPIROLOGY, V18, P1244, DOI 10.1111/resp.12143
   Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748
   Wong JEL, 2020, JAMA-J AM MED ASSOC, V323, P1243, DOI 10.1001/jama.2020.2467
   Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Ye MX, 2020, J MED VIROL, V92, P1890, DOI 10.1002/jmv.25882
   Zhang LB, 2020, AGING-US, V12, P6536, DOI 10.18632/aging.103102
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 67
TC 45
Z9 46
U1 2
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0953-7104
EI 1369-1635
J9 PLATELETS
JI Platelets
PD JUL 3
PY 2020
VL 31
IS 5
BP 627
EP 632
DI 10.1080/09537104.2020.1762852
EA MAY 2020
PG 6
WC Cell Biology; Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Hematology
GA MI6WX
UT WOS:000534124100001
PM 32397915
DA 2022-04-20
ER

PT J
AU Esposito, S
   Marchetti, F
   Lanari, M
   Caramelli, F
   De Fanti, A
   Vergine, G
   Iughetti, L
   Fornaro, M
   Suppiej, A
   Zona, S
   Pession, A
   Biasucci, G
AF Esposito, Susanna
   Marchetti, Federico
   Lanari, Marcello
   Caramelli, Fabio
   De Fanti, Alessandro
   Vergine, Gianluca
   Iughetti, Lorenzo
   Fornaro, Martina
   Suppiej, Agnese
   Zona, Stefano
   Pession, Andrea
   Biasucci, Giacomo
CA Emilia-Romagna Region RE-CO-Ped
TI COVID-19 Management in the Pediatric Age: Consensus Document of the
   COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region
   (RE-CO-Ped), Italy
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE children; COVID-19; MIS-C; pediatrics; SARS-CoV-2
ID MULTISYSTEM INFLAMMATORY SYNDROME; KAWASAKI-DISEASE; ADRENAL
   INSUFFICIENCY; CARE MEDICINE; MENTAL-HEALTH; CHILDREN; SARS-COV-2;
   DIAGNOSIS; RECOMMENDATIONS; AZITHROMYCIN
AB Since December 2019, coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread, becoming the first pandemic of the 21st century by number of deaths (over 2,000,000 worldwide). Many aspects of SARS-CoV-2 infection in children and adolescents remain unclear, and optimal treatment has not yet been defined. Therefore, our goal was to develop a consensus document, practically synthesizing the accumulated data and clinical experience of our expert group. Literature research was carried out using the keywords "COVID-19" or "SARS-CoV-2" and "children" or "pediatrics" and "prevention" or "diagnosis" or "MIS-C" or "treatment" in electronic databases (MEDLINE, PUBMED), existing guidelines and gray literature. The fact that the majority of the problems posed by SARS-CoV-2 infection in pediatric age do not need hospital care and that, therefore, infected children and adolescents can be managed at home highlights the need for a strengthening of territorial pediatric structures. The sharing of hospitalization and therapeutic management criteria for severe cases between professionals is essential to ensure a fair approach based on the best available knowledge. Moreover, the activity of social and health professionals must also include the description, management and limitation of psychophysical-relational damage resulting from the SARS-CoV-2 pandemic on the health of children and adolescents, whether or not affected by COVID-19. Due to the characteristics of COVID-19 pathology in pediatric age, the importance of strengthening the network between hospital and territorial pediatrics, school, educational, social and family personnel both for strictly clinical management and for the reduction in discomfort, with priority in children of more frail families, represents a priority.
C1 [Esposito, Susanna] Univ Hosp, Dept Med & Surg, Paediat Clin, I-43126 Parma, Italy.
   [Marchetti, Federico] AUSL Romagna, Ravenna Hosp, Paediat & Neonatol Unit, I-48121 Ravenna, Italy.
   [Lanari, Marcello] Azienda Osped Univ Bologna, Sci Inst Res & Healthcare IRCCS, Paediat Emergency Unit, I-40138 Bologna, Italy.
   [Lanari, Marcello] Azienda Osped Univ Bologna, Sci Inst Res & Healthcare IRCCS, Paediat Intens Care Unit, I-40138 Bologna, Italy.
   [De Fanti, Alessandro] AUSL IRCCS Reggio Emilia, Santa Maria Nuova Hosp, Paediat Unit, Reggio Emilia, Italy.
   [Vergine, Gianluca] AUSL Romagna, Paediat Unit, I-47921 Rimini, Italy.
   [Iughetti, Lorenzo] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Mothers Children & Adults, Paediat Unit, I-41125 Modena, Italy.
   [Fornaro, Martina] AUSL Romagna, GB Morgagni L Pierantoni, Paediat Unit, I-47121 Forli, Italy.
   [Suppiej, Agnese] Univ Ferrara, Paediat Clin, I-44124 Ferrara, Italy.
   [Zona, Stefano] AUSL Modena, I-41121 Modena, Italy.
   [Pession, Andrea] Azienda Osped Univ Bologna, Sci Inst Res & Healthcare IRCCS, Paediat Unit, I-40138 Bologna, Italy.
   [Biasucci, Giacomo] Guglielmo da Saliceto Hosp, Paediat & Neonatol Unit, I-29121 Piacenza, Italy.
RP Esposito, S (corresponding author), Univ Hosp, Dept Med & Surg, Paediat Clin, I-43126 Parma, Italy.
EM susannamariaroberta.esposito@unipr.it;
   federico.marchetti@auslromagna.it; marcello.lanari@unibo.it;
   fabio.caramelli@aosp.bo.it; Alessandro.DeFanti@ausl.re.it;
   gianluca.vergine@auslromagna.it; lorenzo.iughetti@unimore.it;
   martina.fornaro@auslromagna.it; agnese.suppiej@unife.it;
   s.zona@ausl.mo.it; andrea.pession@unibo.it; G.Biasucci@ausl.pc.it
RI Iughetti, Lorenzo/I-4602-2014; Biasucci, Giacomo/X-9186-2018; Esposito,
   Susanna/AAA-8275-2022; Pession, Andrea/O-3200-2013
OI Iughetti, Lorenzo/0000-0003-0370-7872; Biasucci,
   Giacomo/0000-0002-7441-9248; Cannalire, Giuseppe/0000-0003-0308-2825;
   Pession, Andrea/0000-0002-0379-9562; Zona, Stefano/0000-0003-3451-2744;
   Marchetti, Federico/0000-0002-1257-7312
FU Department of Medicine and Surgery, University of Parma, Parma, Italy
FX This manuscript was supported by the Department of Medicine and Surgery,
   University of Parma, Parma, Italy.
CR AAP, COVID 19 TESTING GUI
   Abrams EM, 2020, J PEDIATR-US, V222, P221, DOI 10.1016/j.jpeds.2020.04.049
   Ahmed M, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100527
   Al-Ghafry M, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28737
   [Anonymous], 1986, OFF J EUR COMMUN, V1, P37
   [Anonymous], 2020, REMD
   ARRIGO S, 2021, VACCINE, V53, P183
   Balduzzi A, 2020, BONE MARROW TRANSPL, V55, P1900, DOI 10.1038/s41409-020-0895-4
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2
   Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
   Bellino S, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-035238
   Bezzerri V, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-020-00909-1
   Bhattacharyya R, 2020, PULM THER, V6, P215, DOI 10.1007/s41030-020-00126-5
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Bignardi G, 2021, ARCH DIS CHILD, V106, P791, DOI 10.1136/archdischild-2020-320372
   Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2
   Bornstein SR, 2016, J CLIN ENDOCR METAB, V101, P364, DOI 10.1210/jc.2015-1710
   Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638
   Capecchi E, 2020, PEDIATR INFECT DIS J, V39, pE288, DOI 10.1097/INF.0000000000002824
   CAPONE CA, 2020, LANCET, V224, P141
   Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467
   CDC, 2020, OVERVIEW TESTING SAR
   Center for Disease Control and Prevention, INTERIM GUIDELINES C
   Centers for Disease Control and Prevention, MULTISYSTEM INFLAMMA
   Centers for Disease Control and Prevention, INFORM PEDIAT HEATH
   Centers for Disease Control and Prevention, CORONAVIRUS DIS 2019
   Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849
   Chen SJ, 2016, JAMA PEDIATR, V170, P1156, DOI 10.1001/jamapediatrics.2016.2055
   Cheng Kar Keung, 2020, Lancet, DOI 10.1016/S0140-6736(20)30918-1
   Cheung EW, 2020, JAMA-J AM MED ASSOC, V324, P294, DOI 10.1001/jama.2020.10374
   Chiang MH, 2021, ARCH DIS CHILD, V106, P662, DOI 10.1136/archdischild-2019-318245
   Chiotos K, 2020, J PEDIAT INF DIS SOC, V9, P393, DOI 10.1093/jpids/piaa069
   Chiotos K, 2020, J PEDIAT INF DIS SOC, V9, P701, DOI 10.1093/jpids/piaa045
   Cusenza F, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9020330
   Davies P, 2020, LANCET CHILD ADOLESC, V4, P669, DOI 10.1016/S2352-4642(20)30215-7
   Davis AL, 2017, PEDIATR CRIT CARE ME, V18, P884, DOI 10.1097/PCC.0000000000001259
   de Graeff N, 2019, RHEUMATOLOGY, V58, P672, DOI 10.1093/rheumatology/key344
   De Lange S, 2002, INTENS CARE MED, V28, P1505, DOI 10.1007/s00134-002-1504-2
   de Miranda DM, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101845
   Dinnes J, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013705
   Dona D, 2020, PEDIATR INFECT DIS J, V39, pE133, DOI 10.1097/INF.0000000000002704
   Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
   Eghbali A, 2020, J CELL MOL ANESTH, V5, P3, DOI DOI 10.22037/JCMA.V5I1.29690
   Esposito S, 2021, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.628072
   Esposito S, 2021, PEDIATR DRUGS, V23, P119, DOI 10.1007/s40272-020-00435-x
   Esposito S, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104522
   Esposito S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01260-2020
   European Center of Disease Prevention and Control, 2020, COVID 19 CHILDREN RO
   European Centre for Disease Prevention and Control, 2020, GUIDANCE DISCHARGE E
   European Centre for Disease Prevention and Control, 2020, PAEDIAT INFLAMMATORY
   European Medicines Agency, EMA GIVES ADVICE USE
   European Medicines Agency, COVID 19 REMINDER RI
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Ferrara G, 2020, PEDIATR DRUGS, V22, P645, DOI 10.1007/s40272-020-00421-3
   Filocamo G, 2021, J RHEUMATOL, V48, P1343, DOI 10.3899/jrheum.200483
   Fiolet T, 2021, CLIN MICROBIOL INFEC, V27, P19, DOI 10.1016/j.cmi.2020.08.022
   Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Garazzino S, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.649358
   Garazzino S, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.18.2000600
   Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2
   Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2
   Goldenberg NA, 2020, J THROMB HAEMOST, V18, P3099, DOI 10.1111/jth.15073
   Greene AG, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.117
   Grimaud M, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00690-8
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Gupta ML, 2021, INDIAN PEDIATR, V58, P123, DOI 10.1007/s13312-021-2125-6
   Hageman JR, 2020, PEDIATR ANN, V49, pE448, DOI 10.3928/19382359-20201014-01
   Hahner S, 2015, J CLIN ENDOCR METAB, V100, P407, DOI 10.1210/jc.2014-3191
   Hall D, 2020, ANAESTHESIA, V75, P822, DOI 10.1111/anae.15047
   Harwood R, 2021, LANCET CHILD ADOLESC, V5, P133, DOI 10.1016/S2352-4642(20)30304-7
   Health Advisory CDC, 2020, MULTISYSTEM INFLAMMA
   Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285
   Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820
   Hoang A, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100433
   HORBY P, 2021, LANCET, V384, P693
   Huff HV, 2020, CLIN INFECT DIS, V71, P2752, DOI 10.1093/cid/ciaa654
   Imai Natsuko, 2020, Wellcome Open Res, V5, P59, DOI 10.12688/wellcomeopenres.15808.1
   Jaimovich DG, 1999, CRIT CARE MED, V27, P843
   Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350
   KACHE S, 2020, CRIT CARE MED, V88, P705
   Kamrath C, 2020, JAMA-J AM MED ASSOC, V324, P801, DOI 10.1001/jama.2020.13445
   Kaushik S, 2020, J PEDIATR-US, V224, P24, DOI 10.1016/j.jpeds.2020.06.045
   Khemani RG, 2015, PEDIATR CRIT CARE ME, V16, pS23, DOI 10.1097/PCC.0000000000000432
   Kneyber M.C.J., PRACTICE RECOMMENDAT
   Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2
   Koker O, 2020, RHEUMATOL INT, V40, P1613, DOI 10.1007/s00296-020-04663-9
   Kone-Paut I, 2018, AUTOIMMUN REV, V17, P768, DOI 10.1016/j.autrev.2018.01.024
   Kuttiatt VS, 2020, INDIAN J MED RES, V152, P21, DOI 10.4103/ijmr.IJMR_977_20
   LAMONTAGNE F, 2020, LANCET, V370
   Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016
   Larremore Daniel B, 2020, medRxiv, DOI [10.1126/sciadv.abd5393, 10.1101/2020.06.22.20136309]
   LAVENTHAL NT, 2020, INDIAN PEDIATR, V95, P260
   Lee PY, 2020, J CLIN INVEST, V130, P5942, DOI 10.1172/JCI141113
   Leis JA, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4125
   Leon MPD, 2020, J PEDIAT INF DIS SOC, V9, P407, DOI 10.1093/jpids/piaa061
   Lin EE, 2020, JAMA SURG, V155, P775, DOI 10.1001/jamasurg.2020.2588
   Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009
   Loi M, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28485
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Mahajan R, 2020, J NEPHROL, V33, P1373, DOI 10.1007/s40620-020-00858-2
   Marchesi A, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0529-2
   Marlais M, 2020, LANCET CHILD ADOLESC, V4, pE17, DOI 10.1016/S2352-4642(20)30145-0
   Martins PR, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13576
   Matava CT, 2020, ANESTH ANALG, V131, P61, DOI 10.1213/ANE.0000000000004872
   Ministero della Salute, COVID 19 INDICATIONS
   Mishra GP, 2021, LANCET RESP MED, V9, pE8, DOI 10.1016/S2213-2600(20)30530-0
   Mitja O, 2021, NEW ENGL J MED, V384, P417, DOI 10.1056/NEJMoa2021801
   Munro APS, 2020, ARCH DIS CHILD, V105, P618, DOI 10.1136/archdischild-2020-319474
   Nakra NA, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7070069
   Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856
   NICASTRO E, 2020, J CLIN VIROL, V26, P1359
   NIH, CORONAVIRUS DIS 2019
   Oldenburg CE, 2020, LANCET, V396, P936, DOI 10.1016/S0140-6736(20)31863-8
   Paediatric Section of the European Union of Medical Specialists (UEMS), 2015, EUROPEAN SYLLABUS PE
   Paget J, 2020, VACCINE, V38, P6485, DOI 10.1016/j.vaccine.2020.08.024
   Pain CE, 2020, LANCET RHEUMATOL, V2, pE376, DOI 10.1016/S2665-9913(20)30137-5
   Palmas Giordano, 2020, Pediatr Infect Dis J, V39, pe267, DOI 10.1097/INF.0000000000002812
   Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818
   Park YJ, 2020, EMERG INFECT DIS, V26, P2465, DOI 10.3201/eid2610.201315
   Parr JB, 2021, JAMA INTERN MED, V181, P12, DOI 10.1001/jamainternmed.2020.6557
   Patel KP, 2020, EUR J CLIN MICROBIOL, V39, P2005, DOI 10.1007/s10096-020-03961-1
   Pouletty M, 2020, ANN RHEUM DIS, V79, P999, DOI 10.1136/annrheumdis-2020-217960
   PREDIERI B, 2020, DIABETES CARE, V11, P965
   Primari di Pediatria dell'Emilia-Romagna, 5 RACCOMANDAZIONI SO
   Radia T, 2021, PAEDIATR RESPIR REV, V38, P51, DOI 10.1016/j.prrv.2020.08.001
   Ramcharan T, 2020, PEDIATR CARDIOL, V41, P1391, DOI 10.1007/s00246-020-02391-2
   Rauf A, 2020, INDIAN J PEDIATR, V87, P745, DOI 10.1007/s12098-020-03357-1
   Ravelli A, 2016, ANN RHEUM DIS, V75, P481, DOI 10.1136/annrheumdis-2015-208982
   Rimensberger PC, 2015, PEDIATR CRIT CARE ME, V16, pS51, DOI 10.1097/PCC.0000000000000433
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   ROSENBERG DI, 2004, RHEUMATOLOGY, V32, P2117
   Royal College of Pediatrics and Child Health, J CLIN ENDOCR METAB
   Russo A, 2020, INFECT DRUG RESIST, V13, P2657, DOI 10.2147/IDR.S264020
   Sakhaie M., 2021, INT J CARDIOL HEART, DOI DOI 10.1016/J.IJCHA.2021.100764T
   Selvin E, 2020, DIABETES CARE, V43, P1690, DOI 10.2337/dc20-1295
   Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304
   Singh S, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113429
   Sodhi M, 2020, CHEST, V158, P55, DOI 10.1016/j.chest.2020.03.040
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665
   Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094
   Tresoldi AS, 2020, J CLIN ENDOCR METAB, V105, P418, DOI 10.1210/clinem/dgz006
   Trottier, ACUTE CARE COMMITTEE
   Van Elslande J, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.07.038
   Vasudevan A, 2020, INDIAN PEDIATR, V57, P641, DOI 10.1007/s13312-020-1893-8
   Venturini E, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-020-00900-w
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Vergine G, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.575290
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Wade M, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113143
   Walker David M, 2020, Pediatr Emerg Med Pract, V17, P1
   Walsh KA, 2020, J INFECTION, V81, P847, DOI 10.1016/j.jinf.2020.10.009
   WALTUCH T, 2020, LANCET, V38, DOI DOI 10.1016/J.AJEM.2020.05.058
   Wang H, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00334
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang X, 2020, INT J INFECT DIS, V94, P107, DOI 10.1016/j.ijid.2020.04.023
   WATSON J, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1808
   Weiss SL, 2020, PEDIATR CRIT CARE ME, V21, pE52, DOI [10.1097/PCC.0000000000002198, 10.1007/s00134-019-05878-6]
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   WHO International Classification of Disease codes, ANN RHEUM DIS
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   Workman JK, 2016, PEDIATR CRIT CARE ME, V17, pE451, DOI 10.1097/PCC.0000000000000906
   World Health Organization, 2020, CRITERIA RELEASING C
   World Health Organization, 2013, POCKET BOOK HOSP CAR
   World Health Organization, MULTISYSTEM INFLAMMA
   World Health Organization (WHO), 2020, CORT COVID 19 LIV GU
   World Health Organization World Health Organization World Health Organization World Health Organization, DIAGNOSTIC TESTING S
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Xu CLH, 2020, PEDIATR INFECT DIS J, V39, pE249, DOI [10.1097/1NE0000000000002814, 10.1097/INF.0000000000002814]
   Yamamoto L, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062065, 10.1590/s1678-9946202062065]
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yonker LM, 2020, J PEDIATR-US, V227, P45, DOI 10.1016/j.jpeds.2020.08.037
   Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 180
TC 9
Z9 10
U1 4
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2021
VL 18
IS 8
AR 3919
DI 10.3390/ijerph18083919
PG 29
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA RT0PM
UT WOS:000644170500001
PM 33917940
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU van Gool, F
   Bongers, I
   Bierbooms, J
   Janssen, R
AF van Gool, Frank
   Bongers, Inge
   Bierbooms, Joyce
   Janssen, Richard
TI Whether and how top management create flexibility in mental healthcare
   organizations: COVID-19 as a test case
SO JOURNAL OF HEALTH ORGANIZATION AND MANAGEMENT
LA English
DT Article; Early Access
DE Top management; Mental healthcare; Flexibility; Resilience; Adaption;
   COVID-19
ID COMPLEX ADAPTIVE SYSTEMS; TEAMS; MODEL
AB Purpose Flexibility is essential for healthcare organizations to anticipate the increasing internal and external dynamics. Mental healthcare organizations in the Netherlands face major policy reforms made by the government, increasing involvement from municipalities and gradual replacement of clinical care with outpatient care. Top management plays an important strategic role in creating this flexibility because they make important choices, give direction and structure the organization. To create flexibility, managers have to deal with complexity and paradoxes. In this study, the authors aim to contribute to the knowledge on how healthcare managers can create flexibility in their organizations. Design/methodology/approach This is a qualitative empirical field study. In total, 21 managers of mental healthcare organizations participated in open in-depth interviews. The authors explored flexibility on three perspectives: organizational direction, structure and operations. The COVID-19 pandemic has provided an opportunity to explore flexibility. The authors asked participants to reflect on their organization's response to the pandemic. Findings Most mental healthcare organizations create flexibility in an implicit way. Flexibility and resilience are closely linked mechanisms. Flexibility ensures a quick response while resilience provides the counterforce and rebound needed to adapt. Adaption ensures that healthcare professionals learn from their experiences and do not return completely to the way things were done before. The primary urge to survive ensured rapid and adequate responses to the COVID-19 pandemic. Whether this is a manifestation of flexibility remains difficult to conclude. Practical implications The complexity theory offers some guidance in creating a flexible organization without losing consistency. Flexibility and resilience are closely linked mechanisms that antagonize and protect each other. With this insight, managers in mental healthcare can utilize the qualities and balance them without falling into the various pitfalls. Originality/value In this research, the authors are concerned with flexibility as a proactive attitude and capacity of organizations. By looking at the response of organizations to the COVID-19 crisis, the authors find out that responding to a disaster out of survival instinct is something else than flexibility. There is an interesting relationship between flexibility, resilience and adaptability, and they can balance each other.
C1 [van Gool, Frank] Tilburg Univ, Tilburg Sch Social & Behav Sci, Dept Tranzo, Sci Ctr Care & Welbeing, Tilburg, Netherlands.
   [van Gool, Frank] Trifler BV, Res & Dev, Rijen, Netherlands.
   [van Gool, Frank; Janssen, Richard] Erasmus Univ, Erasmus Ctr Healthcare Management, Rotterdam, Netherlands.
   [Bongers, Inge; Bierbooms, Joyce; Janssen, Richard] Tilburg Univ, Tilburg Sch Social & Behav Sci, Dept Tranzo, Tilburg, Netherlands.
   [Bongers, Inge; Bierbooms, Joyce] Inst Mental Healthcare Eindhoven GGzE, Eindhoven, Netherlands.
RP van Gool, F (corresponding author), Tilburg Univ, Tilburg Sch Social & Behav Sci, Dept Tranzo, Sci Ctr Care & Welbeing, Tilburg, Netherlands.; van Gool, F (corresponding author), Trifler BV, Res & Dev, Rijen, Netherlands.; van Gool, F (corresponding author), Erasmus Univ, Erasmus Ctr Healthcare Management, Rotterdam, Netherlands.
EM f.w.r.vangool@tilburguniversity.edu
CR Alliger GM, 2015, ORGAN DYN, V44, P176, DOI 10.1016/j.orgdyn.2015.05.003
   Baron RS, 2005, ADV EXP SOC PSYCHOL, V37, P219, DOI 10.1016/S0065-2601(05)37004-3
   Bennett N, 2014, BUS HORIZONS, V57, P311, DOI 10.1016/j.bushor.2014.01.001
   Bierbooms JJPA, 2020, J MED INTERNET RES, V22, DOI 10.2196/21344
   Borkowski N., 2011, ORG BEHAV HLTH CARE
   Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238
   Chaffee MW, 2007, NURS OUTLOOK, V55, P232, DOI 10.1016/j.outlook.2007.04.003
   deNederlandseGGz, 2020, INP VERK CONT VWS
   Harari Y.N., 2018, 21 LESSONS 21 CENTUR
   Herhausen D, 2021, BRIT J MANAGE, V32, P435, DOI 10.1111/1467-8551.12413
   Holden LM, 2005, J ADV NURS, V52, P651, DOI 10.1111/j.1365-2648.2005.03638.x
   Janis I.L., 1972, VICTIMS GROUPTHINK P
   Janssen R, 2017, UNCERTAIN TIMES AMBI
   Kloosterboer P.P., 2011, EXPEDITIE NAAR WAARD
   Kupeli N, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0103-x
   McDaniel RR, 2009, HEALTH CARE MANAGE R, V34, P191, DOI 10.1097/HMR.0b013e31819c8b38
   MINTZBERG H, 1985, STRATEGIC MANAGE J, V6, P257, DOI 10.1002/smj.4250060306
   Paley J, 2007, NURS INQ, V14, P233, DOI 10.1111/j.1440-1800.2007.00359.x
   Pype P, 2017, PATIENT EDUC COUNS, V100, P2028, DOI 10.1016/j.pec.2017.06.029
   Ratnapalan S, 2020, HEALTH CARE MANAG, V39, P18, DOI 10.1097/HCM.0000000000000284
   Roberts N., 2009, GLOBAL J FLEXIBLE SY, V10, P27
   Sopelana A, 2014, SYST PRACT ACT RES, V27, P165, DOI 10.1007/s11213-012-9274-4
   STAW BM, 1981, ADMIN SCI QUART, V26, P501, DOI 10.2307/2392337
   Varlander S, 2012, J APPL BEHAV SCI, V48, P33, DOI 10.1177/0021886311407666
   van de Bovenkamp HM, 2017, PUBLIC POLICY ADMIN, V32, P45, DOI 10.1177/0952076716652934
   van Giessen A, 2020, DEEL 3 KORT CYCLISCH
   van Giessen A., 2020, DEEL 4 KORT CYCLISCH
   van Gool FWR, 2017, INT J HEALTHCARE MAN, V10, P184, DOI 10.1080/20479700.2016.1230581
   van Gool F, 2021, J HEALTH ORGAN MANAG, V35, P409, DOI 10.1108/JHOM-04-2020-0109
   van Nes F, 2010, EUR J AGEING, V7, P313, DOI 10.1007/s10433-010-0168-y
   Volberda H, 2004, FLEXIBELE ONDERNEMIN
   Volberda HW, 1996, ORGAN SCI, V7, P359, DOI 10.1287/orsc.7.4.359
   Volberda HW, 1999, DECIS SUPPORT SYST, V26, P99, DOI 10.1016/S0167-9236(99)00023-8
   Volberda HW, 1997, LONG RANGE PLANN, V30, P169, DOI 10.1016/S0024-6301(96)00110-0
   Zank S, 2019, ECOL SOC, V24, DOI 10.5751/ES-10701-240113
   Zinn JS, 2007, HEALTH SERV RES, V42, P1200, DOI 10.1111/j.1475-6773.2006.00649.x
NR 36
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1477-7266
EI 1758-7247
J9 J HEALTH ORGAN MANAG
JI J. Health Organ. Manag.
DI 10.1108/JHOM-07-2021-0258
EA MAR 2022
PG 13
WC Health Policy & Services
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZO0NC
UT WOS:000765424600001
PM 35238189
OA Bronze
DA 2022-04-20
ER

PT J
AU Tsegaye, D
   Shuremu, M
   Oljira, D
   Dubale, S
   Befekadu, G
   Bidira, K
AF Tsegaye, Dereje
   Shuremu, Muluneh
   Oljira, Dereje
   Dubale, Sileshi
   Befekadu, Getachew
   Bidira, Kebebe
TI COVID-19 related knowledge and preventive practices early in the
   outbreak among health care workers in selected public health facilities
   of Illu aba Bor and Buno Bedelle zones, Southwest Ethiopia
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Knowledge; Practice; COVID-19; Health care workers; Ethiopia
ID INFECTION PREVENTION
AB BackgroundNovel-coronavirus 2019 (COVID-19) disease is currently a worldwide health risk and public health emergency concern. The virus is transmitted from an infected person to another person through close contact and droplets. Frontline health care workers are the most at risk of infection, and so a WHO interim guidance document was issued by the World Health Organization (WHO) which underscores the importance of proper sanitation and waste management practices for COVID- 19 in health-care settings. This study aimed at assessing knowledge and preventive practices towards Covid-19 among health care providers in selected health facilities of Illu Aba Bor and Buno Bedele zones, Southwest Ethiopia.MethodsAn institution-based cross-sectional study was conducted from April to May 2020 among 330 health workers in selected health facilities of Illu Aba Bor and Buno-Bedelle Zones, Southwest Ethiopia. Data were collected using a self-administered structured questionnaire. The collected data were entered into Epidata version 3.1 and exported to SPSS version 23 for analysis. Bivariate and multivariable logistic regression analysis was used to identify independent predictors of preventive practices towards Covid-19. Statistical significance was declared at a p-value of <0.05.ResultThe majority of respondents (93.3%) demonstrated good knowledge of COVID-19, and the mean (SD) knowledge score was 9.041.06. Nearly two-thirds (64.2%) of the study participants had good infection prevention practices. Being male (AOR=3.65, 95% CI: (1.96, 6.80)), education level (AOR=1.82, 95% CI (1.02, 3.22)), profession (AOR=3.17, 95% CI (1.08, 9.33)), service year (5-10years) (AOR=2.00 (1.02, 3.92)) and more than 10years (AOR=3.14 (1.51, 6.52)), availability of personal protective equipment (AOR=1.96 (1.06, 3.61)) and Knowledge level (AOR=2.61 (1.48, 4.62)) were independent predictors of COVID-19 preventive practices.Conclusion The overall level of knowledge of HCWs was good. However, the practice was relatively low. Gender, educational status, profession, year of service, knowledge towards COVID-19, and availability of personal protective equipment were independent predictors of good infection prevention practices. Optimizing the infection prevention and control loop of the health facilities is recommended.
C1 [Tsegaye, Dereje; Shuremu, Muluneh; Oljira, Dereje; Dubale, Sileshi; Befekadu, Getachew; Bidira, Kebebe] Mettu Univ, Coll Hlth Sci, Mettu, Ethiopia.
RP Tsegaye, D (corresponding author), Mettu Univ, Coll Hlth Sci, Mettu, Ethiopia.
EM deretsegaye@gmail.com
RI Donacho, Dereje Oljira/AAS-7401-2021
OI Donacho, Dereje Oljira/0000-0001-6145-2914; Tsegaye,
   Dereje/0000-0001-7358-5423
FU Mettu University
FX Limited funding was received from Mettu University to support the travel
   and data collection expenses.
CR [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   [Anonymous], CHINA DAILY, V2020
   Belfroid E, 2018, J HOSP INFECT, V98, P212, DOI 10.1016/j.jhin.2017.07.001
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   El Bushra HE, 2017, AM J INFECT CONTROL, V45, P502, DOI 10.1016/j.ajic.2016.12.020
   Fix GM, 2019, AM J INFECT CONTROL, V47, P1162, DOI 10.1016/j.ajic.2019.04.174
   Guo XD, 2020, J BONE JOINT SURG AM, V102, P847, DOI 10.2106/JBJS.20.00417
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Ijarotimi IT, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.56.13125
   Lai XQ, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00746-1
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Petersen E, 2020, INT J INFECT DIS, V93, P205, DOI 10.1016/j.ijid.2020.02.052
   Sapkota RN, 2020, JNMA J NEPAL MED ASS, P1
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Tadesse DB., 2020, NEW MICROB NEW INFEC, P1
   UNICEF, 2020, ETHIOPIA COVID 19 SI
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   WHO, 2008, REVISED INJECTION SA
   WHO/UNICEF, 2020, WATER SANITATION HYG
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2009, WHO GUID HAND HYG HL
   World Health Organization, 2020, COVID 19 CASES TOP 1
   Yen MY, 2010, SCAND J INFECT DIS, V42, P510, DOI 10.3109/00365540903582400
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 25
TC 2
Z9 2
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 27
PY 2021
VL 21
IS 1
AR 490
DI 10.1186/s12879-021-06218-0
PG 11
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA SO6OG
UT WOS:000659089800004
PM 34044784
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Koumoutsea, EV
   Vivanti, AJ
   Shehata, N
   Benachi, A
   Le Gouez, A
   Desconclois, C
   Whittle, W
   Snelgrove, J
   Malinowski, AK
AF Koumoutsea, Evangelia Vlachodimitropoulou
   Vivanti, Alexandre J.
   Shehata, Nadine
   Benachi, Alexandra
   Le Gouez, Agnes
   Desconclois, Celine
   Whittle, Wendy
   Snelgrove, John
   Malinowski, Ann Kinga
TI COVID-19 and acute coagulopathy in pregnancy
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE coagulopathy; COVID-19; disseminated intravascular coagulopathy;
   fibrinogen; pregnancy
ID MANAGEMENT
AB We present a putative link between maternal COVID-19 infection in the peripartum period and rapid maternal deterioration with early organ dysfunction and coagulopathy. The current pandemic with SARS-CoV-2 has already resulted in high numbers of critically ill patients and deaths in the non-pregnant population, mainly due to respiratory failure. During viral outbreaks, pregnancy poses a uniquely increased risk to women due to changes to immune function, alongside physiological adaptive alterations, such as increased oxygen consumption and edema of the respiratory tract. The laboratory derangements may be reminiscent of HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome, and thus knowledge of the COVID-19 relationship is paramount for appropriate diagnosis and management. In addition to routine measurements of D-dimers, prothrombin time, and platelet count in all patients presenting with COVID-19 as per International Society on Thrombosis and Haemostasis (ISTH) guidance, monitoring of activated partial thromboplastin time (APTT) and fibrinogen levels should be considered in pregnancy, as highlighted in this report. These investigations in SARS-CoV-2-positive pregnant women are vital, as their derangement may signal a more severe COVID-19 infection, and may warrant pre-emptive admission and consideration of delivery to achieve maternal stabilization.
C1 [Koumoutsea, Evangelia Vlachodimitropoulou; Whittle, Wendy; Snelgrove, John; Malinowski, Ann Kinga] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Div Maternal Fetal Med, Toronto, ON, Canada.
   [Koumoutsea, Evangelia Vlachodimitropoulou; Shehata, Nadine] Univ Toronto, Mt Sinai Hosp, Dept Med, Div Hematol, Toronto, ON, Canada.
   [Vivanti, Alexandre J.; Benachi, Alexandra] Univ Paris Saciay, Antoine Beciere Hosp, AP HP, Dept Obstet & Gynecol, Clamart, France.
   [Le Gouez, Agnes] Univ Paris Saciay, Antoine Beciere Hosp, AP HP, Anaesthesia & Crit Care Dept, Clamart, France.
   [Desconclois, Celine] Univ Paris Saciay, Antoine Beciere Hosp, AP HP, Biol Hematol, Clamart, France.
RP Koumoutsea, EV (corresponding author), Apt 1205,633 Bay St, Toronto, ON M5G 2G4, Canada.
EM evangelia.koumoutsea.11@ucl.ac.uk
RI Vivanti, Alexandre/AAN-1693-2020
OI Vivanti, Alexandre/0000-0002-4921-0047
CR Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8
   Beverley Hunt AR, 2020, PRACTICAL GUIDANCE P
   Charbit B, 2007, J THROMB HAEMOST, V5, P266, DOI 10.1111/j.1538-7836.2007.02297.x
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iba T, 2019, J THROMB HAEMOST, V17, P1989, DOI 10.1111/jth.14578
   Iqbal SN, 2020, UNCOMPLICATED DELIVE
   Jecko Thachil NT, 2020, ISTH INTERIM GUIDANC
   RCOG, 2020, COVID 19 VIR INF PRE
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zeidler C, 2014, HAEMATOLOGICA, V99, P1395, DOI 10.3324/haematol.2013.099101
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
NR 16
TC 62
Z9 64
U1 6
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD JUL
PY 2020
VL 18
IS 7
BP 1648
EP 1652
DI 10.1111/jth.14856
EA MAY 2020
PG 5
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA MG6WK
UT WOS:000535282900001
PM 32302459
OA Bronze
DA 2022-04-20
ER

PT J
AU Naik, N
   Finkelstein, RA
   Howell, J
   Rajwani, K
   Ching, K
AF Naik, Neel
   Finkelstein, Robert Alan
   Howell, Joy
   Rajwani, Kapil
   Ching, Kevin
TI Telesimulation for COVID-19 Ventilator Management Training With
   Social-Distancing Restrictions During the Coronavirus Pandemic
SO SIMULATION & GAMING
LA English
DT Article
DE coronavirus; COVID-19; hybrid intervention; medical education; pandemic;
   simulation; telesimulation; ventilator management
AB Background. In early 2020, the novel coronavirus pandemic forced communities around the globe to shut down and isolate. Routine graduate medical education activities have also been suspended as resident and fellow physicians-in-training have been re-deployed to support critical patient care services.
   Innovation. We developed a two-part hybrid telesimulation model to teach COVID-19 ventilator management strategies while physically separating a group of learners and an instructor from one another. Learners consisted of non-ICU health care providers with limited experience in ventilator management being redeployed to manage ICU level COVID-19 infected patients. In the first week, the video tutorial has been viewed over 500 times and we have facilitated 14 telesimulation sessions, including 48 participants comprised of hospitalists, emergency medicine physicians and physician assistants, pediatric residents, nurses, and a nurse educator.
   Conclusion. We believe that the combination of a video tutorial followed by an interactive telesimulation was successful in providing timely education during a coronavirus pandemic. Furthermore, it reinforced the value and flexibility in which simulation education could continue conveniently for learners despite significant restrictions in place during the coronavirus pandemic. Research is needed to assess the efficacy of this hybrid intervention in preparing healthcare workers and to determine if the knowledge is successfully transferred to the clinical setting.
C1 [Naik, Neel; Finkelstein, Robert Alan; Howell, Joy; Rajwani, Kapil; Ching, Kevin] NewYork Presbyterian Hosp, Weill Cornell Med Ctr, 525 East 68th St, New York, NY 10021 USA.
RP Ching, K (corresponding author), NewYork Presbyterian Hosp, Weill Cornell Med Ctr, 525 East 68th St, New York, NY 10021 USA.
EM nen9010@med.cornell.edu; rof9025@med.cornell.edu;
   jdh2002@med.cornell.edu; kar9043@med.cornell.edu;
   kec9012@med.cornell.edu
CR Accreditation Council for Graduate Medical Education, 2020, ACGME RESP COR COVID
   Ajao A, 2015, DISASTER MED PUBLIC, V9, P634, DOI 10.1017/dmp.2015.105
   Association of American Medical Colleges, 2020, UPD INT GUID MED STU
   Centers for Disease Control and Prevention, 2020, COVID 19SURGE SPREAD
   Chipps J, 2012, WORLDV EVID-BASED NU, V9, P78, DOI 10.1111/j.1741-6787.2012.00241.x
   Clapper TC, 2014, SIMULAT GAMING, V45, P167, DOI 10.1177/1046878113518482
   Haile-Mariam T, 2005, EMERG MED CLIN N AM, V23, P217, DOI 10.1016/j.emc.2004.09.003
   Hayden EM, 2018, ACAD EMERG MED, V25, P144, DOI 10.1111/acem.13299
   Khanna RC, 2020, INDIAN J OPHTHALMOL, V68, P703, DOI 10.4103/ijo.IJO_843_20
   Masic Izet, 2008, Acta Inform Med, V16, P102, DOI 10.5455/aim.2008.16.102-117
   Mccoy CE, 2019, WEST J EMERG MED, V20, P512, DOI 10.5811/westjem.2019.3.40805
   McCoy CE, 2017, AEM EDUC TRAIN, V1, P132, DOI 10.1002/aet2.10015
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Okrainec A, 2010, SURG ENDOSC, V24, P417, DOI 10.1007/s00464-009-0572-6
   Park J, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7668
   Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227
NR 16
TC 10
Z9 11
U1 2
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1046-8781
EI 1552-826X
J9 SIMULAT GAMING
JI Simul. Gaming
PD AUG
PY 2020
VL 51
IS 4
BP 571
EP 577
AR 1046878120926561
DI 10.1177/1046878120926561
EA MAY 2020
PG 7
WC Education & Educational Research; Psychology, Social; Social Sciences,
   Interdisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research; Psychology; Social Sciences - Other
   Topics
GA MK1TO
UT WOS:000533944400001
OA hybrid
DA 2022-04-20
ER

PT J
AU Godovykh, M
   Ridderstaat, J
   Baker, C
   Fyall, A
AF Godovykh, Maksim
   Ridderstaat, Jorge
   Baker, Carissa
   Fyall, Alan
TI COVID-19 and Tourism: Analyzing the Effects of COVID-19 Statistics and
   Media Coverage on Attitudes toward Tourism
SO FORECASTING
LA English
DT Article
DE tourism; attitudes; COVID-19; sentiment analysis; time-series analysis
ID TIME-SERIES; SENTIMENT; TRAVEL; RISK; VULNERABILITY; PERCEPTIONS;
   ARRIVALS; IMPACTS; EBOLA
AB COVID-19 has significantly influenced tourism, including tourists' and residents' attitudes toward tourism. At the same time, attitudes and consumer confidence are important for economic recovery in the tourism sector. This study explores the effects of the COVID-19 pandemic on people's attitudes toward tourism by analyzing time-series data on the number of COVID-19 positive cases, vaccinations, news sentiment, a total number of daily mentions of tourism, and the share of voice for positive and negative sentiment toward tourism. The applied data analysis techniques include descriptive analysis, visual representation of data, data decomposition into trend and cycle components, unit root tests, Granger causality test, and multiple time series regression. The results demonstrate that the COVID-19 statistics and media coverage have significant effects on interest in tourism in general, as well as the positive and negative sentiment toward tourism. The results contribute to knowledge and practice by describing the effects of the disease statistics on attitudes toward tourism, introducing social media sentiment analysis as an opportunity to measure positive and negative sentiment toward tourism, and providing recommendations for government authorities, destination management organizations, and tourism providers.
C1 [Godovykh, Maksim; Ridderstaat, Jorge; Baker, Carissa; Fyall, Alan] Univ Cent Florida, Rosen Coll Hospitality Management, Orlando, FL 32819 USA.
RP Godovykh, M (corresponding author), Univ Cent Florida, Rosen Coll Hospitality Management, Orlando, FL 32819 USA.
EM maksim.godovykh@ucf.edu; Jorge.Ridderstaat@ucf.edu;
   carissa.baker@ucf.edu; alan.fyall@ucf.edu
RI Godovykh, Maksim/AAG-7472-2021
OI Godovykh, Maksim/0000-0003-4484-999X
FU UCF Seed Funding program [AWD00000898]
FX FundingThe authors would like to acknowledge the financial support of
   the UCF Seed Funding program (AWD00000898).
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I., 1985, ACTION CONTROL COGNI, P11
   Andereck K, RESIDENT ATTITUDES T
   Aronica M, 2022, WORLD ECON, V45, P430, DOI 10.1111/twec.13157
   Barua S, 2021, J CLEAN PROD, V298, DOI 10.1016/j.jclepro.2021.126755
   Boone L., 2020, TACKLING FALLOUT COV, P37
   Brown CB, 2015, TOUR MANAG PERSPECT, V16, P266, DOI 10.1016/j.tmp.2014.12.001
   Buckman SR., 2020, FRBSF EC LETT, V2020, P1
   Cahyanto I, 2016, TOUR MANAG PERSPECT, V20, P195, DOI 10.1016/j.tmp.2016.09.004
   Chatfield C., 2001, ANAL TIME SERIES THE
   Chen Ming-Hsiang, 2007, Int J Hosp Manag, V26, P200, DOI 10.1016/j.ijhm.2005.11.004
   Choi KH, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031283
   Crompton J. L., 1979, Annals of Tourism Research, V6, P408, DOI 10.1016/0160-7383(79)90004-5
   DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Dube K, 2021, CURR ISSUES TOUR, V24, P1487, DOI 10.1080/13683500.2020.1773416
   Easterling D. S., 2004, Journal of Travel & Tourism Marketing, V17, P45, DOI 10.1300/J073v17n04_05
   Farzanegan MR, 2021, J TRAVEL RES, V60, P687, DOI 10.1177/0047287520931593
   Godovykh M, 2021, TOURISM ECON, DOI 10.1177/13548166211041227
   Godovykh M, 2021, TOUR REV, V76, P737, DOI 10.1108/TR-06-2020-0257
   Godovykh M, 2020, J DESTIN MARK MANAGE, V17, DOI 10.1016/j.jdmm.2020.100462
   Godovykh M, 2021, TOUR REV, V76, P277, DOI 10.1108/TR-01-2020-0025
   GRANGER CWJ, 1988, J ECONOMETRICS, V39, P199, DOI 10.1016/0304-4076(88)90045-0
   Gursoy D, 2004, ANN TOURISM RES, V31, P495, DOI 10.1016/j.annals.2003.08.008
   Hadinejad A, 2019, TOUR REV, V74, P150, DOI [10.1108/TR-01-2018-0003, 10.1108/tr-01-2018-0003]
   Haque T. H., 2018, Journal of Hospitality and Tourism Management, V36, P92, DOI 10.1016/j.jhtm.2016.12.003
   Hasegawa S, 2020, J MED INTERNET RES, V22, DOI 10.2196/18662
   Hodrick RJ, 1997, J MONEY CREDIT BANK, V29, P1, DOI 10.2307/2953682
   Hove T., 2017, OXFORD RES ENCY COMM, DOI [10.1093/acrefore/9780190228613.001.0001/acrefore-9780190228613-e-283?print=pdf, DOI 10.1093/ACREFORE/9780190228613.013.283]
   Hsu CHC, 2012, J HOSP TOUR RES, V36, P390, DOI 10.1177/1096348010390817
   Huh C, 2008, J TRAVEL RES, V46, P446, DOI 10.1177/0047287507308327
   Hwang J, 2019, INT J CONTEMP HOSP M, V31, P3249, DOI 10.1108/IJCHM-07-2018-0558
   JOHNSON JD, 1994, ANN TOURISM RES, V21, P629, DOI 10.1016/0160-7383(94)90124-4
   Joo D, 2021, J DESTIN MARK MANAGE, V19, DOI 10.1016/j.jdmm.2021.100553
   Kamal H, 2021, COMPR REV FOOD SCI F, V20, P2455, DOI 10.1111/1541-4337.12739
   KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y
   Landry CE, 2021, APPL ECON PERSPECT P, V43, P443, DOI 10.1002/aepp.13119
   Lavraskas P.J., 2008, ENCY SURVEY RES METH
   Law R, 2005, J TEACH TRAVEL TOUR, V5, P53, DOI 10.1300/J172v05n04_04
   Le TH, 2018, INT J HOSP MANAG, V69, P102, DOI 10.1016/j.ijhm.2017.09.016
   Li HY, 2020, ANN TOURISM RES, V83, DOI 10.1016/j.annals.2020.102912
   Liang ZX, 2015, TOURISM GEOGR, V17, P461, DOI 10.1080/14616688.2014.1000954
   Liu B, 2015, SENTIMENT ANALYSIS: MINING OPINIONS, SENTIMENTS, AND EMOTIONS, P1
   Liu SR, 2021, VACCINE, V39, P5499, DOI 10.1016/j.vaccine.2021.08.058
   Ludvigson SC, 2004, J ECON PERSPECT, V18, P29, DOI 10.1257/0895330041371222
   McGuirk M, 2021, J MARK ANAL, V9, P363, DOI 10.1057/s41270-021-00128-5
   McKercher B, 2015, ANN TOURISM RES, V50, P52, DOI 10.1016/j.annals.2014.11.002
   Mehraliyev F, 2022, INT J CONTEMP HOSP M, V34, P46, DOI 10.1108/IJCHM-02-2021-0132
   Meng T, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.628789
   Mitchell V.W., 1992, MANAGE DECIS, V30, P26, DOI [DOI 10.1108/00251749210013050, 10.1108/00251749210013050]
   Moscardo G, 2014, TOUR RECREAT RES, V39, P82
   Murdock MR, 2017, J MARKETING, V81, P83, DOI 10.1509/jm.15.0402
   Nemes L, 2021, J INFORM TELECOMMUN, V5, P1, DOI 10.1080/24751839.2020.1790793
   Neri F, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P919, DOI 10.1109/ASONAM.2012.164
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   Nunkoo R, 2012, ANN TOURISM RES, V39, P243, DOI 10.1016/j.annals.2011.05.006
   Onder I, 2019, TOUR ANAL, V24, P437, DOI 10.3727/108354219X15652651367442
   Pine R., 2004, International Journal of Contemporary Hospitality Management, V16, P139, DOI 10.1108/09596110410520034
   Qiu RTR, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102994
   Sanchez-Canizares SM, 2021, CURR ISSUES TOUR, V24, P970, DOI 10.1080/13683500.2020.1829571
   Sands P, 2016, LANCET, V388, P2443, DOI 10.1016/S0140-6736(16)30594-3
   Scott D, 2019, ANN TOURISM RES, V77, P49, DOI 10.1016/j.annals.2019.05.007
   Seetanah B, 2011, ANN TOURISM RES, V38, P291, DOI 10.1016/j.annals.2010.08.009
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Skare M, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120469
   Sohn HK, 2016, J TRAVEL TOUR MARK, V33, P28, DOI 10.1080/10548408.2015.1024912
   STAVRAKANTONAKI.I, 2012, COMMON VALUE MANAG, V52, P52
   Tasci ADA, 2017, J VACAT MARK, V23, P20, DOI 10.1177/1356766715617499
   Wilson D.J., 2020, J ECONOMETRICS, DOI [10.24148/wp2017-01, DOI 10.1016/J.JECONOM.2020.07.053]
   Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1
   Yang L, 2011, ANN TOURISM RES, V38, P561, DOI 10.1016/j.annals.2010.10.009
   Yue L, 2019, KNOWL INF SYST, V60, P617, DOI 10.1007/s10115-018-1236-4
NR 72
TC 1
Z9 1
U1 11
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2571-9394
J9 FORECASTING-BASEL
JI Forecasting
PD DEC
PY 2021
VL 3
IS 4
BP 870
EP 883
DI 10.3390/forecast3040053
PG 14
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA XY5FC
UT WOS:000736997100001
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Anholon, R
   Serafim, MP
   Dibbern, T
   Leal, W
AF Anholon, Rosley
   Serafim, Milena Pavan
   Dibbern, Thais
   Leal Filho, Walter
TI The importance of ISO management system standards in a scenario of
   profound changes caused by the Covid-19 pandemic to Brazilian companies
SO BRAZILIAN JOURNAL OF OPERATIONS & PRODUCTION MANAGEMENT
LA English
DT Article
DE Management; Covid-19; Brazilian Companies; ISO Management Standards
AB Goal: The aim of this viewpoint is characterized by emphasizing the importance of the management standards of the International Organization for Standardization as an information base for improvements to Brazilian managers in a scenario of profound changes caused by the Covid-19 pandemic.
   Design / Methodology / Approach: Initially, a brief bibliographic research was carried out to base some information presented in the text. Later, the authors of this viewpoint discussed their ideas and established the reflections presented here, many of them based on their experiences and the Brazilian context. Finally, the final considerations were established.
   Results: The main reflections are directed in the sense that most Brazilian companies have felt harshly the consequences of the economic crisis resulting from the pandemic of Covid-19 and, in some way, they need to rethink some of their administrative practices. In this scenario of profound organizational changes, we believe that the management standards of the International Organization for Standardization can be characterized as an important knowledge base, since they present information of high credibility, widely debated by experts and that are easily accessible to Brazilian managers in different themes.
   Limitations of the investigation: Since it is a viewpoint, part of the information presented here are the perceptions and considerations of the authors.
   Practical implications: This viewpoint shows that the standards of the International Organization for Standardization can be used as an important tool for management systems focused on innovation and employee skills management.
   Originality / Value: We hope with this viewpoint to advocate for ISO management standards as important instruments of continuous improvement in a scenario of many organizational changes for Brazilian companies.
C1 [Anholon, Rosley] Univ Estadual Campinas, Sch Mech Engn, Campinas, SP, Brazil.
   [Serafim, Milena Pavan] Univ Estadual Campinas, Sch Appl Sci, Lab Publ Sector Studies, Limeira, SP, Brazil.
   [Dibbern, Thais] Univ Estadual Campinas, Inst Geosci, Limeira, SP, Brazil.
   [Leal Filho, Walter] Hamburg Univ Appl Sci, European Sch Sustainabil Sci & Res, Hamburg, Germany.
   [Leal Filho, Walter] Manchester Metropolitan Univ, Dept Nat Sci, Manchester, Lancs, England.
RP Anholon, R (corresponding author), Univ Estadual Campinas, Sch Mech Engn, Campinas, SP, Brazil.
EM rosley@unicamp.br
RI Leal, Walter/AAU-6997-2021; Anholon, Rosley/C-3650-2018; Pavan Serafim,
   Milena/ABE-6866-2020; Dibbern, Thais Aparecida/A-8084-2019
OI Leal, Walter/0000-0002-1241-5225; Anholon, Rosley/0000-0003-3163-6119;
   Pavan Serafim, Milena/0000-0002-7541-4182; Dibbern, Thais
   Aparecida/0000-0003-4826-4614
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPQ) [307536/2018-1]; CoordenacAo de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) [88887.339816/2019-00]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq
   Productivity Grant-307536/2018-1) ; and CoordenacAo de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES) (Grant-88887.339816/2019-00)
CR Anholon R, 2021, KYBERNETES, V50, P1654, DOI 10.1108/K-10-2020-0707
   Anholon R, 2016, J CLEAN PROD, V135, P740, DOI 10.1016/j.jclepro.2016.06.169
   Lopes APVBV, 2016, BRAZ J OPER PROD MAN, V13, P16, DOI 10.14488/BJOPM.2016.v13.n1.a2
   Brasil Ministerio da Saude, 2021, COR PAN
   Davison RM., 2020, INT J INFORM MANAGE, V55, P102149, DOI [10.1016/j.ijinfomgt.2020.102149, DOI 10.1016/j.ijinfomgt.2020.102149]
   Evans Carolyn, 2020, Bus Econ, V55, P253, DOI 10.1057/s11369-020-00191-3
   Fundacao Nacional da Qualidade-FNQ, 2021, BEST MAN 1992 2020
   International Organization for Standardization-ISO, 2020, 10015 ISO
   International Organization for Standardization-ISO, 2020, 56002 ISO
   J-Figueiredo R, 2017, BRAZ J OPER PROD MAN, V14, P438, DOI 10.14488/BJOPM.2017.v14.n4.a1
   Janjua LR, 2021, BRAZ J OPER PROD MAN, V18, DOI 10.14488/BJOPM.2021.001
   Johns Hopkins University and Medicine, 2021, COR RES CTR
   Martin J, 2021, TOTAL QUAL MANAG BUS, V32, P359, DOI 10.1080/14783363.2019.1576516
   Murphy CN, 2009, GLOB INST, P1
   Schumpeter, 2015, ECONOMIST 0226
   Stepanenko V, 2017, PROC CONF OPEN INNOV, P427, DOI 10.23919/FRUCT.2017.8071344
NR 16
TC 0
Z9 0
U1 0
U2 1
PU ASSOC BRASILEIRA ENGENHARIA PRODUCAO-ABEPRO
PI SAO PAULO
PA AV PROF ALMEIDA PRADO 531, 1O ANDAR, SALA 102, SAO PAULO, 05508-900,
   BRAZIL
SN 2237-8960
J9 BRAZ J OPER PROD MAN
JI Braz. J. Oper. Prod. Manag.
PY 2022
VL 19
IS 1
AR e20221248
DI 10.14488/BJOPM.2021.042
PG 4
WC Operations Research & Management Science
WE Emerging Sources Citation Index (ESCI)
SC Operations Research & Management Science
GA WB8ZV
UT WOS:000703856400004
OA gold, Green Accepted
DA 2022-04-20
ER

PT J
AU Jaffar, N
   Khan, A
   Abbas, K
   Jafri, A
   Siddiqui, SJ
   Kumari, V
AF Jaffar, Nazish
   Khan, Amna
   Abbas, Kiran
   Jafri, Aliya
   Siddiqui, Sarmad Jamal
   Kumari, Vinita
TI Novel COVID-19 Pandemic: A Cross-Sectional Survey among Global Health
   Care Providers
SO WORLD FAMILY MEDICINE
LA English
DT Article
DE COVID-19; Healthcare personnel; practice; knowledge; barriers; pandemic;
   global
AB Background: Covid-19, a highly infectious disease was first reported in Wuhan. China on 31 December, 2019. It was declared a pandemic by World Health Organization on 11 March, 2020 when 118,326 cases were reported globally.
   The present study was designed to determine the knowledge, practices, availability of personal protective equipment to health care providers and hindrance to delivering health care facilities during the COVID-19 pandemic.
   Methods: A descriptive cross sectional study was conducted with 217 health care workers serving in different hospitals/departments across the globe. Sample size was calculated by using Open EPI software and data was analysed by using SPSS version 22.0.
   Results: Knowledge of many 152(73.4%) participants regarding guidelines for isolation of suspected cases and recommendations for wearing a mask in a community setting was not satisfactory. About 51(24.63%) did not receive any personal protective equipment. Inadequate provision of personal protective equipment was reported by 78(37.7%) participants as the most common factor that might impede their willingness to work during the COVID-19 pandemic. About half. 98(47.3%) of the participants admitted that they are not well prepared/trained in handling COVID-19 cases. PCR was correctly reported as diagnostic test for SARS CoV-2 by 136(65.7%) respondents.
   Conclusions . Our study recorded lack of knowledge about newly emerged COVID-19 pandemic among health care workers. Shortage of ventilators, testing kits and personal protective equipment was noted in many hospitals and departments. Lack of personal protective equipment and insufficient training in infection control management may act as barriers in delivering health care during COVID-19.
C1 [Jaffar, Nazish; Kumari, Vinita] Jinnah Sindh Med Univ, Sindh Med Coll, Pathol Dept, Karachi, Pakistan.
   [Khan, Amna] Jinnah Sindh Med Univ, Sindh Med Coll, Karachi, Pakistan.
   [Abbas, Kiran] Jinnah Postgrad Med Ctr, Karachi, Pakistan.
   [Jafri, Aliya] Jinnah Sindh Med Univ, Sindh Med Coll, Biochem Dept, Karachi, Pakistan.
   [Siddiqui, Sarmad Jamal] Shaheed Mohtarma Benazir Bhutto Med Univ Larkana, Fac Community Med & Publ Hlth Sci, Larkana, Pakistan.
RP Khan, A (corresponding author), Jinnah Sindh Med Univ, Sindh Med Coll, Karachi, Pakistan.
EM amnasajidkhan@gmail.com
CR Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chughtai AA, 2020, J INFECT PUBLIC HEAL, V13, P385, DOI 10.1016/j.jiph.2020.02.032
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538
   McMichael TM, 2020, MMWR-MORBID MORTAL W, V69, P339, DOI 10.15585/mmwr.mm6912e1
   Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141
   Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang SS, 2020, CLIN INFECT DIS, V71, P853, DOI 10.1093/cid/ciaa225
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 14
TC 0
Z9 0
U1 0
U2 1
PU MEDI+WORLD INT
PI RADCLIFFE NORTH
PA 3 DAVIS ST, RADCLIFFE NORTH, 4020, AUSTRALIA
SN 1839-0188
EI 1839-0196
J9 WORLD FAM MED
JI World Fam. Med.
PD JAN
PY 2021
VL 19
IS 1
BP 110
EP 118
DI 10.5742/MEWFM.2021.93956
PG 9
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA PR6SY
UT WOS:000607365000014
DA 2022-04-20
ER

PT J
AU Alam, E
   Rahman, KA
   Hridoy, AE
AF Alam, Edris
   Rahman, Kazi Abdur
   Hridoy, Al-Ekram Elahee
TI Public Confidence in COVID-19 Prevention and Response in Bangladesh
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE COVID-19; confidence; preparedness; response; risk management;
   Bangladesh
ID KNOWLEDGE
AB Community confidence in institutional approaches to emergency management directs how they cooperate and comply with public policy responses. In the context of emerging COVID-19 pandemic risk management, this study aims to assess public confidence in the Government of Bangladesh (GoB) and private sector entities for the activities undertaken during preparedness, prevention, and response phases. A survey was conducted with 307 respondents who willingly took part in the study. Cronbach's alpha was calculated to assess the internal reliability and the Mann-Whitney U test was conducted to estimate the mean score difference between the observations. A confirmatory factor analysis (CFA) was applied in the study. The findings suggest that the participants were highly positive about the GoB efforts to organize and provide PPE for doctors in time as a safeguard against COVID-19 and coordination and informed decision making in relation to facing COVID-19. Overall, the participants showed a lower-level confidence in the preparedness and response measures taken by authorities in Bangladesh. The results explored how the GoB failed to reach the public satisfaction level regarding provision of food and financial support to low income and middle income people. A lack of collaboration and coordination among different inter-GoB and private sectors makes mitigation and recovery process difficult. This research provides a set of policy recommendations for future public health emergency management based on the participants' concerns and suggestions, and a review of consequences of policy responses in the early stage.
C1 [Alam, Edris] Rabdan Acad, Fac Resilience, Abu Dhabi, U Arab Emirates.
   [Alam, Edris; Hridoy, Al-Ekram Elahee] Univ Chittagong, Dept Geog & Environm Studies, Chittagong, Bangladesh.
   [Rahman, Kazi Abdur] Govt Peoples Republ Bangladesh, Dhaka, Bangladesh.
RP Alam, E (corresponding author), Rabdan Acad, Fac Resilience, Abu Dhabi, U Arab Emirates.; Alam, E (corresponding author), Univ Chittagong, Dept Geog & Environm Studies, Chittagong, Bangladesh.
EM ealam@ra.ac.ae
CR Al-Zaman MS, 2021, J HEALTH RES, V35, P364, DOI 10.1108/JHR-09-2020-0414
   Alam Edris, 2021, Risk Manag Healthc Policy, V14, P4425, DOI 10.2147/RMHP.S327881
   Alam E, 2021, INT J DISAST RISK RE, V59, DOI 10.1016/j.ijdrr.2021.102220
   Aziz A., 2020, MEDIA ASIA, V47, P144, DOI [10.1080/01296612.2020.1843219, DOI 10.1080/01296612.2020.1843219]
   Cai L., 2021, PREV SCI, V1, P1, DOI [10.1007/S11121-021-01253-4/TABLES/8, DOI 10.1007/S11121-021-01253-4/TABLES/8]
   Perez-Fuentes MD, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041196
   Emerson R. W., 2019, J VISUAL IMPAIRMENT, V113, P327, DOI 10.1177/0145482X19858866
   Frewer LJ, 2002, PUBLIC UNDERST SCI, V11, P363, DOI 10.1088/0963-6625/11/4/304
   Gallagher M. W., 2013, HDB QUANTITATIVE MET, DOI [10.1007/978-94-6209-404-8_14, DOI 10.1007/978-94-6209-404-8_14, 10.1007/978-94-6209-404-8_14.]
   Gob, 2021, COVID 19 SIT REL HLT
   Gu EW, 2020, J CHIN GOV, V5, P160, DOI 10.1080/23812346.2020.1740468
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223
   Hauben M, 2018, TEACH STAT, V40, P60, DOI 10.1111/test.12155
   Islam MD., 2020, COVID 19 BANGLADESH, DOI [10.35542/osf.io/h7sbe, DOI 10.35542/OSF.IO/H7SBE]
   Islam MT, 2020, J PUBLIC HEALTH RES, V9, P389, DOI 10.4081/jphr.2020.1794
   KAISER HF, 1965, PSYCHOMETRIKA, V30, P1, DOI 10.1007/BF02289743
   Kumar Bezon, 2021, Soc Sci Humanit Open, V4, P100194, DOI 10.1016/j.ssaho.2021.100194
   Kumar B, 2021, J PUBLIC AFF, V21, DOI 10.1002/pa.2556
   Kyriazos T.A., 2018, PSYCH, V9, P2207, DOI [10.4236/psych.2018.98126, DOI 10.4236/PSYCH.2018.98126]
   Lai MHC, 2015, STRUCT EQU MODELING, V22, P236, DOI 10.1080/10705511.2014.935928
   Liu HY, 2020, NURS EDUC TODAY, V95, DOI 10.1016/j.nedt.2020.104598
   Muhaimin, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04631
   Najab PE, 2010, CORSINI ENCY PSYCHOL, DOI [10.1002/9780470479216.corpsy0524, DOI 10.1002/9780470479216.CORPSY0524, 10.1002/9780479216.corpsy0524]
   Nguyen DV, 2020, DATA BRIEF, V31, DOI 10.1016/j.dib.2020.105880
   Paul A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238492
   Razu SR, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.647315
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Sakib N, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00289-x
   Schubert AL, 2017, J MATH PSYCHOL, V77, P29, DOI 10.1016/j.jmp.2016.08.004
   Shammi M, 2021, ENVIRON DEV SUSTAIN, V23, P6148, DOI 10.1007/s10668-020-00867-y
   Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2
   Wong CML, 2020, J RISK RES, V23, P1021, DOI 10.1080/13669877.2020.1756386
   Xia Y, 2019, BEHAV RES METHODS, V51, P409, DOI 10.3758/s13428-018-1055-2
   Yang-Wallentin F, 2010, STRUCT EQU MODELING, V17, P392, DOI 10.1080/10705511.2010.489003
   Yildirim M, 2022, DEATH STUD, V46, P1065, DOI 10.1080/07481187.2020.1784311
   Yousaf MA, 2020, SOC WORK PUBLIC HLTH, V35, P569, DOI 10.1080/19371918.2020.1806983
   Yunusa I, 2021, PAN AFR MED J, V38, DOI 10.11604/pamj.2021.38.282.26361
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 39
TC 0
Z9 0
U1 5
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD FEB 3
PY 2022
VL 9
AR 783726
DI 10.3389/fpubh.2021.783726
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZF9UR
UT WOS:000759913300001
PM 35186870
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kunac, N
   Bezic, J
   Vuko, A
   Basic, Z
   Jerkovic, I
   Kruzic, I
   Ljubic, T
   Lozic, B
   Sardelic, S
   Andelinovic, S
AF Kunac, Nenad
   Bezic, Josko
   Vuko, Arijana
   Basic, Zeljana
   Jerkovic, Ivan
   Kruzic, Ivana
   Ljubic, Toni
   Lozic, Bernarda
   Sardelic, Sanda
   Andelinovic, Simun
TI BUILDING THE COVID-19 TESTING CAPACITIES IN CROATIA: ESTABLISHING THE
   INTERDEPARTMENTAL COVID-19 UNIT AT THE SPLIT UNIVERSITY HOSPITAL CENTRE
SO ACTA CLINICA CROATICA
LA English
DT Article
DE COVID-19; RT-PCR; Split; Croatia
AB -This paper presents the chronology, experiences, and challenges in introducing COVID-19 RT-PCR testing in Split, Croatia. We describe the processes from March 12, 2020 to May 26, 2020, starting from the initial knowledge transfer, expert team formation and management, testing implementation, and concluding with the standalone testing facilities, which used automated processes sufficient to meet testing requirements at that time. In the case presented, the COVID-19 unit was organized by joining human and laboratory resources from five clinical departments at the Split University Hospital Centre. Sample preparation procedures and analyses were launched within the restricted time frame while simultaneously training and organizing new laboratory staff and completing equipment requirements. As a result, the process that started with 30 tests per day was constantly improved over time and reached up to 160 tests per day when MagNA Pure was added to automatize RNA extraction at the end of April. At that pace, the cumulative number of samples soon exceeded the first thousand, and by the end of May it exceeded 4000. The case presented provides an example of good practice for crisis response and organization that successfully enabled sufficient COVID-19 testing capacities within the restricted time frame, human and technical resources. Despite limited understanding of COVID-19 at that time, appropriate management, transfer of knowledge, previous experiences in related laboratory and diagnostic work, as well as interdisciplinary and interdepartmental cooperation proved appropriate to overcome the above limitations and ensure adequate healthcare response.
C1 [Kunac, Nenad; Bezic, Josko; Vuko, Arijana; Andelinovic, Simun] Split Univ Hosp Ctr, Dept Pathol Forens Med & Cytol, Split, Croatia.
   [Basic, Zeljana; Jerkovic, Ivan; Kruzic, Ivana; Ljubic, Toni] Univ Split, Univ Dept Forens Sci, Rudera Boskovica 33, HR-21000 Split, Croatia.
   [Lozic, Bernarda] Split Univ Hosp Ctr, Dept Pediat, Split, Croatia.
   [Sardelic, Sanda] Split Univ Hosp Ctr, Dept Microbiol & Parasitol, Split, Croatia.
   [Andelinovic, Simun] Univ Split, Sch Med, Split, Croatia.
RP Ljubic, T (corresponding author), Univ Split, Univ Dept Forens Sci, Rudera Boskovica 33, HR-21000 Split, Croatia.
EM toni.ljubic@unist.hr
RI Bašić, Željana/D-3018-2017
OI Bašić, Željana/0000-0002-8327-1978
CR Civljak R, 2020, CROAT MED J, V61, P1, DOI 10.3325/cmj.2020.61.1
   H rvatski Sabor, 2020, PRIJEDLOG ZAKONA IZM
   H rvatski zavod za javno zdravstvo, COVID 19 PRIOPC PRVO
   Koronavirus.hr, SPLIT DALMATIA COUNT
   Koronavirus.hr [Internet], NEWS 2020
   Webster S, OXFORD COVID 19 GOVT
NR 6
TC 0
Z9 0
U1 1
U2 1
PU SESTRE MILOSRDNICE UNIV HOSPITAL
PI ZAGREB
PA VINOGRADSKA C 29, ZAGREB, HR-10000, CROATIA
SN 0353-9466
EI 1333-9451
J9 ACTA CLIN CROAT
JI Acta Clin. Croat.
PD JUN
PY 2021
VL 60
IS 2
BP 254
EP 258
DI 10.20471/acc.2021.60.02.11
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA WK5LZ
UT WOS:000709768100012
PM 34744275
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Chakraborty, C
   Sharma, AR
   Bhattacharya, M
   Sharma, G
   Agoramoorthy, G
   Lee, SS
AF Chakraborty, C.
   Sharma, A. R.
   Bhattacharya, M.
   Sharma, G.
   Agoramoorthy, G.
   Lee, S-S
TI Diabetes and COVID-19: a major challenge in pandemic period?
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE Diabetes; COVID-19; Risk factor analysis; Therapeutic choice
ID CONVERTING ENZYME-INHIBITORS; INFLAMMATORY CYTOKINES; RECEPTOR BLOCKERS;
   MELLITUS; PNEUMONIA; SARS; METAANALYSIS; MECHANISMS; SECRETION;
   MORTALITY
AB OBJECTIVE: Diabetes is a lifestyle disease and it has become an epidemic worldwide in recent decades. In the ongoing COVID-19 pandemic situation, diabetes has become a serious health concern since large numbers of patients are vulnerable to die from the virus. Thus, the diabetic patients affected by COVID-19 cause a major health crisis now. Reports show that large occurrence of diabetes makes it a serious comorbidity in COVID-19 patients.
   MATERIALS AND METHODS: It is crucial to understand how COVID-19 affects diabetes patients. This paper has reviewed published literature extensively to understand the pattern, importance, care, and medication.
   RESULTS: This review summarizes the association between COVID-19 and diabetes in terms of susceptibility for pneumonia and other diseases. It also discusses the harshness of COVID-19 with diabetes populations and immunological impacts. It further adds the ACE2 receptor role in diabetes with COVID-19 patients.
   CONCLUSIONS: Finally, this paper illustrates different types of diabetes management techniques, such as blood glucose management, self-management, mental health management, and therapeutic management. It also summarizes the current knowledge about diabetic patients with COVID-19 to fight this pandemic.
C1 [Chakraborty, C.] Adamas Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Kolkata, W Bengal, India.
   [Chakraborty, C.; Sharma, A. R.; Bhattacharya, M.; Lee, S-S] Hallym Univ, Inst Skeletal Aging & Orthoped Surg, Chuncheon Sacred Heart Hosp, Chuncheon Si, Gangwon Do, South Korea.
   [Sharma, G.] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon, South Korea.
   [Agoramoorthy, G.] Tajen Univ, Coll Pharm & Hlth Care, Pingtung, Taiwan.
RP Chakraborty, C (corresponding author), Adamas Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Kolkata, W Bengal, India.; Chakraborty, C; Lee, SS (corresponding author), Hallym Univ, Inst Skeletal Aging & Orthoped Surg, Chuncheon Sacred Heart Hosp, Chuncheon Si, Gangwon Do, South Korea.; Agoramoorthy, G (corresponding author), Tajen Univ, Coll Pharm & Hlth Care, Pingtung, Taiwan.
EM drchiranjib@yahoo.com; agoram@tajen.edu.tw; 123sslee@gmail.com
RI Chakraborty, Chiranjib/J-4847-2013
OI Chakraborty, Chiranjib/0000-0002-3958-239X
FU Hallym University Research Fund; Basic Science Research Program through
   the National Research Foundation of Korea (NRF) - Ministry of
   EducationNational Research Foundation of Korea [NRF-2017R1A2B4012944
   NRF-2020R1C1C1008694]
FX This research was supported by Hallym University Research Fund and by
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF) funded by the Ministry of Education (NRF-2017R1A2B4012944
   NRF-2020R1C1C1008694
CR Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051
   ACE A, 2005, NAT MED, V11, P875
   Alanazi KH, 2020, EMERG INFECT DIS, V26, P166, DOI 10.3201/eid2601.190952
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Bhattacharya M, 2020, J MED VIROL, V92, P618, DOI 10.1002/jmv.25736
   Bindom SM, 2010, DIABETES, V59, P2540, DOI 10.2337/db09-0782
   Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243
   CASOUEIRO J, 2012, INDIAN J ENDOCRINOL, V16, pS27
   Ceriell A, 2020, DIABETES RES CLIN PR, V162, P1
   Chakraborty C, 2006, CURR PROTEIN PEPT SC, V7, P113, DOI 10.2174/138920306776359759
   Chakraborty C, 2020, EUR REV MED PHARMACO, V24, P4016, DOI 10.26355/eurrev_202004_20871
   Chakraborty C, 2020, ASIAN PAC J TROP MED, V13, P242, DOI 10.4103/1995-7645.281613
   Chakraborty C, 2016, MINI-REV MED CHEM, V16, P1258, DOI 10.2174/1389557516666160505115512
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Chen YC, 2020, DIABETES CARE, V43, P1399, DOI 10.2337/dc20-0660
   Cristelo C, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108228
   Dariya B, 2020, CYTOKINE GROWTH F R, V53, P43, DOI 10.1016/j.cytogfr.2020.05.001
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dekkers CCJ, 2018, DIABETES OBES METAB, V20, P1988, DOI 10.1111/dom.13301
   Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575
   Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020
   Eloqayli H, 2020, HYPOTHESIS CONTROL C, P1, DOI [10.13140/RG.2.2.32519.75680, DOI 10.13140/RG.2.2.32519.75680]
   Emami A, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.600
   Fadini GP, 2020, J ENDOCRINOL INVEST, V43, P867, DOI 10.1007/s40618-020-01236-2
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Feng Y, 2020, AM J RESP CRIT CARE, V201, P1380, DOI 10.1164/rccm.202002-0445OC
   Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023
   Fralick M, 2017, NEW ENGL J MED, V376, P2300, DOI 10.1056/NEJMc1701990
   Ganesh Jai, 2011, Indian J Endocrinol Metab, V15 Suppl 4, pS374, DOI 10.4103/2230-8210.86982
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guimaraes TA, 2016, ONCOTARGET, V7, P55057, DOI 10.18632/oncotarget.10842
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Gupta R, 2020, DIABETES METAB SYND, V14, P211, DOI 10.1016/j.dsx.2020.03.002
   Gupta S, 2007, INFECT DIS CLIN N AM, V21, P617, DOI 10.1016/j.idc.2007.07.003
   Han M, 2014, INT J FINANC ENG, V1, DOI 10.1142/S2345768614500081
   Hartmann-Boyce J, 2020, DIABETES CARE, V43, P1695, DOI 10.2337/dc20-1192
   Hill MA, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154217
   Hodgson K, 2015, IMMUNOLOGY, V144, P171, DOI 10.1111/imm.12394
   Hu RH, 2018, CLIN IMMUNOL, V195, P139, DOI 10.1016/j.clim.2018.06.003
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang YT, 2009, J FORMOS MED ASSOC, V108, P386, DOI 10.1016/S0929-6646(09)60082-6
   Hulme KD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00861
   Hussain A, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108142
   Iacobellis G, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108125
   Jia HP, 2016, SHOCK, V46, P239, DOI 10.1097/SHK.0000000000000633
   Kappel BA, 2017, CIRCULATION, V136, P969, DOI 10.1161/CIRCULATIONAHA.117.029166
   Kawanami D, 2017, INT J MOL SCI, V18, P1
   King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246
   Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417
   Kulcsar KA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131774
   Kumar A, 2020, DIABETES METAB SYND, V14, P535, DOI 10.1016/j.dsx.2020.04.044
   Lee YS, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3094642
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Lian JS, 2020, CLIN INFECT DIS, V71, P740, DOI 10.1093/cid/ciaa242
   Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415
   Liu J, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181994
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Ma Wan-Xia, 2020, Sichuan Da Xue Xue Bao Yi Xue Ban, V51, P146, DOI 10.12182/20200360606
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Mass SG, 1995, ANN INTERN MED, V123, P919
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0
   Mercuro Nicholas J, 2020, JAMA Cardiol, V5, P1036, DOI 10.1001/jamacardio.2020.1834
   Morra ME, 2018, REV MED VIROL, V28, P1
   Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008
   Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2
   POZZILLI P, 1987, DIABETES RES CLIN EX, V6, P5
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Qiu D, 2015, INT J CLIN PHARM TH, V53, P746, DOI 10.5414/CP202339
   Rajpal A, 2020, J DIABETES, V12, P895, DOI 10.1111/1753-0407.13085
   Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Santilli F, 2004, HORM METAB RES, V36, P319, DOI 10.1055/s-2004-814489
   Sardu C, 2020, DIABETES CARE, V43, P1408, DOI 10.2337/dc20-0723
   Shen L, 2020, J INFECTION, V81, P149, DOI 10.1016/j.jinf.2020.03.038
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Summers KL, 2006, CLIN IMMUNOL, V121, P81, DOI 10.1016/j.clim.2006.05.015
   SZYMCZAK PI, 2019, NUTRIENTS, V11, P1
   Tadic M, 2020, J CLIN HYPERTENS, V22, P943, DOI 10.1111/jch.13912
   Tocci G, 2011, AM J HYPERTENS, V24, P582, DOI 10.1038/ajh.2011.8
   van de Vijv er S, 2017, LANCET DIABETES ENDO, V5, P457
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang A, 2020, DIABETES RES CLIN PR, V162, P1
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang X, 2020, CLIN MICROBIOL INFEC, V26, P1063, DOI 10.1016/j.cmi.2020.03.032
   World Health Organization, 2020, WHO REPORT, P1
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu HJ, 2020, DIABETOLOGIA, V63, P757, DOI 10.1007/s00125-019-05074-7
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao Y., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zheng YS, 2015, IRAN J PUBLIC HEALTH, V44, P1045
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou J, 2020, METABOLISM, V107, P1
NR 109
TC 5
Z9 5
U1 5
U2 8
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PY 2020
VL 24
IS 21
BP 11409
EP 11420
DI 10.26355/eurrev_202011_23634
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA OU2PR
UT WOS:000591376000062
PM 33215463
DA 2022-04-20
ER

PT J
AU Almalki, MJ
AF Almalki, Mohammed J.
TI Knowledge, Attitudes, and Practices Toward COVID-19 Among the General
   Public in the Border Region of Jazan, Saudi Arabia: A Cross-Sectional
   Study
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE knowledge; attitudes; practices; COVID-19; novel coronavirus disease;
   SARS-CoV-2; Jazan; Saudi Arabia
ID RESIDENTS
AB Background: The Saudi government had implemented unprecedented preventive measures to deal with COVID-19. These measures included intermittent curfews, bans on public gatherings, limitations on many services, temporary suspension of Hajj, Umrah, and visit and launching awareness campaigns. Therefore, this study aimed to assess the KAP toward COVID-19 among residents of the border region of Jazan, Saudi Arabia.Methods: An online cross-sectional survey was distributed from May 4 to May 21, 2020, using a Google Form. The survey questionnaire covered demographic characteristics and KAP toward COVID-19. The KAP questions consisted of 17 items on knowledge, four items on attitude, and six items on practice.Results: A total of 597 participants responded to the survey questionnaire. Overall, participants demonstrated a good knowledge of COVID-19, correctly answering 77% of the knowledge questions. Most of the participants exhibited good attitudes and acceptable practices toward COVID-19. Multiple regression analysis revealed that participants with a university education (B = 1.75) or post-graduate education (B = 2.24), those with an income >SR 10,000-20,000 (B = 1.38) or >SR 20,000 (B = 2.07), and those who had received a personal health education (B = 1.19) had higher COVID-19 knowledge scores (p < 0.05). The ordinal logistic regression analysis found that compared to being female, being male was significantly associated with worrying about COVID-19 (p = 0.024, OR = 1.78), willingness to receive a COVID-19 vaccine (p = 0.003, OR = 1.81), and willingness to report potential symptoms of COVID-19 (p = 0.046, OR = 2.28). Worrying about COVID-19 was significantly associated with pre-university education vs. post-graduate education (p <= 0.001, OR = 7.94) and university education vs. post-graduate education (p <= 0.001, OR = 4.17). The binary logistic regression analysis found that compared to being female, being male was significantly associated with less face mask wearing in public (p = 0.009, OR = 0.31): Females were 3.23 times more likely to wear a face mask than were males.Conclusions: Most of the study participants had good knowledge, positive attitudes, and effective practices toward COVID-19. The findings of this study may help guide future awareness resources to the groups most in need in the Jazan region, particularly as the COVID-19 situation develops and changes. Further assessment should consider the groups omitted from this study, including immigrants and the elderly who have not adopted social media and technology.
C1 [Almalki, Mohammed J.] Jazan Univ, Coll Publ Hlth & Trop Med, Hlth Serv Management & Policy, Jazan, Saudi Arabia.
RP Almalki, MJ (corresponding author), Jazan Univ, Coll Publ Hlth & Trop Med, Hlth Serv Management & Policy, Jazan, Saudi Arabia.
EM mjalmalki@jazanu.edu.sa
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Ahmed QA, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101631
   Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Al Zahrani MH, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1081-z
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   AL-Mohaithef M, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.698106
   Alhazmi A, 2020, J PUBLIC HEALTH RES, V9, P345, DOI 10.4081/jphr.2020.1867
   Almalki MJ, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090943
   Alnasser Ali Hassan A, 2021, Med Sci (Basel), V9, DOI 10.3390/medsci9010011
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Baig M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243526
   Bazaid AS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243695
   Centers for Disease Control Prevention, 2020, EP INF WIND
   Centers for Disease Control Prevention, 2020, COV 19
   Choi S, 2021, QUAL SOC WORK, V20, P233, DOI 10.1177/1473325020973333
   Christie L., 2021, COVID 19 VACCINE MIS
   Ebrahim SH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1066
   Ebrahim SH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa029
   Fatmi Z, 2020, E MEDITERR HEALTH J, V26, P1446, DOI 10.26719/emhj.20.133
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117
   General Authority for Statistics, 2017, JAZ POP
   Islam MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251605
   Jazan Health Affairs, 2017, ARAB NEWS
   Jupp PG, 2002, MED VET ENTOMOL, V16, P245, DOI 10.1046/j.1365-2915.2002.00371.x
   Kasemy ZA, 2020, J EPIDEMIOL GLOB HEA, V10, P378, DOI 10.2991/jegh.k.200909.001
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Magadmi RM, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11501-5
   Mahdi HA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020673
   Mannan DKA, 2020, INT RES J BUS SOC SC, V6, DOI [10.2139/ssrn.3576523, DOI 10.2139/SSRN.3576523, 10.2139/ssrn.3578477, DOI 10.2139/SSRN.3578477]
   Megatsari H, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05136
   Ministry of Health, 2020, AV WRONG BEH PREV CO
   Ministry of Health, 2020, NOV COR COVID 19
   Ministry of Health, 2020, ROYAL ORD FREE TREAT
   Ministry of Health, 2021, COV 19
   Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9
   Nzaji MK, 2020, PRAGMAT OBS RES, V11, P103, DOI 10.2147/POR.S271096
   Our World in Data, 2021, VACC SAUD AR
   Pallant J., 2013, SPSS SURVIVAL MANUAL
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010042
   Saudi Press Agency, 2020, MIN INT APPR REV REG
   Saudi Press Agency, 2020, GEN CUST 2 HOL MOSQ
   Saudi Press Agency, 2021, STAT VIOL PREC PREV
   Sollis K., 2020, TRACKING OUTCOMES CO
   Wang KL, 2020, VACCINE, V38, P7049, DOI 10.1016/j.vaccine.2020.09.021
   Weqaya-Saudi CDC, 2020, COR DIS 19 COVID 19
   World Health Organization, 2020, SOC STIGM ASS COVID
   World Health Organization, 2020, COR DIS COVID 19 EV
   World Health Organization, 2020, COMMUNICATION 0311
   World Health Organization, 2020, ADV US MASKS CONT CO, DOI [10.1093/jiaa077, DOI 10.1093/JIAA077]
   World Health Organization (WHO), 2020, COR
   Yue ST, 2021, J COMMUN HEALTH, V46, P286, DOI 10.1007/s10900-020-00877-x
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 54
TC 2
Z9 2
U1 5
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD DEC 8
PY 2021
VL 9
AR 733125
DI 10.3389/fpubh.2021.733125
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XS2IR
UT WOS:000732739400001
PM 34957005
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Malaekah, H
   Aljahany, M
   Alassaf, W
   Alotaibi, M
   Alsaffar, M
AF Malaekah, Haifaa
   Aljahany, Muna
   Alassaf, Wajdan
   Alotaibi, Malak
   Alsaffar, Mashael
TI Attitudes and Preparedness of Non-Frontline Physicians in Saudi Arabia
   Toward the COVID-19 Pandemic
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article; Early Access
DE airway management; COVID-19; disaster management; hospital preparedness;
   personal protective equipment
ID WILLINGNESS; EMERGENCY; STAFF
AB Objective: This study assesses the attitudes (willingness) and preparedness of non-frontline physicians across different specialties in the Kingdom of Saudi Arabia (KSA) toward the management of hospitalized coronavirus disease (COVID-19) patients. Methods: This cross-sectional study conducted between April 15, 2020, and May 5, 2020, included 6209 physicians working in KSA. An electronic questionnaire was designed and validated for the assessment of 3 categorical outcome variables, namely, attitudes, confidence, and knowledge levels. Pearson's chi-square test was used for comparing the distribution of the proportions of these 3 categorical variables. Results: Most participants (63.2%) were willing and prepared to treat COVID-19 patients. A significantly large proportion of participants specializing in anesthesiology (78.2%) had higher knowledge levels, followed by those from plastic surgery (71.1%), pediatrics (69.7%), and obstetrics and gynecology (69.1%) (P < 0.0001). Lower confidence levels were found for airway management skills (38.1%), particularly among dermatologists and radiologists. Conclusion: Higher knowledge levels about personal protective equipment (PPE) use and confidence in airway management skills were proportionally related to the level of willingness to participate in COVID-19 patient management. There is an urgent need to train doctors from certain specialties on PPE use and airway management to enable their frontline support of severely ill COVID-19 patients.
C1 [Malaekah, Haifaa] Dr Sulaiman Al Habib Hosp Altakhassusi, Dept Surg, Riyadh, Saudi Arabia.
   [Aljahany, Muna; Alassaf, Wajdan; Alotaibi, Malak; Alsaffar, Mashael] Princess Nourah Bint Abdulrahman Univ, Coll Med, Dept Clin Sci, Riyadh, Saudi Arabia.
RP Aljahany, M (corresponding author), Princess Nourah Bint Abdulrahman Univ, Coll Med, Dept Clin Sci, Riyadh, Saudi Arabia.
EM msaljahany@pnu.edu.sa
OI Aljahany, Muna/0000-0002-1120-9331; MALAEKAH, HAIFAA/0000-0002-8480-7244
FU Deanship of Scientific Research at Princess Nourah Bint Abdulrahman
   University, Riyadh, Saudi Arabia, through the Fast-track Research
   Funding ProgramPrincess Nourah bint Abdulrahman University
FX This research was funded by the Deanship of Scientific Research at
   Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia,
   through the Fast-track Research Funding Program.
CR Al-Hunaishi W, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030547
   Bagatell S, 2008, AM J MED SCI, V336, P174, DOI 10.1097/MAJ.0b013e318180f60e
   Balicer RD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-99
   Chaffee Mary, 2009, Disaster Med Public Health Prep, V3, P42, DOI 10.1097/DMP.0b013e31818e8934
   Devnani M, 2012, PREHOSP DISASTER MED, V27, P551, DOI 10.1017/S1049023X12001331
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Gowing JR, 2017, PREHOSP DISASTER MED, V32, P321, DOI 10.1017/S1049023X1700019X
   Imai Teppei, 2006, Journal of Infection and Chemotherapy, V12, P124, DOI 10.1007/s10156-006-0436-0
   Lanzilotti Salvatore S, 2002, Hawaii Med J, V61, P162
   Loke Alice Yuen, 2013, J Emerg Manag, V11, P345
   Ministry of Health, 2020, NOV COR COVID 19
   Ogedegbe C, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-29
   Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086
   SHAPIRA Y, 1991, ISRAEL J MED SCI, V27, P704
   Stankovic C, 2009, PEDIATR EMERG CARE, V25, P88, DOI 10.1097/PEC.0b013e318196ea81
   Svoboda T, 2004, NEW ENGL J MED, V350, P2352, DOI 10.1056/NEJMoa032111
   Wong TY, 2008, ANN ACAD MED SINGAP, V37, P458
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2020, COR DIS COVID 19 TEC
NR 19
TC 1
Z9 1
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
AR PII S1935789321000100
DI 10.1017/dmp.2021.10
EA JAN 2021
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZC0QY
UT WOS:000757236700001
PM 33413737
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Paul, S
   Rausch, CR
   Jain, N
   Kadia, T
   Ravandi, F
   DiNardo, CD
   Welch, MA
   Dabaja, BS
   Daver, N
   Garcia-Manero, G
   Wierda, W
   Pemmaraju, N
   Bravo, GM
   Thompson, P
   Verstovsek, S
   Konopleva, M
   Kantarjian, H
   Jabbour, E
AF Paul, Shilpa
   Rausch, Caitlin R.
   Jain, Nitin
   Kadia, Tapan
   Ravandi, Farhad
   DiNardo, Courtney D.
   Welch, Mary Alma
   Dabaja, Bouthaina S.
   Daver, Naval
   Garcia-Manero, Guillermo
   Wierda, William
   Pemmaraju, Naveen
   Bravo, Guillermo Montalban
   Thompson, Philip
   Verstovsek, Srdan
   Konopleva, Marina
   Kantarjian, Hagop
   Jabbour, Elias
TI Treating Leukemia in the Time of COVID-19
SO ACTA HAEMATOLOGICA
LA English
DT Review
DE Acute leukemia; Chronic leukemia; Myelodysplastic syndrome; COVID-19
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA;
   LOW-INTENSITY CHEMOTHERAPY; TRANS-RETINOIC ACID; MYELODYSPLASTIC
   SYNDROME; ARSENIC TRIOXIDE; HYPER-CVAD; SCORING SYSTEM; BLINATUMOMAB;
   COMBINATION
AB The coronavirus disease 2019 (COVID-19) pandemic poses several challenges to the management of patients with leukemia. The biology of each leukemia and its corresponding treatment with conventional intensive chemotherapy, with or without targeted therapies (venetoclax, FLT3 inhibitors, IDH1/2 inhibitors, Bruton's tyrosine kinase inhibitors), introduce additional layers of complexity during COVID-19 high-risk periods. The knowledge about COVID-19 is accumulating rapidly. An important distinction is the prevalence of "exposure" versus "clinical infectivity," which determine the risk versus benefit of modifying potentially highly curative therapies in leukemia. At present, the rate of clinical infection is 30% in patients with cancer, careful consideration should be given to the risk of COVID-19 in leukemia. Instead of reducing patient access to specialized cancer centers and modifying therapies to ones with unproven curative benefit, there is more rationale for less intensive, yet effective therapies that may require fewer clinic visits or hospitalizations. Here, we offer recommendations on the optimization of leukemia management during high-risk COVID-19 periods.
C1 [Paul, Shilpa; Rausch, Caitlin R.] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA.
   [Jain, Nitin; Kadia, Tapan; Ravandi, Farhad; DiNardo, Courtney D.; Welch, Mary Alma; Daver, Naval; Garcia-Manero, Guillermo; Wierda, William; Pemmaraju, Naveen; Bravo, Guillermo Montalban; Thompson, Philip; Verstovsek, Srdan; Konopleva, Marina; Kantarjian, Hagop; Jabbour, Elias] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 428, Houston, TX 77030 USA.
   [Dabaja, Bouthaina S.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.
RP Jabbour, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 428, Houston, TX 77030 USA.
EM ejabbour@mdanderson.org
RI Paul, Shilpa/AAQ-6945-2021
OI Paul, Shilpa/0000-0001-5938-8896; Verstovsek, MD, PhD, Professor of
   Medicine, Srdan/0000-0002-6912-8569; Rausch, Caitlin/0000-0002-4166-5717
CR Abaza Y, 2018, AM J HEMATOL, V93, P91, DOI 10.1002/ajh.24947
   Abaza Y, 2017, BLOOD, V129, P1275, DOI 10.1182/blood-2016-09-736686
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Alfonso A, 2017, AM J HEMATOL, V92, P599, DOI 10.1002/ajh.24735
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Assi R, 2017, CL LYMPH MYELOM LEUK, V17, P897, DOI 10.1016/j.clml.2017.08.101
   Basiorka AA, 2016, BLOOD, V128, P2960, DOI 10.1182/blood-2016-07-730556
   Brunner AM, 2017, BLOOD ADV, V1, P2032, DOI 10.1182/bloodadvances.2017010165
   Burger JA, 2015, NEW ENGL J MED, V373, P2425, DOI 10.1056/NEJMoa1509388
   Burnett AK, 2015, LANCET ONCOL, V16, P1295, DOI 10.1016/S1470-2045(15)00193-X
   Burnett AK, 2013, J CLIN ONCOL, V31, P3360, DOI 10.1200/JCO.2012.47.4874
   Byrd JC, 2020, BLOOD, V135, P1204, DOI 10.1182/blood.2018884940
   Byrd JC, 2016, NEW ENGL J MED, V374, P323, DOI 10.1056/NEJMoa1509981
   Campioni D, 2005, AM J PATHOL, V166, P557, DOI 10.1016/S0002-9440(10)62277-8
   Cao W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa102
   CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6
   Couturier MA, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-111546
   Dabaja BS, 2018, INT J RADIAT ONCOL, V102, P508, DOI 10.1016/j.ijrobp.2018.05.078
   Dai MY, 2020, CANCER DISCOV, V10, P783, DOI 10.1158/2159-8290.CD-20-0422
   DiNardo CD, 2019, BLOOD, V133, P7, DOI 10.1182/blood-2018-08-868752
   DONG E, LANCET INFECT DIS
   Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8
   Fischer K, 2019, NEW ENGL J MED, V380, P2225, DOI 10.1056/NEJMoa1815281
   Ganan-Gomez I, 2015, LEUKEMIA, V29, P1458, DOI 10.1038/leu.2015.69
   Gokbuget N, 2018, BLOOD, V131, P1522, DOI 10.1182/blood-2017-08-798322
   Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079
   Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Huls G, 2019, BLOOD, V133, P1457, DOI 10.1182/blood-2018-10-879866
   Jabbour E, 2018, CANCER-AM CANCER SOC, V124, P4044, DOI 10.1002/cncr.31720
   Jabbour E, 2017, CANCER-AM CANCER SOC, V123, P629, DOI 10.1002/cncr.30383
   Jabbour E, 2010, CANCER-AM CANCER SOC, V116, P3830, DOI 10.1002/cncr.25247
   Jabbour EJ, 2019, CANCER-AM CANCER SOC, V125, P2579, DOI 10.1002/cncr.32139
   Jaramillo S, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.45
   Jawhara S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072272
   Jin XH, 2020, LANCET HAEMATOL, V7, pE351, DOI 10.1016/S2352-3026(20)30074-0
   Kadia TM, 2018, LANCET HAEMATOL, V5, pE411, DOI 10.1016/S2352-3026(18)30132-7
   Kantarjian H, 2018, LANCET ONCOL, V19, P240, DOI 10.1016/S1470-2045(18)30011-1
   Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783
   Kantarjian HM, 2019, CANCER-AM CANCER SOC, V125, P2474, DOI 10.1002/cncr.32116
   Kantarjian HM, 2000, J CLIN ONCOL, V18, P547, DOI 10.1200/JCO.2000.18.3.547
   Kreitman RJ, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-113135
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Lippi G, 2020, J MED VIROL, V92, P1759, DOI 10.1002/jmv.25860
   Liu J, 2020, JAMA ONCOL, V6, P1813, DOI 10.1001/jamaoncol.2020.3955
   Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874
   Lowenberg B, 2011, NEW ENGL J MED, V364, P1027, DOI 10.1056/NEJMoa1010222
   McCloskey JK, 2019, BLOOD, V134, DOI 10.1182/blood-2019-131838
   Montalban-Bravo G, 2018, AM J HEMATOL, V93, P129, DOI 10.1002/ajh.24930
   Naqvi K, 2019, CANCER-AM CANCER SOC, V125, P2233, DOI 10.1002/cncr.32056
   Naqvi K, 2011, J CLIN ONCOL, V29, P2240, DOI 10.1200/JCO.2010.31.3353
   Niyongere S, 2019, LEUKEMIA, V33, P205, DOI 10.1038/s41375-018-0203-0
   O'Brien S, 2018, BLOOD, V131, P1910, DOI 10.1182/blood-2017-10-810044
   Pinnix CC, 2018, INT J RADIAT ONCOL, V102, P53, DOI 10.1016/j.ijrobp.2018.05.067
   Rambaldi A, 2020, CANCER-AM CANCER SOC, V126, P304, DOI 10.1002/cncr.32558
   Rausch CR, 2020, CANCER-AM CANCER SOC, V126, P1152, DOI 10.1002/cncr.32606
   Ravandi F, 2011, BLOOD, V118, P3818, DOI 10.1182/blood-2011-04-351502
   Richard-Carpentier G, 2019, BLOOD, V134, DOI 10.1182/blood-2019-129657
   Roser M., SARPOAOORFHOOCO
   Rousselot P, 2016, BLOOD, V128, P774, DOI 10.1182/blood-2016-02-700153
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Tiacci E, 2015, NEW ENGL J MED, V373, P1733, DOI 10.1056/NEJMoa1506583
   Treon SP, 2020, BLOOD, V135, P1912, DOI 10.1182/blood.2020006288
   Wei AH, 2019, BLOOD, V134, DOI 10.1182/blood-2019-132405
   Wei AH, 2019, J CLIN ONCOL, V37, P1277, DOI 10.1200/JCO.18.01600
   Wei Y, 2013, LEUKEMIA, V27, P1832, DOI 10.1038/leu.2013.180
   Woyach JA, 2018, NEW ENGL J MED, V379, P2517, DOI 10.1056/NEJMoa1812836
   Yahalom J, 2020, BLOOD, V135, P1829, DOI 10.1182/blood.2020006028
   Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296
NR 70
TC 36
Z9 37
U1 6
U2 12
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0001-5792
EI 1421-9662
J9 ACTA HAEMATOL-BASEL
JI Acta Haematol.
PD MAR
PY 2021
VL 144
IS 2
BP 132
EP 144
DI 10.1159/000508199
PG 13
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA RC1QZ
UT WOS:000632577800006
PM 32392559
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Duggal, S
   Ahuja, B
   Biswas, PS
   Choudhuri, AH
AF Duggal, Sakshi
   Ahuja, Bhuvna
   Biswas, Partha S.
   Choudhuri, Anirban Hom
TI A survey of physicians' appreciation and knowledge about airway safety
   measures in the wake of COVID-19 pandemic
SO JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY
LA English
DT Article
DE Airway safety measures; COVID-19 pandemic; SARS CoV2
AB Background and Aims: The implementation of safety measures during airway management is a major concern to prevent COVID-19 transmission during pandemic. Various guidelines and advisories are in vogue to ensure safe practices. However, their success depends on the caregivers' knowledge and understanding. This survey was conducted to assess the knowledge and safety concerns amongst physicians towards airway management in the background of COVID-19 pandemic.
   Material and Methods: A survey instrument of thirty questions covering three timelines of airway management viz. 'before', 'during' and 'after' airway intervention was created. The questionnaire was electronically mailed to the eligible physicians over a period of one month via a web-based platform and the responses were analyzed. The responses were depicted numerically as percentage. A multiple discriminant analysis was used to test the accuracy of responses after adjusting for common variables.
   Results: Out of 407 responses, 300 were eligible for analysis. The respondents with correct answers to questions with single correct response were 46%, 69% and 57.3%, along the three timelines and the respondents with more than 75% correct responses in questions with multiple correct responses were 49%, 58% and 31% along the same timelines. About 75% of the participants became aware of transmission through aerosols aftermath pandemic. About two-third of the participants had knowledge about the safety guidelines and recommendations. Majority of the respondents were aware of the safety measures 'during airway intervention'.
   Conclusion: Our study found satisfactory knowledge and appreciable concern among the practicing physicians regarding airway safety measures in the wake of COVID-19 pandemic. However, more physicians were aware about the measures required to be adopted 'during' airway intervention. The survey highlights the need for a more focused training of the caregivers about safety measures 'before' and 'after' airway intervention.
C1 [Duggal, Sakshi; Choudhuri, Anirban Hom] GB Pant Inst Med Educ & Res, Dept Anesthesiol & Intens Care, New Delhi, India.
   [Biswas, Partha S.] GB Pant Inst Med Educ & Res, Dept Psychiat, New Delhi, India.
   [Ahuja, Bhuvna] ESI Hosp, Dept Anesthesiol & Intens Care, Noida, Uttar Pradesh, India.
RP Choudhuri, AH (corresponding author), GB Pant Inst Med Educ & Res, New Delhi 110002, India.
EM anirban.homchoudhuri@gmail.com
CR Banik RK, 2020, ANESTH ANALG, V131, pE102, DOI 10.1213/ANE.0000000000004933
   Cheung JCH, 2020, LANCET RESP MED, V8, pE19, DOI 10.1016/S2213-2600(20)30084-9
   Choi JW, 2019, KOREAN J ANESTHESIOL, V72, P156, DOI 10.4097/kja.d.18.00198
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Dieckmann Peter, 2020, Adv Simul (Lond), V5, P3, DOI 10.1186/s41077-020-00121-5
   GABA DM, 1995, HUM FACTORS, V37, P20, DOI 10.1518/001872095779049435
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Greenland JR, 2020, ANESTHESIOLOGY, V132, P1346, DOI 10.1097/ALN.0000000000003303
   Guarner J, 2020, AM J CLIN PATHOL, V153, P420, DOI 10.1093/ajcp/aqaa029
   Heffernan DS, 2020, SURG INFECT, V21, P301, DOI 10.1089/sur.2020.101
   Houghton C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013582
   Karimi-Shahanjarini A, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010412.pub2
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Liu J, 2020, J MED VIROL, V92, P491, DOI 10.1002/jmv.25709
   Orser BA, 2020, ANESTH ANALG, V130, P1109, DOI 10.1213/ANE.0000000000004803
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Raboud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010717
   WEINGER MB, 1990, ANESTHESIOLOGY, V73, P995
   Yong PSA, 2020, BRIT J ANAESTH, V125, pE176, DOI 10.1016/j.bja.2020.04.007
NR 20
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0970-9185
EI 2231-2730
J9 J ANAESTH CLIN PHARM
JI J. Anaesth. Clin. Pharm.
PD JUL-SEP
PY 2020
VL 36
IS 3
BP 350
EP 358
DI 10.4103/joacp.JOACP_294_20
PG 9
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA OP5EA
UT WOS:000588105400010
PM 33487902
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Klymenko, O
   Halse, LL
AF Klymenko, Olena
   Halse, Lise Lillebrygfjeld
TI Sustainability practices during COVID-19: an institutional perspective
SO INTERNATIONAL JOURNAL OF LOGISTICS MANAGEMENT
LA English
DT Article; Early Access
DE Sustainable supply chain management; COVID-19 effects; Institutional
   theory
ID SUPPLY CHAIN MANAGEMENT; PRESSURES; GREEN; STRATEGY; RECOVERY; VIEW
AB Purpose The purpose of this paper is to investigate how sustainable practices in supply chains are affected by the COVID-19 pandemic through the lens of institutional theory. Design/methodology/approach This research applies a twofold data collection approach: 1) qualitative semistructured interviews and 2) secondary data collection that includes sustainability reports, newspaper articles, journal articles, strategic plans, research reports and statements made by authorities and stakeholders concerning decision-making. In total, managers representing six companies in Norway were interviewed. Findings The study suggests that during the COVID-19 pandemic, companies tend to focus on short-term decisions and economic issues. The long-term focus on sustainability has, however, increased at the cluster level. The research also indicates that the pandemic has led to the development of new business routines that may transform institutional norms. The diversity of institutional contexts can, on the one hand, drive sustainability transitions through pressures and supportive programs but, on the other hand, also hinder the development of sustainability thinking. Research limitations/implications Institutional factors must be included when analyzing the effects of crises and sustainable transitions. Researchers are encouraged to explore the COVID-19 implications in the form of longitudinal studies. Practical implications Policymakers can benefit from in-depth knowledge on the adverse effects of an institutional environment on sustainability. For managers, the outbreak of the pandemic can afford them additional time to revise their strategies and seek innovation. The pandemic highlights the need to build more resilient and sustainable systems that will aid managers in responding rapidly during future uncertainties and enduring sustainability trajectories in operations. Originality/value The paper offers an in-depth investigation of COVID-19 effects on the sustainability of supply chains by drawing on institutional theory.
C1 [Klymenko, Olena] Molde Univ Coll, Specialized Univ Logist, Fac Logist, Molde, Norway.
   [Halse, Lise Lillebrygfjeld] Specialized Univ Logist, Molde Univ Coll, Fac Business Adm & Social Sci, Molde, Norway.
RP Klymenko, O (corresponding author), Molde Univ Coll, Specialized Univ Logist, Fac Logist, Molde, Norway.
EM olena.klymenko@himolde.no
OI Klymenko, Olena/0000-0003-2550-3395
CR Abbasi M, 2012, SUPPLY CHAIN MANAG, V17, P517, DOI 10.1108/13598541211258582
   Adebanjo D, 2013, SUPPLY CHAIN MANAG, V18, P553, DOI 10.1108/SCM-08-2012-0272
   Ahi P, 2013, J CLEAN PROD, V52, P329, DOI 10.1016/j.jclepro.2013.02.018
   Alam ST, 2021, INT J PROD ECON, V239, DOI 10.1016/j.ijpe.2021.108193
   Amankwah-Amoah J, 2021, ENVIRON INT, V156, DOI 10.1016/j.envint.2021.106719
   Amankwah-Amoah J, 2020, TRANSPORT RES E-LOG, V143, DOI 10.1016/j.tre.2020.102098
   Amankwah-Amoah J, 2020, J CLEAN PROD, V271, DOI 10.1016/j.jclepro.2020.123000
   Amdam RP, 2020, J WORLD BUS, V55, DOI 10.1016/j.jwb.2020.101125
   Bansal P, 2014, STRATEG ORGAN, V12, P70, DOI 10.1177/1476127013520265
   Barbieri P, 2020, OPER MANAGE RES, V13, P131, DOI 10.1007/s12063-020-00160-1
   Bodenheimer M., 2020, Sustainability: Science, Practice & Policy, V17, P61, DOI 10.1080/15487733.2020.1766318
   Bruton GD, 2010, ENTREP THEORY PRACT, V34, P421, DOI 10.1111/j.1540-6520.2010.00390.x
   Butt AS, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-11-2020-0455
   Carter CR, 2019, INT J PHYS DISTR LOG, V50, P122, DOI 10.1108/IJPDLM-02-2019-0056
   Centobelli P, 2017, TRANSPORT RES D-TR E, V53, P454, DOI 10.1016/j.trd.2017.04.032
   Chowdhury P, 2021, TRANSPORT RES E-LOG, V148, DOI 10.1016/j.tre.2021.102271
   Craighead CW, 2020, DECISION SCI, V51, P838, DOI 10.1111/deci.12468
   Davis-Sramek B, 2017, J SUPPLY CHAIN MANAG, V53, P65, DOI 10.1111/jscm.12131
   de Sousa Jabbour A.B.L., 2020, MODERN SUPPLY CHAIN, DOI DOI 10.1108/MSCRA-05-2020-0011
   Di Stefano C., 2019, SINERGIE ITALIAN J M, V37, P119, DOI [10.7433/s109.2019.07, DOI 10.7433/S109.2019.07]
   DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101
   El Baz J, 2021, INT J PROD ECON, V233, DOI 10.1016/j.ijpe.2020.107972
   Galpin T, 2015, CORP GOV-INT J BUS S, V15, P1, DOI 10.1108/CG-01-2013-0004
   Giannarakis G., 2011, INT J MARKETING STUD, V3, P2, DOI [10.5539/ijms.v3n1p2, DOI 10.5539/IJMS.V3N1P2]
   Gong MF, 2019, INT J PROD ECON, V217, P88, DOI 10.1016/j.ijpe.2019.01.033
   Gray JV, 2013, J SUPPLY CHAIN MANAG, V49, P27, DOI 10.1111/jscm.12012
   Guba EG, 1994, HDB QUALITATIVE RES, P105
   Hakovirta M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093727
   Halldorsson A, 2015, SUPPLY CHAIN MANAG, V20, P574, DOI 10.1108/SCM-06-2015-0228
   Halse Lise Lillebrygfjeld, 2017, International Journal of Manufacturing Technology and Management, V31, P176
   Halse L.L., 2019, INT BUSINESS VUCA WO
   Hsu CC, 2016, INT J OPER PROD MAN, V36, P86, DOI 10.1108/IJOPM-06-2014-0252
   Husted BW, 2006, J INT BUS STUD, V37, P838, DOI 10.1057/palgrave.jibs.8400227
   Ibn-Mohammed T, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105169
   Ivanov D, 2021, ANN OPER RES, DOI 10.1007/s10479-021-04047-7
   Ivanov D, 2021, PROD PLAN CONTROL, V32, P775, DOI 10.1080/09537287.2020.1768450
   Jakobsen E.A.A., 2019, MENON PUBLICATION
   Jakobsen Helseth A., 2020, MENON PUBLICATION, V107
   Jia F, 2018, J CLEAN PROD, V189, P263, DOI 10.1016/j.jclepro.2018.03.248
   Karmaker CL, 2021, SUSTAIN PROD CONSUMP, V26, P411, DOI 10.1016/j.spc.2020.09.019
   Kauppi K, 2017, SUPPLY CHAIN MANAG, V22, P458, DOI 10.1108/SCM-01-2017-0004
   Kauppi K, 2013, INT J OPER PROD MAN, V33, P1318, DOI 10.1108/IJOPM-10-2011-0364
   Ketokivi MA, 2004, J OPER MANAG, V22, P63, DOI 10.1016/j.jom.2003.12.002
   Kilpatrick J., 2020, COVID 19 MANAGING SU
   Klima- Og Miljodepartementet, 2019, REGJERINGENS HANDLIN
   Kuzemko C, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101685
   MacKenzie CA, 2012, INT J PROD ECON, V138, P293, DOI 10.1016/j.ijpe.2012.03.032
   Mansi M, 2015, J PURCH SUPPLY MANAG, V21, P125, DOI 10.1016/j.pursup.2014.12.002
   Markard J., 2020, Sustainability: Science, Practice & Policy, V17, P53, DOI 10.1080/15487733.2020.1765679
   Matthews L, 2016, J SUPPLY CHAIN MANAG, V52, P82, DOI 10.1111/jscm.12097
   Miemczyk J, 2008, INT J PROD ECON, V115, P272, DOI 10.1016/j.ijpe.2008.04.013
   Moxham C, 2014, SUPPLY CHAIN MANAG, V19, P413, DOI 10.1108/SCM-09-2013-0332
   Nayal K, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-01-2021-0002
   Nieuwenhuis P, 2019, GREEN IND NETW STUD, V7, P13, DOI 10.1007/978-3-030-15066-2_2
   Norwegian Shipowners Association, 2020, GUID ESG REP SHIPP O
   Norwegian Shipowners Association, 2021, 1 4 TURN LOST DUE CO
   Norwegian Shipowners Association, 2021, COR DROP OIL PRIC RE
   Paul SK, 2021, INT J PHYS DISTR LOG, V51, P104, DOI 10.1108/IJPDLM-04-2020-0127
   Peng MW, 2008, J INT BUS STUD, V39, P920, DOI 10.1057/palgrave.jibs.8400377
   Peng MW, 2009, ACAD MANAGE PERSPECT, V23, P63, DOI 10.5465/AMP.2009.43479264
   Porter ME, 2000, ECON DEV Q, V14, P15, DOI 10.1177/089124240001400105
   Queiroz MM, 2021, ANN OPER RES, DOI 10.1007/s10479-021-04107-y
   Rahman T, 2021, COMPUT IND ENG, V158, DOI 10.1016/j.cie.2021.107401
   Ranjbari M, 2021, J CLEAN PROD, V297, DOI 10.1016/j.jclepro.2021.126660
   Ritter T, 2020, IND MARKET MANAG, V88, P214, DOI 10.1016/j.indmarman.2020.05.014
   Rosenbloom D, 2020, SCIENCE, V368, P447, DOI 10.1126/science.abc4887
   Sarkis J, 2021, INT J OPER PROD MAN, V41, P63, DOI 10.1108/IJOPM-08-2020-0568
   Sarkis J, 2020, RESOUR CONSERV RECY, V159, DOI 10.1016/j.resconrec.2020.104894
   Sarkis J, 2012, SUPPLY CHAIN MANAG, V17, P202, DOI 10.1108/13598541211212924
   Sayed M, 2017, SUPPLY CHAIN MANAG, V22, P542, DOI 10.1108/SCM-10-2016-0365
   Shah SK, 2006, J MANAGE STUD, V43, P1821, DOI 10.1111/j.1467-6486.2006.00662.x
   Sharma HB, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105052
   Sheng J, 2021, BRIT J MANAGE, V32, P1164, DOI 10.1111/1467-8551.12441
   Shih WC, 2020, HARVARD BUS REV, V98, P82
   Silva ME, 2020, J CLEAN PROD, V251, DOI 10.1016/j.jclepro.2019.119621
   Strange R, 2020, J IND BUS ECON, V47, P455, DOI 10.1007/s40812-020-00162-x
   Touboulic A, 2020, INT J LOGIST MANAG, V31, P3, DOI 10.1108/IJLM-08-2019-0222
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Weeraratne B., 2020, RETURN REINTEGRATION
   Wieland A, 2021, J SUPPLY CHAIN MANAG, V57, P58, DOI 10.1111/jscm.12248
   Yin R.K., 2018, CASE STUDY RES APPL
   Zeng HX, 2017, J CLEAN PROD, V155, P54, DOI 10.1016/j.jclepro.2016.10.093
   Zhu Q, 2007, INT J PROD RES, V45, P4333, DOI 10.1080/00207540701440345
NR 83
TC 0
Z9 0
U1 16
U2 16
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0957-4093
EI 1758-6550
J9 INT J LOGIST MANAG
JI Int. J. Logist. Manag.
DI 10.1108/IJLM-05-2021-0306
EA NOV 2021
PG 21
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA XD5XW
UT WOS:000722782500001
DA 2022-04-20
ER

PT J
AU Rahman, MM
   Khan, SJ
   Sakib, MS
   Halim, MA
   Rahman, F
   Rahman, MM
   Jhinuk, MJ
   Nabila, NH
   Yeasmin, MTM
AF Rahman, Md Mostafizur
   Khan, Saadmaan Jubayer
   Sakib, Mohammed Sadman
   Halim, Md. Abdul
   Rahman, Farzana
   Rahman, Md Moshiur
   Jhinuk, Mehjabin Jannate
   Nabila, Nadia Habib
   Yeasmin, Mir Taj Mira
TI COVID-19 responses among general people of Bangladesh: Status and
   individual view toward COVID-19 during lockdown period
SO COGENT PSYCHOLOGY
LA English
DT Article
DE General people; lockdown; COVID-19; developing settlement; Dhaka city;
   Bangladesh
ID CLIMATE-CHANGE; PREPAREDNESS; EARTHQUAKE; DHAKA
AB This cross-sectional study has evaluated the level of the COVID-19 response among the general people of Bangladesh through their COVID-19 basic knowledge, attitude and practice level to reduce the outbreak. A rapid self-administered online survey was conducted during the COVID-19 lockdown period in Bangladesh. Convenience and snowball sampling technique were followed in this study. The online survey was open for all Bangladeshi general people whether they were infected or not. For this study, total 616 Bangladeshi respondents participated where majority of them were from Dhaka city, one of the worst COVID-19 affected cities in the world. Normality of data was checked before statistical analysis. Majority of the respondents reported moderate safety of their current place from COVID-19 with high concern of their mental health during COVID-19 lockdown period. The total COVID-19 responses among these people were moderate along with the alarming high percentages of low COVID-19 responses. The respondents reported moderate COVID-19 knowledge level and moderate attitude level toward the COVID-19 control. They demonstrated that they followed practices to prevent the COVID-19 infection. Female respondents were identified with better COVID-19 responses compared to their male counterpart. Dhaka city residents had less confidence on their current place being safe from COVID-19. They also had low COVID-19 responses during the lockdown period compared to the residents living outside Dhaka city.
C1 [Rahman, Md Mostafizur] Bangladesh Univ Profess, Fac Arts & Social Sci, Dept Disaster & Human Secur Management, Dhaka 1216, Bangladesh.
   [Khan, Saadmaan Jubayer; Sakib, Mohammed Sadman; Halim, Md. Abdul; Rahman, Farzana; Jhinuk, Mehjabin Jannate; Nabila, Nadia Habib; Yeasmin, Mir Taj Mira] Independent Univ, Dept Comp Sci & Engn, Dhaka 1212, Bangladesh.
   [Rahman, Md Moshiur] Khulna Univ, Fisheries & Marine Resource Technol Discipline, Khulna 9208, Bangladesh.
RP Rahman, MM (corresponding author), Bangladesh Univ Profess, Fac Arts & Social Sci, Dept Disaster & Human Secur Management, Dhaka 1216, Bangladesh.
EM Rahmanamimostafiz@gmail.com
OI Sadman Sakib, Mohammed/0000-0002-9971-8703; Rahman, Md
   Moshiur/0000-0001-8319-395X
CR Akram A., 2019, BANGLADESH J INFECT, V6, P1, DOI [https://doi.org/10.3329/bjid.v6i1.42627, DOI 10.3329/BJID.V6I1.42627]
   Ali A, 1999, CLIMATE RES, V12, P109, DOI 10.3354/cr012109
   Ali SA, 2020, J INFECT PUBLIC HEAL, V13, P644, DOI [10.1016/j.jiph.2019.02.033, 10.1016/j.jiph.2020.02.033]
   [Anonymous], 2020, BUSINESS STANDARD
   Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154
   Banu S, 2014, ENVIRON INT, V63, P137, DOI 10.1016/j.envint.2013.11.002
   Basir NABA, 2020, PESQUI BRAS ODONTOPE, V20, DOI 10.1590/pboci.2020.002
   Basolo V, 2009, ENVIRON BEHAV, V41, P338, DOI 10.1177/0013916508317222
   Bourque LB, 2012, ENVIRON BEHAV, V44, P374, DOI 10.1177/0013916510390318
   Chang L, 2020, TRANSFUS MED REV, V34, P75, DOI 10.1016/j.tmrv.2020.02.003
   Chen Y, 2015, CHINESE NURSING RES, V11, P1315
   Chowdhury P., 2017, COMBATING URBAN HAZA
   Deng CX, 2020, INT J BIOL SCI, V16, P1676, DOI 10.7150/ijbs.45587
   Gillani AH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062027
   HAQUE CE, 1995, ENVIRON MANAGE, V19, P719, DOI 10.1007/BF02471954
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703
   Hayat K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103347
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309
   Kabita Das, 2020, Current Trends in Biotechnology and Pharmacy, V14, P196, DOI 10.5530/ctbp.2020.2.20
   Khan S. J., 2020, WATER FLOOD MANAGEME, P315
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951
   Macias AE, 2009, J HOSP INFECT, V73, P280, DOI 10.1016/j.jhin.2009.06.017
   Mamun MA, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102073
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Mutsuddy P, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/3516284
   Namazi H, 2020, FRACTALS, V28, DOI 10.1142/S0218348X20501145
   Nguyen LH, 2006, EARTHQ SPECTRA, V22, P569, DOI 10.1193/1.2219108
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012
   Ozili P., 2020, SPILLOVER COVID 19 I, DOI [DOI 10.2139/SSRN.3562570, 10.2139/ssrn.3562570]
   Paital B, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139088
   Paital B, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138914
   Paul BK, 2010, DISASTERS, V34, P337, DOI 10.1111/j.1467-7717.2009.01132.x
   R Development Core Team, 2019, R LANG ENV STAT COMP
   Rahman MM, 2021, J HUM BEHAV SOC ENVI, V31, P512, DOI 10.1080/10911359.2020.1822978
   Shammi M, 2021, ENVIRON DEV SUSTAIN, V23, P6148, DOI 10.1007/s10668-020-00867-y
   Shammi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04063
   Sintema E. J., 2020, EURASIA J MATH SCI T, V16, DOI DOI 10.29333/EJMSTE/7893
   Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9
   Walter LA, 2020, WEST J EMERG MED, V21, P507, DOI 10.5811/westjem.2020.4.47536
   Zhang HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103370
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 46
TC 5
Z9 5
U1 3
U2 6
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 2331-1908
J9 COGENT PSYCHOL
JI Cogent Psychol.
PD JAN 1
PY 2021
VL 8
IS 1
AR 1860186
DI 10.1080/23311908.2020.1860186
PG 19
WC Psychology, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Psychology
GA PU8KI
UT WOS:000609547700001
OA gold
DA 2022-04-20
ER

PT J
AU Marofi, F
   Azizi, R
   Motavalli, R
   Vahedi, G
   Nasimi, M
   Yousefi, M
   Motavalli, Y
   Tahmasebi, S
   Gharibi, T
   Mohammed, RN
   Etemadi, J
   Khiavi, FM
AF Marofi, Faroogh
   Azizi, Ramyar
   Motavalli, Roza
   Vahedi, Ghasem
   Nasimi, Maryam
   Yousefi, Mehdi
   Motavalli, Yalda
   Tahmasebi, Safa
   Gharibi, Tohid
   Mohammed, Rebar N.
   Etemadi, Jalal
   Khiavi, Farhad M.
TI COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic
   Approaches, and Diagnostic Methods
SO ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE COVID-19; coronavirus; SARS; ARDS; acute respiratory disease syndrome;
   diagnosis
ID RESPIRATORY SYNDROME CORONAVIRUS; RENIN-ANGIOTENSIN SYSTEM; DISEASE 2019
   COVID-19; MERS-COV INFECTION; VIRUS-INFECTION; CLINICAL CHARACTERISTICS;
   LOPINAVIR-RITONAVIR; ENTERIC INVOLVEMENT; SARS; 2019-NCOV
AB Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) firstly emerged in Wuhan, China at the end of 2019. After going through the experimental process, the virus was named the novel coronavirus (2019-nCoV) by the World Health Organization (WHO) in February 2020 which has created a global pandemic. The coronavirus disease 2019 (COVID-19) infection is challenging the people who are especially suffering from chronic health problems such as asthma, diabetes, and heart disease or immune system deteriorating disorders, including cancers, Alzheimer's, etc. Other predisposing/risk factors consist of smoking and age (elderly people are at higher risk). The 2019-nCoV attacks epithelial cells in all organs, particularly epithelial cells in the lungs, resulting in viral pneumonia. The 2019-nCoV starts its invasion with the attachment and entry into the respiratory tract epithelial cells via Angiotensin-Converting Enzyme 2 (ACE2) receptors on the epithelial cells. The critical problem with 2019-nCoV is its ability in human to human asymptomatic transmission which causes the rapid and hidden spread of the virus among the population. Also, there are several reports of highly variable and tightly case-dependent clinical manifestations caused by SARS-CoV2, which made the virus more enigmatic. The clinical symptoms are varied from common manifestations which occurred in flu and cold, such as cough, fever, body-ache, trembling, and runny nose to severe conditions, like the Acute Respiratory Distress Syndrome (ARDS) or even uncommon/unusual symptoms such as anosmia, skin color change, and stroke. In fact, besides serious injuries in the respiratory system, COVID-19 invades and damages various organs, including the kidney, liver, gastrointestinal, and nervous system. Accordingly, to cut the transmission chain of disease and control the infection spread. One of the major solutions seems to be early detection of the carriers, particularly the asymptomatic people, with sensitive and accurate diagnostic techniques. Moreover, developing novel and appropriate therapeutic approaches will contribute to the suitable management of the pandemic. Therefore, there is an urgent necessity to make comprehensive investigations and study reviews about COVID-19, offering the latest findings of novel therapies, drugs, epidemiology, and routes of virus transmission and pathogenesis. In this review, we discuss new therapeutic outcomes and cover and the most significant aspects of COVID-19, including the epidemiology, biological features, organs failure, and diagnostic techniques.
C1 [Marofi, Faroogh] Tabriz Univ Med Sci, Fac Med, Dept Hematol, Tabriz, Iran.
   [Yousefi, Mehdi; Gharibi, Tohid] Tabriz Univ Med Sci, Fac Med, Dept Immunol, Tabriz, Iran.
   [Azizi, Ramyar] Islam Azad Univ, Nursing Dept, Mahabad Branch, Mahabad, Iran.
   [Motavalli, Roza] Tabriz Univ Med Sci, Molecular Med Res Ctr, Tabriz, Iran.
   [Motavalli, Roza] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Mol Med, Tabriz, Iran.
   [Motavalli, Roza] Tabriz Univ Med Sci, Kidney Res Ctr, Tabriz, Iran.
   [Motavalli, Roza] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran.
   [Vahedi, Ghasem] Zanjan Univ Med Sci, Fac Med, Dept Immunol, Zanjan, Iran.
   [Nasimi, Maryam] Univ Tehran Med Sci, Dermatol, Tehran, Iran.
   [Motavalli, Yalda] Tabriz Univ Med Sci, Stem Cell Res Ctr, Tabriz, Iran.
   [Tahmasebi, Safa] Univ Tehran Med Sci, Hlth Fac, Dept Immunol, Tehran, Iran.
   [Mohammed, Rebar N.] Univ Sulaimani, Coll Vet Med, Dept Microbiol, Sulaimani, Iraq.
   [Khiavi, Farhad M.] Pasteur Inst Iran, Dept Virol, Tehran, Iran.
   [Khiavi, Farhad M.] AJA Univ Med Sci, Med Biotechnol Res Ctr, Tehran, Iran.
RP Khiavi, FM (corresponding author), Pasteur Inst Iran, Dept Virol, Tehran, Iran.
EM farhad.motavalli@gmail.com
RI Azizi, Ramyar/AFR-5747-2022
OI Marofi, Faroogh/0000-0002-8110-7808
CR Adedeji AO, 2013, J VIROL, V87, P8017, DOI 10.1128/JVI.00998-13
   Agrawal Umang, 2020, Med J Armed Forces India, V76, P370, DOI 10.1016/j.mjafi.2020.08.004
   Ahmad I, 2020, J CLIN NEUROSCI, V77, P8, DOI 10.1016/j.jocn.2020.05.017
   Ahmed AE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2712-2
   Al Heialy S, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.555039
   Al-Tawfiq JA, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101615
   Alsaad KO, 2018, HISTOPATHOLOGY, V72, P516, DOI 10.1111/his.13379
   Altay O, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101303
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Atluri S, 2020, PAIN PHYSICIAN, V23, pE71
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bastola A, 2020, LANCET INFECT DIS, V20, P279, DOI 10.1016/S1473-3099(20)30067-0
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011
   Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Camdessanche JP, 2020, REV NEUROL-FRANCE, V176, P516, DOI 10.1016/j.neurol.2020.04.003
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa102
   Carr AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02851-4
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chang CK, 2006, J BIOMED SCI, V13, P59, DOI 10.1007/s11373-005-9035-9
   Chau TN, 2004, HEPATOLOGY, V39, P302, DOI 10.1002/hep.20111
   Chen HY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023357
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen J, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa241
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Cherin P, 2016, AUTOIMMUN REV, V15, P71, DOI 10.1016/j.autrev.2015.09.002
   Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x
   COLSON P, 2020, INT J ANTIMICROB AG, V55, DOI [10.1016/j.ijantimicag.2020.105932, DOI 10.1016/J.IJANTIMICAG.2020.105932]
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Costanzo M, 2020, CURR MED CHEM, V27, P4536, DOI 10.2174/0929867327666200416131117
   Couturier J, 2015, AIDS, V29, P667, DOI 10.1097/QAD.0000000000000599
   Cyranoski David, 2020, Nature, V577, P607, DOI 10.1038/d41586-020-00190-6
   Dastan F, 2020, IRAN J PHARM RES, V19, P1, DOI [10.22037/IJPR.2020.113369.14259, 10.22037/ijpr.2020.113369.14259]
   De Meyer S, 2020, INT J INFECT DIS, V97, P7, DOI 10.1016/j.ijid.2020.05.085
   De Ranieri D, 2017, PEDIATR ANN, V46, pE8, DOI 10.3928/19382359-20161213-03
   de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
   Dear C, 2020, LACK EVIDENCE SUPPOR
   DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06
   Devaux CA, 2020, J MICROBIOL IMMUNOL, V53, P425, DOI 10.1016/j.jmii.2020.04.015
   Dhama K, 2020, HUM VACC IMMUNOTHER, V16, P1232, DOI 10.1080/21645515.2020.1735227
   Diao B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22781-1
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   El-Baz LMF, 2020, INNOV INFRASTRUCT SO, V5, DOI 10.1007/s41062-020-00334-7
   Elezkurtaj S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82862-5
   Elfiky AA, 2020, LIFE SCI, V248, DOI 10.1016/j.lfs.2020.117477
   Erol, 2020, HIGH DOSE INTRAVENOU
   Eslami G, 2020, J ANTIMICROB CHEMOTH, V75, P3366, DOI 10.1093/jac/dkaa331
   Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362
   Fan CB, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.563893
   Fan XL, 2020, CELL MOL LIFE SCI, V77, P2771, DOI 10.1007/s00018-020-03454-6
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Ferner RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1432
   Filatov A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7352
   Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027
   Galeotti C, 2017, INT IMMUNOL, V29, P491, DOI 10.1093/intimm/dxx039
   Gao Z C, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE001, DOI 10.3760/cma.j.issn.1001-0939.2020.0001
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   GIESBRECHT GG, 1995, AVIAT SPACE ENVIR MD, V66, P890
   Goo J, 2020, VIRUS RES, V278, DOI 10.1016/j.virusres.2020.197863
   Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan G W, 2020, Zhonghua Gan Zang Bing Za Zhi, V28, P100, DOI 10.3760/cma.j.issn.1007-3418.2020.02.002
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Haddad LB, 2018, NEW ENGL J MED, V379, P2492, DOI 10.1056/NEJMp1814020
   Hanley B, 2020, J CLIN PATHOL, V73, P239, DOI 10.1136/jclinpath-2020-206522
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hong H, 2020, PEDIATR NEONATOL, V61, P131, DOI 10.1016/j.pedneo.2020.03.001
   Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4
   Hosseini A, 2020, BIOMED PHARMACOTHER, V132, DOI 10.1016/j.biopha.2020.110859
   Hu FY, 2020, CLIN RESPIR J, V14, P1067, DOI 10.1111/crj.13243
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang D, 2021, J MED VIROL, V93, P481, DOI 10.1002/jmv.26256
   Huang YQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01071
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Jia X., 2020, 2 THINGS COVID 19 MI, DOI [DOI 10.20944/PREPRINTS202002.0315.V1, 10.20944/preprints202002.0315.v1]
   Jin M, 2020, EMERG INFECT DIS, V26, P1618, DOI 10.3201/eid2607.200445
   Kasgari HA, 2020, J ANTIMICROB CHEMOTH, V75, P3373, DOI 10.1093/jac/dkaa332
   Khalili JS, 2020, J MED VIROL, V92, P740, DOI 10.1002/jmv.25798
   Khanna N, 2008, CLIN INFECT DIS, V46, P402, DOI 10.1086/525263
   Khoury M, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00858-2020
   Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188
   Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Lee N, 2004, J CLIN VIROL, V31, P304, DOI 10.1016/j.jcv.2004.07.006
   Leneva IA, 2016, INT J INFECT DIS, V43, P77, DOI 10.1016/j.ijid.2016.01.001
   Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228
   Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1053/S0016-5085(03)01215-0, 10.1016/j.gastro.2003.08.001]
   Li ET, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010125
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li L.J., N ENGL J MED
   Li Y, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0395-z
   [李仲平 Li Zhongping], 2020, [中国软科学, China Soft Science], P1
   Lian N, 2020, CLIN MICROBIOL INFEC, V26, P917, DOI 10.1016/j.cmi.2020.04.026
   Lim J, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e79
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006
   Liu Y, 2020, SCI PROGRESS-UK, V103, DOI 10.1177/0036850419898659
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Liu ZX, 2020, J MED VIROL, V92, P595, DOI 10.1002/jmv.25726
   Long Y, 2016, INT J CLIN EXP MED, V9, P8865
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801
   Lythgoe MP, 2020, TRENDS PHARMACOL SCI, V41, P363, DOI 10.1016/j.tips.2020.03.006
   Ma YL, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138226
   Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025
   Maier HE, 2018, J INFECT DIS, V218, P1378, DOI 10.1093/infdis/jiy370
   Main H, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-10
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Marcolino VA, 2020, EUR J PHARMACOL, V887, DOI 10.1016/j.ejphar.2020.173467
   Markham A, 2018, DRUGS, V78, P1271, DOI 10.1007/s40265-018-0960-0
   Marrie TJ, 2007, MEDICINE, V86, P103, DOI 10.1097/MD.0b013e3180421c16
   Mathias AA, 2010, CLIN PHARMACOL THER, V87, P322, DOI 10.1038/clpt.2009.228
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Milner JJ, 2015, J IMMUNOL, V194, P4846, DOI 10.4049/jimmunol.1402295
   Misumi I, 2019, CELL REP, V27, P514, DOI 10.1016/j.celrep.2019.03.030
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Muralidharan N, 2021, J BIOMOL STRUCT DYN, V39, P2673, DOI 10.1080/07391102.2020.1752802
   Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0
   Natoli S, 2020, EUR J NEUROL, V27, P1764, DOI 10.1111/ene.14277
   Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021
   Newfield, 2018, SCI J LANDER COLL AR, V12, P3
   Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7
   Nieto-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004077
   Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503
   Okubo K, 2019, ANTICANCER RES, V39, P5891, DOI 10.21873/anticanres.13793
   Owa AB, 2020, J MICROBIOL IMMUNOL, V53, P674, DOI 10.1016/j.jmii.2020.05.014
   Pal M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7423
   Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1
   Panigrahy D, 2020, CANCER METAST REV, V39, P1, DOI [10.1007/s10555-020-09862-1, 10.1007/s10555-020-09889-4]
   Patel VB, 2016, CIRC RES, V118, P1313, DOI 10.1161/CIRCRESAHA.116.307708
   Pei, 2020, ARXIV PREPRINT ARXIV
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732
   Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511
   Pillaiyar T, 2020, DRUG DISCOV TODAY, V25, P668, DOI 10.1016/j.drudis.2020.01.015
   Pinheiro TD, 2017, J NUTR BIOCHEM, V48, P74, DOI 10.1016/j.jnutbio.2017.06.008
   Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
   Qiu H., 2020, ZHONGHUA JIE HE HE H, V43, pE022, DOI DOI 10.3760/CMA.J.CN112147-20200222-00151
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015
   Sahin AR, 2020, EURASIAN J MED ONCOL, V4, P1, DOI 10.14744/ejmo.2020.12220
   Sallard E, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104791
   Santos JR, 2019, AIDS RES HUM RETROV, V35, P513, DOI [10.1089/AID.2018.0178, 10.1089/aid.2018.0178]
   Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0
   Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194
   Sedaghat Z, 2020, J CLIN NEUROSCI, V76, P233, DOI 10.1016/j.jocn.2020.04.062
   Shah RR, 2021, J CLIN PHARM THER, V46, P17, DOI 10.1111/jcpt.13267
   Sharma AK, 2020, RESONANCE, V25, P647, DOI 10.1007/s12045-020-0981-3
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Sheikh A, 2020, J VIROL METHODS, V277, DOI 10.1016/j.jviromet.2019.113806
   Shen KL, 2020, WORLD J PEDIATR, V16, P223, DOI 10.1007/s12519-020-00343-7
   Sheng GH, 2020, CHEST, V157, P1175, DOI 10.1016/j.chest.2019.10.032
   Shetty AK, 2020, AGING DIS, V11, P462, DOI 10.14336/AD.2020.0301
   Shrestha DB, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01412-z
   Smolders EJ, 2020, ANTIVIR THER, V25, P345, DOI 10.3851/IMP3365
   Srinivasan S., 2016, ANTIBODY TECHNOL J, V2016, P1
   Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722
   Takahashi T, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-020-00143-y
   Tan Q, 2020, BIOORG CHEM, V104, DOI 10.1016/j.bioorg.2020.104257
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Thompson R, 2020, LANCET INFECT DIS, V20, P280, DOI 10.1016/S1473-3099(20)30068-2
   Tian Huaiyu, 2020, Zhonghua Yufang Yixue Zazhi, V54, P235, DOI [10.3760/cma.j.issn.0253.9624.2020.03.002, 10.3760/cma.j.issn.0253-9624.2020.03.002, 10.3760/cma.j.issn.0253-9624.2020.0001]
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   Tong S, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106114
   Turner AJ, 2002, CAN J PHYSIOL PHARM, V80, P346, DOI 10.1139/Y02-021
   Uyeki TM, 2018, CLIN INFECT DIS, V66, P1501, DOI 10.1093/cid/cix1150
   Vafaei S, 2019, LANCET
   van der Lans AAJJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12394
   Vanmassenhove J, 2017, LANCET, V389, P2139, DOI 10.1016/S0140-6736(17)31329-6
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Rosa SGV, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.40
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang JT, 2004, EMERG INFECT DIS, V10, P818, DOI 10.3201/eid1005.030640
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Wang Yaning, 2004, Angiogenesis, V7, P335, DOI 10.1007/s10456-004-8272-2
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Wei B, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0372-2020
   Wei G.W., 2020, POTENTIALLY HIGHLY P
   Widjaja I, 2019, EMERG MICROBES INFEC, V8, P516, DOI [10.1080/22221751.2019.1597644, 10.6084/m9.figshare.7937462.v3]
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x
   Wong PF, 2020, CLIN MED, V20, P293, DOI 10.7861/clinmed.2020-0182
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001
   Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008
   Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044
   Wu YH, 2021, IEEE T IMAGE PROCESS, V30, P3113, DOI 10.1109/TIP.2021.3058783
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiang, 2020, POTENTIAL BIOCH MARK
   Xiao SY, 2020, J MED VIROL, V92, P464, DOI 10.1002/jmv.25702
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yan, 2020, SPECIFIC ACE2 EXPRES, DOI 10.1101/2020.02.03.931766
   Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463
   Yao TT, 2020, J MED VIROL, V92, P556, DOI 10.1002/jmv.25729
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yeager, 2020, SCIENTIST
   Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zhang JN, 2020, LANCET RESP MED, V8, pE11, DOI 10.1016/S2213-2600(20)30071-0
   Zhang L, 2020, Zhonghua Fu Chan Ke Za Zhi, V55, P166, DOI 10.3760/cma.j.cn112141-20200218-00111
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zhang ZC, 2020, J MED VIROL, V92, P2631, DOI 10.1002/jmv.26141
   Zhao H, 2020, LANCET NEUROL, V19, P383, DOI 10.1016/S1474-4422(20)30109-5
   Zhao K., 2020, ACUTE MYELITIS SARS, DOI 10.1101/2020.03.16.20035105
   Zhao Yu, 2020, American Journal of Respiratory and Critical Care Medicine, V202, P756, DOI 10.1164/rccm.202001-0179LE
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou L, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE003, DOI 10.3760/cma.j.issn.1001-0939.2020.0003
   ZHOU P, 2020, NATURE          0203, pNIL1, DOI DOI 10.1038/s41586-020-2012-7
   ZHOU P, 2020, DISCOVERY NOVEL CORO
   Zhu Huaping, 2020, Transl Pediatr, V9, P51, DOI 10.21037/tp.2020.02.06
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zhu YF, 2021, STAT BIOSCI, V13, P1, DOI 10.1007/s12561-020-09277-0
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
NR 236
TC 1
Z9 1
U1 3
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1871-5206
EI 1875-5992
J9 ANTI-CANCER AGENT ME
JI Anti-Cancer Agents Med. Chem.
PY 2021
VL 21
IS 16
BP 2142
EP 2162
DI 10.2174/1871520621666210201101245
PG 21
WC Oncology; Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pharmacology & Pharmacy
GA WQ3MH
UT WOS:000713723100005
PM 33563186
DA 2022-04-20
ER

PT J
AU Ejeh, FE
   Saidu, AS
   Owoicho, S
   Maurice, NA
   Jauro, S
   Madukaji, L
   Okon, KO
AF Ejeh, Francis Enenche
   Saidu, Adamu Saleh
   Owoicho, Samuel
   Maurice, Nanven Abraham
   Jauro, Solomon
   Madukaji, Laura
   Okon, Kenneth O.
TI Knowledge, attitude, and practice among healthcare workers towards
   COVID-19 outbreak in Nigeria
SO HELIYON
LA English
DT Article
DE Clinical research; Epidemiology; Infectious disease; Microbiology;
   Public health; Health profession; Virology; COVID-19; KAPs; Nigeria;
   Pandemic; Risk-factors; SARS-CoV-2
ID VIRUS
AB Background: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection is a global pandemic. Healthcare workers' (HCWs) role in patient management is predisposing and can serve as means of hospitals and community transmission. This study evaluated HCWs' knowledge, attitude, and practice towards COVID-19 in Nigeria.
   Methods: we carried out a cross-sectional survey among HCWs during the COVID-19 outbreak in Nigeria from March to June 2020. The study assessed 346 HCWs for Knowledge, attitude, and practice by using an online (Google form) self-administered questionnaire, based on a convinience sampling technique Data were retrieved and analyzed using descriptive statistics. Chi-Square and one-way ANOVA were used to measure association and difference among demographic variables. The relationship between knowledge, attitude, and practice was measured using Spearman's rho correlation test.
   Results: the mean knowledge score of the HCWs was 7.1 on a scale of 0-8. The correct overall rate of the knowledge questionnaire was 88.75%. Knowledge was gained mainly from television (35.0%) and social media (35.0%). The mean attitude score on a scale of 0-6 was 5.31 +/- 0.39. Most (92.5%) participants were confident that Nigerian medical scientists would win the war against COVID-19. The majority (92.2%) of the respondents thought that SARS-CoV-2 was not a biological weapon. About 1 out of 5 respondents held that faith healing or prayer is the only cure for COVID-19. A vast majority of the HCWs were taking precautionary measures such as avoiding crowded places (94.2%), washing of hands (96.0%), and the use of personal protective equipment (91.6%) against SARS-CoV-2 infection. Nevertheless, only 3 out of 5 HCWs used a face mask when leaving home. There was a significant (p = 0.046) positive correlation (0.584) between knowledge and attitude.
   Conclusion: our results showed that HCWs in Nigeria had excellent knowledge and possessed a positive attitude and good practice towards COVID-19. However; there were areas where poor knowledge, negative attitudes and unacceptable practices were observed. We recommend continuous public health education of HCWs on SARS-COV-2 infection control and prevention.
C1 [Ejeh, Francis Enenche; Jauro, Solomon] Univ Maiduguri, Fac Vet Med, Dept Vet Microbiol, Med, Maiduguri, Nigeria.
   [Saidu, Adamu Saleh] Univ Maiduguri, Fac Vet Med, Dept Vet Publ Hlth & Prevent Med, Maiduguri, Nigeria.
   [Owoicho, Samuel] Nigerian Field Epidemiol & Lab Training Program, Maiduguri, Nigeria.
   [Maurice, Nanven Abraham] Nigerian Vet Res Inst, Dept Diagnost & Extens, Vom, Nigeria.
   [Madukaji, Laura] APIN Publ Hlth, Dept TB HIV, Abuja, Nigeria.
   [Okon, Kenneth O.] Fed Med Ctr, Dept Med Microbiol, Makurdi, Nigeria.
RP Ejeh, FE (corresponding author), Univ Maiduguri, Fac Vet Med, Dept Vet Microbiol, Med, Maiduguri, Nigeria.
EM enenchefrancis@yahoo.com
OI Ejeh, Francis, Eneneche/0000-0002-2586-3588
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   AfrCDC, 2020, AFR CDC GUID ASS MON
   Agulanna C., 2010, LUMINA, V21, P1
   Al-Hanawi MK, 2020, RISK MANAG HEALTHC P, V13, P733, DOI 10.2147/RMHP.S264037
   Althaus CL, 2015, EPIDEMICS-NETH, V11, P80, DOI 10.1016/j.epidem.2015.03.001
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bowale A, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.2020.35.2.23262, 10.11604/pamj.supp.2020.35.2.23262]
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Dilucca M., 2020, BIORXIV
   Fani M, 2020, FUTURE VIROL, V15, P317, DOI 10.2217/fvl-2020-0050
   FAO, 2020, FAO AMPL CAMP POT RE
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918
   Homoud AHA, 2014, J INFECT PUBLIC HEAL, V7, P257, DOI 10.1016/j.jiph.2013.08.004
   Kannan S, 2020, EUR REV MED PHARMACO, V24, P2006, DOI 10.26355/eurrev_202002_20378
   Khan M.U., 2014, BMC PUBL HLTH
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   National Center for Immunization and Respiratory Diseases Division of Viral Diseases, 2020, INT INF PREV CONTR R
   NCDC, 2020, COVID 19 UPD
   Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848
   Neumayer E, 2007, ANN ASSOC AM GEOGR, V97, P551, DOI 10.1111/j.1467-8306.2007.00563.x
   Oladokun A.T., 2012, Pan Afr. Med. J.
   Oladokun AT, 2012, PAN AFR MED J, V13
   Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223
   Ramakrishnan D., 2020, INDIAN J COMMUNITY H, V78, P7828
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Tian S., 2020, J. Infect.
   Umberson D., 2014, J HLTH SOC BEHAV
   Wang HH, 2020, EUR J CLIN MICROBIOL, V39, P1629, DOI 10.1007/s10096-020-03899-4
   WHO, 2020, ADV US MASKS COMM HO
   WHO, 2014, WHO DECL END EB OUTB
   WHO, 2020, Q A COR COVID 19
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Wolf M.S., 2020, ANN INTERN MED
   Worldometer, 2020, COVID 19 UPD
   Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270
   Zhang YZ, 2020, CELL, V181, P223, DOI 10.1016/j.cell.2020.03.035
NR 42
TC 21
Z9 21
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
EI 2405-8440
J9 HELIYON
JI Heliyon
PD NOV
PY 2020
VL 6
IS 11
AR e05557
DI 10.1016/j.heliyon.2020.e05557
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA SA6BZ
UT WOS:000649388700126
PM 33230488
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Rao, KD
   Kaur, J
   Peters, MA
   Kumar, N
   Nanda, P
AF Rao, Krishna D.
   Kaur, Japneet
   Peters, Michael A.
   Kumar, Navneet
   Nanda, Priya
TI Pandemic response in pluralistic health systems: a cross-sectional study
   of COVID-19 knowledge and practices among informal and formal primary
   care providers in Bihar, India
SO BMJ OPEN
LA English
DT Article
DE COVID-19; primary care; quality in health care
ID ACUTE RESPIRATORY SYNDROME; CHILDHOOD DIARRHEA; PHYSICIANS; QUALITY;
   PNEUMONIA; ATTITUDE
AB Objectives
   Responding to pandemics is challenging in pluralistic health systems. This study assesses COVID-19 knowledge and case management of informal providers (IPs), trained practitioners of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH) and Bachelor of Medicine, Bachelor of Surgery (MBBS) medical doctors providing primary care services in rural Bihar, India.
   Design
   This was a cross-sectional study of primary care providers conducted via telephone between 1 and 15 July 2020.
   Setting
   Primary care providers from 224 villages in 34 districts across Bihar, India.
   Participants
   452 IPs, 57 AYUSH practitioners and 38 doctors (including 23 government doctors) were interviewed from a census of 1138 primary care providers used by community members that could be reached by telephone.
   Primary outcome measure(s)
   Providers were interviewed using a structured questionnaire with choice-based answers to gather information on (1) change in patient care seeking, (2) source of COVID-19 information, (3) knowledge on COVID-19 spread, symptoms and methods for prevention and (4) clinical management of COVID-19.
   Results
   During the early days of the COVID-19 pandemic, 72% of providers reported a decrease in patient visits. Most IPs and other private primary care providers reported receiving no COVID-19 related engagement with government or civil society agencies. For them, the principal source of COVID-19 information was television and newspapers. IPs had reasonably good knowledge of typical COVID-19 symptoms and prevention, and at levels similar to doctors. However, there was low stated compliance among IPs (16%) and qualified primary care providers (15% of MBBS doctors and 12% of AYUSH practitioners) with all WHO recommended management practices for suspect COVID-19 cases. Nearly half of IPs and other providers intended to treat COVID-19 suspects without referral.
   Conclusions
   Poor management practices of COVID-19 suspects by rural primary care providers weakens government pandemic control efforts. Government action of providing information to IPs, as well as engaging them in contact tracing or public health messaging can strengthen pandemic control efforts.
C1 [Rao, Krishna D.; Kaur, Japneet; Peters, Michael A.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21218 USA.
   [Kumar, Navneet] Oxford Policy Management, Patna, Bihar, India.
   [Nanda, Priya] Bill & Melinda Gates Fdn India, Delhi, India.
RP Rao, KD (corresponding author), Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21218 USA.
EM kdrao@jhu.edu
OI Rao, Krishna/0000-0001-9347-3648
FU Bill and Melinda Gates Foundation, Delhi [OPP119434]
FX Bill and Melinda Gates Foundation, Delhi. Grant #OPP119434. One of the
   authors (PN) is employed by the funder.
CR Al-Amri S, 2019, J FAM MED PRIM CARE, V8, P455, DOI 10.4103/jfmpc.jfmpc_336_18
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   Anand G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220316
   Asaad A, 2020, E MEDITERR HEALTH J, V26, P435, DOI 10.26719/emhj.19.079
   Bener A, 2004, J R SOC PROMO HEALTH, V124, P167, DOI 10.1177/146642400412400408
   Bloom G., 2001, PLURALISM MARKETISAT
   Das Jishnu, 2020, Soc Sci Med, P112799, DOI 10.1016/j.socscimed.2020.112799
   Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356
   Deng JF, 2006, PUBLIC HEALTH, V120, P15, DOI 10.1016/j.puhe.2005.10.001
   Gautham M., 2020, BMJ OPINION
   Gautham M, 2014, HEALTH POLICY PLANN, V29, pI20, DOI 10.1093/heapol/czt050
   Golechha M, 2020, J URBAN HEALTH, V97, P796, DOI 10.1007/s11524-020-00474-2
   Government of India Ministry of Statistics & Programme Implementation and National Statistical Office, 2018, HLTH IND NAT SAMPL S
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Karan A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025979
   Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Kochuparambil J., 2020, J PATIENT SAF INFECT, V8, P17
   Kotian RP, 2020, HEALTH TECHNOL-GER, V10, P1415, DOI 10.1007/s12553-020-00437-2
   Kumar A., 2020, ECON POLIT WEEKLY
   Leonard KL, 2005, SOC SCI MED, V61, P1944, DOI 10.1016/j.socscimed.2005.03.043
   Meessen B, 2011, HEALTH POLICY PLANN, V26, pi30, DOI 10.1093/heapol/czr026
   Mehrotra K., 2020, MONTH COVID HITS MOR
   Mehrotra Sameer, 2021, Med J Armed Forces India, V77, pS437, DOI 10.1016/j.mjafi.2020.07.001
   Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2
   Ministry of Health and Family Welfare, NAT CLIN MAN PROT CO
   Mohanan M, 2016, HEALTH AFFAIR, V35, P1800, DOI 10.1377/hlthaff.2016.0481
   Mohanan M, 2015, JAMA PEDIATR, V169, P349, DOI 10.1001/jamapediatrics.2014.3445
   Office of the Registrar General and Census Commissioner of India, 2011, CENSUS INDIA
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Priya R, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00239
   Puspitasari IM, 2020, J MULTIDISCIP HEALTH, V13, P727, DOI 10.2147/JMDH.S265527
   Rao Krishna D, 2016, WHO South East Asia J Public Health, V5, P133, DOI 10.4103/2224-3151.206250
   StataCorp, 2016, STAT STAT SOFTW REL
   Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978
   Tice AD, 2006, PREHOSP DISASTER MED, V21, P183, DOI 10.1017/S1049023X00003654
   United States Census Bureau, 2020, CS PRO
   World Health Organization, CLIN MAN COVID 19
NR 38
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD APR
PY 2021
VL 11
IS 4
AR e047334
DI 10.1136/bmjopen-2020-047334
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA ZM0NI
UT WOS:000764063100002
PM 33931411
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Mukaetova-Ladinska, EB
   Kronenberg, G
   Raha-Chowdhury, R
AF Mukaetova-Ladinska, Elizabeta B.
   Kronenberg, Golo
   Raha-Chowdhury, Ruma
TI COVID-19 and neurocognitive disorders
SO CURRENT OPINION IN PSYCHIATRY
LA English
DT Review
DE COVID-19 neurocognitive disorders; inflammation; neurotransmitter;
   stress; viral infection
ID CYTOKINE STORM; RISK-FACTOR; DEMENTIA; ACTIVATION; DELIRIUM; VIRUS;
   PATHOGENESIS; STIMULATION; INFECTIONS; DEPRESSION
AB Purpose of review The COVID-19 infection results in various viral-related physical and mental health problems, joined with the long-term psychological impact of the pandemic in general. However, the accompanying neurocognitive changes remain poorly understood. Recent findings We synthetize the current knowledge of viral (SARS-CoV-2) induced inflammation, mechanisms to viral entry into the central nervous system and altered neurotransmitter systems to provide an informed neurobiological explanation for the rise of neurocognitive disorders (defined as per the DSM-5 criteria). The mild and major neurocognitive disorder symptoms due to the COVID-19 pandemic provide a unique opportunity to address the early changes underlying neurocognitive impairment at both clinical and molecular level. We discuss the utilization of the available evidence for their management and future novel therapeutic opportunities.
C1 [Mukaetova-Ladinska, Elizabeta B.] Univ Leicester, Dept Neurosci Psychol & Behav, Leicester LE1 7RH, Leics, England.
   [Mukaetova-Ladinska, Elizabeta B.] Leicestershire Partnership NHS Trust, Evington Ctr, Leicester, Leics, England.
   [Kronenberg, Golo] Univ Leicester, Coll Life Sci, Leicester, Leics, England.
   [Kronenberg, Golo] Leicestershire Partnership NHS Trust, Leicester, Leics, England.
   [Raha-Chowdhury, Ruma] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England.
RP Mukaetova-Ladinska, EB (corresponding author), Univ Leicester, Dept Neurosci Psychol & Behav, Leicester LE1 7RH, Leics, England.
EM eml12@le.ac.uk
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]
   American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders, V3d
   Basova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199861
   Bersano E, 2018, AMYOTROPH LAT SCL FR, V19, P463, DOI 10.1080/21678421.2018.1440405
   Bohmwald K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00386
   Bonaz Bruno, 2020, Bioelectron Med, V6, P15, DOI 10.1186/s42234-020-00051-7
   Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2
   Brundin P, 2020, TRENDS NEUROSCI, V43, P931, DOI 10.1016/j.tins.2020.10.009
   Chiu A, 2021, NEURORADIOLOGY, V63, P147, DOI 10.1007/s00234-020-02554-1
   Cosco TD, 2019, MOL NEUROBIOL, V56, P4751, DOI 10.1007/s12035-018-1409-x
   de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229
   Dobbs MR, 2011, SEMIN NEUROL, V31, P184, DOI 10.1055/s-0031-1277989
   Frileux S, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00554
   Frydman I, 2010, COGN BEHAV NEUROL, V23, P205, DOI 10.1097/WNN.0b013e3181e61ce0
   Gao LL, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0066-0
   Gunak MM, 2020, BRIT J PSYCHIAT, V217, P600, DOI 10.1192/bjp.2020.150
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Johnson RL, 2018, J INFLAMM RES, V11, P203, DOI 10.2147/JIR.S163248
   Kalaria RN, 2012, BRAIN, V135, P2582, DOI 10.1093/brain/aws235
   Karaguzel EO, 2019, COMPR PSYCHIAT, V89, P61, DOI 10.1016/j.comppsych.2018.11.013
   Karnik NS, 2006, NEUROCASE, V12, P332, DOI 10.1080/13554790601125957
   Khalefah MM, 2020, J TAIBAH UNIV MED SC, V15, P550, DOI 10.1016/j.jtumed.2020.10.006
   Khiari HM, 2011, NEUROL SCI, V32, P959, DOI 10.1007/s10072-011-0480-0
   Klein RS, 2017, NAT IMMUNOL, V18, P132, DOI 10.1038/ni.3656
   Kohler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kroker KS, 2013, BRAIN RES BULL, V96, P28, DOI 10.1016/j.brainresbull.2013.04.006
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Li Y, 2004, J VIROL, V78, P3398, DOI 10.1128/JVI.78.7.3398-3406.2004
   Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6
   MacLullich AMJ, 2011, AGE AGEING, V40, P412, DOI 10.1093/ageing/afr062
   Madrigal JLM, 2002, NEUROPSYCHOPHARMACOL, V26, P155, DOI 10.1016/S0893-133X(01)00292-5
   Maloley PM, 2019, SEMIN ARTHRITIS RHEU, V49, P229, DOI 10.1016/j.semarthrit.2019.02.002
   Marazziti D, 2015, INT J INTERFERO CYTO, V7, P35, DOI [10.2147/IJICMR.S76710, DOI 10.2147/IJICMR.S76710, 10.2147/ijicmr.s76710]
   Mashimo M, 2020, INT IMMUNOPHARMACOL, V82, DOI 10.1016/j.intimp.2020.106306
   Matias-Guiu JA, 2020, J ALZHEIMERS DIS, V78, P537, DOI 10.3233/JAD-200940
   Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2
   Matteoli G, 2014, GUT, V63, P938, DOI 10.1136/gutjnl-2013-304676
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mori I, 2015, ACTA VIROL, V59, P338, DOI 10.4149/av_2015_04_338
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Mukaetova-Ladinska EB, 2021, EUR ARCH PSY CLIN N, V271, P235, DOI 10.1007/s00406-020-01210-2
   Oh ES, 2017, JAMA-J AM MED ASSOC, V318, P1161, DOI 10.1001/jama.2017.12067
   Parsons Nicholas, 2020, medRxiv, DOI 10.1101/2020.10.21.20215640
   Pavlov VA, 2008, INT J CLIN EXP MED, V1, P203
   Penny CJ, 2019, BBA-MOL CELL RES, V1866, P1151, DOI 10.1016/j.bbamcr.2018.10.022
   Politi LS, 2020, JAMA NEUROL, V77, P1028, DOI 10.1001/jamaneurol.2020.2125
   Raha AA, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20203092
   Reid RT, 2003, J ALZHEIMERS DIS, V5, P429, DOI 10.3233/JAD-2003-5602
   Ritchie K, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa069
   Sadigh-Eteghad S, 2015, ACTA CIR BRAS, V30, P736, DOI 10.1590/S0102-865020150110000003
   Salluh JIF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2538
   Simanjuntak Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00651
   Sundermann EE., 2020, AIDS
   Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009
   Taquet M., 2020, LANCET PSYCHIAT
   Tavassoly O, 2020, ACS CHEM NEUROSCI, V11, P3704, DOI 10.1021/acschemneuro.0c00676
   van Eijk MMJ, 2010, LANCET, V376, P1829, DOI 10.1016/S0140-6736(10)61855-7
   Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339
   Woodward M, 2010, EUR GERIATR MED, V1, P259, DOI 10.1016/j.eurger.2010.07.012
   Wright EJ, 2008, NEUROL CLIN, V26, P617, DOI 10.1016/j.ncl.2008.03.006
   Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
   Yan CH, 2020, INT FORUM ALLERGY RH, V10, P806, DOI 10.1002/alr.22579
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Younes L, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00074
   Zhang L, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0693-1
NR 66
TC 4
Z9 5
U1 6
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7367
EI 1473-6578
J9 CURR OPIN PSYCHIATR
JI Curr. Opin. Psychiatr.
PD MAR
PY 2021
VL 34
IS 2
BP 149
EP 156
DI 10.1097/YCO.0000000000000687
PG 8
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA ST1ZN
UT WOS:000662249600012
PM 33395101
OA Green Published
DA 2022-04-20
ER

PT J
AU Ndiaye, M
   Diatta, AER
AF Ndiaye, M.
   Diatta, A. E. R.
TI Screening procedure for COVID-19 infection in African structured
   workplace
SO ARCHIVES DES MALADIES PROFESSIONNELLES ET DE L ENVIRONNEMENT
LA French
DT Article
DE Management; COVID-19 disease; Format economy; Sub-Saharan Africa
AB Though there are no specific guidelines in Sub-Saharan Africa, the aim is to suggest to health practitioners, a simple screening tool of COVID-19 cases in the formal workforce in the region. Indeed the COVID-19 response in the formal African workplace should clearly be integrated into the national system and should include: the setting up, in each company, of a response management unit that works in collaboration with the occupational health and safety committee; awareness-raising and training of social partners on aspects relating to knowledge of the disease and prevention measures; implementation of a procedure for screening and handling cases detected; evaluation and monitoring of the psychosociat and economic impact of the disease.
C1 [Ndiaye, M.; Diatta, A. E. R.] UCAD, FMPO, Serv Med Travail & Med Legale, Dakar, Senegal.
RP Ndiaye, M (corresponding author), UCAD, FMPO, Serv Med Travail & Med Legale, Dakar, Senegal.
EM drmorndiaye@yahoo.fr
CR [Anonymous], 2020, REPORT WHO CHINA JOI
   [Anonymous], 2020, LANCET
   Makurumidze R., 2020, J MICROBIOL IMMUNOL, DOI [10.1016/jJmiL2020.04JJ02, DOI 10.1016/JJMIL2020.04JJ02]
   Nicola M, 2020, INT J SURG, V77, P206, DOI 10.1016/j.ijsu.2020.04.001
   Nikayin F, 2014, TECHNOL FORECAST SOC, V89, P326, DOI 10.1016/j.techfore.2014.08.003
   Societe francaise de medecine du travail, 2020, ARCH MAL PROF ENVIRO, DOI [10.1016/j.admp.2020.04.00, DOI 10.1016/J.ADMP.2020.04.00]
   Societe francaise de medecine du travail Service de sante au travail d 'etablissements de sante, 2020, SOC FRANCAISE MED TR, DOI [10.1016/j.admp.2020.03.834, DOI 10.1016/J.ADMP.2020.03.834]
NR 7
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1775-8785
EI 1778-4190
J9 ARCH MAL PROF ENVIRO
JI Arch. Mal. Prof. Environ.
PD AUG
PY 2020
VL 81
IS 4
BP 337
EP 340
DI 10.1016/j.admp.2020.05.007
PG 4
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA NK4GC
UT WOS:000566689600007
OA Bronze
DA 2022-04-20
ER

PT J
AU Jackson, J
   Nowell, L
AF Jackson, Jennifer
   Nowell, Lorelli
TI 'The office of disaster management' nurse managers' experiences during
   COVID-19: A qualitative interview study using thematic analysis
SO JOURNAL OF NURSING MANAGEMENT
LA English
DT Article
DE COVID-19; interviews; nursing leadership; practice management;
   qualitative research; thematic analysis
ID DECISION-MAKING
AB Aim: The purpose of this study was to understand the experiences of nurse managers during the COVID-19 pandemic.
   Background: There is a growing body of knowledge about the experiences of clinical nurses during COVID-19. However, there is less evidence about the experiences of nurse managers during the pandemic.
   Methods: Eight nurse managers, from acute care and outpatient settings, completed semistructured interviews about how their roles had changed during the pandemic, how they felt about these changes, and what had gone well or been difficult. Each participant was interviewed once, for 20-60 min. We used thematic analysis methods to analyse the interview transcripts.
   Findings: Nurse managers had to coordinate care in a context of uncertainty and guidance that changed frequently. Participants found that their roles and responsibilities either expanded to include more duties, or they were asked to take on a completely new role, with no orientation or training. Nurse managers were expected to provide support to their staff and patients, but did not necessarily receive support themselves. Participants were expected to plan simultaneously for care during the pandemic and for a return to normal working conditions. These factors contributed to challenging and difficult participant experiences of managing during COVID-19.
   Conclusion: Nurse managers' experiences during COVID-19 are influenced by changes to their roles and the support they received. Nurse managers continue to support high-quality care despite working a difficult context.
   Implications for nursing management: Where possible, nurse managers can be supported to extend their roles or receive additional education and support if they are required to take on new responsibilities. Nurse managers require support in order to be a resource for their staff.
C1 [Jackson, Jennifer; Nowell, Lorelli] Univ Calgary, Fac Nursing, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
RP Jackson, J (corresponding author), Univ Calgary, Fac Nursing, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
EM jennifer.jackson1@ucalgary.ca
OI Nowell, Lorelli/0000-0002-5401-4462; Jackson,
   Jennifer/0000-0001-9401-761X
FU University of Calgary
FX University of Calgary
CR Allen D, 2015, ROUT ADV HEALT, P1
   Anderson JE, 2015, SAFETY SCI, V80, P105, DOI 10.1016/j.ssci.2015.07.012
   Arcadi P, 2021, J NURS MANAGE, V29, P1111, DOI 10.1111/jonm.13249
   Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806
   Chen HJ, 2020, J CLIN NURS, V29, P4161, DOI 10.1111/jocn.15444
   Ellemers N., 2014, POLICY INSIGHTS BEHA, V1, P46, DOI [DOI 10.1177/2372732214549327, 10.1177/2372732214549327]
   Guba EG, 1994, HDB QUALITATIVE RES, P105
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   Huang LS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2841-7
   Janghorban R, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.24152
   Labrague LJ, 2018, INT NURS REV, V65, P41, DOI 10.1111/inr.12369
   Labrague LJ, 2020, J NURS MANAGE, V28, P1653, DOI 10.1111/jonm.13121
   Lake ET, 2006, NURS RES, V55, P1, DOI 10.1097/00006199-200601000-00001
   Lau PY, 2005, J CLIN NURS, V14, P28, DOI 10.1111/j.1365-2702.2004.00995.x
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Lo Iacono V, 2016, SOCIOL RES ONLINE, V21, DOI 10.5153/sro.3952
   McCallin AM, 2010, J NURS MANAGE, V18, P319, DOI 10.1111/j.1365-2834.2010.01067.x
   McMillan K, 2020, NURS INQ, V27, DOI 10.1111/nin.12345
   Mo YY, 2020, J NURS MANAGE, V28, P1002, DOI 10.1111/jonm.13014
   Morse J.M., 1995, NURSING RES APPL QUA
   Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501
   Murphy J F, 1970, Nurs Forum, V9, P380, DOI 10.1111/j.1744-6198.1970.tb01049.x
   Nowell L., 2020, NURS OPEN
   Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847
   Oates J, 2015, NURSE RES, V22, P13, DOI 10.7748/nr.22.4.13.e1318
   Palinkas LawrenceA., 2015, ADM POLICY MENT HLTH, V42, P533, DOI [10.1007/s10488-013-0528-y, DOI 10.1007/s10488-013-0528-y]
   Rafferty A.M., 2005, WHAT MAKES GOOD EMPL
   Retzlaff KJ, 2020, ASSOC OPER ROOM NURS, V112, P197, DOI 10.1002/aorn.13149
   Shirey MR, 2013, J NURS MANAGE, V21, P17, DOI 10.1111/j.1365-2834.2012.01380.x
   Siirala E, 2016, J NURS MANAGE, V24, P806, DOI 10.1111/jonm.12385
   Spiers J., 2002, INT J QUAL METH, V1, P13, DOI [10.1177/160940690200100202, DOI 10.1177/160940690200100202]
   Sujan M, 2015, RELIAB ENG SYST SAFE, V144, P45, DOI 10.1016/j.ress.2015.07.011
   Tan R, 2020, J NURS MANAGE, V28, P1381, DOI 10.1111/jonm.13095
   Traynor M., 2017, CRITICAL RESILIENCE, DOI [10.4324/9781315638928, DOI 10.4324/9781315638928]
   Weaver K, 2006, J ADV NURS, V53, P459, DOI 10.1111/j.1365-2648.2006.03740.x
   Wu XY, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2918
   Zaghini F, 2020, INT J NURS STUD, V101, DOI 10.1016/j.ijnurstu.2019.103446
NR 37
TC 0
Z9 0
U1 7
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0966-0429
EI 1365-2834
J9 J NURS MANAGE
JI J. Nurs. Manag.
PD NOV
PY 2021
VL 29
IS 8
BP 2392
EP 2400
DI 10.1111/jonm.13422
EA AUG 2021
PG 9
WC Management; Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Business & Economics; Nursing
GA WR2JZ
UT WOS:000684414800001
PM 34270140
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Wen, J
   Hou, HF
   Kozak, M
   Meng, F
   Yu, CE
   Wang, W
AF Wen, Jun
   Hou, Haifeng
   Kozak, Metin
   Meng, Fang
   Yu, Chung-En
   Wang, Wei
TI The missing link between medical science knowledge and public awareness:
   implications for tourism and hospitality recovery after COVID-19
SO EUROPEAN JOURNAL OF MANAGEMENT AND BUSINESS ECONOMICS
LA English
DT Article
DE Coronavirus; COVID-19; Interdisciplinary research; Tourism recovery;
   Medical science; Social science; Public health crisis
ID CORONAVIRUS
AB Purpose - As the world grapples with the pervasive effects of the coronavirus pandemic, a notable disconnect has emerged in the public's understanding of scientific and medical research. Particularly, the travel industry has become unquestionably vulnerable amid the COVID-19 outbreak; this pandemic has interrupted the industry's operations with devastating economic consequences. This paper aims to highlight the importance of deconstructing barriers between medical science and public awareness related to COVID-19, taking tourism as a case in point. It also discusses the role of interdisciplinary research in facilitating the tourism and hospitality industry's recovery and alleviating tourists' uncertainties in the wake of COVID-19.
   Design/methodology/approach - This paper offers a synthesis of news coverage from several media outlets, framed within the literature on knowledge transformation across disciplines. This framing focuses on the medical sciences (e.g. public health) and social sciences (e.g. tourism management) to identify gaps between medical scientific knowledge and public awareness in the context of COVID-19. The authors' experience in public health and tourism management further demonstrates a missing link between academic research and the information made available in public health and everyday settings. Apotential research agenda is proposed accordingly.
   Findings - This paper summarizes how salient issues related to knowledge transfer can become intensified during a global pandemic, such as medical research not being communicated in plain language, which leads some citizens to feel apathetic about findings. Reporting on the prevalence and anticipated consequences of disease outbreaks can hence be difficult, especially early in the development of diseases such as COVID-19.
   Research limitations/implications - By assuming a cross-disciplinary perspective on medical/health and social science research, this paper encourages academic and practical collaboration to bring medical research to the masses. This paper also outlines several research directions to promote public health, safety and sustainability through tourism.
   Practical implications - This paper highlights that it is essential for medical knowledge to be disseminated in a manner that promotes public understanding. The tourism and hospitality industry can benefit from an essential understanding of medical findings, particularly during this pandemic. Without a firm grasp on COVID-19's origins and treatment, the tourism and hospitality industry will likely struggle to recover from this catastrophe.
   Social implications - Taking COVID-19 as a case in point, this study advocates leveraging the strengths of disparate domains to bring medical findings to a wider audience and showcase cutting-edge developments for the greater good. This study also emphasizes the importance of engaging the general public in reputable scientific research findings to increase public awareness in a professional and accurate manner.
   Originality/value - This paper presents a unique and critical discussion of the gap between medical science knowledge and public awareness, as well as its implications for tourism and hospitality recovery after COVID-19, with a focus on applying medical scientific knowledge to post-pandemic industry recovery.
C1 [Wen, Jun] Edith Cowan Univ, Sch Business & Law, Joondalup, Australia.
   [Hou, Haifeng] Shandong First Med Univ, Sch Publ Hlth, Tai An, Shandong, Peoples R China.
   [Kozak, Metin] Dokuz Eylul Univ, Sch Tourism, Izmir, Turkey.
   [Meng, Fang] Univ South Carolina, Sch Hotel Restaurant & Tourism Management, Columbia, SC 29208 USA.
   [Yu, Chung-En] Salzburg Univ Appl Sci, Dept Innovat & Management Tourism, Salzburg, Austria.
   [Wang, Wei] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, Australia.
RP Kozak, M (corresponding author), Dokuz Eylul Univ, Sch Tourism, Izmir, Turkey.
EM metin.kozak@deu.edu.tr
RI Yu, Joanne/P-1427-2019; Kozak, Metin/H-8361-2019; Wen, Jun/AAC-3537-2019
OI Yu, Joanne/0000-0001-7605-6367; Kozak, Metin/0000-0002-9866-7529; Wen,
   Jun/0000-0002-1110-824X; wen, Jun/0000-0002-7544-1076
CR Brownell Sara E, 2013, J Undergrad Neurosci Educ, V12, pE6
   Brussow H, 2020, MICROB BIOTECHNOL, V13, P607, DOI 10.1111/1751-7915.13557
   Carbone EG, 2018, AM J PUBLIC HEALTH, V108, pS383, DOI [10.2105/ajph.2018.304702, 10.2105/AJPH.2018.304702]
   Chen N, 2019, J TRAVEL RES, V58, P916, DOI 10.1177/0047287518794331
   Crouch GI, 2015, J TRAVEL RES, V54, P563, DOI 10.1177/0047287514559036
   Dass M., 2020, TRAVEL TOURISM GLOBA
   Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031
   Duvat VKE, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.478
   Ferguson C., 2021, CONVERSATION
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   Fu YC, 2020, INT J SOCIOL, V50, P434, DOI 10.1080/00207659.2020.1786636
   Ghinea N, 2020, J EVAL CLIN PRACT, V26, P447, DOI 10.1111/jep.13273
   Glasziou P, 2018, J ROY SOC MED, V111, P292, DOI 10.1177/0141076818788819
   HAYNES RB, 1991, ACP J CLUB, V114, pA18
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Ioannidis JPA, 2016, J CLIN EPIDEMIOL, V73, P82, DOI 10.1016/j.jclinepi.2016.02.012
   Jamal T, 2021, J SUSTAIN TOUR, V29, P143, DOI 10.1080/09669582.2020.1835933
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Jin X, 2017, TOURISM MANAGE, V59, P205, DOI 10.1016/j.tourman.2016.08.007
   Kozak M, 2016, J TOUR HIST, V8, P275, DOI 10.1080/1755182X.2017.1284274
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Leslie T., 2020, ABC NEWS
   Li N, 2019, ATMOS POLLUT RES, V10, P1823, DOI 10.1016/j.apr.2019.07.014
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125
   Mao CK, 2010, TOURISM MANAGE, V31, P855, DOI 10.1016/j.tourman.2009.09.003
   Misra S, 2020, PSYCHOL TRAUMA-US, V12, P461, DOI 10.1037/tra0000821
   National Academies of Sciences Engineering and Medicine, 2017, COMM SCI EFF RES AG
   Canh NP, 2020, ANN TOURISM RES, V85, DOI 10.1016/j.annals.2020.103063
   Oliver K, 2017, PALGR COMMUN, V3, DOI 10.1057/s41599-017-0045-9
   Ozili P., 2020, SPILLOVER COVID 19 I, DOI [DOI 10.2139/SSRN.3562570, 10.2139/ssrn.3562570]
   Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Qin E., 2020, CLIN CHARACTERISTICS
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Sackett DL, 1997, SEMIN PERINATOL, V21, P3, DOI 10.1016/S0146-0005(97)80013-4
   Student J, 2020, J SUSTAIN TOUR, V28, P475, DOI 10.1080/09669582.2019.1682593
   University of Cambridge, 2020, COVID 19 GEN NETW AN
   Vahia IV, 2020, AM J GERIAT PSYCHIAT, V28, P695, DOI 10.1016/j.jagp.2020.03.007
   Wen J, 2021, TOUR RECREAT RES, V46, P310, DOI 10.1080/02508281.2020.1761120
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   Wen J, 2020, ANATOLIA, V31, P331, DOI 10.1080/13032917.2020.1730621
   Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao HG, 2006, ANN TOURISM RES, V33, P490, DOI 10.1016/j.annals.2006.01.004
   Xu SQ, 2020, LANCET, V395, P1321, DOI 10.1016/S0140-6736(20)30845-X
   Yang Y, 2020, ANN TOURISM RES, V83, DOI 10.1016/j.annals.2020.102913
   Ying TY, 2021, TOUR RECREAT RES, V46, P304, DOI 10.1080/02508281.2020.1743048
   Zhang Wen, 2005, Current Issues in Tourism, V8, P22, DOI 10.1080/13683500508668203
   Zheng Y, 2020, ANATOLIA, V31, P337, DOI 10.1080/13032917.2020.1747208
NR 52
TC 0
Z9 0
U1 3
U2 3
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2444-8451
EI 2444-8494
J9 EUR J MANAG BUS ECON
JI Eur. J. Manag. Bus. Econ.
PD MAY 31
PY 2021
VL 30
IS 2
BP 230
EP 242
DI 10.1108/EJMBE-11-2020-0329
PG 13
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YY4MH
UT WOS:000754764100006
OA gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Kiren, J
   Geetha, RV
   Sivaswamy, V
AF Kiren, J.
   Geetha, R., V
   Sivaswamy, Vinay
TI Sterilization Protocols Followed by Dentists during Covid-19 Pandemic
   Awareness and Practice Based Survey
SO ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH
LA English
DT Article
DE Sterilization; Dental instruments; Covid-19; Knowledge; Awareness;
   Practitioners
AB Background: Novel Coronavirus 2019 (Covid-19) has become an emerging public health emergency condition and it has created a panic in many countries. Worldwide strict lockdown and social distancing procedures have been followed to prevent the spread of Covid-19 infection. Yet a large number of emergency patients still go to the dental clinics and hospitals for treatment. Dental practitioners use a set of hand instruments to treat patients such as excavators, mouth mirrors, probes etc. It is mandatory for dentists to have knowledge and awareness about diagnosis, precaution and the management of any epidemic infection. Objective: The aim of the study was to assess the knowledge and awareness of instrument sterilization by dental practitioners during Covid-19 pandemic. Materials & Methods: A selfdeveloped questionnaire was developed and distributed among the dental practitioners in Chennai, India. A convenient sampling technique was used for the survey. Data was collected from 100 dental practitioners and analyzed statistically using SPSS software. Results: The findings show that most of the practitioners have good knowledge and are aware of instrument sterilization and different techniques are employed in general before and after the treatment. All the responses were statistically analyzed using SPSS software. Chi-square test was used to find the correlation between parameters (P value>0.05), correlation of age and mode of transmission was done where the P value was 0.120 which is statistically non-significant. Conclusion: The results of the present study show that the knowledge and awareness of instrument sterilization among dental practitioners is adequate during this Covid-19 pandemic.
C1 [Kiren, J.; Geetha, R., V; Sivaswamy, Vinay] Saveetha Inst Med & Tech Sci, Saveetha Dent Coll & Hosp, Dept Microbiol, Chennai, Tamil Nadu, India.
RP Geetha, RV (corresponding author), Saveetha Inst Med & Tech Sci, Saveetha Dent Coll & Hosp, Dept Microbiol, Chennai, Tamil Nadu, India.
EM geetha@saveetha.com
CR Bagg J, 2007, BRIT DENT J, V202, DOI 10.1038/bdj.2007.124
   Chen F, 2019, J PHOTOCH PHOTOBIO B, V197, DOI 10.1016/j.jphotobiol.2019.111518
   Christopher JP, 2018, CLIN IMPLANT DENT R, V20, P531, DOI 10.1111/cid.12609
   Cuny E, 2008, FACILITIES, P5
   Dinesh S, 2019, J POLYM RES, V27, DOI 10.1007/s10965-019-1975-2
   Ezhilarasan D, 2019, J ORAL PATHOL MED, V48, P115, DOI 10.1111/jop.12806
   Fallahi HR, 2020, MAX PLAST RECONSTR S, V42, DOI 10.1186/s40902-020-00256-5
   Girija ASS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01206
   Girija ASS, 2019, J GLOB ANTIMICROB RE, V17, P145, DOI 10.1016/j.jgar.2019.04.001
   Girija ASS, 2019, MED J ISLAM REPUB IR, V33, P11
   Girija SAS, 2018, ACTA MICROBIOL IMM H, V65, P539, DOI 10.1556/030.65.2018.038
   Laneve E, 2019, INT J DENT, V2019, DOI 10.1155/2019/6507286
   MA M, 2019, INT J RES PHARM SCI, V10, P1209, DOI [10.26452/ijrps.v10i2.408, DOI 10.26452/IJRPS.V10I2.408]
   Ma YH, 2019, BIOTECHNOL BIOPROC E, V24, P646, DOI 10.1007/s12257-019-0151-1
   Mahdipour Masoomeh, 2007, J Dent Res Dent Clin Dent Prospects, V1, P103, DOI 10.5681/joddd.2007.018
   Manickam A, 2019, MULTIMED TOOLS APPL, V78, P3065, DOI 10.1007/s11042-018-5633-1
   Marickar RF, 2014, J CLIN PEDIATR DENT, V39, P47, DOI 10.17796/jcpd.39.1.wmw9768314h56666
   Mathew MG, 2020, CLIN ORAL INVEST, V24, P3275, DOI 10.1007/s00784-020-03204-9
   Mehta S, 2017, J INTERDISCIPL MED D, V5, P4, DOI [10.4172/2376-032X.1000222, DOI 10.4172/2376-032X.1000222]
   Murugan MA, 2020, SILICON-NETH, V12, P1847, DOI 10.1007/s12633-019-00297-0
   Np M, 2017, ASIAN J PHARM CLIN R, V10, P3
   Paramasivam A, 2020, HYPERTENS RES, V43, P153, DOI 10.1038/s41440-019-0338-z
   Passi Deepak, 2017, Natl J Maxillofac Surg, V8, P89, DOI 10.4103/njms.NJMS_32_17
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Ponnanikajamideen M, 2019, CAN J DIABETES, V43, P82, DOI 10.1016/j.jcjd.2018.05.006
   Ponnulakshmi R, 2019, TOXICOL MECH METHOD, V29, P276, DOI 10.1080/15376516.2018.1545815
   Pratha AA, 2017, RES J PHARM TECH, V10
   Priyadharsini JV, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e01051
   Priyadharsini JV, 2018, ARCH ORAL BIOL, V94, P93, DOI 10.1016/j.archoralbio.2018.07.001
   Ramadurai N, 2019, CLIN ORAL INVEST, V23, P3543, DOI 10.1007/s00784-018-2775-5
   Ramesh A, 2018, J PERIODONTOL, V89, P1241, DOI 10.1002/JPER.17-0445
   Rani L., 2016, J PHARM SCI RES, V8, P558
   Sachdeva A, 2019, J INDIAN ACAD ORAL M, V31, P4, DOI 10.4103/jiaomr.jiaomr_186_18
   Shahana RY, 2016, RES J PHARM TECH, V9, P1991
   Shahzan MS, 2019, J MYCOL MED, V29, P303, DOI 10.1016/j.mycmed.2019.100899
   Siddiqui HK, 2014, PAK ORAL DENT J, V34, P507
   Smiline ASG, 2018, BRIT J BIOMED SCI, V75, P200, DOI 10.1080/09674845.2018.1492207
   Sridharan G, 2019, J ORAL PATHOL MED, V48, P299, DOI 10.1111/jop.12835
   Subramaniam N, 2019, J INVESTIG CLIN DENT, V10, DOI 10.1111/jicd.12454
   Thanikodi S, 2020, THERM SCI, V24, P575, DOI 10.2298/TSCI190714438T
   Vadivel JK, 2019, J INVESTIG CLIN DENT, V10, DOI 10.1111/jicd.12457
   Vairavel M, 2020, ENVIRON SCI POLLUT R, V27, P8166, DOI 10.1007/s11356-019-07511-x
   Vaishali M, 2018, RES J PHARM TECH RES J PHARM TECHNOLO, V11, P513
   Vijayashree Priyadharsini Jayaseelan, 2019, J Periodontol, V90, P1441, DOI 10.1002/JPER.18-0673
   Wu FL, 2019, ARTIF CELL NANOMED B, V47, P3297, DOI 10.1080/21691401.2019.1647224
NR 45
TC 0
Z9 0
U1 0
U2 0
PU NIGERIAN MEDICAL ASSOC, ENUGU STATE
PI ABUJA
PA 8 BENGHAZI ST, OFF ADDIS ABABA CRES, ABUJA, NIGERIA
SN 2141-9248
EI 2277-9205
J9 ANN MED HEALTH SCI R
JI Ann. Med. Health Sci. Res.
PD MAR
PY 2021
VL 11
SU 1
BP 239
EP 244
PG 6
WC Health Care Sciences & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA TH2OW
UT WOS:000671935200029
DA 2022-04-20
ER

PT J
AU Li, YT
   Liu, GQ
   Egolet, RO
   Yang, RQ
   Huang, YM
   Zheng, ZJ
AF Li, Yutong
   Liu, Guangqi
   Egolet, Robert Okia
   Yang, Runqing
   Huang, Yangmu
   Zheng, Zhijie
TI Knowledge, Attitudes, and Practices Related to COVID-19 Among Malawi
   Adults: A Community-Based Survey
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE KAP; challenge; infodemic; LMIC; COVID-19; Malawi
AB Introduction: It is well-recognized that containing COVID-19 successfully is determined by people's prevention measures which are related to their knowledge, attitudes, and practices (KAP). This perception has attracted attention in low- and middle-income countries (LMIC) due to their fragile health systems and economies. The objective of this study was to understand how residents in Malawi perceived COVID-19, to determine the factors related to KAP. Methods: A semi-structured questionnaire was used for the data collection. A field-based survey was conducted among adult residents in Lilongwe, Malawi. Descriptive statistic, linear regression, the Chi-square test, and Pearson's correlation statistics were used for data analysis. Results: A total of 580 questionnaires were involved. The mean knowledge, attitude, and practice (KAP) scores were 10 (SD = +/- 3, range: 3-19), 16 (SD = +/- 4, range: 5-25), and 2 (SD = +/- 1, range: 0-5), respectively. Lack of money and resources (39%) was the biggest challenge for people who practice prevention measures. Among the participants, the radio (70%) and friends/family (56%) were the main sources of information. A higher economic status was associated with better KAP. Conclusions: A low level of KAP was detected among the population. The people faced challenges regarding a lack of necessary preventive resources and formal information channels. The situation was worse considering vulnerable population who had low economic status. Further all-round health education is urgently needed along with providing adequate health supplies and ensuring proper information management.
C1 [Li, Yutong; Liu, Guangqi; Huang, Yangmu; Zheng, Zhijie] Peking Univ, Sch Publ Hlth, Dept Global Hlth, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.
   [Li, Yutong; Liu, Guangqi; Huang, Yangmu; Zheng, Zhijie] Peking Univ, Inst Global Hlth, Beijing 100191, Peoples R China.
   [Egolet, Robert Okia] Peking Univ, Global Hlth Collaborating Ctr Res & Training Hlth, POB 166,Lilongwe 265, Malawi, Peoples R China.
   [Yang, Runqing] Peking Univ, Univ Town, HSBC Business Sch, Dept Econ, Shenzhen 518055, Peoples R China.
RP Huang, YM (corresponding author), Peking Univ, Sch Publ Hlth, Dept Global Hlth, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.; Huang, YM (corresponding author), Peking Univ, Inst Global Hlth, Beijing 100191, Peoples R China.
EM lyt1997wang@163.com; liugq@pku.edu.cn; egoletroberts@gmail.com;
   runqyang@pku.edu.cn; ymhuang@bjmu.edu.cn; zhengzj@bjmu.edu.cn
OI Liu, Guangqi/0000-0002-1592-771X
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [72042014]; "Double First-Class" Construction
   Program [BMU2020XY010]
FX This study was supported by the National Nature Science Foundation of
   China (No. 72042014) and the "Double First-Class" Construction Program
   (BMU2020XY010).
CR Africa CDC, OUTBR BRIEF 38 COR D
   Al Ahdab S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10353-3
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Alzghoul Bashar I, 2015, Glob J Health Sci, V8, P154, DOI 10.5539/gjhs.v8n6p154
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Banda J, 2021, DEMOGR RES, V44, P459, DOI 10.4054/DemRes.2021.44.20
   Basol Melisa, 2020, J Cogn, V3, P2, DOI 10.5334/joc.91
   Bong CL, 2020, ANESTH ANALG, V131, P86, DOI 10.1213/ANE.0000000000004846
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918
   Hernandez-Garcia I, 2020, JMIR PUBLIC HLTH SUR, V6, P110, DOI 10.2196/18717
   Honarvar B, 2020, INT J PUBLIC HEALTH, V65, P731, DOI 10.1007/s00038-020-01406-2
   Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812
   Kane JC, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1250-8
   Lee K, 2009, GLOB INST, P1
   McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808
   MOH of Malawi, 2015, 2014 15 ANN REV REP
   MOH of Malawi, COVID 19 NAT INF DAS
   Ngwewondo A, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008700
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Okereke M, 2021, AM J TROP MED HYG, V104, P453, DOI 10.4269/ajtmh.20-1488
   Paul A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238492
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Sonenthal PD, 2020, LANCET GLOB HEALTH, V8, pE890, DOI 10.1016/S2214-109X(20)30250-3
   The World Bank, OV MAL
   The World Bank, 2020, P173806 WORLD BANK
   Vieira CM, 2020, MATURITAS, V136, P38, DOI 10.1016/j.maturitas.2020.04.004
   WHO, MUN SEC C
   World Health Organization, TIM WHOS RESP COVID
   World Health Organization, 2016, KNOWLEDGE ATTITUDES
   Yousaf MA, 2020, SOC WORK PUBLIC HLTH, V35, P569, DOI 10.1080/19371918.2020.1806983
   Zar HJ, 2020, PAEDIATR RESPIR REV, V35, P70, DOI 10.1016/j.prrv.2020.06.016
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 34
TC 5
Z9 5
U1 2
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2021
VL 18
IS 8
AR 4090
DI 10.3390/ijerph18084090
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA RS9YV
UT WOS:000644127100001
PM 33924451
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Shemies, RS
   Nagy, E
   Younis, D
   Sheashaa, H
AF Shemies, Rasha Samir
   Nagy, Eman
   Younis, Dalia
   Sheashaa, Hussein
TI Renal replacement therapy for critically ill patients with
   COVID-19-associated acute kidney injury: A review of current knowledge
SO THERAPEUTIC APHERESIS AND DIALYSIS
LA English
DT Review
DE acute kidney injury; COVID-19; critically ill patients; hemodialysis;
   peritoneal dialysis
ID PERITONEAL-DIALYSIS; CLINICAL CHARACTERISTICS; HOSPITALIZED-PATIENTS;
   CORONAVIRUS EPIDEMIC; BLOOD PURIFICATION; SEPTIC PATIENTS; COVID-19;
   MANAGEMENT; WUHAN; PLASMAPHERESIS
AB The outbreak of coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. A significant proportion of COVID-19 patients develops severe symptoms, which may include acute respiratory distress syndrome and acute kidney injury as manifestations of multi-organ failure. Acute kidney injury (AKI) necessitating renal replacement therapy (RRT) is increasingly prevalent among critically ill patients with COVID-19. However, few studies have focused on AKI treated with RRT. Many questions are awaiting answers as regards AKI in the setting of COVID-19; whether patients with COVID-19 commonly develop AKI, what are the underlying pathophysiologic mechanisms? What is the best evidence regarding treatment approaches? Identification of the potential indications and the preferred modalities of RRT in this context, is based mainly on clinical experience. Here, we review the current approaches of RRT, required for management of critically ill patients with COVID-19 complicated by severe AKI as well as the precautions that should be adopted by health care providers in dealing with these cases. Electronic search was conducted in MEDLINE, PubMed, ISI Web of Science, and Scopus scientific databases. We searched the terms relevant to this review to identify the relevant studies. We also searched the conference proceedings and database.
C1 [Shemies, Rasha Samir; Nagy, Eman; Younis, Dalia] Mansoura Univ, Mansoura Nephrol & Dialysis Unit, El Gomhurria St, Mansoura 35516, Egypt.
   [Sheashaa, Hussein] Mansoura Univ, Urol & Nephrol Ctr, Mansoura, Egypt.
RP Shemies, RS (corresponding author), Mansoura Univ, Mansoura Nephrol & Dialysis Unit, El Gomhurria St, Mansoura 35516, Egypt.
EM rashasamirtaha@gmail.com
RI Shemies, Rasha Samir/AAO-2400-2020
OI Shemies, Rasha Samir/0000-0002-0770-8023; madian,
   dalia/0000-0003-1967-1747; Nagy, Eman/0000-0003-3062-2313
CR Adapa Sreedhar, 2020, J Clin Med Res, V12, P276, DOI 10.14740/jocmr4160
   Afaneh C., 2004, WORLD J SURG, V44, P3584
   Al-Hwiesh A, 2018, THER APHER DIAL, V22, P371, DOI 10.1111/1744-9987.12660
   American Society of Nephrology, 2020, REC CAR HOSP PAT COV
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Busund R, 2002, INTENS CARE MED, V28, P1434, DOI 10.1007/s00134-002-1410-7
   Carl DE, 2010, HEMODIAL INT, V14, P11, DOI 10.1111/j.1542-4758.2009.00407.x
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Chang T, 2017, CRIT CARE MED, V45, pE858, DOI 10.1097/CCM.0000000000002362
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Y, 2020, HUMAN KIDNEY IS TARG, DOI [10.1101/2020.03.04.20031120, DOI 10.1101/2020.03.04.20031120]
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Chionh CY, 2013, CLIN J AM SOC NEPHRO, V8, P1649, DOI 10.2215/CJN.01540213
   Di Napoli R, 2020, FEATURES EVALUATION
   Dias DB, 2016, HEMODIAL INT, V20, P631, DOI 10.1111/hdi.12418
   Dias DB, 2021, PERITON DIALYSIS INT, V41, P244, DOI 10.1177/0896860820915021
   Arenas MD, 2020, NEFROLOGIA, V40, P258, DOI 10.1016/j.nefro.2020.04.001
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   Edrees F, 2016, ADV CHRONIC KIDNEY D, V23, P195, DOI 10.1053/j.ackd.2016.03.003
   El Shamy O, 2020, J AM SOC NEPHROL, V31, P1680, DOI 10.1681/ASN.2020050599
   El Shamy O, 2020, KIDNEY MED, V2, P377, DOI 10.1016/j.xkme.2020.04.001
   Endres P, 2021, J THROMB THROMBOLYS, V51, P966, DOI 10.1007/s11239-020-02301-6
   Extra, INTERIM ADDITIONAL G
   Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375
   Gabriel DP, 2008, KIDNEY INT, V73, pS87, DOI 10.1038/sj.ki.5002608
   Gao Z, 2020, NOVEL CORONAVIRUS CA
   Garzotto F, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1355-9
   Ghani RA, 2006, NEPHROLOGY, V11, P386, DOI 10.1111/j.1440-1797.2006.00600.x
   Goldfarb DS, 2020, CLIN J AM SOC NEPHRO, V15, P880, DOI 10.2215/CJN.05180420
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gupta S, 2021, J AM SOC NEPHROL, V32, P161, DOI 10.1681/ASN.2020060897
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Katagiri D, 2021, BLOOD PURIFICAT, V50, P129, DOI 10.1159/000508062
   Kellum JA, 1998, CRIT CARE MED, V26, P1995, DOI 10.1097/00003246-199812000-00027
   Kielstein JT, 2004, AM J KIDNEY DIS, V43, P342, DOI 10.1053/j.ajkd.2003.10.021
   Kobashi S, 2019, ACUTE MED SURG, V6, P60, DOI 10.1002/ams2.382
   Koch B, 2018, BLOOD PURIFICAT, V46, P126, DOI 10.1159/000487224
   Lee EYP, 2020, LANCET INFECT DIS, V20, P384, DOI 10.1016/S1473-3099(20)30134-1
   [李仲平 Li Zhongping], 2020, [中国软科学, China Soft Science], P1
   Liu Linfeng, 2017, Cochrane Database Syst Rev, V12, pCD011457, DOI 10.1002/14651858.CD011457.pub2
   MacLaren G, 2020, JAMA-J AM MED ASSOC, V323, P1245, DOI 10.1001/jama.2020.2342
   Malard B, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0177-2
   Nadim MK, 2020, NAT REV NEPHROL, V16, P747, DOI 10.1038/s41581-020-00356-5
   Nagatomo M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03024-z
   Nalesso F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051529
   National Institutes of Health, 2020, COR DIS 2019 COVID 1
   Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1
   Povlsen JV, 2009, CONTRIB NEPHROL, V163, P261, DOI 10.1159/000223808
   Reiter K, 2002, BLOOD PURIFICAT, V20, P380, DOI 10.1159/000063108
   Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0
   Ronco C, 2020, NAT REV NEPHROL, V16, P308, DOI 10.1038/s41581-020-0284-7
   Ronco C, 2020, BLOOD PURIFICAT, V49, P255, DOI 10.1159/000507039
   Ronco C, 2020, LANCET RESP MED, V8, P240, DOI 10.1016/S2213-2600(20)30060-6
   Schmidt JJ, 2012, BLOOD PURIFICAT, V34, P246, DOI 10.1159/000342631
   Shang Y, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00689-1
   Shankaranarayanan D, 2021, CLIN J AM SOC NEPHRO, V16, P124, DOI 10.2215/CJN.08430520
   Shen Q, 2020, PEDIATR NEPHROL, V35, P1351, DOI 10.1007/s00467-020-04555-x
   Shimada N, 2021, THER APHER DIAL, V25, P544, DOI 10.1111/1744-9987.13599
   Sourial MY, 2020, AM J KIDNEY DIS, V76, P401, DOI 10.1053/j.ajkd.2020.06.001
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Temel S, 2020, J CRIT INTENS CARE, V11, P32, DOI 10.37678/dcybd.2020.2436
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Venkataraman R, 2003, CRIT CARE, V7, P139, DOI 10.1186/cc1889
   Wang CD, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00527-1
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang LW, 2020, AM J NEPHROL, V51, P343, DOI 10.1159/000507471
   WHO, 2021, REC NAT SARS COV 2 T
   Wilbers TJ, 2020, J CRIT CARE, V60, P103, DOI 10.1016/j.jcrc.2020.07.025
   World Health Organization, 2020, PROT ASS POT RISK FA
   Zhang BC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235458
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041
NR 75
TC 1
Z9 1
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-9979
EI 1744-9987
J9 THER APHER DIAL
JI Ther. Apher. Dial.
PD FEB
PY 2022
VL 26
IS 1
BP 15
EP 23
DI 10.1111/1744-9987.13723
EA AUG 2021
PG 9
WC Hematology; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Urology & Nephrology
GA XY5HA
UT WOS:000691083600001
PM 34378870
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Krljanac, G
   Stefanovic, M
   Mladenovic, Z
   Deljanin-Ilic, M
   Janicijevic, A
   Stefanovic, M
   Trifunovic-Zamaklar, D
   Neskovic, A
   Stankovic, I
AF Krljanac, Gordana
   Stefanovic, Maja
   Mladenovic, Zorica
   Deljanin-Ilic, Marina
   Janicijevic, Aleksandra
   Stefanovic, Milica
   Trifunovic-Zamaklar, Danijela
   Neskovic, Aleksandar
   Stankovic, Ivan
TI ECHOS survey on echocardiography in Serbia during the COVID-19 pandemic
SO SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO
LA English
DT Article
DE echocardiography; survey; COVID-19; Serbia
AB Introduction/Objective The purpose of the current Echocardiographic Society of Serbia (ECHOS) survey was to assess echocardiography practice in Serbia during the Coronavirus disease 2019 (COVID-19) pandemic.
   Methods An online survey consisting of 12 questions about the usa of echocardiography, the availability of portable ultrasound devices and personal protective equipment (PPE) was sent to all ECHOS members.
   Results Overall, 126 ECHOS members (43%) answered the survey. One-third of respondents (36%) were physicians from specialized COVID-19 centers. During the pandemic, indications for echocardiographic examination were restricted in both COVID-19 and non-COVID-19 centers. In COVID-19 centers, 41% of respondents performed lung ultrasound to each patient versus 26% in non-COVID-19 centers. Transesophageal echocardiography was not performed in suspected or confirmed COVID-19 cases in any center. Portable ultrasound devices were available to 66% of respondents from COVID-19 versus 44% of respondents from non-COVID-19 centers (p = 0.018). The respondents reported regular use of PPE, regardless of the patient's COVID-19 status and found their personal knowledge about protective measures and use of PPE satisfactory.
   Conclusion During the COVID-19 pandemic in Serbia, indications for echocardiography were restricted to clinical scenarios in which the results of examination were expected to alter patient management. In both COVID-19 and non-COVID-19 centers, the use of PPE was in line with national and international recommendations. A wider availability of portable ultrasound devices and application of lung ultrasound could improve patient management in similar situations in the future.
C1 [Krljanac, Gordana; Trifunovic-Zamaklar, Danijela; Neskovic, Aleksandar; Stankovic, Ivan] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Krljanac, Gordana; Trifunovic-Zamaklar, Danijela] Clin Ctr Serbia, Cardiol Clin, Belgrade, Serbia.
   [Stefanovic, Maja] Univ Novi Sad, Fac Med, Novi Sad, Serbia.
   [Stefanovic, Maja] Inst Cardiovasc Dis Vojvodina, Sremska Kamenica, Serbia.
   [Mladenovic, Zorica] Univ Def, Med Fac, Belgrade, Serbia.
   [Mladenovic, Zorica] Mil Med Acad, Belgrade, Serbia.
   [Deljanin-Ilic, Marina] Univ Nis, Fac Med, Nish, Serbia.
   [Deljanin-Ilic, Marina] Niska Banja Inst Treatment & Rehabil, Clin Cardiol, Niska Banja, Serbia.
   [Janicijevic, Aleksandra; Stefanovic, Milica; Neskovic, Aleksandar; Stankovic, Ivan] Zemun Clin Hosp Ctr, Dept Cardiol, Vukova 9, Belgrade 11080, Serbia.
RP Stankovic, I (corresponding author), Zemun Clin Hosp Ctr, Dept Cardiol, Vukova 9, Belgrade 11080, Serbia.
EM future.ivan@gmail.com
OI Krljanac, Gordana/0000-0002-4849-7031; Mladenovic,
   Zorica/0000-0002-4668-3922
CR AIUM, GUIDELINES CLEANING
   CDC, STRATEGIES OPTIMIZIN
   European centre for disease prevention and control, 2020, INFECT PREVENTION CO
   Holte E, 2020, EUR HEART J-CARD IMG, V21, P828, DOI 10.1093/ehjci/jeaa066
   Insitut za javno zdravlje Srbije, LICNA ZASTITNA OPREM
   Johri AM, 2020, J AM SOC ECHOCARDIOG, V33, P670, DOI 10.1016/j.echo.2020.04.017
   Mitchell C, 2020, J AM SOC ECHOCARDIOG, V33, P654, DOI 10.1016/j.echo.2020.04.014
   Peng QY, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02856-z
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   Soldati G, 2020, J ULTRAS MED, V39, P1459, DOI 10.1002/jum.15284
   Stankovic I, 2021, EUR HEART J-CARD IMG, V22, P367, DOI 10.1093/ehjci/jeaa111
   Stankovic I, 2019, SRP ARK CELOK LEK, V147, P74, DOI 10.2298/SARH171013068S
   Stefanovic M, 2020, SRP ARK CELOK LEK, V148, P430, DOI 10.2298/SARH200125032S
   Szekely Y, 2020, CIRCULATION, V142, P342, DOI 10.1161/CIRCULATIONAHA.120.047971
   World Health Organization, 2020, RATIONAL USE PERSONA
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
NR 16
TC 1
Z9 1
U1 1
U2 1
PU SRPSKO LEKARSKO DRUSTVO
PI BEOGRAD
PA UREDNISTVO CASOPISA SRPSKI ARHIV, UL DZORDZA VASINGTONA 19, BEOGRAD,
   11000, SERBIA
SN 0370-8179
J9 SRP ARK CELOK LEK
JI Srp. Ark. Celok. Lek.
PD SEP-OCT
PY 2020
VL 148
IS 9-10
BP 590
EP 593
DI 10.2298/SARH200606075K
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA OL1FL
UT WOS:000585087000011
OA gold
DA 2022-04-20
ER

PT J
AU Apte, S
   Lele, A
   Choudhari, A
AF Apte, Shantanu
   Lele, Abhijeet
   Choudhari, Atul
TI COVID-19 pandemic influence on organizational knowledge management
   systems and practices: Insights from an Indian engineering services
   organization
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article; Early Access
ID CONSTRUCTION; UNCERTAINTY; DESIGN
AB COVID-19 pandemic unleashed uncertainties around the world. Organizations scrambled to ensure business continuity. COVID-19 pandemic was unprecedented as disruptions were far beyond business continuity scenarios planning with respect to severities, timelines, and geographies. Initially, business disruptions were assumed to last just for a few days or weeks at a local governing region, county, or state level. However, the pandemic lasted much longer and sustained efforts were needed to stay compliant with ever-evolving and changing local, state, federal, and international guidelines, rules, and regulations. Prolonged work from home became an unavoidable and only way to ensure business continuity for many service-oriented organizations. Organizations not only tried to leverage existing knowledge management (KM) practices but also were compelled to critically relook at the efficacy and effectiveness of KM practices. Organizational KM systems and practices (OKMSP) in a typical Indian engineering consulting and design organization were studied. The changes in employee perceptions about OKMSP during the pandemic period were captured and critically analyzed. The study evaluated employee perceptions related to four critical aspects of OKMSP namely, KM processes, usage of KM tools, KM effectiveness, and KM culture. Lack of face-to-face meetings during the COVID-19 period made an important change in the way of working. This paper captures COVID-19 pandemic-induced changes and provides pointers to further research opportunities in the field of OKMSP. The study highlights the need for robust knowledge management systems to face pandemic-induced disruptions.
C1 [Apte, Shantanu; Lele, Abhijeet] Symbiosis Int Univ Deemed Univ SIU, Pune, Maharashtra, India.
   [Lele, Abhijeet] Symbiosis Inst Business Management SIBM, Pune, Maharashtra, India.
   [Choudhari, Atul] Tata Consulting Engineers Ltd TCE, Airoli, India.
RP Apte, S (corresponding author), Symbiosis Int Univ Deemed Univ SIU, Pune, Maharashtra, India.
EM polite_shantanu@yahoo.com
CR Abualqumboz M, 2021, KNOWL PROCESS MANAG, DOI 10.1002/kpm.1698
   Akbari N, 2017, J KNOWL MANAG, V21, P1120, DOI 10.1108/JKM-10-2016-0435
   Alavi M, 2002, J AM SOC INF SCI TEC, V53, P1029, DOI 10.1002/asi.10107
   Ardito L, 2021, R&D MANAGE, V51, P381, DOI 10.1111/radm.12455
   Bangun Y.R., 2020, JURNAL MANAJEMEN TEK, V19, P159, DOI [10.12695/jmt.2020.19.2.4, DOI 10.12695/JMT.2020.19.2.4]
   Bolisani E, 2021, KNOWL MAN RES PRACT, V19, P517, DOI 10.1080/14778238.2021.1911606
   Bolisani E, 2017, J KNOWL MANAG, V21, P233, DOI 10.1108/JKM-02-2016-0071
   Bratianu C, 2021, KNOWL PROCESS MANAG, V28, P11, DOI 10.1002/kpm.1656
   Carrillo P, 2006, J MANAGE ENG, V22, P2, DOI 10.1061/(ASCE)0742-597X(2006)22:1(2)
   Cegarra-Navarro JG, 2021, KNOWL PROCESS MANAG, V28, P134, DOI 10.1002/kpm.1662
   Cegarra-Navarro JG, 2016, J BUS RES, V69, P1544, DOI 10.1016/j.jbusres.2015.10.014
   Cook SDN, 1999, ORGAN SCI, V10, P381, DOI 10.1287/orsc.10.4.381
   D'Ascenzo F., 2021, BAD COUNTER KNOWLEDG, P1, DOI DOI 10.1007/978-3-030-59972-0_1
   Forcada N, 2013, AUTOMAT CONSTR, V29, P83, DOI 10.1016/j.autcon.2012.09.001
   Girard J., 2015, ONLINE J APPL KNOWLE, V3, P1
   Gustafsson J., 2017, SINGLE CASE STUDIES, V12
   Jackson T, 2020, KNOWL PROCESS MANAG, V27, P77, DOI 10.1002/kpm.1622
   Jennex M. E., 2011, CRISIS RESPONSE MANA, P201, DOI [10.4018/978-1-60960-609-1.ch013, DOI 10.4018/978-1-60960-609-1.CH013]
   Joe C, 2013, J KNOWL MANAG, V17, P913, DOI 10.1108/JKM-04-2013-0137
   Klein VB, 2021, KNOWL PROCESS MANAG, V28, P117, DOI 10.1002/kpm.1660
   Kristanti M.M., 2020, INFORM KNOWLEDGE MAN, V10, P14, DOI [10.7176/ikm/10-4-02, DOI 10.7176/IKM/10-4-02]
   McMahon C, 2004, J ENG DESIGN, V15, P307, DOI 10.1080/09544820410001697154
   Meluso J., 2020, MAKING VIRTUAL TEAMS
   Meso P., 2000, Journal of Knowledge Management, V4, P224, DOI 10.1108/13673270010350020
   Mohajan H. K., 2017, EC SERIES, V17, P59, DOI [10.26458/1746, DOI 10.26458/1746]
   Pinto CAS, 2020, BRAZ J OPER PROD MAN, V17, DOI 10.14488/BJOPM.2020.033
   Sharma P, 2020, J BUS RES, V116, P188, DOI 10.1016/j.jbusres.2020.05.026
   Singh MD, 2007, IN C IND ENG ENG MAN, P2091, DOI 10.1109/IEEM.2007.4419560
   Smuttrasen K, 2020, KNOWL PROCESS MANAG, V27, P53, DOI 10.1002/kpm.1620
   Soto-Acosta P, 2020, INFORM SYST MANAGE, V37, P260, DOI 10.1080/10580530.2020.1814461
   Van Looy A, 2021, KNOWL PROCESS MANAG, V28, P107, DOI 10.1002/kpm.1659
   Vermicelli S, 2021, R&D MANAGE, V51, P183, DOI 10.1111/radm.12443
   Wang WT, 2021, KNOWL MAN RES PRACT, V19, P468, DOI 10.1080/14778238.2020.1860665
   Wei XD, 2019, PROC INT CONF EDU IN, P222, DOI 10.1109/EITT.2019.00050
   Yaojie Li, 2021, IEEE Engineering Management Review, V49, P38, DOI 10.1109/EMR.2020.3036816
NR 35
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
DI 10.1002/kpm.1711
EA MAR 2022
PG 13
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA 0A1YR
UT WOS:000773757800001
DA 2022-04-20
ER

PT J
AU Tune, SNBK
   Islam, BZ
   Islam, MR
   Tasnim, Z
   Ahmed, SM
AF Tune, Samiun Nazrin Bente Kamal
   Islam, Bushra Zarin
   Islam, Mir Raihanul
   Tasnim, Zarin
   Ahmed, Syed Masud
TI Exploring the knowledge, attitudes, practices and lived experiences of
   frontline health workers in the times of COVID-19: a qualitative study
   from Bangladesh
SO BMJ OPEN
LA English
DT Article
DE COVID-19; health policy; health & safety; health services administration
   & management; quality in healthcare; public health
ID CARE WORKERS; IMPACT; OUTBREAK; CRISIS
AB Objective This study explored Frontline Health Workers' (FLWs) knowledge, attitude and practice (KAP) on COVID-19 and their lived experiences, in both their personal and work lives, at the early stage of the pandemic in Bangladesh. Design, setting and participants This was a qualitative study conducted through telephone interviews in May 2020. A total of 41 FLWs including physicians, nurses, paramedics, community healthcare workers and hospital support staff from 34 public and private facilities of both urban and rural parts of Bangladesh participated in the interview. A purposive sampling technique supplemented by a snowball sampling method was followed to select the participants. The in-depth interviews followed a semi-structured interview guide, and we applied the thematic analysis method for the qualitative data analysis. Findings Except physicians, the FLWs did not receive any institutional training on COVID-19, including its prevention and management, in most instances. Also, they had no training in the use of personal protective equipment (PPE). Their common source of knowledge was the different websites or social media platforms. The FLWs were at risk while delivering services because patients were found to hide histories and not maintaining safety rules, including physical distancing. Moreover, inadequate supply of PPE, fear of getting infected, risk to family members and ostracisation by the neighbours were mentioned to be quite common by them. This situation eventually led to the development of mental stress and anxiety; however, they tried to cope up with this dire situation and attend to the call of humanity. Conclusion The uncertain work environment during the COVID-19 pandemic simultaneously affected FLWs' physical and emotional health in Bangladesh. However, they showed professional devotion in overcoming such obstacles and continued to deliver essential services. This could be further facilitated by a quick and targeted training package on COVID-19, and the provision of supplies for delivering services with appropriate safety precautions.
C1 [Tune, Samiun Nazrin Bente Kamal; Islam, Bushra Zarin; Tasnim, Zarin; Ahmed, Syed Masud] BRAC Univ, Ctr Excellence Hlth Syst & Universal Hlth Coverag, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.
   [Islam, Mir Raihanul] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Dhaka, Bangladesh.
RP Tune, SNBK (corresponding author), BRAC Univ, Ctr Excellence Hlth Syst & Universal Hlth Coverag, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.
EM samiun.tune@bracu.ac.bd
OI Ahmed, Syed Masud/0000-0001-5032-7181; Raihanul Islam,
   Mir/0000-0003-2125-2218
FU Bangladesh Health Watch; BRAC James P Grand school of Public Health,
   BRAC University
FX The study team expresses its gratitude to Bangladesh Health Watch and
   BRAC James P Grand school of Public Health, BRAC University for giving
   the opportunity and supporting to conduct the study during the COVID-19
   lockdown situation in the country.
CR Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Ahmed J, 2020, CUREUS, V12, DOI 10.7759/cureus.8550
   Al, 2020, J BANGLADESH COLL PH, P43, DOI [DOI 10.3329/JBCPS.V38I0.47442, 10.3329/jbcps.v38i0.47442]
   Bandyopadhyay S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003097
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Chen P, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020308
   Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633
   Gan WH, 2020, SAF HEALTH WORK-KR, V11, P241, DOI 10.1016/j.shaw.2020.03.001
   Hakim M, 2021, HEALTH SECUR, V19, P140, DOI 10.1089/hs.2020.0142
   Hassan MZ, 2021, INFECT CONT HOSP EP, V42, P121, DOI 10.1017/ice.2020.208
   Kar Sujita Kumar, 2020, Neurol Psychiatry Brain Res, V38, P54, DOI 10.1016/j.npbr.2020.10.003
   Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Malik UR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176395
   Marjanovic Z, 2007, INT J NURS STUD, V44, P991, DOI 10.1016/j.ijnurstu.2006.02.012
   Maunder R, 2003, CAN MED ASSOC J, V168, P1245
   Mbachu CNP, 2020, J INFECT DEV COUNTR, V14, P943, DOI 10.3855/jidc.13248
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Park SH, 2020, INFECT CHEMOTHER, V52, P165, DOI 10.3947/ic.2020.52.2.165
   Pecchia L, 2020, HEALTH TECHNOL-GER, V10, P1375, DOI 10.1007/s12553-020-00429-2
   Sakib S.N., 2020, BANGLADESH LOW COVID
   Smith Elizabeth M, 2005, Nurse Res, V12, P32
   The Daily Star, 2020, DAILY STAR
   Verhoeven V, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039674
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   World Health Organization [WHO], 2006, HLTH WORK GLOB PROF HLTH WORK GLOB PROF
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 29
TC 0
Z9 0
U1 2
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD JAN
PY 2022
VL 12
IS 1
AR e051893
DI 10.1136/bmjopen-2021-051893
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA YF9KC
UT WOS:000742117500005
PM 35017240
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Balderas-Delgado, C
   Cabrera-Garcia, A
   Baptista-Gonzalez, HA
AF Balderas-Delgado, Carolina
   Cabrera-Garcia, Alvaro
   Baptista-Gonzalez, Hector A.
TI Pregnancy and COVID-19. Considerations in the practice of Hematology
SO GACETA MEDICA DE MEXICO
LA Spanish
DT Review
DE Pregnancy; COVID-19; Venous thrombosis
ID COAGULATION; MANAGEMENT
AB Coronavirus disease 2019 (COVID-19) in a vulnerable population, such as the pregnant woman, fetus, and newborn, requires an establishment of effective and safe strategies focused on the safety of the mother-child binomial. The objective of this report is to present the results of the review of secondary information sources (meta-analysis and systematic review), of the state of the art in the advancement of knowledge of the disease due to COVID-19 during pregnancy. Different reports have insisted that maternal mortality from COVID-19 is low. However, the maternal mortality ratio (MMR) increased from 30.9 to 45.5 deaths per 100,000 births, that is, it showed an increase of 36.32% compared to the same week of 2019. Due to its unprecedented condition and the particular behavior of the COVID-19 disease during the perinatal period, the generation of new data, its integration into accessible information and its epidemiological clinical analysis will inevitably provide new evidence that must be integrated into clinical management and practice. But the issue is not limited to COVID-19, the increase in MMR is 24% for maternal obstetric hemorrhage, 20% for hypertensive disease, and 28.5% for puerperal sepsis. There is no characteristic hematological behavior and the appearance of thrombotic or hemorrhagic complications in the patient with COVID-19, without clinical characteristics similar to those seen in her non-pregnant peers. The global increase in all causes of maternal mortality are not exclusive to COVID-19, which exposes the deficiencies of the health system in terms of primary health care, prenatal surveillance, family planning, among other programs; additional to the impact of COVID-19. The redesign of public policies in terms of primary health care for the entire population is an urgent need, particularly for pregnant women.
C1 [Balderas-Delgado, Carolina; Cabrera-Garcia, Alvaro] Hosp Reg Alta Especialidad Ixtapaluca, Clin Canc & Embarazo CREHER, Hematol Trasplante Celulas Progenitoras Hematopoy, Ixtapaluca, Edo Mex, Mexico.
   [Baptista-Gonzalez, Hector A.] Inst Nacl Perinatol, Hematol Perinatal, Ciudad De Mexico, Mexico.
   [Baptista-Gonzalez, Hector A.] Med Sur, Med Transfus & Banco Sangre, Ciudad De Mexico, Mexico.
RP Baptista-Gonzalez, HA (corresponding author), Inst Nacl Perinatol, Hematol Perinatal, Ciudad De Mexico, Mexico.; Baptista-Gonzalez, HA (corresponding author), Med Sur, Med Transfus & Banco Sangre, Ciudad De Mexico, Mexico.
EM baptistagh@gmail.com
CR Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8
   Ahmed S, 2020, CLIN RHEUMATOL, V39, P2529, DOI 10.1007/s10067-020-05275-1
   Akhtar H, 2020, GYNECOL OBSTET INVES, V85, P295, DOI 10.1159/000509290
   [Anonymous], Informe semanal de notificacion inmediatra de muerte materna. Semana epidemiologica 50 de 2020
   [Anonymous], 2020, MAN MUJ EMB REC NAC
   [Anonymous], 2015, THROM DIS PREGN PUER
   Bandyopadhyay S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003097
   Bates SM, 2018, BLOOD ADV, V2, P3317, DOI 10.1182/bloodadvances.2018024802
   Benhamou D, 2020, ANAESTH CRIT CARE PA, V39, P351, DOI 10.1016/j.accpm.2020.05.003
   Clark P, 1998, THROMB HAEMOSTASIS, V79, P1166
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   Devis P, 2017, CARDIOVASC DIAGN THE, V7, pS309, DOI 10.21037/cdt.2017.10.08
   Duggan CP, 2020, AM J CLIN NUTR, V112, P1409, DOI 10.1093/ajcn/nqaa341
   Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370
   Favilli A, 2020, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2020.1774875
   Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041
   Gavillet M, 2020, ULTRASOUND OBST GYN, V55, P843, DOI 10.1002/uog.22063
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huntley BJF, 2020, OBSTET GYNECOL, V136, P303, DOI 10.1097/AOG.0000000000004010
   Jafari R, 2020, WORLD J RADIOL, V12, P137, DOI 10.4329/wjr.v12.i7.137
   Juan J, 2020, ULTRASOUND OBST GYN, V56, P15, DOI 10.1002/uog.22088
   Kermali M, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117788
   Khoury R, 2020, OBSTET GYNECOL, V136, P273, DOI 10.1097/AOG.0000000000004025
   Knight M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2107
   Kwiatkowski S, 2020, ULTRASOUND OBST GYN, V55, P841, DOI 10.1002/uog.22049
   Magallanes-Garza GI, 2021, INT J GYNECOL OBSTET, V152, P439, DOI 10.1002/ijgo.13467
   Pettirosso E, 2020, AUST NZ J OBSTET GYN, V60, P640, DOI 10.1111/ajo.13204
   Schindewolf M, 2013, J ALLERGY CLIN IMMUN, V132, P131, DOI 10.1016/j.jaci.2013.02.047
   Siennicka A, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3192350
   Smith V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234187
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Thachil J, 2020, J THROMB HAEMOST, V18, P1023, DOI 10.1111/jth.14810
   Thachil J, 2020, J THROMB HAEMOST, V18, P2408, DOI 10.1111/jth.14956
   The American College of Obstetricians / Gynecologist, 2020, SOC MAT FET MED ULT
   Valk SJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013600
   Violi F, 2020, THROMB HAEMOSTASIS, V120, P949, DOI 10.1055/s-0040-1710317
   Walker KF, 2020, BJOG-INT J OBSTET GY, V127, P1324, DOI 10.1111/1471-0528.16362
   Yee J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75096-4
   Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867
NR 40
TC 0
Z9 0
U1 0
U2 0
PU ACAD NACIONAL MEDICINA MEXICO
PI MEXICO
PA CENTRO MEDICO NACIONAL SIGLO XXI, UNIDAD CONGRESOS, GLOQUE B, PROMER
   PISO, MEXICO, DF 06725, MEXICO
SN 0016-3813
J9 GAC MED MEX
JI Gac. Med. Mex.
PD DEC
PY 2021
VL 157
SU 3
BP 112
EP 119
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA YV0BC
UT WOS:000752397500016
DA 2022-04-20
ER

PT J
AU Mouffak, S
   Shubbar, Q
   Saleh, E
   El-Awady, R
AF Mouffak, Soraya
   Shubbar, Qamar
   Saleh, Ekram
   El-Awady, Raafat
TI Recent advances in management of COVID-19: A review
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review
DE COVID-19; SARS-CoV-2; Ivermectin; Famotidine; Nanobodies; Monoclonal
   antibodies; Remdesivir; SSRI; Fluvoxamine; Dexamethasone; Serotonin;
   Fluoxetine; Tocilizumab; Melatonin
ID FUNCTIONAL INHIBITORS; OXIDATIVE DAMAGE; MELATONIN; ANTIBODIES;
   NANOBODIES; MODEL
AB The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing significant mortality and economic consequences all over the globe. As of today, there are three U.S Food and Drug administration (FDA) approved vaccines, Pfizer-BioNTech, Moderna and Janssen COVID-19 vaccine. Also, the antiviral drug remdesivir and two combinations of monoclonal antibodies are authorized for Emergency use (EUA) in certain patients. Furthermore, baricitinib was approved in Japan (April 23, 2021). Despite available vaccines and EUA, pharmacological therapy for the prevention and treatment of COVID-19 is still highly required. There are several ongoing clinical trials investigating the efficacy of clinically available drugs in treating COVID-19. In this study, selected novel pharmacological agents for the possible treatment of COVID-19 will be discussed. Point of discussion will cover mechanism of action, supporting evidence for safety and efficacy and reached stage in development. Drugs were classified into three classes according to the phase of viral life cycle they target. Phase I, the early infective phase, relies on supportive care and symptomatic treatment as needed. In phase II, the pulmonary phase, treatment aims at inhibiting viral entry or replication. Drugs used during this phase are famotidine, monoclonal antibodies, nanobodies, ivermectin, remdesivir, camostat mesylate and other antiviral agents. Finally, phase III, the hyper-inflammatory phase, tocilizumab, dexamethasone, selective serotonin reuptake inhibitors (SSRI), and melatonin are used. The aim of this study is to summarize current findings and suggest gaps in knowledge that can influence future COVID-19 treatment study design.
C1 [Mouffak, Soraya; Shubbar, Qamar; El-Awady, Raafat] Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates.
   [Saleh, Ekram] Cairo Univ, Natl Canc Inst, Canc Biol Dept, Clin Biochem & Mol Biol Unit, Giza, Egypt.
   [El-Awady, Raafat] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.
RP El-Awady, R (corresponding author), Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates.; El-Awady, R (corresponding author), Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.
EM relawady@sharjah.ac.ae
CR Acuna-Castroviejo D, 2020, J PINEAL RES, V69, DOI 10.1111/jpi.12683
   Ahmed Mukhtar H, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00610-8
   Anderson GM, 2021, PSYCHOPHARMACOLOGY, V238, P611, DOI 10.1007/s00213-020-05753-z
   Annane D, 2021, J INTENSIV MED, V2021, DOI [10.1016/j.jointm.2021.01.002, DOI 10.1016/J.JOINTM.2021.01.002]
   [Anonymous], 2021, LILLYS BAMLANIVIMAB
   [Anonymous], 2021, FDA AUTH REV FACT SH
   [Anonymous], 2020, VIRUS-JAPAN
   [Anonymous], 2020, EUDRACT NUMBER 2020
   [Anonymous], 2021, COR COVID 19 VACC
   [Anonymous], 2021, SIT REP
   [Anonymous], 2021, FACT SHEET GOT HLTH
   [Anonymous], 2020, NATL GUIDELINES CLIN
   Aronson J.K, 2020, CORONAVIRUSES A GEN
   Assimon MM, 2019, J AM SOC NEPHROL, V30, P611, DOI 10.1681/ASN.2018101032
   Berger M, 2002, AM J MED SCI, V324, P14, DOI 10.1097/00000441-200207000-00004
   Biancatelli RMLC, 2020, J THORAC DIS, V12, pS54, DOI 10.21037/jtd.2019.12.85
   Blaess M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144953
   Bloom A., COVID 19 OUTPATIENT
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Cardinali Daniel P, 2020, Sleep Vigil, V4, P81, DOI 10.1007/s41782-020-00111-7
   Carpinteiro A, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100142
   Carrillo-Vico A, 2005, J PINEAL RES, V39, P400, DOI 10.1111/j.1600-079X.2005.00265.x
   Changsun S., 2020, CELL DEATH DIFFER, V27, P5
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chi XJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18387-8
   Cohen MS, 2021, NEW ENGL J MED, V384, P289, DOI 10.1056/NEJMe2034495
   Colantuoni A, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00747
   Desai N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20139-7
   Dong JB, 2020, EMERG MICROBES INFEC, V9, P1034, DOI 10.1080/22221751.2020.1768806
   Escames G, 2006, EXP GERONTOL, V41, P1165, DOI 10.1016/j.exger.2006.09.002
   Eugene A.R., 2020, FLUOXETINE PHARMACOK
   Freedberg DE, 2020, GASTROENTEROLOGY, V159, P1129, DOI 10.1053/j.gastro.2020.05.053
   Gklinos P, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14020092
   Glebov OO, 2020, FEBS J, V287, P3664, DOI 10.1111/febs.15369
   Hammadi T, BIOTECH, V11, P1
   Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/NNM.13.86, 10.2217/nnm.13.86]
   Heidary F, 2020, J ANTIBIOT, V73, P593, DOI 10.1038/s41429-020-0336-z
   Hodgens A., 2020, CORTICOSTEROIDS
   Hoertel N., 2020, MEDRXIV, DOI [10.1101/2020.07.09.20143339v2, DOI 10.1101/2020.07.09.20143339, 10.1101/2020.07.09.20143339]
   Hogan RB, 2020, PULM PHARMACOL THER, V63, DOI 10.1016/j.pupt.2020.101942
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Htar S.U, 2020, CHEMRXIVORG, P10
   Huo JD, 2020, NAT STRUCT MOL BIOL, V27, P846, DOI 10.1038/s41594-020-0469-6
   Janowitz T, 2020, GUT, V69, P1592, DOI 10.1136/gutjnl-2020-321852
   Johns M, 2021, J PHARM PRACT, DOI 10.1177/0897190021998502
   Juarez M, 2018, AM J CANCER RES, V8, P317
   Khan N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.595888
   Koenig PA, 2021, SCIENCE, V371, P691, DOI 10.1126/science.abe6230
   Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101
   Krogan Schoof, 2020, ULTRAPOTENT SYNTHETI, P13
   Lenze EJ, 2020, JAMA-J AM MED ASSOC, V324, P2292, DOI 10.1001/jama.2020.22760
   Liu Di, 2020, Med Drug Discov, V8, P100057, DOI 10.1016/j.medidd.2020.100057
   Lloyd Elizabeth C, 2021, JAMA, V325, P1015, DOI 10.1001/jama.2021.1225
   Lucero D., 2020, EFFECT FAMOTIDINE SA
   Malone RW, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.633680
   Marovich M, 2020, JAMA-J AM MED ASSOC, V324, P131, DOI 10.1001/jama.2020.10245
   Martinez-Delgado Gustavo, 2020, Nat Rev Immunol, V20, P593, DOI 10.1038/s41577-020-00443-5
   Mather JF, 2020, AM J GASTROENTEROL, V115, P1617, DOI 10.14309/ajg.0000000000000832
   Vela JM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.582310
   Mir MA, 2020, FARMACIA, V68, P771, DOI 10.31925/farmacia.2020.5.1
   Morin CM, 2020, CAN J PUBLIC HEALTH, V111, P654, DOI 10.17269/s41997-020-00382-7
   Muyldermans S, 2021, ANNU REV ANIM BIOSCI, V9, P401, DOI 10.1146/annurev-animal-021419-083831
   Nambulli Sham, 2021, bioRxiv, DOI 10.1101/2021.02.23.432569
   Norinder U, 2020, BIOMED PHARMACOTHER, V130, DOI 10.1016/j.biopha.2020.110582
   Ozturk G, 2020, TURK J MED SCI, V50, P1504, DOI 10.3906/sag-2005-356
   Peviani M, 2014, NEUROBIOL DIS, V62, P218, DOI 10.1016/j.nbd.2013.10.010
   Peyvandi F, 2017, J THROMB HAEMOST, V15, P1448, DOI 10.1111/jth.13716
   POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x
   Pradhan SK, 2020, ROLE IVERMECTIN PREV
   Pymm P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101918118
   Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446
   Rajter JC, 2021, CHEST, V159, P85, DOI 10.1016/j.chest.2020.10.009
   Raju R, 2021, FUTUR J PHARM SCI, V7, DOI 10.1186/s43094-021-00217-3
   Reiter RJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00226
   REMAP-CAP Investigators, 2021, N Engl J Med, V384, P1491, DOI 10.1056/NEJMoa2100433
   Robinson J., 2020, J BIOMED SCI, V7, P18, DOI DOI 10.3126/JBS.V7I1.2984
   Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700
   Rosen DA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5266
   Ryskamp DA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00862
   Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340
   Samaee H, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107018
   Scheim D., 2020, IVERMECTIN COVID 19
   Schloer S, 2020, EMERG MICROBES INFEC, V9, P2245, DOI 10.1080/22221751.2020.1829082
   Schoof M, 2020, SCIENCE, V370, P1473, DOI 10.1126/science.abe3255
   Sehirli AO, 2020, MOL BIOL REP, V47, P8229, DOI 10.1007/s11033-020-05830-8
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Siddiquee T.H., 2020, J BANGLADESH COLL PH, P5, DOI DOI 10.3329/JBCPS.V38I0.47514
   Tan, 2020, MELATONIN RES, V3, P12, DOI [10.32794/mr11250061, DOI 10.32794/MR11250061]
   Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295
   Thomas R, TOCILIZUMAB PATIENTS, V2021
   Tian WM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19706-9
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Vlachou M, 2021, INT J MOL MED, V47, DOI 10.3892/ijmm.2021.4880
   Williams DM, 2018, RESP CARE, V63, P655, DOI 10.4187/respcare.06314
   Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008
   Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270
   Wu ZK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26856-x
   Xiang Yufei, 2020, bioRxiv, DOI 10.1101/2020.08.24.264333
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Zare H, 2014, INT J BIOL MARKER, V29, pE169, DOI 10.5301/jbm.5000063
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang R, 2020, LIFE SCI, V250, DOI 10.1016/j.lfs.2020.117583
NR 103
TC 9
Z9 9
U1 20
U2 30
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD NOV
PY 2021
VL 143
AR 112107
DI 10.1016/j.biopha.2021.112107
EA SEP 2021
PG 14
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA UR8IE
UT WOS:000696985100006
PM 34488083
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Rahman, MM
   Chisty, MA
   Sakib, MS
   Quader, MA
   Shobuj, IA
   Alam, MA
   Halim, MA
   Rahman, F
AF Rahman, Md Mostafizur
   Chisty, Musabber Ali
   Sakib, Mohammed Sadman
   Quader, Masrur Abdul
   Shobuj, Ifta Alam
   Alam, Md Ashraful
   Halim, Md Abdul
   Rahman, Farzana
TI Status and perception toward the COVID-19 vaccine: A cross-sectional
   online survey among adult population of Bangladesh
SO HEALTH SCIENCE REPORTS
LA English
DT Article
DE attitude; COVID-19; hesitation; knowledge; vaccine
AB Introduction COVID-19 has become a global public health concern. Safe and effective vaccines are required to control the pandemic. However, positive perception toward the vaccine is also necessary for a successful vaccination effort. Objective A rapid online survey was conducted to evaluate the status and perception toward the newly administered COVID-19 vaccine among the adult population (18 years and above) of Bangladesh. Methods A total of 850 adult people participated. chi(2) or Fisher's exact test was performed to determine the association between the first dose of vaccination and sociodemographic information. Logistic regression analyses were carried out to examine the predictors of knowledge, attitude, and hesitation toward the vaccine. Results Exactly 24.12% of the study population received their first dose of COVID-19 vaccine, whereas 30.23% expressed hesitation about pursuing the vaccine. Older age groups (>70%), married people (49.62%), capital Dhaka city outsiders (32.76%), and high-income groups (>50%) received the vaccine much higher than their counter group. Age, marital status, educational attainment, monthly income, and prior COVID-19 positive status were all significantly associated with the knowledge regarding the vaccine. Only age (>55 years age group = aOR: 4.10; 95% CI: 1.30, 14.31) and level of knowledge (poor knowledge = aOR: 0.17; 95% CI: 0.12, 0.23) were significant determinants of attitudes. In case of hesitation, age group and monthly income were found as significant determinants. Fear of adverse consequences (86.67%) was the most common reason for hesitation, followed by insufficient information (73.85%). Conclusion This study sought to determine the status and perception of the newly administered COVID-19 vaccine to aid in the current inoculation campaign's effectiveness. Collaboration between academics, government officials, and communities is essential in developing a successful COVID-19 vaccination program for the entire population. The authority should develop effective strategies to ensure the implementation of its policy of widespread COVID-19 vaccination coverage.
C1 [Rahman, Md Mostafizur; Sakib, Mohammed Sadman; Quader, Masrur Abdul; Shobuj, Ifta Alam; Halim, Md Abdul] Bangladesh Univ Professionals, Fac Arts & Social Sci, Dept Disaster & Human Secur Management, Dhaka 1216, Bangladesh.
   [Chisty, Musabber Ali] Univ Dhaka, Inst Disaster Management & Vulnerabil Studies, Dhaka, Bangladesh.
   [Alam, Md Ashraful] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan.
   [Rahman, Farzana] Independent Univ Bangladesh, Dept Comp Sci & Engn, Dhaka, Bangladesh.
RP Rahman, MM (corresponding author), Bangladesh Univ Professionals, Fac Arts & Social Sci, Dept Disaster & Human Secur Management, Dhaka 1216, Bangladesh.
EM amimostafiz@gmail.com
RI Alam, Ashraful/D-4637-2019
OI Alam, Ashraful/0000-0002-7562-477X; Chisty, Musabber
   Ali/0000-0002-9638-2212; Rahman, Md Mostafizur/0000-0003-0343-0746;
   Shobuj, Ifta Alam/0000-0002-3910-2034; Sadman Sakib,
   Mohammed/0000-0002-9971-8703
CR Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06
   Abul Kalam M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256496
   Ahmed F, 2021, J LOSS TRAUMA, V26, P782, DOI 10.1080/15325024.2020.1852823
   [Anonymous], 2021, BUSINESS STANDARD
   [Anonymous], 2021, DHAKA TRIBUNE 0802
   [Anonymous], 2021, DAILY STAR
   [Anonymous], DHAKA TRIBUNE 0326
   [Anonymous], 2021, THE DAILY STAR 0224
   [Anonymous], 2021, DHAKA TRIBUNE 0127
   Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154
   Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891
   Callaghan T, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.113638
   Caserotti M, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2021.113688
   CDC, 2020, COVID 19 VACC
   Corey L, 2020, SCIENCE, V368, P948, DOI 10.1126/science.abc5312
   Deng CX, 2020, INT J BIOL SCI, V16, P1676, DOI 10.7150/ijbs.45587
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028
   Hayat K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103347
   Islam MS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0245083
   Johns Hopkins Coronavirus Resource Center, 2021, UND VACC PROGR COUNT
   KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308
   Lange B, 2021, NEW ENGL J MED, V385, P1145, DOI 10.1056/NEJMc2108076
   Latkin CA, 2021, SOC SCI MED, V270, DOI 10.1016/j.socscimed.2021.113684
   Luskin RC, 2011, J POLIT, V73, P547, DOI 10.1017/S0022381611000132
   Mangiafico S., Rcompanion: Functions to Support Extension Education Program Evaluation (R Package Version 2.3.26.)
   Md Mostafizur Rahman P., 2021, J EMERG MANAG, V19, P99, DOI [10.5055/jem.0616, DOI 10.5055/JEM.0616]
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Radhakrishna R.B., 2007, J EXTENS, V45, P1
   Rahman E, 2020, ARCH SUICIDE RES, DOI 10.1080/13811118.2020.1833800
   Rahman M. M., 2021, SciMedicine Journal, V3, P116, DOI 10.28991/SciMedJ-2021-0302-4
   Rahman MM, 2021, COGENT PSYCHOL, V8, DOI 10.1080/23311908.2020.1860186
   Rahman MM, 2021, J HUM BEHAV SOC ENVI, V31, P512, DOI 10.1080/10911359.2020.1822978
   Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043
   Selvarajoo S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66212-5
   Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5
   Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9
   WHO, 2021, BANGL MORB MORT WEEK
   Wibawa T, 2021, TROP MED INT HEALTH, V26, P14, DOI 10.1111/tmi.13503
   World Health Organization [WHO], 2019, 10 HLTH ISS WHO WILL
   Zhang HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103370
   Zhang YN, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003421
NR 42
TC 1
Z9 1
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2398-8835
J9 HEALTH SCI REP-US
JI Health Sci. Rep.
PD DEC
PY 2021
VL 4
IS 4
AR e451
DI 10.1002/hsr2.451
PG 10
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA XW2BK
UT WOS:000735431100018
PM 34938896
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Bronfman, NC
   Repetto, PB
   Cisternas, PC
   Castaneda, JV
AF Bronfman, Nicolas C.
   Repetto, Paula B.
   Cisternas, Pamela C.
   Castaneda, Javiera, V
TI Factors Influencing the Adoption of COVID-19 Preventive Behaviors in
   Chile
SO SUSTAINABILITY
LA English
DT Article
DE preventive behaviors; theory of planned behavior; subjective norms;
   COVID-19
ID SOFT DRINK CONSUMPTION; PLANNED BEHAVIOR; MENTAL-HEALTH; EFFICACY;
   IMPACT; TRUST
AB The COVID-19 pandemic forced people worldwide to implement a series of preventive hygiene and distancing measures that have significantly altered their way of life. This study examined an adapted version of the Theory of Planned Behavior (TPB) on adopting preventive behavior against COVID-19. Data was collected using a web survey completed by 1004 college students a few weeks after the first wave of infections in Chile. Our findings show that the subjective norm was the strongest predictor of adopting preventive behaviors, followed by the knowledge level and perceived behavioral control. Contrary to expectations, we found no evidence that an attitude towards preventive action predicted actual adoption of preventive behavior against COVID-19. However, knowledge and social norms play a significant role. We discuss implications for effective risk communication.
C1 [Bronfman, Nicolas C.] Univ Andres Bello, Engn Sci Dept, Santiago 7500973, Chile.
   [Bronfman, Nicolas C.; Repetto, Paula B.; Cisternas, Pamela C.] Res Ctr Integrated Disaster Risk Management ANID, Santiago 7820436, Chile.
   [Repetto, Paula B.; Castaneda, Javiera, V] Pontificia Univ Catolica Chile, Dept Psychol, Santiago 7820436, Chile.
   [Cisternas, Pamela C.] Pontificia Univ Catolica Chile, Ind & Syst Engn Dept, Santiago 7820436, Chile.
RP Bronfman, NC (corresponding author), Univ Andres Bello, Engn Sci Dept, Santiago 7500973, Chile.; Bronfman, NC (corresponding author), Res Ctr Integrated Disaster Risk Management ANID, Santiago 7820436, Chile.
EM nbronfman@unab.cl; prepetto@uc.cl; pccisternas@uc.cl; jvcastaneda@uc.cl
RI repetto, paula/E-5525-2015; Repetto, Paula/ABC-5982-2021
OI Repetto, Paula/0000-0002-0331-7375; Cisternas, Pamela
   Carmen/0000-0003-3637-7814
FU National Agency of Research and Development of Chile (ANID) of the
   Ministry of Science, Technology, Knowledge and Innovation of Chile
   through the National Fund for Scientific and Technological Research
   [ID1180996/FONDECYT/ANID]; Research Center for Integrated Disaster Risk
   Management (CIGIDEN) [ANID/FONDAP/15110017]
FX This research was partially funded by the National Agency of Research
   and Development of Chile (ANID) of the Ministry of Science, Technology,
   Knowledge and Innovation of Chile through the National Fund for
   Scientific and Technological Research (grant no.
   ID1180996/FONDECYT/ANID) and by the Research Center for Integrated
   Disaster Risk Management (CIGIDEN), (grant no. ANID/FONDAP/15110017).
CR Ahmad M, 2020, ENVIRON RES, V190, DOI 10.1016/j.envres.2020.109995
   Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I., 1985, ACTION CONTROL COGNI, P11
   Ajzen I, 2020, HUM BEHAV EMERG TECH, V2, P314, DOI 10.1002/hbe2.195
   Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995
   Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939
   Ashraf MA, 2019, BRIT FOOD J, V121, P104, DOI 10.1108/BFJ-02-2018-0072
   Bae SY, 2021, CURR ISSUES TOUR, V24, P1017, DOI 10.1080/13683500.2020.1798895
   Barile JP, 2021, ANN BEHAV MED, V55, P82, DOI 10.1093/abm/kaaa109
   Betsch C, 2020, NAT HUM BEHAV, V4, P438, DOI 10.1038/s41562-020-0866-1
   Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826
   Brosius, 2020, HARVARD KENNEDY SCH, V1, DOI [10.37016/mr-2020-023, DOI 10.37016/MR-2020-023]
   Capone V, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12177039
   Chen X., 2020, INT J ENV RES PUB HE, V17, P4437, DOI [10.3390/ijerph17124437, DOI 10.3390/ijerph17124437]
   Cheng C, 2006, J APPL SOC PSYCHOL, V36, P222, DOI 10.1111/j.0021-9029.2006.00059.x
   Das AK, 2021, J HUM BEHAV SOC ENVI, V31, P373, DOI 10.1080/10911359.2020.1833804
   Drury J, 2020, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2020.139
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   George JF, 2002, INTERNET RES, V12, P165, DOI 10.1108/10662240210422521
   Hair JF., 2009, MULTIVARIATE DATA AN
   Kassem NO, 2004, J BEHAV MED, V27, P273, DOI 10.1023/B:JOBM.0000028499.29501.8f
   Kassem NO, 2003, HEALTH EDUC RES, V18, P278, DOI 10.1093/her/cyf017
   Kim HK, 2021, HEALTH COMMUN, DOI 10.1080/10410236.2020.1871170
   Kirk TN, 2019, ADAPT PHYS ACT Q, V36, P164, DOI 10.1123/apaq.2018-0065
   Kline R., 1998, PRINCIPLES PRACTICE
   Latkin CA, 2021, SOC SCI MED, V270, DOI 10.1016/j.socscimed.2021.113684
   Lee Y., 2021, J GERONTOL SOC WORK, DOI [10.1111/1468-5973.12354, DOI 10.1080/01634372.2021.1975342]
   Malecki KMC, 2021, CLIN INFECT DIS, V72, P697, DOI 10.1093/cid/ciaa758
   Masser BM, 2020, TRANSFUSION, V60, P2907, DOI 10.1111/trf.16067
   McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684
   Montanaro EA, 2018, J BEHAV MED, V41, P757, DOI 10.1007/s10865-018-9923-x
   Montano D. E., 2015, HLTH BEHAV, V70, P231
   Nivette A, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113370
   O'Reilly A, 2021, IRISH J PSYCHOL MED, V38, P192, DOI 10.1017/ipm.2020.106
   Oosterhoff B, 2020, J ADOLESCENT HEALTH, V67, P179, DOI 10.1016/j.jadohealth.2020.05.004
   Shi JY, 2020, HEALTH COMMUN, V35, P597, DOI 10.1080/10410236.2019.1573298
   Siegrist M., 2021, RISK ANAL, V0, P1
   Snape MD, 2020, SCIENCE, V370, P286, DOI 10.1126/science.abd6165
   University College London, UNDERSTANDING PSYCHO
   Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9
   World Bank, COVID 19 PLUNG GLOB
   World Health Organization, COR DIS COVID 19 DAS
   World Health Organization (WHO), 2020, RISK COMM COMM ENG R
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
   Zhang LW, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010064
   Zhang N, 2015, HEALTH COMMUN, V30, P1277, DOI 10.1080/10410236.2014.940669
   Zubrod A, 2021, J LANG SOC PSYCHOL, V40, P354, DOI 10.1177/0261927X20958439
NR 50
TC 6
Z9 6
U1 3
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD MAY
PY 2021
VL 13
IS 10
AR 5331
DI 10.3390/su13105331
PG 13
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA ST7CE
UT WOS:000662596900001
OA gold
DA 2022-04-20
ER

PT J
AU Arlindo, VJC
   Nunes, LAL
   Aires, CF
   Pimenta, HCD
AF Arlindo, V. J. C.
   Nunes, L. A. L.
   Aires, C. F.
   Pimenta, H. C. D.
TI BIBLIOMETRIC ANALYSIS OF THE LITERATURE ON HOW FIRMS COPE WITH COVID-19
SO HOLOS
LA English
DT Article
DE Covid-19; firms; bibliometric analysis
ID SUPPLY CHAIN; MANAGEMENT; DESIGN; TRENDS; ADAPT; TOOL
AB Different firms and their supply chains faced many global impacts with the COVID-19 pandemic. The purpose of this paper is to analyse the scientific production about firms and the Covid-19 pandemic through bibliometric indicators associated with the most prolific journals, authors, documents, countries and institutions. IEEE Engineering Management Review and Industrial Marketing Management were the most relevant academic journals, which indicates the adaptation of businesses and supply chain resilience as major tendencies. Ivanov and Kraus are the most relevant authors. This paper contributes to the knowledge by mapping of scientific production regarding firms and COVID-19 and providing a basis for future studies that can help researchers and managers to minimise the effects of the current global crisis.
C1 [Arlindo, V. J. C.; Nunes, L. A. L.; Aires, C. F.; Pimenta, H. C. D.] Inst Fed Educ Ciencia & Tecnol Rio Grande do Nort, Natal, RN, Brazil.
RP Arlindo, VJC (corresponding author), Inst Fed Educ Ciencia & Tecnol Rio Grande do Nort, Natal, RN, Brazil.
EM viniciusjosecorreia@hotmail.com; luizaarnaud2@gmail.com;
   aires.cynthia@gmail.com; handson.pimenta@ifrn.edu.br
CR Altay N, 2018, PROD PLAN CONTROL, V29, P1158, DOI 10.1080/09537287.2018.1542174
   Aria M, 2017, J INFORMETR, V11, P959, DOI 10.1016/j.joi.2017.08.007
   Assuncao M.V.D., 2020, HOLOS, V36, P1
   Bennett NJ, 2020, COAST MANAGE, V48, P336, DOI 10.1080/08920753.2020.1766937
   Cai Min, 2020, J Shanghai Jiaotong Univ Sci, V25, P409, DOI 10.1007/s12204-020-2206-z
   Gallardo EC, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114655
   Chahrour M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7357
   Della Corte V, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11216114
   Dolgui A, 2020, INT J PROD RES, V58, P2184, DOI 10.1080/00207543.2019.1627439
   Dolgui A, 2018, INT J PROD RES, V56, P414, DOI 10.1080/00207543.2017.1387680
   Dubey R, 2015, INT J ADV MANUF TECH, V80, P427, DOI 10.1007/s00170-015-6967-8
   Ellegaard O, 2015, SCIENTOMETRICS, V105, P1809, DOI 10.1007/s11192-015-1645-z
   Filimonau V, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102659
   Golan Maureen S., 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09777-w
   Hughes P, 2020, IND MARKET MANAG, V88, P485, DOI 10.1016/j.indmarman.2020.05.020
   Ivanov D, 2018, INT J PROD RES, V56, P3507, DOI 10.1080/00207543.2017.1343507
   Ivanov D, 2020, INT J PROD RES, V58, P3252, DOI 10.1080/00207543.2019.1634850
   Ivanov D, 2019, COMPUT IND ENG, V127, P558, DOI 10.1016/j.cie.2018.10.043
   Ivanov D, 2018, INT J PROD RES, V56, P3359, DOI 10.1080/00207543.2018.1457813
   Ivanov D, 2017, INT J PROD RES, V55, P2083, DOI 10.1080/00207543.2016.1275873
   Juergensen J, 2020, J IND BUS ECON, V47, P499, DOI 10.1007/s40812-020-00169-4
   Ketchen DJ, 2020, J MANAGE, V46, P1330, DOI 10.1177/0149206320945028
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Liu YP, 2020, ASIAN BUS MANAG, V19, P277, DOI 10.1057/s41291-020-00119-x
   Manolova TS, 2020, INT SMALL BUS J, V38, P481, DOI 10.1177/0266242620949136
   Nenonen S, 2020, IND MARKET MANAG, V88, P265, DOI 10.1016/j.indmarman.2020.05.022
   Nenonen S, 2020, IND MARKET MANAG, V87, P276, DOI 10.1016/j.indmarman.2019.10.006
   Nenonen S, 2019, J ACAD MARKET SCI, V47, P617, DOI 10.1007/s11747-019-00643-z
   Okorie Okechukwu, 2020, IEEE Engineering Management Review, V48, P167, DOI 10.1109/EMR.2020.3012112
   Olisah C, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00964
   Pinto A, 30 YEARS FLEXIBLE JO, V1, P1
   Ramanan SS, 2020, IND CROP PROD, V158, DOI 10.1016/j.indcrop.2020.112972
   Saikia K, 2020, SOL ENERGY, V199, P100, DOI 10.1016/j.solener.2020.02.013
   Seetharaman P, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102173
   Shahbaz M, 2020, J PURE APPL MICROBIO, V14, P1087, DOI 10.22207/JPAM.14.2.01
   Sharma M, 2020, INT J LOGIST-RES APP, DOI 10.1080/13675567.2020.1810213
   Soares Patrícia Bourguignon, 2016, Ambient. constr., V16, P175, DOI 10.1590/s1678-86212016000100067
   Storbacka K, 2011, IND MARKET MANAG, V40, P255, DOI 10.1016/j.indmarman.2010.06.038
   Thorgren S., 2020, J BUS VENTURING INSI, V14, DOI [10.1016/j.jbvi.2020.e00187, DOI 10.1016/J.JBVI.2020.E00187]
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Tsilika T., 2020, J SMALL BUSINESS ENT, P1
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Waiho K, 2020, AQUACULT REP, V18, DOI 10.1016/j.aqrep.2020.100450
   Zhu GY, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145858
NR 44
TC 0
Z9 0
U1 5
U2 8
PU CENTRO FEDERAL EDUCACAO TECNOLOGICA RIO GRANDE NORTE
PI RIO GRANDE DO NORTE
PA AVE SEN SALGADO FILHO, 1559, TIRO, NATAL, RIO GRANDE DO NORTE,
   59015-000, BRAZIL
SN 1518-1634
EI 1807-1600
J9 HOLOS
JI Holos
PY 2021
VL 37
IS 1
AR e11735
DI 10.15628/holos.2021.11735
PG 20
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA SS6TO
UT WOS:000661888400043
DA 2022-04-20
ER

PT J
AU Stein, ML
   Park, RS
   Afshari, A
   Disma, N
   Fiadjoe, JE
   Matava, CT
   McNarry, AF
   von Ungern-Sternberg, BS
   Kovatsis, PG
   Peyton, JM
AF Stein, Mary Lyn
   Park, Raymond S.
   Afshari, Arash
   Disma, Nicola
   Fiadjoe, John E.
   Matava, Clyde T.
   McNarry, Alistair F.
   von Ungern-Sternberg, Britta S.
   Kovatsis, Pete G.
   Peyton, James M.
TI Lessons from COVID-19: A reflection on the strengths and weakness of
   early consensus recommendations for pediatric difficult airway
   management during a respiratory viral pandemic using a modified Delphi
   method
SO PEDIATRIC ANESTHESIA
LA English
DT Article
DE airway management; COVID-19; difficult intubation; pandemic; pediatric
ID INTUBATION; CHILDREN
AB Background The authors recognized a gap in existing guidelines and convened a modified Delphi process to address novel issues in pediatric difficult airway management raised by the COVID-19 pandemic. Methods The Pediatric Difficult Intubation Collaborative, a working group of the Society for Pediatric Anesthesia, assembled an international panel to reach consensus recommendations on pediatric difficult airway management during the COVID-19 pandemic using a modified Delphi method. We reflect on the strengths and weaknesses of this process and ways care has changed as knowledge and experience have grown over the course of the pandemic. Recommendations In the setting of the COVID-19 pandemic, the Delphi panel recommends against moving away from the operating room solely for the purpose of having a negative pressure environment. The Delphi panel recommends supplying supplemental oxygen and using videolaryngoscopy during anticipated difficult airway management. Direct laryngoscopy is not recommended. If the patient meets extubation criteria, extubate in the OR, awake, at the end of the procedure. Reflection These recommendations remain valuable guidance in caring for children with anticipated difficult airways and infectious respiratory pathology when reviewed in light of our growing knowledge and experience with COVID-19. The panel initially recommended minimizing involvement of additional people and trainees and minimizing techniques associated with aerosolization of viral particles. The demonstrated effectiveness of PPE and vaccination at reducing the risk of exposure and infection to clinicians managing the airway makes these recommendations less relevant for COVID-19. They would likely be important initial steps in the face of novel respiratory viral pathogens. Conclusions The consensus process cannot and should not replace evidence-based guidelines; however, it is encouraging to see that the panel's recommendations have held up well as scientific knowledge and clinical experience have grown.
C1 [Stein, Mary Lyn; Park, Raymond S.; Fiadjoe, John E.; Kovatsis, Pete G.; Peyton, James M.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Management, Boston, MA 02115 USA.
   [Stein, Mary Lyn; Park, Raymond S.; Fiadjoe, John E.; Kovatsis, Pete G.; Peyton, James M.] Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA.
   [Afshari, Arash] Copenhagen Univ Hosp, Rigshosp, Dept Pediat & Obstetr Anesthesia, Copenhagen, Denmark.
   [Disma, Nicola] Ist Giannina Gaslini, Dept Paediat Anaesthesia, Unit Res & Innovat, Genoa, Italy.
   [Matava, Clyde T.] Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON, Canada.
   [McNarry, Alistair F.] St Johns Hosp, NHS Lothian, Livingston, Scotland.
   [von Ungern-Sternberg, Britta S.] Perth Childrens Hosp, Dept Anaesthesia & Pain Management, Perth, WA, Australia.
   [von Ungern-Sternberg, Britta S.] Univ Western Australia, Med Sch, Div Emergency Med Anaesthesia & Pain Med, Perth, WA, Australia.
   [von Ungern-Sternberg, Britta S.] Telethon Kids Inst, Team Perioperat Med, Perth, WA, Australia.
RP Peyton, JM (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Management, Boston, MA 02115 USA.
EM James.Peyton@childrens.harvard.edu
RI Afshari, Arash/ABD-2969-2021; McNarry, Alistair/ABC-5143-2020
OI McNarry, Alistair/0000-0003-3429-0299; Peyton,
   James/0000-0002-2667-9344; von Ungern-Sternberg,
   Britta/0000-0002-8043-8541
CR Agarwal A, 2020, CAN J ANESTH, V67, P1217, DOI 10.1007/s12630-020-01740-2
   Ahmad I, 2021, CAN J ANESTH, V68, P196, DOI 10.1007/s12630-020-01804-3
   Alcoforado L, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11070320
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Begley JL, 2020, ANAESTHESIA, V75, P1014, DOI 10.1111/anae.15115
   Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891
   Black AE, 2015, PEDIATR ANESTH, V25, P346, DOI 10.1111/pan.12615
   Brown J, 2021, ANAESTHESIA, V76, P174, DOI 10.1111/anae.15292
   Chagla Z, 2021, ANN INTERN MED, V174, pJC28, DOI 10.7326/ACPJ202103160-028
   Chagla Z, 2021, ANN INTERN MED, V174, pJC15, DOI 10.7326/ACPJ202102160-015
   Cook TM, 2021, ANAESTHESIA, V76, P251, DOI 10.1111/anae.15253
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Cook TM, 2021, ANESTHESIOLOGY, V135, P212, DOI 10.1097/ALN.0000000000003819
   Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002
   El-Boghdadly K, 2020, ANAESTHESIA, V75, P1437, DOI 10.1111/anae.15170
   Fiadjoe JE, 2016, LANCET RESP MED, V4, P37, DOI 10.1016/S2213-2600(15)00508-1
   Foley LJ, 2021, ANESTH ANALG, V133, P876, DOI 10.1213/ANE.0000000000005554
   Gaeckle NT, 2020, AM J RESP CRIT CARE, V202, P1115, DOI 10.1164/rccm.202006-2309OC
   Gaulton TG, 2021, BRIT J ANAESTH, V126, pE184, DOI 10.1016/j.bja.2021.01.019
   Groombridge CJ, 2021, EMERG MED AUSTRALAS, V33, P728, DOI 10.1111/1742-6723.13809
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5
   Krishna SG, 2018, J PEDIATR INTENSIVE, V7, P115, DOI 10.1055/s-0038-1624576
   Liu M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2195
   Malhotra N, 2020, INDIAN J ANAESTH, V64, P355, DOI 10.4103/ija.IJA_454_20
   Matava CT, 2020, ANESTH ANALG, V131, P61, DOI 10.1213/ANE.0000000000004872
   Mellado-Artigas R, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03469-w
   Park R, 2017, BRIT J ANAESTH, V119, P984, DOI 10.1093/bja/aex344
   Parotto M, 2021, CAN J ANESTH, V68, P425, DOI 10.1007/s12630-020-01890-3
   Patwa A, 2020, INDIAN J ANAESTH, V64, pS107, DOI 10.4103/ija.IJA_498_20
   Peyton J, 2021, BRIT J ANAESTH, V126, P331, DOI 10.1016/j.bja.2020.08.010
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Schmidt M, 2021, INTENS CARE MED, V47, P60, DOI 10.1007/s00134-020-06294-x
   Schumacher J, 2020, ANAESTHESIA, V75, P1301, DOI 10.1111/anae.15102
   Shah VP, 2021, INFECT CONT HOSP EP, DOI 10.1017/ice.2021.219
   Shrimpton AJ, 2021, ANAESTHESIA, V76, P1577, DOI [10.1111/anae.15542, 10.1111/anae.15572]
   Simpson JP, 2020, ANAESTHESIA, V75, P1587, DOI 10.1111/anae.15188
   Sorbello M, 2020, ANAESTHESIA, V75, P724, DOI 10.1111/anae.15049
   Sorbello M, 2020, BRIT J ANAESTH, V125, P880, DOI 10.1016/j.bja.2020.08.038
   Suzuki T, 2021, J INFECT CHEMOTHER, V27, P120, DOI 10.1016/j.jiac.2020.09.006
   Tighe NTG, 2021, PEDIATR ANESTH, V31, P461, DOI 10.1111/pan.14091
   Wong DJN, 2021, ANESTHESIOLOGY, V135, P292, DOI 10.1097/ALN.0000000000003791
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 44
TC 0
Z9 0
U1 2
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1155-5645
EI 1460-9592
J9 PEDIATR ANESTH
JI Pediatr. Anesth.
PD OCT
PY 2021
VL 31
IS 10
BP 1074
EP 1088
DI 10.1111/pan.14272
EA AUG 2021
PG 15
WC Anesthesiology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology; Pediatrics
GA UT0GZ
UT WOS:000688452000001
PM 34387013
DA 2022-04-20
ER

PT J
AU Gujski, M
   Humeniuk, E
   Bojar, I
AF Gujski, Mariusz
   Humeniuk, Ewa
   Bojar, Iwona
TI Current State of Knowledge About SARS-CoV-2 and COVID-19 Disease in
   Pregnant Women
SO MEDICAL SCIENCE MONITOR
LA English
DT Review
DE COVID-19; Parturition; Pregnancy; Pregnancy Complications, Infectious;
   Pregnancy Outcome; SARS Virus
AB During any epidemic of infectious diseases, pregnant women constitute an extremely sensitive group due to altered physiology and immune functions, and thus altered susceptibility to infection. With regard to the management of pregnant COVID-19 patients, in addition to the treatment of the infection itself, which is not that different from generally accepted principles, it is interesting to consider which obstetric procedures should be used to minimize the adverse effects on mother and child. Questions arise concerning the continuation of pregnancy, how to terminate the pregnancy, the possibility of virus transmission through the placenta, isolation of the newborn after birth, and breastfeeding.
   The aim of this study was to review the current state of knowledge about SARS-CoV-2 infection and COVID-19 disease in pregnant women. Because the epidemic began in China, most of the available literature comes from studies conducted there. The studies used to prepare this review article are the first non-randomized studies containing small groups of examined women. They do not provide clear indications, but show that in an epidemic situation, special care should be taken in pregnancy management, making decisions about termination of pregnancy, and handling of the newborn baby to minimize the risk of subsequent health consequences. Further analysis is needed on the incidence of COVID-19 among pregnant women and its consequences. This will allow us to develop recommendations on how to deal with patients in the future in case of repeated epidemic emergencies.
C1 [Gujski, Mariusz] Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland.
   [Humeniuk, Ewa] Med Univ Lublin, Dept Pathol & Rehabil Speech, Lublin, Poland.
   [Bojar, Iwona] Inst Rural Hlth Lublin, Dept Womens Hlth, Lublin, Poland.
RP Gujski, M (corresponding author), Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland.
EM mariusz.gujski@wum.edu.pl
RI Gujski, Mariusz/A-3222-2019; Bojar, Iwona/S-6029-2018
OI Gujski, Mariusz/0000-0002-2938-4795; Bojar, Iwona/0000-0002-3171-225X
CR Breslin N, 2020, AM J OBSTET GYNECOL
   Chen DJ, 2020, INT J GYNECOL OBSTET, V149, P130, DOI 10.1002/ijgo.13146
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen Y, 2020, J MED VIROL
   Cucinotta D, 2020, ACTA BIOMED, V91, P157, DOI [10.23750/abm.v91i1.9397, DOI 10.23750/ABM.V91I1.9397]
   Dashraath P, 2020, AM J OBSTET GYNECOL
   Fan C, 2020, CLIN INFECT
   Hormansdorfer S, 2008, J VERBRAUCH LEBENSM, V3, P417, DOI 10.1007/s00003-008-0374-0
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Liu Y, 2020, J INFECT
   Luo YW, 2020, LANCET INFECT DIS, V20, P513, DOI 10.1016/S1473-3099(20)30191-2
   MALINOWSKI A, 2003, GIN PRAKT, V11, P47
   Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014
   Sahu KK, 2020, ACTA OBSTET GYNECOL
   Schwartz DA, 2020, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2020-0901-SA, DOI 10.5858/ARPA.2020-0901-SA]
   Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2
   Wang X, 2020, CLIN INFECT DIS, Vpii, pciaa200
   Wernery U, 2017, VET J, V220, P75, DOI 10.1016/j.tvjl.2016.12.020
   Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics, 2020, Zhongguo Dang Dai Er Ke Za Zhi, V22, P87
   Yu N, 2020, LANCET INFECT DIS, V20, P559, DOI 10.1016/S1473-3099(20)30176-6
   Zhang L, 2020, ZHONGHUA FU CHAN KE
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 22
TC 11
Z9 11
U1 1
U2 79
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD MAY 9
PY 2020
VL 26
AR e924725
DI 10.12659/MSM.924725
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA LL1DG
UT WOS:000531295100001
PM 32385225
OA Green Published
DA 2022-04-20
ER

PT J
AU Alghanem, S
   Alqassim, G
   Abuzeyad, F
   Isa, R
   Falamarzi, H
AF Alghanem, Salah
   Alqassim, Ghada
   Abuzeyad, Feras
   Isa, Ruqaya
   Falamarzi, Horeya
TI Bird's-Eye View of COVID-19 Knowledge, Attitude and Practice Among
   Emergency Physicians in the Kingdom of Bahrain: A Cross-Sectional Study
SO OPEN ACCESS EMERGENCY MEDICINE
LA English
DT Article
DE coronavirus infections; COVID-19; disease outbreaks
ID TRANSMISSION; OUTBREAK; WUHAN
AB Background: Coronavirus 2019 (COVID-19) has exemplified the crucial role played by emergency physicians on the frontlines, by triaging, quarantining and treating myriad patients in time. Despite this, there exists a dearth of literature comprehensively assessing the knowledge and awareness of these health-care workers on the disease in the Kingdom of Bahrain. This study was designed to evaluate the knowledge, attitude, and practice (KAP) of emergency physicians in the Kingdom of Bahrain towards COVID-19.
   Methods: This cross-sectional descriptive study included 142 emergency physicians from three major hospitals in Bahrain. A self-designed questionnaire divided into 4 parts, which consists of demographics, knowledge, attitude and practices towards COVID-19, was completed by the emergency physicians working in these hospitals. Analysis of variance (ANOVA), t-test, chi-square test, and multiple linear regression were employed to evaluate KAP scores.
   Results: The mean COVID-19 knowledge and practice score was 26.29 for a maximum score of 32 suggesting an overall 82.15% correct rate on the knowledge and practice test. Multiple linear regression analysis highlighted age (p=0.038), genders (p=0.033), marital status (p=0.021), organization (p=0.032), having children (p=0.008), and continuing professional development (CPD) activity (p=0.0001) as significant predictors for knowledge and practice scores. The attitude towards the final success in controlling COVID-19 significantly differed across marital status (p=0.021), organization of participants (p=0.020) and position of participants (p=0.012), respectively.
   Conclusion: Adequate knowledge, positive attitude and sufficient safe practice towards COVID-19 were observed in majority of the participants. These findings can foster development of nuanced and salient health management strategies that augment KAP so that proper control and elimination of the disease can be achieved, while prioritizing patient health and satisfaction.
C1 [Alghanem, Salah] Bahrain Def Force Hosp, Emergency Med, POB 28197, West Riffa, Bahrain.
   [Alqassim, Ghada] Bahrain Def Force Hosp, Pediat Emergency Med, West Riffa, Bahrain.
   [Abuzeyad, Feras] King Hamad Univ Hosp, Emergency Med, Muharraq, Bahrain.
   [Isa, Ruqaya] Salmaniya Med Complex, Emergency Med, Manama, Bahrain.
   [Falamarzi, Horeya] Bahrain Def Force Hosp, Emergency Dept, West Riffa, Bahrain.
RP Alghanem, S (corresponding author), Bahrain Def Force Hosp, Emergency Med, POB 28197, West Riffa, Bahrain.
EM salah.alghanem@gmail.com
OI Alghanem, Salah/0000-0002-5077-9644
CR Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Erfani A, 2020, B WORLD HEALTH ORGAN, V76, P648, DOI DOI 10.2471/BLT.20.256651
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3
   Lum LHW, 2020, SINGAP MED J, V61, P55, DOI 10.11622/smedj.2020018
   Ma XQ, 2020, ACAD EMERG MED, V27, P312, DOI 10.1111/acem.13958
   Maheshwari S, 2020, J ACUTE DIS, V9, P100, DOI 10.4103/2221-6189.283886
   Parry J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m236
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   WHO, COR DIS COVID 2019 S
   World Health Organization, 2012, World Health Organ Tech Rep Ser, P1
   World Health Organization Regional Office for Europe, WHO ANN COVID 19 OUT
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 21
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-1500
J9 OPEN ACCESS EMERG M
JI Open Access Emerg. Med.
PY 2021
VL 13
BP 415
EP 423
DI 10.2147/OAEM.S323268
PG 9
WC Emergency Medicine
WE Emerging Sources Citation Index (ESCI)
SC Emergency Medicine
GA UR3GQ
UT WOS:000696640900001
PM 34548822
OA Green Published
DA 2022-04-20
ER

PT J
AU Pathan, F
   Selim, S
   Fariduddin, M
   Rahman, MH
   Ashrafuzzaman, SM
   Afsana, F
   Qureshi, NK
   Hossain, T
   Saifuddin, M
   Kamrul-Hasan, AB
   Mir, AS
AF Pathan, Faruque
   Selim, Shahjada
   Fariduddin, Md
   Rahman, Md Hafizur
   Ashrafuzzaman, S. M.
   Afsana, Faria
   Qureshi, Nazmul Kabir
   Hossain, Tanjina
   Saifuddin, M.
   Kamrul-Hasan, A. B.
   Mir, Ahmed Salam
TI Bangladesh Endocrine Society (BES) Position Statement for Management of
   Diabetes and Other Endocrine Diseases in Patients with COVID-19
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE COVID-19; diabetes mellitus; SARS COV-2; antidiabetic medications;
   endocrine diseases and COVID-19; thyroid disease and COVID-19
ID GLUCOSE; ACE2; RISK
AB Background: The year 2020 witnessed a largely unprecedented pandemic of coronavirus disease (COVID-19), caused by SARS COV-2. Many people with COVID-19 have comorbidities, including diabetes, hypertension and cardiovascular diseases, which are significantly associated with worse outcomes. Moreover, COVID-19 itself is allied with deteriorating hyperglycemia. Therefore, Bangladesh Endocrine Society has formulated some practical recommendations for management of diabetes and other endocrine diseases in patients with COVID-19 for use in both primary and specialist care settings.
   Objective: The objective of the article is to develop a guideline to protect the vulnerable group with utmost preference - the elderly and those with comorbid conditions. Therefore, to ensure the adequate protective measures and timely treatment for COVID-19 patients with diabetes, other endocrine diseases or any other comorbidities.
   Considering and Monitoring Issues:
   The risk of a fatal outcome from COVID-19 may be up to 50% higher in patients with diabetes than in non-diabetics.
   Patients with diabetes and COVID had CFR 7.3-9.2%, compared with 0.9-1.4% in patients without comorbidities.
   Diabetic ketoacidosis may be one of the causes of mortality in COVID-19.
   There is wide fluctuation of blood glucose in these patients, probably due to irregular diet, reduced exercise, increased glucocorticoids secretion, and use of glucocorticoids.
   HbA1c should be <7.0% for the majority of the patients, this target may be relaxed in appropriate clinical settings.
   More emphasis should be given on day-to-day blood glucose levels. Hypoglycemia (<3.9 mmol/l) must be avoided.
   Frequent monitoring of blood glucose is needed in critically ill patients.
   Conclusion: The fight against COVID-19 has been proven to be a challenging one. Therefore, all healthcare personnel should make the best use of updated knowledge and skills to ensure adequate protective measures and timely treatment for COVID-19 patients with diabetes, other endocrine diseases or any other comorbidities.
C1 [Pathan, Faruque; Ashrafuzzaman, S. M.; Afsana, Faria] BIRDEM Gen Hosp, Dept Endocrinol, Dhaka, Bangladesh.
   [Selim, Shahjada; Fariduddin, Md] Bangabandhu Sheikh Mujib Med Univ, Dept Endocrinol, Dhaka 1000, Bangladesh.
   [Rahman, Md Hafizur] Bangladesh Endocrine Soc, Dhaka, Bangladesh.
   [Qureshi, Nazmul Kabir] Natl Healthcare Network NHN Uttara EC, Dhaka, Bangladesh.
   [Hossain, Tanjina] Green Life Med Coll Hosp, Dept Endocrinol, Dhaka, Bangladesh.
   [Saifuddin, M.] Dhaka Med Coll Hosp, Dept Endocrinol, Dhaka, Bangladesh.
   [Kamrul-Hasan, A. B.] Mymensingh Med Coll Hosp, Dhaka, Bangladesh.
   [Mir, Ahmed Salam] BIHS Gen Hosp, Dept Endocrinol, Dhaka, Bangladesh.
RP Selim, S (corresponding author), Bangabandhu Sheikh Mujib Med Univ, Dept Endocrinol, Dhaka 1000, Bangladesh.
EM selimshahjada@yahoo.com
RI Hasan, A.B.M. Kamrul/AAC-8348-2020
OI Hasan, A.B.M. Kamrul/0000-0002-5681-6522; Qureshi, Nazmul
   Kabir/0000-0003-4327-8056
CR Alsifri S, 2020, INT J CLIN MED, V11, P199, DOI [DOI 10.4236/IJCM.2020.115020, 10.4236/ijcm.2020.115020]
   Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS66, DOI 10.2337/dc20-S006
   Amin EF, 2020, FUND CLIN PHARMACOL, V34, P548, DOI 10.1111/fcp.12548
   [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001
   [Anonymous], 2020, AACE POSITION STATEM
   [Anonymous], 2020, COVID 19 DIABETES
   [Anonymous], 2020, FDN NO PATIENTS PROV
   [Anonymous], 2020, COVID 19 DIABETES BA
   [Anonymous], 2020, MENTAL HLTH PSYCHOSO
   [Anonymous], 2020, COVID 19 OUTBREAK GU
   [Anonymous], 2020, REPORT WHO CHINA JOI
   [Anonymous], 2020, VITAMIN D DEFICIENCY
   [Anonymous], 2020, SICK DAY RULES MANAG
   [Anonymous], 2018, BANGLADESH ENDOCRINE
   [Anonymous], 2020, DIABETES MANAGEMENT
   [Anonymous], 2020, ADVICE HEALTHCARE PR
   [Anonymous], 2021, COVID 19 ENDOCRINE D
   [Anonymous], 2020, NATL GUIDELINES CLIN
   Banerjee M, 2020, DIABETES METAB SYND, V14, P351, DOI 10.1016/j.dsx.2020.04.013
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   Barrera FJ, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa102
   Basu Ananda, 2017, J Diabetes Sci Technol, V11, P936, DOI 10.1177/1932296817697329
   Bindom SM, 2009, MOL CELL ENDOCRINOL, V302, P193, DOI 10.1016/j.mce.2008.09.020
   Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2
   Cemiyeti TD, 2020, J CLIN INTERN MED, V37, P215
   Ceriello A, 2008, DIABETES-METAB RES, V24, P14, DOI 10.1002/dmrr.790
   Ceriello A, 2020, DIABETES RES CLIN PR, V163, DOI 10.1016/j.diabres.2020.108151
   Ceriello A, 2020, DIABETES CARE, V43, P1427, DOI 10.2337/dc20-0941
   Drucker DJ, 2020, ENDOCR REV, V41, P457, DOI 10.1210/endrev/bnaa011
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Ganie MA, 2020, THYROID RES PRACT, V17, P4, DOI [10.4103/ trp. trp_ 28_ 20, DOI 10.4103/TRP.TRP_28_20]
   Ghaffari H, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0563-4
   Ghelichkhani P, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.674
   Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Gupta R, 2020, EUR J CLIN NUTR, V74, P864, DOI 10.1038/s41430-020-0652-1
   Hemila H, 1997, PEDIATR INFECT DIS J, V16, P836, DOI 10.1097/00006454-199709000-00003
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Iacobellis G, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108125
   Interim U.S, 2021, GUID RISK ASS WORK R
   Latif ZA, 2017, BIRDEM MED J, V7, P17, DOI [10.3329/birdem. v7i1.31268, DOI 10.3329/BIRDEM.V7I1.31268]
   Liamis G, 2011, J INFECTION, V63, P327, DOI 10.1016/j.jinf.2011.07.013
   Liu YJ, 2020, ARTECH HSE MOB COMM, P1
   Matthews R, 2020, MEDSCAPE DIABETES EN
   National Inpatient Diabetes Covid-19 Response Group, 2020, CONC ADV INP DIAB CO
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Pal R, 2020, DIABETES RES CLIN PR, V163, DOI 10.1016/j.diabres.2020.108146
   Plattner F, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P467
   Rao PV, 2018, INT J DIABETES DEV C, V38, P260, DOI 10.1007/s13410-018-0677-3
   Rayman G, 2020, DIABETIC MED, V37, P1087, DOI 10.1111/dme.14316
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Roca-Ho H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030563
   Roncon L, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104354
   Schuster KM, 2014, J TRAUMA ACUTE CARE, V76, P798, DOI 10.1097/TA.0000000000000127
   Sharma S, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108183
   Singh A, 2020, J DIABETOL, V11, P131, DOI [10.4103/JOD.JOD_53_20, DOI 10.4103/JOD.JOD_53_20]
   Singh AK, 2020, DIABETES OBES METAB, V22, P1915, DOI 10.1111/dom.14124
   Singh AK, 2021, DIABETES METAB SYND, V15, P159, DOI 10.1016/j.dsx.2020.12.026
   Singh AK, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108266
   Thomas P, 2020, J PHYSIOTHER, V66, P73, DOI 10.1016/j.jphys.2020.03.011
   Wang AH, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108118
   Yamamoto JM, URGENT UPDATE TEMPOR
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Yang WJ, 2016, DIABETES-METAB RES, V32, P391, DOI 10.1002/dmrr.2723
   Zhang BC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235458
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505
NR 67
TC 0
Z9 0
U1 1
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2021
VL 14
BP 2217
EP 2228
DI 10.2147/DMSO.S293688
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA SH9IH
UT WOS:000654443300001
PM 34040407
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Mozafari, N
   Azadi, S
   Mehdi-Alamdarlou, S
   Ashrafi, H
   Azadi, A
AF Mozafari, Negin
   Azadi, Soha
   Mehdi-Alamdarlou, Sanaz
   Ashrafi, Hajar
   Azadi, Amir
TI Inflammation: A bridge between diabetes and COVID-19, and possible
   management with sitagliptin
SO MEDICAL HYPOTHESES
LA English
DT Article
DE Sitagliptin; COVID-19; Inflammation; Diabetes
ID NF-KAPPA-B; INSULIN; MECHANISMS; MELLITUS; EXERTS
AB Patients with SARS-CoV-2 infections experience lymphopenia and inflammatory cytokine storms in the severe stage of the disease, leading to multi-organ damage. The exact pattern of immune system changes and their condition during the disease process is unclear. The available knowledge has indicated that the NF-kappa-B pathway, which is induced by several mediators, has a significant role in cytokine storm through the various mechanisms. Therefore, identifying the state of the immune cells and the dominant mechanisms for the production of cytokines incorporated in the cytokine storm can be a critical step in the therapeutic approach. On the other hand, some studies identified a higher risk for diabetic patients. Diabetes mellitus exhibits a close association with inflammation and increases the chance of developing COVID-19. Patients with diabetes mellitus have shown to have more virus entry, impaired immunity response, less viral elimination, and dysregulated inflammatory cytokines. The parallel analysis of COVID-19 and diabetes mellitus pathogenesis has proposed that the control of the inflammation through the interfering with the critical points of major signaling pathways may provide the new therapeutic approaches. In recent years, the role of Dipeptidyl Peptidase 4 (DPP4) in chronic inflammation has been proved. Numerous immune cells express the DPP4 protein. DPP4 regulates antibody production, cytokine secretion, and immunoglobulin class switching. DPP4 inhibitors like sitagliptin reduce inflammation intensity in different states.
   Following the accumulating data, we hypothesize that sitagliptin might reduce COVID-19 severity. Sitagliptin, an available DPP4 inhibitor drug, showed multidimensional anti-inflammatory effects among diabetic patients. It reduces the inflammation mostly by affecting on NF-kappa-B signaling pathway. Under the fact that inflammatory mediators are active in individuals with COVID-19, blocking the predominant pathway could be helpful.
C1 [Mozafari, Negin; Mehdi-Alamdarlou, Sanaz; Ashrafi, Hajar; Azadi, Amir] Shiraz Univ Med Sci, Sch Pharm, Dept Pharmaceut, Shiraz, Iran.
   [Azadi, Soha] Shiraz Univ Med Sci, Sch Pharm, Dept Clin Pharm, Shiraz, Iran.
   [Azadi, Amir] Shiraz Univ Med Sci, Pharmaceut Sci Res Ctr, Shiraz, Iran.
RP Azadi, A (corresponding author), Shiraz Univ Med Sci, Sch Pharm, Dept Pharmaceut, Shiraz, Iran.
EM aazadi@sums.ac.ir
CR Aguilera ER, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00105
   Alexaki VI, 2009, J IMMUNOL, V183, P5948, DOI 10.4049/jimmunol.0901186
   American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005
   Asferg C, 2009, AM J HYPERTENS, V22, P451, DOI 10.1038/ajh.2009.1
   Asif AH, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8060861
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Dorrington MG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00705
   Evans P, 2015, DIABETES PRIMARY CAR, V17, P36
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fung TS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00296
   Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003
   Hodgson K, 2015, IMMUNOLOGY, V144, P171, DOI 10.1111/imm.12394
   Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Hu XY, 2017, ENDOCRINE, V55, P754, DOI 10.1007/s12020-016-1073-8
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jin Y, 2020, VIROLOGY EPIDEMIOLOG
   Kim B, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.3
   Lawrence Toby, 2009, Cold Spring Harb Perspect Biol, V1, pa001651, DOI 10.1101/cshperspect.a001651
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001
   Lin L, 2020, EMERG MICROBES INFEC, V9, P727, DOI 10.1080/22221751.2020.1746199
   Liu C, 2020, ROBOTICS: SCIENCE AND SYSTEMS XVI
   Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y
   Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846
   Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544
   Marette A, 2003, INT J OBESITY, V27, pS46, DOI 10.1038/sj.ijo.0802500
   Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114
   McGonaglea D, 2020, AUTOIMMUN REV
   Muniyappa R, AM J PHYSL ENDOC M
   Nally FK, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060543
   Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200
   Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Sun Q, 2017, BIO-MED MATER ENG, V28, pS139, DOI 10.3233/BME-171635
   Ta NN, 2010, ATHEROSCLEROSIS, V213, P429, DOI 10.1016/j.atherosclerosis.2010.08.064
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Thondawada M, 2018, DRUG DEV IND PHARM, V44, P1120, DOI 10.1080/03639045.2018.1438460
   Ujhelyi J, 2014, REGUL PEPTIDES, V194, P23, DOI 10.1016/j.regpep.2014.09.006
   Vankadari N, 2020, EMERG MICROBES INFEC, V9, P601, DOI 10.1080/22221751.2020.1739565
   Watanabe K, 2020, SOC SCI COMPUT REV, DOI 10.1177/0894439320907027
   Wicinski M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6091014
   Wu DD, 2020, J MICROBIOL IMMUNOL, V53, P368, DOI 10.1016/j.jmii.2020.03.005
   Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003
   Zhang B, 2020, IMMUNE PHENOTYPING B, p2020031220035048, DOI 10.1101/2020.03.12.20035048
   Zhang CP, 2014, HUM IMMUNOL, V75, P289, DOI 10.1016/j.humimm.2014.02.007
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4
NR 53
TC 24
Z9 24
U1 2
U2 6
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD OCT
PY 2020
VL 143
AR 110111
DI 10.1016/j.mehy.2020.110111
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA OA0UL
UT WOS:000577511800079
PM 32721805
OA Bronze, Green Published
DA 2022-04-20
ER

PT C
AU Berardi, M
   Cifolelli, S
   Ziruolo, A
AF Berardi, Marco
   Cifolelli, Simone
   Ziruolo, Andrea
BE GarciaPerez, A
   Simkin, L
TI Overcoming the COVID-19 Crisis with KM and Smart Governance: The
   Challenge for the Italian Public Sector
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE COVID-19 crisis; public sector; smart governance and KM
AB March 2020, Italian prime minister Giuseppe Conte has ordered several restrictions on Italian citizens and locked down the entire country to stop the spreading of COVID-19. This strategy has deeply pushed the digitalization of the Italian public sector through knowledge management patterns, leading to a rethinking of the "Public administration mindset" with a Smart Governance approach (Italian stability act, 2021, Heeks, 2002). This work analyses the paradigm shift occurred in the main Italian reforms that occured in the last year through a "Knowledge Management Toolkit" (Herbert, 2010) along with a report of interviews conducted with local authorities' managers and citizens, showing that while the plague was spreading, the Italian Public sector conducted a silent revolution led by two words: digitalization and knowledge management (Riege et. al, 2006; Velasquez, 2021).
C1 [Berardi, Marco; Cifolelli, Simone] Gabriele dAnnunzio Univ, Dept Management & Business Adm, Accounting Management & Business Econ, Pescara, Italy.
   [Ziruolo, Andrea] Gabriele dAnnunzio Univ, Dept Management & Business Adm, Business Adm, Pescara, Italy.
RP Berardi, M (corresponding author), Gabriele dAnnunzio Univ, Dept Management & Business Adm, Accounting Management & Business Econ, Pescara, Italy.
EM marco.berardi@unich.it; simone.cifolelli@unich.it;
   andrea.ziruolo@unich.it
CR AGID, 2021, SPES ICT NELLA IT CO
   Berardi M., 2021, ORG DIGITIZED WORLD
   De Gooijer, 2000, J KNOWLEDGE MANAGEME, V4, P303, DOI [DOI 10.1108/13673270010379858, 10.1108/13673270010379858]
   Deidda Gagliardo E, 2012, CREAZIONE VALORE NEL
   Heeks R, 2002, INFORM SOC, V18, P101, DOI 10.1080/01972240290075039
   Heeks R., 2003, IGOVERNMENT WORKING
   Herbert R., 2010, GOVERNANCE KNOWLEDGE
   HOOD C, 1991, PUBLIC ADMIN, V69, P3, DOI 10.1111/j.1467-9299.1991.tb00779.x
   Kamara J.M., 2002, INT J PROJ MANAG, V20, P205, DOI [10.1016/S0263-7863(01)00070-9, DOI 10.1016/S0263-7863(01)00070-9]
   Prometeia, 2020, PRIM BIL ANN DALL SC
   Riege A., 2006, Journal of Knowledge Management, V10, P24, DOI 10.1108/13673270610670830
   Sebastiani G, 2020, EUR J EPIDEMIOL, V35, P341, DOI 10.1007/s10654-020-00631-6
   Senate of the Italian Republic, 2021, DOC EM SAN COVID 19
   Velasquez RMA, 2021, TECHNOL SOC, V64, DOI 10.1016/j.techsoc.2020.101479
   Vial G, 2019, J STRATEGIC INF SYST, V28, P118, DOI 10.1016/j.jsis.2019.01.003
   World Bank report, 2020, TRAD DEV AG GLOB VAL
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 54
EP 61
DI 10.34190/EKM.21.023
PG 8
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900007
DA 2022-04-20
ER

PT J
AU Bosch-Barrera, J
   Roque, A
   Teixidor, E
   Carmona-Garcia, MC
   Arbusa, A
   Brunet, J
   Martin-Castillo, B
   Cuyas, E
   Verdura, S
   Menendez, JA
AF Bosch-Barrera, Joaquim
   Roque, Ariadna
   Teixidor, Eduard
   Carmona-Garcia, Maria Carmen
   Arbusa, Aina
   Brunet, Joan
   Martin-Castillo, Begona
   Cuyas, Elisabet
   Verdura, Sara
   Menendez, Javier A.
TI Clinical Management of COVID-19 in Cancer Patients with the STAT3
   Inhibitor Silibinin
SO PHARMACEUTICALS
LA English
DT Article
DE SARS-CoV-2; COVID-19; STAT3; silibinin; Legalon; COVID-GRAM score
ID C-REACTIVE PROTEIN; CHRONIC HEPATITIS-C; LACTATE-DEHYDROGENASE;
   RESPIRATORY-FAILURE; LIVER-DISEASE; HEPATOCYTES; ACTIVATION; MORTALITY;
   INFECTION; SILYMARIN
AB COVID-19 pathophysiology is caused by a cascade of respiratory and multiorgan failures arising, at least in part, from the SARS-CoV-2-driven dysregulation of the master transcriptional factor STAT3. Pharmacological correction of STAT3 over-stimulation, which is at the root of acute respiratory distress syndrome (ARDS) and coagulopathy/thrombosis events, should be considered for treatment of severe COVID-19. In this perspective, we first review the current body of knowledge on the role of STAT3 in the pathogenesis of severe COVID-19. We then exemplify the potential clinical value of treating COVID-19 disease with STAT3 inhibitors by presenting the outcomes of two hospitalized patients with active cancer and COVID-19 receiving oral Legalon(R)-a nutraceutical containing the naturally occurring STAT3 inhibitor silibinin. Both patients, which were recruited to the clinical trial SIL-COVID19 (EudraCT number: 2020-001794-77) had SARS-CoV-2 bilateral interstitial pneumonia and a high COVID-GRAM score, and showed systemic proinflammatory responses in terms of lymphocytopenia and hypoalbuminemia. Both patients were predicted to be at high risk of critical COVID-19 illness in terms of intensive care unit admission, invasive ventilation, or death. In addition to physician's choice of best available therapy or supportive care, patients received 1050 mg/day Legalon(R) for 10 days without side-effects. Silibinin-treated cancer/COVID-19+ patients required only minimal oxygen support (2-4 L/min) during the episode, exhibited a sharp decline of the STAT3-regulated C-reactive protein, and demonstrated complete resolution of the pulmonary lesions. These findings might inspire future research to advance our knowledge and improve silibinin-based clinical interventions aimed to target STAT3-driven COVID-19 pathophysiology.
C1 [Bosch-Barrera, Joaquim; Roque, Ariadna; Teixidor, Eduard; Carmona-Garcia, Maria Carmen; Brunet, Joan] Dr Josep Trueta Hosp Girona, Catalan Inst Oncol, Med Oncol, Girona 17007, Spain.
   [Bosch-Barrera, Joaquim; Brunet, Joan] Univ Girona, Med Sch, Dept Med Sci, Girona 17003, Spain.
   [Bosch-Barrera, Joaquim; Arbusa, Aina; Martin-Castillo, Begona; Cuyas, Elisabet; Verdura, Sara; Menendez, Javier A.] Girona Biomed Res Inst IDIBGI, Salt 17190, Spain.
   [Arbusa, Aina; Cuyas, Elisabet; Verdura, Sara; Menendez, Javier A.] Catalan Inst Oncol, Metab & Canc Grp, Program Canc Therapeut Resistance ProCURE, Girona 17007, Spain.
   [Brunet, Joan] IDIBELL, Catalan Inst Oncol, Lhospitalet De Llobregat 08908, Spain.
   [Martin-Castillo, Begona] Catalan Inst Oncol, Unit Clin Res, Girona 17007, Spain.
RP Bosch-Barrera, J (corresponding author), Dr Josep Trueta Hosp Girona, Catalan Inst Oncol, Med Oncol, Girona 17007, Spain.; Bosch-Barrera, J (corresponding author), Univ Girona, Med Sch, Dept Med Sci, Girona 17003, Spain.; Bosch-Barrera, J; Menendez, JA (corresponding author), Girona Biomed Res Inst IDIBGI, Salt 17190, Spain.; Menendez, JA (corresponding author), Catalan Inst Oncol, Metab & Canc Grp, Program Canc Therapeut Resistance ProCURE, Girona 17007, Spain.
EM jbosch@iconcologia.net; aroque@iconcologia.net;
   eteixidor@iconcologia.net; ccarmona@iconcologia.net; aarbusa@idibgi.org;
   jbrunet@iconcologia.net; bmartin@iconcologia.net; ecuyas@idibgi.org;
   sverdura@idibgi.org; jmenendez@idibgi.org
RI Brunet, Joan/C-5292-2018
OI Brunet, Joan/0000-0003-1945-3512; Bosch-Barrera,
   Joaquim/0000-0002-0893-7821; Arbusa Roca, Aina/0000-0002-7053-7386
FU Spanish Ministry of Science and Innovation (Plan Nacional de I + D + I)
   [PID2019-104055GB-I00]; Fundacio Oncolliga Girona (Lliga catalana
   d'ajuda al malalt de cancer, Girona); Grupo Espanol de Cancer de Pulmon
   (GECP); La Marato de TV3 foundation [201906]; Health Research and
   Innovation Strategic Plan (PERIS 2016-2020; Pla strategic de recerca i
   innovacio en salut; Departament de Salut, Generalitat de Catalunya)
   [SLT006/17/114]; Instituto de Salud Carlos IIIInstituto de Salud Carlos
   IIIEuropean Commission [CP20/00003]; Spanish Ministry of Science and
   Innovation (Spain)Spanish Government
FX Work in the Menendez laboratory is supported by the Spanish Ministry of
   Science and Innovation (Grant PID2019-104055GB-I00, Plan Nacional de I +
   D + I, founded by the European Regional Development Fund, Spain) and by
   an unrestricted research grant from the Fundacio Oncolliga Girona (Lliga
   catalana d'ajuda al malalt de cancer, Girona). Joaquim Bosch-Barrera is
   the recipient of Research Grants from Grupo Espanol de Cancer de Pulmon
   (GECP), La Marato de TV3 foundation (201906), and the Health Research
   and Innovation Strategic Plan (SLT006/17/114; PERIS 2016-2020; Pla
   strategic de recerca i innovacio en salut; Departament de Salut,
   Generalitat de Catalunya). Elisabet Cuyas holds a research contract
   "Miguel Servet" (CP20/00003) from the Instituto de Salud Carlos III,
   Spanish Ministry of Science and Innovation (Spain). The authors would
   like to heartily thank Konig (www.konig.cat, access date 30 May 2021)
   for their generous donation to fund our cancer research on silibinin in
   Girona.
CR Agha Mounzer, 2021, medRxiv, DOI 10.1101/2021.04.06.21254949
   Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c
   Bertuzzi AF, 2021, BRIT J CANCER, V125, P358, DOI 10.1038/s41416-021-01396-9
   Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200
   Blaising J, 2013, CELL MICROBIOL, V15, P1866, DOI 10.1111/cmi.12155
   Bosch-Barrera J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061770
   Bosch-Barrera J, 2017, CANCER TREAT REV, V58, P61, DOI 10.1016/j.ctrv.2017.06.003
   Bosch-Barrera J, 2015, CANCER TREAT REV, V41, P540, DOI 10.1016/j.ctrv.2015.04.008
   Braun DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133028
   Bronte V, 2020, J CLIN INVEST, V130, P6409, DOI 10.1172/JCI141772
   Chavez-MacGregor M, 2022, JAMA ONCOL, V8, P69, DOI 10.1001/jamaoncol.2021.5148
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Dettorre GM, 2021, ESMO OPEN, V6, DOI 10.1016/j.esmoop.2021.100123
   Dettorre GM, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-002277
   Dong XT, 2020, INT J MED SCI, V17, P2225, DOI 10.7150/ijms.47604
   Elkrief A, 2020, EUR J CANCER, V139, P181, DOI 10.1016/j.ejca.2020.08.017
   Fathalah WF, 2017, J INTERF CYTOK RES, V37, P480, DOI 10.1089/jir.2017.0051
   Ferenci P, 2008, GASTROENTEROLOGY, V135, P1561, DOI 10.1053/j.gastro.2008.07.072
   Flaig TW, 2010, PROSTATE, V70, P848, DOI 10.1002/pros.21118
   Fried MW, 2012, JAMA-J AM MED ASSOC, V308, P274, DOI 10.1001/jama.2012.8265
   Fu C, 2021, CANCER-AM CANCER SOC, V127, P3466, DOI 10.1002/cncr.33657
   Gando S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.649122
   Garcia-Ortega A, 2021, J THORAC DIS, V13, P1239, DOI 10.21037/jtd-20-3062
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   He JH, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02097-z
   Higashikuni Y, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222112081
   Hosoi Toru, 2012, Front Endocrinol (Lausanne), V3, P12, DOI 10.3389/fendo.2012.00012
   Jafarzadeh A, 2021, MICROB PATHOGENESIS, V154, DOI 10.1016/j.micpath.2021.104836
   Jimenez M., 2021, BLOOD ADV
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Kang SJ, 2019, IMMUNITY, V50, P1007, DOI 10.1016/j.immuni.2019.03.026
   Kellici TF, 2021, TRENDS PHARMACOL SCI, V42, P431, DOI 10.1016/j.tips.2021.03.006
   Khan SS, 2021, AM J RESP CELL MOL, V65, P238, DOI 10.1165/rcmb.2021-0208ED
   King C, 2021, TRENDS IMMUNOL, V42, P312, DOI 10.1016/j.it.2021.02.003
   Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9
   Kumar G.B., 2021, DRUG DISCOV TODAY
   Lazzeroni M, 2016, CANCER PREV RES, V9, P89, DOI 10.1158/1940-6207.CAPR-15-0123
   Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033
   Liu CH, 2019, MOLECULES, V24, DOI 10.3390/molecules24081552
   Matsuyama T, 2020, CELL DEATH DIFFER, V27, P3209, DOI 10.1038/s41418-020-00633-7
   MCFADDEN RG, 1991, CHEST, V100, P1182, DOI 10.1378/chest.100.4.1182-b
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Monari C, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.662746
   Monin L, 2021, LANCET ONCOL, V22, P765, DOI 10.1016/S1470-2045(21)00213-8
   Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925
   Moreno-Perez O, 2021, JAMA INTERN MED, V181, P1000, DOI 10.1001/jamainternmed.2021.0491
   Navarro VJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221683
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Palich R, 2021, Ann Oncol, V32, P1294, DOI 10.1016/j.annonc.2021.06.018
   Palich R, 2021, ANN ONCOL, V32, P1051, DOI 10.1016/j.annonc.2021.04.020
   Payer BA, 2010, J CLIN VIROL, V49, P131, DOI 10.1016/j.jcv.2010.07.006
   Pinato DJ, 2020, CANCER DISCOV, V10, P1465, DOI 10.1158/2159-8290.CD-20-0773
   Poggiali E, 2020, CLIN CHIM ACTA, V509, P135, DOI 10.1016/j.cca.2020.06.012
   Portier I, 2021, CURR OPIN HEMATOL, V28, P445, DOI 10.1097/MOH.0000000000000666
   Priego N, 2018, NAT MED, V24, P1024, DOI 10.1038/s41591-018-0044-4
   Reis G, 2022, LANCET GLOB HEALTH, V10, pE36, DOI 10.1016/S2214-109X(21)00448-4
   Rendina M, 2014, TRANSPL INT, V27, P696, DOI 10.1111/tri.12324
   Sacconi A, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04299-y
   Speciale A, 2021, PHYTOTHER RES, V35, P4616, DOI 10.1002/ptr.7107
   Spinelli FR, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc5367
   Sun HY, 2011, MOL CELL BIOCHEM, V347, P183, DOI 10.1007/s11010-010-0627-y
   Taoufik Y, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.692598
   Verdura S, 2018, FOOD CHEM TOXICOL, V116, P161, DOI 10.1016/j.fct.2018.04.028
   Wang L, 2020, AGING-US, V12, P24462, DOI 10.18632/aging.104205
   Wang TM, 2013, MOL CELL BIOCHEM, V377, P97, DOI 10.1007/s11010-013-1574-1
   Yarza R, 2020, EUR J CANCER, V135, P242, DOI 10.1016/j.ejca.2020.06.001
   Zhang DX, 1996, J BIOL CHEM, V271, P9503, DOI 10.1074/jbc.271.16.9503
   Zhang H, 2021, JNCI-J NATL CANCER I, V113, P371, DOI 10.1093/jnci/djaa168
   Zhang Y, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13102060
NR 70
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JAN
PY 2022
VL 15
IS 1
AR 19
DI 10.3390/ph15010019
PG 15
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA ZB5VD
UT WOS:000756908600001
PM 35056076
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Luo, L
   Ni, J
   Zhou, MY
   Wang, CY
   Wen, W
   Jiang, JJ
   Cheng, YR
   Zhang, XW
   Wang, MW
   Wang, WJ
AF Luo, Lin
   Ni, Jie
   Zhou, Mengyun
   Wang, Chunyi
   Wen, Wen
   Jiang, Jingjie
   Cheng, Yongran
   Zhang, Xingwei
   Wang, Mingwei
   Wang, Wenjun
TI Food Safety Knowledge, Attitudes, and Self-Reported Practices Among
   Medical Staff in China Before, During and After the COVID-19 Pandemic
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE food safety; medical staff; COVID-19; questionnaire
ID NUTRITION GUIDANCE; PHYSICIANS; HEALTH
AB Purpose: To compare food safety knowledge, attitudes, and self-reported practices among medical staff in China before, during, and after the COVID-19 pandemic. Patients and Methods: The questionnaire was anonymous. All respondents were Chinese medical personnel. A Chi-square contingency table was used to compare the knowledge and attitudes of Chinese medical staff before, during and after COVID-19. R statistical software (v4.0.0) was used for analysis. Results: A total of 1431 valid responses (57.3% from female respondents) were included in our analysis. Medical professionals were geographically distributed as follows: eastern China, 55.5%; central China, 19.7%; western China, 24.1%; Hong Kong, Macau, or Taiwan, 0.05%. Medical professionals reported that they paid greater attention to food safety after the COVID-19 pandemic compared with before the epidemic. Self-reported knowledge of and attitudes toward food safety among medical staff were significantly different before, during, and after the COVID-19 pandemic (both P<0.001). Conclusion: After the COVID-19 pandemic, medical professionals paid increasing attention to food safety, which is a clinically important change. Because medical professionals can influence public understanding of food safety, their increased attention to this subject may enable them to promote food safety knowledge more actively in their work. This may in turn promote a better understanding of food safety and protect the health of the general public.
C1 [Luo, Lin; Wang, Wenjun] Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Jiangxi, Peoples R China.
   [Luo, Lin] Hangzhou Ruolin Hosp Management Co Ltd, Hangzhou 310007, Peoples R China.
   [Luo, Lin] Hangzhou Kaihong Technol Co Ltd, Hangzhou 310059, Peoples R China.
   [Luo, Lin] Gege Med Technol Shanghai Co Ltd, Shanghai 200082, Peoples R China.
   [Ni, Jie; Wang, Chunyi; Wen, Wen; Jiang, Jingjie; Zhang, Xingwei; Wang, Mingwei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou Inst Cardiovasc Dis, Hangzhou 310015, Peoples R China.
   [Zhou, Mengyun] Shinshu Univ, Sch Med, Dept Mol & Cellular Physiol, Nagano 3900803, Japan.
   [Cheng, Yongran] Hangzhou Med Coll, Sch Publ Hlth, Hangzhou 311300, Peoples R China.
RP Wang, WJ (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Jiangxi, Peoples R China.; Wang, MW (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Hangzhou Inst Cardiovasc Dis, Hangzhou 310015, Peoples R China.
EM wmw990556@163.com; wwjun9999@jxau.edu.cn
RI W, Mingwei/AGW-0208-2022
OI W, Mingwei/0000-0001-9060-5107
FU Hangzhou Science and Technology Bureau fund [20150733Q24, 201912 03B96,
   20191203B105, 20171334M01]; Youth Fund of Zhejiang Academy of Medical
   Sciences [2019Y009]; Medical and Technology Project of Zhejiang Province
   [2020362651, 2021KY890]; Clinical Research Fund of Zhejiang Medical
   Association [2020ZYC-A13]; Hangzhou Health and Family Planning
   Technology Plan Key Projects [2017ZD02]; Zhejiang Traditional Chinese
   Medicine Scientific Research Fund Project [2022ZB280]
FX This study was supported by Hangzhou Science and Technology Bureau fund
   (No. 20150733Q24; No. 201912 03B96; No. 20191203B105; No. 20171334M01);
   Youth Fund of Zhejiang Academy of Medical Sciences (No. 2019Y009);
   Medical and Technology Project of Zhejiang Province (No. 2020362651, No.
   2021KY890); Clinical Research Fund of Zhejiang Medical Association (No.
   2020ZYC-A13); Hangzhou Health and Family Planning Technology Plan Key
   Projects (No.2017ZD02). Zhejiang Traditional Chinese Medicine Scientific
   Research Fund Project (No.2022ZB280).
CR Abbas J, 2021, RISK MANAG HEALTHC P, V14, P1917, DOI 10.2147/RMHP.S284313
   Alrobaish WS, 2021, J FOOD SCI, V86, P16, DOI 10.1111/1750-3841.15552
   Auad LI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081784
   Azizi MR, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e07233
   Buccheri C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-45
   Chinese Nutrition Society, 2020, NUTR DIET GUID PER A, V1st
   Chinese Nutrition Society Chinese Medical Doctor Association Chinese Medical Association of Parenteral and Enteral Nutrition, 2020, NUTR DIET GUID PREV
   Clinical Nutrition Branch of Chinese Society of Nutrition, 2020, NUTR SUGG PREV THER
   Dantas KB, 2020, REV BRAS ENFERM, V73, DOI 10.1590/0034-7167-2019-0044
   Desai Angel N, 2020, JAMA, V323, P1982, DOI 10.1001/jama.2020.5877
   Feng ZH, 2020, J INFECTION, V80, P605, DOI 10.1016/j.jinf.2020.02.011
   He SK, 2021, FOODBORNE PATHOG DIS, V18, P510, DOI 10.1089/fpd.2021.0009
   Hiddink GJ, 1997, PREV MED, V26, P29, DOI 10.1006/pmed.1996.9996
   Iftekhar A, 2021, FOODS, V10, DOI 10.3390/foods10061289
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   KOTTKE TE, 1984, PREV MED, V13, P219, DOI 10.1016/0091-7435(84)90053-7
   Krawinkel MB, 2012, ANN NUTR METAB, V61, P39, DOI 10.1159/000345162
   Li Ning, 2017, Journal of Food Science and Technology, V35, P1, DOI 10.3969/j.issn.2095-6002.2017.01.001
   Luo YY, 2021, PUBLIC HEALTH NUTR, V24, P267, DOI 10.1017/S1368980020002797
   Ma LH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7475-9
   Ma NL, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110405
   Martindale R, 2020, JPEN-PARENTER ENTER, V44, P1174, DOI 10.1002/jpen.1930
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502
   NeJhaddadgar N, 2022, J PUBLIC HEALTH-HEID, V30, P1301, DOI 10.1007/s10389-020-01407-8
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Limon MR, 2021, CURR RES FOOD SCI, V4, P63, DOI 10.1016/j.crfs.2021.01.001
   Singla R, 2020, VET RES COMMUN, V44, P119, DOI 10.1007/s11259-020-09781-0
   Su ZH, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-020-00654-4
   van Weel C, 1999, EUR J CLIN NUTR, V53, pS108, DOI 10.1038/sj.ejcn.1600813
   Wang KL, 2020, VACCINE, V38, P7049, DOI 10.1016/j.vaccine.2020.09.021
   Worsley A, 1999, EUR J CLIN NUTR, V53, pS101, DOI 10.1038/sj.ejcn.1600812
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Lebni JY, 2021, INT J SOC PSYCHIATR, V67, P298, DOI 10.1177/0020764020939984
   Zhang WM, 2021, BIOSENSORS-BASEL, V11, DOI 10.3390/bios11030071
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhou YQ, 2020, CTS-CLIN TRANSL SCI, V13, P1077, DOI 10.1111/cts.12805
NR 36
TC 0
Z9 0
U1 5
U2 5
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 5027
EP 5038
DI 10.2147/RMHP.S339274
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA XU0LJ
UT WOS:000733967600001
PM 34938138
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Feng, HY
   Gan, CCR
   Leiva, D
   Zhang, BL
   Davies, SE
AF Feng, Huiyun
   Gan, Connie Cai Ru
   Leiva, Diego
   Zhang, Bao Ling
   Davies, Sara E.
TI COVID-19, sex, and gender in China: a scoping review
SO GLOBALIZATION AND HEALTH
LA English
DT Review
DE Sex-disaggregated data; China; COVID-19; Gendered impacts
ID PSYCHOLOGICAL IMPACT; HEALTH-CARE; CORONAVIRUS; WOMEN; TRANSMISSION;
   DIAGNOSIS; WORKERS; WUHAN
AB Background During the course of the COVID-19 pandemic, states were called upon by the World Health Organization to introduce and prioritise the collection of sex-disaggregated data. The collection of sex-disaggregated data on COVID-19 testing, infection rates, hospital admissions, and deaths, when available, has informed our understanding of the biology of the infectious disease. The collection of sex-disaggregated data should also better inform our understanding of the gendered impacts that contribute to risk of exposure to COVID-19. In China, the country with the longest history of fighting the COVID-19 infection, what research was available on the gender-differential impacts of COVID-19 in the first 6 months of the COVID-19 pandemic? Methods In this scoping review, we examine the first 6 months (January-June 2020) of peer-reviewed publications (n = 451) on sex and gender experiences related to COVID-19 in China. We conducted an exhaustive search of published Chinese and English language research papers on COVID-19 in mainland China. We used a COVID-19 Gender Matrix informed by the JPHIEGO gender analysis toolkit to examine and illuminate research into the gendered impacts of COVID-19 within China. Results In China, only a small portion of the COVID-19-related research focused on gender experiences and differences. Near the end of the six-month literature review period, a small number of research items emerged on women healthcare workers, women's mental health, and pregnant women's access to care. There was an absence of research on the gendered impact of COVID-19 amongst populations. There was minimal consideration of the economic, social and security factors, including gender stereotypes and expectations, that affected different populations' experiences of infection, treatment, and lockdown during the period of review. Conclusion At the outset of health emergencies in China, gender research needs to be prioritised during the first stage of an outbreak to assist with evaluation of the most effective public health measures, identifying access to healthcare and social welfare barriers amongst priority communities. Gender stereotypes and gendered differences lead to different patterns of exposure and treatment. The exclusion of this knowledge in real time affects the design of effective prevention and recovery.
C1 [Feng, Huiyun; Leiva, Diego; Davies, Sara E.] Griffith Univ, Sch Govt & Int Relat, Brisbane, Qld, Australia.
   [Gan, Connie Cai Ru] Griffith Univ, Ctr Environm & Populat Hlth, Nathan, Qld, Australia.
   [Zhang, Bao Ling] Tsinghua Univ, Inst Hosp Management, Shenzhen, Guangdong, Peoples R China.
RP Davies, SE (corresponding author), Griffith Univ, Sch Govt & Int Relat, Brisbane, Qld, Australia.
EM sara.davies@griffith.edu.au
OI Davies, Sara E./0000-0002-7637-2252
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [170639]
FX We acknowledge Julia Smith and Clare Wenham, co-chief investigators of
   the grant that funded this research: Understanding and mitigating
   real-time differential gendered effects of the COVID-19 outbreak,
   Canadian Institutes of Health Research (Grant Number 170639).
CR Addo PC, 2020, SERV IND J, V40, P471, DOI 10.1080/02642069.2020.1751823
   Ahmed SB, 2020, CAN J PUBLIC HEALTH, V111, P980, DOI 10.17269/s41997-020-00417-z
   [Anonymous], The COVID-19 Sex-Disaggregated Data Tracker | Global Health 50/50
   Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]
   Asia-Pacific Gender in Humanitarian Action Working Group, 2020, COVID 19 OUTBR GEND
   Bao, 2020, INTERFACE J SOCIAL M, V21, P53
   Bo L., 2020, QUAN KE HU LI, V18, P980
   Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171
   Cai YH., 2020, CHINESE GEN PRACTICE, V23, P1083
   Cao DM, 2020, INT J INFECT DIS, V95, P294, DOI 10.1016/j.ijid.2020.04.047
   Chao YP., 2020, ZHONG GUO YI YAO DAO, V22, P294
   Chen HJ, 2020, J CLIN NURS, V29, P4161, DOI 10.1111/jocn.15444
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen JJ, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00586-z
   Chen L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009226
   Chen M, 2020, J INFECT PUBLIC HEAL, V13, P883, DOI 10.1016/j.jiph.2020.05.018
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Chen ST, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00591-2
   Cislaghi B, 2020, SOCIOL HEALTH ILL, V42, P407, DOI 10.1111/1467-9566.13008
   COVID-19 Global Gender Response Tracker, UNDP COVID 19 DAT FU
   Duan TX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103387
   Gao YL., 2020, CHENG YI XUE YUAN XU, V15, P178
   Hu L, 2020, EUR REV MED PHARMACO, V24, P4523, DOI 10.26355/eurrev_202004_21035
   Huang FL., 2020, ZHONG GUO FU YOU WEI, V11, P83
   Huang J., 2020, ZHONG GUO PU TONG WA, V29, P153, DOI [10.7659/j.issn.1005-6947.2020.02.006, DOI 10.7659/J.ISSN.1005-6947.2020.02.006]
   Huang L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925669
   Huang MJ., 2020, SHI YONG YI XUE ZHI, V36, P1277, DOI [10.3969/j.issn.1006-5725.2020.10.003, DOI 10.3969/J.ISSN.1006-5725.2020.10.003]
   Jiang BB., 2020, JIANG ZHONG YI YAO, V52, P84
   Jiang JM., 2020, CHENG YI XUE YUAN XU, V15, P289
   Jin ZC., 2020, ZHONG YI XUE, V9, P277, DOI [10.12677/TCM.2020.93041, DOI 10.12677/TCM.2020.93041]
   Ju YM, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00634-8
   Li DG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8292
   Li G, 2020, J NEUROL NEUROSUR PS, V91, P895, DOI 10.1136/jnnp-2020-323134
   Li XN., 2020, HU LI XUE ZHI, V35, P69, DOI [10.3870/j.issn.1001-4152.2020.07.069, DOI 10.3870/J.ISSN.1001-4152.2020.07.069]
   Li Y, 2020, AM J ROENTGENOL, V214, P1280, DOI 10.2214/AJR.20.22954
   Liao JY., 2020, DIAN ZI KE JI XUE BA, V49, P425
   Lin Keke, 2007, Health Care Women Int, V28, P680, DOI 10.1080/07399330701465010
   Liu CY, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001107
   Liu J, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00459
   Liu M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2195
   Mao Y., 2020, SHAN XI ZHONG YI, V41, P427, DOI [10.3969/j.issn.1000-7369.2020.04.006, DOI 10.3969/J.ISSN.1000-7369.2020.04.006]
   Mei YW, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01186
   Meng XZ., 2020, ER JUN YI XUE BAO, V41, P395, DOI [10.16781/j.0258-879x.2020.04.0395, DOI 10.16781/J.0258-879X.2020.04.0395]
   Neitzke AB, 2016, CULT MED PSYCHIAT, V40, P59, DOI 10.1007/s11013-015-9466-3
   Peng ZJ, 2020, J INFECT PUBLIC HEAL, V13, P818, DOI 10.1016/j.jiph.2020.04.004
   Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050
   Qiao J, 2020, LANCET, V395, P760, DOI 10.1016/S0140-6736(20)30365-2
   Shapiro JR, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005714
   Sharma V, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01186-4
   [史逸秋 Shi Yiqiu], 2020, [暨南大学学报. 自然科学与医学版, Journal of Jinan University. Natural Science & Medicine Edition], V41, P366
   Smith J, 2021, GLOB PUBLIC HEALTH, V16, P1364, DOI 10.1080/17441692.2021.1896765
   Tannenbaum C, 2019, NATURE, V575, P137, DOI 10.1038/s41586-019-1657-6
   UN Women, 2016, GEND DIM VULN CLIM C
   UN Women, 2016, GEND DIM VULN CLIM C, px
   United Nations China, 2019, UN CHIN ANN REP 2019, P37
   United Nations China, 2019, UN CHIN ANN REP 2019, P38
   Wang Q., 2020, ZHONG GUO XIONG XIN, V27, P371, DOI [10.7507/1007-4848.202002132, DOI 10.7507/1007-4848.202002132]
   Wei L., 2020, TONG JI XUE BAO YI X, V41, P155, DOI [10.16118/j.1008-0392.2020.02.003, DOI 10.16118/J.1008-0392.2020.02.003]
   Wenham C, 2020, NATURE, V583, P194, DOI 10.1038/d41586-020-02006-z
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   World Health Organization, 2019, NAPHS ALL A COUNTR I
   World Health Organization, 2020, STRAT PREP RESP PLAN
   Wu CC, 2020, VIROL SIN, V35, P305, DOI 10.1007/s12250-020-00227-0
   Wu KL, 2020, MED SCI MONIT BASIC, V26, DOI 10.12659/MSMBR.924085
   Wu MY., 2020, YI YUAN GUAN LI LUN, V37, P49
   Xiao C., 2020, SICHUAN MENTAL HLTH, V33, P15, DOI DOI 10.11886/SCJSWS20200214002
   Xiao X, 2020, J AFFECT DISORDERS, V274, P405, DOI 10.1016/j.jad.2020.05.081
   Xu L., 2020, ZHONG GUO YAO YE, V29, P43
   Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343
   Yang LY., 2020, HU LI XUE ZHI, V35, P66
   Yang XQ., 2020, XIAN DAI FU CHAN KE, V29, P243
   Yin QL, 2020, CLIN PSYCHOL PSYCHOT, V27, P384, DOI 10.1002/cpp.2477
   Yu N, 2020, LANCET INFECT DIS, V20, P559, DOI 10.1016/S1473-3099(20)30176-6
   Yu SM., 2020, SHI JIE ZHONG YI YAO, V15, P494, DOI [10.3969/j.issn.1673-7202.2020.04.004, DOI 10.3969/J.ISSN.1673-7202.2020.04.004]
   Yu WL., 2020, ZHI YE WEI SHENG YU, V38, P106
   Zhang C., 2020, XIAN DAI FU CHAN KE, V29, P165
   Zhang X., 2020, NAN JING ZHONG YI YA, V36, P145, DOI [10.14148/j.issn.1672-0482.2020.0145, DOI 10.14148/J.ISSN.1672-0482.2020.0145]
   Zhang Y., 2020, ZHONG GUO LIAO YANG, V29, P361
   Zhang YH., 2020, HU LI XUE ZHI, V35, P5, DOI [10.3870/j.issn.1001-4152.2020.05.005, DOI 10.3870/J.ISSN.1001-4152.2020.05.005]
   Zhao JQ, 2020, INT J MED SCI, V17, P1744, DOI 10.7150/ijms.47052
   Zheng LC, 2020, CLIN INFECT DIS, V71, P2109, DOI 10.1093/cid/ciaa588
   Zhou H., 2020, ZHONG GUO MIN MIN JI, V29, P55
   Zhou PS., 2020, WEN ZHOU YI KE XUE B, V50, P272, DOI [10.3969/j.issn.2095-9400.2020.04.004, DOI 10.3969/J.ISSN.2095-9400.2020.04.004]
   Zhu JH, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00386
   Zhu Z, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100443
NR 85
TC 0
Z9 0
U1 9
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1744-8603
J9 GLOBALIZATION HEALTH
JI Global. Health
PD FEB 4
PY 2022
VL 18
IS 1
AR 9
DI 10.1186/s12992-022-00804-w
PG 12
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YT4KB
UT WOS:000751329800001
PM 35120533
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Ali, W
   Hussain, I
   Hussain, S
AF Ali, Wajid
   Hussain, Iqtidar
   Hussain, Sabbor
TI Covid-19: People Perception Knowledge and Experience: an Evidence from
   Gilgit-Baltistan Pakistan
SO INTERNATIONAL TRANSACTION JOURNAL OF ENGINEERING MANAGEMENT & APPLIED
   SCIENCES & TECHNOLOGIES
LA English
DT Article
DE Covid-19 protection measures; Social trust; People sensitivity; Public
   sensitivity; Human being; Covid pandemic; Coronavirus epidemic; Aware of
   the sensitivity; Epidemic knowledge; Public precaution measure; Epidemic
   observation; Epidemic public awareness; Social believe; Covid public
   behavior
AB The coronavirus (Covid-19) has become a major cause of huma morbidity and mortality due to its transmitted mode in human beings. The public must follow precautionary practices to protect themselves from this world pandemic. Due to a lack of public practices, knowledge, and sensitivity, this transmitted disease suffers a large number of new cases around the world. This study examines the public's practices, knowledge, an sensitivity related to the Covid-19 in the Gilgit-Baltistan Pakistan area. We applied the exploratory methodology by reviewing the secondary data sources. We survey to collect the data and present the empirical evidence. We distributed five hundred questionnaires via the online and face-to-face approach and received 382 valid responses. The received data were analyzed by using descriptive statistics and a chi-square test. The empirical results indicate that majority of respondents are conscious and aware of the Covid-19 and moderately taking precautionary measures such as social distancing, washing hands, wearing the mask, avoid to handshaking/hug and avoidin: unnecessary traveling. It has been observed that participants are well aware of the sensitivity and the belief that the Covid-19 causes harm, changes expenditure life, exhausted, nervous, lonely, and fear for their individual life. Respondents have trust in social confidence and the roles of electronic media information regarding taking precautionary measures against the covid-19. Inversely, people have not to trust economic and safety measures taken b the government to control the Covid-19 pandemic. (C) 2021 INT TRANS J ENG MANAG SCI TECH.
C1 [Ali, Wajid] Karakoram Int Univ, Dept Math Sci, Gilgit, Pakistan.
   [Hussain, Iqtidar] Shanghai Int Studies Univ, Sch Int Relat & Publ Affairs, Shanghai, Peoples R China.
   [Hussain, Sabbor] Chung Yuan Christian Univ, Coll Business, Taoyuan, Taiwan.
RP Ali, W (corresponding author), Karakoram Int Univ, Dept Math Sci, Gilgit, Pakistan.
EM wajid.ali@kiu.edu.pk
FU Higher Education Commission (HEC) of PakistanHigher Education Commission
   of Pakistan [KIU-ORIC-1(2)/2020]
FX This research is supported by the Higher Education Commission (HEC) of
   Pakistan, under the grant number KIU-ORIC-1(2)/2020.
CR Al-Tawfiq JA, 2019, TRAVEL MED INFECT DI, V27, P27, DOI 10.1016/j.tmaid.2018.12.003
   [Anonymous], 2017, EPIDEMIC EMERGING CO
   Baldwin H., 2013, HUMAN BETACORONAVIRU
   Barbier EB, 2020, WORLD DEV, V135, DOI 10.1016/j.worlddev.2020.105082
   Bouaziz J., 2020, CHILBLAINS IS COMMON
   Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dergisi, 2020, WHAT IS CORONAVIRUSE
   Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC
   Falcon A, DETECTION ALPHA BETA, DOI [10.1007/s00705-011-1057-1, DOI 10.1007/S00705-011-1057-1]
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Hussain I, 2021, INT TRANS J ENG MANA, V12, DOI 10.14456/ITJEMAST.2021.67
   Bonilla-Aldana DK, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101566
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   NHC, 2020, COVID 19 NATL I HLTH
   NHC, GILGIT BALTISTAN COV
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Reusken CBEM, 2010, VECTOR-BORNE ZOONOT, V10, P785, DOI 10.1089/vbz.2009.0173
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Singh A, 2020, DIABETES METAB SYND, V14, P277, DOI 10.1016/j.dsx.2020.04.011
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Waris A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100681
   WHO, 2018, GHO
   Zorlu F, 2020, COVID 19 INFODEMIC S
NR 30
TC 0
Z9 0
U1 0
U2 0
PU TUENGR GROUP
PI PATHUMTAN
PA 88-244 MOO 3 KLONG NO 2 KLONG-LUANG, PATHUMTAN, 12120, THAILAND
SN 2228-9860
EI 1906-9642
J9 INT TRANS J ENG MANA
JI Int. Trans. J. Eng. Manag. Appl. Sci. Technol.
PY 2021
VL 12
IS 6
AR 12A6F
DI 10.14456/ITJEMAST.2021.111
PG 8
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA SU7KZ
UT WOS:000663312700006
DA 2022-04-20
ER

PT J
AU Ghasemi, M
   Nejad, MG
   Aghaei, I
AF Ghasemi, Matina
   Nejad, Mazyar Ghadiri
   Aghaei, Iman
TI Knowledge management orientation and operational performance
   relationship in medical tourism (overview of the model performance in
   the COVID-19 pandemic and post-pandemic era)
SO HEALTH SERVICES MANAGEMENT RESEARCH
LA English
DT Article
DE hospital; innovation; knowledge management area; medical tourism;
   operational performance
ID BEHAVIORAL INTENTIONS; DESTINATION IMAGE; FIRM PERFORMANCE; INNOVATION;
   QUALITY; MARKET; FACILITATORS; PERSPECTIVE; VARIABLES; BARRIERS
AB Despite the considerable growth of interest in medical tourism in the last decade, there is no standard procedure to measure the pivotal factors in medical tourism destinations. Medical tourism is a rising global phenomenon that is strongly dependent on innovation and knowledge management. Being both innovative and systematic in medical tourism requires thought enrichment in knowledge management in hospitals. By applying a quantitative method, "knowledge management-oriented innovation" items have been used in this study to analyze new products or services related to active hospitals in medical tourism in Iran. This study presents the positive effects of the most essential knowledge management areas such as time, cost, and quality management orientation, on operational performance through the mediating role of innovation speed. In the current study, hospitals of Iran that are active in the medical tourism area have been considered as the final destination. Additionaly, because this study coincides with the coronavirus COVID-19 pandemic as the global health crisis which has a considerable effect on medical tourism, the managerial implications have been developed to help managers and decision-makers in order to apply the obtained findings during the pandemic and post-pandemic period.
C1 [Ghasemi, Matina] Girne Amer Univ, Business & Econ Dept, Kyrenia, Northern Cyprus, Turkey.
   [Nejad, Mazyar Ghadiri] Girne Amer Univ, Ind Engn Dept, Kyrenia, Northern Cyprus, Turkey.
   [Aghaei, Iman] Eastern Mediterranean Univ, Gazimagusa, Cyprus.
RP Ghasemi, M (corresponding author), Girne Amer Univ, Business & Econ Dept, Kyrenia, Northern Cyprus, Turkey.
EM matinaghasemi@gau.edu.tr
RI Ghadiri Nejad, Mazyar/K-5320-2018; Nejad, Mazyar Ghadiri/ABA-7613-2021
OI Ghadiri Nejad, Mazyar/0000-0002-8207-2387; 
CR Abd Mutalib NS, 2017, J TRAVEL TOUR MARK, V34, P821, DOI 10.1080/10548408.2016.1250697
   Allocca M.A., 2006, CREAT INNOV MANAG, V15, P279
   Arasli H, 2017, SERV IND J, V37, P607, DOI 10.1080/02642069.2017.1349756
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Bahadori M, 2020, INT J EVID-BASED HEA, V18, P247, DOI 10.1097/XEB.0000000000000210
   Baird K, 2011, INT J OPER PROD MAN, V31, P789, DOI 10.1108/01443571111144850
   Baskerville R., 2006, Knowledge Management Research & Practice, V4, P83, DOI 10.1057/palgrave.kmrp.8500090
   Blyth E, 2005, CRIT SOC POLICY, V25, P91, DOI 10.1177/0261018305048969
   Boes K, 2016, INT J TOUR CITIES, V2, P108, DOI 10.1108/IJTC-12-2015-0032
   Bontis N, 2007, MANAGE DECIS, V45, P789, DOI 10.1108/00251740710746033
   Bortolotti T, 2013, INT J PROD RES, V51, P1117, DOI 10.1080/00207543.2012.678403
   Carbonell P, 2010, J BUS IND MARK, V25, P501, DOI 10.1108/08858621011077736
   Carrera P, 2010, INT J HEALTH SERV, V40, P469, DOI 10.2190/HS.40.3.e
   Cham TH, 2021, J CHINA TOUR RES, V17, P163, DOI 10.1080/19388160.2020.1734514
   Chow C. L. J, 2015, INT J BEHAV HEALTHCA, V5, P88
   Clifton N, 2010, GROWTH CHANGE, V41, P337, DOI 10.1111/j.1468-2257.2010.00529.x
   Connell J, 2013, TOURISM MANAGE, V34, P1, DOI 10.1016/j.tourman.2012.05.009
   Cormany D, 2011, TOURISM MANAGE, V32, P709, DOI 10.1016/j.tourman.2010.02.008
   de la Hoz-Correa A, 2018, TOURISM MANAGE, V65, P200, DOI 10.1016/j.tourman.2017.10.001
   Dehdashti S Z, 2016, INT J TRAVEL MED GLO, V4, P115
   Derakhsh, 2019, PAYESH HLTH MONITOR, V18, P455
   Derckx V, 2006, EUR J HEALTH LAW, V13, P313, DOI 10.1163/157180906779160247
   Esiyok B, 2017, J DESTIN MARK MANAGE, V6, P66, DOI 10.1016/j.jdmm.2016.03.001
   Esterhuizen D, 2012, INT J INFORM MANAGE, V32, P354, DOI 10.1016/j.ijinfomgt.2011.11.013
   Feng M, 2007, J MANUF TECHNOL MANA, V19, P22, DOI 10.1108/17410380810843435
   Fetscherin M, 2016, TOURISM MANAGE, V52, P539, DOI 10.1016/j.tourman.2015.08.010
   Forgione Dana A, 2007, J Health Care Finance, V34, P27
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fugate BS, 2009, J OPER MANAG, V27, P247, DOI 10.1016/j.jom.2008.09.003
   Gallarza MG, 2002, ANN TOURISM RES, V29, P56, DOI 10.1016/S0160-7383(01)00031-7
   Ganguli S, 2017, TOUR MANAG PERSPECT, V21, P74, DOI 10.1016/j.tmp.2016.12.002
   Garg S.R., 2012, MULTI DISCIPLINARY E, V1, P115
   Ghasemi M, 2017, IRAN J PUBLIC HEALTH, V46, P1639
   Glinos IA, 2010, HEALTH PLACE, V16, P1145, DOI 10.1016/j.healthplace.2010.08.001
   Goossens G, 2000, ANN TOURISM RES, V27, P301, DOI 10.1016/S0160-7383(99)00067-5
   Gopalakrishnan S, 2000, IEEE T ENG MANAGE, V47, P14, DOI 10.1109/17.820722
   Ha J, 2012, J SERV MARK, V26, P204, DOI 10.1108/08876041211224004
   Hair J.F., 1998, TECHNOMETRICS, V5, P207, DOI DOI 10.14267/CJSSP.2016.02.04
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Han H, 2018, CURR ISSUES TOUR, V21, P680, DOI 10.1080/13683500.2015.1104292
   Han H, 2013, TOURISM MANAGE, V36, P257, DOI 10.1016/j.tourman.2012.11.016
   Haner UE, 2002, INT J PROD ECON, V80, P31, DOI 10.1016/S0925-5273(02)00240-2
   Heng BC, 2007, EXPERT REV OBSTET GY, V2, P545, DOI DOI 10.1586/17474108.2.5.545
   Hopkins L, 2010, J PUBLIC HEALTH POL, V31, P185, DOI 10.1057/jphp.2010.10
   Howze K.S., 2006, GA L REV, V41, P1013
   Izadi M., 2012, Iranian Journal of Military Medicine, V14, P69
   Jabbari Alireza, 2012, J Educ Health Promot, V1, P39, DOI 10.4103/2277-9531.104809
   John SP, 2016, TOUR REV INT, V20, P73, DOI 10.3727/154427216X14713104855810
   Johnston R, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-23
   Kaushal NK, 2014, GASTROINTEST ENDOSC, V79, P637, DOI 10.1016/j.gie.2013.10.037
   Khosravizadeh O, 2020, J HLTH MANAGE INFORM, V7, P50
   Lega F, 2019, HEALTH SERV MANAG RE, V32, P167, DOI 10.1177/0951484819875834
   Lei P.-W., 2007, ED MEASURE ISSUES PR, V26, P33, DOI [10.1111/j.1745-3992.2007.00099.x, DOI 10.1111/J.1745-3992.2007.00099.X]
   Lu HY, 2018, CURR ISSUES TOUR, V21, P243, DOI 10.1080/13683500.2015.1072503
   Lunt N, 2010, MATURITAS, V66, P27, DOI 10.1016/j.maturitas.2010.01.017
   Lynn LH, 2008, J JPN STUD, V34, P543, DOI 10.1353/jjs.0.0026
   Malekzadeh R, 2020, INT J RISK SAF MED, V32, P1
   Martin-Santana JD, 2017, ANN TOURISM RES, V62, P13, DOI 10.1016/j.annals.2016.11.001
   Martinez-Ros E, 2009, TECHNOVATION, V29, P632, DOI 10.1016/j.technovation.2009.02.004
   Moghadam FN, 2021, INT J HEALTHCARE MAN, V14, P1081, DOI 10.1080/20479700.2020.1732647
   Moghavvemi S, 2017, TOURISM MANAGE, V58, P154, DOI 10.1016/j.tourman.2016.10.010
   Moghimehfar F, 2011, TOURISM MANAGE, V32, P1431, DOI 10.1016/j.tourman.2011.01.005
   Mohamad WN, 2012, PROCD SOC BEHV, V65, P358, DOI 10.1016/j.sbspro.2012.11.134
   Momeni K, 2018, TOURISM MANAGE, V69, P307, DOI 10.1016/j.tourman.2018.05.007
   Musa G, 2012, CURR ISSUES TOUR, V15, P525, DOI 10.1080/13683500.2011.626847
   Nikraftar T, 2020, IRAN J EC STUD, V8, P335
   Oppermann M., 2000, Journal of Travel Research, V39, P78, DOI 10.1177/004728750003900110
   Parasuraman A, 2010, International Journal of Quality and Service Sciences, V2, P277, DOI 10.1108/17566691011090026
   Peng DX, 2011, INT J OPER PROD MAN, V31, P484, DOI 10.1108/01443571111126292
   PETER JP, 1981, J MARKETING RES, V18, P133, DOI 10.2307/3150948
   Pike S, 2005, J PROD BRAND MANAG, V14, P258, DOI 10.1108/10610420510609267
   Pillay R, 2010, HEALTH SERV MANAG RE, V23, P30, DOI 10.1258/hsmr.2009.009015
   PMI, 2013, GUID PROJ MAN BOD KN
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Quan S, 2004, TOURISM MANAGE, V25, P297, DOI 10.1016/S0261-5177(03)00130-4
   Ren SC, 2015, J BUS RES, V68, P102, DOI 10.1016/j.jbusres.2014.04.011
   Rezaei Satar, 2018, Med J Islam Repub Iran, V32, P59, DOI 10.14196/mjiri.32.59
   RNCOS, 2008, AS MED TOUR AN 2008
   Rokni L, 2017, IRAN J PUBLIC HEALTH, V46, P1437
   Rokni L, 2013, IRAN J PUBLIC HEALTH, V42, P272
   Saadatnia F., 2014, INT J MARKETING STUD, V6, P155, DOI DOI 10.5539/IJMS.V6N3P155
   Sadikoglu E, 2010, INT J PROD ECON, V127, P13, DOI 10.1016/j.ijpe.2010.02.013
   Saunila M, 2014, J ADV MANAG RES, V11, P163, DOI 10.1108/JAMR-11-2013-0063
   Sethi R, 2000, J MARKETING, V64, P1, DOI 10.1509/jmkg.64.2.1.17999
   Shin JI, 2013, INT J INFORM MANAGE, V33, P453, DOI 10.1016/j.ijinfomgt.2013.02.003
   Shirani K, 2020, IRAN J MED SCI, V45, P233, DOI 10.30476/ijms.2020.85869.1549
   Sills Eric Scott, 2007, J Exp Clin Assist Reprod, V4, P3, DOI 10.1186/1743-1050-4-3
   Singh N, 2013, CURR ISSUES TOUR, V16, P436, DOI 10.1080/13683500.2012.695341
   Skountridaki L, 2017, TOURISM MANAGE, V59, P254, DOI 10.1016/j.tourman.2016.07.008
   Sokhanvar A, 2018, TOUR REV, V73, P44, DOI [10.1108/tr-07-2017-0108, 10.1108/TR-07-2017-0108]
   Tabachnick B.G., 2007, USING MULTIVARIATE S, V5th
   Tatum D, 2020, SHOCK, V54, P652, DOI 10.1097/SHK.0000000000001585
   Teimouri RB, 2018, TOUR MANAG PERSPECT, V28, P10, DOI 10.1016/j.tmp.2018.07.002
   Thompson C, 2008, EAST ASIAN SCI TECHN, V2, P433, DOI 10.1007/s12280-008-9056-3
   Tremayne Soraya, 2016, Reprod Biomed Soc Online, V2, P62, DOI 10.1016/j.rbms.2016.07.002
   Turner L., 2007, BioSocieties, V2, P303, DOI 10.1017/S1745855207005765
   Veerasoontorn R, 2010, INT J PHARM HEALTHC, V4, P247, DOI 10.1108/17506121011076174
   Wang S, 2010, HUM RESOUR MANAGE R, V20, P115, DOI 10.1016/j.hrmr.2009.10.001
   Wang ZN, 2012, EXPERT SYST APPL, V39, P8899, DOI 10.1016/j.eswa.2012.02.017
   Willcocks LP, 2011, TECHNOL WORK GLOB, P1
   Williams LJ, 2009, ACAD MANAG ANN, V3, P543, DOI 10.1080/19416520903065683
   Wu HC, 2016, J QUAL ASSUR HOSP TO, V17, P114, DOI 10.1080/1528008X.2015.1042621
   Yang ICM, 2019, CURR ISSUES TOUR, V23, P1
   Yu JY, 2012, TOURISM MANAGE, V33, P80, DOI 10.1016/j.tourman.2011.02.002
   Zou B, 2012, TRANSPORT RES E-LOG, V48, P1032, DOI 10.1016/j.tre.2012.03.006
NR 105
TC 5
Z9 5
U1 5
U2 14
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0951-4848
EI 1758-1044
J9 HEALTH SERV MANAG RE
JI Health Serv. Manag. Res.
PD NOV
PY 2021
VL 34
IS 4
BP 208
EP 222
AR 0951484820971438
DI 10.1177/0951484820971438
EA NOV 2020
PG 15
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA XF8AG
UT WOS:000598878600001
PM 33183088
DA 2022-04-20
ER

PT J
AU Butt, AS
AF Butt, Atif Saleem
TI Supply chains and COVID-19: impacts, countermeasures and post-COVID-19
   era
SO INTERNATIONAL JOURNAL OF LOGISTICS MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19; Buyers; Suppliers; Distributors; Interviews; Inbound
   logistics; Outbound logistics; Manufacturing; Demand
ID RESILIENCE DEVELOPMENT; LOGISTICS; KNOWLEDGE; CONFLICTS; GUANXI; RISK
AB Purpose This paper explores the steps/countermeasures taken by firms to address supply chain disruptions in the wake of COVID-19. Design/methodology/approach This study employs a case study methodology and employs 46 semi-structured interviews with senior managers of the three buying firms, four distribution centres and four supplying firms based in four countries (Pakistan, Sri Lanka, China and India). Findings Results reveal that manufacturers are refining production schedules to meet the production challenges. Distributors are working with secondary suppliers to meet the inventory shortage. Finally, supplying firms are evaluating the impact of demand, focusing on short-term demand-supply strategy, preparing for channel shifts, opening up additional channels of communication with key customers, understanding immediate customer's demand and priorities and finally becoming more agile. Research limitations/implications There are some limitations to this study. First, the results of this study cannot be generalized to a wider population. Second, this study explores the interpretations of senior managers based in four Asian countries only. Practical implications Supply chain firms can use these findings to understand how COVID-19 is affecting firms. Firms can also use the suggestions provided in this study to mitigate the impact of COVID-19 and make the best out of this pandemic. Originality/value This study contributes to the supply chain disruption literature by exploring the robust countermeasure taken by supply chain firms amid COVID-19 outbreak. In particular, it explores such countermeasures from the perspective of three different entities (buyer, supplier and distributor) based in four different countries in the South Asian region.
C1 [Butt, Atif Saleem] Amer Univ Ras Al Khaimah, Dept Management, Sch Business, Ras Al Khaymah, U Arab Emirates.
RP Butt, AS (corresponding author), Amer Univ Ras Al Khaimah, Dept Management, Sch Business, Ras Al Khaymah, U Arab Emirates.
EM atifbutt10@hotmail.com
CR [Anonymous], 2020, RETAILDIVE
   [Anonymous], 2020, BILD
   Anparasan AA, 2018, ANN OPER RES, V270, P53, DOI 10.1007/s10479-017-2462-y
   Blackhurst J, 2005, INT J PROD RES, V43, P4067, DOI 10.1080/00207540500151549
   Blackhurst J, 2011, J BUS LOGIST, V32, P374, DOI 10.1111/j.0000-0000.2011.01032.x
   Boone W.J., 2013, RASCH ANAL HUMAN SCI
   Borekci DY, 2015, INT J PROD RES, V53, P6839, DOI 10.1080/00207543.2014.903346
   Butt Atif Saleem, 2019, International Journal of Integrated Supply Management, V12, P193
   Butt A.S, 2021, INT J PHYS DISTRIBUT, DOI [10.1108/IJPDLM-08-2020-0281, DOI 10.1108/IJPDLM-08-2020-0281]
   Butt AS, 2021, KNOWL PROCESS MANAG, V28, P18, DOI 10.1002/kpm.1643
   Butt AS, 2020, KNOWL PROCESS MANAG, V27, P272, DOI 10.1002/kpm.1631
   Butt AS, 2021, TRANSPORT J, V60, P307, DOI 10.5325/transportationj.60.3.0307
   Butt AS, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-11-2020-0455
   Butt AS, 2021, VINE J INF KNOWL MAN, DOI 10.1108/VJIKMS-06-2020-0118
   Butt AS, 2020, J ASIA BUS STUD, V14, P1, DOI 10.1108/JABS-04-2019-0127
   Butt AS, 2020, BENCHMARKING, V27, P2631, DOI 10.1108/BIJ-04-2020-0143
   Butt AS, 2020, INT J KNOWL MANAG, V16, P18, DOI 10.4018/IJKM.2020040102
   Butt AS, 2021, MANAGE DECIS, V59, P1291, DOI 10.1108/MD-01-2020-0038
   Butt AS, 2019, J KNOWL MANAG, V23, P1605, DOI 10.1108/JKM-04-2019-0204
   Butt AS, 2019, BENCHMARKING, V26, P2225, DOI 10.1108/BIJ-02-2019-0067
   Butt AS, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01799
   Butt AS, 2019, MANAG RES REV, V42, P495, DOI 10.1108/MRR-05-2018-0193
   Caniato F.F.A., 2003, BUILDING SECURE RESI
   Chapman R. L., 2003, International Journal of Physical Distribution & Logistics Management, V33, P630, DOI 10.1108/09600030310499295
   Choi TM, 2020, TRANSPORT RES E-LOG, V140, DOI 10.1016/j.tre.2020.101961
   Chopra S, 2004, MIT SLOAN MANAGE REV, V46, P53
   Cooke DL, 2006, SYST DYNAM REV, V22, P213, DOI 10.1002/sdr.338
   Cooke-Davies T., 2002, INT J PROJ MANAG, V20, P185, DOI DOI 10.1016/S0263-7863(01)00067-9
   Correia M, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00156
   Craighead CW, 2020, DECISION SCI, V51, P838, DOI 10.1111/deci.12468
   Creswell J.W., 2013, STEPS CONDUCTING SCH
   Darby JL, 2019, INT J LOGIST MANAG, V30, P395, DOI 10.1108/IJLM-07-2018-0187
   Dasaklis TK, 2012, INT J PROD ECON, V139, P393, DOI 10.1016/j.ijpe.2012.05.023
   Dolgui A, 2019, INT J PROD RES, pNIL_1, DOI 10.1080/00207543.2019.1627438
   Dubey R, 2021, INT J PROD RES, V59, P1586, DOI 10.1080/00207543.2020.1865583
   Dubey R, 2019, ANN OPER RES, V283, P1, DOI 10.1007/s10479-019-03440-7
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   El Baz J, 2021, INT J PROD ECON, V233, DOI 10.1016/j.ijpe.2020.107972
   Ellis SC, 2010, J OPER MANAG, V28, P34, DOI 10.1016/j.jom.2009.07.002
   Fan YY, 2018, INT J PHYS DISTR LOG, V48, P205, DOI 10.1108/IJPDLM-01-2017-0043
   Fawcett SE, 2008, SUPPLY CHAIN MANAG, V13, P35, DOI 10.1108/13598540810850300
   Fredericks E, 2005, IND MARKET MANAG, V34, P555, DOI 10.1016/j.indmarman.2004.09.022
   Fusch PI, 2015, QUAL REP, V20, P1408
   Gammelgaard B, 2017, INT J LOGIST MANAG, V28, P910, DOI 10.1108/IJLM-09-2017-0231
   GLASSER M, 1967, J AM STAT ASSOC, V62, P561, DOI 10.2307/2283983
   Govindan K, 2020, TRANSPORT RES E-LOG, V138, DOI 10.1016/j.tre.2020.101967
   Guba E, 1994, HDB QUALITATIVE RES, P105
   Gunessee S, 2020, INT J OPER PROD MAN, V40, P1201, DOI 10.1108/IJOPM-07-2019-0530
   Haren P., 2020, HARVARD BUS REV
   Ivanov Dmitry, 2020, International Journal of Integrated Supply Management, V13, P90
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2020, INT J PROD RES, V58, P3252, DOI 10.1080/00207543.2019.1634850
   Johnson N, 2013, SUPPLY CHAIN MANAG, V18, P324, DOI 10.1108/SCM-06-2012-0203
   Juttner U, 2011, SUPPLY CHAIN MANAG, V16, P246, DOI 10.1108/13598541111139062
   Ketchen DJ, 2021, J SUPPLY CHAIN MANAG, V57, P50, DOI 10.1111/jscm.12251
   Ketchen DJ, 2020, J MANAGE, V46, P1330, DOI 10.1177/0149206320945028
   Leat P, 2013, SUPPLY CHAIN MANAG, V18, P219, DOI 10.1108/13598541311318845
   Lee Eva K, 2009, International Journal of Risk Assessment & Management, V12, P311, DOI 10.1504/IJRAM.2009.025925
   Mamani Hamed, 2012, IIE Transactions on Healthcare Systems Engineering, V2, P78, DOI 10.1080/19488300.2012.666780
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   McKinsey GL, 2020, ELIFE, V9, DOI 10.7554/eLife.54590
   Mollenkopf DA, 2021, J SERV MANAGE, V32, P190, DOI 10.1108/JOSM-05-2020-0143
   Muhammad K., 2019, SUPPLY CHAIN RESILIE
   Pavlov A., 2019, ANN OPER RES, DOI [10.1007/s10479-019-03182-6, DOI 10.1007/S10479-019-03182-6]
   Pettit TJ, 2013, J BUS LOGIST, V34, P46, DOI 10.1111/jbl.12009
   Pettit TJ, 2010, J BUS LOGIST, V31, P1, DOI 10.1002/j.2158-1592.2010.tb00125.x
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rajesh R, 2021, J RETAIL CONSUM SERV, V62, DOI 10.1016/j.jretconser.2021.102599
   Rizou M, 2020, TRENDS FOOD SCI TECH, V102, P293, DOI 10.1016/j.tifs.2020.06.008
   Salda?a J., 2015, CODING MANUAL QUALIT
   Scholten K, 2015, SUPPLY CHAIN MANAG, V20, P471, DOI 10.1108/SCM-11-2014-0386
   Shah SHH, 2021, TOTAL QUAL MANAG BUS, DOI 10.1080/14783363.2021.1890017
   Shah SHH, 2021, INFORM TECHNOL DEV, V27, P718, DOI 10.1080/02681102.2021.1877604
   Sharma RK, 2021, INT J FINANC ECON, V26, P5666, DOI 10.1002/ijfe.2087
   Sheffi Y., 2001, INT J LOGIST MANAG, V12, P1, DOI [10.1108/09574090110806262, DOI 10.1108/09574090110806262]
   Strauss A., 1990, BASICS QUALITATIVE R
   Swafford PM, 2006, J OPER MANAG, V24, P170, DOI 10.1016/j.jom.2005.05.002
   Thun JH, 2011, INT J PROD ECON, V131, P242, DOI 10.1016/j.ijpe.2009.10.010
   Tu MR, 2018, INT J LOGIST MANAG, V29, P131, DOI 10.1108/IJLM-11-2016-0274
   Urciuoli L, 2014, SUPPLY CHAIN MANAG, V19, P46, DOI 10.1108/SCM-09-2012-0307
   Vakil, 2020, HARVARD BUS REV
   Vergragt P, 2014, J CLEAN PROD, V63, P1, DOI 10.1016/j.jclepro.2013.09.028
   Wamba SF, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03594-9
   Welch C, 2011, J INT BUS STUD, V42, P740, DOI 10.1057/jibs.2010.55
   Yin R.K., 2009, SAGE HDB APPL SOCIAL, V2, P254, DOI DOI 10.4135/9781483348858.N8
   Zhu GY, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145858
   Zsidisin GA., 2003, J PURCHASING SUPPLY, V9, P217, DOI 10.1016/j.purs
   Zsidisin GA, 2010, J BUS LOGIST, V31, P1, DOI 10.1002/j.2158-1592.2010.tb00140.x
NR 88
TC 3
Z9 3
U1 26
U2 33
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0957-4093
EI 1758-6550
J9 INT J LOGIST MANAG
JI Int. J. Logist. Manag.
DI 10.1108/IJLM-02-2021-0114
EA SEP 2021
PG 24
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA UQ2BF
UT WOS:000695874100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Yapi, RB
   Houngbedji, CA
   N'Guessan, DKG
   Dinde, AO
   Sanhoun, AR
   Amin, A
   Gboko, KDT
   Heitz-Tokpa, K
   Fokou, G
   Bonfoh, B
AF Yapi, Richard B.
   Houngbedji, Clarisse A.
   N'Guessan, Daniel K. G.
   Dinde, Arlette O.
   Sanhoun, Aime R.
   Amin, Ariane
   Gboko, Kossia D. T.
   Heitz-Tokpa, Kathrin
   Fokou, Gilbert
   Bonfoh, Bassirou
TI Knowledge, Attitudes, and Practices (KAP) Regarding the COVID-19
   Outbreak in Cote d'Ivoire: Understanding the Non-Compliance of
   Populations with Non-Pharmaceutical Interventions
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; C&#244; te d&#8217; Ivoire; compliance; knowledge; attitudes;
   practices
ID HEALTH-CARE
AB At the beginning of the COVID-19 outbreak, preventive measures seemed the most appropriate method to control its spread. We assessed the knowledge, attitudes, and practices of the Ivorian public regarding preventive measures, conducting a hybrid survey across the country. Participants were invited to complete a questionnaire online, by phone, or face-to-face. Chi-squared, Fisher's exact, and Kruskal-Wallis tests were used to compare the frequency of responses regarding compliance with preventive measures. Data were validated for 564 individuals. Over one-third of respondents believed that COVID-19 was related to non-natural causes. Though the disease was perceived as severe, respondents did not consider it to be highly infectious. Overall, 35.6% of respondents fully trust health officials in the management of the pandemic, and 34.6% trusted them moderately. Individuals who believed COVID-19 was a disease caused by a pathogen and the well-educated were likely to comply with preventive measures. About 70% of respondents stated that their daily expenses had increased due to preventive measures. The study concludes that beyond unfavorable socioeconomic conditions, the level of knowledge regarding COVID-19 and trust in the government/health system are more likely to influence compliance with preventive measures such as self-reporting, physical distancing, the use of face masks, and eventually the acceptability of vaccines.
C1 [Yapi, Richard B.; Houngbedji, Clarisse A.] Univ Alassane Ouattara, Ctr Entomol Med & Vet, Bouake 01 BPV 18, Bouake, Cote Ivoire.
   [Yapi, Richard B.; Houngbedji, Clarisse A.; N'Guessan, Daniel K. G.; Dinde, Arlette O.; Sanhoun, Aime R.; Amin, Ariane; Gboko, Kossia D. T.; Heitz-Tokpa, Kathrin; Fokou, Gilbert; Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Abidjan 01 BP 1303, Abidjan, Cote Ivoire.
   [Dinde, Arlette O.; Sanhoun, Aime R.] Univ Nangui Abrogoua, UFR Sci & Technol Aliments, Abidjan 02 BP 801, Abidjan, Cote Ivoire.
   [Amin, Ariane] Univ Felix Houphouet Boigny, UFR Sci Econ & Gest, Abidjan 01 BPV 34, Abidjan, Cote Ivoire.
   [Heitz-Tokpa, Kathrin] Univ Basel, Inst Social Anthropol, Peterspl 1, CH-4001 Basel, Switzerland.
   [Fokou, Gilbert] Human Sci Res Council HSRC, Dev Capable & Eth State DCES Div, 116-118 Buitengracht St,Private Bag X9182, ZA-8000 Cape Town, South Africa.
RP Yapi, RB (corresponding author), Univ Alassane Ouattara, Ctr Entomol Med & Vet, Bouake 01 BPV 18, Bouake, Cote Ivoire.; Yapi, RB (corresponding author), Ctr Suisse Rech Sci Cote Ivoire, Abidjan 01 BP 1303, Abidjan, Cote Ivoire.
EM richard.yapi@csrs.ci; Clarisse.houngbedji@csrs.ci; k_daniel00@yahoo.fr;
   arlette.dinde@csrs.ci; aime.sanhoun@csrs.ci; ariane.amin@csrs.ci;
   kossia.gboko@csrs.ci; kathrin.heitz-tokpa@csrs.ci;
   gilbert.fokou@csrs.ci; bassirou.bonfoh@csrs.ci
OI Fokou, Gilbert/0000-0002-4989-299X; Bonfoh,
   Bassirou/0000-0003-4190-8202; Yapi, Richard Brou/0000-0002-5167-2961
FU DELTAS Africa Initiative (Afrique One-ASPIRE) [DEL-15-008]; African
   Academy of Sciences (AAS) Alliance for Accelerating Excellence in
   Science in Africa (AESA); New Partnership for Africa's Development
   Planning and Coordinating (NEPAD) Agency; Wellcome TrustWellcome
   TrustEuropean Commission [107753/A/15/Z]; UK government
FX The authors acknowledge support from the DELTAS Africa Initiative
   (Afrique One-ASPIRE/DEL-15-008, http://afriqueoneaspire.org/accessed on
   30 March 2020). Afrique OneASPIRE is funded by a consortium of donors
   including the African Academy of Sciences (AAS) Alliance for
   Accelerating Excellence in Science in Africa (AESA), the New Partnership
   for Africa's Development Planning and Coordinating (NEPAD) Agency, the
   Wellcome Trust (107753/A/15/Z), and the UK government. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Akim A.M., INTERACTION EFFECT L
   Akindes F., CONFINEMENT EST SEUL
   Alqahtani AS, 2017, J INFECT PUBLIC HEAL, V10, P534, DOI 10.1016/j.jiph.2016.11.015
   Andrade C, 2020, INDIAN J PSYCHOL MED, V42, P575, DOI 10.1177/0253717620957496
   Arya R, 2012, INDIAN J PEDIATR, V79, P1482, DOI 10.1007/s12098-012-0763-3
   Asante LA, 2020, AFR SPECTR, V55, P170, DOI 10.1177/0002039720943612
   Braimah AI., 2020, J POLIT SCI INT RELA, V3, P44, DOI [10.11648/j.jpsir.20200303.11, DOI 10.11648/J.JPSIR.20200303.11]
   Caleo G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5158-6
   Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161
   Duchesne V, 2014, ANTHROVISION, DOI [10.4000/anthrovision.681, DOI 10.4000/ANTHROVISION.681]
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Fotso JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-218
   Fukuyama F, 2020, FOREIGN AFF, V99, P26
   González-Padilla Daniel A., 2020, Int. braz j urol., V46, P120, DOI [10.1590/S1677-5538.IBJU.2020.S121, 10.1590/s1677-5538.ibju.2020.s121]
   GOULD SJ, 1988, J CONSUM AFF, V22, P96, DOI 10.1111/j.1745-6606.1988.tb00215.x
   Habib MA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245176
   Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Jahromi AH, 2020, J MED INTERNET RES, V22, DOI 10.2196/19934
   Kakemam E, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.585302
   Kassem AM, 2020, ARAB J GASTROENTEROL, V21, P1, DOI 10.1016/j.ajg.2020.04.010
   Kokolomami J.H.T, 2019, CENT AFR J PUBLIC HL, V5, P316, DOI [10.11648/j.cajph.20190506.24, DOI 10.11648/J.CAJPH.20190506.24]
   Leach M., 2020, SOMATOSPHERE
   Lee M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10285-y
   Liu XP, 2020, INFLUENZA OTHER RESP, V14, P472, DOI 10.1111/irv.12740
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818
   Masoud AT, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043971
   Matuschek C, 2020, EUR J MED RES, V25, DOI 10.1186/s40001-020-00423-4
   Mehtar S, 2020, LANCET GLOB HEALTH, V8, pE881, DOI 10.1016/S2214-109X(20)30212-6
   Ministere de la Communication de L' e conomie Numerique et de la Poste Ministere de la Communication de L' e conomie Numerique et de la Poste, TEL MOB C 6 IVOIRE P
   Murphy K, 2020, AUST NZ J CRIMINOL, V53, P477, DOI 10.1177/0004865820954484
   Nayak M.S.D.P., 2019, J HUMANIT SOC SCI, V24, P31, DOI DOI 10.9790/0837-2405053138
   Nivette A, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113370
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Pan D, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100404
   Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3
   Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Swart K, 2020, SPORT SOC, V23, P1736, DOI 10.1080/17430437.2020.1805900
   WHO, 2020, WHO DIR GEN OP REM M
   WHO WHO, COVID 19 PUBLIC HLTH
   WHO WHO, COVID 19 CAS TOP 100
   WHO-World Health Organization, 2018, MAN EP KEY FACTS MAJ
   Wilkinson A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0305
   Winters M, 2018, EMERG INFECT DIS, V24, P336, DOI 10.3201/eid2402.171028
   Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742
   Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022
   Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou WK, 2020, MATH BIOSCI ENG, V17, P2693, DOI 10.3934/mbe.2020147
NR 52
TC 4
Z9 4
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY
PY 2021
VL 18
IS 9
AR 4757
DI 10.3390/ijerph18094757
PG 21
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA SB8QJ
UT WOS:000650251300001
PM 33946980
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Akter, F
   Ahmad, R
   Haque, M
AF Akter, Farhana
   Ahmad, Rahnuma
   Haque, Mainul
TI Endocrine Flawed In COVID-19 Era
SO BANGLADESH JOURNAL OF MEDICAL SCIENCE
LA English
DT Review
DE Endocrine; SARS-COV; ACE-2; COVID-19; Pandemic; Diabetes Mellitus;
   Thyroid; Adrenal; Obesity; Pancreas
ID DIABETES-MELLITUS; CLINICAL CHARACTERISTICS; VENOUS THROMBOEMBOLISM;
   THYROID-DISORDERS; SARS-COV-2; MANAGEMENT; MORTALITY; CORONAVIRUS;
   INFECTION; VIRUSES
AB The clinical practice and social relationships have been changed since the emergence of COVID-19. It is declared a global pandemic affecting millions of people across the world. SARS-CoV-2 virus while infecting human has been noted to affect several vital organs and biological systems. This can occur directly through virus-induced damage or indirectly due to the host response after virus entry, which produce a negative impact on body systems. Human endocrine system similar fatal effect. Thereafter, the knowledge and clinical expertise about the management of the endocrine pathological consequences of COVID-19 is essential in the current pandemic situation. The need of such clinical proficiency is increasing more demanding as SARS-CoV-2 pandemic is growing towards more devastating phase. The coronavirus enters the human body by using the angiotensin converting enzyme 2 (ACE-2). Other than the pneumocytes, ACE-2 is expressed by several endocrine glands like the pancreas, pituitary gland, adrenal glands, thyroid, ovary, and testes. Diabetes has a significant impact on covid 19. Diabetes Mellitus is one of the comorbidities most frequently linked to severity and mortality resulting from COVID-19 infection. Thus, careful management that includes modification of treatment may be needed to protect from the most dangerous outcomes of the virus infection or hospitalization with COVID-19, not only for patients with a known history of diabetes but also those suffering SARS-CoV-2 induced new-onset diabetes. Those suffering from obesity are more susceptible to SARS-CoV-2 as well as to adverse effects. In order to limit the susceptibility and severity of SARS-CoV-2 infection, there needs to be adequate management of nutrition of obese and undernourished patients. Hypothalamic-pituitary axis suppression, adrenal insufficiency, thyroid dysfunction, hypocalcemia, vitamin D lack, and vertebral fractures have also been reported as frequent findings in COVID-19 infected individuals who needed to be hospitalized and often associated with fatal clinical outcomes. Prompt glucocorticoid adjustment is also required in patients with COVID-19 having adrenal insufficiency. Addressing hormonal status may limit further treatment burden for a COVID-19 infected patient.
C1 [Akter, Farhana] Chittagong Med Coll, Dept Endocrinol, Chattogram 4203, Bangladesh.
   [Ahmad, Rahnuma] Med Coll Women & Hosp, Dept Physiol, Dhaka, Bangladesh.
   [Haque, Mainul] Natl Def Univ Malaysia, Pharmacol Unit, Fac Med & Def Hlth, Kuala Lumpur 57000, Malaysia.
RP Haque, M (corresponding author), Natl Def Univ Malaysia, Pharmacol Unit, Fac Med & Def Hlth, Kuala Lumpur 57000, Malaysia.
EM mainul@upnm.edu.my
RI Ahmad, Rahnuma/ABB-3336-2021
OI Ahmad, Rahnuma/0000-0001-7379-0822
CR AACE, AACE POS STAT COR CO
   Agarwal S, 2020, POSTGRAD MED J, V96, P412, DOI 10.1136/postgradmedj-2020-137934
   Akter F, 2020, DIABETES METAB SYND, V14, P2031, DOI 10.1016/j.dsx.2020.10.016
   Al-kuraishy HM, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.644095
   Alberta Health Services, 2020, COVID 19 SCI ADV GRO
   Almeida MQ, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2022
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Arlt W, 2020, EUR J ENDOCRINOL, V183, pG25, DOI 10.1530/EJE-20-0361
   Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020
   Australian Diabetes Society, 2020, DIAGN TEST GEST DIAB
   Azzolino D, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.581356
   Bajwa Sukhminder Jit Singh, 2012, Indian J Endocrinol Metab, V16, P740, DOI 10.4103/2230-8210.100667
   Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2
   Baud G, 2020, J VISC SURG, V157, pS43, DOI 10.1016/j.jviscsurg.2020.04.018
   Bellastella G, 2020, J ENDOCRINOL INVEST, V43, P1169, DOI 10.1007/s40618-020-01311-8
   Berger H, 2020, JOINT CONSENSUS STAT
   Beyerstedt S, 2021, EUR J CLIN MICROBIOL, V40, P905, DOI 10.1007/s10096-020-04138-6
   Bhalla V, 2021, J HUM HYPERTENS, V35, P935, DOI 10.1038/s41371-020-00459-3
   Boddu SK, 2020, DIABETES METAB SYND, V14, P2211, DOI 10.1016/j.dsx.2020.11.012
   Boelaert K, 2020, EUR J ENDOCRINOL, V183, pG33, DOI 10.1530/EJE-20-0445
   Bornstein SR, 2016, J CLIN ENDOCR METAB, V101, P364, DOI 10.1210/jc.2015-1710
   Bramante CT, 2021, LANCET HEALTH LONGEV, V2, pE34, DOI 10.1016/S2666-7568(20)30033-7
   British Thyroid Association, BTA SFE STAT REG ISS
   British Thyroid Foundation, THYR DIS COR COV 19
   Budreviciute A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.574111
   Caron P, 2020, ANN ENDOCRINOL-PARIS, V81, P507, DOI 10.1016/j.ando.2020.09.001
   Centers for Disease Control and Prevention, 2020, CNOS INP OBST HEALTH
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen M, 2021, THYROID, V31, P8, DOI 10.1089/thy.2020.0363
   Chen WJ, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqab004
   Cheng X, 2020, CELL METAB, V32, P537, DOI 10.1016/j.cmet.2020.08.013
   Chernyak Y., 2020, FACTORS ASS HOSPITAL, DOI [10.1101/2020.04.08.20057794, DOI 10.1101/2020.04.08.20057794]
   Corona G, 2021, REV ENDOCR METAB DIS, V22, P275, DOI 10.1007/s11154-021-09630-8
   Costela-Ruiz VJ, 2020, CYTOKINE GROWTH F R, V54, P62, DOI 10.1016/j.cytogfr.2020.06.001
   Cristelo C, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108228
   Darif D, 2021, MICROB PATHOGENESIS, V153, DOI 10.1016/j.micpath.2021.104799
   De Menis E, 2020, ENDOCR METAB IMMUNE
   Dhindsa S, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.11398
   Drucker DJ, 2020, ENDOCR REV, V41, P457, DOI 10.1210/endrev/bnaa011
   Dworakowska D, 2020, ENDOCRINE, V68, P471, DOI 10.1007/s12020-020-02364-8
   Eljilany I, 2020, VASC HEALTH RISK MAN, V16, P455, DOI 10.2147/VHRM.S280962
   Eskandarani RM, 2020, CLIN MED INSIGHTS-EN, V13, DOI 10.1177/1179551420984125
   Fan CB, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.563893
   Fayfman M, 2017, MED CLIN N AM, V101, P587, DOI 10.1016/j.mcna.2016.12.011
   Fignani D, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.596898
   Fleming N, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14509
   Fliers E, 2015, LANCET DIABETES ENDO, V3, P816, DOI 10.1016/S2213-8587(15)00225-9
   George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3
   Gianchandani R, 2020, DIABETES, V69, P2048, DOI 10.2337/dbi20-0022
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Gupta R, 2020, EUR J CLIN NUTR, V74, P864, DOI 10.1038/s41430-020-0652-1
   Hartmann-Boyce J, 2020, DIABETES CARE, V43, P1695, DOI 10.2337/dc20-1192
   Hashem NM, 2021, SAUDI J BIOL SCI, V28, P1702, DOI 10.1016/j.sjbs.2020.12.012
   Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0
   Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Isidori AM, 2020, J ENDOCRINOL INVEST, V43, P1141, DOI 10.1007/s40618-020-01266-w
   Jaeckel E, 2002, ANN NY ACAD SCI, V958, P7
   John AE, 2021, IMMUNOL REV, V302, P228, DOI 10.1111/imr.12977
   Kandil H, 2021, INFECT DIS CLIN PRAC, V29, pe195, DOI 10.1097/IPC.0000000000000992
   Katsoulis M, 2021, PUBLIC HEALTH, V191, P41, DOI 10.1016/j.puhe.2020.12.003
   Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3
   Khan M. G., 2020, BANGLADESH J MEDICAL, V19, P88, DOI [10.3329/bjms.v19i0.48198, DOI 10.3329/BJMS.V19I0.48198]
   Khan S, 2021, BANGLADESH J MED SCI, V20, P697, DOI 10.3329/bjms.v20i4.54122
   Kimura T, 2020, INT J INFECT DIS, V101, P380, DOI 10.1016/j.ijid.2020.10.015
   Vajari MK, 2021, CELL BIOL INT, V45, P1832, DOI 10.1002/cbin.11623
   Kothandaraman N, 2021, AM J PHYSIOL-ENDOC M, V320, P139, DOI 10.1152/ajpendo.00480.2020
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lania A, 2020, EUR J ENDOCRINOL, V183, P381, DOI 10.1530/EJE-20-0335
   Lee K, 2009, GLOB INST, P1
   Leow MKS, 2005, CLIN ENDOCRINOL, V63, P197, DOI 10.1111/j.1365-2265.2005.02325.x
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liao YH, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123962
   Lim S, 2021, NAT REV ENDOCRINOL, V17, P11, DOI 10.1038/s41574-020-00435-4
   Lima-Martinez MM, 2021, CLIN INVEST ARTERIOS, V33, P151, DOI 10.1016/j.arteri.2020.10.001
   Lisco G, 2021, J CLIN MED, V10, DOI 10.3390/jcm10132920
   Liu FR, 2020, CLIN GASTROENTEROL H, V18, P2128, DOI 10.1016/j.cgh.2020.04.040
   Liu Y, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021806
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Ma L, 2021, J MED VIROL, V93, P456, DOI 10.1002/jmv.26259
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Malik J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249421
   Mantovani A, 2020, NUTR METAB CARDIOVAS, V30, P1236, DOI 10.1016/j.numecd.2020.05.014
   McDonnell ME, 2012, ENDOCRIN METAB CLIN, V41, P175, DOI 10.1016/j.ecl.2012.01.001
   McIntyre HD, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108353
   Mirzaei F, 2021, PRIM CARE DIABETES, V15, P409, DOI 10.1016/j.pcd.2021.01.002
   Moriconi D, 2020, OBES RES CLIN PRACT, V14, P205, DOI 10.1016/j.orcp.2020.05.009
   Muniangi-Muhitu H, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.582936
   Murtas R, 2020, AUTOIMMUN HIGHLIGHTS, V11, DOI 10.1186/s13317-020-00141-1
   Nakeshbandi M, 2020, INT J OBESITY, V44, P1832, DOI 10.1038/s41366-020-0648-x
   Nansen A, 1997, J INFECT DIS, V176, P151, DOI 10.1086/514017
   Nasim MT., 2020, BANGLADESH J MED SCI, V19, DOI 10.3329/bjms.v19i0.48197
   NHS London Clinical Networks, FRONT ENDOCRINOL LAU
   Ni WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03120-0
   Nikoloski Z, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11116-w
   Nogami K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013894
   Pal R, 2020, J ENDOCRINOL INVEST, V43, P1027, DOI 10.1007/s40618-020-01276-8
   Pal R, 2020, DIABETES METAB SYND, V14, P767, DOI 10.1016/j.dsx.2020.05.050
   Pal R, 2020, DIABETES METAB SYND, V14, P513, DOI 10.1016/j.dsx.2020.04.049
   Paschou SA, 2018, ENDOCR CONNECT, V7, pR38, DOI 10.1530/EC-17-0347
   Podder CS, 2020, BIRDEM MED J, V10, pS122
   Porfidia A, 2020, J THROMB HAEMOST, V18, P1516, DOI 10.1111/jth.14842
   Puig-Domingo M, 2021, ENDOCRINE, V72, P301, DOI 10.1007/s12020-021-02734-w
   Puig-Domingo M, 2020, ENDOCRINE, V68, P2, DOI 10.1007/s12020-020-02294-5
   Riddle MC, 2020, DIABETES CARE, V43, P1378, DOI 10.2337/dci20-0024
   Royal College of Obstetricians and Gynaecologists, GUID MAT MED SERV EV
   Rubino F, 2020, NEW ENGL J MED, V383, P789, DOI [10.1056/NEJMc2021832, 10.1056/NEJMc2018688]
   Ruggeri RM, 2021, EXPERT REV CLIN IMMU, V17, P737, DOI 10.1080/1744666X.2021.1932467
   Ryan DH, 2020, OBESITY, V28, P847, DOI 10.1002/oby.22808
   Salamanna F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.594495
   Sandooja R, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/7847526
   Scappaticcio L, 2021, REV ENDOCR METAB DIS, V22, P803, DOI 10.1007/s11154-020-09615-z
   Schaffer, HEALIO 0610
   Selek A, 2021, HORM-INT J ENDOCRINO, V20, P259, DOI 10.1007/s42000-021-00277-3
   Selvaraj K, 2021, REPROD SCI, V28, P2735, DOI 10.1007/s43032-020-00441-x
   Sevilla N, 2000, J VIROL, V74, P3284, DOI 10.1128/JVI.74.7.3284-3292.2000
   Shabto JM, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108229
   Shekhar S, 2020, HORM METAB RES, V52, P471, DOI 10.1055/a-1172-1352
   Shi Q, 2020, DIABETES CARE, V43, P1382, DOI 10.2337/dc20-0598
   Singh AK, 2020, DIABETES METAB SYND, V14, P303, DOI 10.1016/j.dsx.2020.04.004
   Steenblock C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23886-3
   SZOPA TM, 1993, DIABETOLOGIA, V36, P687, DOI 10.1007/BF00401138
   The International Diabetes Federation, 2020, DIAB FACTS FIG
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   van de L'isle Y, 2021, BJOG-INT J OBSTET GY, V128, P917, DOI 10.1111/1471-0528.16482
   Vicente N, 2017, DRUGS R&D, V17, P91, DOI 10.1007/s40268-017-0172-1
   Vitale Rebecca J, 2021, AACE Clin Case Rep, V7, P10, DOI 10.1016/j.aace.2020.11.019
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang W, 2003, J CHIN ANTITUBERCULO, V25, P232
   Wang ZP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040920
   Wei L, 2007, HUM PATHOL, V38, P95, DOI 10.1016/j.humpath.2006.06.011
   Wei L, 2010, BIOCHEM CELL BIOL, V88, P723, DOI 10.1139/O10-022
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   World Health Organization, 2012, World Health Organ Tech Rep Ser, P1
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yadav UN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00508
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Zangiabadian M, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.645194
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   ZHOU P, 2020, NATURE          0203, pNIL1, DOI DOI 10.1038/s41586-020-2012-7
   Zhu HB, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00135-6
   Zhu L, 2020, CARDIORENAL MED, V10, P470, DOI 10.1159/000510916
   Zoumpourlis V, 2020, MOL MED REP, V22, P3035, DOI 10.3892/mmr.2020.11393
NR 147
TC 1
Z9 1
U1 2
U2 2
PU IBN SINA TRUST
PI DHAKA
PA 1-1B KALLYANPUR, MIRPUR RD, DHAKA, 1216, BANGLADESH
SN 2223-4721
EI 2076-0299
J9 BANGLADESH J MED SCI
JI Bangladesh J. Med. Sci.
PY 2021
VL 20
SI SI
BP S49
EP S64
DI 10.3329/bjms.v20i5.55416
PG 16
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA UO8PC
UT WOS:000694952300008
OA gold
DA 2022-04-20
ER

PT J
AU Saqrane, S
   El Mhammedi, MA
   Lahrich, S
   Laghrib, F
   El Bouabi, Y
   Farahi, A
   Bakasse, M
AF Saqrane, S.
   El Mhammedi, M. A.
   Lahrich, S.
   Laghrib, F.
   El Bouabi, Y.
   Farahi, A.
   Bakasse, M.
TI Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic
   option for the COVID-19 infections
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Remdesivir; Clinical tests
ID CORONAVIRUS; EBOLA
AB The management of SARS-CoV-2 has not yet been clearly determined and is based on potential therapies evaluated during the SARS-CoV and MERS-CoV outbreaks. An emerging potential therapeutic approach currently being evaluated in numerous clinical trials is the remdesivir agent, which acts on COVID-19 by interfering with key steps in the virus replication cycle. It is considered a therapeutic option to be evaluated against COVID-19, based on data on its in vitro and in vivo activity against MERS-CoV and SARS-CoV coronaviruses.
   In this work, we provide an overview of remdesivir's discovery, mechanism of action, and the current studies exploring its clinical effectiveness. Recommendations for its use against COVID-19 infection are also summarized.
   (c) 2021 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
C1 [Saqrane, S.; El Mhammedi, M. A.; Lahrich, S.; Laghrib, F.; El Bouabi, Y.; Farahi, A.; Bakasse, M.] Sultan Moulay Slimane Univ Beni Mellal, Polydisciplinary Fac, Lab Chem Modeling & Environm Sci, Khouribga 25000, Morocco.
RP El Mhammedi, MA (corresponding author), Sultan Moulay Slimane Univ Beni Mellal, Polydisciplinary Fac, Lab Chem Modeling & Environm Sci, Khouribga 25000, Morocco.
EM elmhammedi@yahoo.fr
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   [Anonymous], 2020, MONDE
   [Anonymous], 2019, 1 WORLD HLTH, P251
   [Anonymous], 2020, CORONAVIRUS MEDICAME
   [Anonymous], 2020, LE MONDE 0502
   Brown AJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104541
   Buchmeier MJ, 1999, CURR OPIN MICROBIOL, V2, P398
   Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Eastman RT, 2020, ACS CENTRAL SCI, V6, P672, DOI 10.1021/acscentsci.0c00489
   Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679
   Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056
   Green N, 2008, EXPERT OPIN DRUG DIS, V3, P671, DOI 10.1517/17460441.3.6.671
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Hillaker E, 2020, PHARMACOTHERAPY, V40, P592, DOI 10.1002/phar.2403
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Jartti T, 2012, CURR OPIN PULM MED, V18, P271, DOI 10.1097/MCP.0b013e328351f8d4
   Ko WC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105933
   Lescure FX, 2020, LANCET INFECT DIS, V20, pE116
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Saqrane S, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100680
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594
   Singh SK, HUMAN CORONAVIRUSES
   Talbot PJ, 2008, NIDOVIRUSES, P313
   Talbot PJ, 2011, NON-FLAVIVIRUS ENCEPHALITIS, P185
   Vabret A, 2009, PATHOL BIOL, V57, P149, DOI 10.1016/j.patbio.2008.02.018
   Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   WHO, 2013, MIDDLE E RESP SYNDRO
   Williamson BN, 2020, NATURE, V585, P273, DOI [10.1038/s41586-020-2423-5, 10.1101/2020.04.15.043166]
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   ZHOU P, 2020, DISCOVERY NOVEL CORO
NR 41
TC 4
Z9 4
U1 2
U2 5
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAY
PY 2021
VL 14
IS 5
BP 655
EP 660
DI 10.1016/j.jiph.2021.02.006
EA APR 2021
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA RW8NH
UT WOS:000646776000014
PM 33857725
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Mbah, M
   Bang, H
   Ndi, H
   Ndzo, JA
AF Mbah, Marcellus
   Bang, Henry
   Ndi, Humphrey
   Ndzo, Judwin Alieh
TI Community Health Education for Health Crisis Management: The Case of
   COVID-19 in Cameroon
SO INTERNATIONAL QUARTERLY OF COMMUNITY HEALTH EDUCATION
LA English
DT Article; Early Access
DE community health education; COVID-19; Cameroon; integrated approach
ID PUBLIC-HEALTH; DISEASE; PEOPLE
AB The current coronavirus disease 2019 (COVID-19) pandemic has led Cameroon's government to implement public health measures aimed at preventing its spread. This paper investigates how community health education on the virus was being carried out, what gaps exist and what further action could be taken. A survey instrument was used to gather data among a total of 179 Cameroonians recruited via opportunistic and snowball sampling methods. According to our findings, gaps exist. These include the need for adequate community health education on COVID-19, maximising multilingualism and indigenous cultural assets and disbanding misconceptions on the pandemic, as well as stigmatisation. The paper culminates by underlining the significance of an integrated approach to confront the pandemic. This approach captures the need to frame but also firm up community health education architecture on COVID-19 that captures inputs from different stakeholders, including indigenous knowledge holders, for collective wellbeing.
C1 [Mbah, Marcellus] Nottingham Trent Univ, Inst Educ, Nottingham NG1 4FQ, England.
   [Bang, Henry] Bournemouth Univ, Ctr Disaster Management, Bournemouth, Dorset, England.
   [Ndi, Humphrey] Univ Yaounde I, Dept Geog, Higher Teacher Training Coll, Yaounde, Cameroon.
   [Ndzo, Judwin Alieh] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham, England.
RP Mbah, M (corresponding author), Nottingham Trent Univ, Inst Educ, Nottingham NG1 4FQ, England.
EM marcellus.mbah@ntu.ac.uk
RI Bang, Henry Ngenyam/ABE-3229-2020
OI Mbah, Marcellus F./0000-0002-4199-0819
CR Abiodun OA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-814
   Aggleton P, HIV RELATED STIGMA D
   Aggleton P, 2011, AIDS EDUC PREV, V23, P495, DOI 10.1521/aeap.2011.23.6.495
   Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X
   Ataguba JE, 2020, APPL HEALTH ECON HEA, V18, P325, DOI 10.1007/s40258-020-00580-x
   Badcock J., 2020, CORONAVIRUS WHY SPAI
   Baker J, 2004, EQUALITY: FROM THEORY TO ACTION, P1, DOI 10.1057/9780230508088
   Baron SL, 2014, AM J IND MED, V57, P539, DOI 10.1002/ajim.22174
   Berkes F, 2013, SOC NATUR RESOUR, V26, P5, DOI 10.1080/08941920.2012.736605
   Bourdieu Pierre., 1985, SOCIOCRITICISM, V2, P11, DOI DOI 10.1177/0038038504040870
   Bowleg L, 2020, AM J PUBLIC HEALTH, V110, P917, DOI 10.2105/AJPH.2020.305766
   Bradbury-Jones C, 2020, J CLIN NURS, V29, P2047, DOI 10.1111/jocn.15296
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Brennen JS., 2020, REUTERS I, V7
   Chaiklin S., 2003, VYGOTSKYS ED THEORY, V1, P39, DOI [10.1017/CBO9780511840975.004, DOI 10.1017/CBO9780511840975.004]
   Chetterje P, 2020, LANCET INFECT DIS, V20, P544, DOI 10.1016/S1473-3099(20)30300-5
   Chothia F., 2018, BBC NEWS
   Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100
   Ekwebelem OC, 2021, AM J TROP MED HYG, V104, P457, DOI 10.4269/ajtmh.20-1489
   Elliott J., 1996, COMMUNITIES THEIR U
   Fitzsimons C., 2017, COMMUNITY ED NEOLIBE, P227
   Fonchingong CC, 2018, SOCIETIES, V8, P84
   Forku R., 2021, CAMEROON MINISTER UR
   Freire P., 2018, PEDAGOGY OPPRESSED
   Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562
   Gupta L, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e256
   Habermas J., 2002, PRAGMATICS SOCIAL IN
   Habermas J., 2015, THEORY COMMUNICATIVE, V2
   Hays, 2016, QUALITATIVE RES METH, P246
   Holloway I, 2007, DISABIL REHABIL, V29, P1456, DOI 10.1080/09638280601107260
   Ihekweazu C, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01622-w
   Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812
   Jimenez-Pavon D, 2020, PROG CARDIOVASC DIS, V63, P386, DOI 10.1016/j.pcad.2020.03.009
   Kingue S, 2013, B WORLD HEALTH ORGAN, V91, P864, DOI 10.2471/BLT.13.127829
   Kouagheu J., 2020, CAMEROON TOGO CONFIR
   Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255
   Kpanake L, 2016, J PUBLIC HEALTH POL, V37, P160, DOI 10.1057/jphp.2016.1
   Lareau A, 2003, THEOR SOC, V32, P567, DOI 10.1023/B:RYSO.0000004951.04408.b0
   Larson HJ, 2018, NATURE, V562, P309, DOI 10.1038/d41586-018-07034-4
   Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132
   LUEPKER RV, 1994, AM J PUBLIC HEALTH, V84, P1383, DOI 10.2105/AJPH.84.9.1383
   Maeda JM, 2021, SCIENCE, V371, P27, DOI 10.1126/science.abf8832Article
   Mukandavire Z, 2009, APPL MATH MODEL, V33, P2084, DOI 10.1016/j.apm.2008.05.017
   Mwai P., 2021, BBC NEWS
   Ndille R., 2016, EUR J LANG STUD, V3
   Newey S., 2020, IS 2 WAVE BEGINNING
   NHS, 2020, VIS SOM HOSP VIS SOM HOSP
   Oben J, 2020, FUNCT FOODS HEALTH D, V10, P324, DOI [10.31989/ffhd.v10i7.715, 10.31989/ffhd.v10i8.715]
   Obeng-Odoom F., 2020, AFRICAN REV EC FINAN, V12, P3
   OCHA, 2020, 05 OCHA 05 OCHA
   Ojong N, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020176
   Oliver D., 2020, BMJ-BRIT MED J, V368
   Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006
   Peston R., 2020, WHAT WAS GOVT BIGGES
   Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199
   Ruegg Sr, 2018, INTEGRATED APPROACHES TO HEALTH: A HANDBOOK FOR THE EVALUATION OF ONE HEALTH, P1, DOI 10.3920/978-90-8686-875-9
   Salyer SJ, 2021, LANCET, V397, P1265, DOI 10.1016/S0140-6736(21)00632-2
   Samarasekera U., 2021, LANCET, V21, pP324
   Sanders Debra, 2005, Nurse Educ, V30, P203, DOI 10.1097/00006223-200509000-00007
   Services of the Prime Minister, 2020, GOV RESP STRAT COR P GOV RESP STRAT COR P
   Shahi Gautam Kishore, 2021, Online Soc Netw Media, V22, P100104, DOI 10.1016/j.osnem.2020.100104
   Soy, 2020, BBC NEWS
   Stake R.E, 1995, ART CASE STUDY RES
   Stern EB, 1999, STROKE, V30, P720, DOI 10.1161/01.STR.30.4.720
   Tembo J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n457
   UNICEF, 2020, 16 UNICEF 16 UNICEF
   Wallace A, 2007, SOC POLICY SOC, V6, P1, DOI 10.1017/S1474746406003290
   Wang YX, 2019, SOC SCI MED, V240, DOI 10.1016/j.socscimed.2019.112552
   Whitehead D, 2004, J ADV NURS, V47, P311, DOI 10.1111/j.1365-2648.2004.03095.x
   WHO, 2021, WHO AFR REG NUMB GLA WHO AFR REG NUMB GLA
   WHO, 2020, CAM COV 19 SIT CAM COV 19 SIT
   WHO, 2021, CAM COV 19 SIT CAM COV 19 SIT
NR 72
TC 0
Z9 0
U1 4
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0272-684X
EI 1541-3519
J9 INT Q COMMUNITY HEAL
JI Int. Q. Community Health Educ.
AR 0272684X211031106
DI 10.1177/0272684X211031106
EA JUL 2021
PG 10
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA TM6EK
UT WOS:000675643500001
PM 34264140
OA Green Accepted, hybrid
DA 2022-04-20
ER

PT J
AU Goha, A
   Mezue, K
   Edwards, P
   Nunura, F
   Baugh, D
   Madu, E
AF Goha, Ahmed
   Mezue, Kenechukwu
   Edwards, Paul
   Nunura, Felix
   Baugh, Dainia
   Madu, Ernest
TI COVID-19 and the heart: An update for clinicians
SO CLINICAL CARDIOLOGY
LA English
DT Editorial Material
DE acute myocardial injury; COVID-19; myocaritis; NSAID; RAAS
ID CARDIOVASCULAR-DISEASE
AB SARS-CoV-2, the cause of the COVID-19 pandemic has significantly impacted cardiovascular healthcare. Patients with pre-existing cardiovascular disease are at higher risk of morbidity and mortality. The virus may affect the heart directly and indirectly with clinical syndromes of acute myocardial injury, myocarditis, acute coronary syndromes, heart failure, arrhythmias, and venous thromboembolism. Some therapeutics under investigation for COVID-19 may also have adverse cardiac effects. The involvement of the RAAS system in viral entry makes it pertinent to consider the effects of medications that modulate the system. Comprehensive knowledge of peculiar cardiovascular manifestations of COVID-19 and the role of RAAS in the prognosis of COVID-19 disease is needed for optimal patient management.
C1 [Goha, Ahmed] Aga Khan Univ Hosp, 3rd Parklands Ave, Nairobi, Kenya.
   [Goha, Ahmed; Mezue, Kenechukwu; Edwards, Paul; Nunura, Felix; Baugh, Dainia; Madu, Ernest] Caribbean & HIC Heart Hosp, Heart Inst, Kingston, Jamaica.
   [Mezue, Kenechukwu] Altru Hlth Syst, Dept Hosp Med, Grand Forks, ND USA.
RP Goha, A (corresponding author), Aga Khan Univ Hosp, 3rd Parklands Ave, Nairobi, Kenya.; Goha, A (corresponding author), Caribbean & HIC Heart Hosp, Heart Inst, Kingston, Jamaica.
EM dr_goha@hotmail.com
RI NUNURA, FELIX/AAM-7591-2021
OI NUNURA, FELIX/0000-0001-9868-8656; Mezue,
   Kenechukwu/0000-0001-7454-7410; MADU, ERNEST/0000-0001-5739-2816;
   Edwards, Paul/0000-0002-3452-8968
CR Aggarwal G, 2020, INT J STROKE, V15, P385, DOI 10.1177/1747493020921664
   Akhmerov A, 2020, CIRC RES, V126, P1443, DOI 10.1161/CIRCRESAHA.120.317055
   Amici C, 2006, ANTIVIR THER, V11, P1021
   Baggett TP, 2020, JAMA-J AM MED ASSOC, V323, P2191, DOI 10.1001/jama.2020.6887
   Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013
   Barlow A, 2020, PHARMACOTHERAPY, V40, P416, DOI 10.1002/phar.2398
   Beyrouti R, 2020, J NEUROL NEUROSUR PS, V91, P889, DOI 10.1136/jnnp-2020-323586
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117
   ESC, 2020, DSC GUID DIAGN MAN C
   European Medicines Agency, EMA GIV ADV US NONST
   Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219
   Harris JE, 2019, IJC HEART VASC, V22, P145, DOI 10.1016/j.ijcha.2018.12.013
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   JPHMP Direct, ID DIFF COVID 19 RAT
   Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]
   McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Nguyen JL, 2016, JAMA CARDIOL, V1, P274, DOI 10.1001/jamacardio.2016.0433
   Qiao WL, 2015, CARDIOLOGY, V131, P97, DOI 10.1159/000375362
   Reiner Z, 2020, ARCH MED SCI, V16, P490, DOI 10.5114/aoms.2020.94655
   RICHARDSON S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]
   Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001
   Tam CCF, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006631
   Tan WY, 2020, INT J CARDIOL, V309, P70, DOI 10.1016/j.ijcard.2020.03.063
   Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wosten-van Asperen RM, 2011, J PATHOL, V225, P618, DOI 10.1002/path.2987
   World Health Organization, COR DIS COVID 19 SIT
   Xie WM, 2020, J THROMB THROMBOLYS, V50, P98, DOI 10.1007/s11239-020-02112-9
   Xiong TY, 2020, EUR HEART J, V41, P1798, DOI 10.1093/eurheartj/ehaa231
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 40
TC 15
Z9 15
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-9289
EI 1932-8737
J9 CLIN CARDIOL
JI Clin. Cardiol.
PD NOV
PY 2020
VL 43
IS 11
BP 1216
EP 1222
DI 10.1002/clc.23406
EA JUN 2020
PG 7
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA OQ2LT
UT WOS:000539779900001
PM 32533585
OA Green Published
DA 2022-04-20
ER

PT J
AU Rahman, MM
   Khan, SJ
   Sakib, MS
   Halim, MA
   Rahman, MM
   Asikunnaby
   Jhinuk, JM
AF Rahman, Md Mostafizur
   Khan, Saadmaan Jubayer
   Sakib, Mohammed Sadman
   Halim, Md Abdul
   Rahman, Md Moshiur
   Asikunnaby
   Jhinuk, Jannate Mehjabin
TI COVID-19 responses among university students of Bangladesh: assessment
   of status and individual view toward COVID-19
SO JOURNAL OF HUMAN BEHAVIOR IN THE SOCIAL ENVIRONMENT
LA English
DT Article
DE University students; infectious disease; COVID-19; developing
   settlement; lockdown
ID DISASTER PREPAREDNESS; CLIMATE-CHANGE; COMPETENCES; SARS-COV-2;
   ADAPTATION; EXPERIENCE; EARTHQUAKE; EDUCATION; IMPACTS; DHAKA
AB COVID-19 has become one of the poignant infectious diseases in human history. This cross-sectional study intended to evaluate the adverse impact of COVID-19 among university students of Bangladesh. It also disclosed the COVID-19 responses through knowledge, attitude, and practice level across these university students. A rapid online survey was conducted to administer a self-reported questionnaire among these university students during the country's COVID-19 induced lockdown period. Convenience and snowball sampling technique was employed for this study. Total of 418 university students participated. Statistical analyses were conducted based on type and normality distribution of data. Majority of the participated students experienced high impact (61.48%) on their study. They were also exceedingly concerned with their mental health (47.84%) due to this pandemic. Large number of students attended online classes (69.62%). Students living in the capital city Dhaka, reported more unsafe current places than the students living outside Dhaka. Furthermore, universities supported their students through multiple financial and mental assistance initiatives. Participated students reported moderate knowledge, attitude, and high practice scores. They were also observed moderate total KAP score in this study. Female students demonstrated good knowledge and practice scores than the male students.
C1 [Rahman, Md Mostafizur; Khan, Saadmaan Jubayer; Sakib, Mohammed Sadman; Halim, Md Abdul; Asikunnaby; Jhinuk, Jannate Mehjabin] Bangladesh Univ Profess, Fac Arts & Social Sci, Dept Disaster & Human Secur Management, Dhaka 1216, Bangladesh.
   [Rahman, Md Moshiur] Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Tokyo, Japan.
   [Rahman, Md Moshiur] Khulna Univ, Fisheries & Marine Resource Technol Discipline, Khulna, Bangladesh.
RP Rahman, MM (corresponding author), Bangladesh Univ Profess, Fac Arts & Social Sci, Dept Disaster & Human Secur Management, Dhaka 1216, Bangladesh.
EM amimostafiz@gmail.com
OI Sadman Sakib, Mohammed/0000-0002-9971-8703; Rahman, Md
   Moshiur/0000-0001-8319-395X; , Asikunnaby/0000-0002-2477-7354
CR Akram A., 2019, BANGLADESH J INFECT, V6, P1, DOI [https://doi.org/10.3329/bjid.v6i1.42627, DOI 10.3329/BJID.V6I1.42627]
   Ali A, 1999, CLIMATE RES, V12, P109, DOI 10.3354/cr012109
   Ali SA, 2020, J INFECT PUBLIC HEAL, V13, P644, DOI [10.1016/j.jiph.2019.02.033, 10.1016/j.jiph.2020.02.033]
   [Anonymous], 2020, BUSINESS STANDARD
   Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154
   Banu S, 2014, ENVIRON INT, V63, P137, DOI 10.1016/j.envint.2013.11.002
   Basir NABA, 2020, PESQUI BRAS ODONTOPE, V20, DOI 10.1590/pboci.2020.002
   Basolo V, 2009, ENVIRON BEHAV, V41, P338, DOI 10.1177/0013916508317222
   Bourque LB, 2012, ENVIRON BEHAV, V44, P374, DOI 10.1177/0013916510390318
   Chang L, 2020, TRANSFUS MED REV, V34, P75, DOI 10.1016/j.tmrv.2020.02.003
   Chen Y., 2015, CHINESE NURSING RES, V11
   Chowdhury P., 2017, COMBATING URBAN HAZA
   Daily Bangladesh, 2020, DAILY BANGLADES 0613
   Deng CX, 2020, INT J BIOL SCI, V16, P1676, DOI 10.7150/ijbs.45587
   Dhaka Tribune, 2020, DHAKA TRIBUNE   0404
   Djalante R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100080
   Gillani AH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062027
   HAQUE CE, 1995, ENVIRON MANAGE, V19, P719, DOI 10.1007/BF02471954
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Hayat K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103347
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Hoffmann R, 2017, WORLD DEV, V96, P32, DOI 10.1016/j.worlddev.2017.02.016
   Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309
   Jose MM, 2014, NURS EDUC TODAY, V34, P543, DOI 10.1016/j.nedt.2013.07.021
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951
   Loke AY, 2014, INT J ENV RES PUB HE, V11, P3289, DOI 10.3390/ijerph110303289
   Macias AE, 2009, J HOSP INFECT, V73, P280, DOI 10.1016/j.jhin.2009.06.017
   Mamun MA, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102073
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Mutsuddy P, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/3516284
   Nguyen HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114164
   Nguyen LH, 2006, EARTHQ SPECTRA, V22, P569, DOI 10.1193/1.2219108
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012
   Ozili P., 2020, SPILLOVER COVID 19 I, DOI [DOI 10.2139/SSRN.3562570, 10.2139/ssrn.3562570]
   Paul BK, 2010, DISASTERS, V34, P337, DOI 10.1111/j.1467-7717.2009.01132.x
   R Core Team, 2019, R LANG ENV STAT COMP
   Rzymski P, 2020, J INFECT PUBLIC HEAL, V13, P873, DOI 10.1016/j.jiph.2020.04.013
   Shammi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04063
   Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090
   Shimi AC, 2010, DISASTER PREV MANAG, V19, P298, DOI 10.1108/09653561011052484
   Sintema E. J., 2020, EURASIA J MATH SCI T, V16, DOI DOI 10.29333/EJMSTE/7893
   Steckler MS, 2016, NAT GEOSCI, V9, P615, DOI [10.1038/NGEO2760, 10.1038/ngeo2760]
   Tan YB, 2017, DISASTER MED PUBLIC, V11, P310, DOI 10.1017/dmp.2016.124
   Tanner A, 2015, INT J DISAST RISK RE, V13, P409, DOI 10.1016/j.ijdrr.2015.08.007
   The Daily Star, 2020, DAILY STAR
   UNESCO, 2020, ED DISRUPTION RECOVE
   Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9
   Walter LA, 2020, WEST J EMERG MED, V21, P507, DOI 10.5811/westjem.2020.4.47536
   Wang CY, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020036
   Zhang HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103370
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 54
TC 7
Z9 7
U1 7
U2 15
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1091-1359
EI 1540-3556
J9 J HUM BEHAV SOC ENVI
JI J. Hum. Behav. Soc. Environ.
PD MAY 19
PY 2021
VL 31
IS 1-4
BP 512
EP 531
DI 10.1080/10911359.2020.1822978
EA DEC 2020
PG 20
WC Social Work
WE Emerging Sources Citation Index (ESCI)
SC Social Work
GA RK6VY
UT WOS:000604714500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Kazempour, Z
   Soleymani, M
   Najafi, NS
   Ashrafi-rizi, H
AF Kazempour, Zahra
   Soleymani, Mohammad
   Soleimanzade Najafi, Nayere
   Ashrafi-rizi, Hasan
TI Identifying the roles of medical librarians in COVID-19 crisis in Iran
SO JOURNAL OF EDUCATION AND HEALTH PROMOTION
LA English
DT Article
DE COVID-19; crisis management; medical librarians
ID CLINICAL INFORMATION; DISASTER; SANCTIONS; SERVICES; TIMES
AB BACKGROUND: The best mechanisms for medical librarians to be more involved in health, especially during crisis condition, and to expand their roles are using experiences of other individuals and performing new activities. This study aimed to identify the roles of medical librarians in the COVID-19 crisis in Iran. MATERIALS AND METHODS: This research was done by a qualitative content analysis method. Research participants in the first phase included whole scientific papers (19 documents) which had been published by medical librarians related to the COVID-19 issue and in the second phase 10 medical librarians involved in the COVID-19 who were interviewed and continued until data saturation. Data were collected through each interview, and data analysis was performed using content analysis method. Then, obtained information of the first and second phases was merged together, and codes, subcategories as well as main categories were formed. RESULTS: According to the results, 7 main categories and 24 subcategories regarding the roles of librarians in COVID-19 crisis were identified. The main categories include hygiene services promotion, development of health information-seeking skills, health research services, interaction-level development, evidence-based policy development, information dissemination services promotion, and management services development. Furthermore, regarding barriers to the role of medical librarians in the COVID-19 crisis in Iran, four subcategories were identified that are medical librarian-related barriers, organization-related barriers, profession-related barriers, and context of society (country conditions)-related barriers. CONCLUSION: Medical librarians relatively have been able to provide effective health information services to managers, health-care specialists, and the general public in a variety of health fields.
C1 [Kazempour, Zahra] Payame Noor Univ, Fac Media, Dept Lib & Informat Sci, Tehran, Iran.
   [Soleymani, Mohammad; Ashrafi-rizi, Hasan] Isfahan Univ Med Sci, Dept Med Lib & Informat Sci, Hlth Informat Technol Res Ctr, Esfahan, Iran.
   [Soleimanzade Najafi, Nayere] Univ Isfahan, Dept Knowledge & Informat Sci, Esfahan, Iran.
RP Ashrafi-rizi, H (corresponding author), Isfahan Univ Med Sci, Dept Med Lib & Informat Sci, Hlth Informat Technol Res Ctr, Esfahan, Iran.
EM hassanashrafi@mng.mui.ac.ir
RI kazempour, zahra/AAA-7067-2022
OI Kazempour, Zahra/0000-0001-6834-2814
FU Vice Chancellery for Research and Technology, Isfahan University of
   Medical Sciences, Isfahan, Iran
FX This research resulted in a research project that was supported by Vice
   Chancellery for Research and Technology, Isfahan University of Medical
   Sciences, Isfahan, Iran.
CR Alajmi B., 2016, LIBR MANAGE
   Anwar MA, 2017, LIB PHILOS PRACT, V1533, P1
   Ashrafi-rizi H, 2017, STUDY NOVEL SERVICES
   Ashrafi-rizi H, 2020, ARCH ACAD EMERG MED, V8
   Ashrafi-rizi H, 2020, ARCH ACAD EMERG MED, V8
   Ashrafi-Rizi H, 2019, J CONTEMP MED SCI, V5, P218, DOI 10.22317/jcms.08201907
   Ashrafi-Rizi Hasan, 2015, J Educ Health Promot, V4, P26, DOI 10.4103/2277-9531.154117
   Ashrafi-Rzi H, 2020, J EDUC HEALTH PROMOT, V9, DOI 10.4103/jehp.jehp_301_20
   Australian Library and Information Association, 2010, ALIA GUID DIS PLANN
   Beales D., 2003, Journal of Hospital Librarianship, V3, P11, DOI 10.1300/J186v03n04_03
   Biglu MH, 2016, J ANAL RES CLIN MED, V4, P215
   Chizwina S, 2017, LIB REV
   DAVIDOFF F, 1995, BRIT MED J, V310, P1085, DOI 10.1136/bmj.310.6987.1085
   DEMAS JM, 1991, B MED LIBR ASSOC, V79, P17
   Di Pietro G, 2016, STUD CONSERV, V61, P245, DOI 10.1179/2047058415Y.0000000005
   Donahue AE, 2013, J MED LIBR ASSOC, V101, P315, DOI 10.3163/1536-5050.101.4.014
   Fakari FR, 2020, ARCH ACAD EMERG MED, V8
   Featherstone RM, 2008, J MED LIBR ASSOC, V96, P343, DOI 10.3163/1536-5050.96.4.009
   Featherstone RM, 2012, J LIBR ADM, V52, P731, DOI 10.1080/01930826.2012.746875
   Gavgani VZ, 2019, DEPICT HLTH, V8, P193
   Gorji A, 2014, IRAN J PUBLIC HEALTH, V43, P381
   Hariri N., PRINCIPLES METHODS Q
   Ivanitskaya L, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e6
   Kazaempour Z, 2020, J MIL MED, V22, P207
   Lamptey R., 2013, LIB PHILOS PRACTICE, V911, P1
   Linder-Zarankin M., 2017, LATENT RESILIENCE CA
   Mahmood K, 2013, IMPACT WEB 2 0 TECHN IMPACT WEB 2 0 TECHN
   Mansour E, 2017, LIBR MANAGE, V38, P182, DOI 10.1108/LM-08-2016-0063
   Matthews G, 1996, LIB REV
   McKnight Michelynn, 2006, Medical Reference Services Quarterly, V25, P1, DOI 10.1300/J115v25n03_01
   Mohammadesmaeili S, 2015, LIB NATURAL DISASTER
   Movahedi F, 2013, J HLTH ADM J HLTH ADM, V16, P71
   Omona W, 2006, J LIBR INF SCI, V38, P45, DOI 10.1177/0961000606060959
   Pasquarella C, 2012, ANN AGR ENV MED, V19, P209
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Roderer NK, 1993, DISSEMINATION MEDICA
   Sahapong S, 2006, SYSTEMATIC REV ROLES
   Sheikhshoaei F, 2019, J HLTH ADM J HLTH ADM, V22, P22
   Smith R, 1996, BRIT MED J, V313, P1062
   State Management Education Center, 2014, MANN DIS MAN MANN DIS MAN
   Stricker M., 2019, COLLABORATIVE LIB, V11, P4
   Takian A, 2020, LANCET, V395, P1035, DOI 10.1016/S0140-6736(20)30668-1
   The New Jersey State Library, 2016, LIBRARIANS DISASTER
   Winston MD, 2005, NEW LIB WORLD
   Yaeger Lauren H, 2014, Mo Med, V111, P413
   Yates C, 2015, LIBR INFORM SCI RES, V37, P220, DOI 10.1016/j.lisr.2015.04.003
   Yaya JA., 2016, AM J INFORM SCI COMP, V2, P8
   Young, 2018, NEW VISIONS PUBLIC A, V10, P31
   Zach Lisl, 2011, Science & Technology Libraries, V30, P404, DOI 10.1080/0194262X.2011.626341
   Zakaeei-fateh J., 2017, 15 C CIV STUD NAT TE 15 C CIV STUD NAT TE
NR 50
TC 0
Z9 0
U1 5
U2 7
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2277-9531
EI 2319-6440
J9 J EDUC HEALTH PROMOT
JI J. Educ. Health Promot.
PD JAN-DEC
PY 2021
VL 10
IS 1
DI 10.4103/jehp.jehp_1352_20
PG 12
WC Education, Scientific Disciplines; Public, Environmental & Occupational
   Health
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research; Public, Environmental & Occupational
   Health
GA TF3JS
UT WOS:000670611700024
PM 34395663
DA 2022-04-20
ER

PT J
AU Bowyer, S
AF Bowyer, Shane
TI Creation of a COVID-19 business and life lesson: the impact on students'
   learning and behavior
SO ACCOUNTING RESEARCH JOURNAL
LA English
DT Review
DE Tacit knowledge; COVID-19; Current events; Pivot; Teachable moment
AB Purpose
   The purpose of this paper is to encourage other educators to pivot and implement a current event activity when a situation arises. This paper examines the pedagogical benefits of implementing a current event class activity. The author discusses using tacit knowledge of an international trip to heighten awareness of the COVID-19 pandemic while linking it to business management knowledge. Results of a follow-up student survey are also discussed.
   Design/methodology/approach
   Considering the potential impact of COVID-19, an in-class activity was implemented and later followed up by a survey that addressed the activity impact. Students conducted brief research on COVID-19 and were put in small groups that analyzed scenarios for potential spread and identified steps business managers could take as safeguards. The entire class discussed the scenarios and potential actions during the upcoming spring break. The associated survey was for future classroom management and feedback concerning COVID-19 and not designed for research purposes.
   Findings
   The literature analyses and survey results indicate that pivoting from the syllabus and engaging students in a current event activity can be beneficial. In this study, students displayed increased awareness and changed actions as a result of the class activity.
   Originality/value
   This paper shares the author's perspective regarding deviation from the course syllabus to conduct a class activity focused on a current event, which in this case is the COVID-19 pandemic.
C1 [Bowyer, Shane] Minnesota State Univ, Coll Business, Mankato, MN 56001 USA.
RP Bowyer, S (corresponding author), Minnesota State Univ, Coll Business, Mankato, MN 56001 USA.
EM shane.bowyer@mnsu.edu
CR Chugh R., 2013, J ADV MANAGEMENT SCI, V1, P24, DOI [10.12720/joams.1.1.24-28, DOI 10.12720/JOAMS.1.1.24-28]
   Cornely K, 2003, BIOCHEM MOL BIOL EDU, V31, P173, DOI 10.1002/bmb.2003.494031030214
   Cotton DRE, 2006, EDUC RES-UK, V48, P223, DOI 10.1080/00131880600732306
   Deveci, 2007, ED SCI THEORY PRACT, V1, P446
   Doering A., 1952, CLEARING HOUSE, V26, P465
   Eison J.A., 1991, ASHE ERIC HIGHER ED
   Fennell R., 2002, AM J HEALTH PROMOT, V33, P181, DOI 10.1080/19325037.2002.10604736
   Fowler K., 2017, MARKETING ED REV, V27, P97, DOI 10.1080/10528008.2017.1309980
   Ghosh I., 2011, J EC EC RES, V12, P1
   Grise-Owens E, 2010, J SOC WORK EDUC, V46, P133, DOI 10.5175/JSWE.2010.200800062
   Gruber D.A., 2020, BIZED, V19, P50
   Head A., 2014, J BEST TEACHING PRAC, V1, P11
   Higbee J.L., 2002, RES TEACHING DEV ED, V18, P85
   Jurkiewicz CL, 2004, J BUS ETHICS, V53, P283, DOI 10.1023/B:BUSI.0000039416.21807.61
   Lipscomb G., 2002, SOC STUD, V93, P237, DOI [10.1080/00377990209600172, DOI 10.1080/00377990209600172]
   McWilliams V, 2006, J BUS ETHICS, V67, P421, DOI 10.1007/s10551-006-9035-3
   Metrejean C., 2002, ACCOUNT EDUC, V11, P347, DOI [10.1080/0963928021000031466, DOI 10.1080/0963928021000031466]
   Oulton C, 2004, INT J SCI EDUC, V26, P411, DOI 10.1080/0950069032000072746
   PALMER RR, 1957, PEABODY J EDUC, V35, P90, DOI 10.1080/01619565709536777
   Passe, 2008, SOCIAL STUDIES YOUNG, V20, P27
   Pescatore C, 2007, J ADOLESC ADULT LIT, V51, P326, DOI 10.1598/JAAL.51.4.4
   Polanyi M., 1967, TACIT DIMENSION
   Rooks N., 2014, CHRON HIGHER EDUC, V61, P25
   Shakouri, 2016, THEORY PRACTICE LANG, V6, P586, DOI [10.17507/tpls.0603.18, DOI 10.17507/TPLS.0603.18]
   Sikes V., 2010, CURRICULUM TEACHING, V12, P41
   Wright AL, 2013, J MANAG EDUC, V37, P135, DOI 10.1177/1052562912455522
   Wright L. L., 2016, J MASS COMMUN Q, V71, P231, DOI [10.1177/1077695815598435, DOI 10.1177/1077695815598435]
NR 27
TC 5
Z9 5
U1 1
U2 7
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1030-9616
EI 1839-5465
J9 ACCOUNT RES J
JI Account. Res. J.
PD JUL 19
PY 2021
VL 34
IS 2
SI SI
BP 196
EP 205
DI 10.1108/ARJ-08-2020-0243
EA JAN 2021
PG 10
WC Business, Finance
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA TN2UB
UT WOS:000607916100001
DA 2022-04-20
ER

PT J
AU Yasir, M
   Khan, RM
   Fahad, A
   Ansari, AN
AF Yasir, M.
   Khan, R. M.
   Fahad, A.
   Ansari, A. N.
TI COVID-19: Understanding pathology and management in Unani medical
   perspective
SO INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE
LA English
DT Article
DE COVID-19; Humma Balghami; Nazla; Unani pathology; Waba
AB The whole world is facing a big challenge to fight against COVID-19 as it is a novel disease, highly infectious and having no treatment yet. Traditional Unani medicine is reviewed with an aim to find some solution for this disease prevention, control and management. Unani medical literature is extensively reviewed and it is found that there are some presentations similar to this disease and management of those clinical syndromes could be applied in present scenario. Major symptoms like fever, cough, fatigue, shortness of breath and rhinorrhoea are reviewed from Unani medical text having similar aetiology and interlinked pathology. It is demonstrated that in cold & humid atmospheric conditions in persons having Fuzlat (waste) in their body, Nazla (fall) of Balghami Rutubaat (phlegmatic fluids) from head comes towards lungs, infected there resulting in Zatur Riya (pneumonia/pneumonitis) and Humma Mawazba (fever caused by abnormal humour Balgham) and /or Humma Mutbiqa (fever caused by abnormal humour Dam). The bad atmospheric condition favours spread of this infection to other people who come in contact with such patient. The detailed description of these Unani concepts & interpretation is given below.
C1 [Yasir, M.; Fahad, A.] Aligarh Muslim Univ, Ajmal Khan Tibbiya Coll, Dept Ilmul Amraz, Aligarh, Uttar Pradesh, India.
   [Khan, R. M.] Aligarh Unani Ayurved Med Coll, Dept Tahhafuzi Samaji, Aligarh, Uttar Pradesh, India.
   [Ansari, A. N.] Natl Inst Unani Med, Dept Ilaj Bit Tadbeer, Bangalore, Karnataka, India.
RP Yasir, M (corresponding author), Aligarh Muslim Univ, Ajmal Khan Tibbiya Coll, Dept Ilmul Amraz, Aligarh, Uttar Pradesh, India.
EM yasirm7@gmail.com
CR Ahmad Aftab, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P337, DOI 10.1016/S2221-1691(13)60075-1
   [Anonymous], 2013, UNANI SYSTEM MED SCI
   [Anonymous], 2009, UNANI PHARMACOPOEIA
   Arzani A, TIBBE AKBAR
   Canna SW, 2012, PEDIATR CLIN N AM, V59, P329, DOI 10.1016/j.pcl.2012.03.002
   Centre For Disease Control and Prevention, 2020, INT CLIN GUID MAN PA
   Chen HY, 2016, COMPR REV FOOD SCI F, V15, P1124, DOI 10.1111/1541-4337.12228
   Cui HT, 2020, TRADIT MED RES, V5, P65, DOI [10.12032/TMR20200222165, 10.53388/TMR20200222165]
   Ibne Rushd AWM, 1987, KITABUL KULLIYAT
   Ibne Sina AAHIA, 2010, AL QANOON FIT TIB
   Jeelani G, 1998, MAKHZANUL JAWAHAR
   Jurjani A.H., 2010, ZAKHEERA KHWARZAM SH
   Khare C. P., 2007, INDIAN MED PLANTS IL
   Kirmani N I I, 1934, KULLIYATE NAFEESI
   Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9
   Majoosi A I A, 2010, KAAMILUS SANAAH
   Muralidharan-Chari V, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040474
   Rampuri N.G, KHAZAINUL ADVIA
   Razi AMIZ, 1991, KITABUL MANSOORI
   Tabri AHAIM, 1994, MUALAJATUL BUQRATIYA
   Xi Liu RW, 2020, J FORENSIC MED, V36, P19
   Zillur R, 1962, DAURE JADEED AUR TIB
NR 22
TC 0
Z9 0
U1 0
U2 0
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0972-5938
EI 0975-1068
J9 INDIAN J TRADIT KNOW
JI Indian J. Tradit. Knowl.
PD DEC
PY 2020
VL 19
IS 4
SI SI
BP S81
EP S88
PG 8
WC Plant Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences
GA QJ6AA
UT WOS:000619769800010
DA 2022-04-20
ER

PT C
AU Ricciardi, F
   Bertello, A
   Forliano, C
   De Bernardi, P
AF Ricciardi, Francesca
   Bertello, Alberto
   Forliano, Canio
   De Bernardi, Paola
GP IEEE
TI Knowledge behaviors when the commons are at stake: Insights from the
   Covid-19 crisis
SO 2020 IEEE INTERNATIONAL CONFERENCE ON TECHNOLOGY MANAGEMENT, OPERATIONS
   AND DECISIONS (ICTMOD)
SE IEEE International Technology Management Conference
LA English
DT Proceedings Paper
CT IEEE International Conference on Technology Management, Operations and
   Decisions (ICTMOD)
CY NOV 24-27, 2020
CL Marrakech, MOROCCO
SP IEEE
DE knowledge sharing; system resilience; common good
AB How do people's beliefs on the likely system-level consequences of circulating a certain piece of knowledge influence those people's knowledge behaviors? To address this question, we leverage the most recent developments of the theory of the commons as learning systems. According to this theory, people are strongly responsive to perceived threats to the commons they (may) benefit from, and strive to learn and respond accordingly. Through this theoretical lens, we analyze thick qualitative data (January-April 2020) from the Covid-19 crisis, which resulted in unprecedented visibility of commons-related knowledge behaviors. The contribution of this inductive study is fourfold. First, we identify a new emerging taxonomy of knowledge behaviors, including knowledge unleashing and knowledge curbing behaviors. Second, we identify a new emerging taxonomy of commons-related postures, that is, specific cognitive and behavioral attitudes that an individual may display about a certain commons. Third, we identify interesting emerging regularities in the relationships between specific commons-related postures and specific knowledge behaviors. Fourth, we show that the empirical data, analyzed in the light of the theory of the commons, strongly suggest disentangling knowledge behaviors from their consequences: for example, knowledge withholding proved far from being "intrinsically" counter-productive. We argue that these results open up promising research paths and opportunities for new knowledge management approaches in a wide range of organized and self-organizing contexts, such as innovation ecosystems, sustainability transitions, open innovation, or crisis management.
C1 [Ricciardi, Francesca; Bertello, Alberto; De Bernardi, Paola] Univ Turin, Dept Management, Turin, Italy.
   [Forliano, Canio] Univ Palermo, Dept Polit Sci, Turin, Italy.
RP Ricciardi, F (corresponding author), Univ Turin, Dept Management, Turin, Italy.
EM francesca.ricciardi@unito.it; alberto.bertello@unito.it;
   canio.forliano@unipa.it; paola.debernardi@unito.it
RI Ricciardi, Francesca/P-6330-2014
OI Ricciardi, Francesca/0000-0002-0645-7031
CR Ansari S, 2013, ORGAN SCI, V24, P1014, DOI 10.1287/orsc.1120.0799
   Armitage D, 2008, GLOBAL ENVIRON CHANG, V18, P86, DOI 10.1016/j.gloenvcha.2007.07.002
   Baskerville R., 2006, Knowledge Management Research & Practice, V4, P83, DOI 10.1057/palgrave.kmrp.8500090
   Case DO, 2016, STUD INFORM
   Lin Y, 2020, J KNOWL MANAG, V24, P324, DOI 10.1108/JKM-08-2019-0416
   Ostrom Elinor, 1990, GOVERNING COMMONS EV
   Ricciardi F, 2020, TECHNOL FORECAST SOC, V151, DOI 10.1016/j.techfore.2019.119799
   Rice RE, 2019, J KNOWL MANAG, V23, P1, DOI 10.1108/JKM-06-2018-0360
   Schultze U, 2002, MIS QUART, V26, P213, DOI 10.2307/4132331
   Serenko A, 2019, J KNOWL MANAG, V23, P1260, DOI 10.1108/JKM-01-2018-0007
   Serenko A, 2016, J KNOWL MANAG, V20, P1199, DOI 10.1108/JKM-05-2016-0203
   Trusson C, 2017, J KNOWL MANAG, V21, P1540, DOI 10.1108/JKM-04-2017-0146
   Wang J, 2019, J KNOWL MANAG, V23, P466, DOI 10.1108/JKM-02-2018-0061
   Wang S, 2010, HUM RESOUR MANAGE R, V20, P115, DOI 10.1016/j.hrmr.2009.10.001
   Zhu YQ, 2018, J KNOWL MANAG, V22, P76, DOI 10.1108/JKM-06-2016-0218
NR 15
TC 0
Z9 0
U1 4
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2372-7268
BN 978-1-7281-5950-8
J9 IEEE INT TECHNOL MAN
PY 2020
DI 10.1109/ICTMOD49425.2020.9380616
PG 5
WC Engineering, Electrical & Electronic
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Engineering
GA BR6QR
UT WOS:000662940500038
DA 2022-04-20
ER

PT J
AU Raman, EV
   Shivnani, D
AF Raman, Eshwara V.
   Shivnani, Deepa
TI Pediatric Airway Surgeries in COVID 19 Era
SO INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY
LA English
DT Article
DE COVID 19; Pediatric airway surgery; Precautions; Surgical drape
AB To outline a set of recommendations on the management of pediatric cases who requiring airway surgery in the context of COVID 19 pandemic. A set of recommendations have been prepared based on National and International published scientific literature and recent updates on COVID 19. These has been implemented in our tertiary care centre. Due to the evolving nature of COVID 19 and existing knowledge gaps, these recommendations may have to be revised periodically. The incidence of COVID 19 is very low (1-5%) in the pediatric age group with relatively good prognosis. Pediatric airway surgeries should be restricted to emergency cases only. The decision of postponement of the surgical cases should be taken by the team of senior pediatric airway surgeons. Flexible laryngoscopy should be avoided. Foreign body cases should undergo a computed tomography scan to avoid diagnostic bronchoscopies. All the measures should be taken to prevent direct contact of aerosol so powered instruments should not be used unless mandatory. Protective draping method should be adopted to prevent aerosol exposure. As paediatric airway surgeries are aerosol generating procedure where the risk of contracting COVID 19 by the surgeons and support staff is very high, we suggest recommendations to prevent the contact with infected aerosol. We assure these recommendations are easy to follow and can impact good quality outcome during this pandemic crisis.
C1 [Raman, Eshwara V.; Shivnani, Deepa] Manipal Hosp, Dept Otorhinolaryngol Head & Neck Surg, Childrens Airway & Swallowing Ctr, Bangalore, Karnataka, India.
RP Shivnani, D (corresponding author), Manipal Hosp, Dept Otorhinolaryngol Head & Neck Surg, Childrens Airway & Swallowing Ctr, Bangalore, Karnataka, India.
EM deepa.shivnani14@gmail.com
RI Shivnani, Dr Deepa/AAQ-9642-2020
OI Shivnani, Dr Deepa/0000-0003-2772-2065
CR [Anonymous], 19 3 2020 RAT US PER
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI DOI 10.15585/MMWR.MM6912E2
   Brewster DJ, 2020, MED J AUSTRALIA, V212, P472, DOI 10.5694/mja2.50598
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   ENT UK, 2020, TRACH GUID COVID 19
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Royal College of Anaesthetists UK, 2020, COVID 19 AIRW MAN PR
   Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131
NR 11
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 2231-3796
EI 0973-7707
J9 INDIAN J OTOLARYNGOL
JI Indian J. Otolaryngol. Head Neck Surg.
PD MAR
PY 2021
VL 73
IS 1
BP 97
EP 100
DI 10.1007/s12070-020-01989-5
EA JUL 2020
PG 4
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA QG6CI
UT WOS:000552972800002
PM 32837945
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Aprilio, K
   Wilar, G
AF Aprilio, Kevin
   Wilar, Gofarana
TI Emergence of Ethnomedical COVID-19 Treatment: A Literature Review
SO INFECTION AND DRUG RESISTANCE
LA English
DT Review
DE COVID-19; SARS-CoV-2; ethnomedicine; herbal medicine
ID TRADITIONAL CHINESE MEDICINE; PING-FENG-SAN; HERBAL MEDICINE; PHYSICIANS
   ATTITUDES; PELARGONIUM SIDOIDES; ALTERNATIVE MEDICINE;
   ASPARAGUS-RACEMOSUS; ANTIVIRAL ACTIVITY; EPS(R) 7630; COMPLEMENTARY
AB The emergence of COVID-19 as a new pandemic in the modern era has led the public to a new perspective of health. In the earlier days of the COVID-19 pandemic, many factors made people go on their own ways in finding its supposed "cure". With conventional medicines' limited availability and access, traditional medicines become more appealing due to its widespread availability and increased perception of safety. Several herbal medicines are then believed to be able to alleviate or cure COVID-19 and its symptoms. Similarities and patterns in herbal medicines being used show local wisdom of the respective communities regarding their knowledge of diseases and its treatment, known as ethnomedicine. Despite not being approved yet by regulatory bodies as a definitive guideline in COVID-19 management, the application of ethnomedicine results in several herbal medicine candidates that show a promising result regarding its efficacy in managing COVID-19. This literature review aims to study how a society and its knowledge of medicine responds to a new and currently developing disease, and whether if that knowledge merits further study in search of a cure for the pandemic. Furthermore, the narrative aspect in this review also explores socio-politics and public health aspects and considerations of non-conventional COVID19 treatment.
C1 [Aprilio, Kevin; Wilar, Gofarana] Univ Padjadjaran, Fac Pharm, Dept Pharmacol & Clin Pharm, Jalan Raya Bandung Sumedang KM 21, Sumedang 45363, West Java, Indonesia.
RP Aprilio, K (corresponding author), Univ Padjadjaran, Fac Pharm, Dept Pharmacol & Clin Pharm, Jalan Raya Bandung Sumedang KM 21, Sumedang 45363, West Java, Indonesia.
EM kevin18002@mail.unpad.ac.id
OI Wilar, Gofarana/0000-0002-0904-3117
FU Universitas Padjadjaran
FX Authors express deep gratitude to Rizky Abdulah for his guidance in this
   research and grant through Universitas Padjadjaran, Atika, A. P.,
   Kusumo, P. S., Indrajaya, R. M., and other friends of LPPMD Universitas
   Padjadjaran for the discussions and insights, and colleagues in the
   Faculty of Pharmacy, Universitas Padjadjaran. Funding for article
   pro-cessing charge (APC) is granted by Universitas Padjadjaran.
CR Agley J, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10103-x
   Alzahrani SH, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/9370721
   Ang L, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051583
   Babaei F, 2020, FOOD SCI NUTR, V8, P5215, DOI 10.1002/fsn3.1858
   Badreldin HA, 2021, RES SOC ADMIN PHARM, V17, P1946, DOI 10.1016/j.sapharm.2020.05.017
   Bailly C, 2020, PHARMACOL THERAPEUT, V214, DOI 10.1016/j.pharmthera.2020.107618
   Balkrishna A, 2021, DRUG DES DEV THER, V15, P1111, DOI 10.2147/DDDT.S292805
   Bookwalter CM, 2021, US PHARM, V46, P25
   Bopana N, 2007, J ETHNOPHARMACOL, V110, P1, DOI 10.1016/j.jep.2007.01.001
   Cao RY, 2020, ACS INFECT DIS, V6, P2524, DOI 10.1021/acsinfecdis.0c00522
   Caulfield Timothy, 2020, Nature, DOI 10.1038/d41586-020-01266-z
   Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014
   Chaturvedi Sarika, 2020, Indian J Med Ethics, V-, P1, DOI 10.20529/IJME.2020.058
   Chen J, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110281
   Chikhale RV, 2021, J BIOMOL STRUCT DYN, V39, P5033, DOI 10.1080/07391102.2020.1784289
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Chrubasik S, 2005, PHYTOMEDICINE, V12, P684, DOI 10.1016/j.phymed.2004.07.009
   Conrad A, 2007, WIEN MED WOCHENSCHR, V157, P331, DOI 10.1007/s10354-007-0434-6
   Cyranoski D, 2018, NATURE, V561, P448, DOI 10.1038/d41586-018-06782-7
   Dandara C, 2021, OMICS, V25, P209, DOI 10.1089/omi.2020.0099
   Davis L, 2000, J ETHNOPHARMACOL, V71, P193, DOI 10.1016/S0378-8741(99)00206-8
   Demaio A, 2011, ASIA-PAC J PUBLIC HE, V23, P127, DOI 10.1177/1010539509339607
   Donma MM, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109934
   Du CYQ, 2015, PHYTOTHER RES, V29, P656, DOI 10.1002/ptr.5290
   du Toit A, 2019, J ETHNOPHARMACOL, V244, DOI 10.1016/j.jep.2019.112127
   Ekor M, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00177
   El-Saber Batiha G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030872
   Emirik M, 2022, J BIOMOL STRUCT DYN, V40, P2024, DOI 10.1080/07391102.2020.1835719
   Enders AM, 2020, HARVARD KENNEDY SCH, V1, DOI [10.37016/mr-2020-48, DOI 10.37016/MR-2020-48]
   Fan AY, 2020, J INTEGR MED-JIM, V18, P385, DOI 10.1016/j.joim.2020.07.008
   Fang Zhao, 2013, Evid Based Complement Alternat Med, V2013, P136732, DOI 10.1155/2013/136732
   Firenzuoli F, 2007, EVID-BASED COMPL ALT, V4, P37, DOI 10.1093/ecam/nem096
   Fofana MO, 2021, GLOB PUBLIC HEALTH, V16, P1155, DOI 10.1080/17441692.2020.1864754
   Fu L, 2020, TRADIT MED MOD MED, V03, P117, DOI [10.1142/S2575900020500081, DOI 10.1142/S2575900020500081]
   Ghebreyesus TA, 2020, 2020 WHO
   Grimes DR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245900
   Gruessner BM, 2019, PHYTOCHEM REV, V18, P1509, DOI 10.1007/s11101-019-09645-9
   Guo H, 2020, ANN PALLIAT MED, V9, P3235, DOI 10.21037/apm-20-1478
   Gupta G. L., 2007, Pharmacognosy Reviews, V1, P129
   Gupta H, 2020, CLIN EXP DERMATOL, V45, P902, DOI 10.1111/ced.14357
   Gyasi RM, 2017, COMPLEMENT THER CLIN, V29, P1, DOI 10.1016/j.ctcp.2017.07.001
   He T, 2020, SAUDI PHARM J, V28, P1138, DOI 10.1016/j.jsps.2020.08.002
   Hilal M, 2017, J ASS ARAB U BASIC A, V24, P325, DOI [10.1016/j.jaubas.2016.11.001, DOI 10.1016/J.JAUBAS.2016.11.001]
   Hoffmann M, 2020, NATURE, V585, P588, DOI 10.1038/s41586-020-2575-3
   Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]
   Hu CY, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/5157089
   Hu K, 2021, PHYTOMEDICINE, V85, DOI 10.1016/j.phymed.2020.153242
   Jiang MY, 2020, J ETHNOPHARMACOL, V249, DOI 10.1016/j.jep.2019.112439
   Jonas WB, 2005, FORSCH KOMP KLAS NAT, V12, P159, DOI 10.1159/000085412
   Jones AW, 2011, DRUG TEST ANAL, V3, P337, DOI 10.1002/dta.301
   Kageyama Y., 2021, WORLD ACAD SCI J, V3
   Kamala A, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1328-6
   Keck T, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.666546
   Keyaerts E, 2007, ANTIVIR RES, V75, P179, DOI 10.1016/j.antiviral.2007.03.003
   Krup V, 2013, J HOMEOP AYURV MED, V2, P133, DOI DOI 10.4172/2167-1206.1000133
   Kumar P, 2019, INT J ALLIED MED SCI, V7, P1
   Kumar SB, 2021, COMPUT BIOL MED, V134, DOI 10.1016/j.compbiomed.2021.104524
   Lau TF, 2005, AM J CHINESE MED, V33, P345, DOI 10.1142/S0192415X05002965
   Lee DYW, 2021, PHYTOMEDICINE, V80, DOI 10.1016/j.phymed.2020.153337
   Li C, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198073
   Li LC, 2020, BIOMED PHARMACOTHER, V130, DOI 10.1016/j.biopha.2020.110641
   Li ST, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/2710782
   Liew WK, 2015, ASIA PAC ALLERGY, V5, P222, DOI 10.5415/apallergy.2015.5.4.222
   Lin CC, 2020, J ETHNOPHARMACOL, V253, DOI 10.1016/j.jep.2020.112656
   Liu LiSong, 2015, International Journal of Biotechnology for Wellness Industries, V4, P57
   Mbadiko CM, 2020, EUR J NUTR FOOD SAF, V12, P13, DOI [10.9734/ejnfs/2020/v12i730246, DOI 10.9734/EJNFS/2020/V12I730246]
   McLaughlin DM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249937
   Michaelis M, 2011, PHYTOMEDICINE, V18, P384, DOI 10.1016/j.phymed.2010.09.008
   Milden SP, 2004, BEHAV MED, V30, P73, DOI 10.3200/BMED.30.2.73-84
   Mohamad TAST, 2019, PATIENT PREFER ADHER, V13, P1829, DOI 10.2147/PPA.S227780
   Moreira DD, 2014, REV BRAS FARMACOGN, V24, P248, DOI 10.1016/j.bjp.2014.03.006
   Mothupi MC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-432
   Mukherjee A, 2014, NAT PROD COMMUN, V9, DOI [10.1177/ 1934578X1400900239, DOI 10.1177/1934578X1400900239]
   Mwai P., BBC
   Ni L, 2021, FRONT MED-PRC, V15, P704, DOI 10.1007/s11684-021-0853-6
   Niburski K, 2020, J MED INTERNET RES, V22, DOI 10.2196/20044
   Nugraha RV, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/2560645
   Panyod S, 2020, J TRADIT COMPL MED, V10, P420, DOI 10.1016/j.jtcme.2020.05.004
   Pi Q, 2021, LONGHUA CHIN MED, V1, P4
   Poon PMK, 2006, AM J CHINESE MED, V34, P13, DOI 10.1142/S0192415X0600359X
   Pu J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0234855
   Rathnayake H, 2020, SCIENTIFICA, V2020, DOI 10.1155/2020/8239053
   Ren JL, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104743
   Ren W, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.589714
   Rolta R., 2020, CURR PHARM REP, DOI [10.21203/rs.3.rs-30938/v1, DOI 10.21203/RS.3.RS-30938/V1]
   Saag MS, 2020, JAMA-J AM MED ASSOC, V324, P2161, DOI 10.1001/jama.2020.22389
   Sabade M., 2020, ANN AYURVEDIC MED, V9, P171, DOI [10.5455/AAM.109096, DOI 10.5455/AAM.109096]
   Saghir SAM, 2021, THER CLIN RISK MANAG, V17, P371, DOI 10.2147/TCRM.S301817
   Saha S, 2012, ANC SCI LIFE, V31, P151, DOI 10.4103/0257-7941.107344
   Shao GL, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023224
   Shashi Alok, 2013, Asian Pacific Journal of Tropical Disease, V3, P242
   Shelley BM, 2009, ANN FAM MED, V7, P139, DOI 10.1370/afm.947
   Shree P, 2022, J BIOMOL STRUCT DYN, V40, P190, DOI 10.1080/07391102.2020.1810778
   Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207
   Song YL, 2019, CRIT CARE MED, V47, pE735, DOI 10.1097/CCM.0000000000003842
   Sriwijitalai W, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13226
   Su HX, 2020, ACTA PHARMACOL SIN, V41, P1167, DOI 10.1038/s41401-020-0483-6
   Tabish SA, 2008, INT J HEALTH SCI-IJH, V2, P3
   Thakkar S, 2020, REGUL TOXICOL PHARM, V114, DOI 10.1016/j.yrtph.2020.104647
   The House of Representatives of the Republic of Indonesia, 2020, HOUS PROACT JOINS FI
   Tillu G, 2020, J ALTERN COMPLEM MED, V26, P360, DOI 10.1089/acm.2020.0129
   Tollefson J, 2020, NATURE, V586, P190, DOI 10.1038/d41586-020-02800-9
   Wahner-Roedler DL, 2006, EVID-BASED COMPL ALT, V3, P495, DOI 10.1093/ecam/nel036
   Wahner-Roedler DL, 2014, COMPLEMENT THER CLIN, V20, P54, DOI 10.1016/j.ctcp.2013.09.003
   Wang C, 2011, ANN INTERN MED, V155, P217, DOI 10.7326/0003-4819-155-4-201108160-00005
   World Health Organization, 2020, WHO SUPP SCIENT PROV
   World Health Organization World Health Organization, 2013, TRADITIONAL MED
   Wu L, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105101
   Xu J, 2020, COMPLEMENT THER CLIN, V39, DOI 10.1016/j.ctcp.2020.101165
   Xu S, 2008, J POPUL THER CLIN PH, V15, pE1
   Yang Y, 2020, INT J BIOL SCI, V16, P1708, DOI 10.7150/ijbs.45538
   Yang YC, 2020, LANCET, V395, P1689, DOI 10.1016/S0140-6736(20)31143-0
   Yang ZS, 2016, IRAN J BASIC MED SCI, V19, P993
   Yeh CF, 2013, J ETHNOPHARMACOL, V148, P466, DOI 10.1016/j.jep.2013.04.040
   Yin Le-le, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P10
   Yin Q, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/949254
   Yu JS, 2014, EUR J INTEGR MED, V6, P538, DOI 10.1016/j.eujim.2014.06.003
   Zeng MJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238828
   Zhang HW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/987326
   Zhao YH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017845
NR 120
TC 0
Z9 0
U1 6
U2 6
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6973
J9 INFECT DRUG RESIST
JI Infect. Drug Resistance
PY 2021
VL 14
BP 4277
EP 4289
DI 10.2147/IDR.S327986
PG 13
WC Infectious Diseases; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Pharmacology & Pharmacy
GA WL0AX
UT WOS:000710080400002
PM 34703254
OA Green Published
DA 2022-04-20
ER

PT J
AU Aiman, U
   Sholehah, M
   Husein, MG
AF Aiman, Ummu
   Sholehah, Maratus
   Husein, Michael Grant
TI Risk transmission through breastfeeding and antibody in COVID-19 mother
SO GACETA SANITARIA
LA English
DT Article
DE COVID-19; Breast feeding; Antibodies
ID INFLUENZA
AB Objective: SARS-CoV-2 has spread beyond the world and makes a new challenge in the breastfeeding issue. There is some disagreement among breastfeeding management in confirmed COVID-19 patients China consensus but no evidence shows the transmission via breastfeeding. This paper aims to know the risk of transmission through breastfeeding in COVID-19 patients and antibodies in breast milk.
   Method: We conducted a literature review of publicly available information to summarize knowledge about risk transmission through breastfeeding and antibody in mother confirmed COVID-19.
   Result: A maternal woman was positive for COVID-19 in throat swabs show negative SARS-CoV-2 in breast milk. No evidence suggests the transmission of SARS-CoV-2 from mother to baby via vertical route or breast milk. IgG and IgA were detected in breast milk and potentially against SARS-CoV-2.
   Conclusion: Mother with COVID-19 can continuing direct breastfeeding with appropriate hygiene precautions (using a mask and wash hand) and should remain separate (home isolation precautions) from other family members including the infant, except for breastfeeding. (C) 2021 SESPAS. Published by Elsevier Espafia, S.L.U.
C1 [Aiman, Ummu; Sholehah, Maratus; Husein, Michael Grant] Univ Hasanuddin, Med Fac, Makassar, Indonesia.
RP Aiman, U (corresponding author), Univ Hasanuddin, Med Fac, Makassar, Indonesia.
EM ummuaiman24@yahoo.co.id
OI Aiman, Ummu/0000-0002-5425-0756
CR Abuidhail J, 2019, AM J HUM BIOL, V31, DOI 10.1002/ajhb.23197
   Academy of Breastfeeding Medicine, 2020, ABM STAT COR 2019 CO
   Buonsenso D, 2020, AM J PERINAT, V37, P869, DOI 10.1055/s-0040-1710541
   Cantey JB, 2013, AM J PERINAT, V30, P233, DOI 10.1055/s-0032-1323585
   CDC, 2020, COR DIS COVID 19 BRE
   Chao YX, 2020, BRAIN BEHAV IMMUN, V87, P182, DOI 10.1016/j.bbi.2020.05.057
   Cheema Ritu, 2020, Am J Perinatol, DOI 10.1055/s-0040-1714277
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Davanzo R, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.13010
   De Rose DU, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-020-0820-x
   DepKes RI., 2005, KEBIJAKAN DEPARTEMEN
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Dong YZ, 2020, EMERG MICROBES INFEC, V9, P1467, DOI 10.1080/22221751.2020.1780952
   Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496
   El-Gilany A-H., 2020, COVID 19 BREASTFEEDI
   Fan CF, 2021, CLIN INFECT DIS, V72, P862, DOI 10.1093/cid/ciaa226
   Fenizia C, 2020, IN UTERO MOTHER TO C, DOI [10.1101/2020.07.09.20149591, DOI 10.1101/2020.07.09.20149591]
   Fox A., 2020, EVIDENCE SIGNIFICANT, DOI [10.1101/2020.05.04.20089995, DOI 10.1101/2020.05.04.20089995]
   French MA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00780
   Goudoever, 2020, BREASTMILK SOURCE SA, DOI [10.1101/2020.08.18.20176743, DOI 10.1101/2020.08.18.20176743]
   Gross R, 2020, LANCET, V395, P1757, DOI 10.1016/S0140?6736(20)31181?8
   Han MS, 2020, CLIN INFECT DIS, V71, P2236, DOI 10.1093/cid/ciaa447
   International Confederation of Midwives, 2020, WOM RIGHTS CHILDB MU
   Lebrao CW, 2020, J HUM LACT, V36, P609, DOI 10.1177/0890334420960433
   [雷帝 Lei Di], 2020, [中华围产医学杂志, Chinese Journal of Perinatal Medicine], V23, P159
   Lessen R, 2015, J ACAD NUTR DIET, V115, P444, DOI 10.1016/j.jand.2014.12.014
   Li Y, 2020, EMERG INFECT DIS, V26, P1335, DOI 10.3201/eid2606.200287
   Liu W, 2020, FRONT MED-PRC, V14, P193, DOI 10.1007/s11684-020-0772-y
   Melendi GA, 2010, ACTA PAEDIATR, V99, P1517, DOI 10.1111/j.1651-2227.2010.01862.x
   Moore ER, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub4
   Mugadza G., 2018, INT J CONT PEDIAT, V5, P1, DOI [10.18203/2349-3291.ijcp20175564, DOI 10.18203/2349-3291.IJCP20175564]
   Oncel MY, 2021, EUR J PEDIATR, V180, P733, DOI 10.1007/s00431-020-03767-5
   Oot L, 2015, TECH BR FOOD NUTR TE, P360
   Pandolfi E, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00152
   Pereira A, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-00314-8
   Piersigilli F, 2020, LANCET CHILD ADOLESC, V4, P476, DOI 10.1016/S2352-4642(20)30140-1
   Royal College of Paediatrics and Child Health, 2020, COVID 19 GUID PAED S
   Salvatori G, 2020, BREASTFEED MED, V15, P347, DOI 10.1089/bfm.2020.0095
   Savino F, 2013, CELL MOL BIOL, V59, P89, DOI 10.1170/T950
   Trouillet-Assant S, 2020, J ALLERGY CLIN IMMUN, V146, P206, DOI 10.1016/j.jaci.2020.04.029
   Unicef, 2020, BREASTF COVID 19 PAN
   United Nations Population Fund Association, 2020, COVID 19 CONT SPREAD
   Wang SS, 2020, CLIN INFECT DIS, V71, P853, DOI 10.1093/cid/ciaa225
   WHO, 2020, BREASTF ADV COVID 19
   World Health Organization, 2020, FREQUENTLY ASKED QUE
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu Y, 2020, BJOG-INT J OBSTET GY, V127, P1109, DOI 10.1111/1471-0528.16276
   Yang N, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3299
   Yu YY, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-00305-9
   Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861
   ZHANG YH, 2020, CHIN J PEDIAT, V58, pE006, DOI [10.3760/cma.j.issn.0578-1310.2020.03.004, DOI 10.3760/cma.j.issn.0578-1310.2020.0006]
NR 51
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0213-9111
EI 1578-1283
J9 GAC SANIT
JI Gac. Sanit.
PY 2021
VL 35
SU 2
BP S524
EP S529
DI 10.1016/j.gaceta.2021.07.029
EA DEC 2021
PG 6
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA XS3QZ
UT WOS:000732829000104
PM 34929891
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Lai, IKW
   Wong, JWC
AF Lai, Ivan Ka Wai
   Wong, Jose Weng Chou
TI Comparing crisis management practices in the hotel industry between
   initial and pandemic stages of COVID-19
SO INTERNATIONAL JOURNAL OF CONTEMPORARY HOSPITALITY MANAGEMENT
LA English
DT Article
DE Hotel industry; Importance-performance analysis; COVID-19; Tourism
   crisis management; Epidemic prevention
ID IMPORTANCE-PERFORMANCE ANALYSIS; HONG-KONG; TOURISM; SARS; PREPAREDNESS;
   TERRORISM; IMPACT; TRAVEL
AB Purpose - Given the increasing number of travel restrictions, the COVID-19 outbreak has dealt a crippling blow to the hotel industry, and the crisis management practices supporting the industry needs are changing as the pandemic continues. This study aims to compare how the hotel industry has responded to this crisis at the initial stage and the pandemic stage.
   Design/methodology/approach - Data were collected from hotel managers in Macau in two occasions, namely, early February and early April 2020. Importance-usage-performance analysis was conducted to classify six categories of practices (pricing, marketing, maintenance, human resources, government assistance and epidemic prevention) into four executable crisis management strategies (priority, maintain, low priority and possible overkill) for each stage. Follow-up in-person interviews were conducted to validate the results of the study.
   Findings - In the initial stage, priority strategies should be applied in all epidemic prevention, pricing and maintenance practices and in two governmental assistance and human resources practices. In the pandemic stage, all epidemic prevention practices remain at the priority quadrant, but two pricing practices are downgraded. Hotels tended to force labour into unpaid vacations (furlough) and postpone office and system maintenance. Governmental assistance should be at a low priority.
   Originality/value - This study contributes to the knowledge of contingency planning for crisis management across crisis periods. It also demonstrates the processes of importance-usage-performance analysis for researchers to undertake further studies in tourism crisis management. Timely recommendations for governments and hotel industry stakeholders are provided to cope with this crisis.
C1 [Lai, Ivan Ka Wai] City Univ Macau, Fac Int Tourism & Management, Macau, Peoples R China.
   [Wong, Jose Weng Chou] Macau Univ Sci & Technol, Fac Hospitality & Tourism Management, Macau, Peoples R China.
RP Wong, JWC (corresponding author), Macau Univ Sci & Technol, Fac Hospitality & Tourism Management, Macau, Peoples R China.
EM wcwong@must.edu.mo
RI Wong, Jose/AAT-8893-2020
OI Wong, Jose/0000-0002-3557-1829
CR Abdullah A.K., 2019, ACAD STRATEGIC MANAG, V18, P1
   AGB, 2020, MAC GOV REV SPEC COV
   [Anonymous], 2020, MACAU DAILY TIMES
   Backer E, 2017, INT J TOUR RES, V19, P400, DOI 10.1002/jtr.2102
   Bacon DR, 2003, INT J MARKET RES, V45, P55, DOI 10.1177/147078530304500101
   Barbe D, 2018, J HOSP TOUR INSIGHTS, V1, P258, DOI 10.1108/JHTI-02-2018-0009
   Baum T, 2020, INT J CONTEMP HOSP M, V32, P2813, DOI 10.1108/IJCHM-04-2020-0314
   Baum T, 2020, INT J CONTEMP HOSP M, V32, P2397, DOI 10.1108/IJCHM-03-2020-0242
   Buigut S, 2017, ASIA PAC J TOUR RES, V22, P991, DOI 10.1080/10941665.2017.1359193
   Carmeli A, 2008, LONG RANGE PLANN, V41, P177, DOI 10.1016/j.lrp.2008.01.001
   Casino Review, 2020, CASINO REV
   CRESWELL JW, 2007, QUALITATIVE INQUIRY
   De Nisco A, 2015, EUR J TOUR RES, V10, P64
   Alonso-Almeida MD, 2013, INT J HOSP MANAG, V32, P141, DOI 10.1016/j.ijhm.2012.05.004
   DSEC, 2019, TOUR MICE GAM VIS AR
   DSEC, 2018, HOT SIM EST SURV 201
   Evans M. R., 1989, Hospitality Education and Research Journal, V13, P203
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Hilliard TW, 2011, J HOSP MARKET MANAG, V20, P638, DOI 10.1080/19368623.2011.536077
   HNN, 2020, HOTEL NEWS NOW
   Huang GI, 2020, INT J CONTEMP HOSP M, V32, P706, DOI 10.1108/IJCHM-04-2019-0380
   Israeli A. A., 2007, International Journal of Hospitality Management, V26, P807, DOI 10.1016/j.ijhm.2006.07.005
   Israeli A. A., 2003, HOSPITALITY MANAGEME, V22, P353, DOI DOI 10.1016/S0278-4319(03)00070-7
   Israeli AA, 2011, INT J HOSP MANAG, V30, P367, DOI 10.1016/j.ijhm.2010.06.009
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Johnson T., 2008, INT J CONT HOSPITALI, V20, P332
   Kim SeongSeop [Kim S. S. S.], 2005, Asia Pacific Journal of Tourism Research, V10, P369, DOI 10.1080/10941660500363694
   Kovaltchuk A. P, 2016, J ENV MANAGEMENT TOU, V7, P473
   Lai IKW, 2016, TOURISM MANAGE, V55, P139, DOI 10.1016/j.tourman.2016.01.007
   Lai IKW, 2015, TOURISM MANAGE, V48, P242, DOI 10.1016/j.tourman.2014.11.008
   Lee K, 2009, PUBLIC RELAT REV, V35, P74, DOI 10.1016/j.pubrev.2008.06.003
   Mandelbaum R., 2017, HOTEL MANAGERS ARE C
   Mansfeld Y., 1999, Journal of Travel Research, V38, P30, DOI 10.1177/004728759903800107
   MARTILLA JA, 1977, J MARKETING, V41, P77, DOI 10.2307/1250495
   Matzler K, 2003, SERV IND J, V23, P112, DOI 10.1080/02642060412331300912
   McKercher B, 2004, ANN TOURISM RES, V31, P716, DOI 10.1016/j.annals.2003.11.002
   Mikulic J, 2018, J DESTIN MARK MANAGE, V7, P36, DOI 10.1016/j.jdmm.2016.08.001
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   Okumus F, 2005, TOURISM MANAGE, V26, P95, DOI 10.1016/j.tourman.2003.08.013
   Perl Y., 2011, J VACAT MARK, V17, P115, DOI [10.1177/1356766710392478, DOI 10.1177/1356766710392478]
   Pine R., 2004, International Journal of Contemporary Hospitality Management, V16, P139, DOI 10.1108/09596110410520034
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Rial A., 2008, Managing Leisure, V13, P179, DOI 10.1080/13606710802200878
   Ringle C.M., 2015, SMART PLS 3
   Ritchie BW, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102812
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Santana G., 2003, Journal of Travel & Tourism Marketing, V15, P299, DOI 10.1300/J073v15n04_05
   Sausmarez N. de, 2007, Journal of Sustainable Tourism, V15, P700, DOI 10.2167/jost653.0
   Sawalha IHS, 2013, DISASTER PREV MANAG, V22, P210, DOI 10.1108/DPM-09-2012-0101
   Shi WM, 2017, ASIA PAC J TOUR RES, V22, P344, DOI 10.1080/10941665.2016.1250795
   Song HY, 2011, TOURISM MANAGE, V32, P172, DOI 10.1016/j.tourman.2010.05.006
   Tsao CY, 2016, TOURISM GEOGR, V18, P80, DOI 10.1080/14616688.2015.1116600
   U SC, 2020, TOUR MANAG PERSPECT, V33, DOI 10.1016/j.tmp.2019.100628
   Walters G, 2019, J TRAVEL RES, V58, P370, DOI 10.1177/0047287518755503
   Wan YKP, 2013, TOURISM MANAGE, V36, P164, DOI 10.1016/j.tourman.2012.12.005
   WHO, 2020, NOV COR 2019 N COV S
   WHO, 2020, WHO CAR COVID 19 PAN
   WSJ, 2020, OUT LUCK COR SHUTS C
   Zeng BenXiang, 2005, Current Issues in Tourism, V8, P306, DOI 10.1080/13683500508668220
   Zhao Y., 2020, CHINESE PUBLIC ATTEN, DOI [10.1101/2020.03.18.20038026, DOI 10.1101/2020.03.18.20038026]
NR 61
TC 74
Z9 74
U1 30
U2 107
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-6119
EI 1757-1049
J9 INT J CONTEMP HOSP M
JI Int. J. Contemp. Hosp. Manag.
PD OCT 14
PY 2020
VL 32
IS 10
BP 3135
EP 3156
DI 10.1108/IJCHM-04-2020-0325
EA SEP 2020
PG 22
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA OG3EJ
UT WOS:000574019000001
OA Bronze
DA 2022-04-20
ER

PT J
AU Mlezivova, S
   Machala, L
   Novakova, D
   Calda, P
AF Mlezivova, Simona
   Machala, Ladislav
   Novakova, Dana
   Calda, Pavel
TI COVID-19 AND PREGNANCY
SO AKTUALNI GYNEKOLOGIE A PORODNICTVI
LA Czech
DT Review
DE pregnancy; puerperium; breastfeeding; vertical transmission; COVID-19;
   SARS-CoV-2; vaccination
ID CORONAVIRUS DISEASE 2019; SARS-COV-2; CARE
AB The review summarizes current evidence about COVID-19 in relation to women of childbearing age, especially in pregnancy. SARS-CoV-2 potentially endangers not only the mother but also the unborn fetus. We perform a critical analysis of information on vertical and horizontal transmission, we deal with the management of care and treatment of pregnant women and lactation. We report separately on current knowledge about vaccination in relation to pregnancy, the puerperium and breastfeeding. We are aware that this summary is valid at the time of publication and it is possible that the rapid growth of new information may make some claims irrelevant.
C1 [Mlezivova, Simona; Calda, Pavel] Univ Karlovya, Lekarske Fak, Ctr Fetalni Med, Gynekol Porodnicka Klin 1, Apolinarska 18, Prague 2, Czech Republic.
   [Mlezivova, Simona; Calda, Pavel] Vseobecne Fak Nemocnice Praze, Apolinarska 18, Prague 2, Czech Republic.
   [Machala, Ladislav] LF UK Praha, HIV Ctr Fak Nemocnice Bulovka, Infekcni Klin 3, Budinova 2, Prague 8, Czech Republic.
   [Novakova, Dana] Fak Nemocnice Motol, Klin Nukl Med & Endokrinol, V Uvalu 84, Prague 5, Czech Republic.
RP Calda, P (corresponding author), LF UK, Gynekol Porodnicka Klin 1, Apolinarska 18, Prague 12851 2, Czech Republic.; Calda, P (corresponding author), VFN Praze, Apolinarska 18, Prague 12851 2, Czech Republic.
EM pavel.calda@vfn.cz
CR Adhikari EH, 2021, JAMA-J AM MED ASSOC, V325, P1039, DOI 10.1001/jama.2021.1658
   Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320
   [Anonymous], 2021, NIH FUNDS STUDY EVAL
   [Anonymous], 2020, KLINICKA SKUPINA COV
   [Anonymous], 2021, COR COVID 19 INF PRE
   [Anonymous], 2020, BREASTF COVID 19 PAN
   [Anonymous], 2020, JOINT COMMITTEE VACC
   [Anonymous], 2021, ANTISARS COV 2 MONOC
   Bellos I, 2021, EUR J OBSTET GYN R B, V256, P194, DOI 10.1016/j.ejogrb.2020.11.038
   Benski C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218277
   Bloise E, 2021, AM J OBSTET GYNECOL, V224, DOI 10.1016/j.ajog.2020.08.055
   Chandrasekharan P, 2020, AM J PERINAT, V37, P813, DOI 10.1055/s-0040-1709688
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   D'Souza R, 2020, ACTA OBSTET GYN SCAN, V99, P1110, DOI 10.1111/aogs.13962
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Dong YZ, 2020, EMERG MICROBES INFEC, V9, P1467, DOI 10.1080/22221751.2020.1780952
   Fox A., 2020, EVIDENCE SIGNIFICANT, DOI [10.1101/2020.05.04.20089995, DOI 10.1101/2020.05.04.20089995]
   Garibaldi BT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3071
   Gray Kathryn J, 2021, medRxiv, DOI 10.1101/2021.03.07.21253094
   GroSS Rudiger, 2020, Lancet, V395, P1757, DOI 10.1016/S0140-6736(20)31181-8
   Hassanipour S, 2020, INT J REPROD BIOMED, V18, P1005, DOI 10.18502/ijrm.v18i12.8022
   Hinojosa-Velasco A, 2020, INT J INFECT DIS, V100, P21, DOI 10.1016/j.ijid.2020.08.055
   Jafari M, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2208
   Jamieson LE., ANN INTERN MED, V2021, pM21
   Khalil A, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100446
   Kholin, 2021, MATERNAL NEONATAL MO, DOI [10.1001/jamapediatrics.2021.1050, DOI 10.1001/JAMAPEDIATRICS.2021.1050]
   Kimberlin DW, 2020, JAMA-J AM MED ASSOC, V323, P1788, DOI 10.1001/jama.2020.4868
   Kotlyar AM, 2021, AM J OBSTET GYNECOL, V224, P329, DOI 10.1016/j.ajog.2020.11.017
   Mazur-Bialy AI, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113749
   Poon LC, 2020, ULTRASOUND OBST GYN, V55, P848, DOI 10.1002/uog.22061
   Rasmussen SA, 2021, JAMA-J AM MED ASSOC, V325, P1099, DOI 10.1001/jama.2021.1683
   Rodrigues C, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.558144
   Singh V, 2020, J FAM MED PRIM CARE, V9, P5468, DOI 10.4103/jfmpc.jfmpc_950_20
   Vitali, 2021, CLIN TER, V172, P30
   Wong YP, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010094
   Woodworth KR, 2020, MMWR-MORBID MORTAL W, V69, P1635, DOI 10.15585/mmwr.mm6944e2
   Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867
   Zamaniyan M, 2020, PRENATAL DIAG, V40, P1759, DOI 10.1002/pd.5713
NR 38
TC 1
Z9 1
U1 4
U2 9
PU APROFEMA SRO
PI PRAGUE
PA U TRATI 3257-1C, PRAGUE, 100 00, CZECH REPUBLIC
SN 1803-9588
J9 AKTUALNI GYNEKOL POR
JI Aktualni Gynekol. Porod.
PY 2021
VL 13
BP 26
EP 31
PG 6
WC Obstetrics & Gynecology
WE Emerging Sources Citation Index (ESCI)
SC Obstetrics & Gynecology
GA TQ8HB
UT WOS:000678518200001
DA 2022-04-20
ER

PT J
AU Ciuca, IM
AF Ciuca, Ioana M.
TI COVID-19 in Children: An Ample Review
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Review
DE pediatric; COVID-19; SARS-CoV-2 infection; child
ID LUNG ULTRASOUND; PNEUMONIA; WUHAN; CHEST
AB The aim of this review was to describe the current knowledge about coronavirus disease 2019 (COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) in children, from epidemiological, clinical, and laboratory perspectives, including knowledge on the disease course, treatment, and prognosis. An extensive literature search was performed to identify papers on COVID-19 (SARS-CoV-2 infection) in children, published between January 1, 2020 and April 1, 2020. There were 44 relevant papers on COVID-19 in children. The results showed that COVID-19 occurs in 0.39-12.3% of children. Clinical signs and symptoms are comparable to those in adults, but milder forms and a large percentage of asymptomatic carriers are found among children. Elevated inflammatory markers are associated with complications and linked to various co-infections. Chest computed tomography (CT) scans in children revealed structural changes similar to those found in adults, with consolidations surrounded by halos being somewhat specific for children with COVID-19. The recommended treatment includes providing symptomatic therapy, with no specific drug recommendations for children. The prognosis is much better for children compared to adults. This review highlights that COVID-19 in children is similar to the disease in the adult population, but with particularities regarding clinical manifestations, laboratory test results, chest imaging, and treatment. The prognosis is much better for children compared to adults, but with the progression of the pandemic; the cases in children might change in the future.
C1 [Ciuca, Ioana M.] Univ Med & Farm Timisoara, Pediat Pulmonol Unit, Clin Cty Hosp, Pediat Dept, Evlia Celebi 1-3, Timisoara 300226, Romania.
RP Ciuca, IM (corresponding author), Univ Med & Farm Timisoara, Pediat Pulmonol Unit, Clin Cty Hosp, Pediat Dept, Evlia Celebi 1-3, Timisoara 300226, Romania.
EM ciuca.ioana@umft.ro
RI Ciuca, Ioana M/C-7235-2015
OI Ciuca, Ioana M/0000-0002-2879-8080
CR Abramowicz JS, WFUMB POSITION STATE
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   [Anonymous], 2020, GLOBAL SURVEILLANCE
   Bouadma L, 2020, INTENS CARE MED, V46, P579, DOI 10.1007/s00134-020-05967-x
   Brodin P, 2020, ACTA PAEDIATR, V109, P1082, DOI 10.1111/apa.15271
   Bruning A. H. L., 2018, New Microbes and New Infections, V24, P52, DOI 10.1016/j.nmni.2018.04.007
   Buonsenso D, 2020, EUR REV MED PHARMACO, V24, P2776, DOI 10.26355/eurrev_202003_20549
   Centers for Disease Control and Prevention, CAR BREASTF WOM
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen ZM, 2020, WORLD J PEDIATR, V16, P240, DOI 10.1007/s12519-020-00345-5
   Ciuca I, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.PA1261
   Dietrich CF, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.55
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Duan YT, 2020, DRUG DISCOV TODAY, V25, P810, DOI 10.1016/j.drudis.2020.02.011
   Fan CF, 2021, CLIN INFECT DIS, V72, P862, DOI 10.1093/cid/ciaa226
   Fang F, 2020, Zhonghua Er Ke Za Zhi, V58, pE001, DOI 10.3760/cma.j.issn.0578-1310.2020.0001
   Fang F, 2020, ZHONGHUA ER KE ZA ZH, V145
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Fowler AA, 2019, JAMA-J AM MED ASSOC, V322, P1261, DOI 10.1001/jama.2019.11825
   Garcia-Pena P, 2014, PEDIAT CHEST IMAGING
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310
   Henry BM, 2020, CLIN CHEM LAB MED, V58, P1135, DOI 10.1515/cclm-2020-0272
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ji LN, 2020, WORLD J PEDIATR, V16, P267, DOI 10.1007/s12519-020-00356-2
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112
   Li YZ, 2020, PEDIATR PULM, V55, pE1, DOI 10.1002/ppul.24734
   Lichtenstein D, 2009, CHEST, V135, P1421, DOI 10.1378/chest.08-2281
   Lingli, 2019, RADIOLOGY, V2020, DOI [10.1148/radiol.2020200370, DOI 10.1148/RADIOL.2020200370]
   Liu WY, 2020, NEW ENGL J MED, V382, P1370, DOI 10.1056/NEJMc2003717
   Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095
   Lu Q, 2020, J MED VIROL, V92, P564, DOI 10.1002/jmv.25740
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Manolescu D, 2018, CLIN INTERV AGING, V13, P437, DOI 10.2147/CIA.S156615
   Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
   Nickbakhsh S, 2019, P NATL ACAD SCI USA, V116, P27142, DOI 10.1073/pnas.1911083116
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Riccabona M, 2008, EUR RADIOL, V18, P390, DOI 10.1007/s00330-007-0754-3
   Riccabona M, 2018, J ULTRASON, V18, P281, DOI 10.15557/JoU.2018.0040
   Schroeder Alan R, 2020, Hosp Pediatr, V10, pe1, DOI 10.1542/hpeds.2020-000356
   Seyedi SJ, 2020, IRAN J PEDIATR, V30, DOI 10.5812/ijp.102784
   Shen KL, 2020, WORLD J PEDIATR, V16, P223, DOI 10.1007/s12519-020-00343-7
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Sun D, 2020, WORLD J PEDIATR, V16, P251, DOI 10.1007/s12519-020-00354-4
   Tan BS., 2020, RADIOLOGY, DOI DOI 10.1148/RADIOL.2020200988
   Tang A, 2020, EMERG INFECT DIS, V26, P1337, DOI 10.3201/eid2606.200301
   Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731
   Tin ku J, INT PULMONOLOGISTS C
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   [王端 Wang Duan], 2020, [中华儿科杂志, Chinese Journal of Pediatrics], V58, P269
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wang XF., 2020, ZHONGHUA ER KE ZA ZH, V58, pE007, DOI DOI 10.3760/CMA.J.ISSN.0578-1310.2020.0007
   Wang Y, 2020, WORLD J PEDIATR, V16, P271, DOI 10.1007/s12519-020-00353-5
   Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718
   Xie JF, 2020, INTENS CARE MED, V46, P837, DOI 10.1007/s00134-020-05979-7
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Xing, 2020, PROLONGED PRESENCE S, DOI [10.1101/2020.03.11.20033159, DOI 10.1101/2020.03.11.20033159]
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yu H., 2020, DATA DRIVEN DISCOVER
   Yuen KS, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00404-4
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 71
TC 18
Z9 21
U1 1
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 661
EP 669
DI 10.2147/RMHP.S257180
PG 9
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA MG6LA
UT WOS:000546139900001
PM 32636686
OA Green Published
DA 2022-04-20
ER

PT J
AU Vahdat, S
AF Vahdat, Sahar
TI The role of IT-based technologies on the management of human resources
   in the COVID-19 era
SO KYBERNETES
LA English
DT Article; Early Access
DE Information technology; Human resources management; Cloud computing;
   Teleworking; COVID-19
ID E-HRM; PERFORMANCE
AB Purpose The current pandemic will introduce many novel policies, adaptations, innovations and procedures by innovative human resource (HR) creativity. In particular, information technology (IT) implementation is a field that needs more significant focus and a wider range of creative interventions. The author would undoubtedly see a more human-focused approach to HR management (HRM) in the post-coronavirus disease 2019 (post-COVID-19) era, where enterprises and workers have had to reinvent themselves in a brief amount of time drastically. Following the nationwide lockdown caused by COVID-19, many companies were pushed to opt for remote working, which presents both difficulties and benefits for workers and employers. So the purpose of this study is to investigate some key consequences resulting from COVID-19's effect on multiple HRM roles, how technology is empowering and fostering HRM, informative forecasts based on how organizations are coping and finally, the path in the post-pandemic environment. Design/methodology/approach The COVID-19 epidemic has had a significant effect on every area of the global economy. It has had severe implications for public institutions and raises particular questions for medical schools. The emergence of COVID-19 has disrupted many activities and requires intense and prompt attention from medical educators. So, HR leaders now face the difficult task of managing the interests of workers and their corporations. The outbreak of COVID-19 has proved that this is not just a difficult time but rather a testing time for companies across the globe to check and ensure how swiftly they adapt themselves by thinking and planning differently. An enterprise evolves with nature, and change is unavoidable if performance and productivity are to improve. Changes in structure, technology and priorities are overgrowing, posing big obstacles to leaders. Corporations worldwide have looked to technology to pursue creative solutions to some of the world's most pressing problems. This study provides a review of articles related to the role of technology in HRM in the COVID-19 period. The analyzed articles are divided into three groups, including articles related to the role of information communication technology, cloud computing and teleworking in HRM in the COVID-19 era. Also, the most important key challenges are collected, and solutions are provided for them. Findings In times of trouble, authentic leadership shines through. The actions of pioneering HR leaders throughout the COVID-19 epidemic will significantly affect their respective organizations. When COVID-19 expanded around the world, HR agencies made their workers' health and welfare a top priority. HRM's long-term sustainability can be dictated by how they deal with the current crisis. Web-based solutions, such as cloud computing, will also address a vital resource allocation gap. It illustrates the possible efficacy of patient-oriented, web-based applications built on result-driven design, which continues to be validated by more testing and assessment. Many studies have emphasized business innovation as a necessity due to changes in the environment and various challenges and requirements facing businesses. The challenge of observing social distance and limiting face-to-face business services is the challenge of the COVID-19 pandemic era. Research limitations/implications This study could entail a joint international collaboration initiative among research centers, allowing information about COVID-19 impacts to be shared more easily.
   It will favor a worldwide policy to find a response to the epidemic but still address cultural and social issues. Practical implications The survey concludes that, whenever possible, employers and medicals should explore remote working opportunities in all industries to alleviate uncertainty and improve employee psychological well-being. The facilitating considerations and problems are often addressed in order to supply practical views for developing cloud-based solutions. Originality/value This research aims to lead to the advancement of scientific knowledge in the HRM area through the use of IT-based technology. It allows businesses to reinvent HRM techniques to save money and maximize efficiency without compromising their employees' life quality and well-being. More in-depth studies at various pandemic stages would yield more valuable insights into HRM's emerging position.
C1 [Vahdat, Sahar] Isfahan Univ Med Sci, Khorshid Hosp, Sch Med, Isfahan Kidney Dis Res Ctr, Esfahan, Iran.
RP Vahdat, S (corresponding author), Isfahan Univ Med Sci, Khorshid Hosp, Sch Med, Isfahan Kidney Dis Res Ctr, Esfahan, Iran.
EM dr.sahar.vahdat@gmail.com
RI Flaherty, Lisa/ABB-1277-2021
OI Vahdat, Sahar/0000-0002-6043-4877
CR Abbas M.Z, 2021, 3 BEST C HUM BEH DEC
   Abbasi S, 2021, J RES MED SCI, V26, DOI 10.4103/jrms.JRMS_1122_20
   Aghajani G, 2018, ENERGY REP, V4, P218, DOI 10.1016/j.egyr.2017.10.002
   Agrawal K.P., 2020, INT WORK C TRANSF DI
   Aurelia S., 2020, MATER TODAY-PROC, V46, P1
   Bentley TA, 2016, APPL ERGON, V52, P207, DOI 10.1016/j.apergo.2015.07.019
   Biron M, 2021, HUM RESOUR MANAGE R, V31, DOI 10.1016/j.hrmr.2020.100768
   Bissola R, 2020, HRM 40 HUMAN CENTERE
   Bontrager M, 2021, ADV DEV HUM RESOUR, V23, P124, DOI 10.1177/1523422320982930
   Bruce T, 2020, CORONA VIRUS DIS COV
   Chen X, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.652140
   Chowdhury MT, 2020, OPER MANAGE RES, DOI 10.1007/s12063-020-00166-9
   Daft R. L., 2007, ORG THEORY DESIGN
   Davoudi S.M.M., 2012, SPECTRUM, V1, P75
   De Kok A., 2016, NEW WAY WORKING BRIC, P9
   Dehghani M., 2020, SUSTAINABILITY-BASEL, V13, P1
   Dehghani M, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010090
   Devyania R.D., 2020, IETI T EC MANAGEMENT, V1, P19, DOI [10.6897/IETITEM.202007_1(1).0002, DOI 10.6897/IETITEM.202007_1(1).0002]
   Al-Qaralleh RE, 2022, KYBERNETES, V51, P423, DOI 10.1108/K-10-2020-0684
   Eurofound and ILO, 2017, WORK AN AN EFF WORLD
   Ferrel MN, 2020, CUREUS, V12, DOI 10.7759/cureus.7492
   Fletcher G, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102185
   Galbraith J.R., 2014, J ORGAN DES, V3, P2, DOI [DOI 10.7146/J0D.8856, 10.7146/jod.8856, DOI 10.7146/JOD.8856]
   Gardas BB, 2021, KYBERNETES, DOI 10.1108/K-10-2020-0713
   Gigauri I., 2020, EUR J MARK EC, V3, P36, DOI [10.26417/492dnl43d, DOI 10.26417/492DNL43D]
   Gong MC, 2020, J MED INTERNET RES, V22, DOI 10.2196/18948
   Guo H, 2020, FRONT BUS RES CHINA, V14, DOI 10.1186/s11782-020-00087-1
   Hamian M, 2018, ENG APPL ARTIF INTEL, V72, P203, DOI 10.1016/j.engappai.2018.03.022
   He W, 2021, INT J INFORM MANAGE, V57, DOI 10.1016/j.ijinfomgt.2020.102287
   Heidari A, 2022, KYBERNETES, V51, P952, DOI 10.1108/K-12-2020-0909
   Islam M.A., 2020, INT J QUALITY INNOVA, V5, P119
   Jasmine C.A, 2019, IMPACTS COVID 19 CO, P67
   Kansal M., 2021, J XIAN U ARCHITECTUR, P68
   Khanam L., 2017, INDEPENDENT BUSINESS, V10, P85
   Kovach K.A., 2002, EMPLOYMENT RELATIONS, V29, P43
   Krausz Michael, 2020, JMIR Public Health Surveill, V6, pe18995, DOI 10.2196/18995
   Kuhn KM, 2017, ACAD MANAGE PERSPECT, V31, P183, DOI 10.5465/amp.2015.0111
   Kylili A, 2020, ENERG SOURCE PART A, DOI 10.1080/15567036.2020.1831108
   Lei M., 2020, INN LEARN SUMMIT
   Liu Y, 2022, KYBERNETES, V51, P485, DOI 10.1108/K-11-2020-0778
   Lv ZH, 2021, IEEE T INTELL TRANSP, V22, P4579, DOI 10.1109/TITS.2020.3017183
   Lv ZH, 2021, IEEE T INTELL TRANSP, V22, P2048, DOI 10.1109/TITS.2020.3019756
   Martin-Noguerol T, 2021, EUR RADIOL, V31, P601, DOI 10.1007/s00330-020-07205-w
   Martinez-Caro E, 2020, IND MANAGE DATA SYST, V120, P2269, DOI 10.1108/IMDS-10-2019-0554
   Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281
   Munir M., 2020, HUMAN RESOURCE INFOR, DOI [10.20944/preprints202012.0469.v1), DOI 10.20944/PREPRINTS202012.0469.V1]
   Muralidhar, 2020, INT J ADV RES ENG TE, V11, P372
   Nachit M, 2020, IEEE INT TECHNOL MAN, DOI 10.1109/ICTMOD49425.2020.9380608
   Ohannessian, 2015, EUROPEAN RES TELEMED, V4, P95, DOI [DOI 10.1016/J.EURTEL.2015.08.002, 10.1016/j.eurtel.2015.08.002]
   Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810
   Opatha H., 2020, ASIAN J SOCIAL SCI M, V7, P152
   Parry E, 2011, INT J HUM RESOUR MAN, V22, P1146, DOI 10.1080/09585192.2011.556791
   Phillips S., 2020, BUS INFORM REV, V37, P129, DOI [10.1177/ 0266382120953087, DOI 10.1177/0266382120953087]
   Prasad K.D.V., 2020, INDIAN J COMMERCE MA, V11, P1, DOI [10.18843/ijcms/v11i2/01, DOI 10.18843/IJCMS/V11I2/01]
   Rahayuningsih S., 2019, OPCION, V35, P759
   Rahimi M, 2022, KYBERNETES, V51, P1388, DOI 10.1108/K-02-2021-0129
   Rahman M.H., 2020, S ASIAN J SOCIAL STU, V8, P46
   Rahman M.H., 2019, ASIAN BUS REV, V9, P17, DOI DOI 10.18034/ABR.V9I1.221
   Rajagopal K., 2021, HDB RES SUSTAINING S, P191
   Realyvasquez-Vargas A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12219194
   Roshani M, 2021, MEASUREMENT, V168, DOI 10.1016/j.measurement.2020.108427
   Roshani M, 2020, FLOW MEAS INSTRUM, V75, DOI 10.1016/j.flowmeasinst.2020.101804
   Saleh Ayat, 2017, TQM Journal, V29, P705, DOI 10.1108/TQM-12-2016-0109
   Sandhu P, 2020, MED EDUC ONLINE, V25, DOI 10.1080/10872981.2020.1764740
   Sapta IKS, 2021, J ASIAN FINANC ECON, V8, P495, DOI 10.13106/jafeb.2021.vol8.no1.495
   Sattari MA, 2021, MEASUREMENT, V168, DOI 10.1016/j.measurement.2020.108474
   Saxena M, 2021, 2021 11TH INTERNATIONAL CONFERENCE ON CLOUD COMPUTING, DATA SCIENCE & ENGINEERING (CONFLUENCE 2021), P110, DOI 10.1109/Confluence51648.2021.9377167
   Shahi K., 2020, MANAG HUM RESOUR J, V9, P50
   Singh AK, 2020, GLOB BUS REV, V21, P418, DOI 10.1177/0972150918824949
   Souri A, 2020, CLUSTER COMPUT, V23, P2453, DOI 10.1007/s10586-019-03018-9
   Sriyakul T., 2019, J COMPUTATIONAL THEO, V16, P2967
   Sudha S., 2021, HDB RES SUSTAINING S, P60
   Tavares F, 2021, J ENTERP COMMUNITIES, V15, P334, DOI 10.1108/JEC-06-2020-0113
   Ubaidillah E, 2020, 6 INT C ED TECHN ICE
   Vahdat S, 2020, INT J PREVENTIVE MED, V11, DOI 10.4103/ijpvm.IJPVM_54_19
   Vahdat S, 2018, J RES MED SCI, V23, DOI 10.4103/jrms.JRMS_1115_17
   Wamba SF, 2017, J BUS RES, V70, P356, DOI 10.1016/j.jbusres.2016.08.009
   Wang D., 2021, COMPREHENSIVE STUDY
   Wang H, 2021, INT REV ECON FINANC, V71, P237, DOI 10.1016/j.iref.2020.09.011
   Wang LJ, 2021, MECH SYST SIGNAL PR, V156, DOI 10.1016/j.ymssp.2020.107586
   Wu CR, 2010, EUR J OPER RES, V207, P971, DOI 10.1016/j.ejor.2010.04.034
   Wu ZD, 2020, LIBR HI TECH, DOI 10.1108/LHT-07-2020-0178
   Xiao N, 2021, J SIGNAL PROCESS SYS, V93, P811, DOI 10.1007/s11265-021-01666-y
   Yang Y, 2022, J HOSP MARKET MANAG, V31, P1, DOI 10.1080/19368623.2021.1926037
   Yu DM, 2020, J ENERGY STORAGE, V27, DOI 10.1016/j.est.2019.101054
   Yusoff YM, 2010, AFR J BUS MANAGE, V4, P3039
   Zanbouri K, 2020, INT J COMMUN SYST, V33, DOI 10.1002/dac.4259
   Zhang T, 2021, J HAZARD MATER, V416, DOI 10.1016/j.jhazmat.2021.125738
   Zou J, 2022, KYBERNETES, V51, P582, DOI 10.1108/K-11-2020-0804
NR 89
TC 10
Z9 10
U1 39
U2 48
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0368-492X
EI 1758-7883
J9 KYBERNETES
JI Kybernetes
DI 10.1108/K-04-2021-0333
EA SEP 2021
PG 24
WC Computer Science, Cybernetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA UW4BF
UT WOS:000700102800001
OA Bronze
DA 2022-04-20
ER

PT J
AU Ajmal, MM
   Khan, M
   Shad, MK
   AlKatheeri, H
   Jabeen, F
AF Ajmal, Mian M.
   Khan, Mehmood
   Shad, Muhammad Kashif
   AlKatheeri, Haseena
   Jabeen, Fauzia
TI Socio-economic and technological new normal in supply chain management:
   lessons from COVID-19 pandemic
SO INTERNATIONAL JOURNAL OF LOGISTICS MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19; Socio-economic; Technological; New-normal; Supply chain;
   Service industry; Scale development
ID INNOVATIONS; VALIDATION; IMPACT
AB Purpose This paper explores the new normal activities and strategic responses of the service industry towards the challenges created by the coronavirus disease 2019 (COVID-19) outbreak and other constructs and validates the measurement scale for socio-economic and technological new normal activities following lockdown and social distancing practices. Design/methodology/approach First, structured interviews with 28 participants helped us generate items and develop survey instruments for cross-sectional data collection in the second phase. So, the authors received 256 complete responses from the top and middle management of the services industry. Exploratory factor analysis helped us explore the factors and reliability of the items. Confirmatory factor analysis aided us in generating and confirming the factorial structure of the constructs. Findings Results indicated that amid COVID-19's pandemic, new normal activities are emerging in which organizations are deploying crisis strategies to safeguard their business and stakeholders. Organizations are re-opening swiftly, focusing on digital transformation, developing digital platforms for ease in working and improved consumer services, to name a few operational changes. Practical implications Discussion on empirical analysis revolves around the guidelines to service industry's managers and top management to improve shortcomings in combating the challenges they face in their operations. Originality/value Prior studies have provided substantial insights on the COVID-19 pandemic, but relatively little research exists on new normal activities in the supply chain network of the service industry. Among other reasons for such less empirical evidence on new normal activities is the unavailability of a comprehensive tool for measuring the socio-economic and technological new normal activities. This paper is a contribution to bridging this knowledge gap.
C1 [Ajmal, Mian M.; Khan, Mehmood; Jabeen, Fauzia] Abu Dhabi Univ, Coll Business, Abu Dhabi, U Arab Emirates.
   [Ajmal, Mian M.] Univ Vaasa, Ind Management, Vaasa, Finland.
   [Shad, Muhammad Kashif] Univ Teknol PETRONAS, Management & Humanities Dept, Seri Iskandar, Perak, Malaysia.
   [AlKatheeri, Haseena] Zayed Univ, Dubai, U Arab Emirates.
RP Jabeen, F (corresponding author), Abu Dhabi Univ, Coll Business, Abu Dhabi, U Arab Emirates.
EM fauzia.jabeen@adu.ac.ae
OI Ajmal, Mian/0000-0001-9534-7629
CR Aburumman AA, 2020, HUM SOC SCI COMMUN, V7, DOI 10.1057/s41599-020-00630-8
   Ali M, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13137465
   Alicke K., 2020, SUPPLY CHAIN RECOVER
   Amankwah-Amoah J, 2020, J CLEAN PROD, V271, DOI 10.1016/j.jclepro.2020.123000
   Arao R.M., 2020, EC IMPACT COVID 19 O, P1, DOI [10.22617/BRF200096, DOI 10.22617/BRF200096]
   Barter, 2020, COV 19 MAN SUPPLY CH
   Belhadi A, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120447
   Boiral O, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13073993
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Brem A, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120451
   Broughton C., 2020, STUFF
   Buheji M., 2020, BUS MANAG STRATEGY, V11, P160
   Buheji M. etal, 2020, AM J EC, V10, P213, DOI [10.5923/j.economics.20201004.02, DOI 10.5923/J.ECONOMICS.20201004.02]
   Ceylan R F, 2020, RES J ADV HUMANITIES, V1, P21
   CHURCHILL GA, 1979, J MARKETING RES, V16, P64, DOI 10.2307/3150876
   Cichosz M, 2020, INT J LOGIST MANAG, V31, P209, DOI 10.1108/IJLM-08-2019-0229
   Cohen J., 2013, APPL MULTIPLE REGRES
   Craighead CW, 2020, DECISION SCI, V51, P838, DOI 10.1111/deci.12468
   Deliotte, 2020, ADDR IMP COVID 19 NA
   Dodds L., 2020, TELEGRAPH
   Elavarasan RM, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138858
   Ernst Young, 2020, GLOB BOARD RISK SURV
   Flavie P., 2020, UNDERSTANDING IMPACT
   Galanakis CM, 2021, TRENDS FOOD SCI TECH, V110, P193, DOI 10.1016/j.tifs.2021.02.002
   Gonzalez-Torres T, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102733
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Grace D, 2020, J RETAIL CONSUM SERV, V52, DOI 10.1016/j.jretconser.2019.101908
   Hair JF, 2014, REV BRASIL MARK, V13, P43, DOI 10.5585/remark.v13i2.2718
   Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636
   He HW, 2020, J BUS RES, V116, P176, DOI 10.1016/j.jbusres.2020.05.030
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Janssen M, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102180
   Joreskog K., 1993, STRUCTURAL EQUATION
   Kabadayi S, 2020, J SERV MARK, V34, P809, DOI 10.1108/JSM-03-2020-0090
   KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115
   Kaur P, 2021, INT J CONTEMP HOSP M, V33, P1129, DOI 10.1108/IJCHM-05-2020-0477
   Kaur P, 2016, COMPUT HUM BEHAV, V59, P358, DOI 10.1016/j.chb.2016.02.039
   Kaushal V, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102707
   Khan MK, 2020, TELECOMMUN SYST, V73, P1, DOI 10.1007/s11235-019-00647-8
   Khanra S, 2021, J HOSP TOUR MANAG, V46, P26, DOI 10.1016/j.jhtm.2020.11.004
   Kim DKD, 2020, WORLD MED HEALTH POL, V12, P398, DOI 10.1002/wmh3.363
   Kniffin KM, 2021, AM PSYCHOL, V76, P63, DOI 10.1037/amp0000716
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Kumar A, 2021, TECHNOL FORECAST SOC, V166, DOI 10.1016/j.techfore.2021.120643
   Laato S, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102224
   Lartey F.M, 2020, J BUSINESS ADM RES, V9, P44, DOI 10.5430/jbar.v9n1p44
   Lee SM, 2021, TECHNOL FORECAST SOC, V167, DOI 10.1016/j.techfore.2021.120712
   Lenzen M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235654
   Maguire, 2017, AISHE J ALL IRELAND, V9
   Malhotra N. K., 2003, J MARK MANAG, V27, P1208, DOI DOI 10.1016/S0167-4870(02)00151-4
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Mofijur M, 2021, SUSTAIN PROD CONSUMP, V26, P343, DOI 10.1016/j.spc.2020.10.016
   Mollenkopf DA, 2021, J SERV MANAGE, V32, P190, DOI 10.1108/JOSM-05-2020-0143
   Noda Y, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102262
   Notteboom TE, 2020, MARIT ECON LOGIST, V22, P329, DOI 10.1057/s41278-020-00162-7
   Obrenovic B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12155981
   Pantano E, 2020, J BUS RES, V116, P209, DOI 10.1016/j.jbusres.2020.05.036
   Pathirana L.P.D.S., 2020, SSRG INT J EC MANAG, V7, P73, DOI [10.14445/23939125/IJEMS-V7I6P110, DOI 10.14445/23939125/IJEMS-V7I6P110]
   Ramirez MJ, 2021, INT J LOGIST MANAG, V32, P283, DOI 10.1108/IJLM-02-2020-0097
   Rosliza A, 2018, INT J PUBLIC HLTH CL, V5, P1
   Saenger C, 2020, EUR J MARKETING, V54, P671, DOI 10.1108/EJM-03-2018-0206
   Sardak S.E., 2018, INT SCI PRACT C INN, P84
   Shamim A, 2017, J CONSUM MARK, V34, P591, DOI 10.1108/JCM-01-2016-1664
   Sharma R, 2021, INT J HOSP MANAG, V96, DOI 10.1016/j.ijhm.2021.102977
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Subri S.A.M., 2020, ASIAN J BEHAV SCI, V2, P18
   Talwar M, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102341
   Talwar S, 2021, PSYCHOL MARKET, V38, P2142, DOI 10.1002/mar.21550
   Talwar S, 2021, INT J PROD RES, V59, P3509, DOI 10.1080/00207543.2020.1868599
   Tandon A, 2021, TECHNOL FORECAST SOC, V166, DOI 10.1016/j.techfore.2021.120649
   Tonnessen O, 2021, TECHNOL FORECAST SOC, V170, DOI 10.1016/j.techfore.2021.120866
   Tsaur SH, 2016, ASIA PAC J TOUR RES, V21, P1310, DOI 10.1080/10941665.2016.1156003
   Tuzovic S, 2021, J SERV MANAGE, V32, P145, DOI 10.1108/JOSM-05-2020-0140
   Wang YG, 2020, J BUS RES, V116, P214, DOI 10.1016/j.jbusres.2020.05.029
   Worzala E, 2021, J PROP INVEST FINANC, V39, P31, DOI 10.1108/JPIF-06-2020-0068
   Wu LF, 2016, INT J LOGIST MANAG, V27, P395, DOI 10.1108/IJLM-02-2014-0035
   Zhu Q, 2017, INT J LOGIST MANAG, V28, P1123, DOI 10.1108/IJLM-09-2016-0206
   Zhu Z, 2020, INT J INFORM MANAGE, V50, P273, DOI 10.1016/j.ijinfomgt.2019.07.001
   Zimmermann R, 2021, INT J LOGIST MANAG, V32, P141, DOI 10.1108/IJLM-01-2020-0040
   Zou P, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00166-z
NR 81
TC 1
Z9 1
U1 13
U2 13
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0957-4093
EI 1758-6550
J9 INT J LOGIST MANAG
JI Int. J. Logist. Manag.
DI 10.1108/IJLM-04-2021-0231
EA NOV 2021
PG 26
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA WU2YX
UT WOS:000716417000001
OA Bronze
DA 2022-04-20
ER

PT J
AU Hsieh, HC
   Nguyen, XH
   Wang, TC
   Lee, JY
AF Hsieh, Hsiu-Chin
   Nguyen, Xuan-Huynh
   Wang, Tien-Chin
   Lee, Jen-Yao
TI Prediction of Knowledge Management for Success of Franchise Hospitality
   in a Post-Pandemic Economy
SO SUSTAINABILITY
LA English
DT Article
DE COVID-19; knowledge management; franchise; consistent fuzzy preference
   relations; hospitality industry; post-pandemic; influential criteria
ID FUZZY PREFERENCE RELATIONS; GROUP DECISION-MAKING; COVID-19; BUSINESS;
   STRATEGY; RESTAURANTS; INDUSTRY; TOURISM; MODEL
AB Due to its unpredictability, the novel coronavirus (COVID-19) pandemic has changed the global business climate and commercial management practices in unprecedented ways. As a direct result of the pandemic, the hospitality and tourism sectors have shut down, and business failure rates have occurred exponentially. The franchise hospitality industry has experienced significant impact and challenged a basic understanding of knowledge management (KM) implementation in the face of the COVID-19 outbreak. A strategic KM implementation practice can not only guide a large-scale operation, but also adjust an organization's performance and competitiveness. The purpose of this study is to examine the influential criteria of success through effective KM implementation and to predict the probability of successful KM in a post-pandemic era. The conceptual framework for KM applies an analytic hierarchical prediction model reliant upon consistent fuzzy preference relations to assist the franchise hospitality sector's consciousness of the influential criteria. An empirical case study is used to apply pairwise comparisons used to determine the priority weights and two possible outcomes. The case study will assist franchise organizations to analyze whether or not to implement KM, interdict application, or adopt revised actions. This assistance will enhance the success possibility of KM implementation within such a crisis environment. This study uses a case setting by assessing 15 franchises hospitality experts' opinions in Taiwan relevant to KM implementation.
C1 [Hsieh, Hsiu-Chin; Wang, Tien-Chin; Lee, Jen-Yao] Natl Kaohsiung Univ Sci & Technol, Dept Int Business, Kaohsiung 80778, Taiwan.
   [Nguyen, Xuan-Huynh] Vietnam Natl Univ, Hanoi Sch Business & Management, Hanoi 100000, Vietnam.
RP Wang, TC (corresponding author), Natl Kaohsiung Univ Sci & Technol, Dept Int Business, Kaohsiung 80778, Taiwan.
EM 1103405120@nkust.edu.tw; huynhnx@hsb.edu.vn; tcwang@nkust.edu.tw;
   itjylee@nkust.edu.tw
OI Lee, Jen yao/0000-0002-9943-5084
CR Achary V., 2018, P FIN CRIS 10 YEARS, P1
   Aladag OF, 2020, INT J HOSP MANAG, V88, DOI 10.1016/j.ijhm.2020.102556
   Aldaco R, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140524
   Aliperti G, 2020, J HOSP TOUR MANAG, V44, P193, DOI 10.1016/j.jhtm.2020.06.006
   Altinay Levent, 2007, Journal of Services Marketing, V21, P398, DOI 10.1108/08876040710818895
   Altinay L, 2012, J SERV MARK, V26, P278, DOI 10.1108/08876041211237578
   Ayup-Gonzalez J, 2019, ECON RES-EKON ISTRAZ, V32, P982, DOI 10.1080/1331677X.2019.1592008
   Badrinarayanan V, 2016, J BUS RES, V69, P3943, DOI 10.1016/j.jbusres.2016.06.005
   Bargeman B, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102988
   Bartik A., 2020, ARE SMALL BUSINESS A
   Berhanu K, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03439
   Bretas V.P.G., 2020, GLOB BUS ORGAN EXCEL, V39, P6, DOI [10.1002/joe.22053, DOI 10.1002/JOE.22053]
   Brinckmann J., 2020, J BUS VENTUR INSIGHT, V14, DOI [10.1016/j.jbvi.2020.e00186, DOI 10.1016/J.JBVI.2020.E00186]
   Brookes M, 2017, INT J HOSP MANAG, V62, P33, DOI 10.1016/j.ijhm.2016.11.012
   Cetin G, 2016, INT J HOSP MANAG, V57, P132, DOI 10.1016/j.ijhm.2016.06.008
   Chao RJ, 2009, EXPERT SYST APPL, V36, P10657, DOI 10.1016/j.eswa.2009.02.047
   Chen YY, 2010, 2010 INTERNATIONAL COLLOQUIUM ON COMPUTING, COMMUNICATION, CONTROL, AND MANAGEMENT (CCCM2010), VOL II, P28, DOI 10.1109/ICINIS.2010.127
   Choi SH, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102628
   Chou SF, 2020, J HOSP TOUR MANAG, V42, P222, DOI 10.1016/j.jhtm.2020.01.006
   Collier R., 2020, TAX POLICY COVID 19
   Collins-Kreiner N, 2020, ANN TOURISM RES, V82, DOI 10.1016/j.annals.2020.102892
   Crick JM, 2020, IND MARKET MANAG, V88, P206, DOI 10.1016/j.indmarman.2020.05.016
   Cumberland D., 2020, P AHRD 2010 AM C LOU, P1278
   Damnjanovic V, 2020, TOUR HOSP MANAG-CROA, V26, P233
   Cortes-Sanchez JD, 2020, EUR RES MANAG BUS EC, V26, P1, DOI 10.1016/j.jedeen.2019.12.003
   Dhir A, 2020, J CLEAN PROD, V270, DOI 10.1016/j.jclepro.2020.122861
   Diaz-Carrion R, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102631
   Dolnicar S, 2020, TOURISM MANAGE, V80, DOI 10.1016/j.tourman.2020.104103
   Fong LHN, 2021, ANN TOURISM RES, V86, DOI 10.1016/j.annals.2020.102951
   Garcia-Milon A, 2020, TOUR MANAG PERSPECT, V36, DOI 10.1016/j.tmp.2020.100730
   Gossling S., 2020, J SUSTAIN TOUR, V48, P39
   Grewal D, 2011, ENTREP THEORY PRACT, V35, P533, DOI 10.1111/j.1540-6520.2011.00444.x
   Guzman V., 2020, SCI DIRECT PROCEDIA, V43, P543, DOI [10.1016/j.promfg.2020.02.167, DOI 10.1016/J.PROMFG.2020.02.167]
   Hadi S., 2020, J XIAN U ARCHITECTUR, V121, DOI [10.37896/jxat12.04/1149, DOI 10.37896/JXAT12.04/1149]
   Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636
   Herrera-Viedma E, 2004, EUR J OPER RES, V154, P98, DOI 10.1016/S0377-2217(02)00725-7
   Herrera-Viedma E, 2007, IEEE T FUZZY SYST, V15, P863, DOI 10.1109/TFUZZ.2006.889952
   Herrera-Viedma E, 2007, IEEE T SYST MAN CY B, V37, P176, DOI 10.1109/TSMCB.2006.875872
   Higgins-Desbiolles F, 2020, TOURISM GEOGR, V22, P610, DOI 10.1080/14616688.2020.1757748
   Isa R. M., 2008, J HUMAN RESOURCE ADU, V4, P103
   Karabulut G, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102991
   Karim W., 2020, INT TOURISM HOSPITAL, V3, P1, DOI DOI 10.37227/ITHJ-2020-02-09
   Khan NA, 2020, ASIA PAC MANAG REV, V25, P216, DOI 10.1016/j.apmrv.2020.05.001
   Khan Z, 2016, J ASIA BUS STUD, V10, P148, DOI 10.1108/JABS-05-2015-0052
   Kim J, 2020, J HOSP TOUR MANAG, V45, P67, DOI 10.1016/j.jhtm.2020.07.008
   Kloutsiniotis PV, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102610
   Koseoglu MA, 2020, INT J HOSP MANAG, V89, DOI 10.1016/j.ijhm.2020.102574
   Kuhzady S, 2020, J HOSP TOUR MANAG, V44, P131, DOI 10.1016/j.jhtm.2020.05.002
   Kwok LC, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102616
   Laguna L, 2020, FOOD QUAL PREFER, V86, DOI 10.1016/j.foodqual.2020.104028
   Li D, 2016, INT REV SPAT PLAN SU, V4, P45, DOI 10.14246/irspsd.4.3_45
   Liu H, 2016, PROCEEDINGS OF 2016 IEEE ADVANCED INFORMATION MANAGEMENT, COMMUNICATES, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (IMCEC 2016), P1, DOI 10.1109/IMCEC.2016.7867101
   Martin-Rios C, 2019, TOURISM MANAGE, V70, P218, DOI 10.1016/j.tourman.2018.08.018
   Mazurek M., 2020, INNOVATION APPROACH
   Melao N, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03723
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Noble J, 2020, J ANTITRUST ENFORC, V8, P293, DOI 10.1093/jaenfo/jnaa037
   Pellegrini MM, 2020, J KNOWL MANAG, V24, P1445, DOI 10.1108/JKM-01-2020-0034
   Purcell LN, 2020, INT J SURG, V76, P111, DOI 10.1016/j.ijsu.2020.03.002
   Rainone K., 2020, EC IMPACTS COVID 19
   Raudeliuniene J, 2018, ENTREP SUSTAIN ISS, V5, P542, DOI 10.9770/jesi.2018.5.3(10)
   Rephann T., 2020, COVID 19 EC TAX REV
   Rittichainuwat B, 2020, TOUR MANAG PERSPECT, V35, DOI 10.1016/j.tmp.2020.100704
   Ruparel N, 2020, TECHNOL SOC, V63, DOI 10.1016/j.techsoc.2020.101335
   Sa MLL, 2020, ASIA PAC MANAG REV, V25, P65, DOI 10.1016/j.apmrv.2019.07.002
   Saling KC, 2020, PROCEDIA COMPUT SCI, V168, P105, DOI 10.1016/j.procs.2020.02.269
   Sandorova Z, 2020, J HOSP LEIS SPORT TO, V26, DOI 10.1016/j.jhlste.2019.100238
   Sharma P, 2020, J BUS RES, V116, P188, DOI 10.1016/j.jbusres.2020.05.026
   Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Sundqvist J, 2020, INT J GASTRON FOOD S, V22, DOI 10.1016/j.ijgfs.2020.100237
   Tajeddini K, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102605
   Teo STT, 2020, INT J HOSP MANAG, V88, DOI 10.1016/j.ijhm.2019.102415
   Thorgren S., 2020, J BUS VENTURING INSI, V14, DOI [10.1016/j.jbvi.2020.e00187, DOI 10.1016/J.JBVI.2020.E00187]
   Tiago F., 2020, J INNOV KNOWL, V12, P5324
   Tsionas MG, 2021, TOURISM ECON, V27, P1828, DOI 10.1177/1354816620933039
   Tussyadiah I, 2020, ANN TOURISM RES, V81, DOI 10.1016/j.annals.2020.102883
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Wang T.C., 2016, ADV MANAG SCI, V5, P32
   Wang T.C., 2016, INT J BUS MANAG RES, V6, P97
   Wang TC, 2007, EUR J OPER RES, V182, P1313, DOI 10.1016/j.ejor.2006.09.039
   Wang TC, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8050447
   Willis Towers Wastson, 2020, GLOB CIRS HUM CAP RO
   Wohlfarth K, 2020, ENERG POLICY, V137, DOI 10.1016/j.enpol.2019.111070
   Wu CW, 2015, J BUS RES, V68, P1581, DOI 10.1016/j.jbusres.2015.01.055
   Xu D, 2021, TOURISM MANAGE, V82, DOI 10.1016/j.tourman.2020.104186
   Yeung RMW, 2016, INT J CONTEMP HOSP M, V28, P1009, DOI 10.1108/IJCHM-08-2014-0399
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
   Zhang CY, 2020, TOUR MANAG PERSPECT, V35, DOI 10.1016/j.tmp.2020.100715
   Zhang K, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102993
   Zheng Y, 2020, ANATOLIA, V31, P337, DOI 10.1080/13032917.2020.1747208
NR 91
TC 8
Z9 8
U1 9
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD OCT
PY 2020
VL 12
IS 20
AR 8755
DI 10.3390/su12208755
PG 27
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA OI1ZM
UT WOS:000583085500001
OA gold
DA 2022-04-20
ER

PT J
AU Koh, TJW
   Ling, AHZ
   Chiang, CL
   Lee, GSJ
   Tay, HSE
   Yi, H
AF Koh, Tricia Jia Wen
   Ling, Abel Ho Zhi
   Chiang, Christine Li Ling
   Lee, Gabriel Sheng Jie
   Tay, Hannah Si En
   Yi, Huso
TI Attitudes towards COVID-19 precautionary measures and willingness to
   work during an outbreak among medical students in Singapore: a
   mixed-methods study
SO BMC MEDICAL EDUCATION
LA English
DT Article
DE COVID-19; Health policy; Bioethics; Health literacy; Attitude of health
   personnel; Medical education
ID DISASTER MEDICINE; HEALTH; KNOWLEDGE; INFLUENZA; EDUCATION; RESPOND
AB BackgroundThe COVID-19 pandemic has revealed challenges that medical students face when healthcare systems are under intense pressure. There is a need to assess medical students' education needs in pandemic preparedness. The objective of this mixed-methods study was threefold: (1) to assess COVID-19 perceived efficacy, susceptibility, and anxiety in relation to health literacy; (2) to describe attitudes towards a policy of precautionary measures against COVID-19 and willingness to work during an outbreak; and (3) to examine multilevel factors associated with willingness to work.MethodsAn online survey was conducted among 263 medical students in Singapore during the lockdown period in July 2020. Participants were surveyed on COVID-19 related literacy, perceptions, anxiety, attitudes towards a policy of precautionary measures, and willingness to work during an outbreak. Bivariate and multivariate analyses were used to determine the factors associated with the key outcome variable of willingness to work. In addition, open-ended questions were used to assess medical education needs, which were reported using thematic analysis.ResultsPerceived adequacy of COVID-19 information was associated with higher perceived efficacy, lower perceived susceptibility, and lower anxiety levels among the students. Medical students were mostly supportive of COVID-19 precautionary measures except for relatively intrusive measures like in-home surveillance. The degree of willingness to work during an outbreak varied based on certain conditions, in particular family's health and safety, and was associated with self-efficacy, perceived susceptibility, and hospital capacity of outbreak management.ConclusionsMedical students' attitudes towards a policy of precautionary measures varied depending on legality, financial and psychological support, and privacy concerns. Health literacy played an important role in increasing the efficacy of protection against COVID-19 and reducing pandemic-related anxiety among medical students. Their willingness to work during an outbreak was increased by an effective policy of precautionary measures, hospital capacity to manage a pandemic, and assurance of family safety. Medical education should include pandemic preparedness to better prepare students to aid in pandemics, with emphasis on public health policy and ethics coupled with clinical training targeted to managing outbreaks.
C1 [Koh, Tricia Jia Wen; Ling, Abel Ho Zhi; Chiang, Christine Li Ling; Lee, Gabriel Sheng Jie; Tay, Hannah Si En] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Yi, Huso] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Yi, Huso] Natl Univ Hlth Syst, Singapore, Singapore.
RP Yi, H (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Yi, H (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.
EM ephyh@nus.edu.sg
OI Yi, Huso/0000-0003-4724-5235
FU Special National University Health System (NUHS) COVID-19 Seed Grant;
   Ministry of Health (MOH) COVID-19 National Effort Fund/National
   University of Singapore (NUS) Efforts Against COVID-19 in Singapore
FX This work was supported in part by the Special National University
   Health System (NUHS) COVID-19 Seed Grant and the Ministry of Health
   (MOH) COVID-19 National Effort Fund/National University of Singapore
   (NUS) Efforts Against COVID-19 in Singapore.
CR Aker S, 2020, J COMMUN HEALTH, V45, P684, DOI 10.1007/s10900-020-00841-9
   Aoyagi Y, 2015, INFLUENZA OTHER RESP, V9, P120, DOI 10.1111/irv.12310
   Ashcroft J, 2021, POSTGRAD MED J, V97, P368, DOI 10.1136/postgradmedj-2020-137906
   Bank I, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02261-8
   Barratt R, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02238-7
   Barrimah I, 2016, MED TEACH, V38, pS60, DOI 10.3109/0142159X.2016.1142515
   Beh DLL, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa256
   Bloom DE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00549
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Caliskan F, 2020, POSTGRAD MED, V132, P764, DOI 10.1080/00325481.2020.1795486
   Chaffee Mary, 2009, Disaster Med Public Health Prep, V3, P42, DOI 10.1097/DMP.0b013e31818e8934
   DeWitt DE, 2020, ANN INTERN MED, V173, P143, DOI 10.7326/M20-1262
   Gaur Uma, 2020, SN Compr Clin Med, V2, P1992, DOI 10.1007/s42399-020-00528-1
   Gostin LO, 2003, JAMA-J AM MED ASSOC, V290, P3229, DOI 10.1001/jama.290.24.3229
   Gouda P, 2020, DISASTER MED PUBLIC, V14, P308, DOI 10.1017/dmp.2019.81
   Haque A, 2020, BIOCHEM MOL BIOL EDU, V48, P473, DOI 10.1002/bmb.21406
   Huang B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-89
   Jeffrey DI, 2020, J MED ETHICS, V46, P495, DOI 10.1136/medethics-2020-106264
   John A, 2017, MED EDUC ONLINE, V22, DOI 10.1080/10872981.2017.1264125
   Komasawa N, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.576
   Liang ZC, 2020, ACAD MED, V95, P1359, DOI 10.1097/ACM.0000000000003441
   Lin RJH, 2020, MED J AUSTRALIA, V212, P497, DOI 10.5694/mja2.50623
   Lobelo F, 2009, BRIT J SPORT MED, V43, P89, DOI 10.1136/bjsm.2008.055426
   Lum LHW, 2016, ANN ACAD MED SINGAP, V45, P332
   Maeshiro R, 2020, ACAD MED, V95, P1799, DOI 10.1097/ACM.0000000000003517
   Maunder RG, 2008, CAN J PUBLIC HEALTH, V99, P486, DOI 10.1007/BF03403782
   McConnell D, 2020, J MED ETHICS, V46, P360, DOI 10.1136/medethics-2020-106250
   Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   National Medical Undergraduate Curriculum Committee, 2014, OUTC STAND UND MED E
   Norton EJ, 2021, J PUBLIC HEALTH-UK, V43, P67, DOI 10.1093/pubmed/fdaa187
   O'Byrne L, 2020, J MED ETHICS, V46, P623, DOI 10.1136/medethics-2020-106353
   Patel R, 2017, DISASTER MED PUBLIC, V11, P694, DOI 10.1017/dmp.2017.18
   Pek Jen Heng, 2020, Singapore Med J, DOI 10.11622/smedj.2020139
   Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227
   Ruderman Carly, 2006, BMC Med Ethics, V7, pE5, DOI 10.1186/1472-6939-7-5
   Shapira S, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1561-7
   Soled D, 2020, ACAD MED, V95, P1384, DOI 10.1097/ACM.0000000000003401
   Soon C., 2020, The Straits Times
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Taylor HA, 2014, BIOSECUR BIOTERROR, V12, P178, DOI 10.1089/bsp.2014.0009
   Theoret C, 2020, MED EDUC, V54, P591, DOI 10.1111/medu.14181
   Tracy CS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-470
   Wunderlich R, 2017, PREHOSP DISASTER MED, V32, P374, DOI 10.1017/S1049023X17000280
NR 44
TC 2
Z9 2
U1 6
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6920
J9 BMC MED EDUC
JI BMC Med. Educ.
PD JUN 4
PY 2021
VL 21
IS 1
AR 317
DI 10.1186/s12909-021-02762-0
PG 11
WC Education & Educational Research; Education, Scientific Disciplines
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Education & Educational Research
GA SR2KZ
UT WOS:000660873600002
PM 34088316
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Su, JL
   Ma, ZQ
   Zhu, BX
   Xie, HY
   Oteng, AF
   Hu, WJ
AF Su Jialu
   Ma Zhiqiang
   Zhu Binxin
   Xie Haoyang
   Oteng, Agyeman Fredrick
   Hu, Weijun
TI Collaborative Innovation Network, Knowledge Base, and Technological
   Innovation Performance-Thinking in Response to COVID-19
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE COVID-19; collaborative innovation network; network relationship
   strength; knowledge base breadth; technological innovation performance
ID ALLIANCE; CENTRALITY; MARKET; IMPACT
AB Amid the pandemic of COVID-19, the collaborative innovation network of enterprises is conducive to the sharing of innovation resources, knowledge transfer, and technology diffusion, which is closely related to the improvement of corporate technological innovation performance. Based on the patent application data of listed enterprises in Jiangsu, Zhejiang, and Shanghai in China, this study constructs a cooperation matrix, describes the characteristics of collaborative innovation network from two dimensions of network structure and network relationship, introduces the breadth of the knowledge base as a moderating variable, and analyzes the nexus between characteristics of a collaborative innovation network and technological innovation performance. Based on the panel data of 193 listed companies in Jiangsu, Zhejiang, and Shanghai, this study uses a multiple linear regression model for empirical analysis. The results show a U-shaped relationship between clustering coefficient and technological innovation performance. The breadth of knowledge base strengthens the positive relationship between the structural hole and technological innovation performance. In contrast, the breadth of knowledge base weakens the positive relationship between network relationships strength and technological innovation performance. The study findings will enhance enterprises' participation in a suitable collaborative innovation according to their knowledge-based characteristics and improve the technological innovation performance.</p>
C1 [Su Jialu; Ma Zhiqiang; Zhu Binxin; Oteng, Agyeman Fredrick] Jiangsu Univ, Sch Management, Zhenjiang, Jiangsu, Peoples R China.
   [Zhu Binxin] Cranfield Univ, Ctr Competit Creat Design C4D, Cranfield, Beds, England.
   [Xie Haoyang] Zhejiang Univ, Sch Math Sci, Hangzhou, Zhejiang, Peoples R China.
   [Hu, Weijun] Jilin Univ, Sch Archaeol, Changchun, Peoples R China.
RP Hu, WJ (corresponding author), Jilin Univ, Sch Archaeol, Changchun, Peoples R China.
EM huwj@jlu.edu.cn
FU Social Science Funding Project of Jiangsu Province [18GLB024]
FX This study is supported by the Social Science Funding Project of Jiangsu
   Province under Grant No. 18GLB024.
CR Agrawal AK, 2009, ADV STRATEG MANAGE, V26, P13, DOI 10.1108/S0742-3322(2009)0000026033
   Anqi W., 2020, STAT DECIS MAKING, V36, P184, DOI [10.13546/j.cnki.tjyjc.2020.05.042, DOI 10.13546/J.CNKI.TJYJC.2020.05.042]
   Bikard M, 2020, MANAGE SCI, V66, P3425, DOI 10.1287/mnsc.2019.3385
   Chaoying T., 2017, SCI SCI MANAGE S T, V38, P85
   Chenlei L., 2017, SCI SCI MANAGE S T, V38, P54
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943
   Felix Ayadi O., 1996, MANAG FINANC, V22, P18, DOI [10.1108/eb018574, DOI 10.1108/EB018574]
   GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311
   Hong C., 2013, CHIN J MANAGE, V10, P875, DOI [10.3969/j.issn.1672-884x.2013.06.014, DOI 10.3969/J.ISSN.1672-884X.2013.06.014]
   Hongming X., 2012, SCI RES MANAGE, V33, P55, DOI [10.19571/j.cnki.1000-2995.2012.02.008, DOI 10.19571/J.CNKI.1000-2995.2012.02.008]
   Hongtao S., 2013, J IND TECHNOL EC, V32, P14, DOI [10.3969/j.issn.1004-910x.2013.11.002, DOI 10.3969/J.ISSN.1004-910X.2013.11.002]
   Jiang H, 2018, STRATEGIC MANAGE J, V39, P217, DOI 10.1002/smj.2695
   Jianping W., 2019, SCI RES MANAGE, V40
   Jianzhong X., 2015, MANAG REV, V27, P114, DOI [10.14120/j.cnki.cn11-5057/f.2015.01.011, DOI 10.14120/J.CNKI.CN11-5057/F.2015.01.011]
   Jieqiong C., 2015, CHIN J MANAGE SCI, V23, P657
   Karamanos AG, 2016, R&D MANAGE, V46, P261, DOI 10.1111/radm.12163
   Ke W., 2020, CHINA SCI TECHNOL IN, V4, P13, DOI [10.16277/j.cnki.cn11-2502/n.2020.04.008, DOI 10.16277/J.CNKI.CN11-2502/N.2020.04.008]
   Laursen K, 2006, STRATEGIC MANAGE J, V27, P131, DOI 10.1002/smj.507
   Liu CH, 2011, EXPERT SYST APPL, V38, P299, DOI 10.1016/j.eswa.2010.06.064
   Macaulay CD, 2018, J BUS ETHICS, V151, P997, DOI 10.1007/s10551-017-3566-7
   Murray F, 2002, RES POLICY, V31, P1389, DOI 10.1016/S0048-7333(02)00070-7
   Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104
   Ritter T, 2003, J BUS RES, V56, P745, DOI 10.1016/S0148-2963(01)00259-4
   Sampat BN, 2021, HEALTH AFFAIR, V40, P400, DOI 10.1377/hlthaff.2020.02097
   Sarfraz M, 2022, INT J FINANC ECON, V27, P2600, DOI 10.1002/ijfe.2289
   Sarfraz M, 2020, ENVIRON SCI POLLUT R, V27, P45938, DOI 10.1007/s11356-020-10496-7
   Sarfraz M, 2020, AIR QUAL ATMOS HLTH, V13, P1135, DOI 10.1007/s11869-020-00870-2
   Speldekamp D, 2020, RES POLICY, V49, DOI 10.1016/j.respol.2020.103921
   Sullivan BN, 2007, ORGAN SCI, V18, P55, DOI 10.1287/orsc.1060.0229
   Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782
   Wang C.F., 2021, SCI TECHNOL PROG POL, V38, P38, DOI [10.6049/kjjbydc.Q201908306, DOI 10.6049/KJJBYDC.Q201908306]
   Wang HF, 2019, J BUS IND MARK, V34, P1388, DOI 10.1108/JBIM-09-2017-0228
   Wang Y.G., 2020, BUS MANAGE J, V42, P7
   Watts JKM, 2019, J BUS RES, V104, P196, DOI 10.1016/j.jbusres.2019.07.012
   [吴慧 Wu Hui], 2017, [科学学研究, Studies in Science of Science], V35, P1578
   Wu Q, 2018, 2018 5TH INTERNATIONAL CONFERENCE ON INDUSTRIAL ECONOMICS SYSTEM AND INDUSTRIAL SECURITY ENGINEERING (IEIS 2018)
   Xia J, 2018, J MANAGE, V44, P1899, DOI 10.1177/0149206316630379
   Xinyue H., 2018, SYST ENG THEORY PRAC, V38, P3124, DOI [10.12011/1000-6788(2018)12-3124-16, DOI 10.12011/1000-6788(2018)12-3124-16]
   Yan L., 2014, SCI TECHNOL PROGR PO, V31, P59, DOI [10.6049/kjjbydc.2014070383, DOI 10.6049/KJJBYDC.2014070383]
   Yan L., 2011, SCI SCI MANAGE S T, V32, P64
   Yan Y., 2017, SCI TECHNOL MANAGE R, V37, P139, DOI [10.3969/j.issn.1000-7695.2017.19.021, DOI 10.3969/J.ISSN.1000-7695.2017.19.021]
   Yan Y, 2018, TECHNOL FORECAST SOC, V126, P244, DOI 10.1016/j.techfore.2017.09.004
   Yingying F., 2020, INQ EC ISSUES, V458, P175
   Zaheer A, 2005, STRATEGIC MANAGE J, V26, P809, DOI 10.1002/smj.482
   Zhang GP, 2020, SCIENTOMETRICS, V124, P1745, DOI 10.1007/s11192-020-03586-3
   Zhiming C., 2016, S CHINA J EC, V24, P112, DOI [10.19592/j.cnki.scje.2016.07.007, DOI 10.19592/J.CNKI.SCJE.2016.07.007]
   Zhiyong K., 2013, SCI RES MANAGE, V34, P42, DOI [10.19571/j.cnki.1000-2995.2013.06.006, DOI 10.19571/J.CNKI.1000-2995.2013.06.006]
   Zhou KZ, 2012, STRATEGIC MANAGE J, V33, P1090, DOI 10.1002/smj.1959
NR 49
TC 2
Z9 2
U1 55
U2 62
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD SEP 7
PY 2021
VL 12
AR 648276
DI 10.3389/fpsyg.2021.648276
PG 13
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA US3IG
UT WOS:000697326500001
PM 34557126
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Zaoui, S
   Hamou-ou-Brahim, SA
   Zhou, HW
   Omrane, A
   Huang, DC
AF Zaoui, Soukaina
   Hamou-ou-Brahim, Safae Ait
   Zhou, Haiwei
   Omrane, Amina
   Huang, Dechun
TI Consumer Purchasing Behaviour Towards Strategic Innovation Management
   Practices in Morocco During COVID-19 Health Crisis
SO FIIB BUSINESS REVIEW
LA English
DT Article
DE Innovation management practices; consumer purchasing behaviour;
   innovation strategy; COVID-19 crisis; Moroccan companies
ID MARKET ORIENTATION; PRODUCT INNOVATION; CULTURE; PERFORMANCE; FIRMS;
   COMPETITIVENESS; CONSEQUENCES; DETERMINANTS; ENTERPRISES; KNOWLEDGE
AB The global economy has been affected as a result of the unusual circumstances surrounding the COVID-19 outbreak and the restrictive measures taken by governments to contain the crisis. As a result, in order to survive such turmoil, sustain their economic outputs and adapt to change, companies have been invited, and even forced, to innovate. The present study aims at contributing to a better understating of the impacts of strategic innovation management (SIM) practices implemented into a company (i.e., its innovative strategy and culture, product innovation, technological capability, and customer and supplier relationships) on the consumer purchasing behaviour (CPB) in the context of COVID-19 global crisis. Data were gathered from a sample of 57 Moroccan companies operating with international management styles and working according to the standards of the International Organization for Standardization (ISO). Then, the structural equation model (SEM) method was employed to test the proposed hypothesis of the theoretical model. The conclusive results revealed that SIM practices have a significant influence on a company's CPB, essentially via the adoption of an innovative strategy. Therefore, CPB is likely to be upgraded whenever companies seek for improving the implementation of successful SIM practices.
C1 [Zaoui, Soukaina; Hamou-ou-Brahim, Safae Ait; Zhou, Haiwei; Huang, Dechun] Hohai Univ, Sch Business, Jiangning Campus, Nanjing, Peoples R China.
   [Omrane, Amina] Univ Sfax, Fac Econ Sci & Business Adm Sfax FSEGS, Dept Business Adm, Sfax, Tunisia.
RP Zaoui, S (corresponding author), Hohai Univ, Sch Business, Jiangning Campus, Nanjing, Peoples R China.
EM soukainazaoui1994@gmail.com
RI Omrane, Amina/AAZ-8520-2021
OI Omrane, Amina/0000-0001-9057-5307
CR ANDERSON E, 1989, MARKET SCI, V8, P310, DOI 10.1287/mksc.8.4.310
   ANDERSON EW, 1993, MARKET SCI, V12, P125, DOI 10.1287/mksc.12.2.125
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Attuahene-Gima K, 2001, ORGAN SCI, V12, P54
   Awan A. G., 2014, EUROPEAN J BUSINESS, V2, P93
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Belderbos R, 2004, RES POLICY, V33, P1477, DOI 10.1016/j.respol.2004.07.003
   Bessant J., 2007, INNOVATION ENTREPREN
   Betaraya D.M., 2018, FIIB BUS REV, V7, P109
   Blindenbach-Driessen F, 2006, RES POLICY, V35, P545, DOI 10.1016/j.respol.2006.02.005
   Bove LL, 2000, INT J SERV IND MANAG, V11, P491, DOI 10.1108/09564230010360191
   Burgelman R., 2001, STRATEG MANAG
   Cannon JP, 2001, J MARKETING, V65, P29, DOI 10.1509/jmkg.65.1.29.18136
   CAPON N, 1992, MANAGE SCI, V38, P157, DOI 10.1287/mnsc.38.2.157
   Cermak DS., 1994, J APPL BUS RES, V10, P90
   CGEM, 2021, ECON OUTL
   CGEM, 2020, ECON OUTL
   Chin WW, 1998, QUANT METH SER, P295
   Chung S, 2003, RES POLICY, V32, P587, DOI 10.1016/S0048-7333(02)00047-1
   COOPER RG, 1995, ENG MANAGEMENT REV, V23, P112
   Cormican K, 2004, TECHNOVATION, V24, P819, DOI 10.1016/S0166-4972(03)00013-0
   CRAWFORD CM, 1980, SLOAN MANAGE REV, V22, P3
   CZEPIEL JA, 1990, J BUS RES, V20, P13, DOI 10.1016/0148-2963(90)90038-F
   Deaton Angus, 1992, UNDERSTANDING CONSUM
   Dereli DD, 2015, WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP, P1365, DOI 10.1016/j.sbspro.2015.06.323
   DESHPANDE R, 1993, J MARKETING, V57, P23, DOI 10.2307/1252055
   Doney PM, 1997, J MARKETING, V61, P35, DOI 10.2307/1251829
   Eggert A, 2010, IND MARKET MANAG, V39, P1346, DOI 10.1016/j.indmarman.2010.03.003
   File M. K., 1992, J SERV MARK, V6, P5, DOI [10.1108/08876049210037113, DOI 10.1108/08876049210037113]
   Fulton J. C, 1992, POPCORN REPORT FAITH
   Gajjar N. B, 2013, INT J RES HUMANITIES, V1, P2320
   George W.R., 1981, MARKETING SERVICES
   Goffin K., 1999, INNOVATION MANAGEMEN
   Hair J.F., 1992, MULTIVARIATE DATA AN
   Han JK, 1998, J MARKETING, V62, P30, DOI 10.2307/1252285
   HCP, 2019, ENQ NAT AUPR ENTR
   Hippel Eric von, DEMOCRATIZING INNOVA
   Humphreys Michael A., 1996, J PERS SELL SALES M, V16, P47, DOI DOI 10.1080/08853134.1996.10754063
   Igartua JI, 2010, RES TECHNOL MANAGE, V53, P41, DOI 10.1080/08956308.2010.11657630
   Jisana T. K, 2014, SAI J COMMERCE MANAG, V1, P34
   Jolson M. A., 1997, J PERS SELL SALES M, V17, P75, DOI [10.1080/08853134.1997, DOI 10.1080/08853134.1997]
   JORESKOG KG, 1969, PSYCHOMETRIKA, V34, P183, DOI 10.1007/BF02289343
   Kalay F., 2015, RES J BUSINESS MANAG, V2, P412
   KHAN AM, 1989, J BUS VENTURING, V4, P187, DOI 10.1016/0883-9026(89)90020-7
   Khazanchi S, 2007, J OPER MANAG, V25, P871, DOI 10.1016/j.jom.2006.08.003
   KOBERG CS, 1987, J BUS RES, V15, P397, DOI 10.1016/0148-2963(87)90009-9
   Koufaris M, 2002, INFORM SYST RES, V13, P205, DOI 10.1287/isre.13.2.205.83
   Lahindah L., 2018, ASIAN J TECHNOLOGY M, V11, P118, DOI [10.12695/ajtm.2018.11.2.4, DOI 10.12695/AJTM.2018.11.2.4]
   Lehu J. M, 2012, ENCY MARKETING
   Lundvall BA, 2016, ANTHEM STUD INNOV DE, P19
   Martin-de Castro G, 2013, TECHNOL FORECAST SOC, V80, P351, DOI 10.1016/j.techfore.2012.08.012
   Mlouka S. B., 2008, REV SCI GESTION, V5, P77, DOI [10.3917/rsg.233.0077, DOI 10.3917/RSG.233.0077]
   Mowen JC, 2004, J CONSUM PSYCHOL, V14, P52, DOI 10.1207/s15327663jcp1401&2_7
   Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd
   Nybakk E, 2012, INT J INNOV MANAG, V16, DOI 10.1142/S1363919611003374
   O'Regan N, 2006, TECHNOVATION, V26, P30, DOI 10.1016/j.technovation.2005.05.004
   Oke A, 2012, DECISION SCI, V43, P273, DOI 10.1111/j.1540-5915.2011.00350.x
   Osmonbekov T, 2018, J BUS IND MARK, V33, P781, DOI 10.1108/JBIM-10-2015-0190
   Pachauri M., 2001, MARKETING REV, V2, P319, DOI [10.1362/1469347012569896, DOI 10.1362/1469347012569896]
   Pishgar F., 2013, ARABIAN J BUSINESS M, V2, P1
   Qian GM, 2003, STRATEGIC MANAGE J, V24, P881, DOI 10.1002/smj.344
   REGAN WJ, 1963, J MARKETING, V27, P57, DOI 10.2307/1249437
   Roman S, 2008, IND MARKET MANAG, V37, P554, DOI 10.1016/j.indmarman.2006.12.004
   Ortega MJR, 2010, J BUS RES, V63, P1273, DOI 10.1016/j.jbusres.2009.09.007
   Sánchez Alba, 2011, Journal of Technology Management & Innovation, V6, P14, DOI 10.4067/S0718-27242011000200002
   Schiffman L., 2007, CONSUMER BEHAV, V6
   Solomon Michael R., 1996, CONSUMER BEHAV BUYIN
   Straub D, 2004, COMMUN ASS INF SYST, V13, P380, DOI DOI 10.17705/1CAIS.01324
   SZYMANSKI DM, 1988, J MARKETING, V52, P64, DOI 10.2307/1251686
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Terziovski M, 2010, STRATEGIC MANAGE J, V31, P892, DOI 10.1002/smj.841
   Varki S., 2003, J SERV RES-US, V6, P83
   Verhoef PC, 2003, J MARKETING, V67, P30, DOI 10.1509/jmkg.67.4.30.18685
   Verhoef PC, 2002, J ACAD MARKET SCI, V30, P202, DOI 10.1177/00970302030003002
   Waheed A, 2018, BALT J MANAG, V13, P209, DOI 10.1108/BJM-04-2017-0126
   Wheelwright S.C, 1992, REVOLUTIONIZING PROD
   Yang Y, 2011, J ORGAN BEHAV, V32, P1062, DOI 10.1002/job.724
   Yucel-Aybat O, 2018, J ADVERTISING, V47, P198, DOI 10.1080/00913367.2018.1430624
   Zalega T, 2018, HANDEL WEWNTRZNY, V4, P410
   Zhou KZ, 2010, STRATEGIC MANAGE J, V31, P547, DOI 10.1002/smj.830
NR 80
TC 1
Z9 1
U1 1
U2 1
PU SAGE PUBLICATIONS INDIA  PVT LTD
PI NEW DELHI
PA B-1-I-1 MOHAN CO-OPERATIVE INDUSTRIAL AREA, MATHURA RD, POST BAG NO 7,
   NEW DELHI 110 044, INDIA
SN 2319-7145
EI 2455-2658
J9 FIIB BUS REV
JI FIIB Bus. Rev.
PD JUN
PY 2021
VL 10
IS 2
BP 158
EP 171
DI 10.1177/23197145211020714
PG 14
WC Business; Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YV4OE
UT WOS:000752708300009
OA hybrid
DA 2022-04-20
ER

PT J
AU de Miranda, RR
   Lopes, CDA
   Franco, NMAS
   Cabral, LC
   Simamoto, PC
   Novais, VR
AF de Miranda, Rafael Resende
   Almanca Lopes, Camila de Carvalho
   Afonso Silveira Franco, Nathalia Maria
   Cabral, Luana Cardoso
   Simamoto Junior, Paulo Cezar
   Novais, Veridiana Resende
TI Head and neck cancer therapy-related oral manifestation management in
   the COVID-19 pandemic: a critical review
SO BRAZILIAN ORAL RESEARCH
LA English
DT Review
DE Covid-19; Coronavirus Infections; Dental Care; Head and Neck Neoplasms;
   Practice Management; Dental
ID POSITION PAPER; DENTAL-CARIES; RADIOTHERAPY; DYSPHAGIA;
   RADIOCHEMOTHERAPY; ASSOCIATION; PREVENTION; MUCOSITIS; SEQUELAE; DISEASE
AB With the onset of the new coronavirus disease (COVID-19) pandemic, the dental treatment of patients at risk of infection has become quite challenging. In view of this, patients with head and neck cancer may present with oral complications due to anticancer therapy, making dental assistance necessary. Thus, the objective of the study was to review the literature and critically discuss important concerns about the treatment of patients with head and neck cancer during the COVID-19 pandemic. Because dental professionals are in close contact with the main viral transmission routes, this study presents recommendations for management and protection during clinical dental care. The main characteristics and transmission routes of COVID-19 are also discussed. Dental professionals should control pain and the side effects of antineoplastic treatment and use preventive measures for infection control. During this pandemic, patients with head and neck cancer should not undergo elective procedures, even if they do not have symptoms or a history of COVID-19; therefore, in asymptomatic or painless cases, only preventive actions are recommended. In symptomatic or painful cases, precautions for safe interventional treatments must be implemented by following the hygiene measures recommended by health agencies and using personal protective equipment. During health crises, new protocols emerge for cancer treatment, and professionals must act with greater attention toward biosafety and updated knowledge. It is important to offer adequate individualized treatment based on the recommendations of preventative and interventional treatments so that patients can face this difficult period with optimized quality of life.
C1 [de Miranda, Rafael Resende; Afonso Silveira Franco, Nathalia Maria; Novais, Veridiana Resende] Univ Fed Uberlandia UFU, Sch Dent, Dept Operat Dent & Dent Mat, Uberlandia, MG, Brazil.
   [Almanca Lopes, Camila de Carvalho] Univ Fed Uberlandia UFU, Sch Dent, Dept Removable Prosthodont & Dent Mat, Uberlandia, MG, Brazil.
   [Cabral, Luana Cardoso] Fac Morgana Potrich FAMP, Sch Dent, Dept Oclus Fixed Prosthesis & Dent Mat, Mineiros, Go, Brazil.
   [Simamoto Junior, Paulo Cezar] Univ Fed Uberlandia UFU, Sch Dent, Dept Oclus Fixed Prosthesis & Dent Mat, Uberlandia, MG, Brazil.
RP Novais, VR (corresponding author), Univ Fed Uberlandia UFU, Sch Dent, Dept Operat Dent & Dent Mat, Uberlandia, MG, Brazil.
EM veridianaresende@hotmail.com
OI Maria Afonso Silveira Franco, Nathalia/0000-0002-1084-5918; Resende
   Novais, Veridiana/0000-0001-9017-2946; Resende de Miranda,
   Rafael/0000-0002-5510-2747
FU Coordination for the Improvement of Higher Education Personnel
   (Coordenacao de Aperfeicoamento de Nivel Superior -Capes) [001]
FX National Council for Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico and Tecnologico -CNPq), the
   Coordination for the Improvement of Higher Education Personnel
   (Coordenacao de Aperfeicoamento de Nivel Superior -Capes -Financial Code
   001) and the Minas Gerais Research Funding Foundation (Fapemig).
CR Alharbi A, 2020, SAUDI DENT J, V32, P181, DOI 10.1016/j.sdentj.2020.04.001
   Anschau F, 2019, LASER MED SCI, V34, P1053, DOI 10.1007/s10103-019-02722-7
   Ariyawardana A, 2019, SUPPORT CARE CANCER, V27, P3985, DOI 10.1007/s00520-019-04888-w
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Bhandari S, 2020, SPEC CARE DENT, V40, P238, DOI 10.1111/scd.12469
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Chan A, 2020, SUPPORT CARE CANCER, V28, P3485, DOI 10.1007/s00520-020-05544-4
   Chaveli-Lopez Begonya, 2014, J Clin Exp Dent, V6, pe81, DOI 10.4317/jced.51337
   Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785
   Chi AC, 2015, CA-CANCER J CLIN, V65, P401, DOI 10.3322/caac.21293
   Correa MEP, 2020, SUPPORT CARE CANCER, V28, P2449, DOI 10.1007/s00520-019-05217-x
   Dave M, 2020, J DENT RES, V99, P1112, DOI 10.1177/0022034520923323
   De Felice F, 2020, RADIOTHER ONCOL, V147, P84, DOI 10.1016/j.radonc.2020.03.020
   de Morais EF, 2014, BRAZ J OTORHINOLAR, V80, P78, DOI 10.5935/1808-8694.20140015
   Denaro N, 2013, CLIN EXP OTORHINOLAR, V6, P117, DOI 10.3342/ceo.2013.6.3.117
   Denham JW, 1999, RADIOTHER ONCOL, V52, P157, DOI 10.1016/S0167-8140(99)00107-3
   Desideri I, 2020, J GERIATR ONCOL, V11, P1175, DOI 10.1016/j.jgo.2020.05.001
   DREIZEN S, 1977, J DENT RES, V56, P99, DOI 10.1177/00220345770560022101
   Elad S, 2015, SUPPORT CARE CANCER, V23, P223, DOI 10.1007/s00520-014-2378-x
   Fallahi HR, 2020, MAX PLAST RECONSTR S, V42, DOI 10.1186/s40902-020-00256-5
   Fini MB, 2020, ORAL ONCOL, V105, DOI 10.1016/j.oraloncology.2020.104741
   Fonseca Jessica-Montenegro, 2019, J Clin Exp Dent, V11, pe236, DOI 10.4317/jced.55370
   Ge ZY, 2020, J ZHEJIANG UNIV-SC B, V21, P361, DOI 10.1631/jzus.B2010010
   Gosain R, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00934-7
   Vasconcellos AFG, 2020, CARIES RES, V54, P113, DOI 10.1159/000504878
   Guo HQ, 2020, J DENT SCI, V15, P564, DOI 10.1016/j.jds.2020.02.002
   Hong CHL, 2019, SUPPORT CARE CANCER, V27, P3949, DOI 10.1007/s00520-019-04848-4
   Hong CHL, 2018, SUPPORT CARE CANCER, V26, P155, DOI 10.1007/s00520-017-3829-y
   Hovan AJ, 2010, SUPPORT CARE CANCER, V18, P1081, DOI 10.1007/s00520-010-0902-1
   Jawad H, 2015, BRIT DENT J, V218, P69, DOI 10.1038/sj.bdj.2015.29
   Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1061, DOI 10.1007/s00520-010-0837-6
   Joshi VK, 2010, ORAL ONCOL, V46, P475, DOI 10.1016/j.oraloncology.2010.03.010
   Kamstra JI, 2013, SUPPORT CARE CANCER, V21, P951, DOI 10.1007/s00520-012-1610-9
   Kawashita Y, 2020, JPN DENT SCI REV, V56, P62, DOI 10.1016/j.jdsr.2020.02.001
   Kielbassa AM, 2006, LANCET ONCOL, V7, P326, DOI 10.1016/S1470-2045(06)70658-1
   King SN, 2016, DYSPHAGIA, V31, P339, DOI 10.1007/s00455-016-9710-1
   Kochhar AS, 2020, ORAL ONCOL, V106, DOI 10.1016/j.oraloncology.2020.104785
   Kopp M, 2020, CURR ISSUES SPORTS S, V5, P1, DOI [10.15203/CISS_2020.100, DOI 10.15203/CISS_2020.100]
   Langius JAE, 2013, NUTR CANCER, V65, P76, DOI 10.1080/01635581.2013.741749
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m308
   Martins-Chaves RR, 2020, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0048
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Moller P, 2004, ORAL SURG ORAL MED O, V97, P173, DOI 10.1016/S1079-2104(03)00473-6
   Mosel DD, 2011, ORAL DIS, V17, P550, DOI 10.1111/j.1601-0825.2011.01788.x
   Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020
   Murphy BA, 2009, SEMIN RADIAT ONCOL, V19, P35, DOI 10.1016/j.semradonc.2008.09.007
   Newbrun E, 2001, J Dent Educ, V65, P1078
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Pereira LJ, 2020, BRAZ ORAL RES, V34, DOI [10.1590/1807-3107bor-2020.vol34.0041, 10.1590/1807.3107bor-2020.vol34.0041]
   Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031
   Saunders DP, 2020, SUPPORT CARE CANCER, V28, P2473, DOI 10.1007/s00520-019-05181-6
   Scott B, 2008, ORAL ONCOL, V44, P430, DOI 10.1016/j.oraloncology.2007.06.015
   Scully C, 2004, HEAD NECK-J SCI SPEC, V26, P77, DOI 10.1002/hed.10326
   Sroussi HY, 2017, CANCER MED-US, V6, P2918, DOI 10.1002/cam4.1221
   Strojan P, 2017, CANCER TREAT REV, V59, P79, DOI 10.1016/j.ctrv.2017.07.003
   van der Geer SJ, 2019, SUPPORT CARE CANCER, V27, P1129, DOI 10.1007/s00520-018-4402-z
   Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P213, DOI 10.1177/154411130301400306
   Wong HM, 2014, SCI WORLD J, DOI 10.1155/2014/581795
   World Health Organization, 1979, WHO HDB REP RES CANC
   World Health Organization-WHO, 2020, COR DIS COVID 19 WEE
   Worthington HV, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001972.pub3
   Yarom N, 2020, SUPPORT CARE CANCER, V28, P2457, DOI 10.1007/s00520-019-05256-4
   Yeoh CB, 2020, ANESTH ANALG, V131, P16, DOI 10.1213/ANE.0000000000004884
   Young AM, 2020, SUPPORT CARE CANCER, V28, P4001, DOI 10.1007/s00520-020-05604-9
   Zadik Y, 2019, SUPPORT CARE CANCER, V27, P3969, DOI 10.1007/s00520-019-04890-2
NR 67
TC 2
Z9 2
U1 1
U2 1
PU SOCIEDADE BRASILEIRA DE PESQUISA ODONTOLOGICA
PI SAO PAULO
PA CIDADE UNIV, AV PROF LINEU PRESTES, ARMANDO SALLE OLIVEIRA, AVENIDA
   LINEU PRESTES, 2227, CP 8216, SAO PAULO, SP 05508-900, BRAZIL
SN 1807-3107
J9 BRAZ ORAL RES
JI Braz. Oral Res.
PY 2020
VL 34
AR e120
DI 10.1590/1807-3107bor-2020.vol34.0120
PG 10
WC Dentistry, Oral Surgery & Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dentistry, Oral Surgery & Medicine
GA SD7YZ
UT WOS:000651593500001
PM 33146316
OA gold
DA 2022-04-20
ER

PT J
AU Patrucco, F
   Gavelli, F
   Fagoonee, S
   Solidoro, P
   Undas, A
   Pellicano, R
AF Patrucco, Filippo
   Gavelli, Francesco
   Fagoonee, Sharmila
   Solidoro, Paolo
   Undas, Anetta
   Pellicano, Rinaldo
TI Current treatment challenges in the COVID-19 pandemic
SO POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY
   WEWNETRZNEJ
LA English
DT Review
DE coronavirus; COVID-19; SARS-CoV-2
ID CORONAVIRUS DISEASE 2019; RESPIRATORY-DISTRESS-SYNDROME;
   PULMONARY-EMBOLISM; MANAGEMENT; ANTICOAGULATION; ASSOCIATION; PNEUMONIA
AB Infection with SARS-CoV-2, responsible for COVID-19, has spread all over the world since the beginning of 2020. Healthcare providers and researchers have been overwhelmed not only by the rapid diffusion of the disease resulting in a pandemic with more than 4 million cases of death, but also by the lack of therapeutic options. After more than 1 year, the knowledge on COVID-19 has increased thanks to the enormous effort of the scientific community. To date, some algorithms of management have been adopted. While asymptomatic or mildly symptomatic patients should receive only a symptom-based treatment and clinical monitoring when necessary, inpatients could be candidates for antiviral treatment due to fully symptomatic disease. Corticosteroid treatment should be limited to patients with severe disease, particularly those with respiratory failure or acute respiratory distress syndrome. Since the main clinical features of COVID-19 are hypoxemia and dyspnea, oxygen therapy remains the cornerstone of managing more severe cases. In this context, the first-line approach should be represented by low-flow oxygen delivery via a nasal cannula or, more frequently, via a face mask with a known fraction of inspired oxygen. When low-flow oxygen fails to significantly improve oxygen saturation, oxygen therapy using a high-flow nasal cannula is recommended. The current challenges in the treatment of COVID-19 include the need to define the role of convalescent plasma and monoclonal antibodies as well as to identify the optimal target and time for anticoagulation. In this review, we highlight the main aspects of these challenges in light of recent updates.
C1 [Patrucco, Filippo; Gavelli, Francesco] Univ Piemonte Orientale UPO, Dept Translat Med, Novara, Italy.
   [Patrucco, Filippo] AOU Maggiore Carita, Div Resp Dis, Med Dept, Cso Mazzini 18, I-28100 Novara, Italy.
   [Gavelli, Francesco] AOU Maggiore Carita, Emergency Med Dept, Novara, Italy.
   [Fagoonee, Sharmila] CNR, Mol Biotechnol Ctr, Inst Biostruct & Bioimaging, Turin, Italy.
   [Solidoro, Paolo] AOU Citta Salute & Sci, Cardiovasc & Thorac Dept, Pneumol Unit, Turin, Italy.
   [Solidoro, Paolo] Univ Turin, Med Sci Dept, Turin, Italy.
   [Undas, Anetta] Jagiellonian Univ Med Coll, Inst Cardiol, Krakow, Poland.
   [Pellicano, Rinaldo] Molinette SGAS Hosp, Gastroenterol Unit, Turin, Italy.
RP Patrucco, F (corresponding author), AOU Maggiore Carita, Div Resp Dis, Med Dept, Cso Mazzini 18, I-28100 Novara, Italy.
EM patrucco@maggioreosp.novara.it
RI Filippo, Patrucco/AAC-4509-2022; Pellicano, Rinaldo/K-2575-2016;
   Gavelli, Francesco/AAE-6666-2019
OI Gavelli, Francesco/0000-0002-0581-245X
CR Actis GC, 2021, MINERVA MED, V112, P144, DOI 10.23736/S0026-4806.20.07054-8
   Al-Samkari H, 2021, JAMA-J AM MED ASSOC, V325, P1613, DOI 10.1001/jama.2021.4295
   Al-Samkari H, 2021, ANN INTERN MED, V174, P622, DOI 10.7326/M20-6739
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Alhazzani W, 2021, CRIT CARE MED, V49, pE219, DOI 10.1097/CCM.0000000000004899
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bellan M, 2020, MINERVA MED, V111, P303, DOI 10.23736/S0026-4806.20.06664-1
   Bellan M, 2020, PANMINERVA MED, V63, P478, DOI 10.23736/S0031-0808.20.04000-8
   Beurton A, 2021, CRIT CARE MED, V49, pE151, DOI 10.1097/CCM.0000000000004768
   Beurton A, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2306-z
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2
   Celejewska-Wojcik N, 2021, POL ARCH INTERN MED, V131, P658, DOI 10.20452/pamw.16015
   Clementi N, 2020, J INFECT DIS, V222, P722, DOI 10.1093/infdis/jiaa350
   Coppo A, 2020, LANCET RESP MED, V8, P765, DOI 10.1016/S2213-2600(20)30268-X
   Corti D, 2021, CELL, V184, P3086, DOI [10.1016/j.cell.2021.05.005, 10.1016/j.cell.2021.07.027]
   Cruz-Utrilla A, 2020, KARDIOL POL, V78, P937, DOI 10.33963/KP.15436
   De Meyer S, 2020, INT J INFECT DIS, V97, P7, DOI 10.1016/j.ijid.2020.05.085
   Elharrar X, 2020, JAMA-J AM MED ASSOC, V323, P2336, DOI 10.1001/jama.2020.8255
   Engelen MM, 2021, SEMIN THROMB HEMOST, V47, P362, DOI 10.1055/s-0041-1727284
   Flisiak R, 2021, POL ARCH INTERN MED, V131, P103, DOI 10.20452/pamw.15735
   Flisiak R, 2020, POL ARCH INTERN MED, V130, P557, DOI 10.20452/pamw.15424
   Gavelli F, 2021, MINERVA RESPIR MED, V60, P87, DOI 10.23736/S2784-8477.21.01919-2
   Gavelli F, 2021, INTERN EMERG MED, V16, P1649, DOI 10.1007/s11739-021-02735-7
   Gavelli F, 2021, MINERVA MED, V112, P118, DOI 10.23736/S0026-4806.20.07074-3
   Gavelli F, 2020, MINERVA MED, V111, P300, DOI 10.23736/S0026-4806.20.06609-4
   Gavelli F, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-0644-2
   Ghosn L, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013881
   Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI 10.1056/NEJMoa2103417
   Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Gupta RK, 2021, LANCET RESP MED, V9, P349, DOI 10.1016/S2213-2600(20)30559-2
   Harsch IA, 2020, POL ARCH INTERN MED, V130, P438, DOI 10.20452/pamw.15333
   Hasan MJ, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06119-2
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8
   Infectious Diseases Society of America, IDSA GUID TREATM MAN
   Janiaud P, 2021, JAMA-J AM MED ASSOC, V325, P1185, DOI 10.1001/jama.2021.2747
   Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005
   Joyner MJ, 2021, NEW ENGL J MED, V384, P1015, DOI 10.1056/NEJMoa2031893
   Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994
   Kanj S, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050849
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Kosior DA, 2020, KARDIOL POL, V78, P642, DOI 10.33963/KP.15425
   Lai C, 2021, CRIT CARE MED, V49, P781, DOI 10.1097/CCM.0000000000004849
   Lawler PR, 2021, NEW ENGL J MED, V385, P790, DOI 10.1056/NEJMoa2105911
   Longchamp G, 2021, THROMB J, V19, DOI 10.1186/s12959-021-00266-x
   Mariette X, 2021, LANCET RESP MED, V9, P295, DOI 10.1016/S2213-2600(20)30556-7
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   National Institutes of Health, COR DIS 2019 COVID 1
   Patrucco F, 2021, RADIOLOGY, V298, pE152, DOI 10.1148/radiol.2020203776
   Patrucco F, 2021, RESPIRATION, V99, P970, DOI 10.1159/000511964
   Patrucco F, 2020, PANMINERVA MED, V62, P73, DOI 10.23736/S0031-0808.20.03897-5
   Pei L, 2020, POL ARCH INTERN MED, V130, P726, DOI 10.20452/pamw.15543
   Pesavento R, 2020, J THROMB HAEMOST, V18, P2629, DOI 10.1111/jth.15022
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Radovanovic D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041191
   Raoof S, 2020, CHEST, V158, P1992, DOI 10.1016/j.chest.2020.07.013
   Ricard JD, 2020, INTENS CARE MED, V46, P2238, DOI 10.1007/s00134-020-06228-7
   Roberts LN, 2020, BLOOD, V136, P1347, DOI 10.1182/blood.2020008086
   Rochwerg B, 2020, INTENS CARE MED, V46, P2226, DOI 10.1007/s00134-020-06312-y
   Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152
   Sartini C, 2020, JAMA-J AM MED ASSOC, V323, P2338, DOI 10.1001/jama.2020.7861
   Secco E, 2020, KARDIOL POL, V78, P919, DOI 10.33963/KP.15489
   Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980
   Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Stebbing J, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4724
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836
   Udi J, 2021, J INTENSIVE CARE MED, V36, P477, DOI 10.1177/0885066620954364
   US Food and Drug Administration, FACT SHEET HLTH CAR
   VITTORIA BL, 2021, PHARM BASEL, V14, P503
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang Y., 2020, EARLY LOW DOSE SHORT, DOI [10.1101/2020.03.06.20032342, DOI 10.1101/2020.03.06.20032342]
   Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163
   Garcia PWD, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03580-y
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 85
TC 4
Z9 4
U1 2
U2 2
PU MEDYCYNA PRAKTYCZNA SP K SP ZOO
PI KRAKOW
PA REJTANA 2, KRAKOW, 30-510    AP, POLAND
SN 0032-3772
EI 1897-9483
J9 POL ARCH INTERN MED
JI Pol. Intern. Med.
PD SEP 30
PY 2021
VL 131
IS 9
BP 854
EP 861
DI 10.20452/pamw.16077
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA WC9SS
UT WOS:000704590600012
PM 34590451
OA gold
DA 2022-04-20
ER

PT J
AU Reddy, V
   Jajodia, A
   Pasricha, S
   Goyal, S
   Puri, S
AF Reddy, Vikas
   Jajodia, Ankush
   Pasricha, Sunil
   Goyal, Sumit
   Puri, Sunil
TI Rare Case of Spontaneous Pneumorrhachis in a Young Male with COVID-19
SO INDIAN JOURNAL OF RADIOLOGY AND IMAGING
LA English
DT Article
DE pneumomediastinum; pneumorrhachis; COVID-19
AB Here we present a rare case of spontaneous pneumomediastinum complicated with pneumorrhachis (PR) in a young man who is a known case of carcinoma rectosigmoid region. Our young male was diagnosed with novel coronavirus disease 2019 (COVID-19) and remained asymptomatic for any respiratory complaints. Though an association of pneumomediastinum has been reported in COVID 19 patients, to the best of our knowledge, this is the first report of PR in a COVID-19 oncological case. The role of a radiologist is to identify this condition as cases reported earlier may have serious neurological consequences. Pursuing the cause can be a diagnostic challenge but it reaps the clinical benefit in the appropriate management.
C1 [Reddy, Vikas; Jajodia, Ankush; Puri, Sunil] Rajiv Gandhi Canc Inst & Res Ctr, Dept Radiol, Rohini Sect 5, Delhi 110085, India.
   [Pasricha, Sunil] Rajiv Gandhi Canc Inst, Dept Histopathol, Delhi, India.
   [Goyal, Sumit] Rajiv Gandhi Canc Inst & Res Ctr, Dept Med Oncol, Delhi, India.
RP Jajodia, A (corresponding author), Rajiv Gandhi Canc Inst & Res Ctr, Dept Radiol, Rohini Sect 5, Delhi 110085, India.
EM ankushjaj@gmail.com
RI Jajodia, Ankush/ABC-6324-2021
CR B?rbara, 2016, CASE REP PULMONOL, V2016
   Bernaerts A, 2003, EUR RADIOL, V13, P642, DOI 10.1007/s00330-002-1466-3
   Chiba Yasuhisa, 1995, Auris Nasus Larynx, V22, P205
   Coniglio M, 1997, Radiol Med, V94, P531
   Dosios T, 2000, Eur J Cardiothorac Surg, V18, P123, DOI 10.1016/S1010-7940(00)00454-1
   GORDON IJ, 1977, NEURORADIOLOGY, V13, P107, DOI 10.1007/BF00339843
   Lee, 2009, SPINE J, V9, P16
   Vega JML, 2020, EMERG RADIOL, V27, P727, DOI 10.1007/s10140-020-01806-0
   NEWBOLD RG, 1987, AM J ROENTGENOL, V148, P615, DOI 10.2214/ajr.148.3.615
   Oertel M., 2006, EUR SPINE J S5, V15, pS636, DOI DOI 10.1007/S00586-006-0160-6
   TSUJI H, 1989, J COMPUT ASSIST TOMO, V13, P38, DOI 10.1097/00004728-198901000-00007
   Yaginuma Kazufumi, 2019, Radiol Case Rep, V14, P1325, DOI 10.1016/j.radcr.2019.08.010
NR 12
TC 0
Z9 0
U1 1
U2 1
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0971-3026
EI 1998-3808
J9 INDIAN J RADIOL IMAG
JI Indian J. Radiol. Imaging
PD JUL
PY 2021
VL 31
IS 03
BP 761
EP 763
DI 10.1055/s-0041-1735920
EA OCT 2021
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
WE Emerging Sources Citation Index (ESCI)
SC Radiology, Nuclear Medicine & Medical Imaging
GA WW6SH
UT WOS:000704163500015
PM 34790333
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Toruner, M
   Kalkan, IH
   Akyuz, F
   Tezel, A
   Celik, AF
AF Toruner, Murat
   Kalkan, Ismail Hakki
   Akyuz, Filiz
   Tezel, Ahmet
   Celik, Aykut Ferhat
TI Turkish IBD Organization's Position Statement on Inflammatory Bowel
   Disease Management Recommendations During COVID-19 Pandemic
SO TURKISH JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Inflammatory bowel diseases; Crohn's disease; ulcerative colitis;
   COVID-19 pandemic
ID IMMUNE-RESPONSE; OPPORTUNISTIC INFECTIONS; VACCINE; THERAPY; CROHNS;
   RISK
AB The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2, has resulted in high mortality and morbidity worldwide and is still a growing problem. Inflammatory bowel disease (IBD) is a chronic inflammatory disease for which a substantial number of patients are treated with immunosuppressive medications, either occasionally or long-term. Despite the accumulating evidence, there is still a lack of knowledge about the impact of COVID-19 on IBD patients, especially those who are under immunosuppressive treatment. Moreover, following the emergence of several COVID vaccines, there are concerns regarding vaccine effectiveness and possible side effects in such patients. In this context, we tried to briefly summarize the accumulating evidence and recommendations for the management of IBD in the context of the COVID-19 pandemic.
C1 [Toruner, Murat] Ankara Univ, Dept Gastroenterol, Sch Med, Ankara, Turkey.
   [Kalkan, Ismail Hakki] TOBB Univ Econ & Technol, Dept Gastroenterol, Sch Med, Ankara, Turkey.
   [Akyuz, Filiz] Istanbul Univ, Dept Gastroenterol, Istanbul Sch Med, Istanbul, Turkey.
   [Tezel, Ahmet] Trakya Univ, Dept Gastroenterol, Sch Med, Edirne, Turkey.
   [Celik, Aykut Ferhat] Istanbul Univ Cerrahpasa, Cerrahpasa Sch Med, Dept Gastroenterol, Istanbul, Turkey.
RP Toruner, M (corresponding author), Ankara Univ, Dept Gastroenterol, Sch Med, Ankara, Turkey.
EM murattoruner@yahoo.com
CR Alexander JL, 2021, LANCET GASTROENTEROL, V6, P218, DOI 10.1016/S2468-1253(21)00024-8
   Andrisani G, 2013, J CROHNS COLITIS, V7, P301, DOI 10.1016/j.crohns.2012.05.011
   [Anonymous], 2020, COVID 19 DASHBOARD C
   Brenner, 2021, J CROHNS COLITIS
   Brenner EJ, 2020, GASTROENTEROLOGY, V159, P481, DOI 10.1053/j.gastro.2020.05.032
   Caldera F, 2020, INFLAMM BOWEL DIS, V26, P593, DOI 10.1093/ibd/izz164
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cullen G, 2012, GUT, V61, P385, DOI 10.1136/gutjnl-2011-300256
   D'Amico F, 2020, GASTROENTEROLOGY, V159, P14, DOI 10.1053/j.gastro.2020.04.059
   D'Amico F, 2020, LANCET GASTROENTEROL, V5, P631, DOI 10.1016/S2468-1253(20)30151-5
   Eichenberger EM, 2019, BONE MARROW TRANSPL, V54, P1058, DOI 10.1038/s41409-018-0386-z
   Fiorino G, 2012, INFLAMM BOWEL DIS, V18, P1042, DOI 10.1002/ibd.21800
   Gelinck LBS, 2008, VACCINE, V26, P3528, DOI 10.1016/j.vaccine.2008.04.028
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Haberman R, 2020, NEW ENGL J MED, V383, P85, DOI 10.1056/NEJMc2009567
   Hajifathalian K, 2020, GASTROENTEROLOGY, V159, P1137, DOI 10.1053/j.gastro.2020.05.010
   Hakki M, 2015, J CLIN VIROL, V68, P1, DOI 10.1016/j.jcv.2015.04.012
   Higgins PDR, 2020, CROHNS COLITIS 360, V2, DOI 10.1093/crocol/otaa026
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kennedy NA, 2021, GUT, V70, P865, DOI 10.1136/gutjnl-2021-324388
   Kennedy NA, 2020, GUT, V69, P984, DOI 10.1136/gutjnl-2020-321244
   Kluytmans-van Den Bergh MFQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9673
   Kucharzik T, 2021, J CROHNS COLITIS, V15, P879, DOI 10.1093/ecco-jcc/jjab052
   Lee CK, 2014, J CROHNS COLITIS, V8, P384, DOI 10.1016/j.crohns.2013.09.022
   Ling KL, 2020, JGH OPEN, V4, P320, DOI 10.1002/jgh3.12362
   Lu Y, 2009, AM J GASTROENTEROL, V104, P444, DOI 10.1038/ajg.2008.120
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   McGregor C.G., 2021, GUT
   Pan T, 2020, SCAND J GASTROENTERO, V55, P123, DOI 10.1080/00365521.2019.1707275
   Park SH, 2014, INFLAMM BOWEL DIS, V20, P69, DOI 10.1097/01.MIB.0000437736.91712.a1
   Pratt PK, 2018, INFLAMM BOWEL DIS, V24, P380, DOI 10.1093/ibd/izx001
   Rahier JF, 2014, J CROHNS COLITIS, V8, P443, DOI 10.1016/j.crohns.2013.12.013
   Rubin DT, 2020, GASTROENTEROLOGY, V159, P350, DOI 10.1053/j.gastro.2020.04.012
   She JT, 2020, J MED VIROL, V92, P747, DOI 10.1002/jmv.25807
   Siegel CA, 2021, GUT, V70, P635, DOI 10.1136/gutjnl-2020-324000
   Siegel CA, 2020, J CROHNS COLITIS, V14, pS769, DOI 10.1093/ecco-jcc/jjaa135
   Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012
   Toruner M, 2019, TURK J GASTROENTEROL, V30, pS913, DOI 10.5152/tjg.2019.061119
   Ungaro RC, 2021, GUT, V70, P725, DOI 10.1136/gutjnl-2020-322539
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wisniewski A, 2020, UNITED EUR GASTROENT, V8, P303, DOI 10.1177/2050640619889763
   Wong SY, 2021, GASTROENTEROLOGY, V161, P715, DOI 10.1053/j.gastro.2021.04.025
   World Health Organization, GEN OP REM MED BRIEF
   Wyant T, 2015, GUT, V64, P77, DOI 10.1136/gutjnl-2014-307127
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 47
TC 0
Z9 0
U1 1
U2 1
PU AVES
PI SISLI
PA BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY
EI 2148-5607
J9 TURK J GASTROENTEROL
JI Turk. J. Gastroenterol.
PD JUN
PY 2021
VL 32
IS 6
BP 488
EP 492
DI 10.5152/tjg.2021.280721
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA UD2PN
UT WOS:000687054600001
PM 34405814
DA 2022-04-20
ER

PT J
AU Liu, RG
   Nicholas, S
   Leng, AL
   Qian, DF
   Maitland, E
   Wang, J
AF Liu, Rugang
   Nicholas, Stephen
   Leng, Anli
   Qian, Dongfu
   Maitland, Elizabeth
   Wang, Jian
TI The influencing factors of discrimination against recovered Coronavirus
   disease 2019 (COVID-19) patients in China: a national study
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE Discrimination; corona virus disease 2019; recovered COVID-19 patients;
   disease knowledge
ID HEPATITIS-B; HEALTH-PROFESSIONALS; STIGMA; PREVENTION; KNOWLEDGE;
   WORKERS
AB Background: Over 26 million recovered COVID-19 patients will suffer from discrimination in work, education and social interactions. We analyzed the determinants of discrimination against recovered COVID-19 patients and suggest policy recommendations to reduce such discrimination. Methods: Twenty-seven Chinese cities were selected randomly based on their geographical location and GDP rank. One hundred adults were interviewed in each city with an equal number of men and women and three urban residents for every two rural residents. A multiple ordered logistic regression model was used to assess the associations between potential determinants and the COVID-19 discrimination level. Results: Of 2377 participants, 79.76% displayed discrimination toward recovered COVID-19 patients. The female discrimination level was 1.25 times that of males; the discrimination level increased with age; and was occupation-specific, with physicians' (OR = 0.352) and students' (OR = 0.553) discrimination level lower than that of farmers. The discrimination level of participants from the central regions was 1.828 times, and the eastern region 1.504 times, that of participants from western region. The participants' discrimination level was lower when they scored higher in transmission knowledge, prevention knowledge and other COVID-19 knowledge, treatment methods and quarantine time. Conclusion: Sex, age, occupation, infections of relatives and friends, regions and scores on COVID-19 knowledge were determinants of discrimination level against recovered COVID-19 patients. In contrast with qualitative studies, our quantitative study recommends targeted education campaigns, focusing on physicians, women, older people and certain occupations. Only the COVID-19 vaccination program for the whole population will resolve the COVID-19 discrimination problem.
C1 [Liu, Rugang; Qian, Dongfu] Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing, Peoples R China.
   [Liu, Rugang; Qian, Dongfu] Nanjing Med Univ, Ctr Global Hlth, Nanjing, Peoples R China.
   [Nicholas, Stephen] Australian Natl Inst Management & Commerce, 1 Cent Ave Australian Technol Pk, Sydney, NSW, Australia.
   [Nicholas, Stephen] Guangdong Univ Foreign Studies, Res Inst Int Strategies, Guangzhou, Peoples R China.
   [Nicholas, Stephen] Tianjin Normal Univ, Sch Econ, Tianjin, Peoples R China.
   [Nicholas, Stephen] Tianjin Normal Univ, Sch Management, Tianjin, Peoples R China.
   [Nicholas, Stephen] Univ Newcastle, Newcastle Business Sch, Univ Dr, Newcastle, NSW, Australia.
   [Leng, Anli] Shandong Univ, Inst Governance, Sch Polit Sci & Publ Adm, Jinan, Peoples R China.
   [Maitland, Elizabeth] Univ Liverpool, Sch Management, Liverpool, Merseyside, England.
   [Wang, Jian] Wuhan Univ, Dong Fureng Econ & Social Dev Sch, 54 Dongsi Lishi Hutong, Beijing 100010, Peoples R China.
   [Wang, Jian] Wuhan Univ, Sch Econ & Management, Ctr Hlth Econ & Management, Wuhan, Peoples R China.
RP Wang, J (corresponding author), Wuhan Univ, Dong Fureng Econ & Social Dev Sch, 54 Dongsi Lishi Hutong, Beijing 100010, Peoples R China.
EM wangjiannan@sdu.edu.cn
RI Maitland, Elizabeth T/O-7703-2018; Leng, Anli/ABG-3086-2021; NICHOLAS,
   STEPHEN/ABE-4726-2021
OI Maitland, Elizabeth T/0000-0003-1551-4787; 
FU Research projects on National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China (NSFC) [71904089]; NHC
   Key Laboratory of Health Economics and Policy Research under [Shandong
   University] [NHC-HEPR2019006]
FX This work was supported by the Research projects on National Natural
   Science Foundation of China under Grant [71904089]; NHC Key Laboratory
   of Health Economics and Policy Research under Grant [Shandong
   University: NHC-HEPR2019006].
CR [Anonymous], 2020, UN NEWS
   Baldassarre A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176341
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Bruns DP, 2020, J TRANSCULT NURS, V31, P326, DOI 10.1177/1043659620917724
   Chopra K K, 2020, Indian J Tuberc, V67, P284, DOI 10.1016/j.ijtb.2020.07.012
   Coronavirus disease, 2020, WORLD HLTH ORG
   Dar Shabir Ahmad, 2019, Indian J Tuberc, V66, P118, DOI 10.1016/j.ijtb.2018.07.002
   Eguchi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076921
   Grover S, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102381
   Grover S, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102147
   Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2
   Lee S, 2005, SOC SCI MED, V61, P2038, DOI 10.1016/j.socscimed.2005.04.010
   Leng AL, 2016, HUM VACC IMMUNOTHER, V12, P1164, DOI 10.1080/21645515.2015.1131883
   Li L, 2007, INT J EPIDEMIOL, V36, P178, DOI 10.1093/ije/dyl256
   Liu H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-192
   Logie CH, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25504
   Nyblade L, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1256-2
   Siddiqui M, 2013, HUM VACC IMMUNOTHER, V9, P2643, DOI 10.4161/hv.27243
   Singh R, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102222
   Singh S, 2020, MENT HEALTH SOC INCL, V24, P145, DOI 10.1108/MHSI-05-2020-0030
   Tehrani H, 2020, GERIATR GERONTOL INT, V20, P796, DOI 10.1111/ggi.13985
   van der Veen YJJ, 2014, J IMMIGR MINOR HEALT, V16, P811, DOI 10.1007/s10903-013-9872-y
   Wang WL, 2009, J NURS RES, V17, P10, DOI 10.1097/JNR.0b013e3181999ca3
   Wu H, 2009, CAN J GASTROENTEROL, V23, P31, DOI 10.1155/2009/608352
   Yadav, 2017, COMMUNITY ACQUIRED I, V4, P6, DOI [10.4103/2225-6482.203265, DOI 10.4103/2225-6482.203265]
   Yang T, 2011, LANCET, V378, P1059, DOI 10.1016/S0140-6736(11)61460-8
   Yu LJ, 2016, HUM VACC IMMUNOTHER, V12, P70, DOI 10.1080/21645515.2015.1069932
NR 27
TC 2
Z9 2
U1 5
U2 9
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD DEC 31
PY 2022
VL 18
IS 1
DI 10.1080/21645515.2021.1913966
EA MAY 2021
PG 9
WC Biotechnology & Applied Microbiology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Immunology
GA ZS0VW
UT WOS:000657946600001
PM 34085898
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Xu, S
   Murrell, G
   Golding, SE
   Brockett, BFT
   Gatersleben, B
   Scarles, C
   White, EV
   Willis, C
   Wyles, KJ
AF Xu, Shi
   Murrell, George
   Golding, Sarah E.
   Brockett, Beth F. T.
   Gatersleben, Birgitta
   Scarles, Caroline
   White, Emma V.
   Willis, Cheryl
   Wyles, Kayleigh J.
TI #Springwatch #WildMorningswithChris: Engaging With Nature via Social
   Media and Wellbeing During the COVID-19 Lockdown
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE COVID-19; natural world; wellbeing; online engagement; Facebook;
   thematic analysis
ID NATURE EXPERIENCE; EXPOSURE; ENVIRONMENTS; BENEFITS; MECHANISMS;
   GREENSPACE; KNOWLEDGE; RECOVERY; CONTACT; STRESS
AB It is widely understood that nature engagement benefits human wellbeing. Such benefits have been found for real as well as virtual engagements. However, little is known about the role of nature-based videos in social media on wellbeing. With COVID-19 restrictions limiting people's direct engagement with natural environments, this study critically examined people's reactions to nature videos posted on Facebook during the first UK COVID-19 lockdown in 2020. Data consisted of comments on videos containing highlights from the British Broadcasting Corporation's (BBC) Springwatch 2020 television series, and from a UK television presenter and naturalist's (Chris Packham) livestream videos, posted on Facebook from March to July, 2020. Looking at the quantitative profile of a range of videos (i.e. views, likes and shares) and a detailed analysis of the 143,265 comments using thematic analysis, three major themes were generated as: (1) engaging with nature via social media is emotionally complicated, (2) cognitive and reflective reactions are generated from social media nature engagement and (3) engagement with nature-based social media as a mechanism for coping with stress during COVID-19. These findings inform understanding of how nature-related social media content and associated commentary have supported wellbeing throughout the ongoing pandemic and their importance as a means of continued support for wellbeing.
   'We feel that the injection of wildlife into people's homes, particularly at this point, would be really valuable and uplifting'.
   - Chris Packham, 2020
C1 [Xu, Shi; Golding, Sarah E.; Scarles, Caroline] Univ Surrey, Sch Hospitality & Tourism Management, Guildford, Surrey, England.
   [Murrell, George; Gatersleben, Birgitta; White, Emma V.; Wyles, Kayleigh J.] Univ Surrey, Sch Psychol, Guildford, Surrey, England.
   [Brockett, Beth F. T.; Willis, Cheryl] Nat England, Sheffield, S Yorkshire, England.
   [Wyles, Kayleigh J.] Univ Plymouth, Sch Psychol, Plymouth, Devon, England.
RP Xu, S (corresponding author), Univ Surrey, Sch Hospitality & Tourism Management, Guildford, Surrey, England.
EM s.xu@surrey.ac.uk
FU ESRC (Economic and Social Research Council) UKRI (UK Research and
   Innovation) COVID-19 fund [ES/V005464/1]
FX This research was funded by the ESRC (Economic and Social Research
   Council) UKRI (UK Research and Innovation) COVID-19 fund to help support
   the UK Government Green Recovery Strategy from the global COVID-19
   pandemic (code: ES/V005464/1).
CR Ambrey C, 2014, URBAN STUD, V51, P1290, DOI 10.1177/0042098013494417
   Andrews M, 2010, J ENVIRON PSYCHOL, V30, P473, DOI 10.1016/j.jenvp.2010.04.001
   [Anonymous], 2020, BBC SPRINGWATCH
   Berman MG, 2012, J AFFECT DISORDERS, V140, P300, DOI 10.1016/j.jad.2012.03.012
   Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001
   Bhullar N, 2013, J PSYCHOL, V147, P1, DOI 10.1080/00223980.2012.667016
   Bixler R. D., 1999, J ENVIRON EDUC, V30, P4, DOI [DOI 10.1080/00958969909601871, 10.1080/00958969909601871]
   Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456
   Bratman GN, 2015, LANDSCAPE URBAN PLAN, V138, P41, DOI 10.1016/j.landurbplan.2015.02.005
   Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Brown L. M., 1989, ENTERING CIRCLE HERM, P141
   Browning MHEM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02200
   Browning MHEM, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02667
   Cleary A, 2017, LANDSCAPE URBAN PLAN, V158, P119, DOI 10.1016/j.landurbplan.2016.10.003
   Dijkstra MTM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01415
   Dillon, 2016, NATURAL ENGLAND COMM, V208
   Disabato DJ, 2016, PSYCHOL ASSESSMENT, V28, P471, DOI 10.1037/pas0000209
   Dolan R, 2019, EUR J MARKETING, V53, P2213, DOI 10.1108/EJM-03-2017-0182
   GOV.UK, 2020, STAYING HOM AW OTH S
   Grinde B, 2009, INT J ENV RES PUB HE, V6, P2332, DOI 10.3390/ijerph6092332
   Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355
   Hausmann A, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12343
   Holden L. J., 2014, ECOPSYCHOLOGY, V6, P234, DOI DOI 10.1089/ECO.2014.0034
   Huang GH, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104135
   Hunter MR, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00722
   Huta V, 2014, J HAPPINESS STUD, V15, P1425, DOI 10.1007/s10902-013-9485-0
   Jarrahi MH, 2013, J ORG COMP ELECT COM, V23, P110, DOI 10.1080/10919392.2013.748613
   Jiang B, 2016, ENVIRON BEHAV, V48, P607, DOI 10.1177/0013916514552321
   KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2
   Kjellgren A, 2010, J ENVIRON PSYCHOL, V30, P464, DOI 10.1016/j.jenvp.2010.01.011
   Knobloch U, 2017, J TRAVEL RES, V56, P651, DOI 10.1177/0047287516650937
   Labib S.M., 2021, NATURES CONTRIBUTION, DOI [10.32942/osf.io/j2pa8, DOI 10.32942/OSF.IO/J2PA8]
   MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010
   McMahan EA, 2015, J POSIT PSYCHOL, V10, P507, DOI 10.1080/17439760.2014.994224
   Montero-Odasso Manuel, 2020, Can Geriatr J, V23, P149, DOI 10.5770/cgj.23.443
   Natural England, 2020, PEOPL NAT SURV DAT A
   Natural England, 2020, PEOPL NAT SURV ENGL
   Neill C, 2019, J POSIT PSYCHOL, V14, P756, DOI 10.1080/17439760.2018.1557242
   Newman DB, 2014, J HAPPINESS STUD, V15, P555, DOI 10.1007/s10902-013-9435-x
   O'Brien L, 2011, PERSPECT PUBLIC HEAL, V131, P71, DOI 10.1177/1757913910384048
   Packham C., 2020, WILDMORNINGSWITHCHRI
   Polit DF, 2010, INT J NURS STUD, V47, P1451, DOI 10.1016/j.ijnurstu.2010.06.004
   Rieger D, 2014, J COMMUN, V64, P456, DOI 10.1111/jcom.12097
   Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141
   Ryff CD, 2008, J HAPPINESS STUD, V9, P13, DOI 10.1007/s10902-006-9019-0
   Scarles C., 2020, e-Review of Tourism Research, V17, P706
   Schertz KE, 2018, COGNITION, V174, P82, DOI 10.1016/j.cognition.2018.01.011
   Schlosser AE, 2020, CURR OPIN PSYCHOL, V31, P1, DOI 10.1016/j.copsyc.2019.06.025
   Schwartz RS, 2002, J RES SCI TEACH, V39, P205, DOI 10.1002/tea.10021
   Tankovska P.B., 2021, FACEBOOK MAU WORLDWI
   The Health Foundation, 2021, COVID 19 POL TRACK 2
   Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121
   Twohig-Bennett C, 2018, ENVIRON RES, V166, P628, DOI 10.1016/j.envres.2018.06.030
   ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7
   Van Aart CJC, 2018, ENVIRON INT, V120, P456, DOI 10.1016/j.envint.2018.08.028
   von Lindern E, 2017, J ENVIRON PSYCHOL, V49, P8, DOI 10.1016/j.jenvp.2016.11.004
   Weinstein N, 2009, PERS SOC PSYCHOL B, V35, P1315, DOI 10.1177/0146167209341649
   White MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44097-3
   White MP, 2017, HEALTH PLACE, V45, P77, DOI 10.1016/j.healthplace.2017.03.008
   Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976
   Wu YL, 2018, OCEAN COAST MANAGE, V153, P76, DOI 10.1016/j.ocecoaman.2017.12.010
   Yeo NL, 2020, J ENVIRON PSYCHOL, V72, DOI 10.1016/j.jenvp.2020.101500
NR 63
TC 1
Z9 1
U1 7
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD OCT 13
PY 2021
VL 12
AR 701769
DI 10.3389/fpsyg.2021.701769
PG 13
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA WP9HW
UT WOS:000713436900001
PM 34721149
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Leasa, D
   Cameron, P
   Honarmand, K
   Mele, T
   Bosma, KJ
AF Leasa, David
   Cameron, Paul
   Honarmand, Kimia
   Mele, Tina
   Bosma, Karen J.
CA LHSC Ventilation Strategy COVID-19
TI Knowledge translation tools to guide care of non-intubated patients with
   acute respiratory illness during the COVID-19 Pandemic
SO CRITICAL CARE
LA English
DT Review
DE COVID-19; Non-invasive ventilation; High flow nasal oxygen; Prone
   positioning; ROX index
ID EXHALED AIR DISPERSION; NONINVASIVE VENTILATION; LUNG INJURY;
   MANAGEMENT; OXYGEN
AB Providing optimal care to patients with acute respiratory illness while preventing hospital transmission of COVID-19 is of paramount importance during the pandemic; the challenge lies in achieving both goals simultaneously. Controversy exists regarding the role of early intubation versus use of non-invasive respiratory support measures to avoid intubation. This review summarizes available evidence and provides a clinical decision algorithm with risk mitigation techniques to guide clinicians in care of the hypoxemic, non-intubated, patient during the COVID-19 pandemic. Although aerosolization of droplets may occur with aerosol-generating medical procedures (AGMP), including high flow nasal oxygen and non-invasive ventilation, the risk of using these AGMP is outweighed by the benefit in carefully selected patients, particularly if care is taken to mitigate risk of viral transmission. Non-invasive support measures should not be denied for conditions where previously proven effective and may be used even while there is suspicion of COVID-19 infection. Patients with de novo acute respiratory illness with suspected/confirmed COVID-19 may also benefit. These techniques may improve oxygenation sufficiently to allow some patients to avoid intubation; however, patients must be carefully monitored for signs of increased work of breathing. Patients showing signs of clinical deterioration or high work of breathing not alleviated by non-invasive support should proceed promptly to intubation and invasive lung protective ventilation strategy. With adherence to these principles, risk of viral spread can be minimized.
C1 [Leasa, David; Cameron, Paul; Honarmand, Kimia; Mele, Tina; Bosma, Karen J.] London Hlth Sci Ctr, 339 Windermere Rd, London, ON N6A 5A5, Canada.
   [Leasa, David; Cameron, Paul; Honarmand, Kimia; Mele, Tina; Bosma, Karen J.] Western Univ, 1151 Richmond St, London, ON N6A 3K7, Canada.
RP Bosma, KJ (corresponding author), London Hlth Sci Ctr, 339 Windermere Rd, London, ON N6A 5A5, Canada.; Bosma, KJ (corresponding author), Western Univ, 1151 Richmond St, London, ON N6A 3K7, Canada.
EM KarenJ.Bosma@lhsc.on.ca
OI Bosma, Karen/0000-0003-0423-7286
CR Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   [Anonymous], 2020, COR RES CTR
   [Anonymous], NEWS C
   Bellani G, 2017, AM J RESP CRIT CARE, V195, P67, DOI 10.1164/rccm.201606-1306OC
   Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP
   Brown Calvin A 3rd, 2020, J Am Coll Emerg Physicians Open, DOI 10.1002/emp2.12063
   Caputo ND, 2020, ACAD EMERG MED, V27, P375, DOI 10.1111/acem.13994
   CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4
   CEBM, 2020, COVID 19 MAN HEATHC
   Coppo A, 2020, LANCET RESP MED, V8, P765, DOI 10.1016/S2213-2600(20)30268-X
   Denault AY, 2020, CAN J ANESTH, V67, P1393, DOI 10.1007/s12630-020-01704-6
   Ding L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2738-5
   Elharrar X, 2020, JAMA-J AM MED ASSOC, V323, P2336, DOI 10.1001/jama.2020.8255
   England PH, REC PPE HEALTHC WORK
   Esquinas AM, 2012, PRACTICE HUMIDIFICAT, P93
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Ferioli M, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0068-2020
   Ferrando C, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03314-6
   Ferreyro BL, 2020, JAMA-J AM MED ASSOC, V324, P57, DOI 10.1001/jama.2020.9524
   Fowler RHT, 2020, J BROOKS BEHALF COVI
   Franco C, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02130-2020
   Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326
   FREEDMAN S, 1983, THORAX, V38, P50, DOI 10.1136/thx.38.1.50
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Hui DS, 2007, CHEST, V132, P540, DOI 10.1378/chest.07-0636
   Hui DS, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02339-2018
   Hui DS, 2015, CHEST, V147, P1336, DOI 10.1378/chest.14-1934
   Hui DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050845
   Hui DS, 2009, CHEST, V136, P998, DOI 10.1378/chest.09-0434
   Leonard S, 2020, CHEST, V158, P1046, DOI 10.1016/j.chest.2020.03.043
   Li Y, 2020, AM J ROENTGENOL, V214, P1280, DOI 10.2214/AJR.20.22954
   Lockhart SL, 2020, CAN J ANESTH, V67, P1005, DOI 10.1007/s12630-020-01673-w
   Luo MQ, 2020, ANESTHESIOLOGY, V132, P1616, DOI 10.1097/ALN.0000000000003288
   Mission W.-C. J., 2020, REPORT WHO CHINA JOI
   Munshi L, 2017, ANN AM THORAC SOC, V14, pS280, DOI 10.1513/AnnalsATS.201704-343OT
   Ng Z, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01198-2020
   Nurses ICo, 2020, HIGH PROP HEALTHC WO
   Patel BK, 2016, JAMA-J AM MED ASSOC, V315, P2435, DOI 10.1001/jama.2016.6338
   Philips, ADDRESSING USE NIV V
   Pool OVE, MODIFY BREATHING CIR
   Poston JT, 2020, JAMA-J AM MED ASSOC, V323, P1839, DOI 10.1001/jama.2020.4914
   ResMed, RESMED VENT COVID 19
   Roca O, 2019, AM J RESP CRIT CARE, V199, P1368, DOI 10.1164/rccm.201803-0589OC
   Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016
   Sartini C, 2020, JAMA-J AM MED ASSOC, V323, P2338, DOI 10.1001/jama.2020.7861
   Scala R, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03087-y
   Sehlin M, 2011, RESP CARE, V56, P818, DOI 10.4187/respcare.01015
   Seto WH, 2015, J HOSP INFECT, V89, P225, DOI 10.1016/j.jhin.2014.11.005
   Slessarev M, 2020, CAN J ANESTH, V67, P1288, DOI 10.1007/s12630-020-01661-0
   Sorbello M, 2020, ANESTH ANALG, V131, pE128, DOI 10.1213/ANE.0000000000004970
   Spijker EE, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-8
   SWLHIN, 2020, GEOGR COMM
   Telias I, 2020, JAMA-J AM MED ASSOC, V323, P2265, DOI 10.1001/jama.2020.8539
   Thomas P, 2020, J PHYSIOTHER, V66, P73, DOI 10.1016/j.jphys.2020.03.011
   Tobin MJ, 2020, AM J RESP CRIT CARE, V201, P1319, DOI 10.1164/rccm.202004-1076ED
   Tonelli R, 2020, AM J RESP CRIT CARE, V202, P558, DOI 10.1164/rccm.201912-2512OC
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Villarreal-Fernandez E, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03063-6
   Yoshida T, 2012, CRIT CARE MED, V40, P1578, DOI 10.1097/CCM.0b013e3182451c40
   Zuo Mingzhang, 2020, Chinese Medical Sciences Journal, V35, P105, DOI 10.24920/003724
NR 61
TC 8
Z9 8
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1364-8535
EI 1466-609X
J9 CRIT CARE
JI Crit. Care
PD JAN 8
PY 2021
VL 25
IS 1
AR 22
DI 10.1186/s13054-020-03415-2
PG 12
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PQ1FD
UT WOS:000606293800001
PM 33419456
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ishiwatari, M
   Koike, T
   Hiroki, K
   Toda, T
   Katsube, T
AF Ishiwatari, Mikio
   Koike, Toshio
   Hiroki, Kenzo
   Toda, Takao
   Katsube, Tsukasa
TI Managing disasters amid COVID-19 pandemic: Approaches of response to
   flood disasters
SO PROGRESS IN DISASTER SCIENCE
LA English
DT Article
DE COVID-19; Flood response; Human security
AB The world faces difficulties managing disasters while making efforts to slowing the spread of COVID-19. The paper aims at proposing policies and approaches to manage dual disasters of flooding and COVID-19. It reviews on-going efforts of organizations in the humanitarian assistance, water and sanitation, disaster management and health sectors. Based on review works the policy was recommended. The objective of the policy is to protect human life, in particular, vulnerable groups, from the human security perspective. Local organizations and communities play an important role in disaster management, and risk information supported by scientific knowledge is essential. As the experience of disaster management shows, various organizations including health and water should be coordinated to conduct measures.
C1 [Ishiwatari, Mikio] Univ Tokyo, Tokyo, Japan.
   [Koike, Toshio] Int Ctr Water Hazard & Risk Management, Tsukuba, Ibaraki, Japan.
   [Hiroki, Kenzo] Natl Grad Inst Policy Studies, Tokyo, Japan.
   [Toda, Takao; Katsube, Tsukasa] Japan Int Cooperat Agcy, Tokyo, Japan.
RP Ishiwatari, M (corresponding author), Univ Tokyo, Tokyo, Japan.
EM ishiwatari.mikio@jica.go.jp
OI Ishiwatari, Mikio/0000-0002-5606-5036
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19KK0025]
FX This work was supported by JSPS KAKENHI Grant Numbers 19KK0025.
CR [Anonymous], 2015, AUST J EMERG MANAG, V30, P9
   Blaikie P., 2014, RISK NATURAL HAZARDS
   Brassington, 2020, INFECT DIS NEW MILLE
   Cabinet Office, 2020, DAM 2019 TYPH 19
   Cho HB., 2020, COVID 19 INTERKOREAN
   Das S, 2020, LESSONS HAGIBIS LEAR
   Djalante R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100080
   GlobalWater Operators'' Partnerships Alliance, 2020, WHAT WAT SAN OP CAN
   High-level Experts and Leaders Panel on Water and Disasters (HELP), 2020, PRINC ADDR WAT REL D
   High-level Experts and Leaders Panel on Water and Disasters (HELP), 2019, PRINC INV FIN WAT RE
   Inter Sector Coordination Group, 2020, CYCL EM PREP UPD
   Inter-Agency Standing Committee, 2020, COVID 19 OUTBR READ
   International Federation of Red Cross and Red Crescent Societies (IFRC), 2020, VAN TROP CYCL HAR EM
   Ishiwatari M., 2014, DISASTER RISK MANAGE
   Ishiwatari M., 2016, JPN SOC INNOV J, V6, P15, DOI [10.12668/jsij.6.15, DOI 10.12668/JSIJ.6.15]
   Ishiwatari M, 2012, COMM ENV DISAST RISK, V10, P19, DOI 10.1108/S2040-7262(2012)0000010008
   Jacobsen KH, 2020, LANCET, V395, P1013, DOI 10.1016/S0140-6736(20)30559-6
   Jha AK, 2012, CITIES AND FLOODING: A GUIDE TO INTEGRATED URBAN FLOOD RISK MANAGEMENT FOR THE 21ST CENTURY, P1, DOI 10.1596/978-0-8213-8866-2
   Kamogawa City, 2020, COUNT COVID 19 AM EV
   Lautensach S, 2020, J HUM SECUR, V16, P1
   Lo STT, 2017, INT J DISAST RISK SC, V8, P145, DOI 10.1007/s13753-017-0122-0
   Manitoba Province, 2020, HIGH WAT RESP ACT CO
   Nagano Council of Social Welfare, 2020, SUSP VOL CTR DIS MAN
   National Council of Social Welfare, 2020, NUMB VOL
   Ottawa City, 2020, FLOOD PREP AR WELL U
   Pacific Humanitarian Team, TROP CYCL HAR SIT RE
   Ram MH, 2005, J INT DEV STUDIES, V14, P63
   Reynolds B, 2012, CRIS EM RISK COMM
   Sakurai S, 2014, BASIC KNOWLEDGE INFE
   Sphere, 2020, APPL HUM STAND FLIGH
   Sphere Association, 2018, SPHER HDB HUM CHART
   UN-Habitat, 2020, UN HAB COV 19 KEY ME
   UNDRR, 2020, LEAV NO ON COVID 19
   United Nations Office for the Coordination of Humanitarian Affairs (OCHA), 2020, GLOBAL HUMANITARIAN
   WHO, 2019, HLTH EM DIS RISK MAN
   WHO, 2020, WATER SANITATION HYG
   Yang PH, 2020, CELL MOL IMMUNOL, V17, P555, DOI 10.1038/s41423-020-0407-x
NR 37
TC 33
Z9 33
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2590-0617
J9 PROG DISASTER SCI
JI Prog. Disaster Sci.
PD APR
PY 2020
VL 6
AR 100096
DI 10.1016/j.pdisas.2020.100096
PG 4
WC Environmental Sciences; Environmental Studies; Geosciences,
   Multidisciplinary; Public, Environmental & Occupational Health;
   Meteorology & Atmospheric Sciences
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology; Geology; Public, Environmental &
   Occupational Health; Meteorology & Atmospheric Sciences
GA VK7JG
UT WOS:000748948200018
PM 34171012
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Chen, C
   Hayward, K
   Khan, SJ
   Ormeci, B
   Pillay, S
   Rose, JB
   Thanikal, JV
   Zhang, T
AF Chen, Chao
   Hayward, Keith
   Khan, Stuart J.
   Ormeci, Banu
   Pillay, Sudhir
   Rose, Joan B.
   Thanikal, Joseph, V
   Zhang, Tong
TI Role of wastewater treatment in COVID-19 control
SO WATER QUALITY RESEARCH JOURNAL
LA English
DT Article
DE COVID-19; SARS-CoV-2; sludge; wastewater
AB The International Water Association (IWA) initiated a Task Force in April 2020 to serve as a leadership team within IWA whose role is to keep abreast and communicate the emerging science, technology, and applications for understanding the impact and the ability to respond to the COVID-19 pandemic and specifically designed for water professionals and industries. Expertise was nominated across the world with the purpose of collectively providing the water sector with knowledge products for the guidance on the control of COVID-19 and other viruses. This review paper developed by a working group of the IWA Task Force focuses on the control of COVID-19. The purpose of this review paper is to provide an understanding of existing knowledge with regards to COVID-19 and provide the necessary guidance of risk mitigation based on currently available knowledge of viruses in wastewater. This review paper considered various scenarios for both the developed world and the developing world and provided recommendations for managing risk. The review paper serves to pool the knowledge with regards to the pandemic and in relation to other viruses. The IWA Task Team envisage that this review paper provides the necessary guidance to the global response to the ongoing pandemic.
C1 [Chen, Chao] Tsinghua Univ, Sch Environm, Div Drinking Water Safety, Beijing 100084, Peoples R China.
   [Hayward, Keith] Int Water Assoc, Units 1-04 & 1-05 Export Bldg,1 Clove Crescent, London E14 2BA, England.
   [Khan, Stuart J.] Univ New South Wales, Sch Civil & Environm Engn, Sydney, NSW 2052, Australia.
   [Ormeci, Banu] Carleton Univ, Dept Civil & Environm Engn, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.
   [Pillay, Sudhir] Water Res Commiss Water Use & Waste Management, Pretoria, South Africa.
   [Rose, Joan B.] Michigan State Univ, E Lansing, MI 48824 USA.
   [Thanikal, Joseph, V] Amity Univ, RICS Sch Construct, Noida, India.
   [Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Pokfulam, Hong Kong, Peoples R China.
RP Pillay, S (corresponding author), Water Res Commiss Water Use & Waste Management, Pretoria, South Africa.
EM sudhirp@wrc.org.za
RI Khan, Stuart J/E-7523-2012
OI Khan, Stuart J/0000-0001-5147-145X; Zhang, Tong/0000-0003-1148-4322
CR Adham SS, 1998, J AM WATER WORKS ASS, V90, P130
   Ahmed W, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138764
   [Anonymous], ENVIRON ENG SCI, DOI DOI 10.1089/109287502320963436
   Aragon CA, 2011, WATER PRACT TECHNOL, V6, DOI 10.2166/wpt.2011.030
   Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x
   Brackney DE, 2020, SARS COV 2 RNA CONCE, DOI [10.1101/2020.05.19.20105999, DOI 10.1101/2020.05.19.20105999]
   Brdanovic D, 2014, FAECAL SLUDGE MANAGE, DOI [10.2166/9781780404738, DOI 10.2166/9781780404738]
   Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198
   Chen C, 2020, ANN INTERN MED, V172, P832, DOI 10.7326/M20-0991
   Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065
   Douki T, 2013, PHOTOCH PHOTOBIO SCI, V12, P1286, DOI 10.1039/c3pp25451h
   Dowd SE, 1998, APPL ENVIRON MICROB, V64, P405
   Eales K, 2008, IRC S SAN URB POOR P
   Francy DS, 2012, WATER RES, V46, P4164, DOI 10.1016/j.watres.2012.04.044
   Goh GKM, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020331
   GORNER H, 1994, J PHOTOCH PHOTOBIO B, V26, P117, DOI 10.1016/1011-1344(94)07068-7
   Gundy PM, 2009, FOOD ENVIRON VIROL, V1, P10, DOI 10.1007/s12560-008-9001-6
   Hewitt J, 2011, WATER RES, V45, P6267, DOI 10.1016/j.watres.2011.09.029
   Heymans C, 2013, POOR INCLUSIVE URBAN
   Jacangelo JG, 2005, WA SCI TECHNOL, V5, P109, DOI 10.2166/ws.2005.0045
   John DE, 2005, ENVIRON SCI TECHNOL, V39, P7345, DOI 10.1021/es047995w
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Katayama H, 2008, WATER RES, V42, P1441, DOI 10.1016/j.watres.2007.10.029
   Kitajima M, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.139076
   Kitajima M, 2014, SCI TOTAL ENVIRON, V488, P290, DOI 10.1016/j.scitotenv.2014.04.087
   Kocamemi B.A., 2020, MEDRXIV
   Kone D, 2012, BUSINESS ANAL FECAL
   Kushmaro A., 2020, REGRESSING SARS COV, DOI 10.1101/2020.04.26.20073569
   La Rosa G., 2020, SCI TOTAL ENVIRON, V736, DOI [10.1016/j.scitotenv.2020, DOI 10.1016/j.scitotenv.2020.139652]
   La Rosa G, 2020, WATER RES, V179, DOI 10.1016/j.watres.2020.115899
   Lema J.M., 2020, FATE SARS COV 2 WAST
   Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   MADAENI SS, 1995, J MEMBRANE SCI, V102, P65, DOI 10.1016/0376-7388(94)00252-T
   Medema G, 2020, ENVIRON SCI TECH LET, V7, P511, DOI 10.1021/acs.estlett.0c00357
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   National Research Council (NRC), WAT REUS POT EXP NAT, DOI [10.17226/13303, DOI 10.17226/13303]
   Nemudryi Artem, 2020, medRxiv, DOI [10.1016/j.xcrm.2020.100098, 10.1101/2020.04.15.20066746]
   Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020
   Owens JH, 2000, OZONE-SCI ENG, V22, P501, DOI 10.1080/01919510009408793
   Pinon A, 2018, INTERVIROLOGY, V61, P214, DOI 10.1159/000484899
   PRAKASH TM, 1982, J GEN APPL MICROBIOL, V28, P245, DOI 10.2323/jgam.28.245
   Pype ML, 2016, WATER RES, V98, P384, DOI 10.1016/j.watres.2016.04.040
   Qiao Z, 2018, ENVIRON SCI TECHNOL, V52, P10408, DOI 10.1021/acs.est.8b02308
   Qiu Y, 2015, J APPL MICROBIOL, V119, P1729, DOI 10.1111/jam.12971
   Randazzo W, 2020, INT J HYG ENVIR HEAL, V230, DOI 10.1016/j.ijheh.2020.113621
   Rimoldi SG, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.140911
   ROY D, 1982, J AM WATER WORKS ASS, V74, P660
   SANTARPIA JL, 2020, AEROSOL SURFACE TRAN, DOI [10.1101/2020.03.23.20039446, DOI 10.1101/2020.03.23.20039446]
   Simmons FJ, 2011, WATER RES, V45, P2739, DOI 10.1016/j.watres.2011.02.001
   SOBSEY MD, 1988, WATER SCI TECHNOL, V20, P385, DOI 10.2166/wst.1988.0310
   Stefan M. I, 2017, ADV OXIDATION PROCES, P581
   STRAUSS JH, 1963, J MOL BIOL, V7, P43, DOI 10.1016/S0022-2836(63)80017-0
   Sun J, 2020, EMERG MICROBES INFEC, V9, P991, DOI 10.1080/22221751.2020.1760144
   Tang A, 2020, EMERG INFECT DIS, V26, P1337, DOI 10.3201/eid2606.200301
   Tree JA, 2003, APPL ENVIRON MICROB, V69, P2038, DOI 10.1128/AEM.69.4.2038-2043.2003
   U. S. Environmental Protection Agency, 2006, 815R06007 US EPA
   United Nations (U.N.) Water, 2015, WASTEWATER MANAGEMEN, P1
   United States Environmental Protection Agency (US EPA), 2003, EPA816R03004 US EPA
   US EPA, 1999, 815R99013 US EPA, P1
   VAUGHN JM, 1987, APPL ENVIRON MICROB, V53, P2218, DOI 10.1128/AEM.53.9.2218-2221.1987
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Wang XR, 2020, INT J INFECT DIS, V95, P433, DOI 10.1016/j.ijid.2020.04.063
   Wang XW, 2005, J VIROL METHODS, V126, P171, DOI 10.1016/j.jviromet.2005.02.005
   Watanabe T, 2010, RISK ANAL, V30, P1129, DOI 10.1111/j.1539-6924.2010.01427.x
   WHO, 2020, WATER SANITATION HYG
   WHO, 2011, GUID DRINK WAT QUAL, V1
   WHO, 2017, POT REUS GUID PROD S
   WHO, 2020, Q A COR COVID 19
   Wigginton KR, 2015, ENVIRON SCI-WAT RES, V1, P735, DOI [10.1039/c5ew00125k, 10.1039/C5EW00125K]
   Wu Fuqing, 2020, mSystems, V5, DOI 10.1128/mSystems.00614-20
   Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2
   Wurtzer S, 2020, EUROSURVEILLANCE, V25, P38, DOI 10.2807/1560-7917.ES.2020.25.50.2000776
   Xiao F, 2020, EMERG INFECT DIS, V26, P1920, DOI 10.3201/eid2608.200681
   Ye YY, 2018, ENVIRON SCI TECHNOL, V52, P7698, DOI 10.1021/acs.est.8b00824
   Ye YY, 2016, ENVIRON SCI TECHNOL, V50, P5077, DOI 10.1021/acs.est.6b00876
   Zhang CM, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2018-3
   Zhang DY, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140445
   Zheng X, 2006, WA SCI TECHNOL, V6, P51, DOI 10.2166/ws.2006.957
   Zhou JH, 2015, WORLD J MICROB BIOT, V31, P109, DOI 10.1007/s11274-014-1770-5
NR 80
TC 8
Z9 8
U1 9
U2 13
PU IWA PUBLISHING
PI LONDON
PA REPUBLIC-EXPORT BLDG, UNITS 1 04 & 1 05, 1 CLOVE CRESCENT, LONDON,
   ENGLAND
SN 2709-8044
EI 2709-8052
J9 WATER QUAL RES J
JI Water Qual. Res. J.
PD MAY
PY 2021
VL 56
IS 2
BP 68
EP 82
DI 10.2166/wqrj.2020.025
PG 15
WC Water Resources
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Water Resources
GA SM8ER
UT WOS:000657832300003
OA hybrid
DA 2022-04-20
ER

PT J
AU Tatalovic, S
   Malnar, D
AF Tatalovic, Sinisa
   Malnar, Dario
TI THE COVID-19 PANDEMIC AND A NEW UNDERSTANDING OF SECURITY
SO POLITICKA MISAO-CROATIAN POLITICAL SCIENCE REVIEW
LA Croatian
DT Article
DE COVID-19 Pandemic; Security; Security Policies; Security Studies; Crisis
   Management
AB The outbreak of the COVID-19 pandemic in early 2020 led to an unprecedented crisis of global proportions that led to the blockade of vital components of social action on a scale that threatened international and national security. The pandemic has demonstrated the potential to evolve and generate a wider range of threats and has opened up essential questions of understanding the security and security organization of states. It is a threat to which, although recognized in most strategic security documents, the response of national and international security systems has not been successfully defined within the still dominant understanding of security based on traditional security studies. It has been shown that security systems are still determined by a traditional concept that does not fully identify the causes of threats and crises and their correlations, which increases uncertainty and negatively affects the normative and institutional capacity needed to respond effectively to crises. The paper is based on the hypothesis that the COVID-19 pandemic has prompted a security paradigm shift that challenges the scientific community and policy-makers to define new approaches and new methods of researching security phenomena and strategic modelling of security systems and crisis management nationally and globally. The paper will therefore analyse the impact of the crisis triggered by the COVID-19 pandemic on understanding security through an analysis of the threats it has generated and defining the correlation between theoretical knowledge and practical crisis management experiences.
C1 [Tatalovic, Sinisa] Sveuciliste Zagrebu, Fak Politickih Znanosti, Lepusiceva 6, Zagreb 10000, Croatia.
   [Malnar, Dario] Hrvatsko Vojno Uciliste Dr Franjo Tudman, Ilica 256b, Zagreb 10000, Croatia.
RP Tatalovic, S (corresponding author), Sveuciliste Zagrebu, Fak Politickih Znanosti, Lepusiceva 6, Zagreb 10000, Croatia.
EM statal@fpzg.hr; malnar.zg@gmail.com
CR Ajzenhamer V., 2021, POSEBNO IZDANJE, V59, P55
   [Anonymous], 2020, HILL
   Borrell Fontelles J., 2021, EUROPEAN FOREIGN POL
   Bozic S, 2021, SOCIOL PROST, V59, P13
   Burki T, 2020, LANCET INFECT DIS, V20, P1240, DOI 10.1016/S1473-3099(20)30800-8
   Central Committee of the Communist Party of China, 2016, 13 5 YEAR PLAN EC SO
   Department of Homeland Security, 2020, HOM THREAT ASS
   Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557
   Drzavni zbor, 2019, URADNI LIST RS
   European Commission, 2020, 2020 STRAT FOR REP C
   European External Action Service, 2020, EEAS SPEC REP UPD SH
   Europol, 2020, PAND PROF CRIM EXPL
   Europol, INT ORG CRIM THREAT
   Federal Reserve History, 2013, GREAT REC DEC 2007 J
   Gardini G. L., 2020, WORLD COVID 19 INTEL
   Hrvatski sabor, 2017, NAR NOV 73 2017
   Institute for Economics & Peace, 2019, GLOBAL TERRORISM IND
   International Monetary Fund, 2021, POL RESP COVID 19
   Kam E., 2004, SURPRISE ATTACK VICT
   Kolodziej E. A., 2011, SIGURNOST MEDUNARODN
   Kurlantzick J., 2020, COUNCIL FOREIGN RELA
   Kurlantzick J., 2021, COVID 19 ITS EFFECT
   Library of Congress, 2020, HUNG NAT ASS AD ACT
   Ministry of Foreign Affairs of Hungary, 2012, HUNG NAT SEC STRAT
   Narodna skupstina Republike Srbije, 2019, STRAT NAC BEZB REP S
   Our World Data, 2020, COR PAND COVID 19 ST
   PewResearch Center, 2020, MAN COUNTR PEOPL AR
   Predsjednik Republike Srbije, 2020, OBR PREDS REP SRBIJ
   President of the Russian Federation, 2015, ED RUSS FED PRES RUS
   President of the United States, 2017, NATL SECURITY STRATE
   Slipowitz, 2020, DEMOCRACY LOCKDOWN I
   Tatalovic S., 2015, POLITICKE ANALIZE, V23, P23
   The Ministry of Defence Republica Italiana, 2015, WHIT PAP INT SEC DEF
   Turkcan M. L., 2020, 2352020 AA
   Vasilj I., 2020, ZDRAVSTVENI GLASNIK, V6, P9
   Vijece ministara Bosne i Hercegovine, 2020, PRIOPCENJE AUDIO ZAP
   Vlada Republike Slovenije, PREKL EP NEK UC DIJ
   Vlada Republike Slovenije, NOVICE
   Wolfers, 1962, DISCORD COLLABORATIO
   World Health Organization, SHORT PERS PROT EQ E
   World Health Organization, 2020, ARCH WHO TIM COVID 1
   Worldometer, 2021, COUNTR COVID 19 HAS
   Zorko M., 2021, SOCIOLOGIJA PROSTOR, V59, P89
NR 43
TC 0
Z9 0
U1 1
U2 1
PU SVEUCILISTE & ZAGREBU, FAK POLITICKIH ZNANOSTI
PI ZAGREB
PA LEPUSICEVA 6, ZAGREB, 10000, CROATIA
SN 0032-3241
EI 1846-8721
J9 POLIT MISAO
JI Polit. Misao
PD SEP
PY 2021
VL 58
IS 3
BP 132
EP 156
DI 10.20901/pm.58.3.05
PG 25
WC Political Science
WE Emerging Sources Citation Index (ESCI)
SC Government & Law
GA UY8YC
UT WOS:000701801800002
OA gold
DA 2022-04-20
ER

PT J
AU Li, H
   Li, JM
   Xiao, W
   Zhang, YJ
   Lv, Y
   Yu, X
   Zheng, J
AF Li, Hao
   Li, Jianmin
   Xiao, Wei
   Zhang, Yujing
   Lv, Yuan
   Yu, Xing
   Zheng, Jiao
TI The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic
   Cholangiocarcinoma Patients and Those Compromised With COVID-19
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Article
DE Gal-3; COVID-19; ICC; cancer; therapy
ID EXPRESSION; ACTIVATION; BIOMARKERS; MANAGEMENT; CLEARANCE; MICROGLIA;
   PHENOTYPE; DIAGNOSIS
AB The novel coronavirus pneumonia COVID-19 is characterized by all age susceptibility, which imposes a dramatic threat to the human species all over the world. According to current available data, the cytokine storm appears to be the most life-threatening symptom of severe COVID-19 cases accompanied with lung fibrosis. Galectin-3 (Gal-3), a member of soluble beta-galactoside-binding lectin families, has been implicated as a key regulator in various inflammation conditions in addition to its well-documented roles in cancer. The pro-inflammatory activity of Gal-3 in the inflammatory response and lung fibrosis of COVID-19 has been proposed by emerging studies, which suggested that inhibition of Gal-3 may represent a novel treatment approach for COVID-19 patients. Intrahepatic cholangiocarcinoma (ICC) is an aggressive malignancy with poor prognosis. ICC accounts for 10-25% of primary liver cancers with limited therapeutic options, which has higher incidence in Asian countries, particularly in China. Cancer patients, including ICC patients, are highly vulnerable to COVID-19 due to their impaired immune system. It is thus undoubtedly a challenge for our oncology department to establish effective treatment strategies under the influence of the COVID-19 crisis. According to our management procedures in the COVID-19 era, emergency treatment will be applied to ICC patients who are under life-threatening conditions, despite the COVID-19 infection. To the best of our knowledge, the modulatory function of Gal-3 in ICC is still barely explored to date. In order to evaluate the therapeutic potential of Gal-3 for ICC patients or those comprised with COVID-19, we herein report our preliminary investigation into roles of Gal-3 in ICC. Our results exhibited that the expression of Gal-3 was significantly up-regulated in ICC tissues, and a significant correlation was observed between its overexpression and malignant progression of ICC cells. We further discussed the activity and possible molecular mechanisms of Gal-3 in ICC, which may pave the ways for further exploring the possibility of Gal-3 as a potential therapeutic target for treating ICC patients or those with COVID-19-related conditions.
C1 [Li, Hao] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Hepatobiliary Surg, Biliary Tract Surg Lab,Affiliated Hosp 1, Changsha, Peoples R China.
   [Li, Hao] Hunan Normal Univ, Hunan Res Ctr Biliary Dis, Affiliated Hosp 1, Changsha, Peoples R China.
   [Li, Jianmin] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Changsha, Peoples R China.
   [Xiao, Wei] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Med Adm, Affiliated Hosp 1, Changsha, Peoples R China.
   [Zhang, Yujing; Yu, Xing] Hunan Normal Univ, Sch Med, Key Lab Model Anim & Stem Cell Biol Hunan Prov, Changsha, Peoples R China.
   [Lv, Yuan] Hunan Normal Univ, Sch Med, Key Lab Mol Epidemiol Hunan Prov, Changsha, Peoples R China.
   [Zheng, Jiao] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Drug Clin Trial, Affiliated Hosp 1, Changsha, Peoples R China.
RP Yu, X (corresponding author), Hunan Normal Univ, Sch Med, Key Lab Model Anim & Stem Cell Biol Hunan Prov, Changsha, Peoples R China.; Zheng, J (corresponding author), Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Drug Clin Trial, Affiliated Hosp 1, Changsha, Peoples R China.
EM xingyu@hunnu.edu.cn; zhengjiao5120081027@hunnu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81874193]; High Level Talents Converging
   Program of Hunan Province [2019RS1041]; Science Fund for Distinguished
   Young Scholars of Hunan ProvinceNational Natural Science Foundation of
   China (NSFC)National Science Fund for Distinguished Young Scholars
   [2019JJ20011]; Hepatobiliary, pancreatic and intestinal diagnosis and
   treatment capacity enhancement project of Hunan Province [(2019)118];
   COVID-19 special project of Changsha Science and Technology Bureau
   [kq2001025]
FX This work was supported by Grants from National Natural Science
   Foundation of China (81874193), High Level Talents Converging Program of
   Hunan Province (2019RS1041), Science Fund for Distinguished Young
   Scholars of Hunan Province (2019JJ20011), Hepatobiliary, pancreatic and
   intestinal diagnosis and treatment capacity enhancement project of Hunan
   Province ((2019)118), COVID-19 special project of Changsha Science and
   Technology Bureau (kq2001025).
CR Ajani JA, 2018, BRIT J CANCER, V118, P52, DOI 10.1038/bjc.2017.388
   Bambouskova M, 2016, MOL CELL BIOL, V36, P1366, DOI 10.1128/MCB.00064-16
   Borjini N, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1595-0
   Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021
   Cevik M, 2020, CLIN MICROBIOL INFEC, V26, P842, DOI 10.1016/j.cmi.2020.04.023
   De Biasi S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17292-4
   Dolgormaa G, 2020, BRIT J CANCER, V123, P1145, DOI 10.1038/s41416-020-0971-y
   Dong R, 2018, INT J MOL MED, V41, P599, DOI 10.3892/ijmm.2017.3311
   Giuliante F, 2016, JAMA SURG, V151, P916, DOI 10.1001/jamasurg.2016.1769
   Gonnermann D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01328
   Jing N, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01784-7
   Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104
   Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Lalancette-Hebert M, 2012, J NEUROSCI, V32, P10383, DOI 10.1523/JNEUROSCI.1498-12.2012
   Li YS, 2020, INT J BIOL MACROMOL, V142, P463, DOI 10.1016/j.ijbiomac.2019.09.118
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9
   Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x
   Rahnemai-Azar AA, 2017, EXPERT REV GASTROENT, V11, P439, DOI 10.1080/17474124.2017.1309290
   Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3
   Rizvi S, 2018, NAT REV CLIN ONCOL, V15, P95, DOI 10.1038/nrclinonc.2017.157
   Schroeder JT, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.524826
   Shaib YH, 2004, J HEPATOL, V40, P472, DOI 10.1016/j.jhep.2003.11.030
   Shin HS, 2019, CLIN INFECT DIS, V68, P984, DOI 10.1093/cid/ciy595
   Shirabe K, 1999, SURGERY, V126, P842, DOI 10.1067/msy.2099.99874
   Sirica AE, 2009, CLIN GASTROENTEROL H, V7, pS68, DOI 10.1016/j.cgh.2009.08.023
   Song L, 2014, CLIN CHIM ACTA, V431, P185, DOI 10.1016/j.cca.2014.01.019
   Song MJ, 2020, BRIT J CANCER, V123, P1521, DOI 10.1038/s41416-020-1022-4
   Subhash VV, 2016, MICROBIOL-SGM, V162, P1360, DOI 10.1099/mic.0.000322
   Tian F, 2020, TECHNOL HEALTH CARE, V28, P711, DOI 10.3233/THC-192011
   Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984
   Woulfe KC, 2017, J CARD FAIL, V23, P314, DOI 10.1016/j.cardfail.2016.11.006
   Wright RD, 2017, J LEUKOCYTE BIOL, V101, P717, DOI 10.1189/jlb.3A0116-026RR
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yang F, 2020, J BIOL CHEM, V295, P16852, DOI 10.1074/jbc.RA120.012974
   Zheng YL, 2020, J CLIN BIOCHEM NUTR, V67, P323, DOI 10.3164/jcbn.20-27
   Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9
   Zile MR, 2019, J AM COLL CARDIOL, V73, P795, DOI 10.1016/j.jacc.2018.11.042
NR 40
TC 0
Z9 0
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD MAY 24
PY 2021
VL 8
AR 666054
DI 10.3389/fmolb.2021.666054
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA SN5BB
UT WOS:000658303800001
PM 34109213
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Turi, G
   Virag, A
AF Turi, Gergo
   Virag, Attila
TI Experiences and Lessons Learned from COVID-19 Pandemic Management in
   South Korea and the V4 Countries
SO TROPICAL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE COVID-19; South Korea; V4 countries; Czech Republic; Hungary; Poland;
   Slovakia; pandemic management; health policy; research and development
AB In the first year and a half of the COVID-19 pandemic, South Korea suffered significantly less social and economic damage than the V4 countries (Czech Republic, Hungary, Poland, and Slovakia) despite less stringent restrictive measures. In order to explore the causes of the phenomenon, we examined the public health policies and pandemic management of South Korea and the V4 countries and the social and economic outcomes of the measures. We identified the key factors that contributed to successful public health policies and pandemic management in South Korea by reviewing the international literature. Based on the analysis results, South Korea successfully managed the COVID-19 pandemic thanks to the appropriate combination of non-pharmaceutical measures and its advanced public health system. An important lesson for the V4 countries is that successful pandemic management requires a well-functioning surveillance system, a comprehensive testing strategy, an innovative contact tracing system, transparent government communication, and a coordinated public health system. In addition, to develop pandemic management capabilities and capacities in the V4 countries, continuous training of public health human resources, support for knowledge exchange, encouragement of research on communicable disease management, and collaboration with for-profit and non-governmental organizations are recommended.
C1 [Turi, Gergo; Virag, Attila] Corvinus Univ Budapest, Inst Dev Enterprises, Fovam Sq 8, H-1093 Budapest, Hungary.
RP Virag, A (corresponding author), Corvinus Univ Budapest, Inst Dev Enterprises, Fovam Sq 8, H-1093 Budapest, Hungary.
EM gergo.turi2@stud.uni-corvinus.hu; attila.virag@uni-corvinus.hu
CR [Anonymous], 2020, ECDC COMMUNICABLE DI
   Baranski K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084388
   Bogos K, 2021, PATHOL ONCOL RES, V27, DOI 10.3389/pore.2021.1609774
   Campbell M, S KOREAS SUCCESSFUL
   COVID-19 National Emergency Response Center Epidemiology & Case Management Team Korea Centers for Disease Control & Prevention, 2020, Osong Public Health Res Perspect, V11, P60, DOI 10.24171/j.phrp.2020.11.1.09
   Dighe A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01791-8
   ECDC, 2020, GUIDELINES IMPLEMENT
   Elliot AJ, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001314
   European Centre for Disease Prevention and Control, 2020, OUTBR AC RESP SYNDR
   Jeong GH, 2020, J MED INTERNET RES, V22, DOI 10.2196/22103
   Johansson MA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35057
   Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198
   June-Ho K., 2021, EMERGING COVID 19 SU
   Kang H, 2020, COVID 19 HLTH SYSTEM
   Kim Dong-Young, 2020, International Review of Public Administration, V25, P44, DOI 10.1080/12294659.2020.1737371
   Kye B, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100523
   Ladner D, 2020, REPUBLIC KOREAS 1 70
   Lee D, 2021, AM J EPIDEMIOL, V190, P496, DOI 10.1093/aje/kwaa217
   Lee KM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081432
   Lee SM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207548
   Lim H, 2016, NUTR RES PRACT, V10, P555, DOI 10.4162/nrp.2016.10.5.555
   Meskini M, 2021, J INFECT PUBLIC HEAL, V14, P1284, DOI 10.1016/j.jiph.2021.07.021
   Ministry of Health and Welfare Press Release, 2015, MEAS REF NAT INF PRE
   Nam EW, 2007, HEALTH PROMOT INT, V22, P155, DOI 10.1093/heapro/dam004
   Nam EW, 2011, ASIAN PERSPECTIVES AND EVIDENCE ON HEALTH PROMOTION AND EDUCATION, P141, DOI 10.1007/978-4-431-53889-9_14
   OECD, 2020, OECD REV PUBL HLTH K, DOI [10.1787/be2b7063-en, DOI 10.1787/BE2B7063-EN]
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   Oran DP, 2021, ANN INTERN MED, V174, P655, DOI 10.7326/M20-6976
   Public Health England, RES AN SOURC COVID 1
   Rashedi Jalil, 2020, Infez Med, V28, P469
   Sheikhpour M, 2020, THER CLIN RISK MANAG, V16, P933, DOI 10.2147/TCRM.S262936
   University of Oxford, OUR WORLD DAT DAT 20
   Wernli D, 2021, GOVERNANCE AGE COMPL
   Wernli D, 2021, INT J HEALTH POLICY, DOI 10.34172/ijhpm.2021.55
   WHO, 10 ESS PUBL HLTH OP
   WHO, 2019, HLTH EM DIS RISK MAN
   World Bank, 2020, GLOB EC PROSP, DOI [https://doi.org/10.1596/978-1-4648-1553-9, DOI 10.1596/978-1-4648-1553-9, 10.1596/978-1-4648-1553-9]
   World Health Organization, 2018, JOINT EXT EV TOOL IN
   World Health Organization, WHO DIR GEN OP REM M
   World Health Organization, 2020, COVID 19 VIRT PRESS
   Yoo KJ, 2021, HEALTH POLICY, V125, P568, DOI 10.1016/j.healthpol.2021.02.011
NR 41
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2414-6366
J9 TROP MED INFECT DIS
JI Trop. Med. Infect. Dis.
PD DEC
PY 2021
VL 6
IS 4
AR 201
DI 10.3390/tropicalmed6040201
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Parasitology; Tropical Medicine
GA YA5WJ
UT WOS:000738402800001
PM 34941657
OA gold, Green Accepted, Green Published
DA 2022-04-20
ER

PT C
AU Popova, M
   Stryzhak, O
   Mintser, O
   Novogrudska, R
AF Popova, Maryna
   Stryzhak, Oleksandr
   Mintser, Ozar
   Novogrudska, Rina
BE Park, T
   Cho, YR
   Hu, X
   Yoo, I
   Woo, HG
   Wang, J
   Facelli, J
   Nam, S
   Kang, M
TI Medical Transdisciplinary Cluster Development for Multivariable COVID-19
   Epidemiological Situation Modeling
SO 2020 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE
SE IEEE International Conference on Bioinformatics and Biomedicine-BIBM
LA English
DT Proceedings Paper
CT IEEE International Conference on Bioinformatics and Biomedicine (IEEE
   BIBM)
CY DEC 16-19, 2020
CL ELECTR NETWORK
SP IEEE, Seoul Natl Univ, Bioinformat Inst, Korea Genome Open HRD, Korea Genome Organization, Bio Synergy Res Ctr, Korean Federation of Science and Technology Societies, Seoul Natl Univ, Dept Stat, IEEE Tech Comm Computat Life Sci
DE transdisciplinarity; ontology; cluster; knowledge; network resources;
   coronavirus (COVID-19); mathematical epidemiology; prognostic modelling
ID ONTOLOGY; SEARCH
AB The paper proposes to solve the relevant problem of providing public access to scientific and technical information about coronavirus infection by means of cognitive tools for the formation of network-centric management system of distributed processes of accumulation, systematization, storage and presentation of various knowledge-oriented resources, namely medical transdisciplinary cluster that will present current COVID-19 data. It will be harmoniously integrated and synchronized in content with other multilingual information resources and network digital arrays based on interoperability protocols of interaction to form a holistic view of the pandemic. The developed knowledge system will provide organization, processing, analysis and visualization of data and information that extend the methods of COVID-19 research, including prognostic modelling based on the principles of mathematical epidemiology taking into account regional, age and other features of the epidemic process.
C1 [Popova, Maryna; Novogrudska, Rina] Natl Ctr Jr Acad Sci Ukraine, Intelligent Network Tools Dept, Kiev, Ukraine.
   [Stryzhak, Oleksandr] Natl Ctr Jr Acad Sci Ukraine, Sci Work, Kiev, Ukraine.
   [Mintser, Ozar] Shupyk Natl Med Acad Postgrad Educ, Med Informat Dept, Kiev, Ukraine.
RP Popova, M (corresponding author), Natl Ctr Jr Acad Sci Ukraine, Intelligent Network Tools Dept, Kiev, Ukraine.
EM pm@man.gov.ua; stryzhak@man.gov.ua; k-minf05@nmapo.edu.ua; rinan@ukr.net
RI Novogrudska, Rina/J-7531-2017; Mintser, Ozar/K-4636-2015; Popova,
   Maryna/C-8433-2019
OI Novogrudska, Rina/0000-0002-0533-5817; Mintser,
   Ozar/0000-0002-7224-4886; Popova, Maryna/0000-0002-0258-1713
CR Ajami H, 2018, ELECTRONICS-SWITZ, V7, DOI 10.3390/electronics7120371
   [Anonymous], 2015, NUCLEIC ACIDS RES, DOI [10.1093/nar/gku1011, DOI 10.1093/NAR/GKU1011]
   [Anonymous], STRUCT MOD
   [Anonymous], SNOMED RES
   Bhatt M, 2009, J WEB SEMANT, V7, P317, DOI 10.1016/j.websem.2009.05.004
   Campos-Asensio C, 2018, ENFERM INTENSIV, V29, P182, DOI 10.1016/j.enfi.2018.09.001
   De Silva TS, 2011, COMPUT METH PROG BIO, V101, P324, DOI 10.1016/j.cmpb.2011.01.002
   El-Sappagh S, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0651-5
   Farfan F, 2009, PROC INT CONF DATA, P820, DOI 10.1109/ICDE.2009.73
   Globa L. S., 2018, P IEEE INT BLACK SEA, P1, DOI [10.1109/BlackSeaCom.2018.8433710, DOI 10.1109/BLACKSEACOM.2018.8433710]
   Golovin O. O., 2018, WEAP SYST MIL EQUIP, V4, P81, DOI [10.30748/soivt.2018.56.12, DOI 10.30748/SOIVT.2018.56.12]
   Lasierra N, 2013, J BIOMED INFORM, V46, P516, DOI 10.1016/j.jbi.2013.03.006
   LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945
   Mintser O. P., 2018, MED INF ENG, V1, P47
   N4intser P., 2019, MED EDUC, V2, P171, DOI [10.11603/me.2414-5998.2019.2.10360, DOI 10.11603/ME.2414-5998.2019.2.10360]
   Paganelli F., 2008, Information Technology and Tourism, V10, P313, DOI 10.3727/109830508788403150
   Podlipaev V. A., 2018, WEAP SYST MIL EQUIP, V3, P85
   Popova M. A., 2013, INT J INFORM TECHNOL, V7, P362
   Soloviov S. O., 2020, J MED SCI, V52, P43
   Sowa JF, 2000, LECT NOTES ARTIF INT, V1867, P55
   Stryzhak O. Ye., 2020, OFFICIAL B, P402
   Uschold M., 2002, KNOWL ENG REV, V11, P93
   World Health Organization, GLOB RES COR DIS COV
   Zeshan F, 2012, PROCEDIA COMPUT SCI, V10, P340, DOI 10.1016/j.procs.2012.06.045
NR 24
TC 1
Z9 1
U1 2
U2 2
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
SN 2156-1125
EI 2156-1133
BN 978-1-7281-6215-7
J9 IEEE INT C BIOINFORM
PY 2020
BP 1662
EP 1667
DI 10.1109/BIBM49941.2020.9313204
PG 6
WC Biochemical Research Methods; Computer Science, Interdisciplinary
   Applications; Mathematical & Computational Biology
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Computer Science; Mathematical &
   Computational Biology
GA BR6BW
UT WOS:000659487101135
OA Bronze
DA 2022-04-20
ER

PT J
AU Alshutwi, SS
AF Alshutwi, Sitah S.
TI 'Senior Nursing Students and Interns' Concerns and Willingness to Treat
   Patients with COVID-19: A Strategy to Expand National Nursing Workforce
   during the COVID-19 Pandemic
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; nursing interns; nursing students; willingness to treat
ID MEDICAL-STUDENTS; KNOWLEDGE; WORK; DUTY; PREPAREDNESS
AB Background: The coronavirus disease of 2019 (COVID-19) pandemic has challenged the existing healthcare delivery systems worldwide and overwhelmed the globally short healthcare workforce, particularly nurses. Nurses are recognized as front-line responders to the COVID-19 pandemic and are crucial healthcare members to win the fight against the evolving COVID-19. Considering the long-lasting shortage of national nurses, and turnover of the current nursing workforce, it is essential to consider unconventional strategies aiming at expanding the national nursing workforce in order to embrace the impact of COVID-19.
   Objective: This study aimed to measure senior nursing students and intern's willingness to treat patients with COVID-19. Further, this study investigated their feelings, knowledge, and concerns regarding treating patients with COVID-19.
   Methods: This quantitative, cross-sectional study utilized self-reported survey gathered from a convenience sample of 178 senior nursing students and interns. A 7-item scale was used to measure the participants' willingness to treat patients with COVID-19. The data were collected between March 2020 and April 2020.
   Results: Out of 178 participants, 50.56% were at Level 8, 89.33% were single, and 53.37% had a very satisfactory grade point average. The highest proportion of the respondents (38.20%) felt neutral about treating patient with COVID-19, while 53.93% had good knowledge about COVID-19. The perceived willingness to treat of participants had an overall mean score of 20.19, which indicated neutral willingness to treat patients with COVID-19. Participants' feelings about treating patients with COVID-19 predicted their willingness to treat patients with COVID-19 (P<0.001).
   Conclusion/Recommendation: There is a clear need for educational and training programs both in clinical practice and academia for the improvement among nursing students and interns who reported paucity of knowledge about COVID-19. Furthermore, hospital institutions should provide additional incentives or hazard protections to maintain and even increase the number of staff at the frontline who are willing to care for patients amid the deadly pandemic of COVID-19.
C1 [Alshutwi, Sitah S.] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Nursing, Riyadh, Saudi Arabia.
   [Alshutwi, Sitah S.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.
RP Alshutwi, SS (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, Coll Nursing, Riyadh, Saudi Arabia.; Alshutwi, SS (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.
EM Shutwis@ksau-hs.edu.sa
CR Abolfotouh MA, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05443-3
   Aboshaiqah A, 2016, INT NURS REV, V63, P499, DOI 10.1111/inr.12271
   Al Amir K, 2020, CORONAVIRUS SAUDI AR
   Algaissi A, 2020, PREPAREDNESS RESPONS, DOI [10.20944/PREPRINTS202004.0018.V1, DOI 10.20944/PREPRINTS202004.0018.V1]
   AlSaif HI, 2020, INT J GEN MED, V13, P653, DOI 10.2147/IJGM.S272316
   Aoyagi Y, 2015, INFLUENZA OTHER RESP, V9, P120, DOI 10.1111/irv.12310
   Chilton JM, 2016, J PROF NURS, V32, P487, DOI 10.1016/j.profnurs.2016.05.004
   Cousins S., 2020, NAT MIDDLE E, DOI [10.1038/nmiddleeast.2020.36, DOI 10.1038/NMIDDLEEAST.2020.36]
   DANIELS N, 1991, HASTINGS CENT REP, V21, P36, DOI 10.2307/3562338
   European Centre for Disease Prevention and Control, 2020, DIS BACKGR COVID 19
   Ikhlaq A, 2020, PAK J MED SCI, V36, pS32, DOI 10.12669/pjms.36.COVID19-S4.2636
   Irvin CB, 2007, NURSING2007, V37, P35, DOI [10.1097/01.NURSE.0000282708.52888.b7, DOI 10.1097/01.NURSE.0000282708.52888.B7]
   Johns Hopkins University, 2020, NURS FAC UNPR CHALL
   Johns Hopkins University & Medicine Center for Systems Science and Engineering (CSSE), 2020, COR COVID 19 GLOB CA
   Joukar F, 2012, WORLD J GASTROENTERO, V18, P2238, DOI 10.3748/wjg.v18.i18.2238
   Kaiser HE, 2009, DISASTER MED PUBLIC, V3, P210, DOI 10.1097/DMP.0b013e3181aa242a
   Malm H, 2008, AM J BIOETHICS, V8, P4, DOI 10.1080/15265160802317974
   Martin SD, 2013, AM J NURS, V113, P24, DOI 10.1097/01.NAJ.0000438865.22036.15
   Martin SD, 2011, J NURS MANAGE, V19, P98, DOI 10.1111/j.1365-2834.2010.01190.x
   Martinese F, 2009, EMERG MED AUSTRALAS, V21, P12, DOI 10.1111/j.1742-6723.2008.01143.x
   McConnell D, 2020, J MED ETHICS, V46, P360, DOI 10.1136/medethics-2020-106250
   Milikovsky DZ, 2013, J MED ETHICS, V39, P22, DOI 10.1136/medethics-2012-100509
   Ministry of Health, 2020, COVID 19 COMM CONTR
   Nimma V, 2014, ORAL HLTH DENT MANAG, V13, P745
   Osuafor GN, 2019, AFR J NURS MIDWIFERY, V21, DOI 10.25159/2520-5293/6014
   Rokach A, 2010, DISASTERS, V34, P637, DOI 10.1111/j.1467-7717.2010.01161.x
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Wong ELY, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-107
   World Health Organization (WHO), 2020, ROLLING UPDATES CORO
NR 31
TC 1
Z9 1
U1 8
U2 12
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 39
EP 48
DI 10.2147/RMHP.S279569
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA PS4YF
UT WOS:000607927900001
PM 33447108
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Puche-Sanz, I
   Sabio-Bonilla, A
   Sanchez-Conde, V
   Jimenez-Dominguez, AC
   Tamayo-Gomez, A
   Vila-Brana, P
   Vazquez-Alonso, F
   Rivas, JG
   Gomez-Gomez, E
   Campos-Juanatey, F
   Rodriguez, JGO
   Flores-Martin, J
   Moreno-Jimenez, J
   Cozar-Olmo, JM
AF Puche-Sanz, Ignacio
   Sabio-Bonilla, Almudena
   Sanchez-Conde, Victor
   Cristina Jimenez-Dominguez, Ana
   Tamayo-Gomez, Alba
   Vila-Brana, Pedro
   Vazquez-Alonso, Fernando
   Gomez Rivas, Juan
   Gomez-Gomez, Enrique
   Campos-Juanatey, Felix
   Garcia-Olaverri Rodriguez, Jorge
   Flores-Martin, Jose
   Moreno-Jimenez, Juan
   Manuel Cozar-Olmo, Jose
TI Emergency surgery during COVID-19 pandemia
SO ARCHIVOS ESPANOLES DE UROLOGIA
LA Spanish
DT Article
DE SARS-CoV-2; COVID 19; COVID Urology; COVID19 surgery; Emergency care
AB INTRODUCTION: The crisis in the SARS-CoV-2 coronavirus causing COVID-19 is putting health systems around the world to the test. In a great effort to standardize the management and treatment guidelines, the different health authorities and scientific associations have tried to issue recommendations on how to act in this new and complex scenario.
   OBJECTIVE: To synthesize the existing evidence and recommendations about urological emergency surgery during the COVID-19 pandemic situation. Furthermore, we propose a general action protocol for these patients.
   MATERIAL AND METHODS: The document is based on the scarce evidence on SARS/Cov-2 and the experience of the authors in the management of COVID-19 in their institutions, including specialists from Andalusia, Cantabria, Madrid and the Basque Country. A web and PubMed search was performed using the keywords "SARS-CoV-2", "COVID 19", "COVID Urology", "COVID19 surgery" and "emergency care". A narrative review of the literature was carried out until April 30, 2020, including only articles and documents written in Spanish and English. After the nominal group technique modified due to the extraordinary restrictions, a first draft was made to unify criteria. Finally, a definitive version was made, agreed by all the authors on May 12, 2020.
   RESULTS: General principles of action are set out, as well as specific recommendations for the most frequent urgent urological procedures.
   CONCLUSIONS: Given the exceptional nature of the situation, there is a lack of evidence regarding the optimal management of the patient with urgent urological pathology. The information is changing, as the epidemiological knowledge of the disease advances. The establishment of multidisciplinary surgical committees that develop and implement action protocols appropriate to the different resources and particular situations of each center is recommended. Likewise, these committees must individually assess each possible urological surgical emergency situation and ensure compliance with protective measures for the patient and other healthcare personnel.
C1 [Puche-Sanz, Ignacio; Sabio-Bonilla, Almudena; Sanchez-Conde, Victor; Cristina Jimenez-Dominguez, Ana; Tamayo-Gomez, Alba; Vila-Brana, Pedro; Vazquez-Alonso, Fernando; Manuel Cozar-Olmo, Jose] Hosp Univ Virgen Nieves, Serv Urol, Inst Invest Biosanitaria IbsGRANADA, Av Fuerzas Armadas 2, Granada 18014, Spain.
   [Gomez Rivas, Juan] Hosp Univ La Paz, Inst Invest Hosp Univ La Paz IdiPAZ, Serv Urol, Madrid, Spain.
   [Gomez-Gomez, Enrique] Univ Cordoba, Hosp Univ Reina Sofia, Serv Urol, Inst Maimonides Invest Biomed Cordoba Univ IMIBIC, Cordoba, Spain.
   [Campos-Juanatey, Felix] Hosp Univ Marques de Valdecilla, Inst Invest Valdecilla IDIVAL, Serv Urol, Santander, Spain.
   [Garcia-Olaverri Rodriguez, Jorge] Hosp Cruces, Serv Urol, Bilbao, Spain.
   [Flores-Martin, Jose; Moreno-Jimenez, Juan] Hosp Univ Jaen, Serv Urol, Jaen, Spain.
RP Puche-Sanz, I (corresponding author), Hosp Univ Virgen Nieves, Serv Urol, Inst Invest Biosanitaria IbsGRANADA, Av Fuerzas Armadas 2, Granada 18014, Spain.
EM nacho.puchesanz@gmail.com
RI Gomez, Enrique Gomez/ABI-6063-2020; Rivas, Juan Gómez/H-1635-2013;
   Vazquez-Alonso, Fernando/AAO-4650-2021; Puche-Sanz, Ignacio/J-3086-2013
OI Rivas, Juan Gómez/0000-0002-0556-3035; Puche-Sanz,
   Ignacio/0000-0003-4121-0162; Gomez Gomez, Enrique/0000-0002-8753-3306
CR American College of Surgeons, 2020, B ACS COVID 19 NEWSL
   Esteban M, 2020, ACTAS UROL ESP, V44, P383, DOI 10.1016/j.acuro.2020.04.001
   Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663
   Han Y, 2020, J MED VIROL, V92, P639, DOI 10.1002/jmv.25749
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Lei Shaoqing, 2020, EClinicalMedicine, V21, P100331, DOI 10.1016/j.eclinm.2020.100331
   Lescure Francois-Xavier, 2020, Lancet Infect Dis, V20, P697, DOI 10.1016/S1473-3099(20)30200-0
   Little P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1185
   Proietti S, 2020, EUR UROL, V78, P131, DOI 10.1016/j.eururo.2020.03.042
   Ribal MJ, 2020, EUR UROL, V78, P21, DOI 10.1016/j.eururo.2020.04.056
   Sodhi M, 2020, CHEST, V158, P55, DOI 10.1016/j.chest.2020.03.040
   Stensland KD, 2020, EUR UROL, V77, P663, DOI 10.1016/j.eururo.2020.03.027
   Vigneswaran Y, 2020, J GASTROINTEST SURG, V24, P1686, DOI 10.1007/s11605-020-04592-9
NR 13
TC 3
Z9 3
U1 1
U2 4
PU INIESTARES, S.A.
PI MADRID
PA SAN GREGORIO, 8, 3 PTA. 4, MADRID, SPAIN
SN 0004-0614
EI 1576-8260
J9 ARCH ESP UROL
JI Arch. Esp. Urol.
PD JUN
PY 2020
VL 73
IS 5
BP 353
EP 359
PG 7
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA MX2SZ
UT WOS:000557578500005
PM 32538804
DA 2022-04-20
ER

PT J
AU Alsheikh, SH
   Ibrahim, K
   AlFaraj, D
AF Alsheikh, Shahad H.
   Ibrahim, Khaled
   AlFaraj, Dunya
TI The Impact of False Positive COVID-19 Result
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE management; sars-cov-2; impact; rt-pcr; ct; covid-19; false positive
ID HUNTINGTON-DISEASE; CANCER
AB The novel Coronavirus disease 2019 (COVID-19) pandemic has resulted in many adverse outcomes and challenges, and a false-positive result is one of them. Despite that this issue has a substantial impact, there is a scarcity in the literature of its prevalence or impact, and more knowledge is needed. This case report will present the case of a 54-years-old female who was misdiagnosed as COVID-19. The misleading COVID-19 diagnosis can result in significant consequences such as delaying surgeries, unnecessary quarantine and treatments, transplant lists omission, and unnecessary sick leaves. Moreover, as seen in our case, it delayed the other investigations and admitted a healthy patient to a COVID-19 isolation ward. Therefore, physicians should consider the possibility of false-positive results and utilize other investigation tools to further diagnose suspicious cases.
C1 [Alsheikh, Shahad H.] Imam Abdulrahman Bin Faisal Univ, Med & Surg, Dammam, Saudi Arabia.
   [Ibrahim, Khaled; AlFaraj, Dunya] Imam Abdulrahman Bin Faisal Univ, Emergency Med, Dammam, Saudi Arabia.
RP Alsheikh, SH (corresponding author), Imam Abdulrahman Bin Faisal Univ, Med & Surg, Dammam, Saudi Arabia.
EM sheloolshe@hotmail.com
RI alsheikh, shahad/AFR-5758-2022
OI alsheikh, shahad/0000-0002-2408-8014
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Alsharif W, 2021, RADIOGRAPHY, V27, P682, DOI 10.1016/j.radi.2020.09.010
   Chi S, 2008, J LUNG CANC, V7, P36, DOI [10.6058/jlc.2008.7.1.36, DOI 10.6058/JLC.2008.7.1.36]
   Coarelli G, 2017, NEUROLOGY, V88, P1114, DOI 10.1212/WNL.0000000000003725
   Fang Y, 2020, RADIOLOGY, V296, pE115, DOI [DOI 10.1148/RADIOL.2020200432, 10.1148/ radiol.2020200432]
   de Farias LDG, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2027
   Healy B, 2021, CLIN MED, V21, pE54, DOI 10.7861/clinmed.2020-0839
   Katz AP, 2020, HEAD NECK-J SCI SPEC, V42, P1621, DOI 10.1002/hed.26317
   Lee J, 2021, J MED VIROL, V93, P4523, DOI 10.1002/jmv.26994
   Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.0.CO;2-3
   Sousa CM, 2013, EMBO MOL MED, V5, P309, DOI 10.1002/emmm.201201546
   Sultan OM, 2020, EGYPT J RADIOL NUC M, V51, DOI 10.1186/s43055-020-00223-0
   Surkova E, 2020, LANCET RESP MED, V8, P1167, DOI 10.1016/S2213-2600(20)30453-7
   Visseaux B, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104520
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wu MK, 2016, CHINESE MED J-PEKING, V129, P2149, DOI 10.4103/0366-6999.189918
NR 16
TC 1
Z9 1
U1 1
U2 1
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD DEC 12
PY 2021
VL 13
IS 12
AR e20375
DI 10.7759/cureus.20375
PG 7
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA XQ1JH
UT WOS:000731308800014
PM 35036208
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Li, XJ
   Liu, QL
AF Li, Xiaojing
   Liu, Qinliang
TI Social Media Use, eHealth Literacy, Disease Knowledge, and Preventive
   Behaviors in the COVID-19 Pandemic: Cross-Sectional Study on Chinese
   Netizens
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE social media; media use; COVID-19; pandemic; disease knowledge; eHealth
   literacy; public health; preventive behaviors
ID MENTAL-HEALTH LITERACY; MASS-MEDIA; ASSOCIATION; INTERNET
AB Background: Since its outbreak in January 2020, COVID-19 has quickly spread worldwide and has become a global pandemic. Social media platforms have been recognized as important tools for health-promoting practices in public health, and the use of social media is widespread among the public. However, little is known about the effects of social media use on health promotion during a pandemic such as COVID-19.
   Objective: In this study, we aimed to explore the predictive role of social media use on public preventive behaviors in China during the COVID-19 pandemic and how disease knowledge and eHealth literacy moderated the relationship between social media use and preventive behaviors.
   Methods: A national web-based cross-sectional survey was conducted by a proportionate probability sampling among 802 Chinese internet users ("netizens") in February 2020. Descriptive statistics, Pearson correlations, and hierarchical multiple regressions were employed to examine and explore the relationships among all the variables.
   Results: Almost half the 802 study participants were male (416, 51.9%), and the average age of the participants was 32.65 years. Most of the 802 participants had high education levels (624, 77.7%), had high income ><yen>5000 (US $736.29) (525, 65.3%), were married (496, 61.8%), and were in good health (486, 60.6%). The average time of social media use was approximately 2 to 3 hours per day (mean 2.34 hours, SD 1.11), and the most frequently used media types were public social media (mean score 4.49/5, SD 0.78) and aggregated social media (mean score 4.07/5, SD 1.07). Social media use frequency (beta=.20, P<.001) rather than time significantly predicted preventive behaviors for COVID-19. Respondents were also equipped with high levels of disease knowledge (mean score 8.15/10, SD 1.43) and eHealth literacy (mean score 3.79/5, SD 0.59). Disease knowledge (beta=.11, P=.001) and eHealth literacy (beta=.27, P<.001) were also significant predictors of preventive behaviors. Furthermore, eHealth literacy (P=.038) and disease knowledge (P=.03) positively moderated the relationship between social media use frequency and preventive behaviors, while eHealth literacy (beta=.07) affected this relationship positively and disease knowledge (beta=-.07) affected it negatively. Different social media types differed in predicting an individual's preventive behaviors for COVID-19. Aggregated social media (beta=.22, P<.001) was the best predictor, followed by public social media (beta=.14, P<.001) and professional social media (beta=.11, P=.002). However, official social media (beta=.02, P=.597) was an insignificant predictor.
   Conclusions: Social media is an effective tool to promote behaviors to prevent COVID-19 among the public. Health literacy is essential for promotion of individual health and influences the extent to which the public engages in preventive behaviors during a pandemic. Our results not only enrich the theoretical paradigm of public health management and health communication but also have practical implications in pandemic control for China and other countries.
C1 [Li, Xiaojing; Liu, Qinliang] Shanghai Jiao Tong Univ, Ctr Hlth & Med Commun, Sch Media & Commun, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
RP Li, XJ (corresponding author), Shanghai Jiao Tong Univ, Ctr Hlth & Med Commun, Sch Media & Commun, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
EM lixiaojing@sjtu.edu.cn
RI Li, Xiaojing/ABB-4422-2021
OI Li, Xiaojing/0000-0002-8473-5594; Liu, Qinliang/0000-0002-6053-3269
CR Acun I, 2020, INT J INSTR, V13, P35, DOI 10.29333/iji.2020.1313a
   Al-Surimi K, 2017, ADV EXP MED BIOL, V972, P131, DOI 10.1007/5584_2016_132
   Alexander CC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16111963
   Alhuwail D, 2019, J MED INTERNET RES, V21, DOI 10.2196/11174
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   [Anonymous], PREV COR DIS 2019
   [Anonymous], PROT PREV CONTR COVI
   Ashida S, 2011, PUBLIC HEALTH GENOM, V14, P307, DOI 10.1159/000316234
   Bains SS, 2011, DIABETES TECHNOL THE, V13, P335, DOI 10.1089/dia.2010.0160
   Bandura A, 2001, MEDIA PSYCHOL, V3, P265, DOI 10.1207/S1532785XMEP0303_03
   Bujnowska-Fedak MM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030880
   Bull SS, 2012, AM J PREV MED, V43, P467, DOI 10.1016/j.amepre.2012.07.022
   Burns JR, 2006, J ADOLESCENCE, V29, P225, DOI 10.1016/j.adolescence.2005.05.004
   Calder K, 2020, HEALTH PROMOT INT, V35, P111, DOI 10.1093/heapro/day106
   Calzada J, 2020, MARKET SCI, V39, P134, DOI 10.1287/mksc.2019.1150
   Cho H, 2019, J MED INTERNET RES, V21, DOI 10.2196/14303
   Cho YI, 2008, SOC SCI MED, V66, P1809, DOI 10.1016/j.socscimed.2008.01.003
   CNNIC (China Internet Network Information Center), 2019, 44 STAT REP INT DEV
   Costantino C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15051014
   Dellarocas C, 2016, MANAGE SCI, V62, P2543, DOI 10.1287/mnsc.2015.2237
   Deng JG, 2018, COMMUN PUBLIC, V3, P113, DOI 10.1177/2057047318770466
   Edukugho AA, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.21.15120
   El Khoury G, 2015, INT J ENV RES PUB HE, V12, P15486, DOI 10.3390/ijerph121215000
   Erraguntla M, 2019, HEALTH INFORM J, V25, P1170, DOI 10.1177/1460458217747112
   Gajda M, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080434
   Gazmararian JA, 2003, PATIENT EDUC COUNS, V51, P267, DOI 10.1016/S0738-3991(02)00239-2
   Gough Aisling, 2017, JMIR Public Health Surveill, V3, pe14, DOI 10.2196/publichealth.6313
   Guarner J, 2020, AM J CLIN PATHOL, V153, P420, DOI 10.1093/ajcp/aqaa029
   Hansen AH, 2019, J MED INTERNET RES, V21, DOI 10.2196/13465
   Herrera-Diestra JL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225576
   Hokby Sebastian, 2016, JMIR Ment Health, V3, pe31, DOI 10.2196/mental.5925
   Huesch MD, 2016, HEALTH SERV RES, V51, P1273, DOI 10.1111/1475-6773.12496
   Huhman M, 2005, PEDIATRICS, V116, pE277, DOI 10.1542/peds.2005-0043
   HYEYOUNG KIM, 2018, [Advertising Research, 광고연구], V118, P78, DOI 10.16914/ar.2018.118.78
   Jang K, 2019, HEALTH COMMUN, V34, P991, DOI 10.1080/10410236.2018.1449552
   Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396
   Kalichman SC, 2000, AM J PREV MED, V18, P325, DOI 10.1016/S0749-3797(00)00121-5
   Kan JQ, 2017, COMMUN NONLINEAR SCI, V44, P193, DOI 10.1016/j.cnsns.2016.08.007
   Kickbusch IS, 2001, HEALTH PROMOT INT, V16, P289, DOI 10.1093/heapro/16.3.289
   Kim J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4721-x
   Kim KA, 2018, CIN-COMPUT INFORM NU, V36, P438, DOI 10.1097/CIN.0000000000000438
   Kim S, 2004, DIABETES CARE, V27, P2980, DOI 10.2337/diacare.27.12.2980
   Li XJ, 2018, INT J PUBLIC OPIN R, V30, P79, DOI 10.1093/ijpor/edw035
   Lim JS, 2020, COMPUT HUM BEHAV, V108, DOI 10.1016/j.chb.2020.106327
   Lin WY, 2018, INT J SEX HEALTH, V30, P354, DOI 10.1080/19317611.2018.1509921
   Lindau ST, 2002, AM J OBSTET GYNECOL, V186, P938, DOI 10.1067/mob.2002.122091
   Lwin MO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091974
   Moon M, 2019, J COMMUN MANAG, V23, P281, DOI 10.1108/JCOM-01-2019-0002
   Morris NS, 2013, J HEALTH COMMUN, V18, P223, DOI 10.1080/10810730.2013.825667
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Mueller J, 2019, BRIT J HEALTH PSYCH, V24, P31, DOI 10.1111/bjhp.12325
   Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9
   O'Leary ST, 2019, AM J PREV MED, V57, pE125, DOI 10.1016/j.amepre.2019.05.018
   Park S, 2016, J CONTING CRISIS MAN, V26, P69, DOI [10.1111/1468-5973.12137, DOI 10.1111/1468-5973.12137]]
   Repnikova M, 2019, CHINA QUART, V239, P679, DOI 10.1017/S0305741019000316
   Roberts H, 2017, J HEALTH COMMUN, V22, P51, DOI 10.1080/10810730.2016.1209598
   Sarkar U, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8882
   Stawarz K, 2019, JMIR MENT HEALTH, V6, DOI 10.2196/12546
   Stellefson M, 2019, J MED INTERNET RES, V21, DOI 10.2196/12165
   Tennant B, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3992
   van Velsen L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-100
   Silva CV, 2020, DERMATOLOGY, V236, P81, DOI 10.1159/000506458
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4
   Whitehead D, 2000, J ADV NURS, V32, P807, DOI 10.1046/j.1365-2648.2000.01544.x
   World Health Organization, 2020, 133 WHO
   Yang QH, 2021, HEALTH COMMUN, V36, P324, DOI 10.1080/10410236.2019.1692486
   Yang SC, 2019, J MED INTERNET RES, V21, DOI 10.2196/13140
   Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180508
NR 71
TC 46
Z9 47
U1 16
U2 40
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD OCT 9
PY 2020
VL 22
IS 10
AR e19684
DI 10.2196/19684
PG 19
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA PH3FF
UT WOS:000600302400006
PM 33006940
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mohta, A
   Mohta, A
   Nai, RS
   Arora, A
   Aggrawal, A
   Jain, SK
   Mehta, RD
   Singh, A
AF Mohta, Alpana
   Mohta, Achala
   Nai, Radhe Shyam
   Arora, Aakanksha
   Aggrawal, Aditi
   Jain, Suresh Kumar
   Mehta, Rajesh Dutt
   Singh, Arti
TI Evaluation of the Knowledge, Attitude and Practice of Patients on
   Immunosuppressive Drugs Towards COVID-19 Attending Dermatology
   Department- A Multicentric Cross-Section Study
SO INDIAN JOURNAL OF DERMATOLOGY
LA English
DT Article
DE Attitude; coronavirus; COVID-19; hygiene; KAP score; knowledge;
   lockdown; pandemic; practice; SARS-CoV-2; social distancing
ID RESIDENTS; OUTBREAK
AB Background: The deadly COVID-19 (Coronavirus Disease 2019) or SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was identified for the first time in December 2019 from Wuhan, China, and by the beginning of March 2020, it was declared a pandemic by the World Health Organization (WHO). Despite so many government regulations and awareness measures, there is still a lacuna between the gravity of illness and the knowledge of the average person toward it. Objective: We aimed at assessing the knowledge, attitude, and behavioral practice (KAP) of patients on immunosuppressive medication attending the dermatology department toward, COVID-19. Material and Methods: A self-designed printed/digital questionnaire consisting of 30 questions (Hindi and English) was supplied to patients being treated with any systemic immunosuppressives (for at least 3 weeks), for any dermatological ailment. The questionnaire consisted of 12 questions assessing the knowledge, 11 for attitude, and 7 for practices of patients toward COVID-19. Results: The study included 237 patients with a mean age of 44.57 +/- 13.72 years. The correct knowledge toward COVID-19 was present in 126 (53.16%) patients with a mean score of 7.79 +/- 3.08 out of 13. The mean attitude score was 8.35 +/- 2.16 (out of 11) while the mean score of practice was 5.64 +/- 2.03 (out of 8). Increased hygiene levels were seen in 220 (92.83%) patients. Sixty-six (27.85%) patients admitted to stopping their prescribed immunosuppressives by themselves during COVID-19 and a significant proportion agreed to the use of alternative medicines with questionable efficacy (n = 91; 38.39%). A significant difference in KAP was found across various strata of society like gender, age, socioeconomic status, literacy, and residence (P < 0.001). Limitations: Our study was limited by small sample size, absence of a control group with healthy individuals, and short duration of the study. Conclusions: Most of the participants had poor knowledge, a positive attitude, and good practices toward COVID-19. Proper counseling of patients and the use of telemedicine could help combat the gap in KAP without compromising the healthcare facilities needed for the management of such patients.
C1 [Mohta, Alpana; Nai, Radhe Shyam; Arora, Aakanksha; Mehta, Rajesh Dutt] Sardar Patel Med Coll, Dept Dermatol Venereol & Leprosy, Bikaner 334001, Rajasthan, India.
   [Mohta, Achala] Sardar Patel Med Coll, Dept Prevent & Social Med, Bikaner, Rajasthan, India.
   [Aggrawal, Aditi; Jain, Suresh Kumar] Govt Med Coll, Dept Dermatol Venereol & Leprosy, Kota, Rajasthan, India.
   [Singh, Arti] Sawai Mansingh Med Coll, Dept Dermatol Venereol & Leprosy, Jaipur, Rajasthan, India.
RP Mohta, A (corresponding author), Sardar Patel Med Coll, Dept Dermatol Venereol & Leprosy, Bikaner 334001, Rajasthan, India.
EM dralpanamohta10@gmail.com
CR Alnajashi H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241103
   Amalakanti S, 2020, INDIAN J MED MICROBI, V38, P144, DOI 10.4103/ijmm.IJMM_20_263
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bhadra A, 2021, MODEL EARTH SYST ENV, V7, P623, DOI 10.1007/s40808-020-00984-7
   Christy JS, 2020, INDIAN J OPHTHALMOL, V68, P2385, DOI 10.4103/ijo.IJO_2522_20
   De D, 2020, INDIAN DERMATOL ONL, V11, P526, DOI 10.4103/idoj.IDOJ_414_20
   Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557
   Hezima A, 2020, E MEDITERR HEALTH J, V26, P646, DOI 10.26719/emhj.20.076
   Pal R, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108344
   Pandey VK, 2019, INDAN J COMMUNITY HE, V31, P150
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387
   Timmis K, 2020, ENVIRON MICROBIOL, V22, P1986, DOI 10.1111/1462-2920.15029
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wani RT, 2019, J FAM MED PRIM CARE, V8, P1846, DOI 10.4103/jfmpc.jfmpc_288_19
   Yousaf MA, 2020, SOC WORK PUBLIC HLTH, V35, P569, DOI 10.1080/19371918.2020.1806983
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 17
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0019-5154
EI 1998-3611
J9 INDIAN J DERMATOL
JI Indian J. Dermatol.
PD JUL-AUG
PY 2021
VL 66
IS 4
DI 10.4103/ijd.IJD_92_21
PG 9
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA ZB0XM
UT WOS:000756575800038
PM 34759425
DA 2022-04-20
ER

PT J
AU Magro, F
   Rahier, JF
   Abreu, C
   MacMahon, E
   Hart, A
   van der Woude, CJ
   Gordon, H
   Adamina, M
   Viget, N
   Vavricka, S
   Kucharzik, T
   Leone, S
   Siegmund, B
   Danese, S
   Peyrin-Biroulet, L
AF Magro, F.
   Rahier, J-F
   Abreu, C.
   MacMahon, E.
   Hart, A.
   van der Woude, C. J.
   Gordon, H.
   Adamina, M.
   Viget, N.
   Vavricka, S.
   Kucharzik, T.
   Leone, S.
   Siegmund, B.
   Danese, S.
   Peyrin-Biroulet, L.
TI Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The
   Ten Do's and Don'ts from the ECCO-COVID Taskforce
SO JOURNAL OF CROHNS & COLITIS
LA English
DT Article
DE COVID-19; SARS-CoV-2; covid management inflammatory bowel disease
ID CORONAVIRUS; RECOMMENDATIONS; TOFACITINIB; INFECTIONS; INHIBITOR;
   SURGERY; ADULTS; IBD
AB Our knowledge of COVID-19 is changing and evolving rapidly, with novel insights and recommendations, almost on a daily basis. It behooves the medical community to provide updated information on a regular basis, on best practice to facilitate optimal care of infected patients and on appropriate advice for the general population.This is particularly important in the case of patients with chronic conditions, such as inflammatory bowel disease [IBD]. In this review, we have compiled existing evidence on the impact of COVID-19 in IBD patients and provide guidance on the most appropriate care to adopt during the pandemic. Our review highlights that IBD, per se, is not a risk factor for COVID-19. However, all IBD patients with symptoms should be tested for SARS-CoV-2 and the procedures for disease management should be carefully adapted: [i] in SARS-CoV-2-positive IBD patients, medical treatments should be re-evaluated [with a particular focus on corticosteroids] always with the purpose of treating active disease and maintaining remission; [ii] non-urgent surgeries and endoscopic procedures should be postponed for all patients; [iii] online consultancy should be implemented; and [iv] hospitalization and surgery should be limited to life-threatening situations.
C1 [Magro, F.] Univ Porto, Fac Med, Dept Biomed, Unit Pharmacol & Therapeut, Porto, Portugal.
   [Magro, F.] Ctr Hosp Sao Joao, Dept Gastroenterol, Porto, Portugal.
   [Magro, F.] Ctr Hosp Sao Joao, Dept Clin Pharmacol, Porto, Portugal.
   [Rahier, J-F] Catholic Univ Louvain, Serv Hepatogastroenterol, CHU UCL Namur, Yvoir, Belgium.
   [Abreu, C.] Ctr Hosp Univ Sao Joao, Infect Dis Serv, Porto, Portugal.
   [Abreu, C.] Univ Porto, Fac Med, Inst Inovacao & Invest Saude I3s, Dept Med, Porto, Portugal.
   [MacMahon, E.] Guys & St Thomas NHS Fdn Trust, Dept Infect Dis, London, England.
   [Hart, A.] St Marks Hosp, IBD Unit, London, England.
   [van der Woude, C. J.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.
   [Gordon, H.] Barts Hlth NHS Trust, Royal London Hosp, Dept Gastroenterol, London, England.
   [Gordon, H.] Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med, Blizard Inst, London, England.
   [Adamina, M.] Cantonal Hosp Winterthur, Dept Surg, Winterthur, Switzerland.
   [Viget, N.] Tourcoing Hosp, Dept Infect Dis, Tourcoing, France.
   [Vavricka, S.] Ctr Gastroenterol & Hepatol, Zurich, Switzerland.
   [Kucharzik, T.] Univ Hamburg, Luneburg Hosp, Dept Gastroenterol, Luneburg, Germany.
   [Leone, S.] European Federat Crohns & Ulcerat Colitis Assoc, EFCCA, Brussels, Belgium.
   [Siegmund, B.] Charite Univ Med Berlin, Berlin, Germany.
   [Siegmund, B.] Free Univ Berlin, Berlin, Germany.
   [Siegmund, B.] Humboldt Univ, Berlin, Germany.
   [Siegmund, B.] Berlin Inst Hlth, Med Klin Gastroenterol Infektiol & Rheumatol, Berlin, Germany.
   [Danese, S.] Humanitas Univ, IBD Ctr, Div Gastroenterol, Milan, Italy.
   [Peyrin-Biroulet, L.] Nancy Univ Hosp, Dept Gastroenterol, Vandoeuvre Les Nancy, France.
   [Peyrin-Biroulet, L.] Lorraine Univ, Inserm NGERE U1256, Vandoeuvre Les Nancy, France.
RP Peyrin-Biroulet, L (corresponding author), Univ Lorraine, Nancy Univ Hosp, Inserm NGERE, 1 Allee Morvan, F-54511 Vandoeuvre Les Nancy, France.; Peyrin-Biroulet, L (corresponding author), Univ Lorraine, Nancy Univ Hosp, Dept Gastroenterol, 1 Allee Morvan, F-54511 Vandoeuvre Les Nancy, France.
EM peyrinbiroulet@gmail.com
RI Danese, Silvio/ABH-9571-2020; Siegmund, Britta/E-6929-2018
OI Danese, Silvio/0000-0001-7341-1351; peyrin-biroulet,
   laurent/0000-0003-2536-6618; Leone, Salvatore/0000-0003-1690-8147;
   Siegmund, Britta/0000-0002-0055-958X; van der Woude,
   C.Janneke/0000-0003-3875-6957; Magro, Fernando/0000-0003-2634-9668
FU ECCO; IOIBD
FX This paper was published as part of a supplement financially supported
   by ECCO and IOIBD.
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Allocca M, 2020, CLIN GASTROENTEROL H, V18, P2134, DOI 10.1016/j.cgh.2020.04.071
   Aminian A, 2020, ANN SURG, V272, pE27, DOI 10.1097/SLA.0000000000003925
   An P, 2020, LANCET GASTROENTEROL, V5, P525, DOI 10.1016/S2468-1253(20)30121-7
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163
   Beilenhoff U, 2018, ENDOSCOPY, V50, P1205, DOI 10.1055/a-0759-1629
   Bezzio C, 2020, GUT, V69, P1213, DOI 10.1136/gutjnl-2020-321411
   Boor PPC, 2017, TRANSL RES, V188, P67, DOI 10.1016/j.trsl.2016.11.006
   Brat Gabriel A, 2020, Ann Surg, DOI 10.1097/SLA.0000000000003926
   Brindle ME, 2020, ANN SURG, V272, pE1, DOI 10.1097/SLA.0000000000003923
   Bruning A. H. L., 2018, New Microbes and New Infections, V24, P52, DOI 10.1016/j.nmni.2018.04.007
   Byrnes JJ, 2009, INFLAMM RES, V58, P819, DOI 10.1007/s00011-009-0053-3
   Calderwood AH, 2018, GASTROINTEST ENDOSC, V87, P1167, DOI 10.1016/j.gie.2017.12.009
   Carbajo-Lozoya J, 2014, VIRUS RES, V184, P44, DOI 10.1016/j.virusres.2014.02.010
   Cheng KW, 2015, ANTIVIR RES, V115, P9, DOI 10.1016/j.antiviral.2014.12.011
   Cheng PKC, 2004, LANCET, V363, P1699, DOI 10.1016/S0140-6736(04)16255-7
   COVIDSurg Collaborative, 2020, BRIT J SURG, V107, P1097, DOI 10.1002/bjs.11646
   D'Amico F, 2020, GASTROENTEROLOGY, V159, P14, DOI 10.1053/j.gastro.2020.04.059
   D'Amico Ferdinando, 2020, Gastroenterology, V158, P2302, DOI 10.1053/j.gastro.2020.04.032
   D'Amico F, 2020, ALIMENT PHARM THER, V51, P689, DOI 10.1111/apt.15662
   D'Antiga L, 2020, LIVER TRANSPLANT, V26, P832, DOI 10.1002/lt.25756
   Danese S, 2020, NAT REV GASTRO HEPAT, V17, P253, DOI 10.1038/s41575-020-0294-8
   Ding Q, 2020, J MED VIROL, V92, P1549, DOI 10.1002/jmv.25781
   Fiorino G, 2020, J CROHNS COLITIS, V14, P1037, DOI 10.1093/ecco-jcc/jjaa023
   Furer V, 2020, ANN RHEUM DIS, V79, P39, DOI 10.1136/annrheumdis-2019-215882
   Garg M, 2020, GUT, V69, P841, DOI 10.1136/gutjnl-2019-318512
   Geller C, 2012, VIRUSES-BASEL, V4, P3044, DOI 10.3390/v4113044
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310
   Heida A, 2018, J CROHNS COLITIS, V12, P432, DOI 10.1093/ecco-jcc/jjx169
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iacucci M, 2020, LANCET GASTROENTEROL, V5, P598, DOI 10.1016/S2468-1253(20)30119-9
   Ibrahim IM, 2020, J INFECTION, V80, P554, DOI 10.1016/j.jinf.2020.02.026
   Javid B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1442
   Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372
   Kantso B, 2015, AM J GASTROENTEROL, V110, P1582, DOI 10.1038/ajg.2015.284
   Kennedy NA, 2020, GUT, V69, P984, DOI 10.1136/gutjnl-2020-321244
   Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490
   Li YF, 2020, J MED VIROL, V92, P903, DOI 10.1002/jmv.25786
   Lin L, 2020, GUT, V69, P997, DOI 10.1136/gutjnl-2020-321013
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1070, DOI 10.1515/cclm-2020-0285
   Liu Z, 2020, INDIAN J SURG, V82, P124, DOI 10.1007/s12262-020-02173-3
   Long YL, 2020, J EVID-BASED MED, V13, P93, DOI 10.1111/jebm.12381
   Magro F, 2020, UNITED EUR GASTROENT, V8, P520, DOI 10.1177/2050640620920157
   Magro F, 2017, J CROHNS COLITIS, V11, P435, DOI 10.1093/ecco-jcc/jjw170
   Matanock A, 2019, MMWR-MORBID MORTAL W, V68, P1069, DOI 10.15585/mmwr.mm6846a5
   Neurath MF, 2020, GUT, V69, P1335, DOI 10.1136/gutjnl-2020-321269
   Nowak MD, 2020, J MED VIROL, V92, P1699, DOI 10.1002/jmv.25953
   Papamichael K, 2016, J CROHNS COLITIS, V10, P371, DOI 10.1093/ecco-jcc/jjv206
   Pei, 2020, ARXIV PREPRINT ARXIV
   Pryor A, SAGES EAES RECOMMEND
   Puolanne AM, 2019, SCAND J GASTROENTERO, V54, P849, DOI 10.1080/00365521.2019.1618910
   Rahier JF, 2014, J CROHNS COLITIS, V8, P443, DOI 10.1016/j.crohns.2013.12.013
   Remzi FH, 2020, DIS COLON RECTUM, V63, P870, DOI 10.1097/DCR.0000000000001718
   Repici A, 2020, GUT, V69, P1925, DOI 10.1136/gutjnl-2020-321341
   Repici A, 2020, GASTROINTEST ENDOSC, V92, P192, DOI 10.1016/j.gie.2020.03.019
   Rothe, 2020, CLIN PRESENTATION VI, DOI 10.1101/2020.03.05.20030502
   Rubin DT, 2020, GASTROENTEROLOGY, V159, P6, DOI 10.1053/j.gastro.2020.04.002
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Sandborn WJ, 2014, CLIN GASTROENTEROL H, V12, P1485, DOI 10.1016/j.cgh.2014.01.029
   Shang LH, 2020, LANCET, V395, P683, DOI 10.1016/S0140-6736(20)30361-5
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Taxonera C, 2020, ALIMENT PHARM THER, V52, P276, DOI 10.1111/apt.15804
   Tinsley A, 2019, INFLAMM BOWEL DIS, V25, P369, DOI 10.1093/ibd/izy243
   Turner AJ, 2004, TRENDS PHARMACOL SCI, V25, P291, DOI 10.1016/j.tips.2004.04.001
   Van Assche G, 2012, GUT, V61, P229, DOI 10.1136/gutjnl-2011-300755
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Vigneswaran Y, 2020, J GASTROINTEST SURG, V24, P1686, DOI 10.1007/s11605-020-04592-9
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang PQ, 2018, GUT, V67, P1626, DOI 10.1136/gutjnl-2017-315308
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wang X, 2020, J HOSP INFECT, V105, P399, DOI 10.1016/j.jhin.2020.04.019
   WHO, 2020, NONPH PUBL HLTH MEAS
   Wisniewski A, 2020, UNITED EUR GASTROENT, V8, P303, DOI 10.1177/2050640619889763
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   World Health Organization, NAM COR DIS COVID 19
   World Health Organization (WHO), COR DIS COVID 19 ADV
   Worldmeter, WORLD REAL TIM DAT C
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xu D, 2005, EUR J CLIN MICROBIOL, V24, P165, DOI 10.1007/s10096-005-1299-5
   Yan Y, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2106
   Yeo D, 2020, ANN SURG, V272, pE3, DOI 10.1097/SLA.0000000000003957
   Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou W, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0127-9
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zingone F, 2020, LANCET GASTROENTEROL, V5, P525, DOI 10.1016/S2468-1253(20)30085-6
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
NR 93
TC 45
Z9 45
U1 1
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1873-9946
EI 1876-4479
J9 J CROHNS COLITIS
JI J. Crohns Colitis
PD OCT
PY 2020
VL 14
SU 3
BP S798
EP S806
DI 10.1093/ecco-jcc/jjaa160
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA OW7TY
UT WOS:000593085400007
PM 32722754
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Cajanding, RJM
AF Cajanding, Ruff Joseph Macale
TI Comprehensive Review of Cardiovascular Involvement in COVID-19
SO AACN ADVANCED CRITICAL CARE
LA English
DT Review
DE acute coronary syndrome; coronary artery disease; COVID-19; nursing;
   pathophysiology; SARS-CoV-2
ID ANGIOTENSIN-CONVERTING ENZYME; ACUTE RESPIRATORY SYNDROME; SYNDROME
   CORONAVIRUS INFECTION; ACUTE MYOCARDIAL-INFARCTION; SARS CORONAVIRUS;
   ACE2 RECEPTOR; SARS-COV-2; EXPRESSION; RISK; INACTIVATION
AB COVID-19 has emerged as one of the most devastating and clinically significant infectious diseases of the last decade. It has reached global pandemic status at an unprecedented pace and has placed significant demands on health care systems worldwide. Although COVID-19 primarily affects the lungs, epidemiologic reports have shown that the disease affects other vital organs of the body, including the heart, vasculature, kidneys, brain, and the hematopoietic system. Of importance is the emerging awareness of the effects of COVID-19 on the cardiovascular system. The current state of knowledge regarding cardiac involvement in COVID-19 is presented in this article, with particular focus on the cardiovascular manifestations and complications of COVID-19 infection. The mechanistic insights of disease causation and the relevant pathophysiology involved in COVID-19 as they affect the heart are explored and described. Relevant practice essentials and clinical management implications for patients with COVID-19 with a cardiac pathology are presented in light of recent evidence.
C1 [Cajanding, Ruff Joseph Macale] Barts Hlth NHS Trust, Adult Crit Care Unit, St Bartholomews Hosp, 6th Floor,King George V Bldg,2 King Edward St, London EC1A 1HQ, England.
RP Cajanding, RJM (corresponding author), Barts Hlth NHS Trust, Adult Crit Care Unit, St Bartholomews Hosp, 6th Floor,King George V Bldg,2 King Edward St, London EC1A 1HQ, England.
EM ruffcajanding@nhs.net
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Ammirati E, 2020, INT J CARDIOL, V311, P122, DOI 10.1016/j.ijcard.2020.03.086
   Babapoor-Farrokhran Savalan, 2020, SN Compr Clin Med, V2, P1430, DOI 10.1007/s42399-020-00454-2
   Barnes M, 2015, HEART, V101, P1738, DOI 10.1136/heartjnl-2015-307691
   Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080
   Berk BC, 1997, CIRC RES, V80, P607, DOI 10.1161/01.RES.80.5.607
   Bernstein KE, 2018, NAT REV NEPHROL, V14, P325, DOI 10.1038/nrneph.2018.15
   Bhatla A, 2020, HEART RHYTHM, V17, P1439, DOI 10.1016/j.hrthm.2020.06.016
   Borakati A, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042946
   Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210
   Capotosto L, 2020, ECHOCARDIOGR-J CARD, V37, P1454, DOI 10.1111/echo.14834
   Carey RM, 2017, AM J HYPERTENS, V30, P339, DOI 10.1093/ajh/hpw121
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Cleverley J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2426
   Cohen J, SCIENCE
   COLLINS S. D., 1932, Public Health Reports, V47, P2159, DOI 10.2307/4580606
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742
   Dendorfer A, 2002, HYPERTENSION, V40, P348, DOI 10.1161/01.HYP.0000028001.65341.AA
   Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296
   Dolhnikoff M, 2020, LANCET CHILD ADOLESC, V4, P790, DOI 10.1016/S2352-4642(20)30257-1
   Farcas GA, 2005, J INFECT DIS, V191, P193, DOI 10.1086/426870
   Ferrario CM, 1997, HYPERTENSION, V30, P535, DOI 10.1161/01.HYP.30.3.535
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Gallelli L, 2020, J CLIN PHARMACOL, V60, P815, DOI 10.1002/jcph.1644
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Goldman E, 2020, LANCET INFECT DIS, V20, P892, DOI 10.1016/S1473-3099(20)30561-2
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Goulter AB, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-19
   Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2
   Grifoni E, 2020, J INFECTION, V81, P466, DOI 10.1016/j.jinf.2020.06.008
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Haseeb S, 2020, J ELECTROCARDIOL, V62, P39, DOI 10.1016/j.jelectrocard.2020.08.007
   Henry BM, 2020, AM J EMERG MED, V38, P1722, DOI 10.1016/j.ajem.2020.05.073
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Huang L, 2020, CELL MOL IMMUNOL, V17, P1092, DOI 10.1038/s41423-020-00522-6
   Izaguirre G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090837
   Jayaweera M, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109819
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   Judson SD, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100940
   Jurisic V, 2015, ADV EXP MED BIOL, V867, P115, DOI 10.1007/978-94-017-7215-0_8
   Kabbani N, 2020, MOL PHARMACOL, V97, P351, DOI 10.1124/molpharm.120.000014
   Kai H, 2020, HYPERTENS RES, V43, P648, DOI 10.1038/s41440-020-0455-8
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kaur N, 2021, INFECT GENET EVOL, V89, DOI 10.1016/j.meegid.2020.104490
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kuba K, 2013, CIRC J, V77, P301, DOI 10.1253/circj.CJ-12-1544
   Kumar S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050486
   Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0
   Lanini S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244129
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Lillicrap D, 2020, J THROMB HAEMOST, V18, P786, DOI 10.1111/jth.14781
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1201
   Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020
   McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537
   McKee DL, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104859
   Mehra MR, 2020, JACC-HEART FAIL, V8, P512, DOI 10.1016/j.jchf.2020.03.004
   Mensah GA, 2019, J AM COLL CARDIOL, V74, P2529, DOI 10.1016/j.jacc.2019.10.009
   Merrill JT, 2020, NAT REV RHEUMATOL, V16, P581, DOI 10.1038/s41584-020-0474-5
   Modi M, 2020, PREPRINT RES SQ
   Mohd HA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0544-0
   Muscente F, 2020, EUR HEART J SUPPL, V22, pE68, DOI 10.1093/eurheartj/suaa064
   Myers L, 2020, J AM COLL RADIOL, V17, P724, DOI 10.1016/j.jacr.2020.03.025
   Nachimuthu S, 2012, THER ADV DRUG SAF, V3, P241, DOI 10.1177/2042098612454283
   Nicin L, 2020, EUR HEART J, V41, P1804, DOI 10.1093/eurheartj/ehaa311
   Notter J, 2020, CLIN INTEGRATED CARE, V1, DOI [10.1016/j.intcar.2020.100003, DOI 10.1016/J.INTCAR.2020.100003]
   Ortega JT, 2020, EXCLI J, V19, P410, DOI 10.17179/excli2020-1167
   Pal R, 2020, CUREUS, V12, DOI 10.7759/cureus.12067
   Perico L, 2020, NEPHRON, V144, P213, DOI 10.1159/000507305
   Pessoa-Amorim G, 2020, EUR HEART J-QUAL CAR, V6, P210, DOI 10.1093/ehjqcco/qcaa046
   Pirzada Ashar, 2020, CJC Open, V2, P278, DOI 10.1016/j.cjco.2020.05.005
   Pranata R, 2020, POSTGRAD MED J, V96, P387, DOI 10.1136/postgradmedj-2020-137884
   Putot A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060827
   Rabenau HF, 2005, MED MICROBIOL IMMUN, V194, P1, DOI 10.1007/s00430-004-0219-0
   Rey JR, 2020, EUR J HEART FAIL, V22, P2205, DOI 10.1002/ejhf.1990
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2098, DOI 10.1001/jama.2020.7681
   Rosen MA, 2018, AM PSYCHOL, V73, P433, DOI 10.1037/amp0000298
   Rubin GD, 2020, RADIOLOGY, V296, P172, DOI 10.1148/radiol.2020201365
   Sabatino J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237131
   Saleh M, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008662
   Satou R, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0900-0
   Shaha KB, 2021, POSTGRAD MED J, V97, P655, DOI 10.1136/postgradmedj-2020-138284
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Silva GM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.01067
   Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005
   Singh V, 2021, J CARDIOVASC COMPUT, V15, P16, DOI 10.1016/j.jcct.2020.11.004
   Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001
   Sisti N, 2021, POSTGRAD MED J, V97, P175, DOI 10.1136/postgradmedj-2020-138080
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   Soos I, 2020, STATPEARLS INTERNET
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tao XR, 2016, J VIROL, V90, P57, DOI 10.1128/JVI.02009-15
   Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828
   The European Society for Cardiology, ESC GUIDANCE DIAGNOS
   Thomas RJ, 2013, VIRULENCE, V4, P847, DOI 10.4161/viru.27172
   Tsakok Maria, 2020, BJR Open, V2, P20200034, DOI 10.1259/bjro.20200034
   Unudurthi SD, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118482
   van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199
   van den Broek MPH, 2020, NETH HEART J, V28, P406, DOI 10.1007/s12471-020-01429-7
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757
   Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065
   Wang LF, 2006, EMERG INFECT DIS, V12, P1834
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   Wu MY, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01427-8
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu H, 2020, CURR CARDIOL REP, V22, DOI [10.1007/s11886-020-01292-3, 10.1007/s11886-020-01302-4]
   Zhu N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17796-z
NR 123
TC 2
Z9 2
U1 2
U2 3
PU AMER ASSOC CRITICAL CARE NURSES
PI ALISO VIEJO
PA 101 COLUMBIA, ALISO VIEJO, CA 92656 USA
SN 1559-7768
EI 1559-7776
J9 AACN ADV CRIT CARE
JI AACN Adv. Crit. Care
PD SUM
PY 2021
VL 32
IS 2
BP 169
EP 187
DI 10.4037/aacnacc2021302
PG 19
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA SO6SM
UT WOS:000659102500008
PM 33836538
OA Bronze
DA 2022-04-20
ER

PT J
AU Davies, SE
   Wenham, C
AF Davies, Sara E.
   Wenham, Clare
TI Why the COVID-19 response needs International Relations
SO INTERNATIONAL AFFAIRS
LA English
DT Article
DE Covid-19; International Relations; diplomacy; human rights; World Health
   Organization; sovereignty
ID GLOBAL HEALTH; DOMESTIC POLITICS; SOCIAL MEDIA; EBOLA; GOVERNANCE;
   OUTBREAK; LESSONS
AB The COVID-19 pandemic affects all countries, but how governments respond is dictated by politics. Amid this, the World Health Organization (WHO) has tried to coordinate advice to states and offer ongoing management of the outbreak. Given the political drivers of COVID-19, we argue this is an important moment to advance International Relations knowledge as a necessary and distinctive method for inclusion in the WHO repertoire of knowledge inputs for epidemic control. Historical efforts to assert technical expertise over politics is redundant and outdated: the WHO has always been politicized by member states. We suggest WHO needs to embrace the politics and engage foreign policy and diplomatic expertise. We suggest practical examples of the entry points where International Relations methods can inform public health decision-making and technical policy coordination. We write this as a primer for those working in response to COVID-19 in WHO, multilateral organizations, donor financing departments, governments and international non-governmental organizations, to embrace political analysis rather than shy away from it. Coordinated political cooperation is vital to overcome COVID-19.
C1 [Davies, Sara E.] Griffith Univ, Int Relat, Sch Govt & Int Relat, Nathan, Qld, Australia.
   [Wenham, Clare] London Sch Econ & Polit Sci, Global Hlth Policy, London, England.
RP Davies, SE (corresponding author), Griffith Univ, Int Relat, Sch Govt & Int Relat, Nathan, Qld, Australia.
CR Adler Emmanuel, 2000, SECURITY COMMUNITIES, P4
   Allison G., 1999, ESSENCE DECISION, V2nd
   [Anonymous], 2020, ITV NEWS
   [Anonymous], 2020, BBC NEWS
   [Anonymous], 2020, WHO DIRECTOR GEN OPE
   [Anonymous], 2019, REUTERS         1003
   [Anonymous], 2014, BBC NEWS
   [Anonymous], 2020, WHO ELECT STATE PART
   [Anonymous], 2006, CONST WHO
   Aratani L., 2020, GUARDIAN
   Autesserre S., 2014, PEACEL CONFLICT R
   Avant Deborah D., 2012, WHO GOVERNS GLOBE
   Azcona G, 2020, SPOTLIGHT GENDER COV
   Bandiera Oriana, 2018, F39301SLE2 INT GROWT
   Barnett M.N., 2004, RULES WORLD INT ORG
   Betim Felipe, 2020, PAIS
   Bonilla Y, 2015, AM ETHNOL, V42, P4, DOI 10.1111/amet.12112
   BORGER Julian., 2020, GUARDIAN
   Browne, 2020, CNBC
   Cameron David, TIMES
   Carey JM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw7449
   Chalmers AW, 2014, WEST EUR POLIT, V37, P976, DOI 10.1080/01402382.2013.852832
   Chorev N., 2012, WORLD HLTH ORG N S
   Clift Charles, 2014, WHATS WHO
   Cook S, 2019, INT AFF, V95, P1289, DOI 10.1093/ia/iiz179
   Corasaniti Nick, 2020, NY TIMES
   Cortell AP, 2006, POLIT ECON I DECIS, P255, DOI 10.1017/CBO9780511491368.010
   Costello A., 2020, GUARDIAN
   Dalglish SL, 2020, LANCET, V395, P1189, DOI 10.1016/S0140-6736(20)30739-X
   Davies Sara, 2010, GLOBAL POLITICS HLTH, P34
   Davies SE, 2017, MED LAW REV, V25, P270, DOI 10.1093/medlaw/fwx011
   Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704
   Davies SE, 2016, THIRD WORLD Q, V37, P419, DOI 10.1080/01436597.2015.1110015
   Davies SE, 2013, INT J HUM RIGHTS, V17, P133, DOI 10.1080/13642987.2012.710840
   Davies SE, 2012, INT POLITICS, V49, P591, DOI 10.1057/ip.2012.19
   Davies Sara E., 2015, DIS DIPLOMACY INT NO
   Davies SE, 2019, CONTAINING CONTAGION: THE POLITICS OF DISEASE OUTBREAKS IN SOUTHEAST ASIA, P1
   Dionne K.Y., 2018, DOOMED INTERVENTIONS
   Eccleston-Turner Mark, 2020, OPINIOJURIS     0331
   Elbe S., 2009, VIRUS ALERT SECURITY
   Elbe S, 2010, HEALTH POLICY PLANN, V25, P476, DOI 10.1093/heapol/czq050
   Elbe Stefan., 2010, SECURITY GLOBAL HLTH
   Enloe Cynthia, 2014, BANANAS BEACHES BASE
   Eve Frances, 2020, GUARDIAN
   Feldwisch-Drentrup Hinnerk., 2020, FOREIGN POLICY
   Fidler D., 2020, THINK GLOBAL HL 0410
   Fidler DP, 2003, J LAW MED ETHICS, V31, P485, DOI 10.1111/j.1748-720X.2003.tb00117.x
   Freeze M, 2021, POLIT BEHAV, V43, P1433, DOI 10.1007/s11109-020-09597-3
   Frieden Thomas R., 2020, THINK GLOBAL HL 0131
   Georgetown University Medical Center Center for Global Health Science and Security, 2017, IHR COST TOOL
   Ghebreyesus Tedros Adhanom, 2020, BLOOMBERG QUICK 0723
   Gillespie A, 2016, GLOB HEALTH-SCI PRAC, V4, P626, DOI 10.9745/GHSP-D-16-00226
   Glenza J., 2020, GUARDIAN
   Graham-Harrison E., 2020, GUARDIAN
   Grieco JM, 2019, INT STUD REV, V21, P424, DOI 10.1093/isr/viy005
   Griffin A., 2020, INDEPENDENT
   Gulland A., 2020, DAILY TELEGRAPH
   Hanrieder T, 2014, SECUR DIALOGUE, V45, P331, DOI 10.1177/0967010614535833
   Hanrieder Tine, INT ORG ORCHESTRATOR, P192
   Harman S., 2012, GLOBAL HLTH GOVERNAN
   Harman S, 2018, GLOBALIZATIONS, V15, P362, DOI 10.1080/14747731.2017.1414410
   Harman S, 2016, THIRD WORLD Q, V37, P524, DOI 10.1080/01436597.2015.1108827
   Harman S, 2011, GLOBALIZATIONS, V8, P213, DOI 10.1080/14747731.2010.493023
   HARRIS J, 2017, ACHIEVING ACCESS PRO
   Harris Kathleen, 2020, CBC             0305
   Hawkins DG, 2006, POLIT ECON I DECIS, P1, DOI 10.2277/ 0521862094
   Hawn C, 2009, HEALTH AFFAIR, V28, P361, DOI 10.1377/hlthaff.28.2.361
   Herten-Crabb A, 2020, LANCET, V395, P1018, DOI 10.1016/S0140-6736(20)30110-0
   Highfield, 2017, SOCIAL MEDIA EVERYDA
   Horton Richard, 2020, LANCET, V395, P10224
   Howard Philip N., 2011, 20111 PIPTI U WASH
   Huang Pien, 2020, NPR GOATS SODA  0601
   Hurst D., 2020, GUARDIAN
   International Health Regulations, 2005, GLOB PRIOR LIST ANT, P7
   Jephcott FL, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4566
   Kamradt-Scott A, 2016, THIRD WORLD Q, V37, P401, DOI 10.1080/01436597.2015.1112232
   Kamradt-Scott A, 2012, GLOB CHANG PEACE SEC, V24, P57, DOI 10.1080/14781158.2012.641284
   Kamradt-Scott A, 2011, GLOB PUBLIC HEALTH, V6, P801, DOI 10.1080/17441692.2010.513690
   Kamradt-Scott Adam, 2010, J INT ORG STUDIES, V1, P77
   Kamradt-Scott Adam, 2017, INT AFF, V93, P1313
   Kempe F., 2020, CNBC
   Kennedy AB, 2018, INT AFF, V94, P553, DOI 10.1093/ia/iiy044
   Kennedy J, 2017, HEALTH POLICY PLANN, V32, P690, DOI 10.1093/heapol/czw148
   Khor Kheng, 2020, THINK GLOBAL HL 0630
   Khor Swee Kheng, 2020, THINK GLOBAL HL 0124
   Kickbusch Ilona, 2020, BMJ OPINION
   Kiernan Samantha, 2020, THINK GLOBAL HL 0406
   Killeen Olivia J, 2018, Glob Health Gov, V12, P4
   Kittelsen SK, 2019, HEALTH POLICY PLANN, V34, P553, DOI 10.1093/heapol/czz066
   Kluge H, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000656
   Kreuder-Sonnen C, 2019, INT AFF, V95, P535, DOI 10.1093/ia/iiz022
   Lake DA, 2013, EUR J INT RELAT, V19, P567, DOI 10.1177/1354066113494330
   Marquette Heather, 2020, POVERTY POWER
   McInnes C, 2015, INT AFF, V91, P1299, DOI 10.1111/1468-2346.12454
   McPhee E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6978-8
   Nakamura David, 2020, WASH POST
   Nathan L, 2006, EUR J INT RELAT, V12, P275, DOI 10.1177/1354066106064510
   Nuclear Threat Initiative and Johns Hopkins Center for Health Security, 2019, GLOB HLTH SEC IND
   O'Malley Peter, 2009, B WHO, V87
   Pangestika D., 2020, JAKARTA POST
   Patel Nikhil ` Sunny' A., 2020, GUARDIAN
   Patterson A, 2020, INT J HEALTH POLICY, V9, P429, DOI 10.34172/ijhpm.2020.72
   Peterman A., 2020, CTR GLOBAL DEV WORKI
   Phelan AL, 2020, LANCET, V395, P1595, DOI 10.1016/S0140-6736(20)31034-5
   Phillips T, 2020, GUARDIAN
   Price-Smith Andrew T., 2001, HLTH NATIONS
   Purdy Christopher, 2020, LINKEDIN        0307
   PUTNAM RD, 1988, INT ORGAN, V42, P427, DOI 10.1017/S0020818300027697
   Rajan D, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002655
   Reddy SK, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0436-8
   Ross Emma, 2017, S LEONES RESPONSE EB
   Rourke MF, 2019, MILBANK Q, V97, P91, DOI 10.1111/1468-0009.12364
   Sample I., 2013, THE GUARDIAN 1215
   Sekalala Sharifah, 2017, SOFT LAW GLOBAL HLTH
   Smith D., 2020, GUARDIAN
   Smith J., 2019, Gender and Development, V27, P355, DOI 10.1080/13552074.2019.1615288
   Sochas L, 2017, HEALTH POLICY PLANN, V32, P32, DOI 10.1093/heapol/czx108
   Tsai FJ, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-0541-3
   Tsai FJ, 2018, HEALTH SECUR, V16, P304, DOI 10.1089/hs.2018.0019
   Nguyen VK, 2019, NEW ENGL J MED, V380, P1298, DOI 10.1056/NEJMp1902682
   Warton Jane, 2020, METRO
   Wenham C, 2020, NATURE, V583, P194, DOI 10.1038/d41586-020-02006-z
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   Wenham C, 2019, SECUR DIALOGUE, V50, P398, DOI 10.1177/0967010619856458
   Wenham Clare, 2021, CLEAN YOUR HOUSE DON
   Wenham Clare, 2020, BMJ OPINION
   Wesseh CS, 2017, PUBLIC HEAL ACTION, V7, P82, DOI [10.5588/pha.16.0104, DOI 10.5588/PHA.16.0104]
   Wheeler Nicholas J, 2012, PEACE PRINTS S ASIAN, V4, P1
   WHO, 2017, KEY FIG
   WHO, COR DIS COVID 19 DON
   World Health Organization, JOINT EXT EV JEE MIS
   World Health Organization, COVID 19 SOL RESP FU
   Worsnop CZ, 2017, REV INT ORGAN, V12, P365, DOI 10.1007/s11558-016-9260-1
   Yang X, 2020, INT AFF, V96, P419, DOI 10.1093/ia/iiz251
   Yemin Seema, 2016, FOREIGN POLICY
   Youde J, 2010, BIOPOLITICAL SURVEILLANCE AND PUBLIC HEALTH IN INTERNATIONAL POLITICS, P1, DOI 10.1057/9780230104785
   Youde Jeremy, 2012, GLOBAL HLTH GOVERNAN
   Zangl B., 2015, INT ORG ORCHESTRATOR
   Zarakol A., 2017, HIERARCHIES WORLD PO
NR 139
TC 30
Z9 31
U1 13
U2 33
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0020-5850
EI 1468-2346
J9 INT AFF
JI Int. Aff.
PD SEP 1
PY 2020
VL 96
IS 5
BP 1227
EP +
DI 10.1093/ia/iiaa135
PG 26
WC International Relations
WE Social Science Citation Index (SSCI)
SC International Relations
GA OH6CT
UT WOS:000582676200008
PM 34191916
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Kirthana, V
   Venkataiah, B
   Murthy, MRN
AF Kirthana, V.
   Venkataiah, B.
   Murthy, M. R. Narayana
TI COVID 19 in ayurvedic perspective
SO INTERNATIONAL JOURNAL OF HEALTH AND ALLIED SCIENCES
LA English
DT Article
DE Ayurveda; COVID 19; health; prevention; public
AB The age-old science of Ayurveda has many secrets hidden within. The coronavirus disease is a novel disease, as indicated by its nomenclature also. The plural medical system approach is being implemented to combat the disease. There are many references in the ayurvedic textbooks/classics/Samhitas about janapadodwamsa or epidemics in the age of gods and the management of such epidemics or janapadodwamsa can also be evidenced in the classics of Ayurveda. The principles of Ayurveda can be applied for both preventive and curative aspects of disease. The practical knowledge and the knowledge about the stage of the disease are essential to bridge the ayurvedic principles with the preventive and curative aspects of the disease. The efficiency of ayurvedic drugs is known by practice. However, new drugs can be formulated with a combination of drugs. The search for new drugs and new preventive practices in an integrated approach is what the approach is to be to tackle the novel virus. In this regard, the current paper aims to bridge the preventive aspects of COVID 19 with respect to various stages of disease in ayurvedic aspect.
C1 [Kirthana, V.; Murthy, M. R. Narayana] JSSMC, Dept Community Med, Mysore, Karnataka, India.
   [Venkataiah, B.] Dr BRKR Govt Ayurveda Coll, Hyderabad, Telangana, India.
EM kirthana.vdoc@gmail.com
CR [Anonymous], 2019, CORONAVIRUS DIS
   [Anonymous], COVID 19 INDIA
   CDC, 2020, **NON-TRADITIONAL**
   Gupta Ankit, 2010, Ayu, V31, P520, DOI 10.4103/0974-8520.82032
   Krupashree K, 2014, S AFR J BOT, V94, P249, DOI 10.1016/j.sajb.2014.07.001
   Maria Masood, 2015, Pure and Applied Biology, V4, P407
   Nagarajan M, 2015, J Ayurveda Integr Med, V6, P121, DOI 10.4103/0975-9476.146551
   Rastogi Sanjeev, 2022, J Ayurveda Integr Med, V13, P100312, DOI 10.1016/j.jaim.2020.04.002
   Rawat N, 2018, WORLD J PHARM RES, V7, P355
   Shrestha S., 2017, INT AYURVEDIC MED J, V1, P316
   Singh RL, 2012, INDIAN J NAT PROD, V8, P238
   Sushil Bhargava, 2009, Scientia Pharmaceutica, V77, P617, DOI 10.3797/scipharm.0812-10
   Tillu G, 2020, J ALTERN COMPLEM MED, V26, P360, DOI 10.1089/acm.2020.0129
   Upadhyay Avnish K, 2010, Int J Ayurveda Res, V1, P112, DOI 10.4103/0974-7788.64405
NR 14
TC 1
Z9 1
U1 1
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2278-4292
EI 2278-344X
J9 INT J HLTH ALLIED SC
JI Int. J. Health Allied Sci.
PD APR-JUN
PY 2020
VL 9
SU 1
BP 91
EP 96
DI 10.4103/ijhas.IJHAS_110_20
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA QG7MJ
UT WOS:000617767200018
DA 2022-04-20
ER

PT J
AU Preckel, B
   Schultz, MJ
   Vlaar, AP
   Hulst, AH
   Hermanides, J
   de Jong, MD
   Schlack, WS
   Stevens, MF
   Weenink, RP
   Hollmann, MW
AF Preckel, Benedikt
   Schultz, Marcus J.
   Vlaar, Alexander P.
   Hulst, Abraham H.
   Hermanides, Jeroen
   de Jong, Menno D.
   Schlack, Wolfgang S.
   Stevens, Markus F.
   Weenink, Robert P.
   Hollmann, Markus W.
TI Update for Anaesthetists on Clinical Features of COVID-19 Patients and
   Relevant Management
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE COVID-19; SARS-CoV-2; ventilation; emergency care; intubation; antiviral
   therapy
ID DRIVING PRESSURE; RAPID TESTS; MORTALITY; CORONAVIRUS; INFLUENZA;
   INFECTION; SURVIVAL; DRUGS
AB When preparing for the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the coronavirus infection disease (COVID-19) questions arose regarding various aspects concerning the anaesthetist. When reviewing the literature it became obvious that keeping up-to-date with all relevant publications is almost impossible. We searched for and summarised clinically relevant topics that could help making clinical decisions. This is a subjective analysis of literature concerning specific topics raised in our daily practice (e.g., clinical features of COVID-19 patients; ventilation of the critically ill COVID-19 patient; diagnostic of infection with SARS-CoV-2; stability of the virus; Covid-19 in specific patient populations, e.g., paediatrics, immunosuppressed patients, patients with hypertension, diabetes mellitus, kidney or liver disease; co-medication with non-steroidal anti-inflammatory drugs (NSAIDs); antiviral treatment) and we believe that these answers help colleagues in clinical decision-making. With ongoing treatment of severely ill COVID-19 patients other questions will come up. While respective guidelines on these topics will serve clinicians in clinical practice, regularly updating all guidelines concerning COVID-19 will be a necessary, although challenging task in the upcoming weeks and months. All recommendations during the current extremely rapid development of knowledge must be evaluated on a daily basis, as suggestions made today may be out-dated with the new evidence available tomorrow.
C1 [Preckel, Benedikt; Hulst, Abraham H.; Hermanides, Jeroen; Schlack, Wolfgang S.; Stevens, Markus F.; Weenink, Robert P.; Hollmann, Markus W.] Amsterdam Univ Med Ctr, Locat AMC, Dept Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   [Preckel, Benedikt; Schultz, Marcus J.; Vlaar, Alexander P.; Hollmann, Markus W.] Amsterdam Univ Med Ctr, Locat AMC, Lab Expt Intens Care & Anesthesiol LEICA, NL-1105 AZ Amsterdam, Netherlands.
   [Schultz, Marcus J.; Vlaar, Alexander P.] Amsterdam Univ Med Ctr, Locat AMC, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands.
   [Schultz, Marcus J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.
   [Schultz, Marcus J.] Univ Oxford, Nuffield Dept Med, Old Rd Campus Res Build,Roosevelt Dr, Oxford OX3 7DQ, England.
   [de Jong, Menno D.] Amsterdam Univ Med Ctr, Dept Med Microbiol & Infect Prevent, Locat AMC, NL-1105 AZ Amsterdam, Netherlands.
RP Preckel, B; Hermanides, J (corresponding author), Amsterdam Univ Med Ctr, Locat AMC, Dept Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Preckel, B (corresponding author), Amsterdam Univ Med Ctr, Locat AMC, Lab Expt Intens Care & Anesthesiol LEICA, NL-1105 AZ Amsterdam, Netherlands.
EM b.preckel@amsterdamumc.nl; m.j.schultz@amsterdamumc.nl;
   a.p.vlaar@amsterdamumc.nl; a.h.hulst@amsterdamumc.nl;
   j.hermanides@amsterdamumc.nl; m.d.dejong@amsterdamumc.nl;
   w.s.schlack@amsterdamumc.nl; m.f.stevens@amsterdamumc.nl;
   r.p.weenink@amsterdamumc.nl; m.w.hollmann@amsterdamumc.nl
RI Schultz, Marcus/AAB-6379-2021; Weenink, Robert/E-1778-2012
OI Schultz, Marcus/0000-0003-3969-7792; Hermanides,
   Jeroen/0000-0003-2239-1260; Weenink, Robert/0000-0003-3079-4115;
   Stevens, Markus Florian/0000-0002-0032-860X
CR Albert RK, 2014, AM J RESP CRIT CARE, V189, P494, DOI 10.1164/rccm.201311-2056LE
   Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639
   Anguiano L, 2017, CURR MED CHEM, V24, P3231, DOI 10.2174/0929867324666170414162841
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Boudreaux ED, 2002, ANN EMERG MED, V40, P193, DOI 10.1067/mem.2002.124899
   Brodin P, 2020, ACTA PAEDIATR, V109, P1082, DOI 10.1111/apa.15271
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Bruning AHL, 2017, CLIN INFECT DIS, V65, P1026, DOI 10.1093/cid/cix461
   Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171
   CDC, 2019, NOV COR 2019 NCOV RE
   Chen C, 2020, ANN INTERN MED, V172, P832, DOI 10.7326/M20-0991
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Yu Wai, 2020, F1000Res, V9, P129, DOI 10.12688/f1000research.22457.2
   Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Constantin JM, 2019, LANCET RESP MED, V7, P870, DOI 10.1016/S2213-2600(19)30138-9
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Cui YX, 2020, J INFECT DIS, V221, P1775, DOI 10.1093/infdis/jiaa113
   D'Antiga L, 2020, LIVER TRANSPLANT, V26, P832, DOI 10.1002/lt.25756
   Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082
   Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086
   De Luca D, 2020, LANCET CHILD ADOLESC, V4, pE8, DOI 10.1016/S2352-4642(20)30073-0
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Dexter F, 2020, CAN J ANESTH, V67, P1104, DOI 10.1007/s12630-020-01655-y
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Duan LP, 2020, ENERGY TECHNOL-GER, V8, DOI 10.1002/ente.201901401
   Esler M, 2020, J HYPERTENS, V38, P781, DOI 10.1097/HJH.0000000000002450
   Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880
   Fang Y., 2020, RADIOLOGY, DOI [10.1016/S0140-6736(20)30183-5, 10.1148/radiol.2020200280., DOI 10.1148/RADIOL.2020200280]
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Foundation for Innovative New Diagnostic (FIND), COVID 19 DIAGN RES C
   Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114
   Gu, 2020, RELATIONSHIP ABO BLO, DOI [10.1101/2020.03.11.20031096, DOI 10.1101/2020.03.11.20031096]
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310
   Hopkins C, 2020, RHINOLOGY, V58, P295, DOI 10.4193/Rhin20.116
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]
   Kam KQ, 2020, CLIN INFECT DIS, V71, P847, DOI 10.1093/cid/ciaa201
   Kelvin AA, 2020, LANCET INFECT DIS, V20, P633, DOI 10.1016/S1473-3099(20)30236-X
   Krogfelt A., 2020, EVALUATION 9 COMMERC, P1, DOI DOI 10.1101/2020.04.09.20056325
   Lazzerini M, 2020, LANCET CHILD ADOLESC, V4, pE10, DOI 10.1016/S2352-4642(20)30108-5
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Leone M, 2020, INTENS CARE MED, V46, P697, DOI 10.1007/s00134-020-05948-0
   Leva E., 2020, J PEDIAT SURG
   Li KW, 2020, EUR RADIOL, V30, P4407, DOI 10.1007/s00330-020-06817-6
   Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6041
   Liu M, 2019, DIABETES METAB, V45, P286, DOI 10.1016/j.diabet.2018.08.008
   Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848
   Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029
   Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Park S, MANAGING FEVER ADULT
   Perico L, 2020, NEPHRON, V144, P213, DOI 10.1159/000507305
   Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5
   Rismanbaf A, 2020, ARCH ACAD EMERG MED, V8
   Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016
   Roussel Y, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105947
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Shi XD, 2020, J MED VIROL, V92, P1922, DOI 10.1002/jmv.25893
   Sorbello M, 2020, ANAESTHESIA, V75, P724, DOI 10.1111/anae.15049
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Sun D, 2020, WORLD J PEDIATR, V16, P251, DOI 10.1007/s12519-020-00354-4
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Tung A, 2020, BRIT J ANAESTH, V124, P480, DOI 10.1016/j.bja.2019.12.041
   Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   van Meenen DM, 2019, J THORAC DIS, V11, P5004, DOI 10.21037/jtd.2019.12.38
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang HX, 2020, EUR RADIOL, V30, P5578, DOI 10.1007/s00330-020-06943-1
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wen YC, 2018, PHARMACOEPIDEM DR S, V27, P645, DOI 10.1002/pds.4428
   Wen YC, 2017, J INFECT DIS, V215, P503, DOI 10.1093/infdis/jiw603
   Wu J, 2020, J INTERN MED, V288, P128, DOI 10.1111/joim.13063
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Xing YH, 2020, J MICROBIOL IMMUNOL, V53, P473, DOI 10.1016/j.jmii.2020.03.021
   Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Yang SS, 2020, BRIT J ANAESTH, V124, P314, DOI 10.1016/j.bja.2019.11.033
   Yang W., 2020, RADIOLOGY, V295, P3
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Ye Z, 2020, EUR RADIOL, V30, P4381, DOI 10.1007/s00330-020-06801-0
   Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zeng LK, 2020, JAMA PEDIATR, V174, P722, DOI 10.1001/jamapediatrics.2020.0878
   Zhou D, 2020, J ANTIMICROB CHEMOTH, V75, P1667, DOI 10.1093/jac/dkaa114
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou YD, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0153-3
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 107
TC 6
Z9 6
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD MAY
PY 2020
VL 9
IS 5
AR 1495
DI 10.3390/jcm9051495
PG 19
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LY0OO
UT WOS:000540223800252
PM 32429249
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Nnaji, C
   Jin, ZY
   Karakhan, A
AF Nnaji, Chukwuma
   Jin, Ziyu
   Karakhan, Ali
TI p Safety and health management response to COVID-19 in the construction
   industry: A perspective of fieldworkers
SO PROCESS SAFETY AND ENVIRONMENTAL PROTECTION
LA English
DT Article
DE COVID-19; Pandemic; Coronavirus; Construction management; Safety and
   health; Strategies; Technologies
ID WORKERS; PERFORMANCE; TECHNOLOGY; CULTURE
AB The COVID-19 outbreak has significantly impacted the construction industry. The pandemic can exacerbate an already dire safety and health situation in the industry and negatively impact construction employees and employers. The present study investigates the safety and health measures implemented by construction firms in the United States (US), their effectiveness and usefulness, and workers' satisfaction with these COVID-19 measures. A questionnaire survey was developed and distributed to construction fieldworkers in the US to collect their perspectives on the implemented COVID-19 measures in the construction industry. A total of 187 valid responses were received and analyzed to achieve the aim of the study. Results revealed that strategies implemented to increase social distance and minimize group gathering to 10 persons in certain workstations were perceived to be substantially more effective than job-site screening strategies. Furthermore, smaller contractors implemented fewer safety measures and perceived them to be significantly less effective than those used by medium- and large-sized contractors. Fieldworkers were favorably disposed toward using technologies, such as video-conferencing apps and wearable sensing devices, to slow the spread of COVID-19 on construction job sites. The present study contributes to the body of knowledge by identifying safety and health measures to mitigate the spread of COVID-19 in construction. Practically, the study findings provide valuable insights to inform the successful implementation of safety strategies in the construction industry during a pandemic. The results are crucial for industry practitioners responsible for developing and revising pre- and post-pandemic safety and health plans.
C1 [Nnaji, Chukwuma] Univ Alabama, Dept Civil Construct & Environm Engn, 3043 HM Comer, Tuscaloosa, AL 35487 USA.
   [Jin, Ziyu] Univ New Mexico, Dept Civil Construct & Environm Engn, Centennial Engn Ctr Room 3052, Albuquerque, NM 87131 USA.
   [Karakhan, Ali] Univ Baghdad, Dept Reconstruct & Projects, Baghdad, Iraq.
RP Nnaji, C (corresponding author), Univ Alabama, Dept Civil Construct & Environm Engn, 3043 HM Comer, Tuscaloosa, AL 35487 USA.
EM cnnaji@eng.ua.edu; zjin@unm.edu; karakhan@uobaghdad.edu.iq
CR AGC (Associated General Contractors of America), 2021, CONSTR DAT
   Ahn CR, 2019, J CONSTR ENG M, V145, DOI 10.1061/(ASCE)CO.1943-7862.0001708
   Al-Saffar O.T., 2020, THESIS OREGON STATE
   Alsharef A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041559
   Amoah C, 2021, J FACIL MANAG, V19, P111, DOI 10.1108/JFM-08-2020-0061
   Assaad R, 2021, J MANAGE ENG, V37, DOI 10.1061/(ASCE)ME.1943-5479.0000906
   Awolusi I, 2018, AUTOMAT CONSTR, V85, P96, DOI 10.1016/j.autcon.2017.10.010
   Awwad R, 2016, SAFETY SCI, V83, P1, DOI 10.1016/j.ssci.2015.10.016
   Becker D., 2021, AM SOC CIV ENG
   Bureau of Economic Analysis (BEA), 2020, GDP IND
   Centers for Disease Control and Prevention (CDC), 2021, WHAT CONSTR WORK NEE
   Centers for Disease Control and Prevention (CDC), 2020, CONSTR COVID 19 CHEC
   Chen HC, 2020, ASIA-PAC J PUBLIC HE, V32, P485, DOI 10.1177/1010539520963629
   Chen Q, 2013, J CONSTR ENG M, V139, P805, DOI 10.1061/(ASCE)CO.1943-7862.0000659
   Choi B, 2017, AUTOMAT CONSTR, V84, P31, DOI 10.1016/j.autcon.2017.08.005
   Cirrincione L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093603
   Cunningham TR, 2018, SAFETY SCI, V103, P62, DOI 10.1016/j.ssci.2017.11.011
   del Rio-Chanona RM, 2020, OXFORD REV ECON POL, V36, pS94, DOI 10.1093/oxrep/graa033
   Duncan DT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-20
   Facente SN, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11697-6
   Fang DP, 2013, SAFETY SCI, V57, P138, DOI 10.1016/j.ssci.2013.02.003
   Gadaleta M, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00533-1
   Gamil Y., 2020, MEDITERRANEAN J SOCI, V11, P122, DOI 10.36941/mjss-2020-0047
   Gaskin JL, 2013, J AFFECT DISORDERS, V150, P350, DOI 10.1016/j.jad.2013.04.017
   Hinze J, 2003, J CONSTR ENG M ASCE, V129, P159, DOI 10.1061/(ASCE)0733-9364(2003)129:2(159)
   Hinze J., 2006, CONSTRUCTION SAFETY
   Hollingsworth J., 2020, PROFESSIONAL SAF, V65, P32
   Holte KA, 2015, SAFETY SCI, V71, P205, DOI 10.1016/j.ssci.2014.01.007
   Huang YH, 2011, ACCIDENT ANAL PREV, V43, P1, DOI 10.1016/j.aap.2009.09.016
   Jallow H, 2021, SMART SUSTAIN BUILT, V10, P581, DOI 10.1108/SASBE-05-2020-0068
   Jiang KF, 2017, HUM RESOUR MANAGE-US, V56, P69, DOI 10.1002/hrm.21771
   Kamas W. M., 2019, J ENG, V25, P117
   KARAKHAN A, 2019, PROF SAF, V64, P43
   Karakhan AA, 2020, J CONSTR ENG M, V146, DOI 10.1061/(ASCE)CO.1943-7862.0001794
   Karakhan AA, 2018, J CONSTR ENG M, V144, DOI 10.1061/(ASCE)CO.1943-7862.0001503
   Knoll RL, 2020, PEDIATR INFECT DIS J, V39, pE336, DOI 10.1097/INF.0000000000002866
   Koshy K, 2021, SAFETY SCI, V138, DOI 10.1016/j.ssci.2021.105193
   Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235460
   Liao H, 2009, J APPL PSYCHOL, V94, P371, DOI 10.1037/a0013504
   Lin John., 2001, FACILITIES, V19, P131, DOI [10.1108/02632770110381676, DOI 10.1108/02632770110381676]
   Magesh S, 2020, INT J PERVASIVE COMP, V16, P477, DOI 10.1108/IJPCC-07-2020-0082
   Marey-Perez M., 2020, TECHNIUM SOC SCI J, V9, P661, DOI [10.47577/tssj.v9i1.1021, DOI 10.47577/TSSJ.V9I1.1021]
   Meke K.D.P., 2018, J PHY C SER, V1097
   Meng QF, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052644
   Nnaji C., 2020, PROF SAF, V65, P16
   Nnaji C., 2019, INFLUENTIAL SAFETY T
   Nnaji C, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21030682
   Nnaji C, 2020, J BUILD ENG, V29, DOI 10.1016/j.jobe.2020.101212
   Occupational Safety and Health Administration (OSHA), 2016, RECOMMENDED PRACTICE
   Ogunnusi M, 2020, INT J REAL ESTATE ST, V14
   Oksanen L.M.A., 2020, HEALTHCARE WORKERS H, DOI [10.1101/2020.08.17.20176842, DOI 10.1101/2020.08.17.20176842]
   Pradhan D, 2020, ARCH MED RES, V51, P363, DOI 10.1016/j.arcmed.2020.04.020
   Quezon E. T., 2021, GLOB J ENG TECHNOL A, V6, P74
   Rasheed E.K., 2015, J ENG-NY, V21, P1
   Seo HC, 2015, SAFETY SCI, V77, P160, DOI 10.1016/j.ssci.2015.03.010
   Seshadri Dhruv R, 2020, Front Digit Health, V2, P8, DOI 10.3389/fdgth.2020.00008
   Shubina V, 2020, DATA, V5, DOI 10.3390/data5040087
   Simpeh F, 2021, INT J CONSTR MANAG, DOI 10.1080/15623599.2021.1874678
   Sinclair RC, 2014, SAFETY SCI, V64, P32, DOI 10.1016/j.ssci.2013.11.022
   SmartMarket, 2017, SAF MAN CONSTR IND 2
   Stiles S, 2021, HUM FACTOR ERGON MAN, V31, P425, DOI 10.1002/hfm.20882
   Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779
   U.S. Census Bureau, 2020, 2018 SUSB ANN DAT TA
   U.S. Department of Labor, 2020, GUID PREP WORKPL COV
   Whitelaw S, 2020, LANCET DIGIT HEALTH, V2, pE435, DOI 10.1016/S2589-7500(20)30142-4
   WHO, 2021, STAT 2 M INT HLTH RE
   World Health Organization (WHO), COMMUNICATION 0319
   Zamani S. H., 2021, IOP Conference Series: Earth and Environmental Science, V682, DOI 10.1088/1755-1315/682/1/012049
   Zheng L., 2020, FRONT PUBLIC HEALTH, V8, P981
NR 69
TC 1
Z9 1
U1 14
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0957-5820
EI 1744-3598
J9 PROCESS SAF ENVIRON
JI Process Saf. Environ. Protect.
PD MAR
PY 2022
VL 159
BP 477
EP 488
DI 10.1016/j.psep.2022.01.002
PG 12
WC Engineering, Environmental; Engineering, Chemical
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Engineering
GA YL5RT
UT WOS:000745949100004
PM 35068710
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Kabi, A
   Dhar, M
   Arora, P
   Bhardwaj, BB
   Chowdhury, N
   Rao, S
AF Kabi, Ankita
   Dhar, Mridul
   Arora, Poonam
   Bhardwaj, Bharat B.
   Chowdhury, Nilotpal
   Rao, Shalinee
TI Effectiveness of a Simulation-Based Training Program in Improving the
   Preparedness of Health Care Workers Involved in the Airway Management of
   COVID-19 Patients
SO CUREUS
LA English
DT Article
DE aerosol generating procedure; airway management; covid 19 preparedness;
   covid 19 transmission; simulation based training; team dynamics
AB Background
   Coronavirus disease 2019 (COVID-19) has currently emerged as a global threat and a significant public health issue. The role of simulation-based training (SBT) during such a pandemic becomes more relevant for teaching a team approach and building capacity especially when there is a threat to health care workers due to aerosol generation and there is a huge demand for manpower during the pandemic.
   Objective
   To assess the effectiveness of a simulation-based training program in improving knowledge and concept of teamwork of health care workers involved in airway management of suspected or confirmed COVID-19 patients.
   Methods
   After institutional review committee approval, a prospective analytical study was conducted in the department of medical education on participants from various specialties undergoing COVID-19 airway training. The purpose of the study was to assess team dynamics during simulation scenarios and compare lest scores at baseline, immediately post-training, and seven days post-training (using online forms). Scores were compared using the Friedman test followed by post-hoc testing. Sub-group comparison was done using an unpaired t-test.
   Results
   Median scores were significantly higher in the immediate post-training test and seven days post-training test (online) compared to baseline pretest scores in the overall participant group and in individual subgroups. There was no significant difference in immediate versus seven-day post-training test scores overall and in all subgroups. In the sub-group comparisons, median improvement in score was significantly better in the non-anesthesia group and in the resident group. It was observed that team performance in terms of role clarity, closed-loop communication, and idea acceptance improved substantially during the subsequent scenarios.
   Conclusion
   Simulation-based training was effective in improving knowledge and team dynamics amongst health care workers regarding airway management in COVID-19 patients, with retention of up to one week. Similar future research can be planned for the affective and psychomotor domains.
C1 [Kabi, Ankita; Arora, Poonam; Bhardwaj, Bharat B.] All India Inst Med Sci, Emergency Med, Rishikesh, India.
   [Dhar, Mridul] All India Inst Med Sci, Anaesthesiol, Rishikesh, India.
   [Chowdhury, Nilotpal] All India Inst Med Sci, Pathol, Rishikesh, India.
   [Rao, Shalinee] All India Inst Med Sci, Pathol, Adv Ctr Continuous Profess Dev, Rishikesh, India.
RP Arora, P (corresponding author), All India Inst Med Sci, Emergency Med, Rishikesh, India.
EM arorapoonam982@gmail.com
OI Dhar, Mridul/0000-0002-1913-2586
CR Bhagwat M, 2012, INDIAN J ANAESTH, V56, P14, DOI 10.4103/0019-5049.93338
   Christopher DJ, 2020, LUNG INDIA, V37, P238, DOI 10.4103/lungindia.lungindia_189_20
   Clapper T. C., 2012, J EMERGENCY DISASTER, V1, P1
   Grande B, 2017, CURR OPIN ANESTHESIO, V30, P743, DOI 10.1097/ACO.0000000000000523
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Lorello GR, 2014, BRIT J ANAESTH, V112, P231, DOI 10.1093/bja/aet414
   Lucisano Karen E, 2012, AANA J, V80, P25
   McGaghie WC, 2010, MED EDUC, V44, P50, DOI 10.1111/j.1365-2923.2009.03547.x
   Valadares AFM, 2014, ACTA PAUL ENFERM, V27, P138, DOI 10.1590/1982-0194201400025
   Naik VN, 2013, CAN J ANESTH, V60, P192, DOI 10.1007/s12630-012-9860-z
   Pavithran P, 2018, INDIAN J ANAESTH, V62, P991, DOI 10.4103/ija.IJA_121_18
   Ritter KA, 2020, J SURG RES, V252, P57, DOI 10.1016/j.jss.2020.02.008
   Shailaja S, 2019, INDIAN J ANAESTH, V63, P908, DOI 10.4103/ija.IJA_133_19
   Sun YX, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0313-7
   Yang D, 2016, J ANESTH, V30, P284, DOI 10.1007/s00540-015-2116-7
NR 15
TC 0
Z9 0
U1 0
U2 0
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS
JI Cureus
PD AUG 20
PY 2021
VL 13
IS 8
AR e17323
DI 10.7759/cureus.17323
PG 8
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA UE6GP
UT WOS:000687984500019
PM 34557368
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Qureshi, AI
   Abd-Allah, F
   Alsenani, F
   Aytac, E
   Borhani-Haghighi, A
   Ciccone, A
   Gomez, CR
   Gurkas, E
   Hsu, CY
   Jani, V
   Jiao, LQ
   Kobayashi, A
   Lee, J
   Liaqat, J
   Mazighi, M
   Parthasarathy, R
   Steiner, T
   Suri, MFK
   Toyoda, K
   Ribo, M
   Gongora-Rivera, F
   Oliveira-Filho, J
   Uzun, G
   Wang, YJ
AF Qureshi, Adnan, I
   Abd-Allah, Foad
   Alsenani, Fahmi
   Aytac, Emrah
   Borhani-Haghighi, Afshin
   Ciccone, Alfonso
   Gomez, Camilo R.
   Gurkas, Erdem
   Hsu, Chung Y.
   Jani, Vishal
   Jiao, Liqun
   Kobayashi, Adam
   Lee, Jun
   Liaqat, Jahanzeb
   Mazighi, Mikael
   Parthasarathy, Rajsrinivas
   Steiner, Thorsten
   Suri, M. Fareed K.
   Toyoda, Kazunori
   Ribo, Marc
   Gongora-Rivera, Fernando
   Oliveira-Filho, Jamary
   Uzun, Guven
   Wang, Yongjun
TI Management of acute ischemic stroke in patients with COVID-19 infection:
   Report of an international panel
SO INTERNATIONAL JOURNAL OF STROKE
LA English
DT Review
DE Coronavirus; COVID-19; acute stroke; mechanical thrombectomy;
   thrombolysis; ischemic stroke
ID CONSCIOUS SEDATION; GENERAL-ANESTHESIA; CARE; GUIDELINES
AB Background and purpose
   On 11 March 2020, World Health Organization (WHO) declared the COVID-19 infection a pandemic. The risk of ischemic stroke may be higher in patients with COVID-19 infection similar to those with other respiratory tract infections. We present a comprehensive set of practice implications in a single document for clinicians caring for adult patients with acute ischemic stroke with confirmed or suspected COVID-19 infection.
   Methods
   The practice implications were prepared after review of data to reach the consensus among stroke experts from 18 countries. The writers used systematic literature reviews, reference to previously published stroke guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate practice implications. All members of the writing group had opportunities to comment in writing on the practice implications and approved the final version of this document.
   Results
   This document with consensus is divided into 18 sections. A total of 41 conclusions and practice implications have been developed. The document includes practice implications for evaluation of stroke patients with caution for stroke team members to avoid COVID-19 exposure, during clinical evaluation and performance of imaging and laboratory procedures with special considerations of intravenous thrombolysis and mechanical thrombectomy in stroke patients with suspected or confirmed COVID-19 infection.
   Conclusions
   These practice implications with consensus based on the currently available evidence aim to guide clinicians caring for adult patients with acute ischemic stroke who are suspected of, or confirmed, with COVID-19 infection. Under certain circumstances, however, only limited evidence is available to support these practice implications, suggesting an urgent need for establishing procedures for the management of stroke patients with suspected or confirmed COVID-19 infection.
C1 [Qureshi, Adnan, I] Univ Missouri, Zeenat Qureshi Stroke Inst, Columbia, MO USA.
   [Qureshi, Adnan, I; Gomez, Camilo R.] Univ Missouri, Dept Neurol, Columbia, MO USA.
   [Abd-Allah, Foad] Cairo Univ, Kasralainy Sch Med, Dept Neurol, Cairo, Egypt.
   [Alsenani, Fahmi] Firat Univ, Zeenat Qureshi Stroke Inst, Dept Neurol, Elazig, Turkey.
   [Aytac, Emrah] Firat Univ, Dept Neurol, Elazig, Turkey.
   [Borhani-Haghighi, Afshin] Shiraz Univ Med Sci, Clin Neurol Res Ctr, Shiraz, Iran.
   [Ciccone, Alfonso] Hosp Carlo Poma, Dept Neurosci, ASST Mantova, Mantua, Italy.
   [Gurkas, Erdem] Kartal Dr Lutfi Kirdar Training & Res Hosp, Dept Neurol, Stroke Ctr, Istanbul, Turkey.
   [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.
   [Jani, Vishal] Creighton Univ, Dept Neurol, Med Ctr, CHI Hlth, Omaha, NE 68122 USA.
   [Jiao, Liqun] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Kobayashi, Adam] Kazimierz Pulaski Univ Technol & Humanities, Dept Neurol & Intervent Stroke Treatment Ctr, Radom, Poland.
   [Lee, Jun] Yeungnam Univ, Dept Neurol, Sch Med, Daegu, South Korea.
   [Liaqat, Jahanzeb] Pakistan Emirates Mil Hosp JL, Rawalpindi, Pakistan.
   [Mazighi, Mikael] Univ Paris, Rothschild Fdn Hosp, Dept Intervent Neuroradiol, Lab Vasc Translat Sci, Paris, France.
   [Parthasarathy, Rajsrinivas] Stroke & Neurointervent Artemis Hosp, Gurugram, India.
   [Steiner, Thorsten] Frankfurt & Heidelberg Univ Hosp, Dept Neurol, Klinikum Frankfurt Hochst, Heidelberg, Germany.
   [Suri, M. Fareed K.] St Cloud Hosp, St Cloud, MN USA.
   [Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan.
   [Ribo, Marc] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Neurol, Barcelona, Spain.
   [Gongora-Rivera, Fernando] Univ Autonoma Nuevo Lean, Serv Neurol, Hosp Univ Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico.
   [Gongora-Rivera, Fernando] Hosp Zambrano Hellion, Inst Neurol & Neurocirugia, Tecnol Monterrey, San Pedro, Nuevo Leon, Mexico.
   [Oliveira-Filho, Jamary] Univ Fed Bahia, Dept Biomorphol, Salvador, BA, Brazil.
   [Uzun, Guven] Beverly Hills Pain Inst & Neurol, Beverly Hills, CA USA.
   [Wang, Yongjun] Capital Med Univ Beijing, Beijing Tiantan Hosp, Tiantan Comprehens Stroke Ctr, Beijing, Peoples R China.
RP Jani, V (corresponding author), Creighton Univ, Dept Neurol, Immanuel Med Ctr, Sch Med, 6901 N 72 St,Suite 5300, Omaha, NE 68122 USA.
EM vbjani@yahoo.com
RI AYTAC, EMRAH/X-1420-2018; Ribo, Marc/ABG-3202-2021; Haghighi, Afshin
   Borhani/AAF-5212-2022; Jiao, Liqun/T-5944-2017; Ciccone,
   Alfonso/AAB-6942-2022; Gurkas, Erdem/AAB-7113-2022; Ciccone,
   Alfonso/AAB-8068-2022
OI Ribo, Marc/0000-0001-9242-043X; Ciccone, Alfonso/0000-0002-4590-3575;
   Borhani Haghighi, Afshin/0000-0002-4131-7990; GONGORA-RIVERA,
   FERNANDO/0000-0003-1224-3942
CR Agarwal S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000408
   Alhazzani W, SURVIVING SEPSIS CAM
   American College of Surgeons, COVID 19 REC MAN EL
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   Chambers CE, 2006, CATHETER CARDIO INTE, V67, P78, DOI 10.1002/ccd.20589
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b
   Emiru Tenbit, 2014, J Vasc Interv Neurol, V7, P30
   Froehler MT, 2017, CIRCULATION, V136, P2311, DOI 10.1161/CIRCULATIONAHA.117.028920
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Harrison MF, 2018, WEST J EMERG MED, V19, P863, DOI 10.5811/westjem.2018.7.37893
   He Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092763
   Henden PL, 2017, STROKE, V48, P1601, DOI 10.1161/STROKEAHA.117.016554
   Hsu PJ, 2016, CEREBROVASC DIS, V42, P117, DOI 10.1159/000445037
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Kim DH, 2016, STROKE, V47, P232, DOI 10.1161/STROKEAHA.115.011687
   Kullaya V, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00213-18
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431
   Livingston E, 2020, JAMA
   Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466
   Lu J, 2020, EMERG INFECT DIS, V51(1): 240--246
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Martins SCO, 2020, STROKE, V51, P240, DOI 10.1161/STROKEAHA.119.026727
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Muller MC, 2014, CRIT CARE, V18, DOI 10.1186/cc13721
   Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020
   Pernerstorfer T, 2000, BLOOD, V95, P1729, DOI 10.1182/blood.V95.5.1729.005k16_1729_1734
   Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211
   Qureshi Adnan I, 2014, J Vasc Interv Neurol, V7, P21
   Rasmussen M, 2020, JAMA NEUROL, V77, P622, DOI 10.1001/jamaneurol.2019.4838
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   SANTARPIA JL, 2020, TRANSMISSION POTENTI, DOI [10.1101/2020.03.23.20039446, DOI 10.1038/S41598-020-69286-3]
   Schonenberger S, 2016, JAMA-J AM MED ASSOC, V316, P1986, DOI 10.1001/jama.2016.16623
   Schonenberger S, 2015, INT J STROKE, V10, P969, DOI 10.1111/ijs.12488
   Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Silva GS, 2012, CURR NEUROL NEUROSCI, V12, P10, DOI 10.1007/s11910-011-0235-6
   Simonsen CZ, 2018, JAMA NEUROL, V75, P470, DOI 10.1001/jamaneurol.2017.4474
   Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747
   Stravitz RT, 2012, J HEPATOL, V56, P129, DOI 10.1016/j.jhep.2011.04.020
   Tiainen M, 2013, INT J STROKE, V8, P632, DOI 10.1111/ijs.12039
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   van Veenendaal P, 2018, CEREBROVASC DIS, V46, P170, DOI 10.1159/000490421
   Verbeek PR, 2003, CAN MED ASSOC J, V169, P299
   Warren-Gash C, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01794-2017
   Welt FGP, 2020, J AM COLL CARDIOL, V75, P2372, DOI 10.1016/j.jacc.2020.03.021
   Wu J, 2020, J INTERN MED, V288, P128, DOI 10.1111/joim.13063
   Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zeng J, 2020, INTENS CARE MED, V46, P1111, DOI 10.1007/s00134-020-05993-9
   Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zunt J, 2020, NEUROLOGY
NR 57
TC 111
Z9 119
U1 0
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1747-4930
EI 1747-4949
J9 INT J STROKE
JI Int. J. Stroke
PD JUL
PY 2020
VL 15
IS 5
BP 540
EP 554
AR 1747493020923234
DI 10.1177/1747493020923234
EA MAY 2020
PG 15
WC Clinical Neurology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Cardiovascular System & Cardiology
GA MI2TN
UT WOS:000533090700001
PM 32362244
OA Bronze
DA 2022-04-20
ER

PT J
AU Banjar, HR
   Alkhatabi, H
   Alganmi, N
   Almouhana, GI
AF Banjar, Haneen Reda
   Alkhatabi, Heba
   Alganmi, Nofe
   Almouhana, Ghaidaa Ibraheem
TI Prototype Development of an Expert System of Computerized Clinical
   Guidelines for COVID-19 Diagnosis and Management in Saudi Arabia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE expert system; clinical guideline; COVID-19 management; mobile track and
   evolution of expert system
AB The increasing number of COVID-19 patients has increased health care professionals' workloads, making the management of dynamic patient information in a timely and comprehensive manner difficult and sometimes impossible. Compounding this problem is a lack of health care professionals and trained medical staff to handle the increased number of patients. Although Saudi Arabia has recently improved the quality of its health services, there is still no suitable intelligent system that can help health practitioners follow the clinical guidelines and automated risk assessment and treatment plan remotely, which would allow for the effective follow-up of patients of COVID-19. The proposed system includes five sub-systems: an information management system, a knowledge-based expert system, adaptive learning, a notification and follow-up system, and a mobile tracker system. This study shows that, to control epidemics, there is a method to overcome the shortage of specialists in the management of infections in Saudi Arabia, both today and in the future. The availability of computerized clinical guidance and an up-to-date knowledge base play a role in Saudi health organizations, which may not have to constantly train their physician staff and may no longer have to rely on international experts, since the expert system can offer clinicians all the information necessary to treat their patients.
C1 [Banjar, Haneen Reda; Alganmi, Nofe; Almouhana, Ghaidaa Ibraheem] King Abdulaziz Univ, Fac Comp & Informat Technol, Comp Sci Dept, Jeddah 80200, Saudi Arabia.
   [Alkhatabi, Heba] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah 80200, Saudi Arabia.
   [Alkhatabi, Heba; Alganmi, Nofe] King Abdulaziz Univ, Ctr Excellence Genom Med Res CEGMR, Jeddah 80200, Saudi Arabia.
RP Banjar, HR (corresponding author), King Abdulaziz Univ, Fac Comp & Informat Technol, Comp Sci Dept, Jeddah 80200, Saudi Arabia.
EM hrbanjar@kau.edu.sa; halkhattabi@kau.edu.sa; nalghanimi@kau.edu.sa;
   galmouhana@stu.kau.edu.sa
RI Banjar, Haneen R/H-6404-2018
OI Banjar, Haneen R/0000-0003-4475-4878
FU Ministry of Education; King Abdulaziz University, DSR, Jeddah, Saudi
   Arabia;  [IFPHI-159-612-2020]
FX This research work was funded by Institutional Fund Project under grant
   no. IFPHI-159-612-2020. Therefore, the authors gratefully acknowledge
   technical and financial support from the Ministry of Education and King
   Abdulaziz University, DSR, Jeddah, Saudi Arabia.
CR [Anonymous], 2020, SAUDI ARABI MINISTRY
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], 2016, SAUD AR GOV SAUD VIS, P292
   [Anonymous], 2020, SAUDI MOH PROTOCOL A
   Campagna A, 2012, KNOWL INF SYST, V31, P505, DOI 10.1007/s10115-011-0428-y
   Culebro J., 1993, THESIS
   Davenport Thomas, 2019, Future Healthc J, V6, P94, DOI 10.7861/futurehosp.6-2-94
   Deliege D, 2002, Stud Health Technol Inform, V93, P9
   Emergency Medicine Cases, 2020, PRACT COVID 19 RES E
   Freitas, 2013, ACM SIGKDD EXPLORATI, V15, P1, DOI DOI 10.1145/2594473.2594475
   Grosan Abraham C., 2011, INTELLIGENT SYSTEMS
   Howell MD, 2007, ACAD EMERG MED, V14, P709, DOI 10.1197/j.aem.2007.02.036
   Kondylakis H, 2012, STUD HEALTH TECHNOL, V180, P432, DOI 10.3233/978-1-61499-101-4-432
   Kwan JL, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3216
   Liu Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/19786
   Livingston Edward, 2020, JAMA, V323, P1122, DOI 10.1001/jama.2020.2633
   Medicine N., 2020, EUR RESP J, V56, P1
   Ministry of Health in Saudi Arabia, 2020, COR DIS COVID 19 GUI
   Ministry of Health Saudi Arabia, 2020, COR DIS 19 GUID, V19, P1
   Mujawar I. K., 2017, INT J COMPUT ENG APP, V11, P9
   Nguyen T.T., 2020, ARTIFICIAL INTELLIGE, DOI 10.13140/RG.2.2.36491.23846.Artificial
   Peleg M, 2013, J BIOMED INFORM, V46, P744, DOI 10.1016/j.jbi.2013.06.009
   Salman F.M., 2020, DIAGNOSIS, V4, P1
   Shang Y, 2005, ELECTRICAL ENGINEERING HANDBOOK, P367, DOI 10.1016/B978-012170960-0/50031-1
   Smith M, 2013, APPL CLIN INFORM, V4, P359, DOI 10.4338/ACI-2013-04-RA-0019
   Tamal M., 2020, PREPRINT MEDRXIV, DOI [10.1101/2020.10.01.20205146, DOI 10.1101/2020.10.01.20205146]
   Tobaiqy M, 2020, Infect Prev Pract, V2, P100061, DOI 10.1016/j.infpip.2020.100061
   Tso G.J., 2016, AMIA ANN S P, V2016
   Van Ryzin J., 1986, TREES J AM STAT ASS, V81, P253, DOI [10.2307/2288003, DOI 10.2307/2288003]
   Varming Kim, 2004, EJIFCC, V15, P10
   WHO, 2020, NOV COR 2019 NCOV SI
   Yang X., 2020, CHRONIC DIS TRANSL M, V6, P1
   ZADEH LA, 1994, IEEE SOFTWARE, V11, P48, DOI 10.1109/52.329401
NR 33
TC 3
Z9 3
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD NOV
PY 2020
VL 17
IS 21
AR 8066
DI 10.3390/ijerph17218066
PG 19
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA OQ9CV
UT WOS:000589073100001
PM 33147715
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Jahangiri, M
   Cousins, R
   Gharibi, V
AF Jahangiri, Mehdi
   Cousins, Rosanna
   Gharibi, Vahid
TI Let's get back to work: Preventive biological cycle management of
   COVID-19 in the workplace
SO WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION
LA English
DT Editorial Material
DE Lockdown; COVID-19; biological hazard; risk assessment; personal
   protective equipment (PPE)
ID HEALTH
AB BACKGROUND: The primary response to the coronavirus (COVID-19) pandemic has been to minimize social contact through lockdown measures. The closure of non-essential businesses to tackle the spread of the coronavirus has had negative consequences for the global economy, production, and employment.
   OBJECTIVE: To outline how known occupational health principles can be used for preventative management of the coronavirus in workplaces to support resumption of work.
   METHODS: A discussion of current knowledge of COVID-19, the cost of the lockdown strategy, and preventative biological cycle management.
   RESULTS: The evidence-based literature indicates that biological cycle management can control the risk of coronavirus infection, provide a suitable and sufficient exit strategy from lockdown, and support getting employees back to work. Adherence to personal protective equipment standards has been insufficient, indicating a need for workplace investment and education.
   CONCLUSION: Imposed restrictions on workplace operations can be lifted without compromising worker health and safety when a workplace commits to practicing the three principles of biological cycle management.
C1 [Jahangiri, Mehdi; Gharibi, Vahid] Shiraz Univ Med Sci, Dept Occupat Hlth, Sch Hlth, Shiraz, Iran.
   [Cousins, Rosanna] Liverpool Hope Univ, Dept Psychol, Liverpool, Merseyside, England.
   [Gharibi, Vahid] Shahroud Univ Med Sci, Dept Occupat Hlth, Sch Publ Hlth, Shahroud, Iran.
RP Gharibi, V (corresponding author), Shiraz Univ Med Sci, Dept Occupat Hlth, Sch Hlth, Shiraz, Iran.
EM gharibivahid@gmail.com
RI ; Jahangiri, Mehdi/F-2541-2014
OI gharibi, vahid/0000-0002-9974-3060; Jahangiri,
   Mehdi/0000-0002-4703-2523; Cousins, Rosanna/0000-0003-4829-5138
CR Alvarez A, 2020, ETIKK PRAKSIS, V14, P1
   Coibion O, 2020, 8238 CESIFI
   Drydakis N, 2015, SOC SCI MED, V128, P43, DOI 10.1016/j.socscimed.2014.12.025
   Gharibi V, 2020, SEMJ
   Gharibi V, 2020, INT J OCCUP ENV MED, V11, P95, DOI 10.34172/ijoem.2020.1872
   Gilbert M, 2020, NAT MED, V26, P643, DOI 10.1038/s41591-020-0871-y
   Jayjock Michael A, 2000, RISK ASSESSMENT PRIN
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Neiman B., 2020, MANY JOBS CAN BE DON
   Ozili P.K., 2020, 99850 MPRA
   Pennington A, 2020, WORKING HOME OPPORTU
   Rim KT, 2014, SAF HEALTH WORK-KR, V5, P43, DOI 10.1016/j.shaw.2014.03.006
   Tellis GJ, DID US GOVERNORS DEL
NR 14
TC 5
Z9 5
U1 1
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1051-9815
EI 1875-9270
J9 WORK
JI Work
PY 2020
VL 66
IS 4
BP 713
EP 716
DI 10.3233/WOR-203217
PG 4
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA NT2OA
UT WOS:000572785500002
PM 32925132
OA Bronze
DA 2022-04-20
ER

PT J
AU Ganga, K
   Solyar, AY
   Ganga, R
AF Ganga, Kiran
   Solyar, Alla Y.
   Ganga, Roopa
TI Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination
SO ENT-EAR NOSE & THROAT JOURNAL
LA English
DT Article; Early Access
DE vaccination; COVID-19; lymphadenopathy; cervical lymph nodes; vaccine
   side effects
AB The coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute respiratory syndrome coronavirus 2. Rapid spread with rampant growth of cases and deaths brought forth an urgent need for novel therapies including vaccinations. The mRNA vaccines for COVID-19 disease have been implemented at an unprecedented scale in an effort to combat the unrelenting pandemic. Such a massive scale vaccination program is bound to coincide with adverse events related to treatment. We present a case of massive cervical lymphadenopathy in a 58-year-old male patient post-Moderna COVID-19 vaccination. Additional investigations did not identify malignancy and he was diagnosed with vaccine-related lymphadenopathy. Patient significantly improved with corticosteroid treatment within 2 days of admission. Lymphadenopathy is reported as the second most common local reaction to the Moderna vaccine. Promoting knowledge of this side effect, particularly in the setting widespread vaccination efforts, would allow for better management of cases, especially in relation to oncologic patients.
C1 [Ganga, Kiran] Cornell Univ, 616 Thurston Ave, Ithaca, NY 14850 USA.
   [Solyar, Alla Y.] Sinus & Nasal Inst Florida, St Petersburg, FL USA.
   [Ganga, Roopa] Consultants Infect Dis LLC, Kenneth City, FL USA.
RP Ganga, K (corresponding author), Cornell Univ, 616 Thurston Ave, Ithaca, NY 14850 USA.
EM kg377@cornell.edu
CR Ahn Richard W, 2021, Radiol Cardiothorac Imaging, V3, pe210008, DOI 10.1148/ryct.2021210008
   [Anonymous], 2020, LOC REACT SYST REACT
   [Anonymous], CDC COVID DATA TRACK
   Fernandez-Prada M, 2021, EUROSURVEILLANCE, V26, P8, DOI 10.2807/1560-7917.ES.2021.26.10.2100193
   Hanneman K, 2021, RADIOLOGY, V299, pE282, DOI [10.1148/radiol.2021210386, 10.1148/radiol.2021219011]
   Hiller N, 2021, CUREUS, V13, DOI 10.7759/cureus.13524
   McIntosh LJ, 2021, AM J ROENTGENOL, V217, P975, DOI 10.2214/AJR.21.25728
   Toy H, 2010, VACCINE, V28, P2158, DOI 10.1016/j.vaccine.2009.12.043
   Voigt EA, 2016, EXPERT REV VACCINES, V15, P1197, DOI 10.1080/14760584.2016.1175305
NR 9
TC 1
Z9 1
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-5613
EI 1942-7522
J9 ENT-EAR NOSE THROAT
JI ENT-Ear Nose Throat J.
AR 01455613211048984
DI 10.1177/01455613211048984
EA OCT 2021
PG 3
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology
GA WQ4CN
UT WOS:000713766300001
PM 34601889
OA gold
DA 2022-04-20
ER

PT J
AU Amante, LFLS
   Afonso, JTM
   Skrupskelyte, G
AF Amante, Luis Filipe Lima Sobral
   Afonso, Joao Torres Monteiro
   Skrupskelyte, Greta
TI Dentistry and the COVID-19 Outbreak
SO INTERNATIONAL DENTAL JOURNAL
LA English
DT Review
DE Dentistry; Coronavirus; COVID-19; severe acute respiratory coronavirus;
   2 (SARS-CoV-2); Infection
ID DENTAL TRAUMATOLOGY GUIDELINES; ACUTE-RESPIRATORY-SYNDROME;
   INTERNATIONAL ASSOCIATION; TRANSMISSION; CORONAVIRUS; VIRUS; MANAGEMENT;
   INJURIES; EFFICACY; SURFACE
AB Introduction: Infection prevention in dental practice is a principle of utmost importance aiming to protect patients, the dental team, and ultimately, public health. The recent pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has instigated worldwide public concern. This highly contagious disease has called for profound changes in patient care around the world. The goal of this article is to review the current literature and introduce essential knowledge about COVID-19, recommend management protocols and adequate protection for dental professionals during the outbreak.
   Material and methods: The literature search was conducted from April to June 2020. After full-text screening a total of 85 studies were included.
   Results: Given the novelty of SARS-CoV-2, some characteristics of the virus remain yet unknown. The virus is aerosol-transmissible and, because of the nature of dental procedures, this puts dental professionals and patients at a high risk of contamination by this pathogen. Adequate management protocols and specific protective approaches are essential to minimise the spread of COVID-19 in dental settings during the outbreak.
   Discussion: The overall impact of COVID-19 in health care worldwide is yet to be determined. This constitutes a significant limitation to this review because the information obtained risks being outdated as the pandemic progresses. The prudent practitioner will use this review as a starting point and continue to proactively update themselves as the outbreak continues. Further studies are required to investigate the potential impact of infections with SARS-CoV-2 within dental settings. (C) 2020 The Authors. Published by Elsevier Inc. on behalf of FDI World Dental Federation.
C1 [Amante, Luis Filipe Lima Sobral] MyDentist, 540 Barking Rd, London E13 8QE, England.
   [Afonso, Joao Torres Monteiro] Kings Coll London, London, England.
   [Skrupskelyte, Greta] Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England.
RP Amante, LFLS (corresponding author), 7 Elm Rd, Cambridge CB2 9PP, England.
EM luis.filipe.amante@gmail.com
CR Al-Tawfiq JA, 2014, CURR OPIN INFECT DIS, V27, P411, DOI 10.1097/QCO.0000000000000089
   Ali S., 2020, J ISLAMABAD MED DENT, V9, P65, DOI [10.35787/jimdc.v9i1.517, DOI 10.35787/JIMDC.V9I1.517]
   Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   BDA guidance, RISK ASS COVID 19 PA
   British Endodontic Society, DIAGNOSIS MANAGEMENT
   Centers for Disease Control and Prevention, COR DIS 2019 INF CON
   Centers for Disease Control and Prevention, GUID DENT SETT INT I
   Centers for Disease Control and Prevention, 2016, SUMM INF PREV PRACT
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cleveland JL., GUIDELINES INFECT CO
   Cochrane Oral Health, REC REOP DENT SERV R
   Corstjens Paul L A M, 2012, J Am Dent Assoc, V143, p12S
   Darwish S., 2020, DENT UPDATE, V47, P287, DOI [10.12968/denu.2020.47.4.287, DOI 10.12968/DENU.2020.47.4.287]
   Day PF, 2020, DENT TRAUMATOL, V36, P343, DOI 10.1111/edt.12576
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1039, DOI 10.1001/jama.2020.1490
   DiAngelis AJ, 2012, DENT TRAUMATOL, V28, P2, DOI 10.1111/j.1600-9657.2011.01103.x
   European Centre for Disease Prevention and Control, 2020, COR DIS 2019 COVID 1
   European Centre for Disease Prevention and Control, 2020, INF PREV CONTR COVID
   European Federation of Periodontology, EFP ISS COVID 19 SAF
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   FGDP, COVID 19 LAT GUID RE
   Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hokett SD, 2000, J AM DENT ASSOC, V131, P463, DOI 10.14219/jada.archive.2000.0202
   Hu T, 2007, INFECT CONT HOSP EP, V28, P80, DOI 10.1086/510808
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Inderjit MG, 2016, J HLTH SPEC, V4, P105, DOI [DOI 10.4103/1658-600X.179821, 10.4103/1658-600X.179821]
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Khurshid Z, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072225
   Kim E, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102743
   Laheij A M G A, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.17659
   Larson EL, 2000, BEHAV MED, V26, P14, DOI 10.1080/08964280009595749
   Le HT, 2020, LANCET CHILD ADOLESC, V4, P405, DOI 10.1016/S2352-4642(20)30091-2
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li RWK, 2004, BRIT DENT J, V197, P130, DOI 10.1038/sj.bdj.4811522
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Liu L, 2011, J VIROL, V85, P4025, DOI 10.1128/JVI.02292-10
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m408
   Malik YS, 2020, VET QUART, V40, P68, DOI 10.1080/01652176.2020.1727993
   Marui VC, 2019, J AM DENT ASSOC, V150, P1015, DOI 10.1016/j.adaj.2019.06.024
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   MICIK RE, 1969, J DENT RES, V48, P49, DOI 10.1177/00220345690480012401
   Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014
   National Health Commission of China, DIAGN TREATM PROT NO
   Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098
   Office of Chief Dental Officer England, STAND OP PROC PHAS T
   Otter JA, 2016, J HOSP INFECT, V92, P235, DOI 10.1016/j.jhin.2015.08.027
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Reddy A., 2010, WORLD J DENT, V3, P225
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101578
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Sabino-Silva R, 2020, CLIN ORAL INVEST, V24, P1619, DOI 10.1007/s00784-020-03248-x
   Samaranayake LP, 2004, J AM DENT ASSOC, V135, P1292, DOI 10.14219/jada.archive.2004.0405
   SAMARANAYAKE LP, 1989, J DENT CHILD, V56, P442
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y
   Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5
   Tiwari RVC., 2020, J ADV MED DENT SCI, V8, P100
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Vandenberghe B, 2010, EUR RADIOL, V20, P2637, DOI 10.1007/s00330-010-1836-1
   Wahba L, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00160-20
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI [10.1038/s41586-020-2196-x, 10.1159/000505601, 10.1038/s41586-020-2984-3]
   World Health Organization, QUEST ANSW COR
   World Health Organization, UPD COUNTR PREP RESP
   World Health Organization, 162 WHO
   Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Yoon JG, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e195
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 84
TC 2
Z9 2
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0020-6539
EI 1875-595X
J9 INT DENT J
JI Int. Dent. J.
PD OCT
PY 2021
VL 71
IS 5
BP 358
EP 368
DI 10.1016/j.identj.2020.12.010
EA SEP 2021
PG 11
WC Dentistry, Oral Surgery & Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dentistry, Oral Surgery & Medicine
GA WB5HV
UT WOS:000703603700004
PM 33743993
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Deshmukh, V
   Tripathi, SC
   Pandey, A
   Deshmukh, V
   Vykoukal, J
   Patil, A
   Sontakke, B
AF Deshmukh, V.
   Tripathi, S. C.
   Pandey, A.
   Deshmukh, V.
   Vykoukal, J.
   Patil, A.
   Sontakke, B.
TI COVID-19: a conundrum to decipher
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE COVID-19; SARS-CoV-2; Coronavirus; 2019-nCoV SARS
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FUNCTIONAL RECEPTOR; CORONAVIRUS;
   SARS; WUHAN; RISK
AB OBJECTIVE: Recent worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of respiratory coronavirus disease 2019 (COVID-19), is a current, ongoing life-threatening crisis, and international public health emergency. The early diagnosis and management of the disease remains a major challenge. In this review, we aim to summarize the updated epidemiology, causes, clinical manifestation and diagnosis, as well as prevention and control of the novel coronavirus SARS-CoV-2.
   MATERIALS AND METHODS: A broad search of the literature was performed in "PubMed" "Medline" "Web of Science", " Google Scholar" and "World Health Organization-WHO" using the keywords "severe acute respiratory syndrome coronavirus", "2019-nCoV", "COVID-19, "SARS", "SARS-CoV-2" "Epidemiology" "Transmission" "Pathogenesis" "Clinical Characteristics". We reviewed and documented the information obtained from literature on epidemiology, pathogenesis and clinical appearances of SARS-CoV-2 infection.
   RESULTS: The global cases of COVID-19 as of April 2, 2020, have risen to more than 900,000 and morbidity has reached more than 47,000. The incidence rate for COVID-19 has been predicted to be higher than the previous outbreaks of other coronavirus family members, including those of SARS-CoV and the Middle East Respiratory Syndrome Coronavirus ( MERS-CoV). The main clinical presentation of SARS-CoV-2 infection ranges from asymptomatic stages to severe lower respiratory infection in the form of pneumonia. Most of the patients also presented with fever, cough, sore throat, headache, fatigue, myalgia and breathlessness. Individuals at higher risk for severe illness include elderly people and patients with a weakened immune system or that are suffering from an underlying chronic medical condition like hypertension, diabetes mellitus, cancer, respiratory illness or cardiovascular diseases.
   CONCLUSIONS: SARS-Cov-2 has emerged as a worldwide threat, currently affecting 170 countries and territories across the globe. There is still much to be understood regarding SARS-CoV-2 about its virology, epidemiology and clinical management strategies; this knowledge will be essential to both manage the current pandemic and to conceive comprehensive measures to prevent such outbreaks in the future.
C1 [Deshmukh, V.; Sontakke, B.] All India Inst Med Sci, Dept Anat, Nagpur, Maharashtra, India.
   [Tripathi, S. C.] All India Inst Med Sci, Biochem, Nagpur, Maharashtra, India.
   [Pandey, A.] Houston Methodist Ctr, Dept Neurosurg Res, Houston, TX USA.
   [Deshmukh, V.] All India Inst Med Sci, Dept Microbiol, Bhubaneswar, Orrisa, India.
   [Vykoukal, J.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Res, Houston, TX 77030 USA.
   [Patil, A.] All India Inst Med Sci, Dept Physiol, Nagpur, Maharashtra, India.
RP Tripathi, SC (corresponding author), All India Inst Med Sci, Biochem, Nagpur, Maharashtra, India.
EM sctripathi@aiimsnagpur.edu.in
RI Tripathi, Satyendra Chandra/L-9352-2017; Patil, Ashlesh/AAD-4778-2021;
   Pandey, Arvind/J-9091-2019
OI Tripathi, Satyendra Chandra/0000-0003-3917-9645; Patil,
   Ashlesh/0000-0001-5942-8173; Pandey, Arvind/0000-0002-9942-5468
CR ALTHAUS N, 2014, PLOS CURRENTS, V6, DOI DOI 10.1109/TAMD.2014.2310061
   [Anonymous], 2020, TRANSPL INFECT DIS
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Barcena M, 2009, P NATL ACAD SCI USA, V106, P582, DOI 10.1073/pnas.0805270106
   Biggerstaff M, 2014, EPIDEMIOL INFECT, V142, P114, DOI 10.1017/S0950268813000654
   Bourouiba L, 2020, JAMA-J AM MED ASSOC, V323, P1837, DOI 10.1001/jama.2020.4756
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   CDC, 2020, COR DIS 2019 COVID 1
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Chen DJ, 2020, INT J GYNECOL OBSTET, V149, P130, DOI 10.1002/ijgo.13146
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Y H, 2020, Zhonghua Wei Chang Wai Ke Za Zhi, V23, pI, DOI 10.3760/cma.j.issn.1671-0274.2020.02.001
   Colson P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105923
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Epidemic IPaCo, 2014, INF PREV CONTR EP PA
   Fournier JP, 2012, EUR J CLIN PHARMACOL, V68, P1533, DOI 10.1007/s00228-012-1283-9
   Fuhai M, 2020, ZHONGHUA ZHONG LIU Z, V42, pE001, DOI [10.3760/cma.j.cn112152-20200223-00117, DOI 10.3760/CMA.J.CN112152-20200223-00117]
   Gani R, 2001, NATURE, V414, P748, DOI 10.1038/414748a
   Gislason GH, 2009, ARCH INTERN MED, V169, P141, DOI 10.1001/archinternmed.2008.525
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   He X W, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P456, DOI 10.3760/cma.j.cn112148-20200228-00137
   Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang PK, 2020, RADIOLOGY, V295, P22, DOI 10.1148/radiol.2020200330
   JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167
   Kuhn JH, 2004, CELL MOL LIFE SCI, V61, P2738, DOI 10.1007/s00018-004-4242-5
   Li F, 2020, J HEART LUNG TRANSPL, V39, P496, DOI 10.1016/j.healun.2020.03.006
   Li Y, 2020, EMERG INFECT DIS, V26, P1335, DOI 10.3201/eid2606.200287
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Liu B L, 2020, Zhonghua Zhong Liu Za Zhi, V42, P288, DOI 10.3760/cma.j.cn112152-20200221-00110
   Liu JY, 2020, EMERG INFECT DIS, V26, P1320, DOI 10.3201/eid2606.200239
   Long YL, 2020, J EVID-BASED MED, V13, P93, DOI 10.1111/jebm.12381
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0
   Ng PC, 2004, BIOL NEONATE, V85, P293, DOI 10.1159/000078174
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Pan L, 2020, AM J GASTROENTEROL, V115, P766, DOI 10.14309/ajg.0000000000000620
   POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477
   Qian GQ, 2020, CLIN INFECT DIS, V71, P861, DOI 10.1093/cid/ciaa316
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P799, DOI 10.5858/arpa.2020-0901-SA
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   Toki S, 2020, ALLERGY, V75, P1606, DOI 10.1111/all.14196
   van der Hoek L, 2007, ANTIVIR THER, V12, P651
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272
   WHO, 2020, MIDDL E RESP SYNDR C
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics, 2020, Zhongguo Dang Dai Er Ke Za Zhi, V22, P87
   Wu F, 2020, ZHONGHUA ZHONG LIU Z, V42, pE004, DOI [DOI 10.3760/CMA.J.CN112152-20200227-00137, 10.3760/cma.j.cn112152-20200227-00137]
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   [徐燕 Xu Yan], 2020, [中国肺癌杂志, Chinese Journal of Lung Cancer], V23, P136
   Yang H, 2020, ULTRASOUND OBST GYN, V55, P435, DOI 10.1002/uog.22006
   [杨路 Yang Lu], 2020, [中华肿瘤杂志, Chinese Journal of Oncology], V42, P292
   Yu GY, 2020, CHIN J DENT RES, V23, P9, DOI 10.3290/j.cjdr.a44348
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zeng L K, 2020, Zhonghua Er Ke Za Zhi, V58, pE009, DOI 10.3760/cma.j.issn.0578-1310.2020.0009
   Zhang H, 2020, J THORAC ONCOL, DOI [10.1016/j. jtho.2020.02.025, DOI 10.1016/J.JTH0.2020.02.025]
   Zhang J., 2020, ZHONGHUA FU CHAN KE, V55
   Zhang Y., 2020, ZHONGHUA ZHONG LIU Z, V42, DOI DOI 10.3760/CMA.J.CN112152-20200227-00141
   Zhao SL, 2020, QUANT BIOL, V8, P11, DOI 10.1007/s40484-020-0199-0
   Zhao Z, 2020, ZHONGHUA ZHONG LIU Z, V42, pE007
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
NR 72
TC 7
Z9 8
U1 3
U2 9
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PY 2020
VL 24
IS 10
BP 5830
EP 5841
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA LS3PG
UT WOS:000536299300076
PM 32495923
DA 2022-04-20
ER

PT J
AU Fan, JC
   Gao, Y
   Zhao, N
   Dai, RJ
   Zhang, HL
   Feng, XY
   Shi, GX
   Tian, JH
   Chen, C
   Hambly, BD
   Bao, SS
AF Fan, Jingchun
   Gao, Ya
   Zhao, Na
   Dai, Runjing
   Zhang, Hailiang
   Feng, Xiaoyan
   Shi, Guoxiu
   Tian, Jinhui
   Chen, Che
   Hambly, Brett D.
   Bao, Shisan
TI Bibliometric Analysis on COVID-19: A Comparison of Research Between
   English and Chinese Studies
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE bibliometric; COVID-19 outbreaks; SARS-CoV-2; English; Chinese
ID TRANSMISSION
AB Background:As an emerging infectious disease, COVID-19 has garnered great research interest. We aimed to explore the differences between English language and Chinese language Medical/Scientific journals publications, particularly aiming to explore the efficacy/contents of the literature published in English and Chinese in relation to the outcomes of management and characterization of COVID-19 during the early stage of COVID-19 pandemic. Methods:Publications on COVID-19 research were retrieved from both English and Chinese databases. Bibliometric analyses were performed using VOSviewer 1.6.14, and CiteSpace V software. Network maps were generated to evaluate the collaborations between different authors, countries/provinces, and institutions. Results:A total of 143 English and 721 Chinese original research articles and reviews on COVID-19 were included in our study. Most of the authors and institutions of the papers were from China before March 1st, 2020, however, the distribution of authors and institutions were mainly in developed countries or more wealthy areas of China. The range of the keywords in English publications was more extensive than those in Chinese. Traditional Chinese Medicine was seen more frequently in Chinese papers than in English. Of the 143 articles published in English, 54 articles were published by Chinese authors only and 21 articles were published jointly by Chinese and other overseas authors. Conclusions:The publications in English have enabled medical practitioners and scientists to share/exchange information, while on the other hand, the publications in the Chinese language have provided complementary educational approaches for the local medical practitioners to understand the essential and key information to manage COVID-19 in the relatively remote regions of China, for the general population with a general level of education.
C1 [Fan, Jingchun; Zhao, Na; Dai, Runjing; Zhang, Hailiang; Feng, Xiaoyan; Shi, Guoxiu; Hambly, Brett D.; Bao, Shisan] Gansu Univ Chinese Med, Sch Publ Hlth, Lanzhou, Peoples R China.
   [Fan, Jingchun] Gansu Univ Chinese Med, Ctr Evidence Based Med, Lanzhou, Peoples R China.
   [Gao, Ya; Tian, Jinhui] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Peoples R China.
   [Gao, Ya; Tian, Jinhui] Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China.
   [Shi, Guoxiu] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China.
   [Chen, Che] Gansu Univ Chinese Med, Sch Clin Med, Lanzhou, Peoples R China.
   [Hambly, Brett D.; Bao, Shisan] Univ Sydney, Sch Med Sci, Fac Med & Sci, Discipline Pathol,Charles Perkins Ctr, Sydney, NSW, Australia.
RP Bao, SS (corresponding author), Gansu Univ Chinese Med, Sch Publ Hlth, Lanzhou, Peoples R China.; Bao, SS (corresponding author), Univ Sydney, Sch Med Sci, Fac Med & Sci, Discipline Pathol,Charles Perkins Ctr, Sydney, NSW, Australia.
EM bob.bao@sydney.edu.au
RI Bao, Shisan/AAF-6464-2020; Bao, Shisan/C-6072-2014; Hambly, Brett
   D/B-1965-2009
OI Bao, Shisan/0000-0002-6687-3846; Hambly, Brett D/0000-0002-5988-562X
FU Talent Introduction Program of Gansu University of Chinese Medicine
   [2016YJRC-01]; Innovation Capacity Improvement Special Project on
   COVID-19 Prevention and Control from Gansu University of Chinese
   Medicine [2020XGZX-10]; University Innovation Capacity Improvement
   Project in Gansu Province; SJTU [2019]
FX This work was supported by the Talent Introduction Program of Gansu
   University of Chinese Medicine [grant number 2016YJRC-01]; the
   Innovation Capacity Improvement Special Project on COVID-19 Prevention
   and Control from Gansu University of Chinese Medicine [grant number
   2020XGZX-10]; University Innovation Capacity Improvement Project in
   Gansu Province; and SJTU grants [grant number 2019].
CR Arab-Mazar Z, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101630
   Chahrour M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7357
   Chen TM, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00640-3
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   De Felice F, 2020, IN VIVO, V34, P1613, DOI 10.21873/invivo.11951
   Department of Health Australia Government, 2020, LIM PUBL GATH COR CO
   Education Bureau . The Government of the Hong Kong Special Administrative Region, 2019, HONG KONG ED SYST
   Fan JC, 2020, EMERG INFECT DIS, V26, P1257, DOI 10.3201/eid2606.200251
   Gao Y, 2019, ENVIRON SCI POLLUT R, V26, P17809, DOI 10.1007/s11356-019-05071-8
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y
   Li CX, 2017, ENVIRON SCI POLLUT R, V24, P24733, DOI 10.1007/s11356-017-0440-1
   Liang YD, 2017, J PAIN RES, V10, P951, DOI 10.2147/JPR.S132808
   Ling CQ, 2020, J INTEGR MED-JIM, V18, P87, DOI 10.1016/j.joim.2020.02.004
   Lio CF, 2020, PEERJ, V8, DOI 10.7717/peerj.9428
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Lou J, 2020, EUR REV MED PHARMACO, V24, P3411, DOI 10.26355/eurrev_202003_20712
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Merigo JM, 2019, TOURISM GEOGR, V21, P881, DOI 10.1080/14616688.2019.1666913
   Ministry of Education The People's Republic of China, 2020, MOE PART LEAD GROUP
   Mitja O, 2020, LANCET GLOB HEALTH, V8, pE639, DOI 10.1016/S2214-109X(20)30114-5
   Mulet-Forteza C, 2019, INT J CONTEMP HOSP M, V31, P4574, DOI 10.1108/IJCHM-10-2018-0828
   National Bureau of Statistics of China, 2020, ANN DAT GDP
   National Health Commission of The People's Republic of China, 2020, PREV CONTR PLAN COVI
   National Health Commission of The People's Republic of China, 2020, SIT REP UPD COVID 19
   National Science Library Chinese Academy of Sciences, 2014, INTR CHIN SCI CIT DA
   Ni L, 2020, FRONT MED-PRC, V14, P210, DOI 10.1007/s11684-020-0757-x
   Park JH, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102526
   Qiu Jane, 2020, Nature, DOI 10.1038/d41586-020-00822-x
   Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314
   Schwartz KL, 2020, CAN MED ASSOC J, V192, pE410, DOI 10.1503/cmaj.75015
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031
   Smith TRF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16505-0
   Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P139, DOI 10.3760/cma.j.issn.0254-6450.2020.02.002
   Sriwijitalai W, 2020, J DERMATOL TREAT, V31, P324, DOI 10.1080/09546634.2020.1749548
   Sun J, 2018, INT ORTHOP, V42, P461, DOI 10.1007/s00264-018-3828-8
   Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4
   Takian A, 2020, LANCET, V395, P1035, DOI 10.1016/S0140-6736(20)30668-1
   Tang X, 2017, CHINA ED TECHNOL EQU, V3, P109
   The Educaiton Abroad Network, HONG KONG INT
   UK Government, 2020, COVID 19 GUID MASS G
   United Nations in Western Europe, 2020, COVID 19 EU SUSP NON
   WHO, 2020, ADV US MASKS COMM HO
   Wikipedia, 2019, LIST CHIN ADM DIV GD
   Willan J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1117
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   [向天新 Xiang Tianxin], 2020, [中国呼吸与危重监护杂志, Chinese Journal of Respiratory and Critical Care Medicine], V19, P154
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Zhang M, 2018, ENVIRON SCI POLLUT R, V25, P24600, DOI 10.1007/s11356-018-2598-6
   Zhang Qi, 2020, J Med Virol, V92, P540, DOI 10.1002/jmv.25733
   Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 54
TC 33
Z9 34
U1 123
U2 157
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD AUG 14
PY 2020
VL 8
AR 477
DI 10.3389/fpubh.2020.00477
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA NJ7JA
UT WOS:000566218300001
PM 32923422
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Rattis, BAC
   Ramos, SG
   Celes, MRN
AF Rattis, Brune A. C.
   Ramos, Simone G.
   Celes, Mara R. N.
TI Curcumin as a Potential Treatment for COVID-19
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE curcumin; COVID-19; SARS-CoV-2; new therapies; ACE2
ID NF-KAPPA-B; ACUTE LUNG INJURY; NEUTROPHIL EXTRACELLULAR TRAPS;
   VIRUS-INFECTION; PATHWAY INHIBITOR; ENDOTHELIAL-CELLS; MAMMALIAN TARGET;
   FOOD SPICE; RAT MODEL; ACTIVATION
AB Coronavirus disease 2019 (COVID-19) is an infectious disease that rapidly spread throughout the world leading to high mortality rates. Despite the knowledge of previous diseases caused by viruses of the same family, such as MERS and SARS-CoV, management and treatment of patients with COVID-19 is a challenge. One of the best strategies around the world to help combat the COVID-19 has been directed to drug repositioning; however, these drugs are not specific to this new virus. Additionally, the pathophysiology of COVID-19 is highly heterogeneous, and the way of SARS-CoV-2 modulates the different systems in the host remains unidentified, despite recent discoveries. This complex and multifactorial response requires a comprehensive therapeutic approach, enabling the integration and refinement of therapeutic responses of a given single compound that has several action potentials. In this context, natural compounds, such as Curcumin, have shown beneficial effects on the progression of inflammatory diseases due to its numerous action mechanisms: antiviral, anti-inflammatory, anticoagulant, antiplatelet, and cytoprotective. These and many other effects of curcumin make it a promising target in the adjuvant treatment of COVID-19. Hence, the purpose of this review is to specifically point out how curcumin could interfere at different times/points during the infection caused by SARS-CoV-2, providing a substantial contribution of curcumin as a new adjuvant therapy for the treatment of COVID-19.
C1 [Rattis, Brune A. C.; Ramos, Simone G.; Celes, Mara R. N.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, Brazil.
   [Rattis, Brune A. C.; Celes, Mara R. N.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Biosci & Technol, Goiania, Go, Brazil.
RP Celes, MRN (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, Brazil.; Celes, MRN (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Biosci & Technol, Goiania, Go, Brazil.
EM mrubia_celes@ufg.br
RI Rattis, Bruna A C/AAP-5494-2021; Celes, Mara Rubia/I-8707-2019
OI Rattis, Bruna A C/0000-0003-2948-3088; Celes, Mara
   Rubia/0000-0002-4733-007X; Ramos, Simone/0000-0002-1981-5248
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/Brazil)Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) [88882.378587/2019-01]; Fundacao de Amparo a Pesquisa
   do Estado de Goias (FAPEG/BRAZIL) [2017/1026700006-8]
FX The authors acknowledge the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES/Brazil) [88882.378587/2019-01] and Fundacao de
   Amparo a Pesquisa do Estado de Goias (FAPEG/BRAZIL) [2017/1026700006-8]
   for supporting funds. The authors also acknowledge the BioRender for
   making it possible to create the illustrations.
CR Alexandrow MG, 2012, EUR J CANCER PREV, V21, P407, DOI 10.1097/CEJ.0b013e32834ef194
   Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27539
   Almatroodi SA, 2020, MOLECULES, V25, DOI 10.3390/molecules25030724
   Amirfakhryan H, 2021, HELL J CARDIOL, V62, P13, DOI 10.1016/j.hjc.2020.05.007
   Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658
   Anggakusuma, 2014, GUT, V63, P1137, DOI 10.1136/gutjnl-2012-304299
   Antoine F, 2013, INT IMMUNOPHARMACOL, V17, P1101, DOI 10.1016/j.intimp.2013.09.024
   Ashry NA, 2013, PHARM BIOL, V51, P806, DOI 10.3109/13880209.2013.766895
   Aslam M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9091962
   Babaei F, 2020, FOOD SCI NUTR, V8, P5215, DOI 10.1002/fsn3.1858
   Balasubramanian A, 2019, ANTIVIR RES, V162, P71, DOI 10.1016/j.antiviral.2018.12.002
   Beck BR, 2020, COMPUT STRUCT BIOTEC, V18, P784, DOI 10.1016/j.csbj.2020.03.025
   Beevers CS, 2006, INT J CANCER, V119, P757, DOI 10.1002/ijc.21932
   Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367
   Bonaventura A, 2018, THROMB HAEMOSTASIS, V118, P6, DOI 10.1160/TH17-09-0630
   Bosca AR, 2000, MECH AGEING DEV, V114, P207, DOI 10.1016/S0047-6374(00)00089-0
   Butenas S, 2008, THROMB RES, V122, pS42, DOI 10.1016/S0049-3848(08)70018-5
   Carvalho-Schneider C, 2021, CLIN MICROBIOL INFEC, V27, P258, DOI 10.1016/j.cmi.2020.09.052
   Chai YS, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109946
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Cheemanapalli S, 2019, NETW MODEL ANAL HLTH, V8, DOI 10.1007/s13721-019-0196-2
   Chen DY, 2010, FOOD CHEM, V119, P1346, DOI 10.1016/j.foodchem.2009.09.011
   Chen HW, 2007, J ENDOTOXIN RES, V13, P15, DOI 10.1177/0968051907078605
   Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050
   Chen MH, 2012, INT J MOL MED, V30, P1021, DOI 10.3892/ijmm.2012.1096
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Cheng KP, 2018, MED SCI MONITOR, V24, P1178, DOI 10.12659/MSM.908714
   Chung MK, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102907
   Crowley SD, 2017, J AM SOC NEPHROL, V28, P1350, DOI 10.1681/ASN.2016101066
   Czaikoski PG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148142
   D'Alessandro E, 2018, THROMB RES, V168, P130, DOI 10.1016/j.thromres.2018.06.020
   D'Ardes D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21083003
   da Silva LS, 2017, PHARM BIOL, V55, P269, DOI 10.1080/13880209.2016.1260598
   DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13
   Deng Q, 2020, INT J CARDIOL, V311, P116, DOI 10.1016/j.ijcard.2020.03.087
   Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024
   Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398
   Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2
   Eguchi S, 2018, HYPERTENSION, V71, P804, DOI 10.1161/HYPERTENSIONAHA.118.10266
   Elfiky AA, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117592
   Falati S, 1999, BLOOD, V94, P1648, DOI 10.1182/blood.V94.5.1648.417k31_1648_1656
   Fan E, 2020, LANCET RESP MED, V8, P816, DOI 10.1016/S2213-2600(20)30304-0
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Gomez-Moreno D, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12940
   Grobler C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145168
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Gupta P, 2011, MOL DIVERS, V15, P733, DOI 10.1007/s11030-011-9304-7
   Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8
   Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368
   Hassaniazad M, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04824-y
   Hergenhahn M, 2002, MOL CARCINOGEN, V33, P137, DOI 10.1002/mc.10029
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4
   Iba T, 2020, INFLAMM RES, V69, P1181, DOI 10.1007/s00011-020-01401-6
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535
   Jeong EH, 2015, FISH SHELLFISH IMMUN, V45, P184, DOI 10.1016/j.fsi.2015.03.042
   Jia XH, 2019, INT IMMUNOPHARMACOL, V67, P211, DOI 10.1016/j.intimp.2018.12.017
   Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897
   Johnson SM, 2009, ANTICANCER RES, V29, P3185
   Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2
   Kanzawa N, 2006, FEBS LETT, V580, P6807, DOI 10.1016/j.febslet.2006.11.046
   Karunaweera N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00024
   Khan N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.595888
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lang JP, 2020, AM HEART J, V226, P29, DOI 10.1016/j.ahj.2020.04.025
   Lefrancais E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98178
   Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9
   Liao QJ, 2005, ACTA BIOCH BIOPH SIN, V37, P607, DOI 10.1111/j.1745-7270.2005.00082.x
   Lin SC, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2253-8
   Lin SH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01545
   Liu YF, 2017, J NUTR HEALTH AGING, V21, P307, DOI 10.1007/s12603-016-0722-1
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Lv YL, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-284
   Lv YL, 2014, ENVIRON TOXICOL PHAR, V37, P1140, DOI 10.1016/j.etap.2014.04.017
   Ma T, 2015, EUR REV MED PHARMACO, V19, P1305
   Mahmudpour M, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155151
   Manoharan Y, 2020, INDIAN J CLIN BIOCHE, V35, P373, DOI 10.1007/s12291-020-00902-9
   Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020
   Maurya Vimal K., 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00598-8
   Mayanglambam A, 2010, PLATELETS, V21, P211, DOI 10.3109/09537100903528269
   McFadyen JD, 2020, CIRC RES, V127, P571, DOI 10.1161/CIRCRESAHA.120.317447
   Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008
   Motohashi N., 2020, INNOSC THERANOSTICS, V3, P3, DOI [10.36922/itps.v3i2.935, DOI 10.36922/ITPS.V3I2.935]
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027
   Nemmar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039554
   Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010
   Nishimura H, 1997, THROMB HAEMOSTASIS, V77, P1189
   Obata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070225
   Ou JL, 2013, FEBS J, V280, P5829, DOI 10.1111/febs.12503
   Paciello F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57965-0
   Paliogiannis P, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00432
   Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105
   Park JY, 2012, BIOL PHARM BULL, V35, P2036, DOI 10.1248/bpb.b12-00623
   Park JY, 2012, BIOORGAN MED CHEM, V20, P5928, DOI 10.1016/j.bmc.2012.07.038
   Patell R, 2020, BLOOD, V136, P1342, DOI 10.1182/blood.2020007938
   Pendurthi UR, 1997, ARTERIOSCL THROM VAS, V17, P3406, DOI 10.1161/01.ATV.17.12.3406
   Prasad A, 2009, CIRCULATION, V120, P2105, DOI 10.1161/CIRCULATIONAHA.108.814640
   Rahardjo B, 2014, BIOMARK GENOM MED, V6, P105, DOI 10.1016/j.bgm.2014.06.002
   Rapkiewicz AV, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100434
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707
   Roy A, 2020, PHYTOTHER RES, V34, P2425, DOI 10.1002/ptr.6766
   Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005
   Rut W, 2021, NAT CHEM BIOL, V17, P222, DOI 10.1038/s41589-020-00689-z
   Saeedi-Boroujeni A, 2021, BASIC CLIN PHARMACOL, V128, P37, DOI 10.1111/bcpt.13503
   Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366
   Sang Yongming, 2015, J Clin Cell Immunol, V6
   Sathler PC, 2020, AN ACAD BRAS CIENC, V92, DOI 10.1590/0001-3765202020200834
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Schneider EC, 2020, NEW ENGL J MED, V383, P299, DOI 10.1056/NEJMp2014836
   Schonrich G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00366
   Shah BH, 1999, BIOCHEM PHARMACOL, V58, P1167, DOI 10.1016/S0006-2952(99)00206-3
   Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7
   Silva PL, 2015, BEST PRACT RES-CLIN, V29, P301, DOI 10.1016/j.bpa.2015.08.004
   Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831
   Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R
   Skurk T, 2004, ARTERIOSCL THROM VAS, V24, P1199, DOI 10.1161/01.ATV.0000131266.38312.2e
   Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1
   Soni VK, 2020, EUR J PHARMACOL, V886, DOI 10.1016/j.ejphar.2020.173551
   SRIVASTAVA KC, 1995, PROSTAG LEUKOTR ESS, V52, P223, DOI 10.1016/0952-3278(95)90040-3
   Stefanini GG, 2020, CIRCULATION, V141, P2113, DOI 10.1161/CIRCULATIONAHA.120.047525
   Tahmasebi S, 2021, J CELL PHYSIOL, V236, P5325, DOI 10.1002/jcp.30233
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Temiz-Resitoglu M, 2017, EUR J PHARMACOL, V802, P7, DOI 10.1016/j.ejphar.2017.02.034
   Thangapazham RL, 2008, CANCER BIOL THER, V7, P1429, DOI 10.4161/cbt.7.9.6469
   Thimmulappa RK, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06350
   Huynh T, 2020, J PHYS CHEM LETT, V11, P4413, DOI 10.1021/acs.jpclett.0c00994
   Valizadeh H, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107088
   Vallejo N, 2021, EUR HEART J-CASE REP, V5, DOI 10.1093/ehjcr/ytab105
   Vinten-Johansen J, 2005, BASIC RES CARDIOL, V100, P295, DOI 10.1007/s00395-005-0523-x
   Vishvakarma NK, 2011, TOXICOL APPL PHARM, V252, P298, DOI 10.1016/j.taap.2011.03.002
   Wang NP, 2012, BRIT J PHARMACOL, V167, P1550, DOI 10.1111/j.1476-5381.2012.02109.x
   Wang X, 2018, BIOMED PHARMACOTHER, V98, P754, DOI 10.1016/j.biopha.2017.12.100
   Wang YQ, 2018, IMMUNOPHARM IMMUNOT, V40, P476, DOI 10.1080/08923973.2018.1469145
   Wen CC, 2007, J MED CHEM, V50, P4087, DOI 10.1021/jm070295s
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia S, 2020, CELL RES, V30, P343, DOI 10.1038/s41422-020-0305-x
   Xia S, 2020, CELL MOL IMMUNOL, V17, P765, DOI 10.1038/s41423-020-0374-2
   Xiao XF, 2012, J SURG RES, V176, pE31, DOI 10.1016/j.jss.2011.11.1032
   Xu F, 2013, INT IMMUNOPHARMACOL, V16, P1, DOI 10.1016/j.intimp.2013.03.014
   Yadav R, 2015, INDIAN J CLIN BIOCHE, V30, P109, DOI 10.1007/s12291-014-0452-2
   Yang C, 2013, PHARM BIOL, V51, P482, DOI 10.3109/13880209.2012.742116
   Yang M, 2016, MOLECULES, V21, DOI 10.3390/molecules21101401
   Yang XX, 2016, NANOSCALE, V8, P3040, DOI 10.1039/c5nr07918g
   Yeh DYW, 2020, TRANSPL P, V52, P1875, DOI 10.1016/j.transproceed.2020.01.133
   Yin HP, 2018, J IMMUNOL, V200, P2835, DOI 10.4049/jimmunol.1701495
   Zahedipour F, 2020, PHYTOTHER RES, V34, P2911, DOI 10.1002/ptr.6738
   Zhang HN, 2007, ACTA PHARMACOL SIN, V28, P423, DOI 10.1111/j.1745-7254.2007.00501.x
   Zhang L, 2008, ACTA PHARMACOL SIN, V29, P800, DOI [10.1111/j.1745-7254.2008.00813.x, 10.1111/j.1745-7254.2008.00803.x]
   Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405
   Zhang S, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00954-7
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu L, 2015, ACTA VIROL, V59, P221, DOI 10.4149/av_2015_03_221
NR 160
TC 6
Z9 6
U1 5
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD MAY 7
PY 2021
VL 12
AR 675287
DI 10.3389/fphar.2021.675287
PG 14
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA SF2IH
UT WOS:000652584200001
PM 34025433
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Miethke-Morais, A
   Cassenote, A
   Piva, H
   Tokunaga, E
   Cobello, V
   Goncalves, FAR
   Lobo, RD
   Trindade, E
   D'Albuquerque, LAC
   Haddad, L
AF Miethke-Morais, Anna
   Cassenote, Alex
   Piva, Heloisa
   Tokunaga, Eric
   Cobello, Vilson
   Rodrigues Goncalves, Fabio Augusto
   Lobo, Renata dos Santos
   Trindade, Evelinda
   Carneiro D'Albuquerque, Luiz Augusto
   Haddad, Luciana
CA HCFMUSP Covid-19 Study Grp
TI COVID-19-related hospital cost-outcome analysis: The impact of clinical
   and demographic factors
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE COVID-19; Economic evaluation; Cost; Health economics
ID NEW-YORK-CITY; BURDEN
AB Introduction: Although patients' clinical conditions have been shown to be associated with coronavirus disease (COVID-19) severity and outcome, their impact on hospital costs are not known. This economic evaluation of COVID-19 admissions aimed to assess direct and fixed hospital costs and describe their particularities in different clinical and demographic conditions and outcomes in the largest public hospital in Latin America, located in Sao Paulo, Brazil, where a whole institute was exclusively dedicated to COVID-19 patients in response to the pandemic.
   Methods: This is a partial economic evaluation performed from the hospital's perspective and is a prospective, observational cohort study to assess hospitalization costs of suspected and confirmed COVID-19 patients admitted between March 30 and June 30, 2020, to Hospital das Clinicas of the University of Sao Paulo Medical School (HCFMUSP) and followed until discharge, death, or external transfer. Micro- and macro-costing methodologies were used to describe and analyze the total cost associated with each patient's underlying medical conditions, itinerary and outcomes as well as the cost components of different hospital sectors.
   Results: The average cost of the 3254 admissions (51.7% of which involved intensive care unit stays) was US$12,637.42. The overhead cost was its main component. Sex, age and underlying hypertension (US$14,746.77), diabetes (US$15,002.12), obesity (US$18,941.55), chronic renal failure (US$15,377.84), and rheumatic (US$17,764.61), hematologic (US $15,908.25) and neurologic (US$15,257.95) diseases were associated with higher costs. Age strata >69 years, reverse transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19, comorbidities, use of mechanical ventilation or dialysis, surgery and outcomes remained associated with higher costs.
   Conclusion: Knowledge of COVID-19 hospital costs can aid in the development of a comprehensive approach for decision-making and planning for future risk management. (C) 2021 Sociedade Brasileira de Infectologia. Published by Elsevier Espana, S.L.U.
C1 [Miethke-Morais, Anna] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Clin Directors Off, Sao Paulo, SP, Brazil.
   [Cassenote, Alex; Carneiro D'Albuquerque, Luiz Augusto; Haddad, Luciana] Univ Sao Paulo, Fac Med FMUSP, Dept Gastroenterol, Sao Paulo, SP, Brazil.
   [Cassenote, Alex] Discipline Labour Market & Phys Hlth, Santa Marcelina Fac, Sao Paulo, SP, Brazil.
   [Cassenote, Alex] Univ Sao Paulo, Fac Med FMUSP, Dept Prevent Med, Med Demog Study Grp, Sao Paulo, SP, Brazil.
   [Piva, Heloisa] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Inst Cent,Execut Directors Off, Sao Paulo, SP, Brazil.
   [Tokunaga, Eric] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Strategy & Operat Dept, Sao Paulo, SP, Brazil.
   [Cobello, Vilson] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Informat Technol Dept, Sao Paulo, SP, Brazil.
   [Rodrigues Goncalves, Fabio Augusto] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Hlth Technol Assessment Ctr, Sao Paulo, SP, Brazil.
   [Lobo, Renata dos Santos] Univ Sao Paulo, Fac Med FMUSP, Lab Med Invest Pathogenesis & Targeted Therapy On, Sao Paulo, SP, Brazil.
   [Trindade, Evelinda] REPATS SES SP, Sao Paulo State Hlth Secretariat, Sao Paulo State Hlth Technol Assessment Network, Sao Paulo, SP, Brazil.
   [Carneiro D'Albuquerque, Luiz Augusto; Haddad, Luciana] Univ Sao Paulo, Fac Med FMUSP, Gastroenterol Dept, Digest Organs Transplant Div, Sao Paulo, SP, Brazil.
   [Trindade, Evelinda] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Sao Paulo, SP, Brazil.
   [Rodrigues Goncalves, Fabio Augusto] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Cent,Cent Lab Div, Sao Paulo, SP, Brazil.
RP Haddad, L (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Dept Gastroenterol, Sao Paulo, SP, Brazil.; Haddad, L (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Gastroenterol Dept, Digest Organs Transplant Div, Sao Paulo, SP, Brazil.
EM luciana.haddad@hc.fm.usp.br
RI Rodrigues Gonçalves, Fabio Augusto/W-4612-2018
OI Rodrigues Gonçalves, Fabio Augusto/0000-0003-0848-2465; Miethke Morais,
   Anna/0000-0002-5077-4122
CR Bartsch SM, 2020, HEALTH AFFAIR, V39, P927, DOI 10.1377/hlthaff.2020.00426
   CARMONA MJC, 2020, CLINICS, V75
   Castro MC, 2021, SCIENCE, V372, P821, DOI 10.1126/science.abh1558
   Clarke L, 2020, J EVID-BASED MED, V13, P161, DOI 10.1111/jebm.12395
   Cummings Matthew J, 2020, medRxiv, DOI 10.1101/2020.04.15.20067157
   Diario~ Oficial Poder Legislativo., 2020, PRIM TERM AD CONV 01
   Dias Roger Daglius, 2016, J Emerg Manag, V14, P349, DOI 10.5055/jem.2016.0300
   Faico KS, 2020, AM J TROP MED HYG, V103, P2019, DOI 10.4269/ajtmh.20-0954
   FERREIRA JC, 2020, CLIN SAO PAULO, V75
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Herstein JJ, 2016, EMERG INFECT DIS, V22, P350, DOI 10.3201/eid2202.151431
   Huber C, 2018, J INFECT DIS, V218, pS698, DOI 10.1093/infdis/jiy213
   Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198
   Khan AA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207458
   Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006
   Li XZ, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00689-0
   Minist~erio da Saude, 2020, DEF CAS NOT
   Minist ~erio daSaude, 2020, DIR MET EST MICR APL
   Ministerio ~ da Saude, DIR ESTR
   Mitchell A, BMJ BEST PRACTICE CO
   Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046
   Paim JS, 2019, SAUDE DEBATE, V43, P15, DOI DOI 10.1590/0103-11042019S502
   Perondi B, 2020, BRAZ J INFECT DIS, V24, P570, DOI 10.1016/j.bjid.2020.09.005
   Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4
   Shlomai A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03244-3
   WHO, 2020, WHO COVID 19 CAS DEF
   WHO, 2020, PUBL HLTH SURV COVID
   World Health Organization, 2020, R D BLUEPR NOV COR C
   World Health Organization, 2020, LAB TEST COR DIS 201, P2020
NR 32
TC 1
Z9 1
U1 8
U2 8
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JUL-AUG
PY 2021
VL 25
IS 4
AR 101609
DI 10.1016/j.bjid.2021.101609
EA SEP 2021
PG 9
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA UY0WA
UT WOS:000701252500001
PM 34454894
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Yau, O
   Gin, K
   Luong, C
   Jue, J
   Abolmaesumi, P
   Tsang, M
   Nair, P
   Tsang, TSM
AF Yau, Olivia
   Gin, Ken
   Luong, Christina
   Jue, John
   Abolmaesumi, Purang
   Tsang, Michael
   Nair, Parvathy
   Tsang, Teresa S. M.
TI Point-of-care ultrasound in the COVID-19 era: A scoping review
SO ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED
   TECHNIQUES
LA English
DT Review
DE cardiac imaging; COVID-19; diagnostic imaging tools; hand-carried
   ultrasound; POCUS
ID LUNG ULTRASOUND; PNEUMONIA; ECHOCARDIOGRAPHY; DIAGNOSIS; MANAGEMENT;
   STATEMENT; RESOURCE; FAILURE; POCUS; HEART
AB In the midst of the COVID-19 pandemic, unprecedented pressure has been added to healthcare systems around the globe. Imaging is a crucial component in the management of COVID-19 patients. Point-of-care ultrasound (POCUS) such as hand-carried ultrasound emerges in the COVID-19 era as a tool that can simplify the imaging process of COVID-19 patients, and potentially reduce the strain on healthcare providers and healthcare resources. The preliminary evidence available suggests an increasing role of POCUS in diagnosing, monitoring, and risk-stratifying COVID-19 patients. This scoping review aims to delineate the challenges in imaging COVID-19 patients, discuss the cardiopulmonary complications of COVID-19 and their respective sonographic findings, and summarize the current data and recommendations available. There is currently a critical gap in knowledge in the role of POCUS in the COVID-19 era. Nonetheless, it is crucial to summarize the current preliminary data available in order to help fill this gap in knowledge for future studies.
C1 [Yau, Olivia] Univ British Columbia, Fac Med, Vancouver Fraser Med Program, Vancouver, BC, Canada.
   [Gin, Ken; Luong, Christina; Jue, John; Tsang, Michael; Nair, Parvathy; Tsang, Teresa S. M.] Univ British Columbia, Dept Med, Div Cardiol, Vancouver, BC, Canada.
   [Abolmaesumi, Purang] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC, Canada.
RP Tsang, TSM (corresponding author), Univ British Columbia, Dept Med, Div Cardiol, Diamond Hlth Care Ctr, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
EM t.tsang@ubc.ca
RI Tsang, Teresa/AAO-3518-2021
OI Yau, Olivia/0000-0002-4866-8910
CR Abramowicz JS, 2020, ULTRASOUND MED BIOL, V46, P1821, DOI 10.1016/j.ultrasmedbio.2020.03.033
   Abrams ER, 2020, J EMERG MED, V59, P403, DOI 10.1016/j.jemermed.2020.06.032
   Agricola E, 2020, JACC-CARDIOVASC IMAG, V13, P1792, DOI 10.1016/j.jcmg.2020.05.017
   Alharthy A, 2021, J ULTRAS MED, V40, P443, DOI 10.1002/jum.15417
   Allinovi M, 2020, ULTRASOUND MED BIOL, V46, P2908, DOI 10.1016/j.ultrasmedbio.2020.07.018
   Anile A, 2020, ANESTH ANALG, V131, pE232, DOI 10.1213/ANE.0000000000005142
   [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020
   Antunez-Montes O Y, 2022, Med Intensiva, V46, P42, DOI 10.1016/j.medin.2020.04.010
   Antunez-Montes OY, 2021, J ULTRAS MED, V40, P419, DOI 10.1002/jum.15414
   Baig Muhammad Akbar, 2020, J Coll Physicians Surg Pak, V30, P56, DOI 10.29271/jcpsp.2020.Supp1.S56
   Baker Kylie, 2020, Australas J Ultrasound Med, DOI 10.1002/ajum.12213
   Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020
   Boero E, 2020, JACEP OPEN, V1, P1357, DOI 10.1002/emp2.12194
   Buda N, 2020, ANAESTH INTENSIVE TH, V52, P83, DOI 10.5114/ait.2020.96560
   Buonsenso D, 2020, EUR REV MED PHARMACO, V24, P2776, DOI 10.26355/eurrev_202003_20549
   Buonsenso D, 2020, LANCET RESP MED, V8, pE27, DOI 10.1016/S2213-2600(20)30120-X
   Canadian Society of Echocardiography, 2020, PRACT ECH COVID 19 P
   Cheung JCH, 2020, LANCET RESP MED, V8, pE34, DOI 10.1016/S2213-2600(20)30166-1
   Chiem AT, 2021, J ULTRAS MED, V40, P391, DOI 10.1002/jum.15394
   Chinese Medical Ultrasound Society, 2020, CHINESE J MED, V17, P226
   Cho YJ, 2020, KOREAN J INTERN MED, V35, P771, DOI 10.3904/kjim.2020.180
   Convissar DL, 2020, ANESTH ANALG, V131, P345, DOI 10.1213/ANE.0000000000004929
   Di Serafino M, 2020, RADIOL MED, V125, P738, DOI 10.1007/s11547-020-01236-5
   Drake DH, 2020, J AM SOC ECHOCARDIOG, V33, P683, DOI 10.1016/j.echo.2020.04.007
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Dugar S, 2020, INTENS CARE MED, V46, P1637, DOI 10.1007/s00134-020-06094-3
   Duggan NM, 2020, J EMERG MED, V59, P515, DOI 10.1016/j.jemermed.2020.06.033
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Farrow Robert 2nd, 2020, Clin Pract Cases Emerg Med, V4, P129, DOI 10.5811/cpcem.2020.4.47524
   Favot Mark, 2020, Crit Care Explor, V2, pe0176, DOI 10.1097/CCE.0000000000000176
   Fox Steven, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc019
   Gargani L, 2020, EUR HEART J-CARD IMG, V21, P941, DOI 10.1093/ehjci/jeaa163
   Gibson LE, 2020, ANESTH ANALG, V131, pE234, DOI 10.1213/ANE.0000000000005144
   Gregorio-Hernandez R, 2020, EUR J PEDIATR, V179, P1279, DOI 10.1007/s00431-020-03706-4
   Huang G, 2020, J AM SOC ECHOCARDIOG, V33, P903, DOI [10.1016/j.echo.2020.04.023, 10.1016/j.echo.2020.04.027]
   Huang Y, 2020, RES SQUARE, DOI [10.21203/rs. 2.24369/v1, DOI 10.21203/RS.2.24369/V1]
   Inchingolo R, 2020, AM J OBSTET GYNECOL, V223, P9, DOI 10.1016/j.ajog.2020.04.020
   Johri AM, 2020, J AM SOC ECHOCARDIOG, V33, P670, DOI 10.1016/j.echo.2020.04.017
   Kalafat E, 2020, ULTRASOUND OBST GYN, V55, P835, DOI 10.1002/uog.22034
   Kariyanna Pramod Theetha, 2020, Am J Med Case Rep, V8, P225
   Khalili N, 2020, ACAD RADIOL, V27, P1044, DOI 10.1016/j.acra.2020.04.032
   Khanji MY, 2020, PROG CARDIOVASC DIS, V63, P690, DOI 10.1016/j.pcad.2020.07.003
   Kiamanesh O, 2020, CAN J CARDIOL, V36, P1144, DOI 10.1016/j.cjca.2020.05.008
   Kim DJ, 2020, CAN J EMERG MED, V22, P445, DOI 10.1017/cem.2020.364
   Kirkpatrick JN, 2019, J AM SOC ECHOCARDIOG, V2020, P1
   Koratala A, 2020, CARDIORENAL MED, V10, P209, DOI 10.1159/000508544
   Kraemer AXE, 2020, NETH J CRIT CARE, V28, P162
   Kulkarni S, 2020, CLIN RADIOL, V75, DOI 10.1016/j.crad.2020.05.001
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Lomoro P, 2020, EUR J RADIOL OPEN, V7, DOI 10.1016/j.ejro.2020.100231
   Ma IWY, 2020, PANDEMIC, V15, P1
   Manivel V, 2020, EMERG MED AUSTRALAS, V32, P694, DOI 10.1111/1742-6723.13546
   Mathews BK, 2020, J HOSP MED, V15, P353, DOI 10.12788/jhm.3454
   Mohamed MFH, 2020, AM J TROP MED HYG, V103, P815, DOI 10.4269/ajtmh.20-0371
   Moller-Sorensen H, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10070447
   Mongodi S, 2020, ULTRASOUND MED BIOL, V46, P2090, DOI 10.1016/j.ultrasmedbio.2020.04.033
   Moore S, 2020, RADIOGRAPHY, V26, pE297, DOI 10.1016/j.radi.2020.04.005
   Musolino AM, 2020, ULTRASOUND MED BIOL, V46, P2094, DOI 10.1016/j.ultrasmedbio.2020.04.026
   Nouvenne A, 2020, J AM MED DIR ASSOC, V21, P919, DOI 10.1016/j.jamda.2020.05.050
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Orso D, 2020, EUR J EMERG MED, V27, P327, DOI 10.1097/MEJ.0000000000000713
   Page RL, 2016, CIRCULATION, V134, pE32, DOI 10.1161/CIR.0000000000000426
   Pare JR, 2020, WEST J EMERG MED, V21, P771, DOI 10.5811/westjem.2020.5.47743
   Peh WM, 2020, J ULTRASON, V20, pE154, DOI 10.15557/JoU.2020.0025
   Peng QY, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02856-z
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Picard MH, 2020, J AM SOC ECHOCARDIOG, V33, P674, DOI 10.1016/j.echo.2020.04.011
   Piscaglia F, 2020, ULTRASCHALL MED, V41, P228, DOI 10.1055/a-1149-9872
   Poggiali E, 2020, RADIOLOGY, V295, pE6, DOI 10.1148/radiol.2020200847
   Qian F, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03064-5
   Revel MP, 2020, EUR RADIOL, V30, P4903, DOI 10.1007/s00330-020-06865-y
   Roth KR, 2020, JACEP OPEN, V1, P309, DOI 10.1002/emp2.12080
   Roy S, 2020, IEEE T MED IMAGING, V39, P2676, DOI 10.1109/TMI.2020.2994459
   Schmid Mathias, 2020, Dtsch Arztebl Int, V117, P335, DOI 10.3238/arztebl.2020.0335
   Schultz MJ, 2020, AM J TROP MED HYG, V102, P1162, DOI 10.4269/ajtmh.20-0323
   Shokoohi H, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.079
   Smallwood N, 2020, CLIN MED, V20, P486, DOI 10.7861/clinmed.2020-0442
   Smith MJ, 2020, ANAESTHESIA, V75, P1096, DOI 10.1111/anae.15082
   Sofia S, 2020, J ULTRASOUND, V23, P217, DOI 10.1007/s40477-020-00458-7
   Soldati G, 2020, J ULTRAS MED, V39, P1413, DOI 10.1002/jum.15285
   Soldati G, 2020, J ULTRAS MED, V39, P1459, DOI 10.1002/jum.15284
   Sultan LR, 2020, ULTRASOUND MED BIOL, V46, P2530, DOI 10.1016/j.ultrasmedbio.2020.05.012
   Szabo IA, 2020, ANATOL J CARDIOL, V24, P76, DOI 10.14744/AnatolJCardiol.2020.33645
   Tavazzi G, 2020, INTENS CARE MED, V46, P1121, DOI 10.1007/s00134-020-06040-3
   Thomas A, 2020, CAN MED ASSOC J, V192, pE399, DOI 10.1503/cmaj.200414
   Trauer MM, 2020, ULTRASOUND, V28, P208, DOI 10.1177/1742271X20950779
   Tung-Chen Y, 2020, CLIN MED, V20, pE62, DOI 10.7861/clinmed.2020-0123
   VAZQUEZ MJ, 2020, EUR REV MED PHARMACO, V24, P7801
   Verelst F, 2020, EUROSURVEILLANCE, V25, P13, DOI 10.2807/1560-7917.ES.2020.25.13.2000323
   Vetrugno L, 2020, ULTRASOUND J, V12, DOI 10.1186/s13089-020-00185-4
   Vetrugno L, 2020, ECHOCARDIOGR-J CARD, V37, P625, DOI 10.1111/echo.14664
   Vieira ALS, 2020, ULTRASOUND J, V12, DOI 10.1186/s13089-020-00177-4
   Volpicelli G, 2020, INTENS CARE MED, V46, P1445, DOI 10.1007/s00134-020-06048-9
   Volpicelli G, 2020, ULTRASOUND J, V12, DOI 10.1186/s13089-020-00171-w
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   WHO, 2020, INF PREV CONTR HLTH
   Yang Yang, 2020, Australas J Ultrasound Med, V23, P96, DOI 10.1002/ajum.12209
   Yang Y, 2020, INTENS CARE MED, V46, P1761, DOI 10.1007/s00134-020-06096-1
   Yassa M, 2021, J ULTRAS MED, V40, P191, DOI 10.1002/jum.15367
   Yasukawa K, 2020, AM J TROP MED HYG, V102, P1198, DOI 10.4269/ajtmh.20-0280
   Zeng J, 2020, INFECTION 0410, DOI [10.20944/preprints202003.0180.v1, DOI 10.1007/S15010-020-01424-5, 10.1007/s15010-020-01424-5]
   Zhang L, 2020, J AM SOC ECHOCARDIOG, V33, P676, DOI 10.1016/j.echo.2020.04.004
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 103
TC 4
Z9 4
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-2822
EI 1540-8175
J9 ECHOCARDIOGR-J CARD
JI Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.
PD FEB
PY 2021
VL 38
IS 2
BP 329
EP 342
DI 10.1111/echo.14951
EA DEC 2020
PG 14
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA RA1IG
UT WOS:000599428400001
PM 33332638
OA hybrid
DA 2022-04-20
ER

PT J
AU Jin, YH
   Zhan, QY
   Peng, ZY
   Ren, XQ
   Yin, XT
   Cai, L
   Yuan, YF
   Yue, JR
   Zhang, XC
   Yang, QW
   Ji, JG
   Xia, J
   Li, YR
   Zhou, FX
   Gao, YD
   Yu, Z
   Xu, F
   Tu, ML
   Tan, LM
   Yang, M
   Chen, F
   Zhang, XJ
   Zeng, M
   Zhu, Y
   Liu, XC
   Yang, J
   Zhao, DC
   Ding, YF
   Hou, N
   Wang, FB
   Chen, H
   Zhang, YG
   Li, W
   Chen, W
   Shi, YX
   Yang, XZ
   Wang, XJ
   Zhong, YJ
   Zhao, MJ
   Li, BH
   Ma, LL
   Zi, H
   Wang, N
   Wang, YY
   Yu, SF
   Li, LY
   Huang, Q
   Weng, H
   Ren, XY
   Luo, LS
   Fan, MR
   Huang, D
   Xue, HY
   Yu, LX
   Gao, JP
   Deng, T
   Zeng, XT
   Li, HJ
   Cheng, ZS
   Yao, XM
   Wang, XH
AF Jin, Ying-Hui
   Zhan, Qing-Yuan
   Peng, Zhi-Yong
   Ren, Xue-Qun
   Yin, Xun-Tao
   Cai, Lin
   Yuan, Yu-Feng
   Yue, Ji-Rong
   Zhang, Xiao-Chun
   Yang, Qi-Wen
   Ji, Jianguang
   Xia, Jian
   Li, Yi-Rong
   Zhou, Fu-Xiang
   Gao, Ya-Dong
   Yu, Zhui
   Xu, Feng
   Tu, Ming-Li
   Tan, Li-Ming
   Yang, Min
   Chen, Fang
   Zhang, Xiao-Ju
   Zeng, Mei
   Zhu, Yu
   Liu, Xin-Can
   Yang, Jian
   Zhao, Dong-Chi
   Ding, Yu-Feng
   Hou, Ning
   Wang, Fu-Bing
   Chen, Hao
   Zhang, Yong-Gang
   Li, Wei
   Chen, Wen
   Shi, Yue-Xian
   Yang, Xiu-Zhi
   Wang, Xue-Jun
   Zhong, Yan-Jun
   Zhao, Ming-Juan
   Li, Bing-Hui
   Ma, Lin-Lu
   Zi, Hao
   Wang, Na
   Wang, Yun-Yun
   Yu, Shao-Fu
   Li, Lu-Yao
   Huang, Qiao
   Weng, Hong
   Ren, Xiang-Ying
   Luo, Li-Sha
   Fan, Man-Ru
   Huang, Di
   Xue, Hong-Yang
   Yu, Lin-Xin
   Gao, Jin-Ping
   Deng, Tong
   Zeng, Xian-Tao
   Li, Hong-Jun
   Cheng, Zhen-Shun
   Yao, Xiaomei
   Wang, Xing-Huan
CA Evidence Based Med
   CRHA
TI Chemoprophylaxis, diagnosis, treatments, and discharge management of
   COVID-19: An evidence-based clinical practice guideline (updated
   version)
SO MILITARY MEDICAL RESEARCH
LA English
DT Article
DE COVID-19; SARS-CoV-2; Recommendation; Chemoprophylaxis; Diagnosis;
   Treatment; Discharge management; Traditional Chinese medicine; guideline
ID RESPIRATORY-DISTRESS-SYNDROME; CORONAVIRUS DISEASE 2019; LUNG
   TRANSPLANTATION; MANIFESTATIONS; INVOLVEMENT; CHINA
AB The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guidelines for clinicians caring for patients are needed. In the early stage, we have issued "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"; now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based guideline. We formed a working group of clinical experts and methodologists. The steering group members proposed 29 questions that are relevant to the management of COVID-19 covering the following areas: chemoprophylaxis, diagnosis, treatments, and discharge management. We searched the literature for direct evidence on the management of COVID-19, and assessed its certainty generated recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. Recommendations were either strong or weak, or in the form of ungraded consensus-based statement. Finally, we issued 34 statements. Among them, 6 were strong recommendations for, 14 were weak recommendations for, 3 were weak recommendations against and 11 were ungraded consensus-based statement. They covered topics of chemoprophylaxis (including agents and Traditional Chinese Medicine (TCM) agents), diagnosis (including clinical manifestations, reverse transcription-polymerase chain reaction (RT-PCR), respiratory tract specimens, IgM and IgG antibody tests, chest computed tomography, chest x-ray, and CT features of asymptomatic infections), treatments (including lopinavir-ritonavir, umifenovir, favipiravir, interferon, remdesivir, combination of antiviral drugs, hydroxychloroquine/chloroquine, interleukin-6 inhibitors, interleukin-1 inhibitors, glucocorticoid, qingfei paidu decoction, lianhua qingwen granules/capsules, convalescent plasma, lung transplantation, invasive or noninvasive ventilation, and extracorporeal membrane oxygenation (ECMO)), and discharge management (including discharge criteria and management plan in patients whose RT-PCR retesting shows SARS-CoV-2 positive after discharge). We also created two figures of these recommendations for the implementation purpose. We hope these recommendations can help support healthcare workers caring for COVID-19 patients.
C1 [Jin, Ying-Hui; Zhao, Ming-Juan; Li, Bing-Hui; Ma, Lin-Lu; Zi, Hao; Wang, Yun-Yun; Yu, Shao-Fu; Li, Lu-Yao; Huang, Qiao; Weng, Hong; Ren, Xiang-Ying; Luo, Li-Sha; Fan, Man-Ru; Huang, Di; Xue, Hong-Yang; Yu, Lin-Xin; Gao, Jin-Ping; Deng, Tong; Zeng, Xian-Tao; Wang, Xing-Huan] Wuhan Univ, Ctr Evidence Based & Translat Med, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Zhan, Qing-Yuan] China Japan Friendship Hosp, Natl Clin Res Ctr Resp Dis, Beijing 100029, Peoples R China.
   [Zhan, Qing-Yuan] China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing 10029, Peoples R China.
   [Peng, Zhi-Yong; Cai, Lin; Zhang, Xiao-Chun; Xia, Jian; Li, Yi-Rong; Zeng, Xian-Tao; Cheng, Zhen-Shun; Wang, Xing-Huan] Leishenshan Hosp Wuhan, Wuhan 430200, Peoples R China.
   [Peng, Zhi-Yong] Wuhan Univ, Dept Crit Care Med, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Ren, Xue-Qun; Ma, Lin-Lu; Wang, Na] Henan Univ, Inst Evidence based Med & Knowledge Translat, Kaifeng 475000, Henan, Peoples R China.
   [Yin, Xun-Tao] Guizhou Prov Peoples Hosp, Dept Med Imaging, Guiyang 550002, Peoples R China.
   [Cai, Lin] Wuhan Univ, Dept Orthoped, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Yuan, Yu-Feng] Wuhan Univ, Dept Hepatobiliary Surg, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Yue, Ji-Rong] Sichuan Univ, Natl Clin Res Ctr Geriatr, West China Hosp, Chengdu 610041, Peoples R China.
   [Yue, Ji-Rong] Sichuan Univ, Dept Geriatr, West China Hosp, Chengdu 610041, Peoples R China.
   [Zhang, Xiao-Chun] Wuhan Univ, Dept Radiol, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Yang, Qi-Wen] Chinese Acad Med Sci CAMS, Peking Union Med Coll Hosp PUMCH, Peking Union Med Coll, Dept Clin Lab, Beijing 100730, Peoples R China.
   [Ji, Jianguang; Xia, Jian] Lund Univ & Region Skane, Ctr Primary Hlth Care Res, S-25002 Malmo, Sweden.
   [Xia, Jian] Wuhan Univ, Emergency Ctr, Zhongnan Hosp, Wuhan 403371, Peoples R China.
   [Li, Yi-Rong; Gao, Ya-Dong; Wang, Fu-Bing] Wuhan Univ, Dept Allergol, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   Wuhan Univ, Dept Radiat & Med Oncol, Zhongnan Hosp, Wuhan 43071, Peoples R China.
   [Zhou, Fu-Xiang] Wuhan Univ, Dept Crit Care Med, Zhongnan Hosp, Wuhan 430060, Peoples R China.
   [Xu, Feng] Shandong Univ, Dept Emergency Med, Qilu Hosp, Jinan 250002, Peoples R China.
   [Xu, Feng] Shandong Univ, Chest Pain Ctr, Qilu Hosp, Jinan 250002, Peoples R China.
   [Tu, Ming-Li] Hubei Univ Med, Suizhou Cent Hosp, Dept Resp & Crit Care Med, Suizhou 441300, Hubei, Peoples R China.
   [Tu, Ming-Li; Tan, Li-Ming] Second Peoples Hosp Huaihua City, Dept Clin Pharm, Huaihua 418000, Hunan, Peoples R China.
   [Yang, Min] Anhui Med Univ, Dept Intens Care Unit, Affiliated Hosp 2, Hefei 230601, Peoples R China.
   [Chen, Fang] Zhengzhou Univ Hosp, Dept Internal Med, Zhengzhou 450001, Peoples R China.
   [Zhang, Xiao-Ju] Henan Prov Peoples Hosp, Dept Resp & Crit Care Med, Zhengzhou 450003, Peoples R China.
   [Zeng, Mei] Fudan Univ, Dept Infect Dis, Childrens Hosp, Shanghai 201102, Peoples R China.
   [Zhu, Yu] Sichuan Univ, West China Hosp 2, Dept Infect Dis, Chengdu 610041, Peoples R China.
   [Liu, Xin-Can] Henan Univ Chinese Med, Dept Cardiol, Zhengzhou 450000, Peoples R China.
   [Yang, Jian] Three Gorges Univ, Renmin Hosp China, Dept Cardiol, Yichang 443000, Hubei, Peoples R China.
   [Zhao, Dong-Chi] Wuhan Univ, Dept Pediat, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Ding, Yu-Feng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pharm, Wuhan 430030, Peoples R China.
   [Hou, Ning] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Prov Hosp, Dept Pharm, Jinan 250021, Peoples R China.
   [Chen, Hao] Nanjing Univ Chinese Med, Lab Integrated Acupuncture & Drugs, Nanjing 210023, Peoples R China.
   [Zhang, Yong-Gang] Sichuan Univ, West China Hosp, Dept Period Press, Chengdu 610041, Peoples R China.
   [Li, Wei] Qingdao Univ, Yantai Yuhuangding Hosp, Dept Clin Lab, Yantai 264000, Shandong, Peoples R China.
   [Chen, Wen] Hubei Univ Med, Taihe Hosp, Dept Radiol, Shiyan 442000, Hubei, Peoples R China.
   [Shi, Yue-Xian] Peking Univ, Sch Nursing, Beijing 100191, Peoples R China.
   [Yang, Xiu-Zhi] Kaifeng Cent Hosp, Dept Resp & Crit Care Med, Kaifeng 475000, Henan, Peoples R China.
   [Wang, Xue-Jun] Beijing Elect Power Hosp, Dept Emergency, Beijing 100073, Peoples R China.
   [Zhong, Yan-Jun] Cent South Univ, Second Xiangya Hosp, ICU Ctr, Changsha 410008, Peoples R China.
   [Li, Bing-Hui; Wang, Xing-Huan] Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Ma, Lin-Lu] Wuhan Univ, Zhongnan Hosp, Dept Haematol, Wuhan 430071, Peoples R China.
   [Wang, Na] Henan Univ, Henan Med Sch, Coll Nursing & Hlth, Kaifeng 475000, Henan, Peoples R China.
   [Gao, Jin-Ping] Shanxi Med Univ, Sch Nursing, Taiyuan 030001, Peoples R China.
   [Li, Hong-Jun] Capital Med Univ, Beijing Youan Hosp, Dept Diagnost Radiol, Beijing 100069, Peoples R China.
   [Cheng, Zhen-Shun] Wuhan Univ, Dept Resp Med, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Yao, Xiaomei] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada.
   [Yu, Zhui] Wuhan Univ, Dept Crit Care Med, Renmin Hosp, Wuhan 430060, Peoples R China.
RP Zeng, XT; Wang, XH (corresponding author), Wuhan Univ, Ctr Evidence Based & Translat Med, Zhongnan Hosp, Wuhan 430071, Peoples R China.; Zeng, XT; Cheng, ZS; Wang, XH (corresponding author), Leishenshan Hosp Wuhan, Wuhan 430200, Peoples R China.; Wang, XH (corresponding author), Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan 430071, Peoples R China.; Li, HJ (corresponding author), Capital Med Univ, Beijing Youan Hosp, Dept Diagnost Radiol, Beijing 100069, Peoples R China.; Cheng, ZS (corresponding author), Wuhan Univ, Dept Resp Med, Zhongnan Hosp, Wuhan 430071, Peoples R China.; Yao, XM (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada.
EM zengxiantao1128@163.com; lihongjun00113@126.com; chzs1990@163.com;
   yaoxia@mcmaster.ca; wangxinghuan1965@163.com
RI Weng, Hong/I-6590-2019; , 月月/AAS-9999-2021; , 月月/ABF-7551-2020; Wang,
   Xinghuan/AAB-3192-2021; zi, hao/AAD-1444-2019; Ji,
   Jianguang/E-9579-2011; Zhang, Yonggang/I-2028-2018
OI Weng, Hong/0000-0001-7795-5671; , 月月/0000-0002-3730-779X; Wang,
   Xinghuan/0000-0003-3497-0024; Ji, Jianguang/0000-0003-0324-9496; Zhang,
   Yonggang/0000-0002-5251-3815; zhao, Mingjuan/0000-0002-2266-0267; Reis,
   AlessanRSS/0000-0001-8486-7469
FU National Key Research and Development Program of China [2020YFC0845500];
   Special Project for Emergency of Hubei Province [2020FCA008]; First
   Level Funding of the Second Medical Leading Talent Project in Hubei
   Province
FX This work was supported (in part) by the National Key Research and
   Development Program of China (2020YFC0845500), the Special Project for
   Emergency of Hubei Province (2020FCA008), and the First Level Funding of
   the Second Medical Leading Talent Project in Hubei Province. The funding
   organizations had no role in the design and conduct of the study
   collection, management, analysis, and interpretation of the data;
   preparation, review, or approval of the manuscript; and decision to
   submit the manuscript for publication.
CR Alborghetti L., 2020, IL 6 SIGNALLING PATH, DOI 10.1101/2020.04.01.20048561
   Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016
   Altmayer S, 2020, EUR RADIOL, V30, P6485, DOI 10.1007/s00330-020-07018-x
   [Anonymous], 2020, PREEXPOSURE HYDROXYC, DOI [10.1101/2020.06.09.20116806, DOI 10.1101/2020.06.09.20116806]
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   BOREGOWDA U, 2020, FRONT MED-LAUSANNE, V7, DOI [DOI 10.3389/FMED.2020.586221, 10.1101/2020.07.10.20150680]
   Borsetto D, 2020, RHINOLOGY, V58, P430, DOI 10.4193/Rhin20.185
   Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao YH, 2020, J MED VIROL, V92, P1449, DOI 10.1002/jmv.25822
   Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2
   Chai KL, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013600.pub2, 10.1002/14651858.CD013600.pub3]
   Chen J, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-04991-y
   Chen JY, 2020, CHINESE MED J-PEKING, V133, P1390, DOI 10.1097/CM9.0000000000000839
   Chen LW, 2020, ACTA OPHTHALMOL, V98, pE951, DOI 10.1111/aos.14472
   Chen WY, 2020, J MED VIROL, V92, P2702, DOI 10.1002/jmv.26142
   Cheng D.Z., 2020, TIANJIN J TRADIT CHI, P1
   Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065
   Davoudi-Monfared E, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01061-20
   Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652
   Della-Torre E, 2020, ANN RHEUM DIS, V79, P1277, DOI [10.1136/annrheumdis-2020-218122, 10.1136/annrheumdis-2020-218724, 10.1136/annrheumdis-2020-218759]
   Deng LS, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.03.002
   [邓芷晴 Deng Zhiqing], 2020, [中华放射学杂志, Chinese Journal of Radiology], V54, P430
   Elavarasi A, 2020, J GEN INTERN MED, V35, P3308, DOI 10.1007/s11606-020-06146-w
   EQUATOR Network, AGR REP CHECKL TOOL
   Fernandez Cruz A, 2020, ANTIMICROB AGENTS CH, V64, pe01168, DOI [10.1128/AAC.01168-20, DOI 10.1128/AAC.01168-20]
   Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4
   Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041
   Geurtsvankessel C, 2020, CONVALESCENT PLASMA, DOI [10.1101/2020.07.01.20139857, DOI 10.1101/2020.07.01.20139857]
   Gomez-Barquero, 2020, GLUCOCOVID CONTROLLE
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   Gupta M, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00159-y
   Han Weili, 2020, Ann Surg, V272, pe33, DOI 10.1097/SLA.0000000000003955
   HERNANDEZ AV, 2020, ANN INTERN MED, DOI DOI 10.7326/M20-2496.
   Hoang MP, 2020, ASIAN PAC J ALLERGY, V38, P162, DOI 10.12932/AP-210520-0853
   Hong N, 2020, ACTA OPHTHALMOL, V98, pE649, DOI 10.1111/aos.14445
   Hu, 2020, CLIN CHARACTERISTICS, P1, DOI [10.1101/2020.06.23.20138149, DOI 10.1101/2020.06.23.20138149]
   Hu K, 2021, PHYTOMEDICINE, V85, DOI 10.1016/j.phymed.2020.153242
   Hu RJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10475
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huang DZ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2124
   Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Jin YH, 2020, YIXUE XINZHI ZAZHI, V30, P209, DOI DOI 10.12173/J.ISSN.1004-5511.2020.03.07
   JIN YH, 2020, MILITARY MED RES, V7, DOI DOI 10.1186/S40779-020-0233-67003341
   Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343
   Koh J, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00295
   Kronbichler A, 2020, INT J INFECT DIS, V98, P180, DOI 10.1016/j.ijid.2020.06.052
   Kumar VCS, 2020, BMJ OPEN GASTROENTER, V7, DOI 10.1136/bmjgast-2020-000417
   Lan X, 2020, LOPINAVIR RITONAVIR
   [李旷宇 Li Kuangyu], 2020, [中草药, Chinese Traditional and Herbal Drugs], V51, P2046
   Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757
   Li X, 2020, WORLD CHIN MED, P1
   Li Y., 2020, EXPLORATORY RANDOMIZ, DOI [10.1101/2020.03.19.20038984, DOI 10.1101/2020.03.19.20038984]
   Lian N, 2020, CLIN MICROBIOL INFEC, V26, P917, DOI 10.1016/j.cmi.2020.04.026
   Liang L, 2020, ACTA OPHTHALMOL, V98, P223, DOI [10.1111/aos.14413, 10.1001/jamaophthalmol.2020.1291]
   Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774
   Liu R, 2020, CLIN CHIM ACTA, V505, P172, DOI 10.1016/j.cca.2020.03.009
   Lu J, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102960
   Lv R, 2020, J TRADIT CHIN MED
   Ma LL, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00242
   Ma LL, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00238-8
   Magagnoli J, 2020, MED-CAMBRIDGE, V1, P114, DOI [10.1016/j.medj.2020.06.001, 10.1101/2020.04.16.20065920]
   Majmundar M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238827
   Malla C, 2018, GLOB HEALTH RES POL, V3, DOI 10.1186/s41256-018-0084-9
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   Marfella R, 2020, DIABETES METAB, V46, P403, DOI 10.1016/j.diabet.2020.05.005
   Mata T., 2020, CLIN EVALUATION IFN, DOI [10.1101/2020.05.15.20084293, DOI 10.1101/2020.05.15.20084293]
   Mei Q, 2020, LANCET INFECT DIS, V20, P1004, DOI 10.1016/S1473-3099(20)30433-3
   Mohammadi Abbas, 2020, medRxiv, DOI 10.1101/2020.05.14.20102038
   Ni Q., 2020, CHINESE J CLIN INFEC, pE009
   Norris Susan L, 2018, J Evid Based Med, V11, P133, DOI 10.1111/jebm.12314
   Park JH, 2020, CLIN EXP OTORHINOLAR, V13, P95, DOI 10.21053/ceo.2020.00570
   Pormohammad A, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2112
   Rasheed AM, 2020, THERAPEUTIC EFFECTIV, DOI [10.1101/2020.06.24.20121905, DOI 10.1101/2020.06.24.20121905]
   Righy, 2020, EFFECTS TOCILIZUMAB, DOI [10.1101/2020.07.13.20149328, DOI 10.1101/2020.07.13.20149328]
   Rivero HB., 2020, THERAPEUTIC EFFECTIV, DOI [10.1101/2020.05.29.20109199, DOI 10.1101/2020.05.29.20109199]
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Rokkas T, 2020, ANN GASTROENTEROL, V33, P355, DOI 10.20524/aog.2020.0506
   Roshanshad A, 2020, REMDESIVIR EFFICACY, DOI [10.1101/2020.06.15.20131227, DOI 10.1101/2020.06.15.20131227]
   Rossi B., 2020, MEDRXIV, DOI [10.1101/2020.06.06.20122341, DOI 10.1101/2020.06.06.20122341]
   Rossotti R, 2020, J INFECTION, V81, pE11, DOI 10.1016/j.jinf.2020.07.008
   Salton Francesco, 2020, Open Forum Infect Dis, V7, pofaa421, DOI 10.1093/ofid/ofaa421
   Herrero FS, 2021, J INTERN MED, V289, P259, DOI 10.1111/joim.13145
   Schiaffino S, 2020, J THORAC IMAG, V35, pW105, DOI 10.1097/RTI.0000000000000533
   Schunemann HJ, 2007, PLOS MED, V4, P786, DOI 10.1371/journal.pmed.0040119
   Singh AK, 2020, DIABETES METAB SYND, V14, P971, DOI 10.1016/j.dsx.2020.06.054
   Sun PF, 2020, J MED VIROL, V92, P612, DOI 10.1002/jmv.25735
   Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849
   von Bartheld Christopher S, 2020, medRxiv, DOI 10.1101/2020.06.15.20132134
   Wang, 2020, CLIN CHARACTERISTICS
   Wang D., 2020, NO CLEAR BENEFIT USE, DOI [10.1101/2020.04.21.20066258, DOI 10.1101/2020.04.21.20066258]
   Wang M, 2020, CHIN J LAB MED, V4, P341
   Wang YB, 2020, MINER DEPOSITA, V55, P1385, DOI 10.1007/s00126-019-00942-z
   Wang YY, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00245-9
   Wei R, 2020, CHIN J CLIN INFECT D
   WHO, WHO COR DIS COV 19
   Wong J, 2020, J MED VIROL, V92, P2847, DOI 10.1002/jmv.26199
   Wu FQ, 2020, BRIT J HOSP MED, V81, DOI 10.12968/hmed.2020.0156
   Xu K., 2020, CLIN EFFICACY ARBIDO
   Xu P, 2020, MICROBES INFECT, V22, P200, DOI 10.1016/j.micinf.2020.05.012
   XU ZH, 2020, AM J INFECT CONTROL, DOI DOI 10.1016/J.AJIC.2020.06.008
   Xuan TM, 2020, J ZHEJIANG UNIV-SC B, V21, P411, DOI 10.1631/jzus.B2000182
   Yan D, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00799-2020
   Yang C, 2020, VIRAL RNA LEVEL SERU, DOI [10.1101/2020.07.21.20125138, DOI 10.1101/2020.07.21.20125138]
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   [姚开涛 Yao Kaitao], 2020, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V26, P8
   Ye XT, 2020, EUR REV MED PHARMACO, V24, P3390, DOI 10.26355/eurrev_202003_20706
   Yu AR, 2020, HERALD MED, P1
   [余平 Yu Ping], 2020, [中国药学杂志, Chinese Pharmaceutical Journal], V55, P1042
   Yuan ML, 2020, SHOCK, V54, P638, DOI 10.1097/SHK.0000000000001574
   ZENG JH, 2020, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAA398
   Zhang JN, 2020, CURR MED SCI, V40, P480, DOI 10.1007/s11596-020-2203-3
   Zhao Q, 2020, J EUR ACAD DERMATOL, V34, P2505, DOI 10.1111/jdv.16778
   Zheng Y, 2021, J MED VIROL, V93, P241, DOI 10.1002/jmv.26218
   ZHOU Q, 2020, FRONT IMMUNOL, V11, DOI [DOI 10.3389/FIMMU.2020.01061, 10.3389/fimmu.2020.01061]
   Zhou YY, 2020, OPHTHALMOLOGY, V127, P982, DOI 10.1016/j.ophtha.2020.04.028
   Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6
   Zhu H, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23392
   Zhu JY, 2020, J MED VIROL, V92, P1902, DOI 10.1002/jmv.25884
   Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060
NR 122
TC 32
Z9 34
U1 11
U2 40
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2095-7467
EI 2054-9369
J9 MILITARY MED RES
JI MILITARY MED. RES.
PD SEP 4
PY 2020
VL 7
IS 1
AR 41
DI 10.1186/s40779-020-00270-8
PG 33
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA NM8SX
UT WOS:000568363700001
PM 32887670
OA Green Accepted, gold, Green Published
DA 2022-04-20
ER

PT J
AU Ongsakul, V
   Kajla, T
   Raj, S
   Khoa, TT
   Ahmed, ZU
AF Ongsakul, Viput
   Kajla, Tanveer
   Raj, Sahil
   Khoa, Tran Tien
   Ahmed, Zafar U.
TI Changing tourists' preferences in the hotel industry amid COVID-19
   pandemic
SO JOURNAL OF HOSPITALITY AND TOURISM TECHNOLOGY
LA English
DT Article; Early Access
DE TripAdvisor; COVID-19; Tourist type; LDA; Hospitality industry;
   TripAdvisor; COVID-19; ????; LDA; ????
ID SOCIAL MEDIA ANALYTICS; SATISFACTION; HOSPITALITY; TRAVELERS; REVIEWS;
   RATINGS; INFORMATION; PROGRESS; MODEL
AB Purpose The paper aims to find the preferences of different tourist type. Since, COVID-19 pandemic has brought the international hospitality industry to a standstill, there are some early signs of recovery. For this industry's long-term recovery, the tourists' changing preferences need to be analyzed. Moreover, with different types of tourists, a more nuanced and in-depth study is required to analyze the preferences of each tourist type. Design/methodology/approach The research focuses on the changing preferences of the tourist by comparatively analyzing the pre-COVID-19 and current COVID-19 phase. The study extracted online data from TripAdvisor and identified themes by applying Latent Dirichlet Allocation (LDA). Findings The study's findings confirmed the change in preferences of the different types of tourists during the COVID-19 pandemic by performing thematic analysis. New themes emerged in the pandemic phase, providing more insights into tourists' changing preferences in the current COVID-19 phase. The study also found that specific dominant themes in the pre-COVID-19 phase were replaced by new themes in the current COVID-19 phase. Originality/value To the best of the authors' knowledge, this study is the first to compare the pre-COVID-19 and current COVID-19 phase themes to decipher the new themes that managers of the hotels should consider to win back tourists' confidence during the pandemic. The unraveling of changing preferences of the different tourist types in the current COVID-19 pandemic is the novel contribution of the study.
C1 [Ongsakul, Viput] Natl Inst Dev Adm, NIDA Business Sch, Bangkok, Thailand.
   [Kajla, Tanveer] Lovely Profess Univ, Mittal Sch Business, Dept Econ, Phagwara, India.
   [Raj, Sahil] Punjabi Univ, Sch Management, Patiala, Punjab, India.
   [Khoa, Tran Tien] Natl Univ Vietnam Ho Chi Minh City, Int Univ, Ho Chi Minh City, Vietnam.
   [Ahmed, Zafar U.] Natl Univ Vietnam Ho Chi Minh City, Int Univ, Sch Business, Dept Mkt, Ho Chi Minh City, Vietnam.
RP Raj, S (corresponding author), Punjabi Univ, Sch Management, Patiala, Punjab, India.
EM drviput@yahoo.com; er.tanveer47@gmail.com; dr.sahilraj47@gmail.com;
   ttkhoa@hcmiu.edu.vn; zafaruahmed@gmail.com
CR Agarwal P, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102765
   Ahani A, 2019, J RETAIL CONSUM SERV, V51, P331, DOI 10.1016/j.jretconser.2019.06.014
   Al-Tawfiq JA, 2014, TRAVEL MED INFECT DI, V12, P422, DOI 10.1016/j.tmaid.2014.06.007
   Ali F, 2016, J HOSP MARKET MANAG, V25, P449, DOI 10.1080/19368623.2015.1019172
   Baggio R, 2020, J HOSP TOUR TECHNOL, V11, P559, DOI 10.1108/JHTT-01-2019-0011
   Banerjee S, 2016, TOURISM MANAGE, V53, P125, DOI 10.1016/j.tourman.2015.09.020
   Barreda A, 2013, J HOSP TOUR TECHNOL, V4, P263, DOI 10.1108/JHTT-01-2013-0001
   Becken S, 2019, J HOSP TOUR TECHNOL, V11, P19, DOI 10.1108/JHTT-09-2017-0090
   Bi JW, 2019, TOURISM MANAGE, V70, P460, DOI 10.1016/j.tourman.2018.09.010
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Borko S., 2020, TRAVEL IND TURNED UP
   Buhalis D, 2008, TOURISM MANAGE, V29, P609, DOI 10.1016/j.tourman.2008.01.005
   Calheiros AC, 2017, J HOSP MARKET MANAG, V26, P675, DOI 10.1080/19368623.2017.1310075
   CBRE, 2020, INS IMPL COV 19 PAND
   Di Pietro L, 2012, J HOSP TOUR TECHNOL, V3, P60, DOI 10.1108/17579881211206543
   Farmaki A, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102663
   Filieri R, 2016, ANN TOURISM RES, V58, P46, DOI 10.1016/j.annals.2015.12.019
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Guo Y, 2017, TOURISM MANAGE, V59, P467, DOI 10.1016/j.tourman.2016.09.009
   Jamal A., 2021, HINDUSTAN TIMES
   Jiabao C., 2020, XINHUA
   Kaushal V, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102707
   Kim SeongSeop [Kim S. S. S.], 2005, Asia Pacific Journal of Tourism Research, V10, P369, DOI 10.1080/10941660500363694
   Kirilenko AP, 2021, TOURISM MANAGE, V83, DOI 10.1016/j.tourman.2020.104241
   Languepin O., 2020, THAILAND BUSINESS NE
   Law R, 2014, INT J CONTEMP HOSP M, V26, P727, DOI 10.1108/IJCHM-08-2013-0367
   Lee M, 2020, J HOSP TOUR TECHNOL, V11, P137, DOI 10.1108/JHTT-07-2018-0054
   Liu YP, 2018, TOURISM MANAGE, V64, P22, DOI 10.1016/j.tourman.2017.07.016
   Loureiro SMC, 2022, J SUSTAIN TOUR, V30, P258, DOI 10.1080/09669582.2021.1875477
   Luo JM, 2020, J TRAVEL TOUR MARK, V37, P272, DOI 10.1080/10548408.2020.1740138
   Mak AHN, 2017, TOURISM MANAGE, V60, P280, DOI 10.1016/j.tourman.2016.12.012
   Mirzaalian F, 2019, J HOSP TOUR TECHNOL, V10, P764, DOI 10.1108/JHTT-08-2018-0078
   Nanu L, 2020, INT J HOSP MANAG, V89, DOI 10.1016/j.ijhm.2020.102530
   Naumov N, 2021, ANATOLIA, V32, P144, DOI 10.1080/13032917.2020.1771742
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   Osei BA, 2020, J HOSP TOUR TECHNOL, V11, P479, DOI 10.1108/JHTT-08-2019-0107
   Neto AP, 2020, J HOSP TOUR TECHNOL, V11, P241, DOI 10.1108/JHTT-05-2019-0076
   Park E, 2018, J HOSP TOUR TECHNOL, V11, P1, DOI 10.1108/JHTT-08-2017-0075
   Priporas CV, 2017, INT J TOUR RES, V19, P693, DOI 10.1002/jtr.2141
   Radojevic T, 2015, TOUR MANAG PERSPECT, V16, P247, DOI 10.1016/j.tmp.2015.08.004
   Raj Sahil, 2018, Journal for Global Business Advancement, V11, P64
   Rao P. S., 2019, RES J ENGLISH, V4, P65
   Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862
   Rhee HT, 2015, ELECTRON MARK, V25, P211, DOI 10.1007/s12525-014-0161-y
   Rohani L., 2017, INT REV BUSINESS RES, V13, P78
   Seabra C, 2013, TOURISM MANAGE, V36, P502, DOI 10.1016/j.tourman.2012.09.008
   Siu A., 2004, ASIAN ECON PAP, V3, P62, DOI [DOI 10.1162/1535351041747996, 10.1162/1535351041747996]
   Sutherland I, 2020, SUSTAINABILITY-BASEL, V12, P1
   Taecharungroj V, 2019, TOURISM MANAGE, V75, P550, DOI 10.1016/j.tourman.2019.06.020
   TripAdvisor, 2021, 10 BEST HOT BANGK 20
   UNWTO, 2020, GROWTH INT TOUR ARRI
   Varkaris E, 2017, J HOSP TOUR TECHNOL, V8, P101, DOI 10.1108/JHTT-09-2016-0058
   Wang IM, 2019, PERS SOC PSYCHOL B, V45, P120, DOI 10.1177/0146167218780735
   Wang L, 2020, TOURISM MANAGE, V76, DOI 10.1016/j.tourman.2019.103961
   Wong AKF, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102798
   Xiang Z, 2017, TOURISM MANAGE, V58, P51, DOI 10.1016/j.tourman.2016.10.001
   Xu X, 2018, INT J CONTEMP HOSP M, V30, P1663, DOI [10.1108/IJCHM-03-2017-0171, 10.1108/ijchm-03-2017-0171]
   Ye Fang, 2021, Journal of Supercomputing, V77, P111, DOI 10.1007/s11227-020-03264-4
   Ying TY, 2021, TOUR RECREAT RES, V46, P304, DOI 10.1080/02508281.2020.1743048
   Yu J, 2021, J HOSP MARKET MANAG, V30, P529, DOI 10.1080/19368623.2021.1867283
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
   Zhang TT, 2018, J HOSP TOUR TECHNOL, V9, P158, DOI [10.1108/jhtt-04-2017-0032, 10.1108/JHTT-04-2017-0032]
NR 62
TC 0
Z9 0
U1 6
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1757-9880
EI 1757-9899
J9 J HOSP TOUR TECHNOL
JI J. Hosp. Tour. Technol.
DI 10.1108/JHTT-07-2020-0179
EA FEB 2022
PG 19
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA ZJ2AW
UT WOS:000762113900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Hohenstein, NO
AF Hohenstein, Nils-Ole
TI Supply chain risk management in the COVID-19 pandemic: strategies and
   empirical lessons for improving global logistics service providers'
   performance
SO INTERNATIONAL JOURNAL OF LOGISTICS MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19; Pandemic; Supply chain risk management; SCRM; Supply chain
   disruption; Resilience; Logistics service providers; LSP; Dynamic
   capabilities
ID 3RD-PARTY LOGISTICS; DYNAMIC CAPABILITIES; RESILIENCE; PERSPECTIVE;
   SHIPPERS; COLLABORATION; INFORMATION; DISRUPTIONS; AGILITY; IMPACT
AB Purpose The enormous impact of the COVID-19 pandemic showcases the key role of supply chain risk management (SCRM) in achieving and maintaining business performance, competitiveness and survival in the "new normal". The purpose of this paper is to explore what impact the COVID-19 pandemic has had and may yet have on supply chains (SCs), which SCRM approaches have proved successful and how logistics service providers (LSPs) have applied the knowledge they have gained to improve their SCRM practices and resilience so as to prepare better for the next major disruption. Design/methodology/approach This paper combines an extensive literature review with a multiple-case study of 10 internationally operating LSPs and how they have handled the impact of the COVID-19 pandemic so far. To bridge the research-practice gap, this study draws on the dynamic-capabilities view and provide insights that are valuable to both academia and practice. Findings This study provides empirical evidence on the severe impact of the COVID-19 pandemic on SCs, which has posed several challenges to LSPs. The study identifies eight factors that are critical to the adaptive capabilities of LSPs and, therefore, to their resilience in extreme conditions. The findings of this study show that these factors determine whether an SCRM system is robust and agile enough to allow an LSP to anticipate potential disruption and to respond fast enough when disruption occurs. Specifically, this study finds that robustness and agility demonstrably strengthen business performance, while learning from experience proves key to reconfiguring an SCRM design in response to acute disruption. Originality/value This paper is among the first to provide rich, empirical and practically applicable insights into the impact of the COVID-19 pandemic on business in relation to SCRM. These novel insights offer inspiring opportunities for further research.
C1 [Hohenstein, Nils-Ole] Cooperat State Univ Mannheim, Dept Supply Chain Management & Logist, Mannheim, Germany.
RP Hohenstein, NO (corresponding author), Cooperat State Univ Mannheim, Dept Supply Chain Management & Logist, Mannheim, Germany.
EM nils-ole.hohenstein@dhbw-mannheim.de
CR Alvesson M, 2011, ACAD MANAGE REV, V36, P247, DOI 10.5465/AMR.2011.59330882
   Bakshi N, 2009, PROD OPER MANAG, V18, P583, DOI [10.1111/j.1937-5956.2009.01031.x, 10.3401/poms.1080.01031]
   BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108
   Bendul JC, 2016, TRANSPORT RES E-LOG, V90, P206, DOI 10.1016/j.tre.2015.05.008
   Berg Eva, 2008, International Journal of Risk Assessment & Management, V9, P288, DOI 10.1504/IJRAM.2008.019746
   Blackhurst J, 2011, J BUS LOGIST, V32, P374, DOI 10.1111/j.0000-0000.2011.01032.x
   Bode C, 2011, ACAD MANAGE J, V54, P833, DOI 10.5465/AMJ.2011.64870145
   Brandon-Jones E, 2014, J SUPPLY CHAIN MANAG, V50, P55, DOI 10.1111/jscm.12050
   Braunscheidel MJ, 2009, J OPER MANAG, V27, P119, DOI 10.1016/j.jom.2008.09.006
   Chen KD, 2022, DECISION SCI, V53, P8, DOI 10.1111/deci.12513
   Choi TM, 2021, ANN OPER RES, DOI 10.1007/s10479-021-03973-w
   Choi TM, 2021, TRANSPORT RES E-LOG, V145, DOI 10.1016/j.tre.2020.102190
   Choi TM, 2020, TRANSPORT RES E-LOG, V140, DOI 10.1016/j.tre.2020.101961
   Choi TM, 2021, INT J PROD RES, V59, P286, DOI 10.1080/00207543.2020.1722861
   Choi TM, 2018, PROD OPER MANAG, V27, P1868, DOI 10.1111/poms.12838
   Choi TM, 2016, TRANSPORT RES E-LOG, V90, P1, DOI 10.1016/j.tre.2016.03.007
   Choi TM, 2016, PROD OPER MANAG, V25, P379, DOI 10.1111/poms.12534
   Choi TM, 2016, J OPER RES SOC, V67, P159, DOI 10.1057/jors.2015.115
   Chopra S, 2004, MIT SLOAN MANAGE REV, V46, P53
   Chung SH, 2015, IND MANAGE DATA SYST, V115, P1481, DOI 10.1108/IMDS-04-2015-0155
   Cichosz M, 2020, INT J LOGIST MANAG, V31, P209, DOI 10.1108/IJLM-08-2019-0229
   Colicchia C, 2012, SUPPLY CHAIN MANAG, V17, P403, DOI 10.1108/13598541211246558
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Defee CC, 2010, INT J LOGIST MANAG, V21, P180, DOI 10.1108/09574091011071915
   Dolgui A, 2020, INT J PROD RES, V58, P2184, DOI 10.1080/00207543.2019.1627439
   Dolgui A, 2021, INT J PROD RES, V59, P102, DOI 10.1080/00207543.2021.1840148
   Dolgui A, 2019, INT J PROD RES, pNIL_1, DOI 10.1080/00207543.2019.1627438
   Dubey R, 2020, INT J PROD RES, V58, P3381, DOI 10.1080/00207543.2020.1722860
   Dubey R, 2021, INT J PROD RES, V59, P110, DOI 10.1080/00207543.2019.1582820
   Dubey R, 2019, INT J PROD ECON, V210, P120, DOI 10.1016/j.ijpe.2019.01.023
   Dubey R, 2018, INT J OPER PROD MAN, V38, P129, DOI 10.1108/IJOPM-04-2016-0173
   Dunn S, 2016, TRANSPORT RES E-LOG, V90, P39, DOI 10.1016/j.tre.2015.09.011
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Esper Terry L, 2007, Journal of Business Logistics, V28, P57
   Fan YY, 2018, INT J PHYS DISTR LOG, V48, P205, DOI 10.1108/IJPDLM-01-2017-0043
   Fawcett SE, 2012, J SUPPLY CHAIN MANAG, V48, P44, DOI 10.1111/j.1745-493X.2011.03241.x
   Fugate BS, 2009, INT J LOGIST MANAG, V20, P425, DOI 10.1108/09574090911002850
   Gammelgaard B, 2020, INT J LOGIST MANAG, V31, P173, DOI 10.1108/IJLM-03-2020-0121
   Gammelgaard B, 2017, INT J LOGIST MANAG, V28, P910, DOI 10.1108/IJLM-09-2017-0231
   Gligor DM, 2014, INT J LOGIST MANAG, V25, P160, DOI 10.1108/IJLM-07-2012-0062
   Govindan K, 2016, TRANSPORT RES E-LOG, V90, P177, DOI 10.1016/j.tre.2015.11.010
   Hendricks KB, 2005, PROD OPER MANAG, V14, P35
   Ho W, 2015, INT J PROD RES, V53, P5031, DOI 10.1080/00207543.2015.1030467
   Hohenstein NO, 2015, INT J PHYS DISTR LOG, V45, P90, DOI 10.1108/IJPDLM-05-2013-0128
   Hohenstein NO, 2014, INT J PHYS DISTR LOG, V44, P434, DOI 10.1108/IJPDLM-06-2013-0175
   Hosseini S, 2019, TRANSPORT RES E-LOG, V125, P285, DOI 10.1016/j.tre.2019.03.001
   Ivanov D, 2021, INT J PROD RES, V59, P3535, DOI 10.1080/00207543.2021.1890852
   Ivanov D, 2021, ANN OPER RES, DOI 10.1007/s10479-021-04047-7
   Ivanov D, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-11-2020-0448
   Ivanov Dmitry, 2021, Int J Prod Econ, V232, P107921, DOI 10.1016/j.ijpe.2020.107921
   Ivanov D, 2021, PROD PLAN CONTROL, V32, P775, DOI 10.1080/09537287.2020.1768450
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Ivanov D, 2019, INT J PROD RES, V57, P829, DOI 10.1080/00207543.2018.1488086
   Ivanov D, 2014, INT J PROD RES, V52, P2154, DOI 10.1080/00207543.2013.858836
   Ketokivi M, 2014, J OPER MANAG, V32, P232, DOI 10.1016/j.jom.2014.03.004
   Knemeyer AM, 2009, J OPER MANAG, V27, P141, DOI 10.1016/j.jom.2008.06.002
   Konig A, 2016, INT J LOGIST MANAG, V27, P122, DOI 10.1108/IJLM-03-2014-0043
   Krause D, 2018, J SUPPLY CHAIN MANAG, V54, P42, DOI 10.1111/jscm.12159
   Lavastre O, 2012, DECIS SUPPORT SYST, V52, P828, DOI 10.1016/j.dss.2011.11.017
   Leuschner R, 2014, J SUPPLY CHAIN MANAG, V50, P21, DOI 10.1111/jscm.12046
   Li YH, 2021, EUR J OPER RES, V291, P1117, DOI 10.1016/j.ejor.2020.09.053
   Liu CL, 2018, INT J LOGIST MANAG, V29, P5, DOI 10.1108/IJLM-11-2016-0283
   Manuj I, 2008, INT J PHYS DISTR LOG, V38, P192, DOI 10.1108/09600030810866986
   Nagurney A, 2021, EUR J OPER RES, V293, P880, DOI 10.1016/j.ejor.2020.12.054
   Norrman A., 2004, International Journal of Physical Distribution & Logistics Management, V34, P434, DOI 10.1108/09600030410545463
   Norrman A, 2020, INT J PHYS DISTR LOG, V50, P641, DOI 10.1108/IJPDLM-07-2019-0219
   Olavarrieta S., 1997, INT J PHYS DISTR LOG, V27, P559, DOI [10.1108/09600039710188594, DOI 10.1108/09600039710188594]
   Pagell M., 2005, ACAD MANAGEMENT ANN, pB1
   Paul SK, 2021, INT J PHYS DISTR LOG, V51, P104, DOI 10.1108/IJPDLM-04-2020-0127
   Pedrosa AD, 2012, INT J PHYS DISTR LOG, V42, P275, DOI 10.1108/09600031211225963
   Pettit TJ, 2013, J BUS LOGIST, V34, P46, DOI 10.1111/jbl.12009
   Ponomarov SY, 2009, INT J LOGIST MANAG, V20, P124, DOI 10.1108/09574090910954873
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rao S, 2009, INT J LOGIST MANAG, V20, P97, DOI 10.1108/09574090910954864
   Ruel S, 2021, ANN OPER RES, DOI 10.1007/s10479-021-03974-9
   Sodhi MS, 2021, J SUPPLY CHAIN MANAG, V57, P7, DOI 10.1111/jscm.12255
   Sodhi MS, 2012, PROD OPER MANAG, V21, P1, DOI 10.1111/j.1937-5956.2011.01251.x
   Sturm S, 2021, SUPPLY CHAIN MANAG, DOI 10.1108/SCM-08-2020-0403
   Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Trkman P, 2009, INT J PROD ECON, V119, P247, DOI 10.1016/j.ijpe.2009.03.002
   Tummala R, 2011, SUPPLY CHAIN MANAG, V16, P474, DOI 10.1108/13598541111171165
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Wallenburg CM, 2019, J PURCH SUPPLY MANAG, V25, DOI 10.1016/j.pursup.2019.100575
   Wamba SF, 2022, PROD PLAN CONTROL, V33, P193, DOI 10.1080/09537287.2020.1810756
   Wamba SF, 2020, INT J PROD ECON, V222, DOI 10.1016/j.ijpe.2019.09.019
   Wang YL, 2015, EUR J OPER RES, V247, P685, DOI 10.1016/j.ejor.2015.05.053
   Wetzstein A, 2016, INT J PROD ECON, V182, P304, DOI 10.1016/j.ijpe.2016.06.022
   Wieland A, 2021, J SUPPLY CHAIN MANAG, V57, P58, DOI 10.1111/jscm.12248
   Wieland A, 2013, INT J PHYS DISTR LOG, V43, P300, DOI 10.1108/IJPDLM-08-2012-0243
   Wieland A, 2012, INT J PHYS DISTR LOG, V42, P887, DOI 10.1108/09600031211281411
   Wong CY, 2010, INT J PROD ECON, V128, P51, DOI 10.1016/j.ijpe.2009.08.026
   Yin R.K., 2018, CASE STUDY RES APPL
   Zacharia ZG, 2011, J BUS LOGIST, V32, P40, DOI 10.1111/j.2158-1592.2011.01004.x
   Zollo M, 2002, ORGAN SCI, V13, P339, DOI 10.1287/orsc.13.3.339.2780
NR 98
TC 0
Z9 0
U1 18
U2 18
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0957-4093
EI 1758-6550
J9 INT J LOGIST MANAG
JI Int. J. Logist. Manag.
DI 10.1108/IJLM-02-2021-0109
EA JAN 2022
PG 30
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA YO0XY
UT WOS:000747672600001
DA 2022-04-20
ER

PT J
AU Ma, J
   Wang, YX
   An, XL
   Ge, C
   Yu, ZQ
   Chen, JN
   Zhu, QJ
   Dong, GQ
   He, J
   He, ZQ
   Cao, TJ
   Zhu, YT
   Nie, ZW
   Yang, XP
AF Ma, Jun
   Wang, Yixin
   An, Xingle
   Ge, Cheng
   Yu, Ziqi
   Chen, Jianan
   Zhu, Qiongjie
   Dong, Guoqiang
   He, Jian
   He, Zhiqiang
   Cao, Tianjia
   Zhu, Yuntao
   Nie, Ziwei
   Yang, Xiaoping
TI Toward data-efficient learning: A benchmark for COVID-19 CT lung and
   infection segmentation
SO MEDICAL PHYSICS
LA English
DT Article
DE COVID-19 CT; domain generalization; few-shot learning; knowledge
   transfer; lung and infection segmentation
AB Purpose Accurate segmentation of lung and infection in COVID-19 computed tomography (CT) scans plays an important role in the quantitative management of patients. Most of the existing studies are based on large and private annotated datasets that are impractical to obtain from a single institution, especially when radiologists are busy fighting the coronavirus disease. Furthermore, it is hard to compare current COVID-19 CT segmentation methods as they are developed on different datasets, trained in different settings, and evaluated with different metrics.
   Methods To promote the development of data-efficient deep learning methods, in this paper, we built three benchmarks for lung and infection segmentation based on 70 annotated COVID-19 cases, which contain current active research areas, for example, few-shot learning, domain generalization, and knowledge transfer. For a fair comparison among different segmentation methods, we also provide standard training, validation and testing splits, evaluation metrics and, the corresponding code.
   Results Based on the state-of-the-art network, we provide more than 40 pretrained baseline models, which not only serve as out-of-the-box segmentation tools but also save computational time for researchers who are interested in COVID-19 lung and infection segmentation. We achieve average dice similarity coefficient (DSC) scores of 97.3%, 97.7%, and 67.3% and average normalized surface dice (NSD) scores of 90.6%, 91.4%, and 70.0% for left lung, right lung, and infection, respectively.
   Conclusions To the best of our knowledge, this work presents the first data-efficient learning benchmark for medical image segmentation, and the largest number of pretrained models up to now. All these resources are publicly available, and our work lays the foundation for promoting the development of deep learning methods for efficient COVID-19 CT segmentation with limited data.
C1 [Ma, Jun] Nanjing Univ Sci & Technol, Dept Math, Nanjing 210094, Peoples R China.
   [Wang, Yixin] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Comp Technol, Beijing 100190, Peoples R China.
   [An, Xingle; Cao, Tianjia] China Elect Cloud Brain Tianjin Technol CO Ltd, Tianjin 300309, Peoples R China.
   [Ge, Cheng] Jiangsu Univ Technol, Inst Bioinformat & Med Engn, Changzhou 213001, Jiangsu, Peoples R China.
   [Yu, Ziqi] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Shanghai 200433, Peoples R China.
   [Chen, Jianan] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.
   [Zhu, Qiongjie; Dong, Guoqiang; He, Jian] Nanjing Univ, Med Sch, Affiliated Hosp, Dept Radiol,Nanjing Drum Tower Hosp, Nanjing 210008, Peoples R China.
   [He, Zhiqiang] Lenovo Ltd, Beijing 100094, Peoples R China.
   [Zhu, Yuntao; Nie, Ziwei; Yang, Xiaoping] Nanjing Univ, Dept Math, Nanjing 210093, Peoples R China.
RP Ma, J (corresponding author), Nanjing Univ Sci & Technol, Dept Math, Nanjing 210094, Peoples R China.; Yang, XP (corresponding author), Nanjing Univ, Dept Math, Nanjing 210093, Peoples R China.
EM junma@njust.edu.cn; xpyang@nju.edu.cn
OI ma, jun/0000-0002-9739-0855
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [11531005, 11971229]
FX This project is supported by the National Natural Science Foundation of
   China (Nos. 11531005, 11971229). The numerical calculations in this
   paper have been done on the computing facilities in the High Performance
   Computing Center of Nanjing University. We thank all the organizers of
   MICCAI 2018 Medical Segmentation Decathlon, MICCAI 2019 Autom<SUP>double
   dagger double dagger</SUP> and MedSeg for their timely update about
   COVID-19 publications and datasets. Last but not least, we thank the
   anonymous reviewers, Chen Chen, Xin Yang, and Yao Zhang for their
   important and valuable feedback on this work.
CR Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006
   Amyar Amine, 2020, MULTITASK DEEP LEARN
   [Anonymous], **DATA OBJECT**, DOI DOI 10.5281/ZENODO.3757476
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Bilic P, 2019, ARXIVABS190104056
   Buller HR, 2020, RADIOLOGY, DOI [10.1148/radiol.2020201629, DOI 10.1148/radiol.2020201629]
   Cao CS, 2020, ANGEW CHEM INT EDIT, V59, P8586, DOI 10.1002/anie.201914596
   Chassagnon G, 2020, AI DRIVEN CT BASED Q
   Chen C, 2020, IEEE T MED IMAGING, V39, P2494, DOI 10.1109/TMI.2020.2972701
   Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184
   Chen X, 2021, AUTOPHAGY, V17, P2054, DOI 10.1080/15548627.2020.1810918
   Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49
   Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7
   Dadario AMV, 2020, RADIOLOGY, V296, pE192, DOI 10.1148/radiol.2020201178
   Dou Q., 2019, ADV NEURAL INF PROCE, P6450
   Dou Q, 2019, ADV NEURAL INFORM PR, V32, P6450
   Eschweiler Dennis, 2019, Simulation and Synthesis in Medical Imaging. 4th International Workshop, SASHIMI 2019. Held in Conjunction with MICCAI 2019. Proceedings. Lecture Notes in Computer Science (LNCS 11827), P81, DOI 10.1007/978-3-030-32778-1_9
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Gharleghi R, 2020, AUTOMATED SEGMENTATI, DOI [10.5281/zenodo.3714986, DOI 10.5281/ZENODO.3714986]
   He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90
   Heller N, 2019, ARXIV191201054
   Isensee F, 2021, NAT METHODS, V18, P203, DOI 10.1038/s41592-020-01008-z
   Ju Xu, 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12261), P378, DOI 10.1007/978-3-030-59710-8_37
   Khandelwal Pulkit, 2020, Domain Adaptation and Representation Transfer, and Distributed and Collaborative Learning. Second MICCAI Workshop, DART 2020 and First MICCAI Workshop, DCL 2020 Held in Conjunction with MICCAI 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12444), P73, DOI 10.1007/978-3-030-60548-3_8
   Kiser KJ, 2020, MED PHYS, V47, P5941, DOI 10.1002/mp.14424
   Li D, 2019, IEEE I CONF COMP VIS, P1446, DOI 10.1109/ICCV.2019.00153
   Li H, 2020, AUTOMATIC STRUCTURE, DOI [10.5281/zenodo.3718885, DOI 10.5281/ZENODO.3718885]
   Liu QD, 2020, IEEE T MED IMAGING, V39, P2713, DOI 10.1109/TMI.2020.2974574
   Mazzone PJ, 2020, RADIOL IMAGING CANC, V2
   Mellot F., 2020, ARXIV200401279
   Morozov S, 2020, MOSMEDDATA CHEST CT
   Nikolov S., 2018, ARXIV180904430
   Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28
   Roy AG, 2020, MED IMAGE ANAL, V59, DOI 10.1016/j.media.2019.101587
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Song Y, 2020, GUT, V69, P1143, DOI 10.1136/gutjnl-2020-320891
   Wang S, 2021, EUR RADIOL, V31, P6096, DOI [10.1079/9781789246070.0001, 10.1007/s00330-021-07715-1]
   Wang Y, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102724
   Yu F, 2019, LECT NOTES COMPUT SC, V11765, P714, DOI 10.1007/978-3-030-32245-8_79
   Yu Q, 2020, ARXIV200409750
   Zhang K, 2020, CELL, V181, P1423, DOI 10.1016/j.cell.2020.04.045
   Zhao A, 2019, PROC CVPR IEEE, P8535, DOI 10.1109/CVPR.2019.00874
   Zheng C, 2020, DEEP LEARNING BASED
   Zhou TX, 2021, INT J IMAG SYST TECH, V31, P16, DOI 10.1002/ima.22527
   Zhou Y., 2020, INF NET AUTOMATIC CO
   Zhou ZW, 2019, LECT NOTES COMPUT SC, V11767, P384, DOI 10.1007/978-3-030-32251-9_42
   Ziesche RF, 2020, J IMAGING, V6, DOI 10.3390/jimaging6120136
NR 47
TC 22
Z9 23
U1 13
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0094-2405
EI 2473-4209
J9 MED PHYS
JI Med. Phys.
PD MAR
PY 2021
VL 48
IS 3
BP 1197
EP 1210
DI 10.1002/mp.14676
EA FEB 2021
PG 14
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA RB6HM
UT WOS:000615528300001
PM 33354790
OA Green Submitted
DA 2022-04-20
ER

PT J
AU Gupta, R
   Naik, BN
   Ganesh, V
   Singh, A
   Soni, SL
   Puri, GD
AF Gupta, Rekha
   Naik, B. Naveen
   Ganesh, Venkata
   Singh, Ajay
   Soni, Shiv Lal
   Puri, G. D.
TI Evaluation of utility and usefulness of webinars on COVID-19 management:
   a questionnaire-based survey
SO AIN SHAMS JOURNAL OF ANESTHESIOLOGY
LA English
DT Article
DE COVID-19; Webinars; Healthcare workers
AB Background: The COVID-19 pandemic and its consequent "social distancing" has fueled the use of social media platforms for educational purposes. Since the start of the pandemic, a plethora of experts and self-proclaimed experts have been keenly delivering webinars on COVID. This begs the question "Do webinars on COVID-19 really help in the improvement of knowledge base or management skills?". The questionnaire was designed to assess information regarding COVID-webinars and their usefulness from the end-user standpoint. The response to the questions was measured using a 4- or 5-point Likert scale. The survey was open for a 4-week period with the extension of 1 week.
   Results: The response rate was 54% as 270 out of 500 participants responded to the questionnaire. The majority of the respondents were anesthesiologists in-training, post-graduates, fellows, and seniors belonging to tertiary care settings with fewer percentages belonging to physicians and others. Most of the doctors had attended an average of 2 webinars per week. The tests of model effects showed a significant negative correlation of webinar quality ratings for district hospital healthcare setting of the attendees (of p value of 0.013) and for the number of COVID-related webinars attended per week (p value of 0.009).
   Conclusions: Most respondents had favorable perceptions of webinars happening during the pandemic. However, there is a need for improvisation in the volume of webinars, target-audience-based delivery, and participant interaction to add value to this new dimension of teaching-learning.
C1 [Gupta, Rekha; Naik, B. Naveen; Singh, Ajay; Soni, Shiv Lal; Puri, G. D.] Post Grad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Sect 12, Chandigarh 160012, India.
   [Ganesh, Venkata] Post Grad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Chandigarh 160012, India.
RP Singh, A (corresponding author), Post Grad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Sect 12, Chandigarh 160012, India.
EM ajay.ydv2509@gmail.com
RI Singh, Ajay/AAH-1205-2022
OI Singh, Ajay/0000-0003-1526-5370
CR Ahmed H, 2020, LANCET INFECT DIS, V20, P777, DOI 10.1016/S1473-3099(20)30226-7
   Assareh A, 2011, PROCEDIA COMPUT SCI, V3, DOI 10.1016/j.procs.2010.12.129
   Carvalho-Silva D, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006419
   Dharini, 2020, INDIAN J PLAST SURG, V53, P273, DOI 10.1055/s-0040-1716458
   Figueroa F, 2020, ACTA ORTHOP, V91, P543, DOI 10.1080/17453674.2020.1776461
   Hoke AM, 2018, HEALTH EDUC J, V77, P249, DOI 10.1177/0017896917734017
   Nahai F, 2020, AESTHET SURG J, V40, P1040, DOI 10.1093/asj/sjaa123
   O'Doherty D, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1240-0
   Power M., 2014, J ONLINE LEARNING TE, V10, P681
   Rajab MH, 2020, CUREUS, V12, DOI 10.7759/cureus.8966
   Sleiwah A, 2020, J PLAST RECONSTR AES, V73, P1578, DOI 10.1016/j.bjps.2020.05.032
NR 11
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1687-7934
EI 2090-925X
J9 AIN SHAMS J ANESTHES
JI Ain Shams J. Anesthesiol.
PD OCT 20
PY 2021
VL 13
IS 1
AR 67
DI 10.1186/s42077-021-00187-x
PG 7
WC Anesthesiology
WE Emerging Sources Citation Index (ESCI)
SC Anesthesiology
GA WJ8UD
UT WOS:000709312600001
OA gold
DA 2022-04-20
ER

PT J
AU Colakoglu, MK
   Ozgun, YM
   Piskin, E
   Bostanci, EB
   Ozmen, MM
AF Colakoglu, Muhammet Kadri
   Ozgun, Yigit Mehmet
   Piskin, Erol
   Bostanci, Erdal Birol
   Ozmen, Mehmet Mahir
TI The attitude of Turkish general surgeons during the COVID-19 pandemic:
   results of "general surgery COVID-19 pandemic attitude survey"
SO TURKISH JOURNAL OF SURGERY
LA English
DT Article
DE COVID-19; coronavirus; pandemic; surgery; survey
AB Objective: The whole world is dealing with the COVID-19 pandemic, and healthcare professionals are the most affected group. The aim of this study was to evaluate the knowledge of general surgeons about COVID-19 and understand the attitude and current situation of our colleagues.
   Material and Methods:This descriptive study comprised general surgeons working in different parts of Turkey. A survey with 23 questions was prepared to determine the demographic characteristics of the participants, workplace characteristics, change in daily work practices and their attitudes in the pandemic process.
   Results: A total of 332 forms were evaluated. Survey results show that the majority of surgeons have changed their daily surgical practices. Many surgeons take part in the treatment of COVID-19. While most benign cases are delayed, the managemet of malignant cases differs. There are also differences in the evaluation of patients preoperatively and the type of operation. Personal protective measures are followed. While the rate of infected surgeons is low, the majority of surgeons have concerns about infection.
   Conclusion: Turkish surgeons have managed to get a quick reaction from the start of the pandemic. However, there are still differences in preoperative patient evaluation and operation selection and precautions during the operation. Surgeons also should be informed about the management of malignant patients.
C1 [Colakoglu, Muhammet Kadri; Ozgun, Yigit Mehmet; Piskin, Erol; Bostanci, Erdal Birol] Hlth Sci Univ, Ankara City Hosp, Dept Gastrointestinal Surg, Ankara, Turkey.
   [Ozmen, Mehmet Mahir] Istinye Univ, Istanbul Liv Hosp Ankara, Dept Surg, Sch Med, Ankara, Turkey.
RP Colakoglu, MK (corresponding author), Hlth Sci Univ, Ankara City Hosp, Dept Gastrointestinal Surg, Ankara, Turkey.
EM drkadri@gmail.com
CR Agalar C, 2020, TURK J MED SCI, V50, P578, DOI 10.3906/sag-2004-132
   [Anonymous], 2020, MMWR MORB MORTAL WKL, V69, P477, DOI DOI 10.15585/MMWR.MM6915E6
   Chirico F, 2020, INFECT CONT HOSP EP, V41, P1117, DOI 10.1017/ice.2020.148
   Gok AFK, 2020, ULUS TRAVMA ACIL CER, V26, P335, DOI 10.14744/tjtes.2020.79954
   Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5
   Karaca AS, 2020, TURK J SURG, V36, pI, DOI 10.5578/turkjsurg.202001
   Li S, 2020, Zhonghua Wai Ke Za Zhi, V58, P404, DOI 10.3760/cma.j.cn112139-20200317-00226
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
NR 8
TC 3
Z9 3
U1 0
U2 0
PU TURKISH SURGICAL ASSOC
PI ANKARA
PA TURK HEPATOPANC SURG ASSOC & TURK ASSOC ENDOCR SURG-TAES, KORU MAH
   IHLAMUR CAD NO 26 06810 CAYYOLU, ANKARA, 00000, TURKEY
SN 2564-6850
EI 2564-7032
J9 TURK J SURG
JI Turk. J. Surg.
PD JUN
PY 2020
VL 36
IS 2
BP 137
EP 146
DI 10.5578/turkjsurg.4809
PG 10
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA PB0SA
UT WOS:000596036900004
PM 33015559
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Bshesh, K
   Khan, W
   Vattoth, AL
   Janjua, E
   Nauman, A
   Almasri, M
   Ali, AM
   Ramadorai, V
   Mushannen, B
   AlSubaie, M
   Mohammed, I
   Hammoud, M
   Paul, P
   Alkaabi, H
   Haji, A
   Laws, S
   Zakaria, D
AF Bshesh, Khalifa
   Khan, Wafa
   Vattoth, Ahamed Lazim
   Janjua, Emmad
   Nauman, Areej
   Almasri, Muna
   Ali, Ateeque Mohamed
   Ramadorai, Vinutha
   Mushannen, Beshr
   AlSubaie, Mai
   Mohammed, Ibrahim
   Hammoud, Mais
   Paul, Pradipta
   Alkaabi, Haya
   Haji, Aliyaa
   Laws, Sa'ad
   Zakaria, Dalia
TI Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may
   be falsely attributed to oncological disorders: A systematic review
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Review
DE AztraZeneca; coronavirus; COVID-19; COVID-19 vacccine;
   fluorodeoxyglucose (FDG) PET-CT scan; Janssen; lymphadenopathy; Moderna;
   Pfizer
ID COVID-19 VACCINATION; LYMPH-NODES; VACCINES; SAFETY; PET/CT
AB Coronavirus disease 2019 (COVID-19) has caused a global pandemic that continues to cause numerous deaths to date. Four vaccines have been approved by the Food and Drug Administration as of July 2021 to prevent the transmission of COVID-19: Pfizer, Moderna, AstraZeneca, and Janssen. These vaccines have shown great efficacy and safety profile. One side effect that has been widely reported is post-COVID-19 vaccination lymphadenopathy. Due to the mimicry of the lymphadenopathy for metastases in some oncologic patients, there have been reports of patients who underwent biopsies that showed pathologic confirmation of benign reactive lymphadenopathy secondary to the COVID-19 vaccine. Therefore, understanding the incidence of lymphadenopathy post-COVID-19 vaccinations will help guide radiologists and oncologists in their management of patients, both present oncologic patients, and patients with concerns over their newly presenting lymphadenopathy. A systematic literature search was performed using several databases to identify relevant studies that reported lymphadenopathy post-COVID-19 vaccination. Our results revealed that several cases have been detected in patients undergoing follow-up fluorodeoxyglucose (FDG)-positron emission tomography-computerized tomography scans where lymph nodes ipsilateral to the vaccine injection site show increased uptake of FDG. Thus, knowledge of the incidence of lymphadenopathy may help avoid unnecessary biopsies, interventions, and changes in management for patients, especially oncologic patients who are at risk for malignancies.
C1 [Bshesh, Khalifa; Khan, Wafa; Vattoth, Ahamed Lazim; Janjua, Emmad; Nauman, Areej; Almasri, Muna; Ali, Ateeque Mohamed; Ramadorai, Vinutha; Mushannen, Beshr; AlSubaie, Mai; Mohammed, Ibrahim; Hammoud, Mais; Paul, Pradipta; Alkaabi, Haya; Haji, Aliyaa] Qatar Fdn, Div Med Educ, Educ City, Weill Cornell Med Qatar, Doha, Qatar.
   [Laws, Sa'ad] Qatar Fdn, Educ City, Weill Cornell Med Qatar, Distributed eLib, Doha, Qatar.
   [Zakaria, Dalia] Qatar Fdn, Div Premed Educ, Educ City, Weill Cornell Med Qatar, Al Luqta St Ar Rayyan,POB 24144, Doha, Qatar.
RP Zakaria, D (corresponding author), Qatar Fdn, Div Premed Educ, Educ City, Weill Cornell Med Qatar, Al Luqta St Ar Rayyan,POB 24144, Doha, Qatar.
EM dez2003@qatar-med.cornell.edu
OI Paul, Pradipta/0000-0001-6283-1596; Mohamed Ali,
   Ateeque/0000-0002-8836-9448; Zakaria, Dalia/0000-0001-9020-0038
CR Ahn Richard W, 2021, Radiol Cardiothorac Imaging, V3, pe210008, DOI 10.1148/ryct.2021210008
   AstraZeneca, 2020, ASTRAZENECAS COVID 1
   Avner M, 2021, EUR J NUCL MED MOL I, V48, P2659, DOI 10.1007/s00259-021-05278-3
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Bernstine H, 2021, CLIN NUCL MED, V46, P396, DOI 10.1097/RLU.0000000000003648
   Burger IA, 2011, CLIN NUCL MED, V36, P848, DOI 10.1097/RLU.0b013e3182177322
   Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734
   Cellina M, 2021, AM J ROENTGENOL, V216, pW27, DOI 10.2214/AJR.21.25683
   Chu LRC, 2021, VACCINE, V39, P2791, DOI 10.1016/j.vaccine.2021.02.007
   Chung JY, 2021, ADV DRUG DELIVER REV, V170, P1, DOI 10.1016/j.addr.2020.12.011
   Coates EE, 2017, CLIN NUCL MED, V42, P329, DOI 10.1097/RLU.0000000000001603
   Cohen D, 2021, EUR J NUCL MED MOL I, V48, P1854, DOI 10.1007/s00259-021-05314-2
   Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dominguez Jennifer Ledezma, 2021, Radiol Case Rep, V16, P1660, DOI 10.1016/j.radcr.2021.04.015
   DORFMAN RF, 1966, J AMER MED ASSOC, V198, P320, DOI 10.1001/jama.198.3.320
   Edler C, 2021, LEGAL MED-TOKYO, V51, DOI 10.1016/j.legalmed.2021.101895
   Eifer M, 2022, J NUCL MED, V63, P134, DOI 10.2967/jnumed.121.262194
   El-Sahly HM, 2000, CLIN INFECT DIS, V31, P96, DOI 10.1086/313937
   European Medicines Agency, EMA REC COVID 19 VAC
   European Medicines Agency, EMA REC 1 COVID 19 V
   Fernandez-Prada M, 2021, EUROSURVEILLANCE, V26, P8, DOI 10.2807/1560-7917.ES.2021.26.10.2100193
   Finnegan J, 2021, CLIN IMAG, V75, P171, DOI 10.1016/j.clinimag.2021.02.045
   Fischinger S, 2019, SEMIN IMMUNOPATHOL, V41, P239, DOI 10.1007/s00281-018-0726-5
   Food US. Administration Drug, PFIZ BIONTECH COVID
   Geisen UM, 2021, ANN RHEUM DIS, V80, P1306, DOI 10.1136/annrheumdis-2021-220272
   Granata V, 2021, BIOLOGY-BASEL, V10, DOI [10.3390/biology10030214, 10.5281/ZENODO.5501147, 10.5281/ZENODO.5501148]
   Grimm L, SBI RECOMMENDATIONS
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hanneman K, 2021, RADIOLOGY, V299, pE282, DOI [10.1148/radiol.2021210386, 10.1148/radiol.2021219011]
   Hiller N, 2021, CUREUS, V13, DOI 10.7759/cureus.13524
   Holder J., NEW YORK TIMES
   Janssen, 2021, FACT SHEET REC CAR E
   Johnson BJ, 2021, J NUCL MED, V62, P1483, DOI 10.2967/jnumed.121.262108
   Kadali RAK, 2021, J MED VIROL, V93, P4420, DOI 10.1002/jmv.26996
   Kim SH, 2021, J KOREAN MED SCI, V36, DOI 10.3346/jkms.2021.36.e107
   LiuO P., 2021, ADVERSE EFFECTS COVI, DOI [10.1101/2021.04.16.21255618, DOI 10.1101/2021.04.16.21255618]
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Lu Y., CLIN NUCL MED, V2021
   Marais BJ, 2006, PEDIATR INFECT DIS J, V25, P142, DOI 10.1097/01.inf.0000199259.04970.d1
   Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8
   Mehta N, 2021, CLIN IMAG, V75, P12, DOI 10.1016/j.clinimag.2021.01.016
   Mitchell OR, 2021, BRIT J ORAL MAX SURG, V59, P384, DOI 10.1016/j.bjoms.2021.02.002
   Moderna,, MOD ANN FDA AUTH MOD
   Moghimi S, 2021, CLIN NUCL MED, V46, P437, DOI 10.1097/RLU.0000000000003636
   Mortazavi S, 2021, AM J ROENTGENOL, V217, P857, DOI 10.2214/AJR.21.25651
   Nawwar AA, 2021, CLIN NUCL MED, V46, P1004, DOI 10.1097/RLU.0000000000003657
   Nawwar AA, 2021, EUR J NUCL MED MOL I, V48, P2657, DOI 10.1007/s00259-021-05279-2
   Nawwar AA, 2021, EUR J NUCL MED MOL I, V48, P2655, DOI 10.1007/s00259-021-05274-7
   O'Horo, 2021, REAL TIME ANAL MASS, DOI [10.1101/2021.02.20.21252134, DOI 10.1101/2021.02.20.21252134]
   Ozutemiz C, 2021, RADIOLOGY, V300, pE296, DOI 10.1148/radiol.2021210275
   Pereira MP, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2019-231582
   Pittman PR, 2001, VACCINE, V20, P972, DOI 10.1016/S0264-410X(01)00387-5
   Placke JM, 2021, EUR J CANCER, V154, P167, DOI 10.1016/j.ejca.2021.06.023
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Prieto PA, 2021, LANCET ONCOL, V22, pE281, DOI 10.1016/S1470-2045(21)00197-2
   Riad A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071428
   Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544
   Smith MV, 2021, J NUCL MED TECHNOL, V49, P286, DOI 10.2967/jnmt.121.262008
   Thomassen A, 2011, EUR J NUCL MED MOL I, V38, P894, DOI 10.1007/s00259-011-1729-9
   Tu Wendy, 2021, Radiol Imaging Cancer, V3, pe210038, DOI 10.1148/rycan.2021210038
   U.S. Food and Drug Administration, 2021, CBER SURV PROGR BACK
   Ulaner GA, 2021, CLIN NUCL MED, V46, P433, DOI 10.1097/RLU.0000000000003633
   Venkatakrishnan A., 2021, FEMALE MALE DIFFEREN, DOI [10.1101/2021.04.01.21254798, DOI 10.1101/2021.04.01.21254798]
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Washington T., REV COMMENTARY IMAGE, V299, P280, DOI [10.1148/RADIOL.2021210236, DOI 10.1148/RADIOL.2021210236]
   WHO, 2020, PSYCHOL HLTH MED, P1, DOI DOI 10.1080/13548506.2020.1808236
   World Health Organization, OXF ASTRAZENECA COVI
   World Health Organization, 2020, MAT METHODS, V10, P1, DOI [10.13070/mm.en.10.2867, DOI 10.13070/MM.EN.10.2867]
   Xu GF, 2021, CLIN NUCL MED, V46, P353, DOI 10.1097/RLU.0000000000003597
NR 70
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2022
VL 94
IS 5
BP 1833
EP 1845
DI 10.1002/jmv.27599
EA FEB 2022
PG 13
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA ZU8BU
UT WOS:000751931500001
PM 35060149
OA Bronze
DA 2022-04-20
ER

PT J
AU Ohrling, M
   Carlsson, KS
   Brommels, M
AF Ohrling, Mikael
   Carlsson, Karin Solberg
   Brommels, Mats
TI No man is an island: management of the emergency response to the
   SARS-CoV-2 (COVID-19) outbreak in a large public decentralised service
   delivery organisation
SO BMC HEALTH SERVICES RESEARCH
LA English
DT Article
DE Emergency management; Covid-19; Decentralisation; Dynamic capabilities
ID HEALTH-CARE; DECISION SPACE; SYSTEMS; SECTOR; ACCOUNTABILITY;
   COORDINATION; CAPABILITIES; COUNTRIES; QUALITY
AB Background We wanted to better understand whether and how agility can be achieved in a decentralised service delivery organisation in Sweden. The pandemic outbreak of SARS-Cov-2 (Covid-19) provided an opportunity to assess decentralisation as a strategy to improve the responsiveness of healthcare and at the same time handle an unpredictable and unexpected event. Methods Data from in-depth interviews with a crisis management team (n = 23) and free text answers in a weekly survey to subordinated clinical directors, i.e. unit managers, (n = 108) were scrutinised in a directed content analysis. Dynamic capabilities as a prerequisite for dynamic effectiveness, understood as reaching strategic and operative effectiveness simultaneously, were explored by using three frameworks for dynamic effectiveness, dynamic capabilities and delegated authority in a decentralised organisation. Results Unpredictable events, such as the pandemic Covid-19 outbreak, demand a high grade of ability to be flexible. We find that a high degree of operational effectiveness, which is imperative in an emergency situation, also is a driver of seeking new strategic positions to even better meet new demands. The characteristics of the dynamic capabilities evolving from this process are described and discussed in relation to decentralisation, defined by decision space, organisational and individual capacity as well as accountability. We present arguments supporting that a decentralised management model can facilitate the agility required in an emergency. Conclusions This study is, to our knowledge, the first of its kind where a decentralised management model in a service delivery organisation in healthcare is studied in relation to crisis management. Although stemming from one organisation, our findings indicating the value of decentralisation in situations of crisis are corroborated by theory, suggesting that they could be relevant in other organisational settings also.
C1 [Ohrling, Mikael; Carlsson, Karin Solberg; Brommels, Mats] Karolinska Inst, Med Management Ctr, Dept Learning Management & Eth, Stockholm, Sweden.
   [Ohrling, Mikael; Carlsson, Karin Solberg] Stockholm Healthcare Serv, Box 45436, S-10431 Stockholm, Sweden.
RP Ohrling, M (corresponding author), Karolinska Inst, Med Management Ctr, Dept Learning Management & Eth, Stockholm, Sweden.; Ohrling, M (corresponding author), Stockholm Healthcare Serv, Box 45436, S-10431 Stockholm, Sweden.
EM mikael.ohrling@regionstockholm.se
FU Karolinska InstituteKarolinska Institutet
FX Open access funding provided by Karolinska Institute. This study has
   been conducted as a part of the ordinary operations.
CR Aas IHM, 1997, INT J HEALTH PLAN M, V12, P103, DOI 10.1002/(SICI)1099-1751(199704)12:2<103::AID-HPM461>3.0.CO;2-5
   Abimbola S, 2019, HEALTH POLICY PLANN, V34, P605, DOI 10.1093/heapol/czz055
   Abrahamsson M., 2004, Journal of Marketing Channels, V12, P83, DOI 10.1300/J049v12n02_05
   Anell Anders, 2012, Health Syst Transit, V14, P1
   Arain F, 2015, PROCEDIA ENGINEER, V118, P232, DOI 10.1016/j.proeng.2015.08.422
   Bergstrom J, 2016, J CONTING CRISIS MAN, V24, P124, DOI 10.1111/1468-5973.12113
   Bossert T, 1998, SOC SCI MED, V47, P1513, DOI 10.1016/S0277-9536(98)00234-2
   Bossert TJ, 2011, SOC SCI MED, V72, P39, DOI 10.1016/j.socscimed.2010.10.019
   Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027
   Munoz DC, 2017, INT J PUBLIC HEALTH, V62, P219, DOI 10.1007/s00038-016-0872-2
   Comfort LK., 2001, J CONTING CRISIS MAN, V9, P144, DOI [10.1111/1468-5973.00164, DOI 10.1111/1468-5973.00164]
   Comfort LK, 2007, PUBLIC ADMIN REV, V67, P189, DOI 10.1111/j.1540-6210.2007.00827.x
   Engstrom U., 2019, PLA01691
   Evans JM, 2013, ADV HEALTH CARE MANA, V15, P125, DOI 10.1108/S1474-8231(2013)0000015011
   Ferguson JM, 2021, J AM MED INFORM ASSN, V28, P453, DOI 10.1093/jamia/ocaa284
   Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117
   Granasen M., 2019, ATT LEDA BRANDBEKAMP
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Gupta L, 2021, INDIAN J RHEUMATOL, V16, P123, DOI 10.4103/injr.injr_251_20
   Hofmann M, 2015, BUS PROCESS MANAG J, V21, P966, DOI 10.1108/BPMJ-07-2014-0069
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Lega F, 2013, VALUE HEALTH, V16, pS46, DOI 10.1016/j.jval.2012.10.004
   Liwanag HJ, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-018-0402-1
   Mazzocato P, 2010, QUAL SAF HEALTH CARE, V19, P376, DOI 10.1136/qshc.2009.037986
   O'Reilly CA, 2008, RES ORGAN BEHAV, V28, P185, DOI 10.1016/j.riob.2008.06.002
   Ohrling M, 2021, MANAGERS IT TH UNPUB
   Ohrling M, 2021, J HEALTH ORGAN MANAG, V35, P596, DOI 10.1108/JHOM-12-2020-0474
   Ohrling M, 2020, J PRIM HEALTH CARE, V12, P207, DOI 10.1071/HC20082
   Ohrling M, 2021, INT J HEALTH PLAN M, V36, P30, DOI 10.1002/hpm.3058
   Peckham S, 2005, DECENTRALISATION CEN
   Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625
   QSR International, 1999, NVIVO QUAL DAT AN SO
   Rothstein B., 2018, STYRA LEDA MED TILLI, P38
   Rothstein B., 2003, SOCIALA FALLOR TILLI
   Saltman RB, 2007, EUROPEAN OBSERVATORY
   Savage M, 2018, BMJ LEAD, V2, P95, DOI 10.1136/leader-2017-000050
   SLSO, STOCKH LANS SJUKV
   Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862
   Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640
   Thorogood N., 2014, QUALITATIVE METHODS
   Tolf S, 2015, INT J HEALTH CARE Q, V28, P468, DOI 10.1108/IJHCQA-04-2014-0044
   Walshe K, 2007, INT J QUAL HEALTH C, V19, P57, DOI 10.1093/intqhc/mzm004
   Wynen J, 2014, PUBLIC PERFORM MANAG, V37, P496, DOI 10.2753/PMR1530-9576370307
   Wyss K, 2000, INT J HEALTH PLAN M, V15, P103
   Yathish GC, 2021, INDIAN J RHEUMATOL, V16, P200, DOI 10.4103/injr.injr_175_20
NR 45
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6963
J9 BMC HEALTH SERV RES
JI BMC Health Serv. Res.
PD MAR 21
PY 2022
VL 22
IS 1
AR 371
DI 10.1186/s12913-022-07716-w
PG 17
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZW8LY
UT WOS:000771459200003
PM 35313891
DA 2022-04-20
ER

PT J
AU Saito, T
   Asai, T
AF Saito, Tomoyuki
   Asai, Takashi
TI Aerosol containment device for airway management of patients with
   COVID-19: a narrative review
SO JOURNAL OF ANESTHESIA
LA English
DT Review
DE Aerosol box; COVID-19; Tracheal intubation
AB Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is highly contagious. To protect healthcare workers from infection during airway management, some expert recommendations and guidelines recommended wearing P2/N95 masks, goggles or glasses, glove, face-shields, and gowns as standard personal protective equipment (PPE). Nevertheless, several simulation studies have suggested that the standard PPE may not fully protect healthcare workers. Dr. Hsien Yung Lai introduced an acrylic box ("aerosol box") as a part of PPE during airway management. Since then, several companies and healthcare workers have made their own modified devices ("aerosol containment device"), and the use of such a device has spread worldwide, without being formally assessed for its effectiveness, efficacy and safety. Several simulation studies have indicated that "aerosol containment device" would make tracheal intubation more difficult. In addition, the device would prevent the spread of droplets from a patient, but may increase the risk of healthcare workers being exposed to a higher concentration of viral aerosols. Therefore, the current state of knowledge indicates that an "aerosol containment device" without vacuum mechanism has only limited efficacy in protecting healthcare workers from viral transmission.
C1 [Saito, Tomoyuki; Asai, Takashi] Dokkyo Med Univ, Saitama Med Ctr, Dept Anesthesiol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.
RP Saito, T (corresponding author), Dokkyo Med Univ, Saitama Med Ctr, Dept Anesthesiol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.
EM s-tomo@dokkyomed.ac.jp
RI Saito, Tomoyuki/AAU-9453-2020
CR [Anonymous], 2020, ANAESTHESIA 1022, DOI DOI 10.1111/ANAE.15292
   Asai T, 2020, BRIT J ANAESTH, V125, P1, DOI 10.1016/j.bja.2020.04.060
   Asai T, 2012, ANESTHESIOLOGY, V116, P515, DOI 10.1097/ALN.0b013e318246e866
   Begley JL, 2020, ANAESTHESIA, V75, P1014, DOI 10.1111/anae.15115
   Brewster DJ, 2020, MED J AUSTRALIA, V212, P472, DOI 10.5694/mja2.50598
   Brown S, 2020, ANESTH ANALG, V131, pE34, DOI 10.1213/ANE.0000000000004876
   Canelli R, 2020, NEW ENGL J MED, V382, P1957, DOI 10.1056/NEJMc2007589
   Cheung JCH, 2020, LANCET RESP MED, V8, pE19, DOI 10.1016/S2213-2600(20)30084-9
   Cook TM, 2020, ANAESTHESIA, V75, P1121, DOI 10.1111/anae.15158
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Cubillos J, 2020, BRIT J ANAESTH, V125, pE179, DOI 10.1016/j.bja.2020.04.059
   Dalli J, 2020, BRIT J ANAESTH, V125, pE293, DOI 10.1016/j.bja.2020.05.006
   Everington K, TAIWAN NEWS
   Feldman O, 2020, JAMA-J AM MED ASSOC, V323, P2091, DOI 10.1001/jama.2020.6633
   Gould CL, 2020, BRIT J ANAESTH, V125, pE292, DOI 10.1016/j.bja.2020.05.001
   Hellman S, 2020, BRIT J ANAESTH, V125, pE296, DOI 10.1016/j.bja.2020.06.017
   Hirose K, 2020, J ANESTH, V34, P798, DOI 10.1007/s00540-020-02804-9
   Kearsley R, 2020, ANAESTHESIA, V75, P969, DOI 10.1111/anae.15081
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Moraga FAL, 2020, WORLD J SURG, V44, P2049, DOI 10.1007/s00268-020-05542-x
   Malik JS, 2020, ANAESTHESIA, V75, P974, DOI 10.1111/anae.15109
   Matava CT, 2020, CAN J ANESTH, V67, P902, DOI 10.1007/s12630-020-01649-w
   Montoya MP, 2020, BRIT J ANAESTH, V125, pE195, DOI 10.1016/j.bja.2020.03.028
   Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008
   Saito T, 2021, MINERVA ANESTESIOL, V87, P247, DOI 10.23736/S0375-9393.20.14979-4
   Saito T, 2020, J ANESTH, V34, P801, DOI 10.1007/s00540-020-02818-3
   Saito T, 2020, BRIT J ANAESTH, V125, pE284, DOI 10.1016/j.bja.2020.06.002
   Simpson JP, 2020, ANAESTHESIA, V75, P1587, DOI 10.1111/anae.15188
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wakabayashi R, 2020, J ANESTH, V34, P790, DOI 10.1007/s00540-020-02835-2
   Weissman DN, 2020, JAMA-J AM MED ASSOC, V323, P2027, DOI 10.1001/jama.2020.6627
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   Yamakage M, 2021, J ANESTH, V35, P325, DOI 10.1007/s00540-020-02798-4
   Yang SS, 2020, BRIT J ANAESTH, V125, pE190, DOI 10.1016/j.bja.2020.04.083
   Yao WL, 2020, BRIT J ANAESTH, V125, pE28, DOI 10.1016/j.bja.2020.03.026
   Yong PSA, 2020, BRIT J ANAESTH, V125, pE176, DOI 10.1016/j.bja.2020.04.007
   Zuo Mingzhang, 2020, Chinese Medical Sciences Journal, V35, P105, DOI 10.24920/003724
NR 37
TC 6
Z9 6
U1 0
U2 2
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 0913-8668
EI 1438-8359
J9 J ANESTH
JI J. Anesth.
PD JUN
PY 2021
VL 35
IS 3
SI SI
BP 384
EP 389
DI 10.1007/s00540-020-02879-4
EA NOV 2020
PG 6
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA SC7GB
UT WOS:000592015600001
PM 33226519
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Sharifi, A
   Khavarian-Garmsir, AR
AF Sharifi, Ayyoob
   Khavarian-Garmsir, Amir Reza
TI The COVID-19 pandemic: Impacts on cities and major lessons for urban
   planning, design, and management
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Review
DE COVID-19; Smart cities; Environmental factors; Air quality; Urban
   planning; Pandemics
AB Since the early days of the COVID-19 crisis the scientific community has constantly been striving to shed light on various issues such as the mechanisms driving the spread of the virus, its environmental and socio-economic impacts, and necessary recovery and adaptation plans and policies. Given the high concentration of population and economic activities in cities, they are often hotspots of COVID-19 infections. Accordingly, many researchers are struggling to explore the dynamics of the pandemic in urban areas to understand impacts of COVID-19 on cities. In this study we seek to provide an overview of COVID-19 research related to cities by reviewing literature published during the first eight months after the first confirmed cases were reported in Wuhan, China. The main aims are to understand impacts of the pandemic on cities and to highlight major lessons that can be learned for post-COVID urban planning and design. Results show that, in terms of thematic focus, early research on the impacts of COVID-19 on cities is mainly related to four major themes, namely, (1) environmental quality, (2) socioeconomic impacts, (3) management and governance, and (4) transportation and urban design. While this indicates a diverse research agenda, the first theme that covers issues related to air quality, meteorological parameters, and water quality is dominant, and the others are still relatively underexplored. Improvements in air and water quality in cities during lockdown periods highlight the significant environmental impacts of anthropogenic activities and provide a wake-up call to adopt environmentally friendly development pathways. The paper also provides other recommendations related to the socio-economic factors, urban management and governance, and transportation and urban design that can be used for post-COVID urban plann ing and design. Overall, existing knowledge shows that the COVID-19 crisis entails an excellent opportunity for planners and policy makers to take transformative actions towards creating cities that are more just, resilient, and sustainable. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Sharifi, Ayyoob] Hiroshima Univ, Grad Sch Humanities & Social Sci, Hiroshima, Japan.
   [Sharifi, Ayyoob] Hiroshima Univ, Grad Sch Adv Sci & Engn, Hiroshima, Japan.
   [Sharifi, Ayyoob] Network Educ & Res Peace & Sustainabil NERPS, Hiroshima, Japan.
   [Khavarian-Garmsir, Amir Reza] Univ Isfahan, Dept Geog & Urban Planning, Fac Geog Sci & Planning, Esfahan, Iran.
RP Sharifi, A (corresponding author), 1-3-1 Kagamiyama, Hiroshima 7398530, Japan.
EM sharifi@hiroshima-u.ac.jp
RI Sharifi, Ayyoob/M-7584-2013; Khavarian-Garmsir, Amir Reza/ABF-2234-2020
OI Sharifi, Ayyoob/0000-0002-8983-8613; Khavarian-Garmsir, Amir
   Reza/0000-0001-8609-1748
CR Acuto M, 2020, DIALOGUES HUM GEOGR, V10, P221, DOI 10.1177/2043820620934232
   Aguliera E, 2020, INFORM LEARN SCI, V121, P471, DOI 10.1108/ILS-04-2020-0100
   Ai S, 2020, POPULATION MOVEMENT, DOI [10.1101/2020.02.04.20020339, DOI 10.1101/2020.02.04.20020339]
   Aloi A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093870
   Baldasano JM, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140353
   Bao R, 2020, SCI TOTAL ENVIRON, V731, DOI 10.1016/j.scitotenv.2020.139052
   Batty M, 2020, ENVIRON PLAN B-URBAN, V47, P547, DOI 10.1177/2399808320926912
   Berman JD, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.139864
   Bherwani H, 2020, AIR QUAL ATMOS HLTH, V13, P683, DOI 10.1007/s11869-020-00845-3
   Bhowmick GD, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0079-1
   Biswas P. P., 2020, EC POLIT WKLY, V55, P13
   Boterman WR, 2020, TIJDSCHR ECON SOC GE, V111, P513, DOI 10.1111/tesg.12437
   Braga F, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139612
   Bucsky Peter, 2020, Transp Res Interdiscip Perspect, V8, P100141, DOI 10.1016/j.trip.2020.100141
   Budd Lucy, 2020, Transp Res Interdiscip Perspect, V6, P100151, DOI 10.1016/j.trip.2020.100151
   Carteni A, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140489
   Castillo R, 2020, ASIAN ETHN, V21, P560, DOI 10.1080/14631369.2020.1773760
   Cattivelli V, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114444
   Chen B, 2020, DIALOGUES HUM GEOGR, V10, P238, DOI 10.1177/2043820620934267
   COCCIA M, 2020, ENVIRON RES, DOI DOI 10.1080/00207233.2020.1802937
   Coccia M, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138474
   Connolly C, 2020, DIALOGUES HUM GEOGR, V10, P213, DOI 10.1177/2043820620934209
   Connolly C, 2021, URBAN STUD, V58, P245, DOI 10.1177/0042098020910873
   Conticini E, 2020, ENVIRON POLLUT, V261, DOI 10.1016/j.envpol.2020.114465
   Cretan R, 2020, EURASIAN GEOGR ECON, V61, P559, DOI 10.1080/15387216.2020.1780929
   Dantas G, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139085
   Datta A, 2020, DIALOGUES HUM GEOGR, V10, P234, DOI 10.1177/2043820620929797
   de Haas M, 2020, FRONT ROBOT AI, V7, DOI 10.3389/frobt.2020.00101
   de Oliveira LA, 2020, CITY SOC, V32, DOI 10.1111/ciso.12266
   De Vos Jonas, 2020, Transp Res Interdiscip Perspect, V5, P100121, DOI 10.1016/j.trip.2020.100121
   Duggal R., 2020, ECON POLIT WEEKLY, V55, P17
   Earl C, 2020, CITY SOC, DOI [10.1111/ciso.12306, 10.1111/CISO.12306]
   Filonchyk M, 2020, AEROSOL AIR QUAL RES, V20, P1530, DOI 10.4209/aaqr.2020.05.0226
   Finn BM, 2020, DIALOGUES HUM GEOGR, V10, P217, DOI 10.1177/2043820620934310
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Hadjidemetriou Georgios M, 2020, Transp Res Interdiscip Perspect, V6, P100167, DOI 10.1016/j.trip.2020.100167
   Hallema DW, 2020, ECOL PROCESS, V9, DOI 10.1186/s13717-020-00231-y
   Hamidi S, 2020, J AM PLANN ASSOC, V86, P495, DOI 10.1080/01944363.2020.1777891
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Hesse M, 2020, TIJDSCHR ECON SOC GE, V111, P451, DOI 10.1111/tesg.12432
   Honey-Roses J., 2020, CITIES HLTH, P1, DOI DOI 10.1080/23748834.2020.1780074
   Horn S, 2020, ENVIRON TOXICOL CHEM, V39, P1305, DOI 10.1002/etc.4734
   Huang ZW, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139487
   Jahangiri M, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138872
   James P, 2020, DIALOGUES HUM GEOGR, V10, P255, DOI 10.1177/2043820620934211
   Jia CR, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11060630
   Jon I, 2020, PLAN THEOR, V19, P329, DOI 10.1177/1473095220931272
   Kanniah KD, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139658
   Kerimray A, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.139179
   Kihato CW, 2020, CITY SOC, V32, DOI 10.1111/ciso.12265
   Kouril P, 2020, EURASIAN GEOGR ECON, V61, P587, DOI 10.1080/15387216.2020.1783338
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Krzysztofik R, 2020, EURASIAN GEOGR ECON, V61, P573, DOI 10.1080/15387216.2020.1783337
   Kummitha RKR, 2020, GOV INFORM Q, V37, DOI 10.1016/j.giq.2020.101481
   Kunzmann KR, 2020, DISP, V56, P20, DOI 10.1080/02513625.2020.1794120
   Leonard K, 2020, DIALOGUES HUM GEOGR, V10, P164, DOI 10.1177/2043820620934941
   Lian XB, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140556
   Lin C, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.139801
   Liu JT, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138513
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Mangal A, 2020, PROCEEDINGS OF THE CONFLUENCE 2020: 10TH INTERNATIONAL CONFERENCE ON CLOUD COMPUTING, DATA SCIENCE & ENGINEERING, P721, DOI 10.1109/Confluence47617.2020.9057907
   Matthew RA, 2006, J AM PLANN ASSOC, V72, P109, DOI 10.1080/01944360608976728
   Mendes L, 2020, TIJDSCHR ECON SOC GE, V111, P318, DOI 10.1111/tesg.12450
   Menebo MM, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.139659
   Menut L, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140426
   Mishra SV, 2020, HABITAT INT, V103, DOI 10.1016/j.habitatint.2020.102230
   Naddeo V, 2020, ENVIRON SCI-WAT RES, V6, P1213, DOI 10.1039/d0ew90015j
   Napierala T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114697
   Nichol JE, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12132100
   Otmani A, 2020, SCI TOTAL ENVIRON, V735, DOI 10.1016/j.scitotenv.2020.139541
   Prata DN, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138862
   Pulighe G, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125012
   QI HC, 2020, SCI TOTAL ENVIRON, V728, DOI DOI 10.1016/J.SCITOTENV.2020.138778
   Qian Y., 2020, RES SOCIAL STRATIFIC, DOI DOI 10.1016/J.RSSM.2020.100522
   Qiu Y, 2020, J POPUL ECON, V33, P1127, DOI 10.1007/s00148-020-00778-2
   Ren HY, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138995
   Rich K, 2021, LEISURE SCI, V43, P190, DOI 10.1080/01490400.2020.1774001
   Rutynskyi M., 2020, PROBLEMS PERSPECTIVE, V18, P194, DOI [DOI 10.21511/PPM.18(2).2020.17, 10.21511/ppm.18(2).2020.17]
   Saadat S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138870
   Saha J, 2020, CHILD YOUTH SERV REV, V116, DOI 10.1016/j.childyouth.2020.105160
   Sahin M, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138810
   Santos A, 2020, GEOSCIENCES, V10, DOI 10.3390/geosciences10060243
   Shammi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04063
   SHARIFI A, 2020, SUSTAINABILITY-BASEL, V12, DOI DOI 10.3390/SU12155918
   Sharifi A, 2019, CITIES, V93, P238, DOI 10.1016/j.cities.2019.05.010
   Sharifi A, 2019, CITIES, V85, P1, DOI 10.1016/j.cities.2018.11.023
   Sharifi A, 2019, BUILD ENVIRON, V147, P171, DOI 10.1016/j.buildenv.2018.09.040
   Shi P, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138890
   Sicard P, 2020, SCI TOTAL ENVIRON, V735, DOI 10.1016/j.scitotenv.2020.139542
   Sonn JW, 2020, EURASIAN GEOGR ECON, V61, P482, DOI 10.1080/15387216.2020.1768423
   Steele W, 2020, AUST PLAN, V56, P59, DOI 10.1080/07293682.2020.1760904
   Stier A., 2020, COVID 19 ATTACK RATE, DOI DOI 10.1101/2020.03.22.20041004
   Teixeira Joao Filipe, 2020, Transp Res Interdiscip Perspect, V6, P100166, DOI 10.1016/j.trip.2020.100166
   Thoi PT, 2020, CITY SOC, V32, DOI 10.1111/ciso.12284
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   Tosepu R, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138436
   Wade L, 2020, SCIENCE, V368, P700, DOI 10.1126/science.368.6492.700
   Wasdani KP, 2020, LOCAL ENVIRON, V25, P414, DOI 10.1080/13549839.2020.1754375
   Wilkinson A, 2020, ENVIRON URBAN, V32, P503, DOI 10.1177/0956247820922843
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Xie JG, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138201
   Xu H, 2020, SCI TOTAL ENVIRON, V731, DOI 10.1016/j.scitotenv.2020.139211
   Yao Y, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140396
   Zangari S, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140496
   Zhang J, 2020, CITY SOC, V32, DOI 10.1111/ciso.12264
   Zhang YH, 2020, TRANSPORT POLICY, V94, P34, DOI 10.1016/j.tranpol.2020.05.012
   Zoran MA, 2020, SCI TOTAL ENVIRON, V740, DOI 10.1016/j.scitotenv.2020.140005
   Zoran MA, 2020, SCI TOTAL ENVIRON, V738, DOI 10.1016/j.scitotenv.2020.139825
NR 108
TC 194
Z9 196
U1 156
U2 272
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD DEC 20
PY 2020
VL 749
AR 142391
DI 10.1016/j.scitotenv.2020.142391
PG 14
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology
GA OG3MX
UT WOS:000581793800144
PM 33370924
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Terracciano, D
   Buonerba, C
   Scafuri, L
   De Berardinis, P
   Calin, GA
   Ferrajoli, A
   Fabbri, M
   Cimmino, A
AF Terracciano, Daniela
   Buonerba, Carlo
   Scafuri, Luca
   De Berardinis, Piergiuseppe
   Calin, George A.
   Ferrajoli, Alessandra
   Fabbri, Muller
   Cimmino, Amelia
TI Perspective: Cancer Patient Management Challenges During the COVID-19
   Pandemic
SO FRONTIERS IN ONCOLOGY
LA English
DT Article
DE coronavirus disease 2019 (COVID-19); cancer; severe acute respiratory
   syndrome coronavirus 2 (SARS-CoV-2); pandemic; chemotherapy
AB On March 11, 2020, the WHO has declared the coronavirus disease 2019 (COVID-19) a global pandemic. As the last few months have profoundly changed the delivery of health care in the world, we should recognize the effort of numerous comprehensive cancer centers to share experiences and knowledge to develop best practices to care for oncological patients during the COVID-19 pandemic. Patients as well as physicians must be aware of all these constraints and profound social, personal, and medical challenges posed by the tackling of this deadly disease in everyday life in order to adjust to such a completely novel scenario. This review will discuss facing the challenges and the current approaches that cancer centers in Italy and United States are adopting in order to cope with clinical and research activities.
C1 [Terracciano, Daniela] Univ Federico II, Dept Translat Med Sci, Naples, Italy.
   [Buonerba, Carlo; Scafuri, Luca] AOU Federico II, CRTR Rare Tumors Reference Ctr, Naples, Italy.
   [Buonerba, Carlo; Scafuri, Luca] Zoo Prophylact Inst Southern Italy, Environm & Hlth Operat Unit, Portici, Italy.
   [De Berardinis, Piergiuseppe] CNR, Inst Biochem & Cell Biol, Naples, Italy.
   [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.
   [Ferrajoli, Alessandra] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA.
   [Fabbri, Muller] Univ Hawaii, Canc Ctr, Canc Biol Program, Honolulu, HI 96822 USA.
   [Cimmino, Amelia] CNR, Inst Genet & Biophys, Naples, Italy.
RP Terracciano, D (corresponding author), Univ Federico II, Dept Translat Med Sci, Naples, Italy.; Cimmino, A (corresponding author), CNR, Inst Genet & Biophys, Naples, Italy.
EM daniela.terracciano@unina.it; amelia.cimmino@igb.cnr.it
RI Terracciano, Daniela/AAB-9521-2022; De Berardinis,
   Piergiuseppe/AAX-1049-2020
OI Terracciano, Daniela/0000-0003-4296-429X; De Berardinis,
   Piergiuseppe/0000-0001-6579-1729
FU SATIN-POR CAMPANIA FESR
FX This work was supported by SATIN-POR CAMPANIA FESR 2014/2020, to AC and
   PD.
CR [Anonymous], 2020, FOXNEWS
   Buonerba C, 2020, CRIT REV ONCOL HEMAT, V151, DOI 10.1016/j.critrevonc.2020.102992
   Buonerba C, 2020, CANCERS, V12, DOI 10.3390/cancers12020408
   Businessinsider, BUSINESSINSIDER
   Cassaniti I, 2020, J MED VIROL, V92, P1724, DOI 10.1002/jmv.25800
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   EpiCentro, 2020, EP SAN PUBBL I SUP S
   European Society for Medical Oncology (ESMO), 1995, ESMO MAGN CLIN BEN S
   Infantino M, 2020, J MED VIROL, V92, P1671, DOI 10.1002/jmv.25932
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1156, DOI 10.1515/cclm-2020-0473
   Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095
   Long Q.-X., 2020, NAT MED, P1, DOI [10.1038/s41591-020-0897-1, DOI 10.1038/S41591-020-0897-1]
   Luo J, 2020, CANCER DISCOV, V10, P1121, DOI 10.1158/2159-8290.CD-20-0596
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Nationalreview, 2020, NATIONALREVIEW
   Padoan A, 2020, CLIN CHEM LAB MED, V58, P1081, DOI 10.1515/cclm-2020-0443
   PragueMorning, 2020, PRAGUEMORNING
   Rhoads DD, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00760-20
   Roschewski M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd0110
   Snibe, 2017, WORLDS 1 2019 NCOV C, P291, DOI [10.4324/9780429453885-9, DOI 10.4324/9780429453885-9]
   Treon SP, 2020, BLOOD, V135, P1912, DOI 10.1182/blood.2020006288
   Wang HP, 2020, LANCET ONCOL, V21, pE181, DOI 10.1016/S1470-2045(20)30149-2
   Zhegalik AG, 2020, CENT EUR J UROL, V73, P26, DOI 10.5173/ceju.2020.0032
NR 23
TC 1
Z9 1
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2234-943X
J9 FRONT ONCOL
JI Front. Oncol.
PD AUG 18
PY 2020
VL 10
AR 1556
DI 10.3389/fonc.2020.01556
PG 7
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA NS2IR
UT WOS:000572089400001
PM 32984015
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Helmi, M
   Sari, D
   Sulistyowati, Y
   Meliala, A
   Trisnantoro, L
   Nurrobi, T
   Ratmono, T
AF Helmi, Mochamat
   Sari, Djayanti
   Sulistyowati, Yenny
   Meliala, Andreasta
   Trisnantoro, Laksono
   Nurrobi, Tjahja
   Ratmono, Tugas
TI The challenge of education and training in the COVID-19 National
   Emergency Hospital Wisma Atlet Kemayoran in Jakarta
SO AVICENNA
LA English
DT Article
DE COVID-19; emergency hospital; education and training; volunteer;
   Indonesia
ID MEDICAL-EDUCATION; CARE
AB Background
   The Corona virus disease 2019 (COVID-19) pandemic poses a risk of inequality between the number of prepared service staff and patients. Emergency hospitals, that do not have full-time employees due to the voluntary employment system, need to supervise the competence and knowledge of their staff, as they came with diverse backgrounds of knowledge and skill. The National Emergency Hospital Wisma Atlet Kemayoran, which can provide services for nearly 6000 COVID-19 patients, is required to be able to provide education and training continuously to improve the knowledge of its volunteers aiming to improve the quality of the care services.
   Methodology
   The present study is descriptive observational research to explore the challenge of education and training in the COVID-19 National Emergency Hospital Wisma Atlet Kemayoran in Jakarta.
   Results
   The COVID-19 health workers need to be equipped with sufficient knowledge about personal protective equipment (PPE), COVID-19 management, triage, admission, emergency and critical care for the COVID-19 patients. Supervision is needed to ensure that volunteers with various knowledge and skill backgrounds can collaboratively provide good services for the COVID-19 patients at all fronts. With frequent personnel changes, education and training on the same topic are always given repeatedly. To overcome this inefficiency, the Education and Training Department can film every practical skill related to health care service, and then create tutorial videos followed by small groups onsite skill station, when necessary. The hospital received enormous support from the governmental and non-governmental organizations to conduct education and training sessions on regular basis.
   Conclusions
   Education and training are very critical in the Emergency COVID-19 Hospital. The process has become a major challenge due to regular changes of staff. Information and communication technologies remain a more recommended alternative to the traditional onsite face-to-face method of education and training delivery as to prevent the spread of this virus. The training and education program in the National COVID-19 Emergency Hospital Wisma Atlet have received major supports from several Government agencies, and national private/non-government organizations. However, supports from International NGOs, international aid agencies, or humanitarian organizations, apart from the local professional organizations, which generally extend generous support need also to be explored.
C1 [Helmi, Mochamat; Sulistyowati, Yenny; Nurrobi, Tjahja; Ratmono, Tugas] COVID 19 Natl Emergency Hosp Wisma Atlet Kemayora, Jakarta, Indonesia.
   [Helmi, Mochamat] Univ Tarumanagara, Fac Med, Dept Anesthesiol, Jakarta, Indonesia.
   [Sari, Djayanti] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Anesthesiol & Intens Care, Yogyakarta, Indonesia.
   [Sulistyowati, Yenny] Minist Hlth, Board Dev & Empowerment Human Resources Hlth, Jakarta, Indonesia.
   [Meliala, Andreasta; Trisnantoro, Laksono] Univ Gadjah Mada, Fac Med, Dept Hlth Policy & Management, Yogyakarta, Indonesia.
   [Nurrobi, Tjahja] Univ Pertahanan, Fac Med, Bogor, Indonesia.
   [Ratmono, Tugas] Univ Jenderal Achmad Yani, Fac Med, Cimahi, Indonesia.
RP Helmi, M (corresponding author), COVID 19 Natl Emergency Hosp Wisma Atlet Kemayora, Jakarta, Indonesia.; Helmi, M (corresponding author), Univ Tarumanagara, Fac Med, Dept Anesthesiol, Jakarta, Indonesia.
EM emailhelmi@yahoo.com
CR Abbas K, 2020, HEALTH EDUC RES, V35, P353, DOI 10.1093/her/cyaa034
   Abdullah I, 2020, PSYCHOL TRAUMA-US, V12, P488, DOI 10.1037/tra0000878
   Abi-Rafeh Jad, 2020, Can Med Educ J, V11, pe118, DOI 10.36834/cmej.70242
   Abi-Rafeh J, 2020, J PLAST RECONSTR AES, V73, P1580, DOI 10.1016/j.bjps.2020.05.085
   Aggarwal G, 2020, EUR REV MED PHARMACO, V24, P7905, DOI 10.26355/eurrev_202007_22297
   Aghakhania K, 2020, MED EDUC ONLINE, V25, DOI 10.1080/10872981.2020.1770567
   Al-Busaidi IS, 2020, NEW ZEAL MED J, V133, P130
   [Anonymous], 2020, Prof Case Manag, V25, pE17, DOI 10.1097/NCM.0000000000000464
   Ariawan I, 2020, ACTA MED INDONES, V52, P193
   Barasa EW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236308
   Cammarota G, 2020, PREHOSP DISASTER MED, V35, P431, DOI 10.1017/S1049023X20000692
   Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072
   Chong CF, 2020, ARCH ACAD EMERG MED, V8
   Dhanani J, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05259-z
   Hettle David, 2020, Future Healthc J, V7, pe41, DOI 10.7861/fhj.2020-0049
   Kooli C, 2020, INT J KNOWL LEARN, V13, P233
   Li L, 2020, LANCET RESP MED, V8, pE23, DOI 10.1016/S2213-2600(20)30125-9
   Occhipinti V, 2020, INFLAMM BOWEL DIS, V26, P793, DOI 10.1093/ibd/izaa084
   Omess S, 2021, AM J NURS, V121, P48, DOI 10.1097/01.NAJ.0000731664.58705.c3
   Seymour-Walsh AE, 2020, RURAL REMOTE HEALTH, V20, DOI 10.22605/RRH6000
   Sofer D, 2020, AM J NURS, V120, P12, DOI 10.1097/01.NAJ.0000694500.11289.b2
   Soosaipillai G, 2020, J MED EDUC CURRIC DE, V7, DOI 10.1177/2382120520938706
   Vyklyuk Y, 2021, RESULTS PHYS, V20, DOI 10.1016/j.rinp.2020.103662
   Waitzkin H, 2021, INT J HEALTH SERV, V51, P55, DOI 10.1177/0020731420946612
   Wan B, 2021, SCI TOTAL ENVIRON, V753, DOI 10.1016/j.scitotenv.2020.141758
   Wang J, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110349
   Wirawan I Md Ady, 2020, J Prev Med Public Health, V53, P158, DOI 10.3961/jpmph.20.152
   Wolfberg D M, 1998, JEMS, V23, P46
   Zhuang QY, 2021, HEALTH INF MANAG J, V50, P95, DOI 10.1177/1833358320946674
NR 29
TC 1
Z9 1
U1 2
U2 2
PU BLOOMSBURY QATAR FOUNDATION JOURNALS
PI DOHA
PA VILLA 3, EDUCATION CITY, PO BOX 5825, DOHA, 00000, QATAR
SN 2220-2749
J9 AVICENNA
JI Avicenna
PY 2021
VL 2021
IS 2
AR 10
DI 10.5339/avi.2021.10
PG 11
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA XO4ON
UT WOS:000730166500005
DA 2022-04-20
ER

PT J
AU Li, XL
   Li, ZY
   Tian, YH
AF Li, Xiaolin
   Li, Zhiyi
   Tian, Yahe
TI Sentimental Knowledge Graph Analysis of the COVID-19 Pandemic Based on
   the Official Account of Chinese Universities
SO ELECTRONICS
LA English
DT Article
DE knowledge graph; sentimental analysis; public opinion analysis;
   university official account; COVID-19; opinion mining
ID LEARNING-MODEL
AB With the advent of the new media mobile Internet era, the network public opinion in colleges and universities, as an extension of social network public opinion, is also facing a crisis in the prevention, control, and governance system. In this paper, the Fiddler was used to collect the comments and other relevant data of the COVID-19 topic articles on the WeChat Official Accounts of China's top ten universities in 2020. The BILSTM_LSTM sentiment analysis model was used to analyze the sentiment tendency of the comments, and the LDA topic model was used to mine the topics of the comments with different emotional attributes at different stages of COVID-19. Based on sentiment analysis and text mining, entities and relationships in the theme graph of public opinion events in colleges and universities were identified, and the Neo4j graph database was established to construct the sentimental knowledge graph of the pandemic theme of university public accounts. People's attitudes in university public opinion are easily influenced by a variety of factors, and the degree of emotional disposition changes over time, with the stage the pandemic is in, and with different commentators; official account opinion topics change with the development of the time stage of the pandemic, and students' positive and negative comment topics show a diverse trend. By incorporating topic mining into the sentimental knowledge graph, the graph can realize functions such as the emotion retrieval of comments on university public numbers, a source search of security threats in university social networks, and monitoring of comments on public opinion under the theme of the pandemic, which provides new ideas for further exploring the research and governance system of university network public opinion and is conducive to preventing and resolving campus public opinion crises.
C1 [Li, Xiaolin; Li, Zhiyi] South China Normal Univ, Sch Econ & Management, Guangzhou 510006, Peoples R China.
   [Li, Zhiyi] Macau Univ Sci & Technol, Fac Informat Technol, Macau 999078, Peoples R China.
   [Tian, Yahe] Southeast Univ, Sch Cyber Sci & Engn, Nanjing 210096, Peoples R China.
RP Li, ZY (corresponding author), South China Normal Univ, Sch Econ & Management, Guangzhou 510006, Peoples R China.; Li, ZY (corresponding author), Macau Univ Sci & Technol, Fac Informat Technol, Macau 999078, Peoples R China.
EM cervusnippon_lea@foxmail.com; leeds@scnu.edu.cn; 220205329@seu.edu.cn
OI li, xiao lin/0000-0001-7612-7612; li, zhi yi/0000-0001-6407-2554
CR Chen X., 2020, J HIGH ED MANAG, V14, P105, DOI [10.13316/j.cnki.jhem.20201104.012, DOI 10.13316/J.CNKI.JHEM.20201104.012]
   Du HS, 2019, J CLEAN PROD, V239, DOI 10.1016/j.jclepro.2019.117977
   Elfaik H, 2021, IEEE ACCESS, V9, P111214, DOI 10.1109/ACCESS.2021.3102087
   Fatani TH, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02310-2
   Fei X, 2021, J INTELL FUZZY SYST, V40, P3445, DOI 10.3233/JIFS-189382
   Hameed Z, 2019, IEEE INT SYMP SIGNAL
   Hameed Z, 2020, IEEE ACCESS, V8, P73992, DOI 10.1109/ACCESS.2020.2988550
   Han WT, 2021, PSYCHOL RES BEHAV MA, V14, P385, DOI 10.2147/PRBM.S298539
   Huang S., 2021, INFORM SCIENCES, V39, P62
   Imamah, 2020, 2020 6th Information Technology International Seminar (ITIS), P238, DOI 10.1109/ITIS50118.2020.9320958
   Kumar V, 2021, IEEE ACCESS, V9, P7107, DOI 10.1109/ACCESS.2020.3043221
   Kurohashi S., 2018, PHYTOBIONT ECOSYSTEM, V2, P253, DOI [DOI 10.18653/V1/N18-2041, 10.18653/v1/N18-2041]
   Alici NK, 2022, PERSPECT PSYCHIATR C, V58, P141, DOI 10.1111/ppc.12851
   Lang, 2018, INFORM STUDIESTHEORY, V41, P132, DOI [https://doi.org/10.19387/j.cnki.1009-0592.2020.01.178, DOI 10.19387/J.CNKI.1009-0592.2020.01.178]
   Li J., 2020, INTELLIGENCE SCI, V38, P100, DOI [https://doi.org/10.13833/j.issn.1007-7634.2020.07.014, DOI 10.13833/J.ISSN.1007-7634.2020.07.014]
   Li S, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P138
   Lin S., 2020, J FUZHOU U NAT SCI E, V48, P269
   Liu Q, 2020, CUANBO YU BANQ, P185, DOI [10.16852/j.cnki.45-1390/g2.2020.09.066, DOI 10.16852/J.CNKI.45-1390/G2.2020.09.066]
   Lu K., 2020, ED MEAS EVAL, P15, DOI [10.16518/j.cnki.emae.2020.07.003, DOI 10.16518/J.CNKI.EMAE.2020.07.003]
   Ma T, 2020, ED EXPLOR, P53
   Mukhtar K, 2020, PAK J MED SCI, V36, pS27, DOI 10.12669/pjms.36.COVID19-S4.2785
   Sharma AP, 2018, POLYM TEST, V65, P301, DOI 10.1016/j.polymertesting.2017.12.001
   Song C, 2020, FOODS, V9, DOI 10.3390/foods9040511
   Sorour SE, 2021, CMC-COMPUT MATER CON, V66, P2671, DOI 10.32604/cmc.2021.014395
   Tan X, 2021, IEEE ACCESS, V9, P15860, DOI 10.1109/ACCESS.2021.3052566
   Tasso AF, 2021, PSYCHOL TRAUMA-US, V13, P9, DOI 10.1037/tra0000996
   The State Council Information Office of the People's Republic of China, 2020, FIGHTING COVID 19 CH
   Wang Q, 2017, IEEE T KNOWL DATA EN, V29, P2724, DOI 10.1109/TKDE.2017.2754499
   Wu JJ, 2021, RISK MANAG HEALTHC P, V14, P4321, DOI 10.2147/RMHP.S309732
   Xie TY, 2020, LECT NOTE DATA ENG, V41, P236, DOI 10.1007/978-3-030-34986-8_17
   Xu GX, 2019, IEEE ACCESS, V7, P51522, DOI 10.1109/ACCESS.2019.2909919
   Yan, 2020, COMPUTER SIMULATION, V37, P424
   Yao L., 2020, J HULUNBEIER U, V28, P114
   [张琛 Zhang Chen], 2021, [地球信息科学学报, Journal of Geo-Information Science], V23, P341
NR 34
TC 0
Z9 0
U1 10
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-9292
J9 ELECTRONICS-SWITZ
JI Electronics
PD DEC
PY 2021
VL 10
IS 23
AR 2921
DI 10.3390/electronics10232921
PG 24
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering; Physics
GA YE9MW
UT WOS:000741443300001
OA gold
DA 2022-04-20
ER

PT J
AU Santos, E
   Oliveira, M
   Ratten, V
   Tavares, FO
   Tavares, VC
AF Santos, Eulalia
   Oliveira, Margarida
   Ratten, Vanessa
   Tavares, Fernando Oliveira
   Tavares, Vasco Capela
TI A reflection on explanatory factors for COVID-19: A comparative study
   between countries
SO THUNDERBIRD INTERNATIONAL BUSINESS REVIEW
LA English
DT Article
DE climate; coronavirus; country indicators; COVID-19; explanatory factors
   of COVID-19; international business management; internationalization;
   SARS-CoV-2
ID MANAGEMENT RESEARCH; COMMUNICATION
AB The COVID-19 pandemic is the biggest problem facing the world nowadays. Each country in the world has its own characteristics, which means that its governments, at different rhythms, adopt identical measures to combat this new virus. This article aims to perform a comparative study between countries with a population similar to the Portuguese in number of inhabitants and to find out which factors may explain the numbers registered with the COVID-19 pandemic. The results show that the countries that carried out more population tests have higher values in tourism, security, innovation, competitiveness, and GDP per capita indicators. There is a significant and positive relationship between temperature and the daily cases of COVID-19 infections. The results found contribute to a greater knowledge of the behavior of this disease according to the characteristics of each country, making it useful for international business managers to compare and contrast different country environmental conditions in order to define alternative strategies to overcome this great period of disturbance more quickly.
C1 [Santos, Eulalia] Polytech Leiria, Sch Technol & Management, Dept Math, Leiria, Portugal.
   [Oliveira, Margarida] Coimbra Business Sch, ISCAC Higher Inst Accounting & Adm, Coimbra, Portugal.
   [Ratten, Vanessa] La Trobe Univ, La Trobe Business Sch, Dept Management Sport & Tourism, Melbourne, Vic, Australia.
   [Tavares, Fernando Oliveira] ISCET Higher Inst Business & Tourism, Coimbra, Portugal.
   [Tavares, Fernando Oliveira] Univ Aveiro, Dept Ind Management, Aveiro, Portugal.
   [Tavares, Fernando Oliveira] Univ Vigo, Vigo, Portugal.
   [Tavares, Fernando Oliveira] ISCET Inst Super Ciencias Empresariais & Turismo, Porto, Portugal.
   [Tavares, Vasco Capela] Univ Porto, Porto, Portugal.
   [Tavares, Vasco Capela] Univ Porto, FCUP Fac Ciencias, Porto, Portugal.
RP Ratten, V (corresponding author), La Trobe Univ, La Trobe Business Sch, Dept Management Sport & Tourism, Melbourne, Vic, Australia.
EM eulalia.santos@sapo.pt; margarida.foliveira@hotmail.com;
   v.ratten@latrobe.edu.au; faotavares@gmail.com;
   vasco.capela.tavares.bsc@gmail.com
RI Tavares, Fernando Oliveira/AAE-6873-2021; Tavares, Fernando António de
   Oliveira/AAC-5055-2022; santos, Eulália/AAO-4024-2020; Ratten,
   Vanessa/F-7831-2015
OI Tavares, Fernando António de Oliveira/0000-0002-9672-8770; santos,
   Eulália/0000-0001-8069-2657; Freitas Oliveira,
   Margarida/0000-0001-7340-3546; Tavares, Vasco/0000-0002-5651-9755;
   Ratten, Vanessa/0000-0002-2534-4550
CR Accuweather, 2020, MET DIAR
   Agencia EFE, 2020, ERP DOM EST TOQ QUED
   Aveni A., 2020, REV PROC POLIT PUB D, V2, P46
   Barton L., 2007, CRISIS LEADERSHIP NO
   Beching N., 2020, COVID 19
   Beech N, 2020, BRIT J MANAGE, V31, P447, DOI 10.1111/1467-8551.12421
   Bellanger A., 2020, MYSTERE PORTUGIAS FA
   Bhaduri RM, 2019, EUR J TRAIN DEV, V43, P554, DOI 10.1108/EJTD-10-2018-0109
   Branicki LJ, 2020, GENDER WORK ORGAN, V27, P872, DOI 10.1111/gwao.12491
   Budhwar P, 2020, BRIT J MANAGE, V31, P441, DOI 10.1111/1467-8551.12426
   Calderwood L.U., 2019, TRAVEL TOURISM COMPE
   Cauchemez S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-207
   Comfort LK, 2007, PUBLIC ADMIN REV, V67, P189, DOI 10.1111/j.1540-6210.2007.00827.x
   Countryeconomy.com (CEcom), 2020, IND EC SOC
   Darling J.R., 1994, LEADERSHIP ORG DEV J, V15, P3, DOI DOI 10.1108/01437739410073047
   El Nacional, 2020, REP DOM CONF PRIM CA
   El Periodico, 2020, REP DOM EST EM COVID
   European Centre for Disease Prevention and Control, 2020, COR DIS 2019 COVID 1
   Expresso, 2020, MIN CONF PRIM CAS PO
   Farid K., 2005, PUBLIC RELATIONS DEP
   Ferreira L., 2020, IMPACTOS CONFINAMENT
   Folkhalsomyndigheten, 2020, NYTT BEKR COVID 19
   Giugliano Fernando, 2020, GREECE SHOWS HANDLE
   Gobierno de la Republica de Honduras, 2020, SE DET AMPL TOQ QUED
   Gobierno de la Republica de Honduras, 2020, CONG PREC ABS
   Gobierno de la Republica de Honduras, 2020, SAL CONF PRIM CAS CO
   Governo da Republica Portuguesa (GRP), 2020, EST NAO PAR
   Hanusch F, 2020, INT COMMUN GAZ, V82, P319, DOI 10.1177/1748048518822606
   Index Mundi (IM), 2020, COUNTR
   Jalonen H., 2012, J MANAGEMENT RES, V4, P1, DOI [10. 5296/jmr. v4i1. 1039, DOI 10.5296/JMR.V4I1.1039, 10.5296/jmr.v4i1.1039]
   Juni Peter, 2020, CMAJ, V192, pE1374, DOI 10.1503/cmaj.200920-f
   Kaplan R, 2020, BUS SOC, V59, P439, DOI 10.1177/0007650317717958
   Kayed M., 2020, SCH SUSPENDED BORDER
   Kucera J., 2020, RENEWED COVID 19 OUT
   Gomez SM, 2020, MANAG RES, V18, P401, DOI 10.1108/MRJIAM-06-2020-1065
   Maher A., 2006, GEN RULES DEALING CR
   McEnchroe, 2020, CZECH REPUBLIC GOES
   Medici D., 2020, QUE IDOSOS ESTAO ENT
   Miranda R. A. C, 2012, CLIMATOLOGIA GEOGRAF
   Moreira J, 2019, THUNDERBIRD INT BUS, V61, P635, DOI 10.1002/tie.22045
   Mustafa J., 2005, ED ADM NEW ENTRANCES
   Nandkeolyar K., 2020, GULF NEWS
   Numbeo, 2020, CUST VID
   Oliveira I., 2020, COMERCIO EXTERIOR PO
   Pearson CM., 1993, ACAD MANAGEMENT EXEC, V7, P48, DOI DOI 10.5465/AME.1993.9409142058
   Pramsten S., 2020, LAKARTIDNINGEN
   Reuters, 2020, AZ REP 1 CAS COR IF
   Rico C., 2020, CONFIRMADO PRIMEIRO
   Santy C., 2020, PORTUGAL RESIDENT
   Savage, 2020, BBC
   Shenkar O, 2022, J INT BUS STUD, V53, P516, DOI 10.1057/s41267-020-00365-3
   Teune H., 1970, LOGIC COMP SOCIAL IN, P32
   The Global Economy (TGE), 2020, BUS EC DAT 200 COUNT
   Tugwell P., 2020, HUMBLED GREEKS SHOW
   Turak N, 2020, CNBC
   Venkatesh V., 2020, INT J INFORM MANAGEM
   Verbeke A, 2020, BRIT J MANAGE, V31, P444, DOI 10.1111/1467-8551.12422
   Veronika B, 2020, COULD CZECHS MEASURE
   Ward A, 2020, VOX
   Werner A., 2020, PERSPECTIVAS AM LATI
   Worldometers, 2021, COVID 19 COR PAND
   Younes A, 2020, ALJAZEERA
NR 62
TC 5
Z9 5
U1 4
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1096-4762
EI 1520-6874
J9 THUNDERBIRD INT BUS
JI Thunderbird Int. Bus. Rev.
PD MAY
PY 2021
VL 63
IS 3
BP 285
EP 301
DI 10.1002/tie.22188
EA DEC 2020
PG 17
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA RL9IA
UT WOS:000601837100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Usas, A
   Jasinskas, E
   Zagurska-Antoniuk, V
   Savitskyi, V
   Fuhelo, P
AF Usas, Antanas
   Jasinskas, Edmundas
   Zagurska-Antoniuk, Viktoriia
   Savitskyi, Vladyslav
   Fuhelo, Pavlina
TI COVID-19 IMPACT ON E.COMMERCE USAGE
SO INDEPENDENT JOURNAL OF MANAGEMENT & PRODUCTION
LA English
DT Article
DE ecommerce; covid-19 impact; ecommerce usage; ecommerce in Lithuania
ID E-COMMERCE; MANAGEMENT; CONSUMER
AB Online stores, ad portals, shopping apps have become part of everyday life in 2020-2021. The Covid-19 epidemic has rapidly forced numerous entities (public, business, and private) to become predominantly oriented to electronic commerce in the last few months (Pejie-Bach, 2021). Business in the online space faces new challenges that require additional knowledge and skills. The object of the research is the assessment how covid-19 impact on ecommerce usage in Lithuania. The aim of the work is to examine ecommerce usage in Lithuania during covid-19 pandemic. Methods: scientific literature analysis, statistical data analysis. Businesses had to offer a wider range of services in order to survive. The issue of cybersecurity has grown. Consumers have also reacted ambiguously to this situation. Not only are economic factors that determine the frequency or quantity of consumer purchases distinguished, but also social and psychological factors, such as loss of motivation or apathy. The vast majority of Lithuanian shoppers were selling local online shops. The amount of money spent on online shopping has also increased. The pandemic has increased the scope of ecommerce and the range of services in Lithuania despite the deteriorating economic and social situation.
C1 [Usas, Antanas; Jasinskas, Edmundas] Lithuanian Sport Univ, Kaunas, Lithuania.
   [Zagurska-Antoniuk, Viktoriia; Savitskyi, Vladyslav] Zhytomyr Polytech State Univ, Zhytomyr, Ukraine.
   [Fuhelo, Pavlina] State Agr & Engn Univ Podilya, Khmelnytskyi, Ukraine.
RP Usas, A (corresponding author), Lithuanian Sport Univ, Kaunas, Lithuania.
EM Antanas.Usas@lsu.lt; Edmundas.Jasinskas@lsu.lt; kgn.zvf@gmail.com;
   savitskiy_vladislav@ukr.net; Ole18@meta.ua
RI Fuhelo, Pavlina Fugelo/AAA-8609-2020
OI Usas, Antanas/0000-0001-9717-9112
CR Aziz A. A., 2021, J MEDIA INFORM WARFA, V14, P107
   Balabash O, 2021, INDEP J MANAG PROD, V12, pS232, DOI 10.14807/ijmp.v12i3.1538
   Bhatti A., 2020, INT J FUTUR GENER CO, V13, P1449
   Bickauske D, 2020, INDEP J MANAG PROD, V11, P2291, DOI 10.14807/ijmp.v11i9.1404
   Cernikovaite M. E, 2021, 20 INT SCI C GLOB IT
   Europos centrinis bankas, 2021, ZVILGSN PRAEJ MET
   Europos komisija, 2021, DARB VIET IR EK KOR
   Gemius, 2019, KIEK ZMON LIET IS TI
   Ghandour A, 2020, INT ARAB CONF INF TE
   Guthrie C, 2020, J RETAIL CONSUM SERV, V61, DOI 10.1016/j.jretconser.2021.102570
   Hussain A., 2021, PAKISTAN J COMMERCE, V15, P166
   Karpenko L., 2021, J SECURITY SUSTAINAB, V9, P1421, DOI [10.9770/jssi.2020.9.4(25), DOI 10.9770/JSSI.2020.9.4(25)]
   Keane M, 2021, J ECONOMETRICS, V220, P86, DOI 10.1016/j.jeconom.2020.07.045
   Koch J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su122410247
   Kolotylo-Kulkarni M, 2021, J BUS RES, V126, P221, DOI 10.1016/j.jbusres.2020.12.006
   Kumar N., 2018, INT J ENG BUS MANAG, V2, P13
   MacDonald O. B., 2020, THESIS NATL COLL IRE
   Moon J, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041593
   Ribeiro REM, 2021, INDEP J MANAG PROD, V12, P979, DOI 10.14807/ijmp.v12i4.1358
   Naeem M, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102226
   Naseri R. N. N, 2021, TURKISH J COMPUTER M, V12, P7682, DOI [10.17762/turcomat.v12i10.5680, DOI 10.17762/TURCOMAT.V12I10.5680]
   Pejic-Bach M, 2021, J THEOR APPL EL COMM, V16, DOI 10.4067/S0718-18762021000100101
   Peralta S., 2020, WHAT DID PEOPLE BUY
   Priambodo IT, 2021, J ASIAN FINANC ECON, V8, P865, DOI 10.13106/jafeb.2021.vol8.no3.0865
   Rudnichenko Y, 2020, TEM J, V9, P233, DOI 10.18421/TEM91-33
   Salem M.A., 2020, INT J SCI TECHNOL RE, V9, P15
   Shahzad A., 2020, HUMANITIES SOCIAL SC, V8, P599, DOI DOI 10.18510/HSSR.2020.8364
   Sharma K, 2020, GAP GYAN, V3, P54
   Statista, WORLDW MOB APP REV 2
   Taylor S, 2021, J ANXIETY DISORD, V78, DOI 10.1016/j.janxdis.2021.102364
   Thaworm P., 2021, J GLOBAL BUSINESS RE, V23, P13
   Topolko Herceg K, 2021, CRODIM INT J MARKETI, V4, P131
   Tran LTT, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102287
   Veeragandham M., 2020, INT J RES ENG SCI MA, V3, P78
   Ho VT, 2021, INDEP J MANAG PROD, V12, P1019, DOI 10.14807/ijmp.v12i4.1336
   da Silva LHV, 2021, INDEP J MANAG PROD, V12, P909, DOI 10.14807/ijmp.v12i4.1350
   Wu Y, 2021, INFORM MANAGE-AMSTER, V58, DOI 10.1016/j.im.2020.103283
   Xiao H, 2020, CURR PSYCHOL, DOI 10.1007/s12144-020-01220-2
   Zoroja J, 2020, INTERDISCIP DESCR CO, V18, P312, DOI 10.7906/indecs.18.2.17
NR 39
TC 0
Z9 0
U1 23
U2 23
PU INST FEDERAL EDUCACAO, CIENCIA & TECNOLOGIA SAO PAULO
PI SAO PAULO
PA RUA PEDRO VICENTE 625, CANINDE, SAO PAULO, 01109-010, BRAZIL
SN 2236-269X
J9 INDEP J MANAG PROD
JI Indep. J. Manag. Prod.
PD NOV
PY 2021
VL 12
IS 6
BP S445
EP S462
DI 10.14807/ijmp.v12i6.1750
PG 18
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WW5KV
UT WOS:000717956100007
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Li, MY
   Leslie, H
   Qi, B
   Nan, S
   Feng, HS
   Cai, HL
   Lu, XD
   Duan, HL
AF Li, Mengyang
   Leslie, Heather
   Qi, Bin
   Nan, Shan
   Feng, Hongshuo
   Cai, Hailing
   Lu, Xudong
   Duan, Huilong
TI Development of an openEHR Template for COVID-19 Based on Clinical
   Guidelines
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE coronavirus disease; COVID-19; openEHR; archetype; template; knowledge
   modeling; clinical guidelines
AB Background: The coronavirus disease (COVID-19) was discovered in China in December 2019. It has developed into a threatening international public health emergency. With the exception of China, the number of cases continues to increase worldwide. A number of studies about disease diagnosis and treatment have been carried out, and many clinically proven effective results have been achieved. Although information technology can improve the transferring of such knowledge to clinical practice rapidly, data interoperability is still a challenge due to the heterogeneous nature of hospital information systems. This issue becomes even more serious if the knowledge for diagnosis and treatment is updated rapidly as is the case for COVID-19. An open, semantic-sharing, and collaborative-information modeling framework is needed to rapidly develop a shared data model for exchanging data among systems. openEHR is such a framework and is supported by many open software packages that help to promote information sharing and interoperability.
   Objective: This study aims to develop a shared data model based on the openEHR modeling approach to improve the interoperability among systems for the diagnosis and treatment of COVID-19.
   Methods: The latest Guideline of COVID-19 Diagnosis and Treatment in China was selected as the knowledge source for modeling. First, the guideline was analyzed and the data items used for diagnosis and treatment, and management were extracted. Second, the data items were classified and further organized into domain concepts with a mind map. Third, searching was executed in the international openEHR Clinical Knowledge Manager (CKM) to find the existing archetypes that could represent the concepts. New archetypes were developed for those concepts that could not be found. Fourth, these archetypes were further organized into a template using Ocean Template Editor. Fifth, a test case of data exchanging between the clinical data repository and clinical decision support system based on the template was conducted to verify the feasibility of the study.
   Results: A total of 203 data items were extracted from the guideline in China, and 16 domain concepts (16 leaf nodes in the mind map) were organized. There were 22 archetypes used to develop the template for all data items extracted from the guideline. All of them could be found in the CKM and reused directly. The archetypes and templates were reviewed and finally released in a public project within the CKM. The test case showed that the template can facilitate the data exchange and meet the requirements of decision support.
   Conclusions: This study has developed the openEHR template for COVID-19 based on the latest guideline from China using openEHR modeling methodology. It represented the capability of the methodology for rapidly modeling and sharing knowledge through reusing the existing archetypes, which is especially useful in a new and fast-changing area such as with COVID-19.
C1 [Li, Mengyang; Nan, Shan; Feng, Hongshuo; Cai, Hailing; Lu, Xudong; Duan, Huilong] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Room 512,Zhouyiqing Bldg,38 Zheda Rd, Hangzhou 310007, Zhejiang, Peoples R China.
   [Li, Mengyang; Nan, Shan; Feng, Hongshuo; Cai, Hailing; Lu, Xudong; Duan, Huilong] Minist Educ, Key Lab Biomed Engn, Hangzhou, Zhejiang, Peoples R China.
   [Leslie, Heather] Atom Informat, Melbourne, Vic, Australia.
   [Leslie, Heather] openEHR Fdn, London, England.
   [Qi, Bin] Hangzhou Joyrun Med Technol Cooperat, Hangzhou, Zhejiang, Peoples R China.
   [Lu, Xudong] Eindhoven Univ Technol, Sch Ind Engn, Eindhoven, Netherlands.
RP Lu, XD (corresponding author), Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Room 512,Zhouyiqing Bldg,38 Zheda Rd, Hangzhou 310007, Zhejiang, Peoples R China.
EM lvxd@zju.edu.cn
RI Nan, Shan/AAD-1486-2021
OI Nan, Shan/0000-0002-7807-3125; Feng, Hongshuo/0000-0002-6719-487X; Li,
   Mengyang/0000-0003-2302-4884; Qi, Bin/0000-0002-7363-7489; Leslie,
   Heather/0000-0003-3510-0522
FU Chinese National Science and Technology Major Project [2016YFC0901703]
FX This study was funded by Chinese National Science and Technology Major
   Project (grant number 2016YFC0901703).
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   China Law Translate, 2020, NOV COR PNEUM DIAGN
   Chinese Center for Disease Control and Prevention, CLASS INF DIS CHIN
   Frade S, 2013, 2013 IEEE 26TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS (CBMS), P303, DOI 10.1109/CBMS.2013.6627806
   GitHub, OHDSI REP COMPR EV C
   Goossen W, 2010, HEALTHC INFORM RES, V16, P201, DOI 10.4258/hir.2010.16.4.201
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Jiang G, 2017, AIDS RES HUM RETROV, P1
   Jiang G, 2017, CEUR WORKSHOP P, P126
   Miliard M., 2020, HLTHCARE IT NEWS
   Min LT, 2016, STUD HEALTH TECHNOL, V227, P100, DOI 10.3233/978-1-61499-666-8-100
   National Health Commission of the People's Republic of China, NOV COR PNEUM DIAGN
   National Health Commission of the People's Republic of China, CLASS B INF DIS WER
   openEHR, CLIN KNOWL MAN
   openEHR, ARCH DEF LANG
   openEHR, 2020, OPENEHR COMM RIS CHA
   openEHR, COVID 19 PNEUM DIAGN
   openEHR, OC TEMPL
   OpenEHR Foundation, OPENEHR ARCH OV
   Schloeffel P, 2006, HIC 2006 BRIDGING DI, V24, P1
   SNOmed International, 2020, MARCH 2020 SNOMED CT
   Thurston LM, 2006, HIC 2006 HINZ 2006 P, P28
   Wang L, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0212-0
   WHO, COR DIS COVID 2019 S
   WHO, 2021, STAT 2 M INT HLTH RE
   World Health Organization, GLOB RES COR DIS COV
NR 26
TC 9
Z9 9
U1 1
U2 9
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD JUN 10
PY 2020
VL 22
IS 6
AR e20239
DI 10.2196/20239
PG 15
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Medical Informatics
GA LW5AD
UT WOS:000539158200001
PM 32496207
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ayseli, YI
   Aytekin, N
   Buyukkayhan, D
   Aslan, I
   Ayseli, MT
AF Ayseli, Yasemin Ipek
   Aytekin, Nazli
   Buyukkayhan, Derya
   Aslan, Ismail
   Ayseli, Mehmet Turan
TI Food policy, nutrition and nutraceuticals in the prevention and
   management of COVID-19: Advice for healthcare professionals
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Article
DE COVID-19; Immunity; Antiviral; Micronutrients; Nutraceuticals; Nutrition
ID GLUTATHIONE-PEROXIDASE; TRANS-RESVERATROL; IMMUNE-RESPONSES; VITAMIN-C;
   MELATONIN; BIOAVAILABILITY; QUERCETIN; SUPPLEMENTATION; DEFICIENCY;
   METABOLISM
AB Background: The 2019 novel coronavirus (2019-nCoV) represents an ongoing major global health crisis with a potentially unprecedented death toll and socio-economic impact in the modern era. Measures taken to reduce the rate of transmission are too unprecedented, but are deemed necessary. The extensive strain on public health services has meant that individual agency is increasingly called for. To support this, there is a need to review policy and procedure governing the food and commerce industries in particular. Additionally, it is necessary to convey a more comprehensive and nuanced understanding of relevant diet and lifestyle factors to both healthcare practitioners and the general public.
   Scope and approach: To our knowledge, a review of possible additional measures for healthcare proffesionals, which includes the possible nutritional management COVID-19 pandemic does not yet exist.
   Key Findings and Conclusions: This review identifies i) changing trends in consumer awareness and purchasing patterns in response to COVID-19, and their potential future implications for the food and food-commerce industry ii) problematic elements of policy relevant to the outbreak of COVID-19, including the handling of wildlife and food-commerce, ii) newly emergent technologies in food science which represent viable and costeffective means to reduce the risk of transmission of coronavirus, such as anti-microbial packaging, iii) important nutritional considerations with regard to coronavirus disease prevention and management, including nutrition in early infancy, and the role of select micronutrients (vitamins and minerals), phytochemicals and probiotics in conferring protection against both viral infection and pathogenicity.
C1 [Ayseli, Yasemin Ipek] Osman Gazi Family Hlth Ctr, TR-33330 Mezitli, Mersin, Turkey.
   [Aytekin, Nazli] London South Bank Univ, Sch Appl Sci, London SE1 0AA, England.
   [Buyukkayhan, Derya] Univ Hlth Sci Turkey, Div Neonatol, Dept Pediat, Fac Med, TR-34668 Istanbul, Turkey.
   [Aslan, Ismail] Univ Hlth Sci Turkey, Vocat High Sch, TR-34668 Istanbul, Turkey.
   [Ayseli, Mehmet Turan] Yildiz Tech Univ, Fac Chem & Met Engn, Dept Food Engn, TR-34210 Istanbul, Turkey.
   [Ayseli, Mehmet Turan] Mersin Univ Technopark, Genetris Danismanl, TR-33343 Yenisehir, Mersin, Turkey.
RP Ayseli, MT (corresponding author), Yildiz Tech Univ, Fac Chem & Met Engn, Dept Food Engn, TR-34210 Istanbul, Turkey.
EM tayseli@genetris.com
RI Aslan, Ismail/AAC-8353-2021
OI Aslan, Ismail/0000-0001-7075-7103; ayseli, mehmet
   turan/0000-0002-4196-1348
CR Aday S., 2020, FOOD QUALITY SAFETY
   Aguiar GPS, 2018, IND CROP PROD, V112, P1, DOI 10.1016/j.indcrop.2017.11.008
   Akour A, 2020, LETT APPL MICROBIOL, V71, P229, DOI 10.1111/lam.13334
   Annunziata G., 2020, FRONTIERMED, V7
   Avasarala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057285
   Aytekin N, 2019, MED HYPOTHESES, V129, DOI 10.1016/j.mehy.2019.109247
   BALEY JE, 1985, J IMMUNOL, V134, P3042
   Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006
   Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S
   Bergman P., 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0065835
   Bfr, 2020, MEAT PROD COR TRANSM
   Biogaia, 2020, COVID 19 OUTBR PROB
   Blancheton J. P., 2007, Aquacultural engineering and environment, P21
   Boretti A, 2020, PHARMANUTRITION, V12, DOI 10.1016/j.phanu.2020.100190
   Burkon A, 2008, MOL NUTR FOOD RES, V52, P549, DOI 10.1002/mnfr.200700290
   Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973
   Cai Y., 2015, BIOMED RES INT
   Calder P.C., 2020, OPTIMAL NUTR STATUS
   Chen C, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-24
   Chen H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006090.pub2
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Cheng SKW, 2004, BRIT J PSYCHIAT, V184, P359, DOI 10.1192/bjp.184.4.359
   Chow JM, 2005, BIOCHEM PHARMACOL, V69, P1839, DOI 10.1016/j.bcp.2005.03.017
   Dey SK, 2020, J MED VIROL, V92, P632, DOI 10.1002/jmv.25743
   Diamond AM, 2001, BIOFACTORS, V14, P205, DOI 10.1002/biof.5520140126
   Dursun A., 2020, IRAN 6 YEAR OLD CHIL
   El-Missiry MA, 2020, EUR J PHARMACOL, V882, DOI 10.1016/j.ejphar.2020.173329
   Erol A, 2020, HIGH DOSE INTRAVENOU
   Esquifino AI., 2004, CLIN APP IMMUNOL REV, V4, P423, DOI [10.1016/j.cair.2004.08.002, DOI 10.1016/J.CAIR.2004.08.002]
   Etminiani-Esfahani, 2010, J DIABETES METABOLIC, V9, P19
   Fadus Matthew C, 2017, J Tradit Complement Med, V7, P339, DOI 10.1016/j.jtcme.2016.08.002
   Feitosa EL, 2020, INT J MED SCI, V17, P2133, DOI 10.7150/ijms.48053
   Food and Nutrition Board, 2001, DIET REF INT VIT A V
   Fox A., 2020, EVIDENCE SIGNIFICANT
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Furlong C., 2020, FOOD BEVERAGE TRENDS, P5
   Gabryszewski SJ, 2011, J IMMUNOL, V186, P1151, DOI 10.4049/jimmunol.1001751
   Gebicki J, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00297-9
   Goldson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014771
   Grant W. B., 2020, 2020 AUTHORS DISTRIB
   Grebow J., 2020, PEAK DIETARY SUPPLEM
   Grunewald ME, 2020, J VIROL, V94, DOI 10.1128/JVI.01743-19
   HAJAK G, 1991, PHARMACOPSYCHIATRY, V24, P17, DOI 10.1055/s-2007-1014427
   Hall OJ, 2017, MUCOSAL IMMUNOL, V10, P1097, DOI 10.1038/mi.2017.35
   Hall OJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005840
   HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183
   Hazra S, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118096
   Hemila H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040339
   Hemila H, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0478-5
   Hemila H, 2016, CLIN INTERV AGING, V11, P1379, DOI 10.2147/CIA.S114515
   Hollman PCH, 1997, FEBS LETT, V418, P152, DOI 10.1016/S0014-5793(97)01367-7
   Howells LM, 2011, CANCER PREV RES, V4, P1419, DOI 10.1158/1940-6207.CAPR-11-0148
   Hu X., 2020, FUTURE VIROLOGY
   Huang SH, 2010, J PINEAL RES, V48, P109, DOI 10.1111/j.1600-079X.2009.00733.x
   Humane Society International, 2020, CHIN WILDL FARM OFF
   Ibrahim I, 2020, J INFECT
   Iddir M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061562
   Jacob R. A., 2000, PANEL DIETARY ANTIOX
   Jamwal R, 2018, J INTEGR MED-JIM, V16, P367, DOI 10.1016/j.joim.2018.07.001
   Johnson JJ, 2011, MOL NUTR FOOD RES, V55, P1169, DOI 10.1002/mnfr.201100117
   Kanauchi O, 2018, CURR PHARM DESIGN, V24, P710, DOI 10.2174/1381612824666180116163411
   Karak P, 2019, INT J PHARM SCI RES, V10, P1567, DOI 10.13040/IJPSR.0975-8232.10(4).1567-74
   King S, 2019, EUR J PUBLIC HEALTH, V29, P494, DOI 10.1093/eurpub/cky185
   Kocadagli T, 2014, FOOD CHEM, V153, P151, DOI 10.1016/j.foodchem.2013.12.036
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22567
   Li W, 2006, J NUTR, V136, P2611, DOI 10.1093/jn/136.10.2611
   Lin SC, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2253-8
   Lopresti AL, 2018, ADV NUTR, V9, P41, DOI 10.1093/advances/nmx011
   Lu QB, 2021, J RECEPT SIG TRANSD, V41, P488, DOI 10.1080/10799893.2020.1828914
   Manoharan Y, 2020, INDIAN J CLIN BIOCHE, V35, P373, DOI 10.1007/s12291-020-00902-9
   Markus RP, 2018, BRIT J PHARMACOL, V175, P3239, DOI 10.1111/bph.14083
   Maruta H., 2020, MED DRUG DISCOVERY
   Masuelli M.A., 2017, BIOPACKAGING, P36, DOI [10.1201/9781315152349/biopackaging-martin-masuelli?refId=abbf6256-44b1-4c20-97b8-20e8cf98f7f6, DOI 10.1201/9781315152349/BIOPACKAGING-MARTIN-MASUELLI?REFID=ABBF6256-44B1-4C20-97B8-20E8CF98F7F6]
   Mauvais-Jarvis F, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa127
   Mazzucchelli C, 1996, MOL BRAIN RES, V39, P117, DOI 10.1016/0169-328X(96)00017-4
   MCINTOSH K, 1970, AM J EPIDEMIOL, V91, P585, DOI 10.1093/oxfordjournals.aje.a121171
   McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435
   McNamara T, 2020, VECTOR-BORNE ZOONOT, V20, P393, DOI 10.1089/vbz.2020.2650
   Mikirova NA, 2014, MED SCI MONITOR, V20, P725, DOI 10.12659/MSM.890423
   Mintel, 2020, CONS COVID 19 LESS E
   Mossad SB, 1996, ANN INTERN MED, V125, P81, DOI 10.7326/0003-4819-125-2-199607150-00001
   Muscogiuri G, 2020, EUR J CLIN NUTR, V74, P850, DOI 10.1038/s41430-020-0635-2
   Nocker A, 2007, MICROB ECOL, V54, P276, DOI 10.1007/s00248-006-9199-5
   Nordeen SK, 2013, HORM CANCER-US, V4, P293, DOI 10.1007/s12672-013-0150-1
   Pandolfi E, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00152
   Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18
   Popofsky S, 2020, J PEDIAT
   Qin M., 2020, BIORXIV
   Ramirez-Garza SL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121892
   Ran L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1837634
   Reiter R J, 1997, Adv Pharmacol, V38, P103
   Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x
   Romero A, 2022, CELL MOL NEUROBIOL, V42, P489, DOI 10.1007/s10571-020-00938-8
   Ross AC, 2007, VITAM HORM, V75, P197, DOI 10.1016/S0083-6729(06)75008-7
   Rude J, 2020, CAN J AGR ECON, V68, P207, DOI 10.1111/cjag.12228
   Saad N, 2013, LWT-FOOD SCI TECHNOL, V50, P1, DOI 10.1016/j.lwt.2012.05.014
   SACK RL, 1986, J PINEAL RES, V3, P379, DOI 10.1111/j.1600-079X.1986.tb00760.x
   Salehi B, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6030091
   SAPPEY C, 1994, AIDS RES HUM RETROV, V10, P1451, DOI 10.1089/aid.1994.10.1451
   Seabra RM, 2006, BIOMATERIALS FROM AQUATIC AND TERRESTRIAL ORGANISMS, P115
   Shojadoost B, 2019, VET IMMUNOL IMMUNOP, V207, P62, DOI 10.1016/j.vetimm.2018.12.002
   Sirisinha S., 2015, ASIAN PACIFIC J ALLE, V33
   Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007
   Soleimani V, 2018, PHYTOTHER RES, V32, P985, DOI 10.1002/ptr.6054
   Soye KJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-337
   Sultana B, 2008, FOOD CHEM, V108, P879, DOI 10.1016/j.foodchem.2007.11.053
   Suravajhala R., 2020, COMP DOCKING STUDIES
   Suwannarong Kanokwan, 2016, Infection Ecology & Epidemiology, V6, P29941, DOI 10.3402/iee.v6.29941
   Tan D. X., 2020, J EXPT BOT
   Tekin H. O., 2020, RAD RESISTANCE NOVEL
   Telcian AG, 2017, ANTIVIR RES, V137, P93, DOI 10.1016/j.antiviral.2016.11.004
   Vitaglione P, 2005, MOL NUTR FOOD RES, V49, P495, DOI 10.1002/mnfr.200500002
   Vyawahare M., 2020, CHINA BEEFS WILDLIFE
   Wahedi HM, 2021, J BIOMOL STRUCT DYN, V39, P3225, DOI 10.1080/07391102.2020.1762743
   Wei X. S., 2020, CLIN GASTROENTEROLOG
   Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010
   Wieers G, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00454
   Williams P, 2007, NUTR DIET, V64, pS113, DOI 10.1111/j.1747-0080.2007.00197.x
   Wu WJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010006
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Yasmin AR, 2020, FEED ADDITIVES: AROMATIC PLANTS AND HERBS IN ANIMAL NUTRITION AND HEALTH, P115, DOI 10.1016/B978-0-12-814700-9.00007-8
   Yatmaz S, 2013, AM J RESP CELL MOL, V48, P17, DOI 10.1165/rcmb.2011-0345OC
   Yuce E.I., 2020, TURKIYE KLIN COVID 1, V1, P81
   Yuksel S, 2016, J INTERCULT ETHNOPHA, V5, P308, DOI 10.5455/jice.20160331064836
   Yurttas G., 2020, IZMIR KATIP CELEBI U, V5, P153
   Zahedipour F, 2020, PHYTOTHER RES, V34, P2911, DOI 10.1002/ptr.6738
   Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105
   Zhang L, 2014, BIODIVERS CONSERV, V23, P2371, DOI 10.1007/s10531-014-0708-4
   Zhang R, 2020, LIFE SCI, V250, DOI 10.1016/j.lfs.2020.117583
NR 130
TC 17
Z9 17
U1 7
U2 18
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
EI 1879-3053
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PD NOV
PY 2020
VL 105
BP 186
EP 199
DI 10.1016/j.tifs.2020.09.001
PG 14
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA PY4MJ
UT WOS:000612019700004
PM 33519086
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Stiles, S
   Golightly, D
   Ryan, B
AF Stiles, Shelly
   Golightly, David
   Ryan, Brendan
TI Impact of COVID-19 on health and safety in the construction sector
SO HUMAN FACTORS AND ERGONOMICS IN MANUFACTURING & SERVICE INDUSTRIES
LA English
DT Article
DE construction; COVID-19; health and safety; human factors; risk
ID LEADERSHIP; MANAGEMENT; BEHAVIOR; OWNERSHIP; RISKS; LIFE
AB Construction has been significantly affected by COVID-19 yet is critical to the post-COVID economic recovery. Specifically, construction needs to be constantly aware of safety and risk balanced with timely project delivery. Guidance for COVID-19 must therefore be implemented in a way that reflects working practice and pressures. There is, however, a potential knowledge gap regarding the practical feasibility and impact of applying COVID-19 measures within construction, made more difficult by factors such as the temporary nature of projects and complex working arrangements. This article presents a commentary on safe construction during, and beyond, COVID-19, covering the human factors challenges and practicalities of implementing COVID-19 measures. We observe that while guidance is strong on risk management, understanding of how best to implement this guidance is not yet stable. Also, care must be taken that implementing guidance does not detract from general safety, which is also challenged by increased pressures on delivery arising from COVID-19. There may, however, be opportunities for safer working practice arising from new awareness of health, hygiene, and safety risk. The role of safety leadership is overlooked in guidance yet is vital to ensure safe application of COVID-19 working practices. The key message is that COVID-19 needs to be integrated and promoted within a general risk management approach, in part because this takes account of differing priorities regarding safety risks, rather than overly focussing on COVID-19, and also because the effectiveness of COVID-19 mitigations can be amplified by integration with pre-existing safety processes.
C1 [Stiles, Shelly] Gateway Consultants HSW Ltd, Burton Upon Trent, England.
   [Golightly, David] Newcastle Univ, Sch Engn, Stephenson Bldg, Newcastle NE1 7RU, England.
   [Ryan, Brendan] Univ Nottingham, Fac Engn, Nottingham, England.
RP Golightly, D (corresponding author), Newcastle Univ, Sch Engn, Stephenson Bldg, Newcastle NE1 7RU, England.
EM david.golightly@newcastle.ac.uk
OI Golightly, David/0000-0002-0819-276X
CR ANDRIESSEN JHTH, 1978, J OCCUP ACCID, V1, P363, DOI 10.1016/0376-6349(78)90006-8
   Anger WK, 2018, J OCCUP ENVIRON MED, V60, P700, DOI 10.1097/JOM.0000000000001290
   Antwi-Afari MF, 2017, AUTOMAT CONSTR, V83, P41, DOI 10.1016/j.autcon.2017.07.007
   Arditi D, 2005, J CONSTR ENG M ASCE, V131, P866, DOI 10.1061/(ASCE)0733-9364(2005)131:8(866)
   Briscoe G, 2005, SUPPLY CHAIN MANAG, V10, P319, DOI 10.1108/13598540510612794
   Briscoe G., 2001, EUROPEAN J PURCHASIN, V7, P243, DOI DOI 10.1016/S0969-7012(01)00005-3
   Buckley M, 2012, GEOFORUM, V43, P250, DOI 10.1016/j.geoforum.2011.09.001
   Bust PD, 2008, SAFETY SCI, V46, P585, DOI 10.1016/j.ssci.2007.06.026
   Choudhari R, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102254
   CIOB, 2008, LEAD CONSTR IND
   Conchie SM, 2013, SAFETY SCI, V51, P109, DOI 10.1016/j.ssci.2012.05.020
   Construction Leadership Council (CLC), 2020, CONSTR SECT SIT OP P
   de Jong AM, 2002, APPL ERGON, V33, P439, DOI 10.1016/S0003-6870(02)00033-9
   Department for Transport, 2020, DEC TRANSP SETT CHAL
   Dirani KM, 2020, HUM RESOUR DEV INT, V23, P380, DOI 10.1080/13678868.2020.1780078
   Domingo JL, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109861
   Dutta A, 2020, ERGONOMICS, V63, P1182, DOI 10.1080/00140139.2020.1772378
   Fairman R., 2005, MAKING IMPACT SME CO
   Farrington-Darby T, 2005, SAFETY SCI, V43, P39, DOI 10.1016/j.ssci.2004.09.003
   Fennelly KP, 2020, LANCET RESP MED, V8, P914, DOI 10.1016/S2213-2600(20)30323-4
   Fleming M., 2001, 2000049 HLTH SAF EX
   Flin R, 2004, QUAL SAF HEALTH CARE, V13, P45, DOI 10.1136/qshc.2003.009555
   Grote G, 2004, ANNU REV CONTROL, V28, P267, DOI 10.1016/j.arcontrol.2004.03.001
   Hallowell M. R., 2010, PROF SAF, V55, P18
   Hartmann B, 2005, SCAND J WORK ENV HEA, V31, P88
   Haslam RA, 2005, APPL ERGON, V36, P401, DOI 10.1016/j.apergo.2004.12.002
   Health and Safety Executive (HSE), 2011, MEAS HLTH SAF PERF
   Health and Safety Executive (HSE), 2020, WORK SAF COR OUTBR S
   HM Gov, 2020, WORK SAF COVID 19 CO
   Holden S, 2018, INT J INTEGR ENG, V10, P13, DOI 10.30880/ijie.2018.10.02.003
   HSE, 2019, CONSTR STAT GREAT BR
   International Energy Agency, 2019, FUT RAIL OPP EN ENV
   Jones W, 2019, SAFETY SCI, V120, P538, DOI 10.1016/j.ssci.2019.07.038
   Kenyon C, 2020, INT J INFECT DIS, V97, P21, DOI 10.1016/j.ijid.2020.05.102
   Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036
   Laverty AA, 2020, J ROY SOC MED, V113, P251, DOI 10.1177/0141076820938997
   Love PED, 2010, J CONSTR ENG M ASCE, V136, P650, DOI 10.1061/(ASCE)CO.1943-7862.0000165
   Marsh T.W., 1998, J I OCCUPATIONAL SAF, V2, P45
   Maynard S, 2021, APPL ERGON, V90, DOI 10.1016/j.apergo.2020.103237
   McClure ES, 2020, AM J EPIDEMIOL, V189, P1244, DOI 10.1093/aje/kwaa126
   Mitra B, 2020, EMERG MED AUSTRALAS, V32, P867, DOI 10.1111/1742-6723.13578
   Mullan B, 2015, SAFETY SCI, V79, P139, DOI 10.1016/j.ssci.2015.06.004
   Oeppen RS, 2020, BRIT J ORAL MAX SURG, V58, P643, DOI 10.1016/j.bjoms.2020.04.046
   Okpala I, 2020, PRACT PERIOD STRUCT, V25, DOI 10.1061/(ASCE)SC.1943-5576.0000468
   OSHA, 2020, COVID 19 CONTR PREV
   Oswald D, 2019, J CONSTR ENG M, V145, DOI 10.1061/(ASCE)CO.1943-7862.0001634
   Paquet V, 1999, INT J IND ERGONOM, V24, P431, DOI 10.1016/S0169-8141(99)00009-8
   Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530
   Pedersen LM, 2012, SAFETY SCI, V50, P48, DOI 10.1016/j.ssci.2011.06.010
   Penaloza GA, 2020, APPL ERGON, V82, DOI 10.1016/j.apergo.2019.102978
   Pinder J, 2016, POLICY PRACT HEALTH, V14, P34, DOI 10.1080/14773996.2016.1239357
   Rasmussen J, 1997, SAFETY SCI, V27, P183, DOI 10.1016/S0925-7535(97)00052-0
   Rhodes C., 2019, 01432 HOUS COMM
   Rowlinson S.M., 2004, CONSTRUCTION SAFETY
   Rydenfalt C, 2014, BMJ QUAL SAF, V23, P183, DOI 10.1136/bmjqs-2013-002168
   Salguero-Caparros F., 2019, MODERN TRENDS RES IN, P503
   Sauni R, 2001, OCCUP MED-OXFORD, V51, P163, DOI 10.1093/occmed/51.3.163
   Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932
   Snashall D, 2005, SCAND J WORK ENV HEA, V31, P5
   Stephens B, 2019, CURR POLLUT REP, V5, P198, DOI 10.1007/s40726-019-00123-6
   Stiles S., 2018, P 20 C INT ERG ASS I, P213
   Stiles S, 2018, SAFETY SCI, V110, P134, DOI 10.1016/j.ssci.2017.12.030
   Stiles S, 2012, CONTEMPORARY ERGONOMICS AND HUMAN FACTORS 2012, P303
   Suman R, 2020, J CLIN EXP HEPATOL, V10, P386, DOI 10.1016/j.jceh.2020.04.020
   Thompson RC, 1998, J SAFETY RES, V29, P15, DOI 10.1016/S0022-4375(97)00025-X
   van der Molen HF, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006251.pub4
   Vickers I., 2003, CULTURAL INFLUENCES
   Wilson JR, 2009, ERGONOMICS, V52, P774, DOI 10.1080/00140130802642211
   WILSON JR, 1995, INT J IND ERGONOM, V15, P329, DOI 10.1016/0169-8141(94)00080-M
   Winkler C., 2003, CONTRACTORISATION AS
   Woolley M, 2020, SAFETY SCI, V132, DOI 10.1016/j.ssci.2020.104984
   Zohar D, 2002, J ORGAN BEHAV, V23, P75, DOI 10.1002/job.130
   Zohar D, 2003, J SAFETY RES, V34, P567, DOI 10.1016/j.jsr.2003.05.006
NR 73
TC 21
Z9 21
U1 13
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1090-8471
EI 1520-6564
J9 HUM FACTOR ERGON MAN
JI Hum. Factors Ergonom. Manuf. Serv. Ind.
PD JUL
PY 2021
VL 31
IS 4
SI SI
BP 425
EP 437
DI 10.1002/hfm.20882
EA JAN 2021
PG 13
WC Engineering, Manufacturing; Ergonomics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Engineering
GA SV4ZD
UT WOS:000607101000001
PM 33821125
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Zheng, YB
   Sun, J
   Liu, L
   Zhao, YM
   Yan, W
   Yuan, K
   Su, SZ
   Lu, ZA
   Huang, YT
   Zeng, N
   Zhu, XM
   Gong, YM
   Lin, X
   Meng, SQ
   Wong, SYS
   Ran, MS
   Shi, J
   Shi, L
   Kosten, T
   Bao, YP
   Lu, L
AF Zheng, Yong-Bo
   Sun, Jie
   Liu, Lin
   Zhao, Yi-Miao
   Yan, Wei
   Yuan, Kai
   Su, Si-Zhen
   Lu, Zheng-An
   Huang, Yue-Tong
   Zeng, Na
   Zhu, Xi-Mei
   Gong, Yi-Miao
   Lin, Xiao
   Meng, Shi-Qiu
   Wong, Samuel Yeung Shan
   Ran, Mao-Sheng
   Shi, Jie
   Shi, Le
   Kosten, Thomas
   Bao, Yan-Ping
   Lu, Lin
TI COVID-19 Vaccine-Related Psychological Stress Among General Public in
   China
SO FRONTIERS IN PSYCHIATRY
LA English
DT Article
DE COVID-19 vaccine; psychological stress; vaccination; health knowledge;
   general public; China
AB Background: The COVID-19 pandemic is our generation's greatest global challenge to our public health system. Vaccines are considered one of the most effective tools available for preventing COVID-19 infection and its complications and sequelae. Understanding and addressing the psychological stress related to COVID-19 vaccination may promote acceptance of these vaccines.Methods: We conducted an online survey from January 29 to April 26, 2021 to explore stress levels related to COVID-19 vaccination among the general public in China. Participants were asked to evaluate their psychological stress of considering whether or not to get vaccinated at the beginning period of the COVID-19 mass vaccination, after getting access to the information about the vaccine, as well as after getting vaccinated, using visual analog stress scale. Multiple linear regression analysis was performed to explore factors potentially associated with COVID-19-related psychological stress levels before and after getting vaccinated.Results: A total of 34,041 participants were included in the final analysis. The mean stress score concerning COVID-19 vaccination was 3.90 +/- 2.60 among all participants, and significantly decreased over time. In addition, the vaccine-related stress level significantly decreased after accessing information about the COVID-19 vaccine (N = 29,396), as well as after getting vaccinated (N = 5,103). Multivariable regression analysis showed higher stress levels related to COVID-19 vaccination in participants who were younger, having lower education level, having history of chronic diseases, mistrusting vaccine's efficacy, experience of vaccine allergy events, being affected by the COVID-19 epidemic, and having mental illness symptoms. Moreover, mistrust in vaccine efficacy and experience of vaccine allergy events had a long-term impact on psychological stress levels about COVID-19 vaccination even after getting vaccinated.Conclusions: The current findings profiled the COVID-19 vaccine-related psychological stress among the general public in China. Population-specific management and interventions targeting the stress related to COVID-19 vaccination are needed to help governments and policy makers promote individual's willingness to get vaccinations for public well-being during the COVID-19 pandemic.
C1 [Zheng, Yong-Bo; Sun, Jie; Liu, Lin; Yan, Wei; Yuan, Kai; Su, Si-Zhen; Lu, Zheng-An; Huang, Yue-Tong; Zhu, Xi-Mei; Gong, Yi-Miao; Lin, Xiao; Shi, Le; Lu, Lin] Peking Univ, Natl Clin Res Ctr Mental Disorders, Inst Mental Hlth, Hosp 6,NHC Key Lab Mental Hlth, Beijing, Peoples R China.
   [Zheng, Yong-Bo; Lu, Lin] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.
   [Zheng, Yong-Bo; Lu, Lin] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing, Peoples R China.
   [Sun, Jie; Shi, Jie] Peking Univ Third Hosp, Pain Med, Beijing, Peoples R China.
   [Zhao, Yi-Miao; Zeng, Na; Meng, Shi-Qiu; Bao, Yan-Ping; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing, Peoples R China.
   [Zhao, Yi-Miao; Zeng, Na; Meng, Shi-Qiu; Bao, Yan-Ping; Lu, Lin] Peking Univ, Beijing Key Lab Drug Dependence, Beijing, Peoples R China.
   [Zhao, Yi-Miao; Zeng, Na; Bao, Yan-Ping] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China.
   [Zeng, Na] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China.
   [Wong, Samuel Yeung Shan] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.
   [Ran, Mao-Sheng] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China.
   [Kosten, Thomas] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA.
   [Kosten, Thomas] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.
   [Kosten, Thomas] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.
   [Kosten, Thomas] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA.
RP Lu, L (corresponding author), Peking Univ, Natl Clin Res Ctr Mental Disorders, Inst Mental Hlth, Hosp 6,NHC Key Lab Mental Hlth, Beijing, Peoples R China.; Lu, L (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Lu, L (corresponding author), Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Bao, YP; Lu, L (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing, Peoples R China.; Bao, YP; Lu, L (corresponding author), Peking Univ, Beijing Key Lab Drug Dependence, Beijing, Peoples R China.; Bao, YP (corresponding author), Peking Univ, Sch Publ Hlth, Beijing, Peoples R China.; Kosten, T (corresponding author), Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA.; Kosten, T (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.; Kosten, T (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Kosten, T (corresponding author), Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA.
EM kosten@bcm.edu; baoyp@bjmu.edu.cn; linlu@bjmu.edu.cn
RI Zheng, Yongbo/AFR-0439-2022; /I-7957-2013
OI /0000-0001-7343-3729
CR Akarsu B, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13891
   Ali I, 2020, HUM VACC IMMUNOTHER, V16, P2594, DOI 10.1080/21645515.2020.1787065
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Bell S, 2020, VACCINE, V38, P7789, DOI 10.1016/j.vaccine.2020.10.027
   Chou WYS, 2020, HEALTH COMMUN, V35, P1718, DOI 10.1080/10410236.2020.1838096
   de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0
   De Hert M, 2021, WORLD PSYCHIATRY, V20, P54, DOI 10.1002/wps.20826
   de las Heras-Pedrosa C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134859
   Di Gennaro F, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13030371
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   Dutheil F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178948
   Gonzalez-Melado FJ, 2021, ENFERM INFEC MICR CL, V39, P510, DOI [10.1016/j.eimc.2020.08.001, 10.1016/j.eimce.2021.09.001]
   Kaplan RM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021726118
   Khubchandani J, 2021, J COMMUN HEALTH, V46, P270, DOI 10.1007/s10900-020-00958-x
   Kim JH, 2019, KOREAN J ANESTHESIOL, V72, P558, DOI 10.4097/kja.19087
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Marco-Franco JE, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020744
   Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9
   Palgi Y, 2021, J AFFECT DISORDERS, V287, P352, DOI 10.1016/j.jad.2021.03.064
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8
   Sharon AJ, 2020, VACCINE, V38, P2691, DOI 10.1016/j.vaccine.2020.02.010
   Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053
   Shimabukuro T, 2021, MMWR-MORBID MORTAL W, V70, P125, DOI [10.15585/mmwr.mm7004e1externalicon, 10.1111/ajt.16517, 10.15585/mmwr.mm7004e1]
   Shimabukuro T, 2021, MMWR-MORBID MORTAL W, V70, P46, DOI 10.15585/mmwr.mm7002e1
   Soiza RL, 2021, AGE AGEING, V50, P279, DOI 10.1093/ageing/afaa274
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Wang JL, 2020, AAPS PHARMSCITECH, V21, DOI 10.1208/s12249-020-01744-7
   Wang YH, 2021, MOL PSYCHIATR, V26, P4813, DOI 10.1038/s41380-021-01019-y
   Wood S, 2021, JAMA-J AM MED ASSOC, V325, P2435, DOI 10.1001/jama.2021.7707
   World Health Organization (WHO), COVID 19 VACC
   Xia SL, 2021, LANCET INFECT DIS, V21, P39, DOI 10.1016/S1473-3099(20)30831-8
   Yigit M, 2021, HUM VACC IMMUNOTHER, V17, P2946, DOI 10.1080/21645515.2021.1918523
   Zheng YB, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.643988
NR 34
TC 0
Z9 0
U1 3
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-0640
J9 FRONT PSYCHIATRY
JI Front. Psychiatry
PD DEC 7
PY 2021
VL 12
AR 774504
DI 10.3389/fpsyt.2021.774504
PG 11
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA YJ8YV
UT WOS:000744814500001
PM 34950070
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Alomari, MA
   Khabour, OF
   Alzoubi, KH
AF Alomari, Mahmoud A.
   Khabour, Omar F.
   Alzoubi, Karem H.
TI Changes in Physical Activity and Sedentary Behavior Amid Confinement:
   The BKSQ-COVID-19 Project
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE physical activity; sedentary behavior; confinement; COVID-19; pandemic
ID COVID-19; EXERCISE
AB Background: Coronavirus disease 19 (COVID-19) has compelled implementing confinement measure across the globe. These measures can potentially lead to many changes in lifestyle. However, no studies examined the effect of COVID-19-induced confinement on physical activity (PA) and sedentary behavior (SB).
   Methods: During April and May of 2020, the current study surveyed changes in PA and SB induced by COVID-19 confinement.
   Results: The participants of the study were 1844. Among the participants who were regularly involved in PA, the majority (41.8-42.2%) of the participants reported a "decrease" (p<0.05) in walking, jogging, and sports while the majority (46.3-53.1%) reported a "no change" (p<0.05) in swimming, cycling, and weight lifting. With regard to the SB, most of the participants reported an "increase" in watching TV (72.3%), using electronics (82.7%), and logging to social media (81.9%). Additionally, gender, job type, obesity, and being worried to contract the disease were associated (p<0.05) with changes in PA. On the other hand, age, gender, obesity, job type and income were related (p<0.05) to changes in SB.
   Conclusion: Results of the current study might enhance knowledge about the impact of COVID-19 on lifestyle, particularly PA and SB. Subsequently, it can also be used to establish strategies to enhance engagement in activities during the current and future pandemics.
C1 [Alomari, Mahmoud A.] Qatar Univ, Dept Phys Educ, Doha, Qatar.
   [Khabour, Omar F.] Jordan Univ Sci & Technol, Dept Med Lab Sci, Irbid, Jordan.
   [Alzoubi, Karem H.] Jordan Univ Sci & Technol, Dept Clin Pharm, Irbid, Jordan.
RP Alomari, MA (corresponding author), Qatar Univ, Dept Phys Educ, Doha, Qatar.
EM malomari@qu.edu.qa
OI Alomari, Mahmoud/0000-0003-3605-5946
FU Qatar National Library; Deanship of Research at Jordan University of
   Science and Technology, Irbid, Jordan [245/2020]
FX Open Access funding provided by the Qatar National Library. The project
   was supported by the Deanship of Research at Jordan University of
   Science and Technology, Irbid, Jordan (Grant number: 245/2020).
CR Aleksovska K, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-018-0173-9
   Alomari MA, 2012, SCI WORLD J, P1, DOI 10.1100/2012/958752
   Ammar A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061583
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bai ZH, 2020, VIROL SIN, V35, P272, DOI 10.1007/s12250-020-00219-0
   Bhutani S, 2020, OBESITY SILVER SPRIN, DOI [10.1002/oby.22904, DOI 10.1002/0BY.22904]
   Brinkley-Rubinstein Lauren, 2019, N C Med J, V80, P359, DOI 10.18043/ncm.80.6.359
   Calton B, 2020, J PAIN SYMPTOM MANAG, V60, pE12, DOI 10.1016/j.jpainsymman.2020.03.019
   Carlin A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182083
   Carter SJ, 2020, OBESITY, V28, P1176, DOI 10.1002/oby.22838
   Chen PJ, 2020, J SPORT HEALTH SCI, V9, P103, DOI 10.1016/j.jshs.2020.02.001
   Condello G, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0510-2
   Cortis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182709
   Elfiky AA, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117592
   Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114
   Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb
   Hagan BO, 2018, J URBAN HEALTH, V95, P141, DOI 10.1007/s11524-017-0138-1
   Hodkinson PD, 2017, BRIT J ANAESTH, V119, pI143, DOI 10.1093/bja/aex336
   Jaeschke L, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0627-3
   Joynt GM, 2020, LANCET INFECT DIS, V20, P635, DOI 10.1016/S1473-3099(20)30237-1
   Jurak G, 2020, J SPORT HEALTH SCI, V9, P325, DOI 10.1016/j.jshs.2020.05.003
   Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921
   Luan JW, 2020, J MED VIROL, V92, P1649, DOI 10.1002/jmv.25817
   Martin SA, 2009, EXERC SPORT SCI REV, V37, P157, DOI 10.1097/JES.0b013e3181b7b57b
   Meyer J., 2020, CHANGES PHYS ACTIVIT
   MONTEIRO FC, 2020, PSYCHIAT RES, V284
   Narici M, 2021, EUR J SPORT SCI, V21, P614, DOI 10.1080/17461391.2020.1761076
   O'Donoghue G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190737
   Pagel JI, 2016, J APPL PHYSIOL, V120, P1449, DOI 10.1152/japplphysiol.00928.2015
   Pecanha T, 2020, AM J PHYSIOL-HEART C, V318, pH1441, DOI [10.1152/ajpheart.00268.2020, 10.1152/ajpheart.00268.2020.]
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Puggina A, 2018, EUR J PUBLIC HEALTH, V28, P105, DOI 10.1093/eurpub/ckx174
   Rahmati-Ahmadabad Saleh, 2020, Obes Med, V19, P100245, DOI 10.1016/j.obmed.2020.100245
   Romeo J, 2010, P NUTR SOC, V69, P390, DOI 10.1017/S0029665110001795
   Rossi R, 2020, COVID 19 PANDEMIC LO
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sarto F, 2020, SPORTS MED, V50, P1417, DOI 10.1007/s40279-020-01297-6
   Scarmozzino F, 2020, FOODS, V9, DOI 10.3390/foods9050675
   Schuch F, 2020, MODERATE VIGOROUS PH
   Smith L, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000850
   Stanton R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114065
   Stults-Kolehmainen MA, 2014, SPORTS MED, V44, P81, DOI 10.1007/s40279-013-0090-5
   Terama E, 2016, SUSTAIN SCI, V11, P945, DOI 10.1007/s11625-015-0350-4
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
   Zhou M, 2020, FRONT MED-PRC, V14, P126, DOI 10.1007/s11684-020-0767-8
NR 46
TC 38
Z9 38
U1 4
U2 14
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 1757
EP 1764
DI 10.2147/RMHP.S268320
PG 8
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA NU8JF
UT WOS:000573883400001
PM 33061709
OA Green Published
DA 2022-04-20
ER

PT J
AU Ferrer-Oliveras, R
   Mendoza, M
   Capote, S
   Pratcorona, L
   Esteve-Valverde, E
   Cabero-Roura, L
   Alijotas-Reig, J
AF Ferrer-Oliveras, Raquel
   Mendoza, Manel
   Capote, Sira
   Pratcorona, Laia
   Esteve-Valverde, Enrique
   Cabero-Roura, Lluis
   Alijotas-Reig, Jaume
TI Immunological and physiopathological approach of COVID-19 in pregnancy
SO ARCHIVES OF GYNECOLOGY AND OBSTETRICS
LA English
DT Review
DE COVID-19; Immune-mediated; SARS-CoV-2; Pregnancy outcome; Placental
   disease; Hyperinflammation; Obstetric disorder; Viral infection
ID REGULATORY T-CELLS; ACUTE RESPIRATORY SYNDROME; ANGIOTENSIN-CONVERTING
   ENZYME-2; NATRIURETIC PEPTIDE BNP; DISEASE 2019 COVID-19; COMPLEMENT
   ACTIVATION; ANGIOGENIC FACTORS; ALDOSTERONE SYSTEM; ANTIPHOSPHOLIPID
   SYNDROME; TROPHOBLAST INVASION
AB Coronavirus disease-2019 (COVID-19) related to Coronavirus-2 (SARS-CoV-2) is a worldwide health concern. Despite the majority of patients will evolve asymptomatic or mild-moderate upper respiratory tract infections, 20% will develop severe disease. Based on current pathogenetic knowledge, a severe COVID-19 form is mainly a hyperinflammatory, immune-mediated disorder, triggered by a viral infection. Due to their particular immunological features, pregnant women are supposed to be particularly susceptible to complicate by intracellular infections as well as immunological disturbances. As an example, immune-thrombosis has been identified as a common immune-mediated and pathogenic phenomenon both in COVID-19, in obstetric diseases and in COVID-19 pregnant women. According to extensive published clinical data, is rationale to expect an interference with the normal development of pregnancy in selected SARS-CoV-2-infected cases, mainly during third trimester. This manuscript provides insights of research to elucidate the potential harmful responses to SARS-CoV-2 and /or other coronavirus infections, as well as bidirectional interactions between COVID-19 and pregnancy to improve their respective management.
C1 [Ferrer-Oliveras, Raquel; Capote, Sira; Cabero-Roura, Lluis] Hosp Univ Quironsalud Barcelona, Dept Obstet & Gynaecol, Barcelona, Catalonia, Spain.
   [Mendoza, Manel] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Obstet, Maternal Fetal Med Unit, Barcelona, Catalonia, Spain.
   [Pratcorona, Laia] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Obstet, Barcelona, Catalonia, Spain.
   [Esteve-Valverde, Enrique] Althaia Network Hlth Manresa, Dept Internal Med, Barcelona, Spain.
   [Esteve-Valverde, Enrique] Univ Cent Catalunya, Barcelona, Catalonia, Spain.
   [Cabero-Roura, Lluis] Univ Autonoma Barcelona, Obster & Gynaecol, Barcelona, Catalonia, Spain.
   [Alijotas-Reig, Jaume] Vall dHebron Univ Hosp, Dept Internal Med 1, Syst Autoimmune Dis Unit, Barcelona, Spain.
   [Alijotas-Reig, Jaume] Vall dHebron Reseacrh Inst, Syst Autoimmune Res Unit, Barcelona, Spain.
   [Alijotas-Reig, Jaume] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.
RP Ferrer-Oliveras, R (corresponding author), Hosp Univ Quironsalud Barcelona, Dept Obstet & Gynaecol, Barcelona, Catalonia, Spain.; Alijotas-Reig, J (corresponding author), Vall dHebron Univ Hosp, Dept Internal Med 1, Syst Autoimmune Dis Unit, Barcelona, Spain.; Alijotas-Reig, J (corresponding author), Vall dHebron Reseacrh Inst, Syst Autoimmune Res Unit, Barcelona, Spain.; Alijotas-Reig, J (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.
EM raquelfo22@hotmail.com; jalijotas@vhebron.net
RI Mendoza, Manel/AAG-1445-2020; Alijotas-Reig, Jaume/H-9262-2016
OI Mendoza, Manel/0000-0002-3030-3833; Alijotas-Reig,
   Jaume/0000-0002-9212-3619; Pratcorona, Laia/0000-0002-3805-1589
FU ONAGRUP (Barcelona, Spain)
FX The authors stated that ONAGRUP (Barcelona, Spain) is supporting the
   research work of Systemic Autoimmune Research Unit of Vall d'Hebron
   Research Institute.
CR Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8
   Abdel-Wahab N, 2018, LUPUS, V27, P572, DOI 10.1177/0961203317731532
   Abdi-Shayan S, 2016, IRAN J ALLERGY ASTHM, V15, P303
   Aghaeepour N, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan2946
   Agostinis C, 2010, J IMMUNOL, V185, P4420, DOI 10.4049/jimmunol.0903215
   Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663
   Ahmed I, 2020, BRIT J HAEMATOL, V190, pE37, DOI 10.1111/bjh.16849
   Ahmed S, 2020, CLIN RHEUMATOL, V39, P2529, DOI 10.1007/s10067-020-05275-1
   Akhtar H, 2020, GYNECOL OBSTET INVES, V85, P295, DOI 10.1159/000509290
   Al-Azemi M, 2017, CLIN EXP OBSTET GYN, V44, P98, DOI 10.12891/ceog3295.2017
   Al-Samkari H, 2018, ANNU REV PATHOL-MECH, V13, P27, DOI 10.1146/annurev-pathol-020117-043625
   Algarroba GN, 2020, AM J OBSTET GYNECOL, V223, P275, DOI 10.1016/j.ajog.2020.05.023
   Alijotas-Reig J, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102569
   Alijotas-Reig J, 2019, AUTOIMMUN REV, V18, P406, DOI 10.1016/j.autrev.2018.12.006
   Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320
   Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037
   Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678
   Amer Coll Obstet Gynecol, 2002, INT J GYNECOL OBSTET, V77, P67
   Andrikopoulou M, 2020, OBSTET GYNECOL, V136, P291, DOI 10.1097/AOG.0000000000003996
   Asherson RA, 2001, MEDICINE, V80, P355, DOI 10.1097/00005792-200111000-00002
   Atkinson B, 2020, LANCET, V395, P1339, DOI 10.1016/S0140-6736(20)30868-0
   AUGUST P, 1990, AM J OBSTET GYNECOL, V163, P1612, DOI 10.1016/0002-9378(90)90639-O
   Banadakoppa M, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.13033
   Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233
   Bell MJ, 2002, J NEUROSCI RES, V70, P570, DOI 10.1002/jnr.10423
   Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE
   BENEDETTI TJ, 1982, AM J OBSTET GYNECOL, V144, P413, DOI 10.1016/0002-9378(82)90246-0
   BERKOWITZ K, 1990, AM J OBSTET GYNECOL, V163, P981, DOI 10.1016/0002-9378(90)91109-P
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100118
   Brosnihan KB, 2004, BRAZ J MED BIOL RES, V37, P1255, DOI 10.1590/S0100-879X2004000800017
   Brosnihan KB, 1996, HYPERTENSION, V27, P523, DOI 10.1161/01.HYP.27.3.523
   Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004
   Bulla R, 2009, J REPROD IMMUNOL, V82, P119, DOI 10.1016/j.jri.2009.06.124
   Burwick RM, 2013, PLACENTA, V34, P201, DOI 10.1016/j.placenta.2012.11.014
   Buurma A, 2012, HYPERTENSION, V60, P1332, DOI 10.1161/HYPERTENSIONAHA.112.194324
   Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235
   CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019
   Campbell N, 2018, CURR PHARM BIOTECHNO, V19, P781, DOI 10.2174/1389201019666180925121254
   Cavazzana I, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0718-4
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009226
   Chen P, 2020, J HEPATOL, V73, P712, DOI 10.1016/j.jhep.2020.04.028
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   CHEN YF, 1992, HYPERTENSION, V19, P456, DOI 10.1161/01.HYP.19.5.456
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315
   Alzamora MC, 2020, AM J PERINAT, V37, P861, DOI 10.1055/s-0040-1710050
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E
   Crovetto F, 2021, CLIN INFECT DIS, V73, P1768, DOI 10.1093/cid/ciab104
   D'Souza R, 2020, ACTA OBSTET GYN SCAN, V99, P1110, DOI 10.1111/aogs.13962
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   Davies JK, 2000, AM J OBSTET GYNECOL, V183, P1088, DOI 10.1067/mob.2000.108888
   Deniz M, 2020, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2020.1793322
   Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   Di Toro F, 2021, CLIN MICROBIOL INFEC, V27, P36, DOI 10.1016/j.cmi.2020.10.007
   Dietl A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164060
   Dreier JW, 2016, J CHILD PSYCHOL PSYC, V57, P540, DOI 10.1111/jcpp.12480
   Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139
   Esteve-Valverde E, 2016, REV CLIN ESP, V216, P135, DOI 10.1016/j.rce.2015.09.003
   Ferrario CM, 1997, HYPERTENSION, V30, P535, DOI 10.1161/01.HYP.30.3.535
   Fu YJ, 2020, VIROL SIN, V35, P266, DOI 10.1007/s12250-020-00207-4
   Gao L, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01352-w
   Gennari-Moser C, 2013, HYPERTENSION, V61, P1111, DOI 10.1161/HYPERTENSIONAHA.111.00575
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Girardi G, 2006, MOL IMMUNOL, V43, P68, DOI 10.1016/j.molimm.2005.06.017
   Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817
   Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022
   Girardi G, 2018, SEMIN IMMUNOPATHOL, V40, P103, DOI 10.1007/s00281-017-0645-x
   Gonzalez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026877
   Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024
   Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6
   Gottfredsson M, 2008, LAEKNABLADID, V94, P737
   Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18
   Greer IA, 1999, LANCET, V353, P1258, DOI 10.1016/S0140-6736(98)10265-9
   Guerin LR, 2009, HUM REPROD UPDATE, V15, P517, DOI 10.1093/humupd/dmp004
   Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Gustavsen A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006338
   Hantoushzadeh S, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.030
   Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x
   Herraiz I, 2018, FETAL DIAGN THER, V43, P81, DOI 10.1159/000477903
   Hessami K, 2020, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2020.1806817
   Hofmann H, 2004, BIOCHEM BIOPH RES CO, V319, P1216, DOI 10.1016/j.bbrc.2004.05.114
   HOLMES CH, 1990, J IMMUNOL, V144, P3099
   HSI BL, 1991, J REPROD IMMUNOL, V19, P209, DOI 10.1016/0165-0378(91)90036-P
   Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang YH, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101606
   Hui DS, 2017, CLIN CHEST MED, V38, P71, DOI 10.1016/j.ccm.2016.11.007
   Hui DSC, 2019, INFECT DIS CLIN N AM, V33, P869, DOI 10.1016/j.idc.2019.07.001
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Jewell C.P., 2020, NOVEL CORONAVIRUS 20, DOI 10.1101/2020.01.23.20018549
   Jiang YT, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0063-8
   Juan J, 2020, ULTRASOUND OBST GYN, V56, P15, DOI 10.1002/uog.22088
   Junus K, 2014, AM J HYPERTENS, V27, P1225, DOI 10.1093/ajh/hpu033
   Kadir RA, 2020, J THROMB HAEMOST, V18, P3086, DOI 10.1111/jth.15072
   Kalagiri RR, 2016, AM J PERINAT, V33, P1337, DOI 10.1055/s-0036-1582397
   Kello N, 2019, SEMIN ARTHRITIS RHEU, V49, P74, DOI 10.1016/j.semarthrit.2018.11.005
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040
   Kim EN, 2015, VIRCHOWS ARCH, V466, P717, DOI 10.1007/s00428-015-1759-y
   Kim MY, 2018, ANN RHEUM DIS, V77, P549, DOI 10.1136/annrheumdis-2017-212224
   Kotlyar AM, 2021, AM J OBSTET GYNECOL, V224, P35, DOI 10.1016/j.ajog.2020.07.049
   Koumoutsea EV, 2020, J THROMB HAEMOST, V18, P1648, DOI 10.1111/jth.14856
   Kreutz R, 2020, CARDIOVASC RES, V116, P1688, DOI 10.1093/cvr/cvaa097
   Kumari M, 2019, CLIN BIOCHEM, V67, P12, DOI 10.1016/j.clinbiochem.2019.03.005
   Kumpel BM, 2012, VOX SANG, V102, P2, DOI 10.1111/j.1423-0410.2011.01533.x
   Lam CM, 2004, BJOG-INT J OBSTET GY, V111, P771, DOI 10.1111/j.1471-0528.2004.00199.x
   Larsen SB, 2018, PREGNANCY HYPERTENS, V14, P189, DOI 10.1016/j.preghy.2018.10.002
   Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884
   Li MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230295
   Li P, 1997, AM J HYPERTENS, V10, P662, DOI 10.1016/S0895-7061(97)00039-3
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li XC, 2017, PHARMACOL RES, V125, P21, DOI 10.1016/j.phrs.2017.06.005
   Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Liu H, 2020, J REPROD IMMUNOL, V139, DOI 10.1016/j.jri.2020.103122
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549
   Llurba E, 2015, FETAL DIAGN THER, V37, P81, DOI 10.1159/000368605
   Lokken EM, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.05.031
   Lokki AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117840
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Lumbers ER, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00563
   Lumbers ER, 2014, AM J PHYSIOL-REG I, V306, pR91, DOI 10.1152/ajpregu.00034.2013
   Luo YW, 2020, LANCET INFECT DIS, V20, P513, DOI 10.1016/S1473-3099(20)30191-2
   Ma LX, 2020, ANN DIAGN PATHOL
   MADINGER NE, 1989, AM J OBSTET GYNECOL, V161, P657, DOI 10.1016/0002-9378(89)90373-6
   Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x
   Mao DL, 2003, IMMUNITY, V19, P813, DOI 10.1016/S1074-7613(03)00321-2
   Martinelli I, 2020, THROMB RES, V191, P36, DOI 10.1016/j.thromres.2020.04.022
   Martinez-Portilla R., 2020, OBSTET GYNECOL, V56, P257
   MATTHIESEN L, 1995, AM J REPROD IMMUNOL, V33, P31, DOI 10.1111/j.1600-0897.1995.tb01135.x
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mei H, 2020, Zhonghua Xue Ye Xue Za Zhi, V41, P185, DOI 10.3760/cma.j.issn.0253-2727.2020.0002
   Mendoza M, 2020, BJOG-INT J OBSTET GY, V127, P1374, DOI 10.1111/1471-0528.16339
   Meroni PL, 2018, NAT REV RHEUMATOL, V14, P433, DOI 10.1038/s41584-018-0032-6
   Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011
   Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107
   Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64
   Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x
   MORGAN BP, 1994, SPRINGER SEMIN IMMUN, V15, P369, DOI 10.1007/BF01837366
   Mullins E, 2012, AM J REPROD IMMUNOL, V68, P1, DOI 10.1111/j.1600-0897.2012.01132.x
   Mulvey JJ, 2020, ANN DIAGN PATHOL, V46, DOI 10.1016/j.anndiagpath.2020.151530
   Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191
   Muyayalo KP, 2020, AM J REPROD IMMUNOL, V84, DOI 10.1111/aji.13304
   Nauta AJ, 2004, INT ARCH ALLERGY IMM, V134, P310, DOI 10.1159/000079261
   Ng WF, 2006, PATHOLOGY, V38, P210, DOI 10.1080/00313020600696280
   Oelkers WKH, 1996, STEROIDS, V61, P166, DOI 10.1016/0039-128X(96)00007-4
   Othman M, 2019, RES PRACT THROMB HAE, V3, P607, DOI 10.1002/rth2.12243
   Pedroni SMA, 2014, BBA-MOL BASIS DIS, V1842, P107, DOI 10.1016/j.bbadis.2013.10.011
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Penfield CA, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100133
   Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Petitbarat M, 2015, J IMMUNOL, V195, P5602, DOI 10.4049/jimmunol.1501361
   Phipps E, 2016, CLIN J AM SOC NEPHRO, V11, P1102, DOI 10.2215/CJN.12081115
   Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Prompetchara E, 2020, ASIAN PAC J ALLERGY, V38, P1, DOI 10.12932/AP-200220-0772
   Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x
   Racicot K, 2017, J CLIN INVEST, V127, P1591, DOI 10.1172/JCI87490
   Raina R, 2019, THER APHER DIAL, V23, P4, DOI 10.1111/1744-9987.12763
   Rajewska A, 2020, J PERINAT MED, V48, P428, DOI 10.1515/jpm-2020-0132
   Rathbone R, 2011, NEUROLOGY, V77, P1510, DOI 10.1212/WNL.0b013e318233b215
   Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089
   REED SE, 1984, J MED VIROL, V13, P179, DOI 10.1002/jmv.1890130208
   Resnik JL, 2005, AM J OBSTET GYNECOL, V193, P450, DOI 10.1016/j.ajog.2004.12.006
   Ribeiro VR, 2017, IMMUNOLOGY, V152, P163, DOI 10.1111/imm.12757
   Risitano AM, 2020, NAT REV IMMUNOL, V20, P343, DOI 10.1038/s41577-020-0320-7
   RISK JM, 1991, HUM IMMUNOL, V30, P162, DOI 10.1016/0198-8859(91)90030-D
   Lorente ARM, 2020, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2020.1811669
   Saccone G, 2021, ULTRASOUND OBST GYN, V57, P232, DOI 10.1002/uog.23107
   Salmon Jane E, 2007, Trans Am Clin Climatol Assoc, V118, P99
   Salmon JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001013
   Schumacher A, 2009, J IMMUNOL, V182, P5488, DOI 10.4049/jimmunol.0803177
   Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194
   Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089
   Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19
   Shoenfeld Y, 2006, ANN RHEUM DIS, V65, P2, DOI 10.1136/ard.2005.045443
   Shoenfeld Y, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102538
   Sibai BM, 2009, SEMIN PERINATOL, V33, P196, DOI 10.1053/j.semperi.2009.02.004
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Soto E, 2010, J MATERN-FETAL NEO M, V23, P646, DOI 10.3109/14767050903301009
   Santos RAS, 2018, PHYSIOL REV, V98, P505, DOI 10.1152/physrev.00023.2016
   Tabacco S, 2019, LUPUS, V28, P1503, DOI 10.1177/0961203319882507
   Takemoto MLS, 2020, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2020.1786056
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036
   Tetro JA, 2020, MICROBES INFECT, V22, P72, DOI 10.1016/j.micinf.2020.02.006
   TICHENOR JR, 1995, GYNECOL OBSTET INVES, V39, P79, DOI 10.1159/000292384
   Tihtonen KM, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.033
   Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737
   Tincani A, 2010, CLIN REV ALLERG IMMU, V39, P153, DOI 10.1007/s12016-009-8183-5
   Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317
   Uthman IW, 2002, SEMIN ARTHRITIS RHEU, V31, P256, DOI 10.1053/sarh.2002.28303
   Verlohren S, 2017, HYPERTENSION, V69, P1192, DOI [10.1161/HYPERTENSIONAHA.117.09256, 10.1161/hypertensionaha.117.09256]
   Viall CA, 2015, AUTOIMMUN REV, V14, P446, DOI 10.1016/j.autrev.2015.01.008
   VISSCHER HC, 1971, AM J OBSTET GYNECOL, V109, P1187, DOI 10.1016/0002-9378(71)90664-8
   Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008
   Wang CL, 2021, INT J MED SCI, V18, P763, DOI 10.7150/ijms.49923
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang RX, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.28
   Weber M, 2006, HEART, V92, P843, DOI 10.1136/hrt.2005.071233
   WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D
   WHO,, 2020, REP WHO CHIN JOINT
   Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Xia Y, 2013, CIRC RES, V113, P78, DOI 10.1161/CIRCRESAHA.113.300752
   Xie XD, 2006, LIFE SCI, V78, P2166, DOI 10.1016/j.lfs.2005.09.038
   Yan J, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.014
   Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926
   Yang MP, 2020, CELLULOSE, V27, P2847, DOI 10.1007/s10570-019-02963-3
   Yang ZY, 2020, AM J PERINAT, V37, P1055, DOI 10.1055/s-0040-1712161
   Yang ZY, 2005, P NATL ACAD SCI USA, V102, P797, DOI 10.1073/pnas.0409065102
   Yu N, 2020, LANCET INFECT DIS, V20, P1364, DOI 10.1016/S1473-3099(20)30320-0
   Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zheng L, 2019, BLOOD, V134, P1095, DOI 10.1182/blood.2019001040
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 225
TC 4
Z9 4
U1 3
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0932-0067
EI 1432-0711
J9 ARCH GYNECOL OBSTET
JI Arch. Gynecol. Obstet.
PD JUL
PY 2021
VL 304
IS 1
BP 39
EP 57
DI 10.1007/s00404-021-06061-3
EA MAY 2021
PG 19
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA SK1GV
UT WOS:000647097600001
PM 33945026
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Bresadola, V
   Biddau, C
   Puggioni, A
   Tel, A
   Robiony, M
   Hodgkinson, J
   Leo, CA
AF Bresadola, Vittorio
   Biddau, Carlo
   Puggioni, Alessandro
   Tel, Alessandro
   Robiony, Massimo
   Hodgkinson, Jonathan
   Leo, Cosimo Alex
TI General surgery and COVID-19: review of practical recommendations in the
   first pandemic phase
SO SURGERY TODAY
LA English
DT Review
DE SARS-CoV-2; COVID-19; Surgery; Management; Recommendations
AB Background In March, 2020, the World Health Organization declared COVID-19 a pandemic. The absence of previous knowledge of COVID-19 has made decision-making difficult for all in health care, including surgical departments. We reviewed the management recommendations for surgical activity and changes to surgical practice, identifying concordances and discrepancies, based on the literature published in the early phase of the pandemic. Method We searched the electronic datasets, PubMed Database, Google, and Google Scholar, using the keywords "SARS-CoV-2", "COVID-19", "surgery", "recommendations", "guideline", and "triage". The search was limited to the first 2 months after the pandemic began and was closed on May 6, 2020. Results Twenty papers were included in the analysis and their recommendations are divided into the following categories: 1. general aspects, such as maintaining the safety of health personnel and indications for surgery. 2. The preoperative phase, with recommendations about activating different care pathways for COVID-19 positive patients. 3. The operative phase, with recommendations about activating safety measures for aerosol-generating procedures. 4. The postoperative phase, with recommendations for managing operating theatres and patient transfers. Conclusion The recommendations proposed in the revised documents are considered good practices aimed at keeping patients and healthcare professionals safe. However, these recommendations must be contextualized in each individual hospital.
C1 [Bresadola, Vittorio; Biddau, Carlo; Puggioni, Alessandro] Univ Udine, Acad Hosp Udine, Gen Surg Dept, Dept Med, Udine, Italy.
   [Bresadola, Vittorio; Biddau, Carlo; Puggioni, Alessandro] Univ Udine, Acad Hosp Udine, Simulat Ctr, Dept Med, Udine, Italy.
   [Tel, Alessandro; Robiony, Massimo] Univ Udine, Acad Hosp Udine, Maxillofacial Surg Dept, Dept Med, Udine, Italy.
   [Leo, Cosimo Alex] London North West Univ Healthcare NHS Trust, Northwick Pk & St Marks Hosp, Dept Gen & Emergency Surg, Harrow, Middx, England.
   [Hodgkinson, Jonathan; Leo, Cosimo Alex] Imperial Coll London, Dept Surg & Canc, London, England.
RP Bresadola, V (corresponding author), Univ Udine, Acad Hosp Udine, Gen Surg Dept, Dept Med, Udine, Italy.; Bresadola, V (corresponding author), Univ Udine, Acad Hosp Udine, Simulat Ctr, Dept Med, Udine, Italy.
EM vittorio.bresadola@uniud.it
RI Tel, Alessandro/AAI-3577-2021
OI Tel, Alessandro/0000-0001-8395-5272; ROBIONY,
   Massimo/0000-0003-2178-5022; Biddau, Carlo/0000-0002-1225-2921; Leo,
   Cosimo Alex/0000-0001-5759-0345; BRESADOLA, Vittorio/0000-0002-0098-3540
FU Universita degli Studi di Udine within the CRUI-CARE Agreement
FX Open access funding provided by Universita degli Studi di Udine within
   the CRUI-CARE Agreement. We thank the health workers who have been
   fighting this invisible enemy since the beginning of the pandemic.
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Al-Balas M, 2020, AM J SURG, V219, P903, DOI 10.1016/j.amjsurg.2020.04.018
   Alipour S, 2020, ARCH BREAST CANC, V7, P1, DOI [10.19187/abc.2020711-3, DOI 10.19187/ABC.2020711-3]
   American College Of Surgeons (ACS), COVID 19 CONS OPT SU
   [Anonymous], MAN MET PROD LIN GUI
   Associazione Chirurghi Ospedalieri Italiani (ACOI), INT GEN SURG GUID CO
   Associazione Italiana Infermieri di Camera Operatoria (AICO), PRASS PER PIEN ER CO
   Brindle ME, 2020, ANN SURG, V272, pE1, DOI 10.1097/SLA.0000000000003923
   Brucher BLDM, 2020, 4OPEN, V3, DOI [10.1051/fopen/2020002, DOI 10.1051/FOPEN/2020002]
   Coccolini F, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00307-2
   European Society of Surgical Oncology (ESSO), STAT COV 19 ADV SURG
   Istituto superiore di Sanita, FOC INF NUOV COR SAR
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu Z, 2020, INDIAN J SURG, V82, P124, DOI 10.1007/s12262-020-02173-3
   ?olak T., 2020, TURK J COLORECTAL DI, V30, P1, DOI [DOI 10.4274/TJCD.GALENOS.2020.2020-3-7, 10.4274/tjcd.galenos.2020.2020-3-7]
   Royal College of Surgeons (RCS), 2020, UPD INT GEN SURG GUI
   SICE, GUID TEM CHIR DUR PA
   Societa Italiana Chirurgia Oncologica (SICO), COVID 19 WORK GROUP
   Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), 2020, NOT BATTL
   Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61
   The Association of Coloproctology of Great Britain and Ireland (ACPGBI), CONS MULT MAN PAT CO
   Ti LK, 2020, CAN J ANESTH, V67, P756, DOI 10.1007/s12630-020-01617-4
   Tuech JJ, 2020, J VISC SURG, V157, pS7, DOI 10.1016/j.jviscsurg.2020.03.008
   WCHC, WUH MUN HLTH HLTH CO
   World Health Organization, DIR GEN REM MED BEEI
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Zhao ZM, 2020, BIOSCI TRENDS, V14, P227, DOI 10.5582/bst.2020.03098
   Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 29
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0941-1291
EI 1436-2813
J9 SURG TODAY
JI Surg. Today
PD OCT
PY 2020
VL 50
IS 10
BP 1159
EP 1167
DI 10.1007/s00595-020-02086-4
EA JUL 2020
PG 9
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA NQ3EZ
UT WOS:000552930500002
PM 32720009
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Ngandu, NK
   Mmotsa, TM
   Dassaye, R
   Thabetha, A
   Odendaal, W
   Langdown, N
   Ndwandwe, D
AF Ngandu, Nobubelo K.
   Mmotsa, Tshiamo M.
   Dassaye, Reshmi
   Thabetha, Alice
   Odendaal, Willem
   Langdown, Natasha
   Ndwandwe, Duduzile
TI Hospital acquired COVID-19 infections amongst patients before the
   rollout of COVID-19 vaccinations, a scoping review
SO BMC INFECTIOUS DISEASES
LA English
DT Review
DE COVID-19; Hospital acquired infections; Patients; Public healthcare
ID NOSOCOMIAL INFECTION; CANCER SURGERY; 1ST WAVE; SARS-COV-2; OUTBREAK;
   SURVEILLANCE; TRANSMISSION; BUNDLE; COHORT; ADULTS
AB Background Hospital settings are at increased risk of spreading Coronavirus Disease 2019 (COVID-19) infections, hence non-pharmaceutical prevention interventions (NPPIs) and prioritized vaccination of healthcare workers and resident patients are critical. The status of COVID-19 hospital acquired infections (HAIs) in low-income settings is unclear. We aimed to identify and summarize the existing evidence on COVID-19 HAIs amongst patients, prior to the rollout of vaccines in countries worldwide. Methods We conducted a scoping review of English peer-reviewed literature in PubMed, Web of Science and Scopus using a combination of selected search terms. Full texts articles presenting results on COVID-19 HAIs in hospitalised patients before the rollout of vaccines in countries worldwide were eligible. Data extracted from eligible articles included estimates of COVID-19 HAIs, country, and type of hospital setting, and was summarized narratively. Quality assessment of included articles was not possible. Results Literature searches generated a total of 5920 articles, and 45 were eligible for analysis. Eligible articles were from Europe, North America, Asia, and Brazil and none were from low-income countries. The proportion of COVID-19 HAIs ranged from 0% when strict NPPIs were applied, to 65% otherwise. The estimates of COVID-19 HAIs did not differ by country but were lower in studies conducted after implementation of NPPIs and in specialized hospital settings for operative surgery. Studies conducted before the implementation of NPPIs or in long-term care and psychiatric wards often reported high estimates of HAI. Although there was no clear trend in general wards, those situated in academic hospitals managed to reduce HAI rates under strict NPPI protocols. Operative surgery settings, unlike psychiatric settings, effectively prevented COVID-19 HAI using tailored NPPIs. Conclusion The available evidence shows a high risk of COVID-19 HAIs, the feasibility of preventing HAIs in different healthcare settings and the importance of appropriately tailored NPPIs. There were no data from low-income settings, therefore, it is unclear whether the reported NPPI approaches could be equally effective elsewhere. We recommend routine monitoring of COVID-19 HAIs in countries with low vaccination coverage, to identify and close gaps in NPPIs and understand gains made from vaccinating healthcare workers and hospitalized patients.
C1 [Ngandu, Nobubelo K.; Mmotsa, Tshiamo M.; Dassaye, Reshmi; Odendaal, Willem] South African Med Res Council, HIV Prevent Res Unit, Cape Town, South Africa.
   [Thabetha, Alice] Univ Cape Town, Fac Hlth Sci, Cape Town, South Africa.
   [Odendaal, Willem] Stellenbosch Univ, Dept Psychiat, Cape Town, South Africa.
   [Langdown, Natasha] South African Med Res Council, Knowledge & Informat Management Serv, Cape Town, South Africa.
   [Ndwandwe, Duduzile] South African Med Res Council, Cochrane, Cape Town, South Africa.
RP Ngandu, NK (corresponding author), South African Med Res Council, HIV Prevent Res Unit, Cape Town, South Africa.
EM Nobubelo.Ngandu@mrc.ac.za
RI Ndwandwe, Duduzile/L-2296-2013
OI Ndwandwe, Duduzile/0000-0001-7129-3865
FU South African Medical Research CouncilSouth African Medical Research
   CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)
FX NKN was supported by the South African Medical Research Council.
CR Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974
   Ajayi Bisola, 2020, Bone Jt Open, V1, P330, DOI 10.1302/2633-1462.17.BJO-2020-0068.R1
   Al Lawati Adil, 2021, Oman Med J, V36, pe236, DOI 10.5001/omj.2021.110
   Alemu AY, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00263-2
   Ambrosch A, 2020, J INFECT PUBLIC HEAL, V13, P1862, DOI 10.1016/j.jiph.2020.10.005
   [Anonymous], 2020, **NON-TRADITIONAL**
   Axiotakis LG, 2021, ANN SURG, V273, P41, DOI 10.1097/SLA.0000000000004586
   Barranco R, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9091163
   Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891
   Bestilleiro RS, 2021, INT J MED SCI, V18, P2146, DOI 10.7150/ijms.53270
   Bhogal T, LEUKEMIA LYMPHOMA
   Biswas N, 2021, J COMMUN HEALTH, V46, P1244, DOI 10.1007/s10900-021-00984-3
   Carter B, 2020, J HOSP INFECT, V106, P376, DOI 10.1016/j.jhin.2020.07.013
   Cele Sandile, 2021, medRxiv, DOI 10.1101/2021.12.08.21267417
   Choi HS, 2017, AM J INFECT CONTROL, V45, pE45, DOI 10.1016/j.ajic.2017.01.009
   Cochrane, 2017, EFFECTIVE PRACTICE O
   Deplanque D, 2021, THERAPIE, V76, P277, DOI 10.1016/j.therap.2021.05.004
   Doria-Rose N, 2021, NEW ENGL J MED, V384, P2259, DOI 10.1056/NEJMc2103916
   El Guerche-Seblain C, 2021, AM J INFECT CONTROL, V49, P1066, DOI 10.1016/j.ajic.2020.12.003
   Embi PJ, 2021, MMWR-MORBID MORTAL W, V70, P1553, DOI 10.15585/mmwr.mm7044e3
   Gaudart J, 2021, LANCET PUBLIC HEALTH, V6, pE222, DOI 10.1016/S2468-2667(21)00006-2
   Goldberg SA, 2020, J AM MED DIR ASSOC, V21, P980, DOI 10.1016/j.jamda.2020.05.040
   Horing Steffen, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00597-2
   Inweregbu K, 2005, BJA EDUC, V5, P14, DOI 10.1093/bjaceaccp/mki006
   Jackson Rod, 2006, Evid Based Med, V11, P35, DOI 10.1136/ebm.11.2.35
   Jeannon JP, 2021, J LARYNGOL OTOL, V135, P168, DOI 10.1017/S0022215121000426
   Jewkes SV, 2020, CLIN MED, V20, pE173, DOI 10.7861/clinmed.2020-0422
   Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6
   Katikireddi SV, 2022, LANCET, V399, P25, DOI 10.1016/S0140-6736(21)02754-9
   Khonyongwa K, 2020, J HOSP INFECT, V106, P663, DOI 10.1016/j.jhin.2020.10.006
   Lakhani K, 2020, INT ORTHOP, V44, P2505, DOI 10.1007/s00264-020-04798-1
   Lessells R.J., 2020, REPORT NOSOCOMIAL OU
   Li Y, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025142
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Long DR, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa435
   Luong-Nguyen M, 2020, J VISC SURG, V157, pS13, DOI [10.1016/j.jviscsurg.2020.04.016, 10.1016/j.jchirv.2020.04.012]
   Macchia A, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.30800
   Mazzoleni Lionel, 2020, Can J Kidney Health Dis, V7, p2054358120944298, DOI 10.1177/2054358120944298
   Meena MK, 2020, J FAM COMMUNITY MED, V27, P212, DOI 10.4103/jfcm.JFCM_285_20
   Mettias B, 2021, LARYNGOSCOPE, V131, pE2749, DOI 10.1002/lary.29667
   Moore G, 2020, J HOSP INFECT, V108, P189, DOI 10.1016/j.jhin.2020.11.024
   Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
   Page MJ, 2021, INT J SURG, V88, DOI 10.1016/j.ijsu.2021.105906
   Read JM, 2021, LANCET, V398, P1037, DOI 10.1016/S0140-6736(21)01786-4
   Rhee C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20498
   Rodrigues CMC, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01526
   Romao VC, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.576162
   Romics L, 2021, BREAST, V55, P1, DOI 10.1016/j.breast.2020.11.015
   Sahoo Sushanta K, 2020, Neurosurg Focus, V49, pE7, DOI 10.3171/2020.9.FOCUS20705
   Sahu AK, 2020, AM J EMERG MED, V38, P1727, DOI 10.1016/j.ajem.2020.05.113
   Sobrado LF, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e2507
   Tabourin T, 2021, UROL ONCOL-SEMIN ORI, V39, DOI 10.1016/j.urolonc.2020.09.008
   Thompson JW, 2020, PSYCHIAT SERV, V71, P1285, DOI 10.1176/appi.ps.202000270
   Thompson MG, 2021, NEW ENGL J MED, V385, P1355, DOI 10.1056/NEJMoa2110362
   Torres I, 2021, LANCET, V397, P1804, DOI 10.1016/S0140-6736(21)00893-X
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850
   Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421
   Wee LEI, 2020, AM J INFECT CONTROL, V48, P1056, DOI 10.1016/j.ajic.2020.06.188
   Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8
   Wu SJ, 2020, AM J INFECT CONTROL, V48, P910, DOI 10.1016/j.ajic.2020.05.003
   Yan ZP, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14050406
   Yau K, 2020, AM J KIDNEY DIS, V76, P690, DOI 10.1053/j.ajkd.2020.07.001
   Ye G., 2020, J INFECTION, V81, pe1, DOI [10.1016/j.jinf.2020.04.034, DOI 10.1016/j.jinf.2020.04.034]
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
NR 64
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 10
PY 2022
VL 22
IS 1
AR 140
DI 10.1186/s12879-022-07128-5
PG 12
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA YX1KZ
UT WOS:000753868300005
PM 35144556
OA Green Published, gold
DA 2022-04-20
ER

PT C
AU Jacques, S
   Ouahabi, A
   Lequeu, T
AF Jacques, Sebastien
   Ouahabi, Abdeldjalil
   Lequeu, Thierry
BE Klinger, T
   Kollmitzer, C
   Pester, A
TI Synchronous E-learning in Higher Education during the COVID-19 Pandemic
SO PROCEEDINGS OF THE 2021 IEEE GLOBAL ENGINEERING EDUCATION CONFERENCE
   (EDUCON)
SE IEEE Global Engineering Education Conference
LA English
DT Proceedings Paper
CT IEEE Global Engineering Education Conference (IEEE EDUCON)
CY APR 21-23, 2021
CL Vienna, AUSTRIA
SP IEEE
DE COVID-19; synchronous e-learning; remote knowledge acquisition and
   assessment
AB Since the beginning of the COVID-19 pandemic, students around the world have seen their schooling completely disrupted. Their teachers had to reorganize in a hurry to be able to give their classes synchronously but at a distance. Thanks to strong political incentives, both at the national and university levels, many tools have been massively deployed: digital learning management systems (e.g. Moodle), collaborative digital platforms (e.g. Google Meets, Microsoft Teams and Zoom), social networks (e.g. Facebook and Twitter) and even the telephone. While the COVID-19 pandemic has highlighted the essential role of digital technologies in higher education, major issues arise regarding the quality of distance education, the learning process itself and the assessment of knowledge and skills. In this study, 81 engineering students in France were followed during several periods of containment in order to provide some answers to these questions. The results of the various knowledge tests carried out at a distance show that the students obtained local scores similar to those expected from face-to-face teaching. According to the results of the satisfaction surveys, for 91.4% of students who had sufficient hardware and software resources, the synchronous approach to e-learning presented few barriers. For the 8.6% of students affected by the digital divide, telephone communications and social networks played a major role in the learning process.
C1 [Jacques, Sebastien] Univ Tours, INSA Ctr Val de Loire, CNRS, Polytech Tours,GREMAN UMR 7347, Tours, France.
   [Ouahabi, Abdeldjalil] Univ Tours, Imaging & Brain, Polytech Tours, INSERM U930, Tours, France.
   [Lequeu, Thierry] Univ Tours, Tours, France.
RP Jacques, S (corresponding author), Univ Tours, INSA Ctr Val de Loire, CNRS, Polytech Tours,GREMAN UMR 7347, Tours, France.
EM sebastien.jacques@univ-tours.fr; ouahabi@univ-tours.fr;
   thierry.lequeu@univ-tours.fr
CR Adascalitei A, 2019, 2019 INTERNATIONAL CONFERENCE ON ELECTROMECHANICAL AND ENERGY SYSTEMS (SIELMEN)
   Adjabi I, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21030728
   Adjabi I, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9081188
   Anel J. A, 2020, CLOUD SERVERLESS COM
   Auer M. E., 2019, P 21 INT C INT C INT, V1
   Azlan CA, 2020, PHYS MEDICA, V80, P10, DOI 10.1016/j.ejmp.2020.10.002
   Basilaia G., 2020, PEDAGOGICAL RES, V5, DOI [DOI 10.29333/PR/7937, 10.29333/pr/7937]
   Crawford J., 2020, J APPL LEARN TEACH, V3, P1, DOI DOI 10.37074/JALT.2020.3.1.7
   Durrheim DN, 2020, LANCET, V396, pE17, DOI 10.1016/S0140-6736(20)31675-5
   Hanif A, 2018, IEEE ACCESS, V6, P73395, DOI 10.1109/ACCESS.2018.2881384
   Ilag B. N, 2018, INTRO MICROSOFT TEAM
   Jacques S, 2016, INT J EMERG TECHNOL, V11, P36, DOI 10.3991/ijet.v11i12.5996
   Jacques S, 2020, INT J ENG PEDAGOG, V10, P120, DOI 10.3991/ijep.v10i6.16205
   Jacques S, 2020, INT J ENG PEDAGOG, V10, P21, DOI 10.3991/ijep.v10i3.12361
   Jacques S, 2017, INT J ENG PEDAGOG, V7, P117, DOI 10.3991/ijep.v7i4.7408
   Jee C, MIT TECHNOL REV
   Kamenetz A., GROWING NUMBER US CO
   Kiennert C, 2019, IEEE ACCESS, V7, P64110, DOI 10.1109/ACCESS.2019.2915275
   Kurbakova Svetlana, 2020, ICEMT 2020: 2020 4th International Conference on Education and Multimedia Technology, P167, DOI 10.1145/3416797.3416838
   Li H. Y., 2017, DESTECH T ENV ENERGY, P226, DOI DOI 10.12783/DTEEES/EESD2017/12005
   Martin L., 2019, INNOVATIVE PRACTICE, V3
   Merenkov D. V., 2020, P 2020 INT C INF TEC, P1
   Nonthamand N, 2020, INT J EMERG TECHNOL, V15, P140, DOI 10.3991/ijet.v15i03.10842
   Ouahabi A, 2021, PATTERN RECOGN LETT, V144, P27, DOI 10.1016/j.patrec.2021.01.010
   Pirnau C., 2020, P 2020 12 INT C EL C, P1
   Polyakova T, 2020, INT J ENG PEDAGOG, V10, P4, DOI 10.3991/ijep.v10i4.15021
   Prasad N, 2020, J INTERPROF CARE, V34, P706, DOI 10.1080/13561820.2020.1811213
   Raffone A., 2019, P 12 INT C INN LANG
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Salloum SA, 2019, IEEE ACCESS, V7, P128445, DOI 10.1109/ACCESS.2019.2939467
NR 30
TC 6
Z9 6
U1 8
U2 9
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2165-9567
BN 978-1-7281-8478-4
J9 IEEE GLOB ENG EDUC C
PY 2021
BP 1108
EP 1115
DI 10.1109/EDUCON46332.2021.9453887
PG 8
WC Education, Scientific Disciplines; Engineering, Multidisciplinary
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Education & Educational Research; Engineering
GA BS1GK
UT WOS:000689064100165
DA 2022-04-20
ER

PT J
AU Bernstein, HH
   Calabrese, T
   Corcoran, P
   Flint, LE
   Munoz, FM
   Bale, JF
   Davies, HD
   Leffelman, J
   Limjuco, S
   Aird, L
AF Bernstein, Henry H.
   Calabrese, Trisha
   Corcoran, Peter
   Flint, Laurence E.
   Munoz, Flor M.
   Bale, James F.
   Davies, H. Dele
   Leffelman, Jessica
   Limjuco, Shannon
   Aird, Laura
CA COVID-19 Echo Workgrp
TI The Power of Connections: AAP COVID-19 ECHO Accelerates Responses During
   a Public Health Emergency
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE clinical practice; COVID-19 pandemic; pediatrics
ID HEPATITIS-C; CARE
AB Context: Pediatric providers across the United States have sought guidance on how to care for the nation's children during the uncertain historic times of the COVID-19 pandemic. The health care community has been challenged by the unprecedented burden of caring for patients when they have evolving guidelines and limited information about the effects of the virus on children. Program: In response, the American Academy of Pediatrics (AAP) rapidly launched a national initiative to increase child health professionals' knowledge, skills, and self-efficacy. This COVID-19 ECHO (Extension for Community Healthcare Outcomes) program created communities of learners among child health professionals and subject matter expert faculty using didactic and case-based presentations that foster an "all-teach, all-learn" approach. Implementation: The initial AAP COVID-19 ECHO program hosted more than 900 participants in 127 individual virtual sessions, with approximately 25 participants per session. The evolving nature of the pandemic necessitated dynamic and continuous bidirectional flow of concerns and information relevant to participants. Session topics were selected in a "just-in-time" fashion based on participant feedback from the prospective postsession surveys and faculty recommendations; speakers brought data and expert recommendations. Evaluation: To assess impact, the AAP used a mixed-methods approach to evaluate the program's effectiveness in meeting its educational objectives. The 2-phase evaluation collected quantitative and qualitative data through an integrated feedback structure that utilized prospective postsession and retrospective postprogram surveys, along with postprogram focus groups. Discussion: As the COVID-19 pandemic surges and another influenza season is upon us, the ECHO model is an effective strategy for facilitating bidirectional communication and education to build child health professionals' knowledge, skills, and self-efficacy during an unprecedented and ongoing public health emergency.
C1 [Bernstein, Henry H.] Cohen Childrens Med Ctr, Dept Pediat, 410 Lakeville Rd,Ste 311, New Hyde Pk, NY 11042 USA.
   [Bernstein, Henry H.] Hofstra Northwell, Zucker Sch Med, Hempstead, NY USA.
   [Calabrese, Trisha; Corcoran, Peter; Leffelman, Jessica; Limjuco, Shannon; Aird, Laura] Amer Acad Pediat, Dept Hlth Resilient Children Youth & Families Ped, Itasca, IL USA.
   [Bale, James F.] Univ Utah Hlth, Dept Pediat, Salt Lake City, UT USA.
   [Flint, Laurence E.] Newton Med Ctr, Dept Pediat, Newton, NJ USA.
   [Munoz, Flor M.] Baylor Coll Med, Dept Pediat, Sect Infect Dis, Houston, TX USA.
   [Davies, H. Dele] Univ Nebraska Med Ctr, Omaha, NE USA.
RP Bernstein, HH (corresponding author), Cohen Childrens Med Ctr, Dept Pediat, 410 Lakeville Rd,Ste 311, New Hyde Pk, NY 11042 USA.; Calabrese, T (corresponding author), Pediat Populat Hlth, Amer Acad Pediat, 345 Pk Blvd, Itasca, IL 60143 USA.
EM hbernstein@northwell.edu; tcalabrese@aap.org
FU Centers for Disease Control and Prevention (CDC)United States Department
   of Health & Human ServicesCenters for Disease Control & Prevention - USA
   [5NU38OT00028202-00, 5NU38OT000282-03-00]
FX This work was supported by cooperative agreements #5NU38OT00028202-00
   and #5NU38OT000282-03-00, funded by the Centers for Disease Control and
   Prevention (CDC). Its contents are solely the responsibility of the
   authors and do not necessarily represent the official views of the CDC
   or the US Department of Health and Human Services.
CR American Academy of Pediatrics, PROJ ECHO EXT COMM H
   Arora S, 2007, PUBLIC HEALTH REP, V122, P74, DOI 10.1177/00333549071220S214
   Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370
   Aveling Emma-Louise, 2012, J Health Organ Manag, V26, P158
   Hess DW, 2015, J CONTIN EDUC HEALTH, V35, P71, DOI 10.1002/chp.21260
   Tiyyagura G, 2019, ACAD PEDIATR, V19, P985, DOI 10.1016/j.acap.2019.06.018
   World Health Organization, 2020, TEDR ADH GHEBR WHO D
NR 7
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD JAN-FEB
PY 2022
VL 28
IS 1
SI SI
BP E1
EP E8
DI 10.1097/PHH.0000000000001466
PG 8
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XA2BG
UT WOS:000720458700002
PM 34797247
OA hybrid
DA 2022-04-20
ER

PT J
AU Jo, J
   Chae, Y
   Jang, H
   Kong, J
AF Jo, Jinyong
   Chae, Yeonghun
   Jang, Heejin
   Kong, JongUk
TI Federated-Access Management System and Videoconferencing Applications:
   Results from a Pilot Service during COVID-19 Pandemic
SO ELECTRONICS
LA English
DT Article
DE identity and access management; videoconferences; authentication and
   authorization; COVID-19
ID EDUCATION
AB Videoconferencing has become a crucial enabler for sustainable collaboration and learning during the COVID-19 pandemic. However, national regulations often restrict public institutions from introducing commercial videoconferencing services. Open-source software is an attractive option for institutions if it can be protected from potential security threats while ensuring high usability. Unfortunately, to the best of our knowledge, we hardly find available open-source videoconferencing applications in the literature that stress their usability and adopt security-related frameworks. This study presents a federated-access management system called trustHub, which was developed to enable flexible and elaborate access control and protocol-agnostic user authentication. In addition, we introduce two videoconferencing applications that aim to improve the usability of leveraged open-source software. They are prototyped to operate in concert with trustHub to take firm access control and accept various types of identity providers. Consequently, using data collected from trustHub and a prototyped videoconferencing application over a 10-month period, we conduct a comprehensive analysis to understand the usage patterns of federated access and videoconferencing during the pandemic and, thus, verify their feasibility indirectly.
C1 [Jo, Jinyong; Jang, Heejin; Kong, JongUk] Korea Inst Sci & Technol Informat, 245 Daehak Ro, Daejeon 34141, South Korea.
   [Chae, Yeonghun] SEASON Technol, Sejong 30128, South Korea.
RP Jo, J (corresponding author), Korea Inst Sci & Technol Informat, 245 Daehak Ro, Daejeon 34141, South Korea.
EM jiny92@kisti.re.kr; proin@proinlab.com; jhj@kisti.re.kr; kju@kisti.re.kr
FU Korea Institute of Science and Technology InformationKorea Institute of
   Science & Technology Information (KISTI) [K-21-L02-C02-S01]
FX This research was funded by Korea Institute of Science and Technology
   Information, K-21-L02-C02-S01.
CR Andronache I., 2011, J MOBILE EMBED DISTR, V3, P21
   Basney J., 2019, P INT S GRIDS CLOUDS
   Biancini A., 2016, ARXIV161107832
   Byrnes KG, 2021, CLIN ANAT, V34, P82, DOI 10.1002/ca.23649
   Chard K., 2017, P PRACT EXP ADV RES
   Correia AP, 2020, DISTANCE EDUC, V41, P429, DOI 10.1080/01587919.2020.1821607
   Fatani TH, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02310-2
   Gallenmuller S., 2019, ARXIV190411423
   Garcia Boni, 2017, IEEE Communications Standards Magazine, V1, P44, DOI 10.1109/MCOMSTD.2017.1700006
   Gonzales-Zamora Jose A, 2020, Infez Med, V28, P135
   Grozev B., 2015, P 25 ACM WORKSH NETW
   Hasan R, 2021, CONSUM COMM NETWORK, DOI 10.1109/CCNC49032.2021.9369505
   Jason A.D., 2017, P NETW DISTR SYST SE
   Kagan D, 2020, ARXIV200701059
   KEMP J, 2005, AUTHENTICATION CONTE
   Klaas W., 2021, EOSC AUTHENTICATION
   Kotuliak I., 2011, P 9 INT C ICETA STAR
   Lee SY, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12104052
   Lowenthal P., 2020, J TECHNOLOGY TEACHER, V28, P383
   McGrew D., 2010, 5764 RFC IETF
   Milligan M. B., 2018, ACM INT C P SERIES, DOI [10.1145/3219104.3219162, DOI 10.1145/3219104.3219162]
   Minessale I.A., 2016, MASTERING FREESWITCH
   Murugesan S., 2020, INT J APPL ENG RES, V15, P735
   Niels V.D., 2018, WHITE PAPER IMPLEMEN
   Nishimura T., 2016, J INF PROCESS, V24, P609, DOI [10.2197/ipsjjip.24.609, DOI 10.2197/IPSJJIP.24.609]
   Okereafor K, 2020, IJMR, V8, P13, DOI 10.6084/m9.figshare.12421049
   Olups R., 2016, ZABBIX NETWORK MONIT
   Petrangeli S, 2018, PROCEEDINGS OF THE 9TH ACM MULTIMEDIA SYSTEMS CONFERENCE (MMSYS'18), P533, DOI 10.1145/3204949.3208109
   Prochazka M, 2014, 2014 IST-AFRICA CONFERENCE PROCEEDINGS
   Sakimura N., 2014, OPENID CONNECT CORE
   Sefraoui Omar, 2012, INT J COMPUT APPL, V55, P38, DOI DOI 10.5120/8738-2991
   Selvanathan N, 2019, 14TH INTERNATIONAL CONFERENCE ON AVAILABILITY, RELIABILITY AND SECURITY (ARES 2019), DOI 10.1145/3339252.3341492
   Sidpra J, 2020, QUANT IMAG MED SURG, V10, P1422, DOI 10.21037/qims-20-714
   Skulmowski A, 2020, HUM BEHAV EMERG TECH, V2, P212, DOI 10.1002/hbe2.201
   Wenzel M, 2016, INT C COMP SUPP COOP, P334, DOI 10.1109/CSCWD.2016.7566010
   Wlodarczyk JR, 2020, PLAST RECONSTR SURG, V146, p110E, DOI 10.1097/PRS.0000000000007073
NR 36
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-9292
J9 ELECTRONICS-SWITZ
JI Electronics
PD SEP
PY 2021
VL 10
IS 18
AR 2239
DI 10.3390/electronics10182239
PG 19
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering; Physics
GA UV8DV
UT WOS:000699702600001
OA gold
DA 2022-04-20
ER

PT J
AU Chernogorova, Y
   Bliznakov, Z
   Bliznakova, K
AF Chernogorova, Y.
   Bliznakov, Z.
   Bliznakova, K.
TI MANAGEMENT CHALLENGES IN IMPLEMENTING SCIENTIFIC PROJECTS DURING
   COVID-19 PANDEMIC
SO POLISH JOURNAL OF MANAGEMENT STUDIES
LA English
DT Article
DE Project risk management; COVID 19 challenges; Project's activities;
   Deliverables; Scientific projects
ID IMPACT
AB The aim of this work is to outline the management and risk management activities related to the successful implementation of scientific projects, which have been severely affected by the pandemic situation. The methodology includes a comparative analysis between planned and implemented activities on running scientific projects. Time, budget and scope are the main three constraints of the project used in the assessment. Five main groups of activities are analysed: Management, Scientific, Educational, Dissemination and Production. While published studies present qualitative and quantitative risk analysis due to the pandemic, this work goes a step forward by suggesting risk response planning, management procedures and activities to reduce threats to the project's objectives. To the best of authors' knowledge, there is no research systemized by other research groups.
C1 [Chernogorova, Y.; Bliznakov, Z.; Bliznakova, K.] Med Univ Varna, Varna, Bulgaria.
RP Chernogorova, Y (corresponding author), Med Univ Varna, Varna, Bulgaria.
EM yanita.chernogorova@gmail.com; kristina.bliznakova@gmail.com;
   bliznakov.zhivko@gmail.com
OI Chernogorova, Yanita/0000-0003-1610-0762
FU Bulgarian National Science FundNational Science Fund of Bulgaria [DN
   17/2]
FX This work is supported by the Bulgarian National Science Fund under
   grant agreement DN 17/2.
CR Ahmadi-Javid A, 2020, PROJ MANAG J, V51, P77, DOI 10.1177/8756972819866577
   Bagiella E, 2020, J AM COLL CARDIOL, V76, P342, DOI 10.1016/j.jacc.2020.05.041
   Bushuyev S., 2020, INNOV TECHNOL SCI SO, V2, P13, DOI DOI 10.30837/2522-9818.2020.12.013
   Cancer Research UK, 2020, CANC RES UK ANN CUTS
   Carrasco Sierra A., 2020, INT J ENTREPRENEURIA, V8, P42, DOI 10.37335/ijek.v8i2.116.
   Chapman C., 1997, INT J PROJECT MANAGE, V15, P273, DOI DOI 10.1016/S0263-7863(96)00079-8
   Conde M. A., 2020, 8 INT C TECHN EC ENH
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   Egeland B., 2020, WILL GLOBAL PANDEMIC
   EURAXESS Worldwide, 2020, RES MOB CHANG WORLD
   Fu ZY, 2021, J MED INTERNET RES, V23, DOI 10.2196/26799
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Germany's Presidency of the Council of the European Union 2020, 2020, FAQ WHAT IS EUR UN D
   Goodman R., 2005, PMI R GLOB C 2005 AS
   Harper L, 2020, J PEDIATR UROL, V16, P715, DOI 10.1016/j.jpurol.2020.07.002
   Hillson D., 2009, MANAGING RISK PROJEC
   Jallow H, 2021, SMART SUSTAIN BUILT, V10, P581, DOI 10.1108/SASBE-05-2020-0068
   Loh TP, 2020, CLIN CHEM LAB MED, V58, P1433, DOI 10.1515/cclm-2020-0711
   Loh TP, 2020, CLIN CHEM LAB MED, V58, P1441, DOI 10.1515/cclm-2020-0710
   Magan AA, 2020, BONE JOINT RES, V9, P531, DOI 10.1302/2046-3758.98.BJR-2020-0344
   Mukherjee SK., 2001, PROJECT MANAGEMENT J, V32, P45, DOI [DOI 10.1177/875697280103200206, 10.1177/875697280103200206]
   Nocco MA, 2021, BIOL CONSERV, V255, DOI 10.1016/j.biocon.2021.108966
   Padalkar M, 2016, INT J PROJ MANAG, V34, P1305, DOI 10.1016/j.ijproman.2016.06.006
   Project Management Institute, 2003, GUID PROJ MAN BOD KN, V1
   Radecki J., 2020, IMPACTS COVID 19 RES
   Rosales-Mendoza S, 2020, TRENDS BIOTECHNOL, V38, P823, DOI 10.1016/j.tibtech.2020.04.016
   do Vale JWSP, 2018, PROJ MANAG J, V49, P82, DOI 10.1177/8756972818770884
   Sohrabi C, 2021, INT J SURG, V86, P57, DOI 10.1016/j.ijsu.2020.12.008
   Suart C., 2020, LABS CLOSED GRADUATE
   Termini CM, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00821-4
   Vagal A, 2020, RADIOLOGY, V296, pE134, DOI 10.1148/radiol.2020201393
   Wang YL, 2018, INT J PROJ MANAG, V36, P899, DOI 10.1016/j.ijproman.2018.01.007
   Yanow SK, 2020, AM J TROP MED HYG, V102, P1164, DOI 10.4269/ajtmh.20-0325
   Youker R., 2017, PM WORLD J, V6, P1
   Zandi G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217961
NR 35
TC 1
Z9 1
U1 7
U2 9
PU CZESTOCHOWA UNIV TECHNOLOGY
PI CZESTOCHOWA
PA FAC MANAGEMENT, UL ARMII KRAJOWEJ 19B, CZESTOCHOWA, 42-201, POLAND
SN 2081-7452
J9 POL J MANAG STUD
JI Pol. J. Manag. Stud.
PY 2021
VL 23
IS 1
BP 136
EP 150
DI 10.17512/pjms.2021.23.1.09
PG 15
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA TD8JD
UT WOS:000669565100009
OA gold
DA 2022-04-20
ER

PT J
AU Reddy, GB
   Greif, DN
   Rodriguez, J
   Best, TM
   Greditzer, HG
   Jose, J
AF Reddy, Gireesh B.
   Greif, Dylan N.
   Rodriguez, Jose
   Best, Thomas M.
   Greditzer, Harry G.
   Jose, Jean
TI Clinical Characteristics and Multisystem Imaging Findings of COVID-19:
   An Overview for Orthopedic Surgeons
SO HSS JOURNAL
LA English
DT Editorial Material
DE COVID-19; coronavirus; diagnostic imaging; orthopedics
ID CYTOKINE STORM; MYOCARDIAL-INFARCTION; INFECTION; DYSFUNCTION; DISEASE
AB The COVID-19 pandemic holds widespread implications for global public health, economies, societies, and the practice of orthopedic surgery. As our knowledge of the transmissibility of SARS-CoV-2 and the symptomatology and management of COVID-19 expands, orthopedic surgeons must remain up to date on the latest medical evidence and surgical perspectives. While COVID-19 primarily manifests with pulmonary symptoms, cardiovascular, neurologic, and other major organ systems may also be affected and present with hallmark imaging findings. This article reviews initial and emerging literature on clinical characteristics and imaging findings of COVID-19.
C1 [Reddy, Gireesh B.; Best, Thomas M.] Univ Miami, Jackson Mem Hosp, Dept Orthopaed Surg, Miller Sch Med, Miami, FL USA.
   [Rodriguez, Jose; Jose, Jean] Univ Miami, Jackson Mem Hosp, Dept Radiol, Miller Sch Med, Miami, FL USA.
   [Reddy, Gireesh B.; Greif, Dylan N.; Best, Thomas M.; Jose, Jean] Univ Miami, Univ Miami Sports Med Inst, Miller Sch Med, Coral Gables, FL 33146 USA.
   [Greditzer, Harry G.] Hosp Special Surg, Dept Radiol, New York, NY USA.
RP Greif, DN (corresponding author), Univ Miami, Univ Miami Sports Med Inst, Miller Sch Med, Coral Gables, FL 33146 USA.
EM d.greif@med.miami.edu
OI Reddy, Gireesh/0000-0001-6112-2309
CR Aghemo A, 2020, CLIN GASTROENTEROL H, V18, P2366, DOI 10.1016/j.cgh.2020.05.011
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   [Anonymous], 2020, WHIT HOUS
   Anoushiravani AA, 2020, J BONE JOINT SURG AM, V102, P937, DOI 10.2106/JBJS.20.00557
   Atkeson, 2020, WHAT WILL BE EC IMPA
   Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003
   Behzad S, 2020, CLIN IMAG, V66, P35, DOI 10.1016/j.clinimag.2020.05.013
   Beydon M, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-217573
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Bhayana R, 2021, EUR RADIOL, V31, P1359, DOI 10.1007/s00330-020-07228-3
   Chai X., 2020, SPECIFIC ACE2 EXPRES
   Chao CC, 2003, NEUROLOGY, V61, P1820, DOI 10.1212/01.WNL.0000099171.26943.D0
   Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003
   Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7
   COVID 19 Investigation, 2020, NAT MED, V26, P861, DOI 10.1038/s41591-020-0877-5
   Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254
   Desforges M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010014
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Feng G, 2020, J CLIN TRANSL HEPATO, V8, P18, DOI 10.14218/JCTH.2020.00018
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Han CQ, 2020, AM J GASTROENTEROL, V115, P916, DOI 10.14309/ajg.0000000000000664
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Hopkins C, 2020, RHINOLOGY, V58, P295, DOI 10.4193/Rhin20.116
   Hormati A, 2020, J MICROBIOL IMMUNOL, V53, P384, DOI 10.1016/j.jmii.2020.03.020
   Hossain R, 2020, RADIOLOGY, V296, pE173, DOI 10.1148/radiol.2020201743
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang Q, 2020, INT J CLIN PHARM-NET, V42, P837, DOI 10.1007/s11096-020-01031-2
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Jain A, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.20.00602
   Jin M, 2020, EMERG INFECT DIS, V26, P1618, DOI 10.3201/eid2607.200445
   Kandemirli SG, 2020, RADIOLOGY, V297, pE232, DOI 10.1148/radiol.2020201697
   Kim H, 2020, RADIOLOGY, V296, pE145, DOI 10.1148/radiol.2020201343
   Kreutz RP, 2005, J THROMB HAEMOST, V3, P2108, DOI 10.1111/j.1538-7836.2005.01474.x
   Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090
   Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561
   Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672
   Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Long B, 2020, AM J EMERG MED, V38, P1504, DOI 10.1016/j.ajem.2020.04.048
   Lushina N, 2020, RADIOLOGY, V296, pE181, DOI 10.1148/radiol.2020201623
   Mahammedi A, 2020, RADIOLOGY, V297, pE270, DOI 10.1148/radiol.2020201933
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   [梅恒 Mei Heng], 2020, [中华血液学杂志, Chinese Journal of Hematology], V41, P185
   Nascimento Fabio A, 2014, Surg Neurol Int, V5, pS122, DOI 10.4103/2152-7806.130675
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Ortman JM, 2014, AGING NATION OLDER P, P25
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Pan L, 2020, AM J GASTROENTEROL, V115, P766, DOI 10.14309/ajg.0000000000000620
   Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1
   Pleasure SJ, 2020, JAMA NEUROL, V77, P679, DOI 10.1001/jamaneurol.2020.1065
   Poyiadji N, 2020, RADIOLOGY, V297, pE335, DOI 10.1148/radiol.2020201955
   Qanadli SD, 2020, AM J ROENTGENOL, V215, pW15, DOI 10.2214/AJR.20.23185
   Ren B, 2020, CIRCULATION, V142, P181, DOI 10.1161/CIRCULATIONAHA.120.047407
   Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.7681, 10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]
   Sachs JR, 2020, RADIOLOGY, V296, pE184, DOI 10.1148/radiol.2020201753
   Salehi S, 2020, AM J ROENTGENOL, V215, P87, DOI [10.2214/AJR.20.23034, 10.2214/AJR.20.23034S.]
   Sene D, 2009, REV MED INTERNE, V30, P135, DOI 10.1016/j.revmed.2008.05.020
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Stainsby Brynne, 2011, J Can Chiropr Assoc, V55, P32
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191
   Valette X, 2020, LANCET INFECT DIS, V20, P1230, DOI [10.1016/S1473-3099(20)30310-9, 10.1016/S1473-3099(20)30310-8]
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang HL, 2008, AM J EMERG MED, V26, P711, DOI 10.1016/j.ajem.2007.10.031
   Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Zaim S, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100618
   Zang R, 2020, ALLERGY, DOI [10.1101/2020.04.21.054015, DOI 10.1093/AJCN/NQAA095]
   Zhang Q, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8074
   Zhang Y, 2020, Zhonghua Xue Ye Xue Za Zhi, V41, P302, DOI [10.3760/cma.j.issn.0253-2727.2020.0006, 10.3760/cma.j.issn.0253-2727.2020.008]
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 91
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1556-3316
EI 1556-3324
J9 HSS J
JI HSS J.
PD NOV
PY 2020
VL 16
IS 1_SUPPL
SU 1_
SI SI
BP 112
EP 123
DI 10.1007/s11420-020-09775-3
PG 12
WC Orthopedics; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Orthopedics; Surgery
GA VK8DA
UT WOS:000755972100019
PM 32837414
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Singh, H
   Kaur, H
   Singh, K
   Sen, CK
AF Singh, Harjas
   Kaur, Harleen
   Singh, Kanhaiya
   Sen, Chandan K.
TI Cutaneous Manifestations of COVID-19: A Systematic Review
SO ADVANCES IN WOUND CARE
LA English
DT Review
DE wound; skin lesions; COVID-19; maculopapular; chilblain-like; MIS-C
ID MULTISYSTEM INFLAMMATORY SYNDROME; PRESSURE ULCERS; HUMAN BOCAVIRUS;
   MIS-C; CHILDREN; DISEASE; INFECTION; UPDATE; PART; CLASSIFICATION
AB Objective:Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently a pandemic. Although pulmonary health has been the primary focus of studies during the early days of COVID-19, development of a comprehensive understanding of this emergent disease requires knowledge of all possible disease manifestations in affected patients. This Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-compliant review focuses on cutaneous manifestations reported in COVID-19 patients.
   Approach:Literature review was conducted using the PubMed database to examine various cutaneous manifestations related to the SARS-CoV-2 infection. Published articles (n = 56) related to search criteria from the onset of the COVID-19 pandemic to June 30, 2020, were included. The primary literature articles included in this study were mainly from France, Spain, Italy, and the United Kingdom.
   Results:Unique to many other symptoms of COVID-19, its cutaneous manifestations have been found in people of all age groups, including children. The cutaneous manifestations of COVID-19 are varied and include maculopapular, chilblain-like, urticarial, vesicular, livedoid, and petechial lesions. In addition, rashes are common in multisystem inflammatory syndrome in children, a new and serious health condition that shares symptoms with Kawasaki disease and is likely related to COVID-19. In addition, personal protective equipment-related skin wounds are of serious concern since broken cutaneous barriers can create an opening for potential COVID-19 infections. Innovation and
   Conclusion:As this virus continues to spread silently, mainly through asymptomatic carriers, an accurate and rapid identification of these cutaneous manifestations may be vital to early diagnosis and lead to possible better prognosis in COVID-19 patients. This systematic review and photo atlas provide a detailed analysis of the skin pathologies related to COVID-19. Study of these cutaneous manifestations and their pathogenesis, as well their significance in human health will help define COVID-19 in its entirety, which is a prerequisite to its effective management.
C1 [Singh, Harjas; Singh, Kanhaiya; Sen, Chandan K.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
   [Kaur, Harleen] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.
   [Singh, Kanhaiya; Sen, Chandan K.] Indiana Univ Sch Med, Dept Surg, Indiana Univ Hlth Comprehens Wound Ctr, Indianapolis, IN 46202 USA.
   [Singh, Kanhaiya; Sen, Chandan K.] Indiana Univ Sch Med, Indiana Ctr Regenerat Med, Indianapolis, IN 46202 USA.
RP Sen, CK (corresponding author), Indiana Univ Sch Med, Dept Surg, Indiana Univ Hlth Comprehens Wound Ctr, Indianapolis, IN 46202 USA.; Sen, CK (corresponding author), Indiana Univ Sch Med, Indiana Ctr Regenerat Med, Indianapolis, IN 46202 USA.
EM cksen@iu.edu
OI Singh, Kanhaiya/0000-0002-4126-9618
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM069589, GM077185, GM108014,
   NR013898]; Lilly Endowment INCITE (Indiana Collaborative Initiative for
   Talent Enrichment) program; Indiana Clinical and Translational Sciences
   Institute - NIH [UL1TR002529]
FX Work in the laboratory of Dr. Chandan K. Sen is funded by NIH grants
   GM069589, GM077185, GM108014, and NR013898. Research programs lead by
   Dr. Chandan K. Sen are also supported by the Lilly Endowment INCITE
   (Indiana Collaborative Initiative for Talent Enrichment) program. The
   research activities of Harjas Singh were supported by the Indiana
   Clinical and Translational Sciences Institute was funded, in part, by
   UL1TR002529 from the NIH.
CR Abouhashem AS, 2020, ANTIOXID REDOX SIGN, V33, P59, DOI 10.1089/ars.2020.8111
   Ahmed M, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100527
   Algaadi SA, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14290
   Andina D, 2020, PEDIATR DERMATOL, V37, P406, DOI 10.1111/pde.14215
   Arnold JC, 2006, CLIN INFECT DIS, V43, P283, DOI 10.1086/505399
   Askin O, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13896
   Bahrami A, 2021, J PAEDIATR CHILD H, V57, P922, DOI 10.1111/jpc.15048
   Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
   Bouaziz JD, 2020, J EUR ACAD DERMATOL, V34, pE451, DOI 10.1111/jdv.16544
   Duramaz BB, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13594
   Cabrera-Hernandez R, 2020, J EUR ACAD DERMATOL, V34, pE659, DOI 10.1111/jdv.16745
   Cappel JA, 2014, MAYO CLIN PROC, V89, P207, DOI 10.1016/j.mayocp.2013.09.020
   Caputo V, 2020, J EUR ACAD DERMATOL, V34, pE579, DOI 10.1111/jdv.16737
   Caselli D, 2020, BRIT J DERMATOL, V183, P784, DOI 10.1111/bjd.19349
   CHERRY JD, 1993, CLIN INFECT DIS, V16, P199, DOI 10.1093/clind/16.2.199
   Cheung EW, 2020, JAMA-J AM MED ASSOC, V324, P294, DOI 10.1001/jama.2020.10374
   Colonna C, 2020, J AM ACAD DERMATOL, V83, P965, DOI 10.1016/j.jaad.2020.06.019
   Cordoro KM, 2020, PEDIATR DERMATOL, V37, P419, DOI 10.1111/pde.14227
   Criado PR, 2020, INFLAMM RES, V69, P745, DOI 10.1007/s00011-020-01370-w
   Dalal A, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13849
   De Giorgi V, 2020, J AM ACAD DERMATOL, V83, P674, DOI 10.1016/j.jaad.2020.05.073
   de Masson A, 2020, J AM ACAD DERMATOL, V83, P667, DOI 10.1016/j.jaad.2020.04.161
   Diotallevi F, 2020, J MED VIROL, V92, P2332, DOI 10.1002/jmv.26012
   Docampo-Simon A, 2020, J EUR ACAD DERMATOL, V34, pE445, DOI 10.1111/jdv.16665
   Drago F, 2017, FUTURE MICROBIOL, V12, P171, DOI 10.2217/fmb-2016-0147
   Duong TA, 2020, J EUR ACAD DERMATOL, V34, pE348, DOI 10.1111/jdv.16534
   Ebina-Shibuya R, 2020, INT J INFECT DIS, V97, P371, DOI 10.1016/j.ijid.2020.06.014
   El Hachem M, 2020, J EUR ACAD DERMATOL, V34, P2620, DOI 10.1111/jdv.16682
   Ely JW, 2010, AM FAM PHYSICIAN, V81, P735
   Ely JW, 2010, AM FAM PHYSICIAN, V81, P726
   Fernandez-Nieto D, 2020, CLIN EXP DERMATOL, V45, P872, DOI 10.1111/ced.14277
   Fernandez-Nieto D, 2020, J EUR ACAD DERMATOL, V34, pE252, DOI 10.1111/jdv.16470
   Fernandez-Nieto D, 2020, J AM ACAD DERMATOL, V83, pE61, DOI 10.1016/j.jaad.2020.04.093
   Freeman EE, 2020, J AM ACAD DERMATOL, V83, P486, DOI 10.1016/j.jaad.2020.05.109
   Galeotti C, 2020, NAT REV RHEUMATOL, V16, P413, DOI 10.1038/s41584-020-0448-7
   Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163
   Garcia-Garcia M L, 2007, An Pediatr (Barc), V67, P212, DOI 10.1157/13108941
   Garcia-Lara G, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13516
   Gaspari V, 2020, J EUR ACAD DERMATOL, V34, pE552, DOI 10.1111/jdv.16693
   Gefen A, 2020, J WOUND CARE, V29, P311, DOI 10.12968/jowc.2020.29.6.311
   Gefen A, 2020, J WOUND CARE, V29, P245, DOI 10.12968/jowc.2020.29.5.245
   Gianotti R, 2020, AM J DERMATOPATH, V42, P564, DOI 10.1097/DAD.0000000000001707
   Gottlieb M, 2020, AM J EMERG MED, V38, P1715, DOI 10.1016/j.ajem.2020.06.011
   Grimaud M, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00690-8
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Hameed S, 2021, RADIOLOGY, V298, pE1, DOI 10.1148/radiol.2020202543
   Hassan K, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-236981
   Henry D, 2020, J EUR ACAD DERMATOL, V34, pE244, DOI 10.1111/jdv.16472
   Herrero-Moyano M, 2020, J EUR ACAD DERMATOL, V34, pE460, DOI 10.1111/jdv.16631
   Hu KH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020603
   Hughes M, 2016, BEST PRACT RES CL RH, V30, P112, DOI 10.1016/j.berh.2016.04.001
   Jackson D, 2019, INT J NURS STUD, V92, P109, DOI 10.1016/j.ijnurstu.2019.02.006
   Jiang QX, 2020, INT WOUND J, V17, P1300, DOI 10.1111/iwj.13391
   Jiang QX, 2020, ADV WOUND CARE, V9, P357, DOI 10.1089/wound.2020.1212
   Kaushik S, 2020, J PEDIATR-US, V224, P24, DOI 10.1016/j.jpeds.2020.06.045
   Klejtman T, 2020, J Med Vasc, V45, P175, DOI 10.1016/j.jdmv.2020.06.001
   Korman AM, 2017, J AM ACAD DERMATOL, V76, P538, DOI 10.1016/j.jaad.2016.08.034
   Lam UN, 2020, INT WOUND J, V17, P1525, DOI 10.1111/iwj.13398
   LECLEACH L, 2020, BRIT J DERMATOL 0809, DOI DOI 10.1111/BJD.19377
   Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Manalo IF, 2020, J AM ACAD DERMATOL, V83, pE157, DOI 10.1016/j.jaad.2020.05.001
   Marzano AV, 2020, BRIT J DERMATOL, V183, P431, DOI 10.1111/bjd.19264
   Marzano AV, 2020, J AM ACAD DERMATOL, V83, P280, DOI 10.1016/j.jaad.2020.04.044
   Mastrolonardo M, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13617
   McCrindle BW, 2020, JAMA-J AM MED ASSOC, V324, P246, DOI 10.1001/jama.2020.10370
   McGrath A, 2020, PETECHIAE
   Miller J, 2020, GASTROENTEROLOGY, V159, P1571, DOI 10.1053/j.gastro.2020.05.079
   Najafzadeh M, 2020, J EUR ACAD DERMATOL, V34, pE568, DOI 10.1111/jdv.16721
   Ortega-Quijano D, 2020, J AM ACAD DERMATOL, V83, pE103, DOI 10.1016/j.jaad.2020.05.034
   Panupattanapong Sirada, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc039
   Pouletty M, 2020, ANN RHEUM DIS, V79, P999, DOI 10.1136/annrheumdis-2020-217960
   Radonjic-Hoesli S, 2018, CLIN REV ALLERG IMMU, V54, P88, DOI 10.1007/s12016-017-8628-1
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387
   Reymundo A, 2020, J EUR ACAD DERMATOL, V34, pE755, DOI 10.1111/jdv.16707
   Riollano-Cruz M, 2021, J MED VIROL, V93, P424, DOI 10.1002/jmv.26224
   Rongioletti F, 2020, J EUR ACAD DERMATOL, V34, pE581, DOI 10.1111/jdv.16738
   Rubio-Muniz CA, 2020, J EUR ACAD DERMATOL, V34, pE574, DOI 10.1111/jdv.16734
   Sajjan Vijaya Veeranna, 2015, Indian Dermatol Online J, V6, P315, DOI 10.4103/2229-5178.164493
   Sernicola A, 2020, INT WOUND J, V17, P1520, DOI 10.1111/iwj.13397
   Sharma AN, 2020, J AM ACAD DERMATOL, V83, P563, DOI 10.1016/j.jaad.2020.04.024
   Skowronski DM, 2015, INFLUENZA OTHER RESP, V9, P32, DOI 10.1111/irv.12296
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094
   Tursen U, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13476
   van Damme C, 2020, J EUR ACAD DERMATOL, V34, pE300, DOI 10.1111/jdv.16523
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Wang SM, 2006, CLIN MICROBIOL INFEC, V12, P1221, DOI 10.1111/j.1469-0691.2006.01540.x
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   Wollina U, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13549
   Xue XT, 2021, J INVEST DERMATOL, V141, P206, DOI 10.1016/j.jid.2020.05.087
   Yan YC, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13310
   Yin ZQ, 2020, J EUR ACAD DERMATOL, V34, pE294, DOI 10.1111/jdv.16490
   Yozgat CY, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13770
   Zhou Nuo-Ya, 2020, Int J Dermatol Venereol, DOI 10.1097/JD9.0000000000000085
NR 97
TC 23
Z9 24
U1 1
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2162-1918
EI 2162-1934
J9 ADV WOUND CARE
JI Adv. Wound Care
PD FEB 1
PY 2021
VL 10
IS 2
BP 51
EP 80
DI 10.1089/wound.2020.1309
EA OCT 2020
PG 30
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA PL7TS
UT WOS:000581846400001
PM 33035150
OA Green Published
DA 2022-04-20
ER

PT J
AU Lenggogeni, S
   Ashton, AS
   Scott, N
AF Lenggogeni, Sari
   Ashton, Ann Suwaree
   Scott, Noel
TI Humour: coping with travel bans during the COVID-19 pandemic
SO INTERNATIONAL JOURNAL OF CULTURE TOURISM AND HOSPITALITY RESEARCH
LA English
DT Article; Early Access
DE Social media; Emotions; Humour; Coping mechanism; COVID-19; Dark humour;
   Tourism crises and disaster management
ID RISK PERCEPTIONS; STRESS; TOURISM; KNOWLEDGE; EMOTION; STYLES; CRISIS;
   PERSONALITY; STRATEGIES; APPRAISAL
AB Purpose This study aims to extend the use of psychology in the field of tourism crisis and disaster management using coping theory. It examines how resident emotions change in the extended prodromal stage of the COVID-19 pandemic and how residents used humour to cope with stress from not being able to travel. Design/methodology/approach Early COVID-19 (March-April 2020) was characterised by negative media reports, lockdowns and travel restrictions but for Indonesia, no direct effects in terms of loss of life. This unusual context has led to phenomena not previously studied - humour as a coping strategy. This research consists of two studies: Study 1 used thematic analysis of interviews before and during the early lockdown period with a panel of 245 quarantined residents who had travelled in the prior two years. Study 2 followed up using a #hasthtag analysis of travel-related videos content posted on Instagram and TikTok. Findings The COVID-19 global pandemic is an unusual crisis which has resulted in high levels of stress and uncertainty. This study identified the unusual characteristics of the COVID-19 crises and changes of quarantined resident's emotions during the pre-event and prodromal stages. In addition, this study found the use of humour as a coping mechanism during the lockdown period and the use of social media as the vehicle for humour. Research limitations/implications These findings may be generalisable only to a crises and disasters with an extended prodromal stage. Interestingly, climate change has some similar characteristics where warning signs are available, but the personal implications have not yet become apparent. Practical implications The emotions associated with crisis are dynamic and crisis managers may tailor communication to help deal with stress. Social implications This research provides an insight into how humorous content can be used to reduce negative emotions in the early stage of a stressful event associated with travel restrictions. This study may be suitable for use in integrated marketing communication in post-recovery messaging for the tourism industry and destination management organisation in the digital platform. Originality/value To the best of the authors' knowledge, this study is the first to demonstrate "dark humour" during the early stages of COVID-19 and also the use of coping strategies to explain how humour can reduce stress.
C1 [Lenggogeni, Sari] Univ Andalas, Fac Econ, Padang, Indonesia.
   [Lenggogeni, Sari] Univ Andalas, Tourism Dev Ctr, Padang, Indonesia.
   [Ashton, Ann Suwaree] Natl Inst Dev Adm, Grad Sch Tourism Management, Bangkok, Thailand.
   [Scott, Noel] Univ Sunshine Coast, Sustainabil Res Ctr SRC, Sunshine Coast, Australia.
RP Lenggogeni, S (corresponding author), Univ Andalas, Fac Econ, Padang, Indonesia.; Lenggogeni, S (corresponding author), Univ Andalas, Tourism Dev Ctr, Padang, Indonesia.
EM sarilenggogeni@eb.unand.ac.id; suwareeashton@hotmail.com;
   dr.noel.scott@gmail.com
RI Lenggogeni, Sari/AAA-6594-2019
OI Lenggogeni, Sari/0000-0003-1368-5136
CR Aliperti G, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102808
   Beeston G, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P1043, DOI 10.1145/2567948.2579209
   Berberovic S, 2017, EUROPEAN J HUMOUR RE, V5, P4
   BERGER AA, 1987, AM BEHAV SCI, V30, P6, DOI 10.1177/000276487030003002
   Bischetti L, 2021, LINGUA, V249, DOI 10.1016/j.lingua.2020.102963
   Brantner C, 2020, CONVERGENCE-US, V26, P674, DOI 10.1177/1354856519827804
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Chien PM, 2017, J TRAVEL RES, V56, P744, DOI 10.1177/0047287516665479
   Cooper C, 2008, HUM RELAT, V61, P1087, DOI 10.1177/0018726708094861
   Dong MY, 2020, HEALTH EXPECT, V23, P259, DOI 10.1111/hex.13055
   Fang S, 2020, TOUR MANAG PERSPECT, V34, DOI 10.1016/j.tmp.2020.100637
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Fennell DA, 2017, ANN TOURISM RES, V66, P140, DOI 10.1016/j.annals.2017.07.015
   Filep S, 2019, J TRAVEL RES, V58, P343, DOI 10.1177/0047287518759227
   FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150
   FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992
   Francesconi S, 2017, VISUAL COMMUN-US, V16, P395, DOI 10.1177/1470357217716378
   Freud S., 1960, JOKES THEIR RELATION
   Ge J., 2017, INFORM COMMUNICATION, P461
   Giddens A., 2009, POLITICS CLIMATE CHA
   Gonot-Schoupinsky FN, 2018, COMPLEMENT THER MED, V38, P85, DOI 10.1016/j.ctim.2018.04.009
   Gossling S, 2006, CLIMATIC CHANGE, V79, P163, DOI 10.1007/s10584-006-9081-y
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   Highfield Tim, 2015, 1 MONDAY, V20, P1, DOI DOI 10.5210/FM.V20I1.5563
   Janhonen K, 2017, J YOUTH STUD, V20, P1127, DOI 10.1080/13676261.2017.1311404
   Jiang YW, 2019, INT J TOUR RES, V21, P882, DOI 10.1002/jtr.2312
   Jordan EJ, 2015, TOURISM MANAGE, V48, P500, DOI 10.1016/j.tourman.2015.01.002
   Kazarian SS, 2004, EUR J PERSONALITY, V18, P209, DOI 10.1002/per.505
   Khosravi M, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7856
   Kozak M., 2007, International Journal of Tourism Research, V9, P233, DOI 10.1002/jtr.607
   KUIPER NA, 1993, CAN J BEHAV SCI, V25, P81, DOI 10.1037/h0078791
   Kuipers, 2002, EUROPEAN J CULTURAL, V5, P450, DOI [10.1177/1364942002005004296, DOI 10.1177/1364942002005004296]
   Laroche M, 2014, INT J ADVERT, V33, P681, DOI 10.2501/IJA-33-4-681-705
   Laws E, 2007, CRISIS MANAGEMENT IN TOURISM, P1, DOI 10.1079/9781845930479.0000
   Lazarus RS, 1984, STRESS APPRAISAL COP
   Lehto X. R., 2007, Journal of Travel & Tourism Marketing, V23, P29
   Lenggogeni S., 2015, CAUTHE SO CROSS U AU
   Lenggogeni S, 2019, J TRAVEL TOUR MARK, V36, P941, DOI 10.1080/10548408.2019.1661329
   Leven N. V., 2002, SCANDINAVIAN J OCCUP, V9, P148, DOI DOI 10.1080/11038120260501172
   Ma SY, 2021, ANATOLIA, V32, P136, DOI 10.1080/13032917.2020.1808490
   Mair J, 2016, CURR ISSUES TOUR, V19, P1, DOI 10.1080/13683500.2014.932758
   Martin RA, 2007, PSYCHOLOGY OF HUMOR: AN INTEGRATIVE APPROACH, P1, DOI 10.1016/B978-012372564-6/50020-4
   Martin RA, 2003, J RES PERS, V37, P48, DOI 10.1016/S0092-6566(02)00534-2
   Martini A, 2019, CURR ISSUES TOUR, V22, P2353, DOI 10.1080/13683500.2018.1511693
   McCreaddie M., 2018, HDB COMMUNICATION SK, P287
   Moos R.H., 1993, COPING RESOURCES PRO
   Nezlek J.B., 2019, HUMOR, V1
   Nissen ME, 2005, J MANAGE INFORM SYST, V22, P225, DOI 10.2753/MIS0742-1222220308
   Pabel A., 2019, EUROPEAN J HUMOUR RE, V7, P1
   Pabel A., 2019, EUROPEAN J HUMOUR RE, V7, P120
   Pabel A, 2016, ANN TOURISM RES, V57, P190, DOI 10.1016/j.annals.2015.12.018
   Pabel A, 2015, TOUR MANAG PERSPECT, V16, P357, DOI 10.1016/j.tmp.2015.10.002
   Pennington-Gray L, 2018, TOUR MANAG PERSPECT, V25, P136, DOI 10.1016/j.tmp.2017.11.013
   Polizzi C, 2020, CLIN NEUROPSYCHIATR, V17, P59, DOI 10.36131/CN20200204
   Porres-Guerrero M., 2019, EUROPEAN J HUMOUR RE, V7, P46
   Rittichainuwat B, 2018, TOURISM MANAGE, V66, P221, DOI 10.1016/j.tourman.2017.09.013
   ROTH PL, 1992, J OCCUP ORGAN PSYCH, V65, P51, DOI 10.1111/j.2044-8325.1992.tb00483.x
   Ruch W., 2017, POSITIVE PSYCHOL INT, P65, DOI DOI 10.1007/978-3-319-51787-2_5
   RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714
   Schindler S, 2019, PERS INDIV DIFFER, V136, P90, DOI 10.1016/j.paid.2018.01.050
   Schuster R, 2006, LEISURE SCI, V28, P97, DOI 10.1080/01490400500483919
   Scott N., 2007, Journal of Travel & Tourism Marketing, V23, P1
   Scott N., 2005, Journal of Travel & Tourism Marketing, V19, P149, DOI 10.1300/J073v19n02_12
   Scott N., 2013, SAFETY SECURITY TOUR
   Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657
   Sharifpour M, 2014, J VACAT MARK, V20, P111, DOI 10.1177/1356766713502486
   SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Small TA, 2011, INFORM COMMUN SOC, V14, P872, DOI 10.1080/1369118X.2011.554572
   Taecharungroj V, 2015, J CREAT COMMUN, V10, P288, DOI 10.1177/0973258615614420
   Tamir M, 2016, PERS SOC PSYCHOL REV, V20, P199, DOI 10.1177/1088868315586325
   Thunstrom L., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3593098, DOI 10.2139/SSRN.3593098]
   United Nation World Organization, 2020, SUPP JOBS EC THROUGH
   United Nation World Tourism Organization, 2020, COVID 19 REL TRAV RE
   Vada S, 2020, TOUR MANAG PERSPECT, V33, DOI 10.1016/j.tmp.2019.100631
   Volo S., 2020, ANN TOURISM RES, V103098
   Volo S, 2013, CURR ISSUES TOUR, V16, P197, DOI 10.1080/13683500.2012.715629
   Wang BR, 2017, NAT HAZARDS, V89, P161, DOI 10.1007/s11069-017-2960-x
   Weitz E., 2017, EUROPEAN J HUMOUR RE, V4, P1
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   WHO, 2020, WHO2019NCOVMENTALHLT
   Yi SW, 2004, J CONSUM PSYCHOL, V14, P303, DOI 10.1207/s15327663jcp1403_11
   Yiu R.C., 2020, POLICY DES PRACT, P1
   Yu M, 2021, CURR ISSUES TOUR, V24, P2699, DOI 10.1080/13683500.2020.1752632
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
   Zheng DN, 2021, TOURISM MANAGE, V83, DOI 10.1016/j.tourman.2020.104261
   Zheng Y, 2020, ANATOLIA, V31, P337, DOI 10.1080/13032917.2020.1747208
   Zhu MF, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104167
NR 89
TC 0
Z9 0
U1 12
U2 12
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1750-6182
EI 1750-6190
J9 INT J CULT TOUR HOSP
JI Int. J. Cult. Tour. Hosp. Res.
DI 10.1108/IJCTHR-09-2020-0223
EA SEP 2021
PG 16
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA WI8LU
UT WOS:000708607800001
OA Bronze
DA 2022-04-20
ER

PT J
AU Kyrou, I
   Karteris, E
   Robbins, T
   Chatha, K
   Drenos, F
   Randeva, HS
AF Kyrou, Ioannis
   Karteris, Emmanouil
   Robbins, Tim
   Chatha, Kamaljit
   Drenos, Fotios
   Randeva, Harpal S.
TI Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female
   patient population at potentially higher risk during the COVID-19
   pandemic
SO BMC MEDICINE
LA English
DT Article
DE Polycystic ovary syndrome; PCOS; COVID-19; Severe acute respiratory
   syndrome coronavirus-2; SARS-CoV-2; Diabetes; Obesity; Hypertension;
   Androgens; Vitamin D
ID VITAMIN-D SUPPLEMENTATION; DIAGNOSTIC-CRITERIA; HEALTH; WOMEN;
   METAANALYSIS; PHYSICIANS; INFECTION; KNOWLEDGE
AB BackgroundIn women of reproductive age, polycystic ovary syndrome (PCOS) constitutes the most frequent endocrine disorder. Women with PCOS are considered to typically belong to an age and sex group which is at lower risk for severe COVID-19.Main bodyEmerging data link the risk of severe COVID-19 with certain factors such as hyper-inflammation, ethnicity predisposition, low vitamin D levels, and hyperandrogenism, all of which have known direct associations with PCOS. Moreover, in this common female patient population, there is markedly high prevalence of multiple cardio-metabolic conditions, such as type 2 diabetes, obesity, and hypertension, which may significantly increase the risk for adverse COVID-19-related outcomes. This strong overlap of risk factors for both worse PCOS cardio-metabolic manifestations and severe COVID-19 should be highlighted for the clinical practice, particularly since women with PCOS often receive fragmented care from multiple healthcare services. Comprehensively informing women with PCOS regarding the potential risks from COVID-19 and how this may affect their management is also essential.ConclusionDespite the immense challenges posed by the COVID-19 outbreak to the healthcare systems in affected countries, attention should be directed to maintain a high standard of care for complex patients such as many women with PCOS and provide relevant practical recommendations for optimal management in the setting of this fast moving pandemic.
C1 [Kyrou, Ioannis; Robbins, Tim; Randeva, Harpal S.] Univ Hosp Coventry & Warwickshire NHS Trust, WISDEM, Coventry CV2 2DX, W Midlands, England.
   [Kyrou, Ioannis; Randeva, Harpal S.] Aston Univ, Aston Med Res Inst, Aston Med Sch, Birmingham B4 7ET, W Midlands, England.
   [Kyrou, Ioannis; Randeva, Harpal S.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
   [Karteris, Emmanouil; Drenos, Fotios] Brunel Univ London, Coll Hlth & Life Sci, Uxbridge UB8 3PH, Middx, England.
   [Robbins, Tim] Univ Warwick, Inst Digital Healthcare, WMG, Coventry CV4 7AL, W Midlands, England.
   [Chatha, Kamaljit] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Biochem & Immunol, Coventry CV2 2DX, W Midlands, England.
   [Drenos, Fotios] UCL, Inst Cardiovasc Sci, London, England.
RP Randeva, HS (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, WISDEM, Coventry CV2 2DX, W Midlands, England.; Randeva, HS (corresponding author), Aston Univ, Aston Med Res Inst, Aston Med Sch, Birmingham B4 7ET, W Midlands, England.
EM Harpal.Randeva@warwick.ac.uk
RI Chatha, Kamaljit/AAC-2935-2021; Karteris, Emmanouil/AAC-6821-2022
FU General Charities of the City of Coventry
FX IK and HR acknowledge and thank the General Charities of the City of
   Coventry for their support. This review is also dedicated to all of the
   healthcare professionals fighting against the COVID-19 pandemic.
CR ABDULAI I, 2020, CELL, V181, DOI DOI 10.1016/J.AGSY.2020.102812
   Akbari M, 2018, HORM METAB RES, V50, P271, DOI 10.1055/s-0044-101355
   Akincigil A, 2020, HEALTH SERV RES, V55, P596, DOI 10.1111/1475-6773.13297
   Al-Ani F, 2020, THROMB RES, V192, P152, DOI 10.1016/j.thromres.2020.05.039
   Aldridge Robert W, 2020, Wellcome Open Res, V5, P88, DOI [10.12688/wellcomeopenres.15922.2, 10.12688/wellcomeopenres.15922.1]
   [Anonymous], 2020, COR DIS 2019 COVID 1
   Azadi-Yazdi M, 2017, HORM METAB RES, V49, P174, DOI 10.1055/s-0043-103573
   Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z
   Baker JG, 2020, THORAX, V75, P368, DOI 10.1136/thoraxjnl-2020-214913
   Barker J, 2020, THORAX, V75, P367, DOI 10.1136/thoraxjnl-2020-214890
   Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2
   Bornstein SR, 2020, NAT REV ENDOCRINOL, V16, P297, DOI 10.1038/s41574-020-0353-9
   Cai H., 2020, LANCET RESP MED, V8, P4, DOI [10.1016/S2213-2600(20)30117-X7103991, DOI 10.1016/S2213-2600(20)30117-X7103991]
   Cannarella Rossella, 2020, Int J Endocrinol, V2020, P1942126, DOI 10.1155/2020/1942126
   Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004
   Craig S, 2020, GUIDANCE REGARDING C
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Dalpiaz PLM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127515
   Di Guardo F, 2019, MED HYPOTHESES, V126, P1, DOI 10.1016/j.mehy.2019.03.003
   Ding T, 2017, ONCOTARGET, V8, P96351, DOI 10.18632/oncotarget.19180
   Dokras A, 2017, FERTIL STERIL, V107, P1380, DOI 10.1016/j.fertnstert.2017.04.011
   Drucker DJ, 2020, ENDOCR REV, V41, P457, DOI 10.1210/endrev/bnaa011
   Fagone P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102571
   Fletcher-Sandersjoo A, 2020, THROMB RES, V194, P36, DOI 10.1016/j.thromres.2020.06.027
   Garg M, 2020, ALIMENT PHARM THER, V51, P1438, DOI 10.1111/apt.15796
   Gariani K, 2020, THROMB RES, V185, P102, DOI 10.1016/j.thromres.2019.11.019
   Gibson-Helm M, 2018, SEMIN REPROD MED, V36, P19, DOI 10.1055/s-0038-1667155
   Goldacre B., 2020, OPENSAFELY FACTORS A, DOI 10.1101/2020.05.06.20092999
   Goren A, 2020, J COSMET DERMATOL-US, V19, P1545, DOI 10.1111/jocd.13443
   GRANT WB, 2020, NUTRIENTS, V12, DOI [DOI 10.3390/NU12040988, 10.3390/nu12040988]
   Green, 2020, FEATURES 16749 HOSP, DOI [10.1136/bmj.m1985, DOI 10.1101/2020.04.23.20076042]
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo RY, 2015, BMC GENET, V15, DOI 10.1186/s12863-015-0165-4
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050
   Ilie PC, 2020, AGING CLIN EXP RES, V32, P1195, DOI 10.1007/s40520-020-01570-8
   Jakovac H, 2020, AM J PHYSIOL-ENDOC M, V318, pE589, DOI 10.1152/ajpendo.00138.2020
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152
   Kahal H, 2020, SLEEP BREATH, V24, P339, DOI 10.1007/s11325-019-01835-1
   Kahal H, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy085
   Kahal H, 2017, CLIN ENDOCRINOL, V87, P313, DOI 10.1111/cen.13392
   Kaiser UB, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa148
   Kakoly NS, 2018, HUM REPROD UPDATE, V24, P455, DOI 10.1093/humupd/dmy007
   Khomami MB, 2019, OBES REV, V20, P659, DOI 10.1111/obr.12829
   Klonoff DC, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154224
   Kupferschmidt K, 2020, SCIENCE, V367, P963, DOI 10.1126/science.367.6481.963
   Kyrou I, 2018, CLIN PROBLEMS CAUSED
   Kyrou I, 2015, ENDOCRINOLOGY DIABET, P99, DOI DOI 10.1007/978-1-4471-2789-5_13
   La Vignera S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082948
   Lance Colleen G, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc003
   Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006
   Liverpool L., 2020, NEW SCI, V246, P3279, DOI 10.1016/S0262-4079(20)30790-97194695
   Maddaloni E, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3321
   Magrone T, 2020, ENDOCR METAB IMMUNE, V20, P807, DOI 10.2174/1871530320666200427112902
   Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923
   Marik Paul E, 2020, Med Drug Discov, V6, P100041, DOI 10.1016/j.medidd.2020.100041
   Matar R, 2021, CLIN INFECT DIS, V72, P521, DOI 10.1093/cid/ciaa828
   McCoy J, 2020, J COSMET DERMATOL-US, V19, P1542, DOI 10.1111/jocd.13455
   Mehta N, 2020, JAMA CARDIOL, V5, P1020, DOI 10.1001/jamacardio.2020.1855
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mills G, 2020, HUM REPROD, V35, P1666, DOI 10.1093/humrep/deaa099
   Mongioi LM, 2020, ENDOCRINE, V68, P467, DOI 10.1007/s12020-020-02349-7
   Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001
   Muscogiuri G, 2014, EUR J ENDOCRINOL, V171, pR101, DOI 10.1530/EJE-14-0158
   Naver KV, 2014, BJOG-INT J OBSTET GY, V121, P575, DOI 10.1111/1471-0528.12558
   Nussbaumer-Streit Barbara, 2020, Cochrane Database Syst Rev, V9, pCD013574, DOI 10.1002/14651858.CD013574.pub2
   dos Reis GVOP, 2017, J OBSTET GYNAECOL RE, V43, P436, DOI 10.1111/jog.13250
   Panarese A, 2020, ALIMENT PHARM THER, V51, P993, DOI 10.1111/apt.15752
   Pareek M, 2020, LANCET, V395, P1421, DOI 10.1016/S0140-6736(20)30922-3
   Quinn M, 2014, FERTIL STERIL, V101, P1129, DOI 10.1016/j.fertnstert.2014.01.003
   Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003
   Rayman G, 2020, DIABETIC MED, V37, P1087, DOI 10.1111/dme.14316
   Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975
   Rhodes JM, 2020, ALIMENT PHARM THER, V51, P1434, DOI 10.1111/apt.15777
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Sama IE, 2020, EUR HEART J, V41, P1810, DOI 10.1093/eurheartj/ehaa373
   Schroeder M., 2020, MAJORITY MALE PATIEN, DOI 10.1101/2020.05.07.20073817
   Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201
   Sharma S, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108183
   Silberstein M, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109767
   Sriram K, 2020, CLIN PHARMACOL THER, V108, P236, DOI 10.1002/cpt.1863
   Teede HJ, 2018, CLIN ENDOCRINOL, V89, P251, DOI 10.1111/cen.13795
   Tian Y, 2020, ALIMENT PHARM THER, V51, P995, DOI 10.1111/apt.15764
   UK Office for National Statistics, COR COVID 19 REL DEA
   Wambier CG, 2020, DRUG DEVELOP RES, V81, P771, DOI 10.1002/ddr.21688
   Wambier CG, 2020, J AM ACAD DERMATOL, V83, P308, DOI 10.1016/j.jaad.2020.04.032
   Wang SP, 2013, SEMIN REPROD MED, V31, P365, DOI 10.1055/s-0033-1348895
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yan J, 2020, MOL HUM REPROD, V26, P367, DOI 10.1093/molehr/gaaa030
   Yu HF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004863
   Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393
   Zhang YL, 2020, ENDOCR J, V67, P561, DOI 10.1507/endocrj.EJ19-0558
   Zuin M, 2020, J INFECTION, V81, pE84, DOI 10.1016/j.jinf.2020.03.059
NR 95
TC 30
Z9 30
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD JUL 15
PY 2020
VL 18
IS 1
AR 220
DI 10.1186/s12916-020-01697-5
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA MQ8LK
UT WOS:000553144200007
PM 32664957
OA Green Published, Green Accepted, gold
DA 2022-04-20
ER

PT J
AU Verweij, PE
   Bruggemann, RJM
   Azoulay, E
   Bassetti, M
   Blot, S
   Buil, JB
   Calandra, T
   Chiller, T
   Clancy, CJ
   Cornely, OA
   Depuydt, P
   Koehler, P
   Lagrou, K
   de Lange, D
   Lass-Florl, C
   Lewis, RE
   Lortholary, O
   Liu, PWL
   Maertens, J
   Nguyen, MH
   Patterson, TF
   Rijnders, BJA
   Rodriguez, A
   Rogers, TR
   Schouten, JA
   Wauters, J
   van de Veerdonk, FL
   Martin-Loeches, I
AF Verweij, Paul E.
   Bruggemann, Roger J. M.
   Azoulay, Elie
   Bassetti, Matteo
   Blot, Stijn
   Buil, Jochem B.
   Calandra, Thierry
   Chiller, Tom
   Clancy, Cornelius J.
   Cornely, Oliver A.
   Depuydt, Pieter
   Koehler, Philipp
   Lagrou, Katrien
   de Lange, Dylan
   Lass-Florl, Cornelia
   Lewis, Russell E.
   Lortholary, Olivier
   Liu, Peter-Wei Lun
   Maertens, Johan
   Nguyen, M. Hong
   Patterson, Thomas F.
   Rijnders, Bart J. A.
   Rodriguez, Alejandro
   Rogers, Thomas R.
   Schouten, Jeroen A.
   Wauters, Joost
   van de Veerdonk, Frank L.
   Martin-Loeches, Ignacio
TI Taskforce report on the diagnosis and clinical management of COVID-19
   associated pulmonary aspergillosis
SO INTENSIVE CARE MEDICINE
LA English
DT Article
DE Viral pneumonia; SARS-CoV-2; COVID-19; Invasive aspergillosis; ICU
ID CRITICALLY-ILL PATIENTS; INVASIVE ASPERGILLOSIS; VORICONAZOLE
   PHARMACOKINETICS; POSACONAZOLE; DIFFERENTIATION; GUIDELINES; SOCIETY;
   BETA; ICU
AB Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU). Diagnosis and management of COVID-19 associated pulmonary aspergillosis (CAPA) are challenging and our aim was to develop practical guidance. Methods A group of 28 international experts reviewed current insights in the epidemiology, diagnosis and management of CAPA and developed recommendations using GRADE methodology. Results The prevalence of CAPA varied between 0 and 33%, which may be partly due to variable case definitions, but likely represents true variation. Bronchoscopy and bronchoalveolar lavage (BAL) remain the cornerstone of CAPA diagnosis, allowing for diagnosis of invasive Aspergillus tracheobronchitis and collection of the best validated specimen for Aspergillus diagnostics. Most patients diagnosed with CAPA lack traditional host factors, but pre-existing structural lung disease and immunomodulating therapy may predispose to CAPA risk. Computed tomography seems to be of limited value to rule CAPA in or out, and serum biomarkers are negative in 85% of patients. As the mortality of CAPA is around 50%, antifungal therapy is recommended for BAL positive patients, but the decision to treat depends on the patients' clinical condition and the institutional incidence of CAPA. We recommend against routinely stopping concomitant corticosteroid or IL-6 blocking therapy in CAPA patients. Conclusion CAPA is a complex disease involving a continuum of respiratory colonization, tissue invasion and angioinvasive disease. Knowledge gaps including true epidemiology, optimal diagnostic work-up, management strategies and role of host-directed therapy require further study.
C1 [Verweij, Paul E.; Buil, Jochem B.] Radboud Univ Nijmegen, Dept Med Microbiol, Radboudumc Ctr Infect Dis RCI, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [Verweij, Paul E.; Bruggemann, Roger J. M.; Buil, Jochem B.] Radboudumc CWZ Ctr Expertise Mycol, Radboudumc Ctr Infect Dis RCI, Nijmegen, Netherlands.
   [Verweij, Paul E.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Res Diagnost & Lab Surveillance, Bilthoven, Netherlands.
   [Bruggemann, Roger J. M.] Radboud Univ Nijmegen Med Ctr, Dept Pharm, Nijmegen, Netherlands.
   [Bruggemann, Roger J. M.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands.
   [Azoulay, Elie] St Louis Hosp, AP HP, Med Intens Care Unit, Paris, France.
   [Bassetti, Matteo] Osped Policlin San Martino IRCCS, Clin Malattie Infett, Genoa, Italy.
   [Bassetti, Matteo] Univ Genoa, Dept Hlth Sci, DISSAL, Genoa, Italy.
   [Blot, Stijn] Univ Ghent, Dept Internal Med & Paediat, Fac Med & Hlth Sci, Ghent, Belgium.
   [Blot, Stijn] Univ Queensland, Crit Care Res Ctr, Clin Res Ctr, Burns, Brisbane, Qld, Australia.
   [Calandra, Thierry] Lausanne Univ Hosp, Infect Dis Serv, Dept Med, CH-1011 Lausanne, Switzerland.
   [Calandra, Thierry] Univ Lausanne, CH-1011 Lausanne, Switzerland.
   [Chiller, Tom] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.
   [Clancy, Cornelius J.; Nguyen, M. Hong] Univ Pittsburgh, Div Infect Dis, Pittsburgh, PA USA.
   [Cornely, Oliver A.; Koehler, Philipp] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
   [Cornely, Oliver A.; Koehler, Philipp] Univ Cologne, Dept Internal Med, German Ctr Infect Res, ECMM Ctr Excellence Med Mycol, Cologne, Germany.
   [Cornely, Oliver A.] Univ Cologne, Clin Trials Ctr Cologne ZKS Koln, Cologne, Germany.
   [Depuydt, Pieter] Ghent Univ Hosp, Dept Crit Care Med, Ghent, Belgium.
   [Lagrou, Katrien] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.
   [Lagrou, Katrien] Univ Hosp Leuven, Dept Lab Med, Natl Reference Ctr Mycosis, Leuven, Belgium.
   [de Lange, Dylan] Univ Utrecht, Univ Med Ctr, Dept Intens Care Med, Utrecht, Netherlands.
   [Lass-Florl, Cornelia] Med Univ Innsbruck, Div Hyg & Med Microbiol, Innsbruck, Austria.
   [Lewis, Russell E.] Univ Bologna, Infect Dis Hosp, Dept Med & Surg Sci, IRCSS SOrsola Malpighi, Bologna, Italy.
   [Lortholary, Olivier] Univ Paris, Necker Enfants Malades Hosp, Necker Pasteur Ctr Infect Dis & Trop Med, AP HP, Paris, France.
   [Lortholary, Olivier] CNRS, Inst Pasteur, Mol Mycol Unit, Natl Reference Ctr Invas Mycoses & Antifungals,UM, Paris, France.
   [Liu, Peter-Wei Lun] Fu Jen Catholic Univ, Fu Jen Catholic Univ Hosp, Dept Emergency & Crit Care Med, New Taipei, Taiwan.
   [Liu, Peter-Wei Lun] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan.
   [Maertens, Johan] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium.
   [Patterson, Thomas F.] Univ Texas Hlth Sci Ctr, Div Infect Dis, Dept Med, San Antonio, TX USA.
   [Patterson, Thomas F.] South Texas Vet Hlth Care Syst, San Antonio, TX USA.
   [Rijnders, Bart J. A.] Univ Med Ctr, Dept Internal Med & Infect Dis, Erasmus MC, Rotterdam, Netherlands.
   [Rodriguez, Alejandro] Joan XXIII Univ Hosp, Crit Care Dept, Tarragona, Spain.
   [Rogers, Thomas R.] Trinity Coll Dublin, St Jamess Hosp, Dept Clin Microbiol, Dublin, Ireland.
   [Schouten, Jeroen A.] Radboud Univ Nijmegen, Dept Intens Care Med, Med Ctr, Nijmegen, Netherlands.
   [Schouten, Jeroen A.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Sci Ctr Qual Healthcare IQ Healthcare, Med Ctr, Nijmegen, Netherlands.
   [Wauters, Joost] Univ Hosp Leuven, Dept Gen Internal Med, Med Intens Care Unit, Leuven, Belgium.
   [van de Veerdonk, Frank L.] Radboud Univ Nijmegen Med Ctr, Dept Med, Nijmegen, Netherlands.
   [Martin-Loeches, Ignacio] St James Hosp, Dept Intens Care Med, Multidisciplinary Intens Care Res Org MICRO, Dublin, Ireland.
   [Martin-Loeches, Ignacio] Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain.
   [Martin-Loeches, Ignacio] St James Hosp, Dept Clin Med, Multidisciplinary Intens Care Res Org MICRO, Dublin, Ireland.
RP Verweij, PE (corresponding author), Radboud Univ Nijmegen, Dept Med Microbiol, Radboudumc Ctr Infect Dis RCI, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.; Verweij, PE (corresponding author), Radboudumc CWZ Ctr Expertise Mycol, Radboudumc Ctr Infect Dis RCI, Nijmegen, Netherlands.; Verweij, PE (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Res Diagnost & Lab Surveillance, Bilthoven, Netherlands.; Martin-Loeches, I (corresponding author), St James Hosp, Dept Intens Care Med, Multidisciplinary Intens Care Res Org MICRO, Dublin, Ireland.; Martin-Loeches, I (corresponding author), Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain.; Martin-Loeches, I (corresponding author), St James Hosp, Dept Clin Med, Multidisciplinary Intens Care Res Org MICRO, Dublin, Ireland.
EM paul.verweij@radboudumc.nl; drmartinloeches@gmail.com
RI van de Veerdonk, Frank L/C-7256-2008; Koehler, Philipp/J-7985-2019; De
   Lange, Dylan/ABB-8172-2020; Cornely, Oliver A/J-5095-2013; Calandra,
   Thierry/D-9017-2015; Bruggemann, Roger/A-7057-2015; Blot,
   Stijn/H-9015-2013
OI van de Veerdonk, Frank L/0000-0002-1121-4894; Koehler,
   Philipp/0000-0002-7386-7495; De Lange, Dylan/0000-0002-0191-7270;
   Cornely, Oliver A/0000-0001-9599-3137; Calandra,
   Thierry/0000-0003-3051-1285; Bruggemann, Roger/0000-0002-7618-725X;
   Lass-Florl, Cornelia/0000-0002-2946-7785; Blot,
   Stijn/0000-0003-2145-0345; Azoulay, Elie/0000-0002-8162-1508
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR002645] Funding Source: Medline
CR Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496
   Alanio A, 2020, LANCET RESP MED, V8, pE48, DOI 10.1016/S2213-2600(20)30237-X
   Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022
   Antinori S, 2020, TRAVEL MED INFECT DI, V38, DOI 10.1016/j.tmaid.2020.101752
   Armstrong-James D, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02554-2020
   Azoulay E, 2016, ONCOTARGET, V7, P21484, DOI 10.18632/oncotarget.7471
   Blot SI, 2012, AM J RESP CRIT CARE, V186, P56, DOI 10.1164/rccm.201111-1978OC
   Bonate A, 2016, OPEN FORUM INFECT DI, V3, P1950, DOI [10.1093/ofid/ofw172.1498, DOI 10.1093/OFID/OFW172.1498]
   Boots RJ, 1999, THORAX, V54, P1047, DOI 10.1136/thx.54.11.1047
   Borczuk AC, 2020, MODERN PATHOL, V33, P2156, DOI 10.1038/s41379-020-00661-1
   Boyd S, 2021, CLIN INFECT DIS, V73, pE1236, DOI 10.1093/cid/ciab008
   Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9
   Cheng WW, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.571156
   Cricca M, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1065, DOI 10.1093/CID/CIAA1065]
   van de Veerdonk FL, 2021, LANCET RESP MED, V9, P795, DOI 10.1016/S2213-2600(21)00138-7
   Delliere S, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.12.005
   Dolton MJ, 2012, ANTIMICROB AGENTS CH, V56, P4793, DOI 10.1128/AAC.00626-12
   Donnelly JP, 2020, CLIN INFECT DIS, V71, P1367, DOI 10.1093/cid/ciz1008
   Dupont D, 2020, MED MYCOL, V59, P110, DOI 10.1093/mmy/myaa078
   Evert K, 2021, VIRCHOWS ARCH, V479, P97, DOI 10.1007/s00428-020-03014-0
   Fekkar A, 2021, AM J RESP CRIT CARE, V203, P307, DOI 10.1164/rccm.202009-3400OC
   Flikweert AW, 2020, J CRIT CARE, V59, P149, DOI 10.1016/j.jcrc.2020.07.002
   Gao CA, 2021, ANN AM THORAC SOC, V18, P1243, DOI 10.1513/AnnalsATS.202009-1225RL
   Ghelfenstein-Ferreira T, 2021, MED MYCOL CASE REP, V31, P15, DOI 10.1016/j.mmcr.2020.06.006
   Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI 10.1056/NEJMoa2100433
   Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80
   Helleberg M, 2021, CLIN MICROBIOL INFEC, V27, P147, DOI 10.1016/j.cmi.2020.07.047
   Hoenigl M, 2013, ANTIMICROB AGENTS CH, V57, P3262, DOI 10.1128/AAC.00251-13
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   Kiser TH, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0753-8
   Koehler P, 2020, LANCET INFECT DIS, V21, pE149, DOI 10.1016/S1473-3099(20)30847-1
   Koehler P, 2021, MYCOSES, V64, P55, DOI 10.1111/myc.13183
   Koehler P, 2020, MYCOSES, V63, P528, DOI 10.1111/myc.13096
   Lamoth F, 2020, CLIN MICROBIOL INFEC, V26, P1706, DOI 10.1016/j.cmi.2020.07.010
   Lang M, 2020, J THORAC IMAG, V35, P346, DOI 10.1097/RTI.0000000000000542
   Lansbury LE, 2020, CRIT CARE MED, V48, pE98, DOI 10.1097/CCM.0000000000004093
   Lormans P, 2021, INTENS CRIT CARE NUR, V63, DOI 10.1016/j.iccn.2020.102993
   Maertens JA, 2021, LANCET, V397, P499, DOI 10.1016/S0140-6736(21)00219-1
   Meijer EFJ, 2021, MYCOSES, V64, P457, DOI 10.1111/myc.13254
   Meijer EFJ, 2020, J FUNGI, V6, DOI 10.3390/jof6020079
   Mercier T, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03367-7
   Methley AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0579-0
   Mitaka H, 2020, MYCOSES, V63, P1368, DOI 10.1111/myc.13185
   Mohamed A, 2021, MED MYCOL CASE REP, V31, P11, DOI 10.1016/j.mmcr.2020.06.005
   Nasir N, 2020, MYCOSES, V63, P766, DOI 10.1111/myc.13135
   Nyga R, 2020, AM J RESP CRIT CARE, V202, P708, DOI 10.1164/rccm.201910-1931OC
   Pai MP, 2011, ANTIMICROB AGENTS CH, V55, P2601, DOI 10.1128/AAC.01765-10
   Patterson TF, 2016, CLIN INFECT DIS, V63, P433, DOI 10.1093/cid/ciw444
   Permpalung Nitipong, 2022, Clin Infect Dis, V74, P83, DOI 10.1093/cid/ciab223
   Pritchett MA, 2020, J THORAC DIS, V12, P1781, DOI 10.21037/jtd.2020.04.32
   Roman-Montes CM, 2021, MYCOSES, V64, P364, DOI 10.1111/myc.13216
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Rutsaert L, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00686-4
   Salmanton-Garcia J, 2021, EMERG INFECT DIS, V27, P1077, DOI 10.3201/eid2704.204895
   Sarrazyn C, 2021, INFECT CONT HOSP EP, V42, P1149, DOI 10.1017/ice.2020.460
   Schauwvlieghe AFAD, 2018, LANCET RESP MED, V6, P782, DOI 10.1016/S2213-2600(18)30274-1
   Schroeder M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1326-1
   Skok K, 2021, PATHOL RES PRACT, V217, DOI 10.1016/j.prp.2020.153305
   Spriet I, 2009, J ANTIMICROB CHEMOTH, V63, P767, DOI 10.1093/jac/dkp026
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Townsend RW, 2017, EUR J CLIN PHARMACOL, V73, P669, DOI 10.1007/s00228-017-2213-7
   Ullmann AJ, 2018, CLIN MICROBIOL INFEC, V24, pE1, DOI 10.1016/j.cmi.2018.01.002
   van Arkel ALE, 2020, AM J RESP CRIT CARE, V202, P132, DOI 10.1164/rccm.202004-1038LE
   Van Biesen S, 2020, AM J RESP CRIT CARE, V202, P1171, DOI 10.1164/rccm.202005-2018LE
   Van Daele R, 2021, J ANTIMICROB CHEMOTH, V76, P1234, DOI 10.1093/jac/dkab012
   van de Veerdonk FL, 2017, NAT REV MICROBIOL, V15, P661, DOI 10.1038/nrmicro.2017.90
   van Grootveld R, 2021, MYCOSES, V64, P641, DOI 10.1111/myc.13259
   Ventura MAE, 2016, ANTIMICROB AGENTS CH, V60, P2727, DOI 10.1128/AAC.02830-15
   Veringa A, 2017, INT J ANTIMICROB AG, V49, P243, DOI 10.1016/j.ijantimicag.2016.10.010
   Verweij PE, 2020, INTENS CARE MED, V46, P1524, DOI 10.1007/s00134-020-06091-6
   Wang J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03046-7
   Wasmann RE, 2020, J ANTIMICROB CHEMOTH, V75, P1006, DOI 10.1093/jac/dkz546
   White PL., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1298, DOI 10.1093/CID/CIAA1298]
   Zhao YJ, 2020, PHARMACOTHERAPY, V40, P89, DOI 10.1002/phar.2348
NR 76
TC 19
Z9 19
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0342-4642
EI 1432-1238
J9 INTENS CARE MED
JI Intensive Care Med.
PD AUG
PY 2021
VL 47
IS 8
BP 819
EP 834
DI 10.1007/s00134-021-06449-4
EA JUN 2021
PG 16
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA TP8JH
UT WOS:000664831300001
PM 34160631
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Sumaedi, S
   Sumardjo
   Saleh, A
   Syukri, AF
AF Sumaedi, Sik
   Sumardjo
   Saleh, Amiruddin
   Syukri, Agus Fanar
TI A model of digital health communication media use during the Covid-19
   pandemic
SO HEALTH EDUCATION
LA English
DT Article
DE Digital media; Health communication; Healthy food; Covid-19 pandemic
ID INFORMATION-SEEKING; TECHNOLOGY ACCEPTANCE; UNIVERSITY-STUDENTS; SOCIAL
   MEDIA; BEHAVIOR; USAGE; CREDIBILITY; KNOWLEDGE; ADOPTION; DETERMINANTS
AB Purpose This research aims to develop and test a model of digital health communication media (DHCM) use for healthy food information - DHCM usage - during the Covid-19 pandemic. More specifically, this research investigated the simultaneous effects of perceived threat of Covid-19, e-health literacy, attitude toward DHCM usage, knowledge toward DHCM usage, facilitating conditions and information quality on the DHCM usage. Design/methodology/approach The empirical data were collected through a survey. The respondents of the survey are 192 DHCM users who lived in Tangerang Regency. Structural equation modelling (SEM) analysis was performed. Findings The DHCM usage during the Covid-19 pandemic is significantly affected by the attitude towards the DHCM usage and the facilitating conditions. However, the DHCM usage during the Covid-19 pandemic is not significantly affected by the perceived threat of Covid-19, e-health literacy, information quality and knowledge of the DHCM usage. Research limitations/implications This research was conducted only in Tangerang Regency and employed a purposive sampling technique. Future research should be conducted in other contexts to examine the stability of the research findings. Practical implications In order to improve DHCM usage for healthy food information, it is important for building a positive attitude towards DHCM usage and ensuring the availability of the facilitating conditions. Originality/value This paper is the first that develops and tests a model of DHCM usage for healthy food information during the Covid-19 pandemic.
C1 [Sumaedi, Sik; Syukri, Agus Fanar] Indonesian Inst Sci, Jakarta, Indonesia.
   [Sumardjo; Saleh, Amiruddin] IPB Univ, Bogor, Indonesia.
RP Sumaedi, S (corresponding author), Indonesian Inst Sci, Jakarta, Indonesia.
EM sik_s_01@yahoo.com; sumardjo252@gmail.com; amiruddin_ipb@yahoo.co.id;
   agus.fanar.syukri@lipi.go.id
FU Indonesian Institute of SciencesMinistry of Research and Technology of
   the Republic of Indonesia (RISTEK); quality management research group
FX All authors are main contributor of this paper. The authors would also
   like to thanks to the management of Indonesian Institute of Sciences,
   the quality management research group and Nidya J Astrini that have
   supported this research.
CR Ahadzadeh AS, 2018, ONLINE INFORM REV, V42, P58, DOI 10.1108/OIR-02-2016-0066
   Ahadzadeh AS, 2017, SEARCH-J SOUTHEAST A, V9, P47
   Ahadzadeh Ashraf Sadat, 2015, J Med Internet Res, V17, pe45, DOI 10.2196/jmir.3564
   Ahuja V., 2011, GLOBAL MEDIA J INDIA, V2, P1
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Akil M, 2019, J GIZI PANGAN, V14, P1, DOI 10.25182/jgp.2019.14.1.1-8
   Alhuwail D, 2019, J MED INTERNET RES, V21, DOI 10.2196/11174
   Aman F, 2020, PAK J MED SCI, V36, pS121, DOI 10.12669/pjms.36.COVID19-S4.2776
   Ameen, 2019, INT J EMERGING TECHN, V10, P141
   Aminah S., 2015, Journal of Agriculture and Rural Development in the Tropics and Subtropics, V116, P11
   Amrein MA, 2017, APPETITE, V116, P1, DOI 10.1016/j.appet.2017.04.016
   ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411
   APJII, 2020, LAP SURV INT APJ JII
   Bates BR, 2006, MED INFORM INTERNET, V31, P45, DOI 10.1080/14639230600552601
   Bennett JE, 2020, LANCET, V396, P918, DOI 10.1016/S0140-6736(20)31761-X
   Bervell B, 2020, INT J EDUC TECHNOL H, V17, DOI 10.1186/s41239-020-0183-9
   Boon-itt, 2019, J INNOVATION ENTREPR, V8, P1
   Butler MJ, 2020, BRAIN BEHAV IMMUN, V87, P53, DOI 10.1016/j.bbi.2020.04.040
   Cajita MI, 2018, CIN-COMPUT INFORM NU, V36, P376, DOI 10.1097/CIN.0000000000000442
   CALDER BJ, 1981, J CONSUM RES, V8, P197, DOI 10.1086/208856
   Castren J, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-8
   Chang FC, 2015, CYBERPSYCH BEH SOC N, V18, P618, DOI 10.1089/cyber.2015.0110
   Chang YS, 2021, COMPUT HUM BEHAV, V115, DOI 10.1016/j.chb.2020.106629
   Cheng E.W., 2001, J MANAG DEV, V20, P660, DOI DOI 10.1108/02621710110400564
   Cheng TCE, 2006, DECIS SUPPORT SYST, V42, P1558, DOI 10.1016/j.dss.2006.01.002
   Czaja SJ, 2013, J AM MED INFORM ASSN, V20, P277, DOI 10.1136/amiajnl-2012-000876
   Dashti Sareh, 2017, Electron Physician, V9, P3966, DOI 10.19082/3966
   DeLone WH, 1992, INFORM SYST RES, V3, P60, DOI 10.1287/isre.3.1.60
   Deng ZH, 2017, INT J MED INFORM, V105, P98, DOI 10.1016/j.ijmedinf.2017.05.014
   Deng ZH, 2015, INFORM TECHNOL PEOPL, V28, P405, DOI 10.1108/ITP-03-2014-0053
   Deshpande Sameer, 2009, Health Mark Q, V26, P145, DOI 10.1080/07359680802619834
   Dunnebeil S, 2012, INT J MED INFORM, V81, P746, DOI 10.1016/j.ijmedinf.2012.02.002
   Escoffery C, 2005, J AM COLL HEALTH, V53, P183, DOI 10.3200/JACH.53.4.183-188
   Febriani D, 2019, J GIZI PANGAN, V14, P99, DOI 10.25182/jgp.2019.14.2.99-106
   Flanagin A., 2017, OXFORD RES ENCY COMM, DOI [10.1093/acrefore/9780190228613.001.0001/acrefore-9780190228613-e-287, DOI 10.1093/ACREFORE/9780190228613.001.0001/ACREFORE-9780190228613-E-287]
   Garland R., 1991, MARKET B, V2, P66, DOI DOI 10.1016/JIHEDUC.2013.06.002
   Grimes CA, 2018, J NUTR EDUC BEHAV, V50, P547, DOI 10.1016/j.jneb.2018.04.002
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Hall AK, 2015, HEALTH EDUC BEHAV, V42, P202, DOI 10.1177/1090198114547815
   Haluza D, 2017, HEALTH COMMUN, V32, P1342, DOI 10.1080/10410236.2016.1220044
   Harijati S., 2013, JURNAL PENYULUHAN, V9, P41
   Hidayati F, 2019, J PENYUL, V15, P65
   Hong T, 2006, J HEALTH COMMUN, V11, P149, DOI 10.1080/10810730500526679
   Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]
   Hussain A, 2019, INT J INFORM MANAGE, V44, P76, DOI 10.1016/j.ijinfomgt.2018.09.016
   Indonesian Ministry of Health, 2019, LAP PROV BANT RISK 2
   Isaac O, 2020, 2019 1 INT C INT COM, P1
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Kalsum U, 2018, KESMAS, V13, P53, DOI 10.21109/kesmas.v13i2.1694
   Kampmeijer R, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1522-3
   Khatun F, 2015, INT J MED INFORM, V84, P847, DOI 10.1016/j.ijmedinf.2015.06.008
   Knitza J, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19661
   Koivumaki T, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7821
   Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117
   KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007
   Lai WT, 2011, TRANSPORT POLICY, V18, P318, DOI 10.1016/j.tranpol.2010.09.003
   Lavielle P, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-108
   Lee JW, 2002, RES NURS HEALTH, V25, P295, DOI 10.1002/nur.10041
   Lee SM, 2018, J QUAL ASSUR HOSP TO, V19, P151, DOI [10.1080/1528008X.2016.1230036, 10.1080/1528008x.2016.1230036]
   Lin XL, 2016, COMPUT HUM BEHAV, V63, P264, DOI 10.1016/j.chb.2016.05.002
   Lucassen T, 2013, COMPUT HUM BEHAV, V29, P1387, DOI 10.1016/j.chb.2013.01.036
   Malhotra N. K, 2007, MARKETING RES APPL A
   Mitsutake S, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5413
   Mou J, 2016, INFORM TECHNOL PEOPL, V29, P876, DOI 10.1108/ITP-06-2015-0140
   Mujtaba B., 2018, JURNAL PENYULUHAN, V14, P175
   Mulyandari, 2010, CYBER EXTENSION PELU
   Naja F, 2020, EUR J CLIN NUTR, V74, P1117, DOI 10.1038/s41430-020-0634-3
   Neter E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1619
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9
   Noshad K, 2018, INT J MANAG SCI ENG, V13, P215, DOI 10.1080/17509653.2017.1387821
   Paige SR, 2018, DIABETES EDUCATOR, V44, P63, DOI 10.1177/0145721717747228
   Paramastri R, 2020, COMPUT METH PROG BIO, V192, DOI 10.1016/j.cmpb.2020.105459
   Park HH, 2009, INT J RETAIL DISTRIB, V37, P182, DOI 10.1108/09590550910934308
   Rahardjo D, 2016, TURK ONLINE J DISTAN, V17, P30
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Saeed KA, 2008, INFORM MANAGE-AMSTER, V45, P376, DOI 10.1016/j.im.2008.06.002
   Samoggia A, 2020, FOOD RES INT, V128, DOI 10.1016/j.foodres.2019.108766
   Schulz Peter Johannes, 2017, J Med Internet Res, V19, pe166, DOI 10.2196/jmir.6317
   Sekaran U, 2010, RES METHODS BUSINESS
   Sillence E, 2007, SOC SCI MED, V64, P1853, DOI 10.1016/j.socscimed.2007.01.012
   Sillence E, 2007, INTERACT COMPUT, V19, P32, DOI 10.1016/j.intcom.2006.07.009
   Solomon M.R., 2012, CONSUMER BEHAV BUYIN
   Son J, 2019, J EXT, V57
   SUMAEDI S, 2020, INT J HEALTH GOV, V25, P205, DOI 10.1108/IJHG-01-2020-0002
   Sumaedi S, 2020, HEALTH EDUC, V120, P249, DOI 10.1108/HE-07-2020-0048
   Sumaedi S, 2021, BRIT FOOD J, V123, P13, DOI 10.1108/BFJ-01-2020-0019
   Sun YL, 2019, J MED INTERNET RES, V21, DOI 10.2196/12522
   Susanto, 2016, JURNAL PENYULUHAN, V12, P144
   TAO D, 2017, JMIR HUM FACTORS, V4, P1
   Tao D, 2020, COMPUT HUM BEHAV, V104, DOI 10.1016/j.chb.2019.09.023
   TAYLOR S, 1995, INFORM SYST RES, V6, P144, DOI 10.1287/isre.6.2.144
   Tennant B, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3992
   The Indonesian Center Bureau of Statistic, 2019, STAT KES RAK PROV BA
   Thielsch M. T., 2019, MENSCH COMPUTER 2019, P448, DOI 10.18420/muc2019-ws-642
   Trapp GSA, 2015, HEALTH EDUC BEHAV, V42, P759, DOI 10.1177/1090198115578750
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Walker LO, 2017, PUBLIC HEALTH NURS, V34, P561, DOI 10.1111/phn.12347
   Wang J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11174604
   Wang XR, 2021, HIST BIOL, V33, P1705, DOI 10.1080/08912963.2020.1731805
   Ware P, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/13259
   Wheaton B, 1977, SOCIOL METHODOL, V8, P84, DOI DOI 10.2307/270754
   Worldometers, 2021, COVID 19 COR PAND
   Yang SC, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5964
   Yuan SP, 2015, TELEMED E-HEALTH, V21, P735, DOI 10.1089/tmj.2014.0148
   Zhang XJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0726-2
   Zolait AHS, 2014, BEHAV INFORM TECHNOL, V33, P65, DOI 10.1080/0144929X.2011.630419
NR 106
TC 1
Z9 1
U1 7
U2 10
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0965-4283
EI 1758-714X
J9 HEALTH EDUC
JI Health Educ.
PD JUL 26
PY 2021
VL 121
IS 5
BP 465
EP 485
DI 10.1108/HE-03-2021-0040
EA JUN 2021
PG 21
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA TQ9QX
UT WOS:000660292400001
OA Bronze
DA 2022-04-20
ER

PT J
AU Sogut, S
   Dolu, I
   Cangol, E
AF Sogut, Seda
   Dolu, Ilknur
   Cangol, Eda
TI The relationship between COVID-19 knowledge levels and anxiety states of
   midwifery students during the outbreak: A cross-sectional web-based
   survey
SO PERSPECTIVES IN PSYCHIATRIC CARE
LA English
DT Article
DE anxiety; coronavirus; COVID-19; female; midwifery students; pandemic
ID MENTAL-DISORDERS; ACUTE STRESS; HEALTH; RESPONSES
AB Purpose To determine the relationship between the anxiety states and knowledge levels of female midwifery students about COVID-19 during the outbreak.
   Design and Methods This cross-sectional study carried out with online participation of 972 female midwifery students.
   Findings The anxiety levels of the female midwifery students were high among those visiting the hospital during the pandemic and having parents or relatives who had chronic diseases. Female midwifery students had a high level of knowledge regarding COVID-19.
   Practice Implications Female midwives of the future will take part in primary health care services in the protection and promotion of health as an important occupational group in the public health system. To determine mental health and psychological needs of them during the outbreak will greatly contribute to the pandemic management process.
C1 [Sogut, Seda; Cangol, Eda] Canakkale Onsekiz Mart Univ, Fac Hlth Sci, Dept Midwifery, TR-17020 Canakkale, Turkey.
   [Dolu, Ilknur] Bartin Univ, Dept Nursing, Fac Hlth Sci, Bartin, Turkey.
RP Sogut, S (corresponding author), Canakkale Onsekiz Mart Univ, Fac Hlth Sci, Dept Midwifery, TR-17020 Canakkale, Turkey.
EM sedacangol@comu.edu.tr
RI Dolu, İlknur/AAZ-4665-2021
OI Dolu, İlknur/0000-0002-0958-8395; SOGUT, SEDA/0000-0002-4655-0353
CR American Psychological Association (APA), 2020, PANDEMICS
   BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Centre for Addiction and Mental Health, 2020, MENTAL HLTH COVID 19
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen Y, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00104
   Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
   Falchi, 2020, ARE PEOPLE EXCESSIVE, DOI [DOI 10.31234/OSF.IO/364QJ, 10.31234/osf.io/364qj]
   Francis LJ, 2017, J RELIG HEALTH, V56, P1335, DOI 10.1007/s10943-016-0189-8
   GAO JL, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0231924, DOI 10.1371/JOURNAL.PONE.0231924]
   Garfin DR, 2018, J PSYCHOSOM RES, V112, P107, DOI 10.1016/j.jpsychores.2018.05.017
   Gokcay G, 2020, J ISTANB FAC MED, V83, P286, DOI 10.26650/IUITFD.2020.0025
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   Holman EA, 2014, P NATL ACAD SCI USA, V111, P93, DOI 10.1073/pnas.1316265110
   Huang L., 2020, EMOTIONAL RESPONSES, V15, DOI [10.1371/journal.pone.0237303, DOI 10.1101/2020.03.05.20031898, 10.1101/2020.03.05.20031898]
   Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c
   Lemyre A, 2019, AM J DRUG ALCOHOL AB, V45, P230, DOI 10.1080/00952990.2018.1536882
   LIANG, 2020, COVID 19 NLEME TEDAV
   Lippi G, 2020, RESP MED, V167, DOI 10.1016/j.rmed.2020.105941
   Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017
   Murray L, 2009, PSYCHOL MED, V39, P1413, DOI 10.1017/S0033291709005157
   NG (Next Generation), 2020, KAMUOYU ARA T RMAS
   Osborn TL, 2020, J CHILD FAM STUD, V29, P1432, DOI 10.1007/s10826-019-01646-8
   Pewforum.org, 2010, GLOBAL RELIG FUTURES
   Salik Bakanlii Halk Salii Genel Mdrl, 2020, 2019 NCOV HASTAL SA
   Schapman AM, 2002, J ADOLESCENCE, V25, P631, DOI 10.1006/jado.2002.0510
   Siegel RS, 2012, ADOLESC HEALTH MED T, V3, P1, DOI 10.2147/AHMT.S7597
   Sim K, 2010, J PSYCHOSOM RES, V68, P195, DOI 10.1016/j.jpsychores.2009.04.004
   Sogut S, 2021, PERSPECT PSYCHIATR C, V57, P246, DOI 10.1111/ppc.12555
   Thompson RR, 2017, CLIN PSYCHOL SCI, V5, P513, DOI 10.1177/2167702617692030
   Ulusoy M., 1998, J COGN PSYCOTHER INT, V12, P163
   Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X
   WHO, 2020, CORONOVIR S WHO DIRE
   WILDT BT, 2018, REHABILITATION STUTT, V57, P321, DOI DOI 10.1055/s-0043-124392
   World Health Organization, 2020, MENT HLTH PSYCH CONS
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Zendle D, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2171
   Zulkifli NA., 2020, MALAYSIAN J PSYCHIAT, V29, P1, DOI DOI 10.1016/J.SCHRES.2020.05.005
NR 38
TC 23
Z9 23
U1 5
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0031-5990
EI 1744-6163
J9 PERSPECT PSYCHIATR C
JI Perspect. Psychiatr. Care
PD JAN
PY 2021
VL 57
IS 1
BP 246
EP 252
DI 10.1111/ppc.12555
PG 7
WC Nursing; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing; Psychiatry
GA PT2TL
UT WOS:000608471000029
PM 32537821
OA Green Published
DA 2022-04-20
ER

PT J
AU Hu, R
AF Hu, Richard
TI COVID-19, smart work, and collaborative space: A crisis-opportunity
   perspective
SO JOURNAL OF URBAN MANAGEMENT
LA English
DT Article
DE COVID-19; Smart work; Collaborative space; Canberra
AB In this essay, I employ a crisis-opportunity perspective to approach the practice of smart work and the making of collaborative space in responding and adapting to COVID-19. These trends have been emerging at a faster pace in the recent decade, facilitated by a growing knowledge economy and information technological advancement. COVID-19 provides an extreme setting to test and trigger changes, and are likely to translate these emerging trends into a new normal in the way we work and the way we use space. This new normal, once established in the post-CVOID-19 world, will necessitate a new thinking about workplace management and space design to disrupt many norms rooted in an industrial age.
C1 [Hu, Richard] Univ Canberra, Fac Business Govt & Law, Bruce, ACT 2617, Australia.
RP Hu, R (corresponding author), Univ Canberra, Fac Business Govt & Law, Bruce, ACT 2617, Australia.
EM richard.hu@canberra.edu.au
OI Hu, Richard/0000-0002-5167-844X
CR Australian Bureau of Statistics (ABS), 2016, 2016 CENS QUICKSTATS
   BLAKELY EJ, 2019, CRAFTING INNOVATIVE
   CASTELLS M, 2000, RISE NETWORK SOC
   Di Marino M, 2017, J URBAN TECHNOL, V24, P5, DOI 10.1080/10630732.2017.1297520
   Hu RH, 2019, INT J KNOWL-BASED DE, V10, P315
   Hu R, 2015, POLICY STUD-UK, V36, P55, DOI 10.1080/01442872.2014.981058
   NILLES JM, 1975, IEEE T COMMUN, V23, P1142, DOI 10.1109/TCOM.1975.1092687
   Pratchett L., 2017, KNOWLEDGE CITY INDEX
   Spinuzzi C, 2012, J BUS TECH COMMUN, V26, P399, DOI 10.1177/1050651912444070
   Ulubasoglu M., 2020, CONVERSATION
   Watch, 2017, INNOVATION SPACES NE
NR 11
TC 14
Z9 14
U1 9
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2226-5856
EI 2589-0360
J9 J URBAN MANAG
JI J. Urban Manag.
PD SEP
PY 2020
VL 9
IS 3
BP 276
EP 280
DI 10.1016/j.jum.2020.08.001
PG 5
WC Urban Studies
WE Emerging Sources Citation Index (ESCI)
SC Urban Studies
GA NZ2PI
UT WOS:000576938000004
OA gold
DA 2022-04-20
ER

PT J
AU Baigent, C
   Windecker, S
   Andreini, D
   Arbelo, E
   Barbato, E
   Bartorelli, AL
   Baumbach, A
   Behr, ER
   Berti, S
   Bueno, H
   Capodanno, D
   Cappato, R
   Chieffo, A
   Collet, JP
   Cuisset, T
   de Simone, G
   Delgado, V
   Dendale, P
   Dudek, D
   Edvardsen, T
   Elvan, A
   Gonzalez-Juanatey, JR
   Gori, M
   Grobbee, D
   Guzik, TJ
   Halvorsen, S
   Haude, M
   Heidbuchel, H
   Hindricks, G
   Ibanez, B
   Karam, N
   Katus, H
   Klok, FA
   Konstantinides, SV
   Landmesser, U
   Leclercq, C
   Leonardi, S
   Lettino, M
   Marenzi, G
   Mauri, J
   Metra, M
   Morici, N
   Mueller, C
   Petronio, AS
   Polovina, MM
   Potpara, T
   Praz, F
   Prendergast, B
   Prescott, E
   Price, S
   Pruszczyk, P
   Rodriguez-Leor, O
   Roffi, M
   Romaguera, R
   Rosenkranz, S
   Sarkozy, A
   Scherrenberg, M
   Seferovic, P
   Senni, M
   Spera, FR
   Stefanini, G
   Thiele, H
   Tomasoni, D
   Torracca, L
   Touyz, RM
   Wilde, AA
   Williams, B
AF Baigent, Colin
   Windecker, Stephan
   Andreini, Daniele
   Arbelo, Elena
   Barbato, Emanuele
   Bartorelli, Antonio L.
   Baumbach, Andreas
   Behr, Elijah R.
   Berti, Sergio
   Bueno, Hector
   Capodanno, Davide
   Cappato, Riccardo
   Chieffo, Alaide
   Collet, Jean-Philippe
   Cuisset, Thomas
   de Simone, Giovanni
   Delgado, Victoria
   Dendale, Paul
   Dudek, Dariusz
   Edvardsen, Thor
   Elvan, Arif
   Gonzalez-Juanatey, Jose R.
   Gori, Mauro
   Grobbee, Diederick
   Guzik, Tomasz J.
   Halvorsen, Sigrun
   Haude, Michael
   Heidbuchel, Hein
   Hindricks, Gerhard
   Ibanez, Borja
   Karam, Nicole
   Katus, Hugo
   Klok, Fredrikus A.
   Konstantinides, Stavros, V
   Landmesser, Ulf
   Leclercq, Christophe
   Leonardi, Sergio
   Lettino, Maddalena
   Marenzi, Giancarlo
   Mauri, Josepa
   Metra, Marco
   Morici, Nuccia
   Mueller, Christian
   Petronio, Anna Sonia
   Polovina, Marija M.
   Potpara, Tatjana
   Praz, Fabien
   Prendergast, Bernard
   Prescott, Eva
   Price, Susanna
   Pruszczyk, Piotr
   Rodriguez-Leor, Oriol
   Roffi, Marco
   Romaguera, Rafael
   Rosenkranz, Stephan
   Sarkozy, Andrea
   Scherrenberg, Martijn
   Seferovic, Petar
   Senni, Michele
   Spera, Francesco R.
   Stefanini, Giulio
   Thiele, Holger
   Tomasoni, Daniela
   Torracca, Luccia
   Touyz, Rhian M.
   Wilde, Arthur A.
   Williams, Bryan
CA European Soc Cardiology
TI European Society of Cardiology guidance for the diagnosis and management
   of cardiovascular disease during the COVID-19 pandemic: part
   1-epidemiology, pathophysiology, and diagnosis The Task Force for the
   management of COVID-19 of the European Society of Cardiology
SO EUROPEAN HEART JOURNAL
LA English
DT Article
DE ACE2; Arrhythmias; Biomarkers; Cardiogenic shock; COVID-19; Myocardial
   injury; Myocarditis; Non-invasive imaging
ID ACUTE RESPIRATORY SYNDROME; HOSPITAL CARDIAC-ARREST; II RECEPTOR
   BLOCKERS; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; FUNCTIONAL
   RECEPTOR; PULMONARY-EMBOLISM; HEART-FAILURE; D-DIMER; CORONAVIRUS
AB Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two-part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular disease (CVD) in association with COVID-19.
   Methods and results A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, reported here, focuses on the epidemiology, pathophysiology, and diagnosis of cardiovascular (CV) conditions that may be manifest in patients with COVID-19. The second part, which will follow in a later edition of the journal, addresses the topics of care pathways, treatment, and follow-up of CV conditions in patients with COVID-19.
   Conclusion This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.
   [GRAPHICS]
   .
C1 [Baigent, Colin] Nuffield Dept Populat Hlth, MRC Populat Hlth Res Unit, Oxford, England.
   [Windecker, Stephan] Bern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland.
   [Andreini, Daniele; Bartorelli, Antonio L.; Leonardi, Sergio; Marenzi, Giancarlo] IRCCS, Ctr Cardiol Monzino, Milan, Italy.
   [Andreini, Daniele] Univ Milan, Cardiovasc Sect, Dept Clin Sci & Community Hlth, Milan, Italy.
   [Arbelo, Elena] Univ Barcelona, Hosp Clin, Cardiol Dept, Arrhythmia Sect, Barcelona, Spain.
   [Arbelo, Elena] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.
   [Arbelo, Elena; Bueno, Hector; Ibanez, Borja; Rodriguez-Leor, Oriol] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.
   [Arbelo, Elena] EHRA, Cardiogenet Focus Grp, ECGen, Sophia Antipolis, France.
   [Barbato, Emanuele; de Simone, Giovanni] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy.
   [Barbato, Emanuele] Onze Lieve Vrouw Hosp, Cardiovasc Ctr Aalst, Aalst, Belgium.
   [Bartorelli, Antonio L.] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.
   [Bartorelli, Antonio L.] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy.
   [Baumbach, Andreas] Queen Mary Univ London, William Harvey Res Inst, Ctr Cardiovasc Med & Devices, London, England.
   [Baumbach, Andreas] Barts Heart Ctr, London, England.
   [Baumbach, Andreas] Yale Univ, Sch Med, New Haven, CT USA.
   [Behr, Elijah R.] St Georges Univ London, ECGen, Cardiogenet Focus Grp, Cardiol Clin Acad Grp,Inst Mol & Clin Sci,EHRA, London, England.
   [Behr, Elijah R.; Wilde, Arthur A.] European Reference Network Rare & Low Prevalence, London, England.
   [Berti, Sergio] Osped Cuore G Pasquinucci, Fdn Toscana G Monasterio, Dipartimento Cardiotorac, UOC Cardiol Diagnost & Interventist, Massa, Italy.
   [Bueno, Hector; Ibanez, Borja] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain.
   [Bueno, Hector] Hosp Univ 12 Octubre, Cardiol Dept, Madrid, Spain.
   [Bueno, Hector] Hosp 12 Octubre Imasl2, Inst Invest Sanitaria, Madrid, Spain.
   [Capodanno, Davide] Univ Catania, AOU Policlin G Rodolico San Marco, Div Cardiol, Catania, Italy.
   [Cappato, Riccardo] IRCCS Grp MultiMed, Arrhythmia & Electrophysiol Ctr, Milan, Italy.
   [Chieffo, Alaide] Ist Sci San Raffaele, Milan, Italy.
   [Collet, Jean-Philippe] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, ACTION Study Grp,Inst Cardiol, Paris, France.
   [Cuisset, Thomas] CHU Timone, Dept Cardiol, Marseille, France.
   [Cuisset, Thomas] INSERM, UMR1062, Nutr Obes & Risk Thrombosis, Marseille, France.
   [Cuisset, Thomas] Aix Marseille Univ, Fac Med, Marseille, France.
   [de Simone, Giovanni] Federico II Univ Hosp, Hypertens Res Ctr, Naples, Italy.
   [Delgado, Victoria] Leiden Univ Med Ctr, Heart Lung Ctr, Leiden, Netherlands.
   [Dendale, Paul] Jessa Hosp, Heart Ctr Hasselt, Hasseit, Belgium.
   [Dendale, Paul; Scherrenberg, Martijn] Uhasselt, Fac Med & Life Sci, Diepenbeek, Belgium.
   [Dudek, Dariusz] Jagiellonian Univ Med Coll, Inst Cardiol, Krakow, Poland.
   [Dudek, Dariusz] Maria Cecilia Hosp, GVM Care & Res, Ravenna, RA, Italy.
   [Edvardsen, Thor] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway.
   [Elvan, Arif] Isala Heart Ctr, Zwolle, Netherlands.
   [Gonzalez-Juanatey, Jose R.] Univ Santiago de Compostela, Cardiol Dept, Univ Hosp, IDIS,CIBERCV, Santiago De Compostela, Spain.
   [Gori, Mauro; Senni, Michele] Papa Giovanni XXIII Hosp Bergamo, Cardiovasc Dept, Bergamo, Italy.
   [Gori, Mauro; Senni, Michele] Papa Giovanni XXIII Hosp Bergamo, Cardiol Unit, Bergamo, Italy.
   [Grobbee, Diederick] Univ Med Ctr Utrecht, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Guzik, Tomasz J.; Touyz, Rhian M.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.
   [Guzik, Tomasz J.] Jagiellonian Univ Coll Med, Dept Med, Krakow, Poland.
   [Halvorsen, Sigrun] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway.
   [Halvorsen, Sigrun] Univ Oslo, Oslo, Norway.
   [Haude, Michael] Lukaskrankenhaus GmbH, Stadt Kliniken Neuss, Med Clin 1, Neuss, Germany.
   [Heidbuchel, Hein; Sarkozy, Andrea; Spera, Francesco R.] Univ Hosp Antwerp, Dept Cardiol, Antwerp, Belgium.
   [Heidbuchel, Hein; Sarkozy, Andrea; Spera, Francesco R.] Univ Antwerp, Antwerp, Belgium.
   [Hindricks, Gerhard] Univ Hosp Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol Electrophysiol, Leipzig, Germany.
   [Ibanez, Borja] IIS Fdn Jimenez Diaz Hosp, Madrid, Spain.
   [Karam, Nicole] Univ Paris, PARCC, INSERM, Paris, France.
   [Katus, Hugo] Univ Hosp Heidelberg, Dept Internal Med, Heidelberg, Germany.
   [Klok, Fredrikus A.] Leiden Univ Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands.
   [Konstantinides, Stavros, V] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany.
   [Konstantinides, Stavros, V] Democritus Univ Thrace, Dept Cardiol, Alexandroupolis, Greece.
   [Landmesser, Ulf] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany.
   [Landmesser, Ulf] German Ctr Cardiovasc Res DZHK, Berlin Inst Hlth BIH, Partner Site Berlin, Berlin, Germany.
   [Leclercq, Christophe] Univ Rennes, CHU Rennes, INSERM, LTSI UMR 1099, Rennes, France.
   [Leonardi, Sergio] Univ Pavia, Pavia, Italy.
   [Leonardi, Sergio] Fdn IRCCS Policlin S Matteo, Pavia, Italy.
   [Lettino, Maddalena] ASST Monza, San Gerardo Hosp, Cardiothorac & Vasc Dept, Monza, Italy.
   [Mauri, Josepa; Rodriguez-Leor, Oriol] Hosp Badalona Germans Trias & Pujol, Inst Cor, Badalona, Spain.
   [Mauri, Josepa] Govt Catalonia, Hlth Dept, Barcelona, Spain.
   [Metra, Marco; Tomasoni, Daniela] ASST Spedali Civili Brescia, Inst Cardiol, Brescia, Italy.
   [Metra, Marco] Univ Brescia, Dept Med & Surg Special, Radiol Sci & Publ Hlth, Brescia, Italy.
   [Morici, Nuccia] ASST Grande Osped Metropolitano Niguarda, Cardio Ctr, Unita Cure Intens Cardiol & Gasperis, Milan, Italy.
   [Morici, Nuccia] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy.
   [Mueller, Christian] Univ Hosp Basel, Cardiovasc Res Inst Basel CRIB, Basel, Switzerland.
   [Mueller, Christian] Univ Basel, Basel, Switzerland.
   [Petronio, Anna Sonia] Univ Pisa, Cardiothorac & Vasc Dept, Osped Cisanello, Pisa, Italy.
   [Polovina, Marija M.; Seferovic, Petar] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Polovina, Marija M.] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia.
   [Potpara, Tatjana] Univ Belgrade, Sch Med, Belgrade, Serbia.
   [Potpara, Tatjana] Clin Ctr Serbia, Cardiol Clin, Dept Intens Arrhythmia Care, Belgrade, Serbia.
   [Praz, Fabien] Univ Hosp Bern, Dept Cardiol, Bern, Switzerland.
   [Prendergast, Bernard] St Thomas Hosp, London, England.
   [Prendergast, Bernard] Cleveland Clin London, London, England.
   [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.
   [Price, Susanna] Royal Brompton Hosp, London, England.
   [Price, Susanna] Imperial Coll, Natl Heart & Lung Inst, London, England.
   [Pruszczyk, Piotr] Med Univ Warsaw, Dept Internal Med & Cardiol, Warsaw, Poland.
   [Roffi, Marco] Geneva Univ Hosp, Dept Cardiol, Geneva, Switzerland.
   [Romaguera, Rafael] Hosp Univ Bellvitge IDIBELL, Serv Cardiol, Barcelona, Spain.
   [Rosenkranz, Stephan] Univ Cologne, Heart Ctr, Clin Internal Med Cardiol 3, Cologne, Germany.
   [Rosenkranz, Stephan] Univ Cologne, CCRC Heart Ctr, Cologne Cardiovasc Res Ctr CCRC, Cologne, Germany.
   [Rosenkranz, Stephan] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany.
   [Scherrenberg, Martijn] Jessa Hosp, Heart Ctr Hasselt, Hasselt, Belgium.
   [Seferovic, Petar] Serbian Acad Arts & Sci, Belgrade, Serbia.
   [Stefanini, Giulio; Torracca, Luccia] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele Milan, Italy.
   [Stefanini, Giulio; Torracca, Luccia] Humanitas Res Hosp IRCCS, Rozzano Milan, Germany.
   [Thiele, Holger] Leipzig Heart Inst LHI, Leipzig, Germany.
   [Thiele, Holger] Univ Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol, Leipzig, Germany.
   [Tomasoni, Daniela] Univ Brescia, Dept Med & Surg Special Radiol Sci & Publ Hlth, Brescia, Italy.
   [Wilde, Arthur A.] EHRA, ECGen, Cardiogenet Focus Grp, London, England.
   [Wilde, Arthur A.] Univ Amsterdam, Amsterdam UMC, Heart Ctr, Amsterdam, Netherlands.
   [Wilde, Arthur A.] Amsterdam Cardiovasc Sci, Dept Clin Cardiol, Amsterdam, Netherlands.
   [Williams, Bryan] UCL, Inst Cardiovasc Sci, London, England.
RP Baigent, C (corresponding author), Nuffield Dept Populat Hlth, MRC Populat Hlth Res Unit, Oxford, England.; Windecker, S (corresponding author), Bern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland.
EM colin.baigent@ndph.ox.ac.uk; stephan.windecker@insel.ch
RI delgado, victoria/AAL-4731-2021; BUENO, HECTOR/I-3910-2015
OI delgado, victoria/0000-0002-9841-2737; BUENO,
   HECTOR/0000-0003-0277-7596; Rodriguez-Leor, Oriol/0000-0003-2657-5657;
   Williams, Bryan/0000-0002-8094-1841; Behr, Elijah/0000-0002-8731-2853;
   Karam, Nicole/0000-0002-3861-6914
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   American College of Cardiology, 2020, ACR REC US CHEST RAP
   Angeli F, 2020, EUR J INTERN MED, V78, P101, DOI 10.1016/j.ejim.2020.06.015
   [Anonymous], 2021, CLIN INFECT DIS, DOI DOI 10.1093/cid/ciaa722
   Anupama BK, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8426
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Arevalo-Rodriguez I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242958
   Azarkish M, 2020, EUR HEART J, V41, P2131, DOI 10.1093/eurheartj/ehaa307
   Babapoor-Farrokhran Savalan, 2020, SN Compr Clin Med, V2, P1955, DOI 10.1007/s42399-020-00497-5
   Baldi E, 2020, EUR HEART J, V41, P3045, DOI 10.1093/eurheartj/ehaa508
   Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418
   Baran DA, 2019, CATHETER CARDIO INTE, V94, P29, DOI 10.1002/ccd.28329
   Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2
   Bartoloni E, 2020, CARDIOVASC RES, V116, pE193, DOI 10.1093/cvr/cvaa273
   Bavishi C, 2020, PROG CARDIOVASC DIS, V63, P682, DOI 10.1016/j.pcad.2020.05.013
   Bean DM, 2020, EUR J HEART FAIL, V22, P967, DOI 10.1002/ejhf.1924
   BERG R, 1977, AM J CLIN PATHOL, V68, P73
   Bhatla A, 2020, HEART RHYTHM, V17, P1439, DOI 10.1016/j.hrthm.2020.06.016
   Bhatt AS, 2020, J AM COLL CARDIOL, V76, P280, DOI 10.1016/j.jacc.2020.05.038
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Boeddinghaus J, 2018, EUR HEART J, V39, P3780, DOI 10.1093/eurheartj/ehy514
   Bojkova D, 2020, CARDIOVASC RES, V116, P2207, DOI 10.1093/cvr/cvaa267
   Bollmann A, 2020, EUR HEART J-QUAL CAR, V6, P221, DOI 10.1093/ehjqcco/qcaa049
   Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045
   Boriani G, 2020, INTERN EMERG MED, V15, P1445, DOI 10.1007/s11739-020-02487-w
   Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210
   Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985
   Caussy C, 2020, LANCET DIABETES ENDO, V8, P562, DOI [10.1016/S2213-8587(20)30160-1, 10.1016/S2213-8587(20)30160-0]
   Center for Disease Control and Prevention,, 2020, GUID HEALTHC WORK CO
   Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5
   Chan JFW, 2020, J CLIN MICROBIOL, V58, DOI [10.1128/JCM.00310-20, 10.1128/JCM.00310-20.]
   Chau VQ, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007485
   Chen C, 2020, HERZ, V45, P230, DOI 10.1007/s00059-020-04909-z
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Cheung CC, 2020, JACC-CLIN ELECTROPHY, V6, P878, DOI 10.1016/j.jacep.2020.04.001
   China National Health Commission,, 2020, NAT HLTH COMM PEOPL, V7th
   Choi AD, 2020, J CARDIOVASC COMPUT, V14, P101, DOI 10.1016/j.jcct.2020.03.002
   Christ-Crain M, 2008, J INTERN MED, V264, P166, DOI 10.1111/j.1365-2796.2008.01934.x
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Collet JP, 2021, EUR HEART J, V42, P1289, DOI [10.1093/eurheartj/ehaa575, 10.15829/1560-4071-2021-4418]
   Colon CM, 2020, JACC-CLIN ELECTROPHY, V6, P1189, DOI 10.1016/j.jacep.2020.05.015
   Compagnucci P, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008774
   Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229
   Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766
   Crespo-Leiro MG, 2018, EUR J HEART FAIL, V20, P1505, DOI 10.1002/ejhf.1236
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072
   Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082
   de Abajo FJ, 2020, LANCET, V395, P1705, DOI 10.1016/S0140-6736(20)31030-8
   De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409
   del Rio C, 2020, JAMA-J AM MED ASSOC, V324, P1723, DOI 10.1001/jama.2020.19719
   Del Sole F, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13378
   Dengel DR, 2021, INT J SPORTS MED, V42, P789, DOI 10.1055/a-1283-6256
   Deshotels MR, 2014, HYPERTENSION, V64, P1368, DOI 10.1161/HYPERTENSIONAHA.114.03743
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Drummond GR, 2019, NAT REV IMMUNOL, V19, P517, DOI 10.1038/s41577-019-0160-5
   Dweck MR, 2020, EUR HEART J-CARD IMG, V21, P949, DOI 10.1093/ehjci/jeaa178
   Ebinger JE, 2020, J AM COLL CARDIOL, V76, P289, DOI 10.1016/j.jacc.2020.05.039
   European Centre for Disease Prevention and Control,, 2021, OPT US RAP ANT TESTS
   European Centre for Disease Prevention and Control,, 2020, TEST STRAT SARS COV
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1
   Ferrante G, 2020, CARDIOVASC RES, V116, P2239, DOI 10.1093/cvr/cvaa193
   Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461
   Ferreira VM, 2018, J AM COLL CARDIOL, V72, P3158, DOI 10.1016/j.jacc.2018.09.072
   Figliozzi S, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13362
   Flores F, 2019, CLIN CHEM LAB MED, V2
   Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301
   Freaney PM, 2020, JAMA-J AM MED ASSOC, V324, P1499, DOI 10.1001/jama.2020.17445
   Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164
   Gao C, 2020, CRIT CARE MED, V48, P451, DOI 10.1097/CCM.0000000000004207
   Gao C, 2020, EUR HEART J, V41, P2058, DOI 10.1093/eurheartj/ehaa433
   Giannitsis E, 2017, EUR HEART J-ACUTE CA, V6, P69, DOI 10.1177/2048872615610870
   Giustino G, 2020, J AM COLL CARDIOL, V76, P2011, DOI 10.1016/j.jacc.2020.08.059
   Gluckman TJ, 2020, GEN GUIDANCE DEFERRI
   Gomila-Grange A, 2020, SN COMPR CLIN MED, P1
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Guan WJ, 2020, NEW ENGL J MED, V382, P1708
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Han YL, 2020, CIRCULATION, V141, pE810, DOI 10.1161/CIRCULATIONAHA.120.047011
   Harari R, 2021, CATHETER CARDIO INTE, V97, pE661, DOI 10.1002/ccd.28992
   Hayek SS, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3513
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holt A, 2020, EUR HEART J, V41, P3072, DOI 10.1093/eurheartj/ehaa494
   Hou W, 2020, INFECT DIS-NOR, V52, P498, DOI 10.1080/23744235.2020.1759817
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang L, 2020, JACC-CARDIOVASC IMAG, V13, P2330, DOI 10.1016/j.jcmg.2020.05.004
   Iannelli A, 2020, OBES SURG, V30, P4615, DOI 10.1007/s11695-020-04734-7
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Inciardi RM, 2020, EUR HEART J, V41, P1821, DOI 10.1093/eurheartj/ehaa388
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Intensive care National Audit and Research Centre. Centre ICNAaR, 2020, ICNARC REP COVID 19
   Jiang X, 2020, EUR HEART J, V41, P4580, DOI 10.1093/eurheartj/ehaa794
   Kariyanna Pramod Theetha, 2020, Am J Med Case Rep, V8, P299
   Kearon C, 2019, NEW ENGL J MED, V381, P2125, DOI 10.1056/NEJMoa1909159
   Kelle S, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00656-6
   Kesici S, 2020, EUR HEART J, V41, P3021, DOI 10.1093/eurheartj/ehaa515
   Kielian M, 2020, SCIENCE, V370, P765, DOI 10.1126/science.abf0732
   Kim HN, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e258
   Kir Devika, 2020, JACC Case Rep, V2, P1252, DOI 10.1016/j.jaccas.2020.04.026
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Knight DS, 2020, CIRCULATION, V142, P1120, DOI 10.1161/CIRCULATIONAHA.120.049252
   Kollias A, 2020, BRIT J HAEMATOL, V189, P846, DOI 10.1111/bjh.16727
   Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405
   Kramer CM, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00607-1
   Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4
   Kwong JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008087
   Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1101/2020.04.20.20072702, 10.1016/j.jacc.2020.06.007]
   Li J, 2020, EUROPACE, V22, P1841, DOI 10.1093/europace/euaa185
   Li JY, 2020, JAMA CARDIOL, V5, P825, DOI 10.1001/jamacardio.2020.1624
   Li SSL, 2003, CIRCULATION, V108, P1798, DOI 10.1161/01.CIR.0000094737.21775.32
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li Z, 2003, CHINESE MED J-PEKING, V116, P981
   Libby P, 2018, J AM COLL CARDIOL, V72, P2071, DOI 10.1016/j.jacc.2018.08.1043
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Looi MK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4113
   Lopes RD, 2021, JAMA-J AM MED ASSOC, V325, P254, DOI 10.1001/jama.2020.25864
   Lowe DA, 2020, JAMA INTERN MED, V180, P1491, DOI 10.1001/jamainternmed.2020.4153
   Luetkens JA, 2020, CIRC-CARDIOVASC IMAG, V13, DOI 10.1161/CIRCIMAGING.120.010897
   Madjid M, 2007, EUR HEART J, V28, P1205, DOI 10.1093/eurheartj/ehm035
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Maffia P, 2019, EUR HEART J, V40, P2492, DOI 10.1093/eurheartj/ehz133
   Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923
   Marijon E, 2020, LANCET PUBLIC HEALTH, V5, pE437, DOI 10.1016/S2468-2667(20)30117-1
   Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583
   Matsushita K, 2021, ESC HEART FAIL, V8, P380, DOI 10.1002/ehf2.13083
   Metzler B, 2020, EUR HEART J, V41, P1852, DOI 10.1093/eurheartj/ehaa314
   Miller A, 2020, CORRELATION UNIVERSA, DOI [10.1101/2020.03.24.20042937, DOI 10.1101/2020.03.24.20042937]
   Modin D, 2020, CIRCULATION, V142, P2080, DOI 10.1161/CIRCULATIONAHA.120.050809
   Mohammad S, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-020-00212-x
   Mueller C, 2006, AM HEART J, V151, P471, DOI 10.1016/j.ahj.2005.03.036
   Mueller C, 2019, EUR J HEART FAIL, V21, P715, DOI 10.1002/ejhf.1494
   Musher DM, 2019, NEW ENGL J MED, V380, P171, DOI 10.1056/NEJMra1808137
   Nestelberger T, 2016, INT J CARDIOL, V207, P238, DOI 10.1016/j.ijcard.2016.01.112
   Nicin L, 2020, EUR HEART J, V41, P1804, DOI 10.1093/eurheartj/ehaa311
   O'Hearn M, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019259
   Oates CP, 2020, PACE, V43, P1139, DOI 10.1111/pace.14047
   Oikonomou E, 2020, PUBLIC HEALTH, V187, P115, DOI 10.1016/j.puhe.2020.08.007
   Pareek M, 2021, AM J CARDIOL, V146, P99, DOI 10.1016/j.amjcard.2021.01.029
   Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Peltzer B, 2020, CIRC-ARRHYTHMIA ELEC, V13, P1229, DOI 10.1161/CIRCEP.120.009121
   Peltzer B, 2020, J CARDIOVASC ELECTR, V31, P3077, DOI 10.1111/jce.14770
   Pessoa-Amorim G, 2020, EUR HEART J-QUAL CAR, V6, P210, DOI 10.1093/ehjqcco/qcaa046
   Pieske B, 2019, EUR HEART J, V40, P3297, DOI 10.1093/eurheartj/ehz641
   Popkin BM, 2020, OBES REV, V21, DOI 10.1111/obr.13128
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Resnick A, 2021, COVID 19 PAINFUL PRI
   Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Russo V, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13387
   Ryan PM, 2020, OBESITY, V28, P1191, DOI 10.1002/oby.22843
   Sala S, 2020, PACE, V43, P891, DOI 10.1111/pace.13987
   Sanchez-Recalde A, 2020, REV ESP CARDIOL, V73, P669, DOI 10.1016/j.recesp.2020.04.018
   Sandoval Y, 2020, J AM COLL CARDIOL, V76, P1244, DOI 10.1016/j.jacc.2020.06.068
   Shah H, 2021, ACTA DIABETOL, V58, P831, DOI 10.1007/s00592-020-01636-z
   Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005
   Sheth V, 2020, RESUSCITATION, V155, P3, DOI 10.1016/j.resuscitation.2020.07.011
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Shoar S, 2020, AM J CARDIOL, V135, P50, DOI 10.1016/j.amjcard.2020.08.044
   Siedlinski M, 2020, CIRCULATION, V141, P1307, DOI 10.1161/CIRCULATIONAHA.119.045102
   Simpson CR, 2015, J ROY SOC MED, V108, P406, DOI 10.1177/0141076815588321
   Singh S, 2021, HYPERTENSION, V78, P165, DOI 10.1161/HYPERTENSIONAHA.121.17328
   Skali H, 2020, J NUCL MED, V61, P784, DOI [10.1007/s12350-020-02123-2, 10.2967/jnumed.120.246686]
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   Smeda M, 2020, CARDIOVASC RES, V116, pE118, DOI 10.1093/cvr/cvaa190
   Society for Cardiovascular Magnetic Resonance, 2020, SCMRS COVID 19 PREP
   Soldati G, 2020, J ULTRAS MED, V39, P1459, DOI 10.1002/jum.15284
   Santos RAS, 2018, PHYSIOL REV, V98, P505, DOI 10.1152/physrev.00023.2016
   Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215
   Sultanian P, 2021, EUR HEART J, V42, P1094, DOI 10.1093/eurheartj/ehaa1067
   Sun M L, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE014, DOI [10.3760/cma.j.issn.1001-0939.2020.03.016, 10.3760/cma.j.issn.1001-0939.2020.0014]
   Szekely Y, 2020, CIRCULATION, V142, P342, DOI 10.1161/CIRCULATIONAHA.120.047971
   Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828
   Thapa SB, 2021, JAMA INTERN MED, V181, P279, DOI 10.1001/jamainternmed.2020.4796
   Thiele H, 2019, EUR HEART J, V40, P2671, DOI 10.1093/eurheartj/ehz363
   Tomasoni D, 2020, EUR J HEART FAIL, V22, P2238, DOI 10.1002/ejhf.2052
   Toniolo M, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017122
   Tschope C, 2021, NAT REV CARDIOL, V18, P169, DOI 10.1038/s41569-020-00435-x
   Turagam MK, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008920
   Twerenbold R, 2018, CIRCULATION, V137, P436, DOI 10.1161/CIRCULATIONAHA.117.028901
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Vakili K, 2020, REV CARDIOVASC MED, V21, P433, DOI 10.31083/j.rcm.2020.03.129
   van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1
   van der Pol LM, 2019, NEW ENGL J MED, V380, P1139, DOI 10.1056/NEJMoa1813865
   van Diepen S, 2017, CIRCULATION, V136, pE232, DOI 10.1161/CIR.0000000000000525
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wenzel P, 2020, CARDIOVASC RES, V116, P1661, DOI 10.1093/cvr/cvaa160
   WHO, 2020, COR DIS COVID 19 WEE
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Williams B, 2020, LANCET, V395, P1671, DOI 10.1016/S0140-6736(20)31131-4
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Wood DA, 2020, J AM COLL CARDIOL, V75, P3177, DOI 10.1016/j.jacc.2020.04.063
   World Health Organization, 2020, LAB TEST COR DIS 201
   Wu YT, 2020, VIROL SIN, V35, P256, DOI 10.1007/s12250-020-00205-6
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689
   Yu CM, 2006, POSTGRAD MED J, V82, P140, DOI 10.1136/pgmj.2005.037515
   Zhang GQ, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104364
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhou YZ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.588301
   Zoghbi WA, 2020, JACC-CARDIOVASC IMAG, V13, P1615, DOI 10.1016/j.jcmg.2020.06.001
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
NR 223
TC 3
Z9 3
U1 4
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
EI 1522-9645
J9 EUR HEART J
JI Eur. Heart J.
PD MAR 14
PY 2022
VL 43
IS 11
SI SI
BP 1033
EP 1058
DI 10.1093/eurheartj/ehab696
PG 26
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA ZS4OV
UT WOS:000768447300007
PM 34791157
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Carli, LL
AF Carli, Linda L.
TI Women, Gender equality and COVID-19
SO GENDER IN MANAGEMENT
LA English
DT Article
DE Gender roles; Gender equality; COVID-19; Women's advancement
ID TRENDS; TIME
AB Purpose This paper aims to review the existing literature on the effects of the COVID-19 pandemic on gender and work roles to determine whether the pandemic has undermined the status, pay and advancement of women or has provided opportunities for reducing gender inequality. Design/methodology/approach The author reviewed the literature on the effects of COVID-19 and past pandemics on gender equality, focusing on job loss, the effects of being in essential occupations on health and well-being, the increased domestic responsibilities of women and men due to closure of schools and other social services and the effects of telecommuting on gender roles. Findings The pandemic has generally created challenges for women's advancement. More women than men have lost their jobs; more women than men are in essential jobs that expose them to infection and psychological stress, and women have had more work disruption than men have had because of increases in childcare and other responsibilities. On the other hand, telecommuting has increased men's amount of childcare, and this does have the potential to increase men's childcare responsibilities in the long term, thereby reducing the gender gap in domestic responsibilities and increasing gender equality. Research limitations/implications The COVID-19 pandemic is still ongoing and the research on the pandemic's effects are new and ongoing. Originality/value To the best of the author's knowledge, this is the first scholarly review of the literature on the potential effects of COVID-19 on the gender gap in pay and advancement.
C1 [Carli, Linda L.] Wellesley Coll, Dept Psychol, Wellesley, MA 02181 USA.
RP Carli, LL (corresponding author), Wellesley Coll, Dept Psychol, Wellesley, MA 02181 USA.
EM lcarli@wellesley.edu
CR Aguiar M, 2007, Q J ECON, V122, P969, DOI 10.1162/qjec.122.3.969
   Alon T., 2020, 26947 NAT BUR EC RES
   Andrew A., 2020, ARE MOTHERS FATHERS
   [Anonymous], 2020, MMWR MORB MORTAL WKL, V69, P477, DOI DOI 10.15585/MMWR.MM6915E6
   [Anonymous], 2020, WASHINGTON POST
   Badal S., 2020, STRESS WORRY RISE SM
   Bartik A.W., 2020, 26989 NAT BUR EC RES
   Blau FD, 2013, AM ECON REV, V103, P251, DOI 10.1257/aer.103.3.251
   Bloom N, 2015, Q J ECON, V130, P165, DOI 10.1093/qje/qju032
   BLS, 2019, JOB FLEX WORK SCHED
   BLS, 2020, AM TIM US SURV 2019
   BLS, 2020, LAB FORC STAT CURR P
   Blundell R, 2020, FISC STUD, V41, P291, DOI 10.1111/1475-5890.12232
   Boniol M., 2019, WORKING PAPER
   Brand JE, 2006, RES SOC STRAT MOBIL, V24, P275, DOI DOI 10.1016/j.rssm.2006.03.001
   Bunning M, 2015, EUR SOCIOL REV, V31, P738, DOI 10.1093/esr/jcv072
   Carlson D.L., 2020, US COUPLES DIVISIONS
   Choudhury P., 2020, 19054 HARV U HARV BU
   Collins C, 2021, GENDER WORK ORGAN, V28, P101, DOI 10.1111/gwao.12506
   Coskun S., 2020, 1422020 U MANNH
   Davis SJ, 2011, BROOKINGS PAP ECO AC, P1
   Eddleston K. A., 2014, ENTREP THEORY PRACT, V40, P489, DOI DOI 10.1111/etap.12117
   Educators for Excellence, 2020, VOIC VIRT CLASSR SUR
   Flabbi L, 2012, J ECONOMETRICS, V168, P81, DOI 10.1016/j.jeconom.2011.09.003
   Gauthier AH, 2004, POPUL DEV REV, V30, P647, DOI 10.1111/j.1728-4457.2004.00036.x
   Glenza J., 2020, GUARDIAN
   Global Health 50/50, 2020, COVID 19 SEX DIS DAT
   Greenbaum Z., 2020, MONITOR PSYCHOL, V51, P35
   Hartig T, 2007, APPL PSYCHOL-INT REV, V56, P231, DOI 10.1111/j.1464-0597.2006.00252.x
   Hickman A., 2020, REVIEWING REMOTE WOR
   Huerta M., 2013, 140 OECD
   ILO, 2018, CAR WORK CARE JOBS F
   International Labour Organization (ILO), 2020, ILO MON COVID 19 WOR
   Lee Y, 2017, J CHILD FAM STUD, V26, P3439, DOI 10.1007/s10826-017-0850-1
   Lyttelton T., 2020, GENDER DIFFERENCES T
   Miller C.C., 2020, NEARLY HALF MEN SAY
   OECD, 2020, WOM COR FIGHT COVID
   OECD, 2016, BACKGR BRIEF FATH LE
   Queisser, 2014, ENHANCING WOMENS EC
   Robertson Campbell., 2020, NEW YORK TIMES
   Rossi R., 2020, MENTAL HLTH OUTCOMES
   Sayer L.C., 2004, AM PEOPLE WOMEN MEN
   Schneebaum A, 2018, REV INCOME WEALTH, V64, P295, DOI 10.1111/roiw.12281
   Smith M., 2013, GENDER EUROPEAN LABO, P224
   Thulin E, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113067
   U. S. Census, 2020, HOUS PULS SURV PUBL
   UN, 2020, POL IMP COVID 19 WOM
   UN Women, 2020, IMP COVID 19 WOM MEN
   UN Women, 2020, SURV SHOW COVID 19 H
   UNESCO, 2020, COIVID 19 IMP ED
   Wang HY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233410
   World Bank, 2020, PAND REC GLOB EC CRI
   Xing J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233145
NR 53
TC 29
Z9 29
U1 32
U2 71
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1754-2413
EI 1754-2421
J9 GEND MANAG
JI Gend. Manag.
PD DEC 10
PY 2020
VL 35
IS 7-8
SI SI
BP 647
EP 655
DI 10.1108/GM-07-2020-0236
EA SEP 2020
PG 9
WC Business; Management; Women's Studies
WE Social Science Citation Index (SSCI)
SC Business & Economics; Women's Studies
GA PG7RP
UT WOS:000575142900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Chao, HQ
   Fang, X
   Zhang, JJ
   Homayounieh, F
   Arru, CD
   Digumarthy, SR
   Babaei, R
   Mobin, HK
   Mohseni, I
   Saba, L
   Carriero, A
   Falaschi, Z
   Pasche, A
   Wang, G
   Kalra, MK
   Yan, PK
AF Chao, Hanqing
   Fang, Xi
   Zhang, Jiajin
   Homayounieh, Fatemeh
   Arru, Chiara D.
   Digumarthy, Subba R.
   Babaei, Rosa
   Mobin, Hadi K.
   Mohseni, Iman
   Saba, Luca
   Carriero, Alessandro
   Falaschi, Zeno
   Pasche, Alessio
   Wang, Ge
   Kalra, Mannudeep K.
   Yan, Pingkun
TI Integrative analysis for COVID-19 patient outcome prediction
SO MEDICAL IMAGE ANALYSIS
LA English
DT Article
DE COVID-19; Chest CT; Outcome prediction; Artificial intelligence
AB While image analysis of chest computed tomography (CT) for COVID-19 diagnosis has been intensively studied, little work has been performed for image-based patient outcome prediction. Management of high-risk patients with early intervention is a key to lower the fatality rate of COVID-19 pneumonia, as a majority of patients recover naturally. Therefore, an accurate prediction of disease progression with baseline imaging at the time of the initial presentation can help in patient management. In lieu of only size and volume information of pulmonary abnormalities and features through deep learning based image segmentation, here we combine radiomics of lung opacities and non-imaging features from demographic data, vital signs, and laboratory findings to predict need for intensive care unit (ICU) admission. To our knowledge, this is the first study that uses holistic information of a patient including both imaging and non-imaging data for outcome prediction. The proposed methods were thoroughly evaluated on datasets separately collected from three hospitals, one in the United States, one in Iran, and another in Italy, with a total 295 patients with reverse transcription polymerase chain reaction (RT-PCR) assay positive COVID-19 pneumonia. Our experimental results demonstrate that adding non-imaging features can significantly improve the performance of prediction to achieve AUC up to 0.884 and sensitivity as high as 96.1%, which can be valuable to provide clinical decision support in managing COVID-19 patients. Our methods may also be applied to other lung diseases including but not limited to community acquired pneumonia. The source code of our work is available at https://github.com/DIAL-RPI/COVID19- ICUPrediction. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Chao, Hanqing; Fang, Xi; Zhang, Jiajin; Wang, Ge; Yan, Pingkun] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Chao, Hanqing; Fang, Xi; Zhang, Jiajin; Wang, Ge; Yan, Pingkun] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Homayounieh, Fatemeh; Arru, Chiara D.; Digumarthy, Subba R.; Kalra, Mannudeep K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.
   [Babaei, Rosa; Mobin, Hadi K.; Mohseni, Iman] Iran Univ Med Sci, Firoozgar Hosp, Dept Radiol, Tehran, Iran.
   [Saba, Luca] Azienda Osped Univ Cagliari, Cagliari, Italy.
   [Carriero, Alessandro; Falaschi, Zeno; Pasche, Alessio] Osped Maggiore Carita Novara, Azienda Osped, Novara, Italy.
RP Yan, PK (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.; Yan, PK (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Kalra, MK (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.
EM MKALRA@mgh.harvard.edu; yanp2@rpi.edu
OI Karimi Mobin, Hadi/0000-0003-2780-3615; Fang, Xi/0000-0001-8938-1732;
   Arru, Chiara Daniela/0000-0002-2014-2802; Falaschi,
   Zeno/0000-0003-3583-2731
FU National Institute of Biomedical Imaging and Bioengineering
   (NIBIB)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Biomedical
   Imaging & Bioengineering (NIBIB) [R21EB028001]; National Heart, Lung,
   and Blood Institute (NHLBI)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R56HL145172]
FX This work was partially supported by National Institute of Biomedical
   Imaging and Bioengineering (NIBIB) under award R21EB028001 and National
   Heart, Lung, and Blood Institute (NHLBI) under award R56HL145172.
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Cheng H.-T, 2016, P 1 WORKSHOP DEEP LE, P7, DOI 10.1145/2988450.2988454
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Danser A.H.J., 2020, AM HEART ASS
   Fang X., 2020, ARXIV200100208
   Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169
   Gozes O, 2020, ARXIV200402640
   Huang Lu, 2020, Radiol Cardiothorac Imaging, V2, pe200075, DOI 10.1148/ryct.2020200075
   Kikinis R., 2014, INTRAOPERATIVE IMAGI, P277, DOI [DOI 10.1007/978-1-4614-7657-3_19, 10.1007/978-1-4614-7657-3]
   Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343
   Langs G, 2020, AUTOMATIC LUNG SEGME, V2
   Leo B., 1984, WADSWORTH INT GROUP, V8, P452
   Li K, 2021, HEALTH COMMUN, V36, P837, DOI 10.1080/10410236.2020.1719320
   Li L., 2020, RADIOLOGY, DOI [10.1148/radiol.2020200905, DOI 10.1148/RADIOL.2020200905]
   Li TH, 2020, EMERG MICROBES INFEC, V9, P687, DOI 10.1080/22221751.2020.1741327
   Paszke, 2019, ADV NEURAL INFORM PR, P8024, DOI DOI 10.5555/3454287.3455008
   Patrick, 2020, ARXIV200305037
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Rizzo Stefania, 2018, Eur Radiol Exp, V2, P36, DOI 10.1186/s41747-018-0068-z
   Ruan SG, 2020, LANCET INFECT DIS, V20, P630, DOI 10.1016/S1473-3099(20)30257-7
   Shan F, 2020, ARXIV E PRINTS
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Sun L, 2020, IEEE J BIOMED HEALTH, V24, P2798, DOI 10.1109/JBHI.2020.3019505
   Tang ZY, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/abbf9e
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339
   Wang YZ, 2020, NEURORADIOLOGY, V62, P1141, DOI 10.1007/s00234-020-02455-3
   Wu Y.-H., 2020, ARXIV PREPRINT
   Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7
   Yang Ran, 2020, Radiol Cardiothorac Imaging, V2, pe200047, DOI 10.1148/ryct.2020200047
   Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976
   Zhu X, 2020, ARXIV200503405, V67
NR 33
TC 27
Z9 27
U1 8
U2 33
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1361-8415
EI 1361-8423
J9 MED IMAGE ANAL
JI Med. Image Anal.
PD JAN
PY 2021
VL 67
AR 101844
DI 10.1016/j.media.2020.101844
PG 13
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical; Radiology,
   Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering; Radiology, Nuclear Medicine & Medical
   Imaging
GA PF2MK
UT WOS:000598894800002
PM 33091743
OA Green Published, Bronze, Green Submitted
DA 2022-04-20
ER

PT J
AU Peci, A
   Avellaneda, CN
   Suzuki, K
AF Peci, Alketa
   Avellaneda, Claudia Nancy
   Suzuki, Kohei
TI Governmental responses to COVID-19 Pandemic
SO REVISTA DE ADMINISTRACAO PUBLICA
LA English
DT Article
DE COVID-19; comparative public administration; policy response; pandemic
   response; governmental strategies
ID LEADERSHIP; MANAGEMENT; CRISIS
AB In response to the challenges imposed by the COVID-19 pandemic, governments worldwide adopted a variety of strategies that include not just preventive or mitigation strategies adopted to "flatten the curve", but also interventions aiming to mitigate economic and social impacts of the pandemic. RAP's special issue gathered 17 reflexive, timely and relevant contributions of different governmental approaches to the COVID-19 pandemic. In this paper we highlight similarities and differences in governmental responses across countries and regions. We uncover and discuss broad themes covered in the symposium, focusing on: (a) impacts of social distancing strategies; (b) economic-relief responses; c) the role of bargaining, collaboration and coordination across levels of governance; (d) key actors and their role in the pandemic response; (e) pandemic and socio-economic inequalities; and (f) context, policy responses and effectiveness. The symposium adds to an extensive body of knowledge that has been produced on the topic of policy responses to COVID-19 pandemic offering more diverse contextual and comparative analysis.
C1 [Peci, Alketa] Fundacao Getulio Vargas, Brazilian Sch Business & Publ Adm, Rio De Janeiro, RJ, Brazil.
   [Avellaneda, Claudia Nancy] Indiana Univ, ONeill Sch Publ & Environm Affairs, Bloomington, IN USA.
   [Suzuki, Kohei] Leiden Univ, Inst Publ Adm, The Hague, Netherlands.
RP Peci, A (corresponding author), Fundacao Getulio Vargas, Brazilian Sch Business & Publ Adm, Rio De Janeiro, RJ, Brazil.
EM alketa.peci@fgv.br; cavellan@indiana.edu; k.suzuki@fgga.leidenuniv.nl
RI Suzuki, Kohei/AAM-5567-2020
OI Suzuki, Kohei/0000-0002-5403-4826
CR [Anonymous], 2020, BBC
   Antwi-Boasiako J, 2021, REV ADM PUBL-RIO JAN, V55, P122, DOI 10.1590/0034-761220200507
   Baniamin HM, 2020, ASIA PAC J PUBLIC AM, V42, P153, DOI 10.1080/23276665.2020.1784769
   Barberia LG, 2021, REV ADM PUBL-RIO JAN, V55, P27, DOI 10.1590/0034-761220200549
   Bello-Gomez RA, 2021, REV ADM PUBL-RIO JAN, V55, P165, DOI 10.1590/0034-761220200567
   Bertelli AM, 2020, GOVERNANCE, V33, P735, DOI 10.1111/gove.12520
   Boin A, 2003, PUBLIC ADMIN REV, V63, P544, DOI 10.1111/1540-6210.00318
   Boin A, 2010, PUBLIC ADMIN, V88, P706, DOI 10.1111/j.1467-9299.2010.01836.x
   Casaroes G, 2021, REV ADM PUBL-RIO JAN, V55, P197, DOI 10.1590/0034-761220200556
   Cepiku D, 2021, REV ADM PUBL-RIO JAN, V55, P215, DOI 10.1590/0034-761220200424
   Cunha M, 2021, REV ADM PUBL-RIO JAN, V55, P12, DOI 10.1590/0034-761220200530
   dos Santos NDESF, 2021, REV ADM PUBL-RIO JAN, V55, P95, DOI 10.1590/0034-761220200494
   de Oliveira JAP, 2021, REV ADM PUBL-RIO JAN, V55, P243, DOI 10.1590/0034-761220200501
   Duran CA, 2021, REV ADM PUBL-RIO JAN, V55, P140, DOI 10.1590/0034-761220200421
   Kapucu N, 2006, AM REV PUBLIC ADM, V36, P207, DOI 10.1177/0275074005280605
   Kelland Kate, 2020, REUTERS
   Kim MH, 2020, ASIAN STUD REV, V44, P567, DOI 10.1080/10357823.2020.1779658
   Meier KennethJ., 2017, COMP PUBLIC MANAGEME
   Milward B, 2016, GOVERNANCE, V29, P311, DOI 10.1111/gove.12201
   Passos AM, 2021, REV ADM PUBL-RIO JAN, V55, P261, DOI 10.1590/0034-761220200475
   Peci Alketa, 2020, Rev. Adm. Pública, V54, P1, DOI 10.1590/0034-761242020
   Peci A, 2017, INT REV ADM SCI, V83, P99, DOI 10.1177/0020852316637660
   Powell M, 2020, INT J SOCIOL SOC POL, V40, P877, DOI 10.1108/IJSSP-07-2020-0339
   Raudla R, 2021, REV ADM PUBL-RIO JAN, V55, P111, DOI 10.1590/0034-761220200414
   Renteria C, 2021, REV ADM PUBL-RIO JAN, V55, P180, DOI 10.1590/0034-761220200524
   Resende TC, 2021, REV ADM PUBL-RIO JAN, V55, P72, DOI 10.1590/0034-761220200418
   Sanchez-Cruz E, 2021, REV ADM PUBL-RIO JAN, V55, P151, DOI 10.1590/0034-761220200502
   Sobral F, 2020, REV ADM PUBL-RIO JAN, V54, P758, DOI 10.1590/0034-761220200262x
   Sotola DO, 2021, REV ADM PUBL-RIO JAN, V55, P229, DOI 10.1590/0034-761220200427
   Sullivan E, 2021, REV ADM PUBL-RIO JAN, V55, P50, DOI 10.1590/0034-761220200558
   Suzuki K, 2020, PUBLIC MANAG REV, V22, P877, DOI 10.1080/14719037.2019.1619813
   Wallace A, 2021, REV ADM PUBL-RIO JAN, V55, P84, DOI 10.1590/0034-761220200174
   Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4
NR 33
TC 2
Z9 2
U1 7
U2 14
PU FUNDACAO GETULIO VARGAS, EDITORA
PI RIO DE JANEIRO RJ
PA PRAIA BOTAFOGO-190, SAIA 538 5 ANDAR, RIO DE JANEIRO RJ, 22250-900,
   BRAZIL
SN 0034-7612
EI 1982-3134
J9 REV ADM PUBL-RIO JAN
JI Rev. Adm. Publica
PD JAN-FEB
PY 2021
VL 55
IS 1
BP 1
EP 11
DI 10.1590/0034-761220210023
PG 11
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA QT7DW
UT WOS:000626750100001
OA gold
DA 2022-04-20
ER

PT J
AU Rogers, TM
   Robinson, SJ
   Reynolds, LE
   Ladva, CN
   Burgos-Garay, M
   Whiteman, A
   Budge, H
   Soto, N
   Thompson, M
   Hunt, E
   Barson, T
   Boyd, AT
AF Rogers, Tia M.
   Robinson, Susan J.
   Reynolds, Laura E.
   Ladva, Chandresh N.
   Burgos-Garay, Maria
   Whiteman, Ari
   Budge, Holly
   Soto, Natalie
   Thompson, Mariela
   Hunt, Estee
   Barson, Todd
   Boyd, Andrew T.
TI Multifaceted Public Health Response to a COVID-19 Outbreak Among
   Meat-Processing Workers, Utah, March-June 2020
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE attitudes; COVID-19; coronavirus infections; health behavior; health
   disparities; occupational health; outbreak management; risk
   communication; survey
ID COMMUNICATION; INFORMATION; LITERACY; FACILITY
AB Objective: To identify potential strategies to mitigate COVID-19 transmission in a Utah meat-processing facility and surrounding community. Design/Setting: During March-June 2020, 502 workers at a Utah meat-processing facility (facility A) tested positive for SARS-CoV-2. Using merged data from the state disease surveillance system and facility A, we analyzed the relationship between SARS-CoV-2 positivity and worker demographics, work section, and geospatial data on worker residence. We analyzed worker survey responses to questions regarding COVID-19 knowledge, beliefs, and behaviors at work and home. Participants: (1) Facility A workers (n = 1373) with specimen collection dates and SARS-CoV-2 RT-PCR test results; (2) residential addresses of all persons (workers and nonworkers) with a SARS-CoV-2 diagnostic test (n = 1036), living within the 3 counties included in the health department catchment area; and (3) facility A workers (n = 64) who agreed to participate in the knowledge, attitudes, and practices survey. Main Outcome Measures: New cases over time, COVID-19 attack rates, worker characteristics by SARS-CoV-2 test results, geospatially clustered cases, space-time proximity of cases among workers and nonworkers; frequency of quantitative responses, crude prevalence ratios, and counts and frequency of coded responses to open-ended questions from the COVID-19 knowledge, attitudes, and practices survey. Results: Statistically significant differences in race (P = .01), linguistic group (P < .001), and work section (P < .001) were found between workers with positive and negative SARS-CoV-2 test results. Geographically, only 6% of cases were within statistically significant spatiotemporal case clusters. Workers reported using handwashing (57%) and social distancing (21%) as mitigation strategies outside work but reported apprehension with taking COVID-19-associated sick leave. Conclusions: Mitigating COVID-19 outbreaks among workers in congregate settings requires a multifaceted public health response that is tailored to the workforce. Implications for Policy and Practice: Tailored, multifaceted mitigation strategies are crucial for reducing COVID-19-associated health disparities among disproportionately affected populations.
C1 [Rogers, Tia M.; Robinson, Susan J.; Reynolds, Laura E.; Ladva, Chandresh N.; Burgos-Garay, Maria; Whiteman, Ari; Boyd, Andrew T.] Ctr Dis Control & Prevent CDC, COVID 19 Response Team, Atlanta, GA 31034 USA.
   [Rogers, Tia M.; Ladva, Chandresh N.] Ctr Dis Control & Prevent CDC, Epidem Intelligence Serv, Atlanta, GA 31034 USA.
   [Rogers, Tia M.; Reynolds, Laura E.; Boyd, Andrew T.] US PHS, Washington, DC USA.
   [Budge, Holly; Soto, Natalie; Thompson, Mariela; Hunt, Estee; Barson, Todd] Bear River Hlth Dept, Logan, UT USA.
RP Rogers, TM (corresponding author), Ctr Dis Control & Prevent CDC, COVID 19 Response Team, Atlanta, GA 31034 USA.
EM xgf1@cdc.gov
OI Burgos-Garay, Maria/0000-0002-7525-4262
CR Baur C, 2014, HEALTH PROMOT PRACT, V15, P629, DOI 10.1177/1524839914538969
   Brach C., 2012, 10 ATTRIBUTES HLTH L, DOI 10.31478/201206a
   Bui DP, 2020, MMWR-MORBID MORTAL W, V69, P1133, DOI 10.15585/mmwr.mm6933e3
   Centers for Disease Control and Prevention, 2009, SIMPL PUT GUID CREAT
   Centers for Disease Control and Prevention, 2020, CENT DIS CONTROL PRE
   Centers for Disease Control and Prevention, 2020, CRISIS EMERGENCY RIS
   Centers for Disease Control and Prevention, EP INF TM MOB DEV
   Chinn D, 2011, SOC SCI MED, V73, P60, DOI 10.1016/j.socscimed.2011.04.004
   Dew K, 2005, SOC SCI MED, V60, P2273, DOI 10.1016/j.socscimed.2004.10.022
   Donahue M, 2020, MMWR-MORBID MORTAL W, V69, P1020, DOI 10.15585/mmwr.mm6931a3
   Dyal JW, 2020, MMWR-MORBID MORTAL W, V69, P557, DOI 10.15585/mmwr.mm6918e3
   Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1
   Hawkins RP, 2008, HEALTH EDUC RES, V23, P454, DOI 10.1093/her/cyn004
   Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1
   Kreuter MW, 2003, AM J HEALTH BEHAV, V27, pS227
   Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059
   MacQueen K. M., 1998, CULTURAL ANTHR METHO, V10, P31, DOI DOI 10.1177/1525822X980100020301
   Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003
   Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673
   Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686
   Quandt SA., 2020, NEW EMERGING ISSUES, P197
   R Core Team, 2020, R LANG ENV STAT COMP, DOI DOI 10.1007/978-3-540-74686-7
   Rowlands G, 2015, BRIT J GEN PRACT, V65, pE379, DOI 10.3399/bjgp15X685285
   Sabogal F., 1996, HEALTH EDUC BEHAV, V23, P123
   Saldana J., 2014, CODING MANUAL QUALIT, V3
   SAS Institute Inc, 2003, SAS 5 VERS 9 4
   SaTScan, 2020, SATSCANTM V9 6 SOFTW
   Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112
   Steinberg J, 2020, MMWR-MORBID MORTAL W, V69, P1015, DOI 10.15585/mmwr.mm6931a2
   Stephens KK, 2013, HUM COMMUN RES, V39, P230, DOI 10.1111/hcre.12002
   Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2
   Svendsen MT, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08498-8
   Truman BI, 2009, AM J PUBLIC HEALTH, V99, pS278, DOI 10.2105/AJPH.2008.154054
   Waltenburg MA, 2020, MMWR-MORBID MORTAL W, V69, P887, DOI 10.15585/mmwr.mm6927e2
NR 34
TC 0
Z9 0
U1 3
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD JAN-FEB
PY 2022
VL 28
IS 1
SI SI
BP 60
EP 69
DI 10.1097/PHH.0000000000001383
PG 10
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XA2BG
UT WOS:000720458700019
PM 34081669
DA 2022-04-20
ER

PT J
AU Ren, ZM
   Zhang, X
   Zhang, ZK
AF Ren, Zhaomin
   Zhang, Xuan
   Zhang, Zhekai
TI New evidence on COVID-19 and firm performance
SO ECONOMIC ANALYSIS AND POLICY
LA English
DT Article
DE COVID-19; Pandemic portfolio; Chinese equity market
ID IMPACT
AB The Chinese equity market plummeted and was roiled in crisis with the rapid spread of COVID-19 in the first quarter of 2020, but it also exhibits great resilience when the pandemic is gradually under control in China. In this study, we try to quantify the influence of regional COVID-19 outbreaks in 31 provinces on the stock returns of local listed firms by using a difference-in-difference framework. To our limited knowledge, we are the first to study provincial equity market performance during the spread of COVID-19. We show that when there is a COVID-19 outbreak in a province, treated firms first underperform by daily lower returns of 0.54% but abruptly regain their value by daily higher returns of 0.76%. Even though strict lockdown restrictions deteriorate economic prosperity, negative effects on firm values are only temporary in a maximum 20-trading-day window. Our results are also robust when subsamples of provinces and companies are considered. (C) 2021 Economic Society of Australia, Queensland. Published by Elsevier B.V. All rights reserved.
C1 [Ren, Zhaomin] Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing, Peoples R China.
   [Zhang, Xuan; Zhang, Zhekai] Nanjing Audit Univ, Inst Econ & Finance, Nanjing, Peoples R China.
RP Zhang, ZK (corresponding author), Nanjing Audit Univ, Inst Econ & Finance, Nanjing, Peoples R China.
EM zhangzhekai@nau.edu.cn
CR Baker SR, 2020, REV ASSET PRICING ST, V10, P742, DOI 10.1093/rapstu/raaa008
   Borgards O, 2021, RESOUR POLICY, V71, DOI 10.1016/j.resourpol.2020.101966
   Bretscher L, 2020, REV ASSET PRICING ST, V10, P705, DOI 10.1093/rapstu/raaa017
   Corbet S, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101554
   Cui L, 2021, ACCOUNT FINANC, V61, P5543, DOI 10.1111/acfi.12767
   Davis S.J., 2020, SSRN ELECT J
   Ding WZ, 2021, J FINANC ECON, V141, P802, DOI 10.1016/j.jfineco.2021.03.005
   Gormsen NJ, 2020, REV ASSET PRICING ST, V10, P574, DOI 10.1093/rapstu/raaa013
   Greenwald D.L., 2019, WEALTH WAS WON FACTO
   Greenwald D.L., 2020, WHAT EXPLAINS COVID
   Hu SW, 2021, INT REV ECON FINANC, V74, P365, DOI 10.1016/j.iref.2021.03.016
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Onali E., 2020, PANDEMIC RISK DIVERS
   Padhan R, 2021, ECON ANAL POLICY, V70, P220, DOI 10.1016/j.eap.2021.02.012
   Qiu S, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102759
   Reinhart C.M., 2020, PROJECT SYNDICATE
   Shen HY, 2020, EMERG MARK FINANC TR, V56, P2213, DOI 10.1080/1540496X.2020.1785863
   Topcu M, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101691
   Zhang DY, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101528
   Zhang XM, 2021, J CHIN POLIT SCI, V26, P189, DOI 10.1007/s11366-020-09711-6
NR 20
TC 2
Z9 2
U1 14
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0313-5926
J9 ECON ANAL POLICY
JI Econ. Anal. Policy
PD DEC
PY 2021
VL 72
BP 213
EP 225
DI 10.1016/j.eap.2021.08.002
EA SEP 2021
PG 13
WC Economics
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA XG5KM
UT WOS:000724791700016
PM 34934261
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Gu, SY
   Dai, ZZ
   Shen, HC
   Bai, YJ
   Zhang, XH
   Liu, XF
   Xu, GL
AF Gu, Shiyuan
   Dai, Zhengze
   Shen, Huachao
   Bai, Yongjie
   Zhang, Xiaohao
   Liu, Xinfeng
   Xu, Gelin
TI Delayed Stroke Treatment during COVID-19 Pandemic in China
SO CEREBROVASCULAR DISEASES
LA English
DT Article
DE Acute stroke; COVID-19; Intravenous thrombolysis; Treatment delay
ID ACUTE ISCHEMIC-STROKE; PREHOSPITAL DELAY; THROMBOLYSIS; RESIDENTS;
   KNOWLEDGE
AB Background: Social distance, quarantine, pathogen testing, and other preventive strategies implemented during CO-VID-19 pandemic may negatively influence the management of acute ischemic stroke (AIS). Objective: The current study aimed to evaluate the impacts of COVID-19 pandemic on treatment delay of AIS in China. Methods: This study included patients with AIS admitted in 2 hospitals in Jiangsu, China. Patients admitted before and after the COVID-19 pandemic outbreak (January 31, 2020, as officially announced by the Chinese government) were screened to collect sociodemographic data, medical history information, and symptom onset status from clinical medical records and compared for pre- (measured as onset-to-door time [ODT]) and posthospital delay (measured as door-to-needle time [DNT]). The influencing factors for delayed treatment (indicated as onset-to-needle time >4.5 h) were analyzed with multivariate logistic regression analysis. Results: A total of 252 patients were included, of which 153 (60.7%) were enrolled before and 99 (39.3%) after the COVID-19 pandemic. ODT increased from 202 min (interquartile range [IQR] 65-492) before to 317 min (IQR 75-790) after the COVID-19 pandemic (p = 0.001). DNT increased from 50 min (IQR 40-75) before to 65 min (IQR 48-84) after the COVID-19 pandemic (p = 0.048). The proportion of patients with intravenous thrombolysis in those with AIS was decreased significantly after the pandemic (15.4% vs. 20.1%; p = 0.030). Multivariate logistic regression analysis indicated that patients after COVID-19 pandemic, lower educational level, rural residency, mild symptoms, small artery occlusion, and transported by other means than ambulance were associated with delayed treatment. Conclusions: COVID-19 pandemic has remarkable impacts on the management of AIS. Both pre- and posthospital delays were prolonged significantly, and proportion of patients arrived within the 4.5-h time window for intravenous thrombolysis treatment was decreased. Given that anti-COVID-19 measures are becoming medical routines, efforts are warranted to shorten the delay so that the outcomes of stroke could be improved.
C1 [Gu, Shiyuan; Liu, Xinfeng; Xu, Gelin] Nanjing Med Univ, Dept Neurol, Jinling Clin Coll, Nanjing, Peoples R China.
   [Gu, Shiyuan] Jiangsu Univ, Dept Neurol, Affiliated Yixing Hosp, Yixing, Peoples R China.
   [Dai, Zhengze] Nanjing Med Univ, Nanjing Pukou Hosp, Dept Neurol, Affiliated Hosp 4, Nanjing, Peoples R China.
   [Shen, Huachao] Nanjing Med Univ, BenQ Med Ctr, Dept Neurol, Affiliated BenQ Hosp, Nanjing, Peoples R China.
   [Bai, Yongjie] Henan Univ Sci & Technol, Dept Neurol, Affiliated Hosp 1, Luoyang, Peoples R China.
   [Bai, Yongjie] Henan Univ Sci & Technol, Coll Clin Med, Luoyang, Peoples R China.
   [Zhang, Xiaohao; Liu, Xinfeng; Xu, Gelin] Nanjing Univ, Dept Neurol, Jinling Hosp, Med Sch, Nanjing, Peoples R China.
RP Liu, XF; Xu, GL (corresponding author), Nanjing Med Univ, Dept Neurol, Jinling Clin Coll, Nanjing, Peoples R China.; Liu, XF; Xu, GL (corresponding author), Nanjing Univ, Dept Neurol, Jinling Hosp, Med Sch, Nanjing, Peoples R China.
EM xfliu2@vip.163.com; gelinxu@nju.edu.cn
OI Xu, Gelin/0000-0002-6194-0341
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81870947]
FX The work was supported by (National Natural Science Foundation of China)
   grant numbers (81870947).
CR Bouckaert M, 2009, NAT REV NEUROL, V5, P477, DOI 10.1038/nrneurol.2009.116
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Fang J, 2011, CLIN NEUROL NEUROSUR, V113, P85, DOI 10.1016/j.clineuro.2010.09.004
   Gao P, 2020, J NEUROINTERV SURG
   Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656
   Huang Q, 2015, INT J STROKE, V10, pE80, DOI 10.1111/ijs.12568
   Jiang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep29795
   Jin HQ, 2012, STROKE, V43, P362, DOI 10.1161/STROKEAHA.111.623512
   Kyra, 2018, STROKE, V49, pE6
   Le Bonniec A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156933
   Liu X, 2020, DELAYED STROKE TREAT
   Lyden P, 2020, STROKE, V51, P1910, DOI 10.1161/STROKEAHA.120.030023
   McQuilkin PA, 2017, AM J TROP MED HYG, V97, P931, DOI 10.4269/ajtmh.16-0702
   Minnerup J, 2014, EUR J NEUROL, V21, P1344, DOI 10.1111/ene.12367
   Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442
   Price CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076997
   Reeves MJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002477
   Sun HX, 2011, NEUROL RES, V33, P536, DOI 10.1179/016164111X13007856084368
   Yang HJ, 2014, INT J CARDIOL, V172, P533, DOI 10.1016/j.ijcard.2014.01.047
   Yang J, 2014, J STROKE CEREBROVASC, V23, P1216, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.019
NR 20
TC 0
Z9 0
U1 1
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-9770
EI 1421-9786
J9 CEREBROVASC DIS
JI Cerebrovasc. Dis.
PD DEC
PY 2021
VL 50
IS 6
BP 715
EP 721
DI 10.1159/000517075
EA JUL 2021
PG 7
WC Clinical Neurology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Cardiovascular System & Cardiology
GA YW4HL
UT WOS:000673891300001
PM 34247153
OA Green Published, Bronze, Green Submitted
DA 2022-04-20
ER

PT J
AU Moreno, SPC
   Diaz, LC
   Tinjaca, CDC
   Portilla, FEP
   Patino, EXV
AF Carreno Moreno, Sonia Patricia
   Chaparro Diaz, Lorena
   Cifuentes Tinjaca, Cristian David
   Perilla Portilla, Freddy Elias
   Viancha Patino, Erika Ximena
TI Knowledge, attitudes, practices, fear and stress before Covid-19 in
   nursing students and recent graduates in Colombia
SO REVISTA CUIDARTE
LA Spanish
DT Article
DE Coronavirus Infections; fear; Stress Psychological; Health Knowledge;
   Attitudes; Practice
ID HEALTH-CARE WORKERS
AB Introduction: The Covid-19 pandemic has affected the emotional health of human resources in health care, despite having knowledge about the virus and its management, health care personnel, including nurses, have shown stress and fear of Covid-19. Objective. To describe and correlate the level of fear, stress, knowledge, attitudes and practices regarding Covid-19 in nursing students and recent graduates in Colombia. Method. A cross-sectional and analytical observational study was conducted in Colombia between October and November 2020. The instruments of fear, stress and knowledge, attitudes and practices regarding Covid-19 were answered online by 1621 nursing students and recent graduates. Results. A mean fear score of 20.69 +/- 6.1 points, a mean stress score of 89.15 +/- 29.5 points and relative frequencies above 80% for knowledge, attitudes and practices to Covid-19 were observed. Direct correlations were observed between knowledge and attitudes and, in turn, attitudes with the practice. Fear was inversely correlated with knowledge and directly correlated with Covid-19 stress. Conclusion. An adequate cognitive level is observed in nursing students and recent graduates, but an emotional deficiency in the Covid-19, in terms of stress and fear. It is necessary to establish mental health support strategies for this key population in the current and future control of health crisis situations.
C1 [Carreno Moreno, Sonia Patricia; Chaparro Diaz, Lorena] Univ Nacl Colombia, Fac Enfermeria, Grp Invest Cuidado Enfermeria Paciente Cron, Enfermeria, Carrera 30 45-03,Edif 228-306, Bogota 111321, Colombia.
   [Cifuentes Tinjaca, Cristian David] Univ Llanos, Villavicencio, Colombia.
   [Perilla Portilla, Freddy Elias] Univ Francisco Paula Santander, Chinacota, Colombia.
   [Viancha Patino, Erika Ximena] UPTC, Sogamoso, Colombia.
RP Moreno, SPC (corresponding author), Univ Nacl Colombia, Fac Enfermeria, Grp Invest Cuidado Enfermeria Paciente Cron, Enfermeria, Carrera 30 45-03,Edif 228-306, Bogota 111321, Colombia.
EM spcarrenom@unal.edu.co; olchaparrod@unal.edu.co;
   cristian.cifuentes@unillanos.edu.co; fperilla1@gmail.com;
   erika.viancha24@gmail.com
CR Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   Cortes JA, 2020, BIOMEDICA, V40, P159, DOI 10.7705/biomedica.5526
   Ali M, 2020, KNOWLEDGE ATTITUDE P, DOI [10.1101/2020.05.26.20113233, DOI 10.1101/2020.05.26.20113233]
   [Anonymous], REV SEMANA
   [Anonymous], PERIODICO ESPEC 0514
   [Anonymous], PERIODICO TIEMP 0514
   Aslan H, 2021, PERSPECT PSYCHIATR C, V57, P695, DOI 10.1111/ppc.12597
   Bohlken J, 2020, PSYCHIAT PRAX, V47, P190, DOI 10.1055/a-1159-5551
   Consejo de Organizaciones Internacionales de las Ciencias Medicas, 2008, PAUT ET INT INV BIOM, P1
   Eweida RS, 2020, NURSE EDUC PRACT, V49, DOI 10.1016/j.nepr.2020.102915
   Griffiths, 2020, J CONCURRENT DISORDE, V2, P58, DOI [10.1177/2333721420966081, DOI 10.54127/WCIC8036]
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   Instituto Nacional de Salud, COVID 19 COL POBL
   Instituto Nacional de Salud, COVID 19 COL PAN
   Medina IA, 2020, INVEST ED ENFERM, V39, pe05, DOI [10.17533/udea.iee.v39n1-05, DOI 10.17533/UDEA.IEE.V39N1-05]
   Merchan N, 2020, REV CIENTIFICA MULTI, V4, P93, DOI [10.47230/unesum-ciencias.v4.n1.2021.287, DOI 10.47230/UNESUM-CIENCIAS.V4.N1.2021.287]
   Ministerio de Salud y Proteccion Social, DOCUMENTOS TECNICOS
   Montano RLT, 2020, REV INT INVESTIGACIO, V9, P78, DOI [10.20525/ijrbs.v9i4.773, DOI 10.20525/IJRBS.V9I4.773]
   Monterrosa-Castro A, 2020, MEDUNAB, V23, P195, DOI [10.29375/01237047.3890, DOI 10.29375/01237047.3890]
   Moro Matteo, 2020, Acta Biomed, V91, P29, DOI 10.23750/abm.v91i3-S.9419
   Ozamiz-Etxebarria N, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00054020, 10.1590/0102-311X00054020]
   Peres Maria Angélica de Almeida, 2020, Texto contexto - enferm., V29, pe20200236, DOI 10.1590/1980-265x-tce-2020-0236
   Petzold MB, 2020, NERVENARZT, DOI 10.1007.
   Polit DF, 2008, NURSING RES GENERATI
   Polit DF, STAT DATA ANAL NURSI
   Portillo M., 2020, ENFERM INV, V5, P63, DOI DOI 10.31243/EI.UTA.V5I3.913.2020
   Presidencia de la Republica, DECR ABR 2020
   Provenzano Sandro, 2020, Acta Biomed, V91, pe2020001, DOI 10.23750/abm.v91i12-S.10252
   Rios-González Carlos Miguel, 2020, Rev. salud publica Parag., V10, P17, DOI 10.18004/rspp.2020.diciembre.17
   Rodriguez-Hidalgo AJ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.591797
   Ruiz-Pérez José Ignacio, 2020, Rev. logos cienc. tecnol., V12, P20, DOI 10.22335/rlct.v12i3.1251
   Sakib N, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00289-x
   Savitsky B, 2020, NURSE EDUC PRACT, V46, DOI 10.1016/j.nepr.2020.102809
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Taylor S, 2020, J ANXIETY DISORD, V72, DOI 10.1016/j.janxdis.2020.102232
   Winter T, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00342-9
   Wu WZ, 2020, J MED VIROL, V92, P1962, DOI 10.1002/jmv.25914
   Yuan T, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925877
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 40
TC 0
Z9 0
U1 2
U2 2
PU UNIV SANTANDER
PI BUCARAMANGA
PA CALLE 70 NO 55-210, CAMPUS LAGOS CACIQUE, BUCARAMANGA, 680001, COLOMBIA
SN 2216-0973
EI 2346-3414
J9 REV CUID
JI Rev. Cuid.
PY 2021
VL 12
IS 3
AR e2044
DI 10.15649/cuidarte.2044
PG 14
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA ZA4XN
UT WOS:000756168500015
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Benski, C
   Di Filippo, D
   Taraschi, G
   Reich, MR
AF Benski, Caroline
   Di Filippo, Dania
   Taraschi, Gianmarco
   Reich, Michael R.
TI Guidelines for Pregnancy Management During the COVID-19 Pandemic: A
   Public Health Conundrum
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE antenatal care; intrapartum care; postnatal care; COVID-19; Sars-CoV-2;
   pandemic; obstetrics guidelines; public health
AB Pregnant women seem to be at risk for developing complications from COVID-19. Given the limited knowledge about the impact of COVID-19 on pregnancy, management guidelines are fundamental. Our aim was to examine the obstetrics guidelines released from December 2019 to April 2020 to compare their recommendations and to assess how useful they could be to maternal health workers. We reviewed 11 guidelines on obstetrics management, assessing four domains: (1) timeliness: the time between the declaration of pandemics by WHO and a guideline release and update; (2) accessibility: the readiness to access a guideline by searching it on a common browser; (3) completeness: the amount of foundational topics covered; and (4) consistency: the agreement among different guidelines. In terms of timeliness, the Royal College of Obstetricians and Gynaecologists (RCOG) was the first organization to release their recommendation. Only four guidelines were accessible with one click, while only 6/11 guidelines covered more than 80% of the 30 foundational topics we identified. For consistency, the study highlights the existence of 10 points of conflict among the recommendations. The present research revealed a lack of uniformity and consistency, resulting in potentially challenging decisions for healthcare providers.
C1 [Benski, Caroline; Reich, Michael R.] Harvard TH Chan Sch Publ Hlth, Takemi Program Int Hlth, Boston, MA 02115 USA.
   [Benski, Caroline; Taraschi, Gianmarco] Geneva Univ Hosp, Dept Obstet & Gynecol, CH-1205 Geneva, Switzerland.
   [Di Filippo, Dania] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW 2031, Australia.
RP Benski, C (corresponding author), Harvard TH Chan Sch Publ Hlth, Takemi Program Int Hlth, Boston, MA 02115 USA.; Benski, C (corresponding author), Geneva Univ Hosp, Dept Obstet & Gynecol, CH-1205 Geneva, Switzerland.
EM cbenski@hsph.harvard.edu; dariadifilippodaria@gmail.com;
   g.m.t.89@hotmail.it; reich@hsph.harvard.edu
OI Di Filippo, Daria/0000-0001-9345-1625; Reich, Michael
   R./0000-0003-3338-0612
CR ACOG, 2020, NOV COR 2019 COVID 1
   Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233
   Center for Disease Control, 2020, CONS INP OBST HEALTH
   Chen DJ, 2020, INT J GYNECOL OBSTET, V149, P130, DOI 10.1002/ijgo.13146
   Della Gatta AN, 2020, AM J OBSTET GYNECOL, V223, P36, DOI 10.1016/j.ajog.2020.04.013
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   Health Spanish, 2020, MIN MAN MUJ EMBR REC
   Juusela A, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100113
   OGGETTO, 2020, COVID 19 IND GRAV PA
   Poon LC, 2020, ULTRASOUND OBST GYN, V55, P700, DOI 10.1002/uog.22013
   Poon LC, 2020, INT J GYNECOL OBSTET, V149, P273, DOI 10.1002/ijgo.13156
   Prochaska E, 2020, AM J REPROD IMMUNOL, V84, DOI 10.1111/aji.13306
   Rabi DM, 2020, JAMA-J AM MED ASSOC, V323, P1345, DOI 10.1001/jama.2020.1525
   Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V148, pS1, DOI 10.1177/0194599812467004
   Royal College of Obstetricians and Gynaecologists (RCOG), 2020, COR COVID 19 INF PRE
   SIGO, 2020, GRAV TEMP COR SOC IT
   SMFM, 2020, COR COVID 19 PREGN W
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Wang SS, 2020, CLIN INFECT DIS, V71, P853, DOI 10.1093/cid/ciaa225
   WHO, 2020, SUMM PROB SARS CAS O
   WHO, 2020, Q A COVID 19 PREGN C
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
   Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867
   Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861
   Zhao XX, 2020, EUR J CLIN MICROBIOL, V39, P1209, DOI 10.1007/s10096-020-03897-6
NR 25
TC 8
Z9 8
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD NOV
PY 2020
VL 17
IS 21
AR 8277
DI 10.3390/ijerph17218277
PG 17
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA OQ7QS
UT WOS:000588973600001
PM 33182412
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Hassen, LM
   Almaghlouth, IA
   Hassen, IM
   Daghestani, MH
   Almohisen, AA
   Alqurtas, EM
   Alkhalaf, A
   Bedaiwi, MK
   Omair, MA
   Almogairen, SM
   Alarfaj, HF
   Alarfaj, AS
AF Hassen, Lena Mostafa
   Almaghlouth, Ibrahim A.
   Hassen, Ikhlass Mostafa
   Daghestani, Maha H.
   Almohisen, Amal A.
   Alqurtas, Eman M.
   Alkhalaf, Abdulaziz
   Bedaiwi, Mohammed K.
   Omair, Mohammed A.
   Almogairen, Sultan M.
   Alarfaj, Hussein F.
   Alarfaj, Abdulrahman S.
TI Impact of COVID-19 outbreak on rheumatic patients' perceptions and
   behaviors: A cross-sectional study
SO INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
LA English
DT Article
DE COVID-19 outbreak; disease activity perception; health care utilization;
   medication adherence; self-management
ID OBSTRUCTIVE PULMONARY-DISEASE; MEDICATION ADHERENCE; ILLNESS
   PERCEPTIONS; SELF-MANAGEMENT; HEALTH LITERACY; RISK; ARTHRITIS; BELIEFS;
   SEVERITY; ADULTS
AB Aim The dynamics of coronavirus disease 2019 (COVID-19) pandemic has become of special concern to the rheumatology community. Rheumatic patients are required to engage in effective health management but their behavior is often influenced by intrinsic and extrinsic factors. This cross-sectional study aims to examine patients' experiences during the current pandemic and its implication on their health perception and behavior. Method A patient-centered electronic survey was used, randomly sampling rheumatic patients in Saudi Arabia during March and April 2020. Questions included patients' socio-demographics, diseases, medications, COVID-19 knowledge, source of information, fear level, disease activity perception, health care utilization, medication accessibility, and therapeutic compliance (measured using a modified version of Medication Adherence Reporting Scale). Correlation and regression coefficients were used to evaluate associations among the aforementioned variables. Results A total of 637 respondents were included. The majority were rheumatoid arthritis patients (42.7%). Patients' knowledge about COVID-19 was correlated with social media use (P= .012). Fear of COVID-19 infection correlated with healthcare facility for follow-up visits (P= .024) and fear of disease deterioration if contracting the infection correlated with patients' levels of knowledge (P= .035). Both types of fear did not correlate with patients' perceptions of disease activity. However, patients' perceptions of worsened disease activity were correlated with unplanned healthcare visits (P< .001), medication non-adherence, and difficulty accessing medication (P= .010 and .006, respectively). Conclusion The COVID-19 pandemic and surrounding public health measures could affect rheumatic patients' health management which might contribute to disease flare-up and subsequently taxing healthcare systems even further.
C1 [Hassen, Lena Mostafa; Almaghlouth, Ibrahim A.; Alqurtas, Eman M.; Alkhalaf, Abdulaziz; Bedaiwi, Mohammed K.; Omair, Mohammed A.; Almogairen, Sultan M.; Alarfaj, Hussein F.; Alarfaj, Abdulrahman S.] King Saud Univ, Dept Med, Coll Med, Rheumatol Unit, Riyadh, Saudi Arabia.
   [Hassen, Lena Mostafa; Daghestani, Maha H.] King Saud Univ, Dept Zool, Coll Sci, Riyadh, Saudi Arabia.
   [Almaghlouth, Ibrahim A.] King Saud Univ, Res Ctr, Coll Med, Riyadh, Saudi Arabia.
   [Hassen, Ikhlass Mostafa] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA.
   [Almohisen, Amal A.] King Saud Univ, Dept Stat & Operat Res, Coll Sci, Riyadh, Saudi Arabia.
RP Almaghlouth, IA (corresponding author), King Saud Univ, Dept Med, Coll Med, Rheumatol Unit, Riyadh, Saudi Arabia.
EM ialmaghlouth@ksu.edu.sa
RI Omair, Mohammed/AFF-8735-2022; Omair, Mohammed/AAK-9357-2021
OI Omair, Mohammed/0000-0002-9373-5473; Omair,
   Mohammed/0000-0002-9373-5473; Hassen, Lena/0000-0002-2329-2099
FU King Saud University College of Medicine Research Center
FX This study was supported by a grant from King Saud University College of
   Medicine Research Center. Support did not play any role in the design
   and conduct of the study and did not pose any conflict of interest.
CR Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6
   BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720
   Bodini G, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13233
   Calabrese Cassandra, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc027
   Challa DNV, 2017, RHEUMATOL THER, V4, P201, DOI 10.1007/s40744-017-0063-5
   Chen LC, 2014, INT J CLIN PHARM-NET, V36, P120, DOI 10.1007/s11096-013-9867-8
   Chen Y, 2020, DISASTER MED PUBLIC, V14, P1
   Cheng CF, 2020, CLIN RHEUMATOL, V39, P2025, DOI 10.1007/s10067-020-05160-x
   Chisholm-Burns MA, 2012, J AM PHARM ASSOC, V52, P823, DOI 10.1331/JAPhA.2012.11088
   Cori L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093114
   Cowling BJ, 2020, J INFECT DIS, V221, P1749, DOI 10.1093/infdis/jiaa123
   Disler RT, 2012, INT J NURS STUD, V49, P230, DOI 10.1016/j.ijnurstu.2011.11.005
   Dong L, 2020, EMERG INFECT DIS, V26, P1616, DOI 10.3201/eid2607.200407
   Ferro F, 2020, CLIN EXP RHEUMATOL, V38, P175
   Gao X, 2000, AIDS CARE, V12, P387, DOI 10.1080/09540120050123783
   Gianfrancesco MA, 2020, LANCET RHEUMATOL, V2, pE250, DOI 10.1016/S2665-9913(20)30095-3
   Goyal K, 2020, ASIAN J PSYCHIATR, V49, DOI 10.1016/j.ajp.2020.101989
   Grady PA, 2014, AM J PUBLIC HEALTH, V104, pE25, DOI 10.2105/AJPH.2014.302041
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Hassan R, 2020, ARAB NEWS
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jacobi CE, 2001, ARTHRIT RHEUM-ARTHR, V45, P324, DOI 10.1002/1529-0131(200108)45:4<324::AID-ART344>3.0.CO;2-1
   Jones Veena G, 2020, Hosp Pediatr, V10, P537, DOI 10.1542/hpeds.2020-0123
   Jopson NM, 2003, J PSYCHOSOM RES, V54, P503, DOI 10.1016/S0022-3999(02)00455-5
   Khawaja MN, 2017, ARTHRIT CARE RES, V69, P609, DOI 10.1002/acr.23008
   Kingdom of Saudi Arabia Ministry of Health, 2020, MOH NEWS        1005
   Krauskopf K, 2015, COPD, V12, P154, DOI 10.3109/15412555.2014.922067
   Leventhal H, 2008, ANNU REV PSYCHOL, V59, P477, DOI 10.1146/annurev.psych.59.103006.093643
   Levesque Annabel, 2012, INT J PSYCHOL STUDIE, V4, P42, DOI [10.5539/ijps.v4n2p42, DOI 10.5539/IJPS.V4N2P42]
   Lin C-Y, 2020, SOCIAL HLTH BEHAV, V3, P1, DOI [10.4103/SHB.SHB_11_20, DOI 10.4103/SHB.SHB_11_20]
   Mars NJ, 2019, SCAND J RHEUMATOL, V48, P300, DOI 10.1080/03009742.2018.1559878
   Meroni PL, 2018, CLIN EXP RHEUMATOL, V36, P317
   Misra DP, 2020, CLIN RHEUMATOL, V39, P2055, DOI 10.1007/s10067-020-05073-9
   Mountifield R, 2009, INFLAMM BOWEL DIS, V15, P720, DOI 10.1002/ibd.20839
   Orso D, 2020, EUR J EMERG MED, V27, P327, DOI 10.1097/MEJ.0000000000000713
   Paakkari L, 2020, LANCET PUBLIC HEALTH, V5, pE249, DOI 10.1016/S2468-2667(20)30086-4
   Reintjes R, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151258, 10.1371/journal.pone.0]
   Renner B, 2012, VACCINE, V30, P7019, DOI 10.1016/j.vaccine.2012.09.064
   Reyna VF, 2009, PSYCHOL BULL, V135, P943, DOI 10.1037/a0017327
   Rochelle TL, 2013, J HEALTH PSYCHOL, V18, P972, DOI 10.1177/1359105312459094
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Ruksakulpiwat S, 2020, PATIENT PREFER ADHER, V14, P235, DOI 10.2147/PPA.S235107
   Rutherford EJ, 2018, SURG-J R COLL SURG E, V16, P82, DOI 10.1016/j.surge.2016.06.003
   Sawyer AT, 2019, HEALTH PSYCHOL OPEN, V6, DOI 10.1177/2055102919844504
   Selinger Christian P, 2013, J Crohns Colitis, V7, pe206, DOI 10.1016/j.crohns.2012.09.010
   VERBRUGGE LM, 1995, AM J PUBLIC HEALTH, V85, P173, DOI 10.2105/AJPH.85.2.173
   Vervoort VM, 2016, CLIN EXP RHEUMATOL, V34, pS74
   Wise T., 2020, CHANGES RISK PERCEPT, DOI [10.31234/osf.io/dz428., DOI 10.31234/OSF.IO/DZ428, 10.1098/rsos.200742]
   Zanin GM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093024
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
NR 50
TC 15
Z9 15
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1756-1841
EI 1756-185X
J9 INT J RHEUM DIS
JI Int. J. Rheum. Dis.
PD NOV
PY 2020
VL 23
IS 11
BP 1541
EP 1549
DI 10.1111/1756-185X.13959
EA SEP 2020
PG 9
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA OU1RY
UT WOS:000569914500001
PM 32940963
OA Bronze
DA 2022-04-20
ER

PT J
AU Monpara, JD
   Sodha, SJ
   Gupta, PK
AF Monpara, Jasmin D.
   Sodha, Srushti J.
   Gupta, Pardeep K.
TI COVID-19 associated complications and potential therapeutic targets
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE COVID-19; SARS-Cov-2; Pathophysiology; Pharmacotherapy; Clinical trials
ID MANAGEMENT; ENTRY; SARS
AB The global pandemic COVID-19, caused by novel coronavirus SARS-CoV-2, has emerged as severe public health issue crippling world health care systems. Substantial knowledge has been generated about the pathophysiology of the disease and possible treatment modalities in a relatively short span of time. As of August 19, 2020, there is no approved drug for the treatment of COVID-19. More than 600 clinical trials for potential therapeutics are underway and the results are expected soon. Based on early experience, different treatment such as anti-viral drugs (remdesivir, favipiravir, lopinavir/ritonavir), corticostemids (methylprednisolone, dexamethasone) or convalescent plasma therapy are recommended in addition to supportive care and symptomatic therapy. There are several treatments currently being investigated to address the pathological conditions associated with COVID-19. This review provides currently available information and insight into pathophysiology of the disease, potential targets, and relevant clinical trials for COVID-19.
C1 [Monpara, Jasmin D.; Sodha, Srushti J.; Gupta, Pardeep K.] Univ Sci, 600 South 43rd St, Philadelphia, PA 19104 USA.
RP Monpara, JD (corresponding author), Univ Sci, Philadelphia Coll Pharm, Dept Pharmaceut Sci, 600 South 43rd St, Philadelphia, PA 19104 USA.
EM jmonpara@usciences.edu
RI Monpara, Jasmin/AAE-4779-2022; Sodha, Srushti/AAW-9539-2021
OI Reis, AlessanRSS/0000-0001-8486-7469
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Anjaneyulu M, 2004, CLIN EXP PHARMACOL P, V31, P244, DOI 10.1111/j.1440-1681.2004.03982.x
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Armstrong SM, 2013, ANTIVIR RES, V99, P113, DOI 10.1016/j.antiviral.2013.05.003
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Barrett CD, 2020, J THROMB HAEMOST, V18, P2060, DOI 10.1111/jth.14860
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Blaising J, 2013, ANTIVIR RES, V100, P215, DOI 10.1016/j.antiviral.2013.08.008
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Caly L, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104787
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3
   Cao YC, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101647
   Casey K, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.04.011
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1
   Chen R., 2020, OUTCOMES HYPERBARIC
   Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785
   Connors JM, 2020, J THROMB HAEMOST, V18, P1559, DOI 10.1111/jth.14849
   Couzin-Frankel J, 2020, SCIENCE, V368, P455, DOI 10.1126/science.368.6490.455
   D'Ardes D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21083003
   Danilczyk U, 2006, CIRC RES, V98, P463, DOI 10.1161/01.RES.0000205761.22353.5f
   Di Napoli R, 2020, FEATURES EVALUATION
   Dinsmore WW, 2008, BJU INT, V102, P933, DOI 10.1111/j.1464-410X.2008.07764.x
   Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012
   Du YX, 2020, CLIN PHARMACOL THER, V108, P242, DOI 10.1002/cpt.1844
   Ebadi M, 2020, EUR J CLIN NUTR, V74, P856, DOI 10.1038/s41430-020-0661-0
   Erickson T B, 2020, Toxicol Commun, V4, P40, DOI 10.1080/24734306.2020.1757967
   Erol A., 2020, ORTHOMOLECULAR MED N
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   GRANT WB, 2020, NUTRIENTS, V12, DOI [DOI 10.3390/NU12040988, 10.3390/nu12040988]
   Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219
   Gupta D, 2020, BRAZ J INFECT DIS, V24, P369, DOI 10.1016/j.bjid.2020.06.002
   Hamdi H., 2020, HUMAN COVID 19 TANGO, DOI [10.20944/preprints202004.0160.v2., DOI 10.20944/PREPRINTS202004.0160.V2]
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hoffmann M, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00754-20
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Ignarro LJ, 2020, BRIT J PHARMACOL, V177, P3848, DOI 10.1111/bph.15085
   Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Juurlink DN, 2020, CAN MED ASSOC J, V192, pE450, DOI 10.1503/cmaj.200528
   Kalil AC, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2539-x
   Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d
   LABUDZYNSKYI D, 2016, DIABETES, V37, P22
   Lang M, 2020, LANCET INFECT DIS, V20, P1365, DOI 10.1016/S1473-3099(20)30367-4
   Lenzer J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1335
   Li H, 2020, LANCET, V395, P1517, DOI 10.1016/S0140-6736(20)30920-X
   Li TH, 2020, EMERG MICROBES INFEC, V9, P687, DOI 10.1080/22221751.2020.1741327
   Lillicrap D, 2020, J THROMB HAEMOST, V18, P786, DOI 10.1111/jth.14781
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005
   Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549
   Liu Y., 2020, INT J LIGHTWEIGHT MA, V3, P20, DOI [10.1016/j. ijlmm.2019.11.004, DOI 10.1016/J.IJLMM.2019.11.004]
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Luks AM, 2020, ANN AM THORAC SOC, V17, P918, DOI [10.1513/AnnalsATS.202004-327CME, 10.1513/AnnalsATS.202004-327FR]
   Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801
   MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2378
   Mahevas M, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1844, 10.1136/bmj.m2328]
   MARTINEAU AR, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.I6583
   McCartney D M, 2020, Ir Med J, V113, P58
   McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1
   McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Mehta N, 2020, AM J EMERG MED, V38, P1488, DOI 10.1016/j.ajem.2020.04.035
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Mercuro Nicholas J, 2020, JAMA Cardiol, V5, P1036, DOI 10.1001/jamacardio.2020.1834
   Monpara J, 2019, DRUG DELIV TRANSL RE, V9, P106, DOI 10.1007/s13346-018-0571-z
   Moore N, 2020, DRUG SAFETY, V43, P393, DOI 10.1007/s40264-020-00933-4
   Moschuring-Alieva, 2020, J REGEN BIOL MED, V2, P1, DOI DOI 10.37191/MAPSCI-2582-385X-2(2)-020
   National Institute of Health, 2020, COR DIS 2019 COVID 1
   Oldfield V, 2006, DRUGS, V66, P1275, DOI 10.2165/00003495-200666090-00012
   Oudkerk M, 2020, RADIOLOGY, V297, pE216, DOI 10.1148/radiol.2020201629
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Paliani U, 2020, EUR J INTERN MED, V78, P1, DOI 10.1016/j.ejim.2020.06.002
   Park S, 2020, CLIN HYPERTENS, V26, DOI 10.1186/s40885-020-00144-0
   Petrosillo N, 2020, CLIN MICROBIOL INFEC, V26, P729, DOI 10.1016/j.cmi.2020.03.026
   Remy KE, 2020, LANCET RESP MED, V8, P946, DOI 10.1016/S2213-2600(20)30217-4
   Scheim D., 2020, IVERMECTIN COVID 19
   SCHMITH VD, 2020, CLIN PHARMACOL 0607, DOI DOI 10.1002/CPT.1889
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Singh J, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-7
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   South AM, 2020, NAT REV NEPHROL, V16, P305, DOI 10.1038/s41581-020-0279-4
   Spearow J.L., 2020, REV IMPROVING THERAP, DOI [10.31219/osf.io/y7wc2, DOI 10.31219/OSF.IO/Y7WC2]
   Sriram K, 2020, BRIT J PHARMACOL, V177, P4825, DOI 10.1111/bph.15082
   Takashita E, 2021, CSH PERSPECT MED, V11, DOI 10.1101/cshperspect.a038687
   Tan WY, 2020, INT J CARDIOL, V309, P70, DOI 10.1016/j.ijcard.2020.03.063
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Tolouian R., 2020, J RENAL INJ PREV, V9, pe19, DOI 10.34172/jrip.2020.19
   Valencia DN, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7386
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Venkatasubbaiah Meda, 2020, Curr Med Res Pract, V10, P100, DOI 10.1016/j.cmrp.2020.05.013
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Vogelstein Joshua T, 2020, ArXiv
   Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069
   Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wang Y, 2021, SCI CHINA MATH, V64, P1843, DOI 10.1007/s11425-019-1667-5
   WHO, 2020, WHO DISC HYDR LOP RI
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   World Health Organization, 2020, WEEKL EP UPD 1
   Xie J, 2020, MAYO CLIN PROC, V95, P1138, DOI 10.1016/j.mayocp.2020.04.006
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yang ND, 2020, INT J BIOL SCI, V16, P1724, DOI 10.7150/ijbs.45498
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Zaim S, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100618
   Zanoni I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01661
   Zeitouni Nathalie E, 2016, Mol Cell Pediatr, V3, P14, DOI 10.1186/s40348-016-0041-y
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu Y., 2020, EFFICACY SAFETY REMD
   Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060
   Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035
NR 121
TC 9
Z9 10
U1 1
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD NOV 5
PY 2020
VL 886
AR 173548
DI 10.1016/j.ejphar.2020.173548
PG 16
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA OE6JJ
UT WOS:000580634600036
PM 32926918
OA Green Published
DA 2022-04-20
ER

PT J
AU Tsang, HF
   Chan, LWC
   Cho, WCS
   Yu, ACS
   Yim, AKY
   Chan, AKC
   Ng, LPW
   Wong, YKE
   Pei, XM
   Li, MJW
   Cesar, SC
AF Tsang, Hin Fung
   Chan, Lawrence Wing Chi
   Cho, William Chi Shing
   Yu, Allen Chi Shing
   Yim, Aldrin Kay Yuen
   Chan, Amanda Kit Ching
   Ng, Lawrence Po Wah
   Wong, Yin Kwan Evelyn
   Pei, Xiao Meng
   Li, Marco Jing Woei
   Wong, Sze-Chuen Cesar
TI An update on COVID-19 pandemic: the epidemiology, pathogenesis,
   prevention and treatment strategies
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE COVID-19; SARS-CoV-2; coronavirus Disease-2019; severe acute respiratory
   syndrome coronavirus 2; novel coronavirus; COVID-19 management; COVID-19
   treatment
AB Introduction
   To date, the transmission of Coronavirus Disease-2019 (COVID-19) is still uncontrollable with the fact that the numbers of confirmed and death cases are still increasing. Up to 1st October 2020, 33,842,281 confirmed cases and 1,010,634 confirmed deaths have been reported to the World Health Organization from 216 different countries, areas and territories. Despite the urgent demand for effective treatment strategies, there is still no specific antiviral treatment for COVID-19 and the treatment guidelines for COVID-19 vary between countries.
   Area covered
   In this article, we summarized the current knowledge on COVID-19 and the pandemic worldwide. Moreover, the epidemiology, pathogenesis, prevention and different treatment options will be discussed so that we shall prepare ourselves better to fight with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
   Expert opinion
   The situation of the COVID-19 pandemic is still unpredictable. There is no effective vaccine or specific anti-viral drug to treat serve COVID-19 patients. Combination therapies have shown promising clinical improvement. Repurposing FDA-approved drugs might be one of possible treatment options. Without specific treatment and vaccines for COVID-19, the most effective way to prevent from being infected is to generate an ecosystem with effective protection, precautions and preventive measures.
C1 [Tsang, Hin Fung; Chan, Lawrence Wing Chi; Wong, Yin Kwan Evelyn; Pei, Xiao Meng; Wong, Sze-Chuen Cesar] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Peoples R China.
   [Cho, William Chi Shing] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China.
   [Yu, Allen Chi Shing; Yim, Aldrin Kay Yuen; Li, Marco Jing Woei] Codex Genet Ltd, Dept Res, Hong Kong, Peoples R China.
   [Chan, Amanda Kit Ching; Ng, Lawrence Po Wah] Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Peoples R China.
RP Cesar, SC (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Peoples R China.
EM cesar01@netvigator.com
OI Chan, Lawrence/0000-0001-6451-2273; Yu, Allen
   Chi-Shing/0000-0002-9568-8316
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254
   Al-Lami RA, 2020, MAYO CLIN P, V95, P1559
   Ali N, 2020, J INFECT PUBLIC HEAL, V13, P1373, DOI 10.1016/j.jiph.2020.06.021
   Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8
   Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Carriere F, 2020, BIOCHIMIE, V179, P237, DOI 10.1016/j.biochi.2020.05.013
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 LAB
   Centers for Disease Control and Prevention, 2020, MORBIDITY MORTALITY, V69, P382
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 IT SPRE
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Cheng VCC, 2020, J INFECTION, V81, P107, DOI 10.1016/j.jinf.2020.04.024
   Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9
   Golchin A, 2020, STEM CELL REV REP, V16, P427, DOI 10.1007/s12015-020-09973-w
   Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9
   GRANT WB, 2020, NUTRIENTS, V12, DOI [DOI 10.3390/NU12040988, 10.3390/nu12040988]
   Guaraldi G, LANCET, V2, pE474
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hall OJ, 2017, MUCOSAL IMMUNOL, V10, P1097, DOI 10.1038/mi.2017.35
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Huppert LA, 2019, SEMIN RESP CRIT CARE, V40, P31, DOI 10.1055/s-0039-1683996
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Italian National Institute of Health, 2020, CHAR COVID 19 PAT DY
   Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372
   Kaur SP, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198114
   Lan SH, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106103
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951
   Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x
   Lim JK, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e92
   Lip GYH, 2021, J INTERN MED, V289, P42, DOI 10.1111/joim.13140
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Luan JW, 2020, BIOCHEM BIOPH RES CO, V526, P165, DOI 10.1016/j.bbrc.2020.03.047
   Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020
   McCreary EK, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofz538
   Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022
   Ni L, 2020, FRONT MED-PRC, V14, P210, DOI 10.1007/s11684-020-0757-x
   Nishiura H., 2020, SERIAL INTERVAL NOVE, DOI [10.1101/2020.02.03.20019497, DOI 10.1101/2020.02.03.20019497]
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Prompetchara E, 2020, ASIAN PAC J ALLERGY, V38, P1, DOI 10.12932/AP-200220-0772
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Sallard E, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104791
   Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932
   Shu T, 2020, VIROL SIN, V35, P321, DOI 10.1007/s12250-020-00242-1
   Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771
   Stelzig KE, 2020, AM J PHYSIOL-LUNG C, V318, pL1280, DOI 10.1152/ajplung.00153.2020
   Teixeira da Silva Jaime A, 2020, Med J Armed Forces India, V76, P236, DOI 10.1016/j.mjafi.2020.04.006
   Toniati P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102568
   Tu YF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072657
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   WHO, 2020, NOV COR 2019 NCOV SI
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wong SSY, 2008, J ANTIMICROB CHEMOTH, V62, P437, DOI 10.1093/jac/dkn243
   World Health Organization, 2020, 68 WHO
   World Health Organization, CLIN MAN COVID 19
   World Health Organization, OV COR COVID 19
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Xiong YJ, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104461
   Zahedipour F, 2020, PHYTOTHER RES, V34, P2911, DOI 10.1002/ptr.6738
   Zemb P, 2020, J GLOB ANTIMICROB RE, V22, P133, DOI 10.1016/j.jgar.2020.05.006
   Zhai Pan, 2020, Int J Antimicrob Agents, V55, P105955, DOI 10.1016/j.ijantimicag.2020.105955
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang R, 2020, LIFE SCI, V250, DOI 10.1016/j.lfs.2020.117583
   Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 84
TC 33
Z9 34
U1 4
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD JUL 3
PY 2021
VL 19
IS 7
BP 877
EP 888
DI 10.1080/14787210.2021.1863146
EA DEC 2020
PG 12
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA TI7YQ
UT WOS:000603837400001
PM 33306423
OA Bronze
DA 2022-04-20
ER

PT J
AU Hiller, M
   Bracht, H
   Schroeder, S
AF Hiller, Maike
   Bracht, Hendrik
   Schroeder, Stefan
TI One year with the COVID-19 pandemic - Lessons learnt? Intersectoral
   collaboration measures established during the crisis could benefit
   capacity and patient flow management in daily clinical practice
SO JOURNAL OF HEALTH ORGANIZATION AND MANAGEMENT
LA English
DT Article
DE COVID-19; Intensive care capacity management; Patient flow management;
   Data flow management; Communication culture; Intersectoral collaboration
ID ICU
AB Purpose The COVID-19 pandemic has changed the way hospitals work. Strategies that were detached from the boundaries of departments and responsibilities in the COVID-19 pandemic have proven themselves under extreme conditions and show a beneficial influence on patient flow and resource management as well as on the communication culture. The continuation of closer interdisciplinary and cross-sectoral co-operation in a "new clinical routine" could have a positive impact on personnel concepts, communication strategies, and the management of acute care capacities and patient pathways. Design/methodology/approach The aim of the paper is to critically discuss the knowledge gained in the context of the COVID-19 pandemic from the various approaches in patient flow and capacity management as well as interdisciplinary co-operation. More recent research has evaluated patient pathway management, personnel planning and communication measures with regard to their effect and practicability for continuation in everyday clinical practice. Findings Patient flows and acute care capacities can be more efficiently managed by continuing a culture change towards closer interdisciplinary and intersectoral co-operation and technologies that support this with telemedicine functionalities and regional healthcare data interoperability. Together with a bi-directional, more frequent and open communication and feedback culture, it could form a "new clinical routine". Originality/value This paper discusses a holistic approach on the way away from silo thinking towards cross-departmental collaboration.
C1 [Hiller, Maike] Erasmus MC, Dept Intens Care Med, Rotterdam, Netherlands.
   [Hiller, Maike] Philips Medizinsysteme Boblingen GmbH, Dept Clin Serv, Boblingen, Germany.
   [Bracht, Hendrik] Univ Hosp Ulm, Anesthesiol Intens Care Med & Cent Emergency Med, Ulm, Germany.
   [Schroeder, Stefan] Hosp Dueren, Anesthesiol & Intens Care Med, Duren, Germany.
RP Schroeder, S (corresponding author), Hosp Dueren, Anesthesiol & Intens Care Med, Duren, Germany.
EM maike.hiller@philips.com; hendrik.bracht@uniklinik-ulm.de;
   stefan.schroeder@krankenhaus-dueren.de
OI Schroeder, Stefan/0000-0001-7634-166X
CR Akgun KM, 2020, HEART LUNG, V49, P344, DOI 10.1016/j.hrtlng.2020.04.016
   Aziz S, 2020, INTENS CARE MED, V46, P1303, DOI 10.1007/s00134-020-06092-5
   Bergrath S, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2721381
   Cecconi M., 2021, CRIT CARE, V25, P1
   Cecconi M, 2020, INTENS CARE MED, V46, P1590, DOI 10.1007/s00134-020-06140-0
   Divi, 2020, PFLEG PFLEG
   Hiller M, 2020, ANASTH INTENSIVMED, V61, P569, DOI 10.19224/ai2020.569
   Hofinger G., 2020, HUMAN FACTORS PATIEN, P250
   Jansen G, 2021, ANAESTHESIST, V70, P13, DOI 10.1007/s00101-020-00873-9
   Kaisers U.X., 2020, DTSCH ARZTEBLATT, V117, pA2153
   Marckmann G, 2020, MED KLIN-INTENSIVMED, V115, P115, DOI 10.1007/s00063-020-00709-9
   Marks S, 2021, NURSE LEAD, V19, P165, DOI 10.1016/j.mnl.2020.07.008
   Mc Williams, 2020, NEJM CATALYST INNOVA, V1, P1
   Medicine E.S.O.I.C., 2020, C19 SPACE SKILLS PRE
   Murray WB, 2000, J CLIN ANESTH, V12, P633, DOI 10.1016/S0952-8180(00)00223-3
   Peine A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19745
   Philips F.H.I.C.B., 2020, PHILIPS
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Pickkers P, 2020, INTENS CARE MED, V46, P1449, DOI 10.1007/s00134-020-06098-z
   Rommele C, 2020, ANAESTHESIST, V69, P717, DOI 10.1007/s00101-020-00830-6
   Scheidt-Nave C., 2020, J HLTH MONITORING, V5, P2, DOI 10.25646/7168
   Schr?der S., 2021, DTSCH ARZTEBLATT, V118, pA18
   Services  U.S.D.O.H.H., 2020, TOP COLL COVID 19 HE
   Stang A, 2020, DTSCH ARZTEBL INT, V117, P329, DOI 10.3238/arztebl.2020.0329
   Taylor J., 2020, RIGHT CARE RIGHT PLA
   Williams D, 2021, J RURAL HEALTH, V37, P133, DOI 10.1111/jrh.12524
   Wu AW, 2020, ANN INTERN MED, V172, P822, DOI 10.7326/M20-1236
   Zangrillo A, 2020, INTENS CARE MED, V46, P1622, DOI 10.1007/s00134-020-06137-9
   Zergiebel, 2020, ORG SCHULUNGSPROGRAM
NR 29
TC 0
Z9 0
U1 4
U2 5
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1477-7266
EI 1758-7247
J9 J HEALTH ORGAN MANAG
JI J. Health Organ. Manag.
PD MAR 4
PY 2022
VL 36
IS 2
BP 141
EP 148
DI 10.1108/JHOM-06-2021-0211
EA AUG 2021
PG 8
WC Health Policy & Services
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZP1GY
UT WOS:000687729900001
PM 34415689
DA 2022-04-20
ER

PT J
AU Wool, GD
   Miller, JL
AF Wool, Geoffrey D.
   Miller, Jonathan L.
TI The Impact of COVID-19 Disease on Platelets and Coagulation
SO PATHOBIOLOGY
LA English
DT Review
DE COVID-19; Coagulopathy; D-dimer; Thrombocytopenia; Thrombosis
ID ACUTE RESPIRATORY SYNDROME; DISSEMINATED INTRAVASCULAR COAGULATION;
   VON-WILLEBRAND-FACTOR; P-SELECTIN; THROMBOCYTOPENIA; COAGULOPATHY;
   INFLAMMATION; ACTIVATION; MECHANISMS; MANAGEMENT
AB Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some patients develop a severe proinflammatory state which can be associated with a unique coagulopathy and procoagulant endothelial phenotype. Initially, COVID-19 infection produces a prominent elevation of fibrinogen and D-dimer/fibrin(ogen) degradation products. This is associated with systemic hypercoagulability and frequent venous thromboembolic events. The degree of D-dimer elevation positively correlates with mortality in COVID-19 patients. COVID-19 also leads to arterial thrombotic events (including strokes and ischemic limbs) as well as microvascular thrombotic disorders (as frequently documented at autopsy in the pulmonary vascular beds). COVID-19 patients often have mild thrombocytopenia and appear to have increased platelet consumption, together with a corresponding increase in platelet production. Disseminated intravascular coagulopathy (DIC) and severe bleeding events are uncommon in COVID-19 patients. Here, we review the current state of knowledge of COVID-19 and hemostasis.
C1 [Wool, Geoffrey D.; Miller, Jonathan L.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave,Room S339,MC 3083, Chicago, IL 60637 USA.
RP Wool, GD (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave,Room S339,MC 3083, Chicago, IL 60637 USA.
EM Geoffrey.wool@uchospitals.edu
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   Amgalan A, 2020, PLATELETS, V31, P740, DOI 10.1080/09537104.2020.1768523
   Amgalan A, 2020, J THROMB HAEMOST, V18, P1514, DOI 10.1111/jth.14832
   [Anonymous], 2020, LANCET HAEMATOL, V7, pE425, DOI 10.1016/S2352-3026(20)30151-4
   Armstrong PC, 2017, ARTERIOSCL THROM VAS, V37, P949, DOI 10.1161/ATVBAHA.116.308763
   Asakura H, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-20
   ASH, 2020, ASH 2020 GUID US ANT
   Assinger A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00649
   Barrett CD, 2020, J THROMB HAEMOST, V18, P2060, DOI 10.1111/jth.14860
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Blasi A, 2020, J THROMB HAEMOST, V18, P2646, DOI 10.1111/jth.15043
   Bomhof G, 2020, BRIT J HAEMATOL, V190, pE61, DOI 10.1111/bjh.16850
   Bowles L, 2020, NEW ENGL J MED, V383, P288, DOI 10.1056/NEJMc2013656
   Breiman A, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008556
   Chabert A, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0092-1
   Connell NT, 2020, J THROMB HAEMOST, DOI 10.1111/jth.14893
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Escher R, 2020, THROMB RES, V192, P174, DOI 10.1016/j.thromres.2020.05.032
   Escher R, 2020, THROMB RES, V190, P62, DOI 10.1016/j.thromres.2020.04.014
   Estevez B, 2017, PHYSIOLOGY, V32, P162, DOI 10.1152/physiol.00020.2016
   Fara MG, 2020, J THROMB HAEMOST, V18, P2031, DOI 10.1111/jth.14938
   Fijnheer R, 1997, THROMB HAEMOSTASIS, V77, P1081
   Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425
   Gallian P, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104880
   Gerard C, 2020, BRIT J HAEMATOL, V190, pE93, DOI 10.1111/bjh.16884
   Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362
   Goshua George, 2020, Lancet Haematol, V7, pe575, DOI 10.1016/S2352-3026(20)30216-7
   Gu, 2020, RELATIONSHIP ABO BLO, DOI [10.1101/2020.03.11.20031096, DOI 10.1101/2020.03.11.20031096]
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188
   Handtke S, 2020, J THROMB HAEMOST, V18, P1256, DOI 10.1111/jth.14788
   Handtke S, 2019, THROMB HAEMOSTASIS, V119, P407, DOI 10.1055/s-0039-1677875
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369
   Herter JM, 2014, J THROMB HAEMOST, V12, P1764, DOI 10.1111/jth.12730
   Hille L, 2020, J THROMB HAEMOST, V18, P2034, DOI 10.1111/jth.14895
   Hottz ED, 2020, BLOOD, V136, P1330, DOI 10.1182/blood.2020007252
   Hottz ED, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00121
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iba T, 2019, J THROMB HAEMOST, V17, P1989, DOI 10.1111/jth.14578
   Iba T, 2020, CRIT CARE MED, V48, P1358, DOI 10.1097/CCM.0000000000004458
   Iba T, 2019, J THROMB HAEMOST, V17, P1265, DOI 10.1111/jth.14482
   Jiang SQ, 2020, BRIT J HAEMATOL, V190, pE29, DOI 10.1111/bjh.16817
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Kolivras Athanassios, 2020, JAAD Case Rep, V6, P489, DOI 10.1016/j.jdcr.2020.04.011
   Lador A, 2017, J THROMB THROMBOLYS, V44, P291, DOI 10.1007/s11239-017-1533-x
   Latz CA, 2020, ANN HEMATOL, V99, P2113, DOI 10.1007/s00277-020-04169-1
   Lee-Sundlov MM, 2020, J THROMB HAEMOST, V18, P1535, DOI 10.1111/jth.14874
   Letko Michael, 2020, bioRxiv, DOI 10.1101/2020.01.22.915660
   Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9
   Li QB, 2020, LEUKEMIA, V34, P2163, DOI 10.1038/s41375-020-0910-1
   Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1131, DOI [10.1515/cclm-2020-1761, 10.1515/cclm-2020-0198]
   Lisa Baumann Kreuziger AL, 2020, COVID 19 VTE ANTICOA
   Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370
   Liu YL, 2020, PLATELETS, V31, P490, DOI 10.1080/09537104.2020.1754383
   Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Manne BK, 2020, BLOOD, V136, P1317, DOI 10.1182/blood.2020007214
   Marietta M, 2020, BLOOD TRANSFUS-ITALY, V18, P167, DOI 10.2450/2020.0083-20
   Martinelli N, 2020, THROMB RES, V193, P170, DOI 10.1016/j.thromres.2020.07.034
   McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1
   Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730
   Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432
   Nemmar A, 2007, J THROMB HAEMOST, V5, P1217, DOI 10.1111/j.1538-7836.2007.02557.x
   Nishimura S, 2015, J CELL BIOL, V209, P453, DOI 10.1083/jcb.201410052
   Obi AT, 2019, J VASC SURG-VENOUS L, V7, P317, DOI 10.1016/j.jvsv.2018.08.010
   Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Pavoni V, 2020, J THROMB THROMBOLYS, V50, P281, DOI 10.1007/s11239-020-02130-7
   Pouletty M, 2020, ANN RHEUM DIS, V79, P999, DOI 10.1136/annrheumdis-2020-217960
   Psaila B, 2012, BLOOD, V119, P4066, DOI 10.1182/blood-2011-11-393900
   Rainger GE, 2015, PLATELETS, V26, P507, DOI 10.3109/09537104.2015.1064881
   Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854
   Reyes Gil M, 2020, COVID 19 D DIMER FRE
   Seyoum M, 2018, THROMB J, V16, DOI 10.1186/s12959-018-0170-8
   Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Sugiyama MG, 2016, J VIROL, V90, P1812, DOI 10.1128/JVI.02599-15
   TAKAHASHI H, 1985, THROMB HAEMOSTASIS, V54, P445
   Tan CW, 2020, AM J HEMATOL, V95, pE156, DOI 10.1002/ajh.25822
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Thachil J, 2020, RES PRACT THROMB HAE, V4, P731, DOI 10.1002/rth2.12372
   Thachil J, 2020, J THROMB HAEMOST, V18, P2071, DOI 10.1111/jth.14879
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Wada H, 2013, J THROMB HAEMOST, V11, P761, DOI DOI 10.1111/JTH.12155
   Weyrich AS, 2013, ANNU REV PHYSIOL, V75, P569, DOI 10.1146/annurev-physiol-030212-183752
   White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7
   Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wright FL, 2020, J AM COLL SURGEONS, V231, P193, DOI 10.1016/j.jamcollsurg.2020.05.007
   Yang M, 2005, HEMATOLOGY, V10, P101, DOI 10.1080/10245330400026170
   Yang XB, 2020, J THROMB HAEMOST, V18, P1469, DOI 10.1111/jth.14848
   Yin SY, 2021, J THROMB THROMBOLYS, V51, P1107, DOI 10.1007/s11239-020-02105-8
   Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499
   Zhang S, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00954-7
   Zhang YJ, 2020, THROMB RES, V193, P110, DOI 10.1016/j.thromres.2020.06.008
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zou ZS, 2004, CLIN INFECT DIS, V38, P483, DOI 10.1086/380973
NR 104
TC 102
Z9 104
U1 3
U2 11
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-2008
EI 1423-0291
J9 PATHOBIOLOGY
JI Pathobiology
PD JAN
PY 2021
VL 88
IS 1
BP 15
EP 27
DI 10.1159/000512007
PG 13
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA PU7EW
UT WOS:000609464000004
PM 33049751
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Klimek, L
   Jutel, M
   Bousquet, J
   Agache, I
   Akdis, CA
   Hox, V
   Gevaert, P
   Tomazic, PV
   Rondon, C
   Cingi, C
   Toppila-Salmi, S
   Karavelia, A
   Bozkurt, B
   Forster-Ruhrmann, U
   Becker, S
   Chaker, AM
   Wollenberg, B
   Mosges, R
   Huppertz, T
   Hagemann, J
   Bachert, C
   Fokkens, W
AF Klimek, Ludger
   Jutel, Marek
   Bousquet, Jean
   Agache, Ioana
   Akdis, Cezmi A.
   Hox, Valerie
   Gevaert, Philippe
   Tomazic, Peter Valentin
   Rondon, Carmen
   Cingi, Cemal
   Toppila-Salmi, Sanna
   Karavelia, Aspasia
   Bozkurt, Banu
   Foerster-Ruhrmann, Ulrike
   Becker, Sven
   Chaker, Adam M.
   Wollenberg, Barbara
   Moesges, Ralph
   Huppertz, Tilman
   Hagemann, Jan
   Bachert, Claus
   Fokkens, Wytske
TI Management of patients with chronic rhinosinusitis during the COVID-19
   pandemic-An EAACI position paper
SO ALLERGY
LA English
DT Article
DE biologics; chronic rhinosinusitis; COVID-19; CRSwNP; SARS-CoV-2
ID ENDOSCOPIC SINUS SURGERY; FUROATE NASAL SPRAY; ALLERGIC RHINITIS; GERMAN
   SOCIETY; ASTHMA; CORTICOSTEROIDS; POLYPOSIS; EXACERBATIONS; ASSOCIATION;
   INTOLERANCE
AB BackgroundChronic rhinosinusitis is regarded as a chronic airway disease. According to WHO recommendations, it may be a risk factor for COVID-19 patients. In most CRSwNP cases, the inflammatory changes affecting the nasal and paranasal mucous membranes are type-2 (T2) inflammation endotypes.
   MethodsThe current knowledge on COVID-19 and on treatment options for CRS was analyzed by a literature search in Medline, Pubmed, international guidelines, the Cochrane Library and the Internet.
   ResultsBased on international literature, on current recommendations by WHO and other international organizations as well as on previous experience, a panel of experts from EAACI and ARIA provided recommendations for the treatment of CRS during the COVID-19 pandemic.
   ConclusionIntranasal corticosteroids remain the standard treatment for CRS in patients with SARS-CoV-2 infection. Surgical treatments should be reduced to a minimum and surgery preserved for patients with local complications and for those with no other treatment options. Systemic corticosteroids should be avoided. Treatment with biologics can be continued with careful monitoring in noninfected patients and should be temporarily interrupted during the course of the COVID-19 infection.
C1 [Klimek, Ludger] Ctr Allergy & Rhinol, Wiesbaden, Germany.
   [Jutel, Marek] Wroclaw Med Univ, Dept Clin Immunol, Wroclaw, Poland.
   [Jutel, Marek] ALL MED Med Res Inst, Wroclaw, Poland.
   [Jutel, Marek] European Acad Allergy & Clin Immunol, Zurich, Switzerland.
   [Bousquet, Jean] Humboldt Univ, Charite, Univ Med Berlin, Berlin, Germany.
   [Bousquet, Jean] Berlin Inst Hlth, Dept Dermatol & Allergy, Comprehens Allergy Ctr, Berlin, Germany.
   [Bousquet, Jean] Univ Hosp Montpellier, Montpellier, France.
   [Bousquet, Jean] MACVIA France, Montpellier, France.
   [Agache, Ioana] Transylvania Univ, Brasov, Romania.
   [Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.
   [Hox, Valerie] Clin Univ St Luc, Dept Otorhinolaryngol, Brussels, Belgium.
   [Gevaert, Philippe] Univ Ghent, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium.
   [Tomazic, Peter Valentin] Med Univ Graz, Dept Gen Otorhinolaryngol, H&N Surg, Graz, Austria.
   [Rondon, Carmen] Hosp Reg Univ Malaga, WAO Ctr Excellence, Unit Allerg Dis, Malaga, Spain.
   [Rondon, Carmen] Spanish Allergy Network ARADyAL, Malaga, Spain.
   [Cingi, Cemal] Eskisehir Osmangazi Univ, Dept Otorhinolaryngol, Eskisehir, Turkey.
   [Toppila-Salmi, Sanna] Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland.
   [Toppila-Salmi, Sanna] Univ Helsinki, Helsinki, Finland.
   [Karavelia, Aspasia] Gen Hosp Chania, Dept Otorhinolaryngol, Khania, Greece.
   [Bozkurt, Banu] Selcuk Univ, Dept Ophthalmol, Fac Med, Konya, Turkey.
   [Foerster-Ruhrmann, Ulrike] Univ Hosp Charite, Dept Otorhinolaryngol Head & Neck Surg, Berlin, Germany.
   [Becker, Sven] Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Tubingen, Germany.
   [Chaker, Adam M.; Wollenberg, Barbara] Tech Univ Munich, Klinikum Rechts Isar, TUM Sch Med, Munich, Germany.
   [Moesges, Ralph] IMSIE Univ Cologne, ENT Med, Allergol, Hamburg, Germany.
   [Moesges, Ralph] IMSIE Univ Cologne, Med Informat, Hamburg, Germany.
   [Moesges, Ralph] CRI Clin Res Int Ltd, Hamburg, Germany.
   [Huppertz, Tilman; Hagemann, Jan] Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Mainz, Germany.
   [Bachert, Claus] Ghent Univ Hosp, Upper Airways Res Lab, ENT Dept, Ghent, Belgium.
   [Bachert, Claus] Sun Yat Sen Univ, Int Airway Res Ctr, Affiliated Hosp Guangzou 1, Guangzou, Peoples R China.
   [Bachert, Claus] Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden.
   [Bachert, Claus] Karolinska Univ Hosp, Dept ENT Dis, Stockholm, Sweden.
   [Fokkens, Wytske] Amsterdam Univ Med Ctr, Dept Otorhinolaryngol, Locat AMC, Amsterdam, Netherlands.
RP Klimek, L (corresponding author), Ctr Rhinol & Allergol, Quellen 10, D-65183 Wiesbaden, Germany.
EM Ludger.Klimek@Allergiezentrum.org
RI Bachert, Claus/J-8825-2012; Becker, Sven/AAV-5316-2021; Gevaert,
   Philippe/ABA-4588-2021
OI Gevaert, Philippe/0000-0002-1629-8468; Toppila-Salmi,
   Sanna/0000-0003-0890-6686; JUTEL, MAREK/0000-0003-1555-9379; Klimek,
   Ludger/0000-0002-2455-0192; Cingi, Cemal/0000-0003-3934-5092; Hox,
   Valerie/0000-0003-2390-294X; RONDON SEGOVIA, CARMEN/0000-0003-0976-3402;
   Chaker, Adam/0000-0002-5117-4073
CR Abidi K, 2008, CRIT CARE, V12, DOI 10.1186/cc6883
   Agache I, 2020, ALLERGY, V75, P1023, DOI 10.1111/all.14221
   [Anonymous], 2019, DUPILUMAB CORE CO DA
   Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC
   Bousquet J, 2020, ALLERGY, V75, P2440, DOI 10.1111/all.14302
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   CHMP  E.M.A, 2017, ASS REP DUP
   Chong Lee Yee, 2016, Cochrane Database Syst Rev, V4, pCD011996, DOI 10.1002/14651858.CD011996.pub2
   Control E.C.f.D.P.a, 2020, SIT UPD WORLDW
   Criado PR, 2020, INT J DERMATOL, V59, P1294, DOI 10.1111/ijd.15134
   Darveaux JI, 2014, J ALLER CL IMM-PRACT, V2, P658, DOI 10.1016/j.jaip.2014.09.011
   De Greve G, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0157-8
   de Loos DD, 2019, J ALLERGY CLIN IMMUN, V143, P1207, DOI 10.1016/j.jaci.2018.12.986
   Forster-Ruhrmann U, 2020, J ALLERGY CLIN IMMUN, V146, P218, DOI 10.1016/j.jaci.2020.05.005
   Fokkens WJ, 2012, RHINOLOGY, V50, P1
   Fokkens WJ, 2020, RHINOLOGY, V58, pI, DOI 10.4193/Rhin20.600
   Fokkens WJ, 2019, ALLERGY, V74, P2312, DOI 10.1111/all.13875
   Fokkens WJ, 2017, RHINOLOGY, V55, P1, DOI 10.4193/Rhin17.401
   Gandhi NA, 2017, EXPERT REV CLIN IMMU, V13, P425, DOI 10.1080/1744666X.2017.1298443
   Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114
   Ghazi A, 2012, EXPERT OPIN BIOL TH, V12, P113, DOI 10.1517/14712598.2012.642359
   GINA, 2020, GLOB STR ASTHM MAN P
   Gleich GJ, 2013, ALLERGY, V68, P829, DOI 10.1111/all.12169
   Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875
   Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x
   Hayward G, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008116.pub3
   HEAD K, 2016, COCHRANE DB SYST REV, V26, DOI [DOI 10.1002/14651858.CD011991.PUB2, 10.1002/14651858.cd011991.pub2]
   Head K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011991.pub2
   Hellings PW, 2017, ALLERGY, V72, P1297, DOI 10.1111/all.13162
   Hellings PW, 2013, ALLERGY, V68, P1, DOI 10.1111/all.12040
   Hewitt R, 2016, THER ADV RESPIR DIS, V10, P158, DOI 10.1177/1753465815618113
   Hirsch AG, 2017, ALLERGY, V72, P274, DOI 10.1111/all.13042
   Hopkins C, 2018, RHINOLOGY, V56, DOI 10.4193/Rhin17.027
   HORBY P, 2020, NEW ENGL J MED, DOI 10.1101/2020.07.15.20151852
   Howarth P, 2020, J ALLERGY CLIN IMMUN, V145, P1713, DOI 10.1016/j.jaci.2020.02.002
   Hox V, 2020, CLIN TRANSL ALLERGY, V10, DOI 10.1186/s13601-019-0303-6
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m39
   Jackson DJ, 2020, J ALLERGY CLIN IMMUN, V146, P203, DOI 10.1016/j.jaci.2020.04.009
   Keith PK, 2012, PRIM CARE RESP J, V21, P267, DOI 10.4104/pcrj.2012.00039
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Khan A, 2019, RHINOLOGY, V57, P32, DOI 10.4193/Rhin17.255
   Kilty SJ, 2018, RHINOLOGY, V56, P155, DOI 10.4193/Rhin17.115
   Kirsche H, 2015, HNO, V63, P357, DOI 10.1007/s00106-015-0008-7
   Klimek L, 2000, HNO, V48, P544, DOI 10.1007/s001060050614
   Klimek L, 2020, ALLERGOLOGIE, V43, P255, DOI 10.5414/ALX02166
   Klimek L, 2020, LARYNGO RHINO OTOL, V99, P280
   Klimek L, 2019, HNO, V67, P15, DOI 10.1007/s00106-018-0557-7
   Klimek L, 2009, IMMUNOL ALLERGY CLIN, V29, P669, DOI 10.1016/j.iac.2009.07.008
   Klimek L, 2021, ALLERGY, V76, P677, DOI 10.1111/all.14629
   Koennecke Michael, 2018, Allergo J Int, V27, P56, DOI 10.1007/s40629-017-0048-5
   Korn S, 2020, ASTHMA PATIENTEN COV
   Kowalski ML, 2019, ALLERGY, V74, P28, DOI 10.1111/all.13599
   Kulaylat AS, 2018, JAMA SURG, V153, P1127, DOI 10.1001/jamasurg.2018.3174
   Langdon C, 2016, J ASTHMA ALLERGY, V9, P45, DOI 10.2147/JAA.S86251
   Liao B, 2018, ALLERGY, V73, P1459, DOI 10.1111/all.13411
   Lin DC, 2011, AM J RHINOL ALLERGY, V25, P205, DOI 10.2500/ajra.2011.25.3613
   Liu F, 2020, INT J INFECT DIS, V95, P183, DOI 10.1016/j.ijid.2020.03.013
   Lommatzsch M, 2020, ALLERGY, V75, P2705, DOI 10.1111/all.14456
   Luers JC, 2020, LARYNGO RHINO OTOL, V99, P287, DOI 10.1055/a-1095-2344
   Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V116, P1289, DOI 10.1016/j.jaci.2005.08.044
   Organization, 2020, COR VIR COVID 19 PAN
   ORLI R, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI DOI 10.1002/alr.21695
   Ostovar A, 2019, RHINOLOGY, V57, P43, DOI 10.4193/Rhin18.061
   Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x
   Philpott CM, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0823-y
   Pouliquen IJ, 2015, INT J CLIN PHARM TH, V53, P1015, DOI 10.5414/CP202446
   Price DB, 2018, J ASTHMA ALLERGY, V11, P193, DOI 10.2147/JAA.S176026
   Puhakka T, 1998, J ALLERGY CLIN IMMUN, V101, P726, DOI 10.1016/S0091-6749(98)70301-X
   Pundir V, 2016, RHINOLOGY, V54, P3, DOI [10.4193/Rhin15.079, 10.4193/Rhino15.079]
   Qin Jing, 2020, medRxiv, DOI 10.1101/2020.03.06.20032417
   Rondon C, 2015, J INVEST ALLERG CLIN, V25, P276
   Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Rudmik L, 2015, JAMA-J AM MED ASSOC, V314, P926, DOI 10.1001/jama.2015.7544
   Rudmikl L, 2016, RHINOLOGY, V54, P117, DOI 10.4193/Rhino16.023
   Sanofi-Aventis_Deutschland_GmbH D, 2020, 300 MG INK FERT, P21
   Seys SF, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0524-y
   Shaw DE, 2015, EUR RESPIR J, V46, P1308, DOI 10.1183/13993003.00779-2015
   Shi JB, 2015, ALLERGY, V70, P533, DOI 10.1111/all.12577
   Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052
   Stuck BA, 2018, HNO, V66, P38, DOI 10.1007/s00106-017-0401-5
   Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324
   Tsetsos N, 2018, RHINOLOGY, V56, P11, DOI [10.4193/Rhino17.156, 10.4193/Rhin17.156]
   Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI 10.1002/lary.28692
   Van Gerven L, 2020, RHINOLOGY, V58, P289, DOI 10.4193/Rhin20.119
   Voorham J, 2019, ALLERGY, V74, P273, DOI 10.1111/all.13556
   Vultaggio A, 2020, ALLERGY, V75, P2764, DOI 10.1111/all.14407
   Wei CC, 2013, LARYNGOSCOPE, V123, P2347, DOI 10.1002/lary.24066
   Workman AD, 2020, INT FORUM ALLERGY RH, V10, P798, DOI 10.1002/alr.22577
   Wu DW, 2018, J ALLER CL IMM-PRACT, V6, P1297, DOI 10.1016/j.jaip.2017.09.020
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang Y, 2019, ALLERGY, V74, P131, DOI 10.1111/all.13489
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 95
TC 17
Z9 17
U1 2
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-4538
EI 1398-9995
J9 ALLERGY
JI Allergy
PD MAR
PY 2021
VL 76
IS 3
SI SI
BP 677
EP 688
DI 10.1111/all.14629
PG 12
WC Allergy; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Allergy; Immunology
GA QS0YB
UT WOS:000625633400004
PM 33075144
OA Green Accepted, Green Published
DA 2022-04-20
ER

PT J
AU Luo, XF
   Liu, YL
   Ren, MJ
   Zhang, XZ
   Janne, E
   Lv, M
   Wang, Q
   Song, Y
   Mathew, JL
   Ahn, HS
   Lee, MS
   Chen, YL
AF Luo, Xufei
   Liu, Yunlan
   Ren, Mengjuan
   Zhang, Xianzhuo
   Janne, Estill
   Lv, Meng
   Wang, Qi
   Song, Yang
   Mathew, Joseph L.
   Ahn, Hyeong Sik
   Lee, Myeong Soo
   Chen, Yaolong
TI Consistency of recommendations and methodological quality of guidelines
   for the diagnosis and treatment of COVID-19
SO JOURNAL OF EVIDENCE BASED MEDICINE
LA English
DT Article
DE clinical practice guideline; COVID-19; diagnosis; treatment
ID SARS-COV-2 INFECTION; LUNG ULTRASOUND; CORONAVIRUS; MANAGEMENT
AB ObjectiveSince the beginning of the COVID-19 epidemic, a large number of guidelines on diagnosis and treatment of COVID-19 have been developed, but the quality of those guidelines and the consistency of recommendations are unclear. The objective of this study is to evaluate the quality of the diagnosis and treatment guidelines on COVID-19 and analyze the consistency of the recommendations of these guidelines.
   MethodsWe searched for guidelines on diagnosis and/or treatment of COVID-19 through PubMed, CBM, CNKI, and WanFang Data, from January 1, 2020 to August 31, 2020. In addition, we also searched official websites of the US CDC, European CDC and WHO, and some guideline collection databases. We included diagnosis and/or treatment guidelines for COVID-19, including rapid advice guidelines and interim guidelines. Two trained researchers independently extracted data and four trained researchers evaluated the quality of the guidelines using the AGREE II instruments. We extracted information on the basic characteristics of the guidelines, guideline development process, and the recommendations. We described the consistency of the direction of recommendations for treatment and diagnosis of COVID-19 across the included guidelines.
   ResultsA total of 37 guidelines were included. Most included guidelines were assessed as low quality, with only one of the six domains of AGREE II (clarity of presentation) having a mean score above 50%. The mean scores of three domains (stakeholder involvement, the rigor of development and applicability) were all below 30%. The recommendations on diagnosis and treatment were to some extent consistent between the included guidelines. Computed tomography (CT), X-rays, lung ultrasound, RT-PCR, and routine blood tests were the most commonly recommended methods for COVID-19 diagnosis. Thirty guidelines were on the treatment of COVID-19. The recommended forms of treatment included supportive care, antiviral therapy, glucocorticoid therapy, antibiotics, immunoglobulin, extracorporeal membrane oxygenation (ECMO), convalescent plasma, and psychotherapy.
   ConclusionsThe methodological quality of currently available diagnosis and treatment guidelines for COVID-19 is low. The diagnosis and treatment recommendations between the included guidelines are highly consistent. The main diagnostic methods for COVID-19 are RT-PCR and CT, with ultrasound as a potential diagnostic tool. As there is no effective treatment against COVID-19 yet, supportive therapy is at the moment the most important treatment option.
C1 [Luo, Xufei; Liu, Yunlan; Ren, Mengjuan; Lv, Meng; Lee, Myeong Soo; Chen, Yaolong] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China.
   [Zhang, Xianzhuo] Lanzhou Univ, Sch Clin Med 1, Lanzhou, Peoples R China.
   [Janne, Estill] Univ Geneva, Inst Global Hlth, Geneva, Switzerland.
   [Wang, Qi] McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.
   [Wang, Qi] McMaster Univ, McMaster Hlth Forum, Hamilton, ON, Canada.
   [Song, Yang] Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Dept Clin Epidemiol & Publ Hlth, Barcelona, Spain.
   [Mathew, Joseph L.] PGIMER Chandigarh, Adv Pediat Ctr, Chandigarh, India.
   [Ahn, Hyeong Sik] Korea Univ, Dept Prevent Med, Seoul, South Korea.
   [Ahn, Hyeong Sik] Korea Cochrane Ctr, Seoul, South Korea.
   [Lee, Myeong Soo] Korea Inst Oriental Med, Daejeon, South Korea.
   [Lee, Myeong Soo] Univ Sci & Technol, Daejeon, South Korea.
   [Chen, Yaolong] Lanzhou Univ, Inst Hlth Data Sci, 199 DonggangWest Rd, Lanzhou, Gansu, Peoples R China.
   [Chen, Yaolong] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Peoples R China.
   [Chen, Yaolong] Key Lab Evidence Based Med & Knowledge Translat, Lanzhou, Gansu, Peoples R China.
RP Chen, YL (corresponding author), Lanzhou Univ, Inst Hlth Data Sci, 199 DonggangWest Rd, Lanzhou, Gansu, Peoples R China.
EM chenyaolong@lzu.edu.cn
RI Lee, Myeong Soo/C-8147-2013
OI Lee, Myeong Soo/0000-0001-6651-7641; Chen, Yaolong/0000-0002-9841-5233;
   Luo, Xufei/0000-0003-0811-6326; Song, Yang/0000-0002-4094-1388; Zhang,
   Xianzhuo/0000-0003-0160-903X
FU Key Laboratory of Evidence Based Medicine and Knowledge Translation of
   Gansu Province [GSEBMKT-2020YJ01]; National Key Research & Development
   Plan: Research on the Development and Evaluation of International
   Standards of Traditional Chinese Medicine [2019YFC1712000]
FX Special funding for prevention and control of emergency of COVID-19 from
   Key Laboratory of Evidence Based Medicine and Knowledge Translation of
   Gansu Province, Grant/Award Number: GSEBMKT-2020YJ01; National Key
   Research & Development Plan: Research on the Development and Evaluation
   of International Standards of Traditional Chinese Medicine, Grant/Award
   Number: 2019YFC1712000
CR Adarsh B., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa478, DOI 10.1093/CID/CIAA478]
   Akl EA, 2021, RADIOLOGY, V298, pE63, DOI 10.1148/radiol.2020203173
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, HERALD MED
   [Anonymous], 2020, J CAP MED U
   [Anonymous], 2020, CHIN J EVID BASED PE
   [Anonymous], 2020, PHLN GUID LAB TEST S PHLN GUID LAB TEST S
   Api O, 2020, J PERINAT MED, V48, P857, DOI 10.1515/jpm-2020-0265
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449
   Buda N, 2020, ADV MED SCI-POLAND, V65, P378, DOI 10.1016/j.advms.2020.06.005
   Calvo C, 2020, AN PEDIATR, V92, DOI [10.1016/j.anpede.2020.02.002, 10.1016/j.anpedi.2020.02.001]
   Chen Qiong, 2020, Aging Med (Milton), V3, P66, DOI 10.1002/agm2.12113
   Chen ZM, 2020, WORLD J PEDIATR, V16, P240, DOI 10.1007/s12519-020-00345-5
   Chinese Society of Radiology Chinese Medical Association, 2020, CHIN J RADIOL, P279
   Chiotos K, 2020, J PEDIAT INF DIS SOC, V9, P701, DOI 10.1093/jpids/piaa045
   Convissar DL, 2020, ANESTH ANALG, V131, P345, DOI 10.1213/ANE.0000000000004929
   Dagens A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2371
   Flisiak R, 2020, POL ARCH INTERN MED, V130, P352, DOI 10.20452/pamw.15270
   Government of Canada, 2020, CLIN MAN PAT COVID 1
   Government of India Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division), 2020, GUIDELINES CLIN MANA
   Hanson KE, 2021, CLIN INFECT DIS, DOI [10.1093/cid/ciaa760, 10.1093/cid/ciab557]
   Hong KH, 2020, ANN LAB MED, V40, P351, DOI 10.3343/alm.2020.40.5.351
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Kache S, 2020, PEDIATR RES, V88, P705, DOI 10.1038/s41390-020-1053-9
   Kim SB, 2020, INFECT CHEMOTHER, V52, P281, DOI 10.3947/ic.2020.52.2.281
   Kluge S, 2020, MED KLIN-INTENSIVMED, V115, P111, DOI 10.1007/s00063-020-00689-w
   Kow CS, 2021, EUR J HOSP PHARM, V28, P42, DOI 10.1136/ejhpharm-2020-002388
   Li TS, 2020, EMERG MICROBES INFEC, V9, P582, DOI 10.1080/22221751.2020.1735265
   Liu EM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3754
   Luo XF, 2020, OBSTET GYNECOL, V136, P191, DOI [10.1097/AOG.0000000000003978, 10.1097/AOG.0000000000003963]
   McIntosh JJ, 2020, AM J PERINAT, V37, P809, DOI 10.1055/s-0040-1709684
   Namendys-Silva SA, 2020, GAC MED MEX, V156, P246, DOI 10.24875/GMM.M20000375
   National Institute of Health (NIH), 2020, COR DIS 2019 COVID 1
   People's Medical Publishing House Committee of the Infectious Diseases Radiology Group of Chinese Society of Radiology Committee of the Infectious Diseases Radiology Section of Chinese Medical Doctor Association, 2020, NEW MED, V30, P22
   Poston JT, 2020, JAMA-J AM MED ASSOC, V323, P1839, DOI 10.1001/jama.2020.4914
   Public Health Agency of Canada, 2020, CLIN MAN PAT MOD SER
   Public Health Laboratory Network, 2020, PUBL HLTH LAB NETW G
   Rochwerg B, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2924
   Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980
   Snawerdt J, 2020, CRIT CARE NURS Q, V43, P349, DOI 10.1097/CNQ.0000000000000321
   Sorbello M, 2020, ANAESTHESIA, V75, P724, DOI 10.1111/anae.15049
   Sterne JAC, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04641-3
   Thomas P, 2020, J PHYSIOTHER, V66, P73, DOI 10.1016/j.jphys.2020.03.011
   US CDC, 2020, INT GUID MAN CONF CO
   Verdugo-Paiva F, 2020, MEDWAVE, V20, DOI 10.5867/medwave.2020.06.7966
   World Health Organization, COR DIS COVID 19 PAN
   Yang TH, 2021, J CHIN MED ASSOC, V84, P233, DOI 10.1097/JCMA.0000000000000425
   Yao L, 2016, J CLIN EPIDEMIOL, V74, P73, DOI 10.1016/j.jclinepi.2016.01.003
   Ye ZK, 2020, CAN MED ASSOC J, V192, pE536, DOI 10.1503/cmaj.200648
   Zhao SY, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.130
   Zhu RF, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02442-5
NR 51
TC 8
Z9 8
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1756-5383
EI 1756-5391
J9 J EVID-BASED MED
JI J Evid.-Based Med.
PD FEB
PY 2021
VL 14
IS 1
BP 40
EP 55
DI 10.1111/jebm.12419
PG 16
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA TQ2MT
UT WOS:000678120200006
PM 33565225
OA Green Published
DA 2022-04-20
ER

PT J
AU Koken, ZO
   Savas, H
   Gul, S
AF Koken, Zeliha Ozdemir
   Savas, Hafize
   Gul, Senay
TI Cardiovascular nurses' experiences of working in the COVID-19 intensive
   care unit: A qualitative study
SO INTENSIVE AND CRITICAL CARE NURSING
LA English
DT Article
DE Cardiovascular nurse; COVID-19; Critical care; Nursing care
ID MANAGEMENT; INTERVIEWS
AB Background: Cardiovascular nurses' skills and experiences of cardiac critical care, management of cardiovascular emergencies, and mechanical circulatory support have been considered vital in providing nursing care for COVID-19 patients in intensive care units during the COVID-19 pandemic. To our knowledge, there are no studies have focused on the contribution and experiences of cardiovascular nurses in the critical care of COVID19 patients. Objectives: To explore the experiences of cardiovascular nurses working in a COVID-19 intensive care unit during the pandemic. Methods: The study was conducted as a qualitative study with phenomenological approach in June-December 2020. Study data were gathered from ten cardiovascular nurses through semi-structured interviews. Results: Six themes emerged from the interview data: the duties and responsibilities in a COVID-19 intensive care unit; the differences of COVID-19 intensive care unit practices from cardiovascular practices; the transferrable skills of cardiovascular nurses in a COVID-19 intensive care unit; the difficulties encountered working in a COVID-19 intensive care unit; the difficulty of working with personal protective equipment; and the psychosocial effects of working in a COVID-19 intensive care unit. Conclusion: Cardiovascular nurses made an important contribution to the management of nursing services with their experiences and skills in the COVID-19 pandemic.
C1 [Koken, Zeliha Ozdemir] Hacettepe Univ, Fac Nursing, Surg Nursing Dept, Ankara, Turkey.
   [Savas, Hafize] Lokman Hekim Univ, Fac Hlth Sci, Nursing Dept, Ankara, Turkey.
   [Gul, Senay] Hacettepe Univ, Fundamentals Nursing Dept, Fac Nursing, Ankara, Turkey.
RP Koken, ZO (corresponding author), Hacettepe Univ, Fac Nursing, Surg Nursing Dept, Ankara, Turkey.
EM zeliha.ozdemir@hacettepe.edu.tr
CR Ardebili ME, 2021, AM J INFECT CONTROL, V49, P547, DOI 10.1016/j.ajic.2020.10.001
   Chen QH, 2020, J PERIANESTH NURS, V35, P453, DOI 10.1016/j.jopan.2020.05.007
   Colaizzi PF., 1978, PSYCHOL RES PHENOMEN
   Crowe S, 2021, INTENS CRIT CARE NUR, V63, DOI 10.1016/j.iccn.2020.102999
   Di Napoli, 2021, STATPEARLS
   Farooq MB, 2017, MEDITARI ACCOUNT RES, V25, P291, DOI 10.1108/MEDAR-10-2016-0083
   Fernandez R, 2020, INT J NURS STUD, V111, DOI 10.1016/j.ijnurstu.2020.103637
   Fraisse M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03025-y
   Glesne C, 2012, INTRO QUALITATIVE RE
   Hajjar LA, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00820-w
   Halacli B, 2020, TURK J MED SCI, V50, P585, DOI 10.3906/sag-2004-122
   Hampton T, 2020, J LARYNGOL OTOL, V134, P577, DOI 10.1017/S0022215120001437
   Hardin S., 2010, CARDIAC SURG ESSENTI
   Hoernke K, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046199
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Koken Z.O., 2020, J ED RES NURS, V17, P365, DOI [10.5222/KUHEAD.2020.88785, DOI 10.5222/KUHEAD.2020.88785]
   Lauxmann Martin Alexander, 2020, Int. braz j urol., V46, P6, DOI [10.1590/s1677-5538.ibju.2020.s101, 10.1590/S1677-5538.IBJU.2020.S101]
   Lincoln Y.S, 1985, NATURALISTIC INGURY
   Linden B., 2020, BR J CARDIAC NURS, V15, P1, DOI [10.12968/bjca.2020.0036, DOI 10.12968/BJCA.2020.0036]
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Lord H, 2021, INTENS CRIT CARE NUR, V62, DOI 10.1016/j.iccn.2020.102946
   Martin CG, 2006, J CARDIOVASC NURS, V21, P109, DOI 10.1097/00005082-200603000-00006
   Merkouris Anastasios, 2003, Eur J Cardiovasc Nurs, V2, P123, DOI 10.1016/S1474-5151(03)00029-X
   Merriam S.B, 2013, QUALITATIVE RES GUID
   Morrow DA, 2012, CIRCULATION, V126, P1408, DOI 10.1161/CIR.0b013e31826890b0
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Polit DF, 2008, NURSING RES GENERATI
   Qiu HB, 2020, INTENS CARE MED, V46, P576, DOI 10.1007/s00134-020-05966-y
   Raurell-Torreda M, 2020, ENFERM INTENSIV, V31, P49, DOI 10.1016/j.enfi.2020.04.001
   Riley Jillian, 2005, Eur J Cardiovasc Nurs, V4, P15, DOI 10.1016/j.ejcnurse.2005.01.002
   Saarijarvi M, 2021, EUR J CARDIOVASC NUR, V20, P392, DOI 10.1093/eurjcn/zvab038
   Costa IBSD, 2020, ARQ BRAS CARDIOL, V114, P805, DOI 10.36660/abc.20200279
   Schroeder Krista, 2020, Int J Nurs Stud Adv, V2, P100006, DOI 10.1016/j.ijnsa.2020.100006
   Stephens RS, 2015, CRIT CARE MED, V43, P1477, DOI 10.1097/CCM.0000000000001059
   Stucky CH, 2020, J PERIANESTH NURS, V35, P353, DOI 10.1016/j.jopan.2020.04.010
   Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018
   Sutantri S, 2019, EUR J CARDIOVASC NUR, V18, P744, DOI 10.1177/1474515119864208
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   Van Manen M., 1990, RES LIVED EXPERIENCE
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zangrillo A, 2020, CRIT CARE RESUSC, V22, P91
   Zhu CR, 2020, HEART LUNG, V49, P449, DOI 10.1016/j.hrtlng.2020.04.007
NR 44
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0964-3397
EI 1532-4036
J9 INTENS CRIT CARE NUR
JI Intensive Crit. Care Nurs.
PD APR
PY 2022
VL 69
AR 103181
DI 10.1016/j.iccn.2021.103181
PG 7
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA ZH9DA
UT WOS:000761228800009
PM 34895975
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Asmelash, D
   Fasil, A
   Tegegne, Y
   Akalu, TY
   Ferede, HA
   Aynalem, GL
AF Asmelash, Daniel
   Fasil, Alebachew
   Tegegne, Yalewayker
   Akalu, Temesgen Yihunie
   Ferede, Habtamu Asfaw
   Aynalem, Getie Lake
TI Knowledge, Attitudes and Practices Toward Prevention and Early Detection
   of COVID-19 and Associated Factors Among Religious Clerics and
   Traditional Healers in Gondar Town, Northwest Ethiopia: A
   Community-Based Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE knowledge; attitude; practice; COVID-19; religious clerics; traditional
   healers; Ethiopia
AB Background: COVID-19 control measures efforts are affected by the knowledge, attitudes, and practices of the public, particularly religious clerics and traditional healers, who have close contact and are widely accepted by a significant number of community members.
   Methods: A community-based cross-sectional study was conducted to determine knowledge, attitudes and practices towards COVID-19 and its associated factors among religious clerics and traditional healers in Gondar town. Study participants who met our inclusion criteria were selected using a simple random sampling technique. Data were collected by trained data collectors through face-to-face interviews. The reliability of the questionnaire was assessed using Cronbach's alpha. Knowledge, attitudes and practices scores were calculated to give the overall knowledge, attitude and practice score. Binary logistic regression was fitted to identify associated factors and odds ratio was used to measure the strength of the association.
   Results: A total of 410 religious clerics and traditional healers were included in the study with a response rate of 97.1%. Of the total participants, 60.7% (95%: CI (56-65%)) had good knowledge, 34.1% (95%: CI (30-39%)) had a positive attitude and 15.6% (95%: CI (12-19%)) had good practices towards prevention and early detection of COVID-19. Less than one third of the participants practiced physical distancing (28%) and facemask use (17.8%). In multivariate logistic regression, age, educational status and marital status were significantly associated with knowledge score. Likewise, age and marital status were significantly associated with the positive attitude score. In addition, age, educational status, and the presence of underlying disease were significantly associated with the good practice score.
   Conclusion: Majority of the participants had poor practice and negative attitudes. Therefore, there should be a sensitization program to fill the gap in the knowledge, attitudes and practice measures of COVID-19 especially for elderly and illiterates.
C1 [Asmelash, Daniel; Fasil, Alebachew] Univ Gondar, Sch Biomed & Lab Sci, Coll Med & Hlth Sci, Dept Clin Chem, Gondar, Ethiopia.
   [Tegegne, Yalewayker] Univ Gondar, Sch Biomed & Lab Sci, Coll Med & Hlth Sci, Dept Parasitol, Gondar, Ethiopia.
   [Akalu, Temesgen Yihunie] Univ Gondar, Sch Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia.
   [Ferede, Habtamu Asfaw] Univ Gondar, Referral Hosp, Dept Nursing, Gondar, Ethiopia.
   [Aynalem, Getie Lake] Univ Gondar, Sch Midwifery, Coll Med & Hlth Sci, Gondar, Ethiopia.
RP Asmelash, D (corresponding author), Univ Gondar, Sch Biomed & Lab Sci, Coll Med & Hlth Sci, Dept Clin Chem, Gondar, Ethiopia.
EM daniel.asmelash111@gmail.com
RI Gebretensae, Daniel Asmelash/AAN-6039-2020
OI Gebretensae, Daniel Asmelash/0000-0001-8345-2982; Aynalem,
   Getie/0000-0001-8010-7497
FU University of Gondar
FX This study was funded by the University of Gondar. The University of
   Gondar was not involved in the study design, data collection, analysis,
   interpretation and manuscript writing.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Agresti A., 2007, INTRO CATEGORICAL DA, P137, DOI [DOI 10.1002/0470114754, 10.1002/0470114754]
   Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Ali, 2020, KNOWLEDGE ATTITUDE P
   Aynalem YA, 2020, ASSESSMENT UNDERGRAD
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bekele D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0234585
   Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17
   CDC, 2020, COR DIS 2019 INF HEA
   Chen Y, 2020, Zhonghua Yu Fang Yi Xue Za Zhi, V54, pE004, DOI 10.3760/cma.j.issn.0253-9624.2020.0004
   Demoz GT., 2020, KNOWLEDGE ATTITUDE P
   Di Napoli R, 2020, FEATURES EVALUATION
   Elnadi H., 2020, KNOWLEDGE ATTITUDE P
   Erfani A, 2020, B WORLD HEALTH ORGAN, V76, P648, DOI DOI 10.2471/BLT.20.256651
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   FISHER WA, 1995, HEALTH PSYCHOL, V14, P255, DOI 10.1037/0278-6133.14.3.255
   Gugssa SA, 2020, SEIZURE-EUR J EPILEP, V78, P57, DOI 10.1016/j.seizure.2020.03.006
   Jemal B., 2020, KNOWLEDGE ATTITUDE P
   Jing Yang YZ, 2020, INT J INFECT DIS, V3
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Nicholas T, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.2020.35.2.22963, 10.11604/pamj.supp.2020.35.2.22963]
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2
   Vaidya B, 2020, KNOWLEDGE ATTITUDE P
   WHO, COVID 2019 SIT REP 2
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 31
TC 10
Z9 10
U1 0
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 2239
EP 2250
DI 10.2147/RMHP.S277846
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA OC8HL
UT WOS:000579397400001
PM 33117002
OA Green Published
DA 2022-04-20
ER

PT J
AU Scheiber, B
   Spiegl, C
   Wiederin, C
   Schifferegger, E
   Schiefermeier-Mach, N
AF Scheiber, Barbara
   Spiegl, Claudia
   Wiederin, Claudia
   Schifferegger, Erika
   Schiefermeier-Mach, Natalia
TI Post-COVID-19 Rehabilitation: Perception and Experience of Austrian
   Physiotherapists and Physiotherapy Students
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE post-acute COVID-19 syndrome; long COVID-19; physical therapy specialty;
   respiratory therapy; survey; physical and rehabilitation medicine;
   education
ID PULMONARY-FUNCTION; CLINICAL-PRACTICE; COVID-19; SURVIVORS; MANAGEMENT;
   RECOVERY; CAPACITY; OUTCOMES; IMPACT
AB The rehabilitation needs of COVID-19 survivors are increasingly recognized, with a focus on combating respiratory and neuromuscular dysfunctions. The aim here was to explore the perception of Austrian physiotherapists and physiotherapy students on post-COVID-19 rehabilitation care and to identify barriers for the application of sufficient rehabilitation. We analysed current knowledge and practical skills in respiratory physiotherapy, performing a cross-sectional national survey among physiotherapists working in outpatient settings and physiotherapy students in their last academic year of bachelor-level education in Austria. Out of 255 survey participants, one-third already had inquiries to treat post-COVID-19 patients, and the majority of respondents expected a further increased inflow of patients with rehabilitation needs (64.2%). Only 11.2% of respondents reported feeling sufficiently informed about post-COVID-19 rehabilitation. A total of 68.2% of students and up to 48.1% of physiotherapists favoured a COVID-19-specific adaptation already in the basic academic education, and 74.1% of survey participants indicated interest in attending specific training. Concerning respiratory physiotherapy, our data showed discrepancies between the estimation of the importance of specific examination and treatment techniques and the level of current experience. There is a clear lack of experience in implementing effective device-based respiratory therapy. Our data indicate an urgent need to develop new education and training programs with a focus on the interdisciplinary rehabilitation of patients with post-COVID-19 syndrome.
C1 [Scheiber, Barbara; Spiegl, Claudia; Wiederin, Claudia; Schifferegger, Erika] Hlth Univ Appl Sci Tyrol, FH Gesundheit Tirol, Dept Physiotherapy, A-6020 Innsbruck, Austria.
   [Schiefermeier-Mach, Natalia] Hlth Univ Appl Sci Tyrol, FH Gesundheit Tirol, A-6020 Innsbruck, Austria.
RP Schiefermeier-Mach, N (corresponding author), Hlth Univ Appl Sci Tyrol, FH Gesundheit Tirol, A-6020 Innsbruck, Austria.
EM barbara.scheiber@fhg-tirol.ac.at; claudia.spiegl@fhg-tirol.ac.at;
   claudia.wiederin@fhg-tirol.ac.at; erika.schifferegger@fhg-tirol.ac.at;
   natalia.schiefermeier-mach@fhg-tirol.ac.at
OI Schiefermeier-Mach, Natalia/0000-0001-6638-5298
CR Abdullahi A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00454
   Ahmed T, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7482
   Aistleithner R., 2012, HLTH CARE 2020 FORSC
   Arnold DT, 2021, THORAX, V76, P399, DOI 10.1136/thoraxjnl-2020-216086
   Barker-Davies RM, 2020, BRIT J SPORT MED, V54, P949, DOI 10.1136/bjsports-2020-102596
   Beckerman M, 2005, CHEST, V128, P3177, DOI 10.1378/chest.128.5.3177
   Brugliera L, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2678
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Carvalho-Schneider C, 2021, CLIN MICROBIOL INFEC, V27, P258, DOI 10.1016/j.cmi.2020.09.052
   Chopra V, 2021, ANN INTERN MED, V174, P576, DOI 10.7326/M20-5661
   Correa-Martinez CL, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00588-20
   Dachverband der osterreichischen Sozialversicherung Gesundheit Osterreich GmbH, GES OST GMBH OST REH
   de Luca K, 2021, CHIROPR MAN THER, V29, DOI 10.1186/s12998-021-00364-7
   Dean E, 2020, PHYS THER, V100, P1458, DOI 10.1093/ptj/pzaa115
   Demeco A, 2020, J INT MED RES, V48, DOI 10.1177/0300060520948382
   Diermayr G, 2015, J EVAL CLIN PRACT, V21, P1219, DOI 10.1111/jep.12415
   Garrod R, 2007, RESP MED, V101, P2429, DOI 10.1016/j.rmed.2007.06.007
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Harting J, 2009, PHYS THER, V89, P221, DOI 10.2522/ptj.20080185
   Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8
   Holzweber L., 2021, JAHRESBERICHT GESUND
   Hosey MM, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0201-1
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Hui DS, 2005, THORAX, V60, P401, DOI 10.1136/thx.2004.030205
   Inoue S, 2019, ACUTE MED SURG, V6, P233, DOI 10.1002/ams2.415
   Kleinitz P., 2020, REHABILITATION CONSI
   Kreidl P, 2020, WIEN KLIN WOCHENSCHR, V132, P645, DOI 10.1007/s00508-020-01723-9
   Krenek B., 2020, LEITLINIE PHYSIOTHER
   Kulnik ST, 2020, PHYSIOTHER THEOR PR, DOI 10.1080/09593985.2020.1836695
   Lam MHB, 2009, ARCH INTERN MED, V169, P2142, DOI 10.1001/archinternmed.2009.384
   Lau HMC, 2005, AUST J PHYSIOTHER, V51, P213, DOI 10.1016/S0004-9514(05)70002-7
   Liu K, 2020, COMPLEMENT THER CLIN, V39, DOI 10.1016/j.ctcp.2020.101166
   MacDonald CW, 2020, J MAN MANIP THER, V28, P134, DOI 10.1080/10669817.2020.1782059
   Moldofsky H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-37
   Moreno-Perez O, 2021, J INFECTION, V82, P378, DOI 10.1016/j.jinf.2021.01.004
   Moritz S, 2020, PHYSIOAUSTRIA JAHRES
   Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z
   Newstead CJ, 2017, HONG KONG PHYSIOTHER, V36, P33, DOI 10.1016/j.hkpj.2016.08.001
   Ong KC, 2004, EUR RESPIR J, V24, P436, DOI 10.1183/09031936.04.00007104
   Parry SM, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.05.024
   Physio Austria, 2004, BER
   Puchner B, 2021, EUR J PHYS REHAB MED, V57, P189, DOI 10.23736/S1973-9087.21.06549-7
   Rettinger L, 2021, J TELEMED TELECARE, DOI 10.1177/1357633X20986038
   Rooney S, 2020, PHYS THERAPY, V100, P1717, DOI 10.1093/ptj/pzaa129
   Stevens JGA, 2010, PHYS THER, V90, P953, DOI 10.2522/ptj.20090105
   Tansey CM, 2007, ARCH INTERN MED, V167, P1312, DOI 10.1001/archinte.167.12.1312
   Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]
   Thomas P, 2020, J PHYSIOTHER, V66, P73, DOI 10.1016/j.jphys.2020.03.011
   van der Wees PJ, 2008, AUST J PHYSIOTHER, V54, P233, DOI 10.1016/S0004-9514(08)70002-3
   WEINER P, 1992, CHEST, V102, P1357, DOI 10.1378/chest.102.5.1357
   World Health Organization, 2021, EXP OUR UND POSTCOVI
   World Health Organization, WHO COVID 19 DASHB
   Zeng Bin, 2020, Aging Med (Milton), V3, P82, DOI 10.1002/agm2.12120
NR 55
TC 1
Z9 1
U1 8
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG
PY 2021
VL 18
IS 16
AR 8730
DI 10.3390/ijerph18168730
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA UJ0DM
UT WOS:000690965800001
PM 34444477
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Karna, ST
   Thaware, P
   Singh, P
AF Karna, Sunaina Tejpal
   Thaware, Pooja
   Singh, Pooja
TI COVID-19 with peripartum cardiomyopathy: a case report
SO AIN SHAMS JOURNAL OF ANESTHESIOLOGY
LA English
DT Article
DE COVID-19; Cardiomyopathy; Congestive cardiac failure; Echocardiography
AB Background: The world has been facing the novel coronavirus SARS-CoV-2 pandemic. The novel coronavirus primarily affects the lungs but also affects multiple organ systems including the cardiovascular system causing myocarditis, cardiomyopathy, and arrhythmias. Cardiomyopathy has been reported in patients with COVID-19; however, prognosis of peripartum cardiomyopathy in a patient with COVID-19 is still unexplored. More knowledge is required to understand the incidence of cardiomyopathy due to novel coronavirus SARS-CoV-2.
   Case presentation: We report a case of peripartum cardiomyopathy gravida 2 parity 2 COVID-19 confirmed patient who underwent an emergency preterm lower segment caesarean section (LSCS) for severe pre-eclampsia and intrauterine growth retardation (IUGR) and landed up in acute congestive cardiac failure with pulmonary oedema. A postpartum 32 years female presented to our institute, a dedicated COVID-19 hospital with tachycardia, hypertension, anasarca, tachypnea with denaturation on room air. She had undergone emergency caesarean section for severe preeclampsia with intrauterine growth retardation. On post-operative day 2 (POD2), she complained of shortness of breath. On POD 3 she tested positive RT-PCR for COVID-19 infection. She responded to treatment with steroids. However, on POD6, She developed severe pulmonary oedema with poor ejection fraction necessitating endotracheal intubation and pressure control ventilation. Congestive cardiac failure was managed with diuretics and digoxin. Gradually oxygenation improved. She was electively ventilated for 3 days. Gradually, ejection fraction improved with the resolution of B lines. On the 9th POD, after a successful spontaneous breathing trial, she was extubated and non-invasive ventilation with bi-level positive airway pressure was attached. The patient was gradually tapered off of the non-invasive ventilation over 2 days. On the 11th post-operative day, she was maintaining oxygen saturation on nasal prongs and was sent to the ward.
   Conclusions: We recommend early use of bedside lung ultrasonography; echocardiography and close cardiovascular monitoring in severe COVID-19 infected pregnant patients who present with shortness of breath, tachypnea, and hypertensive disorders of pregnancy and previous cardiac abnormalities for expedite management and improved prognosis. An ideal case scenario for extubation may not be present, non-invasive ventilation with bi-level positive airway pressure post-extubation helps in patients with peripartum cardiomyopathy.
C1 [Karna, Sunaina Tejpal; Thaware, Pooja; Singh, Pooja] All India Inst Med Sci, Dept Anesthesiol & Crit Care, Bhopal 462020, Madhya Pradesh, India.
RP Thaware, P (corresponding author), All India Inst Med Sci, Dept Anesthesiol & Crit Care, Bhopal 462020, Madhya Pradesh, India.
EM pthaware20@gmail.com
CR Annuk M, 2001, NEPHROL DIAL TRANSPL, V16, P302, DOI 10.1093/ndt/16.2.302
   Arcari L, 2020, INTERN EMERG MED, V15, P1467, DOI 10.1007/s11739-020-02498-7
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Juusela A, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100113
   Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1687-7934
EI 2090-925X
J9 AIN SHAMS J ANESTHES
JI Ain Shams J. Anesthesiol.
PD JAN 20
PY 2022
VL 14
IS 1
AR 10
DI 10.1186/s42077-021-00204-z
PG 5
WC Anesthesiology
WE Emerging Sources Citation Index (ESCI)
SC Anesthesiology
GA YK1PH
UT WOS:000744993100002
OA gold
DA 2022-04-20
ER

PT J
AU Yao, J
   Liu, YF
   Cheng, J
AF Yao, Jing
   Liu, Yanfang
   Cheng, Jing
TI Standardize the management procedures for breast cancer patients during
   the outbreak of COVID-19 in Wuhan, China
SO BREAST CANCER RESEARCH AND TREATMENT
LA English
DT Article
DE COVID-19; SARS-CoV-2; New coronavirus pneumonia; Breast cancer; Cancer
   therapy
AB Purpose The outbreak of the coronavirus disease 2019 (COVID-19) has led to interruption or delay in treatment of breast cancer patient. This commentary aims to standardize the management procedures and ensure complete or relatively complete treatment for breast cancer patients during the outbreak of COVID-19. Methods Provide detailed online diagnosis, online treatment recommendations, and face-to-face consultation suggestions. Results Breast cancer patients who are at high risk of COVID-19 are advised to consult online first. For patients who have undergone online consultation and need face-to-face consultation, try to go to the clinic alone and take necessary precautions. Medical staff should be provided with necessary training about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and knowledge of standard precautions and personal protective equipment. Conclusions This commentary focused on breast cancer patients and provided suggestions to avoid the spread of COVID-19. Some of these suggestions are also suitable for cancer patients in other lesions. We hope our suggestions are useful to oncologists in other countries and help them to overcome this challenge.
C1 [Yao, Jing; Liu, Yanfang; Cheng, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Jiefang Rd 1277, Wuhan 430022, Peoples R China.
RP Cheng, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Jiefang Rd 1277, Wuhan 430022, Peoples R China.
EM Chenjin1118@hotmail.com
CR Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e61
   Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012
   Oncology ASOC, 2020, COVID 19 PROV PRACT
   Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462
NR 4
TC 2
Z9 2
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0167-6806
EI 1573-7217
J9 BREAST CANCER RES TR
JI Breast Cancer Res. Treat.
PD AUG
PY 2020
VL 183
IS 1
BP 213
EP 216
DI 10.1007/s10549-020-05743-x
EA JUN 2020
PG 4
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA MN9CU
UT WOS:000543688200001
PM 32594281
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Wincewicz-Bosy, M
   Sadowski, A
   Wasowska, K
   Galar, Z
   Dymyt, M
AF Wincewicz-Bosy, Marta
   Sadowski, Adam
   Wasowska, Katarzyna
   Galar, Zbigniew
   Dymyt, Malgorzata
TI Military Food Supply Chain during the COVID-19 Pandemic
SO SUSTAINABILITY
LA English
DT Article
DE military food supply chain; supply chain management; military logistics;
   COVID-19; pandemic; disruptions
ID MANAGEMENT
AB The outbreak of the COVID-19 pandemic in Wuhan, China, disrupted international trade and changed the global food supply chain. Disruptions affected all food supply chains, including those critical to national security. To the best of our knowledge, this study is the first to reveal the impact of the pandemic on the military food supply chain in Poland. In the analysed single case study, we used process mapping to show the diversity of the types of military food supply chains operating in military units. The attention was focused on the internal and external food supply chains in the context of the disruptions and dysfunctions that appeared in the sphere of management. The contribution of the article is twofold. First, we used a situational crisis management approach to isolate four types of internal military food supply chains. Practical guidance concerns showing actions influencing the modification of system solutions in the military sphere in peacetime in connection with the pandemic. As a member of the North Atlantic Treaty Organization (NATO), Poland applies system solutions similar to those in place in other allied countries. The results of our research can be used as recommendations for solving problems in the military food supply chain in other countries within NATO.
C1 [Wincewicz-Bosy, Marta; Dymyt, Malgorzata] Gen Tadeusz Kosciuszko Mil Univ Land Forces, Fac Management Poland, PL-51147 Wroclaw, Poland.
   [Sadowski, Adam] Univ Lodz, Inst Logist & Informat, PL-90214 Lodz, Poland.
   [Wasowska, Katarzyna] Siedlce Univ Nat Sci & Humanities, Inst Management & Qual Sci, PL-08110 Siedlce, Poland.
   [Galar, Zbigniew] Barry Callebaut SSC Europe Sp Zoo, PL-90530 Lodz, Poland.
RP Dymyt, M (corresponding author), Gen Tadeusz Kosciuszko Mil Univ Land Forces, Fac Management Poland, PL-51147 Wroclaw, Poland.
EM marta.wincewicz-bosy@awl.edu.pl; adam.sadowski@uni.lodz.pl;
   katarzyna.wasowska@uph.edu.pl; zbigniew.galar@gmail.com;
   malgorzata.dymyt@awl.edu.pl
RI ; Wasowska, Katarzyna/Q-8666-2017
OI Dymyt, Malgorzata/0000-0002-8238-6917; Wasowska,
   Katarzyna/0000-0001-5854-3268; Wincewicz-Bosy,
   Marta/0000-0002-3844-2678; Sadowski, Adam/0000-0002-8608-5118
FU General Tadeusz Kosciuszko Military University of Land Forces in Wroclaw
   [16/WZ/10/SMON]; Minister of National Defence of the Republic of Poland
FX This research was funded by the General Tadeusz Kosciuszko Military
   University of Land Forces in Wroclaw as part of a research project
   16/WZ/10/SMON financed by a subsidy granted by the Minister of National
   Defence of the Republic of Poland.
CR Aday S, 2020, FOOD QUAL SAF-OXFORD, V4, P167, DOI 10.1093/fqsafe/fyaa024
   Agrawal A, 2015, 2015 2ND INTERNATIONAL CONFERENCE ON COMPUTING FOR SUSTAINABLE GLOBAL DEVELOPMENT (INDIACOM), P1
   Ahmadinejad S.S., 2020, HUM ENV, V18, P21
   Ali A, 2017, SUPPLY CHAIN MANAG, V22, P16, DOI 10.1108/SCM-06-2016-0197
   [Anonymous], 2019, DOKTR LOG SIL ZBROJN
   [Anonymous], 2018, AJP319 NATO
   [Anonymous], 2020, DRAFT REPORT ATTILA
   [Anonymous], 2019, P46 NATO
   Araz OM, 2020, DECISION SCI, V51, P1316, DOI 10.1111/deci.12443
   Baltic T., 2021, IOP C SERIES EARTH E, V854, DOI [10.1088/1755-1315/854/1/012007, DOI 10.1088/1755-1315/854/1/012007]
   Beulens AJM, 2005, FOOD CONTROL, V16, P481, DOI 10.1016/j.foodcont.2003.10.010
   Biazzo S., 2002, BUS PROCESS MANAG J, V8, P42, DOI [10.1108/14637150210418629, DOI 10.1108/14637150210418629]
   Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423
   Bychenko Yuri, 2020, E3S Web of Conferences, V222, DOI 10.1051/e3sconf/202022205012
   Byrnes J., 2020, CORONAVIRUS MANAGE S
   Chavez PJA, 2012, INT J ENG BUS MANAG, V4
   Chenarides L, 2021, APPL ECON PERSPECT P, V43, P270, DOI 10.1002/aepp.13085
   Creswell JW, 2007, COUNS PSYCHOL, V35, P236, DOI 10.1177/0011000006287390
   Darke P, 1998, INFORM SYST J, V8, P273, DOI 10.1046/j.1365-2575.1998.00040.x
   Dasaklis TK, 2012, INT J PROD ECON, V139, P393, DOI 10.1016/j.ijpe.2012.05.023
   Espitia A., 2020, POLICY RES WORKING P
   Falasca M., 2008, P 5 INT ISCRAM C WAS, P596
   FAO (Food and Agriculture Organization of the United Nations), 2020, RESP IMP COVID 19 OU
   Fathi M.R., 2019, IND MANAG J, V11, P621, DOI [10.22059/imj.2019.280393.1007588, DOI 10.22059/IMJ.2019.280393.1007588]
   Galli F., 2013, DOCUMENT DEV FRAMEWO
   Gattorna J., 2006, SUPPLY CHAIN MANAG R, V10, P42
   Giampietri E., 2015, EXPLORING CONSUMERS, V16, P135
   Goniewicz K, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020487
   GS Group, 2013, MANAGING PERFORMANCE
   Gustafsson J, 2017, SOCIOLOGY
   Handfield RB, 1998, J OPER MANAG, V16, P321, DOI 10.1016/S0272-6963(98)00017-5
   Higgins AJ, 2010, J OPER RES SOC, V61, P964, DOI 10.1057/jors.2009.57
   Hill N, 2011, PHILOS T R SOC B, V366, P231, DOI 10.1098/rstb.2010.0213
   Hobbs JE, 2020, CAN J AGR ECON, V68, P171, DOI 10.1111/cjag.12237
   Hofstede G.J., 2003, P EFITA C DEBR HUNG
   Koch N, 2021, SECUR DIALOGUE, V52, P118, DOI 10.1177/0967010620912353
   La Scalia G, 2016, INT J RF TECHNOL-RES, V7, P31, DOI 10.3233/RFT-150073
   Laborde D, 2020, SCIENCE, V369, P500, DOI 10.1126/science.abc4765
   Lambert DM, 2000, IND MARKET MANAG, V29, P65, DOI 10.1016/S0019-8501(99)00113-3
   Lee HL, 2004, HARVARD BUS REV, V82, P102
   Manning L, 2006, BRIT FOOD J, V108, P91, DOI 10.1108/00070700610644915
   Mariotto FL, 2014, RAE-REV ADMIN EMPRES, V54, P358, DOI 10.1590/S0034-759020140402
   Markina I., 2018, INT J SUPPLY CHAIN M, V7, P608
   Naik G, 2018, IIMB MANAG REV, V30, P270, DOI 10.1016/j.iimb.2018.04.001
   Nandi S, 2021, SUSTAIN PROD CONSUMP, V27, P10, DOI 10.1016/j.spc.2020.10.019
   Nasrollahi M, 2021, INT J MANAG SCI ENG, V16, P264, DOI 10.1080/17509653.2021.1965502
   OECD, 2020, FOOD SUPPL CHAINS CO
   OECD (The Organization for Economic Co-Operation and Development), 2020, CORONAVIRUS COVID 19
   Okrent MD, 2004, IND MANAGE DATA SYST, V104, P637, DOI 10.1108/02635570410561618
   Pawlisiak M, 2020, EUR RES STUD J, V23, P71, DOI [10.35808/ersj/1854, DOI 10.35808/ERSJ/1854]
   Ponis S.T., 2012, J APPL BUS RES, V28, P921
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Richanbach P.H., 2014, INDEPENDENT REV DEFE
   Robert L., 2011, POLICIES GOVERNING M, P1
   Sharma HB, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105052
   Sridharan R., 2002, BUS PROCESS MANAG J, V8, P289, DOI [10.1108/14637150210428989, DOI 10.1108/14637150210428989]
   Swartz P., 2020, WHAT CORONAVIRUS COU
   Teegavarapu S., 2008, INT DES ENG TECHN C, P495
   Tendall DM, 2015, GLOB FOOD SECUR-AGR, V6, P17, DOI 10.1016/j.gfs.2015.08.001
   United Nations, 2020, POL BRIEF IMP COV 19
   Walker B, 2004, ECOL SOC, V9
   WHO, 2010, WHAT IS PAND
   Wincewicz-Bosy M., 2020, EUR RES STUD J, V23, P296, DOI [10.35808/ersj/1639, DOI 10.35808/ERSJ/1639]
   Zavala-Alcivar A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166300
NR 64
TC 0
Z9 0
U1 5
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD FEB
PY 2022
VL 14
IS 4
AR 2464
DI 10.3390/su14042464
PG 22
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA ZM4GJ
UT WOS:000764317700001
OA gold
DA 2022-04-20
ER

PT J
AU McMahon, M
   Creatore, MI
   Thompson, E
   Lay, AM
   Hoffman, SJ
   Finegood, DT
   Glazier, RH
AF McMahon, Meghan
   Creatore, Marisa I.
   Thompson, Erin
   Lay, Andrea Morgan
   Hoffman, Steven J.
   Finegood, Diane T.
   Glazier, Richard H.
TI The Promise of Science, Knowledge Mobilization, and Rapid Learning
   Systems for COVID-19 Recovery
SO INTERNATIONAL JOURNAL OF HEALTH SERVICES
LA English
DT Article
DE coronavirus disease 2019 (COVID-19); pandemic recovery; research
   priorities; science strategy; health system preparedness; United Nations
AB The health, economic, and social crises created by the coronavirus disease 2019 (COVID-19) pandemic have been global in scope and inequitable in impact. The global road to recovery can be enhanced with robust, relevant, and timely scientific evidence. This commentary seeks to illustrate the power of science, scientific collaboration, and innovative research funding programs to inform pandemic recovery and inspire transformational changes for a more equitable, resilient, and sustainable future. Specifically, this commentary provides an introduction to the United Nations (UN) Research Roadmap for the COVID-19 Recovery that was published in November 2020. It introduces 5 scoping reviews that helped inform the UN Research Roadmap and that are now available open access within this series of special papers, and it provides an overview of an innovative research funding program that facilitated rapid mobilization and collaboration to produce the scoping reviews. The publication of the scoping reviews in this journal series will help complement and amplify the UN Research Roadmap by furthering knowledge mobilization efforts and informing COVID-19 recovery around the world, to ensure a more equitable, resilient, and sustainable postpandemic future.
C1 [McMahon, Meghan; Thompson, Erin; Glazier, Richard H.] Canadian Inst Hlth Res, Inst Hlth Serv & Policy Res, Toronto, ON, Canada.
   [McMahon, Meghan; Glazier, Richard H.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Creatore, Marisa I.; Lay, Andrea Morgan; Hoffman, Steven J.] Canadian Inst Hlth Res, Inst Populat & Publ Hlth, Toronto, ON, Canada.
   [Creatore, Marisa I.; Glazier, Richard H.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Hoffman, Steven J.] Global Strategy Lab, Toronto, ON, Canada.
   [Hoffman, Steven J.] York Univ, Toronto, ON, Canada.
   [Finegood, Diane T.] Canadian Hlth Serv & Policy Res Alliance, Vancouver, BC, Canada.
   [Finegood, Diane T.] Simon Fraser Univ, Morris J Wosk Ctr Dialogue, Vancouver, BC, Canada.
   [Finegood, Diane T.] Simon Fraser Univ, Vancouver, BC, Canada.
   [Glazier, Richard H.] ICES Inst Clin & Evaluat Sci Cent, Toronto, ON, Canada.
   [Glazier, Richard H.] St Michaels Hosp, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.
   [Glazier, Richard H.] Univ Toronto, Family & Community Med, Toronto, ON, Canada.
RP McMahon, M (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, CIHR Inst Hlth Serv & Policy Res, Toronto, ON, Canada.
EM mmcmahon.ihspr@ices.on.ca
OI Finegood, Diane T./0000-0002-0568-0522
CR Baral P, 2021, INT J HEALTH SERV, V51, P474, DOI 10.1177/0020731421997088
   Blanchette Marc-Andre, 2019, Healthc Policy, V15, P49, DOI 10.12927/hcpol.2019.25980
   Bornstein S, 2018, HEALTH SERV RES, V53, P4004, DOI 10.1111/1475-6773.12847
   Canadian Institutes of Health Research, FUND OPP DET HLTH SY
   Embrett M, 2021, INT J HEALTH SERV, V51, P337, DOI 10.1177/00207314211007100
   Embrett M, 2021, INT J HEALTH POLICY, V10, P528, DOI 10.34172/ijhpm.2020.122
   Highet, 2021, INT J HLTH SERV
   Jewett RL, 2021, INT J HEALTH SERV, V51, P325, DOI 10.1177/0020731421997092
   McMahon Meghan, 2019, Healthc Policy, V15, P34, DOI 10.12927/hcpol.2019.25981
   McMahon Meghan, 2019, Healthc Policy, V15, P61, DOI 10.12927/hcpol.2019.25979
   Menear M, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0477-3
   O'Campo, 2021, INT J HLTH SERV
   Reid, 2016, HEALTHCARE PAPERS, V16, P30, DOI [DOI 10.12927/HCPAP.2016.24724, 10.12927/hcpap.2016.24724]
   United Nations, RES ROADM COVID 19 R
   United Nations, UN FRAM IMM SOC EC R
NR 15
TC 0
Z9 0
U1 1
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0020-7314
EI 1541-4469
J9 INT J HEALTH SERV
JI Int. J. Health Serv.
PD APR
PY 2021
VL 51
IS 2
BP 242
EP 246
AR 0020731421997089
DI 10.1177/0020731421997089
EA MAR 2021
PG 5
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RZ5GN
UT WOS:000630785900001
PM 33736515
OA Bronze
DA 2022-04-20
ER

PT J
AU Younis, I
   Longsheng, C
   Zulfiqar, MI
   Imran, M
   Shah, SAA
   Hussain, M
   Solangi, YA
AF Younis, Ijaz
   Longsheng, Cheng
   Zulfiqar, Muhammad Imran
   Imran, Muhammad
   Shah, Syed Ahsan Ali
   Hussain, Mudassar
   Solangi, Yasir Ahmed
TI Regional disparities in Preventive measures of COVID-19 pandemic in
   China. A study from international students' prior knowledge, perception
   and vulnerabilities
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Novel coronavirus pneumonia; Zoonotic diseases; Epidemic; COVID-19
ID ACUTE RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS; MERS CORONAVIRUS;
   INFLUENZA; INFECTION; TRANSMISSION; PREPAREDNESS; EDUCATION; LESSONS;
   ORIGIN
AB The COVID-19 pandemic needs immediate solution before inflicting more devastation. So far, China has successfully controlled transmission of COVID-19 through implementing stringent preventive measures. In this study, we analyze the effectiveness of preventive measures taken in thirteen regions of China based on the feedback provided by 1135 international students studying in China. The study uses factor analysis combined with varimax rotation of variables. It was found that awareness raising and dispersing actionable knowledge regarding trust and adapting measures remained significantly important. Therefore, recognition of information gaps, improvements in the level of alertness, and development of preventive measures in each sector are imperative. The findings of this study revealed that trust, students' health, waste disposal, and the efforts of the Chinese government/international institute of education to prevent this pandemic were significantly and positively associated with preventive measures. The results showed that prior knowledge, global pandemics, and food and grocery purchases were firmly related to the preventive measures of COVID-19. Moreover, anxiety, transportation, and economic status were negatively related to the preventive measures. During this epidemic situation, international students suffered various types of mental stresses and anxiety, especially living in most affected regions of China. The study adopted a mixed (qualitative and quantitative) approach where the findings can act as a set of guidelines for governmental authorities in formulating, assisting in the preparation, instructing, and guiding policies to prevent and control the epidemic COVID-19 at national, local, and divisional levels.
C1 [Younis, Ijaz; Longsheng, Cheng; Zulfiqar, Muhammad Imran; Imran, Muhammad; Shah, Syed Ahsan Ali; Hussain, Mudassar; Solangi, Yasir Ahmed] Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing 210094, Peoples R China.
RP Younis, I; Longsheng, C (corresponding author), Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing 210094, Peoples R China.
EM ijazyounis@njust.edu.cn; cheng_longsheng@163.com; imran_zr@njust.edu.cn;
   imrankharal@njust.edu.cn; ahsan.shah1@hotmail.com;
   52019116@njust.edu.cn; yasir.solangi@nuaa.edu.cn
RI Zulfiqar, Muhammad Imran/AAB-5998-2021
OI Zulfiqar, Muhammad Imran/0000-0001-9027-6913; Younis,
   Ijaz/0000-0001-9828-8441
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71271114]
FX This research is funded by the National Nature Science Foundation of
   China (71271114).
CR Ajlan AM, 2014, AM J ROENTGENOL, V203, P782, DOI 10.2214/AJR.14.13021
   Alqahtani AS., 2017, INT J COMMUNITY MED, V4, P2641, DOI 10.18203/2394-6040.ijcmph20173153
   Asghari A, 2019, INT J PSYCHOL ED STU, V6, P21, DOI [10.17220/ijpes.2019.01.003, DOI 10.17220/IJPES.2019.01.003]
   Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Benatar SR, 2002, SOC SCI MED, V54, P1131, DOI 10.1016/S0277-9536(01)00327-6
   Bryman A., 2004, QUANTITATIVE DATA AN
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cheng VCC, 2020, J HOSP INFECT, V104, P254, DOI 10.1016/j.jhin.2020.01.010
   Cheng VCC, 2010, J HOSP INFECT, V74, P271, DOI 10.1016/j.jhin.2009.09.009
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Cheng VCC, 2015, INFECT CONT HOSP EP, V36, P87, DOI 10.1017/ice.2014.2
   Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11
   Cohn SK, 2006, QJM-INT J MED, V99, P497, DOI 10.1093/qjmed/hcl076
   Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13
   Comrey, 2013, 1 COURSE FACTOR ANAL
   Comrey A.L., 1992, 1 COURSE FACTOR ANAL, P2
   Corman VM, 2014, EMERG INFECT DIS, V20, P1319, DOI 10.3201/eid2008.140596
   Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P141, DOI 10.1016/S0891-5520(03)00095-3
   Gabutti G, 2020, INFECT DIS THER, V9, P241, DOI 10.1007/s40121-020-00295-5
   Gacel-Avila J., 2005, J STUD INT EDUC, V9, P121, DOI [DOI 10.1177/1028315304263795, 10.1177/1028315304263795]
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Grenwald-Mayes Gloria, 2002, J Atten Disord, V5, P211
   Gunderman RB, 2013, ACAD RADIOL, V20, P1466, DOI 10.1016/j.acra.2013.04.010
   Guo XD, 2020, J BONE JOINT SURG AM, V102, P847, DOI 10.2106/JBJS.20.00417
   Gupta S, 2020, FLEXIBLE SYST MANAG, P127, DOI 10.1007/978-981-13-9640-3_7
   Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134
   Hastings DL, 2016, EMERG INFECT DIS, V22, P794, DOI 10.3201/eid2205.151797
   HINKIN TR, 1995, J MANAGE, V21, P967, DOI 10.1177/014920639502100509
   Holland G, 1999, 1960S
   Hulland J, 1999, STRATEGIC MANAGE J, V20, P195, DOI 10.1002/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.3.CO;2-Z
   Jakovljevic M, 2020, PSYCHIAT DANUB, V32, P6, DOI 10.24869/psyd.2020.6
   Jiani MA, 2017, HIGH EDUC, V74, P563, DOI 10.1007/s10734-016-0066-0
   Joseph A, 2019, J ATTEN DISORD, V23, P1610, DOI 10.1177/1087054718799367
   Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Khan N, 2020, EFFECTS CORONA VIRUS
   Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35
   Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Maslow JN, 2017, HUM VACC IMMUNOTHER, V13, P2918, DOI 10.1080/21645515.2017.1358325
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   Nunally J.C., 1978, PSYCHOMETRIC THEORY
   Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068
   Paek HJ, 2019, PUBLIC RELAT REV, V45, P175, DOI 10.1016/j.pubrev.2019.02.006
   Paez D, 2020, EUR J NUCL MED MOL I, V47, P1615, DOI 10.1007/s00259-020-04825-8
   Pan XC, 2020, MICROBES INFECT, V22, P86, DOI 10.1016/j.micinf.2020.02.004
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017
   Repici A, 2020, GASTROINTEST ENDOSC, V92, P192, DOI 10.1016/j.gie.2020.03.019
   Shortridge KF, 2003, AM J RESP CRIT CARE, V168, P1416, DOI 10.1164/rccm.2310005
   Siemaszko K, 2019, J EURO HIST LAW, V10, P85
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Tabachnick BG., 2001, USING MULTIVARIATE S
   Tameris M, 2019, LANCET RESP MED, V7, P757, DOI 10.1016/S2213-2600(19)30251-6
   Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06
   Turner PA, 1993, I HEARD IT GRAPEVINE
   Ullah EJ, 2020, PAKISTAN J SURG MED, V1, P8, DOI [10.37978/pjsm.v1i1.126, DOI 10.37978/PJSM.V1I1.126]
   Wen W, 2019, J STUD INT EDUC, V23, P303, DOI 10.1177/1028315318797154
   Wheelis M, 2002, EMERG INFECT DIS, V8, P971, DOI 10.3201/eid0809.010536
   Winter SF, 2018, INT J HEALTH POLICY, V7, P210, DOI 10.15171/ijhpm.2017.67
   Wu MY, 2021, EDUC REV, V73, P580, DOI 10.1080/00131911.2019.1662772
   Wu ZY, 2019, CURR HIV-AIDS REP, V16, P458, DOI 10.1007/s11904-019-00471-4
   Xu RH, 2004, EMERG INFECT DIS, V10, P1030, DOI 10.3201/eid1006.030852
   Xu Z, 2020, CAN COMMON CORONAVIR
   Yang DD, 2007, INTEGR ZOOL, V2, P19, DOI 10.1111/j.1749-4877.2007.00043.x
   Zhou L, 2019, TRANSBOUND EMERG DIS, V66, P2180, DOI 10.1111/tbed.13270
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhou ZH, 2020, VIRUS RES, V278, DOI 10.1016/j.virusres.2019.197843
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 71
TC 5
Z9 5
U1 8
U2 17
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD AUG
PY 2021
VL 28
IS 30
SI SI
BP 40355
EP 40370
DI 10.1007/s11356-020-10932-8
EA OCT 2020
PG 16
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology
GA UB1NB
UT WOS:000578542000002
PM 33037960
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Basile, K
   Halliday, C
   Kok, J
   Chen, SCA
AF Basile, Kerri
   Halliday, Catriona
   Kok, Jen
   Chen, Sharon C-A.
TI Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients
SO JOURNAL OF FUNGI
LA English
DT Article
DE COVID-19; SARS-CoV-2; fungal infections; non-Aspergillus fungi
ID CLINICAL-PRACTICE GUIDELINES; PNEUMOCYSTIS-JIROVECII PNEUMONIA; ACUTE
   RESPIRATORY SYNDROME; CORONAVIRUS DISEASE 2019; PULMONARY ASPERGILLOSIS;
   RHEUMATOID-ARTHRITIS; ECIL GUIDELINES; UPDATE; MANAGEMENT; SOCIETY
AB Invasive fungal disease (IFD) associated with Coronavirus Disease 2019 (COVID-19) has focussed predominantly on invasive pulmonary aspergillosis. However, increasingly emergent are non-Aspergillus fungal infections including candidiasis, mucormycosis, pneumocystosis, cryptococcosis, and endemic mycoses. These infections are associated with poor outcomes, and their management is challenged by delayed diagnosis due to similarities of presentation to aspergillosis or to non-specific features in already critically ill patients. There has been a variability in the incidence of different IFDs often related to heterogeneity in patient populations, diagnostic protocols, and definitions used to classify IFD. Here, we summarise and address knowledge gaps related to the epidemiology, risks, diagnosis, and management of COVID-19-associated fungal infections other than aspergillosis.
C1 [Basile, Kerri; Halliday, Catriona; Kok, Jen; Chen, Sharon C-A.] Inst Clin Pathol & Med Res, NSW Hlth Pathol, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia.
   [Halliday, Catriona; Kok, Jen; Chen, Sharon C-A.] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Westmead, NSW 2145, Australia.
   [Chen, Sharon C-A.] Univ Sydney, Sydney Inst Infect Dis, Sydney, NSW 2006, Australia.
RP Chen, SCA (corresponding author), Inst Clin Pathol & Med Res, NSW Hlth Pathol, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia.; Chen, SCA (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Westmead, NSW 2145, Australia.; Chen, SCA (corresponding author), Univ Sydney, Sydney Inst Infect Dis, Sydney, NSW 2006, Australia.
EM kerri.basile@health.nsw.gov.au; Catriona.Halliday@health.nsw.gov.au;
   jen.kok@health.nsw.gov.au; sharon.chen@health.nsw.gov.au
OI Halliday, Catriona/0000-0002-0301-7110; Kok, Jen/0000-0002-8796-283X
CR Al-Tawfiq JA, 2021, INFECTION, V49, P833, DOI 10.1007/s15010-021-01670-1
   Alanio A, 2021, J INFECTION, V82, P114, DOI 10.1016/j.jinf.2020.10.034
   Alanio A, 2020, LANCET RESP MED, V8, pE48, DOI 10.1016/S2213-2600(20)30237-X
   Alanio A, 2016, J ANTIMICROB CHEMOTH, V71, P2386, DOI 10.1093/jac/dkw156
   Alegre-Gonzalez D, 2021, MED MYCOL CASE REP, V34, P35, DOI 10.1016/j.mmcr.2021.10.001
   [Anonymous], OLUMIANT BARICITINIB
   [Anonymous], 2020, ADV USE MASKS CONT C
   Arastehfar A, 2020, J FUNGI, V6, DOI 10.3390/jof6040211
   Armstrong-James D, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02554-2020
   Azar MM, 2020, SEMIN RESP CRIT CARE, V41, P522, DOI 10.1055/s-0040-1702194
   Azar MM, 2017, J CLIN MICROBIOL, V55, P1612, DOI 10.1128/JCM.02430-16
   Bartoletti M, 2021, CLIN INFECT DIS, V73, pE3606, DOI 10.1093/cid/ciaa1065
   Basso RP, 2021, MYCOPATHOLOGIA, V186, P109, DOI 10.1007/s11046-020-00505-1
   Bellanger AP, 2021, INFECT DIS NOW, V51, P633, DOI 10.1016/j.idnow.2021.01.010
   Bertolini M, 2020, INT J STD AIDS, V31, P1222, DOI 10.1177/0956462420957518
   Blaize M, 2020, AM J RESP CRIT CARE, V202, P1734, DOI 10.1164/rccm.202007-2938LE
   Blot SI, 2012, AM J RESP CRIT CARE, V186, P56, DOI 10.1164/rccm.201111-1978OC
   Bohn MK, 2020, PHYSIOLOGY, V35, P288, DOI 10.1152/physiol.00019.2020
   Borman AM, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02136-20
   Cafardi J, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab016
   Campbell L, 2011, RHEUMATOLOGY, V50, P552, DOI 10.1093/rheumatology/keq343
   Chang CC, 2020, J INVEST MED HIGH IM, V8, DOI 10.1177/2324709620972244
   Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z
   Chapman SW, 2008, CLIN INFECT DIS, V46, P1801, DOI 10.1086/588300
   Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992
   Chen SCA, 2021, J FUNGI, V7, DOI 10.3390/jof7010023
   Chong WH, 2021, INFECTION, V49, P1079, DOI 10.1007/s15010-021-01630-9
   Cohen SB, 2017, ANN RHEUM DIS, V76, P1253, DOI 10.1136/annrheumdis-2016-210457
   Coleman H, 2020, AIDS, V34, P1258, DOI 10.1097/QAD.0000000000002571
   Cornely OA, 2019, LANCET INFECT DIS, V19, pE405, DOI 10.1016/S1473-3099(19)30312-3
   De Francesco MA, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030544
   Denny S, 2021, J INFECTION, V82, P288, DOI 10.1016/j.jinf.2021.02.020
   do Monte ES, 2020, CLIN ENDOSC, V53, P746, DOI 10.5946/ce.2020.180
   Donnelly JP, 2020, CLIN INFECT DIS, V71, P1367, DOI 10.1093/cid/ciz1008
   Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000
   Galgiani JN, 2016, CLIN INFECT DIS, V63, pE112, DOI 10.1093/cid/ciw360
   Gangneux JP, 2020, J MYCOL MED, V30, DOI 10.1016/j.mycmed.2020.100971
   Garcia-Vidal C, 2021, CLIN MICROBIOL INFEC, V27, P83, DOI 10.1016/j.cmi.2020.07.041
   Garg D, 2021, MYCOPATHOLOGIA, V186, P289, DOI 10.1007/s11046-021-00528-2
   Gentile I, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182111399
   Gerber V, 2021, J FUNGI, V7, DOI 10.3390/jof7080585
   Ghanem H, 2021, CASE REP INFECT DIS, V2021, DOI 10.1155/2021/5597473
   Ghosh A, 2021, FUNGAL BIOL REV, V38, P67, DOI 10.1016/j.fbr.2021.09.003
   Giacobbe DR, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1763-5
   Heaney AK, 2021, EMERG INFECT DIS, V27, P1266, DOI 10.3201/eid2705.204661
   Hoenigl M, 2021, CLIN INFECT DIS, V73, pE1645, DOI 10.1093/cid/ciaa1342
   Hoenigl M, 2021, LANCET INFECT DIS, V21, pE246, DOI 10.1016/S1473-3099(20)30784-2
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang LN, 2019, CLIN RESPIR J, V13, P202, DOI 10.1111/crj.12995
   Hwang DM, 2005, MODERN PATHOL, V18, P1, DOI 10.1038/modpathol.3800247
   Jeican II, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57040302
   John TM, 2021, J FUNGI, V7, DOI 10.3390/jof7040298
   Kayaaslan B, 2021, MYCOSES, V64, P1083, DOI 10.1111/myc.13332
   Kim D, 2020, JAMA-J AM MED ASSOC, V323, P2085, DOI 10.1001/jama.2020.6266
   Koehler P, 2020, LANCET INFECT DIS, V21, pE149, DOI 10.1016/S1473-3099(20)30847-1
   Koehler P, 2020, MYCOSES, V63, P528, DOI 10.1111/myc.13096
   Krauth DS, 2021, MIL MED, V186, pE1254, DOI 10.1093/milmed/usab132
   Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006
   Lat A, 2010, EMERG INFECT DIS, V16, P971, DOI 10.3201/eid1606.100165
   Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x
   Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Liu SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep37252
   Macauley P, 2021, MYCOSES, V64, P634, DOI 10.1111/myc.13258
   Magira EE, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz247
   Malo Joshua, 2014, Ann Am Thorac Soc, V11, P243, DOI 10.1513/AnnalsATS.201308-286FR
   Mang S, 2021, CLIN INFECT DIS, V72, P1487, DOI 10.1093/cid/ciaa906
   Maschmeyer G, 2016, J ANTIMICROB CHEMOTH, V71, P2405, DOI 10.1093/jac/dkw158
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mehta S, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.10726
   Meijer EFJ, 2020, J FUNGI, V6, DOI 10.3390/jof6020079
   Menon AA, 2020, AM J RESP CRIT CARE, V202, P136, DOI 10.1164/rccm.202003-0766LE
   Messina FA, 2020, J FUNGI, V6, DOI 10.3390/jof6040275
   Mouren D, 2021, RESPIR MED RES-FRANC, V79, DOI 10.1016/j.resmer.2021.100814
   Bayona JVM, 2021, J FUNGI, V7, DOI 10.3390/jof7060440
   Narayanan S, 2021, CLIN INFECT DIS, DOI 10.1093/cid/ciab726
   Nasir N, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.12290
   Nucci M, 2021, MYCOSES, V64, P152, DOI 10.1111/myc.13225
   Pagano L, 2002, BRIT J HAEMATOL, V117, P379, DOI 10.1046/j.1365-2141.2002.03419.x
   Pappas PG, 2016, CLIN INFECT DIS, V62, P409, DOI 10.1093/cid/civ1194
   Pasero D, 2021, INFECTION, V49, P1055, DOI 10.1007/s15010-020-01561-x
   Passarelli Victor C, 2020, SN Compr Clin Med, V2, P2414, DOI 10.1007/s42399-020-00574-9
   Passerini M, 2020, CUREUS, V12, DOI 10.7759/cureus.8254
   Peacock TP, 2021, NAT MICROBIOL, V6, P899, DOI 10.1038/s41564-021-00908-w
   Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858
   Permpalung Nitipong, 2022, Clin Infect Dis, V74, P83, DOI 10.1093/cid/ciab223
   Poignon C, 2020, CLIN MICROBIOL INFEC, V26, P1582, DOI 10.1016/j.cmi.2020.06.026
   Posteraro B, 2020, J FUNGI, V6, DOI 10.3390/jof6030163
   Posteraro B, 2016, J ANTIMICROB CHEMOTH, V71, P2262, DOI 10.1093/jac/dkw112
   Prestel C, 2021, MMWR-MORBID MORTAL W, V70, P56, DOI 10.15585/mmwr.mm7002e3
   Ramirez-Garcia A, 2018, MED MYCOL, V56, pS102, DOI 10.1093/mmy/myx113
   Revannavar SM, 2021, BMJ CASE REP, V14, DOI 10.1136/bcr-2021-241663
   Riche CVW, 2020, J FUNGI, V6, DOI 10.3390/jof6040286
   Salmanton-Garcia J, 2021, EMERG INFECT DIS, V27, P1077, DOI 10.3201/eid2704.204895
   Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814
   Sarkar S, 2021, INDIAN J OPHTHALMOL, V69, P1002, DOI 10.4103/ijo.IJO_3763_20
   Schauwvlieghe AFAD, 2018, LANCET RESP MED, V6, P782, DOI 10.1016/S2213-2600(18)30274-1
   Schiff MH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3455
   Schwartz IS, 2020, CLIN INFECT DIS, V71, P1760, DOI 10.1093/cid/ciaa007
   Seagle EE, 2022, CLIN INFECT DIS, V74, P802, DOI 10.1093/cid/ciab562
   Segrelles-Calvo G, 2020, FUTURE MICROBIOL, V15, P1405, DOI 10.2217/fmb-2020-0156
   Selarka L, 2021, MYCOSES, V64, P1253, DOI 10.1111/myc.13353
   Sen M, 2021, INDIAN J OPHTHALMOL, V69, P244, DOI 10.4103/ijo.IJO_3774_20
   Shah AS, 2020, J INVEST MED HIGH IM, V8, DOI 10.1177/2324709620930540
   Singh AK, 2021, DIABETES METAB SYND, V15, DOI 10.1016/j.dsx.2021.05.019
   Skiada A, 2018, MED MYCOL, V56, pS93, DOI 10.1093/mmy/myx101
   Slavin M, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.021
   Small BA, 2001, J EXP MED, V194, P1835, DOI 10.1084/jem.194.12.1835
   Song G, 2020, MYCOPATHOLOGIA, V185, P599, DOI 10.1007/s11046-020-00462-9
   Soy M, 2020, CLIN RHEUMATOL, V39, P2085, DOI 10.1007/s10067-020-05190-5
   Stasiak CES, 2021, EUR J NUCL MED MOL I, V48, P653, DOI 10.1007/s00259-020-04932-6
   STUCK AE, 1989, REV INFECT DIS, V11, P954
   Szydlowicz M, 2021, TRENDS PARASITOL, V37, P859, DOI 10.1016/j.pt.2021.07.010
   The World Health Organization,, WHO LISTS ADD COVID
   Tolle LB, 2013, J PATHOL, V229, P145, DOI 10.1002/path.4124
   Vallabhaneni S, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0572-1
   van Arkel ALE, 2020, AM J RESP CRIT CARE, V202, P132, DOI 10.1164/rccm.202004-1038LE
   Wheat LJ, 2007, CLIN INFECT DIS, V45, P807, DOI 10.1086/521259
   White PL, 2021, CLIN INFECT DIS, V73, pE1634, DOI 10.1093/cid/ciaa1298
   WHO, TRACK SARS COV 2 VAR
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Yoshikawa T, 2009, J VIROL, V83, P3039, DOI 10.1128/JVI.01792-08
   Zhang HL, 2020, ANN INTERN MED, V172, P629, DOI 10.7326/M20-0533
   Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 127
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2309-608X
J9 J FUNGI
JI J. Fungi
PD JAN
PY 2022
VL 8
IS 1
AR 58
DI 10.3390/jof8010058
PG 17
WC Microbiology; Mycology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology; Mycology
GA YR2CZ
UT WOS:000749805800001
PM 35049999
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Wang, SN
   Feng, K
   Zhang, Y
   Liu, JA
   Wang, W
   Li, YX
AF Wang, Shengnan
   Feng, Kai
   Zhang, Ying
   Liu, Jianan
   Wang, Wei
   Li, Yongxin
TI Antecedents of Public Mental Health During the COVID-19 Pandemic:
   Mediation of Pandemic-Related Knowledge and Self-Efficacy and Moderation
   of Risk Level
SO FRONTIERS IN PSYCHIATRY
LA English
DT Article
DE COVID-19; mental health; pandemic knowledge; self-efficacy; risk level;
   family-based social support
ID PERCEIVED SOCIAL SUPPORT; CONSERVATION; COMMUNICATION; RESOURCES; WORK
AB Background: COVID-19 affects not only patients' physical health but also their mental health. For the general public, although their physical health may not be directly affected, their mental health may be affected by stress, anxiety, and social panic caused by COVID-19. Controlling the pandemic should focus on not only physical health but also mental health. For the general public, mental health is even more important, as good mental health at the individual level can form a positive social mentality conducive to pandemic prevention and control. Therefore, it is important to assess mental health during the pandemic, and analyze risk and protective factors.
   Methods: A self-compiled COVID-19 Social Mentality Questionnaire was used to conduct an online survey. A total of 16,616 participants responded, with 13,511 valid questionnaires.
   Results: Results showed that 10.7% of participants rated their mental health as "worse than usual" during the pandemic, and there were gender, age, and educational differences. Social support was positively correlated with pandemic-related knowledge and self-efficacy, and could indirectly predict mental health. Pandemic-related knowledge was positively correlated with self-efficacy and mental health, and risk level was negatively correlated with mental health. Hierarchical regression analysis showed that pandemic-related knowledge played a partial mediating role in the relationship between social support and self-efficacy, while self-efficacy played a complete mediating role in the relationship between social support and mental health. Logistic regression analysis showed that risk level moderated the relationship between self-efficacy and mental health.
   Conclusions: Social support can increase pandemic-related knowledge, thus improving self-efficacy and maintaining/promoting mental health. High risk levels can undermine the role of self-efficacy in promoting mental health. Therefore, in the fight against the COVID-19, people need to support and cooperate with each other, to improve self-efficacy and reduce risk, thus maintaining and promoting mental health.
C1 [Wang, Shengnan; Wang, Wei; Li, Yongxin] Henan Univ, Inst Psychol & Behav, Dept Psychol, Kaifeng, Peoples R China.
   [Feng, Kai] North China Univ Water Resources & Elect Power, Sch Management & Econ, Zhengzhou, Peoples R China.
   [Zhang, Ying] Henan Univ Anim Husb & Econ, Psychol Hlth Educ Ctr, Zhengzhou, Peoples R China.
   [Liu, Jianan] Henan Univ Anim Husb & Econ, Sch Econ & Trade, Zhengzhou, Peoples R China.
RP Wang, SN; Li, YX (corresponding author), Henan Univ, Inst Psychol & Behav, Dept Psychol, Kaifeng, Peoples R China.; Feng, K (corresponding author), North China Univ Water Resources & Elect Power, Sch Management & Econ, Zhengzhou, Peoples R China.
EM nicolesnwang@163.com; fengkai923@126.com; liyongxin@henu.edu.cn
RI Wang, Shengnan/AAN-1876-2021
OI Wang, Shengnan/0000-0001-7257-7560
FU 2020 Henan province philosophy and social sciences planning annual
   project [2020BJY004]
FX This research was funded by 2020 Henan province philosophy and social
   sciences planning annual project, entitled Research of Investigation and
   Guidance on People's Social Mentality in the Context of Pandemic
   Prevention and Control in Henan Province (2020BJY004). This paper is one
   of the phased outcomes of this project.
CR Adler-Constantinescu C, 2013, PROCD SOC BEHV, V78, P275, DOI 10.1016/j.sbspro.2013.04.294
   Arabian A, 2005, J PSYCHOL, V32, P360
   Baidu, 2020, REAL TIM BIG DAT REP
   Bandura, 1997, SELF EFFICACY EXERCI
   CARVER CS, 1982, PSYCHOL BULL, V92, P111, DOI 10.1037/0033-2909.92.1.111
   [陈珅 Chen Shen], 2020, [中国心理卫生杂志, Chinese Mental Health Journal], V34, P469
   Dai Y, 2020, CHIN J HLTH PSYCHOL, V28, P490, DOI [10.13342/j.cnki.cjhp.2020.04.003, DOI 10.13342/J.CNKI.CJHP.2020.04.003]
   Editorial Team of Covid-19 Protection Manual, 2020, COV 19 PROT MAN PEK, P1
   Freeman P, 2010, EUR J SPORT SCI, V10, P59, DOI 10.1080/17461390903049998
   Gong Y., 1994, PSYCHOL DEV, V2, P34
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Greenhaus JH, 2006, ACAD MANAGE REV, V31, P72, DOI 10.5465/amr.2006.19379625
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Halbesleben JRB, 2014, J MANAGE, V40, P1334, DOI 10.1177/0149206314527130
   Han H, 2017, J KOREAN MED SCI, V32, P1173, DOI 10.3346/jkms.2017.32.7.1173
   Harandi Tayebeh Fasihi, 2017, Electron Physician, V9, P5212, DOI 10.19082/5212
   Hefner J, 2009, AM J ORTHOPSYCHIAT, V79, P491, DOI 10.1037/a0016918
   Hobfoll SE, 2018, ANNU REV ORGAN PSYCH, V5, P103, DOI 10.1146/annurev-orgpsych-032117-104640
   Hobfoll SE, 2011, J OCCUP ORGAN PSYCH, V84, P116, DOI 10.1111/j.2044-8325.2010.02016.x
   Ievers-Landis CE, 2003, J PEDIATR PSYCHOL, V28, P335, DOI 10.1093/jpepsy/jsg023
   Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6
   Kendall PC, 2001, J AM ACAD CHILD PSY, V40, P787, DOI 10.1097/00004583-200107000-00013
   Killgore WDS, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113390
   Killgore William D S, 2020, Psychiatry Res, V290, P113134, DOI 10.1016/j.psychres.2020.113134
   Killgore WDS, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113117
   Kuiper JS, 2016, INT J EPIDEMIOL, V45, P1169, DOI 10.1093/ije/dyw089
   Lei Y, 2015, J XINXIANG MED U, V32, P415, DOI [10.7683/xxyxyxb.2015.05.010, DOI 10.7683/XXYXYXB.2015.05.010]
   LIEBERMAN DA, 1997, LEA COMMUN SER, P103
   Meijman T.F., 1998, HDB WORK ORG PSYCHOL, V2, P15
   [谢晓非 Nie Xiaofei], 2005, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V41, P628
   Omar ND, 2006, ORG COLLECT, V5, P163, DOI [10.18848/1447-9524/CGP/v05i01/49418, DOI 10.18848/1447-9524/CGP/V05I01/49418]
   Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316
   Qiu S, 2003, CHINA PUBLIC HLTH, V19, P8, DOI [10.3321/j.issn:1001-0580.2003.06.006, DOI 10.3321/J.ISSN:1001-0580.2003.06.006]
   Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55
   Sheeran P, 2016, HEALTH PSYCHOL, V35, P1178, DOI 10.1037/hea0000387
   SLATER MD, 1989, COGNITIVE THER RES, V13, P231, DOI 10.1007/BF01173405
   STAINES GL, 1980, HUM RELAT, V33, P111, DOI 10.1177/001872678003300203
   SVENSON O, 1988, RISK ANAL, V8, P199, DOI 10.1111/j.1539-6924.1988.tb01171.x
   Thomas EC, 2016, PSYCHIATR REHABIL J, V39, P352, DOI 10.1037/prj0000199
   Wang W, 2020, PSYCHOSOMATIC SYMPTO, V60, P15, DOI [10.15991/j.cnki.411028.2020.03.003, DOI 10.15991/J.CNKI.411028.2020.03.003]
   [温忠麟 Wen Zhonglin], 2014, [心理学报, Acta Psychologica Sinica], V46, P714
   WIEGMAN O, 1995, BASIC APPL SOC PSYCH, V16, P227, DOI 10.1207/s15324834basp1601&2_14
   WIEGMAN O, 1991, BASIC APPL SOC PSYCH, V12, P325, DOI 10.1207/s15324834basp1203_6
   Xiao J., 2007, CHINESE HLTH EC, V3, P20, DOI 10.3969/j.issn.1003-0743.2007.03.006
   Xiao S, 1987, CHINESE MENTAL HLTH, V4, P41
   Yang X, 2018, CHINA J HLTH PSYCHOL, V26, P775, DOI [10.13342/j.cnki.cjhp.2018.05.001, DOI 10.13342/J.CNKI.CJHP.2018.05.001]
   Yusoff Y. M., 2011, AUSTR J BUSINESS MAN, V1, P1, DOI DOI 10.5539/ass.v11n10p153
   Zhao G, 2020, J HENAN U, V60, P9, DOI [10.15991/j.cnki.411028.2020.03.001, DOI 10.15991/J.CNKI.411028.2020.03.001]
   时勘, 2003, [科学通报, Chinese science bulletin], V48, P1378
NR 49
TC 2
Z9 2
U1 2
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-0640
J9 FRONT PSYCHIATRY
JI Front. Psychiatry
PD NOV 12
PY 2020
VL 11
AR 567119
DI 10.3389/fpsyt.2020.567119
PG 12
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA OV4QU
UT WOS:000592197400001
PM 33304280
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Urzua, A
   Vera-Villarroel, P
   Caqueo-Urizar, A
   Polanco-Carrasco, R
AF Urzua, Alfonso
   Vera-Villarroel, Pablo
   Caqueo-Urizar, Alejandra
   Polanco-Carrasco, Roberto
TI Psychology in the prevention and management of COVID-19. Contributions
   from the initial evidence
SO TERAPIA PSICOLOGICA
LA Spanish
DT Article
DE Corona-Virus; COVID-19; Health Psychology; Public Health
ID FEBRUARY 27; CORONAVIRUS; EARTHQUAKE; PNEUMONIA; STUDENTS; STRESS; RISK
AB In December 2019, highly lethal cases of pneumonia were reported in Wuhan, Hubei Province, China (COVID-19). This disease has spread rapidly around the world with thousands of confirmed cases and deaths, becoming a pandemic and challenging public health systems. There is no vaccine or scientifically proven treatment yet, but the exact behaviours that can prevent transmission and spread have been identified. This article systematizes initial available information on psychology and COVID-19. It is discussed that much of the problem of the disease can be avoided by changing people's behaviors and that psychology can help explain, prevent and intervene to solve it. Psychology has scientific evidence available that explains all these phenomena, evidence that should be highlighted by the same actors in the disciplines available to other areas of knowledge and especially for decision makers.
C1 [Urzua, Alfonso] Univ Catolica Norte, Escuela Psicol, Antofagasta, Chile.
   [Vera-Villarroel, Pablo] Ctr Anal I D, Antofagasta, Chile.
   [Caqueo-Urizar, Alejandra] Univ Tarapaca, Inst Alta Invest, Arica, Chile.
RP Urzua, A (corresponding author), Avda Angamos 0610, Antofagasta, Chile.
EM alurzua@ucn.cl
RI Vera-Villarroel, Pablo/AAQ-8476-2020; Caqueo-Urízar,
   Alejandra/AAW-4045-2021; Urzúa, Alfonso/A-1208-2012
OI Caqueo-Urízar, Alejandra/0000-0002-4614-8380; Urzúa,
   Alfonso/0000-0002-0882-2194; Polanco-Carrasco,
   Roberto/0000-0002-5064-9049
CR Bayes R., 1992, PSICOLOGIA SALUD APO, P1
   Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8
   Dai Y.H. G., 2020, PSYCHOL IMPACT CORON, DOI [10.1101/2020.03.03.20030874, DOI 10.1101/2020.03.03.20030874]
   Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Jeong H., 2016, RESP SYNDROME, V38, P103
   Jiang XX, 2020, PSYCHIAT RES, V286, DOI 10.1016/j.psychres.2020.112903
   Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405
   Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032
   Lopez SV, 2020, AM J SEX EDUC, V15, P201, DOI 10.1080/15546128.2020.1734131
   Lunn PD, 2020, J BEHAV PUBLIC ADM, DOI 10.30636/jbpa.31.147
   Main A, 2011, J COUNS PSYCHOL, V58, P410, DOI 10.1037/a0023632
   Murphy D. J., 2020, FRAMEWORK CONTRIBUTI
   National Health Commission, 2020, PRINC EM PSYCH CRIS
   Park JS, 2018, ARCH PSYCHIAT NURS, V32, P2, DOI 10.1016/j.apnu.2017.09.006
   Poudel Adhikari S., 2020, LITERATURE REVIEW 20, DOI [10.20944/preprints202002.0060.v1, DOI 10.20944/PREPRINTS202002.0060.V1]
   Shen KL, 2020, WORLD J PEDIATR, V16, P223, DOI 10.1007/s12519-020-00343-7
   Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   TORRES-SALAZAR CRISTINA, 2020, Rev. colomb. psicol., V29, P61, DOI 10.15446/rcp.v29n1.75853
   Vera-Villarroel P, 2015, MANUAL ESCALAS CUEST
   Vera-Villarroel P, 2011, PSYCHOL REP, V109, P47, DOI 10.2466/02.13.15.17.PR0.109.4.47-58
   Vogel EH, 2010, TER PSICOL, V28, P143
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459
   Yang S, 2017, AM J INFECT CONTROL, V45, pE53, DOI 10.1016/j.ajic.2017.02.013
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang J, 2020, PRECIS CLIN MED, V3, P3, DOI 10.1093/pcmedi/pbaa006
   Zhu YH, 2020, NEUROSCI BULL, V36, P299, DOI 10.1007/s12264-020-00476-9
NR 28
TC 37
Z9 49
U1 4
U2 28
PU SOCIEDAD CHILENA PSICOLOGIA CLINICA
PI SANTIAGO
PA RICARDO MATTE PEREZ 492 PROVIDENCIA, SANTIAGO, 00000, CHILE
SN 0718-4808
J9 TER PSICOL
JI Ter. Psicol.
PD APR
PY 2020
VL 38
IS 1
BP 103
EP 118
PG 16
WC Psychology, Clinical
WE Social Science Citation Index (SSCI)
SC Psychology
GA LK1AT
UT WOS:000530592100007
DA 2022-04-20
ER

PT J
AU Palandri, F
   Breccia, M
   De Stefano, V
   Passamonti, F
AF Palandri, Francesca
   Breccia, Massimo
   De Stefano, Valerio
   Passamonti, Francesco
TI Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the
   COVID-19 Pandemic: Challenges and Future Scenarios
SO CANCERS
LA English
DT Review
DE coronavirus; COVID-19; MPNs; cancer; pandemic
ID RISK-FACTORS; JAK INHIBITION; SPIKE PROTEIN; HEMATOLOGICAL MALIGNANCIES;
   POLYCYTHEMIA-VERA; PROGNOSTIC VALUE; VIRUS INFECTION; CELL-FUNCTION;
   HEALTH-CARE; SARS-COV
AB Simple Summary: Little information has been reported about the impact of the COVID-19 pandemic in Philadelphia-negative chronic myeloproliferative neoplasms (MPN). In this review, we summarize the knowledge about MPN clinical management, including cytoreductive and antiplatelet/anticoagulant therapy, thrombotic risk, prognosis, and vaccination strategies at the time of COVID-19.
   An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) started in December 2019 in China and then become pandemic in February 2020. Several publications investigated the possible increased rate of COVID-19 infection in hematological malignancies. Based on the published data, strategies for the management of chronic Philadelphia-negative chronic myeloproliferative neoplasms (MPNs) are provided. The risk of severe COVID-19 seems high in MPN, particularly in patients with essential thrombocythemia, but not negligible in myelofibrosis. MPN patients are at high risk of both thrombotic and hemorrhagic complications and this must be accounted in the case of COVID-19 deciding on a case-by-case basis. There are currently no data to suggest that hydroxyurea or interferon may influence the risk or severity of COVID-19 infection. Conversely, while the immunosuppressive activity of ruxolitinib might pose increased risk of infection, its abrupt discontinuation during COVID-19 syndrome is associated with worse outcome. All MPN patients should receive vaccine against COVID-19; reassuring data are available on efficacy of mRNA vaccines in MPNs.
C1 [Palandri, Francesca] IRCCS Azienda Osped Univ Bologna, Ist Ematol Seragnoli, I-40138 Bologna, Italy.
   [Breccia, Massimo] Sapienza Univ, Azienda Osped Policlin Umberto I, Dept Translat & Precis Med, I-00185 Rome, Italy.
   [De Stefano, Valerio] Catholic Univ, Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Radiol & Hematol Sci, Sect Hematol,Sch Med, I-00168 Rome, Italy.
   [Passamonti, Francesco] Univ Insubria, ASST Sette Laghi, Dept Med & Surg, I-21100 Varese, Italy.
RP De Stefano, V (corresponding author), Catholic Univ, Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Radiol & Hematol Sci, Sect Hematol,Sch Med, I-00168 Rome, Italy.
EM francesca.palandri@unibo.it; breccia@bce.uniroma1.it;
   valerio.destefano@unicatt.it; francesco.passamonti@uninsubria.it
RI ; De Stefano, Valerio/J-3650-2018
OI PALANDRI, FRANCESCA/0000-0001-8367-5668; De Stefano,
   Valerio/0000-0002-5178-5827
FU Ministero della Salute, Rome, ItalyMinistry of Health, Italy
   [NET-2018-12365935]; Ministero dell'Istruzione, dell'Universita e della
   Ricerca, Roma, Italy [2017WXR7ZT]
FX This research was funded by the Ministero della Salute, Rome, Italy
   [Finalizzata 2018, NET-2018-12365935, Personalized medicine program on
   myeloid neoplasms: characterization of the patient's genome for clinical
   decision making and systematic collection of real world data to improve
   quality of health care], and by the Ministero dell'Istruzione,
   dell'Universita e della Ricerca, Roma, Italy [PRIN 2017, 2017WXR7ZT;
   Myeloid Neoplasms: an integrated clinical, molecular and therapeutic
   approach]. No funding was received for the APC.
CR Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   Alvarez-Larran A, 2016, BRIT J HAEMATOL, V172, P786, DOI 10.1111/bjh.13886
   Alvarez-Larran A, 2012, BLOOD, V119, P1363, DOI 10.1182/blood-2011-10-387787
   Alvarez-Larran A, 2010, BLOOD, V116, P1205, DOI 10.1182/blood-2010-01-263319
   Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544
   Ash Research Collaborative, 2021, COVID 19 REG
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Barbui T., 2021, LEUKEMIA, P1
   Barbui T, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00509-0
   Barbui T, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00417-3
   Barbui T, 2021, LEUKEMIA, V35, P485, DOI 10.1038/s41375-020-01107-y
   Barbui T, 2014, BLOOD, V124, P3021, DOI 10.1182/blood-2014-07-591610
   Barbui T, 2011, J CLIN ONCOL, V29, P761, DOI 10.1200/JCO.2010.31.8436
   Barbui T, 2010, BLOOD, V115, P778, DOI 10.1182/blood-2009-08-238956
   Barbuil T, 2018, LEUKEMIA, V32, P1057, DOI 10.1038/s41375-018-0077-1
   Barone M, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1782575
   Barosi G, 2014, CURR HEMATOL MALIG R, V9, P331, DOI 10.1007/s11899-014-0227-0
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Benenson S, 2021, NEW ENGL J MED, V384, P1775, DOI 10.1056/NEJMc2101951
   Board on Health Care Services Institute of Medicine, 2012, ROL TEL EV HLTH CAR
   Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9
   Breccia M, 2020, LEUKEMIA, V34, P2813, DOI 10.1038/s41375-020-01032-0
   Briard D, 2003, CLIN IMMUNOL, V106, P201, DOI 10.1016/S1521-6616(02)00046-3
   Caocci G, 2014, LEUKEMIA, V28, P225, DOI 10.1038/leu.2013.235
   Carobbio A, 2011, BLOOD, V117, P5857, DOI 10.1182/blood-2011-02-339002
   Cervantes F, 2000, EUR J HAEMATOL, V65, P104, DOI 10.1034/j.1600-0609.2000.90262.x
   Chen CC, 2016, ANN HEMATOL, V95, P361, DOI 10.1007/s00277-015-2532-7
   Chen CX, 2021, LEUKEMIA, V35, P2616, DOI 10.1038/s41375-021-01266-6
   Chen YY, 2018, J TELEMED TELECARE, V24, P157, DOI 10.1177/1357633X16686777
   Chowdhury O, 2021, BRIT J HAEMATOL, V194, P1010, DOI 10.1111/bjh.17644
   Colomba Claudia, 2012, BMC Res Notes, V5, P552, DOI 10.1186/1756-0500-5-552
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Connors M, 2021, ANN INTERN MED, V174, P687, DOI 10.7326/M21-0111
   Crodel CC, 2020, LEUKEMIA, V34, P1949, DOI 10.1038/s41375-020-0890-1
   Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765
   De Stefano V, 2016, LEUKEMIA, V30, P2032, DOI 10.1038/leu.2016.85
   de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   DeBaun MR, 2020, BLOOD, V135, P1997, DOI 10.1182/blood.2020005992
   Dorsey ER, 2020, LANCET, V395, P859, DOI 10.1016/S0140-6736(20)30424-4
   Du LY, 2007, VACCINE, V25, P2832, DOI 10.1016/j.vaccine.2006.10.031
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Duffy S, 2018, NEW ENGL J MED, V378, P104, DOI 10.1056/NEJMp1710735
   El-Sharkawi D, 2020, BRIT J HAEMATOL, V190, P336, DOI 10.1111/bjh.16956
   Elli EM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01186
   European Medicines Agency, 2021, COVID 19 PAND
   Finazzi G, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0142-z
   FROOM P, 1989, CANCER, V64, P1038, DOI 10.1002/1097-0142(19890901)64:5<1038::AID-CNCR2820640513>3.0.CO;2-W
   Garcia-Suarez J, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00970-7
   Giri M, 2021, SCI PROGRESS-UK, V104, DOI 10.1177/00368504211000906
   Gisslinger H, 2020, LANCET HAEMATOL, V7, pE196, DOI 10.1016/S2352-3026(19)30236-4
   Goldberg RA, 2013, NEW ENGL J MED, V369, P681, DOI 10.1056/NEJMc1302895
   Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m998
   Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840
   Gresele P., HAEMATOLOGICA, V2021
   Griesshammer M, 2018, ANN HEMATOL, V97, P1591, DOI 10.1007/s00277-018-3365-y
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guarda CC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51339-x
   Guglielmelli P, 2021, AM J HEMATOL, V96, pE408, DOI 10.1002/ajh.26305
   Guglielmelli P, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-0289-2
   Harrington P, 2021, LEUKEMIA, V35, P3573, DOI 10.1038/s41375-021-01300-7
   Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556
   Hasselbalch HC, 2021, CYTOKINE GROWTH F R, V60, P28, DOI 10.1016/j.cytogfr.2021.03.006
   Hasselbalch HC, 2011, EXPERT REV HEMATOL, V4, P637, DOI 10.1586/EHM.11.63
   Heine A, 2013, BLOOD, V122, P3843, DOI 10.1182/blood-2013-10-531103
   Tzarfati KH, 2021, AM J HEMATOL, V96, P1195, DOI 10.1002/ajh.26284
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Hultcrantz M, 2015, J CLIN ONCOL, V33, P2288, DOI 10.1200/JCO.2014.57.6652
   Janssen Biotech Inc, 2021, VACCINES RELATED BIO
   Johns Hopkins University,, 2020, COVID 19 DASHB CTR S
   Kadir M.A., 2020, TELEHEALTH MED TODAY, V5
   Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920
   Keohane C, 2015, BRIT J HAEMATOL, V171, P60, DOI 10.1111/bjh.13519
   Khan I, 2020, CUREUS, V12, DOI 10.7759/cureus.8871
   Kiladjian JJ, 2020, LANCET HAEMATOL, V7, pE226, DOI 10.1016/S2352-3026(19)30207-8
   Kiladjian JJ, 2011, BLOOD, V117, P4706, DOI 10.1182/blood-2010-08-258772
   Knoll MD, 2021, LANCET, V397, P72, DOI 10.1016/S0140-6736(20)32623-4
   Koschmieder S, 2016, LEUKEMIA, V30, P1018, DOI 10.1038/leu.2016.12
   Kricheldorf K, 2021, LEUKEMIA RES, V110, DOI 10.1016/j.leukres.2021.106646
   Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572
   Landtblom AR, 2021, LEUKEMIA, V35, P476, DOI 10.1038/s41375-020-0909-7
   Lee Samantha C, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-204950
   Leentjens J, 2021, LANCET HAEMATOL, V8, DOI 10.1016/S2352-3026(21)00105-8
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8
   Lori F, 1999, ANTIVIR THER, V4, P101
   Lurie N, 2018, JAMA INTERN MED, V178, P745, DOI 10.1001/jamainternmed.2018.1314
   Lussana F, 2018, AM J HEMATOL, V93, P339, DOI 10.1002/ajh.24976
   Maneikis K, 2021, LANCET HAEMATOL, V8, pE583, DOI 10.1016/S2352-3026(21)00169-1
   Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500
   Marcucci R, 2021, INTERN EMERG MED, V16, P1113, DOI 10.1007/s11739-021-02793-x
   Marks P., 2021, JOINT CDC FDA STATEM
   Massa M, 2014, LEUKEMIA, V28, P449, DOI 10.1038/leu.2013.296
   McMullin MF, 2019, BRIT J HAEMATOL, V184, P176, DOI 10.1111/bjh.15648
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mesa R., 2021, COVID 19 RESOURCES C
   Mikulska M, 2019, LANCET INFECT DIS, V19, pE188, DOI 10.1016/S1473-3099(18)30601-7
   Mohammadi S, 2020, VOX SANG, V115, P595, DOI 10.1111/vox.12930
   National Comprehensive Cancer Network, 2021, REC PAT WEB MYEL NEO
   Nile SH, 2020, CYTOKINE GROWTH F R, V53, P66, DOI 10.1016/j.cytogfr.2020.05.002
   Omboni S, 2020, TELEMED E-HEALTH, V26, P973, DOI 10.1089/tmj.2020.0106
   Ostergaard SD, 2021, LANCET, V397, P1441, DOI 10.1016/S0140-6736(21)00762-5
   Palandri F, 2021, BRIT J HAEMATOL, V192, pE48, DOI 10.1111/bjh.17208
   Palandri F, 2020, LEUKEMIA, V34, P2805, DOI 10.1038/s41375-020-0953-3
   Palandri F, 2015, ANN HEMATOL, V94, P519, DOI 10.1007/s00277-014-2183-0
   Palmason Robert, 2015, BMC Hematol, V15, P10, DOI 10.1186/s12878-015-0029-1
   Passamonti F, 2021, BRIT J HAEMATOL, V195, P371, DOI 10.1111/bjh.17704
   Passamonti F, 2020, LANCET HAEMATOL, V7, pE737, DOI 10.1016/S2352-3026(20)30251-9
   Passamonti F, 2017, LANCET ONCOL, V18, P88, DOI 10.1016/S1470-2045(16)30558-7
   Pastori D, 2019, BRIT J CLIN PHARMACO, V85, P508, DOI 10.1111/bcp.13837
   Patti G, 2020, AM J CARDIOVASC DRUG, V20, P559, DOI 10.1007/s40256-020-00446-6
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Pavord S, 2020, BRIT J HAEMATOL, V189, P1038, DOI 10.1111/bjh.16775
   Pedersen SF, 2020, J CLIN INVEST, V130, P2202, DOI 10.1172/JCI137647
   Petrosillo N, 2020, CLIN MICROBIOL INFEC, V26, P729, DOI 10.1016/j.cmi.2020.03.026
   Pimpinelli F, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01090-6
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Polverelli N, 2017, AM J HEMATOL, V92, P37, DOI 10.1002/ajh.24572
   Powell RE, 2017, ANN FAM MED, V15, P225, DOI 10.1370/afm.2095
   Rinott E, 2021, MMWR-MORBID MORTAL W, V70, P326, DOI 10.15585/mmwr.mm7009e3
   Rubin LG, 2014, CLIN INFECT DIS, V58, P309, DOI [10.1093/cid/cit816, 10.1093/cid/cit684]
   Rudolph J, 2016, LEUKEMIA, V30, P2119, DOI 10.1038/leu.2016.155
   Saban N, 2009, CANCER CHEMOTH PHARM, V64, P213, DOI 10.1007/s00280-009-0991-z
   Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201
   Sainz B, 2004, VIROLOGY, V329, P11, DOI 10.1016/j.virol.2004.08.011
   Salisbury RA, 2021, LEUKEMIA, V35, P2424, DOI 10.1038/s41375-021-01143-2
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Sangli S, 2021, ANN INTERN MED, V174, P1480, DOI 10.7326/L21-0244
   Saunders J, 2021, HEMASPHERE, V5, DOI 10.1097/HS9.0000000000000609
   Schonberg K, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1071009
   Schonberg K, 2015, CANCER RES, V75, P2187, DOI 10.1158/0008-5472.CAN-14-3198
   Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI 10.1056/NEJMoa2104882
   Scully M, 2021, NEW ENGL J MED, V384, P2202, DOI 10.1056/NEJMoa2105385
   See I, 2021, JAMA-J AM MED ASSOC, V325, P2448, DOI 10.1001/jama.2021.7517
   Seif F, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0177-y
   Shander A, 2020, ANESTH ANALG, V131, P74, DOI 10.1213/ANE.0000000000004844
   Simpson-Poirier K, 2021, AM J HEMATOL, V96, pE200, DOI 10.1002/ajh.26159
   Tefferi A, 2020, AM J HEMATOL, V95, P1599, DOI 10.1002/ajh.26008
   Thachil J, 2020, RES PRACT THROMB HAE, V4, P731, DOI 10.1002/rth2.12372
   Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3
   Tong LX, 2014, J AM ACAD DERMATOL, V70, pE59, DOI 10.1016/j.jaad.2013.09.035
   Vannucchi AM, 2021, LEUKEMIA, V35, P1121, DOI 10.1038/s41375-020-01018-y
   Vannucchi AM, 2015, NEW ENGL J MED, V372, P426, DOI 10.1056/NEJMoa1409002
   Velazquez-Salinas L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01057
   Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557
   Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06
   Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867
   von Hofsten J, 2016, NEW ENGL J MED, V374, P296, DOI 10.1056/NEJMc1413918
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Wang HP, 2020, LANCET ONCOL, V21, pE181, DOI 10.1016/S1470-2045(20)30149-2
   Wang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116723
   Wang JC, 2016, LEUKEMIA RES, V43, P39, DOI 10.1016/j.leukres.2016.02.004
   Wang QQ, 2021, BLOOD REV, V47, DOI 10.1016/j.blre.2020.100775
   Wathes R, 2013, NEW ENGL J MED, V369, P197, DOI 10.1056/NEJMc1302135
   Weinkove R, 2020, MED J AUSTRALIA, V212, P481, DOI 10.5694/mja2.50607
   Willan J, 2020, BRIT J HAEMATOL, V189, P241, DOI 10.1111/bjh.16620
   Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n699
   Wysham NG, 2013, CHEST, V143, P1478, DOI 10.1378/chest.12-1604
   Xia Y, 2020, LANCET ONCOL, V21, pE180, DOI 10.1016/S1470-2045(20)30150-9
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Yajnanarayana SP, 2015, BRIT J HAEMATOL, V169, P824, DOI 10.1111/bjh.13373
   Zahran AM, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029619895111
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 163
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6694
J9 CANCERS
JI Cancers
PD OCT
PY 2021
VL 13
IS 19
AR 4750
DI 10.3390/cancers13194750
PG 22
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 0A4JQ
UT WOS:000773923000006
PM 34638236
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Saadatjoo, S
   Miri, M
   Hassanipour, S
   Ameri, H
   Arab-Zozani, M
AF Saadatjoo, S.
   Miri, M.
   Hassanipour, S.
   Ameri, H.
   Arab-Zozani, M.
TI Knowledge, attitudes, and practices of the general population about
   Coronavirus disease 2019 (COVID-19): a systematic review and
   meta-analysis with policy recommendations
SO PUBLIC HEALTH
LA English
DT Review
DE COVID-19; Knowledge; Attitude; Practice; Systematic review; Policy
   recommendations
ID RESIDENTS; OUTBREAK
AB Objectives: This study aimed to investigate and synthesize the current evidence on knowledge, attitudes, and practices (KAPs) of the general population regarding COVID-19.
   Study design: This is a systematic review and meta-analysis.
   Methods: We conducted a systematic search on PubMed/LitCovid, Scopus, and Web of Sciences databases for papers in the English language only, up to 1 January 2021. We used the Joanna Briggs Institute checklist developed for cross-sectional studies to appraise the quality of the included studies. All stages of the review conducted by two independent reviewers and potential discrepancies were solved with a consultation with a third reviewer. We reported the result as number and percentage. A meta-analysis conducted using a random effect model with a 95% confidence interval.
   Results: Forty-eight studies encompassing 76,848 participants were included in this review. 56.53% of the participants were female. The mean age of the participants was 33.7 years. 85.42% of the included studies were scored as good quality, 12.50% as fair quality, and the remaining (2.08%) as low quality. About 87.5% examined all three components of the KAPs model. The knowledge component was reported as good and poor in 89.5% and 10.5% of the included studies, respectively. Of the studies that examined the attitude component, 100% reported a positive attitude. For the practice component, 93.2% reported satisfactory practice, and 6.8% poor practice. The result of the meta-analysis showed that the overall score of KAPs components about COVID-19 were 78.9, 79.8, and 74.1, respectively.
   Conclusions: This systematic review and meta-analysis showed that the overall KAP components in the included studies were at an acceptable level. In general, knowledge was at a good level, the attitude was positive and practice was at a satisfactory level. Using an integrated international system can help better evaluate these components and compare them between countries. (C) 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
C1 [Saadatjoo, S.; Miri, M.; Arab-Zozani, M.] Birjand Univ Med Sci, Social Determinants Hlth Res Ctr, Birjand, Iran.
   [Hassanipour, S.] Guilan Univ Med Sci, Heshmat Hosp, Cardiovasc Dis Res Ctr, Dept Cardiol,Sch Med, Rasht, Iran.
   [Ameri, H.] Shahid Sadoughi Univ Med Sci, Hlth Policy & Management Res Ctr, Sch Publ Hlth, Dept Hlth Serv Management, Yazd, Iran.
RP Arab-Zozani, M (corresponding author), Birjand Univ Med Sci, Social Determinants Hlth Res Ctr SDHRC, Sch Hlth, Moallem St,PBox 32430076, Birjand, South Khorasan, Iran.
EM ss.saadatjoo1360@gmail.com; mmiri1062@gmail.com; soheil.epid@gmail.com;
   hamery7@yahoo.com; arab.hta@gmail.com
RI Hassanipour, Soheil/Y-7903-2019
OI Hassanipour, Soheil/0000-0002-6661-4908; Arab-Zozani,
   Morteza/0000-0001-7223-6707
CR Abdelghafor MTB., 2020, SUDAN J MED SCI, V15, P32, DOI DOI 10.18502/SJMS.V15I5.7176
   Abed MW., 2020, J IDEAS HLTH, V3, P258
   Adesegun Oluwaseyitan A, 2020, Am J Trop Med Hyg, V103, P1997, DOI 10.4269/ajtmh.20-0461
   Ahmed OB., 2020, J PUBLIC HEALTH RES, P9
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015
   Almofada SK, 2020, CUREUS, V12, DOI 10.7759/cureus.8905
   Alobuia WM, 2020, J PUBLIC HEALTH-UK, V42, P470, DOI 10.1093/pubmed/fdaa069
   Amalakanti S, 2020, INDIAN J MED MICROBI, V38, P144, DOI 10.4103/ijmm.IJMM_20_263
   Arab-Zozani M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039730
   Arab-Zozani M, 2021, DISASTER MED PUBLIC, V15, pE43, DOI 10.1017/dmp.2020.261
   Arab-Zozani M, 2020, VALUE HEALTH REG ISS, V21, P105, DOI 10.1016/j.vhri.2019.07.011
   Arab-Zozani M, 2020, BALK MED J, V37, P231, DOI 10.4274/balkanmedj.galenos.2020.2020.4.67
   Arab-zozani M, 2018, J ELDER ABUSE NEGL, V30, P408, DOI 10.1080/08946566.2018.1523765
   Arora G, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13359
   Ashiq K., 2020, BANGLADESH J MED SCI, V19, P69, DOI [10.3329/bjms.v19i0.48169, DOI 10.3329/BJMS.V19I0.48169]
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Baig M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243526
   Bates BR, 2020, J COMMUN HEALTH, V45, P1158, DOI 10.1007/s10900-020-00916-7
   Bdair IA, 2020, ASIA-PAC J PUBLIC HE, V32, P354, DOI 10.1177/1010539520949421
   Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2
   Cao ZH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234764
   Chan EYY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113869
   Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161
   Curryer C., 2020, INFECT DIS HEALTH, V25, P55
   Davies Stephanie, 2020, Wellcome Open Res, V5, P131, DOI [10.12688/wellcomeopenres.15964.1, 10.12688/wellcomeopenres.15964.2]
   Dehghani M., 2020, INT NURS REV, V13, P1446
   Dewey C, 2020, ANN INTERN MED, V172, P752, DOI 10.7326/M20-1033
   Domiati S, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00542
   Elayeh E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240780
   Fallahi A., 2020, Journal of Military Medicine, V22, pfa580, DOI 10.30491/JMM.22.6.580
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Flinders M, 2020, PARLIAMENT AFF
   Gao HM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09961-2
   Gaythorpe K, 2020, REPORT 8 SYMPTOM PRO
   Ghazi HF., 2020, OPEN ACCESS MACEDON, V8, P137, DOI 10.3889/oamjms.2020.4965
   Griffith Richard, 2020, Br J Nurs, V29, P326, DOI 10.12968/bjon.2020.29.5.326
   Nhu HV, 2020, J COMMUN HEALTH, V45, P1263, DOI 10.1007/s10900-020-00919-4
   Haftom M, 2020, INFECT DRUG RESIST, V13, P3727, DOI 10.2147/IDR.S275744
   Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918
   Haleem Abid, 2020, Curr Med Res Pract, V10, P78, DOI 10.1016/j.cmrp.2020.03.011
   Hassanipour S., 2020, ANN GLOB HEALTH, P86
   Hassanipour S, 2020, INT J REPROD BIOMED, V18, P1005, DOI 10.18502/ijrm.v18i12.8022
   Hezima A, 2020, E MEDITERR HEALTH J, V26, P646, DOI 10.26719/emhj.20.076
   Honarvar B, 2020, INT J PUBLIC HEALTH, V65, P731, DOI 10.1007/s00038-020-01406-2
   Hong KH, 2020, ANN LAB MED, V40, P351, DOI 10.3343/alm.2020.40.5.351
   Hossain MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239646
   Ing EB, 2020, OCCUP MED-OXFORD, V70, P370, DOI 10.1093/occmed/kqaa088
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Kakemam E, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.585302
   Kasemy ZA, 2020, J EPIDEMIOL GLOB HEA, V10, P378, DOI 10.2991/jegh.k.200909.001
   Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007
   LEBNI JY, 2020, INT J SOC PSYCHIAT, V1, P1
   Lee M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10285-y
   Lewin Keith M, 2020, Prospects (Paris), V49, P17, DOI 10.1007/s11125-020-09480-3
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Namikawa Kyoko, 2008, Travel Med Infect Dis, V6, P137, DOI 10.1016/j.tmaid.2008.01.013
   Ngwewondo A, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008700
   Nicholas T, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.2020.35.2.22963, 10.11604/pamj.supp.2020.35.2.22963]
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Organization WH, 7 WHO
   Parmet WE, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2004211
   Pascawati N.A., 2020, INT J PUBLIC HLTH SC, V9, P292
   Paul A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238492
   Paul E, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00756-z
   Porritt K, 2014, AM J NURS, V114, P47, DOI 10.1097/01.NAJ.0000450430.97383.64
   Rahman S. M. M., 2021, Bangladesh Medical Research Council Bulletin, V46, P73, DOI 10.3329/bmrcb.v46i2.49015
   Rajeh M, 2020, OPEN DENT J, V14, P489, DOI 10.2174/1874210602014010489
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Ricco Matteo, 2020, Acta Biomed, V91, P57, DOI 10.23750/abm.v91i2.9573
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Sari C, 2021, J HUM HYPERTENS, V35, P828, DOI 10.1038/s41371-020-00436-w
   Sayedahmed AMS, 2020, SCI AFR, V10, DOI 10.1016/j.sciaf.2020.e00652
   Sengeh P, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040328
   Siedner MJ., 2020, SOCIAL DISTANCING SL, DOI [DOI 10.1371/JOURNAL.PMED.1003244, DOI 10.1101/2020.04.03.20052373]
   Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665
   Tandon T, 2020, J FAM MED PRIM CARE, V9, P4265, DOI 10.4103/jfmpc.jfmpc_818_20
   Tariq Saba, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.408
   Tull MT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113098
   Usman IM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00340
   Vengadassalapathy, 2020, INT J RES PHARM SCI, V11, P892, DOI DOI 10.26452/IJRPS.V11ISPL1.3111
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wu H., 2020, CHILD YOUTH SERV REV, V120
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu H, 2020, J MED INTERNET RES, V22, DOI 10.2196/21372
   Yang KH, 2021, J ADV NURS, V77, P1839, DOI 10.1111/jan.14718
   Yezli S, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101692
   Yousaf MA, 2020, SOC WORK PUBLIC HLTH, V35, P569, DOI 10.1080/19371918.2020.1806983
   Yue ST, 2021, J COMMUN HEALTH, V46, P286, DOI 10.1007/s10900-020-00877-x
   Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 93
TC 10
Z9 10
U1 4
U2 6
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD MAY
PY 2021
VL 194
BP 185
EP 195
DI 10.1016/j.puhe.2021.03.005
EA MAY 2021
PG 11
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA SS5QA
UT WOS:000661809200034
PM 33962095
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Kaptein, FHJ
   Stals, MAM
   Huisman, MV
   Klok, FA
AF Kaptein, F. H. J.
   Stals, M. A. M.
   Huisman, M. V.
   Klok, F. A.
TI Prophylaxis and treatment of COVID-19 related venous thromboembolism
SO POSTGRADUATE MEDICINE
LA English
DT Review
DE COVID-19; venous thromboembolism; incidence; physiopathology;
   prophylaxis; treatment; anticoagulants; blood coagulation disorders
ID SUSPECTED PULMONARY-EMBOLISM; ANTIPHOSPHOLIPID ANTIBODIES; ORAL
   ANTICOAGULANTS; COMPLICATIONS; PNEUMONIA; INFLAMMATION; TOCILIZUMAB;
   INFECTIONS; MANAGEMENT; THROMBOSIS
AB COVID-19 pneumonia has been associated with high rates of thrombo-embolic complications, mostly venous thromboembolism (VTE), which is thought to be a combination of conventional VTE and in situ immunothrombosis in the pulmonary vascular tree. The incidence of thrombotic complications is dependent on setting (intensive care unit (ICU) versus general ward) and the threshold for performing diagnostic tests (screening versus diagnostic algorithms triggered by symptoms). Since these thrombotic complications are associated with in-hospital mortality, all current guidelines and consensus papers propose pharmacological thromboprophylaxis in all hospitalized patients with COVID-19. Several trials are ongoing to study the optimal intensity of anticoagulation for this purpose. As for the management of thrombotic complications, treatment regimens from non-COVID-19 guidelines can be adapted, with choice of anticoagulant drug class dependent on the situation. Parenteral anticoagulation is preferred for patients on ICUs or with impending clinical deterioration, while oral treatment can be started in stable patients. This review describes current knowledge on incidence and pathophysiology of COVID-19 associated VTE and provides an overview of guideline recommendations on thromboprophylaxis and treatment of established VTE in COVID-19 patients.
C1 [Kaptein, F. H. J.; Stals, M. A. M.; Huisman, M. V.; Klok, F. A.] Leiden Univ, Dept Med Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands.
RP Klok, FA (corresponding author), Leiden Univ, Dept Med Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands.
EM f.a.klok@lumc.nl
RI Klok, Erik/U-4870-2019
OI Klok, Erik/0000-0001-9961-0754; Huisman, Menno/0000-0003-1423-5348;
   Stals, Milou/0000-0003-2328-7705
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Akaberi A, 2018, J THROMB HAEMOST, V16, P2454, DOI 10.1111/jth.14302
   Amgalan A, 2020, PLATELETS, V31, P740, DOI 10.1080/09537104.2020.1768523
   Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743
   Artifoni M, 2020, J THROMB THROMBOLYS, V50, P211, DOI 10.1007/s11239-020-02146-z
   Atallah B, 2021, ANAESTHESIA, V76, P327, DOI 10.1111/anae.15300
   Bai CX, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0287-2020
   Barrett CD, 2020, J THROMB HAEMOST, V18, P2060, DOI 10.1111/jth.14860
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Berkman SA, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620945398
   Boon GJAM, 2020, THROMB RES, V190, P45, DOI 10.1016/j.thromres.2020.03.020
   Boon GJAM, 2020, RES PRACT THROMB HAE, V4, P958, DOI 10.1002/rth2.12404
   Borghi MO, 2020, FRONT IMMUNOL, V11, DOI [10.1101/2020.06.17.20134114, 10.3389/fimmu.2020.584241]
   Bowles L, 2020, NEW ENGL J MED, V383, P288, DOI 10.1056/NEJMc2013656
   Campbell CM, 2020, CIRCULATION, V141, P1739, DOI 10.1161/CIRCULATIONAHA.120.047419
   Campochiaro C, 2020, EUR J INTERN MED, V76, P43, DOI 10.1016/j.ejim.2020.05.021
   Cannegieter SC, 2020, RES PRACT THROMB HAE, V4, P439, DOI 10.1002/rth2.12350
   Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097
   Chuang LH, 2018, THROMB RES, V170, P165, DOI 10.1016/j.thromres.2018.08.001
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Cuker A, 2021, BLOOD ADV, V5, P872, DOI 10.1182/bloodadvances.2020003763
   Devreese KMJ, 2020, J THROMB HAEMOST, V18, P2191, DOI 10.1111/jth.14994
   Dhawan RT, 2021, LANCET RESP MED, V9, P107, DOI 10.1016/S2213-2600(20)30407-0
   Di Nisio M, 2021, EUR J INTERN MED, V83, P34, DOI 10.1016/j.ejim.2020.10.020
   Donze J, 2012, AM J MED, V125, P1095, DOI 10.1016/j.amjmed.2012.04.005
   Eck RJ, 2019, SEMIN THROMB HEMOST, V45, P810, DOI 10.1055/s-0039-1696965
   Ende-Verhaar YM, 2018, J THROMB HAEMOST, V16, P2168, DOI 10.1111/jth.14266
   Ende-Verhaar YM, 2019, J HEART LUNG TRANSPL, V38, P731, DOI 10.1016/j.healun.2019.03.003
   Ende-Verhaar YM, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01792-2016
   Frantzeskaki F, 2017, RESPIRATION, V93, P212, DOI 10.1159/000453002
   Galeano-Valle F, 2020, THROMB RES, V192, P113, DOI 10.1016/j.thromres.2020.05.017
   Gil MR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17539
   Gordon A.C., 2021, INTERLEUKIN 6 RECEPT, DOI [10.1101/2021.01.07.21249390, DOI 10.1101/2021.01.07.21249390]
   Grosse C, 2020, CARDIOVASC PATHOL, V49, DOI 10.1016/j.carpath.2020.107263
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guerin L, 2014, THROMB HAEMOSTASIS, V112, P598, DOI 10.1160/TH13-07-0538
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188
   Harzallah I, 2020, J THROMB HAEMOST, V18, P2778, DOI 10.1111/jth.14937
   Hasan Ali O, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1496, DOI 10.1093/CID/CIAA1496]
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huisman MV, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.28
   Hunter R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024805
   Hunter R, 2017, BRIT J HEALTH PSYCH, V22, P8, DOI 10.1111/bjhp.12213
   Iba T, 2020, CRIT CARE MED, V48, P1358, DOI 10.1097/CCM.0000000000004458
   Jimenez-Guiu X, 2021, J VASC SURG-VENOUS L, V9, P592, DOI 10.1016/j.jvsv.2020.08.028
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Kahn SR, 2005, ARCH INTERN MED, V165, P1173, DOI 10.1001/archinte.165.10.1173
   Kahn SR, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2017.03.033
   Kearon C, 2019, NEW ENGL J MED, V381, P2125, DOI 10.1056/NEJMoa1909159
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Klok FA, 2014, BLOOD REV, V28, P221, DOI 10.1016/j.blre.2014.07.003
   Klok FA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01494-2020
   Klok FA, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01687-2018
   Klok FA, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00189-2020
   Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Lazzaroni MG, 2021, BLOOD REV, V46, DOI 10.1016/j.blre.2020.100745
   Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9
   Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Liverpool Drug Interactions Group University of Liverpool, COVID 19 DRUG INT
   Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Longhitano Y, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9100310
   MacDougall K, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041002
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Martin-Rojas RM, 2020, EUR J HAEMATOL, V105, P741, DOI 10.1111/ejh.13501
   Martinelli I, 2021, INTERN EMERG MED, V16, P1223, DOI 10.1007/s11739-020-02585-9
   Mattioli M, 2021, J THROMB THROMBOLYS, V51, P286, DOI 10.1007/s11239-020-02243-z
   Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008
   Minet C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1003-9
   Moores LK, 2020, CHEST, V158, P1143, DOI 10.1016/j.chest.2020.05.559
   Mughal MS, 2020, CUREUS, V12, DOI 10.7759/cureus.12214
   Nahum J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10478
   National Institute for Health and Care Excellence, COVID 19 RAPID GUIDE
   Nopp S, 2020, RES PRACT THROMB HAE, V4, P1178, DOI 10.1002/rth2.12439
   Paolisso P, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01124
   Patell R, 2020, BLOOD, V136, P1342, DOI 10.1182/blood.2020007938
   Pengo V, 2009, J THROMB HAEMOST, V7, P1737, DOI 10.1111/j.1538-7836.2009.03555.x
   Pesavento R, 2020, J THROMB HAEMOST, V18, P2629, DOI 10.1111/jth.15022
   Piagnerelli M, 2020, CRIT CARE EXPLOR, V2
   Piovella C, 2014, INTERN EMERG MED, V9, P847, DOI 10.1007/s11739-014-1073-8
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Qanadli SD, 2020, THROMB RES, V192, P9, DOI 10.1016/j.thromres.2020.05.007
   Qu R, 2020, J MED VIROL, V92, P1533, DOI 10.1002/jmv.25767
   Rabinovich A, 2018, BLOOD, V131, P2215, DOI 10.1182/blood-2018-01-785956
   Radermecker C, 2020, J EXP MED, V217, DOI 10.1084/jem.20201012
   Ren B, 2020, CIRCULATION, V142, P181, DOI 10.1161/CIRCULATIONAHA.120.047407
   Roberts LN, 2020, BLOOD, V136, P1347, DOI 10.1182/blood.2020008086
   Rossi R, 2020, EUR J INTERN MED, V77, P158, DOI 10.1016/j.ejim.2020.06.006
   Russo V, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104965
   Schouwers SME, 2010, THROMB RES, V125, P102, DOI 10.1016/j.thromres.2009.09.001
   Siguret V, 2020, THROMB RES, V195, P74, DOI 10.1016/j.thromres.2020.07.016
   Sista AK, 2018, THROMB RES, V164, P157, DOI 10.1016/j.thromres.2017.06.017
   Sivaloganathan H, 2020, BRIT J HAEMATOL, V190, pE192, DOI 10.1111/bjh.16968
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Stals MAM., 2020, 20248265 MEDRXIV
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tavoly M, 2018, THROMB RES, V171, P84, DOI 10.1016/j.thromres.2018.09.048
   Testa S, 2020, J THROMB HAEMOST, V18, P1320, DOI 10.1111/jth.14871
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   The National Institute of Health, ANT THER PAT COVID 1
   Tomar B, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061383
   Tremblay D, 2020, BLOOD, V136, P144, DOI 10.1182/blood.2020006941
   Tsuda Y, 2019, CLIN ORTHOP RELAT R, V477, P2432, DOI 10.1097/CORR.0000000000000926
   Uthman IW, 2002, SEMIN ARTHRITIS RHEU, V31, P256, DOI 10.1053/sarh.2002.28303
   van Dam LF, 2020, THROMB RES, V193, P86, DOI 10.1016/j.thromres.2020.06.010
   van Dam LF, 2020, EUR J CASE REP INTER, V7
   van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485
   van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1
   van der Pol LM, 2019, NEW ENGL J MED, V380, P1139, DOI 10.1056/NEJMoa1813865
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Veiga VC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n84
   Vidali S, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00260-2020
   Wang D, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.1585, DOI 10.1001/JAMA.2020.1585]
   Weng L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2004794
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   WorldHealthOrganization, NUMB GLANC
   Yin SY, 2021, J THROMB THROMBOLYS, V51, P1107, DOI 10.1007/s11239-020-02105-8
   YU BL, 2020, J THROMB THROMBOLYS, V50, P548, DOI [DOI 10.1007/s11239-020-02171-y, DOI 10.1016/S0140-6736(20)30566-3]
   Zhang L, 2020, CIRCULATION, V142, P114, DOI 10.1161/CIRCULATIONAHA.120.046702
   Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zuo Y, 2021, J THROMB THROMBOLYS, V51, P446, DOI [10.1007/s11239-020-02324-z, 10.1101/2020.04.30.20086736]
NR 129
TC 8
Z9 8
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0032-5481
EI 1941-9260
J9 POSTGRAD MED
JI Postgrad. Med.
PD AUG 6
PY 2021
VL 133
SU 1
SI SI
BP 27
EP 35
DI 10.1080/00325481.2021.1891788
EA MAR 2021
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA UE7WE
UT WOS:000625533100001
PM 33657964
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Dhivagaran, T
   Abbas, U
   Butt, F
   Arunasalam, L
   Chang, O
AF Dhivagaran, Thanansayan
   Abbas, Umaima
   Butt, Fahad
   Arunasalam, Luckshann
   Chang, Oswin
TI Critical appraisal of clinical practice guidelines for the management of
   COVID-19: protocol for a systematic review
SO SYSTEMATIC REVIEWS
LA English
DT Review
DE COVID-19; Systematic review protocol; AGREE II; Critical appraisal;
   Clinical practice guideline; Guideline assessment
ID QUALITY; AGREE
AB Background: In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 was identified as the cause of an acute respiratory disease, coronavirus disease 2019 (COVID-19). Given the lack of validated treatments, there is an urgent need for a high-quality management of COVID-19. Clinical practice guidelines (CPGs) are one tool that healthcare providers may use to enhance patient care. As such, it is necessary that they have access to high-quality evidence-based CPGs upon which they may base decisions regarding the management and use of therapeutic interventions (TI) for COVID-19. The purpose of the proposed study is to assess the quality of CPGs that make management or TI recommendations for COVID-19 using the AGREE II instrument.
   Methods: The proposed systematic review will identify CPGs for TI use and/or the management of COVID-19. The MEDLINE, EMBASE, CINAHL, and Web of Science databases, as well as the Guidelines International Network, National Institute for Health and Clinical Excellence, Scottish Intercollegiate Guidelines Network, and the World Health Organization websites, will be searched from December 2019 onwards. The primary outcome of this study is the assessed quality of the CPGs. The quality of eligible CPGs will be assessed using the Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument. Descriptive statistics will be used to quantify the quality of the CPGs. The secondary outcomes of this study are the types of management and/or TI recommendations made. Inconsistent and duplicate TI and/or management recommendations made between CPGs will be compared across guidelines. To summarize and explain the findings related to the included CPGs, a narrative synthesis will also be provided.
   Discussion: The results of this study will be of utmost importance to enhancing clinical decision-making among healthcare providers caring for patients with COVID-19. Moreover, the results of this study will be relevant to guideline developers in the creation of CPGs or improvement of existing ones, researchers who want to identify gaps in knowledge, and policy-makers looking to encourage and endorse the adoption of CPGs into clinical practice. The results of this review will be published in a peer-reviewed journal and presented at conferences.
C1 [Dhivagaran, Thanansayan; Butt, Fahad; Arunasalam, Luckshann; Chang, Oswin] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada.
   [Abbas, Umaima] McMaster Univ, Fac Sci, Hamilton, ON, Canada.
RP Dhivagaran, T (corresponding author), McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada.
EM dhivagat@mcmaster.ca
OI Dhivagaran, Thanansayan/0000-0003-0571-2894; Chang,
   Oswin/0000-0001-7363-546X
CR [Anonymous], COVID 19 MAP
   [Anonymous], NUCL ACID AMPLIFICAT
   [Anonymous], Interim guidance for antigen testing for SARS-CoV-2
   [Anonymous], overview of Testing for SARS-CoV-2
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449
   Burda BU, 2011, J CLIN EPIDEMIOL, V64, P968, DOI 10.1016/j.jclinepi.2010.12.005
   Burgers JS, 2004, J CLIN ONCOL, V22, P2000, DOI 10.1200/JCO.2004.06.157
   Dagens A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1936
   De Haas E, 2007, J EUR ACAD DERMATOL, V21, P1193, DOI 10.1111/j.1468-3083.2007.02216.x
   Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104806
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Joshi GP, 2019, ANESTH ANALG, V129, P1767, DOI 10.1213/ANE.0000000000004236
   Li YX, 2020, CHIN J INTEGR MED, V26, P786, DOI 10.1007/s11655-020-3431-x
   Lovato A, 2020, ENT-EAR NOSE THROAT, V99, P569, DOI 10.1177/0145561320920762
   LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103
   Malherbe P, 2021, AFR J EMERG MED, V11, P79, DOI 10.1016/j.afjem.2020.08.005
   Ong S, 2020, KOREAN J ANESTHESIOL, V73, P486, DOI 10.4097/kja.20354
   Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
   Page MJ, 2021, PLOS MED, V18, DOI [10.1371/journal.pmed.1003583, 10.1016/j.ijsu.2021.105906]
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Schardt C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-16
   [Anonymous], 2016, BMJ, V354, pi4086, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Wang YY, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.630765
   Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527
   Yeo KT, 2020, ACTA PAEDIATR, V109, P2192, DOI 10.1111/apa.15495
NR 26
TC 1
Z9 1
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2046-4053
J9 SYST REV-LONDON
JI Syst. Rev.
PD DEC 22
PY 2021
VL 10
IS 1
AR 317
DI 10.1186/s13643-021-01871-7
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XT0ZR
UT WOS:000733326000001
PM 34937576
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Rossato, MDS
   Gregorio, D
   de Almeida-Pedrin, RR
   Maia, LP
   Poli, RC
   Berger, SB
   Fernandes, TMF
AF Rossato, Mayara Delfino Sentone
   Gregorio, Danielle
   de Almeida-Pedrin, Renata Rodrigues
   Maia, Luciana Prado
   Poli, Regina Celia
   Berger, Sandrine Bittencourt
   Fernandes, Thais Maria Freire
TI Evaluation of Dental Practices Changes During the COVID-19 Pandemic
SO EVALUATION & THE HEALTH PROFESSIONS
LA English
DT Article
DE COVID-19; pandemic; dentists; dental management; personal protective
   equipment
AB Dentists are healthcare professionals who are at high risk of infection and transmission of the coronavirus disease-19 (COVID-19). The primary objective of the present study was to evaluate the changes in clinical practice made by Brazilian dentists during the COVID-19 pandemic. From June 22 to July 13, 2020, an online questionnaire was sent to dentists using Google Forms. After providing consent, 1,178 dentists answered questions regarding their knowledge and clinical experiences related to COVID-19. Data were analyzed using Chi-square, Fisher's exact, or Kruskal-Wallis tests, with a significance level of 5%. Brazilian dentists significantly changed their routine dental practices. Biosafety measures were added in their offices by 98% of the dentists, increasing operating costs for 88.3% of dentists. Greater discomfort due to the increase in personal protection equipment (PPE) worn during the pandemic was reported by 58.6%. Furthermore, 84.2% reduced heir hours of service. It was found that the dentists decreased their workload, used additional PPE, and took additional biosafety measures.
C1 [Rossato, Mayara Delfino Sentone; Gregorio, Danielle; de Almeida-Pedrin, Renata Rodrigues; Maia, Luciana Prado; Poli, Regina Celia; Berger, Sandrine Bittencourt; Fernandes, Thais Maria Freire] UNOPAR Univ Northern Parana, Londrina, Parana, Brazil.
RP Fernandes, TMF (corresponding author), UNOPAR Univ Northern Parana, Londrina, Parana, Brazil.
EM thaismaria@hotmail.com
RI Fernandes, Thais Maria Freire/H-4975-2018; Fernandes,
   Thais/AAI-2680-2020
OI Fernandes, Thais Maria Freire/0000-0002-4368-8568; Fernandes,
   Thais/0000-0002-4368-8568
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES) [001]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Candeiro GT de M., 2020, DISASTER MED PUBLIC, P1, DOI DOI 10.1017/DMP.2020.342
   Dar-Odeh N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093151
   Epstein JB, 2021, LANCET INFECT DIS, V21, pE73, DOI 10.1016/S1473-3099(20)30636-8
   Faccini Melissa, 2020, Eur J Dent, V14, pS14, DOI 10.1055/s-0040-1715990
   Gelinas L, 2017, AM J BIOETHICS, V17, P3, DOI 10.1080/15265161.2016.1276644
   Guo HQ, 2020, J DENT SCI, V15, P564, DOI 10.1016/j.jds.2020.02.002
   IBM Corp, IBM SPSS STAT WINDOW
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Schwendicke F, 2020, J DENT, V99, DOI 10.1016/j.jdent.2020.103387
   Topolovec-Vranic J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5698
   Weller K, 2015, ONLINE INFORM REV, V39, P281, DOI 10.1108/OIR-03-2015-0069
   Yuan N, 2021, POSTGRAD MED J, V97, P351, DOI 10.1136/postgradmedj-2020-137854
NR 14
TC 5
Z9 5
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0163-2787
EI 1552-3918
J9 EVAL HEALTH PROF
JI Eval. Health Prof.
PD JUN
PY 2021
VL 44
IS 2
BP 192
EP 197
AR 0163278721994902
DI 10.1177/0163278721994902
EA FEB 2021
PG 6
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RZ5GF
UT WOS:000620006000001
PM 33593112
OA Bronze
DA 2022-04-20
ER

PT J
AU Jeong, IK
   Yoon, KH
   Lee, MK
AF Jeong, In-Kyung
   Yoon, Kun Ho
   Lee, Moon Kyu
TI Diabetes and COVID-19: Global and regional perspectives
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Severe acute respiratory syndrome coronavirus-2; Coronavirus
   disease-2019 (COVID-19); Diabetes mellitus; Angiotensin-converting
   enzyme 2
ID SARS CORONAVIRUS; ACE2; PNEUMONIA; RECEPTOR; DISEASE;
   LOPINAVIR/RITONAVIR; GUIDELINES; MANAGEMENT; MELLITUS; OUTCOMES
AB The coronavirus disease-2019 (COVID-19) has been designated as a highly contagious infectious disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) since December 2019, when an outbreak of pneumonia cases emerged in Wuhan, China. The COVID-19 pandemic has led to a global health crisis, devastating the social, economic and political aspects of life. Many clinicians, health professionals, scientists, organizations, and governments have actively defeated COVID-19 and shared their experiences of the SARS-CoV2. Diabetes is one of the major risk factors for fatal outcomes from COVID-19. Patients with diabetes are vulnerable to infection because of hyperglycemia; impaired immune function; vascular complications; and comorbidities such as hypertension, dyslipidemia, and cardiovascular disease. In addition, angiotensin-converting enzyme 2 (ACE2) is a receptor for SARS-CoV-2 in the human body. Hence, the use of angiotensin-directed medications in patients with diabetes requires attention. The severity and mortality from COVID-19 was significantly higher in patients with diabetes than in those without. Thus, the patients with diabetes should take precautions during the COVID-19 pandemic.
   Therefore, we review the current knowledge of COVID-19 including the global and regional epidemiology, virology, impact of diabetes on COVID-19, treatment of COVID-19, and standard of care in the management of diabetes during this critical period. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Jeong, In-Kyung] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Endocrinol & Metab, Sch Med, Seoul, South Korea.
   [Yoon, Kun Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.
   [Lee, Moon Kyu] Soonchunghyang Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Gumi, South Korea.
RP Yoon, KH (corresponding author), 222 Banpo Daero, Seoul, South Korea.; Lee, MK (corresponding author), 179,1 Gongdan Ro, Gumi 39371, Gyunsangbuk Do, South Korea.
EM jik1016@naver.com; yoonk@catholic.ac.kr; leemk4132@gmail.com
CR AHN JY, 2020, J KOREAN MED SCI, V35, DOI [10.3346/jkms.2020.35.e149, DOI 10.3346/JKMS.2020.35.E149]
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006
   Arabi YM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3846-x
   Arabi YM, 2020, CLIN INFECT DIS, V70, P1837, DOI 10.1093/cid/ciz544
   Atri D, 2020, JACC-BASIC TRANSL SC, V5, P518, DOI 10.1016/j.jacbts.2020.04.002
   Austalian Diabetes Society, UPD DIAB COVID 19 CO
   Barbarin V, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-112
   Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen QQ, 2020, INFECTION, V48, P543, DOI 10.1007/s15010-020-01432-5
   Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
   Chung SM, 2020, DIAB META J, V44, pe27, DOI [10.4093/dmj.2020.01050, DOI 10.4093/DMJ.2020.01050]
   COVID-19 National Emergency Response Center Epidemiology and Case Management Team Korea Centers for Disease Control and Prevention, 2020, Osong Public Health Res Perspect, V11, P85, DOI 10.24171/j.phrp.2020.11.2.05
   COVID-19 National Emergency Response Center Epidemiology and Case Management Team Korea Centers for Disease Control and Prevention, 2020, Osong Public Health Res Perspect, V11, P8, DOI 10.24171/j.phrp.2020.11.1.03
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Cure E, 2020, DIABETES METAB SYND, V14, P405, DOI 10.1016/j.dsx.2020.04.024
   Cvetkovic RS, 2003, DRUGS, V63, P769, DOI 10.2165/00003495-200363080-00004
   Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082
   Deng YT, 2020, CAMB CHINA LIBR, P1
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drucker DJ, 2020, ENDOCR REV, V41, P457, DOI 10.1210/endrev/bnaa011
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]
   Felsenstein S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108448
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gentile S, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108137
   Guan WJ, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hong KH, 2020, ANN LAB MED, V40, P351, DOI 10.3343/alm.2020.40.5.351
   Hu Y, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104371
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang I, 2020, DIABETES METAB SYND, V14, P395, DOI 10.1016/j.dsx.2020.04.018
   Kang CK, 2017, J KOREAN MED SCI, V32, P744, DOI 10.3346/jkms.2017.32.5.744
   Kawanami D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051083
   Khan A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1823-x
   Kim ES, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e142
   Kim GU, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.04.040
   Kim J, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e3
   Kim NY, 2020, DIABETES METAB J, V44, P349, DOI 10.4093/dmj.2020.0091
   Kim S, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e143
   Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e132
   Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kym S, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e153
   Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Li JY, 2020, DIABETES OBES METAB, V22, P1935, DOI 10.1111/dom.14057
   Lim JK, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e92
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meyerholz DK, 2016, AM J PATHOL, V186, P78, DOI 10.1016/j.ajpath.2015.09.014
   Monteagudo LA, 2020, ACR OPEN RHEUMATOL, V2, P276, DOI 10.1002/acr2.11135
   Moriarty LF, 2020, MMWR-MORBID MORTAL W, V69, P347, DOI 10.15585/mmwr.mm6912e3
   Oh J, 2020, HEALTH SYST REFORM, V6, DOI 10.1080/23288604.2020.1753464
   Pal R, 2020, DIABETES RES CLIN PR, V163, DOI 10.1016/j.diabres.2020.108146
   Park PG, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e140
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Pullano G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.4.2000057
   Rayman G, 2020, DIABETIC MED, V37, P1087, DOI 10.1111/dme.14316
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Romani-Perez M, 2015, ENDOCRINOLOGY, V156, P3559, DOI 10.1210/en.2014-1685
   Ruan S., 2020, LANCET INFECT DIS, DOI [10.1016/S1473-3099(20)30257-7, DOI 10.1016/S1473-3099(20)30257-7.]
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Salem ESB, 2014, AM J PHYSIOL-RENAL, V306, pF629, DOI 10.1152/ajprenal.00516.2013
   Seo SU, 2019, CURR OPIN VIROL, V37, P63, DOI 10.1016/j.coviro.2019.06.003
   Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]
   Song JY, 2020, NEW ENGL J MED, V382, P1858, DOI 10.1056/NEJMc2001801
   South AM, 2020, NAT REV NEPHROL, V16, P305, DOI 10.1038/s41581-020-0279-4
   South AM, 2019, CLIN SCI, V133, P55, DOI 10.1042/CS20171550
   Sparks MA, 2014, COMPR PHYSIOL, V4, P1201, DOI 10.1002/cphy.c130040
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Tikellis Chris, 2012, Int J Pept, V2012, P256294, DOI 10.1155/2012/256294
   Tripathy D, 2013, DIABETOLOGIA, V56, P2153, DOI 10.1007/s00125-013-2976-z
   Ursini F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01236
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang AH, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108118
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Won KC, 2020, DIABETES METAB J, V44, P211, DOI 10.4093/dmj.2020.0092
   World Health Organization, 109 WHO
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu JX, 2017, CIRC RES, V121, P43, DOI 10.1161/CIRCRESAHA.116.310509
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang J, 2018, AM J RESP CRIT CARE, V198, P509, DOI 10.1164/rccm.201712-2570OC
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang XH, 2020, BLOOD ADV, V4, P1307, DOI 10.1182/bloodadvances.2020001907
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu L, 2020, CARDIORENAL MED, V10, P470, DOI 10.1159/000510916
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594
NR 112
TC 15
Z9 17
U1 2
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD AUG
PY 2020
VL 166
AR 108303
DI 10.1016/j.diabres.2020.108303
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA NT3KU
UT WOS:000572845000019
PM 32623038
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Ahmadi, S
   Shushtari, ZJ
   Shirazikhah, M
   Biglarian, A
   Irandoost, SF
   Paykani, T
   Almasi, A
   Rajabi-Gilan, N
   Mehedi, N
   Salimi, Y
AF Ahmadi, Sina
   Shushtari, Zahra Jorjoran
   Shirazikhah, Marzieh
   Biglarian, Akbar
   Irandoost, Seyed Fahim
   Paykani, Toktam
   Almasi, Ali
   Rajabi-Gilan, Nader
   Mehedi, Nafiul
   Salimi, Yahya
TI Social Determinants of Adherence to COVID-19 Preventive Guidelines in
   Iran: A Qualitative Study
SO INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING
LA English
DT Article
DE COVID-19; adherence; preventive guidelines; social determinants;
   qualitative study
ID BEHAVIORS; KNOWLEDGE
AB Introduction Adherence to COVID-19 preventative guidelines may be influenced by a variety of factors at the individual, societal, and institutional levels. The current study sought to investigate the social factors of adherence to those preventive measures from the perspective of health professionals. Methods In October 2020, we performed qualitative research in Tehran, Iran, using the directed content analysis method. For the preparation of our interview guide and data analysis, we employed the WHO conceptual framework of socioeconomic determinants of health. Semi-structured interviews were conducted with 15 health professionals and policymakers who were chosen using a purposive sampling approach. MAXQDA-18 software was used to analyze the data. The Goba and Lincoln criteria were used to assess the quality of the results. Results There are 23 subcategories and 9 categories, which include socio-economic and political context (unstable macroeconomic environment, poor management of the pandemic, media and knowledge transfer), cultural and social values (fatalism, cultural norms, value conflicts, social customs), socio-economic positions (livelihood conditions), social capital (social cohesion, low trust), living conditions (housing conditions), occupational conditions (precarious employment), individual characteristics (demographic characteristics, personality traits, COVID-19 knowledge, and attitude), psycho-social factors (normalization of the disease, social pressure, and stigma), and health system leadership (health system problems, not taking evidence-based decisions, non-comprehensive preventive guidelines, non-operational guidelines, inadequate executive committee) were obtained. Conclusion To limit the new COVID-19 transmission, people must be encouraged to follow COVID-19 prevention instructions. Improving adherence to COVID-19 preventive guidelines necessitates dealing with the complexities of responding to social determinants of those guidelines. Increasing public health literacy and knowledge of COVID-19, informing people about the consequences of social interactions and cultural customs in the spread of COVID-19, strengthening regulatory lockdown laws, improving guarantees for adhering to preventive guidelines, providing easy access to preventive supplies, and strengthening financial support for households with precarious employment are all important.
C1 [Ahmadi, Sina; Shushtari, Zahra Jorjoran; Shirazikhah, Marzieh; Biglarian, Akbar] Univ Social Welf & Rehabil Sci, Social Determinants Hlth Res Ctr, Tehran, Iran.
   [Ahmadi, Sina] Univ Social Welf & Rehabil Sci, Dept Social Welf Management, Tehran, Iran.
   [Irandoost, Seyed Fahim] Urmia Univ Med Sci, Social Determinants Hlth Res Ctr, Clin Res Inst, Orumiyeh, Iran.
   [Paykani, Toktam] Gonabad Univ Med Sci, Social Dev & Hlth Promot Res Ctr, Gonabad, Iran.
   [Almasi, Ali; Rajabi-Gilan, Nader; Salimi, Yahya] Kermanshah Univ Med Sci, Social Dev & Hlth Promot Res Ctr, Hlth Inst, Isar Sq, Kermanshah 6719851351, Iran.
   [Mehedi, Nafiul] Shahjalal Univ Sci & Technol, Dept Social Work, Sylhet, Bangladesh.
RP Salimi, Y (corresponding author), Kermanshah Univ Med Sci, Social Dev & Hlth Promot Res Ctr, Hlth Inst, Isar Sq, Kermanshah 6719851351, Iran.
EM salimiyahya@yahoo.com
CR Abramowitz S, 2017, J HEALTH COMMUN, V22, P59, DOI 10.1080/10810730.2016.1209599
   Ahmadi S., FRONT PUBLIC HEALTH, V5, P2389
   Baloch Z, 2020, J INFECT PUBLIC HEAL, V13, P1247, DOI 10.1016/j.jiph.2020.06.034
   Benfer EA, 2021, J URBAN HEALTH, V98, P1, DOI 10.1007/s11524-020-00502-1
   Bezerra Anselmo César Vasconcelos, 2020, Ciênc. saúde coletiva, V25, P2411, DOI 10.1590/1413-81232020256.1.10792020
   Bong CL, 2020, ANESTH ANALG, V131, P86, DOI 10.1213/ANE.0000000000004846
   Brown V, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0853-y
   Canete JJO, 2021, J PUBLIC HEALTH-UK, V43, pE413, DOI 10.1093/pubmed/fdab114
   Casero-Ripolles A, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.mar.23
   Chan EYY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113869
   Chen MY., 2007, DISCOURSE, V29, P367
   Chen Q, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106380
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Doosti-Irani A., 2020, GLOBAL EPIDEMIOLOGY, V2, P1
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Fernandes N., 2020, SSRN ELECT J
   Flick U., 2009, INTRO QUALITATIVE RE, V4
   Gouin JP, 2021, CAN J PUBLIC HEALTH, V112, P17, DOI 10.17269/s41997-020-00457-5
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Hills S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10379-7
   Jimenez T, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100615
   Jones A., 2020, CITIES HLTH, P1, DOI [10.1080/23748834.2020. 1785164, DOI 10.1080/23748834.2020.1785164]
   Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3
   Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron
   Lebni JY, 2021, WOMENS HEALTH, V17, DOI 10.1177/17455065211063291
   Lebni JY, 2021, J RELIG HEALTH, V60, P2387, DOI 10.1007/s10943-021-01295-6
   Lim VW, 2021, B WORLD HEALTH ORGAN, V99, P92, DOI 10.2471/BLT.20.269142
   Lincoln YS., 2011, SAGE HDB QUALITATIVE, V4, P97
   MacIntyre CR, 2021, INT J INFECT DIS, V106, P199, DOI 10.1016/j.ijid.2021.03.056
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Mishra S, 2019, J TRANSP GEOGR, V78, P135, DOI 10.1016/j.jtrangeo.2019.05.017
   Mounesan L, 2020, IRAN J MICROBIOL, V12, P73, DOI 10.18502/ijm.v12i2.2607
   Nielsen JH, 2021, WEST EUR POLIT, V44, P1180, DOI 10.1080/01402382.2021.1909964
   Nordfjaern T., 2021, FRONT PSYCHOL, P12
   Nzaji MK, 2020, J MULTIDISCIP HEALTH, V13, P1215, DOI 10.2147/JMDH.S274944
   Ozdil K, 2021, PUBLIC HEALTH NURS, V38, P770, DOI 10.1111/phn.12898
   Plohl N, 2021, PSYCHOL HEALTH MED, V26, P1, DOI 10.1080/13548506.2020.1772988
   Reicher S, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n137
   Rogers D, 2020, INT J HOUS POLICY, V20, P177, DOI 10.1080/19491247.2020.1756599
   Salehi-Isfahani D., 2020, GULF INSIGHTS, V33, P1
   Shushtari Zahra Jorjoran, 2021, Osong Public Health Res Perspect, V12, P346, DOI 10.24171/j.phrp.2021.0180
   SoleimanvandiAzar N, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10889-4
   Speziale HS., 2011, QUALITATIVE RES NURS
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Thacker SB., 2009, EMERG INFECT DIS, V15, P360
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   World Health Organization, 2010, CONCEPTUAL FRAMEWORK
   Yoosefi Lebni Javad, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.498
   Lebni JY, 2021, INT J SOC PSYCHIATR, V67, P298, DOI 10.1177/0020764020939984
NR 49
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0046-9580
EI 1945-7243
J9 INQUIRY-J HEALTH CAR
JI Inquiry-J. Health Care Organ. Provis. Financ.
PD MAR
PY 2022
VL 59
AR 00469580221084185
DI 10.1177/00469580221084185
PG 15
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA 0F8CJ
UT WOS:000777581300001
PM 35349357
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Jia, YH
   Qi, YB
   Bai, L
   Han, YF
   Xie, ZP
   Ge, J
AF Jia, Yuehui
   Qi, Yanbo
   Bai, Li
   Han, Yunfeng
   Xie, Zhiping
   Ge, Jie
TI Knowledge-attitude-practice and psychological status of college students
   during the early stage of COVID-19 outbreak in China: a cross-sectional
   study
SO BMJ OPEN
LA English
DT Article
DE COVID-19; anxiety disorders; epidemiology
AB Objectives
   This study aimed to investigate the knowledge-attitude-practice (KAP) of Chinese college students regarding COVID-19 and evaluate their psychological status against the background of the COVID-19 outbreak.
   Design
   This was a cross-sectional study.
   Setting
   This study covered 31 provinces, municipalities and autonomous regions of mainland China.
   Participants
   The participants, who were college students with ordinary full-time status, were surveyed anonymously on their KAP regarding COVID-19 by using self-made questionnaires. In addition, the Self-Rating Anxiety Scale was used to assess the psychological status of the students.
   Methods
   The online cross-sectional study among Chinese college students was conducted in February 2020. Logistic regression analysis was used to analyse the predictors of anxiety symptoms.
   Primary outcome measures
   The level of KAP and anxiety symptoms.
   Results
   A total of 740 college students from 31 provinces, municipalities and autonomous regions in China were recruited in the survey. Among them, 139 (18.78%) revealed having anxiety. Multivariable logistic regression analysis revealed that female gender was the risk factor for anxiety symptoms with an increased 2.164-fold risk than male gender (OR=2.164, 95% CI=1.279 to 3.662). The knowledge (OR=0.825, 95% CI=0.779 to 0.873) and attitude (OR=0.822, 95% CI=0.762 to 0.887) regarding COVID-19 were protective factors against anxiety symptoms.
   Conclusions
   The level of KAP regarding COVID-19 was significantly negatively correlated with anxiety symptoms. Thus, understanding the level of KAP among college students during the early stages of major public health emergencies, such as a pandemic, is important. Such understanding plays an important role in adopting targeted health education strategies and reducing the psychological damage caused by these emergencies.
C1 [Jia, Yuehui; Han, Yunfeng; Xie, Zhiping; Ge, Jie] Qiqihar Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Qiqihar, Peoples R China.
   [Qi, Yanbo] Qiqihar Med Univ, Dept Environm Hyg, Sch Publ Hlth, Qiqihar, Peoples R China.
   [Bai, Li] Qiqihar Med Univ, Dept Hlth Management, Sch Publ Hlth, Qiqihar, Peoples R China.
RP Ge, J (corresponding author), Qiqihar Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Qiqihar, Peoples R China.
EM gejieqiao@126.com
OI Jia, Yuehui/0000-0002-0098-5941
FU Heilongjiang Department of Education [2016-KYYWF-0885]
FX This study was supported by the Heilongjiang Department of Education
   (grant no: 2016-KYYWF-0885).
CR Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092
   Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103577
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen PJ, 2020, J SPORT HEALTH SCI, V9, P103, DOI 10.1016/j.jshs.2020.02.001
   Cook JA, 2020, PSYCHIAT SERV, V71, P883, DOI 10.1176/appi.ps.71902
   Cowling BJ, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.6.2000110
   Cui YH, 2020, EUR CHILD ADOLES PSY, V29, P743, DOI 10.1007/s00787-020-01548-x
   Fan JC, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101741
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Gao HM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09961-2
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Jia R, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040620
   Jin H, 2020, J INFECT PUBLIC HEAL, V13, P897, DOI 10.1016/j.jiph.2020.05.007
   Kang CY, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102176
   KNIGHT RG, 1983, BRIT J CLIN PSYCHOL, V22, P245, DOI 10.1111/j.2044-8260.1983.tb00610.x
   Le XTT, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00824
   Li W, 2020, INT J BIOL SCI, V16, P1732, DOI 10.7150/ijbs.45120
   Lin KG, 2020, AM J PSYCHIAT, V177, P635, DOI 10.1176/appi.ajp.2020.20040374
   Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8
   Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Soh HL, 2020, SLEEP MED, V75, P315, DOI 10.1016/j.sleep.2020.08.020
   Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055
   Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462
   Tee ML, 2020, J AFFECT DISORDERS, V277, P379, DOI 10.1016/j.jad.2020.08.043
   Tran BX, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.564452
   Tran BX, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565153
   Wang CY, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.569981
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
   Xiao X, 2020, J AFFECT DISORDERS, V274, P405, DOI 10.1016/j.jad.2020.05.081
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
   Yan B, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102205
   Yang JZ, 2020, BRAIN BEHAV IMMUN, V87, P113, DOI 10.1016/j.bbi.2020.04.075
   Yao H, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102015
   Yousaf MA, 2020, SOC WORK PUBLIC HLTH, V35, P569, DOI 10.1080/19371918.2020.1806983
   Zhang H, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039711
   Zhang MWB, 2017, TECHNOL HEALTH CARE, V25, P163, DOI 10.3233/THC-161261
   Zhou JY, 2020, AM J PSYCHIAT, V177, P574, DOI 10.1176/appi.ajp.2020.20030304
   Zhou SJ, 2020, EUR CHILD ADOLES PSY, V29, P749, DOI 10.1007/s00787-020-01541-4
   Zhu Z, 2020, J PSYCHIATR RES, V129, P1, DOI 10.1016/j.jpsychires.2020.05.026
NR 45
TC 4
Z9 4
U1 5
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PY 2021
VL 11
IS 2
AR e045034
DI 10.1136/bmjopen-2020-045034
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA QR6XH
UT WOS:000625358900002
PM 33550266
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Fong, JH
   Koay, SMA
   Foo, EHW
   Mah, YL
   Eu, WC
AF Fong, Jing Hong
   Koay, Sabrina Mei Ann
   Foo, Edwin Hsiang Win
   Mah, Yew Leng
   Eu, Wei Cheong
TI Coronavirus Disease 2019 (COVID-19) and Ecchymosis: A Case Report
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE covid and skin; pericarditis; non allergic rash; rash; vasculopathy;
   cutaneous manifestation; covid 19; ecchymosis
ID MANIFESTATIONS
AB Extrapulmonary symptoms such as cutaneous manifestations are increasingly being reported in coronavirus disease 2019 (COVID-19) infection. The rashes of COVID-19 are usually livedo and purpuric and have been classified into six main patterns. This is the first case reported in Malaysia of ecchymosis associated with COVID-19 occurring on a patient without prior history of coagulopathy. The report of this rare clinical association could have a potential pathophysiological implication and contributes to the current data of the cutaneous manifestations of COVID-19. Further knowledge regarding these cutaneous lesions could help in the diagnosis of COVID-19 related complications and earlier management.
C1 [Fong, Jing Hong] North West Reg Hosp, Dept Emergency Med, Burnie, Tas, Australia.
   [Fong, Jing Hong; Koay, Sabrina Mei Ann; Mah, Yew Leng; Eu, Wei Cheong] Penang Gen Hosp, Dept Orthopaed & Traumatol, George Town, Malaysia.
   [Foo, Edwin Hsiang Win] Hosp Sultanah Bahiyah, Dept Orthopaed & Traumatol, Dept Internal Med, Alor Setar, Malaysia.
RP Fong, JH (corresponding author), North West Reg Hosp, Dept Emergency Med, Burnie, Tas, Australia.; Fong, JH (corresponding author), Penang Gen Hosp, Dept Orthopaed & Traumatol, George Town, Malaysia.
EM adrianfong22@gmail.com
CR Agnihothri R, 2021, DERMATOL CLIN, V39, P487, DOI 10.1016/j.det.2021.05.006
   Daneshgaran G, 2020, AM J CLIN DERMATOL, V21, P627, DOI 10.1007/s40257-020-00558-4
   Freeman EE, 2020, J AM ACAD DERMATOL, V83, P1118, DOI 10.1016/j.jaad.2020.06.1016
   Genovese G, 2021, DERMATOLOGY, V237, P1, DOI 10.1159/000512932
   Gisondi P, 2021, DERMATOLOGY THER, V11, P695, DOI 10.1007/s13555-021-00526-8
   Rahimi H, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1236520
   Shams S, 2021, DERMATOL THER, V34, DOI 10.1111/dth.14788
   Singh H, 2021, ADV WOUND CARE, V10, P51, DOI 10.1089/wound.2020.1309
NR 8
TC 0
Z9 0
U1 0
U2 0
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD MAR 19
PY 2022
VL 14
IS 3
AR e23326
DI 10.7759/cureus.23326
PG 5
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA 0A6JB
UT WOS:000774057300016
OA gold
DA 2022-04-20
ER

PT J
AU Shankar, A
   Varadan, B
   Ethiraj, D
   Sudarsanam, H
   Hakeem, AR
   Kalyanasundaram, S
AF Shankar, Abhinaya
   Varadan, Baskaran
   Ethiraj, Dillibabu
   Sudarsanam, Hemanth
   Hakeem, Abdul Rahman
   Kalyanasundaram, Srinivasan
TI Systemic arterio-venous thrombosis in COVID-19: A pictorial review
SO WORLD JOURNAL OF RADIOLOGY
LA English
DT Review
DE COVID-19; Coronavirus; Thrombus; Arterial; Aorta; Tomography
ID ACUTE MESENTERIC ISCHEMIA; ANGIOGRAPHY; STROKE
AB Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Systemic complications include cardiovascular, neurological, hepatic, renal and altered coagulation. Derangements in haemostasis with SARS-CoV-2 infection have been termed COVID-19 associated coagulopathy (CAC). CAC is postulated to be one of the significant causes for sudden deaths in this pandemic, with infection of endothelial cells and subsequent endotheliitis through angiotensin-converting enzyme-2 receptors playing a key role in the pathogenesis. In this pictorial review, we describe the imaging findings in a multitude of extrapulmonary arterial (aorta, cerebral, mesenteric, renal and peripheral arterial system) and venous thrombotic phenomena detected on contrast-enhanced computed tomography and magnetic resonance imaging of COVID-19 patients which could not be attributed to any other causes. Knowledge of incidence of these complications, lowering the threshold for diagnostic imaging in symptomatic patients and timely radiological detection can play a vital role in subsequent management of these critically ill patients.
C1 [Shankar, Abhinaya; Varadan, Baskaran; Ethiraj, Dillibabu; Sudarsanam, Hemanth; Kalyanasundaram, Srinivasan] Dr Rela Inst & Med Ctr, Dept Radiol, 7 CLC Works Rd, Chennai 600044, Tamil Nadu, India.
   [Hakeem, Abdul Rahman] Leeds Teaching Hosp NHS Trust, HPB Surg & Liver Transplantat, Leeds LS9 7TF, W Yorkshire, England.
RP Kalyanasundaram, S (corresponding author), Dr Rela Inst & Med Ctr, Dept Radiol, 7 CLC Works Rd, Chennai 600044, Tamil Nadu, India.
CR Conte SM, 2018, HEART LUNG CIRC, V27, P427, DOI 10.1016/j.hlc.2017.10.014
   Cumurciuc R, 2005, J NEUROL NEUROSUR PS, V76, P1084, DOI 10.1136/jnnp.2004.056275
   Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254
   de Barry Olivier, 2020, Radiol Case Rep, V15, P1054, DOI 10.1016/j.radcr.2020.04.055
   Di Minno A, 2020, SEMIN THROMB HEMOST, V46, P763, DOI 10.1055/s-0040-1715456
   Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20
   Ferro JM, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0523-2
   Fleischmann D, 2006, J VASC INTERV RADIOL, V17, P3, DOI 10.1097/01.RVI.0000191361.02857.DE
   Fugate JE, 2014, LANCET INFECT DIS, V14, P869, DOI 10.1016/S1473-3099(14)70755-8
   Garzelli L, 2020, AM J ROENTGENOL, V215, P29, DOI 10.2214/AJR.19.22625
   Goldman IA, 2020, RADIOLOGY, V297, pE263, DOI 10.1148/radiol.2020202348
   Hekimian G, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02931-5
   Hess DC, 2020, TRANSL STROKE RES, V11, P322, DOI 10.1007/s12975-020-00818-9
   Iba T, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03077-0
   John S, 2020, AM J NEURORADIOL, V41, P2263, DOI 10.3174/ajnr.A6799
   Kaminetzky Mark, 2020, Radiol Cardiothorac Imaging, V2, pe200308, DOI 10.1148/ryct.2020200308
   Kawashima A, 2000, RADIOGRAPHICS, V20, P1321, DOI 10.1148/radiographics.20.5.g00se141321
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9
   Mezalek ZT, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620948137
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Navas-Campo R, 2020, RADIOLOGIA-MADRID, V62, P336, DOI 10.1016/j.rx.2020.02.001
   Nuzzo A, 2017, REV MED INTERNE, V38, P592, DOI 10.1016/j.revmed.2017.01.018
   Parry AH, 2020, ACAD RADIOL, V27, P1190, DOI 10.1016/j.acra.2020.05.016
   Poillon G, 2021, J NEURORADIOLOGY, V48, P121, DOI 10.1016/j.neurad.2020.05.003
   Rotzinger DC, 2020, THROMB RES, V190, P58, DOI 10.1016/j.thromres.2020.04.011
   Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca
   Sena G, 2020, J VASC SURG, V72, P758, DOI 10.1016/j.jvs.2020.04.489
   Ullah Waqas, 2020, JACC Case Rep, V2, P1379, DOI 10.1016/j.jaccas.2020.04.008
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Woehl Bastien, 2020, JACC Case Rep, V2, P1397, DOI 10.1016/j.jaccas.2020.06.003
   Xie Yuanliang, 2020, Radiol Cardiothorac Imaging, V2, pe200067, DOI 10.1148/ryct.2020200067
   Yang SY, 2017, J THORAC CARDIOV SUR, V153, P791, DOI 10.1016/j.jtcvs.2016.12.015
NR 33
TC 1
Z9 1
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1949-8470
J9 WORLD J RADIOL
JI World J. Radiol.
PD JAN 28
PY 2021
VL 13
IS 1
DI 10.4329/wjr.v13.i1.19
PG 11
WC Radiology, Nuclear Medicine & Medical Imaging
WE Emerging Sources Citation Index (ESCI)
SC Radiology, Nuclear Medicine & Medical Imaging
GA QF5VN
UT WOS:000616961900002
PM 33574991
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kucirka, LM
   Norton, A
   Sheffield, JS
AF Kucirka, Lauren M.
   Norton, Alexandra
   Sheffield, Jeanne S.
TI Severity of COVID-19 in pregnancy: A review of current evidence
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Review
DE clinical course; COVID-19; epidemiology; outcomes; pregnancy
ID ACUTE RESPIRATORY SYNDROME; DISEASE; WOMEN; INFECTION; OUTCOMES; STATES
AB Coronavirus disease 19 (COVID-19) has recently emerged as a major threat to human health. Infections range from asymptomatic to severe (increased respiratory rate, hypoxia, significant lung involvement on imaging) or critical (multi-organ failure or dysfunction or respiratory failure requiring mechanical ventilation or high-flow nasal cannula). Current evidence suggests that pregnancy women are at increased risk of severe disease, specifically the need for hospitalization, ICU admission, and mechanical ventilation, and the already complex management of infection with an emerging pathogen may be further complicated by pregnancy. The goal of this review is to provide an overview of what is known about the clinical course of COVID-19 in pregnancy, drawing on (a) experience with other coronaviruses such as SARS and MERS, (b) knowledge of immunologic and physiologic changes in pregnancy and how these might impact infection with SARS-CoV-2, and (c) the current literature reporting outcomes in pregnant women with SARS-CoV-2. We also briefly summarize considerations in management of severe COVID-19 in pregnancy.
C1 [Kucirka, Lauren M.; Norton, Alexandra; Sheffield, Jeanne S.] Johns Hopkins Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21231 USA.
RP Kucirka, LM (corresponding author), Johns Hopkins Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21231 USA.
EM lauren@jhmi.edu
CR Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8
   Al-Tawfiq JA, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101641
   Algarroba GN, 2020, AM J OBSTET GYNECOL, V223, P275, DOI 10.1016/j.ajog.2020.05.023
   [Anonymous], 2020, INT GUID COVID 19 PE
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Blanco JL, 2020, LANCET HIV, V7, pE314, DOI 10.1016/S2352-3018(20)30111-9
   Blitz MJ, 2020, AM J OBSTET GYNECOL, V223, P290, DOI 10.1016/j.ajog.2020.05.004
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   Breslin N, 2020, AM J OBSTET GYNECOL, V2, P100118, DOI [DOI 10.1016/J.AJOGMF.2020.100118, 10.1016/j.ajogmf.2020.100118]
   Casadevall A, 2020, JAMA-J AM MED ASSOC, V324, P455, DOI 10.1001/jama.2020.10218
   CDC, 2020, COR DIS 2019 COVID 1
   CDC, 2020, COR DIS 2019 COV 19
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Collin J, 2020, ACTA OBSTET GYN SCAN, V99, P819, DOI 10.1111/aogs.13901
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   Doria M, 2020, EUR J OBSTET GYN R B, V250, P261, DOI 10.1016/j.ejogrb.2020.05.029
   Ellington S, 2020, MMWR-MORBID MORTAL W, V69, P769, DOI 10.15585/mmwr.mm6925a1externalicon
   Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Govind A, 2020, EUR J OBSTET GYN R B, V251, P272, DOI 10.1016/j.ejogrb.2020.05.004
   Gujski M, 2020, MED SCI MONITOR, V9
   Hantoushzadeh S, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.030
   Jamieson DJ, 2005, CLIN PERINATOL, V32, P765, DOI 10.1016/j.clp.2005.04.008
   Kayem G, 2020, J GYNECOL OBSTET HUM, V49, DOI 10.1016/j.jogoh.2020.101826
   Khan S, 2020, CLIN MICROBIOL INFEC, V26, P788, DOI 10.1016/j.cmi.2020.03.034
   Knight M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2107
   Koumoutsea EV, 2020, J THROMB HAEMOST, V18, P1648, DOI 10.1111/jth.14856
   Lamouroux A, 2020, AM J OBSTET GYNECOL, V223, P91, DOI 10.1016/j.ajog.2020.04.039
   Liao J, 2020, INT J GYNECOL OBSTET, V150, P53, DOI 10.1002/ijgo.13188
   Liu H, 2020, J REPROD IMMUNOL, V139, DOI 10.1016/j.jri.2020.103122
   London V, 2020, AM J PERINAT, V37, P991, DOI 10.1055/s-0040-1712164
   Longman RE, 2007, CURR OPIN OBSTET GYN, V19, P120, DOI 10.1097/GCO.0b013e328028fdc7
   Mahevas M, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1844, 10.1136/bmj.m2328]
   Maxwell C, 2017, J OBSTET GYNAECOL CA, V39, pE130, DOI 10.1016/j.jogc.2017.04.024
   Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0
   Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014
   Oxford CM, 2009, CLIN OBSTET GYNECOL, V52, P611, DOI 10.1097/GRF.0b013e3181c11edf
   Penfield CA, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100133
   Pereira A, 2020, ACTA OBSTET GYN SCAN, V99, P839, DOI 10.1111/aogs.13921
   Pierce-Williams RAM, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100134
   Qiao J, 2020, LANCET, V395, P760, DOI 10.1016/S0140-6736(20)30365-2
   Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017
   Reinhard G, 1998, BIOCHEM BIOPH RES CO, V245, P933, DOI 10.1006/bbrc.1998.8549
   Schwartz DA, 2020, VIRUSES, V12, P1
   Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089
   Tang W, 2020, HYDROXYCHLOROQUINE P, DOI [DOI 10.1101/2020.04.10.20060558, 10.1101/2020.04.10.20060558]
   Vintzileos WS, 2020, AM J OBSTET GYNECOL, V223, P284, DOI 10.1016/j.ajog.2020.04.024
   Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6
   WHO, 2015, UPD 49 SARS CAS FAT
   WHO, 2020, MIDDL E RESP SYNDR C
   Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019
   World Health Organization, COR DIS COVID 19 DAS
   Wu CC, 2020, VIROL SIN, V35, P305, DOI 10.1007/s12250-020-00227-0
   Xu QC, 2020, INT J INFECT DIS, V95, P376, DOI 10.1016/j.ijid.2020.04.065
   Yan J, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.014
   Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548
   Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867
   Zhang Jian-ping, 2003, Zhonghua Fu Chan Ke Za Zhi, V38, P516
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2233, DOI 10.1093/cid/ciaa408
NR 60
TC 16
Z9 16
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD NOV
PY 2020
VL 84
IS 5
SI SI
AR e13332
DI 10.1111/aji.13332
EA OCT 2020
PG 7
WC Immunology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Reproductive Biology
GA OU1NI
UT WOS:000574757600001
PM 32865300
OA Bronze
DA 2022-04-20
ER

PT J
AU Ullah, I
   Murtaza, BN
   Mumtaz, M
   Tabassum, S
   Khan, AUD
   Mushtaq, R
   Qasim, M
   Khan, MF
   Malik, A
AF Ullah, Inam
   Murtaza, Bibi Nazia
   Mumtaz, Muhammad
   Tabassum, Sadia
   Khan, Aziz ud Din
   Mushtaq, Rubina
   Qasim, Muhammad
   Khan, Muhammad Fiaz
   Malik, Arif
TI Socio-economic effects of COVID-19 - a study of the University students
   and teachers in Pakistan
SO ADVANCEMENTS IN LIFE SCIENCES
LA English
DT Article
DE Coronavirus; COVID-19; Knowledge; Socio-economic; Pakistan
ID OUTBREAK; EPIDEMIC; IMPACT
AB Background: Coronavirus Disease-2019 (COVID-19) has appeared as a deadly pandemic affecting most of the countries across the world. The disease has caught humanity unprepared; therefore, there has been a lack of awareness about the causes, and transmission and mortality rates. It has also affected the overall socioeconomics from individual to worldwide levels. COVID-19 is an unprecedented and first-time challenge for Pakistan and a lockdown imposed by the Government of Pakistan has further devastated the economy of the country. This online survey was conducted to know the effects of the Covid-19 pandemic on the social life and economic status of the people of Pakistan. In this article, we mainly focused on teachers and students from different Universities of Pakistan for data generation because they can provide better information due to the use of modern technologies as a source of information.
   Methods: An online questionnaire survey covering 11 parameters including age, gender, employment status, mortality rate, education, marital status and, information about the pathogen responsible for the disease was filled by 1260 individuals from Pakistan.
   Results: The results obtained show that 56.6% of the responders were males,43.4% were females, 59.9% were unmarried, 37.7% were graduate students and, 48.7% unemployed. Most of the responders (55.6%) said that COVID-19 negatively affected the jobs of the people. We found (93%) of the responders with good knowledge about COVID-19.
   Conclusion: We conclude from the results that most of the responders were males, educated and they knew the pathogenic effect of the COVID-19 virus on humans. These results also show that the disease has drastically affected the economy and social life of the people of Pakistan.
C1 [Ullah, Inam; Mushtaq, Rubina; Malik, Arif] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore 54590, Pakistan.
   [Murtaza, Bibi Nazia] Univ Haripur, Dept Zool, Haripur 22620, Pakistan.
   [Mumtaz, Muhammad] Univ Haripur, Dept Management Sci, Haripur 22620, Pakistan.
   [Tabassum, Sadia; Khan, Muhammad Fiaz] Hazara Univ, Dept Zool, Garden Campus, Mansehra 21300, Pakistan.
   [Khan, Aziz ud Din] Hazara Univ, Dept Genet, Garden Campus, Mansehra 21300, Pakistan.
   [Ullah, Inam; Qasim, Muhammad] Govt Coll Univ Faisalabad, Dept Zool, Faisalabad, Pakistan.
   Univ Haripur, Dept Med Lab Technol, Mansehra 22620, Pakistan.
RP Ullah, I (corresponding author), Univ Lahore, Inst Mol Biol & Biotechnol, Lahore 54590, Pakistan.
EM inamgenetics@gmail.com
CR Ahmed, 2020, PUBLIC KNOWLEDGE PRA
   Ayittey FK, 2020, J MED VIROL, V92, P473, DOI 10.1002/jmv.25706
   Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117
   Bhatti R, 2014, LIB PHILOS PRACTICE, V3, P1
   Blustein DL, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103436
   Borjas GJ, 2020, RWP20008 HK, DOI [10.2139/ssrn.3572329, DOI 10.2139/SSRN.3572329]
   Buchanan L, 2020, NEW YORK TIMES, P1
   Burgen S, 2020, GUARDIAN, P1
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chhachhar AR, 2013, J BASIC APPL SCI RES, V3, P31
   De Vos Jonas, 2020, Transp Res Interdiscip Perspect, V5, P100121, DOI 10.1016/j.trip.2020.100121
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Didar-Ul Islam SM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04399
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   Glenza J., 2020, GUARDIAN, P10
   Griffiths, 2020, J CONCURRENT DISORDE, V2, P58, DOI [10.1177/2333721420966081, DOI 10.54127/WCIC8036]
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Hayat K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103347
   Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1
   Kawohl W, 2020, LANCET PSYCHIAT, V7, P389, DOI 10.1016/S2215-0366(20)30141-3
   Ko CH, 2006, PSYCHIAT CLIN NEUROS, V60, P397, DOI 10.1111/j.1440-1819.2006.01522.x
   Kundu S, 2020, KNOWLEDGE ATTITUDES
   Maital S., 2020, SAMUEL NEAMAN I NATL, V2020, P1
   Mamun MA, 2019, ASIAN J PSYCHIATR, V40, P46, DOI 10.1016/j.ajp.2019.01.017
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Montenovo L., 2020, DETERMINANTS DISPARI
   Mumtaz M, 2021, INT J SOC PSYCHIATR, V67, P303, DOI 10.1177/0020764020954487
   Nelson LM, 2020, JAMA INTERN MED, V180, P1020, DOI 10.1001/jamainternmed.2020.1369
   Pappas G, 2009, CLIN MICROBIOL INFEC, V15, P743, DOI 10.1111/j.1469-0691.2009.02947.x
   Peng EYC, 2010, J FORMOS MED ASSOC, V109, P524, DOI 10.1016/S0929-6646(10)60087-3
   Plaza S, 2019, MIGRATION REMITTANCE, P31
   Reznik A, 2021, INT J MENT HEALTH AD, V19, P1903, DOI 10.1007/s11469-020-00283-3
   Salik KM., 2020, REMITTANCES COVID 19
   Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500
   Shultz JM, 2015, JAMA-J AM MED ASSOC, V313, P567, DOI 10.1001/jama.2014.17934
   Taha SA, 2014, STRESS HEALTH, V30, P149, DOI 10.1002/smi.2505
   UNDP, 2020, SOC IMP OF COV 19
   Vesoulis Abby, 2020, TIME
   Wang LS, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138394
   Woodward Alex, 2020, INDEPENDENT
   World Health Organization, 2020, WHO COR DIS COVID 19
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
   Yeung NCY, 2017, EMERG INFECT DIS, V23, P813, DOI 10.3201/eid2305.160768
   Zhou M, 2020, FRONT MED-PRC, V14, P126, DOI 10.1007/s11684-020-0767-8
NR 44
TC 0
Z9 0
U1 0
U2 0
PU CENTRE EXCELLENCE MOLECULAR BIOLOGY-CEMB
PI LAHORE
PA 87-WEST BANK, CANAL RD, LAHORE, 00000, PAKISTAN
SN 2310-5380
J9 ADV LIFE SCI-PAK
JI Advan. Life Sci.
PD DEC
PY 2021
VL 8
IS 4
BP 368
EP 373
PG 6
WC Biology
WE Emerging Sources Citation Index (ESCI)
SC Life Sciences & Biomedicine - Other Topics
GA YY4BO
UT WOS:000754734800009
DA 2022-04-20
ER

PT J
AU Shetty, KV
   Sonkar, S
   Mahadevaiah, M
AF Shetty, Kannappa V.
   Sonkar, Suruchi
   Mahadevaiah, Mahesh
TI Technology-Based PsychoSocial Management for Psychological Distress Due
   to Stigma Associated with COVID-19: A Case Study from North Karnataka
SO JOURNAL OF MENTAL HEALTH AND HUMAN BEHAVIOUR
LA English
DT Article
DE COVID-19 positive; family intervention; management of stigma;
   psychoeducation for rural population; treatment of psychological
   distress
ID INTERVENTION
AB COVID-19 is associated with a significant distress and stigma. Due to the nature of the disease, it is difficult to conduct counseling and therapy without taking significant precautions such as wearing a complete personal protective equipment kit which impedes with rapport and dampens the speech which is quite essential for therapy. Herewith, we present a case where we used technology-based interventions, course, and outcome. Although the results of this case study cannot be generalized, few factors clearly stand out in the treatment of psychological distress among COVID-19-positive clients - psychoeducation, supportive therapy components of Cognitive Behavioral Therapy (CBT), and management of expressed emotion may play a key role in dealing with rural population. Family interventions were used to facilitate healthy family communication pattern (using technology) toward healthier involvement, connectedness aid client's recovery in the aftermath and acceptance of COVID-19 diagnosis. Intervention should also equip and empower client and family to deal with stigma and helplessness through clarifying misconceptions, providing knowledge, and enhancing agency or mastery over circumstances. These can serve as guidelines during treatment of psychological distress among COVID-19-positive clients and their families.
C1 [Shetty, Kannappa V.] Dharwad Inst Mental Hlth & Neurosci, Dept Psychiat Social Work, Dharwad, Karnataka, India.
   [Sonkar, Suruchi] Dharwad Inst Mental Hlth & Neurosci, Dept Clin Psychol, Dharwad, Karnataka, India.
   [Mahadevaiah, Mahesh] Dharwad Inst Mental Hlth & Neurosci, Dept Psychiat, Dharwad, Karnataka, India.
RP Sonkar, S (corresponding author), Dharwad Inst Mental Hlth & Neurosci, Dept Clin Psychol, Dharwad, Karnataka, India.
EM suruchisonkar.phd@gmail.com
CR Austin LN, 1948, J SOC CASEW, V29, P203, DOI 10.1177/104438944802900601
   Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9
   Chopra K K, 2020, Indian J Tuberc, V67, P284, DOI 10.1016/j.ijtb.2020.07.012
   Devaramane V, 2011, ASIAN J PSYCHIATR, V4, P183, DOI 10.1016/j.ajp.2011.06.004
   Earnshaw VA, 2020, STIGMA HEALTH, V5, P390, DOI 10.1037/sah0000255
   HARRISON CA, 1992, AUST NZ J PSYCHIAT, V26, P408, DOI 10.3109/00048679209072063
   Hart JL, 2020, J PAIN SYMPTOM MANAG, V60, pE93, DOI 10.1016/j.jpainsymman.2020.04.017
   Hooley JM, 1998, BEHAV THER, V29, P631
   Kulhara P, 2009, ACTA PSYCHIAT SCAND, V119, P472, DOI 10.1111/j.1600-0447.2008.01304.x
   Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Salins N, 2020, INDIAN J CRIT CARE M, V24, P435, DOI 10.5005/jp-journals-10071-23400
NR 12
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0971-8990
EI 2543-1897
J9 J MENT HEALTH HUM BE
JI J. Mental Health Human Behav.
PD JAN-JUN
PY 2021
VL 26
IS 1
BP 36
EP 39
DI 10.4103/jmhhb.jmhhb_225_20
PG 4
WC Psychiatry
WE Emerging Sources Citation Index (ESCI)
SC Psychiatry
GA TY5EW
UT WOS:000683808600006
OA gold
DA 2022-04-20
ER

PT J
AU Levine, L
   Kay, A
   Shapiro, E
AF Levine, Livia
   Kay, Avi
   Shapiro, Ephraim
TI The anxiety of not knowing: Diagnosis uncertainty about COVID-19
SO CURRENT PSYCHOLOGY
LA English
DT Article; Early Access
DE Anxiety; COVID-19; Diagnosis; Testing; Uncertainty
AB The emergence and swift global spread of COVID-19 brought increased anxiety worldwide (Santabarbara et al. (Progress in Neuro-Psychopharmacology & Biological Psychiatry, 109, 110207, 2021)). Research regarding the COVID-19 outbreak addressed factors that contribute to anxiety people experienced as they tried to handle the changes in their lives associated with COVID-19 (Holmes et al. (The Lancet Psychiatry, 7(6), 547-560, 2020)). This paper focuses on diagnosis uncertainty as a particular source of anxiety. We use self-reported anxiety measures to understand how different stressors, and particularly how being sick or being unsure if one or one's close friends or relatives are sick, relate to overall anxiety levels. Five-hundred and thirty-three participants from a country with a stringent COVID-19 testing policy were surveyed in the spring of 2020 on various aspects of their anxiety and risk for depression, as well as on whether they or their friends or family had COVID-19. Analysis of survey results found that anxiety related to uncertainty regarding whether the survey responder or their friends or family were carrying COVID-19 may be even greater than fear of the virus itself. This paper discusses directional issues related to this finding and offers policy implications for decreasing anxiety during pandemics for certain types of communities. In addition to the main findings regarding diagnosis uncertainty and anxiety, this paper's results also indicate the importance of providing participants with an option for "not sure" in closed questions and imply the increased knowledge that can be gained by analyzing an unsure response independently of "yes" or "no".
C1 [Levine, Livia; Kay, Avi] Jerusalem Coll Technol, Dept Business Management, Jerusalem, Israel.
   [Shapiro, Ephraim] Ariel Univ, Dept Hlth Syst Management, Ariel, Israel.
RP Levine, L (corresponding author), Jerusalem Coll Technol, Dept Business Management, Jerusalem, Israel.
EM LiviaLevine@gmail.com
OI Kay, Avi/0000-0002-0091-6401; Shapiro, Ephraim/0000-0001-9692-7430
CR [Anonymous], 2020, WORLDOMETER REAL TIM
   Averbuch E., 2021, FACTS APPROACHES HLT
   Canady VA., 2020, MENTAL HLTH WEEKLY, V30, P3
   Chakraborty N, 2020, PROG NEUROL PSYCHIAT, V24, P21, DOI 10.1002/pnp.666
   Clark D., 2020, PSYCHOL TODAY
   de Bruijn A. L., 2020, WHY DID ISRAELIS COM
   Durodie B, 2020, PSYCHOL TRAUMA-US, V12, pS61, DOI 10.1037/tra0000713
   Forte G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061802
   Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Gavi.org, 2020, DOES COVID 19 COMP P
   Gheihman G, 2020, MED TEACH, V42, P493, DOI 10.1080/0142159X.2019.1579308
   Hofstede, 2020, COUNTR COMP TOOL HOF
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Jahrami M, 2020, INT J APPL PSYCHOL, V10, P21
   Jefferson T, 2020, COVID 19 WHAT PROPOR
   Lee HKK, 2003, EMERG INFECT DIS, V9, P1491, DOI 10.3201/eid0911.030401
   Limandri BJ, 2020, J PSYCHOSOC NURS MEN, V58, P7, DOI 10.3928/02793695-20200616-02
   Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258
   Mitchell AJ, 2016, BJPSYCH OPEN, V2, P127, DOI 10.1192/bjpo.bp.115.001685
   Nakase-Richardson R., 2020, ARCH PHYS MED REHABI
   Nephawe N., 2021, AGRARIS J AGRIBUSINE, V7, P11
   Newby JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236562
   Nikcevic AV, 2021, J AFFECT DISORDERS, V279, P578, DOI 10.1016/j.jad.2020.10.053
   Nogrady B, 2020, NATURE, V587, P534, DOI 10.1038/d41586-020-03141-3
   Noor FM, 2020, J COMMUN HEALTH, V45, P1270, DOI 10.1007/s10900-020-00920-x
   Paolini D, 2020, CURR PSYCHOL, DOI 10.1007/s12144-020-01141-0
   Romiti GF, 2021, J GEN INTERN MED, V36, P3562, DOI 10.1007/s11606-021-06809-2
   Rowthorn R, 2020, OXFORD REV ECON POL, V36, pS38, DOI 10.1093/oxrep/graa030
   Rutter H, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3349
   Sahin MK, 2020, J COMMUN HEALTH, V45, P1168, DOI 10.1007/s10900-020-00921-w
   Santabarbara J, 2021, PROG NEURO-PSYCHOPH, V109, DOI 10.1016/j.pnpbp.2020.110207
   Sauer KS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197241
   Scarella TM, 2016, PSYCHOSOMATICS, V57, P200, DOI 10.1016/j.psym.2015.10.006
   Scarinci IC, 2021, J COMMUN HEALTH, V46, P932, DOI 10.1007/s10900-021-00976-3
   Schwartz SH, 2000, J PERS, V68, P309, DOI 10.1111/1467-6494.00099
   SCHWARTZ SH, 2000, CULTURE SUBJECTIVE W, P219
   Seabold S., 2010, P 9 PYTH SCI C, P92, DOI DOI 10.25080/MAJORA-92BF1922-011
   Shapiro E, 2021, J RELIG HEALTH, V60, P81, DOI 10.1007/s10943-020-01131-3
   Shapiro E, 2020, PSYCHOL TRAUMA-US, V12, P499, DOI 10.1037/tra0000864
   Shuwiekh HAM, 2020, CURR PSYCHOL, DOI 10.1007/s12144-020-01148-7
   Sun L, 2019, JAMA ONCOL, V5, P1718, DOI 10.1001/jamaoncol.2019.3323
   Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390
   Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8
   Wong TW, 2007, STRESS HEALTH, V23, P31, DOI 10.1002/smi.1116
   Yu H, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02826-3
NR 47
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1046-1310
EI 1936-4733
J9 CURR PSYCHOL
JI Curr. Psychol.
DI 10.1007/s12144-022-02783-y
EA FEB 2022
PG 8
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA YS5AD
UT WOS:000750688700001
PM 35132299
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Mostafa, AS
   Abdalbaky, A
   Fouda, EM
   Shaaban, HH
   Elnady, HG
   Hassab-Allah, M
   Rashad, MM
   El Attar, MM
   Alfishawy, M
   Hussien, SM
   Hamed, T
   Hamed, DH
   Sarhan, DT
AF Mostafa, Abla S.
   Abdalbaky, Ashraf
   Fouda, E. M.
   Shaaban, Hala H.
   Elnady, Hala G.
   Hassab-Allah, Magda
   Rashad, Mohamed M.
   El Attar, Mona M.
   Alfishawy, Mostafa
   Hussien, Shahenaz M.
   Hamed, Tarek
   Hamed, Dina H.
   Sarhan, Dina T.
TI Practical approach to COVID-19: an Egyptian pediatric consensus
SO EGYPTIAN PEDIATRIC ASSOCIATION GAZETTE
LA English
DT Review
DE COVID-19; Pandemic; Egyptian; Health care worker; Breastfeeding;
   Pediatrics
AB Background: Outbreak of a novel corona virus was reported in China on December 2019. Sooner, a global spread was reported and WHO announced a public health emergency of international concern and then declared it as a pandemic. Egypt announced the first case on February 14, 2020, and since that time, cases are increasing.
   Main body: There is increasing need to simplify the practical approach for pediatricians and other health care workers in a step wise manner; how to deal with COVID-19 cases, how to care for the newborn babies as regards to breastfeeding, and how to ensure safety of health care workers assess their risk of infection and management accordingly. A national practical approach guideline was prepared including case definition, diagnosis, and management of pediatric COVID-19 suspected and confirmed cases in an algorithmic pattern.
   Conclusion: Up to the current knowledge, this is a simple and practical guidance for clinical management of children during the current pandemic.
C1 [Mostafa, Abla S.] Cairo Univ, Pediat Pulmonol, Fac Med, Giza, Egypt.
   [Abdalbaky, Ashraf] Ain Shams Univ, Pediat, Fac Med, Cairo, Egypt.
   [Fouda, E. M.] Ain Shams Univ, Pediat Pulmonol, Fac Med, Cairo, Egypt.
   [Shaaban, Hala H.] Cairo Univ, Pediat Pulmonol & Allergy, Fac Med, Giza, Egypt.
   [Elnady, Hala G.] Natl Res Ctr, Div Med, Child Hlth, Giza, Egypt.
   [Hassab-Allah, Magda] Al Azhar Univ, Pediat, Fac Med, Cairo, Egypt.
   [Rashad, Mohamed M.] Benha Univ, Pediat & Pediat Pulmonol, Fac Med, Banha, Egypt.
   [El Attar, Mona M.; Hamed, Dina H.] Cairo Univ, Pediat, Fac Med, Giza, Egypt.
   [Alfishawy, Mostafa] Aswan Heart Ctr, Infect Dis, Aswan, Egypt.
   [Hussien, Shahenaz M.] Azher Univ, Pediat, Fac Med, Cairo, Egypt.
   [Hamed, Tarek] Zagazig Univ, Dept Pediat, Fac Med, Zagazig, Egypt.
   [Sarhan, Dina T.] Zagazig Univ, Univ Hosp Children, Dept Pediat, Fac Med, Zagazig, Al Sharkiya Gov, Egypt.
RP Sarhan, DT (corresponding author), Zagazig Univ, Univ Hosp Children, Dept Pediat, Fac Med, Zagazig, Al Sharkiya Gov, Egypt.
EM dinatawfek7@yahoo.com
RI Alfishawy, Mostafa/AAF-6398-2021; Hossam, Dina/L-1407-2019
OI Alfishawy, Mostafa/0000-0002-9153-3237; Hossam, Dina/0000-0002-6927-5294
CR [Anonymous], 2020, MAN PROT COVID 19 PA
   [Anonymous], DAT EG AR REP
   [Anonymous], 2020, HLTH SYST TREATM GUI
   [Anonymous], 2020, COVID 19 GINA ANSWER
   CDC, 2020, CDC WEBSITE CORONAVI
   CDC T, 2020, INTERIM INFECT PREVE
   Center for Disease Control and Prevention, 2020, INT CLIN GUID MAN PA
   Centers for Disease Control and Prevention, 2019, NOV COR WUH CHIN INF
   Chen ZM, 2020, WORLD J PEDIATR, V16, P240, DOI 10.1007/s12519-020-00345-5
   David JC, 2020, CORONAVIRUS DIS 2019
   Klein JD, 2020, ARCH DIS CHILD, V105, P620, DOI 10.1136/archdischild-2020-319370
   National Institutes of Health, COVID 19 TREATM GUID
   Tang B, 2020, INFECT DIS MODEL, V5, P248, DOI 10.1016/j.idm.2020.02.001
   Thampi S, 2020, PEDIATR ANESTH, V30, P642, DOI 10.1111/pan.13863
   Wang D, 2020, Zhonghua Er Ke Za Zhi, V58, P269, DOI 10.3760/cma.j.cn112140-20200225-00138
   WHO, 2020, BREASTF ADV COVID 19
   WHO, TIM COV 19
   WHO, DIR GEN OP REM MED B
   World Health Organization, 2020, 26 WHO
   World Health Organization, DIR GEN REM MED BRIE
   World Health Organization, 2020, WHO INT GUID CLIN MA
   Yoon SH, 2020, KOREAN J RADIOL, V21, P494, DOI 10.3348/kjr.2020.0132
   Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P355, DOI 10.1097/INF.0000000000002660
NR 23
TC 4
Z9 4
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1110-6638
EI 2090-9942
J9 EGYPT PEDIATR ASSO
JI EGYPT. PEDIATR. ASSOC. GAZ.
PD AUG 28
PY 2020
VL 68
IS 1
AR 28
DI 10.1186/s43054-020-00037-9
PG 8
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA NK0JR
UT WOS:000566428500001
OA gold
DA 2022-04-20
ER

PT J
AU Waizenegger, L
   McKenna, B
   Cai, WJ
   Bendz, T
AF Waizenegger, Lena
   McKenna, Brad
   Cai, Wenjie
   Bendz, Taino
TI An affordance perspective of team collaboration and enforced working
   from home during COVID-19
SO EUROPEAN JOURNAL OF INFORMATION SYSTEMS
LA English
DT Article
DE Affordance; COVID-19; knowledge workers; qualitative; team
   collaboration; working from home
ID FAMILY CONFLICT; TECHNOLOGY USE; SMARTPHONE USE; SOCIAL MEDIA;
   CONNECTIVITY; EXPERIENCES; TELEWORKERS; STRATEGIES; MANAGEMENT; AUTONOMY
AB COVID-19 has caused unprecedented challenges to our lives. Many governments have forced people to stay at home, leading to a radical shift from on-site to virtual collaboration for many knowledge workers. Existing remote working literature does not provide a thorough explanation of government-enforced working from home situations. Using an affordance lens, this study explores the sudden and enforced issues that COVID-19 has presented, and the technological means knowledge workers use to achieve their team collaboration goals. We interviewed 29 knowledge workers about their experiences of being required to work from home and introduced the term "enforced work from home". This paper contributes to the affordance theory by providing an understanding of the substitution of affordances for team collaboration during COVID-19. The shifting of affordances results in positive and negative effects on team collaboration as various affordances of technology were perceived and actualised to sustain "business as usual".
C1 [Waizenegger, Lena] Auckland Univ Technol, Fac Business & Law, Business Informat Syst, Auckland, New Zealand.
   [McKenna, Brad] Univ East Anglia, Norwich Business Sch, Norwich, Norfolk, England.
   [Cai, Wenjie] Univ Greenwich, Mkt Events & Tourism, London, England.
   [Bendz, Taino] Phone Free Day, Auckland, New Zealand.
RP Waizenegger, L (corresponding author), Auckland Univ Technol, Fac Business & Law, Business Informat Syst, Auckland, New Zealand.
EM lena.waizenegger@aut.ac.nz
OI Waizenegger, Lena/0000-0002-2975-4135; Cai, Wenjie/0000-0002-1505-7240;
   McKenna, Brad/0000-0002-2219-7508
CR Agerfalk PJ, 2020, EUR J INFORM SYST, V29, P203, DOI 10.1080/0960085X.2020.1771968
   Allen TD, 2015, PSYCHOL SCI PUBL INT, V16, P40, DOI 10.1177/1529100615593273
   Ashforth BE, 2000, ACAD MANAGE REV, V25, P472, DOI 10.2307/259305
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Brink H I, 1993, Curationis, V16, P35
   Brynjolfsson E., 2020, W27344 NAT BUR EC RE
   Bygstad B, 2016, J INF TECHNOL, V31, P83, DOI 10.1057/jit.2015.13
   Cai WJ, 2020, J TRAVEL RES, V59, P909, DOI 10.1177/0047287519868314
   Charalampous M, 2019, EUR J WORK ORGAN PSY, V28, P51, DOI 10.1080/1359432X.2018.1541886
   Chemero A, 2003, ECOL PSYCHOL, V15, P181, DOI 10.1207/S15326969ECO1502_5
   Coibion O, 2020, LABOR MARKETS COVID
   Collins M, 2005, NEW TECH WORK EMPLOY, V20, P115, DOI 10.1111/j.1468-005X.2005.00148.x
   Cooper CD, 2002, J ORGAN BEHAV, V23, P511, DOI 10.1002/job.145
   Delanoeije J, 2019, HUM RELAT, V72, P1843, DOI 10.1177/0018726718823071
   Derks D, 2016, HUM RELAT, V69, P1045, DOI 10.1177/0018726715601890
   Dery K, 2014, EUR J INFORM SYST, V23, P558, DOI 10.1057/ejis.2014.13
   Dimitrova D, 2003, NEW TECH WORK EMPLOY, V18, P181, DOI 10.1111/1468-005X.00120
   Engle S., 2020, STAYING HOME MOBILIT, DOI DOI 10.2139/SSRN.3565703
   Faraj S., 2012, MAT ORG SOCIAL INTER, P237, DOI DOI 10.1093/ACPROF:OSO/9780199664054.003.0012
   Fonner KL, 2012, NEW TECH WORK EMPLOY, V27, P242, DOI 10.1111/j.1468-005X.2012.00290.x
   Gajendran RS, 2007, J APPL PSYCHOL, V92, P1524, DOI 10.1037/0021-9010.92.6.1524
   Gao G, 2020, GENDER WORK ORGAN, V27, P754, DOI 10.1111/gwao.12468
   Gaver WW, 1996, ECOL PSYCHOL, V8, P111, DOI 10.1207/s15326969eco0802_2
   Georganas S., 2020, CONVERSATION
   Gibson JJ, 1977, THEORY AFFORDANCES
   Gilstrap C, 2019, TEAM PERFORM MANAG, V25, P84, DOI 10.1108/TPM-02-2018-0014
   Golden TD, 2006, J APPL PSYCHOL, V91, P1340, DOI 10.1037/0021-9010.91.6.1340
   Golden TD, 2012, J BUS PSYCHOL, V27, P255, DOI 10.1007/s10869-011-9247-0
   Gottlieb C., 2020, COVID EC
   Grgecic D, 2015, J ASSOC INF SYST, V16, P580, DOI 10.17705/1jais.00402
   Haeger DL, 2014, TECHNOL FORECAST SOC, V89, P316, DOI 10.1016/j.techfore.2014.08.009
   Hughes R., 2020, BBC NEWS
   Kelliher C, 2010, HUM RELAT, V63, P83, DOI 10.1177/0018726709349199
   Klein HK, 1999, MIS QUART, V23, P67, DOI 10.2307/249410
   Kolb DG, 2012, ORGAN STUD, V33, P267, DOI 10.1177/0170840611431653
   Koslowski NC, 2019, CULT ORGAN, V25, P159, DOI 10.1080/14759551.2017.1349128
   Kossek EE, 2006, J VOCAT BEHAV, V68, P347, DOI 10.1016/j.jvb.2005.07.002
   Kramer A, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103442
   Kreijns K, 2013, EDUC PSYCHOL-US, V48, P229, DOI 10.1080/00461520.2012.750225
   Laato S, 2020, EUR J INFORM SYST, V29, P288, DOI 10.1080/0960085X.2020.1770632
   Lankton NK, 2015, J ASSOC INF SYST, V16, P880, DOI 10.17705/1jais.00411
   Leonardi PM, 2013, MIS QUART, V37, P749, DOI 10.25300/MISQ/2013/37.3.04
   Majchrzak A., 2012, TECHNOLOGY AFFORDANC
   Majchrzak A, 2013, J COMPUT-MEDIAT COMM, V19, P38, DOI 10.1111/jcc4.12030
   Mansour O., 2013, 34 INT C INF SYST, P1
   Marsh K, 2008, GENDER WORK ORGAN, V15, P31, DOI 10.1111/j.1468-0432.2007.00353.x
   Matusik SF, 2011, HUM RELAT, V64, P1001, DOI 10.1177/0018726711405552
   Mazmanian M, 2013, ORGAN SCI, V24, P1337, DOI 10.1287/orsc.1120.0806
   Mazzi A., 1996, P TEL 96 C
   McCarthy A., 2020, REMOTE WORKING COVID
   McGrath L, 2016, COMPUT HUM BEHAV, V63, P717, DOI 10.1016/j.chb.2016.05.086
   McKenna B, 2020, INFORM SYST J, V30, P185, DOI 10.1111/isj.12256
   McKibbin W., 2020, 192020 CAMA AUSTR NA
   Mulki JP, 2011, INT J HUM RESOUR MAN, V22, P902, DOI 10.1080/09585192.2011.555133
   Mysirlaki S, 2020, LEADERSHIP ORG DEV J, V41, P551, DOI 10.1108/LODJ-01-2019-0035
   Naidoo R, 2020, EUR J INFORM SYST, V29, P306, DOI 10.1080/0960085X.2020.1771222
   Nash M, 2020, GENDER WORK ORGAN, V27, P833, DOI 10.1111/gwao.12484
   Nayyar G., 2020, FACE TO FACE INTERAC
   Oksa R, 2021, NEW MEDIA SOC, V23, P2303, DOI 10.1177/1461444820921938
   Rice Daniel J, 2007, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V16, P567, DOI 10.1007/s10606-007-9070-3
   Richter A, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102157
   Rysavy MDT, 2020, J LIBR ADM, V60, P532, DOI 10.1080/01930826.2020.1760569
   Satava R, 2020, ANN LAPAROSC ENDOSC, V5, DOI 10.21037/ales.2020.02.04
   Savic D., 2020, GREY J TGJ, V16, P101
   Sewell G, 2015, ORGAN STUD, V36, P1507, DOI 10.1177/0170840615593587
   Sheehy N., 2008, INTRO WORK ORG PSYCH
   Sonnentag S, 2008, J APPL PSYCHOL, V93, P674, DOI 10.1037/0021-9010.93.3.674
   Strong DM, 2014, J ASSOC INF SYST, V15, P53
   Suh A, 2017, INTERNET RES, V27, P140, DOI 10.1108/IntR-06-2015-0181
   Surawski B, 2019, MANAG-POL, V23, P105, DOI 10.2478/manment-2019-0007
   Tietze S, 2011, HUM RESOUR MANAG J, V21, P318, DOI 10.1111/j.1748-8583.2010.00137.x
   Treem J. W., 2013, COMMUN YB, V36, P143, DOI DOI 10.1080/23808985.2013.11679130
   Unsworth K, 2020, HUM RELAT, V73, P1036, DOI 10.1177/0018726720926457
   Usher K, 2020, J CLIN NURS, V29, P2756, DOI 10.1111/jocn.15290
   van Dijk S, 2011, ORGAN STUD, V32, P1485, DOI 10.1177/0170840611421253
   Versey HS, 2015, DEV PSYCHOL, V51, P1672, DOI 10.1037/a0039607
   Volkoff O., 2013, MIS Q, V37, P3
   von Gaudecker H. -M., 2020, LABOUR SUPPLY EARLY
   Walker PGT, 2020, GLOBAL IMPACT COVID, P1, DOI [10.25561/77735., DOI 10.25561/77735]
   Zammuto RF, 2007, ORGAN SCI, V18, P749, DOI 10.1287/orsc.1070.0307
   Zhang S. X., 2020, PSYCHIAT RES
   Zheng YQ, 2016, INFORM SYST J, V26, P289, DOI 10.1111/isj.12096
NR 82
TC 85
Z9 85
U1 65
U2 135
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0960-085X
EI 1476-9344
J9 EUR J INFORM SYST
JI Eur. J. Inform. Syst.
PD JUL 3
PY 2020
VL 29
IS 4
SI SI
BP 429
EP 442
DI 10.1080/0960085X.2020.1800417
EA AUG 2020
PG 14
WC Computer Science, Information Systems; Information Science & Library
   Science; Management
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science; Information Science & Library Science; Business &
   Economics
GA OB2ZX
UT WOS:000559646500001
OA Bronze, Green Accepted
DA 2022-04-20
ER

PT J
AU Yin, JM
   Yin, J
   Tian, ZW
   Li, PQ
   Chen, XQ
AF Yin, Jinmei
   Yin, Jun
   Tian, Zhiwu
   Li, Peiqiu
   Chen, Xiaoqiu
TI Integrated management is effective in the prevention and control of
   COVID-19 in the blood purification center: joint efforts from multiple
   departments
SO RENAL REPLACEMENT THERAPY
LA English
DT Article
DE COVID-19; Multi-department integrated management; Blood Purification
   Center; Prevention and control
AB Background During the outbreak of new coronavirus pneumonia, many hospitals in China became the designated hospitals for the treatment of new coronavirus pneumonia. The goal was to develop rapid and effective prevention and control methods for blood purification centers. Research design and methods The medical department, hospital department, nursing department, and blood purification center jointly set up a multi-department integrated COVID-19 prevention and control management team to manage the blood purification center. The efforts included the establishment of the continuous renal replacement therapy (CRRT) team for COVID-19, the integrated training and assessment of medical personnel, the integrated education of patients and their families, and the integrated management of the workflow of the hemodialysis room. Results No infected persons, including medical staff, patients, and their families, have been found in the dialysis center. After multi-departmental integrated training, the theoretical performance of medical staff in our dialysis center has increased from 82.36 +/- 8.10 to 95.29 +/- 4.95 (p < 0.05), and the unqualified rate dropped from 23.21 to 1.78% (p < 0.05). In addition, the three operational skills evaluation scores have also been significantly improved, from 86.00 +/- 4.02, 88.01 +/- 6.20, 92.01 +/- 2.46 to 95.90 +/- 0.30, 97.21 +/- 0.87, 96.00 +/- 1.00 (p < 0.01), and the passing rate from 80.36 to 100% (p < 0.05). Conclusion Medical staff's knowledge of novel coronavirus pneumonia prevention and control can be improved by multi-sectoral integrated management, and CRRT treatment of COVID-19 patients is effective.
C1 [Yin, Jinmei; Tian, Zhiwu; Li, Peiqiu; Chen, Xiaoqiu] Sun Yat Sen Univ, Blood Purificat Ctr, Affiliated Hosp 5, Zhuhai, Peoples R China.
   [Yin, Jun] Sun Yat Sen Univ, Blood Purificat Ctr, Affiliated Hosp 3, Guangzhou, Peoples R China.
RP Chen, XQ (corresponding author), Sun Yat Sen Univ, Blood Purificat Ctr, Affiliated Hosp 5, Zhuhai, Peoples R China.
EM 1614410877@qq.com
CR China National Kidney Disease Medical Quality Control Center, 2020, EXP ADV PREV CONTR N
   Chinese Centers for Disease Control and Prevention, 2020, REP EP CHAR NOV COR
   Expert Panel for Consensus on Clinical Application of Blood Purification in Emergency Medicine, 2017, CHINESE J EMERGENCY, V26, P24
   Guangdong Provincial Blood Purification Quality Control Center, 2020, REC PREV NOV COR PNE
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   National Health Commission of the People's Republic of China, 2020, NOV COR PNEUM DIAGN, V6th
   National Health Commission of the People's Republic of China, 2020, PREV CONTR 2019 NOV
   National Health Committee of the People's Republic of China, 2020, TECHNICAL GUIDELINES, V1
   Sisi K., 2019, CHIN J SOC MED, V36, P643
   Vieillard-Baron A, 2016, INTENS CARE MED, V42, P739, DOI 10.1007/s00134-016-4326-3
   Wang W., 2014, MED REV, V20, P3743
   Wu A., 2019, CHINESE GEN PRACTICE, V22, P2176
NR 12
TC 0
Z9 0
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-1381
J9 RENAL REPLACE THER
JI Renal Replace. Ther.
PD APR 12
PY 2021
VL 7
IS 1
AR 19
DI 10.1186/s41100-021-00334-y
PG 5
WC Urology & Nephrology
WE Emerging Sources Citation Index (ESCI)
SC Urology & Nephrology
GA WE2UI
UT WOS:000705479800001
PM 33868717
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Girma, S
   Alenko, A
   Agenagnew, L
AF Girma, Shimelis
   Alenko, Arefayne
   Agenagnew, Liyew
TI Knowledge and Precautionary Behavioral Practice Toward COVID-19 Among
   Health Professionals Working in Public University Hospitals in Ethiopia:
   A Web-Based Survey
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; knowledge; precautionary health behavior; Ethiopia
AB Background: The novel coronavirus disease, COVID-19, causes massive death, threatens the life and health of the world population. Thousands of health professionals were died and tested positive.
   Objective: This study was designed to determine knowledge and precautionary behavior practice for coronavirus disease-19 among health professionals working in public university hospitals in Ethiopia.
   Methods: A web-based online survey was conducted on health professionals working in Ethiopian public university hospitals. A survey questionnaire consisted of socio-demographic, coronavirus disease knowledge questions and precautionary behavioral practice. The survey questions were designed using Google form. All health professionals working (academic and clinical staff) in university hospitals were invited to participate in the online survey carried out from May 1 to 14, 2020. The data were analyzed using the Statistical Package for Social Sciences version 24.0. Descriptive statistics were computed, and tables and figures were used to present the results. Linear regression analysis was used to identify knowledge-related factors independently associated with precautionary behavior practice.
   Results: A total of 273 health professionals participated in this study. The mean (+/- SD) age of participants was 31.03 +/- 5.11. Two-third (61.5%) and one-fourth (26%) of participants attended second degree and medical doctors, respectively. More than one-fourth of the study participants (27.5%) reported social media as the source of information. In this study, we found a significant gap between the level of knowledge and practical implementation of the recommended precautionary measures, especially for wearing masks and gloves. The final multiple linear regression analysis indicated a positive association between knowledge of the source of infection, incubation period, and mode of disease transmission with recommended behavioral practice.
   Conclusion and Recommendation: There was a significant gap in the implementation of the behavioral practice, especially for wearing masks and gloves. Therefore, there is a need to motivate and monitor health professionals' adherence to recommended precautionary measures.
C1 [Girma, Shimelis; Alenko, Arefayne] Jimma Univ, Inst Hlth, Dept Psychiat, Jimma, Ethiopia.
   [Agenagnew, Liyew] Jimma Univ, Dept Psychiat, Jimma, Ethiopia.
RP Girma, S (corresponding author), Jimma Univ, Inst Hlth, Dept Psychiat, Jimma, Ethiopia.
EM shimelisgirma@gmail.com
RI Alenko, Arefayne/ABB-4332-2020
OI Girma, Shimelis/0000-0001-6946-4020
CR [Anonymous], NEWS CORONAVIRUS PAN
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x
   Committee(IASC) I-AS, 2020, IASC INT BRIEF NOT A
   Heung Y Y Jenny, 2005, Nurse Educ Today, V25, P112, DOI 10.1016/j.nedt.2004.11.003
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Market for Eastern and Southern Africa, 2020, COVID 19 PAND ITS PO
   Memish ZA, 2013, NEW ENGL J MED, V369, P884, DOI 10.1056/NEJMc1308698
   WHO, 2020, COVID 19 OP GUID MAI
   WHO, COR DIS COVID 19 TEC
   World Health Organization (WHO), COR DIS COVID 19 ADV
   World Health Organization (WHO), 2020, RISK COMM COMM ENG R
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
   Wu A, 2020, CHIN J INFECT CONTRO, V19, P1
   Zhan SY, 2020, EMERG MICROBES INFEC, V9, P534, DOI 10.1080/22221751.2020.1732232
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 16
TC 10
Z9 10
U1 0
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 1327
EP 1334
DI 10.2147/RMHP.S267261
PG 8
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA NF1MU
UT WOS:000563067100001
PM 32922101
OA gold, Green Published
DA 2022-04-20
ER

EF
